Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 73.6"	"Low region specificity"	"Detected in all"							"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	18.8	42.2	7.5	7.5	11.4	5.2	16.2	10.9	8.6	13.8	15.8	9.5	16.9	10.1	18.0	9.5	12.4	13.4	11.8	35.0	7.5	6.4	12.8	15.5	11.8	3.5	13.0	6.8	14.3	18.1	6.9	11.1	7.9	9.9	12.6	8.3	10.0	16.7	14.5	155.8	13.0	13.6	21.0	15.3	7.4	14.2	14.4	13.1	6.5	14.1	15.7	5.0	14.4	17.0	8.1	13.2	43.3	11.9	13.7	18.0	6.4	7.8	6.4	10.0	7.1	29.3	20.4	2.7	13.0	8.9	11.8	14.8	73.6	11.9	5.3	12.7	21.8	11.7	4.4	15.0	8.7	14.1	12.2	12.1	5.1	11.1	13.5	14.4	2.8	4.6	27.1	6.0	12.4	6.6	11.0	35.0	7.1	5.8	8.6	24.9	9.2	6.0	11.4	4.7	22.0	11.0	5.8	17.2	5.1	15.6	4.7	3.5	13.4	16.5	7.2	9.2	15.6	11.1	5.7	36.4	12.5	6.8	23.6	4.3	9.3	14.5	9.7	4.8	4.7	6.9	43.3	11.9	12.3	6.1	6.6	7.8	7.0	11.9	10.0	12.7	8.1	10.4	7.8	6.9	13.7	6.4	13.2	18.0	6.4	7.5	11.4	10.9	8.6	7.5	6.4	13.0	6.8	9.9	13.1	77.4	23.1	12.7	70.3	57.1	10.1	103.7	63.7	44.2	25.0	75.0	3.9	21.7	122.7	56.1	47.2	50.1	92.1	0.0	64.0	37.5	60.8	57.8	40.4	94.8	39.9	11.1	21.8	93.9	31.4	27.5	63.3	28.7	79.2	82.0	49.3	57.0	62.2	98.2	60.5	133.6	12.6	45.3	59.7	89.5	53.2	88.1	13.2	17.5	57.2	63.6
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 137.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.8	33.7	7.3	14.7	9.9	11.5	13.5	13.4	9.8	15.3	13.6	23.1	14.6	37.7	17.1	11.6	24.6	18.4	27.7	15.4	20.7	19.1	20.7	17.5	13.3	16.1	12.1	28.1	14.9	10.1	27.7	19.7	17.6	13.6	11.0	18.4	24.2	11.3	13.2	15.2	30.9	21.3	9.3	12.0	12.9	20.0	22.1	20.2	12.7	18.4	15.9	6.9	19.7	8.1	18.0	16.8	14.1	14.5	12.3	11.8	20.0	25.0	42.0	12.8	18.2	28.4	14.7	21.0	20.8	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0											20.8	28.8	32.8	36.7	38.8	12.4	16.1	28.1	36.1	40.9	24.4	21.6	62.0	8.3	31.9	21.4	24.3	32.8	23.3	41.6	49.6	22.2	22.9	46.2	13.9	41.7	17.5	15.4	8.6	24.5	50.0	21.9	36.5	27.0	64.9	22.6	26.9	40.2	25.9	21.9	36.9	22.5	32.3	37.3	47.2	30.2	38.3	137.1	42.4	29.3	33.1
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.0;U-87 MG: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.7	2.2	0.0	6.5	2.5	2.0	2.8	10.9	0.9	1.0	0.4	0.4	3.8	3.1	2.8	10.7	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.5	11.8	0.0	6.7	17.0	0.7	11.1	0.2	10.6	1.0	0.3	0.0	9.8	0.2	0.3	2.3	5.2	3.1	0.5	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	4.5	0.0	1.9	1.0	3.0	0.2	3.9	3.1	3.8	1.8	2.3	39.0	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0	98.3	9.4	5.1	4.8	26.4	11.9	7.8	12.7	2.7	9.1	10.4	45.2	21.2	0.0	3.8	1.5	9.3	3.2	0.0	1.4	4.6	28.8	3.1	46.1	162.2	63.2	0.0	8.7	25.2	103.3	0.7	28.7	31.4	25.3	2.8	2.4	0.1	4.9	3.5	26.5	17.0	5.5	45.3	16.4	1.2	0.7	16.9	7.4	4.4	2.3	8.9
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 382.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1.0	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0.0	0.0	12.9	0.0	1.0	2.0	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0.0	2.1	5.2	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382.0	0.0	0.4	0.6	16.5	5.1	2.5	4.0	17.0	17.4	11.8	0.0	0.0	4.6	7.7	4.2	0.2	0.0	3.3	0.0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0.0	3.2	1.5	9.5	6.5	3.1	1.9	14.0	1.4	0.0	2.5	0.6	0.1
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Leydig cells: 465.4;Muller glia cells: 138.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	16.6	37.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.1	0.0	0.0	27.9	0.0	0.4	0.0	0.2	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7	47.6	0.6	0.0	1.3	5.4	1.4	12.5	0.0	0.0	7.9	0.0	2.0	0.1	0.0	0.0	4.2	4.2	0.0	0.0	0.0	0.1	35.3	0.3	1.1	35.8	0.9	4.8	0.0	7.4	1.9	4.3	465.4	1.8	1.7	0.0	0.0	138.5	0.0	0.0	66.1	0.0	2.1	38.8	6.2	1.1	1.2	4.1	0.2	0.0	0.0	0.2
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell type enhanced"	"Detected in many"	14	"Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 38.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.6	0.9	3.8	1.5	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	38.6	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.1	0.5	0.1	0.2	4.9	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2											26.8	26.9	3.6	0.7	0.1	0.3	2.4	20.4	18.7	9.1	8.7	0.0	0.0	38.1	1.6	0.2	0.6	19.1	0.0	7.1	0.0	1.0	1.6	1.1	56.7	1.1	0.0	2.9	1.8	4.1	0.4	1.4	1.5	1.7	1.0	13.4	1.3	2.9	3.5	5.3	117.8	0.7	0.0	0.5	0.1	0.2	0.6	0.0	0.0	13.3	0.4
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797401-21942529	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	21.6	4.7	5.5	2.6	5.4	1.2	25.8	1.5	8.6	12.4	6.8	4.8	5.1	3.0	15.3	6.3	9.1	9.5	9.6	26.2	5.7	2.6	5.6	31.1	6.2	2.7	2.9	4.2	11.8	5.8	1.7	2.7	2.8	5.5	7.0	1.6	10.8	4.8	8.4	33.2	3.3	4.1	17.1	4.9	3.5	9.1	3.4	4.2	0.1	6.3	14.5	1.2	9.5	8.4	1.6	0.9	1.8	0.8	0.5	0.9	0.0	0.6	0.1	7.5	0.2	17.6	8.0	0.2	4.1	10.1	4.5	2.3	16.0	0.7	0.3	0.8	0.4	0.5	0.2	0.0	0.0	4.7	0.2	0.1	0.3	0.5	0.2	0.0	0.3	0.4	21.0	0.0	4.5	1.7	0.3	0.0	0.3	0.2	0.9	0.2	0.9	0.2	0.2	1.0	0.8	0.4	0.3	0.2	0.2	0.0	0.8	0.3	1.2	0.2	0.4	0.1	1.2	0.8	0.2	0.2	17.5	1.3	1.5	5.3	0.8	0.8	0.3	4.3	0.2	0.3	0.9	0.5	0.4	0.9	0.4	0.6	0.7	0.7	0.7	0.2	1.6	0.6	0.8	1.8	0.5	0.8	0.9	0.4	0.0	5.5	5.4	1.5	8.6	5.7	2.6	2.9	4.2	5.5	4.2	32.8	47.6	0.0	1.0	3.1	0.4	27.8	0.0	36.1	39.8	0.0	0.0	0.2	0.0	0.0	0.2	4.9	0.0	0.0	0.2	0.1	10.6	0.4	22.1	84.7	0.1	1.6	0.0	11.1	3.3	0.0	0.3	2.1	10.1	0.0	0.0	13.1	0.1	0.0	0.4	0.0	1.1	129.4	47.2	0.5	0.7	1.9	0.2	0.0	0.0	1.4
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567137	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	22.6	3.5	4.9	6.0	3.2	5.4	21.6	2.9	4.1	3.8	8.8	4.2	4.4	8.5	4.2	3.1	4.1	4.3	7.8	6.6	2.1	1.9	8.4	21.2	5.6	12.7	2.7	3.9	2.8	10.9	8.8	8.5	3.2	4.3	4.0	5.0	3.6	4.5	4.6	2.1	3.4	12.7	5.5	3.3	9.1	6.3	1.4	4.6	1.6	5.2	2.7	6.0	5.6	9.1	2.0	17.0	11.1	0.4	7.2	5.0	0.7	3.8	15.0	1.9	5.3	20.6	9.0	7.9	5.3	5.9	5.3	4.9	3.4	2.0	5.7	3.9	5.7	9.4	10.6	6.6	2.3	2.9	17.7	5.0	2.3	7.4	4.3	6.3	5.9	10.7	6.7	6.2	5.1	0.9	3.9	3.8	3.4	3.0	5.5	2.8	5.2	5.6	6.9	0.4	13.0	4.5	13.1	7.3	13.2	9.5	5.9	1.3	2.2	8.0	3.6	2.0	2.1	9.1	13.7	4.7	3.1	3.9	7.7	4.6	9.3	6.2	3.0	6.1	3.7	6.5	11.1	0.4	1.8	1.9	0.2	5.0	1.0	1.0	1.7	1.0	2.0	0.3	1.0	0.5	7.2	0.2	17.0	0.9	0.7	4.9	3.2	2.9	4.1	2.1	1.9	2.7	3.9	4.3	4.6	3.0	5.5	5.6	1.1	1.1	0.0	2.0	5.1	5.3	4.5	7.0	0.0	0.9	0.0	2.8	0.2	1.4	8.3	0.0	6.6	1.0	3.8	1.2	2.3	25.3	6.6	1.6	6.9	3.7	6.7	0.2	4.4	8.2	5.0	3.6	6.3	0.9	4.8	0.0	4.2	5.4	0.7	0.0	2.0	0.5	0.4	2.0	0.2	14.4	6.3	1.1
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2"	P08910	15	89087459-89202360	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 303.3;Hepatocytes: 272.0;Late spermatids: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 29.0;neutrophil: 22.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Cell line enriched"	"Detected in all"	4	"HEL: 85.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	13.2	24.8	14.8	9.5	19.3	15.6	11.7	25.2	23.4	10.7	16.1	12.0	6.5	23.4	18.2	34.7	9.0	12.1	32.2	24.5	12.2	11.3	11.8	76.4	22.2	11.2	11.1	14.8	13.1	28.3	11.2	18.1	5.6	19.8	22.9	9.6	22.6	11.8	10.0	19.3	7.5	18.5	11.4	8.3	14.2	35.8	42.9	7.6	7.7	8.6	8.1	12.1	13.5	10.4	1.1	3.0	29.0	7.0	4.7	3.5	2.5	8.1	15.8	3.9	4.2	7.7	10.4	2.1	5.5	16.5	5.3	5.0	3.9	14.2	2.3	6.4	6.9	14.6	10.9	8.6	6.7	7.5	12.2	3.8	85.1	3.7	3.0	3.9	5.8	20.0	5.3	4.8	18.8	12.1	8.7	6.4	5.3	7.5	7.3	14.5	3.4	3.6	1.4	1.7	19.2	4.7	5.2	8.2	17.7	7.1	12.9	6.7	10.1	10.5	4.9	8.8	3.7	5.5	4.6	9.8	18.6	6.3	6.7	13.8	6.0	11.9	2.8	15.2	5.4	14.4	3.1	5.6	29.0	1.6	4.8	0.9	1.1	1.5	1.5	3.0	1.1	1.4	1.5	22.7	4.7	7.0	2.4	3.5	2.5	14.8	19.3	25.2	23.4	12.2	11.3	11.1	14.8	19.8	7.6	89.3	113.5	3.0	42.1	16.6	23.6	42.1	163.1	95.0	100.1	40.1	17.7	3.6	1.7	43.2	303.3	25.9	52.7	23.3	74.0	6.2	25.7	185.3	57.9	272.0	39.6	19.1	46.9	22.7	53.9	360.0	30.5	37.9	55.6	12.6	45.6	51.3	79.4	31.3	56.3	11.3	14.4	77.6	50.5	77.4	9.8	15.3	2.2	22.5	31.7	70.1
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.4;U-266/70: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: AB_2683638"	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	5.4	14.7	24.7	6.0	23.6	6.4	3.7	20.3	34.0	4.6	5.4	4.1	6.1	4.6	5.9	3.7	3.9	6.2	5.4	6.8	22.0	17.5	6.1	12.4	7.3	6.5	12.3	17.1	9.3	11.0	11.4	9.1	8.9	9.0	7.9	1.6	8.5	12.6	11.6	11.4	6.8	3.6	4.6	4.6	7.7	6.5	19.6	6.9	4.8	6.6	3.2	3.8	4.8	4.6	1.3	6.0	5.6	4.8	3.2	3.6	1.7	11.4	3.3	1.7	6.7	2.2	0.7	18.1	2.3	3.2	2.5	3.3	2.9	7.9	0.8	3.2	1.8	4.0	1.6	1.6	4.0	0.5	13.5	11.1	3.7	5.0	4.9	7.3	0.2	5.3	2.1	2.5	4.3	0.5	4.0	1.9	6.6	3.3	6.6	1.0	0.6	4.5	0.6	3.2	1.9	28.4	6.8	5.3	3.3	2.2	1.1	2.1	11.3	5.2	1.7	7.2	1.5	7.2	6.6	1.1	2.4	5.2	12.0	4.1	21.7	16.3	4.1	8.0	4.5	2.1	0.1	4.8	5.6	2.5	3.7	1.7	0.7	3.6	2.1	6.0	1.3	2.9	2.6	3.0	3.2	4.0	2.9	2.5	1.7	24.7	23.6	20.3	34.0	22.0	17.5	12.3	17.1	9.0	6.9	0.0	2.2	3.0	4.6	3.4	51.4	1.8	7.6	0.0	3.4	7.0	17.7	15.8	6.6	12.4	114.8	3.6	0.5	0.0	7.5	7.4	7.3	5.2	4.6	12.5	19.9	68.3	6.9	1.8	7.6	221.4	11.5	6.0	1.7	26.2	3.1	27.9	7.4	2.9	24.1	7.8	30.3	6.5	3.5	18.4	1.4	3.6	20.7	3.8	1.4	2.8
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.2	16.1	17.2	20.8	25.3	30.9	6.3	12.7	19.9	14.9	12.6	12.6	9.4	11.9	7.3	16.8	15.3	14.0	8.7	11.7	11.0	7.4	5.4	7.8	27.4	10.7	17.3	11.9	10.9	22.5	12.9	26.6	16.5	20.8	20.6	15.4	43.5	9.5	18.1	13.7	15.1	9.8	19.1	11.3	11.9	17.5	22.3	12.8	15.1	8.5	16.1	20.1	21.3	8.3	10.2	10.5	16.2	11.0	23.6	57.2	14.8	21.8	19.9	2.9	6.8	15.9	23.5	9.9	18.1	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2	8.9	9.9	4.2	6.4	8.1	6.2	5.8	12.7	5.3	5.7	14.0	11.8	11.3	1.7	12.6	3.1	14.3	15.4	0.0	9.5	3.5	27.8	8.1	2.3	13.4	13.7	9.5	21.2	20.3	13.7	7.4	25.9	6.5	5.0	3.6	15.7	15.7	14.3	20.3	24.1	8.4	9.7	19.4	21.0	11.9	13.6	5.9	12.7	7.9	19.1	6.4
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 32.3;TIME: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.1	5.6	3.7	2.5	3.2	7.4	2.3	11.3	9.3	13.9	10.1	4.1	3.1	5.9	8.4	8.0	9.6	5.1	5.4	3.8	19.8	3.7	4.9	2.8	5.1	2.0	5.9	3.1	0.9	6.8	5.0	19.8	32.3	6.0	15.4	3.0	6.7	1.7	18.1	2.7	2.5	1.7	3.6	2.0	1.8	3.7	6.3	2.9	4.7	1.6	2.3	5.2	9.4	3.0	23.2	5.9	2.7	2.6	30.1	14.5	10.8	6.9	18.1	3.1	3.9	6.1	6.8	1.8	13.9	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6	20.8	26.6	12.4	33.8	41.7	36.0	7.0	17.8	6.7	10.3	10.4	157.1	7.7	10.0	12.7	14.0	46.7	9.7	0.0	11.9	6.7	36.0	32.7	16.2	14.5	21.0	23.8	25.9	33.7	32.7	21.4	14.1	36.5	65.8	12.6	9.6	9.8	30.1	14.4	12.7	8.4	34.1	6.5	29.3	18.2	26.3	33.5	8.7	10.1	13.9	20.7
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0;skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Intestinal endocrine cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	4.0	3.8	8.2	1.9	19.1	0.8	2.1	4.0	26.0	1.4	2.1	2.3	0.0	1.1	1.2	1.3	10.5	1.4	1.7	5.7	3.4	5.1	2.5	1.2	1.8	1.4	2.8	7.6	1.1	3.3	2.4	6.1	1.2	9.9	1.8	2.1	1.3	2.6	1.2	71.8	3.8	1.8	2.1	1.8	14.8	1.8	1.5	4.0	0.0	2.4	1.9	2.3	1.5	1.7	0.7	0.5	0.0	0.2	0.0	3.0	0.2	1.0	0.0	0.2	1.5	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.3	2.9	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.6	1.9	0.1	0.0	1.2	2.7	0.9	0.1	1.0	0.6	0.2	0.0	13.2	1.0	5.8	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	3.0	0.0	2.5	0.0	0.5	0.7	1.2	0.9	0.0	0.0	0.2	0.0	1.2	0.2	8.2	19.1	4.0	26.0	3.4	5.1	2.8	7.6	9.9	4.0	0.0	1.4	0.0	0.1	2.3	5.1	3.6	0.0	2.7	0.0	3.5	0.0	0.0	0.0	3.0	1.7	2.7	7.5	0.0	3.8	0.5	0.4	0.3	2.3	0.4	0.1	11.1	10.3	1.3	0.3	4.2	0.0	0.0	0.0	0.0	3.0	2.7	3.4	4.5	3.5	0.3	2.9	6.5	4.2	0.0	1.5	5.5	0.0	0.0	5.2	0.1
ABR	MDB	ENSG00000159842	"Active BCR-related"	Q12979	17	1003518-1229021	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 8.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	12.9	5.8	31.8	18.0	28.7	6.0	5.8	7.0	43.6	6.6	19.9	12.0	2.3	9.4	7.9	4.0	11.0	6.1	6.7	26.6	24.0	16.9	6.8	4.0	9.3	6.9	14.1	27.0	3.9	5.0	8.3	6.0	7.2	11.3	4.6	21.6	19.4	23.7	3.4	2.9	5.9	11.9	25.1	8.1	8.1	13.6	3.8	11.3	2.9	7.0	2.3	18.0	7.2	7.4	0.3	0.7	8.9	0.8	0.0	0.8	0.0	0.5	0.6	0.2	0.0	0.9	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.0	18.8	0.3	0.1	0.8	0.0	2.0	0.0	0.4	5.8	10.2	0.0	0.2	0.0	0.4	2.3	6.7	0.2	0.0	0.1	6.7	20.2	0.0	0.0	0.0	0.0	12.6	0.7	0.0	2.5	0.1	0.4	0.1	0.1	0.0	10.8	0.1	0.2	0.2	0.3	0.0	0.0	1.0	0.0	5.9	2.9	20.9	0.1	0.2	2.1	21.0	0.0	0.2	15.4	1.0	4.1	0.4	8.9	0.3	1.0	0.2	0.8	0.4	0.1	0.3	0.0	0.7	0.3	0.0	0.3	0.9	0.0	0.4	0.0	0.8	0.0	31.8	28.7	7.0	43.6	24.0	16.9	14.1	27.0	11.3	11.3	29.8	21.1	7.8	15.2	15.1	60.3	21.8	25.5	10.7	17.0	1.8	2.0	1.9	0.0	15.6	33.8	21.5	39.3	0.0	5.5	2.5	13.4	17.6	18.5	0.8	27.7	11.1	14.5	18.4	24.0	112.5	12.7	28.3	18.6	18.0	35.9	29.4	29.8	25.9	8.9	5.8	18.0	38.8	21.7	1.9	7.5	14.8	1.8	13.8	49.9	22.6
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028682-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 308.6;Proximal tubular cells: 337.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 77.9;U-937: 75.7"	"Low region specificity"	"Detected in all"							HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7400000	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	12.2	4.2	12.0	25.5	10.1	23.1	22.1	1.8	19.0	6.5	28.4	2.4	10.6	22.6	10.3	43.8	23.5	6.0	10.9	7.9	15.1	7.1	29.0	26.8	14.0	39.0	5.5	10.3	5.1	9.5	10.3	9.3	12.9	4.8	8.2	26.9	4.3	19.9	9.7	2.3	12.8	35.5	7.1	5.1	45.6	13.7	20.1	5.0	60.2	13.2	19.2	26.0	23.0	9.0	17.1	37.2	30.5	82.9	24.6	48.8	51.8	11.2	6.0	15.5	14.4	6.2	9.7	17.0	9.0	6.4	6.8	14.0	13.4	13.2	0.0	16.4	8.8	29.4	17.1	13.6	19.4	7.9	29.9	25.1	43.9	3.4	4.6	9.0	73.2	20.2	8.7	16.4	9.1	7.5	12.3	35.5	31.0	5.5	15.4	19.4	23.6	45.6	77.9	18.5	17.6	11.8	29.5	9.5	3.5	18.2	33.4	34.7	3.8	6.1	17.2	28.0	22.9	6.8	55.0	26.4	4.3	3.7	9.0	15.9	8.4	23.8	3.0	5.5	75.7	12.8	30.5	31.7	18.9	29.8	55.8	46.1	15.3	48.8	38.1	33.8	17.1	47.7	44.3	8.6	24.6	82.9	37.2	43.5	51.8	12.0	10.1	1.8	19.0	15.1	7.1	5.5	10.3	4.8	5.0	17.9	26.9	128.7	58.7	124.0	0.2	2.8	30.6	20.1	22.7	41.8	0.0	69.4	51.4	124.4	2.6	35.9	215.0	0.0	127.3	176.9	29.2	47.3	79.5	178.9	308.6	0.0	41.3	49.1	193.8	9.4	4.4	118.3	82.7	71.3	101.8	34.9	147.3	167.5	12.0	337.1	1.3	32.3	17.4	1.4	2.1	78.7	40.6	137.1	116.5	103.7
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150988-34358008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 31.6"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 16.2;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"eosinophil: 8.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	3.1	13.7	4.8	2.7	6.7	3.2	2.2	5.0	5.8	8.0	8.5	10.6	18.2	11.7	7.4	6.3	4.4	4.1	3.2	13.0	4.7	3.9	8.4	8.0	2.9	2.7	9.0	1.5	2.8	2.2	0.3	2.8	8.1	15.8	4.5	3.6	7.5	8.7	31.6	19.4	5.6	20.2	3.6	20.2	1.2	3.0	3.1	7.7	6.4	2.1	3.5	2.8	3.4	5.0	0.0	2.8	8.1	0.4	0.0	0.1	0.1	4.0	12.0	4.9	1.3	1.3	0.1	4.9	2.4	1.9	2.1	4.1	2.9	3.0	0.1	4.1	3.0	12.7	7.8	2.7	2.7	1.7	0.1	6.6	0.0	7.1	12.7	0.7	6.4	0.9	0.7	1.5	4.2	1.8	7.8	0.0	0.5	1.3	0.3	1.3	10.1	0.2	7.8	6.1	6.0	6.6	1.2	2.9	4.5	7.6	9.7	6.2	5.1	6.0	18.7	4.7	3.4	4.0	2.8	0.6	2.4	0.4	7.4	4.3	0.7	0.3	0.1	5.5	1.8	7.3	0.0	0.1	8.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.1	0.1	4.8	6.7	5.0	5.6	4.7	3.9	9.0	1.5	15.8	7.7	0.0	2.9	0.8	2.3	4.1	2.8	7.4	5.1	0.0	0.0	12.2	0.0	1.9	5.0	4.5	0.8	0.6	10.3	0.0	3.9	0.9	5.5	5.8	1.1	5.7	0.7	0.0	6.9	0.0	1.0	0.0	1.1	0.8	1.7	16.2	1.6	6.2	7.3	0.8	5.6	1.1	0.3	0.0	3.3	0.5	0.6	4.3	23.7	0.0	1.3	6.0
AC004593.3		ENSG00000285162	"Beta-chimaerin isoform 3 "		7	29122340-29514667	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.3;brain: 16.3"	"Group enriched"	"Detected in some"	11	"Collecting duct cells: 1.8;Early spermatids: 1.0;granulocytes: 1.1;Hepatocytes: 2.4;Late spermatids: 1.1"									"Group enriched"	"Detected in some"	34	"classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	59	"dendritic cells: 6.3;monocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;GAMG: 3.3;HaCaT: 3.5;HEL: 2.5;U-266/84: 4.1"									HPA019026			Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA019026: "																		0.1	0.3	0.1	0.2	0.1	0.2	0.1	16.3	0.1	0.1	0.2	0.1	0.1	2.6	0.4	0.1	0.1	0.0	0.4	1.2	0.1		0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.5	1.9	2.9	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	6.3	0.1	6.2	0.0	0.0	2.2	0.0	0.2	0.7	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	1.5	0.0	2.7	0.0	3.3	3.5	0.1	0.0	0.0	0.1	1.2	2.5	0.8	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	1.2	0.0	1.6	1.3	0.7	0.0	0.2	0.0	0.3	0.6	0.2	0.1	0.8	1.2	0.9	1.6	0.4	0.1	0.7	0.6	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.0	1.7	0.0	6.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	2.5	0.1	0.0	2.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004754.1		ENSG00000269881			16	249547-269943	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"intestine: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9"									"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-2)"	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.3	0.6	0.6	0.2			15.3	0.3	0.3	0.1	0.2	0.0	0.9	0.4	1.4	0.3	0.1	0.0	0.0	0.7		0.1	1.7	0.0	0.2	0.0		0.2	0.0		0.0	0.3	1.0	0.1	7.4	0.2	0.7	0.0	0.1	0.9			0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.4	1.8	2.4	2.4	0.5	0.0	1.2	0.0	0.1	0.3	0.1	0.0	5.1	1.1	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	1.0	0.0	0.2	1.0	2.9	0.7	0.1	0.0	0.3	0.0	2.1	0.0	0.2	1.2	0.6	0.0	1.3	0.0	0.0	0.9	0.0	0.3	1.0	0.0	0.0	0.4	0.2	1.0	0.6	0.0	0.4	0.0	1.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.8	0.0	0.5	1.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.7	3.7	5.7	11.9	3.3	3.8	6.8	4.3	3.8	6.0	7.7	6.4	8.7	5.0	4.9	5.0	7.1	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.6	8.5	2.6	5.0	7.9	2.3	7.3	6.4	6.8	1.8	4.1	8.5	6.5	11.9	5.0	7.1	7.1	7.3	4.5	1.6	2.2	4.9	5.4	7.9	5.0	6.0	7.7	5.8	3.8	3.5	10.8	3.9	4.2	4.5	3.1	5.7	7.5	4.4	6.8	7.5	13.8	11.2	4.2	6.2	5.2	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
AC008758.5		ENSG00000268870			19	12391949-12441082	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 7.6;RT4: 6.1"									"HPA003150, HPA018683"	Uncertain		Uncertain	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"																		2.1	1.3	1.3	4.3	1.4	1.4	3.3	6.5	2.3	3.3	3.6	0.2	10.8	1.2	2.7	1.4	1.7	0.8	1.5	1.1	1.4	0.7	4.9	3.0	1.7	3.1	1.5	0.7	1.4	2.3	0.3	1.3	3.0	1.8	2.9	2.5	0.1	3.5	6.2	1.9	1.8	4.0	1.0	2.3	1.6	1.3	1.6	1.4	8.4	2.0	1.1	1.2	3.4	4.4	2.5	1.6	0.6	0.4	1.1	2.6	1.2	1.6	0.0	1.1	2.4	0.2	0.0	3.7	1.2	0.0	0.3	0.0	1.5	0.1	1.1	3.7	1.0	1.0	0.0	0.0	0.9	0.0	0.0	0.7	3.6	0.0	2.3	0.0	2.0	3.9	0.0	1.6	1.9	0.0	0.0	1.4	1.7	1.5	0.0	0.0	0.2	1.8	0.6	1.9	3.5	0.0	0.9	7.6	0.0	0.0	6.1	0.0	1.1	0.1	0.7	0.0	2.9	3.5	2.6	0.6	0.4	0.4	3.0	0.3	0.0	1.0	2.0	0.8	0.2	1.1	0.0	0.4	0.6	1.7	0.2	2.6	2.5	2.2	1.9	1.6	1.7	2.5	0.1	0.3	1.1	0.1	0.3	2.2	1.2	1.3	1.4	6.5	2.3	1.4	0.7	1.5	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010487.3		ENSG00000283088			19	52880663-52962768	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 22.4"									HPA062474			Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"HPA062474: AB_2732685"																		2.4	0.1	1.7	3.3	3.5	1.1	2.9	1.6	2.6	4.5	2.5	1.5	5.7	2.2	4.7	4.4	3.5	4.1	4.3	2.2	1.7		4.1	0.3	2.8	2.3	4.6	0.8	5.6	1.6	9.7	5.3	4.9	2.3	7.3	3.0	1.5	2.9	4.3	1.1	0.0	2.9	3.3	3.9	4.9	1.9	1.9	3.8	9.1	4.5	2.1	2.6	6.2	4.1	1.0	2.2	2.8	2.2	4.6	2.6	1.4	2.0	0.0	3.7	3.9	0.2	0.0	2.2	2.0	1.7	1.9	3.2	1.3	0.5	2.4	1.5	1.2	1.9	0.3	0.0	0.8	1.2	0.0	0.5	1.5	3.4	0.0	2.1	0.0	1.8	0.7	0.0	2.1	0.8	1.7	2.3	0.9	1.9	0.0	2.3	0.0	2.5	0.0	3.9	0.0	2.3	2.0	2.5	1.5	0.3	22.4	1.8	4.7	0.0	0.7	0.0	6.1	2.2	0.1	1.3	1.0	1.8	0.2	1.9	1.5	6.5	1.6	0.0	0.0	2.2	2.8	0.7	0.8	1.9	1.6	2.0	0.5	1.4	1.1	1.8	1.0	2.6	0.8	0.3	4.6	2.2	2.2	0.9	1.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC023509.3		ENSG00000267281			12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 3.0;Club cells: 3.4;Collecting duct cells: 1.8;granulocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	4.5	2.4	3.9	2.0	6.0	4.5	4.6	14.9	5.2	3.3	2.7	7.8	2.1	1.4	4.5	1.8	3.2	3.6	3.8	3.7	4.4	2.8	2.4	3.8	7.0	3.6	6.8	2.3	5.1	3.5	1.4	3.6	2.9	5.1	3.3	3.5	3.1	3.0	4.3	4.5	3.4	2.4	5.7	4.7	2.9	3.1	4.7	6.6	1.9	2.4	1.7	4.1	5.9	2.5	0.7	1.4	2.9	2.2	0.2	2.5	0.5	0.6	4.5	0.0	0.5	1.8	2.3	0.0	0.0	1.5	1.6	0.3	0.5	0.7	1.7	0.4	0.0	0.0	1.4	0.3	1.2	1.3	1.8	0.9	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.5	0.9	0.0	0.0	2.0	1.9	0.0	1.8	0.0	0.0	0.0	0.2	0.8	0.2	0.7	0.3	0.0	0.5	0.0	0.2	0.0	1.4	0.0	0.0	0.3	1.3	2.3	1.8	0.0	0.6	0.6	0.0	0.3	0.0	0.6	1.5	0.8	0.9	0.0	2.9	1.7	0.5	2.5	2.2	0.5	0.2	0.2	0.4	0.9	0.7	0.0	0.4	2.4	0.2	0.0	1.4	0.3	0.5	3.9	6.0	14.9	5.2	4.4	2.8	6.8	2.3	5.1	6.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.8	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC073610.3		ENSG00000272822			12	48903503-48957365	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;hTERT-RPE1: 8.0"									HPA068942			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA068942: AB_2732124"	"unprognostic (7.48e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.01e-12)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.06e-2)"	6.8	3.4	10.5	2.2	20.7	3.6	4.6	7.7	27.5	6.4	4.9	6.3	2.6	2.2	9.7	7.3	5.1	4.7	7.6	7.2	8.8	7.2	5.0	4.1	5.5	5.5	5.7	13.7	6.1	7.4	2.2	5.3	3.3	10.6	5.4	4.6	3.5	4.8	4.5	3.4	4.4	4.2	10.6	4.6	4.7	4.0	8.4	4.3	3.3	5.0	2.3	4.4	4.9	3.9	0.8	1.8	1.1	1.1	1.3	3.2	2.0	1.0	0.4	3.8	2.9	4.1	1.6	0.0	1.6	7.9	2.3	1.0	0.0	1.1	1.1	2.4	1.4	2.5	0.4	1.4	0.0	2.1	5.1	0.6	1.1	0.6	0.0	2.8	0.0	1.1	0.4	2.0	0.6	1.3	8.0	1.0	1.9	0.1	1.4	1.3	0.4	0.2	0.6	0.0	2.1	1.1	2.2	0.6	0.2	0.2	0.3	1.9	0.5	0.9	0.7	0.8	0.7	0.2	0.5	4.3	0.7	0.5	0.2	0.5	2.0	0.3	0.7	1.8	1.1	0.4	0.9	1.1	0.3	2.7	0.4	3.2	0.6	0.9	1.8	0.9	0.8	2.3	2.6	1.1	1.3	0.4	1.8	0.5	2.0	10.5	20.7	7.7	27.5	8.8	7.2	5.7	13.7	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC073896.1		ENSG00000144785			12	56285916-56316059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"Club cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 25.7"									"HPA038466, HPA068007"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA038466: AB_10672646, HPA068007: "	"unprognostic (3.07e-2)"	"unprognostic (9.89e-3)"	"unprognostic (8.23e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.63e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.26e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.93e-1)"	6.4	12.2	6.7	7.8	7.4	4.5	5.4	12.4	13.6	7.2	20.3	7.2	13.3	15.3	6.5	10.9	6.9	5.7	5.9	8.3	5.0	5.5	8.5	18.1	5.3	5.1	6.4	6.6	8.5	20.5	6.9	12.5	13.2	6.6	7.1	4.8	5.6	15.5	10.9	8.6	5.9	8.3	2.9	7.5	10.6	10.0	5.8	6.1	3.4	12.5	4.3	4.6	5.4	4.8	22.5	19.3	7.9	13.2	9.7	12.5	18.8	6.5	3.8	4.9	6.7	3.0	1.9	5.1	9.7	3.1	3.3	1.8	0.8	5.6	3.0	22.7	2.3	2.1	14.4	6.3	1.0	2.0	7.8	4.3	1.0	4.4	2.9	0.2	7.5	11.8	3.4	0.4	2.4	0.2	3.9	4.0	6.4	2.8	3.3	1.6	1.8	4.1	4.1	14.4	1.6	11.3	18.6	7.0	4.8	0.6	1.8	8.5	11.3	2.8	9.6	9.4	1.2	5.1	15.4	0.0	9.0	5.8	5.0	14.3	11.0	25.7	7.7	15.2	6.5	11.1	7.9	7.6	4.1	12.4	13.2	10.0	22.5	7.7	12.5	15.1	19.0	9.0	11.8	1.6	9.7	6.6	19.3	11.4	18.8	6.7	7.4	12.4	8.3	5.0	5.5	6.4	6.6	6.6	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC240274.1		ENSG00000271254			Unmapped	4612-29626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Spermatocytes: 132.8;Spermatogonia: 61.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		1.1	5.4		0.7		0.5	1.0		1.0	1.6	3.1			2.3	2.6	1.7	0.8	2.9	1.4	0.3			2.0	0.4	1.4	0.0			5.4	0.0	7.0		1.8		1.3	3.5		1.0	0.8	0.7	1.1	3.9	2.3		1.2	0.5	6.9			1.3		0.2	0.7		2.1	1.4	2.7	2.1	6.4	3.1	0.9	11.0	14.8	16.7	11.8	5.6	6.2	3.8	16.8	10.2	15.7	13.3	5.3	4.3	8.8	1.3	15.4	5.4	6.3	6.4	3.1	21.3	5.8	13.2	2.4	8.1	7.3	7.6	7.5	5.2	4.0	4.6	8.9	7.2	10.2	4.4	14.5	10.5	3.0	6.1	15.2	9.2	3.2	2.6	1.6	35.8	16.7	10.7	1.2	3.8	6.2	12.5	20.3	16.6	14.0	6.9	5.1	12.6	2.3	5.9	9.7	10.0	24.1	7.5	3.6	12.0	7.4	2.4	11.6	3.4	2.7	1.7	2.7	1.7	2.1	3.1	1.5	1.0	1.1	0.7	2.1	1.8	1.9	2.0	6.4	1.5	1.4	0.1	0.9											20.8	12.3	0.0	1.7	0.0	2.0	0.0	0.0	20.1	7.9	0.0	3.9	7.3	1.7	2.1	15.2	0.1	1.6	0.0	2.3	13.2	0.9	0.8	14.0	2.4	5.8	0.0	0.0	2.5	2.5	4.3	15.5	2.9	0.0	1.8	5.5	2.2	2.2	3.5	17.3	1.5	1.3	6.5	0.0	132.8	61.7	0.0	2.2	0.0	4.5	0.9
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292376-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 148.4;Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	8.7	7.8	16.4	4.2	24.5	10.4	7.3	42.0	23.6	6.4	6.4	11.5	4.3	7.9	5.9	4.2	10.6	3.7	5.1	7.9	19.5	8.7	4.8	4.9	4.7	4.0	13.0	15.4	5.5	8.2	5.1	11.2	4.3	10.4	5.8	3.4	5.6	14.6	7.7	14.2	26.5	7.7	11.8	8.1	6.0	8.0	3.1	12.8	3.1	2.7	4.5	3.5	5.6	6.4	0.9	1.2	1.5	2.0	0.0	1.4	0.7	5.3	6.0	2.8	4.8	7.1	4.9	3.0	13.5	4.4	3.9	3.0	7.6	4.6	5.9	7.0	7.5	3.9	12.3	2.7	3.6	0.9	6.6	12.0	2.5	22.3	14.3	4.9	5.0	6.2	3.4	2.9	3.3	2.1	3.6	1.8	7.0	6.8	8.2	4.4	7.4	10.5	7.2	2.9	7.2	14.0	10.2	6.4	22.7	2.3	2.9	21.4	15.1	8.1	5.0	12.7	2.6	5.4	3.9	5.9	7.3	5.1	5.8	4.7	6.6	4.7	5.1	10.1	13.3	3.1	0.0	1.4	1.5	1.3	2.0	0.0	0.9	1.0	0.6	1.2	0.8	1.4	1.2	0.2	0.0	1.4	1.0	0.5	0.7	16.4	24.5	42.0	22.1	19.5	8.7	13.0	15.4	10.4	12.8	0.0	6.6	10.0	5.2	28.5	148.4	22.4	17.8	2.7	1.2	1.8	98.2	7.4	3.3	8.2	1.9	6.3	12.4	0.0	4.3	6.8	9.1	4.9	0.0	12.1	6.2	50.9	31.0	14.1	19.0	5.8	14.1	8.3	8.5	1.0	11.9	23.8	9.6	9.5	12.4	5.9	208.8	6.5	14.3	4.2	9.5	29.9	8.5	10.2	10.9	8.1
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 168.5;Exocrine glandular cells: 155.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 48.1"					"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.7	6.3	42.7	16.3	6.1	11.3	1.4	5.9	7.1	14.1	24.4	24.5	8.6	5.6	3.0	4.7	48.1	6.5	17.7	46.2	16.7	3.3	18.1	13.1	10.2	40.6	6.1	7.6	3.5	6.1	3.4	23.3	10.0	2.1	6.9	16.0	14.1	9.6	8.5	11.9	13.0	12.1	14.3	6.7	4.6	8.1	9.6	17.4	32.9	8.7	11.4	6.5	6.9	4.5	2.4	2.0	8.5	15.1	4.3	5.2	4.5	7.3	15.2	4.6	8.4	13.8	1.5	14.9	7.8	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2											11.9	35.5	24.6	29.0	23.2	14.0	1.2	40.8	20.1	21.6	19.2	2.0	44.4	59.7	47.3	168.5	10.9	23.5	0.0	155.7	84.2	22.6	31.4	12.7	55.7	46.8	12.7	16.4	12.9	10.5	110.0	12.7	23.1	28.7	92.8	21.4	21.8	47.0	17.5	18.0	33.8	19.6	0.0	34.0	14.7	48.7	18.3	29.4	26.6	23.3	27.6
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	7.5	9.5	8.1	8.5	15.3	3.5	6.7	10.8	10.9	8.6	19.6	4.9	14.4	25.9	9.2	6.8	8.3	10.1	10.7	6.2	8.1	6.8	12.3	43.1	6.3	8.0	6.1	11.1	10.4	14.2	13.6	8.5	5.4	6.3	11.1	5.4	9.9	12.3	13.6	5.4	7.5	29.0	10.3	4.8	8.3	7.3	2.5	6.3	3.9	11.3	4.4	7.3	8.5	7.2	8.8	3.5	5.6	4.3	6.3	7.7	5.4	5.9	11.6	1.5	3.3	2.7	5.2	4.1	2.2	4.7	3.7	7.3	4.5	8.4	6.3	5.8	3.2	2.2	5.7	2.0	3.8	1.5	9.1	4.6	3.1	7.5	8.9	6.1	1.2	8.7	5.1	3.6	1.3	1.9	12.7	3.6	5.9	2.0	10.2	1.8	4.0	4.4	1.6	0.2	6.3	3.2	3.7	0.3	14.0	9.2	3.8	2.5	1.1	1.6	2.4	6.4	0.8	15.6	2.2	1.3	0.9	2.9	1.4	1.4	16.0	4.4	1.9	5.4	1.6	1.6	5.5	3.8	5.6	5.3	4.3	5.7	6.8	6.2	5.9	3.5	8.8	6.7	7.7	1.0	6.3	2.8	2.2	7.1	5.4	8.1	15.3	10.8	10.9	8.1	6.8	6.1	11.1	6.3	6.3	3.0	4.8	2.9	5.7	1.6	14.6	8.0	17.8	1.4	0.0	3.5	21.6	5.5	6.6	5.7	1.3	5.3	10.5	0.0	6.3	1.0	4.3	3.8	8.1	20.8	4.6	11.1	5.8	4.9	1.6	2.7	6.4	1.7	3.3	5.4	5.8	12.3	5.2	10.5	7.1	15.1	15.8	6.5	7.2	0.7	3.8	1.6	5.3	4.4	7.0	1.7
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 143.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	6.5	7.5	7.3	9.7	7.7	9.1	7.1	17.4	8.1	8.0	5.2	6.5	9.6	5.8	8.6	7.6	5.4	6.0	7.1	8.9	6.6		6.8	5.5	6.8	11.2	6.1	7.9	10.5	9.7	6.8	10.5	11.3	5.8	6.8	5.0	6.5	7.2	7.6	9.5	6.3	5.2	7.8	4.0	6.8	6.1	18.2	7.3	8.1	8.1	7.7	7.1	7.6	6.9	11.5	14.5	2.7	13.3	16.4	10.9	7.7	21.2	15.8	13.6	10.0	9.5	16.6	28.5	9.8	19.7	17.1	15.5	22.3	15.6	18.8	20.3	9.6	8.4	15.3	10.0	18.1	10.9	14.2	19.5	14.8	14.3	12.7	24.5	25.3	13.4	15.0	25.9	10.6	16.7	15.0	19.0	15.3	23.2	15.3	13.7	19.3	21.6	23.9	15.0	14.5	7.5	21.8	11.3	35.9	14.5	11.1	21.4	27.4	13.1	22.0	13.1	14.2	23.1	18.9	15.3	12.8	15.4	15.6	21.1	32.4	16.7	42.7	14.0	15.6	15.1	1.9	8.4	2.7	9.3	13.3	10.7	11.5	8.0	7.9	14.5	8.8	10.0	10.9	0.6	16.4	10.0	11.8	7.4	7.7											29.8	24.1	29.2	23.8	18.9	50.3	40.9	17.8	34.8	39.8	15.7	37.3	143.2	34.9	32.0	69.5	28.1	4.2	0.0	36.3	31.1	30.4	19.4	18.6	11.6	38.5	49.3	18.7	20.9	11.1	43.0	47.5	25.5	35.4	34.3	18.7	36.3	29.4	14.0	47.7	38.9	5.8	58.2	26.4	104.2	59.8	19.6	70.6	22.5	24.7	15.2
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 170.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 884.1;Late spermatids: 605.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 11.0;monocytes: 17.6"	"Cell line enhanced"	"Detected in some"		"HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	0.8	0.4	0.3	0.9	0.8	2.5	0.5	1.3	0.6	0.4	1.6	0.6	0.5	2.2	0.4	4.2	0.5	0.6	1.7	1.0	0.6	0.3	0.9	0.7	0.8	3.6	0.4	0.3	0.4	1.5	0.0	0.5	0.4	0.8	0.7	0.4	0.8	0.5	0.1	0.3	0.4	3.3	0.6	0.6	2.3	0.6	170.4	0.3	0.5	3.9	0.3	0.8	0.7	0.5	1.2	11.0	1.6	17.6	0.3	0.1	6.5	0.2	0.1	0.9	2.7	1.0	1.3	1.4	0.0	0.0	0.1	0.1	0.0	1.9	0.3	0.9	0.2	0.1	0.0	0.5	0.0	0.2	0.6	0.0	5.5	0.6	0.0	2.1	0.1	7.3	0.1	3.7	1.0	0.1	0.7	0.6	1.9	3.6	0.0	0.1	0.4	0.2	1.9	1.7	4.5	0.0	0.3	0.1	0.3	0.6	0.1	1.1	0.2	0.0	0.7	1.2	1.4	0.0	2.0	0.8	0.1	0.8	0.6	0.0	16.3	10.7	0.5	0.6	2.0	0.0	0.9	7.7	0.7	0.1	9.8	0.0	0.8	0.0	0.0	11.0	1.2	0.1	0.1	1.6	0.3	17.6	2.8	0.0	6.5	0.3	0.8	1.3	0.6	0.6	0.3	0.4	0.3	0.8	0.3	0.0	2.2	0.0	0.2	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	884.1	0.5	1.2	0.0	0.4	0.2	0.4	0.0	5.8	0.0	9.0	0.0	0.0	2.5	11.7	605.9	7.5	3.9	0.0	0.0	0.9	1.0	0.2	0.9	4.2	0.8	1.5	6.5	0.1	127.7	7.2	0.0	0.1	0.0	0.9	0.1
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 197.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.2	14.0	34.9	18.4	13.4	14.7	27.4	18.7	14.6	34.9	29.6	31.6	22.8	36.2	33.6	17.5	40.6	21.4	30.5	23.0	43.5	35.8	25.4	29.6	15.5	23.9	15.3	36.7	18.6	10.2	23.6	22.5	19.0	11.0	19.8	21.9	23.0	20.7	25.1	31.6	32.1	22.7	31.0	42.0	31.4	30.2	29.2	66.9	27.6	18.7	28.7	20.5	28.8	28.8	28.8	18.2	56.2	30.3	14.9	24.9	21.5	25.5	56.3	13.5	20.1	55.5	13.8	39.1	27.4	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0	20.8	23.9	24.3	37.3	41.9	4.8	6.0	28.1	30.8	23.9	26.2	7.9	42.0	29.9	42.1	15.5	20.7	13.0	0.0	39.2	57.0	28.9	28.3	13.9	14.0	30.6	0.0	29.2	12.3	18.6	11.4	30.0	16.7	28.7	33.3	24.6	16.3	32.2	17.5	28.3	17.9	12.3	25.8	23.6	197.2	97.8	40.1	25.6	19.2	36.2	35.1
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.5	8.1	15.9	13.1	13.1	16.5	11.9	15.5	19.8	21.0	16.8	12.6	8.0	20.0	4.6	21.3	15.5	5.6	11.9	10.7	20.0	8.1	4.9	19.9	12.6	13.4	15.5	21.1	17.9	12.9	11.0	21.7	13.7	16.3	16.2	10.7	8.9	7.0	21.1	7.6	7.0	12.6	14.8	9.5	12.9	9.3	9.9	12.0	15.9	18.4	4.7	13.7	10.1	8.8	8.9	15.7	5.7	11.8	11.0	16.1	10.5	14.7	14.0	19.6	24.9	20.5	11.9	15.5	10.0	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9	3.0	7.7	7.8	6.1	6.9	6.5	17.8	10.2	2.7	4.5	3.5	3.9	10.4	18.3	13.2	35.7	7.7	5.2	0.0	13.7	9.4	7.1	5.7	5.7	4.7	10.2	1.6	10.4	7.4	6.3	71.4	10.0	8.2	5.0	13.6	9.0	7.0	11.6	2.9	9.2	15.9	4.7	0.0	9.2	17.6	15.4	5.6	8.6	12.2	5.7	5.4
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053221-75069483	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		92000	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	8.7	27.4	23.0	13.9	20.4	12.7	16.2	24.0	25.2	10.6	14.9	14.8	14.3	11.3	10.2	26.9	11.6	21.4	7.1	10.8	19.9	30.2	12.2	5.2	10.9	17.6	28.7	19.3	9.1	7.0	8.9	38.2	10.4	24.4	10.0	19.8	9.4	9.7	12.9	22.3	24.4	11.3	11.4	27.5	10.9	14.0	16.7	22.9	8.3	20.2	10.3	19.0	7.5	12.0	10.6	7.6	12.3	6.6	10.0	17.8	5.1	24.8	13.7	19.8	12.1	8.0	9.4	11.0	14.3	5.6	14.6	20.8	13.8	28.1	27.5	8.8	5.9	8.7	22.4	13.0	6.3	23.9	39.9	16.0	17.8	36.1	9.7	4.8	11.2	18.7	5.2	9.1	20.1	10.4	9.4	19.1	26.1	14.0	33.2	19.1	17.0	25.1	20.9	6.0	21.8	13.8	20.2	26.1	12.8	20.5	13.2	36.3	14.7	9.8	6.7	22.2	9.8	14.8	11.1	9.0	10.0	18.5	20.1	15.3	7.9	16.0	28.8	15.3	13.2	10.7	3.9	2.2	12.3	8.6	4.3	9.7	10.0	14.5	9.9	3.8	10.6	12.2	11.3	0.9	10.0	6.6	7.6	17.8	5.1	23.0	20.4	24.0	25.2	19.9	30.2	28.7	19.3	24.4	22.9	6.0	7.8	18.2	36.9	25.4	31.8	17.9	35.7	80.3	19.4	62.8	11.8	19.4	33.2	16.7	18.7	25.1	15.8	70.0	16.2	27.5	20.2	16.2	11.5	4.3	19.1	41.3	28.9	6.7	3.8	7.0	15.5	11.7	37.1	10.0	22.3	16.1	18.0	20.1	15.6	17.3	29.9	25.8	25.8	90.7	15.8	21.0	11.4	22.3	32.3	31.1
ADAM32		ENSG00000197140	"ADAM metallopeptidase domain 32"	Q8TC27	8	39106990-39284911	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 47.0"	"Cell type enhanced"	"Detected in many"	27	"Early spermatids: 134.9;Late spermatids: 35.0;Spermatocytes: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA044156, HPA062151"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044156: AB_10796798, HPA062151: AB_2684699"	"unprognostic (2.13e-1)"	"unprognostic (6.92e-2)"	"unprognostic (4.63e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-7)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.34e-3)"	"unprognostic (7.82e-2)"	0.6	0.6	0.3	0.2	0.4	0.4	0.6	0.3	0.5	0.6	0.3	0.2	0.2	0.0	0.3	0.8	0.2	0.3	0.5	0.4	0.3	0.7	0.2	0.2	0.2	0.2	0.3	0.6	0.5	1.2	0.1	0.2	0.2	0.4	0.3	0.4	0.4	0.2	0.7	0.2	0.8	0.3	0.2	0.2	0.5	0.1	47.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.9	0.2	1.5	0.4	2.6	0.9	0.0	0.7	0.3	0.1	0.4	2.0	0.2	0.2	1.3	0.4	1.2	0.4	0.1	2.6	0.0	0.5	2.4	0.1	0.2	0.5	0.0	1.5	0.1	0.3	0.0	2.2	0.3	0.3	0.2	0.8	2.7	0.2	0.1	0.0	1.9	0.1	0.3	0.2	0.5	1.3	2.8	0.4	0.6	0.0	1.4	0.0	0.2	0.1	0.0	0.1	0.3	1.0	0.4	0.2	0.4	0.0	0.3	1.1	0.0	0.0	2.6	3.8	0.1	1.4	0.0	0.4	0.1	0.9	0.1	0.7	1.5	0.4	0.2	0.7	0.4	0.3	0.9	0.6	0.9	0.1	0.8	0.7	0.8	1.0	2.6	0.4	0.2	0.2	0.0	0.3	0.4	0.3	0.5	0.3	0.7	0.3	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.8	8.0	1.4	0.0	1.4	0.0	1.8	17.7	0.2	0.0	0.2	134.9	1.0	0.0	0.0	1.2	0.1	1.9	1.3	0.0	0.4	0.4	0.0	4.1	0.6	0.0	35.0	2.6	0.0	0.0	0.0	0.7	1.1	2.0	0.0	2.8	0.0	4.2	0.0	0.7	21.9	1.8	0.0	0.1	0.0	1.1	1.0
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.9;HHSteC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.5	2.9	3.1	2.1	3.4	2.1	3.5	6.9	4.4	5.0	0.5	1.0	5.8	10.5	3.8	0.3	3.7	8.9	7.6	0.7	3.3	6.9	27.9	3.3	32.3	4.7	3.4	11.6	3.9	2.4	7.2	2.6	7.2	9.6	1.6	0.4	20.0	2.3	3.1	4.5	4.0	1.6	4.8	0.9	2.4	3.2	1.5	1.0	14.7	3.9	17.1	0.7	5.4	4.3	1.6	3.8	7.6	2.3	2.8	9.2	8.0	3.1	1.4	0.8	2.0	11.1	12.1	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0	0.0	0.6	3.2	2.5	9.8	52.9	17.1	0.0	0.0	2.3	0.0	11.8	0.4	0.0	1.3	2.0	13.5	0.4	0.0	0.4	0.9	11.0	4.9	8.1	5.9	6.1	65.2	0.0	14.7	3.4	1.9	3.4	2.9	5.0	7.2	0.7	34.4	1.0	0.0	5.3	2.2	15.5	0.0	18.6	4.1	11.5	6.4	0.8	6.9	1.2	2.0
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.5	15.6	37.1	19.1	55.0	41.2	13.9	31.5	37.9	32.9	27.9	22.9	23.6	9.7	16.6	54.0	38.6	11.9	27.7	26.5	27.6	12.4	12.7	27.5	13.5	22.0	26.9	16.3	19.6	40.6	24.9	28.9	11.6	34.3	40.9	18.5	28.5	23.6	37.5	10.9	50.2	22.8	20.8	17.1	22.2	22.3	20.6	11.4	24.1	41.3	22.2	28.9	22.8	9.3	19.5	29.4	21.8	15.5	49.4	27.0	13.9	22.1	26.0	19.0	15.4	12.4	26.0	20.3	26.0	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0	65.5	42.1	48.2	25.8	23.9	91.0	71.2	40.8	34.8	51.2	57.6	379.0	29.9	13.3	33.6	44.3	61.8	38.1	0.0	39.8	26.5	52.3	36.5	35.9	41.0	35.3	104.9	55.5	59.5	43.4	29.2	71.9	38.1	33.7	57.7	42.6	228.9	44.9	31.6	114.5	36.3	557.2	97.0	52.0	40.7	36.8	32.0	30.6	55.8	35.2	27.7
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.9"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2	3.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	121.8	14.8	0.0	3.9	0.0	0.0	0.0	236.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.2	2.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.2	3.0	0.0	0.0	0.0	0.0	0.0
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.1"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		600000	"Plasma membrane"	Nucleoplasm	"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	12.7	2.1	2.0	3.2	3.1	0.5	8.9	1.1	3.9	11.2	5.5	2.2	3.9	2.2	13.3	14.0	6.8	8.8	45.6	34.8	1.9	1.5	1.6	5.2	18.6	0.6	4.2	2.2	12.5	11.8	0.3	3.5	26.6	2.4	13.3	2.4	13.0	1.6	2.3	11.6	3.8	6.4	66.1	6.4	1.9	10.2	3.8	2.6	0.0	6.3	7.1	2.1	29.5	30.8	0.2	2.4	0.0	4.9	0.5	0.0	1.2	0.0	0.7	0.0	2.6	0.1	0.0	0.1	5.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.0	6.7	0.0	14.5	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.9	0.0	0.1	0.2	2.2	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.4	0.0	0.5	7.1	1.9	0.1	0.1	1.8	0.9	0.1	0.0	0.0	0.0	4.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.5	3.6	0.0	0.0	1.2	2.0	3.1	1.1	3.9	1.9	1.5	4.2	2.2	2.4	2.6	20.8	29.1	0.0	0.0	0.0	0.0	39.1	0.0	4.0	9.1	1.8	0.0	0.9	0.0	0.0	14.7	1.0	0.0	0.0	0.3	0.6	20.1	0.1	1.1	2.6	2.3	0.0	0.0	3.1	2.4	14.7	12.7	0.7	0.0	1.8	0.0	0.0	0.5	0.0	14.9	0.0	0.7	6.5	0.9	2.6	5.7	0.0	0.8	0.0	0.0	0.3
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	4.6	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	9.7	17.2	8.4	13.1	10.0	21.5	27.1	6.1	32.1	11.6	27.4	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	8.2	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9	62.5	87.9	109.0	118.8	67.5	8.0	255.0	285.3	33.5	56.9	144.8	13.7	343.4	752.7	121.5	6.7	56.4	182.2	46.7	76.6	194.2	104.6	159.8	40.5	1079.9	211.6	7.9	54.8	164.5	143.1	16.8	126.8	60.1	194.0	117.2	123.2	123.6	76.7	181.4	197.7	1041.1	13.1	161.7	119.7	4.6	8.9	67.1	319.0	55.1	135.6	117.6
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968192-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 1712.2;Smooth muscle cells: 2588.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"A-431: 25.7;HaCaT: 66.5;PC-3: 36.3;RT4: 46.2"					"Low region specificity"	"Detected in many"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		123.4	9.5	15.7	21.4	6.1	1.5	109.7	1.6	8.4	44.3	65.3	6.8	21.6	66.2	25.3	34.6	24.3	34.7	29.9	24.8	17.3	6.1	20.3	10.3	32.5	5.4	10.5	9.3	54.7	12.6	7.2	11.7	8.7	7.2	38.6	7.0	23.6	41.5	38.8	30.5	23.7	69.5	19.8	9.6	10.0	12.2	12.5	9.9	1.2	29.7	38.6	8.3	39.5	41.6	0.0	0.3	0.0	0.3	0.0	3.9	0.6	25.7	0.3	0.0	0.0	2.1	12.7	1.8	9.0	9.7	0.0	0.0	0.9	3.3	0.0	0.3	11.0	0.6	66.5	0.0	2.1	0.1	0.9	0.0	0.0	2.7	0.2	1.2	0.0	0.4	0.3	4.1	0.0	5.9	0.9	3.6	0.3	0.1	3.6	0.3	3.2	0.1	0.7	0.1	0.5	36.3	0.1	0.0	0.3	0.4	46.2	1.6	0.1	3.0	13.8	0.1	0.0	17.0	0.3	9.8	0.3	2.1	1.7	0.0	0.5	0.4	0.0	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.3	0.0	3.9	2.8	0.0	0.0	0.0	0.0	0.2	0.6	15.7	6.1	1.6	7.9	17.3	6.1	10.5	9.3	7.2	9.9	1712.2	356.0	16.7	133.5	469.5	4.8	0.0	50.9	125.8	883.8	177.9	2.0	235.3	1145.6	5.7	8.2	494.5	1530.9	23.3	240.4	10.7	324.4	500.6	48.4	93.5	24.0	0.0	28.8	792.4	7.8	23.6	1212.4	52.8	578.6	174.1	95.1	265.3	201.2	1122.8	441.6	716.9	13.2	1448.7	2588.8	2.5	4.4	383.4	139.5	13.1	194.6	684.0
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	14.3	8.5	2.3	10.9	4.6	2.5	14.8	1.2	2.4	7.1	6.2	4.7	14.6	1.9	7.9	6.2	5.0	5.4	6.6	8.4	2.3	2.4	5.1	5.5	17.4	18.9	3.7	2.7	3.6	11.9	8.1	2.8	23.0	4.0	6.3	3.9	6.8	6.5	14.5	19.7	3.1	6.4	8.8	4.7	13.6	5.1	4.1	3.6	5.3	7.4	5.8	12.0	7.1	6.9	8.2	8.0	13.3	13.0	3.4	9.6	4.9	1.6	2.0	0.5	0.0	1.7	1.9	0.0	1.4	0.3	1.2	1.6	0.6	1.3	0.4	0.6	2.1	0.0	0.1	1.4	0.0	1.2	16.0	0.1	11.5	0.2	0.0	2.8	0.0	13.0	2.8	0.0	0.6	0.0	0.5	5.0	0.0	1.0	17.6	7.6	0.5	0.0	2.7	4.8	0.1	4.0	0.0	5.7	0.7	0.7	0.6	0.3	0.0	0.0	0.1	4.3	0.7	3.1	7.2	4.1	0.0	0.8	3.2	0.3	17.2	3.8	0.0	2.1	0.0	3.1	7.8	13.0	13.3	0.6	12.0	0.6	8.2	1.4	1.3	8.0	4.9	0.2	0.6	0.4	3.4	9.2	7.0	9.6	4.9	2.3	4.6	1.2	2.4	2.3	2.4	3.7	2.7	4.0	3.6	8.9	7.5	4.5	0.7	0.7	0.6	4.1	2.5	2.7	4.5	3.5	3.9	4.8	1.7	2.2	0.8	8.4	0.0	0.0	2.9	3.2	1.1	0.9	10.4	1.3	8.4	0.0	0.0	5.5	9.4	0.4	0.3	10.6	1.7	7.2	0.1	0.8	2.4	0.0	2.8	0.8	4.6	0.0	2.9	0.5	0.2	0.6	9.8	1.3	0.0	0.1
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 121.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.7	16.6	8.0	11.8	9.5	19.5	26.5	6.5	12.2	20.2	21.0	10.5	18.9	11.1	27.4	16.6	15.8	18.6	15.3	22.4	10.3	5.3	27.6	15.5	18.4	12.9	9.3	5.5	24.7	19.0	28.6	18.5	121.7	9.5	16.8	14.3	27.0	16.0	25.6	58.8	18.6	16.2	20.3	11.5	13.9	15.0	6.7	10.3	17.0	38.8	21.1	13.9	19.5	26.5	11.3	14.6	21.1	5.4	5.1	8.8	2.8	7.9	7.3	6.1	6.4	10.1	12.1	8.6	8.0	11.8	6.1	9.2	7.7	14.8	9.0	11.0	9.8	7.8	3.6	9.6	12.1	8.5	15.4	3.8	18.8	19.1	6.4	7.8	18.0	14.9	9.8	8.8	10.5	9.3	8.9	22.5	7.6	11.5	25.6	2.6	2.1	16.2	5.2	8.1	13.3	2.6	12.9	3.6	11.5	18.1	7.6	13.9	2.5	12.3	8.1	3.9	13.4	4.8	15.1	11.3	11.4	10.4	6.9	4.4	22.2	12.3	15.6	9.4	20.8	4.1	3.5	5.4	11.7	6.7	4.1	7.4	8.0	8.8	6.6	6.0	11.3	4.7	4.4	21.1	5.1	2.2	14.6	7.5	2.8	8.0	9.5	6.5	12.2	10.3	5.3	9.3	5.5	9.5	10.3	38.7	57.2	25.4	12.5	21.4	44.7	96.4	40.8	40.2	31.8	87.2	212.1	0.9	3.3	11.6	6.6	38.8	30.8	46.7	10.9	3.8	14.6	24.9	23.3	27.7	11.3	17.5	31.0	65.1	43.0	5.4	27.0	25.6	21.9	8.2	40.8	22.0	11.1	31.7	26.9	40.9	150.1	25.8	15.6	3.5	6.4	27.7	27.5	15.2	25.3	14.4
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100142739	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.6"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.7;Horizontal cells: 44.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	16	"B-cells: 27.5;dendritic cells: 12.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;U-698: 35.1"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.2	2.4	6.0	40.2	6.1	10.3	16.6	20.5	9.9	4.2	4.2	1.8	0.8	1.2	8.9	1.7	4.1	4.1	2.3	4.9	6.3	6.2	1.8	2.4	7.6	23.3	5.4	6.8	7.5	1.1	0.3	5.2	6.9	4.4	18.9	2.3	5.5	6.6	3.3	1.0	1.0	5.9	8.6	6.6	43.6	4.8	6.0	2.5	34.7	1.7	0.7	42.0	7.4	2.7	27.5	12.8	0.2	0.2	0.9	1.2	0.4	0.1	0.0	10.0	3.5	0.0	0.4	0.0	1.4	0.3	3.0	1.0	0.0	0.0	23.7	0.1	1.5	7.6	0.1	0.2	0.0	1.8	6.0	2.9	0.0	0.1	0.0	0.2	0.1	6.8	0.6	0.0	6.2	0.1	7.7	0.0	1.3	0.1	0.0	0.0	0.1	1.9	0.3	1.3	0.0	1.6	3.2	0.0	0.1	0.0	0.0	9.9	3.5	0.1	0.1	6.4	1.3	11.9	10.9	3.9	9.5	2.6	0.3	1.5	0.2	0.0	35.1	8.8	0.8	0.8	0.2	0.2	0.0	0.0	0.2	0.2	16.2	0.1	0.0	2.9	27.5	1.2	0.0	0.1	0.9	0.2	12.8	0.0	0.4	6.0	6.1	20.5	9.9	6.3	6.2	5.4	6.8	4.4	2.5	6.0	29.7	79.7	0.4	1.5	15.0	9.6	0.0	0.0	6.8	0.0	11.8	0.2	0.0	0.0	25.7	1.2	0.0	0.0	0.0	0.1	4.7	14.7	0.0	0.8	1.4	44.5	22.0	0.6	7.0	28.0	10.0	12.9	13.5	0.0	0.3	8.9	0.0	0.0	19.8	0.8	1.4	0.0	6.9	5.1	7.0	1.1	0.1	2.2	0.0	0.1
AFF4	"AF5Q31, MCEF"	ENSG00000072364	"AF4/FMR2 family member 4"	Q9UHB7	5	132875379-132963634	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023690, HPA029634"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA023690: AB_1844633, HPA029634: AB_2673129"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.69e-1)"	22.9	29.6	22.8	19.1	38.7	38.3	23.6	37.8	25.6	26.2	21.8	25.2	22.1	14.6	27.6	19.5	29.8	20.8	26.8	21.3	18.7	18.7	25.7	24.2	24.8	19.6	19.0	19.7	34.0	24.9	48.8	40.1	20.4	18.3	26.7	18.5	27.5	25.2	25.1	32.1	22.2	17.8	24.4	18.8	17.3	24.8	17.6	24.4	26.6	33.9	15.7	19.2	26.3	24.7	8.7	5.2	12.2	4.9	3.8	5.5	1.5	16.8	13.6	18.7	20.7	14.4	17.5	14.7	18.2	19.6	16.8	21.5	20.0	11.1	8.5	21.7	23.8	20.4	8.4	15.0	22.5	28.2	6.1	9.7	10.6	18.5	7.1	18.5	3.7	11.0	20.4	15.1	29.1	29.6	18.1	16.1	7.8	7.5	7.3	20.9	6.4	10.2	3.9	7.2	5.0	5.5	6.8	18.3	3.2	14.6	23.7	14.6	15.4	20.7	5.1	20.6	27.0	10.7	6.0	22.6	20.2	17.2	17.8	19.3	10.1	17.2	7.8	19.0	6.9	13.8	12.2	2.4	3.8	5.5	2.0	4.1	7.7	5.1	3.7	2.9	8.7	5.3	4.6	5.2	3.8	4.9	5.2	2.5	1.5	22.8	38.7	37.8	25.6	18.7	18.7	19.0	19.7	18.3	24.4	74.5	31.6	45.5	71.7	70.7	71.8	55.7	68.8	48.2	73.9	55.8	149.2	32.2	6.6	46.4	222.1	55.8	54.9	0.0	40.0	37.0	72.8	98.0	41.6	20.2	36.3	74.7	93.7	57.1	46.7	140.8	64.2	53.7	65.8	30.7	46.2	72.9	61.9	60.4	63.3	26.2	136.3	77.6	56.1	34.9	20.1	75.7	58.5	51.1	37.9	92.8
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.7	4.3	8.3	4.9	2.2	3.3	1.7	2.1	3.0	2.4	2.2	2.5	1.8	1.6	2.2	2.3	5.2	1.9	4.1	3.4	2.7	73.5	5.1	3.9	4.8	2.0	1.3	2.8	5.0	3.0	4.4	1.9	3.0	4.1	4.8	3.2	1.7	9.3	3.1	2.5	4.2	3.7	4.1	2.7	3.0	2.8	2.2	4.4	4.9	3.6	3.8	2.4	4.9	2.1	2.9	7.2	2.0	2.1	2.7	2.1	1.2	5.5	2.2	3.9	4.4	2.2	5.4	3.1	3.2	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6	56.6	75.8	3.4	4.5	13.9	9.4	4.5	17.8	5.3	19.4	5.2	5.9	8.4	10.0	3.6	61.0	3.9	114.1	0.0	4.9	2.2	3.1	6.2	5.7	4.9	3.9	4.8	8.7	4.3	8.3	20.3	3.7	5.1	23.6	7.2	29.7	87.7	4.5	30.8	6.3	15.7	5.0	6.5	1.2	4.6	2.4	8.5	12.7	3.2	32.7	13.9
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.6"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 140.0;granulocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	23.1	12.2	2.5	13.2	3.5	19.8	19.1	1.6	3.5	14.6	14.0	5.7	8.7	8.5	11.9	10.1	14.2	11.2	22.2	14.8	3.2	2.2	7.3	23.9	26.4	20.0	6.5	2.5	21.3	6.8	4.5	3.8	69.6	3.7	21.4	8.9	10.9	11.1	8.5	5.2	16.6	13.7	12.1	4.8	15.6	13.3	6.8	4.0	7.1	12.4	7.9	12.3	26.7	26.6	1.1	9.3	5.6	7.6	3.1	2.9	2.0	3.0	2.5	1.0	0.0	7.7	5.3	0.4	6.3	9.1	2.9	4.3	3.0	6.8	0.0	1.9	9.2	11.6	8.4	0.6	5.7	7.7	0.1	1.4	1.8	3.2	2.7	14.3	3.0	4.5	7.2	28.0	11.1	29.2	13.3	9.7	0.0	0.2	0.0	13.2	1.5	0.0	4.8	0.8	23.0	4.0	0.0	0.0	0.1	9.3	24.0	0.9	0.0	4.7	5.1	4.6	7.7	3.6	1.0	1.6	1.2	0.0	15.9	0.0	1.3	0.0	0.0	20.4	11.7	20.0	0.7	7.6	5.6	0.7	3.6	1.1	0.8	2.6	1.4	9.3	1.1	1.5	1.1	0.8	3.1	1.3	2.2	2.9	2.0	2.5	3.5	1.6	3.5	3.2	2.2	6.5	2.5	3.7	4.0	140.0	72.8	9.4	40.0	66.9	34.6	12.9	43.3	42.8	75.1	7.0	7.9	3.1	0.0	15.8	4.8	55.4	13.6	0.0	13.4	1.2	31.0	42.7	130.4	40.0	24.3	41.3	5.2	44.2	75.1	2.4	3.4	73.2	67.4	36.9	10.6	0.5	24.6	16.9	2.5	5.6	5.7	6.5	41.1	2.4	2.3	78.0	18.0	7.5	12.6	90.1
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	304176-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 44.3"	"Group enriched"	"Detected in some"	8	"Early spermatids: 233.3;Late spermatids: 118.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.8;HMC-1: 35.8;NB-4: 43.1;WM-115: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021483			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	0.8	0.4	1.0	4.6	0.8	0.2	2.4	0.4	1.4	2.4	1.2	0.7	1.4	0.7	1.6	0.9	1.4	0.5	4.4	0.3	1.2	1.0	0.6	0.4	6.2	0.4	0.3	0.0	2.1	1.0	0.1	1.3	2.1	0.9	0.6	1.2	2.7	0.9	0.3	0.6	5.8	1.7	0.9	0.3	4.7	0.7	44.3	0.3	0.1	0.9	1.8	4.2	2.0	3.6	0.9	2.3	1.0	0.5	0.0	1.0	0.3	0.1	4.0	0.6	0.5	2.2	4.6	4.7	8.5	11.5	4.8	9.5	0.1	3.2	0.3	4.4	15.4	1.3	0.2	0.7	0.2	2.1	0.6	1.7	4.0	23.8	0.1	1.6	1.2	35.8	0.9	0.3	3.3	0.4	6.4	1.7	1.0	0.6	0.3	5.1	0.3	0.3	43.1	0.1	1.0	4.0	0.6	0.2	0.4	0.1	0.0	5.6	0.2	11.3	2.1	5.8	0.1	0.2	14.7	2.1	8.9	1.1	10.0	0.3	1.3	2.1	0.3	3.8	0.3	25.2	0.0	0.5	1.0	0.3	0.0	0.1	0.2	0.6	0.3	0.0	0.9	0.1	0.1	0.5	0.0	0.1	2.3	1.0	0.3	1.0	0.8	0.4	1.4	1.2	1.0	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	233.3	1.0	0.0	0.0	0.2	4.3	3.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	3.1	2.2	18.6	10.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	6.5	1.4	21.3	7.0	1.3	0.7	0.0	0.0	0.1
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 123.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.1;OE19: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.1	0.1	1.4	0.4	0.3	2.9	0.1	0.5	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.3	1.1	0.0	0.3	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.8	0.1	0.1	0.1	0.0	123.7	2.3	0.1	0.1	2.4	0.1	0.1	0.1	1.0	0.2	3.3	0.1	0.2	0.4	0.1	0.2	0.1	0.1	1.0	1.1	2.2	0.7	1.1	0.6	0.0	0.1	1.5	0.5	0.1	0.1	0.0	0.4	0.0	0.3	0.1	0.5	0.1	0.1	0.3	0.1	0.0	0.1	4.1	0.1	0.2	0.2	0.2	0.3	0.4	1.7	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.4	0.2	0.1	0.8	7.6	1.3	0.1	0.0	0.0	0.1	1.0	0.2	0.2	0.9	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.2	0.4	0.3	0.3	0.1	0.1	0.6	0.5	0.2	0.9	0.7	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.3	1.0	0.3	0.4	2.2	1.1	0.5	1.1	0.4	0.0	1.4	0.3	0.5	0.5	0.6	0.5	0.5	0.1	0.1	0.1	3.0	0.6	0.0	1.0	0.7	109.4	0.6	0.0	0.0	2.3	0.0	388.8	0.1	0.0	0.0	7.5	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	62.0	0.0	2.5	0.0	1.0	0.0	0.3	1.7	0.0	0.0	135.1	0.1	0.0	0.4	0.0	1307.2	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	2.0
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971174-22982642	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 55.0"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 42.2;Sertoli cells: 32.3;Suprabasal keratinocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.9;hTCEpi: 52.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	2.9	2.0	1.1	2.4	1.8	0.0	4.1	1.1	1.6	11.1	2.0	1.6	4.9	0.5	8.8	4.4	12.3	4.7	7.9	3.2	2.3	0.6	15.6	55.0	8.5	2.2	1.5	1.3	8.2	5.6	5.5	1.4	12.5	2.6	9.2	1.1	7.1	5.5	11.0	1.5	31.3	1.7	4.3	0.5	2.9	2.6	4.1	1.3	7.1	15.4	5.3	6.6	3.7	10.0	1.3	1.0	2.6	1.2	2.9	2.5	0.6	10.4	12.4	16.6	6.4	1.6	2.9	13.3	10.3	13.6	24.2	21.7	26.4	10.9	0.2	10.8	21.2	16.7	34.0	12.7	49.9	29.6	1.0	1.1	0.8	20.1	29.7	19.0	1.1	0.7	9.3	52.3	10.1	39.0	17.2	9.2	1.9	0.4	0.6	22.3	8.4	1.0	1.2	1.0	19.6	17.1	2.8	13.8	0.2	24.2	16.3	0.0	1.4	31.1	9.2	2.0	14.1	12.8	1.0	8.2	10.5	21.2	1.7	9.8	0.1	0.3	0.1	1.6	0.9	4.7	2.2	1.2	0.5	1.4	0.5	0.5	0.4	1.2	2.5	0.4	1.3	1.5	0.9	2.6	2.9	0.8	1.0	0.2	0.6	1.1	1.8	1.1	1.6	2.3	0.6	1.5	1.3	2.6	1.3	17.9	5.4	0.0	12.1	42.2	0.0	4.0	15.3	4.0	9.1	7.0	0.0	8.2	5.0	13.1	4.3	5.0	0.0	0.0	12.9	9.4	5.4	3.4	0.0	14.0	1.5	0.0	0.0	1.8	0.0	3.8	3.4	0.7	3.3	0.0	0.3	7.7	24.1	0.0	0.7	17.8	0.0	32.3	12.7	6.0	2.5	43.3	3.3	0.0	0.9	4.3
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991223-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 1447.5;Late spermatids: 943.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	30.2	20.8	28.3	21.1	29.4	43.1	16.8	17.6	30.3	16.2	23.3	35.0	20.4	15.9	20.6	29.5	19.8	19.5	28.6	40.8	30.1	34.0	29.2	35.0	19.8	25.5	32.1	21.0	17.0	18.2	25.9	34.5	19.5	31.3	25.5	25.0	20.3	18.2	25.7	20.7	12.0	19.2	28.2	41.8	20.5	24.3	68.0	23.6	25.6	24.5	11.2	27.1	22.6	22.4	14.8	22.7	43.1	15.8	29.3	28.6	20.1	16.4	7.7	33.2	27.0	16.2	19.3	23.5	19.4	20.4	19.6	20.1	19.6	13.8	13.1	18.1	18.4	14.1	11.6	32.0	17.4	31.7	19.5	16.0	38.8	11.7	24.9	21.5	36.8	21.3	19.8	22.8	25.5	21.1	17.6	18.1	17.2	26.3	13.1	24.5	6.7	15.6	15.9	69.9	12.5	12.9	25.0	24.1	13.0	21.8	20.3	22.9	15.7	21.5	11.4	42.0	54.3	10.6	19.1	16.0	12.0	19.5	13.0	19.6	19.0	24.4	28.1	20.7	21.9	20.4	12.2	15.8	33.2	14.6	13.5	22.4	14.8	24.1	22.6	22.7	13.0	28.6	18.3	43.1	29.3	15.0	17.1	21.7	20.1	28.3	29.4	17.6	30.3	30.1	34.0	32.1	21.0	31.3	23.6	59.6	44.0	57.9	73.6	122.5	43.4	42.7	28.1	25.4	40.9	36.6	45.2	66.3	79.6	41.6	1447.5	35.9	34.6	46.7	35.5	58.5	56.4	57.9	47.3	31.4	40.1	52.4	90.8	28.8	40.3	943.7	40.9	47.8	40.5	101.0	32.3	47.2	39.9	31.7	42.8	28.4	42.1	51.8	47.4	71.1	89.7	121.1	140.1	47.3	28.1	70.7
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 32.0;MOLT-4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.8	1.5	8.0	1.6	1.9	1.5	1.2	2.7	1.6	17.5	1.6	1.4	2.8	3.4	1.2	0.4	0.5	32.0	0.7	1.8	0.7	1.8	15.4	16.9	19.2	2.6	2.8	1.3	1.4	2.2	2.7	15.8	1.7	21.2	0.6	2.5	30.4	22.0	6.9	3.4	1.8	18.9	0.3	4.0	14.6	0.8	0.9	1.7	0.4	1.4	4.7	2.4	4.0	9.3	4.4	0.8	1.7	0.3	1.4	4.4	4.9	14.8	1.0	8.6	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8	11.9	28.1	43.3	5.9	4.6	25.8	3.1	0.0	29.4	12.5	22.7	139.4	7.7	0.0	3.4	16.1	6.3	6.7	0.0	7.0	5.7	8.0	6.2	31.3	8.5	16.0	4.8	12.2	13.5	41.0	20.2	13.6	31.2	5.0	26.2	19.5	6.5	5.0	10.5	6.3	0.9	137.4	0.0	10.8	0.6	0.7	3.0	2.9	94.4	12.9	7.5
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Group enriched"	"Detected in some"	41	"Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	96.2	0.4	0.0	0.0	1.3	1.9	85.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.1
AKR1E2	"AKR1CL2, AKRDC1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"testis: 35.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 126.7;Late spermatids: 125.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 11.3;RT4: 9.4;U-2197: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	3.3	1.6	1.8	3.2	2.6	2.4	4.2	1.4	2.5	2.6	2.3	0.7	3.4	1.8	5.0	1.7	1.9	1.4	5.0	2.7	1.5	1.5	1.8	1.1	4.4	2.8	1.4	2.1	1.5	2.7	3.7	1.2	2.6	1.9	1.7	1.7	5.0	1.9	2.6	2.3	2.0	1.7	2.9	2.1	1.5	2.1	35.0	0.9	0.8	4.5	2.0	0.6	1.7	2.9	0.1	1.8	3.2	0.4	0.0	1.4	0.3	0.4	5.1	2.0	0.9	0.0	0.0	0.1	2.0	0.1	0.1	0.0	8.0	0.8	0.0	0.0	5.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	1.0	5.5	1.0	0.0	0.0	5.9	11.3	4.5	0.0	0.0	4.8	0.6	0.0	2.1	7.2	3.8	0.0	0.0	0.0	1.4	9.4	0.0	4.4	7.5	2.1	4.0	2.2	4.0	2.2	3.5	0.0	1.8	17.8	0.0	2.4	0.0	0.0	0.1	0.0	1.4	3.2	0.4	0.3	0.1	0.2	0.0	0.1	0.4	0.2	1.6	0.0	1.4	0.4	0.1	0.0	0.0	1.8	0.0	0.3	1.8	2.6	1.4	2.5	1.5	1.5	1.4	2.1	1.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	126.7	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.1	1.6	0.0	1.8	0.6	125.1	2.6	0.5	3.3	1.0	0.0	0.3	0.1	0.0	1.4	0.3	1.1	0.0	0.9	23.0	4.7	0.1	0.0	0.0	0.0	0.1
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Cell line enhanced"	"Detected in all"		"MCF7: 115.3"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.4	30.8	25.5	37.9	19.7	20.5	28.5	28.4	34.6	42.0	33.7	20.2	18.7	18.7	21.9	38.9	21.4	20.1	18.0	26.4	18.3	42.6	7.3	14.1	18.4	21.7	21.9	23.0	36.9	29.3	22.3	21.0	14.0	20.2	31.4	18.4	12.3	20.8	26.9	115.3	28.9	29.4	6.6	30.3	22.1	27.3	23.6	12.7	19.4	38.4	29.3	24.3	23.7	31.0	17.8	11.9	40.6	34.3	25.0	28.2	13.5	40.1	28.5	22.6	10.9	16.1	23.8	19.5	33.9	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8	14.9	24.3	13.4	13.8	11.0	24.3	13.8	40.8	5.3	11.4	21.0	11.8	15.1	11.6	21.0	1.2	19.6	22.2	0.0	30.3	25.7	18.8	34.2	2.3	38.4	20.2	39.7	28.8	24.5	23.7	3.1	26.4	18.1	10.1	17.2	36.1	35.8	43.4	17.3	29.0	13.9	24.0	25.8	11.8	0.9	5.1	12.2	19.6	18.1	26.9	30.8
AL139260.3		ENSG00000274944			1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.3;testis: 15.5"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.2	0.0	0.4	1.3	0.9	0.0	0.4	0.4	1.0	0.4	3.3	0.6	0.4	2.0	0.4	0.4	3.0	0.0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	7.3	2.8	4.0	0.0	1.7	0.0	12.4	1.3	3.3	0.0	0.6	0.0	3.6	0.4	0.0	0.0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0.0	0.9	0.0	7.9	2.1	2.8	2.5	2.2	0.0	17.0	5.0	0.0	0.0	1.6	1.1	1.5	2.0	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8.0	12.6	0.0	7.0	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0.0	1.3	0.2	0.5	1.9	1.1	3.0	0.2	0.5	4.2	2.0	0.4	0.4	2.8	0.0	4.0	7.3	1.7	0.0											0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		24000	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.1	1.6	0.8	0.5	0.2	1.4	0.4	0.5	0.1	1.0	0.5	0.7	0.4	0.6	0.0	0.4	1.1	1.1	0.1	0.9	1.2	5.6	3.7	3.9	5.3	0.6	1.5	2.0	1.6	1.8	0.4	0.9	1.2	0.4	1.8	5.4	2.2	0.2	0.1	1.8	2.4	0.3	0.4	1.1	0.1	0.5	0.5	6.4	0.8	1.7	0.6	0.3	0.1	1.3	0.5	0.9	0.3	0.4	0.8	3.2	1.3	1.5	5.6	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3	3.0	1.1	2.2	0.2	0.0	1.8	0.3	2.5	0.0	1.2	29.6	0.0	0.2	16.6	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	0.0	129.5	0.1	3.2	0.0	3.1	1.3	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.0	94.1	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.2	3.3	2.8	2.5	2.2	3.8	2.5	3.8	4.1	3.9	3.3	3.9	1.8	2.7	4.0	4.7	4.7	3.6	3.2	3.6	4.7	5.7	5.5	1.5	3.6	5.9	3.6	3.6	1.0	4.1	3.7	2.9	2.9	3.2	3.3	3.6	2.9	3.6	3.7	2.5	3.8	2.3	1.7	5.2	4.8	2.4	5.7	2.9	4.4	3.0	2.5	3.2	2.1	7.2	6.3	2.2	3.2	3.1	2.6	2.5	2.8	4.4	7.9	2.3	2.2	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2	0.0	12.6	5.2	10.9	10.4	14.8	7.3	10.2	8.1	11.4	15.7	5.9	28.7	16.6	21.4	5.4	8.0	19.2	23.3	46.6	23.6	21.1	9.2	1.1	30.6	17.2	7.9	4.1	14.7	6.3	6.5	13.3	10.8	30.4	11.8	11.1	28.5	21.0	25.9	9.6	34.3	12.9	32.3	12.5	33.6	22.6	7.5	21.1	4.4	24.9	9.1
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.3	8.0	6.5	4.4	7.0	7.7	8.2	5.6	7.3	12.4	14.0	8.1	3.3	8.3	3.2	5.1	5.8	4.9	14.2	6.1	14.7	5.6	5.6	4.4	4.7	6.8	9.9	4.6	2.9	6.5	10.1	7.3	11.6	5.5	10.1	6.5	6.8	4.8	6.6	8.5	6.2	6.0	7.2	8.1	10.3	6.2	6.6	5.5	7.1	4.8	8.4	6.3	4.6	4.8	6.1	5.6	11.8	4.8	4.6	5.2	5.3	5.7	4.5	6.0	9.5	8.1	3.5	6.7	5.1	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6	0.0	4.6	3.7	4.9	7.4	4.0	6.5	0.0	5.3	3.4	1.8	2.0	8.9	8.3	5.3	3.3	4.1	4.2	0.0	6.1	6.7	6.0	3.8	9.2	3.0	6.5	0.0	2.4	3.1	4.6	3.1	6.1	5.6	5.0	5.4	4.6	7.3	5.7	0.0	4.9	5.1	4.9	6.5	5.2	15.8	14.9	4.6	10.2	4.4	4.2	3.0
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	8.4	7.0	14.1	6.4	15.2	6.8	6.3	7.8	18.9	5.8	8.2	7.8	2.5	6.6	6.5	6.6	6.5	8.2	7.7	9.2	13.0	14.9	5.7	12.6	6.8	8.7	14.8	12.5	5.4	3.4	8.2	8.5	6.2	19.5	9.7	4.6	6.5	8.7	9.9	6.3	5.8	6.4	8.5	10.5	8.9	9.6	4.2	4.9	5.7	6.2	3.7	8.4	7.2	4.7	18.1	13.5	29.5	15.0	15.7	19.5	9.4	10.3	11.1	4.2	6.2	6.6	4.0	7.1	10.3	6.9	12.1	12.3	4.6	5.5	9.1	16.5	5.7	6.3	4.1	4.4	11.9	6.4	14.3	8.0	5.2	4.2	4.9	7.5	4.5	16.0	6.0	8.6	10.0	3.4	4.2	8.2	13.9	8.1	6.9	6.5	10.8	10.8	5.9	3.3	10.8	7.2	6.9	5.8	6.5	8.7	4.6	5.1	5.3	7.0	8.5	8.6	6.2	6.7	10.2	3.5	6.3	9.3	14.3	10.0	13.0	7.7	6.4	13.7	5.1	6.7	29.5	11.4	27.3	17.1	15.0	13.0	18.1	15.5	16.1	9.6	14.6	13.2	12.8	9.6	15.7	11.7	13.5	19.5	9.4	14.1	15.2	7.8	18.9	13.0	14.9	14.8	12.5	19.5	4.9	3.0	1.7	11.5	10.4	6.1	6.0	1.4	10.2	0.0	1.2	17.4	0.0	16.3	5.0	9.6	4.7	4.7	7.7	23.3	8.1	13.8	6.9	7.1	0.0	12.9	9.3	9.5	12.6	8.0	4.9	4.0	10.3	7.9	8.5	19.8	9.6	4.9	10.7	14.0	4.2	8.7	3.3	6.5	9.6	3.1	2.5	4.4	15.9	15.8	8.0	8.8
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502726-107565746	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	9.7	6.7	7.2	14.1	12.6	6.1	11.3	9.9	11.7	8.6	7.4	7.6	9.4	6.7	9.5	7.1	9.8	7.4	6.0	12.4	7.4	7.6	9.2	9.5	7.5	11.5	7.2	5.5	9.9	7.0	13.4	10.0	6.9	7.9	8.9	7.9	8.1	7.7	7.5	12.6	9.7	7.8	9.0	7.0	10.8	6.8	5.8	5.8	9.2	11.1	5.7	12.0	8.9	8.1	3.7	3.3	0.5	4.1	4.8	6.2	2.2	4.9	6.0	6.3	6.8	3.5	7.8	5.2	9.6	7.1	7.1	7.7	11.1	9.1	11.6	5.5	9.1	9.7	8.9	9.3	7.7	9.2	10.3	6.2	9.7	2.4	5.1	5.2	12.3	12.0	4.8	8.8	9.1	11.6	3.6	8.7	9.1	13.7	3.9	5.6	4.4	11.1	6.2	8.3	9.6	10.0	10.2	9.7	8.0	5.6	5.4	5.7	6.4	5.5	4.1	4.0	3.9	6.8	3.7	8.2	15.4	9.2	5.0	11.8	3.6	3.9	9.1	4.3	8.3	15.1	0.0	2.0	0.5	4.5	4.1	4.3	1.9	3.3	3.9	3.3	3.7	6.2	5.2	0.0	4.8	2.7	2.0	3.5	2.2	7.2	12.6	9.9	11.7	7.4	7.6	7.2	5.5	7.9	5.8	0.0	4.0	2.9	1.7	1.8	5.9	10.0	7.6	0.0	4.5	1.8	5.9	1.8	0.0	1.8	0.2	2.2	1.1	0.0	2.9	2.3	3.4	1.1	9.3	6.4	2.4	1.6	1.2	4.3	2.5	0.0	2.6	2.2	3.3	3.6	3.0	2.5	1.9	4.0	3.9	2.6	3.5	0.0	2.3	1.7	2.9	3.6	0.7	5.0	3.8	0.6
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504175-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 27.9;Rod photoreceptor cells: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5"	"Group enriched"	"Detected in many"	21	"NK-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.6;SK-BR-3: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	5.3	14.8	11.8	3.7	19.1	1.0	4.7	23.4	33.9	4.8	6.6	4.8	4.0	3.2	5.7	16.4	4.1	4.9	4.3	11.0	12.2	14.3	7.6	3.5	6.4	5.2	9.9	15.0	12.8	9.2	21.1	8.1	3.0	15.6	9.2	3.7	10.3	9.6	11.1	22.4	3.3	4.1	6.5	6.0	4.6	5.0	4.1	5.3	1.7	9.1	1.9	4.6	4.5	3.8	0.1	0.0	0.0	0.1	1.9	5.4	0.9	2.6	1.2	2.7	9.5	3.6	1.5	3.4	4.4	2.2	5.1	2.4	0.5	0.1	0.2	1.2	2.8	1.2	1.4	7.3	0.3	4.3	1.0	0.6	0.0	1.7	0.8	2.9	2.1	5.4	0.7	3.2	1.7	0.0	0.5	1.2	1.5	2.1	0.0	0.1	4.4	0.4	4.4	1.7	2.2	3.0	0.7	0.0	0.4	5.9	1.3	9.6	3.2	1.0	12.6	3.5	1.2	3.6	3.1	1.1	0.2	5.9	3.4	1.8	0.2	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	1.5	0.1	1.6	0.1	2.2	2.5	0.0	0.0	5.4	3.9	0.0	1.9	0.0	0.0	1.5	0.9	11.8	19.1	23.4	33.9	12.2	14.3	9.9	15.0	15.6	5.3	3.0	1.3	0.0	0.4	0.6	27.9	6.7	2.5	0.0	0.0	3.5	3.9	1.0	0.0	1.0	0.0	0.8	1.0	0.0	0.8	0.1	0.6	1.1	0.0	0.8	0.2	4.8	4.6	0.6	0.0	0.0	2.0	0.0	0.0	1.0	0.7	7.1	0.7	0.9	5.3	0.5	8.8	0.0	1.0	0.7	0.9	0.4	0.2	0.0	1.5	0.3
AMMECR1		ENSG00000101935	"Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1"	Q9Y4X0	X	110194186-110440233	"Disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	7.2	6.6	2.4	10.1	4.5	17.0	5.3	2.9	6.5	6.3	6.2	3.9	5.0	4.6	5.3	6.0	15.9	6.3	6.5	3.0	3.1	2.9	7.5	8.5	5.9	5.8	2.6	3.2	12.4	7.4	5.0	9.5	22.7	6.6	4.3	6.1	9.7	6.5	7.0	3.2	14.2	7.8	4.5	2.4	9.7	5.8	4.0	2.3	12.5	6.0	11.1	11.3	6.8	8.9	4.3	2.9	1.5	4.8	1.2	6.7	1.9	11.3	5.6	4.1	2.0	4.7	7.0	4.5	7.9	7.1	6.5	9.6	8.9	8.3	6.7	3.8	10.4	5.2	5.4	13.1	8.9	6.7	4.7	5.9	9.3	12.9	1.8	11.9	7.4	3.9	3.9	15.9	7.4	13.3	3.5	5.1	3.3	25.9	20.2	4.9	9.5	3.5	2.6	18.9	9.7	11.0	7.7	4.4	11.9	11.0	9.6	6.6	3.2	13.3	13.1	11.1	5.2	3.2	7.4	2.3	4.5	2.8	13.3	7.1	4.2	4.7	10.8	6.9	15.5	15.0	1.3	1.9	1.5	3.4	1.3	4.6	3.3	6.7	5.4	2.9	4.3	4.6	3.9	1.3	1.2	4.8	1.3	4.6	1.9	2.4	4.5	2.9	6.5	3.1	2.9	2.6	3.2	6.6	2.3	0.0	9.8	8.2	3.8	8.5	29.6	3.8	5.1	5.3	3.4	3.5	49.1	19.3	19.9	8.0	0.4	4.2	7.9	70.0	10.4	9.3	11.3	5.9	2.3	6.0	6.1	1.6	14.5	25.2	7.8	0.8	11.8	4.0	3.3	7.2	10.2	5.8	9.8	0.0	16.3	8.2	93.5	12.9	4.7	1.8	6.9	23.3	72.3	10.0	9.9	11.5
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 45.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	7.8	6.4	5.2	5.2	5.2	5.0	7.1	5.7	5.2	7.6	5.5	5.2	5.2	4.6	8.7	5.2	6.4	6.9	5.9	5.2	5.2	3.3	5.2	7.7	5.6	5.2	5.2	5.2	7.6	8.8	7.6	5.2	7.3	5.2	6.4	5.7	45.9	5.9	5.2	5.2	7.2	5.8	7.5	5.2	6.8	6.1	7.9	5.2	5.2	6.1	5.2	5.4	5.8	7.3	4.2	5.4	9.0	3.7	3.5	6.1	3.2	12.3	8.3	17.1	14.0	16.2	13.2	16.2	14.6	13.3	16.1	14.6	18.4	9.3	12.1	9.8	14.4	7.6	12.3	16.5	12.2	17.8	14.2	12.1	15.2	12.3	10.4	19.4	15.1	15.7	14.6	26.7	19.8	26.7	15.5	16.9	12.4	13.9	12.1	13.0	8.7	14.0	14.6	13.5	9.5	15.3	14.8	13.7	6.8	12.8	10.8	11.3	12.8	12.1	18.9	29.4	14.6	8.8	10.5	16.7	20.0	18.7	9.3	11.0	10.2	15.0	12.4	9.6	9.7	13.2	1.6	3.2	9.0	4.7	3.7	6.1	3.6	4.5	4.1	4.8	4.2	4.1	3.8	4.3	3.5	3.7	5.4	4.2	3.2	5.2	5.2	5.7	5.2	5.2	3.3	5.2	5.2	5.2	5.2	17.9	7.2	8.2	7.4	16.0	5.1	11.2	7.6	18.7	11.4	3.5	5.9	4.4	0.0	5.2	10.1	6.7	6.3	0.0	4.9	5.8	11.0	10.9	6.9	14.3	3.9	1.6	5.2	8.0	6.6	12.4	6.4	6.1	5.0	1.8	11.6	4.3	7.3	7.0	7.8	4.1	5.5	0.0	8.0	6.3	10.4	13.8	6.4	2.5	9.1	12.5
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 27.9;Cytotrophoblasts: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;HAP1: 16.7;OE19: 13.4;SuSa: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	2.7	0.0	15.6	0.6	0.3	0.3	5.7	0.5	0.0	0.0	0.0	6.5	0.5	0.3	3.2	2.4	0.0	5.6	16.7	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	3.5	0.4	3.2	0.1	0.3	0.0	0.0	0.3	0.2	4.2	0.2	6.9	13.4	0.1	5.4	4.8	0.1	7.2	7.1	0.0	5.3	0.0	0.0	6.0	24.5	0.5	0.1	0.1	1.9	4.6	0.0	6.2	0.4	0.0	0.0	0.7	0.0	4.0	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5	3.0	1.3	0.0	2.1	1.5	1.0	1.2	0.0	8.1	6.8	27.9	0.0	35.2	1.7	3.4	0.1	3.0	4.6	0.0	1.8	2.6	3.8	8.2	0.0	3.6	5.2	0.0	15.2	3.7	1.5	0.0	6.4	0.6	3.3	2.8	9.2	4.5	2.2	3.5	6.0	14.4	0.4	6.5	3.1	0.5	2.1	1.0	13.3	0.0	6.3	2.2
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.4	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.3	29.9	1.1	0.0	0.1	0.3	0.7	0.0	0.4	1.1	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.2	5.4	0.0	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.9	0.1	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4	3.0	11.6	3.7	11.4	2.5	17.2	18.3	17.8	6.7	7.9	0.0	19.6	22.7	0.0	0.7	1.7	2.7	19.7	0.0	0.6	6.5	4.7	10.1	7.0	37.3	4.4	7.9	12.2	3.1	2.7	1.6	9.8	3.5	5.0	0.0	16.2	21.5	0.5	14.0	6.0	0.7	17.7	6.5	4.3	1.4	0.4	2.4	8.6	5.7	31.1	8.6
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	19.0	15.6	16.4	11.9	22.1	14.0	23.4	29.8	24.6	19.3	14.4	16.6	10.6	7.1	19.3	21.3	13.8	17.5	12.5	21.4	17.2	17.6	21.2	21.0	15.8	15.0	18.1	16.2	19.9	14.2	15.1	28.6	19.6	25.9	15.4	16.7	15.9	14.5	15.5	23.8	13.7	11.7	19.4	20.2	14.8	13.1	27.3	20.5	20.4	19.2	13.3	16.7	15.4	15.5	13.5	13.9	18.2	8.4	14.1	15.1	6.7	9.1	5.2	14.0	5.2	13.3	14.3	9.1	11.1	11.8	15.0	10.8	11.6	12.7	14.4	7.3	8.4	10.6	5.7	11.7	15.8	15.3	12.2	9.2	7.7	4.0	9.5	16.9	15.8	9.0	11.8	10.9	12.0	19.1	11.9	12.0	15.9	21.2	18.9	15.0	6.8	27.1	19.0	9.2	11.0	11.7	12.8	11.7	8.3	16.2	6.0	9.5	7.8	8.0	6.5	14.3	13.3	6.1	13.2	9.6	9.4	6.2	9.1	14.9	15.7	17.2	21.8	13.1	20.1	12.6	18.2	6.8	8.6	11.9	8.4	12.0	13.5	12.8	12.2	9.4	10.9	13.0	12.9	2.0	14.1	8.2	13.9	15.1	6.7	16.4	22.1	29.8	24.6	17.2	17.6	18.1	16.2	25.9	20.5	11.9	13.4	18.6	19.9	14.4	8.3	14.1	5.1	22.7	19.4	14.0	0.0	32.6	39.7	20.4	45.0	20.2	7.7	0.0	22.8	30.5	14.3	19.9	25.4	15.3	31.0	4.8	2.9	19.0	11.1	14.9	31.4	20.5	10.1	33.3	12.0	15.4	22.4	12.4	25.5	37.2	8.8	32.3	20.6	111.9	38.5	17.3	24.7	20.8	12.1	22.2
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 944.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	41.4	97.5	23.2	34.3	18.5	21.1	26.6	20.1	15.8	18.3	20.9	40.0	36.6	13.1	22.5	17.7	20.2	24.2	9.3	25.7	6.6	19.2	70.6	19.6	43.3	60.3	20.8	14.6	17.4	23.4	23.5	18.7	15.3	11.9	29.3	17.9	26.7	38.2	18.9	74.7	35.5	24.2	21.9	40.3	72.8	14.8	22.1	26.3	16.7	37.3	29.2	47.4	21.7	34.3	39.4	16.7	41.9	35.6	17.4	35.6	28.5	38.1	37.7	18.7	7.8	16.5	37.4	22.3	28.4	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3	119.1	121.6	108.7	168.5	132.0	55.6	277.3	203.8	155.2	153.6	188.5	19.6	436.4	442.7	236.1	329.1	152.3	247.2	186.9	293.4	435.1	217.2	291.4	105.2	427.2	386.6	31.8	182.7	139.3	155.4	944.1	168.2	179.2	248.0	315.6	205.6	112.3	274.1	235.0	154.9	400.2	53.7	103.5	220.7	379.1	245.5	163.2	425.4	121.6	237.2	254.5
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	10.7	14.9	29.5	13.8	30.1	40.3	14.0	9.1	32.5	9.9	20.0	13.7	13.2	14.9	15.3	19.9	17.2	13.4	13.3	22.2	23.6	19.8	16.0	16.9	12.2	19.5	25.2	20.6	8.0	16.6	9.4	11.7	12.7	19.3	17.4	20.5	11.6	18.2	20.6	41.5	14.1	14.8	21.8	17.7	14.4	15.1	22.1	12.6	22.5	21.6	23.1	20.9	12.8	9.4	27.0	45.6	39.9	52.7	20.5	44.0	35.5	19.6	29.7	24.4	15.4	7.2	11.8	11.5	21.0	19.3	33.9	22.6	34.7	21.5	26.6	20.5	29.9	16.5	33.5	36.7	39.3	32.1	17.0	17.4	30.2	34.0	22.4	8.6	29.3	28.3	12.3	15.6	19.2	25.8	12.8	22.2	37.5	21.8	18.5	22.0	33.8	56.3	27.3	19.7	41.7	17.2	23.9	60.6	18.0	29.1	13.7	17.3	15.1	21.5	21.2	33.3	13.7	24.8	15.7	20.0	15.6	20.6	30.8	22.1	19.0	18.4	33.9	9.6	23.6	8.7	7.5	52.7	39.9	24.0	33.4	25.4	27.0	30.9	27.9	45.6	19.9	37.1	33.9	21.7	20.5	30.4	36.6	44.0	35.5	29.5	30.1	9.1	32.5	23.6	19.8	25.2	20.6	19.3	12.6	14.9	13.9	33.5	62.0	37.2	30.5	2.8	12.7	40.2	35.2	22.7	25.5	72.2	104.5	44.3	13.8	19.6	61.2	0.0	89.5	62.0	19.8	46.4	30.0	37.8	71.7	12.7	47.5	19.0	44.0	9.1	6.4	47.5	25.3	51.3	52.0	22.6	43.9	54.5	21.5	83.0	32.0	19.4	29.7	92.2	129.0	35.9	39.0	41.5	65.5	51.5
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	15.6	20.3	17.8	14.7	25.1	12.2	19.9	24.8	25.1	20.6	16.2	16.8	12.2	11.9	21.4	19.8	34.2	20.9	15.6	18.8	19.1	18.5	21.4	16.8	16.6	20.8	16.2	22.1	18.1	16.7	26.6	14.9	9.6	17.6	21.8	18.9	16.4	19.7	21.3	29.7	16.0	13.3	24.0	17.1	16.8	14.9	36.3	16.3	25.8	23.2	24.5	22.2	19.2	22.5	14.9	17.7	17.6	15.1	20.1	22.4	12.5	18.7	25.9	18.9	16.1	19.9	10.1	10.8	13.2	12.0	24.4	17.0	26.4	12.1	30.0	13.4	17.7	14.1	19.1	28.2	18.1	24.9	16.0	22.7	26.5	19.2	21.8	14.5	23.7	12.6	11.0	13.0	21.1	14.1	17.4	23.6	21.6	41.6	6.2	19.1	20.1	35.8	17.7	16.5	18.4	22.6	27.7	18.8	35.7	16.5	24.1	24.7	14.2	20.6	16.3	21.6	17.5	34.4	21.5	14.8	14.6	13.7	12.9	15.5	10.9	22.1	40.5	16.3	20.3	16.8	14.3	10.5	17.6	17.2	15.1	20.2	13.3	18.5	16.5	17.7	14.9	15.5	16.5	8.3	20.1	13.1	9.7	22.4	12.5	17.8	25.1	24.8	25.1	19.1	18.5	16.2	22.1	17.6	16.3	14.9	13.6	11.2	18.2	9.0	18.1	15.9	12.7	14.7	25.0	12.2	19.6	10.3	10.0	15.4	5.7	13.5	7.4	0.0	13.1	8.1	9.4	15.1	15.1	13.5	19.4	20.6	10.4	11.6	15.9	8.5	17.0	10.3	16.9	9.0	10.2	16.7	13.1	7.0	20.5	11.9	22.2	12.9	11.2	79.8	34.1	11.7	6.1	15.2	14.5	15.5
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	1500000	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.4	3.6	0.1	1.2	0.1	0.2	0.0	0.0	6.0	0.0	9.0	2.5	1.3	0.8	0.0	65.4	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.7	0.2	10.0	0.2	1.8	5.0	0.1	0.3	0.2	17.7	0.5	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.2	3.2	1.2	0.0	0.1	7.5	0.8	1.1	0.4	1.9	0.1	33.0	19.4	0.1	9.8	0.0	0.0	0.0	0.0	13.3	0.0	3.6	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7	35.7	4.3	0.5	32.6	12.5	0.1	3.6	2.5	4.0	10.3	14.0	0.0	5.4	0.0	91.5	0.5	17.6	26.4	0.0	15.3	96.9	44.0	38.8	2.3	145.0	7.4	0.0	0.0	20.9	1.6	0.4	81.4	6.1	8.5	3.6	8.6	4.1	173.2	7.0	123.8	3.7	0.0	32.3	98.2	0.0	0.9	10.0	33.5	1.9	1.7	72.4
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 81.0"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 96.9"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"Hep G2: 26.8;MCF7: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	320000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	8.0	0.1	0.0	0.6	0.0	0.0	5.1	0.0	0.1	0.1	5.7	0.0	0.0	0.2	0.1	0.8	0.1	0.1	1.0	0.6	0.0	0.0	1.5	81.0	0.1	3.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.7	26.8	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.2	0.0	0.2	0.3	0.7	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	96.9	0.1	0.0	0.0	6.7	5.9	1.3	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 2.3;testis: 9.0"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 63.4;Late spermatids: 36.4;Rod photoreceptor cells: 48.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"TIME: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.0	0.2	0.0	0.4	0.2	0.2	0.2	0.2			0.0	0.3	0.7	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.2	0.5	0.2		0.2	0.2	1.2	0.3	0.1		0.5	0.3		0.4	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.6	9.0			0.6		0.1	0.2	0.2	2.3	0.3	0.5	0.4	0.0	0.6	0.1	0.6	0.5	0.4	0.5	0.4	1.1	0.0	0.0	0.7	0.2	0.5	0.9	1.1	0.3	0.3	1.0	0.1	0.8	0.7	0.0	0.3	1.0	0.6	0.6	0.5	1.3	0.0	1.8	0.2	1.3	0.2	0.3	1.4	0.2	0.0	0.0	0.1	0.9	0.3	0.4	0.0	0.5	0.0	0.8	0.7	0.3	0.4	0.0	0.6	2.3	0.0	0.0	0.5	0.3	0.8	0.1	2.4	1.8	2.7	0.8	1.1	0.0	0.0	1.1	0.4	0.1	0.5	0.1	0.2	0.0	0.0	0.5	0.6	0.4	0.1	0.6	0.3	0.1	0.1	2.3	0.2	0.5	0.0	0.0	0.3	0.3	0.0	0.1											3.0	5.1	0.5	5.6	1.1	12.0	4.1	2.5	1.4	3.4	10.4	13.7	1.2	1.7	3.0	63.4	6.8	3.4	0.0	3.7	0.9	4.6	3.6	0.0	2.1	2.1	3.2	0.0	3.7	1.3	36.4	20.1	4.0	6.8	1.0	4.5	8.9	3.5	5.5	13.1	2.1	48.1	6.5	3.3	11.1	4.7	1.1	0.1	4.4	3.8	3.5
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6"					"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.9	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.4	16.8	0.0	0.0	0.9	0.7	0.1	0.0	0.1	0.0	0.1	1.5	0.0	1.7	0.0	0.3	0.1	5.8	0.0	0.0	0.0	0.4	5.6	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0	0.0	0.6	0.0	0.1	0.5	0.0	0.6	0.0	34.8	0.0	0.0	0.0	0.3	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.6	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	6.5	0.3	5.9	2.1	0.4	2.4	0.0	0.0	0.9
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9"	"Group enriched"	"Detected in some"	7	"Erythroid cells: 23.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2"					"Low region specificity"	"Detected in all"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.6	0.5	1.0	12.9	3.1	22.6	0.6	8.3	1.4	0.7	0.7	0.6	0.2	0.3	0.9	1.3	0.5	0.8	0.5	0.2	1.0	1.2	0.5	0.5	1.3	3.7	1.6	0.7	1.7	0.2	0.6	0.9	1.1	1.4	1.0	0.5	0.4	0.7	0.6	0.9	1.4	1.2	0.9	1.2	5.7	0.3	1.0	0.5	8.9	0.6	0.2	5.3	1.0	0.7	3.0	2.2	0.7	4.3	0.0	0.4	0.8	0.1	0.3	1.5	0.8	0.0	0.3	1.5	0.5	0.1	0.3	0.2	7.0	0.4	30.8	0.3	0.1	0.0	0.6	11.9	0.1	0.3	9.3	1.6	12.6	4.9	0.0	0.1	13.5	5.2	0.1	0.4	1.2	0.0	0.3	0.2	2.6	1.6	3.6	0.1	0.2	9.3	17.4	3.8	0.1	1.1	7.5	0.0	3.1	0.1	0.1	0.4	2.7	3.0	0.2	0.2	0.3	0.0	8.9	0.6	0.1	0.5	0.6	0.3	0.3	0.3	10.9	0.1	24.2	0.6	0.0	1.8	0.7	0.0	4.3	0.0	3.0	0.0	0.4	2.2	1.7	0.1	0.0	0.0	0.0	3.1	1.1	0.0	0.8	1.0	3.1	8.3	1.4	1.0	1.2	1.6	0.7	1.4	0.5	0.0	0.3	0.8	0.8	0.7	2.0	0.8	0.0	1.4	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.2	0.0	23.3	0.2	0.4	0.4	0.3	1.1	0.0	0.7	0.0	0.0	0.0	0.8	0.0	1.7	1.2	0.0	1.0	0.7	0.2	0.4	0.0	1.4	0.0	1.5	6.5	0.4	0.5	0.9	0.4	0.3	0.0	0.0	0.1
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599776-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067100			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA067100: AB_2685777"	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	9.6	10.3	14.5	6.6	30.1	10.0	11.8	14.6	28.7	12.4	13.6	9.0	13.3	12.2	10.8	10.4	9.4	13.1	11.1	30.2	18.5	12.7	13.3	8.9	9.4	6.7	12.7	21.2	21.5	9.6	13.2	14.9	7.3	20.4	11.3	14.1	11.8	11.4	16.3	17.3	8.5	13.5	14.4	11.9	8.8	19.1	8.0	7.8	8.9	17.7	7.5	7.1	14.6	11.6	6.7	4.9	18.5	8.9	10.6	10.2	5.2	10.5	9.0	12.3	12.2	11.7	12.3	6.6	12.9	15.8	10.0	15.4	15.0	16.2	2.1	15.1	13.5	20.9	11.1	8.3	4.9	15.0	4.7	5.7	19.1	10.8	6.7	7.6	14.2	7.4	10.6	2.6	10.0	10.1	13.9	9.0	13.0	19.6	3.5	14.1	2.8	6.0	9.9	8.2	32.7	10.7	9.9	11.1	5.1	15.5	9.2	7.8	4.7	8.7	6.4	5.2	12.0	7.6	12.8	5.5	7.7	6.9	17.2	8.8	12.9	9.4	3.3	11.9	11.7	12.3	18.5	3.2	14.3	10.0	4.3	9.6	6.7	8.2	10.2	4.9	6.7	6.9	8.2	2.7	10.6	8.9	4.7	8.3	5.2	14.5	30.1	14.6	28.7	18.5	12.7	12.7	21.2	20.4	7.8	3.0	10.8	3.7	9.1	4.1	13.2	33.4	12.7	40.2	19.4	10.4	5.9	11.7	18.3	5.8	18.4	5.8	14.9	0.0	8.0	9.4	11.8	5.1	5.8	5.0	8.0	7.9	18.5	3.7	4.8	26.3	11.8	5.0	13.5	7.2	14.1	16.0	4.9	10.5	12.7	9.7	18.2	25.8	14.6	3.7	4.1	3.6	14.2	6.2	15.0	5.4
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 12578.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.5	0.9	38.0	1.4	0.0	104.9	0.1	4.0	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.7	2.3	0.0	0.0	3.7	0.0	0.7	1.8	57.1	35.8	0.0	0.0	0.0	128.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	41.0	0.0	0.1	179.4	0.3	13.8	0.2	14.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	848.6	37.7	0.0	1.3	0.0	0.0	12578.5	10.2	1.4	9.1	0.0	0.0	0.1	0.0	19.0	2.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267619-89490561	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	23.3	22.8	25.6	23.1	48.7	41.4	32.3	31.7	22.0	24.1	22.9	22.0	22.4	26.9	18.9	25.0	23.4	23.4	22.2	24.6	20.0	17.8	15.1	32.3	33.8	20.8	21.0	32.6	27.9	33.7	31.5	18.8	19.3	20.5	14.9	23.3	21.4	25.8	27.0	35.8	24.1	26.7	20.3	26.1	22.6	21.3	22.1	26.1	21.6	19.3	19.6	23.4	34.4	4.2	7.2	11.7	5.9	9.8	4.5	1.8	21.9	27.5	27.7	21.2	17.1	17.7	26.8	25.1	16.9	15.2	10.8	32.0	23.6	20.4	17.4	18.2	17.1	22.3	18.9	23.1	17.2	10.1	22.6	16.1	19.1	25.6	25.9	11.8	18.3	19.6	23.5	19.9	25.8	22.1	18.2	34.3	34.5	16.3	19.0	20.8	19.5	29.8	24.3	11.4	25.4	40.4	32.0	17.0	15.8	18.5	16.3	20.0	36.2	7.6	26.0	14.7	17.8	18.6	33.6	32.1	30.0	17.7	27.5	29.8	10.4	25.4	25.8	19.6	17.3	7.5	3.9	3.7	3.8	4.0	4.3	3.1	4.3	4.5	2.1	4.2	3.8	3.5	11.7	9.8	5.9	7.2	4.2	1.8	22.8	23.1	32.3	31.7	24.6	20.0	20.8	21.0	19.3	22.1	122.1	96.0	57.0	118.7	103.5	174.0	224.2	89.2	33.5	56.9	68.0	149.2	36.4	26.6	65.7	85.7	83.9	67.5	46.7	62.6	29.3	87.3	94.1	53.2	57.8	42.6	147.8	102.5	75.5	58.0	27.9	96.1	74.6	45.5	95.6	51.2	90.0	94.9	50.7	99.7	28.0	102.5	38.8	89.3	78.8	102.6	106.9	32.4	71.0	51.7	144.5
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	17.0	10.9	22.2	23.1	26.1	19.6	15.4	48.1	25.4	17.8	18.8	10.1	18.2	13.7	14.6	15.4	16.1	12.1	16.1	12.3	19.9	13.5	14.7	16.5	14.6	22.1	20.2	18.3	16.3	16.7	15.5	16.4	19.2	17.4	15.9	13.6	9.5	15.7	20.6	25.8	21.8	18.1	17.2	21.3	20.3	15.3	29.3	23.8	11.4	18.2	13.0	19.5	24.2	22.6	18.7	19.2	51.2	10.7	8.8	19.0	5.2	4.2	2.9	4.0	2.6	6.4	6.6	3.2	6.6	6.2	2.4	3.3	2.6	3.3	5.9	3.9	4.5	7.3	3.9	2.9	2.6	6.5	6.2	3.6	2.7	2.1	3.8	4.7	6.3	8.7	3.4	5.8	3.4	5.5	5.4	4.0	3.5	6.1	46.8	5.8	2.4	4.2	4.3	1.5	10.5	3.0	3.8	5.6	21.5	3.1	6.8	9.3	3.4	6.5	3.2	4.7	3.7	4.0	5.3	8.6	17.7	8.2	14.1	6.1	13.7	21.1	11.0	8.7	3.4	6.6	27.4	8.7	25.5	14.5	7.7	16.1	18.7	18.7	13.9	5.9	17.3	19.0	14.8	51.2	8.8	10.7	19.2	13.0	5.2	22.2	26.1	48.1	25.4	19.9	13.5	20.2	18.3	17.4	23.8	259.1	252.1	212.5	167.3	96.2	295.2	122.2	76.5	112.4	180.9	64.6	492.8	36.1	16.6	83.3	150.6	136.7	122.5	70.0	72.2	31.7	114.1	175.8	178.3	57.2	58.3	270.1	88.9	119.7	80.5	178.4	124.8	126.0	86.0	167.7	80.4	131.0	84.0	75.9	133.0	29.3	294.9	109.9	138.1	215.6	153.7	83.9	65.3	191.8	63.5	140.5
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67288547-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	9.1	9.1	18.2	18.1	17.6	80.8	18.9	20.2	18.7	9.0	7.6	7.7	13.7	8.0	9.0	10.4	14.6	10.2	11.9	8.8	20.2	14.0	8.3	4.5	12.4	20.8	12.4	11.4	9.4	7.7	6.0	17.0	9.2	10.7	12.7	4.5	10.9	17.5	12.0	4.2	28.1	8.6	9.9	9.6	24.1	8.9	6.8	12.0	9.6	6.4	6.2	14.4	14.3	13.4	2.6	8.1	11.4	4.6	3.8	6.7	1.9	6.3	4.5	3.4	8.1	5.2	5.1	6.4	3.9	3.8	4.6	2.9	5.3	7.0	6.9	6.6	4.4	6.2	10.6	2.5	5.0	0.7	9.7	3.0	5.8	6.8	3.0	8.1	6.4	23.5	5.5	7.9	4.1	5.3	6.9	4.3	7.0	4.1	8.4	4.0	10.3	8.6	49.8	3.9	9.8	5.7	21.6	3.7	4.8	6.5	8.7	4.0	6.8	3.4	10.2	27.2	2.7	10.5	18.3	5.5	7.3	4.7	7.4	5.1	8.5	6.1	4.1	9.6	18.0	4.7	7.2	3.3	11.4	6.7	4.6	4.4	2.6	3.8	5.4	1.9	2.4	2.4	5.8	10.8	3.8	3.8	8.1	2.8	1.9	18.2	17.6	20.2	18.7	20.2	14.0	12.4	11.4	10.7	12.0	0.0	22.6	9.3	10.5	12.6	49.4	4.5	2.5	18.7	10.3	15.7	70.7	6.9	1.7	7.8	17.6	14.2	2.6	0.0	6.0	6.4	13.6	15.3	24.3	2.4	17.5	39.7	10.4	25.2	48.3	5.1	20.4	28.1	11.8	14.4	6.2	25.2	7.9	2.9	15.9	1.4	45.9	12.9	12.1	2.8	5.5	22.0	6.3	29.9	6.9	15.7
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	19.6	20.2	28.9	23.2	32.4	10.3	24.8	41.2	29.9	22.8	19.4	21.2	19.5	18.2	19.3	24.2	22.2	23.5	18.8	20.4	23.4	21.6	25.3	25.3	18.0	17.4	22.3	19.4	23.4	22.8	40.2	34.6	23.2	31.8	19.7	24.2	21.5	23.1	23.1	32.7	22.2	18.5	20.7	18.0	17.7	19.2	13.5	25.1	22.3	22.7	15.9	21.1	21.1	18.9	4.5	7.6	3.2	2.8	9.3	5.3	1.7	12.3	13.6	21.7	17.1	24.5	21.6	11.9	18.2	21.5	16.4	15.9	16.5	16.3	33.6	15.2	18.6	8.7	10.4	27.1	16.1	22.8	13.0	11.5	22.8	14.8	23.9	13.1	29.8	14.1	18.2	17.6	23.5	18.8	17.1	21.8	13.8	31.9	12.4	19.6	11.4	24.4	10.6	14.1	16.0	13.8	19.5	23.9	13.9	17.5	18.7	21.1	14.3	17.6	19.9	9.5	17.7	10.7	11.8	26.2	17.4	16.7	15.5	14.2	10.4	5.2	25.7	14.1	13.1	17.7	2.3	2.8	3.0	5.3	1.8	2.7	3.0	3.3	3.6	2.3	4.5	3.2	3.6	3.2	9.3	2.1	7.6	2.0	1.7	28.9	32.4	41.2	29.9	23.4	21.6	22.3	19.4	31.8	25.1	44.7	48.2	16.6	32.2	67.7	55.9	71.9	33.1	22.7	48.9	38.4	115.8	24.2	6.6	26.7	4.0	47.7	39.9	0.0	25.0	20.0	36.8	36.1	30.1	45.3	23.8	65.2	43.4	40.5	26.7	4.2	32.5	26.4	27.0	22.6	40.3	32.1	25.1	17.3	35.3	19.8	77.0	19.4	28.2	24.7	28.7	71.0	28.3	24.9	41.9	42.2
ANKRD29	FLJ25053	ENSG00000154065	"Ankyrin repeat domain 29"	Q8N6D5	18	23598926-23662885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 202.5;Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.7;BJ hTERT+: 12.1;hTCEpi: 12.0;PC-3: 11.5;U-2197: 15.0;U-87 MG: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041272, HPA049419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA041272: AB_2677387, HPA049419: AB_2680757"	"unprognostic (4.52e-3)"	"unprognostic (8.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (1.92e-5)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.98e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.54e-1)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.10e-2)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.64e-5)"	11.8	6.1	8.9	6.6	6.6	0.2	9.9	1.9	15.1	8.4	3.0	3.7	3.0	1.2	13.1	6.4	6.5	9.6	4.4	4.9	9.8	5.3	2.5	1.6	25.2	14.6	8.7	6.2	12.4	0.8	18.4	6.0	0.3	17.9	7.0	1.8	4.3	5.1	7.5	3.2	3.2	4.5	9.8	3.2	2.0	11.7	2.9	3.1	1.6	2.3	5.5	11.1	4.8	9.1	0.0	1.6	0.0	0.0	0.0	1.1	0.0	1.6	4.8	0.0	0.0	1.2	12.7	0.1	4.8	12.1	1.9	2.4	2.2	0.4	0.0	0.7	2.2	9.5	2.4	0.0	6.3	0.4	0.1	4.4	0.0	3.1	0.1	0.2	0.0	0.3	3.3	12.0	1.9	3.2	1.8	1.2	0.0	0.0	0.2	3.2	0.5	0.0	0.0	0.8	4.0	11.5	0.0	0.3	1.1	3.0	1.7	0.7	5.9	1.2	0.2	0.1	0.2	1.4	0.0	2.8	0.3	1.7	15.0	4.2	0.0	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	8.9	6.6	1.9	15.1	9.8	5.3	8.7	6.2	17.9	3.1	202.5	27.6	0.0	7.4	4.5	4.2	7.1	5.1	2.7	10.3	1.8	62.8	0.0	5.0	1.8	30.7	19.4	0.4	0.0	1.0	0.0	2.0	4.4	3.5	0.9	2.3	39.7	1.7	9.2	0.6	20.2	6.6	2.4	6.8	0.0	0.5	0.9	6.8	0.2	19.1	8.6	3.7	12.9	38.7	2.7	2.0	2.5	0.0	0.0	0.9	2.7
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	11.0	0.3	1.6	4.0	0.5	1.3	0.4	0.0	0.0	0.3	1.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	1.3	3.1	0.1	3.8	0.5	0.3	0.1	0.1	0.5	0.0	0.0	0.0	2.4	0.0	0.0	4.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3	0.0	0.0	0.0	14.7	4.0	1.5	1.2	2.5	4.0	1.2	1.8	0.0	0.1	0.0	0.0	3.6	1.0	0.0	0.0	0.4	0.1	20.2	8.0	19.5	8.6	8.7	0.0	0.0	1.8	1.6	4.7	33.6	1.1	5.0	0.0	0.0	39.3	0.1	0.0	47.7	0.0	1.4	0.0	5.2	0.0	0.9	10.8	0.2	7.5	0.0	12.9
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113496-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 71.9;Spermatocytes: 72.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.9"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	5.1	3.3	8.8	6.0	14.5	22.0	6.8	20.5	10.2	5.6	4.6	4.8	2.2	3.0	8.5	7.7	2.4	6.0	3.8	3.9	7.6	3.3	3.2	1.8	5.0	5.0	4.0	11.3	8.9	5.1	5.3	9.2	2.3	6.8	4.8	5.2	4.7	4.3	3.1	2.2	5.9	4.3	4.7	3.7	5.9	5.1	13.3	8.2	5.6	5.4	2.1	3.7	4.0	4.9	9.9	11.7	9.3	3.3	4.9	9.2	1.7	6.2	1.5	5.1	3.2	1.1	2.6	2.4	2.4	1.7	1.9	1.9	1.6	3.2	8.0	1.6	2.3	1.5	3.1	1.9	2.1	1.6	3.8	2.8	6.0	6.8	2.9	0.5	4.4	2.6	1.7	1.4	1.4	2.4	3.0	3.4	11.2	4.1	13.9	0.8	1.1	5.5	5.8	1.2	0.5	2.9	5.3	2.1	2.2	1.4	3.0	3.6	2.6	2.5	1.5	0.8	2.9	1.6	2.5	5.2	5.4	5.3	6.2	2.8	8.2	3.5	6.5	3.1	6.4	1.8	9.3	2.6	3.5	9.2	1.2	9.1	9.9	8.4	7.3	1.2	9.9	8.6	9.2	3.9	4.9	3.3	11.7	7.0	1.7	8.8	14.5	20.5	10.2	7.6	3.3	4.0	11.3	6.8	8.2	41.7	27.2	12.9	8.0	14.0	47.0	19.1	0.0	44.2	27.3	7.0	70.7	0.9	0.0	5.7	53.0	19.6	2.0	0.0	15.9	4.8	14.4	5.5	25.5	0.8	4.5	20.6	13.2	9.8	4.6	5.3	24.2	17.3	37.1	4.6	6.8	13.0	9.3	3.4	17.0	1.4	71.9	0.0	23.1	72.1	11.9	8.2	0.3	25.4	8.5	12.9
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4"	"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	1.0	1.5	2.0	2.8	7.0	16.4	3.3	6.8	6.7	1.4	1.7	1.6	0.2	1.3	3.8	2.0	0.5	2.0	2.1	0.8	3.1		1.1	0.4	2.2	2.3	4.3	6.2	3.8	1.7	1.8	3.3	0.7	3.9	1.8	2.7	1.0	2.6	3.0	0.7	3.6	2.1	1.9	1.9	1.7	1.7	7.5	4.0	4.2	1.3	2.8	2.1	1.2	0.8	3.5	2.6	3.4	0.7	2.6	3.0	0.3	3.6	2.3	2.7	2.3	1.6	3.6	1.7	2.6	1.7	1.7	1.9	2.2	4.5	5.2	1.4	2.1	1.6	1.7	1.7	1.2	1.8	1.5	4.2	4.1	4.7	1.6	1.2	3.2	2.4	2.4	2.1	2.1	3.5	4.0	2.2	10.7	5.5	4.4	2.0	0.9	4.0	5.8	1.3	0.8	2.7	5.0	1.3	1.8	1.8	2.3	3.0	4.3	1.9	1.6	1.4	3.6	2.6	3.0	3.3	3.0	3.5	3.5	3.4	6.1	7.7	4.8	1.8	4.3	1.5	3.4	0.7	0.9	2.2	0.3	2.0	2.2	2.6	1.8	0.3	3.5	3.0	2.3	0.5	2.6	0.2	2.6	1.3	0.3											11.9	16.7	6.2	6.2	0.0	34.4	12.2	2.5	30.8	31.8	8.7	19.6	1.3	0.0	6.9	39.2	6.8	2.6	0.0	11.9	3.0	2.6	4.5	22.0	0.6	2.9	15.9	13.8	3.1	2.7	3.6	11.8	3.9	0.0	10.0	9.0	9.5	8.7	4.0	7.1	0.5	35.1	6.5	1.4	49.5	6.8	0.0	0.1	13.8	5.8	10.4
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.6"	"Cell type enhanced"	"Detected in many"	9	"Exocrine glandular cells: 514.5;Pancreatic endocrine cells: 319.5;Urothelial cells: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 25.5"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.2	1.0	4.2	1.8	4.1	13.2	5.3	8.0	5.8	3.1	3.1	0.5	2.8	0.7	3.2	1.9	1.8	2.6	4.0	1.5	3.3	1.8	1.2	0.8	2.0	2.7	1.6	1.7	5.6	3.1	1.2	3.9	0.9	3.1	1.6	2.1	2.1	9.2	1.5	0.9	2.9	2.6	1.5	1.9	2.4	4.5	10.1	1.1	2.8	1.6	2.4	4.0	2.5	2.2	11.1	19.6	18.1	2.0	7.2	12.5	0.7	6.6	1.3	2.8	1.9	1.8	4.9	1.0	1.6	1.1	2.1	2.7	1.5	1.5	6.6	2.1	1.1	2.1	1.5	2.5	1.2	2.7	3.8	3.3	2.7	3.2	1.9	0.4	7.8	2.0	1.4	1.0	1.6	0.8	2.1	3.5	9.6	2.6	8.4	2.3	0.9	6.0	2.9	0.6	0.3	25.5	3.2	2.1	2.7	1.0	1.3	2.5	2.2	1.0	1.7	1.1	1.1	0.8	1.9	3.9	2.6	2.9	2.0	1.9	3.2	2.6	7.2	0.7	5.4	1.0	18.1	2.0	1.5	12.5	0.3	8.1	9.2	10.0	8.1	1.4	11.1	8.7	8.5	0.1	7.2	0.5	19.6	8.3	0.7	4.2	4.1	8.0	5.8	3.3	1.8	1.6	1.7	3.1	1.1	35.7	24.0	8.3	28.7	9.5	80.2	21.4	5.1	61.6	79.6	8.7	74.6	0.2	0.0	187.2	85.1	14.3	7.4	23.3	514.5	0.7	15.0	147.9	31.4	1.3	6.9	31.8	20.2	8.0	6.7	8.4	30.2	13.0	13.5	40.5	53.0	17.5	319.5	7.4	34.3	0.3	74.8	19.4	17.0	86.7	12.4	6.5	0.2	28.8	13.0	431.0
ANKRD39	MGC41816	ENSG00000213337	"Ankyrin repeat domain 39"	Q53RE8	2	96836611-96858095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042678	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042678: AB_10794532"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (9.53e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.12e-3)"	"prognostic favorable (6.12e-5)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (6.78e-9)"	"unprognostic (3.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.21e-4)"	8.9	16.2	17.1	9.2	19.2	12.0	6.9	29.4	20.8	7.4	8.3	15.0	7.2	11.2	11.7	5.9	7.6	10.9	7.9	17.6	14.8	14.7	6.5	12.6	7.6	13.0	13.5	14.0	7.3	11.2	11.7	14.2	7.4	13.4	10.4	5.6	10.3	9.5	10.1	6.3	10.9	8.4	9.5	10.7	8.9	7.9	3.7	13.0	5.4	6.3	4.3	8.7	9.0	5.8	15.5	29.0	7.1	9.0	14.4	27.8	8.7	6.4	4.2	2.4	5.3	0.8	1.6	5.9	5.0	2.3	6.3	4.8	10.4	2.7	4.1	7.4	3.6	5.0	2.8	3.1	4.7	1.4	4.7	9.3	2.9	3.8	14.1	4.2	6.6	7.2	3.1	2.8	5.7	2.2	2.3	4.5	8.6	6.1	73.5	2.3	10.1	6.2	5.2	3.1	2.2	9.8	4.7	1.7	23.0	3.2	3.3	5.6	3.7	3.6	8.5	6.3	2.3	2.5	3.6	2.2	3.9	3.9	4.4	8.8	3.8	4.1	6.7	4.0	7.6	4.1	7.1	6.9	5.3	19.6	8.3	16.4	15.5	19.4	17.2	6.8	13.6	10.8	13.3	3.5	14.4	9.0	29.0	27.8	8.7	17.1	19.2	29.4	20.8	14.8	14.7	13.5	14.0	13.4	13.0	6.0	6.2	15.2	17.4	8.4	22.4	15.9	22.9	45.5	11.4	8.7	3.9	39.8	21.6	26.0	4.0	12.0	12.9	0.0	27.9	33.6	16.9	10.0	12.7	24.6	26.7	31.8	17.9	9.8	9.9	2.0	11.5	10.8	27.0	8.2	17.9	14.6	32.4	8.6	13.8	20.7	27.7	25.8	24.0	12.5	17.8	15.6	18.1	24.9	16.8	13.6
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.3	4.3	12.3	5.7	9.8	6.3	1.2	6.0	5.1	3.1	2.0	1.9	3.0	0.0	1.9	8.5	2.8	2.1	8.1	4.6	5.5	0.0	1.7	1.9	5.6	1.8	7.0	3.2	2.5	6.3	6.3	4.9	22.2	5.9	22.1	2.2	3.5	4.2	5.9	5.3	4.0	1.1	2.5	3.4	6.4	3.3	3.8	0.5	3.9	9.6	3.5	4.4	4.1	2.6	4.8	5.3	2.8	2.7	55.6	6.7	5.2	3.2	5.1	3.1	0.0	0.8	3.0	1.4	7.6	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8	29.8	18.2	0.5	15.0	35.8	2.8	8.4	15.3	8.1	6.8	5.2	0.0	1.9	0.0	8.8	35.0	14.5	3.8	0.0	17.2	23.7	15.5	12.9	4.7	6.8	4.8	20.6	8.1	31.9	10.0	45.7	6.4	8.7	10.1	2.8	3.1	2.9	13.7	2.9	11.3	3.3	1.0	0.0	18.6	16.8	9.7	26.8	3.4	0.0	4.5	15.8
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	10.7	23.2	12.3	13.2	19.6	12.1	10.8	23.1	23.5	10.8	11.6	15.6	9.1	11.9	13.8	8.9	10.9	11.5	12.7	12.0	12.7	13.4	13.2	8.3	9.8	12.3	13.3	14.7	14.6	14.1	28.4	14.5	12.6	22.8	11.9	12.1	14.8	11.6	13.6	30.8	15.8	13.0	15.8	8.8	11.9	10.9	8.5	13.5	10.5	12.4	11.4	13.4	12.3	11.8	1.1	1.1	2.4	0.6	0.3	1.2	0.5	11.7	29.2	13.0	23.5	10.6	8.4	9.2	23.6	10.5	21.2	9.6	18.9	6.6	12.6	15.1	23.0	7.4	15.4	14.3	10.3	12.3	12.1	14.5	22.6	19.0	7.2	7.3	17.7	13.2	8.6	11.7	19.7	10.0	15.6	12.3	10.4	9.2	6.9	19.8	16.4	14.2	5.9	5.4	7.7	13.5	11.2	9.0	5.0	14.0	15.1	9.9	9.0	25.7	16.5	9.4	10.5	13.3	6.9	16.9	22.2	19.5	12.4	14.7	6.4	8.4	6.2	22.8	5.9	14.4	2.4	0.6	0.9	1.2	0.1	1.0	0.8	0.4	0.7	0.3	1.1	0.6	0.7	0.3	0.3	0.4	1.1	0.3	0.5	12.3	19.6	23.1	23.5	12.7	13.4	13.3	14.7	22.8	13.5	6.0	4.0	4.7	2.9	10.0	4.7	5.6	2.5	0.0	0.0	12.2	25.5	5.1	0.0	8.4	0.3	4.8	8.3	0.0	8.0	6.2	5.3	4.5	1.1	6.0	6.2	7.9	9.2	6.2	6.5	0.8	5.8	3.9	10.1	4.6	6.8	3.7	12.4	9.0	4.6	5.8	6.1	0.0	5.2	6.7	8.1	9.5	3.1	4.8	7.3	3.7
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889265-35091413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 74.5;Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	13.6	15.6	11.8	10.5	20.7	5.0	11.5	19.2	19.9	8.8	20.3	11.6	33.9	9.8	10.2	11.0	15.4	19.8	9.9	14.8	11.7	8.0	10.3	11.6	14.5	8.0	15.0	8.8	14.6	11.0	13.9	12.8	27.3	12.8	9.3	8.7	19.7	8.5	30.4	14.8	11.6	10.9	13.9	10.6	18.6	12.3	23.6	13.9	9.5	11.3	4.2	9.1	22.7	9.9	1.3	3.4	2.4	4.3	0.5	1.5	1.1	8.1	3.6	8.4	8.1	3.8	3.5	12.9	3.4	3.8	3.8	5.0	10.1	4.9	5.4	5.4	3.3	7.3	8.3	9.7	9.1	4.2	4.3	11.4	3.9	4.7	7.6	2.3	6.2	3.9	4.3	8.4	4.9	6.2	4.4	9.1	6.0	6.7	2.5	3.6	5.4	3.7	7.0	6.1	10.5	4.4	4.8	4.4	5.8	8.3	15.7	32.8	8.2	4.9	8.0	25.0	11.0	6.1	7.2	7.9	4.1	5.2	4.2	4.9	3.8	5.8	2.6	3.2	9.4	11.4	0.0	2.0	1.2	0.9	2.9	1.2	1.3	0.8	1.5	1.5	0.5	1.0	0.8	2.4	0.5	4.3	3.4	1.0	1.1	11.8	20.7	19.2	19.9	11.7	8.0	15.0	8.8	12.8	13.9	74.5	10.7	4.6	6.7	10.8	27.5	21.2	12.7	29.4	9.1	12.2	60.9	7.4	0.0	6.6	11.3	34.4	11.8	0.0	5.1	6.3	8.5	9.5	2.3	4.9	9.8	7.9	12.7	50.3	26.9	8.1	11.8	10.1	5.0	4.6	11.3	21.8	8.6	5.8	28.3	5.6	44.8	19.4	8.9	5.8	4.9	17.9	10.4	2.5	7.7	11.5
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	6.9	10.1	7.4	6.4	12.0	4.2	8.9	14.5	11.1	8.1	9.3	8.2	5.0	6.2	8.7	6.7	8.2	9.3	6.8	5.6	8.3	8.5	10.5	5.0	5.8	8.6	10.0	10.9	15.7	16.5	6.8	14.2	5.6	9.7	9.1	3.2	10.9	14.4	10.2	7.7	8.3	4.8	11.7	7.0	5.2	6.1	8.0	7.5	3.2	9.4	3.4	4.7	7.6	7.5	3.3	5.3	0.0	1.6	1.3	3.8	1.1	1.9	23.2	3.0	6.6	5.9	4.9	7.0	8.7	7.1	8.1	7.3	12.0	4.9	4.4	11.0	5.8	3.2	3.9	6.5	4.7	3.6	5.7	12.5	4.0	10.8	2.9	6.4	2.1	3.6	3.0	5.1	7.8	7.5	4.9	1.5	2.9	9.4	1.4	4.8	7.1	4.2	7.9	8.1	2.9	4.5	6.8	7.5	7.9	6.2	2.4	9.8	9.5	4.5	6.6	3.7	1.8	6.6	2.8	2.7	6.0	8.1	11.1	4.4	6.9	12.3	6.6	3.2	2.3	6.8	0.0	1.1	0.0	2.4	1.6	2.9	3.3	2.7	1.7	1.9	3.3	3.8	2.5	0.0	1.3	1.4	5.3	1.7	1.1	7.4	12.0	14.5	11.1	8.3	8.5	10.0	10.9	9.7	7.5	6.0	14.7	4.7	12.4	6.8	42.9	3.2	10.2	12.0	9.1	21.0	104.1	9.6	16.6	15.3	5.5	7.5	7.8	0.0	7.4	7.2	11.0	10.5	0.0	5.7	6.9	47.7	8.6	8.6	2.1	4.2	25.0	6.0	10.1	15.4	10.4	12.4	9.9	14.8	26.5	11.3	98.5	6.5	13.5	24.1	25.8	8.4	5.6	13.1	10.7	6.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	14	"Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.1	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	3.3	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.2	0.6	2.5	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.7	0.1	78.6	0.0	1.5	0.0	0.0	0.3	1.1	24.1	0.0	0.0	24.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	34.5	1.2	1.2	31.7	0.0	28.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	21.9	0.3
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	68.4	14.4	12.0	9.1	1.6	4.2	12.9	43.2	25.3	52.2	39.2	9.8	21.2	3.4	12.5	21.8	27.8	35.3	9.4	25.2	100.3	2.3	6.8	4.7	16.2	8.1	0.2	6.7	5.5	0.9	1.1	34.0	22.4	6.2	16.2	4.6	9.8	7.3	42.5	10.3	5.7	7.8	13.3	10.5	15.2	4.2	36.0	2.3	11.5	11.2	5.1	6.0	22.7	26.4	3.9	17.4	17.8	7.7	15.3	32.7	36.8	19.2	50.4	3.0	4.8	6.4	11.1	10.9	68.6	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5	0.0	0.6	0.0	1.0	12.6	0.0	0.6	0.0	2.7	1.2	0.0	0.0	2.5	0.0	0.5	106.8	0.1	0.9	0.0	0.2	20.2	3.5	1.3	0.0	0.0	8.0	0.0	0.0	1.8	1.5	41.2	1.1	2.6	0.0	0.0	2.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.4	20.9	14.9	8.2	2.4	1.5	1.6	1.4
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	32.9	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.6	0.0	0.0	61.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	43.3	4.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.5	0.2	0.3	3.9	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9	0.0	0.0	0.0	18.1	15.8	0.0	2.8	25.5	0.0	1.2	0.0	0.0	1.1	0.0	2.9	56.2	2.2	0.0	0.0	0.0	0.6	3.5	9.1	4.6	117.3	0.2	0.0	0.0	4.9	1.6	50.1	1.7	0.9	5.0	0.0	11.4	1.0	0.6	0.0	1.4	0.4	0.3	45.3	42.3	1.4	1.5	40.8	3.4	0.0	0.2	17.8
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Group enriched"	"Detected in many"	12	"Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.2	0.0	4.0	0.0	0.0	0.2	1.9	0.0	8.6	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.7	0.0	0.8	0.0	0.0	4.1	2.0	0.0	1.7	0.0	0.9	0.1	0.1	0.0	0.0	2.1	1.4	0.0	3.7	1.2	0.0	0.2	0.0	22.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	7.4	1.1	0.0	0.0	0.0	0.0	76.6	1.1	0.0	0.0	58.6	3.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.2	9.5	0.0	1.8	0.0	219.4	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.4	0.0	168.7	0.0	0.4	1.5	1.3	0.1	2.1	0.0	0.0	0.0
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		530000	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	44.1	7.3	19.4	27.8	23.8	37.0	61.1	22.8	24.4	26.4	34.4	8.6	18.4	28.6	20.2	36.4	49.5	23.9	47.5	57.1	17.2	8.3	39.1	21.9	35.1	38.1	10.8	14.2	27.3	24.0	26.2	9.7	35.0	7.5	28.9	27.6	16.7	20.2	27.8	39.5	18.6	44.1	28.1	11.2	22.9	29.3	15.1	6.6	45.7	18.9	39.2	31.8	34.9	39.6	12.7	14.4	77.9	12.1	11.6	21.9	13.0	35.1	30.8	1.8	9.2	39.5	39.0	19.7	26.3	67.8	16.4	17.0	27.9	55.0	2.3	19.1	39.3	1.3	46.1	7.9	22.0	10.0	59.8	14.0	14.4	18.3	21.6	23.2	15.8	35.8	41.2	13.3	9.1	7.0	32.5	23.3	19.0	14.1	26.7	12.9	20.9	19.2	34.9	3.3	35.4	65.5	14.7	2.7	53.3	27.7	32.7	0.8	6.4	11.3	45.5	25.7	16.1	13.5	19.4	28.0	11.5	17.3	26.3	13.8	16.3	22.2	15.2	12.0	26.4	7.6	22.6	12.1	77.9	14.5	9.6	15.3	12.7	18.3	20.3	9.1	10.9	17.3	14.9	43.8	11.6	10.7	14.4	21.9	13.0	19.4	23.8	22.8	24.4	17.2	8.3	10.8	14.2	7.5	6.6	89.3	65.4	74.2	217.3	45.4	1.2	269.2	201.2	96.4	109.2	209.3	0.0	234.0	281.8	337.9	2.4	74.8	352.8	0.0	309.2	260.9	113.9	251.0	115.3	34.3	206.7	3.2	74.5	82.9	136.2	4.7	86.0	136.1	86.0	249.7	151.8	36.1	317.7	312.1	87.0	110.5	2.3	90.5	126.4	2.8	34.1	36.8	155.2	122.2	162.8	514.6
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 23.8;HDLM-2: 12.3"					"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.3	180.9	5.3	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	43.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	139.9	0.0	0.1	18.7	0.0	18.5	9.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	20.0	0.0
ANXA7	ANX7	ENSG00000138279	"Annexin A7"	P20073	10	73375101-73414076	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 438.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004312, HPA064290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		540000	Nucleoplasm	Cytosol	"CAB004312: AB_626681, HPA064290: AB_2685233"	"unprognostic (1.48e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.06e-2)"	27.4	27.1	28.0	18.5	28.7	24.1	29.3	23.5	33.1	25.2	21.1	25.0	15.5	13.0	25.1	28.2	24.7	19.7	20.7	36.6	27.2	26.8	39.4	40.8	21.5	33.0	26.0	28.8	26.2	24.2	103.3	28.1	23.3	24.9	24.1	25.4	22.8	26.0	25.3	75.4	21.5	17.3	32.3	25.4	21.3	18.0	11.7	15.5	17.1	30.2	28.2	26.7	27.6	20.5	35.3	36.4	53.0	34.9	33.0	44.4	42.5	24.7	17.9	7.0	17.1	27.5	27.1	15.3	16.6	43.7	21.7	18.4	26.2	29.4	9.9	16.9	31.2	14.3	20.8	13.0	19.6	21.6	24.4	9.7	14.0	9.0	23.2	24.3	19.9	6.4	16.8	19.1	27.1	48.7	19.1	19.2	10.8	18.1	28.2	27.6	19.8	11.2	12.8	7.8	14.8	124.5	9.3	20.0	18.0	37.6	15.2	5.6	7.8	18.6	43.1	15.6	10.3	26.9	10.6	17.9	8.9	16.1	26.8	21.3	18.3	25.9	14.0	21.0	25.8	6.8	53.0	34.9	45.1	22.2	26.2	30.1	35.3	34.4	27.7	36.4	24.0	31.5	27.7	35.4	33.0	25.6	15.6	44.4	42.5	28.0	28.7	23.5	33.1	27.2	26.8	26.0	28.8	24.9	15.5	62.5	47.8	60.3	122.2	76.5	30.6	118.6	63.7	88.3	48.9	89.0	13.7	182.8	164.2	134.1	6.4	80.4	61.4	23.3	132.0	94.9	102.4	102.2	105.2	113.2	105.4	9.5	184.2	56.4	82.6	3.6	126.8	86.9	81.0	438.2	73.6	57.2	111.8	42.1	164.1	200.8	21.6	25.8	92.7	20.5	33.6	80.8	148.3	76.1	67.3	127.8
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.8	11.4	11.7	7.4	8.0	2.7	4.9	4.0	0.9	6.0	5.8	7.0	9.5	4.6	7.3	7.0	4.4	3.2	4.2	18.3	1.7	7.7	3.1	4.5	2.2	4.2	13.8	4.8	2.4	4.9	12.0	6.8	3.9	5.9	4.5	5.0	0.5	2.0	2.5	1.7	7.1	14.3	3.6	2.0	6.3	7.4	5.1	9.5	8.1	8.9	7.3	1.1	5.3	4.3	0.8	10.6	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.9	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7	35.7	17.9	12.7	10.5	12.7	45.7	11.3	22.9	20.1	14.8	59.3	56.9	33.3	33.2	32.3	35.0	28.7	39.6	23.3	15.9	35.6	25.3	20.9	26.5	52.5	68.3	95.3	33.7	81.0	78.2	20.9	31.9	26.9	8.5	30.7	27.3	29.4	24.3	20.1	26.2	42.7	64.8	25.8	14.4	46.9	25.1	9.9	23.8	20.8	32.0	9.7
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 beta 1 subunit"	O00203	5	78000525-78294755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	30.1	19.9	16.5	23.1	20.7	16.5	19.0	15.2	16.6	21.7	20.8	17.4	21.1	17.0	21.2	50.3	26.5	14.6	14.2	16.6	15.6	15.1	28.3	13.7	16.1	27.1	22.2	11.4	18.3	22.0	29.4	36.1	20.1	17.4	18.8	25.6	15.0	23.3	18.8	12.9	18.9	24.8	18.1	20.2	25.5	19.1	13.0	20.9	38.0	24.0	18.6	22.9	19.4	18.2	26.2	10.1	9.0	9.2	5.2	6.7	4.5	20.0	16.2	18.8	25.8	22.6	27.2	16.5	22.8	26.6	20.5	28.0	12.4	17.8	21.2	13.5	28.0	17.2	14.9	18.1	38.2	26.4	24.1	12.8	14.9	14.8	22.6	13.3	13.0	19.5	19.7	14.2	17.4	17.6	19.9	26.0	4.4	10.4	14.0	35.7	12.4	16.8	21.2	9.9	15.1	9.7	17.6	33.0	29.4	30.6	19.3	6.6	10.6	21.0	13.7	19.6	16.2	16.6	22.4	26.2	15.5	12.3	18.7	22.8	10.8	16.6	14.5	20.2	19.4	19.6	8.5	7.3	6.3	6.0	7.5	6.7	18.5	5.1	6.2	10.1	26.2	4.4	5.6	9.0	5.2	9.2	8.6	6.0	4.5	16.5	20.7	15.2	16.6	15.6	15.1	22.2	11.4	17.4	20.9	41.7	28.9	51.7	18.1	14.1	16.2	22.4	5.1	30.8	37.5	29.6	21.6	26.3	21.6	28.5	9.1	22.8	29.0	0.0	33.1	32.1	20.5	19.7	31.3	14.8	34.9	19.1	18.4	24.5	36.5	15.6	14.7	33.9	25.3	57.7	31.0	25.3	34.9	23.0	15.6	19.4	27.1	25.8	15.5	11.4	9.6	20.6	24.9	18.7	25.2	18.2
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 sigma 1 subunit"	Q9NUS5	20	3820524-3828837	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	9.4	14.9	10.1	8.6	13.4	10.7	6.8	7.9	15.3	6.7	10.6	12.0	13.9	10.4	7.1	11.8	8.5	8.2	10.6	13.2	10.2	9.3	12.4	18.9	7.9	19.3	8.9	10.7	8.1	16.9	12.1	9.4	13.0	7.1	8.2	7.5	13.4	13.8	7.0	27.2	7.3	9.9	6.7	8.2	10.2	9.9	19.9	6.3	11.2	13.2	11.2	8.3	7.0	5.8	7.8	10.8	4.7	12.9	6.5	11.9	6.6	11.0	21.2	3.0	2.0	4.1	5.3	3.6	6.7	5.5	6.7	5.3	17.9	11.9	6.4	7.3	7.1	12.7	9.9	2.5	10.9	2.3	3.5	7.0	10.6	6.2	15.4	7.0	7.3	6.5	9.0	6.2	8.3	6.6	4.5	7.8	7.8	7.5	12.6	8.8	18.1	16.9	6.4	2.6	8.0	17.3	7.2	5.0	6.6	7.5	9.0	9.1	3.6	6.7	20.5	11.1	2.1	10.1	3.7	10.6	14.1	6.7	7.2	12.7	6.8	7.5	3.5	4.9	6.6	12.0	1.7	8.3	4.7	11.9	12.9	9.2	6.1	10.1	9.9	10.8	7.8	9.4	8.7	2.1	6.5	7.0	8.7	10.3	6.6	10.1	13.4	7.9	15.3	10.2	9.3	8.9	10.7	7.1	6.3	0.0	8.8	3.7	4.0	1.4	14.4	10.1	10.2	5.3	4.5	3.5	9.8	17.2	10.0	8.7	2.6	6.7	8.5	0.0	11.0	12.0	4.2	4.0	13.9	7.4	13.6	23.8	12.1	6.7	5.1	2.5	5.5	6.2	5.0	13.6	5.9	12.3	9.1	7.4	3.9	6.2	19.6	12.9	3.9	14.9	8.5	0.9	15.4	4.9	5.2	2.7
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 zeta 1 subunit"	O43299	7	4775622-4794312	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	15.2	18.6	9.5	19.2	11.1	20.8	11.3	14.3	14.9	10.7	12.6	13.5	6.3	22.2	14.0	11.0	10.8	10.6	9.9	8.0	8.6	6.8	9.9	9.2	12.6	18.6	10.9	9.7	12.6	16.9	5.6	11.5	9.6	10.3	11.6	4.6	13.1	15.0	12.8	8.4	21.8	19.1	13.0	8.5	23.4	17.1	10.1	12.6	18.2	11.3	6.6	16.9	13.2	10.6	11.7	11.3	15.7	17.0	12.3	13.4	9.8	10.7	4.8	1.2	8.6	5.4	3.9	11.9	8.5	4.9	6.7	5.5	9.3	10.0	7.4	5.1	5.6	22.6	12.9	1.1	5.3	0.7	5.6	5.2	5.5	11.4	6.7	18.0	9.6	15.7	7.9	4.2	5.6	2.2	2.0	4.4	5.6	9.5	8.1	2.8	11.5	2.8	21.7	8.0	2.8	11.8	7.0	4.2	6.9	2.1	10.3	4.9	9.1	7.2	11.4	8.2	1.1	10.1	15.5	11.1	7.1	8.3	14.1	6.4	17.1	11.0	4.4	10.5	11.9	14.2	1.7	12.9	15.7	13.4	17.0	10.7	10.5	9.2	11.8	11.3	11.7	10.1	8.4	13.5	12.3	14.2	10.2	8.6	9.8	9.5	11.1	14.3	14.9	8.6	6.8	10.9	9.7	10.3	12.6	8.9	12.9	9.3	2.7	6.2	11.1	3.6	17.8	5.3	1.2	10.4	3.9	10.2	0.0	11.8	1.9	7.1	14.0	0.0	11.8	6.6	8.9	4.7	16.2	7.5	24.2	17.5	11.5	13.5	11.9	1.1	12.4	11.0	13.5	28.9	11.5	8.0	16.0	12.2	10.3	5.9	8.5	0.0	8.2	5.6	9.7	9.7	13.8	13.6	10.1	3.1
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916499	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	23.2	29.8	12.0	13.7	18.7	9.6	15.8	7.6	12.6	12.7	13.8	17.9	16.8	10.5	15.3	10.8	12.2	13.9	12.1	15.4	14.5	11.7	24.8	21.8	16.2	14.4	21.5	11.7	13.2	19.7	13.4	10.3	12.5	21.1	14.1	12.6	10.4	18.5	20.4	48.7	6.8	13.9	16.0	27.8	13.9	19.1	9.7	21.1	23.9	19.0	12.9	11.5	19.0	16.1	14.2	25.6	14.9	19.8	17.5	15.8	10.6	8.6	9.3	11.0	2.6	9.0	9.0	4.9	12.8	12.3	12.6	14.4	5.5	7.6	26.6	7.8	4.7	13.0	10.4	20.1	8.6	16.3	16.3	19.1	13.7	9.9	13.9	13.9	38.0	10.5	8.8	6.4	8.0	13.2	5.6	10.3	15.5	32.2	16.4	8.7	8.3	18.1	17.5	8.8	11.8	22.0	11.7	32.3	9.1	13.0	12.5	9.3	4.5	16.1	12.9	15.7	5.5	13.5	11.8	8.6	9.5	9.6	24.3	3.1	16.1	12.0	30.0	11.8	8.1	12.1	4.7	16.9	14.9	11.0	17.5	13.6	14.2	13.4	11.9	25.6	13.4	13.8	11.7	4.1	17.5	19.8	16.5	15.8	10.6	12.0	18.7	7.6	12.6	14.5	11.7	21.5	11.7	21.1	21.1	32.8	26.7	21.4	29.7	22.1	22.7	19.8	40.8	48.2	28.4	17.4	3.9	31.1	159.2	23.6	5.4	20.4	30.7	23.3	28.4	20.1	20.0	35.6	19.7	21.2	67.0	17.5	34.1	22.1	46.7	7.4	22.2	39.5	20.3	66.7	30.2	16.6	21.6	24.6	23.3	70.8	21.9	38.8	25.8	22.8	24.0	23.1	22.1	24.1	38.3	41.1
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39053910	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	6.9	9.0	1.9	7.9	2.3	2.5	3.1	0.7	2.0	9.6	5.4	3.9	14.5	3.1	8.2	5.6	5.6	8.1	3.1	6.7	2.4	1.7	5.9	4.5	5.4	13.1	1.8	1.2	14.1	5.5	3.9	4.9	1.7	2.6	6.4	2.4	6.6	6.4	16.3	3.2	1.6	5.0	3.9	3.6	14.3	4.3	11.9	1.9	7.3	4.2	2.5	15.9	5.4	4.5	23.2	4.3	5.9	9.1	9.3	6.9	4.7	4.4	3.5	1.4	5.5	4.1	6.1	2.0	3.4	6.3	8.1	12.9	3.0	8.0	10.6	3.6	7.1	6.7	5.6	1.3	5.3	3.2	10.0	4.4	14.3	0.0	1.5	8.1	1.5	6.0	8.0	2.3	4.1	1.4	4.4	7.4	2.8	1.0	17.7	4.0	3.2	3.2	1.9	0.6	0.0	0.5	5.3	0.5	2.3	6.7	5.9	0.7	1.1	4.1	1.1	2.2	3.3	4.2	1.2	1.9	1.7	4.7	0.2	1.5	3.1	1.6	0.5	4.9	1.4	2.6	1.4	3.3	5.9	6.1	6.6	6.9	16.4	4.0	6.2	4.3	23.2	2.5	3.9	1.5	9.3	9.1	3.7	5.4	4.7	1.9	2.3	0.7	2.0	2.4	1.7	1.8	1.2	2.6	1.9	0.0	0.3	5.2	4.0	0.8	0.0	4.4	10.2	2.7	0.0	0.0	0.0	1.4	1.7	7.1	2.1	1.5	0.5	0.0	3.5	1.2	2.2	3.4	2.3	0.9	5.0	0.0	1.2	4.3	2.1	3.3	4.6	1.9	5.0	6.4	2.1	2.0	4.6	2.8	6.0	2.8	0.3	0.0	1.9	0.3	0.2	0.6	1.4	5.3	1.5	6.2
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077005-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 66.5;monocytes: 92.8;T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	6.0	6.1	1.9	8.0	2.2	4.8	3.8	1.4	1.8	6.4	4.2	2.8	8.0	1.7	6.1	4.3	3.7	8.8	7.2	4.6	2.4	1.7	4.1	4.1	5.1	16.0	2.5	1.3	12.4	0.9	2.0	3.4	3.4	2.5	5.0	3.3	4.8	3.8	28.0	3.3	1.2	5.6	3.6	3.1	18.9	3.5	15.6	1.4	6.5	3.8	2.6	15.2	7.4	6.0	16.1	8.6	5.9	17.5	35.5	64.4	39.1	1.9	0.0	0.0	0.0	2.5	4.9	0.1	0.4	8.2	9.6	14.8	0.7	11.9	20.0	0.2	3.4	6.1	0.0	0.1	0.6	2.8	16.7	0.0	10.3	0.0	0.1	11.1	3.4	4.9	7.4	0.2	5.2	1.1	0.0	1.3	0.6	0.9	23.0	1.4	0.0	3.8	3.4	0.3	0.0	0.7	7.7	0.0	12.7	0.0	8.8	0.0	0.0	0.2	0.0	1.1	0.9	0.0	6.5	0.0	1.5	0.1	0.0	0.0	0.0	1.9	0.2	1.7	3.1	2.5	4.0	6.8	4.5	64.4	15.1	37.7	16.1	20.2	49.8	8.6	11.6	6.9	30.3	5.9	35.5	17.5	5.5	15.8	39.1	1.9	2.2	1.4	1.8	2.4	1.7	2.5	1.3	2.5	1.4	3.0	12.8	66.5	12.9	1.5	0.2	2.2	2.5	8.1	12.5	0.0	2.0	2.9	5.0	8.7	39.3	8.7	0.0	23.3	2.1	1.2	7.7	7.9	11.6	0.8	27.1	0.0	5.8	10.4	18.7	11.7	17.5	15.2	6.8	92.8	1.7	7.8	2.3	1.5	8.5	1.0	1.0	19.4	8.0	0.7	1.1	1.1	0.8	124.6	1.1	18.5
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.7;ductus deferens: 14.1"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 6.2;monocytes: 18.0;T-cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5"	"Group enriched"	"Detected in many"	14	"NK-cells: 11.8;T-cells: 15.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.4;HDLM-2: 4.3;Karpas-707: 11.3;U-266/70: 7.5"									"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	1.7	2.2	0.7	6.2	1.2	4.9	1.0	0.8	0.9	1.5	2.3	0.9	14.1	0.4	1.7	6.4	1.5	1.9	2.7	5.9	0.7	0.7	2.3	1.3	4.2	5.3	2.0	1.0	0.9	3.8	0.8	2.0	1.3	1.2	1.6	5.6	1.1	3.3	3.6	2.7	0.5	2.7	1.6	2.1	7.5	2.0	4.0	0.3	3.7	1.8	1.2	5.5	3.1	1.5	1.0	0.1	0.0	1.0	11.8	15.7	2.9	0.0	0.7	0.1	0.0	0.0	0.4	3.2	0.0	0.2	0.3	0.1	0.0	0.4	4.4	1.7	0.4	0.0	0.2	0.0	0.9	0.0	4.3	0.5	1.0	0.2	0.1	0.4	0.0	3.3	2.9	2.5	0.3	0.4	0.3	0.0	0.2	0.0	11.3	1.3	1.3	2.0	0.4	0.0	0.1	0.0	2.4	0.0	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	1.7	0.1	0.7	0.0	0.0	0.2	0.0	0.0	7.5	1.0	0.2	0.3	1.9	0.1	0.0	0.2	0.0	15.7	0.3	6.6	1.0	8.6	13.2	0.1	0.3	0.5	6.4	0.0	11.8	1.0	0.0	7.5	2.9	0.7	1.2	0.8	0.9	0.7	0.7	2.0	1.0	1.2	0.3	0.0	6.2	0.8	0.5	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.5	0.0	3.8	0.0	0.0	0.6	0.6	0.0	0.0	0.8	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	23.2	0.0	0.6
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.2	0.8	0.8	1.5	0.2	4.2	7.0	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.5	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.4	10.9	3.2	2.4	0.4	1.8	2.2	0.9	0.7	0.7	0.1	1.0	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.6	0.4	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.5	2.8	4.9	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4	6.0	4.0	21.4	2.2	16.1	4.2	7.0	7.6	8.1	9.1	0.0	3.9	1.5	0.0	0.9	1.6	140.0	1.1	70.0	0.4	1.1	8.4	3.7	7.0	1.6	5.1	3.2	3.5	65.7	14.5	1.1	4.0	5.7	27.0	3.6	4.7	64.4	0.8	0.0	0.4	0.3	3.3	109.9	101.3	3.2	0.7	13.6	0.8	20.8	6.3	2.8
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.6	37.7	7.4	33.3	9.1	18.1	39.4	19.4	17.3	22.9	8.9	38.8	31.2	23.9	38.1	11.0	10.9	27.5	12.1	31.9	4.6	16.8	72.1	20.3	17.8	40.5	28.8	13.9	16.7	19.3	34.6	18.3	23.2	10.6	28.6	40.7	42.7	17.9	11.6	94.5	39.2	41.1	28.5	26.7	49.4	42.3	11.5	56.5	25.3	17.5	36.8	22.6	37.0	21.7	20.9	7.2	71.5	27.7	18.5	20.7	18.1	16.7	19.1	35.2	29.5	65.7	30.5	37.0	18.3	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2	107.2	125.0	285.8	232.8	283.3	20.2	39.3	252.3	87.0	112.6	87.2	5.9	238.4	344.8	378.2	9.5	147.6	262.7	70.0	383.2	347.1	184.5	203.2	130.3	282.7	315.2	14.3	202.5	130.8	259.2	24.9	222.1	260.5	281.7	449.1	262.5	57.6	343.1	185.9	127.3	427.1	16.1	38.8	137.7	8.1	99.7	432.5	144.4	269.7	340.7	292.1
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.6	16.4	12.5	10.8	12.8	11.2	16.6	14.5	15.1	17.7	19.6	21.8	7.7	16.9	8.7	12.1	11.0	11.5	20.3	19.4	22.0	22.8	8.3	10.0	23.5	22.2	14.8	16.1	9.6	15.0	23.8	20.3	26.4	11.3	16.9	13.1	15.1	16.9	16.5	9.3	14.4	23.7	19.1	14.2	17.7	13.1	8.7	12.0	14.5	13.2	8.7	7.3	13.3	11.9	9.7	12.1	13.5	6.6	10.4	9.9	13.2	17.1	14.9	7.3	12.0	16.9	14.7	13.2	7.9	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5	17.9	31.9	15.7	18.7	14.8	13.6	12.9	28.1	25.4	19.4	8.7	9.8	23.7	24.9	20.4	49.1	11.9	11.6	0.0	24.6	22.8	12.6	16.4	16.1	17.4	16.5	12.7	16.1	6.7	15.2	35.4	12.4	14.5	13.5	20.8	12.6	17.8	24.5	3.5	9.9	24.1	16.2	12.9	12.2	35.9	27.0	18.4	23.3	14.1	15.1	20.4
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.0	3.3	1.4	2.2	3.2	0.8	1.4	1.7	0.8	1.6	0.7	7.8	1.6	1.6	0.8	0.7	12.3	1.0	0.5	0.1	0.8	4.8	1.3	1.3	1.1	13.0	1.0	2.7	1.5	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.8	1.0	1.8	1.6	1.0	1.8	1.4	7.5	3.0	1.4	3.5	0.6	0.9	1.2	1.4	1.0	2.1	0.4	0.8	1.1	1.6	0.4	0.9	1.3	4.1	2.5	1.1	1.1	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7	0.0	0.0	0.0	0.7	0.1	7.5	0.4	7.6	0.0	0.0	1.8	0.0	6.6	0.0	1.2	30.5	0.3	15.8	0.0	3.4	10.1	0.9	1.2	4.6	21.5	1.0	0.0	4.1	0.0	0.3	51.4	14.4	0.0	1.7	0.0	3.1	29.1	3.7	3.1	10.6	15.3	5.0	0.0	0.7	35.9	5.8	0.1	13.3	0.0	5.6	0.1
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.6	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	0.1	28.1	1.3	0.1	0.0	13.4	1.3	0.9	51.2	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.0	0.1	28.8	14.3	13.0	1.5	6.2	12.8	5.0	1.1	19.2	0.1	0.2	21.3	2.3	0.2	47.6	0.4	1.1	7.1	32.9	0.0	1.9	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.1	44.2	3.2	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0	35.7	265.4	2.2	608.6	1708.5	1.4	2.1	104.4	136.5	215.0	1526.7	2.0	0.6	0.0	27.2	1.3	40.5	4.2	93.5	41.7	1.3	46.3	959.6	19.7	111.7	2.2	0.0	7.9	16.0	3.8	0.0	30.8	32.1	150.1	1.0	63.7	0.3	32.0	2.9	1.1	28.8	0.4	0.0	42.2	0.0	1.0	2172.4	42.0	43.3	3.5	2008.6
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	20.3	29.3	12.6	20.2	19.2	15.3	17.0	17.2	18.2	25.7	23.7	23.9	25.0	12.1	14.1	23.0	21.6	28.7	22.2	23.7	14.8	22.3	26.1	12.1	31.1	12.3	27.0	24.0	37.2	20.1	24.2	24.5	21.5	17.0	19.7	15.4	22.5	23.9	17.4	34.4	17.4	25.9	18.1	17.2	32.8	16.2	16.4	27.3	14.7	19.5	14.3	11.0	18.5	17.1	10.1	20.8	32.2	18.2	18.7	16.7	18.8	33.3	17.3	31.0	19.8	9.4	22.2	27.2	13.3	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3	14.9	36.4	18.8	19.6	14.0	4.0	23.6	30.6	8.1	10.3	17.4	9.8	27.3	19.9	24.2	1.1	17.9	37.6	0.0	29.9	25.3	15.5	19.0	16.1	35.8	24.8	12.7	30.5	22.7	22.7	3.0	16.1	21.7	32.1	55.1	36.8	13.3	23.6	40.2	16.6	22.1	8.2	19.4	18.6	5.6	10.2	14.2	37.3	27.4	26.6	21.6
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919385-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041703	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041703: AB_10794304"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.76e-4)"	25.0	23.2	12.3	22.5	21.7	10.1	20.6	12.2	15.8	15.1	15.8	22.9	6.8	14.3	21.4	12.4	19.1	16.8	15.4	18.9	13.4	5.4	15.0	12.6	17.8	28.7	28.0	8.7	15.1	14.0	17.0	20.5	62.6	16.3	13.7	16.0	19.3	16.4	10.9	22.0	19.2	25.5	15.1	19.6	40.8	16.5	18.6	24.8	16.9	17.1	12.4	29.6	13.4	16.8	25.7	24.6	8.0	17.2	5.7	7.2	6.8	20.5	11.8	15.8	16.7	16.3	17.2	17.8	14.6	13.9	15.5	15.0	18.3	8.2	9.6	9.7	25.6	14.5	5.8	15.7	9.2	16.3	14.9	21.7	8.5	28.0	30.0	18.6	11.1	7.9	21.9	5.5	16.5	11.9	10.9	25.5	8.4	10.4	0.0	16.9	14.4	10.3	13.9	19.0	5.6	10.8	48.5	13.4	3.7	18.7	4.5	11.0	11.5	14.4	14.7	5.5	13.3	8.1	28.1	34.9	11.6	9.4	25.8	11.0	9.9	12.3	5.6	14.1	16.4	10.1	3.5	9.0	8.0	6.3	17.2	5.7	25.7	5.6	6.4	13.9	24.0	6.4	6.2	4.7	5.7	14.0	24.6	7.2	6.8	12.3	21.7	12.2	15.8	13.4	5.4	28.0	8.7	16.3	24.8	8.9	11.2	6.4	5.7	12.9	5.5	22.7	12.7	6.7	7.9	5.2	9.8	9.2	3.3	11.9	4.5	28.4	31.3	0.0	13.8	16.2	9.9	8.7	6.9	5.8	23.1	9.5	20.2	28.3	25.4	7.3	12.4	15.9	15.1	6.4	22.2	6.1	15.0	28.3	11.0	3.8	7.2	25.8	24.7	4.4	14.9	21.0	13.2	13.6	15.3	11.3
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 94.2;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 49.9;granulocytes: 196.2;T-cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 94.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.2"	"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4"	"Low region specificity"	"Detected in many"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	7.4	3.5	2.6	33.1	3.6	14.6	5.7	0.9	3.2	3.1	4.9	6.7	1.6	2.5	4.0	10.5	3.5	3.5	7.2	4.3	2.8	2.3	5.7	4.6	12.9	39.0	5.9	1.9	8.1	2.2	0.6	3.1	4.5	4.2	3.7	4.2	3.1	5.7	1.5	2.0	3.3	14.3	3.5	6.3	48.7	3.4	2.2	3.3	20.9	4.0	2.3	40.6	6.1	4.7	23.6	7.5	94.2	12.5	22.8	26.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.1	0.0	0.0	0.7	0.0	5.8	0.0	0.6	0.0	18.7	0.0	0.0	0.3	4.1	75.2	0.0	0.7	0.1	2.4	0.0	0.0	6.4	0.1	6.8	0.0	0.0	4.7	13.1	0.3	0.0	0.0	5.2	1.2	0.2	0.0	1.5	1.2	0.1	0.0	0.0	0.4	0.4	0.0	3.4	1.0	0.0	0.2	0.0	0.1	14.9	7.9	4.7	0.0	9.3	0.1	27.5	8.7	72.8	26.3	10.9	16.4	23.6	11.8	22.7	5.3	14.5	8.5	15.0	94.2	22.8	12.5	7.5	14.2	15.7	2.6	3.6	0.9	3.2	2.8	2.3	5.9	1.9	4.2	3.3	3.0	19.6	49.9	9.3	4.9	0.6	1.4	2.5	9.4	3.4	0.0	0.0	0.3	1.7	0.0	1.5	14.1	0.0	0.0	0.2	0.2	0.9	1.0	196.2	0.6	39.1	0.0	2.9	12.9	22.8	2.2	1.4	21.0	1.7	38.7	0.3	0.3	0.0	0.0	2.5	0.0	0.0	6.5	1.9	0.7	1.3	1.3	0.2	57.3	0.0	2.4
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 38.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 60.1;Paneth cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 12.4;HMC-1: 11.6;OE19: 14.6;RT4: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	6.0	3.1	4.9	21.9	8.7	15.0	5.5	5.2	6.3	9.3	23.1	6.4	2.7	14.9	3.2	7.8	35.0	4.5	17.4	7.0	7.5	3.2	11.0	2.4	10.5	24.1	8.2	2.4	2.4	3.5	4.3	4.0	9.7	7.5	6.1	13.0	3.8	13.6	9.1	2.6	11.6	38.8	3.8	10.2	28.6	8.8	2.9	8.0	29.4	6.3	5.8	34.1	8.0	15.0	4.1	7.8	10.4	11.2	1.9	3.1	3.5	4.3	4.3	0.1	1.3	0.6	0.3	12.4	0.0	0.2	0.3	0.1	3.8	8.7	4.0	8.5	0.3	1.9	2.8	0.5	0.8	0.2	8.0	2.7	0.2	1.6	2.4	0.1	0.0	11.6	0.6	3.5	0.0	1.3	0.4	2.6	4.3	1.0	7.2	0.3	3.0	3.7	1.3	0.2	14.6	3.6	3.1	0.2	1.3	2.8	18.8	0.6	0.4	0.5	3.7	0.2	1.5	2.9	7.3	4.1	0.0	1.1	0.0	0.4	9.0	5.8	0.8	0.2	1.1	0.0	1.0	4.7	4.2	2.8	9.3	1.8	4.1	1.7	3.1	4.5	3.4	1.4	1.4	10.4	1.9	11.2	7.8	2.3	3.5	4.9	8.7	5.2	6.3	7.5	3.2	8.2	2.4	7.5	8.0	6.0	19.1	20.6	15.4	9.2	2.6	9.8	17.8	2.7	7.9	17.4	3.9	6.4	3.3	4.9	0.8	20.2	60.1	0.0	3.0	8.9	2.5	21.5	4.6	1.5	13.3	1.6	18.4	16.5	38.7	0.9	0.3	16.4	6.8	1.0	29.2	1.2	11.8	59.6	0.0	5.0	1.4	0.0	3.1	2.3	1.9	7.5	11.8	14.9	32.0	47.8
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.5	26.2	1.6	0.0	0.2	0.2	1.3	0.0	0.0	7.1	1.0	10.2	0.1	0.5	1.1	18.6	17.3	0.0	0.1	0.0	0.1	0.1	2.6	6.6	0.0	26.9	0.1	1.3	25.3	0.3	0.8	0.1	0.0	12.0	3.5	49.8	0.1	0.2	2.4	3.6	0.2	0.6	0.2	0.3	5.9	24.3	0.5	0.1	0.3	0.2	0.1	16.3	13.9	23.2	0.2	21.7	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2	8.9	33.9	40.2	0.5	3.1	9.8	30.4	2.5	13.4	4.5	17.4	3.9	1.7	5.0	0.7	0.1	10.6	3.9	0.0	0.6	1.2	2.1	0.4	33.5	0.5	71.1	3.2	4.6	4.3	73.8	0.0	0.9	43.6	10.1	12.6	2.1	1.3	0.1	0.0	0.0	0.6	4.4	0.0	0.9	0.5	4.9	1.5	1.1	48.4	3.9	0.4
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	7.0	14.0	12.0	9.1	16.0	8.3	13.7	7.0	10.5	11.0	8.1	9.4	7.5	0.9	12.3	12.3	8.4	7.7	8.1	7.3	6.1	10.1	5.0	3.5	8.3	6.1	9.3	7.1	12.5	12.7	8.0	10.1	7.9	8.3	7.9	3.1	5.7	0.6	7.3	9.2	1.8	3.9	14.9	11.2	8.6	0.2	5.9	3.9	5.4	11.6	2.3	13.7	15.1	12.2	12.8	10.9	10.9	16.2	11.8	11.3	7.2	9.9	7.2	10.1	6.2	0.7	7.2	0.9	37.4	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9	3.0	3.4	0.8	2.3	1.0	47.5	11.8	0.0	1.4	2.3	1.8	88.4	1.5	1.7	1.0	5.3	3.5	14.6	0.0	1.4	0.5	3.0	3.2	9.2	4.9	3.6	20.6	5.2	2.5	7.5	6.7	4.4	4.0	1.7	0.0	4.0	12.3	1.1	5.1	4.2	0.8	54.7	0.0	4.1	3.0	4.8	1.8	1.3	0.0	3.9	2.2
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3"					"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	6.0	33.6	0.0	0.9	0.0	0.0	1.4	2.5	45.5	18.2	12.2	0.0	0.1	8.3	4.2	1.2	0.0	4.1	0.0	5.0	0.1	0.0	13.9	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	7.7	0.0	3.3	5.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.4
ARID2	"BAF200, DKFZp686G052, FLJ30619, KIAA1557"	ENSG00000189079	"AT-rich interaction domain 2"	Q68CP9	12	45729665-45908040	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 522.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063044			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA063044: AB_2684929"	"unprognostic (8.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (5.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (9.71e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.53e-2)"	9.0	7.9	7.1	14.6	7.2	14.0	11.8	15.7	8.8	10.2	11.4	8.2	17.9	6.4	12.2	10.7	11.5	8.8	10.6	8.2	7.4	5.8	8.7	6.9	10.2	13.0	9.6	3.8	12.2	10.7	18.4	15.1	10.3	7.5	9.9	8.1	10.1	9.7	20.6	8.6	13.5	12.6	12.5	7.3	10.2	9.0	30.9	11.0	33.3	11.5	8.2	11.2	10.0	10.0	2.1	5.3	10.5	4.9	3.1	4.4	1.3	5.4	7.8	14.0	6.1	6.0	4.2	7.6	3.8	5.4	5.3	5.0	11.1	5.6	10.5	7.1	5.2	3.9	6.6	11.3	6.5	7.7	4.6	5.4	13.9	8.6	5.4	4.1	10.9	6.4	3.4	4.9	6.7	10.8	7.5	5.4	15.9	11.7	10.9	4.7	7.1	15.6	7.8	8.4	0.0	4.2	12.1	10.0	10.1	5.1	9.1	7.6	9.7	6.2	7.2	6.0	8.4	11.0	21.9	6.4	5.7	6.9	3.8	4.9	7.3	6.1	29.4	4.4	28.8	4.0	10.5	1.7	4.2	4.1	2.2	4.3	1.7	3.7	4.4	2.4	2.1	3.6	3.3	2.4	3.1	4.9	5.3	3.1	1.3	7.1	7.2	15.7	8.8	7.4	5.8	9.6	3.8	7.5	11.0	26.8	27.9	10.2	11.5	30.0	49.0	12.6	5.1	9.4	12.5	27.9	64.8	11.9	6.6	11.2	522.0	21.5	15.0	0.0	8.7	8.9	17.5	17.9	20.9	13.1	9.9	30.2	20.2	16.5	27.5	122.6	23.0	20.0	13.5	12.6	19.9	19.7	15.6	24.6	21.2	6.9	67.9	25.8	22.7	61.7	16.5	36.1	19.6	24.5	16.0	16.5
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 38.3"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	4.0	2.3	1.7	6.2	2.3	11.5	4.4	4.8	3.8	3.6	5.0	1.6	3.3	4.2	2.9	2.9	4.1	2.7	3.2	2.1	2.2	1.5	4.4	2.6	6.1	7.8	2.8	2.0	1.6	5.5	3.4	4.1	38.3	2.1	2.3	1.8	2.6	2.8	5.6	2.0	3.3	5.0	2.6	2.4	8.3	3.4	17.8	2.5	6.6	2.1	2.1	4.6	4.0	6.9	1.5	9.2	6.4	2.9	1.9	0.5	0.8	1.1	1.5	5.3	1.3	2.2	1.7	64.0	5.0	3.2	2.7	1.8	21.6	0.1	0.4	1.2	1.7	0.6	0.4	2.1	1.1	1.2	6.6	1.5	2.1	1.9	19.4	0.9	7.4	5.5	2.4	1.7	1.7	0.4	0.4	0.9	1.7	27.8	6.2	0.7	1.7	2.8	8.4	5.1	0.8	0.3	6.5	1.6	4.1	0.3	1.1	2.5	4.9	1.6	1.3	0.9	12.3	2.3	19.9	1.5	1.8	2.4	2.5	0.5	14.6	13.0	3.8	1.1	4.3	1.2	0.8	2.4	1.6	0.5	2.1	0.5	1.5	0.3	0.4	1.5	0.9	0.5	0.2	6.4	1.9	2.9	9.2	0.3	0.8	1.7	2.3	4.8	3.8	2.2	1.5	2.8	2.0	2.1	2.5	6.0	3.2	27.9	7.8	13.2	8.8	6.5	0.0	0.0	1.2	14.0	7.9	156.8	8.3	4.8	29.9	7.8	3.2	23.3	2.8	418.2	16.2	7.5	3.5	6.7	78.2	6.4	45.1	9.8	34.1	2.0	6.6	32.5	15.1	35.1	11.2	2.3	9.8	0.0	6.0	4.5	3.3	0.0	12.8	0.6	8.5	13.4	433.4	10.9	4.3	1.8
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Smooth muscle cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 73.1;RPMI-8226: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.5	0.8	0.9	2.2	1.4	4.9	1.7	1.5	0.8	0.2	0.2	1.0	0.8	2.6	1.3	0.4	0.0	0.5	73.1	1.1	1.8	0.3	1.7	1.0	1.2	1.4	0.6	1.6	1.4	0.2	1.5	1.5	2.2	1.5	11.1	0.6	0.8	2.4	4.3	0.9	0.4	0.0	3.3	3.0	32.2	0.2	0.7	0.6	0.3	0.1	0.1	1.1	0.4	0.0	2.7	1.4	1.5	1.9	1.7	1.2	6.8	5.3	0.9	0.8	3.0	1.4	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2	3.0	28.9	11.8	34.4	46.5	17.4	12.2	5.1	10.7	11.4	3.5	29.5	3.6	3.3	29.9	14.9	43.6	3.2	0.0	27.0	7.0	17.5	22.9	58.0	22.2	62.8	0.0	0.0	22.1	29.8	23.3	3.4	64.4	55.6	95.6	5.4	6.2	24.8	5.3	6.0	5.0	24.7	45.3	294.5	2.7	17.6	28.4	3.3	91.4	2.6	17.8
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474326-72602985	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003295, HPA073245"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA003295: AB_1845017, HPA073245: AB_2686587"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	15.3	15.6	11.4	17.4	15.5	24.6	13.3	20.4	21.5	15.8	14.5	10.4	14.0	17.0	21.1	11.2	14.2	12.3	14.4	19.7	10.5	10.5	10.9	10.5	13.7	9.3	10.1	15.0	17.3	13.5	12.9	14.0	15.4	12.6	14.0	7.6	13.0	13.2	13.1	68.3	16.3	13.5	15.8	10.7	11.4	12.5	55.2	10.0	16.9	11.7	13.0	12.7	18.4	20.4	1.9	1.1	4.6	1.5	2.1	2.5	0.3	9.4	9.9	9.8	5.7	5.1	3.6	11.5	10.6	3.9	4.8	3.3	10.0	8.1	9.2	16.0	4.5	17.0	13.5	10.0	5.5	2.7	16.4	6.9	7.0	12.2	6.6	3.6	10.4	8.1	4.2	1.9	5.3	6.9	4.6	3.5	6.8	7.3	11.0	4.7	6.1	10.0	4.0	10.6	3.4	3.6	11.4	11.9	5.2	2.7	15.8	9.2	10.5	13.8	6.2	16.3	13.5	5.0	12.0	9.1	8.0	11.1	30.7	14.8	11.6	23.2	10.8	5.3	9.5	8.4	4.6	1.0	2.2	1.7	1.5	1.5	0.7	1.3	1.1	0.7	1.9	1.6	1.5	3.4	2.1	0.7	1.1	2.5	0.3	11.4	15.5	20.4	14.0	10.5	10.5	10.1	15.0	12.6	10.0	17.9	30.7	20.4	42.7	58.8	62.5	41.5	20.4	29.4	30.7	17.4	86.4	15.9	3.3	17.2	84.9	33.4	23.6	0.0	16.2	16.9	29.1	45.9	43.7	24.7	16.7	58.8	44.6	41.1	23.7	41.4	26.4	21.3	15.1	10.0	22.7	24.7	20.6	20.1	25.8	12.2	60.6	19.4	46.1	40.7	29.7	52.2	34.1	30.5	20.9	52.0
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.4	14.6	20.1	14.7	9.4	14.0	3.5	6.7	10.3	8.2	9.0	5.0	4.4	3.5	6.5	10.8	9.9	6.3	7.6	9.0	10.3	9.2	7.9	5.7	10.4	4.7	10.1	2.6	5.8	7.1	7.6	11.3	6.7	21.9	9.3	7.1	2.5	3.6	13.6	8.7	5.4	4.2	7.7	5.4	5.8	4.5	14.9	3.1	10.9	4.5	7.1	15.5	5.1	1.1	7.9	11.6	26.8	2.6	5.3	5.6	7.9	11.3	9.2	2.5	5.0	6.5	14.8	7.9	4.8	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3	50.6	35.3	24.6	62.4	28.5	163.4	124.2	25.5	234.2	69.4	59.3	110.0	37.6	198.9	63.3	31.0	37.3	8.7	0.0	38.5	31.6	63.5	46.4	32.3	23.7	54.8	92.2	71.9	38.1	15.3	15.4	56.1	32.0	72.6	102.8	28.8	161.1	29.6	11.5	97.9	174.9	241.8	25.8	102.0	184.2	20.1	27.7	27.0	20.1	26.6	42.6
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1213.7;Late spermatids: 2876.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;K-562: 73.5"	"Low region specificity"	"Detected in all"							HPA064513			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064513: AB_2685276"	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	22.6	3.6	12.3	6.7	6.7	30.8	21.5	3.0	15.8	16.9	19.4	3.2	7.4	11.3	13.6	9.9	23.5	11.0	7.5	7.0	6.0	4.6	5.2	6.6	8.6	9.5	10.3	11.0	5.2	3.5	1.8	5.6	19.2	8.5	12.0	13.7	4.0	39.0	6.8	4.2	34.9	44.6	12.8	6.5	9.5	10.3	71.2	6.7	3.7	8.8	9.2	6.5	10.5	25.0	22.8	7.4	3.3	15.4	6.5	17.6	7.3	10.1	10.9	29.0	61.8	4.7	7.8	0.0	4.1	3.8	6.8	4.1	9.6	7.7	0.0	1.8	5.8	17.5	2.9	6.4	5.3	6.9	2.2	4.8	2.1	14.2	8.9	9.7	8.9	3.8	3.5	21.1	4.0	17.9	4.3	16.3	4.1	73.5	10.0	6.9	4.4	0.4	12.6	10.5	29.7	12.5	0.0	10.1	4.7	9.0	4.9	5.3	5.0	6.9	7.3	1.4	7.8	3.6	7.3	5.6	2.7	9.7	10.3	16.7	4.6	6.0	2.3	7.1	3.7	10.9	3.3	7.8	0.3	6.3	13.0	17.6	21.4	15.0	9.7	7.4	22.8	7.4	6.1	1.1	6.5	15.4	6.6	8.9	7.3	12.3	6.7	3.0	15.8	6.0	4.6	10.3	11.0	8.5	6.7	20.8	20.7	36.3	179.9	301.7	21.4	12.9	40.8	100.4	60.3	19.2	80.5	129.5	23.2	34.7	1213.7	160.4	353.7	23.3	25.7	18.5	63.5	47.1	78.5	18.7	55.4	3.2	60.0	103.2	124.4	2876.1	63.9	134.7	114.7	54.1	63.0	9.4	39.9	112.2	25.1	13.0	114.7	12.9	42.2	236.6	53.4	205.1	371.3	38.3	56.5	52.6
ARL6	"BBS3, RP55"	ENSG00000113966	"ADP ribosylation factor like GTPase 6"	Q9H0F7	3	97764521-97801242	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 22.7;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 54.6;Spermatocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019361	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA019361: AB_1845028"	"unprognostic (1.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.88e-2)"	"unprognostic (5.55e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (9.49e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.97e-1)"	5.5	9.2	8.8	3.6	18.6	1.6	6.0	10.0	17.7	6.5	4.9	5.0	7.3	2.7	7.9	7.3	5.3	11.9	6.2	5.9	17.1	11.0	13.2	4.4	8.4	3.9	8.9	14.1	6.4	5.6	22.6	22.3	5.0	12.9	7.1	4.6	7.3	9.1	6.5	2.9	5.2	3.2	7.2	8.0	4.7	5.0	10.9	9.0	4.2	9.1	2.0	3.8	5.6	5.1	2.7	1.0	0.5	1.0	4.1	4.8	1.6	7.7	4.4	4.0	3.3	10.1	7.1	1.0	5.1	4.8	4.5	5.8	1.6	3.1	4.2	4.9	2.4	7.4	3.8	5.1	5.8	9.2	5.2	3.1	1.2	3.3	1.7	4.9	5.3	2.8	3.6	4.2	6.0	1.5	4.0	4.4	5.5	1.4	0.8	7.2	2.8	3.0	2.6	5.0	4.1	5.0	1.5	4.2	2.5	5.1	2.2	22.0	11.7	4.4	3.0	9.2	2.8	3.6	2.1	3.3	4.5	3.9	3.9	6.8	3.5	4.2	4.9	8.3	2.9	5.4	0.5	0.5	0.2	2.4	0.7	4.8	1.9	2.1	2.5	0.9	2.7	3.6	3.0	0.0	4.1	1.0	1.0	3.6	1.6	8.8	18.6	10.0	17.7	17.1	11.0	8.9	14.1	12.9	9.0	3.0	2.2	0.5	2.8	2.9	11.0	1.8	0.0	22.7	5.7	8.7	25.5	1.1	3.3	3.4	15.0	2.9	0.0	0.0	2.2	1.7	2.3	1.7	0.0	2.6	1.6	4.8	2.4	4.9	1.3	3.7	3.7	0.8	1.7	0.0	1.3	6.5	2.0	2.0	3.9	8.2	54.6	6.5	3.3	30.4	5.3	1.8	0.6	1.5	1.2	1.4
ARL6IP4	"SFRS20, SR-25, SRp25, SRrp37"	ENSG00000182196	"ADP ribosylation factor like GTPase 6 interacting protein 4"	Q66PJ3	12	122980060-122982913	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052098	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052098: AB_2681724"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.04e-3)"	"unprognostic (6.48e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.03e-5)"	"unprognostic (4.01e-2)"	"unprognostic (8.41e-8)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.43e-2)"	"prognostic favorable (1.08e-4)"	42.1	59.6	63.3	35.7	46.8	55.3	40.3	36.9	55.9	36.7	43.0	32.2	38.9	43.7	33.8	30.7	38.9	42.9	40.1	57.0	42.8	40.9	45.2	59.1	33.9	51.6	45.2	38.3	50.0	94.4	30.0	34.7	29.7	35.1	38.9	24.7	39.7	59.7	41.2	131.1	30.7	44.9	64.3	36.1	38.1	41.6	35.2	27.7	35.5	39.1	43.4	39.9	39.5	39.9	54.4	72.4	58.1	81.5	46.5	59.6	61.3	49.0	53.6	35.3	23.6	24.8	32.9	27.7	28.3	34.1	42.6	32.4	26.4	20.9	46.9	35.6	35.8	19.9	26.0	28.1	45.9	19.0	41.5	29.3	77.9	47.5	51.8	47.8	42.4	34.4	34.0	37.1	32.7	43.1	46.8	46.8	37.9	34.5	22.8	34.0	57.9	49.3	77.2	27.7	29.7	34.0	37.6	38.8	55.4	36.8	41.9	34.3	41.1	26.7	44.8	65.1	16.1	58.7	55.3	41.8	24.7	45.0	23.5	35.2	49.0	23.6	53.4	35.6	49.8	30.8	32.9	58.4	58.1	47.4	72.2	51.0	54.4	57.0	52.5	72.4	50.6	55.1	49.4	16.1	46.5	81.5	49.3	59.6	61.3	63.3	46.8	36.9	55.9	42.8	40.9	45.2	38.3	35.1	27.7	86.4	116.6	229.3	258.2	181.7	102.3	0.0	173.3	87.0	80.8	200.7	41.2	248.7	437.7	251.9	151.9	255.7	444.9	46.7	552.1	221.9	252.2	285.2	160.8	400.6	340.2	92.2	214.5	213.6	390.7	256.2	206.0	341.0	357.7	480.7	268.3	146.1	343.4	291.0	170.1	721.8	106.3	174.6	249.2	209.1	156.8	177.7	200.9	256.7	288.4	330.8
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 60.2"	"Group enriched"	"Detected in some"	65	"Early spermatids: 374.1;Late spermatids: 785.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2"	"Not detected"	"Not detected"							"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	0.5	0.4	0.9	0.5	1.2	0.7	0.7	0.5	0.9	0.6	0.5	0.5	0.5	0.0	0.5	5.8	0.5	0.6	0.8	0.5	0.7	0.9	0.5	1.4	0.5	1.1	0.7	0.5	1.0	0.5	0.1	4.8	0.5	0.5	1.1	0.3	0.6	0.5	1.0	0.5	0.5	0.5	0.6	0.5	0.8	0.1	60.2	0.5	0.5	0.7	0.5	0.6	0.5	0.5	0.1	2.9	0.0	1.0	0.2	3.2	0.4	0.0	0.5	3.2	3.8	7.3	3.4	0.0	0.1	0.2	0.3	0.4	0.1	0.2	0.7	0.1	0.1	1.1	0.1	1.1	0.2	0.2	1.6	0.9	0.4	0.1	0.1	3.8	0.0	0.0	9.7	2.3	0.1	1.3	3.7	0.7	2.8	0.1	4.5	1.1	0.4	6.6	0.8	0.5	0.0	0.2	3.0	0.0	0.0	0.8	0.0	0.9	3.2	0.0	0.0	0.5	1.5	2.0	0.3	0.0	0.6	0.3	0.1	0.0	1.0	0.3	7.2	0.3	4.0	0.3	0.0	1.0	0.0	0.1	0.0	1.2	0.0	1.2	0.5	0.7	0.1	0.7	3.2	0.0	0.2	0.1	2.9	0.0	0.4	0.9	1.2	0.5	0.6	0.7	0.9	0.7	0.5	0.5	0.5	0.0	0.0	0.0	1.7	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	374.1	0.6	0.0	0.0	0.0	0.0	0.4	0.5	0.0	2.4	0.0	0.0	0.0	0.0	1.6	785.6	7.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	3.9	0.1	0.1	0.0	0.5	8.9	5.4	0.1	0.0	0.0	0.0	0.3
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	14.9	0.1	13.3	12.1	0.1	16.3	20.5	0.4	0.4	0.0	6.3	0.0	0.0	21.4	0.0	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.5	0.0	14.1	0.1	0.0	19.1	5.2	12.8	0.1	20.2	17.3	0.0	0.0	0.1	48.1	0.0	0.0	0.2	34.7	0.9	0.1	4.0	26.6	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	27.9	7.6	0.0	3.8	18.4	19.6	11.5	0.1	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7	14.9	5.4	4.4	13.8	3.8	11.2	22.2	7.6	2.7	15.9	31.4	7.9	1.0	3.3	8.0	0.1	13.0	0.0	0.0	1.8	0.4	20.2	13.8	2.3	0.4	3.6	1.6	8.7	16.0	2.1	0.4	22.5	4.0	5.0	11.8	2.2	7.0	3.1	0.0	23.0	4.2	9.7	58.2	26.4	1.4	1.1	2.6	4.2	2.5	1.2	6.2
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing, X-linked 4"		X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 10.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 24.7;Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favorable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	1.5	4.6	1.9	0.8	2.7	0.3	2.9	3.2	5.7	2.4	1.7			0.6	4.0	2.8	0.7	2.8	1.1	1.2	2.0	2.9	1.2	0.5	1.5	0.5	1.9		8.5	1.4	10.8	4.3	1.6		4.1	1.6		1.2	5.7	1.6	2.1	1.5	2.8	1.4	1.3	1.3	0.4			2.4		0.5	2.1	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.3	0.6	8.2	0.0	4.0	4.2	0.8	5.6	4.4	4.6	9.0	1.9	0.8	0.0	2.2	8.3	0.1	1.0	0.0	0.1	7.6	0.0	0.9	0.6	2.3	0.0	2.3	0.0	3.1	2.6	0.4	10.0	0.0	0.0	8.0	0.0	0.0	0.7	2.0	0.0	0.3	0.3	6.0	0.8	0.0	0.4	6.8	0.0	1.2	1.4	5.6	5.1	0.8	0.0	3.0	1.4	0.6	1.2	3.0	2.1	1.3	6.4	0.0	0.0	0.0	0.0	3.9	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0											3.0	5.0	0.5	6.3	2.2	24.7	8.7	0.0	14.7	11.4	26.2	7.9	1.4	14.9	2.2	0.2	7.7	2.6	0.0	2.0	0.6	7.0	8.5	3.5	2.1	2.0	22.3	2.9	4.3	4.6	0.4	9.8	2.0	16.9	2.8	2.7	10.8	2.1	3.5	11.7	4.4	7.4	0.0	11.4	1.0	1.2	3.0	1.3	1.8	3.6	3.9
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809705-150876768	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	23.5	20.8	12.1	14.5	12.6	11.3	25.1	25.4	14.4	28.0	17.2	18.7	12.8	10.9	26.1	14.4	16.6	20.4	17.9	20.0	10.2	8.2	14.4	32.2	21.6	12.0	11.6	9.5	31.8	22.4	16.5	22.9	31.7	12.3	18.2	16.4	28.3	15.2	16.3	25.5	21.9	15.2	22.6	14.0	19.2	16.5	14.9	12.3	18.8	16.1	13.9	18.0	23.0	24.4	6.6	12.7	23.9	15.6	8.0	8.8	9.7	4.0	4.2	6.4	4.8	13.7	13.2	8.6	4.6	9.2	6.4	5.8	3.6	4.2	4.3	4.2	8.3	3.1	4.7	5.8	5.2	5.6	6.9	3.5	5.2	7.2	4.2	7.9	6.1	6.1	10.3	4.9	7.7	6.8	7.7	7.8	5.9	6.6	8.7	6.5	8.0	4.9	3.4	5.2	7.4	3.3	6.2	7.7	6.1	5.0	4.2	4.2	6.3	9.0	6.2	3.6	9.0	7.8	13.4	5.5	5.3	4.8	4.2	4.0	9.9	7.2	97.0	6.5	0.2	3.6	23.9	15.6	13.9	8.8	14.7	7.9	6.2	7.2	8.4	12.7	6.6	7.0	7.1	8.1	8.0	14.7	5.2	7.2	9.7	12.1	12.6	25.4	14.4	10.2	8.2	11.6	9.5	12.3	12.3	11.9	9.3	9.7	7.8	12.6	20.9	10.6	22.9	6.7	11.4	10.4	51.1	20.7	3.3	8.1	4.2	11.7	8.6	0.0	8.5	31.6	20.3	7.2	3.5	36.0	17.1	6.4	19.5	31.9	35.9	2.1	30.0	15.7	10.1	14.4	15.1	7.7	8.6	7.0	30.8	9.3	37.6	12.9	15.0	18.6	15.7	13.4	24.7	10.1	8.0	8.6
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	12.3	28.5	13.4	10.3	13.3	13.4	18.2	24.4	25.2	16.4	10.3	5.7	10.6	11.8	10.4	6.5	9.3	9.7	9.4	8.1	11.5	7.5	11.1	17.3	12.1	15.0	6.7	13.1	21.1	9.8	6.1	17.8	9.2	9.3	7.5	8.9	8.6	11.2	8.2	19.2	27.2	10.9	11.7	9.6	10.4	9.6	16.2	9.3	29.2	17.6	0.7	12.2	8.1	17.0	2.8	6.1	20.0	7.8	9.8	19.7	7.3	6.9	6.7	6.2	4.2	11.9	7.7	4.9	7.0	7.5	6.8	8.1	3.4	10.1	0.1	2.2	5.2	9.9	2.7	4.8	8.4	5.9	11.8	5.1	3.2	5.5	1.7	21.3	1.4	13.2	9.6	22.0	2.5	18.4	5.0	4.9	13.6	1.9	12.4	6.9	3.7	3.3	0.7	1.7	6.0	3.7	4.2	7.8	3.4	6.7	1.6	1.3	12.0	5.8	2.0	6.7	7.0	4.5	5.9	9.5	7.2	5.6	17.0	4.0	3.6	9.5	0.0	7.1	3.7	6.2	4.4	6.7	13.7	14.3	6.9	19.7	2.4	13.4	12.9	6.1	2.8	7.8	9.1	20.0	9.8	7.8	1.1	8.5	7.3	13.4	13.3	24.4	25.2	11.5	7.5	6.7	13.1	9.3	9.3	23.8	16.0	4.2	11.8	27.4	25.4	7.2	10.2	4.0	13.6	1.8	15.7	13.7	14.9	6.0	1.2	6.3	10.2	0.0	5.8	1.7	9.3	5.8	2.3	18.7	7.2	28.6	1.2	12.9	15.1	2.5	11.8	10.5	3.3	9.0	4.7	16.9	5.7	5.9	18.7	7.8	29.1	12.9	8.2	4.1	3.8	28.2	5.3	18.1	3.4	12.1
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.3;U-2197: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.9	5.6	1.2	0.4	1.1	3.4	17.7	7.8	10.3	5.1	8.0	5.3	17.1	0.2	4.4	3.7	15.8	9.1	3.6	27.4	13.1	35.3	4.7	4.2	3.7	4.4	1.5	8.5	1.8	1.2	2.4	17.8	14.0	8.8	23.9	5.3	2.1	9.0	5.8	2.6	4.6	4.6	9.7	7.5	19.7	8.6	20.7	1.3	4.3	12.6	4.1	0.7	4.0	0.6	0.1	3.1	0.8	2.8	16.2	16.6	9.6	48.3	32.2	1.3	2.4	0.0	14.3	6.9	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3	3.0	2.2	0.0	32.7	0.7	1.1	0.8	17.8	0.0	7.9	8.7	0.0	1.3	0.0	22.0	3.3	4.2	0.7	0.0	23.8	3.5	2.3	33.6	0.0	4.2	1.3	0.0	1.2	3.1	2.8	3.0	0.0	5.0	1.7	26.2	2.7	0.0	57.8	0.0	0.0	0.6	0.0	0.0	2.1	3.4	4.9	1.9	3.5	0.0	0.6	126.8
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555074-95605064	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	8.5	10.2	6.9	4.8	7.6	4.7	7.6	14.2	12.3	8.9	8.6	4.3	9.6	5.1	8.5	9.6	6.7	7.4	6.9	8.5	7.9	7.1	11.5	9.7	7.4	5.6	8.4	9.9	12.8	11.7	29.3	14.5	11.2	7.2	10.7	5.9	7.3	6.7	11.2	5.5	8.4	5.4	6.7	8.8	5.5	9.7	4.5	7.5	10.6	15.8	2.8	4.5	9.2	14.0	6.7	2.7	10.0	1.6	3.9	9.2	2.3	3.4	2.2	4.6	4.6	23.2	12.1	6.7	10.9	6.3	4.3	8.8	2.8	5.4	4.7	5.7	3.7	7.7	3.3	4.0	6.9	9.4	5.0	5.9	3.7	5.5	4.5	6.8	2.0	3.0	8.9	6.2	6.5	4.2	9.0	6.9	6.4	3.7	5.1	9.4	1.6	5.6	3.9	6.0	1.1	10.5	3.5	7.4	7.4	9.8	0.8	3.3	3.3	6.7	2.2	6.5	6.7	6.2	2.2	12.4	6.8	5.5	10.5	6.6	4.4	7.4	5.6	6.8	5.5	25.2	10.0	1.6	2.5	5.3	1.5	6.1	5.3	6.0	6.7	0.8	6.7	9.2	6.9	1.5	3.9	1.0	2.7	4.5	2.3	6.9	7.6	14.2	12.3	7.9	7.1	8.4	9.9	7.2	7.5	3.0	2.1	2.7	7.4	3.9	8.1	3.9	2.5	5.3	2.3	7.0	11.8	9.0	3.3	3.0	6.3	5.4	2.5	0.0	2.2	43.9	10.4	4.5	23.0	12.1	3.9	9.5	2.9	3.7	3.1	1.8	10.0	5.2	5.0	6.4	1.8	13.2	1.9	3.5	11.0	4.5	9.1	0.0	8.3	2.2	7.9	6.0	4.2	9.6	3.0	1.6
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	10.6	15.5	8.7	5.9	9.9	0.7	15.2	2.6	8.3	11.0	8.9	6.6	13.5	2.4	7.9	7.7	12.9	8.7	7.8	20.7	6.9	5.1	10.7	7.4	7.9	2.3	9.2	6.1	29.6	13.7	13.7	7.4	12.4	16.3	12.0	6.8	8.2	14.6	25.5	24.2	32.5	3.7	9.9	15.4	1.9	8.9	9.4	6.7	0.2	12.0	12.0	6.2	7.0	17.7	0.1	0.0	0.0	1.6	0.0	0.4	0.4	1.0	1.0	10.6	6.9	19.6	18.6	13.1	1.9	2.3	3.0	3.8	0.7	0.0	5.4	2.2	3.7	1.7	5.0	7.3	1.7	1.7	0.2	0.9	0.3	2.8	6.8	10.6	0.0	0.5	23.7	2.7	4.7	4.3	8.9	2.3	0.8	3.6	0.0	1.8	2.2	0.7	0.0	1.8	2.9	2.5	2.8	1.1	0.0	2.0	2.1	0.4	3.6	8.3	2.1	2.1	5.5	7.9	0.0	0.8	1.2	3.2	3.6	0.1	2.3	2.3	0.6	0.5	0.0	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.4	8.7	9.9	2.6	8.3	6.9	5.1	9.2	6.1	16.3	6.7	8.9	7.0	0.0	1.7	1.8	1.0	11.6	0.0	2.7	2.3	3.5	0.0	1.6	3.3	4.0	3.5	3.1	2.1	0.0	5.2	32.0	6.7	3.3	1.1	3.4	1.6	0.0	1.2	3.7	0.0	5.6	11.5	0.4	0.0	0.0	7.0	7.5	4.0	0.0	12.7	4.9	0.5	0.0	1.9	6.0	8.1	3.8	1.1	0.0	3.7	1.1
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 44.9;Hepatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 30.0;RPMI-8226: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	7.7	14.0	5.8	5.8	7.3	2.7	10.8	12.2	18.2	7.4	23.7	7.3	6.9	21.6	6.5	11.0	7.5	11.8	9.6	7.9	5.3	5.8	18.4	28.5	5.4	14.7	5.8	5.5	13.6	8.4	2.8	5.9	3.3	8.7	6.7	5.9	41.1	6.1	6.3	8.1	8.1	26.4	5.1	5.1	7.0	6.9	4.7	4.9	2.1	4.6	7.0	11.7	9.3	8.6	2.3	10.8	0.4	9.5	0.8	3.5	5.2	4.7	6.1	2.7	11.8	11.5	3.1	4.7	0.8	2.2	2.7	3.5	5.2	9.1	30.0	7.4	1.8	1.1	7.5	6.2	6.2	0.5	1.4	10.5	4.3	3.8	4.0	7.3	3.9	0.4	5.0	10.0	1.7	2.3	3.3	2.5	8.0	5.3	0.6	0.8	3.4	4.6	3.6	5.6	14.2	3.7	1.9	0.2	31.9	3.8	7.7	5.3	12.4	5.8	3.9	9.4	0.8	12.3	5.0	0.6	1.7	2.9	7.0	2.5	1.4	3.7	20.1	5.2	10.1	1.3	0.0	9.5	0.2	1.2	6.7	2.1	1.5	3.5	1.5	10.8	2.3	3.5	1.6	0.4	0.8	5.0	0.3	0.9	5.2	5.8	7.3	12.2	18.2	5.3	5.8	5.8	5.5	8.7	4.9	0.0	7.2	0.0	1.5	1.4	44.9	6.9	7.6	6.7	5.7	1.8	17.7	4.6	5.0	4.6	0.6	3.7	18.4	0.0	4.0	1.2	5.8	2.3	3.5	52.1	6.5	15.9	4.1	3.7	11.9	0.0	12.4	4.5	8.5	1.8	6.5	8.5	3.8	11.2	20.1	25.4	11.4	6.5	8.1	0.2	2.2	1.5	1.7	2.5	11.7	1.0
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	17.2	23.3	23.2	13.3	25.9	10.9	20.9	27.4	23.8	21.2	12.4	25.7	19.6	9.5	16.9	21.3	16.4	17.2	16.0	26.4	24.7	21.6	18.6	24.3	12.7	19.8	35.2	14.9	21.9	24.8	19.3	22.0	14.5	28.2	15.4	12.9	13.1	11.9	19.5	25.7	14.8	12.5	18.0	35.4	16.9	13.7	20.9	34.5	20.8	17.8	9.4	20.9	18.0	15.7	24.9	22.9	25.4	14.9	19.7	24.2	14.6	13.4	17.7	13.5	25.5	18.7	19.6	10.3	8.2	17.6	14.0	17.3	19.2	48.6	18.2	16.9	11.9	10.2	17.5	10.8	16.5	15.2	12.8	9.6	11.4	14.6	17.7	16.9	12.5	12.1	18.4	36.2	15.0	21.1	19.4	17.1	20.1	15.8	22.7	14.9	12.8	16.4	17.3	7.1	9.8	4.3	9.3	10.9	13.3	24.1	9.1	12.8	9.2	11.4	29.4	22.2	12.0	10.1	8.5	16.2	7.1	13.5	5.6	8.6	14.1	18.2	22.0	11.4	28.6	5.5	16.5	14.9	25.4	14.5	14.7	14.4	24.3	17.2	15.2	15.1	24.9	24.2	21.9	9.4	19.7	11.5	22.9	21.6	14.6	23.2	25.9	27.4	23.8	24.7	21.6	35.2	14.9	28.2	34.5	8.9	4.3	18.4	13.0	5.6	11.5	19.7	5.1	5.3	7.9	12.2	13.7	14.9	19.9	17.7	22.1	10.8	4.5	23.3	17.8	16.4	12.8	6.0	12.7	17.7	15.8	23.8	3.5	7.4	28.5	10.0	19.0	7.9	18.6	27.9	4.9	17.7	13.3	4.5	19.4	9.2	13.9	12.9	17.9	28.9	20.6	6.0	12.7	16.6	4.7	8.2
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957686-102960516	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;liver: 23.0;pituitary gland: 29.4"	"Cell type enriched"	"Detected in some"	7	"Intestinal endocrine cells: 34.9"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"SCLC-21H: 33.4;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0.0	0.9	1.0	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23.0	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1.0	0.0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6.0	1.0	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	18.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.1	4.8	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105242-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	22.3	17.0	24.2	16.7	26.7	24.0	19.7	26.1	28.2	20.9	20.0	21.9	14.7	14.5	20.8	16.1	21.6	18.2	19.6	20.6	21.0	23.4	21.0	20.6	16.0	21.4	20.3	26.8	24.1	30.1	28.3	13.9	24.3	23.1	19.4	20.9	16.0	18.1	20.0	31.8	18.8	23.0	21.8	20.1	20.3	18.8	41.7	16.0	36.2	19.5	15.3	24.1	20.1	17.4	12.6	17.0	33.9	16.6	16.6	13.2	11.4	14.1	7.5	12.6	12.6	9.1	11.4	16.2	14.4	15.2	18.2	16.1	8.0	6.4	16.0	12.3	12.1	9.1	8.5	16.2	8.1	17.3	6.2	7.3	65.0	8.0	16.9	13.2	10.5	13.2	9.8	7.7	8.4	9.4	9.2	14.2	15.0	43.5	12.4	17.7	8.2	27.7	13.1	16.4	12.6	4.8	11.5	14.0	6.9	9.4	10.7	5.8	10.4	10.7	7.0	11.6	13.1	8.5	12.3	11.1	11.3	11.4	16.0	11.4	11.8	14.8	14.2	11.5	13.7	15.5	18.2	13.9	33.9	11.1	16.6	11.8	12.5	12.5	13.1	17.0	12.6	13.2	12.1	11.8	16.6	15.0	9.7	13.0	11.4	24.2	26.7	26.1	28.2	21.0	23.4	20.3	26.8	23.1	16.0	11.9	18.6	12.7	7.9	6.2	12.1	15.3	10.2	25.4	17.0	12.2	9.8	31.2	6.6	17.1	6.6	11.3	10.6	0.0	25.1	31.4	12.7	5.3	18.5	10.2	20.4	6.4	10.4	13.5	18.9	11.2	21.6	14.8	21.9	29.7	10.5	14.8	16.9	7.0	19.4	13.2	14.9	12.9	9.5	30.1	32.2	5.9	25.9	15.0	11.4	6.5
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.2;U-266/84: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.6	2.4	6.8	0.9	27.1	1.5	1.3	20.1	15.4	3.6	2.3	0.9	0.5	2.9	4.9	3.5	0.6	2.4	1.9	2.4	6.5	5.3	1.5	1.3	2.7	1.9	4.2	9.9	3.0	1.4	1.4	7.1	1.8	6.2	1.9	1.8	0.7	1.7	1.4	9.0	3.5	2.7	2.4	6.0	2.1	2.8	10.2	2.2	0.5	1.1	0.5	1.9	0.9	1.2	0.0	0.0	0.0	0.8	0.0	0.7	0.0	1.3	3.6	1.7	2.4	3.3	0.0	7.4	0.4	0.0	0.3	0.4	0.7	1.6	0.9	0.4	0.2	1.6	2.3	0.9	0.0	0.7	7.8	4.2	1.6	2.7	0.0	0.0	0.1	3.9	0.5	0.5	0.2	0.0	2.6	0.1	0.9	3.8	6.4	0.5	6.0	0.3	0.4	1.7	0.1	2.8	2.9	1.6	0.5	0.3	1.3	2.2	8.6	0.6	0.4	4.1	4.6	1.7	0.4	0.1	1.5	2.2	4.0	1.0	17.2	9.1	0.1	2.1	5.7	1.4	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	27.1	20.1	15.4	6.5	5.3	4.2	9.9	6.2	2.2	0.0	0.3	0.0	0.0	0.6	8.6	1.6	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.2	11.6	0.3	0.3	0.0	0.3	0.1	0.5	0.2	9.2	0.6	0.6	6.4	0.0	0.0	0.6	43.6	1.4	0.3	0.0	1.0	0.0	1.9	0.3	0.0	1.8	0.3	5.0	0.0	0.0	9.2	5.1	0.6	0.6	0.0	0.2	0.1
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		52000	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.6	27.8	14.9	32.1	29.7	18.3	18.4	17.5	24.2	34.0	26.8	21.7	16.8	15.5	27.4	22.7	39.0	18.1	20.6	23.4	16.3	23.8	32.3	13.4	21.0	24.6	31.8	19.8	26.1	21.1	20.6	27.4	16.3	22.0	24.0	18.4	16.6	21.1	26.5	75.3	26.1	15.9	37.7	21.7	52.4	19.4	23.2	30.3	31.7	28.8	27.7	23.5	23.7	31.9	28.0	13.3	26.3	19.1	20.4	48.1	16.3	53.2	40.6	38.0	63.9	14.3	33.7	32.4	26.4	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5	3.0	6.5	44.7	52.5	61.4	33.5	7.4	66.2	9.4	5.7	52.4	15.7	89.1	112.7	135.7	88.0	42.9	87.6	46.7	116.1	66.8	58.1	46.3	34.5	24.5	125.2	27.0	53.9	36.8	50.0	143.9	44.5	54.1	77.6	138.9	56.6	59.9	93.6	94.7	53.0	177.7	23.1	32.3	54.5	52.9	128.0	69.5	92.6	59.8	57.4	54.0
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.9;kidney: 24.7;liver: 59.8"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 137.5;Proximal tubular cells: 442.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA		51000	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	1.3	3.2	11.7	1.6	16.2	1.3	0.9	7.4	26.9	0.9	1.0	8.9	0.0	6.9	1.1	0.9	1.2	0.9	2.3	1.2	12.9	8.3	24.7	59.8	1.1	1.6	9.2	9.8	0.9	1.5	0.9	7.7	0.9	4.1	1.2	0.9	1.0	2.3	0.9	1.1	1.8	2.9	0.9	5.1	1.4	1.1	1.1	6.6	1.3	1.7	0.0	0.9	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.6	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	1.6	0.0	1.6	15.9	0.1	0.0	0.5	0.3	0.3	0.3	1.1	0.0	0.2	1.8	9.5	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	3.7	0.7	2.0	0.2	2.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.7	16.2	7.4	26.9	12.9	8.3	9.2	9.8	4.1	6.6	0.0	0.0	0.9	0.0	0.0	22.8	0.3	2.5	0.0	0.0	8.7	3.9	0.0	38.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	6.8	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	442.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		33000	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.7	0.0	2.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4	0.0	1.4	0.0	0.0	59.6	0.5	3.6	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.3	5.8	0.0	0.0	0.0	0.0	60.7	0.0	1.1	0.4	0.2	0.0	0.0	22.7	0.0	0.2	5.5	0.5	13.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	38.8	29.5	0.0	0.0	23.6	0.0	0.0	0.0	0.0
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.7	1.1	1.3	2.2	8.9	22.7	4.3	14.0	87.4	2.8	8.5	5.0	3.3	0.0	9.5	28.9	0.8	82.8	5.8	0.5	1.9	2.0	2.6	0.0	1.8	12.8	31.0	1.7	0.1	15.0	80.5	4.5	8.1	0.0	0.1	37.6	0.4	52.2	2.8	58.1	0.6	24.5	1.8	60.2	2.6	0.1	1.5	134.1	7.6	5.8	33.8	0.5	50.0	52.7	3.9	5.4	36.2	100.4	0.0	1.1	7.0	0.2	1.2	8.7	8.3	2.9	22.0	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2	23.8	25.8	33.7	45.3	62.6	0.0	5.0	94.3	20.1	50.0	45.4	0.0	159.6	112.7	79.7	0.8	23.2	457.5	0.0	98.3	5.0	15.7	85.0	5.7	809.9	12.7	0.0	11.5	35.0	18.0	2.7	28.7	2.6	3.3	2.8	129.1	4.8	73.5	143.8	117.4	889.6	0.3	0.0	10.8	1.1	2.0	15.3	120.5	12.5	77.1	385.2
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116425225-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Early spermatids: 119.3;Late spermatids: 157.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	4.1	11.9	13.0	3.3	14.9	4.4	5.3	17.2	25.5	5.6	4.6	20.0	5.5	4.6	3.8	5.3	3.2	9.6	3.4	18.6	13.5	16.3	5.5	5.2	3.0	3.0	15.4	19.4	4.0	7.4	5.6	10.7	2.6	16.1	29.2	4.2	6.7	6.1	13.6	7.7	3.5	5.2	3.6	11.3	3.1	4.1	16.7	16.9	1.9	2.4	0.9	2.4	3.6	3.0	2.3	1.3	2.5	0.7	7.8	10.3	1.3	2.5	7.8	3.1	4.7	5.2	4.8	10.4	3.8	1.5	1.7	1.9	5.4	3.0	5.8	4.5	2.5	6.3	0.9	7.6	0.4	2.1	3.1	2.0	2.2	3.7	11.1	2.0	1.4	4.2	6.5	0.7	5.2	0.4	3.7	1.2	6.9	2.7	4.3	5.2	2.6	2.7	1.1	9.1	6.9	4.7	3.3	18.4	1.7	5.3	8.3	4.3	24.9	4.6	1.5	3.2	10.5	10.4	0.9	2.4	4.0	6.5	3.9	3.3	6.3	3.6	5.5	7.1	1.4	16.9	2.5	0.6	0.6	3.9	0.4	4.8	2.0	4.2	3.2	0.3	2.3	4.0	3.3	2.4	7.8	0.7	1.3	10.3	1.3	13.0	14.9	17.2	23.2	13.5	16.3	15.4	19.4	16.1	16.9	6.0	6.2	0.0	3.6	1.1	2.1	19.3	2.5	17.4	7.9	1.8	9.8	0.4	3.3	0.7	119.3	0.7	0.7	0.0	1.0	0.3	3.6	12.1	5.8	1.8	2.5	9.5	12.1	0.6	0.0	157.4	2.6	0.3	0.0	0.0	0.9	3.3	0.7	2.6	5.3	5.7	4.7	0.0	3.8	5.1	13.0	0.5	0.2	2.5	1.7	2.0
ASXL1	KIAA0978	ENSG00000171456	"Additional sex combs like 1, transcriptional regulator"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA064156: AB_2685200"	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	24.3	19.6	19.0	35.0	18.2	39.0	24.7	28.3	23.8	32.4	22.7	17.7	16.9	15.6	32.4	22.2	14.3	20.5	21.6	17.9	19.7	10.7	21.2	25.2	27.3	26.7	20.3	14.7	28.1	27.1	21.2	16.3	19.8	18.2	20.6	16.4	16.6	17.4	23.3	25.5	18.2	21.8	21.8	12.2	28.2	19.7	32.1	23.0	47.4	26.8	15.8	29.0	23.2	35.3	9.8	3.1	1.3	0.8	1.7	14.6	1.9	22.9	13.3	20.9	11.6	9.6	12.0	18.2	15.4	13.2	26.9	19.9	39.6	14.8	21.7	9.9	19.0	25.6	16.0	17.6	14.8	22.0	32.5	9.6	34.6	21.1	21.6	8.6	14.4	14.4	13.3	9.9	18.7	14.1	13.3	14.8	17.9	16.7	11.8	12.5	7.0	19.7	11.6	5.0	10.7	15.4	11.5	25.1	9.4	11.0	11.1	9.6	15.1	27.9	9.3	12.2	11.6	13.3	10.2	15.3	28.6	25.0	13.2	17.1	13.8	14.7	16.0	14.5	38.4	10.9	0.0	0.8	1.3	4.4	0.7	3.5	9.8	5.2	5.6	0.7	5.8	5.8	5.9	0.9	1.7	0.7	3.1	14.6	1.9	19.0	18.2	28.3	23.8	19.7	10.7	20.3	14.7	18.2	23.0	47.6	38.1	41.7	41.8	35.5	18.7	18.5	15.3	21.4	25.0	26.2	49.1	16.2	21.6	12.4	73.4	61.8	21.2	0.0	10.8	12.8	37.0	40.7	17.4	29.3	18.3	17.5	6.9	34.4	16.8	61.5	23.6	23.6	74.2	10.0	12.1	12.6	14.1	11.5	13.8	22.1	30.4	6.5	44.0	25.6	13.5	26.7	4.9	41.5	15.5	32.6
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 15.7"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"Daudi: 4.0;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	87.1	20.1	0.0	0.0	0.0	0.0	0.1
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 644.1;Intestinal endocrine cells: 855.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 39.9;SuSa: 49.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.1	0.3	12.3	2.6	1.2	3.2	39.9	4.4	3.5	3.8	9.1	8.1	4.6	0.1	2.0	0.2	20.8	3.4	7.3	1.1	6.3	29.1	7.1	0.4	3.6	2.9	22.6	2.6	6.9	5.5	19.8	10.6	24.7	0.7	0.7	7.1	2.8	23.2	0.5	0.8	7.9	1.6	8.8	3.3	2.6	2.3	8.2	5.2	0.5	0.9	5.5	5.6	5.7	10.3	17.3	49.4	6.0	1.9	0.7	1.1	5.9	3.7	2.0	18.3	7.7	2.1	3.6	1.4	3.2	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4	393.1	144.2	7.7	234.8	180.1	3.7	604.8	73.9	128.5	135.4	52.4	0.0	136.7	1.7	158.3	2.8	136.2	500.9	0.0	108.1	256.8	236.1	644.1	77.3	21.2	99.6	1.6	855.0	28.8	13.4	2.5	16.1	211.8	165.4	55.1	427.3	12.1	155.6	312.1	1.1	1.2	2.5	97.0	421.2	0.3	2.1	177.2	351.7	6.9	216.0	169.1
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	24	"liver: 470.7"	"Cell type enhanced"	"Detected in all"	19	"Hepatocytes: 1071.5;monocytes: 428.4"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 18.7;monocytes: 11.9"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 45.9;Karpas-707: 79.8;THP-1: 66.5;U-266/84: 101.3;U-698: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	4.6	6.6	2.1	5.0	2.7	2.9	7.0	1.3	2.2	2.4	2.9	2.4	3.9	4.6	2.3	4.0	3.4	2.6	3.1	4.2	2.1	2.1	3.0	470.7	2.8	5.0	2.2	1.4	2.6	3.8	1.4	1.9	4.4	2.1	2.8	1.6	2.6	3.1	2.5	4.3	2.1	4.2	2.5	2.6	3.3	2.8	5.3	1.9	3.8	20.0	3.3	5.5	5.6	7.1	1.1	18.7	2.2	11.9	1.5	1.3	2.5	10.0	7.0	2.7	1.8	2.8	2.4	2.7	7.4	6.2	7.6	4.6	5.3	5.5	9.0	3.7	4.2	5.2	3.6	3.4	3.0	3.6	45.9	3.4	6.1	2.2	4.0	1.9	23.7	17.5	17.0	4.8	5.5	1.3	1.9	3.2	20.1	5.5	79.8	3.7	9.4	3.4	5.2	1.3	2.7	9.5	28.5	2.9	3.6	8.6	13.6	4.3	3.1	17.0	7.3	5.1	1.0	6.0	66.5	5.5	14.8	9.4	1.7	7.5	2.1	101.3	47.6	11.6	9.5	5.5	0.3	11.9	0.7	0.7	11.7	1.3	1.1	0.9	0.9	7.5	0.7	0.7	0.9	2.2	1.5	3.0	18.7	0.9	2.5	2.1	2.7	1.3	2.2	2.1	2.1	2.2	1.4	2.1	1.9	11.9	11.0	53.7	10.0	20.0	3.2	6.9	48.4	9.4	5.7	15.7	5.9	27.8	11.6	11.4	203.6	16.7	30.2	46.7	25.7	13.8	18.6	21.5	5.8	1071.5	79.6	87.4	20.6	44.2	56.2	107.0	12.4	56.5	38.8	428.4	16.5	9.5	17.3	14.4	15.6	28.4	7.2	12.9	15.1	6.2	5.7	21.0	29.7	10.2	18.3	15.5
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.7	2.9	8.1	3.0	6.0	6.8	2.9	3.3	3.1	7.3	9.1	9.4	15.7	14.3	11.5	29.1	10.5	4.6	10.9	21.8	5.3	2.9	12.0	1.0	15.1	10.0	19.9	1.1	17.4	11.4	9.7	1.3	20.2	18.4	19.7	26.9	18.9	19.0	18.5	7.4	10.0	7.0	2.4	14.0	0.5	0.7	3.5	6.4	6.5	1.4	0.5	0.8	14.2	7.7	19.2	3.7	24.2	1.8	8.5	4.0	4.4	6.4	9.8	19.1	8.2	6.7	9.2	6.6	9.8	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0	11.9	14.6	95.8	29.3	22.0	84.7	1.7	45.9	28.1	10.3	52.4	90.3	71.4	5.0	39.2	2.4	30.3	49.8	0.0	37.3	41.1	28.7	30.1	16.1	18.3	46.0	41.3	51.5	37.4	39.0	3.2	65.6	45.4	30.4	53.3	48.7	43.1	31.4	49.1	48.8	11.3	83.5	58.2	28.4	71.1	55.1	22.1	74.6	74.8	52.7	35.4
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	22.6	12.2	18.3	14.6	25.3	11.4	21.5	56.1	22.9	17.8	17.7	31.6	12.1	10.5	21.5	13.0	19.7	14.6	15.6	18.8	20.1	9.5	15.1	12.3	18.0	10.3	28.2	12.9	23.5	15.6	15.3	17.3	15.4	22.2	17.1	18.6	15.6	21.9	13.4	23.1	20.9	12.2	24.5	22.3	11.4	16.1	12.4	27.5	11.4	15.2	10.8	13.1	18.1	18.4	11.5	11.4	14.2	19.5	15.5	11.5	9.3	10.0	19.5	10.4	11.4	19.9	25.5	6.9	12.1	12.6	13.5	9.0	14.0	15.7	15.8	16.1	14.9	5.5	12.6	8.1	13.4	12.4	15.2	10.3	13.6	22.5	14.9	13.4	17.4	10.2	19.9	17.6	16.8	19.1	22.5	26.4	8.6	15.5	14.6	20.1	18.6	10.4	12.2	10.3	11.4	10.6	13.9	12.5	15.2	20.3	13.0	8.7	9.3	18.5	13.7	19.2	10.6	18.3	10.8	19.4	16.1	11.4	12.8	10.9	7.2	8.6	10.1	13.2	16.5	14.7	12.9	14.8	14.2	8.6	19.5	8.7	10.8	11.5	8.4	11.4	11.5	8.5	9.9	9.3	15.5	14.3	7.8	10.8	9.3	18.3	25.3	56.1	22.9	20.1	9.5	28.2	12.9	22.2	27.5	11.9	15.9	15.9	19.8	19.7	8.2	13.6	25.5	13.4	10.3	14.0	23.6	19.3	31.5	26.8	29.2	25.1	15.8	0.0	27.5	19.6	17.7	30.9	28.8	12.5	22.3	9.5	17.9	27.6	21.9	26.4	25.0	17.3	23.6	16.2	19.1	22.1	21.8	14.0	23.0	37.9	9.6	25.8	23.7	8.1	16.3	25.2	23.3	17.9	19.9	24.1
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	17.5	15.0	11.1	36.4	15.3	25.2	16.6	29.4	12.7	18.0	12.9	14.1	16.0	7.3	16.1	14.5	20.2	13.0	15.2	18.3	11.7	8.3	11.3	14.0	16.2	25.2	13.8	10.7	19.5	13.0	23.3	23.3	22.4	11.9	15.7	12.3	14.4	21.7	18.0	25.4	15.6	16.6	15.4	12.3	23.9	12.5	30.1	13.6	38.8	20.2	12.6	24.5	17.2	27.3	25.0	9.9	15.9	9.7	8.6	13.4	6.6	10.9	6.5	27.1	15.7	14.3	18.3	5.9	11.5	6.7	9.3	14.4	15.0	11.8	18.3	8.1	8.1	17.1	11.1	16.8	10.9	21.2	13.1	9.8	12.3	11.2	3.2	8.4	8.3	7.3	9.8	9.1	11.5	12.0	14.8	20.3	6.7	7.2	10.0	14.7	10.4	11.9	7.3	17.3	5.7	6.2	24.9	29.9	9.9	8.1	21.6	8.7	7.2	13.5	7.9	7.6	23.0	8.0	9.8	9.3	13.2	8.5	7.5	9.8	6.5	6.3	26.0	8.4	7.9	14.1	15.9	8.1	13.6	12.9	6.3	13.4	16.9	11.0	12.5	7.2	25.0	8.9	12.2	13.5	8.6	9.7	9.9	13.4	6.6	11.1	15.3	29.4	12.7	11.7	8.3	13.8	10.7	11.9	13.6	62.5	34.4	42.4	10.8	6.0	51.5	58.1	15.3	32.1	38.7	33.2	64.8	13.8	6.6	13.0	53.7	33.7	9.3	23.3	10.6	7.7	14.3	12.4	24.4	25.9	17.2	60.4	27.0	27.6	42.9	13.3	27.0	26.9	5.0	26.2	21.6	26.7	13.6	10.5	27.6	14.0	38.8	12.9	11.3	42.6	23.5	5.8	12.9	45.7	19.5	9.1
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972025-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	8.2	9.2	8.4	6.3	13.6	8.4	11.7	11.3	15.4	7.2	8.9	14.7	7.5	5.5	12.0	13.7	10.9	7.2	7.3	8.0	8.4	7.9	9.3	10.4	7.1	8.3	10.3	13.5	5.8	9.9	23.0	9.5	7.9	11.3	9.6	10.2	12.4	8.6	9.6	10.3	10.9	6.0	9.1	10.4	6.7	7.1	27.0	8.9	22.8	11.7	4.6	9.9	9.2	8.2	7.6	11.4	12.2	9.3	9.2	8.9	6.0	3.4	9.2	6.0	17.0	4.0	7.7	15.3	4.0	3.2	2.9	4.5	2.7	12.5	6.0	3.4	6.4	22.4	2.0	4.3	8.9	3.9	10.2	3.1	6.6	8.7	2.8	3.9	3.4	5.5	7.1	6.1	4.3	3.6	4.5	5.5	13.0	7.9	5.2	10.6	6.9	7.8	4.0	8.5	2.5	6.0	5.9	8.6	14.4	7.5	4.8	8.9	12.8	6.5	3.6	7.4	10.7	7.0	6.5	4.3	5.6	5.2	2.8	8.3	7.0	11.7	8.3	7.4	8.3	8.9	3.3	9.3	12.2	8.4	8.8	7.9	5.9	7.5	7.7	11.4	7.6	7.2	8.9	12.1	9.2	6.5	8.8	7.4	6.0	8.4	13.6	11.3	15.4	8.4	7.9	10.3	13.5	11.3	8.9	14.9	14.1	6.0	15.3	22.0	16.1	7.0	12.7	9.4	18.2	12.2	9.8	22.1	13.3	13.4	56.8	11.3	7.8	0.0	16.0	38.5	13.5	10.0	10.5	11.9	15.9	17.5	9.2	9.2	11.9	69.6	6.4	17.8	30.4	20.8	7.6	11.4	14.5	9.9	9.6	13.5	14.7	0.0	13.4	45.1	18.1	28.0	17.6	15.2	10.9	11.2
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917248	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	8.4	8.3	6.0	8.4	10.4	63.7	7.1	12.2	14.3	7.2	9.2	11.6	8.2	10.0	9.5	5.5	6.1	7.7	8.9	6.4	7.0	6.4	9.0	33.2	9.3	7.7	7.5	7.5	11.8	11.7	7.6	8.7	8.9	9.0	8.5	4.3	12.1	9.3	8.4	12.4	15.9	11.4	9.7	6.7	11.1	9.2	8.0	8.2	13.2	8.4	7.8	9.4	7.9	6.2	1.0	2.3	16.5	2.0	1.5	2.6	0.9	9.9	9.7	3.6	9.6	4.7	3.3	9.5	5.5	8.3	7.6	5.6	8.6	7.9	7.2	11.7	4.8	9.8	8.6	3.6	6.6	2.0	6.7	12.4	6.4	14.5	7.7	6.7	5.0	14.9	9.1	5.8	9.6	5.1	4.4	6.3	7.3	12.1	5.9	3.3	16.2	6.0	17.0	4.1	2.8	10.8	6.7	5.6	10.4	4.1	8.6	13.1	5.1	8.1	11.8	10.2	2.8	11.4	6.4	8.0	7.2	7.1	14.2	4.2	11.5	4.0	5.1	10.6	4.0	4.5	2.8	2.0	2.0	2.6	1.9	2.2	0.8	1.7	2.2	1.3	1.0	1.4	2.5	16.5	1.5	1.5	2.3	0.9	0.9	6.0	10.4	12.2	14.3	7.0	6.4	7.5	7.5	9.0	8.2	8.9	14.4	11.8	7.7	25.6	17.0	5.6	2.5	10.7	10.3	8.7	31.4	11.2	1.7	8.3	1.7	9.0	26.4	0.0	8.9	4.7	14.6	10.6	9.2	17.5	9.7	12.7	34.4	8.6	14.6	2.5	11.8	16.9	28.7	10.8	12.8	10.3	12.5	16.1	9.6	5.2	25.4	12.9	10.7	6.2	5.5	33.5	56.0	39.2	15.6	13.5
ATG4B	"Apg4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	10.9	16.5	19.6	16.6	21.3	31.3	15.1	34.8	25.7	13.5	18.7	21.7	23.2	14.6	33.5	24.0	26.7	17.7	18.8	19.5	20.5	21.5	17.2	15.5	15.8	19.4	29.2	19.7	17.3	19.2	18.7	27.4	15.4	20.3	20.5	18.9	20.8	22.8	14.2	17.2	26.6	21.1	18.9	23.1	18.7	15.5	28.0	21.4	21.2	18.2	7.3	21.9	15.3	14.4	16.5	20.3	18.9	18.6	11.4	19.6	16.8	8.7	13.6	19.5	15.0	19.5	14.2	19.3	12.8	14.0	16.6	13.8	14.9	15.5	6.7	5.8	23.0	13.4	12.9	18.5	24.4	16.1	14.3	18.8	19.8	22.0	32.2	25.4	11.4	11.1	14.1	17.0	18.6	18.0	17.7	17.1	26.1	16.8	10.3	18.8	21.4	20.4	20.1	22.7	15.7	14.5	35.2	17.9	10.1	13.0	28.3	19.5	13.5	10.9	14.5	15.3	16.6	16.0	16.8	18.6	15.8	10.8	10.5	13.8	11.6	12.1	25.7	19.2	14.2	14.8	4.6	18.6	18.9	18.7	15.5	15.5	15.7	15.2	16.5	20.3	16.5	19.6	14.7	14.8	11.4	16.2	16.3	19.3	16.8	19.6	21.3	34.8	25.7	20.5	21.5	29.2	19.7	20.3	21.4	29.8	35.6	22.7	23.7	21.6	21.6	14.1	33.1	10.7	13.6	26.2	31.4	31.0	16.6	32.4	12.9	23.6	57.6	23.3	34.9	23.5	23.5	30.3	18.5	24.9	29.3	39.7	34.4	24.5	27.8	19.8	20.4	31.5	27.0	64.1	34.3	30.2	33.1	28.1	23.3	18.2	25.2	19.4	23.4	44.0	53.5	22.2	45.1	33.0	27.0	27.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784135-62865513	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.8	9.8	19.4	11.3	32.8	6.0	9.2	16.7	23.4	10.6	9.5	29.8	7.2	7.7	9.6	7.2	8.6	8.0	10.4	7.2	23.7	15.5	13.5	12.6	9.2	13.7	42.6	16.5	10.3	11.2	15.5	11.3	15.0	22.4	8.0	10.6	4.9	10.8	8.0	6.4	6.3	7.8	11.2	26.5	13.3	8.6	8.9	40.4	11.0	12.0	3.7	12.4	13.4	6.8	20.6	19.4	16.0	10.9	7.0	9.4	6.7	7.6	6.1	9.5	8.3	12.5	13.5	9.5	11.5	7.8	11.1	12.5	4.5	6.1	16.3	8.9	5.8	13.0	5.9	11.3	8.7	16.1	12.2	10.4	18.3	6.5	5.8	8.9	14.8	12.3	11.1	6.2	11.8	5.6	10.8	13.3	18.0	15.5	13.3	9.3	3.6	14.9	5.7	13.9	11.0	10.1	17.9	22.8	11.5	8.0	5.6	12.9	6.5	7.6	14.4	14.8	17.2	7.0	7.0	5.2	8.9	8.7	15.0	12.6	11.6	15.6	13.3	10.2	14.7	10.7	16.0	10.9	8.5	4.8	8.8	6.6	20.6	6.6	5.6	19.4	19.1	9.4	7.7	1.6	7.0	5.0	11.6	5.7	6.7	19.4	32.8	16.7	23.4	23.7	15.5	42.6	16.5	22.4	40.4	6.0	8.8	28.4	6.2	4.4	5.1	8.1	10.2	1.4	9.1	7.0	2.0	33.2	16.6	6.4	1.3	11.6	3.6	0.0	7.3	24.5	8.4	4.1	11.5	8.9	31.5	4.8	5.8	13.5	18.6	1.4	8.1	20.5	8.5	30.7	4.4	9.7	4.5	4.5	9.2	19.9	5.1	6.5	7.6	30.5	13.3	3.4	24.3	9.6	6.6	2.7
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.7	3.9	7.7	4.1	10.0	14.6	2.0	6.1	6.8	3.5	5.9	4.8	6.5	9.6	9.1	4.9	5.6	4.1	5.8	5.1	5.5	7.7	3.4	8.7	4.8	4.8	5.3	10.5	9.4	9.4	3.2	5.4	10.4	7.7	7.4	8.2	8.4	6.6	6.9	2.0	7.1	9.7	6.3	4.1	3.9	5.6	5.3	15.1	4.0	5.5	5.2	6.4	7.1	3.3	10.5	7.1	5.0	5.9	11.5	8.8	4.9	5.0	5.7	4.4	4.6	48.5	5.8	11.5	9.8	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9	35.7	21.0	122.7	17.4	11.2	101.7	35.4	10.2	13.4	19.4	21.0	198.3	14.8	5.0	7.7	12.8	18.8	4.9	0.0	10.6	10.5	26.4	9.5	12.7	21.2	26.0	57.2	19.5	36.8	82.2	2.7	36.5	48.1	25.3	9.0	15.9	35.9	7.6	10.5	26.2	10.3	196.6	25.8	17.3	18.7	33.6	10.8	3.5	111.7	11.7	9.9
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 744.7;Proximal tubular cells: 898.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"		NA	NA		27000	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	27.0	37.2	43.1	25.6	40.4	23.4	39.1	22.8	38.5	29.0	23.9	29.7	32.3	30.2	21.4	37.6	28.4	24.5	33.4	27.7	37.5	45.7	50.5	96.1	21.3	48.9	54.3	37.0	16.2	29.0	31.5	23.0	25.6	35.2	25.7	24.4	25.0	34.7	29.8	12.8	26.3	31.6	28.1	46.5	34.1	21.0	28.7	33.8	24.5	36.3	29.7	44.8	27.2	22.1	22.5	49.9	43.3	54.8	20.1	22.8	24.2	14.1	23.3	13.7	9.5	36.6	30.0	18.1	25.6	29.0	25.8	35.2	31.5	30.6	28.5	31.2	43.8	57.9	13.2	16.6	64.1	21.2	18.3	28.4	12.5	15.1	32.0	34.1	17.2	14.3	38.7	13.5	32.3	21.3	19.1	37.7	17.9	10.3	84.2	39.0	34.7	12.7	38.2	7.8	31.7	48.9	7.8	15.8	44.0	24.7	12.3	18.0	10.6	21.9	62.6	95.4	16.2	30.6	21.1	42.2	26.8	21.3	32.6	44.3	69.6	61.1	17.0	36.3	11.7	110.2	27.5	48.7	43.3	18.3	54.8	16.7	22.5	16.6	15.8	39.1	16.2	13.2	14.3	36.4	20.1	37.4	49.9	22.8	24.2	43.1	40.4	22.8	38.5	37.5	45.7	54.3	37.0	35.2	33.8	53.6	54.1	119.1	60.7	60.1	20.6	93.1	175.8	60.2	37.5	200.7	13.7	132.7	459.3	179.7	119.0	146.1	314.3	70.0	138.4	184.0	143.5	107.5	72.6	744.7	575.7	23.8	144.8	249.2	183.4	241.2	76.8	138.6	226.0	621.2	138.5	98.0	246.1	221.7	97.2	898.1	22.2	90.5	140.1	71.6	147.1	93.1	99.3	57.9	140.1	99.5
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 57.5;Syncytiotrophoblasts: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.4"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.4	1.0	2.3	1.6	6.7	7.3	0.4	10.4	12.6	5.0	9.0	5.4	9.0	4.6	3.9	16.8	8.5	2.7	24.4	8.7	7.7	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.5	16.5	8.4	2.3	0.0	2.5	13.6	0.5	2.4	0.7	0.8	0.0	1.3	2.8	5.3	0.0	9.1	1.8	1.5	2.9	4.8	1.2	3.1	5.4	2.2	1.2	12.7	12.4	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	3.9	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3	8.9	6.9	15.0	7.9	17.1	10.9	3.6	0.0	2.7	2.3	15.7	29.5	27.1	1.7	4.3	1.6	14.0	1.6	0.0	4.1	7.4	11.8	5.8	2.3	4.9	11.7	12.7	9.2	17.8	16.1	0.6	57.5	9.1	6.8	7.2	4.3	28.8	2.7	2.5	23.7	9.1	8.9	25.8	9.8	0.4	2.7	23.6	147.8	11.5	3.7	6.5
ATP5S	"ATPW, HSU79253"	ENSG00000125375	"ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)"	Q99766	14	50312326-50335558	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 234.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046967, HPA062690"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA046967: AB_2679880, HPA062690: AB_2684836"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (5.73e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.37e-8)"	"unprognostic (5.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.95e-1)"	5.5	5.0	8.4	6.0	12.5	10.0	7.0	5.6	11.0	5.9	5.2	13.9	7.9	9.4	7.0	7.6	7.9	6.0	5.7	9.0	8.8	9.0	6.8	5.0	5.4	6.6	10.0	10.5	6.3	7.3	3.3	11.2	3.5	10.1	5.6	4.6	8.3	5.6	4.7	11.6	11.7	6.5	3.6	12.4	5.4	5.4	19.8	10.3	5.1	10.1	8.0	6.1	5.1	5.1	17.0	14.2	15.4	14.1	9.2	12.9	9.6	7.9	2.0	3.8	2.1	4.7	8.5	12.0	2.9	3.7	5.0	7.3	3.3	6.0	9.1	2.7	4.7	3.4	4.9	1.3	2.7	3.1	5.2	2.4	4.8	4.1	13.9	1.1	7.1	7.4	7.6	6.7	0.7	1.4	2.1	3.6	6.7	1.6	16.1	3.4	7.2	1.7	5.3	2.5	6.3	4.2	5.2	5.6	4.7	2.4	11.4	5.5	3.5	2.4	7.6	5.4	1.6	8.1	3.7	2.2	6.4	9.1	3.9	3.0	8.1	5.3	5.3	1.0	5.4	5.1	9.8	10.4	15.4	11.4	11.4	10.0	17.0	9.4	11.0	7.7	14.1	11.9	12.9	1.1	9.2	14.1	14.2	10.8	9.6	8.4	12.5	5.6	11.0	8.8	9.0	10.0	10.5	10.1	10.3	20.8	20.5	18.2	24.5	13.6	25.6	57.7	17.8	37.5	22.7	24.4	21.6	30.9	28.2	25.5	234.6	18.6	18.0	23.3	37.3	20.1	16.7	20.9	40.5	21.2	25.1	35.0	23.7	16.5	23.7	98.5	24.7	26.0	15.1	31.5	21.0	27.3	25.0	14.4	15.6	28.9	61.8	19.4	18.6	38.2	20.6	17.9	34.9	23.2	26.8	30.3
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA			"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.4	0.8	1.7	2.0	13.8	0.2	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.8	0.0	12.7	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	31.3	0.0	1.8	0.3	0.0	0.3	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	1.8	0.1	0.8	0.4	0.0	1.4	1.2	0.0	7.9	143.1	41.4	0.0	0.6	0.6	0.0	0.0	0.5	41.7	0.7	0.7	0.0	0.0	10.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.3	0.5	0.0	1.1	0.0	3.4	0.0	0.3	0.4	1.3	0.4	54.2	0.0	0.0	0.6
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	17.1	23.1	25.1	16.8	36.7	6.5	15.7	26.2	58.8	13.6	11.1	11.4	7.6	12.1	14.1	10.9	10.6	12.2	13.7	19.0	28.5	28.0	35.0	18.1	12.9	15.9	23.2	33.3	14.4	12.9	21.3	29.2	20.2	45.1	13.2	13.7	11.5	10.4	12.2	11.7	8.5	12.8	14.5	15.0	14.3	12.1	13.0	12.5	10.7	26.9	8.4	15.6	15.5	10.7	10.6	16.3	27.9	24.3	10.0	12.5	10.8	29.1	17.5	9.3	6.9	24.4	15.8	11.5	21.9	21.8	24.6	29.1	12.9	29.6	18.8	25.1	17.4	39.3	11.8	18.3	17.0	35.2	12.3	14.1	18.3	13.3	15.3	26.0	9.8	22.1	15.1	22.2	33.0	15.9	14.8	18.5	12.2	23.3	15.4	27.3	13.2	18.3	7.2	8.1	26.5	17.0	10.6	16.4	14.2	27.5	21.0	11.9	10.2	12.3	11.7	38.3	17.3	24.5	11.6	22.0	14.3	14.5	31.7	15.3	20.2	7.3	17.9	27.7	20.4	13.8	8.4	17.4	20.6	9.1	24.3	10.2	10.6	7.7	8.9	16.3	10.2	9.0	9.7	27.9	10.0	22.1	8.8	12.5	10.8	25.1	36.7	26.2	58.8	28.5	28.0	23.2	33.3	45.1	12.5	29.8	23.7	18.1	27.2	31.0	29.7	39.1	12.7	41.5	18.2	29.6	15.7	32.6	54.7	34.3	128.0	23.1	13.6	23.3	27.3	30.1	23.0	29.4	23.1	15.3	87.3	35.0	15.0	18.4	45.4	117.5	22.5	45.4	18.6	26.2	12.6	31.4	26.9	14.4	17.3	112.2	20.4	19.4	32.5	10.5	20.2	28.7	62.6	17.5	13.4	25.0
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Group enriched"	"Detected in some"	4	"HMC-1: 21.6;JURKAT: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.6	0.2	0.0	0.0	0.0	0.6	0.5	9.6	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.1	0.3	0.1	0.4	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4	0.0	9.8	0.9	0.1	0.9	20.0	2.2	2.5	0.0	0.0	0.0	90.3	1.2	0.0	0.3	29.4	1.5	0.0	0.0	0.0	0.3	0.4	0.2	4.7	0.0	2.4	20.6	0.0	0.0	0.0	24.5	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.1	0.6	86.2	12.9	0.0	12.9	9.9	0.4	0.9	0.5	0.0	0.0
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948992	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		33000000	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.9	11.7	8.6	0.7	15.9	0.3	2.1	2.2	26.0	0.9	2.3	2.1	1.1	0.8	12.0	1.1	1.5	1.0	0.8	2.9	9.3	5.8	4.8	2.9	0.6	1.0	4.0	15.7	17.5	2.3	0.3	11.1	3.3	8.4	6.9	0.9	2.0	1.8	8.3	3.8	0.6	1.0	13.4	2.0	0.8	0.9	13.0	2.5	0.0	2.0	0.0	0.9	1.1	1.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	20.5	0.0	0.0	0.0	0.1	0.4	3.0	4.4	0.1	0.1	0.0	1.4	0.5	4.2	0.0	1.1	0.0	3.5	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	8.6	0.0	8.6	0.0	6.9	9.4	0.2	8.0	0.0	6.7	0.0	0.1	5.9	13.7	8.9	3.1	0.0	3.4	9.9	0.0	0.0	0.2	3.8	1.2	0.0	0.0	0.0	2.5	0.0	2.9	11.3	0.0	3.3	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	15.9	2.2	26.0	9.3	5.8	4.0	15.7	8.4	2.5	0.0	0.0	0.0	0.1	0.6	40.4	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.6	37.4	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.0	0.0	2.2	9.5	0.0	32.5	3.2	28.8	1.4	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.7	0.3	4.4	0.0	0.4	41.3	5.3	0.1	0.2	0.0	0.0	0.0
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	6.0	4.9	5.0	4.1	5.8	6.6	6.6	3.5	6.5	7.5	6.1	6.9	5.9	5.8	2.1	6.8	8.1	4.0	6.4	6.6	8.0	15.2	2.6	10.1	5.8	2.1	2.9	4.2	12.2	6.3	3.6	11.1	12.4	5.6	5.6	9.6	3.8	17.7	4.6	14.4	8.9	3.5	3.4	4.1	2.2	3.8	4.6	7.0	3.7	7.2	2.0	3.7	7.8	5.2	7.1	4.2	3.6	6.1	7.7	6.5	8.9	9.5	8.1	8.0	8.1	6.4	7.7	7.1	6.2	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000285258	"Ataxin 7"	O15265	3	63864557-64003462	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.9"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034989: AB_10602596"																		0.4	0.0		1.5		2.8	1.3		0.0	2.0	0.7			0.0	2.0	2.0	0.0	0.9	0.8	0.0			1.0	0.9	0.9	2.1			0.5	1.0	3.0		1.9		0.9	0.9		0.5	0.6	0.3	3.1	0.8	0.3		1.5	1.0	0.0			0.8		1.8	0.1		4.9	3.6	8.9	1.9	2.5	4.3	0.7	2.4	0.1	3.5	3.3	3.3	6.1	3.3	3.0	2.5	4.1	5.6	1.5	3.2	6.9	1.1	2.1	4.8	2.8	3.4	2.3	4.9	6.6	2.6	6.3	4.3	2.5	4.6	4.6	5.8	1.9	6.9	5.2	6.8	4.2	2.9	3.9	2.3	9.8	2.9	13.2	3.0	4.0	2.2	1.6	0.8	5.8	2.9	2.5	2.6	3.4	1.1	1.7	6.0	4.9	3.9	2.9	1.4	6.7	4.0	6.1	3.3	3.6	4.7	5.4	4.8	4.3	2.4	4.8	3.6	5.7	1.9	2.7	2.5	1.2	2.9	4.9	2.9	2.4	1.6	4.3	3.5	2.5	8.9	2.5	1.4	3.6	4.3	0.7											8.9	7.8	5.7	20.9	38.7	67.5	0.0	33.1	8.1	5.7	5.2	96.2	0.0	0.0	2.5	11.6	15.5	24.4	0.0	3.7	0.0	4.1	20.9	14.9	17.4	0.0	23.8	25.3	33.7	34.3	6.2	11.8	10.2	11.8	8.2	19.4	28.6	2.0	27.1	12.4	0.3	72.4	0.0	19.6	12.5	15.3	40.4	0.0	40.6	18.2	34.4
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105605067-105876604	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 68.4;Late spermatids: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	10.8	10.7	10.3	12.1	16.6	7.7	10.6	24.7	13.4	13.3	11.7	9.7	12.3	7.9	9.2	9.1	9.6	11.7	8.4	6.4	8.5	6.2	14.1	12.3	7.8	15.6	7.1	7.3	13.3	7.2	11.2	17.8	10.8	6.9	10.1	11.6	8.3	11.4	12.1	5.2	12.2	10.9	9.7	6.9	10.4	9.8	20.8	9.9	12.4	11.8	4.6	17.9	11.3	11.7	3.9	3.1	4.3	4.8	4.2	14.5	3.4	2.9	3.9	8.4	3.9	5.2	6.1	2.6	5.2	5.2	4.7	4.4	3.8	5.6	1.2	4.1	5.4	4.1	2.7	4.7	5.3	3.4	16.1	3.1	3.9	2.9	3.6	3.1	6.3	13.0	4.2	4.4	3.1	3.1	3.4	4.2	2.8	4.6	2.6	3.8	6.9	3.4	3.5	15.5	8.0	3.9	3.4	2.8	0.8	3.5	2.9	5.2	3.5	3.7	7.3	7.3	8.6	3.8	6.4	10.5	7.3	3.4	6.0	2.0	0.6	0.0	0.1	4.6	9.8	7.3	2.3	4.2	4.3	2.9	4.8	2.1	3.9	7.5	6.4	3.1	3.6	8.2	4.7	1.4	4.2	2.8	2.1	14.5	3.4	10.3	16.6	24.7	13.4	8.5	6.2	7.1	7.3	6.9	9.9	0.0	4.6	3.6	4.7	4.5	8.2	2.4	2.5	16.0	2.3	5.2	2.0	5.6	5.0	3.3	68.4	3.6	10.8	0.0	2.3	3.1	4.9	5.1	4.7	13.4	6.5	7.9	5.2	6.7	10.3	39.7	6.1	6.3	8.5	7.2	8.2	2.0	3.7	10.5	4.2	29.8	0.6	6.5	4.2	7.9	1.7	3.4	4.5	8.7	8.1	3.3
AUP1		ENSG00000115307	"AUP1, lipid droplet regulating VLDL assembly factor"	Q9Y679	2	74526645-74529939	"Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007674	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007674: AB_1078251"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (2.97e-9)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.96e-2)"	18.8	21.7	13.9	15.5	16.9	9.4	24.2	18.0	16.7	25.7	28.2	14.6	18.4	14.0	14.6	17.8	25.6	15.4	12.5	14.1	11.8	11.2	19.2	44.5	14.4	21.1	18.4	8.0	11.8	44.2	26.4	14.1	20.6	15.1	13.6	25.9	13.5	29.8	17.6	34.6	25.2	31.3	18.0	12.2	18.2	26.0	10.6	14.4	13.5	19.0	11.7	19.9	16.7	13.5	26.3	38.0	30.6	46.3	20.7	31.6	36.4	15.1	22.7	5.8	9.9	34.7	17.3	16.0	11.0	25.3	20.4	10.7	35.4	10.9	15.5	7.8	21.4	38.8	18.6	25.0	19.3	14.5	13.3	23.8	23.0	11.6	29.5	36.7	12.0	11.9	22.9	42.6	30.8	28.6	11.8	21.3	20.2	30.3	21.5	21.7	21.8	12.4	14.4	15.0	58.5	19.5	16.0	24.0	45.5	22.8	12.9	9.3	10.5	10.9	33.7	26.1	9.9	14.8	19.1	8.1	16.5	10.2	4.0	17.4	5.4	8.7	19.0	19.8	16.2	29.1	28.4	39.3	30.6	25.0	46.3	30.2	24.3	26.4	27.3	38.0	26.3	22.1	24.7	19.1	20.7	40.4	35.8	31.6	36.4	13.9	16.9	18.0	16.7	11.8	11.2	18.4	8.0	15.1	14.4	62.5	39.4	71.5	92.4	65.0	32.0	29.5	63.7	32.1	45.5	64.6	13.7	119.5	19.9	114.5	16.9	64.6	148.5	23.3	181.0	166.6	79.4	112.4	86.7	93.6	145.8	35.0	70.9	41.7	72.1	22.0	41.1	89.5	92.8	62.3	95.5	74.6	135.1	112.2	35.7	52.8	33.4	58.2	59.8	85.0	60.7	68.8	187.2	80.9	105.4	119.9
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Late spermatids: 2457.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	26.6	29.3	30.3	19.6	30.5	20.9	16.3	17.8	40.5	14.1	27.9	18.7	18.3	33.5	14.3	18.3	25.0	14.5	22.9	55.2	25.3	23.4	35.0	59.1	14.4	17.6	29.0	23.0	14.8	41.2	16.8	18.7	23.6	21.9	17.2	13.6	20.0	35.8	20.4	115.9	20.2	29.5	15.9	18.5	16.9	24.7	73.8	12.6	16.0	27.1	41.4	20.7	18.2	15.2	53.4	81.9	82.5	67.5	36.1	61.6	59.2	38.9	23.7	13.0	23.3	11.5	14.6	24.0	23.7	15.8	37.6	26.8	41.5	36.2	20.6	35.4	16.0	18.9	28.9	17.8	31.4	10.9	24.7	50.3	16.6	31.0	38.3	22.7	21.4	22.6	19.1	14.2	26.3	10.7	11.0	20.4	19.7	32.7	28.5	21.8	29.7	26.2	76.5	24.6	24.6	67.5	30.7	16.0	44.2	29.7	10.4	41.8	31.3	17.0	59.4	56.3	8.3	25.7	50.1	15.2	23.3	29.9	27.7	34.9	37.3	34.0	43.2	32.5	31.7	15.7	60.8	67.5	70.6	51.1	53.6	48.4	53.1	53.9	53.7	58.0	53.4	50.7	49.3	82.5	36.1	46.0	81.9	61.6	59.2	30.3	30.5	17.8	40.5	25.3	23.4	29.0	23.0	21.9	12.6	44.7	60.9	130.3	137.2	144.1	107.1	195.9	180.9	89.7	56.9	157.1	60.9	351.3	573.6	261.8	1001.4	114.7	553.0	116.8	362.4	394.1	140.0	198.9	86.5	355.2	260.5	98.5	195.6	106.2	140.4	2457.2	126.0	155.3	205.8	225.4	267.9	199.3	331.2	287.5	111.4	527.2	88.0	155.2	136.5	419.6	143.7	172.8	366.4	100.2	314.0	225.6
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.6	28.6	42.7	20.5	0.9	1.4	16.4	20.0	10.8	41.5	38.3	37.0	12.6	41.6	10.4	7.9	17.3	30.7	30.9	13.7	34.3	18.2	50.8	24.8	16.4	31.2	0.1	13.0	24.4	0.7	0.6	24.3	15.2	4.1	19.0	27.4	15.4	16.1	18.1	19.8	47.5	18.6	26.5	13.7	12.7	32.2	39.3	17.2	9.0	8.2	9.3	13.2	17.8	8.0	13.6	13.3	14.0	8.8	7.4	16.6	17.1	14.9	52.0	11.8	7.8	31.3	8.0	19.9	33.6	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4	0.0	0.3	2.2	0.3	3.9	0.0	1.1	0.0	0.0	3.4	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.4	46.7	0.0	76.2	4.7	0.4	4.6	0.6	23.9	0.0	0.0	4.9	6.3	0.0	0.6	4.4	1.7	0.0	4.2	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.3	0.7	2.0	2.0	7.6	2.5	6.3	1.4
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"AUTS2, activator of transcription and developmental regulator"	Q8WXX7	7	69598296-70793495	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.6;naive B-cell: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	10.3	7.3	29.3	11.6	30.3	9.3	20.3	14.3	19.1	10.5	14.0	17.3	4.1	8.9	10.5	12.4	13.7	8.0	16.6	5.6	22.2	12.9	14.6	19.7	14.7	6.1	14.8	12.3	17.2	6.0	9.9	17.4	5.7	18.9	14.6	13.1	9.9	52.1	8.3	14.9	23.3	18.8	13.6	10.2	8.2	11.3	10.0	20.6	10.5	6.7	7.9	8.9	13.0	10.8	11.6	3.2	0.8	0.2	1.5	2.2	0.7	0.1	2.5	28.1	1.5	1.8	1.1	0.3	1.7	0.0	0.1	0.1	9.5	0.1	4.1	0.6	1.7	0.1	9.1	3.4	3.8	0.8	18.6	7.5	2.0	2.6	0.1	0.8	0.0	0.1	2.9	5.2	4.2	1.0	1.0	0.0	4.5	0.1	2.2	2.4	1.6	0.4	0.8	20.0	6.2	0.0	27.4	13.7	11.6	0.0	4.1	38.5	20.9	1.8	3.1	0.0	12.7	26.3	0.0	0.0	0.1	9.4	3.0	17.2	0.0	0.0	14.2	0.0	0.0	0.0	0.8	0.2	0.2	1.6	0.1	2.2	8.6	1.1	1.5	0.7	11.6	0.2	0.9	0.5	1.5	0.1	3.2	0.2	0.7	29.3	30.3	14.3	19.1	22.2	12.9	14.8	12.3	18.9	20.6	17.9	31.0	10.7	17.8	25.3	35.0	19.0	10.2	12.0	19.4	8.7	15.7	1.0	5.0	9.8	26.8	8.3	16.3	0.0	1.1	0.1	11.3	21.3	0.0	24.5	0.7	60.4	27.7	16.0	3.1	14.8	14.7	4.3	16.9	1.0	20.8	14.3	2.6	14.0	13.8	9.8	22.5	25.8	7.4	11.3	15.4	14.1	1.1	19.2	22.7	20.3
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687323	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 211.2;Syncytiotrophoblasts: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0;HHSteC: 30.0;hTCEpi: 56.5;SK-MEL-30: 45.6;U-2197: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	21.5	27.4	5.1	4.7	8.5	3.3	11.0	6.3	17.7	13.0	18.6	3.6	4.8	10.7	5.8	8.2	16.3	6.5	19.9	8.5	5.5	5.8	5.6	29.9	17.1	1.7	7.3	5.6	43.3	10.8	4.1	7.2	19.3	8.0	15.3	15.0	13.6	10.7	13.8	8.3	35.5	15.3	8.5	12.6	11.9	12.7	8.4	2.5	1.3	8.2	9.7	7.6	22.0	16.6	3.5	12.4	2.3	7.1	2.0	5.0	3.0	9.0	23.9	0.1	3.5	5.0	2.3	4.9	4.4	24.4	6.1	9.3	4.4	11.4	0.2	3.2	2.5	4.4	9.6	1.8	7.7	2.3	0.2	2.1	0.6	29.0	12.3	30.0	0.6	0.7	3.6	56.5	4.6	12.1	5.6	0.8	0.8	1.3	0.5	3.3	7.8	0.4	0.7	0.8	2.5	2.2	0.3	2.7	0.3	6.0	5.0	0.4	1.0	15.4	5.5	45.6	0.8	4.2	0.7	1.3	1.5	2.9	33.0	1.1	1.1	0.7	0.1	5.5	1.9	0.9	0.0	7.1	2.3	5.0	6.1	2.3	3.5	3.3	3.7	12.4	2.2	3.6	4.4	0.7	2.0	0.5	2.4	2.9	3.0	5.1	8.5	6.3	17.7	5.5	5.8	7.3	5.6	8.0	2.5	17.9	14.7	1.4	58.4	85.3	9.6	6.7	30.6	13.4	17.0	36.6	5.9	126.4	36.5	16.0	51.3	6.0	96.5	0.0	21.5	57.2	30.8	25.7	5.8	38.1	39.2	12.7	30.5	22.7	16.7	211.2	9.5	40.5	79.2	9.0	38.3	125.0	29.4	66.6	13.8	9.1	12.7	6.5	29.8	2.7	1.6	94.7	162.8	9.6	58.7	83.6
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Group enriched"	"Detected in many"	6	"Glandular cells: 2272.6;Hepatocytes: 3981.0"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	160000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.4	0.0	49.6	0.0	0.0	0.5	38.9	0.0	0.0	0.0	0.6	0.2	7.9	3.8	0.0	13.0	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.2	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7	20.8	187.7	32.0	321.8	3.8	0.0	94.8	420.4	5.3	50.0	5.2	2.0	0.0	39.7	11.0	1.3	0.4	8.5	46.7	221.1	0.0	0.2	2272.6	3.5	3981.0	0.0	0.0	11.9	58.3	79.1	3.1	0.9	0.3	59.1	3.6	5.4	22.6	173.5	5.8	0.0	512.3	0.2	0.0	1.1	4.3	0.4	8.4	0.0	15.2	6.3	497.4
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Cell type enriched"	"Detected in many"	7	"Cone photoreceptor cells: 237.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5.0	8.9	5.2	11.5	9.9	4.3	12.6	14.0	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5.0	10.1	14.1	8.0	7.0	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12.0	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11.0	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17.0	0.0	5.8	13.0	6.7	7.3	0.0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27.0	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9.0	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0.0	14.4	16.6	34.1	26.0	18.8	5.3	5.2	31.0
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell type enhanced"	"Detected in many"	16	"Ito cells: 27.0;Muller glia cells: 94.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.9	0.2	0.2	7.4	0.0	1.3	8.7	0.0	0.1	0.2	0.0	0.1	0.2	4.7	0.1	0.4	0.4	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.6	0.0	0.5	1.5	1.4	0.3	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.5	0.1	0.1	0.5	0.0	0.0	13.6	10.0	0.3	0.0	0.0	2.3	0.1	0.1	1.4	7.9	0.5	0.2	0.5	0.0	0.1	0.1	37.1	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6	0.0	2.6	0.0	0.7	4.8	2.5	0.6	12.7	17.4	1.2	0.0	0.0	0.0	6.6	17.6	3.0	18.8	0.0	0.0	21.5	0.0	2.6	0.4	0.0	0.5	1.0	0.0	17.0	27.0	2.2	5.6	1.4	0.7	13.5	8.2	0.0	94.5	6.5	0.0	0.0	0.0	2.9	0.0	3.0	0.0	0.1	3.4	0.0	1.7	0.0	0.8
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 165.1;Late spermatids: 300.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 46.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	23.3	7.8	7.9	15.5	13.1	44.7	10.3	4.7	8.8	13.5	12.8	9.6	6.7	9.9	16.0	10.0	18.6	8.9	15.6	10.7	8.0	5.8	11.7	17.6	25.2	21.9	10.8	5.5	9.5	12.5	5.3	9.2	28.8	11.1	14.9	7.8	9.2	12.2	5.3	30.7	22.9	17.9	15.9	16.0	22.9	9.5	20.6	11.1	14.3	11.3	12.6	14.0	19.4	15.8	4.0	7.6	46.7	15.2	2.1	4.4	4.0	7.6	3.1	9.7	2.5	7.6	22.2	6.1	8.4	20.1	8.1	9.1	6.4	10.6	9.1	6.8	7.6	8.5	4.0	5.8	11.2	14.4	7.5	4.8	28.0	6.5	6.6	10.1	8.0	10.5	11.4	17.2	15.9	23.8	9.6	4.2	5.0	14.1	48.1	11.1	2.7	6.8	4.7	14.9	3.0	3.2	7.0	23.0	11.7	4.3	6.0	4.0	4.6	4.5	8.6	10.6	10.1	6.3	9.8	10.7	8.0	11.1	8.6	4.2	27.9	17.8	9.8	6.5	10.0	23.9	17.9	15.2	11.3	1.6	12.4	1.3	3.2	2.7	1.4	7.6	4.0	3.9	1.9	46.7	2.1	13.3	1.8	4.4	4.0	7.9	13.1	4.7	8.8	8.0	5.8	10.8	5.5	11.1	11.1	26.8	15.4	19.9	36.3	52.4	17.0	19.0	17.8	16.0	27.3	14.0	17.7	11.1	6.6	16.3	165.1	28.5	21.5	0.0	14.0	13.5	23.3	45.2	45.3	15.7	19.4	12.7	29.6	28.8	52.8	300.7	12.4	74.4	20.3	39.7	16.5	10.6	22.1	14.0	13.4	9.8	11.9	32.3	23.6	21.8	17.9	50.7	33.2	13.8	9.3	37.3
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 187.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Group enriched"	"Detected in some"	6	"Daudi: 52.7;U-698: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	52.7	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.2	0.0	0.0	3.4	2.1	4.6	0.0	0.1	1.0	0.0	0.5	0.0	0.4	7.2	1.3	0.9	0.0	0.1	1.7	4.9	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.5	0.1	30.9	0.2	0.5	0.4	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9	0.0	0.3	43.2	8.5	6.6	5.6	2.0	0.0	0.0	3.4	3.5	39.3	0.1	0.0	4.4	17.2	1.1	0.0	0.0	2.4	0.2	5.3	14.0	0.0	2.4	0.5	187.5	0.0	2.5	0.3	5.3	5.5	0.9	3.3	0.0	0.1	0.6	3.8	0.0	4.2	0.0	1.9	0.0	1.7	0.0	1.5	6.8	0.0	5.1	0.0	3.1
BAG6	"BAT3, D6S52E, G3"	ENSG00000204463	"BCL2 associated athanogene 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 339.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	20.8	30.1	16.1	18.4	21.7	16.9	18.1	22.1	31.2	23.9	23.8	22.3	17.9	38.2	25.1	38.6	19.9	23.8	21.4	25.5	15.1	14.1	20.6	41.8	25.7	18.1	15.9	15.6	22.0	22.2	6.6	20.7	27.0	17.5	20.5	30.7	24.4	20.9	19.6	50.5	22.3	31.0	17.3	13.2	23.7	26.1	101.8	16.2	39.9	22.9	30.4	27.1	18.3	19.3	4.8	8.4	8.2	7.5	3.2	6.3	3.1	1.9	14.4	16.8	3.4	8.4	13.0	3.8	3.4	2.7	3.3	3.6	35.8	1.6	2.5	26.0	27.8	20.7	2.4	2.0	29.5	5.4	4.1	39.5	11.1	1.8	22.7	12.6	3.3	33.0	10.4	11.9	2.9	3.9	15.0	9.7	20.4	21.0	11.6	24.1	5.6	2.0	19.6	2.1	3.2	2.6	4.9	2.3	4.6	14.4	5.2	2.4	4.5	1.3	4.1	3.3	4.3	30.2	27.7	1.9	11.4	8.7	2.0	3.3	15.2	20.0	22.1	15.5	2.7	3.6	8.2	5.7	6.6	6.3	7.5	5.0	4.4	4.4	4.1	4.5	4.8	3.5	4.2	5.8	3.2	6.8	8.4	3.0	3.1	16.1	21.7	22.1	31.2	15.1	14.1	15.9	15.6	17.5	16.2	44.7	36.5	27.4	30.3	28.5	26.7	70.2	43.3	36.1	39.8	34.9	17.7	53.0	26.6	57.4	195.1	37.0	85.3	23.3	43.3	57.5	32.9	30.2	48.4	36.0	49.4	47.7	73.6	38.1	38.8	339.6	30.8	35.7	27.0	30.7	49.7	29.6	55.0	57.5	37.1	40.2	39.7	38.8	37.2	93.9	52.8	31.0	99.9	35.4	49.8	33.1
BANF1	BAF	ENSG00000175334	"Barrier to autointegration factor 1"	O75531	11	66002079-66004149	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		77000	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	31.2	39.7	38.2	31.6	33.9	24.0	33.5	30.8	38.1	40.7	32.4	33.2	26.5	25.0	38.8	44.4	43.8	58.4	33.4	51.0	35.4	32.5	38.6	61.0	24.6	35.7	33.8	24.7	60.0	40.8	33.5	27.3	40.1	27.5	52.6	33.1	31.1	38.0	38.8	112.7	25.5	29.9	38.9	35.8	39.7	26.8	44.2	27.8	57.6	71.5	54.5	43.8	36.4	45.8	40.0	44.6	14.7	42.8	32.5	30.4	43.8	63.9	64.7	43.6	42.3	22.3	29.7	22.1	35.6	33.2	66.5	42.1	37.5	51.6	55.4	65.8	47.0	54.2	45.1	57.3	59.3	48.9	43.5	34.3	64.4	41.0	46.6	27.3	46.6	49.8	27.6	38.2	42.4	37.4	41.6	48.4	53.5	51.3	44.5	64.1	103.7	52.2	91.7	49.3	41.0	45.4	49.1	43.2	125.7	59.7	32.5	35.3	45.4	38.5	63.8	44.1	33.8	71.1	36.0	33.5	51.0	56.5	57.6	49.7	32.7	59.0	69.4	44.8	39.8	46.2	14.7	41.6	13.9	29.2	41.7	27.6	40.0	24.5	28.3	44.6	37.8	28.3	30.4	4.4	32.5	42.8	40.0	20.6	43.8	38.2	33.9	30.8	38.1	35.4	32.5	33.8	24.7	27.5	27.8	50.6	37.0	151.2	131.4	112.6	49.6	28.6	114.7	113.8	61.4	186.7	23.6	256.8	276.8	168.3	13.4	125.9	55.0	0.0	153.9	288.2	139.3	117.6	138.4	109.1	284.8	47.7	137.2	73.1	75.3	32.5	131.5	149.4	177.2	175.9	138.1	83.5	151.2	91.2	116.3	188.4	42.8	71.1	136.7	219.1	317.9	103.3	146.1	124.6	162.6	122.5
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA047164: AB_2679964"	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	11.9	14.2	17.0	19.4	20.7	21.1	15.4	35.8	21.5	13.6	11.3	11.8	22.0	10.1	14.3	7.2	10.7	13.5	10.0	10.9	13.2	9.0	10.9	17.6	13.4	17.1	24.4	8.9	18.2	12.7	16.5	15.2	14.9	18.3	12.9	7.5	11.7	12.4	17.7	13.6	12.2	12.4	9.0	16.3	17.7	10.3	19.0	23.3	23.2	13.8	8.0	13.0	12.1	27.5	14.4	16.4	36.0	11.4	12.8	15.2	10.2	9.0	14.5	7.2	10.8	6.4	7.9	24.4	11.0	5.6	10.9	7.4	15.8	12.6	12.2	14.9	2.6	9.9	10.5	10.8	5.0	3.9	9.4	11.6	7.6	9.0	13.0	5.5	8.0	6.3	2.3	8.1	6.6	4.8	9.8	6.6	8.1	12.7	7.0	6.5	10.5	11.0	10.5	12.5	7.0	17.6	11.9	8.4	8.8	6.5	4.3	10.7	8.8	13.9	8.2	10.1	11.2	10.1	10.4	8.1	11.7	8.2	6.9	10.8	5.8	9.8	18.9	7.0	12.5	11.3	12.1	11.2	21.7	13.3	9.9	11.0	14.4	14.0	11.6	13.7	13.2	15.2	13.4	36.0	12.8	11.4	16.4	12.3	10.2	17.0	20.7	35.8	21.5	13.2	9.0	24.4	8.9	18.3	23.3	8.9	8.8	12.4	10.8	13.3	15.2	4.4	15.3	5.3	2.3	15.7	3.9	16.6	3.3	10.4	4.2	10.5	8.4	23.3	7.0	22.2	15.6	12.7	8.1	7.3	11.2	25.4	11.6	4.9	11.1	6.4	10.0	14.6	18.6	11.8	8.3	14.3	9.7	7.0	10.3	6.8	16.5	12.9	36.4	29.5	21.6	18.6	47.4	13.8	7.7	10.5
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	14.8	16.9	20.6	17.4	19.9	12.8	23.2	14.7	19.1	24.0	18.6	20.5	13.9	21.4	7.4	20.5	27.1	12.1	21.6	23.8	15.3	21.1	20.5	26.4	35.8	21.2	18.5	24.8	23.5	19.1	31.9	26.5	14.2	13.2	19.1	41.2	22.6	18.9	18.0	12.9	29.4	34.0	23.2	11.8	20.6	12.7	16.7	21.1	14.8	24.1	7.8	25.3	18.1	5.3	21.5	12.1	14.8	34.3	20.4	21.7	20.0	26.0	27.3	28.7	37.7	30.6	23.7	26.2	25.6	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7	0.0	13.6	15.0	8.8	28.0	15.3	19.3	10.2	5.3	9.1	24.4	0.0	12.2	10.0	12.0	81.1	12.4	17.6	0.0	14.3	13.1	11.8	9.7	20.7	25.8	11.0	9.5	10.4	15.4	19.3	32.6	9.5	10.2	11.8	11.8	12.9	9.9	12.6	15.3	11.0	14.6	11.3	19.4	13.2	30.9	12.4	20.6	10.1	11.3	16.4	8.5
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951622-93955372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 59.7"	"Cell type enhanced"	"Detected in single"	23	"Early spermatids: 2.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	4.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.2	2.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.4	1.5	0.0	0.2	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	59.7	5.6	0.0	0.0	0.5	12.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	11.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	3.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616692	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 292.6;Rod photoreceptor cells: 350.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 24.1;neutrophil: 54.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 54.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	16.7	20.7	22.1	12.7	37.7	23.5	16.5	30.3	28.5	25.8	18.3	30.0	19.4	12.4	25.4	17.7	16.6	19.2	19.3	13.4	26.1	13.1	13.3	12.3	18.1	9.8	37.2	20.4	33.4	16.4	27.1	45.4	14.9	29.5	17.1	12.4	13.0	19.0	24.6	19.2	12.7	14.5	20.0	42.3	14.4	14.4	18.6	48.9	6.5	19.0	9.1	9.6	18.6	19.2	2.4	5.9	54.6	7.0	4.7	2.7	1.4	3.6	7.3	25.2	15.2	7.6	12.2	4.4	7.8	9.6	4.3	5.1	11.1	10.2	6.3	13.4	7.6	4.3	8.5	10.0	10.6	6.8	2.1	5.7	11.5	12.7	1.5	5.0	7.8	8.0	9.5	11.7	10.7	11.8	15.8	22.1	3.9	12.5	1.2	6.8	4.3	2.7	4.8	8.3	0.7	6.4	6.4	8.1	4.3	8.7	13.3	16.7	14.6	15.4	1.9	9.1	13.5	2.9	21.5	21.8	7.8	15.8	3.2	5.2	4.7	0.4	7.0	7.2	8.5	4.9	24.1	7.0	8.8	2.7	3.0	2.2	1.5	1.6	2.7	4.4	2.4	1.1	1.7	54.6	4.7	2.6	5.9	1.7	1.4	22.1	37.7	30.3	28.5	26.1	13.1	37.2	20.4	29.5	48.9	92.3	148.1	29.6	60.8	29.0	86.6	49.4	58.6	93.7	85.3	64.6	292.6	16.0	8.3	42.8	118.0	64.1	41.6	23.3	33.7	5.4	30.0	44.2	69.6	25.9	22.6	89.0	95.8	58.9	53.8	22.7	55.0	50.5	13.5	59.5	45.4	116.6	43.6	49.2	32.9	7.5	350.6	12.9	23.6	123.2	15.1	32.9	22.3	30.5	40.3	81.3
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX, HMG-box containing"	Q8WY36	3	107522936-107811324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 761.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	10.6	22.6	13.1	11.0	20.6	11.2	10.8	12.8	15.1	14.3	13.2	15.4	27.8	6.7	15.1	28.3	10.2	13.2	12.7	11.5	14.8	11.6	14.9	7.3	10.8	10.4	24.5	9.0	21.0	9.0	35.7	39.6	17.8	17.5	17.4	7.3	9.1	11.8	25.1	8.5	7.5	9.4	14.0	26.7	14.1	9.6	43.9	25.5	13.5	19.3	8.0	10.1	15.9	15.6	33.7	16.3	25.2	17.5	25.2	26.1	11.4	18.6	17.3	14.9	22.3	13.3	19.4	12.2	17.7	18.3	16.1	17.9	1.9	15.2	9.7	22.2	11.2	18.4	13.0	16.7	21.5	24.4	12.5	7.8	14.5	14.0	4.1	15.8	19.9	9.0	16.2	15.8	16.2	32.6	22.7	13.5	11.7	6.7	14.6	13.6	6.2	11.2	2.0	7.3	0.2	14.7	15.9	14.1	11.0	10.2	14.1	10.7	10.9	31.3	3.1	15.4	16.0	12.4	4.5	17.7	19.8	14.7	7.3	12.6	6.2	4.1	11.0	17.9	10.3	11.5	25.2	9.1	21.6	22.6	9.2	26.1	32.8	20.3	22.8	12.7	33.7	25.7	21.1	14.9	25.2	17.5	16.3	13.4	11.4	13.1	20.6	12.8	15.1	14.8	11.6	24.5	9.0	17.5	25.5	59.6	69.7	91.3	125.6	75.7	90.3	93.6	76.5	44.2	45.5	90.7	60.9	172.5	41.4	69.4	761.4	73.0	16.6	46.7	65.1	74.7	80.3	95.3	31.2	27.6	41.9	162.1	63.8	57.1	54.0	372.5	144.7	68.9	64.1	36.1	33.3	141.5	56.6	43.5	193.7	88.0	61.1	142.3	128.8	73.5	118.0	66.0	165.9	68.7	36.0	108.0
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	24.0	25.0	27.9	28.8	28.0	32.3	33.4	28.0	30.2	20.8	23.0	15.0	27.8	19.7	21.1	35.9	27.6	21.3	17.9	28.7	28.7	21.3	35.0	45.9	19.0	27.6	23.6	22.0	28.0	29.2	19.8	27.6	19.8	33.5	27.3	26.3	14.4	34.7	26.7	132.7	19.3	23.5	29.7	35.6	27.2	28.2	28.6	24.1	24.6	26.0	32.0	28.7	24.0	47.9	30.9	30.7	16.1	35.4	26.0	33.8	19.0	54.8	28.5	32.4	35.8	18.5	20.4	27.1	29.5	28.3	36.5	34.0	46.6	36.9	38.6	18.6	27.0	27.5	30.5	55.3	41.8	51.2	35.5	37.5	38.8	24.6	51.4	23.4	53.2	24.7	20.9	25.3	43.5	46.1	27.8	34.7	36.5	42.8	19.8	30.9	32.8	34.4	53.8	25.0	46.3	43.1	33.0	34.1	23.1	32.3	26.4	17.2	17.6	22.0	36.2	36.2	27.6	19.5	23.7	23.2	17.1	30.1	25.1	53.1	20.3	22.6	57.4	33.5	27.8	13.1	12.4	28.7	16.1	24.6	34.7	33.8	30.9	28.2	26.8	30.7	28.9	31.9	28.6	4.7	26.0	35.4	26.5	29.7	19.0	27.9	28.0	28.0	30.2	28.7	21.3	23.6	22.0	33.5	24.1	59.6	61.1	29.0	39.2	59.4	23.5	74.2	22.9	92.3	78.5	22.7	21.6	35.7	66.3	28.3	8.2	26.2	18.0	23.3	38.0	30.2	29.3	38.3	25.5	42.9	32.0	15.9	24.8	24.5	28.9	7.7	34.2	29.8	21.9	35.1	20.2	25.8	38.2	14.0	29.4	48.8	23.1	25.8	31.5	79.8	108.7	45.7	28.3	24.9	31.1	42.9
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836039-49843129	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	5.6	9.3	6.9	6.0	8.4	2.6	7.8	8.9	9.0	6.1	6.0	7.2	6.9	4.9	8.3	7.5	9.1	7.7	4.9	5.3	5.9	4.5	7.3	10.5	4.5	8.3	9.8	4.8	8.5	11.9	8.4	12.7	6.5	6.6	8.7	5.7	5.2	15.4	6.9	32.8	7.6	8.4	5.3	7.6	9.3	8.4	5.3	7.7	15.2	9.9	4.2	10.8	7.4	6.0	9.9	5.0	5.9	6.6	6.2	10.3	4.6	3.4	4.9	4.7	7.3	9.9	5.8	4.9	4.7	6.2	5.0	5.2	2.6	9.0	3.0	5.4	2.1	3.8	4.6	4.7	2.8	2.8	10.4	6.3	4.2	3.8	1.6	7.9	4.8	4.2	3.1	11.2	3.5	5.0	6.3	2.3	6.5	7.5	8.3	3.1	8.6	5.3	7.7	4.7	7.5	8.7	5.6	4.4	5.9	4.9	3.1	6.5	9.1	5.6	9.1	6.7	3.9	11.4	5.3	2.6	4.2	3.2	6.3	2.5	7.9	6.8	5.7	4.5	3.5	2.8	5.9	5.4	2.8	7.6	6.5	10.1	9.9	9.4	7.2	5.0	9.1	10.3	9.7	4.6	6.2	6.6	3.0	7.8	4.6	6.9	8.4	8.9	9.0	5.9	4.5	9.8	4.8	6.6	7.7	29.8	23.5	12.6	7.6	1.9	6.7	2.4	2.5	18.7	11.4	1.8	0.0	11.0	11.6	8.2	1.7	2.9	4.3	0.0	8.5	6.0	5.0	5.7	10.4	6.4	5.0	4.8	1.7	4.3	4.9	0.7	7.8	4.8	0.0	1.0	5.5	7.1	5.8	6.0	6.0	6.7	5.8	0.0	4.1	8.2	10.0	2.8	6.4	10.0	5.0	2.0
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"B cell CLL/lymphoma 11A"	Q9H165	2	60450520-60555154	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 107.1"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 89.5;Erythroid cells: 93.5;Horizontal cells: 49.3;Suprabasal keratinocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1"	"Group enriched"	"Detected in many"	16	"B-cells: 53.7;dendritic cells: 107.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;MOLT-4: 19.1;REH: 19.5;U-698: 42.7;U-937: 13.7"	"Group enriched"	"Detected in all"	5	"amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9"	"CAB014891, HPA029003, HPA075941"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: AB_2672863, HPA075941: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	1.5	2.4	6.6	13.9	14.6	17.0	5.5	1.8	34.5	3.9	8.6	0.2	0.1	7.6	1.8	1.4	13.6	4.8	2.2	4.7	14.5	3.4	1.7	1.5	3.0	21.2	3.5	14.4	1.6	11.3	1.2	3.9	0.9	9.6	4.8	5.1	0.0	11.4	2.0	1.4	24.9	11.4	2.9	2.0	13.5	3.3	2.0	2.6	20.9	2.4	4.0	30.4	3.6	7.8	53.7	107.1	1.3	5.1	1.0	0.1	1.2	0.2	0.0	1.7	0.0	0.3	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	20.7	0.1	0.0	0.0	4.2	6.4	3.0	0.0	0.3	6.2	0.0	0.2	0.1	0.0	7.4	0.0	0.7	1.7	0.0	1.0	1.7	1.0	7.0	0.3	0.1	0.0	0.0	19.1	7.6	11.8	3.0	0.1	19.5	0.5	7.9	0.0	0.3	8.4	2.0	0.1	0.1	0.1	3.5	0.1	3.6	0.5	0.1	4.9	0.1	0.0	0.3	0.0	42.7	0.0	13.7	0.6	0.4	2.9	0.5	0.0	5.1	0.1	39.6	0.0	0.0	10.7	53.7	0.1	0.1	1.3	1.0	3.7	107.1	0.1	1.2	6.6	14.6	1.8	34.5	14.5	3.4	3.5	14.4	9.6	2.6	0.0	9.0	89.5	14.8	41.1	0.5	12.2	5.1	5.3	7.9	1.8	0.0	0.5	5.0	7.7	9.4	1.2	8.4	93.5	5.6	0.7	5.1	4.2	9.3	0.0	32.9	49.3	19.0	0.6	8.2	3.6	0.3	17.9	15.1	6.4	11.7	0.1	5.4	13.6	0.0	0.3	0.1	0.0	1.3	1.6	5.9	61.1	0.7	0.0	24.2	4.1
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Group enriched"	"Detected in many"	8	"Basal keratinocytes: 55.8;Suprabasal keratinocytes: 62.4;T-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Group enriched"	"Detected in some"	6	"JURKAT: 24.7;MOLT-4: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.0	24.7	0.0	2.8	0.0	1.6	29.5	0.4	0.3	2.2	0.0	4.6	0.0	0.0	0.0	1.6	2.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.8	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6	3.0	0.0	2.7	1.6	55.8	0.1	3.1	5.1	0.0	1.2	0.0	0.0	0.1	1.7	0.3	0.0	0.1	4.3	0.0	0.4	0.0	1.1	0.2	4.7	0.0	0.2	0.0	1.2	4.3	1.2	0.2	0.6	0.7	5.0	0.0	2.6	0.0	0.7	4.3	0.0	0.3	0.0	0.0	3.3	0.7	4.9	62.4	0.0	48.4	6.9	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2, apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7"	"Group enriched"	"Detected in many"	8	"B-cells: 5.2;T-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 22.8;U-266/70: 79.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.9	3.0	10.1	15.7	9.4	5.3	24.6	4.7	8.4	14.8	7.8	7.4	9.1	5.0	17.1	9.3	4.7	12.2	9.2	6.5	10.0	8.1	8.5	2.3	5.0	14.6	10.8	5.6	18.2	2.9	19.6	7.0	22.4	9.2	8.4	5.9	10.8	5.4	15.7	20.0	6.3	10.5	8.6	9.3	17.8	5.4	3.5	10.5	21.0	35.6	2.9	13.4	7.9	16.4	5.2	0.3	0.7	0.2	0.7	7.6	1.9	0.5	0.1	2.3	1.8	2.8	0.4	0.8	0.2	0.2	0.8	0.5	1.1	0.1	0.0	0.4	0.2	1.5	0.1	2.1	0.3	0.4	13.6	0.4	0.1	0.6	0.2	0.5	12.4	1.8	0.5	0.2	0.9	1.9	0.3	0.2	1.4	0.2	22.8	0.4	0.4	2.6	5.4	0.5	0.2	0.4	11.7	0.5	8.8	3.9	1.9	1.9	1.8	0.0	0.0	2.8	0.5	0.1	10.5	0.1	3.0	1.0	0.3	1.5	79.4	10.4	0.9	0.5	8.8	1.7	0.7	0.0	0.0	2.3	0.0	7.6	5.2	6.3	3.8	0.1	4.1	5.1	4.5	0.1	0.7	0.2	0.3	6.7	1.9	10.1	9.4	4.7	8.4	10.0	8.1	10.8	5.6	9.2	10.5	0.0	0.6	41.9	30.2	17.3	1.0	15.4	17.8	0.0	3.4	7.0	0.0	8.5	13.3	2.5	0.2	3.5	0.8	0.0	0.0	0.9	10.3	31.5	15.1	1.5	8.3	0.0	5.2	3.7	10.4	2.1	8.1	16.9	43.9	29.7	9.9	18.9	0.3	0.0	13.1	13.5	0.5	25.8	10.8	0.3	0.6	15.4	41.1	28.7	10.6	39.2
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306835-23325369	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	11.4	5.3	14.2	5.8	17.7	12.0	17.7	16.4	24.2	17.9	21.0	14.4	11.4	4.5	13.7	6.9	14.4	16.1	16.0	11.2	17.8	9.5	7.1	6.9	10.3	6.4	13.1	21.2	8.0	21.4	29.1	11.4	18.0	17.5	16.3	5.6	7.5	22.1	37.7	7.0	14.5	7.7	18.6	20.2	9.7	13.0	15.0	14.8	0.0	14.4	5.7	5.4	16.6	12.1	1.9	1.1	2.1	4.4	3.5	0.3	1.1	5.1	6.6	4.2	3.4	0.3	9.6	3.3	1.4	13.8	21.5	23.4	5.4	16.8	1.7	1.2	7.2	5.2	7.3	4.8	6.6	5.6	3.5	5.3	0.4	0.9	8.7	2.9	1.8	10.4	8.7	12.2	7.9	1.5	1.7	5.1	0.1	1.6	5.1	6.5	7.9	0.2	1.1	5.3	1.0	4.2	3.2	0.1	1.1	3.7	2.1	7.0	2.8	2.1	7.1	1.9	0.7	3.8	2.8	1.9	5.6	4.4	5.5	3.6	2.8	2.6	0.5	2.3	3.8	8.6	2.1	4.4	0.3	0.2	1.6	0.2	1.4	0.0	0.0	0.6	1.9	0.3	0.1	0.8	3.5	2.6	1.1	0.0	1.1	14.2	17.7	16.4	24.2	17.8	9.5	13.1	21.2	17.5	14.8	3.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BCL7A	BCL7	ENSG00000110987	"BCL tumor suppressor 7A"	Q4VC05	12	122019422-122062044	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 8.4;plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	10	"B-cells: 8.4;dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;MOLT-4: 19.2;U-698: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019762	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA019762: AB_10962489"	"unprognostic (3.27e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (5.18e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.86e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.51e-2)"	3.8	3.7	13.0	9.8	14.5	9.9	6.5	19.8	18.2	6.7	4.2	6.8	3.3	3.6	6.0	7.4	3.3	10.3	4.3	9.4	9.5	7.5	10.7	5.3	5.1	19.4	6.6	15.9	4.9	11.7	8.3	6.1	2.8	6.8	6.3	3.8	3.8	8.2	7.2	12.8	8.2	3.4	4.1	5.1	6.5	4.4	3.1	7.9	26.4	11.1	3.5	15.8	6.9	5.4	8.4	9.7	0.1	0.1	0.5	0.9	0.6	1.7	2.4	8.0	5.6	0.5	0.3	1.7	1.0	1.1	1.7	1.5	1.0	0.7	26.2	2.9	0.8	1.0	2.3	5.8	5.5	1.5	0.0	9.5	1.3	0.2	1.4	1.7	4.0	2.3	1.3	5.3	1.2	7.2	2.0	2.1	12.3	5.9	0.0	1.0	3.6	19.2	0.3	2.9	2.4	4.1	10.6	2.8	0.3	3.2	4.5	8.0	9.0	1.3	0.3	3.3	2.0	5.4	3.3	1.9	0.3	1.7	3.0	1.7	2.7	1.8	30.3	0.5	2.6	1.8	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.2	0.2	2.2	8.4	0.9	0.6	0.1	0.5	0.1	9.7	0.0	0.6	13.0	14.5	19.8	18.0	9.5	7.5	6.6	15.9	6.8	7.9	20.8	8.6	37.2	47.6	31.9	38.8	25.8	38.2	14.7	22.7	36.6	17.7	1.0	49.7	25.7	6.1	3.1	1.7	0.0	9.5	0.8	8.7	26.5	10.4	16.8	3.2	101.7	20.6	4.3	3.5	9.8	13.0	8.5	11.8	5.4	8.0	5.6	10.5	7.0	7.4	18.9	13.5	6.5	15.6	0.5	4.3	26.3	0.5	0.0	11.4	26.0
BCL9		ENSG00000116128	"B cell CLL/lymphoma 9"	O00512	1	147541412-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	4.5	7.8	10.2	5.9	9.2	3.1	4.8	22.3	12.6	18.2	9.4	8.1	10.9	5.3	23.9	15.9	6.8	18.9	5.2	8.3	8.0	7.4	9.6	4.3	5.0	4.0	5.9	8.7	17.0	6.1	14.6	10.6	4.5	6.8	10.5	7.9	11.8	8.1	13.2	7.9	7.8	5.5	15.7	5.4	3.8	7.6	6.1	6.5	22.4	7.8	8.0	6.0	9.6	8.0	0.4	0.0	0.6	0.3	0.1	2.6	1.0	2.9	2.9	20.6	15.3	2.3	2.8	4.0	2.4	3.9	2.7	2.6	3.8	4.5	2.8	5.5	2.3	4.5	2.4	13.0	4.4	2.5	6.7	3.6	1.3	3.1	2.5	2.0	0.8	4.1	2.7	3.8	3.2	2.3	4.8	4.1	9.4	2.6	4.6	2.3	6.7	7.0	0.6	24.3	6.0	6.4	7.5	5.2	5.5	10.4	3.3	5.6	12.2	2.7	5.1	4.7	19.8	6.4	1.3	3.0	1.9	9.0	5.3	3.8	20.9	5.3	5.4	4.8	0.8	9.1	0.0	0.3	0.6	1.0	0.0	0.9	0.2	1.2	1.2	0.0	0.4	2.6	1.6	0.2	0.1	0.1	0.0	0.9	1.0	10.2	9.2	22.3	12.6	8.0	7.4	5.9	8.7	6.8	6.5	0.0	2.1	0.0	5.2	2.7	7.9	4.7	7.6	2.7	2.3	12.2	2.0	1.8	10.0	3.4	9.0	2.8	1.8	0.0	4.0	2.0	4.6	7.6	8.1	2.6	1.1	6.4	27.2	6.2	2.8	4.2	8.9	0.4	0.0	1.0	10.9	4.3	3.8	0.0	7.4	4.9	2.8	0.0	3.8	3.2	6.8	3.1	1.7	0.5	6.9	2.7
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058083	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Syncytiotrophoblasts: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HAP1: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007"	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	7.5	7.9	7.7	5.2	9.1	9.8	9.1	19.8	10.5	8.7	8.3	10.7	8.1	5.4	9.2	5.4	5.8	9.3	4.2	6.9	8.4	4.5	7.5	4.7	6.7	5.3	7.6	5.9	11.4	8.9	13.4	15.0	28.9	7.5	8.1	4.5	6.0	6.5	8.4	6.0	6.5	6.0	8.8	5.3	7.7	6.6	26.1	8.1	6.8	10.3	2.2	5.1	6.7	8.5	1.2	1.6	3.5	1.3	0.8	1.3	0.7	2.2	5.5	12.9	20.4	7.6	5.5	3.6	3.0	3.5	3.9	4.5	6.6	1.4	1.0	6.7	6.0	3.7	1.3	30.8	1.2	3.7	2.2	4.5	10.6	2.7	2.2	3.8	2.6	3.1	3.4	2.5	7.7	0.4	5.8	4.7	3.5	5.1	10.8	2.5	1.3	3.9	8.0	3.5	1.8	3.9	8.3	5.2	1.4	2.2	0.3	2.1	7.3	1.6	0.4	2.0	7.2	4.5	4.0	3.9	3.2	4.1	3.8	2.9	3.5	6.3	1.6	2.1	5.4	1.5	0.1	1.3	2.8	1.3	0.2	1.0	1.2	0.9	0.8	1.6	1.0	0.6	0.7	3.5	0.8	0.5	0.7	0.2	0.7	7.7	9.1	19.8	10.5	8.4	4.5	7.6	5.9	7.5	8.1	0.0	3.2	0.0	2.3	10.5	1.8	6.4	5.1	2.7	1.2	7.0	0.0	10.7	0.0	3.2	0.4	7.1	2.7	0.0	0.9	4.2	5.8	2.9	6.9	3.0	2.8	7.9	11.5	3.1	2.6	1.0	4.4	1.8	6.8	1.0	1.7	3.1	2.3	0.0	3.5	2.2	1.0	6.5	4.5	3.5	5.3	10.0	78.1	1.5	2.8	2.5
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427297-66493529	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 5.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053851: AB_2682280"	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	1.2	1.2	2.9	1.1	2.5	2.9	1.2	6.9	9.6	1.2	0.7	0.1	0.0	0.6	1.2	1.9	1.8	1.9	1.4	3.0	4.6	4.1	0.9	1.1	1.4	0.9	2.3	3.2	1.4	1.9	0.1	0.4	4.5	11.6	1.0	0.9	5.0	1.9	0.4	3.6	3.2	0.8	0.8	1.7	1.2	1.2	3.1	0.2	0.0	1.9	3.1	0.9	1.0	1.0	0.3	2.4	5.2	0.5	0.4	0.2	0.1	0.8	1.0	1.0	9.7	0.3	0.1	4.9	0.3	0.0	0.1	0.1	0.0	1.0	0.1	0.6	0.3	0.6	0.2	0.1	0.1	0.3	0.0	0.7	0.0	0.2	0.7	0.7	0.1	0.0	0.7	1.9	0.6	0.3	1.4	0.0	0.2	0.1	0.3	0.2	0.5	0.0	0.4	0.3	0.1	0.6	0.1	0.2	0.5	8.6	0.6	0.1	0.2	0.2	0.2	1.4	0.7	0.2	0.1	0.3	0.4	2.7	0.1	0.4	0.5	0.1	0.1	5.6	0.2	1.4	0.4	0.5	1.9	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	5.2	0.4	0.2	2.4	0.1	0.1	2.9	2.5	6.9	9.6	4.6	4.1	2.3	3.2	11.6	0.2	0.0	0.0	0.0	0.2	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	8.4	0.3	0.0	0.0	0.0	8.9	0.6	1.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	8.0	0.3	0.0	3.3	0.0	0.0	0.0	1.0	0.0	2.1	0.0	0.9	0.0	0.5	2.9	0.3	0.1	2.4	0.0	0.0	0.3
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955126-57027342	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.2;Horizontal cells: 39.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 11.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.2;fHDF/TERT166: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.5	3.1	12.0	2.0	10.7	1.0	1.1	29.2	29.7	5.8	1.7	2.5	0.6	0.8	3.2	1.3	1.8	1.1	5.2	3.1	11.2	10.0	1.0	0.5	1.0	1.2	11.3	8.6	2.9	0.8	2.8	1.1	2.7	33.0	3.4	2.2	0.2	1.0	3.4	4.3	1.5	1.2	4.8	7.2	1.2	1.3	1.5	4.1	0.0	1.3	0.0	1.3	3.9	1.6	0.0	11.1	0.0	0.0	2.1	0.0	0.1	3.4	1.5	0.8	0.4	12.1	20.2	3.3	10.4	10.1	4.7	5.4	0.1	1.6	0.0	3.4	18.4	6.5	0.4	1.2	0.5	5.9	1.5	0.6	2.2	4.9	0.2	3.2	6.3	0.1	8.7	2.9	6.4	2.9	8.0	3.1	8.7	2.8	6.0	9.4	3.5	3.8	1.6	2.9	0.1	0.8	0.0	0.1	1.6	1.7	3.4	4.1	4.1	6.9	0.9	0.8	4.2	0.2	3.8	3.9	14.2	0.4	9.6	2.2	8.3	9.1	2.7	8.3	4.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	11.1	0.0	0.1	12.0	10.7	29.2	20.8	11.2	10.0	11.3	8.6	33.0	4.1	0.0	0.0	0.0	0.2	0.8	68.2	3.6	0.0	0.0	1.2	0.0	3.9	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.2	6.9	0.6	0.0	0.0	0.1	39.7	0.0	1.8	0.0	0.6	1.7	2.1	3.3	0.0	0.0	3.7	0.3	0.0	2.8	0.3	4.1	0.0	1.9	0.5	4.1	0.9	0.0	0.0	0.0	0.0
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	18.6	20.3	11.4	23.4	15.2	9.2	19.2	14.4	19.8	22.3	18.0	21.0	34.1	17.0	23.4	28.6	16.2	21.7	25.3	18.7	11.6	12.6	21.4	30.3	20.4	20.4	14.9	13.7	33.8	62.2	29.3	31.4	17.3	15.8	27.3	18.0	24.4	35.1	28.0	11.6	18.6	22.4	26.1	13.4	22.3	21.8	27.4	10.5	18.4	27.0	15.6	22.4	25.8	21.0	18.1	12.3	34.3	15.1	15.1	22.5	15.9	18.5	15.5	9.2	11.4	28.7	25.4	13.4	19.9	26.2	21.4	22.0	19.3	18.0	16.5	9.7	35.9	15.4	17.4	10.6	18.2	16.4	12.7	11.5	15.2	8.2	19.4	26.6	17.2	29.7	28.5	24.5	12.6	33.9	24.9	14.4	11.7	22.1	17.3	13.6	10.1	12.5	10.9	14.1	27.1	17.6	13.1	13.7	11.1	17.6	8.3	10.1	12.2	17.7	28.7	19.3	13.9	14.7	13.6	15.9	16.6	7.7	6.7	9.7	30.5	13.9	14.5	22.5	14.5	15.1	27.0	10.4	34.3	16.7	15.1	20.0	18.1	19.3	17.0	10.5	15.1	22.5	17.3	24.5	15.1	13.2	12.3	14.6	15.9	11.4	15.2	14.4	19.8	11.6	12.6	14.9	13.7	15.8	10.5	11.9	14.2	6.7	14.7	8.2	6.4	14.0	12.7	6.7	4.5	14.0	7.9	13.5	18.3	11.3	46.5	9.2	28.5	0.0	20.3	20.8	15.4	22.9	36.9	33.1	20.4	3.2	7.5	17.8	18.0	91.1	20.4	14.6	6.8	12.6	19.3	8.2	16.7	23.0	17.7	24.5	8.9	6.5	11.7	41.4	14.9	10.2	22.0	15.8	13.3	19.3
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215092-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 37.9;HMC-1: 45.9;K-562: 53.1"					"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	9.8	36.8	63.8	8.6	71.4	21.5	20.8	53.6	68.8	20.7	14.3	29.5	11.5	6.4	25.5	99.8	17.7	24.5	14.8	35.1	61.6	77.6	34.9	5.1	15.8	10.7	54.3	54.7	38.8	12.6	40.7	34.1	29.4	50.5	30.1	10.1	18.0	27.1	32.1	2.5	7.5	8.7	20.9	51.2	23.1	9.6	16.2	24.4	8.6	47.8	3.5	12.3	14.1	11.5	12.9	28.3	36.7	10.4	34.0	25.7	15.0	0.0	0.0	23.5	0.0	6.0	4.1	21.0	5.5	4.7	10.4	19.2	0.0	0.3	0.0	9.3	3.8	8.8	0.1	9.4	1.2	11.5	0.0	8.8	37.9	0.0	0.0	18.4	28.4	45.9	15.5	3.1	5.4	0.0	11.6	12.0	14.8	53.1	0.1	3.1	0.1	19.8	0.2	28.4	0.0	1.6	0.0	6.8	0.1	9.5	0.5	17.5	26.8	1.9	0.3	1.1	23.9	0.9	0.3	0.3	1.3	8.4	0.2	0.0	3.0	1.3	0.0	3.9	0.0	1.1	36.7	8.6	14.8	12.1	10.4	10.1	12.9	14.7	12.2	18.2	12.6	25.7	20.2	1.9	34.0	8.5	28.3	13.5	15.0	63.8	71.4	53.6	68.8	61.6	77.6	54.3	54.7	50.5	24.4	32.8	30.2	36.0	116.3	24.3	176.9	67.8	43.3	36.1	56.9	94.2	23.6	266.1	253.7	53.3	2.2	46.6	6.3	0.0	12.2	138.8	44.1	99.1	108.3	0.8	81.6	209.7	60.6	49.1	47.6	6.7	58.7	61.3	109.6	191.2	37.7	161.0	15.3	24.6	57.7	144.4	67.7	51.8	44.8	22.8	14.5	21.1	304.7	33.2	28.0	91.2
BHLHA15	"bHLHa15, BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211427-98212979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"pancreas: 145.8;salivary gland: 95.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.7"	"Group enriched"	"Detected in some"	8	"Karpas-707: 17.1;RPMI-8226: 31.7;U-266/70: 37.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.2	0.8	0.2	0.0	0.1	0.1	0.2	0.3	1.2	0.0	3.5	0.9	0.1	0.1	0.4	0.1	0.8	0.1	0.3	0.2	0.3	4.7	0.5	1.8	0.1	0.0	0.0	145.8	0.0	0.4	0.0	0.0	1.6	0.1	0.0	95.2	6.8	0.4	0.2	0.8	0.0	0.1	1.9	6.2	0.1	0.0	0.0	0.2	1.2	2.7	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	1.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.1	0.0	0.3	0.0	0.0	0.5	1.2	0.5	0.2	0.0	31.7	0.0	0.0	1.9	0.7	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	37.9	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 21.1"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 11.3;Cone photoreceptor cells: 11.8;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000887			Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA000887: AB_2666130"	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	2.8	6.4	8.6	1.6	13.0	2.7	3.7	15.3	20.6	5.5	3.4	8.7	2.3	2.1	7.5	5.8	2.9	4.5	3.0	4.9	8.9	12.5	6.3	3.8	2.6	1.5	7.2	12.7	9.9	3.6	9.1	7.1	4.8	21.1	7.2	2.9	3.9	3.6	8.2	4.8	3.4	2.5	7.2	6.3	2.7	2.5	4.4	7.3	1.7	6.6	1.2	2.0	4.1	3.4	0.7	0.3	0.9	0.2	5.3	2.0	0.5	0.5	4.0	13.1	3.9	4.2	2.5	5.3	3.5	4.7	5.8	11.1	3.4	2.4	0.0	3.7	3.9	3.8	2.8	7.2	3.8	6.5	0.0	4.3	1.0	3.3	0.7	6.7	0.7	1.3	4.4	3.4	2.6	0.3	5.3	5.8	0.2	3.0	3.6	5.0	2.2	2.6	0.4	7.6	1.4	3.0	1.4	3.8	0.0	3.8	5.8	5.8	5.5	3.8	1.1	0.4	4.9	3.3	1.8	5.9	1.5	4.0	2.2	3.3	1.9	4.8	0.0	3.6	0.9	2.4	0.9	0.2	0.2	1.0	0.1	0.9	0.4	1.1	2.0	0.1	0.7	1.3	1.7	0.7	5.3	0.1	0.3	1.6	0.5	8.6	13.0	15.3	20.6	8.9	12.5	7.2	12.7	21.1	7.3	6.0	1.0	0.0	1.0	1.5	11.3	7.0	2.5	0.0	1.2	3.5	11.8	3.3	6.6	1.2	0.0	2.1	0.5	0.0	0.7	0.8	2.5	1.7	0.0	1.0	1.1	3.2	4.6	3.7	2.1	0.4	2.6	0.0	0.0	1.0	0.6	11.0	0.2	0.0	2.5	1.7	6.0	6.5	1.0	3.9	6.5	1.0	1.1	0.0	1.1	0.6
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	7.6	3.5	1.7	0.8	1.3	0.1	0.5	0.0	4.8	0.0	0.7	1.5	11.4	4.0	0.1	0.6	0.4	0.0	0.6	0.3	0.0	0.0	0.3	1.9	0.1	0.5	0.4	2.8	5.5	33.8	0.0	0.0	0.0	14.3	0.8	0.4	0.0	1.3	3.7	1.3	2.8	0.0	0.6	10.9	1.8	44.7	0.0	0.0	0.5	0.2	10.1	0.2	0.0	0.0	2.3	2.6	3.1	0.3	2.0	19.2	11.0	0.0	16.5	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0	0.0	0.6	22.9	50.0	5.4	333.3	33.5	33.1	42.8	10.3	27.9	172.8	22.2	0.0	35.8	0.2	4.8	10.8	0.0	19.8	2.4	18.8	38.9	5.7	0.0	71.2	236.8	12.6	3.1	2.7	0.4	27.9	35.2	13.5	47.7	3.0	283.4	13.9	5.7	25.1	2.1	289.4	6.5	6.6	0.5	0.4	2.9	5.9	0.0	3.3	52.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 530.1;monocytes: 1925.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.5	5.3	0.0	0.1	0.1	0.7	0.6	0.5	4.4	0.6	0.7	0.9	38.4	33.7	17.4	0.3	5.5	3.6	0.0	0.9	2.1	31.9	0.1	0.1	1.6	0.2	6.6	0.5	0.7	0.7	4.7	2.1	33.6	1.2	0.1	2.7	0.1	0.0	0.8	0.0	2.3	0.3	0.1	3.1	0.2	0.0	0.3	1.7	8.7	3.4	0.0	0.1	0.5	0.6	0.3	0.2	1.7	0.3	1.7	7.3	0.8	0.4	6.7	22.5	19.2	11.9	1.3	1.9	0.9	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7	134.0	68.1	285.1	318.0	89.9	0.3	12.0	76.5	30.8	73.9	38.4	0.0	1.7	6.6	193.4	1.3	50.1	284.0	46.7	153.8	0.5	71.9	371.3	530.1	3.4	11.1	0.0	14.5	7.4	18.1	1.3	4.6	71.9	182.2	1925.2	27.1	0.1	190.8	361.2	2.1	8.8	0.0	0.0	133.5	0.5	0.4	73.9	0.5	89.3	29.9	164.7
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.5	7.8	8.8	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.9	3.9	14.2	2.6	1.1	5.9	9.2	13.5	3.7	6.1	8.6	10.0	14.9	8.5	2.2	0.0	14.3	7.4	0.0	0.0	4.7	2.4	0.6	3.3	7.7	12.8	4.4	4.9	3.4	10.7	7.8	9.3	12.1	1.7	10.9	16.5	5.5	1.1	9.9	6.5	6.1	3.3	4.5	2.6	8.6	3.1	11.7	1.8	3.4	6.3	3.5	8.8	3.3	13.2	14.8	1.9	10.1	5.9	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5	3.0	12.8	18.6	0.5	0.2	2.9	8.4	0.0	9.4	6.8	0.0	2.0	1.8	1.7	0.9	2.0	0.7	0.0	0.0	0.6	6.5	1.5	0.6	12.7	0.5	4.8	0.0	0.0	2.5	9.7	1.6	0.0	3.8	0.0	1.0	1.2	1.2	0.8	0.0	0.4	0.0	6.5	0.0	0.4	12.0	11.8	0.5	0.8	8.7	2.3	0.3
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	17.5	13.5	15.7	12.2	18.6	19.7	17.3	21.0	24.1	19.6	14.3	7.8	12.7	10.5	14.4	13.2	29.3	11.8	14.5	14.7	13.8	11.6	19.6	13.1	11.3	9.4	14.0	18.0	17.4	12.0	15.5	30.3	16.9	20.5	19.9	14.1	7.5	16.0	15.2	13.5	15.7	17.3	18.8	16.7	10.9	12.4	35.6	15.8	19.1	19.1	17.5	13.6	22.1	20.8	5.2	5.1	31.4	7.5	8.9	10.9	5.1	24.9	8.0	8.0	6.9	12.2	18.9	13.0	22.3	15.7	23.7	26.2	9.3	16.4	3.7	12.6	14.8	15.0	18.3	7.8	13.9	18.7	7.7	7.7	6.7	9.9	6.5	12.8	12.8	9.5	13.8	17.9	17.7	16.1	13.3	12.4	7.4	11.6	10.1	21.7	5.3	5.5	5.9	9.7	18.0	12.0	3.3	12.6	7.8	22.8	8.5	5.0	15.1	14.6	19.8	16.6	14.2	22.0	9.2	14.8	14.1	11.0	13.1	18.0	10.2	12.1	9.4	10.9	5.9	21.7	31.4	5.9	23.2	6.2	7.5	7.9	5.2	7.7	7.0	5.1	4.8	6.9	7.4	12.0	8.9	7.0	3.9	10.9	5.1	15.7	18.6	21.0	24.1	13.8	11.6	14.0	18.0	20.5	15.8	20.8	16.0	8.1	38.5	16.4	14.4	27.9	12.7	36.1	22.7	10.4	13.7	15.4	19.9	21.3	111.7	10.3	14.0	0.0	11.6	14.4	16.6	14.2	25.4	4.3	12.2	31.8	12.1	8.6	10.2	53.5	13.6	11.1	13.5	6.4	10.5	15.1	24.8	11.5	16.6	16.7	25.7	0.0	20.2	33.9	22.8	13.7	16.8	15.0	8.5	70.2
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.1	15.0	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12.0	7.0	15.5	6.1	21.7	10.8	11.0	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.6	8.8	14.0	13.6	10.8	12.0	12.1	10.5	10.5	4.7	8.7	2.0	14.0	24.2	9.0	10.9	7.3	9.3	16.5	6.0	5.0	6.1	5.8	7.3	9.7	1.7	4.8	9.9	8.8	7.7	10.3	16.2	30.2	2.5	3.9	10.0	12.9	10.8	1.4	1.6	3.1	2.8	5.0	3.9	11.0	3.0	8.9	12.3	5.7	5.7	12.8	7.6	14.1	14.3	5.9	4.0	33.3	21.4	11.4	7.3	7.2	1.4	1.7	0.6	5.1	3.9	6.2	0.5	2.0	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8	98.3	38.9	17.1	16.1	29.8	51.7	46.4	12.7	21.4	39.8	19.2	76.6	14.0	1.7	27.3	2.4	119.4	12.7	0.0	24.7	19.4	40.9	19.9	23.1	15.5	16.2	33.4	24.1	109.2	20.0	2.3	31.4	17.4	40.5	15.4	16.3	38.7	36.3	20.9	40.3	10.7	29.9	64.7	45.7	17.7	11.1	31.5	16.7	13.8	13.4	22.7
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Group enriched"	"Detected in some"	9	"Endothelial cells: 18.5;Ito cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1	0.0	1.4	0.0	0.5	0.3	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.1	0.0	4.1	51.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1
BORCS8	MEF2BNB	ENSG00000254901	"BLOC-1 related complex subunit 8"	Q96FH0	19	19176903-19192591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045700	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA045700: AB_10968570"	"unprognostic (4.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.82e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.00e-2)"	11.3	17.0	25.0	12.9	26.8	12.2	13.3	19.3	31.0	10.1	13.5	17.3	14.5	15.5	12.9	15.8	13.8	14.0	14.8	17.9	23.9	30.0	16.0	14.1	12.0	14.0	26.3	12.2	10.5	10.1	11.7	20.1	11.3	15.6	10.9	15.3	13.6	12.4	15.5	12.0	9.6	9.5	13.0	13.9	11.9	11.2	11.1	12.9	12.4	13.0	11.1	13.8	10.9	8.5	8.7	9.8	25.6	14.6	5.0	7.1	6.7	9.7	5.5	9.1	7.4	9.9	5.4	9.1	10.3	8.7	16.2	15.0	9.6	9.6	7.2	14.4	11.9	12.7	6.4	9.8	12.6	7.7	3.9	12.5	5.4	12.5	10.2	8.1	3.9	7.7	6.5	9.4	12.4	6.2	7.3	14.2	12.4	9.7	10.5	17.1	17.6	14.8	9.1	4.9	11.7	12.1	7.1	3.6	8.2	14.0	6.0	18.5	10.2	9.4	6.2	7.6	7.3	6.8	7.6	7.2	5.6	8.3	19.0	15.5	6.6	7.8	8.3	11.1	6.7	11.4	10.6	9.6	16.0	4.9	13.7	4.8	8.7	5.7	5.6	7.4	6.3	4.7	5.2	25.6	5.0	14.6	9.8	7.1	6.7	25.0	26.8	19.3	31.0	23.9	30.0	26.3	12.2	15.6	12.9	11.9	22.9	13.7	12.0	0.0	15.5	0.0	28.1	24.1	13.6	14.0	9.8	27.4	36.5	34.2	2.6	9.7	16.6	0.0	28.6	29.2	3.1	15.0	9.3	15.3	35.2	17.5	10.5	12.9	26.3	4.5	7.2	17.5	0.0	43.3	12.4	10.6	32.6	10.5	6.3	29.8	13.3	0.0	0.0	32.2	21.5	0.0	33.1	15.0	12.5	15.3
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 64.7;Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.7	25.6	14.1	11.2	2.3	5.2	13.8	18.6	8.0	15.6	14.9	15.5	12.3	36.4	3.4	7.1	18.5	18.3	19.1	10.4	26.2	16.6	14.0	17.1	20.1	13.4	0.5	30.5	14.9	1.4	1.7	23.5	7.5	4.0	8.1	17.0	25.8	15.6	14.7	10.5	25.5	10.1	7.7	10.6	6.8	17.6	29.7	14.9	5.8	15.3	9.7	10.4	14.3	4.7	7.0	10.0	12.6	14.1	5.2	14.0	11.4	18.1	19.3	7.3	17.8	28.0	11.3	18.1	14.6	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0	0.0	3.2	5.2	3.8	2.6	8.3	10.4	7.6	13.4	5.7	1.8	21.6	7.0	0.0	2.6	11.1	2.9	1.0	0.0	1.0	17.5	2.9	2.4	8.1	16.1	8.6	11.1	0.0	5.5	4.0	5.2	2.3	5.3	0.0	3.6	3.7	2.8	1.6	3.1	1.4	0.8	21.1	6.5	1.4	64.7	61.1	1.9	3.3	2.5	3.5	2.5
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2, DNA repair associated"	P51587	13	32315474-32400266	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 16.9"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	2.4	1.0	0.6	13.8	0.6	11.6	3.2	0.6	0.6	1.8	4.0	0.2	0.2	1.4	1.5	2.7	3.0	1.0	0.7	2.1	0.6	0.7	1.0	1.4	3.5	5.3	0.7	0.5	1.4	3.3	0.4	0.7	7.0	0.8	0.9	2.0	0.1	1.8	0.3	3.3	1.8	3.2	0.8	2.1	6.6	1.5	16.9	0.1	23.2	0.9	4.8	4.2	1.3	1.7	1.3	1.9	0.4	0.2	1.5	0.8	0.0	4.0	3.5	6.1	4.6	0.6	1.6	6.2	4.3	2.7	5.0	4.6	8.3	5.3	14.2	2.9	2.1	6.9	5.4	5.0	2.5	9.7	9.2	2.7	9.0	2.2	3.2	0.2	12.8	4.5	0.4	0.3	9.2	6.4	0.5	4.1	7.2	5.9	4.9	5.7	4.6	10.3	7.6	7.2	4.6	1.9	10.1	15.7	2.7	1.3	4.3	2.3	4.4	5.2	2.3	2.1	2.2	2.7	6.4	3.2	5.8	6.2	6.4	6.0	1.9	2.9	7.3	3.0	5.1	5.5	0.1	0.2	0.2	0.3	0.2	0.1	0.9	0.4	0.2	0.2	1.3	0.6	0.8	0.4	1.5	0.2	1.9	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.5	0.8	0.1	8.9	1.6	1.9	2.8	2.3	0.0	1.6	0.0	4.0	2.3	0.0	0.0	9.1	0.0	1.8	4.3	3.6	1.0	23.3	1.4	9.1	3.5	0.6	3.5	0.8	8.2	0.0	1.2	2.5	6.7	2.5	2.0	13.2	3.3	31.5	3.0	0.2	1.1	1.5	1.1	0.6	0.0	12.9	2.0	75.1	82.4	1.1	4.6	3.8	5.3	1.4
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368934	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	23.5	26.9	38.8	33.7	39.0	42.2	39.1	34.5	35.9	24.5	30.7	32.4	26.4	23.4	29.0	38.1	37.3	27.1	24.4	41.2	35.3	31.9	29.9	22.9	27.9	32.1	38.4	26.9	26.8	36.5	53.3	35.1	37.9	42.6	29.5	30.3	22.2	26.9	30.7	37.9	31.2	31.1	27.2	48.1	32.1	29.0	41.5	36.4	46.1	31.2	26.5	36.4	24.5	40.0	8.8	11.2	9.6	6.8	12.3	12.1	3.7	22.3	19.7	34.7	20.6	14.7	14.6	22.9	18.4	18.2	29.1	13.2	33.1	22.8	33.4	19.3	16.3	18.1	20.7	31.7	18.5	33.6	15.1	26.3	22.6	15.8	45.7	17.3	31.1	25.0	10.6	27.9	14.9	25.8	17.7	19.3	33.2	32.6	10.7	17.7	14.5	35.2	42.0	27.2	23.6	18.8	43.4	32.6	24.2	25.4	15.8	27.0	21.9	22.3	21.7	15.0	31.0	13.0	28.3	19.4	18.5	22.5	15.2	17.8	5.1	1.9	57.1	14.5	22.7	18.3	8.2	6.8	9.6	8.8	5.7	6.8	8.0	8.9	8.1	5.4	8.8	10.1	12.1	4.0	12.3	5.1	11.2	8.5	3.7	38.8	39.0	34.5	35.9	35.3	31.9	38.4	26.9	42.6	36.4	35.7	59.7	42.5	27.5	45.1	90.5	31.9	48.4	50.9	36.4	47.1	62.8	63.5	91.2	20.0	32.8	31.4	37.2	46.7	19.9	40.7	28.7	42.0	15.0	35.5	26.0	85.8	34.5	23.9	27.0	15.6	30.2	35.5	25.3	14.4	38.2	74.8	20.8	37.0	26.5	46.0	113.1	51.8	22.1	155.1	163.9	55.3	60.5	24.9	35.5	64.3
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139766-138178986	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	11.9	14.1	21.0	10.4	22.1	14.0	18.2	28.9	24.8	17.1	15.7	21.1	14.4	11.1	20.0	31.2	13.8	18.9	12.0	11.6	16.5	16.6	15.5	14.2	14.0	13.5	18.5	16.8	24.9	17.8	19.8	37.0	17.7	22.1	17.2	18.4	15.4	14.7	18.5	15.3	16.8	12.8	18.7	16.6	16.4	14.3	54.6	20.7	25.5	20.5	7.7	15.3	14.3	14.0	9.7	10.6	17.8	9.6	20.7	15.3	8.3	11.4	15.0	26.5	42.4	19.3	18.2	24.0	17.8	19.8	25.9	27.3	22.5	25.8	11.5	17.9	16.5	26.6	13.5	27.9	17.2	28.0	20.1	20.7	15.6	35.7	15.2	10.8	9.4	16.5	13.5	11.4	20.5	18.7	20.9	16.4	21.6	13.9	14.9	17.2	12.8	19.1	15.1	11.9	13.3	7.8	18.7	21.9	14.0	17.4	16.9	23.5	11.8	21.3	9.3	16.2	37.5	16.0	17.5	10.2	12.8	14.9	8.8	15.4	13.3	14.7	15.9	9.8	14.0	11.8	12.7	9.6	11.9	14.1	6.9	14.8	9.7	12.0	12.4	10.6	9.6	15.3	15.1	17.8	20.7	7.1	7.4	11.0	8.3	21.0	22.1	28.9	24.8	16.5	16.6	18.5	16.8	22.1	20.7	23.8	28.1	13.4	8.4	6.2	29.9	31.6	12.7	40.2	37.5	26.2	35.3	22.4	16.6	14.7	69.4	21.5	13.6	23.3	10.8	10.9	16.2	15.0	22.1	15.1	10.3	28.6	30.0	11.6	14.2	29.1	29.1	15.4	23.6	36.1	19.4	28.9	14.4	14.4	22.6	9.2	33.8	25.8	10.3	193.0	44.5	6.0	21.2	15.2	18.3	6.7
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1, RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	12.1	11.8	15.2	11.0	15.9	9.2	8.2	21.7	25.9	10.4	9.6	24.7	11.0	11.8	11.0	7.0	9.1	15.4	10.5	10.6	16.4	19.1	10.0	9.8	11.3	11.2	19.1	14.5	14.4	20.8	18.0	16.6	9.3	18.3	12.1	6.9	13.2	15.8	11.0	21.8	12.4	12.3	12.5	21.2	12.0	10.5	11.1	14.8	9.9	9.7	6.1	9.5	8.9	7.6	3.3	6.4	4.0	7.4	4.9	3.6	2.8	7.3	16.6	7.1	15.6	6.4	7.2	7.5	11.1	6.8	9.5	7.7	11.7	11.3	5.8	10.9	7.2	4.6	15.0	8.5	7.1	5.2	15.7	9.4	6.8	8.6	5.4	7.2	8.1	15.0	6.9	5.9	5.7	7.0	4.8	6.8	11.8	8.1	4.4	4.6	22.9	9.5	10.3	5.4	12.2	17.9	17.1	5.0	5.7	4.7	17.9	23.1	17.2	11.1	8.8	9.4	3.5	20.2	11.3	10.0	7.4	6.4	13.9	8.5	8.9	6.7	5.3	8.9	6.7	10.0	0.7	2.3	4.0	3.6	2.2	2.5	3.2	2.5	3.5	2.5	3.3	3.4	2.9	1.0	4.9	7.4	6.4	3.1	2.8	15.2	15.9	21.7	25.9	16.4	19.1	19.1	14.5	18.3	14.8	3.0	5.1	5.9	5.9	6.6	16.4	7.2	2.5	12.0	6.8	3.5	15.7	10.2	3.3	5.0	1.9	6.8	8.6	0.0	6.0	7.4	6.6	6.4	2.3	10.2	6.1	28.6	9.2	9.8	5.4	0.7	6.1	6.4	8.5	4.6	10.2	8.3	4.2	7.0	4.2	5.6	18.4	0.0	7.3	7.0	13.6	7.8	7.8	10.7	9.0	4.1
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993700-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.8	3.2	10.8	12.6	13.7	4.7	6.8	13.4	16.0	3.8	16.8	8.8	2.4	22.5	2.9	3.0	10.7	5.0	9.8	3.0	11.0	10.8	8.3	7.5	3.4	14.2	10.9	10.3	2.2	11.2	9.8	4.0	2.6	10.5	3.8	17.8	4.7	4.1	3.1	2.0	8.0	21.8	3.3	12.6	7.3	9.0	2.6	7.7	11.1	5.4	4.5	17.8	3.6	4.3	2.4	5.7	9.5	2.5	1.5	1.2	0.7	9.4	12.5	4.6	4.3	4.0	2.1	5.0	6.7	1.5	4.0	1.9	7.9	6.5	38.1	7.9	1.7	2.8	11.7	10.8	6.0	3.9	7.0	5.9	17.5	5.6	7.1	0.7	25.4	22.0	0.9	3.5	4.7	2.6	1.9	1.7	13.9	6.0	2.2	4.2	10.1	13.0	11.4	2.5	10.3	4.9	8.3	7.7	8.3	6.2	14.5	6.2	4.0	8.2	9.0	3.0	1.6	16.0	21.0	2.0	3.6	3.8	3.8	6.7	7.4	13.3	46.8	3.8	9.5	9.8	4.5	2.5	9.5	1.2	1.7	1.1	1.8	0.9	0.9	2.4	2.4	0.8	1.2	3.8	1.5	1.6	5.7	0.8	0.7	10.8	13.7	13.4	16.0	11.0	10.8	10.9	10.3	10.5	7.7	8.9	7.2	26.7	7.9	10.9	35.5	6.3	45.9	8.1	5.7	8.7	13.7	8.8	3.3	9.0	23.9	3.0	55.2	0.0	9.2	18.3	5.5	8.0	18.4	25.2	17.3	23.8	7.5	3.7	28.3	128.6	1.1	15.5	10.1	3.6	39.6	13.2	14.1	35.1	3.9	10.9	25.6	0.0	5.9	0.9	8.1	15.9	4.3	8.7	67.9	7.8
BRICD5	"C16orf79, MGC21830"	ENSG00000182685	"BRICHOS domain containing 5"	Q6PL45	16	2209253-2211950	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 29.7;testis: 42.8"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA063522			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA063522: AB_2685029"	"prognostic favorable (9.74e-4)"	"unprognostic (7.12e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.34e-3)"	"unprognostic (7.56e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (8.06e-5)"	2.0	4.0	3.2	3.7	4.9	3.0	2.0	29.7	5.3	2.0	2.0	2.0	2.0	5.4	2.8	2.0	2.0	1.6	2.0	2.9	3.5	4.4	2.9	2.0	2.1	4.6	3.1	2.8	2.0	3.0	2.2	3.6	2.9	2.5	2.4	0.5	9.9	3.7	4.0	9.1	2.7	5.2	2.0	3.3	6.3	2.7	42.8	2.0	2.4	6.1	2.0	2.0	2.0	2.0	0.8	0.6	2.3	0.8	0.8	1.7	0.4	2.8	5.6	7.7	4.4	1.2	1.3	14.1	2.7	0.5	1.5	2.3	7.1	7.0	1.6	1.8	0.5	1.8	7.6	1.0	1.0	1.1	5.2	3.4	1.7	13.4	1.8	0.7	0.7	4.4	1.5	2.1	2.3	0.5	2.3	0.9	6.4	1.9	4.0	0.6	7.6	4.8	10.8	7.5	0.9	3.2	14.8	5.8	5.0	1.7	2.2	5.4	4.9	2.7	3.4	2.6	3.7	3.4	4.0	2.2	7.4	6.0	6.4	2.3	12.1	5.2	4.0	1.4	4.5	3.5	0.4	0.7	2.2	0.6	0.8	0.3	0.3	0.3	0.1	0.6	0.8	1.7	0.4	2.3	0.8	0.2	0.4	0.4	0.4	3.2	4.9	29.7	5.3	3.5	4.4	3.1	2.8	2.5	2.0	3.0	4.1	0.0	0.5	0.3	10.7	0.4	0.0	4.0	0.0	5.2	23.6	1.6	0.0	0.8	2.1	1.1	1.8	0.0	0.5	0.7	1.0	0.8	4.6	1.0	1.1	4.8	1.2	1.8	2.2	5.9	1.1	2.5	1.7	1.0	1.2	4.3	0.7	0.0	2.5	0.3	11.0	0.0	0.5	3.9	1.9	1.0	0.7	0.0	2.3	0.4
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61681266-61863521	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Group enriched"	"Detected in many"	11	"Early spermatids: 136.2;Late spermatids: 148.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	1.0	0.9	0.7	6.3	3.5	9.1	1.1	0.6	1.4	1.4	2.6	0.2	0.6	2.8	1.5	1.2	3.7	0.8	1.8	0.4	0.5	0.5	0.6	2.3	1.3	4.0	0.5	0.9	2.1	1.3	0.1	0.4	1.7	0.7	1.0	2.8	0.4	1.4	0.0	0.4	2.7	5.5	1.0	0.5	2.3	1.3	10.8	0.4	30.1	0.4	2.0	6.6	1.3	1.7	2.2	0.5	2.1	0.3	0.6	3.7	0.5	12.5	4.3	12.4	7.1	0.4	1.1	2.7	11.6	6.8	12.4	16.1	4.4	4.0	7.5	2.7	2.4	3.6	4.5	6.4	2.4	16.8	1.9	7.8	7.6	6.8	5.4	0.1	9.8	4.5	0.2	0.1	9.9	2.6	1.7	2.7	7.4	5.3	5.1	7.8	42.2	15.5	3.4	2.7	3.0	3.7	9.7	23.9	3.6	1.7	5.7	5.0	12.9	4.5	1.6	1.8	4.9	4.2	3.8	2.3	18.3	13.4	6.7	13.3	3.2	6.1	8.0	3.7	4.7	4.5	2.1	0.3	1.5	0.5	0.2	0.6	2.2	1.2	0.6	0.4	1.8	1.8	0.9	1.0	0.6	0.2	0.5	3.7	0.5	0.7	3.5	0.6	1.4	0.5	0.5	0.5	0.9	0.7	0.4	0.0	0.3	1.5	1.3	2.1	0.1	0.5	0.0	1.4	6.8	0.0	0.0	0.7	0.0	0.3	136.2	0.3	0.9	0.0	0.2	2.5	0.6	0.1	0.0	3.0	1.4	0.0	0.0	0.6	0.3	148.4	1.1	0.4	3.3	1.0	1.5	0.3	0.5	0.0	1.1	0.0	0.2	0.0	0.9	13.3	4.5	0.4	0.2	0.8	2.5	0.3
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	9.6	21.8	11.9	12.3	11.7	12.3	25.8	22.4	16.7	11.9	15.2	10.9	28.3	13.5	16.0	13.4	9.5	10.8	10.6	10.9	10.3	9.1	15.9	16.5	9.6	7.7	10.4	11.7	15.2	20.8	18.1	18.8	8.7	7.4	15.2	15.3	8.0	16.5	31.0	22.9	14.5	17.0	12.2	9.8	9.8	12.4	22.9	11.8	11.8	18.3	4.4	7.1	13.9	22.3	0.8	0.5	3.0	0.2	0.1	2.0	0.6	6.7	6.5	16.4	12.8	9.1	7.7	14.0	10.2	10.8	14.4	11.4	19.0	6.4	10.5	11.0	10.0	18.2	6.6	14.4	7.3	12.7	9.9	8.9	7.4	6.0	11.2	9.6	5.7	10.4	9.8	6.3	17.1	8.6	10.5	10.7	5.1	15.4	9.7	7.8	9.6	6.5	2.5	8.2	8.3	5.6	19.1	6.7	3.2	4.7	13.9	23.5	7.4	8.3	9.1	8.7	10.6	10.2	15.9	11.2	15.1	12.9	4.1	11.8	8.0	10.3	7.9	2.5	9.2	17.7	3.0	0.2	1.4	1.9	0.2	2.0	0.8	0.5	0.6	0.2	0.4	0.9	0.6	1.5	0.1	0.1	0.5	1.2	0.6	11.9	11.7	22.4	16.7	10.3	9.1	10.4	11.7	7.4	11.8	6.0	10.1	2.9	6.8	8.5	10.1	10.9	12.7	2.7	5.7	5.2	5.9	4.2	0.0	4.7	13.2	7.1	15.1	0.0	9.2	3.7	9.5	10.3	2.3	16.6	3.7	0.0	18.9	11.6	5.0	10.4	10.3	2.5	6.8	5.4	26.5	4.3	10.0	10.5	8.9	11.4	6.7	0.0	6.2	17.9	12.2	9.9	6.9	4.3	13.9	8.4
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80670854-80809688	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	7.7	5.7	7.5	9.1	7.7	10.5	13.0	20.9	8.5	9.3	8.2	5.6	8.6	8.5	8.0	6.2	10.8	8.1	6.3	5.0	7.4	4.6	5.6	7.5	12.7	9.3	5.3	5.5	11.9	7.8	7.3	12.5	8.6	6.5	6.7	8.1	7.7	8.2	11.3	3.7	14.0	10.3	5.8	12.7	8.9	7.3	9.3	7.1	10.1	9.0	6.0	9.1	10.7	12.7	1.1	0.7	2.8	1.1	0.5	1.2	0.5	4.6	5.1	7.7	5.1	3.1	3.9	5.6	2.7	2.4	3.5	4.8	2.3	6.5	5.0	6.4	2.5	4.3	8.3	11.8	4.6	4.7	4.3	4.8	10.2	8.2	3.5	2.3	5.8	6.9	2.6	3.2	4.0	5.5	5.1	5.3	4.5	7.4	12.7	4.0	0.8	3.3	5.4	11.8	5.1	2.1	3.0	13.5	2.9	4.0	4.0	1.8	4.4	6.6	3.6	2.9	15.1	1.6	5.7	4.8	4.1	5.2	3.8	2.9	5.6	5.9	6.0	3.3	11.8	2.7	0.5	1.1	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.6	1.1	0.6	1.2	2.8	0.5	0.8	0.7	0.6	0.5	7.5	7.7	20.9	8.5	7.4	4.6	5.3	5.5	6.5	7.1	11.9	11.2	7.5	6.9	15.5	23.2	7.7	15.3	4.0	18.2	5.2	15.7	4.9	0.0	5.3	0.9	10.5	12.9	0.0	5.2	6.5	8.2	9.4	10.5	5.8	4.7	58.8	6.9	5.5	10.3	3.0	9.2	12.7	1.7	1.8	10.2	10.8	8.4	21.0	9.6	3.1	21.0	6.5	7.6	6.6	8.3	18.2	6.4	10.0	10.2	19.5
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	18.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.8	11.6	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	2.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.4	0.1	0.0	0.0	27.0	0.3	0.0	0.4	31.4	0.0	0.4	0.0	14.1	1.8	3.9	6.2	0.0	0.0	13.6	0.0	0.8	13.7	1.9	0.0	0.0	0.0	0.0	0.0	4.4	5.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8	6.0	5.8	2.4	1.7	0.9	0.6	1.6	15.3	2.7	4.5	26.2	5.9	8.1	33.2	59.2	0.1	0.1	12.9	0.0	58.0	0.7	0.4	15.4	3.5	0.8	1.2	0.0	19.7	0.0	0.0	0.2	0.0	0.1	10.1	1.8	19.3	0.3	56.5	14.0	0.0	15.3	9.1	0.0	0.0	0.5	2.3	12.4	5.6	0.5	24.3	13.9
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923769-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA070682: AB_2686294"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	21.8	13.7	15.1	20.2	23.1	26.7	20.8	19.9	21.6	20.8	19.7	18.3	17.4	15.9	24.3	22.0	19.4	26.2	15.5	15.9	16.0	7.0	13.8	15.5	20.1	29.3	22.2	13.4	30.4	19.7	21.1	22.3	13.8	16.5	18.2	16.4	18.1	21.0	18.3	15.8	48.6	23.4	22.1	22.4	22.4	19.6	21.2	23.8	29.0	19.5	10.8	25.8	24.3	21.2	6.9	9.6	6.8	6.3	4.4	5.3	2.6	16.8	8.2	19.4	23.5	10.3	16.3	9.7	9.9	11.8	9.8	14.7	11.3	10.3	18.2	6.4	9.7	6.1	18.3	13.0	8.8	14.8	12.4	14.0	12.9	19.3	11.8	10.6	19.3	13.5	11.5	11.4	14.9	21.8	21.2	9.4	15.6	10.5	21.0	10.0	7.3	14.9	12.3	8.8	4.9	6.5	12.1	12.1	8.4	9.2	10.4	7.5	8.8	9.5	4.8	12.2	13.4	9.8	12.9	10.1	8.9	7.1	11.9	14.0	24.4	11.2	15.0	13.9	17.9	2.3	6.8	5.5	2.9	5.3	3.7	4.6	5.1	3.9	3.6	4.0	6.9	4.9	3.7	3.9	4.4	6.3	9.6	3.1	2.6	15.1	23.1	19.9	21.6	16.0	7.0	22.2	13.4	16.5	23.8	17.9	26.9	9.3	10.2	19.3	24.2	12.6	2.5	30.8	17.0	19.2	43.2	5.5	1.7	5.6	6.5	12.7	7.3	0.0	5.7	8.6	10.8	12.3	23.1	7.8	6.3	17.5	15.5	8.0	8.9	3.6	10.9	15.4	5.0	7.2	6.4	12.8	5.8	5.8	11.0	2.2	37.4	6.5	18.6	18.7	8.5	26.1	12.2	13.8	7.8	14.0
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016422-83067354	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	11.6	9.4	17.6	7.9	17.3	10.4	10.0	11.9	22.5	9.2	11.0	13.8	4.7	10.8	8.5	9.8	10.4	10.9	9.8	35.0	17.0	14.3	13.0	11.3	8.1	11.1	17.0	11.5	8.5	6.1	12.8	10.0	8.0	18.0	10.6	12.3	6.9	8.7	8.7	96.2	6.6	10.6	9.3	18.2	9.2	7.9	18.4	11.5	10.5	12.7	21.3	11.0	9.8	7.4	4.6	8.8	9.3	6.7	3.9	7.2	2.1	15.4	14.9	13.2	12.9	20.8	35.9	6.9	22.5	30.8	19.5	21.7	9.4	16.1	31.1	28.0	25.2	16.2	19.6	28.8	18.0	23.1	24.8	23.5	26.4	22.3	13.4	24.5	24.9	29.5	29.2	16.3	13.2	19.8	25.3	28.6	12.2	23.4	17.5	41.0	8.1	18.9	13.0	18.4	13.6	16.5	19.3	33.5	15.4	19.6	36.8	23.1	16.6	26.1	21.7	36.9	18.8	16.3	21.0	28.7	22.1	16.5	30.4	31.1	18.0	27.7	30.3	23.9	42.3	15.3	2.2	4.9	9.3	5.5	5.4	4.9	4.5	5.2	7.2	8.8	4.6	5.9	5.8	2.9	3.9	6.7	3.8	4.8	2.1	17.6	17.3	11.9	22.5	17.0	14.3	17.0	11.5	18.0	11.5	14.9	4.3	16.8	11.9	13.5	8.9	78.3	7.6	30.8	21.6	10.4	5.9	7.1	14.9	12.7	24.1	14.7	14.8	23.3	9.1	11.1	13.3	10.4	17.3	9.2	16.1	11.1	22.3	14.7	23.0	20.5	8.1	19.5	11.8	19.0	11.5	7.3	12.1	17.3	10.6	12.1	7.8	6.5	13.2	44.2	14.9	10.7	6.8	15.8	16.5	15.9
BTBD10	"GMRP-1, GMRP1, MGC13007"	ENSG00000148925	"BTB domain containing 10"	Q9BSF8	11	13388001-13463297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 111.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046777	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA046777: AB_2679801"	"unprognostic (2.38e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.27e-1)"	11.0	10.3	18.7	10.5	36.3	9.3	11.0	17.7	33.2	13.0	14.2	9.4	12.7	10.5	13.5	9.8	23.3	9.8	12.1	13.6	17.0	18.8	9.2	7.7	10.2	11.0	14.6	17.4	11.8	7.1	16.4	13.3	19.1	23.7	12.5	16.8	7.1	9.2	14.9	10.5	10.4	9.1	17.2	13.3	9.4	13.8	28.8	12.4	8.9	10.8	10.2	13.4	18.6	16.3	9.4	14.5	33.1	23.3	12.1	11.5	8.4	22.1	15.8	14.3	9.5	12.9	12.7	18.2	23.4	13.7	18.2	16.6	15.2	26.2	15.4	11.2	17.4	18.6	18.1	10.8	25.1	21.5	15.2	11.4	8.2	6.0	9.0	20.1	11.0	19.0	11.0	28.1	10.5	24.2	13.9	36.7	11.1	4.6	15.8	18.7	13.5	11.1	6.0	6.1	20.3	14.4	9.9	12.2	9.4	28.8	18.0	6.2	8.7	14.0	11.4	7.9	17.1	8.1	5.9	33.2	18.7	15.4	18.0	13.4	5.9	20.6	10.3	12.9	9.4	15.9	18.1	12.6	18.4	9.7	19.3	11.5	9.4	9.2	10.6	14.5	9.0	10.5	10.4	33.1	12.1	23.3	6.3	11.3	8.4	18.7	36.3	17.7	33.2	17.0	18.8	14.6	17.4	23.7	12.4	14.9	6.5	9.3	25.5	25.0	12.0	12.2	17.8	20.1	11.4	5.2	3.9	20.6	5.0	31.2	66.5	18.8	9.1	0.0	22.0	47.0	13.2	25.4	22.0	5.4	19.6	7.9	15.6	11.6	14.6	18.9	9.2	12.1	16.9	27.9	12.6	7.7	36.2	11.5	17.3	7.9	12.1	6.5	16.1	111.4	48.7	31.2	51.9	16.0	12.8	50.9
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.3	3.9	0.0	1.5	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.8	0.1	1.8	7.0	3.9	7.3	0.2	0.0	1.2	0.0	0.1	10.2	0.0	0.1	0.0	1.6	3.1	0.0	2.3	3.0	0.5	8.0	0.0	0.0	0.1	0.6	12.9	1.5	4.0	0.4	9.1	0.0	6.2	0.0	0.0	8.7	5.0	1.9	0.0	0.2	0.0	0.4	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.1	2.0	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2	0.0	0.0	0.0	3.1	4.6	1.0	1.7	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	0.0	0.5	0.3	1.6	3.4	0.0	0.8	0.0	0.6	2.0	0.0	0.0	0.0	0.3	0.2	0.0	3.9	0.6	0.3	0.0	1.1	0.0	0.0	6.8	0.3	0.0	0.0	3.8
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056125-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	22.3	29.1	20.6	14.8	22.1	26.7	26.2	25.5	52.3	17.5	12.8	17.2	8.4	7.1	19.5	16.7	20.3	19.6	12.5	28.4	23.7	22.4	18.5	20.8	19.6	38.8	20.4	23.8	29.2	47.6	21.0	24.3	19.1	16.7	15.7	12.6	16.5	26.4	13.5	36.9	19.3	9.8	22.4	23.1	14.1	14.2	19.2	14.6	20.7	22.9	13.6	20.4	19.0	16.2	23.2	34.1	32.2	36.0	21.3	28.2	27.9	28.0	6.8	33.5	17.5	18.1	23.3	34.7	27.8	28.0	31.9	34.4	12.4	14.7	26.2	28.0	19.5	37.7	16.4	32.3	21.7	40.9	18.1	22.6	30.0	12.5	18.5	49.6	33.2	20.8	23.9	30.0	29.5	41.7	26.5	25.2	21.7	22.6	16.7	28.6	12.0	22.9	19.7	59.6	21.8	15.0	15.2	39.0	30.8	30.8	22.6	26.4	29.9	32.5	30.1	40.0	38.8	27.2	35.6	18.4	18.0	19.5	23.2	32.7	29.3	48.3	25.6	15.6	25.9	22.6	24.1	35.4	32.2	15.0	36.0	20.1	23.2	21.7	15.4	34.1	22.1	25.4	19.4	15.1	21.3	31.0	16.1	28.2	27.9	20.6	22.1	25.5	52.3	23.7	22.4	20.4	23.8	16.7	14.6	32.8	18.2	57.0	77.6	95.7	41.1	40.3	43.3	40.2	31.8	66.3	31.4	99.7	142.6	93.1	81.2	49.3	16.0	93.5	69.0	113.3	65.9	74.4	22.0	66.1	115.8	36.5	50.2	45.4	117.9	13.6	67.0	77.6	74.2	55.9	28.5	42.6	74.2	28.1	52.3	110.7	28.6	58.2	77.3	111.6	14.3	140.0	122.0	50.7	33.3	87.5
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145897	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 190.7"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	52.0	22.1	11.5	58.3	13.4	126.9	114.4	66.8	10.4	41.7	40.1	5.5	21.9	15.5	30.1	22.0	28.7	27.9	39.9	49.2	11.9	8.1	22.2	58.1	85.6	190.7	10.4	8.2	29.1	64.2	17.6	17.1	23.4	13.3	28.7	18.1	21.0	19.0	25.9	31.6	70.6	34.3	26.0	24.6	77.1	26.4	19.0	8.9	148.9	15.7	14.3	58.2	54.2	35.2	58.3	6.6	94.3	14.0	47.1	95.2	26.1	7.0	8.8	9.7	1.1	36.3	50.4	4.2	7.9	17.4	5.3	5.3	5.2	2.4	7.5	1.6	8.3	8.4	4.8	3.2	8.8	9.9	9.0	6.8	1.5	6.1	2.7	36.8	5.5	2.6	43.0	26.7	12.1	37.5	23.5	10.6	5.0	5.2	10.0	6.0	7.2	3.9	17.7	2.3	7.7	10.0	13.4	5.4	2.3	16.3	14.6	5.4	10.8	9.8	7.6	25.5	7.8	32.0	12.8	3.4	6.0	1.8	4.6	4.8	13.8	7.4	12.5	4.7	4.4	6.7	22.3	13.6	94.3	17.0	10.6	20.1	44.5	34.3	29.8	6.6	58.3	95.2	39.1	52.3	47.1	14.0	6.2	39.2	26.1	11.5	13.4	66.8	10.4	11.9	8.1	10.4	8.2	13.3	8.9	89.3	164.0	1133.8	898.4	2444.1	509.3	99.7	695.5	18.7	63.7	165.7	184.6	344.9	271.9	357.5	306.7	258.8	666.0	140.2	222.2	261.3	225.7	728.6	288.8	235.3	359.2	400.5	434.2	206.2	468.4	134.9	265.8	682.9	933.0	1485.2	192.1	767.8	308.3	596.2	227.4	96.3	342.5	530.3	1116.5	68.9	113.5	2626.0	1122.8	1563.2	226.0	1040.3
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 927.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.5;HMC-1: 39.2;RT4: 30.5;U-266/70: 60.7;U-266/84: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	61.6	45.9	10.1	61.4	20.6	46.9	27.8	13.0	10.4	23.0	53.3	27.8	27.0	15.2	27.1	24.6	55.7	103.7	76.1	65.3	10.4	10.0	22.3	4.3	40.7	20.0	12.2	5.5	102.0	117.6	7.0	52.2	42.7	28.3	61.0	38.5	30.4	18.1	104.1	98.9	30.5	36.6	50.8	22.7	32.7	67.1	11.5	9.9	82.9	36.7	45.2	49.0	64.7	21.5	14.1	17.3	34.5	14.2	5.7	8.5	7.1	0.9	1.4	2.6	1.0	3.3	2.4	22.1	2.6	5.1	0.7	2.5	1.9	0.4	37.5	1.8	0.8	0.4	16.5	9.5	10.0	1.3	2.4	4.6	19.6	2.7	4.3	7.3	0.1	39.2	2.5	18.6	2.5	4.6	2.3	13.7	1.9	9.1	26.0	6.8	0.8	4.1	1.2	1.1	0.4	0.2	2.6	8.9	18.8	1.3	30.5	0.4	2.7	2.0	0.8	0.3	20.6	2.2	2.3	3.4	0.0	4.4	0.6	0.1	60.7	30.6	24.0	0.5	0.9	1.5	3.2	8.1	9.9	4.7	12.1	7.1	14.1	5.3	4.8	5.1	13.1	8.5	5.9	34.5	5.7	14.2	17.3	4.9	7.1	10.1	20.6	13.0	10.4	10.4	10.0	12.2	5.5	28.3	9.9	145.9	242.1	142.2	203.8	204.5	25.9	219.9	10.2	57.6	52.4	177.9	27.5	38.6	13.3	59.7	0.8	123.6	335.6	23.3	145.5	16.4	143.3	218.8	358.2	1.6	99.0	3.2	927.5	46.6	65.9	1.7	67.3	167.7	114.7	31.5	370.7	221.0	58.8	329.8	51.9	10.8	21.5	122.9	223.5	0.9	0.6	391.6	115.4	202.7	212.8	200.1
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 68.1"	"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1.0	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43.0	22.5	10.0	32.8	16.4	22.6	10.8	16.9	21.8	20.0	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22.0	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1	0.0	1.0	7.8	0.2	0.5	0.0	0.8	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.2	8.3	0.0	0.0	0.0	0.0	8.1	0.3	0.2	0.0	0.2	6.6	0.0	0.0	1.3	1.3	4.7	0.3	1.7	0.0	1.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	68.0	14.1	0.4	0.6	2.5	2.0	0.9
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.2	24.6	9.0	71.4	12.4	11.1	15.0	15.4	13.9	19.9	16.3	34.0	30.1	26.0	8.1	16.5	34.3	16.0	20.7	14.9	18.4	18.2	24.0	11.3	28.7	13.7	15.7	31.7	16.6	10.0	17.2	17.5	15.9	10.1	12.8	21.5	44.7	48.2	17.2	35.1	19.9	43.6	21.5	51.7	28.3	17.8	17.6	113.3	22.0	16.1	27.3	20.5	20.6	55.0	22.8	9.3	34.6	25.4	13.7	17.2	21.9	21.7	32.9	16.7	29.2	43.7	39.4	24.2	35.9	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5	41.7	53.9	0.0	0.0	0.0	0.0	0.0	0.0	144.6	78.5	43.6	0.0	64.0	82.9	81.2	0.0	0.0	0.0	0.0	122.2	66.3	0.0	0.0	43.0	0.0	62.2	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	36.9	0.0	0.0	97.5	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	0.0	89.2	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299193-49327487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 104.2;tongue: 35.0"	"Cell type enriched"	"Detected in single"	478	"Cardiomyocytes: 47.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"K-562: 9.2;RH-30: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057556			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.0	1.7	0.1	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	3.3	15.3	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	104.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.5	35.0	3.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in some"	23	"Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	30.8	0.0	0.1	0.3	11.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.1	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0	0.0	6.2	1.9	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	15.1	0.0	3.4	0.0	0.0	1.3	14.3	0.0	0.0	12.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.5	0.0	0.0
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245805-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 7.6"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 51.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	2.6			1.2	1.6	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0		0.9	0.8	0.0	0.6	1.2		0.4	2.4		4.1	0.0	3.2	0.0	3.0	0.0	0.0	0.0	4.5	7.6			0.0		0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	11.2	0.0	2.1	0.0	51.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	6.6	0.3	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	1.7	3.5
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 123.3;liver: 55.9"	"Group enriched"	"Detected in all"	5	"Cholangiocytes: 165.6;Distal tubular cells: 150.9;Hepatocytes: 260.8;Proximal tubular cells: 596.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		640000	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	6.0	10.2	5.0	4.3	7.6	1.8	7.2	6.7	6.0	5.9	12.0	7.7	7.8	12.2	6.4	7.3	6.8	7.5	10.6	8.5	5.3	5.0	123.3	55.9	8.0	4.6	8.4	5.1	8.5	13.9	5.6	11.6	5.7	7.3	9.7	10.0	8.9	8.3	6.5	14.2	5.2	20.0	6.7	9.3	5.2	8.4	5.1	7.8	8.9	11.3	5.3	5.3	6.9	4.9	10.6	12.4	37.6	11.7	9.3	11.9	7.2	3.8	5.5	12.7	7.8	9.9	11.4	14.8	5.3	8.8	5.4	7.5	2.1	21.6	15.7	35.4	10.2	6.0	9.0	14.6	3.9	7.5	15.8	5.0	8.6	12.8	10.1	11.3	7.2	4.6	10.6	7.5	10.0	7.2	14.6	8.7	10.9	11.3	11.0	5.5	3.0	13.1	10.0	4.6	25.6	8.8	12.5	16.5	24.8	30.9	7.4	6.5	8.3	9.7	12.2	11.7	9.9	27.1	5.7	5.7	5.5	4.4	9.6	2.8	4.9	14.3	15.5	4.2	11.9	9.4	23.7	11.7	27.3	9.0	8.5	9.3	10.6	9.3	10.2	8.9	9.5	11.5	10.1	37.6	9.3	7.4	12.4	11.9	7.2	5.0	7.6	6.7	6.0	5.3	5.0	8.4	5.1	7.3	7.8	59.6	41.2	13.2	10.0	4.8	16.3	31.1	165.6	41.5	40.9	45.4	15.7	42.4	150.9	13.7	7.6	15.8	55.5	23.3	12.2	12.2	12.6	30.6	15.0	260.8	15.3	14.3	21.4	22.7	28.8	4.7	23.9	10.6	8.5	13.6	34.5	17.1	11.1	37.0	21.5	596.3	16.8	6.5	7.2	31.1	12.4	8.7	51.8	10.2	31.6	13.7
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16756881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	44.5	47.1	34.7	37.8	49.0	34.7	40.5	59.7	43.0	40.3	42.1	32.3	29.7	27.3	54.1	35.3	51.6	36.3	34.0	55.1	32.4	33.3	42.6	56.4	41.6	43.0	36.5	38.9	54.2	39.6	35.8	53.7	58.9	35.7	42.0	23.6	30.6	40.1	36.3	69.5	36.4	28.4	43.0	38.9	41.1	35.1	27.5	33.9	50.6	47.6	32.6	36.5	52.0	39.2	97.7	91.8	87.4	74.8	67.4	91.1	123.2	66.2	53.4	63.9	31.5	35.6	32.5	45.0	66.0	34.4	44.0	40.3	50.5	63.0	57.3	53.1	40.0	49.6	38.8	43.0	31.1	47.7	75.2	46.0	50.6	46.1	45.6	44.1	72.4	45.6	32.1	43.6	26.1	57.7	36.2	30.7	36.5	63.3	40.0	37.7	38.8	77.6	35.3	47.3	31.9	30.5	63.2	64.5	30.1	34.1	38.0	43.9	45.0	57.7	43.9	78.4	39.6	39.0	50.3	57.2	55.2	45.2	66.0	62.3	26.8	99.0	79.7	48.1	42.3	50.4	78.3	65.8	87.4	72.2	72.9	83.0	97.7	80.2	75.8	71.4	89.3	91.1	78.9	31.3	67.4	74.8	91.8	81.5	123.2	34.7	49.0	59.7	43.0	32.4	33.3	36.5	38.9	35.7	33.9	229.3	197.2	206.1	231.6	228.4	159.6	184.4	135.0	259.6	228.6	190.1	141.4	273.3	363.1	215.1	28.5	242.4	57.2	116.8	199.0	283.9	266.4	215.5	227.9	146.0	198.9	135.1	152.8	152.9	158.4	25.1	190.7	234.1	217.6	267.9	113.4	201.7	195.9	92.6	192.0	246.7	201.4	155.2	279.5	283.4	219.5	241.8	379.3	210.4	107.6	232.0
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 83.2"	"Group enriched"	"Detected in many"	15	"Early spermatids: 502.7;Late spermatids: 1567.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063943, HPA074787"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA063943: AB_2685157, HPA074787: AB_2686712"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	3.9	7.3	5.7	3.4	12.1	2.2	5.7	4.1	8.1	4.2	4.9	10.2	5.6	5.5	3.7	18.0	3.2	5.4	3.9	5.4	6.9	6.1	10.6	15.0	3.9	4.3	10.3	4.7	5.0	6.9	8.7	6.9	2.5	6.7	5.6	4.6	5.7	7.2	5.0	9.9	5.6	5.1	2.1	5.7	5.4	5.2	83.2	12.2	6.4	9.5	4.7	3.2	3.1	3.1	10.5	13.6	14.5	17.7	13.2	11.9	11.3	1.2	3.3	3.5	11.1	5.3	3.1	2.5	0.5	1.4	1.4	1.3	2.7	19.9	5.3	7.1	0.8	6.9	5.1	2.3	2.3	1.7	6.1	1.4	4.0	2.4	5.3	5.0	2.3	4.5	5.0	2.6	1.8	5.6	1.6	1.7	8.9	4.1	5.0	2.6	4.5	4.2	3.5	1.8	4.4	2.1	3.1	2.8	13.6	3.1	2.4	9.6	3.8	12.5	1.4	1.9	3.8	9.4	1.3	1.7	0.3	5.2	3.9	0.9	4.9	7.9	4.1	0.7	5.5	1.4	11.7	17.7	11.1	10.3	11.1	6.3	7.0	7.0	7.1	10.6	10.5	11.4	11.9	14.5	13.2	12.2	13.6	7.7	11.3	5.7	12.1	4.1	8.1	6.9	6.1	10.3	4.7	6.7	12.2	3.0	11.2	1.5	13.8	2.4	9.8	18.7	0.0	24.1	5.7	5.2	3.9	14.3	69.6	12.0	502.7	7.0	13.5	0.0	16.8	2.2	3.7	14.4	5.8	0.0	10.1	12.7	17.4	0.0	0.0	1567.4	12.0	9.1	5.0	10.0	19.0	23.4	11.0	17.5	8.5	59.7	12.5	6.5	4.1	23.4	8.8	2.3	12.2	1.7	15.1	9.5
C12orf45	MGC40397	ENSG00000151131	"Chromosome 12 open reading frame 45"	Q8N5I9	12	104986310-105074197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 82.3"	"Lineage enriched"	"Detected in all"	13	"dendritic cells: 82.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038722	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA038722: AB_10673118"	"unprognostic (1.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.58e-10)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.19e-2)"	12.1	11.4	14.1	14.4	14.4	15.9	10.8	6.5	15.4	9.0	13.6	9.4	12.4	14.9	9.6	10.0	11.1	7.3	7.1	9.2	12.3	11.5	8.0	18.8	7.7	14.6	11.4	11.0	10.2	35.3	2.7	10.8	7.9	16.0	10.3	11.7	7.5	21.6	13.8	7.7	10.6	10.6	9.7	9.6	12.3	14.1	8.1	9.7	11.0	12.1	8.5	15.4	9.0	11.1	5.9	82.3	1.2	6.2	4.7	5.5	3.5	9.4	13.5	6.5	16.6	5.5	5.6	30.2	8.5	2.1	5.2	2.9	13.5	4.8	18.1	8.6	3.8	13.1	6.3	5.4	12.9	5.8	5.1	9.7	12.0	6.9	18.5	8.1	17.9	9.5	8.3	5.5	7.8	8.5	8.7	8.4	15.2	10.0	4.7	5.0	15.8	11.8	30.7	12.7	14.2	19.6	15.9	7.9	40.8	7.0	12.4	8.4	6.1	8.2	17.7	12.7	12.4	14.7	7.3	4.0	13.1	8.5	11.1	12.9	9.9	11.2	19.1	6.1	12.6	12.3	1.2	6.2	0.1	2.6	5.2	3.2	5.9	3.5	3.2	18.7	4.4	3.6	3.4	0.7	4.7	2.9	82.3	5.5	3.5	14.1	14.4	6.5	15.4	12.3	11.5	11.4	11.0	16.0	9.7	6.0	33.1	19.3	31.8	34.7	9.6	34.4	28.1	25.4	31.8	31.4	23.6	29.8	23.2	25.1	16.4	17.7	9.1	0.0	47.4	53.7	16.7	19.3	19.7	42.3	33.7	3.2	12.0	10.4	20.2	8.5	14.1	56.0	37.1	52.3	18.7	15.6	38.0	18.4	9.6	32.1	11.1	0.0	28.3	17.2	30.2	28.5	18.4	20.8	25.3	32.5
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803572-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 342.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	1.7	8.9	2.6	2.3	9.9	1.7	1.8	1.9	4.7	1.5	1.3	4.8	1.6	0.7	1.1	2.9	1.3	2.9	1.8	5.4	3.7	2.0	4.8	8.7	2.0	3.2	6.3	4.7	1.5	2.1	1.7	3.8	1.6	7.2	2.1	1.2	5.1	1.9	1.4	2.5	1.3	1.4	0.8	9.2	5.5	1.9	22.5	4.9	1.7	3.3	1.0	2.0	1.5	1.7	3.9	1.1	3.6	1.4	3.3	4.5	1.2	2.5	2.8	2.8	8.1	3.1	2.2	2.5	1.9	1.0	2.0	2.4	1.2	2.8	2.2	2.3	0.6	3.0	2.9	3.1	6.2	2.7	5.0	3.1	1.7	0.8	1.9	2.5	2.6	0.9	1.1	3.8	2.0	4.2	2.7	3.8	3.6	2.8	0.5	2.7	0.8	1.0	1.5	9.6	3.8	1.6	3.1	4.8	3.3	3.6	0.8	2.0	2.5	4.1	1.0	3.6	8.6	3.2	1.2	2.9	1.8	2.0	1.4	2.1	1.4	0.9	7.3	2.2	2.4	2.5	0.3	1.3	3.6	2.3	1.4	3.7	3.9	1.9	3.3	1.1	2.6	4.5	3.8	0.3	3.3	0.8	1.0	3.6	1.2	2.6	9.9	1.9	4.7	3.7	2.0	6.3	4.7	7.2	4.9	0.0	0.0	7.5	0.4	0.2	3.3	3.3	0.0	5.3	2.3	5.2	19.6	1.4	6.6	1.3	342.1	2.3	0.0	0.0	1.0	1.7	1.2	0.4	0.0	0.8	1.0	1.6	0.0	0.0	1.2	51.4	2.8	1.1	0.0	3.6	0.1	2.5	0.6	0.0	2.5	2.9	16.1	19.4	1.0	10.5	7.9	0.9	0.2	2.5	0.3	0.3
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 70.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.6	0.0	0.1	0.0	21.7	0.0	0.0	1.6	0.0	17.6	0.2	2.3	0.0	1.1	0.0	4.8	0.0	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.6	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.7	0.0	1.0	0.0	0.0	70.5	6.1	0.0	0.0	0.0	0.0	0.1
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985908-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	10.4	6.1	10.2	11.8	7.3	12.4	9.8	14.3	7.9	12.0	12.2	8.3	16.7	8.1	10.8	13.5	10.3	11.1	10.3	7.2	9.6	4.6	10.3	9.7	8.7	10.3	6.8	5.9	12.2	15.9	12.9	18.9	5.4	7.4	11.0	10.9	9.1	9.8	10.2	7.3	20.3	9.4	8.4	11.0	12.9	9.5	5.8	9.0	22.7	16.3	7.8	14.6	11.6	9.5	9.7	8.8	21.3	11.3	8.8	12.4	6.6	3.9	7.4	6.3	8.8	10.2	22.9	8.8	4.6	7.2	3.7	4.9	4.6	11.7	11.1	4.4	4.2	5.2	8.4	3.8	11.7	3.5	4.3	2.7	7.0	9.0	10.5	8.9	5.0	6.0	16.5	9.2	5.5	7.0	13.5	6.8	7.2	7.5	2.4	3.8	11.1	6.4	9.4	2.1	8.5	5.2	10.4	6.0	6.7	4.8	6.0	23.0	10.0	6.2	6.0	6.3	7.1	9.3	8.9	3.8	7.0	9.3	3.1	4.6	8.6	2.3	7.6	4.8	6.3	7.1	11.7	7.5	21.3	8.3	6.9	7.3	9.7	6.8	8.6	8.8	9.4	10.2	9.8	10.7	8.8	11.3	6.2	12.4	6.6	10.2	7.3	14.3	7.9	9.6	4.6	6.8	5.9	7.4	9.0	8.9	0.6	4.7	4.8	2.7	1.2	2.8	2.5	5.3	1.2	0.0	3.9	3.0	6.6	2.8	0.5	2.9	2.9	0.0	2.6	4.3	2.4	2.0	6.9	1.1	3.3	0.0	15.1	1.3	2.7	1.0	4.0	3.4	5.0	0.0	5.2	2.9	3.4	7.0	3.9	3.0	1.9	6.5	3.1	1.5	7.9	1.4	2.5	4.3	4.9	1.4
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042980	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.5	16.3	14.3	11.1	15.4	15.1	13.5	15.9	15.8	10.9	13.9	15.0	16.3	16.3	9.6	24.2	10.8	10.6	10.1	9.0	13.1	9.1	17.2	16.3	9.2	16.0	13.2	13.8	13.9	16.7	12.3	14.1	9.0	12.7	10.3	10.0	11.9	13.8	12.1	13.4	18.2	16.8	10.6	10.5	13.8	11.3	14.3	10.3	14.3	16.0	11.9	12.5	9.9	10.4	27.9	18.8	27.0	14.1	26.5	24.7	12.2	9.1	11.6	7.6	10.4	9.7	9.0	7.3	6.0	9.8	5.9	6.8	8.4	16.3	10.0	8.4	4.6	14.8	17.8	16.9	12.5	6.8	19.0	11.8	9.4	15.6	9.6	9.6	15.6	10.0	7.9	17.6	9.9	11.3	8.0	10.3	26.4	12.8	16.6	5.7	9.4	13.3	8.5	13.4	14.2	7.9	17.9	10.8	13.3	10.2	14.4	18.7	11.4	16.0	11.5	22.6	10.3	14.5	9.3	6.6	12.9	18.1	9.7	10.8	15.4	23.4	18.9	16.2	16.1	14.0	27.0	14.1	18.8	19.3	13.6	21.1	27.9	20.5	19.9	13.2	24.4	24.1	20.7	15.1	26.5	12.6	18.8	24.7	12.2	14.3	15.4	15.9	15.8	13.1	9.1	13.2	13.8	12.7	10.3	26.8	23.8	25.3	23.3	10.6	26.7	10.1	43.3	62.9	50.0	24.4	11.8	40.7	79.6	40.9	25.5	18.5	46.7	23.3	48.5	24.2	18.6	24.2	25.6	32.6	26.7	28.6	27.6	20.9	27.8	25.0	30.8	31.9	25.3	40.5	29.1	29.3	50.2	27.1	33.9	93.6	27.5	19.4	15.3	101.2	55.6	13.4	29.7	32.4	31.5	21.3
C15orf59	"INSYN1, LOC388135, MGC131524"	ENSG00000205363	"Chromosome 15 open reading frame 59"	Q2T9L4	15	73735431-73752747	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 24.1;heart muscle: 16.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Cardiomyocytes: 12.5;Muller glia cells: 6.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.6;fHDF/TERT166: 7.7;HEK 293: 7.9;NTERA-2: 4.9;SK-BR-3: 6.9;U-2 OS: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	1.2	1.9	9.3	0.4	9.7	0.0	0.9	5.5	24.1	2.2	0.7			0.3	1.0	2.4	9.4	6.5	1.5	16.2	9.1	8.3	3.5	0.0	1.7	0.0	14.4		4.8	1.0	0.0	0.7	0.2		4.5	0.2		0.7	10.1	1.4	8.4	1.0	2.1	4.2	0.0	0.8	1.9			0.4		0.4	1.6	3.8	0.8	0.6	1.5	0.5	0.8	0.5	0.0	0.0	0.5	2.9	1.8	11.6	0.2	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.1	1.0	7.7	1.6	3.0	2.5	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.9	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.7	1.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.6	6.9	0.7	1.8	3.1	0.2	0.1	1.9	6.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.1	0.8	0.5	0.5	1.5	0.8	0.3	0.6	0.3	0.0											0.0	0.3	0.0	0.4	0.0	8.5	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408548-55418764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 50.9;Early spermatids: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	3.4	3.1	6.5	0.9	7.4	0.8	5.4	2.4	6.7	7.7	5.2	3.7	5.4	2.9	3.7	11.2	3.4	13.7	5.3	7.0	6.0	7.6	11.2	1.9	3.8	2.2	5.2	6.8	4.6	11.0	6.2	17.2	1.2	12.0	5.8	6.2	2.8	27.6	5.3	8.7	2.4	2.5	3.7	3.4	1.9	7.8	11.3	4.6	1.7	7.1	0.6	1.8	3.6	1.5	2.3	0.6	6.5	1.6	0.0	0.7	0.4	0.8	1.7	2.9	1.8	4.5	6.7	0.5	1.6	2.2	1.4	2.8	0.0	1.5	1.3	4.4	5.2	3.5	1.3	0.0	2.7	0.5	2.4	2.0	1.2	10.1	0.4	8.8	2.9	1.6	2.8	14.9	4.2	1.2	7.8	2.7	0.0	2.3	4.3	6.2	2.2	0.1	9.3	0.9	5.3	3.3	0.5	0.0	11.2	7.6	0.0	7.9	4.8	2.0	3.4	12.8	1.6	6.9	2.8	1.9	2.4	0.9	2.5	0.9	1.9	5.0	1.2	6.2	7.2	1.2	6.5	1.1	3.9	0.5	1.6	0.0	1.9	0.1	0.7	0.6	2.3	0.1	0.0	2.1	0.0	0.8	0.2	0.0	0.4	6.5	7.4	2.4	6.7	6.0	7.6	5.2	6.8	12.0	4.6	3.0	0.6	0.8	3.6	1.1	0.8	7.3	2.5	50.9	4.5	5.2	0.0	1.0	14.9	7.1	140.3	3.6	2.1	0.0	9.6	1.1	3.1	4.5	4.6	1.0	2.5	3.2	3.5	3.1	1.9	6.8	4.0	0.2	3.3	1.0	16.7	3.6	7.0	11.5	5.3	16.8	7.5	6.5	2.8	5.8	2.8	1.5	0.0	0.0	4.6	1.7
C16orf45	FLJ32618	ENSG00000166780	"Chromosome 16 open reading frame 45"	Q96MC5	16	15434295-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 125.3;Late spermatids: 336.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.1;U-2197: 24.0;U-87 MG: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	11.5	10.2	38.8	6.8	27.6	1.3	8.4	30.6	72.3	28.4	10.4	10.1	3.8	5.9	21.3	12.7	14.2	12.3	14.6	28.7	39.2	30.4	9.4	12.9	6.0	4.1	21.8	33.8	26.1	5.6	2.2	11.3	1.4	61.3	15.0	6.2	8.5	6.5	17.8	25.5	4.9	4.4	21.5	12.5	5.3	7.6	13.8	12.0	0.0	5.7	4.4	3.0	14.2	10.7	2.7	0.5	0.6	0.1	0.2	11.1	1.5	0.4	10.7	4.5	0.4	20.2	17.2	0.0	5.8	20.1	5.2	2.9	0.0	0.2	0.0	1.3	33.1	12.7	0.0	1.2	1.6	2.7	0.2	0.2	2.5	4.1	0.3	6.6	0.0	4.4	8.4	1.7	11.6	0.2	8.6	8.0	4.7	0.1	0.1	7.7	6.4	1.4	0.2	5.7	0.1	4.1	0.3	6.1	0.0	2.8	1.8	8.9	8.7	0.3	2.9	1.8	0.8	0.1	0.1	4.6	11.7	6.0	24.0	2.9	2.0	4.6	0.0	41.3	0.0	2.8	0.1	0.1	0.2	11.1	0.0	2.0	2.7	2.1	6.2	0.5	1.6	2.0	3.3	0.6	0.2	0.1	0.3	2.7	1.5	38.8	27.6	30.6	52.4	39.2	30.4	21.8	33.8	61.3	12.0	0.0	0.3	0.0	14.8	7.9	42.1	49.5	5.1	17.4	12.5	1.8	13.7	0.0	26.6	13.2	125.3	26.0	0.0	0.0	72.8	0.0	29.8	4.3	11.5	11.9	0.8	17.5	15.6	17.8	3.2	336.0	18.4	10.9	13.5	18.0	0.0	7.6	41.6	0.0	45.3	7.0	15.7	12.9	42.0	35.1	15.8	5.1	0.1	1.8	0.0	8.8
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	2.0	2.5	5.2	1.8	6.8	2.2	3.1	3.3	8.6	2.8	1.4	3.5	1.3	1.3	2.8	4.4	1.7	8.6	2.0	1.4	5.8	5.8	2.4	3.0	2.2	1.1	5.9	6.0	1.7	2.6	2.9	14.4	3.2	8.6	3.0	1.4	3.5	2.0	2.4	2.5	1.0	1.0	1.9	4.2	1.1	1.1	25.2	2.5	1.5	8.9	0.5	1.3	1.9	1.3	0.2	0.4	1.1	0.4	0.0	2.0	0.0	2.8	0.5	1.1	0.5	5.2	1.0	2.6	0.6	3.6	2.0	1.2	0.6	4.0	0.7	1.8	0.7	2.5	1.0	1.1	2.0	3.6	0.6	0.7	0.8	2.3	2.7	3.1	1.0	2.2	2.1	1.6	4.7	2.9	2.2	1.7	1.4	1.7	1.4	1.6	2.0	0.3	5.5	1.3	1.0	0.6	2.2	0.3	0.4	3.5	1.7	1.5	1.4	4.0	1.3	0.7	1.7	1.2	1.4	1.4	0.9	0.4	0.8	0.7	1.5	2.1	1.6	1.8	1.4	1.0	0.0	0.4	1.1	0.2	0.0	2.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	5.2	6.8	3.3	8.6	5.8	5.8	5.9	6.0	8.6	2.5	0.0	2.9	0.0	8.1	1.6	2.1	2.0	0.0	20.1	3.4	0.0	3.9	6.3	5.0	0.8	80.6	1.6	0.0	0.0	0.4	13.6	2.3	6.0	0.0	2.9	2.8	0.0	1.2	1.3	1.2	78.6	7.5	1.0	5.0	0.0	1.2	2.9	0.4	0.0	7.1	3.1	7.0	0.0	2.0	32.0	4.9	2.4	5.3	0.0	0.9	5.5
C16orf72	"FLJ41272, PRO0149"	ENSG00000182831	"Chromosome 16 open reading frame 72"	Q14CZ0	16	9091648-9121640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 187.0;Late spermatids: 474.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041568, HPA067492"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041568: AB_10796677, HPA067492: AB_2685850"	"unprognostic (3.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.64e-3)"	"unprognostic (6.51e-2)"	20.1	16.5	15.4	15.8	22.5	80.1	17.7	15.2	25.5	20.1	19.5	18.3	17.4	13.5	17.3	16.7	24.0	14.9	22.6	24.9	13.6	14.4	17.2	23.7	19.3	20.1	14.3	19.3	17.3	16.8	31.3	14.0	20.5	19.0	16.5	14.3	17.8	16.6	16.3	34.5	19.2	17.3	16.7	14.1	19.4	16.6	20.2	12.6	20.1	17.5	20.6	21.2	17.7	21.5	4.1	3.8	14.3	4.1	3.0	5.8	1.9	9.1	10.2	16.3	14.8	19.5	15.3	8.6	18.0	15.0	10.4	10.8	8.5	11.9	16.4	10.4	20.7	8.2	10.8	15.0	15.9	22.0	10.7	8.4	11.0	14.2	17.9	25.2	13.8	12.9	23.0	25.1	17.4	25.1	16.8	18.0	17.2	16.5	25.1	18.4	13.2	12.2	12.3	19.8	9.4	9.0	21.0	20.0	17.5	13.6	16.8	10.6	11.9	21.6	15.3	18.1	15.9	17.6	14.1	20.6	20.5	13.5	26.2	11.5	28.7	24.6	23.3	18.2	12.4	16.5	5.5	3.8	4.0	5.1	4.0	5.8	3.5	4.4	3.6	2.8	4.1	5.1	4.5	14.3	3.0	4.1	3.8	3.4	1.9	15.4	22.5	15.2	25.5	13.6	14.4	14.3	19.3	19.0	12.6	44.7	39.9	33.3	37.4	68.3	43.2	33.4	22.9	9.4	20.5	21.0	82.5	23.7	16.6	24.0	187.0	26.3	30.0	0.0	25.3	28.8	34.7	42.7	17.4	52.9	28.8	41.3	46.4	38.6	79.4	474.2	22.7	35.5	30.4	19.8	35.5	37.0	32.5	38.6	25.5	29.8	48.0	32.3	42.3	35.2	21.5	56.2	47.7	31.5	34.3	57.2
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 100.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	28.3	21.9	32.7	30.7	29.1	55.4	25.8	24.9	32.1	21.4	20.7	20.9	13.9	18.5	19.1	29.9	29.7	27.2	25.6	25.6	28.4	24.5	23.3	34.3	30.4	45.2	25.9	21.1	19.0	25.1	20.8	20.9	29.7	19.7	20.4	23.2	22.5	22.7	16.8	32.7	30.2	19.2	18.4	23.1	44.6	18.4	21.8	17.9	60.4	31.4	30.7	53.7	25.7	18.8	52.3	78.9	48.8	49.8	82.3	48.3	40.4	18.3	24.5	38.8	30.0	27.7	39.4	13.3	10.0	16.4	20.1	16.5	12.0	15.2	17.7	27.7	23.9	6.5	15.3	9.6	19.4	15.4	61.7	25.6	15.9	7.8	23.1	20.8	10.1	21.3	24.7	26.2	15.0	30.4	14.5	31.4	14.4	5.8	50.6	24.5	21.0	16.6	33.9	12.9	21.1	14.4	10.4	11.4	25.6	22.7	12.3	10.6	30.1	17.6	9.1	17.7	14.6	11.5	13.1	17.1	11.7	14.5	19.7	25.4	18.2	10.3	5.9	18.3	15.1	16.7	48.8	37.6	34.4	47.0	49.8	29.8	52.3	48.3	47.0	57.6	50.6	32.3	35.7	34.3	82.3	37.1	78.9	47.9	40.4	32.7	29.1	24.9	32.1	28.4	24.5	25.9	21.1	19.7	17.9	3.0	10.1	19.8	5.3	9.3	1.0	0.4	0.0	4.0	7.9	1.8	0.0	9.5	14.9	15.3	0.1	9.3	5.6	0.0	20.0	13.6	6.9	2.7	17.4	1.5	9.7	0.0	29.4	8.0	8.7	1.0	3.7	18.0	23.6	100.0	10.0	2.0	18.7	13.6	1.4	3.7	3.9	6.5	15.5	4.6	18.8	10.3	8.7	20.8	16.0	4.6
C17orf53	MGC3130	ENSG00000125319	"Chromosome 17 open reading frame 53"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1"	"Cell type enhanced"	"Detected in some"	12	"Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	2.0	0.7	0.5	3.5	0.4	13.4	2.0	2.8	1.4	1.2	1.5	0.6	0.5	1.4	1.3	1.1	4.0	0.9	1.4	1.9	0.8	0.7	0.8	0.8	1.3	2.4	0.5	0.2	1.3	1.2	0.7	0.7	2.3	1.0	1.0	1.7	0.6	1.1	1.1	1.8	2.4	2.2	1.1	0.5	1.9	1.0	32.1	0.4	8.2	0.5	1.5	4.8	0.8	1.7	1.4	3.7	0.9	1.1	0.3	2.0	0.6	7.5	9.5	7.5	6.7	0.6	2.1	8.9	5.9	5.2	11.5	12.6	9.7	4.7	8.1	5.3	5.2	12.0	6.6	9.7	9.4	10.2	9.1	12.2	5.2	8.7	6.5	0.3	5.7	6.5	1.7	1.4	14.2	7.1	1.5	4.8	8.9	11.7	10.6	5.6	5.6	13.5	8.5	5.1	3.5	9.3	8.5	12.0	10.0	2.7	6.1	4.7	2.7	3.6	3.6	2.9	8.9	7.2	6.6	2.2	11.1	8.7	7.5	8.6	6.1	10.2	7.0	5.2	4.4	6.3	0.0	1.1	0.9	1.1	0.8	0.4	0.8	0.8	0.2	0.4	1.4	0.6	0.4	0.0	0.3	0.4	3.7	2.0	0.6	0.5	0.4	2.8	1.4	0.8	0.7	0.5	0.2	1.0	0.4	0.0	0.0	0.5	0.6	1.6	0.2	0.8	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.5	2.5	0.1	0.0	0.0	0.2	7.0	0.7	0.3	0.0	0.2	2.5	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.2	0.5	0.7	0.0	1.1	0.2	0.0	0.0	0.3	8.9	13.0	1.0	1.5	0.0	0.6	0.3
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 74.5"	"Cell type enhanced"	"Detected in some"	30	"Early spermatids: 846.4;Late spermatids: 397.1;Spermatocytes: 173.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.8;granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.4;MCF7: 11.0;THP-1: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	74.5	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.0	5.8	2.5	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	1.3	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.2	0.5	1.7	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.6	0.0	11.0	0.3	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	2.7	0.3	0.0	0.1	0.1	0.0	1.7	1.3	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.1	0.5	0.0	1.0	0.3	0.0	1.8	0.2	0.0	0.6	2.5	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	846.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	397.1	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	173.7	15.3	0.1	0.0	0.0	0.0	0.0
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 128.4;Late spermatids: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.0	10.5	12.8	8.5	13.2	2.4	10.6	27.8	15.4	11.3	11.7	8.4	5.3	9.1	13.1	9.0	10.8	11.2	7.8	13.5	13.8	10.0	11.5	8.6	10.2	11.0	11.8	12.7	16.0	10.1	17.2	24.9	10.9	11.8	11.6	9.0	9.4	9.0	11.2	22.2	7.5	10.4	12.4	14.4	9.9	9.7	32.5	11.3	16.1	14.6	8.3	10.3	10.3	13.3	6.5	7.1	14.6	5.0	5.2	8.7	3.9	9.9	10.5	14.6	8.9	10.7	9.2	14.2	13.1	11.4	18.6	17.7	9.9	8.2	18.9	9.3	6.7	12.7	10.0	20.2	7.5	21.8	6.8	13.7	17.4	11.0	11.6	9.4	18.3	10.3	7.2	9.4	12.3	10.2	9.3	15.9	12.8	18.7	11.3	12.3	5.7	21.1	8.7	11.5	11.0	11.3	12.8	40.2	9.6	9.7	7.5	17.9	16.1	6.9	12.8	15.2	24.1	14.0	11.5	8.7	19.5	18.0	6.3	12.4	12.9	15.3	18.3	7.8	8.3	12.3	14.6	4.0	5.7	8.5	5.0	8.7	6.5	6.3	7.5	4.6	5.8	6.0	8.6	1.9	5.2	4.7	7.1	8.6	3.9	12.8	13.2	27.8	15.4	13.8	10.0	11.8	12.7	11.8	11.3	6.0	10.8	3.4	1.6	4.4	8.2	17.9	7.6	25.4	11.4	5.2	19.6	7.3	8.3	4.8	128.4	7.1	5.1	0.0	3.4	4.8	4.1	1.7	7.0	3.9	4.1	7.9	5.2	4.3	5.3	75.5	4.9	5.4	1.7	5.4	3.0	9.8	4.2	4.0	7.1	5.3	14.7	0.0	4.7	23.5	12.3	3.9	14.1	4.1	4.4	1.3
C18orf25	"ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	5.3	4.9	5.8	6.4	8.2	18.6	6.5	10.1	10.1	6.1	4.9	5.5	6.5	4.4	7.7	5.3	54.0	6.2	3.8	11.4	4.8	4.9	5.4	6.2	5.9	6.8	5.3	6.5	5.9	5.0	15.3	6.3	7.3	8.3	5.2	5.7	9.5	11.3	4.8	13.1	6.2	5.5	5.7	4.7	6.3	5.1	7.8	5.7	8.2	7.4	10.2	11.8	7.2	12.7	8.1	11.0	19.0	11.0	2.8	11.1	5.5	11.2	11.3	9.5	10.8	6.8	6.2	12.2	16.4	8.7	17.6	15.0	8.7	13.0	8.7	15.7	11.1	6.3	25.8	17.6	11.1	19.2	14.5	5.6	7.6	9.7	6.5	11.8	14.3	10.4	5.7	13.1	20.5	17.1	10.3	6.9	8.2	8.5	10.4	9.7	8.5	10.8	7.3	8.4	3.9	4.5	9.9	11.3	12.8	16.9	20.4	13.4	7.0	12.0	8.6	8.5	12.1	5.6	8.9	10.1	16.1	11.5	3.9	15.1	13.7	11.6	14.1	8.3	15.2	17.2	4.2	7.5	15.4	5.7	8.4	9.9	5.9	11.1	8.6	7.4	8.1	8.0	6.3	19.0	2.8	11.0	11.0	7.1	5.5	5.8	8.2	10.1	10.1	4.8	4.9	5.3	6.5	8.3	5.7	11.9	10.8	11.5	9.5	22.3	13.2	26.0	10.2	8.1	4.5	14.0	19.6	5.7	1.7	7.4	2.1	15.5	9.5	0.0	5.7	8.3	10.4	10.0	15.0	12.5	7.9	12.7	11.5	8.0	10.4	2.5	7.5	11.4	6.8	4.6	8.3	9.8	14.0	10.5	9.9	6.5	29.9	19.4	10.8	16.7	12.4	27.9	20.4	11.7	9.2	16.9
C18orf32	FLJ23458	ENSG00000177576	"Chromosome 18 open reading frame 32"	Q8TCD1	18	49477250-49487252	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 217.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040921	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA040921: AB_10795423"	"unprognostic (5.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.76e-2)"	"prognostic favorable (8.89e-9)"	"unprognostic (1.02e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.36e-2)"	17.1	16.5	67.0	7.1	59.0	19.1	25.5	27.4	48.4	22.2	24.2	29.5	16.1	10.7	12.7	35.0	13.6	17.2	19.4	25.1	57.5	49.8	42.2	38.6	19.6	14.8	67.8	28.3	16.5	20.1	23.8	20.5	15.7	47.0	21.3	22.4	17.0	21.6	18.9	10.8	10.2	14.2	14.9	78.5	13.6	23.4	15.5	25.2	8.3	28.8	8.0	12.7	19.4	9.6	16.1	21.4	57.2	22.1	9.8	15.4	21.0	7.7	9.0	17.0	10.5	15.4	13.7	19.5	11.8	13.1	11.5	9.8	1.7	3.5	7.0	29.8	10.0	7.6	9.1	3.9	13.3	9.9	22.5	8.0	6.3	6.0	10.8	24.6	12.4	13.6	11.9	29.7	7.7	11.5	15.7	15.4	14.3	7.2	13.5	23.8	4.8	7.8	6.4	4.7	10.9	9.0	7.4	5.9	14.1	30.7	15.3	19.6	33.7	7.7	6.1	16.0	20.8	8.7	4.5	16.4	11.9	10.1	3.4	12.7	41.3	24.5	7.6	9.4	8.4	11.1	36.3	17.1	43.2	13.9	19.3	15.4	16.1	13.7	14.3	14.1	12.8	11.7	15.4	57.2	9.8	22.1	21.4	14.6	21.0	67.0	59.0	27.4	48.4	57.5	49.8	67.8	28.3	47.0	25.2	41.7	20.3	28.9	4.1	4.8	34.9	4.3	25.5	52.2	20.5	22.7	41.2	17.0	33.2	73.7	217.6	11.1	72.2	0.0	72.4	14.3	10.6	4.9	43.9	39.5	19.7	17.5	91.7	22.1	40.2	140.1	15.8	19.2	21.9	101.8	54.1	24.7	79.0	66.6	9.6	38.9	33.0	19.4	7.6	11.7	13.0	6.8	32.4	19.1	36.5	4.6
C19orf44	FLJ21742	ENSG00000105072	"Chromosome 19 open reading frame 44"	Q9H6X5	19	16496311-16521352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 37.3;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041683, HPA049414"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA041683: AB_10793929, HPA049414: AB_2680754"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.19e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.02e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-1)"	5.0	4.6	8.1	3.6	8.1	6.1	5.6	11.2	8.8	9.9	7.7	7.4	10.2	3.9	12.7	5.8	5.1	11.5	7.6	5.9	6.3	5.1	6.9	4.3	4.5	3.8	4.0	3.8	13.2	8.1	14.9	19.7	4.1	5.9	11.0	2.9	11.2	10.6	9.9	6.9	7.7	3.8	8.2	5.9	3.9	5.3	19.7	5.8	4.1	9.1	3.1	4.3	6.4	6.1	3.5	1.6	5.7	1.7	1.5	2.7	1.0	5.5	6.3	5.4	7.7	3.5	8.8	7.2	4.7	4.5	5.9	8.6	3.8	6.9	4.8	8.4	3.7	4.2	3.9	4.6	4.1	4.6	2.8	11.3	2.3	9.0	4.9	6.3	2.6	2.5	4.5	4.1	7.8	5.8	10.5	3.2	6.4	6.7	1.5	3.2	7.6	4.2	6.8	3.4	6.3	8.3	3.1	2.7	6.6	6.2	2.5	6.4	3.9	4.6	6.8	4.1	5.1	5.9	2.8	6.4	8.0	3.8	5.6	6.4	4.8	3.4	2.7	5.7	2.5	6.7	5.7	1.5	0.5	1.6	0.7	0.4	3.5	1.5	0.7	0.6	3.4	1.7	2.7	3.3	1.5	1.7	1.6	0.6	1.0	8.1	8.1	11.2	8.8	6.3	5.1	4.0	3.8	5.9	5.8	0.0	6.4	0.0	0.8	0.3	3.5	3.6	5.1	6.7	7.9	7.0	11.8	1.5	0.0	1.3	37.3	1.6	0.4	0.0	1.0	1.6	1.7	0.5	0.0	1.0	0.6	0.0	6.9	1.3	0.3	52.0	2.8	1.2	0.0	1.8	0.9	2.5	1.2	0.9	4.9	2.7	7.4	0.0	2.1	7.2	2.1	0.4	0.5	0.0	1.1	0.2
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774168-13778462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	37.3	41.5	55.6	31.1	53.7	42.1	33.1	22.0	41.7	40.4	35.7	27.0	34.2	28.0	33.9	55.6	43.1	44.0	39.3	67.0	46.2	44.8	42.8	68.4	35.5	42.4	47.2	34.7	49.9	46.9	27.4	41.8	27.2	37.3	39.2	26.4	30.1	45.9	35.7	90.7	31.5	29.2	39.6	37.0	34.8	31.3	34.1	30.0	59.6	53.5	47.7	41.6	43.1	43.1	67.9	63.0	57.3	49.6	36.3	75.8	92.4	35.4	50.6	25.2	21.0	35.8	40.5	16.7	33.4	29.7	41.6	41.5	46.9	17.3	18.9	41.7	40.4	30.6	19.0	23.3	50.5	21.5	22.6	73.5	17.7	54.7	50.9	37.1	27.7	23.5	49.4	36.5	38.5	21.8	26.5	35.6	28.2	27.4	32.6	32.4	79.9	39.1	28.7	32.1	27.2	89.7	21.5	19.2	32.7	36.9	44.0	23.0	27.7	23.4	27.8	33.9	19.5	25.3	28.5	23.7	47.3	18.9	50.6	45.7	36.5	46.4	28.2	28.7	31.5	25.6	48.1	48.8	57.3	49.0	49.6	55.5	67.9	63.4	57.0	44.2	63.3	75.8	68.0	23.7	36.3	43.1	63.0	69.4	92.4	55.6	53.7	22.0	41.7	46.2	44.8	47.2	34.7	37.3	30.0	107.2	86.2	241.2	221.7	258.6	46.5	224.1	198.7	117.8	97.8	254.7	21.6	202.0	532.2	215.9	134.2	206.4	254.0	163.5	291.0	335.7	214.9	274.6	125.8	284.8	320.6	33.4	218.2	154.1	231.7	499.2	202.5	228.8	219.4	359.7	182.1	129.2	247.0	245.4	171.5	582.8	48.4	90.5	205.0	94.7	135.7	304.6	178.2	221.8	197.3	276.6
C19orf66	"FLJ11286, IRAV, RyDEN"	ENSG00000130813	"Chromosome 19 open reading frame 66"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.9;BJ hTERT+ SV40 Large T+ RasG12V: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	9.8	13.8	13.7	17.6	12.1	9.0	9.9	10.6	16.9	14.5	11.2	8.4	10.3	9.6	12.6	14.1	8.9	16.4	15.5	6.9	11.0	13.9	11.5	55.8	11.6	14.4	9.0	13.5	14.5	10.0	14.1	12.8	9.8	10.0	12.4	6.1	11.6	13.0	15.8	3.7	7.6	14.2	9.7	8.6	14.0	8.3	3.7	8.6	9.8	11.9	5.4	13.0	12.9	10.1	8.8	6.7	11.6	12.0	17.5	21.2	10.0	2.8	1.6	1.7	1.3	6.6	8.9	0.7	3.3	18.4	24.9	26.4	0.2	2.4	1.7	1.0	8.7	7.5	1.2	0.8	6.2	0.4	12.0	0.0	5.2	1.2	4.1	12.9	1.8	2.9	16.0	4.6	3.9	0.6	8.3	7.1	7.2	0.7	6.9	5.0	2.3	5.9	3.5	0.4	2.6	2.5	5.4	0.0	3.2	3.7	4.4	0.2	1.5	4.8	0.4	14.1	0.1	0.2	4.7	5.2	2.1	1.0	2.8	0.4	8.4	2.6	0.4	5.7	1.6	4.2	11.1	8.3	11.6	15.9	7.4	21.2	8.8	13.5	17.1	6.7	6.9	11.5	12.1	10.8	17.5	12.0	1.3	13.9	10.0	13.7	12.1	10.6	16.9	11.0	13.9	9.0	13.5	10.0	8.6	20.8	26.6	27.2	22.7	13.4	62.6	2.5	22.9	16.0	37.5	26.2	35.3	4.8	14.9	28.5	8.9	40.5	24.0	0.0	30.6	5.1	30.4	24.7	31.1	94.1	28.7	52.4	17.9	46.1	23.4	23.8	37.7	26.6	16.9	57.7	15.9	33.5	32.5	20.1	35.7	11.1	32.9	71.1	26.4	1.6	3.2	13.2	2.2	64.3	11.5	18.6
C19orf70	"MIC13, P117, QIL1"	ENSG00000174917	"Chromosome 19 open reading frame 70"	Q5XKP0	19	5678421-5680896	"Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	13	"Late spermatids: 2933.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	20.2	23.6	32.9	14.5	28.4	13.2	16.0	11.0	29.8	13.0	22.2	13.5	17.8	25.4	12.2	26.8	22.7	16.7	24.0	70.2	27.2	26.5	30.5	38.4	12.7	21.1	32.1	21.1	13.5	24.2	13.2	15.6	12.4	16.9	16.6	11.7	13.6	28.7	22.7	79.1	17.6	20.7	14.7	20.9	14.1	18.2	33.4	12.3	11.6	20.3	45.0	12.6	15.4	11.8	43.6	48.2	11.6	42.2	27.4	39.5	40.7	24.2	20.1	7.0	13.4	16.5	17.1	9.1	16.1	15.3	18.6	15.4	16.0	12.7	10.6	26.2	14.0	9.9	18.1	3.6	22.8	5.3	17.4	38.4	10.3	14.0	17.8	23.3	14.1	13.0	20.0	20.6	10.0	13.9	11.7	13.3	16.3	15.9	33.1	14.0	21.9	21.3	16.8	7.4	17.8	64.4	11.7	8.5	38.7	20.3	15.3	16.4	20.9	4.9	31.8	22.5	4.7	19.4	17.4	13.5	18.3	7.8	33.4	22.7	50.0	33.1	8.4	27.3	22.6	18.5	8.9	35.5	11.6	33.6	42.2	39.5	43.6	38.6	37.2	41.2	35.6	38.1	35.9	5.6	27.4	35.6	48.2	30.9	40.7	32.9	28.4	11.0	29.8	27.2	26.5	32.1	21.1	16.9	12.3	65.5	61.7	101.3	135.8	87.3	47.7	288.5	122.3	167.3	76.2	150.1	25.5	132.2	623.4	178.9	798.0	106.8	325.2	46.7	265.1	165.3	137.3	120.3	92.3	251.0	214.9	17.5	154.8	98.8	146.2	2933.3	115.3	157.0	163.6	263.3	176.9	49.5	211.4	214.0	112.8	383.4	42.2	109.9	170.0	106.7	73.5	109.3	105.3	94.8	219.4	109.5
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118397-49119140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	2.5	3.4	5.0	2.3	6.7	1.0	3.7	10.2	8.7	1.4	3.9	4.1	3.1	7.7	1.3	5.6	2.6	1.4	2.1	3.5	4.9	4.5	2.5	4.8	1.5	2.3	9.2	4.9	0.7	12.9	3.3	5.4	1.4	5.0	2.5	2.9	1.8	6.3	2.1	3.6	4.1	4.4	1.3	4.7	3.6	2.9	2.1	5.6	1.1	3.1	1.2	1.7	1.5	1.4	6.2	5.5	0.7	4.1	7.9	4.6	2.3	2.4	3.1	1.2	6.0	2.0	0.4	1.3	0.7	0.4	1.3	0.9	0.2	1.4	1.8	0.7	0.5	1.9	1.6	1.6	0.2	0.2	3.5	12.7	1.5	1.9	2.0	2.0	0.0	0.7	0.2	4.1	0.9	3.4	1.0	0.4	6.2	2.8	2.9	0.6	2.6	1.9	1.8	0.9	2.6	0.6	1.8	2.4	2.3	2.3	1.0	6.3	2.9	1.2	1.5	2.3	0.9	1.5	0.6	1.2	1.6	2.7	0.5	0.6	1.8	3.4	2.0	1.1	2.1	1.8	0.0	3.3	0.7	2.9	1.9	4.6	2.7	2.2	2.6	5.5	6.2	4.3	3.2	0.1	7.9	4.1	4.2	1.9	2.3	5.0	6.7	10.2	8.7	4.9	4.5	9.2	4.9	5.0	5.6	0.0	0.0	4.5	8.9	1.9	3.6	0.7	5.1	1.4	1.2	3.5	0.0	0.7	3.3	2.2	0.4	0.5	3.3	0.0	1.7	0.8	1.4	6.4	0.0	3.9	1.2	1.6	2.9	1.8	1.2	0.7	0.0	1.3	3.3	0.0	4.2	3.4	1.9	0.0	1.4	7.0	4.3	0.0	1.1	0.4	3.4	2.3	0.3	1.8	4.7	3.5
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	17.1	20.1	15.9	13.3	17.9	31.5	17.2	13.9	26.5	15.4	16.3	12.4	15.4	14.7	14.9	14.6	13.8	13.9	12.4	15.8	14.9	15.6	28.4	29.8	14.4	21.0	14.8	16.8	14.9	27.3	12.5	25.3	18.6	17.0	14.8	13.9	8.6	13.5	14.0	29.4	11.7	19.2	12.2	17.2	16.4	15.1	13.8	18.6	17.4	18.0	16.4	14.7	13.2	20.0	20.0	16.1	32.1	19.6	22.6	19.7	9.4	21.9	12.3	15.4	12.9	15.6	19.8	20.5	28.5	19.7	20.0	16.5	21.5	24.7	27.7	17.4	19.0	21.2	10.8	18.1	13.3	31.2	29.5	21.8	32.5	10.5	24.6	15.8	40.3	34.5	16.3	22.4	15.0	14.3	24.4	15.3	26.2	25.8	24.2	18.3	11.1	26.8	34.9	16.5	20.4	15.3	16.9	18.3	21.8	18.1	15.9	13.5	15.5	10.4	18.2	28.2	18.6	13.3	27.4	17.0	17.3	19.9	21.1	25.0	23.2	25.8	35.0	22.0	25.1	19.6	28.1	14.3	32.1	15.9	18.5	18.7	20.0	18.0	13.2	16.1	17.2	19.6	19.7	29.0	22.6	19.6	15.0	19.0	9.4	15.9	17.9	13.9	26.5	14.9	15.6	14.8	16.8	17.0	18.6	71.5	36.3	61.4	75.3	75.6	34.8	30.5	61.1	75.0	45.5	61.1	21.6	86.5	198.9	74.3	40.6	40.9	39.1	23.3	52.1	69.0	56.7	67.4	42.8	75.7	76.6	33.4	49.7	40.5	54.7	18.1	51.5	56.0	54.0	76.7	38.4	39.8	54.5	63.3	55.5	180.4	29.5	97.0	44.0	91.4	84.7	75.4	90.2	57.5	31.5	88.7
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"	18	"granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7"									HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	45.4	0.1	0.1	0.1	0.0	0.2	22.1	3.7	0.0	0.9	0.3	0.3	0.3	0.6	0.2	0.2	0.1	0.1	0.1	0.1	12.3	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	17.5	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	36.7	0.5	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9	20.8	66.7	71.8	0.5	7.0	3.7	3.1	12.7	1.4	7.9	7.0	2.0	1.1	0.0	0.2	33.3	3.7	0.6	0.0	0.2	1.2	5.8	0.7	175.8	6.4	198.4	0.0	1.7	17.8	675.1	60.1	2.6	367.2	11.8	1.0	0.0	0.3	0.2	0.0	0.7	0.6	3.9	32.3	4.2	1.8	1.7	5.6	1.4	95.6	0.6	0.3
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387058-184629020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5"	"Group enriched"	"Detected in many"	12	"NK-cells: 7.5;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	12.0	15.9	16.8	7.5	9.5	2.1	25.2	17.5	18.8	20.2	18.5	4.4	16.7	8.7	17.3	14.2	14.1	10.1	9.2	20.0	12.5	8.8	4.1	7.5	12.2	3.5	8.3	13.3	13.9	4.7	12.6	7.6	5.7	11.8	17.8	13.1	10.7	5.1	18.9	51.7	30.1	15.8	25.2	7.6	8.2	10.7	4.1	5.4	1.5	4.4	13.6	3.9	22.0	23.5	0.0	0.7	0.2	0.1	7.5	11.4	2.1	0.6	0.1	3.6	0.3	11.4	9.4	6.1	3.2	3.1	2.0	1.8	0.0	0.3	0.0	0.0	3.6	0.7	2.0	2.3	2.6	1.9	23.3	3.7	0.1	1.0	0.0	4.5	2.0	1.0	11.3	7.7	2.3	2.0	8.2	2.4	3.5	0.0	17.7	3.1	2.4	2.3	0.6	5.4	4.8	0.6	3.0	3.8	3.5	0.0	1.2	2.1	5.4	1.6	1.4	6.6	3.4	0.2	0.2	2.3	4.1	2.1	6.2	3.9	11.0	5.1	0.0	4.1	3.3	4.7	0.0	0.1	0.0	11.4	0.0	1.1	0.0	1.9	5.9	0.7	0.0	0.6	5.9	0.2	7.5	0.0	0.2	0.0	2.1	16.8	9.5	17.5	15.9	12.5	8.8	8.3	13.3	11.8	5.4	35.7	88.4	1.5	208.9	135.5	27.4	78.1	28.1	17.4	53.4	1.8	0.0	92.1	6.6	5.0	34.6	101.3	150.2	0.0	16.6	76.1	45.1	118.1	9.3	55.0	34.1	25.4	18.4	81.6	6.3	26.6	70.8	10.1	60.8	32.5	59.7	30.7	19.0	164.9	18.0	5.7	8.7	19.4	53.8	2.3	16.6	127.2	238.0	44.5	61.0	172.9
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713875-35719472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 22.3;Rod photoreceptor cells: 26.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	4.3	4.4	12.5	2.1	10.5	1.1	2.4	5.0	22.1	4.7	3.5			1.0	4.1	5.0	2.1	2.5	3.0	4.0	12.1	9.7	0.7	1.8	3.1	2.4	7.0		3.5	1.2	2.0	1.8	1.6		3.1	2.0		1.1	4.4	5.1	2.9	1.2	7.0	5.2	2.2	1.2	3.4			1.4		2.5	2.4	1.4	2.5	3.2	0.1	3.7	0.8	7.3	3.0	3.4	8.0	4.4	5.7	20.1	14.8	2.9	9.8	11.5	14.5	13.9	4.7	7.3	4.3	7.1	14.3	11.9	3.3	10.9	6.4	12.5	14.0	5.2	25.7	11.7	1.3	7.6	12.7	17.0	15.1	8.2	10.4	3.3	10.7	9.4	3.2	10.2	11.6	15.5	5.6	5.1	10.9	6.4	3.7	6.8	3.4	5.8	3.5	5.0	4.0	5.9	5.9	9.3	1.9	19.0	2.7	3.6	5.7	11.2	11.8	9.4	8.8	10.1	3.5	8.7	3.2	11.8	12.3	18.4	0.0	3.2	0.1	5.9	3.7	1.9	2.5	4.7	7.3	3.2	1.4	1.1	4.4	0.1	0.8	2.7	0.7	1.6	3.0											0.0	2.1	0.0	2.9	5.4	18.4	6.4	0.0	0.0	1.2	1.8	13.7	2.0	0.0	5.5	10.2	6.0	0.0	0.0	2.4	1.2	4.7	1.8	4.6	1.7	6.9	22.3	1.7	5.5	4.0	6.8	7.8	5.4	15.1	8.2	0.0	16.2	2.2	0.0	19.4	0.7	26.6	0.0	6.9	2.8	2.2	4.0	0.9	5.0	0.3	1.4
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 24.6"	"Cell type enhanced"	"Detected in some"	29	"Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 11.4;U-87 MG: 33.0"	"Low region specificity"	"Detected in many"							HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.6	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.2	1.8	0.5	0.7	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	53.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	12.2	0.5	0.0	0.0	0.0	0.0	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.5"	"Group enriched"	"Detected in many"	5	"Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	30000	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	62.4	18.3	1.7	7.4	4.3	0.4	60.5	1.3	5.1	14.3	10.3	5.2	30.8	2.5	11.0	14.2	10.2	14.4	19.1	77.5	2.0	4.1	9.5	19.4	9.7	16.6	4.8	2.5	25.2	7.5	10.1	4.2	34.0	7.6	13.3	3.3	19.6	13.8	51.8	11.9	8.6	6.1	6.9	2.5	14.3	6.1	8.8	2.8	1.3	26.9	13.3	5.0	14.8	27.5	0.5	0.3	1.9	0.3	1.2	0.4	0.0	0.0	8.2	0.0	0.0	84.6	7.6	0.0	4.2	19.8	1.8	3.5	0.6	4.0	0.0	0.4	1.2	5.2	0.2	0.2	0.1	1.3	0.0	0.9	0.0	3.1	0.4	32.0	0.0	0.0	17.0	0.0	3.8	0.2	2.6	2.4	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.9	8.6	0.0	5.5	0.1	0.0	0.1	0.3	1.6	2.7	0.4	7.9	0.3	0.0	0.0	0.3	9.0	0.2	1.0	1.2	0.0	0.0	0.0	20.0	0.0	0.8	1.9	0.3	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.1	0.5	0.2	0.4	0.4	1.2	0.2	0.3	0.0	0.0	1.7	4.3	1.3	4.2	2.0	4.1	4.8	2.5	7.6	2.8	0.0	1.1	0.0	0.6	5.8	0.0	9.4	10.2	0.0	0.0	1.8	0.0	17.3	0.0	13.9	0.1	10.5	1.3	0.0	5.3	1.2	14.4	1.2	0.0	1.5	2.3	0.0	4.6	145.5	10.5	0.0	9.8	0.7	3.3	19.0	6.8	0.5	3.2	2.9	3.2	0.0	0.3	103.5	105.0	0.0	0.7	4.0	39.6	0.5	4.5	0.5
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	181.7	92.7	0.1	20.4	80.0	24.2	49.3	0.2	0.3	0.0	0.6	15.9	1.6	0.3	1.7	0.8	3.4	1.9	0.1	0.0	0.6	0.6	34.9	0.1	0.2	107.4	0.5	11.0	0.8	18.4	0.4	0.1	0.0	2.5	3.1	0.0	0.9	0.1	0.8	0.0	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.7	0.4	0.4	0.2	0.0	0.0	0.0	5.8	0.9	26.7	0.1	0.1	0.4	0.0	8.3	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9	20.8	84.7	28.4	53.6	48.5	0.2	14.6	168.2	6.7	34.2	17.4	2.0	2.9	3.3	164.2	3.5	51.3	0.3	23.3	39.1	4.8	462.9	14.1	9.3	1385.8	10.3	0.0	0.0	128.9	25.4	9.4	1057.9	10.1	50.6	2.8	0.6	15.1	74.1	0.6	364.9	5.0	0.9	168.1	97.8	5.7	4.1	35.0	4.3	13.1	0.7	9.8
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell type enhanced"	"Detected in many"	21	"Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.3	99.3	132.1	0.4	17.9	42.1	9.5	17.4	0.0	0.2	0.0	2.4	22.2	2.5	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.7	29.9	0.2	0.1	70.1	0.3	7.7	0.5	11.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.9	0.2	0.2	2.1	0.0	0.0	0.0	4.4	0.3	16.9	0.0	0.0	0.0	0.1	9.5	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3	14.9	34.2	18.3	17.5	67.8	0.6	21.4	152.8	6.7	20.5	3.5	0.0	2.9	1.7	170.0	5.7	37.8	0.0	46.7	37.9	3.5	388.0	7.4	4.7	2464.3	7.1	4.8	0.0	105.6	49.3	8.8	1104.9	9.4	84.4	1.8	0.0	15.1	43.6	0.0	601.8	4.1	0.9	135.8	123.7	5.0	4.1	47.0	2.2	4.3	0.0	3.0
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3768387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 64.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 38.5;monocytes: 46.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		87000	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	23.1	9.7	10.2	11.8	64.7	51.9	17.2	4.9	15.8	12.0	22.6	7.7	3.7	10.3	16.9	10.9	14.4	18.7	26.6	7.3	9.2	14.4	5.0	5.4	8.4	13.5	14.5	6.1	20.9	8.5	3.9	5.3	6.7	13.7	18.3	4.9	5.0	9.0	7.1	11.2	9.6	9.4	22.3	5.7	13.4	21.2	6.0	13.2	6.0	5.4	7.9	6.1	27.4	10.3	7.8	38.5	1.1	46.6	5.8	8.5	13.8	34.4	36.4	5.7	24.3	11.9	6.5	9.0	8.9	5.9	16.5	12.1	24.9	13.1	21.6	8.7	10.4	22.0	29.7	15.3	22.3	6.3	5.0	27.4	12.2	7.4	44.4	8.5	17.5	5.4	9.2	9.4	21.0	10.5	5.7	11.1	15.8	21.7	13.6	8.5	48.7	23.1	41.7	24.6	24.1	49.5	17.9	14.0	25.5	10.3	12.6	25.7	11.7	8.1	36.1	17.8	2.7	8.0	22.0	6.8	23.1	16.0	36.6	27.2	10.5	17.5	16.0	6.8	33.3	11.3	0.2	28.1	0.4	5.9	46.6	8.5	7.8	7.0	7.8	38.5	7.3	8.0	7.8	1.1	5.8	42.2	7.3	6.4	13.8	10.2	64.7	4.9	15.8	9.2	14.4	14.5	6.1	13.7	13.2	0.0	3.5	24.6	18.0	21.5	9.4	2.8	7.6	1.4	2.3	10.4	2.0	15.9	24.9	31.1	8.2	25.0	10.5	70.0	26.1	38.9	26.3	9.4	23.0	14.7	123.1	1.6	15.1	13.5	94.5	13.7	30.2	60.1	35.4	4.6	10.2	20.0	28.5	16.4	23.3	27.0	12.7	64.7	66.1	18.7	30.1	28.7	6.1	16.2	30.3	20.0
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 29.3"									"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.1	5.6	14.8	9.2	1.5	2.0	8.2	7.5	2.8	5.3	5.2	2.5	9.0	8.8	1.9	2.1	6.2	9.8	3.9	3.2	1.6	9.2	8.6	14.1	14.6	1.4	0.3	4.0	8.1	0.9	0.7	3.7	0.9	1.9	3.3	22.0	8.0	23.5	4.3	5.0	19.8	5.4	6.3	3.4	2.8	29.3	6.7	7.8	1.6	2.3	12.2	7.6	5.6	4.0	1.8	3.3	9.9	8.0	2.2	3.2	9.3	3.2	4.5	9.5	4.2	4.2	5.7	17.5	8.4	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2	3.0	1.6	3.0	1.2	0.8	17.1	3.6	0.0	203.4	22.7	1.8	25.5	3.5	0.0	1.9	13.4	1.1	2.3	140.2	0.9	5.4	3.6	1.8	2.3	1.6	3.4	4.8	66.7	3.7	1.8	25.4	4.9	2.7	0.0	1.0	3.5	4.3	1.1	3.5	2.5	0.6	28.6	0.0	2.1	52.4	42.1	1.3	1.1	2.6	5.9	0.7
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"	NA	NA			Nucleoplasm	Nucleoli	"HPA052741: AB_2681933"	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.8	4.5	11.1	6.8	8.2	8.7	10.1	7.5	8.1	6.4	8.6	4.5	5.8	5.5	5.5	6.2	6.3	4.1	5.7	5.8	7.7	19.7	5.4	6.1	9.4	3.8	4.8	4.5	12.0	6.9	7.8	10.7	7.6	4.9	1.6	8.6	9.9	8.2	5.6	14.6	3.5	5.5	4.5	13.4	3.5	5.1	9.2	6.1	5.4	6.1	2.7	4.2	8.7	7.9	11.3	8.5	9.0	5.5	4.3	8.4	14.4	4.4	3.9	17.5	17.8	5.1	5.0	5.5	11.4	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7											11.9	16.5	7.1	3.9	1.9	9.4	18.9	5.1	8.1	11.4	7.0	13.7	8.3	1.7	4.2	65.6	7.1	8.4	0.0	4.2	5.8	4.9	2.0	7.0	4.0	4.2	3.2	2.9	9.2	7.3	8.2	4.9	8.3	1.7	9.0	7.2	9.7	3.7	3.7	6.0	1.3	6.2	0.0	3.5	12.0	11.5	2.3	7.1	15.8	4.0	1.4
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 calcium dependent domain containing 3"	Q4AC94	11	74012714-74171210	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 65.5;Alveolar cells type 2: 98.8;Ciliated cells: 88.3;Club cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 14.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	7.4	11.9	10.5	13.5	11.2	17.3	8.4	14.9	11.8	8.1	6.8	14.3	4.4	6.3	10.9	10.3	7.8	12.5	6.4	8.3	9.6	6.5	8.5	8.4	9.7	8.5	12.0	8.1	10.2	6.9	17.5	15.0	13.5	11.4	8.6	9.0	10.4	8.5	7.9	6.9	9.7	7.3	7.2	11.3	10.0	7.7	19.9	13.2	16.7	13.1	4.2	12.1	8.1	9.7	5.3	2.0	14.8	3.2	3.3	2.6	0.5	5.7	11.3	8.4	10.1	4.9	4.4	3.9	8.4	6.0	11.0	9.6	15.8	4.6	5.9	6.2	5.1	10.4	10.2	9.3	4.0	13.0	9.8	4.7	8.6	12.7	6.2	5.3	9.7	13.5	3.2	3.8	11.5	6.8	3.9	6.9	7.7	8.6	11.6	9.6	5.5	10.4	5.2	5.8	10.3	5.5	8.9	39.4	6.4	3.2	9.2	10.1	6.5	15.9	5.6	12.6	7.8	9.7	5.3	7.4	7.9	12.2	8.3	7.4	9.0	6.2	18.4	2.7	5.8	8.7	14.8	1.9	2.2	2.6	2.2	2.2	2.3	1.5	2.1	1.0	5.3	2.0	1.9	13.1	3.3	3.2	2.0	1.0	0.5	10.5	11.2	14.9	11.8	9.6	6.5	12.0	8.1	11.4	13.2	65.5	98.8	2.7	3.4	4.6	8.1	4.2	2.5	88.3	61.4	8.7	3.9	3.1	0.0	3.3	25.7	5.3	4.3	0.0	2.2	2.1	3.3	4.0	33.7	2.4	4.3	11.1	7.5	6.2	7.8	19.0	4.0	7.4	6.8	3.6	4.5	6.3	3.0	2.9	6.0	1.2	13.8	6.5	4.1	9.9	6.5	4.0	1.9	9.6	5.2	2.3
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 22.3"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 68.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.3;SiHa: 4.5"					"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	1.0	0.5	0.1	0.4	0.5	0.2	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.4	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.6	22.3	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.0	0.3	0.3	1.0	0.0	0.6	0.1	1.6	1.6	2.3	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	2.1	0.8	2.0	0.0	1.5	0.5	0.0	0.0	0.0	1.4	0.4	3.0	1.2	1.6	0.0	1.7	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.9	1.2	2.2	0.1	0.4	0.0	0.8	0.4	0.8	0.0	1.2	1.3	0.6	0.0	1.5	6.3	1.1	4.5	1.2	0.6	0.4	1.0	1.1	2.7	1.5	2.1	1.0	1.0	0.4	0.0	1.9	0.5	0.3	2.1	0.0	1.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	68.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	1.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337359-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	15.9	14.8	17.2	15.8	20.4	24.3	17.3	25.6	22.4	19.7	15.0	21.9	19.9	13.4	22.0	13.5	18.6	19.0	14.2	21.3	20.0	16.0	13.4	15.0	14.0	16.9	25.3	19.9	30.7	19.3	13.0	12.0	19.2	18.1	17.2	15.1	12.4	15.9	17.2	28.2	14.3	14.8	18.3	22.9	15.3	19.7	19.2	22.1	26.5	18.8	13.1	18.8	18.1	21.2	16.7	18.4	17.9	13.5	8.2	11.7	6.4	13.6	9.8	12.4	12.5	13.9	17.2	22.1	13.8	14.4	12.2	16.8	21.3	13.7	16.2	17.3	11.8	33.0	13.2	16.9	11.7	15.9	21.0	12.9	17.5	8.4	16.4	17.2	14.5	14.5	12.4	20.5	17.2	15.7	17.5	10.9	12.8	24.3	13.4	17.1	10.7	17.6	16.8	16.2	9.2	11.8	11.8	18.2	18.5	13.7	13.2	14.7	11.7	12.2	11.1	16.1	14.4	10.9	16.4	17.9	13.0	18.3	9.2	11.1	17.0	13.8	17.0	13.0	14.8	12.5	10.2	13.5	11.1	9.4	7.9	9.2	14.3	10.5	9.1	8.8	16.7	11.7	9.8	17.9	8.2	10.6	18.4	11.6	6.4	17.2	20.4	25.6	22.4	20.0	16.0	25.3	19.9	18.1	22.1	14.9	11.0	27.3	12.2	25.8	36.0	25.4	12.7	46.8	22.7	24.4	27.5	18.6	21.6	19.7	30.9	16.9	14.7	0.0	15.8	23.4	13.6	10.4	16.1	19.5	14.3	22.3	10.9	14.1	13.6	30.0	25.6	16.2	6.8	13.6	15.0	37.4	19.7	15.2	27.3	14.3	42.6	19.4	15.5	29.7	29.0	21.7	30.8	18.1	13.6	14.8
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.6	1.4	0.1	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	5.3	0.1	3.2	1.0	0.0	0.0	57.4	0.0	0.0	0.4	0.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	50.6	1.7	0.0	0.8	2.5	0.0	0.3	0.0	1.4	10.3	1.8	0.0	1.1	5.0	1.4	0.0	0.0	2.1	0.0	3.2	0.1	0.4	1.3	0.0	3.4	0.0	0.0	48.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.5	0.0	10.5	56.1	0.0	12.6	0.0	0.0	0.2	0.0	0.0	22.7	0.2	0.0	1.2	6.3
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 9.4;RT4: 3.5;TIME: 3.9"									HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.1	0.5	0.3	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	1.1	0.2	0.3	0.6	9.4	1.0	0.1	0.0	0.1	0.8	0.7	1.4	0.2	0.2	0.2	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	3.5	0.4	0.2	0.0	0.1	0.1	0.4	0.0	0.0	3.9	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9	0.0	0.0	1.9	0.0	0.1	0.6	0.3	33.1	0.0	0.0	0.0	0.0	1.4	1.7	2.0	7.3	0.0	15.3	0.0	1.8	9.0	0.0	0.9	0.0	111.5	0.5	0.0	4.7	3.7	2.5	25.8	0.3	0.0	1.7	0.0	13.2	9.7	1.0	62.8	3.9	1.4	0.3	0.0	0.1	0.5	0.9	0.0	4.3	0.0	24.3	0.1
C2orf81	"hCG40743, LOC388963"	ENSG00000284308	"Chromosome 2 open reading frame 81"		2	74414176-74421591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.9;testis: 20.0"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 17.4;Early spermatids: 35.6;Late spermatids: 23.4;Spermatocytes: 16.4"									"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 12.2;RPMI-8226: 11.6;SCLC-21H: 15.2;SH-SY5Y: 16.5"									"HPA049564, HPA054835"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA049564: , HPA054835: AB_2682620"																		0.4	0.9	2.2	1.2	5.5	0.5	0.9	1.2	3.4	1.3	0.8	2.6	8.2	0.9	2.2	4.9	1.6	17.9	2.0	0.7	2.1		1.9	0.0	2.5	3.0	0.0	2.8	3.2	1.6	4.9	13.7	1.0	1.9	1.8	0.2	3.2	1.3	3.5	0.8	0.3	1.1	0.7	0.0	2.1	1.7	20.0	0.8	5.3	2.1	0.7	1.9	1.9	0.0	6.5	13.2	0.2	1.8	3.1	3.4	1.3	3.5	6.6	2.0	7.4	2.3	1.9	0.7	0.6	2.2	0.6	0.7	0.4	4.1	8.6	1.6	1.0	1.8	1.3	0.1	1.7	0.7	4.8	0.5	0.9	0.5	0.1	1.1	1.8	1.9	1.1	4.4	0.9	0.9	2.6	0.0	4.7	0.3	1.4	1.1	12.2	2.2	4.5	4.0	2.1	1.5	1.1	0.7	11.6	2.6	1.5	15.2	16.5	2.1	3.3	0.9	0.3	3.1	1.6	0.1	0.7	3.3	2.3	1.8	3.2	5.6	2.8	4.6	1.7	1.5	0.1	1.8	0.0	0.6	1.8	0.3	5.7	0.7	0.8	6.2	6.5	3.4	1.5	0.2	3.1	1.4	13.2	0.6	1.3											0.0	3.7	0.0	1.0	0.6	0.6	1.1	2.5	17.4	4.5	3.5	0.0	0.0	5.0	2.9	35.6	1.4	0.1	0.0	1.9	0.0	2.1	0.6	0.0	0.0	0.0	3.2	6.9	2.5	2.1	23.4	3.1	3.0	3.3	9.0	1.6	4.8	2.0	0.0	7.1	4.2	3.5	6.5	3.9	16.4	1.5	0.6	0.0	0.0	1.1	0.2
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	6.0	8.5	4.0	5.6	0.3	5.1	1.8	2.5	4.0	2.5	6.1	2.9	7.7	1.1	6.2	2.6	3.8	0.9	4.1	0.1	4.6	2.9	6.0	3.7	1.4	7.8	7.1	5.0	1.2	4.0	4.5	2.7	5.3	3.3	4.3	6.3	5.8	2.9	4.3	4.4	5.3	4.5	5.4	5.5	1.9	5.4	2.2	5.9	14.1	2.8	3.1	4.1	5.8	7.8	5.2	2.2	10.7	6.6	2.7	2.9	2.1	6.1	6.5	4.9	4.6	0.0	2.1	4.7	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9	3.0	7.9	0.0	5.1	1.1	7.9	9.8	2.5	5.3	7.9	0.0	5.9	3.0	5.0	3.2	5.2	2.2	1.3	0.0	2.9	2.5	4.6	4.0	6.9	3.0	2.2	6.4	3.5	1.3	0.3	4.2	5.8	1.6	1.7	0.0	3.1	15.6	1.6	3.4	7.4	5.3	7.0	0.0	3.1	11.3	17.2	1.3	3.1	2.5	4.1	2.0
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	16.6	12.4	15.9	12.7	21.5	3.4	15.9	20.5	21.3	14.7	12.5	23.5	12.6	10.5	14.9	21.9	16.2	11.4	12.2	12.8	16.0	17.5	15.3	14.0	10.7	13.1	20.6	12.3	22.1	11.9	24.1	18.6	17.2	25.1	16.5	12.6	13.2	12.9	15.4	7.2	14.1	11.9	16.8	22.1	12.8	11.5	9.4	18.5	16.2	19.0	6.9	14.0	18.9	13.5	5.6	6.8	21.0	7.4	5.6	7.4	7.9	7.4	5.7	11.7	24.4	24.0	18.9	12.8	8.8	15.3	12.5	13.4	5.7	7.7	8.0	10.9	9.8	21.8	4.8	15.4	8.3	18.1	10.7	4.7	7.7	17.3	8.5	29.1	9.8	5.9	18.4	12.1	14.6	16.9	8.0	10.7	9.7	13.7	13.8	13.2	7.7	9.2	10.1	11.6	4.5	3.1	8.1	16.2	12.4	8.3	7.2	7.1	11.1	28.1	13.5	14.5	10.9	15.0	10.1	7.7	14.9	8.9	11.2	8.5	7.0	11.3	8.2	16.5	17.3	10.5	21.0	6.9	6.6	4.7	5.6	6.0	5.1	5.5	5.0	6.8	5.6	7.4	4.9	4.7	5.6	7.4	4.1	3.9	7.9	15.9	21.5	20.5	21.3	16.0	17.5	20.6	12.3	25.1	18.5	29.8	8.6	14.5	7.4	8.9	9.2	13.4	12.7	10.7	9.1	14.0	5.9	11.0	8.3	9.8	9.1	9.0	5.1	0.0	6.7	10.7	9.3	9.4	4.7	16.3	12.5	7.9	10.4	8.6	16.1	8.9	8.3	6.7	6.8	10.8	9.2	14.5	7.3	5.8	7.4	10.8	9.0	12.9	11.3	6.6	7.8	11.5	14.1	5.0	7.4	9.1
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.5	9.1	3.3	4.9	4.6	2.5	3.6	7.0	2.6	4.6	4.2	5.9	4.6	9.2	5.4	6.7	6.7	6.0	3.5	6.2	5.3	4.4	8.7	4.8	9.3	3.6	8.4	3.6	3.1	5.1	4.2	4.6	4.7	2.3	3.5	5.9	6.1	2.1	3.8	6.6	1.9	3.5	4.0	3.2	11.8	2.2	3.5	3.8	2.6	8.7	4.1	4.6	10.3	3.1	3.6	4.8	4.1	3.5	9.4	4.6	5.3	5.0	4.4	4.9	10.9	2.8	4.3	4.6	9.9	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3	0.0	0.6	0.8	0.4	0.2	1.0	0.5	0.0	1.4	0.0	3.5	3.9	0.6	1.7	0.8	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.5	0.0	0.6	0.2	0.0	0.0	1.8	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.7	1.0	0.5	0.0	0.4	1.2	1.2	0.4	0.7	0.0	0.0	0.1
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.6	26.7	8.9	27.2	4.8	6.9	18.9	18.7	9.3	16.7	14.2	18.8	17.9	12.5	12.4	12.0	21.2	26.5	10.7	22.6	3.3	11.9	21.6	11.4	18.9	25.5	19.7	14.5	7.9	9.8	18.1	15.5	14.3	7.3	11.4	10.6	20.3	12.0	7.4	60.2	6.7	38.9	21.9	18.8	39.7	19.8	3.3	20.7	7.8	11.6	20.6	29.5	15.4	18.3	25.2	6.2	43.9	26.8	13.1	9.7	43.2	28.9	24.5	10.3	13.8	11.4	19.5	24.2	30.6	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8	32.8	64.7	92.5	33.2	20.6	74.8	64.4	40.8	56.2	30.7	62.8	17.7	65.3	250.4	73.5	7.0	40.5	17.6	23.3	74.9	70.2	42.1	41.1	54.3	32.5	140.0	54.0	87.1	33.7	63.1	3.4	34.2	61.3	67.4	120.8	45.0	82.9	55.6	17.3	41.8	101.0	58.5	25.8	67.4	18.1	41.5	21.3	38.9	48.4	57.1	30.7
C8orf33	FLJ20989	ENSG00000182307	"Chromosome 8 open reading frame 33"	Q9H7E9	8	145052378-145056030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024812, HPA026104"	Approved		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA024812: AB_10599490, HPA026104: AB_10600875"	"prognostic unfavorable (2.77e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (4.75e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	14.3	41.8	14.4	8.8	13.5	5.5	23.2	10.7	17.3	25.3	19.3	13.4	11.3	11.3	11.9	15.0	12.1	14.4	13.1	15.0	15.3	12.1	15.5	11.8	9.4	12.4	14.3	12.0	24.3	13.5	32.4	8.5	12.9	18.1	13.9	24.9	11.9	12.5	24.4	21.7	11.5	7.6	9.5	21.8	9.3	10.2	9.3	13.5	9.1	16.6	10.5	8.5	10.1	9.4	8.7	13.7	4.9	12.0	17.9	13.0	11.3	8.3	8.6	3.0	1.4	17.7	6.2	5.8	5.8	12.1	11.2	8.1	1.7	0.7	9.8	19.3	6.8	1.6	2.8	12.2	12.9	8.1	4.4	22.1	12.8	5.2	2.7	16.8	6.6	2.8	13.3	21.8	6.2	11.5	5.5	8.7	12.5	24.2	2.1	5.3	12.1	13.8	3.7	7.2	7.3	22.8	8.6	3.8	11.6	7.5	2.9	7.0	10.7	16.5	1.8	7.5	5.3	1.9	2.6	4.5	2.9	8.6	4.3	7.4	7.0	4.8	20.7	9.5	15.3	5.0	0.3	10.0	4.9	10.3	12.0	13.0	8.7	10.9	11.5	13.7	8.6	12.9	10.3	0.6	17.9	9.4	12.6	7.8	11.3	14.4	13.5	10.7	17.3	15.3	12.1	14.3	12.0	18.1	13.5	26.8	22.7	32.8	25.8	39.4	43.0	15.7	50.9	28.1	38.7	24.4	29.5	32.9	53.0	60.8	2.6	44.6	31.5	0.0	56.0	33.0	30.5	21.9	20.8	57.2	25.9	47.7	33.9	37.4	16.7	3.7	35.1	22.8	15.1	28.9	32.5	47.3	45.2	34.5	36.4	31.4	50.3	25.8	34.4	22.4	38.2	37.5	20.8	24.2	44.8	23.5
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566843-13568287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7;testis: 17.3"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 23.2;Late spermatids: 38.1;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.1;U-87 MG: 11.2;WM-115: 8.4"					"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	2.7	0.7	3.6	1.2	11.7	0.1	3.7	0.8	2.9	3.0	1.3	0.9	0.2	0.9	2.3	6.0	1.4	3.9	2.5	4.0	2.8	1.6	4.1	1.7	2.4	1.2	1.7	3.0	2.1	1.2	0.5	1.5	2.8	2.8	2.2	1.0	2.4	2.2	1.0	0.9	2.7	0.9	1.9	1.1	1.1	1.9	17.3	1.5	0.0	8.9	0.3	0.5	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	1.7	0.0	5.9	5.9	0.0	5.2	5.8	2.8	4.8	0.0	0.0	0.0	0.0	2.7	13.1	0.6	0.2	1.0	5.5	0.0	0.5	0.5	0.0	0.0	2.1	0.0	0.9	1.9	3.5	3.8	1.0	0.7	3.6	0.0	0.1	0.0	7.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	3.1	0.0	0.2	5.8	2.0	0.0	0.0	1.6	4.9	4.8	5.7	4.6	0.0	0.0	0.0	11.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	11.7	0.8	2.9	2.8	1.6	1.7	3.0	2.8	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	1.4	1.2	0.0	2.0	0.0	0.0	2.6	23.2	0.5	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.5	0.1	0.0	0.0	1.3	0.0	38.1	4.6	0.0	5.0	0.0	0.0	0.9	0.3	0.0	2.8	2.4	4.3	6.5	4.1	9.9	2.0	0.4	0.0	0.0	0.0	0.1
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219957-123241398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.8"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavorable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	11.9	15.4	13.5	11.4	21.8	13.8	14.5	18.5	15.2	12.0	13.5	11.5	27.0	11.8	9.2	16.1	16.4	9.5	11.2	11.1	11.5	11.8	10.1	19.3	10.2	15.9	11.8	10.6	9.8	12.3	8.5	24.0	15.5	10.9	11.5	15.8	12.5	13.9	23.7	16.9	10.0	12.5	10.8	9.4	15.9	10.4	7.4	14.4	18.8	13.9	9.9	18.3	10.3	10.7	12.7	17.2	24.4	18.9	13.4	18.6	11.0	8.5	7.9	7.4	5.2	7.2	6.7	5.0	8.1	7.9	9.5	9.6	7.2	6.3	5.9	8.9	7.7	7.1	6.6	8.4	4.4	10.8	9.3	12.0	6.9	3.6	10.1	13.1	3.6	5.7	4.9	8.6	8.5	7.1	5.7	8.4	9.3	9.8	4.6	7.8	25.0	10.5	8.2	6.0	20.9	13.8	5.6	3.8	6.7	8.1	7.1	9.7	9.1	8.1	59.8	8.5	7.9	7.3	8.8	4.6	5.4	10.4	5.8	6.6	6.1	6.7	6.3	5.8	8.2	5.8	15.9	16.7	24.4	13.3	18.9	13.9	11.2	14.5	16.8	17.2	12.7	13.9	13.7	9.8	13.4	15.3	14.9	18.6	11.0	13.5	21.8	18.5	15.2	11.5	11.8	11.8	10.6	10.9	14.4	11.9	1.3	15.7	15.3	11.9	7.9	4.8	5.1	14.7	5.7	1.8	9.8	23.3	5.0	14.4	2.3	5.8	16.8	0.0	10.4	25.8	12.4	15.5	21.9	9.8	20.4	128.7	23.7	8.0	17.1	3.0	11.8	16.5	13.5	19.0	12.8	10.2	13.7	14.4	7.1	7.9	7.1	19.4	4.5	13.1	19.3	10.0	33.6	13.8	14.0	34.2
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 63.3;testis: 47.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.6;T-47d: 23.4;U-2197: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	1.5	7.2	8.0	1.0	9.2	1.0	2.2	1.5	6.2	4.1	1.1	6.2	8.2	1.1	3.3	22.1	1.0	63.3	2.7	1.5	9.6	9.3	7.8	1.5	9.8	0.9	4.9	4.9	9.3	4.5	3.3	7.6	1.5	19.9	2.0	1.3	1.7	2.0	5.0	1.4	1.2	1.0	1.3	2.6	1.0	1.8	47.8	2.6	0.1	6.7	0.2	1.2	2.2	0.3	1.7	0.9	0.1	2.6	1.8	4.2	1.1	5.9	10.3	4.5	7.1	2.0	4.3	0.9	4.0	2.9	4.9	3.3	3.9	6.0	1.0	5.4	2.7	2.7	4.1	5.0	2.2	4.2	0.3	4.6	0.0	11.4	11.9	5.6	0.8	2.8	3.0	1.7	2.4	0.8	4.0	2.3	4.8	5.5	0.8	2.3	22.6	3.0	1.0	9.6	9.3	12.1	4.7	2.2	3.7	11.6	4.3	4.4	4.7	5.7	2.4	0.6	2.2	23.4	1.0	1.1	2.8	3.7	24.2	1.5	2.7	6.6	0.9	8.4	0.3	0.8	0.1	2.6	0.0	1.9	1.6	4.2	0.7	1.3	1.4	0.9	1.7	2.4	1.8	0.0	1.8	0.4	0.4	1.6	1.1	8.0	9.2	1.5	6.2	9.6	9.3	4.9	4.9	19.9	2.6	8.9	5.6	0.0	2.5	0.8	4.6	1.4	7.6	473.8	29.6	14.0	13.7	9.7	10.0	23.1	387.4	1.5	0.7	0.0	7.0	1.8	2.7	2.3	1.1	1.6	3.1	3.2	1.2	0.6	1.9	493.5	7.5	1.9	0.0	3.6	1.0	6.5	9.2	1.4	7.1	40.0	15.4	0.0	1.0	87.1	20.2	0.3	3.8	0.0	1.7	1.4
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	16	"Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"OE19: 57.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	8.9	12.3	0.0	2.5	0.2	0.0	0.2	22.9	5.3	10.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	7.7	0.0	9.9	0.0	0.2	16.2	0.0	0.9	0.1	0.0	24.9	0.0	0.0	0.0	0.0	0.2	10.1	0.0	113.3	0.0	5.3	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	69.7	4.7
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397832	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 47.6;fallopian tube: 76.2;testis: 23.7"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.5	1.2	12.7	1.0	20.0	0.8	1.0	1.5	10.8	3.3	1.6	12.2	0.0	2.1	1.3	7.2	1.1	76.2	1.0	4.8	11.2	11.0	1.9	1.0	10.3	0.9	5.3	6.4	6.2	1.5	0.8	3.1	0.9	47.6	1.5	1.3	0.0	2.0	1.1	1.6	1.2	4.3	1.2	2.0	0.9	1.4	23.7	3.0	0.0	1.2	0.1	1.0	0.9	0.0	0.6	0.4	0.1	0.1	0.9	3.6	0.5	0.8	0.0	1.6	0.6	0.3	0.0	1.3	0.6	0.6	0.3	1.4	1.4	0.0	0.3	0.6	0.0	0.7	1.2	0.5	0.2	0.0	2.3	1.3	0.0	1.6	4.1	0.0	0.1	2.0	0.3	0.2	0.4	0.0	0.5	0.6	1.0	0.0	0.6	0.2	0.0	1.3	0.9	0.6	1.2	0.9	0.6	0.1	0.1	0.5	0.1	1.6	0.6	0.0	0.4	0.1	0.1	1.1	0.0	0.0	1.3	1.0	0.5	0.9	2.5	1.4	0.4	1.4	0.2	2.5	0.0	0.0	0.0	1.1	0.1	0.0	0.6	1.3	0.4	0.4	0.0	3.6	1.1	0.1	0.9	0.0	0.0	1.7	0.5	12.7	20.0	1.5	10.8	11.2	11.0	5.3	6.4	47.6	3.0	6.0	13.7	0.0	2.6	1.9	1.0	34.3	2.5	1197.9	128.5	7.0	0.0	0.5	61.3	0.5	656.4	1.0	15.5	0.0	1.3	0.2	0.5	2.8	8.1	2.9	0.4	0.0	11.6	1.8	0.3	2140.7	9.8	2.5	0.0	0.0	9.8	1.2	0.3	6.2	6.7	5.7	0.8	32.3	0.3	10.8	3.8	0.9	0.5	0.0	16.4	1.7
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	14.4	14.6	15.9	18.5	22.9	34.2	13.4	47.2	29.2	17.5	17.3	23.3	22.6	17.6	24.9	17.2	12.4	23.7	16.9	15.4	14.7	13.2	18.2	13.7	19.7	22.4	12.7	17.4	16.6	18.2	24.4	24.9	12.0	17.8	17.6	11.4	19.0	18.6	24.2	10.2	20.7	16.7	18.0	10.9	21.2	18.6	24.4	10.8	22.5	27.0	10.6	19.3	14.1	14.2	4.1	2.7	15.9	3.7	4.8	7.0	2.0	12.5	9.2	12.5	11.0	11.4	13.2	17.7	10.6	9.3	8.6	9.8	11.3	6.2	14.7	5.9	10.6	11.1	12.0	14.9	9.7	7.7	24.5	14.6	12.6	10.4	23.7	5.4	29.0	13.7	11.2	6.3	10.5	7.9	10.3	14.3	13.3	26.1	8.1	4.9	16.2	13.7	31.5	7.8	17.7	6.6	13.4	9.2	18.3	7.8	12.8	16.2	13.9	13.2	9.2	13.4	11.9	8.2	13.1	11.6	19.9	15.6	7.6	7.6	14.2	8.4	8.9	9.3	13.9	8.3	5.9	3.7	12.9	5.5	2.5	6.2	2.5	4.2	7.0	2.3	4.1	5.0	4.6	15.9	4.8	1.7	2.7	3.2	2.0	15.9	22.9	47.2	29.2	14.7	13.2	12.7	17.4	17.8	10.8	20.8	35.7	15.2	7.4	7.3	31.7	10.2	5.1	20.1	6.8	8.7	84.4	11.7	6.6	9.2	12.4	12.9	12.3	0.0	8.3	5.7	12.0	8.0	17.3	8.2	18.8	31.8	14.3	15.4	12.9	11.5	19.8	12.6	10.1	19.8	10.9	13.3	9.9	3.5	18.7	6.2	52.5	19.4	22.6	37.5	30.6	8.3	18.8	34.6	12.1	6.4
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.6"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 24.3;Cone photoreceptor cells: 27.5;Ito cells: 29.4;Melanocytes: 27.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.9;U-266/70: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	12.0	2.9	22.3	1.6	31.5	1.8	40.6	8.6	23.4	4.7	4.1	3.0	0.0	6.0	7.7	2.7	5.6	9.2	4.2	3.2	13.9	11.9	10.8	8.0	17.0	2.0	17.2	12.9	3.3	2.0	31.3	2.6	8.4	13.6	2.8	4.2	17.1	17.0	3.9	1.1	13.5	5.1	5.7	3.8	2.6	11.6	2.8	9.2	0.3	12.2	0.2	1.8	5.4	7.1	0.3	0.5	0.0	0.2	4.2	0.4	0.0	3.5	4.0	3.3	0.2	2.0	0.1	5.8	0.8	4.9	1.2	0.7	2.6	6.4	0.2	3.8	4.1	12.1	3.2	2.5	0.6	0.9	0.1	5.5	0.2	11.0	10.2	1.8	0.6	0.2	1.2	0.6	1.5	1.7	7.7	13.3	0.6	0.1	4.6	3.3	8.3	0.0	2.4	2.1	17.8	13.2	0.8	12.0	13.7	6.0	8.7	3.2	2.3	7.3	9.2	42.9	2.5	14.8	2.0	22.1	13.8	0.1	0.4	1.0	62.0	23.5	7.5	0.0	5.3	4.6	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.0	0.4	0.0	4.2	0.2	0.5	0.1	0.0	22.3	31.5	8.6	23.4	13.9	11.9	17.2	12.9	13.6	9.2	20.8	24.3	3.9	1.7	4.5	1.6	1.4	10.2	2.7	3.4	3.5	27.5	0.7	1.7	1.0	1.4	1.5	4.6	0.0	2.0	0.9	2.7	0.6	0.0	7.8	12.8	0.0	3.4	29.4	3.1	2.8	0.0	3.5	27.0	0.0	3.9	0.7	1.5	4.8	5.6	14.6	17.4	0.0	1.6	0.0	2.5	5.8	0.2	0.0	2.0	1.6
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138956-24161603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 91.1"	"Group enriched"	"Detected in some"	47	"Early spermatids: 2235.7;Late spermatids: 2707.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	5	"B-cells: 7.1;granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040703: AB_2677087, HPA047801: AB_2680159"	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	0.8	1.2	3.9	0.7	3.2	0.7	2.3	0.7	4.8	3.0	0.7	3.5	0.0	0.7	1.5	1.2	1.0	1.8	1.0	0.5	3.6	2.1	0.6	0.5	0.6	0.8	3.1	3.0	0.9	0.7	0.4	9.5	0.7	5.4	1.0	0.8	0.6	0.9	1.0	0.6	1.1	0.7	1.7	2.3	0.7	0.8	91.1	2.9	0.0	0.7	0.0	0.7	1.5	0.6	7.1	0.7	6.3	0.5	1.3	1.0	0.4	3.4	9.1	2.5	1.3	2.9	7.1	10.9	6.1	3.9	7.5	8.2	1.8	6.8	0.1	5.0	9.1	0.3	3.3	2.6	5.3	8.1	0.4	4.1	0.2	4.9	2.0	4.0	0.3	0.4	8.6	8.5	9.8	2.6	3.7	2.2	0.4	0.0	0.2	2.0	1.0	0.1	0.3	8.1	0.4	5.3	0.5	0.3	0.1	3.3	4.2	5.3	6.6	18.6	3.8	0.3	1.6	8.6	0.9	1.2	0.6	1.8	2.5	0.1	0.2	0.2	0.0	3.6	0.7	0.3	6.3	0.5	1.0	0.4	0.3	0.2	6.6	0.5	0.5	0.2	7.1	0.4	1.0	2.9	1.3	0.5	0.7	0.2	0.4	3.9	3.2	0.7	4.8	3.6	2.1	3.1	3.0	5.4	2.9	0.0	0.0	0.0	0.8	0.2	1.9	0.3	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.6	2235.7	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	2707.1	21.6	0.0	1.7	0.0	0.0	0.0	0.2	0.2	20.5	0.0	1.8	19.4	0.4	52.7	14.1	0.0	0.0	0.0	0.0	0.1
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"		1	64470792-64693058	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 37.5;Club cells: 18.2"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	11	"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	5.4	7.6	6.5	0.5	8.4	0.0	4.7	1.2	4.3	7.3	0.8			0.2	6.1	5.2	1.6	8.5	2.1	1.2	3.5	4.2	3.3	0.4	4.7	0.4	2.3		14.2	3.7	5.5	4.5	5.5		4.0	1.0		4.4	4.3	0.8	3.0	0.9	5.3	0.6	1.7	3.3	0.5			2.4		0.2	2.1	4.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.8	21.4	3.1	8.5	3.0	0.0	3.0	3.9	5.1	4.9	12.4	0.1	0.0	8.8	4.8	3.7	1.5	11.9	2.5	5.2	2.3	6.4	4.4	1.3	0.0	0.0	1.9	0.0	2.6	1.7	0.6	3.2	2.9	2.7	3.0	0.0	0.0	0.0	0.3	0.3	0.0	29.3	0.1	2.2	2.3	2.1	0.0	0.0	0.6	0.5	11.2	6.5	0.0	2.6	19.1	0.8	0.2	1.9	0.5	3.8	15.0	2.6	0.0	0.0	0.0	0.4	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0											6.0	37.5	0.0	6.1	15.3	12.7	1.4	0.0	13.4	18.2	3.5	0.0	0.0	0.0	2.0	7.7	11.8	0.0	0.0	2.5	0.1	4.1	1.2	2.3	0.9	0.2	0.0	0.0	3.1	0.3	2.3	13.3	1.8	1.7	0.0	0.0	5.2	1.3	0.0	2.8	3.1	1.1	6.5	5.7	0.4	0.4	12.9	0.0	0.0	0.1	4.8
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6"	"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.9	1.9	15.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	28.9	0.0	0.0	5.9	9.6	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	8.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1	0.0	0.0	0.0	0.0	1.3	16.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	1.2	0.0	0.0	0.0	0.0	0.2	3.3	4.6	8.1	0.1	0.0	10.4	0.6	0.0	13.2	7.8	0.0	0.0	0.0	0.3	0.8	0.7	0.0	24.4	0.8	1.0	25.8	16.5	1.8	4.5	3.0	0.0	0.0	0.0	0.5
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.3	21.0	30.9	13.2	10.3	11.6	19.9	23.3	13.8	30.2	22.1	21.6	19.0	32.0	24.3	16.5	21.7	16.6	38.5	17.0	31.3	16.9	23.5	24.0	20.7	23.1	7.8	32.2	15.1	7.8	10.5	24.8	15.0	15.6	21.2	28.8	48.0	18.0	21.7	11.3	49.5	29.5	29.4	45.8	9.8	22.4	22.0	36.9	21.5	24.3	21.3	20.5	15.8	27.7	24.0	43.6	21.5	28.2	10.9	17.2	18.4	24.0	37.3	17.4	50.0	71.0	14.4	28.3	19.9	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5	80.4	34.1	105.0	107.7	103.9	56.2	89.6	38.2	80.3	52.4	33.2	58.9	184.6	129.3	83.6	75.6	64.3	63.7	23.3	82.6	245.4	120.8	92.6	91.1	35.8	172.4	28.6	114.6	40.5	47.3	21.9	79.7	120.6	102.9	341.8	42.9	55.2	88.9	53.2	69.3	119.5	79.1	32.3	106.6	100.9	149.2	74.9	120.0	115.4	82.3	81.3
CADM4	"IGSF4C, Necl-4, SynCAM4, TSLL2"	ENSG00000105767	"Cell adhesion molecule 4"	Q8NFZ8	19	43622368-43639839	"Predicted membrane proteins"	"Cell adhesion"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.9"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 19.9;Proximal tubular cells: 22.7"	"Cancer enhanced"	"Detected in all"		"glioma: 108.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.7"	"Cell line enriched"	"Detected in many"	5	"WM-115: 112.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012612	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		5900000	"Nuclear membrane"	Nucleoplasm	"HPA012612: AB_1851530"	"unprognostic (8.80e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.81e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.39e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.93e-2)"	3.0	12.6	29.7	3.4	31.0	0.9	6.6	22.2	68.9	4.6	5.3	32.8	2.5	3.0	10.4	6.7	10.8	3.0	3.7	5.5	31.2	26.5	13.2	3.4	3.1	1.8	37.2	20.4	5.2	10.9	26.1	7.5	1.1	29.1	13.7	2.8	4.9	13.3	10.8	5.0	10.8	3.0	6.8	47.8	1.9	4.0	1.9	26.4	0.0	3.3	1.7	3.4	2.9	2.9	0.1	4.7	0.6	0.3	0.0	0.0	0.0	8.8	2.5	13.7	17.9	0.0	0.3	0.7	0.4	0.7	1.2	1.9	3.8	1.5	0.0	3.3	0.1	0.7	2.1	3.0	1.8	1.5	0.1	2.4	0.0	0.6	5.6	1.6	0.0	1.4	0.5	4.0	6.6	0.2	6.5	0.8	0.8	0.9	0.1	0.1	1.3	1.3	0.1	1.5	1.8	0.9	7.1	0.1	0.8	1.8	1.8	1.6	8.8	0.9	2.7	3.5	2.1	2.0	0.4	0.3	0.1	21.2	0.1	0.8	1.3	0.8	0.0	1.0	0.1	112.4	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	4.7	0.0	0.0	29.7	31.0	22.2	34.0	31.2	26.5	37.2	20.4	29.1	26.4	0.0	1.7	0.0	17.0	4.4	16.4	2.8	5.1	1.4	1.2	7.0	2.0	0.2	5.0	10.4	17.6	1.9	0.0	0.0	2.7	0.1	1.1	19.9	0.0	2.6	0.4	19.1	0.0	4.3	0.0	14.7	0.3	0.0	13.5	0.0	0.3	15.4	4.2	0.0	1.4	22.7	3.7	0.0	4.7	0.5	0.8	7.4	0.0	0.5	1.0	12.8
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318425-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 105.4"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 325.7"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	5.1	11.2	5.1	1.9	7.1	0.0	9.5	105.4	21.1	16.5	5.3	1.4	13.3	6.1	16.3	16.4	5.7	5.7	8.0	4.6	6.8	8.8	20.3	6.2	9.0	1.3	14.0	9.3	5.2	13.2	15.4	17.7	2.7	7.0	10.4	5.4	4.7	23.0	11.5	2.6	2.4	4.7	11.2	4.1	3.3	9.8	1.9	1.4	0.4	9.4	2.4	1.6	4.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.4	2.5	0.1	0.2	6.3	1.4	6.4	0.0	5.9	0.0	0.0	2.9	0.2	0.0	0.2	0.8	0.6	0.0	5.2	2.0	0.0	11.4	8.2	0.0	0.1	2.6	1.1	1.0	0.8	5.7	20.3	0.0	0.0	26.5	0.1	13.9	0.0	0.0	5.9	29.0	10.0	0.0	0.0	10.5	0.3	6.6	10.3	0.0	0.2	11.5	0.5	1.6	4.4	0.0	5.8	2.2	1.5	0.0	4.1	7.9	0.3	0.0	8.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	105.4	21.1	6.8	8.8	14.0	9.3	7.0	1.4	8.9	31.6	0.0	7.7	1.9	0.0	10.1	5.1	8.1	17.0	38.4	0.0	0.2	14.9	4.7	5.5	19.6	4.5	0.0	9.4	0.3	3.8	16.7	1.1	10.2	0.3	3.2	4.6	16.0	2.7	5.3	8.9	1.1	3.3	0.0	11.6	28.4	6.6	2.9	9.6	6.9	1.3	0.0	5.1	0.5	2.5	1.3	0.2	0.0	7.6	7.4
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.7;U-266/70: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.6	3.0	0.2	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.6	2.0	1.4	0.3	0.2	1.5	1.4	3.6	0.5	0.5	47.7	1.8	5.7	8.5	0.2	0.5	0.1	5.2	0.1	2.3	1.2	0.1	6.4	0.3	3.1	0.1	0.2	0.7	3.0	11.1	2.3	2.0	0.0	1.2	8.5	1.6	2.6	0.1	2.8	4.6	2.1	5.7	2.1	0.0	0.4	1.5	1.4	0.1	2.5	3.7	7.9	1.7	22.0	6.9	4.8	3.7	3.7	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8	3.0	28.0	44.7	7.2	20.4	148.3	10.3	15.3	20.1	29.6	1.8	369.1	0.2	0.0	7.8	7.2	8.3	8.8	0.0	19.1	0.7	22.0	3.5	22.0	11.0	15.1	42.9	15.4	11.1	39.3	7.4	21.9	37.1	3.3	24.4	26.1	18.0	9.6	35.1	57.3	0.5	206.3	25.8	9.2	3.9	9.6	36.0	0.2	10.2	29.3	16.3
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.3	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0.0	0.3	0.0	3.3	0.4	6.0	0.1	0.1	8.1	0.2	3.7	19.0	5.5	1.6	0.6	2.2	20.0	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0.0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5	0.0	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	58.8	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	4.8	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell type enhanced"	"Detected in many"	27	"Bipolar cells: 47.8;Early spermatids: 236.0;Late spermatids: 80.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.4;JURKAT: 27.3;MOLT-4: 12.0;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	0.9	0.3	1.1	0.0	0.3	3.0	3.6	3.6	0.0	0.0	0.0	1.9	0.1	2.4	0.1	3.0	0.3	2.6	39.4	2.4	0.5	1.3	0.0	0.1	0.2	0.1	0.1	0.0	7.6	0.8	2.2	0.6	27.3	0.0	1.4	0.2	0.0	12.0	0.0	1.8	0.0	0.1	1.8	2.3	0.1	1.3	0.0	8.6	15.4	0.5	0.0	2.6	0.1	0.0	0.2	0.0	7.5	4.4	0.0	6.6	1.2	0.1	0.0	3.6	0.0	2.8	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6	0.0	0.6	4.2	0.2	1.0	47.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	236.0	0.7	0.0	0.0	0.0	0.1	1.6	0.4	4.6	0.2	0.2	0.0	0.0	0.6	1.0	80.4	3.7	1.1	0.0	0.0	0.1	2.1	0.8	0.0	1.4	0.0	4.1	0.0	4.5	3.2	6.1	0.9	0.0	29.9	0.0	0.3
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.7	0.1	25.2	0.0	0.1	0.8	0.0	4.8	0.0	0.0	8.6	5.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0	0.0	0.0	0.0	0.0	0.2	2.3	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.2	1.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.1	0.0
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.4	1.4	0.2	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	20.1	4.5	2.3	3.6	0.0	0.9	7.5	3.3	2.2	0.0	1.5	7.7	0.0	0.3	11.4	0.0	0.0	3.5	0.0	4.3	0.0	0.3	0.3	0.0	3.4	0.7	0.0	0.0	9.6	0.1	0.1	5.2	6.2	3.7	0.5	0.0	2.8	1.5	4.5	6.5	6.9	1.0	9.8	0.0	1.3	8.2	1.3	0.0	0.0	1.6	0.0	0.3	4.0	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1	8.9	19.2	0.0	2.4	8.8	22.3	0.8	17.8	0.0	4.5	8.7	0.0	0.4	3.3	5.2	4.4	0.6	31.9	0.0	10.2	0.6	0.3	9.0	5.7	20.3	0.2	9.5	12.6	0.6	1.3	2.7	1.4	0.4	0.0	0.0	18.0	1.3	11.5	21.0	0.0	11.3	12.8	0.0	0.7	0.5	1.7	16.6	0.5	0.9	14.0	4.3
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.2	7.9	7.8	6.0	3.0	2.5	13.6	6.7	2.8	4.5	4.3	5.8	12.5	4.0	2.3	2.3	6.3	8.9	2.0	4.5	2.3	15.1	13.8	7.3	13.1	10.1	4.9	4.7	10.3	2.2	3.1	4.7	1.9	4.6	3.3	11.5	8.1	5.0	1.8	4.6	10.5	18.0	11.7	6.3	5.5	10.0	5.5	8.4	7.0	6.2	19.7	15.4	4.3	6.1	8.5	2.7	3.1	5.8	5.8	7.7	6.6	6.2	8.0	12.3	2.8	7.1	7.3	8.6	7.2	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7	3.0	5.9	3.7	6.1	4.0	12.5	8.1	12.7	4.0	3.4	8.7	13.7	4.1	6.6	11.8	1.3	5.5	7.8	0.0	7.9	4.3	3.7	7.6	23.0	3.0	5.9	46.1	10.9	4.9	3.2	2.0	8.3	7.0	1.7	9.0	4.9	11.6	11.2	3.5	8.9	5.1	16.7	0.0	6.2	12.1	8.0	4.5	4.6	5.0	6.0	6.0
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	0.3	1.3	0.0	0.8	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.6	0.8	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.4	0.1	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.7	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1	11.9	27.1	15.9	8.0	8.4	1.2	0.6	50.9	5.3	5.7	5.2	0.0	1.5	0.0	9.1	0.4	1.8	4.2	0.0	6.3	8.2	1.1	2.3	4.7	12.7	0.9	0.0	3.5	1.3	1.0	0.2	0.6	2.0	3.3	0.0	18.8	1.7	4.0	3.5	0.4	16.5	0.6	0.0	1.7	0.3	2.4	8.3	2.4	25.4	16.4	4.3
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"OE19: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.3	5.5	3.7	3.6	13.9	13.4	0.3	5.5	9.6	5.7	4.2	3.2	1.6	0.2	4.0	9.6	6.5	0.2	1.5	0.4	2.4	0.3	0.3	1.1	0.1	0.3	3.5	0.1	0.3	6.6	0.6	9.2	2.2	8.0	6.6	2.6	0.1	0.1	10.6	7.7	0.9	0.1	3.1	44.2	4.3	0.8	12.5	0.2	1.9	6.9	0.2	6.7	1.3	1.0	2.5	2.4	0.8	0.0	13.7	11.1	6.6	15.3	0.7	0.4	0.7	0.0	5.7	0.1	2.6	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3	0.0	0.3	0.8	0.2	1.4	1.5	1.7	28.1	4.0	7.9	22.7	0.0	0.0	1.7	9.0	0.9	2.1	114.7	0.0	29.7	0.4	6.2	2.3	0.0	37.5	0.8	1.6	21.5	2.5	1.8	1.1	11.5	1.2	6.8	0.0	72.0	6.4	15.2	69.1	4.2	5.9	1.8	0.0	2.2	0.4	2.3	0.6	0.0	0.0	49.0	1.4
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139575-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		50000000	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	67.8	59.4	58.7	49.6	53.1	47.1	54.4	29.9	92.0	74.8	87.8	50.8	45.3	61.3	50.1	48.8	111.9	74.9	70.6	137.2	55.7	61.0	104.0	67.5	70.7	74.0	56.6	52.0	63.0	45.1	72.3	48.6	48.1	71.5	59.8	69.6	62.8	61.4	71.8	95.7	30.9	95.6	69.2	47.4	63.6	50.4	49.2	27.8	45.4	71.4	65.9	87.3	56.7	57.9	13.4	25.7	11.3	33.2	9.6	20.3	8.1	40.6	102.1	25.6	36.5	61.8	75.7	5.2	33.3	71.2	68.0	52.8	23.1	60.5	14.6	49.4	110.9	24.2	21.7	30.6	81.6	57.8	61.6	15.0	17.0	30.8	38.9	71.8	16.8	43.0	81.0	50.9	43.9	62.5	83.0	73.8	18.0	20.5	59.0	103.3	53.5	30.1	30.6	14.7	78.2	51.8	15.9	20.7	27.1	127.6	41.0	17.3	21.8	40.1	57.0	15.8	33.7	33.2	27.7	47.7	60.4	45.9	20.1	33.4	21.1	28.0	13.1	68.5	23.1	51.6	8.8	22.5	9.3	20.3	31.4	13.0	12.9	14.3	16.2	19.8	13.4	8.8	11.8	11.3	9.6	33.2	25.7	14.0	8.1	58.7	53.1	29.9	92.0	55.7	61.0	56.6	52.0	71.5	27.8	116.1	91.8	59.6	67.7	27.2	19.1	134.0	140.1	65.6	69.4	155.3	0.0	63.2	53.0	186.3	77.2	116.2	213.8	23.3	219.3	74.8	68.1	79.4	62.3	66.0	137.4	15.9	103.5	152.2	233.3	179.9	86.3	85.5	37.1	193.8	203.5	55.8	195.6	175.4	71.5	84.9	23.3	45.3	70.7	91.6	5.5	25.2	58.6	61.8	108.1	99.3
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No			"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.5	6.4	0.0	0.0	2.2	0.0	0.9	0.1	0.0	0.1	0.0	4.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.0	1.3	2.2	0.0	0.5	0.0	0.0	19.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	455.0	51.2	1.8	0.0	0.0	1.7	0.0	136.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	117.8	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	19.6	28.1	11.9	24.8	13.0	25.6	37.1	18.2	14.5	21.8	20.2	17.6	21.2	17.8	18.5	23.0	20.2	16.8	26.9	26.0	9.9	10.3	17.0	21.4	19.9	26.7	11.3	14.1	17.6	31.7	11.5	19.7	12.5	11.7	17.5	15.0	16.6	19.0	21.3	39.7	16.1	20.1	22.1	11.7	19.7	17.9	11.2	11.4	21.8	19.2	18.5	21.9	16.9	16.7	3.4	4.0	3.1	6.8	0.6	2.2	1.7	35.4	11.8	6.8	16.5	18.1	17.0	9.2	15.8	14.5	16.0	19.7	16.6	16.0	16.6	22.2	17.2	24.4	18.9	11.6	19.8	13.1	15.1	19.3	10.3	25.0	18.9	18.5	25.2	12.6	21.2	15.8	13.9	16.8	11.4	11.4	12.6	7.1	5.2	22.5	8.2	11.2	8.2	5.7	27.2	11.7	16.6	5.0	6.8	17.1	10.4	12.1	9.2	12.7	19.7	18.2	7.6	9.5	28.1	10.2	13.4	5.0	16.9	15.8	9.4	10.7	9.6	65.5	15.1	13.2	0.0	4.7	0.7	2.0	5.1	2.2	3.4	0.6	0.8	4.0	1.4	2.0	1.0	3.1	0.6	6.8	3.4	0.7	1.7	11.9	13.0	18.2	14.5	9.9	10.3	11.3	14.1	11.7	11.4	8.9	15.7	17.6	19.1	11.4	22.3	34.3	12.7	2.7	7.9	26.2	23.6	21.5	43.1	14.9	53.5	10.8	19.0	0.0	4.1	25.5	14.3	16.8	16.1	23.1	25.1	22.3	18.0	9.8	26.7	173.5	19.0	29.2	11.8	13.6	17.0	23.0	12.9	7.0	17.0	29.6	24.7	6.5	18.6	7.2	4.7	11.8	14.1	12.9	22.3	18.2
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.9	14.0	13.4	8.0	9.1	7.4	4.3	9.6	8.0	5.6	5.2	30.1	17.9	0.1	4.9	11.9	10.2	22.0	14.7	9.8	9.4	9.7	8.2	0.0	12.6	10.6	9.4	1.7	1.5	8.4	26.9	10.7	13.7	11.3	4.6	6.4	0.8	8.5	12.2	12.8	3.1	0.7	12.3	15.8	9.1	5.1	33.0	5.2	12.7	23.8	12.3	6.5	18.0	7.2	5.5	22.6	7.7	0.3	5.3	10.5	10.7	9.0	5.3	3.3	2.1	3.7	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3	11.9	14.8	0.9	33.3	29.0	40.5	6.5	10.2	20.1	14.8	7.0	21.6	1.6	43.1	13.2	0.8	10.8	22.7	0.0	12.7	0.7	17.5	19.6	0.0	13.0	16.2	47.7	13.3	4.9	3.5	0.2	9.2	6.8	10.1	0.0	30.6	11.9	17.9	28.1	8.9	17.0	26.0	19.4	14.4	1.6	1.9	28.4	1.4	12.5	36.5	26.9
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196525	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 30.4"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 19.0;Cone photoreceptor cells: 7.9;Horizontal cells: 39.7;Muller glia cells: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;HDLM-2: 17.0;HEK 293: 3.8;SCLC-21H: 7.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	1.1	1.8	17.7	1.2	18.1	1.1	1.4	15.0	30.4	1.5	1.2	2.3	0.0	1.2	1.5	1.3	1.2	1.4	1.2	2.5	16.4	12.8	1.3	1.1	1.1	1.1	12.4	11.7	1.2	1.5	1.9	1.4	1.2	11.1	1.8	1.2	1.8	2.5	1.4	1.3	2.2	1.3	1.2	2.8	1.1	1.3	1.8	4.0	0.0	1.6	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	4.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.0	0.0	1.2	0.3	0.0	17.0	3.8	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	1.1	0.1	0.0	1.3	0.0	1.0	0.8	0.0	0.0	0.9	0.0	0.4	0.2	0.0	7.8	3.8	0.1	0.2	0.2	0.2	1.0	0.5	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	18.1	15.0	21.7	16.4	12.8	12.4	11.7	11.1	4.0	0.0	0.0	0.0	0.2	0.3	19.0	2.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	39.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.6	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	0.0
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4"	"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.3	0.3	1.9	38.4	4.8	13.5	0.0	0.2	6.2	0.8	2.2	8.9	2.7	0.0	18.2	1.1	4.0	0.0	0.3	0.2	0.4	20.6	7.2	0.0	7.3	12.9	3.9	10.6	12.6	2.1	0.1	0.0	0.0	1.1	0.0	0.2	10.1	0.0	0.0	0.1	6.0	0.1	4.9	0.1	3.0	0.1	0.1	5.7	0.4	8.4	0.0	0.4	16.7	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.8	45.4	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0	17.9	35.4	32.0	33.0	23.1	0.0	2.6	12.7	12.0	11.4	10.4	0.0	1.3	1.7	15.7	0.0	24.1	33.9	0.0	11.7	1.0	13.1	5.7	15.1	1.7	83.5	0.0	5.8	17.8	119.3	0.2	3.1	125.6	5.0	34.3	32.1	0.0	4.7	49.2	3.2	1.0	0.1	0.0	5.4	0.0	0.0	19.4	0.9	48.4	29.9	41.4
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		310000	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.3	4.7	18.7	8.9	11.6	15.5	10.8	25.3	19.2	17.8	10.3	8.5	7.1	11.7	4.0	12.3	8.4	7.2	14.8	9.0	20.3	30.0	8.1	18.7	3.7	19.7	13.9	15.2	17.8	21.1	11.0	11.3	9.1	12.8	22.0	12.1	15.4	74.2	18.3	3.6	24.0	14.2	18.5	9.3	5.9	17.4	8.8	11.3	15.3	13.8	10.7	11.7	10.9	10.0	14.2	19.4	5.4	9.9	14.9	8.1	7.5	6.0	11.7	34.5	32.3	8.0	9.9	10.6	11.5	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9	17.9	12.0	18.6	18.8	43.3	17.6	14.1	5.1	25.4	20.5	12.2	0.0	41.4	11.6	16.0	7.6	23.3	28.6	0.0	20.9	27.1	16.9	14.4	17.3	12.9	20.5	12.7	17.3	20.9	25.1	3.2	6.9	17.5	28.7	55.9	34.1	13.8	20.4	19.9	7.1	6.5	10.2	12.9	14.4	7.5	14.2	25.0	43.0	36.2	21.5	31.5
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.6	4.1	8.5	7.7	6.2	6.1	12.6	7.1	4.9	6.4	6.9	6.8	26.1	1.3	8.3	7.3	8.9	5.9	10.1	11.2	5.1	20.1	6.6	11.1	3.7	6.0	5.0	11.1	7.9	6.7	8.4	6.1	1.5	8.6	12.1	15.1	14.4	39.6	10.3	7.1	28.7	7.0	6.5	8.7	7.5	10.0	5.4	6.9	21.0	12.0	9.0	6.7	7.5	13.6	4.2	10.7	5.8	4.1	10.2	7.1	7.5	3.4	8.0	5.8	10.5	1.4	9.2	13.4	3.6	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3	14.9	13.4	8.5	9.5	9.6	5.2	3.3	30.6	25.4	20.5	19.2	5.9	16.7	8.3	35.9	2.0	9.2	52.0	0.0	40.5	34.0	12.1	6.6	9.3	17.8	17.1	0.0	56.7	6.2	8.6	1.6	11.8	8.5	1.7	25.2	48.2	12.8	42.5	56.1	9.2	26.3	1.3	6.5	6.9	1.7	8.3	10.2	4.8	12.8	64.3	7.8
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.5	12.4	3.6	10.1	10.1	14.8	5.6	6.4	6.3	7.6	12.6	16.6	25.4	1.6	14.1	4.9	13.7	7.4	7.9	7.6	15.1	9.4	7.2	14.2	10.1	15.8	8.2	11.0	15.4	12.8	18.8	14.4	11.3	6.4	7.2	12.3	12.7	31.6	6.9	6.0	14.3	11.6	5.9	8.0	11.1	10.8	7.5	25.9	14.3	16.2	1.1	0.5	8.3	13.8	8.2	3.5	3.6	8.6	9.0	8.2	8.6	4.3	5.0	28.7	12.8	9.9	12.3	14.8	7.7	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7	23.8	26.1	34.1	10.1	6.6	1.5	1.6	7.6	16.0	18.2	5.2	9.8	7.5	13.3	9.0	5.6	7.1	19.8	0.0	7.3	10.3	3.8	8.1	23.2	10.4	11.2	0.0	4.1	5.5	25.6	0.7	2.3	21.7	6.8	19.8	13.0	0.1	9.6	12.7	0.7	20.0	0.4	0.0	1.4	0.7	0.4	6.8	2.9	55.4	12.1	12.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 573.3;Rod photoreceptor cells: 490.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 9.7;HDLM-2: 10.5;SCLC-21H: 16.3;SK-BR-3: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	3.4	0.9	0.3	2.5	1.5	2.8	6.0	0.3	0.7	6.1	20.7	0.5	14.7	8.8	11.0	2.4	9.9	3.4	13.8	9.9	0.2	0.2	4.5	1.4	7.4	0.8	0.8	0.3	1.7	4.4	0.0	4.0	1.2	0.9	12.1	2.4	19.8	17.0	17.4	29.9	25.3	27.1	8.0	0.2	1.2	9.2	1.0	0.8	0.2	1.9	14.4	6.2	7.2	7.2	0.5	3.5	1.9	2.2	1.6	1.6	0.4	9.7	0.8	1.8	1.7	0.0	0.0	0.4	0.3	0.1	0.3	0.4	2.1	2.2	0.4	2.0	0.4	0.8	8.4	1.9	1.9	0.1	10.5	3.3	0.7	1.6	2.2	0.3	1.1	3.1	0.1	7.2	0.1	0.6	0.0	0.3	1.5	0.0	0.0	0.0	5.2	0.6	7.0	0.2	5.1	0.5	0.8	1.2	0.1	1.6	4.0	16.3	1.5	2.5	15.4	0.2	0.7	8.2	1.0	0.1	0.0	1.4	0.8	0.2	0.0	0.0	1.0	0.0	3.0	0.1	1.9	0.2	1.2	1.6	0.4	0.7	0.4	0.6	1.1	0.6	0.5	0.0	0.5	0.4	1.6	2.2	3.5	0.3	0.4	0.3	1.5	0.3	0.7	0.2	0.2	0.8	0.3	0.9	0.8	26.8	20.0	0.0	17.1	29.3	11.2	21.0	10.2	14.7	7.9	14.0	573.3	0.5	3.3	12.2	0.4	11.7	41.1	0.0	7.7	0.8	2.6	37.9	4.6	4.0	1.0	130.3	39.6	6.7	0.3	0.9	0.0	1.8	1.7	10.8	33.5	24.9	13.7	29.1	6.3	1.0	490.7	0.0	7.1	1.7	2.3	53.4	0.6	3.2	22.9	24.5
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor beta subunit"	Q13951	16	67029116-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 101.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	15.9	10.9	15.9	26.4	25.1	20.5	15.0	9.5	14.3	15.4	10.6	23.3	11.8	8.8	15.3	10.2	20.5	14.3	16.3	21.5	16.2	13.2	12.1	14.4	16.1	32.6	23.6	12.4	17.3	13.6	40.4	18.8	13.2	17.5	14.6	11.1	13.7	19.6	10.3	33.3	14.8	12.2	11.7	22.4	18.2	17.1	7.3	24.2	42.2	17.0	14.8	31.0	15.9	18.8	6.5	9.1	20.5	9.2	14.8	7.0	5.1	15.6	10.5	9.2	14.9	6.7	8.6	14.7	18.2	10.9	17.2	15.2	21.0	18.0	34.7	17.4	15.5	7.2	15.6	16.4	10.2	23.2	11.9	9.4	24.1	9.0	16.7	9.6	31.4	51.9	8.7	7.0	19.2	14.8	9.1	13.9	17.2	25.6	12.4	17.8	11.9	32.3	16.8	9.0	8.3	14.8	65.6	39.7	29.5	12.1	14.0	13.5	12.1	46.7	7.1	18.6	11.3	6.4	22.6	19.3	26.7	18.3	15.1	24.4	17.0	30.2	101.5	20.3	21.6	24.0	20.5	7.4	7.4	6.7	9.2	7.0	6.5	6.6	7.0	9.1	6.4	6.3	5.3	4.6	14.8	6.1	3.3	7.0	5.1	15.9	25.1	9.5	14.3	16.2	13.2	23.6	12.4	17.5	24.2	8.9	19.8	29.2	37.0	49.9	4.5	15.4	15.3	13.4	17.0	38.4	11.8	12.1	23.2	14.4	4.4	17.4	7.3	0.0	24.0	26.0	32.1	38.3	26.6	14.0	33.8	9.5	18.2	27.0	43.0	5.7	22.2	46.5	49.0	10.8	12.4	12.3	47.8	5.8	19.8	9.8	14.2	12.9	24.7	13.4	16.3	55.2	14.2	54.9	11.5	52.5
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.3	7.7	3.8	8.9	9.0	5.0	5.8	2.9	1.7	2.7	2.9	2.0	3.6	4.0	3.0	2.7	2.9	1.0	1.0	2.1	2.8	2.9	2.0	12.0	1.9	13.1	1.4	1.5	8.6	3.1	4.5	12.3	6.4	5.6	3.7	2.1	11.7	3.6	2.1	2.0	0.9	2.7	2.0	3.3	4.2	2.3	0.6	4.1	7.4	6.0	6.5	6.8	0.8	8.9	5.6	1.7	2.9	3.1	23.9	2.0	3.2	1.4	6.6	0.6	5.7	6.4	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2	14.9	6.7	21.6	6.8	9.6	44.8	39.9	0.0	10.7	6.8	12.2	25.5	8.9	5.0	6.0	27.4	22.6	8.7	0.0	6.9	53.5	21.6	9.6	8.1	6.7	12.2	3.2	12.1	39.3	11.3	9.0	6.9	10.4	15.1	5.4	16.2	7.4	11.7	7.0	10.3	3.1	27.4	6.5	19.9	9.8	15.8	6.0	38.0	52.3	10.7	3.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA			Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.9	26.3	0.0	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1	0.0	1.6	0.0	28.6	13.4	0.0	0.2	5.1	5.3	11.4	7.0	0.0	4.6	1.7	37.5	0.0	0.1	105.9	0.0	42.7	1.3	0.4	14.4	0.0	8.5	0.3	0.0	16.7	0.0	0.0	0.0	0.0	0.9	0.0	1.0	35.8	0.0	67.6	84.2	0.0	9.9	0.0	0.0	0.4	0.0	1.7	22.5	2.1	0.7	54.6	56.4
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 641.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.3	39.1	4.8	12.3	25.1	25.4	0.2	28.5	20.5	15.6	18.7	14.4	14.9	6.4	18.8	26.5	30.1	18.7	9.8	27.9	12.0	31.5	23.1	19.1	22.8	9.8	14.4	10.6	17.6	12.4	35.2	15.1	6.6	17.9	16.6	0.0	0.0	4.7	14.3	25.1	5.3	11.1	0.0	0.0	28.6	0.0	0.1	17.7	41.4	12.7	14.0	12.5	27.5	40.0	32.4	3.9	18.9	14.8	16.7	17.5	7.4	44.3	20.6	32.0	57.9	0.1	32.1	10.6	25.3	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9	113.2	54.7	13.0	59.4	113.9	11.9	19.9	81.5	111.1	96.7	90.7	2.0	102.1	641.6	73.2	5.9	17.8	131.2	46.7	60.9	77.8	54.3	48.6	34.6	203.8	78.0	3.2	37.1	54.6	65.5	2.9	113.6	47.2	86.0	102.8	58.6	65.5	81.3	71.8	124.5	200.8	7.4	25.8	60.8	4.2	11.3	108.0	74.6	30.9	77.6	42.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.2	3.5	1.5	3.1	12.0	18.6	2.4	13.4	15.9	15.4	12.3	0.1	2.6	0.0	3.9	13.7	5.4	5.7	2.0	2.7	6.2	16.7	6.4	0.5	3.7	0.1	1.0	0.0	0.0	2.6	0.3	10.7	1.4	7.4	9.3	1.4	0.0	0.1	4.5	9.2	1.1	5.4	1.2	3.8	15.5	2.6	2.9	23.9	5.1	5.2	0.8	1.1	10.2	12.5	19.5	0.8	3.7	1.4	6.4	10.0	0.8	11.2	12.9	0.6	0.2	0.0	10.4	0.3	17.9	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7	0.0	2.7	0.0	23.4	63.1	0.2	0.2	5.1	5.3	11.4	0.0	0.0	0.9	8.3	3.3	0.5	11.3	1.1	0.0	0.6	0.2	7.7	36.1	5.7	0.0	7.4	0.0	0.0	8.6	3.7	1.1	62.7	5.6	62.4	36.1	8.9	1.4	2.1	1.1	71.1	0.0	0.4	0.0	20.3	0.4	0.2	40.8	0.2	1.3	2.9	11.5
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 239.1;Spermatogonia: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		35000	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	17.4	19.1	39.4	19.5	40.5	8.6	25.5	40.0	39.7	31.3	18.8	22.0	15.4	11.1	39.6	29.3	18.7	22.5	16.4	18.3	35.0	33.4	22.9	12.5	15.6	18.6	32.2	38.0	47.6	12.4	27.8	20.7	19.9	30.8	23.1	19.9	13.5	15.5	29.3	35.4	16.7	11.8	32.8	41.8	18.5	14.2	39.6	31.8	30.9	23.5	12.9	26.1	20.2	19.6	12.7	7.6	25.0	9.1	6.3	9.5	4.1	38.5	22.1	72.9	34.3	14.8	13.3	40.4	35.9	17.4	35.1	37.7	57.8	15.5	26.6	38.5	28.2	27.0	15.5	26.8	22.7	62.0	49.3	21.6	21.6	22.2	21.2	9.0	20.5	13.4	9.4	12.7	26.1	33.5	27.0	28.6	32.2	26.8	12.4	28.1	24.1	57.3	14.0	27.7	21.1	28.7	43.2	60.4	17.0	20.3	22.2	25.9	64.6	24.8	8.2	12.9	54.8	38.9	14.6	19.9	49.1	45.3	20.8	36.1	17.5	39.6	25.6	13.4	9.1	21.7	2.8	9.1	11.2	9.5	9.1	7.9	11.4	8.6	7.8	7.1	12.7	9.1	7.5	25.0	6.3	6.4	7.6	8.4	4.1	39.4	40.5	40.0	35.1	35.0	33.4	32.2	38.0	30.8	31.8	62.5	22.2	26.7	28.9	38.7	41.3	65.0	12.7	44.2	37.5	40.1	19.6	47.7	29.9	61.5	24.8	37.9	9.6	0.0	25.7	68.8	49.4	25.7	38.2	14.9	56.4	47.7	38.8	20.9	29.1	41.0	74.2	25.3	38.8	51.3	25.2	83.7	31.1	7.0	86.3	22.4	31.7	38.8	34.0	239.1	235.7	31.7	23.2	21.9	28.9	17.7
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	50.3	22.3	47.7	47.1	17.2	31.3	37.6	39.6	30.2	30.2	30.7	26.3	42.6	76.6	32.0	26.1	64.7	40.3	39.8	33.0	49.4	21.1	29.7	43.7	29.4	29.3	18.9	69.0	42.5	22.9	29.0	23.8	34.2	37.5	40.7	48.9	69.9	37.9	51.1	28.8	66.5	83.3	60.7	43.8	32.3	43.6	44.3	63.2	44.0	28.3	58.4	64.8	32.8	69.8	36.3	52.9	59.3	62.7	30.2	27.5	49.9	32.0	52.5	56.3	81.1	130.3	23.9	59.5	123.9	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7	101.3	77.8	131.1	75.5	127.6	104.6	114.5	129.9	139.2	130.8	61.1	72.6	154.4	119.3	152.3	115.5	136.8	88.3	303.7	123.2	293.9	107.2	64.5	211.9	239.9	127.2	47.7	105.7	149.1	266.0	31.0	126.2	175.5	99.5	110.0	127.3	132.2	139.2	87.7	92.3	112.3	126.4	77.6	91.0	234.4	415.8	94.4	226.4	163.9	186.9	86.2
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839429	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.0;SK-MEL-30: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	7.1	9.9	11.6	11.3	14.8	109.1	7.0	9.0	22.5	5.9	6.2	20.4	6.3	8.3	5.9	6.3	14.8	6.7	10.3	12.0	12.9	12.9	6.5	15.3	9.0	13.9	15.4	10.8	9.3	16.8	16.2	14.8	17.0	13.9	8.9	4.8	14.5	12.9	6.9	3.8	20.6	8.5	5.2	12.6	16.3	10.8	5.5	13.1	29.2	8.3	6.7	19.2	8.6	7.1	3.6	4.2	5.2	1.7	1.0	3.8	1.3	10.8	9.7	3.0	12.7	1.9	1.7	8.3	4.9	2.9	1.8	1.9	7.0	6.1	4.2	7.0	1.9	4.0	5.6	3.2	3.2	1.3	4.5	6.2	2.3	9.3	13.0	9.2	12.4	18.6	2.3	19.3	1.6	3.0	3.0	1.5	12.4	7.2	23.7	1.9	7.8	17.0	12.7	1.6	11.3	9.8	17.7	3.0	18.8	2.5	5.2	3.1	5.9	7.4	39.0	43.4	1.3	9.2	19.9	3.8	10.6	9.4	6.5	6.3	20.5	10.4	11.8	6.7	10.8	14.0	3.9	1.4	4.1	2.4	1.5	1.8	3.3	3.1	3.3	0.9	3.6	3.8	3.5	5.2	1.0	1.7	4.2	0.5	1.3	11.6	14.8	9.0	22.5	12.9	12.9	15.4	10.8	13.9	13.1	3.0	14.9	15.9	2.2	20.7	30.6	37.0	12.7	9.4	9.1	1.8	21.6	27.3	0.0	7.5	0.1	13.5	11.5	23.3	6.4	3.3	11.4	6.6	6.9	13.5	11.7	19.1	50.6	20.3	20.6	0.6	4.0	10.2	16.9	4.6	38.4	26.1	7.5	15.9	5.3	2.6	40.4	6.5	11.0	0.0	2.5	26.8	7.2	16.0	26.7	4.8
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861450-38872314	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	15.0	15.0	44.7	14.5	35.1	21.7	7.4	27.8	53.8	14.0	19.5	15.3	9.8	6.5	19.3	14.2	12.9	18.8	10.9	14.0	40.6	18.3	12.1	5.9	13.0	12.0	15.8	21.8	23.4	13.1	62.2	15.5	4.7	19.3	16.1	7.4	17.0	12.5	25.4	5.5	7.7	9.2	23.8	12.1	11.2	12.0	5.0	12.0	11.3	13.4	4.5	13.8	16.6	9.5	4.7	26.9	2.6	7.4	5.2	11.7	9.2	16.6	17.7	3.9	13.4	30.4	17.1	1.2	18.2	10.5	9.5	8.9	8.8	15.6	27.3	13.7	12.4	6.6	19.9	7.3	7.7	5.2	26.2	22.9	2.7	7.6	3.0	16.6	13.4	13.6	25.4	3.9	21.6	10.3	13.1	10.7	7.9	6.1	13.9	6.4	18.8	8.2	3.9	3.5	9.6	13.7	12.5	13.2	10.7	13.4	15.8	19.3	4.3	11.7	15.6	9.8	1.4	10.7	8.0	13.8	8.3	25.5	14.3	12.4	14.3	13.7	10.0	16.2	14.1	17.1	1.1	5.5	2.6	11.7	7.4	9.7	4.2	8.1	8.2	5.4	4.7	6.7	8.2	2.3	5.2	6.8	26.9	4.6	9.2	44.7	35.1	27.8	53.8	40.6	18.3	15.8	21.8	19.3	12.0	14.9	14.3	23.1	30.9	30.1	95.1	23.3	38.2	5.3	13.6	69.8	37.3	9.4	29.9	79.7	0.5	30.3	1.3	0.0	43.0	1.9	41.4	21.2	5.8	29.7	17.5	117.6	117.7	33.7	40.3	0.9	68.7	20.0	77.6	119.0	0.7	80.1	41.4	7.0	76.0	41.9	56.5	71.1	86.3	2.1	6.0	29.6	3.9	35.8	0.5	68.7
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152674	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.0;U-266/70: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146"	"prognostic favorable (6.18e-4)"	"prognostic favorable (3.63e-4)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favorable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	17.6	23.1	26.1	14.2	34.3	4.0	14.0	45.0	44.7	20.1	29.3	17.2	24.1	12.3	27.8	21.9	18.0	24.7	19.1	36.5	23.9	19.5	17.6	6.4	19.1	17.2	18.7	29.5	36.9	15.0	33.4	17.1	6.2	19.7	27.1	10.6	21.1	24.0	44.0	38.6	15.4	15.8	35.9	12.9	22.0	18.8	6.5	19.9	4.5	16.9	10.8	15.1	26.2	21.1	3.7	0.7	5.5	0.9	1.7	5.1	1.6	4.5	1.9	0.9	7.4	9.1	3.5	2.4	4.3	5.3	2.4	2.8	0.9	3.1	0.7	5.1	3.2	4.3	1.7	0.6	2.0	1.8	24.0	2.4	0.1	3.1	0.4	3.1	1.1	9.5	1.7	3.0	1.1	0.5	3.0	0.7	3.7	1.1	12.2	1.8	4.3	1.6	0.5	0.5	5.7	3.3	1.8	1.5	6.5	1.2	1.8	2.4	0.6	2.2	3.2	4.9	1.6	3.9	1.8	1.7	4.0	7.6	4.0	1.9	20.8	11.7	2.8	8.1	1.8	1.7	0.6	0.5	4.8	3.7	0.1	3.8	2.9	4.0	4.0	0.1	3.7	5.1	4.8	5.5	1.7	0.9	0.7	3.8	1.6	26.1	34.3	45.0	44.7	23.9	19.5	18.7	29.5	19.7	19.9	6.0	8.3	29.6	11.6	4.0	49.8	60.2	22.9	4.0	13.6	14.0	33.4	2.9	8.3	2.8	7.4	14.7	7.2	0.0	3.3	1.2	8.4	9.8	10.4	10.9	3.7	57.2	4.1	20.3	12.3	6.4	32.5	5.5	18.6	10.0	8.0	16.2	2.9	3.5	26.2	11.0	57.0	45.3	27.8	3.9	2.7	4.3	3.0	17.5	6.2	6.3
CC2D1B	KIAA1836	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366193	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA		140000	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	14.6	16.0	12.6	14.5	20.0	7.4	11.5	12.9	18.8	9.6	13.0	22.5	10.8	14.3	11.1	15.2	16.5	9.6	13.6	14.9	14.3	14.9	17.7	15.5	17.9	18.7	21.0	17.2	14.1	17.2	15.3	20.0	16.2	20.6	12.7	11.0	17.3	16.1	14.0	25.6	15.6	14.9	11.3	29.2	16.9	14.4	24.3	19.2	17.9	17.1	17.1	15.7	12.8	10.8	2.9	1.7	11.2	1.8	2.7	4.0	1.9	9.3	13.3	5.9	8.7	20.5	7.6	14.5	12.4	18.8	15.0	11.9	9.2	7.3	6.7	10.6	13.0	31.9	6.7	7.3	14.6	6.3	11.0	8.6	7.4	11.2	7.1	15.2	8.4	16.4	11.9	13.6	17.1	12.2	14.0	9.4	9.2	11.3	6.7	15.0	7.1	9.2	6.8	10.9	7.8	13.0	6.2	12.0	7.8	13.9	13.7	7.1	6.1	11.5	17.1	15.6	14.3	6.2	11.1	12.7	19.2	10.7	10.2	13.7	9.8	9.2	7.3	21.4	9.7	19.3	11.2	1.8	4.0	4.0	1.0	3.0	2.9	3.2	2.9	1.7	2.2	2.5	3.4	2.6	2.7	0.8	1.7	2.3	1.9	12.6	20.0	12.9	18.8	14.3	14.9	21.0	17.2	20.6	19.2	8.9	14.9	7.4	3.3	2.9	4.4	4.9	5.1	5.3	9.1	10.4	0.0	7.8	3.3	8.9	2.9	5.8	7.8	0.0	11.0	8.6	4.1	3.9	15.1	6.7	9.9	1.6	5.8	8.6	4.8	1.3	3.1	4.2	1.7	6.4	4.8	6.3	9.9	5.8	6.0	3.7	4.0	0.0	2.1	12.7	5.1	2.8	13.2	7.0	3.6	2.7
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	24.2	28.0	22.6	38.7	27.9	27.8	24.6	36.9	31.7	26.0	28.7	21.5	24.7	22.7	23.9	23.7	26.5	19.7	23.2	21.6	21.3	20.5	27.4	22.3	23.4	37.5	31.7	17.9	32.1	22.9	28.6	44.3	29.2	23.6	25.0	31.1	26.0	26.7	37.9	47.0	32.3	25.4	24.5	30.4	28.6	23.5	18.9	29.9	42.1	28.5	20.6	37.4	28.8	25.0	12.4	18.6	12.3	12.8	8.8	16.0	9.1	26.5	27.9	32.1	21.5	13.9	13.5	25.0	23.8	20.5	26.0	17.8	36.7	21.7	31.3	13.1	16.4	13.0	21.0	33.5	18.9	28.5	21.4	21.1	25.1	19.2	22.7	15.9	39.6	29.5	13.5	23.5	21.9	27.0	16.0	20.8	15.9	34.1	20.3	25.0	19.1	26.4	25.1	32.1	20.7	26.0	30.9	19.2	18.7	22.7	20.2	18.6	16.2	23.4	38.6	23.4	26.3	26.1	24.3	20.3	16.2	20.4	17.4	25.6	14.1	18.4	33.6	13.6	26.7	15.3	4.9	12.8	12.3	15.5	11.5	13.8	12.3	11.0	14.9	18.6	12.4	13.3	14.0	3.1	8.8	12.8	11.8	16.0	9.1	22.6	27.9	36.9	31.7	21.3	20.5	31.7	17.9	23.6	29.9	32.8	82.3	47.7	44.3	32.7	48.9	60.4	50.9	49.5	43.3	43.6	55.0	60.8	19.9	54.9	17.6	45.3	37.7	23.3	68.1	73.7	49.1	41.9	65.8	38.5	43.1	52.4	44.3	42.4	40.5	9.5	49.8	41.4	20.3	55.1	49.6	36.7	64.1	24.6	47.4	16.5	65.5	64.7	40.1	90.4	82.9	32.6	91.5	44.7	56.2	39.6
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		5300	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	28.6	32.7	27.8	35.4	38.3	63.1	29.9	45.0	59.1	26.7	33.0	38.4	28.0	25.7	37.3	24.6	31.7	32.8	30.0	21.9	24.6	25.0	25.2	28.1	29.7	39.7	24.8	36.3	37.8	28.0	34.5	31.5	32.3	33.2	28.8	23.4	27.2	29.1	25.4	44.4	39.8	30.9	25.2	22.4	41.2	29.7	62.4	25.0	63.5	29.4	23.3	37.0	30.6	26.2	13.3	10.7	14.4	21.0	12.2	24.3	14.3	26.7	50.1	48.5	25.2	19.2	16.2	32.3	26.3	26.0	38.9	34.8	44.9	22.2	44.3	33.2	28.7	35.8	33.6	44.5	31.2	28.2	17.9	26.6	52.3	38.7	34.8	17.8	28.6	44.8	16.7	28.1	30.9	19.1	22.6	27.9	40.3	54.6	28.2	28.7	32.0	86.1	30.2	70.6	29.0	18.3	57.7	40.1	23.7	20.1	63.8	24.3	56.7	29.6	34.1	22.7	24.5	31.0	27.1	45.0	28.9	38.3	34.7	34.6	20.8	25.8	52.2	32.5	25.2	44.8	12.9	10.1	14.4	24.3	17.4	20.7	13.3	18.2	18.3	10.7	13.2	18.3	19.0	3.7	12.2	21.0	10.1	20.9	14.3	27.8	38.3	45.0	59.1	24.6	25.0	24.8	36.3	33.2	25.0	14.9	3.4	11.0	8.0	12.4	11.5	7.1	7.6	14.7	5.7	15.7	15.7	21.1	8.3	16.3	3.9	8.7	18.0	0.0	15.6	18.8	9.5	9.9	8.1	10.5	13.4	9.5	21.4	9.8	10.8	5.6	13.8	8.6	11.8	10.8	17.8	14.3	17.7	11.5	11.3	7.7	11.8	19.4	12.2	30.0	21.7	13.4	19.8	14.9	18.3	8.6
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512178-57536599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 18.1;Peritubular cells: 32.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.9	7.4	2.1	0.8	12.1	2.0	2.4	12.1	9.7	1.8	8.1	4.5	11.1	7.2	5.5	7.9	8.4	6.4	1.6	1.5	5.6	2.2	9.9	6.2	2.0	2.8	8.2	4.6	3.6	2.4	5.0	4.2	13.5	0.9	5.5	4.6	8.6	2.6	4.3	4.3	17.2	2.9	5.8	4.7	2.9	2.2	7.7	7.2	3.9	5.2	10.6	21.2	2.4	1.0	0.3	0.0	1.6	3.5	0.7	5.7	7.0	2.7	3.9	0.9	1.4	5.7	3.8	2.1	2.2	1.1	2.8	6.8	5.3	15.2	1.2	2.9	4.3	1.4	2.0	0.8	4.3	6.2	0.7	3.2	1.2	3.5	0.4	7.1	3.3	1.3	1.8	0.4	4.9	1.7	1.9	4.0	0.0	0.7	2.3	4.7	4.6	6.6	0.6	13.3	4.2	3.1	2.1	2.8	0.9	0.5	7.2	5.9	1.9	2.7	1.1	4.1	2.6	4.7	4.0	13.6	0.3	3.4	6.4	2.3	2.0	2.3	1.9	6.7	0.0	0.0	0.0	3.1	0.0	2.6	2.4	0.8	3.5	0.0	1.3	1.4	2.4	0.3	1.6	0.0	1.0	0.1	0.7	1.9	2.1	2.0	2.4	1.6	1.5	2.0	2.8	4.2	2.2	0.0	4.0	2.2	7.9	11.4	0.0	2.4	2.5	1.4	3.4	7.0	0.0	1.4	8.3	1.4	0.5	9.0	0.4	0.0	0.8	1.0	13.9	6.2	0.0	0.9	0.3	0.0	0.0	4.3	0.0	0.9	18.1	1.2	1.7	0.0	0.7	3.3	0.9	0.0	32.5	7.9	0.0	19.4	11.2	1.7	5.9	5.0	0.2	7.5	0.8	2.6
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	15.9	18.7	31.6	8.7	43.9	4.4	14.5	27.2	29.8	13.9	10.4	14.3	10.5	7.2	13.2	11.2	13.0	12.5	14.2	18.0	32.3	21.2	23.5	19.2	10.4	14.8	20.3	14.4	20.9	13.8	19.2	17.5	8.8	15.2	14.7	5.2	12.4	18.0	19.6	34.1	9.3	8.3	20.0	15.1	15.6	13.0	15.9	10.8	13.7	18.0	6.5	14.1	16.9	10.0	11.1	9.0	0.0	2.4	0.6	3.4	1.5	3.9	15.5	6.8	11.9	4.9	4.7	0.9	3.4	6.0	11.9	10.0	3.3	6.1	11.5	2.7	6.3	0.3	3.4	11.5	7.4	3.4	0.6	39.5	12.2	10.4	5.9	14.7	0.8	7.0	7.5	0.9	2.8	0.6	8.3	3.7	7.5	8.9	7.4	5.8	1.0	7.3	4.8	3.2	0.4	8.6	11.5	3.5	7.9	12.3	0.3	7.5	14.0	2.7	19.4	6.7	4.2	8.4	7.9	4.1	3.7	3.8	0.3	2.5	4.4	1.5	14.9	9.9	3.9	0.2	0.0	2.4	0.0	0.5	1.6	1.5	7.8	0.5	0.7	3.0	11.1	3.4	2.0	0.0	0.6	0.1	9.0	0.3	1.5	31.6	43.9	27.2	29.4	32.3	21.2	20.3	14.4	15.2	10.8	0.0	2.2	8.3	7.6	2.3	21.3	19.5	12.7	0.0	1.2	19.2	3.9	11.2	34.9	16.1	3.0	11.3	5.5	0.0	6.3	12.7	8.9	4.6	9.2	14.9	14.5	35.0	4.7	5.5	7.8	1.5	13.0	7.1	3.3	18.0	7.0	18.8	9.0	5.8	17.7	41.5	7.1	12.9	7.2	5.9	19.6	3.1	7.3	3.8	4.7	2.0
CCDC122	FLJ31846	ENSG00000151773	"Coiled-coil domain containing 122"	Q5T0U0	13	43823909-43879727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 11.4;hTERT-HME1: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034233, HPA054995, HPA061456"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.75e-2)"	4.3	6.7	5.0	8.5	9.5	1.8	7.5	2.4	5.6	5.5	5.5	7.2	8.8	3.3	8.0	10.7	4.5	8.6	5.9	8.3	6.1	5.0	10.4	5.7	5.5	4.6	9.8	5.8	12.2	6.9	8.4	15.6	8.2	6.0	9.8	6.9	3.6	5.7	4.8	3.3	7.8	7.3	9.8	6.4	7.7	5.8	9.7	11.0	5.2	10.9	4.5	4.7	6.2	11.8	3.6	3.0	6.4	2.6	3.6	1.9	1.0	2.2	1.8	0.8	0.0	0.7	4.5	2.3	5.9	6.5	3.0	3.4	3.2	8.0	3.6	3.3	3.5	5.2	3.5	0.8	0.9	4.3	5.8	2.8	1.5	1.0	1.8	8.6	0.9	0.4	11.4	7.2	4.5	11.8	2.6	1.5	1.5	0.0	1.1	4.2	2.7	0.5	0.6	1.0	0.5	1.9	0.8	0.0	1.9	4.7	1.3	2.1	3.1	3.9	0.1	3.5	4.8	0.7	0.6	6.9	0.2	0.8	5.3	0.0	0.0	0.0	1.6	3.0	0.1	3.1	6.4	1.6	2.4	1.3	1.4	1.6	2.4	1.9	1.4	1.2	3.6	1.3	1.4	3.9	3.6	2.6	3.0	1.7	1.0	5.0	9.5	2.4	5.6	6.1	5.0	9.8	5.8	6.0	11.0	8.9	9.4	2.7	7.8	2.7	1.5	11.2	7.6	25.4	11.4	7.0	0.0	14.2	16.6	10.3	2.0	5.8	4.4	0.0	9.0	8.0	6.1	7.9	1.1	3.9	1.8	9.5	17.3	7.4	2.2	0.4	16.4	2.5	1.7	1.0	9.1	12.3	7.2	0.0	7.4	8.7	0.6	0.0	5.1	20.5	23.7	3.3	6.6	1.3	8.1	5.9
CCDC127	FLJ25701	ENSG00000164366	"Coiled-coil domain containing 127"	Q96BQ5	5	196871-218215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045052	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA045052: AB_10960630"	"prognostic unfavorable (7.01e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (2.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (2.42e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-1)"	10.3	14.3	10.3	7.3	13.0	3.8	9.7	14.0	16.2	10.7	10.0	10.6	8.2	8.7	11.6	7.7	13.4	10.5	12.7	16.3	9.8	11.8	8.1	6.8	6.9	12.4	12.0	9.8	15.3	8.6	5.0	14.9	10.2	13.9	10.5	4.1	10.5	8.1	6.1	18.4	12.4	10.1	8.1	9.5	7.2	9.4	11.1	12.2	9.6	23.5	7.4	5.2	9.9	7.9	9.0	8.1	7.2	5.3	8.6	11.0	5.3	4.0	5.3	6.0	10.9	7.3	5.6	5.9	7.8	4.0	3.5	3.5	5.6	8.5	8.5	11.4	3.6	4.6	5.4	3.7	3.0	3.4	21.6	6.6	3.0	25.0	4.9	4.3	2.4	5.5	4.6	4.9	3.3	2.3	8.4	2.9	4.7	4.9	3.0	3.7	3.2	4.2	4.8	5.1	2.4	6.9	5.0	4.4	6.9	6.6	4.1	6.7	10.5	10.8	7.5	7.1	5.0	9.8	4.5	6.6	9.0	5.3	3.6	3.2	5.0	4.2	5.8	5.8	4.2	5.6	4.6	4.5	7.2	8.1	5.3	8.7	9.0	8.3	9.6	4.5	8.8	9.8	11.0	2.9	8.6	4.7	8.1	6.2	5.3	10.3	13.0	14.0	14.7	9.8	11.8	12.0	9.8	13.9	12.2	14.9	7.2	7.0	12.0	12.6	16.5	23.8	7.6	18.7	9.1	5.2	17.7	27.5	3.3	24.3	5.1	15.1	8.1	0.0	13.3	19.7	13.2	13.4	9.2	11.9	17.2	36.5	8.1	15.4	6.9	6.5	19.2	10.3	8.5	29.7	7.7	29.9	13.9	2.9	18.7	7.5	26.8	12.9	9.5	20.9	31.3	6.9	25.2	12.8	6.8	10.6
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 57.6;Early spermatids: 83.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	2.6	2.5	5.7	5.0	7.0	6.1	4.8	13.5	8.2	3.1	3.9	4.9	1.6	2.1	6.0	2.8	5.5	8.6	3.8	2.3	6.8	5.0	3.6	5.5	2.8	8.1	4.3	5.1	3.7	3.5	2.3	7.4	2.8	8.0	3.1	4.8	1.9	3.3	2.1	2.1	4.8	3.4	3.3	6.4	3.2	3.7	19.4	6.5	19.5	2.3	2.9	7.2	4.3	6.1	5.4	8.1	3.1	2.1	3.2	4.8	2.4	8.3	3.8	13.2	6.8	1.1	1.2	8.4	3.6	1.1	8.7	6.3	12.4	4.9	20.0	5.4	1.1	4.3	7.1	9.5	4.9	7.8	4.6	12.3	9.2	7.2	10.3	1.3	12.6	1.4	0.8	1.5	10.2	3.0	1.3	4.5	8.7	17.5	9.3	4.4	4.6	17.9	8.6	19.6	4.5	4.0	11.9	12.5	12.2	4.8	6.6	9.3	9.1	7.9	4.3	6.3	8.5	4.6	6.1	2.8	5.5	9.7	3.5	7.6	2.9	6.7	20.9	2.3	9.8	5.4	3.1	0.9	1.3	2.1	2.1	3.9	5.1	2.8	4.0	0.9	5.4	4.1	4.8	0.5	3.2	0.8	8.1	4.1	2.4	5.7	7.0	13.5	8.2	6.8	5.0	4.3	5.1	8.0	6.5	0.0	3.5	2.9	3.2	2.2	7.3	0.8	0.0	57.6	12.5	1.8	7.9	3.8	1.7	3.0	83.9	2.2	0.5	0.0	1.2	4.4	3.0	0.9	4.6	1.8	1.9	6.4	5.2	1.3	0.6	22.1	3.4	1.3	1.7	1.0	2.1	1.5	2.7	0.0	1.8	1.7	6.9	0.0	2.3	18.5	21.2	2.5	1.1	4.3	2.6	2.4
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 44.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 52.2;Cone photoreceptor cells: 51.1;Early spermatids: 46.7;Rod photoreceptor cells: 51.7;Spermatocytes: 128.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.1;TIME: 9.4"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	3.7	1.9	2.5	2.7	3.5	5.5	2.7	12.0	3.6	2.1	3.1	2.8	0.4	0.9	5.4	3.9	1.3	2.6	1.7	2.5	4.7	0.8	1.0	1.5	2.8	2.3	4.3	1.8	7.3	5.4	0.2	16.7	3.7	10.3	3.0	1.4	1.7	2.2	1.5	2.4	3.7	2.0	2.5	4.2	2.4	2.2	44.4	2.8	2.4	1.8	0.4	1.5	2.8	4.9	1.0	0.8	0.8	1.3	1.0	3.8	0.0	0.6	3.9	0.9	2.4	3.5	11.1	0.4	0.2	0.0	0.2	0.2	4.9	0.1	0.5	3.4	6.8	0.3	6.0	5.0	0.3	0.3	3.5	0.3	0.5	0.5	0.4	0.2	0.7	3.2	2.0	0.1	2.3	0.2	1.1	0.1	0.2	0.5	0.3	2.2	0.2	0.1	1.2	0.8	1.0	0.4	1.5	0.2	0.1	0.1	4.7	1.3	1.4	0.7	0.2	1.4	2.0	4.0	0.2	9.4	0.8	0.5	5.3	1.5	6.7	6.9	0.2	0.4	7.0	1.8	0.7	0.6	0.3	2.2	0.5	1.4	1.0	2.1	1.4	0.4	0.5	3.8	1.9	0.8	1.0	1.3	0.8	2.1	0.0	2.5	3.5	12.0	3.6	4.7	0.8	4.3	1.8	10.3	2.8	0.0	9.3	3.0	6.4	3.5	52.2	2.5	2.5	5.3	2.3	0.0	51.1	4.2	0.0	1.6	46.7	6.5	1.3	0.0	0.0	5.8	8.2	6.7	25.4	1.7	3.5	31.8	1.2	3.7	5.1	2.9	6.6	4.9	5.0	0.0	2.0	8.3	2.2	3.4	8.5	0.5	51.7	6.5	5.7	128.1	36.1	3.1	1.6	6.9	1.6	5.1
CCDC144NL	MGC87631	ENSG00000205212	"Coiled-coil domain containing 144 family, N-terminal like"	Q6NUI1	17	20836447-20896140	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"brain: 13.1;testis: 10.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 26.7"									HPA023457	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA023457: AB_2671217"	"unprognostic (1.29e-1)"				"unprognostic (6.71e-2)"	"unprognostic (1.21e-1)"		"unprognostic (3.53e-1)"		"unprognostic (7.53e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.33e-2)"		"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"		"unprognostic (2.28e-1)"	0.3	0.9	0.9	0.2	13.1	0.5	1.0	2.4	6.6	0.3	0.4	1.4	0.0	0.5	1.5	0.3	0.3	0.9	0.2	0.5	1.2	1.1	0.3	0.6	0.5	0.5	1.7	1.4	1.3	0.4	0.2	1.2	0.8	4.5	1.6	0.5	0.6	0.3	1.8	0.8	0.3	0.2	1.2	4.5	0.4	0.5	10.6	0.0	0.4	0.4	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	26.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	13.1	2.4	6.6	1.2	1.1	1.7	1.4	4.5	0.0	0.0	0.3	0.0	0.6	0.2	1.7	0.4	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	7.2	0.7	0.0	0.0	0.0	1.6	0.9	0.5	0.0	0.0	0.4	1.6	1.2	0.0	0.0	1.3	2.8	0.3	1.7	0.0	0.0	1.4	0.1	0.0	1.1	0.3	7.5	0.0	0.9	25.8	7.3	0.3	0.1	0.0	0.0	0.4
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.8	0.1	2.7	3.5	0.0	4.6	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.0	3.4	3.6	0.0	0.0	0.4	0.0	0.3	0.2	10.6	4.4	2.7	0.1	0.0	4.4	0.0	1.9	0.0	7.0	1.4	10.6	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.3	0.0	0.1	0.0	4.2	0.4	0.1	0.1	0.2	19.2	4.4	0.1	0.1	12.8	0.1	5.6	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5	56.6	31.3	4.9	0.2	3.3	13.9	8.1	0.0	6.7	13.6	1.8	0.0	1.3	0.0	0.6	5.7	3.5	2.3	0.0	1.0	1.0	10.4	0.3	9.2	4.0	2.3	31.8	1.2	4.9	10.5	5.3	6.1	2.9	3.3	1.0	2.5	33.6	2.0	2.9	7.1	0.5	2.2	0.0	6.6	65.5	22.6	3.4	1.5	10.9	1.2	0.3
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.5;HEL: 14.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.2	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.5	0.7	0.8	2.5	0.4	0.9	1.3	1.5	2.0	0.9	14.8	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	1.0	0.6	5.4	0.4	2.6	1.6	0.7	4.1	1.9	1.7	0.8	2.1	4.9	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.6	1.9	1.1	1.5	1.1	2.9	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3	0.0	6.9	0.0	5.3	2.5	24.3	7.0	0.0	17.4	9.1	3.5	15.7	4.8	5.0	2.0	152.4	2.6	2.7	0.0	3.1	3.6	1.9	0.5	1.1	0.8	1.6	9.5	1.2	2.5	0.3	134.7	5.5	1.1	0.0	1.8	2.6	11.2	2.0	0.0	5.6	1.4	44.6	12.9	2.1	149.3	27.2	2.9	4.7	0.7	3.6	2.6
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 128.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	3.8	2.3	2.7	20.0	4.3	13.4	4.6	3.7	2.7	2.2	3.2	0.4	2.9	2.5	1.8	4.0	3.2	1.8	1.7	2.6	3.4	1.9	2.0	3.0	3.8	11.9	1.7	1.8	2.8	1.5	0.7	4.8	1.9	2.6	1.9	4.1	1.3	2.0	3.1	6.2	3.1	3.4	2.3	3.8	6.0	2.3	12.6	2.5	15.8	2.1	2.8	8.2	2.9	3.3	12.2	11.9	6.0	3.9	1.1	2.7	0.5	15.7	5.3	12.4	3.9	3.0	3.2	6.5	9.8	5.2	10.1	10.3	2.7	5.4	20.4	5.5	5.2	9.9	7.5	5.4	7.7	14.7	10.1	7.1	14.0	11.3	4.8	1.1	14.5	6.5	2.1	0.6	7.6	7.5	2.8	6.5	9.2	14.9	15.8	13.4	2.2	6.9	5.9	11.3	4.3	6.6	9.0	14.8	6.0	4.9	7.1	5.5	3.5	13.9	7.1	4.1	5.8	3.4	8.5	5.0	11.9	8.4	7.6	11.1	6.8	8.8	12.3	2.5	13.0	3.1	3.4	3.8	5.3	2.4	3.9	2.7	8.8	2.2	2.1	1.6	12.2	1.7	2.0	6.0	1.1	3.5	11.9	2.2	0.5	2.7	4.3	3.7	2.7	3.4	1.9	1.7	1.8	2.6	2.5	17.9	11.1	17.6	6.5	3.7	2.4	8.1	0.0	6.7	4.5	3.5	3.9	2.6	0.0	1.9	17.7	3.7	1.7	0.0	2.6	5.8	6.8	3.3	18.5	2.9	7.2	1.6	0.0	4.3	12.4	8.5	5.8	19.5	3.3	9.0	2.5	1.1	1.8	3.5	6.0	1.0	0.6	6.5	5.7	128.6	37.7	6.4	2.4	14.1	3.1	6.4
CCDC188		ENSG00000234409	"Coiled-coil domain containing 188"	H7C350	22	20148427-20151065	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.1;testis: 23.1"	"Group enriched"	"Detected in some"	125	"Early spermatids: 318.9;Late spermatids: 769.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	47	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	47	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.8;SCLC-21H: 8.0;SH-SY5Y: 10.5;TIME: 4.2;U-2 OS: 4.5"					"Not detected"	"Not detected"			HPA049901			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA049901: AB_2680943"	"unprognostic (9.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-2)"	1.1	0.9	0.4	0.5	0.6	0.5	0.5	1.4	1.2	0.4	0.4	0.4	0.4	1.0	0.6	0.4	0.4	0.4	0.4	0.4	0.4	1.9	0.4	0.4	0.6	0.7	0.5	0.4	0.4	0.4	0.0	6.1	0.8	0.4	0.4	0.0	0.4	0.4	0.4	0.7	1.5	0.5	0.4	0.4	1.8	0.8	23.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.8	0.3	0.0	0.7	0.0	1.7	0.8	1.4	0.9	0.1	0.1	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.1	0.2	0.0	1.4	0.2	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.1	0.9	0.2	3.8	1.2	0.5	0.0	0.3	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.1	8.0	10.5	0.5	0.0	0.6	0.1	0.0	0.1	4.2	2.4	4.5	3.0	0.2	0.7	0.1	0.2	3.9	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.4	0.6	1.4	0.6	0.4	1.9	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	318.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	769.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"A549: 9.3;RPTEC TERT1: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.3	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.3	0.1	0.2	0.1	0.2	0.1	0.0	0.2	27.7	0.4	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0	3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	58.0	18.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	165.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235467-49250526	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888"	Uncertain	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000229: , HPA000888: AB_1078420"	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	11.5	15.4	12.1	18.2	14.9	26.0	16.3	20.7	16.5	12.5	11.8	13.7	17.2	16.3	14.8	12.3	15.8	13.7	11.9	12.9	12.2	9.8	13.9	14.2	19.8	24.7	12.2	15.9	13.7	20.3	12.1	13.5	11.0	11.8	15.2	8.6	12.8	19.2	21.3	23.0	15.1	15.3	14.6	12.4	23.9	14.2	4.5	14.1	25.0	13.0	15.5	17.9	12.6	12.3	12.4	23.5	13.9	22.1	6.1	13.9	15.1	10.6	9.3	5.7	19.8	5.3	5.4	12.2	6.4	4.6	7.1	8.2	9.4	9.3	3.9	9.5	5.6	8.5	8.7	6.2	10.4	2.9	10.3	13.8	4.2	8.8	8.8	9.0	11.7	7.4	5.0	9.0	9.4	5.2	3.6	7.0	8.0	8.2	7.0	5.0	33.1	8.6	13.8	6.6	5.4	13.7	12.5	9.3	17.1	5.6	5.4	6.8	5.2	9.7	11.4	8.5	6.1	17.8	11.6	7.7	9.3	10.0	11.3	6.6	12.7	6.9	7.1	10.1	22.1	7.2	5.1	22.1	13.9	12.0	19.2	13.1	12.4	12.5	13.9	23.5	11.6	11.4	12.9	1.8	6.1	15.7	9.3	12.9	15.1	12.1	14.9	20.7	16.5	12.2	9.8	12.2	15.9	11.8	14.1	0.0	4.1	16.0	7.9	4.9	9.9	2.0	15.3	2.7	9.1	10.4	5.9	12.2	13.3	12.2	0.1	7.1	12.3	0.0	6.4	12.3	8.4	6.3	11.5	6.4	27.5	1.6	6.4	9.8	16.7	0.0	7.5	14.7	6.8	16.2	14.4	9.3	7.9	7.2	7.1	10.2	7.6	6.5	10.3	0.0	0.7	5.8	16.9	11.3	12.2	7.4
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	81	"testis: 53.3"	"Group enriched"	"Detected in some"	46	"Early spermatids: 60.7;Late spermatids: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"THP-1: 6.2"									HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"	Q8IWP9	6	138773509-138793319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	12.9	30.8	25.4	19.8	28.7	20.9	17.9	22.6	27.9	15.6	17.4	13.3	18.7	18.5	11.5	24.8	12.4	22.6	16.8	11.0	31.4	32.2	36.5	40.5	17.4	19.2	22.2	21.7	14.2	22.2	25.5	19.2	19.3	28.3	16.1	15.4	16.4	31.6	20.8	17.4	11.0	21.3	13.9	16.1	18.3	16.5	15.0	13.4	18.2	33.9	9.3	19.8	19.3	12.5	30.0	29.3	73.5	27.3	30.6	44.5	24.5	3.4	6.2	4.7	8.6	8.9	12.5	9.6	5.7	10.0	7.5	12.4	5.3	6.8	14.8	11.1	5.6	10.7	6.0	7.7	7.9	12.3	17.1	17.2	12.0	7.7	10.6	14.1	20.8	12.7	8.0	10.1	5.4	16.2	15.6	12.3	21.1	12.1	20.8	8.5	7.6	17.0	27.4	4.3	13.9	6.5	10.3	4.7	13.7	9.0	5.1	5.9	9.1	7.5	6.9	16.4	9.8	3.3	23.0	9.4	5.9	6.8	11.0	8.6	27.9	24.6	10.9	6.4	12.9	5.2	33.2	27.3	33.7	26.0	27.0	23.2	30.0	27.6	28.3	29.3	29.7	32.1	29.5	73.5	30.6	22.9	25.8	44.5	24.5	25.4	28.7	22.6	27.9	31.4	32.2	22.2	21.7	28.3	13.4	29.8	34.4	36.3	23.6	11.8	15.2	9.4	15.3	60.2	20.5	34.9	17.7	69.7	104.5	12.9	140.9	19.6	31.3	0.0	27.6	36.9	20.0	38.9	41.6	41.9	35.0	9.5	23.7	28.3	38.3	64.6	15.5	34.4	30.4	35.1	32.2	20.5	17.7	32.0	14.2	100.3	12.5	12.9	12.2	40.2	30.3	13.0	91.1	37.6	22.2	27.7
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.5	0.0	7.5	1.3	13.6	2.5	0.4	22.3	5.7	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.6	0.3	0.0	10.7	0.6	0.5	0.0	0.1	0.7	0.1	0.0	3.7	1.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	3.3	0.0	0.0	0.0	0.0	14.8	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1	0.0	0.0	0.0	6.2	44.5	1.0	4.4	0.0	0.0	1.2	0.0	0.0	0.2	1.7	0.0	0.2	8.3	0.0	0.0	0.0	0.1	9.1	1.9	0.0	0.2	0.3	0.0	0.0	8.0	0.0	1.1	20.8	1.6	13.5	0.0	0.0	0.5	0.1	0.0	57.0	0.3	1.9	32.3	95.9	0.0	3.8	32.5	0.2	0.0	0.0	1.0
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774327-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 44.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 7.7"					"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.2	0.3	0.1	0.3	0.1	0.1	0.3	0.7	0.2	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.7	0.2	0.1	0.3	0.1	0.6	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.2	0.1	0.1	0.2	0.3	0.0	44.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	1.1	2.4	0.6	0.8	1.9	0.4	0.4	0.5	0.3	1.0	0.1	0.7	0.9	0.2	0.3	0.8	0.3	0.3	0.7	1.6	0.2	0.0	0.4	0.3	0.5	0.2	0.4	0.7	0.7	2.6	0.3	0.2	0.0	1.7	2.1	0.3	1.0	1.1	0.4	0.2	0.1	1.8	0.9	0.8	1.1	0.3	0.2	3.4	0.4	0.1	1.9	2.0	0.8	0.3	0.6	0.3	1.5	0.0	0.3	0.9	1.2	0.6	0.1	1.7	0.4	0.9	7.7	0.4	0.4	1.0	0.7	0.7	0.0	0.7	0.5	1.5	0.6	0.4	0.5	0.3	0.9	0.3	0.3	0.4	0.2	1.0	0.8	0.7	2.4	0.8	0.3	1.1	1.9	0.4	0.3	0.3	0.3	0.7	0.7	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.5	1.2	0.8	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	148.4	0.2	0.0	0.0	0.2	0.4	0.3	0.5	0.0	0.0	0.1	1.6	0.0	0.0	0.3	50.4	2.8	0.0	1.7	0.0	0.0	0.8	0.1	0.0	2.5	0.0	1.1	12.9	0.0	78.8	3.0	0.6	0.0	0.0	0.1	0.1
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 127.2;T-cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 18.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 19.6;SCLC-21H: 23.8;U-266/70: 20.9;U-266/84: 29.4"	"Low region specificity"	"Detected in all"							HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	3.6	0.9	2.7	31.1	18.7	15.0	6.9	0.9	2.3	3.0	8.9	1.8	15.5	9.6	4.7	4.0	8.9	9.7	11.8	2.2	2.0	2.4	5.0	2.6	11.1	34.5	2.0	0.3	2.0	14.8	6.7	4.0	1.8	1.6	6.4	4.7	4.1	12.1	11.7	1.5	4.5	9.6	6.0	2.9	14.5	8.1	4.8	3.7	18.5	2.5	6.0	27.6	7.1	5.3	2.3	1.8	5.2	3.2	3.1	11.0	2.8	3.1	2.9	3.3	3.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	3.0	4.7	13.5	2.5	0.0	0.1	0.1	4.8	2.7	0.0	11.3	1.8	3.5	1.9	4.2	0.3	7.0	3.0	0.0	4.0	0.0	0.0	0.2	3.7	19.6	4.1	16.9	0.0	10.2	7.0	9.3	3.3	2.4	4.4	5.8	0.1	4.5	0.8	4.5	23.8	5.3	2.0	6.9	1.6	2.5	3.7	6.5	1.1	0.0	0.0	0.0	0.0	20.9	29.4	6.9	0.0	6.3	0.0	5.2	3.2	1.3	9.0	1.8	8.7	2.3	6.1	9.3	1.8	1.9	3.9	5.8	2.6	3.1	2.5	1.5	11.0	2.8	2.7	18.7	0.9	2.3	2.0	2.4	2.0	0.3	1.6	3.7	3.0	27.4	43.1	14.2	8.2	0.0	18.3	10.2	127.2	21.6	14.0	0.0	2.8	0.0	4.0	6.8	12.6	18.6	0.0	5.1	1.7	4.1	16.5	2.3	1.0	5.4	0.0	23.0	16.5	20.3	14.0	3.7	5.0	1.7	1.0	13.4	7.0	6.2	20.1	2.8	11.5	0.0	0.0	4.4	4.1	22.2	8.3	1.5	71.0	16.1	16.3
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	52	"Early spermatids: 1874.4;Late spermatids: 6111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	14.3	16.8	16.3	14.5	20.6	9.4	14.6	14.8	22.5	11.3	12.9	10.8	14.4	10.5	16.3	16.6	14.5	11.3	13.4	26.5	16.1	19.8	18.2	13.4	11.3	13.1	18.2	17.1	16.8	22.9	23.3	26.2	10.6	32.3	14.0	11.5	11.5	14.2	15.6	32.7	9.1	11.9	21.2	21.6	13.9	14.8	36.3	15.3	23.3	22.3	9.7	11.6	21.0	16.1	6.5	4.2	16.0	5.4	7.1	8.5	3.6	10.3	7.4	6.8	0.3	7.1	6.6	12.9	8.8	9.4	7.8	10.0	5.2	14.0	5.4	7.7	10.4	4.8	12.0	6.3	14.2	11.8	15.8	5.1	17.9	14.3	4.2	11.1	17.0	8.9	6.5	14.3	7.7	22.7	14.9	6.2	9.7	16.2	18.2	7.4	3.7	16.8	14.6	14.1	8.0	7.0	10.4	19.9	9.3	12.6	7.1	5.8	10.6	16.7	5.7	26.6	19.7	10.9	13.6	4.6	16.6	11.5	16.3	5.1	23.0	24.9	14.9	14.3	14.0	9.3	16.0	2.4	3.4	5.5	4.6	7.3	6.5	7.1	7.9	3.4	5.5	8.5	7.7	0.8	7.1	5.4	4.2	8.1	3.6	16.3	20.6	14.8	22.5	16.1	19.8	18.2	17.1	32.3	15.3	35.7	37.1	20.6	30.7	31.0	61.0	77.1	15.3	58.9	43.3	21.0	43.2	11.4	36.5	38.7	1874.4	19.1	21.3	0.0	41.1	13.3	17.8	30.2	38.3	22.2	27.2	42.9	36.9	11.6	32.1	6111.6	53.5	32.8	35.4	34.3	20.0	49.2	32.1	23.0	48.8	25.1	69.8	38.8	31.7	64.0	34.0	35.4	13.4	40.6	15.0	26.7
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 64.8;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.6	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.2	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	11.8	10.6	4.4	2.5	0.9	3.4	2.7	2.4	4.4	1.0	1.9	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	5.7	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0	17.9	22.0	4.7	6.2	3.4	17.5	37.2	25.5	9.4	11.4	17.4	13.7	3.8	6.6	12.6	64.8	12.7	8.0	0.0	9.4	2.1	13.8	7.0	19.7	11.9	15.4	20.6	4.6	11.1	8.6	48.4	12.7	9.5	8.5	10.8	7.2	12.8	12.3	2.9	16.3	27.1	12.1	71.1	17.6	44.0	5.3	2.6	4.7	7.9	5.2	6.0
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.7;Collecting duct cells: 19.2;Ductal cells: 27.2;Pancreatic endocrine cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.9;hTERT-RPE1: 35.2;WM-115: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	2.8	4.8	3.6	9.4	5.8	1.5	4.5	3.4	6.2	9.4	29.6	6.3	38.1	5.7	11.5	14.1	19.8	5.0	12.3	30.5	5.8	3.2	5.1	2.1	6.8	1.7	6.7	4.7	2.6	12.0	9.7	4.8	2.3	5.7	10.3	7.6	12.9	13.9	40.6	35.0	7.7	8.3	16.2	3.6	2.5	11.0	5.3	6.3	0.3	21.3	16.1	6.1	13.0	7.2	0.5	0.5	6.7	0.6	0.9	0.3	0.4	14.9	2.1	0.0	0.1	0.3	1.5	0.8	4.5	4.5	5.1	5.0	0.1	13.9	0.1	6.4	14.6	18.5	37.9	0.0	12.4	4.8	0.0	0.1	4.5	17.7	1.4	2.7	0.0	0.9	1.8	2.8	2.2	6.4	35.2	3.6	0.2	0.0	0.2	8.6	0.0	0.1	0.0	0.1	7.0	4.0	0.0	1.3	0.0	15.3	0.8	0.0	1.1	2.7	6.0	2.6	0.0	0.6	0.7	19.1	9.5	15.2	2.5	11.9	0.0	0.0	0.1	11.5	0.8	43.1	6.7	0.6	0.6	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.3	0.2	1.2	0.9	0.2	0.5	0.0	0.4	3.6	5.8	3.4	5.3	5.8	3.2	6.7	4.7	5.7	6.3	11.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	19.2	0.0	0.0	1.7	27.2	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442882	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;parathyroid gland: 24.2;testis: 50.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 98.3;Late spermatids: 70.5;Spermatocytes: 99.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 20.7;ovarian cancer: 18.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	108	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	233	"granulocytes: 24.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 87.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.8	7.3	0.4	6.2	1.3	0.6	0.2	4.7	4.0	0.3	1.6	0.0	0.4	2.6	4.7	0.3	11.1	0.6	0.3	4.5	5.9	0.3	0.2	1.0	1.0	1.9	5.5	1.2	0.5	24.2	4.8	0.2	3.1	0.3	0.3	0.1	0.4	0.2	1.3	0.2	0.3	5.1	1.0	0.3	0.4	50.4	0.4	0.2	0.4	0.0	0.5	0.4	0.6	0.1	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	3.8	0.3	3.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.8	87.1	0.0	8.5	0.1	0.7	1.4	0.2	0.4	0.0	0.1	0.0	1.0	0.1	17.0	0.6	0.0	2.1	0.0	2.0	0.0	0.6	0.0	0.6	1.4	0.0	2.0	0.0	0.4	0.0	17.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	21.5	0.1	24.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	6.2	0.2	4.7	4.5	5.9	1.9	5.5	3.1	0.4	0.0	1.1	0.0	0.5	0.6	0.2	0.3	0.0	16.0	3.4	0.0	0.0	0.0	0.0	0.1	98.3	0.1	0.0	0.0	0.0	0.6	0.4	0.2	4.7	0.0	0.2	0.0	0.0	0.0	0.0	70.5	2.8	1.0	0.0	0.0	0.0	1.8	0.0	0.0	2.5	0.0	0.8	6.5	0.1	99.1	2.5	0.4	0.2	0.0	0.0	0.7
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 70.0;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.7	10.1	27.7	11.8	1.5	3.8	22.7	27.1	11.9	36.0	26.8	22.0	24.1	35.7	7.3	14.2	12.7	13.1	34.8	15.9	29.7	17.1	16.1	28.6	13.4	21.3	0.3	43.1	20.3	1.0	1.2	14.9	8.9	5.7	21.5	19.0	40.7	35.9	28.5	13.9	54.9	25.0	21.8	24.3	11.3	25.2	53.7	17.4	10.2	7.7	11.8	12.5	14.2	17.4	7.5	21.7	14.5	18.3	12.7	16.9	25.7	17.8	25.8	22.8	24.1	40.9	9.7	43.9	18.7	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8	0.0	0.6	0.0	0.7	2.5	1.1	0.7	0.0	2.7	1.2	0.0	11.8	5.7	0.0	0.3	4.8	0.7	1.5	70.0	0.2	72.3	3.3	1.1	0.0	1.5	21.0	0.0	1.2	2.5	7.5	1.5	0.9	2.9	1.7	0.0	3.1	1.3	0.4	1.5	1.1	0.0	14.2	0.0	0.9	6.1	7.9	1.1	7.1	3.2	6.4	1.3
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542380-99568973	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	18.0	21.1	14.5	16.8	20.4	13.7	23.8	23.2	24.3	15.6	17.3	8.7	21.8	19.8	13.5	28.1	26.5	11.7	24.7	12.0	14.9	16.9	31.5	47.4	16.2	23.4	13.6	12.6	13.5	35.6	20.8	31.8	24.4	17.6	18.2	15.9	12.4	37.0	20.9	13.1	15.4	22.6	17.3	12.1	21.1	20.2	8.6	10.0	27.3	30.7	16.8	21.9	17.5	15.5	20.1	15.0	21.5	13.9	17.7	26.6	18.8	27.3	8.1	15.7	30.6	11.8	16.1	39.4	19.9	23.9	24.1	30.9	31.3	16.1	53.6	21.4	16.4	23.9	17.9	24.0	26.9	38.2	13.5	25.8	33.2	13.6	27.3	21.2	37.1	10.9	15.9	16.4	17.0	21.4	16.7	23.9	29.8	45.0	20.0	21.1	13.9	13.5	27.4	21.0	16.7	13.5	23.3	26.4	21.3	31.2	30.9	23.6	14.4	10.0	22.6	23.2	24.4	13.2	35.5	19.1	13.3	17.7	13.9	29.2	14.2	21.8	46.0	22.4	26.5	16.3	21.5	12.9	10.7	14.2	13.9	26.6	20.1	17.9	14.5	15.0	16.0	20.1	15.7	2.5	17.7	10.4	15.0	18.0	18.8	14.5	20.4	23.2	24.3	14.9	16.9	13.6	12.6	17.6	10.0	41.7	32.8	32.0	84.7	66.6	40.4	13.7	50.9	26.8	37.5	22.7	21.6	96.3	71.3	107.0	19.5	44.4	29.0	0.0	162.8	75.7	39.3	116.5	32.3	46.4	37.2	23.8	41.9	33.7	29.7	33.8	20.8	32.2	55.6	39.7	33.7	45.2	119.1	24.6	23.7	103.7	40.3	19.4	43.4	58.1	15.7	59.0	147.5	37.4	38.8	113.6
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197176	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.4"	"Cell type enhanced"	"Detected in all"	12	"Cytotrophoblasts: 313.6;Syncytiotrophoblasts: 883.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"HEL: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	15.6	10.9	3.4	12.6	5.3	55.4	17.5	10.8	9.5	8.8	9.4	5.6	11.5	7.6	11.3	10.7	18.3	10.4	9.6	14.1	3.9	6.9	8.2	8.4	11.6	23.6	6.1	5.6	5.6	13.4	5.2	9.6	24.1	9.3	8.8	9.0	7.7	11.3	12.8	21.1	12.0	12.9	8.2	6.0	12.8	11.8	5.9	5.4	8.3	15.6	5.9	11.0	15.9	11.7	5.4	2.9	16.9	8.0	4.6	7.6	1.6	0.3	0.4	0.6	0.3	1.6	1.1	0.6	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.5	1.4	0.2	0.6	1.4	0.6	0.3	0.9	1.4	16.9	0.8	0.6	1.2	0.8	1.0	2.0	1.6	0.2	0.6	1.7	1.3	0.3	1.0	0.6	0.6	0.0	0.5	1.9	1.2	0.7	0.5	0.5	0.6	1.5	2.2	0.7	0.8	1.3	0.6	0.5	0.4	0.7	0.1	1.6	1.6	0.5	0.2	1.3	0.3	2.0	0.7	0.3	1.7	1.8	0.5	16.9	1.9	4.9	5.2	3.3	5.4	4.4	5.6	5.1	1.6	5.4	5.9	6.1	6.1	4.6	8.0	2.9	7.6	1.6	3.4	5.3	10.8	9.5	3.9	6.9	6.1	5.6	9.3	5.4	44.7	55.2	77.3	44.9	30.8	27.2	52.0	35.7	92.3	50.0	27.9	19.6	313.6	76.3	59.3	11.5	45.0	55.7	140.2	52.3	67.6	49.5	41.5	54.4	28.2	77.3	42.9	44.4	47.9	82.6	10.0	43.7	59.8	60.8	151.5	49.4	52.2	58.5	56.1	27.6	38.5	63.1	45.3	48.9	65.4	36.8	35.3	883.1	83.0	45.2	73.2
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.3	1.3	23.4	12.4	15.5	19.9	15.8	8.7	25.2	6.8	12.8	1.5	15.1	20.9	14.1	8.1	6.5	7.5	6.1	28.9	13.2	14.5	4.1	1.7	6.0	3.0	8.1	3.1	21.9	16.8	14.4	3.2	7.1	22.9	10.2	12.4	1.0	12.8	12.5	4.0	14.2	6.6	2.3	5.0	1.4	8.2	22.8	1.3	43.0	28.8	6.2	19.9	10.3	16.4	6.1	14.6	12.2	4.7	9.5	9.3	9.5	6.7	1.4	9.5	7.2	14.8	6.5	4.9	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8	11.9	10.5	50.6	33.0	33.0	67.4	4.0	5.1	4.0	4.5	52.4	21.6	23.6	72.9	23.7	0.6	35.4	27.6	0.0	17.2	86.4	68.4	86.4	38.1	1.6	26.8	23.8	16.0	31.9	38.3	0.9	25.6	27.7	54.0	67.7	29.5	17.3	37.9	17.5	25.8	40.8	46.6	64.7	34.8	5.2	10.0	23.3	13.2	22.4	13.5	38.8
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;AN3-CA: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: AB_2683623"	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	7.1	10.5	5.0	8.9	9.2	18.1	7.7	11.4	8.2	6.9	8.6	6.4	9.3	8.1	10.8	8.3	6.7	8.7	8.0	5.3	4.9	5.5	11.4	6.4	8.2	8.2	5.0	3.7	8.7	9.3	11.3	11.0	7.4	6.6	7.1	7.1	9.2	7.6	7.3	7.3	5.3	11.7	7.7	5.0	13.4	7.4	9.9	5.7	16.3	7.2	5.8	8.3	6.8	5.0	1.9	6.9	1.1	4.0	1.2	3.1	2.1	5.1	4.2	25.5	25.4	2.6	2.0	3.7	3.2	3.9	5.0	4.4	10.6	2.3	7.1	3.8	3.1	4.0	3.1	16.9	3.5	6.4	3.4	6.8	6.9	3.1	15.0	6.1	6.9	3.3	3.9	4.8	4.6	11.0	4.5	11.4	6.6	10.0	0.1	3.0	5.0	11.7	7.9	14.1	0.4	3.5	14.1	1.1	0.5	5.6	4.9	3.9	13.6	3.7	1.0	7.0	8.8	5.9	7.6	5.7	3.1	6.8	3.5	7.6	1.4	0.5	6.6	3.6	12.2	2.0	0.3	4.0	1.1	2.3	3.3	3.1	1.8	2.0	1.2	6.9	1.9	2.9	2.6	0.5	1.2	3.2	1.4	1.5	2.1	5.0	9.2	11.4	8.2	4.9	5.5	5.0	3.7	6.6	5.7	6.0	1.9	3.7	2.5	1.6	4.9	2.8	2.5	5.3	2.3	5.2	13.7	1.3	3.3	2.4	2.8	3.3	1.3	0.0	2.4	1.8	2.3	3.0	0.0	1.3	3.2	1.6	4.1	7.4	8.4	5.4	1.7	3.6	1.7	1.0	3.9	3.4	3.5	0.0	1.8	2.1	3.3	0.0	3.1	6.3	4.3	1.3	0.9	1.7	3.1	2.7
CCNL1	ania-6a	ENSG00000163660	"Cyclin L1"	Q9UK58	3	157146508-157160760	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057911			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA057911: AB_2683553"	"unprognostic (1.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.71e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.96e-7)"	32.0	23.2	12.4	36.1	18.7	60.9	26.5	17.1	15.0	16.8	24.3	13.6	17.0	19.8	15.2	20.0	16.7	21.5	25.8	15.6	11.7	8.7	20.4	29.5	23.2	20.6	20.9	9.8	23.3	24.2	13.5	25.3	17.5	18.7	18.0	10.4	15.9	14.9	26.5	16.1	18.5	28.0	19.2	24.6	27.7	19.8	8.6	18.0	25.9	18.5	17.7	20.8	20.2	22.4	12.3	11.3	24.0	8.5	13.1	15.0	6.7	13.3	8.7	11.8	8.6	12.2	8.0	12.3	8.6	10.0	10.2	9.4	15.2	10.5	15.2	7.7	6.3	7.0	11.4	9.0	10.1	9.3	13.3	11.0	10.1	9.4	12.6	10.0	6.6	5.7	9.6	18.7	9.7	12.9	10.0	8.0	8.0	6.4	8.9	7.3	11.1	12.2	12.1	10.6	10.3	10.5	11.5	10.5	21.8	6.4	8.2	6.9	13.0	7.1	6.2	17.0	9.3	6.2	18.1	6.6	9.4	5.5	10.3	10.9	18.6	15.3	19.3	9.5	9.3	8.9	4.3	8.5	12.5	11.6	7.1	12.2	11.2	10.8	11.9	10.6	12.3	15.0	12.1	24.0	13.1	8.2	11.3	11.9	6.7	12.4	18.7	17.1	15.0	11.7	8.7	20.9	9.8	18.7	18.0	202.5	402.1	106.8	367.8	238.1	68.5	43.3	109.5	174.0	241.1	64.6	125.7	121.6	19.9	124.2	27.5	202.1	397.6	46.7	112.4	131.0	201.5	320.1	214.0	72.5	144.7	38.1	237.5	142.4	220.1	14.0	118.5	210.1	133.3	125.4	150.2	55.6	123.2	199.9	70.7	16.6	185.9	129.4	199.9	42.5	20.4	242.1	174.8	208.8	128.5	426.8
CCNQ	FAM58A	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587919-153600045	"Disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 61.3;Extravillous trophoblasts: 78.8;Syncytiotrophoblasts: 101.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	3.1	5.7	4.2	6.1	12.8	4.2	9.7	3.7	11.1	4.5	5.2	6.4	4.2	6.1	3.7	10.5	5.1	5.1	4.0	14.7	7.9		6.5	6.3	5.0	10.9	9.5	6.1	4.1	9.5	3.0	6.4	6.4	7.3	5.7	6.1	3.5	8.0	6.8	10.3	4.0	5.0	4.9	6.7	7.3	5.4	2.7	7.4	3.9	4.9	4.2	8.7	5.2	4.5	7.4	1.9	6.8	2.3	1.1	4.8	1.4	19.8	15.5	6.0	21.3	11.0	5.6	9.4	12.0	10.5	11.4	11.7	14.9	7.1	16.1	23.2	12.7	17.2	12.9	19.8	11.4	11.8	9.8	20.1	3.9	9.3	11.4	9.7	13.6	9.4	7.4	10.2	7.7	8.5	5.2	9.7	8.4	4.8	7.8	9.7	23.1	9.5	16.6	7.6	21.5	26.2	10.8	9.7	8.4	8.7	8.5	7.9	10.4	6.2	9.7	14.0	6.4	3.5	12.4	6.9	10.1	14.3	22.3	18.1	11.2	10.6	20.4	9.1	21.2	7.4	0.0	2.3	6.8	4.0	2.1	1.8	7.4	3.7	2.8	1.9	6.2	4.0	2.8	1.4	1.1	1.0	1.9	4.8	1.4											3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.7	7.0	0.0	36.5	61.3	22.4	0.0	0.0	0.0	0.0	32.2	78.8	0.0	0.0	2.3	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	39.7	0.0	0.0	27.4	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	101.1	0.0	0.0	0.0
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328558-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"Early spermatids: 1964.7;Late spermatids: 4316.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	14.9	8.7	18.5	7.9	18.2	7.3	16.7	22.1	21.8	16.4	18.3	17.9	11.4	9.4	15.7	13.1	22.7	9.2	10.3	42.9	19.6	18.2	9.9	10.5	13.3	9.0	21.7	15.9	11.8	9.9	11.8	8.8	15.3	28.3	12.6	10.4	9.4	10.3	13.5	46.2	13.0	15.5	24.2	22.2	8.2	10.6	45.7	15.2	11.8	19.9	14.6	9.1	17.1	11.9	5.2	4.4	5.2	3.0	14.6	15.0	5.4	8.1	6.3	7.5	16.6	11.1	18.2	5.3	9.8	16.3	6.1	12.0	3.5	8.7	5.4	6.4	18.1	9.8	7.0	5.6	6.2	9.2	17.9	3.5	1.9	3.0	4.4	10.2	2.8	4.1	8.8	9.0	9.9	31.9	15.9	16.7	10.3	2.5	16.6	11.0	5.0	4.9	2.0	3.2	2.8	5.1	5.1	3.8	2.0	5.5	8.7	2.3	4.2	5.4	3.6	16.8	10.9	6.6	1.4	14.9	18.4	8.4	9.1	10.3	16.8	5.6	4.3	11.9	3.7	7.9	2.7	3.0	5.2	14.9	2.8	15.0	5.2	11.1	13.7	2.9	5.0	10.0	10.5	4.2	14.6	2.2	4.4	6.7	5.4	18.5	18.2	22.1	21.8	19.6	18.2	21.7	15.9	28.3	15.2	38.7	32.6	20.4	45.4	31.4	85.2	186.4	7.6	17.4	23.9	15.7	29.5	20.9	31.5	27.4	1964.7	54.3	18.1	0.0	40.4	16.4	42.3	44.4	13.9	19.5	18.3	58.8	15.6	33.2	15.6	4316.6	47.8	31.8	25.3	47.7	24.3	49.5	27.2	14.1	56.3	21.9	51.3	12.9	46.9	67.4	64.1	41.0	57.2	64.8	16.6	56.7
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868089-61888804	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	35.1	42.3	34.8	33.3	38.7	32.4	63.3	41.2	40.6	37.7	36.2	26.0	34.4	26.7	43.1	32.6	47.9	44.6	25.3	49.0	31.4	33.7	43.1	37.6	28.7	54.1	42.1	33.9	66.4	65.9	39.7	32.8	37.7	40.0	37.6	35.4	21.5	32.1	35.9	52.5	37.5	28.1	42.5	39.7	36.2	38.1	49.4	37.7	55.6	50.0	40.8	50.9	39.3	93.4	30.3	31.4	13.7	29.8	31.6	39.1	34.6	42.4	49.6	33.1	30.7	27.5	42.0	55.7	38.9	27.9	56.2	37.8	86.2	30.9	68.5	39.6	27.8	58.7	30.7	64.9	49.8	59.4	33.6	63.8	43.7	25.7	54.1	24.8	53.7	29.3	35.6	34.7	45.2	47.2	43.0	46.9	35.4	62.1	22.1	47.8	38.2	46.3	73.9	59.5	58.0	44.2	52.6	51.8	46.3	39.1	29.3	28.9	24.3	28.2	36.0	50.2	40.7	26.1	39.8	29.4	31.3	45.5	23.2	63.0	33.9	45.3	116.2	31.0	62.2	40.9	13.7	19.0	7.5	27.8	27.2	35.7	30.3	29.6	33.3	31.4	27.5	39.1	38.0	2.7	31.6	29.8	20.3	30.7	34.6	34.8	38.7	41.2	40.6	31.4	33.7	42.1	33.9	40.0	37.7	68.5	48.3	130.2	269.5	135.5	48.5	42.1	68.8	100.4	55.7	69.8	13.7	227.3	114.4	153.0	142.9	101.6	46.8	23.3	113.0	234.5	111.0	163.9	94.6	76.0	145.9	30.2	134.7	81.6	97.3	43.3	81.7	92.2	89.4	124.4	81.3	55.3	126.9	70.2	91.9	129.9	47.9	90.5	130.6	212.4	146.7	132.2	151.0	116.1	119.0	187.2
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314487-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.0"	"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 17.8"	"Lineage enriched"	"Detected in single"	122	"T-cells: 17.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		27000000	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	59.2	3.5	0.8	14.4	2.5	0.0	55.2	0.6	2.2	21.2	7.6	1.9	6.3	2.7	14.1	22.9	14.8	17.7	12.3	18.2	1.2	0.5	5.3	1.7	9.3	16.2	1.3	1.6	15.6	4.9	1.4	2.3	71.0	2.1	10.6	2.7	11.5	4.6	8.0	6.7	13.3	7.5	27.6	1.2	1.9	7.5	8.0	0.7	4.1	9.4	6.6	4.5	19.5	17.6	0.1	0.0	0.0	0.0	0.0	17.8	1.9	0.0	0.0	0.6	0.0	68.1	67.2	0.0	29.4	44.3	2.2	2.0	0.0	0.0	0.0	0.7	59.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	13.5	0.0	0.0	71.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.3	0.0	0.1	2.8	17.8	0.0	0.0	0.0	0.0	0.0	1.9	0.8	2.5	0.6	2.2	1.2	0.5	1.3	1.6	2.1	0.7	0.0	0.0	0.0	0.0	11.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.3	2.5	0.0	0.0	0.0	2.5	70.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.4	69.3	0.0	11.8	1.0	0.0	3.6	0.4	0.0	19.1	0.0	0.0	32.3	12.2	0.1	0.0	7.2	3.7	0.0	0.0	0.0
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"	"Cell line enhanced"	"Detected in some"		"HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0"									"CAB011442, HPA035832, HPA064807"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	28.5	0.1	0.0	0.0	37.9	28.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	7.2	0.0	0.0	0.0	18.1	0.0	0.0	8.7	0.0	1.5	20.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.2	4.9	0.4	0.6	0.0	0.1	2.4	0.0	3.3	28.0	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8	0.0	10.7	1.4	0.5	1.5	0.1	0.6	0.0	1.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.4	1.5	0.3	73.9	0.8	67.4	0.0	0.0	8.6	119.1	1.3	0.3	56.4	1.7	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.5	0.9	0.7	1.7	0.0	0.3
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell type enriched"	"Detected in some"	4	"B-cells: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.9	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.7	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.6	0.0	2.8	0.0	8.2	0.7	0.0	0.2	1.7	0.1	0.0	0.1	5.3	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	28.3	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2	0.0	1.1	82.7	0.3	0.9	0.0	0.6	2.5	1.4	0.0	3.5	0.0	0.1	0.0	0.6	0.1	0.5	0.5	0.0	0.6	0.2	0.6	0.4	0.0	0.0	19.7	0.0	1.7	0.6	16.7	0.0	0.9	8.0	0.0	1.8	0.0	0.5	1.2	0.0	0.4	0.3	0.7	0.0	0.8	0.2	1.2	1.0	0.2	4.9	0.3	0.1
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	52.6	25.7	35.9	23.4	1.2	3.2	34.4	24.4	21.9	71.2	38.0	40.3	43.8	30.5	14.3	22.4	25.1	37.1	39.2	46.6	59.5	23.9	29.0	44.6	25.4	24.9	0.3	31.1	16.3	1.0	2.2	49.4	44.8	6.2	30.1	29.3	20.1	21.0	32.2	20.4	29.9	19.1	45.4	25.1	34.6	43.5	49.3	19.3	17.3	14.0	21.2	10.4	43.1	29.2	13.5	28.8	20.5	39.4	15.6	21.3	50.0	23.6	75.6	16.1	14.3	31.6	15.3	38.8	31.7	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7	0.0	0.6	16.2	2.0	9.3	0.0	0.7	0.0	2.7	1.2	0.0	0.0	13.4	0.0	2.1	97.6	0.7	3.2	70.0	0.3	127.9	4.1	2.0	0.0	1.0	30.9	0.0	0.0	8.0	5.0	7.0	2.6	5.2	0.0	2.8	2.9	0.2	0.7	0.0	1.8	2.1	2.6	0.0	1.4	74.9	48.1	7.3	8.9	1.3	15.5	2.6
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 106.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4.0	13.4	10.9	16.4	4.0	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5.0	17.0	23.1	12.1	7.2	4.1	25.6	16.0	26.4	7.0	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12.0	4.0	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	106.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.5	14.7	0.1	0.3	0.0	0.8	5.7	0.5	0.4	0.0	0.2	2.5	0.0	1.2	1.3	0.3	22.9	1.4	0.0	0.0	0.0	1.5	0.5	0.9	0.0	1.8	0.2	0.4	0.0	0.4	15.8	13.7	0.0	0.2	0.0	3.2	0.3
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121997-193253901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	23.4	20.0	18.1	16.8	22.9	21.0	20.1	25.6	22.6	20.4	20.1	14.5	16.3	12.0	26.8	15.2	20.6	14.9	16.4	21.4	18.4	15.0	18.8	17.1	17.2	16.6	19.7	15.9	23.3	14.5	27.1	24.8	17.3	19.4	26.9	16.2	13.6	17.3	19.0	44.5	15.0	14.5	25.6	23.9	16.0	15.7	16.3	22.1	20.6	27.1	14.1	15.8	26.8	35.0	6.6	6.7	10.2	7.0	9.0	12.5	5.2	13.4	12.1	16.0	10.3	15.0	14.6	12.3	14.5	14.1	17.6	15.4	8.3	16.0	17.5	10.3	17.8	9.7	13.2	14.5	13.7	21.5	11.1	6.9	12.7	10.9	8.0	14.1	17.2	12.7	11.9	13.3	16.5	15.8	15.6	14.9	10.0	19.2	14.2	23.5	12.4	14.1	8.5	15.4	19.8	4.5	12.6	9.7	16.7	20.6	9.4	4.8	13.2	18.1	22.4	20.7	18.6	19.2	12.5	16.6	17.1	4.0	14.5	14.8	13.3	9.9	14.4	10.3	10.6	29.9	6.6	7.0	10.2	9.3	6.8	12.5	6.6	9.2	9.2	6.7	5.4	8.4	8.7	7.4	9.0	5.7	4.9	9.3	5.2	18.1	22.9	25.6	22.6	18.4	15.0	19.7	15.9	19.4	22.1	32.8	20.1	34.3	31.1	33.1	31.2	36.4	20.4	20.1	19.4	31.4	33.4	21.8	28.2	29.4	11.9	30.1	16.2	23.3	28.5	34.0	29.2	33.5	39.4	14.3	28.0	20.6	10.9	22.1	25.9	6.1	31.1	38.8	27.0	47.7	15.3	33.5	28.2	13.1	33.9	26.4	36.3	25.8	57.1	56.5	32.0	30.6	31.8	29.8	16.1	23.2
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol		No	Yes			"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	6.0	2.1	14.2	16.0	11.7	12.6	27.6	7.6	3.6	5.5	10.3	28.4	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.4	5.9	2.7	0.9	7.7	6.5	1.8	6.4	36.5	14.9	6.3	4.1	7.9	61.8	40.7	21.1	23.4	5.3	43.7	13.6	17.5	6.9	8.7	5.2	9.2	9.4	3.1	5.0	16.7	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.8	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0	0.0	1.1	1.4	12.6	18.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.4	1.1	6.7	0.0	0.2	21.5	2.6	2.4	0.0	0.0	8.9	0.0	11.7	0.0	0.8	1.8	49.8	1.6	3.3	0.0	19.1	0.6	0.7	7.0	32.5	0.0	0.0	0.0	4.3	9.4	30.1	13.9	8.5	6.9	66.1	1.7
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	51	"Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.0	4.0	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	21.9	1.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.3	0.1	94.0	0.1	0.2	0.0	0.7	0.1	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.3	0.1	36.3	0.0	0.1	0.1	0.1	0.2	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	404.8	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	149.4	0.0	0.0	316.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	191.5	0.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.5	1.6	0.4	0.0	0.1	6.0	0.9	5.9	5.1	9.5	1.6	0.2	6.1	4.9	1.8	0.1	5.0	21.2	1.0	13.4	9.5	18.0	6.4	24.6	4.0	8.6	11.3	5.9	11.0	5.3	0.9	1.1	4.7	8.7	0.3	4.9	6.7	0.4	6.7	11.3	12.2	4.3	4.7	25.5	4.9	49.0	1.2	0.1	16.6	7.2	12.0	0.5	7.5	2.5	2.2	4.8	0.2	3.1	9.0	2.1	0.2	13.1	12.1	18.1	0.1	8.8	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7	14.9	6.5	15.6	20.1	26.3	67.6	23.4	2.5	0.0	6.8	15.7	11.8	1.2	44.7	11.0	75.7	16.0	12.0	0.0	7.9	1.3	12.5	12.9	23.0	15.6	16.4	66.7	9.2	24.5	12.4	17.9	16.7	12.3	13.5	2.8	2.3	40.4	9.9	14.4	15.6	47.3	13.1	6.5	13.7	6.4	19.0	13.0	5.6	23.0	3.3	10.6
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.9	18.6	49.6	19.6	3.2	5.0	20.4	37.0	27.0	45.2	43.6	43.6	43.3	44.9	14.4	10.1	16.6	30.5	33.7	21.5	47.1	31.9	24.6	23.5	18.4	25.3	0.6	36.0	24.3	0.9	2.1	29.2	28.5	10.3	27.1	29.6	35.9	55.3	50.2	13.0	45.3	25.9	21.8	29.6	39.3	39.4	46.2	22.0	17.2	16.3	23.3	20.4	24.9	37.8	19.2	28.1	40.8	22.1	11.1	19.3	41.2	20.3	50.6	21.7	34.8	40.5	16.6	40.4	23.9	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2	0.0	2.7	2.2	3.6	35.3	1.0	0.5	0.0	14.7	7.9	17.4	0.0	11.0	3.3	0.7	8.8	4.5	1.7	280.4	0.0	116.8	5.1	1.0	0.0	0.8	46.3	0.0	2.9	9.8	15.3	6.3	2.0	8.8	1.7	1.8	4.0	1.0	0.3	0.0	0.7	2.1	0.5	0.0	1.4	104.2	29.6	16.3	18.4	7.0	5.6	6.0
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.9	11.1	6.7	6.2	4.9	5.5	6.2	8.1	6.9	11.1	8.3	13.6	5.5	12.7	7.1	8.5	11.3	14.6	13.3	10.2	10.8	8.3	11.4	13.7	7.5	10.5	4.8	18.7	9.6	5.9	7.1	13.5	10.7	4.6	6.7	7.7	23.2	8.4	6.3	4.2	15.3	4.8	7.0	4.4	5.0	10.1	14.4	7.2	4.2	10.7	7.2	4.6	10.3	87.5	7.0	10.1	11.2	8.1	7.2	10.1	8.1	7.0	10.4	6.9	4.9	17.9	7.2	7.9	6.6	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3	23.8	26.1	37.7	45.0	57.5	45.4	12.1	35.7	29.4	40.9	36.6	60.9	27.7	11.6	24.4	15.9	29.6	32.0	23.3	23.8	24.7	35.7	62.9	27.8	38.9	23.9	33.4	29.9	27.6	37.0	14.0	34.5	34.5	25.3	27.9	26.9	31.5	36.1	31.6	31.8	12.9	67.7	32.3	33.0	113.1	90.5	60.3	48.7	42.9	28.8	77.9
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 44.0;Horizontal cells: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.1	0.0	14.3	1.8	13.4	13.7	3.3	6.0	5.7	3.7	4.0	0.1	3.5	25.4	0.7	5.9	5.4	2.1	0.7	8.4	7.1	0.0	3.4	0.0	4.7	0.1	6.2	7.2	0.1	9.7	2.1	10.9	3.9	6.1	4.7	0.1	0.1	31.3	7.4	0.0	0.0	2.8	9.0	0.0	3.9	19.5	19.7	19.3	1.9	1.9	3.2	9.2	15.2	0.0	0.3	6.7	1.9	3.6	11.5	15.9	20.4	13.3	9.2	17.7	13.5	18.1	6.0	9.5	15.5	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5	17.9	3.2	27.7	7.4	0.7	5.1	11.1	10.2	4.0	13.6	10.4	0.0	0.2	6.6	9.4	44.0	2.1	0.0	0.0	5.8	0.1	12.5	8.3	0.0	9.6	4.0	163.7	1.7	1.3	5.1	27.0	14.4	4.6	5.0	1.0	0.1	8.8	9.4	0.2	14.9	18.1	9.5	0.0	6.6	3.8	6.5	1.1	0.0	0.5	0.0	2.3
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.2	14.9	5.6	12.2	0.0	1.5	0.0	0.0	1.3	0.2	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	35.2	2.1	0.0	1.5	0.8	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.2	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 44.5;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	16.3	9.1	20.6	13.9	47.0	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21.0	12.9	8.0	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28.0	29.6	9.4	6.1	16.6	11.0	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.9	4.2	11.0	2.9	5.4	14.3	7.8	11.1	15.7	9.8	9.3	2.5	2.9	7.4	7.7	8.0	5.3	4.5	6.5	6.9	13.4	7.8	5.0	10.6	2.8	3.5	11.7	5.6	6.1	10.3	7.1	14.5	26.2	17.4	44.5	6.3	7.7	6.0	22.1	3.0	5.3	8.8	4.8	2.4	7.3	9.3	5.9	6.3	11.6	4.2	5.7	3.9	6.5	6.1	8.1	8.7	4.6	5.1	53.3	8.7	3.3	4.6	6.0	8.5	6.5	7.9	3.3	2.4	6.4	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47.0	17.8	24.6	25.3	17.3	23.8	21.0	14.8	28.0	14.9	6.2	24.4	8.9	23.8	10.8	8.9	5.1	9.4	10.3	8.7	15.7	10.0	0.0	4.6	2.7	42.9	6.0	0.0	3.2	25.8	15.5	10.4	17.4	8.9	10.5	4.8	14.5	35.6	15.3	3.2	9.2	9.4	16.9	7.2	7.4	20.2	5.7	3.5	8.9	6.9	9.2	6.5	27.8	6.5	7.6	22.6	11.4	27.7	5.5	11.8
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 84.5;Late spermatids: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007053: AB_1233803"	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	5.3	3.3	18.1	6.1	29.4	9.7	6.0	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8.0	22.1	12.9	9.7	3.1	8.0	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7.0	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.9	13.7	16.5	7.4	10.7	7.1	11.9	12.7	4.5	5.9	4.9	4.1	9.3	4.3	8.3	9.0	2.1	5.2	2.5	10.3	11.5	3.0	15.8	5.8	5.7	4.5	6.4	11.9	7.3	5.6	6.1	9.5	11.3	4.4	7.9	4.8	13.0	9.6	5.9	8.6	9.6	1.3	5.2	2.7	9.2	7.0	3.5	5.2	6.7	7.0	13.0	9.0	7.4	10.6	4.8	2.5	23.6	4.9	9.4	5.0	18.9	7.2	1.4	1.9	8.0	9.9	8.7	9.7	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3	3.0	16.2	8.1	13.2	8.8	17.3	6.2	12.7	4.0	7.9	15.7	15.7	5.4	1.7	7.5	84.5	11.7	13.8	0.0	4.1	17.1	10.8	49.2	6.9	10.5	14.4	22.3	12.1	14.7	33.3	95.4	10.0	18.4	25.3	3.6	14.2	34.3	6.0	17.5	15.2	5.6	14.1	6.5	8.5	38.1	14.1	14.2	6.6	12.8	12.9	7.4
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486619-32491256	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 58.8"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 43.2;Early spermatids: 15.1;Late spermatids: 13.7;Muller glia cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.2;SK-MEL-30: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000252: AB_2665953"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	1.6	3.3	21.9	6.4	21.1	4.9	1.8	26.0	58.8	1.2	1.6	3.6	0.0	2.0	1.6	1.0	5.5	1.5	1.6	1.6	21.4	17.3	1.5	1.3	1.4	11.5	7.6	24.5	3.2	2.0	1.3	3.0	1.4	7.8	1.4	1.5	0.9	1.2	1.3	1.8	2.2	2.0	1.3	4.1	7.7	2.2	5.2	3.2	1.2	1.1	0.3	12.3	1.7	1.1	0.6	1.8	2.9	0.9	0.7	4.2	1.5	2.0	1.2	5.3	1.7	0.6	1.0	0.6	1.2	0.7	1.5	2.0	3.1	0.5	1.0	1.2	1.1	1.3	1.0	2.0	1.3	2.1	0.4	4.0	0.3	0.5	1.2	0.2	0.6	1.1	0.6	3.2	1.6	1.3	0.6	1.1	3.7	2.0	1.2	3.3	0.8	1.8	0.8	3.4	0.7	1.1	1.5	3.2	3.7	0.7	0.9	32.2	8.7	1.2	0.7	23.1	0.8	1.3	2.4	1.1	2.2	3.3	0.8	3.3	0.6	0.8	1.0	1.9	3.0	5.2	0.0	0.9	1.2	2.3	0.8	1.8	0.6	3.1	1.3	0.2	0.5	4.2	2.6	2.9	0.7	0.4	1.8	0.4	1.5	21.9	21.1	26.0	37.3	21.4	17.3	7.6	24.5	7.8	3.2	0.0	1.0	1.4	0.4	1.3	10.4	2.8	0.0	0.0	0.0	0.0	43.2	0.5	0.0	0.1	15.1	0.6	0.2	0.0	0.5	0.3	0.4	0.9	0.0	0.8	0.8	1.6	0.0	1.3	3.8	13.7	0.0	0.4	3.3	0.0	0.8	17.0	1.1	0.2	0.7	1.2	5.6	0.0	1.4	3.2	5.7	1.1	0.9	4.4	0.9	0.3
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 219.8;Late spermatids: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 93.5;REH: 45.7"					"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.2	2.9	8.0	5.1	2.3	2.6	1.7	6.4	4.0	3.2	3.0	7.8	4.8	4.8	3.7	4.3	2.0	3.8	4.4	9.2	7.6	10.5	3.1	12.0	5.5	7.5	1.4	7.4	0.6	2.6	5.0	4.3	20.4	3.0	1.2	19.6	11.5	13.3	5.7	1.2	93.5	0.8	2.5	7.9	2.6	45.7	28.1	8.1	4.4	0.1	4.2	27.3	0.7	2.2	3.7	6.1	0.1	12.3	4.7	10.5	16.5	4.1	12.9	7.1	0.1	6.4	1.5	25.5	13.9	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0	23.8	3.0	11.9	19.5	53.5	0.2	14.8	25.5	4.0	27.3	21.0	0.0	42.7	8.3	31.7	219.8	24.1	11.0	0.0	20.1	3.4	21.6	18.1	24.3	18.4	15.0	0.0	16.1	7.4	23.4	186.0	4.6	21.9	18.6	20.8	46.7	0.5	63.1	14.0	3.2	5.1	0.0	6.5	22.1	2.6	46.4	44.2	14.8	20.3	68.3	23.3
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	9.0	16.4	10.3	11.3	11.7	9.2	13.5	9.3	13.7	9.7	8.8	12.2	10.2	15.9	10.9	10.5	13.4	18.3	6.8	15.2	3.7	14.2	8.1	14.8	17.8	10.0	17.1	14.3	23.8	16.1	18.6	10.3	11.6	12.6	20.0	14.2	12.8	21.3	8.7	23.8	15.6	21.6	22.8	13.7	17.6	45.2	8.8	22.7	14.1	10.1	10.2	12.2	14.0	14.8	8.3	8.4	18.6	13.6	22.9	11.7	13.2	10.0	9.0	38.9	29.9	14.2	10.9	9.8	10.6	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1	11.9	14.3	20.4	20.9	21.4	13.1	12.9	15.3	18.7	7.9	10.4	2.0	18.7	13.3	26.6	3.2	26.7	12.9	0.0	32.7	18.8	16.4	18.5	24.3	23.6	20.6	23.8	18.5	31.9	17.0	4.3	18.1	18.9	15.1	64.9	11.8	16.2	30.5	11.8	29.4	12.7	7.5	0.0	22.7	7.5	24.0	19.3	42.9	23.5	13.1	23.1
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 17.9;Ciliated cells: 34.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	7.1	2.1	7.5	1.8	5.1	0.9	3.0	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3.0	2.0	12.3	10.5	2.0	1.4	1.4	4.9	2.9	4.0	5.7	1.6	2.5	8.4	1.7	3.0	3.0	7.7	3.1	3.7	2.0	1.9	1.4	1.3	5.0	6.1	2.1	7.0	5.6	5.7	1.3	6.0	2.5	3.8	6.7	2.6	6.1	4.9	0.6	2.4	6.5	7.9	0.3	2.1	3.9	2.2	2.6	2.0	5.8	0.4	2.6	4.6	2.2	4.2	0.9	0.6	2.5	6.7	2.4	6.5	2.1	1.7	7.4	5.9	3.5	1.7	3.6	4.6	10.1	1.8	8.5	6.2	2.7	2.6	1.0	0.3	1.9	3.1	0.7	1.6	2.3	0.7	2.8	1.9	6.9	2.3	1.1	1.3	2.5	16.7	0.6	0.1	0.2	5.0	2.7	5.7	2.9	5.7	4.7	0.9	0.4	0.4	1.0	6.2	7.0	6.0	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2.0	12.3	2.9	1.4	17.9	6.9	1.3	3.2	2.7	0.4	0.4	0.0	34.8	4.5	10.4	0.0	0.1	5.0	0.9	0.3	2.1	4.7	0.0	1.6	0.1	4.7	1.2	1.1	0.2	0.3	0.0	1.7	6.7	1.9	0.9	8.3	1.1	0.0	0.0	2.3	0.8	1.2	3.7	3.2	5.5	0.7	0.0	1.3	0.0	0.2	2.4	0.2	2.5	3.4	1.4
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 261.7;Late spermatids: 219.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA027751			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	2.5	2.7	7.0	2.2	7.1	1.6	2.5	7.0	8.5	2.6	2.4	5.9	5.5	2.3	3.9	5.3	2.6	3.7	2.6	6.6	6.1	6.5	4.5	2.8	2.2	2.5	8.0	4.3	3.0	2.4	3.2	6.5	2.2	8.6	2.8	2.6	3.9	2.0	3.2	7.5	2.7	2.5	4.6	8.4	2.7	2.2	33.4	9.3	1.3	3.9	2.1	3.0	2.8	2.2	1.5	2.7	1.0	1.1	1.4	4.0	1.3	1.0	2.1	3.1	2.2	5.4	4.6	1.3	2.9	2.6	1.3	3.2	1.9	1.5	2.7	1.8	1.8	6.0	0.9	2.6	1.8	2.6	2.9	2.0	1.4	2.3	3.3	3.3	0.6	0.9	2.2	4.7	3.9	1.2	2.2	1.3	6.5	1.5	1.2	3.5	1.1	2.1	8.0	2.1	0.6	1.0	3.4	1.3	0.8	1.7	0.9	4.8	1.4	2.1	0.5	3.5	3.7	1.8	1.6	0.9	2.6	0.6	3.5	1.0	3.3	4.4	5.2	4.0	2.1	2.0	0.0	0.9	1.0	0.9	1.1	4.0	1.5	1.4	2.5	2.7	1.0	3.8	3.8	0.2	1.4	0.4	1.6	2.3	1.3	7.0	7.1	7.0	8.5	6.1	6.5	8.0	4.3	8.6	9.3	0.0	3.0	0.0	5.7	9.6	12.7	1.6	0.0	5.3	3.4	5.2	3.9	2.4	8.3	2.6	261.7	3.6	0.5	0.0	4.4	1.6	6.9	4.0	3.5	1.8	3.1	6.4	2.9	3.1	0.6	219.5	4.6	4.0	10.1	2.8	0.7	10.0	1.5	0.9	8.5	6.1	9.6	0.0	5.6	30.5	13.2	9.7	3.8	3.2	1.1	3.3
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687339	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 552.0;Suprabasal keratinocytes: 587.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 21.0;non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	8	"B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 99.1;HSkMC: 72.8;hTCEpi: 94.2;LHCN-M2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	81.2	27.0	8.2	21.9	29.8	22.0	38.0	4.8	13.7	25.2	60.8	13.9	10.2	39.8	17.5	17.7	63.5	49.4	47.3	35.9	22.2	8.4	29.1	102.2	55.8	6.3	16.6	4.9	59.1	45.5	12.8	22.8	38.6	44.1	42.0	40.7	8.8	18.0	11.4	98.6	43.5	144.9	40.2	29.6	13.6	25.2	25.3	10.3	6.6	22.7	42.2	27.4	50.5	44.4	8.8	8.5	1.8	27.7	0.2	1.1	13.3	3.0	12.6	9.8	0.2	34.4	61.5	17.9	51.2	41.5	6.4	24.9	1.1	3.0	2.1	1.8	32.1	5.8	7.1	0.4	56.5	10.3	4.1	2.6	0.3	10.5	15.7	99.1	0.0	15.3	72.8	94.2	58.1	18.3	38.4	33.0	0.1	0.5	14.4	73.5	6.5	0.4	1.3	1.2	13.2	1.8	6.2	8.0	3.6	11.2	23.5	4.4	4.2	11.9	1.0	2.4	24.0	3.8	12.8	18.2	11.1	10.5	0.7	4.1	24.3	4.7	6.2	14.3	1.1	30.8	0.0	9.3	0.2	0.2	21.0	0.3	8.8	0.4	0.3	8.0	5.7	0.1	0.1	1.8	0.2	27.7	8.5	1.1	13.3	8.2	29.8	4.8	13.7	22.2	8.4	16.6	4.9	44.1	10.3	77.4	46.3	55.8	285.6	391.3	0.8	136.8	25.5	111.1	48.9	64.6	0.0	32.4	39.7	181.3	0.8	177.8	381.7	0.0	232.1	45.7	194.3	196.1	100.6	63.5	65.3	0.0	168.6	36.2	64.4	2.7	31.9	187.2	207.5	477.9	174.4	59.3	293.5	115.8	15.6	11.0	1.8	25.8	552.0	0.3	1.7	587.4	129.9	10.2	43.4	488.6
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722371	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Muller glia cells: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	29.8	30.9	30.2	25.0	30.0	40.2	45.3	64.5	50.6	31.6	34.4	35.6	19.9	29.2	33.1	19.8	26.0	24.3	24.3	21.2	33.0	29.5	20.8	23.3	29.2	38.5	42.9	25.1	46.2	15.1	22.2	15.9	26.8	26.3	25.1	22.2	31.4	23.5	24.2	48.8	26.1	26.4	19.4	46.0	34.3	19.4	19.2	39.0	43.0	29.4	21.4	25.5	34.1	29.1	6.2	3.3	19.2	4.5	6.2	10.6	2.9	12.4	6.2	33.2	5.8	11.4	6.5	16.3	11.7	18.6	16.2	20.0	17.7	14.1	0.1	4.4	6.6	5.8	11.9	15.5	5.7	14.5	21.1	11.0	9.7	17.1	17.8	15.3	8.2	6.9	7.1	12.4	5.3	15.6	38.1	9.6	18.8	10.4	35.5	5.7	15.9	11.5	11.8	13.3	10.8	5.8	8.5	10.8	20.9	7.8	13.5	12.6	20.7	16.8	12.1	21.9	12.4	6.4	18.5	6.5	8.0	12.8	7.2	11.3	30.8	20.3	11.2	10.0	12.4	7.7	4.5	3.1	6.8	5.4	3.1	5.6	6.2	6.9	6.5	3.2	4.8	7.4	5.2	19.2	6.2	4.5	3.3	10.6	2.9	30.2	30.0	64.5	50.6	33.0	29.5	42.9	25.1	26.3	39.0	41.7	24.0	37.6	14.6	46.8	43.1	37.8	20.4	48.2	27.3	8.7	25.5	36.5	13.3	8.0	57.9	56.5	24.9	23.3	8.0	38.1	31.0	32.5	30.1	26.7	22.7	9.5	43.9	46.6	57.3	37.2	51.8	41.9	70.9	14.4	35.8	157.6	10.4	17.5	25.1	12.1	25.0	90.5	40.9	7.7	4.9	45.9	32.6	76.1	40.2	13.6
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974633	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 53.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	42.1	12.6	5.9	10.7	7.9	14.9	31.7	4.3	5.7	13.1	13.0	8.7	7.7	6.6	17.1	13.9	11.5	8.4	13.7	20.1	5.7	3.1	7.4	3.3	7.9	11.0	13.7	5.3	22.5	9.4	23.1	5.7	3.1	3.9	10.3	5.7	6.0	5.4	12.2	9.2	8.5	7.9	15.1	7.5	8.5	5.3	5.3	8.9	54.2	8.0	4.9	9.8	17.4	21.7	3.4	7.4	12.2	2.5	6.0	14.1	3.8	14.0	5.8	1.1	19.4	20.0	2.9	0.2	13.4	13.6	22.5	19.8	0.3	4.8	27.6	12.1	11.4	8.2	1.7	13.0	1.7	11.1	16.7	17.5	20.9	44.3	3.5	1.0	14.5	9.6	1.0	0.3	6.1	2.6	8.5	5.9	22.9	9.4	0.0	13.0	3.5	18.7	7.0	0.0	5.3	14.2	22.3	18.3	0.0	7.1	5.9	9.8	23.0	18.3	12.8	4.3	0.1	6.3	49.3	4.7	25.8	10.0	15.6	0.2	28.3	26.9	22.7	0.0	53.0	22.8	12.2	2.5	11.0	5.2	1.4	6.0	3.4	7.7	6.8	6.1	1.9	4.3	4.1	0.2	6.0	0.6	7.4	14.1	3.8	5.9	7.9	4.3	5.7	5.7	3.1	13.7	5.3	3.9	8.9	0.0	4.6	5.3	2.5	9.0	4.2	12.5	2.5	2.7	2.3	3.5	15.7	1.1	14.9	3.3	3.6	5.3	3.9	70.0	3.1	11.0	20.6	2.5	16.1	6.0	22.5	4.8	8.1	17.2	19.7	5.3	36.5	11.2	6.8	24.4	4.8	27.8	4.0	4.0	44.9	26.6	9.7	84.1	18.6	5.1	6.8	9.8	1.6	33.8	3.9	1.0
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566462-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;bone marrow: 119.4"	"Cell type enhanced"	"Detected in all"	6	"Spermatocytes: 111.8;Spermatogonia: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;MOLT-4: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	5.5	4.7	27.9	6.8	24.2	119.4	4.1	14.3	28.7	2.6	3.9	4.2	0.5	3.9	2.4	2.5	3.8	3.0	4.0	8.4	22.9	17.9	2.7	2.1	6.6	11.1	14.3	14.3	2.8	2.8	2.6	3.4	4.8	11.8	2.5	3.6	2.4	3.2	3.0	6.3	6.0	3.5	4.6	5.7	9.7	2.8	10.9	3.6	18.6	1.8	2.8	8.4	4.2	2.4	17.3	16.0	44.1	10.7	11.9	11.3	9.5	11.0	1.7	5.7	3.7	3.0	4.7	1.4	7.3	8.6	8.1	7.1	2.2	2.7	3.1	2.4	7.7	8.2	2.3	1.9	1.8	2.9	12.3	4.6	32.8	2.0	3.6	3.5	3.3	26.6	1.9	6.1	4.1	3.1	6.7	2.2	19.5	1.3	27.0	8.0	1.5	40.4	17.3	1.1	8.5	8.5	6.6	5.5	1.8	3.6	0.9	8.0	4.2	5.1	3.9	5.6	1.1	3.5	8.7	1.7	9.6	4.9	15.8	10.8	16.9	5.7	5.7	10.1	5.6	6.8	35.9	5.6	23.5	10.0	6.8	8.0	17.3	8.3	11.3	5.4	15.9	7.9	9.4	44.1	11.9	10.7	16.0	6.7	9.5	27.9	24.2	14.3	28.7	22.9	17.9	14.3	14.3	11.8	3.6	6.0	9.5	48.4	13.8	20.6	28.1	8.5	2.5	5.3	3.4	5.2	11.8	2.4	8.3	6.0	15.3	15.3	5.8	46.7	4.3	7.1	11.0	10.0	20.7	3.0	8.7	44.5	6.9	20.3	36.0	8.5	6.6	24.1	28.7	10.8	5.8	17.7	9.9	10.5	5.6	3.4	29.5	19.4	30.3	111.8	87.1	29.0	4.1	44.9	3.6	23.8
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	23.0	0.0	28.4	11.0	0.1	0.6	0.2	2.2	2.2	0.0	0.0	0.0	0.0	0.2	8.3	0.0	8.1	0.0	3.2	0.0	4.0	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	0.6	2.9	0.0	0.0	0.0	2.6	0.0	0.5	0.1	8.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.0	0.0	2.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3	0.0	2.2	0.0	0.5	0.7	16.3	1.6	0.0	0.0	0.0	1.8	5.9	255.3	0.0	6.0	5.8	3.2	0.0	0.0	0.2	7.4	16.4	1.0	0.0	126.0	20.1	1.6	1.7	21.5	4.9	8.9	84.3	0.2	1.7	1.0	0.0	31.8	0.5	0.0	35.3	0.6	2.9	12.9	3.3	1.5	0.2	1.1	403.0	0.0	0.0	0.1
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	7.3	12.7	10.4	9.4	10.9	5.3	7.8	10.6	12.4	10.1	11.4	11.4	5.3	7.0	12.4	11.8	6.0	11.9	8.3	14.1	10.4	6.8	9.4	8.5	9.4	9.0	10.7	9.5	11.2	8.5	8.0	11.1	7.9	10.9	11.0	6.0	10.3	15.5	11.8	12.3	7.7	9.4	8.2	8.7	11.6	9.9	4.0	10.9	12.9	11.2	5.2	9.6	8.1	12.2	8.9	11.6	11.0	8.5	8.3	11.6	7.3	5.5	4.1	6.6	9.6	4.2	7.3	5.5	3.0	4.4	6.1	5.7	0.7	5.7	5.6	3.2	2.2	3.5	6.4	3.0	1.0	3.7	5.3	10.5	3.0	6.2	6.2	7.6	8.1	4.5	7.9	5.9	4.5	5.5	5.0	4.5	10.5	5.8	7.1	4.3	4.0	10.0	5.8	5.1	7.9	4.0	6.4	2.7	12.1	4.6	1.8	3.3	8.0	3.7	6.6	6.3	2.7	7.1	3.4	3.5	11.5	7.3	6.4	3.7	7.0	3.3	4.4	5.3	5.9	11.2	1.5	6.5	11.0	10.1	8.0	9.5	7.3	9.9	8.9	5.5	8.9	11.6	8.4	1.7	8.3	8.5	11.6	7.4	7.3	10.4	10.9	10.6	12.4	10.4	6.8	10.7	9.5	10.9	10.9	6.0	3.8	10.4	2.2	1.5	4.5	4.7	5.1	8.1	2.3	7.0	0.0	11.4	6.6	8.3	0.8	7.1	2.0	0.0	9.8	8.3	4.9	4.0	13.9	4.3	8.2	0.0	4.1	4.3	3.7	0.2	4.6	4.0	5.0	11.8	3.3	4.4	6.3	0.0	7.4	5.4	4.8	12.9	7.3	2.4	7.0	1.8	3.8	7.2	4.9	1.8
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.4	6.8	0.2	2.0	0.2	0.7	0.2	0.5	1.5	0.2	0.7	5.1	15.6	0.1	0.4	1.3	1.6	28.6	0.4	0.3	0.4	2.4	0.3	0.1	9.7	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.1	0.4	0.0	1.2	0.8	0.1	0.4	0.2	0.2	7.1	0.8	0.0	0.4	0.0	1.9	3.7	0.1	0.2	2.3	2.0	0.1	0.8	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0											0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.4	0.0	0.0	0.0	0.0	0.3
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.4	0.2	0.6	0.1	0.0	0.0	12.0	0.0	0.1	0.3	0.2	4.8	20.5	0.0	0.9	0.0	2.4	12.1	3.7	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.6	0.0	3.7	0.4	0.0	0.7	0.0	0.0	0.0	8.1	0.1	0.0	1.7	19.7	0.8	0.0	0.0	2.4	5.7	8.7	4.8	0.1	1.3	27.8	0.0	2.3	8.5	0.2	0.0	0.0	0.6	1.2	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3	14.9	36.5	0.5	24.3	25.8	16.5	1.6	17.8	105.7	27.3	38.4	9.8	49.0	3.3	23.6	5.9	2.1	44.6	0.0	20.1	9.6	1.5	29.0	0.0	0.0	10.4	20.6	21.5	1.8	2.2	3.1	0.6	5.6	0.0	1.0	45.1	28.4	30.8	31.6	0.4	14.7	28.1	0.0	1.3	2.3	3.8	47.3	47.9	0.0	47.2	32.3
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803213-88809258	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease mutation, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.2;esophagus: 7.1"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 46.7;Extravillous trophoblasts: 78.3;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 39.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.4	0.4	0.7	2.7	0.9	25.2	0.4	0.0	1.2	1.2	2.5			2.9	0.3	0.0	7.1	0.3	0.0	0.1	0.6	2.2	0.5	0.6	0.9	3.2	1.7		0.0	0.4	0.9	2.1	2.0		0.3	1.0		0.8	0.1	0.0	3.3	3.2	0.3	0.8	3.1	1.7	3.3			0.1		2.1	0.2	1.9	3.7	2.1	3.5	0.9	1.7	4.0	0.7	9.7	10.2	4.4	7.5	0.2	0.9	17.9	6.6	1.8	5.2	3.3	20.8	10.0	14.4	7.4	1.4	3.5	12.6	5.6	4.5	1.7	5.1	23.9	13.5	9.0	17.4	0.0	7.6	5.9	0.4	0.3	5.3	1.1	0.4	1.6	18.6	21.9	4.8	1.9	24.1	31.3	39.6	11.5	3.0	8.2	33.5	6.0	12.6	1.1	7.4	10.7	7.9	11.5	3.6	5.0	2.0	11.4	15.7	1.7	7.3	11.7	11.0	9.7	17.9	15.5	19.8	5.4	19.5	8.8	0.5	0.9	3.5	2.7	0.5	1.1	1.2	2.7	2.7	1.0	3.7	4.0	2.4	2.1	1.7	0.7	2.1	3.0	0.7											0.0	0.6	7.5	3.4	10.0	0.2	1.6	2.5	2.7	2.3	1.8	0.0	24.8	1.7	1.0	0.2	1.2	2.1	46.7	0.0	78.3	1.3	1.7	0.0	0.9	16.4	0.0	2.4	0.6	4.1	0.7	0.3	2.5	1.7	2.8	9.3	1.1	0.5	0.0	0.4	1.0	1.8	0.0	2.0	2.7	28.5	6.1	20.7	3.2	18.0	3.4
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT/enhancer binding protein alpha"	P49715	19	33299934-33302564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 52.3;liver: 44.3"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 84.7;Hofbauer cells: 76.1;Suprabasal keratinocytes: 150.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.0;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 43.5;Hep G2: 23.3;NB-4: 24.0;THP-1: 86.8;U-937: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	40.7	1.5	2.3	7.6	4.6	8.4	52.3	2.1	4.0	3.5	9.0	5.2	1.1	9.0	2.2	2.1	6.1	2.4	6.4	6.6	3.9	2.4	2.0	44.3	39.9	10.3	4.1	3.1	1.3	9.0	4.5	1.7	17.4	2.7	3.8	5.1	1.9	5.6	1.6	15.4	23.7	12.7	2.9	6.6	3.0	3.5	1.2	2.6	2.2	2.5	10.7	3.5	5.4	7.9	0.1	4.1	11.0	11.8	0.0	0.6	1.5	0.5	1.1	0.0	1.5	12.5	0.0	43.5	0.0	0.3	0.0	0.0	5.3	0.0	0.0	0.6	0.0	0.2	2.0	1.2	0.1	0.0	7.5	1.5	0.0	0.0	23.3	0.2	7.6	9.3	0.5	5.6	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	2.6	0.0	24.0	1.1	13.1	0.6	0.0	0.0	0.2	0.0	3.8	0.0	0.3	0.1	0.1	0.1	1.4	3.0	86.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	27.8	0.0	11.0	6.0	0.0	0.6	9.4	0.6	0.0	0.1	0.4	4.1	0.1	0.2	0.4	2.1	0.0	11.8	0.2	0.0	1.5	2.3	4.6	2.1	4.0	3.9	2.4	4.1	3.1	2.7	2.6	14.9	27.8	1.4	20.5	33.2	0.7	0.4	25.5	6.7	5.7	0.0	0.0	27.5	3.3	0.6	0.0	0.6	62.2	0.0	5.0	35.2	6.1	11.7	1.1	84.7	76.1	0.0	4.1	1.3	21.4	0.0	2.8	23.2	5.0	1.0	22.1	8.0	2.1	31.3	1.4	3.7	0.3	0.0	4.1	0.2	0.7	150.2	177.5	1.0	26.9	9.5
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Group enriched"	"Detected in some"	4	"HL-60: 59.4;NB-4: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	30.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.6	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT/enhancer binding protein zeta"	Q03701	2	37201612-37231713	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.3	23.0	13.1	23.7	14.4	20.0	21.7	17.0	16.4	22.4	17.8	8.4	17.2	12.8	17.2	16.6	18.6	17.4	12.6	19.4	12.0	12.9	30.5	22.6	15.4	16.7	13.2	12.9	24.2	17.2	18.8	27.3	18.2	16.5	20.4	15.5	8.2	15.5	17.9	88.0	14.0	19.1	19.5	15.4	23.1	15.5	27.3	14.1	19.5	22.5	18.7	17.5	30.1	41.0	20.8	17.4	17.2	14.7	17.0	23.1	9.2	19.8	15.5	16.0	8.8	15.8	17.1	13.6	19.0	13.2	16.1	17.5	24.5	15.1	36.6	17.0	11.2	22.1	17.1	41.3	19.5	20.8	23.3	18.2	34.0	16.0	19.9	12.5	34.1	15.4	13.0	19.3	21.4	21.9	10.7	14.5	9.3	37.0	16.9	16.4	10.3	19.8	26.8	52.1	26.6	14.6	15.9	26.0	27.6	15.5	18.8	17.1	27.7	15.8	19.5	21.4	24.2	14.1	15.0	11.8	15.8	18.0	14.0	26.0	19.0	19.9	29.7	14.1	31.6	17.3	17.2	11.7	10.6	17.2	14.7	21.7	20.3	18.2	16.6	11.8	20.8	23.1	19.1	4.2	17.0	14.3	17.4	14.0	9.2	13.1	14.4	17.0	16.4	12.0	12.9	13.2	12.9	16.5	14.1	80.4	74.1	56.7	60.0	95.1	42.9	29.1	56.0	68.3	106.9	47.1	41.2	45.8	91.2	46.1	195.9	50.1	23.4	46.7	53.9	30.2	41.0	51.4	70.6	63.1	30.5	41.3	42.4	44.8	35.3	23.2	56.4	35.5	20.3	47.7	48.2	52.7	48.9	24.6	47.7	55.4	87.8	51.8	44.3	132.2	95.3	88.3	37.6	59.7	48.5	54.3
CECR2	KIAA1740	ENSG00000099954	"CECR2, histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.1;skeletal muscle: 30.6"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 94.7"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.8;HAP1: 11.7;K-562: 6.4;NTERA-2: 18.7;SCLC-21H: 8.4;SuSa: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	1.8	1.3	4.6	1.0	8.8	1.5	2.0	25.1	8.4	1.1	1.2	10.6	0.8	1.0	4.3	1.7	1.4	2.5	1.0	4.4	6.1	2.8	1.9	6.5	4.1	0.9	8.0	4.0	5.4	5.6	0.8	8.4	4.7	5.8	2.3	1.1	4.9	1.9	1.1	30.6	1.6	1.2	2.2	5.7	1.4	1.1	6.0	8.0	0.0	2.7	2.2	0.9	2.3	2.5	0.2	0.1	0.9	0.8	0.5	0.1	0.0	0.1	0.0	12.8	4.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	11.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.1	0.0	0.4	18.7	0.0	0.0	1.4	0.8	0.0	0.0	4.1	8.4	0.0	0.0	0.1	0.7	7.8	1.3	2.0	0.1	0.1	2.8	0.0	0.0	4.8	1.1	1.0	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.1	0.0	0.0	0.0	4.6	8.8	25.1	5.0	6.1	2.8	8.0	4.0	5.8	8.0	6.0	8.8	0.0	0.8	0.0	21.9	10.0	0.0	1.4	1.2	1.8	159.0	7.6	0.0	0.0	3.1	1.9	0.0	0.0	0.2	2.0	0.3	1.6	0.0	9.7	0.6	4.8	0.0	3.7	0.0	3.2	1.1	0.0	0.0	0.0	0.0	22.4	0.2	0.0	1.1	1.1	94.7	6.5	1.0	1.5	15.5	0.1	27.6	0.0	0.0	3.7
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.1;HaCaT: 15.2;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.7	24.1	4.6	3.9	0.0	0.0	2.2	0.7	1.5	1.4	0.3	5.7	6.8	0.0	11.9	0.1	9.3	15.2	3.8	11.5	0.5	0.0	4.6	0.0	9.7	0.2	0.2	1.5	0.6	0.0	10.8	0.0	9.6	9.1	0.0	0.6	0.0	0.0	0.0	10.9	0.0	1.7	1.7	2.8	3.8	0.0	0.0	2.8	6.4	5.4	0.2	0.3	7.5	6.0	1.2	1.9	17.3	5.1	0.3	0.0	0.1	0.0	0.1	4.6	0.2	2.4	6.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0	38.7	16.8	1.3	3.3	15.1	0.0	10.2	0.0	33.5	27.3	5.2	0.0	1.0	0.0	1.4	1.2	5.5	0.0	0.0	0.6	1.7	1.7	3.6	0.0	1.6	2.4	0.0	1.2	1.3	0.0	5.0	0.0	1.3	5.0	1.8	2.0	1.3	2.6	0.0	0.0	11.0	0.3	0.0	1.0	0.2	0.2	13.7	0.7	0.0	1.5	4.7
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786690	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477"	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	30.4	18.9	41.2	18.0	41.6	11.9	22.9	13.0	28.9	22.4	23.0	41.1	18.7	19.6	18.4	19.8	22.3	18.1	27.3	26.9	41.9	29.1	19.8	20.3	20.0	16.0	48.0	14.7	25.0	23.9	22.7	12.1	15.2	22.0	18.6	12.3	13.0	27.6	24.3	58.3	32.6	19.9	20.1	55.8	19.8	21.9	9.0	21.9	19.6	21.7	26.4	14.9	20.7	28.0	3.7	4.2	1.4	4.5	3.9	5.0	2.5	32.0	41.4	8.1	17.3	17.3	13.8	5.2	23.1	16.9	14.9	12.1	16.8	23.2	11.2	7.2	21.4	23.3	26.0	6.4	26.3	7.5	15.9	11.0	23.8	14.9	14.8	20.2	7.7	8.0	15.6	14.1	21.3	13.7	11.7	12.7	14.6	15.3	7.1	12.6	52.9	23.0	17.8	10.2	18.2	49.4	19.2	1.0	8.2	15.5	19.9	20.0	14.9	19.1	26.9	18.0	3.8	16.9	17.2	21.5	25.9	14.0	22.3	35.2	8.6	12.4	6.6	9.0	27.8	16.9	0.1	4.5	1.4	5.0	4.0	3.5	2.5	3.6	3.1	3.2	3.7	3.3	3.8	0.6	3.9	2.6	4.2	1.0	2.5	41.2	41.6	13.0	28.9	41.9	29.1	48.0	14.7	22.0	21.9	6.0	17.9	1.5	4.7	12.4	16.8	13.6	33.1	10.7	10.3	14.0	9.8	4.5	3.3	16.2	0.8	17.9	29.0	0.0	25.4	6.4	12.7	10.4	7.0	22.2	19.3	20.6	19.7	17.8	20.8	3.9	20.1	13.0	16.9	10.8	24.3	28.3	24.5	20.4	24.4	6.5	12.2	12.9	13.7	1.2	1.3	12.3	3.8	6.4	21.0	6.2
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.7;testis: 28.9"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 9.5;Spermatocytes: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	6.9	6.0	6.6	7.6	7.8	15.4	6.3	6.2	11.9	4.4	6.6	8.3	2.6	6.5	4.6	3.9	6.3	3.6	3.4	3.3	8.4	6.4	5.3	3.5	4.9	9.2	6.2	6.5	6.6	4.9	4.2	5.2	6.7	7.9	4.4	7.9	3.6	4.1	2.8	5.6	7.9	6.0	4.6	6.3	6.6	4.8	28.9	5.7	28.7	5.0	6.5	11.4	4.7	4.9	1.6	4.1	0.3	1.2	2.1	3.5	1.3	13.9	16.6	19.3	10.2	2.3	3.6	10.7	16.9	10.1	24.1	18.5	21.1	7.1	9.7	2.0	10.5	14.1	7.5	18.9	6.5	16.2	12.6	9.9	15.3	10.5	14.0	1.1	12.7	11.6	1.7	1.1	24.0	5.3	4.4	11.1	11.7	17.8	11.1	14.8	9.8	17.4	9.3	13.8	9.5	10.5	14.1	25.0	5.2	6.1	8.6	12.7	13.9	10.0	7.9	3.7	9.1	7.6	5.4	7.1	22.3	20.4	7.4	18.8	6.8	9.0	19.7	6.9	12.5	17.0	0.0	1.2	0.0	3.5	0.9	1.5	1.6	1.6	2.0	1.9	1.3	1.2	2.7	0.3	2.1	1.1	4.1	2.7	1.3	6.6	7.8	6.2	11.9	8.4	6.4	6.2	6.5	7.9	5.7	3.0	2.1	1.4	0.6	1.0	1.0	4.5	0.0	0.0	1.2	3.5	0.0	1.9	1.7	1.4	3.2	0.9	1.8	0.0	1.2	9.5	2.0	0.5	1.1	0.8	4.1	1.6	0.0	2.5	1.8	7.0	0.3	1.0	1.7	1.0	1.6	1.5	1.0	0.0	1.1	1.4	0.3	0.0	1.4	12.0	7.5	1.3	2.4	0.8	1.3	0.7
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.1	5.1	2.9	3.2	6.7	8.4	4.7	10.5	8.4	2.3	4.6	10.1	3.9	2.7	9.7	9.6	6.8	4.6	9.8	14.4	8.0	10.3	4.5	3.3	1.5	21.1	10.0	3.4	2.6	10.2	6.6	1.4	5.3	10.0	11.1	14.7	8.0	5.0	29.6	6.4	5.7	15.0	9.5	10.0	11.6	11.3	1.6	8.0	15.8	5.5	9.5	6.1	3.0	5.3	3.2	6.5	2.5	10.3	5.1	15.5	12.0	9.8	11.4	13.3	11.5	10.5	9.3	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5	0.0	0.3	1.5	3.6	56.2	6.4	2.0	2.5	0.0	1.2	0.0	7.9	2.7	1.7	0.9	15.3	3.1	0.7	0.0	2.0	8.2	5.6	2.1	0.0	0.8	13.9	1.6	1.2	1.3	1.3	3.6	4.0	3.0	13.5	0.0	0.6	2.5	1.2	0.0	4.6	1.1	7.5	6.5	6.7	11.1	5.7	88.2	3.2	4.3	1.7	2.4
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 353.4;Late spermatids: 668.4;Spermatocytes: 448.9;Spermatogonia: 166.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.3	6.6	28.4	14.3	1.5	2.5	15.1	14.1	6.3	11.6	8.0	7.9	13.5	19.5	1.3	6.6	8.9	9.4	23.4	14.4	11.8	9.4	9.3	16.8	6.0	4.0	0.2	29.6	11.7	1.2	0.7	14.2	2.7	3.9	12.0	20.2	18.4	58.6	21.6	15.5	38.0	18.9	15.0	5.6	8.9	30.1	9.2	5.7	6.4	9.0	20.1	21.4	10.2	13.1	10.7	12.1	18.0	16.2	7.2	10.4	13.5	10.6	16.2	8.7	8.7	16.0	14.5	23.0	33.9	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6	8.9	2.7	6.0	3.6	12.4	0.9	2.4	2.5	6.7	10.3	1.8	0.0	13.0	3.3	4.4	353.4	0.7	1.1	23.3	2.2	45.0	5.2	2.9	9.2	0.8	18.2	0.0	0.0	1.3	5.4	668.4	8.3	9.9	0.0	7.2	5.6	0.3	2.7	0.0	6.3	0.6	1.3	19.4	1.0	448.9	166.7	18.7	6.3	4.4	8.5	5.4
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635538-66192084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 912.3;Late spermatids: 1163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.0;RH-30: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024481			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA024481: AB_1846153"	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	10.0	3.8	6.0	9.0	8.3	1.7	9.6	2.9	6.5	11.5	6.7	1.9	14.9	1.9	8.8	10.2	4.3	6.9	6.6	7.4	5.9	4.3	5.2	2.9	6.9	2.2	4.3	3.4	7.7	4.3	8.4	28.3	6.6	6.8	8.6	3.2	7.2	2.9	13.9	9.5	3.1	2.9	9.8	7.4	7.9	4.5	39.5	4.3	4.2	6.8	6.9	1.8	6.6	13.6	3.0	4.1	4.3	1.3	2.9	2.7	0.5	2.5	5.3	7.0	2.0	3.8	7.8	0.2	2.3	4.1	2.9	2.7	0.7	1.1	0.9	2.3	5.1	8.3	0.3	1.5	1.5	4.2	1.4	2.4	0.1	2.3	0.9	1.7	0.3	0.1	4.6	2.6	2.7	0.8	5.9	8.9	1.4	0.1	2.7	17.0	0.3	2.6	0.2	0.7	0.5	2.2	0.7	40.1	0.2	3.2	0.1	1.9	3.9	2.5	0.2	1.8	6.4	2.0	0.2	3.9	7.8	4.4	2.0	3.5	1.2	1.0	0.1	2.4	0.1	2.8	2.9	1.3	1.1	1.1	0.6	1.9	1.0	2.7	1.2	0.7	3.0	1.7	1.4	4.3	2.9	0.8	4.1	1.7	0.5	6.0	8.3	2.9	6.5	5.9	4.3	4.3	3.4	6.8	4.3	8.9	27.3	0.8	2.4	2.3	21.5	23.0	2.5	37.5	26.1	1.8	19.6	0.6	1.7	5.2	912.3	18.7	0.0	0.0	4.1	1.2	8.5	1.8	2.3	0.2	1.4	1.6	1.7	8.6	0.6	1163.2	23.0	4.4	13.5	0.0	0.0	14.1	4.6	0.0	18.7	2.8	150.6	12.9	7.2	22.8	13.1	1.4	0.1	0.9	1.5	1.4
CEP126	KIAA1377	ENSG00000110318	"Centrosomal protein 126"	Q9P2H0	11	101915015-102001058	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 47.3"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;EFO-21: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038381, HPA038399"			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038381: AB_10669780, HPA038399: AB_10670157"	"unprognostic (7.61e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.55e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.72e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.99e-3)"	7.6	11.1	9.0	2.4	20.2	2.4	8.3	16.8	14.8	7.9	4.2	5.0	4.2	2.0	9.1	6.7	5.3	17.5	4.9	4.5	9.6	8.3	3.8	1.4	6.1	3.3	7.5	10.2	11.4	5.0	6.4	47.3	2.6	12.4	6.6	4.8	3.2	3.2	7.6	2.3	8.5	2.7	7.3	9.2	3.1	4.0	19.2	8.9	0.5	7.4	1.5	2.5	3.9	9.7	2.5	4.8	1.4	0.5	3.3	2.0	0.5	0.9	2.2	1.1	1.3	10.0	5.5	0.5	2.1	1.8	1.0	0.9	0.6	3.0	1.3	9.5	1.9	4.4	0.9	1.3	2.4	0.9	3.1	1.5	0.3	3.7	1.2	1.1	0.2	0.3	1.9	4.7	1.3	2.8	5.1	3.0	1.3	0.3	0.4	2.5	1.1	1.1	0.3	0.8	1.1	1.7	0.2	1.1	0.2	2.0	1.2	2.7	4.2	1.3	1.9	0.3	2.0	3.7	0.4	1.7	3.3	1.9	1.0	2.2	2.2	1.2	0.2	3.2	0.3	1.3	0.7	0.5	1.0	2.0	0.1	0.9	1.8	1.2	1.6	0.4	2.5	1.7	1.7	1.4	3.3	0.2	4.8	0.3	0.5	9.0	20.2	16.8	14.8	9.6	8.3	7.5	10.2	12.4	8.9	8.9	7.0	0.5	4.6	0.0	17.6	7.5	5.1	254.3	43.3	17.4	43.2	1.2	3.3	2.0	13.5	3.0	0.0	0.0	0.3	0.7	3.5	2.8	0.0	0.0	0.3	96.9	64.4	3.1	0.0	6.9	49.8	1.4	0.0	0.0	10.3	26.8	1.0	0.0	48.1	4.4	47.8	6.5	1.6	115.1	25.4	0.0	0.1	7.0	1.3	2.0
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 428.0;Early spermatids: 226.1;Late spermatids: 212.9;Rod photoreceptor cells: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	9.0	12.6	9.3	18.4	9.4	16.0	3.0	17.9	10.1	12.9	12.7	15.5	14.7	17.9	13.0	11.0	12.7	12.0	10.3	10.5	11.1	17.7	8.5	5.4	12.4	4.9	13.8	7.7	12.1	11.1	9.0	19.5	19.1	11.6	16.7	8.9	14.6	11.7	10.1	7.8	7.1	7.0	6.6	5.9	13.7	9.6	11.1	7.0	5.7	7.8	10.8	15.7	14.3	8.7	10.3	10.9	12.0	9.1	18.0	15.4	9.6	14.8	16.4	4.2	5.0	10.6	7.5	8.8	10.2	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3	6.0	16.2	12.3	9.5	6.8	78.2	4.2	7.6	37.5	11.4	10.4	428.0	3.8	1.7	9.8	226.1	15.7	5.1	0.0	12.7	5.7	11.2	7.3	18.5	8.1	11.2	69.9	14.9	8.6	6.9	212.9	22.2	10.3	5.0	18.0	8.8	21.5	9.9	5.8	15.9	4.5	288.7	0.0	13.7	36.7	17.4	7.0	1.8	15.9	9.3	4.7
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	18.4	7.3	12.7	9.2	17.0	5.0	16.2	24.8	22.2	19.2	13.2	11.9	8.5	6.6	20.0	10.4	11.7	16.9	12.7	15.7	12.5	11.9	8.4	3.3	9.2	10.6	11.3	17.6	26.4	10.6	13.2	7.5	11.8	15.0	14.2	8.6	11.6	12.0	15.4	28.2	13.6	8.7	17.3	10.3	10.2	9.7	7.6	7.8	10.3	11.6	12.9	9.9	13.4	13.0	5.1	8.7	1.5	5.5	5.2	11.1	3.0	2.8	5.1	9.9	7.2	8.9	10.1	18.2	2.7	4.8	4.2	3.7	3.9	2.5	4.8	3.4	4.9	4.3	3.9	6.5	4.1	4.5	5.8	5.5	6.5	1.8	4.7	2.5	3.7	4.7	9.5	5.9	3.8	5.4	7.5	12.0	10.1	6.0	15.5	5.3	3.3	6.1	6.7	10.0	5.2	4.1	6.5	12.0	5.6	3.7	3.8	17.5	11.9	5.4	4.0	5.7	6.4	2.3	2.4	4.7	4.0	5.5	6.2	2.7	17.0	4.7	11.3	2.1	2.9	4.8	1.0	1.7	0.4	3.0	3.1	3.4	3.4	7.0	5.6	4.3	5.1	11.1	6.6	1.5	5.2	5.5	8.7	5.1	3.0	12.7	17.0	24.8	22.2	12.5	11.9	11.3	17.6	15.0	7.8	26.8	10.4	11.5	13.0	6.4	22.8	13.2	5.1	21.4	20.5	8.7	23.6	13.1	8.3	8.8	2.8	39.8	2.7	0.0	18.9	6.3	11.3	5.9	5.8	5.4	8.4	22.3	12.6	17.2	7.9	4.1	35.1	14.4	6.8	26.2	5.7	14.7	10.1	3.5	25.5	7.5	21.7	32.3	11.4	10.7	23.0	5.1	28.5	12.8	10.6	6.3
CEP83	"CCDC41, NPHP18, NY-REN-58"	ENSG00000173588	"Centrosomal protein 83"		12	94306449-94459988	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038161	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA038161: AB_10674547"	"unprognostic (4.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.59e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (5.00e-10)"	"unprognostic (1.29e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-2)"	6.8	9.8	10.1	11.3	10.5	8.4	9.7	11.8	10.1	8.7	7.4	7.6	7.0	5.5	12.3	12.7	6.7	16.2	6.1	19.0	9.0	6.6	8.2	6.3	7.1	7.7	6.2	7.7	11.0	12.2	9.3	12.1	6.3	8.9	6.8	10.3	7.8	10.0	8.5	7.3	6.3	5.4	11.0	6.3	6.9	6.3	22.3	7.3	10.6	9.7	9.4	8.0	6.7	9.2	7.6	8.5	1.9	3.5	5.7	6.6	2.0	5.7	6.4	10.9	10.3	4.8	6.5	9.4	10.1	3.3	7.3	7.6	7.9	4.8	15.0	2.2	3.0	4.7	8.1	13.1	7.7	11.4	8.6	9.5	8.8	6.7	8.0	4.8	14.4	6.1	4.2	6.5	6.1	18.8	4.4	6.9	12.2	11.3	6.1	7.6	5.7	9.8	24.0	12.5	9.8	11.9	13.5	10.3	15.0	6.7	7.2	11.4	4.7	8.5	10.1	6.9	10.2	6.8	9.1	4.0	8.7	5.4	4.3	7.9	8.1	9.0	13.6	3.6	15.3	8.2	0.6	3.5	1.9	5.8	3.5	5.2	6.6	5.8	4.4	7.7	7.6	6.1	5.4	1.4	5.7	1.5	8.5	6.6	2.0	10.1	10.5	11.8	10.1	9.0	6.6	6.2	7.7	8.9	7.3	14.9	12.5	10.7	13.1	0.0	11.9	22.3	0.0	88.3	21.6	3.5	13.7	5.5	1.7	4.2	27.1	6.5	3.8	0.0	2.9	8.9	4.9	7.3	25.5	4.9	5.0	4.8	14.3	1.8	4.0	10.1	10.0	5.1	0.0	19.8	8.2	4.3	2.8	3.5	6.0	3.7	10.0	0.0	6.4	39.4	22.0	0.0	2.7	5.1	10.3	10.2
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.2	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	2.6	0.1	0.1	0.1	0.0	0.4	26.5	0.3	0.0	0.1	14.7	0.7	0.2	0.3	0.1	0.2	4.0	0.0	17.0	0.0	4.7	0.0	0.0	35.5	31.3	0.6	0.0	0.2	7.6	2.2	0.6	0.3	0.0	23.9	0.7	0.0	0.0	0.1	0.2	0.0	14.8	2.4	1.2	0.6	0.1	1.0	11.4	6.4	2.0	0.9	9.9	10.8	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1	3.0	0.3	0.0	0.1	0.0	0.4	0.7	0.0	52.2	7.9	0.0	17.7	0.0	8.3	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.8	20.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 63.6;Muller glia cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.6;NB-4: 39.0;U-937: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	6.2	6.7	17.5	10.5	22.9	2.5	21.6	14.5	19.3	13.2	6.8	24.3	7.8	4.6	9.9	41.8	26.4	11.9	7.7	9.7	16.1	10.8	16.5	32.4	12.9	12.2	26.9	13.3	13.8	56.7	11.6	10.1	2.2	16.8	22.4	3.2	26.2	34.8	12.8	2.1	20.9	6.1	8.5	20.3	8.6	9.9	8.4	29.0	6.4	38.1	9.5	15.9	9.3	13.2	13.3	2.7	16.9	4.4	13.5	5.2	3.5	0.1	0.9	0.9	10.2	0.3	0.0	0.7	1.3	3.4	1.5	0.7	7.6	0.8	15.9	11.3	0.0	4.0	5.5	6.6	0.1	0.7	14.0	5.2	3.1	0.1	21.6	13.2	0.0	8.7	5.1	8.5	3.6	7.8	4.3	0.1	7.3	2.2	0.5	0.0	0.3	1.2	39.0	10.4	0.0	3.8	19.2	0.2	1.2	2.5	0.0	3.9	5.2	1.7	0.3	5.5	7.2	7.5	3.6	0.0	1.2	3.3	7.6	0.0	10.0	8.0	12.2	0.0	24.4	1.1	5.9	4.4	16.9	5.2	2.3	3.9	13.3	3.0	3.1	2.7	12.1	2.8	2.6	14.0	13.5	1.5	2.6	3.5	3.5	17.5	22.9	14.5	19.3	16.1	10.8	26.9	13.3	16.8	29.0	6.0	12.5	16.4	11.3	16.0	23.7	3.0	12.7	16.0	15.9	1.8	17.7	2.2	6.6	15.6	1.1	6.0	0.0	0.0	26.2	0.4	11.8	36.8	12.7	63.6	12.8	11.1	23.0	6.7	9.8	4.6	13.3	5.6	25.3	29.7	0.2	146.0	15.3	0.0	15.2	35.3	25.4	6.5	10.3	0.7	1.7	22.6	2.4	17.5	0.6	9.8
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.2	10.4	23.0	6.5	12.8	10.8	19.5	20.5	17.7	19.7	18.7	24.5	14.7	14.0	17.2	29.0	10.3	8.7	10.0	7.9	19.6	22.1	10.2	11.7	8.8	14.8	25.6	11.9	16.0	18.5	12.0	16.2	15.1	25.9	17.9	12.3	8.8	13.0	24.7	16.2	10.3	32.4	14.7	5.2	10.1	13.5	15.0	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	15.8	11.2	13.7	17.1	17.0	11.4	12.7	8.9	12.7	12.1	11.3	13.4	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4	17.9	17.3	12.1	17.3	15.3	41.7	5.6	15.3	9.4	14.8	14.0	19.6	27.6	6.6	19.6	0.6	14.9	9.1	0.0	12.2	48.5	20.0	10.2	15.0	3.8	17.4	30.2	15.0	15.4	17.0	1.1	15.5	16.5	11.8	30.7	7.0	21.7	14.2	7.0	16.3	6.8	36.1	32.3	17.6	8.1	7.5	12.5	28.1	20.0	6.0	11.3
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168455862-168775137	"Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044683, HPA063527"	Approved		Uncertain	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA044683: AB_10965059, HPA063527: AB_2685030"	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	12.3	13.5	17.7	12.2	17.5	9.6	14.2	28.0	23.2	12.3	24.4	6.5	19.8	22.4	17.4	17.0	12.7	9.8	9.7	26.9	14.5	15.9	12.1	11.7	9.4	12.5	11.0	15.9	15.6	7.3	15.8	14.6	8.3	9.2	12.2	27.1	13.4	6.9	17.1	9.4	20.0	28.3	11.0	8.5	6.9	21.0	11.0	8.1	25.1	24.1	7.4	7.5	11.8	30.5	0.8	9.0	0.7	1.7	1.1	1.7	0.5	5.9	5.3	9.5	10.9	23.6	17.6	0.0	6.0	6.1	6.4	8.7	8.4	13.2	0.0	8.7	5.4	9.1	11.3	12.2	13.9	10.8	0.0	8.4	10.9	5.7	6.0	20.7	22.9	5.3	19.5	40.1	13.5	10.6	6.4	3.2	16.3	5.8	0.0	13.3	6.5	20.1	6.4	8.8	12.8	7.8	15.6	18.0	10.3	6.1	17.9	13.2	15.9	5.8	15.0	3.1	8.2	13.3	13.1	1.8	16.5	6.9	4.5	10.3	0.1	0.0	0.0	10.8	12.2	11.0	0.7	1.7	0.0	0.3	1.2	0.6	0.2	0.6	0.3	1.3	0.8	1.7	1.3	0.2	1.1	1.0	9.0	0.0	0.5	17.7	17.5	28.0	23.2	14.5	15.9	11.0	15.9	9.2	8.1	6.0	10.1	10.9	40.4	96.7	20.6	40.6	30.6	25.4	18.2	10.4	0.0	0.5	0.0	12.6	4.2	12.7	42.8	0.0	20.1	0.8	10.8	29.9	10.3	41.4	21.3	35.0	99.7	14.7	43.8	2.7	18.4	31.6	10.1	96.4	94.8	31.2	14.0	35.1	37.4	8.4	2.3	64.7	18.6	3.9	3.0	81.1	0.5	8.6	107.7	39.9
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	2.1	1.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.4	1.2	1.1	0.6	0.4	0.5	0.3	0.1	9.1	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	80.3	13.6	0.0	0.0	0.1	1.7	0.1	214.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.1	0.7	0.4	0.0	0.0	42.3	2.0	0.0	0.0	0.0	0.0	0.0
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 1061.9;Spermatocytes: 279.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	13.0	22.7	34.6	9.9	46.6	7.3	25.3	16.7	39.4	23.3	16.7	10.2	18.1	7.8	24.4	39.1	12.3	32.7	21.1	15.4	28.6	34.9	32.4	9.1	15.1	11.0	27.7	29.5	29.3	15.8	32.8	47.1	10.6	36.7	22.1	12.1	13.5	10.6	24.6	6.5	8.1	8.4	19.7	19.3	8.8	16.6	66.4	14.4	8.9	39.9	7.7	9.8	21.7	13.3	8.0	6.2	6.3	2.9	5.5	25.2	8.3	18.1	14.3	15.6	20.3	20.6	39.8	9.4	11.4	23.4	17.6	14.7	10.8	6.7	6.5	26.7	14.9	26.4	12.0	12.0	15.9	22.7	15.7	23.8	9.5	14.1	11.2	22.6	17.6	11.9	19.6	25.9	23.8	28.2	46.6	19.5	13.6	12.0	5.4	22.2	13.5	10.6	19.6	7.9	11.8	14.4	8.3	18.5	6.8	35.8	10.2	23.4	11.8	15.5	8.0	21.0	8.4	13.0	6.1	10.0	18.0	11.0	18.6	15.4	9.6	4.4	2.2	30.4	8.0	8.2	6.3	2.1	6.2	9.1	2.3	17.5	8.0	25.2	14.5	2.7	5.2	21.0	12.8	2.4	5.5	2.9	6.2	13.7	8.3	34.6	46.6	16.7	39.4	28.6	34.9	27.7	29.5	36.7	14.4	44.7	27.1	4.3	48.0	0.0	37.3	31.9	35.7	182.0	50.0	33.2	7.9	12.5	77.9	54.5	1061.9	38.3	4.5	0.0	53.7	20.8	26.9	36.9	36.0	7.2	22.4	22.3	16.4	30.1	6.5	151.0	69.6	14.2	0.0	22.6	15.7	95.2	35.5	14.0	63.6	119.5	74.3	58.2	36.3	279.8	29.1	0.0	6.5	20.3	10.7	27.7
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 29.5;fallopian tube: 46.9;testis: 26.8"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 149.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6.0	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.7	1.3	0.9	0.9	0.0	0.1	0.0	0.0	0.1	3.9	0.0	0.4	0.0	1.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	4.8	0.0	0.7	0.3	6.2	0.2	3.3	0.0	0.1	0.4	0.9	0.8	0.0	0.7	1.3	0.0	0.9	2.9	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	8.4	0.3	2.5	5.9	6.0	0.5	0.5	29.5	3.5	0.0	2.9	0.0	0.2	0.0	0.4	0.3	0.0	149.9	18.2	0.0	5.9	0.5	1.7	0.0	21.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	1.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.8	0.2	2.0	0.0	0.0	25.2	0.3	0.0	0.8	0.0	0.0	0.1
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433485	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 441.3;Paneth cells: 557.6;Proximal tubular cells: 451.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	21.3	33.0	38.3	23.3	32.9	18.7	28.5	31.8	35.4	35.6	24.3	19.5	24.6	18.9	37.4	40.9	21.3	36.1	18.8	19.2	33.7	40.5	40.2	26.6	20.6	16.9	33.6	28.4	54.5	26.9	20.9	53.0	38.5	32.7	28.4	25.8	21.1	23.8	25.6	25.9	20.8	22.2	33.8	38.6	18.0	19.1	38.5	29.7	27.2	28.7	12.6	21.4	26.0	41.1	20.1	28.2	33.7	27.6	15.1	37.8	15.0	16.5	12.3	42.1	15.5	38.3	42.8	12.6	16.6	19.4	22.0	32.0	21.1	22.7	15.9	24.7	20.4	24.7	18.6	32.2	26.4	44.3	6.9	15.3	16.6	11.9	45.1	26.4	17.4	14.5	26.6	22.7	26.6	32.5	38.6	23.9	29.7	23.1	7.4	24.6	37.7	25.6	38.6	20.5	28.1	6.5	46.4	17.3	27.5	24.5	9.1	25.2	21.3	27.8	5.8	22.8	37.9	24.1	31.0	14.2	15.8	17.1	16.6	10.5	14.5	22.6	59.8	15.9	23.2	13.9	28.7	27.3	33.7	19.4	27.6	27.3	19.8	26.7	21.3	28.2	20.1	24.5	23.1	22.4	15.1	25.0	28.1	37.8	15.0	38.3	32.9	31.8	35.4	33.7	40.5	33.6	28.4	32.7	29.7	35.7	47.3	55.9	92.1	51.4	87.2	29.5	86.6	139.2	73.9	109.9	110.0	100.8	167.5	63.8	109.9	72.1	441.3	70.0	82.6	93.0	53.5	100.2	27.7	133.3	67.3	58.8	79.0	55.9	48.2	54.7	115.9	50.3	32.1	44.1	151.7	51.5	79.7	557.6	105.7	451.1	103.9	97.0	53.6	273.8	142.2	57.3	129.5	38.3	90.4	107.8
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539309	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 105.4;Spermatocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	13.3	12.8	18.3	5.7	19.2	10.2	17.3	21.9	18.9	12.7	11.4	16.2	12.7	8.0	14.3	20.1	8.4	12.6	8.3	12.7	15.2	15.4	20.8	10.3	9.9	10.9	16.6	14.6	11.4	19.5	11.2	16.5	10.0	20.1	14.7	9.9	9.8	9.7	16.3	20.7	5.0	9.6	12.4	18.2	8.8	10.2	24.9	16.7	3.0	18.0	6.3	7.2	12.6	9.2	11.9	6.4	31.3	10.7	12.4	13.7	11.7	8.5	7.6	8.0	7.2	13.8	8.6	6.0	8.3	7.5	12.1	11.9	7.0	9.5	4.6	10.5	6.8	13.3	7.5	8.5	7.0	14.3	9.7	7.2	6.5	1.9	8.8	17.2	3.8	3.8	8.5	13.6	9.0	14.8	7.6	8.4	7.8	2.6	5.8	10.9	15.0	3.8	5.8	5.3	7.7	12.0	8.6	9.7	2.8	9.3	11.1	5.7	4.8	6.6	3.5	12.5	7.4	9.4	3.3	7.2	14.9	12.7	6.3	6.9	4.3	5.0	6.7	9.2	4.6	9.9	31.3	7.9	13.4	12.3	9.0	12.3	11.1	13.4	13.5	6.4	11.9	13.7	12.6	8.0	12.4	10.7	5.6	13.5	11.7	18.3	19.2	21.9	18.9	15.2	15.4	16.6	14.6	20.1	16.7	8.9	7.8	12.4	17.2	6.8	17.8	18.5	5.1	18.7	10.3	15.7	9.8	12.5	19.9	19.5	105.4	17.7	12.0	0.0	14.8	9.3	18.6	18.7	28.8	8.6	15.2	11.1	10.3	20.3	11.0	31.0	15.5	13.6	15.1	12.6	8.7	22.4	14.4	12.7	21.2	21.9	12.0	19.4	26.2	79.4	35.5	3.0	10.1	19.2	11.3	11.8
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402662-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 46.7;Spermatocytes: 48.8;Spermatogonia: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.2;granulocytes: 4.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	5.3	5.3	6.3	14.6	7.3	28.2	5.3	12.6	8.8	4.7	7.2	4.9	8.6	6.9	4.7	5.1	11.5	4.7	5.2	4.0	6.1	3.9	3.0	4.5	4.6	13.3	5.5	5.6	4.6	4.4	3.3	4.3	7.5	5.4	6.5	7.2	4.1	7.8	8.1	12.2	11.3	7.0	6.8	4.8	8.2	5.6	20.4	4.9	27.8	3.3	9.8	11.5	6.7	5.9	1.7	15.2	4.3	2.4	1.0	0.8	0.9	21.4	14.7	24.5	15.4	2.4	3.0	12.6	20.4	8.4	17.3	19.6	17.8	7.7	33.1	8.5	6.5	9.8	16.9	20.9	13.9	20.5	19.0	22.9	20.6	21.9	14.0	1.2	23.8	16.8	1.7	2.9	14.2	6.1	3.2	8.1	18.5	24.8	30.0	10.6	12.4	38.4	13.3	27.3	11.0	12.2	28.6	19.4	18.9	4.5	25.6	17.4	13.5	14.0	9.9	8.1	16.1	8.7	17.8	5.8	14.3	12.5	24.2	24.7	15.1	22.3	31.8	12.0	30.7	16.8	2.9	2.3	4.3	0.5	2.4	0.4	1.7	0.6	0.1	2.0	0.8	0.6	0.4	1.2	1.0	0.4	15.2	0.8	0.9	6.3	7.3	12.6	8.8	6.1	3.9	5.5	5.6	5.4	4.9	0.0	4.6	11.2	5.5	8.7	12.5	5.0	2.5	5.3	2.3	5.2	2.0	15.4	1.7	5.7	5.6	3.3	3.8	46.7	5.9	33.8	3.7	3.9	2.3	3.9	10.3	1.6	1.7	2.5	2.8	5.3	2.8	8.7	1.7	12.6	6.2	5.0	5.1	0.0	3.5	2.1	8.4	32.3	3.4	48.8	120.2	13.0	12.2	5.7	10.0	4.1
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98928957	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	13.0	7.4	5.5	15.8	7.5	41.7	10.2	14.9	5.5	9.4	9.3	4.7	7.9	6.6	11.3	7.5	7.6	10.8	10.6	6.8	4.9	3.1	7.3	10.1	12.1	8.8	8.8	3.2	18.1	8.3	9.3	12.0	11.1	6.4	7.7	7.4	5.6	8.1	11.5	13.2	8.2	12.3	8.3	7.2	17.2	8.6	12.0	7.4	70.1	8.1	5.5	9.3	10.4	11.3	10.1	7.1	16.7	8.2	8.1	8.4	2.2	11.0	10.2	23.9	16.2	8.1	8.4	20.9	11.5	7.5	9.3	12.2	12.6	8.6	9.4	11.2	6.6	15.2	9.2	18.7	12.6	19.5	14.7	14.1	16.6	12.1	9.6	8.9	15.9	12.9	7.2	5.2	16.2	16.4	6.3	11.2	30.8	20.0	14.5	9.3	8.9	31.6	6.9	16.0	3.5	12.4	26.9	16.7	14.0	8.2	10.6	11.2	9.6	14.7	7.7	18.6	13.0	7.5	11.0	12.7	20.1	10.8	12.5	20.2	10.1	10.6	19.9	11.0	16.0	12.0	11.4	8.2	10.7	6.5	7.5	8.2	10.1	6.1	6.1	7.1	9.4	8.4	6.6	16.7	8.1	7.1	5.2	6.3	2.2	5.5	7.5	14.9	5.5	4.9	3.1	8.8	3.2	6.4	7.4	44.7	61.6	41.0	98.1	138.2	37.4	25.7	20.4	61.6	79.6	34.9	41.2	44.3	6.6	31.7	85.6	50.1	37.2	0.0	27.6	32.9	75.7	63.5	85.6	26.0	30.8	31.8	30.5	36.2	71.6	14.8	30.0	68.0	64.1	52.3	28.7	17.0	29.9	35.1	18.0	11.0	50.1	45.3	96.8	51.7	52.7	164.7	75.5	54.3	26.9	58.2
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.3;SCLC-21H: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.9	2.0	26.3	4.6	0.1	0.0	8.3	0.2	0.0	0.9	0.8	4.9	3.7	7.6	0.5	0.0	1.2	2.4	13.5	3.9	0.8	2.9	7.2	17.9	3.3	6.4	1.1	5.4	3.3	0.5	3.0	0.0	4.4	1.6	3.9	6.2	1.3	6.8	0.6	4.0	8.4	6.2	18.0	3.9	0.9	17.6	6.2	2.4	2.0	4.5	24.0	11.9	0.7	3.0	7.3	9.7	5.3	5.1	4.5	0.3	4.3	0.3	2.1	7.3	4.2	11.9	1.5	0.6	6.7	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2	29.8	17.4	46.9	22.3	27.0	32.3	30.7	30.6	20.1	23.9	15.7	227.8	7.1	1.7	15.6	11.9	29.6	17.6	0.0	9.7	5.5	7.1	31.3	38.3	9.5	11.9	66.7	83.8	27.0	12.9	7.6	0.9	10.3	20.3	19.8	30.6	155.9	13.9	22.6	0.4	4.2	196.3	0.0	4.4	4.9	3.4	28.2	5.1	13.8	21.7	25.1
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 473.2;Rod photoreceptor cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.8	6.8	15.2	12.3	11.3	16.6	2.6	10.7	7.9	5.7	2.5	3.7	5.2	7.8	7.0	8.8	3.9	7.1	7.9	5.6	8.0	2.7	5.9	11.0	6.5	2.4	7.9	15.2	9.2	11.5	5.6	8.3	10.5	7.6	8.4	4.4	12.9	2.6	7.1	2.3	7.6	3.5	5.5	1.7	5.2	26.8	18.2	3.3	3.4	5.5	6.4	7.2	9.5	3.1	7.9	5.7	3.4	7.0	16.2	10.7	5.4	3.9	7.1	8.1	5.6	13.6	7.6	6.6	10.5	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7	65.5	56.6	64.3	103.8	50.8	251.0	33.9	43.3	68.3	67.1	85.5	473.2	14.5	39.7	49.7	11.6	77.2	66.9	46.7	32.4	24.2	77.4	86.0	91.5	61.4	61.8	208.2	84.2	88.4	58.8	14.5	100.4	67.6	64.1	74.9	67.1	159.3	29.5	60.4	116.0	47.5	752.2	58.2	73.1	79.9	36.0	65.6	20.8	48.9	69.8	73.2
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	13.0	10.6	23.9	14.5	4.9	10.5	10.4	18.3	8.8	11.7	12.6	25.9	28.8	34.0	18.8	7.2	15.6	15.7	14.6	9.6	14.5	21.3	6.7	63.1	8.9	13.2	1.5	32.2	12.0	5.4	2.0	14.8	10.5	7.0	13.9	23.2	32.0	30.0	15.4	6.7	47.8	15.8	24.2	21.3	9.6	29.1	22.3	17.9	10.8	17.4	15.1	16.0	15.0	10.4	4.4	16.9	28.0	10.5	9.3	16.9	14.4	8.1	16.8	6.7	12.0	48.5	6.2	24.3	19.8	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5	3.0	0.3	6.0	4.4	5.6	1.4	3.7	33.1	2.7	5.7	7.0	0.0	9.6	3.3	3.7	3.3	1.9	3.3	23.3	1.0	31.3	5.6	2.0	0.0	0.8	9.4	0.0	1.7	4.9	0.0	2.2	1.4	2.4	0.0	4.6	5.6	2.7	2.4	3.7	1.1	6.8	1.5	0.0	4.1	23.3	60.3	4.3	6.5	4.4	12.0	1.4
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.9	4.8	13.7	17.0	3.9	19.5	8.8	7.4	8.7	9.8	14.4	12.1	10.2	17.7	6.3	5.2	10.6	14.4	20.8	13.6	11.5	12.6	16.0	23.3	9.2	20.2	3.8	14.7	17.1	8.2	6.3	12.6	11.2	6.0	10.8	14.2	14.0	15.5	9.2	21.0	11.8	23.7	19.3	18.5	12.2	25.6	9.4	20.6	6.1	6.2	8.1	4.6	8.3	14.7	8.2	10.6	10.1	13.6	3.7	7.9	9.5	6.9	3.9	9.4	16.5	34.6	7.5	15.5	10.0	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6	8.9	4.5	7.5	4.5	5.7	1.0	1.0	0.0	2.7	4.5	1.8	0.0	10.5	0.0	1.7	4.7	2.2	2.0	23.3	1.2	11.7	8.9	2.3	3.5	0.9	8.4	0.0	1.2	3.1	2.1	0.5	5.8	6.6	1.7	2.8	4.7	0.6	1.3	3.5	4.2	3.2	1.2	0.0	2.8	2.5	20.2	1.9	2.9	4.3	7.9	3.4
CHID1	"FLJ42707, MGC3234"	ENSG00000177830	"Chitinase domain containing 1"	Q9BWS9	11	867860-915058	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 289.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039374	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"	"Intracellular and membrane"	No	No		1700000	"Nucleoplasm, Intermediate filaments"		"HPA039374: AB_10673609"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.96e-2)"	"prognostic favorable (6.76e-4)"	"unprognostic (4.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	18.2	26.6	19.3	17.8	22.2	16.5	19.7	13.4	25.2	20.4	18.3	14.1	23.3	12.9	18.1	40.1	18.5	27.8	25.9	22.0	16.0	19.3	21.0	47.5	14.2	19.6	17.1	17.8	26.1	63.0	20.1	26.8	27.8	13.7	19.5	12.8	21.0	36.8	23.0	14.5	12.8	14.3	22.4	16.5	29.7	16.8	36.4	12.9	10.9	20.3	21.9	13.8	15.6	15.7	20.5	33.6	8.3	23.1	18.4	17.9	18.8	19.5	19.1	14.6	35.5	56.3	30.0	24.6	21.9	26.1	21.6	21.1	20.9	57.8	16.1	20.6	32.1	21.5	38.8	14.4	25.6	15.9	14.0	35.6	11.5	7.1	19.1	26.0	26.6	10.3	29.0	16.3	14.6	21.3	35.8	18.1	20.5	20.9	41.3	14.9	13.8	14.9	35.0	12.9	37.1	29.1	12.9	14.0	29.0	15.8	5.7	27.9	23.0	23.9	33.7	20.4	15.2	13.6	41.0	17.6	24.7	10.8	6.9	17.7	24.4	20.5	9.7	27.6	23.4	19.2	7.6	23.1	8.3	16.9	20.4	17.9	20.5	16.4	17.6	33.6	15.1	17.4	17.4	3.0	18.4	19.2	31.4	14.1	18.8	19.3	22.2	13.4	25.2	16.0	19.3	17.1	17.8	13.7	12.9	38.7	36.7	23.1	47.9	20.3	39.9	20.1	48.4	30.8	23.9	50.6	17.7	97.8	61.3	53.7	96.5	24.8	30.3	23.3	50.7	67.4	51.5	73.1	28.8	71.4	70.9	28.6	51.2	53.4	51.8	289.6	58.1	27.5	52.3	34.3	40.4	59.1	39.0	45.6	54.8	66.6	40.6	51.8	30.3	108.0	122.6	20.5	76.5	17.5	64.8	43.7
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM, Rab escort protein 1"	P24386	X	85861180-86047562	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	12.6	18.8	13.9	9.7	23.2	3.2	11.2	17.8	22.9	14.3	9.3	9.0	8.3	6.6	14.5	7.1	9.7	15.9	10.4	9.9	12.6	11.0	17.7	10.9	9.9	9.2	9.3	12.1	11.8	8.3	20.2	31.9	13.2	17.9	11.3	9.3	7.5	10.4	10.8	16.3	8.1	8.0	12.5	12.1	10.8	10.2	6.6	11.9	14.6	15.6	8.4	8.7	12.1	10.4	7.4	4.6	6.2	7.1	4.9	6.0	3.9	9.0	6.0	6.1	4.1	10.1	10.7	3.9	10.7	9.0	7.5	8.3	4.8	8.4	3.1	13.9	7.7	26.3	5.2	13.3	6.0	12.9	6.2	6.4	1.8	8.7	4.9	8.0	7.6	13.6	8.1	5.7	12.1	15.4	8.3	12.8	5.2	6.4	10.7	11.6	2.6	4.7	2.8	9.2	6.3	9.8	5.0	11.0	4.7	7.0	5.3	5.5	8.4	12.9	4.5	10.1	8.9	3.3	3.7	9.1	9.6	6.8	33.3	5.3	4.0	14.7	4.4	10.3	6.5	8.3	6.2	5.8	4.0	5.5	7.1	5.0	6.6	4.4	5.6	4.6	7.4	5.8	6.0	3.2	4.9	5.6	4.6	5.5	3.9	13.9	23.2	17.8	22.9	12.6	11.0	9.3	12.1	17.9	11.9	3.0	8.3	7.5	14.7	6.2	34.6	10.2	17.8	20.1	12.5	15.7	7.9	8.1	16.6	13.3	0.6	14.3	7.3	0.0	10.7	8.0	11.8	18.5	16.1	11.3	13.6	22.3	18.0	14.7	19.4	0.9	14.4	13.8	5.0	11.8	10.6	28.5	13.0	8.6	11.7	27.6	21.2	45.3	13.7	2.9	10.7	6.5	15.3	13.6	8.8	12.6
CHML	REP-2	ENSG00000203668	"CHM like, Rab escort protein 2"	P26374	1	241628853-241640254	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	6.5	3.8	6.0	5.7	10.5	10.8	7.7	3.6	18.0	6.0	6.4	3.1	1.4	3.8	7.6	5.0	6.1	7.2	5.6	5.1	5.3	5.1	6.5	21.1	12.5	10.0	4.9	13.1	13.3	5.6	8.5	8.2	30.7	4.2	3.7	6.1	2.0	5.8	3.0	7.1	6.5	6.5	5.6	3.7	9.3	5.6	9.9	2.2	14.8	11.0	2.2	5.1	5.2	6.6	1.6	2.9	3.0	1.3	0.5	1.4	0.2	17.6	5.5	8.6	6.8	2.6	7.8	16.8	7.0	3.5	6.1	4.2	10.0	3.3	4.8	10.7	4.6	5.0	3.6	12.0	7.6	11.4	9.3	11.0	6.4	22.4	7.0	5.2	15.2	8.3	6.5	3.4	8.1	8.4	4.3	4.7	13.2	17.2	6.0	7.2	6.9	10.0	10.2	11.4	6.7	17.8	15.3	10.6	16.3	6.1	11.0	11.0	18.2	8.8	6.8	7.6	8.8	7.9	9.9	9.6	12.5	24.3	6.3	13.2	7.0	17.2	5.2	12.2	9.2	19.3	3.0	0.9	0.6	0.5	1.3	0.8	1.3	0.3	0.4	0.8	1.6	1.4	1.1	0.1	0.5	0.8	2.9	0.1	0.2	6.0	10.5	3.6	18.0	5.3	5.1	4.9	13.1	4.2	2.2	44.7	6.5	11.1	3.4	7.6	2.6	16.1	2.5	1.4	9.1	0.0	0.0	19.5	5.0	11.7	10.8	6.8	4.2	0.0	17.8	19.9	5.1	3.9	3.5	1.9	6.4	4.8	6.4	3.1	10.7	16.3	9.8	20.4	16.9	13.6	4.0	2.9	18.3	2.8	17.0	2.1	4.3	12.9	10.3	5.9	12.3	6.4	16.8	4.4	4.3	4.2
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody		Yes	No			"Nucleoplasm, Midbody"		"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.3	12.1	15.7	13.3	20.6	14.5	22.8	13.2	22.4	9.0	12.1	15.6	12.4	7.7	19.9	14.3	15.1	10.6	7.1	18.4	8.1	7.1	8.8	5.5	18.5	12.8	15.3	21.2	9.6	21.0	39.9	10.1	23.5	20.3	13.0	17.6	9.4	10.0	14.2	15.3	14.6	16.3	6.6	39.4	6.1	7.5	8.1	13.1	24.1	17.0	15.3	15.3	22.5	10.6	20.2	15.3	8.6	19.6	19.0	20.3	10.7	16.0	14.1	12.0	13.7	9.8	18.8	9.9	9.6	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0	62.5	46.0	82.1	114.0	372.7	31.1	17.9	56.0	44.2	44.3	125.6	7.9	122.5	51.4	101.8	65.5	63.6	178.4	0.0	71.3	124.5	68.5	78.7	149.7	34.7	112.4	27.0	137.9	43.0	124.4	36.5	35.1	124.4	150.1	100.0	90.8	29.6	115.6	199.9	35.0	109.2	14.1	77.6	64.8	16.4	20.6	450.0	211.8	80.6	63.8	219.0
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.1"	"Cell type enhanced"	"Detected in many"	4	"B-cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 31.7"	"Group enriched"	"Detected in all"	12	"B-cells: 15.2;T-cells: 31.7"	"Cell line enhanced"	"Detected in all"		"Daudi: 24.9;U-698: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	6.4	12.7	7.3	29.2	7.4	15.4	11.0	10.5	9.2	7.5	9.2	5.6	6.4	8.1	10.0	4.5	7.5	7.3	7.6	9.8	6.3	8.0	6.9	7.4	7.2	48.8	7.8	5.8	8.1	12.4	4.4	7.0	5.3	7.3	7.4	7.3	4.1	12.5	7.9	13.8	7.5	13.7	9.8	6.5	26.2	10.5	7.0	6.8	76.1	7.7	5.9	43.3	9.3	13.7	15.2	1.3	1.8	1.9	1.8	31.7	11.8	3.9	5.3	2.9	4.9	2.7	2.7	3.3	3.3	2.3	4.7	4.0	6.1	3.0	24.9	3.9	2.3	4.5	3.7	2.7	3.9	1.8	6.7	5.0	5.2	6.9	3.2	2.4	1.3	7.5	2.3	2.7	4.6	1.3	2.6	3.8	10.8	5.8	3.4	2.7	3.9	4.4	5.8	4.7	3.8	4.1	1.8	2.4	3.4	2.4	5.1	3.7	3.6	2.5	3.7	1.4	1.6	4.0	2.8	4.3	5.8	3.8	4.1	2.5	9.9	5.2	29.8	4.5	4.2	4.3	0.4	1.9	1.8	2.5	1.7	5.2	14.6	16.6	7.7	1.3	15.2	31.7	17.9	1.7	1.8	1.2	1.1	17.3	11.8	7.3	7.4	10.5	9.2	6.3	8.0	7.8	5.8	7.3	6.8	6.0	6.4	49.8	13.7	12.0	9.2	11.6	7.6	5.3	4.5	14.0	3.9	13.5	16.6	17.9	32.6	9.8	13.9	0.0	13.8	15.6	10.2	11.9	11.5	6.4	13.8	12.7	13.2	6.2	6.3	8.9	9.2	9.2	15.1	12.6	11.8	18.4	16.4	10.8	9.9	16.1	10.1	6.5	13.4	14.2	15.2	9.4	17.3	8.7	9.9	17.6
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;intestine: 44.3"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 299.6;Early spermatids: 94.3;Hepatocytes: 85.0;Late spermatids: 83.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;HMC-1: 36.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	2.7	4.4	7.9	3.3	21.8	1.4	2.1	89.2	14.7	6.6	14.1	19.2	0.3	44.3	2.7	2.1	1.9	5.0	4.8	6.9	10.5	7.0	8.2	22.0	3.7	2.0	34.7	6.9	13.4	13.9	0.5	1.9	6.4	16.5	5.3	5.9	4.6	1.6	2.9	2.7	1.5	36.3	3.0	16.5	5.1	4.2	2.3	29.2	0.8	4.7	0.0	1.7	3.5	4.0	0.3	8.5	3.9	11.2	9.3	2.5	2.6	0.1	0.4	1.6	0.0	0.0	0.0	9.7	0.0	0.0	0.4	0.0	5.1	1.5	0.5	3.1	0.1	0.6	2.7	5.1	0.0	0.0	9.1	1.7	18.6	0.8	9.9	0.1	0.0	36.3	0.0	3.4	0.0	0.7	0.0	1.9	3.0	0.7	0.2	0.1	0.2	5.0	0.2	0.6	3.4	1.8	0.4	0.0	1.0	9.4	6.3	9.7	0.7	2.2	3.3	5.9	5.5	0.3	1.0	0.2	0.5	0.1	0.0	0.2	1.8	7.1	0.0	0.1	1.1	0.7	3.9	10.5	0.1	2.5	11.2	1.8	0.3	0.4	2.2	8.5	0.2	0.5	1.0	0.6	9.3	6.4	1.0	0.0	2.6	7.9	21.8	89.2	14.7	10.5	7.0	34.7	6.9	16.5	29.2	6.0	5.1	1.4	0.6	2.4	299.6	10.6	2.5	10.7	3.4	3.5	41.2	22.2	0.0	0.2	94.3	5.5	13.6	0.0	1.8	28.5	3.4	1.2	23.1	85.0	15.9	6.4	37.7	1.8	19.1	83.5	4.6	19.6	16.9	0.0	18.9	8.5	0.3	12.9	4.6	1.6	15.0	0.0	1.1	2.3	5.9	0.5	13.7	15.2	8.6	0.6
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Group enriched"	"Detected in some"	6	"Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 4.9;OE19: 15.2"	"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4"	"Group enriched"	"Detected in many"	7	"amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.0	0.5	1.1	0.2	11.7	1.6	0.0	0.0	6.0	0.0	0.6			3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.0	0.2		0.0	0.2	0.0	0.5	0.0		0.0	0.1		0.0	0.0	0.0	1.2	8.0	0.1	0.0	17.2	0.8	4.1			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	3.0	0.0	0.1	0.2	0.1	1.5	0.2	0.3	0.3	0.0	2.6	0.1	1.8	0.1	0.0	2.2	0.3	0.5	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.6	0.2	0.0	1.1	0.2	0.2	0.6	0.1	0.2	0.0	5.0	0.0	0.0	0.1	14.5	0.4	0.4	0.1	0.1	0.3	0.1	2.4	0.0	0.4	4.2	0.0	0.1	0.8	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573784-46598408	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.1	7.5	4.9	3.8	6.6	4.7	12.1	4.7	10.3	10.5	4.4	3.6	2.5	2.2	5.0	4.1	4.2	3.2	10.7	25.6	4.1	4.0	3.6	11.0	5.4	3.7	4.5	4.7	27.0	3.4	2.4	3.4	5.9	3.6	3.9	2.2	1.4	2.7	3.7	4.3	5.4	3.3	3.5	1.9	17.1	3.4	3.6	1.8	2.4	4.2	1.4	2.0	4.1	8.7	1.0	1.0	9.4	8.0	0.4	15.4	1.6	4.1	3.5	3.0	2.7	8.6	6.0	0.1	5.8	4.2	1.5	2.1	0.9	1.6	0.0	18.0	2.4	1.0	3.1	2.9	1.0	1.3	2.4	6.3	0.8	0.3	3.1	13.4	1.4	0.1	2.1	0.9	2.9	2.4	2.7	4.8	1.9	0.0	3.7	1.1	1.9	0.5	1.8	16.1	0.3	13.4	2.7	2.5	7.5	4.2	0.1	6.9	2.7	0.8	0.2	0.7	7.9	1.0	0.3	1.1	4.9	0.5	2.6	2.7	8.7	1.8	1.3	5.4	0.0	0.3	1.2	1.9	0.6	1.4	5.9	1.3	1.0	5.3	2.5	1.0	0.6	1.1	1.0	9.4	0.4	8.0	0.6	15.4	1.6	4.9	6.6	4.7	10.3	4.1	4.0	4.5	4.7	3.6	1.8	0.0	1.9	3.7	1.7	11.0	0.8	5.5	5.1	1.4	1.2	1.8	0.0	3.4	1.7	2.2	0.0	9.8	1.0	0.0	2.2	3.5	12.2	3.3	0.0	2.9	10.3	3.2	0.0	17.2	8.6	0.0	17.5	7.9	13.5	91.0	2.3	3.8	1.9	1.1	56.6	1.1	0.7	51.8	10.3	0.5	1.2	11.5	1.1	7.5	0.7	1.4
CHTF18	"C16orf41, C321D2.4, CHL12, Ctf18"	ENSG00000127586	"Chromosome transmission fidelity factor 18"	Q8WVB6	16	788046-800737	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 20.9;Extravillous trophoblasts: 16.6;Spermatogonia: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040976, HPA056209"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040976: AB_2677232, HPA056209: AB_2683066"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.80e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.78e-4)"	2.4	3.1	8.3	6.7	5.6	16.8	3.1	11.1	4.7	5.0	5.3	4.1	4.1	6.1	4.1	2.8	5.1	3.2	2.4	1.7	2.7	2.3	2.6	2.0	2.9	4.4	4.4	4.6	5.2	3.1	0.7	2.4	4.1	3.5	3.2	1.7	4.0	4.0	2.6	2.4	8.3	7.2	1.8	2.3	5.9	6.7	11.3	4.3	15.5	3.1	3.8	7.3	2.9	3.6	1.0	1.4	4.6	3.0	2.1	2.4	0.7	8.0	3.9	3.2	2.6	0.3	0.2	28.4	5.1	1.4	2.6	1.8	7.0	6.2	9.1	5.3	0.8	1.3	9.0	0.7	3.9	0.0	5.1	11.6	4.0	4.6	3.6	0.0	2.5	7.9	0.1	0.5	2.5	1.3	0.3	2.2	9.5	6.0	3.0	0.6	15.5	9.7	9.3	4.2	1.8	4.8	17.5	8.2	11.8	0.8	2.3	4.2	5.4	3.7	8.2	2.7	0.4	6.0	6.0	1.4	3.8	14.0	6.9	6.8	7.2	2.4	5.1	1.2	3.6	6.6	4.6	0.6	0.0	2.4	3.0	1.5	0.4	1.1	1.9	1.4	1.0	1.3	0.3	0.3	2.1	1.6	0.8	1.4	0.7	8.3	5.6	11.1	4.7	2.7	2.3	4.4	4.6	3.5	4.3	3.0	3.4	3.7	3.2	4.7	20.9	3.6	0.0	2.7	3.4	1.8	2.0	10.9	1.7	2.4	1.0	1.8	0.9	0.0	3.3	16.6	3.3	1.0	4.6	1.8	5.4	6.4	6.3	2.5	2.1	1.1	1.7	2.9	0.0	0.0	3.3	2.8	1.6	0.0	1.4	0.7	6.7	0.0	3.3	13.3	23.5	1.8	7.2	2.5	3.3	1.4
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.8	13.5	13.8	20.6	13.3	12.0	10.6	20.3	20.0	19.0	23.2	15.1	9.4	21.6	12.0	13.8	13.2	15.8	23.0	10.7	21.3	22.9	19.9	14.3	10.7	16.6	11.4	26.4	21.1	9.6	11.5	21.8	21.4	13.2	13.5	17.9	16.2	17.9	20.6	9.6	20.9	16.3	9.0	12.7	9.9	13.7	15.4	9.8	12.0	10.3	8.3	12.3	11.0	8.5	17.6	11.4	17.0	16.2	14.1	11.9	13.4	12.9	23.0	21.1	19.0	21.0	13.0	21.5	9.4	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6	11.9	7.8	9.0	4.9	17.5	5.0	6.9	5.1	4.0	4.5	5.2	2.0	5.5	10.0	6.6	6.7	8.3	8.3	0.0	10.3	6.5	5.6	8.2	8.1	13.0	9.4	12.7	5.8	6.2	17.2	6.1	5.8	10.7	6.8	11.8	6.3	4.8	7.9	6.6	5.6	15.3	4.8	19.4	8.1	8.0	13.6	16.7	11.6	7.5	6.0	10.9
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266132-96273349	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	19.8	39.7	23.6	22.2	27.6	11.1	21.4	17.9	31.9	22.1	18.4	19.9	22.3	20.4	19.4	16.5	24.0	22.3	18.3	26.1	18.3	18.2	25.4	32.5	17.7	17.7	19.2	22.7	20.4	22.2	30.6	17.8	22.2	24.5	16.4	21.1	19.2	22.0	23.5	26.1	16.3	18.5	21.5	19.7	21.8	19.3	19.1	19.0	21.6	19.4	12.2	26.0	19.9	16.9	29.6	39.8	33.1	39.7	25.9	35.2	38.5	20.8	21.0	16.0	14.8	20.6	16.7	26.1	16.1	17.1	26.0	25.7	35.7	15.5	22.1	34.2	19.9	27.8	16.0	24.6	23.8	18.8	11.7	40.6	17.0	15.6	38.6	13.3	19.7	15.5	16.7	19.1	21.6	27.1	15.8	29.0	18.5	21.7	15.1	17.6	33.1	19.6	18.5	22.4	20.7	42.6	19.8	14.1	25.6	17.1	19.6	17.2	19.7	10.0	27.4	19.2	20.8	13.7	14.5	14.9	16.3	23.2	19.3	21.3	20.7	21.8	19.6	21.1	19.2	15.9	30.6	35.3	33.1	32.7	29.3	35.2	25.3	28.7	34.9	39.8	29.6	28.5	34.2	32.4	25.9	39.7	24.0	27.6	38.5	23.6	27.6	17.9	31.9	18.3	18.2	19.2	22.7	24.5	19.0	26.8	26.1	20.5	22.6	25.8	22.9	22.2	15.3	44.2	28.4	14.0	13.7	47.9	33.2	34.2	15.1	24.5	20.7	0.0	29.2	49.0	27.1	21.4	34.8	26.0	40.8	25.4	15.1	16.0	26.9	18.2	18.7	27.5	18.6	45.1	16.9	17.9	30.2	11.5	15.6	66.2	22.6	32.3	23.1	34.8	37.9	30.2	41.6	30.4	20.6	36.3
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 1100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	16.5	40.1	15.0	31.1	14.7	42.5	21.8	4.1	13.8	24.1	51.6	15.4	31.0	31.6	12.2	37.2	39.9	37.2	43.3	47.7	14.8	14.0	49.8	74.5	27.9	27.6	17.5	13.8	17.8	67.8	20.2	24.0	20.6	18.3	30.3	34.0	16.7	40.4	44.5	21.2	10.0	67.5	13.9	13.6	29.3	23.8	25.7	11.0	21.5	37.8	27.8	44.3	38.0	16.3	87.9	43.0	49.4	45.4	35.9	55.2	64.9	24.5	55.6	4.9	17.8	21.8	22.9	8.2	26.1	22.8	21.6	19.3	21.8	43.9	7.1	28.2	30.6	27.9	25.6	10.5	30.1	11.7	16.9	23.9	15.9	38.3	36.1	21.5	31.9	15.6	16.2	18.1	20.1	13.9	24.3	27.5	17.8	21.4	11.3	16.4	48.2	24.0	37.2	7.9	47.2	28.6	13.7	13.5	28.9	55.0	42.0	4.1	4.9	35.6	28.9	27.8	9.3	22.5	19.3	17.3	23.9	17.0	28.8	31.9	15.4	24.1	8.3	38.5	36.5	10.2	25.3	39.3	49.4	46.0	45.4	37.7	87.9	55.2	50.2	43.0	70.7	46.0	45.5	22.8	35.9	41.0	28.5	44.3	64.9	15.0	14.7	4.1	13.8	14.8	14.0	17.5	13.8	18.3	11.0	83.4	104.1	147.3	209.7	76.1	10.0	74.5	152.8	653.1	152.4	174.5	9.8	90.9	384.7	302.9	295.2	73.0	544.4	0.0	585.6	97.5	113.1	427.5	136.2	209.7	199.6	3.2	93.2	65.1	107.8	1100.8	97.5	194.3	121.4	222.8	293.7	96.5	506.2	613.7	87.0	538.0	22.1	38.8	86.5	141.6	49.6	58.8	55.3	173.0	242.6	478.0
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	18.6	15.7	30.5	22.8	29.9	28.1	20.3	46.8	31.6	17.5	14.7	24.7	13.0	16.5	28.6	12.3	12.3	22.1	17.4	12.1	25.5	15.2	14.9	15.1	15.8	21.5	25.2	20.1	31.5	22.6	16.6	22.6	13.2	20.4	14.4	6.2	19.0	23.8	20.8	21.0	34.1	16.1	16.3	16.5	24.7	14.5	31.5	25.6	13.6	16.8	10.6	13.4	13.6	17.4	2.3	2.0	5.0	2.6	0.6	2.5	1.6	17.7	32.1	12.4	17.0	8.0	15.2	6.1	13.6	11.3	11.5	10.6	9.1	11.0	12.3	12.9	10.7	9.5	8.7	6.9	20.5	3.7	29.9	9.3	10.4	20.3	10.8	10.1	5.8	29.5	18.0	12.1	13.0	7.6	12.1	10.5	7.8	10.1	26.0	6.4	16.9	11.5	11.2	7.7	5.7	18.3	9.9	10.5	7.4	9.6	16.7	16.0	13.1	12.8	8.1	10.1	4.1	9.5	12.5	20.0	27.5	22.3	9.4	16.5	21.6	14.8	8.4	21.3	9.2	16.2	3.4	1.8	1.0	2.5	2.6	1.9	1.7	1.3	1.6	1.7	2.3	0.9	1.5	5.0	0.6	1.9	2.0	0.5	1.6	30.5	29.9	46.8	31.6	25.5	15.2	25.2	20.1	20.4	25.6	0.0	4.0	8.0	14.4	23.0	32.4	5.6	22.9	2.7	1.2	8.7	19.6	5.9	3.3	11.2	3.5	17.5	10.7	0.0	13.1	4.3	11.3	8.6	11.5	17.4	10.3	39.7	14.3	12.3	18.4	2.5	20.1	10.7	23.6	10.8	9.4	17.4	13.4	10.5	17.0	5.0	18.3	25.8	13.7	10.2	22.9	16.9	10.9	11.7	8.4	9.8
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 13.8;Late spermatids: 28.3;Sertoli cells: 12.9"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 17.9;SK-MEL-30: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.9	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	6.4	0.4	0.0	1.8	2.5	0.3	0.2	0.0	0.0	0.1	3.5	0.3	0.2	0.2	0.3	0.0	0.0	0.1	0.7	0.1	0.1	0.2	0.0	1.4	1.0	0.1	1.2	0.0	1.2	0.9	0.0	0.2	8.1	4.2	0.1	1.6	71.3	0.1	0.5	0.4	0.0	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0	0.0	0.0	0.0	1.0	0.1	3.2	0.3	2.5	0.0	0.0	3.5	5.9	0.1	0.0	0.0	13.8	0.2	0.1	0.0	0.7	0.0	0.2	8.6	0.0	0.0	0.1	0.0	1.2	0.0	0.0	28.3	6.9	0.0	3.3	0.0	0.1	0.8	0.4	7.2	2.8	0.3	3.5	12.9	0.3	6.8	3.7	0.0	0.0	0.0	0.1	0.9
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Cell type enhanced"	"Detected in some"	21	"Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 81.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	13.3	67.3	0.0	0.0	1.0	0.0	42.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	2.8	0.1	0.9	28.7	2.9	0.0	138.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701938-8704106	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Enterocytes: 128.5;Paneth cells: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4;plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070578			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA070578: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	9.1	1.0	0.3	7.1	1.4	0.3	6.1	0.4	0.6	2.6	14.8	0.5	3.8	5.5	1.0	6.3	2.8	1.4	10.6	1.4	0.9	0.2	6.5	13.3	8.7	3.1	1.1	0.3	2.6	3.2	1.5	0.7	15.7	1.7	3.3	8.8	2.8	6.0	2.5	0.9	10.0	20.0	0.5	0.3	2.4	18.0	1.5	0.5	0.4	8.8	4.3	3.0	6.0	5.3	0.5	3.9	0.8	2.4	0.0	0.0	0.6	0.2	3.2	0.0	0.2	1.0	0.1	9.8	2.4	1.9	2.6	4.0	1.9	5.2	7.8	0.0	0.1	1.0	3.1	0.0	0.1	0.2	1.5	0.0	0.0	1.0	0.1	4.6	0.0	0.1	1.3	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.3	4.0	0.1	0.2	2.5	0.4	1.6	0.0	0.0	0.0	1.2	8.3	0.4	1.2	3.2	8.5	0.1	1.0	1.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.8	0.0	2.4	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.6	0.3	1.4	0.4	0.6	0.9	0.2	1.1	0.3	1.7	0.5	8.9	1.9	1.3	6.7	0.1	0.0	0.5	20.4	6.7	1.2	1.8	0.0	15.9	6.6	19.6	0.0	1.0	128.5	0.0	9.5	15.2	3.5	2.8	4.6	6.8	15.3	0.0	7.5	8.0	1.9	0.0	0.3	2.9	3.3	1.0	23.5	0.2	20.1	76.4	0.4	3.8	1.1	6.5	2.1	0.0	0.0	0.5	7.9	0.0	18.9	10.5
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944488-11182189	"Disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 97.8;Late spermatids: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	9.2	9.7	11.1	12.7	13.7	15.8	8.3	17.2	19.5	8.7	9.4	14.2	9.5	11.0	9.4	10.8	11.5	9.7	6.9	10.7	11.0	10.7	11.2	12.9	12.0	11.4	12.4	10.1	7.7	7.3	22.5	21.8	9.6	13.6	8.6	8.6	12.2	9.4	9.2	14.0	15.9	10.8	9.7	14.4	9.5	8.5	43.1	11.6	15.4	11.5	5.2	12.9	8.3	8.7	7.7	5.0	6.6	6.7	4.0	5.6	2.4	5.3	5.7	4.4	5.7	7.4	5.3	3.9	5.5	5.5	4.7	6.2	6.3	10.1	10.6	13.0	6.8	5.1	4.8	5.6	10.4	6.1	51.8	5.9	4.8	7.8	6.7	5.2	5.2	10.6	6.1	5.1	7.7	6.7	4.3	6.4	5.9	8.0	6.7	5.6	8.8	8.3	4.2	3.5	4.7	4.5	11.4	3.7	6.2	9.9	4.0	5.6	7.5	8.0	8.3	4.3	5.4	5.8	8.4	6.8	6.1	8.0	8.9	4.9	4.7	4.1	8.9	7.7	7.7	6.2	5.5	4.5	3.2	5.5	3.7	3.4	4.4	4.7	3.7	3.6	7.7	5.6	4.8	6.6	4.0	6.7	5.0	3.3	2.4	11.1	13.7	17.2	19.5	11.0	10.7	12.4	10.1	13.6	11.6	14.9	7.7	8.2	3.4	6.4	10.8	4.9	12.7	6.7	10.3	3.5	35.3	2.8	0.0	5.2	97.8	3.6	10.5	0.0	5.5	2.1	4.1	3.2	8.1	11.5	4.2	11.1	7.5	9.8	3.8	56.1	5.2	4.4	3.3	10.0	7.0	5.4	5.8	4.9	8.1	2.6	19.1	0.0	3.1	14.4	5.6	7.2	3.2	5.4	6.0	4.1
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859175	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 95.0;eosinophil: 27.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 95.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		340000	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	22.0	23.3	12.6	27.1	18.8	38.1	18.8	13.6	14.7	22.0	27.9	10.0	43.8	28.8	19.1	30.3	56.4	17.1	40.3	23.4	14.0	12.7	40.8	48.6	22.3	19.2	11.7	11.7	20.1	25.3	47.9	25.9	30.1	14.3	21.5	23.7	11.3	39.9	47.1	38.7	26.0	34.6	30.9	13.0	19.0	29.4	12.1	13.0	23.6	30.3	23.3	32.8	37.1	33.8	7.8	9.9	95.0	7.8	8.8	12.7	7.5	22.7	33.0	23.5	21.8	32.8	27.7	33.8	32.2	33.4	31.9	45.0	46.0	36.1	43.0	36.9	30.6	41.3	34.5	31.9	37.2	45.5	20.3	25.7	28.6	29.7	22.9	33.5	39.1	38.9	20.5	28.0	35.7	40.3	19.9	29.7	25.3	24.5	24.0	25.5	20.1	30.7	21.8	24.6	22.4	34.2	27.6	35.3	36.3	31.9	41.1	20.7	22.6	23.2	40.3	31.7	31.1	27.7	27.7	29.9	27.9	20.7	25.3	31.5	28.0	26.6	55.2	22.5	44.8	24.4	95.0	7.4	27.6	7.4	7.8	12.7	7.8	7.1	7.3	9.9	7.0	6.2	6.6	2.8	8.8	7.8	7.8	10.1	7.5	12.6	18.8	13.6	14.7	14.0	12.7	11.7	11.7	14.3	13.0	56.6	99.2	47.4	59.4	50.7	20.8	83.7	107.0	167.3	144.5	64.6	7.9	38.0	81.2	70.0	3.2	43.5	56.7	46.7	56.4	59.6	50.0	79.2	80.0	72.7	26.7	11.1	52.4	21.5	38.0	2.9	43.7	46.0	33.7	103.6	70.8	23.6	54.4	66.6	26.9	71.1	17.5	38.8	32.4	38.1	40.0	68.4	57.1	39.6	82.7	260.7
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23.0	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31.0	21.9	21.8	35.3	28.2	30.1	56.0	23.1	48.1	20.9	36.6	41.5	40.0	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25.0	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.2	6.2	10.4	3.2	11.9	13.1	8.2	9.0	12.8	9.1	12.2	11.6	5.4	2.8	6.1	5.6	5.3	8.9	13.1	4.1	18.7	12.5	11.6	8.5	15.7	14.3	7.1	8.8	14.4	6.0	18.9	11.4	20.2	10.9	5.3	4.5	10.2	37.3	12.9	5.6	10.4	26.8	6.6	5.2	14.2	10.6	12.4	14.8	6.3	5.4	10.5	8.3	7.8	2.9	13.0	6.5	2.4	6.1	8.1	10.2	7.0	9.8	9.8	22.0	9.1	6.5	6.5	7.2	6.9	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13.0	7.4	27.8	43.4	40.1	40.7	31.0	21.9	56.0	23.1	34.4	52.6	41.7	97.6	120.6	205.3	149.9	55.8	85.6	28.1	76.3	79.6	26.2	94.2	37.9	16.6	25.9	1.9	110.1	100.8	23.3	23.3	39.1	151.1	171.5	133.9	37.6	51.4	49.3	128.8	78.0	91.9	5.1	86.0	167.5	146.8	47.7	56.3	46.1	27.4	66.6	71.1	11.1	91.9	109.9	142.2	31.2	22.0	132.6	75.5	146.6	44.8	153.2
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
CLK3	clk3	ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16.0	19.6	21.9	29.3	14.5	23.7	21.8	19.0	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21.0	12.0	23.7	23.2	19.8	38.9	36.0	60.7	46.0	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.6	14.9	15.3	24.2	21.9	26.9	19.3	14.8	20.4	11.4	13.6	30.6	15.8	35.0	14.7	14.3	29.0	19.2	25.0	21.1	13.3	38.5	6.7	19.4	23.2	29.4	28.8	24.0	26.8	24.0	20.8	12.2	14.9	12.7	15.8	19.9	22.7	12.0	22.2	10.1	16.1	9.0	13.4	17.1	16.3	10.6	12.5	12.2	13.6	13.5	15.1	12.9	13.5	11.0	13.0	10.0	8.1	20.0	24.5	19.6	16.8	11.4	33.1	16.4	32.9	34.4	45.0	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46.0	36.0	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3	6.0	35.5	20.9	38.8	40.0	34.9	14.9	20.4	17.4	18.2	12.2	53.0	22.9	26.6	29.6	59.6	28.3	37.1	23.3	21.0	31.4	22.7	32.5	20.8	10.9	24.3	27.0	28.2	17.2	24.0	14.8	25.6	28.5	27.0	32.5	24.6	17.7	28.8	28.1	19.1	14.2	42.2	12.9	24.4	37.1	17.5	36.6	49.0	39.2	22.6	53.1
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.6	5.9	5.4	8.4	8.1	8.2	2.7	14.1	11.6	9.9	9.1	3.7	10.9	3.7	7.3	16.4	7.4	11.4	6.9	10.9	16.7	4.5	2.5	2.9	6.3	4.6	7.2	4.7	3.4	4.8	10.9	13.6	13.4	7.4	9.2	3.1	6.7	7.5	14.8	7.5	2.6	2.7	3.9	11.2	6.9	1.7	6.2	2.4	7.6	7.4	5.3	4.7	10.2	12.6	6.4	4.7	4.2	2.6	12.7	13.4	14.4	4.4	18.9	6.8	4.9	2.3	11.9	4.2	10.6	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0	38.7	23.0	9.8	18.1	27.6	61.3	50.4	12.7	12.0	13.6	14.0	41.2	9.5	1.7	11.5	25.0	28.9	20.3	0.0	14.4	5.7	30.8	25.1	3.5	25.9	10.1	31.8	38.2	28.8	12.7	12.1	22.2	14.3	10.1	8.2	19.3	29.6	19.8	15.3	33.9	17.0	39.4	12.9	30.8	56.9	73.3	32.9	4.3	10.2	14.9	46.9
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.7	7.3	15.9	8.4	1.1	2.1	5.9	18.0	5.0	13.2	17.7	11.5	8.2	18.7	5.8	4.8	9.6	8.8	15.5	6.2	20.7	12.8	7.0	26.3	15.9	5.1	0.0	21.5	15.5	0.4	0.2	22.7	1.6	1.5	7.1	11.2	17.7	13.0	12.6	5.7	22.6	4.9	15.0	6.0	5.2	14.4	24.1	5.6	2.7	14.5	5.9	6.9	15.6	4.8	3.1	11.2	4.1	8.5	5.1	19.0	14.4	11.6	20.0	4.7	11.4	19.7	6.0	15.4	15.3	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5	0.0	0.3	1.5	4.6	4.9	7.9	1.1	2.5	0.0	3.4	0.0	11.8	5.5	0.0	1.3	6.2	1.9	0.4	0.0	0.6	33.9	3.9	1.4	1.1	0.0	14.0	1.6	1.2	3.7	3.2	4.9	2.3	6.5	3.3	15.4	1.6	6.6	0.9	1.9	0.4	0.0	96.1	6.5	2.5	71.5	133.3	1.8	8.7	5.1	4.1	2.6
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500924-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 215.5;Early spermatids: 173.4;Rod photoreceptor cells: 118.6;Spermatocytes: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	8.3	10.4	12.3	6.8	22.3	3.3	12.7	13.6	18.8	19.2	11.7	12.1	15.7	4.0	23.0	14.7	10.2	27.6	9.5	9.4	11.4	12.5	16.5	6.8	10.5	6.7	11.9	17.8	22.7	10.7	30.5	22.1	9.3	15.8	15.4	8.9	12.0	10.0	18.3	8.8	6.0	6.0	17.6	11.7	5.7	8.8	34.6	10.3	8.2	19.5	6.2	5.2	12.7	9.1	4.7	4.5	2.7	2.7	5.5	19.8	4.1	8.3	10.0	11.6	15.5	17.6	18.4	6.0	10.5	14.2	17.2	12.9	2.8	17.0	4.0	9.3	17.1	10.4	8.7	7.6	12.4	14.8	3.3	7.2	3.7	5.8	5.5	20.6	6.6	4.1	11.8	13.8	16.1	16.1	18.3	9.3	9.0	10.9	0.6	12.7	9.9	6.2	7.3	12.0	3.5	5.9	13.8	8.1	8.2	25.9	2.5	12.9	11.1	6.3	4.9	7.6	9.4	10.3	15.4	6.1	11.8	7.9	9.0	8.1	7.0	5.6	1.1	4.5	3.9	8.1	2.7	2.5	0.7	4.5	2.7	8.5	4.7	13.0	7.7	4.5	4.0	19.8	13.4	1.0	5.5	1.6	4.5	6.7	4.1	12.3	22.3	13.6	18.8	11.4	12.5	11.9	17.8	15.8	10.3	20.8	15.6	4.2	12.2	4.9	38.6	10.9	7.6	215.5	35.2	14.0	102.1	17.4	36.5	18.2	173.4	8.4	4.0	0.0	7.0	6.6	15.6	7.9	4.7	8.9	9.0	36.5	16.8	17.2	3.8	47.7	29.1	4.8	3.3	26.2	7.7	41.5	8.7	3.5	31.1	27.8	118.6	6.5	14.4	118.6	62.8	3.6	7.8	10.2	9.2	4.2
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81445170-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 53.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		360000	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	19.1	19.7	34.3	25.6	27.9	19.6	15.4	13.1	46.5	28.5	26.5	13.0	7.1	33.5	15.5	14.1	26.5	20.3	27.8	9.3	28.1	35.7	15.8	11.4	18.8	17.2	19.4	30.6	17.7	16.5	8.9	26.4	23.8	19.4	13.4	20.0	7.8	15.5	14.0	6.3	24.5	40.5	19.1	15.7	18.0	28.2	11.0	13.2	20.8	11.3	10.2	16.1	22.2	37.2	0.8	0.5	5.7	1.7	0.5	1.0	0.9	11.5	38.6	7.6	3.9	4.0	3.2	15.7	8.4	5.7	5.3	2.3	13.0	23.8	5.2	7.2	6.9	7.1	11.8	4.9	27.9	5.1	3.3	3.6	24.9	7.3	22.7	4.0	7.6	53.9	3.2	11.9	9.8	12.7	8.1	14.6	9.3	21.6	4.5	3.2	11.6	13.3	9.6	6.0	11.3	8.2	24.1	2.5	5.0	6.6	11.4	40.2	8.0	19.6	7.3	2.4	8.0	5.6	10.2	10.0	8.5	9.1	8.2	7.6	5.7	4.4	22.5	10.1	9.0	3.4	4.8	1.7	2.1	1.0	1.2	0.5	0.1	0.2	0.3	0.5	0.8	0.1	0.5	5.7	0.5	0.3	0.5	0.2	0.9	34.3	27.9	13.1	33.7	28.1	35.7	19.4	30.6	19.4	13.2	11.9	17.6	24.6	49.5	95.4	16.2	6.5	63.7	42.8	20.5	14.0	0.0	39.9	6.6	19.3	59.6	46.7	44.3	0.0	21.1	99.7	24.7	54.5	44.9	29.6	29.0	23.8	69.3	63.8	68.0	71.8	44.0	48.6	11.8	32.5	109.8	7.8	43.7	25.9	134.7	36.3	3.2	12.9	17.6	5.6	13.4	125.5	74.1	20.3	36.4	103.9
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	8.8	3.8	3.0	6.8	8.1	14.5	4.2	0.9	5.0	2.7	4.2	4.0	1.3	5.0	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4.0	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3.0	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3.0	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	14.2	12.9	0.0	1.4	3.1	0.8	0.0	3.7	0.2	0.0	0.0	0.0	0.3	0.2	20.1	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.0	4.9	0.1	0.0	0.1	11.0	3.7	0.3	0.0	1.1	3.5	0.0	0.0	0.0	0.4	0.3	0.5	0.2	0.0	1.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3.0	8.1	0.9	5.0	3.3	3.9	3.2	5.7	3.6	0.4	3.0	6.9	2.7	0.8	0.3	1.6	1.4	0.0	4.0	0.0	1.8	0.0	2.0	1.7	2.4	2.5	4.7	5.3	70.0	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0.0	6.9	7.4	6.7	1.1	1.4	5.1	0.0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0.0	2.0	0.1	4.1	0.4	0.7	4.3	0.9	1.6
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	7.0	6.7	9.7	15.8	11.0	10.1	11.8	8.4	11.7	21.5	24.1	10.1	4.7	14.7	9.6	12.4	20.2	7.9	12.3	8.7	16.5	10.1	10.9	8.1	7.8	11.2	8.5	11.6	5.5	8.7	6.5	11.8	8.5	11.3	10.0	13.7	17.9	10.8	11.2	11.5	14.7	10.4	4.8	4.7	6.4	11.7	11.5	8.4	6.9	8.6	10.7	8.1	9.5	7.3	12.1	7.3	12.4	9.0	9.2	12.9	9.7	5.1	9.4	12.4	6.4	77.6	5.1	12.2	14.1	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8	8.9	8.6	7.3	3.4	3.2	13.3	7.9	7.6	13.4	15.9	7.0	31.4	14.0	0.0	4.0	20.1	9.0	4.2	23.3	7.4	6.2	6.4	3.4	3.5	7.4	6.6	11.1	8.1	9.2	5.9	8.3	7.2	7.5	3.3	13.6	7.5	10.1	6.4	3.5	6.3	3.5	10.9	6.5	4.9	14.4	9.9	4.1	17.4	8.7	5.4	2.8
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		43000	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.7	36.6	53.4	42.3	53.4	45.8	42.2	48.6	77.1	53.0	60.9	53.6	43.5	82.2	41.7	45.2	38.9	46.5	69.8	56.3	71.9	55.1	50.8	79.4	37.8	57.7	53.2	85.1	45.7	44.3	66.2	37.1	134.1	36.1	46.7	46.4	59.4	56.6	55.5	73.9	78.8	62.6	65.1	55.1	61.9	69.3	49.6	97.9	54.9	59.5	72.8	58.3	38.3	37.9	103.0	32.6	43.6	58.6	49.2	39.3	38.7	53.9	49.1	53.2	48.4	129.3	40.5	58.4	51.8	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1	241.2	236.8	168.8	346.4	466.2	151.2	559.4	112.1	211.5	257.0	75.0	31.4	228.5	316.7	172.7	25.7	265.4	148.7	46.7	254.5	331.1	308.6	248.1	302.0	134.8	219.0	87.4	164.4	125.8	185.1	30.7	292.6	305.9	301.9	415.6	158.2	306.6	196.4	147.3	300.5	191.8	122.5	258.7	447.2	255.1	271.9	512.9	243.9	251.4	182.3	305.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70242994-70354993	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA067711: AB_2685893"	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	27.8	19.9	18.9	24.6	23.8	44.5	24.9	53.3	24.7	24.0	21.7	21.9	21.6	20.1	37.5	25.8	22.5	20.6	18.8	20.1	18.7	16.2	21.8	24.1	25.9	24.8	23.8	21.2	26.8	20.5	25.0	41.2	30.1	19.8	24.3	24.9	20.5	21.6	21.9	27.6	36.7	24.4	25.5	23.4	26.8	18.8	16.3	24.8	46.1	22.7	20.9	28.8	24.8	24.5	28.8	33.1	37.1	36.5	32.2	41.3	27.2	19.8	18.9	32.1	20.2	17.7	20.0	26.7	22.0	26.6	24.5	21.0	24.2	19.3	42.6	20.3	25.1	15.7	19.6	22.3	21.6	27.5	20.4	20.2	28.0	17.4	22.7	18.9	36.1	25.0	21.8	24.3	23.0	28.0	36.8	25.9	26.4	25.5	24.7	21.3	21.4	41.2	25.8	27.3	20.3	20.2	32.0	26.5	25.8	22.7	40.0	21.4	25.3	25.9	21.0	18.5	28.7	26.8	30.0	18.9	22.9	15.7	20.9	17.7	22.6	25.8	33.7	23.4	17.7	17.9	37.1	26.0	28.3	29.4	36.5	32.8	28.8	31.9	32.9	33.1	27.6	38.0	41.3	15.1	32.2	29.3	23.0	29.7	27.2	18.9	23.8	53.3	24.7	18.7	16.2	23.8	21.2	19.8	24.8	38.7	39.2	30.3	33.3	45.3	61.2	26.6	50.9	44.2	40.9	34.9	53.0	39.0	28.2	41.8	19.7	42.9	38.2	23.3	38.7	40.0	42.0	37.1	73.0	29.8	35.6	49.3	55.7	44.8	51.1	6.5	42.3	42.3	30.4	26.2	38.5	47.8	37.7	41.8	43.9	21.7	50.2	38.8	47.0	33.9	39.8	56.0	29.6	65.4	35.5	38.9
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234384049	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	11.0	17.8	26.4	14.4	33.9	9.4	16.6	14.3	27.5	9.7	17.7	5.7	12.9	26.4	8.4	20.3	15.5	9.4	14.2	19.1	19.3	15.7	21.4	21.4	13.6	16.2	16.3	16.1	9.1	16.7	7.6	9.5	8.7	13.4	13.3	15.6	6.0	13.6	11.6	52.7	8.7	19.7	10.6	11.4	12.5	14.4	5.8	13.3	13.1	13.6	20.2	12.0	11.6	14.6	27.5	33.3	19.7	31.3	18.3	36.6	20.2	17.8	22.9	8.3	9.4	8.7	17.3	26.4	13.1	8.0	13.8	13.0	17.6	23.9	17.8	24.4	7.5	25.9	22.8	12.9	16.2	11.0	22.1	55.1	8.0	26.0	46.6	33.6	19.6	15.6	11.4	21.8	18.1	14.0	12.1	17.0	19.8	38.8	16.1	14.9	9.5	18.6	38.1	20.4	40.3	10.9	11.1	10.0	35.0	17.2	16.9	14.8	10.8	12.7	22.6	40.4	5.5	20.0	33.9	12.8	16.4	13.6	21.9	39.2	19.2	37.2	21.8	12.5	31.2	29.2	19.7	31.3	9.7	18.5	28.5	18.2	27.5	29.9	23.0	33.3	18.0	31.3	23.1	8.1	18.3	23.8	22.5	36.6	20.2	26.4	33.9	14.3	27.5	19.3	15.7	16.3	16.1	13.4	13.3	8.9	20.0	38.5	39.3	50.8	13.8	71.2	22.9	53.5	26.1	45.4	3.9	44.1	87.9	47.5	2.9	23.3	63.5	23.3	59.9	71.2	34.2	56.7	21.9	46.9	75.0	11.1	21.4	22.1	35.3	3.4	24.2	49.2	28.7	43.3	52.3	20.6	56.3	40.3	26.5	86.4	13.3	19.4	24.5	17.2	25.3	51.3	36.5	30.0	65.5	64.8
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684451-52698366	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	8.8	8.5	9.0	6.9	10.6	4.6	9.7	7.9	16.6	6.6	10.1	7.0	4.1	10.1	8.5	6.0	9.5	6.6	5.2	8.6	7.6	9.2	12.8	15.7	5.5	4.9	8.4	12.4	6.7	19.1	7.2	7.7	7.4	10.0	4.9	10.3	4.2	6.7	5.2	26.3	8.6	7.2	8.0	7.6	6.1	7.0	4.3	7.8	2.3	9.6	9.9	5.8	6.9	7.9	3.7	5.9	3.3	8.4	2.3	3.4	2.7	12.3	7.1	6.5	10.7	10.6	9.2	14.3	9.4	7.8	11.7	9.9	8.7	4.4	28.5	6.4	5.5	14.8	9.6	15.7	13.2	15.3	8.8	15.8	24.0	11.2	10.1	13.0	23.5	8.2	10.1	11.7	13.3	16.7	5.2	8.0	8.2	21.8	5.1	8.8	8.2	7.9	12.1	28.7	13.3	20.2	15.7	22.3	20.7	10.3	12.6	14.6	7.7	13.6	17.5	17.3	9.6	10.2	16.1	8.8	9.3	12.2	12.7	12.9	10.6	26.6	13.3	4.3	17.1	7.5	3.1	5.9	1.8	2.5	8.4	3.4	3.7	2.6	2.5	5.9	1.8	2.4	2.6	3.3	2.3	4.0	2.8	1.5	2.7	9.0	10.6	7.9	16.6	7.6	9.2	8.4	12.4	10.0	7.8	6.0	11.3	4.5	15.2	10.2	7.3	12.6	5.1	2.7	7.9	3.5	3.9	14.1	23.2	9.6	0.1	8.2	8.5	0.0	11.5	12.9	7.2	10.1	0.0	11.5	12.1	15.9	2.4	4.9	4.9	0.4	6.9	8.2	1.7	9.0	5.5	7.0	9.0	5.8	7.1	14.4	9.6	6.5	7.6	3.7	12.5	11.3	13.8	4.5	9.6	10.7
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201555-107564514	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	17.2	15.8	15.2	13.7	14.9	16.5	13.9	16.1	17.7	24.8	12.1	15.0	18.3	8.8	28.4	14.0	16.4	10.9	20.3	25.7	13.3	10.3	12.7	8.9	12.9	9.5	14.7	12.5	16.7	18.9	40.3	28.4	14.4	13.4	25.6	14.1	10.5	34.0	20.6	16.5	15.8	12.5	23.8	17.5	10.8	13.1	12.6	15.3	14.0	26.3	11.5	17.3	13.9	21.4	9.8	8.6	10.1	12.9	7.0	12.3	8.9	16.2	7.5	6.8	2.6	2.0	1.8	6.7	12.0	14.3	6.4	10.2	4.8	7.5	2.3	4.6	11.8	14.7	8.4	2.8	2.1	9.3	11.3	2.1	1.8	3.1	8.0	1.5	4.6	10.7	6.1	1.1	12.5	14.0	12.2	18.4	4.6	5.2	8.9	12.3	8.0	4.8	0.0	0.9	16.0	8.1	2.1	3.0	4.2	5.5	7.8	1.5	10.1	4.1	12.4	13.1	8.5	1.2	3.0	20.9	3.9	6.6	19.9	7.0	2.9	6.7	5.0	10.5	6.4	19.0	9.9	10.8	10.1	9.6	12.5	12.3	9.8	12.0	10.3	8.6	8.2	10.2	10.1	5.1	7.0	12.9	5.5	9.5	8.9	15.2	14.9	16.1	17.7	13.3	10.3	14.7	12.5	13.4	15.3	3.0	13.3	7.0	10.2	10.9	20.8	22.6	5.1	12.0	12.5	14.0	31.4	8.8	1.7	9.2	12.8	11.7	13.0	0.0	9.5	6.7	12.2	18.0	3.5	4.9	10.2	11.1	9.9	7.4	11.0	17.5	10.9	12.3	11.8	10.8	14.9	7.8	8.4	10.5	11.7	5.4	17.5	25.8	6.2	14.0	13.2	11.7	8.8	13.8	12.5	12.3
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 16.0;Cone photoreceptor cells: 17.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9"	"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.3	2.0	0.2	0.3	0.0	0.9	1.2	0.5	0.0	0.1	0.0	3.3	0.1	0.2	0.0	0.1	1.0	0.0	0.5	0.1	0.9	1.0	0.0	0.7	1.8	0.0	14.2	3.8	0.0	0.2	0.8	6.9	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2	0.0	2.6	0.0	0.1	0.2	4.6	0.8	0.0	16.0	5.7	3.5	17.7	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.1	4.8	0.0	3.1	0.0	0.8	0.9	0.0	0.0	0.0	0.3	2.4	0.5	2.8	0.7	0.3	4.5	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.3	0.1
COL4A3BP	"CERT, GPBP, STARD11"	ENSG00000113163	"Collagen type IV alpha 3 binding protein"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.0;WM-115: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	30.0	25.5	16.5	17.1	21.9	17.9	21.4	34.4	21.2	26.9	19.9	14.9	21.5	13.5	20.5	11.6	21.9	17.1	17.4	14.9	15.2	16.3	21.1	22.7	19.6	13.4	22.5	12.4	17.9	12.4	24.6	25.9	17.8	18.2	19.0	14.6	14.8	17.5	16.1	33.4	14.2	19.3	18.9	16.6	17.2	17.0	21.3	20.7	17.8	37.4	14.3	15.9	21.8	19.1	6.4	9.8	20.9	16.6	5.1	8.8	5.7	16.6	8.6	8.3	7.2	52.0	14.5	11.1	9.4	11.6	7.2	9.6	12.9	9.6	8.1	20.3	9.9	10.0	10.1	12.6	12.9	11.1	9.9	5.8	6.7	9.5	6.8	13.2	6.6	7.8	10.9	9.2	8.5	9.7	11.8	8.3	10.7	12.1	12.2	9.5	8.8	7.9	5.0	10.7	3.8	6.4	6.7	11.0	7.4	11.8	20.2	6.4	6.4	11.8	8.3	11.6	18.3	8.1	11.4	11.3	4.9	5.9	8.8	7.7	11.3	14.9	9.4	8.5	11.4	45.0	5.0	13.9	10.6	6.0	15.6	5.6	6.0	6.2	5.6	9.8	6.4	5.9	5.8	20.9	5.1	16.6	5.7	8.8	5.7	16.5	21.9	34.4	21.2	15.2	16.3	22.5	12.4	18.2	20.7	56.6	58.5	6.4	28.0	16.7	30.7	32.7	22.9	71.0	75.1	17.4	21.6	13.6	18.3	19.6	83.3	28.1	19.2	0.0	19.2	13.9	20.9	36.3	47.5	17.9	31.6	41.3	26.4	55.9	33.0	73.0	32.2	37.4	49.0	19.8	15.6	31.1	21.5	13.1	39.3	22.3	33.1	19.4	19.6	41.5	31.5	23.3	23.2	21.3	14.3	38.3
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 280.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1.0	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0.0	0.7	0.0	0.0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0.0	0.0	0.0	0.2	0.0	0.5	0.0	7.4	0.0	0.9	0.4	0.7	0.8	0.0	0.4	0.8	0.0	2.4	0.0	5.2	0.5	0.8	0.0	4.4	0.4	2.6	5.6	38.3	0.0	0.0	4.5	0.0	0.1	0.5	0.0	1.2	0.3	4.5	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0.0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0.0	2.3	0.0	6.3	0.0	0.0	3.3	0.0	0.7	0.4	1.4	7.8	26.4	0.0	3.3	0.0	12.2	1.3	0.3	0.8	2.0	6.5	1.7	30.7	5.5	280.3	3.6	7.0	0.0	0.1	7.8	0.0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3"	"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	53.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.5	21.2	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	2.4	2.9	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.6	1.8	0.1	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2	3.0	0.0	13.7	1.7	2.9	1.0	1.2	0.0	0.0	0.0	5.2	9.8	4.0	1.7	1.3	120.8	3.1	0.9	0.0	0.0	35.4	10.4	0.9	0.0	2.4	2.1	0.0	4.1	3.1	2.7	311.3	3.7	1.3	3.3	0.0	2.6	91.3	0.1	6.2	1.4	9.5	2.5	0.0	1.1	2.5	4.1	6.0	3.3	0.0	1.5	0.8
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	2.1	9.4	10.8	1.7	16.6	1.9	2.8	10.6	39.0	2.0	3.0	31.3	0.0	1.4	3.0	5.2	1.7	3.5	3.7	11.7	15.3	7.9	1.8	1.0	4.5	1.1	20.2	12.9	2.3	3.5	1.0	1.9	0.8	17.4	8.1	2.0	3.5	4.4	3.7	11.0	1.1	1.4	3.0	21.8	1.3	3.4	5.0	22.5	0.0	5.1	1.8	1.5	2.4	1.4	0.0	0.0	8.1	0.0	0.7	0.6	0.1	0.1	0.0	4.4	0.2	2.3	3.4	0.1	1.2	0.5	0.6	0.7	2.1	0.2	0.0	0.3	3.3	0.8	0.0	4.2	0.0	1.1	4.6	2.3	0.3	0.0	12.7	0.1	4.1	0.0	2.0	0.0	0.6	0.1	6.4	0.0	0.1	4.1	5.4	4.6	0.1	0.2	0.2	3.0	10.2	0.0	0.4	0.0	0.0	0.0	0.9	1.7	2.7	0.2	0.0	13.7	2.9	0.0	0.2	0.0	0.5	0.4	0.0	13.1	8.0	0.0	0.0	0.4	2.0	16.9	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	10.8	16.6	10.6	17.2	15.3	7.9	20.2	12.9	17.4	22.5	0.0	0.0	0.0	0.4	0.3	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	38.2	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	52.3	2.0	1.5	1.7	0.0	0.0	4.8	1.0	0.0	3.9	0.2	0.2	12.9	0.5	0.3	0.4	0.4	0.0	3.5	0.0	0.3
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: AB_2680680"	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	19.6	26.2	18.6	23.2	22.3	14.2	22.8	26.7	21.4	20.1	16.6	16.7	21.2	18.2	21.0	26.2	25.3	18.0	16.8	41.7	16.1	15.2	25.4	28.8	15.6	17.3	17.8	22.4	19.9	32.8	15.0	30.0	21.2	16.8	19.0	19.0	17.9	26.6	24.3	32.1	21.0	14.4	24.7	19.9	16.1	19.5	26.8	19.0	16.3	23.6	20.3	19.7	17.6	19.5	33.0	42.7	17.1	36.5	31.2	31.8	35.7	10.1	13.1	15.1	11.6	19.4	22.6	12.9	12.2	20.8	24.9	18.2	22.4	9.3	18.0	10.5	22.8	20.9	7.9	8.2	15.0	26.9	19.4	10.0	14.0	7.7	24.7	16.7	21.7	11.0	16.4	17.4	12.1	14.4	18.2	25.0	10.5	8.5	29.5	26.3	19.1	16.7	38.6	12.8	8.4	18.0	12.0	19.6	20.6	22.6	11.2	9.0	10.2	13.8	23.4	12.4	15.4	14.8	9.5	11.7	22.4	19.3	13.9	18.7	12.9	10.1	22.4	13.2	19.3	19.5	16.5	36.5	17.1	25.1	30.8	24.6	33.0	28.4	27.7	42.7	30.7	27.2	29.0	3.0	31.2	26.2	39.6	31.8	35.7	18.6	22.3	26.7	21.4	16.1	15.2	17.8	22.4	16.8	19.0	32.8	32.7	37.2	66.2	48.3	32.5	159.4	33.1	25.4	28.4	33.2	9.8	110.1	109.5	64.2	152.9	54.2	32.7	46.7	56.9	62.1	58.0	45.1	56.6	57.1	88.4	27.0	20.7	56.4	36.8	131.8	38.3	63.2	79.2	174.1	26.2	26.9	53.3	36.5	46.7	157.5	28.9	32.3	61.3	74.2	54.8	54.0	123.1	40.5	29.2	54.2
COMMD2	HSPC042	ENSG00000114744	"COMM domain containing 2"	Q86X83	3	149738470-149752499	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044190	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044190: AB_10966289"	"unprognostic (2.17e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.86e-2)"	14.1	11.2	13.3	9.6	16.1	10.3	20.9	22.0	18.3	17.2	10.9	21.1	4.8	10.6	18.8	10.5	14.6	13.2	10.6	11.2	13.4	12.3	21.9	17.2	17.0	13.2	16.0	12.5	18.1	11.3	14.4	14.2	22.3	18.7	14.0	11.7	14.1	14.6	12.2	9.4	13.3	15.8	17.0	19.6	15.2	10.4	9.6	14.4	20.5	19.3	9.6	14.6	12.4	12.8	8.7	10.0	16.4	14.2	11.7	11.4	9.4	17.0	5.0	16.3	9.4	14.3	16.5	10.8	10.7	11.2	16.6	16.8	8.7	10.6	13.7	12.3	10.4	10.5	10.9	15.5	13.0	19.4	10.1	14.8	12.3	6.9	5.8	15.3	17.6	5.6	12.4	14.4	8.2	14.7	11.2	11.6	8.7	6.0	7.8	11.8	5.3	12.2	8.7	18.0	10.4	6.7	11.3	16.5	18.3	15.7	4.5	7.5	11.5	12.4	10.1	22.9	13.5	18.6	11.7	10.1	9.8	3.9	9.7	12.6	14.1	5.5	22.6	9.5	15.9	4.0	16.4	8.2	13.9	8.0	12.0	11.4	8.7	9.8	9.5	10.0	8.0	10.4	10.9	6.4	11.7	14.2	6.2	7.8	9.4	13.3	16.1	22.0	18.3	13.4	12.3	16.0	12.5	18.7	14.4	59.6	21.7	26.8	30.7	18.5	54.4	14.9	30.6	28.1	51.2	21.0	176.7	44.6	36.5	47.3	2.3	33.1	18.8	23.3	34.6	49.7	36.6	22.9	45.1	14.4	39.4	27.0	23.6	31.9	20.9	3.2	33.6	37.2	32.1	121.8	16.3	33.3	44.0	20.1	33.9	23.3	98.2	51.8	29.9	48.9	49.0	18.9	26.7	32.4	20.0	20.5
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046905: AB_2732535"	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	24.7	22.3	18.2	16.7	18.1	27.6	14.6	26.0	22.9	15.2	19.1	18.1	17.7	17.8	16.6	15.3	18.9	15.9	17.0	20.9	18.4	17.1	18.0	21.8	20.0	21.0	23.8	12.2	13.4	20.3	11.0	18.3	16.3	15.9	15.8	10.5	16.4	22.4	17.4	16.0	17.5	15.5	17.9	18.5	22.2	16.9	11.7	16.8	17.7	23.6	14.3	19.0	20.2	15.1	29.3	36.6	36.3	42.6	32.0	33.8	31.8	15.8	18.6	9.1	12.1	11.2	9.0	8.1	9.2	9.9	15.8	12.5	11.4	12.5	11.0	20.6	11.1	9.1	10.8	11.3	15.2	6.8	14.3	15.9	23.0	17.9	18.9	15.1	7.8	20.0	11.9	13.9	10.7	8.1	7.6	12.1	4.0	16.4	20.3	12.7	28.9	7.0	8.1	13.8	22.2	37.9	9.1	10.5	16.8	15.2	14.2	21.4	18.6	15.4	9.4	13.2	6.3	18.2	14.6	11.1	12.0	23.5	16.7	18.0	8.5	9.0	10.1	16.5	14.5	15.3	28.5	42.6	36.3	29.3	34.6	26.1	29.3	22.8	28.7	36.6	26.1	22.8	25.3	25.7	32.0	21.8	13.4	33.8	31.8	18.2	18.1	26.0	22.9	18.4	17.1	23.8	12.2	15.9	16.8	11.9	16.7	22.5	17.6	24.6	12.1	9.5	15.3	26.8	7.9	15.7	11.8	30.3	33.2	41.3	2.8	30.6	23.3	0.0	35.0	21.2	23.7	27.3	25.3	16.8	60.7	11.1	19.1	24.5	32.2	1.2	17.3	27.5	25.3	40.5	13.4	18.4	39.9	17.3	21.9	30.5	13.8	12.9	15.1	10.9	13.2	26.2	27.7	26.3	16.7	24.3
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450796-47463719	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	11.4	14.0	14.7	13.9	21.3	13.1	10.9	9.5	18.8	9.7	12.5	5.7	7.7	13.1	9.7	17.3	21.1	8.3	10.0	19.1	14.1	14.0	32.5	16.1	15.1	21.4	13.9	15.0	8.4	10.4	15.5	20.5	20.0	11.3	9.2	13.4	6.5	9.8	9.2	7.7	12.5	17.1	12.8	11.6	14.5	10.0	16.9	10.9	15.2	15.7	19.7	17.5	15.5	12.7	21.1	32.7	39.8	36.4	23.9	22.9	27.9	12.5	6.9	6.1	3.1	13.0	18.6	8.5	18.9	12.6	12.4	16.9	11.6	14.8	20.1	15.9	17.8	28.1	6.7	19.6	15.4	22.5	11.8	8.8	11.5	7.8	9.0	17.8	28.1	14.9	16.0	20.8	11.8	13.2	11.6	15.7	13.3	8.5	8.2	30.2	7.0	16.7	22.9	4.2	8.5	9.1	8.4	14.0	4.3	35.6	10.3	12.1	6.1	7.8	6.4	15.0	11.2	11.8	18.7	12.9	17.8	17.1	15.8	22.5	8.7	10.4	16.1	19.3	37.0	12.8	39.8	26.2	29.5	21.3	34.9	22.9	21.1	19.6	21.1	32.7	18.8	18.5	21.0	12.9	23.9	36.4	15.3	22.0	27.9	14.7	21.3	9.5	18.8	14.1	14.0	13.9	15.0	11.3	10.9	20.8	13.9	28.1	10.6	20.0	18.5	38.3	10.2	52.2	19.4	27.9	3.9	74.5	91.2	38.2	28.4	22.9	18.0	0.0	40.4	94.8	31.8	6.4	32.3	10.2	81.6	6.4	20.2	20.9	60.2	8.5	50.3	51.3	11.8	59.5	20.0	25.7	23.9	21.5	38.2	147.8	18.8	19.4	34.0	66.9	52.6	26.2	88.4	57.3	24.6	7.3
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246820-17281293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		29000	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: AB_2681176"	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (1.56e-4)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	15.2	15.2	16.3	15.7	21.9	51.9	16.3	20.8	24.7	15.4	15.4	15.7	14.9	13.9	14.3	14.1	21.0	12.1	10.0	22.7	17.5	18.8	16.1	21.0	11.7	18.7	17.4	15.2	16.0	26.2	17.6	21.8	21.7	26.7	16.5	17.1	11.9	17.1	15.7	69.4	15.7	13.3	16.9	15.9	14.3	15.8	39.5	11.8	31.4	15.2	24.4	21.9	16.1	14.0	28.1	45.2	37.7	35.8	32.3	33.0	38.2	35.5	33.4	26.2	22.7	12.6	17.2	16.0	27.7	17.0	40.1	32.3	54.7	13.3	49.2	22.5	22.0	18.0	26.0	35.5	27.5	45.6	19.6	50.5	34.3	25.9	23.5	21.5	29.4	39.1	15.5	20.9	27.8	27.9	12.0	23.2	28.7	27.9	18.3	25.3	35.7	54.1	37.3	23.4	39.7	21.5	40.8	46.8	25.6	16.1	15.6	20.5	17.9	24.3	11.3	22.0	78.7	17.0	19.8	16.6	24.4	27.4	44.1	47.3	14.7	19.0	26.3	21.2	29.3	24.6	20.8	30.5	29.4	27.6	35.8	31.9	27.2	32.2	31.6	45.2	28.1	32.2	30.5	37.7	32.3	34.6	21.8	33.0	38.2	16.3	21.9	20.8	24.7	17.5	18.8	17.4	15.2	26.7	11.8	29.8	15.5	44.7	36.9	48.1	21.8	44.5	22.9	17.4	23.9	14.0	13.7	80.5	28.2	39.9	106.3	32.3	14.2	46.7	44.5	69.1	35.2	30.0	39.3	20.8	57.9	23.8	36.0	25.8	31.1	49.2	36.8	45.3	33.7	49.5	34.2	38.1	31.1	11.5	35.7	27.3	28.6	19.4	42.4	228.3	92.9	41.7	87.3	52.2	37.2	29.3
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6723741-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		66000	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	24.1	26.0	31.6	16.6	38.1	8.8	20.5	29.6	59.5	18.2	18.5	25.0	14.1	15.8	20.1	27.9	29.1	25.8	20.1	42.2	29.6	27.9	26.2	29.6	18.8	14.6	31.6	36.9	20.1	23.1	33.9	24.3	25.4	45.3	24.7	17.5	23.8	22.1	24.5	44.6	20.9	14.1	24.2	22.5	16.2	18.1	14.9	13.9	9.2	26.1	29.6	17.6	22.7	17.6	13.7	27.1	35.9	28.4	11.5	16.5	17.8	19.0	20.2	9.7	9.5	28.9	34.6	23.7	23.6	30.8	23.8	24.2	14.1	26.7	13.3	10.2	31.4	13.9	15.4	13.2	24.0	22.9	18.1	14.6	12.4	13.9	17.8	25.0	12.9	7.6	32.1	23.3	28.1	56.0	29.2	18.5	8.1	8.8	5.4	33.4	15.4	7.5	8.1	26.2	26.1	18.6	5.1	19.9	13.1	20.2	19.2	5.5	13.1	15.5	19.7	25.9	24.8	8.4	18.8	19.0	25.4	13.3	22.4	22.7	6.1	6.6	10.7	43.3	16.7	27.8	29.4	23.1	35.9	15.9	28.4	16.5	11.3	13.7	14.2	27.1	13.7	14.2	14.0	18.7	11.5	22.5	16.8	12.1	17.8	31.6	38.1	29.6	59.5	29.6	27.9	31.6	36.9	45.3	13.9	14.9	13.7	11.2	25.7	12.4	36.3	32.7	15.3	20.1	13.6	22.7	5.9	63.6	56.3	39.4	3.2	19.1	15.8	0.0	43.6	48.1	31.9	27.1	16.1	22.1	54.8	28.6	12.1	22.1	21.6	5.1	21.3	20.6	11.8	61.3	17.1	41.3	38.6	17.5	24.1	38.4	19.6	38.8	24.7	18.1	34.3	12.2	49.4	13.8	17.8	22.0
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085312-237100466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 79.4;U-138 MG: 94.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		110000	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	20.1	23.1	25.2	15.6	37.0	15.7	17.9	15.2	33.8	20.6	14.0	16.7	8.6	7.7	20.9	18.3	12.5	18.0	19.9	37.8	31.7	27.9	24.2	15.6	12.3	13.5	23.6	25.8	23.7	10.8	18.2	15.0	19.8	28.1	16.6	11.7	18.6	12.7	18.1	64.5	12.3	9.7	25.4	21.3	10.4	13.5	20.8	15.4	14.8	17.5	20.3	14.5	18.0	13.2	32.4	26.9	26.1	25.9	32.2	36.2	31.7	9.6	8.2	17.9	8.9	51.6	40.8	11.9	17.0	17.0	17.5	19.5	5.4	9.8	6.7	6.5	18.5	27.7	7.3	17.6	23.2	24.6	15.6	11.3	9.7	10.5	18.9	35.6	12.5	5.8	67.3	26.8	17.6	79.4	21.8	20.5	14.4	13.4	6.4	55.4	9.2	15.4	12.9	15.9	10.5	12.0	11.8	21.4	13.3	21.6	7.8	8.8	15.2	10.2	8.8	25.4	15.0	10.2	10.3	21.5	94.0	15.8	18.4	18.4	12.4	10.3	21.3	29.4	7.7	23.7	21.9	22.8	26.1	29.7	25.0	36.2	32.4	31.7	33.8	26.9	26.9	30.8	32.1	7.0	32.2	25.9	19.4	33.1	31.7	25.2	37.0	15.2	32.3	31.7	27.9	23.6	25.8	28.1	15.4	29.8	19.5	35.0	43.5	67.0	53.6	97.2	33.1	32.1	15.9	31.4	25.5	54.6	121.0	57.0	21.2	51.6	12.7	0.0	35.9	64.8	116.7	38.2	42.6	21.7	53.3	33.4	20.2	38.1	30.8	17.3	67.3	28.8	119.8	55.1	14.7	79.9	40.5	17.5	71.1	72.0	46.0	58.2	89.6	85.8	92.6	56.3	37.2	45.7	18.5	34.8
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 422.7;Exocrine glandular cells: 329.4;Hofbauer cells: 279.6;Pancreatic endocrine cells: 292.2;Proximal tubular cells: 474.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	31.9	29.1	81.6	20.6	73.2	24.0	40.9	22.6	61.6	29.1	27.6	22.7	20.5	25.6	17.2	53.2	34.5	23.5	25.4	62.3	75.8	44.7	30.5	23.5	17.8	26.7	64.3	24.3	23.2	64.3	8.9	27.6	17.6	32.9	25.9	18.9	19.0	43.3	26.5	86.9	20.6	24.5	21.1	52.6	22.6	25.8	18.8	25.9	26.5	34.7	41.6	19.8	23.5	20.9	68.2	79.9	90.7	67.7	52.4	82.0	79.9	27.2	36.9	29.1	30.4	40.3	33.0	26.8	39.4	27.6	25.9	33.2	26.7	24.5	7.5	11.9	35.9	41.3	21.9	25.7	36.5	17.9	31.9	94.9	22.6	38.0	82.7	32.1	22.6	21.3	38.7	30.2	19.3	24.1	24.0	37.9	38.6	26.0	16.4	37.6	58.8	36.2	70.6	44.3	34.3	80.7	28.6	39.1	23.5	32.0	47.0	33.8	33.9	20.7	28.2	42.1	23.5	26.0	44.2	30.6	34.3	38.3	43.6	37.4	33.6	28.5	38.0	42.7	26.9	33.7	90.7	67.2	87.6	68.6	66.6	68.0	68.2	71.2	70.1	62.6	52.8	62.6	70.5	24.1	52.4	67.7	79.9	82.0	79.9	81.6	73.2	22.6	61.6	75.8	44.7	64.3	24.3	32.9	25.9	119.1	114.6	0.0	0.0	0.0	0.0	0.0	0.0	123.1	102.4	261.7	0.0	149.7	422.7	189.2	0.0	0.0	0.0	0.0	329.4	162.4	0.0	0.0	57.0	0.0	279.6	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	253.3	0.0	0.0	292.2	0.0	0.0	474.2	0.0	0.0	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369400-99394204	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 37.1;Distal tubular cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	5.2	7.8	8.6	4.2	10.8	3.2	7.5	13.6	16.3	4.5	8.9	4.5	4.3	6.9	4.3	6.8	8.2	4.5	3.0	21.7	8.2	7.5	10.2	12.4	2.9	7.1	6.9	12.0	6.0	5.7	11.6	7.4	2.5	9.8	6.8	11.0	7.3	11.7	7.6	28.0	5.8	6.3	6.6	4.6	4.8	5.2	2.3	6.0	4.1	4.3	16.8	7.0	7.5	4.6	6.6	8.0	9.4	7.4	9.7	12.5	5.3	12.0	6.9	8.4	11.9	5.5	6.2	11.6	10.4	6.5	15.8	18.3	9.6	5.2	11.8	7.0	7.8	10.2	11.2	14.0	16.3	19.3	12.5	17.9	14.4	9.5	10.3	7.2	20.8	5.7	3.9	10.0	9.3	9.4	3.5	9.6	14.6	21.9	9.0	8.4	11.9	9.1	17.4	10.2	11.9	13.4	4.5	8.6	15.7	12.4	10.5	13.2	7.0	7.2	11.2	13.6	5.9	13.7	13.7	3.4	6.9	10.1	10.6	15.8	3.2	5.9	18.6	8.8	20.2	10.1	9.4	3.3	2.4	6.0	7.4	6.8	6.6	7.6	9.5	8.0	3.1	12.5	9.5	0.5	9.7	6.3	5.2	5.5	5.3	8.6	10.8	13.6	16.3	8.2	7.5	6.9	12.0	9.8	6.0	3.0	3.0	6.1	8.0	3.9	7.1	37.1	7.6	0.0	5.7	3.5	0.0	13.0	28.2	10.0	0.4	4.5	3.2	0.0	9.3	11.0	4.1	2.0	1.1	7.8	5.7	6.4	0.0	3.7	0.6	0.0	7.5	3.3	5.0	1.8	6.5	10.4	7.0	6.0	5.6	8.8	7.8	6.5	8.2	3.4	12.4	3.8	5.3	4.4	9.0	3.1
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067599-19080095	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 45.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 45.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	9.1	14.2	13.5	7.8	12.9	4.0	12.6	11.3	18.5	11.2	12.8	12.8	15.2	11.4	14.7	17.4	11.9	15.0	13.9	21.1	12.1	13.0	13.5	11.4	14.6	11.1	12.2	12.0	19.4	12.2	23.7	15.1	9.4	12.9	17.1	12.5	16.5	11.3	14.7	37.3	7.5	12.1	11.1	12.4	8.7	11.8	34.7	10.7	9.4	15.3	24.7	7.6	12.1	10.0	5.1	5.3	45.2	4.0	4.1	4.4	1.8	12.6	13.6	11.8	6.9	6.7	7.1	9.9	7.4	6.1	10.2	10.5	8.6	10.6	9.6	36.1	5.7	11.0	13.4	16.4	9.3	7.4	8.2	16.6	5.1	12.5	26.4	8.3	12.2	11.3	5.9	8.2	9.4	6.9	8.4	8.2	11.6	14.0	9.0	7.1	22.7	12.7	9.9	9.0	4.9	7.3	15.6	13.1	12.3	8.8	8.5	17.2	9.8	6.9	15.3	8.6	6.0	14.1	16.6	8.9	10.8	6.3	7.9	10.6	8.4	13.6	10.5	11.6	7.1	6.9	10.8	4.0	5.8	3.5	3.5	3.3	5.1	3.2	3.1	4.3	5.0	4.4	3.9	45.2	4.1	3.9	5.3	2.0	1.8	13.5	12.9	11.3	18.5	12.1	13.0	12.2	12.0	12.9	10.7	14.9	9.3	38.9	25.6	9.7	30.8	19.0	22.9	21.4	9.1	15.7	37.3	18.0	38.1	20.5	10.9	11.3	47.3	0.0	15.9	14.6	13.0	14.3	25.3	8.9	20.1	19.1	23.1	13.5	18.7	6.2	17.3	15.3	10.1	9.0	30.7	39.8	11.7	24.3	13.1	19.5	53.8	19.4	15.1	77.6	54.5	10.8	26.9	33.1	29.9	22.2
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.0"	"Cell type enhanced"	"Detected in many"	15	"Late spermatids: 16.0;Spermatocytes: 18.2;Spermatogonia: 47.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	27	"B-cells: 1.8;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 16.1;U-2197: 46.5;U-87 MG: 17.0"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.1	5.6	7.5	1.6	10.8	0.5	2.1	11.9	15.7	5.2	5.3	9.4	0.2	1.6	4.2	8.7	4.0	9.2	4.3	2.9	6.2	6.2	1.6	0.8	1.9	0.8	12.4	9.0	15.4	1.6	1.4	8.3	0.6	13.0	2.7	2.9	3.9	1.4	4.4	2.2	1.5	2.2	3.9	7.7	0.9	2.6	32.0	8.1	0.0	2.7	0.0	0.8	5.5	3.8	1.8	0.0	0.0	0.0	0.0	3.5	0.6	0.0	1.5	0.1	0.1	1.1	0.1	0.0	1.2	0.1	0.8	0.6	0.0	0.0	0.0	2.8	0.4	8.7	0.0	2.2	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.8	0.0	1.0	0.6	0.0	1.5	0.0	0.1	0.0	3.3	3.7	0.0	0.5	0.0	0.2	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	1.0	4.0	0.2	16.1	5.2	0.0	0.5	0.0	8.4	3.4	46.5	2.5	2.3	5.9	0.6	17.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.3	1.8	0.0	0.5	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.6	7.5	10.8	11.9	15.7	6.2	6.2	12.4	9.0	13.0	8.1	0.0	0.0	0.0	0.3	0.7	10.3	1.2	0.0	4.0	0.0	0.0	9.8	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	2.1	0.1	1.1	0.0	0.2	11.1	0.0	0.0	0.0	16.0	3.7	0.2	5.0	0.0	0.0	4.5	0.2	0.0	2.1	0.3	3.5	6.5	2.3	18.2	47.3	0.5	0.1	0.0	0.0	0.1
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047259, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		160000	"Nucleoplasm, Nuclear membrane"		"HPA047259: AB_2680004, HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	32.0	25.3	23.1	32.9	25.6	36.5	31.8	34.0	24.7	35.5	31.5	23.9	26.3	18.4	38.8	35.1	30.8	34.3	27.8	22.1	22.1	16.0	25.4	23.2	33.3	28.7	22.0	24.8	41.6	27.5	21.5	33.3	39.3	19.4	30.0	27.6	27.4	27.9	25.9	23.9	32.9	31.9	40.5	19.2	42.4	26.3	25.6	23.1	64.8	36.3	27.1	44.4	34.9	33.7	39.4	43.9	52.1	31.0	60.1	53.8	44.7	41.5	32.9	18.7	7.8	2.4	3.2	14.2	20.1	36.0	49.0	32.4	98.9	18.3	29.3	19.4	29.9	42.5	16.1	14.4	38.1	30.4	5.4	11.0	73.8	25.9	71.5	22.6	23.9	10.3	20.9	39.2	19.7	23.5	29.8	30.9	30.0	9.6	15.0	23.7	22.9	35.4	32.1	4.6	42.3	31.8	25.3	56.0	19.9	19.9	30.0	13.2	14.7	45.5	21.7	30.8	5.3	22.5	23.9	20.1	52.0	9.5	16.9	21.2	10.1	10.3	20.2	37.4	13.2	11.5	13.6	31.0	52.1	39.6	30.4	53.8	39.4	38.0	36.6	43.9	37.0	37.7	37.4	42.9	60.1	28.9	24.0	46.0	44.7	23.1	25.6	34.0	24.7	22.1	16.0	22.0	24.8	19.4	23.1	17.9	34.1	35.8	60.3	48.9	31.5	13.2	28.1	29.4	40.9	24.4	19.6	114.0	21.6	56.4	30.6	49.6	28.4	0.0	33.1	69.7	50.3	49.5	47.3	20.2	56.7	20.6	32.2	27.6	34.4	9.4	50.6	44.1	45.5	117.2	29.0	24.1	43.3	37.0	58.0	24.9	17.1	45.3	60.4	11.7	24.0	42.9	88.9	76.2	38.1	60.3
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;prostate: 35.7"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1"	"Low region specificity"	"Detected in many"							"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	1.4	1.4	7.0	0.8	11.6	0.8	0.7	0.4	27.2	1.0	1.1	2.5	0.7	1.6	0.9	1.6	1.1	1.2	0.7	1.9	17.5	5.3	2.1	0.8	1.2	0.7	1.3	11.8	0.7	0.8	3.8	9.5	0.7	3.1	35.7	1.0	0.1	1.1	6.0	0.6	1.0	1.4	1.2	4.6	1.8	1.4	2.3	3.6	0.0	1.1	0.0	0.7	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	9.9	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	2.8	1.3	0.6	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	3.1	1.4	0.6	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	2.3	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	7.0	11.6	0.4	27.2	17.5	5.3	1.3	11.8	3.1	3.6	0.0	0.0	0.0	0.4	0.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	0.1	1.6	4.7	0.0	0.0	3.6	0.3	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	1.2	0.5	0.0	0.8	1.2	1.1	0.1	0.0	0.0	0.0	0.8
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121937-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	20.5	24.0	14.6	24.1	16.3	10.6	16.7	14.5	16.5	18.3	16.4	19.3	21.5	15.1	19.3	16.5	25.7	15.4	15.9	16.3	14.9	13.6	16.8	22.2	17.3	20.1	20.8	11.8	21.5	16.5	24.9	28.9	19.6	16.0	17.1	18.1	14.7	18.5	25.3	36.6	14.9	19.0	18.8	19.7	23.8	17.8	25.7	18.1	44.0	22.6	19.4	25.0	19.7	17.7	9.3	13.0	15.0	14.4	12.8	13.4	9.7	18.5	18.6	19.0	19.6	9.9	8.8	28.3	24.1	23.7	22.5	22.3	16.1	25.9	20.0	15.9	25.7	15.2	27.6	26.1	21.9	32.5	32.3	9.0	29.2	19.2	15.4	29.3	29.4	24.8	14.4	18.8	21.3	38.5	14.9	20.9	21.8	26.3	25.4	24.9	27.2	33.8	10.4	21.5	30.1	17.0	33.4	29.5	17.9	15.3	26.5	21.0	14.2	28.4	16.1	20.5	17.9	33.4	18.5	22.3	18.0	11.4	13.5	20.5	15.3	24.9	40.8	21.8	23.2	27.9	15.0	14.4	10.4	9.6	13.6	12.9	9.3	8.6	10.2	13.0	5.3	7.8	10.5	5.2	12.8	10.7	8.4	13.4	9.7	14.6	16.3	14.5	16.5	14.9	13.6	20.8	11.8	16.0	18.1	26.8	25.6	13.7	10.9	9.2	12.2	21.8	15.3	41.5	31.8	7.0	27.5	21.2	11.6	16.5	18.7	17.9	10.7	0.0	20.6	19.5	15.2	23.6	29.0	24.5	21.6	11.1	13.3	22.1	36.9	8.4	17.5	27.0	3.3	28.9	17.0	14.1	18.7	15.2	21.5	14.4	22.2	32.3	18.6	50.6	43.6	11.2	21.2	16.6	14.4	19.7
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457371	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	15.2	11.6	19.3	11.8	19.0	15.7	11.8	20.9	25.6	9.3	9.8	19.8	13.1	12.4	11.1	11.4	13.6	11.2	10.3	10.0	21.5	16.0	10.0	11.7	9.3	20.3	16.8	17.4	13.4	25.4	7.3	12.7	15.1	21.9	11.6	10.2	9.9	17.3	12.2	21.2	18.4	9.6	10.5	20.3	13.9	11.5	38.4	14.6	8.7	11.0	10.7	17.8	10.5	10.4	10.2	6.4	3.1	4.1	5.0	9.7	3.9	14.8	13.1	22.3	17.7	9.1	10.5	26.4	9.8	12.4	15.4	20.3	21.4	20.1	21.5	13.4	9.7	19.5	13.0	15.4	15.5	14.8	15.6	16.4	10.2	15.0	20.7	47.9	18.4	13.1	19.0	13.4	16.2	24.8	11.6	14.1	15.7	26.4	25.5	14.5	36.8	37.8	33.8	20.3	20.2	18.5	15.3	15.0	25.4	9.6	14.1	17.7	20.5	11.4	23.7	23.3	24.8	9.9	19.7	7.7	14.5	20.1	24.8	18.8	23.8	25.1	31.2	11.1	18.3	17.1	1.4	4.1	3.1	4.4	3.3	5.8	10.2	6.7	7.9	5.2	8.5	8.5	7.6	1.6	5.0	2.6	6.4	9.7	3.9	19.3	19.0	20.9	25.6	21.5	16.0	16.8	17.4	21.9	14.6	6.0	9.9	6.7	14.2	7.8	3.8	8.6	7.6	1.4	6.8	1.8	9.8	47.0	13.3	12.3	2.7	9.2	7.0	0.0	14.8	28.0	9.5	12.1	12.7	7.6	18.7	6.4	7.5	4.9	8.1	4.2	25.3	10.5	8.5	21.6	10.0	6.9	12.9	3.5	16.3	14.0	6.0	19.4	19.5	14.7	22.0	8.2	38.0	10.1	11.9	12.7
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239537-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No		500000	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	22.3	26.4	29.4	28.1	32.6	52.0	23.1	49.1	32.2	24.8	20.7	24.3	21.3	21.8	27.4	34.5	27.1	23.2	17.0	21.8	24.3	16.4	20.0	19.7	21.6	36.1	23.6	26.8	42.2	23.5	28.6	36.4	21.0	24.9	21.5	21.5	22.2	25.6	21.4	25.4	23.3	23.1	22.3	20.7	24.7	21.9	22.1	25.8	42.8	25.5	10.5	32.9	21.3	24.2	22.0	25.5	21.0	21.5	19.3	30.2	12.4	28.7	24.2	35.8	25.1	13.9	15.9	27.0	19.0	22.7	27.1	25.7	25.2	19.8	45.9	19.6	19.2	15.1	27.2	35.1	22.4	29.0	29.9	23.9	37.0	25.0	28.8	20.8	49.9	27.1	19.0	17.8	21.8	9.0	18.2	20.8	27.7	38.0	49.3	22.4	33.5	46.7	32.7	34.6	24.0	20.7	47.5	28.4	32.1	21.3	34.3	30.2	26.6	25.5	23.9	25.9	22.4	28.7	35.4	23.9	20.5	25.1	19.3	31.0	31.7	25.6	57.4	16.6	29.3	26.3	21.0	17.1	18.7	19.7	21.5	20.9	22.0	22.0	20.2	25.5	19.0	17.0	20.1	5.2	19.3	17.8	18.3	30.2	12.4	29.4	32.6	49.1	32.2	24.3	16.4	23.6	26.8	24.9	25.8	11.9	19.8	32.8	39.9	67.5	52.9	29.0	22.9	21.4	25.0	17.4	35.3	55.0	31.5	46.3	14.2	31.0	20.8	0.0	49.2	71.9	38.1	25.5	34.6	18.7	34.7	84.2	50.4	17.2	27.8	13.5	52.6	28.0	23.6	55.9	26.2	35.0	48.6	21.0	49.8	20.2	42.9	38.8	30.4	71.1	72.7	51.7	42.8	35.2	31.1	46.0
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	23.3	25.6	23.2	24.3	39.0	34.5	25.6	31.6	49.5	26.9	25.4	35.4	34.9	22.6	41.6	33.5	27.0	31.6	19.9	20.9	25.0	19.9	25.2	33.6	24.0	28.5	24.3	24.9	40.5	29.0	36.1	47.8	26.9	29.2	27.6	25.5	33.2	28.4	28.4	36.7	33.9	27.6	32.5	27.2	33.9	26.9	31.3	28.5	45.6	36.0	19.8	32.3	27.1	26.3	10.4	10.5	14.2	8.3	8.5	12.9	7.4	26.5	26.7	37.4	29.6	20.3	18.0	26.3	22.1	21.2	29.4	22.6	31.1	22.9	39.9	23.8	23.6	25.0	32.9	35.8	25.3	36.0	26.4	18.3	33.6	34.4	24.9	20.5	40.6	29.9	19.0	20.7	31.2	45.7	17.9	19.8	26.0	40.3	25.6	21.2	32.2	40.2	33.1	36.7	18.5	21.1	37.9	29.5	32.9	22.0	33.0	25.5	26.0	29.4	26.0	27.2	23.9	36.0	17.5	20.0	32.6	27.9	30.5	22.8	35.5	41.7	46.0	19.0	19.6	23.9	14.2	7.4	9.2	12.2	8.3	12.9	10.4	9.7	12.3	10.5	10.0	10.7	10.8	14.0	8.5	6.1	8.9	6.6	7.4	23.2	39.0	31.6	49.5	25.0	19.9	24.3	24.9	29.2	28.5	32.8	20.5	21.7	16.3	20.6	18.3	9.8	15.3	13.4	11.4	15.7	37.3	22.8	14.9	14.1	22.1	17.5	17.6	0.0	12.1	14.6	16.6	19.0	23.1	26.1	17.2	30.2	21.4	21.5	32.9	20.3	25.3	18.3	3.3	32.5	20.4	26.4	16.1	8.6	23.7	13.4	21.7	38.8	24.7	32.5	26.8	23.1	23.0	19.1	24.2	20.1
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.4	0.5	12.0	0.1	15.6	23.4	0.0	22.2	163.8	1.8	2.2	18.6	38.6	0.1	11.0	23.6	0.2	13.6	2.9	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.1	0.0	0.2	7.4	1.1	2.6	0.0	1.4	0.0	0.2	0.1	0.2	0.2	62.5	0.1	0.1	14.4	1.2	5.9	0.1	0.0	0.3	0.2	0.4	29.8	2.1	0.3	38.7	0.1	23.5	126.9	0.0	0.0	0.4	6.8	3.7	1.3	1.0	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9	0.0	1.6	0.0	100.3	57.8	1.7	0.6	0.0	4.0	10.3	15.7	2.0	42.7	0.0	12.0	2.0	4.3	0.4	0.0	4.5	5.4	286.6	140.0	0.0	0.0	8.9	0.0	0.0	10.4	0.0	0.7	18.4	1.0	59.1	0.0	0.5	0.8	11.9	0.0	35.3	0.0	0.5	0.0	22.7	1.4	6.6	166.6	15.1	2.9	0.6	412.9
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	7.8	15.9	11.0	4.4	14.2	7.1	10.4	12.5	10.4	8.8	9.3	11.5	16.7	14.8	10.6	11.9	9.9	8.3	9.6	35.7	12.3	8.9	14.8	31.4	7.5	7.1	9.8	9.7	8.5	9.7	18.7	21.2	6.5	13.3	9.4	7.5	11.3	10.3	8.8	22.1	8.0	15.4	12.2	11.5	8.3	9.5	15.0	13.2	9.7	8.6	15.5	5.5	10.2	8.4	8.6	7.6	25.3	12.2	10.8	15.0	6.8	6.1	14.0	6.9	7.9	10.1	18.3	8.8	7.1	8.8	6.3	7.4	13.1	2.5	11.1	4.4	8.2	4.8	6.4	7.5	9.4	8.1	11.6	10.1	5.8	6.0	9.6	10.4	5.3	5.7	16.6	14.3	10.1	7.9	6.6	7.5	12.4	16.6	5.3	7.4	9.9	7.8	9.6	8.9	7.0	10.8	13.2	3.6	15.3	6.1	4.6	10.8	10.3	9.6	9.5	17.0	7.0	16.8	10.5	8.0	14.6	7.2	6.9	7.1	12.4	6.7	10.2	6.8	7.9	6.9	24.9	6.9	25.3	14.7	8.3	13.0	8.6	10.3	15.0	5.6	7.2	11.1	8.2	19.4	10.8	12.2	7.6	11.5	6.8	11.0	14.2	12.5	10.4	12.3	8.9	9.8	9.7	13.3	13.2	8.9	4.6	9.0	8.0	6.5	5.7	37.0	5.1	13.4	9.1	7.0	7.9	12.5	19.9	14.5	112.7	14.5	24.0	23.3	19.6	10.0	9.7	13.0	4.6	34.4	9.8	22.3	7.5	9.8	10.0	23.6	16.4	8.8	3.3	9.0	11.8	14.3	16.5	17.6	22.3	46.2	14.1	6.5	17.8	29.5	10.6	7.0	9.0	12.5	12.9	7.4
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 149.6;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		13000	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.1	12.0	16.1	9.3	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	12.7	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.7	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.1	12.4	3.5	1.6	3.8	9.7	3.6	0.3	8.1	1.5	19.8	8.2	9.1	12.3	6.0	9.2	0.3	2.1	6.6	0.0	4.1	2.7	2.1	26.6	4.0	11.1	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4	6.0	3.0	5.4	4.5	2.9	1.4	52.0	20.4	1.4	3.4	3.5	2.0	38.4	14.9	16.6	149.6	12.6	94.4	0.0	19.6	46.4	21.8	14.9	6.9	58.6	18.0	1.6	14.9	14.1	8.1	410.0	20.4	8.8	5.0	9.0	16.9	13.4	12.1	38.6	23.0	41.0	1.4	6.5	14.6	94.3	6.9	4.0	42.1	10.7	22.1	9.9
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 120.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.3	12.0	0.2	20.5	20.4	9.0	20.4	33.0	14.3	14.5	8.6	3.7	0.8	5.5	22.1	7.8	2.2	7.0	14.9	28.0	5.9	3.5	25.7	8.6	20.5	13.6	7.7	36.9	8.4	9.5	18.0	21.1	14.7	18.8	2.1	13.2	12.0	16.7	7.3	2.4	9.5	4.3	5.6	4.5	5.4	6.5	6.8	11.2	4.2	3.1	7.2	6.6	17.1	9.1	7.3	2.5	5.8	20.0	19.2	2.9	23.1	7.4	14.2	4.9	5.3	23.0	21.8	42.5	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1	6.0	20.4	20.6	8.1	10.9	7.2	14.1	20.4	10.7	18.2	22.7	9.8	50.6	11.6	9.3	48.0	20.2	32.0	0.0	15.3	76.5	40.4	27.0	48.5	24.5	49.4	14.3	15.1	30.1	33.2	14.1	57.2	25.1	25.3	10.0	17.0	6.7	15.1	17.3	96.9	9.1	12.4	38.8	42.4	1.1	4.3	6.1	120.8	27.3	14.9	17.2
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.6	14.5	18.8	8.3	11.5	11.4	9.8	8.1	13.7	14.0	13.7	13.1	10.6	15.6	9.7	15.5	9.0	10.9	21.6	6.7	16.0	26.3	8.7	12.2	13.4	8.3	12.8	12.2	17.6	10.1	6.8	15.6	18.9	8.7	10.5	8.0	13.9	21.4	7.6	19.3	8.1	5.9	15.4	5.4	6.0	38.3	14.9	11.9	5.4	7.6	15.7	10.3	13.9	13.7	8.2	12.7	12.2	12.0	16.3	17.2	17.2	8.8	7.4	10.0	10.8	30.3	3.5	7.3	12.1	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2	41.7	45.9	13.8	25.5	49.9	31.9	37.0	43.3	32.1	33.0	10.4	23.6	14.6	5.0	17.4	38.0	35.3	24.0	0.0	17.7	9.4	24.3	32.2	30.0	25.1	17.8	27.0	14.5	32.5	38.7	57.1	52.3	33.5	16.9	27.9	22.4	31.4	22.7	17.3	48.1	10.7	15.8	45.3	36.0	33.1	46.0	51.4	25.7	35.9	23.8	31.6
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85659708-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	15.4	18.7	16.6	19.5	23.3	13.2	19.8	31.4	21.7	23.1	18.1	23.7	18.5	22.0	29.0	19.9	15.0	22.3	18.2	13.3	16.9	10.5	14.9	16.2	17.5	25.0	34.0	18.7	31.5	27.2	30.0	23.8	18.3	20.2	21.2	20.6	20.0	19.3	17.0	13.1	18.2	24.4	20.0	21.3	26.1	20.2	12.7	24.8	21.6	27.1	11.7	21.3	19.1	21.3	3.1	2.4	2.3	2.8	1.9	3.8	0.8	3.6	11.1	9.3	3.1	3.9	4.3	11.4	5.8	3.4	5.0	6.6	11.1	17.8	9.3	5.9	3.2	20.7	13.4	7.5	3.9	7.5	7.5	9.3	9.6	32.1	3.4	3.1	9.6	5.6	4.5	9.3	5.5	8.2	4.7	2.8	6.8	8.3	15.8	4.5	5.9	8.6	13.8	3.7	11.0	5.8	17.5	10.7	6.7	4.4	7.0	9.8	9.3	9.2	13.1	2.3	4.9	15.6	15.7	4.3	10.7	8.7	17.2	8.0	5.9	5.2	12.9	2.9	6.9	8.6	1.9	1.6	1.4	2.3	1.4	3.8	3.1	1.5	1.9	2.0	2.9	2.5	2.3	2.3	1.9	2.8	2.4	1.1	0.8	16.6	23.3	31.4	21.7	16.9	10.5	34.0	18.7	20.2	24.8	17.9	19.2	20.4	20.2	36.7	100.5	11.3	12.7	14.7	14.8	21.0	86.4	13.0	8.3	10.5	19.0	26.4	25.1	23.3	7.4	12.3	29.2	26.1	21.9	26.0	8.7	85.8	37.8	22.1	18.6	13.7	28.4	14.6	32.1	9.0	23.6	57.0	8.3	20.9	31.5	5.3	112.5	12.9	28.9	20.0	5.9	36.1	12.0	25.8	19.9	21.0
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 1553.0;Late spermatids: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	21.9	61.4	14.3	21.3	15.1	8.1	15.4	6.2	13.8	10.6	8.0	8.4	10.2	4.1	13.3	10.8	8.2	9.9	19.7	19.5	14.5	15.2	15.4	26.1	19.6	7.1	12.7	8.3	21.4	8.2	8.3	24.2	42.0	20.1	12.2	6.4	9.6	5.7	19.2	10.0	3.2	7.0	11.0	15.5	21.8	7.5	74.9	7.7	8.1	10.8	6.8	7.3	18.1	11.7	6.4	11.2	10.1	4.9	8.6	14.6	8.2	9.1	14.8	12.5	12.8	8.8	9.2	12.5	12.1	9.5	7.6	10.6	1.7	3.9	15.7	11.8	7.0	8.3	2.1	10.7	7.9	11.2	38.5	7.9	5.6	10.2	6.9	10.5	1.3	5.9	8.1	10.0	14.9	4.6	6.7	21.2	11.9	16.2	6.5	11.7	7.4	9.5	4.0	3.7	3.4	34.1	5.9	6.5	2.9	13.4	3.6	2.9	8.0	5.7	5.0	32.0	14.9	2.8	4.1	28.1	5.8	7.5	16.0	7.9	2.9	3.9	5.4	13.9	12.4	5.0	4.7	3.3	10.1	11.5	4.9	14.2	6.4	12.7	10.1	3.8	5.5	9.0	10.4	9.0	8.6	3.6	11.2	14.6	8.2	14.3	15.1	6.2	13.8	14.5	15.2	12.7	8.3	20.1	7.7	17.9	64.8	33.0	45.1	127.4	16.5	58.9	20.4	53.5	31.8	157.1	5.9	87.7	82.9	30.2	1553.0	61.6	13.0	0.0	38.6	102.1	73.7	43.8	344.6	37.7	100.7	9.5	66.1	14.1	50.2	579.8	24.2	113.1	234.5	315.6	10.3	26.0	26.6	17.5	30.8	49.4	18.2	45.3	183.3	211.4	136.9	94.7	192.3	100.1	11.0	45.0
CRIPT	HSPC139	ENSG00000119878	"CXXC repeat containing interactor of PDZ3 domain"	Q9P021	2	46616416-46625742	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046080, HPA056765"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA046080: AB_2679529, HPA056765: AB_2683230"	"unprognostic (3.38e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.42e-2)"	13.8	17.1	29.3	9.4	26.2	10.0	18.9	24.3	23.9	12.2	11.4	28.7	10.8	15.5	18.2	17.5	12.6	14.6	10.5	22.1	26.5	23.1	19.8	18.8	9.3	11.9	27.6	18.1	17.5	9.8	12.7	21.9	14.3	23.2	14.9	13.4	13.6	16.8	12.5	18.4	13.6	14.2	12.1	36.6	10.1	11.3	12.3	26.2	13.4	14.0	8.8	13.2	14.4	10.8	13.3	14.0	20.9	9.4	11.5	15.5	9.0	15.7	9.3	9.9	8.6	12.2	13.1	12.6	11.0	8.3	9.6	10.0	12.0	12.0	8.5	30.1	12.3	14.0	8.4	10.0	10.7	14.8	18.3	11.8	9.0	11.8	15.4	14.0	8.7	8.6	10.1	14.2	12.3	8.8	20.0	14.3	7.5	13.0	12.8	11.2	8.4	9.0	17.4	10.2	18.6	12.9	8.2	19.0	16.5	13.4	10.2	14.2	20.6	11.5	9.6	15.8	11.2	7.2	8.1	9.9	13.7	11.9	11.1	14.6	9.9	10.6	10.9	17.9	10.3	12.3	20.9	9.4	17.8	8.8	8.4	8.6	13.3	9.8	8.5	9.9	11.2	9.9	9.0	19.1	11.5	6.8	14.0	15.5	9.0	29.3	26.2	24.3	23.3	26.5	23.1	27.6	18.1	23.2	26.2	17.9	10.7	43.3	56.4	38.2	28.4	54.3	40.8	29.4	30.7	29.6	23.6	49.5	58.0	55.6	24.5	30.2	49.6	46.7	34.7	69.1	37.1	49.4	27.7	49.7	42.7	15.9	62.5	25.8	42.4	10.5	33.6	28.6	28.7	45.1	34.8	31.4	60.2	59.6	24.1	73.3	48.6	19.4	42.0	55.7	45.0	46.3	80.0	35.5	29.3	51.5
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	19	"Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	15.3	5.7	23.8	11.6	10.3	9.3	6.6	1.5	0.9	0.0	1.0	10.1	2.7	0.3	0.0	0.0	9.4	0.0	0.0	0.1	0.2	0.0	56.8	0.0	0.1	23.8	0.0	2.7	0.0	3.1	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	1.5	0.6	0.0	0.1	0.1	0.1	1.8	2.3	0.1	2.7	1.2	0.2	3.4	4.7	0.3	1.3	0.1	0.6	9.7	0.3	0.1	0.0	1.9	0.0	0.2	1.4	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1	3.0	2.9	0.8	7.9	41.0	0.6	7.6	0.0	1.4	2.3	0.0	0.0	6.0	0.0	1.1	10.8	12.0	0.4	0.0	0.4	24.6	126.1	19.2	6.9	0.0	4.4	1.6	2.9	60.2	40.4	10.7	251.5	12.2	45.5	0.0	4.2	5.0	0.8	0.0	250.0	0.0	0.5	90.5	678.7	0.9	0.9	37.4	7.6	4.8	1.3	5.2
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		1500000	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.5	6.9	15.6	12.2	10.5	6.8	16.8	7.8	9.6	12.1	13.7	11.4	5.2	14.8	6.3	8.2	8.3	14.8	18.2	12.5	14.4	12.5	17.8	20.5	7.5	12.5	10.5	21.8	10.5	6.8	16.6	10.5	18.0	9.9	10.6	12.0	89.5	12.2	9.7	10.8	12.7	10.2	12.2	12.0	7.5	16.5	24.7	3.5	8.0	10.1	10.1	12.9	13.1	11.6	9.5	19.5	9.9	12.2	8.5	19.2	21.9	7.2	9.8	11.8	11.3	17.3	14.2	9.3	11.7	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8	8.9	16.2	15.6	11.6	48.1	16.8	20.3	10.2	10.7	10.3	5.2	13.7	17.3	1.7	6.8	20.7	14.3	12.4	23.3	7.3	32.0	16.2	13.4	1.1	21.2	15.0	17.5	19.5	18.4	13.7	43.2	14.1	11.1	23.6	10.8	21.5	16.0	9.1	8.6	14.5	8.4	12.7	12.9	11.1	11.6	11.3	52.8	22.8	10.0	14.5	17.4
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529925-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	22.3	14.0	13.7	17.0	20.9	11.4	26.6	15.0	16.2	21.2	22.2	27.5	15.3	8.9	23.9	14.5	15.1	19.4	21.5	17.2	14.0	9.7	10.7	11.7	19.2	21.7	24.1	10.9	45.9	13.9	17.1	9.6	20.2	15.7	18.2	11.7	17.4	19.9	22.0	16.1	15.8	13.7	31.8	20.3	13.1	14.2	15.3	23.6	12.8	22.7	9.2	18.1	24.0	29.6	5.3	2.1	16.0	2.5	3.3	6.6	3.0	4.8	8.0	5.5	8.9	11.9	8.8	25.1	6.2	9.0	9.8	9.3	6.6	4.9	0.1	4.5	12.8	8.1	8.2	8.8	5.4	7.7	8.4	10.2	12.3	40.0	3.0	13.5	3.2	21.1	9.9	8.7	8.1	10.9	7.2	7.0	5.5	6.5	2.8	7.2	5.6	1.3	4.6	2.0	1.4	3.7	4.2	8.8	0.2	3.5	10.3	10.1	8.9	18.1	6.0	10.1	6.0	6.0	6.0	8.6	10.9	8.0	10.0	7.1	3.8	5.1	3.7	4.5	6.4	5.2	16.0	2.5	1.4	3.7	0.8	4.2	3.1	4.5	4.0	1.6	5.3	6.6	4.1	0.5	3.3	0.3	2.1	4.2	3.0	13.7	20.9	15.0	16.2	14.0	9.7	24.1	10.9	15.7	23.6	6.0	8.6	37.4	23.2	20.9	21.6	13.4	17.8	0.0	4.5	12.2	25.5	12.1	1.7	12.0	22.9	18.0	6.4	0.0	9.4	36.5	23.1	23.5	23.1	13.5	13.5	54.0	15.0	20.9	19.7	14.7	24.7	21.3	16.9	8.2	10.0	20.4	9.0	10.5	41.1	8.4	55.7	45.3	38.4	7.7	16.5	21.0	14.9	30.5	11.3	31.1
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 45.5"	"Cell type enhanced"	"Detected in single"	35	"Muller glia cells: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	140	"Hep G2: 28.9"									"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	8.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"		21	6560714-6564489	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"kidney: 34.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	200	"Hep G2: 28.9"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			34.4	5.3	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	18.9	17.6	32.6	14.1	27.6	18.4	19.4	36.6	32.4	20.5	21.5	24.8	13.2	13.4	26.9	18.0	17.6	17.2	15.1	17.9	26.4	23.0	21.6	16.0	14.5	14.7	30.8	19.4	20.4	13.6	18.5	27.7	19.3	25.2	17.3	18.8	17.2	15.2	21.7	15.5	20.9	13.3	19.8	29.9	13.2	15.6	28.9	27.0	18.2	22.6	9.7	13.4	20.8	15.6	27.5	30.7	24.8	26.1	31.5	33.8	18.2	20.9	9.3	26.6	19.6	14.4	20.9	13.5	15.0	21.6	19.2	17.3	13.6	16.7	14.8	13.6	18.3	14.9	11.7	14.0	15.4	17.6	13.7	14.7	27.2	19.9	12.3	22.7	17.1	17.4	19.6	13.6	20.3	15.9	25.4	24.1	24.4	20.1	15.4	17.9	10.7	16.5	17.7	18.6	21.7	12.6	15.9	21.3	20.4	27.1	18.9	11.6	18.3	19.7	9.9	21.4	23.3	19.7	12.7	25.4	15.6	14.9	12.8	11.6	25.3	34.8	16.1	20.3	12.8	17.3	21.7	25.2	24.8	24.2	26.1	25.9	26.5	25.9	22.5	30.7	27.5	33.8	27.4	14.4	31.5	23.7	24.2	20.3	18.2	32.6	27.6	36.6	32.4	26.4	23.0	30.8	19.4	25.2	27.0	29.8	15.9	13.6	40.2	20.9	45.3	22.7	35.7	21.4	19.4	29.6	29.5	59.3	41.4	31.7	56.7	31.7	21.2	0.0	25.5	34.3	29.6	18.4	62.5	10.9	28.8	44.5	20.2	20.3	22.2	20.6	40.9	28.3	35.4	34.3	18.6	41.5	22.8	28.1	38.5	36.3	49.0	19.4	44.3	79.9	15.5	18.7	37.3	25.5	29.9	33.3
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41560763-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 84.8;ovary: 48.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 64.6;Muller glia cells: 39.5;Proximal tubular cells: 29.3;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HeLa: 8.1;U-2 OS: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	2.5	39.0	4.7	2.1	9.6	1.1	1.2	30.5	15.3	16.8	2.6	2.7	5.5	1.6	18.4	2.0	2.2	4.1	2.6	84.8	6.0	8.5	9.9	1.2	2.8	1.1	9.0	6.0	48.5	25.5	1.1	4.1	1.3	17.7	5.3	1.4	5.6	1.4	11.7	1.5	1.1	1.5	9.1	10.5	1.2	1.6	11.1	3.4	0.0	1.1	0.3	1.0	5.8	6.2	1.0	1.0	1.7	1.1	0.4	1.6	0.7	0.0	0.1	1.0	0.1	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	3.1	0.3	0.1	0.0	0.0	0.0	0.0	2.1	0.0	8.1	0.9	2.4	0.0	0.0	1.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.1	29.6	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	1.0	1.0	1.7	1.3	1.1	0.5	1.0	0.8	0.7	1.0	1.0	1.5	0.7	1.0	0.4	0.9	0.2	1.6	0.7	4.7	9.6	30.5	14.7	6.0	8.5	9.0	6.0	17.7	3.4	0.0	0.0	0.0	0.2	0.2	8.1	64.6	0.0	1.4	0.0	7.0	2.0	0.1	16.6	0.3	1.1	0.1	0.0	0.0	9.2	0.1	1.9	0.1	0.0	0.0	0.2	6.4	0.0	0.6	0.0	3.6	4.9	0.0	1.7	0.0	0.0	39.5	2.3	0.0	2.5	29.3	3.1	71.1	22.6	0.2	0.2	0.1	0.2	0.0	0.0	0.0
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 153.6;Spermatogonia: 127.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	No		64000	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	36.2	25.2	30.9	23.7	12.0	15.5	33.4	28.6	15.2	90.0	38.2	82.4	29.3	37.1	38.4	18.1	36.5	42.0	45.3	53.7	86.0	6.0	22.0	25.7	29.7	39.9	7.3	28.3	14.2	8.6	20.2	44.0	25.5	12.4	29.7	20.7	36.3	14.7	33.7	12.4	34.1	14.6	25.9	30.3	37.6	21.7	50.8	28.9	19.8	25.3	27.2	15.8	45.7	49.5	16.2	24.5	41.3	18.5	19.1	48.0	40.3	28.2	40.5	8.6	20.8	34.8	28.6	22.9	25.5	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0	6.0	23.2	18.2	20.7	26.9	14.3	23.5	35.7	21.4	18.2	26.2	9.8	56.3	11.6	28.2	61.2	21.5	7.8	0.0	23.0	50.5	21.6	15.7	4.6	23.2	26.0	14.3	5.2	20.9	15.1	39.7	23.6	19.3	25.3	29.7	9.1	21.8	23.6	10.5	29.7	17.0	11.9	38.8	19.1	153.6	127.3	30.2	60.8	16.6	18.2	20.0
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 287.2;Late spermatids: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.6	25.8	14.7	20.3	19.4	20.8	29.6	31.9	20.1	22.9	21.5	21.2	18.7	19.8	25.3	22.7	24.3	21.0	13.8	32.3	18.5	16.8	33.4	24.6	20.5	22.6	56.4	20.2	18.9	31.4	23.0	15.5	23.2	28.6	33.3	14.7	27.7	10.5	21.6	25.3	26.0	21.2	15.8	25.7	40.7	22.4	18.2	17.6	24.1	34.0	18.2	32.9	38.1	31.8	35.7	21.4	22.8	26.6	35.1	32.9	29.6	28.6	24.2	23.1	11.1	21.2	26.4	17.3	23.8	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6	44.7	51.2	45.8	92.5	50.4	45.6	14.1	25.5	64.3	62.6	40.1	25.5	56.2	28.2	62.7	287.2	39.4	93.0	0.0	60.1	78.4	37.7	85.7	57.8	25.6	57.5	90.6	44.4	40.5	51.6	600.1	27.9	56.2	27.0	73.1	56.1	34.9	72.9	48.0	37.8	40.4	47.4	38.8	58.6	35.2	26.6	42.2	105.8	64.7	38.3	96.3
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19.0	37.3	27.3	23.4	28.0	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24.0	23.2	20.9	21.8	13.0	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4.0	1.2	23.6	11.5	31.3	30.0	15.7	24.1	23.6	30.9	39.5	28.1	27.3	14.8	18.5	17.8	13.5	29.1	18.9	20.2	23.7	42.7	20.4	28.4	51.7	5.7	38.1	11.3	32.3	12.4	15.2	23.0	36.2	42.8	58.0	36.9	29.8	15.6	12.6	36.8	27.1	15.8	17.3	15.3	22.9	17.2	16.7	32.4	22.4	27.9	25.8	19.9	46.4	18.2	26.3	27.3	30.8	19.4	13.9	18.1	33.9	25.5	27.8	14.7	24.6	16.5	23.6	25.1	37.8	14.0	42.6	3.8	1.8	3.4	3.4	0.8	4.0	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9	35.7	17.1	22.2	117.4	69.8	122.3	44.0	38.2	16.0	23.9	22.7	56.9	29.6	6.6	26.6	42.8	62.1	10.7	0.0	35.7	33.5	53.2	138.6	3.5	18.6	19.2	68.3	60.3	44.8	14.9	42.7	79.1	18.5	57.3	11.8	40.8	105.4	42.3	29.6	62.2	4.1	58.4	71.1	106.1	6.0	9.6	91.6	104.9	13.4	31.9	208.0
CSPG4	"HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Sertoli cells: 116.4;Smooth muscle cells: 29.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		28000000	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	36.1	3.1	8.3	10.0	7.9	1.0	19.5	1.6	7.8	15.3	29.2	7.2	6.9	4.6	21.3	14.9	19.9	9.4	18.2	9.2	6.5	5.2	3.5	1.5	10.9	1.4	6.6	5.2	7.0	3.8	3.0	1.6	20.9	6.6	11.4	3.9	10.0	3.4	16.7	25.7	8.0	9.1	37.9	5.4	3.8	14.0	2.5	6.3	0.0	4.7	6.0	1.3	30.3	10.9	0.0	0.1	0.0	0.0	1.9	0.0	0.0	3.6	0.0	0.3	2.2	0.5	3.2	0.0	20.1	9.0	14.1	9.2	0.0	14.0	0.0	0.5	14.0	1.9	0.2	0.0	0.1	4.3	0.1	0.0	0.0	5.9	0.0	3.2	0.0	0.0	1.5	0.0	4.2	0.5	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	45.8	0.4	0.3	0.3	0.0	29.6	5.8	1.1	0.2	0.0	0.0	0.0	6.5	0.1	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	8.3	7.9	1.6	5.9	6.5	5.2	6.6	5.2	6.6	6.3	0.0	0.0	0.0	0.6	2.5	0.0	9.8	0.0	1.4	1.2	1.8	0.0	0.1	0.0	0.0	0.6	2.8	0.0	0.0	0.0	0.2	6.5	0.6	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.3	0.8	11.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	116.4	29.5	0.0	1.3	1.6	0.2	0.0	0.0	0.3
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;HEK 293: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.8	4.7	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.1	0.0	2.0	0.4	2.2	0.2	0.2	0.0	7.4	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.7	0.0	0.9	5.2	0.2	0.1	1.2	0.2	0.3	2.6	1.9	2.7	0.4	0.2	0.6	1.1	0.9	2.8	1.3	1.7	3.4	0.1	0.7	1.3	2.4	0.2	0.0	5.6	0.1	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1	3.0	1.3	0.0	0.1	0.7	28.1	1.2	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.5	0.2	6.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	86.9	0.2	0.0	0.0	0.0	19.5	0.0	0.2	17.2	1.0	0.5	0.1	0.0	0.2	0.1
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.3	1.4	2.7	2.7	2.8	4.4	8.7	12.3	7.3	6.0	7.5	2.2	7.8	1.9	6.6	5.3	2.7	1.6	11.6	3.6	11.6	2.2	8.9	4.3	5.6	3.3	2.2	8.9	1.3	6.3	11.5	1.8	6.6	9.9	2.1	6.7	13.9	6.0	7.5	0.4	3.6	6.4	4.0	4.5	3.6	5.8	12.7	5.8	8.7	3.9	0.6	4.8	36.2	2.9	8.6	4.0	4.1	4.9	3.7	16.0	3.1	6.4	3.6	3.0	3.6	8.2	2.8	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5	44.7	66.0	21.2	65.0	91.8	1.4	12.9	17.8	9.4	17.0	10.4	0.0	13.0	8.3	30.2	47.7	63.8	51.3	23.3	34.0	40.3	70.9	58.0	96.7	34.8	35.2	0.0	56.9	49.7	35.1	34.1	1.4	49.4	65.8	20.8	34.8	4.3	37.1	28.1	3.9	4.8	1.6	12.9	150.2	0.2	3.2	69.5	75.9	27.7	25.5	32.3
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 49.8;Cone photoreceptor cells: 66.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Approved		Uncertain	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.9	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.1	0.8	0.7	0.0	9.5	7.7	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8	3.0	3.2	0.0	2.6	4.6	49.8	6.7	10.2	0.0	1.2	10.4	66.8	0.3	3.3	1.8	2.5	2.9	0.5	0.0	2.1	0.1	4.7	0.3	0.0	2.9	2.0	11.1	7.5	1.3	0.3	1.3	6.9	0.0	6.8	0.0	2.6	18.3	1.0	1.9	7.8	5.0	17.9	6.5	14.6	0.7	0.7	4.0	0.2	0.0	2.9	1.4
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		39000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.7	0.1	0.0	0.4	3.9	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.7	0.0	10.5	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.8	0.8	13.6	0.2	3.8	149.9	0.3	14.7	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.8	0.0	0.0	1.6	0.9	1.2	0.0	0.1	93.6	0.0	0.2	2.4	0.0	0.1	0.0	0.2	59.6	3.2	29.8	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6	6.0	27.0	9.0	93.6	74.1	0.0	0.0	2.5	30.8	34.2	0.0	0.0	203.1	0.0	2.0	0.2	3.5	1.3	0.0	19.8	10.9	5.6	14.2	12.8	90.0	136.3	0.0	0.0	8.0	712.6	0.6	9.5	248.7	8.5	1063.2	0.5	0.0	27.6	1.1	3.5	0.5	0.0	32.3	4.2	0.1	0.1	179.2	279.5	4.3	0.8	83.6
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100840932	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	8.6	11.1	10.1	14.1	14.6	12.2	10.5	18.8	14.5	10.0	14.9	9.1	15.8	11.4	11.9	11.8	30.1	11.3	8.8	7.8	12.7	10.5	10.3	7.9	9.1	14.7	11.2	11.6	9.8	8.1	11.9	12.7	9.5	10.8	10.3	16.5	9.7	13.0	16.8	7.2	11.8	12.7	10.7	12.5	11.8	9.1	18.9	11.2	20.6	9.0	9.4	24.2	11.3	12.8	15.8	19.6	14.6	20.9	19.1	21.2	12.7	16.8	19.9	12.6	12.4	7.3	6.2	18.5	13.5	12.0	22.4	33.7	21.8	15.0	16.6	16.6	8.7	30.7	17.4	31.1	17.0	25.5	15.5	20.0	15.0	18.8	14.9	10.3	19.8	16.9	5.9	8.4	24.2	15.2	6.3	13.5	15.2	24.0	16.6	13.2	20.4	16.5	15.2	36.6	26.3	19.6	17.3	21.9	19.8	8.8	15.5	11.5	14.7	21.5	10.0	9.4	12.8	10.1	11.1	11.1	13.3	21.6	17.1	17.3	10.7	21.9	20.4	11.4	24.0	16.0	14.6	14.6	10.1	21.2	16.5	16.6	15.8	18.7	20.0	19.6	13.4	16.4	16.2	2.4	19.1	20.9	13.5	20.3	12.7	10.1	14.6	18.8	14.5	12.7	10.5	11.2	11.6	10.8	11.2	3.0	0.6	6.0	3.4	3.8	2.0	3.2	0.0	4.0	2.3	0.0	2.0	15.4	5.0	10.9	5.8	3.6	5.1	0.0	7.4	15.4	3.3	1.8	3.5	1.5	9.2	3.2	4.1	2.5	2.1	1.9	4.4	3.2	1.7	7.2	3.5	3.7	10.4	5.7	3.9	3.1	2.4	6.5	3.1	7.6	23.4	3.6	6.4	5.3	6.0	4.8
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695487-51699591	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	20.2	23.5	16.5	20.0	21.6	14.0	15.2	16.2	24.0	14.8	13.5	29.6	9.9	14.3	16.8	13.4	13.1	19.0	12.7	17.4	18.4	16.6	15.5	15.4	11.9	21.7	21.3	16.5	23.3	16.3	30.2	14.1	14.6	23.5	15.8	13.5	12.6	13.4	12.5	25.0	13.3	16.8	16.8	28.0	24.6	17.7	11.6	20.1	31.9	17.0	12.6	22.9	17.0	13.2	4.6	5.5	5.5	5.1	13.9	6.8	3.2	8.5	10.1	15.3	16.0	21.7	14.9	1.0	12.1	11.3	14.0	13.7	13.5	12.5	24.6	7.0	10.5	8.5	13.4	11.5	12.7	12.8	14.2	13.0	14.2	10.8	2.5	10.5	5.4	13.0	21.4	9.9	12.3	14.4	8.9	10.5	14.5	15.2	14.0	12.1	7.3	22.2	8.8	5.6	10.4	21.9	17.7	30.9	5.2	10.7	7.1	12.9	16.6	10.1	10.6	10.8	16.7	19.7	10.1	11.1	9.0	12.3	8.3	15.0	17.9	6.6	17.7	18.7	12.8	7.7	3.7	5.0	5.5	4.9	5.1	6.8	2.3	3.6	3.8	5.5	4.6	6.2	5.3	1.5	13.9	3.4	3.5	5.7	3.2	16.5	21.6	16.2	24.0	18.4	16.6	21.3	16.5	23.5	20.1	8.9	6.9	15.9	6.1	8.0	14.6	11.4	10.2	17.4	6.8	8.7	7.9	20.3	19.9	13.7	0.7	16.5	6.4	0.0	13.3	13.9	9.3	3.3	19.7	13.7	13.1	19.1	5.8	17.2	15.6	2.1	22.2	12.0	0.0	22.6	6.6	11.8	11.2	6.5	18.7	10.7	12.8	6.5	11.4	36.7	13.8	5.6	5.1	21.5	10.0	4.8
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 70.1;Karpas-707: 32.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	32.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.5	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell type enriched"	"Detected in some"	16	"Spermatogonia: 57.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	7.3	31.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	57.9	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"testis: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	15.6			0.0		0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 2.2;Spermatogonia: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.5	0.0	0.0	0.9	66.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 47.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	5	"testis: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.4	0.0		0.0		0.0	0.0		0.8	0.0	0.0			0.1	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846499-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	16	"testis: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.2;HMC-1: 30.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863776-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HMC-1: 55.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224821-8248095	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	9.9	10.0	9.9	15.2	12.2	18.0	12.2	28.5	15.3	10.3	11.3	12.4	8.7	8.9	15.6	12.7	8.2	10.5	10.7	7.0	6.8	7.5	11.8	14.4	13.8	24.1	9.7	7.4	14.5	14.5	12.2	18.5	7.9	9.2	11.2	12.2	11.5	11.0	12.2	5.0	15.5	15.7	13.4	7.4	25.0	9.9	8.8	10.6	32.9	12.5	4.0	23.0	9.1	10.6	6.1	4.6	5.1	2.4	2.7	6.3	2.0	2.5	5.6	5.2	4.9	16.4	3.9	6.5	3.0	3.2	4.3	2.9	4.3	7.6	9.2	3.0	5.1	3.1	8.6	6.1	4.4	2.7	6.7	5.9	4.5	5.4	5.5	2.8	1.4	14.2	3.9	4.9	5.6	7.7	8.5	7.6	13.4	4.3	3.1	3.0	3.3	15.6	6.2	4.3	8.3	1.4	7.4	2.0	5.9	10.9	5.9	4.6	5.3	5.8	7.6	5.0	10.2	4.6	4.3	10.0	1.4	3.2	3.2	3.4	6.5	3.8	6.1	2.6	5.5	3.9	3.6	1.6	2.4	4.7	1.9	4.4	5.0	4.5	4.1	1.5	6.1	6.3	5.8	5.1	2.7	2.4	4.6	3.5	2.0	9.9	12.2	28.5	15.3	6.8	7.5	9.7	7.4	9.2	10.6	0.0	12.0	11.5	2.6	1.6	5.9	3.9	5.1	2.7	3.4	5.2	35.3	5.2	1.7	3.0	2.7	3.1	3.3	0.0	3.3	3.5	2.5	3.2	5.8	8.1	3.3	1.6	6.4	3.7	9.7	4.3	4.0	3.2	0.0	6.4	5.5	2.3	4.5	5.3	2.1	1.5	17.7	0.0	2.8	4.3	4.4	1.8	9.3	7.0	3.2	3.3
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679801-79756623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 89.2;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	10.6	8.2	6.2	12.8	9.5	21.8	9.5	7.5	12.2	7.9	12.0	14.4	5.3	13.4	11.9	9.3	11.4	9.8	10.0	6.6	6.8	5.7	8.9	13.4	10.2	14.4	12.3	5.1	7.7	13.4	4.6	7.9	10.6	9.1	9.1	6.2	8.4	10.6	8.3	12.1	20.9	13.8	8.2	6.8	15.3	12.2	27.2	10.6	26.2	9.4	8.8	14.8	11.4	8.9	0.7	1.5	6.4	1.0	2.4	2.0	0.5	8.1	9.1	5.1	7.2	4.1	3.4	16.9	5.5	4.0	5.0	5.0	6.0	5.2	10.4	2.6	3.6	6.1	10.0	4.3	5.7	2.1	9.6	7.8	5.4	4.5	8.1	5.9	23.7	13.3	5.7	5.5	5.4	2.5	3.1	6.0	7.9	6.5	5.3	1.9	7.3	15.8	18.7	7.9	2.7	12.2	12.3	6.7	12.5	3.7	8.5	7.9	8.1	6.5	6.5	8.7	4.0	5.2	13.9	8.2	8.7	12.6	3.4	5.9	4.5	16.6	10.3	7.4	12.0	6.1	0.0	1.0	6.4	1.3	0.9	1.1	0.7	1.0	2.0	1.5	0.4	1.3	0.7	2.7	2.4	0.9	0.2	0.3	0.5	6.2	9.5	7.5	12.2	6.8	5.7	12.3	5.1	9.1	10.6	0.0	2.6	3.7	4.2	7.6	9.8	3.1	5.1	6.7	3.4	3.5	13.7	7.8	1.7	4.4	89.2	5.2	11.7	23.3	6.2	6.5	4.2	8.1	6.9	5.5	7.7	22.3	5.8	7.4	7.3	97.9	7.2	9.5	6.8	0.0	15.1	7.8	8.0	14.4	9.9	5.7	14.3	0.0	5.1	5.9	6.8	8.8	15.9	13.3	10.6	11.5
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846739	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 169.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	44.5	43.6	28.2	31.6	34.8	17.6	39.6	57.1	33.4	49.0	48.4	36.7	47.7	24.4	50.4	32.9	38.0	41.9	37.7	34.6	31.2	16.5	32.8	32.6	51.3	31.3	37.1	19.9	52.5	53.9	33.7	25.4	42.9	31.0	40.5	38.6	29.3	45.8	60.9	48.8	39.9	36.1	44.1	25.7	38.1	43.1	21.0	40.9	62.9	40.1	32.8	33.9	46.1	63.0	7.3	9.3	18.7	9.7	8.2	11.5	7.1	11.0	4.8	23.1	14.7	20.8	35.9	7.7	12.0	22.8	11.9	10.7	6.1	18.1	13.6	13.8	25.5	4.6	8.9	9.6	11.7	12.5	4.5	4.1	18.8	7.4	4.9	19.4	8.5	11.0	34.3	12.4	10.8	9.2	25.6	18.6	8.3	9.8	24.1	5.9	5.1	9.1	5.1	11.7	7.0	6.1	12.2	169.3	17.8	9.3	16.1	4.3	9.6	16.7	9.6	14.4	14.7	17.4	14.9	14.9	10.6	11.6	11.9	4.2	7.2	7.7	16.4	11.9	7.9	8.2	11.5	9.7	14.7	6.9	9.0	8.2	7.3	9.9	8.0	9.3	6.5	11.5	8.7	18.7	8.2	7.7	7.7	6.4	7.1	28.2	34.8	57.1	33.4	31.2	16.5	37.1	19.9	31.0	40.9	68.5	36.0	33.5	41.6	60.0	18.7	31.1	79.0	13.4	23.9	45.4	15.7	36.7	13.3	64.0	44.2	58.1	55.7	0.0	117.0	34.7	57.1	49.1	24.3	49.7	36.0	19.1	46.8	80.4	63.9	111.0	48.1	36.8	40.5	66.7	42.3	41.1	88.4	51.8	45.6	23.9	10.8	71.1	55.2	5.8	25.8	66.6	47.0	40.6	35.4	58.0
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		10000	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.8	6.9	2.9	9.0	11.3	16.2	21.4	10.9	13.8	7.6	8.9	10.0	13.0	0.0	6.7	13.5	3.1	13.3	7.0	20.7	6.1	0.0	5.5	9.7	7.4	22.6	10.3	0.0	2.4	8.3	50.9	8.0	9.6	8.6	10.6	4.4	3.1	0.0	12.5	5.0	3.9	0.0	11.8	6.5	1.0	4.4	5.5	0.1	24.3	10.6	2.4	7.5	6.0	10.8	12.2	12.1	10.4	2.6	8.4	5.5	7.7	10.2	6.8	0.2	0.0	0.0	6.1	5.4	10.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3	62.5	19.3	0.0	13.3	26.8	9.6	33.8	71.4	14.7	31.8	22.7	0.0	27.6	19.9	10.8	21.9	17.5	10.3	0.0	4.2	7.7	21.7	12.0	1.1	13.9	6.3	9.5	43.5	19.0	9.5	32.3	66.4	5.5	8.5	0.0	17.7	7.1	10.0	5.8	92.3	14.9	1.6	25.8	22.7	2.8	15.8	25.1	7.9	2.2	29.9	14.2
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432661	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	18.8	26.2	29.9	14.9	28.5	13.0	16.2	22.0	49.7	19.8	20.3	19.0	18.5	10.8	19.6	20.8	17.1	25.1	22.7	38.7	25.5	22.3	20.1	18.2	14.9	15.3	27.5	29.5	27.9	23.3	24.4	16.7	14.6	25.4	20.7	12.6	17.5	21.5	22.4	61.6	13.2	11.2	23.6	23.6	15.1	16.3	13.5	18.2	16.5	20.0	25.5	15.8	17.1	14.9	37.4	50.1	35.5	50.5	38.2	36.1	36.0	15.1	17.4	27.2	32.0	22.7	29.2	10.2	12.8	41.3	27.5	21.1	5.4	15.3	25.3	27.3	21.4	12.5	15.0	17.6	27.7	13.6	22.5	17.9	15.6	14.8	5.4	38.4	11.9	10.6	34.4	25.8	26.8	26.7	53.0	28.3	31.6	12.1	25.3	30.8	16.3	27.8	26.6	9.3	11.7	10.9	32.3	33.3	13.0	27.9	7.0	13.5	32.3	8.6	8.5	26.1	11.7	25.9	19.0	16.2	13.7	13.0	17.4	17.1	31.3	25.3	16.8	24.8	41.7	10.9	34.1	50.5	35.5	32.3	39.7	36.1	34.8	32.1	33.7	50.1	37.4	32.0	30.7	19.2	38.2	24.6	43.3	35.7	36.0	29.9	28.5	22.0	49.7	25.5	22.3	27.5	29.5	25.4	18.2	29.8	21.6	30.6	36.9	28.2	50.1	49.7	40.8	20.1	20.5	43.6	23.6	56.6	68.0	58.9	15.1	40.5	20.8	23.3	40.9	25.8	56.9	34.1	50.7	37.6	66.4	63.5	53.5	53.4	50.0	29.8	52.9	44.6	49.0	116.4	32.4	74.4	42.9	31.6	56.6	125.1	35.9	38.8	58.4	59.4	29.7	29.5	38.1	34.6	33.3	28.6
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 377.8;Late spermatids: 391.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.8	24.0	23.6	36.5	18.6	20.9	30.0	25.5	30.2	25.8	24.7	25.5	21.6	42.4	20.5	25.2	41.8	20.9	33.7	23.8	30.5	27.7	28.6	25.0	17.0	24.8	21.8	28.4	23.8	17.1	23.4	18.9	19.2	23.4	28.1	21.4	38.6	32.7	28.1	29.5	24.6	32.5	44.2	26.3	23.0	29.9	20.8	40.8	21.2	22.6	34.0	24.9	29.8	35.5	20.1	29.0	11.6	22.6	21.6	18.5	6.4	37.4	29.3	30.7	21.3	42.0	37.6	31.7	27.2	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7	32.8	29.7	24.2	26.3	24.7	29.4	23.2	10.2	42.8	42.1	8.7	27.5	57.0	14.9	24.9	377.8	21.8	9.5	23.3	22.9	69.2	23.6	16.6	22.0	37.5	26.1	20.6	15.0	19.0	15.2	391.5	20.1	22.4	27.0	64.1	19.5	32.1	23.7	14.4	28.7	9.3	42.8	32.3	27.8	53.2	33.0	22.2	61.2	20.8	16.5	17.9
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	19.3	12.7	22.9	19.2	24.4	19.5	12.3	48.6	29.9	31.6	26.4	23.1	17.3	22.2	52.1	17.4	23.9	24.5	23.2	53.8	18.8	18.3	27.4	16.0	22.0	11.8	20.4	11.7	33.0	41.4	34.4	30.2	24.4	16.9	22.8	17.2	26.8	26.3	16.9	31.0	15.9	25.3	27.5	31.6	15.0	23.4	8.3	17.1	44.0	33.5	23.2	24.1	31.8	21.9	2.0	12.1	4.7	21.0	3.0	2.2	4.5	14.5	15.6	11.0	13.7	9.0	18.6	6.9	14.7	15.6	6.2	4.1	9.3	9.4	18.9	23.6	14.5	11.5	12.0	7.0	11.8	3.7	9.0	7.8	6.6	11.6	7.7	23.9	8.5	3.6	12.9	24.1	4.8	10.9	17.9	8.0	12.2	15.3	16.0	5.8	30.0	27.8	10.5	4.5	22.5	16.4	18.4	9.2	22.3	10.2	16.7	10.2	30.3	12.8	32.2	12.5	9.6	6.3	10.3	11.9	26.3	17.8	19.8	8.3	10.5	4.9	40.8	24.3	7.9	18.3	2.1	8.6	1.5	2.1	8.8	2.2	2.0	1.6	2.2	7.0	1.7	1.6	2.2	4.7	3.0	21.0	12.1	1.5	4.5	22.9	24.4	48.6	29.9	18.8	18.3	20.4	11.7	16.9	17.1	92.3	45.5	28.3	27.6	23.4	53.5	101.2	28.1	46.8	45.5	38.4	64.8	44.1	8.3	29.7	7.2	31.1	49.5	0.0	20.8	48.4	40.9	44.0	11.5	30.9	29.9	50.9	40.8	32.5	70.3	7.4	38.3	36.4	16.9	25.2	44.2	49.6	28.5	54.3	57.3	53.1	57.1	25.8	24.5	12.0	13.8	37.9	73.6	20.8	37.2	42.8
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like 1, cell cycle control (S. pombe)"	Q69YN2	10	100232298-100267680	"Disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	13.8	9.8	8.6	13.6	12.5	20.5	15.8	18.3	18.6	11.8	9.9	15.4	6.1	7.9	13.8	9.0	11.0	12.9	8.7	10.6	9.0	10.3	11.2	14.8	11.6	19.1	11.5	8.6	14.3	14.1	12.4	12.4	12.2	12.4	10.5	11.5	12.3	11.0	10.6	14.1	14.7	11.8	14.4	11.2	19.1	10.1	19.7	10.8	22.3	13.8	11.2	22.6	12.5	10.1	12.2	12.2	18.6	13.9	13.9	15.4	11.1	14.4	10.9	9.8	14.2	4.8	6.5	10.2	9.5	14.2	22.4	19.2	10.8	11.2	16.7	9.9	8.5	8.3	13.4	22.8	13.0	23.9	11.6	9.2	9.5	9.7	8.8	8.1	23.5	9.1	8.1	5.4	16.3	15.3	7.0	14.8	14.7	11.0	13.9	11.9	8.5	18.3	7.8	7.0	6.7	9.7	6.2	18.6	9.8	6.9	7.9	4.5	8.5	12.4	4.8	12.3	7.1	19.4	6.5	11.8	7.9	10.4	8.8	15.7	11.4	15.2	10.1	10.4	18.5	5.1	9.8	13.9	18.6	12.1	13.2	15.4	12.2	12.7	13.0	12.2	12.0	14.1	13.8	7.2	13.9	11.7	4.8	15.2	11.1	8.6	12.5	18.3	18.6	9.0	10.3	11.5	8.6	12.4	10.8	17.9	9.6	6.6	6.0	3.9	8.4	7.0	5.1	14.7	13.6	5.2	3.9	8.8	6.6	4.5	13.3	7.1	3.6	0.0	6.6	8.9	6.1	4.6	17.3	5.8	8.2	9.5	4.1	3.7	17.3	4.5	6.4	6.0	8.5	13.6	3.4	5.1	5.9	4.8	3.9	5.4	11.9	0.0	7.1	11.4	11.3	6.8	9.2	10.9	4.3	3.8
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 59.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	7.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	5.6	0.5	2.7	0.0	8.5	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2	0.0	2.2	25.2	0.2	0.5	0.0	0.2	0.0	2.7	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	15.0	0.0	20.5	0.0	0.0	0.6	21.1	0.0	0.0	39.3	8.5	5.4	0.0	2.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.2	1.3	0.0	0.1
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	16.5	19.4	11.7	13.3	13.4	9.8	15.0	11.4	11.8	17.9	16.2	16.8	16.8	26.1	28.7	13.3	37.4	11.0	29.5	15.1	25.2	15.7	22.3	9.3	17.7	11.2	10.7	25.8	15.0	10.8	13.1	21.9	18.8	10.4	12.5	16.5	20.9	16.7	8.7	29.0	16.2	13.6	17.5	21.9	20.1	15.8	12.1	19.7	10.7	13.0	8.1	14.1	22.1	12.3	15.3	13.4	10.2	11.3	12.0	10.8	7.5	20.0	24.1	14.5	25.6	26.6	9.8	25.3	13.8	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6	3.0	11.5	11.1	7.2	5.6	15.6	10.6	5.1	8.1	4.5	3.5	5.9	16.9	18.3	7.7	1.2	6.8	8.1	0.0	5.8	16.9	6.7	4.9	17.3	3.9	8.9	7.9	8.2	4.9	10.5	1.0	8.9	7.4	11.8	19.8	5.6	17.0	5.8	8.5	10.6	10.5	10.2	12.9	9.1	3.4	7.8	5.1	29.7	5.7	8.4	7.3
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	9.3	0.0	0.0	2.7	0.0	2.6	0.1	0.1	0.0	0.0	5.4	0.0	0.1	12.5	2.3	0.0	0.6	0.0	3.1	0.3	0.0	0.0	0.0	1.7	0.0	0.1	10.2	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3	0.0	5.4	0.0	0.8	0.2	41.0	12.8	0.0	14.7	2.3	0.0	29.5	0.1	0.0	0.1	0.2	1.6	0.9	0.0	2.9	0.0	0.4	0.5	0.0	2.4	0.1	42.9	98.1	1.3	0.3	0.4	0.3	0.0	1.7	0.0	4.3	13.3	2.1	0.0	10.3	0.7	25.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.4
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 68.2"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 594.9;Horizontal cells: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	12.3	9.5	22.4	9.3	19.9	22.2	9.2	68.2	38.8	17.5	10.2	39.3	5.1	6.0	9.9	18.0	10.1	18.1	11.4	15.8	23.9	16.7	25.6	33.8	9.0	15.5	30.9	21.7	5.4	24.9	18.2	18.6	10.4	25.4	8.1	7.9	14.2	30.0	11.7	39.7	9.8	9.1	8.4	36.7	18.1	11.4	19.0	27.5	20.5	12.5	7.7	13.5	9.6	9.9	29.3	19.1	0.7	2.1	21.8	10.2	3.4	9.4	8.0	8.8	3.3	12.4	17.0	3.4	6.2	9.5	2.7	5.4	17.6	9.6	12.5	27.6	16.5	16.3	10.9	1.8	4.8	1.3	1.3	3.1	18.6	7.1	12.3	5.3	4.1	0.6	6.1	1.1	4.5	1.3	26.2	0.7	0.4	17.4	2.0	19.5	24.7	4.4	13.2	10.7	10.3	2.2	8.0	18.1	19.1	20.3	6.9	28.2	29.1	2.2	57.1	4.6	20.4	31.2	19.5	3.9	22.2	4.4	10.5	5.5	7.5	15.6	23.6	33.4	1.4	12.2	0.3	2.1	0.1	3.2	0.4	10.2	27.7	0.3	2.3	1.8	29.3	0.2	0.9	0.7	21.8	0.1	19.1	0.4	3.4	22.4	19.9	68.2	38.8	23.9	16.7	30.9	21.7	25.4	27.5	44.7	16.8	79.0	14.3	23.4	189.2	39.2	91.7	25.4	18.2	139.6	23.6	2.7	268.5	104.4	594.9	41.3	10.1	23.3	127.1	18.5	63.9	34.4	20.8	98.7	39.4	511.7	17.9	26.4	25.4	156.4	36.2	34.8	57.3	50.5	49.6	220.2	83.9	5.8	28.7	146.6	42.7	12.9	77.3	5.4	7.8	18.2	31.5	24.5	24.3	15.8
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 205.4;Late spermatids: 439.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.9;memory B-cell: 12.2"	"Group enriched"	"Detected in many"	9	"B-cells: 12.2;granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7"	"Low region specificity"	"Detected in many"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	3.3	1.9	9.3	2.8	12.1	1.9	7.7	3.1	12.3	6.6	2.3	26.1	4.2	1.3	10.0	13.1	8.0	5.2	3.4	2.0	11.2	5.3	2.4	2.5	4.6	3.8	22.3	7.3	14.9	2.2	23.1	0.6	6.7	11.6	7.8	2.7	12.2	12.8	11.6	0.8	23.4	1.7	6.8	12.4	2.0	2.2	58.8	14.5	0.2	2.6	6.7	4.9	5.9	7.1	12.2	0.0	5.9	1.0	0.0	0.2	0.7	2.3	1.2	0.5	0.0	0.1	0.6	7.9	14.8	42.5	22.7	20.7	0.2	3.2	0.0	3.5	7.6	7.0	0.2	0.0	0.1	18.2	0.0	0.0	0.0	1.3	0.3	12.3	0.1	2.3	6.2	0.5	0.1	1.2	0.0	1.9	0.0	2.2	0.0	0.1	0.0	0.0	0.0	23.9	2.4	1.1	11.2	0.0	0.0	0.0	1.5	0.0	0.2	0.1	9.5	0.6	4.0	1.6	3.1	0.0	2.1	0.0	0.1	1.1	0.0	0.0	3.5	0.1	0.0	32.7	0.0	1.0	5.9	0.0	0.5	0.0	12.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.7	9.3	12.1	3.1	12.3	11.2	5.3	22.3	7.3	11.6	14.5	20.8	3.2	0.0	7.4	6.3	0.8	1.9	0.0	8.1	2.3	3.5	19.6	4.6	0.0	1.4	205.4	1.0	0.0	0.0	4.2	16.5	7.1	4.8	2.3	1.1	2.3	0.0	0.0	0.0	0.0	439.8	4.4	1.4	5.0	0.0	1.4	0.8	4.6	0.9	5.6	0.0	37.7	12.9	12.6	63.0	5.9	8.8	3.8	0.0	1.4	10.5
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.3	2.9	3.4	3.8	5.4	7.8	3.1	13.8	20.2	14.4	8.5	2.4	4.4	10.7	5.0	13.5	15.7	3.6	4.0	8.4	21.5	47.2	6.1	5.3	5.2	2.0	10.7	5.3	25.3	8.5	6.8	17.4	18.2	13.7	5.8	7.6	2.2	9.4	20.1	1.4	5.2	7.7	3.6	2.9	4.9	4.7	6.9	10.3	4.7	3.2	4.4	3.3	11.7	4.0	3.4	5.4	4.0	6.7	6.5	24.7	5.6	8.6	5.6	24.8	23.5	12.0	18.1	6.0	5.2	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7	41.7	25.6	39.6	48.8	106.7	75.4	32.7	25.5	12.0	19.4	17.4	88.4	5.4	5.0	18.3	32.8	37.9	13.4	46.7	16.5	3.8	37.2	52.3	78.5	22.1	19.0	63.5	29.9	21.5	32.3	24.7	23.6	47.1	70.9	34.3	10.3	22.6	15.2	18.7	19.8	10.3	49.3	6.5	34.4	52.6	13.8	135.9	3.4	73.4	12.0	56.3
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	17.4	12.4	20.7	28.5	36.0	34.4	12.0	17.7	27.5	10.1	17.4	64.1	5.0	13.2	7.7	6.5	25.9	10.2	15.5	10.3	21.5	16.0	11.5	16.0	25.7	42.3	44.4	27.4	5.9	16.0	7.5	8.4	15.8	32.1	15.2	19.9	10.1	17.3	5.3	17.5	15.9	21.4	10.0	31.2	31.8	24.8	7.9	45.2	19.3	15.2	9.2	50.1	14.4	12.1	24.7	19.1	45.9	20.0	21.8	39.4	31.3	9.1	6.4	6.4	5.5	4.4	5.7	6.2	4.3	3.8	5.3	6.3	4.0	10.3	6.8	4.4	5.7	9.1	8.1	3.1	11.3	4.3	14.3	8.7	2.7	8.1	7.4	3.2	5.6	27.6	2.7	9.3	6.0	6.3	3.6	17.1	23.0	4.5	26.4	6.3	4.7	36.3	5.0	1.6	14.9	5.7	9.6	7.1	23.9	5.8	6.4	3.7	13.6	7.6	14.8	6.0	6.8	7.2	6.7	8.1	4.2	6.2	6.7	4.4	30.7	14.1	25.0	3.1	5.7	4.4	45.9	16.2	31.4	39.4	20.0	28.6	24.7	32.8	31.8	13.7	23.0	36.5	30.7	33.8	21.8	17.6	19.1	24.5	31.3	20.7	36.0	17.7	27.5	21.5	16.0	44.4	27.4	32.1	45.2	56.6	46.2	41.5	26.5	36.6	62.3	16.6	17.8	33.5	31.8	5.2	104.1	2.4	6.6	10.4	23.5	51.6	24.0	0.0	16.1	7.5	15.4	34.8	33.7	24.6	41.7	41.3	26.6	30.7	66.6	33.2	4.0	73.5	35.4	139.7	45.7	16.5	31.3	24.9	4.9	5.8	74.3	6.5	11.7	14.1	15.3	30.1	6.1	71.7	15.2	45.7
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.6"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	24.0	9.1	10.9	6.6	14.4	6.1	22.0	14.2	17.6	10.4	16.4	7.0	5.7	15.1	13.0	8.1	13.4	12.6	13.9	21.1	11.4	7.2	8.8	3.0	14.0	5.4	9.4	10.7	11.0	6.6	9.4	7.1	66.6	9.4	6.8	6.7	17.8	8.6	8.7	12.3	15.6	18.5	15.2	8.5	7.5	9.2	26.0	6.5	2.9	20.4	10.8	5.0	7.7	16.5	0.6	1.8	0.7	0.4	3.3	5.9	0.4	21.6	5.5	5.2	3.6	24.5	29.0	7.4	12.8	11.2	12.7	12.1	8.4	10.8	2.9	7.8	25.8	16.4	20.4	3.6	9.3	8.5	0.2	5.1	0.8	6.5	1.0	11.6	0.9	1.4	20.5	4.2	6.7	9.8	5.7	2.2	4.3	3.4	0.4	9.2	3.5	0.7	3.8	3.6	2.9	7.4	3.8	14.0	1.6	9.8	2.6	3.4	6.5	7.9	27.8	22.5	4.7	1.7	6.1	8.0	8.7	23.2	9.4	7.8	1.0	0.3	3.0	2.8	2.3	35.5	0.7	0.4	0.0	2.2	0.2	5.9	0.3	1.0	2.4	0.4	0.6	0.1	1.5	0.3	3.3	0.4	1.8	0.8	0.4	10.9	14.4	14.2	17.6	11.4	7.2	9.4	10.7	9.4	6.5	14.9	8.0	2.4	1.7	13.5	4.8	16.5	2.5	2.7	3.4	3.5	7.9	12.6	5.0	3.3	9.9	14.7	7.5	0.0	2.4	7.4	14.4	3.0	12.7	1.5	9.9	14.3	2.9	16.0	2.7	12.1	15.3	4.6	30.4	1.0	5.8	8.8	6.4	5.3	12.4	1.0	1.8	38.8	24.0	19.5	10.5	9.9	12.7	5.0	6.9	1.6
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.4;lymphoid tissue: 92.9"	"Cell type enriched"	"Detected in many"	4	"monocytes: 788.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.6;HDLM-2: 11.7;Karpas-707: 39.9;RPMI-8226: 12.2;U-266/70: 68.0;U-266/84: 25.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Not detected"	"Not detected"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.4	1.4	1.4	33.3	1.6	32.3	3.9	0.8	1.0	4.4	9.7	1.6	0.8	9.3	3.1	4.2	6.6	2.8	5.8	3.8	1.5	1.5	4.1	3.9	26.8	92.9	3.1	0.6	2.9	3.1	0.0	1.5	1.3	2.0	2.4	5.0	3.1	11.5	3.1	1.4	2.1	17.4	2.1	4.3	48.3	14.4	3.3	1.3	40.5	3.2	3.8	61.8	24.1	3.2	21.9	13.0	48.5	53.3	19.9	53.4	31.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	39.9	0.2	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	12.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	68.0	25.5	6.6	0.6	1.8	0.0	48.5	8.4	24.5	30.6	27.8	30.9	21.9	32.4	28.9	13.0	21.1	53.4	40.7	48.2	19.9	53.3	6.7	31.3	31.6	1.4	1.6	0.8	1.0	1.5	1.5	3.1	0.6	2.0	1.3	3.0	16.4	102.3	1.0	18.5	0.0	2.0	5.1	0.0	2.3	1.8	0.0	0.5	13.3	0.2	1.2	1.2	0.5	23.3	1.7	9.8	8.5	0.5	6.9	1.0	24.4	0.0	1.7	4.9	80.4	1.7	0.0	153.9	79.2	788.1	1.9	0.0	0.2	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.2	15.6	2.5	190.7	1.5	0.1
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 70.5;Horizontal cells: 82.6;Late spermatids: 80.3;Muller glia cells: 155.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	15	"basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;HAP1: 12.8;HEK 293: 9.6;HL-60: 20.7;NB-4: 9.2;SCLC-21H: 21.3;SH-SY5Y: 17.1;THP-1: 15.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 34.7"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.0"	"HPA012672, HPA012938"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012672: AB_1847466, HPA012938: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.9	12.2	0.6	3.8	15.5	5.7	9.2	1.8	2.9	11.4	5.4	0.0	3.5	5.4	6.3	4.1	0.9	2.9	15.8	3.0	0.2		10.2	1.9	10.2	0.3	0.0	1.5	0.9	1.8	7.3	24.4	7.3	4.9	7.9	3.5	19.6	1.9	6.9	3.6	0.6	9.6	2.1	2.9	7.8	1.8	6.1	6.6	6.1	0.0	1.2	0.2	2.1	10.2	0.0	7.5	9.2	0.2	4.9	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.8	0.0	0.0	0.0	9.6	0.1	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	9.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.3	17.1	0.0	0.0	0.0	0.0	0.5	15.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	4.7	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	4.9	0.0	7.5	0.0	0.1											0.0	1.1	0.0	2.9	1.4	10.4	1.6	0.0	1.4	0.0	7.0	3.9	0.0	5.0	0.5	70.5	17.3	1.1	0.0	0.0	0.0	0.8	9.2	4.7	0.0	0.2	82.6	32.7	1.8	1.6	80.3	3.1	1.1	0.0	0.0	13.3	155.3	0.5	0.0	1.8	3.5	4.8	12.9	1.4	21.1	7.0	1.1	0.0	0.0	3.7	1.8
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647612-46661138	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 15.7;Early spermatids: 18.3;Smooth muscle cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 9.4;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	5.2	3.8	21.0	5.8	15.9	1.7	1.6	3.7	32.3	10.7	17.3	24.6	3.5	4.2	21.6	14.8	7.8	10.9	7.4	10.5	21.7	13.9	3.9	2.2	5.6	1.5	17.4	13.6	8.8	1.5	1.4	1.2	2.1	14.1	11.7	7.2	13.7	1.7	25.1	1.7	2.8	4.7	30.3	17.0	4.8	7.4	5.7	9.4	0.0	1.6	1.5	1.3	13.2	6.0	1.6	1.2	5.9	0.9	2.0	0.7	0.3	0.2	0.3	5.2	4.9	1.8	1.4	0.5	2.9	4.7	0.9	1.4	0.3	0.3	0.4	1.9	9.4	1.0	0.3	3.2	0.1	1.0	0.4	1.7	1.3	0.7	0.2	2.6	0.2	2.2	4.7	0.1	1.2	0.0	0.6	0.4	0.8	1.6	1.7	0.8	0.4	0.2	1.2	2.0	0.2	0.7	4.2	1.4	0.3	0.3	0.4	2.0	23.0	0.5	0.2	0.4	5.6	0.4	0.4	0.5	2.4	3.0	2.5	0.5	1.5	0.5	0.7	0.6	0.8	1.8	5.9	0.9	1.0	0.7	0.5	0.5	0.7	0.7	0.5	0.2	1.6	0.7	0.7	4.6	2.0	0.7	1.2	0.5	0.3	21.0	15.9	3.7	32.3	21.7	13.9	17.4	13.6	14.1	9.4	6.0	8.5	0.0	1.1	2.1	13.7	15.7	0.0	0.0	1.2	0.0	2.0	4.3	0.0	0.0	18.3	2.2	0.0	0.0	0.0	2.5	7.3	0.8	5.8	0.0	0.9	1.6	1.7	2.5	1.5	6.1	7.2	1.9	3.3	1.0	0.0	5.8	0.1	0.0	13.8	0.3	4.9	6.5	27.6	2.1	1.7	2.9	8.2	0.0	0.2	0.9
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.0	19.4	12.1	7.5	9.2	13.1	15.5	12.8	10.6	18.5	14.2	18.2	26.1	15.7	17.5	10.2	12.2	29.8	33.4	21.6	25.3	17.9	16.4	13.6	9.7	12.6	9.0	11.5	12.4	9.5	9.9	18.7	19.1	5.9	18.4	11.9	27.5	12.4	15.4	8.0	14.6	6.5	23.4	32.5	17.4	17.2	15.4	28.9	16.8	9.7	15.9	14.5	14.0	31.3	20.2	19.0	32.8	15.2	8.1	9.5	15.0	13.1	20.4	9.7	24.5	18.2	5.5	12.7	20.5	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9	3.0	1.9	4.3	3.6	1.5	2.2	10.5	7.6	1.4	3.4	5.2	0.0	7.3	6.6	3.9	1.9	3.2	4.5	23.3	2.3	13.0	3.4	2.3	5.7	4.3	8.9	3.2	4.1	1.3	3.5	1.0	2.8	5.0	1.7	6.4	5.0	2.4	3.6	0.0	1.4	6.4	2.7	0.0	2.3	5.7	6.4	1.4	3.5	2.9	6.0	2.5
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	10.4	14.3	10.7	13.5	11.9	8.8	10.8	11.3	14.8	11.8	12.2	9.4	7.3	11.2	13.2	43.7	13.5	12.6	12.1	9.1	9.7	7.3	9.2	12.0	10.3	18.3	10.2	8.5	13.8	18.6	24.4	10.4	11.6	11.6	13.0	14.1	7.3	10.7	15.2	14.8	11.6	12.7	15.5	8.1	20.4	10.5	20.2	11.5	25.0	16.1	6.8	30.9	11.5	10.9	17.0	5.9	12.6	11.2	15.3	18.2	21.8	2.1	0.0	7.1	2.8	1.2	2.3	4.7	7.0	22.9	17.9	13.2	0.8	2.4	6.9	2.5	5.4	20.5	1.3	0.1	5.7	16.6	8.2	15.6	9.0	12.4	11.1	3.9	9.6	2.6	6.0	8.5	2.0	5.3	5.3	0.5	4.5	5.0	4.5	5.5	5.2	3.8	21.3	0.4	0.1	3.3	5.9	0.1	7.7	1.4	0.7	8.5	2.2	0.0	0.4	3.7	3.5	2.2	0.2	5.9	4.4	5.6	0.2	0.1	7.8	16.2	14.9	3.3	4.4	4.7	7.8	7.5	12.6	16.3	8.0	18.2	16.6	15.4	15.8	5.9	17.0	13.9	14.1	7.4	15.3	11.2	5.9	17.1	21.8	10.7	11.9	11.3	14.8	9.7	7.3	10.2	8.5	11.6	11.5	6.0	21.4	27.0	17.6	52.0	17.3	7.5	15.3	14.7	25.0	12.2	17.7	21.7	19.9	29.4	9.8	20.6	18.0	0.0	33.3	29.5	26.3	21.9	35.9	13.5	21.9	14.3	20.2	11.6	13.7	4.7	16.4	20.8	23.6	60.5	19.5	17.7	46.9	21.0	21.9	11.9	73.3	12.9	23.7	48.8	34.9	53.2	20.7	51.7	20.9	30.2
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1700000	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	22.1	15.0	11.4	33.1	14.2	37.1	32.9	16.1	19.4	15.2	21.4	22.2	17.2	28.3	17.8	11.0	30.9	16.0	13.5	26.7	11.5	9.2	17.1	38.1	18.7	29.2	16.8	12.4	20.7	28.3	11.9	11.4	22.2	13.3	15.9	15.6	16.8	17.0	12.0	31.4	20.2	28.7	17.7	10.9	28.5	22.0	46.8	15.0	43.8	15.9	22.6	21.0	21.4	27.7	7.1	6.1	4.3	7.5	6.5	7.1	3.1	53.2	19.4	13.0	23.7	5.8	7.1	37.4	24.0	12.0	19.7	16.2	19.3	26.4	62.8	14.8	11.7	9.6	30.1	17.2	22.9	16.7	43.9	27.2	32.3	18.6	19.6	13.5	39.1	27.8	7.0	15.1	13.4	24.6	8.4	17.2	26.7	48.1	33.2	12.3	21.8	68.5	34.8	40.2	19.6	19.6	49.4	20.8	38.7	14.8	18.1	25.9	23.3	15.9	25.0	28.9	17.7	22.7	52.2	18.6	16.2	22.0	28.3	52.5	39.3	40.3	49.8	19.6	38.1	24.8	3.2	5.5	4.3	6.5	7.5	7.1	7.1	6.0	6.9	4.9	5.5	6.0	6.4	2.4	6.5	5.2	6.1	6.1	3.1	11.4	14.2	16.1	19.4	11.5	9.2	16.8	12.4	13.3	15.0	8.9	25.1	51.6	76.4	61.6	49.4	34.3	33.1	10.7	18.2	24.4	33.4	33.1	19.9	45.8	41.0	31.5	47.0	23.3	47.1	91.4	34.5	63.8	26.5	38.1	42.1	25.4	31.8	30.7	39.5	45.6	25.9	40.6	38.8	24.4	62.3	27.0	52.0	42.1	22.3	37.7	38.4	25.8	48.4	128.2	37.5	65.5	57.7	39.8	68.9	92.5
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909541	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11.8;testis: 34.2"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 250.0;Spermatocytes: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	1.1	1.2	1.4	5.9	2.0	1.8	3.0	1.9	1.9	1.4	2.1	0.0	0.6	1.2	1.2	1.4	1.7	1.1	1.5	1.0	1.5	1.4	1.2	1.1	2.4	5.0	1.3	1.0	3.4	1.3	1.2	1.8	1.4	0.8	1.2	1.2	0.0	1.2	1.1	1.9	1.3	1.5	0.9	1.2	4.6	1.1	34.2	0.7	11.8	1.4	1.9	2.7	1.6	1.1	1.3	0.9	4.0	0.4	0.9	1.6	0.5	1.3	1.4	3.0	3.8	0.7	0.6	0.9	1.4	0.3	1.5	3.0	2.3	0.9	3.1	1.1	0.9	2.6	1.3	3.1	0.8	1.6	2.3	2.1	2.0	1.7	0.5	0.2	2.4	1.6	0.7	0.8	1.7	1.6	0.5	1.3	2.9	1.7	6.5	2.0	2.4	4.2	3.0	3.0	3.1	2.9	1.1	4.7	3.7	1.2	0.2	4.4	2.8	1.9	3.3	1.5	2.5	1.4	2.5	0.6	1.8	2.2	4.7	3.0	3.7	7.7	3.1	1.3	4.4	3.9	4.0	0.4	0.4	1.2	0.3	0.3	0.8	1.1	0.6	0.2	1.3	1.1	1.3	1.1	0.9	0.4	0.9	1.6	0.5	1.4	2.0	1.9	1.9	1.5	1.4	1.3	1.0	0.8	0.7	3.0	13.0	34.9	16.3	13.9	5.8	3.6	0.0	14.7	5.7	8.7	11.8	12.2	3.3	5.4	250.0	8.5	4.5	46.7	12.9	31.0	7.6	10.6	30.1	5.4	13.9	3.2	14.3	7.4	8.8	57.4	14.4	14.2	11.8	9.0	18.6	1.9	10.7	7.0	8.9	4.4	15.5	12.9	8.2	291.4	77.1	11.0	8.0	21.5	15.8	11.4
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 27.8;Horizontal cells: 28.6;Spermatocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA048465	Uncertain		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"HPA048465: AB_2680405"	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	2.6	2.0	8.0	5.8	6.1	5.6	3.4	7.1	9.4	3.6	4.1	5.3	3.3	2.4	6.4	11.4	3.5	5.9	4.3	2.0	6.7	3.7	3.1	1.6	3.0	4.7	6.7	4.7	5.9	2.3	2.6	4.5	3.3	6.2	5.4	4.1	6.4	3.3	4.8	5.4	6.5	3.7	5.3	4.7	4.4	3.2	10.9	6.4	6.9	6.8	2.5	5.2	4.2	3.2	1.5	0.9	1.8	1.6	0.0	2.2	0.5	3.9	8.3	6.2	4.5	0.6	1.2	5.4	4.2	1.8	8.9	8.8	3.5	3.4	5.8	2.3	1.5	8.0	3.8	5.4	1.7	10.3	9.6	8.6	7.4	6.3	4.6	0.3	4.9	6.4	0.5	0.6	4.9	1.6	2.0	4.4	9.9	9.3	6.1	4.8	4.1	7.3	3.0	2.7	8.2	4.4	6.5	7.2	2.5	2.1	2.4	3.5	3.7	4.0	1.3	3.3	7.0	4.2	3.3	1.9	3.1	5.9	3.9	7.6	2.8	3.6	7.6	2.3	4.4	4.8	0.0	0.9	1.8	0.3	1.6	0.2	1.5	0.2	0.3	0.9	0.4	0.0	2.2	0.0	0.0	1.3	0.7	0.6	0.5	8.0	6.1	7.1	9.4	6.7	3.7	6.7	4.7	6.2	6.4	0.0	1.4	7.5	2.4	0.6	27.8	1.0	0.0	2.7	3.4	5.2	11.8	3.2	0.0	0.2	8.1	2.2	0.0	0.0	0.7	1.1	1.3	2.2	3.5	0.2	1.2	28.6	4.1	1.3	1.6	5.5	1.1	2.2	5.0	1.0	0.5	11.7	0.3	0.0	2.8	0.3	16.1	0.0	0.9	36.9	11.3	0.1	1.1	1.0	0.6	2.0
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 160.5;skeletal muscle: 84.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Ciliated cells: 9.4;Club cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	12.2	7.8	56.5	9.9	64.9	2.1	15.3	21.3	88.8	11.0	26.4	132.3	5.0	16.6	14.9	13.6	18.3	17.7	10.2	68.4	85.1	47.3	5.9	2.5	13.9	5.8	98.2	31.5	6.5	6.7	18.4	5.0	13.2	51.8	14.2	28.4	3.1	9.0	29.1	84.2	10.4	19.4	31.0	160.5	5.0	13.3	3.0	70.7	2.7	4.8	10.5	8.2	16.8	8.2	0.3	15.0	0.3	9.3	0.6	7.9	3.5	21.7	3.9	3.1	22.0	2.0	0.9	4.4	12.8	13.9	10.7	7.3	10.5	29.8	0.3	2.2	12.6	4.0	32.2	21.5	1.1	6.6	0.1	12.6	18.1	16.8	9.5	12.9	0.9	27.6	0.3	3.7	4.0	3.8	18.7	7.3	18.6	1.3	0.4	0.8	27.6	1.5	1.3	4.1	14.3	23.2	0.0	0.3	0.2	30.6	0.4	7.2	3.7	4.4	2.4	27.5	2.3	30.1	5.6	11.7	0.4	21.3	14.2	13.9	0.3	0.4	0.1	1.5	0.1	3.1	0.0	8.4	0.0	7.9	9.3	2.9	0.1	6.9	5.8	6.0	0.3	6.4	6.0	0.3	0.6	5.0	15.0	5.8	3.5	56.5	64.9	21.3	62.5	85.1	47.3	98.2	31.5	51.8	70.7	3.0	0.3	0.0	0.1	0.0	0.0	1.0	0.0	9.4	4.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"monocytes: 471.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		15000000	Cytosol	Nucleoplasm	"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	23.9	19.6	21.2	45.4	17.4	34.1	20.5	11.4	24.0	23.9	21.0	19.6	23.5	17.9	22.0	21.8	65.6	19.1	32.7	18.0	18.3	18.8	18.9	18.4	23.6	49.8	19.1	23.8	15.2	19.2	16.7	18.5	25.8	16.1	21.0	15.2	17.2	23.4	22.3	15.9	26.2	23.2	25.2	19.8	46.8	24.7	13.0	15.8	31.0	18.2	32.0	52.3	23.6	31.6	46.7	66.0	64.1	73.7	31.6	35.4	80.5	19.6	28.6	17.9	19.4	22.3	14.4	16.6	32.3	27.0	32.2	27.1	28.7	27.4	44.0	23.5	35.2	40.3	34.9	10.4	37.8	12.1	23.5	12.1	14.9	21.4	16.3	22.7	22.3	27.8	13.6	15.1	30.6	10.7	21.0	22.1	27.5	18.7	15.3	30.5	28.5	39.9	25.1	14.6	20.2	24.2	22.2	14.6	21.8	20.8	27.4	21.8	28.9	22.0	43.3	6.9	13.4	31.9	31.1	35.3	26.5	24.0	15.3	37.4	35.9	15.4	24.6	24.9	25.3	62.6	39.2	66.3	50.2	35.4	73.7	28.0	46.7	26.7	28.8	63.9	45.8	27.0	28.2	64.1	31.6	71.0	66.0	31.3	80.5	21.2	17.4	11.4	24.0	18.3	18.8	19.1	23.8	16.1	15.8	41.7	39.3	122.1	30.1	15.7	32.3	28.5	25.5	16.0	19.4	29.6	33.4	67.1	38.1	80.6	8.5	35.4	50.3	46.7	64.8	122.0	37.7	30.1	63.6	19.2	155.2	38.1	36.4	29.4	130.7	6.2	34.2	90.1	52.3	471.5	44.3	39.0	78.0	73.7	31.8	24.0	36.5	6.5	39.1	19.9	13.0	23.3	73.0	66.0	34.9	51.4
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 8.8;Ciliated cells: 9.4;Club cells: 12.5;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.8	13.4	13.0	11.8	11.8	9.4	12.4	12.2	9.2	13.2	13.0	14.6	10.6	26.5	6.8	9.6	20.3	9.6	24.5	10.9	17.2	18.4	12.1	22.7	18.3	12.5	8.6	29.5	16.5	6.2	12.7	17.1	12.5	8.7	10.2	14.7	13.2	17.3	10.3	11.1	22.5	12.0	13.7	13.0	14.7	9.6	14.0	17.5	10.3	17.0	6.8	12.1	13.5	12.5	7.4	10.0	8.5	12.6	12.8	10.9	14.6	17.9	18.7	11.8	15.9	27.3	12.7	20.3	8.9	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	12.5	3.5	0.0	6.6	1.7	5.9	0.0	0.0	0.0	0.0	5.8	4.8	0.0	0.0	5.8	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.6	0.0	0.0	6.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Group enriched"	"Detected in all"	4	"Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	23.0	11.0	6.1	9.9	20.3	28.9	21.6	23.6	35.4	16.8	25.1	18.3	19.5	19.1	13.8	30.5	8.0	17.4	9.6	17.7	23.8	10.8	10.2	20.3	16.8	13.1	16.4	9.1	9.7	20.5	17.9	15.9	13.3	25.6	18.3	6.1	22.9	15.8	24.7	5.3	10.1	8.3	3.9	12.9	12.3	7.8	12.7	14.8	41.9	11.3	9.0	7.2	18.9	17.4	12.9	13.4	29.7	11.2	25.8	16.8	10.5	16.2	9.7	17.0	13.8	14.9	22.4	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8	53.6	33.4	19.8	24.8	51.4	13.4	200.2	45.9	60.2	53.4	24.4	21.6	61.0	14.9	25.7	375.8	29.8	24.8	46.7	16.9	26.6	39.2	32.0	18.5	81.0	17.8	4.8	20.3	25.8	28.6	573.8	53.2	22.6	35.4	176.7	27.3	14.6	18.0	28.1	45.6	26.9	16.7	32.3	37.1	78.4	58.9	34.8	68.0	20.8	28.8	23.7
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550461-63594266	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	17.0	18.4	27.6	25.8	24.8	7.9	15.6	20.8	27.3	21.1	22.9	27.1	22.5	24.9	19.4	19.4	20.5	19.6	20.1	17.1	24.9	22.3	26.7	20.9	23.5	25.5	22.2	16.5	17.1	20.0	39.2	19.0	25.7	19.4	22.4	25.7	21.1	18.0	24.5	11.5	15.8	26.7	18.8	24.4	28.8	19.8	32.5	22.2	47.1	21.9	13.0	30.3	20.7	16.2	10.2	12.1	13.6	17.3	10.0	13.6	8.4	11.3	16.1	28.4	18.1	9.8	8.1	7.5	11.4	10.1	12.6	10.7	11.8	12.4	21.0	9.2	11.3	13.2	12.2	23.6	16.0	16.3	8.0	15.1	27.4	10.4	13.8	10.2	30.4	15.9	6.8	10.6	7.3	16.9	15.3	19.7	17.9	28.8	9.8	16.0	13.9	32.8	14.7	9.2	19.8	21.9	26.3	33.8	11.9	18.5	17.3	27.4	50.6	10.3	20.0	13.4	26.3	14.7	24.8	20.7	20.9	9.6	10.5	18.7	10.3	13.2	11.3	11.9	19.8	12.4	11.5	12.6	13.6	13.6	15.0	11.0	9.4	9.5	10.5	12.1	10.2	8.7	9.2	5.5	10.0	17.3	9.0	6.6	8.4	27.6	24.8	20.8	27.3	24.9	22.3	22.2	16.5	19.4	22.2	41.7	48.2	37.3	25.6	27.8	52.6	21.4	45.9	42.8	25.0	64.6	72.6	40.4	19.9	43.3	50.6	38.7	48.4	23.3	39.3	40.6	25.0	38.1	58.9	33.4	49.0	62.0	69.2	51.5	52.9	14.3	32.5	48.5	25.3	52.3	48.0	47.3	45.5	31.6	35.7	39.4	51.4	58.2	30.0	54.4	26.8	30.5	18.1	51.0	51.9	37.2
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	17.1	21.5	24.4	22.0	30.7	23.3	21.3	20.4	28.9	17.1	15.3	22.6	29.8	19.0	38.3	23.1	12.6	21.3	11.8	19.2	10.8	43.5	23.2	21.1	30.1	17.7	25.0	17.6	27.0	27.6	20.3	15.2	22.1	19.0	26.4	24.6	19.0	35.0	15.8	16.3	22.7	17.6	17.5	22.6	21.4	22.3	14.4	37.1	19.6	30.6	16.6	16.0	34.2	38.3	22.9	24.7	35.9	26.7	31.7	21.1	10.9	12.9	18.8	57.5	39.2	30.9	23.5	16.6	17.2	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5	53.6	45.7	13.9	17.0	16.4	43.6	50.1	22.9	48.2	38.7	24.4	60.9	25.4	53.0	18.8	1.7	23.6	23.7	0.0	18.8	17.5	22.0	14.7	31.4	60.2	20.7	38.1	24.1	17.2	29.6	1.9	25.9	19.5	13.5	30.7	19.1	36.1	17.3	10.5	30.8	27.6	56.3	12.9	25.5	27.5	17.9	21.1	37.1	28.0	19.0	8.2
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"THP-1: 6.7"									HPA048308	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048308: AB_2680349"																		0.2	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.6			0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.5	3.0	0.2		0.0	0.3	0.0	0.0	0.0		0.1	0.4		0.2	0.1	0.1	2.2	2.0	0.0	0.2	2.7	0.1	0.0			0.2		1.6	0.1	0.2	0.0	1.0	0.1	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 84.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	16.7	15.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	12.9	19.8	0.0	10.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	14.6	7.3	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	1.1	0.0	0.5	0.0	4.1	2.5	0.0	0.0	1.2	6.1	0.0	0.0	0.0	0.0	3.4	4.3	0.7	0.1	0.0	0.0	1.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0.0	1.0	13.5	2.2	5.1	0.0	4.0	4.5	3.5	3.9	0.0	0.0	0.0	1.3	2.9	0.0	0.0	0.0	0.0	9.3	0.5	0.0	0.0	0.1	9.5	0.0	0.6	0.3	0.9	19.2	0.0	13.5	0.0	0.0	84.2	0.3	0.0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0.0	0.0	0.0	1.3
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	3.4	7.1	7.0	4.1	8.1	4.5	6.1	10.2	9.9	5.0	5.3	3.7	4.5	4.7	5.9	6.9	6.5	5.0	4.0	4.8	6.0	6.4	7.3	15.6	7.0	7.5	6.0	2.6	6.5	9.4	10.7	16.9	4.8	8.4	7.4	6.3	5.6	5.4	5.0	6.8	4.2	5.2	4.8	5.5	6.8	5.9	5.2	5.2	8.2	6.1	2.8	6.0	5.1	3.4	1.4	2.1	1.8	0.8	1.9	6.0	2.5	10.8	9.0	13.9	14.0	1.8	3.1	7.9	6.6	6.7	9.0	10.4	7.1	14.9	8.4	7.5	3.3	7.0	9.1	13.2	5.8	11.7	16.5	11.3	14.2	6.0	9.0	6.1	14.9	13.5	2.0	7.0	7.5	13.4	6.0	5.4	11.5	16.3	9.2	5.0	6.4	7.1	6.0	6.7	8.6	4.9	4.2	16.5	5.5	5.9	5.1	6.1	10.0	3.8	6.6	9.7	9.9	7.8	7.3	4.7	5.2	10.3	7.0	10.8	10.7	12.2	13.0	7.8	21.9	7.4	1.8	0.6	1.4	5.8	0.4	3.8	1.4	2.6	3.9	2.1	0.7	1.9	3.2	0.3	1.9	0.8	0.9	6.0	2.5	7.0	8.1	10.2	9.9	6.0	6.4	6.0	2.6	8.4	5.2	6.0	2.6	0.0	0.7	0.6	5.0	6.2	7.6	6.7	3.4	1.8	0.0	2.6	6.6	1.6	0.4	1.4	1.4	0.0	1.0	1.5	1.1	0.9	1.1	6.0	2.6	6.4	3.4	1.8	4.9	0.4	1.4	1.1	0.0	4.6	2.5	3.4	1.3	2.9	1.4	3.1	3.3	0.0	0.7	3.4	4.5	0.5	0.6	2.2	2.5	0.5
DCLRE1B	"FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905141-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 15.4;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	8.7	4.9	6.7	8.3	6.8	13.1	7.3	15.4	7.8	6.7	6.8	8.3	0.4	4.3	6.9	4.3	8.4	7.0	5.8	5.4	7.0	5.6	5.3	4.2	8.0	15.1	6.7	4.5	7.7	3.8	3.4	3.1	8.7	6.5	4.4	7.8	6.1	4.6	5.0	3.4	7.0	5.5	8.7	8.5	12.8	4.7	7.2	6.4	20.9	5.1	8.2	9.6	5.9	5.9	2.3	4.2	2.4	7.0	8.7	4.4	3.5	8.3	3.1	5.9	6.6	4.4	3.1	3.7	6.6	4.8	9.1	10.0	3.7	2.7	7.9	4.5	5.1	4.7	4.3	8.1	7.2	11.9	6.8	5.7	6.5	4.9	3.2	1.1	7.4	6.6	3.9	2.5	13.1	7.2	2.5	4.8	9.9	9.8	6.7	9.8	34.0	11.4	5.6	4.6	4.2	7.3	9.2	17.8	3.8	3.1	3.0	5.2	4.6	6.4	5.4	4.3	5.3	3.5	7.5	2.8	11.1	11.8	18.0	9.3	3.2	3.3	8.9	9.3	7.7	18.3	2.4	7.0	1.9	3.4	6.4	4.3	1.4	4.4	3.1	4.2	2.3	2.6	3.6	0.3	8.7	3.7	1.5	2.4	3.5	6.7	6.8	15.4	7.8	7.0	5.6	6.7	4.5	6.5	6.4	3.0	1.3	2.7	1.0	3.2	2.8	0.8	2.5	4.0	0.0	0.0	2.0	3.5	1.7	4.0	0.8	2.3	0.2	0.0	2.4	8.0	1.5	1.2	1.1	1.0	8.9	1.6	2.9	3.1	5.9	0.0	1.7	11.7	0.0	15.4	1.8	0.8	2.7	0.0	2.1	1.4	1.3	25.8	3.8	3.4	12.0	2.4	1.1	2.9	3.4	1.1
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	7.0	5.1	4.8	13.8	9.9	15.2	6.9	6.8	5.9	6.2	6.0	6.0	6.2	6.0	5.7	4.8	9.5	5.8	4.6	4.8	5.4	3.5	5.9	3.3	5.9	14.8	6.9	3.4	6.1	4.4	5.3	7.2	5.0	6.3	7.0	6.2	5.0	6.8	9.2	3.7	7.8	7.8	8.2	8.2	13.3	6.9	2.8	8.3	23.3	7.1	5.6	16.5	9.7	8.0	23.5	17.2	19.3	14.5	8.0	12.2	6.7	12.0	5.9	4.9	10.6	5.1	6.6	5.2	7.5	4.0	10.3	10.4	6.5	10.1	16.2	3.0	5.8	7.2	10.1	5.6	3.9	8.5	9.5	5.9	12.1	5.3	4.3	4.0	7.5	14.2	5.3	3.7	9.9	4.1	6.3	5.6	10.6	7.8	13.7	6.2	5.5	11.0	7.3	3.5	10.6	2.7	12.5	6.9	9.1	5.3	4.7	2.7	5.2	8.0	8.4	20.9	4.4	9.8	13.8	4.7	6.3	9.3	13.0	7.9	7.8	13.7	16.6	6.4	8.0	8.8	19.3	11.1	14.9	10.1	14.5	12.1	19.3	11.7	12.2	16.2	23.5	10.2	11.3	10.7	8.0	12.7	17.2	9.0	6.7	4.8	9.9	6.8	5.9	5.4	3.5	6.9	3.4	6.3	8.3	3.0	5.8	22.9	17.0	15.3	24.2	4.1	12.7	8.1	6.8	14.0	58.9	12.5	3.3	7.6	20.7	9.5	9.5	0.0	9.7	17.7	11.3	16.9	5.8	1.0	9.0	30.2	6.4	6.7	17.4	1.5	11.5	16.7	18.6	11.8	5.4	7.2	10.6	11.8	10.6	2.2	42.0	19.4	13.9	10.0	18.4	18.4	4.2	20.2	5.6	35.5
DCPS	"HINT-5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126303752-126345749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	11.1	13.1	6.8	14.4	8.2	13.5	9.2	8.5	14.5	12.1	10.6	6.8	8.0	7.8	12.4	9.6	14.4	9.9	13.9	10.9	5.5	6.1	13.3	39.6	9.9	18.5	6.3	5.8	11.8	17.2	7.0	9.5	14.1	6.8	12.7	11.7	13.3	17.4	9.4	21.8	11.3	9.7	11.3	7.1	21.9	9.6	13.4	6.5	22.0	12.7	18.5	22.1	15.1	9.8	13.2	39.5	3.2	14.3	7.8	14.6	7.1	9.5	6.0	7.5	12.4	5.8	7.8	6.3	5.1	7.5	7.8	7.9	11.3	19.7	13.0	19.2	8.1	5.1	11.2	10.6	16.0	5.2	24.7	5.7	19.1	6.8	9.8	12.6	20.5	17.3	7.9	10.1	9.9	13.5	3.9	10.4	10.9	7.7	22.4	8.5	13.8	13.0	23.5	5.2	51.3	20.6	9.1	11.0	24.8	7.5	10.7	9.7	7.4	15.4	12.6	9.3	4.7	21.4	12.8	6.6	12.2	5.7	5.8	9.5	9.0	8.3	13.5	3.5	35.5	30.7	1.7	9.2	3.2	8.8	14.3	8.2	13.2	8.5	9.0	15.4	9.0	6.0	6.8	0.5	7.8	12.6	39.5	14.6	7.1	6.8	8.2	8.5	14.5	5.5	6.1	6.3	5.8	6.8	6.5	11.9	12.8	34.4	16.6	6.2	6.5	4.5	53.5	16.0	5.7	40.1	0.0	37.0	48.0	17.0	5.4	8.7	5.2	0.0	25.4	38.8	12.7	9.2	16.2	22.8	26.1	3.2	7.0	7.4	13.7	1.7	15.8	10.4	16.9	14.4	9.7	7.8	16.6	14.0	17.3	10.8	7.1	19.4	11.3	11.2	28.0	7.9	22.7	27.7	13.4	19.7
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.7	21.0	21.4	19.8	32.4	44.3	28.1	43.9	39.2	31.5	19.5	21.3	44.2	7.9	10.9	42.7	21.5	11.3	15.6	27.4	29.0	38.3	11.8	36.5	12.2	25.3	34.8	35.5	22.9	36.8	29.2	27.6	28.8	31.9	26.9	17.5	36.2	79.2	41.8	16.6	23.0	21.7	17.0	9.2	18.3	25.1	15.3	15.3	25.4	27.3	21.2	13.1	20.7	17.9	20.5	20.8	13.7	18.6	31.3	26.2	20.2	12.6	33.4	30.4	16.4	10.1	28.9	23.3	30.8	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7	11.9	15.0	31.7	28.8	22.6	4.3	20.6	38.2	18.7	11.4	31.4	3.9	16.6	31.5	61.9	6.3	32.1	15.5	23.3	47.4	19.9	41.7	29.4	22.0	38.0	48.4	3.2	13.9	25.2	29.6	13.2	40.9	29.6	25.3	38.7	28.6	31.5	60.2	10.5	33.2	34.1	6.3	32.3	28.2	9.3	15.4	20.1	6.1	27.4	29.9	34.5
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.1	27.9	27.9	13.3	27.3	41.0	25.7	30.3	36.5	19.8	15.9	32.4	17.7	15.9	20.6	27.6	20.0	18.4	16.5	20.6	27.3	29.0	20.0	22.0	17.8	13.3	30.8	24.0	26.3	32.5	23.9	27.7	25.9	33.2	24.1	18.6	21.3	15.7	22.4	42.0	19.0	15.4	21.3	34.7	13.9	18.0	22.9	25.4	18.8	24.8	15.3	14.5	23.3	16.2	5.0	10.9	16.4	10.7	3.0	6.9	5.2	9.5	11.5	20.9	34.8	25.5	24.7	17.1	17.0	17.1	20.5	20.8	21.5	12.1	9.4	23.8	20.1	18.0	11.7	25.6	19.9	25.2	18.8	20.1	12.1	13.3	13.4	23.3	14.6	17.3	24.9	17.8	18.3	32.3	21.0	14.5	11.7	18.4	12.1	26.6	10.0	8.9	7.8	10.5	11.3	18.1	7.9	12.6	10.4	15.2	16.5	47.4	19.9	18.0	24.6	25.2	15.1	23.8	19.5	16.1	23.0	12.9	15.0	17.9	10.7	13.8	5.6	26.4	19.6	18.7	3.2	10.7	10.5	5.5	7.8	5.6	5.0	6.2	5.4	10.9	4.4	5.9	6.9	16.4	3.0	6.4	5.1	4.3	5.2	27.9	27.3	30.3	33.3	27.3	29.0	30.8	24.0	33.2	25.4	44.7	29.8	14.5	12.5	15.8	19.1	31.7	33.1	13.4	11.4	15.7	19.6	18.8	10.0	10.6	1.9	15.7	15.7	0.0	14.1	14.7	17.4	17.4	11.6	33.6	26.2	28.6	36.1	22.1	41.2	3.3	20.4	19.3	11.8	10.0	26.4	26.6	16.5	17.3	18.0	17.3	31.0	12.9	14.3	18.6	16.7	17.9	24.8	12.9	16.2	14.4
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641392-23677455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	16.9	16.4	26.6	17.5	38.8	36.9	15.9	19.0	47.1	15.3	19.3	26.9	13.3	20.9	19.2	13.1	30.4	14.6	14.7	17.3	19.4	17.2	22.0	15.4	17.4	20.7	19.1	23.8	14.7	18.6	23.2	17.6	21.1	29.0	18.4	26.1	17.4	19.7	15.5	21.0	23.8	22.2	22.3	19.7	21.5	19.4	20.1	19.9	16.2	19.6	10.5	31.6	20.9	18.7	14.5	17.0	19.0	19.3	20.2	17.9	16.0	12.0	24.0	23.5	19.5	16.8	12.5	16.5	21.4	13.3	13.8	16.7	26.8	16.7	16.9	17.4	22.3	14.5	12.6	38.7	20.6	17.2	19.3	15.3	20.9	28.8	37.8	11.4	25.4	16.2	10.4	14.9	17.0	18.2	15.4	21.8	21.3	39.8	13.1	22.1	33.3	19.5	7.3	27.7	17.5	10.6	23.9	20.3	18.4	11.2	25.5	19.7	20.5	18.7	15.3	12.7	21.6	21.3	21.6	29.4	18.7	8.5	14.6	14.9	17.9	26.8	27.2	17.8	12.7	20.2	11.2	16.1	19.0	16.2	13.5	17.9	14.5	15.0	17.5	17.0	11.2	12.8	15.1	7.0	20.2	19.3	11.8	17.3	16.0	26.6	38.8	19.0	47.1	19.4	17.2	19.1	23.8	29.0	19.9	14.9	25.8	16.2	11.1	13.1	49.6	23.4	15.3	13.4	15.9	19.2	86.4	26.9	10.0	21.9	17.5	19.4	27.4	23.3	22.1	30.2	15.6	13.0	26.6	12.1	24.5	49.3	21.2	18.4	18.6	20.3	12.0	15.7	6.8	34.3	20.1	24.4	33.6	14.0	17.0	18.9	42.0	12.9	10.5	64.6	15.5	12.4	40.3	18.1	20.8	15.3
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.0"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 9862.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		70000	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	5.0	5.2	7.9	5.0	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5.0	7.2	11.2	4.3	5.0	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8.0	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95.0	7.6	7.2	6.7	5.2	6.0	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8.0	5.7	23.3	10.4	13.9	6.0	14.7	14.5	11.8	15.0	16.9	16.9	16.6	15.3	17.4	27.4	33.0	14.0	25.5	13.1	11.6	12.0	22.5	22.4	6.3	26.4	8.1	6.4	9.3	15.5	19.9	10.3	14.7	9.4	8.9	12.5	11.6	16.8	8.8	14.4	12.3	12.5	15.2	8.3	11.3	17.6	9.5	12.0	14.7	18.1	12.2	16.5	10.1	10.1	26.3	18.9	14.1	15.3	38.7	12.6	11.2	10.5	10.1	14.3	17.6	11.9	22.0	27.8	13.2	14.7	15.1	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15.0	11.2	6.3	8.2	8.0	5.7	7.9	7.1	9.3	8.3	7.4	5.0	9.3	6.8	8.0	7.6	20.8	25.6	17.1	21.7	38.5	14.2	28.2	17.8	20.1	27.3	45.4	9.8	16.2	31.5	26.1	2225.5	18.8	26.6	46.7	26.5	15.7	27.7	32.3	28.9	42.3	24.9	17.5	25.8	17.8	32.1	9862.3	80.3	36.4	11.8	45.1	19.9	16.6	27.2	23.4	60.5	33.6	20.5	77.6	25.5	86.4	52.0	37.1	16.7	25.3	19.6	34.8
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 38.4"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 30.6;ASC TERT1: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	19.2	9.9	4.3	6.0	4.6	2.7	17.2	7.9	5.6	7.5	6.0	5.5	3.2	3.4	7.7	5.9	8.5	6.6	9.6	8.9	2.5	2.8	10.0	17.4	9.7	3.1	5.2	3.0	5.3	6.6	6.4	9.5	9.4	6.7	6.6	4.1	6.3	3.9	4.5	38.4	7.1	4.9	11.9	3.9	4.5	6.4	7.9	3.8	1.5	4.8	11.5	4.5	6.7	15.8	1.4	1.6	4.8	2.5	2.6	2.7	1.0	2.7	4.8	2.4	5.2	30.6	23.1	3.3	9.1	7.9	4.6	6.3	6.0	5.2	1.7	7.4	8.9	2.8	3.7	2.8	3.8	6.2	2.3	1.9	1.4	3.8	8.7	8.0	2.2	13.9	15.2	5.2	8.7	4.9	4.9	12.6	1.7	1.6	4.7	9.3	3.7	2.0	3.2	5.7	2.3	1.6	3.4	2.7	1.7	4.0	2.8	2.2	3.0	3.5	3.9	2.1	3.0	2.6	1.0	6.2	9.8	3.4	4.1	2.4	4.0	2.3	1.2	10.4	2.3	5.0	4.8	1.4	1.2	1.7	2.5	1.7	1.0	1.2	2.7	1.6	1.4	1.5	2.7	1.9	2.6	2.2	1.2	1.0	1.0	4.3	4.6	7.9	5.6	2.5	2.8	5.2	3.0	6.7	3.8	11.9	17.1	0.0	12.6	27.8	12.1	4.0	5.1	0.0	6.8	8.7	33.4	3.0	0.0	3.5	50.8	14.3	4.3	0.0	4.4	1.7	12.7	8.1	0.0	12.9	2.1	12.7	19.4	10.4	7.1	34.5	10.0	8.0	11.8	0.0	4.7	5.2	3.9	0.0	9.2	4.0	23.2	6.5	12.2	4.6	3.5	19.7	4.2	4.3	3.8	16.9
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	16.9	22.9	15.9	9.9	26.1	3.5	13.5	15.4	24.8	15.9	14.3	12.8	15.5	7.6	17.8	17.3	13.4	13.6	14.2	14.9	29.8	22.3	19.4	36.5	10.4	10.7	17.7	22.0	20.8	9.8	9.9	19.8	9.3	24.6	16.6	12.0	9.4	15.9	22.9	14.3	10.2	9.8	31.4	24.0	11.4	14.6	20.4	13.4	3.9	16.8	8.6	8.2	20.3	13.7	4.6	2.9	10.2	4.2	4.4	10.7	5.3	5.7	10.3	13.9	20.1	14.3	14.3	5.3	17.9	13.3	10.2	9.2	6.6	6.2	4.3	11.6	20.1	13.5	5.8	17.7	11.2	14.1	2.7	5.2	7.6	8.0	15.9	30.2	10.5	10.3	14.8	13.2	11.7	10.2	13.6	10.2	4.1	8.4	3.2	17.6	8.4	12.9	7.4	8.2	11.6	8.5	6.2	7.2	2.4	13.3	6.8	8.2	8.9	7.7	9.6	14.8	8.2	9.8	6.7	16.6	13.6	11.1	10.9	14.2	5.8	8.3	4.0	9.5	10.1	7.7	5.5	4.2	10.2	7.2	3.7	10.7	4.6	8.1	8.0	2.9	3.3	7.8	8.5	1.7	4.4	2.6	1.9	3.7	5.3	15.9	26.1	15.4	24.8	29.8	22.3	17.7	22.0	24.6	13.4	6.0	13.1	10.4	16.2	33.1	22.1	33.1	20.4	16.0	12.5	15.7	15.7	4.6	11.6	9.4	58.2	21.5	8.7	0.0	10.5	7.4	21.0	13.4	12.7	32.7	7.2	28.6	6.4	18.4	6.3	89.6	13.8	10.8	30.4	3.6	6.9	14.1	10.8	10.5	24.4	19.5	15.9	0.0	18.6	22.8	27.9	29.1	2.9	10.1	8.1	13.7
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103062076-103092215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	20.9	18.3	18.9	17.2	24.5	13.4	19.1	22.5	28.8	12.9	13.5	15.9	11.5	11.4	15.9	13.7	26.5	12.9	10.6	24.2	20.3	16.6	14.4	19.0	13.9	21.5	15.6	21.0	12.2	17.7	14.5	17.0	17.3	23.6	15.4	13.9	9.9	15.6	13.5	38.7	14.0	11.3	18.4	17.5	15.7	16.0	24.0	21.0	19.4	13.2	24.2	21.3	14.4	14.7	14.4	17.3	11.8	13.1	20.5	17.0	13.4	22.3	12.4	13.7	21.0	11.2	14.2	15.2	22.2	12.1	18.3	18.9	47.5	26.2	10.8	39.3	15.8	19.0	21.3	28.8	28.1	18.9	19.0	19.4	28.9	10.7	18.4	19.0	41.4	15.0	12.4	25.0	24.5	25.4	9.6	22.7	26.4	47.2	0.0	17.3	20.2	27.3	32.4	26.7	19.5	31.7	11.6	21.9	27.4	13.9	23.0	18.6	19.7	20.7	21.2	18.4	14.7	24.8	17.4	18.4	14.9	18.1	26.4	19.8	9.1	14.4	36.0	10.6	40.7	15.4	11.8	11.1	10.2	13.8	13.1	16.3	14.4	16.3	14.2	13.7	14.1	14.0	16.3	4.0	20.5	10.0	17.3	17.0	13.4	18.9	24.5	22.5	28.8	20.3	16.6	15.6	21.0	23.6	21.0	14.9	8.3	25.2	44.6	70.6	11.0	26.6	15.3	14.7	14.8	8.7	7.9	51.2	41.4	60.4	3.0	19.7	6.9	23.3	48.3	76.2	37.5	35.6	15.1	21.3	40.1	6.4	13.8	20.9	29.7	5.9	13.3	22.6	28.7	25.2	16.1	14.8	51.7	14.0	18.4	31.1	12.3	25.8	31.1	118.2	114.7	73.1	36.6	24.5	23.4	57.0
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323301	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 364.2;Syncytiotrophoblasts: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	11.6	15.5	24.5	12.7	26.6	16.1	9.9	14.6	36.2	10.8	14.6	13.5	9.6	15.4	11.6	9.9	13.4	13.5	11.8	16.4	18.9	19.8	12.9	17.9	14.6	14.7	19.0	24.4	12.9	13.4	10.9	10.9	26.4	23.0	12.9	13.1	10.8	13.6	15.9	17.8	20.8	16.9	11.5	13.2	13.4	17.4	29.6	12.0	15.9	10.5	10.9	13.7	12.4	9.9	7.1	12.7	11.5	8.0	6.5	8.8	5.7	12.5	11.2	8.5	6.7	8.9	6.4	13.2	8.5	10.9	13.1	12.1	9.9	11.1	5.0	11.9	8.7	6.3	10.7	6.2	12.4	6.4	8.2	16.5	6.1	8.8	9.3	10.8	6.8	11.9	9.7	14.3	7.8	7.3	8.0	7.6	11.6	7.2	8.7	6.8	6.3	13.7	10.2	9.7	12.6	19.2	8.7	6.7	8.3	10.3	9.4	8.7	13.0	6.2	14.4	7.4	5.3	7.3	9.1	11.4	8.8	7.4	22.6	11.8	10.7	14.5	6.9	19.3	11.8	8.6	5.0	7.3	11.5	8.6	8.0	7.4	7.1	7.2	8.5	5.9	6.6	8.3	8.0	8.2	6.5	6.9	12.7	8.8	5.7	24.5	26.6	14.6	36.2	18.9	19.8	19.0	24.4	23.0	12.0	26.8	13.1	28.4	28.3	48.4	17.7	14.5	2.5	16.0	18.2	26.2	11.8	121.6	33.2	69.0	364.2	20.2	49.3	0.0	40.5	112.0	27.8	33.7	38.1	21.7	56.2	12.7	19.4	14.7	21.1	84.5	20.8	27.9	28.7	77.5	38.9	25.1	96.6	38.6	25.5	44.5	14.3	19.4	29.8	67.3	35.1	54.1	212.0	34.6	23.5	76.5
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.4	22.7	9.5	7.1	6.1	12.4	11.2	9.2	21.7	11.9	14.0	3.7	4.9	20.3	1.9	8.4	8.9	14.8	5.4	18.8	5.9	5.0	10.2	4.7	21.7	16.8	6.0	5.5	12.7	16.6	21.4	5.9	13.2	3.8	34.6	5.3	1.2	9.9	19.4	15.9	21.1	2.6	3.0	11.1	8.2	10.6	2.4	10.9	5.0	8.3	5.0	6.2	11.3	3.3	3.0	11.9	20.8	1.8	14.9	36.4	16.6	7.9	4.3	10.4	7.9	4.5	13.7	7.0	13.0	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6	14.9	20.3	19.2	35.4	34.6	4.6	7.2	12.7	10.7	13.6	5.2	9.8	2.1	8.3	9.6	1.1	17.8	7.9	0.0	12.0	7.7	14.1	9.5	22.0	12.4	15.9	1.6	7.5	14.1	16.5	1.6	17.5	16.5	18.6	221.8	13.6	14.2	15.3	7.0	9.9	6.2	11.6	0.0	15.5	0.7	9.9	26.5	1.3	38.8	14.0	21.3
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.5	4.4	8.0	8.3	11.0	8.7	7.8	4.7	3.6	4.2	3.6	10.7	6.9	19.0	5.6	5.2	3.1	8.0	17.4	7.6	7.1	8.7	11.6	14.8	7.4	10.5	4.7	19.6	7.5	8.6	9.1	7.8	8.4	5.2	8.5	12.4	23.8	7.0	5.1	5.1	11.3	6.5	7.6	11.2	3.6	10.7	11.3	11.2	5.9	6.3	9.8	5.4	8.8	14.4	13.1	9.4	7.5	5.1	7.4	6.0	5.2	6.8	5.8	6.6	8.0	15.4	4.7	14.3	4.7	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0	8.9	15.2	11.9	12.2	13.6	23.7	23.0	12.7	29.4	22.7	3.5	13.7	17.5	1.7	6.8	1.5	12.1	15.1	46.7	6.6	16.1	13.9	22.6	1.1	54.8	13.2	33.4	14.5	16.0	21.2	0.4	11.8	12.5	15.1	6.4	22.4	8.0	12.5	3.5	6.3	16.5	36.7	6.5	12.3	10.0	7.8	17.7	33.6	12.7	20.1	12.7
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999309	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 40.8;skeletal muscle: 73.8"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.5;Ito cells: 1.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.6;RPMI-8226: 20.1;SCLC-21H: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.7	0.7	40.5	0.8	40.8	1.3	0.7	0.0	38.5	0.7	0.7	0.2	0.0	0.7	0.7	3.8	1.0	0.7	0.7	0.9	30.5	2.0	4.8	0.7	0.7	0.9	2.9	9.3	0.7	0.8	0.8	0.0	0.7	0.0	1.6	0.7	0.0	0.7	0.7	73.8	0.8	0.8	0.7	0.0	0.8	0.8	0.8	1.2	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	4.5	0.4	0.0	0.2	0.0	0.0	1.6	10.6	0.0	0.1	0.5	4.8	2.3	0.5	1.0	0.0	5.5	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	3.5	0.2	0.1	5.3	6.0	0.1	0.8	1.4	4.9	0.3	20.1	0.0	0.1	10.6	1.0	0.2	0.5	0.2	0.1	0.3	0.7	0.1	0.2	0.5	0.2	0.0	1.2	2.3	4.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	40.5	40.8	0.0	31.9	30.5	2.0	2.9	9.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15631111	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 352.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		46000	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	23.8	28.2	29.3	17.6	35.0	17.1	30.1	35.3	37.2	25.1	24.5	15.0	20.5	21.0	24.3	25.6	27.7	21.0	15.8	47.6	34.7	25.3	35.8	35.2	17.8	16.0	24.5	36.9	23.6	27.6	42.1	41.2	28.1	35.1	22.2	28.1	14.8	23.9	24.5	67.5	24.5	25.9	31.0	21.0	17.1	24.1	19.2	23.0	23.0	29.6	24.8	21.5	26.1	19.8	18.7	22.8	19.2	25.1	23.0	26.6	19.9	19.3	29.7	42.2	31.5	36.7	32.2	48.7	40.7	34.2	40.1	33.8	47.4	20.0	50.3	19.8	46.9	29.6	29.5	57.7	39.1	42.5	21.4	37.5	55.1	39.7	59.7	27.6	45.0	25.9	25.0	26.9	33.4	32.1	25.4	36.1	23.8	56.0	16.6	39.5	27.1	24.6	34.0	54.3	48.9	25.1	29.7	63.9	36.4	45.9	39.0	34.1	42.6	27.8	29.4	37.0	31.6	20.4	19.1	29.1	33.7	34.8	21.1	45.9	21.7	37.7	67.9	30.3	36.1	31.3	19.2	20.0	11.5	20.2	25.1	21.3	18.7	23.4	23.4	22.8	18.0	26.6	23.6	3.1	23.0	23.2	19.5	21.6	19.9	29.3	35.0	35.3	37.2	34.7	25.3	24.5	36.9	35.1	23.0	74.5	45.2	27.6	50.5	35.7	56.6	352.9	63.7	95.0	68.2	85.5	49.1	96.2	121.0	87.1	11.9	56.2	48.4	23.3	104.7	96.0	66.4	31.2	54.4	106.7	46.5	42.9	50.1	40.5	25.3	12.7	67.3	39.1	47.2	31.5	56.7	55.3	88.0	59.6	73.6	95.2	67.2	58.2	49.9	167.4	57.2	36.9	67.1	26.6	62.9	32.7
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	22.0	50.5	24.0	25.4	24.0	16.6	25.5	27.4	21.1	31.1	19.8	49.1	29.5	27.9	30.1	22.7	29.4	20.0	52.0	24.9	26.7	43.7	27.6	37.0	43.0	22.1	12.9	37.3	33.7	16.0	22.4	33.0	19.8	21.4	25.5	24.8	48.9	25.0	22.6	30.7	35.3	35.4	35.7	31.4	24.0	37.8	28.4	22.2	18.4	31.1	29.6	17.3	27.4	31.5	11.4	25.7	30.8	34.3	22.8	23.6	17.3	11.6	21.7	18.9	26.3	33.7	20.0	26.3	12.9	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0	23.8	25.5	22.4	12.7	11.4	16.9	17.1	22.9	44.2	31.8	12.2	23.6	22.5	13.3	22.3	6.9	21.0	23.3	23.3	33.5	24.6	16.2	21.2	17.4	16.3	16.7	14.3	13.4	17.8	9.9	4.1	22.7	15.0	13.5	24.4	22.7	24.3	28.9	31.6	20.8	10.2	24.0	19.4	18.4	33.8	36.1	13.2	22.2	24.2	23.9	17.1
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.3;testis: 64.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 250.3;Spermatocytes: 190.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.7	2.8	8.7	0.8	13.2	0.9	0.8	7.9	17.3	0.8	0.8	2.0	0.0	1.0	0.9	0.9	0.8	0.9	0.8	0.7	8.4	7.1	2.7	0.8	0.8	0.8	4.8	8.9	1.2	1.8	2.6	7.1	0.9	5.9	0.9	0.8	2.3	0.8	1.0	0.8	1.6	0.8	0.7	3.4	0.9	1.0	64.2	3.0	0.0	4.3	0.0	0.8	0.7	0.2	0.6	0.5	3.3	0.3	1.3	0.5	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.2	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.5	1.6	0.0	11.4	0.5	0.0	0.4	0.0	0.0	0.0	0.1	9.2	2.1	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	2.1	0.3	0.6	0.3	0.2	0.2	0.4	0.5	0.2	0.1	0.6	0.4	0.3	3.3	1.3	0.2	0.5	0.1	0.1	8.7	13.2	7.9	12.5	8.4	7.1	4.8	8.9	5.9	3.0	0.0	0.3	0.0	0.7	0.1	18.2	0.8	0.0	0.0	0.0	0.0	15.7	0.0	3.3	0.1	250.3	0.9	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.5	0.1	15.9	0.0	0.6	0.0	41.7	3.4	0.1	0.0	0.0	0.0	16.0	0.1	0.0	4.6	1.8	16.0	0.0	0.1	190.6	24.5	0.0	0.0	0.0	0.0	0.1
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 631.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.8	51.1	47.7	26.2	56.2	47.7	29.1	33.5	47.1	34.4	27.6	52.5	30.9	0.5	23.9	37.4	41.4	31.0	58.3	47.1	57.3	27.2	45.4	29.2	50.8	31.5	29.2	54.7	52.5	34.5	33.4	57.9	56.0	38.5	53.9	25.7	53.6	28.9	31.9	34.7	34.4	17.1	45.9	24.4	20.6	40.4	50.8	37.4	32.4	61.9	32.6	49.4	75.8	38.9	40.1	50.2	35.0	37.2	48.6	35.5	37.9	37.9	39.7	33.7	40.0	45.3	35.7	33.2	33.6	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0	80.4	161.8	98.4	138.2	234.8	74.1	130.3	81.5	65.6	85.3	55.8	123.7	79.4	36.5	59.8	317.8	170.8	178.1	116.8	73.8	80.3	155.2	122.4	162.7	142.1	107.7	57.2	176.3	120.3	200.6	631.6	61.5	160.4	121.4	72.1	136.1	88.8	86.2	143.8	59.1	71.7	117.4	71.1	155.5	15.7	55.7	291.5	144.6	132.3	100.9	182.7
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 237.5;Late spermatids: 436.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.3;HEL: 42.1;U-266/84: 34.9;U-698: 30.7"	"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.7	0.0	0.0	0.0	0.0	5.6	18.9	13.5	10.0	12.3	0.0	0.0	41.3	0.0	18.6	0.0	0.0	0.0	0.0	17.6	10.3	0.0	42.1	0.0	12.4	9.9	0.0	0.0	10.5	11.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	11.8	0.0	16.3	0.0	7.5	0.0	0.0	0.0	5.0	7.6	10.6	11.4	12.4	0.0	0.0	0.0	13.8	12.7	0.0	9.8	13.5	15.5	0.0	0.0	12.4	22.3	34.9	30.7	1.9	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0	44.7	70.4	32.3	85.6	83.6	48.4	24.1	12.7	117.8	50.0	8.7	39.3	34.0	5.0	8.7	237.5	56.2	0.0	0.0	0.2	11.4	45.1	53.9	88.1	0.6	15.6	39.7	15.3	28.3	37.0	436.7	35.9	93.0	25.3	15.4	3.7	57.0	8.2	0.0	37.1	14.7	46.4	19.4	59.7	36.2	65.8	70.3	31.6	51.1	0.0	62.4
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.2	24.3	13.3	15.7	13.7	16.3	44.9	19.1	11.6	14.1	10.4	39.6	19.8	23.9	29.1	18.0	24.7	17.4	17.4	43.7	9.6	57.0	21.8	30.3	24.7	23.5	18.2	31.3	32.2	15.9	15.4	13.3	17.9	12.0	17.9	23.9	26.2	17.0	16.5	45.8	26.1	15.4	23.5	19.9	19.7	28.4	16.2	28.1	15.7	24.8	15.8	17.3	20.3	27.0	22.8	8.1	18.9	45.8	19.1	25.7	15.2	16.4	29.7	20.5	24.0	40.7	28.2	34.6	16.9	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4	23.8	19.1	26.4	18.3	18.7	17.4	7.1	25.5	14.7	15.9	8.7	2.0	40.7	34.9	39.1	8.4	20.3	22.6	23.3	34.4	49.6	19.5	16.0	28.9	16.3	43.7	7.9	10.9	12.3	22.2	16.2	13.8	21.8	11.8	41.5	23.7	15.8	29.9	20.1	19.8	28.9	9.4	12.9	20.6	24.2	23.2	17.8	31.4	22.3	26.3	16.3
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		150000	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	55.1	20.8	63.0	39.9	58.4	55.0	40.1	54.7	70.6	67.1	67.2	22.5	33.8	80.9	31.4	71.8	47.8	32.9	67.8	62.9	75.9	28.7	48.7	52.6	15.9	17.2	42.8	66.9	56.1	61.9	54.3	61.3	47.8	37.4	71.6	69.9	41.7	69.1	51.7	32.8	139.9	19.5	36.7	50.9	64.3	87.6	66.6	56.9	41.1	26.5	44.3	74.3	53.1	51.5	66.6	56.7	48.2	37.7	50.3	40.8	45.6	43.9	56.6	38.6	76.1	142.8	43.2	32.9	48.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8	497.3	661.1	481.3	1231.3	781.2	369.6	221.7	262.4	725.4	624.4	350.7	316.1	372.7	283.5	416.6	432.3	643.3	503.6	116.8	366.6	307.8	528.8	417.0	836.7	222.3	399.0	397.3	638.0	483.1	539.2	80.3	384.6	631.0	410.0	779.1	366.4	576.1	376.0	445.4	411.5	208.8	514.0	485.0	599.5	374.0	341.8	652.0	741.9	719.3	310.9	1106.4
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 210.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.8	9.9	1.0	9.8	5.5	4.9	4.2	6.5	5.8	8.6	8.3	5.0	1.8	2.7	4.5	4.3	1.8	4.4	10.9	7.1	11.5	6.5	12.3	6.1	6.2	4.0	5.4	7.8	3.2	5.1	7.3	5.6	6.9	4.1	9.8	2.7	0.8	1.9	5.0	1.5	11.7	4.0	5.6	2.7	0.4	7.6	8.6	5.0	9.7	5.4	7.2	5.8	7.8	1.8	4.8	5.7	3.4	6.0	6.6	7.0	4.4	3.6	7.4	2.4	3.9	5.5	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5											38.7	19.5	26.1	27.2	30.7	28.6	28.7	28.1	28.1	38.7	26.2	31.4	30.7	29.9	64.6	210.7	26.3	24.7	0.0	45.3	25.7	21.9	24.4	26.5	32.8	22.8	44.5	25.2	29.4	23.8	70.2	22.7	23.7	16.9	47.7	26.7	23.2	47.9	21.0	22.6	32.3	32.6	25.8	12.6	28.9	57.6	29.1	20.9	34.4	36.5	43.1
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.1	14.5	11.1	11.2	9.6	7.6	16.8	12.6	4.6	11.3	7.8	16.4	7.5	15.1	10.1	5.5	10.2	12.6	16.9	9.4	13.2	11.3	15.3	20.4	16.0	12.1	7.3	25.0	16.1	6.4	10.0	13.4	15.5	8.8	8.1	12.3	20.8	8.0	7.9	10.5	24.5	34.1	17.2	11.8	14.4	18.5	11.9	9.8	7.9	17.7	13.2	11.0	10.3	13.4	17.2	9.7	23.8	16.2	8.3	9.8	12.9	15.9	15.6	14.8	18.3	27.4	9.3	18.0	16.6	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8	20.8	11.5	9.0	8.3	9.7	18.5	2.2	7.6	13.4	10.3	7.0	21.6	11.2	6.6	9.6	42.5	10.5	5.1	46.7	10.4	13.9	10.1	8.4	24.3	8.5	12.6	14.3	6.9	6.2	6.6	50.7	15.8	7.9	6.8	4.6	10.5	15.6	11.6	7.0	13.8	5.4	25.4	6.5	8.5	17.9	19.6	14.8	6.4	10.2	8.3	7.8
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669969	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	14.0	14.4	12.1	16.4	14.8	23.7	22.7	16.7	11.2	14.5	11.6	10.8	12.6	8.1	15.8	17.6	12.0	13.8	11.4	18.0	12.0	9.9	13.6	15.1	11.8	15.1	15.1	6.7	17.1	21.6	13.9	10.7	46.5	12.8	14.1	12.5	15.0	19.4	12.9	28.6	21.5	12.4	14.0	17.2	20.9	10.4	9.9	14.5	18.5	15.1	10.1	13.2	12.8	12.7	12.2	9.5	23.1	16.2	12.4	15.6	7.9	9.4	10.9	12.7	10.6	5.7	10.0	28.3	10.6	9.5	11.4	9.3	3.4	11.1	9.6	5.4	8.4	9.3	9.0	7.1	10.8	8.1	30.3	7.3	7.3	14.0	10.1	11.5	10.5	13.6	10.7	16.4	8.6	23.5	9.5	8.7	13.8	9.2	14.3	11.0	10.9	6.3	15.8	13.4	5.7	8.9	5.3	8.8	18.5	12.2	11.0	7.7	20.0	16.8	17.5	18.6	17.2	15.1	14.8	7.8	9.6	5.4	9.5	10.9	10.9	14.2	12.7	9.2	6.6	16.4	23.1	10.3	19.0	13.0	8.9	10.6	12.2	10.9	11.7	8.5	11.5	11.3	10.3	18.2	12.4	16.2	9.5	15.6	7.9	12.1	14.8	16.7	11.2	12.0	9.9	15.1	6.7	12.8	14.5	17.9	19.0	14.5	11.1	14.3	3.3	15.9	5.1	10.7	7.9	7.0	2.0	18.5	13.3	7.5	2.0	15.9	7.4	0.0	7.3	22.7	10.8	10.1	19.7	6.4	11.5	6.4	1.2	10.4	8.6	0.2	7.5	11.7	5.0	17.2	10.7	8.5	7.9	8.0	12.7	8.4	6.0	0.0	12.3	12.1	19.0	13.7	36.6	13.1	8.8	8.6
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1, transcription factor"	O75398	11	644233-706715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: AB_2673421"	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	4.8	5.9	36.1	6.5	19.9	4.5	16.9	19.4	26.2	5.4	4.3	5.3	5.2	4.8	7.5	6.3	6.8	9.8	6.0	8.3	30.2	15.7	4.5	2.8	5.3	4.4	18.3	3.4	6.0	13.2	5.9	14.5	5.2	9.7	6.7	2.2	3.6	11.8	4.7	7.8	6.6	4.0	7.2	8.1	4.0	7.2	5.7	9.8	15.2	12.0	2.7	5.3	7.0	20.3	1.2	4.4	3.3	3.0	3.5	5.9	1.6	7.5	4.6	7.4	3.9	7.3	9.5	5.8	5.6	7.2	11.9	8.7	4.9	6.5	2.1	6.1	5.5	3.2	5.0	7.1	5.1	1.7	9.1	42.1	5.0	2.6	3.7	13.2	11.0	8.2	8.0	7.0	2.1	6.0	7.6	9.4	5.8	11.1	8.8	4.4	3.8	4.1	10.1	17.4	7.8	9.7	10.1	2.6	8.2	8.4	0.9	10.6	11.1	4.0	6.0	4.0	1.9	3.7	3.2	10.8	3.9	2.2	1.6	4.8	9.8	3.6	3.9	4.4	7.3	7.7	0.0	3.0	3.3	2.4	1.7	2.6	1.2	4.7	2.7	4.4	0.8	5.9	3.2	1.8	3.5	1.9	0.5	1.7	1.6	36.1	19.9	19.4	26.2	30.2	15.7	18.3	3.4	9.7	9.8	0.0	3.8	9.0	22.8	11.7	18.3	6.1	10.2	5.3	4.5	33.2	9.8	11.6	44.7	17.9	3.0	13.5	11.1	0.0	9.7	5.1	14.9	30.4	0.0	10.4	8.8	57.2	10.5	4.9	7.0	5.1	18.4	9.0	16.9	12.6	8.6	20.4	12.8	10.7	28.3	22.3	17.1	12.9	15.5	6.7	11.7	13.6	12.9	8.7	8.9	26.8
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89947925-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	18.0	15.9	25.4	22.4	23.0	25.3	15.6	42.4	30.6	12.6	16.4	15.4	19.4	12.0	17.1	14.1	22.5	14.3	16.3	23.7	23.7	24.8	14.9	12.2	15.4	42.8	28.0	29.0	18.2	22.5	19.0	18.0	11.5	20.5	14.5	9.2	13.9	21.4	18.9	19.5	27.4	13.6	17.6	23.6	16.6	15.2	8.8	15.0	4.8	14.5	13.6	32.4	15.5	23.8	23.0	27.4	32.0	16.7	5.3	11.5	11.1	15.2	31.2	14.2	19.2	14.6	15.5	16.2	23.7	20.2	35.1	16.4	33.0	18.5	18.5	17.9	16.1	14.3	10.1	16.7	28.1	15.6	4.5	47.6	8.3	16.6	47.2	15.8	6.0	13.2	17.4	23.3	25.1	14.8	15.5	26.2	17.1	27.2	6.3	20.8	55.7	11.7	18.2	17.9	7.1	31.9	24.4	10.4	15.8	18.8	14.7	21.0	21.6	38.2	14.3	13.3	7.8	13.3	19.5	26.2	20.3	22.2	10.8	25.1	12.3	8.7	23.2	21.7	15.5	23.7	2.3	16.7	32.0	11.5	13.4	10.5	19.6	9.6	8.4	10.7	23.0	6.6	6.4	22.5	5.3	7.6	27.4	11.4	11.1	25.4	23.0	42.4	30.6	23.7	24.8	28.0	29.0	20.5	15.0	0.0	11.3	33.5	18.0	39.8	22.8	26.6	25.5	8.1	10.3	14.0	25.5	26.2	24.9	43.1	5.6	26.4	18.2	0.0	79.2	44.9	34.3	30.7	9.3	20.2	55.6	28.6	20.7	25.8	24.7	16.0	19.5	29.4	43.9	64.1	14.3	13.8	83.0	14.4	31.5	36.3	23.3	19.4	41.1	5.6	9.0	47.8	27.1	16.2	13.2	19.7
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111187174-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 51.0;lymphoid tissue: 67.6"	"Cell type enhanced"	"Detected in many"	8	"T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7"	"Group enriched"	"Detected in all"	6	"NK-cells: 45.1;T-cells: 51.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	8.9	11.1	0.9	42.9	2.6	3.5	6.5	0.8	1.6	4.9	10.4	1.4	4.9	6.4	2.4	5.9	19.5	6.4	9.9	2.5	1.0	1.0	11.4	9.3	11.5	42.0	2.6	0.8	3.0	7.5	8.8	8.0	20.2	1.9	9.2	6.9	3.7	21.1	4.7	1.3	7.9	13.8	1.3	3.2	33.8	9.0	5.1	1.8	39.2	8.0	7.0	67.6	15.7	8.2	8.2	3.2	3.5	3.5	45.1	51.0	29.6	10.4	0.4	0.0	0.0	2.6	1.0	0.1	0.6	0.0	1.1	0.2	3.1	5.1	11.1	3.7	1.6	0.0	3.3	0.0	0.5	1.1	21.0	0.0	3.3	0.7	0.0	3.9	0.0	3.4	3.1	2.3	0.3	0.0	3.5	0.1	4.2	0.0	3.5	0.3	8.9	52.9	0.3	0.0	13.2	1.4	1.3	0.0	16.1	3.7	11.3	3.7	0.0	3.7	34.3	1.2	0.0	10.1	10.5	0.0	0.0	0.0	0.0	0.0	3.2	1.3	8.3	0.0	9.3	0.0	0.8	3.5	2.3	44.8	2.5	38.2	7.2	32.5	45.6	3.2	8.2	51.0	48.4	3.5	45.1	1.8	2.4	13.7	29.6	0.9	2.6	0.8	1.6	1.0	1.0	2.6	0.8	1.9	1.8	6.0	15.6	29.2	15.0	4.4	0.0	0.9	7.6	18.7	18.2	19.2	0.0	1.2	16.6	23.6	26.8	2.9	16.1	0.0	14.1	2.1	4.1	21.1	17.3	4.9	46.9	0.0	5.8	9.2	28.5	38.6	1.1	9.9	6.8	1.0	23.6	0.0	13.8	14.0	0.4	21.0	0.5	0.0	0.7	13.0	0.7	3.4	9.6	105.1	20.4	26.5
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946696	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	14.5	9.6	14.4	21.5	13.6	30.7	9.9	23.5	19.7	8.6	8.3	11.9	3.1	9.2	10.3	7.9	7.7	8.8	9.9	12.4	10.5	9.8	8.6	7.9	14.2	25.8	12.5	8.5	12.4	11.0	8.5	8.3	10.1	12.6	7.9	6.3	8.0	10.2	7.6	40.6	8.6	12.7	8.8	9.3	25.9	9.2	5.5	12.9	15.7	9.4	5.9	21.1	10.7	7.7	3.0	4.8	3.9	6.2	2.0	3.9	3.0	5.9	11.5	8.9	8.9	5.3	5.2	9.3	5.8	6.4	9.3	8.8	6.9	6.9	15.0	10.0	3.9	7.1	10.6	8.0	5.4	4.2	13.7	7.2	13.2	12.0	6.6	7.4	13.8	26.9	4.7	9.5	8.7	9.4	7.8	6.6	16.5	14.0	8.5	5.3	12.3	16.7	12.8	12.3	7.1	11.2	18.0	6.0	8.5	4.5	8.9	10.6	13.0	6.2	14.7	8.3	9.3	10.6	34.2	6.8	10.1	9.8	8.3	9.3	25.7	18.0	19.8	6.9	10.9	12.0	2.5	3.8	1.1	3.3	6.2	3.9	2.9	2.6	1.9	3.7	3.0	1.3	2.8	3.9	2.0	4.9	4.8	1.7	3.0	14.4	13.6	23.5	19.7	10.5	9.8	12.5	8.5	12.6	12.9	8.9	13.0	8.3	3.2	4.1	20.5	18.1	12.7	4.0	5.7	7.0	5.9	3.8	5.0	4.4	1.2	10.9	4.3	23.3	5.5	4.0	4.9	4.5	17.3	8.3	15.5	33.4	4.7	11.1	26.6	0.4	6.9	22.4	5.0	6.4	4.8	6.1	5.6	3.5	7.4	2.3	16.9	6.5	5.0	5.4	8.9	3.0	2.9	14.9	6.3	4.3
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6;testis: 19.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 29.0;Erythroid cells: 70.0;Extravillous trophoblasts: 29.4;Late spermatids: 57.0;Spermatocytes: 71.4;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	1.3	0.8	0.7	12.1	0.5	5.1	1.9	0.3	0.7	1.2	3.3	0.1	0.5	2.9	0.5	0.7	6.5	0.6	0.3	1.3	2.1	0.6	0.7	0.8	2.0	5.5	0.5	0.2	0.6	0.5	0.3	0.4	7.4	0.3	2.5	4.3	0.5	1.3	0.0	0.4	1.7	3.7	1.5	0.4	3.1	1.4	19.5	0.0	28.6	0.5	5.4	5.7	1.5	2.0	0.3	0.0	0.0	0.0	0.8	2.6	0.3	15.5	7.2	13.8	6.3	0.9	2.0	10.8	20.0	9.2	17.1	14.8	6.0	6.5	0.0	14.9	8.2	27.4	10.5	20.0	10.4	29.0	13.6	13.1	12.7	12.8	3.4	0.2	10.9	0.0	0.7	0.5	19.5	10.9	3.5	12.3	5.6	8.7	12.4	30.3	3.5	0.0	4.1	11.9	6.5	9.9	0.0	41.2	5.1	6.9	4.2	15.5	7.2	20.0	8.5	10.4	9.3	7.7	5.5	7.2	11.0	12.6	19.4	23.1	7.8	16.7	0.1	10.4	3.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.6	0.3	0.7	0.5	0.3	0.7	2.1	0.6	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	3.0	0.4	0.5	0.0	0.0	0.0	1.8	0.0	3.1	0.0	0.1	29.0	0.0	0.7	70.0	0.0	29.4	1.9	1.8	0.0	0.0	6.9	0.0	0.0	0.6	1.9	57.0	0.3	1.3	0.0	0.0	1.9	0.0	0.1	0.0	0.4	0.0	0.2	0.0	1.0	71.4	20.2	1.1	2.4	1.3	2.5	1.4
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.4	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	30.3	0.7	0.3	0.0	0.1	1.6	0.0	0.1	0.6	0.8	4.1	0.2	0.1	3.9	0.8	7.1	1.7	2.9	0.2	0.1	0.0	0.0	0.5	0.0	5.0	0.1	2.0	0.0	0.7	0.4	13.2	1.0	0.1	1.4	54.0	44.7	1.2	0.9	0.2	0.5	3.3	0.9	0.9	2.9	0.1	0.0	0.1	0.2	6.4	0.1	13.4	3.1	15.9	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5	6.0	9.4	4.5	12.1	4.6	2.2	2.2	15.3	0.0	5.7	24.4	0.0	0.5	72.9	3.3	1.3	3.6	3.9	0.0	10.6	1.5	8.2	11.1	11.5	10.5	2.8	0.0	16.0	4.3	11.8	1.1	10.9	7.6	13.5	1.8	2.9	0.9	1.3	20.9	3.2	24.6	0.4	0.0	1.7	3.2	3.2	4.8	0.3	0.0	14.7	16.9
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	4.7	4.1	6.0	5.0	7.8	3.8	4.0	13.2	7.8	3.8	4.3	4.2	2.0	12.5	5.9	1.5	3.1	4.9	4.2	4.1	4.1	1.8	2.9	2.0	3.5	2.9	5.4	4.1	6.7	9.3	1.3	8.7	4.8	2.9	3.0	1.6	4.3	3.3	3.3	1.9	2.3	5.6	2.6	3.0	5.6	4.1	1.7	6.3	2.8	3.2	1.0	5.6	4.7	3.4	3.1	6.3	6.9	8.2	2.7	6.4	3.7	3.1	2.9	1.4	4.0	0.9	1.0	0.9	2.7	0.9	3.0	2.9	1.7	1.3	1.2	1.8	0.6	0.3	0.9	0.4	1.7	0.2	7.3	7.5	11.0	1.2	1.6	2.6	6.0	8.6	0.5	0.3	2.7	0.1	0.8	3.3	4.9	6.1	1.3	0.7	0.9	6.6	3.6	2.2	1.1	6.3	5.5	2.3	2.4	0.6	0.4	2.9	5.0	2.0	3.0	8.3	0.0	0.7	3.6	5.0	1.2	1.0	5.8	2.4	2.4	3.6	3.4	1.4	9.4	1.7	5.3	5.5	6.9	4.7	5.1	2.9	3.1	3.0	3.8	6.3	1.2	2.8	4.5	1.7	2.7	8.2	0.1	6.4	3.7	6.0	7.8	13.2	7.8	4.1	1.8	5.4	4.1	2.9	6.3	3.0	5.8	0.0	1.0	0.6	4.4	0.8	2.5	1.4	2.3	1.8	43.2	3.0	1.7	1.9	0.8	2.1	2.0	0.0	1.4	23.7	2.1	0.7	0.0	1.6	2.5	14.3	2.4	3.1	5.3	1.1	1.1	1.9	0.0	0.0	4.1	3.5	1.6	0.0	4.6	2.2	19.3	0.0	0.5	1.8	3.2	0.3	1.1	3.2	3.7	0.7
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834099-56869567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.5;MOLT-4: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	7.8	4.9	7.8	8.3	17.7	5.5	5.2	21.3	18.6	9.5	7.4	4.4	5.6	5.4	13.3	8.9	5.0	8.2	9.4	4.9	7.4	9.2	4.2	4.9	8.1	9.3	5.6	10.0	7.3	6.5	9.5	14.5	5.5	9.9	8.9	7.0	17.4	4.3	7.3	2.4	3.4	7.1	9.3	6.8	12.7	6.4	12.5	5.4	14.5	8.3	2.5	8.6	6.5	15.3	2.4	2.4	1.2	0.8	1.9	4.5	0.8	1.7	1.6	1.5	0.1	0.3	0.5	0.7	2.9	2.3	2.0	2.3	3.8	2.1	2.5	3.6	1.5	1.0	2.1	3.6	1.6	4.1	8.0	4.7	3.2	4.0	2.5	1.7	6.2	4.5	0.9	2.0	2.1	4.2	1.8	2.7	7.4	2.6	43.5	2.4	2.5	14.5	3.5	1.1	2.2	4.9	4.5	6.3	5.9	2.0	3.8	2.4	1.6	2.3	1.2	0.1	1.0	2.7	3.0	2.4	0.5	2.7	0.8	0.4	5.7	11.7	1.7	1.7	3.6	0.1	0.3	0.5	0.0	2.7	0.4	2.0	2.4	1.9	2.3	0.6	0.9	1.9	2.5	1.2	1.9	0.8	2.4	4.5	0.8	7.8	17.7	21.3	18.6	7.4	9.2	5.6	10.0	9.9	5.4	3.0	5.9	2.2	10.2	7.9	167.4	5.5	15.3	1.4	4.5	15.7	178.7	3.2	0.0	6.5	13.1	23.3	3.4	0.0	4.0	2.2	4.3	13.9	0.0	3.8	1.9	7.9	10.9	32.5	5.6	7.4	4.0	4.1	3.3	2.8	7.1	13.8	4.9	5.5	4.9	0.0	165.4	6.5	10.3	25.4	18.5	5.8	2.9	13.8	4.6	8.8
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933682-48944969	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 32.4;kidney: 18.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 5.8;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0"					"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2.0	18.0	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0.0	5.8	0.0	0.0	4.8	0.5	2.8	0.0	0.2	1.4	0.8	0.6	1.1	0.0	0.4	0.5	1.4	2.7	2.2	0.0	0.5	0.0	1.8	0.8	0.9	2.0	0.9	1.0	2.2	3.9	0.9	1.0	0.0	0.0	0.9	0.5	0.2	1.1	0.0	0.7	0.0	6.3	1.2	0.4	0.0	0.6	0.0	0.2	0.6	4.0	1.8	1.4	0.2	1.9	0.3	0.9	4.2	2.3	0.5	0.3	0.9	0.3	1.9	0.1	0.0	0.0	1.7	0.6	0.1	6.4	5.0	1.6	1.3	0.0	0.4	5.8	0.0	0.9	1.6	0.0	0.8	0.0	1.6	0.7	0.0	0.1	4.8	3.1	0.1	0.0	0.0	0.0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2.0	0.4	0.4	0.6	0.1	3.0	5.4	0.0	2.6	0.7	1.3	0.4	0.0	0.0	4.5	3.5	0.0	0.1	8.3	1.3	0.5	0.6	1.7	0.0	0.3	0.1	0.5	5.2	1.1	0.0	10.9	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.7	1.5	1.2	2.9	0.0	56.2	4.3	0.0	0.1	0.0	0.6	0.1	0.1	0.0	0.6	2.6
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No		63000	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	52.6	15.9	9.2	20.2	47.7	18.7	11.7	17.0	43.8	6.2	13.8	8.8	35.7	5.5	10.2	15.9	15.8	22.7	12.0	23.9	9.1	38.3	11.2	13.6	7.8	14.4	25.1	16.1	0.4	13.9	28.8	9.8	33.3	11.1	11.9	14.0	4.1	11.9	15.5	15.9	9.3	15.3	4.3	31.1	16.1	9.7	12.4	6.4	27.7	18.0	19.8	24.8	17.2	26.1	37.7	11.8	18.3	7.1	8.3	30.9	10.5	8.4	9.7	4.2	1.9	9.8	16.8	15.6	21.2	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0	50.6	96.5	40.4	57.0	30.2	23.6	16.5	147.7	46.8	59.1	82.0	78.5	22.0	16.6	184.7	1.5	65.9	155.6	0.0	145.2	76.8	60.2	242.6	172.3	147.5	88.2	39.7	44.6	30.1	58.9	2.0	76.2	101.1	102.9	178.5	77.9	88.0	174.5	89.2	79.2	41.6	54.4	84.1	70.6	1.1	3.1	22.2	17.4	135.7	66.0	41.6
DHX34	"DDX34, KIAA0134"	ENSG00000134815	"DExH-box helicase 34"	Q14147	19	47349281-47382704	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 48.6;Spermatocytes: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042159, HPA043558"	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA			"Nucleoplasm, Intermediate filaments"		"HPA042159: AB_10963066, HPA043558: AB_10961262"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (8.63e-6)"	"unprognostic (9.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (7.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.21e-3)"	6.8	6.9	12.6	11.0	11.5	20.3	6.6	18.7	13.3	8.2	5.9	9.1	8.9	7.7	10.4	5.3	8.3	9.0	5.7	6.0	11.2	6.4	7.2	10.9	8.9	7.9	12.3	8.4	13.3	12.9	7.8	14.2	7.8	11.4	8.9	4.6	8.5	9.9	8.3	7.8	11.8	7.0	6.6	10.5	13.5	6.7	21.8	12.5	5.6	9.6	4.6	9.6	7.3	11.2	1.5	1.9	13.5	2.2	0.8	1.8	1.1	7.2	19.1	4.7	9.2	4.1	2.8	9.0	5.8	1.9	6.0	5.4	12.2	7.2	11.2	5.9	3.2	6.5	10.7	6.5	7.6	3.1	9.3	17.7	11.7	10.4	9.2	4.6	9.0	5.0	3.6	6.2	10.1	5.7	3.9	4.0	5.1	19.4	4.9	4.0	8.6	8.9	22.6	9.8	9.5	11.5	9.9	3.7	6.7	3.2	9.8	8.4	5.2	7.1	7.1	4.7	5.6	6.4	5.8	4.5	7.0	9.1	4.4	10.2	7.4	10.2	10.4	5.6	6.6	8.2	1.0	2.0	0.8	1.3	2.2	1.2	1.2	1.0	1.8	1.9	1.5	1.6	0.7	13.5	0.8	1.7	1.5	0.6	1.1	12.6	11.5	18.7	13.3	11.2	6.4	12.3	8.4	11.4	12.5	6.0	7.2	2.2	5.1	6.6	7.7	2.8	0.0	6.7	3.4	7.0	2.0	4.2	0.0	4.3	20.8	3.1	3.4	0.0	2.8	4.7	3.0	5.1	3.5	4.4	6.7	0.0	3.5	3.1	5.9	48.6	4.9	10.4	1.7	3.6	3.9	1.5	3.1	2.9	4.6	1.4	5.1	6.5	3.6	24.5	11.7	6.4	4.2	3.2	4.3	5.2
DHX36	"DDX36, KIAA1488, MLEL1"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324497	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035399	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	16.3	14.0	11.5	14.1	27.5	12.6	15.7	19.0	21.3	17.9	14.7	10.3	12.4	10.7	20.4	10.6	14.5	14.3	13.7	23.9	13.4	12.7	16.7	17.1	14.6	17.0	12.2	15.0	20.0	13.7	34.0	36.2	16.4	20.1	15.7	12.2	9.3	15.5	20.5	53.4	14.7	14.3	15.1	13.7	18.9	13.4	28.3	11.3	24.3	20.4	13.4	17.1	20.7	15.6	6.3	5.9	3.1	5.7	4.8	6.9	1.1	27.0	18.5	25.1	14.4	11.9	16.7	12.5	17.7	17.8	20.2	24.1	18.8	21.8	26.2	28.7	15.5	18.6	17.5	23.6	15.0	31.8	25.1	15.6	19.0	15.9	10.7	20.2	26.4	16.7	18.8	12.7	21.6	26.6	11.0	17.3	16.3	17.8	15.1	18.6	13.2	21.8	5.8	33.4	14.4	17.8	22.7	21.2	37.8	14.5	19.2	23.6	25.1	18.4	19.6	25.7	17.9	20.1	13.5	19.5	21.2	13.4	19.8	35.3	28.4	18.3	37.9	17.1	13.9	22.4	1.9	2.7	3.1	6.9	2.8	4.4	4.7	6.1	4.7	2.3	6.3	5.8	6.0	1.1	4.8	5.7	5.9	5.4	1.1	11.5	27.5	19.0	21.3	13.4	12.7	12.2	15.0	20.1	11.3	53.6	78.8	70.6	103.5	82.5	148.4	52.9	61.1	50.9	96.7	57.6	121.7	106.5	33.2	60.5	381.7	74.4	34.4	23.3	54.3	56.1	68.1	82.0	99.5	71.8	54.2	146.2	88.2	62.6	59.6	255.9	102.4	80.8	50.6	65.9	47.0	93.9	58.1	42.4	114.2	44.2	123.0	77.6	80.4	174.2	142.0	72.6	309.5	99.1	47.7	105.0
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43544463	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	21.9	18.6	17.5	17.0	22.9	47.8	22.3	21.6	29.8	20.3	21.0	25.3	17.2	17.1	26.1	28.4	26.6	17.9	16.7	18.5	18.1	18.7	18.5	20.1	19.8	21.0	20.8	19.7	19.5	17.4	35.4	23.0	21.7	22.7	22.1	24.6	20.1	21.7	21.7	25.2	32.9	22.0	24.6	19.2	27.3	19.5	34.6	20.6	40.8	20.5	17.8	28.9	19.4	22.6	11.5	16.3	23.3	20.4	9.5	14.9	9.8	12.5	35.7	19.4	24.1	19.4	19.8	10.7	13.2	27.9	29.2	28.1	16.2	12.8	17.4	12.3	25.9	21.0	17.0	29.1	23.2	34.3	18.2	23.0	14.7	27.2	25.1	16.6	25.5	22.4	9.9	19.7	24.0	26.4	14.1	25.9	22.9	16.3	17.2	22.6	13.7	32.3	22.7	15.8	15.3	13.7	19.7	37.0	17.9	19.8	26.4	16.8	25.3	14.8	8.5	11.8	24.4	19.8	25.2	17.6	22.8	12.4	16.4	19.7	12.9	15.3	19.7	18.9	15.9	18.2	23.3	15.2	17.2	13.7	20.4	13.6	11.5	11.4	14.9	16.3	10.6	11.2	10.9	19.2	9.5	19.6	8.4	11.7	9.8	17.5	22.9	21.6	29.8	18.1	18.7	20.8	19.7	22.7	20.6	6.0	12.9	15.2	5.8	10.5	15.7	11.9	12.7	12.0	22.7	21.0	17.7	7.9	11.6	14.1	16.1	13.5	8.9	0.0	15.3	7.0	11.1	7.5	13.9	13.1	9.6	6.4	25.6	12.9	13.3	8.1	11.5	12.0	16.9	17.2	13.1	10.1	15.6	11.5	10.3	10.1	18.6	19.4	11.1	24.9	14.5	11.7	17.7	16.0	10.2	14.4
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		97000	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.7	35.0	50.3	27.6	26.3	20.4	49.7	31.7	29.1	46.1	31.3	39.1	27.6	57.4	31.0	28.4	27.6	31.0	76.3	34.3	51.7	23.3	37.9	38.2	28.7	26.4	14.8	55.3	26.2	18.1	17.3	45.2	12.3	20.9	36.0	29.5	60.0	20.6	36.9	31.4	55.9	13.6	63.7	38.5	21.6	51.0	46.9	32.8	29.8	41.6	36.3	41.6	44.9	28.4	18.5	44.2	33.3	31.3	28.1	28.6	32.0	29.0	42.9	21.7	35.4	68.1	18.0	30.4	38.8	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4	38.7	64.9	41.5	53.0	47.7	55.9	37.2	35.7	72.3	69.4	48.8	49.1	40.4	16.6	39.6	17.1	44.9	31.7	0.0	43.7	37.7	35.9	40.6	42.8	24.3	35.2	27.0	51.6	38.1	37.7	32.0	55.8	34.4	28.7	27.1	33.8	42.7	42.4	25.9	44.2	33.5	72.8	38.8	45.7	63.0	65.2	41.3	41.4	32.4	45.7	48.7
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	25.5	14.7	11.7	17.6	24.8	23.8	22.4	23.4	19.4	20.3	18.8	11.6	17.0	11.8	18.0	19.3	23.1	17.8	16.0	21.6	12.4	13.6	20.2	25.6	19.3	22.2	13.9	17.0	23.4	15.3	15.8	22.8	26.3	18.7	18.0	15.6	9.8	17.4	19.3	19.9	17.3	17.9	17.5	12.9	22.8	16.2	27.7	14.6	23.7	21.3	19.1	23.0	26.7	19.3	6.9	6.8	11.1	9.7	10.3	10.0	5.0	15.7	7.4	14.5	12.2	15.5	18.5	9.6	14.1	17.2	14.4	17.7	11.2	13.2	19.2	12.3	14.4	9.1	13.1	19.8	16.2	23.4	15.7	14.6	22.5	15.8	10.1	19.3	38.0	13.1	19.3	11.4	16.3	21.6	14.4	15.4	14.7	15.0	8.1	17.5	5.5	16.1	18.7	13.6	24.1	8.7	13.0	11.1	8.7	14.4	12.7	13.1	17.3	11.5	9.7	13.6	15.8	9.3	17.4	14.3	8.7	7.1	9.8	14.8	15.6	17.5	15.4	24.4	18.1	12.6	11.1	5.5	7.8	6.5	9.7	9.4	6.9	8.5	7.3	6.8	6.0	8.1	7.6	3.4	10.3	7.6	4.3	10.0	5.0	11.7	24.8	23.4	19.4	12.4	13.6	13.9	17.0	18.7	14.6	32.8	30.4	16.8	29.7	22.7	38.6	24.2	25.5	37.5	45.5	8.7	27.5	20.7	19.9	16.8	123.4	38.3	15.1	0.0	17.3	19.4	13.5	23.6	32.4	21.2	12.8	30.2	29.2	25.2	16.2	100.0	26.7	13.6	11.8	31.5	15.2	20.6	18.9	2.9	26.5	13.6	39.7	6.5	19.6	23.7	35.3	27.4	18.9	21.0	18.6	45.4
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358235-40378639	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 37.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059903: AB_2684156"	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.8	2.5	9.0	1.5	7.6	1.3	0.6	37.2	14.5	0.7	4.0	1.0	0.0	3.4	0.9	0.9	0.7	1.1	1.1	0.8	9.0	7.0	0.5	0.7	0.9	1.5	2.9	14.0	1.3	1.4	0.6	2.8	1.0	11.4	0.8	3.9	0.3	1.2	1.8	0.8	1.3	3.0	1.4	2.0	1.1	3.9	2.4	1.8	0.0	3.4	0.0	0.6	1.2	0.4	0.9	1.1	2.9	0.4	1.1	0.6	0.2	1.5	0.6	0.4	2.5	0.1	0.1	0.9	0.2	0.1	1.0	1.5	2.3	0.7	0.2	1.7	0.9	5.2	8.1	0.3	1.3	0.6	0.2	0.5	0.4	0.5	0.1	0.0	0.5	1.5	1.8	0.0	0.3	0.2	0.3	0.5	0.9	0.6	1.0	1.3	0.3	0.2	0.4	0.4	2.0	1.1	0.2	0.4	0.5	0.3	2.1	16.7	2.4	0.3	0.2	0.2	0.5	0.4	0.2	0.5	1.2	0.9	0.2	0.2	0.3	0.2	0.3	0.4	0.7	2.3	2.1	0.4	0.5	0.6	0.3	0.4	0.5	0.4	0.4	0.2	0.9	0.5	0.6	2.9	1.1	0.4	1.1	0.4	0.2	9.0	7.6	37.2	14.5	9.0	7.0	2.9	14.0	11.4	1.8	3.0	5.1	0.0	2.0	0.0	15.6	1.4	2.5	4.0	7.9	3.5	9.8	0.2	0.0	0.3	0.9	1.0	12.9	0.0	0.3	0.2	0.8	1.1	8.1	0.0	0.8	17.5	9.2	0.6	0.0	1.5	1.1	0.9	0.0	0.0	14.1	1.7	0.2	2.9	0.0	0.0	7.2	0.0	0.4	4.2	6.6	0.0	0.2	0.0	4.8	1.0
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479166-11537584	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;testis: 7.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054579: AB_2682529"	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.9	1.9	7.3	1.1	10.0	0.9	0.9	4.1	17.4	0.9	1.0	9.0	0.0	1.3	1.1	0.9	0.8	1.0	0.8	0.8	7.3	5.7	0.9	0.8	0.9	1.2	4.0	6.5	0.9	1.6	0.8	4.2	0.8	5.1	1.6	0.9	5.4	0.9	0.8	0.8	0.8	1.3	1.0	2.1	1.1	1.2	7.5	6.8	0.0	0.9	0.0	1.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	7.9	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.8	0.0	2.0	0.0	0.2	3.2	11.0	2.4	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	10.0	4.1	12.9	7.3	5.7	4.0	6.5	5.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 114.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		40000	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (2.94e-4)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	17.6	18.1	17.2	22.5	17.3	42.3	25.8	19.6	20.7	16.6	20.3	14.8	20.7	17.4	19.7	17.1	33.6	18.5	15.9	16.9	15.4	16.3	15.2	22.5	15.2	26.8	15.6	16.6	23.9	38.7	22.6	24.6	19.1	17.0	17.1	26.2	13.7	20.8	18.7	40.8	25.5	18.5	18.3	20.9	25.8	17.6	33.1	16.7	31.3	26.6	28.7	33.2	16.4	20.8	23.5	18.5	16.7	15.5	20.8	26.8	14.8	36.7	20.5	12.7	18.0	7.9	8.2	18.8	14.0	9.9	21.0	19.9	25.8	18.4	70.3	37.0	11.8	19.6	19.8	38.6	23.1	31.6	16.9	21.5	35.9	21.5	22.4	11.2	47.1	21.6	7.8	22.2	23.2	52.9	7.7	14.5	23.5	32.3	17.7	14.2	21.4	31.7	36.3	21.1	36.8	25.7	27.7	28.5	36.4	13.2	20.9	27.9	13.8	12.4	21.7	19.1	12.9	11.0	19.0	11.6	15.1	22.7	19.4	46.3	32.7	45.2	114.9	10.3	49.9	16.4	4.8	13.1	16.7	21.4	15.5	26.8	23.5	17.6	22.7	18.5	17.1	23.3	22.2	4.0	20.8	14.9	13.4	13.4	14.8	17.2	17.3	19.6	20.7	15.4	16.3	15.6	16.6	17.0	16.7	23.8	28.8	32.8	45.8	88.6	31.1	28.6	17.8	37.5	38.7	24.4	13.7	49.0	34.9	41.0	1.9	32.1	7.5	23.3	39.2	59.7	35.2	32.7	53.4	20.8	39.9	22.3	32.7	14.7	19.2	6.2	23.9	30.6	47.2	38.7	31.9	25.7	36.3	8.6	26.9	18.8	27.3	12.9	41.0	35.3	81.7	85.9	28.6	30.5	47.6	46.7
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.4	1.6	9.9	4.2	2.6	3.1	6.9	2.0	2.3	1.1	1.1	9.8	8.1	0.0	4.8	2.0	0.8	7.5	19.2	4.5	0.7	4.0	5.8	0.0	8.8	5.3	5.0	0.1	1.3	3.2	3.0	1.4	3.2	10.2	0.4	6.6	1.8	13.8	1.1	12.1	7.8	0.0	16.7	28.0	11.6	7.3	4.9	1.4	6.7	10.6	4.7	0.3	1.6	19.2	3.7	8.6	10.1	0.0	0.7	1.3	1.3	1.2	1.5	9.1	6.8	4.3	1.9	0.0	1.9	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5	17.9	16.1	3.2	4.8	0.7	15.6	16.7	25.5	32.1	12.5	8.7	0.0	5.5	10.0	11.9	0.0	0.3	27.4	0.0	21.3	2.0	5.0	15.9	1.1	0.0	0.6	4.8	24.6	1.8	0.3	0.0	1.4	1.3	1.7	2.8	22.3	10.3	21.5	17.3	6.0	3.7	5.8	6.5	5.1	0.4	1.7	1.8	1.4	3.8	17.2	9.0
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.5"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 37.2"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4;naive CD8 T-cell: 3.3"	"Group enriched"	"Detected in many"	13	"B-cells: 5.4;T-cells: 3.3"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 42.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA056533			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0.0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0.0	0.7	0.0	0.6	0.6	0.0	5.4	0.3	0.0	0.0	0.0	3.3	0.4	0.0	2.0	0.4	1.0	0.0	0.0	0.3	0.5	0.0	0.3	0.1	0.3	0.4	0.0	2.0	0.0	0.8	0.0	1.2	0.5	0.1	0.6	3.1	0.1	0.0	0.2	0.1	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.0	3.2	0.3	0.1	0.1	0.1	0.1	7.4	7.6	1.5	0.0	42.1	0.1	0.0	0.1	0.0	0.0	1.4	0.1	0.5	0.7	0.0	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.9	0.0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	2.9	0.0	0.0	1.6	1.1	0.0	1.7	0.0	0.0	0.5	0.2	0.0	1.4	0.0	0.6	6.5	0.0	5.4	37.2	0.1	0.2	0.0	0.0	0.0
DLST	DLTS	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903745	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		800000	"Nucleoplasm, Mitochondria"		"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	32.2	38.6	12.0	22.7	19.9	28.5	31.3	19.1	25.6	31.2	36.0	18.5	15.9	24.7	26.3	28.3	31.4	19.2	29.7	47.6	10.8	11.8	43.7	45.1	20.8	26.7	13.5	13.7	21.5	27.1	25.8	16.2	25.2	19.7	20.9	26.8	19.2	22.3	20.1	59.2	26.9	43.2	32.9	11.4	20.8	24.3	21.0	10.4	23.5	27.2	49.8	28.4	26.9	21.1	3.8	6.3	8.4	4.3	7.7	5.3	3.2	25.8	27.0	20.7	14.6	32.5	36.9	31.7	33.8	34.4	34.6	32.4	26.5	28.1	26.3	14.4	38.8	15.6	29.2	34.8	33.4	36.6	19.0	14.6	21.5	22.6	23.2	33.6	15.2	14.8	37.7	29.3	33.5	41.4	31.2	35.6	11.9	16.4	17.9	37.5	34.7	18.0	21.6	17.7	45.7	25.4	23.1	30.4	14.5	42.9	31.8	24.6	20.9	31.9	42.6	22.0	19.3	39.0	22.0	31.5	21.1	27.6	25.7	23.1	12.7	13.2	23.1	30.8	15.8	22.0	8.4	3.0	5.0	5.0	4.3	4.5	3.8	4.5	3.9	4.7	2.7	4.0	5.3	3.0	7.7	3.9	6.3	4.4	3.2	12.0	19.9	19.1	25.6	10.8	11.8	13.5	13.7	19.7	10.4	6.0	4.5	20.7	19.3	23.5	17.5	23.4	20.4	2.7	3.4	19.2	29.5	33.7	48.0	32.5	6.2	14.6	39.3	0.0	22.3	30.6	23.8	21.8	20.7	37.3	28.4	12.7	14.3	24.5	16.2	3.4	16.7	16.5	21.9	36.1	28.3	8.5	35.0	25.9	19.4	51.5	20.0	25.8	17.9	9.3	11.7	24.8	66.5	20.3	36.1	20.8
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597"	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.2	18.7	9.8	9.7	9.2	21.6	11.0	14.8	26.7	23.1	21.6	15.6	18.7	15.0	17.7	10.5	10.2	16.6	14.2	14.2	14.9	26.9	17.1	23.6	21.3	17.6	16.8	13.1	14.4	15.8	22.0	12.7	17.2	17.2	17.9	11.9	17.2	15.5	14.4	23.4	21.1	26.6	6.4	16.9	23.8	18.9	20.3	14.0	15.8	17.4	14.4	20.7	14.9	21.0	18.9	12.3	19.4	16.5	7.6	22.9	17.4	22.2	20.9	12.5	14.9	14.3	16.7	12.4	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0	29.8	27.9	19.5	20.8	17.1	38.2	20.9	20.4	26.8	14.8	10.4	23.6	62.4	24.9	28.1	32.9	20.7	35.1	46.7	36.4	27.8	20.5	10.0	26.5	17.4	28.6	22.3	52.2	18.4	21.5	52.0	16.7	14.0	16.9	27.1	25.6	36.1	20.7	25.9	16.6	28.1	52.1	6.5	19.6	25.4	33.4	15.6	43.8	20.0	24.0	11.9
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 7442.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	32.0	5.2	0.0	0.0	1.3	2.0	9.0	0.1	4.3	0.2	0.3	39.6	34.0	0.0	13.0	0.3	1.6	18.0	9.8	51.9	0.4	0.1	9.5	0.0	0.0	8.8	1.5	0.0	0.1	17.8	14.0	0.9	30.2	3.0	0.0	0.0	0.1	0.0	0.1	28.0	0.0	0.0	28.8	23.3	2.1	0.0	0.0	1.3	51.3	21.2	0.1	0.0	7.8	0.0	3.1	8.6	13.0	0.0	0.0	5.0	15.2	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3	98.3	94.2	3.7	121.7	1442.2	1.4	15.2	94.3	261.0	92.1	193.7	0.0	0.7	195.6	125.9	15.0	6.0	1.3	0.0	120.1	1.1	57.3	55.5	7.0	2.0	1.0	0.0	47.4	5.5	0.8	67.8	12.0	5.1	290.1	4.6	4.2	9.3	137.6	5.8	14.9	4.4	0.7	0.0	14.2	7.1	16.4	7442.2	1.9	5.3	11.0	72.7
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 3.7;Intestinal endocrine cells: 1.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	1.9	0.0	1.3	4.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	3.3	3.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Group enriched"	"Detected in many"	17	"B-cells: 2.2;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	1.3		0.0		0.0	0.0		4.0	0.6	0.1			0.0	1.1	0.0	0.1	2.1	0.2	0.0			0.0	0.0	0.0	0.6			1.3	0.0	0.0		0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.1	0.6		0.7	0.0	1.1			2.0		0.8	0.0		2.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	2.2	0.7	1.2	0.0	0.0	0.0	0.0	0.4	0.1											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726701-786475	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	11.5	13.0	9.3	13.5	11.4	10.7	12.3	17.4	14.2	15.5	16.3	14.7	10.3	12.0	18.4	13.9	16.7	23.4	15.4	18.8	11.6	8.6	15.0	18.2	9.9	11.8	9.5	7.6	20.6	22.5	14.4	21.1	12.1	10.4	16.1	9.9	14.0	17.6	14.3	33.9	12.0	13.6	13.9	9.2	12.5	13.0	14.8	9.4	20.7	15.9	11.2	14.2	15.6	12.4	3.3	4.6	1.4	2.8	3.0	4.7	1.9	30.7	24.4	7.3	16.9	4.8	5.3	18.4	6.4	6.2	8.0	7.6	24.3	16.4	18.9	9.3	6.7	19.1	18.7	13.4	16.1	6.2	3.2	22.8	4.6	14.5	17.5	6.6	14.0	8.4	6.4	6.9	10.0	7.4	5.3	10.8	9.6	29.3	3.9	5.8	30.3	8.3	12.6	26.8	10.2	19.4	15.4	2.3	13.0	9.3	13.0	15.3	25.4	10.5	25.9	7.4	8.7	22.8	11.8	9.0	4.5	16.0	15.3	14.3	7.7	9.2	10.9	9.8	14.8	23.3	0.0	1.9	1.4	2.2	2.8	3.3	1.6	3.5	4.7	2.7	3.3	3.3	2.5	0.0	3.0	2.0	4.6	0.8	1.9	9.3	11.4	17.4	14.2	11.6	8.6	9.5	7.6	10.4	9.4	17.9	7.8	0.0	5.2	0.0	5.8	12.5	5.1	14.7	7.9	8.7	25.5	6.8	13.3	6.0	0.5	5.6	3.8	0.0	3.6	11.2	5.1	3.9	0.0	8.2	5.0	9.5	3.5	5.5	8.2	1.3	6.6	2.7	0.0	0.0	10.5	9.1	8.6	0.0	8.1	8.6	16.1	0.0	3.9	6.7	20.0	0.0	3.8	2.2	11.2	3.5
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 99.4"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 37.5;Smooth muscle cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 7.7;neutrophil: 7.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	7.2	6.3	5.9	5.1	7.2	0.9	2.6	8.6	13.0	6.5	19.1	6.2	9.2	3.8	18.5	9.7	15.7	9.6	8.7	29.3	6.6	6.3	3.7	2.0	3.7	2.2	4.7	3.4	6.5	3.1	2.2	8.6	1.4	6.0	13.8	6.2	5.7	3.7	26.2	99.4	1.5	6.1	29.9	4.5	5.6	11.3	8.1	3.5	1.6	4.4	38.0	2.9	23.0	3.6	0.7	7.7	7.6	1.5	0.5	1.3	0.7	2.5	2.1	13.4	7.1	7.9	6.1	1.5	11.2	8.2	17.3	15.4	1.5	0.6	2.4	2.8	12.3	18.2	0.3	5.1	8.8	14.7	3.5	1.6	0.9	3.1	0.7	9.1	0.3	8.1	8.9	0.6	10.2	5.1	7.7	11.0	4.6	0.2	5.2	13.9	1.8	4.2	3.6	6.3	1.1	4.5	3.2	13.9	1.3	2.4	0.2	5.7	9.3	6.0	0.3	1.3	12.1	2.2	0.8	4.9	8.3	18.2	4.3	3.4	1.9	1.3	1.7	9.5	1.0	8.9	0.1	1.5	0.0	0.4	0.4	1.3	0.7	0.3	0.1	7.7	0.3	0.5	1.1	7.6	0.5	0.1	0.2	1.3	0.7	5.9	7.2	8.6	8.5	6.6	6.3	4.7	3.4	6.0	3.5	6.0	1.0	0.9	1.9	1.8	4.1	37.5	2.5	1.4	1.2	0.0	5.9	0.1	0.0	2.1	5.3	5.2	0.7	0.0	3.0	0.5	3.1	1.5	0.0	1.1	4.7	1.6	0.0	2.5	1.5	5.1	1.4	2.8	5.0	1.0	0.0	12.0	4.2	0.0	7.4	3.7	2.5	6.5	19.4	8.0	0.9	2.6	0.7	0.8	0.0	0.6
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	24.0	23.1	38.0	17.9	35.0	51.3	40.5	42.2	41.3	17.1	25.5	21.7	19.1	14.5	23.3	38.8	33.2	20.9	17.3	37.0	31.7	32.2	24.5	16.7	19.4	16.4	37.6	32.2	22.8	18.8	17.2	20.2	24.4	37.7	19.5	17.2	15.3	20.1	25.6	96.9	34.2	15.6	31.7	33.9	17.2	16.8	38.3	35.2	12.2	17.9	23.5	21.9	23.4	51.9	32.7	30.4	74.3	48.1	35.5	42.1	55.0	37.8	23.0	28.0	28.3	28.4	25.8	25.9	42.6	34.9	39.7	43.6	31.3	38.3	14.6	80.3	31.5	36.1	24.3	19.0	29.8	61.6	29.2	26.0	26.1	13.9	22.1	26.2	19.3	22.0	22.6	28.9	30.0	14.3	39.9	29.5	15.7	42.3	14.6	50.8	25.7	48.2	38.1	56.0	26.8	30.7	26.0	20.2	20.3	32.7	23.2	16.9	44.7	33.3	26.1	31.1	60.4	19.0	27.4	36.7	25.1	19.1	59.7	36.6	28.0	39.9	17.1	35.7	44.5	31.7	70.6	41.5	48.8	36.2	41.6	36.1	32.7	33.2	37.2	30.4	28.1	42.1	39.3	74.3	35.5	48.1	27.6	38.9	55.0	38.0	35.0	42.2	41.3	31.7	32.2	37.6	32.2	37.7	35.2	44.7	57.9	61.6	535.0	672.2	87.1	103.2	40.8	135.1	83.0	92.5	76.6	239.3	164.2	120.8	82.9	125.4	92.1	46.7	61.0	198.1	160.4	315.0	212.0	42.7	149.9	89.0	185.4	94.5	124.0	94.1	139.8	162.9	268.2	444.6	63.2	102.0	105.0	73.7	190.2	165.4	87.6	97.0	208.1	297.0	373.7	839.6	425.0	152.3	79.1	816.5
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631352-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 41.9"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	5.1	10.2	3.3	3.9	4.6	1.9	5.8	4.5	4.2	3.4	5.1	2.5	5.7	4.6	4.1	7.7	3.4	3.8	3.6	6.7	4.3	3.8	7.8	41.9	3.5	4.1	2.7	2.3	5.7	7.0	7.4	9.0	4.4	3.3	5.9	3.0	3.6	9.7	4.0	3.6	2.4	6.9	5.0	2.9	2.9	3.7	4.2	1.9	1.4	4.3	2.4	2.2	6.4	4.5	0.6	1.1	1.2	1.9	0.4	0.8	0.3	2.6	2.0	1.4	2.4	14.7	6.6	5.4	10.2	4.9	4.0	4.0	3.9	1.7	2.3	4.0	7.0	6.3	8.6	1.5	2.9	3.9	1.9	2.0	2.3	0.0	7.9	4.8	4.3	3.4	5.7	8.3	3.1	5.9	3.2	3.3	1.3	4.6	2.0	5.1	2.9	1.3	0.2	2.5	5.1	4.8	2.2	7.5	2.1	8.4	2.9	2.4	1.3	5.7	8.0	3.6	2.6	4.2	1.1	6.4	4.9	2.2	13.1	5.8	3.7	5.6	1.3	8.4	2.1	4.3	0.0	0.1	1.2	0.6	1.9	0.2	0.3	0.5	0.0	0.5	0.6	0.5	0.2	0.8	0.4	1.0	1.1	0.8	0.3	3.3	4.6	4.5	4.2	4.3	3.8	2.7	2.3	3.3	1.9	6.0	11.0	14.5	13.2	9.4	7.7	9.0	7.6	13.4	12.5	10.4	19.6	11.8	11.6	13.6	7.8	4.9	17.6	0.0	14.1	18.7	13.1	26.6	1.1	75.4	10.9	12.7	16.6	6.7	5.0	1.4	9.5	7.9	11.8	4.6	14.9	3.9	11.0	7.4	9.6	10.7	20.2	12.9	11.3	29.8	11.9	8.2	11.6	7.9	10.9	17.1
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976433-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: AB_2681811"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	22.9	24.2	42.0	27.6	49.3	24.7	28.3	36.6	44.1	22.2	30.5	25.0	21.0	21.5	18.6	32.3	31.4	19.3	19.9	30.6	36.5	38.6	36.9	30.8	21.8	30.1	38.1	30.5	26.4	29.0	37.7	38.2	24.4	48.2	20.4	29.0	21.0	21.0	22.1	44.3	28.0	22.4	18.9	28.9	23.7	22.0	25.2	32.9	31.8	26.5	29.0	40.9	24.3	33.5	15.8	48.1	14.0	21.2	17.8	16.2	13.2	19.7	33.8	31.8	23.7	19.5	32.8	27.1	20.4	29.0	38.7	31.0	39.0	20.1	30.6	24.3	29.5	28.2	29.8	49.9	36.6	46.2	27.3	70.0	24.6	28.9	54.2	27.9	35.7	22.4	27.2	21.6	35.5	33.4	26.1	30.4	32.1	37.7	21.7	32.7	16.5	38.5	29.6	31.0	19.7	24.7	27.0	36.3	27.0	29.0	25.9	30.9	24.3	17.1	50.8	24.9	36.8	28.5	29.8	23.9	21.2	20.1	22.2	33.8	15.8	35.8	28.3	23.0	26.1	22.5	14.0	20.6	13.6	13.2	21.2	14.6	15.8	14.6	15.1	21.6	15.0	14.4	13.8	8.9	17.8	20.4	48.1	16.2	13.2	42.0	49.3	36.6	44.1	36.5	38.6	38.1	30.5	48.2	32.9	32.8	34.7	92.6	81.7	58.2	80.9	58.1	45.9	41.5	25.0	62.8	127.6	95.7	97.8	80.1	64.8	73.4	61.4	23.3	115.2	83.9	52.6	65.4	55.4	49.4	90.4	60.4	106.9	57.1	81.0	35.7	62.5	108.0	45.5	127.2	54.6	91.4	101.3	56.8	57.7	112.8	125.2	45.3	55.4	75.7	114.1	60.1	106.1	79.9	63.5	83.9
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73248862	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.2"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 140.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	3.1	4.0	4.0	5.0	4.3	24.2	4.6	12.9	5.8	3.0	4.6			4.2	4.0	3.9	6.8	2.9	1.7	2.7	4.2	5.2	2.8	3.5	2.9	7.7	3.5		5.2	2.6	3.6	4.3	5.4		3.6	5.8		3.6	3.9	3.4	5.3	4.1	3.8	3.1	5.9	3.4	4.3			2.9		9.9	3.1	4.4	15.6	9.4	13.2	4.9	10.6	16.5	8.8	26.5	16.4	21.3	17.6	5.1	5.0	9.4	21.6	12.8	21.7	22.7	28.1	18.7	18.4	7.1	9.5	9.3	18.1	21.3	14.3	24.6	21.3	14.7	39.1	16.8	18.6	3.5	34.3	15.8	4.0	7.9	22.8	20.0	10.6	14.3	23.4	34.9	21.4	17.1	24.6	33.2	26.0	7.8	12.6	46.0	24.7	18.6	10.1	10.8	12.9	10.2	17.2	15.8	26.0	11.3	10.2	13.6	16.1	10.4	14.5	25.7	15.5	32.9	10.0	15.1	29.6	14.6	34.2	9.3	7.3	1.8	13.2	13.0	4.9	14.4	15.6	15.9	14.1	3.0	12.7	15.6	13.8	2.1	10.6	4.7	9.4	16.5	8.8											8.9	10.5	40.2	29.5	42.4	24.8	2.4	25.5	29.4	27.3	8.7	7.9	69.3	18.3	29.2	74.3	18.0	13.1	140.2	27.2	89.2	17.4	20.5	39.5	8.2	51.9	14.3	11.5	9.8	11.3	30.7	13.0	16.8	30.4	31.5	17.2	26.4	30.7	17.3	19.1	11.3	38.3	25.8	22.7	21.1	59.5	38.0	48.5	45.3	32.2	33.3
DNAL1	"1700010H15RiK, C14orf168, CILD16, MGC12435"	ENSG00000119661	"Dynein axonemal light chain 1"	Q4LDG9	14	73644875-73703732	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 129.8;Early spermatids: 234.2;Spermatocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053129, HPA060974"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA053129: AB_2682051, HPA060974: "	"unprognostic (1.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.17e-8)"	"unprognostic (9.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	6.2	6.3	9.9	5.2	15.0	5.2	4.7	9.2	15.6	5.6	4.7	10.6	7.2	2.4	9.8	11.2	4.1	20.2	8.6	7.6	16.0	9.6	9.9	3.9	6.7	4.3	7.3	14.2	7.1	5.7	11.8	15.0	4.2	18.8	5.5	5.0	7.6	5.5	7.7	4.4	2.9	3.1	8.2	8.5	4.1	5.0	42.4	7.6	3.5	14.2	2.9	3.9	4.8	4.4	6.8	10.9	6.3	4.7	3.8	7.5	2.4	9.2	6.8	8.4	7.6	6.0	7.6	6.9	9.3	7.2	12.3	12.7	7.1	14.7	3.7	7.0	9.8	11.6	5.6	7.9	7.2	17.7	5.5	3.3	3.0	10.1	2.5	6.2	3.5	3.8	5.7	5.8	13.3	9.6	9.3	7.8	5.9	3.4	8.5	14.7	15.1	9.0	4.3	3.9	7.7	6.8	6.5	12.7	1.5	10.1	9.8	13.1	6.1	15.5	3.0	7.2	6.9	16.6	2.4	7.4	15.3	27.6	11.4	8.6	5.0	10.4	7.9	12.5	1.8	10.6	6.3	4.3	4.5	5.2	4.7	7.5	4.9	5.1	5.3	3.9	6.8	4.8	5.2	4.1	3.8	3.7	10.9	4.3	2.4	9.9	15.0	9.2	15.6	16.0	9.6	7.3	14.2	18.8	7.6	17.9	12.2	5.6	6.2	2.9	13.9	11.5	20.4	129.8	26.1	17.4	56.9	4.4	8.3	13.8	234.2	10.5	2.6	0.0	12.4	7.6	10.5	6.3	9.3	5.5	7.5	14.3	9.8	8.0	7.5	33.5	16.1	6.3	11.8	8.2	6.0	18.8	9.5	5.1	15.6	18.2	38.1	12.9	8.2	109.4	22.6	1.8	2.1	5.7	5.4	4.1
DND1	"MGC34750, RBMS4"	ENSG00000256453	"DND microRNA-mediated repression inhibitor 1"	Q8IYX4	5	140670794-140673586	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.2;testis: 12.0"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059723			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA059723: "																		0.5	0.2	1.7	0.4	0.8	0.4	0.7	3.2	0.4	0.6	0.6	0.4	0.4	0.3	0.4	0.5	0.4	0.7	0.4	0.4	0.4	0.4	0.4	0.8	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.1	0.4	0.4	0.6	0.9	0.4	0.4	0.6	0.4	0.3	0.4	0.5	0.5	0.7	0.4	12.0	0.4	0.4	0.4	0.4	1.4	0.4	0.4	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.5	0.8	0.6	0.9	0.4	2.1	0.2	0.9	3.5	3.2	1.0	0.7	0.8	0.3	0.6	0.4	0.8	2.2	1.1	1.4	0.7	2.0	0.3	1.4	0.3	1.4	0.5	1.0	0.7	3.4	2.9	1.8	0.4	1.2	1.1	0.7	0.1	1.2	0.2	0.2	2.6	0.6	0.0	2.2	2.1	0.5	0.4	1.8	0.4	1.4	1.2	0.2	0.1	0.8	0.7	0.3	0.5	0.0	0.8	1.6	0.6	0.1	4.0	1.1	0.4	0.0	0.5	0.8	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	3.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	1.4	1.3	0.8	0.5	10.3	0.0	0.0	0.0	1.2	3.5	3.9	0.2	0.0	0.2	44.0	0.7	0.4	0.0	0.3	0.3	0.7	1.6	0.0	0.9	0.5	19.1	1.2	0.0	1.0	5.6	0.6	1.1	0.0	0.0	0.1	3.9	0.2	0.0	0.4	0.0	3.8	0.0	0.3	6.9	26.2	0.9	0.2	3.2	0.6	1.2
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 58.7"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 46.7;Spermatocytes: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	1.9	2.1	3.6	1.9	5.9	6.8	2.1	6.8	3.4	2.6	2.9	1.6	2.2	2.2	2.8	3.5	1.3	2.0	3.1	1.8	2.3	1.9	1.5	3.1	3.1	3.4	1.5	1.6	3.3	1.6	1.3	2.0	1.3	2.0	2.3	2.0	2.0	2.3	3.2	1.9	3.4	3.6	6.4	2.2	3.5	1.8	58.7	1.3	1.3	2.5	1.3	2.8	2.2	11.0	1.8	1.5	3.0	0.4	0.1	2.2	0.5	4.3	4.6	4.3	4.0	3.5	5.1	4.3	2.0	2.0	2.3	1.5	3.5	3.9	3.7	0.9	1.6	3.2	7.4	2.1	1.7	2.7	2.3	3.9	3.1	6.0	2.7	2.2	4.3	1.9	3.5	2.9	4.2	6.2	2.2	1.0	5.2	3.7	4.4	1.6	0.9	1.4	4.8	4.3	1.2	3.4	2.2	1.8	2.8	2.4	2.5	2.3	4.4	1.3	4.2	3.1	3.4	2.2	4.6	1.9	2.3	2.5	5.1	2.9	10.7	8.4	5.7	2.2	4.8	2.7	0.0	0.4	3.0	1.3	0.0	1.4	0.3	1.3	0.5	0.6	1.8	1.9	2.2	1.3	0.1	0.3	1.5	1.3	0.5	3.6	5.9	6.8	3.4	2.3	1.9	1.5	1.6	2.0	1.3	0.0	4.3	3.0	1.1	0.8	9.3	3.6	0.0	4.0	5.7	0.0	3.9	0.3	0.0	0.2	8.7	2.2	2.0	46.7	0.3	0.2	1.1	1.8	1.1	4.9	0.7	9.5	0.0	3.1	1.5	9.6	0.9	1.2	0.0	1.0	1.7	5.6	0.3	1.5	1.1	0.3	9.1	0.0	1.2	17.5	1.7	3.3	0.6	0.5	1.7	1.6
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363789	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.2;MCF7: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.6	11.3	13.8	13.0	11.9	13.4	10.4	8.1	13.9	9.7	8.9	9.2	4.0	12.8	10.0	6.2	13.4	7.4	7.1	29.9	11.2	9.1	13.7	14.0	8.0	14.9	11.4	3.5	13.6	25.3	5.0	6.5	7.1	8.5	11.2	2.8	6.2	9.2	7.0	29.6	7.0	7.2	9.9	8.0	13.7	8.3	6.3	6.8	11.6	11.2	7.4	8.9	8.0	9.2	8.6	4.2	8.0	3.1	0.9	6.9	1.2	4.1	7.6	2.6	7.7	1.3	2.8	6.8	6.9	3.8	5.6	2.5	9.1	4.5	9.9	25.3	5.0	4.1	9.2	1.6	4.0	0.6	40.2	10.0	3.5	3.8	3.8	5.2	8.0	6.7	3.5	4.1	4.1	2.5	1.4	2.9	4.3	5.7	7.1	3.6	31.6	9.4	13.1	11.5	6.1	20.1	28.7	3.8	11.4	6.8	4.4	11.7	16.9	7.0	6.5	6.2	1.1	8.1	7.3	6.4	9.4	8.5	6.5	10.5	6.2	8.9	8.7	6.9	3.9	8.6	8.0	1.8	0.3	3.8	3.1	4.8	8.6	5.3	5.6	2.4	5.7	5.4	4.5	1.4	0.9	1.7	4.2	6.9	1.2	13.8	11.9	8.1	11.7	11.2	9.1	11.4	3.5	8.5	6.8	0.0	0.0	1.7	0.9	7.4	0.4	0.8	0.0	0.0	1.2	5.2	0.0	0.8	1.7	0.4	0.1	0.5	0.8	0.0	1.0	0.8	1.0	0.5	0.0	0.9	0.9	0.0	0.0	0.6	0.3	0.0	1.1	1.0	1.7	0.0	1.1	0.5	0.5	0.0	1.1	2.4	0.4	0.0	3.3	0.9	4.8	8.0	0.9	0.0	1.1	1.0
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229484	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 381.3;Proximal tubular cells: 791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		370000	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	17.4	25.5	24.1	16.2	27.5	10.1	8.4	7.0	18.7	11.9	39.3	15.0	10.2	53.1	12.3	13.2	19.3	19.5	18.5	12.0	17.3	16.7	48.7	34.7	10.0	14.8	17.2	14.0	13.7	38.8	17.2	9.3	7.3	13.4	13.1	9.7	16.9	22.4	11.8	40.8	10.7	51.0	10.4	10.4	18.8	22.2	5.4	10.8	14.6	14.2	19.2	19.3	12.2	8.9	44.1	36.2	0.9	46.7	7.5	52.6	19.5	32.0	23.5	3.6	15.2	2.6	8.1	11.4	7.8	2.8	5.3	7.0	9.6	11.7	23.1	12.4	2.6	0.2	16.4	2.8	6.2	1.5	12.3	55.9	10.8	21.5	27.2	6.2	9.1	7.1	5.1	7.9	1.6	4.8	2.1	6.9	16.9	24.6	41.0	4.2	53.1	8.7	22.9	7.3	93.7	14.3	14.8	4.9	58.5	9.1	11.0	14.2	17.1	7.2	19.1	15.7	1.2	26.3	30.5	8.6	4.0	7.0	9.1	15.3	28.7	13.1	18.0	2.5	12.3	6.3	0.1	23.3	0.9	9.2	46.7	16.7	44.1	30.4	16.2	36.2	38.2	27.2	18.3	0.8	7.5	33.2	27.4	52.6	19.5	24.1	27.5	7.0	18.7	17.3	16.7	17.2	14.0	13.4	10.8	26.8	33.9	82.4	72.2	54.5	10.6	78.7	186.0	178.0	37.5	109.9	2.0	50.2	381.3	174.9	0.5	25.1	264.9	0.0	92.9	48.7	52.6	77.9	34.5	174.5	265.7	6.4	62.2	33.2	57.1	2.2	62.2	60.3	104.6	40.5	164.0	37.3	143.5	157.8	56.3	791.8	15.3	0.0	47.4	5.4	42.8	64.4	27.0	27.7	262.6	70.6
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.3;Late spermatids: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 49.7;REH: 172.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	0.0	172.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell type enhanced"	"Detected in many"	11	"granulocytes: 34.8;Horizontal cells: 92.2;Kupffer cells: 46.3;Macrophages: 38.8;monocytes: 40.5;T-cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.6;HDLM-2: 21.5;TIME: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	8.9	2.8	0.0	3.7	7.9	0.0	19.0	15.5	9.1	6.8	0.0	0.0	0.2	0.0	12.0	31.6	0.2	0.0	0.0	7.3	21.5	0.0	0.2	1.9	0.0	0.1	1.8	0.9	1.8	0.2	13.2	5.2	3.6	9.0	2.9	0.0	17.9	15.3	0.8	3.2	2.5	1.1	0.0	2.1	4.3	4.1	2.6	0.4	0.0	0.1	2.3	0.0	0.0	1.9	0.5	0.6	8.2	20.1	9.9	2.4	4.7	6.4	0.0	0.0	0.0	14.0	12.2	4.2	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5	3.0	10.8	18.5	0.5	4.1	5.6	0.8	0.0	4.0	4.5	5.2	0.0	0.2	1.7	0.1	1.7	2.2	0.0	0.0	0.0	0.1	2.3	0.5	34.8	0.9	29.1	92.2	2.4	2.5	46.3	2.2	0.6	38.8	8.5	40.5	2.7	1.3	0.3	0.0	0.0	0.2	2.0	12.9	8.6	0.1	0.2	3.6	0.7	37.4	3.3	0.6
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	0.1	1.0	0.0	3.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	27.8	0.0	1.1	0.2	1.2	0.1	0.0	5.4	0.2	1.8	2.4	0.5	0.1	2.3	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4	0.0	1.0	0.0	3.2	0.0	0.2	11.9	0.0	1.4	4.5	5.2	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.0	0.0	0.1	0.0	5.8	0.0	0.0	4.8	0.9	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.4	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7
DOPEY1	"dJ202D23.2, KIAA1117"	ENSG00000083097	"Dopey family member 1"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	9.7	8.7	15.7	11.3	19.5	5.5	13.3	25.2	21.2	11.9	9.5	10.1	10.1	9.5	13.9	9.5	9.5	12.0	8.9	10.6	15.2	7.0	8.9	7.5	9.1	8.3	10.9	12.9	17.7	12.1	20.3	21.7	7.3	17.3	12.4	11.0	9.0	13.8	14.9	12.7	16.6	11.7	9.5	13.1	9.5	9.5	14.9	12.8	10.7	16.9	8.5	8.9	12.2	10.7	2.3	2.8	1.4	1.4	1.2	4.1	1.3	3.7	2.7	9.1	8.2	8.2	8.7	4.3	6.4	5.3	4.4	6.4	5.8	0.9	7.3	4.6	6.9	5.5	5.0	9.1	6.9	5.5	6.3	10.3	6.1	3.7	2.1	4.5	8.9	6.4	6.9	9.7	6.1	15.9	5.8	6.4	11.4	12.6	5.4	4.7	3.5	2.6	4.0	1.9	2.7	5.5	7.3	6.9	2.6	5.8	10.5	16.4	3.0	4.8	3.0	1.2	6.8	4.8	5.1	10.7	5.5	2.0	5.6	4.9	6.8	4.8	4.2	3.0	4.1	4.3	0.1	1.3	1.4	1.9	1.4	1.6	2.3	1.6	4.1	2.8	1.9	3.0	1.4	0.2	1.2	1.2	1.2	1.5	1.3	15.7	19.5	25.2	21.2	15.2	7.0	10.9	12.9	17.3	12.8	17.9	7.8	3.2	6.1	10.2	24.8	8.1	2.5	14.7	15.9	3.5	37.3	3.7	1.7	5.4	4.0	6.2	10.2	0.0	7.6	0.9	3.7	2.9	15.1	4.3	3.5	11.1	9.8	8.6	6.9	2.7	9.8	6.4	1.7	1.0	8.3	6.3	4.5	11.8	8.9	4.1	42.6	6.5	4.2	23.8	16.0	8.5	2.9	6.9	8.1	5.9
DOPEY2	"C21orf5, KIAA0933"	ENSG00000142197	"Dopey family member 2"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	4.6	2.3	5.5	7.5	9.5	17.1	4.9	28.7	11.6	5.1	11.8	3.8	6.8	9.7	2.8	3.3	13.5	3.6	6.5	4.3	4.6	4.0	3.5	7.2	7.2	5.8	3.1	5.8	2.3	3.8	43.1	3.1	4.7	9.5	9.8	12.0	2.8	15.2	9.1	11.1	7.4	13.9	3.8	3.7	5.2	15.8	3.3	3.3	9.3	3.6	7.5	10.6	5.4	6.5	12.0	6.4	6.3	3.2	1.1	3.1	1.3	14.9	3.2	2.4	4.0	2.7	5.2	23.2	7.1	8.5	10.1	6.3	2.2	1.2	2.8	1.1	5.3	7.7	3.1	4.6	1.6	8.2	5.1	4.2	6.4	0.7	0.8	2.4	6.2	3.3	1.8	3.3	6.6	1.7	6.1	4.2	6.7	2.0	4.6	2.9	16.8	4.9	6.4	2.0	17.7	3.3	8.9	1.4	13.6	5.4	6.0	6.5	3.7	4.7	21.5	6.1	3.4	7.8	7.7	7.2	3.9	1.1	5.1	5.7	3.4	8.4	1.3	5.6	13.5	2.2	1.0	3.2	6.3	3.1	3.1	1.7	8.6	2.0	1.8	2.1	12.0	1.3	1.1	5.5	1.1	2.6	6.4	1.5	1.3	5.5	9.5	28.7	11.6	4.6	4.0	3.1	5.8	9.5	3.3	0.0	5.8	31.4	6.9	2.7	5.3	4.0	10.2	6.7	3.4	8.7	3.9	1.5	3.3	8.1	0.7	3.3	17.3	0.0	2.8	9.8	2.8	21.2	8.1	8.5	15.7	0.0	28.2	6.2	15.4	0.0	2.3	12.0	5.0	7.2	56.5	1.5	7.5	24.6	2.8	1.3	3.0	0.0	2.5	4.4	13.0	4.5	6.8	7.5	19.5	10.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	26	"Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	20.3	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	3.0	2.6	14.9	0.0	0.5	3.3	0.3	0.0	0.0	1.2	22.7	0.0	0.1	48.0	0.3	10.3	0.1	4.2	0.0	171.7	0.3	4.5	0.0	1.1	0.0	0.5	0.0	8.5	1.8	0.0	29.1	268.4	1.7	5.0	1.8	1.9	0.0	43.8	11.5	1144.5	391.6	0.1	6.5	0.3	15.6	2.9	0.3	0.3	0.5	1.2	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 8.6;Club cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.1	16.1	4.4	10.7	13.8	10.1	12.2	12.1	18.2	20.6	13.4	15.4	7.5	17.9	15.7	35.8	7.9	7.3	14.8	13.6	11.2	4.6	33.9	4.1	7.6	9.2	13.1	5.2	6.8	15.1	13.9	16.5	13.4	14.7	9.3	10.4	14.0	7.4	8.1	12.1	9.1	3.4	4.1	11.2	16.5	10.6	3.1	13.9	9.2	5.7	8.3	9.7	10.9	12.5	12.1	4.3	18.1	4.3	6.4	14.4	6.6	17.7	10.9	7.3	5.0	4.4	14.2	7.1	5.0	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9	3.0	8.6	0.0	0.8	0.3	1.9	1.3	0.0	2.7	4.5	0.0	2.0	1.2	0.0	0.4	0.9	0.6	0.4	0.0	0.5	0.7	1.3	0.5	2.3	0.0	0.5	1.6	0.0	0.6	0.0	1.0	0.6	1.0	0.0	0.0	0.3	1.0	0.0	0.0	0.4	0.4	3.0	0.0	1.2	0.7	0.3	0.3	1.1	0.7	0.4	0.6
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257978-16264972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	17.6	13.9	15.7	10.6	14.8	8.0	21.3	10.7	15.0	12.6	15.3	8.9	8.2	12.4	13.2	13.0	12.6	11.5	12.1	15.4	14.2	17.3	17.9	27.4	12.5	10.0	19.3	6.9	15.8	9.1	7.6	19.3	17.3	18.6	11.0	10.4	5.6	7.2	13.6	33.2	5.4	32.8	17.3	17.4	15.3	12.0	13.2	12.6	12.8	14.4	10.1	9.0	15.3	12.8	7.3	11.3	25.6	15.6	7.2	10.6	8.7	5.3	7.9	16.9	10.4	31.3	22.9	13.5	15.6	12.5	14.7	17.2	9.7	3.3	5.1	5.2	19.1	12.8	3.3	15.5	9.9	17.7	25.7	10.6	8.5	6.3	10.8	19.7	12.6	8.5	15.8	13.2	20.0	8.7	9.4	13.4	9.3	14.6	8.8	20.8	7.0	9.4	8.2	13.6	8.4	8.2	6.7	11.1	7.9	13.1	4.3	3.7	10.8	7.2	3.6	17.7	14.6	6.9	12.4	15.6	12.7	7.9	22.3	12.9	6.9	22.8	6.8	18.2	14.2	10.9	15.3	12.0	17.8	8.6	15.6	10.6	7.3	9.2	10.4	11.3	6.6	7.8	9.1	25.6	7.2	14.4	4.5	8.1	8.7	15.7	14.8	10.7	15.0	14.2	17.3	19.3	6.9	18.6	12.6	17.9	19.0	32.8	34.6	45.8	11.4	33.0	25.5	25.4	27.3	15.7	11.8	40.7	34.9	45.9	86.0	30.1	55.8	23.3	49.9	63.0	35.9	36.4	50.8	35.8	86.6	6.4	17.1	26.4	41.7	53.8	19.0	47.4	27.0	82.0	20.7	14.9	53.2	34.5	14.9	37.6	13.9	12.9	28.0	54.9	41.1	45.8	67.6	32.4	15.6	45.1
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	5.7	4.3	2.6	1.6	5.2	2.1	2.4	5.2	4.5	5.6	2.6	1.4	3.1	0.7	7.8	3.4	1.3	3.7	2.4	12.9	1.8	2.4	6.0	0.3	1.1	0.8	1.7	3.1	7.3	2.3	7.4	10.9	1.2	3.0	5.7	1.2	5.1	2.3	6.3	0.5	1.4	0.9	4.3	0.7	1.1	1.5	44.0	0.9	0.5	8.4	1.4	0.7	2.7	3.1	0.1	0.0	0.1	0.0	0.1	3.4	0.4	1.2	3.1	2.8	6.6	0.7	0.0	0.3	2.1	2.2	2.9	3.8	0.4	1.0	3.4	2.2	0.9	3.6	0.5	3.3	0.3	4.4	1.7	2.0	5.4	1.4	2.0	0.6	3.9	1.7	1.5	0.1	1.4	0.0	7.4	0.8	2.6	2.2	3.4	4.7	2.1	0.2	1.6	2.5	0.5	2.5	0.1	2.3	0.0	5.6	0.5	8.5	0.9	0.8	0.3	1.2	1.2	2.4	1.1	0.6	4.0	5.2	0.6	5.4	9.1	10.4	0.0	4.3	1.9	3.6	0.1	0.0	0.0	0.6	0.0	3.4	0.0	0.1	0.6	0.0	0.1	1.0	2.7	0.0	0.1	0.0	0.0	0.0	0.4	2.6	5.2	5.2	4.5	1.8	2.4	1.7	3.1	3.0	0.9	3.0	0.0	0.0	2.9	0.5	41.9	24.2	2.5	16.0	6.8	12.2	13.7	1.1	5.0	0.4	300.2	2.3	0.0	0.0	0.0	1.1	1.0	3.0	2.3	0.0	0.3	3.2	0.0	0.0	0.0	304.6	6.6	0.0	6.8	0.0	0.0	11.1	0.2	0.0	8.1	5.6	6.2	25.8	15.6	171.9	4.1	0.4	1.1	0.0	0.0	0.9
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30, histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039812	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	20.3	41.8	38.2	22.6	34.8	14.6	34.2	30.1	36.0	30.5	25.8	19.4	28.9	23.1	25.6	44.3	31.8	49.7	23.8	23.9	35.4	44.2	42.1	44.7	23.6	24.6	40.4	33.1	24.5	25.8	21.4	39.4	23.4	38.6	32.0	25.6	17.6	34.7	35.1	24.5	26.2	24.6	26.8	41.4	19.8	24.2	13.4	31.0	22.1	49.1	26.9	25.3	26.4	25.4	57.8	35.2	50.6	37.2	34.4	67.7	43.5	52.4	36.3	27.5	21.1	24.1	36.1	36.8	27.3	24.4	22.2	21.9	52.1	42.6	32.4	28.0	24.0	40.8	21.4	25.0	31.6	24.2	37.9	40.2	29.1	26.5	58.4	21.3	29.5	18.2	24.3	36.9	23.8	21.1	30.0	34.9	14.7	34.0	23.1	33.7	57.0	33.1	59.7	37.9	48.6	37.9	27.1	32.4	40.7	38.6	36.2	44.4	31.8	27.1	38.2	36.5	33.9	26.6	21.7	26.8	20.3	32.9	18.8	32.9	27.3	40.3	42.5	21.4	32.2	24.7	46.0	37.2	50.6	36.3	34.0	43.8	57.8	51.0	44.4	35.2	46.1	45.8	43.0	41.4	34.4	37.0	32.1	67.7	43.5	38.2	34.8	30.1	36.0	35.4	44.2	40.4	33.1	38.6	31.0	47.6	52.8	71.9	90.2	87.0	17.3	55.3	81.5	258.3	58.0	97.7	0.0	169.8	240.4	92.4	31.9	66.8	75.0	46.7	102.0	216.8	70.6	105.2	46.1	76.7	107.9	20.6	88.4	52.8	65.3	11.4	67.0	75.2	62.4	109.2	92.2	30.6	113.3	105.2	82.7	223.0	23.2	84.1	62.8	57.6	58.2	107.1	116.0	69.0	110.7	99.5
DPYSL5	"CRAM, CRMP-5, CRMP5, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 47.1"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 80.5;Early spermatids: 30.8;Late spermatids: 97.8"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 41.9;HAP1: 34.9;SCLC-21H: 50.0;SH-SY5Y: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	1.2	4.7	6.1	1.6	18.4	1.1	1.1	7.8	36.6	1.4	1.6	43.5	0.0	1.7	1.2	1.1	1.3	1.2	1.1	1.1	10.3	11.3	1.2	1.1	1.1	1.1	24.3	8.8	1.1	1.1	1.1	2.8	1.2	21.9	1.3	1.5	1.6	1.1	1.1	1.2	1.2	1.7	1.6	47.1	1.1	1.1	10.3	19.7	0.0	1.1	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	41.9	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	1.1	0.0	34.9	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.0	29.6	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	18.4	7.8	11.8	10.3	11.3	24.3	8.8	21.9	19.7	0.0	0.0	0.0	0.3	0.0	9.2	5.3	0.0	0.0	0.0	0.0	80.5	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.0	0.1	7.9	0.0	0.0	0.0	97.8	1.4	0.2	1.7	0.0	0.0	15.6	0.0	0.0	1.1	0.0	12.4	0.0	0.0	3.2	2.3	0.3	0.0	0.0	0.0	0.1
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 68.5"	"Group enriched"	"Detected in some"	100	"Early spermatids: 369.6;Late spermatids: 442.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 15.6"									HPA020446			Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.5	0.5	0.5	0.5	0.5	1.3	0.8	1.0	0.5	0.5	0.5	0.5	0.5	0.1	1.3	9.7	0.5	0.6	0.5	0.5	0.5	0.3	1.2	0.5	0.5	0.7	0.5	0.5	1.3	0.9	8.3	0.8	0.5	0.5	0.7	0.2	0.5	0.5	0.6	0.5	1.3	0.6	0.5	0.5	0.8	0.4	68.5	0.5	0.5	1.0	0.5	0.5	0.5	0.5	0.0	0.0	0.4	0.6	0.0	1.0	0.0	0.7	0.9	2.2	0.6	2.7	0.6	2.0	0.0	0.0	0.1	0.1	15.6	0.6	1.0	0.1	0.6	0.5	1.5	3.0	0.1	0.4	0.2	1.5	0.5	1.2	0.7	1.0	0.4	2.4	1.2	1.3	0.5	0.0	0.9	0.4	0.4	1.2	0.3	0.2	0.8	0.3	0.7	0.2	0.7	0.8	1.6	0.1	0.0	0.4	1.7	1.0	0.7	0.0	1.3	1.1	0.5	0.3	0.1	0.4	0.0	2.8	2.5	0.2	1.0	1.4	0.1	2.6	0.6	0.2	0.0	0.3	0.0	1.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.5	0.3	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	369.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	442.6	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.3	0.0	0.0	0.0	4.1	1.5	0.0	0.1	0.0	0.0	0.0
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400497-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	15.7	16.8	18.4	17.7	32.1	12.2	16.1	33.7	33.7	17.4	16.3	19.1	12.2	15.9	22.3	25.8	16.0	18.2	14.1	15.2	16.6	15.1	15.3	11.7	13.9	17.8	13.6	16.4	26.7	17.8	23.9	38.9	17.0	18.9	17.2	19.2	23.7	17.5	19.2	23.6	16.0	17.5	16.9	19.4	16.8	16.0	12.8	16.4	25.6	21.9	13.4	19.8	18.2	16.2	4.7	6.4	3.3	4.8	4.8	6.4	3.1	12.4	15.7	17.4	23.6	9.3	11.4	25.1	16.5	8.1	15.4	11.5	16.5	16.2	14.0	19.0	12.1	17.9	10.9	21.4	12.5	17.2	13.1	15.1	17.2	51.6	11.9	8.4	19.2	51.4	8.9	8.8	17.2	8.3	11.8	13.1	15.0	21.8	6.6	13.4	12.4	18.5	14.4	16.4	10.1	12.6	16.8	33.3	10.1	8.7	14.2	9.1	12.0	41.9	17.2	10.1	16.2	15.8	11.1	11.4	14.9	17.3	13.3	15.6	12.1	19.8	15.4	10.3	21.7	14.2	1.8	2.4	3.3	5.2	2.6	5.5	4.2	5.4	6.0	5.2	4.7	6.4	4.4	0.8	4.8	4.8	6.4	5.1	3.1	18.4	32.1	33.7	33.7	16.6	15.1	13.6	16.4	18.9	16.4	11.9	14.7	3.0	4.6	3.2	18.2	21.0	7.6	20.1	15.9	5.2	0.0	6.6	3.3	7.2	2.5	6.2	7.3	0.0	7.0	6.4	7.4	5.0	9.2	5.1	6.7	6.4	10.9	9.2	7.8	4.3	10.0	3.2	1.7	9.0	10.1	10.5	7.8	8.6	12.4	4.2	16.8	6.5	4.7	5.8	8.4	3.0	4.1	5.7	10.0	5.1
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase-like"	Q8IZU8	18	67506582-67516980	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060942: AB_2684392"	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	10.2	3.4	8.8	3.2	15.5	1.6	9.4	7.9	12.8	10.9	4.5	15.7	2.5	2.2	5.7	4.0	3.1	7.1	8.3	5.1	8.6	8.4	9.0	7.1	6.0	1.9	13.2	4.5	7.6	3.6	3.6	1.3	11.5	9.7	4.8	3.5	2.4	2.3	4.9	1.9	3.2	2.7	7.4	11.1	4.5	3.1	3.4	10.9	0.0	2.8	1.1	1.6	3.6	8.4	0.2	0.1	0.6	0.1	0.3	3.2	0.3	0.0	0.0	2.4	0.0	4.7	7.0	0.3	19.9	11.5	5.1	2.2	0.0	0.0	0.0	0.0	10.1	1.3	0.1	0.4	0.9	4.9	0.0	0.0	0.0	2.2	0.0	4.0	0.0	0.0	7.0	1.3	3.1	7.4	1.9	1.0	0.0	0.0	0.2	24.9	0.0	0.0	0.0	0.3	0.0	2.1	0.2	5.3	0.0	2.3	0.0	0.9	1.1	1.8	0.0	0.0	1.1	0.0	0.0	1.7	25.9	0.8	1.8	2.2	0.1	0.0	0.0	5.4	0.0	2.2	0.6	0.1	0.2	0.2	0.0	1.7	0.1	0.8	1.2	0.0	0.2	0.5	3.2	0.5	0.3	0.1	0.1	0.2	0.3	8.8	15.5	7.9	9.9	8.6	8.4	13.2	4.5	9.7	10.9	6.0	14.4	2.0	8.0	10.3	9.4	14.3	43.3	0.0	2.3	10.4	3.9	2.4	0.0	7.9	1.1	11.3	0.5	0.0	2.0	69.4	40.8	6.6	4.6	12.9	2.2	3.2	6.3	16.0	2.1	1.4	22.7	2.9	6.8	0.0	0.1	14.3	5.4	0.0	34.6	18.8	4.2	12.9	12.3	13.1	11.7	11.5	7.4	2.5	0.6	5.4
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 28.3;CAPAN-2: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.9	28.3	4.2	6.2	2.4	2.3	9.1	2.8	2.4	3.1	4.3	7.9	46.8	4.0	2.0	2.8	16.4	9.7	2.2	13.4	1.9	9.0	4.8	2.3	5.8	6.9	3.2	3.3	5.8	4.2	8.2	8.0	4.3	2.4	2.3	7.2	7.0	6.1	3.7	6.3	5.1	11.6	6.1	9.8	4.3	5.6	3.9	7.2	1.4	10.1	1.7	3.5	4.5	7.8	3.8	3.9	7.8	8.9	2.4	17.5	8.4	5.9	11.2	4.6	5.4	4.6	3.8	3.6	9.0	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4											6.0	5.3	7.3	17.3	30.1	2.6	1.7	5.1	29.4	18.2	7.0	7.9	16.0	3.3	16.6	13.7	4.7	27.5	0.0	9.5	11.1	6.0	16.5	3.5	3.2	18.8	3.2	8.7	9.2	11.1	6.7	5.2	11.6	6.8	9.0	26.8	5.0	19.5	35.3	4.6	2.9	8.7	6.5	4.1	9.2	10.1	30.9	31.5	8.3	21.7	51.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.1	3.4	1.0	2.9	4.6	10.6	3.8	2.9	10.7	34.2	42.4	3.3	11.4	1.2	5.7	4.7	32.9	11.2	3.4	4.6	7.5	9.4	1.3	9.7	2.6	3.5	9.0	4.9	7.6	9.1	5.5	5.1	2.9	6.5	6.4	6.2	1.2	6.9	2.5	3.4	12.0	3.5	0.6	3.4	6.3	13.4	7.8	2.1	8.7	7.2	1.4	1.5	6.0	2.7	21.6	0.7	3.1	6.3	7.9	3.9	5.5	0.3	3.7	2.5	1.4	5.9	6.8	6.5	4.0	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9	29.8	25.5	10.7	7.5	7.9	0.2	4.4	20.4	16.0	15.9	7.0	0.0	3.1	0.0	21.6	1.5	16.6	25.5	0.0	27.9	13.8	9.6	16.0	15.1	50.5	24.2	0.0	17.7	24.5	34.9	0.6	7.8	19.5	5.0	20.8	21.5	5.0	28.4	11.5	8.5	11.1	0.2	32.3	6.6	0.9	0.7	5.3	1.5	13.4	16.9	18.6
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791238	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	9.1	9.4	7.4	11.4	9.4	25.4	9.5	7.1	13.2	8.9	12.4	13.7	8.7	16.6	13.1	7.7	12.3	11.1	11.1	7.8	6.0	5.0	9.9	17.5	7.9	12.6	8.3	6.7	11.8	17.6	4.7	8.6	11.1	7.8	11.8	4.6	12.4	12.4	10.1	14.3	17.5	14.4	7.6	7.5	12.5	12.3	42.5	8.1	15.6	11.7	10.3	11.1	8.8	9.7	13.5	19.2	4.3	18.6	15.8	16.6	9.9	11.0	10.9	3.2	11.0	0.9	1.4	10.3	3.7	2.1	3.9	2.9	16.9	5.1	11.2	14.0	1.5	4.4	7.1	2.6	3.6	0.6	8.2	24.9	7.3	5.6	6.3	5.5	16.4	21.6	3.4	3.8	4.3	3.1	0.5	2.6	7.4	19.6	0.0	2.0	14.3	13.7	16.7	11.2	4.0	29.5	7.1	6.5	13.7	1.6	7.9	10.9	11.0	3.8	6.4	7.2	0.7	4.5	13.4	3.4	5.5	9.7	16.3	15.7	32.2	23.7	10.7	5.3	17.0	6.2	4.3	13.2	3.4	14.8	18.6	16.6	10.2	11.0	13.5	18.7	13.5	15.1	14.4	1.5	15.8	14.4	19.2	12.5	9.9	7.4	9.4	7.1	13.2	6.0	5.0	8.3	6.7	7.8	8.1	8.9	10.6	15.2	16.4	13.1	6.5	2.6	5.1	5.3	6.8	1.8	11.8	16.8	6.6	8.9	27.8	8.0	10.1	0.0	19.1	14.3	10.1	6.1	35.7	6.8	13.3	11.1	7.5	3.7	5.6	6.6	11.8	9.4	5.0	3.6	9.4	4.5	10.0	6.6	6.0	5.6	10.1	19.4	10.8	36.1	10.8	11.2	18.2	10.0	13.6	13.2
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.2	6.2	10.9	12.7	0.9	1.9	0.1	0.7	5.9	0.1	1.4	0.1	4.8	18.3	0.1	0.6	0.0	1.1	2.0	0.8	0.4	1.3	4.8	2.9	3.8	2.0	0.6	0.2	0.2	0.4	0.0	8.0	0.3	0.8	0.2	0.2	0.0	0.0	0.7	0.5	0.2	2.7	0.7	1.3	0.1	0.4	0.7	1.2	3.2	0.6	1.0	0.8	8.7	2.0	0.1	4.1	0.0	0.2	0.1	0.0	0.0	10.5	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5											6.0	4.8	5.9	152.9	159.6	6.2	14.2	5.1	52.2	26.1	7.0	7.9	141.3	24.9	33.6	35.0	22.7	0.0	0.0	13.2	71.8	47.7	52.8	87.4	10.2	17.0	14.3	2.4	14.7	2.8	40.7	12.7	10.4	59.1	43.3	1.0	9.0	46.1	1.1	5.6	11.8	18.7	0.0	52.6	28.9	29.2	80.9	56.8	6.4	0.8	72.6
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 136.7;T-cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.3	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.6	2.1	0.0	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	14.2	0.0	17.5	0.1	2.6	12.5	14.5	3.4	0.4	5.4	0.0	0.2	12.1	0.1	17.4	15.5	0.8	0.7	0.2	2.8	0.0	1.0	7.2	0.0	0.0	4.1	0.0	0.9	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7	0.0	10.6	47.7	90.1	86.0	22.1	33.5	2.5	0.0	1.2	8.7	21.6	0.8	1.7	0.9	0.7	8.2	3.3	0.0	1.2	1.1	24.2	63.5	105.8	2.8	75.6	0.0	84.2	8.6	27.5	0.7	1.7	90.7	136.7	0.0	12.3	1.3	0.9	2.9	1.8	1.0	2.5	0.0	35.3	0.5	4.3	95.9	1.4	346.4	21.8	28.5
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.5	19.2	7.4	7.9	21.6	11.6	6.3	8.0	19.2	18.8	22.8	18.4	7.1	1.6	12.7	15.0	39.0	9.2	11.4	9.8	19.9	3.6	8.7	5.3	8.8	15.0	26.4	0.6	5.6	10.7	17.8	14.5	12.6	20.6	13.1	5.4	4.8	1.8	21.9	7.6	2.7	2.7	3.4	15.1	14.0	3.4	22.3	4.0	26.1	11.2	4.1	7.5	9.4	6.3	23.6	21.3	28.1	14.9	13.6	21.3	14.5	30.2	13.2	9.8	13.0	0.4	25.3	7.5	7.1	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8	23.8	16.8	7.2	42.9	19.9	16.3	242.3	48.4	14.7	9.1	40.1	23.6	14.4	34.9	42.9	73.8	32.1	42.0	0.0	50.5	17.5	18.4	41.2	38.1	99.4	73.0	19.1	34.9	27.6	34.5	128.1	13.6	40.3	10.1	32.5	17.6	14.8	50.2	28.1	24.8	69.4	16.6	32.3	35.5	2.4	2.9	25.2	37.6	6.4	14.6	32.8
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225341-7234545	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	14.6	16.7	16.9	11.0	24.6	12.5	14.2	22.3	16.2	20.2	15.7	20.0	12.3	12.6	24.3	12.3	22.6	18.0	15.3	12.8	14.5	8.2	13.2	7.8	12.2	14.8	16.7	12.3	30.6	12.7	15.7	26.3	14.9	12.5	18.9	8.6	18.9	14.4	19.3	11.9	21.2	12.9	18.2	10.9	12.7	11.4	14.5	17.0	24.6	16.1	9.5	16.3	16.7	19.7	11.7	7.8	11.6	5.4	7.2	12.1	6.9	13.1	19.2	23.1	23.0	17.7	16.0	10.0	9.2	16.8	22.3	28.6	16.3	11.2	18.8	14.0	10.2	17.4	19.0	19.1	12.4	8.5	18.5	22.0	12.2	20.4	17.1	31.1	6.8	10.6	24.0	21.4	21.1	11.5	15.6	9.2	22.0	10.3	8.9	13.3	12.3	25.9	6.8	7.9	8.8	7.4	38.2	15.0	11.4	12.2	11.7	10.2	20.8	16.7	8.4	20.1	11.0	12.1	9.5	7.6	12.6	11.4	23.5	17.0	13.9	11.6	8.6	14.7	10.3	19.5	11.6	4.7	10.7	12.1	5.4	10.1	10.4	8.3	10.7	5.6	11.7	9.9	10.1	2.1	7.2	5.1	7.8	5.0	6.9	16.9	24.6	22.3	16.2	14.5	8.2	16.7	12.3	12.5	17.0	8.9	8.9	5.7	20.2	15.5	14.9	5.6	7.6	5.3	9.1	17.4	23.6	17.9	5.0	9.3	0.7	9.0	9.3	0.0	9.0	13.9	17.8	13.7	14.9	4.3	12.2	9.5	12.7	7.4	8.2	1.5	24.2	7.4	10.1	12.6	13.0	12.8	6.9	10.5	20.8	4.2	30.2	12.9	11.3	18.9	30.6	16.8	30.6	10.0	20.8	12.0
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 145.5;Late spermatids: 469.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.4	5.9	4.8	4.5	0.7	2.7	1.7	2.5	2.3	0.8	3.3	1.3	10.6	3.2	0.1	2.9	1.2	1.9	2.2	4.9	7.3	0.6	5.4	0.8	4.0	0.3	1.8	6.1	1.2	0.8	2.8	8.2	0.6	3.3	1.4	1.9	0.4	4.3	1.9	0.8	2.0	2.5	2.0	0.9	0.1	0.6	5.4	2.1	12.2	13.8	4.2	4.2	0.2	4.7	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6	0.0	1.1	13.7	3.6	3.1	14.9	5.3	5.1	1.4	0.0	15.7	19.6	1.8	8.3	11.7	145.5	5.7	9.1	0.0	3.7	1.5	4.0	5.4	1.1	3.0	4.9	9.5	19.5	6.2	9.2	469.8	6.6	2.7	5.0	3.6	9.4	8.1	8.6	8.6	4.9	11.2	13.0	0.0	2.3	22.4	14.0	2.5	1.1	6.9	8.5	3.2
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 72.1;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.8	7.8	11.7	8.4	5.9	8.1	9.4	14.1	9.2	6.9	3.9	10.3	7.7	25.8	17.4	20.3	4.2	16.1	9.3	5.5	7.4	11.1	12.2	4.1	5.2	3.9	2.3	9.4	9.1	6.6	7.9	18.6	14.9	11.7	3.8	11.0	5.1	13.5	8.8	7.9	8.0	4.6	10.1	9.0	12.6	21.5	11.6	11.4	8.0	17.4	15.5	18.3	5.9	7.9	8.1	8.3	5.4	7.9	5.7	11.0	10.4	7.5	11.1	6.5	1.0	14.3	10.5	6.4	11.3	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9	8.9	12.2	6.4	9.1	10.1	17.2	33.5	22.9	12.0	10.3	1.8	21.6	2.7	0.0	17.2	0.4	10.5	72.1	0.0	15.8	6.4	18.2	11.3	5.7	4.7	14.1	76.3	23.6	6.2	11.6	1.6	10.6	9.8	8.5	6.4	50.5	15.3	15.6	48.2	12.4	7.5	21.9	12.9	21.1	2.5	8.7	14.2	3.8	21.0	26.7	28.1
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in many"	5	"Spermatogonia: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	16.0	15.6	18.1	14.1	1.8	1.3	13.8	15.4	7.5	19.7	16.6	27.6	16.6	29.6	15.6	6.9	23.9	12.1	8.8	8.2	8.8	8.9	12.6	24.2	23.2	16.0	0.1	11.3	15.3	1.0	0.5	10.8	1.9	2.0	5.0	18.6	6.4	20.9	12.1	14.2	24.0	24.0	5.4	16.2	22.5	23.9	49.4	12.2	3.3	9.8	27.1	19.1	18.8	13.1	7.6	5.4	16.4	14.3	2.7	23.0	13.5	15.9	21.8	20.5	13.8	24.4	19.2	6.7	13.6	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0	0.0	0.6	2.9	0.7	2.6	2.2	0.4	0.0	0.0	2.3	0.0	0.0	2.6	0.0	0.9	0.7	0.1	0.5	0.0	0.2	7.9	1.1	0.6	0.0	0.8	3.8	0.0	0.0	0.6	0.0	2.3	2.0	0.9	1.7	0.0	2.9	1.2	0.5	0.0	1.1	0.0	2.0	0.0	0.9	3.8	37.5	1.5	1.5	0.7	4.6	0.9
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.2	16.8	7.9	12.7	5.5	7.9	9.6	9.2	7.0	11.4	9.5	12.2	8.4	11.5	9.5	8.5	7.1	9.3	29.7	16.9	10.9	4.6	14.4	6.7	10.3	20.6	8.9	7.4	8.4	8.5	10.1	10.2	14.4	8.6	5.1	11.6	20.7	6.1	8.1	17.5	7.3	5.3	20.8	11.8	5.9	13.2	9.1	22.1	14.4	7.2	14.1	10.4	7.2	13.6	7.3	13.3	18.4	8.3	4.0	9.0	8.0	9.9	11.6	11.2	10.6	9.3	9.1	10.3	13.3	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4	8.9	5.1	3.0	3.5	1.9	3.8	9.8	2.5	6.7	2.3	3.5	2.0	12.9	5.0	6.5	2.1	3.5	1.3	23.3	3.1	9.9	3.3	3.5	5.7	10.5	6.3	7.9	5.2	4.3	1.8	1.9	2.3	3.1	5.0	6.4	5.5	2.8	4.1	0.0	1.8	6.8	3.7	0.0	1.9	4.3	10.4	2.6	9.5	2.5	5.5	2.7
EBF1	"EBF, OLF1"	ENSG00000164330	"Early B cell factor 1"	Q9UH73	5	158695916-159099761	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Leydig cells: 264.3;Peritubular cells: 114.2;Sertoli cells: 97.0;Smooth muscle cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 23.6"	"Group enriched"	"Detected in some"	62	"memory B-cell: 11.8;naive B-cell: 10.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 11.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.4;HSkMC: 15.1;REH: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (7.86e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (9.62e-7)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (5.75e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.37e-3)"	33.7	3.3	1.9	9.7	2.5	3.1	25.0	23.6	2.0	15.9	5.8	1.1	9.0	1.2	19.7	13.0	5.0	8.5	9.4	15.5	2.0	2.4	3.3	0.9	5.2	12.7	3.2	1.2	7.4	3.7	1.8	2.6	10.7	4.7	8.5	3.4	10.4	4.7	10.8	15.5	4.8	4.5	25.7	6.6	5.4	3.4	8.4	1.0	0.1	6.8	13.2	9.1	11.7	12.5	11.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	6.2	0.0	19.4	8.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	5.6	0.0	2.3	1.2	0.0	0.2	0.0	0.1	1.3	0.0	0.0	1.6	0.0	0.3	0.0	0.0	15.1	0.0	6.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	40.6	0.2	0.0	0.0	0.0	3.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.8	8.5	0.1	0.0	0.0	5.6	4.9	0.4	6.7	0.1	0.0	0.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	2.5	23.6	1.6	2.0	2.4	3.2	1.2	4.7	1.0	0.0	0.3	44.7	0.4	10.9	4.1	4.3	0.0	1.4	1.2	1.8	0.0	0.1	0.0	2.4	15.8	55.5	0.0	0.0	0.0	0.3	40.4	0.6	0.0	1.0	0.7	0.0	0.0	2.5	0.8	15.5	264.3	1.0	13.5	16.2	0.0	1.7	0.2	0.0	114.2	0.0	2.0	97.0	110.4	2.2	0.4	6.0	0.3	1.3	0.0	0.5
EBF2	"COE2, FLJ11500"	ENSG00000221818	"Early B cell factor 2"	Q9HAK2	8	25841730-26045397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.8"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9"	"Low region specificity"	"Detected in some"			"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3.0	4.2	0.0	2.9	0.2	3.0	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0.0	3.9	4.0	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1.0	5.4	10.1	0.2	1.2	4.2	0.0	0.4	7.4	11.6	0.5	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.5	25.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	14.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.1	12.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0.0	2.8	0.0	0.0	0.3	0.0	0.1	0.1	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.2	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	38.8	9.5	0.2	0.2	0.3	0.0	0.0	0.0	0.0
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	10.1	7.8	0.1	0.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	11.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	18.9	0.1	0.0	23.8	0.1	0.0	0.0	0.3	10.3	0.0	0.0	0.1	24.4	0.3	0.0	0.0	0.0	0.2	0.0	10.0	0.0	0.0	1.2	6.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1	0.0	0.0	0.0	0.0	1.6	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.0	11.8	0.0	0.9	0.6	0.0	0.0	0.0	0.0
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.2	1.2	0.0	2.1	0.0	15.3	2.6	0.5	0.3	2.4	1.5			1.0	2.6	2.5	1.8	3.1	1.1	2.1	0.1	0.0	0.8	1.8	3.1	1.7	0.1		5.1	2.6	1.2	1.2	1.9		1.6	2.4		3.1	0.5	1.3	2.2	2.1	1.4	1.0	2.1	1.8	0.9			2.4		1.5	2.4	2.9	2.6	2.2	6.3	1.5	1.1	3.8	0.2	1.3	0.9	5.3	4.7	1.4	3.0	4.0	2.1	0.4	1.3	1.0	2.6	4.3	3.3	0.8	2.8	1.3	1.8	2.0	2.2	2.7	1.3	1.2	2.2	5.0	2.3	0.8	4.2	4.9	2.9	1.6	2.7	2.6	2.6	1.8	2.9	1.6	5.1	1.5	2.8	2.0	5.9	3.3	1.1	1.4	5.3	1.3	2.0	1.4	5.5	1.2	2.6	1.3	2.3	0.7	3.9	3.5	1.6	3.4	1.5	2.9	4.0	3.2	5.1	2.4	2.6	1.5	4.6	2.6	0.3	1.5	6.3	3.6	0.5	3.0	1.5	3.2	3.1	0.5	2.6	2.7	3.8	3.3	1.1	0.6	2.2	3.7	0.2											0.0	2.1	5.0	11.6	5.0	4.7	0.8	15.3	2.7	2.3	3.5	7.9	7.1	0.0	3.1	1.5	4.5	4.5	23.3	1.4	5.4	6.2	7.7	1.1	4.4	2.5	3.2	4.1	7.4	3.3	0.2	7.8	3.9	1.7	1.8	3.3	2.8	3.5	3.5	3.5	0.1	5.0	6.5	3.1	3.7	4.8	5.5	12.2	7.5	3.3	11.2
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	23.2	22.3	22.2	22.4	23.8	34.8	23.2	34.7	27.0	20.4	18.6	21.8	20.0	15.6	23.7	20.9	21.2	17.0	20.6	18.8	17.9	16.9	22.4	23.6	17.7	21.4	23.4	16.7	24.1	21.1	32.5	32.1	23.4	25.5	21.8	18.1	16.7	21.4	21.3	19.9	23.3	16.8	19.9	19.4	20.5	18.5	25.4	23.1	32.7	24.2	18.7	22.4	22.1	20.7	20.4	16.8	23.3	26.3	25.4	27.2	15.7	18.9	13.7	15.6	23.6	14.3	14.2	12.8	14.8	23.3	24.2	28.4	24.8	20.0	14.9	14.6	14.5	18.1	15.9	16.6	17.6	24.9	12.1	16.2	18.8	11.2	17.7	21.7	22.4	12.6	15.9	14.7	20.3	25.6	18.7	25.8	13.6	19.4	10.5	22.8	16.0	20.1	12.4	15.9	17.7	39.7	14.9	17.3	8.1	19.4	14.1	6.9	12.9	13.4	30.5	19.0	16.8	17.5	10.8	15.8	10.6	21.4	11.3	17.0	12.2	8.2	25.4	19.7	18.8	9.0	15.0	19.3	20.9	21.8	20.5	23.2	20.4	20.6	21.4	16.8	18.6	27.2	19.4	23.3	25.4	26.3	11.5	19.7	15.7	22.2	23.8	34.7	27.0	17.9	16.9	23.4	16.7	25.5	23.1	26.8	8.9	6.1	23.3	9.7	13.9	10.5	10.2	6.7	23.9	7.0	23.6	20.2	6.6	13.1	32.2	15.5	8.9	23.3	10.7	12.7	11.4	10.9	18.5	8.1	14.5	19.1	10.4	18.4	16.5	7.8	14.7	9.4	13.5	8.2	9.7	9.9	12.3	3.5	12.4	10.3	12.4	6.5	12.7	27.0	12.6	9.5	27.8	13.1	7.3	23.3
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.2	0.6	2.3	0.0	14.0	77.4	2.1	22.7	53.9	14.2	18.6	0.3	3.5	0.1	0.2	50.8	1.6	13.1	0.0	2.7	14.9	0.1	0.1	0.9	0.8	0.1	3.9	0.0	23.5	6.8	0.1	36.5	1.3	20.9	3.9	0.1	4.8	0.1	39.5	0.0	0.0	0.7	0.2	26.5	0.7	0.3	17.0	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.4	1.1	0.0	6.0	1.0	30.1	4.5	3.4	4.9	0.1	0.2	0.2	15.8	2.1	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0	0.0	0.6	1.4	1.8	13.1	0.7	1.1	12.7	0.0	2.3	3.5	0.0	1.3	0.0	4.8	0.2	4.4	0.2	0.0	3.7	26.0	80.6	1.0	10.3	0.6	16.0	1.6	0.0	56.4	2.1	0.0	9.2	4.8	70.9	0.0	0.3	0.8	42.0	0.0	20.8	0.0	1.1	12.9	16.1	0.5	0.4	16.7	9.2	0.0	0.2	5.8
ECSIT	SITPEC	ENSG00000130159	"ECSIT signalling integrator"	Q9BQ95	19	11505916-11529174	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	15.3	16.8	13.8	10.7	15.5	12.9	12.8	20.0	24.5	13.5	21.0	9.5	11.1	24.2	13.1	6.8	19.7	16.2	13.8	49.5	12.9	11.6	15.6	27.7	8.4	9.9	13.5	10.8	27.2	28.5	14.7	10.5	6.4	12.5	16.3	12.0	13.2	26.8	11.0	64.2	11.8	17.9	12.9	9.1	10.1	18.4	8.2	11.9	13.8	21.4	29.5	12.7	14.1	14.2	21.4	22.3	6.2	20.9	13.1	18.6	15.2	15.0	13.6	8.2	12.1	12.8	14.6	9.2	8.0	11.0	17.5	14.3	20.3	10.5	22.5	17.3	10.5	14.9	20.4	20.9	17.1	6.2	12.9	17.1	21.0	8.8	18.4	12.5	12.0	17.6	15.3	18.8	14.3	16.0	9.1	12.9	21.1	22.7	23.5	6.5	20.8	20.9	17.9	22.4	19.7	36.6	20.9	8.8	30.0	9.5	9.7	31.7	20.0	9.6	16.2	16.2	3.9	18.4	18.2	6.6	18.4	12.8	26.0	15.0	21.0	40.5	11.2	15.3	18.0	13.1	2.1	17.2	6.2	15.2	20.9	17.3	21.4	16.5	14.1	22.3	20.3	18.6	16.9	3.5	13.1	18.6	12.6	18.1	15.2	13.8	15.5	20.0	24.5	12.9	11.6	13.5	10.8	12.5	11.9	8.9	14.9	23.9	52.4	39.5	21.3	69.0	38.2	17.4	17.0	19.2	11.8	33.5	69.6	33.6	15.8	25.3	48.3	0.0	67.2	36.4	26.8	37.2	23.0	46.1	27.4	17.5	35.8	20.9	28.3	43.1	31.9	21.0	27.0	10.0	44.9	20.5	38.7	23.0	30.1	82.0	26.1	32.3	45.3	14.1	40.7	36.6	21.1	21.3	78.1	50.6
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.2	33.0	26.1	13.5	2.7	5.6	13.0	20.5	16.8	30.8	30.0	18.3	49.1	11.5	31.2	12.0	29.5	20.4	21.0	13.1	42.1	16.4	11.6	7.2	18.1	9.3	1.2	11.1	8.3	1.8	2.2	18.3	18.7	8.7	13.2	17.1	7.4	16.9	24.3	16.3	11.3	8.3	21.2	38.3	18.0	8.1	25.6	14.8	23.4	10.8	17.4	11.2	25.9	29.5	10.4	13.7	49.1	8.3	11.4	15.0	14.4	20.1	42.6	8.3	11.1	21.7	13.2	9.7	19.5	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8	6.0	2.7	9.0	4.3	17.3	3.4	3.1	7.6	10.7	4.5	3.5	60.9	4.9	0.0	9.0	2.7	6.4	3.2	70.0	7.9	13.0	7.0	8.8	0.0	1.5	6.1	0.0	4.6	5.5	3.1	2.3	0.9	5.1	6.8	1.8	10.8	2.9	14.3	3.5	1.4	1.9	13.4	0.0	3.3	33.1	37.4	11.2	3.2	1.5	6.2	7.8
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 37.6;RT4: 30.4"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.8	0.1	0.0	0.0	0.0	7.7	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	2.0	4.2	3.0	4.5	0.7	6.0	3.6	0.0	0.0	0.6	0.0	0.1	37.6	0.0	1.3	0.5	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.3	0.1	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	30.4	0.2	0.1	0.0	0.6	0.1	0.2	7.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2	0.0	2.2	0.8	6.8	6.2	0.0	2.8	5.1	1.4	6.8	0.0	0.0	22.7	3.3	1.2	4.8	1.8	0.0	0.0	0.8	12.0	2.0	3.1	20.9	0.0	3.1	0.0	0.0	4.3	2.7	5.8	0.3	0.7	11.8	6.4	0.0	0.4	1.0	0.0	0.4	0.2	0.0	0.0	1.7	3.1	3.4	4.5	18.9	5.0	0.0	5.8
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873023-67884503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 28.5;Ciliated cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	11.3	12.6	14.4	13.2	20.2	25.2	12.1	33.3	27.0	11.9	18.5	17.5	11.2	16.5	15.5	13.0	14.3	15.4	15.2	11.9	12.8	11.9	12.8	10.8	12.9	18.0	14.4	15.2	19.7	18.6	23.6	18.4	13.1	15.6	13.2	14.3	15.0	13.4	13.4	22.0	19.1	15.0	13.5	10.7	15.4	15.8	18.1	15.1	25.6	12.9	6.8	19.2	15.9	11.4	6.2	6.6	4.4	11.0	9.1	12.2	6.4	9.5	13.4	9.2	8.3	8.7	6.4	18.3	8.8	7.3	17.8	14.4	21.7	9.0	15.7	9.7	12.0	7.6	13.3	18.3	6.9	9.4	6.0	23.2	11.2	8.4	11.5	10.3	13.3	12.5	8.7	9.6	18.0	8.6	10.7	13.5	11.6	19.4	2.8	10.6	14.4	17.4	34.5	9.1	6.4	7.7	26.6	11.2	16.8	7.0	7.0	16.0	8.6	23.3	6.5	6.4	7.9	12.0	18.4	8.9	7.3	10.5	6.8	11.7	15.0	8.7	38.3	5.6	16.3	6.7	0.7	5.9	4.4	10.2	7.0	9.5	6.2	9.0	9.8	6.6	5.4	9.0	6.4	2.9	9.1	11.0	4.8	12.2	6.4	14.4	20.2	33.3	27.0	12.8	11.9	14.4	15.2	15.6	15.1	20.8	28.5	0.0	0.1	0.0	1.3	1.6	0.0	8.1	5.7	0.0	3.9	0.1	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.1	3.5	0.0	0.3	0.0	1.2	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.0	1.2	6.5	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.1
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866286	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		140000	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	49.5	68.5	77.7	58.3	67.3	55.6	71.0	68.2	75.2	51.6	68.7	35.1	75.3	106.6	55.0	60.9	68.4	57.3	66.7	83.2	66.5	61.8	65.4	107.5	47.2	75.3	64.9	64.2	72.1	273.4	44.5	64.4	47.7	62.3	64.1	46.5	38.2	123.3	96.5	175.4	69.4	102.3	64.3	71.9	48.8	61.9	49.5	44.8	43.6	64.5	75.1	51.5	51.9	57.7	78.2	116.5	58.0	70.5	68.6	83.6	85.4	63.7	85.8	47.8	48.5	47.7	50.3	94.1	73.7	49.9	59.8	46.7	69.4	44.7	56.1	68.7	64.1	53.3	77.2	37.2	56.4	22.0	60.6	45.3	39.0	108.0	94.3	94.9	66.4	53.4	49.7	72.6	46.8	54.6	55.8	57.4	50.9	56.4	72.7	51.1	139.7	59.2	105.8	50.4	99.2	73.6	52.1	69.8	113.2	79.3	68.2	61.3	58.9	76.9	108.4	74.5	33.0	104.7	93.4	69.5	65.4	49.4	70.7	68.5	42.0	70.1	47.2	85.4	40.0	59.8	45.7	70.5	58.0	69.9	59.9	77.2	78.2	74.8	72.1	70.8	71.9	66.9	68.8	28.2	68.6	48.9	116.5	83.6	85.4	77.7	67.3	68.2	75.2	66.5	61.8	64.9	64.2	62.3	44.8	211.4	257.9	360.4	480.4	463.8	134.8	270.5	479.0	235.5	258.2	298.4	37.3	561.0	978.2	614.3	98.1	432.9	1611.3	163.5	1109.8	593.2	450.9	513.8	287.2	695.8	501.5	89.0	425.8	343.1	356.1	224.5	538.4	426.7	499.4	906.3	749.8	223.0	954.5	1406.3	401.0	993.5	116.5	271.7	418.6	236.6	258.3	542.3	942.8	422.7	608.2	611.5
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	O60344	3	184249650-184259585	"Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.5"	"Group enriched"	"Detected in some"	4	"Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		2.1	1.7	0.2	3.3	0.8	1.8	1.9	0.3	0.5	1.3	4.2	0.0	2.5	2.5	0.6	0.5	4.1	0.4	1.4	2.4	0.4		4.2	29.5	2.3	2.5	0.2	0.0	1.7	8.3	1.0	3.1	8.4	0.8	1.6	2.3	0.8	5.7	2.7	5.4	2.4	4.3	1.1	0.1	3.7	1.6	13.0	0.6	4.8	6.9	4.5	3.7	1.3	1.6	4.9	10.1	1.2	12.0	3.4	7.6	5.6	13.1	6.9	1.6	4.4	2.4	1.6	10.1	1.5	2.9	2.3	2.2	12.9	2.0	15.6	10.3	1.7	12.2	4.9	7.4	7.5	1.3	6.1	8.7	4.1	4.4	8.2	2.9	10.8	3.5	2.0	9.1	2.6	4.5	1.0	1.9	5.2	7.4	14.5	1.1	20.6	4.4	13.1	3.3	17.2	13.1	9.2	2.2	12.6	2.7	3.2	8.0	2.7	3.0	23.7	5.8	2.4	19.9	5.0	1.4	2.6	3.5	6.1	7.6	8.7	17.5	15.4	2.1	17.9	2.7	0.0	12.0	1.2	4.3	9.7	4.8	4.9	4.6	4.2	10.1	3.2	3.3	5.2	0.2	3.4	6.2	9.0	7.6	5.6											0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	7.0	0.0	0.0	13.3	14.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	10.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	O60344	3	184249695-184293031	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 22.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"REH: 5.1"									HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		1.2	6.6	0.0	2.1	0.1	0.3	0.3	0.0	1.5	0.6	2.9	0.0	1.5	0.9	0.3	0.3	2.8	0.5	0.6	2.1	0.0		2.8	22.6	1.3	1.5	0.0	0.0	0.9	6.0	1.5	2.0	6.1	0.2	1.4	0.6	0.2	4.0	1.6	3.8	0.3	2.9	0.4	0.0	2.4	0.3	9.7	0.0	3.3	4.9	3.1	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		900000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: AB_2681305"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	58.0	47.7	25.2	48.0	23.6	67.6	61.7	20.1	25.9	56.4	54.7	35.0	50.8	33.8	57.2	50.8	63.0	39.5	68.6	58.5	24.5	20.5	43.0	89.4	49.1	123.8	27.3	18.7	95.0	258.8	23.3	27.8	34.6	22.3	70.7	25.3	50.2	98.6	48.3	95.1	56.2	45.4	65.7	31.2	60.1	49.9	33.4	23.3	73.4	76.4	82.3	77.4	57.8	94.6	122.6	75.1	35.9	46.3	69.1	128.4	143.7	47.2	69.1	30.9	26.6	27.9	34.5	34.3	36.8	47.3	58.7	46.7	94.3	45.1	36.3	38.9	41.0	17.6	47.2	31.8	59.3	25.5	28.7	52.5	35.6	121.9	91.8	41.7	22.1	30.3	66.2	86.8	35.4	40.4	34.1	39.2	30.2	33.3	54.0	33.2	152.8	86.2	56.3	32.5	61.0	91.7	38.3	22.2	71.1	50.1	80.4	30.6	33.2	32.0	78.8	76.9	19.9	58.9	56.7	30.3	34.2	100.5	50.8	79.0	36.7	14.1	37.9	38.4	45.3	29.6	19.5	46.3	21.3	80.0	41.6	103.1	114.0	102.4	83.8	53.3	122.6	128.4	103.5	35.9	69.1	36.6	75.1	96.2	143.7	25.2	23.6	20.1	25.9	24.5	20.5	27.3	18.7	22.3	23.3	151.8	402.8	1440.8	1444.3	1639.8	62.4	3.4	624.2	165.9	319.6	324.5	19.6	620.5	724.5	707.0	361.5	548.9	855.0	397.1	1547.6	714.1	839.0	1217.7	435.3	711.1	705.0	74.7	329.6	699.7	1314.5	782.6	825.3	1016.5	1029.1	1074.0	721.8	200.1	963.8	568.1	595.0	1184.5	78.1	472.1	1232.9	20.2	140.9	1441.1	595.9	1397.5	726.5	1215.8
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102578	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	10.5	21.8	20.1	14.2	26.9	34.0	18.5	20.0	24.6	10.8	12.2	13.5	12.3	8.2	13.6	19.2	15.9	10.3	9.5	12.5	19.4	27.0	34.9	19.2	9.9	19.7	26.9	16.2	10.8	26.6	19.8	28.6	11.7	41.2	12.5	15.2	9.6	13.5	13.4	14.4	8.4	8.4	13.3	21.3	11.8	14.8	36.3	19.4	9.9	13.9	15.8	20.3	11.6	9.3	20.9	29.6	6.8	15.0	14.0	21.3	13.5	28.1	14.9	24.0	16.5	7.9	13.3	14.6	23.7	15.0	21.4	22.1	24.3	11.8	30.9	52.3	15.4	39.2	11.7	27.1	27.3	36.1	17.3	35.3	24.9	19.7	42.2	14.7	49.3	18.4	11.1	25.8	25.5	26.5	15.0	30.2	25.5	59.5	8.6	20.4	11.8	21.1	40.1	21.6	27.5	24.0	25.9	14.1	48.5	35.0	21.7	35.7	11.1	10.1	22.8	28.2	33.9	18.1	17.0	15.6	17.9	17.7	16.2	34.3	13.5	61.1	43.9	10.0	20.9	28.4	6.2	11.0	6.8	13.5	15.0	19.1	20.9	18.1	17.8	29.6	20.5	20.3	20.6	1.1	14.0	11.2	13.0	21.3	13.5	20.1	26.9	20.0	24.6	19.4	27.0	26.9	16.2	41.2	19.4	14.9	28.8	28.9	35.2	58.5	35.8	20.7	15.3	33.5	37.5	57.6	9.8	71.1	119.3	54.7	233.2	31.6	7.7	23.3	76.4	54.8	31.5	42.5	15.1	26.4	44.1	28.6	38.5	23.4	30.6	155.8	24.5	35.1	40.5	22.6	35.3	32.1	63.6	7.0	22.3	129.8	16.8	12.9	36.0	118.9	83.7	66.6	27.0	27.3	39.8	36.5
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.9"	"Group enriched"	"Detected in many"	21	"Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.6	1.5	5.4	0.5	9.5	0.9	2.5	0.2	4.1	8.1	0.8	14.0	10.3	0.9	8.6	19.0	0.9	61.9	0.9	0.6	9.1	8.4	0.6	0.9	16.5	0.5	2.7	3.9	13.7	1.8	0.4	2.0	0.8	23.9	4.2	0.7	1.9	1.8	4.6	0.5	3.5	1.1	2.7	1.4	0.6	0.8	19.7	3.0	0.0	0.5	0.3	0.6	1.4	2.1	1.0	0.0	4.1	0.0	1.1	1.1	0.3	9.1	0.0	1.2	0.0	4.0	9.3	0.0	0.1	0.9	0.0	0.3	0.0	4.5	0.0	0.0	0.2	0.0	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	3.3	0.3	3.8	1.6	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	2.1	7.2	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.1	1.0	0.7	0.8	0.0	0.8	0.5	0.3	4.1	1.1	0.0	0.0	0.7	0.3	5.4	9.5	0.2	4.1	9.1	8.4	2.7	3.9	23.9	3.0	0.0	5.1	0.0	6.6	6.1	0.0	0.4	0.0	342.6	18.2	0.0	0.0	0.3	0.0	0.1	456.6	0.1	0.0	0.0	1.3	0.1	1.9	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	332.2	4.4	1.2	1.7	0.0	0.0	0.0	2.0	0.0	5.3	0.0	0.0	0.0	0.8	5.7	4.4	1.6	0.2	0.0	0.0	1.8
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489731-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 134.4;Muller glia cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.7;OE19: 27.9;SH-SY5Y: 24.4;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		760000	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	15.7	4.9	11.2	8.2	11.0	0.8	21.8	8.3	14.0	13.2	23.1	5.8	13.1	13.9	10.8	5.2	11.4	13.6	11.2	11.8	10.4	6.5	9.3	11.8	50.1	7.8	6.2	11.5	8.4	3.7	5.7	6.1	27.7	5.2	11.8	18.4	15.2	12.7	20.6	6.6	14.3	20.6	10.5	5.0	9.3	21.3	7.2	5.9	7.3	11.2	8.8	5.9	7.7	12.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	11.6	1.1	48.7	0.0	0.1	0.3	0.1	5.3	3.3	5.3	3.0	11.8	17.8	0.0	5.1	1.6	0.4	13.9	1.8	6.8	5.7	0.0	10.4	0.0	4.0	0.0	1.0	3.8	0.3	2.2	12.2	0.2	10.4	2.6	6.6	0.1	0.0	0.0	5.7	2.0	0.1	0.0	2.6	27.9	2.3	9.8	1.9	0.0	7.5	1.5	3.4	24.4	2.0	1.0	0.0	14.3	0.6	0.1	5.2	10.4	0.0	0.3	11.9	0.1	0.0	0.0	21.9	0.2	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	11.2	11.0	8.3	14.0	10.4	6.5	6.2	11.5	5.2	5.9	6.0	29.4	1.9	48.4	73.8	9.4	7.4	7.6	9.4	12.5	24.4	0.0	1.1	0.0	6.9	0.4	80.4	63.8	0.0	1.2	2.6	17.1	25.9	18.4	0.4	1.0	6.4	48.6	134.4	8.6	0.5	0.3	1.3	30.4	0.0	38.0	92.0	27.1	53.7	0.4	0.0	2.8	0.0	20.3	0.6	3.2	75.2	1.6	3.2	27.5	75.5
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356402-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 18.7;Syncytiotrophoblasts: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.2;AN3-CA: 15.4;BEWO: 23.7;SH-SY5Y: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	11.7	4.4	15.7	0.6	13.1	9.4	21.2	17.9	8.5	29.4	8.0	2.8	17.0	9.8	18.3	10.0	6.7	5.5	14.3	8.3	3.2	1.2	5.7	2.8	14.9	8.2	23.7	1.5	25.0	3.2	33.1	15.6	17.9	3.1	8.3	15.6	18.6	3.8	42.3	3.9	13.0	25.7	4.5	4.7	4.4	16.0	0.4	6.8	15.5	10.0	11.8	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	28.2	15.4	7.1	8.2	23.7	2.1	4.3	0.7	0.3	0.0	0.0	0.0	0.0	11.6	0.1	10.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	4.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	9.0	0.0	0.0	9.0	3.1	27.0	6.0	0.9	0.0	3.6	6.7	0.0	0.0	3.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	15.7	9.4	11.8	14.3	8.3	14.9	8.2	15.6	16.0	0.0	4.1	0.0	7.2	10.3	2.7	0.6	0.0	1.4	4.5	0.0	5.9	8.0	1.7	0.0	0.7	1.4	0.0	0.0	0.0	12.8	13.0	6.3	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.4	18.7	0.0	6.8	0.0	0.0	8.0	0.0	0.0	13.1	0.1	8.1	6.5	5.1	0.5	0.4	11.7	15.1	0.0	0.0	4.7
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 102.0;Intestinal endocrine cells: 272.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4"	"Group enriched"	"Detected in many"	10	"amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2"	"Group enriched"	"Detected in many"	9	"amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favorable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	20.7	17.7	11.5	12.3	33.6	5.6	7.1	0.8	35.0	7.4	3.3	11.1	0.2	0.9	3.8	1.0	4.0	14.6	20.6	8.5	13.7	2.0	3.0	2.0	4.1	7.3	1.9	12.8	10.6	2.9	12.8	5.0	1.2	3.6	10.3	2.2	2.6	2.3	4.0	1.6	28.4	3.6	8.3	1.6	2.8	5.3	4.1	2.1	5.5	5.8	1.3	5.8	12.3	2.5	0.8	0.0	2.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	1.5	4.6	0.1	0.4	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.3	0.3	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.2	0.2	0.0	0.6	0.1	0.1	0.2	0.1	0.0	24.5	0.0	0.2	0.1	1.7	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.4	0.0	16.4	0.2	1.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.7	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	11.5	33.6	0.8	35.0	13.7	2.0	1.9	12.8	3.6	2.1	6.0	18.6	7.5	26.7	20.5	1.6	35.5	0.0	2.7	3.4	0.0	0.0	1.2	0.0	2.5	19.0	17.5	0.9	0.0	3.9	1.1	23.9	18.9	102.0	0.4	3.7	0.0	272.8	20.9	12.3	6.2	2.8	11.0	20.3	0.0	12.8	3.0	2.6	2.9	0.4	0.0	1.1	0.0	23.7	0.0	0.2	43.7	8.1	0.0	4.3	3.1
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.7	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.8	0.0	4.4	0.0	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	29.4	0.2	0.0	0.0	0.2	4.7	53.2	0.0	0.0	0.1	3.6	0.0	0.0	53.9	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5	44.7	66.1	0.0	340.0	97.3	0.0	0.4	43.3	235.5	254.8	52.4	0.0	0.0	13.3	55.4	8.4	0.2	36.0	0.0	76.2	0.0	1.9	138.5	1.1	0.6	0.1	0.0	22.3	0.0	0.0	0.0	0.0	5.3	11.8	9.0	45.3	3.9	68.8	28.8	0.0	0.1	0.0	0.0	2.3	0.1	0.0	148.7	1.1	0.0	33.6	370.0
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.1	22.4	25.1	23.3	10.7	11.1	21.1	14.8	9.4	10.8	8.9	14.6	14.0	34.3	14.4	11.2	13.1	24.1	15.0	16.2	8.6	19.2	10.6	14.5	22.4	9.3	9.3	22.0	17.4	9.9	11.4	13.1	12.8	8.0	17.8	13.0	21.7	11.9	7.7	25.8	25.8	10.9	24.5	17.7	14.9	33.2	21.6	19.8	9.1	20.6	22.3	18.1	28.1	19.8	6.4	18.8	22.2	17.8	16.7	12.8	13.3	19.6	14.0	7.6	21.1	28.3	9.5	11.8	13.8	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5	17.9	16.3	36.9	20.3	15.5	38.3	24.3	17.8	21.4	22.7	21.0	49.1	18.6	3.3	20.9	68.8	24.8	19.8	0.0	18.3	18.0	18.4	25.8	17.4	28.8	17.0	47.7	27.0	17.8	23.4	119.3	33.1	16.5	11.8	23.4	20.2	23.1	20.1	25.9	35.3	11.9	48.0	12.9	15.3	58.1	54.9	17.7	22.2	23.3	20.5	22.0
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 69.1"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 291.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6"	"Low region specificity"	"Detected in single"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	1.7	1.7	2.0	2.9	2.7	3.0	1.7	4.0	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1.0	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.2	0.3	1.0	2.3	2.4	2.0	9.5	7.8	4.6	7.8	0.2	0.5	0.1	0.1	2.1	2.1	0.2	0.3	0.8	6.8	0.6	0.1	1.9	8.6	1.5	3.4	0.2	0.5	3.2	0.0	2.9	0.6	0.4	0.7	0.4	0.1	0.6	2.8	0.1	3.4	1.4	0.5	0.2	2.0	0.3	0.0	0.1	2.5	0.3	0.1	0.0	6.3	0.4	0.2	0.2	0.0	0.0	1.4	0.1	0.3	2.3	0.4	0.5	0.2	0.1	0.2	0.0	1.0	0.0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2.0	2.7	4.0	2.6	1.9	1.9	1.2	2.3	2.2	1.6	0.0	5.9	2.9	50.8	11.8	3.4	1.1	0.0	4.0	1.2	1.8	25.5	2.0	0.0	2.4	44.2	5.2	1.3	0.0	1.2	1.1	8.0	25.2	1.1	1.7	1.7	11.1	0.0	6.2	4.0	12.9	8.1	6.1	1.7	5.4	0.0	7.6	5.0	0.2	4.2	1.0	17.5	6.5	8.2	291.8	33.6	6.8	2.1	10.2	0.7	39.4
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.8	26.4	21.2	32.2	20.3	18.4	27.9	21.6	19.7	19.3	24.5	24.2	28.3	32.8	23.7	23.7	34.7	29.6	27.5	19.7	24.9	20.3	42.2	33.8	28.7	36.4	16.7	28.7	30.9	14.7	24.9	18.2	19.7	20.4	20.5	25.9	54.0	31.7	18.1	41.9	15.7	36.7	26.6	24.4	29.8	34.7	22.3	38.5	24.6	20.5	26.4	47.5	41.5	55.5	18.4	30.9	41.8	35.2	19.6	11.1	41.5	19.5	22.9	32.3	32.2	33.5	22.4	37.9	32.1	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6	35.7	43.2	44.9	27.9	21.2	28.0	44.8	43.3	34.8	29.6	41.8	15.7	180.9	56.3	48.3	6.9	22.4	43.3	116.8	39.3	64.2	22.2	37.8	19.7	55.5	47.3	30.2	37.0	20.3	29.0	11.9	31.9	31.4	23.6	59.5	60.3	40.2	46.9	35.1	35.3	51.5	23.0	12.9	17.0	32.5	42.3	19.6	310.3	35.0	47.0	25.5
EIF3A	"EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	36.7	27.4	19.6	29.4	20.2	41.4	42.4	22.4	22.3	27.8	29.2	21.7	32.3	26.0	33.4	26.0	35.7	22.7	25.0	36.7	19.9	18.6	28.2	41.5	24.6	39.0	24.2	20.1	29.2	61.9	35.8	33.2	33.7	25.5	26.9	26.4	14.4	31.4	31.6	92.3	36.0	29.2	49.3	29.8	29.8	34.1	18.6	22.6	45.8	28.6	33.6	28.7	40.5	38.9	15.0	20.2	21.6	29.7	14.2	27.6	13.9	50.9	38.6	31.8	43.5	34.6	50.2	24.7	46.4	48.3	29.9	30.1	36.3	33.7	59.8	17.3	38.3	23.6	51.3	41.4	35.6	42.7	32.8	34.0	51.4	29.8	40.3	39.6	75.1	38.2	43.4	40.1	44.1	76.0	50.3	33.9	24.4	52.6	39.5	38.6	30.2	31.1	35.5	30.5	19.8	19.7	32.1	68.8	28.5	28.7	43.1	14.9	31.5	36.5	34.4	48.1	28.7	22.0	48.1	49.7	29.1	26.9	30.3	67.1	34.2	37.5	58.9	30.8	74.2	19.9	21.6	21.2	12.6	16.5	23.9	19.1	15.0	19.9	14.9	20.2	13.3	13.9	15.0	5.7	14.2	29.7	11.6	27.6	13.9	19.6	20.2	22.4	22.3	19.9	18.6	24.2	20.1	25.5	22.6	217.4	278.3	92.9	185.7	270.3	56.3	294.1	114.7	196.7	246.9	61.1	58.9	145.7	23.2	129.2	164.6	122.4	96.0	93.5	158.7	131.5	136.7	213.5	137.9	165.4	112.9	41.3	135.5	80.4	187.8	87.8	100.7	140.0	140.0	160.5	137.9	70.1	165.5	84.2	110.7	43.0	50.4	58.2	140.5	137.2	105.1	318.1	211.0	121.1	152.2	227.0
EIF3B	"eIF3b, EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		22000	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	27.5	27.3	16.5	28.9	21.8	38.7	28.8	20.0	26.2	23.5	33.3	22.4	25.7	20.3	29.6	24.1	38.8	28.6	26.2	32.1	15.8	16.5	24.3	51.4	21.7	29.6	22.2	19.4	31.2	66.6	24.2	20.3	34.6	21.1	26.0	24.0	18.0	34.1	24.2	72.3	39.8	23.9	33.0	16.5	31.6	29.7	45.2	19.0	44.9	23.1	34.3	35.9	32.9	29.7	6.5	8.0	3.7	7.3	16.5	9.5	4.4	85.9	44.0	18.2	49.4	20.6	18.7	45.1	30.3	22.7	34.5	32.4	57.4	33.7	50.2	25.0	32.1	48.8	46.9	50.1	39.8	38.1	15.0	58.8	38.2	42.7	38.7	29.1	46.5	28.4	23.2	26.3	37.3	39.3	18.2	27.7	23.4	97.1	23.4	31.5	61.0	22.4	52.3	56.8	30.1	39.6	27.7	36.9	51.7	22.1	39.4	41.6	31.1	32.0	71.3	17.3	33.2	47.4	51.6	29.2	26.7	58.9	40.9	54.5	25.9	34.7	50.9	30.3	52.2	65.1	1.8	7.3	3.7	7.6	6.8	9.5	6.3	7.4	8.4	7.8	6.5	8.8	8.9	0.6	16.5	5.8	8.0	8.7	4.4	16.5	21.8	20.0	26.2	15.8	16.5	22.2	19.4	21.1	19.0	23.8	61.0	27.4	38.7	57.1	36.2	30.7	28.1	24.1	48.9	26.2	60.9	54.0	3.3	33.5	9.1	45.4	29.7	0.0	52.8	53.4	38.1	43.4	16.2	53.9	42.2	49.3	45.8	70.6	38.4	13.9	40.6	33.2	15.1	16.2	54.8	41.2	58.1	20.1	35.0	25.4	44.8	25.8	40.6	29.9	34.0	68.4	69.1	28.9	53.9	38.6
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		22000000	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	30.9	18.4	17.4	17.5	19.8	26.4	55.1	34.4	19.3	40.7	29.1	16.1	16.7	20.8	36.1	18.9	33.4	24.2	14.0	15.5	15.0	15.6	23.7	36.1	18.4	31.3	14.0	13.4	63.4	78.8	20.2	26.8	27.9	17.7	38.7	23.8	21.5	39.6	31.0	40.3	30.6	25.2	35.8	15.6	24.7	22.7	19.6	11.4	44.0	54.8	32.3	31.0	38.6	22.0	33.6	58.1	9.8	35.9	25.0	42.5	55.2	16.8	9.6	27.1	19.6	26.3	58.8	19.5	16.2	39.0	26.2	35.8	16.0	12.5	58.2	4.5	18.9	9.1	10.9	29.8	22.4	30.9	7.6	49.8	20.5	14.0	7.5	16.4	54.4	17.7	31.6	25.7	19.3	29.2	45.4	32.5	19.3	17.0	15.9	30.2	6.6	14.5	25.2	15.4	20.6	25.3	16.6	37.2	17.0	19.9	10.2	19.8	30.6	16.0	18.8	21.9	31.8	14.3	22.0	15.7	16.3	19.9	9.9	12.9	9.5	15.5	23.7	15.3	24.1	13.3	9.8	35.9	9.6	20.7	35.4	34.6	33.6	30.0	25.0	58.1	27.5	42.5	31.8	4.8	25.0	29.1	28.4	29.1	55.2	17.4	19.8	34.4	19.3	15.0	15.6	14.0	13.4	17.7	11.4	110.2	191.5	294.7	357.3	352.7	56.1	1.4	165.6	77.6	174.0	62.8	27.5	578.0	353.1	204.0	111.9	215.8	81.1	116.8	400.6	517.3	230.5	236.6	216.1	101.7	227.0	23.8	189.5	125.8	250.1	286.2	206.0	267.8	215.9	373.3	211.0	74.0	242.7	189.4	199.4	249.7	32.9	161.7	287.4	90.7	87.1	375.5	588.1	261.5	327.6	377.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030341-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7;salivary gland: 109.8"	"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 638.8;Pancreatic endocrine cells: 291.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	17.7	3.4	2.5	4.9	3.6	9.2	21.7	1.8	3.2	5.5	15.4	2.0	7.7	6.2	5.3	2.1	22.2	5.0	7.0	9.4	2.2	1.8	6.0	39.6	6.9	7.4	4.3	1.4	9.3	94.7	1.7	2.2	8.7	2.8	7.4	4.6	2.8	109.8	8.0	38.4	4.9	9.0	7.1	4.2	9.3	10.6	3.0	2.7	2.7	3.7	12.6	9.2	11.3	11.1	16.3	41.3	31.3	53.5	4.0	7.6	28.0	20.5	10.6	3.1	18.5	4.0	3.5	13.7	22.8	10.7	12.4	19.8	7.0	5.3	8.0	15.9	11.3	7.5	11.0	10.4	18.6	7.4	6.2	33.7	47.1	4.8	9.7	42.0	15.2	7.6	9.8	30.4	13.7	25.7	3.9	19.8	5.5	25.7	21.5	5.2	12.9	13.3	37.0	23.1	10.4	42.9	11.7	13.1	28.4	4.6	2.0	43.4	33.0	4.6	7.5	53.8	2.0	10.1	17.9	18.6	7.4	24.5	22.0	17.3	31.0	16.8	9.2	17.4	27.0	16.1	5.1	53.5	31.3	3.9	41.2	3.5	16.3	4.5	4.0	41.3	13.5	3.6	3.6	4.7	4.0	31.4	31.3	7.6	28.0	2.5	3.6	1.8	3.2	2.2	1.8	4.3	1.4	2.8	2.7	8.9	8.8	22.0	33.9	66.1	3.6	36.7	76.5	18.7	7.9	19.2	2.0	28.3	24.9	210.7	13.0	33.7	22.3	46.7	638.8	158.3	47.3	50.3	18.4	91.8	194.5	0.0	38.6	74.3	87.1	71.0	40.3	79.1	69.2	40.5	88.6	11.9	291.0	56.1	18.0	71.9	1.8	12.9	44.1	1.1	21.0	74.5	32.3	24.2	76.7	54.2
EIF4EBP2		ENSG00000148730	"Eukaryotic translation initiation factor 4E binding protein 2"	Q13542	10	70404379-70428618	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019415, HPA037410, HPA061665"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580"	"unprognostic (9.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.61e-2)"	57.3	27.2	22.1	28.2	21.8	20.2	77.1	22.7	23.0	28.7	47.9	16.7	25.9	30.8	24.8	18.3	28.3	22.7	37.9	52.4	18.0	15.8	44.4	40.1	31.8	21.6	19.0	14.7	33.4	28.4	23.2	13.3	36.2	18.6	33.2	31.6	34.8	25.5	50.2	54.5	27.6	51.2	32.4	17.8	30.5	28.7	17.9	16.2	34.8	23.5	29.2	22.1	39.8	64.3	7.0	14.0	20.6	17.5	9.3	14.2	14.2	17.1	5.6	30.7	29.9	59.4	22.6	16.6	10.5	13.1	7.9	8.5	24.5	15.4	17.9	6.4	15.5	4.9	11.1	14.9	9.7	8.9	19.0	7.7	12.9	6.8	9.6	13.9	22.9	9.1	25.1	10.1	9.6	8.7	16.0	11.9	14.8	21.0	16.4	12.1	9.8	19.5	23.6	25.8	17.1	10.2	20.1	12.3	11.5	10.0	17.9	16.6	25.1	14.5	33.5	13.9	21.9	15.2	20.5	12.9	5.1	6.4	8.3	9.3	11.0	21.5	21.1	5.9	34.3	5.2	13.8	15.5	20.6	14.2	13.8	11.6	7.0	11.5	11.7	14.0	6.1	9.8	10.1	17.0	9.3	17.5	4.7	12.5	14.2	22.1	21.8	22.7	23.0	18.0	15.8	19.0	14.7	18.6	16.2	23.8	32.8	41.3	43.1	47.1	42.0	128.1	66.2	17.4	25.0	34.9	19.6	37.6	36.5	37.0	19.7	34.3	154.3	23.3	51.0	104.3	50.6	50.3	11.5	142.1	41.5	22.3	25.4	65.7	88.3	40.0	60.9	37.0	20.3	45.9	79.3	63.3	50.7	84.0	57.7	108.0	15.4	77.6	30.7	32.9	41.7	61.2	47.9	42.4	61.8	85.2
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005042, HPA061298"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005042: AB_562281, HPA061298: AB_2684472"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	69.0	55.6	37.9	57.0	40.4	83.1	44.5	35.0	59.8	44.6	54.8	37.5	39.8	47.4	47.2	45.5	107.0	38.1	52.9	55.8	35.6	33.6	58.5	192.9	46.6	67.2	34.3	35.9	50.3	126.0	26.0	34.1	73.9	34.0	38.0	57.2	40.7	87.7	40.7	100.6	71.1	49.0	45.4	29.5	65.5	42.9	56.8	24.2	77.9	57.9	105.4	79.0	48.6	50.7	64.7	87.7	44.4	75.7	75.2	79.3	64.3	132.8	165.9	51.2	102.4	39.5	51.0	71.9	100.3	66.2	135.7	94.9	99.2	56.8	128.8	65.0	77.1	55.6	90.9	111.1	129.3	123.5	71.6	161.3	77.5	137.4	127.0	70.1	58.8	80.2	54.0	67.9	100.2	136.1	45.9	87.1	38.7	106.5	36.0	91.8	82.4	69.1	85.1	97.1	77.7	81.9	68.4	62.2	118.7	81.9	73.9	59.5	77.4	64.3	78.4	62.1	40.8	62.0	45.4	81.5	95.7	68.9	63.5	158.5	30.3	41.4	83.3	90.4	88.6	108.9	44.4	56.0	38.9	65.1	75.7	79.3	64.7	67.1	57.7	85.8	62.6	62.3	62.6	25.1	75.2	68.6	87.7	58.9	64.3	37.9	40.4	35.0	59.8	35.6	33.6	34.3	35.9	34.0	24.2	50.6	35.2	135.1	56.5	310.0	85.2	62.9	114.7	41.5	36.4	59.3	13.7	296.4	63.0	289.3	125.7	155.1	221.7	163.5	206.2	541.5	192.2	120.0	138.2	197.7	267.8	47.7	144.4	98.8	106.6	60.7	93.2	101.1	249.7	306.6	167.0	82.0	274.1	169.5	76.4	70.8	45.7	90.5	172.0	216.9	81.3	274.3	358.2	71.9	197.1	61.2
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	8.7	15.0	7.7	7.7	9.7	3.3	9.4	7.1	11.9	8.0	9.1	12.8	12.1	7.6	11.3	20.1	7.5	10.0	9.6	7.2	7.3	8.3	12.4	15.2	7.6	11.2	7.6	7.2	8.8	19.5	17.1	15.7	12.3	8.7	9.9	10.8	13.7	20.1	12.2	6.8	7.7	11.7	8.3	7.1	10.8	10.1	16.7	3.9	10.1	15.6	7.0	9.9	8.7	6.6	14.2	12.4	7.8	9.1	16.1	15.7	8.1	7.0	4.9	13.0	11.0	14.6	6.2	5.5	7.8	10.3	7.3	5.2	1.8	6.7	5.5	5.4	7.2	5.8	7.2	4.0	8.2	5.0	12.0	1.1	6.8	1.8	1.3	8.6	17.0	4.9	7.8	6.6	3.9	9.1	5.8	7.6	8.0	6.9	13.8	12.9	3.2	5.9	5.1	6.5	6.0	2.2	6.7	4.6	10.2	8.5	3.0	7.7	8.8	6.4	1.1	12.4	5.7	6.0	13.1	6.7	9.6	5.0	2.8	5.2	12.9	10.8	7.3	8.9	5.7	12.0	4.1	7.8	7.8	13.2	9.1	14.6	14.2	12.7	12.9	12.4	13.6	12.4	15.7	0.9	16.1	8.7	10.4	10.0	8.1	7.7	9.7	7.1	11.9	7.3	8.3	7.6	7.2	8.7	3.9	6.0	6.2	8.5	4.6	2.2	7.1	5.6	5.1	10.7	3.4	3.5	2.0	20.4	16.6	12.5	16.4	5.8	8.8	0.0	12.0	13.8	5.4	6.3	8.1	13.9	13.7	4.8	9.9	8.0	6.6	12.8	4.6	5.2	5.0	10.8	8.3	10.8	10.1	7.0	6.7	17.7	7.4	0.0	5.9	27.3	9.4	3.0	15.8	5.0	9.5	3.4
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 30.7;testis: 45.3"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 154.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	1.0	2.4	8.7	1.0	13.4	1.4	1.1	18.3	27.5	1.0	1.3	0.7	0.0	1.0	1.5	1.4	1.1	1.0	1.1	1.0	8.1	19.2	1.4	0.8	1.1	1.0	16.3	18.9	2.1	0.8	1.2	2.5	0.9	30.7	1.2	1.5	0.5	1.0	1.0	1.0	1.5	1.1	1.1	5.0	1.0	1.0	45.3	1.1	0.0	1.2	0.0	1.0	1.6	0.3	1.8	1.1	5.1	0.9	1.4	1.3	0.1	10.1	0.1	15.6	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.2	6.5	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	4.0	0.0	4.7	0.0	0.1	0.0	0.3	0.5	2.2	0.0	0.0	0.0	4.1	0.0	4.9	0.0	5.6	0.1	0.0	0.0	52.1	4.9	0.1	0.1	0.1	4.2	0.2	0.7	0.0	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	2.7	0.9	1.6	0.5	0.6	0.6	1.0	0.5	0.4	0.4	1.8	1.1	1.3	5.1	1.4	0.5	1.1	0.6	0.1	8.7	13.4	18.3	27.5	8.1	19.2	16.3	18.9	30.7	1.1	0.0	0.0	0.0	0.3	0.9	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.9	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	15.9	4.1	0.0	0.0	30.7	2.8	0.0	0.0	0.0	0.7	2.7	0.0	0.0	1.4	0.0	9.6	0.0	0.3	12.2	154.0	0.6	0.0	0.0	0.8	0.8
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50048014-50203786	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.1"	"Group enriched"	"Detected in some"	11	"Early spermatids: 111.8;Intestinal endocrine cells: 31.6;Late spermatids: 117.9"	"Group enriched"	"Detected in some"	10	"glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.1"	"Cell line enriched"	"Detected in some"	19	"SH-SY5Y: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.9	11.4	11.5	3.3	12.8	0.8	1.0	11.6	43.1	0.9	3.0	0.9	0.0	2.3	0.9	0.8	1.1	0.9	1.0	1.0	12.3	16.5	0.9	1.0	1.0	0.9	10.6	30.7	0.8	2.8	0.8	7.1	0.9	37.0	1.0	3.8	0.0	0.9	0.9	0.8	1.2	3.1	2.0	8.5	1.0	1.9	7.8	1.4	0.1	0.8	0.0	1.0	0.9	0.5	0.0	0.6	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.6	0.0	0.0	11.5	12.8	11.6	40.4	12.3	16.5	10.6	30.7	37.0	1.4	0.0	0.0	0.0	0.0	0.7	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	31.6	0.0	4.5	117.9	1.4	2.3	1.7	0.0	0.0	1.0	0.5	0.0	0.4	0.0	3.0	0.0	0.0	7.5	7.9	0.6	0.1	0.0	0.0	0.0
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	35.3	12.6	13.2	17.4	24.9	34.3	24.2	29.7	21.6	23.4	22.4	15.2	25.7	12.7	22.9	17.5	18.8	19.0	15.7	20.3	16.1	11.6	15.6	17.4	18.6	19.8	29.3	10.2	25.5	19.5	19.5	23.6	22.8	17.7	23.4	16.9	14.2	21.0	22.4	27.6	19.1	17.9	30.0	23.4	22.8	16.2	30.1	25.1	31.1	21.6	22.4	17.6	25.2	35.0	19.3	19.1	12.5	8.0	10.6	14.8	4.8	9.1	6.8	17.0	12.3	17.2	20.8	16.1	11.1	19.2	11.9	13.7	12.7	18.2	18.6	11.2	14.8	6.3	9.5	25.3	14.8	12.5	11.6	10.9	16.9	15.7	10.9	13.2	18.6	13.4	18.4	15.1	11.3	13.9	16.4	17.7	11.1	27.1	10.7	10.0	15.4	20.8	15.6	10.6	21.6	7.5	20.5	22.1	16.9	14.4	16.1	17.2	19.2	13.5	16.7	9.9	20.0	11.4	21.3	14.8	11.0	9.6	10.0	7.1	24.2	27.0	16.4	8.2	19.0	9.9	8.6	8.0	12.5	12.4	6.4	12.9	15.3	11.8	10.5	8.8	19.3	14.8	13.4	8.0	10.6	6.4	19.1	9.3	4.8	13.2	24.9	29.7	21.6	16.1	11.6	29.3	10.2	17.7	25.1	44.7	22.7	30.8	38.3	47.3	40.0	35.1	38.2	49.5	42.1	38.4	70.7	26.9	36.5	22.2	16.6	56.3	26.2	0.0	21.2	26.4	42.7	41.9	33.5	40.9	19.4	63.5	45.4	47.9	43.9	18.1	48.6	35.4	28.7	25.2	31.6	41.7	20.8	29.6	35.7	13.2	51.7	38.8	55.6	47.2	42.1	41.7	19.8	42.8	26.7	32.4
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130064874-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	16.9	3.6	2.0	18.1	2.5	27.6	16.9	0.5	3.0	7.7	10.8	3.1	7.0	8.4	10.5	8.1	10.5	9.5	11.0	7.3	3.1	1.2	5.9	2.5	21.9	33.3	3.8	0.9	12.7	4.5	3.8	4.2	23.5	3.0	6.6	10.9	3.6	5.4	7.9	5.7	9.1	16.3	6.4	4.2	18.9	12.3	3.5	2.9	18.1	3.9	7.4	11.5	11.7	14.4	3.9	6.1	9.4	10.3	8.4	10.3	5.1	22.8	8.5	1.5	0.1	3.9	8.5	22.3	10.7	13.6	13.0	14.4	11.8	16.3	11.7	21.4	14.4	18.0	14.9	8.5	12.5	12.7	12.5	7.0	23.0	11.4	5.4	8.8	20.0	29.5	8.8	14.1	20.8	20.6	8.1	12.5	2.6	8.8	3.2	7.0	13.2	3.2	11.4	1.0	11.6	8.4	7.1	2.7	5.0	7.9	26.4	5.9	2.5	9.5	9.3	2.9	8.4	4.6	19.3	11.6	9.1	7.2	16.9	19.6	1.8	0.7	9.4	10.7	18.5	2.1	1.6	5.4	7.8	10.3	10.3	8.3	3.9	6.2	8.8	6.1	3.5	6.2	7.2	9.4	8.4	7.0	3.7	6.3	5.1	2.0	2.5	0.5	3.0	3.1	1.2	3.8	0.9	3.0	2.9	8.9	4.1	0.5	8.0	12.0	0.0	0.6	0.0	6.7	5.7	0.0	0.0	9.1	0.0	2.2	0.1	4.5	15.6	0.0	3.6	31.1	5.6	5.4	1.1	0.4	8.7	0.0	8.6	6.7	10.2	0.4	1.7	8.9	3.3	7.2	6.6	0.0	5.7	14.0	1.1	0.3	0.0	6.5	3.8	0.0	3.8	9.2	9.4	5.3	5.9	15.5
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		11000	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	3.0	6.3	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	2.9	1.2	0.0	0.7	19.5	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	12.3	18.0	20.9	0.0	0.0	0.2	5.3	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0											0.0	1.1	0.0	0.4	0.1	1.0	1.6	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.8	0.1	0.0	0.0	9.8	0.6	0.0	0.9	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.7	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427470	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 30.0"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	1.0	2.1	26.8	0.9	10.9	0.9	0.9	0.7	30.0	0.9	0.9	1.9	0.0	0.9	0.9	0.9	0.9	1.0	1.9	0.8	16.2	8.7	1.2	0.8	2.0	1.0	6.7	15.0	0.8	1.1	0.8	0.1	0.8	5.8	2.2	0.9	0.9	0.9	0.9	0.9	1.5	0.9	0.8	3.8	0.9	1.1	4.2	3.9	0.1	0.8	0.0	0.9	0.9	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	3.7	0.0	0.0	0.0	0.7	0.0	4.0	2.1	0.9	0.0	1.4	8.4	0.2	5.2	2.8	9.4	6.1	0.4	0.8	0.1	0.2	0.0	0.0	3.9	0.0	0.2	0.0	0.1	0.7	0.1	0.3	1.2	3.5	0.3	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.2	5.2	8.0	0.1	0.0	8.4	16.4	0.0	0.7	0.0	3.6	4.6	0.0	0.0	0.0	0.1	0.4	0.0	18.7	0.1	2.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	10.9	0.7	16.8	16.2	8.7	6.7	15.0	5.8	3.9	0.0	3.2	0.0	0.0	0.1	43.2	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.3	1.6	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.9	7.8	8.0	4.2	20.4	38.4	2.0	16.5	31.7	13.2	10.2	0.4	9.7	2.1	5.7	18.5	9.9	4.6	0.9	26.5	23.3	5.6	3.0	0.6	3.3	2.9	6.2	6.3	1.5	22.5	5.0	27.2	20.6	26.9	31.5	1.6	1.5	8.7	44.5	2.0	1.2	4.2	9.8	1.8	10.4	10.3	13.5	2.3	11.3	3.4	0.4	8.5	5.4	2.4	8.2	12.7	1.3	3.4	19.3	36.3	14.2	22.3	14.3	16.7	13.9	0.5	12.8	7.4	25.1	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3	6.0	30.6	17.6	31.5	29.0	0.5	4.8	5.1	91.0	54.6	5.2	3.9	0.9	5.0	18.1	0.6	133.8	0.7	0.0	13.5	3.1	34.2	29.1	16.2	3.6	20.8	0.0	1.2	151.0	36.0	1.3	10.6	22.2	11.8	3.6	3.0	4.7	36.9	2.9	9.9	0.0	0.4	12.9	24.3	0.0	14.7	23.6	0.9	15.9	2.9	67.8
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.9;RH-30: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	3.5	0.4	2.2	0.3	0.4	0.0	1.8	0.1	0.0	0.1	1.2	0.1	0.0	0.4	0.1	0.0	0.0	0.1	11.9	1.5	0.0	0.1	0.8	0.1	0.0	0.1	0.5	0.0	1.8	0.0	27.1	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.3	0.0	0.7	0.1	0.0	0.0	3.6	0.0	2.1	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9	0.0	3.8	0.0	0.4	0.0	30.4	3.6	0.0	8.1	2.3	0.0	15.7	0.1	0.0	0.0	8.5	0.7	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.8	0.1	35.0	0.0	0.6	0.3	14.0	0.3	1.4	0.0	0.0	0.0	6.5	0.0	0.0	0.4	3.6	17.8	0.0	0.5	0.9	0.4	2.8	0.0	0.0	0.0	0.3
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	18.5	14.5	11.0	10.5	17.4	4.9	15.0	15.4	14.7	13.4	12.0	18.4	18.6	9.5	12.7	11.6	8.7	13.8	11.5	9.2	13.2	8.6	10.7	14.4	8.4	9.0	20.2	8.8	12.0	11.4	14.4	15.6	11.7	14.2	13.7	9.7	13.0	11.6	14.5	18.8	9.7	10.6	13.4	11.1	11.1	12.1	12.3	17.4	7.6	13.0	6.8	10.2	11.9	10.7	4.5	4.5	10.8	6.6	6.1	7.6	3.9	4.0	5.2	6.0	8.8	18.7	8.4	3.5	7.5	5.8	11.2	10.3	4.3	2.1	3.1	5.8	6.0	13.7	4.3	8.3	10.3	10.2	11.0	5.8	5.4	2.9	3.0	9.8	4.1	7.2	8.6	9.1	10.6	12.2	9.4	7.9	6.4	5.5	3.7	10.3	3.1	6.0	2.4	2.8	8.4	5.5	4.3	12.2	2.9	5.1	2.5	5.6	2.9	4.6	6.4	6.9	7.1	3.5	3.1	4.4	8.0	4.3	6.9	6.8	4.6	8.2	4.2	8.0	4.8	8.1	9.1	3.9	10.8	7.6	2.6	4.0	4.5	4.9	3.0	4.5	4.1	4.2	7.3	3.5	6.1	6.6	1.2	7.3	3.9	11.0	17.4	15.4	14.7	13.2	8.6	20.2	8.8	14.2	17.4	6.0	5.9	13.7	8.8	4.1	26.2	4.8	12.7	6.7	13.6	10.4	27.5	11.6	6.6	7.1	3.8	7.2	17.8	0.0	7.9	4.9	8.7	10.2	9.2	7.3	7.6	28.6	8.1	9.2	9.2	3.6	17.8	11.0	16.9	12.6	8.9	19.7	7.8	14.0	22.3	4.8	29.2	19.4	6.6	13.0	10.1	5.6	10.4	13.8	11.9	7.1
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108867517-108934116	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.7;Ciliated cells: 12.0;Collecting duct cells: 14.0;Exocrine glandular cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	10.4	33.0	18.7	10.6	22.9	10.8	13.1	37.6	19.9	13.0	11.5	17.2	11.4	8.2	15.7	17.3	9.8	15.1	10.3	15.3	14.8	15.2	13.0	14.7	11.2	12.8	20.9	17.3	26.4	12.9	41.3	42.3	11.2	20.5	13.1	12.6	15.0	12.0	12.8	11.6	15.7	11.2	14.4	16.7	13.3	11.3	11.7	19.3	12.1	15.4	8.3	13.2	10.4	13.4	2.1	2.7	26.9	2.6	4.0	4.2	1.9	9.2	17.9	15.4	10.0	17.0	16.3	12.6	15.2	10.5	15.5	12.3	16.8	6.8	17.0	6.9	13.6	17.9	23.9	23.6	19.0	17.1	16.0	14.8	9.9	27.8	45.5	12.6	19.3	8.9	12.4	13.3	21.6	20.4	15.7	13.3	21.4	23.4	12.0	14.2	15.8	16.5	12.0	19.6	23.7	17.9	14.4	20.7	10.6	11.7	12.0	18.7	15.0	16.7	16.7	10.3	17.4	21.7	8.7	12.7	8.9	10.3	19.8	15.1	11.4	25.5	8.6	14.9	12.8	12.0	26.9	1.7	2.5	3.1	2.0	4.2	2.1	3.0	4.0	2.7	1.4	2.9	3.6	0.3	4.0	2.6	1.3	2.4	1.9	18.7	22.9	37.6	19.9	14.8	15.2	20.9	17.3	20.5	19.3	11.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.7	14.0	0.0	5.6	0.0	5.7	0.0	0.0	0.0	0.0	18.1	5.2	0.0	0.0	2.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	8.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180556	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	21.3	19.8	16.5	21.0	22.4	10.5	32.9	23.2	23.6	23.2	19.8	21.6	29.6	14.0	32.3	29.7	15.0	27.2	18.7	21.0	15.8	16.2	17.8	41.0	16.1	17.1	18.6	18.0	46.3	26.7	22.0	43.6	18.7	21.3	28.0	15.4	22.5	19.7	27.4	34.7	23.7	15.6	22.5	18.0	18.1	18.3	19.4	21.7	23.5	20.2	14.1	20.5	25.2	19.5	17.1	14.2	13.4	18.2	17.3	18.8	11.1	10.2	7.4	13.8	12.4	19.6	29.7	15.3	21.2	30.8	17.8	23.9	7.7	9.5	21.5	14.8	17.7	12.0	14.6	17.6	15.7	25.4	9.7	9.5	8.3	12.8	13.3	21.5	26.9	8.9	24.1	18.1	17.7	28.9	27.0	19.9	14.9	13.9	11.4	18.9	12.3	12.9	11.6	16.4	7.9	5.6	21.1	16.6	15.0	16.2	23.9	11.0	21.0	19.9	7.8	31.0	20.8	10.0	13.6	11.7	16.2	9.4	5.9	10.8	13.7	10.8	19.9	13.6	14.5	13.9	13.4	9.7	7.7	10.9	14.3	15.3	17.1	14.7	12.8	14.1	14.3	18.8	16.4	1.6	17.3	18.2	14.2	14.4	11.1	16.5	22.4	23.2	23.6	15.8	16.2	18.6	18.0	21.3	21.7	44.7	27.4	28.6	43.3	29.2	46.3	43.6	7.6	32.1	17.0	33.2	41.2	30.6	24.9	22.1	41.1	26.0	16.0	0.0	19.2	32.9	31.9	48.4	34.8	60.6	20.2	31.8	23.7	20.9	21.8	50.5	40.3	23.1	21.9	40.5	17.8	30.7	16.3	7.0	34.3	14.6	46.5	6.5	29.7	35.8	30.7	32.0	33.3	27.7	22.4	34.1
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 320.1;Late spermatids: 402.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	12.4	18.2	14.0	13.6	14.0	11.8	10.4	14.1	17.8	11.1	15.5	12.2	13.3	11.4	13.1	13.5	10.9	12.6	11.9	23.0	13.2	12.0	16.5	21.3	9.1	15.0	13.6	12.8	15.2	10.6	9.6	15.9	12.6	12.5	14.0	11.0	16.4	20.9	12.7	28.3	7.8	14.6	18.0	11.2	14.1	10.7	103.3	12.4	23.6	15.7	17.2	16.1	11.6	11.0	31.1	36.7	16.3	29.3	27.6	34.7	21.5	12.4	35.3	15.9	14.4	28.0	22.2	6.9	11.2	13.3	18.0	16.7	35.2	8.2	24.8	12.4	17.8	31.6	9.4	40.2	26.4	13.0	15.3	56.6	22.8	11.9	32.0	13.9	16.2	9.0	15.6	19.9	12.2	24.3	11.4	15.3	31.6	15.7	6.7	27.9	21.1	41.0	31.0	13.1	13.1	24.5	35.3	17.9	13.4	20.0	11.8	7.8	15.5	21.8	6.6	17.2	16.6	9.4	11.8	17.3	10.4	12.2	19.9	17.8	7.8	10.4	28.8	18.9	15.8	13.4	16.3	25.3	12.4	27.9	29.3	34.7	31.1	24.9	25.5	30.0	31.0	26.4	31.2	4.4	27.6	19.3	36.7	33.8	21.5	14.0	14.0	14.1	17.8	13.2	12.0	13.6	12.8	12.5	12.4	8.9	9.4	30.5	41.1	19.6	21.3	59.0	10.2	6.7	18.2	43.6	19.6	35.0	82.9	28.6	320.1	27.1	27.3	0.0	11.8	67.2	24.2	62.2	6.9	20.8	36.0	27.0	40.0	14.1	10.8	402.6	31.7	24.4	20.3	27.1	33.9	22.3	22.6	35.1	31.1	76.9	29.6	38.8	32.4	100.6	36.9	19.1	48.4	32.0	48.2	43.2
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	31.2	30.8	13.5	14.1	9.7	7.8	26.0	22.5	11.0	18.5	17.1	18.6	11.8	19.7	32.8	10.5	16.3	30.2	15.6	15.8	13.4	19.0	58.3	14.3	21.6	25.8	14.1	9.9	14.7	9.8	18.0	17.0	11.9	14.6	14.0	23.7	17.9	14.3	13.5	19.0	20.2	29.2	19.4	19.1	34.8	18.9	12.6	18.6	25.9	8.9	11.1	20.2	18.4	14.5	23.9	14.1	16.9	10.7	15.3	15.5	19.2	23.3	32.8	14.0	15.4	12.9	24.3	13.0	18.6	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1	14.9	23.4	62.6	99.3	79.0	40.5	0.3	94.3	53.5	23.9	55.8	33.4	102.2	140.9	117.4	202.1	52.2	55.0	23.3	123.7	126.4	43.1	113.2	54.3	108.8	90.3	31.8	49.3	39.3	53.3	121.5	35.6	54.6	64.1	101.0	61.0	85.4	129.4	63.1	32.2	149.9	38.8	38.8	51.5	146.4	87.0	89.1	107.9	52.2	68.0	156.9
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580698	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.7"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	16.5	2.0	5.0	7.9	5.1	0.0	26.2	3.4	4.7	14.8	10.4	3.4	6.1	4.2	7.3	13.8	35.7	7.4	7.3	14.0	5.5	3.0	3.1	47.5	118.7	5.7	5.4	2.5	14.0	3.2	19.9	3.2	23.5	5.3	11.1	10.0	10.8	9.9	5.8	7.7	40.2	6.6	12.8	3.4	5.3	9.3	5.6	4.1	2.2	7.5	26.4	18.4	10.6	16.3	1.3	1.1	4.1	1.1	1.4	1.0	0.4	6.3	8.8	3.6	4.3	8.2	7.1	7.2	9.1	8.4	5.5	8.3	28.8	22.3	0.0	2.9	10.9	4.0	28.3	9.3	11.2	7.3	0.0	5.9	0.0	18.5	15.7	1.4	0.0	0.1	4.3	3.0	7.3	0.7	1.2	2.3	0.0	2.1	0.6	15.2	59.5	0.1	0.1	4.2	10.3	2.1	1.6	4.2	13.8	1.2	40.9	5.1	5.8	11.2	58.8	3.3	11.0	35.9	1.4	1.2	17.6	7.6	5.9	5.0	0.1	0.2	0.0	7.7	0.1	17.2	3.4	1.0	1.0	0.8	0.8	1.0	1.0	0.8	0.7	0.5	1.3	0.9	0.9	4.1	1.4	1.1	1.1	0.8	0.4	5.0	5.1	3.4	4.7	5.5	3.0	5.4	2.5	5.3	4.1	3868.0	343.3	4.5	123.1	317.0	1.8	48.0	109.5	153.9	326.4	40.1	0.0	59.0	0.0	2.5	4.2	191.2	51.9	0.0	60.2	16.3	121.0	91.1	34.8	181.1	8.8	0.0	100.6	112.3	14.0	5.0	176.6	42.0	82.7	58.7	141.3	5.2	27.3	172.1	259.6	0.0	1.1	51.8	141.5	2.3	13.2	1026.6	40.2	4.3	139.9	220.6
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8"	"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.5	0.2	14.4	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	4.2	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	8.8	0.9	9.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	2.3	0.0	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell type enhanced"	"Detected in single"	16	"Spermatocytes: 1.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1"	"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.5	27.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.9	0.0	5.9	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	3.5	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	8.1	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.1	0.2	2.7	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.9	0.1	1.1	0.1	0.0	0.7	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	1.2	0.6	0.9	0.0	2.2	0.1	0.0	1.8	5.2	0.0	0.5	0.0	0.8	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9	0.0	0.0	0.0	0.2	0.1	4.4	0.2	0.0	36.1	0.0	0.0	21.6	0.2	0.0	0.3	11.9	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	4.8	1.7	0.0	0.0	8.8	1.1	0.1	0.0	1.0	0.0	1.3	0.2	0.0	0.7	0.6	9.0	0.0	0.2	7.6	2.7	0.0	0.1	0.0	0.1	0.0
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430562-82461091	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		140000	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	10.2	15.4	43.4	12.1	37.1	14.3	16.3	22.9	38.8	13.8	12.7	34.7	5.1	12.2	10.5	23.3	13.5	10.4	9.0	11.1	44.2	34.9	20.8	13.3	11.1	16.0	47.5	26.4	12.9	14.6	17.8	11.7	17.7	31.0	17.2	15.3	8.9	11.4	11.9	9.8	13.1	11.0	11.1	66.2	12.8	13.2	6.1	29.4	14.2	18.0	8.2	18.6	10.7	9.5	13.0	14.1	4.3	10.4	14.4	20.2	12.2	18.5	12.3	22.1	13.7	13.5	13.3	24.2	21.6	14.5	19.8	17.7	22.4	20.8	37.0	22.7	16.4	21.7	10.0	29.2	27.4	35.9	22.2	13.6	22.4	12.0	29.8	21.9	37.0	19.4	12.8	29.1	20.7	24.6	14.3	20.0	23.5	28.9	20.4	25.8	23.9	40.8	22.0	20.3	47.0	10.0	29.1	33.9	20.1	32.3	18.4	31.3	19.1	12.3	37.3	27.5	20.7	16.8	17.9	14.7	24.6	18.3	24.3	28.5	23.5	20.1	46.1	15.9	23.1	33.0	3.4	8.7	4.3	14.4	10.4	18.0	13.0	17.3	16.5	12.7	11.0	20.2	16.2	0.7	14.4	8.8	14.1	18.4	12.2	43.4	37.1	22.9	38.4	44.2	34.9	47.5	26.4	31.0	29.4	14.9	8.0	28.1	32.4	60.9	36.5	11.3	12.7	12.0	15.9	12.2	15.7	71.0	74.6	41.8	4.1	24.5	12.6	0.0	22.6	47.0	29.3	32.2	38.0	10.2	49.6	27.0	28.2	13.5	22.1	4.1	24.5	27.7	37.1	45.1	21.1	46.8	34.7	8.6	22.6	42.5	27.7	12.9	30.9	6.8	22.6	56.0	39.0	34.8	25.8	31.0
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 68.3;Muller glia cells: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		300000	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.7	1.9	3.9	0.2	4.0	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	1.9	0.0	0.5	2.5	5.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	6.9	9.2	0.0	0.0	0.0	1.3	0.0	0.1	5.8	7.9	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5	11.9	9.8	0.0	4.7	0.8	11.0	8.1	7.6	68.3	9.1	22.7	3.9	4.2	1.7	6.9	0.8	0.1	1.4	0.0	6.5	2.4	3.3	16.0	4.6	0.0	0.3	9.5	7.9	0.6	0.0	1.5	2.6	0.7	0.0	1.0	3.4	94.1	2.7	2.9	11.3	16.2	2.9	6.5	0.7	0.2	2.3	0.5	0.2	3.8	2.5	2.6
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2, transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345953	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	31.9	35.0	28.7	28.1	34.3	44.4	34.8	20.6	31.4	28.2	34.5	18.7	28.3	31.8	24.6	33.8	30.1	22.9	19.1	34.0	31.8	26.2	44.1	58.8	24.7	26.6	27.6	28.3	19.6	27.8	16.5	35.8	30.6	29.1	24.0	33.7	19.9	27.2	25.9	66.7	20.3	31.6	28.4	31.9	30.6	29.0	21.3	24.3	26.1	24.3	29.5	30.3	29.6	23.3	14.0	32.1	30.3	38.9	13.0	14.6	22.6	42.3	35.5	52.8	23.7	20.1	25.8	15.2	33.9	21.9	34.8	44.0	26.2	26.4	27.6	31.9	26.3	15.8	21.7	23.6	24.0	42.5	43.7	27.9	53.0	26.7	53.9	21.5	18.2	33.0	19.5	16.4	22.9	21.7	25.5	52.3	27.3	50.4	15.6	39.5	69.1	55.0	41.4	38.3	49.6	34.6	35.1	23.0	34.2	47.0	32.6	31.9	34.4	21.2	26.7	28.9	30.4	33.9	31.6	35.5	23.4	39.5	24.2	34.3	26.7	28.5	52.2	23.6	30.8	27.2	16.3	35.6	30.3	10.7	37.1	13.2	14.0	14.6	13.0	32.1	9.6	12.1	13.3	19.4	13.0	38.9	26.5	14.2	22.6	28.7	34.3	20.6	31.4	31.8	26.2	27.6	28.3	29.1	24.3	65.5	81.6	148.3	163.4	164.9	66.1	154.2	137.6	89.7	112.6	137.9	115.8	224.8	323.3	190.8	103.7	229.2	183.6	46.7	173.6	235.2	173.8	163.6	89.0	317.8	241.4	42.9	147.9	137.5	200.9	78.7	137.2	217.4	150.1	225.4	166.7	92.6	220.3	192.9	105.7	416.4	119.0	77.6	185.8	187.5	108.4	152.6	139.9	126.9	175.3	175.2
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.3	5.7	0.3	0.4	27.6	17.8	46.9	16.9	46.2	9.7	10.6	1.0	0.9	0.0	4.2	32.2	9.7	2.6	0.1	13.5	7.3	0.1	0.2	0.0	1.8	12.0	58.7	0.0	3.4	26.0	18.7	19.0	13.4	7.2	33.4	0.1	0.5	0.0	5.9	4.6	0.1	0.1	0.2	3.7	3.2	0.1	0.6	1.7	6.0	58.1	0.2	12.0	13.3	30.6	3.6	12.5	2.0	2.3	58.0	50.4	1.4	6.7	1.4	0.0	0.0	0.0	36.7	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0	71.5	137.9	8.1	61.5	42.7	3.5	58.5	50.9	30.8	96.7	3.5	9.8	93.6	1.7	15.5	12.6	341.0	66.4	0.0	45.9	256.0	104.5	46.7	40.4	77.4	47.9	0.0	4.1	438.9	58.4	41.8	11.5	23.9	27.0	0.0	13.6	89.1	25.9	40.4	6.0	24.0	57.7	278.1	281.4	1.2	1.7	29.1	292.5	9.6	11.6	58.0
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 68.8;Ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 20.0;HeLa: 22.6;RT4: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	21.4	3.7	3.5	5.0	4.0	2.1	19.0	2.1	6.1	7.3	3.0	1.7	22.1	1.9	6.1	11.3	13.6	6.2	11.7	9.3	4.0	3.1	10.0	4.8	21.9	6.9	3.7	2.0	4.9	4.2	14.3	4.3	8.9	3.7	5.3	3.8	10.5	7.7	22.0	6.8	7.2	3.2	5.9	4.3	6.7	4.3	4.8	1.9	2.1	15.7	8.2	6.9	5.5	12.2	3.6	0.5	1.3	1.2	0.4	4.8	0.9	0.5	3.5	9.2	0.9	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.9	7.8	3.8	20.0	0.0	0.5	4.7	0.6	4.3	0.0	0.6	3.2	6.1	22.6	1.2	0.1	1.6	2.0	0.0	1.9	0.0	0.0	1.0	5.8	1.1	1.2	3.6	0.0	1.1	2.8	2.1	1.7	0.7	0.7	1.4	7.0	0.8	5.4	13.6	7.7	4.0	6.8	3.4	2.7	6.7	10.2	0.8	10.0	0.4	1.6	1.2	2.7	3.6	0.7	2.9	0.9	3.2	0.5	1.3	0.4	0.2	4.8	0.6	2.7	3.6	1.5	1.4	0.5	3.3	2.4	4.7	0.5	0.4	1.2	0.3	1.4	0.9	3.5	4.0	2.1	3.9	4.0	3.1	3.7	2.0	3.7	1.9	26.8	7.7	4.2	14.0	5.4	4.0	7.6	68.8	42.8	27.3	14.0	3.9	6.0	10.0	12.3	16.7	18.0	2.6	0.0	6.8	0.9	6.7	12.1	8.1	1.7	2.1	1.6	1.2	30.1	5.6	14.1	1.7	1.3	3.3	4.6	6.3	7.7	10.4	10.5	1.8	20.3	31.5	0.0	4.7	1.6	6.1	7.0	2.1	1.7	4.5	16.3
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 186.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	92	"HEL: 43.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3	0.0	0.0	0.5	1.2	1.6	3.7	0.3	2.5	0.0	0.0	0.0	5.9	3.3	0.0	0.0	7.7	0.6	1.1	186.9	0.0	1.9	1.7	1.0	4.6	0.5	1.0	6.4	0.0	1.3	0.3	8.0	2.6	0.8	1.7	0.0	0.8	2.8	0.0	1.7	0.7	0.0	7.8	6.5	1.2	12.1	3.8	2.5	5.6	4.4	0.6	1.6
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	17.3	10.0	13.2	19.9	14.3	35.0	19.4	45.3	16.3	20.1	18.0	15.6	13.6	10.6	21.4	15.1	11.7	17.3	12.4	13.5	13.0	10.5	12.3	13.9	13.7	20.5	14.1	10.1	25.4	19.9	20.4	35.7	12.5	12.6	17.2	16.1	15.8	15.1	14.7	22.0	16.8	15.5	21.5	14.3	18.9	13.2	10.2	17.8	41.2	17.9	14.4	19.9	19.1	17.8	12.7	11.1	16.1	6.1	6.6	9.1	3.1	8.0	8.3	17.1	14.4	8.1	11.6	6.7	9.4	5.7	10.3	10.1	5.7	9.6	14.7	6.3	9.5	5.0	7.7	9.0	7.4	7.6	12.1	8.5	12.7	7.0	7.0	8.9	8.6	14.5	9.7	12.4	6.8	5.0	11.9	9.4	9.9	10.6	18.4	9.8	7.9	15.9	6.2	3.8	8.0	3.2	18.0	13.9	7.0	8.4	7.6	13.1	13.5	8.3	6.2	12.6	9.3	6.0	14.3	9.7	7.4	10.6	5.1	7.6	7.9	6.0	15.5	7.2	13.8	6.8	14.6	6.1	10.9	8.6	4.0	9.1	10.7	8.6	7.8	3.9	12.7	8.9	8.1	16.1	6.6	5.8	11.1	8.7	3.1	13.2	14.3	45.3	16.3	13.0	10.5	14.1	10.1	12.6	17.8	38.7	44.0	77.3	86.8	25.3	99.6	29.1	45.9	42.8	43.3	38.4	64.8	30.6	8.3	43.7	7.1	51.7	46.2	23.3	38.1	32.8	45.2	61.4	82.1	31.6	31.0	108.1	94.6	41.1	43.7	8.9	87.8	51.5	38.8	56.9	46.9	54.5	39.7	45.2	64.0	15.9	84.6	97.0	49.1	82.2	32.8	21.8	38.6	107.8	41.2	54.7
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.0	12.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.0	25.1	0.2	0.0	0.0	0.0	0.1	20.9	0.2	0.0	0.0	10.8	0.0	0.1	24.1	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0	0.0	0.0	0.0	3.4	2.1	0.3	4.8	7.6	0.0	0.0	17.4	0.0	52.4	5.0	5.6	0.4	0.1	9.3	0.0	10.0	5.6	0.3	4.4	0.0	0.0	5.1	0.0	3.5	0.0	0.0	1.8	2.6	0.0	0.0	1.0	17.7	0.5	5.2	10.5	0.0	0.0	0.3	0.0	0.3	0.0	0.4	4.8	8.9	0.0	16.6	5.8
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.6	6.2	12.9	18.1	7.7	9.1	6.8	18.0	12.4	23.3	17.9	14.3	8.7	4.5	10.3	17.5	8.5	6.5	9.0	15.1	8.9	10.9	14.8	7.7	11.7	15.1	16.3	12.2	13.6	10.5	2.4	26.6	15.1	13.0	13.5	13.0	18.6	5.1	16.0	6.1	7.1	8.1	5.9	11.6	10.9	13.8	9.2	3.8	6.7	11.2	7.5	8.2	16.0	11.3	6.4	10.2	10.7	16.2	17.5	22.3	12.2	9.4	40.0	11.9	6.8	6.5	6.6	7.4	9.8	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8	6.0	4.3	3.6	3.9	5.6	0.0	6.0	10.2	6.7	5.7	5.2	0.0	9.4	11.6	7.6	4.1	3.8	2.9	0.0	7.0	10.0	6.8	3.5	0.0	11.5	9.8	0.0	6.9	9.2	7.3	2.2	6.1	4.6	3.3	1.8	7.8	0.0	6.2	3.5	7.4	11.3	0.0	0.0	5.2	33.8	11.0	5.0	4.0	2.9	7.7	3.3
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"Q03468, P0DP91, Q8N328"	10	49455368-49539538	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 25.1;hTERT-RPE1: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	7.9	6.9	11.5	6.0	12.3	13.9	11.1	21.0	13.9	9.8	7.0	8.9	10.6	6.4	9.3	8.6	13.5	8.1	7.7	9.1	12.7	6.5	10.1	10.0	8.0	7.9	9.2	11.4	12.5	13.1	20.3	14.2	9.7	10.1	10.5	8.8	9.2	10.5	13.7	9.6	14.4	9.1	7.9	11.8	9.2	7.6	7.8	12.4	7.8	13.6	8.2	9.6	9.9	11.6	7.9	5.1	10.9	8.1	1.6	5.3	2.1	4.8	2.5	1.9	1.2	3.3	5.5	1.5	8.7	12.1	6.0	4.2	2.6	3.0	2.1	1.6	7.8	2.9	4.6	2.7	6.9	6.1	3.4	1.7	1.6	9.6	1.4	1.9	2.2	1.7	1.9	9.4	5.8	25.1	57.2	8.7	1.5	3.2	0.6	7.7	3.5	1.5	1.3	1.7	1.9	4.5	1.4	2.8	1.2	2.0	3.5	2.5	2.7	6.4	2.3	3.9	4.4	4.2	1.2	16.7	3.3	2.7	4.0	2.2	2.3	2.2	2.0	4.1	2.4	2.4	10.9	4.1	9.7	5.3	3.7	4.2	7.9	3.1	2.9	5.1	6.3	3.8	1.8	9.8	1.6	8.1	2.8	4.0	2.1	11.5	12.3	21.0	13.9	12.7	6.5	9.2	11.4	10.1	12.4	14.9	10.4	2.4	1.3	3.2	0.0	4.9	7.6	13.4	12.5	8.7	0.0	1.9	5.0	4.6	8.2	2.0	3.8	0.0	5.3	1.5	3.5	2.3	7.0	4.0	2.3	0.0	1.2	3.7	3.8	10.6	2.6	3.9	1.7	14.4	4.5	0.0	4.8	3.5	2.1	2.8	0.0	6.5	1.9	5.4	4.2	3.6	1.5	5.0	2.4	1.6
ERCC6L2	"C9orf102, FLJ37706, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95875701-96014571	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021260, HPA022422"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021260: AB_1859544, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	13.5	13.9	14.6	12.7	17.4	7.6	13.6	21.8	19.3	17.7	12.9	13.2	13.9	10.4	18.7	11.8	11.6	11.4	11.8	13.3	14.0	9.7	12.4	11.7	12.7	15.0	15.3	12.2	21.7	10.6	26.2	22.0	11.7	16.1	15.5	11.5	11.0	11.2	12.7	13.9	10.1	13.5	16.1	12.1	15.8	13.4	12.5	15.4	29.7	20.3	7.1	12.4	17.4	13.8	7.3	12.7	4.3	5.3	5.1	12.9	4.0	11.4	14.6	17.3	12.4	6.8	11.6	8.3	10.2	10.4	10.4	11.9	11.2	5.1	13.0	5.7	14.6	14.9	14.3	16.6	7.1	15.4	9.3	8.0	11.7	11.1	7.2	6.6	14.9	11.6	10.3	7.3	12.8	10.2	9.6	9.7	13.4	15.1	7.3	10.7	9.2	12.4	5.6	12.9	12.3	8.8	11.6	22.5	4.6	8.8	10.5	16.2	12.4	7.2	7.6	7.3	9.4	7.1	7.7	10.2	11.7	14.9	14.4	12.0	4.9	7.4	6.2	11.3	7.1	16.9	3.2	4.4	4.3	8.7	5.3	8.4	5.7	8.3	9.3	4.8	7.3	12.9	9.4	2.7	5.1	4.2	12.7	9.9	4.0	14.6	17.4	21.8	19.3	14.0	9.7	15.3	12.2	16.1	15.4	14.9	15.2	4.7	11.1	4.4	0.0	15.9	7.6	21.4	18.2	0.0	0.0	4.5	0.0	7.6	6.2	7.2	5.9	23.3	7.0	2.8	7.5	8.6	15.0	6.0	5.5	0.0	4.7	8.0	9.1	3.0	24.7	10.6	3.3	8.2	7.1	0.0	6.3	3.5	26.2	2.8	0.0	19.4	10.3	15.2	9.6	3.9	4.0	12.8	5.6	7.5
ERG	"erg-3, p55"	ENSG00000157554	"ERG, ETS transcription factor"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 84.3;granulocytes: 22.1;Ito cells: 63.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.7;NK-cell: 1.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 1.0"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 43.7;MOLT-4: 14.3;REH: 46.4;TIME: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018377, HPA046598"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	39.1	4.2	5.7	6.5	8.5	6.6	20.5	3.6	7.0	17.9	5.2	2.3	5.6	3.3	16.9	9.0	6.2	9.2	11.6	10.1	6.2	3.6	10.8	6.0	19.9	7.4	8.0	1.8	7.7	4.8	2.3	3.9	23.2	8.0	8.1	3.6	7.8	4.2	5.6	13.5	5.3	6.2	11.8	4.7	32.5	5.0	4.8	5.0	2.4	10.8	9.1	3.6	9.6	15.8	0.0	1.7	0.0	0.2	1.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.1	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	35.4	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	5.7	8.5	3.6	7.0	6.2	3.6	8.0	1.8	8.0	5.0	0.0	4.6	1.9	1.5	3.1	0.0	2.5	7.6	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.5	84.3	0.0	0.0	0.0	0.0	2.1	0.4	22.1	0.8	0.2	0.0	0.0	63.3	9.8	1.5	0.9	1.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.9	3.0	0.0	0.0	0.0	0.6
ERG28	"C14orf1, NET51"	ENSG00000133935	"Ergosterol biosynthesis 28 homolog"	Q9UKR5	14	75649791-75661189	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 130.3;Ductal cells: 84.3;Exocrine glandular cells: 97.0;Extravillous trophoblasts: 121.7;Syncytiotrophoblasts: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043172, HPA063568"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043172: AB_10793942, HPA063568: AB_2685043"	"unprognostic (2.68e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (4.30e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.20e-1)"	6.4	20.0	14.2	6.3	16.3	8.1	12.6	9.2	25.5	11.8	11.7	16.3	10.5	14.9	11.3	29.6	23.7	12.4	11.8	9.4	13.6	15.5	17.6	48.3	19.3	9.4	11.9	10.4	15.0	12.4	16.5	13.2	15.6	17.9	15.5	11.2	26.2	15.4	10.6	6.6	15.6	16.9	10.5	18.2	7.1	9.5	52.2	9.6	7.5	24.3	21.3	15.6	9.2	13.5	18.1	18.2	11.8	6.0	14.2	22.0	13.9	14.2	8.0	16.3	12.6	11.0	20.6	10.1	5.8	18.0	11.3	19.5	12.3	34.1	6.0	8.5	7.2	22.7	15.8	14.3	24.8	13.0	11.3	9.5	6.5	8.2	17.4	16.1	7.1	9.8	25.7	21.4	16.2	9.1	9.1	13.1	16.7	5.8	14.8	7.8	28.0	10.8	7.9	15.8	22.8	13.0	8.7	11.0	12.0	37.1	18.5	14.0	7.8	14.7	12.6	8.7	15.0	21.0	10.6	9.4	6.2	12.5	5.9	5.8	9.7	11.3	13.1	9.9	10.5	10.4	11.8	6.0	8.9	20.1	5.9	19.8	18.1	22.0	20.9	14.2	15.3	20.2	20.1	3.2	14.2	5.9	18.2	19.4	13.9	14.2	16.3	9.2	25.5	13.6	15.5	11.9	10.4	17.9	9.6	20.8	41.5	0.0	0.0	0.0	0.0	0.0	0.0	33.5	20.5	57.6	0.0	130.3	41.4	84.3	0.0	0.0	0.0	0.0	97.0	121.7	0.0	0.0	4.7	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	65.9	0.0	0.0	61.2	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	97.3	0.0	0.0	0.0
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834275-172952685	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 213.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	30.2	56.5	14.2	20.6	13.8	12.0	44.6	25.5	18.1	42.9	30.5	12.3	35.6	24.6	26.4	24.9	22.6	23.7	30.3	20.7	14.2	11.4	36.4	120.8	28.6	29.3	14.5	11.4	22.5	55.5	15.6	18.9	25.5	13.5	48.1	32.9	19.2	51.5	29.3	27.1	16.7	32.6	22.0	10.8	30.8	36.5	15.8	13.2	29.1	41.5	20.9	25.8	21.3	45.8	6.6	4.2	20.8	9.2	8.5	3.8	3.0	20.6	19.8	17.0	37.8	65.2	48.8	9.4	42.2	32.0	19.0	17.8	28.1	21.3	19.9	30.2	71.1	32.8	7.6	12.4	56.0	22.4	15.8	12.3	12.3	29.1	15.0	47.8	5.7	3.9	41.3	23.4	28.0	26.3	31.5	30.5	20.9	7.3	28.0	31.5	25.9	16.3	9.8	10.1	49.3	18.3	56.3	11.3	61.2	44.5	12.0	9.6	17.3	14.7	42.0	21.1	17.2	17.5	6.5	23.2	31.1	12.7	29.8	17.1	44.5	49.7	8.3	43.3	13.7	13.6	2.1	4.9	12.1	2.3	7.1	3.8	6.6	1.2	1.5	4.2	4.9	1.0	1.6	20.8	8.5	9.2	2.1	0.7	3.0	14.2	13.8	25.5	18.1	14.2	11.4	14.5	11.4	13.5	13.2	53.6	29.3	64.1	27.9	20.3	36.1	28.5	68.8	20.1	17.0	47.1	15.7	17.7	18.3	91.9	9.5	25.1	68.5	0.0	52.8	71.8	28.5	108.1	23.1	213.3	39.2	20.6	25.0	42.4	73.2	21.3	60.1	52.3	6.8	111.0	176.8	39.2	69.9	52.6	54.8	35.9	11.1	38.8	23.7	1.4	8.9	23.5	7.6	26.1	58.7	42.7
ERH	DROER	ENSG00000100632	"ERH, mRNA splicing and mitosis factor"	P84090	14	69380123-69398627	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	42.6	45.4	54.9	43.9	46.7	47.0	51.3	45.1	48.4	46.6	43.5	31.1	39.4	42.1	53.3	63.3	44.8	46.4	35.9	40.6	47.6	51.1	56.1	62.2	34.5	52.5	43.5	48.5	47.8	38.7	23.9	45.5	55.2	45.4	40.4	50.3	41.3	58.5	40.3	43.3	31.0	47.3	46.9	43.6	55.2	35.6	54.6	28.4	72.2	55.2	37.5	64.4	47.7	36.8	38.7	37.3	24.2	32.4	34.1	35.3	38.8	90.9	59.0	59.1	39.4	29.7	21.9	35.8	47.7	27.5	43.1	40.4	60.1	37.8	86.3	21.0	31.9	32.9	26.7	59.8	39.6	51.3	45.0	36.5	43.3	39.2	67.1	45.8	37.6	31.5	24.9	21.3	38.5	34.6	24.5	35.2	56.0	41.7	29.0	35.2	104.0	56.8	53.6	46.1	48.2	56.0	46.1	58.6	29.5	43.4	62.2	45.5	42.4	45.5	41.7	26.1	35.0	51.3	52.7	37.6	42.2	62.5	28.0	47.4	32.6	30.9	96.5	31.3	40.0	40.7	15.3	32.4	24.2	26.1	30.1	25.7	38.7	32.5	28.6	34.0	30.6	30.7	27.2	15.4	34.1	27.1	37.3	35.3	38.8	54.9	46.7	45.1	48.4	47.6	51.1	43.5	48.5	45.4	28.4	56.6	48.3	181.6	193.1	242.6	132.5	105.5	158.0	116.4	66.0	240.8	35.3	400.5	570.3	308.1	69.0	200.3	146.7	93.5	240.5	449.3	263.5	196.9	126.7	237.4	297.7	69.9	181.0	155.9	148.1	29.8	250.8	172.7	291.8	355.3	176.1	207.1	246.0	166.8	243.6	389.2	92.5	187.5	273.0	273.2	229.3	278.7	234.1	150.3	215.6	194.6
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7;Spermatocytes: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 11.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	18.5	14.3	9.2	7.5	10.4	8.5	15.0	7.8	11.9	8.3	11.2	12.0	9.3	12.2	8.2	12.1	12.4	9.1	8.9	8.4	9.0	7.9	12.7	19.4	8.2	5.3	11.7	7.4	9.9	14.4	19.2	14.9	10.1	11.1	12.0	15.7	8.1	10.3	11.0	7.0	10.7	12.1	11.8	12.2	6.4	12.7	21.3	9.7	10.8	9.7	12.1	6.6	9.6	15.1	0.6	2.4	11.8	2.9	0.7	0.9	0.6	10.8	5.2	14.3	6.2	4.4	5.6	8.6	8.5	5.1	7.8	9.9	6.5	11.3	3.0	9.9	4.7	5.4	8.2	14.2	8.9	14.6	9.6	7.5	7.4	6.1	11.2	4.0	14.1	6.2	5.1	11.1	10.5	8.8	4.2	4.7	0.0	23.3	9.0	13.1	9.6	2.0	12.6	8.8	11.3	2.9	16.2	11.7	6.7	7.2	8.5	7.3	8.9	5.5	10.6	6.5	7.9	22.2	15.7	3.5	8.4	4.7	8.0	11.4	5.5	8.3	1.8	7.9	11.5	11.5	11.8	2.3	2.0	0.6	1.7	0.4	0.6	0.5	0.6	2.4	0.1	0.4	0.3	0.1	0.7	2.9	0.8	0.9	0.6	9.2	10.4	7.8	11.9	9.0	7.9	11.7	7.4	11.1	9.7	14.9	4.1	0.0	5.0	4.4	4.5	6.4	5.1	14.7	9.1	8.7	0.0	6.2	8.3	3.5	14.0	2.9	5.1	46.7	4.5	7.5	3.3	4.6	0.0	9.6	7.2	3.2	0.0	2.5	6.1	11.4	5.8	4.1	1.7	6.4	9.6	4.7	4.5	7.8	4.9	5.7	3.1	0.0	3.3	36.3	22.0	3.1	3.1	2.2	7.6	4.3
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 823.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	12.6	15.4	30.7	8.3	32.0	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10.0	23.9	26.8	18.6	15.7	24.0	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11.0	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.6	22.2	28.2	31.2	18.5	23.3	17.7	18.8	25.0	33.4	31.2	14.3	30.7	20.5	31.8	23.1	17.1	16.6	25.2	32.0	23.6	22.9	48.6	22.9	37.5	20.2	27.1	23.1	13.2	23.7	30.1	25.3	34.8	24.8	22.9	22.9	22.3	16.7	21.9	19.3	25.6	21.6	33.4	25.5	35.2	24.7	25.9	30.0	25.9	15.1	48.1	22.7	20.5	28.1	33.2	23.3	18.4	19.1	13.9	22.1	23.1	24.0	28.4	15.9	18.5	22.0	27.4	20.1	27.8	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14.0	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32.0	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9	23.8	16.8	23.4	29.6	28.0	20.9	13.7	10.2	10.7	9.1	27.9	2.0	80.0	82.9	48.6	192.5	20.2	20.0	0.0	54.5	67.1	42.9	35.8	15.0	21.3	39.5	23.8	113.7	19.6	24.3	823.2	33.6	22.4	45.5	35.1	48.9	30.3	33.0	25.9	34.3	131.8	13.5	6.5	31.1	46.2	48.7	30.2	51.5	15.4	35.1	23.5
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443158-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 78.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 73.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.4	21.0	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0.0	10.0	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.9	0.0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	73.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0
ERP29	"C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013316-112023451	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"	NA	NA		4900000	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	19.1	37.1	20.2	32.4	19.8	55.1	39.7	29.5	30.8	23.3	45.8	16.8	66.5	32.0	23.1	38.3	30.6	24.6	39.0	24.2	18.6	24.9	34.9	67.5	33.8	61.2	22.5	19.7	28.5	111.2	33.3	35.9	46.1	23.4	30.9	29.6	23.2	61.5	58.8	13.0	37.0	35.6	27.2	21.4	41.6	39.5	31.7	16.3	35.8	53.8	28.3	37.6	24.4	30.9	49.2	83.9	60.6	43.3	14.8	37.7	46.6	20.3	19.9	14.6	28.4	55.4	22.2	31.2	20.0	24.6	16.3	21.0	30.9	23.7	21.8	15.7	34.8	17.3	25.4	27.2	25.9	13.3	18.6	15.2	24.7	22.6	34.7	37.5	60.3	24.2	31.6	34.0	26.3	30.7	43.4	22.6	23.4	28.1	40.7	12.3	23.6	19.7	109.7	23.8	72.3	15.0	16.4	17.8	70.1	33.4	31.4	13.3	17.9	24.9	20.7	60.1	28.9	25.9	83.2	16.8	13.8	21.4	13.1	14.8	45.2	51.8	18.4	23.3	38.1	10.7	14.8	43.3	60.6	25.5	32.0	27.6	47.9	33.8	31.6	41.9	49.2	37.7	30.7	8.7	14.8	29.0	83.9	31.5	46.6	20.2	19.8	29.5	30.8	18.6	24.9	22.5	19.7	23.4	16.3	77.4	153.2	311.9	160.1	125.5	118.0	81.5	201.2	108.4	83.0	176.2	104.1	416.0	79.6	181.9	5.0	100.2	238.7	46.7	186.3	318.9	107.4	199.9	87.6	289.4	332.4	76.3	189.9	117.9	288.1	11.5	119.3	206.5	160.3	143.3	207.8	130.1	146.6	273.5	100.4	213.5	151.3	51.8	107.2	40.1	200.2	140.8	369.3	228.4	248.2	181.2
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		5000000	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.5	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	28.2	6.0	0.0	0.6	0.1	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	20.3	0.0	3.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	1.9	1.8	0.8	0.0	0.0	0.0	15.1	0.4	1.2	0.3	1.9	0.8	0.0	3.0	2.5	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3	0.0	0.0	0.0	1.1	0.5	0.0	2.4	0.0	0.0	0.0	7.0	0.0	66.3	0.0	2.3	3.2	0.1	0.0	0.0	0.7	80.6	1.3	1.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.3	0.2	0.4	0.1	14.5	0.0	0.4	1.1
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784886	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047083: AB_2679924, HPA050396: AB_2681111"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.4	10.5	13.5	9.7	19.7	7.1	11.9	17.0	17.4	10.8	8.8	6.9	9.2	7.7	11.2	11.5	11.9	9.2	9.1	9.7	17.2	11.6	10.8	14.6	7.0	10.3	16.8	17.5	14.1	8.7	12.9	20.0	11.9	17.2	12.2	10.7	4.2	8.9	8.6	29.9	11.3	7.5	12.9	28.9	10.7	8.1	14.3	17.9	9.2	11.5	12.1	10.1	11.2	9.2	13.8	14.6	2.0	10.6	11.5	12.4	3.7	13.4	12.8	11.9	6.0	9.1	11.0	6.6	14.4	8.8	10.5	9.0	13.6	12.7	17.7	7.3	6.8	19.6	20.7	17.7	14.4	18.7	4.7	8.4	23.3	5.2	31.9	12.7	28.0	6.4	8.8	10.3	17.2	14.0	7.8	7.9	9.2	32.3	8.1	11.9	11.9	21.2	16.8	11.4	12.5	7.7	13.8	29.5	12.9	7.4	11.9	11.7	7.2	11.6	18.3	17.9	11.6	9.2	12.3	10.7	16.2	11.2	11.8	26.6	8.2	19.7	21.7	6.8	12.3	14.7	1.8	6.9	2.0	8.7	8.6	10.0	13.6	10.0	9.3	6.9	13.8	12.4	11.3	0.4	11.5	10.6	14.6	7.5	3.7	13.5	19.7	17.0	17.4	17.2	11.6	16.8	17.5	17.2	17.9	20.8	32.3	50.2	39.5	55.0	83.6	53.4	40.8	40.2	51.2	31.4	43.2	41.7	28.2	45.6	67.2	39.8	42.3	0.0	36.5	34.4	44.1	25.1	25.4	49.7	38.2	90.6	46.6	38.1	29.7	20.6	60.4	41.3	25.3	49.5	47.3	45.9	48.7	42.1	69.3	31.9	67.2	32.3	50.5	168.4	174.8	46.9	34.7	29.9	52.5	31.5
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Cell type enhanced"	"Detected in some"	6	"Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.6	12.9	13.8	11.3	0.3	1.2	8.5	8.3	4.2	14.3	9.1	7.0	11.1	22.8	4.6	3.4	8.4	10.5	16.0	4.9	7.5	7.1	16.2	15.3	11.7	5.3	0.0	9.6	12.7	0.4	0.3	8.3	4.1	1.4	7.3	11.3	20.5	20.6	4.2	13.1	15.0	8.2	11.2	7.5	7.0	14.1	14.8	9.5	2.0	5.3	10.0	7.7	7.0	10.3	5.4	6.8	17.0	6.4	3.3	7.2	14.0	6.0	11.4	15.3	14.2	15.4	4.1	9.1	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.2	0.6	0.4	4.1	0.0	0.0	1.9	1.0	0.3	0.0	4.9	2.1	0.0	3.4	1.3	0.6	1.1	0.0	1.3	0.0	0.0	1.2	0.0	1.0	0.2	0.4	5.6	0.0	0.0	0.4	6.5	2.7	0.5	0.2	0.0	3.1	0.5
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 68.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 36.0;Hepatocytes: 48.4;Horizontal cells: 58.8"	"Group enriched"	"Detected in many"	9	"breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MCF7: 24.9;T-47d: 32.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	3.0	0.9	0.5	1.6	0.5	0.2	16.2	0.8	0.4	64.5	1.5	0.2	2.2	0.1	68.9	27.7	1.1	26.7	1.9	1.1	0.5	0.8	1.5	6.6	3.6	1.6	0.4	0.1	14.2	0.4	0.0	9.3	0.9	0.6	3.6	0.1	2.6	1.6	4.1	2.0	0.6	0.5	20.8	0.4	1.6	0.3	1.9	0.4	1.9	1.3	2.2	2.5	3.8	23.7	0.6	1.0	0.0	0.8	0.3	2.5	1.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.1	32.2	0.0	0.0	0.1	0.1	0.3	0.0	3.0	0.5	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.3	0.2	1.0	0.6	1.3	0.4	1.0	0.4	2.5	0.9	0.0	0.3	0.0	0.0	0.3	1.0	0.5	0.5	0.8	0.4	0.5	0.8	0.4	0.1	0.6	0.4	0.0	0.6	0.0	1.4	0.9	3.8	4.5	0.0	1.4	1.2	0.0	7.9	0.1	1.7	0.0	36.0	0.6	0.0	0.0	0.2	0.1	4.7	0.6	2.3	48.4	0.9	58.8	1.7	6.7	4.7	6.9	3.7	2.4	1.7	0.0	0.0	2.7	0.2	0.0	2.1	3.3	4.0	0.0	1.4	1.6	1.2	1.5	0.1	0.0	0.0	8.4
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 65.1"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.6	0.5	0.5	15.1	0.5	0.0	7.6	0.5	0.6	9.7	18.1	0.2	18.7	7.7	3.3	21.3	43.1	6.6	14.5	0.6	0.5	0.5	6.4	0.7	15.5	0.8	0.5	0.2	1.8	65.1	11.8	10.1	18.5	0.3	8.9	20.8	0.2	38.2	15.1	0.5	24.8	12.7	1.9	0.5	0.5	12.1	1.0	0.2	1.4	20.2	30.4	28.9	9.0	16.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	33.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	10.9	35.1	0.0	0.9	0.0	0.0	20.4	0.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.4	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	16.2	0.4	0.1	3.1	34.8	0.8	0.0	0.0	4.4	4.4	24.4	8.9	0.0	0.0	5.2	3.3	5.6	27.1	0.2	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.2	0.3	0.2	35.7	23.4	0.5	19.5	39.6	0.0	0.7	20.4	30.8	22.7	26.2	0.0	45.8	11.6	18.7	5.9	0.0	53.4	0.0	24.0	54.1	2.0	25.5	1.1	0.0	5.1	0.0	31.9	0.0	0.0	6.8	0.0	0.6	23.6	1.0	101.9	0.0	21.5	42.1	0.7	0.3	0.0	0.0	0.9	0.2	0.7	69.3	51.9	0.0	68.9	33.0
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 14.5;retina: 50.2"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.2	0.1	0.3	0.0	1.0	0.0	0.6	0.3	0.6	0.1	0.0	0.8	0.3	0.0	0.1	0.4	0.1	0.1	0.0	7.8	0.3	0.4	14.5	0.1	0.1	0.9	0.5	0.4	0.0	0.2	0.0	0.3	0.1	1.3	0.2	0.0	50.2	0.1	0.4	9.5	0.0	0.1	0.0	0.5	1.2	5.1	2.0	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.5	0.5	0.0	0.1	0.0	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.7	0.4	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	1.0	0.1	0.5	4.9	1.4	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.3	0.6	0.3	0.4	0.5	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.0	0.0	0.0	2.0	0.0	11.6	0.0	14.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	52.4	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.3	40.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
ETAA1	ETAA16	ENSG00000143971	"ETAA1, ATR kinase activator"	Q9NY74	2	67397319-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	9.3	23.4	6.4	11.0	11.3	6.6	14.7	14.0	10.6	15.4	11.7	6.3	9.4	7.2	14.6	13.9	12.0	13.9	15.7	9.4	8.7	5.5	17.5	11.1	11.3	14.8	9.7	10.4	15.6	16.2	14.2	13.9	8.8	10.7	11.6	9.2	6.1	12.4	13.7	11.4	12.4	11.1	10.6	8.5	11.8	10.5	11.3	10.3	19.2	15.9	9.7	9.8	11.6	12.7	7.5	4.4	3.4	5.2	4.2	7.4	3.1	9.1	7.0	12.0	10.8	9.4	13.0	9.8	9.8	13.0	10.4	10.1	5.6	11.1	17.1	5.4	8.0	14.7	11.2	10.1	11.8	15.0	10.0	8.1	9.5	17.0	8.2	8.9	9.4	9.0	10.2	16.9	7.7	12.1	16.6	16.5	14.0	7.7	7.4	14.3	4.1	13.9	10.4	12.2	14.7	7.7	10.1	19.1	7.9	12.7	6.0	10.1	20.1	9.9	9.1	9.3	12.3	7.9	4.6	11.4	14.2	10.9	6.7	11.4	8.3	7.4	13.8	13.2	10.0	10.7	3.4	2.5	2.0	5.5	4.1	6.0	7.5	5.1	3.2	3.1	7.0	7.0	6.2	0.2	4.2	5.2	4.4	7.4	3.1	6.4	11.3	14.0	10.6	8.7	5.5	9.7	10.4	10.7	10.3	20.8	16.0	0.0	6.9	2.2	4.8	8.5	17.8	22.7	10.3	12.2	0.0	5.7	10.0	15.6	0.3	3.1	4.2	0.0	15.9	5.0	7.6	6.2	5.8	8.2	4.1	4.8	10.3	7.4	5.1	1.5	11.2	6.7	1.7	9.0	6.1	5.2	16.4	3.5	12.4	10.0	4.3	0.0	3.1	11.4	7.8	2.3	1.7	5.0	6.0	4.7
ETV3	PE-1	ENSG00000117036	"ETS variant 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 155.1;Suprabasal keratinocytes: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	15.2	7.0	8.9	9.2	10.1	17.8	10.9	9.0	9.3	14.2	12.7	10.2	13.1	13.0	13.1	10.6	20.8	10.8	11.3	9.4	8.6	7.7	6.4	7.4	13.0	8.1	8.9	5.7	11.8	7.2	25.9	7.5	19.5	9.9	12.7	8.6	9.7	11.0	8.1	9.9	37.2	15.1	13.2	7.1	10.7	10.4	8.9	11.0	14.4	8.4	13.6	17.0	14.0	14.3	4.4	7.4	8.9	8.1	6.6	10.8	3.8	6.9	6.9	7.2	6.1	10.8	7.2	6.1	6.5	6.9	6.6	6.2	7.3	6.9	8.4	8.4	8.0	3.5	10.8	7.9	10.1	8.5	18.3	5.0	7.0	7.1	3.9	6.5	11.0	11.1	8.0	11.9	9.8	8.2	5.2	6.6	5.5	8.1	6.2	7.3	9.2	3.3	6.2	23.4	10.1	5.3	5.1	8.5	9.6	4.9	26.2	6.0	11.7	7.1	17.0	17.3	13.2	8.6	12.2	11.2	8.3	7.4	8.0	8.2	15.2	7.8	10.2	9.6	6.4	27.3	8.3	8.1	5.4	7.9	6.7	10.8	3.8	6.9	7.8	7.4	4.4	7.2	6.3	8.9	6.6	6.2	2.2	5.2	3.8	8.9	10.1	9.0	9.3	8.6	7.7	8.9	5.7	9.9	11.0	32.8	15.2	9.0	15.3	62.5	2.5	7.3	10.2	24.1	20.5	12.2	9.8	6.4	0.0	5.2	7.3	14.6	16.6	0.0	5.5	6.6	20.6	12.8	21.9	6.8	8.3	1.6	10.3	16.5	13.7	4.7	3.7	27.5	15.1	155.1	11.3	3.8	8.0	11.8	4.2	2.2	5.4	12.9	11.2	6.4	9.0	68.8	12.5	22.4	11.3	42.4
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711197-5814305	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 8.0;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	5.0	2.9	2.5	4.6	2.7	0.0	4.1	1.9	2.3	13.2	4.3	1.8	8.4	0.6	17.2	10.1	6.0	8.1	16.0	3.8	2.2	2.2	26.5	3.7	6.4	1.0	2.3	1.4	20.2	9.2	14.9	2.3	1.8	2.9	10.2	1.6	12.0	9.1	5.7	2.4	4.2	2.8	15.8	2.4	2.1	3.6	5.3	1.0	1.0	6.9	3.9	3.8	7.5	9.0	0.1	0.3	1.2	0.1	0.1	0.5	0.0	3.0	3.9	2.2	5.7	14.3	20.7	0.8	6.9	26.4	8.0	10.4	0.0	0.0	0.0	2.2	10.9	13.4	3.7	2.3	5.7	6.6	5.1	1.5	0.0	2.2	1.0	10.6	0.0	0.6	10.2	8.4	10.7	26.4	22.9	5.5	0.0	0.0	0.0	18.5	0.0	0.0	0.0	2.4	0.0	3.6	4.7	6.0	0.0	2.8	0.5	1.2	3.7	0.0	0.0	2.8	2.2	1.4	0.2	9.6	6.8	1.3	4.8	6.0	4.2	3.4	0.3	19.6	0.0	6.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.3	0.5	0.0	2.5	2.7	1.9	2.3	2.2	2.2	2.3	1.4	2.9	1.0	3.0	2.9	0.0	1.6	3.1	0.0	1.6	2.5	1.4	1.2	3.5	0.0	0.0	1.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.7	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	5.0	0.0	0.0	2.1	0.2	0.0	0.7	1.1	0.0	0.0	1.7	0.0	0.0	2.5	0.1	0.0	0.0	1.1
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31317560-31321884	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.7;brain: 74.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6"									"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA045033: AB_2679191, HPA057051: AB_2683321"	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	6.4	4.7	26.8	25.8	36.0	15.1	4.7	3.8	30.0	5.2	6.2	16.5	0.0	6.3	2.2	1.6	3.5	2.1	10.6	2.6	42.5	21.8	2.2	5.3	12.5	27.4	64.7	13.9	1.6	1.6	1.0	1.6	11.6	33.7	2.4	8.2	0.0	3.0	2.0	1.2	1.5	6.8	4.1	74.0	20.4	6.9	1.2	59.7	32.1	2.0	0.6	22.6	14.2	2.2	8.6	17.9	51.7	26.5	8.9	19.2	23.9	0.0	0.0	0.0	0.0	1.7	10.6	0.0	1.3	2.2	1.7	6.1	0.0	0.5	9.0	0.0	1.7	9.9	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	20.2	10.4	11.4	13.1	0.0	2.4	7.0	2.6	0.6	8.3	0.3	33.4	13.2	0.1	7.4	11.4	0.0	0.0	0.0	7.8	1.3	51.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.4	4.3	7.3	0.2	0.3	4.8	15.0	0.0	10.1	5.9	7.6	6.0	1.3	26.5	1.0	11.3	12.7	13.7	8.6	16.1	13.1	17.9	4.2	19.2	16.8	51.7	8.9	9.6	5.9	17.1	23.9	26.8	36.0	3.8	24.0	42.5	21.8	64.7	13.9	33.7	59.7	0.0	6.4	31.5	0.3	3.5	0.2	0.3	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.5	2.6	0.2	75.5	0.8	100.8	0.0	0.0	7.4	231.8	0.0	0.3	127.6	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.7	0.0	1.6	0.1	0.2	2.8	1.1	130.3	0.0	0.3
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377662-18389647	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.2;lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5"									HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	3.3	0.5	0.0	0.7	0.4	0.8	0.9	22.2	0.4	0.8	0.0	0.0	0.0	0.9	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.7	0.2	0.0	2.1	3.1	0.1	7.8	0.4	1.4	0.0	0.1	1.7	2.5	0.0	0.1	2.2	9.5	10.4	3.5	7.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	2.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.5	0.0	0.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	3.4	1.1	0.0	0.0	0.0	1.0
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No			Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	35.3	43.2	45.3	41.3	51.3	67.5	32.1	58.2	48.6	32.4	39.8	43.2	31.3	41.0	45.1	38.5	40.8	37.6	25.9	40.7	40.1	32.8	33.0	48.5	33.4	50.5	32.7	49.9	38.4	32.0	47.2	44.3	34.0	41.7	35.0	39.9	41.5	32.3	38.2	52.8	34.8	36.6	40.5	33.8	44.1	34.5	85.6	32.5	39.9	32.5	30.9	55.4	36.4	34.5	52.0	65.8	50.6	81.1	58.4	67.8	76.1	57.2	44.6	61.4	47.7	31.3	26.0	42.2	34.9	55.8	57.9	49.7	50.8	29.8	78.3	22.1	53.5	44.0	45.0	87.4	71.4	59.7	53.3	62.3	59.1	39.5	48.6	46.9	90.9	42.3	39.7	30.1	48.3	78.4	27.8	44.8	37.5	44.2	35.4	42.8	57.5	91.2	34.8	43.1	47.4	34.0	64.1	59.1	47.3	53.2	60.9	50.3	48.1	43.4	50.9	37.6	42.2	32.7	49.5	45.7	35.4	39.3	22.2	50.6	46.0	36.9	72.6	33.7	40.5	43.0	48.4	57.9	50.6	60.2	81.1	60.7	50.4	56.6	59.6	65.8	52.0	55.8	53.6	43.3	58.4	78.6	35.3	67.8	76.1	45.3	51.3	58.2	48.6	40.1	32.8	32.7	49.9	41.7	32.5	95.3	103.6	96.6	120.0	61.7	71.3	60.0	89.2	124.5	102.4	61.1	70.7	120.3	56.3	106.1	87.5	78.6	71.5	70.0	93.8	108.0	78.0	80.7	117.8	64.2	85.5	77.9	77.7	82.3	69.0	21.4	57.0	89.6	77.6	112.8	73.3	66.1	95.4	94.7	58.4	59.1	77.8	51.8	86.8	180.0	109.0	51.2	127.5	88.0	89.6	101.6
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.1	10.1	16.7	11.0	1.0	2.7	14.1	20.2	6.8	18.1	19.8	12.6	8.6	16.6	9.9	4.7	9.5	15.1	21.1	8.4	21.5	25.6	18.5	15.4	10.8	6.4	0.3	21.9	11.5	0.6	0.4	18.0	4.9	2.2	5.6	16.3	30.8	21.9	14.4	7.0	23.6	12.4	22.8	18.5	10.0	17.1	15.6	17.7	3.7	9.6	18.7	23.7	13.2	10.7	7.1	8.2	9.9	13.6	2.0	17.6	15.5	16.5	27.2	16.1	21.3	26.7	6.1	17.9	20.9	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1	0.0	0.0	0.0	0.1	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	0.0	0.0	0.0	14.1	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	9.8	6.9	0.1	3.3	0.7	0.6	0.1
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	8.6	9.1	9.9	8.6	12.4	6.5	16.9	13.9	10.4	8.6	8.4	5.5	11.1	6.9	11.7	8.9	8.5	8.4	7.5	10.3	8.5	5.9	9.9	10.7	8.3	12.3	6.4	10.2	7.5	8.1	8.4	6.9	8.1	6.5	8.9	8.4	7.3	9.0	11.8	6.2	8.2	10.0	12.5	6.1	13.8	7.2	10.1	7.5	15.7	7.3	5.8	16.9	8.6	10.8	11.8	7.9	16.4	9.8	8.6	14.9	7.0	5.5	2.0	5.0	8.3	3.3	3.0	3.4	7.5	1.9	6.8	8.2	3.5	6.7	7.5	4.7	4.8	7.7	6.9	4.8	5.0	8.2	2.5	3.1	6.5	9.4	4.9	4.1	0.0	6.5	3.1	3.2	9.4	3.5	2.0	4.3	5.3	7.5	0.0	9.7	2.3	10.2	5.1	7.5	0.9	0.8	7.8	16.9	2.9	3.4	8.6	6.0	5.3	9.7	3.5	6.2	7.9	4.9	57.6	4.7	4.7	14.1	10.5	7.3	2.2	6.9	0.0	0.6	2.0	9.3	7.5	6.6	16.4	14.9	9.8	12.3	11.8	10.4	10.7	7.9	9.8	12.8	12.4	11.3	8.6	7.2	6.4	13.4	7.0	9.9	12.4	13.9	10.4	8.5	5.9	6.4	10.2	6.5	7.5	0.0	1.7	1.4	0.9	0.8	3.0	0.8	2.5	2.7	2.3	7.0	3.9	3.8	0.0	4.1	0.9	2.5	1.7	0.0	2.1	4.4	2.5	0.7	5.7	1.8	4.4	3.2	1.2	1.8	1.5	0.8	3.1	2.1	1.7	5.4	3.0	4.3	2.6	2.0	1.8	2.1	3.2	6.5	2.3	3.9	3.2	0.9	1.6	2.2	3.7	0.3
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443158-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	18.7	15.6	22.0	20.7	22.4	19.1	16.5	20.1	28.6	18.1	22.4	22.5	22.3	18.3	22.2	14.9	26.3	19.0	20.9	20.8	22.5	17.3	15.9	14.1	15.6	18.8	23.3	29.5	21.6	23.5	20.8	18.0	17.9	22.7	17.6	13.3	14.5	23.9	20.2	47.5	24.9	17.1	26.7	16.2	18.2	20.8	40.7	21.0	13.3	19.8	20.7	17.4	20.8	17.6	3.6	3.5	31.0	6.2	9.8	6.4	4.4	12.7	21.5	7.3	16.2	12.5	10.8	18.1	11.3	11.8	11.5	13.9	10.8	18.9	10.9	17.7	14.2	14.1	14.6	5.8	9.8	8.4	40.0	10.1	11.7	45.1	8.1	11.7	17.5	29.6	11.0	7.3	12.8	11.3	12.1	12.8	7.2	8.9	7.1	8.9	15.1	12.5	20.8	6.0	7.8	12.9	10.3	8.3	13.9	9.7	16.1	7.3	9.3	28.3	16.1	11.0	7.4	21.7	20.2	9.5	11.4	14.1	8.7	9.1	12.1	8.7	7.7	12.0	21.2	10.3	5.4	5.7	31.0	6.4	6.2	5.4	3.3	5.0	5.1	3.5	3.6	6.4	5.9	7.9	9.8	4.4	2.6	6.4	4.4	22.0	22.4	20.1	28.6	22.5	17.3	23.3	29.5	22.7	21.0	20.8	26.1	14.5	14.7	38.0	13.8	26.6	12.7	33.5	20.5	14.0	33.4	20.2	23.2	23.4	22.8	15.3	23.8	0.0	25.9	19.0	15.8	14.7	23.0	15.7	20.9	60.4	5.2	13.5	24.4	44.8	18.7	21.7	25.3	21.6	18.6	16.9	24.4	20.1	15.9	20.3	19.2	19.4	22.3	30.9	16.2	47.0	28.5	19.1	20.7	20.4
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.5	10.7	11.4	7.5	0.6	0.7	4.1	3.9	10.9	3.6	4.4	4.0	7.3	9.7	8.3	1.9	2.9	5.4	9.2	2.5	4.6	8.6	9.3	14.1	3.8	5.0	4.4	15.2	12.6	1.0	1.3	3.2	2.2	6.6	46.7	6.4	11.9	6.5	1.7	4.6	6.4	9.9	1.5	17.4	3.1	9.7	4.9	5.0	7.8	5.8	3.8	5.4	4.1	4.1	5.1	3.0	8.1	8.0	9.5	0.2	3.7	3.4	6.4	4.9	5.2	7.9	1.2	17.2	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1	14.9	14.7	15.9	8.5	3.0	36.3	10.8	22.9	12.0	13.6	15.7	37.3	18.0	5.0	22.6	4.1	34.6	10.2	70.0	13.2	6.2	3.6	13.6	10.4	13.4	17.9	22.3	24.5	55.9	20.6	10.9	4.0	14.9	5.0	4.6	14.7	20.2	13.2	8.5	13.8	7.1	133.9	12.9	3.3	15.7	22.4	4.3	17.2	12.8	10.0	15.7
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97436142-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	18.2	23.3	22.3	28.8	26.2	24.8	23.4	22.8	26.6	19.9	21.9	21.4	23.4	21.9	22.9	45.6	25.1	20.2	19.2	19.4	21.6	23.2	20.5	24.6	18.3	30.1	24.2	19.8	22.3	35.0	21.0	33.6	22.8	21.8	21.5	26.2	20.6	32.5	27.7	23.6	22.1	20.7	24.2	22.4	27.4	26.2	15.6	20.8	36.6	23.4	21.1	34.1	23.5	19.9	37.3	32.2	30.9	43.0	18.5	47.2	28.4	19.0	19.3	12.3	20.4	17.1	18.3	16.1	17.0	29.4	23.1	26.9	31.1	21.1	21.4	17.0	19.0	16.0	21.4	19.4	22.9	22.6	22.7	24.0	13.2	16.7	23.5	30.0	29.4	14.5	18.9	30.2	26.1	39.7	26.2	26.8	31.8	15.9	35.6	17.9	24.3	27.9	48.8	19.1	24.7	16.7	20.3	14.4	37.0	15.4	11.0	7.0	12.3	12.0	10.1	25.3	17.0	23.7	33.4	13.2	11.5	13.1	17.4	35.5	22.4	27.4	37.3	18.7	37.3	8.7	24.3	31.6	30.9	28.1	43.0	35.3	37.3	35.5	31.9	32.2	29.4	34.2	29.6	13.0	18.5	39.0	28.1	47.2	28.4	22.3	26.2	22.8	26.6	21.6	23.2	24.2	19.8	21.8	20.8	23.8	21.1	55.1	30.1	16.9	30.3	19.1	28.1	30.8	14.8	41.8	25.5	42.5	33.2	32.2	10.1	26.3	18.7	23.3	36.2	48.1	24.7	20.3	24.3	20.4	45.2	28.6	13.7	32.5	31.3	14.7	30.2	29.3	28.7	64.9	24.4	21.5	34.0	17.3	22.6	35.2	46.4	25.8	28.1	26.2	37.3	21.3	34.4	35.9	26.4	31.4
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.6	27.9	16.7	14.8	6.0	6.8	12.2	20.5	9.9	20.5	15.9	22.5	11.9	27.2	11.2	11.0	22.6	25.0	26.7	20.4	22.8	16.1	13.0	21.7	27.4	15.6	11.4	32.7	14.4	8.7	7.7	28.8	33.7	7.5	14.5	18.3	23.6	11.8	14.2	24.2	23.0	9.1	20.7	37.4	18.1	18.2	30.7	29.6	9.6	12.7	10.3	11.5	23.9	18.3	10.8	12.2	19.0	11.8	8.9	20.3	15.8	18.0	28.9	6.1	23.8	41.2	14.5	19.1	15.8	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6	6.0	18.6	18.5	10.3	9.4	12.8	7.4	2.5	9.4	5.7	3.5	5.9	14.1	5.0	10.0	1.0	6.8	3.6	0.0	9.8	17.2	9.3	5.7	12.7	8.6	11.5	4.8	1.2	7.4	3.8	0.2	7.8	8.0	6.8	4.6	6.4	10.4	7.3	0.0	7.4	8.7	12.5	6.5	10.8	4.2	13.5	7.3	7.0	10.2	10.5	7.1
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.9	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.5	10.3	19.5	13.3	28.0	19.8	3.7	6.4	6.8	9.3	8.5	3.9	17.8	32.1	12.5	12.7	14.9	9.6	22.4	12.4	4.7	19.1	10.0	9.6	3.4	5.8	16.0	16.6	20.1	4.1	23.4	19.3	15.8	16.6	25.4	16.6	18.3	12.9	25.2	5.0	12.8	18.2	13.6	11.0	18.3	18.6	3.2	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.4	10.2	32.4	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8	3.0	3.7	19.5	26.4	27.1	5.6	8.1	17.8	18.7	11.4	17.4	3.9	24.0	31.5	14.5	7.3	9.0	5.1	23.3	18.3	115.4	11.0	15.5	4.7	17.9	26.6	6.4	8.2	4.3	13.8	5.6	15.5	19.8	13.5	14.4	16.8	4.8	20.0	5.8	11.7	19.5	2.1	6.5	18.4	11.9	27.2	29.1	17.7	11.7	30.9	22.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 108.4;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.5	9.2	24.9	14.8	3.9	8.0	12.1	25.4	14.7	36.4	28.2	9.9	16.4	34.3	6.3	15.8	11.0	7.0	26.9	11.8	32.5	15.2	12.3	17.2	14.2	12.8	8.2	29.1	16.0	6.0	6.1	25.4	7.3	7.5	17.9	22.1	29.4	13.6	34.0	11.4	44.6	22.5	13.1	7.6	10.8	24.9	41.7	15.4	12.4	6.4	15.9	16.7	9.3	13.9	15.4	13.2	11.8	18.8	10.8	16.3	24.1	13.7	24.4	19.8	15.0	41.2	16.9	20.3	10.7	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0	41.7	15.5	16.4	12.6	11.3	10.7	11.1	7.6	18.7	26.1	3.5	9.8	24.1	1.7	17.1	108.4	14.2	4.5	0.0	26.6	25.0	13.6	7.6	30.1	4.9	21.1	15.9	5.8	12.3	10.3	9.2	12.0	18.0	8.5	20.8	7.9	13.8	16.5	8.7	10.3	7.1	16.3	6.5	11.3	107.2	58.5	12.9	9.2	19.2	10.5	12.9
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 175.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.2	2.7	20.1	21.0	22.3	16.5	12.8	9.0	14.9	7.1	15.9	2.6	4.0	5.8	8.8	8.3	5.6	5.1	7.3	7.7	14.4	11.8	5.1	7.1	9.7	7.2	7.3	11.0	3.8	19.5	2.7	14.2	2.8	15.0	25.9	7.4	8.9	0.7	17.9	2.7	5.8	6.1	25.3	4.7	6.1	4.2	20.7	4.7	7.6	4.0	8.3	23.6	6.9	1.8	16.2	15.3	4.3	5.0	10.8	17.8	10.5	11.4	9.5	6.2	5.5	3.6	28.3	11.4	5.8	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3	11.9	5.9	2.2	11.4	7.6	20.3	9.7	10.2	29.4	14.8	14.0	33.4	175.5	10.0	5.2	19.7	10.8	2.0	0.0	1.8	25.1	33.5	5.4	17.3	14.7	21.3	3.2	9.1	15.4	7.0	27.2	23.3	3.6	21.9	10.0	3.9	18.6	2.5	2.9	32.5	10.8	17.8	12.9	16.5	29.8	8.1	7.0	62.1	6.9	6.3	3.0
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.8	16.8	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	1.2	0.0	0.9	0.0	13.0	5.5	0.0	0.0	1.3	31.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	12.0	9.1	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	1.0	0.1	0.5	0.0	0.0	0.0
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"Fanconi anemia core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	11.4	10.0	7.7	21.1	8.6	9.8	13.4	33.2	10.9	9.0	12.2	13.4	9.6	13.0	11.1	13.6	11.7	11.0	22.6	9.0	6.9	7.1	11.7	19.3	9.6	20.0	8.4	7.6	12.7	20.1	9.7	14.1	9.6	6.9	12.5	5.5	12.8	15.9	11.9	9.4	16.8	14.0	14.0	7.0	23.8	11.1	11.3	5.9	16.7	15.1	14.5	15.5	9.9	9.2	6.1	6.5	2.3	6.1	4.7	5.3	3.6	7.7	14.1	6.4	17.9	7.6	8.0	9.8	7.9	3.7	9.4	5.8	9.1	9.4	13.8	6.4	10.0	9.4	10.0	3.2	9.4	2.2	3.9	10.3	9.4	14.0	12.4	7.9	10.1	11.1	9.6	7.1	6.9	8.0	12.1	17.9	14.4	13.6	11.2	4.7	14.8	15.6	16.4	7.5	8.9	6.1	14.1	6.5	12.4	7.0	13.7	14.0	11.6	5.7	16.3	6.7	6.9	17.7	13.4	15.1	20.6	13.2	5.4	12.7	13.0	1.0	6.5	5.6	6.4	9.5	0.0	6.1	2.3	5.3	5.6	4.1	6.1	3.4	3.6	5.9	4.7	3.2	2.5	0.9	4.7	2.8	6.5	3.6	3.6	7.7	8.6	33.2	10.9	6.9	7.1	8.4	7.6	6.9	5.9	3.0	9.8	8.8	3.2	0.0	9.8	7.1	10.2	2.7	4.5	14.0	3.9	5.1	3.3	7.3	1.5	5.2	6.4	0.0	6.0	3.9	7.2	4.7	0.0	10.0	7.3	6.4	7.0	8.6	16.4	2.2	4.6	4.7	0.0	4.6	9.1	6.0	7.5	3.5	4.9	5.6	4.5	0.0	4.7	7.4	6.7	0.0	2.6	5.0	8.1	3.2
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"Fanconi anemia core complex associated protein 24"	Q9BTP7	19	32972209-32978222	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	3.7	3.5	1.8	4.1	2.1	5.3	3.9	2.3	2.9	3.0	2.9	2.4	3.3	2.8	3.3	4.6	4.8	2.6	6.7	1.9	1.5	1.7	4.3	2.5	2.3	4.6	3.8	0.9	4.2	2.4	0.2	2.0	6.1	3.1	9.6	4.0	3.3	3.2	1.9	1.0	4.6	5.1	2.2	2.6	6.1	2.8	16.9	2.0	8.7	3.0	3.1	8.6	3.6	2.7	7.2	7.7	16.0	8.0	7.7	6.2	3.7	5.1	12.7	5.3	8.2	2.7	5.6	4.3	6.5	6.9	12.6	16.6	8.9	8.4	6.0	9.7	2.7	9.7	3.6	10.0	4.9	10.1	16.2	5.2	13.0	5.8	6.7	1.6	4.5	6.7	3.1	3.1	7.9	4.8	2.2	5.1	9.8	6.8	6.1	9.2	5.8	9.5	6.0	2.4	7.3	5.7	8.6	4.7	3.3	2.5	3.2	5.5	4.3	7.4	8.6	5.3	5.7	5.9	11.4	3.0	12.6	6.1	5.3	6.0	4.9	10.0	8.2	9.0	9.9	8.1	10.8	6.4	8.7	3.9	7.3	4.4	6.6	4.7	5.6	4.0	7.2	4.3	6.2	16.0	7.7	8.0	7.7	6.0	3.7	1.8	2.1	2.3	2.9	1.5	1.7	3.8	0.9	3.1	2.0	3.0	0.6	6.5	3.2	0.0	1.1	0.4	2.5	0.0	2.3	3.5	2.0	8.6	1.7	1.2	5.9	1.2	2.0	0.0	6.8	13.0	2.2	2.7	1.1	0.4	7.1	4.8	1.2	1.8	4.3	8.0	3.1	3.7	0.0	10.0	2.6	0.2	3.2	3.2	3.2	0.7	1.0	0.0	2.2	26.7	8.0	0.0	4.2	4.4	2.1	2.2
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 26.2;Hep G2: 83.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	26.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	83.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	1.4	7.7	0.0	0.1	0.8	5.7	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.7	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4	0.0	0.0	173.3	0.0	0.0	0.0	0.4	119.8	0.0	0.0	57.6	0.0	0.1	132.6	0.0	0.0	0.0	8164.5	140.2	0.0	0.1	0.0	0.3	133.2	5503.1	1.4	0.0	251.5	124.0	159.5	0.0	0.0	0.0	0.0	0.0	830.4	0.0	0.1	3221.0	0.0	668.9	0.0	0.0	0.0	0.0	0.1	0.0	1.1	51.0	1046.9	0.0
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203163-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 83.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (7.29e-2)"	16.1	20.2	7.9	13.3	8.9	7.1	13.5	10.9	11.8	13.7	16.2	10.9	20.8	13.5	18.0	18.7	18.8	13.3	19.7	11.4	7.8	8.0	17.9	17.4	11.0	19.2	10.5	6.6	12.9	24.9	9.1	9.3	26.3	7.9	12.5	12.7	10.1	14.4	14.5	10.3	13.7	16.9	10.1	8.3	18.8	14.0	8.7	7.4	33.5	16.9	12.4	19.8	14.6	15.1	18.6	17.6	42.7	19.5	16.6	24.6	16.0	83.5	14.1	7.0	6.4	8.5	6.9	6.3	14.4	11.4	12.6	8.4	12.0	13.6	12.4	13.9	9.5	12.0	12.4	6.8	12.8	9.8	11.5	7.5	5.6	8.1	6.1	7.7	7.0	7.6	6.8	9.1	13.6	17.3	10.1	11.8	6.9	9.2	6.4	11.0	12.3	8.6	12.5	11.1	19.2	23.3	6.7	17.0	11.9	12.3	6.2	6.2	5.9	10.6	10.0	29.5	8.4	10.8	7.8	13.2	9.8	9.5	15.0	13.7	9.0	6.8	7.3	14.2	7.2	13.7	15.0	17.1	12.7	21.0	17.7	24.1	18.6	22.3	24.6	17.6	16.4	23.2	20.9	42.7	16.6	19.5	16.0	20.7	16.0	7.9	8.9	10.9	11.8	7.8	8.0	10.5	6.6	7.9	7.4	0.0	4.0	17.1	11.9	10.5	6.7	0.1	10.2	0.0	1.2	17.4	0.0	60.4	18.3	47.2	0.5	15.7	19.5	0.0	30.3	34.1	9.5	9.2	1.1	8.3	27.5	3.2	2.4	12.9	9.7	1.1	12.4	8.9	30.4	27.9	12.1	8.9	37.0	16.9	15.6	25.9	3.9	0.0	9.0	6.5	16.6	9.3	25.7	12.5	16.1	13.7
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		230000000	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.5	7.6	3.1	3.9	14.7	15.1	7.8	5.8	13.3	6.2	5.3	4.6	8.4	0.0	9.6	12.2	8.6	6.7	11.2	13.9	6.0	2.9	6.3	38.8	4.5	23.8	76.6	18.3	21.5	26.1	8.6	5.3	9.6	20.3	8.6	8.9	16.2	8.3	11.5	6.9	5.0	9.1	2.2	3.5	8.7	2.8	4.5	29.1	17.8	5.5	0.1	1.9	6.5	18.0	18.2	5.3	13.7	12.5	29.9	11.3	7.1	6.0	9.8	7.6	15.5	3.1	23.5	42.9	6.3	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0	3.0	14.4	5.2	13.1	6.1	0.4	12.0	10.2	5.3	4.5	31.4	0.0	32.5	44.7	8.5	6.3	2.5	15.8	23.3	3.1	9.0	17.2	8.6	42.5	250.1	63.7	0.0	4.1	11.1	20.0	10.6	9.2	23.1	18.6	3.6	11.8	3.5	4.6	14.4	7.4	236.8	0.3	0.0	8.1	1.5	2.1	5.0	18.4	8.7	22.4	12.8
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.4	19.1	9.1	16.1	12.1	8.8	5.7	13.9	6.9	9.3	10.2	12.2	8.8	5.4	11.7	8.6	14.4	17.4	7.1	11.2	8.4	8.2	16.9	4.8	16.5	28.1	11.8	8.3	9.4	11.6	14.7	8.5	5.7	7.9	12.1	6.6	5.0	5.7	11.6	38.7	4.5	12.6	5.4	7.8	14.3	10.4	12.4	15.2	33.4	10.6	17.8	14.8	18.2	14.7	21.8	6.4	21.5	5.7	17.6	15.3	10.9	9.0	7.5	8.2	17.2	6.4	9.7	6.1	6.5	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5	23.8	16.0	12.3	12.4	12.5	20.0	37.0	22.9	17.4	17.0	40.1	25.5	18.6	43.1	43.5	88.6	14.7	72.1	23.3	34.0	12.3	14.7	9.4	4.7	30.5	26.4	17.5	28.2	8.0	8.1	38.9	13.6	18.2	15.1	23.4	22.1	16.9	34.9	30.9	14.5	175.3	22.4	12.9	14.1	7.0	8.3	21.0	12.8	10.7	41.2	8.1
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1144.0;Late spermatids: 1283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	9.3	7.2	8.7	9.1	9.0	23.2	12.4	10.8	7.9	9.9	9.1	6.9	7.4	7.8	8.4	8.4	10.4	6.6	8.5	11.6	8.1	7.0	6.4	10.0	8.2	10.1	6.9	8.3	8.2	11.4	8.4	11.2	14.2	6.4	9.3	8.1	8.4	8.3	8.0	11.9	11.7	10.1	7.3	7.1	11.8	13.3	74.8	6.5	14.6	9.2	7.1	11.2	9.9	11.6	21.3	19.7	34.3	20.3	26.7	49.5	29.9	23.0	19.0	9.5	17.7	14.7	13.8	31.4	18.9	19.9	20.9	21.6	15.9	14.9	13.5	15.6	18.1	20.3	14.7	12.3	13.8	22.7	15.8	16.5	19.6	16.3	24.0	19.5	17.1	33.8	14.6	18.3	18.5	13.6	13.7	24.4	16.4	15.2	22.6	25.0	15.7	30.4	11.8	13.2	17.0	24.3	16.7	26.7	13.0	15.9	19.0	15.8	21.0	11.0	16.1	20.2	18.7	22.6	17.7	16.9	24.7	28.6	16.8	22.0	22.4	22.1	16.4	22.1	18.8	18.2	24.5	20.3	34.3	24.7	17.6	23.7	21.3	30.3	28.1	19.7	20.2	22.2	26.7	33.3	26.7	18.6	12.8	49.5	29.9	8.7	9.0	10.8	7.9	8.1	7.0	6.9	8.3	6.4	6.5	8.9	12.2	25.3	20.2	50.6	15.0	5.0	20.4	16.0	12.5	21.0	5.9	95.7	26.6	29.8	1144.0	18.8	18.8	23.3	22.0	52.3	27.1	25.6	28.8	17.8	31.7	25.4	19.0	11.1	20.2	1283.3	32.5	21.6	23.6	33.3	24.5	18.6	28.1	24.3	22.6	15.4	19.4	6.5	17.5	121.4	59.8	57.5	271.7	30.5	18.4	48.7
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"granulocytes: 17.3;NK-cells: 14.5;T-cells: 32.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 65.1;HDLM-2: 77.8;Karpas-707: 55.8;THP-1: 51.6"									"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	15.0	15.2	30.0	27.5	44.7	48.7	19.3	13.1	21.7	15.0	20.2	56.3	85.8	10.4	15.7	7.0	8.3	7.0	21.8	5.9	44.1	23.8	40.1	47.4	20.8	45.7	49.7	14.6	3.5	40.7	16.4	10.7	17.2	38.5	10.0	14.0	3.9	27.7	85.7	2.1	8.4	17.8	10.5	66.3	15.4	37.9	11.6	44.7	7.5	6.2	4.1	41.9	15.5	9.8	3.5	1.4	17.3	3.7	14.5	32.4	19.2	10.5	22.8	9.1	0.6	1.4	0.3	3.8	10.6	15.3	6.5	4.7	14.0	8.9	65.1	9.6	4.8	2.4	3.3	2.8	6.4	11.6	77.8	2.5	1.8	10.3	16.5	4.9	23.4	4.2	0.7	5.0	2.7	1.3	7.7	27.6	12.9	0.1	55.8	5.0	2.7	5.7	6.8	2.2	12.7	5.0	41.7	7.0	23.9	14.9	6.8	3.4	9.7	4.2	2.2	6.9	8.5	8.2	51.6	9.0	6.8	5.7	21.4	3.5	24.7	22.0	42.1	1.2	20.6	1.8	11.5	1.7	17.3	29.8	2.0	29.1	3.5	24.0	25.1	1.4	3.1	32.4	32.0	7.2	14.5	3.7	1.0	21.1	19.2	30.0	44.7	13.1	21.7	44.1	23.8	49.7	14.6	38.5	44.7	98.3	44.3	102.5	106.0	79.7	4.0	3.9	127.4	91.0	58.0	272.2	2.0	13.9	189.0	38.0	23.9	29.6	36.4	0.0	92.2	29.2	52.6	147.0	117.6	155.2	36.2	190.7	13.7	63.3	52.4	41.5	2.3	57.8	49.0	43.3	91.1	13.5	84.5	17.3	4.6	157.5	13.2	0.0	41.2	55.4	35.6	72.0	52.3	117.6	22.4	208.7
FAM111A	"FLJ22794, KIAA1895"	ENSG00000166801	"Family with sequence similarity 111 member A"	Q96PZ2	11	59142748-59155039	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, DNA replication, Host-virus interaction"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039529, HPA040176"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039529: AB_10795149, HPA040176: AB_10793958"	"unprognostic (4.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.39e-4)"	16.3	13.7	4.8	28.1	6.7	9.9	14.5	3.3	4.8	14.7	14.2	8.3	13.2	12.8	18.1	16.8	10.2	11.3	15.9	6.7	5.5	3.9	14.5	11.7	17.5	19.6	7.4	3.8	11.2	10.7	17.8	17.4	10.8	8.1	22.5	11.7	13.2	13.4	13.0	5.6	11.0	19.3	14.0	12.3	29.5	12.9	5.9	6.5	73.4	19.5	12.9	21.3	10.9	13.2	4.6	6.5	7.7	6.3	6.9	8.6	2.4	21.2	5.5	2.7	2.6	6.1	7.4	1.8	30.4	16.6	13.1	19.3	8.3	20.0	31.2	12.8	9.8	17.9	7.4	9.0	13.3	16.6	27.7	0.4	11.7	7.0	2.5	6.3	18.6	15.9	5.1	3.4	12.2	3.9	7.6	12.1	19.3	1.4	25.8	14.1	6.0	28.1	12.5	1.2	6.6	6.0	19.4	9.8	7.3	8.8	19.0	0.0	0.7	15.6	13.1	5.9	1.5	26.9	8.4	11.7	21.4	19.3	14.6	14.2	13.2	13.7	5.1	11.7	13.3	25.7	6.2	6.3	6.7	6.6	5.4	8.6	4.2	4.5	4.8	6.5	4.6	4.4	3.7	7.7	6.9	2.6	1.8	4.6	2.4	4.8	6.7	3.3	4.8	5.5	3.9	7.4	3.8	8.1	6.5	59.6	39.5	24.4	9.7	7.6	2.2	3.9	12.7	46.8	26.1	15.7	0.0	8.9	8.3	10.1	0.0	17.5	12.9	0.0	6.6	1.2	14.9	15.7	26.6	7.9	24.4	0.0	5.8	27.6	31.6	1.1	12.0	25.0	6.8	12.6	19.1	29.9	8.0	15.8	6.3	7.6	6.5	0.0	10.7	0.4	1.9	7.8	3.7	21.8	15.3	10.9
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.4	6.3	9.4	0.1	1.0	1.8	0.1	18.6	9.3	11.1	16.5	13.3	9.7	30.5	12.6	5.4	9.3	19.0	13.7	12.6	19.8	15.8	3.3	3.3	12.0	5.8	0.0	0.1	3.9	0.4	0.4	10.7	0.8	2.1	5.9	8.3	0.9	28.8	13.0	9.2	19.2	0.2	0.1	14.8	7.4	20.3	14.0	11.9	5.9	21.1	1.8	6.0	15.4	17.8	3.0	3.6	19.7	1.7	3.2	8.6	18.8	26.0	16.9	22.2	16.0	0.2	12.5	0.1	12.3	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6	0.0	0.0	4.8	2.0	3.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	2.4	0.1	0.5	6.3	0.9
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202635188-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	5.8	12.5	10.1	11.1	10.3	4.3	10.0	20.8	18.1	5.5	7.9	3.2	7.1	7.0	5.0	7.5	9.6	6.6	6.2	4.3	8.6	10.8	8.3	3.6	6.2	13.0	5.9	9.1	8.8	11.6	24.7	7.5	11.0	4.7	8.6	7.9	3.7	8.6	9.3	5.8	9.0	6.0	7.3	5.7	8.2	6.6	12.6	5.8	22.4	5.5	4.8	11.7	7.2	12.7	9.0	4.8	2.3	8.9	4.5	9.9	3.3	1.6	2.0	8.9	6.1	3.0	1.7	8.6	0.5	0.8	0.5	1.0	2.5	3.5	6.7	5.5	1.0	1.3	1.6	7.5	3.8	1.5	0.1	6.1	5.6	3.8	9.4	2.4	4.7	2.5	2.3	5.3	1.1	1.7	4.0	2.4	8.9	8.0	1.4	0.5	3.2	12.7	9.9	9.0	4.7	3.8	10.1	1.8	7.8	4.7	4.3	15.1	13.1	6.6	4.4	3.2	7.8	1.9	6.6	1.4	1.1	2.1	1.5	0.9	4.9	2.8	8.9	2.0	3.7	1.1	0.3	4.5	1.6	1.6	8.9	4.0	9.0	3.6	3.1	4.8	8.5	9.9	6.8	2.3	4.5	8.8	1.7	1.3	3.3	10.1	10.3	20.8	18.1	8.6	10.8	5.9	9.1	4.7	5.8	3.0	6.9	14.1	1.9	15.2	4.7	3.9	10.2	2.7	2.3	17.4	3.9	6.1	0.0	6.7	1.7	3.3	5.2	0.0	5.5	4.9	8.4	7.0	5.7	1.7	2.5	6.4	24.8	5.5	22.9	0.9	12.0	9.9	3.3	1.0	12.9	1.9	5.7	7.0	22.3	4.9	2.7	6.5	3.1	4.4	16.3	17.3	2.3	6.4	11.9	5.4
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	32	"Early spermatids: 546.2;Late spermatids: 1520.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	10.4	7.1	9.6	11.5	11.7	12.1	5.9	8.9	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	15.6	13.7	9.4	9.8	6.9	14.9	12.2	6.4	7.9	4.6	12.3	4.2	5.5	8.7	8.7	9.2	5.3	6.6	10.1	8.6	7.7	3.0	12.0	7.6	17.6	11.6	3.8	6.3	10.0	6.9	8.5	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4	20.8	14.5	2.7	4.7	3.2	15.0	15.7	15.3	14.7	13.6	14.0	31.4	8.9	0.0	8.3	546.2	15.3	8.6	0.0	8.0	6.4	6.5	11.1	9.3	7.6	9.5	6.4	9.2	11.1	8.2	1520.1	17.8	8.7	18.6	1.8	13.9	6.6	7.9	8.5	13.4	4.9	11.5	32.3	5.3	16.1	11.5	5.1	11.2	5.1	7.4	5.5
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780034-68784608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	21.0	21.3	13.9	12.0	20.2	9.8	21.4	22.5	24.6	23.1	15.5	17.0	12.4	10.0	20.3	15.6	17.6	19.7	14.4	24.2	13.8	14.3	21.5	21.2	14.1	14.7	16.8	14.2	24.2	17.9	25.3	20.8	21.8	18.0	20.6	14.9	22.4	17.0	19.8	20.0	15.1	15.0	17.6	13.9	17.7	15.0	16.2	14.6	18.1	19.1	14.8	15.4	15.7	16.5	5.8	6.7	4.3	5.1	4.5	9.8	2.5	5.4	3.7	5.1	4.4	17.6	11.5	7.0	7.7	7.3	6.9	5.5	1.3	2.7	11.4	3.9	8.2	5.0	10.2	5.7	5.2	8.6	12.3	6.0	6.3	6.1	4.5	10.9	11.4	4.5	9.3	12.0	6.3	4.9	7.8	6.8	8.3	6.7	13.0	7.3	2.9	6.3	3.0	6.5	12.9	6.6	7.8	7.1	3.5	6.2	4.5	8.2	3.7	5.7	4.8	3.9	7.5	2.9	5.0	8.4	6.4	4.6	11.9	5.7	15.3	6.2	4.7	6.9	7.3	7.1	4.3	5.1	3.7	4.5	4.9	4.0	3.6	4.5	4.9	5.7	5.8	9.8	5.5	2.9	4.5	4.8	6.7	4.9	2.5	13.9	20.2	22.5	24.6	13.8	14.3	16.8	14.2	18.0	14.6	3.0	6.0	19.1	16.1	20.9	17.5	13.9	7.6	25.4	6.8	5.2	15.7	24.6	56.3	13.9	23.4	14.8	11.2	46.7	11.9	13.7	16.9	11.3	17.3	15.3	19.0	7.9	17.2	13.5	19.4	11.4	14.1	17.4	13.5	8.2	15.4	31.5	13.0	13.3	15.9	20.3	18.4	45.3	45.6	36.3	17.7	20.7	25.6	17.5	12.5	15.3
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.3"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HAP1: 13.3;HUVEC TERT2: 7.9;NTERA-2: 26.1;SH-SY5Y: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	5.3	3.5	7.7	4.7	19.6	0.7	2.6	2.6	15.0	3.3	7.2	40.3	0.3	1.4	3.8	8.4	2.4	3.6	4.3	7.1	13.5	7.4	6.7	1.5	3.3	1.5	29.1	7.7	1.3	2.7	1.2	1.5	6.2	18.8	6.5	2.6	3.8	12.4	8.1	1.8	1.9	2.1	8.9	25.3	13.2	4.1	2.3	26.7	0.3	2.8	0.6	1.1	4.1	1.8	0.8	1.0	2.7	0.9	1.2	0.8	0.3	0.0	1.2	0.9	0.8	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.4	0.0	0.0	1.6	0.1	13.3	0.1	0.1	0.0	2.0	0.0	0.3	0.0	1.0	0.6	0.8	0.3	0.1	0.4	0.0	0.0	7.9	3.5	0.1	0.0	0.0	0.2	3.2	0.2	26.1	0.2	2.0	0.7	0.0	1.9	0.0	0.1	1.9	10.0	0.4	1.6	1.5	2.0	0.2	0.7	0.1	0.0	0.9	0.7	0.9	0.2	0.0	0.0	1.2	2.3	1.1	2.7	0.8	0.8	0.8	0.6	0.8	0.6	0.5	0.6	0.4	0.8	0.7	0.7	2.4	1.2	0.9	1.0	0.6	0.3	7.7	19.6	2.6	11.8	13.5	7.4	29.1	7.7	18.8	26.7	0.0	0.0	0.0	2.1	0.7	7.7	8.9	0.0	2.7	0.0	1.8	47.1	0.0	3.3	1.9	3.5	6.8	0.0	0.0	0.7	0.0	0.9	1.6	1.1	0.0	0.2	6.4	0.0	6.7	0.3	3.3	0.6	0.5	3.3	0.0	0.0	3.4	0.8	0.0	0.4	8.4	43.8	0.0	2.1	0.0	1.4	0.1	0.0	0.0	0.0	0.4
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402085	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.8;blood: 18.0"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 18.0;eosinophil: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	28.8	0.6	1.6	1.4	1.9	5.9	16.0	0.6	1.8	4.2	2.1	1.6	0.7	1.3	2.4	2.5	2.6	1.8	1.7	2.4	2.2	2.2	1.4	2.6	5.8	0.8	2.0	0.6	2.5	0.5	9.4	0.8	12.5	1.8	3.9	1.5	4.0	1.7	0.6	4.3	2.6	1.5	3.5	2.1	0.8	1.2	2.3	0.2	1.0	2.9	0.8	1.0	3.4	2.6	0.0	5.6	18.0	2.1	3.8	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	49.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	2.1	11.6	0.1	1.6	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.1	3.8	0.5	0.0	1.7	0.7	1.6	1.9	0.6	1.8	2.2	2.2	2.0	0.6	1.8	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.1	0.2	0.0	4.6	0.2	0.4	0.0	0.0	1.3	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	10.5	6.9	9.8	8.7	17.2	22.1	7.3	28.7	21.1	5.9	10.3	6.5	5.9	9.8	6.8	6.3	12.1	5.8	6.4	6.5	9.3	9.2	12.0	10.9	9.4	7.9	7.3	11.6	7.8	7.1	9.8	16.6	7.2	15.1	5.8	9.6	8.8	7.0	4.9	5.6	10.2	9.3	5.8	8.1	10.6	11.0	6.3	6.4	8.3	10.3	2.9	8.7	5.5	8.1	2.1	1.2	20.3	1.9	2.3	3.4	1.5	3.3	1.8	2.5	2.7	2.7	3.6	5.5	3.2	1.9	2.5	2.5	4.5	4.0	3.1	3.1	3.2	2.4	4.1	5.1	2.0	4.0	4.4	3.2	8.9	4.7	4.1	2.2	10.7	7.8	1.5	2.5	3.5	2.1	2.0	2.5	3.3	8.2	11.4	2.6	2.0	6.4	7.1	1.7	2.2	3.0	3.8	3.8	2.7	2.4	3.7	5.0	2.5	3.4	3.9	2.8	3.4	2.7	4.7	4.9	4.8	3.5	2.4	2.9	8.5	35.4	6.6	2.8	4.2	3.3	1.7	1.4	5.1	3.1	1.8	3.4	2.1	2.6	2.4	1.2	2.0	2.6	3.1	20.3	2.3	1.9	0.9	1.7	1.5	9.8	17.2	28.7	21.1	9.3	9.2	7.3	11.6	15.1	6.4	26.8	19.2	18.5	8.9	46.8	48.4	13.4	20.4	14.7	14.8	19.2	155.1	13.2	14.9	8.8	4.8	18.0	46.6	23.3	9.3	7.9	12.8	13.1	24.3	17.7	10.4	25.4	35.6	34.4	29.2	2.5	29.4	26.5	28.7	13.6	19.0	21.4	15.0	26.6	24.1	13.5	38.9	19.4	17.6	30.8	20.3	64.7	14.5	30.5	16.5	16.1
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Cell type enriched"	"Detected in some"	37	"B-cells: 63.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Group enriched"	"Detected in some"	22	"Daudi: 29.8;REH: 15.0;U-698: 18.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	1.1	63.2	0.7	0.1	0.1	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.0	0.0	1.3	0.3	0.4	0.0	0.4	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.9	0.3	0.1	0.0	0.0	0.3
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	5.0	0.0	4.1	5.2	0.0	0.2	1.2	0.8	0.2	10.3	0.0	0.0	0.0	0.3	0.0	0.2	2.0	0.4	0.7	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	6.5	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.3	16.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	16.4	0.5	0.2	1.2	0.0	1.1	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.4	0.6	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 14.8;pituitary gland: 8.2;testis: 16.1"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7"					"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.5	3.0	4.7	0.4	14.8	0.3	0.8	2.3	7.7	1.7	0.5	0.5	0.0	0.4	1.0	0.8	0.4	1.1	0.7	2.2	2.5	4.5	0.4	0.4	0.5	0.4	2.3	4.4	1.4	0.4	0.4	8.2	0.4	3.7	0.4	0.5	0.2	0.4	0.5	0.3	0.6	0.5	0.8	4.5	0.5	0.4	16.1	2.6	0.0	0.9	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	22.2	0.0	0.0	0.0	0.0	0.5	0.0	5.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.4	0.5	11.6	0.5	17.4	37.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	14.8	2.3	7.3	2.5	4.5	2.3	4.4	3.7	2.6	0.0	0.0	0.0	0.0	0.6	12.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.1	0.0	1.3	0.0	18.2	1.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	1.1	0.0	0.2	21.3	34.9	0.1	0.0	0.0	0.0	0.0
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	13.1	6.8	19.2	29.4	11.3	12.0	11.5	14.9	16.1	14.6	17.8	10.9	14.6	21.5	14.5	10.1	12.7	10.6	15.1	9.4	22.4	12.1	19.7	17.4	10.0	21.8	11.8	19.1	15.1	8.0	9.9	11.2	14.0	11.5	8.6	16.8	22.9	27.3	15.6	16.0	30.0	29.9	26.2	12.0	8.8	21.8	19.3	17.8	14.5	14.1	18.6	18.0	12.8	16.3	17.3	18.8	15.1	14.1	9.9	16.8	26.7	19.5	16.7	7.1	7.5	38.5	10.1	25.2	21.6	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3	53.6	65.5	102.1	185.5	101.5	81.2	25.7	180.9	38.8	62.6	83.7	70.7	55.8	84.6	78.1	31.4	87.5	92.6	163.5	75.9	52.0	92.4	103.6	86.4	97.3	62.9	52.4	131.6	108.1	107.2	13.2	95.0	114.5	72.6	69.5	83.4	83.5	72.6	112.3	83.4	48.4	75.1	51.8	103.0	97.0	117.4	91.7	59.0	97.2	97.8	127.1
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14.0	10.7	9.6	13.3	4.0	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8.0	6.9	16.4	13.8	22.7	8.5	18.9	13.0	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11.0	6.0	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.9	3.4	7.7	4.8	3.6	2.6	6.9	1.9	3.8	2.1	3.5	6.7	4.8	10.6	13.9	1.4	10.1	5.8	7.6	4.8	3.6	5.1	6.3	4.8	3.7	5.9	4.4	8.9	5.0	2.3	11.1	4.0	11.1	2.6	5.5	3.4	7.6	5.5	2.4	0.7	1.6	4.2	5.0	7.1	2.8	5.2	24.2	5.0	7.9	3.2	8.1	2.4	2.3	2.1	2.3	5.1	1.4	4.0	2.7	1.8	4.6	1.7	4.4	6.6	7.5	4.3	1.3	8.1	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3.0	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1.0	1.7	1.5	6.4	6.8	14.0	10.7	5.4	5.2	6.1	7.1	8.5	6.0	26.8	12.2	1.4	9.5	14.2	18.2	9.4	15.3	8.1	5.7	19.2	27.5	2.2	5.0	5.8	24.9	10.0	28.4	0.0	10.7	1.2	5.9	32.9	8.1	5.7	5.1	225.6	22.4	9.2	14.2	17.3	14.4	13.1	5.0	9.0	26.1	12.8	13.3	30.0	12.4	6.8	27.5	6.5	6.6	25.1	8.2	29.4	6.9	3.9	19.4	11.2
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138496822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.1;brain: 14.3;testis: 10.3"	"Cell type enhanced"	"Detected in some"	27	"Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RH-30: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.6	8.1	12.1	0.9	6.8	0.6	0.7	13.9	14.3	0.7	2.7	1.3	0.0	1.4	0.6	0.9	0.7	0.7	0.7	0.8	9.3	4.5	1.4	0.8	0.7	0.6	4.6	5.6	0.6	1.9	0.6	3.6	0.6	5.2	1.3	2.3	0.7	0.7	1.4	0.6	0.6	1.4	0.8	2.5	0.6	2.5	10.3	3.5	0.0	0.6	0.0	0.6	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	14.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	6.8	13.9	12.3	9.3	4.5	4.6	5.6	5.2	3.5	0.0	0.0	0.0	0.0	0.0	27.7	1.1	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	96.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	22.0	1.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246129-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 36.1;Early spermatids: 31.6;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.3;HSkMC: 6.9;hTERT-RPE1: 4.6;NTERA-2: 5.7;SCLC-21H: 11.4;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	11.8	17.0	16.1	3.8	22.3	0.3	7.7	12.4	24.9	9.4	6.4	36.6	3.2	4.5	9.0	8.7	14.4	15.3	11.6	7.8	18.9	15.9	3.8	2.3	10.0	4.5	23.8	18.8	22.2	2.5	4.0	8.3	2.9	21.2	17.9	6.7	16.5	4.9	8.7	15.3	7.3	5.0	12.5	33.2	5.0	3.9	5.2	28.9	0.0	6.0	7.6	2.5	7.4	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.3	0.1	0.0	1.6	0.0	5.3	2.4	0.2	0.0	0.0	6.9	0.8	0.3	0.0	4.6	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	5.7	0.0	0.5	0.0	1.1	0.0	0.0	1.7	11.4	6.7	0.0	0.3	0.0	0.5	1.0	0.0	0.0	3.3	3.1	0.1	2.6	0.0	0.0	0.1	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	22.3	12.4	23.4	18.9	15.9	23.8	18.8	21.2	28.9	0.0	0.0	0.0	9.5	4.2	10.0	2.8	0.0	36.1	1.2	0.0	5.9	0.0	6.6	0.0	31.6	12.6	0.0	0.0	0.0	0.0	3.0	4.5	0.0	0.6	0.0	3.2	0.0	2.5	0.0	17.2	21.3	0.5	3.3	0.0	0.0	8.8	0.0	0.0	19.8	0.4	13.1	38.8	18.6	0.9	0.7	5.5	0.0	0.0	0.0	0.5
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089159-22104898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	15.8	11.8	9.6	13.1	10.0	6.6	14.3	14.3	14.8	12.9	13.2	12.9	20.8	12.0	13.2	16.9	13.7	14.1	14.5	26.0	8.5	6.9	12.3	9.8	11.0	11.2	12.5	10.5	11.4	22.1	15.3	14.1	22.4	10.9	14.4	6.0	13.4	18.8	25.1	15.1	24.4	13.4	25.3	10.4	12.3	16.1	6.4	10.3	6.5	16.0	11.6	13.2	19.9	11.2	2.7	0.9	0.5	1.4	1.7	3.2	2.1	3.7	9.3	4.5	6.9	9.1	8.4	6.9	5.8	12.6	8.6	6.0	3.8	4.6	3.9	6.4	18.2	7.8	5.3	3.3	10.4	1.8	3.4	3.5	5.8	2.5	2.6	12.3	1.5	5.3	14.1	7.1	6.3	4.2	8.9	8.8	8.9	3.9	3.3	8.1	7.8	4.2	2.2	1.8	7.9	3.3	4.4	3.3	2.2	7.3	9.2	1.6	4.8	3.5	7.5	4.8	4.7	4.5	3.4	8.4	8.7	6.7	7.8	4.0	2.6	0.8	0.7	9.2	2.8	9.4	0.0	1.2	0.5	3.2	0.7	1.9	2.7	2.1	2.6	0.8	2.3	1.9	2.7	0.3	1.7	1.4	0.9	0.3	2.1	9.6	10.0	14.3	14.8	8.5	6.9	12.5	10.5	10.9	10.3	11.9	15.0	9.0	8.7	5.3	22.4	21.8	20.4	2.7	4.5	12.2	25.5	7.0	0.0	8.0	3.6	12.2	13.8	0.0	12.8	11.4	8.0	10.8	6.9	12.2	6.4	22.3	12.7	17.8	11.8	1.9	10.0	5.4	1.7	4.6	9.7	12.7	13.7	12.5	5.3	3.8	24.2	0.0	7.3	1.7	5.9	6.6	12.5	8.6	8.6	8.1
FAM171A1	"C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.9"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 104.4;Ito cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	23	"T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"TIME: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		96000	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	6.9	3.7	22.1	5.5	37.9	0.2	4.6	11.1	31.8	8.8	16.1	25.3	6.5	13.7	9.7	4.8	4.7	11.8	9.3	7.0	24.1	17.5	17.8	6.2	5.3	3.7	25.1	14.3	10.9	13.8	8.9	1.9	2.9	21.5	8.4	12.9	2.5	10.0	9.4	5.1	2.4	8.9	9.0	43.9	8.5	10.3	2.4	21.9	0.6	4.3	1.1	4.6	6.0	6.2	0.0	0.0	0.0	0.0	0.3	7.4	1.3	0.0	6.3	13.0	5.0	5.3	10.1	0.1	7.9	1.5	4.0	3.5	1.1	7.4	0.0	9.6	20.5	9.1	0.6	9.3	0.1	4.5	2.6	14.6	18.4	2.0	18.2	5.8	0.0	14.9	7.9	1.9	10.9	1.6	14.6	20.0	2.7	7.2	0.0	12.7	0.5	3.1	0.0	12.5	3.5	3.5	12.4	6.9	1.9	5.0	0.0	9.0	11.5	4.4	0.1	0.0	14.5	0.0	0.2	42.6	5.5	23.2	19.9	8.3	2.7	0.7	0.0	12.2	0.0	4.2	0.0	0.0	0.0	2.6	0.0	6.8	0.0	3.8	3.3	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.7	1.3	22.1	37.9	11.1	23.1	24.1	17.5	25.1	14.3	21.5	21.9	0.0	0.0	0.0	3.3	1.1	3.8	5.1	104.4	2.7	2.3	14.0	0.0	0.1	3.3	17.1	0.6	18.9	12.0	0.0	10.5	0.1	8.9	13.8	1.1	18.3	0.3	6.4	20.2	41.1	4.4	1.0	4.9	0.0	1.7	1.0	25.9	1.5	15.9	8.6	5.3	4.1	1.1	0.0	6.2	2.3	3.5	1.6	0.1	1.3	31.1	2.1
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186693971-186765965	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enriched"	"Detected in many"	6	"Bipolar cells: 137.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.4;U-138 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	3.1	13.1	32.0	2.0	32.6	1.1	3.7	12.7	62.0	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2.0	1.6	9.1	23.0	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2.0	2.4	1.6	10.4	0.0	2.7	0.0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.8	4.2	13.1	12.5	9.5	0.1	2.6	4.6	3.2	4.6	7.7	12.6	0.0	0.9	7.3	5.5	0.3	5.7	2.5	4.6	0.0	3.3	2.8	1.3	0.0	1.0	0.8	1.0	12.1	1.0	2.5	2.0	4.2	7.0	2.2	0.0	25.4	6.1	1.6	1.6	0.0	5.6	0.0	2.8	0.0	8.1	0.6	5.0	9.0	13.2	7.2	1.3	0.8	3.5	2.6	1.0	0.6	4.1	17.6	2.3	0.3	1.6	6.8	6.5	0.0	5.4	0.0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1.0	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32.0	32.6	12.7	30.4	25.5	13.1	9.1	23.0	9.7	10.4	0.0	0.0	0.0	2.1	7.9	137.0	0.8	10.2	0.0	2.3	0.0	13.7	7.9	0.0	0.7	1.4	10.5	0.0	0.0	0.3	0.8	6.6	1.2	0.0	0.0	1.7	22.3	4.6	8.0	0.3	2.5	7.2	1.1	3.3	1.0	0.0	16.5	0.5	0.0	13.1	0.1	15.5	0.0	4.1	0.1	1.4	4.5	6.9	0.0	0.0	0.5
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.6	5.4	13.3	14.9	16.0	19.4	6.9	9.9	7.7	4.3	4.3	3.7	6.5	6.7	7.5	11.6	7.7	4.1	4.0	14.0	10.1	4.5	4.8	8.9	11.3	2.5	6.8	6.8	10.3	16.9	8.0	3.9	7.6	15.6	9.8	6.3	1.8	2.0	17.7	5.1	5.7	5.2	2.0	8.6	4.4	6.4	14.0	6.3	6.8	9.0	11.9	21.2	8.0	3.4	7.3	8.7	8.2	8.3	9.7	10.3	9.3	6.7	11.7	8.6	12.5	7.6	16.2	7.6	18.8	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6	50.6	23.7	24.4	21.0	10.9	48.1	20.2	28.1	62.9	25.0	10.4	29.5	11.1	51.4	16.4	38.4	23.3	15.8	0.0	18.6	10.7	16.0	19.5	24.3	12.4	10.1	39.7	16.3	17.8	18.0	23.9	35.6	17.5	20.3	22.6	11.5	34.6	17.2	13.9	34.3	27.9	51.6	12.9	17.9	19.0	23.5	8.8	9.2	23.5	16.4	20.4
FAM173B	JS-2	ENSG00000150756	"Family with sequence similarity 173 member B"	Q6P4H8	5	10226330-10249897	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074513			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA074513: AB_2686698"	"prognostic unfavorable (1.32e-6)"	"unprognostic (8.87e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.03e-1)"	10.1	14.6	17.7	10.4	16.2	3.3	9.0	20.1	18.6	7.9	9.7	12.2	8.8	7.7	9.3	12.6	7.9	9.2	9.9	8.8	14.9	18.1	12.1	13.1	7.5	8.9	18.8	9.9	8.6	6.8	19.2	22.8	5.3	18.6	12.2	12.4	10.3	8.8	12.3	7.3	7.4	7.1	10.1	13.2	5.6	7.8	6.5	18.9	8.4	12.7	6.2	8.7	11.6	13.9	5.7	8.9	11.6	9.7	5.1	8.6	4.5	7.3	8.1	8.0	7.6	8.8	6.7	2.8	11.4	5.7	6.1	4.8	8.5	12.2	9.5	20.5	8.1	15.4	5.5	12.2	10.4	9.9	15.8	7.5	7.9	27.6	6.3	5.9	12.2	9.5	6.1	11.6	10.1	3.4	6.9	11.8	9.4	11.0	9.7	17.2	6.9	6.0	10.8	4.9	17.1	9.8	8.3	5.5	8.4	15.6	9.7	6.4	6.4	40.2	14.2	6.4	6.3	14.5	12.7	6.5	13.0	7.7	7.9	8.3	6.6	7.2	10.6	8.2	14.0	5.3	5.0	9.3	11.6	7.0	9.7	8.4	5.7	6.7	8.5	8.9	4.2	6.8	8.6	3.4	5.1	7.7	3.1	7.8	4.5	17.7	16.2	20.1	18.6	14.9	18.1	18.8	9.9	18.6	18.9	3.0	1.4	3.0	5.1	1.3	8.4	5.9	5.1	14.7	3.4	10.4	2.0	5.0	5.0	6.0	4.1	4.9	3.6	0.0	3.7	3.9	6.3	5.8	9.2	7.4	6.9	9.5	2.4	1.8	4.5	2.5	3.4	2.3	3.3	5.4	3.9	7.8	3.4	6.0	6.3	6.3	12.2	6.5	2.5	10.0	15.8	1.6	2.2	5.0	5.3	3.4
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		180000	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	20.8	25.6	29.5	17.5	29.2	24.9	20.6	14.1	25.9	27.2	45.8	29.2	19.6	32.6	16.3	17.9	22.2	12.7	22.0	44.2	31.6	35.3	35.5	49.1	36.0	10.4	41.1	24.2	14.4	21.5	14.2	43.8	17.7	39.6	37.9	41.6	13.6	19.5	22.3	33.8	17.4	34.0	25.5	45.4	15.7	24.1	42.6	22.2	13.3	31.0	19.0	12.8	27.6	18.2	14.1	16.8	56.7	15.1	9.4	18.5	9.7	20.3	16.5	12.6	10.1	21.8	21.9	17.0	33.3	18.1	17.3	19.0	16.8	27.0	8.5	23.8	31.6	23.6	21.4	15.2	18.8	22.2	23.8	11.6	6.5	20.9	56.8	26.9	9.9	15.1	19.6	24.8	20.9	16.5	25.5	19.8	15.4	15.4	26.2	33.3	29.2	12.2	9.2	10.3	32.1	23.5	7.0	17.8	11.8	31.3	22.1	17.6	15.8	39.3	30.9	25.6	26.0	28.6	7.6	23.2	22.7	20.1	25.2	17.0	20.4	24.4	10.0	14.0	6.6	22.1	20.9	15.1	24.9	10.7	11.4	12.6	14.1	14.2	12.2	10.9	11.3	11.3	11.0	56.7	9.4	9.7	16.8	18.5	9.7	29.5	29.2	14.1	25.9	31.6	35.3	41.1	24.2	39.6	22.2	223.4	156.1	82.9	157.1	142.8	34.3	125.5	66.2	148.5	129.7	99.5	25.5	63.2	101.2	106.7	472.3	134.1	241.2	46.7	217.0	95.5	80.8	234.3	79.8	184.5	67.0	22.3	128.5	82.9	53.3	400.3	50.0	70.6	141.7	179.5	172.8	36.1	275.5	227.7	49.8	271.4	43.2	45.3	134.8	116.8	87.3	149.8	103.1	90.6	196.2	201.3
FAM192A	"C16orf94, NIP30"	ENSG00000172775	"Family with sequence similarity 192 member A"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 195.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	21.2	23.1	39.3	31.3	42.5	60.4	31.0	38.0	45.6	22.4	33.4	41.8	19.1	30.3	25.2	31.0	28.0	25.4	21.9	25.8	37.2	36.3	26.9	27.0	25.3	39.6	44.8	32.5	26.1	33.9	52.1	31.1	28.4	36.7	28.1	41.1	24.7	24.8	24.6	31.8	40.7	32.4	25.4	40.8	42.0	27.5	41.4	40.0	47.2	33.2	21.9	42.6	23.1	23.9	26.6	30.4	48.5	38.1	17.9	22.2	20.8	31.4	40.3	45.0	30.2	19.8	24.5	42.4	37.2	27.9	46.1	29.9	38.1	33.4	47.7	41.9	28.4	23.4	42.3	31.2	37.3	46.8	21.2	25.1	33.2	36.1	39.4	28.6	40.6	47.4	24.5	37.3	43.7	35.5	28.3	32.9	36.4	44.4	15.4	30.3	23.4	44.2	37.9	29.0	23.5	30.4	54.4	65.6	46.2	31.1	26.0	32.4	37.2	68.0	29.0	25.0	32.8	24.0	28.2	32.5	34.2	28.7	24.9	27.7	37.0	28.9	61.3	35.0	29.5	32.6	48.5	26.6	40.1	17.3	30.6	16.8	26.6	16.7	16.0	30.4	23.9	17.4	18.0	36.8	17.9	38.1	21.0	22.2	20.8	39.3	42.5	38.0	45.6	37.2	36.3	44.8	32.5	36.7	40.0	50.6	43.5	36.6	26.3	15.5	24.2	69.4	25.5	62.9	44.3	33.2	11.8	50.4	131.0	53.3	180.9	38.6	42.8	0.0	51.0	50.0	31.3	28.4	54.4	28.0	56.7	35.0	27.6	31.9	55.1	195.2	31.4	62.2	40.5	77.5	31.3	41.0	53.0	34.5	23.3	51.5	20.1	38.8	24.7	107.5	36.5	19.2	44.4	26.2	29.8	26.9
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.3	7.1	15.8	13.8	7.8	7.6	34.3	4.9	5.2	8.1	7.7	19.1	10.4	10.2	7.5	4.7	10.2	9.3	7.2	10.2	6.0	22.4	7.5	7.2	11.2	9.1	4.6	7.0	14.8	7.5	11.4	6.8	7.5	14.5	8.1	16.2	6.9	10.1	5.7	17.9	12.7	20.4	11.0	4.7	5.7	20.8	3.5	8.6	7.7	15.3	14.7	9.4	5.6	16.3	4.8	12.5	15.9	9.7	10.0	9.0	7.4	5.8	5.7	11.1	4.6	8.2	7.2	11.4	7.4	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2	17.9	29.0	6.0	5.1	7.7	10.9	6.4	22.9	8.1	13.6	10.4	17.7	4.3	0.0	5.4	5.1	9.2	9.1	0.0	7.6	6.8	7.8	7.9	4.7	10.4	4.2	11.1	8.1	14.1	7.6	7.4	9.2	7.8	8.5	3.6	13.9	9.1	5.5	5.8	4.9	2.2	12.4	6.5	9.9	10.6	12.9	11.3	3.8	7.9	10.3	5.4
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.6	9.8	16.1	22.4	16.1	17.6	9.2	17.1	32.3	24.9	22.6	11.5	20.3	15.4	10.7	18.4	11.2	18.7	13.4	17.9	22.7	24.1	16.7	12.7	10.0	10.1	24.1	33.1	18.2	12.1	22.0	18.2	38.4	20.9	21.1	19.9	13.3	18.2	20.5	12.0	20.3	30.8	11.4	9.5	8.7	17.4	31.2	11.2	22.5	11.0	10.4	16.4	11.7	11.0	25.2	8.3	17.5	24.0	14.7	13.1	12.2	11.5	26.0	13.1	11.6	22.1	25.5	35.9	13.2	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9	56.6	51.4	57.2	54.8	49.3	36.8	71.2	50.9	53.5	47.8	41.8	68.7	32.9	114.4	58.3	206.7	61.6	25.0	46.7	98.7	40.6	62.0	51.0	65.9	40.6	54.1	31.8	40.3	59.5	64.6	82.8	70.8	79.5	57.3	48.7	48.6	54.4	77.4	58.3	65.7	92.5	54.8	25.8	71.2	217.2	170.6	44.3	25.6	57.4	45.3	52.2
FAM208B	"bA318E3.2, C10orf18, FLJ20360, KIAA2006"	ENSG00000108021	"Family with sequence similarity 208 member B"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	15.4	15.5	10.1	22.9	13.6	16.1	16.4	18.9	13.4	18.7	15.0	11.8	13.6	8.6	21.2	20.7	14.6	19.6	13.4	16.9	12.0	9.3	13.6	15.9	15.1	20.5	15.0	10.6	23.8	19.4	26.2	24.3	16.0	12.6	15.9	15.8	12.9	15.6	17.0	26.9	12.7	16.4	17.4	12.8	16.7	15.7	29.7	14.0	19.5	22.6	14.1	21.1	17.4	22.0	4.3	2.2	1.8	2.4	8.6	3.2	0.8	17.5	14.9	9.6	16.3	12.4	14.8	13.5	15.0	9.6	12.9	16.4	15.7	10.4	35.9	9.6	14.7	8.2	13.9	27.4	15.4	21.0	7.0	18.4	16.7	11.6	10.5	12.4	12.3	10.0	11.3	17.3	21.0	17.9	8.7	14.9	14.0	26.9	8.4	14.4	11.8	15.9	4.4	11.7	11.4	9.7	11.9	13.4	12.5	7.8	16.0	11.8	13.3	14.9	13.6	10.7	11.3	17.8	9.7	14.9	16.4	17.7	31.5	20.4	10.3	9.8	32.1	8.1	12.2	8.6	1.4	2.4	0.5	2.4	2.3	2.2	2.1	1.8	2.3	1.4	4.3	1.8	3.2	1.8	8.6	0.9	2.2	2.4	0.8	10.1	13.6	18.9	13.4	12.0	9.3	15.0	10.6	12.6	14.0	23.8	20.2	21.5	15.6	30.7	32.0	24.6	20.4	12.0	38.7	10.4	35.3	9.2	1.7	13.8	20.4	26.3	9.8	0.0	9.8	8.6	27.3	25.1	3.5	14.3	8.9	20.6	13.2	21.5	13.5	6.2	25.0	14.4	20.3	16.2	15.4	14.3	13.9	11.5	26.9	8.1	36.0	25.8	25.9	60.2	44.9	36.6	6.1	20.8	19.4	27.5
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.9	16.5	12.8	13.5	22.9	24.2	14.2	15.0	17.2	10.6	9.5	8.2	18.0	9.3	19.8	26.4	8.7	13.2	13.0	11.0	15.6	11.8	8.8	29.7	15.6	10.4	11.4	19.6	18.8	14.0	12.1	14.4	11.2	16.2	13.0	13.1	33.0	13.7	16.9	10.0	8.5	7.1	16.8	20.3	3.5	10.5	13.5	12.4	8.9	20.4	17.1	42.1	15.8	18.0	15.3	19.0	15.5	14.4	13.7	16.9	14.9	23.2	20.2	11.2	20.4	8.2	16.8	9.6	16.7	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4	6.0	10.7	11.2	8.9	13.9	12.3	31.9	17.8	8.1	7.9	17.4	23.6	8.0	3.3	8.2	4.2	11.2	4.1	0.0	11.0	5.7	12.4	14.8	16.2	12.2	6.9	36.5	13.8	10.4	8.9	2.5	16.4	6.9	15.1	10.0	7.6	7.8	11.0	0.0	20.1	5.4	20.2	12.9	20.3	12.9	15.8	11.3	6.3	6.9	6.6	23.8
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM212A	"C3orf54, INKA1"	ENSG00000185614	"Family with sequence similarity 212 member A"	Q96EL1	3	49803254-49805030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 25.8;skin 1: 30.0"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 22.2;granulocytes: 19.8;Hofbauer cells: 41.3;Ito cells: 39.3;Suprabasal keratinocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4"	"Group enriched"	"Detected in many"	6	"B-cells: 25.8;granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 31.9;HMC-1: 21.9;NB-4: 17.7;THP-1: 19.7;U-937: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	6.0	4.1	5.8	3.2	4.7	5.0	3.5	8.0	6.3	6.8	2.6	4.9	1.4	1.7	5.5	2.8	16.3	2.9	4.8	7.6	4.4	4.3	3.4	1.2	7.3	5.9	6.3	4.8	3.6	2.3	0.8	2.0	5.2	5.6	5.4	1.4	3.2	4.5	3.9	15.3	30.0	3.5	5.3	8.3	6.9	2.2	2.4	4.3	1.8	1.9	10.4	8.4	4.8	8.5	25.8	3.6	19.0	2.9	0.0	1.5	2.8	0.6	0.5	0.7	0.5	0.9	2.0	0.0	1.4	0.9	0.7	0.8	0.0	0.0	6.9	0.2	1.0	0.7	4.1	0.2	4.9	0.0	1.2	0.0	31.9	0.3	0.1	1.3	4.8	21.9	2.7	7.0	1.4	1.3	0.4	2.9	0.5	2.1	0.6	0.6	0.3	0.4	17.7	0.5	0.0	2.8	6.5	0.4	1.5	0.0	7.9	0.3	2.5	1.3	0.2	0.7	0.2	0.1	19.7	1.8	3.6	0.4	1.6	0.6	0.8	0.7	0.5	1.5	16.4	0.8	19.0	0.9	4.3	0.6	2.2	0.1	25.8	0.6	0.7	0.2	23.4	0.9	1.5	0.5	0.0	2.9	3.6	0.6	2.8	5.8	4.7	8.0	6.3	4.4	4.3	6.3	4.8	5.6	4.3	3.0	1.1	0.0	11.6	22.2	1.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	1.6	7.5	0.0	0.0	0.0	0.4	7.5	1.1	19.8	0.0	41.3	0.0	0.0	39.3	2.2	7.4	1.7	0.0	11.8	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.4	12.9	0.5	1.7	3.2	24.1	0.9	0.0	0.0	4.7
FAM213B	"C1orf93, MGC26818"	ENSG00000157870	"Family with sequence similarity 213 member B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.7;U-2197: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	6.0	9.1	14.7	5.7	14.9	3.8	4.6	7.4	20.0	7.9	15.4	6.2	5.2	22.0	4.5	6.7	5.7	10.5	23.7	3.2	15.0	15.5	7.4	3.5	6.0	5.8	11.7	11.0	7.1	4.6	4.4	4.3	8.4	10.7	5.7	7.4	9.0	5.3	7.7	1.8	6.1	20.2	4.8	6.5	7.4	11.7	3.3	4.7	5.4	5.2	0.9	5.2	6.3	3.5	2.1	2.2	1.5	2.3	7.5	6.3	3.2	7.7	4.3	4.4	4.8	2.1	2.4	0.6	7.0	2.9	6.6	2.9	3.1	9.1	2.0	7.1	4.5	2.7	6.5	3.9	4.9	2.2	5.8	2.0	4.8	3.3	4.9	5.1	2.7	1.4	3.5	2.5	4.6	1.7	3.1	9.3	3.6	6.5	3.1	6.6	5.6	6.3	1.2	5.3	9.0	16.6	6.9	6.5	5.1	6.9	3.9	5.9	9.8	6.0	26.7	8.0	1.1	4.6	1.0	13.5	5.8	6.7	22.9	2.6	2.9	4.3	1.4	5.4	9.2	1.1	1.5	2.0	1.1	3.8	2.3	6.3	2.1	4.2	4.1	2.2	1.5	3.5	5.4	1.5	7.5	2.0	1.0	5.6	3.2	14.7	14.9	7.4	20.0	15.0	15.5	11.7	11.0	10.7	4.7	3.0	1.7	3.9	4.5	3.7	11.0	4.5	12.7	10.7	6.8	33.2	0.0	0.4	6.6	24.6	0.6	11.6	37.6	0.0	8.8	0.4	4.0	3.7	0.0	2.6	8.0	22.3	15.1	12.3	4.9	1.1	4.9	7.6	6.8	8.2	25.7	6.0	31.4	38.2	3.9	11.8	5.2	19.4	8.1	0.9	11.1	4.5	0.6	6.9	32.8	7.0
FAM214B	"bA182N22.6, FLJ11560, KIAA1539"	ENSG00000005238	"Family with sequence similarity 214 member B"	Q7L5A3	9	35104112-35116341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"TIME: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048831, HPA055751"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048831: AB_2680535, HPA055751: AB_2682906"	"unprognostic (2.91e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.15e-2)"	13.0	10.3	14.1	12.4	14.9	35.0	6.7	10.4	18.9	7.3	12.0	25.9	10.7	10.9	7.7	7.9	22.4	6.1	12.5	16.5	15.4	14.4	12.5	7.7	13.6	7.4	17.0	11.4	7.5	5.6	10.4	10.9	26.3	20.8	8.6	11.5	9.3	8.6	11.1	8.9	10.9	10.6	11.8	20.5	19.1	10.7	5.8	8.4	3.7	9.1	12.2	12.0	10.4	8.8	0.5	4.4	14.6	8.5	1.7	2.1	2.5	2.9	2.4	6.7	4.8	5.3	8.2	1.4	14.4	13.0	8.0	5.2	1.6	2.0	0.7	4.3	23.2	21.1	1.3	1.1	4.6	5.2	3.7	0.3	3.7	5.2	1.5	5.4	0.9	15.9	5.8	8.3	9.4	6.0	18.7	15.4	3.7	1.9	2.9	16.7	0.8	1.4	4.4	1.2	2.1	3.6	1.6	1.1	0.8	10.5	0.6	0.4	4.4	2.3	1.6	7.7	7.4	2.1	2.4	26.2	11.3	5.5	5.4	5.2	1.9	1.8	0.3	17.8	1.8	12.5	4.7	5.2	4.7	2.1	6.9	0.7	0.5	1.3	1.4	4.4	0.2	0.5	0.9	14.6	1.7	8.5	1.1	0.7	2.5	14.1	14.9	10.4	18.9	15.4	14.4	17.0	11.4	20.8	8.4	0.0	4.6	1.4	4.6	7.4	3.1	6.5	0.0	0.0	3.4	15.7	13.7	2.3	3.3	9.4	9.8	8.6	21.3	0.0	11.1	7.9	7.4	8.1	8.1	5.4	14.1	0.0	5.2	20.3	27.6	49.2	3.1	21.0	15.1	16.2	9.0	8.4	25.8	14.2	7.4	9.0	3.3	6.5	7.2	3.1	5.4	12.7	3.5	4.8	7.6	6.0
FAM219B	"C15orf17, FLJ00005"	ENSG00000178761	"Family with sequence similarity 219 member B"	Q5XKK7	15	74899987-74907121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048929, HPA058064"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA048929: AB_2680561, HPA058064: AB_2683592"	"unprognostic (1.12e-1)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.11e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.91e-3)"	16.5	14.4	12.5	10.0	16.5	5.9	28.7	18.5	20.0	11.3	11.6	10.1	10.3	11.2	11.1	22.9	16.6	14.6	12.1	22.7	13.0	13.6	11.7	4.7	13.4	10.6	13.8	12.5	13.0	11.0	22.3	21.5	9.1	15.1	18.6	9.8	13.8	15.9	13.7	12.0	18.1	10.1	12.8	10.2	18.2	11.2	5.2	11.0	4.4	13.7	8.1	11.8	16.8	11.2	3.7	1.4	6.9	1.5	2.1	3.7	1.1	2.5	5.7	11.1	5.4	15.9	9.9	5.8	8.1	4.1	6.8	5.2	2.3	6.4	7.2	5.3	5.2	4.5	9.1	12.1	4.9	3.7	13.8	12.3	2.9	9.8	1.3	5.9	4.2	7.7	5.6	16.6	2.6	6.4	11.6	5.5	5.3	4.4	5.7	6.5	0.6	3.9	5.3	6.5	6.5	10.0	9.5	3.6	4.0	13.0	5.6	9.7	5.1	7.2	6.3	10.9	6.9	10.0	2.8	10.9	4.6	4.1	3.8	6.4	6.6	4.8	3.5	6.9	10.5	5.2	3.8	1.0	6.9	2.2	1.4	3.7	3.7	2.8	0.9	1.4	2.9	2.3	1.8	2.4	2.1	1.5	0.3	0.3	1.1	12.5	16.5	18.5	20.0	13.0	13.6	13.8	12.5	15.1	11.0	17.9	12.7	13.7	18.7	5.7	40.0	4.0	15.3	14.7	13.6	26.2	55.0	13.3	11.6	12.9	0.7	15.5	16.7	0.0	9.1	9.6	14.2	19.3	24.3	4.7	15.0	22.3	20.1	16.0	10.7	3.2	21.6	14.3	13.5	19.8	16.8	24.9	12.7	14.4	26.9	9.8	65.3	25.8	18.1	7.9	18.5	6.8	7.0	16.6	15.2	19.0
FAM234A	"C16orf9, DKFZP761D0211, FLJ32603, ITFG3"	ENSG00000167930	"Family with sequence similarity 234 member A"	Q9H0X4	16	234546-268971	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA		3700000	Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	20.2	19.1	11.3	11.7	24.3	6.4	16.5	12.2	16.2	11.6	20.3	56.0	13.7	36.3	17.4	12.6	26.4	14.0	16.0	31.1	8.3	7.3	18.3	15.6	11.4	10.5	39.8	9.0	13.4	29.6	24.3	19.2	15.4	37.8	16.8	12.4	15.5	14.1	15.4	51.4	14.9	26.8	29.0	42.0	9.7	18.8	13.0	27.2	7.2	16.6	16.2	6.3	19.0	11.7	10.3	17.8	12.5	17.4	14.2	11.5	12.5	9.0	18.7	23.4	54.2	36.4	21.7	12.3	22.0	27.9	13.4	17.3	18.9	26.1	8.2	35.8	27.7	11.9	18.3	7.4	13.2	11.2	11.3	13.1	11.5	11.7	15.2	22.2	6.1	6.9	22.5	20.5	18.9	15.5	37.1	21.6	10.8	12.7	2.1	14.5	37.2	6.9	6.8	29.5	13.2	9.5	20.9	16.5	40.8	23.1	8.8	29.7	24.0	35.6	20.9	18.6	20.5	26.7	10.6	21.5	28.3	8.3	15.1	6.7	5.0	2.0	10.8	19.9	9.8	38.5	11.3	17.4	12.5	10.8	16.9	5.6	8.0	9.6	10.2	17.8	10.3	11.1	11.5	7.6	14.2	16.5	6.3	9.3	12.5	11.3	24.3	12.2	16.2	8.3	7.3	39.8	9.0	37.8	27.2	8.9	13.0	2.2	9.1	0.0	8.6	0.0	10.2	12.0	9.1	29.6	23.6	49.9	6.6	41.4	21.8	13.9	34.2	0.0	23.0	42.1	9.7	12.0	8.1	19.8	22.9	9.5	33.9	20.9	14.5	52.2	15.5	11.9	0.0	57.7	30.3	9.3	17.1	51.6	20.5	15.1	11.9	19.4	0.0	16.4	28.1	0.0	55.4	6.9	42.9	9.8
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	37.2	42.9	56.2	34.0	37.6	53.1	43.9	33.4	56.2	29.0	39.9	18.7	33.1	50.5	37.2	35.1	41.2	30.9	35.4	32.5	51.6	35.7	39.8	54.9	31.7	35.5	34.9	45.9	30.3	32.5	25.1	24.8	51.1	41.5	30.4	38.8	18.6	34.6	33.4	52.0	42.7	56.7	35.2	45.8	43.2	40.4	24.1	34.3	32.8	33.5	29.8	37.5	40.3	38.9	27.9	41.5	94.9	65.7	27.6	32.2	51.5	29.3	22.6	35.5	22.9	42.0	32.4	33.7	28.6	32.5	35.4	39.0	31.0	35.6	19.5	50.0	36.8	25.5	22.7	36.3	31.2	31.3	25.7	39.9	36.2	20.4	27.4	34.0	45.5	42.6	37.3	32.9	28.3	26.1	31.5	38.1	40.6	28.3	28.9	34.9	39.1	35.1	47.6	51.0	48.9	55.9	37.1	24.6	32.2	38.7	29.5	30.7	46.6	24.1	23.1	30.6	26.7	19.6	52.1	35.3	27.6	16.4	50.3	35.8	34.5	57.0	30.8	40.1	55.5	23.8	41.0	47.8	94.9	24.7	60.1	26.1	27.9	23.7	26.7	41.5	27.8	28.8	31.4	41.0	27.6	65.7	28.5	32.2	51.5	56.2	37.6	33.4	56.2	51.6	35.7	34.9	45.9	41.5	34.3	41.7	44.0	67.1	29.7	41.4	26.9	32.3	50.9	45.5	35.2	34.9	19.6	83.5	77.9	90.3	13.7	55.9	94.4	0.0	90.4	92.4	53.1	40.3	61.2	86.3	76.1	39.7	65.1	40.5	62.3	28.5	35.9	54.8	55.6	104.6	53.1	39.3	101.4	119.3	49.1	57.2	18.8	25.8	42.9	23.5	40.4	46.5	88.4	65.0	48.0	48.7
FAM35A	"bA163M19.1, FAM35A1, MGC5560"	ENSG00000122376	"Family with sequence similarity 35 member A"	Q86V20	10	87094161-87191468	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	17.3	16.9	5.4	14.4	7.2	5.4	15.4	6.4	4.9	12.6	20.2	4.7	9.1	15.0	10.8	10.6	12.6	9.3	7.4	11.5	6.0	6.1	31.2	35.3	12.5	16.4	9.0	3.5	12.7	10.2	3.6	19.4	7.4	6.8	14.0	11.6	7.4	11.4	14.0	9.3	9.1	33.1	14.8	6.9	15.6	8.7	7.1	7.9	12.0	30.7	12.6	9.4	12.3	13.6	9.0	10.7	4.9	11.1	11.2	13.7	8.5	16.1	13.1	7.5	17.2	8.5	8.2	11.0	10.9	15.4	14.7	16.2	15.0	12.5	11.9	6.1	14.8	8.6	10.8	18.5	8.3	15.2	16.9	12.2	16.4	12.5	14.1	13.1	25.6	14.4	7.5	15.4	13.4	23.2	13.0	9.8	13.0	20.8	21.5	13.6	9.3	20.7	18.3	8.6	11.8	9.2	12.9	14.9	13.1	13.5	13.6	3.7	15.5	8.4	10.0	14.5	7.3	22.0	14.5	9.5	8.4	7.7	12.5	21.7	12.1	26.4	28.8	14.2	32.0	4.5	4.9	7.0	2.3	6.8	11.1	13.7	9.0	10.3	10.0	10.7	7.2	10.5	10.5	0.1	11.2	8.4	3.7	9.7	8.5	5.4	7.2	6.4	4.9	6.0	6.1	9.0	3.5	6.8	7.9	17.9	16.3	7.2	11.3	9.3	7.7	0.0	15.3	14.7	21.6	0.0	13.7	5.6	0.0	0.0	16.8	8.6	14.8	0.0	0.0	13.2	13.9	20.1	9.2	58.0	13.0	6.4	6.9	16.0	18.4	17.8	19.0	20.0	16.9	0.0	16.0	14.3	0.0	12.9	18.7	0.0	21.1	12.9	5.3	15.7	6.8	9.8	1.8	13.1	15.7	14.6
FAM46A	"C6orf37, FLJ20037"	ENSG00000112773	"Family with sequence similarity 46 member A"	Q96IP4	6	81491439-81752774	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 106.4"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 311.3;Horizontal cells: 276.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	10.0	7.1	1.4	4.9	1.4	64.7	5.6	2.8	0.9	14.4	17.7	1.3	24.2	5.1	12.8	20.0	4.2	8.8	17.1	19.4	1.2	4.4	3.2	11.8	5.8	2.3	1.4	0.9	20.1	3.5	6.5	20.4	106.4	3.5	16.2	5.6	4.9	49.8	45.6	4.5	7.0	32.6	15.3	2.5	5.8	13.2	6.8	1.4	1.2	7.7	6.7	3.7	13.4	31.1	12.0	12.4	22.4	22.2	8.3	6.2	6.1	1.0	1.5	1.0	0.0	22.1	9.8	1.9	8.4	6.0	5.0	7.6	15.7	0.8	0.1	0.3	25.4	3.2	0.9	0.7	1.3	3.7	0.0	1.9	0.0	25.1	2.4	6.9	28.8	2.2	4.3	0.7	3.9	0.7	16.4	0.6	0.2	0.4	0.0	3.3	4.4	0.0	20.4	0.2	8.9	1.2	0.0	9.1	0.0	0.6	1.9	1.0	1.4	3.7	1.6	2.5	3.3	0.3	49.6	1.4	5.7	1.2	2.4	2.3	0.1	0.1	0.1	8.1	22.3	2.4	16.1	14.9	22.4	6.2	15.1	3.7	8.0	2.4	3.0	12.4	12.0	4.7	4.4	7.3	8.3	22.2	4.3	2.7	6.1	1.4	1.4	2.8	0.9	1.2	4.4	1.4	0.9	3.5	1.4	59.6	92.4	0.9	134.5	49.9	25.9	0.0	45.9	21.4	102.4	0.0	70.7	30.7	0.0	0.0	0.4	20.4	311.3	23.3	0.0	89.3	98.1	34.0	210.9	34.5	26.7	276.5	183.7	6.7	35.9	0.5	95.3	46.7	62.4	0.0	64.6	75.7	0.0	105.2	37.1	0.0	45.1	25.8	43.8	0.9	5.4	31.7	135.5	20.3	33.3	105.6
FAM49B	BM-009	ENSG00000153310	"Family with sequence similarity 49 member B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.5;bone marrow: 80.1"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 468.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		990000	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	19.2	14.5	23.2	42.8	33.1	80.1	20.6	28.0	36.9	7.2	14.3	18.2	5.5	14.2	8.0	10.6	17.9	7.9	14.9	9.8	25.5	25.2	11.8	12.3	19.1	49.6	28.5	19.6	6.4	10.0	7.5	16.1	19.4	21.2	7.6	17.4	7.3	12.0	7.9	16.8	9.0	19.3	13.5	38.8	41.3	12.9	13.6	21.2	28.2	13.8	9.7	46.4	20.6	8.4	21.0	47.3	93.5	42.2	30.8	29.3	43.4	32.2	17.3	18.9	10.6	1.7	2.5	25.2	9.8	9.5	13.6	14.6	9.9	22.3	32.3	21.6	6.4	10.8	16.1	15.6	25.9	20.5	67.5	10.9	32.3	9.7	11.2	6.6	20.9	27.9	4.0	12.1	9.2	19.2	11.2	12.0	26.3	23.1	37.5	14.9	14.4	71.0	15.5	16.0	25.4	24.0	31.0	12.8	54.1	27.9	13.3	12.6	16.5	19.6	12.4	29.0	17.9	14.5	27.2	7.4	5.0	32.4	10.6	20.8	12.5	36.7	53.5	7.9	45.6	13.0	45.5	35.3	65.6	29.3	42.2	22.4	21.0	16.7	23.9	47.3	15.1	15.0	24.6	93.5	30.8	36.5	30.4	22.5	43.4	23.2	33.1	28.0	36.9	25.5	25.2	28.5	19.6	21.2	21.2	29.8	31.5	95.1	103.3	116.3	33.0	23.3	35.7	13.4	33.0	73.3	39.3	108.2	44.7	52.9	13.3	30.0	27.9	0.0	43.3	127.2	26.9	56.3	64.6	16.1	225.8	23.8	26.6	22.7	194.9	6.5	5.8	254.2	45.5	468.9	24.3	12.1	64.0	38.6	4.2	23.5	17.1	19.4	15.5	29.9	40.7	72.6	50.6	182.7	28.1	113.6
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.6;Early spermatids: 11.4;Spermatocytes: 14.4;Spermatogonia: 11.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.9"	"Low region specificity"	"Detected in all"							"HPA036452, HPA058138"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.3	0.8	0.8	0.6	0.7	0.9	1.2	1.6	1.1	0.9	1.0			0.0	1.6	6.0	0.8	2.1	1.5	0.5	1.1	0.7	0.7	1.2	0.7	0.9	1.5		1.5	4.0	1.3	6.8	0.1		1.1	0.2		1.7	0.8	1.5	3.3	0.4	1.0	2.7	0.8	0.9	12.7			5.7		0.2	0.9	0.6	2.4	4.9	0.6	3.8	0.9	4.4	1.0	1.2	0.8	2.0	4.0	1.4	3.5	0.8	6.6	3.6	6.4	4.3	1.6	2.9	3.2	3.3	1.8	2.5	0.2	0.0	1.3	1.7	0.8	0.9	0.8	0.3	0.7	5.6	0.0	1.2	2.7	3.8	3.2	6.4	1.3	1.0	6.8	2.4	0.9	2.8	0.8	1.9	2.0	2.5	0.6	9.1	0.9	0.5	0.1	1.7	1.9	9.9	4.2	2.5	0.5	4.7	1.5	3.1	2.1	1.6	0.3	0.4	1.2	0.8	0.4	1.6	0.8	0.1	1.2	7.8	0.0	1.1	0.6	0.5	3.8	1.2	2.4	0.7	0.8	2.5	1.6	4.4	0.2	0.0	0.9	1.5	4.9	1.0	1.0											0.0	0.0	0.0	0.4	1.1	0.8	3.6	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.3	11.4	0.5	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.8	0.2	0.0	0.0	1.3	0.0	1.3	0.6	0.3	0.0	1.0	0.0	0.3	0.4	0.0	0.4	0.3	0.4	0.0	0.9	14.4	11.8	0.4	0.0	0.0	0.4	0.1
FAM69A	FLJ23493	ENSG00000154511	"Family with sequence similarity 69 member A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	13.3	3.4	20.7	10.4	22.5	7.0	7.8	19.4	22.2	7.3	13.2	15.9	4.2	8.8	15.7	3.8	9.3	8.3	11.1	5.3	22.6	18.0	6.1	24.7	4.5	10.1	25.0	12.2	6.0	3.5	20.5	4.1	12.8	17.7	9.5	12.4	5.4	5.5	11.3	7.5	5.6	8.2	19.4	24.7	7.6	8.8	6.4	24.4	9.6	6.2	3.6	8.8	12.2	6.0	22.5	7.1	0.2	0.9	11.8	14.2	6.7	4.3	4.8	2.0	4.8	7.5	14.1	2.4	13.6	28.1	7.7	15.7	2.7	0.9	14.8	2.5	25.0	15.4	5.6	0.3	10.2	12.8	5.9	4.8	0.5	3.8	6.9	2.7	1.3	0.9	8.4	8.2	17.0	3.9	13.1	0.1	9.1	5.2	15.7	9.7	1.6	4.9	1.2	3.5	7.3	1.9	4.4	14.5	4.5	1.1	4.5	4.9	3.8	3.8	3.8	5.0	4.6	1.8	0.4	0.5	9.1	7.0	17.7	4.8	23.8	22.7	17.3	4.3	0.9	0.8	0.0	0.9	0.0	10.5	0.4	8.1	22.5	12.1	8.2	4.3	13.6	14.2	12.1	0.2	11.8	0.2	7.1	10.7	6.7	20.7	22.5	19.4	22.0	22.6	18.0	25.0	12.2	17.7	24.4	0.0	2.4	9.3	3.5	10.1	1.3	3.6	7.6	10.7	1.2	5.2	2.0	25.6	3.3	1.6	1.5	3.0	1.3	0.0	2.1	4.9	9.9	3.7	0.0	13.2	3.7	7.9	0.0	4.9	3.7	2.3	0.9	2.2	6.8	16.2	3.2	0.7	2.8	0.0	7.1	4.4	1.3	0.0	9.2	0.7	1.6	8.2	21.2	5.7	2.5	1.8
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725979-27763122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 122.7;Late spermatids: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	22.1	8.6	10.6	12.2	17.2	14.3	14.1	17.9	18.3	14.7	12.8	17.4	8.4	10.2	15.9	16.6	13.9	13.8	15.3	13.8	11.3	11.4	13.7	13.8	13.1	11.3	9.5	16.1	14.6	14.4	11.7	19.5	12.8	14.3	12.9	16.2	15.7	12.4	16.8	39.7	15.4	12.1	17.8	11.9	12.1	13.8	28.5	10.9	13.6	18.7	17.8	13.8	14.0	14.1	13.6	14.6	13.7	12.2	12.0	16.0	6.4	8.8	7.1	8.1	8.4	10.3	9.0	14.7	8.3	8.7	12.3	12.1	8.1	11.9	16.1	5.4	9.2	11.6	11.7	10.2	9.1	9.6	8.3	7.7	5.0	10.0	9.5	8.3	7.9	7.8	9.1	9.9	13.4	13.6	6.2	6.1	8.7	9.4	15.2	8.8	8.5	18.7	7.3	12.8	8.5	7.1	11.4	9.7	9.1	9.7	12.7	11.8	5.3	9.5	10.3	9.9	10.4	7.4	3.1	6.5	14.6	6.3	16.8	5.7	13.9	15.1	13.2	9.0	10.4	6.2	10.0	12.2	13.7	14.7	12.1	15.6	12.2	15.3	14.0	10.4	13.6	14.5	16.0	8.3	12.0	12.1	14.6	11.3	6.4	10.6	17.2	17.9	18.3	11.3	11.4	9.5	16.1	14.3	10.9	26.8	17.1	25.3	8.5	16.9	27.1	13.2	7.6	26.8	9.1	22.7	25.5	23.1	18.3	9.7	122.7	11.3	8.6	23.3	8.5	9.5	13.4	4.4	10.5	15.3	10.5	27.0	4.1	20.9	15.6	84.8	15.5	14.5	37.1	7.2	9.5	20.5	8.4	8.5	35.0	12.4	35.8	19.4	17.9	20.0	49.8	23.6	38.0	17.8	8.5	3.9
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768942-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 212.1;Late spermatids: 286.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	10.1	6.2	5.3	12.1	9.3	35.7	9.3	12.3	9.7	8.5	10.8	6.2	6.1	9.5	8.2	7.5	7.8	7.3	10.1	4.9	6.1	4.4	5.2	13.6	8.2	16.8	10.5	5.6	8.3	6.7	6.3	9.5	8.2	7.1	9.0	5.7	6.3	9.1	8.2	5.6	8.7	9.0	9.8	8.9	8.8	6.6	28.2	10.1	12.0	8.4	4.1	17.8	8.6	7.9	3.0	7.3	8.7	3.0	4.5	7.6	2.8	4.4	3.5	13.1	7.1	2.2	2.2	10.9	7.7	3.8	5.7	6.6	13.0	8.9	17.1	9.9	3.8	7.4	8.7	7.6	2.6	6.1	9.1	5.6	20.0	6.3	6.8	5.5	14.0	11.5	2.8	4.4	6.6	5.9	3.8	5.4	10.2	11.8	9.5	3.2	3.3	15.7	16.5	7.3	4.9	3.2	17.1	9.8	10.0	4.3	5.1	5.5	15.8	9.5	5.4	5.8	4.6	7.2	6.1	5.5	8.0	8.6	9.3	7.0	5.2	11.0	26.3	1.9	13.7	11.2	0.1	2.9	5.2	5.4	3.0	4.4	3.0	4.9	5.4	2.0	2.6	4.5	6.7	8.7	4.5	2.8	7.3	7.6	2.8	5.3	9.3	12.3	9.7	6.1	4.4	10.5	5.6	7.1	10.1	6.0	13.9	22.8	11.5	12.2	15.0	6.9	7.6	10.7	18.2	5.2	25.5	7.4	0.0	6.2	212.1	15.5	9.1	46.7	6.5	8.4	10.6	12.1	10.4	14.7	7.2	11.1	19.5	16.5	14.8	286.0	15.8	16.0	15.1	9.0	12.1	15.6	7.1	11.5	14.5	2.1	13.2	25.8	15.5	20.5	19.2	14.1	6.4	19.2	9.9	9.0
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.6	0.8	0.2	18.5	0.2	0.1	0.2	0.1	0.1	0.1	7.7	0.1	0.1	0.3	0.0	7.4	0.1	0.0	1.9	0.6	17.4	0.2	0.1	0.3	17.2	0.8	0.2	0.4	0.0	0.0	0.2	10.3	5.0	6.1	2.2	0.2	2.6	0.7	27.2	1.2	0.1	0.3	1.8	1.1	10.7	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.4	0.6	24.3	0.3	1.1	1.2	0.6	0.0	1.6	0.8	4.4	0.1	16.3	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4	0.0	1.0	24.3	0.0	0.8	57.8	12.8	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	73.4	3.1	0.0	0.0	0.0	28.2	1.3	0.0	1.1	0.0	22.1	0.0	0.0	3.7	14.3	101.2	4.6	10.1	1.7	5.4	0.0	0.8	0.2	0.0	3.2	0.0	1.7	0.0	0.5	1.2	0.4	0.6	1.1	14.4	0.0	0.1
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5;plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.5"	"Cell line enriched"	"Detected in many"	4	"Daudi: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001847: AB_2666462, HPA065797: AB_2685560"	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	1.0	0.8	13.7	3.1	14.0	0.4	1.8	1.2	32.2	8.4	5.2	3.2	0.7	3.0	3.3	5.7	1.0	7.8	2.1	1.9	16.1	8.7	8.7	0.8	1.1	5.7	5.6	17.7	1.1	2.5	0.6	3.3	1.1	3.7	3.1	6.6	1.2	3.3	2.2	0.9	1.5	1.8	1.7	4.3	1.8	3.1	2.2	1.9	0.0	2.7	0.0	6.6	0.9	1.1	2.6	12.5	0.4	0.6	0.1	0.0	0.3	5.8	8.5	0.6	0.1	0.2	0.1	3.5	0.3	0.0	0.6	1.7	1.0	1.0	37.3	0.2	0.1	8.2	4.5	4.8	1.4	1.1	0.4	2.5	0.0	5.7	0.3	0.0	3.1	0.8	0.0	0.9	0.2	0.4	0.4	0.0	1.5	0.1	0.0	0.5	2.0	0.0	0.1	0.5	1.5	3.1	0.8	8.6	0.9	1.9	2.1	1.8	0.5	3.4	0.1	5.5	0.4	1.5	1.9	0.2	1.4	4.4	1.7	6.3	0.0	0.0	0.4	1.4	1.2	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	2.6	0.0	0.0	0.4	0.1	0.0	12.5	0.0	0.3	13.7	14.0	1.2	32.2	16.1	8.7	5.6	17.7	3.7	1.9	0.0	2.2	1.9	0.9	0.5	0.0	6.2	0.0	6.7	1.2	29.6	0.0	0.1	5.0	0.4	0.4	0.6	0.7	0.0	0.2	1.1	0.4	2.1	1.1	0.0	1.1	9.5	1.2	0.0	0.3	0.4	0.3	0.7	8.5	0.0	0.9	1.0	0.3	1.9	0.0	0.1	0.1	0.0	0.9	0.1	1.3	0.4	0.0	0.0	3.7	0.9
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	23.0	0.0	7.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.3	0.0	0.0	0.0	0.0	0.1	11.0	24.3	0.0	0.2	2.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	11.8	25.4	0.5	5.1	2.5	2.7	1.2	22.7	0.0	0.1	3.3	8.6	20.7	0.8	31.6	0.0	13.2	0.1	1.6	13.1	1.1	1.0	0.2	0.0	12.6	0.0	0.8	52.5	1.7	0.9	1.7	0.0	18.3	1.0	11.4	20.1	2.1	5.0	0.7	0.0	0.8	7.2	2.2	30.2	1.1	0.0	12.7	15.2
FAM90A1	FLJ10408	ENSG00000171847	"Family with sequence similarity 90 member A1"	Q86YD7	12	8221260-8227618	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.8"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 2.5;Early spermatids: 1.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (2.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.69e-3)"	"unprognostic (1.94e-4)"	"unprognostic (4.37e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.30e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.06e-2)"	0.2	2.5	2.1	1.2	4.1	0.1	0.3	4.1	9.8	0.3	0.2			0.6	1.9	1.4	1.0	1.6	2.9	2.0	2.3	2.7	0.5	0.0	1.4	0.8	2.2		5.8	2.5	0.0	3.3	0.4		1.7	0.0		2.8	0.6	0.4	2.3	0.3	0.2	1.8	0.7	0.4	2.1			3.1		0.1	0.6	0.5	0.1	2.8	0.0	1.1	0.1	0.2	0.2	0.0	0.0	0.7	1.3	0.2	0.0	5.3	0.4	0.4	0.1	0.0	0.0	2.2	0.3	0.9	0.1	0.3	0.0	3.4	0.0	0.0	7.9	0.4	0.5	0.0	0.1	0.0	0.1	0.0	0.5	1.3	0.3	0.2	2.5	0.2	0.8	2.9	0.4	0.0	1.1	0.1	2.9	19.1	0.0	0.0	0.2	0.1	0.0	1.3	0.4	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.8	0.0	0.2	0.1	0.4	2.9	0.0	2.0	2.5	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.2	2.0	0.0	0.2											0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"		4	9170409-9176730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.2	1.6	0.0	0.0			0.0	0.1	0.1	0.0	0.3	0.4	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0		0.7	0.3	0.0	0.2	0.0		0.2	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM91A1	FLJ23790	ENSG00000176853	"Family with sequence similarity 91 member A1"	Q658Y4	8	123768456-123815452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027978	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Nucleoplasm, Microtubules"		"HPA027978: AB_10600004"	"unprognostic (2.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	21.9	15.3	12.2	16.1	14.3	39.1	17.3	17.2	15.2	17.3	18.7	11.8	26.7	15.3	16.4	15.5	20.0	13.6	17.3	14.6	12.6	14.4	20.0	30.6	18.4	17.9	15.4	11.6	18.8	15.4	25.2	20.3	26.9	15.6	14.0	16.3	16.1	18.0	24.2	9.2	17.1	23.0	12.8	18.4	31.3	14.4	11.9	14.0	24.4	19.8	12.0	20.0	15.3	16.2	5.7	8.9	12.0	10.4	6.6	4.3	4.2	25.6	17.3	5.5	9.4	10.4	11.3	8.7	14.9	16.2	14.2	18.1	8.5	10.6	12.1	16.7	12.2	11.4	12.6	12.7	16.1	25.3	23.0	12.3	19.0	9.1	10.2	16.3	8.7	24.7	10.6	13.0	18.4	23.1	9.7	12.7	7.7	6.7	17.2	12.7	30.2	14.9	5.7	5.3	21.2	15.6	8.1	8.9	8.9	11.9	26.4	6.5	9.1	19.7	42.6	19.8	8.3	13.1	9.2	12.8	13.5	24.4	14.9	21.6	13.5	25.8	11.7	21.2	15.7	16.4	6.9	8.3	12.0	3.8	10.4	3.4	5.7	3.8	3.2	8.9	5.0	3.3	4.3	11.4	6.6	9.1	3.5	3.3	4.2	12.2	14.3	17.2	15.2	12.6	14.4	15.4	11.6	15.6	14.0	23.8	10.4	19.1	15.9	35.1	12.6	5.6	35.7	4.0	14.8	24.4	21.6	9.7	5.0	10.6	18.5	22.5	17.3	23.3	13.5	10.2	17.4	24.8	8.1	50.5	23.8	22.3	26.4	21.5	65.1	17.5	13.0	29.0	20.3	10.0	18.8	17.4	25.8	17.5	13.8	14.7	19.9	12.9	20.8	11.2	10.5	40.8	16.0	17.5	13.3	39.9
FAM96A	"CIA2A, FLJ22875"	ENSG00000166797	"Family with sequence similarity 96 member A"	Q9H5X1	15	64072559-64094018	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	13.6	32.3	11.2	19.1	12.8	17.0	13.9	9.0	10.3	8.5	24.3	13.6	17.7	31.3	8.1	14.9	13.6	8.3	14.0	20.6	11.2	10.8	39.4	89.7	18.1	22.7	15.2	8.0	7.8	27.0	10.6	15.4	25.2	11.2	17.2	20.2	10.7	16.5	15.7	28.2	7.6	45.5	6.4	14.9	25.2	17.9	8.9	13.8	20.5	30.1	18.3	19.3	14.6	9.0	51.8	63.7	23.7	48.6	11.8	21.3	38.2	19.9	29.3	17.9	11.2	15.2	18.7	11.8	15.7	17.5	21.0	22.3	28.9	32.3	33.2	27.7	9.9	27.9	22.1	35.0	15.4	17.9	27.1	18.9	27.0	26.5	27.1	12.0	43.7	23.4	14.7	15.5	13.6	12.2	14.3	21.2	18.7	36.9	25.7	14.8	33.8	16.6	37.9	26.0	24.9	15.6	26.8	23.7	73.5	27.1	23.5	19.2	14.5	12.5	28.6	30.4	20.8	21.0	45.8	12.7	16.7	23.7	19.0	33.8	24.9	58.7	29.8	20.2	79.2	15.8	16.2	48.6	16.9	10.1	44.1	12.4	51.8	15.3	13.5	42.6	48.8	12.3	11.6	23.7	11.8	36.7	63.7	21.3	38.2	11.2	12.8	9.0	10.3	11.2	10.8	15.2	8.0	11.2	13.8	35.7	30.8	96.4	18.3	15.9	7.2	70.8	79.0	45.5	40.9	33.2	3.9	101.5	140.9	70.9	2.4	23.8	94.1	0.0	74.8	83.9	35.7	38.2	19.7	217.6	196.6	14.3	55.4	41.1	140.8	3.6	15.3	99.6	40.5	211.0	97.7	14.5	84.6	87.7	7.8	151.8	6.7	12.9	23.7	21.4	49.8	19.2	74.3	58.6	129.3	21.4
FAM96B	"CGI-128, CIA2B, MIP18"	ENSG00000166595	"Family with sequence similarity 96 member B"	Q9Y3D0	16	66932055-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	22.5	34.2	38.7	26.5	38.2	17.7	31.9	26.8	34.5	19.6	28.8	30.3	19.8	26.3	20.4	27.5	43.5	28.6	25.0	58.0	36.7	33.6	41.6	57.8	27.4	30.6	39.4	27.4	29.5	38.3	23.2	30.0	27.3	30.7	22.0	25.6	16.6	21.9	22.2	89.6	14.2	29.4	22.3	41.4	25.3	24.3	32.2	28.5	24.1	41.2	40.8	25.3	25.7	37.0	51.8	92.7	46.3	52.7	40.7	61.2	44.8	25.6	58.3	19.8	24.8	25.0	23.8	24.1	23.5	26.4	36.1	45.4	61.4	29.9	23.3	30.6	27.7	31.2	34.1	28.3	28.4	25.8	28.9	39.9	14.2	17.3	71.6	47.7	21.0	56.7	23.4	27.6	42.6	37.4	27.5	24.4	41.8	23.8	15.6	29.2	49.4	35.6	50.6	26.4	22.1	70.9	30.5	21.2	44.8	53.4	23.2	34.9	39.0	50.5	13.7	35.6	16.0	15.0	35.0	20.6	27.1	32.2	15.2	32.6	34.3	27.4	59.2	48.1	21.8	35.2	41.5	47.0	46.3	43.2	51.2	42.3	51.8	46.3	46.9	51.7	44.4	37.3	41.5	23.0	40.7	52.7	92.7	61.2	44.8	38.7	38.2	26.8	34.5	36.7	33.6	39.4	27.4	30.7	28.5	74.5	131.2	134.8	130.5	127.4	54.2	121.8	109.5	168.6	113.7	165.7	21.6	175.4	261.9	198.2	44.5	121.5	197.1	23.3	125.1	149.7	134.5	169.2	157.1	149.9	179.2	31.8	148.2	106.2	88.6	19.0	101.5	151.1	155.3	184.9	122.5	115.3	214.6	139.8	101.1	426.3	53.3	155.2	140.2	112.5	201.2	146.8	207.9	152.4	157.1	199.3
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	15.6	15.6	20.4	16.9	21.0	10.8	17.0	27.3	24.4	13.7	19.3	12.7	8.7	12.5	17.9	12.9	14.9	14.5	11.0	15.8	20.1	19.6	17.7	10.1	10.6	16.3	18.6	20.3	15.6	10.6	27.5	18.3	20.1	17.7	16.5	15.7	9.3	11.2	14.2	16.2	11.5	12.8	17.4	21.0	13.8	12.0	13.0	14.0	27.4	15.7	12.3	16.8	14.8	13.4	3.5	2.5	3.7	1.1	3.8	6.6	0.7	13.8	7.4	36.5	18.6	6.8	12.5	17.8	17.8	13.0	17.6	17.8	16.3	6.7	9.5	19.7	14.7	17.9	14.7	22.0	18.2	24.8	9.8	11.9	28.2	17.0	12.5	9.8	26.7	16.3	11.5	11.4	15.7	18.3	13.0	18.0	21.2	20.2	12.0	16.8	6.2	22.5	14.3	19.6	15.8	10.3	24.0	19.7	8.0	15.2	18.3	22.5	23.1	19.6	12.6	8.5	17.1	15.4	16.5	15.0	20.1	24.5	13.3	19.9	22.5	20.1	34.8	11.0	17.7	20.8	3.7	0.9	2.5	5.3	0.8	4.6	2.8	5.4	4.4	1.1	3.5	6.6	5.1	0.8	3.8	1.1	2.5	3.3	0.7	20.4	21.0	27.3	24.4	20.1	19.6	18.6	20.3	17.7	14.0	14.9	18.4	13.2	9.5	13.1	35.6	45.7	15.3	22.7	21.6	15.7	15.7	27.3	6.6	14.9	2.3	13.7	9.3	0.0	17.1	17.8	11.1	9.8	12.7	9.4	10.9	19.1	12.1	14.7	14.2	1.7	11.5	11.9	5.0	22.6	19.3	14.8	12.6	5.8	15.9	11.3	27.6	6.5	10.0	28.6	14.6	12.9	18.0	14.9	17.3	12.3
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase beta subunit"	Q9NSD9	2	222570536-222656337	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	15.7	10.8	11.9	12.6	23.5	11.5	16.0	15.1	28.5	11.6	17.3	13.7	5.9	15.9	14.2	11.7	19.1	10.8	7.2	13.4	13.7	15.1	11.7	18.3	9.0	12.0	11.6	18.0	16.7	18.6	15.0	15.7	8.8	29.4	11.2	20.7	9.6	12.3	11.5	33.2	14.1	11.5	14.9	9.7	10.3	13.9	15.6	11.2	15.6	11.9	17.1	14.2	11.8	12.0	16.3	16.0	1.2	11.4	18.5	20.0	14.6	22.2	13.1	15.3	20.0	14.0	20.1	23.6	22.7	14.4	22.5	18.4	33.2	12.3	10.9	17.3	16.6	18.7	18.8	29.4	25.5	33.1	16.3	15.2	25.1	14.8	21.1	21.8	36.5	10.4	13.4	20.0	25.6	39.4	8.0	21.2	19.3	37.7	22.6	27.3	20.8	21.8	20.7	19.5	26.9	16.4	21.5	36.8	35.4	18.4	14.6	24.8	8.1	9.5	16.7	19.6	19.5	15.5	15.4	11.5	19.3	15.9	27.6	27.4	10.8	10.8	39.9	15.0	24.6	20.1	0.2	8.5	1.2	11.4	10.3	16.8	16.3	15.4	14.0	16.0	14.0	20.0	17.2	0.9	18.5	11.4	8.0	13.3	14.6	11.9	23.5	15.1	28.5	13.7	15.1	11.6	18.0	29.4	11.2	6.0	5.4	20.0	16.1	11.0	15.1	26.0	2.5	16.0	10.3	21.0	3.9	30.6	29.9	19.9	43.7	9.9	12.3	0.0	26.1	35.9	12.8	11.4	4.7	16.2	24.6	3.2	20.1	7.4	9.7	57.3	14.1	10.8	6.8	9.0	19.0	9.8	18.6	7.0	18.7	20.7	17.1	6.5	16.5	59.3	37.3	12.4	18.5	13.3	40.3	12.0
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	7.1	15.5	8.6	9.7	13.3	7.6	12.3	9.1	15.0	8.3	10.7	8.6	7.9	10.4	8.8	10.2	8.9	7.5	6.5	7.2	8.7	7.3	17.8	14.5	8.3	10.0	9.2	13.7	9.3	8.4	13.0	10.8	6.4	8.0	8.6	13.5	8.1	11.1	15.8	10.2	9.0	12.1	7.8	8.8	12.0	9.1	6.0	7.4	12.2	8.9	7.4	12.2	9.1	7.0	9.6	6.7	7.4	7.3	4.8	10.3	4.7	7.1	6.3	6.2	8.0	3.9	4.9	12.1	6.0	5.2	9.5	7.3	9.4	7.7	24.9	12.2	6.3	12.1	7.6	15.1	8.4	13.5	6.8	7.8	8.6	20.6	7.4	5.3	14.2	7.2	5.6	3.6	8.8	5.5	4.3	5.2	10.2	11.8	4.4	7.1	5.1	9.5	8.3	5.6	7.5	9.0	11.1	7.6	5.7	7.7	7.7	4.3	4.1	18.1	8.0	8.8	5.8	7.2	6.6	3.5	9.4	9.6	9.7	9.9	5.1	4.8	15.9	6.2	13.2	7.6	3.8	5.4	7.4	6.1	7.3	8.2	9.6	9.4	6.5	6.7	6.8	10.3	9.7	0.2	4.8	5.7	3.8	10.2	4.7	8.6	13.3	9.1	15.0	8.7	7.3	9.2	13.7	8.0	7.4	14.9	5.1	5.2	1.9	2.3	2.9	3.6	7.6	5.3	0.0	0.0	0.0	6.3	5.0	7.2	0.4	4.3	8.0	0.0	10.3	7.0	4.6	2.3	3.5	9.9	7.3	4.8	6.9	4.9	7.0	0.4	4.9	5.8	1.7	14.4	6.2	3.5	9.3	3.5	4.2	14.9	5.1	0.0	5.1	3.4	5.4	4.8	3.5	6.9	6.6	1.6
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529116-168530634	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 8.1;Cone photoreceptor cells: 5.9;Horizontal cells: 6.4;Intestinal endocrine cells: 6.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 19.4;SH-SY5Y: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.8	6.2	10.3	0.9	12.1	0.7	1.1	10.6	24.9	1.0	0.9	0.9	0.0	1.4	0.8	0.8	0.8	1.4	1.1	1.3	11.0	18.4	1.1	0.9	0.9	0.7	9.7	8.5	1.2	2.1	1.8	7.4	1.0	7.9	1.4	0.9	0.5	1.4	1.3	0.9	1.5	1.6	1.1	3.0	0.8	1.4	5.1	1.7	0.0	0.8	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.4	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.4	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	16.1	1.6	0.0	0.9	0.0	0.0	1.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.1	10.6	16.9	11.0	18.4	9.7	8.5	7.9	1.7	0.0	0.0	0.0	0.0	0.1	8.1	1.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.0	0.1	6.4	6.4	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.1	0.5	0.3	0.0	0.0	0.0	2.6	6.5	0.0	2.3	0.2	0.1	0.0	0.0	0.2	0.0
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.5	16.4	0.0	2.7	4.7	3.4	17.9	0.0	15.9	11.9	0.0	0.0	0.0	0.0	23.9	0.0	2.7	10.6	2.7	14.9	0.0	4.2	0.0	7.5	0.0	38.0	2.3	0.0	27.1	1.4	6.7	59.9	5.1	33.7	0.0	0.0	0.0	9.8	0.0	0.0	0.9	7.1	0.0	5.4	5.1	5.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	14.0	0.0	5.0	0.0	6.4	12.2	18.3	0.0	0.0	0.0	0.0	1.9	0.0	6.7	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2	0.0	0.3	0.0	0.1	0.0	0.0	11.3	0.0	0.0	2.3	0.0	0.0	251.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	27.7	3.3	1.5	0.0	0.0	29.6	0.0	0.0	0.0	12.9	5.3	1.1	1.8	1.7	0.0	0.0	3.1	0.1	0.0	2.1	0.0	0.0	6.5	0.2	12.7	3.8	0.4	136.7	0.0	0.0	0.1
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513798	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	6.4	6.2	11.0	7.2	15.0	8.5	3.7	10.8	17.7	3.0	4.6	8.1	4.3	5.6	5.1	3.4	6.1	4.4	3.3	5.0	10.2	8.0	4.3	3.6	4.4	5.7	6.6	12.3	4.3	8.0	6.2	4.8	4.2	7.6	5.0	3.2	5.6	5.3	3.8	10.8	10.2	5.0	4.3	5.4	5.4	4.6	5.7	7.7	4.3	4.8	2.8	5.6	4.8	3.2	3.4	2.5	8.9	4.0	3.9	2.7	1.8	9.3	12.3	3.5	7.5	3.2	3.4	6.1	5.6	2.9	3.5	3.7	9.3	6.0	4.3	6.8	2.7	6.6	14.8	4.1	9.8	2.6	3.3	5.1	2.2	9.3	3.0	2.4	4.8	3.6	2.8	5.3	5.4	2.6	2.6	4.1	2.7	6.8	3.8	2.4	9.8	2.5	3.0	11.3	3.3	10.2	6.3	6.8	2.3	2.2	4.9	7.6	10.6	8.7	14.8	2.9	4.5	14.5	2.9	9.5	11.5	16.5	8.4	8.5	5.1	6.3	3.3	5.9	5.9	13.6	7.9	3.5	1.3	2.7	3.2	2.7	2.1	1.7	2.5	2.5	3.4	1.9	2.4	8.9	3.9	4.0	2.5	2.0	1.8	11.0	15.0	10.8	17.7	10.2	8.0	6.6	12.3	7.6	7.7	6.0	4.5	0.8	1.7	2.3	8.8	3.9	2.5	2.7	7.9	0.0	3.9	3.2	0.0	1.8	1.1	1.6	2.6	0.0	2.1	2.5	2.3	1.3	2.3	1.7	1.3	1.6	4.6	1.8	3.2	0.0	1.4	2.2	0.0	2.8	1.9	4.8	1.7	2.6	0.7	1.0	6.4	0.0	1.4	2.6	5.1	2.9	1.8	2.9	3.8	1.6
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA008867			Approved	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	6.1	5.8	3.1	7.7	3.6	6.0	8.2	8.1	5.6	6.9	13.4	3.7	9.9	14.3	4.4	7.5	8.3	4.4	12.0	2.7	2.9	3.1	5.7	15.5	11.6	9.9	3.8	2.6	2.7	13.8	5.1	4.6	6.1	3.2	4.9	6.3	3.6	9.6	9.4	4.6	7.5	19.1	3.1	2.9	8.3	6.2	5.6	3.5	6.0	3.9	6.8	6.5	5.1	4.7	0.7	2.4	1.9	4.3	0.8	1.2	0.2	8.1	2.5	1.8	11.9	2.5	0.6	3.7	4.2	4.6	4.1	2.8	2.7	3.5	3.9	5.2	1.9	2.0	5.4	2.2	5.4	0.9	7.1	3.2	7.9	1.5	6.8	3.8	1.9	7.9	1.1	4.9	2.3	6.1	1.0	3.4	6.0	3.7	6.0	1.5	14.1	5.2	1.9	2.6	8.6	8.0	6.3	2.2	12.5	5.3	2.6	3.0	2.9	4.7	7.2	7.0	1.1	11.9	3.3	2.9	2.0	7.8	9.8	4.9	2.4	1.8	2.7	3.1	4.7	2.6	0.0	0.6	1.9	1.2	1.3	1.1	0.7	0.9	0.8	0.5	0.5	0.1	0.4	0.2	0.8	4.3	2.4	0.1	0.2	3.1	3.6	8.1	5.6	2.9	3.1	3.8	2.6	3.2	3.5	6.0	1.3	10.8	5.1	5.0	9.1	1.2	5.1	1.4	5.7	0.0	13.7	7.4	5.0	3.8	1.7	3.8	31.6	0.0	5.3	8.6	4.5	5.9	1.1	5.9	6.2	1.6	2.4	6.7	4.1	1.0	4.9	7.3	5.0	1.0	13.3	7.3	6.4	9.5	1.8	6.3	8.1	0.0	4.2	2.3	8.0	5.8	3.2	5.9	13.5	5.1
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576349	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 30.0;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AF22: 18.0;HHSteC: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	3.8	7.5	4.8	7.5	8.3	1.2	3.4	4.4	12.1	3.6	6.7	4.9	6.3	2.8	5.0	16.9	4.7	2.8	4.5	4.3	6.3	5.9	3.9	4.0	3.5	7.7	4.0	6.7	3.1	7.4	6.4	20.8	3.1	3.9	4.0	2.9	5.3	15.0	5.2	27.0	2.9	4.8	5.0	3.1	10.1	3.6	12.2	3.3	2.9	11.7	6.0	7.7	4.5	2.9	5.9	0.8	0.0	0.2	0.2	1.1	0.5	1.6	4.1	18.0	4.6	8.4	3.0	1.4	3.2	5.6	3.9	5.9	2.3	1.1	10.5	1.1	3.3	1.6	0.1	6.5	1.5	2.9	5.8	5.2	2.1	3.8	2.0	25.8	5.5	0.7	6.9	1.2	3.5	2.3	2.6	5.5	1.0	7.2	2.9	6.9	1.4	2.1	1.8	8.3	2.4	1.5	4.1	7.9	1.3	2.2	1.1	3.8	9.6	2.0	2.5	2.2	5.5	1.0	5.7	4.3	2.8	4.9	2.5	2.2	3.6	2.8	1.7	2.4	2.2	2.6	0.0	0.1	0.0	0.7	0.2	0.7	5.9	1.1	0.7	0.0	3.2	0.1	0.1	0.0	0.2	0.2	0.8	0.2	0.5	4.8	8.3	4.4	12.1	6.3	5.9	4.0	6.7	3.9	3.3	0.0	0.6	6.1	0.1	0.2	3.3	1.4	0.0	1.4	0.0	1.8	3.9	0.3	0.0	1.2	30.0	0.6	0.0	0.0	1.3	0.7	0.6	0.6	0.0	0.9	3.2	3.2	5.2	6.7	0.3	29.3	0.9	0.0	1.7	1.0	0.5	1.5	1.4	0.0	1.4	1.3	0.9	0.0	0.9	3.1	1.9	0.5	0.2	0.0	0.3	0.3
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47905793	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	18.0	13.8	18.6	15.7	18.8	17.5	26.1	42.2	31.7	21.3	15.3	12.7	15.1	10.4	28.9	16.8	14.5	16.3	15.0	14.1	16.9	13.6	14.3	17.0	22.3	15.0	17.4	21.7	28.9	12.4	25.2	14.4	14.5	19.7	15.3	13.3	12.0	15.6	16.5	22.9	14.5	13.5	19.9	16.4	14.5	13.3	25.1	16.0	14.6	17.3	9.8	17.2	19.3	21.9	4.7	4.3	8.2	2.7	4.8	6.6	2.0	25.5	13.3	31.9	27.2	22.4	21.1	19.0	17.9	24.6	16.7	16.5	11.2	13.0	16.5	23.4	25.1	20.8	12.7	21.8	18.9	24.7	11.0	10.8	15.4	10.9	17.8	21.5	16.0	16.4	20.6	21.3	14.9	25.2	26.6	21.4	8.3	15.0	17.1	20.5	12.3	15.3	15.6	19.4	16.9	13.1	20.0	29.6	12.3	23.9	20.9	22.5	26.6	16.9	15.9	26.1	24.7	7.4	13.7	23.1	20.8	19.2	13.9	19.6	14.8	7.7	30.1	14.1	15.1	21.1	8.2	2.3	4.3	3.8	2.7	3.8	4.7	3.4	4.1	3.1	3.6	6.6	4.1	4.1	4.8	2.4	4.3	3.6	2.0	18.6	18.8	42.2	31.7	16.9	13.6	17.4	21.7	19.7	16.0	14.9	36.6	13.7	38.4	59.5	42.4	7.8	12.7	37.5	23.9	17.4	31.4	16.6	10.0	15.5	22.2	26.9	15.8	0.0	13.2	13.7	43.3	34.1	27.8	17.0	21.7	52.4	23.0	29.4	42.9	29.9	27.9	40.9	33.7	17.2	16.7	30.9	20.6	14.4	37.4	11.3	39.1	19.4	35.3	51.9	40.4	51.6	30.1	26.6	16.9	57.8
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;pancreas: 52.5"	"Cell type enriched"	"Detected in many"	5	"Exocrine glandular cells: 606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 1.4;T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11.0	3.0	2.5	40.0	23.0	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0.0	3.8	2.6	2.9	1.4	0.1	0.0	0.0	0.0	3.1	0.6	6.9	2.1	0.0	6.8	0.1	0.0	1.0	0.3	0.6	0.1	0.0	21.1	2.0	0.0	8.7	0.0	1.8	0.0	0.7	18.5	0.0	0.1	0.2	0.0	0.2	44.2	0.9	0.0	0.0	0.6	3.4	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.0	1.6	0.5	0.7	0.9	83.5	0.0	0.8	0.7	4.1	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0.0	0.0	0.0	0.0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40.0	23.0	25.7	24.3	0.0	1.0	6.6	52.3	17.4	10.7	2.4	17.8	5.3	5.7	45.4	2.0	0.6	72.9	20.7	1.7	0.6	0.0	0.0	606.0	3.5	2.4	21.4	4.6	87.3	0.4	27.0	1.2	2.5	1.6	1.8	32.2	1.2	42.2	5.4	0.0	65.1	127.3	0.0	38.2	5.8	10.3	0.0	1.9	11.4	10.4	8.7	0.8	12.9	0.0	22.5
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114087-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003289			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	17.4	13.1	16.4	14.9	19.7	12.1	19.6	22.5	21.6	18.7	15.9	15.0	13.1	13.3	16.2	13.3	22.2	14.1	15.1	15.0	15.3	15.6	21.4	26.6	14.0	14.9	15.9	13.6	18.7	13.4	25.7	16.2	15.8	20.2	16.5	17.1	11.9	16.6	14.9	24.6	32.3	14.4	15.7	15.6	16.1	13.7	11.9	15.5	19.4	15.7	13.1	16.1	17.5	20.0	10.3	10.0	14.7	8.9	10.9	11.0	5.7	14.1	6.3	9.8	10.4	10.3	11.8	16.1	14.3	11.7	9.7	9.3	8.6	11.1	6.8	14.8	13.0	6.2	12.5	14.4	13.9	16.8	9.6	16.1	8.6	7.9	6.2	12.8	16.3	11.4	11.5	16.8	14.0	25.6	11.4	16.1	8.9	14.1	9.8	17.4	4.6	8.4	8.3	23.3	18.8	13.5	9.0	14.0	12.8	18.3	9.4	15.9	17.0	14.9	22.9	15.9	10.7	12.1	16.4	18.4	12.1	9.2	15.1	26.9	10.7	12.6	10.7	15.0	8.0	23.4	8.9	8.7	14.7	7.8	8.1	10.1	10.3	8.2	9.6	10.0	10.2	8.3	9.1	5.3	10.9	8.9	4.7	11.0	5.7	16.4	19.7	22.5	21.6	15.3	15.6	15.9	13.6	20.2	15.5	6.0	8.8	12.3	21.3	30.5	18.7	10.6	7.6	6.7	11.4	10.4	21.6	12.1	8.3	10.9	19.1	14.2	10.6	23.3	9.8	11.5	11.0	18.7	13.9	22.2	12.3	17.5	17.7	9.8	16.3	11.5	12.0	13.9	27.0	10.8	14.0	10.1	13.4	10.5	12.4	17.9	18.4	12.9	11.3	26.0	26.5	34.3	19.2	17.5	11.9	27.2
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002467: AB_2666602"	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	18.2	16.0	18.4	8.7	33.9	14.1	17.4	27.7	30.3	16.1	13.3	17.1	11.5	11.2	16.4	15.8	21.1	15.0	13.5	28.1	17.3	19.3	29.3	25.3	12.2	10.3	15.2	15.4	18.8	16.5	35.9	21.8	15.3	27.8	16.6	15.0	16.7	17.0	16.9	67.6	18.4	16.3	19.0	12.4	12.6	14.6	15.1	15.2	18.6	21.6	24.2	16.6	15.9	16.6	11.1	8.4	13.0	9.2	15.7	22.8	10.4	11.5	10.4	14.1	15.0	17.1	13.5	8.5	13.8	13.9	11.3	14.1	11.8	11.7	7.7	9.8	15.0	13.9	20.1	18.8	18.3	18.9	7.7	26.1	3.9	16.3	9.6	10.9	9.1	9.3	13.6	18.6	7.7	12.4	16.5	14.8	5.7	13.4	15.5	12.6	7.8	6.7	5.3	7.1	26.2	16.0	5.2	31.6	10.9	16.3	14.7	20.0	11.0	19.6	13.5	10.1	14.2	19.5	7.0	13.5	14.0	12.3	19.7	11.6	8.7	11.3	13.1	12.5	7.1	13.7	13.0	7.8	11.1	15.1	7.5	16.6	10.9	17.9	17.0	8.4	11.1	22.8	15.9	8.4	15.7	9.2	4.3	21.4	10.4	18.4	33.9	27.7	30.3	17.3	19.3	15.2	15.4	27.8	15.2	32.8	15.0	18.2	54.0	43.4	58.2	36.0	12.7	33.5	18.2	24.4	25.5	19.9	48.0	41.8	83.0	29.3	20.5	0.0	22.0	24.3	25.4	28.3	16.1	34.2	10.5	54.0	23.0	30.1	12.0	42.2	27.6	14.1	27.0	9.0	18.0	50.1	28.5	19.9	25.5	47.3	42.8	58.2	31.1	51.9	29.8	59.0	30.6	33.2	16.2	46.2
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.7	0.3	0.0	0.0	3.8	0.9	0.6	0.3	3.9	0.2	0.4	0.0	1.0	0.0	1.1	2.9	17.4	0.1	0.0	0.3	0.3	59.1	1.3	0.0	2.0	0.0	5.2	0.0	0.2	7.6	2.6	0.9	1.1	20.6	0.2	0.8	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.5	0.1	0.3	0.4	6.7	6.8	0.4	6.6	0.1	0.2	1.1	0.3	0.3	17.7	6.1	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6	0.0	3.0	0.9	172.4	10.2	7.9	242.3	2.5	2.7	20.5	7.0	33.4	13.8	8.3	11.6	2.6	7.7	43.7	23.3	26.4	10.2	11.3	165.2	0.0	1.5	4.9	20.6	98.1	0.6	3.2	2.7	36.8	2.9	42.2	1.0	40.8	51.7	39.4	23.2	57.7	3.3	92.8	19.4	73.6	5.4	1.3	5.5	91.3	21.0	19.3	65.2
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013109	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053865: AB_2682282"	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	4.0	7.8	8.9	1.9	12.6	1.9	7.3	4.1	12.2	6.7	2.8	11.9	4.7	3.2	5.4	8.9	3.8	21.7	3.9	2.9	8.3	9.1	10.3	3.7	4.9	2.1	8.1	6.9	6.8	3.7	11.7	11.7	3.6	10.1	6.4	3.0	9.3	5.0	5.8	2.0	6.1	3.2	3.9	8.9	2.1	3.7	14.0	5.2	2.7	14.8	2.8	2.7	2.9	3.3	2.8	3.6	0.8	1.7	2.7	4.5	1.2	1.3	2.6	3.1	1.2	1.5	9.4	6.1	1.6	4.3	2.3	4.0	0.8	4.1	0.1	0.9	2.8	2.8	1.0	1.4	0.8	4.0	0.3	0.9	0.5	0.9	1.6	6.0	1.0	0.4	9.9	7.0	4.4	3.4	3.0	2.4	4.5	1.8	0.8	2.7	5.2	2.2	2.4	8.1	2.8	2.9	2.6	0.9	0.6	4.1	1.0	2.9	3.7	2.6	2.1	1.1	3.6	4.5	1.8	1.8	3.8	1.4	6.1	0.6	2.8	2.3	0.9	4.7	0.5	2.8	0.1	1.7	0.1	2.5	1.3	2.1	2.8	1.9	1.7	3.6	2.0	4.5	2.5	0.8	2.7	0.9	1.7	3.5	1.2	8.9	12.6	4.1	12.2	8.3	9.1	8.1	6.9	10.1	5.2	8.9	1.4	0.0	2.9	3.4	7.0	3.1	0.0	54.9	10.3	10.4	33.4	1.6	13.3	4.9	33.5	2.4	1.8	0.0	5.8	1.5	3.1	2.8	0.0	2.4	0.9	9.5	0.0	1.8	1.0	5.4	3.1	1.2	3.3	4.6	1.4	6.6	4.5	0.0	3.9	7.5	27.5	6.5	2.7	34.9	10.3	4.0	1.8	0.5	1.5	1.1
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 373.8;Late spermatids: 465.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		430000	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	22.9	27.8	25.5	16.2	28.6	92.9	27.7	14.5	30.6	23.7	22.5	55.9	17.0	20.1	22.5	29.6	18.5	28.3	18.8	16.3	29.3	26.2	43.3	51.2	24.9	26.0	39.9	18.2	27.7	26.9	27.6	23.2	31.8	33.4	23.0	22.7	35.9	18.6	23.6	12.4	20.7	28.4	24.0	52.7	29.5	20.6	42.1	24.4	33.3	77.6	16.4	24.4	19.7	26.3	22.0	25.4	60.4	21.7	28.6	33.0	24.9	21.7	15.3	20.0	22.5	30.9	29.4	14.5	18.7	33.8	29.6	35.2	15.1	14.8	20.0	15.6	31.9	26.1	14.5	29.0	23.9	30.4	34.3	26.3	27.6	16.7	23.4	37.7	35.9	24.6	24.6	38.7	26.0	20.0	27.2	31.8	16.0	21.9	26.0	32.0	16.0	17.9	22.5	7.8	29.1	11.4	17.6	21.2	24.1	33.9	22.8	29.3	19.2	23.3	18.7	65.9	29.6	10.4	19.0	22.2	15.5	22.1	14.9	14.6	18.4	19.4	19.2	29.1	18.3	61.7	60.4	18.9	39.8	27.6	21.7	33.0	22.0	25.3	27.0	25.4	19.6	22.4	24.3	7.2	28.6	20.7	16.7	30.7	24.9	25.5	28.6	14.5	30.6	29.3	26.2	39.9	18.2	33.4	24.4	38.7	25.9	50.0	58.7	41.1	27.1	13.4	68.8	16.0	21.6	47.1	17.7	76.9	82.9	65.2	233.2	55.5	48.7	373.8	68.0	90.0	53.6	57.0	55.3	76.9	64.6	31.8	64.9	51.5	51.5	465.0	41.7	49.7	113.1	151.5	41.6	38.9	60.2	45.8	46.0	104.8	33.7	45.3	50.5	117.2	135.2	37.9	59.8	62.3	42.8	67.6
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174284264	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	16.8	18.5	13.5	9.2	14.1	7.3	16.4	19.4	14.0	15.6	17.3	14.0	10.7	13.4	13.1	19.5	16.4	15.1	13.1	19.1	13.3	12.0	20.2	43.5	11.8	9.5	14.6	10.1	15.7	22.6	16.5	26.9	27.1	14.3	16.8	15.3	14.7	13.3	13.1	7.4	16.0	18.9	18.8	14.7	13.9	14.7	10.0	14.0	18.2	19.9	6.5	12.4	20.6	18.2	12.6	8.6	19.2	8.9	9.8	15.5	7.8	4.8	3.2	6.6	2.2	14.9	16.3	5.2	9.9	9.1	6.6	6.7	2.5	8.6	3.7	9.4	6.4	5.6	3.1	4.4	5.7	7.0	11.1	10.0	3.2	5.5	4.0	11.4	4.4	3.6	9.3	14.2	6.0	8.0	11.8	6.5	4.1	6.8	19.1	8.6	4.8	4.5	4.6	1.8	7.8	3.4	2.7	4.3	5.8	10.2	2.0	6.2	40.1	4.4	7.8	11.0	6.7	4.4	4.8	7.4	3.8	3.7	11.0	5.5	9.9	4.7	3.1	13.0	3.2	5.3	19.2	6.2	12.7	12.3	7.8	15.5	12.6	14.2	12.1	8.5	10.7	13.5	11.8	6.2	9.8	8.9	8.6	15.0	7.8	13.5	14.1	19.4	14.0	13.3	12.0	14.6	10.1	14.3	14.0	3.0	11.4	16.0	15.8	18.3	11.9	9.0	12.7	18.7	13.6	21.0	5.9	29.9	43.1	14.8	14.7	16.8	18.2	23.3	9.7	44.8	19.0	18.2	2.3	50.0	18.5	17.5	11.6	19.0	16.9	4.1	16.1	8.5	10.1	19.8	20.1	20.7	11.1	19.3	24.8	32.6	16.1	12.9	14.7	33.3	17.4	27.5	74.9	17.5	13.4	20.6
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536063	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.1;skin 1: 45.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	9.2	6.8	27.0	8.9	27.9	11.1	9.8	27.2	60.1	5.5	6.1	3.6	3.8	4.9	6.0	18.3	9.8	10.6	6.3	10.9	21.4	10.1	4.1	7.3	6.9	9.8	9.1	40.5	6.4	8.0	6.4	7.3	6.2	37.2	5.1	6.9	2.8	7.6	5.3	15.8	45.0	6.5	6.1	6.4	10.1	8.0	13.7	5.7	6.5	6.8	10.6	12.3	7.9	6.5	2.9	2.2	16.6	3.4	7.8	5.0	1.3	4.9	4.0	10.3	7.5	7.2	5.2	8.6	7.2	6.6	4.5	4.2	8.0	6.4	12.9	2.0	6.9	3.4	3.0	8.9	16.2	6.3	7.3	4.2	6.0	4.9	5.7	7.3	14.6	5.5	8.2	25.8	7.7	13.1	4.7	7.8	10.5	9.4	13.8	5.6	7.0	16.8	5.8	5.0	4.2	3.2	16.9	4.4	2.5	5.5	8.6	6.6	5.7	4.6	6.3	3.9	12.2	3.4	6.9	8.2	6.1	6.9	3.1	4.0	38.0	21.7	12.6	4.9	4.8	4.3	16.6	3.1	1.7	5.0	3.4	3.3	2.9	3.7	3.2	1.8	2.4	3.9	3.2	5.5	7.8	2.5	2.2	3.3	1.3	27.0	27.9	27.2	60.1	21.4	10.1	9.1	40.5	37.2	5.7	8.9	18.5	27.6	32.1	179.3	67.8	54.1	7.6	8.1	13.6	8.7	29.5	9.7	3.3	11.6	13.1	26.4	13.5	0.0	11.7	33.1	24.6	28.4	15.1	15.6	9.4	11.1	13.9	17.8	16.2	7.4	14.1	20.2	27.0	16.2	11.7	30.1	15.8	15.8	10.6	6.0	40.5	12.9	25.6	57.9	80.3	152.9	26.1	34.6	11.3	48.9
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	28.2	8.1	0.2	0.6	1.1	1.7	1.0	0.1	12.4	0.9	2.2	0.7	2.8	0.3	6.9	4.8	0.0	0.1	0.1	0.2	0.2	0.7	14.0	11.0	13.5	0.0	7.8	16.0	12.5	1.7	6.6	13.4	13.6	0.1	19.4	0.1	0.5	0.6	1.3	0.1	2.8	0.4	0.4	2.7	7.0	0.5	0.1	2.0	0.5	0.2	8.6	3.9	15.2	0.4	17.4	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3	0.0	1.0	10.4	0.4	0.0	6.7	0.8	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.4	1.0	0.8	0.8	0.0	0.0	3.7	0.4	0.2	9.2	0.0	6.5	0.0	1.2	3.7	12.6	0.0	2.3	11.9	1.7	4.6	1.4	0.2	1.4	0.0	8.1	0.0	0.7	0.0	0.4	0.7	1.7	0.5	0.7	5.4	1.0	0.1
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	7.5	6.6	9.2	16.1	14.1	15.2	8.6	3.0	12.5	11.7	9.9	11.1	4.9	9.7	12.5	8.6	8.6	8.5	13.7	5.4	8.8	6.6	6.8	2.9	9.6	18.6	18.8	4.3	17.7	7.5	23.8	12.6	7.9	14.5	10.0	4.8	5.6	10.3	6.1	2.6	18.5	15.3	8.8	14.5	18.4	10.5	7.4	15.4	7.4	10.6	8.8	23.2	12.1	13.8	5.3	1.9	9.8	3.0	2.3	7.2	2.9	7.3	4.6	6.3	13.1	5.3	6.8	11.0	16.0	8.2	14.4	22.7	8.7	15.8	3.1	8.0	12.3	2.3	4.2	2.0	8.8	6.5	13.0	3.4	6.4	6.2	3.1	4.1	2.0	21.9	8.3	7.1	11.3	3.7	12.2	8.2	0.2	4.0	5.8	1.6	6.5	1.6	3.9	1.8	2.6	4.3	0.0	0.0	2.9	4.9	11.0	0.7	7.1	0.3	6.0	9.1	5.0	7.3	6.1	16.6	0.2	4.0	5.8	6.6	7.0	2.3	1.6	12.6	7.3	6.9	6.3	1.7	5.6	7.0	2.0	5.2	5.3	3.8	7.2	1.9	3.0	3.6	4.9	9.8	2.3	3.0	1.7	5.0	2.9	9.2	14.1	3.0	12.5	8.8	6.6	18.8	4.3	14.5	15.4	0.0	2.1	9.0	3.2	2.4	4.3	0.4	5.1	1.4	2.3	3.5	11.8	0.8	0.0	4.0	6.4	2.9	4.1	0.0	5.7	3.8	3.5	3.0	9.2	0.8	4.7	50.9	4.1	2.5	2.2	4.3	3.7	3.3	3.3	1.8	4.4	1.9	5.6	3.4	3.5	0.3	1.1	6.5	3.1	1.8	3.9	2.5	1.1	10.5	2.4	2.0
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
FDXACB1	"hCG_2033039, LOC91893"	ENSG00000255561	"Ferredoxin-fold anticodon binding domain containing 1"	Q9BRP7	11	111874056-111881243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 35.1;Late spermatids: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039012, HPA061375"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039012: AB_10670916, HPA061375: "	"unprognostic (2.91e-2)"	"unprognostic (3.32e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.81e-7)"	"unprognostic (1.32e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.95e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.79e-2)"	3.7	6.7	4.4	6.2	5.2	4.0	5.8	2.2	6.1	4.4	3.2	4.7	3.1	4.0	3.9	6.0	3.9	3.7	5.0	2.8	6.6	4.7	3.4	4.3	5.2	8.5	3.6	3.4	4.3	5.1	5.3	3.6	3.0	5.2	3.4	4.2	4.1	6.2	2.2	1.6	6.6	4.3	3.0	5.3	7.6	3.2	11.1	4.0	11.2	3.4	2.6	7.9	4.2	2.7	6.5	4.8	1.8	4.6	5.6	10.4	4.5	1.6	2.1	3.0	6.0	2.3	2.0	1.4	1.2	1.3	1.3	1.6	2.6	3.6	5.9	3.3	1.1	2.2	4.8	2.8	2.7	2.9	7.4	1.3	6.7	1.1	2.1	1.3	6.7	6.0	1.7	1.6	1.9	2.4	1.2	2.3	7.5	4.6	7.9	2.5	2.2	6.4	6.5	1.6	6.6	3.1	4.0	1.9	7.2	3.0	2.9	1.4	2.0	1.8	3.6	1.8	1.9	5.1	4.1	1.8	3.2	3.2	3.6	2.9	4.0	5.8	16.0	1.8	9.9	4.2	0.2	3.2	1.8	6.8	4.6	9.0	6.5	6.1	6.2	4.8	5.2	9.4	10.4	0.9	5.6	3.8	4.6	3.2	4.5	4.4	5.2	2.2	6.1	6.6	4.7	3.6	3.4	5.2	4.0	6.0	1.1	5.4	1.1	0.7	3.2	1.2	0.0	1.4	2.3	0.0	0.0	2.7	5.0	1.7	35.1	1.4	0.7	0.0	2.9	1.8	1.4	1.4	1.1	1.3	3.7	1.6	2.4	1.3	1.0	12.1	2.8	2.7	0.0	2.8	1.1	3.2	1.9	0.0	0.4	2.0	2.1	6.5	0.9	6.5	8.6	1.1	1.8	1.9	1.8	0.9
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277803-68295865	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 706.2;Late spermatids: 207.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	13.4	10.5	13.1	11.2	17.0	38.1	17.7	23.0	22.9	14.8	14.6	14.1	13.6	11.1	23.2	12.6	18.5	14.1	11.1	16.9	13.7	13.7	10.4	14.6	11.9	14.2	17.8	16.1	17.4	8.5	14.0	12.9	13.7	17.2	15.0	12.4	12.4	12.3	16.6	42.9	18.7	14.2	22.3	14.3	11.9	10.4	55.4	15.4	12.9	12.9	11.4	13.1	18.7	17.8	4.4	4.4	4.0	7.9	6.5	6.9	3.0	7.3	13.5	14.0	13.1	12.7	11.8	9.3	10.5	11.0	10.8	10.0	9.1	9.9	16.9	7.7	14.2	7.8	26.8	29.0	13.3	9.1	8.0	11.5	18.6	16.0	5.7	11.0	15.1	11.6	10.8	29.1	13.1	31.9	15.6	8.5	8.7	15.5	20.8	9.2	8.6	10.8	7.7	14.2	5.9	4.3	15.7	15.8	21.8	6.9	26.7	18.8	11.9	10.8	11.3	29.1	18.5	10.1	14.1	11.0	19.0	16.7	6.5	9.6	13.6	29.2	18.1	10.8	16.5	11.2	0.0	5.1	3.6	5.7	7.9	5.8	3.7	5.7	6.2	4.4	4.4	6.9	5.0	4.0	6.5	6.3	3.2	3.0	3.0	13.1	17.0	23.0	22.9	13.7	13.7	17.8	16.1	17.2	15.4	20.8	27.8	14.9	44.9	87.6	31.7	35.5	22.9	22.7	17.0	17.4	11.8	13.5	0.0	20.6	706.2	21.1	16.7	0.0	10.4	10.3	23.6	28.1	13.9	27.9	26.6	36.5	19.1	17.2	24.2	207.4	22.7	15.0	38.8	8.2	24.3	16.3	15.2	17.5	26.2	10.5	12.7	25.8	30.9	16.5	6.1	97.2	14.1	11.7	17.4	48.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.7;Spermatogonia: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.2	28.8	31.6	17.0	3.1	3.9	20.1	27.7	15.8	33.9	38.6	25.1	23.6	45.1	21.6	11.7	32.0	33.1	44.4	24.2	34.8	23.7	24.5	23.8	39.3	25.6	2.4	37.0	24.7	2.7	3.3	31.3	8.3	5.0	13.2	25.5	36.0	32.7	28.1	39.4	51.6	33.3	34.7	24.6	28.2	35.4	36.6	46.6	13.5	29.6	36.0	29.9	18.5	24.2	15.9	15.5	35.1	26.0	8.8	30.2	38.2	38.4	27.8	25.9	40.2	46.9	21.1	24.8	26.0	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9	0.0	2.1	12.6	4.8	9.2	21.1	4.0	5.1	6.7	3.4	0.0	11.8	28.6	6.6	11.6	16.8	2.7	3.1	23.3	10.5	61.7	7.6	4.4	0.0	6.8	21.8	14.3	4.6	1.3	5.1	9.8	5.2	7.1	5.0	19.0	5.3	29.9	9.3	6.0	6.7	4.7	20.5	0.0	4.2	33.0	63.4	5.4	25.9	14.1	13.0	3.7
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 58.8;SCLC-21H: 25.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	58.8	1.4	1.0	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.4	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.0	4.4	5.2	0.3	0.0	0.0	4.2	0.3	0.0	0.0	9.0	0.0	8.2	0.0	0.3	0.0	2.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.3	29.2	0.0	10.7	9.6	9.2	0.2	2.1	0.5	9.5	0.0	7.4	0.0	16.5	0.6	0.2	0.0	7.1	0.2	0.2	2.8	9.7	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.6	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5	20.8	11.6	2.7	0.7	0.7	0.0	2.2	2.5	0.0	3.4	8.7	0.0	2.1	0.0	5.5	52.4	1.4	0.0	0.0	0.2	2.9	0.8	0.0	18.5	0.6	12.6	0.0	1.7	2.5	17.8	74.6	0.3	12.6	1.7	2.8	0.3	0.3	0.4	0.0	0.4	0.6	4.2	0.0	0.9	1.6	1.9	0.9	3.8	38.3	0.1	0.4
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139395-192767764	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 381.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.2	21.5	8.8	0.7	15.8	0.6	1.0	17.7	31.9	0.9	0.9	1.9	0.0	1.0	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2.0	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1.0	2.7	6.8	0.9	1.7	2.8	0.0	1.4	0.0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0.0	0.8	11.8	0.0	0.0	0.0	0.1	0.0	0.1	1.1	1.4	0.0	0.1	0.6	5.7	0.2	0.2	0.1	0.0	0.0	1.3	0.1	0.1	2.4	5.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.0	3.3	0.0	0.0	8.1	5.4	0.2	0.0	0.1	0.0	3.7	1.4	18.9	0.0	0.0	0.4	0.0	1.4	0.9	0.2	0.3	4.9	2.5	0.0	11.3	0.1	1.8	0.0	1.0	0.0	13.7	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8	0.0	0.0	0.0	4.3	0.6	77.1	381.1	0.0	1.4	3.4	5.2	3.9	0.1	6.6	0.7	15.9	4.9	0.0	0.0	11.4	0.2	0.8	1.0	0.0	0.0	0.1	31.8	0.0	8.6	0.3	21.4	6.4	0.0	1.7	0.0	0.0	2.9	4.0	0.2	1.1	0.2	13.0	0.0	0.5	2.1	6.1	0.1	0.0	0.0	0.0	1.4
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 12.4;Smooth muscle cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500		"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.8	6.9	4.4	7.4	0.0	57.4	33.7	24.1	14.0	0.0	0.1	0.0	6.7	62.3	19.0	0.2	1.8	0.1	24.3	4.5	0.8	0.0	6.5	0.0	13.0	0.3	0.0	3.9	0.4	23.8	34.4	12.1	2.6	0.0	1.7	1.9	6.2	0.0	0.0	0.0	5.2	0.0	1.4	0.0	0.9	0.0	7.6	0.0	1.0	0.9	11.1	0.0	0.4	10.8	0.0	0.1	2.4	20.0	3.9	7.4	4.9	3.4	3.6	0.0	5.7	0.0	2.1	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3	6.0	0.0	0.0	1.5	1.4	3.5	3.9	0.0	0.0	2.3	7.0	0.0	1.8	3.3	6.9	8.7	5.8	0.0	0.0	0.8	0.0	12.4	5.2	0.0	0.4	0.4	0.0	1.7	7.4	0.0	2.5	9.2	0.9	5.0	1.0	0.0	8.4	6.7	0.0	7.8	0.4	1.8	0.0	15.5	3.1	0.2	1.1	4.0	0.0	0.0	0.3
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	24.2	22.3	0.0	7.3	4.5	0.0	0.0	0.0	0.1	0.0	0.1	10.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.1	0.0	22.6	0.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	12.2	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0	11.9	13.4	0.9	13.5	12.8	7.9	40.0	5.1	0.0	0.0	8.7	2.0	4.7	101.2	1.1	2.8	5.3	0.0	0.0	0.6	3.8	91.0	9.0	1.1	2.5	1.8	3.2	0.0	0.0	1.0	3.1	77.1	3.1	6.8	0.0	0.0	7.3	0.6	0.0	4.6	24.5	6.0	6.5	82.4	0.3	0.1	11.0	2.4	1.0	0.0	7.1
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.3	34.2	9.9	16.6	12.3	7.3	47.5	15.1	5.4	25.0	16.9	34.0	18.8	20.5	4.3	9.7	17.4	21.1	61.5	20.5	30.1	37.5	39.4	22.6	25.1	12.0	9.5	17.6	6.2	6.6	18.8	29.5	29.6	14.9	14.5	20.8	20.7	29.3	10.0	44.1	30.9	16.0	84.3	45.3	24.7	18.6	17.4	12.3	21.0	19.6	14.3	20.5	17.5	47.8	7.6	64.7	64.4	12.0	7.7	12.3	38.7	13.8	38.0	7.3	11.2	30.3	10.9	26.4	12.5	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1	6.0	8.6	47.9	182.5	127.9	60.2	11.7	40.8	16.0	12.5	50.6	70.7	148.6	131.0	77.3	90.2	33.8	86.8	0.0	22.4	85.7	62.6	189.3	39.1	41.9	54.7	92.2	101.7	12.3	15.0	26.1	32.2	42.7	87.7	52.3	61.6	41.8	62.2	84.2	36.4	112.7	51.3	84.1	88.6	179.1	92.0	116.1	186.7	20.2	77.5	121.3
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FK506 binding protein like"	Q9UIM3	6	32128707-32130291	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.6	5.6	4.1	2.7	4.7	4.6	7.1	12.1	6.2	4.4	4.5	3.9	8.9	6.0	4.1	8.7	12.7	7.0	4.5	6.0	4.1	3.5	5.9	6.7	4.5	7.7	7.1	2.4	7.0	13.2	6.2	5.0	6.9	5.8	3.8	4.9	3.7	8.0	3.6	5.1	11.5	4.4	5.1	3.6	7.8	6.6	7.6	6.8	10.5	11.6	2.8	6.8	4.7	6.3	3.4	3.7	8.3	4.8	3.3	4.6	1.5	0.0	2.0	4.4	11.9	6.6	4.7	3.8	2.9	3.3	5.5	5.3	9.5	4.0	3.3	3.4	5.1	7.4	2.2	6.2	5.7	3.8	5.9	7.6	0.0	6.6	5.3	3.7	0.0	3.6	4.6	5.8	10.7	6.7	4.1	5.8	8.7	11.1	8.3	5.6	3.2	3.6	4.1	3.3	8.6	1.7	3.0	5.8	7.3	5.7	0.7	8.5	2.0	2.9	5.3	6.4	2.3	9.2	6.4	2.5	8.0	6.6	4.1	7.0	4.4	7.7	3.0	3.1	5.4	4.9	4.9	3.4	2.3	4.6	4.8	4.4	2.8	2.6	3.3	3.7	3.4	3.0	2.9	8.3	3.3	2.5	2.9	1.1	1.5	4.1	4.7	12.1	6.2	4.1	3.5	7.1	2.4	5.8	6.8	6.0	5.1	4.7	3.2	10.0	2.9	2.0	5.1	0.0	4.5	1.8	0.0	8.3	5.0	6.7	2.2	4.5	8.1	0.0	5.9	10.6	7.4	3.3	2.3	2.8	4.5	9.5	5.8	3.7	3.2	4.0	2.6	4.4	6.8	4.6	4.9	6.4	5.4	3.7	3.2	7.7	4.0	0.0	6.2	8.9	8.3	8.9	11.8	6.5	5.0	4.1
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.2"	"Group enriched"	"Detected in many"	6	"B-cells: 32.3;Endothelial cells: 76.4;granulocytes: 22.0;Hofbauer cells: 36.1;Ito cells: 49.7;Kupffer cells: 85.1;Macrophages: 24.6;T-cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 41.0;HUVEC TERT2: 22.8;REH: 19.2;TIME: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	14.7	2.5	3.5	15.8	4.4	10.6	9.9	1.4	3.2	6.7	5.1	3.8	2.1	3.3	7.8	6.5	4.8	5.3	6.0	7.5	3.8	3.1	4.2	3.6	17.4	24.4	6.2	1.6	4.0	3.2	2.5	2.0	11.4	3.8	4.3	3.1	4.8	4.2	3.3	5.2	3.2	6.9	5.7	6.6	40.2	4.1	2.7	4.6	26.8	5.7	2.8	17.9	6.2	6.7	4.5	13.1	20.1	12.0	7.8	8.8	11.6	0.0	0.0	2.1	0.0	0.2	0.4	0.0	1.2	3.4	1.4	1.2	0.0	0.0	7.0	12.5	4.1	0.4	0.0	0.3	5.1	1.6	3.2	0.1	41.0	0.2	0.0	2.4	4.9	5.8	0.3	0.4	3.0	6.9	4.3	22.8	9.8	0.0	9.0	0.3	0.0	4.9	2.8	0.6	0.0	1.2	19.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	7.9	23.6	0.2	0.0	0.1	1.3	2.9	6.0	6.0	0.0	11.9	1.9	20.1	9.5	16.1	7.2	10.3	8.8	4.5	6.2	5.8	13.1	3.6	2.6	5.6	7.8	7.8	12.0	2.2	7.4	11.6	3.5	4.4	1.4	3.2	3.8	3.1	6.2	1.6	3.8	4.6	6.0	7.7	32.3	0.2	4.5	0.0	5.0	5.1	1.4	0.0	1.8	0.0	0.3	0.0	0.0	0.5	76.4	0.0	0.0	0.0	0.2	5.6	0.3	22.0	1.0	36.1	0.0	0.0	49.7	85.1	0.0	1.7	24.6	6.8	6.4	0.0	0.1	0.0	0.0	0.7	0.3	0.0	6.5	2.8	0.3	0.1	3.6	0.2	47.8	0.0	0.4
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765545-33194733	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 21.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 121.0;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 98.9"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.5;RH-30: 12.8;SK-MEL-30: 13.3;T-47d: 11.6;U-138 MG: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	7.0	2.1	3.7	3.9	5.3	2.2	4.9	0.6	12.1	8.9	8.5	1.8	2.6	2.6	2.2	4.8	3.9	5.1	4.0	2.4	3.3	2.0	4.7	1.4	7.7	3.3	5.9	7.3	1.1	2.5	2.6	8.0	5.1	4.6	3.8	6.9	21.9	6.4	2.5	2.2	9.2	4.3	3.7	6.4	3.0	11.7	12.4	4.6	1.8	4.7	1.5	2.0	2.7	6.8	0.6	1.8	2.8	0.7	0.1	0.7	0.1	1.6	1.8	0.3	0.2	0.0	0.2	2.0	2.3	1.9	0.6	1.7	0.2	2.2	0.2	0.8	2.8	1.6	1.4	0.0	1.5	1.8	0.0	0.1	1.3	0.4	0.1	0.1	0.0	0.1	0.7	0.0	2.8	0.0	1.3	0.0	0.0	0.0	9.5	4.1	1.7	0.0	0.0	0.5	3.2	0.1	0.2	12.8	2.2	0.8	0.6	0.1	0.3	0.0	1.5	13.3	0.4	11.6	0.0	1.6	7.4	1.2	6.8	0.7	0.0	0.0	0.4	3.5	0.0	4.6	2.8	0.7	0.0	0.3	0.0	0.5	0.0	0.7	0.6	1.4	0.6	0.4	0.0	0.1	0.1	0.0	1.8	0.1	0.1	3.7	5.3	0.6	12.1	3.3	2.0	5.9	7.3	4.6	4.6	38.7	42.2	0.5	2.3	3.3	121.0	3.2	12.7	38.8	27.3	0.0	208.1	9.7	10.0	4.9	11.6	0.7	5.9	0.0	1.6	3.5	1.1	6.3	22.1	0.5	9.0	44.5	8.6	0.0	28.5	9.5	0.9	16.2	32.1	5.4	16.7	4.3	7.1	9.3	0.7	1.1	98.9	0.0	0.9	19.5	14.9	3.0	15.3	1.3	7.9	4.0
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712657-108742740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 5.2"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 1.1;Early spermatids: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8"	"Not detected"	"Not detected"							"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.1	0.1	0.6	0.1	0.8	0.6	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.5	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.9	0.5	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.3	0.1	0.0	1.1	0.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.5	0.3	0.3	0.1	0.4	0.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	1.1	1.7	0.7	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.0;HMC-1: 14.0;hTCEpi: 8.7;Karpas-707: 7.2;SK-BR-3: 10.3"	"Group enriched"	"Detected in many"	4	"amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8"	"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	72.7	13.0	2.3	111.4	7.4	39.2	10.0	5.5	7.7	62.9	9.0	14.9	2.2	1.7	32.1	6.1	18.9	135.1	102.6	14.1	2.5	2.9	3.4	8.6	22.9	6.0	2.0	1.2	29.1	12.2	8.1	8.1	129.0	8.5	12.2	7.9	38.6	8.7	59.1	2.2	59.5	10.8	36.3	2.5	2.6	30.5	21.7	1.3	4.0	33.6	114.5	8.2	16.7	4.4	0.2	1.7	9.0	1.6	0.2	0.7	0.2	0.4	0.7	0.2	0.3	1.3	0.3	2.3	2.4	1.1	0.7	0.7	0.5	1.0	2.0	0.4	1.5	12.0	0.9	0.5	1.6	0.5	0.3	0.7	0.6	0.7	0.4	0.8	1.1	14.0	0.5	8.7	1.8	2.0	0.4	1.0	2.4	0.7	7.2	0.2	0.2	0.2	1.2	0.5	1.0	0.4	0.5	0.1	1.4	0.7	1.3	3.3	0.4	1.5	10.3	1.2	2.1	0.5	0.8	0.1	0.5	0.6	1.2	0.7	5.4	0.7	0.5	1.1	0.8	1.3	1.5	1.6	1.7	0.3	0.2	0.7	0.1	0.4	0.3	1.7	0.2	0.0	0.0	9.0	0.2	0.1	0.1	0.1	0.2	2.3	7.4	5.5	7.7	2.5	2.9	2.0	1.2	8.5	1.3	637.2	863.6	170.2	357.4	337.9	23.2	156.7	221.7	108.4	179.7	10.4	127.6	182.1	1.7	82.5	6.6	228.5	437.9	23.3	65.2	252.3	314.2	253.2	799.2	48.7	184.0	7.9	843.2	193.3	203.0	5.1	222.4	274.6	163.6	26.2	718.0	71.6	106.5	426.1	55.9	1.9	178.0	297.5	219.5	1.1	3.1	333.0	331.9	203.1	555.5	158.8
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589984-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 47.0;prostate: 44.4"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 103.5;Glandular cells: 100.2;Intestinal endocrine cells: 81.2;Urothelial cells: 133.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 127.0"	"Region enriched"	"Detected in single"	6	"midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.6;MCF7: 36.1;PC-3: 25.2;RT4: 33.8;SK-BR-3: 34.2;T-47d: 48.4"	"Group enriched"	"Detected in some"	15	"hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.1	0.0	0.1	6.1	0.1	0.0	23.5	0.1	0.3	1.5	9.4	0.1	0.1	4.6	0.1	0.5	7.2	1.3	6.5	0.1	0.1	0.3	0.4	47.0	13.2	0.1	2.0	0.1	0.6	0.2	0.0	1.1	0.1	0.2	44.4	6.0	0.2	9.4	0.7	0.1	0.7	5.1	2.4	0.1	0.1	13.0	0.6	0.1	0.2	0.1	4.4	9.9	12.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.4	0.9	0.0	0.5	0.0	0.0	8.4	4.7	1.1	0.0	0.0	8.3	0.0	1.4	16.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.3	0.0	0.0	36.1	0.0	0.1	0.0	11.0	25.2	0.0	0.4	0.1	3.5	33.8	4.3	0.0	1.6	34.2	0.0	0.0	48.4	0.1	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	2.0	0.1	0.2	0.1	26.8	38.7	0.0	103.5	0.9	0.0	1.1	25.5	52.2	37.5	3.5	0.0	0.0	0.0	1.8	0.3	0.3	14.7	0.0	2.1	0.0	0.0	100.2	2.3	27.6	0.0	0.0	81.2	1.3	1.2	0.5	0.0	0.1	3.3	1.8	34.4	0.0	3.1	21.0	0.0	0.0	0.0	0.0	0.1	0.5	1.3	0.1	0.0	0.0	25.3	133.4
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2"	"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2	89.3	60.1	0.0	1.0	0.0	0.0	0.3	48.4	17.4	22.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	4.9	0.0	31.8	0.0	0.0	0.6	4.6	51.3	0.0	0.0	27.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	82.6	0.0	24.8	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	33.6	0.0
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004222-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 16.7"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 18.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.7"	"Cell type enriched"	"Detected in single"	4	"T-reg: 3.8"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1"	"Region enhanced"	"Detected in some"		"hypothalamus: 7.7"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	0.3	0.5	4.1	0.2	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.2	0.1	6.2	0.0	0.1	0.1	1.8	6.5	0.0	0.0	0.4	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	8.4	0.1	1.8	2.6	3.7	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	2.6	0.0	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.3	11.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.3	4.1	0.6	0.0	0.1	6.2	6.5	0.0	16.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.3	0.8	0.2	39.8	1.8	2.1	1.2	3.7	4.4	2.3	1.9	2.8	1.5	0.0	4.3	2.2	1.7	8.4	3.8	2.7	1.9	2.3	38.8	1.5	2.2	1.3	1.2	0.5	2.6	7.0	3.8	3.2	3.6	1.2	3.4	0.2	1.0	0.0	1.0	1.6	0.0	0.8	0.1	3.7	3.2	0.0	1.6	0.2	15.6	5.6	1.5	3.4	4.6	0.0	2.6	2.1	1.1	0.6	0.8	5.1	3.1	2.6	3.9	0.1	0.3	0.0	1.4	1.9	4.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6	0.0	1.1	0.0	25.0	15.8	0.0	5.6	0.0	26.8	14.8	10.4	0.0	4.5	1.7	3.4	0.4	40.9	0.0	0.0	15.0	0.4	3.6	7.7	0.0	0.0	1.1	0.0	0.0	36.2	0.3	0.9	15.0	1.4	1.7	0.0	0.2	0.3	11.8	0.0	26.5	4.6	0.0	0.0	27.0	0.2	1.9	5.6	0.7	0.0	0.3	55.7
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86567251-86569728	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.6"	"Group enriched"	"Detected in some"	5	"Peritubular cells: 29.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 15.9;HUVEC TERT2: 12.2;LHCN-M2: 19.5;TIME: 21.7;U-138 MG: 11.6;U-2197: 19.5;U-87 MG: 15.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	4.8	5.7	1.1	1.6	1.4	0.5	6.4	1.1	3.4	6.2	2.0	2.2	0.1	1.1	1.6	5.3	3.0	3.9	5.6	8.8	1.1	1.1	9.1	0.9	4.9	5.4	4.3	2.6	4.0	1.3	0.6	3.7	0.9	9.9	2.1	1.0	17.6	4.2	2.9	3.2	1.5	0.9	2.1	8.5	0.5	1.1	7.7	0.7	0.0	3.3	1.0	0.9	4.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.1	0.0	6.5	8.9	5.0	1.0	0.0	0.0	0.0	0.9	0.9	7.0	0.0	0.1	2.0	4.5	0.0	0.4	0.0	4.9	0.0	1.7	0.0	0.0	0.8	2.2	15.9	5.1	9.2	12.2	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.9	0.0	0.0	21.7	11.6	0.0	19.5	0.0	0.0	0.0	0.0	15.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.1	3.4	1.1	1.1	4.3	2.6	9.9	0.7	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	1.4	0.0	1.7	0.0	0.0	0.0	0.2	0.0	29.0	0.0	0.0	19.4	4.2	0.2	0.9	0.0	0.0	0.0	0.0	1.0
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032703-8055503	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	19.6	9.7	7.6	9.2	8.6	14.8	14.2	23.7	14.6	20.8	14.7	11.7	17.3	8.1	20.5	11.6	12.3	14.7	13.3	17.3	9.4	5.8	8.5	6.5	12.9	8.4	8.8	8.4	19.9	11.0	21.0	10.2	12.1	7.3	15.4	9.0	11.7	12.4	19.7	25.7	18.1	10.8	17.9	8.4	11.7	12.5	6.7	9.8	13.0	12.0	13.5	13.2	17.0	14.7	4.2	4.5	6.9	3.5	7.3	5.0	2.4	7.4	6.4	7.0	8.7	8.1	9.0	15.4	10.8	11.1	10.6	7.9	9.0	8.3	0.1	2.0	13.0	9.8	8.2	6.2	7.2	11.4	13.0	4.2	9.9	7.3	3.1	10.2	4.4	27.9	7.9	10.9	13.7	20.1	11.1	7.5	8.1	7.2	5.0	8.5	5.8	6.3	4.0	7.9	11.2	4.3	6.8	10.8	3.6	4.4	5.0	2.9	4.0	13.6	9.5	4.8	15.3	2.2	5.4	6.8	13.0	16.0	9.1	6.5	4.1	4.0	5.0	8.4	3.6	7.6	6.3	3.4	5.1	4.0	2.7	5.0	2.3	4.0	4.6	4.3	4.2	4.7	4.1	6.9	7.3	3.5	4.5	3.1	2.4	7.6	8.6	23.7	14.6	9.4	5.8	8.8	8.4	7.3	9.8	14.9	12.5	3.7	3.9	16.8	9.0	18.0	10.2	2.7	1.2	0.0	7.9	4.7	0.0	5.3	0.2	9.4	4.9	0.0	6.4	2.6	9.1	6.9	3.5	8.3	8.7	7.9	4.7	25.2	15.9	0.5	9.8	9.5	6.8	8.2	8.4	5.0	9.2	3.5	15.9	1.8	7.1	19.4	4.7	0.7	5.8	18.7	5.1	5.3	6.0	3.6
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682309-4771443	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	13.0	16.7	15.5	12.7	16.0	24.7	10.3	18.1	23.8	14.1	15.4	18.4	9.5	10.1	16.9	8.3	12.4	14.4	11.7	13.6	14.4	13.7	10.7	8.4	14.3	11.9	19.3	13.9	15.5	17.6	10.6	22.2	9.9	14.2	11.7	9.3	13.8	12.6	14.0	27.4	21.0	11.3	15.5	12.1	15.6	11.9	14.7	19.9	12.5	9.2	9.5	11.0	14.9	19.0	3.2	2.8	1.9	4.0	3.7	6.5	2.9	8.7	11.3	7.3	14.5	7.2	5.5	9.1	4.0	3.6	2.9	3.3	11.2	10.0	15.0	4.8	6.5	9.4	14.5	7.9	9.9	3.0	4.3	4.9	7.0	11.7	6.3	7.1	8.7	8.1	10.4	5.6	7.0	9.7	4.7	5.6	5.8	15.1	3.3	3.5	10.1	3.3	15.6	11.0	3.6	5.7	12.5	7.3	9.5	4.2	13.1	6.6	8.3	6.1	13.4	4.8	6.0	7.4	11.6	17.1	5.1	16.1	7.8	8.6	9.3	7.6	9.9	6.8	10.2	8.0	1.9	2.4	1.0	4.6	4.0	6.5	3.2	4.5	4.3	2.8	3.2	5.1	4.7	1.4	3.7	3.7	2.3	2.2	2.9	15.5	16.0	18.1	21.4	14.4	13.7	19.3	13.9	14.2	19.9	29.8	13.7	14.4	10.4	29.8	16.7	11.1	10.2	10.7	9.1	14.0	21.6	11.0	5.0	8.8	33.5	14.3	7.8	0.0	13.2	3.8	16.7	21.0	7.0	10.6	9.5	22.3	12.6	11.6	19.4	86.3	17.8	8.8	15.1	10.8	9.2	9.8	16.4	8.6	26.9	14.7	14.2	19.4	34.0	14.0	15.7	43.7	3.3	14.4	15.6	18.8
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;fHDF/TERT166: 6.5;HEL: 9.2;hTCEpi: 8.5;K-562: 9.4;SiHa: 6.5;THP-1: 6.7"	"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Midbody ring"		NA	NA			Nucleoplasm	"Midbody ring"	"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.2	0.3	4.0	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.7	6.5	0.2	1.3	0.0	0.0	0.1	0.0	0.0	9.2	1.1	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.4	0.0	0.0	9.4	0.0	3.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	6.5	0.0	0.0	0.3	0.0	6.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.7	6.2	12.7	13.9	17.4	45.5	13.6	23.6	13.8	8.1	7.4	25.0	3.2	8.2	8.2	4.6	9.1	6.5	9.8	8.3	16.1	9.5	6.8	18.7	10.6	17.4	23.3	12.8	6.2	8.4	9.8	7.0	12.6	19.0	6.2	8.0	2.9	7.1	4.7	8.0	5.9	10.1	9.5	23.6	17.2	7.4	6.1	26.0	17.8	7.9	6.9	15.7	10.9	8.2	7.6	11.3	42.3	11.3	8.3	9.9	5.6	6.9	10.7	12.3	10.9	9.8	7.2	13.6	7.8	8.6	6.6	7.4	9.4	8.8	15.3	10.5	9.2	8.1	8.9	7.4	8.9	9.7	11.8	6.5	29.8	7.6	9.4	17.1	16.3	23.8	6.5	3.8	7.1	12.5	5.4	7.0	6.4	14.1	18.3	10.7	5.3	18.0	10.8	9.3	5.2	5.6	9.0	25.8	12.5	5.8	8.9	6.9	7.1	3.8	7.2	13.8	4.4	3.2	9.7	8.1	9.1	9.1	8.6	8.2	9.9	7.4	22.1	7.9	15.1	12.2	35.1	11.1	42.3	8.7	8.9	9.9	7.5	8.3	7.9	11.3	7.6	6.4	6.4	14.1	8.3	11.3	7.0	9.5	5.6	12.7	17.4	23.6	13.8	16.1	9.5	23.3	12.8	19.0	26.0	0.0	6.1	9.5	17.5	13.9	6.9	9.0	15.3	1.4	6.8	1.8	0.0	5.6	5.0	5.3	3.3	17.0	7.7	0.0	4.7	28.3	9.9	31.0	22.0	17.0	16.1	12.7	2.4	19.0	31.1	3.3	11.2	31.1	11.8	35.1	8.6	7.1	8.8	7.0	10.6	4.0	3.7	6.5	13.0	11.1	7.5	18.4	13.8	17.3	8.3	34.0
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	26.8	14.5	12.6	23.2	11.3	33.9	35.2	46.9	10.7	17.2	28.4	15.3	12.2	18.2	19.3	11.2	21.0	17.4	11.9	20.2	12.8	7.8	7.5	15.4	14.1	20.1	11.3	7.4	28.8	15.1	35.0	10.1	11.3	13.2	15.7	11.1	17.8	13.4	12.6	44.3	29.5	31.1	25.1	14.0	13.2	15.9	12.6	13.2	34.0	8.8	18.4	19.9	25.7	31.7	9.6	19.3	21.4	14.2	17.3	24.3	15.2	0.1	2.7	7.3	4.3	29.7	9.6	5.0	5.5	5.9	5.1	8.5	2.6	2.1	8.6	2.9	8.8	3.6	1.9	12.5	8.1	7.6	37.2	2.4	2.8	5.4	9.0	9.6	5.6	5.1	22.5	4.7	0.4	3.6	6.3	10.9	12.1	3.3	24.6	8.6	3.3	11.1	5.6	7.6	5.0	4.9	17.5	24.8	8.0	0.6	8.9	3.8	13.0	8.1	8.1	2.3	24.7	4.5	16.2	19.2	8.9	11.9	8.6	8.3	22.0	37.3	15.5	3.0	10.0	5.2	21.4	13.0	18.8	24.3	14.2	19.5	7.8	16.4	20.8	19.3	9.6	21.5	20.5	5.4	17.3	8.7	4.3	19.2	15.2	12.6	11.3	46.9	10.7	12.8	7.8	11.3	7.4	13.2	13.2	29.8	33.4	42.2	20.1	79.3	120.0	94.3	45.9	13.4	46.6	8.7	0.0	28.4	18.3	8.5	51.6	50.4	42.4	23.3	18.2	16.8	35.5	24.5	12.7	73.7	37.8	74.7	57.0	52.2	76.4	26.5	89.2	69.9	30.4	26.2	40.3	32.4	15.4	24.6	80.2	10.5	9.3	38.8	52.6	2.3	10.0	129.0	24.7	76.1	43.5	22.0
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40469953-40666597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.9"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;Daudi: 20.4;HSkMC: 25.7;U-698: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	41.6	6.9	7.0	18.4	11.2	8.0	35.5	2.3	5.0	21.4	13.4	8.4	7.7	3.5	27.4	9.8	9.5	17.2	13.3	9.9	7.8	3.9	8.3	25.6	15.3	22.4	8.3	3.9	46.0	12.2	3.8	6.2	9.5	6.5	7.9	6.8	5.7	7.5	9.3	85.9	12.3	7.6	18.6	9.7	10.8	7.4	12.3	9.0	9.4	13.1	9.0	15.6	14.4	16.2	6.1	0.5	2.8	1.6	1.1	7.1	1.0	0.3	0.6	5.7	0.1	19.3	3.8	5.5	0.8	1.1	0.2	0.1	1.5	1.3	20.4	3.8	0.5	0.9	4.9	4.5	2.4	0.3	9.2	4.6	0.0	0.6	4.5	9.2	0.1	0.5	25.7	16.7	0.1	3.2	1.1	14.5	1.5	0.3	6.5	1.4	0.7	0.0	0.2	8.3	2.8	1.4	14.5	6.7	1.6	10.7	2.6	1.2	0.3	0.7	3.9	0.8	6.9	0.6	0.5	8.5	0.1	1.1	0.0	0.5	3.7	1.4	26.4	0.5	0.9	2.6	0.9	0.8	0.5	1.5	1.0	2.3	3.2	3.9	2.2	0.5	6.1	7.1	5.3	2.8	1.1	1.6	0.0	5.5	1.0	7.0	11.2	2.3	5.0	7.8	3.9	8.3	3.9	6.5	9.0	0.0	4.1	9.5	18.7	26.1	3.0	9.8	7.6	9.4	9.1	8.7	11.8	0.2	0.0	9.5	5.5	37.9	19.3	0.0	15.3	1.7	28.8	9.2	1.1	39.4	5.7	4.8	50.2	72.4	15.5	2.0	17.3	11.0	11.8	18.0	18.4	5.0	15.9	13.6	12.4	6.3	8.3	6.5	9.3	4.8	14.9	23.3	0.7	12.9	9.8	9.1
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546426-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 38.6;Mucus-secreting cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 39.3;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	12.1	7.8	6.3	13.7	12.6	4.4	15.5	12.3	10.0	28.2	15.8	14.0	16.4	18.7	20.7	8.4	10.5	10.1	29.5	12.9	6.6	7.3	16.4	18.9	14.4	9.1	12.9	4.9	17.1	24.8	5.9	12.6	5.5	9.4	21.7	7.2	21.2	30.1	13.0	7.9	7.1	19.3	11.7	7.9	5.8	37.0	15.4	10.9	12.0	23.9	6.3	14.0	11.7	27.6	2.0	1.0	0.3	0.9	0.6	1.5	0.4	9.1	12.6	15.9	17.0	3.0	1.0	16.3	5.0	2.7	4.5	3.1	39.3	2.9	10.6	9.5	3.0	13.5	7.0	4.6	4.8	1.9	8.4	7.3	8.4	7.0	26.3	5.8	5.3	6.9	2.5	5.9	4.0	2.4	6.6	4.4	6.6	10.4	4.3	2.1	24.8	6.2	9.2	4.0	48.5	4.4	6.8	5.1	7.1	3.9	7.6	4.5	6.4	5.4	12.9	9.0	5.1	7.3	13.0	6.1	5.7	14.2	8.9	8.5	3.4	2.1	14.7	4.7	9.0	5.3	0.3	0.7	0.3	0.7	0.9	1.2	1.0	0.6	1.5	0.6	2.0	0.1	0.3	0.3	0.6	0.3	1.0	1.1	0.4	6.3	12.6	12.3	9.2	6.6	7.3	12.9	4.9	9.4	10.9	0.0	9.4	0.5	4.9	8.1	4.7	14.6	10.2	1.4	3.4	5.2	2.0	2.1	0.0	6.9	22.9	2.8	18.6	0.0	14.0	2.7	5.7	13.8	3.5	15.5	3.6	0.0	38.6	7.4	3.2	16.3	3.7	2.6	1.7	7.2	37.4	0.8	16.6	20.1	8.1	6.9	2.6	12.9	8.9	2.1	7.2	6.8	3.7	3.2	15.0	8.4
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844301-31845619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	28	"Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	5.9	3.1	2.7	3.0	4.7	0.3	11.7	2.7	4.9	9.7	2.6	4.8	1.8	0.9	15.5	6.2	2.8	3.6	11.7	14.0	3.2	2.6	5.5	0.9	6.5	4.6	4.1	4.8	4.0	1.1	0.8	3.2	14.4	5.2	5.0	1.6	7.0	2.0	7.0	4.5	1.8	1.8	3.7	2.6	5.5	1.6	9.7	0.6	3.0	4.9	7.0	3.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	14.8	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	2.7	4.9	3.2	2.6	4.1	4.8	5.2	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.4	0.0	3.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	4.0	4.6	0.0	1.7	0.0	0.0	0.0	3.3	0.0	53.4	0.0	0.0	129.4	31.6	0.5	0.5	0.3	0.2	0.0	0.0	0.0
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 46.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.0	1.2	4.4	1.9	1.9	3.3	6.2	6.5	4.3	1.2	1.1	10.1	9.1	4.7	1.5	9.7	14.0	8.7	4.5	7.2	1.5	13.9	10.5	1.6	10.1	1.8	5.8	4.0	4.6	5.8	7.5	2.1	0.9	8.7	6.0	17.6	21.7	17.7	8.8	6.2	1.4	9.2	4.5	4.8	6.3	5.2	1.5	9.6	6.0	14.9	14.5	22.0	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.1	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3	0.0	4.6	7.7	21.9	28.2	16.8	5.6	7.6	4.0	2.3	14.0	3.9	4.1	10.0	2.1	31.9	4.7	16.0	0.0	4.5	15.6	4.8	26.8	1.1	8.2	7.7	11.1	13.3	3.1	18.0	31.4	2.0	6.4	10.1	1.0	28.5	4.3	4.1	17.3	2.5	2.2	16.9	0.0	7.6	1.2	3.9	46.0	6.5	5.7	27.3	25.6
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.0;RT4: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	2.5	4.2	0.7	1.0	0.3	0.3	0.8	0.6	0.2	0.0	0.1	3.3	4.1	1.1	3.9	0.6	0.6	6.1	0.3	1.2	0.1	3.5	0.4	1.4	3.6	2.8	0.2	1.0	0.9	0.3	1.7	0.4	0.4	0.5	0.2	0.7	0.7	2.6	1.0	1.4	0.8	0.6	1.1	19.0	0.7	1.2	3.7	1.3	5.2	8.0	0.9	1.0	0.9	5.4	0.5	1.1	1.6	0.8	1.0	1.2	1.2	0.9	0.6	4.0	2.8	1.8	1.2	0.7	0.8	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5	0.0	10.1	0.0	15.3	2.4	0.7	8.4	12.7	22.7	15.9	22.7	0.0	4.3	10.0	16.5	73.1	0.3	35.5	0.0	14.3	3.8	3.5	20.3	3.5	19.2	0.8	6.4	19.0	1.8	0.6	17.7	0.6	0.5	0.0	1.8	13.0	0.3	19.1	20.1	1.1	22.5	0.0	12.9	7.5	1.4	0.7	2.8	0.7	0.5	16.1	34.6
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 28.2;TIME: 34.4;WM-115: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	20.5	2.9	8.2	4.6	13.6	2.6	5.6	4.2	22.4	5.3	3.6	2.0	5.9	2.5	4.3	3.4	4.6	4.4	4.9	5.8	10.3	9.5	5.6	6.0	6.1	5.0	7.3	10.3	3.8	8.5	1.1	9.3	12.3	4.3	5.4	2.9	7.8	7.5	9.6	3.8	18.5	3.4	3.3	5.0	17.1	3.3	7.6	1.5	2.6	3.7	2.0	4.5	4.1	3.6	1.9	2.1	2.0	0.9	1.4	2.0	0.2	1.9	1.2	21.3	0.1	1.9	5.4	5.3	5.5	11.4	8.0	13.1	3.7	0.6	0.0	6.3	5.5	6.0	4.1	0.1	1.0	6.9	0.1	3.1	0.4	0.2	0.0	2.6	0.1	0.3	3.7	1.0	28.2	4.0	22.9	22.6	0.9	4.0	0.1	15.7	2.6	1.3	0.2	3.7	0.1	0.8	0.1	4.7	0.0	5.3	1.7	0.7	3.7	0.0	10.3	17.1	3.6	5.8	0.7	34.4	13.0	3.0	8.4	8.1	0.1	0.0	0.0	10.1	0.3	48.8	0.4	0.5	0.5	0.4	0.9	0.7	1.9	1.8	0.6	0.4	0.8	0.8	0.5	2.0	1.4	0.6	2.1	2.0	0.2	8.2	13.6	4.2	22.4	10.3	9.5	7.3	10.3	4.3	1.5	29.8	1.6	0.0	11.4	31.1	60.0	9.7	25.5	4.0	5.7	31.4	17.7	56.1	10.0	10.6	32.6	27.0	0.2	23.3	3.4	30.6	9.3	7.0	15.0	4.7	31.7	76.3	4.6	46.1	57.5	64.5	2.0	21.7	15.1	4.6	2.5	54.5	2.4	0.0	1.8	1.9	9.9	12.9	25.9	1.0	0.7	28.5	24.0	1.5	5.3	3.6
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		6200	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	26.6	24.1	24.3	18.5	24.3	10.5	21.8	23.9	30.3	22.8	24.0	37.7	22.9	19.9	32.7	20.7	24.2	22.1	25.4	24.3	24.6	20.0	22.4	37.6	19.9	18.7	27.4	22.8	25.2	27.7	36.6	23.8	33.8	23.9	26.1	20.4	21.9	26.1	25.3	15.2	22.0	20.5	26.9	30.0	20.2	22.0	30.0	27.5	26.4	39.9	18.1	20.1	23.2	22.9	4.5	5.6	2.1	4.5	7.3	6.9	3.0	20.8	19.2	28.1	23.1	20.3	23.1	35.6	29.9	26.8	24.2	18.8	27.7	19.3	20.2	15.8	28.3	21.4	36.4	23.6	25.4	28.8	22.3	20.2	22.4	30.6	20.3	27.8	33.6	25.3	22.3	20.5	25.4	24.0	20.3	19.7	16.9	35.5	12.6	25.0	28.0	25.9	17.1	36.1	32.9	24.6	23.2	35.0	27.1	21.2	22.1	18.7	30.9	31.8	23.6	19.5	22.1	32.4	25.6	25.0	43.9	20.9	29.5	34.6	11.6	19.1	26.3	24.5	14.6	31.2	0.0	3.7	2.1	4.7	4.5	6.9	4.5	5.1	5.6	5.6	3.3	5.9	5.1	1.0	7.3	3.5	4.9	4.0	3.0	24.3	24.3	23.9	23.7	24.6	20.0	27.4	22.8	23.9	27.5	17.9	19.4	18.0	17.5	29.8	22.5	16.5	25.5	21.4	12.5	15.7	13.7	24.3	24.9	18.3	3.2	20.4	13.2	0.0	16.5	25.4	24.2	24.1	7.0	48.6	22.9	30.2	20.8	30.1	22.9	7.2	19.0	17.2	35.4	16.2	18.9	52.7	20.0	17.3	26.2	29.5	27.4	12.9	30.9	14.3	10.4	35.8	38.3	15.4	15.5	22.6
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 102.2;Hepatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.4	8.8	2.0	8.9	14.5	9.4	22.7	18.2	13.9	7.5	5.3	12.9	15.8	0.5	46.8	13.2	13.5	26.0	4.0	9.4	1.6	41.6	10.3	25.3	15.8	16.8	7.7	3.5	41.7	10.6	10.6	8.5	3.9	18.3	24.0	4.2	19.3	2.5	5.0	9.9	1.3	11.4	6.3	12.2	2.6	2.2	7.7	3.3	11.7	11.0	4.0	2.7	15.4	8.4	12.8	9.9	3.0	9.2	35.4	8.5	18.2	13.0	26.6	4.5	25.6	1.2	16.2	11.4	17.2	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9	3.0	30.9	6.7	7.5	17.2	11.9	15.0	10.2	1.4	5.7	21.0	23.6	16.5	0.0	44.3	0.4	25.5	23.8	23.3	102.2	11.4	12.3	26.5	15.1	114.9	22.3	7.9	36.4	23.4	26.1	0.2	10.3	24.1	15.1	7.2	27.3	11.7	83.4	21.8	10.3	5.6	25.2	25.8	12.5	2.3	3.4	20.1	70.5	11.7	16.1	13.9
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	12.6	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.1	70.3	0.0	26.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.0	239.6	0.1	0.0	0.0	0.0	0.0	66.8	15.7	0.1	0.0	65.8	4.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0	708.7	211.8	0.0	720.0	512.4	2.3	1.3	239.5	860.6	417.5	127.4	0.0	696.6	1.7	18.8	0.1	3.8	1850.8	0.0	640.2	148.4	41.3	1079.2	23.0	0.6	70.8	1.6	937.0	0.0	0.0	0.0	0.0	12.2	391.4	2.8	1977.6	233.2	377.2	3546.9	0.0	0.6	8.5	0.0	25.8	0.2	0.2	756.6	1264.5	0.7	1253.7	1183.0
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 142.8"	"Group enriched"	"Detected in many"	4	"Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"classical monocyte: 21.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	12.9	38.7	41.2	9.5	46.2	3.1	8.1	49.1	142.8	24.3	52.0	30.2	9.2	7.6	54.8	19.0	9.8	26.7	29.0	25.6	35.4	51.6	12.3	10.4	21.5	8.5	18.4	59.5	82.8	9.5	3.5	28.5	5.6	20.2	35.6	11.7	11.9	9.8	22.9	11.0	3.9	16.3	58.5	12.8	42.8	17.6	23.2	18.5	2.9	15.9	6.4	5.9	38.1	13.9	0.0	3.6	0.5	21.9	0.0	0.3	5.1	0.0	0.2	37.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.4	0.1	25.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.4	1.6	0.1	7.6	0.0	0.0	0.0	15.7	0.2	0.9	0.0	57.4	32.7	0.0	0.1	1.3	10.9	0.6	0.6	0.0	0.0	9.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	21.9	0.0	0.0	5.3	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	5.1	41.2	46.2	49.1	78.8	35.4	51.6	18.4	59.5	20.2	18.5	6.0	2.1	0.0	2.7	6.0	2.1	4.8	2.5	2.7	1.2	0.0	2.0	0.8	1.7	5.2	2.2	57.8	0.0	0.0	0.3	1.1	30.7	2.3	0.0	0.4	57.8	1.6	12.0	132.6	22.4	8.6	220.4	9.7	15.1	3.6	0.0	51.6	0.6	0.0	341.9	0.0	3.0	349.3	63.8	1.4	3.2	3.3	1.1	0.0	0.0	1.4
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105255-39274528	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 153.7;lymphoid tissue: 63.5"	"Cell type enhanced"	"Detected in some"	17	"Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6600000	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	7.0	3.5	6.3	36.0	18.3	22.1	3.9	1.8	10.1	3.5	4.4	8.3	0.3	4.1	2.7	6.5	4.9	4.2	7.9	3.5	6.8	6.6	5.7	6.2	13.8	35.5	15.5	2.7	2.6	2.5	1.3	3.5	8.7	11.7	3.8	5.3	3.0	5.4	1.5	1.9	2.4	11.7	5.6	29.4	41.5	5.2	3.5	12.2	63.5	4.1	1.8	28.0	10.1	3.6	0.1	11.9	153.7	41.3	8.6	28.7	30.8	0.0	1.1	0.0	0.0	0.1	0.0	6.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.2	4.5	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.1	0.0	0.0	58.0	0.0	0.0	0.0	0.0	55.5	3.5	0.0	0.0	0.0	16.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.1	1.6	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	21.5	0.0	11.9	33.8	32.3	7.9	38.6	5.5	0.1	22.5	13.8	11.9	0.1	28.7	17.3	153.7	8.6	41.3	3.0	21.7	30.8	6.3	18.3	1.8	10.1	6.8	6.6	15.5	2.7	11.7	12.2	14.9	34.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	10.3	14.0	0.0	25.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	14.0	0.0	145.5	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0
FZD3		ENSG00000104290	"Frizzled class receptor 3"	Q9NPG1	8	28494205-28574268	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 92.3;Rod photoreceptor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.8;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AF22: 31.1;Karpas-707: 16.0;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024995, HPA042320"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB024995: , HPA042320: AB_2677948"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.69e-2)"	"unprognostic (4.26e-4)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.09e-3)"	2.2	6.4	13.3	3.4	21.1	3.2	5.4	14.4	20.9	5.3	4.4	5.2	8.7	3.2	7.5	15.6	4.4	7.8	3.2	3.0	9.1	7.8	5.7	1.9	2.6	4.3	4.4	14.4	15.0	7.1	8.2	12.5	3.1	9.6	9.6	3.1	4.3	7.0	12.4	2.7	3.3	2.5	5.8	5.4	1.8	5.1	9.9	4.3	1.3	7.4	0.3	3.3	5.2	3.7	1.6	11.8	0.9	0.3	1.1	3.1	0.9	8.2	1.7	31.1	5.8	0.0	0.4	4.8	0.3	0.6	1.7	0.8	1.7	1.7	4.1	1.5	0.2	3.8	2.9	4.7	4.9	1.2	5.1	3.6	2.6	0.6	1.1	0.0	1.4	4.6	0.3	2.6	0.1	1.3	0.3	0.3	4.1	1.9	16.0	0.1	2.0	0.1	3.2	7.8	3.5	2.6	1.8	4.6	3.7	2.4	2.4	22.9	6.2	1.6	4.3	4.8	4.2	4.2	2.2	0.0	0.0	8.4	1.1	2.1	2.9	3.3	3.7	2.4	0.0	1.5	0.9	0.3	0.0	2.2	0.2	2.8	1.6	1.6	3.1	1.2	0.9	2.2	2.3	0.2	1.1	0.0	11.8	0.0	0.9	13.3	21.1	14.4	20.9	9.1	7.8	4.4	14.4	9.6	4.3	8.9	8.1	7.8	6.9	6.0	26.0	5.2	2.5	12.0	15.9	8.7	92.3	9.6	1.7	10.9	12.8	3.0	1.0	0.0	12.8	7.4	7.3	12.2	5.7	2.4	3.3	20.6	27.5	11.6	1.8	11.0	44.5	2.9	32.1	0.0	4.2	15.3	14.2	3.5	48.1	10.2	82.4	25.8	13.9	23.2	29.3	4.1	4.0	2.5	5.5	6.4
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955391	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 75.7"	"Cell type enhanced"	"Detected in many"	18	"Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	75.7	5.3	3.4	6.0	4.8	0.5	57.8	1.5	4.3	11.5	9.0	1.4	32.6	2.0	13.1	13.5	6.3	9.6	8.7	12.5	3.1	2.2	17.0	8.9	19.0	4.7	2.9	3.2	12.8	6.0	4.4	10.1	7.3	5.5	9.3	4.3	20.0	7.1	56.0	17.9	3.7	5.4	8.6	2.8	8.6	8.2	5.5	1.6	0.5	11.4	11.1	3.0	8.3	20.7	0.4	0.2	0.8	0.4	1.4	0.3	0.0	0.5	0.4	1.1	2.0	25.9	6.8	1.5	3.2	2.9	1.2	1.3	2.7	0.3	0.0	0.7	1.0	1.7	1.1	1.2	0.5	1.0	0.1	0.8	1.0	0.8	32.6	7.7	0.0	0.0	18.8	0.2	1.1	0.2	3.0	36.8	0.0	1.4	0.1	0.8	0.8	0.0	0.0	1.5	2.8	7.4	0.0	1.9	0.0	3.6	5.3	0.2	0.3	1.3	0.4	0.5	2.3	4.7	0.0	18.0	3.1	2.1	3.6	0.6	0.1	0.5	0.0	0.4	0.0	0.8	0.7	0.3	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.8	1.4	0.4	0.2	0.0	0.0	3.4	4.8	1.5	4.3	3.1	2.2	2.9	3.2	5.5	1.6	0.0	2.2	1.9	0.4	1.3	0.7	7.8	7.6	1.4	1.2	34.9	9.8	0.1	3.3	0.6	0.4	26.3	0.8	0.0	1.4	0.1	4.3	0.8	0.0	10.4	0.2	0.0	0.0	108.6	11.2	1.7	8.6	0.9	0.0	0.0	1.1	0.3	1.0	0.0	6.3	6.9	0.1	32.3	5.1	0.2	3.0	0.5	0.2	0.0	0.6	0.1
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506273-3538330	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.7;Late spermatids: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	10.3	16.9	15.4	12.0	19.9	37.2	10.6	39.1	23.1	13.3	13.8	17.7	11.0	29.0	14.6	10.1	14.6	12.3	14.5	10.3	13.0	16.6	12.0	13.8	10.7	12.6	11.7	14.3	16.4	20.6	13.2	22.5	15.4	16.1	12.3	5.0	14.9	24.6	15.1	18.1	15.7	18.0	12.0	10.7	15.3	16.3	29.7	14.1	18.9	15.6	9.3	15.8	10.6	12.9	3.0	1.7	5.7	2.1	3.3	3.5	1.5	23.2	14.2	12.1	11.8	3.4	5.6	10.5	14.8	7.6	14.3	11.3	14.3	11.5	12.9	7.6	9.5	7.8	13.9	6.7	12.3	2.9	17.6	13.1	6.2	10.0	14.0	7.5	11.1	13.1	5.0	6.5	8.8	5.1	5.4	9.2	12.5	11.1	20.8	7.7	12.2	19.6	7.9	11.3	7.2	11.1	14.6	11.6	12.6	7.3	11.8	11.6	14.0	13.1	9.3	7.2	2.8	9.7	8.8	13.9	9.8	12.2	23.7	25.2	24.1	5.6	9.9	13.4	21.7	11.9	3.5	1.9	5.7	3.5	2.1	2.0	3.0	3.4	2.4	1.7	2.6	1.8	2.7	3.7	3.3	1.5	1.4	2.4	1.5	15.4	19.9	39.1	23.1	13.0	16.6	11.7	14.3	16.1	14.1	0.0	5.3	15.1	31.9	15.9	20.9	2.9	2.5	1.4	3.4	12.2	9.8	18.6	5.0	14.2	78.7	8.5	17.3	46.7	13.0	11.5	11.2	17.6	3.5	14.7	14.4	28.6	20.7	7.4	6.5	132.8	11.8	11.0	11.8	25.2	14.5	8.3	21.4	17.3	8.9	10.8	14.3	6.5	9.9	25.7	16.2	19.7	38.0	9.6	12.2	24.3
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor beta subunit 1"	Q06547	15	50275392-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	Yes			Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: AB_2685842"	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	15.4	12.6	8.1	13.8	16.8	31.7	14.3	16.0	14.0	12.7	9.5	8.4	8.6	8.1	14.1	10.8	13.8	12.0	12.6	10.3	8.8	7.2	9.1	16.2	15.2	25.7	9.1	8.7	12.1	10.6	8.7	11.5	15.1	7.3	11.4	11.8	10.7	12.1	8.1	15.2	10.4	12.8	13.9	7.3	17.1	11.2	17.3	9.9	35.7	16.2	12.5	20.8	13.4	11.9	23.1	16.8	26.8	15.0	19.1	21.1	14.3	11.8	13.7	20.1	15.6	5.3	7.5	26.9	15.7	12.4	18.6	16.4	23.3	9.8	15.6	9.6	12.9	14.7	19.7	18.0	13.4	23.7	21.6	10.7	18.5	14.3	15.8	12.8	17.7	14.4	9.9	13.2	17.4	22.7	10.5	32.4	17.2	16.9	19.8	12.3	27.0	26.1	16.0	13.8	13.1	9.3	32.3	14.7	14.9	11.2	15.2	19.0	15.7	13.9	13.2	15.8	20.1	11.5	17.6	15.4	17.0	14.1	29.6	27.9	14.1	19.2	27.5	10.5	16.4	17.0	26.8	12.2	23.6	15.9	15.0	21.1	23.1	15.7	16.9	16.8	21.3	14.6	16.8	12.4	19.1	11.1	13.3	20.4	14.3	8.1	16.8	16.0	14.0	8.8	7.2	9.1	8.7	7.3	9.9	8.9	9.1	53.0	89.7	41.9	40.4	15.3	12.7	8.1	0.0	7.0	33.4	37.1	3.3	11.0	80.1	35.3	15.8	0.0	6.7	41.1	28.6	72.8	47.2	24.6	31.6	35.0	48.5	39.3	56.1	27.9	53.5	11.6	18.6	25.2	23.1	30.3	11.9	21.0	36.0	6.5	40.6	25.8	24.5	27.4	31.1	31.2	46.3	116.7	26.4	90.9
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor beta subunit 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 26.5"	"Low region specificity"	"Detected in all"							"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	9.9	8.3	9.5	9.3	13.3	12.2	10.9	12.3	12.2	10.0	8.5	14.8	10.7	7.0	10.1	8.0	8.7	10.2	10.7	11.0	11.6	5.8	7.9	6.4	7.7	9.9	14.4	9.7	17.6	7.8	15.1	12.8	6.5	11.4	9.4	9.8	11.0	7.6	12.6	10.0	13.9	8.1	12.0	10.2	10.1	9.8	20.2	15.2	15.7	10.0	11.6	9.8	9.9	16.6	4.7	5.0	4.7	5.1	2.6	4.8	2.6	6.9	2.4	1.7	2.1	6.1	9.0	2.2	6.4	4.0	3.7	2.6	0.7	5.2	7.2	2.4	6.1	2.0	6.1	3.7	3.3	5.5	2.7	1.4	2.0	3.8	0.1	4.1	7.8	4.1	4.9	3.8	5.1	7.7	2.9	1.4	7.7	4.8	5.1	4.4	9.8	10.8	1.4	0.8	4.0	2.7	3.2	2.8	3.4	3.1	1.9	3.0	1.2	8.2	2.9	2.4	1.7	7.2	8.6	4.1	1.0	3.2	6.6	5.1	2.8	1.3	26.5	3.0	5.9	4.4	3.6	2.8	1.6	4.4	3.3	2.7	3.1	4.8	3.9	2.5	4.7	4.3	4.7	4.7	2.6	5.1	5.0	1.7	2.6	9.5	13.3	12.3	12.2	11.6	5.8	14.4	9.7	11.4	15.2	8.9	12.6	13.8	9.2	10.2	26.2	21.4	25.5	24.1	18.2	12.2	23.6	4.9	8.3	5.6	28.3	9.0	9.8	0.0	5.1	4.2	10.8	6.2	6.9	5.9	7.3	31.8	9.2	16.0	14.8	13.9	20.8	8.0	8.5	9.0	15.4	15.4	4.6	10.5	20.1	3.3	39.9	6.5	16.0	54.6	51.3	8.8	3.8	14.4	14.9	6.7
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor alpha1 subunit"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 58.6"	"Cell type enriched"	"Detected in some"	24	"Bipolar cells: 209.5"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		1.0	2.6	8.5	1.0	21.9	1.0	1.0	35.2	58.6	1.0	1.0	1.8	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	10.5	8.8	1.0	1.0	1.0	1.0	6.7	22.0	1.0	1.0	1.0	0.1	1.0	7.4	1.2	1.0	0.2	1.0	1.1	1.0	1.0	1.0	1.0	1.3	1.1	1.5	1.1	0.0	0.0	1.0	0.0	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	209.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor alpha2 subunit"	P47869	4	46248427-46475230	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	2.2	1.3	38.5	1.4	34.4	1.2	1.9	10.4	52.6	1.7	4.5	4.9	0.0	2.0	1.4	11.7	1.7	1.0	1.6	1.0	38.9	7.7	8.8	1.4	1.0	1.4	3.7	31.0	1.9	1.0	0.9	0.6	1.5	10.5	1.0	3.5	0.0	1.2	1.9	1.0	1.3	7.7	1.3	6.9	2.3	1.6	1.5	7.1	0.0	1.1	0.0	1.4	1.2	0.8	0.2	0.3	1.0	0.1	0.1	0.1	0.0	0.5	0.5	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.1	0.6	0.2	0.5	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.8	0.2	0.0	0.4	0.0	0.3	0.9	1.8	0.1	0.0	0.6	0.4	0.1	0.6	0.2	0.0	0.1	0.3	0.0	0.6	0.4	0.4	0.1	0.5	9.6	0.5	0.1	0.8	1.2	0.2	4.5	0.4	5.1	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	38.5	34.4	10.4	31.4	38.9	7.7	3.7	31.0	10.5	7.1	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	38.4	3.9	0.0	3.3	0.0	6.4	0.2	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	30.6	0.0	0.0	6.9	0.6	0.0	1.7	0.0	1.9	0.3	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor alpha3 subunit"	P34903	X	152166234-152451358	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 30.1"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 12.1"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.7	0.7	7.7	0.6	15.2	0.7	0.7	1.3	30.1	2.2	0.8	3.3	0.0	0.8	1.2	0.8	1.3	0.7	0.7	0.7	10.9	15.9	0.7	0.7	0.7	0.7	4.7	10.5	0.6	0.7	0.6	0.9	5.2	6.2	0.8	0.8	0.4	0.7	1.8	0.8	1.1	0.9	0.8	2.1	0.7	0.7	1.8	1.1	0.0	0.7	0.0	0.9	1.8	0.4	0.0	0.1	1.5	0.3	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	13.0	0.0	0.0	0.0	0.0	2.4	5.5	7.6	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	4.8	0.4	0.3	0.1	1.2	0.0	4.9	6.5	0.3	1.4	7.0	11.6	0.0	7.7	0.0	4.9	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.0	7.7	15.2	1.3	28.4	10.9	15.9	4.7	10.5	6.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	1.6	0.0	0.0	0.3
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor alpha5 subunit"	P31644	15	26866363-26949207	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 52.6"	"Cell type enhanced"	"Detected in single"	18	"Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB079022: , HPA029363: , HPA077031: AB_2686825"	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.8	0.8	12.0	0.8	48.2	0.8	0.8	0.1	52.6	0.8	0.8	0.8	0.0	0.8	0.8	0.7	2.5	0.8	1.5	0.9	20.9	6.0	0.9	0.8	0.8	0.8	2.3	15.2	0.7	0.7	0.7	0.1	0.8	1.0	1.0	0.7	0.0	0.7	0.9	0.7	0.8	0.7	1.4	0.3	0.8	1.1	1.4	2.0	1.3	0.9	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	9.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	48.2	0.1	26.0	20.9	6.0	2.3	15.2	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Smooth muscle cells: 2211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	50.5	37.3	10.3	24.6	33.8	142.2	34.2	6.7	26.4	20.0	29.2	17.9	4.1	9.7	14.2	10.7	17.6	34.3	44.6	59.0	22.5	15.6	26.2	143.6	49.8	14.7	17.1	3.9	36.3	45.5	16.7	27.5	22.6	32.4	27.2	6.6	26.6	28.1	36.9	38.4	22.1	12.3	14.5	32.8	14.7	27.1	12.4	13.1	6.7	53.9	29.5	13.7	35.0	15.0	12.2	13.5	45.1	14.9	14.9	22.6	10.1	21.4	4.3	0.5	2.9	16.3	12.6	1.3	21.9	6.4	17.3	8.9	6.0	8.3	10.2	14.9	10.8	6.2	11.9	1.1	7.3	4.2	7.8	3.9	1.1	4.7	2.3	27.7	2.3	7.1	20.4	4.7	5.2	25.8	18.7	6.8	1.1	0.5	27.8	17.8	6.9	2.6	11.4	2.6	2.1	9.2	9.9	7.9	16.0	7.8	3.9	0.2	0.2	24.4	18.3	7.0	10.0	9.7	17.2	27.9	17.3	15.9	12.3	27.3	12.5	9.2	4.2	4.2	6.9	5.6	11.7	11.8	45.1	22.6	14.9	20.4	7.4	15.8	17.3	11.9	12.2	14.1	18.5	34.5	14.9	11.6	13.5	19.1	10.1	10.3	33.8	6.7	26.4	22.5	15.6	17.1	3.9	32.4	13.1	393.1	604.5	105.2	327.2	303.6	9.8	755.2	165.6	246.3	216.1	48.8	5.9	91.9	162.5	250.0	1.5	410.0	221.1	0.0	188.1	49.6	617.1	761.5	748.2	106.8	373.8	12.7	81.8	133.2	143.4	1.7	68.4	643.2	490.9	244.3	77.7	120.7	209.6	203.4	27.6	91.0	27.0	174.6	2211.4	1.6	5.7	269.9	120.6	154.5	59.8	284.3
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957236	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	23.9	31.8	32.7	22.3	29.1	28.1	19.3	17.2	31.4	16.9	18.9	11.2	17.9	21.1	19.2	20.0	22.3	17.5	25.0	41.9	26.4	27.6	24.3	31.5	15.3	21.0	26.0	23.6	20.7	29.6	10.1	18.5	21.3	17.7	18.7	9.7	13.1	36.2	21.7	85.5	18.4	19.2	19.5	19.3	19.8	20.0	17.2	17.1	14.8	27.0	37.9	14.8	17.5	21.5	34.2	17.7	4.8	14.1	16.1	23.6	10.6	20.1	17.2	7.2	10.1	5.1	6.6	10.1	14.9	7.5	14.9	12.3	23.7	8.2	14.6	24.9	8.9	10.7	14.1	8.8	14.5	3.9	9.5	43.2	10.3	23.2	26.6	12.4	17.1	15.8	7.8	11.8	10.3	8.5	7.9	8.6	14.1	15.6	5.7	9.2	29.6	27.0	36.0	19.9	13.1	54.3	20.1	7.3	23.3	11.4	11.9	22.2	20.3	11.1	15.0	16.8	3.7	11.7	16.2	13.9	28.9	10.1	25.1	27.3	22.7	15.8	15.1	20.1	21.5	16.6	4.1	14.1	4.8	14.4	13.4	14.5	34.2	22.1	22.8	17.7	28.0	23.6	17.4	0.9	16.1	11.3	16.9	17.5	10.6	32.7	29.1	17.2	29.1	26.4	27.6	26.0	23.6	17.7	17.1	38.7	48.8	182.3	139.8	129.1	56.0	138.4	114.7	85.6	58.0	130.9	21.6	278.6	339.8	261.6	30.0	159.5	164.2	116.8	326.4	297.6	155.1	145.6	72.7	225.1	217.4	35.0	133.6	149.8	133.3	39.7	177.2	143.5	170.4	318.4	137.1	65.9	279.8	125.8	160.1	483.6	62.7	187.5	150.4	81.2	152.0	140.6	170.8	107.6	173.2	145.0
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.7	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.3	3.1	0.3	12.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.3	5.3	0.6	0.0	0.1	0.3	0.9	3.3	8.5	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.6	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8	0.0	0.0	0.0	0.1	0.3	0.7	0.6	38.2	0.0	0.0	3.5	0.0	0.0	13.3	5.6	0.9	0.1	17.4	0.0	9.7	0.0	0.0	0.2	0.0	1.3	0.1	0.0	10.5	0.0	0.8	0.6	1.4	0.0	0.0	0.0	7.4	29.4	4.6	7.0	2.1	18.9	1.1	0.0	0.0	3.1	7.5	0.3	0.2	0.0	8.0	0.0
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell type enriched"	"Detected in some"	6	"Hofbauer cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.1	7.6	2.2	2.2	1.3	1.8	0.4	0.2	0.7	0.5	7.4	2.3	8.6	0.2	1.3	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.7	3.4	3.9	0.4	2.8	2.5	3.1	1.1	0.1	2.4	0.3	2.7	0.1	1.3	8.2	0.9	2.2	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.6	0.7	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.7	1.4	0.4	29.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2	0.0	0.3	0.0	2.0	3.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	6.0	0.3	0.0	0.0	38.9	0.0	0.0	1.8	0.3	0.0	4.4	0.7	5.0	1.0	0.6	0.5	0.5	2.9	4.9	0.0	0.0	0.0	2.2	0.4	0.2	7.0	0.7	0.0	6.0	0.9
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	12.7	24.9	10.2	9.2	15.3	6.5	12.4	15.7	15.3	14.7	16.3	15.3	25.6	21.5	16.0	9.9	11.5	13.5	9.9	14.2	11.3	10.3	32.3	28.4	12.7	8.0	16.2	9.4	11.5	18.5	19.4	34.2	10.8	15.3	11.1	17.9	13.2	12.2	16.3	12.5	11.6	17.9	11.8	13.9	12.8	13.9	9.2	14.8	14.6	16.7	10.9	11.5	10.3	11.6	9.6	10.4	24.2	11.3	12.8	23.1	8.7	6.3	7.4	3.4	4.5	8.8	13.7	10.0	6.6	8.8	6.6	7.8	9.4	6.7	2.0	5.3	6.9	8.2	9.3	13.5	9.4	9.3	11.4	4.0	11.8	7.0	7.9	9.6	8.1	3.7	7.1	17.3	7.0	17.5	7.6	13.3	4.9	11.8	11.5	7.1	6.8	5.9	6.5	1.4	19.3	7.1	7.2	4.2	30.6	12.2	6.0	4.1	2.7	7.3	15.2	12.4	7.1	7.5	7.9	7.2	6.4	4.4	26.3	6.2	9.5	32.7	3.9	10.0	31.1	8.8	24.2	10.6	18.6	12.8	11.3	13.6	9.6	13.1	12.6	10.4	6.7	10.5	10.7	5.4	12.8	10.8	9.2	23.1	8.7	10.2	15.3	15.7	15.3	11.3	10.3	16.2	9.4	15.3	14.8	3.0	9.3	11.5	12.7	4.9	12.6	1.1	30.6	30.8	9.1	5.2	35.3	12.4	24.9	15.8	5.0	7.1	15.5	23.3	11.4	23.6	8.9	10.4	2.3	24.2	17.8	14.3	8.6	22.7	14.6	3.1	10.6	11.0	13.5	13.6	22.6	10.3	11.8	17.0	10.6	37.9	24.8	0.0	7.5	19.1	5.4	5.5	21.5	10.8	15.8	9.5
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 42.7"	"Cell type enhanced"	"Detected in some"	18	"Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		9400	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	1.5	0.9	3.7	4.3	1.1	1.8	9.6	1.4	0.6	1.8	0.3	0.6	0.6	1.0	10.2	1.1	3.7	0.4	1.6	1.5	42.7	1.2	0.6	2.6	1.2	2.3	0.9	2.7	7.6	5.7	0.2	0.9	1.7	0.2	2.1	1.7	0.2	0.4	1.9	3.1	0.7	0.8	1.8	0.6	1.6	0.3	0.1	1.1	1.0	4.2	2.0	1.4	1.4	0.0	10.6	0.0	0.0	0.0	0.1	11.1	13.1	0.0	0.0	0.0	0.0	0.0	3.7	2.0	2.5	0.3	0.0	0.0	10.4	3.8	0.2	0.0	0.0	0.4	0.5	0.4	0.3	1.3	5.8	0.0	0.0	0.0	8.4	0.0	0.1	2.3	0.0	8.6	0.1	0.0	0.3	0.0	9.3	0.0	5.1	0.0	0.0	6.2	0.0	0.0	7.3	0.0	15.2	22.4	16.6	12.3	8.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.8	0.0	0.2	0.9	2.8	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	1.5	3.7	1.8	9.6	1.6	1.5	1.2	2.3	0.9	0.3	0.0	0.0	0.8	3.8	2.5	0.2	0.4	0.0	0.0	1.2	8.7	0.0	0.0	11.6	2.5	5.3	0.6	0.4	0.0	0.3	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	11.1	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	39.7	0.3	6.5	0.8	0.4	3.4	0.6	0.0	0.0	0.0	1.0
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 35.4"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 164.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	3.1	1.8	4.0	4.1	9.5	4.4	10.6	1.0	5.1	19.5	13.4	15.4	0.5	11.8	0.9	14.4	2.8	3.7	6.8	0.8	7.1	3.6	2.5	0.8	4.1	4.0	14.4	3.6	1.4	6.3	0.4	1.6	9.9	5.8	1.3	3.9	0.9	23.8	6.3	0.6	5.5	16.9	0.8	8.3	5.5	35.4	0.8	9.7	6.6	1.8	2.3	6.6	2.2	2.2	2.9	3.7	23.8	6.5	10.8	3.4	2.8	11.5	1.2	0.2	0.0	0.0	0.1	18.5	19.3	33.6	8.3	5.6	33.2	6.1	0.1	1.8	10.9	0.0	11.1	0.6	8.4	5.2	2.6	1.2	7.3	0.2	0.2	0.3	3.9	26.1	0.7	7.8	7.4	7.1	0.0	20.3	4.2	1.6	0.3	0.0	22.6	12.4	2.9	1.6	28.5	20.9	0.0	0.0	3.3	6.5	0.8	0.1	7.4	0.1	33.8	0.0	3.9	18.8	1.7	23.9	0.0	4.2	0.0	0.0	0.6	0.1	1.0	2.3	8.7	0.1	4.5	4.4	23.8	3.4	3.7	1.4	0.8	1.7	2.6	3.7	2.9	2.7	2.3	0.8	10.8	6.5	3.1	1.1	2.8	4.0	9.5	1.0	5.1	7.1	3.6	14.4	3.6	5.8	9.7	3.0	3.7	15.2	2.7	2.6	0.4	0.8	2.5	10.7	14.8	1.8	0.0	11.3	3.3	2.7	1.6	1.4	20.4	0.0	9.8	40.7	1.7	5.0	164.7	0.0	13.2	0.0	0.0	2.5	12.0	1.0	0.0	11.8	1.7	1.0	14.2	0.0	15.6	26.2	0.4	1.8	0.0	0.0	0.9	0.2	1.2	8.2	4.0	8.7	9.2	5.4
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.4	10.7	10.6	3.3	5.7	8.4	15.2	5.4	6.1	5.1	7.0	3.3	32.5	11.4	4.0	4.8	13.7	17.5	4.4	9.5	6.9	44.2	8.7	13.9	22.3	0.1	3.8	20.4	9.9	5.4	8.6	11.3	5.7	19.3	33.5	8.3	9.2	17.8	25.7	6.7	15.0	11.3	10.4	20.4	7.1	15.0	9.8	2.9	37.2	9.6	8.5	6.5	2.5	15.0	7.4	14.4	6.0	6.1	40.0	3.6	16.2	0.1	11.6	5.2	0.0	6.1	14.8	12.3	13.0	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8	6.0	29.4	4.7	7.8	1.5	36.4	5.9	12.7	14.7	30.7	19.2	2.0	0.9	0.0	12.2	1.8	6.9	70.2	0.0	43.4	2.9	6.6	85.7	23.1	0.0	9.6	9.5	21.9	8.0	21.3	3.1	8.6	8.8	8.5	8.2	125.7	7.5	33.8	50.7	4.9	8.6	23.6	12.9	6.8	2.3	4.4	1.0	0.7	4.4	37.4	15.7
GALR1	"GALNR, GALNR1"	ENSG00000166573	"Galanin receptor 1"	P47211	18	77250549-77277896	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.0"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"hypothalamus: 6.1"	"Low region specificity"	"Detected in many"			HPA074584			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074584: "	"unprognostic (1.65e-1)"				"unprognostic (1.56e-2)"	"unprognostic (2.85e-1)"			"unprognostic (3.00e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.34e-3)"	"unprognostic (7.33e-3)"	"unprognostic (9.49e-2)"	"unprognostic (2.18e-1)"		1.1	5.3	1.2	0.3	0.8	0.7	0.5	0.0	3.5	0.0	0.3			0.4	0.2	0.5	0.0	0.3	0.1	0.1	0.7	2.0	0.1	0.5	0.0	0.1	0.8		0.1	0.5	0.0	4.9	0.0		0.8	0.5		0.5	0.7	0.1	0.4	0.5	0.1	0.9	0.0	0.3	0.4			0.3		0.0	0.0	0.1	0.4	0.4	1.6	0.2	0.5	0.3	0.0	0.3	0.4	0.6	0.8	0.5	1.2	0.6	0.2	0.5	0.1	0.1	0.8	1.1	0.8	0.2	0.4	0.2	0.4	0.4	0.3	0.1	1.1	0.6	1.1	0.8	0.5	0.3	0.5	0.8	0.8	0.4	0.3	0.3	0.5	0.3	0.5	0.4	1.6	0.1	0.9	0.4	0.9	0.6	0.1	0.5	0.5	0.4	0.4	0.2	0.6	1.5	0.5	0.2	0.4	0.4	0.9	0.5	0.4	0.6	0.6	0.7	1.1	0.1	0.6	0.3	0.4	0.8	0.3	0.4	1.0	0.2	0.3	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.2	0.2	1.6	0.5	0.2	0.4	0.1	0.0											0.0	5.1	0.0	0.7	0.0	1.8	0.4	0.0	21.4	1.2	1.8	0.0	0.0	0.0	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.1	0.0	16.9	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6946.0"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.5	16.5	4.6	6.9	0.0	0.0	3.9	1.3	0.0	0.0	0.0	10.0	7.6	7.5	2.2	0.0	1.9	5.5	0.0	0.0	0.0	7.3	8.0	5.0	10.5	5.1	0.1	4.5	6.0	0.0	0.0	0.0	0.0	2.9	0.0	7.3	12.0	4.4	0.0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0.0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6.0	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1712.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	6946.0	23.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	25.8	0.2	30.4	13.5	0.1	0.0	0.0	0.0	0.0
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	16.6	18.9	15.2	19.5	19.9	34.7	22.4	11.0	16.5	14.6	20.9	12.4	15.5	17.0	24.3	14.8	26.6	17.2	17.8	11.6	14.2	13.3	15.6	20.0	13.7	17.2	15.5	17.1	20.2	24.1	15.7	19.1	24.8	13.8	17.3	21.0	14.5	23.3	17.5	13.8	25.4	16.3	19.0	18.1	18.8	15.1	27.7	16.3	29.5	17.3	27.6	22.4	15.5	15.5	11.3	9.3	7.4	9.3	9.5	10.7	4.3	15.9	18.5	12.7	17.2	6.8	9.7	11.0	16.6	9.0	13.7	11.1	28.8	20.2	38.8	10.9	12.5	14.6	7.6	23.3	16.5	22.8	11.5	22.9	23.2	16.7	31.5	16.5	49.5	12.2	8.8	17.3	16.9	12.1	9.6	16.6	17.9	55.2	11.9	16.8	34.0	30.6	34.2	20.7	25.2	22.4	20.7	20.8	14.4	18.0	22.4	18.7	19.2	10.4	27.2	14.7	10.1	9.6	14.8	14.4	13.7	19.2	10.1	21.1	15.1	24.5	48.0	9.8	24.3	14.8	7.4	5.9	3.3	9.7	9.3	10.3	11.3	9.2	9.8	9.3	10.0	10.7	9.9	1.0	9.5	8.0	9.2	9.6	4.3	15.2	19.9	11.0	16.5	14.2	13.3	15.5	17.1	13.8	16.3	3.0	13.4	29.0	25.3	51.4	11.1	12.3	15.3	34.8	30.7	15.7	13.7	56.9	21.6	40.4	1.1	23.2	12.3	46.7	46.3	54.6	20.3	18.3	18.5	18.7	31.5	4.8	17.9	17.8	12.3	3.6	20.4	16.5	16.9	10.8	34.7	25.7	41.7	24.6	17.7	33.6	8.6	6.5	18.6	42.1	37.3	52.4	73.5	17.0	40.4	30.3
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470484	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.5"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 48.3;Urothelial cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	11.1	8.7	9.7	2.9	10.9	8.0	6.0	17.6	11.1	6.0	7.2	19.5	0.3	6.5	4.2	3.4	11.0	4.8	4.9	8.9	11.8	5.8	15.3	12.5	5.2	1.3	16.3	10.1	4.4	43.5	1.9	5.1	4.8	13.2	4.3	6.3	3.0	11.2	5.1	7.7	13.9	7.8	4.6	12.9	3.1	12.7	6.7	16.4	0.0	3.5	3.1	2.9	9.3	9.1	1.9	5.0	2.6	1.0	3.1	1.4	0.0	1.0	1.6	1.7	0.3	4.7	3.3	4.8	0.3	0.0	0.0	0.0	0.3	2.6	3.0	2.5	0.2	2.0	3.4	2.6	5.0	0.0	1.0	1.6	0.0	3.0	1.0	2.4	0.3	0.2	3.9	12.2	0.2	21.2	0.2	0.2	1.8	0.1	0.6	1.8	2.5	0.8	0.1	1.9	7.9	0.9	1.2	6.9	5.3	6.1	18.0	5.7	14.9	3.9	5.1	0.2	2.2	1.0	2.6	0.2	1.2	1.4	0.0	0.5	2.1	0.2	0.7	1.9	0.0	1.4	0.0	1.0	0.2	0.5	0.1	0.2	0.3	0.8	0.5	0.1	1.9	1.0	1.4	2.6	3.1	0.1	5.0	0.1	0.0	9.7	10.9	17.6	11.1	11.8	5.8	16.3	10.1	13.2	16.4	8.9	35.2	0.0	30.5	0.0	31.8	0.0	7.6	8.1	15.9	24.4	3.9	15.6	1.7	9.4	10.1	0.0	6.3	0.0	11.4	2.0	0.3	48.3	3.5	7.7	1.6	39.7	3.5	0.6	3.7	2.5	1.7	0.9	0.0	1.0	10.2	41.9	10.3	7.0	4.9	20.9	7.0	0.0	0.0	1.4	2.5	0.0	28.0	0.0	8.3	68.5
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	4.2	8.4	11.4	2.5	13.5	0.4	6.4	33.3	19.6	9.1	3.6	12.9	3.8	3.0	10.6	6.6	7.0	8.5	5.8	16.3	7.5	9.6	3.4	3.0	3.8	2.0	7.8	10.7	6.6	3.5	15.7	3.1	2.3	12.9	9.0	3.1	4.3	7.0	6.4	2.2	4.3	2.7	10.1	7.2	2.4	2.9	4.0	9.4	0.0	8.6	1.5	2.1	7.9	4.8	0.5	3.8	0.0	0.5	0.0	1.3	0.2	0.8	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.5	0.3	1.7	1.8	0.6	0.0	1.6	0.1	0.6	0.9	3.2	0.0	0.3	0.0	1.3	0.0	2.7	1.8	0.8	0.7	0.3	0.1	2.5	0.0	0.0	2.3	1.2	2.8	1.3	1.0	0.1	0.9	0.0	0.6	0.7	7.8	2.6	0.1	1.9	5.6	3.0	3.9	2.0	6.1	1.3	4.4	0.5	1.0	1.5	0.0	0.0	0.3	1.8	0.0	0.6	3.9	3.7	1.9	0.8	0.9	0.8	0.0	0.5	0.0	1.2	0.1	0.3	0.2	0.1	1.3	0.5	0.5	0.8	0.0	0.0	0.0	0.0	3.8	0.6	0.2	11.4	13.5	33.3	19.6	7.5	9.6	7.8	10.7	12.9	9.4	0.0	0.0	0.0	1.8	2.4	11.8	6.2	5.1	0.0	3.4	3.5	0.0	0.5	1.7	0.3	1.4	1.0	0.5	0.0	0.6	0.1	3.7	3.3	0.0	1.8	0.7	1.6	1.2	1.3	1.8	0.4	6.9	0.6	1.7	0.0	0.9	5.7	0.6	0.9	3.2	1.1	0.9	0.0	1.7	1.4	3.9	1.8	0.2	0.0	0.8	0.8
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475970	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.1;intestine: 23.6"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 4.1;Fibroblasts: 1.8;Ito cells: 4.3;Late spermatids: 1.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HEL: 5.0;K-562: 7.9;SiHa: 3.5;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067583			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	1.9	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.4	15.9	0.0	5.2	14.8	3.8	1.7	0.3	9.1	22.1	6.8	0.0	0.0	3.3	0.7	1.6	0.0	0.0	0.0	3.1	0.0	0.3	0.6	0.6	0.0	11.3	0.0	1.0	0.4	0.8	0.1	0.3	23.6	18.3	0.2	0.1	10.3	16.8	0.0	0.0	1.2	0.0	0.0	14.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.6	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.3	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	3.5	0.0	0.0	1.6	8.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.3	0.0	0.0	4.3	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0"									"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	40.1	39.4	4.7	24.4	14.3	8.9	31.9	2.3	11.0	38.2	35.7	3.3	9.5	11.0	29.0	20.6	39.0	17.5	18.5	12.6	4.6	4.1	21.6	17.9	42.8	21.3	14.3	2.9	35.5	4.9	39.8	5.9	17.3	12.2	48.7	13.8	12.4	14.2	15.4	20.1	19.5	39.6	48.1	26.7	27.5	20.2	13.0	6.0	7.7	22.0	18.2	15.3	63.1	40.3	3.1	8.5	78.9	44.2	20.1	61.2	22.2	6.1	0.5	0.0	0.0	17.7	15.4	4.6	1.6	15.9	2.6	6.1	0.1	9.7	0.0	23.9	10.6	12.0	1.2	0.0	0.2	1.4	26.3	0.0	0.1	4.5	1.3	4.7	0.7	1.1	16.1	0.1	3.9	0.0	8.9	18.0	0.0	0.3	1.0	7.3	0.0	0.0	5.8	0.0	5.6	0.4	0.1	6.8	0.0	5.0	33.0	0.0	0.2	7.8	2.2	0.2	0.5	0.2	1.0	12.2	2.0	0.4	2.8	1.7	19.1	0.0	0.0	6.1	0.1	0.3	12.2	20.5	6.6	24.6	31.2	32.6	3.1	26.3	27.1	8.5	2.7	18.0	18.9	78.9	20.1	44.2	0.5	61.2	22.2	4.7	14.3	2.3	11.0	4.6	4.1	14.3	2.9	12.2	6.0	23.8	30.1	5.9	100.6	41.3	0.1	2.8	28.1	24.1	17.0	17.4	0.0	26.1	0.0	75.3	22.8	54.8	48.0	23.3	62.4	50.9	30.1	66.0	44.1	22.2	33.3	0.0	9.8	22.1	68.8	22.5	4.4	82.4	8.5	45.9	9.7	0.6	67.5	28.1	8.1	7.7	0.0	19.4	69.6	0.7	2.1	54.1	48.3	77.8	8.6	78.8
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108448561-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	10.9	10.6	12.0	15.2	21.6	20.5	13.1	5.0	16.8	11.9	13.6	3.9	26.7	13.4	10.9	32.0	9.5	12.4	13.2	8.0	9.3	5.8	12.8	8.3	14.2	13.0	7.8	15.6	17.6	13.1	11.5	24.3	8.6	15.0	14.6	13.6	4.3	14.9	32.3	9.6	9.3	18.1	8.4	11.4	11.7	18.1	15.5	10.5	11.1	13.8	6.1	10.0	16.3	11.3	14.3	17.6	20.3	8.8	7.9	23.0	4.5	7.6	5.8	7.7	2.7	5.7	13.6	13.4	10.6	12.6	4.0	6.7	11.3	9.4	8.9	12.7	7.3	9.0	6.3	4.3	7.5	8.6	10.8	7.5	12.1	9.9	7.5	6.2	15.6	8.9	14.4	7.1	10.6	8.9	7.7	7.0	7.0	15.4	7.3	7.6	4.7	6.5	8.1	12.3	3.7	7.7	6.6	9.0	8.4	4.7	12.7	8.0	9.1	11.9	8.8	9.1	7.4	4.4	5.1	12.0	8.3	12.5	7.9	4.1	9.7	16.9	10.7	9.3	4.0	5.1	20.1	5.2	13.7	15.4	4.6	14.9	14.3	16.9	16.0	4.0	13.6	23.0	19.7	20.3	7.9	8.8	17.6	12.3	4.5	12.0	21.6	5.0	16.8	9.3	5.8	7.8	15.6	15.0	10.5	140.0	86.0	63.4	57.6	21.2	153.9	76.3	66.2	305.1	113.7	99.5	131.6	36.7	43.1	92.4	48.8	52.5	110.3	0.0	71.8	48.3	34.8	87.9	78.7	28.8	32.2	66.7	82.1	52.2	44.7	34.5	66.2	49.5	32.1	88.4	140.1	60.4	93.5	112.2	77.8	56.4	118.6	51.8	39.6	164.6	90.6	15.3	54.3	109.0	68.0	89.7
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496842-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	16	"liver: 60.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 76.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA052227"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034098: AB_2247323, HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.2	2.0	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.3	0.4	0.0	3.9	0.5	0.1	0.0	0.2	60.9	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.5	3.1	0.9	0.2	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.8	2.6	1.2	1.7	0.9	0.7	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	12.7	0.5	19.4	0.8	0.1	0.4	0.3	1.0	0.5	0.1	2.2	6.2	0.0	0.0	0.2	0.2	0.1	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.1	3.8	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	2.6	1.2	0.3	0.6	1.0	0.6	0.8	0.4	0.4	0.1	2.4	0.9	0.8	2.1	1.7	0.3	0.8	0.1	0.7	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.3	0.4	0.0	0.0	9.0	0.0	0.0	0.3	0.0	76.9	0.1	0.0	0.0	1.3	1.9	2.8	0.3	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.6	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.4	0.0	0.0	1.5	0.0	0.3	0.1	0.0	1.4	0.0	0.4	5.7	0.0	0.0	0.0	2.6	0.2	26.6	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6											3.0	5.3	0.0	5.5	0.6	0.0	0.4	35.7	0.0	4.5	12.2	0.0	27.4	8.3	6.1	0.1	1.0	6.7	0.0	3.7	0.7	1.1	1.5	7.0	0.8	2.1	0.0	0.0	4.9	0.8	0.0	3.7	0.0	0.0	1.0	0.5	0.0	4.9	1.7	2.5	0.6	0.0	6.5	0.9	0.0	0.2	0.1	20.4	0.0	0.6	4.1
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37839686	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in single"	9	"Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Low region specificity"	"Detected in many"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	1.9	0.3	0.6	1.9	2.3	0.0	0.4	14.1	1.3	0.8	9.4	0.4	0.4	1.6	1.7	3.4	1.0	0.9	0.9	0.9	0.6	0.4	1.0	0.7	0.4	0.4	0.6	1.2	4.5	0.4	0.0	0.4	6.3	1.4	1.6	3.1	1.1	0.4	6.3	12.4	1.4	2.5	2.5	0.5	0.4	1.9	3.9	2.4	0.4	0.4	1.5	0.4	0.6	1.1	0.8	0.4	1.2	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	3.4	2.1	0.6	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.0	1.0	0.1	25.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.7	7.8	0.0	0.0	0.0	3.4	0.0	0.8	3.9	2.3	0.0	0.0	7.6	0.0	27.5	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.8	0.2	0.4	1.2	0.9	0.2	0.4	0.1	0.0	0.6	2.3	14.1	1.3	0.6	0.4	0.6	1.2	1.4	2.4	0.0	0.0	0.0	0.0	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.6	0.0	0.8	0.3	0.1	0.0	0.0	0.5
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: AB_2674753"	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	9.2	17.0	10.8	12.8	11.7	4.8	12.0	8.2	13.1	9.3	10.2	8.4	8.1	12.7	12.0	15.5	11.8	13.2	8.1	8.1	9.6	10.5	17.7	21.0	8.1	13.9	9.9	11.0	14.8	18.8	9.2	11.7	10.5	9.7	9.2	12.6	8.5	11.0	8.0	15.8	7.7	10.7	12.5	11.9	12.9	11.1	29.2	13.1	12.7	13.5	11.0	16.9	10.6	9.3	20.5	14.8	4.6	17.1	15.0	18.4	12.9	18.3	15.0	10.6	12.3	13.8	12.1	18.1	15.7	7.9	14.0	11.7	15.9	8.8	25.2	18.1	8.1	19.6	8.8	16.3	15.3	20.4	21.6	20.7	16.3	8.9	25.8	9.5	13.6	8.6	8.2	11.3	18.6	9.3	9.6	14.6	6.9	16.7	8.8	13.9	13.0	16.4	17.5	18.1	21.7	18.1	11.4	18.6	13.8	12.5	6.5	13.3	20.9	4.0	15.3	11.8	12.9	7.9	4.7	7.9	13.6	17.3	10.6	23.4	18.2	35.5	24.6	10.9	20.7	13.5	1.6	15.5	4.6	13.0	17.1	14.2	20.5	13.4	13.2	14.8	18.9	16.5	17.0	2.4	15.0	15.2	10.9	18.4	12.9	10.8	11.7	8.2	13.1	9.6	10.5	9.9	11.0	9.7	13.1	11.9	29.5	25.3	9.1	7.3	6.4	7.8	12.7	26.8	19.4	10.4	3.9	26.1	24.9	19.8	82.9	13.0	7.8	0.0	15.5	32.0	12.3	7.4	11.6	27.0	23.8	11.1	1.2	14.1	20.8	15.1	19.0	18.7	10.1	19.8	9.8	8.4	17.6	13.9	10.6	51.5	7.4	19.4	10.3	50.9	17.2	10.0	6.1	10.8	17.0	6.5
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091524	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052075: AB_2681718"	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (8.00e-4)"	9.7	10.6	8.9	13.0	12.2	18.3	12.3	22.1	19.0	8.1	13.6	10.0	8.2	18.9	10.0	8.7	18.5	9.0	9.6	13.3	9.8	9.7	12.4	20.2	10.3	21.6	10.0	9.0	8.5	24.1	6.1	20.4	12.9	12.8	11.9	13.2	12.7	16.8	9.5	20.7	14.7	16.5	9.7	6.9	24.3	17.4	5.3	10.5	12.8	12.5	14.7	17.1	13.1	11.7	28.4	22.9	15.2	14.3	29.6	32.0	18.9	20.6	27.5	16.2	19.8	12.4	12.9	12.5	16.0	11.7	24.5	27.3	16.7	13.3	20.8	11.0	13.7	13.6	13.0	23.4	19.0	14.8	16.6	30.4	22.9	12.6	21.7	17.4	18.2	13.7	19.3	15.6	13.6	9.9	12.6	23.8	12.6	23.9	21.8	9.5	30.6	17.4	19.0	15.2	31.8	14.3	21.0	7.5	26.9	18.5	15.3	16.1	11.3	12.5	27.1	14.0	13.7	18.3	19.6	12.8	9.1	17.3	5.9	20.9	22.7	33.4	33.1	14.6	18.5	14.6	10.7	14.3	15.2	32.0	11.5	30.2	28.4	23.6	29.4	20.1	23.7	18.3	23.8	7.9	29.6	8.3	22.9	19.8	18.9	8.9	12.2	22.1	19.0	9.8	9.7	10.0	9.0	12.8	10.5	17.9	8.9	32.5	8.8	16.1	5.3	8.4	15.3	1.4	10.3	3.5	0.0	31.5	18.3	34.5	1.1	9.8	16.8	0.0	29.3	47.6	11.6	8.3	3.5	17.9	30.0	1.6	12.7	15.4	21.9	2.4	13.3	14.3	11.8	82.0	18.3	7.7	35.1	20.3	6.0	21.2	3.2	6.5	7.1	4.3	8.8	20.7	21.6	21.7	24.0	11.1
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14008279-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (7.73e-5)"	13.4	13.5	14.5	12.9	17.0	12.0	19.9	12.3	20.0	16.5	13.9	24.0	27.3	9.0	21.5	16.9	13.2	22.8	16.4	15.5	14.8	14.0	16.7	12.9	14.5	16.0	16.6	14.7	28.9	22.2	18.7	27.4	10.3	21.0	13.1	11.9	16.8	24.7	30.2	7.6	15.7	10.0	17.1	23.3	12.5	13.6	8.2	12.7	14.6	21.3	7.9	13.2	12.7	13.0	11.3	15.4	0.8	6.9	9.9	15.2	7.5	6.3	6.4	7.5	1.8	12.2	18.7	3.7	6.0	6.7	5.2	3.6	3.3	11.0	14.8	14.2	4.9	6.0	8.5	4.6	10.4	5.0	7.9	9.5	3.8	4.7	7.4	7.1	9.0	8.0	15.0	17.2	9.0	15.7	16.0	11.2	11.4	6.6	13.1	7.8	8.5	9.1	14.2	8.1	7.5	3.7	13.9	5.2	26.3	8.7	6.3	7.4	20.5	6.4	11.9	7.0	17.2	16.3	9.0	8.5	3.8	2.2	11.1	2.4	8.9	4.4	9.3	8.8	5.5	2.2	0.6	6.7	0.2	9.4	6.4	11.6	11.3	15.2	8.9	12.2	9.8	13.1	9.8	0.8	9.9	6.9	15.4	8.4	7.5	14.5	17.0	12.3	20.0	14.8	14.0	16.6	14.7	21.0	12.7	6.0	6.2	8.5	10.4	6.8	3.1	5.0	7.6	13.4	13.6	8.7	0.0	12.2	16.6	18.2	14.8	7.7	3.9	0.0	10.4	14.3	8.3	6.0	5.8	5.9	9.6	9.5	3.4	4.3	4.8	0.8	9.5	5.5	1.7	8.2	9.9	6.0	11.9	5.8	8.1	30.7	5.6	0.0	8.0	4.4	5.3	8.3	7.0	6.4	10.3	7.1
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 71.0;bone marrow: 29.2"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 70.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"basophil: 31.2;eosinophil: 71.0"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 71.0"	"Group enriched"	"Detected in some"	5	"HEL: 55.6;HMC-1: 36.0;K-562: 17.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.2	0.0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0.0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0.0	0.1	0.0	0.1	0.2	0.0	0.1	1.2	0.0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1.0	0.2	3.3	0.3	4.0	0.0	1.0	0.2	0.0	0.5	0.4	0.2	0.0	0.3	71.0	2.7	0.1	0.1	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	7.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	55.6	0.1	0.0	0.0	0.0	36.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	31.2	0.0	71.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.1	2.7	0.1	0.0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	70.0	0.0	0.1	0.0	0.5	13.9	0.0	0.1	0.0	1.2	0.0	0.8	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.3	0.1
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
GFM2	"EFG2, FLJ21661"	ENSG00000164347	"G elongation factor mitochondrial 2"	Q969S9	5	74721204-74767371	"Predicted intracellular proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.7	23.8	14.7	8.7	22.4	12.1	13.1	14.2	24.8	10.7	12.8	12.7	17.8	8.3	12.3	16.8	13.0	21.6	8.7	29.5	18.5	15.6	21.9	30.8	9.1	10.3	13.8	18.1	11.6	12.9	19.8	24.9	12.9	20.4	12.5	15.3	11.6	15.7	11.2	26.4	10.5	10.3	10.4	11.7	10.3	16.3	13.7	10.4	18.0	12.3	12.8	14.2	12.3	12.6	8.3	6.1	17.1	9.8	15.6	7.4	4.6	19.4	16.6	14.0	26.6	10.7	14.5	14.3	21.4	13.0	21.9	23.4	18.2	12.7	20.1	22.9	11.3	34.4	16.3	28.2	29.9	28.5	17.7	16.6	11.9	16.8	12.4	13.6	11.6	13.1	16.3	13.4	17.3	20.8	15.6	14.8	19.9	19.9	16.8	24.8	10.9	16.0	7.1	5.8	7.2	15.1	20.1	22.9	22.9	16.0	12.4	23.7	12.8	24.7	19.0	21.1	15.9	16.5	20.2	11.8	8.4	14.4	10.6	13.5	9.8	18.7	20.4	12.8	16.6	12.8	17.1	6.3	8.0	6.6	6.5	6.4	8.3	5.4	7.2	6.1	7.0	7.4	7.2	3.3	15.6	9.8	4.0	6.2	4.6	14.7	22.4	14.2	24.8	18.5	15.6	13.8	18.1	20.4	10.4	11.9	11.7	3.9	6.5	5.4	9.7	10.0	5.1	69.6	6.8	7.0	5.9	15.7	18.3	8.3	5.7	5.8	7.8	23.3	4.6	13.5	5.0	5.3	2.3	19.6	8.4	15.9	5.2	6.7	9.8	1.4	6.6	5.5	8.5	25.2	8.9	12.0	7.6	8.6	7.1	8.4	8.0	0.0	5.2	15.4	9.5	6.0	13.4	4.6	9.0	6.5
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.2	9.3	19.2	9.5	7.1	11.0	7.8	10.1	14.6	15.0	12.9	8.6	15.8	7.3	9.0	7.8	11.8	9.6	9.0	12.4	9.4	11.8	4.0	8.1	18.3	7.2	6.5	7.8	5.9	10.4	19.3	5.8	7.2	21.0	16.2	8.2	3.1	8.1	19.9	10.6	7.8	12.6	5.6	8.3	17.0	5.5	12.2	8.9	13.3	19.1	11.2	19.3	6.5	5.9	5.7	9.9	4.3	16.1	11.4	11.4	10.1	7.7	8.0	11.3	17.2	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1	0.0	5.9	5.4	11.8	20.4	12.7	3.7	20.4	20.1	10.3	10.4	13.7	8.1	5.0	17.9	77.4	35.6	18.8	0.0	10.2	17.9	10.3	10.3	4.6	39.5	5.8	20.6	41.5	26.4	6.3	21.4	8.1	4.7	8.5	3.6	15.0	11.3	13.3	18.2	10.6	10.1	9.9	6.5	12.3	14.2	17.9	23.8	18.5	10.2	15.6	15.5
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273467	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Exocrine glandular cells: 12.1;Fibroblasts: 17.1;Hepatocytes: 38.6;Muller glia cells: 12.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.1;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;EFO-21: 18.2;fHDF/TERT166: 33.0;HBF TERT88: 25.0;MCF7: 21.8;U-251 MG: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		89000	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	24.0	4.3	6.3	9.5	13.8	0.3	26.8	0.8	8.4	12.5	14.9	1.8	5.9	2.2	6.7	23.4	11.1	12.7	11.5	6.4	4.8	6.7	7.0	21.9	3.2	7.4	9.5	2.7	10.0	7.3	2.2	3.9	0.3	2.9	12.1	4.8	3.4	5.4	6.6	7.5	6.8	7.2	9.8	3.4	5.8	7.8	5.3	1.9	2.6	2.6	10.7	8.1	10.5	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	0.0	0.0	0.0	0.0	2.9	0.1	17.1	29.9	0.0	0.0	0.0	18.2	33.0	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	4.3	0.0	1.5	0.0	3.6	0.0	0.0	2.2	21.8	2.7	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	13.8	0.8	4.6	4.8	6.7	9.5	2.7	2.9	1.9	0.0	0.0	0.9	0.0	5.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	12.1	0.0	17.1	0.1	5.8	38.6	0.0	0.0	5.8	0.0	1.0	8.3	7.5	0.0	5.0	0.0	0.0	12.1	0.2	0.0	0.0	1.1	0.3	0.0	8.6	0.1	0.4	4.0	0.0	0.0	0.0	0.1
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938119-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	14.0	14.1	23.0	15.4	18.7	35.5	21.5	20.7	23.5	20.8	18.6	14.3	21.0	15.1	18.2	19.5	55.9	23.0	19.0	15.9	17.4	10.9	15.6	29.6	15.2	24.2	15.5	22.9	30.6	30.0	22.2	15.7	15.1	14.7	17.8	16.1	17.7	21.2	17.7	19.7	34.0	17.1	19.8	14.1	19.6	20.1	22.4	17.2	23.6	20.6	26.0	24.6	22.8	28.7	9.3	9.8	16.0	10.4	12.9	15.0	8.3	15.7	10.1	15.1	13.6	12.5	9.8	14.8	8.8	7.4	25.3	11.5	48.5	15.4	19.8	15.2	11.4	10.4	18.3	13.8	18.3	15.4	5.2	6.8	18.4	13.1	23.2	9.8	21.4	15.6	10.8	20.4	10.9	12.7	9.2	12.3	13.2	14.1	8.6	8.7	22.1	25.4	19.1	15.2	26.3	15.1	20.2	28.4	11.8	9.3	22.3	15.7	12.9	20.8	20.5	12.8	11.7	28.5	20.7	12.3	15.2	19.1	11.9	11.9	9.1	10.4	20.6	10.2	10.5	9.6	5.8	10.4	16.0	11.7	8.7	13.7	8.4	12.3	13.0	9.8	9.3	13.6	15.0	15.2	12.9	8.1	7.4	10.6	8.3	23.0	18.7	20.7	23.5	17.4	10.9	15.5	22.9	14.7	17.2	17.9	27.2	31.3	42.8	45.8	21.3	25.4	43.3	17.4	20.5	38.4	5.9	83.9	34.9	39.5	12.5	33.3	40.2	46.7	35.2	85.8	31.3	46.5	26.5	68.6	45.9	15.9	43.3	38.6	41.2	13.8	30.5	33.4	23.6	50.5	43.5	27.0	35.3	31.6	39.6	32.0	15.2	12.9	28.3	38.7	59.5	69.8	131.2	40.8	49.4	46.5
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: AB_2684491"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	6.0	9.3	5.0	5.7	9.5	1.4	8.0	15.0	9.6	9.0	7.0	6.5	6.1	4.9	7.0	5.6	7.2	6.4	3.7	12.7	5.8	5.1	7.9	8.3	5.6	6.6	14.0	4.2	11.0	6.0	8.4	17.4	5.1	9.4	8.3	6.7	3.6	6.1	7.6	14.6	4.5	5.9	5.8	11.4	6.9	6.3	9.3	10.8	8.6	9.1	6.1	6.7	9.4	9.5	4.6	3.3	4.8	7.1	3.7	8.3	2.8	5.5	6.0	7.6	5.5	3.6	9.3	6.2	7.4	5.1	5.6	5.0	3.6	7.2	3.3	7.0	2.9	4.8	6.6	7.0	10.5	7.6	4.2	5.6	4.8	5.8	4.0	7.5	4.3	3.1	3.6	11.7	5.1	10.5	6.0	4.4	5.5	4.2	4.9	8.8	4.0	5.9	2.8	6.5	4.0	9.4	5.3	8.7	8.6	7.4	4.6	6.2	4.5	4.9	4.1	7.1	5.7	12.0	6.5	3.6	5.7	3.5	6.1	5.6	6.0	4.8	4.8	7.3	6.8	4.6	0.4	2.7	4.8	3.4	3.4	3.9	4.6	4.6	5.0	3.3	3.8	5.6	5.6	3.8	3.7	7.1	3.2	8.3	2.8	5.0	9.5	15.0	9.6	5.8	5.1	14.0	4.2	9.4	10.8	8.9	4.0	1.4	4.8	0.8	9.5	16.5	0.0	8.1	3.4	5.2	0.0	6.6	19.9	6.7	1.0	3.0	3.2	0.0	3.7	4.0	2.4	3.6	16.1	3.9	4.8	0.0	4.1	3.1	3.2	0.2	4.6	5.3	0.0	3.6	3.3	8.5	3.6	3.1	6.3	6.7	12.1	6.5	3.9	24.0	12.8	1.8	6.9	4.3	3.2	3.1
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 13.0;monocytes: 15.4;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.7	14.0	19.8	8.9	1.2	1.6	8.2	13.9	8.4	14.4	17.0	12.9	8.5	13.5	5.7	7.0	11.0	7.4	15.9	11.4	21.3	5.0	8.9	19.6	10.3	8.7	0.3	4.2	10.2	0.8	0.5	23.8	5.3	3.3	7.1	16.4	9.6	4.5	10.1	6.6	17.6	4.8	11.0	10.4	7.7	16.6	18.5	5.7	5.1	9.3	6.1	4.8	9.8	4.4	4.0	10.5	11.3	4.7	4.9	9.8	14.9	18.0	13.9	5.3	7.8	16.1	7.0	10.1	23.7	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6	0.0	1.4	13.0	2.6	2.5	5.0	0.8	0.0	0.0	1.2	8.7	2.0	6.2	0.0	1.3	0.5	0.7	0.4	0.0	1.6	10.0	2.6	1.1	1.1	0.5	4.0	0.0	3.4	1.3	1.9	0.0	1.1	4.0	0.0	15.4	2.3	1.9	1.5	0.0	2.1	0.8	1.8	0.0	1.4	7.7	11.5	1.0	4.9	4.9	3.3	0.8
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	6.4	17.0	0.8	3.2	0.9	0.0	4.0	0.4	1.0	2.6	27.0	0.3	0.2	19.6	5.4	4.5	5.7	1.4	8.1	3.1	0.5	0.5	21.3	10.4	3.2	2.2	0.5	0.3	3.7	24.7	3.3	2.5	1.6	1.3	2.1	7.8	1.5	6.9	1.0	1.8	2.7	64.0	1.4	0.6	22.7	3.0	2.2	0.4	0.1	1.5	4.9	1.4	2.5	5.1	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	5.2	0.0	0.8	0.0	0.4	0.9	4.1	2.7	1.2	0.0	0.4	0.0	4.9	0.0	0.0	2.7	0.1	0.0	0.6	0.0	18.3	1.0	0.0	0.0	0.8	0.0	2.9	0.1	0.0	19.3	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	1.0	0.6	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	0.5	0.5	0.5	0.3	1.3	0.4	0.0	2.2	1.3	2.0	11.4	0.4	2.6	25.5	12.0	3.4	8.7	2.0	5.2	28.2	9.6	1.7	13.7	48.7	0.0	29.0	1.9	1.6	0.5	0.0	39.9	10.0	0.0	2.9	11.1	0.6	0.5	1.1	0.2	0.0	1.8	34.6	0.0	18.0	31.7	0.0	149.4	0.5	0.0	1.3	0.5	0.2	19.1	1.4	0.5	50.7	5.6
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	11.0	2.8	4.0	2.7	8.3	15.9	6.9	3.7	2.6	4.1	2.6	4.2	6.1	8.0	3.3	3.5	4.5	4.7	4.6	3.5	5.4	2.8	4.4	5.2	6.6	3.1	4.5	5.9	6.9	6.5	3.1	2.7	3.6	2.6	2.3	9.2	4.5	4.9	7.3	7.1	5.2	4.9	2.6	7.4	3.2	4.9	4.3	2.9	4.2	6.9	3.9	2.9	10.2	10.8	3.3	2.5	15.0	3.9	2.5	3.2	2.7	7.1	4.0	5.1	4.9	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3	35.7	27.8	0.0	11.1	3.5	30.1	9.3	15.3	21.4	27.3	26.2	27.5	11.1	6.6	12.3	2.0	5.9	31.1	0.0	17.9	6.4	7.8	21.5	8.1	11.1	5.0	14.3	26.9	2.5	10.0	3.6	31.4	8.2	3.3	1.0	51.9	13.2	13.9	39.1	43.9	5.1	35.7	25.8	4.9	4.2	4.7	3.4	5.7	17.5	38.6	11.6
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 158.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	6.0	0.6	3.3	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.1	19.6	0.0	6.5	0.0	2.7	20.7	9.9	0.1	0.0	0.0	9.4	0.0	2.6	0.2	0.9	0.0	11.4	0.1	0.3	0.0	0.0	0.0	0.0	3.0	9.9	0.0	0.0	5.8	1.6	1.1	1.8	47.6	7.2	0.0	0.0	0.5	5.6	4.3	14.0	5.2	4.4	5.6	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0.0	2.6	0.0	4.2	1.9	6.1	1.0	2.5	8.1	3.4	0.0	39.3	0.2	0.0	2.0	1.7	0.6	9.7	0.0	2.1	0.9	1.5	7.6	0.0	0.0	0.2	4.8	8.6	0.0	0.0	4.9	1.1	0.0	5.0	0.0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0.0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.6	7.2	0.0	0.1	66.8	0.0	0.0	0.0	0.0	15.9	0.1	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.3	3.8	0.0	0.0	10.6	0.0	0.0	14.5	0.0	0.0	0.5	0.0	0.2	2.7	1.2	0.0	0.1	0.3	0.3	0.2	0.0	7.8	1.2	1.2	0.3	0.0	0.1	27.7	0.3	6.4	3.3	0.0	6.2	0.0	4.1	1.4	0.0	0.9	0.1	0.2	0.8	0.3	0.3	9.2	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8	0.0	0.0	4.3	0.0	0.0	0.3	0.6	7.6	0.0	0.0	29.6	0.0	59.4	5.0	0.0	8.8	0.0	0.0	0.0	0.2	35.6	0.0	0.0	0.0	126.2	6.1	0.0	0.0	3.1	2.1	9.0	0.3	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	29.3	0.2	0.0	0.3	4.4	5.0	0.0	38.4	0.5	0.0	0.0
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57460135-57472262	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"Leydig cells: 27.3;Peritubular cells: 40.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 12.2;BJ hTERT+: 7.8;NTERA-2: 7.9;RH-30: 35.9;U-266/70: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	3.2	1.7	4.0	2.1	2.5	0.6	2.1	8.2	4.4	14.4	3.5	0.0	3.0	3.7	12.8	8.3	0.7	4.7	8.3	2.7	2.9	1.9	3.2	1.8	2.0	1.3	1.5	2.0	4.7	1.0	0.1	1.2	0.6	3.3	5.6	4.9	9.6	2.9	4.3	3.1	2.4	3.7	3.8	2.8	1.2	2.4	6.2	2.5	0.6	3.3	3.4	1.4	4.8	4.6	0.9	0.4	5.2	0.2	0.1	0.5	0.1	0.0	5.6	1.7	12.2	0.2	0.0	0.2	0.7	7.8	1.3	1.4	0.2	0.4	1.9	0.0	0.3	1.4	1.0	1.0	0.7	0.2	2.1	0.1	0.0	0.6	0.1	1.3	0.3	0.6	0.5	0.2	1.3	0.4	2.5	0.2	1.2	0.4	4.1	0.6	0.0	0.4	0.2	7.9	0.4	0.5	0.6	35.9	0.8	1.5	0.0	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.1	0.0	1.4	4.5	0.4	0.2	10.0	0.4	3.2	1.2	0.8	2.2	2.2	0.2	0.9	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.4	0.4	0.3	5.2	0.1	0.1	0.4	0.5	0.1	4.0	2.5	8.2	4.4	2.9	1.9	1.5	2.0	3.3	2.5	0.0	0.0	0.5	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	27.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.3	1.0	0.0	12.9	0.5	0.3	0.8	0.5	0.1	0.0	0.0	0.1
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Group enriched"	"Detected in some"	4	"Leydig cells: 23.3;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	19.6	3.9	2.1	4.2	0.0	7.5	1.7	3.3	2.1	0.0	0.6	0.0	0.8	3.7	0.5	0.3	5.5	0.0	1.6	0.0	3.5	0.5	4.8	0.0	4.7	0.0	1.5	2.1	0.0	10.6	0.0	2.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.9	1.2	6.0	0.0	2.2	1.2	0.0	0.0	0.8	3.4	3.4	0.0	0.5	4.1	0.0	0.2	5.9	0.0	20.3	2.1	0.0	0.0	0.0	0.0	7.4	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	6.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	23.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	29.0	0.0	0.0	0.0	2.3	0.0	3.8	1.5	0.0	0.0	0.0	0.0
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	13.5	5.7	14.9	15.7	17.6	11.6	10.6	12.8	12.0	10.0	12.0	13.7	13.7	14.2	10.0	6.9	10.7	8.3	8.9	8.5	16.4	12.4	9.6	11.2	9.6	13.9	10.3	11.6	11.0	18.4	8.0	7.4	5.0	8.5	9.7	8.6	13.5	20.0	14.0	10.3	13.8	13.4	11.8	9.7	13.4	11.6	11.6	6.9	12.0	10.6	12.8	17.1	9.0	8.2	1.5	3.5	0.9	1.1	3.4	2.2	0.6	4.9	10.2	4.8	7.5	7.9	3.2	5.3	2.9	1.8	2.2	2.7	2.9	14.5	6.4	5.6	4.8	3.2	6.5	2.6	3.3	1.5	11.3	7.7	9.9	4.7	3.3	5.6	3.0	3.3	10.1	1.7	3.0	6.6	5.2	4.8	10.0	5.2	10.8	6.1	13.4	14.2	2.5	4.4	9.4	14.3	8.7	2.2	6.4	5.3	11.2	4.6	5.4	8.9	3.8	6.0	4.6	16.9	1.4	2.7	3.4	9.4	4.8	3.0	14.4	6.7	5.1	5.5	5.9	5.5	0.0	1.1	0.0	1.4	1.0	2.2	1.5	1.6	0.9	0.6	1.4	2.0	1.0	0.9	3.4	0.0	3.5	2.1	0.6	14.9	17.6	12.8	12.0	16.4	12.4	10.3	11.6	8.5	6.9	0.0	0.0	12.9	14.5	6.5	14.5	1.4	17.8	0.0	0.0	12.2	19.6	4.5	21.6	2.4	5.2	4.0	13.1	0.0	3.4	3.6	7.8	6.9	4.6	8.1	6.0	6.4	11.1	7.4	9.1	3.1	15.0	5.6	8.5	2.8	7.4	11.3	3.5	17.3	15.6	14.0	11.5	6.5	11.3	13.3	13.3	9.4	2.4	13.8	13.0	5.5
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.2	4.7	15.8	8.7	5.6	8.9	14.6	8.5	7.1	10.7	9.6	9.7	4.9	12.4	13.8	5.1	15.3	9.3	8.3	7.8	15.5	8.8	11.7	16.6	9.4	9.6	5.6	20.9	8.7	6.9	4.5	12.5	5.7	4.2	11.5	10.8	13.7	7.6	14.0	2.8	12.8	15.9	24.1	5.8	8.6	11.1	21.7	8.6	12.1	11.9	14.6	7.6	14.9	14.1	8.9	9.2	6.7	20.2	7.2	7.8	7.5	13.3	12.8	6.7	9.2	15.7	2.9	21.1	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7	8.9	8.8	10.0	10.8	7.9	25.7	7.5	5.1	1.4	4.5	12.2	96.2	13.1	1.7	5.2	1.5	6.8	2.0	0.0	4.5	9.1	10.4	6.7	8.1	2.0	7.2	25.4	10.3	4.9	2.4	1.0	11.5	5.3	8.5	4.6	4.2	13.3	4.5	2.9	7.4	6.8	128.0	6.5	8.1	13.0	28.1	7.9	13.2	20.1	3.9	6.3
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 789.5;Late spermatids: 1440.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	14.1	17.9	13.8	9.7	12.2	10.7	16.3	7.4	22.0	7.8	14.9	6.6	7.4	14.7	6.7	14.5	13.1	5.1	8.8	23.5	13.0	13.3	14.3	28.2	7.8	6.1	16.5	13.1	5.4	10.4	4.6	9.9	9.5	22.3	21.8	11.7	7.4	8.6	11.6	28.5	8.9	12.7	10.9	12.3	7.6	10.3	27.9	8.7	2.3	7.7	11.6	9.0	9.6	10.2	10.8	17.4	19.6	21.4	11.6	14.1	10.9	13.9	17.2	4.4	9.8	16.3	10.6	7.8	20.5	8.9	17.0	14.1	10.6	13.4	6.2	11.5	8.5	20.7	13.6	5.2	11.7	17.4	13.7	9.7	12.0	11.6	12.3	17.4	9.8	12.1	7.1	10.2	23.3	11.8	6.6	10.7	4.1	17.7	6.6	20.5	19.3	7.8	18.0	5.1	22.3	12.6	7.1	7.1	14.2	16.3	9.2	4.2	3.8	8.3	24.6	69.6	6.8	10.7	11.1	6.5	13.3	3.4	28.9	21.1	13.3	13.7	11.9	12.7	11.3	18.4	7.8	15.2	19.6	10.8	17.9	11.9	10.8	11.3	9.7	17.4	8.2	10.2	11.4	7.6	11.6	21.4	7.3	14.1	10.9	13.8	12.2	7.4	22.0	13.0	13.3	16.5	13.1	22.3	8.7	8.9	8.5	18.7	19.2	16.3	7.1	57.9	15.3	8.1	7.9	15.7	5.9	33.7	24.9	36.1	789.5	17.5	28.0	0.0	35.9	32.5	22.1	28.9	45.1	29.9	40.5	1.6	13.3	10.4	12.1	1440.5	16.1	26.5	25.3	24.4	19.0	6.6	33.9	28.1	17.0	53.0	11.2	6.5	24.5	10.8	26.4	17.3	20.7	13.8	20.9	15.9
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847342	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	24.1	33.2	39.1	29.4	37.4	27.5	22.5	26.3	44.8	24.8	32.6	31.0	32.8	30.7	30.0	20.6	32.1	33.9	26.1	28.3	29.8	24.8	39.0	30.5	24.5	27.6	27.0	33.1	22.2	27.4	53.4	34.7	24.1	37.1	30.4	32.3	28.5	29.9	29.4	41.6	24.3	29.9	30.1	27.3	30.7	33.9	17.4	26.0	27.6	29.6	17.2	30.0	35.3	22.7	7.6	8.3	22.2	14.5	5.2	7.5	5.5	13.1	14.7	24.3	15.1	21.4	17.2	23.3	24.9	18.6	19.1	16.4	20.7	23.5	21.5	23.8	22.9	15.7	14.6	30.4	20.9	17.3	34.9	18.3	22.1	17.7	14.5	12.1	35.7	41.2	16.3	16.6	18.0	13.3	18.4	24.2	20.3	37.0	18.6	20.7	21.4	29.0	19.8	28.8	19.8	11.1	37.5	19.1	26.4	23.5	19.8	29.7	15.1	27.0	25.3	11.5	27.9	28.4	37.8	26.8	13.1	14.7	59.1	15.5	15.5	21.6	45.0	9.4	17.8	26.8	6.3	10.9	5.7	7.5	9.8	6.5	5.1	4.9	7.1	7.3	7.6	5.2	4.6	22.2	5.2	14.5	8.3	4.9	5.5	39.1	37.4	26.3	44.8	29.8	24.8	27.0	33.1	37.1	26.0	35.7	45.5	25.1	16.3	16.9	31.8	36.2	30.6	93.7	46.6	29.6	27.5	23.2	56.3	20.8	7.9	26.3	37.1	0.0	16.8	26.4	21.1	25.4	30.1	47.3	28.0	42.9	44.5	25.8	38.6	8.0	22.5	29.5	20.3	44.1	38.4	22.8	24.2	37.4	15.2	42.9	40.9	19.4	16.9	20.9	24.5	21.1	29.9	17.5	33.2	17.0
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	9.3	8.2	7.4	9.0	9.8	29.8	8.4	13.5	11.5	8.7	10.5	7.7	6.9	9.6	10.6	6.1	10.0	11.0	9.5	7.4	8.1	6.2	7.7	9.3	8.7	11.5	6.0	6.5	11.5	17.6	9.6	9.5	14.5	7.2	9.9	5.1	9.8	16.0	7.5	10.1	10.0	11.0	10.3	7.1	12.1	8.8	18.8	5.7	24.7	18.0	9.5	10.4	9.2	13.8	3.0	2.6	4.4	5.6	1.9	4.5	2.2	10.8	6.6	8.1	7.0	4.0	3.7	10.8	7.5	4.8	12.1	6.4	20.5	8.1	8.6	7.9	6.5	8.8	15.5	6.3	11.1	5.4	4.6	7.1	6.6	9.7	9.8	5.3	6.3	11.1	5.2	10.6	7.8	9.8	5.1	5.3	11.0	9.8	6.3	4.2	11.6	15.4	13.9	5.8	12.9	10.7	16.8	8.3	7.9	5.0	9.6	12.2	10.0	13.6	12.0	7.8	3.9	14.7	10.4	6.6	13.4	7.3	7.9	8.3	12.0	9.8	13.7	8.0	5.9	8.6	0.0	1.9	3.2	4.5	2.6	4.3	2.1	4.0	3.9	2.1	3.0	4.5	3.9	4.4	1.9	5.6	2.6	2.7	2.2	7.4	9.8	13.5	11.5	8.1	6.2	6.0	6.5	7.2	5.7	3.0	6.4	2.2	10.1	5.4	5.1	2.8	7.6	1.4	4.5	3.5	0.0	3.7	1.7	3.9	18.0	4.7	5.1	0.0	4.6	5.3	3.0	11.1	2.3	5.7	3.8	7.9	9.2	4.3	2.8	5.1	3.7	2.6	1.7	1.0	7.9	1.7	5.0	7.0	5.3	3.0	4.7	6.5	3.7	14.9	9.7	4.6	9.6	4.3	5.3	10.3
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No		160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.2	10.6	14.3	9.3	16.6	23.5	13.1	10.9	19.4	15.3	19.6	12.4	7.3	12.3	9.9	15.9	9.8	12.8	15.8	23.6	21.9	11.6	11.6	9.7	6.6	45.2	15.6	15.8	15.2	22.0	16.9	8.1	16.8	21.4	24.8	17.7	5.6	11.6	15.4	17.2	15.7	14.2	11.1	13.6	13.8	11.9	9.7	10.1	21.1	15.2	10.1	14.4	7.8	17.2	14.6	15.2	14.9	12.7	12.7	7.3	5.8	9.5	7.9	25.9	24.8	8.1	6.0	12.1	7.0	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1	23.8	16.0	23.8	32.5	9.7	16.4	10.5	40.8	33.5	25.0	50.6	3.9	53.9	86.2	34.2	9.9	19.0	34.2	0.0	29.0	39.0	17.4	19.6	31.1	22.4	45.3	17.5	9.9	11.6	32.6	7.7	26.7	30.1	20.3	23.4	20.4	34.1	30.5	30.6	23.7	96.9	13.6	25.8	25.8	15.2	9.6	9.4	41.2	23.0	27.6	21.0
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11688956-11885685	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.7"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 82.7"	"Group enriched"	"Detected in some"	4	"basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	13	"basal ganglia: 183.9"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.2	1.5	17.8	3.0	82.7	0.7	4.2	2.7	18.1	8.0	3.7	3.2	3.3	1.6	6.7	2.4	8.2	4.1	4.6	2.2	7.1	7.6	4.2	1.3	2.5	5.1	6.6	5.3	3.2	1.3	1.0	20.7	2.9	8.8	9.9	3.7	2.1	4.6	18.1	18.3	7.0	2.0	9.9	3.3	1.8	2.1	6.2	11.3	0.9	8.0	1.4	5.7	9.5	7.7	0.4	0.2	1.7	0.2	0.5	4.2	1.4	0.5	6.1	7.4	0.5	0.6	0.1	0.8	0.1	0.2	0.5	0.0	6.5	1.1	18.4	1.2	0.1	4.2	0.3	6.9	5.9	0.0	3.8	6.3	0.1	18.8	3.7	0.0	0.2	0.4	0.9	8.8	0.0	0.1	0.3	0.0	0.2	1.6	0.2	0.2	0.2	0.2	0.5	6.1	5.0	0.1	0.1	1.0	0.2	0.4	0.2	6.9	0.1	8.6	0.4	2.1	1.8	0.2	0.2	1.0	0.7	9.7	0.3	1.8	0.3	0.1	0.1	0.3	0.2	0.2	1.1	0.2	0.4	4.2	0.1	0.1	0.4	0.5	2.9	0.0	0.3	0.2	2.2	1.7	0.5	0.1	0.2	0.1	1.4	17.8	82.7	2.7	12.7	7.1	7.6	6.6	5.3	8.8	11.3	3.0	5.1	0.0	10.1	9.4	6.7	3.4	0.0	13.4	7.9	3.5	15.7	0.4	1.7	0.4	3.6	4.4	1.4	0.0	2.7	2.8	5.6	4.9	5.7	1.3	0.9	3.2	0.0	0.6	0.3	2.2	0.9	1.3	13.5	0.0	0.2	0.9	1.2	2.0	2.8	3.8	3.1	6.5	13.9	1.9	5.3	6.6	0.5	1.3	1.2	12.9
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768909-132828858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	17.5	14.2	14.7	17.6	17.0	13.8	14.5	23.7	21.4	20.1	19.9	17.6	20.6	12.3	18.2	20.0	18.3	14.3	20.7	17.0	14.6	16.7	11.2	18.7	15.5	16.0	15.8	13.2	20.5	39.1	16.1	32.1	18.8	16.2	18.0	16.8	14.3	26.9	19.8	20.5	21.4	15.5	24.6	12.9	18.2	22.2	13.9	14.1	9.8	15.3	15.4	18.2	17.1	16.1	7.3	8.0	5.1	4.6	7.3	7.5	3.5	9.8	20.1	7.2	12.1	25.3	17.1	13.3	16.9	12.8	10.7	9.3	19.0	4.4	13.4	9.1	24.9	9.0	10.3	7.8	10.2	7.3	3.5	9.0	13.5	20.3	12.4	14.7	14.7	19.9	12.9	12.5	14.4	14.5	13.7	10.3	9.3	13.1	5.3	11.1	15.2	12.8	13.7	7.4	7.7	13.6	10.2	8.0	4.8	6.8	23.5	9.1	5.8	14.0	12.5	8.0	8.1	16.3	10.9	21.1	12.6	9.3	14.1	10.8	16.4	13.7	18.2	15.8	8.8	16.0	5.1	4.2	3.6	7.5	4.5	6.6	4.6	5.5	5.9	4.1	7.3	6.3	6.6	3.2	7.3	4.6	8.0	4.5	3.5	14.7	17.0	23.7	21.4	14.6	16.7	15.8	13.2	16.2	14.1	41.7	37.6	16.4	9.3	19.3	25.8	31.4	10.2	16.0	26.1	14.0	94.2	11.6	6.6	14.1	23.9	20.0	46.6	23.3	24.0	20.0	25.5	24.2	11.5	23.7	14.3	17.5	21.4	18.4	8.8	27.7	23.9	11.4	16.9	12.6	43.4	20.3	26.8	27.5	21.2	8.4	104.5	6.5	19.6	19.4	23.9	29.0	19.3	14.1	19.7	22.6
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	22.3	20.6	16.7	14.0	29.0	11.4	30.6	26.9	27.1	19.1	25.1	14.5	29.1	23.9	12.8	18.4	22.0	11.3	16.7	34.3	18.1	12.3	22.1	32.7	15.2	12.2	30.5	12.8	14.8	27.7	27.1	42.8	34.5	18.9	21.1	18.1	20.2	24.8	24.4	64.6	29.8	29.1	19.0	23.9	14.8	21.2	26.0	24.9	10.3	29.9	22.6	11.8	20.5	24.8	10.0	9.9	19.8	11.0	13.0	14.9	3.2	23.7	16.5	8.5	10.7	22.5	19.4	21.7	30.6	25.7	12.1	14.6	14.1	13.3	8.2	8.0	26.0	13.9	14.0	13.5	21.7	25.2	10.4	9.9	11.1	14.6	22.4	22.6	11.7	8.1	10.4	20.8	19.0	37.2	19.6	17.5	6.2	13.5	12.9	19.4	10.2	8.9	5.1	9.3	12.2	15.7	2.0	25.8	8.6	15.0	25.0	5.5	7.3	18.9	20.5	23.4	17.1	30.2	8.6	21.0	12.4	14.4	23.9	21.8	15.9	11.2	7.2	22.0	10.3	14.5	19.8	5.5	12.0	14.9	6.4	12.5	8.1	9.2	10.3	4.5	10.0	9.6	7.2	7.7	13.0	11.0	9.9	6.0	3.2	16.7	29.0	26.9	27.1	18.1	12.3	30.5	12.8	18.9	24.9	220.3	277.4	69.8	105.1	140.7	166.1	608.0	73.9	104.4	195.7	43.6	337.7	86.2	24.9	103.7	122.0	85.9	153.6	23.3	105.1	100.5	87.0	136.9	59.1	125.8	75.0	178.0	85.9	71.8	62.7	17.5	111.0	62.5	65.8	83.8	108.9	122.0	118.5	95.4	106.8	55.9	360.2	84.1	88.0	351.1	212.3	153.6	208.7	59.7	96.2	157.6
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	21.1	26.0	18.3	18.2	24.4	23.4	20.4	31.9	30.4	22.3	14.7	18.9	13.8	12.0	16.9	18.9	15.3	14.6	16.4	17.0	19.1	22.4	23.2	40.1	19.9	16.0	20.1	16.2	14.1	30.9	11.3	34.9	31.1	23.8	19.0	16.8	16.1	17.4	15.3	15.9	14.5	13.0	19.6	22.2	17.8	15.3	11.6	17.5	13.5	19.1	11.6	15.6	22.5	14.2	17.7	22.2	26.7	22.9	14.8	21.1	19.4	11.4	12.1	10.0	12.9	20.2	31.5	17.0	45.1	17.2	14.3	23.4	15.8	17.0	6.9	11.6	23.4	26.6	11.1	8.3	9.3	25.1	10.1	7.9	10.1	7.9	11.0	22.5	13.0	13.0	15.9	18.2	17.1	31.5	24.6	12.9	8.6	6.3	7.7	21.9	10.7	5.8	21.6	27.6	9.9	8.7	5.0	24.4	14.5	11.8	7.0	2.7	8.4	18.4	7.2	24.6	33.8	10.0	14.7	14.4	16.9	18.4	20.8	24.5	7.5	16.3	18.3	23.1	12.5	22.7	26.7	20.6	14.8	17.9	22.9	21.1	17.7	21.1	19.5	20.2	16.5	19.3	19.2	5.6	14.8	20.9	22.2	20.4	19.4	18.3	24.4	31.9	30.4	19.1	22.4	20.1	16.2	23.8	17.5	8.9	14.1	38.8	20.4	41.4	28.9	15.5	15.3	8.1	25.0	15.7	9.8	25.0	23.2	28.8	2.7	27.1	10.5	0.0	29.2	54.0	45.6	35.7	20.8	21.7	37.8	17.5	12.6	17.8	21.3	3.6	16.1	35.7	50.6	22.6	22.7	17.8	30.7	14.4	18.7	17.4	6.7	12.9	30.7	22.9	31.0	55.8	53.5	33.1	13.2	20.5
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749662-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	17.4	12.5	13.5	16.1	18.9	13.6	18.3	30.1	21.6	17.6	15.7	14.4	18.7	11.8	25.8	18.3	13.7	15.9	12.0	14.0	14.8	10.2	14.9	12.7	16.7	18.3	14.8	13.0	17.2	16.3	26.0	22.3	15.9	15.3	16.1	15.4	16.3	15.2	15.8	18.8	17.8	17.5	18.3	16.5	21.1	15.1	14.1	16.0	25.1	18.8	11.4	24.8	16.9	16.0	7.0	5.2	10.2	4.7	8.4	6.6	2.5	11.4	9.5	18.4	11.3	11.6	14.6	11.6	10.4	12.9	13.5	13.2	11.3	10.5	13.2	11.4	13.6	6.8	13.3	13.6	12.1	15.7	12.3	9.6	13.2	11.7	6.3	11.0	15.5	12.3	12.9	10.7	14.9	14.2	13.9	15.9	14.7	16.8	5.1	11.3	11.7	13.4	9.4	20.3	14.4	10.9	12.4	11.7	14.7	9.9	13.8	10.3	17.3	12.7	12.9	10.0	19.4	14.1	18.6	17.8	11.0	9.1	11.2	12.9	20.7	13.8	22.2	9.6	9.3	12.1	5.0	4.7	4.0	6.6	3.7	4.4	3.7	4.3	4.6	4.7	7.0	4.5	4.1	10.2	8.4	3.1	5.2	4.2	2.5	13.5	18.9	30.1	21.6	14.8	10.2	14.8	13.0	15.3	16.0	14.9	32.6	21.4	18.8	10.8	69.8	18.6	15.3	16.0	34.2	19.2	123.7	20.5	8.3	19.9	17.3	35.0	19.8	0.0	15.7	19.3	20.6	22.5	38.0	11.0	17.2	73.1	31.2	23.4	16.3	8.5	32.5	21.6	15.1	34.3	17.7	44.4	18.7	20.1	25.8	10.1	164.4	38.8	17.6	49.5	37.5	15.3	37.6	34.6	19.6	19.5
GON7	C14orf142	ENSG00000170270	"GON7, KEOPS complex subunit"	Q9BXV9	14	93202894-93207094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 174.0;Distal tubular cells: 58.0;Proximal tubular cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA051832	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli rim"		"HPA051832: AB_2681628"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favorable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	7.3	15.5	11.4	8.7	13.2	5.4	11.0	11.3	13.4	14.6	14.2	4.9	21.5	12.5	6.8	20.5	7.5	33.8	9.8	18.6	10.9	13.6	21.1	14.7	10.1	13.7	10.4	11.3	7.6	11.5	9.5	14.8	6.1	13.2	8.7	12.9	7.6	9.4	12.1	13.2	5.1	17.4	6.4	8.2	10.3	9.3	8.9	9.5	13.6	14.6	9.5	11.8	8.3	8.8	14.2	14.8	10.7	10.8	10.6	17.6	8.8	4.9	6.7	7.0	7.2	6.2	7.6	5.6	6.3	5.8	9.2	10.5	4.3	7.8	15.5	4.8	4.0	6.8	7.0	7.7	5.5	10.9	9.0	6.0	4.0	9.8	10.3	4.7	15.3	7.7	4.6	5.2	7.0	5.8	2.4	6.8	10.6	9.5	10.4	8.2	16.6	10.3	13.4	4.6	19.5	13.2	14.9	9.0	8.0	9.0	6.4	11.6	7.8	5.7	7.3	10.3	4.2	9.5	10.8	4.5	4.7	5.7	8.3	5.0	11.5	25.6	14.6	9.8	9.4	5.7	10.7	9.7	8.1	9.6	10.8	12.5	14.2	11.0	10.1	12.3	9.8	10.4	11.4	3.5	10.6	9.8	14.8	17.6	8.8	11.4	13.2	11.3	13.4	10.9	13.6	10.4	11.3	13.2	9.5	6.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	174.0	18.2	14.0	0.0	15.3	58.0	24.7	0.0	0.0	0.0	0.0	19.0	15.9	0.0	0.0	9.3	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	11.8	0.0	0.0	13.8	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 276.4;Late spermatids: 609.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499"	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	22.4	24.6	27.9	18.7	27.8	12.5	22.6	22.2	31.1	24.1	25.3	28.9	38.0	43.9	25.9	30.0	19.7	19.6	21.4	28.7	25.2	26.5	37.4	39.7	21.0	23.8	27.0	22.8	27.5	33.6	26.8	40.6	27.6	23.5	22.0	25.1	25.8	28.4	29.8	34.4	19.2	38.2	27.1	27.8	31.5	20.6	38.8	18.4	23.6	24.9	15.2	30.7	20.9	21.0	16.9	15.5	15.1	37.0	13.9	17.6	15.5	18.3	20.8	14.8	18.0	25.3	18.2	17.2	26.4	26.1	28.8	26.1	26.3	11.5	16.4	15.1	33.3	30.3	13.4	19.2	21.5	35.7	35.0	14.7	24.7	17.1	25.7	28.0	19.2	20.0	19.0	21.1	23.5	33.6	22.2	23.6	19.0	24.1	22.2	20.8	20.3	20.8	10.4	13.7	25.8	29.6	17.9	28.8	19.0	18.2	15.8	13.1	27.6	14.5	8.7	20.4	27.1	24.3	13.4	27.6	27.3	17.6	21.2	25.2	28.9	16.2	25.9	25.8	12.4	29.9	15.1	15.5	13.1	16.8	28.9	15.5	14.8	15.0	13.8	15.5	16.9	14.9	13.0	1.8	13.9	37.0	14.0	17.6	15.5	27.9	27.8	22.2	31.1	25.2	26.5	27.0	22.8	23.5	18.4	23.8	18.9	31.8	12.9	14.7	15.9	13.2	17.8	13.4	9.1	31.4	5.9	25.2	19.9	30.2	276.4	16.2	24.0	23.3	37.2	27.0	16.9	16.6	13.9	19.8	38.2	22.3	6.9	20.9	22.6	609.8	15.5	16.8	10.1	24.4	14.3	15.6	42.8	20.1	13.4	42.5	18.6	0.0	15.6	29.6	24.5	14.8	44.1	16.0	10.2	20.7
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 398.1;Distal tubular cells: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	17.2	9.6	11.3	28.6	8.7	7.5	32.0	14.2	26.1	24.7	27.1	21.7	14.1	16.9	4.9	11.9	21.0	21.7	25.8	18.7	27.4	5.8	11.0	6.4	12.3	28.2	46.5	18.3	11.0	11.9	20.2	21.0	57.1	16.8	12.0	11.2	16.5	26.5	15.8	15.6	9.8	13.8	7.2	27.0	13.4	10.7	10.8	17.6	43.2	9.5	4.9	7.2	10.7	15.2	52.9	17.4	29.0	6.3	5.5	6.3	14.1	6.8	16.2	18.9	22.3	17.3	16.6	9.6	8.4	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7	14.9	14.4	29.9	39.5	10.5	86.5	398.1	96.8	26.8	14.8	69.8	58.9	29.8	203.9	43.4	86.1	13.5	75.3	46.7	27.1	14.9	9.9	11.6	32.2	145.9	26.2	71.5	18.9	17.2	11.6	9.5	10.3	9.5	47.2	14.4	30.8	29.4	25.5	30.3	13.4	123.7	55.6	12.9	14.1	28.9	11.5	9.2	46.1	12.1	50.2	36.7
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038966, HPA058739"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: AB_2683804"	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	15.6	17.9	19.8	13.8	28.1	16.4	15.0	27.6	24.9	18.1	15.0	15.0	14.5	13.7	18.3	15.5	14.4	13.8	12.5	14.4	19.4	15.3	13.9	13.7	12.7	19.1	14.2	23.3	20.9	12.2	9.1	17.8	19.7	16.8	14.9	15.0	10.8	12.7	16.0	15.0	10.3	14.4	17.6	14.3	16.1	15.3	13.9	19.9	19.4	19.6	12.6	18.8	15.6	15.8	10.4	13.0	11.1	8.5	10.1	10.6	5.1	8.7	7.6	14.3	8.8	6.8	11.3	10.0	12.6	10.4	14.7	14.1	13.2	16.3	20.1	8.4	10.2	10.1	14.8	14.0	10.2	16.5	17.3	16.5	15.2	9.8	9.3	11.0	21.5	7.5	8.8	7.3	9.6	8.7	8.9	11.7	15.1	13.1	4.4	10.8	9.8	20.4	14.9	9.8	21.4	7.1	20.0	11.8	8.5	8.2	8.8	5.8	10.0	10.7	6.3	8.1	10.4	6.6	17.2	13.4	7.9	5.7	9.3	9.5	6.0	7.4	20.2	8.5	13.3	10.2	2.6	8.5	11.1	9.0	7.1	7.6	8.7	9.5	7.6	10.7	10.4	10.6	9.6	4.0	10.1	6.5	13.0	7.8	5.1	19.8	28.1	27.6	24.9	19.4	15.3	14.2	23.3	16.8	19.9	29.8	22.7	5.7	13.2	6.4	23.5	13.2	15.3	32.1	29.6	22.7	17.7	25.3	19.9	11.4	3.8	17.3	7.4	0.0	11.5	10.3	16.4	9.8	20.8	15.3	13.1	22.3	17.2	14.7	14.8	2.0	24.7	11.7	11.8	4.6	10.7	22.5	10.0	10.5	25.1	16.1	24.3	25.8	13.2	44.4	20.4	8.2	15.2	13.8	12.5	11.6
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	15.3	12.4	15.5	14.6	20.6	40.1	14.3	17.9	22.4	12.8	14.1	18.1	9.0	10.5	17.0	12.9	14.8	12.3	16.0	20.6	11.2	9.3	12.2	11.2	16.2	14.5	14.3	12.7	16.2	12.4	14.0	20.2	14.1	16.7	14.4	13.9	17.9	13.4	13.8	18.2	13.9	14.0	19.1	12.2	13.0	12.8	19.7	14.4	18.1	14.4	8.7	16.2	15.5	15.0	8.7	10.6	11.5	10.9	7.6	8.1	5.1	12.3	16.4	12.9	10.6	7.8	13.6	10.9	14.7	10.4	14.6	14.2	10.9	20.9	15.0	8.8	11.2	11.7	14.9	15.8	9.8	25.4	16.6	9.0	13.6	16.5	7.0	10.0	8.9	19.3	12.4	9.3	12.2	15.9	11.1	14.6	12.8	13.6	21.0	12.7	20.5	11.9	11.9	16.6	7.4	11.9	13.5	16.1	7.6	10.1	25.2	10.7	13.8	16.7	14.8	8.4	14.1	17.2	14.3	16.1	18.7	10.9	10.4	11.1	21.0	19.8	19.4	15.0	12.4	19.1	6.9	10.9	11.5	5.7	9.3	4.8	8.7	3.1	8.1	10.6	6.8	6.7	4.8	8.3	7.6	6.7	8.2	6.4	5.1	15.5	20.6	17.9	22.4	11.2	9.3	14.3	12.7	16.7	14.4	14.9	15.6	16.6	30.0	20.7	94.4	44.7	17.8	22.7	23.9	17.4	98.2	13.6	3.3	16.8	141.6	25.3	21.3	0.0	11.4	9.6	27.5	39.6	42.7	11.3	21.8	149.4	45.9	26.4	38.7	102.9	23.0	38.6	21.9	26.2	16.2	55.2	22.1	31.6	35.3	9.2	132.1	25.8	33.0	51.4	25.3	23.8	14.5	30.2	17.9	37.0
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900466	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	11.7	14.5	13.1	10.2	13.6	31.8	13.0	19.5	20.9	9.4	11.7	15.8	11.8	13.0	11.8	14.5	11.6	10.3	12.0	9.6	11.6	10.9	10.9	14.8	10.5	12.4	12.6	10.8	11.8	11.8	12.0	10.1	13.3	13.6	10.3	10.1	10.1	10.4	10.5	21.5	16.0	11.7	10.4	12.1	15.4	12.0	17.2	16.2	16.9	10.1	10.5	11.7	10.5	12.2	12.4	17.4	22.4	16.8	8.1	16.0	12.8	8.9	7.4	7.0	11.1	6.7	6.5	9.5	7.0	8.0	14.1	12.3	9.8	10.7	8.3	7.8	6.9	7.4	9.4	11.6	12.9	7.4	9.3	17.5	16.0	16.2	20.8	9.5	11.1	11.2	10.0	12.0	14.1	7.5	6.1	9.1	11.3	18.8	11.0	5.8	8.2	9.4	21.6	16.3	10.4	11.2	12.0	9.9	13.2	7.1	4.9	9.2	11.3	13.6	12.0	20.9	7.9	10.6	11.6	9.3	9.1	10.5	12.2	7.9	14.2	19.4	11.0	8.2	16.0	7.9	22.4	16.8	19.7	16.0	13.7	12.9	12.4	13.3	14.0	17.4	12.1	14.0	13.2	7.1	8.1	15.8	13.3	11.4	12.8	13.1	13.6	19.5	20.9	11.6	10.9	12.6	10.8	13.6	16.2	3.0	4.6	13.4	4.8	8.7	5.6	3.1	2.5	2.7	2.3	0.0	11.8	13.7	5.0	9.3	0.6	6.8	9.9	0.0	10.7	8.1	6.2	3.7	5.7	5.1	9.5	4.8	10.9	8.0	7.6	1.0	4.9	7.3	8.5	18.0	4.7	5.6	8.3	7.0	6.7	6.7	4.8	6.5	7.1	8.9	22.9	8.5	25.2	10.2	5.2	4.2
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.7	10.0	14.4	9.2	7.1	13.0	21.3	8.5	16.7	9.8	24.2	13.0	41.4	17.7	14.9	10.8	12.0	22.7	18.8	18.5	12.3	22.5	24.7	23.2	18.5	8.3	55.1	16.0	8.0	15.9	31.6	28.0	4.7	11.7	13.5	40.4	10.4	13.5	32.0	22.6	13.3	43.8	29.9	25.0	22.6	17.1	28.7	11.5	20.4	15.8	23.8	20.4	44.9	13.1	11.4	14.7	26.8	17.8	15.9	21.7	16.5	38.1	19.1	21.0	53.4	14.4	28.6	24.0	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2	29.8	34.7	41.0	38.8	65.5	7.1	24.8	28.1	16.0	40.9	15.7	7.9	31.9	21.6	38.5	7.6	30.2	8.5	23.3	48.9	40.5	22.6	43.6	56.6	37.8	33.7	7.9	35.5	14.7	10.7	7.4	24.7	22.6	21.9	19.8	19.7	4.3	44.1	14.0	25.1	25.9	5.9	32.3	59.0	37.1	39.9	54.7	12.9	29.7	28.3	36.6
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	47.7	1.8	2.0	0.3	5.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	16.4	0.2	0.0	0.0	27.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	25.0	0.0	0.7	0.1	4.3	0.0	63.0	1.8	0.0	0.3	0.2	0.0	0.0	57.9	0.7	0.7	0.0	4.9	5.8	0.0	3.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4	47.6	20.3	0.0	3.3	1.3	0.0	3.4	5.1	9.4	9.1	22.7	0.0	0.3	3.3	6.4	0.4	0.6	2.9	0.0	10.9	33.8	6.9	1.1	0.0	0.0	2.5	0.0	2.4	0.0	0.8	0.9	2.0	2.4	1.7	1.8	9.3	0.8	12.6	3.5	0.4	34.9	0.0	0.0	14.4	1.2	21.2	0.4	2.6	0.0	10.2	0.6
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Cell type enriched"	"Detected in some"	23	"Distal tubular cells: 54.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"CACO-2: 31.4;HeLa: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	18.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6	0.0	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.1	54.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	21.0	21.6	24.2	16.6	26.8	12.5	23.7	28.1	28.0	25.0	24.0	35.9	20.5	13.3	24.0	19.1	22.5	26.2	20.9	20.6	22.3	26.6	24.4	22.9	23.0	17.4	29.5	23.1	21.8	26.6	34.4	21.6	40.7	29.9	28.4	26.3	29.3	23.0	24.4	20.5	25.6	15.4	26.7	28.8	17.2	18.9	23.9	22.9	17.3	40.0	15.4	19.7	19.4	17.3	2.0	3.4	6.3	6.3	1.4	2.4	2.3	12.7	18.7	17.9	14.1	19.2	20.4	17.9	20.4	23.0	17.3	17.3	17.9	17.4	7.1	15.1	22.5	20.3	32.2	13.7	12.6	14.9	11.0	9.2	7.5	23.0	10.2	18.6	15.6	11.0	17.0	19.7	17.2	17.4	19.7	15.9	8.6	10.6	7.1	14.8	15.7	8.3	6.3	12.0	26.0	14.2	7.9	26.3	11.2	14.5	17.8	6.3	13.8	26.7	19.0	14.4	16.3	33.3	8.2	18.7	22.0	11.8	17.9	15.4	4.5	15.0	6.8	19.6	7.5	20.7	2.8	5.7	3.4	1.5	6.1	2.1	1.8	1.6	1.7	3.4	2.0	1.0	2.4	6.3	1.4	6.3	2.1	1.5	2.3	24.2	26.8	28.1	27.6	22.3	26.6	29.5	23.1	29.9	22.9	23.8	17.1	3.9	4.2	5.7	15.8	20.6	25.5	13.4	12.5	15.7	37.3	11.3	0.0	11.0	5.3	9.0	11.9	0.0	15.2	14.5	12.6	12.8	5.8	11.5	13.2	17.5	9.2	24.5	18.1	4.9	17.5	8.3	13.5	13.6	17.2	12.0	17.7	10.5	18.0	6.1	15.2	0.0	8.9	11.7	9.5	9.5	22.3	6.5	13.2	7.3
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0.0	5.9	6.5	5.1	5.4	24.0	1.0	0.0	3.3	8.9	9.6	18.4	3.7	5.8	3.0	2.3	4.8	2.2	3.0	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2.0	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6.0	1.8	6.7	0.0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0.0	0.0	0.0	2.8	0.0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8	3.0	0.6	0.0	5.0	1.9	1.7	2.0	0.0	1.4	1.2	0.0	0.0	0.4	0.0	3.6	0.4	6.3	0.0	0.0	7.2	0.2	6.3	4.6	0.0	0.0	0.7	149.4	0.0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0.0	15.9	0.0	1.5	19.4	12.2	0.0	0.7	1.3	0.3	0.0	2.3	2.3
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell type enhanced"	"Detected in some"	23	"granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.4	0.1	1.1	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.3	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4	0.0	3.2	2.7	0.2	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.3	1.7	0.1	35.9	0.0	198.9	0.0	1.2	3.1	113.1	0.6	0.9	46.2	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	19.4	0.0	0.0	0.1	0.9	2.1	1.7	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Predicted intracellular proteins"			"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	3.7	12.2	13.8	1.5	22.6	0.2	6.1	16.9	30.0	7.7	3.7	3.4	1.7	1.3	13.8	7.4	3.3	8.8	4.0	10.9	15.8	22.3	8.1	5.2	3.9	1.2	8.7	22.5	24.8	7.1	13.3	11.5	2.8	18.7	10.2	2.5	3.6	6.6	9.8	5.2	4.4	1.8	8.3	7.2	3.0	2.2	3.6	4.1	0.8	12.0	1.3	1.3	3.6	3.8	0.4	1.6	0.0	0.6	2.1	4.7	1.2	0.5	5.1	13.7	10.5	4.3	5.2	1.0	7.8	7.0	6.7	13.1	1.7	2.4	0.0	2.7	8.0	3.4	1.8	16.3	4.2	8.5	0.0	6.3	0.7	1.5	0.4	3.1	1.2	1.0	5.4	4.5	7.5	0.3	7.9	4.7	1.3	1.9	0.5	8.1	2.4	3.6	0.5	6.8	1.6	7.1	4.7	2.2	0.0	4.2	1.9	3.0	9.4	7.8	1.6	1.0	4.4	4.4	2.7	4.2	4.8	10.0	9.6	7.4	0.2	0.3	0.0	6.4	0.8	2.6	0.0	0.4	0.0	0.9	0.6	0.8	0.4	1.1	1.3	0.8	0.4	4.7	1.9	0.0	2.1	0.2	1.6	1.6	1.2	13.8	22.6	16.9	30.0	15.8	22.3	8.7	22.5	18.7	4.1	0.0	1.0	0.0	5.3	2.1	16.1	14.9	10.2	0.0	4.5	5.2	2.0	5.0	8.3	1.3	0.4	4.3	0.2	0.0	0.8	0.6	4.9	3.2	0.0	7.3	0.8	15.9	2.9	8.0	1.6	0.8	11.2	0.3	0.0	0.0	1.3	10.0	1.5	1.9	11.7	7.7	6.4	6.5	4.1	4.4	4.3	2.6	1.8	0.0	1.1	0.5
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 75.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	12.1	0.1	0.0	12.6	0.2	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	5.7	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2	0.0	19.9	3.7	0.7	1.0	9.4	14.6	5.1	1.4	9.1	3.5	0.0	0.1	1.7	1.1	0.1	3.6	9.6	0.0	8.2	0.0	2.3	0.2	7.0	0.0	18.9	25.4	75.7	2.5	26.9	0.0	0.3	31.5	1.7	5.4	25.1	0.8	1.7	5.8	1.1	1.8	10.3	77.6	8.2	0.1	0.1	0.9	0.2	34.6	21.8	0.3
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	27.1	50.8	18.9	24.7	13.4	12.9	26.8	18.3	14.7	29.1	24.1	44.4	17.0	13.5	16.5	18.3	21.2	20.7	18.0	23.4	9.9	8.9	64.3	22.8	28.5	49.2	22.3	24.8	22.1	18.5	17.2	25.7	15.4	11.7	30.3	23.4	21.3	15.6	16.1	53.7	42.2	28.2	24.0	26.2	38.0	26.0	26.0	21.9	17.9	28.4	32.5	50.9	18.6	34.5	27.0	15.1	39.1	22.5	17.2	29.1	34.5	22.4	29.3	28.7	12.0	14.2	22.7	16.0	26.1	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2	11.9	21.9	21.6	19.7	22.2	28.4	50.0	28.1	32.1	18.2	19.2	23.6	60.9	51.4	48.6	24.6	27.5	66.9	23.3	60.4	58.8	33.4	21.0	24.3	47.8	53.5	46.1	39.6	30.7	32.4	58.5	27.9	36.5	32.1	45.9	33.5	36.5	43.4	45.6	29.7	84.8	24.9	6.5	35.6	48.3	48.5	26.2	45.2	25.8	42.2	17.0
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 32.2;Cone photoreceptor cells: 21.6;Muller glia cells: 33.2;Rod photoreceptor cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	7.8	10.2	15.2	5.6	8.3	5.6	4.2	38.6	23.0	10.5	5.3	12.8	4.8	4.7	13.4	10.1	2.6	7.1	8.3	25.5	8.8	11.6	5.5	1.8	13.8	3.2	8.8	14.2	16.4	28.1	4.4	6.6	8.8	10.5	12.7	2.2	20.4	7.7	8.6	2.8	12.0	4.6	9.0	9.1	8.0	6.1	12.0	9.9	2.8	3.9	3.7	2.0	5.0	8.2	0.4	0.7	0.0	2.0	0.0	2.1	0.3	1.7	2.8	6.7	11.7	3.9	6.7	5.6	19.3	8.1	5.5	3.0	5.6	1.8	0.0	8.2	11.7	4.6	1.3	1.0	4.0	1.2	15.2	11.4	2.2	9.1	1.0	16.5	0.1	2.8	10.9	2.7	5.0	2.9	6.8	5.5	2.7	5.8	0.1	3.6	6.3	1.0	2.1	7.1	0.6	10.2	36.1	12.1	5.6	1.5	1.3	16.4	20.4	3.6	0.4	6.0	2.7	8.1	3.8	8.9	10.2	8.1	11.8	3.9	3.5	0.1	0.0	6.1	0.0	9.6	0.0	0.3	0.0	0.7	2.0	0.8	0.0	1.2	0.1	0.7	0.4	0.5	0.3	0.0	0.0	0.0	0.0	2.1	0.3	15.2	8.3	38.6	18.8	8.8	11.6	8.8	14.2	10.5	9.9	3.0	3.5	0.0	2.1	3.8	32.2	9.7	0.0	0.0	0.0	0.0	21.6	0.4	10.0	2.6	0.5	3.6	0.0	0.0	1.6	0.7	8.4	3.9	5.7	0.0	1.0	9.5	1.7	5.5	0.8	1.1	9.8	1.8	8.5	0.0	0.0	33.2	5.9	0.0	8.9	0.0	40.9	0.0	4.7	0.0	1.7	2.9	0.2	0.0	0.0	2.4
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"OE19: 309.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Not detected"	"Not detected"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	71.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.4	0.0	0.1	19.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	309.4	0.0	0.0	0.0	0.0	0.0	47.5	21.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	11.8	173.3	8.9	0.1	0.4	484.1	2.7	2.3	22.7	0.0	0.1	10.0	152.1	13.5	0.5	203.5	0.0	233.6	0.1	0.4	34.2	13.8	821.3	0.0	0.0	110.6	14.1	19.9	38.7	0.9	0.3	0.0	5.4	410.2	0.0	220.5	261.9	0.0	18.9	0.6	0.0	1.0	0.5	0.0	8.4	0.0	6.9	621.9	833.9
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492812-164621848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 17.7"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 77.9;Hepatocytes: 35.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;HUVEC TERT2: 10.8;RPTEC TERT1: 8.9;TIME: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	1.6	2.9	1.0	1.2	1.5	0.0	6.0	0.7	3.6	0.8	1.2	0.0	1.1	1.2	0.6	7.5	1.7	0.5	0.3	10.8	5.7	1.1	8.3	17.7	0.7	0.1	0.9	2.0	2.4	6.0	0.0	1.8	2.2	1.4	0.8	0.4	1.2	1.0	0.5	3.2	0.5	0.8	0.6	0.6	0.6	1.1	3.1	0.4	0.0	5.5	3.0	0.1	0.6	1.1	0.0	0.0	0.4	0.1	0.0	0.0	3.0	0.9	5.7	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.6	0.0	3.5	0.0	1.0	0.4	0.9	1.6	0.4	0.0	4.9	0.0	0.3	1.4	0.1	0.0	0.0	0.4	1.0	2.1	0.0	1.9	10.8	0.0	0.0	0.1	1.7	2.3	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.1	8.9	0.4	3.4	0.4	0.0	0.3	0.0	1.1	0.6	0.0	13.5	0.2	1.5	0.0	0.1	0.5	0.1	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.0	1.0	1.5	0.7	3.6	5.7	1.1	0.9	2.0	1.4	0.4	0.0	4.8	0.0	0.3	0.1	0.1	16.1	15.3	0.0	0.0	15.7	0.0	0.1	77.9	7.2	1.3	0.8	0.0	0.0	2.9	0.1	0.2	0.5	0.0	35.1	0.0	0.0	0.0	1.8	0.6	2.1	8.6	0.1	18.6	1.0	2.7	0.1	6.3	0.0	16.3	12.2	0.8	12.9	0.0	0.7	2.1	0.0	0.1	0.0	0.2	0.1
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		1900000	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	29.0	29.2	36.1	48.2	40.3	56.3	23.6	42.2	41.6	18.5	27.8	28.2	19.1	29.2	28.3	19.4	27.0	22.1	22.5	32.2	34.7	33.9	24.9	32.2	33.7	54.8	30.9	29.2	21.8	16.7	21.8	21.8	33.1	26.9	21.4	27.9	21.8	21.2	25.6	27.8	18.6	30.5	30.6	42.6	56.7	22.8	10.8	27.1	45.8	20.4	15.6	53.1	29.8	19.2	24.7	25.0	64.9	42.8	12.0	13.4	20.7	25.3	22.1	15.2	18.3	16.9	15.8	34.7	26.8	21.8	28.3	27.2	19.0	17.1	33.1	15.9	24.4	23.4	15.2	21.9	19.3	29.3	16.3	20.1	35.5	14.6	27.6	15.2	40.8	69.4	14.6	20.2	29.5	14.7	16.3	33.9	31.9	23.9	23.0	20.5	31.6	47.8	39.5	10.5	24.6	22.6	28.6	32.6	24.0	21.5	18.9	18.4	26.6	22.7	22.1	28.3	28.3	24.4	66.0	21.5	27.1	20.6	21.5	27.3	42.3	32.5	53.3	20.9	32.0	19.4	25.1	32.1	38.5	13.4	38.4	11.7	23.7	12.1	13.2	25.0	24.7	12.7	12.0	64.9	12.0	42.8	16.7	13.2	20.7	36.1	40.3	42.2	41.6	34.7	33.9	30.9	29.2	26.9	27.1	56.6	54.7	133.3	29.5	41.8	36.1	52.5	45.9	71.0	58.0	15.7	29.5	59.8	44.7	59.4	2.0	57.8	58.2	23.3	55.2	288.5	37.3	45.6	117.1	36.3	231.5	33.4	40.2	41.7	166.3	4.0	23.3	221.8	43.9	209.2	41.2	45.1	62.3	69.1	39.3	55.3	47.2	6.5	46.7	17.7	47.0	39.1	72.9	66.3	37.4	100.3
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.3;skin 1: 34.4"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 4.8;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.8"	"Group enriched"	"Detected in some"	4	"BEWO: 66.4;SK-BR-3: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	1.7	0.6	1.5	0.2	2.4	2.8	15.9	2.0	1.6	10.2	0.9	0.2	10.8	0.3	0.9	3.8	40.3	0.7	1.0	1.6	1.9	1.2	2.5	4.9	2.3	0.2	0.7	1.4	0.5	1.5	12.9	2.6	31.0	0.8	6.1	0.2	1.8	17.5	9.7	0.9	34.4	0.7	5.1	0.6	0.6	1.3	1.6	0.4	0.4	2.8	22.3	25.3	6.7	16.9	0.1	0.2	4.8	0.2	0.5	0.6	4.5	3.2	0.0	0.4	0.9	0.1	0.1	66.4	0.3	0.4	0.2	0.3	0.2	2.3	0.4	0.1	0.0	0.4	2.0	4.0	0.4	0.9	0.9	1.8	0.1	0.6	1.2	0.0	0.2	0.3	0.1	1.7	1.9	0.0	0.0	0.3	0.7	0.6	1.2	0.0	4.2	0.6	0.5	0.2	1.0	0.7	0.2	0.3	0.5	0.4	12.6	0.7	0.5	0.6	34.9	0.8	5.7	4.2	0.1	0.3	0.2	0.8	1.0	0.4	0.8	0.5	0.4	0.2	0.5	0.5	0.0	0.2	4.8	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.6	4.5	1.5	2.4	2.0	1.6	1.9	1.2	0.7	1.4	0.8	0.4	3.0	7.2	0.0	18.6	35.5	20.9	1.2	0.0	6.7	29.6	19.2	58.9	48.9	0.0	2.8	6.0	3.1	0.5	0.0	8.0	69.0	6.1	30.1	10.3	5.7	6.7	11.1	3.4	3.1	1.3	2.1	0.0	2.7	20.3	1.0	0.6	1.7	4.8	0.0	0.4	1.7	11.8	0.0	6.1	5.1	5.3	115.9	154.4	1.3	0.4	97.4
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 748.4;Proximal tubular cells: 664.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.9	46.2	26.2	23.9	24.1	26.8	26.5	25.6	34.0	35.0	38.1	17.4	13.9	30.7	15.1	30.0	26.2	14.5	15.0	33.4	20.9	41.0	18.8	18.0	43.0	30.9	38.1	17.1	18.7	31.9	29.4	20.2	26.1	29.6	30.3	21.0	32.9	12.7	30.7	24.5	16.6	17.6	15.9	29.2	20.1	16.4	19.2	17.0	46.6	18.2	10.9	19.6	22.0	42.1	23.9	24.7	23.7	22.1	32.9	19.2	30.9	13.3	22.1	10.1	7.7	20.5	27.3	9.9	28.1	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7	53.6	20.9	43.5	39.7	38.5	33.3	86.0	219.1	29.4	26.1	48.8	19.6	128.8	210.5	67.4	10.2	41.4	82.6	46.7	77.8	76.0	63.3	42.0	49.6	748.4	97.6	22.3	59.7	76.1	83.4	10.4	69.0	49.3	75.9	86.6	59.5	85.7	64.8	60.5	92.6	664.7	23.4	77.6	62.6	17.5	16.2	49.2	74.4	37.9	71.9	35.2
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.0	8.9	0.1	0.0	24.4	0.0	0.1	4.0	0.0	7.0	15.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5	0.0	0.0	0.0	0.1	0.3	21.4	2.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.0	0.0	17.5	0.0	0.0	0.0	2.2	0.9	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.4	0.0	20.6	0.0	0.9	3.8	1.5	0.4	0.0	0.0	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	1.9	5.8	1.9	4.1	0.5	8.5	0.6	1.8	1.8	3.2	3.0	3.3	10.6	0.1	0.1	5.2	0.1	5.8	4.3	5.5	20.4	3.8	4.9	0.6	6.7	0.1	15.8	8.3	1.0	3.0	1.3	2.3	0.3	0.3	33.6	0.5	0.0	2.1	2.6	11.3	1.1	4.1	5.7	0.0	5.1	9.3	1.8	0.0	3.1	13.7	18.5	1.0	0.0	4.4	5.6	1.6	6.3	0.1	0.0	12.0	0.1	2.3	1.2	4.2	8.3	7.8	5.6	1.8	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7	14.9	44.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	30.7	0.0	0.0	1.5	1.7	7.0	0.0	0.0	0.0	0.0	1.6	22.7	0.0	0.0	17.4	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	47.7	0.0	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 103.0"									"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	4.0	0.0	1.3	13.3	2.0	1.3	2.8	4.8	1.7	2.1	33.1	1.4	2.0	25.2	1.3	1.7	1.3	1.3	14.4	1.3	1.3	0.6	2.2	17.1	2.4	3.5	1.3	1.3	2.0	2.8	0.0	1.3	1.8	1.3	3.5	22.4	1.3	1.3	2.7	1.3	2.8	71.3	3.9	1.3	4.7	18.1	1.4	1.5	1.6	2.9	1.3	2.8	4.1	4.5	0.8	0.0	1.8	0.0	0.1	2.8	0.4	0.4	0.3	0.6	0.1	1.5	1.0	0.6	0.4	0.2	0.1	0.4	0.3	12.2	0.6	0.5	0.3	0.2	1.6	0.3	0.3	0.9	2.5	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.6	2.0	0.5	0.7	1.0	0.2	2.0	0.2	0.7	0.1	0.1	0.6	1.3	0.1	3.9	0.4	0.6	0.2	0.9	0.0	0.4	0.2	0.3	0.1	103.0	0.3	3.1	0.5	0.4	0.3	0.4	0.7	1.1	0.2	2.2	1.9	0.6	0.1	0.4	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.8	2.8	1.4	0.0	0.0	2.6	0.6	0.7	0.1	0.0	0.0	0.4	0.4	1.3	2.0	4.8	1.7	1.3	0.6	1.3	1.3	1.3	1.5	3.0	11.8	4.2	1.2	1.6	2.1	2.4	12.7	2.7	4.5	5.2	3.9	1.2	0.0	1.6	4.4	1.4	65.9	0.0	7.0	0.6	1.4	1.5	1.1	8.1	0.3	1.6	5.8	0.0	1.9	3.3	1.1	1.1	3.3	1.8	26.1	2.0	7.3	57.5	1.8	0.0	2.3	0.0	2.1	0.5	1.1	3.0	0.2	2.5	15.0	5.0
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.9"	"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;K-562: 48.4;T-47d: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	15.8	11.1	4.9	18.2	6.6	17.3	21.4	18.0	9.5	13.5	14.9	2.9	14.6	9.7	11.0	11.7	11.6	10.9	16.1	18.7	3.8	5.8	11.1	10.1	23.5	6.5	3.8	5.7	17.8	28.0	34.4	26.9	81.9	3.7	8.7	7.2	18.2	17.7	25.2	22.5	13.3	14.8	8.8	4.2	12.1	13.2	10.4	2.1	59.0	14.9	12.0	17.4	10.2	16.9	3.5	2.5	4.5	6.0	1.9	3.2	1.1	4.5	8.2	5.5	13.8	3.5	3.2	43.6	6.2	4.3	3.5	1.3	7.0	6.3	2.7	7.5	7.0	3.1	4.3	8.7	2.3	1.8	5.0	7.3	19.8	7.7	8.6	4.6	9.1	11.3	6.1	5.7	3.7	1.8	3.6	0.9	16.1	48.4	0.5	1.1	30.7	32.6	8.0	9.6	5.0	2.4	21.5	1.8	6.9	3.2	1.7	35.9	24.9	12.2	22.9	1.1	5.2	49.9	22.8	1.5	7.2	9.0	1.9	1.6	7.5	4.5	15.9	4.1	5.8	6.3	4.0	1.6	4.5	3.2	2.9	3.1	3.5	1.2	2.0	2.5	3.4	0.6	2.4	1.3	1.9	6.0	0.0	0.0	1.1	4.9	6.6	18.0	9.5	3.8	5.8	3.8	5.7	3.7	2.1	62.5	65.7	11.5	7.5	12.5	61.9	31.4	33.1	24.1	29.6	36.6	137.4	45.4	1.7	14.3	3.8	19.0	19.6	46.7	10.5	65.7	18.6	12.3	41.7	26.7	11.0	33.4	57.4	15.4	8.9	4.7	43.7	13.5	10.1	3.6	60.0	5.2	16.5	17.3	57.7	4.4	61.6	6.5	7.1	1.8	17.8	26.2	152.4	17.0	22.4	10.5
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 123.8"	"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.7	21.8	16.9	28.8	23.7	45.3	7.3	41.5	73.7	27.6	30.0	27.3	34.0	28.3	18.0	27.5	35.2	18.3	11.0	36.8	29.1	14.1	26.4	20.9	15.5	59.6	42.5	26.7	35.1	34.3	15.7	40.0	48.3	39.3	52.7	26.5	42.9	17.7	57.7	17.3	20.7	37.6	15.6	34.4	15.2	15.3	11.1	11.9	40.9	20.4	8.4	10.5	13.4	9.6	123.8	29.8	10.5	21.5	48.6	32.7	17.1	50.8	36.9	0.3	0.4	0.2	61.3	46.5	12.9	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2	71.5	58.2	98.7	286.1	83.2	26.3	290.4	244.5	58.9	78.5	96.0	19.6	399.2	281.8	289.2	13.5	118.6	130.2	70.0	215.9	135.5	154.5	94.2	142.1	611.8	643.1	22.3	99.4	338.8	323.0	12.0	106.2	397.5	119.8	265.1	129.8	50.2	258.3	117.9	106.1	410.6	24.7	148.8	123.7	5.4	2.6	68.8	92.8	101.2	167.3	176.7
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.3	0.0	22.6	0.5	0.6	0.9	3.2	1.8	4.6	4.8	9.7	0.0	0.0	5.1	7.9	12.0	9.5	0.0	10.0	2.1	0.0	0.8	0.3	12.7	1.5	33.3	0.0	3.6	13.7	1.6	13.2	2.7	13.3	3.7	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.3	4.8	0.0	16.8	0.0	10.2	0.0	0.4	9.5	3.1	0.0	23.0	0.0	25.5	0.3	12.3	3.8	2.6	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											3.0	2.2	0.0	8.7	0.0	3.5	0.1	2.5	0.0	2.3	0.0	0.0	1.2	24.9	7.2	0.4	1.6	0.0	23.3	7.9	3.6	0.1	7.9	1.1	27.7	8.3	0.0	1.2	15.4	4.0	1.3	9.2	0.2	0.0	5.4	0.4	19.5	4.7	0.0	26.9	3.8	2.6	6.5	0.3	0.5	0.4	0.0	1.5	0.0	0.0	2.3
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	16.9	14.9	18.2	15.7	23.3	8.7	17.1	32.6	23.4	15.7	12.9	17.7	12.7	12.2	16.0	20.1	17.9	12.5	13.1	12.7	17.0	17.8	15.3	18.4	11.6	18.9	16.2	17.0	17.6	14.7	21.0	20.6	24.5	19.9	14.8	14.7	14.0	14.5	13.1	20.3	14.7	12.4	16.2	18.5	17.2	13.4	23.9	16.7	36.3	30.4	11.3	18.5	15.9	15.0	1.3	3.2	9.3	3.9	1.5	2.3	0.8	10.7	10.7	22.6	15.1	12.9	10.9	8.2	12.9	13.4	12.0	10.8	15.9	10.9	17.5	10.6	10.8	8.8	8.1	15.5	9.8	21.3	14.8	4.6	16.0	12.4	9.5	12.7	11.2	16.5	10.0	7.6	16.4	21.5	12.5	12.1	14.4	9.7	24.2	15.3	17.9	28.4	6.6	12.2	8.2	10.4	15.3	19.8	10.8	8.0	22.0	21.4	12.6	30.6	12.5	13.7	11.4	18.7	9.5	15.2	12.2	9.3	16.8	13.5	19.5	20.8	18.2	9.7	13.0	19.2	9.3	1.2	2.1	2.3	0.9	2.0	1.3	2.1	1.3	0.7	1.2	1.9	2.1	2.0	1.5	3.9	3.2	1.1	0.8	18.2	23.3	32.6	23.4	17.0	17.8	16.2	17.0	19.9	16.7	17.9	12.8	11.5	8.0	16.0	22.8	23.4	2.5	6.7	14.8	22.7	33.4	12.6	1.7	9.6	55.2	18.0	15.4	0.0	11.2	10.7	13.2	14.4	30.0	23.7	14.5	38.1	17.9	17.8	25.7	4.9	11.8	19.2	10.1	28.9	16.5	23.4	10.4	14.1	12.7	12.6	15.2	25.8	15.6	25.1	26.2	21.3	21.7	16.0	10.9	8.0
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852932-88891944	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	23.7	27.0	22.2	27.1	29.8	54.9	30.2	25.7	30.0	24.2	21.9	12.5	19.2	18.8	23.4	32.9	26.4	23.0	24.6	16.0	22.0	21.7	23.7	34.8	22.8	30.6	24.3	17.9	28.2	23.8	21.6	25.9	30.2	23.8	19.2	24.7	13.8	24.9	20.8	21.6	26.4	29.3	21.6	20.6	30.0	22.5	15.2	23.5	44.4	27.6	24.0	30.8	22.6	22.7	28.6	31.6	51.1	28.2	25.8	34.4	23.8	19.7	7.4	19.0	9.4	28.9	20.3	23.0	16.7	22.2	25.1	26.8	9.8	13.7	22.9	19.1	15.7	30.0	11.9	20.2	17.9	22.1	22.6	18.9	24.1	12.3	16.4	18.8	27.8	14.8	17.8	18.3	22.0	12.8	18.7	13.2	22.8	21.5	19.8	26.3	7.0	28.3	25.3	14.6	19.1	16.3	18.1	23.4	17.4	26.7	22.1	14.4	12.6	15.9	19.9	29.2	18.2	8.5	27.6	11.7	10.7	13.1	18.6	20.0	19.4	13.4	30.4	7.1	23.6	9.0	37.9	25.5	39.3	25.6	28.2	29.1	28.6	28.5	27.2	31.6	24.2	34.4	29.5	51.1	25.8	28.1	21.3	34.2	23.8	22.2	29.8	25.7	30.0	22.0	21.7	24.3	17.9	23.8	23.5	6.0	30.1	29.7	68.6	41.1	13.1	8.1	12.7	40.2	23.9	10.4	2.0	67.5	33.2	42.9	11.6	26.6	28.2	23.3	34.0	50.4	30.8	22.8	48.4	15.3	36.1	17.5	19.4	13.5	28.9	5.6	33.6	39.2	27.0	35.1	21.2	24.1	41.2	59.6	27.6	32.3	17.3	12.9	41.6	21.4	28.5	43.7	125.5	54.6	17.7	77.4
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658251	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	19.0	21.9	11.4	16.2	17.0	7.5	26.7	21.2	13.1	16.4	19.1	10.7	15.1	16.8	17.7	15.8	20.0	12.3	11.7	12.7	11.1	10.9	14.7	21.1	13.4	20.3	11.6	12.2	24.2	44.6	14.1	22.5	14.5	11.9	14.2	14.4	12.1	12.6	13.8	9.9	14.8	26.2	16.3	11.6	17.2	20.9	31.0	11.7	21.4	17.2	10.6	22.0	16.9	27.5	16.4	8.0	5.6	4.2	8.7	7.9	2.6	21.7	17.6	12.2	12.8	32.9	29.4	9.2	23.6	21.4	19.4	24.8	10.5	15.6	28.1	20.1	21.0	28.1	15.4	20.0	22.0	25.9	12.5	11.8	14.0	12.3	24.9	32.0	6.7	12.4	21.5	29.2	20.8	21.2	19.4	26.7	21.0	26.9	17.3	30.4	14.7	32.8	16.9	13.7	26.3	21.2	17.3	13.2	14.0	21.0	14.9	9.4	12.2	13.1	8.8	18.4	16.8	8.5	8.3	20.3	12.8	13.3	10.8	16.0	17.7	24.0	30.4	20.2	11.6	16.9	3.0	4.2	5.6	3.9	3.3	4.2	16.4	6.0	7.9	7.2	9.3	5.9	5.9	2.2	8.7	3.3	8.0	6.7	2.6	11.4	17.0	21.2	13.1	11.1	10.9	11.6	12.2	11.9	11.7	0.0	9.6	39.5	36.7	42.6	8.9	7.8	17.8	21.4	11.4	14.0	9.8	36.2	16.6	26.8	61.8	21.5	30.5	0.0	29.1	39.9	29.8	60.5	11.5	25.6	31.1	4.8	12.7	27.6	20.2	43.8	36.5	28.3	20.3	76.7	19.8	7.3	37.7	23.2	66.4	35.1	13.8	25.8	30.9	56.0	82.0	40.7	51.9	30.9	21.8	88.4
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 199.3;Late spermatids: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.3	28.3	20.6	32.7	13.9	22.6	16.3	27.0	25.3	33.7	32.2	29.6	15.2	23.4	38.0	17.7	24.2	35.0	19.3	17.1	16.6	35.7	24.6	32.5	21.1	26.3	24.2	37.6	26.4	23.7	22.9	24.0	18.4	28.6	19.8	23.2	39.6	31.8	18.6	26.7	37.3	21.4	37.3	17.8	36.1	34.6	22.8	29.9	18.8	22.0	25.3	34.8	27.9	21.4	29.8	13.0	27.2	30.0	28.0	26.5	22.3	45.7	38.0	56.5	63.4	25.3	33.0	39.5	29.6	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1	44.7	44.6	45.7	42.2	21.6	25.9	26.2	20.4	115.1	78.5	24.4	7.9	38.5	18.3	42.3	199.3	33.5	64.5	23.3	44.2	36.6	30.1	27.3	60.3	23.7	51.8	23.8	29.2	52.8	50.9	301.8	41.1	31.9	32.1	62.3	38.4	32.6	42.6	35.9	46.7	29.3	28.8	32.3	43.2	51.5	36.8	18.3	45.2	56.5	40.9	36.7
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120515-45284909	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	15.1	24.7	23.5	21.1	23.6	22.5	20.9	12.0	21.0	16.3	21.8	14.8	18.5	14.9	16.8	23.4	21.8	12.0	15.9	27.5	21.4	21.1	18.3	16.0	15.1	17.5	22.9	19.0	17.3	14.6	16.5	27.5	23.9	18.2	16.7	21.2	18.2	20.8	20.2	32.0	31.5	12.9	28.2	19.5	17.8	15.2	22.2	24.2	22.6	19.2	27.7	19.9	20.5	19.0	15.4	16.3	24.9	15.3	16.1	12.9	8.5	15.5	5.8	11.1	8.2	6.8	10.1	9.2	17.2	11.3	17.5	17.2	9.8	24.5	15.7	9.7	12.5	17.1	17.4	16.6	13.8	25.7	11.8	14.4	18.5	7.8	12.8	10.9	20.5	10.6	8.4	21.2	13.1	22.2	19.9	11.2	12.3	13.1	5.9	47.1	8.7	15.0	23.6	13.2	25.1	14.4	14.1	8.4	9.0	38.2	5.5	5.9	9.9	8.7	8.6	14.3	10.9	7.0	16.8	8.8	14.8	12.6	11.7	29.3	3.8	5.2	15.7	17.2	13.2	15.4	12.0	14.2	24.9	9.7	14.1	11.5	15.3	11.3	11.5	16.3	15.4	12.9	12.6	19.8	16.1	15.3	12.7	12.3	8.5	23.5	23.6	12.0	21.0	21.4	21.1	22.9	19.0	18.2	24.2	38.7	28.0	38.3	76.6	66.6	18.2	68.7	10.2	33.5	33.0	10.4	3.9	28.1	41.4	45.9	94.3	28.4	21.3	23.3	28.9	40.9	31.4	27.4	39.2	17.8	42.4	7.9	27.1	12.3	27.1	62.8	22.5	37.1	72.6	31.5	24.5	34.7	38.8	25.9	29.7	30.5	18.5	6.5	27.8	59.2	80.1	63.6	28.3	27.1	37.6	64.0
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.4	2.4	3.0	8.0	19.2	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.4	33.4	0.1	0.3	7.1	19.2	5.4	22.6	18.3	4.0	4.7	6.8	0.0	8.7	11.8	1.2	8.2	10.3	11.3	6.1	12.6	7.5	8.7	14.8	6.5	10.6	14.5	9.8	17.8	8.7	6.8	10.6	9.3	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7	8.9	8.0	0.0	9.4	7.0	29.7	7.2	7.6	10.7	4.5	8.7	31.4	0.9	10.0	6.4	0.5	2.7	3.3	0.0	8.1	1.4	4.6	16.3	2.3	2.6	2.2	20.6	4.1	1.8	2.4	0.0	3.7	4.0	6.8	1.0	4.0	5.6	8.5	2.9	5.3	12.4	38.9	0.0	4.6	0.0	5.1	5.8	2.4	0.0	6.8	14.2
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"gdT-cell: 20.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	13.6	18.4	19.4	12.1	25.9	17.3	10.6	25.3	31.2	17.3	12.8	21.0	18.8	11.0	19.0	12.0	39.3	19.9	16.5	23.7	15.8	16.2	16.9	13.2	14.1	13.5	14.3	19.1	20.7	24.0	33.8	33.2	13.5	15.8	35.4	12.4	22.3	15.3	16.9	29.5	41.5	11.7	19.3	12.8	14.2	15.7	24.4	17.1	25.2	35.8	18.8	21.0	12.3	20.7	1.9	4.2	2.1	2.1	7.8	20.6	3.6	12.9	28.5	21.0	24.5	18.9	15.3	11.9	14.1	15.9	19.6	16.8	21.3	12.2	14.2	20.8	17.2	15.0	14.5	26.6	17.9	16.2	6.4	25.5	11.8	24.1	30.4	10.6	13.4	15.7	18.7	13.7	24.0	10.7	13.2	19.4	16.5	14.5	11.7	15.4	31.8	14.9	16.2	28.2	7.0	13.6	27.9	26.0	14.6	12.3	13.6	26.6	17.8	14.2	12.1	8.7	17.6	21.7	10.2	20.5	19.8	12.0	12.4	14.4	12.5	11.3	14.5	8.2	15.0	14.5	1.0	2.1	2.1	20.6	1.9	15.2	1.9	2.4	10.3	2.7	1.6	2.5	6.7	1.6	7.8	2.0	4.2	2.5	3.6	19.4	25.9	25.3	31.2	15.8	16.2	14.3	19.1	15.8	17.1	17.9	22.9	5.6	6.3	16.4	42.3	23.4	10.2	25.4	15.9	12.2	88.4	6.4	5.0	10.2	2.0	12.8	10.9	0.0	9.9	3.8	13.3	16.1	18.5	12.5	9.2	25.4	28.8	15.4	12.3	4.0	17.8	6.4	3.3	8.2	15.9	13.3	13.1	8.6	14.9	7.9	30.3	12.9	7.2	19.1	14.9	18.1	3.5	27.7	11.1	6.2
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763032-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	19.3	20.3	14.9	14.3	20.0	34.6	23.4	17.3	21.2	17.3	15.3	16.3	14.1	13.1	19.7	18.7	18.1	17.5	21.5	16.1	12.6	11.7	16.2	16.6	15.1	20.0	20.9	16.4	20.3	23.5	21.5	30.8	20.4	23.4	17.2	18.3	11.8	17.7	15.0	22.6	23.9	20.1	18.3	22.3	19.4	18.0	17.5	20.3	29.8	18.6	19.1	18.7	19.5	25.4	14.3	11.8	16.3	15.0	12.6	14.3	7.4	11.0	11.9	21.4	16.2	10.4	14.3	23.7	18.4	12.4	18.4	17.5	26.1	17.4	22.8	14.4	11.7	22.8	16.1	21.4	17.9	23.7	25.8	20.3	28.7	33.3	23.8	17.9	24.8	21.9	19.9	18.7	15.4	21.0	19.6	17.4	22.8	32.5	33.3	10.0	20.3	24.5	20.3	13.9	13.1	22.0	19.9	17.7	15.6	13.8	26.5	15.8	16.9	14.3	11.8	15.3	33.4	11.1	18.9	15.1	15.8	13.1	12.6	16.4	20.3	24.7	16.8	17.7	18.4	14.5	16.3	11.0	10.8	11.2	10.5	13.4	12.6	11.5	12.2	11.8	14.3	14.3	12.9	7.1	12.6	15.0	10.4	12.4	7.4	14.9	20.0	17.3	21.2	12.6	11.7	20.9	16.4	23.4	20.3	20.8	13.6	6.8	10.9	3.5	18.1	30.2	2.5	41.5	21.6	14.0	17.7	12.7	11.6	11.2	3.0	12.8	8.4	0.0	10.8	10.4	8.9	7.4	13.9	6.8	11.6	0.0	12.0	14.1	10.5	3.8	12.4	10.3	6.8	23.4	9.0	12.6	13.5	7.0	10.3	8.1	14.9	6.5	7.8	43.3	19.0	4.8	13.2	10.2	10.3	6.8
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.5	12.2	15.5	13.3	7.7	9.1	11.2	8.2	10.9	11.7	8.6	14.9	6.4	13.3	5.6	10.7	10.9	19.8	23.7	13.5	13.0	8.0	9.8	11.2	17.6	6.3	7.6	16.5	7.1	7.0	10.3	12.0	15.7	7.1	10.0	8.9	18.2	6.8	8.4	14.0	10.1	7.7	19.7	13.0	11.9	10.0	18.9	11.7	8.6	7.2	21.6	14.6	14.8	15.0	9.1	10.1	20.9	6.8	10.4	19.4	10.9	8.8	12.3	2.8	6.4	14.8	8.2	10.4	11.9	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4	17.9	8.6	7.8	6.7	27.2	15.0	11.2	2.5	18.7	6.8	3.5	13.7	6.2	6.6	7.2	4.8	9.0	3.5	0.0	5.4	6.0	11.5	9.1	1.1	7.8	5.4	19.1	12.6	7.4	7.3	2.1	17.5	4.6	3.3	2.8	7.4	11.3	5.8	7.0	18.0	5.6	16.9	0.0	7.6	15.1	12.6	35.0	5.4	6.1	8.0	4.6
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958560-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	17.0	21.6	26.4	14.3	25.3	12.8	14.6	10.9	17.4	15.8	22.1	14.2	12.7	17.4	12.3	12.9	17.3	16.4	23.0	32.1	21.2	20.1	31.1	23.5	10.9	15.6	24.8	17.8	15.6	14.7	21.6	15.5	11.0	18.1	32.7	18.4	12.1	14.7	16.1	95.8	10.4	17.5	15.7	21.4	19.7	18.1	20.3	20.3	17.9	13.2	30.7	18.7	17.2	13.1	36.2	38.8	19.0	37.6	23.4	63.5	33.3	14.8	27.8	19.6	20.6	9.7	19.2	26.8	25.1	18.3	24.1	19.6	40.2	11.1	21.0	24.0	22.3	4.6	6.3	21.9	21.4	18.1	31.6	36.9	39.5	25.8	51.8	19.6	56.0	32.2	19.3	17.3	18.4	17.6	13.1	26.6	26.6	47.4	11.4	34.9	28.7	27.6	58.1	27.1	14.8	22.4	27.6	15.0	17.6	31.3	32.6	17.4	24.7	18.1	2.4	18.6	13.8	9.1	30.1	28.3	6.0	18.2	44.1	37.9	10.0	20.4	35.9	6.3	33.7	30.0	19.0	26.9	14.9	25.1	37.6	27.9	36.2	31.6	30.9	35.6	26.3	24.8	29.2	4.3	23.4	29.9	38.8	63.5	33.3	26.4	25.3	10.9	17.4	21.2	20.1	24.8	17.8	18.1	20.3	65.5	40.1	59.5	60.5	27.0	36.8	263.0	203.8	61.6	42.1	99.5	15.7	80.1	258.6	151.4	140.9	51.7	98.6	23.3	256.8	207.8	47.9	134.2	52.1	79.5	242.8	25.4	105.5	52.8	67.6	203.2	60.1	78.3	52.3	200.2	92.0	74.5	175.0	112.2	64.3	317.0	26.5	64.7	52.8	104.2	113.1	26.0	75.6	66.1	106.5	98.7
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"		X	304529-318819	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	6.3	4.9	22.2	5.6	40.5	8.1	33.6	30.5	29.9	18.9	5.2	0.6	0.6	7.0	17.0	0.6	4.7	6.3	3.1	19.7	22.7	5.9	21.1	4.0	4.1	6.0	39.5	15.0	18.2	11.9	2.1	16.6	16.6	26.4	4.1	1.6	0.6	11.2	4.7	22.8	5.7	7.6	1.9	25.5	6.4	7.5	2.4	34.2	0.6	4.1	0.6	1.9	3.7	25.4	7.3	11.1	8.1	6.3	5.3	9.2	3.8	15.2	25.3	5.6	11.7	6.5	7.1	20.9	9.5	7.1	12.1	11.1	38.7	12.8	19.2	13.6	5.3	16.4	9.5	5.9	9.2	2.0	15.9	17.2	15.8	12.4	26.4	17.6	10.6	15.5	8.8	12.3	8.0	5.9	4.5	9.7	12.8	11.6	9.0	4.9	30.2	18.8	14.0	13.7	3.1	18.1	8.4	9.9	30.6	7.0	17.9	15.8	13.5	10.4	11.8	17.5	3.2	10.6	9.3	12.8	17.7	12.3	26.1	14.6	12.3	11.0	29.6	9.2	14.0	8.1	8.1	6.3	6.7	7.8	6.3	7.6	7.3	6.9	8.7	6.1	6.0	8.5	7.7	0.9	5.3	5.8	11.1	9.2	3.8	22.2	40.5	30.5	29.9	22.7	5.9	39.5	15.0	26.4	34.2	17.9	16.3	23.9	39.0	25.0	27.0	16.8	28.1	5.3	10.3	26.2	25.5	20.5	44.7	10.7	0.9	23.7	23.1	0.0	12.8	38.8	22.6	37.4	11.5	32.1	26.3	12.7	17.1	14.1	12.6	1.4	18.1	23.2	25.3	11.8	23.0	15.2	11.3	8.6	17.7	74.7	25.1	6.5	31.3	5.1	12.1	23.2	24.6	27.7	32.2	44.8
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678427-44700926	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	10.0	11.3	12.7	7.5	16.6	11.4	10.8	9.7	17.7	7.6	11.5	9.4	8.7	9.4	10.2	9.1	13.2	8.9	7.9	12.3	12.6	9.9	15.1	16.0	6.6	10.8	10.4	11.6	10.6	9.3	11.5	11.3	7.8	13.0	10.6	12.4	7.4	10.4	8.0	31.1	11.5	12.5	7.6	11.8	9.7	15.4	11.7	11.1	13.9	11.2	13.1	9.3	11.7	9.2	4.8	4.7	4.6	6.1	5.2	7.0	3.9	7.7	3.9	7.4	9.4	3.1	6.4	16.3	10.6	5.6	11.1	8.6	7.0	5.6	16.9	8.5	5.2	10.1	6.2	12.7	12.3	12.7	5.7	8.1	20.2	3.4	4.8	10.0	21.9	8.7	6.4	5.6	8.2	7.2	5.2	7.9	10.1	20.3	3.3	8.9	3.8	12.2	4.6	4.8	5.6	9.3	8.8	15.3	7.1	3.3	3.0	10.2	7.6	6.8	2.9	7.5	6.0	4.5	6.4	7.9	7.6	8.8	10.1	12.7	12.2	11.1	12.4	8.3	13.1	6.4	1.1	4.6	4.6	4.7	6.1	6.1	4.8	4.7	4.2	4.3	4.4	4.5	4.6	0.1	5.2	4.0	4.7	7.0	3.9	12.7	16.6	9.7	17.7	12.6	9.9	10.4	11.6	13.0	11.1	6.0	7.4	12.1	7.4	3.5	9.7	19.3	2.5	22.7	10.3	7.0	2.0	11.2	11.6	7.9	1.4	6.8	9.1	23.3	8.8	14.4	7.3	8.4	1.1	13.4	10.4	11.1	10.9	10.4	11.7	1.5	5.2	6.6	6.8	6.4	12.4	8.6	11.9	5.8	6.7	8.4	10.2	0.0	8.2	9.2	9.6	6.1	11.2	8.9	11.9	9.1
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	44.6	38.2	106.4	32.5	76.0	76.7	43.0	25.2	74.4	31.5	33.3	30.1	27.3	41.5	26.3	34.1	77.0	28.0	42.5	61.6	93.1	43.9	31.9	43.5	34.6	39.0	60.0	52.9	24.7	62.2	12.8	26.0	29.2	40.1	25.5	12.1	37.4	66.5	29.4	35.8	59.6	42.1	34.8	49.6	36.1	44.3	22.2	34.9	27.5	31.6	29.3	24.1	45.9	44.5	43.9	97.7	110.1	62.9	55.8	83.7	84.5	57.5	20.3	9.0	27.7	27.1	32.6	45.0	38.4	19.7	22.4	17.6	11.6	40.1	21.7	45.6	25.0	18.8	38.3	7.7	42.1	2.4	33.0	59.7	12.9	50.1	25.2	49.3	14.6	22.7	45.2	25.7	15.6	12.6	16.1	30.2	47.0	34.7	34.7	18.3	48.0	65.8	31.5	28.1	28.2	88.0	25.2	16.9	57.6	21.1	27.1	29.6	53.1	24.7	42.4	49.6	2.4	31.3	31.5	52.7	40.9	27.0	59.9	63.1	32.0	34.6	24.0	51.5	23.8	41.2	55.5	57.1	110.1	77.3	59.8	75.2	43.9	64.8	83.7	48.9	36.6	48.7	61.1	74.9	55.8	62.9	97.7	64.6	84.5	106.4	76.0	25.2	74.4	93.1	43.9	60.0	52.9	40.1	34.9	56.6	78.2	181.8	216.6	586.3	182.4	113.0	193.6	93.7	91.0	225.1	675.4	207.7	588.6	495.6	100.8	397.7	599.7	607.3	597.7	329.8	327.6	443.3	180.0	320.2	368.6	103.3	258.9	305.7	236.3	483.4	216.3	309.1	492.6	406.6	288.0	169.2	724.2	491.0	229.1	543.7	445.9	245.8	394.4	82.0	73.0	629.1	219.5	279.1	243.7	436.5
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373063	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	7.6	25.8	12.3	7.1	12.5	35.7	6.6	14.1	17.2	8.8	7.1	14.9	8.0	5.4	9.0	7.6	6.1	8.2	7.5	15.6	11.5	10.6	9.2	8.7	7.1	6.5	13.0	10.4	11.4	7.8	12.0	9.8	8.4	12.9	8.3	5.9	7.1	7.7	11.2	10.0	5.8	5.6	10.7	12.4	6.7	6.6	16.5	13.0	7.4	9.6	5.3	6.3	9.3	9.8	3.2	4.4	3.4	4.5	1.3	3.2	2.4	5.6	9.9	6.4	6.4	7.5	7.4	5.1	6.9	6.4	7.1	6.7	7.5	4.5	11.5	6.1	5.9	13.9	10.1	7.3	9.3	8.1	1.9	4.8	10.6	4.0	10.1	9.8	6.3	6.5	7.4	6.9	7.7	11.8	10.0	4.7	8.0	7.2	18.0	10.1	7.4	9.8	7.9	4.7	7.9	13.7	6.5	15.3	7.9	5.3	5.7	9.9	5.7	6.1	11.0	14.4	5.5	7.2	9.2	6.1	11.6	6.7	8.7	7.3	14.7	6.0	10.1	3.4	29.0	6.2	0.0	4.5	2.0	2.0	2.7	1.5	3.2	3.0	3.1	4.4	1.6	3.0	3.2	3.4	1.3	3.2	3.7	0.9	2.4	12.3	12.5	14.1	17.2	11.5	10.6	13.0	10.4	12.9	13.0	6.0	8.1	15.7	2.5	9.6	11.4	16.2	0.0	8.1	4.5	3.5	17.7	4.0	6.6	3.2	14.0	6.7	2.7	0.0	2.9	2.8	5.9	2.4	12.8	4.5	7.4	6.4	5.2	2.5	13.7	21.5	8.6	10.9	1.7	0.0	2.6	10.8	3.5	2.9	7.8	3.8	11.4	0.0	11.2	16.3	8.0	7.3	4.7	2.5	3.3	1.6
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	No			Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.4	16.0	25.3	15.1	2.3	1.7	26.7	30.1	9.2	17.0	15.0	25.3	11.4	18.2	18.2	6.9	12.8	27.5	11.9	8.6	4.6	26.8	33.5	36.9	4.4	26.0	2.4	18.1	23.0	1.4	1.9	7.2	4.4	2.7	8.5	24.0	29.8	30.0	8.1	67.5	41.4	54.2	18.4	12.1	33.9	40.5	29.8	8.5	7.7	11.5	27.0	32.1	23.9	13.9	4.2	4.5	20.8	13.8	10.4	16.5	43.6	13.4	22.3	8.2	8.0	18.4	3.8	29.5	32.1	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5	6.0	12.6	41.6	30.9	27.4	17.4	16.3	15.3	2.7	9.1	7.0	19.6	39.1	10.0	14.6	7.0	21.1	36.5	46.7	9.9	93.2	26.6	29.8	32.3	3.6	37.9	9.5	33.3	25.8	20.0	2.5	13.3	24.5	18.6	37.9	33.9	37.9	14.1	24.5	10.3	7.5	43.2	12.9	36.5	72.1	17.9	24.7	53.7	30.5	50.3	20.8
H2BFS		ENSG00000234289	"H2B histone family member S"	P57053	21	43565189-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.0"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 3.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4.0	3.3	12.2	0.1	0.5	2.2	4.2	0.0	0.0	4.5	0.4	5.3	1.8	0.8	3.0	2.1	1.0	0.4	3.0	1.8	0.7	5.7	2.0	7.9	0.0	65.0	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2.0	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5.0	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0.0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1.0	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5.0	1.1	11.8	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
H2BFS		ENSG00000274559	"H2B histone family member S"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"blood: 16.0"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.9;Ciliated cells: 4.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.4	0.3		0.5		1.0	0.0		0.0	1.0	0.9			1.4	1.3	2.9	3.3	2.8	2.8	0.0			0.0	2.2	0.3	2.3			0.2	1.2	0.0		0.8		3.7	0.9		1.9	0.0	0.0	0.0	1.8	0.7		0.6	1.1	0.9			1.6		1.0	1.2		7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2.0	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5.0	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0.0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1.0	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5.0	1.1	11.8	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2											11.9	2.9	0.9	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	1.0	0.0	0.0	0.0	1.8	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.6
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560704-15601852	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 34.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	12.9	12.1	9.1	7.3	12.5	7.6	11.6	20.7	14.1	9.0	22.4	13.5	5.8	39.6	13.1	13.2	6.7	7.9	6.6	7.9	6.7	6.0	18.8	38.1	7.5	9.0	9.1	8.3	7.9	14.3	12.9	16.8	6.4	10.1	8.2	9.0	10.9	8.5	6.9	15.7	9.9	31.6	7.2	8.2	11.0	11.5	18.4	10.3	16.6	15.1	6.1	10.7	8.2	6.5	8.5	6.5	34.1	9.1	9.1	9.3	5.0	6.0	12.5	4.0	13.9	7.0	5.6	39.4	5.9	9.6	12.7	12.5	12.9	6.0	6.2	4.3	8.0	5.0	4.5	9.2	11.4	11.3	5.2	17.5	12.2	9.5	12.5	10.5	13.3	10.7	6.4	8.4	18.0	7.5	3.8	15.9	8.3	10.0	10.4	10.8	13.3	6.4	6.3	9.1	9.6	14.6	6.0	9.8	8.2	13.6	9.5	4.2	5.5	8.8	9.7	11.6	6.6	3.1	12.5	9.7	6.9	6.8	8.5	10.8	12.8	21.6	12.2	12.9	12.1	7.8	34.1	6.5	7.0	6.0	8.2	9.3	6.4	6.5	7.5	6.5	8.5	6.4	7.1	1.4	9.1	9.1	4.0	7.8	5.0	9.1	12.5	20.7	14.1	6.7	6.0	9.1	8.3	10.1	10.3	8.9	15.9	11.9	9.6	9.2	18.3	4.9	12.7	37.5	15.9	10.4	27.5	24.4	11.6	10.9	53.9	11.1	8.8	0.0	22.1	15.1	8.6	8.1	12.7	26.4	11.8	12.7	8.7	8.6	9.1	43.3	21.6	8.7	11.8	24.4	5.8	22.5	12.7	10.5	14.5	27.1	32.9	6.5	9.0	49.7	22.6	6.1	15.8	18.7	8.6	5.8
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 36.0;SuSa: 67.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Uncertain		Uncertain	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	36.0	0.0	0.0	0.0	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 61.4;placenta: 62.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 81.1;Leydig cells: 36.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.2	24.2	0.2	10.9	0.2	0.0	4.7	0.4	0.2	34.3	42.7	0.2	7.5	1.9	42.7	7.9	16.6	9.7	61.4	54.1	0.2	0.2	0.2	8.2	0.2	0.1	0.2	0.0	13.4	3.8	0.0	0.3	62.9	0.0	13.1	3.6	5.2	1.1	4.2	0.6	1.7	13.5	37.5	0.2	1.8	19.9	5.4	0.0	0.0	1.5	2.7	2.2	25.7	12.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.9	3.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	81.1	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.4	1.1	13.7	0.0	0.0	0.0	2.3	0.0	0.0	11.1	0.0	0.8	36.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	2.2	0.1	0.1	0.3	1.9	0.0	0.0	0.0
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	152687-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.9;placenta: 5.0;testis: 9.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 144.1;Late spermatids: 212.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	79	"K-562: 227.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000000	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.8	0.0	0.8	0.1	0.5	8.9	0.6	0.6	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.6	3.3	0.7	0.3	0.1	1.1	0.6	0.1	1.1	0.1	0.7	0.1	0.0	0.1	5.0	0.1	1.2	0.0	0.1	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.8	0.1	9.9	0.1	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.6	0.6	0.7	0.3	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	41.3	0.7	0.0	23.3	0.0	16.4	1.4	0.0	0.0	0.0	144.1	0.0	0.0	0.0	0.0	212.4	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.7	6.5	2.0	1.1	0.9	0.1	8.7	0.0	0.0	0.0
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018312, HPA078588"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA018312: AB_1850522, HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.4	20.1	13.7	17.3	5.7	4.1	20.1	6.3	4.9	7.5	6.9	21.2	10.4	28.1	16.3	8.2	12.4	12.7	14.7	10.4	3.9	14.8	17.3	16.8	16.0	16.6	3.9	20.6	27.9	6.4	6.8	13.1	5.7	4.5	8.0	20.5	23.3	17.8	5.3	21.6	28.5	26.7	17.7	10.1	12.4	33.3	11.3	16.9	5.7	14.4	15.2	16.5	11.7	12.2	6.5	6.9	11.2	18.6	10.5	14.4	17.8	12.4	20.4	28.3	38.7	35.2	11.7	20.1	13.6	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9	17.9	19.1	10.4	11.5	14.7	17.2	34.6	17.8	4.0	9.1	12.2	13.7	13.4	3.3	15.2	0.4	15.8	11.7	0.0	14.1	18.9	12.9	17.4	3.5	23.1	18.5	19.1	18.4	19.0	30.2	1.3	16.1	12.5	5.0	16.2	20.4	15.0	16.1	7.0	20.5	8.6	11.5	6.5	13.7	6.5	25.1	12.2	13.3	17.5	20.9	13.1
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.3	14.5	27.0	40.9	26.1	20.8	17.5	15.6	34.3	35.4	50.8	31.0	18.3	31.1	20.2	20.2	25.2	18.6	27.1	36.5	43.9	26.5	29.1	24.3	13.3	17.6	18.4	29.2	22.3	17.7	23.5	20.5	26.8	18.4	22.8	28.1	23.7	16.6	22.3	20.2	32.4	25.3	23.8	13.3	11.5	23.5	28.2	22.4	18.9	21.5	22.6	18.3	20.6	21.4	25.7	17.9	22.8	18.5	11.5	22.0	13.8	16.8	25.5	13.5	16.6	29.3	18.5	27.8	18.8	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6	8.9	10.4	32.3	23.0	39.3	30.6	12.3	15.3	5.3	11.4	12.2	56.9	47.2	18.3	28.5	7.6	20.2	15.4	0.0	31.4	44.3	29.3	18.8	18.4	14.8	34.9	47.7	17.2	20.9	15.4	3.4	20.8	33.0	30.4	66.7	17.7	27.7	27.2	14.0	20.8	15.7	30.4	25.8	24.0	22.3	24.5	44.9	51.1	31.9	22.7	26.5
HDAC8	"HDACL1, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573103	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease mutation, FDA approved drug targets, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048560	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048560: AB_2680442"	"unprognostic (1.42e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.10e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.12e-3)"	9.6	22.5	14.7	9.9	16.2	10.2	12.4	31.4	20.6	12.6	10.4	13.9	11.5	8.6	12.3	28.2	11.0	9.4	9.4	12.6	15.0	15.2	16.8	18.6	10.2	9.6	14.9	9.4	12.8	15.9	13.6	22.0	11.2	19.3	13.3	12.8	14.3	12.2	10.3	10.4	9.3	8.4	13.1	12.2	9.5	10.7	3.6	14.0	8.0	15.0	8.2	11.9	10.4	10.1	9.4	12.8	19.7	13.2	7.7	11.4	7.7	12.5	17.1	12.6	17.4	17.3	12.9	8.7	7.3	14.1	11.2	12.7	12.4	12.9	8.7	23.0	10.0	17.5	9.2	23.5	14.2	14.9	14.3	16.7	11.5	22.0	14.4	9.5	19.1	20.4	13.5	10.4	13.7	10.3	15.9	17.2	11.7	12.8	24.4	14.9	15.8	8.9	25.1	17.5	19.3	24.8	12.2	16.2	15.6	19.5	13.2	9.0	19.7	17.1	13.7	17.5	16.4	6.9	16.3	12.9	9.2	13.3	13.2	8.1	9.4	15.0	11.1	12.5	21.1	11.9	7.2	13.2	19.7	8.8	11.8	6.9	9.4	9.5	7.3	12.8	9.1	7.6	7.1	0.7	7.7	10.5	4.8	11.4	7.7	14.7	16.2	31.4	20.6	15.0	15.2	14.9	9.4	19.3	14.0	3.0	18.8	8.1	10.0	5.5	16.0	10.8	12.7	13.4	10.3	7.0	41.2	14.3	8.3	11.9	0.5	10.5	8.1	0.0	10.7	11.6	8.6	13.3	11.5	9.7	13.8	22.3	8.7	11.6	7.8	1.3	10.9	10.6	6.8	6.4	9.1	10.8	10.1	2.9	9.9	17.8	16.8	25.8	9.5	5.1	0.7	5.5	11.3	11.4	9.7	10.9
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		19000	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	17.5	29.8	50.5	12.0	36.1	11.3	21.1	26.4	31.7	14.8	15.2	11.1	31.6	12.4	12.9	25.2	19.6	17.2	12.4	34.7	41.1	37.0	31.3	8.9	13.4	18.8	45.0	18.9	18.3	22.9	16.3	15.6	11.5	23.4	15.7	16.9	19.3	54.8	42.0	42.8	13.5	16.1	19.0	25.8	12.2	14.4	25.7	16.8	12.9	24.3	35.4	18.2	17.7	11.2	27.3	15.4	4.4	14.2	23.6	33.9	17.7	8.6	24.1	15.0	61.5	12.2	16.8	20.9	11.6	17.7	12.6	13.1	37.9	10.4	40.0	25.2	22.1	29.1	8.6	21.0	17.0	16.1	15.7	49.3	18.5	13.4	37.2	27.8	23.9	13.7	23.5	26.2	17.9	41.3	19.8	9.0	22.2	69.9	17.3	27.2	48.0	18.5	25.2	17.6	25.8	19.6	27.9	11.9	8.4	29.4	11.0	29.4	14.3	14.2	27.7	25.4	14.7	16.2	40.6	5.5	12.7	14.0	19.5	23.4	20.6	14.2	33.1	18.3	43.3	25.9	4.4	14.2	2.5	22.9	12.2	18.7	27.3	25.3	31.0	14.7	22.0	31.4	33.9	3.2	23.6	11.1	15.4	21.5	17.7	50.5	36.1	26.4	31.7	41.1	37.0	45.0	18.9	23.4	16.8	23.8	38.7	42.4	51.6	39.6	51.4	109.7	33.1	34.8	30.7	59.3	13.7	75.6	286.8	71.8	43.7	26.4	42.4	23.3	86.1	127.4	62.7	54.8	36.9	18.1	98.5	65.2	61.9	11.6	46.6	33.2	84.3	41.0	75.9	12.6	64.1	45.8	55.3	45.6	107.8	202.1	18.2	38.8	76.2	115.5	66.8	37.6	38.2	62.3	78.2	45.1
HDDC3	MGC45386	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929964-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	14.3	18.8	16.3	8.9	17.1	10.7	11.3	10.3	17.6	8.2	13.1	9.3	12.6	12.4	5.4	12.8	7.7	12.7	7.1	15.2	12.9	12.3	14.7	18.3	7.8	9.0	14.6	12.5	10.3	30.3	15.1	10.4	10.4	11.0	8.7	11.1	9.7	24.8	14.0	14.2	9.3	17.1	6.1	11.4	13.1	11.2	4.5	8.2	11.8	12.0	10.1	10.7	7.5	7.5	19.9	25.3	5.6	15.6	16.4	21.5	14.3	6.7	8.3	2.9	3.5	6.7	6.8	4.9	4.5	6.2	4.3	6.3	4.1	14.0	12.7	4.8	3.8	3.4	10.5	6.1	10.6	3.6	16.1	12.9	16.0	3.2	9.3	13.7	6.1	7.9	5.9	16.8	7.8	14.0	6.8	9.4	10.6	12.7	11.5	3.8	9.8	8.3	5.3	2.4	25.5	8.5	7.0	1.1	20.3	8.8	7.1	7.4	4.7	3.8	10.7	11.4	6.4	16.2	16.5	5.3	2.7	5.9	4.4	5.8	18.8	21.1	8.8	9.8	12.0	7.9	5.6	11.8	4.7	14.0	15.6	18.4	19.9	18.4	16.2	15.9	17.5	21.5	15.7	2.8	16.4	14.2	25.3	17.4	14.3	16.3	17.1	10.3	17.6	12.9	12.3	14.6	12.5	11.0	8.2	26.8	6.1	27.0	11.4	4.9	12.4	0.8	43.3	20.1	19.4	15.7	3.9	39.0	64.6	34.0	3.9	14.7	23.8	23.3	49.1	27.5	8.7	13.1	6.9	33.8	39.5	14.3	19.1	15.4	12.9	2.4	13.3	18.0	13.5	48.7	31.2	29.5	27.9	30.6	11.0	53.5	35.3	6.5	7.3	16.3	14.0	7.3	20.3	17.5	34.4	10.3
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.7	16.4	28.5	26.4	12.4	12.7	19.9	22.4	12.1	24.7	22.0	18.7	12.1	24.5	13.1	16.4	13.0	15.9	18.9	20.4	14.5	27.3	30.0	15.0	12.3	24.6	16.1	14.8	21.5	18.1	11.1	16.9	8.3	17.6	22.5	23.2	17.2	30.9	11.9	19.7	33.4	29.7	32.6	11.2	29.5	33.3	23.5	15.7	15.3	14.2	31.5	31.1	21.8	12.5	18.1	16.3	12.3	23.6	29.7	15.6	21.4	29.3	21.1	38.4	20.0	17.2	21.9	23.9	16.4	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	17.4	9.1	12.2	0.0	31.1	16.6	22.5	0.0	0.0	0.0	0.0	17.5	24.9	0.0	0.0	1.1	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	26.2	0.0	0.0	19.1	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065941-50106387	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	14.7	13.6	8.8	17.8	16.1	10.1	9.3	19.5	14.0	10.2	11.5	12.4	11.1	10.1	9.2	10.3	13.0	8.5	9.4	9.9	9.4	9.6	10.7	20.7	10.5	14.6	10.9	8.1	7.1	19.2	14.8	13.3	12.1	8.7	8.4	13.8	7.8	12.4	7.8	19.6	13.3	10.9	11.3	10.5	21.6	11.4	15.6	11.1	14.5	6.4	10.7	12.9	9.2	8.0	2.4	4.2	2.2	7.0	2.0	2.9	2.2	10.8	11.1	10.3	16.3	6.4	8.6	11.1	13.2	8.8	13.3	5.3	13.6	8.3	20.5	9.6	12.6	5.0	13.0	12.4	9.9	15.5	5.2	13.3	10.1	7.8	17.2	9.2	17.5	20.6	6.7	6.8	9.4	5.7	5.8	10.7	10.9	12.8	3.6	13.0	6.7	13.4	22.0	12.1	13.2	11.6	14.9	14.0	16.6	7.4	8.9	13.4	7.1	12.8	16.6	8.3	8.3	7.5	12.8	13.9	10.7	7.2	8.2	10.1	8.7	6.9	18.4	10.6	17.7	10.5	1.3	6.2	1.4	2.6	7.0	2.8	1.6	1.6	2.9	4.2	2.4	2.3	2.4	2.2	2.0	6.1	3.7	2.6	2.2	8.8	16.1	19.5	14.0	9.4	9.6	10.9	8.1	8.7	11.1	3.0	4.3	2.7	0.7	2.9	7.2	5.2	5.1	2.7	1.2	1.8	15.7	3.0	6.6	2.2	9.3	3.6	3.8	0.0	2.6	2.9	2.6	1.9	1.1	6.7	8.3	1.6	3.4	2.5	25.3	13.3	3.1	7.0	1.7	3.6	3.3	1.9	2.6	2.9	2.1	3.4	7.3	0.0	2.1	4.8	4.5	1.5	0.8	4.4	4.9	1.4
HEBP1	"HBP, HEBP"	ENSG00000013583	"Heme binding protein 1"	Q9NRV9	12	12974864-13000273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056417, HPA075277"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		130000	Vesicles	Nucleoplasm	"HPA056417: AB_2683122, HPA075277: AB_2686741"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.45e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.43e-2)"	23.4	36.0	12.3	7.6	21.1	16.0	24.5	7.7	14.0	17.7	46.8	18.0	20.0	79.8	14.2	13.9	13.9	13.6	25.4	18.3	11.8	11.7	20.4	48.5	16.2	11.2	16.7	8.0	27.8	27.6	13.3	9.0	13.9	17.2	17.8	7.6	20.0	18.2	16.4	12.8	19.1	79.1	22.9	22.2	19.3	13.4	11.2	15.1	5.5	52.8	13.9	8.7	18.2	23.9	5.3	21.4	9.0	27.4	7.1	9.4	9.9	17.0	10.3	7.2	12.6	54.4	42.4	4.9	15.5	22.1	14.9	19.9	6.5	6.2	5.0	6.2	30.3	12.7	15.5	8.9	12.3	17.3	0.7	7.3	2.8	12.3	16.5	39.1	4.9	2.7	32.6	11.7	19.7	24.5	46.1	30.4	6.0	3.1	4.3	25.2	10.6	4.0	8.1	10.0	16.6	7.3	9.3	20.5	5.1	12.0	16.4	4.0	3.6	20.6	9.6	19.2	21.8	5.0	7.4	33.2	11.0	13.3	17.3	8.0	4.0	3.2	1.8	17.5	9.0	4.4	4.6	27.4	6.8	4.3	19.8	6.0	4.9	7.3	4.7	21.4	5.3	9.4	5.4	9.0	7.1	26.5	10.7	4.1	9.9	12.3	21.1	7.7	14.0	11.8	11.7	16.7	8.0	17.2	15.1	50.6	17.6	17.9	45.0	33.3	5.0	24.6	79.0	4.0	6.8	54.1	3.9	30.7	84.6	74.8	15.7	52.4	88.1	46.7	88.6	23.2	57.2	40.0	1.1	121.3	73.3	6.4	19.5	141.2	67.3	5.6	82.6	41.0	59.1	62.3	33.8	30.7	71.9	44.1	88.4	72.5	5.8	51.8	41.2	13.8	7.4	31.6	22.0	21.8	48.4	46.5
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 43.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 133.5;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.8	7.1	11.3	6.3	16.3	26.6	7.7	43.3	22.7	8.9	9.0	14.0	10.8	5.4	11.1	10.0	10.0	9.0	6.5	6.6	10.1	10.3	7.4	6.3	7.3	8.1	11.4	13.7	10.9	10.1	13.8	14.0	8.0	17.2	12.3	7.4	9.4	8.7	9.6	12.9	16.6	7.0	8.8	13.0	7.4	8.8	14.6	12.7	8.3	12.8	5.0	7.7	8.3	9.0	2.9	2.4	2.8	1.2	1.0	1.8	0.7	5.6	10.7	8.6	7.6	11.7	7.9	4.9	4.2	4.0	5.4	4.6	10.4	1.9	6.0	3.8	6.8	5.7	5.8	11.2	5.5	4.1	7.7	10.1	8.4	11.3	5.8	4.2	6.0	8.3	6.6	6.7	8.3	5.5	10.1	8.2	11.2	10.5	4.7	5.1	6.3	7.1	12.7	4.1	7.8	8.0	9.6	4.4	3.9	4.3	9.0	14.0	9.6	9.7	9.5	3.7	8.4	7.1	8.5	11.9	6.3	4.6	6.6	5.6	15.9	6.0	6.7	5.1	3.9	4.0	2.8	1.2	0.6	1.8	0.5	1.2	1.1	0.6	0.9	0.8	2.9	1.0	0.9	1.4	1.0	1.1	2.4	0.1	0.7	11.3	16.3	43.3	22.7	10.1	10.3	11.4	13.7	17.2	12.7	17.9	17.3	9.3	7.3	10.2	47.4	18.5	12.7	10.7	5.7	12.2	133.5	8.5	0.0	7.5	5.6	10.9	9.7	0.0	7.5	3.9	9.1	13.7	8.1	13.9	5.7	76.3	26.5	16.0	7.6	4.5	10.6	7.0	6.8	7.2	12.4	17.8	8.4	8.6	14.9	4.4	55.4	0.0	8.3	19.1	8.0	13.0	7.4	7.9	11.9	6.5
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455856	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	10.5	20.8	6.3	12.2	7.8	7.2	10.4	12.6	9.2	10.7	9.8	9.3	8.2	5.6	9.9	8.7	8.2	9.1	9.0	10.5	6.2	5.7	11.9	10.0	8.0	15.3	6.8	5.7	17.4	8.1	13.3	20.7	11.7	9.0	11.4	7.2	11.0	10.0	10.4	14.6	8.7	9.8	8.0	8.4	14.4	8.4	10.7	7.4	18.5	14.3	8.3	13.4	10.2	9.2	10.1	4.6	6.8	4.7	5.5	9.7	2.9	4.3	3.3	7.1	4.6	8.7	9.2	3.7	6.5	9.8	8.5	8.4	3.1	4.5	12.2	5.2	5.6	5.8	4.4	8.6	4.8	8.9	7.0	3.8	7.3	5.4	4.2	5.6	8.8	18.0	7.1	6.5	6.7	7.0	7.5	6.7	8.2	9.6	10.7	8.6	5.1	8.0	6.3	3.6	6.9	2.4	6.2	8.2	4.3	7.0	2.7	5.8	4.8	6.3	6.9	7.1	7.1	4.3	9.5	5.1	6.4	5.6	8.2	5.1	9.9	4.2	10.3	5.4	6.7	7.1	5.4	3.7	6.8	5.7	4.0	5.4	5.8	6.3	6.4	4.6	10.1	9.7	8.7	2.3	5.5	4.7	4.5	7.8	2.9	6.3	7.8	12.6	9.2	6.2	5.7	6.8	5.7	9.0	7.4	3.0	9.4	10.0	8.0	3.8	9.2	9.2	7.6	22.7	7.9	5.2	7.9	9.6	10.0	5.1	20.9	7.1	3.5	0.0	4.8	8.1	6.4	4.9	7.0	4.0	9.1	6.4	0.0	10.4	5.6	5.8	12.0	8.4	6.8	7.2	4.5	9.1	4.7	6.0	7.4	8.8	13.2	0.0	8.2	20.0	12.8	3.3	9.6	13.1	5.2	4.7
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.6	1.7	0.1	0.3	0.1	1.6	0.5	0.3	8.8	47.0	35.0	0.1	3.3	0.0	0.6	0.8	7.6	1.0	4.3	2.2	3.1	5.3	0.9	2.4	1.5	0.2	1.5	4.3	1.7	2.1	0.5	3.6	0.1	2.8	1.3	2.0	0.0	0.6	1.0	1.5	2.0	1.3	0.6	2.3	0.9	1.3	0.0	0.1	3.2	3.2	0.1	1.1	3.2	1.1	5.2	2.4	1.9	0.8	0.4	0.6	0.9	0.1	0.8	0.1	0.0	0.0	2.1	1.0	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3	11.9	8.8	2.4	4.4	2.5	11.4	10.6	5.1	16.0	10.3	5.2	15.7	4.9	0.0	6.6	0.9	8.4	5.2	0.0	15.0	1.3	3.7	8.2	5.7	2.1	4.3	1.6	1.7	4.3	3.7	1.3	4.0	2.2	5.0	4.6	2.9	4.3	9.1	3.1	5.3	3.6	1.0	6.5	2.0	0.5	1.1	1.0	2.1	7.7	1.7	6.2
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.7	0.5	0.5	2.3	0.2	0.3	0.3	0.4	0.6	0.8	2.4	0.1	0.4	7.2	0.1	0.0	1.1	0.7	9.2	0.6	0.0	7.3	4.4	0.3	13.7	0.1	0.8	0.8	0.9	0.2	1.2	2.0	5.2	1.3	0.1	1.2	0.2	3.2	0.1	0.1	0.1	0.4	0.2	0.5	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.3	0.4	0.0	0.4	0.1	0.1	0.0	0.7	0.0	1.5	1.6	2.3	4.5	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2	0.0	0.0	0.0	0.9	1.9	2.4	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.3	1.0	0.0	0.5	0.0	0.0	0.4	0.0	0.8	0.0	4.2	0.0	0.6	1.4	0.2	0.0	0.0	0.1
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"Hexamethylene bisacetamide inducible 1"	O94992	17	45148502-45152101	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	14.8	25.3	30.0	12.6	25.3	30.4	13.7	41.4	37.4	16.2	21.0	10.7	18.5	17.8	17.0	17.2	18.6	18.2	18.6	16.0	31.1	15.6	20.9	19.0	15.8	11.8	24.9	19.2	14.8	15.6	12.2	24.4	56.7	27.5	19.9	10.8	12.6	16.4	25.2	29.7	22.6	20.2	19.5	31.4	20.7	17.3	17.1	21.7	8.9	17.2	14.3	12.3	17.8	30.6	3.7	3.4	15.9	6.7	3.8	4.6	2.3	13.0	41.6	8.7	12.5	14.4	7.7	21.3	11.6	10.5	9.6	10.8	19.5	18.6	5.7	35.9	12.2	4.6	10.6	5.2	11.4	7.8	11.8	12.4	17.7	22.9	23.8	12.6	11.0	23.6	9.0	9.8	7.1	3.1	24.2	4.8	10.1	7.8	13.9	7.2	17.5	11.5	12.8	8.0	12.1	12.6	4.8	7.6	7.0	25.3	23.2	4.7	3.5	17.5	19.8	18.7	9.2	20.6	8.7	9.1	9.7	13.5	5.5	21.5	12.7	4.0	3.7	8.9	10.4	11.0	15.9	4.3	6.6	4.5	6.1	2.7	3.3	4.6	4.0	3.3	3.7	4.2	4.4	10.5	3.8	6.7	3.4	3.9	2.3	30.0	25.3	41.4	37.4	31.1	15.6	24.9	19.2	27.5	21.7	68.5	92.7	29.4	49.2	75.1	23.7	46.8	86.6	41.5	59.1	24.4	21.6	110.7	6.6	30.0	2.1	58.5	171.5	23.3	20.3	55.9	57.3	53.6	120.4	33.6	37.7	14.3	50.7	41.1	29.4	2.1	32.5	51.4	50.6	42.3	63.9	24.3	22.5	108.7	41.1	40.3	26.5	25.8	75.9	2.1	6.4	62.5	390.9	55.4	47.5	30.7
HEXIM2	FLJ32384	ENSG00000168517	"Hexamethylene bisacetamide inducible 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 121.3;Late spermatids: 208.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.0	7.7	8.3	4.2	8.0	3.6	3.4	9.0	11.8	4.3	4.8	5.0	6.5	8.8	4.3	5.6	4.2	5.1	7.9	6.3	6.7	6.2	9.3	9.6	4.1	5.6	7.8	6.7	5.7	9.3	7.5	6.1	3.0	6.6	5.1	2.5	6.9	9.9	5.5	36.4	5.6	6.4	4.3	5.4	5.2	6.9	27.7	6.4	6.4	9.1	6.6	3.0	4.7	4.7	9.7	13.2	10.0	12.2	7.3	8.6	13.3	5.0	18.2	4.0	8.9	4.5	7.4	7.7	2.8	3.4	4.6	5.1	6.9	13.5	3.1	14.8	2.0	2.3	8.4	3.9	3.4	1.4	7.2	6.3	2.3	17.0	30.9	3.2	2.0	5.2	6.4	3.3	4.0	1.4	8.9	2.2	6.5	2.5	7.8	2.1	8.7	3.2	4.3	4.4	7.1	8.0	4.3	6.1	9.5	5.8	5.0	4.8	4.2	2.5	5.1	11.7	3.0	13.6	3.4	2.2	8.3	4.4	5.5	6.6	12.2	12.9	2.9	6.5	3.7	6.2	8.4	12.2	10.0	5.4	9.7	8.6	9.7	3.8	6.1	10.3	6.5	3.0	5.3	8.3	7.3	3.0	13.2	4.6	13.3	8.3	8.0	9.0	11.8	6.7	6.2	7.8	6.7	6.6	6.4	0.0	1.0	4.7	3.5	1.8	12.7	0.2	5.1	0.0	1.2	1.8	3.9	10.7	16.6	3.9	121.3	4.0	4.0	0.0	1.4	4.5	3.4	1.8	6.9	6.2	6.3	3.2	4.6	2.5	7.0	208.9	5.5	2.8	3.3	4.6	4.3	8.0	2.1	3.5	6.7	26.1	10.6	0.0	3.4	18.2	12.0	2.6	5.1	1.3	4.1	1.6
HFE	HLA-H	ENSG00000010704	Hemochromatosis	Q30201	6	26087281-26098343	"Disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	7.2	13.7	2.2	4.4	2.7	0.0	6.2	1.2	2.5	6.7	7.1	3.5	10.3	4.2	6.8	13.9	7.6	5.2	13.3	8.9	2.0	1.4	5.4	12.8	9.0	16.1	2.3	2.0	8.1	16.2	14.6	2.2	7.6	4.3	12.6	5.3	13.7	7.0	8.1	3.1	3.2	5.8	10.4	3.2	14.4	6.1	4.9	1.2	2.0	7.7	3.9	5.0	8.6	5.2	3.5	4.6	1.9	10.5	0.2	2.2	3.4	8.2	18.9	0.3	9.2	14.0	10.8	0.0	5.9	14.1	7.6	12.0	1.6	16.8	0.8	16.1	9.7	11.5	5.3	0.0	6.9	9.7	2.1	0.1	0.2	4.5	1.2	2.7	0.0	0.3	11.1	2.0	8.4	0.7	6.7	5.1	0.0	0.3	0.2	6.5	3.4	0.0	0.1	0.4	3.9	0.0	1.1	0.0	0.1	6.3	5.5	0.0	0.0	3.5	0.0	5.1	0.1	26.9	0.9	3.9	5.4	0.5	5.3	5.1	0.1	0.1	0.1	8.0	0.1	11.6	1.2	10.5	0.0	1.7	10.2	1.3	3.5	1.7	2.2	4.6	1.5	0.4	1.2	1.9	0.2	8.2	0.3	0.3	3.4	2.2	2.7	1.2	2.5	2.0	1.4	2.3	2.0	4.3	1.2	3.0	3.2	1.9	2.3	1.4	0.7	2.8	5.1	6.7	7.9	5.2	2.0	1.2	0.0	2.5	0.1	3.0	3.4	0.0	3.0	0.6	3.0	3.8	2.3	8.1	8.8	0.0	1.7	8.6	21.1	0.0	3.4	5.7	0.0	0.0	3.7	3.7	2.5	0.0	5.6	2.2	2.0	0.0	1.4	0.2	1.0	3.0	1.5	0.7	3.7	1.3
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689951-92695646	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051894, HPA055460"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051894: AB_2681653, HPA055460: AB_2682820"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	6.3	8.2	2.8	12.0	3.6	28.1	13.7	0.9	2.2	4.5	3.2	3.0	1.1	2.3	3.6	3.8	2.9	2.7	18.0	7.3	2.8	2.1	2.8	33.1	15.3	29.7	3.6	0.9	1.9	15.6	0.7	1.5	6.4	2.8	4.3	2.4	2.3	1.9	1.6	2.8	2.2	8.4	9.3	2.9	18.3	2.7	1.9	2.8	1.8	71.4	2.0	11.3	6.5	7.1	25.0	13.5	21.4	17.8	0.3	0.3	4.9	3.1	5.9	3.1	0.0	0.2	0.2	0.0	1.6	13.5	2.2	1.9	1.1	0.7	3.0	26.0	0.2	0.0	0.6	2.7	0.0	2.7	0.0	3.2	28.2	2.4	19.0	6.3	16.4	31.3	0.0	0.0	1.9	0.0	1.1	30.9	0.0	42.9	0.0	0.1	0.9	0.1	28.6	0.0	8.6	3.4	9.6	0.9	0.0	0.2	1.2	1.4	0.3	1.8	0.0	0.0	0.1	0.9	8.7	10.7	0.0	0.1	0.0	0.0	0.7	0.5	6.0	0.0	22.7	14.9	7.9	14.7	21.4	0.3	16.4	0.1	21.4	0.0	0.0	11.3	25.0	0.0	0.0	11.8	0.3	17.8	13.5	0.1	4.9	2.8	3.6	0.9	2.2	2.8	2.1	3.6	0.9	2.8	2.8	0.0	4.8	30.4	1.6	5.7	0.0	2.0	94.3	1.4	2.3	0.0	0.0	0.5	0.0	86.4	0.2	66.2	0.0	0.0	10.0	0.8	2.1	2.9	6.9	48.7	58.0	0.0	5.1	65.1	61.3	0.4	0.3	22.7	6.8	1.8	0.3	0.0	14.5	0.0	1.1	0.0	0.0	0.0	1.9	0.2	1.4	3.1	0.9	5.2	0.2	0.6
HHLA3		ENSG00000197568	"HERV-H LTR-associating 3"	Q9XRX5	1	70354805-70385339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 51.4;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031323	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031323: AB_10601477"	"unprognostic (2.31e-3)"	"unprognostic (8.35e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.60e-2)"	6.9	20.0	18.2	4.1	19.5	7.6	8.5	6.9	19.3	8.9	6.4	20.1	7.2	4.6	8.2	25.7	8.0	15.8	6.8	5.1	15.8	16.5	16.8	17.6	4.6	9.7	17.5	14.6	18.0	15.5	15.8	14.1	6.8	13.4	11.4	6.1	13.1	14.4	8.6	2.8	11.0	4.3	7.9	17.0	7.3	5.2	8.9	15.4	5.8	13.6	3.2	9.0	7.6	13.2	13.4	8.5	4.5	3.0	5.2	11.2	3.9	7.8	3.6	14.0	7.9	12.1	9.9	2.0	2.2	5.1	3.7	4.8	1.2	9.0	7.4	9.7	9.3	16.8	4.9	13.7	6.3	6.6	21.1	7.9	5.0	7.5	3.5	11.8	2.4	4.0	12.8	7.5	7.9	9.3	8.4	1.2	9.9	9.1	21.1	5.4	5.8	4.9	8.5	13.8	5.6	4.8	10.3	1.0	3.6	17.1	1.2	5.1	4.0	16.8	5.3	9.9	17.6	3.1	5.5	3.1	4.0	2.3	8.3	2.7	10.6	8.5	20.2	8.1	7.5	7.7	4.5	2.5	1.4	6.5	3.0	6.5	10.5	6.7	7.0	3.7	13.4	11.2	9.9	0.7	5.2	2.2	8.5	10.8	3.9	18.2	19.5	6.9	19.3	15.8	16.5	17.5	14.6	13.4	15.4	0.0	3.2	6.0	11.4	4.5	2.8	1.2	20.4	8.1	5.7	21.0	0.0	12.7	51.4	5.7	0.6	4.6	2.6	0.0	6.6	11.5	5.4	10.3	6.9	17.4	6.9	6.4	4.1	11.1	8.6	1.0	6.9	2.7	1.7	12.6	3.9	18.6	6.4	5.8	14.2	35.6	2.8	0.0	5.1	3.7	13.4	7.4	13.3	4.9	5.0	8.3
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 alpha subunit inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	8.8	12.7	11.6	11.9	10.8	7.6	12.9	9.5	14.1	9.2	10.7	11.5	8.8	9.7	11.6	10.4	11.1	9.6	12.5	16.0	10.2	9.4	10.3	8.8	9.3	12.3	13.0	9.5	14.5	14.3	17.1	10.6	10.2	10.8	10.7	9.3	9.2	10.6	12.1	46.8	13.3	10.6	14.9	9.7	11.1	10.0	17.9	10.3	13.5	8.1	14.8	12.3	10.8	10.8	9.7	8.5	16.9	14.0	10.1	11.3	9.3	9.1	9.7	13.1	13.2	20.4	8.5	11.4	9.8	23.7	14.6	17.2	15.0	7.9	9.9	8.9	14.6	10.8	10.7	11.5	8.8	15.9	10.9	7.0	9.4	8.6	11.4	10.6	11.3	12.6	8.3	8.9	14.1	15.5	20.6	8.2	13.3	4.1	5.6	16.3	9.6	12.1	7.4	4.3	7.8	4.7	8.8	16.3	4.8	10.1	12.3	5.0	8.3	8.4	5.2	9.2	11.5	17.8	6.1	6.8	7.5	9.7	7.3	9.8	7.6	7.7	7.6	12.4	9.3	5.5	13.1	8.8	16.9	9.8	12.4	9.6	9.7	10.1	9.0	8.5	7.5	9.8	9.9	9.3	10.1	14.0	3.1	11.3	9.3	11.6	10.8	9.5	14.1	10.2	9.4	13.0	9.5	10.8	10.3	0.0	6.2	14.3	9.8	9.7	16.8	34.6	12.7	4.0	5.7	10.4	15.7	23.3	8.3	15.7	15.4	9.0	14.8	0.0	12.1	15.1	7.1	8.2	5.8	8.7	13.0	23.8	12.7	7.4	17.7	39.0	10.3	10.4	3.3	16.2	11.3	14.3	15.3	14.0	11.3	14.7	21.9	6.5	12.2	39.9	22.2	10.2	27.3	11.7	11.4	8.4
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42784298-42804531	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 535.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 89.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	27.7	30.4	50.1	15.5	43.4	9.6	20.4	20.3	56.4	18.3	63.8	25.2	10.8	35.2	15.7	24.8	36.7	13.5	18.8	68.6	43.2	43.3	45.9	78.4	15.3	16.0	54.4	35.9	12.8	12.8	14.7	29.2	17.2	50.9	24.4	67.3	21.8	16.6	26.8	34.9	15.0	28.4	22.8	58.8	13.0	31.6	14.7	20.7	8.9	28.1	30.6	16.9	20.1	25.0	11.9	89.9	25.9	26.6	12.3	18.8	30.1	27.4	15.4	34.3	28.1	87.8	52.5	33.4	37.1	30.5	36.4	33.4	27.2	28.0	16.8	22.3	32.4	22.6	16.6	27.5	40.9	45.5	24.1	30.4	51.9	27.7	50.3	40.1	29.8	24.5	54.4	45.0	27.8	38.8	18.1	31.9	25.6	51.2	18.0	50.7	11.2	16.4	10.9	28.8	23.3	37.6	13.4	24.3	11.9	89.7	68.2	14.5	18.9	32.5	24.7	35.0	35.7	24.7	22.5	27.9	21.5	19.5	60.1	38.3	16.8	34.7	34.7	28.3	31.7	16.6	16.9	14.7	25.9	15.4	22.7	13.7	11.9	15.1	15.1	16.3	8.5	12.9	15.3	14.9	12.3	26.6	89.9	18.8	30.1	50.1	43.4	20.3	56.4	43.2	43.3	54.4	35.9	50.9	20.7	50.6	73.8	43.3	134.0	116.5	33.4	319.5	79.0	48.2	60.3	130.9	9.8	99.0	535.5	105.9	6.7	57.3	183.7	93.5	127.6	162.8	82.5	160.2	92.2	169.5	69.4	27.0	78.7	55.3	46.3	9.1	28.4	70.1	167.0	114.6	120.5	121.0	198.7	300.1	49.1	213.1	25.1	77.6	125.8	135.9	72.8	178.8	250.8	45.7	135.9	173.3
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4;esophagus: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	24.5	5.2	25.3	5.5	34.2	14.1	16.2	8.6	53.9	15.7	14.4	6.4	2.8	4.7	9.1	6.3	71.4	7.9	7.2	16.7	25.1	8.5	10.4	10.3	13.2	4.9	22.4	3.1	22.9	5.0	3.0	4.2	25.7	46.5	7.0	6.2	2.8	7.7	6.1	5.2	14.4	4.4	6.9	66.4	3.0	6.4	10.1	21.1	1.7	5.6	6.9	6.0	60.5	18.6	9.2	5.9	31.7	3.6	6.9	3.3	2.0	11.2	23.8	13.0	14.2	17.8	6.6	24.4	4.1	5.2	8.7	9.7	5.9	10.3	7.7	3.3	6.2	8.9	7.2	7.3	8.8	11.1	4.2	6.7	4.7	5.0	5.3	4.0	7.4	6.5	10.9	7.6	6.8	4.6	8.9	7.1	12.2	6.8	3.2	8.6	13.9	22.2	13.5	16.1	8.3	10.5	16.8	6.1	11.9	4.8	16.8	12.5	11.5	6.4	45.2	8.0	12.2	36.8	7.2	5.2	11.2	5.5	8.4	5.1	3.1	2.3	9.8	21.1	11.5	9.6	9.2	3.5	31.7	2.3	3.6	3.3	7.8	2.9	2.8	3.4	9.2	3.0	2.9	1.4	6.9	2.7	5.9	1.9	2.0	25.3	34.2	8.6	53.9	25.1	8.5	22.4	3.1	46.5	21.1	8.9	5.6	5.8	11.4	57.1	6.2	3.1	5.1	33.5	47.8	1.8	17.7	95.4	0.0	16.4	0.3	26.9	2.9	0.0	7.6	142.7	49.5	20.7	17.4	3.2	23.2	25.4	12.6	7.4	4.3	1.7	28.1	20.8	35.4	20.8	7.7	14.1	55.4	5.5	23.0	8.4	22.5	6.5	49.5	5.9	16.3	45.5	201.6	5.1	15.3	8.0
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell type enhanced"	"Detected in all"	6	"Glandular cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		1800000	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.9	4.2	3.1	3.4	8.1	1.6	0.1	2.9	4.9	14.1	15.0	2.3	4.3	0.4	17.2	3.9	5.1	2.6	1.0	2.3	3.9	5.7	3.7	2.4	4.7	2.6	2.4	1.1	5.9	11.5	3.1	1.8	3.1	4.3	2.2	2.7	50.0	37.6	7.0	2.6	3.0	2.6	1.7	14.5	6.5	1.6	1.4	19.1	8.3	4.3	8.2	2.8	47.6	8.2	3.3	3.1	10.1	1.7	1.0	6.4	93.7	1.9	1.3	103.9	98.7	4.5	4.7	38.9	2.2	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4	65.5	28.8	111.5	307.6	7.2	72.6	41.5	30.6	100.4	35.2	66.3	47.1	37.6	44.7	79.4	2.2	29.5	161.7	256.9	100.4	59.2	37.4	442.5	18.6	102.4	61.4	49.3	37.3	33.7	27.5	4.2	24.2	37.4	3.3	16.2	65.1	147.0	86.1	92.5	10.3	161.0	135.9	25.8	23.3	14.2	90.3	6.9	249.6	48.4	36.8	295.6
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in some"	10	"Enterocytes: 1.6;Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.4	1.1	1.6	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.6	0.0	0.3	1.4	0.6	3.7	3.6	0.0	0.0	4.5	4.9	2.2	0.7	2.1	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.3	5.5	0.0	0.3	0.3	0.3	0.9	0.8	6.1	0.0	0.7	1.8	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6											0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.3	0.1	0.0	0.3	0.0
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"	"Cell line enhanced"	"Detected in many"		"K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	3.0	1.8	0.9	0.9	0.9	0.5	1.1	3.0	1.1	2.0	1.7	2.4	1.8	1.1	5.7	1.0	1.5	2.3	1.2	1.2	1.0	2.7	1.0	0.9	2.7	4.1	1.2	1.4	3.8	12.6	0.7	0.8	0.5	1.0	0.8	0.9	17.0	9.5	3.8	3.4	3.2	3.1	1.0	3.2	5.5	1.4	1.3	7.0	3.5	0.7	4.3	1.4	33.6	2.6	1.2	2.6	14.3	1.3	2.4	2.5	23.5	1.5	1.2	19.4	23.8	5.7	1.1	3.7	1.7	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5	6.0	2.7	3.0	40.5	0.8	3.0	1.8	5.1	21.4	7.9	3.5	0.0	3.9	1.7	6.8	42.1	2.9	9.5	0.0	8.0	5.4	4.1	78.6	4.6	13.0	5.8	0.0	1.7	1.8	3.7	4.5	1.4	4.6	0.0	1.8	7.4	2.9	25.5	9.9	1.1	3.5	3.9	0.0	1.8	1.8	3.2	1.0	35.8	10.1	4.9	103.5
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 105.0;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.2;U-266/84: 39.2"					"Low region specificity"	"Detected in some"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.2	3.7	2.1	29.3	2.7	1.1	4.7	2.7	6.2	3.9	4.1	4.4	2.4	30.1	5.6	6.9	8.5	2.1	2.0	2.9	11.0	5.2	1.6	9.8	4.3	3.1	2.1	4.6	19.2	3.2	1.7	2.4	2.4	1.5	2.3	16.9	13.5	1.1	19.3	4.8	5.4	3.9	23.1	5.7	1.9	2.4	16.0	5.8	3.9	12.0	5.1	29.9	7.8	4.6	7.6	19.8	0.8	0.9	7.7	20.1	3.1	1.0	37.2	39.2	6.1	1.0	10.0	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6	3.0	5.6	15.9	54.2	1.5	13.9	21.3	12.7	53.5	10.3	21.0	0.0	6.4	19.9	4.3	27.1	2.8	22.0	0.0	3.8	6.2	3.0	105.0	2.3	20.7	3.9	41.3	44.7	1.3	4.0	5.4	6.6	6.9	3.3	3.6	20.2	4.0	12.0	33.1	1.4	75.4	10.4	0.0	1.4	0.9	0.7	2.4	33.0	6.9	14.3	63.6
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.2;REH: 8.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.7	3.0	0.9	3.0	0.4	0.4	3.1	1.0	0.5	0.3	0.8	2.1	0.7	1.4	0.5	1.7	4.3	0.5	1.1	0.6	1.6	1.0	0.5	1.5	0.2	0.2	0.3	2.5	0.6	0.2	0.6	0.3	1.1	0.3	0.9	2.4	1.8	0.1	1.6	4.6	8.2	2.4	1.6	1.0	8.0	0.2	2.6	1.4	1.8	2.7	3.7	4.0	1.5	0.9	1.6	2.8	1.6	0.8	1.5	2.7	1.1	1.9	2.4	4.5	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8											0.0	0.0	5.6	4.5	0.0	4.3	0.3	2.5	2.7	0.0	1.8	3.9	0.7	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.9	0.3	5.8	1.1	1.0	0.8	9.5	1.2	0.6	4.1	0.0	1.4	0.7	0.0	1.0	0.4	1.2	0.2	0.0	0.7	0.4	2.4	0.0	0.0	1.6	0.9	0.0	0.7	0.0	1.6	4.0
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 21.8;U-266/84: 15.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.3	0.9	0.4	0.1	0.3	0.7	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.1	0.4	1.7	3.9	0.0	0.1	3.3	1.4	0.5	0.7	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.2	0.8	0.0	0.3	3.8	0.2	0.1	0.3	1.9	0.0	0.5	21.8	15.3	1.2	0.1	1.0	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2											0.0	0.3	6.7	3.6	0.0	5.4	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.4	0.0	5.5	0.0	0.4	1.0	0.0	0.0	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.4	1.2	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.5	2.5	1.0	5.1
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 58.7;Glandular cells: 91.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.5	0.1	1.2	0.0	3.9	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.2	0.0	3.2	0.3	0.8	2.7	1.1	1.0	1.1	2.2	1.3	0.7	1.2	1.1	0.6	0.3	2.1	1.5	0.5	0.6	0.0	0.1	0.4	0.1	7.8	0.1	0.0	1.8	2.2	1.7	1.2	5.9	1.6	1.5	0.7	4.4	1.2	0.6	7.3	1.1	8.9	3.3	1.0	3.4	18.1	0.8	0.2	0.0	1.0	0.3	0.4	16.9	0.1	0.0	0.3	1.1	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0											0.0	12.7	29.3	58.7	0.8	40.1	0.7	5.1	4.0	4.5	5.2	5.9	6.3	0.0	4.8	0.6	0.5	27.1	0.0	0.0	6.6	3.2	91.9	9.3	2.5	17.2	23.8	29.8	2.5	3.5	0.0	2.0	8.0	0.0	1.8	17.9	9.5	1.1	16.4	0.0	1.3	3.0	6.5	0.4	1.4	16.2	0.0	20.1	10.7	14.2	42.2
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 7.5;U-266/70: 18.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.5	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.5	1.1	0.0	1.8	0.1	1.9	3.6	0.0	0.6	1.9	0.9	0.1	1.4	5.6	0.4	0.0	0.0	4.3	0.3	0.3	0.5	0.5	0.0	0.3	1.0	2.7	6.6	0.1	2.0	3.8	2.7	1.7	0.0	1.9	4.1	0.0	1.0	0.0	2.8	3.4	3.1	4.4	1.5	0.6	0.3	2.2	3.4	0.0	0.6	0.0	0.8	3.2	18.1	4.5	0.0	0.5	1.5	4.0	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3											0.0	0.0	6.7	2.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.5	0.0	0.2	21.0	0.5	1.0	0.0	0.0	6.1	0.0	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	3.8	4.9	3.7	3.6
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.9	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.4	0.8	0.0	0.9	0.5	0.5	0.7	0.9	1.8	0.5	0.8	2.7	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	1.8	2.2	0.0	3.9	0.0	0.8	15.1	2.5	2.9	0.6	0.0	4.1	0.0	5.0	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.1	0.0	6.3	0.9	0.9	0.0	0.6	3.1	3.2	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.8	4.8	1.4	1.3	7.2	0.5	1.9	2.1	1.3	8.5	3.6	4.1	2.2	0.6	6.9	2.3	3.9	2.8	2.1	1.9	4.7	4.5	3.6	1.1	5.5	0.2	0.6	0.5	3.0	3.4	0.2	1.8	0.8	1.2	0.5	1.7	42.1	24.8	2.2	2.0	1.7	2.5	1.7	3.9	4.5	0.9	1.2	3.8	1.0	1.4	9.4	1.1	37.9	2.5	1.1	2.1	0.1	1.5	1.1	2.1	42.0	1.6	0.9	35.8	44.0	10.1	0.5	11.8	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2	0.0	0.0	0.0	10.4	5.5	0.0	2.0	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.4	63.4	0.6	4.0	23.3	0.3	3.2	2.4	25.8	0.0	1.5	3.3	0.0	12.6	4.9	2.6	19.3	1.1	2.4	6.8	4.6	2.6	0.0	2.4	7.0	1.4	0.0	0.0	0.0	3.1	30.9	9.1	4.6	5.1	4.5	2.3	9.5
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.2	16.3	2.6	4.5	11.7	4.4	9.0	10.4	7.5	15.0	9.7	14.7	8.3	2.0	35.1	5.9	10.5	8.2	3.1	3.2	2.2	9.3	15.7	3.5	10.2	0.5	5.1	2.7	21.3	21.0	2.8	2.5	2.8	4.2	3.0	1.3	117.4	23.8	6.7	17.1	5.0	5.0	2.3	22.7	7.0	3.2	1.7	26.5	5.6	2.8	13.2	7.6	61.8	21.2	5.6	2.4	54.8	3.2	3.4	6.7	107.1	6.2	1.8	32.7	140.9	18.6	3.9	28.0	3.8	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9	23.8	9.4	4.3	0.6	28.0	0.0	0.4	0.0	13.4	6.8	0.0	0.0	1.2	0.0	1.3	0.1	2.1	2.6	0.0	1.0	2.6	1.9	0.5	4.7	1.7	0.9	0.0	0.0	2.5	2.2	0.0	0.0	4.9	38.8	4.6	1.0	0.0	2.0	1.1	0.0	0.0	0.0	0.0	1.5	0.4	3.0	29.2	3.2	9.6	1.2	0.5
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell type enhanced"	"Detected in single"	13	"Club cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.2;U-266/84: 13.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.3	3.3	1.0	1.7	0.9	0.5	0.3	0.7	1.6	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.4	1.0	0.0	0.0	0.0	0.2	0.7	2.1	2.2	5.8	0.0	6.1	13.2	4.9	2.2	1.6	3.4	3.1	0.0	1.4	0.0	2.2	3.1	1.1	4.0	1.6	0.2	0.2	1.4	1.0	0.5	0.1	1.7	1.3	1.0	3.3	13.0	4.3	0.4	5.1	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.2
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.3	0.0	0.0	0.5	1.1	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.2	17.7	0.0	0.5	4.6	11.4	3.4	1.1	0.8	7.3	0.0	0.4	0.0	0.0	0.2	2.0	0.8	1.1	0.0	0.1	1.0	3.4	0.0	0.0	2.0	1.2	0.1	13.7	0.5	7.0	1.1	1.3	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0											0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 27.8;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	2.0	0.9	0.7	1.1	0.7	0.8	0.5	0.9	0.8	3.0	0.7	0.9	2.1	1.3	0.5	0.3	1.5	4.5	0.7	3.7	1.4	1.4	1.0	3.7	1.3	0.4	0.1	1.3	1.1	0.2	1.4	8.9	7.0	0.8	1.8	2.9	4.5	1.4	1.2	1.0	2.1	1.0	5.3	0.4	0.9	9.8	2.0	3.5	1.3	3.0	1.0	2.5	0.8	1.5	2.2	2.1	1.2	0.7	6.1	9.2	3.6	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5	0.0	3.2	20.4	5.8	0.9	7.5	2.3	0.0	5.3	2.3	0.0	2.0	9.8	1.7	0.1	3.8	2.7	27.8	0.0	0.7	3.9	3.3	5.0	3.5	1.7	9.0	6.4	4.1	1.8	4.3	0.9	2.8	4.9	6.8	1.0	10.0	15.8	0.8	7.0	1.8	2.0	26.9	0.0	8.3	0.9	2.1	2.0	4.2	20.0	5.2	1.7
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 29.4"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.5	4.4	0.7	0.0	2.7	0.8	0.1	5.5	5.4	1.1	1.3	2.6	1.9	0.2	1.2	2.3	2.5	0.5	0.7	1.8	1.9	1.7	4.5	1.7	0.0	0.2	1.1	0.3	0.0	0.4	0.5	0.1	1.4	2.1	6.5	7.3	0.2	0.5	11.2	9.4	1.7	1.7	2.2	6.5	1.5	4.9	0.9	0.3	6.3	1.3	4.7	1.2	0.7	0.5	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.1	29.4	7.5	0.9	9.5	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5											0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 128.7;Syncytiotrophoblasts: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.3	2.8	0.9	4.1	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.6	2.4	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.6	0.8	3.2	0.3	5.4	9.4	3.4	0.7	2.8	2.1	0.5	1.7	4.9	24.3	2.1	6.9	1.2	2.1	1.2	9.4	2.5	1.5	0.7	5.5	1.6	0.9	13.1	2.1	14.1	1.9	1.0	4.8	10.0	0.9	0.7	1.3	14.7	0.9	0.3	40.5	21.7	1.1	1.7	1.5	0.8	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6	8.9	11.7	10.4	57.7	5.4	47.2	56.8	2.5	12.0	5.7	34.9	21.6	22.3	23.2	13.5	1.1	4.5	15.3	23.3	5.9	10.4	14.1	128.7	10.5	5.9	22.3	20.6	53.7	8.6	11.0	0.0	4.6	16.7	18.6	4.6	18.8	12.9	8.3	21.0	0.4	8.8	32.5	0.0	9.8	0.5	6.1	11.8	134.0	22.4	9.0	59.1
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 32.1"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.6	0.6	4.6	3.1	0.3	7.9	4.1	6.0	5.3	0.3	2.2	0.4	0.6	4.5	5.2	1.3	0.1	0.5	4.7	1.2	0.9	0.4	1.5	0.0	6.7	0.2	1.8	5.5	0.0	7.8	1.9	1.7	3.4	0.3	1.2	2.4	0.8	0.9	3.1	3.8	0.4	4.1	1.0	0.3	1.1	0.7	2.9	0.4	2.7	7.3	4.2	3.5	0.3	0.7	1.3	9.8	1.4	1.5	0.0	11.5	2.0	32.1	1.0	1.3	5.3	0.3	3.4	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1	0.0	0.3	2.2	6.9	0.3	6.0	1.7	0.0	4.0	1.2	1.8	2.0	1.5	3.3	1.0	0.9	0.4	5.1	0.0	0.3	1.2	0.9	16.2	0.0	0.6	6.7	4.8	3.4	2.5	4.9	1.4	2.6	2.9	0.0	1.8	2.7	6.6	0.7	2.9	0.0	0.5	0.9	6.5	1.5	0.2	0.4	0.5	4.3	4.9	1.8	5.7
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.3	0.4	0.1	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.2	1.5	0.5	1.0	0.4	0.3	0.1	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.5	4.4	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7	6.0	0.0	0.0	1.2	0.1	3.8	0.8	0.0	4.0	0.0	0.0	5.9	0.2	1.7	0.0	0.0	0.0	0.2	23.3	0.0	0.1	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.7	2.9	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.3	0.8	2.5	0.4	0.5
HKR1	ZNF875	ENSG00000181666	"HKR1, GLI-Kruppel zinc finger family member"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	13.0	25.8	14.6	13.2	22.4	12.6	24.9	29.8	27.2	20.5	14.5	22.9	21.5	7.7	24.8	24.1	12.4	22.9	17.9	26.9	14.6	15.6	19.3	12.3	12.9	14.3	14.9	17.4	22.6	14.2	31.0	35.5	17.2	21.2	27.5	13.8	49.4	18.7	19.3	18.1	27.1	13.4	17.0	13.3	20.2	14.2	22.6	15.5	16.4	30.9	13.7	20.1	15.0	15.6	12.4	7.9	10.0	5.1	9.9	14.8	5.7	4.1	10.4	13.5	17.9	9.9	8.6	9.4	7.0	10.7	13.1	14.2	5.2	4.9	14.6	17.1	7.4	5.9	3.5	8.8	9.4	13.6	7.6	15.0	5.1	12.6	5.6	13.0	4.7	12.5	12.7	11.6	8.8	19.4	13.4	7.9	10.5	0.9	0.9	9.4	8.4	10.5	9.3	27.1	7.2	6.0	7.1	5.9	5.6	11.4	16.8	16.8	22.8	7.0	9.0	8.8	20.6	12.8	9.0	7.1	10.4	7.5	7.8	10.9	18.8	19.7	15.1	1.1	5.8	11.6	10.0	4.2	6.6	8.0	5.1	14.8	10.7	10.6	11.4	6.3	12.4	14.4	12.0	4.0	9.9	3.6	7.9	12.2	5.7	14.6	22.4	29.8	27.2	14.6	15.6	14.9	17.4	21.2	15.5	6.0	2.9	7.8	6.4	4.6	45.3	16.5	2.5	18.7	11.4	10.4	102.1	9.3	16.6	7.7	9.5	11.1	2.9	0.0	6.8	4.6	6.1	9.7	11.5	5.9	6.1	39.7	9.2	9.2	3.7	5.9	11.2	5.5	8.5	9.0	5.0	22.8	5.1	3.5	12.0	10.9	129.7	6.5	7.6	15.5	16.3	5.4	8.2	8.5	5.4	7.3
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"	"Group enriched"	"Detected in some"	6	"HDLM-2: 47.2;REH: 22.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.0	0.0	0.0	0.0	47.2	2.2	1.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	22.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	6.0	0.1	3.9	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2	62.5	286.9	1312.2	21.4	267.0	12.2	9.3	73.9	46.8	77.3	27.9	15.7	5.1	3.3	33.6	3.2	238.9	10.6	0.0	13.0	4.7	50.0	41.9	61.1	5.5	1159.7	7.9	9.2	88.4	1265.6	4.0	25.3	2334.4	307.1	5192.2	12.2	24.1	8.0	4.0	19.8	36.3	19.2	45.3	33.2	1.2	5.9	203.9	7.6	173.0	6.5	13.9
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879400-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 25.8;neutrophil: 28.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;THP-1: 47.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	27.7	3.0	2.7	8.8	3.0	54.0	18.4	0.9	2.3	5.7	24.3	2.0	3.8	4.5	7.4	3.6	8.7	5.0	7.5	15.2	3.3	0.9	4.0	11.5	14.3	10.5	6.2	0.3	4.9	4.9	1.8	2.0	14.0	2.5	6.9	2.4	4.2	2.3	3.8	10.4	5.7	11.1	4.2	6.4	10.9	3.1	3.9	3.1	1.4	6.3	3.0	3.2	10.4	12.9	2.2	5.5	28.5	6.3	0.2	0.1	1.8	0.0	1.9	0.0	1.4	4.3	6.9	3.6	5.2	8.6	6.0	5.0	0.4	0.1	0.0	0.1	3.2	1.1	0.0	1.1	0.0	2.5	1.3	3.8	0.0	2.2	0.2	7.6	1.7	0.4	8.0	0.2	6.7	0.4	0.5	2.6	0.0	2.2	0.0	0.8	0.0	0.0	6.2	0.2	0.0	3.6	0.1	4.1	0.0	0.6	0.0	0.0	2.0	0.7	0.1	13.5	0.3	0.0	47.4	0.8	4.0	0.0	0.6	4.1	0.0	0.0	0.0	6.5	5.4	1.6	25.8	6.3	10.7	0.0	1.8	0.0	2.2	0.0	0.0	5.5	1.1	0.0	0.0	28.5	0.2	0.3	3.5	0.1	1.8	2.7	3.0	0.9	2.3	3.3	0.9	6.2	0.3	2.5	3.1	8.9	7.7	1.5	0.1	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	11.7	0.0	23.3	0.3	0.6	4.6	0.1	3.5	6.7	27.0	0.0	0.0	38.6	17.7	0.0	2.3	17.3	0.0	67.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	6.5	9.5	0.1	1.0	2.8	0.3	0.0	0.0	0.1
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA		18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	121.6	48.2	24.7	17.2	11.5	85.4	108.0	49.2	56.3	38.2	21.3	31.5	85.4	57.4	24.8	20.1	24.0	26.1	29.1	87.7	30.4	12.5	19.5	17.6	16.2	42.1	24.4	62.8	20.3	36.6	9.8	69.1	36.1	98.7	115.2	32.8	70.8	2.9	53.1	12.3	54.4	77.4	120.4	60.7	81.6	80.9	0.5	63.3	25.8	11.2	43.2	18.3	5.2	25.0	45.4	40.8	10.0	67.4	99.8	19.9	62.8	28.9	46.0	23.6	36.5	74.1	42.1	26.2	99.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2	26.8	23.7	124.5	686.8	384.1	27.4	24.5	38.2	10.7	36.4	38.4	3.9	784.6	39.7	243.5	6.1	27.0	148.7	46.7	242.2	663.0	71.9	750.7	66.8	10.6	337.7	11.1	112.2	16.0	59.4	17.5	5.2	107.5	86.0	66.7	165.5	27.9	1097.2	162.4	2.5	9.0	27.8	0.0	34.9	38.5	398.0	315.9	688.1	51.7	282.8	1250.0
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell type enhanced"	"Detected in all"	15	"Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 166.6;MOLT-4: 171.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	Yes		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.9	8.4	72.2	32.2	9.0	9.0	27.7	26.1	19.9	28.8	25.8	23.7	48.8	118.3	5.9	14.5	15.4	13.7	47.3	14.2	45.0	72.4	22.1	130.0	21.2	34.7	8.8	115.0	50.2	8.7	4.3	14.4	32.8	15.7	29.5	62.9	49.0	166.6	26.3	29.2	171.4	106.6	26.3	20.9	14.6	86.7	37.1	43.9	16.5	15.0	62.5	56.4	26.3	15.3	11.7	26.4	21.2	83.9	16.9	12.9	38.3	15.9	39.1	53.9	30.1	135.4	11.0	84.1	33.6	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6	26.8	58.1	117.6	176.4	141.0	43.0	211.0	35.7	147.2	66.0	52.4	33.4	154.7	121.0	20.6	24.5	124.1	53.3	2616.4	14.4	751.8	109.8	81.7	104.4	22.2	176.6	42.9	71.7	149.1	275.5	29.5	97.5	149.6	64.1	109.2	104.0	79.8	10.0	83.9	54.1	36.3	129.5	77.6	96.6	461.9	435.2	117.1	107.7	264.5	185.0	64.8
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 108.8;U-698: 98.0"									HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062583: AB_2684800"	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.7	16.7	52.8	27.5	2.2	6.6	65.8	16.6	10.9	19.3	10.0	13.2	15.7	26.5	53.5	12.7	10.9	18.2	48.1	108.8	21.8	18.0	14.0	23.0	16.2	20.8	3.3	34.6	11.7	5.2	25.8	7.9	20.0	4.9	24.9	16.3	11.9	15.7	22.9	29.0	38.1	26.6	31.3	24.8	20.5	46.8	43.0	15.0	14.2	18.1	38.1	24.9	24.7	26.6	8.2	31.5	23.5	22.9	18.7	8.0	19.0	25.5	36.5	14.3	17.8	98.0	9.6	17.7	16.3	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2	35.7	27.4	16.2	16.0	21.1	0.5	13.2	10.2	145.9	134.2	29.6	2.0	337.0	31.5	72.8	184.3	11.3	24.9	186.9	75.5	539.5	20.8	18.7	8.1	72.9	88.3	0.0	63.0	10.4	18.3	46.6	3.4	26.0	20.3	35.1	29.3	3.1	76.6	25.9	3.2	39.4	1.4	0.0	8.3	19.9	49.6	17.8	1171.0	14.0	52.8	17.0
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	83.3	28.9	83.9	35.2	7.8	18.1	32.8	41.3	23.8	80.9	62.5	29.8	78.2	93.9	39.5	33.6	23.6	48.2	105.8	41.0	68.9	57.8	74.9	100.8	34.3	29.1	14.7	213.4	58.9	19.0	21.6	44.2	26.2	16.9	37.6	62.7	79.7	45.1	42.4	61.6	152.1	97.0	70.3	96.0	53.8	105.9	131.8	57.5	25.4	22.9	83.7	51.9	124.1	34.9	45.7	21.8	57.2	101.2	27.9	40.4	75.5	77.3	68.8	55.2	74.8	104.6	25.9	224.6	80.0	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1	318.6	348.4	323.5	270.1	256.3	146.9	79.2	191.1	714.7	343.5	247.7	133.5	686.4	315.0	197.4	143.3	140.8	163.3	537.3	235.1	491.1	459.0	285.8	361.7	123.4	660.0	89.0	554.4	172.5	336.2	26.8	172.0	473.8	215.9	762.9	372.7	230.4	94.5	305.1	142.8	214.8	300.1	122.9	297.7	273.8	419.4	186.6	772.2	318.1	517.4	227.4
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	26.6	57.2	53.6	22.9	52.7	18.8	37.2	73.1	84.6	26.1	28.3	22.6	28.4	27.7	29.9	55.4	29.0	66.8	26.4	68.6	53.3	33.4	52.5	44.6	34.4	35.5	70.8	36.1	34.9	27.8	38.7	66.8	35.4	53.0	27.4	23.5	28.0	47.4	30.6	41.8	24.8	22.3	33.0	53.2	27.7	31.0	24.8	63.5	21.9	36.1	37.9	32.8	26.1	25.6	28.0	52.3	7.7	38.3	32.8	29.4	36.4	14.3	13.1	45.9	19.8	18.5	15.2	10.4	10.0	10.8	11.2	16.5	73.2	12.2	0.1	18.6	8.1	15.0	9.2	29.8	11.3	11.1	42.3	25.0	50.7	41.0	38.1	11.8	41.4	7.7	18.4	12.7	7.4	4.1	10.9	25.0	10.8	29.6	40.6	18.1	13.1	19.0	80.1	33.6	12.5	32.9	32.6	70.1	14.7	77.1	21.0	18.7	25.1	19.1	22.0	14.1	42.2	12.5	70.0	10.9	3.1	13.7	10.8	22.1	35.0	51.6	0.2	1.7	0.1	15.0	7.7	38.3	3.2	29.4	36.2	25.5	28.0	20.6	24.6	44.8	23.2	24.3	29.2	1.8	32.8	33.3	52.3	21.9	36.4	53.6	52.7	73.1	84.6	53.3	33.4	70.8	36.1	53.0	63.5	89.3	143.6	96.0	158.6	151.9	231.2	376.3	186.0	619.7	254.8	230.3	70.7	769.9	510.6	171.3	36.2	149.3	30.7	0.0	172.6	615.0	191.6	116.6	106.3	217.9	268.2	184.3	262.2	186.6	174.4	27.1	173.2	154.2	244.6	542.8	88.7	204.1	113.5	63.1	157.0	607.4	113.5	142.3	169.0	21.1	50.0	131.0	464.4	124.6	105.7	145.7
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.0;Karpas-707: 66.4"					"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.9	28.8	5.0	1.6	1.2	1.6	2.5	0.4	0.7	0.7	10.9	45.0	5.1	0.7	0.4	1.9	34.8	4.1	1.1	26.3	13.9	18.8	21.2	0.3	0.5	31.2	18.6	1.3	1.1	1.8	1.7	1.6	2.3	29.0	24.8	66.4	2.9	1.0	28.4	11.1	26.2	6.3	7.6	1.1	24.6	21.2	7.1	0.8	0.2	0.7	0.2	0.6	1.9	5.3	3.6	7.4	2.6	0.9	7.7	4.5	6.1	4.6	1.9	7.2	2.8	12.3	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6	8.9	13.1	10.4	21.3	14.2	2.8	11.3	17.8	72.3	14.8	43.6	0.0	0.5	58.0	9.9	14.1	16.1	17.1	70.0	16.2	0.4	10.2	18.1	12.7	74.1	13.2	1.6	16.7	19.0	13.3	43.8	27.3	13.9	8.5	1.0	22.4	20.4	6.7	17.5	38.5	60.3	1.5	45.3	19.4	7.2	8.4	13.0	0.3	7.5	39.1	17.4
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135962-123137741	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;intestine: 5.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"hypothalamus: 6.8;pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.3;hypothalamus: 8.0"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				1.9	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.9	0.0	0.4	0.2	0.0	0.0	0.9	0.7	0.0	1.3	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.8	0.7	5.6	5.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	18.3	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	6.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686432-37745247	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.7;kidney: 66.2;pancreas: 18.6"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 73.9;Collecting duct cells: 54.1;Distal tubular cells: 38.1;Ductal cells: 37.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"					"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 53.3"	"Group enriched"	"Detected in some"	5	"basal ganglia: 0.7;hypothalamus: 2.3"	"Not detected"	"Not detected"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.1	4.5	0.0	4.8	3.8	0.9	7.8	0.0	2.8	34.7	0.0	0.0		66.2	7.7	3.7	0.0	0.0	0.0	0.8	18.6	1.6	0.0	0.6	0.0	1.6	3.4	0.0	0.0	3.8	0.0	0.0	5.5	0.3	0.0	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	53.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											8.9	10.2	0.0	2.2	0.0	0.0	0.6	73.9	5.3	3.4	54.1	0.0	0.0	38.1	37.2	26.8	0.0	10.9	0.0	22.1	0.0	0.0	1.8	5.7	4.0	0.1	0.0	13.8	0.0	0.3	7.4	0.6	0.0	0.0	1.8	11.4	0.0	25.3	7.0	0.0	31.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	19.4	2.7
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.4	8.5	8.2	13.4	5.9	9.5	4.8	6.2	4.5	5.6	1.8	9.5	9.5	3.9	4.4	10.7	14.6	11.4	11.6	5.6	5.1	3.9	3.3	3.6	8.8	16.8	4.8	2.8	9.2	11.9	3.4	7.7	10.2	8.6	11.0	9.2	4.0	7.9	9.8	3.7	3.4	3.4	13.8	2.6	5.8	6.4	4.1	8.6	18.3	2.7	3.5	4.5	12.9	5.1	13.9	7.8	5.9	9.1	3.2	1.4	3.9	2.1	16.0	6.8	3.3	1.7	3.5	4.6	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4	6.0	6.5	6.9	14.8	2.5	4.7	6.5	10.2	6.7	9.1	22.7	5.9	6.0	11.6	9.6	220.5	3.5	6.3	0.0	9.5	5.4	4.6	9.3	3.5	4.4	7.6	9.5	3.5	5.5	2.9	54.5	6.4	5.5	3.3	20.8	9.8	6.8	8.8	3.5	7.1	15.1	3.4	6.5	3.8	5.7	4.5	4.4	7.8	2.9	9.3	27.4
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 709.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	6.8	0.0	11.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	54.2	0.1	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	22.1	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	32.3	0.1	709.1	118.4	8.2	1.8	0.0	0.0	0.0
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170591-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 48.2;endometrium 1: 45.6"	"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 28.2;Intestinal endocrine cells: 65.4;Mucus-secreting cells: 25.9;Paneth cells: 38.6;Undifferentiated cells: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 7.8;NK-cell: 12.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;NK-cells: 12.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 56.0;THP-1: 29.4;U-937: 30.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	5.9	2.7	0.3	4.6	0.4	1.2	2.5	0.3	0.3	48.2	15.9	0.3	4.0	0.0	45.6	5.4	0.3	3.4	0.5	0.3	0.3	0.0	7.9	0.3	0.3	0.5	0.3	0.3	1.3	0.3	0.0	0.3	7.7	0.3	22.2	5.3	0.3	0.6	6.6	28.0	2.4	3.1	19.2	0.4	0.3	0.0	3.4	0.3	2.2	0.3	0.3	0.3	19.0	7.6	0.2	1.2	7.8	0.1	12.7	2.3	0.3	6.2	1.3	0.0	18.7	9.4	9.1	0.0	12.4	8.5	5.7	5.3	1.8	5.5	0.0	3.5	9.7	0.0	7.0	4.8	0.0	4.2	2.8	56.0	6.5	4.8	0.1	0.2	2.8	9.9	5.7	0.3	0.4	0.0	0.0	8.6	1.9	0.2	0.0	4.1	0.0	0.0	19.0	0.0	5.0	5.9	0.6	1.2	0.0	10.9	2.9	14.8	0.0	4.3	0.0	0.0	2.1	0.0	29.4	0.0	0.0	5.2	6.6	0.0	0.1	0.0	0.0	0.0	30.5	0.1	7.8	0.1	0.3	2.3	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.0	12.7	0.0	0.4	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	5.8	3.3	0.0	1.0	0.0	0.0	0.0	7.0	0.0	0.4	16.6	0.0	0.0	0.2	18.7	0.0	0.0	0.4	28.2	11.3	0.0	0.0	0.7	0.0	65.4	0.0	4.6	0.0	0.0	2.3	5.0	0.0	25.9	0.0	0.0	38.6	0.4	20.7	0.0	0.0	12.7	1.4	2.3	3.6	0.5	4.4	27.1	7.4
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102811	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 18.1"	"Cell type enhanced"	"Detected in some"	17	"Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	44	"pons and medulla: 15.7"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in single"	35	"pons and medulla: 6.1"	"Region enriched"	"Detected in single"	27	"pons and medulla: 7.7"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	2.7	1.6	0.3	1.9	0.1	0.0	2.6	0.1	0.2	1.4	4.5	0.2	8.7	1.5	3.4	9.7	8.3	6.3	4.9	1.8	0.1	0.0	4.2	0.7	4.7	1.9	0.3	0.1	3.8	0.4	9.6	0.1	0.1	15.7	2.8	3.5	0.1	0.1	4.1	1.2	2.7	4.3	2.4	18.1	2.9	3.7	0.8	0.1	3.8	2.2	2.9	3.3	3.2	3.5	0.0	0.0	1.8	0.3	0.0	0.1	0.0	1.2	0.8	4.2	16.8	0.0	0.0	0.0	0.2	0.1	0.0	0.1	2.2	4.1	0.2	1.9	0.2	2.3	6.9	0.2	0.0	0.0	0.0	2.4	0.0	0.1	0.4	1.9	0.1	0.3	1.0	0.0	3.6	3.4	0.0	2.8	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.1	1.0	0.7	0.0	5.5	0.7	1.2	0.0	0.2	0.0	1.1	0.3	0.0	0.0	2.8	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.7	3.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.1	15.7	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.6	6.2	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.3
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Group enriched"	"Detected in some"	9	"AN3-CA: 29.3;HEK 293: 39.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	29.3	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.7	3.4	0.7	1.1	0.2	0.1	1.3	0.7	0.0	0.0	0.8	39.9	0.4	0.5	0.4	0.0	0.6	1.0	2.4	0.0	0.0	0.3	0.0	1.3	0.9	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	2.8	1.8	3.1	0.0	1.3	0.1	0.6	0.0	0.3	0.3	0.0	0.0	0.4	1.6	1.0	0.0	0.0	0.6	0.0	2.8	2.9	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0											0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	4.8	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	4.4	1.0
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 111.0;Proximal tubular cells: 39.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.9	2.4	0.0	7.5	0.0	0.0	0.4	2.5	4.3	5.2	6.0	3.6	2.7	4.8	7.0	1.9	0.2	4.8	19.7	0.0	3.1	0.0	12.4	0.3	2.8	0.1	0.5	0.4	0.2	4.1	0.2	0.6	7.0	0.0	9.8	8.4	0.0	0.0	1.9	1.2	0.0	1.1	0.3	5.0	0.7	2.5	4.6	0.0	24.4	4.8	19.7	0.0	13.6	0.0	0.0	1.4	0.2	1.9	0.8	0.0	4.7	14.0	2.4	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2	0.0	0.0	0.0	7.5	8.0	0.0	0.3	0.0	0.0	0.0	12.2	0.0	0.4	111.0	0.0	15.9	2.2	3.0	0.0	0.0	4.6	2.7	4.0	0.0	0.0	0.2	0.0	15.5	0.0	0.0	2.1	0.6	0.5	3.3	0.0	11.2	0.0	0.1	10.4	0.0	39.0	0.0	0.0	7.3	0.4	0.2	10.8	0.2	0.9	15.7	2.6
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	23	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.9	3.9	1.9	0.0	0.0	0.2	0.1	2.2	2.0	3.1	23.4	1.5	0.4	0.1	4.1	0.0	0.0	8.0	11.3	7.6	0.7	0.0	5.0	0.0	14.4	3.8	0.0	5.7	0.0	0.8	6.6	5.2	11.4	0.2	5.6	0.0	1.8	0.0	0.0	2.1	0.0	0.0	4.4	1.6	4.6	1.9	0.0	0.0	0.6	0.0	2.9	1.6	0.4	1.5	2.5	0.3	0.2	0.8	0.2	1.9	4.0	0.7	1.6	0.0	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1											0.0	0.0	1.7	0.9	3.4	0.0	0.8	0.0	1.4	0.0	61.1	0.0	18.4	10.0	0.1	0.0	7.1	0.8	0.0	0.0	11.0	9.7	0.4	3.5	0.0	3.2	0.0	0.0	15.4	1.8	0.0	0.3	1.9	5.0	0.0	2.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	5.2	0.2	21.8	1.6	5.0	10.5	1.5	2.6
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Group enriched"	"Detected in many"	8	"Collecting duct cells: 129.1;Distal tubular cells: 96.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	25	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.5	0.0	2.9	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.0	13.4	6.5	0.9	0.0	0.6	0.2	0.0	0.1	36.8	3.2	9.1	0.0	3.8	0.2	8.6	3.3	0.1	5.3	0.1	2.0	2.5	0.2	2.1	0.0	7.3	0.1	0.0	0.1	0.0	9.1	2.2	0.0	6.2	0.3	25.0	1.2	0.0	0.0	2.0	0.0	3.6	0.0	0.9	1.2	13.9	0.5	2.9	2.3	10.1	0.0	0.0	0.0	0.4	0.0	4.5	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	0.0	0.0	129.1	0.0	0.2	96.2	0.1	0.6	2.2	14.0	0.0	1.6	1.6	2.6	0.3	0.0	0.0	1.4	0.0	7.5	4.9	14.7	0.0	0.9	1.7	0.0	0.0	7.5	0.0	0.9	14.1	0.0	2.1	0.0	0.0	2.1	4.2	6.8	1.0	0.2	1.0	10.3	0.6
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.2;skeletal muscle: 53.2"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 18.8;Distal tubular cells: 53.0;Proximal tubular cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;ASC diff: 23.1;ASC TERT1: 21.3;fHDF/TERT166: 17.9;T-47d: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	8.0	0.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.5	0.3	0.0	0.4	0.0	1.6	6.8	0.1	2.5	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.3	53.2	6.8	0.8	0.5	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	78.1	23.1	21.3	0.1	2.7	6.5	3.7	3.5	0.1	0.2	0.1	0.7	17.9	0.5	8.4	1.1	0.0	1.8	3.9	1.5	0.7	9.7	0.0	0.1	0.0	1.0	10.0	0.1	0.2	0.0	0.0	0.0	2.2	0.6	0.0	2.5	0.4	0.0	1.9	0.0	9.5	0.3	0.0	0.1	0.0	8.2	0.0	0.0	1.0	1.8	2.7	4.0	0.1	26.6	0.5	0.0	2.2	2.8	0.0	3.4	0.3	0.0	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.3	0.0	0.0	0.0	15.7	0.0	0.0	53.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.7	81.2	0.0	0.0	0.1	3.0	4.5	16.8	0.1	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 6.6;Distal tubular cells: 1.7;Fibroblasts: 2.3;Melanocytes: 3.3;Spermatocytes: 3.8;Suprabasal keratinocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;BJ hTERT+: 11.7;HaCaT: 10.3;T-47d: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.7	0.0	23.3	2.2	3.4	0.0	3.4	11.7	5.0	3.7	0.2	0.9	0.0	0.2	3.2	0.0	10.3	4.4	0.0	2.3	0.6	0.1	0.1	7.6	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.0	0.2	1.0	0.0	3.2	1.4	0.0	0.0	0.0	6.6	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.3	2.0	0.2	18.4	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	3.8	0.2	3.3	0.0	0.0	0.0	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.2	0.0	8.5	5.1	6.2	0.0	0.5	0.4	1.0	0.7	3.6	0.5	0.0	0.6	2.5	0.0	1.4	0.2	0.0	0.3	2.7	3.0	0.0	1.0	0.1	0.2	0.0	0.1	5.8	0.6	4.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.3	0.6	0.2	4.4	1.2	1.7	0.1	0.0	1.5	0.9	3.2	0.3	0.0	0.0	0.0	0.2	0.2	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	2.1	3.2	0.6	0.6	0.2	0.0	0.0	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8"	"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.5	1.8	0.0	38.1	13.9	13.3	0.4	1.9	1.9	3.1	2.9	1.6	2.9	1.1	2.5	19.0	0.9	4.3	1.5	0.2	2.8	31.8	11.0	2.0	4.9	0.0	1.5	0.2	4.8	12.6	2.0	6.2	2.2	0.0	0.1	0.1	1.3	0.0	11.0	0.6	0.0	1.2	0.0	0.3	1.6	0.0	1.4	0.0	9.6	0.1	0.0	4.7	2.9	2.8	7.8	3.4	6.7	0.5	0.0	4.0	8.6	4.3	2.7	0.3	0.3	0.0	1.4	0.3	8.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.3	14.9	0.0	1.1	0.2	0.0	0.0	0.0	2.5	27.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	20.8	0.4	11.8	0.0	0.0	0.2	0.0	0.0	14.2	7.8	1.9	6.5	5.0	39.3	1.1	3.4	0.2	0.0	0.0	0.0
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54009106-54012362	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8"	"Cell type enhanced"	"Detected in some"	12	"Fibroblasts: 17.3;Melanocytes: 10.1;Peritubular cells: 7.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.2;ASC TERT1: 15.8;fHDF/TERT166: 28.1;HSkMC: 19.3;LHCN-M2: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.4	0.4	0.7	0.2	0.0	7.1	0.2	0.3	0.5	0.5	0.2	0.2	0.0	0.3	16.7	0.4	6.3	0.6	0.6	0.2	0.0	7.0	0.2	0.2	2.2	0.2	0.5	25.2	0.2	0.0	0.2	1.9	0.4	0.3	0.0	0.2	0.2	0.2	12.8	2.6	4.8	7.9	2.5	0.2	0.0	2.6	0.2	0.3	0.7	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	8.5	24.2	15.8	0.1	1.6	0.0	2.8	1.8	2.5	1.3	0.0	0.2	28.1	0.4	1.0	2.2	0.7	3.2	2.9	3.0	0.4	1.1	0.0	3.0	0.0	3.3	19.3	2.2	9.0	5.3	0.3	0.2	0.5	0.3	0.0	21.1	0.7	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	3.2	0.0	0.0	1.1	2.9	0.5	7.4	2.1	0.8	0.0	0.0	0.5	4.5	3.9	0.9	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.4	0.2	0.0	0.0	0.0	0.1	4.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	17.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	10.1	0.0	0.0	0.0	0.0	0.0	7.4	4.4	0.8	6.5	1.7	5.4	2.7	3.8	0.2	0.0	0.0	0.0
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	32	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	9.9	0.5	14.2	9.5	0.1	0.1	3.9	0.2	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	13.3	0.0	12.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	1.6	0.0	0.0	0.3	0.7	0.5	1.1	0.0	0.0	0.5	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell type enhanced"	"Detected in some"	17	"Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1"					"Region enriched"	"Detected in single"	28	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.8	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.3	1.6	0.4	0.1	1.5	0.0	0.2	0.0	22.1	0.2	0.0	0.0	0.3	0.0	0.0	5.0	1.5	0.0	0.2	0.1	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	16.4	2.6	1.3	2.2	0.3	0.0	6.1	0.4	0.0	0.0	2.8	0.2	0.1	1.4	1.2	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	3.7	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	4.4	0.0	1.7	0.0	0.6	0.0	0.1	0.0	2.8	5.3	0.0	6.5	0.5	0.2	0.2	0.5	0.0	0.0	1.2	0.0
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.7	1.1	0.6	5.7	0.0	0.0	0.7	0.0	12.2	0.0	0.7	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	14.4	5.3	3.3	16.8	4.1	0.0	9.2	0.8	0.0	0.0	12.7	0.0	2.8	4.1	4.4	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	1.5	2.2	0.0	0.6	0.0	0.0	0.0	22.7	0.0	0.0	31.5	0.0	0.2	11.7	0.0	0.0	0.0	0.2	1.0	0.9	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.5	31.7	0.0	1.7	0.0	2.1	0.0	0.0	0.0	25.1	2.2	0.0	38.8	0.8	0.7	1.2	1.6	0.0	0.0	4.1	0.5
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	35	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	47.2	0.6	0.0	0.8	0.2	11.7	3.1	2.4	0.1	0.6	0.0	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.0	0.3	13.3	0.3	0.5	0.1	0.5	0.0	0.0	0.9	0.0	0.0	2.2	0.1	5.8	8.6	16.6	0.2	9.1	0.0	2.6	0.0	7.7	0.1	0.1	9.3	0.6	6.0	29.8	4.6	0.6	0.0	2.5	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.3	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6	0.0	0.0	1.9	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.6	3.3	0.5	0.1	0.3	0.7	0.0	0.0	1.7	0.4	0.9	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	2.1	1.0	4.2	0.0	6.6	1.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	12.3	11.4	25.2	9.1	34.5	5.0	16.2	16.1	25.3	7.9	9.5	8.1	10.8	8.9	6.2	9.2	22.3	8.3	10.9	28.7	22.2	22.4	8.2	6.5	8.9	8.0	23.2	12.9	7.7	9.7	11.7	10.3	10.1	15.0	10.0	6.2	8.2	10.1	12.7	51.8	32.0	8.2	8.4	17.0	6.5	7.2	6.1	11.0	5.9	8.1	24.5	9.3	9.9	19.8	2.1	1.1	0.7	4.6	0.1	2.0	0.3	22.1	19.7	9.4	8.4	5.8	4.1	12.2	11.0	5.9	17.4	14.8	9.9	8.8	8.6	3.4	15.0	12.3	17.6	10.0	26.8	4.9	7.0	22.4	4.4	7.9	8.6	8.9	3.5	3.4	6.3	30.0	9.4	10.2	3.6	8.6	7.2	8.9	12.5	9.7	18.2	12.9	12.2	9.6	7.7	19.5	10.3	11.9	7.6	9.7	5.5	36.7	14.6	10.3	18.3	7.9	5.9	15.0	6.8	13.7	15.5	12.2	5.7	14.2	4.6	6.2	6.5	14.6	6.4	14.5	0.0	0.6	0.7	1.4	1.2	1.6	0.8	1.4	1.3	0.7	2.1	2.0	0.6	0.0	0.1	4.6	1.1	2.0	0.3	25.2	34.5	16.1	21.1	22.2	22.4	23.2	12.9	15.0	11.0	11.9	12.5	12.6	82.5	116.5	44.6	21.9	15.3	17.4	4.5	33.2	17.7	72.6	63.0	32.7	1.1	22.2	44.1	0.0	32.3	45.3	34.0	46.2	2.3	13.4	33.9	46.1	28.2	19.0	7.6	5.2	15.8	17.6	60.8	16.2	22.1	28.3	35.8	21.0	21.5	42.9	29.1	32.3	38.7	4.7	23.4	127.5	65.3	12.2	21.3	96.6
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.8	0.3	1.1	0.1	1.3	2.8	0.0	0.0	0.1	0.1	4.5	1.0	0.0	2.1	0.0	0.1	5.8	3.9	0.4	0.0	0.0	1.3	0.0	0.5	4.8	0.4	0.5	0.0	1.3	2.3	0.2	0.0	0.0	0.0	3.5	0.3	0.0	0.0	2.8	0.1	0.1	8.7	21.3	0.7	0.0	0.1	10.2	0.4	10.3	11.4	0.7	0.6	10.2	0.4	1.0	4.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3	0.0	0.3	0.0	8.0	1.3	0.0	0.5	33.1	0.0	1.2	181.5	0.0	0.8	38.1	1.7	0.1	0.0	273.5	0.0	2.7	0.7	3.1	15.6	9.2	1.3	1.3	0.0	25.8	1.3	0.0	0.0	23.6	0.0	1.7	0.0	229.5	0.0	0.8	137.2	6.3	14.6	0.0	12.9	0.4	0.2	1.0	3.0	95.8	0.0	114.3	5.7
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 1569.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.8;U-266/84: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.5	0.0	9.0	0.9	11.8	0.8	2.1	4.6	1.0	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17.0	0.0	0.0	1.3	0.0	0.0	2.5	0.4	0.0	23.3	0.0	2.4	4.8	9.9	0.0	1569.2	0.3	0.0	0.0	31.3	41.1	1.5	11.5	0.1	0.0	1.8	0.3	1.0	0.1	0.0	1.4	0.0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314722	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	24.7	22.9	17.4	21.0	20.9	20.8	30.8	24.4	23.6	21.3	26.9	18.3	17.7	18.9	23.3	16.7	25.5	28.5	22.9	42.8	17.0	17.5	21.2	19.5	20.3	23.6	17.4	15.9	32.4	36.8	25.8	21.8	22.8	17.8	26.7	15.2	20.7	26.4	24.6	55.2	20.3	17.8	35.1	14.4	20.3	23.6	42.6	17.8	23.2	29.9	24.2	19.8	30.3	33.9	16.9	20.3	20.3	24.2	12.9	18.4	14.2	14.9	20.3	8.8	7.5	14.8	13.9	14.6	11.2	10.1	11.1	9.7	13.5	13.1	17.2	16.5	15.5	10.9	10.9	13.4	16.1	7.1	10.9	15.4	21.6	20.8	18.4	23.3	6.2	16.7	13.4	15.1	15.6	28.8	11.9	14.9	15.8	14.3	10.3	11.1	30.3	21.0	9.5	11.3	19.5	58.5	13.7	7.6	21.8	7.9	15.2	13.2	10.7	17.1	13.7	19.8	9.6	15.5	12.8	15.1	11.5	25.8	18.0	18.3	7.2	5.5	14.7	16.3	11.7	10.9	10.6	18.9	20.3	14.5	19.9	15.2	16.9	15.7	18.4	20.3	15.5	15.6	13.9	8.1	12.9	24.2	10.3	18.1	14.2	17.4	20.9	24.4	23.6	17.0	17.5	17.4	15.9	17.8	17.8	6.0	9.1	21.9	60.6	45.6	58.9	41.2	17.8	10.7	19.4	27.9	58.9	60.8	127.6	35.7	199.9	36.5	42.1	116.8	35.5	68.5	39.0	54.5	38.0	51.9	43.8	65.2	39.3	33.7	16.6	84.0	34.5	33.3	32.1	83.0	34.7	20.4	41.5	46.0	40.3	29.1	29.9	58.2	52.3	56.5	53.2	39.6	92.8	41.7	42.2	66.0
HSF2BP		ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529192-43659493	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 28.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 98.0;Late spermatids: 32.5;Spermatocytes: 127.5;Spermatogonia: 47.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 14.6"	"Low region specificity"	"Detected in some"							"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.7	0.8	1.3	0.6	3.1	0.5	1.1	1.4	4.1	0.9	0.6	3.5	1.8	0.6	1.1	1.1	0.8	1.2	0.7	0.7	1.3	1.5	0.8	0.6	0.6	0.7	2.3	3.0	1.4	0.6	1.2	2.3	1.6	2.7	0.8	0.6	2.6	1.2	1.4	0.5	0.8	0.7	0.7	2.0	0.5	0.7	28.5	1.6	1.0	1.0	0.0	0.6	0.8	0.8	1.5	0.2	0.0	0.1	1.5	2.8	0.8	5.1	1.1	1.4	0.6	0.2	1.4	1.3	1.8	1.1	1.9	1.6	6.9	5.1	3.9	2.9	1.0	6.6	2.0	0.7	14.6	0.6	1.0	1.3	0.6	2.2	0.4	1.7	1.6	0.4	0.9	9.6	0.8	4.5	8.8	0.5	2.3	1.5	1.2	4.5	0.9	2.2	1.6	4.5	1.2	2.2	3.3	1.4	0.5	2.3	1.0	1.5	1.1	3.8	1.9	2.0	0.6	2.0	1.9	2.9	1.0	3.5	0.2	2.7	1.4	0.9	3.1	1.0	3.4	2.6	0.0	0.1	0.0	0.2	0.0	1.6	1.2	0.5	1.4	0.2	1.5	2.7	2.8	0.0	1.5	0.1	0.2	0.0	0.8	1.3	3.1	1.4	3.6	1.3	1.5	2.3	3.0	2.7	1.6	0.0	0.0	0.0	1.2	0.8	1.0	0.4	0.0	4.0	1.2	0.0	0.0	1.5	0.0	1.0	98.0	0.1	0.0	0.0	0.2	2.3	1.0	0.7	0.0	0.0	0.6	0.0	0.0	0.6	0.0	32.5	1.7	0.3	0.0	0.0	0.0	2.3	1.6	0.0	1.4	0.5	2.5	12.9	1.0	127.5	47.1	0.4	0.7	0.0	0.0	1.0
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Group enriched"	"Detected in many"	19	"Early spermatids: 201.6;Late spermatids: 418.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	1.0	0.0	0.0	6.8	0.0	0.0	0.2	0.2	1.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2	0.0	0.6	0.0	0.6	0.8	2.1	3.6	0.0	1.4	1.2	0.0	7.9	0.4	0.0	0.7	201.6	1.0	0.5	0.0	0.2	0.4	0.5	1.1	0.0	0.9	1.1	3.2	1.7	3.1	2.4	418.3	4.6	1.5	5.0	1.8	0.6	3.3	0.3	0.8	2.1	0.3	2.8	0.0	1.4	16.4	7.7	0.1	0.3	2.5	1.0	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0;skeletal muscle: 90.5"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 125.6;Distal tubular cells: 202.2;Extravillous trophoblasts: 456.2;Spermatocytes: 391.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.1;BEWO: 39.2;BJ hTERT+: 33.5;CAPAN-2: 17.8;SCLC-21H: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		77000000	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	5.2	3.3	21.1	5.2	45.3	1.5	5.2	3.7	37.6	3.3	23.3	87.0	0.1	4.4	13.8	12.8	25.2	7.2	4.2	22.8	33.2	18.7	26.6	2.6	4.5	3.2	71.0	20.6	2.4	3.8	7.5	4.3	37.6	37.7	3.8	6.9	3.5	10.2	4.0	90.5	14.8	7.8	17.9	83.8	8.5	5.7	58.8	65.2	0.0	2.3	8.2	3.9	12.4	4.0	0.7	0.3	2.4	0.6	0.9	3.7	0.5	9.9	25.1	3.9	0.0	2.8	0.2	39.2	14.2	33.5	5.7	9.4	0.9	17.8	2.4	5.7	15.4	1.2	11.2	0.0	0.7	3.5	1.4	1.9	0.0	1.4	0.0	2.8	0.0	3.4	1.3	0.5	0.8	0.0	1.4	0.4	0.1	0.0	2.0	2.8	4.4	0.1	0.1	2.8	3.8	3.0	1.9	0.0	0.0	8.8	1.5	34.8	2.0	0.6	1.2	0.0	1.4	0.9	1.0	0.5	0.1	0.0	1.2	0.0	2.6	0.0	0.0	3.1	0.0	3.8	0.9	0.2	0.1	1.8	0.4	0.1	0.7	1.7	0.8	0.0	0.5	0.6	0.6	2.4	0.9	0.6	0.3	3.7	0.5	21.1	45.3	3.7	28.3	33.2	18.7	71.0	20.6	37.7	65.2	0.0	6.9	3.7	22.1	48.0	0.8	28.8	5.1	0.0	1.2	125.6	0.0	29.0	202.2	6.3	19.7	28.0	12.9	0.0	4.7	456.2	53.6	6.7	12.7	0.8	13.8	0.0	27.0	29.4	4.3	20.1	8.1	5.5	28.7	0.0	33.0	13.8	5.0	6.6	7.1	1.2	2.3	25.8	25.0	391.8	54.3	36.9	63.5	5.3	9.3	12.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133051962-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		10000000	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	20.6	35.0	26.6	25.6	27.6	20.5	39.0	25.9	35.6	19.4	20.5	18.7	19.9	17.4	23.3	20.2	42.0	19.2	18.9	32.9	26.4	31.9	30.3	31.1	17.2	28.9	30.9	24.5	23.2	19.5	37.1	32.8	24.5	34.3	18.9	23.9	16.0	20.3	19.2	48.3	19.6	18.5	23.6	25.9	20.0	20.9	39.8	29.5	27.3	26.8	24.8	38.6	24.5	77.1	27.7	17.9	15.5	23.0	14.1	14.9	11.5	32.4	44.7	31.2	50.9	29.8	25.1	56.8	35.6	26.8	34.6	42.9	83.9	34.1	54.0	37.5	34.2	81.6	29.0	54.2	58.9	50.1	24.9	31.1	39.8	30.0	45.9	23.8	24.7	34.9	24.9	24.9	44.5	29.3	19.8	32.9	26.4	41.6	16.7	37.7	28.6	34.6	18.4	42.8	25.3	20.7	31.8	38.3	28.7	31.2	42.8	24.9	20.5	33.9	17.8	47.3	61.0	26.2	24.2	28.8	31.5	45.3	26.9	42.1	19.3	42.6	41.5	26.9	41.0	31.2	14.8	14.4	15.5	12.6	23.0	14.9	22.6	11.6	13.0	17.9	27.7	12.1	11.2	9.6	14.1	16.4	6.8	11.3	11.5	26.6	27.6	25.9	35.6	26.4	31.9	30.9	24.5	34.3	29.5	59.6	36.4	64.0	74.4	37.2	50.9	98.8	30.6	76.3	54.6	21.0	51.1	57.8	23.2	43.7	30.6	26.4	31.6	23.3	43.2	54.8	30.3	48.9	54.2	27.0	56.2	33.4	45.3	19.0	22.6	20.2	21.6	43.3	28.7	66.7	30.9	56.8	43.7	22.8	24.4	39.4	121.6	25.8	30.7	92.5	94.9	36.5	72.9	27.7	26.5	65.5
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526910	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;vagina: 99.8"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 208.5;Cone photoreceptor cells: 119.8;Glandular cells: 327.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 67.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 67.6"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 34.0"									"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	6.8	11.9	9.4	10.3	12.4	3.5	43.0	3.5	6.0	1.4	1.9	2.2	1.7	1.9	2.2	1.3	3.2	1.1	9.6	4.5	4.5	9.3	3.1	14.6	13.5	2.1	13.7	1.3	9.3	5.4	0.9	5.4	20.8	5.7	3.3	1.9	1.7	2.9	5.8	1.4	4.4	1.7	4.2	13.2	11.2	3.6	1.4	5.0	1.3	5.8	1.8	2.8	3.1	99.8	0.0	2.5	67.6	9.0	1.6	1.4	2.1	0.5	1.0	0.0	0.2	0.0	0.8	0.7	0.4	0.3	0.1	0.3	0.3	0.5	0.1	1.5	0.1	0.5	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.9	0.0	0.0	0.1	2.2	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.4	34.0	0.0	0.0	0.1	0.8	0.0	0.2	3.6	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.6	1.9	0.1	0.3	0.4	0.1	0.1	0.3	0.3	2.3	4.7	0.2	0.0	0.9	0.8	1.5	0.8	7.5	2.7	1.4	9.0	0.2	0.0	0.1	0.7	2.5	0.0	0.0	0.3	67.6	1.6	7.3	0.0	0.0	2.1	9.4	12.4	3.5	6.0	4.5	9.3	13.7	1.3	5.7	5.0	8.9	12.4	14.4	208.5	26.1	28.3	9.9	0.0	2.7	2.3	5.2	119.8	0.9	0.0	0.1	1.3	20.4	0.0	0.0	0.0	6.9	58.3	327.0	2.3	0.0	62.4	9.5	68.0	1.3	51.5	0.4	5.2	96.6	97.8	0.0	0.0	27.5	0.4	0.0	0.0	1.0	32.8	0.0	68.0	1.9	0.2	19.1	15.3	34.5	0.0	46.1
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 2008.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		210000000	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	70.0	96.8	93.7	78.1	102.8	58.1	73.8	119.5	125.1	52.8	64.1	72.0	77.3	77.7	59.9	98.3	83.4	76.2	76.7	106.4	83.1	102.4	128.6	114.2	68.9	93.3	105.7	72.4	66.7	191.1	97.2	98.3	71.6	169.2	65.3	81.0	53.1	62.4	69.9	224.6	31.2	74.4	75.4	91.8	79.7	92.7	58.3	98.1	92.9	90.9	98.3	124.4	76.1	123.2	77.4	47.5	41.1	84.2	76.1	124.3	200.0	81.9	124.3	82.5	71.3	76.5	82.0	109.4	163.1	90.4	199.5	120.1	186.5	108.0	133.6	103.0	90.7	141.2	111.7	235.9	59.1	199.2	115.5	35.8	144.9	58.5	90.9	20.9	140.8	111.4	43.7	95.7	61.3	19.1	103.7	106.7	18.2	156.8	69.6	159.8	73.0	146.4	104.5	130.6	200.3	110.8	132.1	58.9	75.5	103.3	60.0	84.8	64.2	118.8	129.0	45.0	91.8	112.5	55.1	104.9	100.3	80.5	86.1	144.5	47.0	115.8	114.7	111.7	201.3	120.9	30.3	41.5	41.1	96.5	82.9	115.9	77.4	113.4	105.2	47.5	53.7	109.6	105.1	14.9	76.1	84.2	34.4	124.3	200.0	93.7	102.8	119.5	125.1	83.1	102.4	105.7	72.4	169.2	98.1	178.6	194.1	380.7	2008.3	250.8	192.6	358.3	247.1	397.5	238.8	123.9	119.8	806.4	447.6	560.1	23.5	383.9	634.1	256.9	544.3	848.9	487.1	803.7	432.1	181.5	715.5	171.6	498.1	192.8	238.1	50.8	206.0	453.5	501.0	661.9	246.7	285.3	500.3	403.3	253.8	795.2	189.9	239.3	546.5	180.9	436.7	248.7	1264.6	601.2	394.7	698.3
HSPB11	"C1orf41, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945929	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	12.2	19.7	21.5	20.1	19.5	22.6	19.5	13.1	18.6	17.4	15.6	9.5	19.4	11.0	19.1	30.6	19.0	31.9	11.0	12.9	15.4	16.0	16.0	20.0	19.9	24.0	15.0	18.7	20.8	13.4	9.5	31.3	18.2	16.8	15.1	14.6	22.4	13.3	25.1	5.6	16.0	13.1	17.8	17.3	16.0	15.6	19.6	10.0	27.1	40.4	15.0	24.2	23.5	14.3	28.6	35.9	37.5	20.0	31.1	35.0	16.8	20.7	8.9	27.5	6.5	9.5	12.6	11.1	18.6	15.9	25.8	30.5	20.5	11.7	25.1	14.5	12.6	46.9	16.9	11.3	17.7	30.9	20.3	16.3	30.8	19.3	27.5	10.3	15.4	21.6	13.1	13.5	24.4	6.9	17.0	13.5	15.4	18.0	6.0	32.1	4.3	34.3	23.8	11.1	16.4	19.3	23.3	34.9	12.9	20.9	23.1	14.0	11.5	26.3	12.1	16.7	27.5	75.5	22.4	10.0	18.1	22.2	20.2	19.5	10.9	16.2	24.8	28.6	14.5	15.5	35.4	14.8	37.5	28.0	19.0	25.1	28.6	27.8	33.0	16.8	22.9	21.9	28.0	10.3	31.1	20.0	35.9	35.0	16.8	21.5	19.5	13.1	18.6	15.4	16.0	15.0	18.7	16.8	10.0	29.8	26.1	55.8	65.1	94.4	20.9	30.8	43.3	235.5	68.2	48.8	7.9	156.8	99.5	53.0	36.0	40.6	41.8	0.0	57.6	83.4	59.6	60.9	60.0	64.4	99.0	12.7	74.2	30.1	40.7	11.5	57.0	60.6	74.2	95.6	37.1	67.6	70.4	49.1	59.8	97.6	16.4	38.8	75.1	103.5	92.0	72.4	97.7	63.3	38.8	99.6
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 738.6;Urothelial cells: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	13.7	26.5	21.8	2.1	21.0	11.9	14.5	23.9	21.3	37.2	17.3	31.1	21.5	35.8	15.0	16.6	52.9	26.8	84.1	21.2	48.1	28.0	10.6	31.0	14.6	27.4	6.9	21.5	24.8	7.5	49.2	24.8	14.3	19.5	21.5	12.6	25.9	5.7	26.1	18.8	30.8	24.6	31.0	67.6	19.8	24.3	17.9	11.8	28.1	16.8	22.6	18.8	21.8	21.4	11.0	34.9	7.2	21.0	13.1	12.8	16.3	18.4	26.4	4.5	14.7	30.7	10.7	26.1	21.4	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6	122.1	81.5	33.2	738.6	190.6	38.7	130.6	17.8	302.5	185.4	43.6	392.7	17.7	24.9	44.8	71.1	92.6	26.2	0.0	31.1	55.8	207.2	407.7	251.8	21.5	79.0	28.6	217.9	24.5	27.7	22.4	31.4	113.0	155.3	47.7	22.5	16.6	37.1	45.6	36.7	22.8	57.7	38.8	156.8	128.9	138.0	125.3	35.6	28.0	26.7	485.8
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3074681-3243960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 170.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	12.9	13.8	19.4	16.6	18.3	14.1	12.3	24.7	32.3	10.0	13.6	11.6	11.0	10.5	11.5	15.9	16.3	11.6	9.4	8.9	19.7	12.1	11.3	13.1	21.5	18.1	11.8	19.5	13.0	27.0	29.5	13.0	12.0	12.8	10.5	11.4	13.3	10.2	11.4	19.1	25.4	12.8	12.0	10.4	17.4	12.0	14.9	10.4	17.4	13.3	7.3	15.6	11.7	9.6	2.9	3.5	2.8	4.5	2.9	4.3	1.9	12.4	8.7	12.2	7.2	22.4	12.8	12.4	5.8	7.2	8.8	8.3	11.5	8.1	19.1	6.2	14.0	16.1	7.1	14.4	10.6	8.9	5.0	10.6	18.2	12.4	12.2	5.3	12.2	26.7	8.9	6.5	17.2	8.1	6.0	10.2	8.6	11.9	6.9	7.7	12.0	13.0	11.5	14.9	6.3	14.1	11.7	11.7	3.7	9.4	12.9	13.4	9.5	10.4	3.9	10.2	9.7	10.8	7.6	14.1	12.3	7.7	8.4	13.0	5.3	6.2	15.2	9.2	11.3	8.8	0.0	2.6	2.8	3.5	3.4	2.4	2.9	2.7	4.3	3.5	2.4	2.0	2.4	0.4	2.9	4.5	2.6	3.5	1.9	19.4	18.3	24.7	32.3	19.7	12.1	11.8	19.5	12.8	10.4	23.8	15.0	13.9	7.0	12.2	42.6	10.1	20.4	5.3	13.6	14.0	170.8	10.3	5.0	10.2	9.0	10.8	18.4	0.0	14.9	9.2	10.8	13.1	11.5	13.5	23.3	42.9	17.7	23.9	23.5	7.5	15.0	14.5	8.5	13.6	11.4	19.1	18.0	20.1	11.0	9.8	45.2	12.9	7.1	10.4	19.4	17.6	7.0	10.2	16.2	9.9
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9.0	3.4	1.1	3.3	1.0	1.7	3.7	3.2	6.0	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4.0	6.5	9.1	1.5	11.1	0.6	5.0	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1.0	3.8	7.7	1.0	0.7	1.7	0.5	0.5	0.5	0.1	0.0	3.0	10.6	0.1	0.0	0.0	13.0	1.0	0.0	0.2	0.0	4.2	0.1	0.0	0.4	4.9	0.2	0.1	6.2	0.0	0.0	0.0	3.2	0.0	2.8	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.2	0.9	8.0	0.0	0.1	0.1	14.4	0.0	1.1	0.0	11.7	7.8	10.3	0.8	0.4	7.7	4.3	1.1	0.0	0.0	7.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.0	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1.0	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2	6.0	7.8	0.0	1.8	4.5	4.3	3.2	17.8	1.4	4.5	7.0	2.0	8.1	0.0	3.8	0.0	0.9	2.7	0.0	2.9	11.6	10.6	1.6	0.0	0.9	2.3	3.2	4.7	0.0	0.0	0.0	0.3	0.0	3.3	0.0	3.9	11.4	2.6	2.9	0.0	1.5	1.2	0.0	1.4	0.9	0.7	5.1	5.1	0.0	9.0	0.8
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.3"	"Cell type enhanced"	"Detected in some"	9	"monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.5	0.1	0.1	0.5	0.1	3.3	0.6	0.0	0.0	1.4	0.4			1.3	0.9	0.7	0.9	0.2	0.6	0.5	0.2	0.1	0.6	0.8	1.0	0.2	0.3		0.8	0.0	0.0	0.8	1.1		1.4	0.2		0.5	0.1	0.0	0.9	0.3	1.0	0.6	1.0	0.1	4.3			0.7		0.2	0.3	1.2	1.6	1.6	0.0	0.7	0.0	1.9	0.6	0.7	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.8	0.1	0.3	0.5	0.1	0.4	0.0	0.5	0.0	0.4	1.3	4.4	0.9	0.0	0.0	0.4	0.0	1.5	0.0	0.3	0.4	0.4	0.0	0.1	1.1	1.7	1.0	0.5	0.0	0.5	2.4	2.8	0.0	1.4	0.9	0.8	2.5	0.2	0.6	1.0	0.2	0.3	0.0	0.7	0.5	0.1	0.1	0.4	0.7	0.8	1.5	0.4	2.3	5.1	1.0	0.1	0.6	5.5	0.0	0.7	0.0	0.7	0.3	0.5	1.6	1.1	0.9	0.0	0.8	1.0	1.9	0.0	0.0	0.0	1.6	0.7	0.6											0.0	0.0	0.5	0.6	0.6	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.7	0.7	0.0	0.0	0.5	1.0	0.4	0.5	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.5	0.9	0.0	1.1	0.0	1.7	6.5	0.5	7.6	4.7	1.5	1.3	1.5	0.2	0.3
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.2	31.0	20.2	14.2	35.4	21.2	24.9	15.1	19.5	16.0	16.7	23.6	16.2	26.4	10.3	27.5	28.8	24.2	45.6	25.3	21.9	38.0	20.2	21.0	27.8	18.3	32.5	31.4	12.9	20.2	19.0	38.3	44.1	15.8	27.6	20.7	20.9	17.1	20.7	31.0	17.0	17.6	27.6	13.8	22.3	15.7	27.8	16.0	26.5	34.9	16.9	12.2	42.7	19.1	13.6	39.5	27.3	15.3	35.1	14.7	21.1	21.0	19.2	15.0	14.8	23.0	15.7	30.8	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7	47.6	43.2	23.8	25.3	26.8	53.1	98.6	45.9	37.5	36.4	38.4	47.1	26.9	1.7	35.4	22.3	29.2	24.7	0.0	30.4	29.3	24.4	33.4	20.9	43.1	21.9	77.9	45.8	31.3	25.6	21.6	26.2	26.1	25.3	40.5	28.4	20.9	40.0	17.3	36.7	12.2	31.9	12.9	33.0	17.1	43.7	36.4	31.7	37.1	29.2	40.4
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43803043	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	7.5	11.3	10.8	10.1	13.7	22.1	7.3	29.4	11.1	7.0	8.3	8.4	7.0	8.4	8.5	8.8	8.2	7.9	7.3	17.3	9.3	6.5	13.2	30.5	13.7	11.3	13.3	9.7	10.4	18.0	6.7	11.9	8.1	14.1	13.3	13.5	5.7	11.0	7.1	36.8	13.4	10.2	7.4	8.6	11.1	14.4	14.0	12.0	6.0	11.1	13.1	11.0	8.3	10.8	7.8	3.9	8.3	8.9	4.4	9.6	1.5	1.5	1.9	5.6	3.4	4.7	5.4	3.5	3.0	1.3	2.2	1.6	4.9	1.8	2.5	1.8	1.5	1.3	5.2	4.7	3.6	2.2	2.5	3.3	3.5	9.0	2.7	2.4	2.0	2.7	4.2	6.7	1.6	3.0	6.2	2.3	5.0	3.9	4.9	2.3	4.2	2.5	5.1	1.8	3.0	4.1	3.2	1.8	2.9	3.7	5.5	3.5	2.5	2.4	5.0	0.7	3.9	5.0	2.4	4.5	6.2	3.6	4.1	2.8	5.8	6.1	5.8	4.8	5.9	2.4	6.2	4.4	4.2	5.4	3.2	8.0	3.2	7.5	6.3	3.0	7.8	9.6	7.8	8.3	4.4	8.9	3.9	5.2	1.5	10.8	13.7	29.4	11.1	9.3	6.5	13.3	9.7	14.1	12.0	6.0	12.6	9.5	13.9	26.7	10.4	0.8	5.1	14.7	15.9	7.0	51.1	5.6	8.3	1.5	2.3	5.8	5.5	0.0	7.2	3.8	9.7	13.6	8.1	5.5	3.4	12.7	10.3	8.6	2.1	0.9	4.6	13.4	21.9	2.8	7.6	4.0	4.7	3.6	2.1	8.6	27.1	0.0	15.0	4.2	3.7	32.6	4.1	8.6	7.1	8.1
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.0	36.3	20.3	32.0	33.5	37.8	32.2	37.2	35.5	29.5	36.1	12.7	22.6	47.6	14.7	57.4	32.5	43.9	62.6	48.4	37.3	29.9	23.3	29.0	31.3	22.6	70.8	39.5	21.5	36.8	54.4	51.4	85.1	19.4	31.0	57.2	51.1	43.3	41.4	25.5	36.5	15.4	32.9	74.5	33.6	25.6	30.9	22.9	24.3	17.6	26.0	21.6	25.2	27.7	35.0	22.9	22.2	24.8	22.8	21.8	27.3	36.0	30.2	31.7	40.5	25.2	51.0	30.5	40.2	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9	17.9	25.5	29.7	27.4	60.8	34.2	44.5	40.8	24.1	27.3	17.4	43.2	23.5	13.3	22.2	8.9	20.8	5.4	0.0	25.9	26.2	31.1	25.2	36.9	26.0	15.7	9.5	11.5	16.0	21.6	4.0	26.4	17.7	13.5	11.8	23.8	15.5	26.0	8.6	27.6	29.1	34.6	6.5	32.5	39.2	38.1	59.2	14.5	18.7	26.3	27.4
ICE1	KIAA0947	ENSG00000164151	"Interactor of little elongation complex ELL subunit 1"	Q9Y2F5	5	5420664-5490234	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054452, HPA061934"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA054452: AB_2682492, HPA061934: AB_2684641"	"unprognostic (1.45e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.39e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.33e-1)"	14.3	13.2	16.3	13.2	17.3	17.4	18.1	26.7	20.6	17.7	15.1	10.3	13.4	10.6	18.3	14.2	11.6	15.0	10.8	12.3	14.4	13.3	15.5	11.3	12.0	15.5	15.5	16.8	21.7	14.2	27.3	22.5	18.5	17.1	13.5	12.0	8.8	12.9	14.0	28.2	12.8	13.4	20.0	16.3	14.0	13.6	10.7	14.2	21.6	15.5	13.8	16.2	15.5	17.8	3.4	3.8	3.6	2.3	3.4	3.9	1.2	9.3	11.9	13.6	13.0	13.3	13.1	17.6	8.1	9.7	9.8	10.9	9.1	7.0	12.7	11.4	11.7	19.4	8.9	18.7	9.5	16.6	17.6	9.5	10.3	35.9	6.6	8.1	23.2	8.5	10.4	10.3	11.7	18.3	9.8	12.1	9.7	14.6	10.7	10.2	8.2	16.9	8.3	11.5	6.0	10.1	19.9	12.4	8.6	8.3	10.7	8.9	9.2	28.3	9.3	10.9	13.8	8.0	7.4	13.6	12.8	16.4	16.4	12.7	11.7	13.7	21.6	10.8	17.6	10.8	1.5	1.8	3.6	3.3	2.3	3.9	3.4	3.0	3.1	1.7	3.0	2.7	3.2	0.5	3.4	1.2	3.8	3.5	1.2	16.3	17.3	26.7	20.6	14.4	13.3	15.5	16.8	17.1	14.2	20.8	25.6	14.9	12.0	0.0	37.6	27.4	12.7	12.0	26.1	15.7	29.5	30.4	21.6	19.6	4.4	21.2	9.3	0.0	19.5	19.2	15.8	14.8	10.5	11.3	13.3	42.9	8.6	13.5	16.1	4.5	20.8	13.6	0.0	22.6	10.5	25.0	19.3	5.8	20.8	12.0	34.8	6.5	20.8	30.9	45.8	0.0	9.2	21.3	9.9	15.5
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	12.1	11.5	7.7	9.2	11.5	6.7	11.0	9.8	9.2	11.4	9.1	10.2	14.1	6.1	11.9	8.0	9.6	10.3	8.8	8.2	8.2	6.0	10.6	9.2	8.6	10.9	13.3	6.3	15.4	9.1	44.0	25.6	10.2	9.7	11.7	9.6	7.7	9.4	9.9	10.7	9.1	8.6	10.8	10.1	10.0	9.0	8.6	13.4	19.5	14.0	8.1	12.3	10.7	11.3	10.9	6.6	5.9	7.4	4.4	11.7	6.9	8.8	15.7	13.3	12.7	10.1	11.1	6.9	5.2	8.2	8.4	9.2	12.2	6.6	15.5	11.6	5.6	16.0	16.9	17.6	7.0	11.7	18.6	7.9	15.6	11.1	7.1	5.4	17.1	11.1	5.5	8.6	6.9	12.6	11.2	13.8	15.4	23.8	14.6	10.4	3.8	13.6	4.5	16.5	16.3	10.6	16.3	10.5	13.6	6.8	11.0	15.1	14.5	7.4	7.6	9.3	16.4	12.3	8.9	6.5	11.8	10.4	9.9	16.2	6.9	18.5	22.7	7.7	19.8	10.8	4.5	5.1	5.9	7.1	7.4	11.7	9.1	8.7	9.2	6.6	10.9	11.6	11.2	0.8	4.4	6.0	5.6	8.9	6.9	7.7	11.5	9.8	9.2	8.2	6.0	13.3	6.3	9.7	13.4	17.9	15.8	17.6	16.5	0.0	29.6	17.7	20.4	36.1	31.8	19.2	37.3	19.5	18.3	10.4	12.5	20.1	9.3	0.0	8.9	12.2	12.2	19.1	28.9	17.1	11.7	28.6	18.5	30.7	12.4	11.9	23.6	15.1	0.0	16.2	15.0	18.4	12.8	17.0	16.6	15.6	33.3	0.0	8.0	17.7	31.4	0.0	12.2	23.5	18.8	16.8
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088712-181092899	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	9.4	7.2	4.7	16.2	5.4	45.7	13.8	6.2	12.6	7.8	7.8	5.1	5.9	6.6	12.8	5.3	20.9	14.3	10.3	22.9	6.0	4.9	3.7	6.7	22.6	9.6	10.1	5.7	4.4	4.3	1.8	4.6	34.5	6.9	6.7	6.9	3.7	5.7	4.9	42.3	16.6	10.8	9.6	7.2	27.3	6.8	5.1	5.0	11.2	4.3	22.9	19.8	8.4	16.3	5.4	1.6	5.4	7.8	1.5	2.1	0.9	12.1	10.7	5.9	5.1	8.2	11.4	15.8	21.6	23.0	12.3	10.9	2.9	6.9	4.0	9.6	8.3	8.6	22.5	1.9	14.7	8.0	23.0	9.3	3.6	5.5	2.0	12.9	4.1	11.7	8.1	15.0	14.2	9.5	9.3	8.3	3.4	14.8	18.3	21.6	5.5	4.1	6.6	6.1	4.6	5.4	4.7	10.3	15.1	4.4	6.7	8.6	9.3	10.9	10.7	23.9	7.5	8.5	3.6	12.5	8.8	15.5	10.0	13.0	12.1	4.2	3.1	6.9	4.4	2.4	5.4	2.1	3.8	1.6	7.8	1.9	5.4	1.4	2.1	1.6	3.6	0.3	0.9	1.8	1.5	7.3	0.2	1.8	0.9	4.7	5.4	6.2	12.6	6.0	4.9	10.1	5.7	6.9	5.0	20.8	75.0	63.8	120.3	62.0	22.9	92.8	17.8	14.7	19.4	8.7	35.3	8.9	0.0	9.0	3.6	66.0	73.5	0.0	6.0	36.7	51.2	79.2	34.7	4.9	43.9	7.9	54.2	36.2	111.7	8.2	11.2	133.8	43.9	41.5	70.2	18.9	15.6	54.7	8.9	1.1	19.9	0.0	68.4	3.6	5.0	52.1	28.6	25.4	34.5	130.7
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.4	13.8	3.7	10.3	2.4	1.9	6.0	6.4	4.2	3.5	2.4	18.9	9.9	0.1	8.2	4.8	4.0	21.2	2.8	13.5	2.8	50.5	2.5	0.1	2.6	7.4	1.7	1.4	16.2	1.2	13.8	4.7	6.0	5.8	7.4	0.4	0.6	1.7	2.3	1.7	1.4	1.3	1.6	8.7	3.3	4.7	2.3	3.6	2.0	5.4	11.9	0.6	4.8	6.8	4.7	4.0	1.8	0.7	20.2	4.7	6.6	2.7	18.3	3.6	3.9	0.2	3.2	2.1	5.5	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6	3.0	4.8	0.9	68.5	107.4	5.7	5.5	15.3	12.0	4.5	1.8	0.0	4.1	1.7	12.7	1.2	7.1	1.0	0.0	15.2	5.8	3.6	12.6	3.5	3.9	2.0	23.8	2.4	6.2	0.8	2.2	1.1	4.0	13.5	2.8	0.6	5.1	13.4	2.9	2.8	8.1	1.6	0.0	8.5	0.7	0.5	87.7	3.3	2.9	1.0	39.7
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33402896-33479348	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 309.5;Urothelial cells: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 55.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (9.58e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.13e-10)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.15e-3)"	27.2	13.4	11.9	20.8	12.6	45.1	64.4	4.6	18.0	12.5	21.6	5.7	13.0	18.5	10.6	14.1	21.9	11.5	15.2	17.7	11.1	10.1	14.6	20.2	26.3	46.3	8.7	9.4	13.0	21.7	7.1	12.6	20.5	12.2	14.9	11.7	12.1	21.9	11.7	13.1	16.7	20.0	15.3	18.1	27.4	30.3	14.1	7.2	7.9	18.1	19.4	18.9	14.8	26.8	13.2	7.7	55.1	22.8	0.3	3.3	13.8	3.0	2.6	1.3	2.7	3.8	6.5	4.3	8.8	6.4	2.0	3.3	3.1	1.7	5.3	4.9	5.3	5.9	2.3	2.8	6.1	1.1	20.4	17.2	1.5	1.1	2.7	2.6	7.6	4.8	4.9	4.0	3.5	3.5	3.8	5.2	2.6	8.0	2.6	2.8	0.9	1.8	5.2	4.9	3.6	16.7	4.5	4.2	4.4	2.2	4.1	1.9	4.7	4.4	0.5	8.4	0.7	1.6	4.9	8.8	2.5	5.5	2.1	2.1	5.6	7.6	6.8	2.2	6.8	12.0	12.9	22.2	14.8	0.1	22.0	0.1	11.5	1.3	0.1	7.7	13.2	3.3	1.4	55.1	0.3	22.8	2.4	1.4	13.8	11.9	12.6	4.6	18.0	11.1	10.1	8.7	9.4	12.2	7.2	38.7	25.1	76.3	178.2	64.0	8.7	16.6	43.3	13.4	19.4	26.2	7.9	28.1	23.2	100.9	35.4	41.3	130.0	0.0	48.9	66.1	81.2	309.5	59.9	24.9	150.7	14.3	49.5	36.8	129.5	44.6	38.9	162.5	54.0	211.0	45.2	7.8	102.1	105.2	30.8	39.8	7.2	12.9	30.1	3.9	1.7	61.2	14.5	13.8	35.8	502.7
IFT27	"BBS19, RABL4, RAYL"	ENSG00000100360	"Intraflagellar transport 27"	Q9BW83	22	36758202-36776256	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 246.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"U-138 MG: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018418	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018418: AB_1856029"	"unprognostic (3.04e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.06e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (9.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.62e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (5.55e-4)"	10.9	17.0	21.1	12.7	27.4	8.5	9.2	13.4	20.6	14.9	12.8	15.8	21.9	13.4	12.5	22.1	10.9	40.5	13.0	18.5	19.3	20.6	16.4	17.4	10.2	9.5	19.4	16.4	14.9	17.6	20.9	30.2	8.9	20.0	16.4	11.0	16.1	15.4	19.6	14.7	9.6	12.9	9.9	17.4	9.3	13.7	20.1	14.5	18.6	23.2	6.0	9.8	11.0	11.8	17.7	27.0	23.3	22.6	14.5	19.9	13.9	6.2	7.9	9.3	10.5	7.5	7.2	5.5	5.2	6.6	6.7	6.0	0.3	5.8	6.9	9.0	4.7	9.8	5.8	5.1	5.7	5.2	13.2	13.5	1.8	1.6	0.0	13.8	2.2	8.6	5.8	9.4	7.2	3.3	5.5	7.1	5.7	3.2	5.7	4.5	11.6	2.7	1.9	5.0	12.3	10.3	13.0	0.0	3.8	6.6	4.1	9.0	9.8	5.4	4.2	12.9	8.2	9.4	3.9	4.2	60.8	3.5	7.8	0.9	13.5	8.2	2.4	9.4	5.5	12.8	8.5	22.6	23.3	18.3	16.4	18.2	16.7	15.2	16.8	27.0	17.7	15.1	14.3	8.1	14.5	19.3	20.9	19.9	13.9	21.1	27.4	13.4	20.6	19.3	20.6	19.4	16.4	20.0	14.5	6.0	17.3	15.2	23.2	20.7	32.7	16.8	20.4	246.3	38.7	38.4	27.5	18.3	89.5	24.7	40.8	18.3	24.3	0.0	20.1	14.0	30.5	29.6	33.4	18.6	34.4	28.6	51.2	27.6	14.9	13.6	25.3	19.2	33.7	9.0	39.8	51.0	18.0	14.4	29.7	43.0	34.6	12.9	18.6	105.4	16.8	29.1	14.6	23.5	29.0	23.3
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	17.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7	0.0	0.0	0.0	0.2	0.0	4.0	0.5	0.0	0.0	0.0	1.8	31.4	90.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	38.7	0.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.9	12.6	0.0	34.6	0.0	0.0	0.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381464-65423072	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.1"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		34000000	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	1.7	6.2	8.3	3.7	5.0	0.2	1.3	2.0	4.9	6.1	1.4	8.0	0.0	1.0	2.3	7.2	2.6	2.9	6.7	2.2	6.2	4.1	0.6	0.3	0.7	1.1	5.6	3.1	13.3	0.7	0.2	2.4	8.2	6.1	0.9	1.2	1.6	1.5	1.3	14.1	1.5	1.7	3.1	5.0	0.5	1.9	2.5	6.5	0.0	4.6	4.0	1.5	4.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	10.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.4	0.6	8.9	0.0	5.1	0.4	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.0	5.7	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.8	7.7	0.0	0.0	0.0	2.5	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.5	6.1	0.0	0.0	0.0	4.1	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.0	2.0	3.9	6.2	4.1	5.6	3.1	6.1	6.5	0.0	0.0	0.0	0.0	2.1	5.8	2.0	0.0	0.0	0.0	3.5	29.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	17.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	32.2	0.4	5.0	0.0	0.0	0.5	0.3	0.0	3.9	0.7	12.0	6.5	0.5	0.4	0.9	1.0	0.7	0.0	0.0	0.0
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0"	"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	67.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.1	0.0	19.5	0.1	0.0	0.0	69.8	67.7	1.1	0.0	0.0	43.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Group enriched"	"Detected in some"	64	"CACO-2: 28.9;OE19: 58.1"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.9	1.9	0.4	0.0	0.0	1.2	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.5	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.4	8.0	7.0	4.1	2.2	0.0	1.3	0.0
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu binding protein 2"	P38935	11	68903842-68940602	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	7.2	6.0	6.9	8.1	11.0	13.8	9.4	17.7	14.9	8.1	14.6	8.3	14.3	9.7	12.0	5.4	8.8	8.5	7.8	7.7	6.6	5.3	6.7	8.7	7.3	7.9	4.6	7.0	9.4	9.6	7.7	6.0	6.5	6.6	9.0	6.1	7.9	12.7	10.0	12.2	11.7	9.4	8.1	4.1	8.9	9.1	36.9	5.7	10.0	7.3	5.9	8.8	8.8	8.3	5.0	3.3	4.7	12.1	2.7	5.1	2.7	8.0	9.3	5.6	8.9	4.5	3.5	8.4	8.1	5.1	10.0	6.6	18.8	8.1	7.0	11.4	4.1	8.1	12.9	9.3	5.1	4.2	8.3	7.8	10.0	10.9	6.1	5.2	7.6	9.5	2.6	6.1	10.6	5.4	5.0	5.1	12.4	11.7	9.0	3.4	6.3	11.9	13.6	4.9	11.0	9.8	10.0	8.4	8.6	4.7	7.3	8.9	6.5	9.6	8.2	19.1	3.8	12.7	5.7	6.9	8.6	7.6	11.5	8.3	10.1	7.7	8.1	6.1	7.4	7.8	0.0	3.9	2.2	5.1	3.3	4.7	5.0	3.4	4.0	3.3	3.3	2.4	3.3	4.7	2.7	12.1	2.5	4.0	2.7	6.9	11.0	17.7	14.9	6.6	5.3	4.6	7.0	6.6	5.7	6.0	10.6	2.9	3.6	5.0	9.1	4.3	5.1	2.7	6.8	1.8	19.6	3.9	1.7	4.8	77.4	5.8	3.5	0.0	4.3	3.8	5.0	6.2	6.9	4.7	5.0	11.1	2.9	2.5	3.2	25.6	7.2	5.2	1.7	8.2	3.4	6.6	4.9	5.8	6.7	2.0	9.6	0.0	6.6	20.9	6.5	5.8	5.6	5.1	4.3	4.8
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA051811: AB_2681621, HPA054591: AB_2682535"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.7	0.0	0.6	14.0	0.5	0.0	1.0	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.3	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	6.4	2.3	0.0	0.0	0.3	0.0	2.6	0.5	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	7.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.6	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.5;WM-115: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.4	9.3	7.2	1.8	1.6	3.5	19.3	0.0	0.2	0.7	0.2	5.3	3.1	0.0	2.9	0.0	4.0	15.2	3.2	7.5	0.3	62.5	2.3	2.9	3.6	0.1	0.0	0.2	5.7	0.4	5.9	0.0	1.3	1.3	0.0	1.0	0.9	0.0	0.1	19.1	0.2	0.1	4.5	3.3	0.2	2.2	8.8	0.0	5.5	6.8	4.2	12.8	2.2	21.5	13.7	14.4	7.2	0.3	0.0	1.2	4.3	0.0	5.6	0.0	0.3	0.0	0.5	0.1	60.3	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9	14.9	25.2	0.0	7.0	17.4	1.9	14.4	12.7	8.1	5.7	14.0	0.0	10.1	3.3	13.2	1.8	2.1	14.7	0.0	1.7	24.6	6.6	7.2	1.1	0.0	1.9	6.4	2.9	1.8	1.6	2.1	1.1	0.9	8.5	5.4	5.5	12.8	11.2	8.6	0.0	11.3	0.5	0.0	2.1	0.5	4.3	24.2	11.1	0.0	7.1	9.6
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	9.2	0.0	0.0	0.0	16.3	42.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	11.9	3.2	0.0	0.0	33.5	16.2	0.4	0.0	0.0	36.3	0.0	7.6	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	22.5	0.0	0.0	0.3	0.0	0.0	14.6	7.5	68.8	0.1	17.7	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1	3.0	16.4	46.7	0.1	2.5	0.0	1.1	5.1	2.7	3.4	1.8	0.0	0.3	0.0	0.1	3.0	2.9	0.0	23.3	0.0	0.2	3.4	0.1	22.0	1.0	27.1	0.0	0.0	4.3	47.2	4.5	0.0	43.8	18.6	70.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.7	2.4	0.6	103.3	0.0	0.1
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757715-39864188	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;lymphoid tissue: 55.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 27.4;B-cells: 90.1;granulocytes: 44.2;T-cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.3;T-cells: 17.7"	"Group enriched"	"Detected in some"	4	"Daudi: 27.2;Karpas-707: 14.3;U-266/70: 17.3;U-266/84: 19.2;U-698: 44.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.7	0.7	0.5	41.7	0.5	3.1	1.0	0.5	0.5	1.1	4.5	0.0	0.6	1.8	1.2	0.6	3.6	1.2	2.4	0.9	0.6	0.6	1.5	1.4	5.3	30.5	0.6	0.0	0.9	0.9	0.0	0.7	0.4	0.1	1.5	1.7	1.2	5.5	1.3	0.6	0.8	11.3	1.2	0.9	41.0	3.3	2.6	0.1	55.1	1.6	1.8	54.1	4.0	1.3	8.3	0.3	0.7	0.1	2.6	17.7	4.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	1.6	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	14.3	0.0	0.1	2.4	0.9	0.1	1.5	0.0	0.1	0.1	4.9	0.0	1.6	0.1	0.1	0.5	0.2	0.0	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	17.3	19.2	44.1	0.0	0.1	0.0	0.5	0.1	0.4	16.3	0.1	17.7	8.3	6.7	12.1	0.0	7.7	2.8	7.5	0.7	2.6	0.1	0.3	10.6	4.1	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.0	0.1	0.1	8.9	27.4	90.1	2.1	0.1	1.4	4.0	0.0	1.4	10.3	1.8	0.0	0.1	0.0	0.1	11.6	1.2	0.0	0.0	0.0	0.3	0.2	1.4	44.2	0.6	0.1	0.0	0.0	5.5	6.5	7.4	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	1.4	0.0	0.1	4.9	2.0	0.1	0.2	76.1	0.0	1.4
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.3;T-reg: 5.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046270: AB_2679607, HPA049016: AB_2680600"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	5.6	14.5	7.7	7.4	8.5	6.7	8.1	13.9	7.6	7.2	6.9	6.5	7.1	3.4	7.7	8.5	4.1	10.0	5.9	5.6	6.3	6.3	5.6	4.1	7.3	4.2	5.9	9.8	16.2	5.7	20.8	22.1	5.9	9.2	8.1	4.3	9.2	3.7	8.6	16.8	4.1	4.5	10.8	8.4	4.1	5.7	9.1	5.9	5.2	8.8	4.5	4.5	6.4	14.0	0.3	0.3	0.0	0.4	0.1	5.3	0.3	1.3	1.5	9.2	3.1	1.9	2.0	2.1	1.5	2.5	1.7	2.5	4.7	2.0	0.8	1.6	2.3	1.9	0.9	1.1	1.2	3.8	28.2	1.4	5.2	1.5	2.3	2.1	2.4	2.1	3.4	1.7	1.8	1.4	3.2	1.7	0.2	8.1	4.5	2.7	1.5	3.0	1.2	4.0	1.4	1.1	2.6	2.5	1.1	2.5	1.4	3.6	3.0	2.0	0.6	3.3	2.4	2.4	2.6	0.9	1.5	2.6	1.4	1.1	2.7	1.6	1.3	3.0	2.4	1.9	0.0	0.3	0.0	0.3	0.3	0.5	0.3	1.3	0.0	0.2	0.2	0.3	0.4	0.0	0.1	0.4	0.3	5.3	0.3	7.7	8.5	13.9	7.6	6.3	6.3	5.9	9.8	9.2	5.9	3.0	10.3	1.4	1.5	3.2	18.9	5.7	10.2	1.4	4.5	3.5	7.9	2.7	1.7	2.4	8.5	3.4	1.6	0.0	3.8	2.1	5.0	1.9	1.1	5.6	2.4	7.9	5.8	4.9	8.6	1.6	8.1	2.3	5.0	5.4	2.7	16.7	2.9	2.5	10.3	3.3	11.5	0.0	9.2	18.4	4.9	2.9	3.3	2.5	2.2	1.4
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727572-118794539	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		4500000	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	31.5	17.5	9.3	15.3	13.3	2.1	19.8	3.6	10.2	16.6	23.8	12.6	7.2	18.9	16.6	18.0	33.0	15.4	17.7	17.5	11.4	9.4	22.7	73.3	27.7	33.9	15.2	6.0	25.2	12.9	9.5	16.1	15.2	13.4	15.3	25.2	14.5	21.8	13.0	22.3	10.2	37.7	16.3	24.5	17.4	18.5	9.9	11.9	4.8	24.0	20.1	20.0	16.5	15.4	1.9	10.9	19.0	6.9	0.0	0.1	1.7	8.2	10.3	4.9	13.5	11.2	33.2	8.9	17.4	24.2	8.3	10.8	6.0	15.4	0.0	30.6	23.9	24.1	7.9	5.3	7.4	9.2	45.2	4.1	1.4	9.3	15.1	6.8	0.1	3.6	30.1	6.7	11.3	14.0	25.1	17.3	0.0	4.4	0.9	11.7	12.1	0.0	2.2	4.5	15.8	9.9	0.0	12.1	0.0	12.4	9.1	1.8	1.7	27.3	10.0	6.8	6.7	6.4	7.9	22.0	16.2	7.7	27.3	13.6	0.2	4.1	0.0	35.8	4.3	6.8	0.0	6.9	7.1	0.0	1.7	0.0	1.9	0.0	0.0	10.9	1.8	0.0	0.0	19.0	0.0	0.6	1.9	0.1	1.7	9.3	13.3	3.6	10.2	11.4	9.4	15.2	6.0	13.4	11.9	65.5	43.2	10.0	29.8	15.2	2.0	9.2	53.5	40.2	51.2	27.9	15.7	7.4	8.3	30.4	30.3	46.6	51.4	0.0	85.9	27.9	14.8	39.1	0.0	133.7	39.4	0.0	89.3	79.8	108.2	5.6	22.5	97.3	20.3	235.4	131.1	39.2	63.8	20.1	17.7	20.5	10.7	32.3	30.6	3.6	26.6	10.7	7.9	3.8	25.1	29.4
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636599-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"monocytes: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.5;Karpas-707: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.7	1.1	21.3	1.5	2.9	9.2	1.8	2.2	6.0	8.8	0.8	2.2	6.3	11.3	7.4	5.6	4.6	9.9	9.3	1.1	1.5	6.9	3.7	14.4	18.8	2.3	1.6	3.2	3.1	0.5	4.5	9.9	2.1	7.7	5.7	5.9	6.9	3.6	9.1	3.2	14.2	7.1	2.6	17.0	5.3	2.6	2.0	9.8	18.1	5.9	11.0	9.8	16.9	3.7	4.6	8.1	14.0	2.6	4.5	4.4	2.4	5.2	0.2	0.5	0.8	4.7	1.3	5.6	5.2	5.8	4.7	2.8	6.8	2.3	7.3	4.8	5.0	3.6	0.1	3.0	3.2	15.5	1.4	0.4	13.7	0.4	3.9	1.6	1.1	1.7	1.2	3.8	0.4	11.9	3.7	1.8	3.8	15.2	3.7	0.8	3.4	0.3	2.6	1.8	1.6	0.9	13.4	0.3	7.6	0.6	0.5	1.3	2.4	3.7	2.7	0.6	0.9	0.2	5.5	5.9	3.8	1.7	3.4	10.7	1.3	0.7	6.3	0.6	2.1	8.1	14.0	0.8	2.5	12.4	4.5	3.7	2.9	2.2	4.6	3.4	1.2	1.3	1.0	2.6	12.5	0.1	1.5	4.4	1.1	1.5	1.8	2.2	1.1	1.5	2.3	1.6	2.1	2.0	0.0	3.2	10.4	2.8	5.5	0.3	2.4	0.0	4.0	7.9	5.2	0.0	1.0	0.0	8.1	4.0	11.3	3.9	0.0	12.2	1.8	7.2	4.3	0.0	1.7	4.9	0.0	0.0	11.6	18.3	1.5	2.6	19.3	8.5	96.4	4.7	15.1	14.3	3.5	1.1	8.4	0.5	6.5	3.1	0.5	0.7	3.0	0.2	6.4	2.3	2.1
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 15.4;Late spermatids: 17.2;Leydig cells: 10.6;Peritubular cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.6;AN3-CA: 28.7;NTERA-2: 16.6;SH-SY5Y: 43.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	2.7	1.3	5.2	1.8	6.5	0.4	8.9	2.8	6.1	14.7	7.7	7.6	7.4	0.9	18.5	13.7	3.4	8.4	6.1	3.0	4.8	3.6	7.1	0.5	1.1	0.7	4.0	2.4	12.6	1.4	20.8	14.0	0.7	5.7	8.1	2.5	10.2	7.2	10.8	1.0	2.6	1.8	14.7	7.2	3.1	2.2	11.2	3.1	0.0	1.0	2.2	1.4	8.9	5.2	0.6	0.6	1.5	0.5	0.6	0.4	0.0	1.6	0.3	10.6	28.7	0.0	0.2	1.7	0.2	0.1	0.1	0.3	0.2	0.7	0.0	0.0	0.6	2.3	0.1	2.0	0.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.2	7.1	0.4	0.2	0.0	0.0	0.5	0.2	0.0	0.0	16.6	0.9	0.8	0.0	3.8	0.0	2.2	0.4	0.2	43.7	0.4	0.6	1.2	3.6	0.3	0.0	0.3	0.5	0.7	0.5	1.7	0.0	0.0	0.0	0.3	0.0	0.7	1.4	0.5	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.6	0.4	0.4	1.5	0.6	0.3	0.6	0.3	0.0	5.2	6.5	2.8	4.0	4.8	3.6	4.0	2.4	5.7	3.1	0.0	2.9	0.0	1.6	0.8	0.0	1.1	2.5	2.7	2.3	0.0	0.0	0.3	0.0	2.6	15.4	2.2	0.0	0.0	0.2	0.1	3.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	10.6	0.7	0.0	0.0	0.3	0.5	0.6	0.0	24.4	5.1	0.0	0.0	0.4	8.8	7.6	0.6	0.1	0.0	0.0	0.5
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851379-55922853	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;tongue: 6.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 1.8;Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"amygdala: 10.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.5;hippocampal formation: 1.1"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.3	0.1	10.3	1.0	0.1	5.3	0.2	0.1	0.4	0.2	1.5	0.0	0.0	0.4	1.2	1.8	1.7	0.1	0.2	0.4	1.6	0.2	0.3	0.3	0.5	0.1	0.1	0.0	0.5	0.7	0.0	0.7	0.7	0.0	1.0	0.4	0.4	1.3	0.2	2.6	2.5	0.8	1.8	0.1	0.3	0.5	5.9	0.0	1.4	0.5	6.4	0.5	0.5	2.2	0.0	1.2	0.2	2.2	0.0	0.1	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.4	0.1	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.2	25.6	0.0	0.0	7.8	1.6	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	5.2	2.6	3.7	9.4	0.4	2.9	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.0	0.0	5.2	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	1.3	0.4	13.9	0.0	0.8	0.0	0.0	0.0	16.1	0.0	2.2	0.1	2.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	10.3	0.1	0.1	0.4	1.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.9	0.0	0.0	0.0
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 19.9;U-2197: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	19.7	8.6	13.7	17.7	13.2	0.0	14.8	7.4	6.7	33.0	16.7	4.6	9.1	3.4	29.2	14.8	32.3	13.5	13.8	29.6	12.7	5.6	3.9	22.3	22.0	57.7	5.8	7.9	18.6	2.5	1.9	6.0	25.2	5.9	39.8	8.3	16.6	9.5	13.9	6.6	18.1	9.6	42.0	6.3	7.9	21.6	9.2	6.0	1.3	13.9	11.6	17.4	53.2	15.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.1	0.1	19.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	13.2	7.4	6.7	12.7	5.6	5.8	7.9	5.9	6.0	6.0	11.1	0.0	10.2	21.5	0.0	5.6	7.6	112.4	135.4	0.0	0.0	0.0	0.0	2.2	0.6	153.6	0.0	23.3	6.7	0.0	9.7	1.7	1.1	2.6	0.1	0.0	10.3	400.8	26.5	0.7	19.0	1.5	1.7	0.0	0.0	9.6	7.1	0.0	11.7	0.0	0.0	0.0	12.4	0.0	0.4	42.3	0.1	1.5	0.1	1.7
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 55.0"	"Cell type enhanced"	"Detected in single"	22	"Suprabasal keratinocytes: 2.5"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"					"Cell type enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.9;PC-3: 10.6;RT4: 5.7"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.8	0.1	0.0	0.0	0.2	0.4	4.9	0.3	0.5	0.5	0.6	0.0	0.5	0.3	0.5	0.1	0.2	0.8	1.5	0.3	0.0	1.8	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.4	0.0	0.1	0.0	0.1	1.1	0.0	0.0	1.4	0.5	0.4	10.6	0.1	0.0	0.0	0.0	5.7	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.0	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell type enriched"	"Detected in many"	12	"monocytes: 1188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.8	1.1	0.3	1.0	1.8	18.0	0.2	1.5	0.3	0.2	0.0	0.1	31.2	0.1	0.8	0.0	0.2	0.1	0.6	6.4	0.5	0.2	0.3	0.0	0.2	1.4	0.2	0.1	25.3	0.0	0.2	0.4	1.0	0.2	0.4	0.1	0.5	0.5	1.7	1.2	1.6	0.4	0.4	0.2	0.5	0.3	0.1	0.2	1.4	1.5	3.8	0.5	0.0	0.5	2.2	4.7	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4	0.0	0.0	0.0	0.5	8.7	0.0	0.6	0.0	0.0	1.2	3.5	0.0	0.3	0.0	1.9	52.0	3.1	0.0	0.0	3.4	0.6	1.4	1.0	1.1	0.0	102.3	0.0	0.0	1.8	1.8	11.1	0.3	40.3	3.3	1188.5	0.0	0.1	0.5	0.0	0.4	1.6	0.2	0.0	2.1	11.9	2.5	7.2	0.7	5.0	0.1	1.4
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.4	23.2	11.3	19.5	20.1	11.5	16.7	17.3	13.8	14.2	16.4	17.8	18.1	24.5	18.9	9.0	15.7	34.0	37.1	28.0	12.6	18.4	44.5	25.7	19.1	30.8	14.8	26.0	17.9	10.5	23.2	11.4	14.1	10.6	9.3	20.1	33.1	20.0	12.8	24.6	20.6	63.7	30.3	20.9	24.5	22.5	13.8	26.9	19.2	27.9	19.3	19.9	14.6	25.6	31.4	17.1	22.3	24.3	10.5	18.5	14.9	13.2	23.3	27.4	50.4	27.5	20.4	42.3	12.1	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3	35.7	34.5	89.1	67.5	203.1	22.0	11.4	66.2	52.2	52.4	38.4	13.7	88.6	122.7	81.1	1.3	74.4	52.6	23.3	93.2	83.2	66.4	58.7	46.3	101.8	81.8	20.6	42.2	68.2	45.6	4.1	56.4	60.5	92.8	116.4	61.3	53.7	92.0	59.6	41.4	158.4	20.3	25.8	71.8	14.0	43.8	207.5	45.9	74.0	84.6	70.1
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.2	9.7	2.6	4.6	3.4	2.5	60.5	1.6	4.3	0.7	1.0	7.8	5.0	1.3	3.8	2.3	5.7	4.3	3.1	1.6	0.2	7.4	3.8	0.0	12.7	6.7	2.0	10.7	0.5	5.8	8.7	2.3	1.2	2.0	0.9	7.0	1.5	0.0	2.5	6.2	4.3	5.6	9.1	67.8	7.3	7.3	7.3	6.4	29.2	3.5	3.5	0.0	36.5	8.3	3.5	3.4	7.8	13.4	0.0	1.3	2.5	17.9	1.6	5.0	13.3	3.7	5.8	7.2	2.2	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0	17.9	25.4	6.9	15.2	93.8	0.2	10.6	45.9	9.4	9.1	21.0	0.0	35.5	373.0	57.8	2.3	5.8	44.1	0.0	96.5	196.1	13.1	33.2	2.3	62.3	36.5	0.0	16.8	8.6	39.4	4.7	4.4	16.7	13.5	4.6	70.8	21.8	73.4	51.8	3.5	383.7	0.9	103.5	9.5	0.4	11.7	123.6	88.9	4.4	78.2	45.7
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 41.6"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 105.7;Late spermatids: 240.7;Spermatocytes: 81.7;Spermatogonia: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	1.7	2.2	5.5	3.5	6.3	0.5	2.5	10.1	7.2	2.3	2.2	3.1	1.0	7.0	3.3	1.6	3.1	2.0	4.5	3.9	4.9	2.1	2.3	2.6	2.7	5.0	5.1	3.0	5.5	2.2	0.9	4.4	1.6	5.9	2.7	0.3	1.7	3.6	1.5	6.1	5.0	4.9	1.2	4.1	4.3	3.1	41.6	3.6	0.5	5.2	1.3	0.4	2.8	9.4	1.5	1.3	0.7	4.4	0.3	2.4	0.6	4.0	4.6	3.3	3.0	2.2	0.9	3.9	4.4	0.4	1.2	1.2	3.2	4.8	19.1	2.9	1.2	3.8	11.4	0.5	0.2	0.7	8.0	4.8	4.1	5.5	2.1	1.5	0.6	10.2	1.2	0.0	0.7	0.4	7.1	0.4	6.8	5.1	9.0	0.8	2.1	5.8	1.3	1.4	1.8	1.2	7.1	1.7	1.7	0.8	1.3	9.7	2.9	2.1	2.8	2.6	3.6	5.7	0.9	8.8	4.1	1.6	3.9	3.3	1.5	0.8	0.9	4.0	10.2	2.1	0.5	2.4	0.0	0.8	4.4	2.0	1.5	1.2	1.7	0.9	1.0	2.4	1.9	0.7	0.3	3.4	1.3	0.7	0.6	5.5	6.3	10.1	7.2	4.9	2.1	5.1	3.0	5.9	3.6	0.0	0.6	0.5	1.2	1.0	0.4	0.5	2.5	1.4	1.2	3.5	2.0	0.5	0.0	0.6	105.7	0.6	6.8	0.0	1.4	0.6	1.4	0.5	4.6	1.3	1.2	0.0	0.0	0.6	0.0	240.7	6.6	1.2	1.7	1.0	1.6	4.6	1.1	7.0	1.1	1.7	0.8	6.5	1.2	81.7	50.4	0.6	0.7	0.0	1.8	0.9
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 141.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876"	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	11.8	11.1	8.9	11.7	10.2	24.9	19.8	12.8	12.1	15.7	14.9	6.9	9.5	13.9	16.3	8.3	10.7	13.7	20.0	9.5	9.4	9.0	9.3	16.7	14.1	20.5	11.6	8.0	25.8	11.8	3.8	9.5	13.3	11.7	13.3	6.6	9.5	13.6	10.9	12.2	8.5	13.6	11.1	10.2	17.6	10.0	26.0	12.0	22.0	11.5	8.3	10.6	18.3	14.8	15.5	3.0	21.4	3.7	12.3	11.6	6.1	17.6	7.0	12.7	12.1	6.0	4.1	12.7	9.1	7.7	5.9	7.2	13.3	12.6	11.4	14.9	3.6	9.2	11.2	5.1	4.5	5.0	21.3	9.7	10.0	9.7	9.9	3.4	13.2	9.7	3.7	4.7	5.1	3.1	4.7	4.1	12.4	9.3	9.6	3.8	10.1	22.8	15.3	12.4	11.0	5.9	16.6	6.4	6.4	5.1	9.1	12.5	13.5	9.0	18.1	12.5	4.6	6.1	15.7	6.2	7.3	9.0	7.6	10.2	11.6	11.7	14.5	12.2	10.9	11.9	21.4	2.9	11.1	10.8	3.6	11.1	14.8	9.1	9.7	2.8	15.5	9.4	7.8	4.0	12.3	3.7	3.0	11.6	6.1	8.9	10.2	12.8	12.1	9.4	9.0	11.6	8.0	11.7	12.0	8.9	22.6	17.6	10.5	32.3	15.2	21.4	10.2	21.4	6.8	7.0	13.7	11.0	6.6	9.1	141.8	18.0	28.4	0.0	6.0	70.2	33.8	19.5	2.3	22.9	14.7	3.2	12.0	9.8	17.1	32.8	8.6	12.7	16.9	6.4	20.1	14.5	6.8	19.3	13.8	11.1	20.2	12.9	25.0	17.0	16.6	38.1	12.8	13.1	18.4	17.1
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455023-74457960	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070644			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA070644: AB_2732159"	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	18.7	22.4	31.0	20.5	33.4	21.4	22.6	31.3	48.6	23.3	16.2	15.6	24.8	24.0	28.5	23.4	22.6	26.8	21.5	19.7	39.3	20.0	20.3	22.5	18.7	22.5	19.6	32.6	39.8	31.8	36.6	32.3	14.0	38.2	25.6	16.7	15.5	32.1	37.6	28.1	39.7	18.0	20.0	49.6	19.3	22.1	28.3	25.0	21.3	30.0	15.9	24.7	20.6	23.8	4.9	6.5	6.8	5.4	4.4	3.8	1.3	12.8	14.3	3.9	5.7	8.2	13.3	11.9	12.2	9.8	8.4	7.4	9.2	14.2	22.1	15.0	8.0	8.0	13.6	3.7	8.3	8.0	20.8	14.2	16.6	6.7	8.9	8.4	16.1	7.4	12.0	14.7	12.0	14.7	22.8	10.9	11.5	9.3	7.2	7.2	15.4	18.3	21.3	2.8	8.0	19.7	10.7	15.8	20.1	10.2	9.0	7.3	15.3	6.3	16.2	5.4	5.3	5.4	5.1	9.7	6.9	12.5	14.0	8.7	28.5	22.1	8.0	15.3	9.6	7.0	3.9	5.4	2.0	2.7	3.7	3.2	4.8	2.9	1.5	3.1	4.9	2.7	2.3	6.8	4.4	2.8	6.5	3.8	1.3	31.0	33.4	31.3	48.6	39.3	20.0	19.6	32.6	38.2	25.0	0.0	2.1	4.8	2.3	24.8	13.2	0.8	2.5	9.4	4.5	3.5	11.8	3.7	0.0	13.2	1.7	3.1	6.9	0.0	23.3	3.6	3.3	1.2	5.7	8.9	4.9	12.7	4.6	4.3	7.8	5.1	2.8	5.6	5.0	16.2	7.5	4.9	15.7	3.5	2.8	6.8	15.3	0.0	8.0	4.9	2.3	27.7	4.5	6.4	5.5	1.4
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995294-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	26.7	30.0	31.2	37.1	31.6	27.5	29.1	28.8	37.9	32.9	35.4	35.1	37.7	18.0	33.8	34.0	31.7	43.8	29.2	25.0	30.1	26.1	30.1	31.0	28.5	30.2	30.7	30.0	39.7	29.2	44.7	29.8	24.8	27.8	32.2	39.5	26.3	33.9	39.3	28.1	28.3	38.9	43.0	33.8	30.6	28.6	28.3	28.0	39.1	35.9	24.6	46.9	34.1	28.3	4.5	4.8	4.2	5.4	2.6	4.8	15.3	23.0	27.6	18.3	27.5	17.3	15.2	17.2	20.7	23.9	31.3	30.6	16.2	26.3	31.2	32.0	23.4	19.5	15.2	23.3	34.9	26.9	32.0	21.7	15.1	17.6	22.3	20.4	20.0	17.3	17.3	29.2	35.5	29.1	18.1	37.6	41.3	19.2	16.5	29.1	33.8	41.9	24.0	37.6	16.2	13.6	55.5	22.5	29.9	22.6	12.0	28.8	35.4	11.3	19.3	25.3	16.7	25.0	16.7	19.9	20.8	15.2	18.6	25.6	15.9	35.3	28.7	23.3	29.0	29.6	0.7	4.7	4.2	3.9	3.2	3.4	4.5	2.9	4.8	4.8	2.9	2.5	3.0	2.7	2.6	5.4	4.0	4.3	15.3	31.2	31.6	28.8	37.9	30.1	26.1	30.7	30.0	27.8	28.0	35.7	18.7	19.5	16.5	13.2	13.7	0.8	17.8	10.7	21.6	19.2	19.6	31.2	28.2	25.8	1.7	21.5	30.4	0.0	34.0	32.5	19.0	13.1	15.1	14.1	24.5	7.9	33.8	18.4	23.1	4.2	24.2	23.2	18.6	23.4	24.9	18.4	29.2	28.1	26.2	22.3	19.3	25.8	24.0	36.7	21.8	15.1	15.1	29.3	29.5	13.7
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594390	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	9.0	15.0	11.4	13.5	23.1	12.3	7.0	24.0	28.4	7.5	8.5	8.3	3.8	7.7	8.2	5.7	8.4	6.7	11.0	10.8	12.9	7.8	8.1	7.2	13.5	17.0	6.1	19.8	8.3	8.2	12.7	7.0	8.6	17.9	6.8	8.6	16.1	9.3	7.2	13.6	7.3	12.1	10.5	10.4	24.0	8.4	6.4	6.8	17.6	8.4	2.7	13.4	16.8	6.9	0.8	5.9	3.8	5.1	5.8	6.4	1.8	6.4	5.4	10.0	8.0	5.7	6.5	10.0	5.6	5.0	6.0	6.2	6.9	5.7	4.1	6.4	8.2	7.3	6.0	7.1	5.5	4.9	13.7	6.1	4.8	4.9	3.2	5.1	9.1	17.8	5.8	5.2	5.7	5.1	5.1	8.4	23.3	4.4	34.2	4.4	7.8	13.8	8.1	9.4	3.6	5.3	6.0	7.0	26.7	2.9	19.8	6.6	8.6	6.4	5.2	5.1	10.7	2.4	7.3	7.9	7.0	8.9	5.5	3.8	24.3	14.1	2.8	5.7	8.7	6.0	2.0	1.8	3.8	5.5	3.9	6.4	0.8	3.1	3.7	1.9	0.2	4.3	4.9	2.0	5.8	5.1	5.9	1.6	1.8	11.4	23.1	24.0	28.4	12.9	7.8	6.1	19.8	17.9	6.8	6.0	9.6	10.0	4.7	7.1	46.8	10.5	2.5	0.0	10.3	5.2	7.9	7.2	3.3	3.9	12.8	10.1	1.7	0.0	1.3	6.6	7.2	4.6	0.0	3.2	9.0	31.8	5.2	14.7	37.8	5.4	8.6	17.7	10.1	4.6	5.4	9.2	3.8	3.4	11.3	2.2	13.8	6.5	9.0	9.7	11.2	5.4	7.9	39.8	3.5	5.4
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817140-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	21.9	20.9	31.4	18.9	30.2	22.8	23.5	38.5	28.4	23.7	23.2	23.2	19.9	21.3	18.8	17.4	21.8	31.4	17.0	20.9	31.1	27.1	25.0	42.7	19.2	21.9	28.3	18.4	21.6	39.1	18.1	25.5	18.0	21.2	24.5	22.2	17.3	23.2	26.0	20.7	25.7	19.5	22.0	28.7	21.4	19.4	12.0	24.3	26.9	34.9	21.1	25.0	20.8	23.7	17.8	20.0	8.8	15.0	16.9	21.2	12.6	15.0	22.0	12.1	15.8	18.2	20.4	16.6	11.0	18.7	15.4	14.7	12.2	7.6	42.4	19.4	12.0	16.7	16.2	14.3	14.1	17.3	8.4	16.1	19.6	24.6	23.7	13.5	16.9	13.6	16.2	22.3	11.5	17.9	9.6	14.7	24.5	23.6	34.1	10.4	13.1	30.5	20.2	17.2	33.5	12.0	16.5	14.6	27.5	19.1	23.4	12.4	9.8	15.5	19.4	13.6	11.7	10.1	17.3	12.0	9.8	14.1	23.0	15.3	9.6	12.2	32.1	20.0	23.9	16.1	6.6	15.0	8.8	13.9	13.8	21.2	17.8	17.8	17.5	20.0	15.1	19.9	17.6	5.4	16.9	11.5	17.0	19.9	12.6	31.4	30.2	38.5	28.4	31.1	27.1	28.3	18.4	21.2	24.3	14.9	45.6	29.2	34.7	33.4	56.9	17.3	35.7	92.3	43.3	19.2	49.1	29.7	29.9	37.3	45.1	29.2	27.1	0.0	34.7	39.2	34.7	41.9	34.6	51.9	36.5	66.7	19.5	28.8	32.4	20.0	32.2	27.8	16.9	22.6	31.4	31.4	30.6	24.6	32.9	30.0	84.8	12.9	31.5	8.1	27.2	39.4	18.7	35.8	39.8	27.6
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324691	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 66.8;Extravillous trophoblasts: 54.3;monocytes: 63.1;Syncytiotrophoblasts: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	21.4	22.5	22.8	25.4	24.9	23.2	26.9	50.8	30.4	26.5	31.2	32.1	24.1	29.1	33.1	39.8	25.3	39.1	24.8	29.8	23.7	19.8	23.5	26.7	19.7	25.7	25.9	25.8	34.1	33.5	24.1	26.9	25.8	21.0	29.5	19.9	20.4	33.8	28.0	52.8	28.6	25.4	34.0	20.0	27.3	27.9	57.8	25.9	28.5	23.3	23.5	22.5	27.5	25.7	24.6	37.7	22.0	42.2	28.4	35.2	32.4	21.3	22.1	12.5	23.9	21.5	17.5	13.5	11.8	19.8	27.4	20.3	19.9	27.1	24.0	17.1	24.0	16.6	15.7	18.5	26.4	12.2	22.4	24.2	18.4	30.1	26.7	33.1	14.5	20.3	29.5	14.4	25.0	37.6	15.7	28.7	23.6	21.8	21.8	13.5	19.3	28.7	19.8	15.2	20.6	23.8	22.6	11.8	34.4	19.2	10.9	17.6	16.3	11.9	32.2	33.5	10.1	17.3	21.3	20.5	17.1	15.5	19.4	15.0	34.2	36.6	31.1	23.9	25.9	8.4	22.0	32.3	20.8	31.7	37.2	33.8	24.6	28.1	29.3	37.7	20.3	26.5	24.9	15.3	28.4	42.2	24.5	35.2	32.4	22.8	24.9	50.8	30.4	23.7	19.8	25.9	25.8	21.0	25.9	35.7	28.9	0.0	0.0	0.0	0.0	0.0	0.0	26.8	23.9	17.4	0.0	66.8	26.6	47.9	0.0	0.0	0.0	0.0	46.7	54.3	0.0	0.0	9.3	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	63.1	0.0	0.0	47.3	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	64.4	0.0	0.0	0.0
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.2	13.9	10.1	14.5	11.5	13.0	10.3	10.1	7.3	12.1	9.8	9.7	12.6	11.5	20.3	13.3	7.2	13.5	19.3	13.0	9.9	12.1	11.3	7.2	21.2	4.6	7.8	10.7	13.0	11.7	6.5	10.4	9.5	11.0	11.6	8.6	10.1	9.4	9.3	10.8	10.0	5.7	12.4	15.3	12.9	13.6	5.7	7.4	6.2	17.4	8.0	11.7	9.6	23.2	6.4	14.7	13.4	14.5	8.5	12.0	5.2	11.8	9.1	8.4	7.7	12.7	13.1	6.6	8.3	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0	20.8	21.4	8.8	8.7	9.3	22.5	4.0	10.2	13.4	10.3	29.6	19.6	11.5	0.0	10.1	12.1	12.6	8.1	0.0	7.1	11.7	11.9	9.9	5.7	13.6	10.7	20.6	11.6	27.0	11.8	5.9	8.9	14.3	6.8	13.6	16.1	19.3	9.6	10.8	11.3	12.4	23.9	25.8	9.0	9.3	13.0	8.9	8.6	7.7	12.2	11.2
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	13.8	13.2	9.1	14.0	8.9	6.5	17.2	9.7	16.5	12.8	11.0	7.0	14.3	10.9	16.0	10.6	16.0	19.1	14.0	14.3	7.4	6.7	12.0	19.9	11.6	22.3	7.8	7.6	15.4	21.3	17.4	9.5	12.1	6.9	12.4	8.5	11.0	16.0	17.4	17.3	15.7	11.2	11.9	5.5	14.8	12.4	9.4	6.6	26.0	16.4	10.8	12.8	12.6	15.7	7.6	7.2	5.1	6.2	10.1	14.3	7.0	11.3	14.0	8.3	7.7	16.4	12.0	7.7	9.4	9.7	12.8	9.2	9.9	12.7	21.7	17.1	11.9	10.6	17.8	16.6	21.9	6.2	13.5	11.5	11.2	11.2	6.6	14.8	12.3	10.8	13.8	17.2	13.6	11.7	9.7	12.6	9.7	17.1	12.8	10.9	23.3	14.0	14.4	12.6	13.5	17.8	14.5	11.2	26.0	9.8	7.5	11.2	9.4	10.6	14.9	14.6	6.1	21.1	8.5	10.4	12.2	9.5	18.7	8.4	18.1	13.8	15.6	14.1	9.3	11.5	5.1	6.2	4.8	8.7	4.6	14.3	5.8	8.2	7.7	7.1	7.6	9.6	8.7	2.6	10.1	5.1	7.2	6.1	7.0	9.1	8.9	9.7	16.5	7.4	6.7	7.8	7.6	6.9	6.6	3.0	5.6	8.0	6.1	1.9	7.0	2.2	5.1	8.1	6.8	3.5	0.0	11.4	10.0	10.5	4.9	4.5	4.9	0.0	9.1	9.3	3.8	5.2	9.2	10.4	7.6	9.5	6.4	8.6	5.1	6.0	6.1	3.3	0.0	13.6	7.3	10.3	9.3	0.0	7.4	7.5	3.6	12.9	4.9	5.2	13.4	3.6	16.6	5.7	6.8	4.7
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	13.3	13.7	12.9	14.4	14.6	11.3	23.9	23.8	15.8	12.5	11.9	10.6	17.4	9.5	12.1	10.9	16.4	10.3	12.3	13.0	14.1	8.9	11.1	24.5	13.6	15.7	16.9	9.1	14.6	44.2	14.4	24.1	11.5	13.2	12.2	9.5	8.5	12.3	19.2	10.6	13.3	13.9	12.2	12.3	11.4	12.9	46.4	17.8	21.7	13.0	9.5	13.4	12.3	15.9	6.1	6.5	7.8	2.8	6.7	9.2	3.2	7.7	6.1	14.9	7.1	8.5	18.4	9.9	15.0	15.0	15.9	11.9	7.9	19.3	9.6	3.4	12.6	9.9	13.9	19.4	9.3	23.6	17.4	5.6	16.6	9.9	9.6	20.8	19.7	16.0	13.5	18.1	16.5	26.2	21.5	14.7	13.5	11.1	14.2	17.3	6.0	13.7	15.0	11.3	22.5	7.5	9.4	10.0	7.5	12.6	5.1	8.9	9.5	15.7	12.3	12.0	12.7	7.1	22.5	10.2	8.6	7.0	10.1	9.8	13.9	8.8	14.8	7.7	11.8	14.6	7.3	2.8	4.2	7.9	1.8	8.9	4.9	5.9	7.1	2.8	6.1	8.4	9.2	7.8	6.7	2.0	6.5	6.3	3.2	12.9	14.6	23.8	15.8	14.1	8.9	16.9	9.1	13.2	17.8	23.8	43.8	51.1	45.0	67.9	60.8	71.8	43.3	12.0	20.5	21.0	111.9	60.8	13.3	19.6	64.4	45.0	74.9	0.0	22.6	39.9	44.2	57.5	48.4	31.6	30.7	42.9	72.9	63.8	51.1	64.5	40.9	38.9	21.9	23.4	75.3	60.6	22.3	52.1	29.7	9.9	77.1	25.8	47.4	97.7	42.2	63.2	61.7	60.9	65.3	59.9
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 35.3;Ito cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	25.5	15.3	13.6	14.2	17.1	8.8	22.2	18.4	18.3	19.5	13.7	14.2	17.4	10.4	19.9	13.9	18.6	16.1	16.4	20.0	15.2	13.4	18.5	16.9	12.8	14.2	14.9	13.7	18.6	14.4	23.9	20.9	24.4	17.1	15.9	13.7	13.2	14.8	16.6	19.0	14.0	12.3	17.0	14.4	26.3	13.7	30.9	13.3	18.8	21.7	15.7	15.0	19.8	24.4	4.2	3.6	12.2	5.6	18.0	5.3	3.2	11.9	11.3	10.5	16.1	8.5	11.6	14.2	12.9	9.9	13.6	15.2	12.6	9.4	20.5	10.3	13.1	17.0	9.9	21.6	15.0	21.4	7.7	11.4	9.5	11.6	11.3	6.2	10.8	5.5	8.2	8.7	16.2	17.5	6.8	51.2	10.2	17.9	6.7	13.5	11.3	11.4	14.0	13.4	7.0	6.9	13.9	15.5	18.6	8.4	11.8	11.1	6.5	11.3	8.9	9.2	11.0	11.5	7.5	23.0	8.2	9.0	9.0	11.7	5.3	8.6	14.2	10.1	15.1	9.7	12.2	2.1	1.8	3.5	3.4	4.2	3.1	3.7	3.6	3.6	4.2	5.3	3.8	2.1	18.0	5.6	2.3	2.3	3.2	13.6	17.1	18.4	18.3	15.2	13.4	14.9	13.7	17.1	13.3	8.9	3.0	6.0	3.7	7.6	3.6	10.7	0.0	30.8	4.5	7.0	2.0	6.2	3.3	3.3	35.3	30.0	1.7	23.3	4.6	5.4	5.8	4.2	12.7	5.8	4.4	4.8	2.9	41.7	6.5	18.8	5.2	4.5	3.3	1.8	5.5	3.3	2.5	0.0	3.9	3.4	4.8	6.5	6.6	12.9	16.3	7.8	4.2	4.9	4.6	4.0
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024297	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 1043.3;Late spermatids: 1438.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		92000	"Nucleoplasm, Cytosol"		"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	26.3	13.8	16.5	14.5	18.3	13.0	23.5	16.3	20.2	20.2	19.7	15.9	13.5	9.6	21.1	13.4	19.4	18.9	12.4	23.9	15.7	12.7	18.9	23.2	14.1	16.0	20.8	15.9	33.5	60.7	12.5	13.0	14.3	15.3	19.1	16.6	11.0	13.9	20.2	65.0	13.5	11.3	25.5	24.3	14.9	18.9	79.5	19.4	23.3	23.0	24.1	21.1	21.8	23.9	8.0	11.0	1.1	7.3	10.3	12.3	6.1	28.6	19.3	36.3	33.2	24.7	62.9	22.3	42.2	33.3	59.5	42.3	39.6	22.1	82.8	14.8	50.7	13.4	25.0	75.4	28.9	82.3	20.9	23.7	45.1	36.7	31.0	17.7	48.6	16.1	35.3	19.0	48.2	40.6	25.4	33.8	25.6	31.1	11.2	50.7	7.8	36.7	13.2	36.4	43.3	23.2	47.2	41.3	24.5	14.3	18.8	26.9	22.0	21.6	25.3	15.8	46.0	19.2	26.9	23.7	40.2	20.2	20.0	38.3	15.0	18.4	25.8	41.5	30.9	27.5	0.5	4.4	1.1	7.1	7.3	12.3	8.0	8.3	8.8	11.0	7.6	11.6	9.6	0.6	10.3	5.1	5.4	8.5	6.1	16.5	18.3	16.3	20.2	15.7	12.7	20.8	15.9	15.3	19.4	17.9	23.8	15.7	33.9	36.9	31.1	68.2	35.7	18.7	22.7	21.0	5.9	28.6	23.2	26.7	1043.3	35.1	7.8	0.0	36.0	38.4	34.0	35.8	13.9	40.9	21.3	60.4	33.9	28.3	24.1	1438.4	48.9	18.7	25.3	14.4	20.2	40.9	32.7	3.5	41.4	35.7	20.2	25.8	49.1	109.7	53.2	32.2	27.0	19.2	36.5	33.9
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.7	29.5	34.8	27.6	35.3	45.6	27.9	46.0	29.6	34.0	36.8	25.5	34.8	35.4	16.8	35.3	30.9	29.7	49.3	35.7	56.9	16.8	40.7	29.3	33.5	25.6	22.1	44.7	22.3	29.1	38.7	22.4	52.7	34.8	40.1	12.2	43.9	21.3	44.3	15.3	26.9	21.9	34.2	35.0	34.3	28.4	54.8	16.0	28.1	35.7	13.8	27.2	20.5	40.7	33.1	28.9	18.7	22.5	31.5	41.9	28.9	43.1	49.1	6.2	23.6	24.5	27.5	24.2	22.7	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8	62.5	53.8	24.3	76.2	128.0	37.1	127.5	30.6	49.5	67.1	33.2	55.0	44.9	28.2	32.5	3.3	40.5	18.6	0.0	35.7	54.7	55.8	105.1	35.9	39.4	31.6	33.4	29.9	25.2	47.7	3.6	25.9	41.8	37.1	26.2	36.8	30.1	37.3	28.8	33.6	35.8	38.8	12.9	55.6	15.4	22.6	129.4	30.7	22.3	45.0	129.0
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 360.6;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	5.5	7.6	15.1	6.8	17.0	7.0	7.4	11.1	18.7	6.9	10.2	12.8	6.7	13.1	9.6	12.3	6.6	17.1	11.2	7.1	14.3	15.6	7.1	3.6	9.1	4.7	12.0	12.1	9.7	8.4	12.9	15.4	4.1	11.3	8.1	9.9	7.3	9.8	11.2	4.5	8.1	10.9	7.9	11.1	5.1	10.6	35.3	9.6	2.8	11.9	3.0	3.9	6.0	7.4	0.7	4.3	8.3	2.1	0.3	1.3	0.3	20.0	10.5	4.5	13.8	5.6	8.5	7.8	4.2	7.1	5.6	6.1	5.4	11.6	1.4	4.9	9.8	12.2	10.4	3.1	4.9	5.9	3.5	6.5	2.7	12.7	1.7	4.1	7.2	4.0	3.5	8.1	5.4	5.7	6.5	6.0	5.8	8.6	2.6	7.4	20.4	3.2	5.5	3.9	9.0	7.7	3.1	5.2	5.2	6.0	9.4	9.5	11.2	4.7	20.0	4.4	3.3	24.6	9.8	5.9	4.7	9.5	17.8	7.1	2.9	4.9	0.3	9.2	5.2	13.1	1.1	1.4	3.6	1.3	2.1	0.5	0.5	0.7	0.6	0.6	0.7	0.5	1.1	8.3	0.3	0.7	4.3	0.3	0.3	15.1	17.0	11.1	18.7	14.3	15.6	12.0	12.1	11.3	9.6	11.9	11.0	0.0	5.0	4.8	7.8	7.7	22.9	60.2	14.8	12.2	56.9	3.7	14.9	16.6	360.6	3.6	15.8	0.0	17.4	6.9	6.4	7.3	1.1	2.8	8.7	19.1	8.1	7.4	6.4	290.7	13.0	5.9	0.0	10.8	10.7	14.1	17.5	11.8	14.5	8.1	38.1	19.4	3.6	43.3	53.7	3.8	1.6	4.4	10.0	3.3
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Cell type enhanced"	"Detected in some"	14	"Cholangiocytes: 5.1;Late spermatids: 16.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	Yes			"Nucleoli rim"	Nucleoplasm	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.4	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.5	13.0	21.8	2.1	6.5	10.3	9.1	22.5	7.3	9.0	15.5	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.3	4.2	10.0	5.1	6.3	3.4	12.6	12.4	2.2	5.5	7.8	23.3	11.5	7.6	12.0	2.4	4.4	8.1	6.8	10.5	15.9	18.7	6.4	13.1	14.9	10.3	6.5	15.6	18.7	12.7	20.6	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3	0.0	0.0	0.5	0.0	1.1	0.0	0.8	5.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	1.1	0.0	0.0	3.1	0.5	0.2	0.0	0.0	3.4	0.0	1.2	4.3	0.3	16.8	0.3	2.2	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	3.8	2.4	0.9	0.7	0.0	2.9	0.4
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain 3"	Q9UPP2	12	66765-178460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 32.6;Horizontal cells: 108.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	5.6	1.3	5.6	0.7	4.2	0.8	0.4	19.8	15.5	1.6	0.4	0.5	0.0	0.5	2.0	0.5	0.4	5.2	2.2	1.9	6.5	5.1	2.4	0.2	2.9	0.5	3.7	4.7	2.1	1.2	0.0	2.2	1.3	5.0	1.5	0.2	0.4	0.2	4.5	1.3	0.2	0.7	1.9	1.4	0.3	0.6	1.2	0.8	0.0	0.3	0.0	0.2	1.3	0.6	0.0	2.1	0.0	0.0	0.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	13.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	1.2	0.0	0.5	0.0	2.1	0.0	0.4	5.6	4.2	19.8	12.4	6.5	5.1	3.7	4.7	5.0	0.8	3.0	0.0	0.0	0.0	0.2	32.6	1.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.1	0.1	2.3	0.0	1.2	108.1	0.0	1.8	1.0	3.3	0.6	0.0	0.0	0.0	0.0	6.1	0.2	0.0	0.0	4.5	15.7	0.0	0.0	2.2	8.8	0.1	0.0	0.5	0.0	0.0
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	77.0	30.0	4.3	34.6	8.5	6.8	18.5	11.5	10.9	17.8	16.5	23.7	34.2	32.9	64.8	12.3	27.3	21.1	9.8	18.8	6.9	25.8	29.3	12.0	27.0	14.1	19.5	28.3	20.6	9.4	16.5	16.9	18.7	9.2	10.6	6.7	21.1	38.1	12.4	28.4	11.6	25.3	10.5	24.6	59.8	30.2	21.5	55.2	11.8	14.6	23.8	17.2	13.7	15.3	22.7	1.7	5.9	30.2	14.5	21.6	34.2	49.3	71.3	48.0	30.6	60.3	31.5	34.1	22.3	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8	0.0	14.1	25.2	11.0	11.8	8.1	8.2	20.4	6.7	19.4	10.4	5.9	9.6	6.6	45.8	0.6	13.7	36.0	0.0	97.4	17.8	12.1	24.0	12.7	32.6	52.7	15.9	19.7	10.4	45.4	1.8	16.7	26.5	13.5	11.8	24.2	14.0	61.0	24.6	20.1	13.3	5.0	0.0	14.5	1.7	6.3	11.4	10.3	14.0	28.8	23.4
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132481609-132490798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: AB_2684945"	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	19.7	8.5	4.1	64.2	9.9	43.8	21.0	3.9	4.6	10.6	27.3	4.0	4.4	31.1	11.4	9.9	12.4	11.8	18.1	11.8	4.2	3.5	14.2	20.9	49.3	41.0	6.8	1.4	11.5	14.5	2.8	8.8	24.7	10.3	18.9	13.6	10.3	13.2	10.3	14.0	8.4	52.1	11.3	8.0	51.7	17.5	5.7	4.9	36.6	26.5	14.7	33.0	14.7	26.7	12.1	16.2	103.0	42.1	21.3	28.5	21.3	9.0	7.4	0.6	2.5	7.2	6.2	14.9	4.3	18.5	13.9	17.4	3.8	27.1	9.0	5.9	6.5	20.8	12.7	2.3	10.5	4.7	19.1	2.5	12.1	3.5	2.7	47.5	5.9	10.4	11.8	2.6	10.3	9.8	8.7	6.5	6.0	2.1	34.8	3.8	5.0	32.0	9.9	0.8	2.8	5.2	37.2	7.8	11.0	7.1	10.2	1.4	1.1	4.6	10.4	4.4	3.4	1.7	8.1	4.1	8.0	2.8	4.6	6.4	27.6	6.9	6.4	9.1	9.4	5.7	23.1	26.2	40.2	28.5	40.0	19.4	12.1	18.7	22.9	16.2	11.5	11.5	16.0	103.0	21.3	42.1	8.2	20.2	21.3	4.1	9.9	3.9	4.6	4.2	3.5	6.8	1.4	10.3	4.9	95.3	109.6	113.9	70.4	78.3	13.4	11.8	35.7	113.8	61.4	21.0	31.4	19.3	16.6	94.9	95.1	107.4	136.0	23.3	99.6	32.8	121.3	247.1	102.7	13.6	47.7	1.6	83.5	49.7	57.7	7.8	25.3	107.0	69.2	266.1	57.5	16.3	73.7	119.3	7.4	13.9	36.6	12.9	178.3	1.1	3.6	72.3	9.4	207.0	53.2	80.6
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Group enriched"	"Detected in some"	6	"Melanocytes: 42.2;monocytes: 92.8"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.1	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.9	0.0	45.1	0.0	0.0	0.1	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	31.4	13.7	0.0	0.0	25.6	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1	0.0	4.0	12.0	0.1	7.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	3.1	6.9	42.2	92.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	3.8	0.1	6.2	0.0	0.0
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.4	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.1	0.0	0.0	3.4	5.8	0.0	0.0	0.0	0.0	59.6	0.0	21.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	24.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	2.1	21.3	5.3	1.7	0.4	9.5	0.5	1.1	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3	14.9	7.2	0.8	177.1	344.0	0.0	23.2	40.8	46.8	50.0	33.2	0.0	79.7	23.2	31.5	0.9	4.3	54.6	0.0	16.8	20.9	7.3	126.3	2.3	30.2	7.1	0.0	57.5	1.3	1.2	0.0	0.6	2.3	33.7	1.8	54.2	5.2	36.6	51.8	0.0	10.3	0.4	0.0	10.3	9.0	3.6	482.8	135.1	0.0	36.4	297.3
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615999	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	12	"plasmacytoid DC: 81.1"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 81.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.1;JURKAT: 2.9;Karpas-707: 10.7;SCLC-21H: 5.3;SK-BR-3: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	9.6	4.7	4.5	9.9	6.1	17.2	12.1	2.9	4.9	4.8	4.6	2.5	2.2	2.2	4.2	5.1	6.9	4.9	9.0	5.2	3.7	2.0	8.2	23.3	11.6	12.8	4.6	1.4	4.8	3.6	2.2	3.8	4.8	5.5	5.3	2.9	5.2	5.4	7.4	6.1	4.1	8.4	5.7	4.5	19.0	4.5	4.0	5.2	8.5	9.0	2.4	12.8	7.5	3.9	2.5	81.1	3.7	6.6	2.1	1.5	1.8	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.3	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.1	2.9	0.0	10.7	0.9	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.1	5.3	0.0	0.0	3.2	0.0	0.9	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	3.7	1.1	6.6	1.1	2.5	1.0	1.2	3.3	2.4	1.1	1.2	1.7	2.1	6.1	81.1	1.5	1.8	4.5	6.1	2.9	4.9	3.7	2.0	4.6	1.4	5.5	5.2	14.9	24.2	54.6	23.1	30.6	0.2	4.4	12.7	16.0	9.1	19.2	0.0	5.2	8.3	25.9	3.8	20.4	38.6	23.3	15.1	33.9	18.3	29.0	31.1	24.9	34.1	0.0	25.2	10.4	19.3	16.9	11.2	41.8	35.4	75.7	24.1	2.9	23.7	31.6	4.6	5.9	4.3	12.9	17.5	0.4	6.1	24.8	20.1	31.9	10.1	30.8
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 6.0;Collecting duct cells: 5.2;Distal tubular cells: 13.3;Smooth muscle cells: 4.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.2;REH: 29.0;U-251 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6	6.0	3.0	0.0	0.0	3.2	0.5	2.0	0.0	2.7	1.2	5.2	0.0	0.2	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.2	2.6	0.2	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3"	"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	40.5	0.0	2.2	1.6	24.3	2.4	1.3	2.0	1.6	4.8	0.0	0.0	0.0	4.5	0.0	13.8	0.0	9.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.6	0.9	8.2	0.0	0.0	0.0	0.0	0.0	1.4	7.8	0.0	0.0	4.5	10.5	0.0	0.0	2.5	0.0	9.0	0.0	1.5	0.0	7.9	16.3	0.0	6.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2	101.3	59.1	0.0	14.0	179.6	0.5	2.4	0.0	10.7	30.7	7.0	0.0	23.0	23.2	0.1	3.9	0.5	0.5	0.0	0.0	17.1	12.8	15.9	1.1	0.0	2.8	0.0	0.0	0.0	0.0	8.9	0.0	1.3	18.6	0.0	1.5	0.2	0.5	1.9	0.0	0.5	2.4	0.0	16.9	0.7	3.8	114.7	12.7	0.0	1.9	9.2
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell type enhanced"	"Detected in some"	21	"Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.5	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.7	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1	0.0	0.0	0.0	4.2	43.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.6	12.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	17.7	3.1	0.0	0.0	1.3
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	10.6	0.0	0.2	0.1	0.1	1.8	6.8	0.1	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.6	1.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.8	0.0	0.0	3.3	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.9	0.1	0.0	0.0	0.0
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.5;HEL: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.4	1.3	1.9	1.1	1.5	8.5	1.9	1.3	1.6	1.4	2.7	2.2	0.0	4.1	2.7	0.8	3.1	1.4	0.0	2.9	1.0	1.5	11.7	1.5	0.6	1.4	0.9	1.5	2.7	1.2	1.3	0.2	0.8	1.2	1.0	2.8	0.3	4.2	0.5	1.1	1.1	2.2	1.0	0.3	0.0	1.9	0.1	2.8	0.8	2.0	1.3	1.4	2.5	2.5	2.7	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4	0.0	2.9	0.0	1.6	0.3	6.0	7.3	0.0	2.7	4.5	3.5	7.9	2.1	1.7	1.0	7.5	2.2	0.4	0.0	0.6	7.9	2.2	2.2	1.1	4.7	0.7	4.8	1.2	4.9	0.3	1.2	1.4	0.0	1.7	0.0	2.0	4.1	2.6	0.0	3.2	5.8	5.8	0.0	0.7	6.6	6.1	0.9	2.4	0.5	1.2	1.7
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"intestine: 22.2"	"Group enriched"	"Detected in some"	49	"Enterocytes: 22.5;Intestinal endocrine cells: 18.7;Mucus-secreting cells: 15.4;Paneth cells: 21.0;Undifferentiated cells: 19.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 3.5;Hep G2: 9.8"					"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.1	0.0	0.1	2.0	0.1	0.0	0.1	0.1	0.1	0.1	16.3	0.1	0.1	22.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	15.8	0.1	0.1	0.1	0.1	0.0	19.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Cell line enriched"	"Detected in many"	4	"BEWO: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.8	8.6	20.5	6.1	0.1	0.0	103.8	1.3	0.2	0.1	0.0	4.9	5.2	0.0	7.0	0.6	0.0	7.4	0.6	0.0	0.0	7.7	23.6	10.3	0.5	15.9	2.2	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.3	0.2	21.1	0.4	0.0	16.6	0.7	0.7	10.7	2.6	6.9	14.2	0.0	4.8	1.7	0.0	6.3	15.8	0.3	1.9	10.5	4.4	14.0	1.1	3.9	0.1	0.2	0.1	0.3	3.3	1.4	0.6	0.6	0.4	3.6	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5	3.0	0.6	2.2	67.1	10.6	0.0	4.2	7.6	4.0	4.5	45.4	2.0	829.0	44.7	34.8	81.2	19.7	1.3	0.0	7.5	57.3	25.4	8.5	13.9	0.9	73.6	0.0	62.2	19.0	5.3	178.1	34.5	3.7	21.9	7.2	2.6	7.2	4.6	0.0	47.4	4.7	0.5	310.4	167.1	59.2	21.8	5.0	865.2	9.6	4.6	31.8
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.2	13.4	13.7	9.8	15.1	21.6	16.4	16.5	18.9	20.7	20.2	37.6	31.3	9.9	16.0	21.0	28.2	25.7	20.8	33.3	25.2	7.4	6.7	28.8	11.4	22.5	15.8	11.8	13.0	11.0	17.0	17.4	27.4	18.7	15.5	14.4	16.3	17.2	16.1	10.1	17.2	6.2	6.6	12.5	15.9	14.5	28.9	22.9	12.3	35.3	8.4	6.1	30.8	12.1	18.5	14.1	14.5	10.7	15.0	24.7	14.8	16.1	12.2	13.7	14.3	14.5	15.3	7.6	14.4	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3	11.9	17.9	13.3	15.9	13.4	19.6	20.1	7.6	28.1	33.0	29.6	23.6	15.1	5.0	11.7	46.0	17.5	21.6	0.0	14.1	17.6	16.0	23.0	18.5	43.1	14.0	14.3	11.5	16.5	22.8	102.3	20.8	21.2	25.3	23.4	15.8	34.3	16.6	21.0	14.5	18.0	26.8	12.9	17.8	25.7	21.5	14.2	39.2	20.6	9.9	38.9
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.4	5.0	0.4	0.2	1.3	2.4	1.5	19.6	29.9	0.7	1.2	9.3	13.7	0.0	3.4	8.3	11.5	30.2	1.6	22.1	2.8	0.0	1.5	1.4	1.2	5.5	4.5	0.2	0.4	0.9	3.8	19.7	3.5	28.1	27.8	1.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	5.0	10.0	0.0	0.1	0.0	6.3	10.3	0.2	1.1	1.0	1.3	2.0	0.8	3.2	0.0	23.8	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.6	0.0	15.8	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0	53.6	13.6	0.0	300.3	134.2	2.3	1.2	20.4	88.3	161.5	50.6	3.9	0.2	8.3	157.1	0.0	15.8	20.6	0.0	144.3	1.6	1.9	266.4	1.1	0.0	0.3	0.0	13.3	5.5	0.0	0.0	1.1	3.8	11.8	1.8	32.4	18.0	350.7	15.2	0.0	2.9	5.0	0.0	4.2	0.0	0.9	32.5	0.3	1.9	28.1	321.7
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253846-47311816	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enhanced"	"Detected in some"	10	"Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 2.8;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		710000000	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	10.0	0.6	1.0	6.2	2.5	2.7	7.0	0.4	1.6	4.6	13.6	0.9	2.4	2.2	9.7	5.7	6.4	6.4	2.8	8.5	0.7	0.6	16.0	3.7	5.2	1.2	2.3	0.1	4.6	0.6	0.7	1.6	23.5	1.6	6.4	4.8	1.8	2.5	11.5	4.9	2.4	5.0	17.0	1.8	9.5	3.6	2.6	0.6	0.2	36.6	1.9	0.9	11.0	7.8	0.1	0.0	2.8	0.1	0.0	0.0	9.5	0.0	0.4	0.1	0.0	2.4	1.0	0.0	1.2	6.1	2.6	2.4	0.0	0.0	0.1	46.6	0.3	3.6	0.0	0.0	0.0	3.4	0.9	0.0	41.2	0.1	0.0	2.0	0.0	0.0	1.0	0.0	15.6	0.4	1.8	11.6	0.6	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	26.8	0.0	0.0	0.1	1.5	0.0	8.4	2.4	0.0	0.0	12.6	0.5	0.7	0.3	2.8	0.0	0.0	0.3	21.1	0.0	67.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	9.5	1.0	2.5	0.4	1.6	0.7	0.6	2.3	0.1	1.6	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	2.7	1.4	0.0	0.0	0.4	0.0	0.8	0.1	0.0	0.8	0.8	0.0	0.0	1.8	0.0	4.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	1.1	3.5	0.0	6.5	1.9	0.0	2.3	0.4	1.0	0.0	0.0	0.1
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		69000	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	32.7	25.9	12.8	13.3	8.5	12.6	8.5	14.9	20.7	19.6	17.2	20.7	30.5	14.1	13.6	13.6	19.2	28.5	17.6	22.3	13.7	9.2	26.3	35.3	10.7	31.4	16.1	15.1	12.0	12.0	17.1	18.4	11.5	8.1	14.9	11.4	24.2	9.7	17.5	15.0	17.8	43.9	21.4	37.0	26.2	17.1	17.8	37.0	26.8	10.4	19.4	22.9	11.7	41.1	27.3	5.9	17.1	25.2	10.4	22.0	12.3	14.4	31.4	14.5	18.2	26.7	10.2	28.0	23.9	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5	20.8	43.1	32.8	43.8	35.6	18.3	8.0	40.8	26.8	37.5	41.8	13.7	62.7	49.7	88.7	2.3	18.6	41.6	0.0	90.9	108.9	44.0	43.6	41.5	32.1	103.0	4.8	26.4	29.4	43.0	2.3	28.7	50.7	38.8	123.6	48.5	17.1	82.5	52.6	20.8	63.4	20.3	19.4	36.4	14.6	19.4	43.0	47.0	46.3	66.6	52.1
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26336515-26833198	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.8	20.6	12.8	14.5	13.8	6.1	18.5	9.3	15.0	7.9	9.9	7.8	3.7	6.0	7.2	7.8	12.0	7.3	8.0	7.1	14.2	6.0	14.4	47.1	6.5	8.1	12.8	4.6	8.0	9.2	17.4	9.9	11.9	13.0	6.6	7.8	4.8	17.6	3.8	4.7	13.3	8.9	5.4	20.3	12.5	5.9	3.4	15.3	35.3	5.3	6.6	10.7	5.5	8.1	4.3	9.0	17.3	5.2	3.6	3.1	0.7	2.7	1.2	1.6	2.6	5.0	5.1	1.8	2.5	3.5	1.8	1.9	0.1	1.4	9.4	1.6	3.4	1.9	3.0	8.7	5.3	2.4	2.2	2.9	7.5	2.5	15.1	4.6	6.7	3.4	4.8	0.7	3.7	7.0	3.5	16.6	3.7	3.3	3.0	2.2	2.3	4.7	9.0	7.2	2.4	0.9	1.5	3.9	5.9	4.1	4.3	0.5	2.6	11.4	2.1	6.3	7.0	4.3	3.3	36.3	3.6	1.4	3.4	3.2	2.8	2.1	17.6	3.3	3.1	2.3	17.3	5.2	7.1	2.4	2.2	2.0	4.2	2.1	1.9	1.0	4.3	2.5	2.2	13.5	3.6	3.0	9.0	3.1	0.7	12.8	13.8	9.3	15.0	14.2	6.0	12.8	4.6	13.0	15.3	44.7	38.7	25.7	17.2	18.5	3.1	19.1	35.7	8.1	13.6	22.7	137.4	16.2	6.6	19.4	2.6	26.3	10.3	23.3	20.5	7.7	11.6	22.1	43.8	96.9	31.6	0.0	75.3	16.5	35.2	4.7	16.7	48.3	32.1	6.4	36.5	12.6	14.9	35.3	16.6	14.6	67.9	0.0	11.7	2.8	4.9	23.3	23.3	16.0	8.4	14.6
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		66000	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.7	17.4	15.4	13.5	0.4	13.5	13.2	17.3	10.8	19.8	7.6	0.3	25.8	17.0	14.9	10.3	18.4	19.9	10.7	12.6	14.8	22.7	15.4	19.0	27.1	9.2	22.6	20.6	6.9	9.6	20.2	20.0	17.1	24.4	1.0	1.1	15.5	13.8	11.4	14.3	8.2	0.5	16.9	16.7	13.3	10.4	20.5	23.7	16.6	9.2	18.6	40.5	8.2	9.4	34.9	40.7	14.5	14.4	9.4	10.1	10.8	21.8	14.9	0.3	13.5	9.2	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7	26.8	46.2	14.3	16.6	2.1	24.6	72.6	45.9	42.8	40.9	41.8	13.7	16.5	81.2	15.9	4.4	18.0	17.7	23.3	13.0	4.8	15.4	16.0	32.5	123.8	25.1	15.9	18.9	17.2	20.2	4.9	19.0	13.9	5.0	31.5	22.5	25.1	14.1	3.5	23.3	60.9	18.9	19.4	13.9	19.0	4.3	0.5	8.2	12.2	33.1	11.2
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: AB_2685326"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	4.9	12.6	3.5	2.7	5.1	1.5	6.2	3.3	4.9	5.7	4.5	7.1	14.0	1.9	9.5	16.3	4.7	4.3	3.2	5.2	3.9	3.3	3.7	7.7	4.3	4.1	9.2	1.4	7.2	8.7	3.0	2.1	15.9	4.7	5.4	3.2	2.1	4.3	12.2	3.3	3.8	3.5	6.0	8.5	9.8	4.7	14.5	8.4	8.4	4.2	1.4	7.5	7.6	13.1	4.8	1.7	0.0	0.3	0.2	0.2	0.4	6.4	5.8	9.5	6.5	3.5	2.6	36.4	3.8	3.2	4.3	4.9	6.6	5.6	0.0	2.7	2.8	6.4	2.5	11.5	3.1	6.3	17.1	7.5	5.1	6.5	6.4	5.7	3.8	2.7	2.0	4.3	3.0	9.9	2.6	8.1	9.8	3.5	3.0	3.3	6.6	13.8	4.6	7.4	4.1	4.9	14.2	10.7	8.9	3.6	5.9	8.2	7.3	11.0	10.2	6.0	16.4	6.8	4.0	5.0	4.6	8.0	6.4	2.5	2.3	2.0	12.2	1.2	3.3	4.4	0.0	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.2	0.3	1.7	0.0	0.4	3.5	5.1	3.3	4.9	3.9	3.3	9.2	1.4	4.7	8.4	0.0	8.5	0.5	2.3	3.8	1.5	3.3	2.5	0.0	1.2	5.2	0.0	7.9	0.0	2.1	0.3	4.5	0.9	0.0	3.2	8.1	2.2	3.8	0.0	11.1	1.5	0.0	8.1	3.7	1.2	2.0	4.4	0.8	3.3	4.6	1.9	1.2	2.9	0.0	3.5	2.1	1.6	6.5	1.9	9.2	26.6	7.0	11.9	0.5	2.3	3.3
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		17000	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.2	0.1	0.7	0.2	0.4	0.5	11.6	1.5	5.5	0.0	0.0	0.1	0.0	0.2	7.0	0.0	1.6	0.0	3.4	11.3	0.5	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.3	0.0	16.2	0.0	0.4	0.0	0.2	5.6	0.1	0.3	0.1	5.7	0.1	0.0	2.1	3.7	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	13.1	1.2	0.1	1.8	1.5	0.0	0.0	9.6	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2	0.0	2.9	1.4	1.4	6.6	1.5	31.9	0.0	1.4	0.0	3.5	13.7	0.3	0.0	0.3	12.9	151.0	0.0	0.0	0.2	2.2	18.5	1.2	0.0	0.0	1.0	0.0	0.0	49.7	2.2	13.2	9.2	1.4	15.1	0.0	0.0	0.9	0.1	0.0	23.0	0.0	3.6	0.0	7.6	4.8	3.9	5.8	0.7	0.0	0.0	0.7
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193740-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 202.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 24.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 7.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 113.6"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	6.7	2.1	0.9	23.1	1.1	6.6	2.1	5.3	0.8	4.1	8.4	0.7	1.3	6.1	3.8	9.6	4.0	3.1	8.9	3.1	0.9	0.9	3.4	4.3	34.4	43.2	3.7	0.5	2.1	1.8	0.0	2.7	4.2	2.3	3.4	8.3	6.7	6.7	1.1	1.0	2.2	14.0	4.7	1.8	43.4	3.9	1.9	0.6	14.3	2.6	5.9	25.0	9.8	3.0	0.3	60.5	202.6	59.0	1.4	25.2	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	2.3	0.3	2.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	5.8	59.0	202.6	3.9	36.6	25.2	0.3	7.0	7.4	60.5	0.1	8.3	6.7	126.6	1.4	17.1	46.6	11.1	40.1	0.9	1.1	5.3	0.8	0.9	0.9	3.7	0.5	2.3	0.6	6.0	48.3	15.4	0.1	0.0	0.0	0.0	0.0	4.0	10.3	1.8	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.4	0.1	14.0	2.1	29.9	0.0	0.0	8.0	117.5	0.9	0.0	185.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.3	45.3	0.0	0.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180743	"Disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 85.4;Late spermatids: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	11.9	65.2	18.7	13.4	13.1	16.7	17.7	26.9	19.2	50.1	23.0	8.5	12.8	3.4	34.1	18.4	8.4	11.9	9.9	17.0	14.0	14.8	4.8	12.2	9.9	10.8	8.9	16.9	11.6	5.7	5.6	19.0	12.3	11.1	23.6	7.3	4.8	4.2	28.1	5.6	5.9	6.7	29.7	12.2	11.0	7.4	14.3	10.0	6.3	12.1	5.5	11.9	18.7	24.3	4.6	12.5	17.6	3.7	4.3	4.6	2.4	0.7	0.6	2.4	0.6	18.6	22.7	0.0	5.8	14.7	9.7	11.8	0.0	3.8	16.8	11.8	11.7	6.5	0.3	3.2	4.2	7.7	2.5	5.1	6.0	4.2	0.0	12.7	2.5	1.7	10.2	5.2	7.2	4.8	7.3	5.9	1.3	0.1	27.5	5.2	0.7	0.7	8.7	5.2	0.1	3.9	1.8	1.1	5.1	3.4	0.1	1.5	2.6	4.6	0.1	6.0	7.7	1.7	3.0	5.8	15.3	6.0	4.1	6.4	5.0	1.4	6.5	4.9	6.2	8.4	17.6	3.7	5.5	4.6	3.0	1.3	2.9	1.4	3.1	3.3	4.6	0.6	3.1	3.2	4.3	3.2	12.5	2.9	2.4	18.7	13.1	26.9	18.7	14.0	14.8	8.9	16.9	11.1	10.0	3.0	6.5	8.0	2.6	13.1	7.4	23.4	10.2	14.7	3.4	1.8	5.9	0.5	6.6	12.7	85.4	8.0	0.0	23.3	2.1	1.0	21.1	2.5	24.2	4.2	9.1	15.9	5.2	2.5	22.5	64.7	50.9	27.7	21.9	17.2	0.7	3.9	4.3	0.0	32.5	1.4	3.9	12.9	15.5	8.4	15.8	9.8	1.1	13.4	0.2	1.4
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 71.9;Muller glia cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	27.0	14.4	11.2	19.3	12.5	46.0	59.6	10.6	15.1	16.3	15.3	13.7	6.5	15.3	12.7	10.5	17.1	14.8	21.3	20.7	13.5	9.0	9.7	14.3	24.8	13.2	14.0	8.7	21.8	15.8	7.4	10.1	12.0	11.2	13.9	8.1	16.6	19.5	11.4	13.3	15.2	22.4	17.8	15.7	39.7	15.8	4.7	11.8	1.4	20.7	18.7	9.7	14.2	60.4	11.0	2.1	6.9	10.5	0.1	0.2	1.1	4.4	3.9	0.7	7.8	24.7	18.4	26.8	13.8	15.0	9.0	11.4	9.5	3.9	3.5	7.0	26.2	1.6	17.4	4.9	4.7	3.9	4.7	0.5	4.8	7.3	3.4	50.8	6.8	0.3	32.4	28.3	3.7	9.1	3.5	0.4	4.0	0.6	6.8	8.1	21.7	0.3	11.2	2.7	8.6	2.5	2.4	0.1	9.5	4.3	2.4	0.6	3.1	14.2	20.4	15.8	9.2	19.5	14.9	1.8	11.4	17.7	0.7	2.0	5.7	1.6	8.3	3.4	25.8	5.6	0.1	4.1	3.8	0.0	7.0	0.0	11.0	0.2	0.0	2.1	5.1	0.0	0.0	6.9	0.1	10.5	1.8	0.2	1.1	11.2	12.5	10.6	15.1	13.5	9.0	14.0	8.7	11.2	11.8	11.9	31.0	5.6	5.5	14.5	14.3	16.9	12.7	6.7	7.9	8.7	9.8	1.6	0.0	2.3	0.3	11.3	14.9	0.0	5.7	4.7	22.2	3.7	2.3	7.4	8.9	7.9	5.2	11.1	71.9	0.2	16.7	9.4	11.8	2.8	12.7	43.2	6.9	8.6	15.6	2.2	30.5	6.5	7.1	0.1	0.4	7.9	0.2	0.0	8.0	9.1
JHY	"C11orf63, FLJ23554, Jhy"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882528-122959798	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 51.0"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 11.9;Ciliated cells: 34.8;Club cells: 13.6;Proximal tubular cells: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	3.6	0.9	1.9	1.6	2.1	0.2	2.3	1.6	2.2	2.1	2.4	1.2	1.0	0.7	1.5	2.5	1.0	5.1	1.5	1.6	1.5	2.6	5.3	1.0	2.8	1.0	1.7	1.4	2.1	1.5	6.3	4.2	2.3	1.7	2.3	0.8	1.9	1.0	1.5	2.4	1.0	1.2	1.0	2.2	1.3	1.0	51.0	1.3	1.4	3.4	1.5	1.2	1.7	1.2	2.4	4.9	0.3	0.6	4.3	4.1	1.1	2.6	3.7	2.2	0.1	0.6	0.4	0.7	5.7	6.6	2.4	1.0	0.2	9.9	0.0	1.4	8.8	13.4	2.3	2.6	1.3	1.1	8.8	2.7	0.1	1.8	0.1	0.9	1.5	4.6	2.8	7.3	0.4	0.6	6.2	3.6	3.9	0.0	0.0	1.8	1.6	0.0	0.6	0.3	7.7	3.4	0.9	0.0	1.2	6.9	3.0	5.7	4.0	6.8	3.7	2.4	2.9	4.5	0.6	1.2	7.8	1.0	0.2	4.5	0.1	0.0	0.0	2.0	2.0	5.2	0.3	0.6	0.1	2.9	0.1	4.1	2.4	3.0	3.9	4.9	1.4	2.1	2.1	0.3	4.3	0.0	1.1	0.6	1.1	1.9	2.1	1.6	2.2	1.5	2.6	1.7	1.4	1.7	1.3	11.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	34.8	13.6	5.2	0.0	0.0	3.3	4.9	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	2.9	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: AB_2686429"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	19.0	29.5	19.3	13.0	25.5	15.7	24.2	16.7	28.4	17.5	21.3	25.0	18.1	13.8	22.8	19.6	18.6	23.2	21.7	18.3	18.8	29.4	38.9	26.1	22.2	16.2	29.5	19.5	19.7	18.7	42.3	44.5	24.1	36.9	22.9	22.5	22.8	24.9	20.3	15.9	17.5	25.0	20.7	30.3	22.1	18.7	24.6	27.0	18.6	24.6	18.0	14.7	21.0	16.7	14.9	29.0	37.0	31.7	18.0	18.3	21.5	19.9	23.6	20.3	16.6	15.2	20.1	15.5	31.3	26.8	18.5	22.1	7.4	36.6	9.9	28.1	28.9	21.3	14.5	14.9	19.3	25.0	29.7	8.5	10.0	15.2	14.7	20.2	16.6	19.7	21.9	21.9	17.3	11.9	29.7	18.8	13.8	9.0	19.9	34.7	18.0	9.1	12.8	11.1	16.9	20.8	10.7	24.7	9.1	31.9	19.8	8.7	15.2	28.4	22.8	16.6	15.5	23.0	12.8	24.7	19.5	25.6	17.8	20.5	9.3	16.5	11.5	27.6	11.3	24.5	28.2	25.2	32.5	15.1	29.8	14.6	14.9	16.5	15.9	21.2	13.6	17.7	16.6	37.0	18.0	31.7	29.0	18.3	21.5	19.3	25.5	16.7	28.4	18.8	29.4	29.5	19.5	36.9	27.0	20.8	28.2	18.6	27.3	26.7	28.5	9.4	48.4	64.3	19.4	43.6	17.7	52.1	6.6	41.7	127.9	21.5	16.0	70.0	47.9	55.4	37.6	25.8	34.6	34.4	51.7	27.0	30.0	31.9	57.1	50.5	32.8	38.3	45.5	31.5	24.3	40.3	41.2	21.0	29.7	46.2	24.2	12.9	28.6	93.1	41.2	25.5	24.9	26.6	23.5	13.7
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	31.7	10.9	8.7	26.0	10.9	25.9	16.2	43.0	11.1	21.8	16.6	5.4	11.8	12.2	18.1	17.4	16.4	13.1	18.5	11.7	10.8	8.1	14.1	16.7	29.9	20.9	9.6	6.5	19.2	12.6	27.1	18.6	10.3	14.1	14.1	9.2	13.8	15.3	15.6	13.4	11.0	22.2	11.7	17.6	29.1	12.9	10.9	13.3	27.2	15.6	20.1	15.3	21.9	11.8	4.8	4.2	15.2	2.8	1.7	3.1	1.1	11.0	5.6	13.2	10.1	7.0	13.0	4.6	7.7	16.0	7.0	9.6	9.5	11.9	15.0	4.7	7.2	6.3	9.1	3.7	7.4	12.5	4.0	4.7	5.7	5.8	6.9	8.6	12.2	2.1	12.9	7.7	12.3	36.1	15.9	12.5	10.8	10.0	11.4	16.3	3.0	9.3	6.6	14.1	2.5	19.8	16.2	28.7	7.1	7.1	8.0	7.2	11.8	11.6	7.3	11.1	10.1	7.2	22.2	14.9	6.5	9.2	5.6	9.6	10.2	8.1	14.3	7.9	7.3	5.8	0.6	2.8	3.1	2.0	1.9	3.1	4.7	2.2	2.1	2.4	4.8	3.1	2.6	15.2	1.7	1.6	4.2	1.9	1.1	8.7	10.9	43.0	11.1	10.8	8.1	9.6	6.5	14.1	13.3	104.2	81.3	88.7	263.2	135.0	89.5	52.3	45.9	113.8	121.7	52.4	143.3	28.1	11.6	51.6	31.8	129.1	72.6	0.0	41.5	23.6	115.8	122.0	90.2	30.6	51.0	111.2	82.5	89.6	79.2	32.2	96.1	141.3	72.6	41.5	51.6	62.3	60.4	56.1	84.1	23.1	170.7	71.1	102.3	135.2	137.3	117.1	27.8	76.7	33.1	223.6
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 44.2"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	1.3	3.6	27.2	1.6	24.1	1.1	1.2	18.9	44.2	1.5	1.4	1.2	0.0	1.4	1.3	1.2	2.4	1.4	1.2	1.2	30.9	14.6	1.2	1.2	1.2	1.2	8.3	12.2	1.1	1.5	1.2	4.4	1.2	6.4	1.3	1.3	0.8	1.2	1.7	1.1	1.2	1.7	1.3	3.3	1.2	1.5	1.8	3.5	0.0	1.2	0.0	1.2	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	6.5	0.0	0.0	5.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	7.5	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.2	24.1	18.9	30.3	30.9	14.6	8.3	12.2	6.4	3.5	0.0	0.0	0.0	0.0	0.0	25.0	2.8	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	44.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.7	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.9	3.4	0.0	0.1	0.0	0.0	0.0
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578800	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;seminal vesicle: 37.8"	"Group enriched"	"Detected in many"	19	"Bipolar cells: 144.6;Horizontal cells: 387.7"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.9;monocytes: 5.4"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013492			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013492: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.9	12.3	33.6	2.0	43.8	1.3	1.6	45.3	63.7	3.4	1.9	2.1	8.0	1.8	17.1	6.2	1.5	5.1	1.6	1.3	32.3	16.8	2.7	1.3	3.4	2.0	8.3	27.6	6.2	1.5	3.1	23.2	1.6	9.8	11.6	1.7	0.8	1.2	37.8	1.2	1.6	2.2	13.9	4.2	2.9	1.7	2.2	10.9	0.0	1.3	0.0	1.7	1.7	1.8	0.0	5.9	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	10.1	25.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	33.6	43.8	45.3	42.6	32.3	16.8	8.3	27.6	9.8	10.9	0.0	1.1	0.0	0.1	0.0	144.6	1.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.6	387.7	1.7	2.5	1.3	0.0	10.0	1.8	0.0	0.0	0.0	1.5	0.0	0.0	13.8	0.0	7.7	12.9	0.3	0.4	2.7	0.0	0.0	0.0	0.0	0.8
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ciliated cells: 36.1;Early spermatids: 121.0;Late spermatids: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	11.5	7.8	10.4	10.2	12.3	1.4	10.3	11.1	9.8	12.5	10.1	6.2	7.9	8.2	13.0	9.1	9.7	12.3	8.7	8.4	9.2	6.8	9.1	5.9	8.0	9.7	10.0	7.8	16.4	7.0	13.4	15.6	12.0	10.0	13.5	10.7	6.0	9.7	11.7	9.9	8.9	12.4	12.8	17.9	10.4	9.9	17.9	13.1	11.6	14.0	6.3	10.3	12.4	14.8	5.3	9.0	6.0	5.7	3.9	7.6	3.4	6.8	4.3	9.0	6.6	18.2	20.2	6.5	11.6	8.0	8.4	11.0	7.3	16.6	9.4	17.0	10.7	10.7	10.7	4.4	7.9	9.8	10.1	4.1	8.7	11.1	5.5	14.6	4.9	5.6	9.6	12.6	12.1	15.2	15.6	7.5	10.9	4.6	4.1	13.5	1.4	6.3	14.1	1.3	12.3	5.9	6.5	8.7	7.6	10.3	7.2	3.6	6.5	6.7	4.7	5.1	8.8	5.7	6.7	9.2	16.2	7.2	14.1	4.6	3.5	7.7	5.5	7.5	7.9	6.9	6.0	5.7	5.5	3.8	4.5	5.3	5.3	6.0	4.7	5.7	4.1	7.6	6.8	2.1	3.9	5.2	9.0	2.8	3.4	10.4	12.3	11.1	9.8	9.2	6.8	10.0	7.8	10.0	13.1	8.9	4.3	5.0	9.5	4.1	7.1	5.5	12.7	36.1	15.9	0.0	3.9	5.3	1.7	9.6	121.0	5.5	5.7	0.0	4.5	4.6	7.1	6.7	3.5	2.1	4.3	7.9	5.8	7.4	4.1	37.3	7.8	5.2	1.7	4.6	8.8	4.5	6.4	5.5	8.9	5.4	11.5	0.0	9.0	9.5	4.3	5.3	3.3	3.8	7.3	6.4
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.7	1.4	0.9	1.4	0.6	32.4	2.5	0.1	0.4	3.6	2.2	0.2	0.8	0.0	1.1	0.0	0.3	19.8	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.5	1.6	0.0	4.5	0.1	0.4	2.4	0.0	0.0	2.0	11.2	3.2	1.0	1.6	0.0	0.1	0.3	1.2	9.3	0.4	0.3	0.3	3.6	0.7	0.1	8.2	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4	3.0	3.8	0.0	1.4	1.4	71.2	33.4	17.8	8.1	0.0	15.7	5.9	7.3	1.7	4.7	45.5	26.9	30.6	0.0	7.2	0.7	4.8	2.8	3.5	17.4	0.8	0.0	9.2	50.3	2.6	34.6	3.4	0.7	3.3	0.0	12.2	5.4	3.9	20.4	31.1	2.4	2.7	19.4	14.6	1.9	1.7	1.0	11.9	0.7	10.0	1.4
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	15.3	15.2	8.2	15.4	10.8	15.9	16.9	10.6	13.3	16.6	14.0	13.6	17.8	9.9	21.5	15.3	12.7	17.2	12.1	9.2	7.5	4.8	13.2	9.8	13.7	9.9	10.9	7.3	20.1	17.5	17.0	13.7	12.4	9.6	16.5	9.3	20.2	16.6	19.8	15.7	14.2	15.7	18.0	6.1	15.0	13.4	36.0	8.4	14.8	18.1	10.5	11.0	20.1	14.8	3.6	1.4	4.2	2.6	5.7	5.9	2.8	9.3	5.7	19.1	14.5	8.0	4.3	8.6	7.5	11.9	15.0	16.3	10.6	6.2	13.8	10.9	11.7	11.5	6.1	13.4	7.1	13.0	9.1	10.7	18.9	5.8	11.9	10.7	12.9	7.5	11.0	5.0	10.0	8.5	9.1	8.3	14.8	13.1	9.8	9.3	5.3	23.2	10.3	9.3	4.8	9.7	18.5	13.0	7.5	8.8	9.5	20.4	12.5	8.9	9.8	8.7	11.6	8.5	4.8	12.3	10.4	9.1	7.7	6.7	8.2	5.0	11.6	5.5	14.6	9.6	4.2	2.6	0.8	5.8	2.6	4.3	3.1	3.5	5.9	1.2	3.6	2.6	4.5	0.2	5.7	2.2	1.4	2.5	2.8	8.2	10.8	10.6	13.3	7.5	4.8	10.9	7.3	9.6	8.4	41.7	25.0	4.7	9.1	4.0	14.0	23.7	15.3	12.0	25.0	10.4	41.2	6.6	3.3	8.3	10.9	11.4	10.7	0.0	8.3	3.6	6.6	9.7	17.4	10.6	7.2	14.3	12.6	17.2	8.8	22.8	9.2	8.4	6.8	11.8	16.7	11.4	10.5	5.8	12.0	3.8	29.4	12.9	9.2	23.2	10.5	5.6	9.3	12.5	13.8	9.2
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74825582-75032622	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	11.6	9.5	11.1	13.2	11.9	15.1	12.4	19.0	11.6	16.7	12.2	13.3	15.3	7.2	25.1	13.0	12.0	13.2	12.0	10.0	10.6	9.5	9.0	7.3	9.2	9.0	9.0	9.9	24.6	13.3	24.8	31.1	9.4	8.9	13.5	9.6	10.1	17.9	12.0	15.3	10.6	11.3	16.2	9.3	10.4	13.0	12.8	12.1	26.6	13.0	8.9	12.5	14.3	12.7	3.2	1.9	1.6	1.1	5.3	3.7	1.5	3.9	4.1	7.4	6.3	5.9	8.7	3.6	3.5	7.0	3.0	3.4	2.7	4.6	8.5	1.9	6.4	3.2	3.1	3.9	3.1	5.0	3.6	5.7	3.1	3.3	3.9	4.4	7.4	2.1	5.6	5.0	4.2	6.7	9.9	3.5	6.7	3.3	7.3	3.8	4.3	7.1	3.4	4.1	4.3	22.9	11.1	3.8	1.8	2.2	2.0	3.7	6.2	3.6	6.6	3.2	2.8	3.7	2.9	4.2	4.3	5.1	2.8	3.3	5.4	6.3	5.7	4.6	7.8	0.9	0.7	1.1	1.6	3.2	0.9	3.4	2.4	2.4	2.7	1.2	3.2	3.7	3.4	0.9	5.3	0.8	1.9	2.4	1.5	11.1	11.9	19.0	11.6	10.6	9.5	9.0	9.9	8.9	12.1	41.7	50.1	23.2	20.4	17.6	50.8	43.1	10.2	38.8	35.2	8.7	64.8	8.7	8.3	8.6	4.4	18.6	17.3	23.3	15.8	8.8	28.2	22.8	39.4	14.4	9.7	41.3	22.8	13.5	11.0	6.7	39.1	13.9	13.5	4.6	18.3	49.8	10.2	14.4	37.8	8.0	53.6	25.8	24.0	25.6	21.2	15.3	19.0	34.6	15.5	17.1
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.3	17.8	12.4	8.4	11.1	21.5	11.3	13.2	20.4	14.6	28.3	9.3	14.9	18.4	12.0	17.8	11.4	16.9	11.8	24.1	16.2	16.7	17.7	13.3	11.7	12.5	18.1	14.8	10.6	11.9	18.3	22.9	11.8	15.0	16.6	19.6	14.9	19.1	19.8	25.7	13.0	44.1	27.9	16.0	16.2	28.4	12.9	9.5	14.7	19.3	16.4	11.6	6.9	10.6	28.1	25.5	16.0	9.0	25.9	14.0	11.3	14.7	21.8	23.8	17.5	11.7	10.9	16.1	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1	23.8	17.6	14.7	9.0	14.9	30.8	23.6	20.4	24.1	20.5	26.2	29.5	18.8	8.3	9.4	17.4	18.6	10.4	0.0	6.5	13.0	11.4	13.2	23.1	9.0	11.5	42.9	24.1	12.3	16.1	11.0	15.5	11.1	13.5	12.6	12.1	15.3	8.2	8.6	17.3	8.7	25.3	38.8	13.9	69.0	33.2	17.6	28.3	20.2	11.4	7.2
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 312.3;Late spermatids: 142.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.5	7.8	9.3	11.9	9.8	14.2	11.7	13.0	9.5	13.8	12.1	15.0	6.0	7.6	15.3	10.3	12.5	10.9	10.1	11.3	9.1	6.7	13.7	8.4	10.8	11.8	10.4	7.9	18.7	9.6	5.7	12.1	11.0	15.0	12.7	9.5	17.5	10.1	10.5	21.2	12.0	10.8	12.4	8.9	12.2	10.4	36.7	12.0	22.5	13.9	10.3	14.0	15.1	12.7	19.6	19.4	23.5	20.8	12.7	24.2	14.9	11.5	4.1	9.5	20.7	11.5	18.4	14.7	14.5	12.3	15.3	20.3	9.9	6.1	16.1	8.4	14.4	11.1	9.1	18.6	9.5	20.0	14.7	15.7	21.4	8.9	13.7	15.9	29.9	8.1	11.6	11.3	17.5	13.9	14.2	14.0	21.7	22.1	11.8	13.5	16.0	20.5	19.5	9.3	12.9	7.0	14.1	17.3	7.8	10.9	6.5	7.7	10.9	26.4	7.6	10.1	13.9	7.8	29.2	12.0	8.0	12.2	21.0	16.7	11.0	10.1	22.1	10.5	21.3	13.0	23.5	15.2	21.0	19.9	20.8	17.5	19.6	20.2	20.0	19.4	14.2	17.2	17.3	7.0	12.7	18.0	16.7	24.2	14.9	9.3	9.8	13.0	9.5	9.1	6.7	10.4	7.9	15.0	12.0	14.9	9.9	13.7	31.3	26.1	8.6	15.9	10.2	24.1	13.6	14.0	27.5	18.4	14.9	16.5	312.3	15.5	9.7	23.3	10.9	15.9	23.8	16.3	19.7	6.6	15.3	12.7	5.8	10.4	11.8	142.0	19.5	18.0	10.1	22.6	8.4	10.9	12.0	10.5	15.6	16.6	34.9	6.5	18.9	100.5	54.7	25.1	21.4	17.5	8.9	15.2
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307484	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.6"					"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	11.0	5.7	12.2	6.4	12.5	7.6	12.0	11.0	14.4	14.1	11.4	10.4	4.6	2.2	12.7	4.2	8.1	6.6	5.4	22.6	8.5	9.8	5.9	5.4	6.7	8.2	10.3	14.9	6.3	2.9	3.2	11.9	4.2	11.9	6.7	5.9	4.1	3.5	8.5	7.1	3.8	4.2	19.7	10.8	4.5	4.7	25.1	7.8	12.0	4.4	3.3	9.1	7.7	7.9	5.2	6.9	3.4	1.0	9.5	7.1	1.4	5.5	4.6	8.1	4.3	6.2	13.2	0.2	23.0	7.4	12.3	9.7	0.9	5.6	8.9	2.7	30.6	15.5	1.5	5.7	5.9	18.8	7.7	2.1	6.4	5.7	2.1	3.3	3.1	4.3	5.1	3.0	13.8	3.4	11.6	12.9	5.0	3.4	3.9	15.0	1.1	7.0	2.9	3.5	0.1	3.0	7.9	9.6	0.9	4.4	0.4	3.4	7.1	6.1	1.2	4.3	7.1	2.0	1.9	11.7	10.9	16.6	5.9	9.2	2.1	3.8	12.3	4.3	3.1	15.6	1.9	0.9	3.4	5.8	0.5	2.9	2.6	4.6	5.8	2.3	5.2	1.1	2.6	0.3	9.5	1.0	6.9	7.1	1.4	12.2	12.5	11.0	14.4	8.5	9.8	10.3	14.9	11.9	7.8	8.9	2.6	1.9	3.5	5.3	9.0	35.3	2.5	16.0	2.3	5.2	25.5	0.2	3.3	5.4	107.1	6.4	0.0	0.0	1.3	0.7	9.4	1.6	9.3	9.0	2.8	20.6	9.8	6.7	2.1	42.6	8.3	3.4	16.9	35.1	0.5	8.5	4.5	0.0	4.9	5.7	17.6	6.5	11.2	41.6	21.5	5.0	0.2	7.5	0.6	1.3
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 30.3;testis: 33.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.5	2.9	8.2	4.1	9.7	2.8	7.1	4.0	7.5	2.5	2.4	11.3	2.5	1.8	2.8	7.1	2.7	8.6	5.1	4.3	8.1	7.6	9.5	5.2	4.6	3.4	9.6	6.2	3.1	3.3	30.3	7.0	2.2	9.0	3.4	3.1	6.4	3.4	3.7	6.0	8.0	1.5	2.3	8.7	3.3	2.0	33.2	6.3	2.4	15.5	1.1	3.0	2.3	2.5	3.1	0.6	2.7	1.3	0.8	1.5	0.3	1.9	4.3	2.4	15.0	4.9	5.9	1.1	1.8	1.6	1.5	1.9	0.2	5.1	19.8	1.5	2.8	1.9	0.6	4.7	0.5	1.1	2.0	2.5	0.8	1.3	0.3	2.0	1.2	1.9	12.2	1.8	2.5	0.6	3.4	0.5	9.1	0.7	1.6	8.5	1.9	1.2	2.6	5.4	2.5	2.7	5.5	1.1	0.0	4.7	0.4	5.4	6.0	1.9	0.4	0.6	8.8	11.4	11.0	1.0	5.0	0.5	2.0	1.2	1.3	1.0	13.3	2.7	12.5	9.6	1.7	0.7	0.5	1.1	1.3	0.9	2.2	0.9	0.5	0.3	3.1	1.5	1.4	2.7	0.8	0.9	0.6	0.2	0.3	8.2	9.7	4.0	7.5	8.1	7.6	9.6	6.2	9.0	6.3	0.0	1.4	0.0	2.6	1.3	10.4	2.2	0.0	46.8	6.8	3.5	5.9	0.0	11.6	0.4	59.9	1.4	0.8	0.0	0.2	0.0	1.5	1.2	0.0	3.9	2.8	11.1	0.0	3.1	1.0	47.0	1.4	0.6	3.3	1.0	0.3	2.4	0.2	0.0	2.1	5.2	2.1	0.0	0.8	11.2	4.3	1.0	0.1	0.0	1.5	1.4
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	20.9	12.3	13.9	15.0	15.7	34.4	16.4	18.3	18.0	13.6	12.2	12.9	10.2	11.3	17.3	8.1	12.8	12.0	18.5	17.0	13.8	14.3	11.2	15.3	17.5	24.9	18.2	13.4	13.9	9.6	16.2	13.8	18.4	17.5	12.5	14.6	12.1	11.7	11.6	36.5	12.2	13.4	18.3	21.1	21.1	10.9	12.5	13.8	26.3	15.2	18.2	16.8	13.6	20.4	6.9	3.5	25.1	8.6	6.8	7.4	2.3	18.3	9.2	23.9	11.8	14.4	14.6	8.6	16.5	16.8	15.7	19.1	9.1	14.3	15.5	11.5	17.0	26.5	13.6	12.1	12.9	19.9	6.1	8.7	13.1	15.2	11.7	14.9	14.0	17.3	15.4	13.6	17.1	16.7	14.6	17.3	14.2	23.7	23.1	23.1	15.1	11.7	23.0	19.3	12.8	8.8	11.3	20.9	13.0	13.9	11.1	12.5	23.5	10.6	14.5	18.2	20.9	10.3	24.0	14.9	15.3	19.8	14.2	22.5	19.2	18.9	28.4	15.0	17.0	38.1	9.2	4.2	13.0	7.4	7.7	6.2	4.5	3.6	6.5	3.5	6.9	2.8	4.7	25.1	6.8	8.6	1.8	4.7	2.3	13.9	15.7	18.3	18.0	13.8	14.3	18.2	13.4	17.5	13.8	26.8	19.2	12.7	14.0	35.8	14.2	16.5	15.3	4.0	31.8	1.8	9.8	5.5	0.0	10.3	3.9	43.6	14.7	0.0	10.5	7.5	19.3	14.5	42.7	13.2	11.6	7.9	14.3	32.5	21.6	4.3	12.0	20.7	23.6	4.6	11.9	9.0	12.8	13.1	5.6	3.6	7.9	19.4	18.1	15.8	7.0	31.6	6.3	13.8	10.5	13.9
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.6	21.7	19.4	14.9	20.5	19.9	33.1	29.6	27.5	28.4	19.0	26.5	29.9	30.1	29.8	40.1	28.4	18.4	15.1	28.6	37.6	22.5	10.5	19.2	16.4	27.0	40.2	21.1	18.3	20.5	45.3	27.8	77.2	25.4	21.4	16.3	19.0	24.0	28.4	25.5	20.3	11.7	21.2	35.2	18.3	14.7	27.3	18.8	25.7	24.3	18.7	14.0	17.2	22.0	28.7	23.3	10.2	13.5	18.2	29.1	28.3	27.1	30.7	27.4	33.8	30.5	21.9	15.6	21.7	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5	29.8	28.2	27.9	82.6	63.0	31.1	41.6	20.4	10.7	25.0	12.2	13.7	22.2	21.6	33.1	65.6	24.8	41.1	23.3	45.9	22.3	26.3	94.5	17.3	29.8	18.4	68.3	18.5	25.8	25.1	87.4	23.9	22.8	25.3	23.4	27.6	31.3	46.8	35.9	27.3	28.6	27.5	25.8	36.8	31.0	29.4	69.1	34.1	19.1	28.1	106.5
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.2"	"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539157-49558308	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5"	"Group enriched"	"Detected in many"	11	"amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0"	"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.9	3.8	24.3	1.5	18.5	1.4	1.0	5.8	30.7	0.9	0.8	0.5	0.0	0.9	1.3	0.9	0.7	8.7	1.7	1.2	22.0	3.0	1.6	0.7	1.2	1.9	1.9	13.0	0.8	1.4	6.3	9.3	0.8	0.0	1.2	0.7	0.0	1.1	1.6	0.8	1.1	1.0	1.0	0.6	1.4	1.4	2.6	2.1	0.0	1.7	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.8	0.4	3.6	0.5	1.0	9.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.3	2.3	0.7	0.2	0.0	0.1	0.4	0.0	0.5	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.3	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	11.8	0.0	1.8	0.3	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.0	12.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.0	3.6	0.0	0.3	1.1	0.1	0.0	1.1	2.6	0.6	0.4	0.1	0.0	0.4	0.5	24.3	18.5	5.8	30.7	22.0	3.0	1.9	13.0	0.0	2.1	0.0	0.3	0.0	0.2	0.1	0.0	0.6	2.5	9.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.6	2.4	1.3	0.8	3.6	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.9	2.5	0.3	0.0	1.0	0.0	0.0
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7;Late spermatids: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 11.2;NB-4: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	3.0	2.0	0.7	2.9	0.7	1.2	3.3	0.2	0.6	1.8	2.0			1.9	2.0	2.3	0.7	1.0	2.4	1.8	1.0	0.9	2.2	4.0	1.2	2.9	1.1		1.6	5.3	3.7	2.1	6.6		2.9	2.2		2.7	1.4	0.5	0.6	2.2	1.9	1.5	5.9	2.6	4.5			2.4		2.6	1.9	1.5	3.5	0.3	2.3	0.4	3.6	1.0	0.0	3.0	0.7	1.2	0.0	1.4	1.1	1.9	0.8	0.5	1.3	0.6	6.5	2.6	0.1	3.0	0.6	2.7	1.1	0.0	0.2	1.5	3.8	0.4	11.2	2.9	2.5	1.2	0.2	3.7	1.9	0.6	0.9	0.0	1.0	1.1	0.1	0.4	0.1	1.5	1.8	0.1	7.6	0.0	1.2	2.3	3.3	0.0	0.1	1.0	2.1	1.5	0.4	1.0	1.2	0.7	1.1	3.1	6.1	0.7	0.6	1.1	0.3	0.9	1.0	0.4	3.6	0.6	4.3	0.8	2.3	0.4	0.5	1.0	0.3	0.6	3.5	0.6	0.8	0.1	2.1	0.4	0.7	1.9	3.6	0.1	0.3	0.9	0.0											0.0	2.2	0.8	1.8	0.2	2.3	0.6	2.5	1.4	2.3	0.0	13.7	1.0	0.0	4.3	8.0	2.7	1.5	0.0	3.1	1.0	1.2	1.6	2.3	1.5	1.0	0.0	4.7	1.8	1.6	10.9	2.6	0.8	0.0	1.0	1.3	1.9	2.7	0.0	2.8	0.0	5.3	6.5	1.4	1.6	1.4	0.1	1.0	0.0	1.1	0.7
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	15.0	2.3	0.3	0.1	0.0	0.2	0.0	0.5	0.0	2.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.1	0.0	0.2	0.0	1.2	5.7	0.0	0.0	0.1	0.0	0.7	0.3	0.1	1.8	0.0	0.0	0.2	10.6	0.3	0.2	18.7	0.2	0.0	0.4	1.7	0.0	0.1	0.0	0.1	1.8	6.7	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5	0.0	0.6	0.0	0.1	0.2	6.8	10.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	5.2	0.0	0.0	0.8	0.0	0.9	4.5	0.0	14.7	0.0	0.0	0.0	6.2	1.0	0.0	0.0	0.0	20.3	0.0	0.5	0.3	1.4	0.0	0.0	0.5	7.2	0.0	0.5	0.5	3.2	0.3	0.0	0.0	0.4	0.1
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448656-109477544	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	29.1	16.2	10.4	16.3	17.1	8.4	21.3	10.6	20.0	25.3	26.9	14.1	15.1	8.5	30.5	15.6	24.4	18.1	23.2	16.1	11.0	16.4	23.2	9.3	20.5	13.9	11.7	8.4	16.7	7.9	14.6	12.7	19.2	16.9	19.8	22.2	29.4	14.4	29.8	9.9	19.3	14.1	36.4	9.6	17.5	19.4	13.5	12.6	12.8	30.8	15.4	17.5	27.8	19.0	6.2	10.4	7.9	14.0	20.8	12.7	11.8	9.2	9.8	28.7	9.5	23.2	33.2	6.4	20.2	26.6	13.4	13.4	9.2	7.6	9.0	11.9	46.1	6.8	7.3	10.2	16.7	12.9	8.7	6.9	10.4	6.3	5.8	14.9	7.6	9.1	31.6	10.3	17.7	9.7	19.6	31.4	8.8	6.9	3.9	23.4	4.8	9.8	10.3	17.0	4.1	12.2	9.7	12.5	7.0	13.5	16.0	10.2	15.3	12.2	12.6	12.7	18.0	15.5	6.2	23.1	14.3	5.5	8.1	11.1	8.8	16.6	12.5	16.1	6.7	21.0	7.9	8.1	5.4	12.7	12.4	9.3	6.2	7.6	9.2	10.4	6.2	8.4	10.5	5.9	20.8	14.0	7.9	8.4	11.8	10.4	17.1	10.6	20.0	11.0	16.4	11.7	8.4	16.9	12.6	14.9	34.6	5.7	16.8	13.1	5.2	10.5	15.3	8.1	9.1	5.2	15.7	7.3	5.0	14.0	8.4	22.7	13.6	0.0	11.3	10.5	16.9	12.3	13.9	4.0	10.5	7.9	11.1	26.4	12.3	7.8	10.6	10.4	15.1	19.0	12.5	2.6	17.7	11.5	17.7	8.4	4.6	25.8	28.8	9.1	5.6	14.4	11.3	10.2	13.3	16.5
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29927035	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	5.7	5.4	20.4	12.3	28.4	9.5	5.6	11.4	26.0	6.0	6.6	16.0	6.2	11.5	7.2	13.2	5.8	6.3	13.1	3.8	24.4	11.4	6.1	4.2	4.3	13.5	15.7	14.7	8.0	5.7	9.2	11.9	5.3	10.5	7.4	10.6	6.1	6.9	9.6	3.1	15.1	9.9	4.3	9.7	9.7	9.2	33.9	15.7	6.4	10.5	3.6	11.0	5.6	5.7	3.9	2.5	8.8	2.8	2.9	5.7	1.6	6.0	11.0	3.5	7.4	1.8	2.7	7.9	3.2	0.6	0.9	3.2	4.8	11.5	12.1	3.9	2.7	5.8	10.1	3.2	3.5	2.3	5.1	7.4	2.7	7.8	2.6	0.8	4.3	6.8	4.3	5.5	6.2	1.4	2.5	2.2	7.2	5.8	6.5	4.0	6.9	5.2	4.9	4.1	2.9	2.5	9.5	3.7	3.2	2.5	6.7	9.4	3.2	3.5	4.9	8.6	4.0	5.2	2.7	5.4	4.5	3.3	8.7	5.0	6.2	2.3	4.6	3.6	8.1	6.3	4.9	2.8	7.4	3.0	2.3	3.5	2.2	5.7	4.6	2.5	3.9	5.0	4.0	8.8	2.9	2.7	2.1	4.0	1.6	20.4	28.4	11.4	26.0	24.4	11.4	15.7	14.7	10.5	15.7	0.0	11.9	5.7	4.5	5.4	7.7	3.0	7.6	4.0	2.3	0.0	7.9	4.8	3.3	6.3	14.1	3.3	4.5	0.0	3.8	4.3	5.0	6.0	2.3	1.6	6.7	4.8	7.5	5.5	3.2	6.0	5.8	4.9	8.5	5.4	7.0	4.8	8.4	7.8	6.0	2.1	5.6	0.0	6.1	21.6	15.1	8.0	5.6	7.7	5.5	6.1
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 47.3"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 14.1;Ito cells: 25.8;Suprabasal keratinocytes: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	8.7	4.0	10.5	7.1	7.9	3.4	7.7	7.7	11.0	15.5	13.6	8.6	4.6	4.7	20.3	6.2	14.6	12.7	9.4	6.8	13.0	5.1	6.2	7.1	13.3	4.1	5.8	8.4	14.3	15.6	1.6	3.4	7.3	9.4	9.0	4.2	12.4	3.7	13.7	4.8	47.3	5.8	13.8	9.3	8.3	8.1	10.6	8.9	1.0	8.9	5.1	4.6	9.4	13.0	0.0	3.4	7.7	6.3	0.0	1.2	0.9	5.8	13.4	12.1	18.5	4.0	2.1	9.6	7.7	1.4	4.3	2.2	7.5	4.0	0.0	17.6	10.8	2.0	6.9	8.8	6.0	1.6	6.3	15.4	24.1	8.3	7.2	11.2	4.6	4.4	4.2	25.5	1.6	9.8	0.0	8.4	3.5	5.9	0.1	0.7	14.8	0.1	13.2	11.1	9.8	22.7	11.2	6.5	2.2	4.8	2.7	9.4	32.4	15.1	21.5	28.0	5.4	15.9	12.3	13.7	20.3	18.2	0.4	1.3	15.0	0.7	9.5	0.0	8.1	24.7	0.6	2.5	7.7	0.0	4.6	0.1	0.0	1.2	0.2	3.4	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.7	0.9	10.5	7.9	7.7	9.2	13.0	5.1	5.8	8.4	9.4	8.9	0.0	1.7	0.0	3.2	14.1	2.9	2.0	0.0	0.0	3.4	0.0	9.8	0.2	3.3	0.8	0.5	8.0	0.8	0.0	7.2	0.2	4.9	2.2	8.1	1.6	1.2	1.6	1.2	25.8	3.5	1.4	4.0	4.7	5.0	0.0	2.9	2.8	3.0	0.0	8.5	0.2	10.7	0.0	5.2	0.0	0.4	16.9	0.2	0.0	0.9	2.5
KDELC2	MGC33424	ENSG00000178202	"KDEL motif containing 2"	Q7Z4H8	11	108472105-108498432	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.0"	"Cell type enhanced"	"Detected in many"	4	"Fibroblasts: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	20.8	7.8	4.2	12.7	4.7	2.7	19.7	3.6	3.2	27.2	11.1	4.8	9.7	4.1	21.8	21.1	16.1	17.6	18.0	13.3	4.1	4.2	11.4	13.5	12.5	10.0	4.6	2.7	25.6	9.5	19.8	5.1	65.0	4.6	20.6	8.0	13.4	13.0	14.5	8.1	6.9	7.3	24.4	5.0	9.9	8.9	9.5	4.4	10.0	9.2	8.7	6.5	19.5	20.0	0.9	2.0	0.2	1.5	4.5	4.6	1.0	3.1	3.6	14.2	14.5	24.0	27.9	13.7	14.2	13.2	20.3	22.1	17.3	23.6	0.0	8.8	18.4	22.5	2.4	10.7	0.3	21.5	5.6	8.3	5.3	4.0	8.0	9.7	13.9	0.0	16.0	4.5	10.7	0.3	12.4	17.1	0.0	11.9	0.1	30.6	2.3	8.9	8.0	6.2	3.4	10.5	0.4	22.2	0.0	3.7	8.9	3.0	9.1	26.7	1.8	3.9	6.8	12.8	5.3	17.0	39.3	7.8	3.3	14.7	0.1	0.0	0.0	10.1	14.6	31.1	0.1	0.3	0.0	4.6	1.5	3.9	0.5	2.3	3.8	1.1	0.9	2.4	3.6	0.2	4.5	0.7	2.0	1.9	1.0	4.2	4.7	3.6	3.2	4.1	4.2	4.6	2.7	4.6	4.4	3.0	10.1	3.2	5.2	10.3	9.9	5.0	2.5	10.7	9.1	15.7	5.9	21.7	1.7	2.2	0.9	11.2	1.5	0.0	6.3	13.2	35.1	7.9	3.5	9.7	14.2	0.0	1.7	14.7	2.4	0.0	26.2	6.9	5.0	3.6	8.3	3.8	4.2	3.5	29.4	5.2	6.0	12.9	16.7	0.5	1.0	8.3	17.7	8.5	6.8	2.3
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.3	15.7	44.9	39.6	11.9	15.2	32.0	12.9	16.3	26.4	23.6	14.7	29.5	22.6	18.6	21.2	13.4	34.1	41.6	24.6	33.6	20.5	25.2	31.7	26.2	35.7	15.2	24.4	14.0	14.1	17.7	28.0	19.8	23.3	32.9	42.0	34.7	10.7	18.7	18.0	53.2	18.7	29.2	16.9	22.9	51.1	29.6	15.3	22.1	19.6	56.2	42.5	58.3	15.4	19.2	32.9	15.4	18.3	26.6	11.8	19.9	21.8	17.6	13.9	10.9	26.3	12.3	29.0	16.7	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1	17.9	26.1	9.0	22.9	16.6	27.5	21.6	15.3	26.8	17.0	22.7	25.5	25.8	14.9	30.7	32.2	12.8	14.4	0.0	21.5	47.0	17.4	18.6	11.5	13.9	13.3	14.3	21.9	14.1	13.9	16.3	19.8	15.0	11.8	28.9	20.5	19.3	25.4	14.0	21.5	12.6	20.0	0.0	15.9	100.4	63.4	11.2	13.8	8.7	24.7	17.5
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153595	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 67.3;Cone photoreceptor cells: 92.3;Horizontal cells: 69.9;Rod photoreceptor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9"	"Cell line enhanced"	"Detected in all"		"T-47d: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062872			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062872: AB_2684890"	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	13.3	16.0	14.8	15.1	13.4	22.0	20.0	26.1	18.7	19.4	12.6	18.3	24.3	12.1	24.2	18.1	15.9	18.4	12.0	12.6	13.3	9.2	10.4	18.2	11.8	19.2	13.8	12.9	18.5	19.0	12.1	17.9	29.4	11.2	24.8	6.0	18.8	16.5	22.6	38.0	21.1	12.9	16.2	13.3	21.2	12.0	19.9	13.8	14.6	28.9	8.8	13.7	13.3	21.9	7.1	2.5	6.9	0.9	1.3	0.8	0.5	8.9	3.1	7.4	8.9	4.3	4.3	15.0	4.5	3.4	4.0	5.0	5.3	2.5	12.5	4.8	5.1	3.2	5.1	4.5	5.3	2.5	5.6	11.4	4.2	5.4	4.4	8.1	4.2	9.8	6.6	5.7	3.3	2.7	7.2	5.3	7.1	10.3	7.7	3.5	4.6	4.8	6.4	6.5	3.2	7.8	8.2	5.6	10.4	4.0	5.9	13.8	10.6	5.8	6.5	7.1	7.5	35.5	11.1	7.7	6.0	3.4	7.2	4.5	21.3	8.8	9.6	11.7	8.5	3.4	1.6	0.9	2.6	0.5	0.3	0.3	6.1	0.4	0.4	0.4	7.1	0.6	0.8	6.9	1.3	0.4	2.5	0.5	0.5	14.8	13.4	26.1	18.7	13.3	9.2	13.8	12.9	11.2	13.8	6.0	7.2	13.7	11.9	6.5	67.3	12.7	15.3	2.7	5.7	7.0	92.3	21.3	6.6	9.5	13.7	10.5	8.4	0.0	6.6	19.1	10.3	19.8	8.1	23.7	8.0	69.9	8.1	12.3	11.8	8.8	17.0	9.1	10.1	9.0	16.5	20.7	14.6	13.3	21.9	5.2	74.4	6.5	8.1	18.4	7.7	13.4	20.1	10.2	8.4	10.8
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 181.0;Spermatocytes: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	10.6	4.3	28.9	13.9	13.7	12.4	24.4	7.3	11.3	7.7	8.2	3.6	11.3	0.0	5.0	11.4	5.7	16.4	13.6	12.0	9.9	0.1	5.2	5.8	4.1	5.8	11.7	18.0	7.7	12.9	20.0	11.0	14.5	20.8	17.1	7.2	18.0	0.0	7.7	10.8	5.0	21.5	19.6	7.4	7.6	21.2	0.0	0.0	11.1	18.4	8.8	19.5	15.5	9.5	12.9	39.6	19.5	12.9	12.6	6.8	5.1	0.8	4.2	1.1	0.7	4.5	6.0	6.7	2.8	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2	83.4	33.4	5.4	32.8	57.2	30.9	7.3	10.2	54.9	40.9	15.7	58.9	35.8	5.0	41.9	155.3	25.3	16.1	0.0	19.5	25.5	34.2	40.2	25.5	9.6	7.0	14.3	41.9	19.0	17.8	181.0	33.6	10.8	25.3	10.0	31.3	68.3	38.0	17.3	30.8	5.9	133.9	32.3	21.7	261.1	71.6	101.6	68.9	12.5	27.0	45.7
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	16.9	23.1	24.8	19.0	17.2	15.7	17.6	10.6	12.4	14.4	13.4	15.6	11.1	15.8	13.8	13.9	40.6	15.2	28.0	22.7	11.0	11.8	41.4	15.3	24.7	11.0	21.2	18.1	30.6	12.4	16.7	28.1	34.7	20.6	21.2	13.2	29.7	10.5	10.5	21.7	13.2	20.4	21.0	8.8	21.7	15.0	14.8	17.1	9.1	16.3	18.7	24.1	32.2	29.9	12.1	23.8	20.9	16.0	14.5	16.1	13.9	14.4	10.3	15.3	12.4	12.0	20.9	21.5	11.9	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2	11.9	12.2	11.9	9.7	10.8	25.0	7.7	17.8	12.0	12.5	7.0	23.6	10.6	3.3	13.4	0.6	14.3	21.7	0.0	18.7	11.4	11.3	12.4	12.7	19.8	12.4	23.8	30.0	18.4	14.6	1.7	13.6	9.4	13.5	10.0	27.8	10.9	20.8	24.6	14.9	4.2	16.1	0.0	10.3	7.0	14.6	13.9	17.4	10.2	15.6	15.9
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140177035	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	20.1	3.2	6.6	15.2	4.7	18.7	10.4	8.7	6.1	13.2	12.0	4.7	4.6	10.3	8.9	5.8	13.0	5.8	6.0	8.0	5.7	3.5	4.9	8.5	9.7	10.1	4.8	2.8	5.0	6.4	7.0	6.7	15.5	6.7	6.9	12.2	3.7	11.4	4.5	24.6	15.0	16.3	9.3	6.0	6.7	11.9	9.4	5.9	10.8	6.4	10.3	15.2	13.1	9.1	2.8	3.0	6.1	2.3	1.8	1.6	0.8	0.9	0.4	2.9	3.1	2.7	2.3	5.9	1.3	1.9	0.5	0.6	0.3	0.4	2.0	2.0	1.3	1.6	1.1	4.1	2.5	0.9	11.3	2.5	0.1	0.4	5.3	2.7	1.9	2.1	2.7	5.6	1.6	8.8	1.4	2.8	5.4	6.4	8.9	0.5	0.8	3.5	3.1	4.7	6.5	1.6	4.0	0.2	4.0	1.0	1.2	5.2	6.3	3.0	7.0	3.0	4.9	9.6	0.7	4.9	0.6	1.1	1.9	0.8	3.1	0.4	6.6	1.6	5.2	1.1	1.6	2.3	0.9	1.1	1.3	0.9	1.5	1.6	1.5	3.0	2.8	1.5	1.0	6.1	1.8	0.5	1.2	1.3	0.8	6.6	4.7	8.7	6.1	5.7	3.5	4.8	2.8	6.7	5.9	14.9	27.5	13.2	37.9	44.3	12.4	12.1	10.2	26.8	25.0	15.7	25.5	7.1	1.7	6.4	4.1	20.3	28.2	23.3	8.2	2.5	15.4	28.1	8.1	16.9	9.7	6.4	50.6	24.5	36.3	3.4	7.2	33.7	3.3	3.6	38.6	3.7	10.2	26.8	3.9	2.6	9.5	6.5	17.6	24.7	10.0	40.7	31.7	13.1	21.9	43.9
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11.0	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6.0	3.8	0.9	3.0	2.3	2.2	3.2	5.7	4.1	5.7	3.0	2.1	2.2	3.7	3.8	7.7	2.3	4.0	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0.0	1.7	0.5	0.2	0.2	1.0	1.0	0.0	9.4	2.3	0.0	2.0	1.3	3.3	0.9	0.4	1.0	1.6	0.0	0.6	0.4	0.8	0.4	0.0	46.0	1.6	0.0	5.2	1.3	1.3	0.0	0.3	1.2	0.0	1.0	1.3	1.6	0.7	0.0	1.1	1.2	2.5	0.0	0.8	0.9	2.5	0.0	1.1	0.5	1.1	0.1
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	12	"HEL: 15.3;K-562: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.1	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	2.3	3.5	0.0	0.0	1.7	0.2	1.9	0.0	0.0	46.7	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.0
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	18.3	16.7	8.3	24.2	12.8	21.1	18.1	18.9	9.4	21.6	22.4	14.3	25.2	16.9	18.7	19.5	24.3	18.3	28.8	11.2	8.6	5.9	11.8	12.5	16.8	19.2	12.9	7.2	30.7	23.2	17.6	12.8	31.5	11.3	21.5	16.1	10.8	17.0	20.0	15.1	16.9	21.2	24.5	13.6	22.7	24.6	9.3	12.5	20.1	16.1	16.6	26.0	19.7	30.7	6.6	4.5	7.0	5.8	4.5	5.8	3.7	12.6	15.3	12.7	10.1	14.1	13.9	13.5	12.4	14.4	14.4	11.2	9.5	21.8	17.9	7.2	11.0	11.9	12.0	11.2	19.6	10.3	27.2	5.6	8.0	13.7	17.2	15.1	11.6	17.0	14.1	44.2	15.4	19.2	18.6	16.1	13.0	10.3	15.9	8.3	17.0	4.0	7.0	3.4	22.6	13.3	6.4	0.1	8.8	8.7	18.2	9.4	9.9	10.5	6.6	16.3	13.3	7.7	13.1	16.2	12.6	11.3	14.9	7.0	30.7	16.5	11.9	6.9	6.2	11.7	4.7	4.1	7.0	5.8	5.8	3.4	4.6	4.5	4.9	3.1	6.6	3.5	3.3	5.7	4.5	4.8	4.5	4.4	3.7	8.3	12.8	18.9	9.4	8.6	5.9	12.9	7.2	11.3	12.5	11.9	12.3	7.8	20.6	7.9	2.5	2.9	17.8	1.4	7.9	7.0	2.0	17.5	1.7	15.2	0.3	13.4	27.4	0.0	36.6	11.0	8.5	26.7	13.9	7.6	12.3	0.0	10.4	9.2	10.8	2.0	13.0	9.0	11.8	14.4	22.1	8.3	32.5	14.4	10.6	3.3	7.6	12.9	15.6	1.4	1.5	11.2	22.4	12.5	15.3	26.9
KIAA0141	DELE	ENSG00000081791	KIAA0141	Q14154	5	141923808-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	26.2	35.7	17.9	28.5	21.0	31.0	27.4	39.6	26.8	24.8	27.2	28.1	33.5	27.3	32.9	29.0	23.5	26.1	29.4	66.5	17.9	16.2	27.0	35.2	28.9	35.6	21.7	25.8	26.2	28.4	25.2	25.2	28.2	22.0	26.2	28.6	23.1	22.1	38.8	40.9	20.1	24.6	27.5	23.2	43.0	26.0	19.0	21.2	19.9	26.9	26.5	24.8	27.6	24.9	10.2	26.2	8.8	28.8	10.9	12.3	10.7	10.0	13.6	20.0	29.3	15.8	21.0	13.3	13.2	21.5	23.1	25.7	19.5	23.7	23.8	15.2	14.3	13.4	15.7	12.0	27.7	12.9	13.6	10.6	14.4	15.8	15.1	20.1	20.4	28.5	25.5	13.9	20.2	16.6	20.8	24.1	5.1	9.1	32.5	11.9	13.1	5.4	11.2	7.7	12.5	21.2	18.6	13.3	26.4	16.7	15.0	11.3	14.3	15.3	24.1	31.2	13.6	31.1	18.4	19.3	17.7	10.8	9.2	11.7	9.1	9.7	14.5	14.4	16.4	19.4	7.7	20.3	6.5	10.4	26.4	9.8	10.2	8.4	10.2	26.2	9.4	7.2	9.2	8.8	10.9	28.8	10.6	12.3	10.7	17.9	21.0	39.6	26.8	17.9	16.2	21.7	25.8	22.0	21.2	11.9	27.4	12.8	15.2	7.2	7.4	0.0	28.1	14.7	10.3	0.0	27.5	22.7	0.0	0.0	0.7	29.7	19.2	0.0	0.0	11.4	12.3	13.8	18.5	25.9	24.6	33.4	20.8	28.3	26.1	1.1	14.7	18.7	15.1	0.0	20.9	4.8	0.0	10.5	8.5	0.0	19.5	12.9	7.2	3.0	5.5	9.4	21.5	15.2	25.0	17.2
KIAA0391	"MRPP3, PRORP"	ENSG00000100890	KIAA0391	O15091	14	35121846-35277614	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	13.9	26.1	18.8	17.6	20.1	12.5	17.5	23.1	21.9	17.4	22.4	20.6	15.6	16.6	13.0	19.4	26.1	14.7	13.2	16.7	17.6	16.3	31.1	29.5	20.9	29.5	20.2	17.7	10.8	16.5	29.8	27.4	13.4	19.2	14.1	24.9	15.8	18.0	21.8	22.2	23.0	16.5	15.0	23.0	18.7	15.8	17.1	20.9	31.2	18.9	21.3	24.8	18.2	16.0	10.0	9.7	10.9	5.4	12.1	25.5	12.4	22.8	18.3	12.7	16.8	13.9	16.5	11.2	15.4	13.8	19.7	17.1	17.3	14.2	25.1	20.1	14.6	5.6	17.8	23.3	26.6	22.3	19.7	7.2	11.3	14.1	36.9	14.4	13.9	12.4	17.6	20.5	18.6	17.2	17.0	28.5	21.6	18.2	7.3	24.0	25.9	21.0	15.3	13.6	19.8	18.1	20.2	21.1	14.5	27.7	23.4	11.8	13.4	19.9	22.1	12.8	17.1	32.2	11.5	21.6	15.2	13.7	11.7	13.2	8.0	18.6	26.3	7.7	15.1	15.9	10.9	5.4	3.4	15.4	5.2	22.4	10.0	23.8	16.6	7.2	7.0	21.2	15.6	6.3	12.1	4.3	9.7	25.5	12.4	18.8	20.1	23.1	21.9	17.6	16.3	20.2	17.7	19.2	20.9	3.0	1.3	1.3	0.5	0.0	1.3	1.5	0.0	1.4	2.3	0.0	0.0	0.8	1.7	1.0	0.0	1.0	1.4	0.0	0.8	0.5	0.8	1.0	2.3	1.6	1.0	0.0	0.0	1.8	0.8	0.0	0.6	0.8	0.0	0.0	0.9	1.2	1.5	0.0	0.4	1.4	1.5	0.0	0.3	0.5	1.1	0.0	0.6	0.0	1.6	0.9
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 86.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.9	12.5	0.0	1.1	3.0	0.0	0.3	2.2	1.9	4.5	0.0	0.0	0.0	0.0	0.4	10.9	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	1.4	0.0	1.2	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.1	0.0	2.1	0.0	0.7	0.0	31.5	15.6	0.0	0.0	0.3	0.0	0.0	0.9	0.0	8.6	1.4	0.0	2.0	0.0	0.0	0.0	5.0	0.2	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2	86.4	19.0	0.0	0.1	0.0	3.3	0.0	0.0	6.7	5.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	7.9	0.0	1.3	0.8	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.9	0.1	0.0	0.1	0.0	0.0	0.0
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 46.1;Late spermatids: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 15.9;monocytes: 13.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		8400	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.2	11.0	20.8	8.8	30.8	14.3	2.8	57.6	57.6	6.9	8.1	4.6	1.8	4.7	3.3	3.1	7.6	2.3	4.9	4.5	19.7	14.9	3.0	1.9	6.7	5.2	11.3	27.6	2.9	13.0	4.1	14.8	4.0	17.6	6.2	6.1	2.9	8.3	5.2	5.6	9.9	6.0	5.6	6.9	7.4	10.1	5.7	4.6	0.5	2.8	1.0	6.2	8.3	3.5	0.0	3.6	15.9	13.6	0.7	0.9	3.1	5.7	6.2	4.2	6.1	7.9	5.9	1.0	5.8	9.3	8.4	4.9	2.8	2.7	2.0	2.6	7.0	5.1	5.1	3.9	9.2	5.2	4.3	3.2	3.7	1.9	1.5	3.8	0.4	5.3	10.9	4.9	9.6	1.2	3.6	4.4	4.1	16.2	4.8	7.4	9.0	0.7	1.5	4.1	6.7	5.0	0.7	5.4	1.2	7.8	4.2	12.4	1.9	6.8	11.4	2.8	4.4	9.2	1.2	8.9	5.2	3.9	7.8	2.0	7.6	1.3	4.1	6.8	2.9	5.6	11.0	7.2	10.6	0.9	8.3	0.3	0.0	0.6	0.6	2.6	0.0	0.6	0.6	15.9	0.7	13.6	3.6	0.2	3.1	20.8	30.8	57.6	45.9	19.7	14.9	11.3	27.6	17.6	4.6	6.0	7.2	3.0	6.5	3.5	13.4	5.8	2.5	1.4	2.3	1.8	5.9	0.4	0.0	2.0	38.3	3.2	5.9	0.0	4.1	0.6	3.9	11.1	2.3	2.4	6.7	46.1	10.9	5.5	18.3	149.1	15.0	8.8	3.3	5.4	8.4	2.5	6.6	7.0	25.1	1.3	5.9	0.0	3.1	3.6	4.9	3.9	2.9	4.4	3.5	26.5
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551289	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 76.6;Early spermatids: 97.7;Late spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	9.5	9.9	10.2	9.2	14.7	9.8	9.9	23.9	13.0	9.9	8.3	7.5	8.0	6.1	9.4	10.7	9.4	7.5	8.3	8.0	12.4	9.6	7.4	11.1	7.9	11.2	15.3	10.7	13.5	8.2	14.6	33.2	6.7	14.5	9.7	11.0	7.0	8.1	8.6	10.4	9.1	8.3	15.8	19.8	9.5	7.6	25.0	14.8	24.5	9.0	7.4	12.7	10.0	8.6	9.1	5.0	13.5	3.6	13.1	10.9	3.1	14.3	10.7	17.8	7.4	12.2	11.0	6.6	13.4	9.5	11.4	10.4	4.3	8.0	17.9	8.5	8.8	5.2	9.2	16.5	8.0	19.6	15.8	6.0	14.6	9.2	12.4	7.2	19.8	10.8	7.0	3.4	9.4	12.4	6.1	13.4	16.4	14.8	9.5	18.4	9.0	10.7	8.5	7.1	9.0	17.4	15.3	20.1	10.8	8.2	6.7	11.1	6.9	13.8	8.3	6.5	9.1	10.6	10.5	12.7	16.9	14.6	9.5	10.6	4.8	8.6	14.3	11.2	14.6	10.5	13.5	2.8	6.1	9.3	2.4	8.6	7.3	9.0	7.1	3.2	9.1	10.9	8.7	3.2	13.1	3.6	5.0	8.5	3.1	10.2	14.7	23.9	13.0	12.4	9.6	15.3	10.7	14.5	14.8	11.9	12.6	13.0	5.3	2.9	27.5	11.3	10.2	29.4	12.5	8.7	76.6	5.9	5.0	5.7	97.7	11.7	3.3	0.0	4.6	6.5	5.6	3.5	19.8	4.3	7.9	30.2	10.3	8.0	7.3	81.1	9.5	6.9	8.5	4.6	6.5	21.5	5.6	2.9	11.3	5.4	50.2	0.0	6.6	51.5	21.3	4.0	4.0	13.8	6.5	3.1
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175602-67184040	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 69.1;Cone photoreceptor cells: 41.2;Early spermatids: 91.4;Horizontal cells: 101.7;Late spermatids: 145.2;Rod photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.3;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065996: AB_2685593"	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	9.5	20.7	18.1	8.1	19.8	5.2	5.9	46.3	25.0	8.8	6.8	11.5	11.5	10.7	15.4	13.4	6.6	15.0	10.0	7.7	15.1	10.6	9.8	4.6	8.7	3.6	13.0	27.7	21.8	7.6	18.0	24.1	9.5	18.5	10.5	8.8	13.2	8.4	10.3	5.9	9.8	9.5	11.7	16.2	11.0	13.7	13.5	12.4	4.4	13.2	4.3	3.2	7.2	6.8	0.0	2.8	0.0	0.8	0.2	1.1	0.3	2.3	4.1	14.7	9.2	2.7	6.5	9.8	6.4	1.6	2.8	2.6	4.0	2.4	4.4	4.2	2.4	2.5	9.2	4.1	3.5	1.7	4.3	5.7	6.5	10.5	3.8	2.2	2.8	13.3	3.6	1.5	3.5	1.3	10.2	4.6	9.5	6.6	4.3	3.6	3.7	6.7	4.9	3.3	2.2	6.7	18.6	7.2	8.3	4.8	5.6	17.5	14.7	7.2	3.7	1.8	7.0	8.1	4.7	5.4	10.0	7.1	4.6	2.6	5.7	4.6	4.6	12.6	4.3	5.2	0.0	0.8	0.0	0.2	0.7	0.0	0.0	0.9	1.1	2.3	0.0	0.1	0.2	0.0	0.2	0.4	2.8	0.0	0.3	18.1	19.8	46.3	24.1	15.1	10.6	13.0	27.7	18.5	12.4	3.0	9.3	1.7	3.6	2.6	69.1	2.8	5.1	2.7	11.4	7.0	41.2	3.3	3.3	4.8	91.4	3.8	4.2	0.0	2.2	5.4	3.7	5.3	4.6	3.6	3.5	101.7	12.6	9.8	0.6	145.2	6.4	1.7	5.0	1.0	4.4	18.9	3.6	4.5	10.3	1.1	68.7	19.4	3.9	4.7	10.2	2.0	2.5	0.9	5.4	3.7
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.4	5.4	12.5	8.3	21.0	27.3	6.5	7.5	14.1	7.7	8.5	4.0	8.7	8.7	4.4	17.6	10.4	6.2	7.7	9.2	12.6	6.5	4.9	9.5	9.8	7.4	10.9	8.9	5.3	15.7	11.1	9.2	12.8	21.1	16.4	9.4	6.2	10.5	15.8	5.5	7.7	7.0	4.2	7.9	5.9	4.4	17.5	2.2	13.6	12.4	7.4	6.6	4.7	5.4	10.5	21.2	5.9	7.3	21.9	9.6	9.6	7.9	7.6	10.2	6.5	6.3	10.2	7.9	7.0	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2	80.4	33.9	13.7	17.7	18.5	114.9	62.7	7.6	37.5	44.3	40.1	117.8	8.9	1.7	11.4	26.6	33.8	40.9	23.3	15.1	5.7	21.1	21.2	20.8	21.5	11.1	87.4	20.7	36.2	31.0	20.3	47.5	20.1	15.1	17.2	25.2	59.6	17.8	25.9	47.7	10.5	143.8	32.3	29.9	49.5	31.9	21.3	10.9	32.4	23.9	23.0
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	21.7	14.6	19.8	13.2	16.9	9.0	18.8	17.2	21.7	18.9	15.7	13.6	11.9	10.4	19.9	13.3	17.9	16.5	12.8	22.0	19.9	17.9	16.2	11.4	13.6	13.8	21.4	12.7	26.0	16.2	22.2	15.2	14.5	18.8	20.9	12.2	9.1	13.3	15.3	28.9	16.0	14.2	17.9	21.7	16.7	12.7	9.4	16.7	25.0	19.4	16.5	15.8	23.3	17.8	6.6	5.5	9.5	8.7	7.6	7.4	4.5	6.6	4.3	12.4	8.6	8.4	13.2	6.2	7.7	10.8	9.9	10.1	4.4	5.9	16.4	5.9	8.0	4.7	4.7	14.5	8.1	13.1	9.0	4.9	11.9	8.1	5.3	5.8	14.9	8.4	9.4	9.9	10.1	9.6	11.0	8.2	10.2	16.8	9.0	9.6	3.8	16.5	10.5	11.6	7.1	5.6	6.8	11.8	9.2	6.3	5.7	6.2	10.6	8.9	7.0	6.1	8.6	11.6	12.8	9.4	5.5	5.0	14.4	8.7	5.8	16.5	10.0	10.2	14.5	8.0	5.3	5.7	9.5	7.4	6.3	6.5	6.6	6.4	5.9	5.5	6.3	6.8	6.2	5.7	7.6	8.7	3.7	5.3	4.5	19.8	16.9	17.2	21.7	19.9	17.9	21.4	12.7	18.8	16.7	35.7	29.6	39.6	25.1	30.7	17.4	23.8	30.6	32.1	45.5	22.7	7.9	37.2	58.0	37.7	149.2	31.5	17.6	0.0	53.7	48.7	27.7	35.1	37.0	22.9	30.8	14.3	15.0	30.7	39.1	61.4	34.8	35.6	13.5	26.2	22.9	41.7	40.6	23.5	46.3	29.3	12.2	0.0	25.5	46.8	40.9	24.3	47.8	34.8	24.1	36.6
KIAA1211		ENSG00000109265	KIAA1211	Q6ZU35	4	56049073-56328625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.9;testis: 27.0"	"Group enriched"	"Detected in some"	15	"Early spermatids: 102.6;Late spermatids: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 16.0;SH-SY5Y: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	1.0	2.1	4.5	4.2	3.7	3.0	0.8	4.2	6.8	2.3	12.6	3.3	3.2	11.8	3.7	3.9	1.0	2.7	14.4	1.6	5.7	7.0	1.6	1.0	1.4	1.8	5.3	3.0	2.2	1.6	7.6	1.9	2.3	13.4	1.6	7.2	4.7	0.9	5.5	0.7	0.9	39.9	4.0	4.8	2.1	2.4	27.0	1.5	0.2	0.8	0.0	1.6	1.5	2.2	1.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	1.7	6.7	0.5	0.2	0.0	2.4	0.0	0.2	0.3	0.7	1.9	0.2	5.9	0.1	0.0	5.4	0.0	5.6	0.1	0.2	0.5	3.3	3.2	3.0	0.3	0.9	2.7	0.5	0.3	0.1	0.0	0.1	2.2	3.1	5.3	0.0	5.8	0.0	0.8	4.0	0.2	3.6	5.0	4.3	3.9	3.7	0.1	0.0	1.5	16.0	34.2	0.6	0.2	4.1	5.9	1.4	0.3	1.2	0.1	1.7	0.4	1.5	5.8	3.9	0.0	1.7	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	3.7	4.2	6.8	5.7	7.0	5.3	3.0	13.4	1.5	0.0	0.0	0.0	0.0	0.1	2.3	2.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	102.6	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	4.7	0.6	0.0	87.5	0.6	0.0	0.0	0.0	0.7	2.7	1.8	0.9	0.4	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.1	0.0	1.1	0.0
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 91.1"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.0;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	24.9	12.7	3.3	6.6	8.7	0.0	21.6	5.5	16.2	10.2	15.1	2.7	18.0	7.5	7.2	16.5	22.6	10.4	11.9	8.6	5.1	3.7	13.5	10.4	8.6	1.4	4.3	8.1	8.4	10.1	34.1	5.5	12.2	8.8	15.1	8.9	16.9	28.8	26.6	91.1	12.0	13.7	4.1	3.8	5.7	10.1	16.8	1.8	3.3	20.5	20.4	8.8	10.1	13.0	0.0	0.0	0.0	0.0	0.9	2.8	0.0	7.6	3.9	1.5	0.0	1.0	2.8	34.0	1.5	2.4	3.5	7.6	6.6	12.3	0.4	7.7	3.0	7.2	12.8	1.9	14.5	3.9	2.8	1.4	0.1	8.9	7.7	1.7	0.0	0.1	10.7	9.4	7.8	2.1	1.6	0.0	0.7	0.0	30.9	1.8	2.7	4.2	0.2	3.5	7.5	3.5	0.3	9.1	6.3	8.3	10.1	1.0	0.5	3.8	12.9	0.0	16.6	6.2	0.0	8.1	5.4	5.9	21.7	1.9	13.8	11.6	0.0	18.1	0.2	0.2	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.3	8.7	5.5	16.2	5.1	3.7	4.3	8.1	8.8	1.8	35.7	24.2	0.8	63.7	107.7	12.4	33.1	17.8	32.1	95.5	31.4	7.9	43.5	3.3	26.0	24.9	10.8	21.2	0.0	23.1	16.7	14.6	36.0	1.1	21.2	4.6	0.0	23.0	25.8	10.5	7.0	16.4	2.7	1.7	0.0	21.3	121.7	20.1	22.0	31.1	4.5	2.7	12.9	19.6	0.5	0.7	44.5	54.5	0.7	16.6	47.2
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376466-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 30.4;parathyroid gland: 64.4"	"Cell type enriched"	"Detected in some"	4	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		27000	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.8	0.9	8.2	0.7	20.5	0.6	1.2	6.2	30.4	0.7	0.7	1.7	0.0	0.6	0.7	0.6	0.9	0.6	0.8	0.6	5.3	2.4	0.9	0.6	0.6	0.7	1.6	17.1	0.7	0.8	64.4	1.0	1.4	2.3	0.7	0.7	0.0	0.7	0.6	0.6	1.9	0.6	0.7	1.1	0.6	0.7	1.3	1.6	0.0	0.6	0.0	1.1	0.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	3.3	0.1	0.5	3.7	0.0	13.3	7.8	2.1	1.2	0.0	0.3	10.2	0.1	11.7	10.2	0.7	0.4	3.8	3.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	5.8	7.6	9.5	0.2	0.0	9.7	8.3	0.0	0.1	0.0	0.7	0.0	4.9	0.0	0.8	0.0	0.0	5.1	1.1	1.2	0.1	0.0	3.2	0.1	0.0	0.0	23.0	30.4	6.4	0.7	10.6	0.0	0.0	0.0	8.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	20.5	6.2	30.4	5.3	2.4	1.6	17.1	2.3	1.6	0.0	0.0	0.0	0.3	1.8	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.6	0.4	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	3.2	0.0	1.8	0.0	0.4	0.0	0.2	16.9	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.5
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	7.2	8.7	11.9	5.7	19.7	11.7	9.0	33.8	15.7	9.1	6.8	2.9	6.5	3.6	10.4	6.5	5.7	6.1	7.8	6.0	10.4	8.7	6.1	8.0	5.9	6.9	10.9	9.3	13.3	5.4	9.8	19.7	15.3	12.4	9.1	4.5	2.6	5.0	6.5	4.1	4.3	5.3	7.5	8.4	7.4	4.7	12.5	10.4	6.2	9.6	3.6	6.4	9.0	6.6	5.5	6.3	3.1	4.2	8.2	7.1	3.2	4.9	2.1	13.1	14.9	5.3	8.6	7.3	8.3	6.9	7.3	8.7	3.4	1.6	1.9	6.9	6.1	6.4	2.5	10.0	4.9	10.0	6.2	7.6	20.6	4.8	7.8	6.9	16.5	7.7	6.2	3.6	6.4	7.1	5.2	6.8	5.4	28.3	1.6	8.5	3.9	7.9	10.1	8.5	1.7	3.1	7.3	9.6	4.7	4.8	10.3	11.1	10.3	5.4	1.8	6.2	9.4	4.3	15.0	5.5	11.2	4.7	10.7	5.9	6.6	8.7	9.7	6.9	12.2	4.5	0.3	4.2	3.1	3.9	3.0	4.3	5.5	5.7	4.9	5.9	4.4	7.1	6.0	0.3	8.2	2.8	6.3	6.5	3.2	11.9	19.7	33.8	15.7	10.4	8.7	10.9	9.3	12.4	10.4	8.9	4.6	9.0	4.2	9.3	14.8	20.8	2.5	12.0	7.9	7.0	2.0	36.3	10.0	5.7	45.2	7.1	0.7	0.0	4.7	25.6	16.5	1.6	12.7	3.9	10.7	9.5	5.2	8.0	7.3	18.2	11.8	5.6	3.3	7.2	2.3	8.9	3.2	0.0	13.8	12.4	7.8	19.4	10.3	18.1	18.9	3.9	8.9	7.4	3.3	1.6
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	5.1	3.6	9.8	3.9	8.9	2.3	4.3	13.3	12.4	10.0	7.1	7.0	1.0	5.5	4.4	6.8	3.8	7.5	3.6	5.2	9.6	11.6	2.6	2.3	8.0	3.2	8.8	12.1	2.4	3.6	3.9	8.2	3.5	20.6	9.6	8.3	3.6	3.6	3.1	3.7	8.5	5.9	5.4	10.1	3.3	5.6	7.5	6.2	3.3	4.0	2.7	3.5	4.3	3.7	1.5	1.2	4.8	2.5	1.4	3.7	0.6	4.6	9.0	11.8	5.1	6.8	7.7	3.7	8.9	2.2	4.6	4.3	2.7	3.0	1.9	2.4	6.8	9.5	5.9	7.5	3.0	6.5	8.1	1.8	1.7	6.2	7.5	3.7	2.1	1.7	3.6	4.9	8.3	2.9	5.3	6.4	2.7	1.7	1.5	12.8	0.4	1.8	1.4	3.7	5.4	1.8	6.0	9.7	0.4	5.8	9.5	7.0	4.4	10.7	2.4	3.2	9.2	1.8	2.5	8.4	7.5	2.8	6.0	6.0	0.8	2.4	2.8	5.4	1.5	5.1	0.8	1.4	4.8	1.3	1.5	1.2	1.5	1.2	0.6	1.2	0.6	0.2	1.0	3.0	1.4	2.5	0.8	3.7	0.6	9.8	8.9	13.3	12.4	9.6	11.6	8.8	12.1	20.6	6.2	6.0	4.3	0.0	2.9	2.3	12.4	6.5	2.5	69.6	15.9	3.5	53.0	0.9	0.0	3.1	2.4	3.8	5.1	0.0	5.4	2.2	6.6	4.4	1.1	1.0	5.0	7.9	7.5	5.5	4.0	1.7	3.4	4.2	3.3	9.0	4.3	4.8	7.6	7.0	1.8	0.5	45.8	0.0	3.6	10.4	19.2	2.9	0.3	2.2	4.5	2.6
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.8	1.5	0.9	0.4	1.0	0.0	1.2	2.0	0.7	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.4	1.0	0.0	0.1	0.6	0.0	1.8	0.1	0.0	0.0	2.5	0.1	1.8	0.0	0.1	0.0	0.6	0.0	0.7	1.5	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.6	5.1	0.5	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	2.7	0.0	1.8	3.9	0.1	0.0	0.0	35.8	12.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	4.0	0.0	0.0	16.5	1.5	60.3	1.1	3.3	1.7	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	19.4	1.4	1.5	4.2	1.1	1.4	0.0	0.0	0.1
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low cell line specificity"	"Detected in many"											"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.5	15.8	23.9	11.7	1.1	2.0	9.4	17.2	9.2	23.5	20.5	17.7	13.3	13.9	10.8	8.4	18.2	13.6	25.8	9.3	26.6	15.9	13.0	15.7	19.3	12.5	0.2	17.4	10.9	0.7	0.5	19.5	11.2	2.8	14.3	10.7	19.9	30.9	22.1	14.5	15.9	8.6	24.1	24.1	16.8	17.7	32.3	13.0	5.6	8.9	15.8	13.2	28.0	11.9	7.3	12.6	9.5	6.8	9.9	15.6	20.3	16.7	20.4	8.9	15.3	20.1	8.2	19.1	23.4	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1	0.0	0.3	0.0	0.2	1.5	0.0	0.4	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	46.7	0.0	10.3	1.0	0.1	0.0	0.0	4.3	0.0	1.2	1.8	0.6	0.5	0.0	0.9	0.0	0.0	1.2	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.2	5.8	0.3	1.5	0.5	2.1	0.3
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018132	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 9.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"									"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA			"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.4	0.1	0.0	0.1	0.6	0.0	0.1	0.3	0.0	0.9	0.0	0.5	0.0	0.2	0.5	0.1	0.0	0.1	0.7	0.1	0.4	1.0	0.4	0.0	0.4	0.7	0.0	0.3	0.2	0.0	0.0	1.1	0.6	0.2	2.4	0.4	0.0	0.8	0.5	0.5	0.1	0.5	0.7	1.2	1.0	0.0	0.7	0.5	0.6	1.3	0.2	0.3	0.0	0.5	0.5	0.2	0.8	1.3	0.7	1.2	0.4	0.6	0.5	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	8.0	6.9	3.3	7.4	4.9	2.9	7.9	4.9	3.5	2.6	2.6	2.7	10.0	8.4	2.8	2.7	4.4	16.5	3.3	4.4	1.1	8.5	2.9	5.1	17.0	3.5	6.3	1.4	15.0	3.8	15.7	2.6	3.4	12.5	1.7	8.3	5.5	8.8	2.0	13.8	6.1	4.3	0.5	8.9	10.3	15.3	0.2	5.0	11.0	12.7	10.6	9.7	3.5	10.7	3.9	2.8	28.4	2.8	4.7	5.2	15.7	5.5	4.9	4.3	2.1	2.3	10.1	7.1	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6	8.9	9.9	2.2	2.6	5.4	8.9	0.8	7.6	2.7	6.8	14.0	5.9	1.6	1.7	3.2	5.2	0.6	17.3	0.0	1.2	1.5	2.6	3.1	8.1	5.4	2.4	14.3	22.4	2.5	6.2	6.9	7.2	4.8	3.3	1.0	9.9	7.2	2.7	14.0	2.8	4.3	3.3	0.0	1.9	5.1	5.5	9.9	2.5	5.7	9.9	2.6
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Peritubular cells: 26.9;T-cells: 26.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064146: AB_2685198, HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.1	0.9	0.4	2.9	0.4	0.9	1.9	0.6	3.4	2.1	1.5			0.1	1.7	7.1	0.7	1.1	1.1	3.2	0.4	0.5	2.9	5.8	2.0	6.1	0.5		2.8	0.6	0.0	3.5	0.0		1.2	1.1		0.9	1.4	1.9	1.4	1.2	1.4	1.3	3.9	1.4	1.5			2.1		5.5	1.7	2.1	1.7	0.9	0.9	0.6	2.6	5.1	1.4	0.0	1.0	10.2	0.0	5.7	12.7	0.1	4.0	2.0	4.5	4.7	0.8	2.5	7.6	1.9	6.0	1.8	2.7	2.7	3.1	12.0	4.9	3.7	0.2	4.5	0.0	1.9	5.0	1.9	11.0	0.8	6.3	5.1	8.6	8.8	5.9	0.0	1.9	13.4	0.8	9.6	0.0	1.4	0.3	2.0	5.3	3.7	0.0	2.5	0.2	2.4	10.5	2.8	1.3	4.6	4.0	0.3	0.8	0.0	8.7	2.7	3.9	1.9	5.3	6.7	2.4	15.4	0.0	4.4	0.9	0.1	0.1	4.2	0.4	5.1	1.7	3.7	4.7	0.5	1.4	2.6	4.0	0.0	2.6	0.6	0.9	1.9	1.4											6.0	2.6	10.8	1.3	3.8	16.4	14.6	5.1	4.0	4.5	3.5	35.3	0.0	3.3	1.8	0.5	3.6	0.9	0.0	0.0	0.1	5.1	2.5	0.0	18.1	0.1	7.9	0.0	2.5	6.0	1.1	19.2	3.5	3.3	5.4	0.7	11.7	0.3	2.9	26.9	6.0	12.5	0.0	10.3	0.4	0.4	5.8	0.1	26.6	4.6	1.0
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	22.2	10.1	10.3	15.1	12.0	40.7	17.3	30.2	12.0	12.2	12.1	14.6	9.3	5.7	19.7	13.4	11.6	10.2	13.8	12.1	10.3	8.0	9.9	8.4	17.1	15.7	12.9	9.1	17.1	6.1	3.0	6.4	7.0	17.4	10.2	6.7	7.0	8.9	9.3	6.2	7.9	11.9	24.2	25.7	11.3	10.7	7.9	14.7	14.4	10.8	8.5	8.3	18.4	18.2	4.5	3.0	24.0	11.7	12.9	9.0	3.5	4.5	3.2	8.7	0.6	3.0	8.0	1.8	5.3	4.2	8.2	3.6	0.0	3.7	0.0	3.4	10.7	14.3	11.3	7.4	24.2	4.4	3.1	0.4	0.1	8.9	1.8	5.3	2.3	3.6	10.6	8.2	5.7	19.0	11.9	9.5	2.4	0.0	4.3	6.3	0.1	2.8	0.8	5.1	0.5	1.6	1.2	2.3	3.2	2.0	3.5	13.5	16.5	4.5	6.4	4.3	7.3	1.0	3.6	18.8	16.4	7.9	6.9	6.2	3.3	2.2	0.0	14.5	2.0	3.2	11.5	5.4	6.8	0.9	6.8	0.4	3.0	5.1	1.0	3.0	4.5	9.0	6.1	24.0	12.9	11.7	1.4	4.1	3.5	10.3	12.0	30.2	12.0	10.3	8.0	12.9	9.1	17.4	14.7	38.7	7.0	15.0	23.7	19.5	5.6	12.5	20.4	8.1	15.9	8.7	11.8	0.4	1.7	20.8	4.5	58.3	0.9	0.0	44.8	0.2	12.4	9.7	11.5	13.5	13.1	11.1	5.8	86.0	44.8	3.3	12.7	20.0	3.3	17.2	0.7	8.2	55.3	0.3	9.6	4.5	8.5	45.3	20.2	0.5	7.5	13.4	0.9	4.9	0.6	7.4
KLHL11	FLJ10572	ENSG00000178502	"Kelch like family member 11"	Q9NVR0	17	41853545-41865431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"Early spermatids: 91.3;Late spermatids: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023021, HPA052403, HPA054269"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432"	"unprognostic (9.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.07e-2)"	4.0	4.6	7.0	3.5	10.6	15.5	5.1	10.4	13.3	4.7	6.3	6.4	3.4	3.0	6.0	3.3	4.2	6.1	3.2	7.1	5.8	5.5	4.5	3.6	4.4	4.4	5.9	9.3	7.0	5.4	9.2	7.7	4.0	10.9	5.4	3.8	5.1	4.7	6.0	12.2	5.0	5.2	4.2	3.9	4.6	4.8	25.0	5.9	5.7	8.4	2.8	5.4	6.1	4.0	3.7	2.0	0.3	1.3	1.2	3.1	1.0	2.8	7.6	4.2	8.9	3.6	2.3	6.6	2.9	3.0	3.4	3.7	6.0	1.8	9.0	3.2	3.5	3.1	8.8	11.1	4.1	6.2	4.5	5.6	3.4	10.0	4.6	2.7	4.2	3.9	2.5	1.8	4.6	7.6	2.7	3.4	5.9	3.5	9.5	3.6	2.8	7.0	1.9	3.2	1.5	1.8	6.3	9.8	5.7	1.2	6.9	10.3	4.5	5.7	18.0	2.1	4.2	9.8	1.6	4.7	4.7	6.8	4.7	4.8	5.8	5.0	7.8	5.1	3.2	4.7	0.0	1.3	0.0	1.4	0.2	3.1	2.4	2.0	1.1	2.0	3.7	1.7	1.3	0.3	1.2	1.2	0.3	1.2	1.0	7.0	10.6	10.4	13.3	5.8	5.5	5.9	9.3	10.9	5.9	0.0	0.3	0.0	1.0	0.5	2.7	0.1	0.0	0.0	2.3	0.0	3.9	0.4	0.0	0.3	91.3	0.6	0.3	0.0	0.2	0.3	0.4	0.6	0.0	0.0	0.2	7.9	0.0	0.0	0.0	33.4	0.3	1.1	1.7	1.0	0.3	2.3	0.5	0.0	0.0	0.0	3.4	6.5	0.8	2.6	2.0	0.3	0.3	1.0	0.2	0.9
KLHL17		ENSG00000187961	"Kelch like family member 17"	Q6TDP4	1	960587-965715	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031251	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA031251: AB_10601539"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (3.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.73e-2)"	4.7	7.0	9.9	8.7	8.9	8.2	8.8	14.0	10.0	6.2	5.1	4.9	4.1	8.4	6.5	4.8	9.9	4.6	5.8	4.2	8.4	4.2	7.2	6.1	5.6	8.1	6.7	3.4	1.5	9.5	5.4	12.4	5.7	6.3	6.8	2.3	6.0	11.6	5.6	5.2	19.1	6.1	6.6	4.2	9.8	7.7	9.8	8.2	5.6	5.4	4.0	7.6	6.5	6.7	0.4	1.0	0.0	1.2	0.0	1.7	0.4	4.6	5.2	6.5	15.5	2.3	2.4	7.1	9.1	2.5	5.1	5.0	6.8	7.0	1.7	6.4	3.9	4.9	9.9	6.0	3.7	0.8	9.3	14.4	3.0	18.9	9.6	1.5	3.4	9.5	2.0	1.8	5.0	1.4	6.4	3.1	9.7	9.9	3.0	2.2	5.4	5.6	12.0	7.1	1.8	7.7	9.1	2.6	3.2	2.7	1.8	15.8	14.9	2.6	8.2	8.3	2.1	4.5	6.1	5.4	9.8	13.2	8.5	7.5	6.0	2.1	3.9	5.6	7.8	4.5	0.0	1.2	0.0	1.7	0.1	0.4	0.4	0.3	0.4	0.0	0.4	0.7	0.4	0.0	0.0	0.6	1.0	0.0	0.4	9.9	8.9	14.0	10.0	8.4	4.2	6.7	3.4	6.3	8.2	0.0	1.9	2.0	0.9	2.3	4.5	2.5	0.0	0.0	0.0	3.5	2.0	1.1	0.0	0.9	1.1	0.7	0.9	0.0	0.7	1.6	1.1	0.8	0.0	0.6	1.1	6.4	2.9	4.3	1.8	1.5	0.3	1.9	3.3	0.0	1.6	1.0	1.6	0.0	1.4	1.0	6.4	0.0	1.0	3.7	5.5	2.6	0.7	0.9	1.0	1.0
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	9.1	9.0	11.5	9.7	12.2	21.1	7.1	16.7	15.7	7.8	8.2	10.4	11.7	6.8	9.1	8.4	13.8	7.7	8.5	9.3	8.8	9.4	7.2	5.8	9.6	9.7	7.7	13.5	6.6	8.5	13.9	9.8	8.6	10.6	8.2	7.4	16.0	7.2	10.7	23.7	20.0	8.4	10.3	6.3	13.9	7.6	9.6	9.9	7.0	11.3	9.3	11.2	9.5	10.1	3.5	6.7	4.6	14.0	1.1	3.7	4.5	7.4	9.6	7.4	10.9	8.2	5.9	5.3	10.2	5.3	10.4	8.5	10.1	4.6	14.5	5.8	8.5	9.5	4.6	22.2	10.8	10.8	11.4	7.4	21.3	13.8	9.2	8.4	11.3	9.8	6.8	8.4	14.9	14.0	5.8	11.5	8.0	25.7	6.1	8.3	6.1	8.6	6.6	13.5	6.0	19.3	6.0	4.9	8.5	9.8	14.1	5.1	6.8	7.1	8.8	5.1	7.9	5.1	6.3	12.0	9.7	9.9	11.0	12.8	6.9	13.2	12.7	6.2	13.2	10.1	4.6	10.2	3.2	1.9	9.2	2.9	3.5	1.5	3.7	6.7	2.1	1.3	1.8	4.5	1.1	14.0	1.8	1.5	4.5	11.5	12.2	16.7	15.7	8.8	9.4	7.7	13.5	10.6	9.9	11.9	10.7	16.7	8.4	10.1	66.8	53.4	2.5	5.3	5.7	3.5	19.6	9.3	18.3	13.9	2.4	13.5	11.0	23.3	12.8	10.4	6.6	8.2	34.7	16.3	25.5	12.7	9.1	16.5	25.7	2.1	5.5	16.7	0.0	10.8	8.2	12.5	14.5	10.5	7.8	19.2	47.9	6.5	11.7	10.1	15.0	18.3	11.8	10.0	8.9	9.5
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207618-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	10.5	11.2	25.1	10.4	36.0	16.4	12.1	9.7	41.6	6.1	5.8	19.6	4.0	5.0	7.0	13.4	15.8	8.9	9.5	5.0	37.2	17.7	13.3	23.8	10.6	9.4	25.7	14.7	3.8	6.6	5.3	18.4	6.9	15.1	7.8	6.5	4.0	16.3	9.7	3.2	4.7	5.6	9.6	25.7	11.1	7.4	5.4	25.0	1.6	11.3	3.4	8.4	10.9	7.2	1.3	1.2	10.8	1.9	0.3	1.6	0.6	8.7	8.1	5.6	5.8	8.7	7.8	6.0	11.9	9.4	6.2	6.7	4.8	6.6	9.1	3.0	6.0	11.0	6.1	9.1	6.3	8.0	14.8	3.5	7.6	7.2	7.5	7.6	7.8	11.1	6.5	18.0	5.6	21.2	10.9	14.8	3.4	3.4	19.2	9.5	3.3	0.2	2.5	3.4	5.0	3.6	3.1	4.2	2.8	11.3	8.5	28.8	4.8	7.5	2.7	7.2	10.9	1.8	8.9	20.4	4.9	10.1	5.6	8.0	12.5	8.7	7.3	6.0	5.6	9.6	1.9	1.4	1.9	0.8	1.4	0.5	0.4	0.6	0.5	1.2	1.3	1.4	1.6	10.8	0.3	1.9	0.7	0.7	0.6	25.1	36.0	9.7	24.7	37.2	17.7	25.7	14.7	15.1	25.0	6.0	14.1	5.6	11.1	5.4	8.3	4.0	7.6	5.3	7.9	21.0	13.7	3.5	23.2	6.7	1.1	13.4	4.1	0.0	11.3	8.3	5.4	10.1	9.2	30.8	7.4	30.2	14.9	17.2	40.5	1.3	3.7	20.7	5.0	4.6	4.7	3.2	8.8	4.8	4.2	14.7	6.4	0.0	6.8	2.1	7.1	6.6	3.1	7.0	3.1	16.1
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 108.6;Cone photoreceptor cells: 84.4;Sertoli cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.8	2.5	14.1	6.1	13.6	1.8	8.3	16.4	16.4	11.9	26.0	6.9	7.5	11.3	26.7	5.8	12.7	11.4	8.7	10.8	12.7	10.7	7.1	6.3	7.8	3.2	8.9	14.3	19.3	7.9	8.8	17.2	13.0	8.1	14.6	14.7	8.6	8.1	13.8	11.0	2.5	11.8	25.4	8.7	2.9	8.6	20.1	7.9	9.1	10.3	4.5	3.3	11.0	6.2	0.8	2.0	0.1	0.1	6.6	2.3	0.7	6.2	3.2	24.6	6.9	1.4	0.5	16.8	3.0	2.3	5.5	6.1	6.8	5.4	3.9	2.5	0.3	8.0	1.0	25.5	2.1	8.4	13.7	12.5	11.5	6.5	11.0	2.1	16.0	1.8	1.0	1.8	2.3	3.9	3.6	4.2	14.4	15.6	0.5	1.8	3.0	23.4	6.5	20.1	3.3	2.5	7.5	21.0	0.4	5.0	18.6	32.0	22.0	4.7	0.4	2.8	8.1	4.0	5.2	1.5	2.2	7.2	2.1	5.0	1.8	1.7	17.5	1.7	4.8	3.4	0.0	0.1	0.0	1.6	0.0	2.2	0.6	1.4	1.2	0.2	0.8	2.3	2.2	0.1	6.6	0.0	2.0	1.6	0.7	14.1	13.6	16.4	13.1	12.7	10.7	8.9	14.3	8.1	7.9	3.0	5.4	0.0	5.8	1.3	108.6	41.9	17.8	6.7	6.8	0.0	84.4	3.7	3.3	15.1	3.0	5.6	8.0	0.0	27.4	7.4	3.9	14.9	0.0	10.2	0.8	38.1	30.6	8.6	1.0	2.7	2.3	1.0	0.0	0.0	19.5	12.9	16.7	14.1	8.1	13.4	35.6	168.1	38.7	3.2	9.8	0.9	1.0	4.3	20.2	3.9
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759323-85795030	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 31.5"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 12.1;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 36.7;hippocampal formation: 25.8"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	10.6	4.2	5.2	6.8	12.1	1.5	12.7	3.9	21.5	4.7	4.8	7.5	7.7	9.9	7.9	7.2	8.2	6.2	5.2	4.2	5.7	5.9	4.3	18.3	4.8	4.0	5.3	5.8	4.4	3.6	4.4	4.6	2.8	5.4	5.7	2.9	3.8	6.2	7.6	7.8	9.7	7.0	6.2	3.0	2.6	7.5	16.3	4.3	3.7	4.7	2.5	3.9	4.1	31.5	0.6	1.2	0.5	6.1	5.1	3.5	1.0	2.3	7.2	10.5	5.1	2.1	1.2	5.4	3.0	1.4	4.3	3.2	9.6	4.0	1.5	1.6	2.5	2.7	5.9	11.3	5.7	0.9	1.4	5.2	0.4	3.0	7.3	2.5	0.4	1.9	2.2	1.9	4.1	1.4	1.9	2.3	5.2	0.6	1.4	1.8	4.4	3.7	2.3	9.5	4.1	3.8	7.6	6.3	2.4	1.6	5.0	14.7	10.2	4.4	5.1	1.9	4.5	9.3	0.6	1.9	4.5	8.2	2.9	5.4	1.5	3.1	1.5	2.0	2.6	2.5	0.0	0.2	0.5	2.0	2.3	1.1	0.1	2.1	1.5	0.5	0.6	3.5	2.2	0.0	5.1	6.1	1.2	1.8	1.0	5.2	12.1	3.9	11.1	5.7	5.9	5.3	5.8	5.4	4.3	0.0	3.4	0.0	4.2	2.4	1.9	2.5	2.5	1.4	1.2	0.0	0.0	0.7	1.7	1.8	12.1	2.1	3.8	0.0	2.3	1.2	1.9	3.4	0.0	9.6	0.7	12.7	10.3	3.1	1.5	3.1	0.9	0.7	6.8	1.0	6.6	2.2	3.8	2.9	1.4	1.7	0.9	6.5	2.3	3.2	3.9	4.1	1.5	1.5	2.8	3.5
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 72.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.7	0.6	0.1	0.1	16.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	72.0	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.7	0.0	1.0	0.0	0.0	0.0	0.2	9.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 5.7;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.1;Karpas-707: 8.4"					"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	1.9	1.4	1.0	0.6	1.5	1.2	1.5	0.9	1.2	0.9	4.3	3.3	0.6	0.5	0.9	1.6	1.2	1.3	0.6	0.8	0.5	1.1	2.5	1.0	1.1	2.4	0.9	1.1	1.4	1.1	1.5	1.6	0.5	8.1	0.7	8.4	0.9	2.8	6.4	2.6	0.8	1.0	0.8	4.2	0.3	4.1	0.8	1.4	0.8	1.6	1.4	1.1	0.2	1.4	2.7	1.9	0.5	1.0	0.5	1.6	0.6	4.9	5.0	4.7	1.7	4.7	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5											0.0	0.0	0.0	0.1	0.1	1.5	2.0	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.2	2.7	0.5	1.6	0.0	0.2	0.3	0.5	0.2	5.7	0.4	0.3	3.2	0.0	0.6	0.3	1.1	0.0	0.0	0.0	0.0	1.6	2.4	0.2	0.9	0.0	1.3	1.1	6.5	0.5	0.2	1.4	0.4	0.5	0.0	1.0	0.1
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607886	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 178.9"	"Cell type enriched"	"Detected in many"	21	"T-cells: 765.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 178.9"	"Group enriched"	"Detected in many"	133	"NK-cells: 53.0;T-cells: 178.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.0;Karpas-707: 2.2"					"Low region specificity"	"Detected in all"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.8	0.8	0.8	22.8	0.8	18.6	2.1	0.5	0.6	2.9	9.1	0.0	1.3	5.0	1.8	3.7	2.6	1.8	7.3	1.3	0.7	0.8	3.8	4.9	11.8	23.7	1.1	0.2	2.0	1.0	0.0	0.9	2.1	0.8	1.8	3.9	0.9	4.8	1.4	0.9	0.8	20.4	0.6	1.8	25.2	4.4	1.3	0.2	6.2	1.9	2.9	17.7	5.5	2.0	0.1	0.3	0.8	0.2	53.0	178.9	18.5	0.1	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.0	0.9	0.2	1.9	0.0	0.0	0.2	0.0	3.0	0.0	0.4	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.2	2.2	0.0	0.8	0.8	0.6	0.5	0.5	0.0	1.1	0.3	0.9	0.0	0.5	0.4	0.6	0.6	0.7	0.1	1.7	0.3	0.2	0.0	1.6	0.0	0.4	0.7	0.6	0.4	1.5	0.0	1.8	1.0	0.5	0.1	0.0	43.1	0.1	178.9	0.1	25.6	28.1	0.1	0.1	1.5	8.7	0.8	53.0	0.2	0.3	5.7	18.5	0.8	0.8	0.5	0.6	0.7	0.8	1.1	0.2	0.8	0.2	0.0	12.8	14.5	0.6	8.7	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	5.1	1.3	0.0	5.5	0.9	0.0	0.0	35.6	22.5	0.0	0.0	3.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.5	0.0	0.0	7.8	0.8	765.3	0.3	1.3
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 61.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.5	19.5	9.0	9.9	4.7	4.6	9.4	5.6	4.1	5.7	4.4	13.0	5.9	10.3	8.8	4.6	6.1	7.6	8.1	4.8	2.5	15.2	9.0	18.5	9.1	6.5	4.6	11.2	21.2	6.2	6.5	5.8	6.4	5.1	5.5	10.7	15.4	12.9	3.7	11.8	9.5	9.7	8.3	10.0	6.9	15.0	5.9	5.6	3.1	10.3	10.2	8.2	8.5	13.8	5.9	5.0	8.4	12.0	7.7	11.4	12.4	7.6	11.8	17.8	10.9	8.2	6.2	10.4	7.9	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9	8.9	19.1	13.3	8.5	11.3	61.2	7.7	10.2	4.0	5.7	8.7	49.1	5.2	0.0	5.5	2.1	11.7	14.0	0.0	6.7	4.9	8.1	13.1	4.7	9.7	7.3	33.4	19.4	11.6	8.7	4.1	7.5	6.4	5.0	6.4	10.4	27.2	7.1	11.4	11.7	4.2	74.2	0.0	8.2	28.1	36.4	11.3	7.9	10.2	11.3	12.8
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E"	Q8IZD2	7	105014179-105114361	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	22.7	11.8	18.6	24.5	23.5	44.8	20.9	41.6	22.4	26.4	20.9	18.6	21.7	14.7	25.3	15.8	16.5	18.6	18.2	16.8	20.6	15.1	14.2	11.6	22.8	20.1	22.7	17.4	33.5	15.6	20.5	20.1	18.7	18.6	21.2	20.5	17.6	19.6	19.2	21.3	25.7	18.5	26.2	23.1	21.6	17.9	12.9	27.2	24.6	21.7	15.1	22.7	26.6	21.4	38.2	24.7	72.9	20.8	20.3	30.6	14.7	15.1	10.7	22.7	19.5	14.1	16.9	5.8	11.6	17.4	9.8	12.1	8.7	13.9	12.6	11.6	13.6	13.2	11.8	12.5	11.5	16.3	20.3	7.2	12.7	14.0	7.4	13.3	17.0	16.0	11.8	10.8	13.6	14.6	17.9	17.7	14.1	17.3	36.1	13.8	11.9	27.1	14.6	7.9	8.3	8.6	23.4	14.0	14.6	9.7	15.4	13.0	15.7	16.1	13.9	8.8	15.9	6.0	10.2	21.8	23.2	16.2	26.5	11.5	27.6	21.8	29.1	15.2	13.0	15.9	48.5	18.0	39.4	30.6	13.6	30.3	35.6	28.4	26.1	12.8	38.2	28.0	26.0	72.9	20.3	20.8	24.7	23.6	14.7	18.6	23.5	41.6	22.4	20.6	15.1	22.7	17.4	18.6	27.2	131.0	136.3	133.9	100.8	130.3	219.2	86.5	76.5	84.3	142.1	109.9	237.6	33.5	29.9	70.0	19.2	197.7	91.8	93.5	59.6	38.6	151.9	115.7	236.2	33.7	53.7	174.8	96.0	86.5	76.0	18.6	130.6	138.7	133.3	110.0	88.5	114.4	63.9	84.2	123.8	28.6	269.1	122.9	222.6	98.9	71.7	117.7	54.6	186.4	107.4	119.5
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.4	7.9	9.5	14.6	6.1	10.9	13.0	18.6	8.9	10.8	9.5	9.0	7.3	28.7	10.8	12.3	4.0	11.6	13.6	6.8	11.6	12.1	14.1	24.1	8.3	4.5	9.1	18.7	6.1	4.6	8.6	11.7	10.9	10.4	8.8	12.3	43.6	13.4	8.8	9.0	18.9	27.9	4.4	11.3	9.0	22.5	8.1	7.8	7.5	15.2	13.0	10.2	18.5	9.4	8.5	8.8	13.1	23.9	11.2	12.2	8.9	14.5	13.3	7.5	7.8	26.3	8.4	9.8	10.2	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6	11.9	12.6	0.0	14.2	0.0	19.6	0.0	5.1	21.4	12.5	26.2	5.9	10.7	6.6	8.0	7.4	11.3	8.5	0.0	8.1	13.9	8.7	20.1	2.3	13.4	15.1	3.2	4.7	28.8	17.1	2.1	15.0	10.3	0.0	1.0	28.5	22.4	11.3	10.5	40.3	8.3	16.8	6.5	0.0	8.9	11.7	0.0	11.9	8.2	12.4	19.3
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 54.7;testis: 35.6"	"Cell type enhanced"	"Detected in some"	12	"Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.7	0.5	0.3	7.1	0.4	5.4	0.7	0.3	0.3	0.6	4.0	0.1	0.0	1.5	0.4	0.8	3.9	0.4	0.9	0.5	0.4	0.4	0.9	1.0	1.3	4.7	0.3	0.0	0.5	0.5	0.0	0.4	2.8	0.1	0.5	1.5	0.0	0.8	0.0	0.4	0.8	3.9	0.5	0.4	3.3	0.8	35.6	0.0	54.7	0.5	4.1	3.7	0.7	0.9	2.9	1.2	0.7	0.5	0.7	2.5	0.0	10.9	5.6	11.5	8.3	0.3	1.7	5.1	12.8	5.2	10.0	8.5	6.9	4.4	7.3	4.1	5.5	7.6	13.7	10.8	6.0	10.6	12.6	3.0	21.4	9.6	2.0	0.0	16.3	10.8	0.3	0.2	6.7	4.2	1.3	8.5	13.0	13.7	12.2	11.7	3.7	13.9	3.3	5.6	6.6	6.0	12.7	16.5	3.6	1.5	9.7	9.9	4.6	11.1	6.3	1.3	3.8	6.8	5.0	7.9	11.7	10.4	13.4	7.1	4.7	15.9	14.2	4.7	11.1	11.1	0.4	0.2	0.1	0.1	0.1	0.0	2.9	1.1	0.1	1.2	2.2	0.0	0.7	0.7	0.7	0.5	0.1	2.5	0.0	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	1.8	0.0	2.4	1.7	0.2	0.0	0.0	0.0	0.0	0.5	9.3	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.9	17.8	30.7	15.5	20.0	22.1	9.7	23.2	19.7	25.5	23.1	21.4	14.7	21.9	21.4	25.5	20.2	15.8	24.0	19.8	37.7	5.9	9.1	26.9	16.0	11.9	11.7	23.8	12.4	15.3	25.8	18.3	25.8	12.5	27.8	11.9	18.8	12.7	23.1	14.0	17.2	5.7	13.3	21.2	19.2	17.7	25.5	14.0	11.1	21.1	21.2	12.8	24.9	13.6	20.2	25.1	18.0	14.1	23.7	16.0	17.6	7.8	17.9	12.2	12.3	40.7	22.4	16.7	16.2	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5	14.9	28.5	15.2	21.0	36.9	27.4	26.5	25.5	46.8	42.1	14.0	29.5	18.8	11.6	21.1	89.9	29.2	15.5	46.7	28.8	20.9	21.6	27.0	38.1	43.9	20.5	19.1	15.6	26.4	29.7	145.2	20.8	25.2	16.9	25.2	17.0	23.9	27.4	17.5	23.3	16.7	47.9	12.9	33.5	30.1	16.6	39.6	20.8	27.3	10.7	24.2
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 663.6;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	62.2	81.9	78.2	31.3	11.6	11.3	49.7	55.0	42.7	88.9	69.4	56.3	29.2	58.5	17.4	31.7	44.3	34.5	86.4	42.9	102.4	23.5	50.9	51.8	39.6	53.7	12.2	44.5	35.7	7.0	8.1	51.1	31.5	12.5	85.5	25.0	41.1	42.3	78.8	58.1	55.5	28.7	52.8	50.8	42.5	30.7	71.4	32.0	35.0	29.2	31.1	34.6	30.9	99.8	32.3	74.7	58.1	22.4	33.3	49.3	61.0	34.7	73.9	35.1	50.2	58.4	24.0	38.3	52.9	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0	11.9	32.3	47.6	33.0	97.4	19.1	12.6	7.6	8.1	18.2	17.4	7.9	59.0	13.3	31.3	663.6	49.2	9.8	70.0	22.3	244.0	94.4	18.1	43.8	15.3	104.7	30.2	41.1	16.0	36.5	186.9	17.8	52.4	50.6	104.6	9.7	29.4	18.3	10.5	13.8	26.9	17.8	32.3	72.6	296.7	211.0	77.3	99.4	34.5	15.8	20.4
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 254.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	14.1	9.8	18.9	15.8	19.4	21.3	9.5	25.8	21.4	22.7	16.6	29.8	13.2	30.6	5.3	30.0	15.3	16.7	22.5	20.7	38.0	18.3	15.8	22.4	9.7	34.6	18.9	33.4	14.6	15.6	15.1	19.0	25.1	15.0	28.0	12.9	12.3	8.3	31.2	6.5	17.9	18.2	21.8	19.8	6.9	23.5	18.6	9.3	13.9	11.8	7.9	12.6	9.4	11.8	10.2	16.4	7.0	13.5	25.4	16.8	13.7	15.3	17.1	6.7	9.4	27.0	10.2	15.5	16.6	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8	62.5	29.8	19.7	23.8	38.2	22.9	70.2	10.2	37.5	25.0	12.2	31.4	13.2	14.9	42.7	254.1	35.9	17.7	23.3	46.6	15.0	28.3	24.7	32.3	33.4	29.7	49.3	29.2	35.0	34.0	136.0	20.4	32.3	18.6	37.9	17.6	46.9	45.4	10.5	47.0	20.9	62.4	25.8	29.3	52.1	29.9	43.5	8.8	27.7	20.2	28.7
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 204.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.0	13.5	12.1	15.5	18.6	16.4	14.2	13.8	16.3	20.2	19.6	15.0	18.7	14.3	16.4	24.8	12.2	14.8	18.5	21.1	25.9	14.4	10.2	14.7	20.8	12.1	16.5	16.1	12.1	16.5	20.1	25.0	24.0	17.1	21.0	11.3	14.2	13.2	19.1	9.4	13.0	9.2	28.1	11.1	10.1	13.1	17.4	11.7	17.6	15.7	11.6	9.8	25.1	15.1	13.4	30.9	10.6	8.6	24.4	18.8	13.0	24.4	19.8	9.5	10.8	11.3	20.5	15.1	17.9	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6	38.7	37.4	43.4	31.3	56.4	47.6	28.5	33.1	40.2	21.6	27.9	55.0	38.1	14.9	32.5	204.0	37.9	20.6	0.0	27.4	36.4	38.2	41.3	12.8	56.3	26.8	49.3	44.3	35.6	32.3	48.0	31.7	26.8	23.6	28.9	37.1	29.8	38.9	17.5	38.2	28.3	40.5	32.3	29.9	55.9	52.6	74.4	113.5	32.6	29.2	51.1
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 8.9;Muller glia cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.8	16.2	3.5	3.5	6.8	3.3	4.2	5.4	6.2	0.4	1.7	1.9	7.1	4.2	11.0	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.3	3.7	2.0	6.4	4.9	10.5	14.1	2.0	2.7	2.4	9.0	5.3	9.3	2.9	3.8	9.5	3.1	1.0	4.1	5.0	6.2	10.4	5.1	14.9	3.5	3.7	2.6	5.4	5.0	6.6	2.9	0.0	4.6	9.6	3.1	8.4	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5	0.0	2.7	1.5	2.1	1.5	6.3	8.9	0.0	0.0	0.0	3.5	3.9	0.9	0.0	4.5	0.5	0.9	0.0	0.0	2.3	1.9	2.3	2.2	0.0	0.8	4.2	7.9	0.0	0.6	3.0	0.9	3.7	1.1	0.0	1.0	0.0	11.2	1.2	0.0	3.2	1.5	4.4	6.5	1.7	0.7	3.6	1.6	1.0	1.0	0.0	1.5
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	8	"placenta: 78.4;testis: 68.5"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 1048.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 9.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 9.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1.0	2.3	2.1	2.7	0.5	2.5	1.0	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	10.6	0.0	0.0	0.0	22.9	0.0	11.2	0.8	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.5	0.0	16.1	10.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	8.2	0.0	31.8	0.0	3.4	1.1	0.0	1.7	0.0	0.6	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.9	0.0	9.0	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6	0.0	1.6	0.0	2.5	0.0	6.5	4.8	5.1	1.4	3.4	5.2	2.0	9.4	16.6	4.1	134.8	0.4	0.7	0.0	10.5	8.6	1.6	1.5	0.0	0.5	2.0	1.6	0.0	1.3	0.0	72.9	18.7	0.0	0.0	0.0	0.8	12.4	6.2	1.9	12.7	1.7	7.4	12.9	3.3	1048.9	159.2	0.0	7.6	0.0	1.7	0.8
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Cell type enhanced"	"Detected in many"	19	"Basal glandular cells: 1816.1;Basal keratinocytes: 1163.5;Urothelial cells: 567.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HaCaT: 123.1;hTCEpi: 95.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		580000000	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.2	0.0	0.2	0.0	1.3	123.1	0.0	4.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.4	0.0	95.2	0.2	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.6	0.0	0.0	10.4	0.3	0.7	0.2	0.0	0.1	1.8	0.1	0.0	2.3	0.0	2.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6	11.9	10.1	0.0	1816.1	1163.5	0.6	0.7	7.6	22.7	230.9	1.8	0.0	0.4	1.7	6.9	90.0	0.5	4.7	0.0	6.8	6.5	13.4	221.8	2.3	0.0	0.3	0.0	4.6	0.0	0.0	35.8	1.4	5.1	303.7	0.0	10.4	0.0	8.6	9.7	0.4	0.0	0.6	0.0	22.7	0.6	0.7	169.3	1.0	0.5	6.0	567.2
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Group enriched"	"Detected in some"	17	"Early spermatids: 4.5;Late spermatids: 11.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ: 66.1"									"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Nucleoplasm, Vesicles"		"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	66.1	2.9	7.9	15.6	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	8.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8"	"Group enriched"	"Detected in many"	19	"B-cells: 5.4;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favorable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	0.9	1.0	0.5	10.0	0.8	0.5	6.3	1.3	1.7	4.6	24.4	0.7	13.3	16.2	1.5	3.2	8.5	9.8	16.5	1.7	0.7	0.3	4.8	6.5	11.8	1.9	0.7	1.4	2.7	28.8	3.3	6.9	1.5	1.5	9.7	6.2	1.9	17.4	22.6	1.0	4.9	34.8	0.9	0.9	1.0	16.7	1.8	0.8	2.3	12.3	6.9	5.4	7.6	4.5	5.4	0.0	0.1	0.0	0.3	7.0	1.8	28.1	0.2	0.7	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.1	9.0	32.2	0.2	0.2	0.0	0.0	10.3	0.2	7.3	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.1	0.0	0.7	0.3	0.1	0.0	7.5	0.3	1.9	6.1	14.3	0.1	0.1	0.2	0.7	0.0	0.0	15.1	0.5	0.4	9.4	0.6	0.5	0.2	0.2	0.0	0.3	0.7	0.3	0.2	1.6	1.1	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.6	0.0	6.9	5.4	6.2	3.2	0.0	4.6	7.0	3.3	0.0	0.3	0.0	0.0	4.8	1.8	0.5	0.8	1.3	1.7	0.7	0.3	0.7	1.4	1.5	0.8	20.8	18.0	3.7	106.9	20.7	2.6	0.2	86.6	56.2	43.3	40.1	7.9	15.0	5.0	85.6	4.7	0.8	81.3	0.0	157.5	26.3	1.5	101.7	4.6	12.1	1.8	1.6	59.7	1.3	0.6	3.6	0.3	1.8	6.8	4.6	108.5	1.5	121.7	98.2	0.0	4.9	5.9	0.0	1.0	2.7	33.8	13.6	6.6	1.0	162.2	123.8
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell type enhanced"	"Detected in many"	18	"Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Cell line enhanced"	"Detected in some"		"A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	37.9	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.6	0.5	2.2	0.1	0.0	62.8	0.1	0.0	0.0	0.0	0.1	0.0	0.8	42.3	25.7	0.5	0.1	0.2	3.6	3.1	22.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	19.3	0.0	2.3	0.1	0.0	0.1	0.0	0.2	0.1	0.6	19.6	0.1	0.0	21.0	3.1	0.2	0.2	10.5	5.4	0.3	1.2	0.1	18.5	0.0	0.1	0.0	0.0	66.4	4.4	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6	3.0	2.4	22.6	0.5	3.5	0.1	1.2	5.1	2.7	10.3	3.5	3.9	2.8	5.0	12.1	34.6	2.9	0.0	0.0	7.8	1.5	3.3	0.8	0.0	44.8	38.5	9.5	0.0	3.1	59.7	39.6	1.7	94.5	1.7	360.7	0.0	0.2	37.4	0.0	0.4	23.0	0.5	6.5	1.3	40.0	8.0	2.8	87.5	0.0	0.0	4.2
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886174	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 29.6;brain: 54.5"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.0;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		59000000	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	4.4	29.6	19.9	8.0	21.9	1.2	1.7	54.5	43.6	2.8	16.3	1.5	2.0	4.9	1.7	3.0	5.3	2.6	3.2	5.2	11.2	20.6	12.3	1.3	1.3	3.7	7.3	22.4	1.4	3.0	1.0	6.1	1.4	19.3	3.5	5.7	6.2	5.9	10.8	1.6	9.9	7.6	6.1	3.5	1.7	4.8	1.5	3.4	0.0	1.2	1.3	2.6	2.3	3.9	2.2	0.0	0.0	0.0	0.0	0.3	0.2	17.9	1.4	5.4	0.0	0.0	0.0	2.3	25.5	73.5	24.6	40.4	7.3	0.1	0.0	24.3	0.1	20.6	0.7	0.6	0.4	12.9	0.0	0.1	0.0	53.0	1.1	0.0	0.0	4.0	0.1	0.3	3.7	2.5	0.0	0.0	0.0	0.0	0.0	0.1	24.4	0.0	0.5	1.2	0.0	0.9	0.0	32.2	0.1	43.2	0.3	16.2	10.6	14.3	12.7	10.3	12.7	1.3	0.3	0.0	0.0	10.8	1.1	12.1	0.2	0.3	0.1	0.1	0.2	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.9	21.9	54.5	30.2	11.2	20.6	7.3	22.4	19.3	3.4	0.0	0.0	0.8	0.0	1.0	8.5	0.8	0.0	0.0	0.0	80.3	3.9	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	31.8	0.0	1.8	0.0	0.0	0.9	0.0	42.2	0.0	0.0	0.8	0.0	0.0	0.0	0.2	8.6	0.0	0.4	0.0	0.1	1.1	0.1	0.0	0.0	0.1
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL1, histone methyl-lysine binding protein"	Q9Y468	20	43507680-43550950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 16.2;Cone photoreceptor cells: 13.7;Spermatocytes: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.7;SuSa: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068051			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA068051: AB_2732778"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	3.3	5.7	12.6	4.3	11.7	6.4	5.2	25.0	14.3	5.6	4.9	10.5	8.3	4.3	8.2	10.7	4.0	10.4	3.9	5.7	13.8	16.4	4.5	1.8	4.2	4.7	16.3	9.6	11.2	3.3	7.1	14.6	5.1	10.1	6.6	4.4	7.5	8.1	8.0	9.0	9.7	4.7	6.0	7.4	5.6	4.2	13.3	14.5	4.6	7.2	0.7	5.5	4.3	5.4	0.5	1.3	1.5	0.2	2.5	1.8	1.4	0.2	2.0	5.5	3.7	0.1	0.0	10.7	1.2	1.5	1.8	3.1	0.5	5.7	3.1	2.0	2.0	2.4	4.8	0.0	1.1	1.5	0.0	4.9	2.5	4.9	3.8	1.4	0.0	2.9	2.2	2.5	1.2	0.0	5.1	1.1	4.3	2.9	2.1	1.0	0.6	1.3	3.2	2.7	2.0	2.9	2.4	1.3	0.8	4.1	1.3	2.0	6.2	2.0	1.3	0.3	11.1	2.7	3.2	2.0	1.0	3.7	0.0	0.9	4.0	1.0	1.1	3.9	3.9	1.1	0.0	0.2	0.6	0.8	0.2	1.3	0.5	1.0	1.0	0.9	0.4	1.8	0.6	1.5	2.5	0.1	1.3	0.3	1.4	12.6	11.7	25.0	14.3	13.8	16.4	16.3	9.6	10.1	14.5	3.0	2.7	0.0	1.9	0.8	16.2	1.6	0.0	6.7	5.7	5.2	13.7	1.9	1.7	1.1	1.6	1.0	1.1	0.0	0.2	2.8	1.1	2.0	4.7	0.8	1.1	6.4	1.2	1.3	1.9	2.1	4.6	2.4	3.3	0.0	1.1	6.4	0.6	1.9	5.6	0.3	11.7	0.0	1.4	15.1	10.2	1.0	1.6	1.5	1.7	1.4
L3MBTL4	"FLJ35936, HsT1031"	ENSG00000154655	"L3MBTL4, histone methyl-lysine binding protein"	Q8NA19	18	5954706-6415237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 50.7;Late spermatids: 66.8;monocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.3;NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;Karpas-707: 5.9;RPMI-8226: 13.8;SCLC-21H: 6.7;SH-SY5Y: 7.3;U-2 OS: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA064194, HPA069042"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064194: AB_2685208, HPA069042: AB_2686071"	"unprognostic (1.33e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	6.3	6.9	8.4	3.7	12.8	2.1	6.8	0.8	8.1	6.2	3.4	12.3	4.8	4.2	4.9	5.4	5.9	6.2	4.3	8.6	9.6	3.5	9.9	12.0	5.9	2.7	13.7	5.5	12.3	14.2	18.8	8.2	1.1	4.6	3.4	3.0	6.0	5.9	9.6	1.4	9.9	4.8	2.0	3.6	4.0	4.4	17.0	13.4	0.6	8.2	2.5	2.3	3.1	7.1	5.3	1.3	0.4	2.2	6.4	1.4	0.8	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.6	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	2.0	0.1	0.2	2.9	2.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.3	0.0	1.8	3.8	0.0	13.8	0.0	2.4	6.7	7.3	0.0	0.1	0.3	0.5	0.0	0.0	0.1	0.1	4.4	0.1	1.7	0.2	0.0	0.1	1.7	0.1	2.1	0.4	2.2	0.1	1.4	0.6	0.1	1.1	0.2	0.2	1.3	5.3	0.3	0.4	0.3	6.4	1.4	0.3	0.1	0.8	8.4	12.8	0.8	8.1	9.6	3.5	13.7	5.5	4.6	13.4	3.0	9.8	0.0	5.5	6.9	0.8	4.5	12.7	1.4	6.8	5.2	15.7	0.1	3.3	7.1	50.7	3.6	0.9	0.0	4.5	0.0	2.8	4.9	1.1	8.5	3.3	0.0	10.9	1.3	2.5	66.8	9.5	2.6	1.7	45.1	1.3	1.0	3.8	1.9	12.0	6.0	0.3	6.5	6.2	11.8	1.3	7.2	0.1	1.0	3.8	3.9
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA036122: AB_2674951, HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favorable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	10.9	18.3	24.6	9.1	23.0	20.1	7.9	12.4	27.4	10.0	9.7	9.4	5.3	8.5	6.1	11.1	6.8	7.3	7.9	11.0	22.3	15.6	6.7	12.3	7.3	11.3	16.3	20.7	11.3	20.2	5.1	16.6	6.9	12.1	9.7	6.2	8.6	17.5	9.0	22.0	12.2	7.5	7.4	12.3	10.9	11.2	5.0	10.4	16.7	6.2	8.1	10.8	8.4	6.3	14.5	27.5	10.8	10.8	18.4	36.5	15.6	12.6	12.1	4.5	9.5	4.9	4.0	13.3	3.9	2.7	5.9	6.6	7.8	6.9	27.1	35.6	5.1	10.5	5.5	11.1	3.8	2.0	15.4	17.7	9.8	11.3	4.4	8.3	13.1	14.7	6.2	2.6	8.8	2.3	4.5	4.1	13.2	9.6	13.2	8.0	29.9	17.4	38.2	8.5	17.1	29.4	15.4	7.7	30.2	3.4	3.5	12.5	11.6	9.0	21.8	15.7	3.2	9.4	9.6	4.6	4.2	12.6	17.7	14.7	31.2	32.4	40.8	7.5	23.5	9.8	10.8	10.8	4.2	11.7	9.8	14.8	14.5	16.2	17.1	14.8	12.2	36.5	18.7	1.2	18.4	8.0	27.5	12.3	15.6	24.6	23.0	12.4	27.4	22.3	15.6	16.3	20.7	12.1	10.4	8.9	14.3	71.5	41.6	51.5	53.2	30.2	63.7	14.7	4.5	33.2	7.9	50.3	107.8	40.4	1.7	41.3	31.9	23.3	81.3	104.5	43.3	40.6	46.1	41.5	106.6	22.3	54.2	29.4	37.2	4.7	38.6	58.8	87.7	76.7	44.6	51.0	42.4	23.0	34.6	60.2	15.4	6.5	45.3	15.7	103.1	48.9	47.5	40.6	51.3	36.1
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 71.5;Cytotrophoblasts: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 30.9;CACO-2: 42.6;EFO-21: 31.8;HaCaT: 29.0;HeLa: 27.8;TIME: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054609, CAB078157"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		1200000	Vesicles	Nucleoplasm	"CAB078157: AB_2665809, HPA054609: AB_2682540"	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	22.6	5.9	5.6	8.1	5.9	2.5	16.8	24.0	6.6	16.7	28.0	3.1	18.6	7.6	23.2	13.8	18.0	14.2	27.4	13.7	4.7	2.9	17.0	7.3	19.7	4.4	3.7	2.3	6.9	13.9	8.3	6.0	33.3	5.5	17.4	2.6	18.6	12.7	25.0	9.4	45.2	9.0	25.0	4.5	8.8	13.3	4.4	3.4	2.0	18.4	11.8	10.4	19.4	24.9	0.9	1.2	0.2	0.0	0.0	0.0	0.0	3.9	30.9	0.6	4.0	0.7	8.8	23.8	1.1	0.6	0.9	0.1	42.6	16.0	0.3	31.8	0.0	0.9	29.0	0.8	12.4	0.0	0.1	1.7	1.0	27.8	12.1	2.8	0.0	4.6	0.4	8.2	2.1	2.2	1.5	4.1	0.0	1.8	0.4	0.0	5.9	0.0	0.1	2.0	5.1	18.0	0.0	0.3	3.3	8.0	18.9	0.3	12.3	17.1	17.1	0.3	3.3	17.0	0.2	37.3	0.4	11.8	0.2	5.0	0.2	0.0	0.1	8.8	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	5.6	5.9	24.0	6.6	4.7	2.9	3.7	2.3	5.5	3.4	71.5	26.6	8.3	15.9	15.1	1.3	15.3	22.9	13.4	35.2	36.6	7.9	73.3	0.0	28.3	4.3	36.5	0.0	0.0	3.8	24.9	7.8	13.3	2.3	9.4	11.6	3.2	2.4	17.8	0.0	1.1	9.2	2.5	1.7	1.8	0.0	8.2	10.9	0.0	18.4	10.2	1.7	25.8	31.9	0.7	1.9	11.0	47.9	1.0	0.2	24.5
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054752-156058510	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No		17000	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	24.3	33.5	30.3	18.8	27.2	23.4	35.3	14.2	30.6	22.5	27.5	13.8	34.3	24.5	17.0	38.1	27.6	25.4	25.7	37.2	25.8	24.9	31.7	63.5	27.7	37.9	26.4	22.8	11.4	75.2	16.6	18.0	21.1	23.4	18.8	27.5	16.4	35.9	34.3	35.5	20.4	26.2	26.2	19.3	26.0	27.3	12.1	20.3	20.2	20.9	30.2	23.6	21.9	17.0	47.2	89.8	60.4	80.6	32.6	47.6	56.7	15.1	34.5	16.4	22.4	33.3	27.1	18.0	13.6	23.1	17.0	19.5	15.8	26.0	22.5	23.7	26.2	15.0	22.4	16.6	36.7	9.6	18.7	25.2	13.1	23.4	20.8	26.4	18.5	21.4	31.9	23.0	18.1	23.3	23.8	34.6	33.8	11.8	16.9	24.4	30.6	19.1	26.4	17.2	60.3	51.9	16.2	12.2	32.9	37.3	22.3	6.3	36.5	17.3	48.2	27.5	27.2	33.9	54.5	23.4	14.4	13.3	20.9	12.7	25.6	37.5	13.1	25.7	20.6	15.4	41.8	80.6	60.4	30.9	71.6	30.2	47.2	34.2	33.5	89.8	38.3	26.2	28.2	39.6	32.6	56.5	47.5	47.6	56.7	30.3	27.2	14.2	30.6	25.8	24.9	26.4	22.8	23.4	20.3	53.6	42.8	84.0	54.8	42.9	27.7	101.0	124.9	48.2	29.6	102.9	5.9	124.2	328.3	164.5	35.9	83.1	242.4	23.3	156.0	159.6	83.8	73.9	107.1	259.1	359.6	6.4	121.0	78.0	197.4	46.6	43.7	177.6	150.1	338.2	124.1	62.7	171.6	238.4	47.7	425.0	20.8	32.3	55.6	21.8	36.0	69.9	64.5	60.9	143.9	71.1
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365448-55433742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.4;Late spermatids: 42.1"	"Cancer enhanced"	"Detected in all"		"glioma: 52.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"A-431: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.1	4.9	20.4	2.3	17.0	3.1	5.9	9.9	28.5	6.1	4.6	19.8	1.8	5.0	9.6	5.3	3.5	5.6	3.8	3.9	17.2	11.3	6.0	4.8	3.0	4.0	12.9	21.1	9.6	3.4	10.4	4.2	3.9	10.1	5.9	4.7	2.4	3.3	6.9	5.7	5.3	4.2	7.0	10.8	2.8	3.5	5.7	13.1	3.3	6.6	0.3	2.7	2.8	2.7	2.7	4.7	0.7	4.5	3.6	6.0	2.6	58.4	2.0	4.1	2.7	1.2	2.2	2.3	2.7	3.2	4.1	3.5	2.0	1.7	4.1	2.5	3.8	4.1	2.6	2.2	1.5	2.5	1.8	4.3	1.4	1.6	2.0	2.2	4.5	2.7	3.9	1.6	3.1	1.0	2.1	2.0	1.9	2.5	2.7	3.8	1.7	1.1	2.1	7.9	1.6	2.5	1.7	1.9	2.0	2.7	4.7	7.2	6.8	3.8	5.7	1.5	1.6	2.3	4.8	3.3	2.6	3.5	4.9	5.1	2.6	3.1	4.4	2.0	1.0	4.9	0.4	3.6	0.7	2.6	4.5	4.5	2.7	3.4	3.9	4.7	2.6	3.1	2.7	0.5	3.6	3.0	3.7	6.0	2.6	20.4	17.0	9.9	28.5	17.2	11.3	12.9	21.1	10.1	13.1	3.0	6.2	7.6	5.5	3.5	8.0	7.5	7.6	8.1	4.5	10.4	5.9	10.6	5.0	6.7	38.4	4.8	6.6	23.3	10.4	11.1	9.3	4.3	11.5	7.3	6.6	14.3	12.1	9.2	6.3	42.1	8.3	5.0	0.0	9.0	8.6	10.6	6.7	7.0	7.1	19.5	8.2	0.0	3.1	12.0	10.9	3.3	15.9	4.4	10.3	4.7
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein domain family member 7"	Q4G0J3	4	112636964-112657592	"Disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	22.9	20.2	26.5	24.2	37.0	23.9	23.9	32.5	33.2	26.8	24.7	15.0	24.5	20.7	26.8	23.3	26.4	21.9	20.0	38.3	34.3	21.3	38.8	26.9	18.1	25.6	33.3	26.5	26.3	14.4	21.4	42.6	23.1	34.7	27.3	23.9	11.5	19.2	19.9	35.5	19.1	35.2	31.1	46.9	32.4	20.0	16.0	41.2	27.5	26.4	21.2	25.2	30.1	20.9	23.8	34.6	30.7	27.8	17.8	19.2	10.4	11.2	11.2	23.6	11.9	16.2	18.9	11.9	14.3	12.0	13.3	12.7	7.7	17.9	27.6	12.7	13.7	12.6	7.6	22.2	12.9	18.0	23.1	15.7	15.8	9.4	12.1	12.0	37.4	23.5	15.1	15.3	11.9	7.0	18.6	12.5	13.4	19.2	14.2	17.2	9.7	30.0	13.9	60.8	19.2	8.4	16.9	18.9	12.0	20.6	12.3	13.0	17.9	9.2	22.8	14.1	41.2	10.0	14.7	12.0	12.6	12.7	12.7	15.2	9.5	15.9	28.0	16.2	14.0	13.3	30.7	15.0	25.3	18.5	20.7	16.5	23.8	18.8	19.2	12.3	22.8	18.4	17.8	18.3	17.8	27.8	34.6	18.1	10.4	26.5	37.0	32.5	33.2	34.3	21.3	33.3	26.5	34.7	41.2	89.3	68.1	68.6	56.9	22.0	61.3	101.6	96.8	136.5	94.4	45.4	27.5	68.0	94.5	57.3	9.9	57.6	66.6	0.0	56.1	62.9	53.2	37.8	100.6	146.5	61.4	55.6	37.3	81.6	89.8	8.5	87.5	66.9	23.6	73.1	66.9	107.4	53.1	75.9	94.0	93.8	47.4	116.4	44.3	77.9	66.8	18.2	84.0	66.0	67.8	40.9
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.4	8.0	9.4	8.9	8.6	9.7	10.1	10.0	10.3	18.7	13.9	14.2	8.9	13.3	8.6	11.6	13.7	7.0	34.9	20.9	14.2	11.6	8.8	14.4	13.0	13.8	9.0	20.8	5.3	12.5	12.9	17.8	9.4	9.7	11.6	16.1	22.3	7.5	11.6	7.0	14.9	7.6	23.5	10.8	14.9	8.5	9.3	14.8	16.6	15.5	7.4	9.3	15.9	9.0	8.3	11.2	14.3	12.2	10.2	11.4	8.5	9.5	12.0	6.0	10.8	14.2	13.5	14.1	10.1	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8	0.0	1.3	2.7	1.1	1.0	5.0	7.8	2.5	2.7	1.2	5.2	3.9	4.1	5.0	2.5	0.6	3.8	2.3	0.0	2.4	4.2	1.6	2.2	1.1	6.7	4.4	1.6	4.6	2.5	3.7	1.1	1.1	1.6	1.7	2.8	4.3	3.6	2.8	6.6	2.1	2.1	4.4	0.0	1.2	0.7	2.4	1.1	2.4	1.8	6.3	1.6
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 67.7"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 16.0;Club cells: 4.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;JURKAT: 33.3"									"HPA012127, HPA023592"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.7	14.7	1.7	6.2	3.9	6.9	4.2	3.4	3.6	3.8	4.0	3.9	7.6	4.0	2.3	5.4	4.0	4.1	5.3	67.7	3.4	2.1	4.1	8.3	4.4	8.3	1.8	3.3	3.3	4.1	7.5	4.4	2.3	3.7	4.6	4.1	4.5	4.2	10.0	4.8	2.6	6.0	2.5	3.1	10.4	4.6	6.7	2.3	6.2	4.6	3.0	6.5	4.8	2.6	4.9	7.1	5.7	6.2	8.0	7.0	4.3	1.6	2.8	1.7	1.3	2.7	5.1	3.9	2.2	3.3	3.7	2.9	2.3	19.1	5.7	4.9	2.7	3.8	7.4	1.9	5.2	2.9	7.7	5.9	4.8	7.8	1.6	4.0	4.4	6.3	7.0	0.6	6.5	2.0	4.1	2.0	33.3	4.9	5.2	2.3	2.8	2.8	6.7	2.2	3.9	2.5	6.8	4.3	10.4	4.8	3.3	1.9	2.9	2.5	3.5	7.1	2.5	6.3	6.7	1.5	2.3	1.4	2.3	2.4	8.6	7.4	5.4	2.1	4.5	2.4	2.2	6.2	5.7	6.6	4.5	5.7	4.6	3.7	7.0	5.4	4.9	5.1	4.1	1.8	8.0	3.4	7.1	2.2	4.3	1.7	3.9	3.4	3.6	3.4	2.1	1.8	3.3	3.7	2.3	3.0	2.4	0.0	0.1	0.0	1.9	0.8	0.0	16.0	4.5	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.2	0.2	1.6	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.4	0.3	7.3	0.0	0.0	0.6	0.9	0.0	0.2	0.0	0.0	0.3
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 13.8"	"Cell type enhanced"	"Detected in some"	11	"Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.3;olfactory region: 0.9"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	4.4	0.4	1.5	1.0	0.5	0.3	1.3	0.5	0.5	1.1	6.8	0.0	1.5	8.3	2.2	2.6	0.5	0.6	3.9	1.8	0.3	0.3	1.9	13.8	3.7	0.4	0.3	0.6	0.6	3.4	0.0	0.3	2.6	0.5	0.6	0.0	0.2	1.5	0.4	0.8	1.3	7.3	0.1	0.4	1.9	4.9	1.3	0.0	0.3	1.1	1.7	2.1	0.8	0.6	0.2	2.1	1.6	4.8	2.5	1.0	1.5	3.8	1.4	0.0	0.1	1.7	1.4	6.5	0.3	0.2	0.4	0.4	9.3	5.7	0.2	1.6	0.7	0.6	1.5	0.0	0.3	0.0	8.0	1.7	4.1	0.5	19.3	1.3	0.2	2.6	1.8	1.4	1.4	0.3	0.2	1.6	0.1	2.7	2.0	0.3	2.0	0.1	0.8	0.4	1.6	0.2	0.4	0.4	0.2	0.2	1.2	0.2	1.1	2.3	0.3	8.4	0.1	0.2	0.3	3.6	1.4	6.1	7.4	0.1	2.6	2.0	0.2	1.4	0.7	4.3	0.8	4.0	0.3	0.8	1.9	0.5	0.2	0.2	1.0	2.1	0.2	0.2	0.7	1.6	2.5	4.8	0.6	0.1	1.5	1.5	0.5	0.5	0.5	0.3	0.3	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.5	0.0	0.0	1.6	0.0	0.6	0.4	0.3	0.0	0.0	2.8	0.9	0.0	2.4	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	6.3	0.0	6.5	0.2	0.0	0.0	0.1	0.5	0.0	0.8	0.1
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"LCA5L, lebercilin like"	O95447	21	39405844-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 57.2"	"Cell type enhanced"	"Detected in many"	28	"Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.9;T-47d: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: AB_2674110"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.3	1.4	0.3	3.7	0.3	1.2	1.1	1.6	1.2	0.6	2.3	2.7	0.4	0.9	4.6	0.4	4.4	1.0	0.5	1.9	1.2	1.6	1.3	1.0	0.3	0.7	1.2	0.8	1.1	1.7	9.1	0.3	3.1	0.7	0.4	2.2	0.8	1.8	1.7	0.7	0.4	0.5	0.7	0.4	0.6	57.2	1.1	0.3	2.9	0.4	0.3	0.5	0.5	0.3	0.7	0.2	0.5	0.0	1.1	0.0	1.7	1.8	1.0	3.2	1.6	1.4	0.2	0.5	0.8	1.0	0.1	1.0	1.9	1.2	1.5	1.7	0.4	0.5	0.1	1.0	0.6	0.6	1.5	0.9	1.9	0.2	1.3	2.0	0.0	1.2	4.2	3.0	3.4	2.2	0.6	1.9	3.1	1.2	1.1	6.9	0.6	0.7	6.2	1.3	1.9	0.4	0.4	1.2	3.3	0.6	2.1	0.9	3.8	1.6	2.5	0.6	7.4	0.3	0.1	0.6	0.4	1.8	0.5	3.7	1.9	0.4	2.8	0.7	1.2	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.5	0.6	0.2	0.3	0.0	1.1	0.2	0.0	0.5	0.7	0.0	0.0	1.4	3.7	1.1	1.6	1.9	1.2	0.7	1.2	3.1	1.1	3.0	0.3	0.0	0.8	0.5	2.0	1.7	2.5	84.3	27.3	7.0	5.9	0.8	16.6	2.7	967.3	1.0	0.0	0.0	2.0	0.1	1.5	0.5	0.0	1.5	0.5	1.6	4.1	1.8	0.6	347.9	6.1	1.0	1.7	1.0	1.3	3.1	1.7	0.0	7.4	9.1	15.3	19.4	0.9	191.0	27.7	0.5	0.2	0.0	0.8	0.5
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111729-25178231	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 149.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	9.8	18.0	27.9	11.6	30.6	13.9	18.1	27.5	36.4	15.4	17.1	15.5	17.5	13.1	16.2	26.7	13.4	16.8	14.1	25.3	22.8	27.5	17.8	7.5	10.8	11.9	21.7	26.7	23.8	31.4	25.3	20.5	18.9	24.8	15.7	17.2	15.0	14.4	18.3	31.6	16.5	12.7	15.1	18.9	10.1	12.6	29.8	14.4	16.9	15.5	14.3	15.3	11.7	12.1	19.7	17.6	21.6	18.9	15.8	38.9	19.5	17.0	16.1	15.0	20.8	13.5	19.8	15.4	10.7	17.7	15.6	20.6	20.3	15.7	10.4	15.3	16.2	19.9	8.8	15.5	14.7	21.2	10.6	23.7	5.6	16.4	32.9	30.9	13.4	9.3	22.4	16.3	17.8	18.6	23.0	14.2	23.7	8.9	13.7	17.2	43.6	16.0	25.8	22.9	10.8	16.7	19.0	13.8	20.2	17.7	12.1	24.5	15.2	12.8	19.9	24.4	18.4	20.1	6.2	8.4	15.6	10.9	10.1	10.5	17.9	18.1	11.0	19.1	11.8	11.4	12.7	18.9	21.6	20.6	16.7	22.6	19.7	25.6	22.3	17.6	14.3	23.1	21.1	7.4	15.8	17.5	9.1	38.9	19.5	27.9	30.6	27.5	36.4	22.8	27.5	21.7	26.7	24.8	14.4	14.9	13.7	23.2	24.4	21.4	25.3	30.5	15.3	22.7	7.9	31.4	2.0	149.0	41.4	46.1	60.5	21.8	58.0	0.0	58.2	63.7	29.6	28.2	9.2	9.0	41.1	22.3	49.3	17.8	33.7	98.3	24.2	25.1	32.1	33.3	47.4	20.7	45.5	40.3	22.6	69.2	18.9	25.8	18.4	50.2	46.6	27.9	137.0	33.1	48.4	31.3
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330605	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039401, HPA048176"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA039401: AB_10805478, HPA048176: AB_2680299"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	7.9	10.9	6.5	8.3	8.1	2.5	25.9	11.4	10.1	10.8	7.4	7.2	10.6	5.2	10.3	12.7	11.0	10.2	6.7	8.4	6.7	8.4	11.9	9.2	6.2	9.9	6.1	7.6	13.0	8.2	13.7	10.1	6.4	9.6	10.2	7.5	8.9	10.3	13.8	7.9	6.2	8.4	8.6	4.8	9.6	8.7	7.1	9.6	12.2	9.8	11.2	13.9	7.4	9.6	6.3	6.9	5.5	4.0	3.3	10.5	5.0	6.0	4.9	11.5	9.9	12.3	3.8	5.6	7.5	9.0	9.8	10.8	7.2	2.8	5.2	15.3	8.5	10.3	14.4	0.0	9.9	7.5	8.0	5.3	9.3	13.0	4.2	7.5	0.0	7.0	5.8	9.6	7.2	6.7	6.6	3.1	12.1	11.7	7.0	11.8	9.5	10.4	4.4	4.9	13.5	4.1	12.3	10.1	5.0	17.1	7.0	15.4	13.1	9.9	8.3	4.3	9.4	10.2	14.3	2.6	11.6	5.2	13.1	12.2	4.7	11.1	2.2	7.2	7.7	11.9	2.4	4.0	5.5	4.0	3.8	5.5	5.0	6.7	4.8	6.9	6.3	10.5	6.8	1.3	3.3	3.5	3.9	5.3	5.0	6.5	8.1	11.4	10.1	6.7	8.4	6.1	7.6	9.6	9.6	0.0	1.9	3.2	3.5	2.7	6.9	2.8	7.6	6.7	7.9	3.5	7.9	3.6	3.3	5.4	1.4	2.8	1.3	0.0	3.5	2.1	2.2	2.8	1.1	3.4	2.3	3.2	5.2	5.5	1.6	1.3	4.6	1.5	0.0	2.8	2.7	8.6	3.2	2.3	1.4	4.2	6.6	6.5	3.1	7.5	8.3	2.5	2.1	2.5	3.4	2.0
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	8.3	7.8	11.3	5.7	11.9	5.1	6.6	21.9	10.4	7.0	9.2	6.9	4.7	14.2	6.3	5.1	7.3	4.6	7.1	3.9	10.3	9.8	9.6	7.2	7.5	8.0	14.8	6.5	7.6	6.4	8.4	11.3	8.7	8.9	5.9	8.8	5.0	7.0	5.3	7.9	8.6	22.3	5.8	16.2	12.6	9.1	12.2	15.3	17.1	8.1	2.7	5.7	6.5	5.4	4.4	3.8	8.2	4.6	2.4	3.2	1.5	4.8	3.2	13.0	4.0	6.9	10.8	3.3	6.0	5.9	5.2	6.8	1.6	6.5	9.4	3.2	4.0	8.0	2.2	6.2	2.5	7.3	2.6	3.9	7.5	5.7	3.9	4.4	6.0	6.1	5.9	3.0	3.5	7.3	7.6	7.0	6.1	4.5	15.0	7.0	1.3	5.8	12.3	4.5	4.3	4.7	5.8	8.0	5.2	8.4	2.6	9.7	9.3	4.3	2.2	4.2	5.1	3.9	5.8	4.7	8.2	4.1	5.1	9.4	12.2	4.6	7.9	6.7	8.1	6.5	8.2	4.5	4.9	2.9	4.6	2.4	4.4	2.0	1.8	3.8	3.0	2.3	2.7	2.2	2.4	3.6	2.6	3.2	1.5	11.3	11.9	21.9	10.4	10.3	9.8	14.8	6.5	8.9	15.3	11.9	10.4	17.9	3.8	21.2	18.3	8.1	40.8	17.4	6.8	7.0	39.3	7.3	8.3	9.7	26.0	20.2	18.1	0.0	9.7	7.4	8.7	8.5	18.5	11.9	13.9	19.1	34.0	9.2	11.7	15.2	13.6	22.6	3.3	8.2	17.8	9.8	10.0	14.1	7.1	14.0	20.9	19.4	6.1	40.8	15.6	16.7	8.2	6.9	14.9	4.2
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Cell type enriched"	"Detected in some"	15	"Ciliated cells: 499.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.7;Hep G2: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.7	0.0	1.9	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.3	0.8	15.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.3	0.0	0.1	1.0	0.0	0.1	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	499.2	34.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	4.7	0.0	0.1	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 36.5;Peritubular cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.8	4.6	12.8	8.0	9.8	0.0	7.1	8.8	9.7	13.6	0.0	11.7	0.0	5.6	11.6	9.6	14.0	5.0	10.4	6.9	0.0	9.2	0.0	16.1	0.0	3.1	0.0	2.8	17.3	5.4	8.4	4.5	7.8	8.2	0.0	0.2	0.0	8.7	40.1	0.0	0.0	4.8	0.0	50.3	0.0	4.1	0.0	11.9	7.0	0.0	4.0	0.0	6.2	0.0	2.6	7.9	0.0	14.8	0.0	9.6	0.0	29.9	0.0	0.0	0.0	5.0	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6	0.0	4.0	0.0	15.7	5.4	25.2	1.6	22.9	5.3	10.3	22.7	7.9	1.9	36.5	12.0	0.5	11.3	0.0	0.0	12.3	1.6	11.7	14.6	2.3	0.0	0.8	19.1	5.2	11.1	0.8	0.9	20.4	1.6	3.3	0.0	0.2	20.6	11.6	0.0	36.4	26.8	9.6	12.9	19.4	0.9	7.7	5.9	1.3	5.7	0.0	14.0
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.6;U-266/70: 6.2"	"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.6	2.7	0.1	1.6	1.2	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	2.0	1.1	2.6	2.5	0.0	0.5	2.7	1.2	0.6	2.5	0.5	0.0	0.0	2.1	0.6	3.1	1.6	0.5	1.9	0.8	0.6	0.1	1.5	1.6	2.4	2.4	0.0	1.9	2.2	1.9	1.5	0.0	1.8	1.5	2.1	0.6	4.2	1.7	2.2	1.5	0.1	0.5	4.6	3.6	0.0	0.4	0.7	0.5	1.0	6.2	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7	0.0	1.4	0.0	1.1	1.1	1.3	0.8	2.5	34.8	3.4	3.5	2.0	0.2	3.3	0.6	63.2	0.4	1.3	0.0	1.4	0.1	0.5	0.7	1.1	1.6	0.2	3.2	0.0	0.0	1.8	32.2	1.4	1.1	1.7	1.8	0.6	1.4	0.7	0.0	1.8	3.3	4.5	0.0	0.3	49.4	3.2	0.6	0.1	1.3	0.8	0.8
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	9.6	8.0	8.2	8.0	11.1	6.1	7.3	10.1	9.5	7.5	10.8	11.5	10.8	7.6	13.4	8.7	6.1	11.9	9.6	12.7	8.2	7.9	7.6	7.2	8.9	6.3	11.2	7.6	10.3	9.7	7.3	8.5	7.3	10.3	9.3	10.7	6.6	21.6	10.4	13.1	9.9	14.8	7.5	10.8	21.8	8.8	12.3	13.1	10.1	10.8	7.6	6.8	8.2	15.8	3.8	3.2	4.1	3.3	2.8	3.8	0.8	0.1	0.4	5.7	0.2	0.6	0.2	0.4	0.8	0.1	0.6	0.3	0.2	0.0	0.0	0.2	0.0	0.5	8.3	0.3	0.2	0.2	5.1	1.3	0.0	0.5	0.1	0.0	0.0	0.5	3.9	0.7	0.2	0.5	0.2	0.1	0.5	0.1	0.0	4.8	0.6	0.4	0.5	0.0	0.2	0.6	0.0	0.1	0.8	0.5	0.5	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.1	0.7	0.4	0.4	0.2	0.4	0.1	0.2	0.0	5.6	0.1	2.7	1.0	2.7	4.1	2.5	3.3	2.8	1.6	3.7	3.8	2.2	3.8	3.7	2.9	3.7	2.8	1.6	3.2	2.7	0.8	8.2	11.1	10.1	9.5	8.2	7.9	11.2	7.6	10.3	13.1	17.9	9.1	29.1	20.5	18.3	10.2	6.4	15.3	18.7	6.8	17.4	0.0	24.4	19.9	18.7	76.0	20.3	33.5	0.0	24.7	12.4	18.9	14.1	54.2	15.5	26.7	6.4	25.9	25.8	16.2	6.4	20.8	26.0	20.3	26.2	20.4	14.5	21.8	17.8	14.2	21.2	13.9	38.8	26.8	23.1	29.4	18.7	35.8	35.5	16.6	14.7
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462037	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 564.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 102.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA042056, HPA061571"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	58.7	37.3	45.7	53.2	47.3	48.4	30.7	81.5	55.3	37.9	32.9	48.1	54.4	78.1	56.3	66.3	22.9	44.8	39.2	24.1	42.2	21.6	35.0	22.7	36.2	45.8	52.1	30.2	50.3	62.7	13.8	46.4	27.4	38.1	41.9	22.1	48.9	66.7	59.1	36.5	37.2	75.5	35.6	34.3	80.0	53.2	32.6	57.5	24.8	42.2	18.7	33.5	31.5	32.0	4.0	5.6	8.0	1.9	1.7	1.6	0.6	14.5	11.4	14.6	7.4	4.6	7.5	7.8	12.2	1.9	2.3	4.5	9.2	21.1	11.4	5.3	9.9	0.6	19.3	4.7	5.6	1.7	19.2	102.5	17.4	31.4	6.4	5.0	2.6	14.0	16.8	8.7	1.4	5.8	20.0	3.5	8.8	13.2	16.5	2.9	5.0	10.7	13.6	3.4	3.3	2.6	17.3	4.3	16.1	6.0	4.3	11.8	6.1	1.3	9.0	2.8	7.8	8.8	3.8	16.9	10.3	10.7	1.6	12.9	15.6	7.3	4.6	8.4	18.6	6.7	3.9	1.9	2.3	1.6	1.2	1.6	1.4	0.8	1.5	1.0	4.0	1.5	1.1	8.0	1.7	0.9	5.6	1.0	0.6	45.7	47.3	81.5	55.3	42.2	21.6	52.1	30.2	38.1	57.5	17.9	30.7	24.9	18.7	25.5	123.6	1.7	45.9	21.4	29.6	38.4	106.0	15.1	1.7	17.8	25.8	24.8	65.9	23.3	27.1	10.2	22.7	34.5	10.5	37.6	22.3	90.6	100.9	44.2	43.7	9.1	40.3	25.1	23.6	18.0	78.8	36.3	27.0	52.6	34.6	5.3	564.9	19.4	19.6	16.7	13.6	33.6	17.6	19.5	50.5	29.3
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786167	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 1.0;HDLM-2: 2.3"									HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.6		0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675608-37679806	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 4031.4;Hofbauer cells: 3788.4;monocytes: 10290.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	No		19000000	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	167.5	49.3	23.0	56.0	22.9	29.8	213.7	7.6	30.9	158.6	94.5	20.1	44.2	22.0	150.9	80.3	74.0	66.8	78.8	108.6	18.9	29.3	24.0	20.8	55.8	45.4	41.4	28.9	105.1	18.2	5.1	17.5	80.1	53.6	85.9	23.4	35.7	34.9	89.6	117.1	29.2	29.2	145.8	88.3	40.3	40.0	42.4	20.5	16.7	19.6	59.1	20.4	99.8	81.7	29.0	185.2	44.0	149.1	19.6	73.1	180.2	94.5	55.8	1.2	49.5	116.0	227.9	1.1	219.9	258.2	162.9	162.4	6.2	12.5	0.1	22.6	222.0	56.2	10.1	1.9	144.6	57.0	97.1	1.0	8.3	58.6	25.6	75.7	4.8	110.9	141.1	9.9	129.9	55.6	149.1	178.8	0.0	6.0	40.1	126.0	42.2	0.1	67.3	0.4	21.0	132.4	0.1	83.0	25.9	67.0	0.2	0.1	29.4	43.9	7.7	54.9	2.4	40.9	56.9	241.8	217.7	108.9	96.6	112.2	24.6	16.4	0.4	255.8	25.1	86.6	44.0	149.1	5.3	40.8	114.2	6.1	29.0	38.0	39.8	185.2	10.8	6.6	26.8	6.3	19.6	120.0	45.7	73.1	180.2	23.0	22.9	7.6	30.9	18.9	29.3	41.4	28.9	53.6	20.5	154.9	138.0	222.9	146.3	648.8	7.2	914.1	63.7	54.9	94.4	155.3	5.9	84.3	14.9	558.2	21.5	662.6	6.4	23.3	75.7	807.6	4031.4	43.7	528.7	472.3	3788.4	7.9	2.9	939.1	2674.9	59.6	903.3	2724.8	2709.5	10290.5	1.7	156.0	264.8	1.7	1222.7	15.1	31.2	1623.4	2845.4	14.7	12.1	513.9	126.7	373.6	0.9	48.4
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 46.8;Hep G2: 26.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.0	46.8	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	26.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	9.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.1	0.2	0.7	0.7	2.7	0.9	0.4	1.9	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4	6.0	4.6	32.7	0.1	15.1	0.0	0.1	800.0	1.4	2.3	27.9	0.0	0.1	107.8	20.9	0.0	0.1	838.5	0.0	175.0	0.2	3.5	0.1	2.3	0.6	27.7	0.0	70.9	0.6	23.7	0.0	0.6	71.1	23.6	13.6	374.8	0.0	476.7	354.2	0.0	1320.5	0.0	0.0	6.2	0.0	0.2	10.8	0.2	2.5	571.4	0.1
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748702	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 1236.6;Ito cells: 365.8;Syncytiotrophoblasts: 348.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"plasmacytoid DC: 54.2"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 54.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 129.9;U-266/70: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	42.9	16.3	8.6	17.4	10.7	3.5	19.9	5.8	17.9	13.3	22.3	11.7	13.9	24.2	12.1	48.1	17.4	14.1	32.7	38.8	10.3	10.1	87.6	44.6	31.5	42.4	8.3	10.1	20.5	14.6	54.4	9.7	113.6	9.9	22.0	24.5	23.2	22.6	8.4	17.3	11.9	37.1	23.3	11.5	58.3	23.7	14.0	7.9	17.2	36.8	19.2	17.3	31.4	18.2	4.7	54.2	0.7	0.8	1.0	4.3	1.7	4.9	7.1	4.8	8.7	14.9	12.0	16.7	10.6	10.2	11.1	13.1	5.5	8.9	2.7	15.8	17.4	6.9	12.3	0.0	9.2	5.3	0.2	5.5	0.1	3.9	6.3	4.4	0.1	0.4	8.5	4.5	10.7	6.2	3.3	13.1	5.1	1.0	23.0	0.8	6.6	1.3	0.2	2.3	31.1	4.9	1.2	4.2	129.9	12.0	19.3	5.2	3.5	14.8	9.1	7.7	11.0	6.7	0.0	7.1	5.5	7.0	9.9	3.2	71.5	8.4	3.7	3.1	0.1	10.5	0.7	0.4	0.1	0.2	0.8	0.4	4.7	1.4	0.4	5.0	3.4	4.3	2.5	0.5	1.0	0.2	54.2	2.6	1.7	8.6	10.7	5.8	17.9	10.3	10.1	8.3	10.1	9.9	7.9	53.6	113.7	33.9	33.3	20.5	9.9	25.0	45.9	18.7	34.2	29.6	88.4	130.6	8.3	49.8	0.8	31.3	68.2	0.0	45.2	121.5	45.8	47.6	8.1	36.1	1236.6	12.7	35.1	365.8	242.3	2.3	28.1	82.0	45.5	62.3	31.1	25.8	41.2	52.6	54.5	101.8	15.3	19.4	64.6	22.3	17.7	15.3	348.2	8.5	40.4	39.9
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Cell type enhanced"	"Detected in some"	23	"Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.2;SH-SY5Y: 47.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.4	16.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	5.3	0.7	1.0	0.0	0.0	0.0	6.5	0.1	47.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.7	1.7	0.0	0.0	0.4	5.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	22.1	0.0	11.5	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	1.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9	0.0	0.0	0.0	2.8	1.1	0.0	8.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.0	3.3	0.1	0.7	0.5	1.7	0.3
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.6	0.1	0.1	0.0	0.0	5.7	0.1	0.1	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.9	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	1.9	0.1	0.4	0.1	0.1	0.4	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	4.0	3.4	0.0	0.0	1.7	1.7	0.0	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.3	2.2	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.5	0.0
LHFPL4		ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.1;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4"	"Group enriched"	"Detected in some"	13	"glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.9	4.9	8.0	1.0	11.4	0.9	0.9	16.0	29.1	0.9	1.4	1.5	0.0	1.2	0.9	0.8	0.9	0.9	0.9	0.8	8.4	8.5	0.9	0.8	1.0	0.8	4.2	8.6	0.8	1.8	1.2	9.0	0.8	9.2	0.9	1.4	1.7	0.9	0.9	0.8	0.9	1.3	0.9	4.2	0.8	1.3	1.6	1.8	0.0	0.9	0.0	0.8	0.8	0.1	0.0	1.2	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.1	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	10.5	0.0	0.5	0.0	3.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	8.0	11.4	16.0	15.6	8.4	8.5	4.2	8.6	9.2	1.8	0.0	0.0	0.0	2.6	0.0	39.8	0.6	0.0	0.0	0.0	0.0	17.7	0.5	0.0	0.3	0.4	0.0	0.5	0.0	0.2	0.8	0.3	1.5	1.1	0.0	0.2	14.3	1.2	4.9	0.3	0.4	0.0	0.0	0.0	0.0	0.6	1.3	0.3	1.4	0.0	0.1	16.4	0.0	0.1	1.7	1.0	0.0	1.1	0.0	1.0	2.5
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	4.0	3.1	4.0	3.8	8.4	8.2	3.4	4.6	2.6	4.3	2.9	5.0	5.5	14.6	5.3	1.7	10.9	3.6	11.3	6.3	5.8	1.6	2.8	6.1	1.6	5.0	7.7	13.2	4.0	7.9	10.5	5.1	16.2	9.6	4.9	9.1	14.4	3.6	5.2	2.5	7.4	17.0	5.3	10.6	10.1	6.5	10.8	8.8	5.1	2.1	4.4	3.8	2.7	3.6	14.9	5.8	4.0	6.1	1.8	3.5	7.7	4.5	10.7	7.1	10.8	10.2	5.4	15.4	3.0	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2	8.9	9.3	13.4	11.9	8.7	24.0	16.5	10.2	20.1	13.6	17.4	9.8	21.5	18.3	10.7	82.3	7.1	13.1	0.0	5.5	12.9	8.0	5.2	17.3	17.0	15.4	9.5	17.4	5.5	11.7	80.7	9.5	10.9	1.7	17.2	12.1	15.2	9.0	10.5	11.7	23.2	23.3	0.0	9.5	47.0	20.9	8.2	8.0	12.9	18.1	8.4
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	8.8	12.4	11.6	10.4	15.9	4.3	9.1	14.2	20.6	5.4	7.1	10.2	7.8	8.9	5.8	11.4	8.1	5.9	8.7	8.8	15.6	14.4	11.2	16.7	8.7	12.7	15.5	10.6	7.9	8.3	17.0	20.3	8.3	19.6	7.5	8.7	3.8	6.7	7.1	9.5	6.6	8.6	8.4	14.4	12.6	9.7	11.7	13.6	18.6	10.0	5.4	10.2	8.1	5.3	3.3	2.1	6.8	10.7	2.7	2.7	1.5	8.9	3.4	9.2	6.1	7.7	8.3	3.3	8.8	6.7	6.7	8.1	4.0	4.0	15.2	7.2	5.8	8.3	3.7	6.1	5.9	11.8	8.9	5.8	7.1	7.8	2.1	9.2	9.5	7.6	7.5	9.9	6.5	5.9	6.5	8.0	28.1	2.5	2.8	10.4	4.8	15.8	7.0	2.3	7.3	2.1	14.5	3.6	2.4	8.9	5.7	5.8	6.0	1.9	5.4	6.6	7.5	4.6	14.8	11.9	4.0	4.4	4.5	7.9	7.5	4.9	24.7	15.5	5.5	9.1	0.8	2.3	6.8	1.8	3.8	2.5	2.6	2.0	1.9	2.1	3.3	2.0	2.7	3.2	2.7	10.7	1.4	2.7	1.5	11.6	15.9	14.2	20.6	15.6	14.4	15.5	10.6	19.6	13.6	8.9	7.4	2.4	2.3	2.4	9.6	10.1	0.0	26.8	11.4	1.8	7.9	1.9	8.3	4.6	9.5	3.6	4.1	0.0	6.5	1.0	2.3	3.0	3.5	7.8	5.0	17.5	9.2	4.3	7.3	3.6	2.6	5.0	1.7	8.2	4.6	6.9	6.8	5.3	5.6	5.6	12.6	12.9	2.5	16.4	2.7	5.0	1.5	2.5	2.8	2.0
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686338	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 35.7;B-cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	12.6	7.0	4.8	14.9	5.5	6.2	13.9	2.5	6.0	10.2	9.7	8.1	13.0	8.4	14.4	12.0	10.4	9.6	10.9	11.5	5.1	4.1	8.3	16.6	24.8	17.1	9.2	2.2	7.6	24.5	11.3	5.5	11.7	9.4	12.1	9.2	20.2	19.1	8.2	25.2	8.3	12.2	12.5	6.8	16.4	11.4	6.2	6.4	20.3	17.9	10.7	24.9	12.9	18.9	6.7	8.8	4.1	5.5	1.1	1.6	1.0	7.4	14.2	5.2	7.0	4.6	9.0	10.4	7.2	10.1	7.7	6.7	6.7	3.9	0.9	4.8	6.6	15.7	5.1	11.0	5.9	6.4	15.7	6.7	8.3	11.2	5.5	4.7	7.4	10.7	3.7	4.9	11.4	6.0	5.6	6.7	8.6	6.9	23.5	7.6	4.9	9.0	4.7	8.4	6.0	13.7	4.5	6.0	11.3	4.0	13.3	2.4	4.7	6.1	11.1	7.2	5.6	6.7	6.7	11.9	8.5	7.7	8.5	7.6	22.5	28.9	3.7	18.5	6.8	9.2	4.1	1.4	1.4	1.6	3.1	1.0	3.9	1.3	1.4	1.4	6.7	1.4	1.4	1.6	1.1	5.5	8.8	1.3	1.0	4.8	5.5	2.5	6.0	5.1	4.1	9.2	2.2	9.4	6.4	35.7	20.6	31.3	5.1	2.6	1.5	14.2	12.7	10.7	13.6	7.0	2.0	5.1	1.7	6.0	1.0	4.3	5.9	0.0	4.6	10.3	4.8	9.5	3.5	16.3	14.1	6.4	6.4	9.8	15.3	0.2	10.9	9.0	5.0	1.0	16.0	7.0	5.6	3.5	3.2	3.0	1.0	6.5	8.0	0.7	4.1	1.9	4.5	7.4	8.8	3.6
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695902-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 175.1;lymphoid tissue: 98.4"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 358.9;Hofbauer cells: 123.5;Kupffer cells: 178.4;T-cells: 223.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 54.7;NB-4: 38.1;SH-SY5Y: 38.1;THP-1: 28.6;U-698: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	3.6	2.0	6.5	54.8	14.8	28.7	2.3	1.2	8.5	2.7	2.9	3.0	1.3	3.9	2.6	3.2	3.0	2.6	5.1	2.7	9.6	3.3	3.7	5.1	8.1	63.5	3.6	3.7	2.8	1.7	0.8	3.5	6.4	2.8	4.1	2.8	5.0	11.3	1.7	1.1	1.8	12.9	2.6	3.0	51.1	5.5	6.1	1.7	98.4	2.5	2.2	79.7	7.4	2.6	81.9	55.1	175.1	65.1	46.6	67.5	73.0	0.1	1.7	21.6	5.3	0.2	0.5	0.5	0.5	0.3	2.2	1.5	0.9	0.4	54.7	4.8	2.6	2.2	0.8	4.7	0.2	0.6	18.8	1.9	16.2	0.3	4.6	4.2	21.0	1.7	5.4	0.2	2.2	0.0	2.5	5.8	3.8	1.4	3.2	2.4	0.2	18.5	38.1	11.6	0.0	1.0	7.7	8.7	9.6	3.0	0.2	26.0	38.1	2.7	0.0	5.0	5.8	0.1	28.6	7.3	3.0	6.6	0.1	0.7	0.6	0.2	57.0	0.3	3.0	5.2	175.1	54.6	122.9	35.7	63.3	35.1	64.6	49.4	41.5	55.1	81.9	67.5	48.1	112.7	46.6	65.1	20.8	58.1	73.0	6.5	14.8	1.2	8.5	9.6	3.3	3.6	3.7	2.8	1.7	0.0	5.8	358.9	7.5	6.6	0.8	0.8	2.5	1.4	3.4	10.4	3.9	1.3	5.0	15.9	14.6	16.3	0.5	0.0	8.0	2.7	7.3	13.6	53.0	1.5	123.5	3.2	21.4	27.0	178.4	36.6	3.1	84.5	35.4	24.4	2.0	5.0	22.0	5.9	4.6	1.7	1.0	6.5	7.3	4.9	6.8	5.3	1.3	223.7	2.1	3.1
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 14.7;neutrophil: 37.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in all"		"BEWO: 37.6;hTCEpi: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	9.4	6.6	23.5	23.6	26.2	29.4	17.0	9.9	16.8	11.0	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6.0	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20.0	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20.0	1.0	1.6	37.2	1.9	2.4	5.6	1.6	7.0	1.1	4.9	2.7	2.1	2.5	37.6	4.6	2.2	4.7	4.0	6.0	3.3	6.9	8.3	7.0	2.2	14.3	5.7	24.5	2.9	5.0	6.2	5.0	5.5	6.5	3.2	9.2	9.2	4.0	69.7	3.8	11.5	32.0	11.9	5.6	2.7	5.0	6.4	5.5	5.6	3.1	4.6	18.2	1.8	7.4	8.3	3.8	5.4	16.7	6.3	5.6	3.5	22.6	9.3	15.9	18.8	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6.0	2.6	4.3	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1.0	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9	29.8	17.0	3.0	42.2	31.9	7.0	19.8	12.7	33.5	28.4	5.2	19.6	59.9	3.3	10.9	1.0	19.3	16.9	0.0	38.9	46.0	10.8	19.1	23.1	6.8	15.7	3.2	12.7	12.9	7.9	1.3	4.0	11.8	3.3	2.8	41.8	15.6	22.5	10.5	4.2	8.1	23.2	19.4	4.1	9.8	10.4	34.3	96.6	8.7	49.0	20.7
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098412-36151961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 11.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	6.2	9.7	12.1	6.6	21.4	2.2	8.8	12.8	25.5	7.3	8.7	9.5	7.6	9.6	5.3	7.2	6.8	4.8	5.8	8.2	14.2	11.4	10.5	14.2	5.7	7.6	9.9	15.6	5.0	7.7	16.9	16.9	8.4	14.1	9.7	9.1	4.8	7.6	6.8	11.1	7.7	9.6	5.5	10.5	6.7	10.1	5.2	8.6	8.4	12.8	2.9	7.4	7.6	6.1	1.5	1.2	11.0	1.2	1.0	2.3	0.8	4.9	3.7	4.5	7.4	9.4	8.3	15.9	10.3	5.4	7.6	7.6	4.6	10.8	8.9	5.2	5.4	7.8	6.8	5.9	3.6	12.5	12.7	3.6	6.9	12.6	0.8	6.0	8.3	9.2	4.9	6.4	6.5	6.5	5.7	4.1	6.9	8.1	9.4	9.1	3.3	7.1	5.5	2.5	7.7	4.7	5.4	10.5	5.4	6.5	4.4	8.5	6.6	14.8	8.8	3.6	4.6	10.0	10.1	5.4	9.1	2.4	11.5	5.4	7.7	11.3	7.8	8.6	9.5	6.2	11.0	1.2	2.0	1.6	1.2	1.1	1.5	1.4	1.4	1.0	1.3	1.9	1.9	0.8	1.0	1.2	1.2	2.3	0.8	12.1	21.4	12.8	25.5	14.2	11.4	9.9	15.6	14.1	8.6	8.9	9.8	5.6	4.2	6.2	10.8	22.2	10.2	9.4	2.3	12.2	7.9	8.0	3.3	4.4	1.3	5.8	11.8	0.0	6.6	5.6	6.6	8.8	6.9	25.2	9.7	14.3	6.4	9.8	13.2	1.4	4.4	7.7	6.8	6.4	14.8	11.6	5.6	3.5	6.7	10.2	10.7	12.9	7.9	21.2	8.1	8.8	16.2	6.7	10.4	2.5
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140089	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"granulocytes: 1139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4"	"Cell line enhanced"	"Detected in many"		"WM-115: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660, HPA012078"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		3200000	"Nucleoplasm, Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231, HPA012078: "	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	64.0	37.3	7.4	51.4	11.8	21.3	88.6	9.0	10.8	62.8	32.6	21.9	27.2	28.6	69.1	52.3	62.2	40.1	77.7	62.5	8.8	7.5	25.9	26.6	51.8	39.6	15.7	11.2	60.3	30.9	15.2	17.4	73.3	18.1	34.0	15.2	32.7	37.5	26.4	36.3	68.7	29.9	63.0	10.3	22.4	36.7	30.2	12.9	9.4	31.5	140.0	35.6	46.4	51.2	1.1	34.8	10.4	3.5	1.7	35.4	6.4	59.1	58.7	6.5	17.4	32.9	57.1	20.0	64.0	81.5	48.3	33.4	14.8	58.6	0.5	38.0	98.4	24.9	69.3	9.5	49.6	12.6	20.1	5.6	18.7	47.2	34.3	29.7	3.2	55.2	34.1	21.6	39.2	27.0	25.0	43.1	0.0	10.0	4.5	52.9	46.7	0.1	10.3	4.8	68.6	74.8	0.2	22.7	17.3	47.8	28.4	6.6	13.3	43.2	46.9	59.4	10.0	39.6	15.4	76.8	46.1	29.3	56.9	51.6	4.4	1.2	1.2	75.3	3.1	137.4	10.4	3.5	0.1	1.2	0.8	1.0	1.1	8.9	3.4	34.8	0.0	0.1	0.3	0.8	1.7	0.1	0.3	35.4	6.4	7.4	11.8	9.0	10.8	8.8	7.5	15.7	11.2	18.1	12.9	244.2	393.4	23.4	924.2	542.3	8.1	85.2	119.8	93.7	315.1	153.5	45.2	422.7	92.9	335.7	28.0	269.0	358.5	46.7	313.5	336.4	599.3	268.8	1139.0	91.5	324.9	12.7	414.0	194.0	35.3	30.8	267.2	305.5	814.9	19.0	337.1	35.8	392.9	289.2	270.1	93.5	18.0	200.5	784.5	74.2	30.2	526.5	569.5	18.5	345.1	767.5
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.6	2.4	3.1	5.5	1.2	0.2	0.0	0.3	0.2	0.1	0.0	3.5	0.1	0.2	0.1	0.3	0.9	0.1	1.0	0.8	2.0	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	0.1	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.7	0.1	0.5	0.4	0.2	0.2	0.2	6.7	0.1	6.9	0.2	0.4	3.9	0.8	0.3	1.5	0.3	0.2	0.9	24.0	0.2	0.8	1.3	1.7	0.3	1.6	2.6	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5	0.0	0.0	0.5	1.1	0.0	0.0	0.4	0.0	26.8	2.3	0.0	0.0	0.2	1.7	0.0	38.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.7
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328468-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 105.3;T-47d: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	19.3	7.5	39.8	11.7	36.4	8.0	13.9	10.3	102.4	22.7	16.2	9.8	10.9	11.5	19.4	18.1	22.2	13.7	21.0	17.2	62.3	18.0	12.8	14.5	16.6	11.5	21.0	50.9	18.4	10.4	11.6	13.3	27.5	13.0	26.0	14.3	11.2	36.2	37.9	18.4	17.1	21.1	15.3	16.5	15.8	38.6	12.0	11.0	4.4	14.2	12.5	36.3	15.4	21.4	7.8	7.2	18.9	8.2	15.3	6.9	3.6	9.4	7.4	5.8	105.3	17.9	21.3	14.8	8.6	6.8	8.1	9.1	18.2	6.0	22.2	11.0	10.0	13.2	7.9	2.3	6.0	8.1	11.8	5.8	20.2	16.2	5.6	17.2	10.9	27.5	11.1	13.9	12.6	7.2	14.7	5.5	8.6	4.5	19.7	4.3	3.8	0.3	7.1	21.3	10.2	7.0	12.6	8.1	4.8	10.0	36.4	4.8	0.3	34.6	5.1	25.5	11.6	67.0	30.0	3.5	38.2	7.2	9.1	28.1	18.1	11.9	5.0	4.7	2.4	5.4	18.9	6.8	13.0	6.0	8.2	6.9	7.8	5.4	6.1	5.0	4.4	1.4	3.5	10.9	15.3	7.7	7.2	1.4	3.6	39.8	36.4	10.3	102.4	62.3	18.0	21.0	50.9	13.0	11.0	41.7	27.4	50.6	46.8	87.3	192.0	49.2	163.1	29.4	48.9	34.9	68.7	270.0	53.0	48.7	1.6	54.7	57.7	23.3	112.7	251.2	186.2	38.4	292.9	75.1	64.5	104.9	29.9	81.6	115.9	4.5	88.1	61.6	62.4	25.2	66.7	78.4	77.9	34.8	221.3	42.6	34.0	32.3	148.3	3.9	34.7	81.2	214.1	67.1	38.3	32.9
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.6	3.1	0.4	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.2	3.7	1.7	1.3	0.0	1.2	2.2	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.6	0.2	0.9	0.0	0.0	2.0	0.1	2.8	1.4	2.9	0.0	3.1	0.6	0.8	1.1	2.4	0.9	3.9	0.0	1.3	1.1	0.8	0.7	2.9	0.1	10.2	0.0	0.6	3.9	0.2	0.1	0.0	0.8	0.1	0.0	9.5	7.7	0.4	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3	3.0	1.7	0.8	9.2	0.5	16.4	2.2	2.5	4.0	4.5	7.0	0.0	4.3	21.6	19.4	0.1	0.0	0.7	0.0	0.4	2.5	0.9	15.7	0.0	0.0	1.0	17.5	0.0	1.3	0.3	0.0	0.6	0.3	3.3	0.0	1.0	7.3	10.7	0.0	0.0	0.6	1.9	0.0	0.7	2.4	1.3	1.6	5.7	0.0	0.6	44.3
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923892-176002839	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Ciliated cells: 16.0;Collecting duct cells: 15.7;Extravillous trophoblasts: 15.2;Hofbauer cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 60.1"	"Low region specificity"	"Detected in all"							HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	14.2	10.8	13.4	8.4	16.0	29.4	11.3	12.9	26.5	15.0	13.3	13.4	7.1	8.6	11.9	7.7	15.1	8.2	9.1	13.6	13.8	16.1	9.8	16.3	8.1	7.6	19.9	14.2	12.8	6.4	16.8	22.8	9.4	21.1	12.0	11.9	10.1	8.6	10.1	33.5	13.5	8.4	11.3	26.2	6.6	8.9	25.4	14.6	16.4	10.3	14.8	8.7	12.2	15.1	7.1	6.7	11.6	7.3	9.7	11.6	5.2	8.7	4.4	10.6	14.9	22.3	13.9	5.3	25.9	12.5	12.1	17.1	6.1	10.4	8.8	14.8	11.4	15.9	9.7	9.9	6.9	16.9	13.3	10.1	9.9	5.7	5.4	5.3	16.7	12.3	11.4	6.6	11.7	5.8	9.9	2.2	7.0	10.1	11.7	16.5	5.7	11.0	6.7	3.4	9.0	8.6	11.2	10.7	6.4	5.1	8.0	12.2	12.4	11.4	6.5	8.6	10.4	9.7	5.5	3.3	60.1	8.9	20.0	12.1	6.9	12.6	7.3	18.6	5.5	11.2	5.7	6.6	11.6	8.1	7.3	9.5	7.1	7.2	8.9	6.0	5.0	7.2	11.2	5.6	9.7	6.7	6.7	11.6	5.2	13.4	16.0	12.9	23.3	13.8	16.1	19.9	14.2	21.1	14.6	17.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	11.4	15.7	0.0	4.3	5.0	14.3	0.0	0.0	0.0	0.0	8.3	15.2	0.0	0.0	10.5	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	3.6	0.0	0.0	11.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 14.9;Basal glandular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.8	3.9	4.2	2.1	3.4	4.6	10.8	15.8	6.1	1.9	4.1	2.0	1.6	2.9	2.4	3.1	1.7	2.5	3.9	3.9	5.0	1.9	3.6	15.4	11.8	0.8	1.7	3.7	2.0	8.1	0.4	3.5	0.9	4.4	3.0	5.5	4.1	8.1	3.0	13.8	1.4	2.3	10.8	2.7	1.1	4.5	2.7	2.5	0.0	9.9	1.9	1.1	4.7	6.6	0.0	0.1	0.8	0.8	0.0	7.4	0.7	3.7	5.5	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.0	2.7	0.0	9.9	0.0	1.1	0.0	0.0	0.1	3.1	4.7	9.0	5.3	3.1	4.0	0.6	0.0	0.0	0.0	0.0	1.7	1.4	0.4	10.6	0.0	0.8	4.5	0.0	1.8	0.0	12.0	12.1	0.0	2.5	0.0	3.3	1.5	0.2	0.0	11.0	0.3	9.6	0.1	0.0	3.5	0.2	0.1	0.2	0.0	5.8	1.2	4.7	0.0	2.6	4.1	2.4	0.0	0.8	0.0	4.5	0.0	7.4	0.0	2.0	1.5	0.1	0.0	1.1	1.6	0.8	0.0	0.0	0.0	0.7	0.7	4.2	3.4	15.8	6.1	5.0	1.9	1.7	3.7	4.4	2.5	6.0	14.9	0.0	13.8	1.3	3.6	3.2	0.0	0.0	10.3	1.8	0.0	0.5	1.7	2.4	1.3	1.9	5.8	0.0	3.8	0.0	2.8	4.7	5.8	4.0	2.9	1.6	1.2	3.1	3.7	0.4	0.9	3.8	3.3	0.0	2.3	6.1	4.6	3.1	1.4	0.7	0.2	0.0	3.1	1.7	4.1	0.1	0.3	1.3	2.5	9.8
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947185-110964079	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	9.0	11.2	13.7	15.4	15.5	5.9	20.7	15.6	14.7	7.9	7.5	6.6	7.8	7.0	8.1	23.9	8.1	9.6	6.7	16.1	12.7	13.3	9.6	16.7	11.9	17.6	10.5	7.5	18.4	6.9	5.8	17.5	25.1	10.3	9.9	7.6	7.3	8.6	9.2	20.5	10.6	8.4	6.0	12.4	14.0	8.1	27.7	10.1	16.8	12.6	10.2	19.0	10.0	28.5	21.0	11.4	21.4	8.2	18.0	19.4	8.4	12.0	5.3	10.2	6.9	4.7	7.7	11.5	7.4	8.6	13.1	10.6	13.4	15.3	9.2	10.7	5.6	14.0	7.9	4.8	4.4	15.9	16.7	5.7	10.2	5.4	13.8	14.0	19.2	12.5	4.8	12.4	9.0	15.9	5.5	7.0	9.9	31.8	42.6	8.7	4.0	1.9	15.3	15.3	7.4	12.3	12.8	16.7	11.2	3.4	6.3	8.5	9.4	0.0	12.9	21.6	6.5	10.6	31.3	4.9	11.6	0.4	13.6	6.0	19.8	6.8	17.4	6.6	22.0	20.0	13.0	5.7	12.3	15.3	6.3	19.4	21.0	12.1	15.8	11.4	15.5	13.5	18.5	21.4	18.0	8.2	10.3	11.1	8.4	13.7	15.5	15.6	14.7	12.7	13.3	10.5	7.5	10.3	10.1	11.9	6.7	21.2	56.0	12.8	19.8	20.2	10.2	21.4	10.3	8.7	17.7	16.2	13.3	13.9	9.9	18.0	11.4	0.0	17.5	26.9	16.6	45.6	8.1	25.1	12.1	14.3	10.9	13.5	8.5	8.9	14.7	18.8	30.4	19.0	10.4	26.9	17.0	13.9	13.1	7.9	30.3	12.9	23.0	32.1	49.1	15.4	31.6	28.7	9.8	43.3
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073209-113132260	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		510000	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	8.3	7.7	10.1	11.4	10.6	4.7	10.7	15.6	10.0	11.6	9.2	16.1	6.0	10.8	15.1	14.9	7.8	9.2	8.2	7.3	9.3	9.1	9.2	6.3	8.0	9.7	13.0	6.7	15.0	8.5	13.4	11.6	10.1	9.2	9.3	8.6	14.6	9.0	11.2	13.1	16.6	9.5	8.9	11.6	10.1	8.1	9.4	13.4	10.4	12.6	5.0	10.7	8.6	10.7	4.4	2.6	4.9	2.5	4.8	3.9	1.7	4.3	2.4	6.7	5.0	6.4	6.6	3.8	2.8	4.2	3.4	5.8	3.5	2.8	4.5	5.0	3.5	1.9	5.0	4.6	3.0	5.7	3.1	2.7	4.8	4.5	1.7	6.5	5.7	2.3	6.5	5.5	5.4	7.1	5.3	4.4	6.3	5.7	4.3	4.2	3.2	5.7	6.1	6.2	1.8	4.0	5.3	8.4	2.2	3.3	2.9	4.8	3.8	5.0	3.3	6.4	5.7	2.5	6.4	6.6	6.4	3.4	8.7	4.5	4.7	2.2	4.6	6.8	3.6	5.9	4.9	2.5	1.5	3.1	2.0	3.5	3.1	3.4	3.2	1.9	4.4	3.9	3.6	1.7	4.8	2.1	2.6	2.6	1.7	10.1	10.6	15.6	10.0	9.3	9.1	13.0	6.7	9.2	13.4	0.0	13.3	5.9	2.5	7.4	19.1	8.1	12.7	12.0	6.8	14.0	35.3	5.8	0.0	3.2	0.9	6.3	9.9	0.0	2.3	3.7	5.7	4.7	5.7	4.3	4.1	17.5	5.2	6.2	8.5	0.0	17.0	5.9	6.8	1.8	7.1	27.0	2.7	7.0	15.2	4.1	21.3	0.0	4.2	8.6	14.9	5.8	4.5	7.0	8.3	3.4
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431453-76560167	"Disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 28.2;Hofbauer cells: 48.4;Proximal tubular cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 23.6;myeloid DC: 27.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;HMC-1: 14.3;NB-4: 26.5;SK-MEL-30: 37.3;THP-1: 19.8;U-937: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	12.7	35.3	4.6	4.7	6.4	13.2	6.1	2.6	3.6	7.1	4.6	8.2	12.5	3.1	12.5	34.9	5.3	5.7	8.9	13.2	3.7	5.1	11.5	19.1	13.1	5.6	7.4	3.1	8.6	21.0	6.8	9.7	6.9	6.7	8.3	4.0	19.8	10.7	8.8	2.2	2.3	4.5	5.3	8.1	7.8	8.6	5.8	5.0	0.1	13.2	6.9	3.9	5.5	5.3	0.0	27.3	8.7	23.6	2.6	0.1	6.7	0.1	2.6	0.1	0.0	1.2	1.5	0.0	0.3	0.0	0.1	0.2	3.1	5.5	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.6	1.3	18.4	0.5	3.7	14.3	0.7	0.5	0.3	0.0	2.3	0.5	0.0	0.0	0.6	0.0	0.4	0.0	26.5	0.1	1.6	1.1	0.0	0.1	0.0	0.2	3.4	0.1	0.2	3.3	0.0	37.3	0.1	0.2	19.8	0.3	0.1	1.4	1.0	2.1	0.2	0.0	0.0	9.6	17.7	4.7	2.6	23.6	8.7	0.0	11.2	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.0	1.3	2.6	6.4	0.2	0.0	6.7	4.6	6.4	2.6	3.6	3.7	5.1	7.4	3.1	6.7	5.0	20.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	12.2	0.0	0.9	28.2	17.1	0.0	0.0	0.0	0.0	13.8	0.8	0.0	0.0	7.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	11.8	0.0	0.0	15.2	0.0	0.0	72.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128493-57213351	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 153.3;Leydig cells: 216.0;Peritubular cells: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.8;monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 83.1;ASC TERT1: 84.4;fHDF/TERT166: 36.2;HSkMC: 54.7;hTERT-RPE1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		88000000	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	77.8	12.0	19.8	21.5	21.3	6.1	27.7	28.1	25.3	31.4	19.7	11.9	9.0	17.8	26.9	18.2	19.2	21.0	24.1	26.0	18.6	10.4	6.3	31.4	24.7	5.5	13.9	15.6	56.9	8.8	8.5	8.0	29.4	17.1	21.4	9.5	20.0	14.8	17.0	11.3	15.7	14.2	22.4	14.3	11.3	11.8	11.1	15.4	0.3	13.2	9.3	3.1	22.9	39.4	0.0	2.8	0.1	7.6	0.0	0.2	1.9	1.2	2.3	5.1	4.0	83.1	84.4	15.3	14.0	18.1	4.6	4.5	4.3	2.0	0.0	1.7	36.2	1.0	5.5	0.8	1.4	1.6	0.1	0.2	0.0	2.7	9.0	11.4	0.0	2.4	54.7	0.5	10.3	1.2	42.1	0.2	0.1	0.0	0.2	14.4	0.2	0.0	0.0	5.8	1.7	1.4	0.5	28.8	0.2	0.3	0.3	0.2	2.8	3.1	0.1	2.2	7.4	0.4	0.2	0.2	16.2	6.0	9.0	0.8	0.1	0.0	0.0	28.4	0.0	3.1	0.0	7.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	1.9	19.8	21.3	28.1	19.7	18.6	10.4	13.9	15.6	17.1	15.4	11.9	9.6	3.7	11.4	21.3	25.5	12.1	20.4	5.3	11.4	1.8	0.0	65.3	0.0	7.8	1.6	5.8	72.1	0.0	1.6	42.2	117.6	4.4	5.8	153.3	72.0	7.9	4.1	16.0	118.9	3.6	216.0	50.7	27.0	3.6	14.3	130.1	9.9	18.6	173.2	2.2	3.8	38.8	44.2	1.4	2.2	14.1	105.3	0.9	20.9	10.2
LRP10	"DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087"	ENSG00000197324	"LDL receptor related protein 10"	Q7Z4F1	14	22871613-22881580	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000932			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA000932: AB_2281523"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (3.54e-7)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.55e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (3.06e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.14e-2)"	33.1	20.1	12.7	26.0	13.1	23.7	37.2	5.8	10.3	32.0	52.4	16.2	41.0	31.7	39.0	46.8	66.1	27.1	65.1	27.7	13.6	6.0	46.5	63.3	34.1	30.0	14.2	8.1	30.7	36.6	31.4	11.7	32.0	14.4	36.9	19.0	22.6	36.1	41.1	21.2	32.9	65.9	32.0	11.2	26.1	37.9	19.1	12.9	20.7	46.9	34.1	36.2	43.3	42.8	3.8	2.3	29.7	2.6	2.4	6.3	3.4	15.4	18.9	4.1	10.8	56.7	32.9	14.1	24.5	46.6	15.5	21.5	5.8	55.1	8.1	12.3	55.1	17.7	22.2	2.7	28.0	6.1	13.2	2.9	2.8	10.4	4.0	25.3	6.4	25.9	35.9	32.8	23.1	12.0	43.0	28.2	3.7	3.4	31.4	20.8	17.8	1.8	1.9	0.9	15.0	25.5	4.1	4.2	8.1	16.6	27.6	0.3	4.5	13.5	26.0	10.6	3.2	13.6	4.6	29.3	23.9	6.8	12.3	10.0	14.7	8.7	3.7	12.3	2.6	10.2	5.9	2.2	15.8	5.1	2.3	5.0	3.8	6.3	6.0	2.3	2.7	5.5	3.1	29.7	2.4	2.6	1.9	6.0	3.4	12.7	13.1	5.8	10.3	13.6	6.0	14.2	8.1	14.4	12.9	98.3	51.7	60.9	74.0	34.2	2.2	27.2	107.0	37.5	59.1	78.5	0.0	55.7	8.3	146.7	9.9	50.6	243.0	46.7	208.6	82.1	65.3	100.3	34.6	35.4	52.6	0.0	63.9	69.3	49.2	11.4	52.6	36.1	52.3	101.0	99.6	89.2	227.5	199.9	68.6	40.8	8.3	64.7	65.9	2.6	6.7	41.5	110.6	62.3	73.3	132.4
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8"	"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	6.8	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	20.1	4.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	19.4	11.8	0.5	0.9	0.3	0.1	0.0	0.0	0.0
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	9.4	10.3	11.9	15.0	11.9	9.5	26.5	14.3	22.3	10.4	10.5	15.1	5.0	11.0	13.7	8.9	11.5	10.6	11.3	9.7	12.4	8.2	9.4	8.9	10.0	12.2	15.3	16.0	11.2	17.5	16.9	13.5	8.4	12.7	15.6	7.9	9.4	16.8	12.9	9.8	17.6	10.6	12.7	9.2	11.9	11.0	9.6	12.1	9.7	13.8	6.2	9.8	11.9	9.4	10.6	9.8	4.7	8.6	13.1	10.3	8.7	9.6	19.9	5.4	8.7	5.8	4.7	7.7	8.7	3.8	7.0	6.0	8.8	11.8	7.9	9.2	6.4	4.3	10.6	8.4	8.6	3.2	10.5	19.4	11.7	21.2	3.6	5.4	5.0	9.7	5.7	7.4	7.0	3.5	5.8	6.0	9.1	15.4	9.5	6.8	11.9	18.3	6.5	4.4	8.5	28.8	15.7	4.5	11.1	4.2	8.5	14.7	8.2	13.3	10.7	6.2	3.3	16.4	5.5	6.4	12.0	21.3	10.6	12.7	5.3	3.1	9.8	11.3	11.6	7.3	1.9	8.6	1.8	10.3	8.1	10.2	9.0	7.7	9.6	8.4	10.6	8.6	7.0	4.7	13.1	6.7	9.8	7.2	8.7	11.9	11.9	14.3	22.3	12.4	8.2	15.3	16.0	12.7	12.1	6.0	1.9	12.4	4.6	5.7	11.7	3.5	12.7	5.3	5.7	8.7	2.0	5.7	5.0	4.8	1.1	4.5	7.9	0.0	7.0	5.8	3.9	6.7	6.9	9.0	6.6	11.1	5.2	10.4	5.2	2.4	6.9	3.7	1.7	7.2	6.6	8.9	5.7	3.5	7.4	6.0	7.6	6.5	5.2	27.9	24.3	5.1	4.6	6.9	11.4	3.5
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.1	29.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 111.8"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 28.5;Early spermatids: 20.2;Hepatocytes: 14.5;Late spermatids: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	1.3	2.5	5.6	1.4	7.2	1.6	1.4	5.2	11.2	3.3	3.2	2.5	0.0	1.4	2.7	3.1	7.1	2.4	2.1	15.8	5.0	3.9	1.2	8.3	2.2	1.7	3.7	6.3	2.2	1.3	2.1	3.6	1.1	4.9	2.6	2.0	1.8	1.8	2.4	111.8	1.6	1.4	3.5	2.0	1.4	1.6	3.5	1.9	1.6	2.6	14.3	3.1	2.2	4.8	0.9	2.6	0.0	1.0	1.1	4.1	1.1	14.6	11.3	7.3	15.6	4.1	3.3	0.0	1.9	6.6	5.0	4.7	9.6	15.3	2.9	7.8	1.4	15.6	5.3	7.1	10.6	3.5	8.2	2.3	1.7	2.5	22.0	4.5	4.2	1.4	1.3	3.2	6.9	2.3	4.9	9.7	19.4	2.1	4.7	4.6	2.3	16.0	3.5	2.4	11.0	25.7	13.4	4.2	8.3	6.5	1.5	18.5	8.0	1.2	1.3	5.1	1.9	1.9	4.3	5.9	4.0	34.6	5.3	4.5	7.6	13.4	4.8	6.5	17.4	0.8	0.0	0.9	0.0	1.7	1.0	1.4	0.9	1.3	1.9	2.6	0.0	4.1	1.5	0.0	1.1	0.7	0.4	0.2	1.1	5.6	7.2	5.2	11.2	5.0	3.9	3.7	6.3	4.9	1.9	0.0	5.8	0.0	0.5	1.3	8.0	28.5	2.5	0.0	1.2	0.0	3.9	0.1	0.0	3.5	20.2	2.7	0.4	0.0	4.2	0.1	2.0	0.7	0.0	14.5	0.4	1.6	5.2	1.3	0.3	32.8	2.8	0.0	1.7	1.0	1.3	7.8	4.1	1.7	1.4	1.4	1.7	0.0	1.7	4.3	4.5	0.5	0.0	0.8	1.9	0.6
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132379918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 52.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 394.8;Late spermatids: 739.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;hTERT-RPE1: 18.9"	"Low region specificity"	"Detected in all"							"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	2.1	2.8	8.1	1.5	8.4	1.0	4.1	2.2	8.9	3.6	2.1	6.1	7.5	2.0	3.8	5.6	1.6	10.5	3.5	2.2	6.6	5.4	4.4	2.4	3.1	1.9	4.3	7.3	5.4	3.1	7.5	5.8	2.1	6.5	4.1	2.1	4.8	3.1	4.0	1.2	2.1	2.6	3.4	3.5	3.3	3.0	52.9	4.5	0.7	5.1	1.0	1.2	2.5	1.8	4.7	7.8	4.4	6.8	3.1	2.8	2.7	2.5	4.7	10.3	14.5	9.1	9.3	1.0	2.5	8.1	4.2	3.8	0.8	5.2	1.4	1.5	5.8	3.2	1.8	2.3	1.2	2.6	2.9	2.0	0.3	3.3	2.4	6.5	1.1	1.7	4.0	8.0	4.2	5.7	18.9	3.0	3.6	0.8	1.0	3.2	4.3	2.2	3.2	2.9	1.8	1.6	1.9	1.7	0.8	7.5	0.6	1.8	5.2	1.2	0.8	3.3	2.2	2.3	2.6	3.9	1.7	2.1	3.8	1.5	0.7	0.3	0.8	7.7	2.2	1.0	4.4	6.8	1.1	1.7	5.7	1.3	3.4	1.1	1.0	7.3	4.7	2.8	1.6	0.5	3.1	3.6	7.8	0.7	2.7	8.1	8.4	2.2	8.9	6.6	5.4	4.3	7.3	6.5	4.5	8.9	10.9	1.3	2.4	2.5	7.8	4.4	7.6	48.2	7.9	3.5	9.8	3.1	16.6	5.9	394.8	4.5	1.7	0.0	4.6	1.0	5.2	2.9	8.1	2.1	6.6	7.9	5.2	14.7	8.0	739.5	4.4	7.1	6.8	7.2	1.9	8.9	3.3	0.0	11.0	11.9	17.7	6.5	2.3	75.2	20.4	2.8	1.1	4.9	3.3	1.4
LRRC41	MUF1	ENSG00000132128	"Leucine rich repeat containing 41"	Q15345	1	46261196-46303608	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051941	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA051941: AB_2681669"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.66e-9)"	"unprognostic (6.09e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-2)"	24.2	27.6	19.7	14.6	20.3	14.1	23.3	26.0	31.9	29.9	23.6	25.7	32.6	18.4	35.0	25.1	29.1	36.2	25.2	25.7	19.5	17.3	21.8	27.6	21.5	16.4	17.5	20.2	38.3	30.6	37.4	29.4	45.2	17.7	28.8	16.6	25.4	27.0	36.7	32.2	26.3	25.1	29.4	15.3	19.1	22.6	26.1	17.9	30.4	31.7	21.8	24.1	29.5	25.1	14.8	29.1	16.4	20.1	19.4	16.9	17.0	14.3	10.5	18.2	19.7	24.6	30.9	17.1	14.9	27.7	21.7	14.6	8.8	4.8	9.1	19.9	35.3	29.1	11.2	17.7	21.1	11.1	11.0	19.2	14.8	12.1	12.8	34.6	9.1	7.9	37.8	28.5	20.3	24.5	31.3	27.7	17.3	14.7	9.4	23.7	9.1	12.1	12.2	27.2	9.4	10.3	10.1	9.4	14.7	24.3	17.6	17.0	19.3	20.1	20.0	24.0	29.3	11.8	27.8	18.2	19.1	8.7	15.9	14.2	15.5	7.2	4.0	17.9	7.0	13.2	16.4	20.1	9.2	14.3	19.0	15.1	12.7	15.4	15.9	29.1	14.8	16.9	13.0	2.0	19.4	12.7	16.6	14.9	17.0	19.7	20.3	26.0	31.9	19.5	17.3	17.5	20.2	17.7	17.9	17.9	24.3	13.3	31.1	25.2	23.2	10.9	17.8	14.7	14.8	33.2	23.6	74.9	33.2	37.3	20.8	17.5	29.6	23.3	26.2	40.3	30.1	28.8	6.9	25.6	31.5	44.5	35.2	27.0	17.7	13.8	32.2	15.8	10.1	23.4	26.7	27.3	26.9	20.1	31.1	24.0	26.3	38.8	32.0	27.4	33.6	25.3	119.2	19.8	26.6	28.1
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	15.8	30.1	12.7	10.7	14.3	10.0	15.4	13.9	14.8	15.4	13.3	16.3	11.3	9.6	14.5	11.3	14.6	11.0	9.7	9.6	12.9	9.6	19.2	14.1	10.9	12.7	15.9	10.5	19.7	13.1	21.0	9.8	12.1	14.4	15.1	9.9	13.2	11.6	12.1	9.2	13.8	12.2	15.5	22.9	14.6	10.0	7.9	15.5	27.9	18.3	9.0	11.0	17.2	16.1	5.7	6.4	3.5	5.8	3.7	8.4	3.4	24.8	8.8	6.0	7.7	14.0	13.4	9.6	8.9	7.8	9.6	12.0	8.2	7.7	16.3	11.2	9.6	13.6	10.9	11.1	8.8	18.3	6.3	6.9	17.4	12.0	9.5	9.4	28.1	9.0	9.8	11.3	11.6	15.0	6.2	5.6	10.5	9.8	21.0	10.3	11.3	22.0	9.0	6.1	11.0	16.1	4.9	16.2	10.5	7.3	9.2	7.7	10.3	15.7	10.8	22.3	4.4	11.8	12.8	8.3	16.1	17.9	10.7	11.3	18.1	20.8	34.6	16.2	21.3	13.4	2.4	5.8	2.3	4.4	5.1	6.4	5.4	5.5	5.6	5.5	5.7	8.4	6.2	3.5	3.7	3.9	6.4	5.4	3.4	12.7	14.3	13.9	13.5	12.9	9.6	15.9	10.5	14.4	15.5	68.5	57.6	28.8	17.3	45.2	28.0	15.5	28.1	37.5	38.7	17.4	53.0	14.2	10.0	19.4	6.7	20.4	18.0	23.3	26.5	21.7	39.0	27.8	33.6	31.0	24.2	23.8	16.1	25.2	43.8	4.0	51.8	30.3	32.1	8.2	22.2	43.2	26.4	14.4	68.6	33.1	20.4	25.8	33.5	17.4	24.0	49.8	11.3	27.7	29.0	14.4
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 22.2;Muller glia cells: 39.6;Proximal tubular cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.7;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	4.2	1.9	7.5	1.4	6.0	3.0	2.6	3.8	6.6	3.5	3.8	2.6	11.5	1.4	2.4	5.8	3.4	3.3	9.8	4.3	5.5	9.1	6.0	3.4	1.7	1.7	7.8	4.0	7.3	7.2	1.4	1.5	2.3	4.1	6.9	2.0	4.9	7.5	15.0	10.7	4.3	8.2	6.7	7.0	2.7	2.6	8.3	0.5	0.0	8.6	3.0	2.1	5.5	2.7	0.0	0.3	2.7	0.4	2.0	0.2	0.0	0.1	4.2	0.0	2.3	0.6	1.7	0.4	0.6	0.7	1.5	1.6	3.1	0.0	0.0	1.0	1.2	1.2	4.7	0.4	2.3	0.0	1.3	2.8	0.3	0.6	8.3	4.2	0.0	0.0	0.0	1.8	1.5	0.2	0.9	1.1	0.0	0.4	0.0	0.1	7.4	0.0	1.5	2.1	5.0	1.7	0.0	0.2	0.0	1.9	0.4	2.2	6.6	2.2	0.7	0.6	0.5	0.0	0.7	2.4	2.5	1.6	0.9	0.8	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	7.5	6.0	3.8	5.6	5.5	9.1	7.8	4.0	4.1	0.5	11.9	5.1	0.0	2.0	0.0	2.2	3.1	17.8	0.0	0.0	7.0	0.0	1.7	10.0	8.0	1.1	0.8	14.2	0.0	7.9	0.3	1.8	7.4	0.0	22.2	1.0	1.6	1.2	1.3	1.6	5.8	11.8	0.5	0.0	0.0	5.5	39.6	4.2	3.4	9.2	38.2	0.9	0.0	4.1	0.5	0.7	0.0	0.9	0.0	4.5	1.0
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 34.1"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;JURKAT: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.8	1.3	0.9	0.9	2.7	0.2	0.9	0.3	1.5	0.8	0.4	1.1	0.1	0.3	0.4	1.2	0.6	2.8	0.6	0.6	1.0	1.1	3.5	1.7	1.6	0.9	2.5	1.4	2.5	0.6	2.1	7.2	0.3	2.4	0.6	0.3	0.6	0.8	0.6	0.4	0.3	0.4	0.2	1.3	1.6	0.5	34.1	1.0	1.4	1.9	0.0	0.8	0.5	0.4	3.9	1.1	1.9	1.1	1.1	4.0	0.9	0.3	1.5	0.2	0.6	1.6	0.6	1.0	0.9	0.6	1.3	1.4	0.2	2.1	2.1	1.9	0.2	12.2	0.2	3.3	3.0	1.6	5.2	0.0	1.9	0.5	1.0	0.2	3.4	1.1	1.1	1.6	2.2	0.8	0.5	0.6	7.3	1.6	3.0	2.1	0.0	1.3	0.5	1.7	3.7	1.0	1.6	1.2	2.1	1.9	0.2	1.6	1.1	0.2	0.2	4.6	0.3	1.3	1.9	0.2	0.2	1.1	0.8	1.8	3.1	1.1	1.7	2.3	0.3	1.6	0.0	0.2	1.9	2.3	1.1	2.9	3.9	2.6	2.9	0.3	2.0	2.5	3.5	0.0	1.1	0.3	1.1	4.0	0.9	0.9	2.7	0.3	1.5	1.0	1.1	2.5	1.4	2.4	1.0	0.0	1.0	0.0	1.0	1.0	0.8	0.4	0.0	36.1	1.2	0.0	3.9	1.4	11.6	1.4	144.3	0.1	0.0	0.0	1.6	1.5	0.2	1.2	0.0	1.0	1.1	0.0	2.9	0.0	0.6	74.3	1.7	0.4	0.0	1.0	0.9	1.1	0.7	0.0	1.4	4.2	0.6	0.0	0.4	156.8	22.6	0.1	0.2	0.7	0.6	0.7
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.8	26.5	12.7	1.6	21.2	1.1	2.1	20.0	23.8	3.6	1.4	1.9	0.8	1.0	1.0	3.1	1.9	1.3	1.6	9.0	10.4	10.7	0.9	2.7	8.7	3.6	7.7	13.0	7.9	1.5	0.7	4.9	6.7	9.0	4.7	1.6	0.8	1.9	6.4	4.0	0.8	2.1	1.0	2.9	2.0	0.9	16.4	6.3	8.8	22.3	0.0	4.4	1.6	1.3	0.2	0.0	0.1	0.0	0.0	20.3	4.0	0.0	0.0	14.7	1.8	6.8	2.9	0.0	8.3	18.2	0.8	0.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.9	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	26.4	0.0	0.0	0.0	8.5	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.0	20.3	18.4	0.1	0.0	0.0	0.0	0.2	4.0	12.7	21.2	20.0	23.8	10.4	10.7	7.7	13.0	9.0	6.3	0.0	7.0	0.0	0.0	0.0	33.5	12.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.3	9.6	0.0	1.1	0.0	0.7	3.2	1.7	1.3	0.0	3.4	52.0	0.0	1.7	0.0	0.0	10.8	0.0	0.0	15.2	0.0	3.9	0.0	1.2	0.9	0.5	0.1	0.3	3.2	0.0	0.1
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686402-62689899	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 17.2;Leydig cells: 25.0;Melanocytes: 32.1;Peritubular cells: 16.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;ASC TERT1: 19.1;HHSteC: 14.9;HSkMC: 8.0;LHCN-M2: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	15.7	4.8	0.2	5.0	0.6	0.6	11.6	0.6	0.9	27.2	12.1	0.1	3.5	2.1	27.0	14.0	19.1	11.4	6.7	9.3	0.3	0.2	0.8	0.2	3.1	1.8	0.3	0.6	24.9	2.1	0.4	1.2	4.4	2.2	10.8	2.5	17.8	3.2	6.7	17.0	6.8	4.3	15.1	1.9	0.3	5.7	8.5	0.0	0.0	3.5	10.4	2.4	18.2	11.2	0.9	0.6	3.3	0.8	0.8	0.6	0.1	0.0	0.1	0.2	0.2	5.7	19.1	0.2	2.0	2.9	0.2	1.0	0.2	0.1	0.1	0.2	3.2	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.1	14.9	0.2	0.1	8.0	0.2	0.4	0.0	0.1	0.0	0.3	0.2	0.1	9.7	0.1	0.2	0.4	0.4	0.1	0.1	0.1	1.3	0.3	0.0	0.1	0.6	0.2	0.3	0.2	0.6	0.1	0.1	0.2	0.2	1.8	0.1	2.0	0.1	0.2	0.2	0.2	1.1	0.2	0.0	0.9	0.8	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.1	0.9	0.5	0.6	3.3	0.8	0.4	0.6	0.2	0.1	0.2	0.6	0.6	0.9	0.3	0.2	0.3	0.6	2.2	0.0	0.0	2.6	0.0	1.9	6.0	1.9	1.1	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.1	17.2	0.8	1.1	0.0	0.3	1.6	1.2	1.3	1.2	0.0	25.0	1.5	32.1	0.0	0.1	0.3	0.0	0.0	16.3	0.1	0.7	0.0	1.7	0.4	0.2	6.0	0.1	0.0	0.0	1.0
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 137.5;Late spermatids: 100.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	100.5	8.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.3	0.0	0.3	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397892	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	15.0	11.9	19.8	17.7	20.2	12.6	21.1	11.1	20.9	12.3	20.8	9.5	16.7	11.9	14.2	19.1	15.0	11.4	15.7	28.2	18.6	19.7	17.3	21.3	11.8	27.3	17.7	14.4	14.6	18.6	12.1	16.4	13.2	17.0	16.2	11.0	13.8	16.9	19.5	82.0	10.1	13.0	17.8	12.5	21.1	14.5	12.1	10.3	10.3	18.9	22.0	26.8	19.1	25.0	73.8	45.9	66.7	50.5	19.1	31.0	49.9	18.9	29.0	10.9	29.2	25.8	25.3	11.3	17.1	25.1	27.5	21.1	12.9	18.2	44.9	23.7	23.1	20.4	10.5	18.5	22.2	18.3	30.4	22.1	22.5	17.2	30.3	31.4	16.9	33.1	21.2	19.8	24.7	17.6	15.0	28.1	25.8	20.7	22.0	19.3	33.7	18.8	19.3	28.1	23.6	30.1	14.3	10.5	30.3	26.5	11.6	14.0	10.5	13.9	17.8	41.5	18.4	9.2	14.6	18.6	12.6	17.4	32.7	26.6	29.1	39.1	35.1	25.2	26.0	28.3	35.7	50.5	61.4	25.6	48.7	27.8	70.6	25.5	26.5	36.0	73.8	23.1	25.0	66.7	19.1	44.9	45.9	31.0	49.9	19.8	20.2	11.1	20.9	18.6	19.7	17.7	14.4	17.0	10.3	11.9	15.6	88.7	31.6	28.6	15.4	45.2	15.3	5.3	11.4	43.6	5.9	48.1	119.3	34.9	7.6	35.4	23.8	46.7	41.3	51.7	42.8	37.2	40.4	54.6	93.0	17.5	27.1	30.1	72.9	16.5	35.9	85.7	49.0	44.1	20.4	20.9	37.9	34.5	44.2	91.1	12.7	12.9	49.5	8.4	23.0	35.0	33.4	57.3	25.4	24.3
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743695-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	3.4	3.7	10.8	3.6	4.7	2.9	6.4	13.6	11.8	5.3	8.9	1.9	4.9	4.6	9.1	3.2	4.7	4.6	4.7	2.4	5.1	6.1	2.8	2.7	3.1	3.9	4.7	9.2	7.3	3.7	5.0	4.2	4.2	5.8	9.2	5.4	2.7	3.4	10.2	2.5	4.4	3.8	21.0	3.3	3.1	4.1	9.0	1.4	1.9	2.6	2.6	4.2	15.0	8.0	1.0	0.6	1.6	0.9	2.7	1.8	0.5	3.7	2.7	7.6	8.0	3.5	4.4	6.6	5.2	2.3	4.4	5.8	8.2	3.8	8.3	6.1	3.0	3.1	4.4	9.7	5.7	4.8	5.9	9.2	3.4	9.8	5.2	1.2	10.1	4.3	2.0	3.8	5.3	5.4	5.0	7.1	6.9	6.4	4.5	4.7	3.6	5.6	5.9	2.3	3.1	8.4	9.1	9.5	3.4	2.2	3.5	4.5	7.1	3.4	4.6	4.6	5.9	3.9	6.3	5.1	8.6	3.4	5.0	8.1	3.7	2.4	8.3	3.4	10.6	3.8	1.6	0.9	0.5	1.4	0.7	1.8	0.7	1.8	1.4	0.6	1.0	1.6	1.5	0.7	2.7	0.4	0.4	1.2	0.5	10.8	4.7	13.6	11.8	5.1	6.1	4.7	9.2	5.8	1.4	6.0	5.5	1.3	3.2	3.2	29.9	2.0	0.0	2.7	4.5	3.5	5.9	1.4	0.0	1.5	9.0	2.7	2.1	0.0	0.7	3.6	3.3	2.9	1.1	1.8	1.9	7.9	2.9	4.9	3.7	11.1	1.4	4.5	0.0	0.0	1.7	2.0	1.5	3.5	3.9	1.3	7.3	0.0	3.4	7.2	9.1	3.8	1.0	2.9	3.9	3.7
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.6	11.9	12.8	13.2	6.0	7.0	32.7	12.2	8.1	15.6	15.0	13.4	11.6	16.2	10.1	8.4	11.0	6.9	14.4	11.8	15.4	15.3	17.9	17.1	17.2	12.8	3.1	19.1	12.5	5.2	8.6	15.6	6.7	7.0	8.0	14.2	18.4	13.0	11.5	16.8	20.2	26.1	22.2	16.5	16.2	11.2	15.9	17.8	14.5	15.2	7.2	11.7	13.9	19.5	11.3	15.4	22.5	24.4	7.2	10.0	16.0	12.1	20.7	9.2	26.9	30.5	12.7	18.8	14.2	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9	62.5	87.7	130.3	102.5	86.8	44.5	230.9	170.7	87.0	91.0	120.4	17.7	322.3	411.1	178.6	266.0	108.5	137.9	70.0	230.7	336.7	102.8	94.5	135.1	199.8	207.0	52.4	100.7	114.8	112.2	107.8	129.8	142.9	92.8	201.0	161.2	94.1	180.4	182.4	131.5	513.1	53.0	103.5	91.2	226.0	285.5	88.3	266.3	100.1	174.8	132.7
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184032-118192824	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	27.5	20.8	16.8	30.8	19.7	39.7	27.1	33.1	25.9	18.5	20.1	12.8	18.8	20.6	23.0	25.4	26.2	19.3	16.2	25.1	19.1	10.1	20.2	19.9	23.1	34.1	19.8	17.2	22.9	27.0	13.2	28.3	16.8	20.1	22.3	22.8	13.6	24.5	21.2	21.4	21.9	26.2	23.6	28.3	33.8	22.3	21.0	20.2	30.0	24.6	23.2	38.2	22.1	21.6	29.8	40.6	22.0	28.2	18.2	35.3	16.2	14.7	9.8	22.5	17.1	8.2	13.3	9.2	16.1	14.0	11.1	14.5	8.0	15.5	30.6	33.6	8.3	21.6	10.5	13.5	10.4	11.8	15.8	14.5	20.4	20.6	15.9	18.3	26.5	23.6	12.0	12.7	13.6	12.7	10.8	11.3	23.2	21.2	30.5	13.8	6.7	46.8	66.8	20.4	12.9	15.0	14.8	13.3	21.2	11.6	9.9	13.4	17.1	14.3	36.4	30.8	19.4	7.6	29.7	9.3	17.8	10.1	20.9	20.0	26.1	18.5	35.4	13.1	32.5	22.7	22.0	21.0	19.1	29.0	28.2	28.1	29.8	32.2	35.3	22.4	26.5	31.2	31.7	7.0	18.2	26.6	40.6	31.4	16.2	16.8	19.7	33.1	25.9	19.1	10.1	19.8	17.2	20.1	20.2	23.8	61.2	138.3	86.7	0.0	39.3	40.2	61.1	66.9	64.8	59.3	45.2	106.7	76.3	84.3	27.9	60.3	67.5	70.0	148.8	162.8	58.6	85.5	99.3	65.7	119.9	39.7	83.0	72.4	145.9	11.0	90.0	92.8	0.0	140.7	82.5	44.7	124.3	90.0	71.5	76.7	38.2	84.1	22.3	105.0	109.7	0.0	101.0	138.4	90.9	91.2
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 197.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.5"					"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.5	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.5	0.0	1.1	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.5	0.0	0.8	1.0	0.4	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9	0.0	1.1	0.0	0.1	0.9	0.1	3.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	41.7	0.0	0.9	0.0	0.2	0.1	0.3	0.3	4.7	0.0	0.1	0.0	0.0	0.0	0.0	197.4	1.1	0.0	1.7	0.0	0.4	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.7	1.6	1.0	1.1	0.1	0.0	0.6	0.1
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 215.6;Kupffer cells: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	21.0	22.6	31.8	18.9	27.6	30.9	13.9	8.8	26.1	17.4	20.3	16.5	18.2	47.1	11.1	13.1	13.7	27.7	26.0	35.9	23.8	16.1	25.2	17.3	14.5	20.0	16.3	9.1	10.5	29.4	30.3	24.0	29.5	79.5	34.5	27.6	10.5	8.3	25.1	14.4	23.9	28.0	37.0	25.1	30.7	22.4	23.7	27.1	32.0	26.8	16.5	19.5	17.8	20.8	19.1	25.5	25.9	11.2	12.3	7.4	12.5	10.5	9.5	11.2	19.4	21.8	5.2	16.5	5.8	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5	35.7	107.1	87.8	57.2	46.0	19.4	23.4	17.8	48.2	91.0	36.6	31.4	27.0	63.0	34.2	44.9	33.1	22.4	0.0	24.3	24.3	27.5	27.6	7.0	18.1	215.6	11.1	20.7	47.3	278.8	8.1	33.9	139.0	20.3	38.7	40.9	32.1	23.4	24.6	38.5	53.1	58.0	6.5	18.5	45.1	12.5	65.5	17.4	34.8	53.6	42.1
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell type enhanced"	"Detected in some"	7	"Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.5	4.4	1.9	1.8	0.4	0.6	7.7	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	1.9	15.9	1.3	2.7	1.0	4.0	4.9	2.2	3.5	1.6	0.5	3.6	4.2	0.5	3.6	2.0	2.3	1.2	0.6	5.8	2.8	3.6	0.6	4.8	1.9	3.8	1.0	0.1	5.4	7.9	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	2.1	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.3	5.2	0.5	6.1	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4	0.0	0.0	0.0	3.0	0.2	0.2	0.0	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.0	1.2	0.1	0.0	0.2	0.0	0.8	0.6	3.2	1.7	1.3	2.2	0.0	0.3	0.2	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.7	0.2	0.1	0.2	0.0	0.6	0.9
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843344-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	20.0	20.6	15.6	19.5	26.2	39.3	26.7	19.4	26.0	14.6	16.5	11.1	17.9	13.8	21.2	14.7	21.2	18.0	11.3	15.7	25.1	10.9	14.4	29.0	18.9	21.2	21.0	17.1	20.6	20.9	13.3	19.7	17.3	17.4	16.3	18.9	8.0	16.6	18.5	52.0	23.5	17.2	20.7	18.5	20.8	18.3	17.5	18.1	15.0	16.1	26.4	21.8	16.6	25.5	17.3	18.4	4.1	12.9	21.2	16.1	8.3	11.7	11.0	13.1	29.1	9.7	11.9	15.2	18.3	13.5	20.3	16.2	17.8	6.1	24.8	14.8	16.5	22.3	13.3	21.8	17.9	28.4	14.2	21.3	49.0	12.6	27.3	17.2	60.2	28.5	13.3	13.2	22.5	24.8	8.4	14.0	14.5	46.5	16.5	15.6	19.8	20.5	25.7	15.5	13.5	12.2	17.8	24.8	11.1	15.0	16.4	11.6	14.0	18.7	15.5	17.0	12.5	8.7	38.6	12.6	13.0	15.0	28.9	33.5	20.6	25.3	33.7	13.0	31.6	18.2	1.2	10.1	4.1	12.1	12.9	13.1	17.3	12.7	13.0	15.2	14.3	14.1	16.1	0.3	21.2	11.0	18.4	10.9	8.3	15.6	26.2	19.4	26.0	25.1	10.9	21.0	17.1	17.4	18.1	6.0	28.5	25.1	16.5	22.8	9.2	21.2	10.2	29.4	30.7	7.0	2.0	22.4	11.6	22.5	19.1	16.8	7.4	0.0	24.9	25.7	22.1	9.1	24.3	17.3	24.9	11.1	18.9	11.1	11.1	6.2	23.9	21.1	5.0	37.9	11.7	9.9	24.3	8.6	25.8	12.4	8.7	6.5	15.6	50.2	65.1	28.1	13.6	16.6	16.4	15.6
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	23.8	24.5	30.4	26.5	30.9	25.3	24.0	42.6	30.0	21.9	20.1	29.9	25.8	21.3	29.4	37.7	15.5	19.2	24.5	12.7	34.1	26.5	26.9	19.9	18.8	31.0	33.1	24.3	29.3	24.2	31.2	40.3	23.1	25.4	35.2	18.2	24.3	25.1	25.2	20.3	28.8	23.9	24.4	29.2	32.1	22.6	29.8	33.1	23.2	40.2	15.9	21.0	16.6	26.3	6.5	11.1	3.5	11.7	3.9	6.9	5.6	5.4	24.4	25.9	9.7	10.0	7.7	11.4	10.1	7.7	16.5	12.0	25.4	6.4	9.9	13.3	5.8	8.7	6.9	30.8	9.2	16.6	17.7	21.1	12.1	16.6	29.7	11.2	14.0	13.6	6.9	10.7	13.3	5.3	14.3	12.7	8.6	14.3	6.4	13.2	26.2	23.0	24.4	38.6	12.3	11.8	19.8	11.3	10.4	23.6	5.8	15.4	17.3	10.9	7.6	9.4	16.0	9.8	7.6	10.3	12.0	18.1	5.0	12.1	7.0	9.3	10.5	3.6	10.0	10.7	0.3	9.1	3.5	6.7	10.4	5.2	6.5	6.3	6.5	9.8	3.0	3.7	2.8	1.2	3.9	11.7	11.1	6.9	5.6	30.4	30.9	42.6	30.0	34.1	26.5	33.1	24.3	25.4	33.1	47.6	61.1	29.6	38.6	47.3	48.4	18.3	12.7	40.2	58.0	22.7	35.3	24.9	10.0	29.4	34.2	45.0	22.2	0.0	18.2	33.5	35.8	31.0	39.4	10.0	21.2	42.9	40.6	25.2	14.5	14.7	30.2	28.9	37.1	35.1	16.5	30.8	22.7	28.1	30.4	11.3	61.8	25.8	46.4	62.1	51.9	47.4	41.8	27.7	17.1	27.1
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.2	0.0	1.0	4.9	6.8	0.0	1.7	9.1	2.2	2.5	0.0	1.1	0.0	0.6	8.7	10.8	1.3	0.0	0.1	1.7	0.0	0.4	0.4	3.0	1.7	45.3	0.0	0.0	2.6	4.3	8.1	36.3	3.8	1.5	0.0	0.0	11.9	1.2	0.7	0.0	0.0	0.0	4.1	3.5	0.0	0.6	0.0	8.9	0.5	6.9	0.6	1.9	1.2	1.5	0.8	52.1	0.1	0.5	2.0	0.3	5.0	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9	8.9	17.3	0.0	29.2	80.1	4.1	5.3	15.3	5.3	17.0	1.8	2.0	0.4	6.6	56.6	2.6	6.3	32.8	0.0	10.3	1.2	27.7	116.6	10.4	28.7	0.5	17.5	25.6	1.8	0.0	0.8	8.6	0.6	25.3	0.0	8.9	3.6	22.9	77.2	2.8	4.1	9.3	38.8	40.0	0.1	0.3	56.2	0.9	0.0	13.4	93.3
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672693	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 129.8;granulocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Approved		Approved	Nucleoplasm,Cytosol		No	NA		4200000	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	32.3	31.5	2.8	13.6	3.3	9.4	35.8	11.7	3.5	11.8	20.9	1.2	12.7	12.4	9.8	17.7	14.0	15.2	17.2	24.4	5.7	3.6	13.6	4.0	16.9	17.8	3.0	2.1	37.1	15.0	7.9	20.6	15.5	4.4	34.0	18.6	11.1	29.3	11.3	7.8	4.8	24.1	22.8	2.6	10.0	7.0	8.5	1.3	12.4	15.8	6.6	7.3	29.3	31.5	5.9	4.5	22.2	3.6	5.2	17.0	4.2	0.0	5.3	0.4	0.0	2.3	8.0	0.4	4.1	10.5	1.0	2.0	0.0	12.0	0.0	3.8	1.1	0.0	1.8	1.0	1.6	1.5	0.0	5.2	2.5	4.6	0.0	2.6	0.6	0.0	17.9	0.3	1.9	0.3	161.2	38.9	0.0	0.0	0.1	0.0	21.2	0.2	0.0	0.4	0.9	1.3	0.7	0.0	5.0	3.6	14.7	0.6	0.0	0.0	5.6	1.3	1.3	0.0	0.0	5.5	0.0	0.0	5.6	0.0	0.1	0.0	0.0	2.0	0.2	0.0	13.8	3.6	5.0	3.7	3.4	3.6	5.9	7.6	5.9	4.3	4.1	8.5	4.7	22.2	5.2	2.1	4.5	17.0	4.2	2.8	3.3	11.7	3.5	5.7	3.6	3.0	2.1	4.4	1.3	14.9	8.6	7.5	61.6	4.9	0.2	3.4	2.5	129.8	31.8	15.7	3.9	11.7	13.3	14.9	2.9	28.6	33.3	23.3	23.6	13.4	20.3	29.5	113.9	0.4	21.7	0.0	33.7	49.1	4.0	7.2	7.8	14.2	18.6	27.9	63.3	8.3	13.1	69.1	2.5	11.5	1.4	12.9	3.7	0.4	8.8	7.2	3.3	7.7	25.5	71.1
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.3"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 5.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2"									"HPA017770, CAB075742, CAB075743"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	6.6	0.4	1.4	0.3	1.8	0.4	7.6	0.9	3.8	1.8	1.6	0.1	9.8	0.5	0.7	0.8	10.9	0.8	1.2	1.2	1.5	1.9	2.0	0.2	0.6	1.9	1.7	0.0	0.7	0.4	0.0	0.3	6.3	1.0	1.1	0.1	0.1	1.4	7.0	6.3	4.3	0.2	0.6	1.1	0.3	0.4	39.3	0.2	0.2	1.1	4.5	6.8	1.0	3.2	0.1	0.1	5.3	0.2	0.4	0.2	0.0	28.8	0.5	0.0	1.5	0.6	1.9	0.3	31.3	3.7	9.7	5.9	0.0	0.2	0.0	2.6	3.5	3.4	2.6	0.0	1.7	8.2	0.3	0.0	0.0	34.1	0.0	0.4	0.0	0.0	2.9	5.1	7.2	9.3	0.0	0.8	0.0	0.0	0.1	18.2	0.2	0.0	0.0	1.0	0.9	0.5	0.0	0.1	0.0	1.6	0.4	0.9	0.1	49.0	0.6	9.5	1.7	0.1	0.0	1.2	0.4	2.8	66.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.3	0.4	0.1	0.1	0.0	0.0	1.4	1.8	0.9	1.7	1.5	1.9	1.7	0.0	1.0	0.2	3.0	0.3	0.0	65.7	34.6	0.3	0.1	10.2	1.4	7.9	24.4	0.0	11.3	0.0	0.5	5.0	3.3	0.0	0.0	0.0	132.9	2.9	88.0	0.0	0.0	5.3	0.0	0.0	1.3	0.0	10.1	3.7	2.8	11.8	0.0	0.0	0.5	3.9	0.0	2.8	0.0	0.7	0.0	13.3	359.5	76.0	39.3	21.2	0.0	0.0	76.5
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.9;BEWO: 9.1;HaCaT: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.9	0.0	0.3	0.0	0.1	0.0	9.1	0.5	0.0	0.8	1.0	0.7	2.1	0.3	1.1	0.7	2.3	9.5	0.0	1.1	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.9	2.6	0.4	1.1	0.0	0.3	0.2	0.1	0.3	0.0	0.3	0.2	0.1	0.6	3.1	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	1.9	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7	0.0	0.0	0.0	2.6	3.2	1.5	0.6	0.0	1.4	0.0	0.0	0.0	0.9	3.3	0.4	25.8	1.7	0.0	0.0	0.8	7.4	0.2	1.4	0.0	0.0	2.0	0.0	0.0	0.6	0.0	48.7	0.3	0.7	16.9	0.0	1.8	1.0	0.4	0.2	1.1	0.0	0.6	0.0	0.1	1.1	2.6	2.5	18.1	0.0	0.4	5.1
LYPLA1	LPL1	ENSG00000120992	"Lysophospholipase I"	O75608	8	54046367-54102017	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 729.6;Late spermatids: 528.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1700000	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	14.1	17.7	7.2	12.2	8.9	13.4	16.4	10.8	15.2	10.7	14.6	6.9	4.7	15.4	8.0	11.1	30.4	8.0	11.9	27.1	6.8	6.8	31.1	37.3	13.6	23.4	7.3	4.9	12.3	24.3	9.0	7.4	51.1	12.0	15.3	15.2	17.0	23.3	7.1	26.4	22.1	17.6	10.4	6.3	14.0	14.9	64.8	4.1	21.3	13.3	19.3	19.7	24.6	17.3	29.1	37.1	42.7	40.4	27.1	29.2	35.1	30.2	17.1	22.3	20.0	8.1	13.2	28.1	18.1	10.4	16.8	15.8	12.3	29.4	53.0	21.2	11.7	18.5	20.3	31.3	30.1	23.4	19.2	17.1	36.9	10.9	19.8	13.3	22.5	50.1	11.6	26.6	13.0	29.4	14.4	43.3	23.1	37.4	16.1	23.2	8.0	34.3	17.2	33.1	50.7	7.9	20.8	11.8	24.2	25.8	41.0	11.7	20.0	12.7	23.8	27.8	22.1	34.7	20.2	20.8	10.1	14.8	17.5	16.7	22.5	33.8	47.8	13.7	24.0	19.8	31.4	33.1	42.7	19.1	31.1	19.0	29.1	18.2	18.4	37.1	23.9	18.4	17.8	19.5	27.1	40.4	23.8	29.2	35.1	7.2	8.9	10.8	15.2	6.8	6.8	7.3	4.9	12.0	4.1	26.8	44.0	77.0	68.7	54.8	33.9	58.1	45.9	38.8	33.0	59.3	49.1	180.5	257.0	74.6	729.6	72.2	62.9	0.0	77.4	255.5	43.3	142.6	49.5	102.9	105.0	17.5	55.2	78.0	108.6	528.5	26.2	78.4	70.9	59.5	73.4	26.2	94.9	67.1	21.5	145.1	62.5	45.3	42.2	70.4	176.9	70.9	279.5	61.2	78.8	160.0
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase II"	O95372	1	23790970-23795539	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	12.4	13.6	14.8	13.3	34.8	20.6	13.5	10.7	17.7	9.9	21.2	12.3	5.6	21.3	10.9	17.2	25.4	19.2	21.6	14.4	9.9	9.5	33.2	34.5	14.3	19.0	7.6	12.8	10.3	18.3	32.0	12.0	31.6	35.4	14.8	12.7	11.3	21.1	11.2	14.2	17.7	24.0	9.5	5.4	22.1	19.1	9.9	6.9	27.7	16.5	9.5	16.5	15.3	13.5	29.5	32.3	50.0	40.6	32.0	48.0	42.4	25.5	15.8	19.3	22.3	9.8	11.9	26.6	15.8	15.1	15.0	12.8	21.8	41.6	13.9	22.3	14.9	10.6	24.3	13.9	41.0	6.4	26.0	19.6	17.5	26.0	35.8	15.2	16.4	23.1	14.7	25.4	22.6	8.6	19.3	35.3	15.9	24.4	14.0	16.4	25.3	22.0	26.7	39.3	21.5	22.3	24.4	11.1	25.6	35.3	19.6	28.0	48.6	17.9	28.7	26.8	14.7	23.3	17.3	30.3	15.1	20.0	18.2	13.1	38.0	32.1	19.4	24.9	37.9	19.0	28.9	40.6	50.0	48.0	39.6	38.7	27.6	40.1	41.6	32.3	29.5	35.2	36.0	48.4	32.0	31.2	24.6	35.6	42.4	14.8	34.8	10.7	17.7	9.9	9.5	7.6	12.8	35.4	6.9	8.9	26.4	19.0	29.7	34.6	31.0	13.7	35.7	37.5	20.5	34.9	17.7	93.7	58.0	104.5	13.5	26.9	80.5	23.3	98.3	88.0	17.6	27.9	36.8	28.8	60.5	22.3	42.6	17.8	16.8	9.9	9.8	20.4	18.6	82.0	39.0	26.1	99.3	53.5	6.0	76.2	20.4	25.8	12.4	6.8	19.0	36.3	96.9	32.4	45.1	36.5
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 144.2;Late spermatids: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	12.1	13.0	12.1	9.6	32.9	26.2	4.0	10.1	16.9	5.8	8.8	14.6	15.2	8.5	39.5	12.1	8.5	8.5	5.3	10.6	9.5	15.9	8.3	3.9	3.6	37.6	24.5	12.7	7.7	19.0	9.4	16.3	46.8	16.5	24.1	12.7	8.5	15.1	25.2	16.1	12.5	8.6	12.6	18.1	6.9	17.2	6.7	10.2	21.0	7.1	11.9	11.4	6.3	10.5	16.8	7.0	10.8	7.4	6.4	8.4	6.1	13.2	6.9	14.9	20.9	13.3	21.9	13.7	7.3	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0	17.9	13.9	29.7	49.4	18.7	29.4	53.1	25.5	24.1	10.3	22.7	13.7	23.9	64.6	36.2	144.2	28.7	7.0	0.0	38.2	7.9	24.2	36.6	15.1	41.4	13.8	14.3	28.8	11.1	11.6	327.6	26.7	12.7	16.9	55.9	15.3	26.4	29.5	14.0	35.7	98.2	27.2	12.9	22.0	66.8	24.3	18.2	12.5	26.1	25.2	44.5
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 240.8;Spermatocytes: 162.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	13.6	14.2	21.4	12.8	18.0	11.4	17.7	13.6	21.6	18.2	19.2	24.5	15.1	19.5	18.3	13.5	17.6	16.9	14.1	21.0	19.8	16.5	20.0	20.4	11.5	13.6	24.3	10.3	25.5	15.3	26.1	15.9	14.9	20.5	15.8	19.4	13.0	16.6	14.6	21.7	13.9	23.7	21.3	28.2	11.0	12.2	44.3	20.1	20.2	17.2	13.2	15.6	14.9	23.1	13.9	28.1	28.3	22.7	16.8	21.0	12.9	16.1	10.7	20.6	14.6	12.8	21.3	9.2	14.7	12.5	20.8	20.2	13.3	28.4	19.6	16.8	18.5	13.1	12.3	19.4	21.3	31.3	18.1	13.3	28.5	13.9	21.8	12.4	26.0	14.8	13.9	30.6	29.1	27.6	14.9	16.3	26.0	35.3	11.2	19.1	11.4	21.3	12.7	10.4	20.4	17.5	22.8	27.3	15.7	11.2	7.3	10.3	16.3	18.0	7.9	34.6	20.5	13.1	13.4	14.8	14.5	19.8	20.5	15.4	9.2	21.0	33.6	14.8	38.9	19.2	22.0	18.8	28.3	16.0	20.7	14.0	13.9	16.3	15.5	18.1	13.8	16.3	16.9	18.9	16.8	22.7	28.1	21.0	12.9	21.4	18.0	13.6	21.6	19.8	16.5	24.3	10.3	20.5	20.1	6.0	12.9	11.9	18.9	11.3	8.9	52.1	10.2	33.5	11.4	7.0	5.9	24.8	41.4	22.9	240.8	16.9	27.5	0.0	18.4	37.8	16.2	18.9	30.0	19.2	37.4	39.7	8.7	11.6	21.1	51.9	24.5	26.4	13.5	28.9	17.2	47.0	20.3	25.9	25.8	42.9	14.5	19.4	17.6	162.6	67.1	14.6	28.8	17.5	20.6	18.3
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.8	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.7	1.4	2.6	1.4	0.4	0.7	1.9	1.0	0.9	1.1	1.1	1.9	3.6	0.3	0.3	1.6	1.1	0.0	0.8	1.0	1.1	0.3	1.3	18.2	3.1	0.4	0.5	0.7	1.0	6.3	0.4	1.1	0.5	3.5	2.1	8.0	10.0	4.3	1.5	0.1	0.7	1.3	1.0	1.6	0.8	1.5	3.1	0.2	0.1	1.5	0.5	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9	47.6	151.9	14.5	37.6	3.9	89.0	4.0	12.7	12.0	67.1	12.2	37.3	4.4	8.3	9.1	28.4	2.1	1.1	0.0	1.4	0.2	2.6	4.4	1.1	3.9	0.8	7.9	1.2	2.5	0.3	46.6	3.1	1.0	3.3	0.0	3.7	9.3	4.6	1.1	16.6	5.1	18.6	6.5	4.1	17.9	16.4	5.8	1.7	0.0	2.4	3.8
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 225.4;Late spermatids: 498.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	11.8	7.6	11.4	17.3	29.7	19.1	9.0	15.7	15.0	10.0	9.3	12.1	6.1	8.8	10.4	8.5	12.3	9.2	10.9	11.4	12.3	10.0	7.9	17.6	13.3	23.2	14.8	13.3	10.3	10.7	7.8	10.7	9.3	10.5	9.4	6.8	12.0	10.3	8.3	16.8	17.4	9.8	10.3	11.9	21.2	9.8	15.4	11.0	25.9	10.5	7.2	19.1	11.3	11.3	25.4	21.9	25.8	21.6	6.7	46.8	18.2	17.0	6.8	8.5	12.9	6.0	5.2	11.2	12.6	7.9	13.6	11.0	13.4	10.3	10.6	4.8	7.5	19.8	13.6	7.9	9.2	7.8	5.4	8.0	11.8	10.4	20.8	7.9	8.1	23.3	6.6	7.6	14.8	7.6	3.0	6.7	6.1	13.5	8.2	7.2	17.1	3.4	32.0	14.0	2.8	8.1	18.3	9.1	7.9	7.5	9.8	5.9	16.2	10.0	10.2	28.9	6.5	7.8	28.0	8.3	9.8	27.6	27.8	12.6	12.9	12.0	13.0	8.6	25.7	33.4	25.8	12.1	8.6	27.9	21.6	26.0	19.7	27.2	27.1	21.9	25.4	37.7	26.2	3.4	6.7	19.6	8.1	46.8	18.2	11.4	29.7	15.7	15.0	12.3	10.0	14.8	13.3	10.5	11.0	3.0	7.2	29.6	12.2	15.7	6.9	7.5	0.0	6.7	9.1	7.0	9.8	13.5	13.3	10.9	225.4	10.8	7.0	0.0	9.9	13.5	13.2	7.9	40.5	28.0	35.1	22.3	31.2	4.3	18.6	498.1	11.5	30.9	35.4	29.7	7.7	17.4	12.6	6.0	9.9	8.6	11.6	19.4	9.8	28.6	33.1	18.7	20.5	41.5	6.5	9.5
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216511	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 114.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.9;NK-cells: 14.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	45.8	15.4	5.0	10.7	10.7	18.8	32.9	4.1	10.4	16.5	14.7	5.1	6.4	5.1	17.1	4.9	21.5	18.3	27.2	17.2	5.2	5.4	8.6	16.5	31.5	2.9	9.8	1.5	24.5	12.4	3.5	6.2	114.6	12.6	20.1	6.9	5.9	8.8	34.0	60.7	14.3	8.6	15.0	6.5	4.2	13.9	6.9	8.4	0.9	11.3	10.3	8.2	28.6	34.4	0.6	0.9	16.9	2.2	14.1	2.2	1.2	7.5	1.2	1.7	2.6	2.7	8.7	7.9	15.3	21.2	7.8	8.4	2.2	6.2	0.2	1.5	6.5	11.8	5.1	0.4	6.1	13.3	1.4	0.2	0.8	0.8	1.9	7.3	0.5	2.7	3.7	10.2	31.3	17.4	7.0	16.4	0.8	1.5	7.3	6.1	1.7	0.3	2.0	1.2	8.4	6.2	0.5	1.4	1.5	7.9	11.6	0.9	1.4	2.3	6.1	37.2	4.4	1.3	0.6	21.4	9.9	7.3	7.3	5.1	2.7	2.8	0.3	15.0	0.6	6.2	16.9	0.3	0.2	2.2	0.5	2.1	0.6	1.2	1.5	0.9	0.4	1.6	1.2	5.9	14.1	2.2	0.1	0.5	1.2	5.0	10.7	4.1	10.4	5.2	5.4	9.8	1.5	12.6	8.4	50.6	43.7	7.5	289.5	111.8	2.2	13.7	33.1	29.4	33.0	10.4	0.0	30.6	6.6	37.6	0.4	35.0	98.6	0.0	21.5	52.9	80.2	257.7	21.9	5.0	23.2	0.0	100.5	14.7	7.8	0.0	9.2	26.4	55.6	17.2	43.3	16.8	51.3	62.0	3.5	2.4	2.0	19.4	116.4	0.9	1.0	90.2	400.7	27.7	35.7	321.4
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"GAMG: 42.1"									"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.9	0.0	0.2	0.0	7.0	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	12.1	8.9	0.0	9.4	0.0	0.0	0.0
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"U-266/70: 29.6;U-266/84: 20.1"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 14.2"	"Group enriched"	"Detected in some"	22	"Sertoli cells: 6.5;Spermatocytes: 10.7;Spermatogonia: 4.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 29.3;RT4: 47.2;U-266/70: 20.4;U-266/84: 25.2"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	2.2	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	20.4	25.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	10.7	4.8	0.0	0.1	0.0	0.0	0.0
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Group enriched"	"Detected in some"	25	"Spermatocytes: 4.7;Spermatogonia: 9.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 37.0"									"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	9.7	0.0	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909388	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 23.5"	"Group enriched"	"Detected in some"	7	"Sertoli cells: 6.5;Spermatocytes: 5.9;Spermatogonia: 14.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 22.9;Karpas-707: 22.9;U-2 OS: 15.4;U-2197: 29.1;U-266/70: 20.9;U-266/84: 18.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	15.4	29.1	0.0	20.9	18.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	5.9	14.9	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202345-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	319	"testis: 31.8"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 30.7;Spermatogonia: 86.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 35.8;U-266/84: 40.4"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	1.5	0.0	0.0	0.0	0.1	2.5	0.4	4.9	0.0	0.0	40.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	30.7	86.6	0.0	0.0	0.0	0.0	0.0
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: AB_2674074, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.8	0.9	1.8	1.3	3.9	4.9	4.2	1.9	2.9	10.5	2.5	0.0	0.7	5.8	1.5	0.9	2.4	1.7	3.0	0.0	1.4	24.8	3.0	7.0	1.1	0.0	0.8	1.9	1.5	6.4	1.3	4.9	4.2	3.3	10.5	0.0	1.9	2.1	0.0	0.0	11.8	8.4	1.5	0.0	2.5	0.6	2.3	9.4	2.8	7.7	1.9	2.3	0.0	6.0	4.5	0.0	1.1	6.0	4.4	1.5	2.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7	71.5	24.3	2.2	16.9	19.8	93.8	31.3	91.7	37.5	30.7	22.7	70.7	11.8	3.3	33.9	112.5	42.5	30.4	0.0	28.1	2.1	7.3	19.7	1.1	50.5	3.7	219.3	35.1	72.4	7.8	11.8	6.1	1.9	5.0	1.0	37.8	13.0	33.5	25.1	8.1	12.4	23.8	32.3	13.0	16.9	9.7	16.4	4.2	1.0	22.1	10.8
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"		X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 39.7;Proximal tubular cells: 31.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"neutrophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.7;RT4: 15.5;SK-BR-3: 7.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		NA	NA			Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	0.5	0.3	0.0	0.9	1.2	0.5	0.0	3.9	1.2	1.6	1.2	0.5	8.0	1.0	1.5	4.0	0.7	1.8	6.2	2.6	1.8		5.0	4.2	1.1	0.0	0.0	0.0	0.5	5.9	3.1	0.0	0.4	1.0	2.0	0.4	1.1	9.0	5.7	1.2	0.8	0.6	0.0	0.8	0.3	4.5	0.0	0.0	0.3	0.7	0.8	0.7	0.8	0.0	1.2	2.6	7.9	2.0	1.2	1.1	1.1	0.3	2.4	0.5	0.6	0.7	0.2	1.8	0.3	0.4	0.4	0.3	1.4	6.7	0.7	0.6	0.7	0.9	1.5	0.4	1.5	0.0	1.9	2.2	2.8	3.8	0.8	0.3	0.7	5.9	0.7	0.2	0.5	0.1	0.7	0.6	1.0	0.4	2.5	0.5	0.8	0.6	2.0	0.6	1.8	1.2	0.4	0.1	1.2	1.2	15.5	3.0	0.7	1.3	7.1	0.6	0.4	5.6	0.6	0.3	0.8	1.8	0.7	0.5	1.7	0.9	0.5	2.9	0.9	2.2	4.3	2.0	3.3	0.2	1.8	0.8	1.1	0.9	0.1	1.3	1.2	0.6	1.1	7.9	1.2	1.8	2.6	0.1	1.1											3.0	4.8	0.9	6.6	2.9	7.2	6.5	10.2	10.7	3.4	12.2	2.0	1.8	39.7	9.3	0.2	2.2	29.3	0.0	18.2	3.7	1.9	6.2	0.0	29.9	4.4	7.9	16.8	3.1	1.6	0.0	0.6	4.7	1.7	6.4	17.6	7.3	10.6	22.1	0.4	31.6	9.2	0.0	2.3	2.1	1.5	3.9	3.2	2.2	12.3	8.9
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.6	2.6	1.5	2.9	0.6	0.1	18.9	2.7	0.3	0.3	0.6	2.0	1.6	1.4	0.6	0.7	0.8	2.2	0.3	1.3	0.0	2.1	0.9	0.8	5.3	2.3	1.2	0.2	4.9	0.8	1.7	1.4	0.6	1.4	0.6	2.5	2.7	1.2	0.2	4.2	1.0	3.7	1.4	1.1	0.7	1.6	0.4	2.5	0.9	1.4	1.7	2.1	0.6	1.3	1.1	1.0	4.4	0.9	0.8	7.6	4.8	1.5	0.4	3.1	1.6	0.4	1.7	2.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2	0.0	4.3	0.0	0.8	0.7	5.4	6.2	12.7	2.7	0.0	1.8	0.0	2.2	1.7	0.8	1.7	1.4	19.8	0.0	4.4	2.8	2.6	1.3	0.0	16.6	2.4	15.9	0.0	2.5	2.4	1.9	1.7	2.2	0.0	1.0	19.5	2.6	0.9	12.5	1.4	2.1	7.4	0.0	1.4	1.2	2.2	0.4	1.9	1.3	10.3	0.7
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Ito cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1200000	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.7	2.7	9.5	7.4	3.7	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	1.7	0.1	1.2	0.1	0.2	4.0	0.5	0.2	0.2	0.0	1.1	2.1	5.3	47.0	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	2.3	3.3	0.0	0.1	0.2	7.8	0.2	0.1	0.2	7.5	0.2	0.3	2.0	0.6	2.4	1.0	1.5	0.0	0.0	0.7	8.6	0.3	14.0	0.0	0.0	1.9	4.5	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1											3.0	2.7	1.9	2.9	6.0	19.1	6.4	5.1	2.7	7.9	21.0	51.1	8.3	8.3	0.5	0.3	11.1	0.0	0.0	3.4	1.0	9.9	2.6	2.3	37.6	19.1	20.6	2.9	82.9	16.5	0.9	25.0	3.6	1.7	0.0	0.0	20.6	2.2	0.0	20.8	12.8	4.5	6.5	3.1	0.2	2.0	4.5	35.7	5.3	0.0	1.3
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Macrophages: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"	"Low cell line specificity"	"Detected in all"											"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.5	8.5	8.7	10.2	29.0	19.5	24.6	12.3	26.0	11.0	10.8	6.8	7.0	18.2	15.0	9.7	3.1	13.0	4.4	8.2	5.3	9.0	13.5	6.3	4.2	11.0	14.8	41.5	43.3	23.2	16.2	6.1	7.8	11.9	10.4	6.9	8.0	13.8	5.8	12.9	5.6	23.4	7.2	8.3	10.8	13.0	11.9	9.0	13.0	19.2	2.7	8.5	12.2	10.5	20.0	5.5	16.2	25.7	13.6	15.0	6.2	14.5	11.5	18.4	20.2	9.0	10.1	40.9	16.7	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2	6.0	6.9	14.4	1.6	3.2	2.6	0.7	2.5	5.3	1.2	1.8	0.0	2.0	1.7	1.6	2.0	1.0	2.5	23.3	2.0	2.3	2.8	2.2	1.1	0.8	7.9	0.0	1.7	2.5	10.2	8.1	3.4	18.6	1.7	5.4	0.9	1.3	1.0	2.9	4.2	1.1	3.0	12.9	1.2	0.5	1.5	2.9	2.3	5.4	1.7	1.6
MANBAL	dJ1141E15.2	ENSG00000101363	"Mannosidase beta like"	Q9NQG1	20	37289638-37317260	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052348	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA052348: AB_2681795"	"unprognostic (1.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (7.07e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.70e-2)"	17.3	25.2	19.6	10.7	27.6	2.9	29.8	11.4	32.7	22.5	22.1	15.9	21.9	17.0	26.7	29.7	22.1	28.9	23.3	13.9	20.8	20.1	19.0	14.5	15.1	19.3	18.9	23.2	28.5	21.4	15.1	16.9	16.1	22.1	24.0	20.3	27.5	16.6	32.9	7.1	19.8	15.6	33.5	13.4	11.1	18.7	17.6	11.2	9.8	23.2	13.7	13.7	20.5	28.3	18.0	21.7	25.4	19.3	14.5	17.3	11.1	17.2	33.9	17.3	17.4	28.4	20.7	15.0	24.1	25.2	23.4	18.5	39.9	23.6	4.4	29.0	29.3	23.9	23.8	16.3	37.7	16.1	3.3	16.9	4.7	14.2	35.4	30.7	4.9	3.0	22.5	26.8	21.7	36.1	23.6	16.3	5.9	7.5	4.9	23.3	20.3	6.2	6.5	13.7	29.0	31.8	3.7	22.7	5.2	22.2	24.1	16.6	19.0	24.5	36.9	19.8	15.5	24.8	8.0	17.8	43.2	16.2	24.2	18.5	6.6	8.9	3.7	31.0	2.7	22.2	9.2	17.0	23.7	11.8	19.3	13.6	18.0	14.2	14.0	15.5	17.8	17.3	16.6	25.4	14.5	15.1	21.7	9.3	11.1	19.6	27.6	11.4	32.7	20.8	20.1	18.9	23.2	22.1	11.2	23.8	31.4	8.3	66.3	26.8	21.0	16.9	33.1	13.4	25.0	41.8	3.9	82.3	33.2	65.8	4.1	25.8	22.5	0.0	96.6	107.8	49.0	70.0	7.0	18.7	26.4	19.1	29.3	30.7	12.6	5.7	43.4	19.2	43.9	21.6	32.4	50.8	77.2	44.8	64.3	47.6	11.3	19.4	44.2	23.2	48.1	26.6	64.3	10.7	32.7	98.7
MAP1LC3B	ATG8F	ENSG00000140941	"Microtubule associated protein 1 light chain 3 beta"	Q9GZQ8	16	87383995-87404779	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037216, HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (4.70e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.98e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (2.77e-7)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	35.8	36.4	37.4	15.3	34.6	89.0	35.9	58.5	46.6	21.2	18.7	25.8	22.9	11.1	22.7	20.0	19.5	17.5	24.5	41.0	35.6	40.5	24.7	22.2	20.6	22.3	49.0	40.2	19.6	15.9	27.9	20.5	31.2	46.7	19.6	20.4	18.6	19.6	22.4	67.4	22.9	13.6	28.3	43.1	18.0	15.8	27.5	28.8	13.6	27.2	23.1	20.9	22.0	31.9	15.5	15.8	50.0	18.6	20.8	21.8	19.9	10.5	6.1	12.0	10.9	36.2	28.1	8.0	20.9	24.0	16.5	11.4	9.9	7.7	6.8	16.1	28.3	18.3	9.6	17.5	13.2	23.5	8.9	15.4	7.1	7.8	16.7	60.1	5.1	8.0	37.3	44.0	25.6	61.3	24.9	19.5	10.6	19.0	14.6	27.8	10.9	9.0	11.4	12.6	4.8	14.9	14.3	8.0	6.7	22.0	5.0	9.8	11.3	32.2	5.4	40.3	16.7	8.9	6.2	24.6	17.9	11.5	16.2	11.7	19.4	23.7	24.9	25.4	12.3	12.8	48.1	18.6	42.0	17.5	16.5	17.8	15.5	16.9	17.7	14.4	12.8	13.1	13.8	50.0	20.8	17.2	15.8	21.8	19.9	37.4	34.6	58.5	46.6	35.6	40.5	49.0	40.2	46.7	28.8	83.4	75.1	94.3	175.2	196.3	67.1	164.8	63.7	120.5	68.2	73.3	49.1	124.6	222.2	290.4	163.3	131.2	195.1	256.9	117.1	101.7	121.4	182.7	127.1	55.7	184.9	82.6	126.6	77.3	139.1	218.9	84.0	179.4	178.8	251.5	103.4	145.6	263.3	235.0	83.8	141.7	98.8	58.2	173.1	309.4	159.5	186.7	528.2	136.3	87.6	216.2
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576448	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"blood: 33.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 31.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.2"									"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	0.4	3.5	0.4	0.4	0.4	2.0	0.4	0.4	1.8	0.4	0.7	0.4	0.4	2.2	1.0	0.4	0.5	0.0	0.4	0.4	0.4		0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.0	0.4	0.4	2.6	0.4	0.2	0.4	0.8	0.4	3.9	1.1	0.8	0.6	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.7	0.4	7.0	8.0	33.1	10.1	7.2	11.4	8.5	2.7	0.0	0.7	3.0	0.4	1.5	1.6	3.0	0.6	0.2	0.4	3.7	2.6	0.2	3.7	0.7	2.2	1.6	1.1	0.8	1.2	0.7	0.0	0.0	0.6	3.2	2.3	1.9	1.8	0.4	1.0	2.3	1.9	0.7	0.5	0.3	1.6	4.7	0.7	0.9	1.4	2.9	1.7	0.1	0.7	2.0	0.4	0.6	0.4	1.4	0.9	4.4	1.2	1.1	11.2	0.4	1.5	0.2	0.9	4.1	1.1	3.6	2.6	3.8	3.0	4.7	4.7	1.2	2.4	22.7	9.3	25.1	6.6	8.9	6.2	7.0	7.4	6.3	7.7	6.1	5.1	5.6	33.1	7.2	10.1	8.0	11.4	8.5											0.0	1.7	1.4	17.3	21.5	1.1	31.3	0.0	1.4	3.4	0.0	0.0	2.2	6.6	0.2	9.2	8.2	3.5	0.0	0.0	1.9	8.9	10.1	6.9	1.5	3.9	12.7	1.7	3.1	8.1	13.4	4.4	10.2	10.1	0.0	1.0	0.5	0.3	3.5	3.5	1.3	1.2	0.0	14.4	20.0	8.4	18.7	9.5	6.9	0.8	18.6
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.4	21.7	2.9	13.2	17.6	11.3	11.0	33.2	36.1	26.5	24.4	24.1	13.8	19.4	13.6	52.0	22.4	21.3	9.2	29.5	18.9	20.1	16.8	11.2	12.5	21.8	5.5	14.7	23.1	8.7	8.4	36.1	10.9	8.3	11.8	11.4	2.1	9.7	22.1	21.3	7.4	14.0	8.3	38.6	12.5	15.3	18.7	14.3	15.0	22.6	7.9	2.8	12.3	13.3	23.1	30.1	6.6	5.0	10.8	25.2	20.6	26.9	21.4	12.1	6.1	25.0	24.3	12.7	13.0	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1	35.7	59.6	38.8	149.8	229.1	5.9	17.0	45.9	29.4	45.5	21.0	3.9	51.1	63.0	81.6	1.1	21.1	72.0	210.2	69.2	75.4	38.0	143.0	94.4	63.8	45.6	17.5	115.4	21.5	64.9	0.7	11.2	56.1	82.7	15.4	50.2	16.4	93.5	56.1	15.6	27.9	6.9	0.0	70.0	0.9	4.4	190.7	56.1	56.1	31.9	222.1
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 43.8;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	24.4	11.0	13.3	4.7	2.6	1.6	0.1	3.6	1.0	1.5	0.7	1.1	0.6	9.0	0.5	0.8	1.2	3.8	0.5	0.3	0.8	2.0	0.1	6.9	6.8	4.7	1.0	1.0	12.1	0.3	0.3	0.0	1.0	17.5	3.3	0.0	1.7	0.0	0.1	12.7	0.5	7.8	0.5	4.5	4.6	1.1	0.3	4.9	3.4	4.9	7.4	1.0	0.9	2.2	6.1	3.4	1.3	3.1	1.3	1.6	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4	3.0	7.9	4.7	3.2	2.4	4.9	1.4	2.5	6.7	5.7	0.0	2.0	7.5	19.9	1.2	8.5	2.4	17.0	0.0	3.6	5.4	2.8	1.9	1.1	2.0	5.1	3.2	43.8	4.9	8.9	1.9	4.0	7.0	3.3	0.0	22.4	32.9	1.2	8.6	3.5	1.1	3.8	0.0	3.1	0.0	0.2	3.8	0.7	11.5	23.7	2.3
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	18.5	14.5	13.7	20.1	14.5	41.0	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18.0	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20.0	28.5	17.9	13.0	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17.0	18.0	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.4	7.0	5.6	5.7	7.9	10.5	9.4	10.3	11.2	10.2	8.3	8.4	7.3	10.9	17.8	14.7	9.4	14.0	9.0	6.9	11.5	27.3	7.0	10.1	12.8	7.3	9.2	10.1	21.9	9.4	7.6	12.3	15.2	9.0	4.7	8.2	4.7	21.8	10.0	6.0	11.9	7.2	5.8	4.6	9.2	7.8	10.6	8.1	4.1	15.5	11.2	6.0	15.0	9.2	9.3	4.8	6.0	7.8	10.7	20.0	18.8	9.2	13.9	22.7	16.3	11.2	9.6	6.7	8.6	4.0	2.9	2.0	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2.0	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13.0	12.3	14.3	77.4	39.5	24.5	32.1	64.0	51.3	27.5	38.2	57.6	46.6	27.9	100.1	16.2	11.6	17.3	3.2	38.8	49.0	23.3	29.5	16.3	51.8	41.5	60.0	61.1	46.1	68.3	43.6	22.1	61.3	3.8	39.1	76.0	54.0	23.4	36.2	25.5	35.7	24.6	48.8	27.2	56.9	19.4	48.6	31.4	55.2	68.6	22.0	30.5	24.4	35.7
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Urothelial cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	18.1	8.4	1.6	2.0	0.0	0.0	5.6	0.4	0.2	1.7	1.6	6.0	7.0	3.7	2.5	0.1	3.7	8.6	5.3	10.2	1.9	2.4	1.5	0.2	2.9	4.0	0.3	0.4	0.8	0.1	5.6	1.2	10.6	3.1	0.0	3.3	1.3	0.8	0.4	7.3	2.8	0.4	3.5	7.2	3.9	1.0	3.2	0.7	3.9	8.3	11.6	2.5	5.2	6.2	1.0	3.2	5.6	0.6	0.0	0.0	7.4	0.0	2.8	1.9	4.4	1.9	2.8	0.3	1.1	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8	6.0	14.9	0.9	10.9	7.7	15.8	1.8	15.3	0.0	10.3	7.0	11.8	2.5	1.7	5.5	13.2	0.7	3.1	0.0	4.0	1.3	0.8	9.0	1.1	4.9	1.0	28.6	8.1	0.6	0.8	15.9	0.6	1.4	3.3	0.0	3.4	3.4	7.4	3.5	0.0	1.9	12.3	0.0	1.0	5.4	8.5	8.0	3.3	2.9	5.0	25.4
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 41.6;RT4: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14.0	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33.0	17.8	17.2	18.6	15.3	11.5	26.1	21.0	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1.0	1.3	0.4	9.9	6.2	41.6	6.6	6.8	13.6	11.4	8.8	11.3	8.8	7.5	5.2	5.0	2.1	10.0	6.0	9.1	5.4	15.6	7.8	13.4	2.4	6.4	3.6	4.4	12.1	17.7	1.6	5.9	12.2	7.8	11.4	12.4	9.3	7.5	2.0	4.6	4.1	11.7	5.4	3.4	2.3	12.5	9.4	9.4	3.8	13.5	1.6	11.6	38.5	7.4	8.5	5.2	8.3	23.0	13.7	5.6	2.2	6.1	6.8	8.1	6.1	4.7	6.2	3.5	0.7	8.4	2.6	7.9	2.5	0.7	0.0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0.0	1.0	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5	3.0	6.7	5.1	15.6	15.7	23.8	32.7	17.8	13.4	15.9	21.0	23.6	9.2	16.6	9.0	38.6	10.3	11.9	0.0	10.7	5.5	15.6	20.0	2.3	16.2	9.1	6.4	9.2	15.4	9.5	80.0	19.2	12.2	5.0	1.8	12.5	15.2	12.8	7.0	16.6	10.9	41.2	19.4	12.7	19.5	20.8	16.8	8.7	4.4	9.3	29.0
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 38.7"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 80.1;Spermatocytes: 34.1;Spermatogonia: 117.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.8;CACO-2: 12.7;HEK 293: 17.4;HeLa: 15.1;Hep G2: 7.5;SCLC-21H: 20.0;SiHa: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.7	3.6	11.1	0.9	18.5	1.3	1.0	12.9	30.8	0.7	1.3	0.8	0.7	1.3	1.2	38.7	0.9	3.0	1.1	0.9	16.5	10.3	4.1	0.7	0.9	0.8	10.4	15.0	0.8	1.7	0.7	3.0	8.1	24.2	1.5	1.5	0.8	0.8	2.8	1.0	1.5	1.8	1.0	7.1	0.7	8.9	9.7	2.1	0.0	0.6	0.0	0.9	0.7	0.5	0.0	0.8	5.5	0.1	0.0	0.3	0.0	0.0	8.8	0.8	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.1	12.7	0.3	1.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	17.4	0.0	15.1	7.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.6	0.0	0.2	0.0	0.0	1.0	0.0	20.0	3.4	8.5	3.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	1.0	0.0	0.9	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	11.1	18.5	12.9	21.7	16.5	10.3	10.4	15.0	24.2	2.1	3.0	0.0	0.0	0.4	1.5	29.4	1.1	0.0	9.4	1.2	0.0	2.0	80.1	3.3	1.1	10.2	0.5	2.0	0.0	0.7	5.5	1.0	0.6	0.0	0.0	5.1	17.5	9.2	0.0	0.0	16.3	0.6	0.7	0.0	0.0	0.3	1.9	0.6	3.2	1.8	13.3	7.3	0.0	0.1	34.1	117.0	1.4	25.6	0.0	1.4	0.4
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051631-55070192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	37.7	27.1	22.9	23.9	23.7	65.9	27.9	25.7	29.3	26.3	24.7	24.2	20.0	17.3	32.1	28.6	28.6	31.5	24.9	32.6	20.1	25.8	41.9	32.6	27.6	33.6	21.3	18.0	41.1	21.2	25.7	32.8	36.4	22.8	23.9	23.6	28.5	33.8	30.6	38.5	26.7	29.5	32.8	19.9	33.3	26.7	30.8	17.4	37.7	25.9	26.6	39.1	32.9	24.2	27.5	30.8	28.8	30.4	21.4	30.7	19.6	19.6	17.4	30.7	19.5	24.9	24.6	23.9	22.1	23.6	27.6	32.1	13.9	17.5	22.8	18.9	29.5	16.6	21.8	33.0	33.6	38.8	20.6	21.1	22.0	17.0	20.9	27.3	26.8	24.3	31.7	25.3	23.0	36.7	20.2	36.5	14.7	20.3	20.4	39.8	23.7	22.5	20.8	22.3	18.7	29.4	19.4	33.9	13.7	37.8	22.2	20.1	23.3	21.4	15.4	20.0	28.8	27.4	15.6	27.5	28.4	37.3	17.5	19.7	12.6	18.1	30.2	22.7	14.1	20.3	28.8	22.2	25.7	21.4	30.4	28.2	27.5	25.5	23.1	23.9	23.6	23.8	23.4	16.5	21.4	28.1	30.8	30.7	19.6	22.9	23.7	25.7	29.3	20.1	25.8	21.3	18.0	22.8	17.4	65.5	67.1	61.8	149.4	63.8	21.0	62.4	25.5	29.4	52.4	45.4	35.3	104.9	59.7	58.1	17.0	57.5	43.4	46.7	60.7	94.2	53.6	91.3	81.9	48.3	65.8	36.5	55.6	41.7	57.7	6.7	47.5	53.4	47.2	65.9	50.1	56.2	70.4	41.2	50.9	82.4	22.3	32.3	53.6	84.9	56.9	62.6	126.5	57.4	37.9	127.6
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;SuSa: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	3.6	5.8	4.8	3.7	24.1	10.1	5.6	5.0	4.6	6.9	6.4	6.7	0.6	2.2	4.0	8.6	5.1	4.1	5.6	4.6	4.3	3.8	4.3	1.0	4.1	2.9	10.4	0.9	3.7	10.6	3.2	10.5	3.7	6.0	5.1	4.3	1.9	0.8	6.9	2.4	7.4	3.9	5.5	3.7	3.8	4.0	7.0	1.5	2.3	2.0	2.2	6.4	5.1	0.5	2.5	29.6	3.1	1.2	2.8	7.4	5.5	8.2	3.4	1.4	2.1	0.6	8.6	0.9	4.5	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5	6.0	3.5	6.2	5.5	4.8	2.0	1.7	0.0	1.4	2.3	5.2	2.0	4.8	5.0	7.1	6.3	7.1	9.0	0.0	5.3	6.9	8.3	5.5	2.3	1.3	6.7	0.0	10.3	6.7	6.7	5.9	10.6	6.3	3.3	2.8	5.7	14.5	6.2	13.5	11.0	3.0	2.0	25.8	8.6	31.4	10.6	3.8	4.2	4.4	6.1	5.2
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"Mitogen-activated protein kinase associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	27.2	33.9	35.0	24.4	41.4	20.4	22.6	20.3	30.4	27.0	30.1	21.0	20.6	20.1	26.4	25.6	30.3	20.5	21.3	44.9	29.5	24.9	37.5	37.5	20.1	21.3	28.3	20.4	29.1	24.8	29.8	24.1	31.3	27.1	21.7	26.7	22.8	29.7	26.2	60.7	18.2	23.3	33.2	28.5	27.0	25.1	24.9	22.1	24.1	32.7	23.2	24.7	27.2	25.7	7.6	7.1	18.8	6.1	5.4	7.5	2.5	23.7	27.0	18.2	19.3	25.2	24.1	30.4	30.1	30.9	23.4	16.5	27.3	26.8	24.4	18.5	42.0	25.7	33.2	28.2	35.4	31.9	27.6	11.5	17.5	32.6	25.8	28.4	31.3	20.5	23.6	32.7	33.4	35.1	26.2	34.5	24.1	27.8	19.3	49.6	49.6	23.1	12.6	29.0	56.1	33.9	19.6	43.2	32.4	25.7	17.3	22.2	21.8	30.2	28.5	18.9	25.9	33.0	18.4	22.2	33.3	22.0	39.9	50.0	24.2	59.4	24.9	47.5	14.5	35.9	3.6	6.1	5.3	4.6	5.8	6.2	7.5	5.0	5.0	4.8	7.6	4.4	7.5	18.8	5.4	5.2	7.1	5.4	2.5	35.0	41.4	20.3	30.4	29.5	24.9	28.3	20.4	27.1	22.1	11.9	14.2	27.4	23.3	14.1	24.1	59.7	30.6	14.7	36.4	14.0	39.3	28.8	46.4	43.0	56.5	22.7	24.3	23.3	57.0	40.4	18.6	34.5	17.3	28.8	47.0	30.2	9.2	14.1	24.3	91.3	17.5	38.5	21.9	66.7	20.1	28.1	47.7	20.1	16.6	60.6	25.2	6.5	23.4	54.5	81.3	16.9	42.6	24.5	23.4	26.9
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	21.2	8.4	11.7	13.2	34.6	20.3	14.6	14.8	33.7	22.7	21.4	16.1	10.4	10.2	10.4	29.9	14.2	16.1	8.7	15.8	16.3	11.9	6.6	17.2	10.5	10.3	26.7	25.4	57.6	28.0	20.2	21.8	24.1	18.9	18.5	13.9	19.8	46.7	18.3	26.4	10.2	18.4	13.5	7.5	11.8	26.2	24.6	3.3	17.1	13.1	9.4	12.1	17.5	29.6	20.5	22.8	14.4	24.7	17.6	20.5	17.3	23.7	20.2	60.9	54.0	8.3	23.2	15.5	6.7	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6	50.6	53.7	28.9	47.2	75.9	11.3	97.2	40.8	6.7	29.6	29.6	19.6	5.0	13.3	28.0	71.3	26.3	27.4	23.3	50.4	7.0	28.6	55.9	34.6	34.4	22.4	0.0	59.3	21.5	27.7	20.1	21.0	27.9	32.1	12.6	32.0	17.7	50.5	21.2	16.3	21.0	14.8	25.8	48.7	11.8	4.1	63.0	13.8	37.4	24.1	68.1
MAPKAPK5	PRAK	ENSG00000089022	"Mitogen-activated protein kinase-activated protein kinase 5"	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21.0	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23.0	28.4	21.1	18.0	18.4	19.8	16.7	22.0	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	14.9	19.8	19.2	16.1	13.9	14.1	29.3	15.0	18.1	23.0	16.0	25.6	12.3	22.6	11.1	17.6	13.7	14.9	25.2	15.7	21.6	15.0	13.8	20.1	13.8	20.5	16.8	25.2	14.2	14.8	22.6	22.0	26.2	17.5	16.9	20.6	27.7	8.9	16.8	16.8	25.0	39.9	27.3	36.8	14.0	24.8	14.0	21.7	18.3	21.7	23.7	20.1	17.0	29.0	20.8	18.3	23.5	28.9	14.7	13.1	13.2	13.4	18.7	18.3	22.4	26.7	15.9	18.4	18.5	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4.0	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22.0	3.0	17.2	13.8	19.4	18.2	45.9	15.7	22.9	9.4	15.9	3.5	39.3	26.2	11.6	25.6	11.1	15.5	36.7	0.0	25.7	28.0	17.4	20.5	2.3	11.1	17.5	22.3	35.2	16.5	15.8	5.6	14.4	16.6	8.5	24.4	39.9	19.2	27.7	28.8	16.6	16.8	34.7	19.4	17.9	18.0	36.8	18.6	25.2	22.3	30.8	24.3
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.7	15.2	12.5	13.1	6.9	9.0	17.3	9.3	8.9	13.4	10.4	16.3	24.1	16.8	16.4	9.7	14.5	29.5	12.0	14.5	11.6	11.6	9.4	18.5	12.0	10.6	7.7	20.1	24.5	4.9	19.8	12.3	10.7	6.3	11.0	15.9	15.7	19.4	8.8	28.0	21.0	14.3	14.2	18.4	11.1	17.4	9.3	18.6	10.0	18.8	17.2	11.6	16.0	41.1	10.7	14.0	29.9	12.0	10.4	14.2	8.9	18.3	10.3	11.8	12.2	16.5	9.7	10.6	11.3	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7	6.0	5.0	13.9	16.2	22.3	26.0	10.9	35.7	6.7	6.8	19.2	7.9	19.2	1.7	18.5	0.4	11.9	59.3	0.0	18.5	16.8	10.6	28.8	17.3	12.1	15.7	19.1	28.7	13.5	19.5	0.7	11.8	11.3	3.3	8.2	35.1	19.1	20.0	35.9	10.3	6.9	17.8	19.4	9.2	8.4	21.8	30.1	54.3	23.6	28.2	30.9
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 27.1;BJ hTERT+: 103.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	27.1	103.4	0.4	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7	0.0	2.6	0.0	0.1	2.6	0.0	32.5	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.2	11.0	0.0	0.0	57.1	0.4	0.0	0.0	30.7	2.4	3.8	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	5.9	0.0	0.0	1.5	0.1	0.5	0.0	0.1
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5.0	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6.0	8.2	10.7	5.0	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.6	4.2	2.1	0.1	6.9	6.2	5.0	1.7	2.6	0.6	0.5	3.8	2.1	0.5	3.6	1.4	1.6	6.9	6.4	17.8	0.7	22.6	2.1	18.7	2.4	1.6	0.5	0.0	6.6	10.3	9.8	3.9	7.9	7.3	14.1	1.7	1.8	2.1	4.8	6.6	2.7	0.1	1.4	0.6	3.4	0.6	1.8	0.4	1.7	22.9	3.0	2.4	2.3	0.9	0.1	1.5	1.5	0.1	13.5	1.6	2.3	2.5	2.9	5.5	2.4	0.1	4.3	0.0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5.0	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5.0	29.8	44.7	9.0	428.6	327.4	18.2	114.6	17.8	29.4	59.1	17.4	2.0	33.2	31.5	46.4	104.5	72.0	17.3	0.0	103.5	42.2	34.0	324.3	92.3	37.2	4.6	7.9	30.9	60.2	6.0	92.7	38.3	9.8	45.5	2.8	14.9	56.5	55.6	15.6	30.8	73.9	3.5	38.8	35.8	11.4	8.5	348.9	114.8	15.2	15.0	641.7
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	30.0	44.6	52.4	32.5	36.1	44.1	31.0	37.8	34.9	39.8	42.5	36.4	101.4	70.5	24.9	45.9	32.5	46.9	65.9	56.4	51.2	35.7	48.4	42.1	64.6	31.5	66.0	62.4	47.1	39.9	57.2	42.9	30.0	50.7	37.7	41.0	47.3	55.5	90.3	25.8	56.9	68.8	34.8	25.9	57.5	60.6	49.6	45.7	60.1	47.7	41.3	38.1	34.2	33.0	60.9	27.7	27.9	33.5	36.6	48.9	29.5	26.9	45.1	34.3	27.2	51.0	31.9	78.4	25.6	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4	44.7	76.0	36.8	172.0	127.5	81.9	4.5	86.6	34.8	63.7	68.0	64.8	30.7	16.6	50.4	46.3	49.1	61.0	23.3	49.9	34.3	63.9	55.3	83.1	40.6	57.5	25.4	79.9	36.2	106.8	20.7	66.7	92.6	64.1	35.1	55.5	59.7	55.5	42.1	78.8	119.6	80.9	109.9	101.9	51.4	57.7	103.4	31.9	36.2	51.7	86.6
MAU2	"KIAA0892, mau-2, MAU2L, MGC75361, SCC4"	ENSG00000129933	"MAU2 sister chromatid cohesion factor"	Q9Y6X3	19	19320681-19358755	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059897			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA059897: AB_2684154"	"unprognostic (3.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.57e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	15.3	15.2	17.5	17.4	23.6	24.5	15.8	30.5	21.1	15.7	15.0	28.2	18.9	16.9	18.9	21.6	20.8	20.1	16.9	19.9	15.7	14.4	14.8	12.7	19.5	26.5	28.3	13.1	25.2	19.3	17.8	20.9	15.9	18.3	16.6	10.5	17.2	16.8	20.4	43.6	25.0	15.9	17.8	19.7	22.0	14.1	18.0	25.9	20.6	16.6	12.2	18.6	15.3	16.0	7.0	6.8	14.1	13.4	8.2	9.8	7.4	8.5	6.6	11.8	10.5	9.8	10.3	16.4	8.1	8.3	11.0	10.0	9.5	12.1	10.6	17.6	8.7	5.5	10.1	10.0	8.3	5.1	5.5	25.7	8.3	10.3	8.2	11.4	14.7	13.0	11.3	9.4	7.9	9.1	11.6	10.5	9.7	11.1	13.2	7.3	9.8	15.1	20.5	10.2	11.9	19.0	17.0	7.6	11.4	7.8	11.2	17.2	15.7	10.0	10.5	10.5	6.3	9.1	20.8	9.3	17.2	3.9	16.9	12.2	17.3	14.5	10.7	8.4	15.6	12.9	4.1	7.7	5.5	8.7	6.5	9.8	6.9	7.5	8.0	6.8	7.0	8.3	7.6	14.1	8.2	13.4	6.8	7.1	7.4	17.5	23.6	30.5	21.1	15.7	14.4	28.3	13.1	18.3	25.9	17.9	19.4	10.2	5.7	5.6	29.6	15.7	20.4	20.1	9.1	10.4	51.1	8.3	3.3	7.3	8.2	9.2	10.7	23.3	8.0	6.2	7.6	8.0	9.3	7.2	7.5	47.7	13.8	12.9	14.5	9.0	14.1	10.5	10.1	3.6	14.1	12.8	10.1	7.0	13.1	4.8	31.4	6.5	8.3	31.2	13.2	8.4	12.7	12.1	13.0	6.4
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	14.7	21.7	18.0	18.8	20.8	29.4	15.7	27.1	29.4	15.3	17.2	18.8	16.2	18.7	18.4	16.6	21.1	16.4	16.8	19.7	19.2	14.0	17.4	18.9	16.0	20.9	21.8	23.1	20.7	19.7	28.2	24.2	19.4	18.2	18.0	13.9	15.0	19.6	19.5	25.9	24.2	18.3	18.3	15.2	22.6	18.0	72.3	21.5	19.1	19.9	20.0	18.2	19.1	20.0	13.1	11.7	22.2	11.6	14.3	17.4	12.1	10.4	9.9	11.1	12.6	12.0	9.8	12.0	12.6	14.5	17.5	13.5	7.4	8.3	16.6	9.2	12.2	10.2	18.9	12.7	22.0	10.2	18.5	8.1	10.4	14.0	7.8	23.2	25.2	22.1	11.4	35.6	19.9	45.7	11.1	14.3	16.6	13.1	26.0	13.4	9.7	21.1	13.2	10.5	5.5	7.9	19.6	8.2	18.0	8.6	4.7	14.8	14.0	9.3	9.0	11.5	9.4	11.4	23.1	15.5	19.0	8.7	6.1	12.7	48.3	20.4	17.4	12.3	19.4	17.1	15.2	11.6	22.2	17.4	10.1	16.4	13.0	15.2	14.4	11.7	13.1	15.9	12.8	15.6	14.3	7.9	10.7	13.9	12.1	18.0	20.8	27.1	29.4	19.2	14.0	21.8	23.1	18.2	21.5	8.9	24.0	8.2	12.0	20.1	15.2	24.2	12.7	13.4	19.4	15.7	17.7	24.4	11.6	13.0	58.6	18.8	17.5	0.0	11.9	19.1	14.4	10.8	8.1	16.3	16.1	14.3	12.5	14.7	14.3	75.6	14.4	15.2	15.1	12.6	19.9	16.3	16.7	17.0	18.0	8.4	19.0	12.9	17.6	96.5	17.9	25.6	43.0	14.6	17.1	15.6
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151601-54224788	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	29.8	11.9	8.5	27.9	9.8	15.3	24.0	9.9	9.0	17.5	22.5	7.4	20.1	10.5	12.5	14.8	33.1	11.3	18.7	17.9	7.9	8.1	23.3	23.2	21.3	33.7	10.0	5.3	15.3	19.3	13.1	12.5	38.1	8.6	18.3	15.0	12.1	23.3	17.3	13.9	24.1	26.7	15.7	11.7	36.9	12.5	26.1	9.4	31.0	31.0	25.4	32.2	22.8	27.1	2.0	1.5	2.2	8.2	0.4	2.6	0.8	12.7	5.8	10.8	5.3	12.7	10.8	10.6	12.1	15.2	14.0	12.3	3.7	7.1	30.2	6.2	18.6	6.2	20.5	9.1	16.3	15.4	22.5	5.0	4.4	9.1	8.0	13.2	14.1	8.2	9.4	18.4	10.7	15.7	9.3	16.1	9.3	3.4	28.1	12.6	6.1	14.2	7.9	11.3	5.0	7.8	9.6	6.3	12.2	20.1	13.2	11.8	5.0	9.4	9.5	6.3	14.9	4.9	7.2	13.9	14.3	6.6	4.9	10.7	30.5	16.6	23.3	12.6	12.0	8.5	0.1	2.6	1.2	1.2	4.6	1.6	1.4	1.3	1.9	1.5	2.0	0.7	1.2	2.2	0.4	8.2	1.2	2.6	0.8	8.5	9.8	9.9	9.0	7.9	8.1	10.0	5.3	8.6	9.4	26.8	16.0	24.2	25.1	43.8	17.7	28.8	20.4	24.1	20.5	31.4	15.7	11.3	6.6	23.6	1.7	25.3	29.7	23.3	49.8	45.1	20.5	42.9	8.1	17.9	28.1	20.6	15.6	24.5	111.1	3.3	23.3	44.3	25.3	33.3	38.0	36.6	44.0	20.1	24.8	19.0	23.2	25.8	18.1	5.2	4.3	54.6	15.3	17.5	33.1	78.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		NA	NA			"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	8.5	11.3	13.9	14.1	13.7	6.8	9.0	26.1	14.7	13.7	16.3	10.1	8.9	7.2	12.6	8.7	9.9	9.6	13.4	10.3	11.7	10.6	13.7	6.9	8.2	8.7	9.3	9.9	14.2	5.7	25.5	24.7	10.4	11.3	11.5	8.1	10.8	7.5	11.6	9.9	6.6	8.2	15.7	11.8	9.8	9.1	11.0	12.5	17.3	12.8	6.0	8.6	15.1	10.1	1.3	1.1	3.6	1.2	1.0	2.2	0.7	1.4	1.5	9.0	6.5	6.5	7.4	4.0	6.7	7.3	4.5	3.8	3.4	4.5	2.5	1.7	5.7	2.2	1.0	4.7	7.4	6.4	2.2	2.2	5.4	4.9	1.7	2.7	0.7	0.8	5.6	6.5	6.0	4.0	9.3	7.5	4.5	2.0	6.1	7.6	3.4	2.9	3.9	3.0	4.0	2.4	2.9	1.5	0.9	6.0	7.2	5.2	7.3	4.3	2.3	4.5	5.5	2.9	4.5	5.5	5.3	2.2	0.7	2.9	4.4	1.7	2.2	9.0	2.5	6.1	3.6	0.4	1.9	1.6	0.3	1.1	0.7	1.8	1.5	0.9	1.3	1.4	2.2	0.6	1.0	1.2	1.1	0.6	0.7	13.9	13.7	26.1	14.7	11.7	10.6	9.3	9.9	11.3	12.5	14.9	10.7	3.9	10.8	3.4	23.3	8.7	12.7	12.0	23.9	12.2	35.3	6.1	3.3	16.7	52.0	9.0	4.6	0.0	13.8	7.3	7.9	8.0	3.5	7.4	6.0	12.7	11.1	11.6	14.9	28.9	16.7	14.6	0.0	10.8	5.5	9.0	16.2	3.5	9.9	11.6	16.8	6.5	5.2	5.1	7.3	2.9	7.1	13.8	6.9	10.7
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458203-90474768	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	5.2	7.4	11.2	5.7	16.8	2.7	9.5	16.7	14.7	8.7	5.7	7.4	7.4	6.1	9.6	6.6	7.2	7.5	5.0	5.2	12.7	14.2	9.3	11.1	5.5	11.1	10.6	9.8	16.3	7.4	21.8	10.0	5.4	9.7	8.6	6.2	4.8	7.8	7.8	4.3	9.5	5.4	7.1	10.7	6.6	4.8	6.1	7.0	8.1	9.7	3.1	7.0	6.5	6.9	5.3	2.9	1.1	3.8	3.3	4.8	2.3	5.8	2.5	4.4	5.5	5.8	7.9	5.4	4.6	4.3	4.0	4.3	1.9	4.4	13.7	2.8	4.1	5.6	6.0	5.7	7.0	6.3	7.7	3.9	6.1	4.1	4.4	6.1	6.0	2.7	6.8	9.4	2.9	11.2	4.7	5.1	7.4	9.2	7.6	6.8	3.6	5.8	8.3	2.8	1.2	12.3	6.3	7.3	18.6	6.1	2.2	7.6	8.9	4.2	6.2	11.2	2.7	5.1	4.5	6.3	5.0	3.5	6.1	6.0	5.4	6.0	6.1	4.3	12.7	6.8	0.0	1.5	1.1	3.2	3.8	3.9	3.1	3.6	3.5	2.9	5.3	4.8	3.7	0.1	3.3	1.9	1.0	1.3	2.3	11.2	16.8	16.7	14.7	12.7	14.2	10.6	9.8	9.7	7.0	3.0	2.2	1.4	0.8	2.4	6.4	4.0	5.1	2.7	1.2	1.8	7.9	3.0	1.7	1.6	0.3	4.4	2.0	0.0	1.1	2.7	2.2	0.8	0.0	4.9	2.2	3.2	4.1	3.7	5.3	0.6	3.7	1.2	1.7	1.0	2.8	5.6	2.0	0.0	4.9	3.9	6.2	0.0	2.7	2.8	4.6	2.9	0.7	2.1	3.5	0.7
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	55.9	17.5	14.5	50.8	17.0	28.5	43.8	11.8	14.5	46.4	44.0	10.8	18.0	15.2	41.1	23.6	33.3	22.3	27.5	29.9	14.3	12.9	18.6	16.5	39.6	45.6	18.0	9.1	30.5	12.5	12.5	16.0	10.4	12.6	30.5	26.0	12.7	18.3	25.1	87.6	22.8	29.5	59.8	22.1	39.6	23.1	14.6	17.4	71.9	18.5	34.5	46.0	64.4	29.3	25.0	30.7	38.2	27.4	33.6	39.9	40.2	27.8	23.0	3.7	8.4	29.6	30.6	2.8	35.0	28.4	23.1	19.4	10.1	16.4	28.7	17.9	49.0	7.2	12.8	6.9	20.2	34.3	22.3	9.4	31.3	11.7	4.7	16.5	37.4	22.9	14.2	11.0	26.6	20.8	17.8	47.4	11.6	15.9	39.2	22.4	9.6	34.8	13.7	1.5	8.2	18.4	35.7	11.6	35.9	11.7	14.1	3.0	3.4	15.2	8.3	14.8	1.4	11.5	57.1	39.8	31.7	12.2	21.0	30.1	41.0	23.4	33.0	18.5	46.8	17.0	32.6	22.7	38.2	37.2	27.4	39.9	25.0	30.5	30.9	30.7	24.1	38.9	33.3	35.4	33.6	22.8	11.1	27.0	40.2	14.5	17.0	11.8	14.5	14.3	12.9	18.0	9.1	12.6	17.4	140.0	156.6	98.0	41.0	189.8	25.7	160.6	45.9	78.9	139.9	36.6	60.9	20.0	18.3	32.5	2.1	146.2	138.0	70.0	54.4	8.3	91.5	50.3	155.2	83.5	55.2	30.2	45.4	75.5	193.7	5.9	82.8	171.1	97.8	129.0	61.7	16.0	47.0	71.9	67.1	29.9	84.3	97.0	113.3	4.9	10.9	213.0	12.4	228.4	54.7	46.0
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	9.0	6.8	8.8	10.6	14.2	11.0	13.5	21.2	12.0	10.7	8.8	13.2	8.6	9.2	14.3	9.6	9.3	8.3	7.1	5.8	9.9	5.8	7.4	11.2	7.2	9.3	12.6	8.1	15.4	11.0	8.8	9.6	10.0	8.8	8.9	9.3	8.3	9.0	8.8	7.9	16.7	9.8	11.9	7.7	11.7	9.5	27.9	11.7	32.4	10.1	4.8	9.0	9.5	10.5	0.9	1.1	5.1	0.4	0.4	0.9	0.1	3.7	3.5	19.0	7.6	4.6	5.3	10.0	2.9	3.6	3.1	3.9	4.2	4.9	14.8	6.9	2.1	2.2	3.7	8.6	2.1	5.9	4.1	7.9	15.3	4.0	6.4	3.1	10.2	4.6	4.6	4.1	2.3	4.3	6.2	5.5	13.1	11.8	3.7	2.4	3.8	13.9	10.7	10.8	8.1	3.2	16.1	11.5	7.3	4.8	7.2	12.1	18.4	2.6	5.1	6.1	16.7	7.3	20.2	3.3	3.4	3.4	2.5	3.1	9.2	5.8	13.3	2.0	6.8	1.9	5.1	0.4	1.9	0.7	0.3	0.2	0.9	0.7	0.5	0.7	0.6	0.4	0.9	0.9	0.4	0.4	1.1	0.8	0.1	8.8	14.2	21.2	12.0	9.9	5.8	12.6	8.1	8.8	11.7	14.9	12.9	8.2	5.9	15.2	7.9	6.2	15.3	5.3	6.8	7.0	15.7	6.4	1.7	4.3	44.2	8.9	7.3	0.0	4.5	4.2	7.6	8.0	4.7	10.0	5.0	9.5	13.2	9.8	13.1	11.1	13.6	8.4	10.1	7.2	14.7	5.6	5.7	10.5	9.9	3.9	11.4	0.0	8.0	28.1	14.5	19.3	7.2	8.2	11.6	6.8
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.7	15.5	18.4	13.9	0.6	1.1	8.0	14.4	2.2	16.2	16.9	15.1	9.8	20.7	6.5	3.6	6.0	16.1	25.8	8.5	15.0	10.8	12.3	25.8	6.9	10.0	0.0	13.2	11.7	0.2	0.3	16.4	1.5	1.3	5.2	16.8	30.4	14.2	8.8	12.3	31.3	5.7	10.9	13.2	3.8	24.8	16.3	12.8	3.7	5.0	3.7	14.0	11.6	8.3	2.2	10.0	10.4	9.1	3.2	10.3	19.4	15.5	15.5	4.4	17.1	27.2	6.6	14.6	8.0	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3	0.0	0.0	1.5	0.2	1.4	0.0	1.2	0.0	0.0	1.2	0.0	0.0	4.1	0.0	0.4	1.1	0.1	0.0	23.3	0.2	17.2	1.0	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	1.9	5.9	14.0	0.4	2.9	1.0	1.8	0.0
MCPH1	"BRIT1, FLJ12847"	ENSG00000147316	"Microcephalin 1"	Q8NEM0	8	6406592-6648504	"Disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008238, HPA012064, CAB012177"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: "	"unprognostic (1.00e-1)"	"unprognostic (2.17e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.79e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.94e-1)"	13.5	10.0	11.6	10.7	14.6	35.0	14.0	19.9	16.8	13.6	11.7	12.4	15.1	9.1	17.2	10.0	12.2	12.5	9.4	11.9	12.2	10.0	11.4	11.0	10.8	15.0	11.0	11.3	14.3	13.4	13.2	19.4	14.4	13.9	13.6	10.6	10.2	14.4	15.4	24.9	11.9	11.2	12.3	14.2	15.3	11.7	17.1	12.5	21.6	14.0	10.7	17.0	14.3	17.6	6.9	4.1	11.7	4.1	6.0	6.2	3.0	4.6	4.1	7.5	5.2	3.7	6.7	6.4	7.0	6.2	9.0	6.7	5.2	3.5	8.9	1.9	5.7	8.2	5.4	9.4	6.7	10.7	3.7	5.2	11.4	4.2	6.9	6.2	5.7	9.0	6.4	7.0	6.1	8.8	6.3	6.5	9.7	13.8	9.0	6.8	3.0	15.3	6.2	12.9	8.5	4.1	9.2	7.1	5.4	5.2	8.5	5.2	6.9	5.2	5.5	7.6	8.7	4.8	8.1	5.4	7.0	3.8	2.3	6.6	4.2	5.7	13.3	6.4	6.6	9.5	2.2	3.0	11.7	4.8	3.4	6.2	6.0	4.2	5.5	3.0	6.9	5.4	5.6	0.5	6.0	4.1	4.1	4.2	3.0	11.6	14.6	19.9	16.8	12.2	10.0	11.0	11.3	13.9	12.5	3.0	10.7	14.5	11.1	4.0	12.6	12.4	17.8	40.2	25.0	14.0	15.7	9.3	3.3	9.4	34.4	10.8	4.2	46.7	9.2	8.6	6.2	7.7	19.6	6.4	6.1	28.6	0.0	9.8	12.9	20.9	11.2	6.7	0.0	10.8	5.9	14.2	8.6	8.0	12.4	6.5	9.5	6.5	9.6	17.0	10.9	5.3	10.3	17.0	6.4	9.1
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	20.0	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	20.5	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.9	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	8.5	20.7	3.0	0.1	28.3	7.4	0.2	0.5	6.8	1.6	0.1	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.6	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1	3.0	9.6	0.0	0.1	16.1	2.0	2.5	0.0	4.0	6.8	3.5	0.0	0.3	0.0	0.0	20.6	29.9	0.0	0.0	0.2	0.1	3.0	0.6	61.2	0.5	10.7	3.2	0.0	1.8	33.5	12.2	0.6	35.3	11.8	0.0	0.0	3.6	0.8	0.0	0.0	0.0	3.7	0.0	2.2	1.4	1.4	11.7	0.2	2.2	0.0	0.4
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.6"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 35.7;Mucus-secreting cells: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	5.3	4.1	0.8	19.7	1.7	12.6	2.7	0.7	1.5	5.4	12.3	0.0	6.9	5.6	4.0	9.5	5.7	4.5	10.3	4.6	1.0	2.2	3.6	2.3	12.4	18.4	2.5	0.8	3.8	10.0	5.3	24.4	17.1	0.6	6.8	10.2	2.5	16.8	9.6	0.8	4.0	10.9	4.0	0.9	41.6	3.7	1.7	0.4	3.0	8.7	4.1	12.9	6.2	14.8	2.7	0.1	21.2	0.5	6.8	4.4	1.1	2.5	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.8	0.2	0.1	1.7	3.1	7.3	0.3	0.0	0.0	5.7	0.1	4.7	0.0	1.4	0.5	14.5	2.0	0.8	1.0	3.0	12.0	0.8	5.8	0.1	6.0	0.0	0.0	2.5	0.5	4.1	0.0	0.0	1.4	8.0	0.6	2.4	2.6	3.3	0.1	2.7	0.3	7.6	1.4	0.3	0.1	2.4	0.9	0.5	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.7	0.1	15.9	18.0	7.9	0.9	3.2	0.5	7.7	4.4	0.1	2.1	2.2	1.2	1.9	0.0	2.7	0.5	1.9	21.2	6.8	0.5	0.1	0.0	1.1	0.8	1.7	0.7	1.5	1.0	2.2	2.5	0.8	0.6	0.4	3.0	24.7	20.4	10.8	3.8	0.8	0.8	5.1	5.3	15.9	3.5	0.0	13.2	0.0	2.7	3.2	2.1	18.6	0.0	4.1	5.9	7.2	13.7	35.7	1.3	7.5	0.0	15.0	1.3	12.7	3.9	0.3	2.1	1.7	0.0	42.4	0.2	4.0	21.0	0.0	1.7	0.5	0.0	0.8	0.1	2.0	1.9	20.5	19.7	18.7	14.9
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717889	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 15.7;AN3-CA: 12.3;HEK 293: 29.8"					"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	10.8	3.6	5.7	9.5	5.9	4.9	5.5	10.2	8.0	6.9	6.3	8.5	3.8	3.8	9.9	5.1	3.7	8.3	5.0	5.0	5.2	2.4	5.1	6.2	5.1	5.4	4.9	3.7	11.3	5.7	3.1	12.5	3.1	6.0	6.4	2.9	9.4	5.5	3.5	11.1	11.7	6.4	6.1	5.5	7.1	7.7	26.7	5.3	11.4	11.9	2.4	13.0	5.2	5.4	2.0	1.8	0.4	0.2	3.8	1.2	0.3	15.7	1.1	1.2	12.3	3.9	3.9	1.0	1.3	0.7	2.7	1.1	1.0	1.7	2.6	6.7	7.8	6.4	1.6	2.4	4.5	2.5	2.2	29.8	1.9	3.0	0.7	0.5	1.1	1.4	1.0	0.9	4.2	2.0	0.3	0.4	6.4	3.9	2.9	0.4	1.5	0.7	0.2	0.9	0.8	0.8	2.2	1.3	2.9	4.5	3.4	2.6	1.3	0.6	3.2	0.5	2.2	2.9	2.2	1.0	1.0	1.5	2.0	1.5	1.9	7.3	6.8	0.3	4.4	2.1	0.4	0.1	0.3	1.1	0.2	0.9	0.8	0.9	1.2	0.2	2.0	1.0	0.8	0.1	3.8	0.1	1.8	0.0	0.3	5.7	5.9	10.2	8.0	5.2	2.4	4.9	3.7	6.0	5.3	14.9	15.4	9.7	4.8	3.9	10.7	6.3	7.6	8.1	6.8	5.2	7.9	4.4	3.3	3.8	3.4	5.6	1.0	0.0	5.4	9.5	7.3	2.5	16.2	11.4	5.6	4.8	6.4	5.5	5.9	2.1	7.2	4.5	1.7	8.2	2.6	10.0	4.8	0.0	5.6	2.8	17.0	12.9	5.0	75.3	17.2	3.1	1.6	6.9	4.4	0.8
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922154-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Muller glia cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	39.4	21.1	4.6	29.3	4.6	5.1	62.4	2.5	4.0	18.4	15.5	5.1	13.9	3.7	22.8	8.8	18.2	7.7	9.7	15.9	4.4	4.7	8.3	8.6	17.5	48.0	4.7	4.1	11.2	5.9	15.2	6.6	11.2	13.6	11.9	5.8	11.2	14.4	19.4	13.7	8.1	9.4	16.7	13.7	28.3	6.6	4.0	3.4	17.8	16.1	11.2	24.1	18.0	25.4	3.6	8.1	1.1	2.5	2.7	6.9	1.2	0.0	4.8	6.4	0.0	13.7	19.0	2.7	24.4	29.4	5.6	7.1	0.1	14.5	3.4	0.3	16.0	9.0	2.8	2.0	4.2	9.7	12.0	5.7	0.0	6.0	0.0	7.0	7.4	5.0	15.8	4.1	12.7	4.0	14.4	3.7	3.3	0.0	23.6	19.0	0.0	0.0	0.6	5.2	0.3	5.5	0.0	18.9	7.3	5.7	5.9	0.2	0.0	10.6	10.0	11.0	9.2	3.1	6.7	10.4	20.9	5.9	38.6	11.7	9.6	0.0	0.0	14.6	0.0	17.8	0.2	1.5	1.1	3.0	1.9	4.6	3.6	6.9	6.4	2.4	3.2	4.0	3.4	0.1	2.7	2.5	8.1	5.6	1.2	4.6	4.6	2.5	4.0	4.4	4.7	4.7	4.1	13.6	3.4	14.9	25.0	24.0	5.8	8.4	0.5	23.2	10.2	20.1	17.0	14.0	0.0	6.9	8.3	2.0	1.3	27.3	0.0	0.0	2.5	4.5	13.4	6.6	2.3	13.9	22.0	0.0	0.0	48.5	50.6	0.9	4.0	28.8	35.4	5.4	2.1	111.3	6.0	2.0	2.5	4.1	3.4	6.5	8.3	0.0	0.5	12.0	3.1	40.1	4.2	6.4
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 615.5;Late spermatids: 1508.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	38.7	22.4	33.6	26.6	30.8	20.6	13.4	26.0	27.7	32.5	35.7	33.3	10.2	20.3	27.3	31.7	47.5	19.7	25.9	35.3	30.6	23.2	35.1	37.7	24.5	35.9	15.9	27.4	19.8	16.4	17.6	43.1	28.2	33.1	19.5	33.3	25.4	22.8	35.5	74.3	36.7	31.8	15.8	110.3	19.8	18.0	20.0	20.2	22.4	36.8	32.5	22.8	20.0	17.2	29.5	28.3	26.2	30.0	14.4	35.9	28.9	23.2	44.8	26.0	21.5	33.9	18.0	20.6	29.1	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7	23.8	11.8	43.2	62.1	58.8	20.2	24.9	43.3	58.9	39.8	52.4	3.9	94.6	142.6	74.9	615.5	56.2	55.4	0.0	80.2	87.3	55.2	61.8	46.1	39.4	95.1	15.9	28.7	41.7	31.9	1508.8	58.7	50.6	64.1	93.8	42.8	52.2	71.4	49.1	56.3	121.5	14.8	116.4	68.9	194.8	94.1	60.9	71.1	58.2	45.3	74.3
MED11	"HSPC296, MGC88387"	ENSG00000161920	"Mediator complex subunit 11"	Q9P086	17	4731428-4733610	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056669	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA056669: AB_2683204"	"unprognostic (4.01e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (8.24e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	12.8	30.8	15.5	16.5	26.4	7.0	16.2	14.5	19.3	16.6	20.9	16.4	22.3	20.7	14.7	22.8	20.5	19.7	21.5	22.0	16.9	13.2	29.5	35.4	16.4	19.6	25.0	19.7	13.8	30.6	24.3	14.4	19.0	22.8	17.5	18.4	13.7	27.7	16.4	24.7	20.8	26.8	18.8	21.9	25.4	20.3	11.7	23.3	13.9	22.8	25.9	19.9	16.4	14.7	23.8	18.6	51.3	23.3	14.2	21.5	13.0	12.2	35.9	13.3	13.7	14.4	17.7	10.4	8.8	15.1	13.2	16.3	12.4	9.7	17.1	9.5	10.9	8.7	18.9	13.4	25.1	9.7	20.3	30.7	8.3	20.1	18.9	9.0	6.0	10.2	15.3	17.7	14.0	8.8	14.3	14.8	17.8	8.5	13.1	11.4	17.9	11.7	7.6	7.9	19.0	11.5	11.6	9.7	11.1	26.7	12.8	5.4	9.0	11.5	15.6	8.6	11.4	13.9	7.2	8.7	7.1	7.1	13.5	14.1	6.2	5.4	6.5	12.2	10.5	9.2	14.7	11.8	28.0	16.8	16.6	17.9	22.8	16.5	16.8	11.6	23.8	19.6	21.5	51.3	14.2	23.3	18.6	12.4	13.0	15.5	26.4	14.5	19.3	16.9	13.2	25.0	19.7	22.8	23.3	6.0	16.8	45.4	26.9	10.9	21.7	11.5	35.7	36.1	21.6	14.0	9.8	37.6	54.7	29.5	1.1	10.8	45.9	0.0	31.1	29.4	14.7	21.4	27.8	23.1	29.5	28.6	10.4	20.9	18.3	2.1	16.1	26.6	10.1	54.1	26.4	17.5	22.4	48.9	13.1	52.6	25.3	19.4	18.6	31.6	30.4	16.4	20.9	25.9	26.5	27.1
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13 like"	Q71F56	12	115953872-116277338	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"T-47d: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	21.3	7.9	9.8	14.7	10.6	39.1	22.0	29.7	11.1	17.3	13.6	12.1	12.3	7.8	21.6	11.1	13.2	13.9	12.2	9.4	11.0	7.0	9.0	7.3	15.2	16.7	11.5	9.1	20.5	15.6	14.3	13.6	13.4	9.6	14.6	10.9	11.7	14.2	14.2	18.1	21.9	13.1	15.3	11.9	14.3	12.8	14.9	11.2	55.9	14.0	10.8	15.4	13.8	22.7	2.5	1.9	13.1	1.1	1.4	1.1	0.7	6.4	15.4	7.2	8.1	9.7	16.0	7.7	6.8	9.0	9.4	6.7	15.3	2.3	4.4	5.7	12.2	5.9	4.7	8.2	5.4	12.4	10.0	5.3	9.1	4.6	5.7	10.7	8.1	12.2	12.8	9.3	10.3	15.8	7.3	6.8	11.9	9.9	4.4	8.1	14.5	15.9	17.1	4.0	2.3	3.6	11.3	7.8	10.7	6.1	5.9	7.4	6.4	6.1	3.2	6.0	16.8	50.7	17.9	8.4	10.7	7.1	7.8	8.1	8.4	3.8	8.1	5.0	8.9	5.6	13.1	1.1	3.6	1.0	0.9	1.1	2.5	1.0	1.1	1.5	1.3	0.8	0.9	4.1	1.4	1.1	1.9	0.7	0.7	9.8	10.6	29.7	11.1	11.0	7.0	11.5	9.1	9.6	11.2	59.6	40.0	33.7	33.5	88.0	49.8	29.5	20.4	28.1	45.5	24.4	51.1	8.0	3.3	11.3	48.2	59.1	24.3	0.0	22.2	18.4	39.9	36.4	13.9	25.2	18.1	54.0	30.1	55.9	55.0	39.2	85.4	26.9	30.4	13.6	34.1	23.6	22.2	14.4	62.9	11.7	43.8	45.3	53.1	19.1	18.8	88.8	11.9	22.7	25.1	43.3
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	13.5	11.5	12.4	14.8	11.7	13.0	15.3	8.6	8.3	12.3	9.9	14.6	9.3	18.4	17.1	10.1	7.0	10.3	21.1	11.6	15.6	10.6	6.7	16.5	8.9	12.8	11.2	14.0	10.4	10.1	18.2	11.7	17.6	9.8	15.2	17.8	22.3	8.9	14.7	12.1	15.6	10.0	16.1	43.1	9.3	21.7	14.9	6.6	17.6	8.7	11.5	9.1	12.3	5.8	11.6	15.4	11.7	14.7	14.8	8.7	19.0	5.3	10.6	9.2	12.3	38.9	4.8	15.6	12.3	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5	8.9	3.8	7.7	3.5	3.3	2.1	4.0	0.0	4.0	5.7	7.0	0.0	19.8	6.6	5.5	0.4	2.8	5.1	0.0	2.9	15.6	5.3	4.1	6.9	7.3	7.2	1.6	9.2	8.6	6.0	0.0	3.1	3.0	1.7	1.8	6.4	4.0	4.1	3.5	6.3	8.0	3.7	0.0	3.4	4.1	13.4	5.0	20.8	2.5	6.6	4.7
MED23	"CRSP130, CRSP3, DRIP130, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628229	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	14.0	17.1	12.1	19.7	12.7	21.8	16.3	23.0	17.6	14.7	12.3	12.1	17.8	12.7	21.6	13.3	14.9	14.6	10.2	10.2	11.7	8.3	12.2	9.6	13.1	15.4	15.9	12.3	20.5	18.7	23.9	16.1	12.3	11.3	13.9	14.4	12.3	19.8	16.8	14.8	15.0	15.4	14.3	11.0	13.7	14.9	13.1	13.3	22.7	18.0	7.4	16.7	16.2	20.7	6.0	6.8	8.8	5.7	15.0	10.9	4.6	5.2	5.9	14.0	17.6	17.4	13.3	12.9	13.3	15.0	12.3	17.9	6.1	7.4	11.7	9.7	13.6	11.8	9.5	7.5	8.6	19.2	13.3	10.5	12.3	10.7	10.3	12.6	20.2	20.9	11.7	10.3	13.6	13.9	14.4	15.2	12.8	15.7	12.3	12.9	8.1	15.3	12.8	6.6	9.1	5.9	13.9	8.7	7.0	9.5	7.8	10.5	9.5	9.4	13.3	8.6	16.9	3.6	14.3	15.3	9.2	10.4	14.6	12.0	13.1	8.8	16.9	11.3	9.3	12.2	4.5	5.3	8.8	7.3	5.7	10.9	6.0	7.2	8.0	6.8	5.2	7.4	6.7	4.5	15.0	3.9	3.6	7.8	4.6	12.1	12.7	23.0	17.6	11.7	8.3	15.9	12.3	11.3	13.3	17.9	8.1	15.2	5.3	8.1	21.1	5.7	5.1	5.3	12.5	22.7	15.7	7.2	3.3	6.7	1.4	9.8	12.5	0.0	6.6	5.7	9.0	11.5	13.9	10.6	7.1	11.1	13.8	12.3	15.4	0.9	13.3	9.1	5.0	6.4	17.6	8.9	7.4	17.3	9.6	7.3	20.5	12.9	6.9	13.0	4.8	7.5	6.5	15.4	13.2	6.3
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	22.7	21.9	19.0	18.3	22.0	22.0	22.9	30.0	25.8	20.4	21.1	21.9	19.0	21.7	18.4	24.8	33.4	15.0	16.1	15.9	18.5	19.0	22.1	34.6	19.4	18.3	21.0	17.2	19.2	25.6	17.7	34.5	26.8	20.3	19.3	24.5	19.2	25.0	21.1	16.5	27.3	21.2	23.5	21.3	20.9	22.5	18.5	20.6	14.2	27.0	19.3	25.9	24.9	20.6	27.0	34.6	32.5	35.0	18.4	25.5	22.1	22.2	14.0	13.2	15.7	20.4	20.5	17.4	22.4	20.6	27.0	28.6	26.6	16.4	13.5	16.1	28.1	17.8	14.2	20.7	19.0	26.3	18.7	20.3	22.2	24.3	33.3	34.8	19.5	23.6	20.0	25.2	28.5	35.1	16.2	21.5	12.5	19.6	23.1	17.3	14.3	10.2	16.0	12.6	20.9	16.3	12.0	15.2	20.7	18.0	14.6	13.9	10.4	13.3	21.8	44.0	19.1	14.8	39.3	15.9	11.8	21.5	23.1	31.7	27.6	31.8	15.8	25.1	24.4	15.7	25.3	35.0	32.5	22.0	31.3	20.9	27.0	20.2	24.8	34.6	21.1	20.7	21.5	28.0	18.4	27.3	16.0	25.5	22.1	19.0	22.0	30.0	25.8	18.5	19.0	21.0	17.2	20.3	20.6	14.9	8.0	15.6	20.0	16.7	28.3	11.8	25.5	8.1	11.4	14.0	13.7	44.7	28.2	39.6	9.7	21.0	24.2	93.5	65.5	56.4	27.8	21.2	31.1	23.1	52.8	15.9	18.6	18.4	20.8	18.1	22.7	29.1	18.6	38.7	19.9	27.7	46.2	19.3	20.5	41.8	47.9	25.8	17.9	66.2	30.9	22.2	73.9	24.9	19.6	25.5
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476986-17493226	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	10.2	12.7	16.0	6.5	23.5	12.3	14.1	16.3	29.1	13.0	11.2	9.2	10.9	11.2	11.7	17.3	8.2	11.7	6.6	30.0	14.3	13.6	13.9	19.1	8.2	11.5	13.6	14.5	12.4	10.2	20.3	11.3	7.9	12.6	11.4	10.5	8.9	15.8	14.9	34.4	11.3	10.5	8.6	10.3	9.5	10.1	12.9	8.6	14.9	13.4	15.2	9.1	7.5	7.8	11.4	12.8	11.8	11.4	10.3	13.4	7.4	7.3	9.4	8.1	8.7	6.6	5.9	7.0	6.0	7.4	9.3	8.4	13.7	3.7	9.1	6.9	6.2	5.6	9.6	10.3	8.3	8.8	5.7	16.4	5.5	6.2	9.8	7.0	4.4	4.8	9.6	7.9	7.8	8.1	7.0	6.3	13.3	6.5	4.2	6.2	6.2	19.7	9.1	7.5	15.3	9.7	15.3	18.4	5.9	8.1	5.2	5.3	8.4	7.9	6.3	13.3	32.1	7.4	5.8	4.3	6.9	8.0	11.8	9.4	8.0	5.6	5.0	8.6	7.8	7.2	2.7	7.0	11.8	10.3	9.6	13.4	11.4	10.7	10.6	7.8	10.4	11.6	12.8	2.4	10.3	11.4	12.8	10.3	7.4	16.0	23.5	16.3	29.1	14.3	13.6	13.6	14.5	12.6	8.6	3.0	4.1	0.9	8.0	4.0	14.2	17.7	7.6	5.3	4.5	8.7	13.7	7.7	10.0	5.6	5.3	3.7	6.6	0.0	4.0	4.5	5.5	7.3	0.0	4.5	5.3	15.9	15.1	5.5	2.4	5.2	5.2	3.8	1.7	3.6	9.3	22.1	2.9	5.8	8.9	4.5	22.8	0.0	6.1	8.8	25.4	4.3	8.0	5.0	7.3	7.4
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 255.0;Ito cells: 239.4;Sertoli cells: 329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HEL: 53.4;Karpas-707: 29.4;REH: 60.8;U-266/70: 22.3;WM-115: 34.8"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.9	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	24.2	0.1	2.8	0.6	0.7	2.3	2.1	0.0	7.3	3.0	53.4	3.2	0.0	0.6	2.3	0.1	5.3	0.0	0.0	0.0	0.3	8.4	0.0	2.8	29.4	2.1	0.0	0.0	0.0	0.5	0.0	2.0	60.8	15.3	11.6	0.0	0.3	0.0	2.0	0.0	0.1	7.0	1.0	0.0	13.5	9.6	1.3	0.2	0.1	1.2	22.3	2.5	14.6	0.3	16.5	34.8	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4	29.8	48.3	255.0	4.7	9.5	22.0	80.9	12.7	6.7	39.8	1.8	202.2	0.8	23.2	0.8	6.9	155.1	1.6	70.0	11.1	1.1	13.9	1.6	4.7	3.0	134.1	4.8	1.2	239.4	207.6	5.3	27.6	138.9	64.1	28.9	0.3	65.1	0.4	2.9	67.5	0.5	196.7	329.8	171.0	1.2	16.6	7.3	1.4	7.9	1.9	1.6
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 163.0;Sertoli cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.6	8.6	1.8	2.8	4.4	6.1	2.8	6.1	8.0	3.2	3.5	2.7	6.3	10.8	7.1	8.2	3.2	4.6	2.1	3.5	1.9	14.7	2.8	2.6	10.7	1.5	5.4	6.3	8.6	6.8	5.9	5.6	7.7	6.8	6.1	3.4	1.9	19.1	5.1	4.4	4.2	14.6	2.6	2.6	4.4	20.8	3.9	12.4	2.8	2.3	3.0	4.7	5.9	12.9	10.2	3.7	3.5	55.0	10.2	7.7	7.2	5.6	4.5	48.3	49.9	20.7	6.5	5.0	4.1	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9	6.0	18.1	14.4	10.3	33.1	78.1	35.2	20.4	2.7	15.9	1.8	163.0	3.9	0.0	7.0	1.3	21.1	33.9	0.0	9.7	4.3	21.3	16.3	3.5	11.3	15.8	66.7	20.6	18.4	22.5	4.6	29.1	18.3	13.5	10.0	29.7	16.8	18.5	28.1	30.4	2.6	80.6	97.0	38.1	5.1	9.8	33.2	12.8	12.9	11.0	14.9
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV, pyrin innate immunity regulator"	O15553	16	3242028-3256627	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 7.0;Kupffer cells: 14.8;Macrophages: 7.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"THP-1: 12.1"									HPA077497			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	4.2	1.2	0.5	9.8	1.0	9.7	0.9	0.4	0.9	1.1	1.4	0.3	0.0	1.0	0.6	2.7	1.2	1.6	1.8	4.2	0.5	0.5	1.3	1.5	11.4	14.8	2.8	0.1	1.2	1.8	0.2	0.7	1.8	0.8	0.9	0.6	1.7	0.8	0.7	1.7	0.6	1.3	1.6	2.2	23.3	1.0	2.2	1.3	1.2	1.7	0.2	1.4	2.7	4.1	0.4	2.1	10.0	6.5	0.5	0.3	1.3	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	1.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.1	12.1	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.2	0.4	2.1	0.0	2.5	3.8	0.2	0.1	4.2	0.1	0.2	0.2	0.1	2.1	0.4	0.1	0.3	10.0	0.5	6.5	0.3	0.1	1.3	0.5	1.0	0.4	0.9	0.5	0.5	2.8	0.1	0.8	1.3	0.0	2.2	0.0	0.0	0.2	0.0	7.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.0	0.0	0.6	14.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.7	10.7	9.4	2.9	13.1	8.1	3.0	2.8	2.4	0.7	1.0	0.6	1.6	10.1	4.2	2.6	3.4	11.8	13.5	4.8	2.0	8.2	3.9	1.4	20.1	4.4	5.6	4.0	8.7	3.8	14.8	4.6	3.7	26.3	6.6	5.5	3.2	4.8	7.8	7.8	7.9	1.4	0.4	6.0	2.9	6.0	10.5	4.3	19.3	8.9	9.3	7.9	3.3	2.7	7.9	1.6	8.1	4.1	7.7	2.8	1.6	10.4	4.2	8.8	10.3	3.3	4.0	4.8	16.1	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8	80.4	47.6	4.9	4.8	24.4	27.8	23.0	15.3	6.7	21.6	22.7	200.3	0.3	0.0	3.9	0.6	7.3	6.5	23.3	4.7	1.1	6.1	8.8	6.9	41.0	5.9	12.7	6.3	10.4	54.2	0.9	10.6	18.5	25.3	2.8	3.3	28.2	11.0	6.8	11.0	5.0	70.5	12.9	9.9	8.4	6.1	38.3	1.0	9.6	6.0	5.7
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 108.0;Cone photoreceptor cells: 239.5;Ito cells: 148.5;Rod photoreceptor cells: 121.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	49	"basophil: 4.8;eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 41.7;SH-SY5Y: 39.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 83.2;olfactory region: 364.7"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	6.3	16.5	9.6	6.5	36.8	0.4	7.7	7.4	12.4	26.4	17.0	4.3	12.0	15.1	35.6	6.3	10.6	17.8	16.9	11.3	6.7	3.9	7.3	5.9	7.5	5.2	3.9	6.9	16.4	10.0	2.8	19.8	6.4	10.7	28.8	5.2	6.4	39.0	16.7	1.0	2.9	5.2	34.6	6.2	5.6	11.3	2.6	8.6	2.2	3.5	4.6	3.2	19.5	16.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	4.7	4.4	5.7	16.2	6.5	8.0	1.3	10.3	5.8	12.3	6.9	6.2	3.9	2.7	0.2	41.7	7.9	8.3	10.0	2.6	6.9	3.9	6.4	21.0	5.9	5.1	11.0	6.2	21.5	10.6	2.3	8.3	2.5	16.4	7.0	1.0	7.0	0.0	2.5	5.0	0.0	2.4	0.0	5.7	1.4	0.0	4.2	1.5	0.0	9.3	4.4	39.4	3.9	2.7	3.0	6.6	1.2	4.9	9.9	14.2	1.7	3.7	4.4	2.8	2.8	5.3	16.8	3.5	3.5	4.8	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	36.8	7.4	8.0	6.7	3.9	3.9	6.9	10.7	8.6	0.0	8.2	2.9	108.0	15.5	14.5	21.8	66.2	25.4	6.8	1.8	239.5	21.3	0.0	42.0	11.8	23.5	0.9	0.0	24.0	5.7	46.8	24.7	61.2	7.9	2.8	3.2	1.7	148.5	6.6	4.4	44.3	1.7	8.5	1.0	0.0	11.8	22.0	0.0	38.9	0.0	121.2	32.3	43.2	1.8	2.7	5.4	3.8	1.9	0.6	43.1
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	12.1	20.6	13.2	15.6	17.7	11.8	12.5	25.8	26.9	15.5	14.9	16.4	22.2	16.9	14.8	18.4	18.9	17.6	14.7	9.0	12.4	11.5	15.9	23.0	12.8	22.1	12.5	15.6	19.7	25.9	16.8	18.0	16.1	16.0	15.9	11.6	16.6	23.3	19.9	8.4	21.6	15.8	11.0	9.8	20.6	15.3	21.2	12.3	33.2	23.9	6.2	20.3	13.7	15.5	5.2	2.9	3.4	1.5	1.8	4.8	1.0	16.3	22.0	14.1	22.1	15.8	10.2	16.6	11.8	11.7	18.4	12.4	12.7	16.2	23.3	19.3	9.1	15.4	23.4	19.1	16.3	11.1	19.9	28.2	19.3	17.7	16.9	14.0	12.4	13.1	11.7	12.3	15.5	12.8	11.1	17.0	30.0	28.0	8.9	10.2	30.6	31.3	25.1	18.4	13.8	33.1	24.3	16.0	22.3	11.9	15.2	19.9	17.5	13.9	19.7	14.3	10.5	29.3	13.8	10.7	17.4	16.7	20.8	9.9	14.0	16.2	11.8	13.8	9.7	11.0	0.9	1.3	3.4	3.7	1.5	4.8	3.7	2.6	4.6	1.3	5.2	4.5	2.6	0.2	1.8	0.5	2.9	1.9	1.0	13.2	17.7	25.8	26.9	12.4	11.5	12.5	15.6	16.0	12.3	3.0	4.8	19.3	3.8	5.0	8.3	3.7	2.5	1.4	1.2	3.5	5.9	15.7	3.3	7.3	0.9	4.4	8.4	0.0	6.2	18.5	4.6	4.9	1.1	9.4	7.9	3.2	4.1	8.0	0.3	0.6	11.2	2.6	8.5	6.4	8.7	8.4	7.1	10.1	3.5	6.2	5.7	12.9	2.7	16.6	15.5	6.0	13.6	6.7	9.5	3.0
MEPCE	"BCDIN3, FLJ20257, MePCE"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434126	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	17.5	24.1	17.7	13.9	22.8	18.5	15.0	24.1	24.1	15.7	14.0	16.7	26.9	14.1	18.8	22.5	16.1	18.6	22.9	12.4	20.1	13.7	18.7	20.8	13.5	19.7	19.7	16.4	29.2	18.3	32.5	15.0	19.0	19.3	15.8	10.2	17.2	18.5	24.2	21.4	26.1	15.8	15.7	17.7	34.9	14.4	63.1	20.4	21.7	25.7	17.1	17.9	16.3	20.4	8.4	8.7	9.3	3.6	7.3	9.1	10.6	13.5	17.6	13.1	14.0	12.7	12.8	9.7	15.2	22.3	16.5	12.8	14.3	20.0	28.0	25.4	9.5	13.0	12.6	14.2	11.5	10.9	12.5	16.2	14.4	13.6	10.8	10.7	18.4	17.9	13.2	13.8	18.8	23.9	9.0	13.7	9.0	28.5	20.8	15.7	50.5	21.0	42.0	24.1	11.4	19.6	17.0	10.5	25.4	11.0	8.4	19.7	17.0	23.8	46.7	15.9	6.8	11.9	16.9	11.7	27.8	21.6	18.7	20.0	13.8	13.1	31.2	15.6	23.1	24.3	2.5	3.6	4.8	5.6	3.2	6.5	8.0	6.4	6.0	4.4	8.4	9.1	8.0	9.3	7.3	2.6	8.7	5.7	10.6	17.7	22.8	24.1	24.1	20.1	13.7	19.7	16.4	19.3	20.4	8.9	20.5	18.0	14.7	26.9	8.9	19.8	17.8	9.4	7.9	21.0	7.9	13.3	13.3	9.0	21.7	18.0	26.9	0.0	10.4	7.0	12.5	12.5	17.4	17.9	10.9	11.1	10.3	33.2	27.3	44.1	16.1	14.2	8.5	18.0	18.8	16.7	8.8	24.6	14.5	11.7	9.1	6.5	12.8	34.9	13.7	22.0	17.7	15.8	15.5	8.6
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.7	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.3	0.0	0.7	0.0	0.4	0.0	0.0	5.0	5.0	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.1	0.8	1.4	0.0	0.0	9.5	0.2	0.0	1.3	0.1	0.0	4.4	0.1	1.1	1.9	1.2	0.0	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.3	0.8	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9	0.0	0.6	0.8	2.6	0.2	10.5	5.2	12.7	0.0	0.0	1.8	9.8	1.8	10.0	16.5	3.7	0.7	17.0	0.0	37.0	0.1	1.0	36.0	4.6	11.5	2.0	7.9	5.8	3.1	2.2	1.0	1.1	2.1	6.8	2.8	4.6	12.7	7.1	10.5	0.0	11.1	15.3	0.0	1.0	42.6	14.3	0.3	0.2	4.4	11.0	5.0
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.1	16.4	9.3	8.9	7.0	8.9	8.7	7.8	6.8	8.9	7.4	21.8	4.0	19.3	8.5	7.1	9.5	8.9	21.4	10.7	12.2	7.3	13.6	9.9	13.5	9.9	7.6	9.1	8.0	7.5	10.2	12.3	18.2	6.1	9.2	11.3	12.9	10.4	6.0	6.7	13.0	5.4	10.6	7.6	6.9	21.7	9.8	8.7	6.5	5.6	4.9	7.7	11.7	6.4	6.9	10.0	8.1	5.8	6.7	8.2	5.3	11.6	11.3	6.1	7.5	13.8	11.1	7.6	11.1	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5	11.9	31.0	7.0	19.7	10.2	26.4	14.0	15.3	34.8	36.4	7.0	43.2	7.3	11.6	8.4	12.4	12.9	15.8	0.0	9.2	7.9	8.9	15.5	24.3	7.3	8.9	25.4	19.5	19.6	9.2	5.4	13.8	8.2	8.5	9.0	12.7	25.1	8.0	3.5	12.0	7.0	38.8	6.5	13.2	11.4	17.4	11.2	5.0	20.8	14.0	13.5
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794966	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	8.7	7.3	12.1	9.9	9.0	3.8	11.5	13.5	11.8	6.5	6.8	3.5	8.4	5.6	7.7	9.8	7.8	8.2	5.2	10.2	8.5	6.8	8.6	8.5	5.9	16.5	11.1	10.1	10.4	9.4	31.9	9.4	6.3	9.2	11.2	6.8	3.4	8.4	7.5	5.0	6.5	9.2	6.3	12.7	14.3	8.2	6.7	11.2	9.8	10.0	8.0	11.8	7.8	8.9	13.4	5.4	12.2	5.8	12.4	19.3	9.8	9.0	5.2	8.5	5.8	5.0	9.3	5.9	4.2	4.9	5.4	4.7	6.6	14.7	15.4	11.8	5.6	7.9	10.4	8.5	9.6	7.3	9.2	6.8	11.0	4.7	5.4	10.3	11.6	5.1	4.2	10.1	5.5	6.0	5.5	10.3	11.9	11.6	7.3	7.2	4.4	12.2	7.9	10.7	19.5	13.1	9.1	8.4	11.6	8.7	9.1	6.3	9.7	9.0	10.2	12.4	13.2	13.5	12.8	4.6	6.8	6.5	6.8	9.8	14.3	18.6	20.8	5.0	9.3	6.8	9.3	5.2	12.2	14.6	5.8	18.5	12.1	16.3	17.0	5.4	13.4	19.3	18.3	3.0	12.4	3.4	4.2	18.4	9.8	12.1	9.0	13.5	11.8	8.5	6.8	11.1	10.1	9.2	11.2	3.0	5.8	1.5	5.6	1.3	7.5	5.3	5.1	13.4	5.7	5.2	0.0	11.5	21.6	9.3	13.7	7.8	3.9	0.0	6.9	4.9	5.6	3.4	6.9	2.6	6.5	6.4	2.9	2.5	4.7	3.6	5.8	2.8	5.0	1.0	4.9	8.5	5.3	5.8	4.9	7.0	6.1	0.0	2.8	14.4	9.4	0.6	9.6	10.0	4.9	2.1
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	10.4	9.1	16.5	13.8	18.2	20.2	14.6	14.0	16.9	9.0	9.3	8.7	3.8	8.1	10.0	8.4	6.7	8.3	7.1	13.2	16.3	15.4	11.1	20.9	8.9	15.4	25.8	10.6	12.0	10.6	11.6	10.1	12.7	20.2	8.8	9.2	8.8	8.4	7.1	19.5	9.0	8.3	8.3	19.2	15.4	12.3	7.1	18.8	18.5	15.2	6.2	14.8	10.1	24.3	25.2	14.8	25.9	20.6	7.5	14.4	8.3	8.0	7.6	12.6	9.5	5.6	5.9	24.5	4.5	5.6	7.3	7.4	14.4	13.0	11.7	10.0	3.5	12.9	4.7	18.0	5.9	6.1	6.8	12.4	13.6	12.2	23.7	9.9	17.8	13.8	5.2	7.9	3.6	6.1	9.1	8.2	19.6	19.6	6.9	4.8	13.1	17.9	30.5	20.9	11.0	5.4	13.2	5.3	16.9	10.5	6.8	14.9	12.3	9.7	3.4	9.4	18.3	4.7	26.4	4.2	6.4	14.0	5.9	7.9	10.2	12.8	24.1	10.5	14.0	9.5	13.8	14.4	25.9	5.0	13.9	8.3	25.2	7.6	7.1	11.8	21.6	14.4	9.2	5.0	7.5	20.6	14.8	5.9	8.3	16.5	18.2	14.0	16.9	16.3	15.4	25.8	10.6	20.2	18.8	14.9	22.3	43.0	29.8	14.2	19.9	23.8	15.3	25.4	21.6	10.4	7.9	32.6	24.9	21.2	24.4	14.8	9.7	0.0	22.0	25.1	20.5	35.0	46.1	10.9	26.1	17.5	5.2	12.3	20.6	28.4	9.2	39.1	42.2	19.0	14.2	15.6	18.5	61.9	7.1	19.3	19.9	12.9	12.5	9.8	17.2	11.0	8.8	18.3	16.6	16.6
METTL22	"C16orf68, FLJ12433, MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 86.1;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	8.4	10.6	5.4	10.5	8.8	12.5	8.0	17.1	10.2	9.6	10.9	10.9	13.6	9.2	13.0	12.2	7.6	8.6	9.8	15.0	7.0	7.3	7.1	9.5	6.5	10.8	7.9	6.8	10.8	10.6	7.3	7.6	9.4	9.3	10.5	7.9	10.2	9.5	15.6	45.2	15.7	6.4	11.4	6.3	8.1	9.8	27.8	9.3	10.4	10.1	10.0	9.1	9.7	9.9	1.1	2.8	12.6	3.0	1.8	1.6	1.4	3.7	7.7	8.8	8.3	3.3	8.5	7.6	6.4	3.4	7.7	8.7	7.5	8.7	5.8	5.8	5.6	2.8	7.1	5.5	10.2	5.1	8.5	7.5	6.0	13.4	21.2	10.0	6.1	4.6	8.5	7.4	8.4	9.2	4.7	6.1	8.1	8.0	6.0	5.8	13.2	6.3	14.8	4.7	1.7	7.6	9.6	6.6	12.1	3.7	4.0	10.8	7.2	5.6	6.6	4.2	5.0	7.2	5.1	4.7	9.1	7.9	7.4	2.9	8.1	4.3	9.1	3.3	8.2	4.2	1.4	3.0	2.4	1.3	2.3	1.2	1.1	1.1	1.3	2.8	1.1	1.5	0.7	12.6	1.8	2.5	1.6	1.6	1.4	5.4	8.8	17.1	10.2	7.0	7.3	7.9	6.8	9.3	9.3	8.9	6.4	9.7	6.4	3.0	13.1	16.7	5.1	2.7	5.7	0.0	3.9	10.3	10.0	8.1	86.1	6.7	5.6	0.0	8.3	8.2	4.3	8.9	8.1	6.2	26.1	1.6	6.9	5.5	27.8	289.3	10.0	22.9	1.7	2.8	5.1	5.4	7.7	8.2	13.1	6.8	12.2	0.0	4.7	22.1	12.9	2.4	11.1	5.7	5.9	6.5
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046141	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 15.6;testis: 33.3"	"Group enriched"	"Detected in many"	21	"Early spermatids: 185.8;Late spermatids: 144.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.5;HEL: 24.6;SH-SY5Y: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.0	0.6	1.5	1.8	1.6	2.0	1.6	3.8	4.5	15.6	2.8	1.6	2.5	0.8	7.9	0.6	1.1	1.2	2.8	2.0	2.0	1.4	1.0	1.0	1.4	2.8	2.2	3.3	6.8	0.7	0.2	0.9	3.3	1.0	3.7	0.9	1.2	3.0	3.8	1.6	1.1	1.1	4.0	1.0	1.2	1.0	33.3	0.7	8.4	1.0	1.8	1.2	3.1	4.2	0.0	1.3	0.0	0.1	0.4	0.1	0.0	0.1	1.2	8.8	33.5	0.7	1.0	2.5	1.0	0.5	1.8	1.6	0.2	0.2	1.5	0.6	1.9	0.5	0.2	4.1	0.1	1.3	0.3	2.7	24.6	1.4	1.1	1.4	0.3	7.8	0.5	0.7	1.0	2.0	4.3	3.8	3.1	1.2	0.0	3.1	0.8	4.0	2.1	11.4	0.0	0.3	5.6	5.4	0.8	0.0	0.0	7.0	13.7	1.7	0.3	1.1	2.6	0.1	0.4	3.5	4.6	5.4	2.5	1.5	3.2	1.6	1.8	1.5	2.4	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	1.6	3.8	4.5	2.0	1.4	2.2	3.3	1.0	0.7	0.0	1.1	0.0	0.4	2.5	3.3	3.7	0.0	0.0	0.0	0.0	2.0	7.7	0.0	0.8	185.8	1.9	0.0	0.0	0.2	7.2	4.3	0.9	1.1	0.0	1.5	0.0	1.2	3.7	1.0	144.1	6.1	3.6	6.8	0.0	1.6	5.7	0.6	0.0	4.2	0.0	2.8	6.5	4.0	2.6	4.3	1.8	2.1	0.0	1.1	0.3
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824802	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	23.7	32.9	23.8	25.4	25.0	12.5	24.3	35.5	29.2	22.5	19.5	17.7	20.0	15.9	25.2	27.2	28.0	21.2	16.8	21.9	24.6	21.2	28.1	20.0	16.8	26.7	21.5	30.9	29.2	20.0	38.5	33.0	25.2	24.0	26.3	20.7	15.5	21.9	21.8	33.3	24.4	19.3	21.5	26.7	23.9	21.0	21.7	27.3	33.9	28.2	19.2	34.1	24.1	28.2	21.2	20.3	34.3	21.5	29.6	26.0	15.1	15.5	16.2	28.2	18.5	24.0	15.2	17.4	25.1	17.5	20.4	23.9	25.2	10.2	16.7	24.0	15.5	20.8	28.3	25.1	20.5	24.2	28.2	15.0	40.5	29.2	18.8	18.9	24.0	21.7	14.1	22.5	19.5	17.7	19.7	19.9	19.3	36.6	14.4	24.4	11.6	19.5	18.2	19.9	29.1	14.2	28.7	28.3	10.7	21.2	23.3	17.9	17.6	22.1	19.0	10.2	23.5	28.5	15.5	18.8	20.8	14.8	22.8	20.2	17.7	42.6	36.6	17.5	23.0	15.2	21.4	15.8	34.3	23.4	21.5	22.9	21.2	23.4	22.0	20.3	18.6	24.1	23.5	14.4	29.6	17.1	16.7	26.0	15.1	23.8	25.0	35.5	29.2	24.6	21.2	21.5	30.9	24.0	27.3	32.8	24.6	22.3	53.2	27.0	43.5	27.8	22.9	76.3	37.5	48.8	5.9	80.4	48.0	35.7	4.6	33.8	18.8	0.0	25.6	46.4	25.7	30.0	46.1	16.3	30.6	30.2	10.9	19.0	22.6	4.7	25.9	22.6	25.3	32.5	19.6	45.9	21.9	28.1	33.6	32.8	30.7	19.4	23.5	42.6	76.1	24.2	123.1	30.6	18.8	39.7
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038906-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	21.3	7.6	5.8	8.0	12.2	7.9	11.3	12.6	11.4	11.1	8.3	6.3	7.8	7.2	14.1	7.3	11.6	7.5	8.9	9.2	7.2	6.8	9.5	9.4	10.9	6.8	6.4	7.1	9.4	6.3	27.2	9.6	15.0	8.8	7.8	8.4	9.5	8.8	6.4	13.2	6.4	9.5	11.7	8.9	7.9	7.4	8.3	7.0	9.1	11.3	6.3	9.2	12.2	10.1	3.0	10.6	14.6	10.3	7.7	9.6	5.4	9.7	12.7	21.6	22.7	19.5	18.3	21.2	17.6	18.9	18.4	23.8	19.1	22.2	14.0	20.5	16.6	18.3	22.0	20.3	22.0	29.5	6.3	13.3	9.2	19.5	6.9	18.6	16.4	10.8	19.7	21.9	22.0	18.7	15.2	25.7	12.7	10.4	15.2	16.0	6.4	9.1	3.7	11.2	10.4	7.5	8.7	25.6	12.8	11.9	13.8	22.3	24.9	19.3	21.8	17.4	20.0	22.9	8.1	23.3	24.0	16.8	13.2	17.9	15.3	19.6	13.2	12.2	11.3	18.8	8.1	10.3	14.6	6.5	9.8	9.6	3.0	5.6	4.9	10.6	3.0	7.4	5.4	8.4	7.7	7.0	3.8	4.9	5.4	5.8	12.2	12.6	11.4	7.2	6.8	6.4	7.1	8.8	7.0	0.0	0.3	0.0	0.9	5.4	3.3	2.0	0.0	0.0	0.0	5.2	5.9	3.5	1.7	0.9	4.5	4.8	2.0	0.0	1.0	2.4	2.7	1.1	4.6	1.6	1.6	3.2	0.0	0.0	1.2	3.3	1.7	2.5	8.5	1.0	0.6	7.8	0.9	0.0	0.0	1.1	4.3	0.0	3.0	2.1	2.1	4.8	5.0	1.3	0.6	1.4
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 409.5;Late spermatids: 1347.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	2.0	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	3.4	1.8	6.9	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.4	1.2	2.1	0.2	0.6	1.0	0.2	2.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	0.4	3.0	0.0	1.1	0.0	5.2	23.5	1.6	3.5	3.2	21.6	6.9	12.8	1.2	0.0	0.1	1.9	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8	0.0	6.4	0.0	0.2	2.3	9.2	2.5	0.0	0.0	0.0	34.9	19.6	2.9	5.0	0.4	409.5	2.3	0.4	23.3	1.0	0.9	0.5	0.5	4.6	43.3	0.9	3.2	2.4	4.9	1.0	1347.3	4.9	0.6	6.8	0.0	0.1	2.3	1.3	0.0	8.5	17.3	14.7	19.4	3.4	18.0	13.6	7.3	7.9	0.0	0.4	2.1
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893645	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	8.0	2.7	10.1	14.9	10.2	12.5	5.8	10.3	10.0	8.7	16.6	5.0	5.0	7.6	7.7	4.8	7.6	9.9	10.7	7.6	10.0	6.5	15.8	10.5	12.5	12.1	6.2	4.7	6.8	6.3	6.2	3.3	11.1	7.4	8.9	14.9	5.4	7.6	6.1	4.4	8.5	9.5	10.4	3.6	13.5	9.0	7.6	5.2	24.9	10.8	3.6	10.6	9.3	15.0	1.1	0.5	0.0	0.3	0.4	3.9	0.9	7.9	6.0	3.6	2.7	3.4	4.4	12.0	3.3	7.1	2.4	3.2	9.5	1.5	11.6	4.1	3.1	6.9	2.7	3.8	3.0	2.1	15.0	3.4	0.8	2.2	6.1	4.1	3.3	1.2	2.4	6.4	3.2	3.2	2.6	5.2	14.5	5.3	0.0	1.9	2.8	51.2	2.9	7.1	10.5	2.5	7.0	5.6	1.8	16.7	8.3	5.8	4.7	1.9	3.0	5.2	6.5	2.0	4.5	2.2	2.9	4.3	11.5	6.3	0.6	2.7	9.1	5.4	4.4	1.7	0.0	0.3	0.0	2.5	0.1	2.1	1.1	3.9	2.2	0.5	1.0	1.9	1.7	0.0	0.4	0.0	0.1	3.1	0.9	10.1	10.2	10.3	10.0	10.0	6.5	6.2	4.7	7.4	5.2	50.6	44.0	7.4	22.5	33.3	17.4	14.0	22.9	5.3	25.0	29.6	3.9	2.5	11.6	10.6	1.9	16.1	8.6	23.3	13.2	2.5	21.6	32.3	21.9	15.3	25.5	3.2	18.1	27.0	25.7	1.9	10.6	10.6	10.1	2.8	28.4	21.8	21.5	5.8	7.8	14.6	8.1	0.0	42.2	1.9	20.2	43.7	1.9	20.8	24.0	15.4
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934859	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	21.6	9.1	10.3	15.2	10.7	62.9	34.4	20.2	13.0	17.1	18.1	8.9	17.5	13.8	16.0	17.1	18.0	16.3	23.5	13.5	9.6	10.1	15.7	6.0	16.8	17.6	9.1	10.1	20.6	20.9	4.2	13.3	13.5	8.4	22.0	5.2	7.1	27.1	14.5	10.3	10.0	19.0	10.9	7.7	16.3	18.7	11.1	7.4	8.3	29.9	15.0	14.9	15.2	16.7	18.4	22.2	42.5	33.1	16.1	33.2	15.0	12.9	12.3	3.5	9.0	6.0	4.3	9.8	12.0	5.9	5.9	6.8	6.5	31.4	2.3	6.4	7.5	10.9	12.2	3.2	17.3	1.6	14.6	11.1	4.9	10.5	6.7	10.1	15.5	7.2	6.5	10.2	6.6	4.2	9.1	6.7	5.2	6.8	4.8	4.4	14.0	4.4	71.8	11.7	10.2	14.8	5.4	1.7	10.8	8.7	8.0	9.3	11.1	2.8	8.4	12.5	3.8	22.1	29.5	9.8	4.7	8.3	5.9	9.5	3.2	1.4	3.5	13.7	39.7	7.5	21.0	21.4	42.5	29.9	26.4	25.3	18.4	19.3	33.2	22.2	14.8	9.9	17.3	16.8	16.1	33.1	17.4	12.6	15.0	10.3	10.7	20.2	13.0	9.6	10.1	9.1	10.1	8.4	7.4	35.7	29.0	29.6	60.0	27.8	6.7	4.6	28.1	29.4	21.6	43.6	7.9	55.4	3.3	85.0	10.1	33.1	37.5	0.0	39.9	70.0	33.4	67.6	32.3	2.9	65.2	14.3	27.1	38.6	37.6	12.2	33.6	46.5	40.5	72.1	34.1	9.8	74.5	42.1	21.2	17.3	9.4	90.5	37.6	14.3	16.0	23.5	70.0	69.2	41.7	89.7
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 59.6;WM-115: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	25.9	13.0	15.4	19.0	14.4	23.5	9.3	10.4	22.9	8.1	8.9	24.3	11.2	12.5	10.2	12.7	11.1	14.3	10.0	7.6	23.9	12.8	38.0	21.5	13.8	15.2	20.7	10.0	9.7	19.8	15.7	11.9	46.6	15.6	10.2	5.7	13.5	23.7	10.5	8.1	43.6	13.8	9.9	18.6	19.7	14.1	7.5	16.1	37.0	9.1	6.1	11.8	7.9	7.8	2.4	12.9	2.6	7.9	0.5	3.1	1.6	17.0	13.8	3.4	8.9	7.1	5.5	12.3	10.5	5.7	12.3	13.5	5.9	5.8	4.8	8.0	5.5	19.6	10.7	4.4	5.4	4.4	10.5	12.5	2.8	44.2	6.0	8.9	6.0	9.5	4.9	8.2	12.6	2.9	4.7	3.3	7.2	13.4	7.0	3.1	10.2	5.9	10.8	6.4	7.5	11.2	4.3	4.9	20.3	5.1	7.3	12.9	6.5	20.7	9.7	59.6	4.4	3.3	12.6	13.5	5.6	8.2	22.7	11.8	8.0	4.5	4.4	24.6	15.6	113.8	0.1	4.0	2.6	2.1	7.9	2.1	2.4	3.1	1.6	2.8	1.7	2.7	2.1	1.3	0.5	7.6	12.9	0.5	1.6	15.4	14.4	10.4	22.9	23.9	12.8	20.7	10.0	15.6	16.1	6.0	3.2	15.2	3.8	23.6	15.8	1.6	12.7	4.0	4.5	19.2	5.9	10.7	0.0	19.3	101.3	10.8	13.8	0.0	26.4	117.0	8.0	13.6	0.0	19.2	73.9	35.0	26.9	8.6	19.6	20.9	2.3	32.4	185.5	19.8	9.3	8.3	29.4	17.3	3.2	33.8	11.5	12.9	5.0	4.2	9.1	22.2	77.5	7.5	8.6	13.2
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.7	13.1	10.2	28.8	20.7	20.9	25.3	22.0	22.5	22.1	8.4	31.1	31.3	15.1	21.7	26.1	57.4	15.6	16.1	22.0	22.3	8.4	10.7	16.1	12.6	20.5	33.8	20.0	18.9	24.4	23.8	18.3	12.6	19.2	17.2	20.3	18.6	29.9	19.7	24.7	19.4	19.2	38.0	13.5	12.4	30.1	10.1	24.0	20.0	12.6	16.6	21.5	25.5	26.7	16.4	11.6	20.0	20.6	23.6	16.7	36.2	23.3	20.6	25.5	8.6	21.0	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2	6.0	21.9	13.7	20.2	0.0	11.2	0.0	17.8	13.4	12.5	41.8	3.9	12.4	6.6	15.2	2.6	11.3	7.1	0.0	16.4	22.4	13.2	30.5	3.5	10.4	25.8	4.8	7.0	27.0	63.5	2.1	15.5	18.5	0.0	10.8	26.6	18.1	22.0	15.8	15.2	5.7	9.1	12.9	0.0	10.4	17.5	0.0	16.0	13.8	14.9	41.4
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	12.3	26.9	20.8	9.3	23.3	4.2	13.8	19.4	33.1	15.3	20.0	29.0	29.0	12.6	7.1	22.3	26.6	13.0	10.3	11.1	25.4	26.5	7.4	2.0	16.9	8.7	36.2	22.9	3.5	10.9	28.2	35.7	5.6	43.1	15.7	19.0	12.2	19.2	29.6	3.8	18.9	15.4	9.5	36.7	12.7	20.2	4.9	18.3	13.0	25.5	10.8	12.7	13.3	13.6	2.4	2.6	8.1	2.0	3.3	5.6	1.2	10.6	6.6	0.2	2.3	4.8	6.2	9.1	5.5	11.1	3.7	4.7	2.4	13.6	16.7	2.6	11.4	7.0	18.2	3.2	9.6	4.2	33.9	5.0	8.9	6.5	1.2	1.9	3.5	2.8	0.9	17.5	5.5	3.6	12.2	1.3	13.3	2.2	18.6	0.9	4.1	16.3	0.7	1.5	11.6	7.1	3.6	0.5	14.3	7.1	19.5	21.2	5.4	7.8	18.4	10.6	0.7	6.0	4.1	5.5	0.6	1.3	7.3	8.4	8.6	3.5	6.0	6.1	7.3	3.0	8.1	2.0	0.6	2.6	0.6	2.7	2.4	3.5	3.6	2.6	1.3	1.6	3.6	0.1	3.3	0.9	1.3	5.6	1.2	20.8	23.3	19.4	33.1	25.4	26.5	36.2	22.9	43.1	18.3	29.8	21.2	3.9	9.9	5.7	8.3	17.9	5.1	108.4	37.5	22.7	7.9	0.1	0.0	12.6	37.9	12.8	13.4	0.0	17.7	0.1	2.3	15.4	22.1	0.6	4.2	27.0	34.0	11.1	2.1	9.9	5.2	9.2	8.5	4.6	38.6	7.1	20.1	17.5	4.9	1.3	7.7	0.0	3.1	0.9	1.1	15.9	0.0	10.2	14.4	19.0
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.1	8.2	8.2	4.3	11.9	3.9	12.2	11.2	13.2	6.9	8.4	6.3	11.8	9.1	6.7	4.8	7.8	6.6	7.2	5.0	5.9	6.2	2.1	7.7	5.8	4.1	8.7	6.1	8.1	5.3	11.6	7.7	4.3	1.7	1.4	8.6	4.6	4.6	0.5	4.5	5.8	11.9	7.3	2.6	7.8	8.0	3.3	5.7	4.7	3.4	4.5	2.7	2.8	10.1	5.9	11.5	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2	11.9	13.1	8.1	4.7	2.9	16.3	2.8	2.5	10.7	13.6	15.7	19.6	9.8	1.7	7.4	9.5	5.6	7.0	0.0	6.1	6.5	5.6	4.3	12.7	9.4	6.6	11.1	4.1	8.0	7.5	10.7	8.6	6.0	3.3	6.4	6.8	11.0	6.3	9.7	8.9	5.7	21.2	6.5	3.8	11.4	4.3	5.0	18.4	14.4	6.8	3.5
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MGA, MAX dimerization protein"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: AB_2683632"	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	9.3	11.3	13.8	13.6	15.3	14.3	13.0	28.2	16.9	14.5	10.1	13.3	12.2	6.8	14.2	11.5	9.8	11.3	7.8	10.1	11.2	7.7	10.1	8.5	8.5	12.7	18.7	10.5	22.7	12.0	18.0	27.6	12.4	13.7	11.0	9.7	7.2	10.3	10.8	11.8	11.2	10.6	11.8	16.1	12.5	9.8	16.4	14.7	22.4	13.9	5.3	13.4	11.6	11.5	5.0	4.1	4.9	4.9	9.8	5.0	1.5	1.4	8.5	10.7	7.0	8.4	6.7	8.6	4.2	4.3	5.1	5.0	9.0	5.0	10.0	7.7	4.9	9.2	5.9	16.5	3.7	7.0	4.7	5.4	21.3	14.0	8.0	7.5	19.5	10.6	5.1	4.6	7.0	7.0	2.1	6.5	9.8	24.7	4.6	4.5	4.1	11.8	7.6	6.6	4.3	4.4	13.4	10.9	5.2	2.7	6.1	10.2	9.9	15.1	5.3	2.7	8.2	4.3	12.5	6.9	6.1	8.7	6.3	5.0	6.3	9.4	9.8	3.9	7.5	3.0	4.9	2.3	2.5	4.7	1.8	4.6	4.8	3.7	5.0	2.4	5.0	3.9	4.3	1.2	9.8	4.9	4.1	1.8	1.5	13.8	15.3	28.2	16.9	11.2	7.7	18.7	10.5	13.7	14.7	20.8	17.5	20.6	9.5	7.0	24.2	25.5	5.1	20.1	21.6	12.2	31.4	14.6	6.6	10.4	11.7	15.0	7.0	23.3	4.6	10.4	12.5	11.4	13.9	8.1	10.1	12.7	7.5	15.4	11.0	4.6	19.2	11.8	8.5	2.8	9.2	13.5	7.3	11.5	19.4	4.2	21.2	38.8	13.4	27.3	40.0	9.8	21.7	17.5	10.5	8.7
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604214	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	14.8	32.4	23.9	23.5	23.2	20.9	22.9	28.6	25.4	19.5	25.4	17.3	16.1	18.0	16.7	21.1	19.9	17.8	16.3	41.7	22.9	24.1	52.8	24.5	15.6	16.8	23.4	25.6	17.0	16.9	19.5	30.3	31.2	20.6	20.3	23.9	14.5	16.9	23.6	39.6	15.5	21.0	14.7	28.1	19.4	20.1	17.5	22.6	25.2	26.3	25.6	19.4	15.6	15.4	33.2	21.8	26.5	23.5	22.8	30.7	17.2	11.8	6.8	16.2	10.3	14.5	19.5	14.0	20.1	16.5	21.5	15.0	9.9	19.2	18.5	13.1	19.1	11.1	15.9	15.9	16.9	29.7	18.7	16.5	31.9	7.4	11.4	17.5	23.9	18.6	16.8	16.8	12.1	8.6	19.3	14.3	17.5	11.2	8.3	35.0	10.2	15.9	22.8	11.0	41.9	10.8	17.5	41.4	12.3	42.3	9.7	13.1	10.1	13.7	16.2	13.0	14.8	15.8	22.6	17.6	9.4	8.4	19.0	16.5	6.2	8.2	13.5	9.2	20.0	23.2	22.1	20.1	26.5	26.1	23.5	24.1	33.2	23.0	26.0	21.8	20.8	20.9	26.0	18.7	22.8	19.3	20.1	30.7	17.2	23.9	23.2	28.6	25.4	22.9	24.1	23.4	25.6	20.6	22.6	35.7	23.2	29.6	35.2	26.7	24.7	68.6	30.6	50.9	37.5	48.8	21.6	50.6	122.7	36.4	20.1	21.0	30.6	23.3	23.9	37.2	35.7	25.7	24.3	21.3	32.4	39.7	29.2	19.6	34.1	10.0	31.4	30.0	45.5	39.7	26.0	60.5	29.6	54.7	33.9	82.6	49.4	58.2	27.8	59.5	48.0	22.3	58.8	35.4	29.2	26.8
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.89e-4)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	15.5	6.8	9.1	9.3	11.8	4.3	9.7	14.4	12.5	8.6	7.5	10.0	6.6	9.8	12.0	7.8	9.4	7.9	8.5	9.1	9.8	6.7	6.4	3.4	12.5	8.5	9.1	7.8	8.5	11.6	3.7	9.8	13.5	9.1	10.9	3.3	8.3	12.9	10.9	17.0	18.4	9.3	6.4	6.4	17.2	10.3	31.5	12.1	4.6	8.3	7.1	6.6	9.1	16.5	2.2	6.6	6.4	5.8	1.6	3.3	3.0	8.9	5.7	5.1	5.9	1.9	2.8	11.1	7.4	3.5	5.6	5.9	8.8	2.9	4.7	4.0	3.8	2.2	7.7	3.3	4.3	1.7	11.2	15.8	2.8	4.5	6.6	5.6	0.0	22.2	3.6	3.3	4.5	1.6	3.7	6.3	6.4	7.8	0.0	3.1	9.5	7.3	10.0	13.2	2.7	0.0	6.4	1.7	1.2	2.7	5.1	8.2	7.4	4.3	3.2	7.3	3.2	3.7	5.0	6.6	7.6	5.3	11.6	8.2	13.6	6.7	3.8	7.2	4.0	7.5	6.4	5.8	4.2	2.0	5.2	1.8	0.9	2.7	3.0	6.6	2.2	3.3	2.2	0.5	1.6	5.8	3.7	1.1	3.0	9.1	11.8	14.4	12.5	9.8	6.7	9.1	7.8	9.1	12.1	0.0	4.8	6.0	10.5	10.0	6.4	1.1	7.6	2.7	3.4	3.5	15.7	19.2	1.7	7.9	4.7	8.7	3.5	0.0	4.8	14.6	4.7	8.4	0.0	1.6	9.0	3.2	10.3	9.8	7.0	13.3	5.8	6.5	5.0	4.6	4.2	6.6	6.4	6.2	5.3	1.0	11.5	6.5	4.2	17.7	25.6	9.4	24.6	5.2	4.9	11.3
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 1397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 129.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	49.8	11.0	2.4	11.2	0.9	2.3	18.7	18.8	3.1	6.1	7.8	8.3	8.2	23.7	14.9	1.3	2.8	22.2	2.6	11.4	0.7	19.9	129.4	8.9	10.1	17.2	4.9	34.6	21.1	4.7	6.8	3.6	1.7	4.5	4.8	17.8	13.8	12.1	2.0	25.1	23.5	64.2	14.3	9.8	60.3	30.2	4.1	66.5	4.7	3.4	32.5	37.8	12.0	12.7	31.0	0.6	16.4	10.4	13.7	5.3	35.6	3.2	0.4	52.3	18.4	24.4	21.5	12.9	10.8	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2	145.9	147.8	297.7	257.6	597.1	25.5	0.3	433.1	384.1	354.8	657.8	2.0	427.6	1397.6	643.7	166.1	220.2	275.4	0.0	324.9	742.0	370.2	224.8	172.4	900.8	252.9	20.6	335.5	293.4	221.5	97.3	311.3	223.0	733.9	288.6	378.1	30.6	687.0	340.1	284.6	1307.4	25.0	135.8	432.6	7.9	117.5	663.2	573.7	251.6	418.6	198.5
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	13.2	9.4	12.2	17.0	17.3	53.4	10.8	13.7	15.3	11.1	11.4	11.9	11.6	11.0	16.5	8.8	11.1	13.0	8.9	13.3	12.9	10.1	9.2	11.7	13.3	18.3	15.9	10.6	20.4	13.5	5.8	7.1	14.6	17.0	11.3	4.5	8.5	18.1	14.2	26.3	14.8	12.7	12.3	11.0	20.4	10.0	18.2	15.2	10.5	22.5	9.7	12.5	12.3	11.9	14.8	45.0	18.3	27.1	10.6	19.0	12.5	5.0	3.4	2.7	5.2	1.4	1.6	9.4	2.7	1.4	5.4	4.1	6.6	8.1	6.4	6.6	1.4	3.8	5.3	2.0	3.1	0.7	90.6	7.5	4.0	5.4	7.0	3.1	6.1	12.4	2.2	4.0	4.7	2.1	0.9	3.0	8.8	11.9	5.9	1.6	5.1	6.0	9.1	4.8	3.7	5.1	8.6	3.4	9.8	2.3	1.5	5.0	5.3	4.0	5.1	9.8	1.5	3.4	10.6	3.2	5.0	5.3	9.9	4.2	5.0	6.3	8.6	3.2	10.7	5.0	4.9	23.2	7.1	9.0	25.9	8.4	14.8	9.3	7.8	14.2	13.0	5.8	4.5	18.3	10.6	27.1	45.0	19.0	12.5	12.2	17.3	13.7	15.3	12.9	10.1	15.9	10.6	17.0	15.2	11.9	7.7	14.7	6.9	11.6	14.2	5.0	2.5	6.7	2.3	8.7	7.9	31.4	21.6	13.8	26.0	9.8	14.7	23.3	15.9	82.3	17.4	10.1	17.3	12.5	36.1	7.9	16.0	9.2	17.8	38.7	7.8	20.3	15.1	64.1	9.7	14.2	13.7	14.4	6.3	10.1	14.5	12.9	14.7	14.7	41.9	15.1	27.7	20.8	13.4	5.9
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860520	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Ciliated cells: 21.4;Hofbauer cells: 31.6;Syncytiotrophoblasts: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	14.6	22.0	17.9	10.0	22.2	15.2	18.4	22.0	32.0	19.1	13.7	19.7	11.4	8.2	18.6	20.0	13.4	15.3	13.3	8.9	20.1	18.8	16.0	15.8	15.5	11.9	22.9	14.0	18.1	12.8	16.3	14.4	20.1	25.8	18.9	18.0	13.5	11.8	16.5	4.1	15.3	11.4	16.7	32.0	11.8	14.6	18.8	16.1	10.5	17.2	7.7	12.6	17.8	14.1	3.4	4.2	5.7	8.0	3.4	6.2	2.9	6.6	6.2	12.1	12.8	18.0	17.1	10.0	21.3	10.8	16.3	19.1	5.4	10.5	5.0	4.1	23.0	11.3	6.2	10.3	12.7	14.6	15.3	14.4	16.3	8.8	5.8	22.6	3.3	13.7	12.9	11.1	14.5	10.3	16.0	12.8	12.2	9.9	4.2	16.1	7.2	7.1	4.0	4.4	10.8	11.9	3.5	7.1	3.5	18.2	5.1	10.0	11.1	10.4	10.1	8.5	11.3	11.3	8.1	13.4	10.6	8.2	17.8	6.2	23.1	9.8	8.6	12.2	7.4	8.4	5.7	3.6	3.1	4.9	7.1	4.1	3.1	3.4	5.2	4.0	3.4	2.3	4.4	3.1	3.4	8.0	4.2	6.2	2.9	17.9	22.2	22.0	32.0	20.1	18.8	22.9	14.0	25.8	16.1	20.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	21.4	6.8	14.0	0.0	16.7	16.6	10.4	0.0	0.0	0.0	0.0	7.3	13.3	0.0	0.0	1.1	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.8	0.0	0.0	7.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	18.9	8.5	10.3	12.3	8.1	17.5	8.6	14.9	11.9	9.5	9.6	10.5	7.5	16.8	4.7	8.8	25.6	17.2	10.4	10.9	12.7	6.8	9.1	4.1	10.2	7.0	11.4	18.0	4.7	14.5	13.7	8.5	21.4	9.4	8.5	5.7	20.9	13.8	40.2	13.2	4.0	8.2	20.8	9.6	9.1	12.5	15.7	16.1	8.6	9.7	10.8	17.5	7.9	22.7	8.8	19.8	12.3	16.2	7.4	14.9	16.0	8.2	12.6	12.3	13.5	15.0	13.0	10.5	17.3	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8	8.9	11.0	15.3	12.4	10.8	7.9	16.5	10.2	12.0	9.1	7.0	11.8	14.7	14.9	11.0	29.5	6.4	6.3	0.0	15.2	7.3	5.7	25.8	9.2	15.1	13.8	11.1	4.1	6.7	20.9	40.8	5.5	13.5	6.8	5.4	8.1	7.8	11.3	9.0	7.1	8.4	15.6	12.9	6.6	24.4	28.0	16.6	17.7	12.5	9.3	16.5
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268219-32279069	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 118.1;Spermatogonia: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	5.5	7.5	7.8	6.6	10.7	13.8	7.4	16.4	8.3	6.1	8.9	5.4	1.9	7.9	6.6	6.3	11.4	5.6	5.3	3.9	6.8	4.7	6.7	5.7	3.7	9.7	6.8	9.3	9.8	5.8	3.3	4.3	7.1	6.6	5.5	10.6	4.4	6.0	4.1	4.0	7.8	8.5	7.7	6.2	7.3	6.1	26.6	5.4	19.3	3.9	6.8	11.3	5.3	6.5	18.5	13.2	8.2	11.7	10.4	15.5	6.4	21.1	5.3	15.3	14.6	2.3	4.0	23.5	11.2	5.8	11.0	9.6	10.5	11.8	23.2	8.3	4.2	13.3	7.2	15.0	8.5	13.3	13.2	16.6	26.6	5.6	13.5	1.5	22.7	9.0	1.7	3.7	9.2	6.7	3.6	7.7	23.7	30.9	19.6	10.7	14.5	26.0	20.7	31.6	14.7	15.5	22.8	22.9	21.7	7.6	7.3	18.4	9.1	17.1	14.6	10.5	11.5	17.6	13.9	4.5	13.9	25.7	10.8	11.5	10.6	16.8	29.3	8.9	36.6	12.5	2.4	5.3	8.2	10.2	6.8	10.2	18.2	11.2	11.7	4.9	18.5	15.5	11.5	1.7	10.4	11.7	13.2	14.6	6.4	7.8	10.7	16.4	8.3	6.8	4.7	6.8	9.3	6.6	5.4	17.9	6.2	11.5	6.8	13.9	10.1	5.2	5.1	10.7	5.7	10.4	3.9	29.4	11.6	9.4	4.3	6.8	2.0	0.0	10.7	41.8	12.1	4.6	3.5	7.3	14.5	7.9	5.8	14.1	5.4	5.3	9.8	6.3	5.0	6.4	17.5	9.7	8.2	7.8	9.6	13.7	7.4	19.4	6.6	118.1	79.0	12.9	12.2	8.9	15.3	3.5
MKL1	"BSAC, KIAA1438, MAL, MKL, MRTF-A"	ENSG00000196588	"Megakaryoblastic leukemia (translocation) 1"	Q969V6	22	40410281-40636702	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 87.5;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 50.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	18.1	11.1	15.4	25.4	19.1	69.2	15.8	16.2	26.1	17.6	14.2	13.5	10.1	11.3	27.6	12.9	12.3	17.5	13.2	16.3	14.2	11.1	11.3	8.9	17.4	25.6	11.8	16.6	16.9	14.5	10.2	10.5	18.9	12.6	14.2	9.4	13.3	16.9	15.7	14.3	18.0	13.6	15.7	11.0	23.9	14.3	25.4	10.8	28.2	17.3	9.0	25.5	15.5	14.6	4.9	26.4	50.9	15.0	3.8	5.6	7.5	10.9	14.8	6.5	7.7	8.2	6.2	12.7	10.7	7.0	9.9	9.6	7.0	3.3	11.7	4.4	11.3	8.5	14.4	5.4	13.2	6.4	13.0	9.5	19.4	16.6	10.3	8.1	22.4	38.2	6.7	15.9	9.5	6.6	7.3	7.2	6.9	5.4	5.3	4.6	10.7	8.7	25.2	5.1	5.6	5.2	14.2	7.2	5.9	7.8	8.2	3.6	3.8	17.5	8.9	6.5	8.7	6.0	25.4	11.8	6.7	18.1	8.9	9.2	7.1	6.3	16.9	5.5	11.4	13.0	12.0	15.0	50.9	4.4	11.6	4.1	3.2	4.0	3.4	17.8	4.9	5.6	4.7	14.5	3.8	15.0	26.4	5.2	7.5	15.4	19.1	16.2	26.1	14.2	11.1	11.8	16.6	12.6	10.8	6.0	8.3	7.8	6.0	13.9	11.5	7.3	2.5	8.1	2.3	8.7	21.6	7.0	3.3	9.5	87.5	7.1	7.4	0.0	12.0	6.9	9.1	8.9	16.1	3.9	10.9	3.2	6.4	6.7	17.0	76.0	10.3	13.9	6.8	16.2	6.5	3.7	14.1	2.9	7.4	2.6	12.0	25.8	12.1	9.2	9.5	11.2	6.5	10.1	3.7	8.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	28.4	22.0	17.2	25.5	27.3	23.9	24.3	19.6	25.5	15.5	17.9	9.0	30.0	20.7	30.8	19.1	31.0	13.9	19.3	21.6	19.7	40.9	16.7	21.5	13.2	16.6	22.0	18.4	33.2	23.8	32.6	17.4	16.5	25.6	15.4	14.3	16.9	26.1	14.8	24.5	21.5	32.9	44.2	24.0	16.3	15.6	14.7	31.6	24.8	33.0	23.8	24.6	24.6	33.4	35.1	26.5	16.4	16.0	21.8	10.9	8.7	26.5	17.9	62.3	45.6	18.1	31.2	28.9	22.4	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2	47.6	30.4	57.3	58.0	72.9	58.8	51.3	63.7	33.5	43.3	40.1	33.4	63.4	87.9	55.8	227.6	33.8	112.4	256.9	59.7	76.6	47.0	74.5	36.9	38.9	53.2	112.8	93.6	40.5	91.7	263.0	61.5	68.3	65.8	87.4	100.7	52.1	52.9	123.8	58.7	39.1	43.2	45.3	49.5	153.2	47.1	83.4	115.4	66.0	96.2	100.8
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 562.3;Late spermatids: 587.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.5	14.9	11.2	23.3	22.7	28.8	16.7	17.9	21.3	17.9	12.0	10.7	15.3	9.6	18.4	9.8	6.6	19.3	16.4	19.0	17.3	16.3	21.8	14.3	16.1	26.9	21.4	9.9	25.2	15.3	24.8	15.6	19.1	17.4	21.3	20.3	21.7	18.3	15.2	26.2	11.1	9.9	10.5	22.0	25.3	14.4	17.2	14.9	14.3	8.7	14.8	14.5	7.4	14.8	11.0	16.8	19.0	17.6	14.6	14.3	17.3	22.6	16.5	33.7	32.8	15.8	25.7	21.9	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7	17.9	8.1	9.3	8.8	8.5	14.5	12.1	2.5	17.4	11.4	5.2	3.9	16.1	16.6	13.6	562.3	11.6	7.3	0.0	14.7	16.7	10.4	6.8	18.5	5.4	13.3	11.1	2.4	6.7	9.8	587.8	19.0	7.9	15.1	24.4	11.9	18.1	12.7	12.9	19.4	8.1	12.4	12.9	14.7	60.0	42.8	8.2	13.5	9.6	11.4	7.9
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672875-27746060	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 21.3;prostate: 24.3"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	3.7	3.2	1.6	1.4	2.1	0.3	3.0	2.6	5.9	4.9	4.3	1.4	0.9	0.5	1.8	3.4	1.8	7.1	2.7	0.8	1.4	2.5	0.6	1.9	1.2	0.5	2.7	1.4	21.3	1.0	0.3	13.9	0.3	6.7	24.3	1.5	2.9	0.9	7.7	0.5	1.0	0.7	10.6	2.7	0.8	3.4	1.3	0.1	0.0	4.5	0.5	0.3	8.7	1.6	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	11.1	12.7	8.7	0.0	0.0	0.0	0.0	55.2	0.5	0.0	0.1	0.0	3.4	0.0	1.2	0.0	3.5	0.0	0.5	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	1.2	0.0	2.4	0.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	2.6	5.9	1.4	2.5	2.7	1.4	6.7	0.1	0.0	3.4	0.0	0.0	0.0	0.1	1.4	0.0	6.7	2.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Group enriched"	"Detected in many"	15	"Early spermatids: 4250.8;Late spermatids: 9284.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"A-431: 33.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	33.7	4.4	11.4	0.0	6.0	7.1	3.4	3.5	3.3	12.8	11.7	0.0	19.2	0.0	13.4	6.0	18.7	6.6	0.1	5.9	17.1	0.0	7.4	2.0	3.3	0.3	4.1	0.0	2.5	4.4	8.7	6.1	3.4	13.4	3.0	0.0	2.5	0.0	8.4	4.9	0.0	0.1	2.7	18.0	9.9	0.0	6.4	0.4	9.8	2.4	14.7	8.7	15.9	5.6	16.7	11.7	16.2	3.4	1.1	12.0	12.2	14.1	13.6	6.1	3.8	0.0	8.7	0.0	8.6	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7	23.8	26.2	2.2	109.9	39.8	12.6	168.2	0.0	238.3	60.3	19.2	31.4	0.6	61.3	22.4	4250.8	23.3	4.2	0.0	6.9	3.5	36.8	26.1	43.8	0.0	6.4	9.5	32.5	8.0	2.7	9284.2	64.7	13.2	21.9	1.8	14.3	25.9	7.6	14.4	47.4	27.5	58.5	19.4	36.9	440.7	150.0	29.9	1.4	8.9	10.3	65.9
MLLT11	AF1Q	ENSG00000213190	"MLLT11, transcription factor 7 cofactor"	Q13015	1	151057758-151068497	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.1"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 72.1;Late spermatids: 161.6;monocytes: 56.9"	"Cancer enhanced"	"Detected in all"		"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 38.6;EFO-21: 29.3;SH-SY5Y: 42.4;U-698: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	1.9	7.5	13.6	3.4	9.1	1.1	1.2	16.3	42.1	1.9	2.1	5.1	1.2	0.8	3.7	1.2	1.3	0.8	11.1	11.8	11.3	16.4	1.2	1.2	5.3	2.3	10.3	1.2	4.2	1.3	8.4	1.8	1.2	3.2	1.3	1.1	1.2	1.5	1.2	2.6	1.0	2.0	4.2	5.8	2.1	0.9	1.2	1.2	2.0	1.2	1.2	2.6	3.2	1.2	2.4	1.0	6.5	1.0	4.2	9.2	2.8	1.2	5.3	38.6	6.1	0.6	1.0	0.6	2.4	2.6	2.3	4.2	0.5	2.5	1.9	29.3	1.8	6.5	1.5	9.3	2.2	1.3	11.3	2.6	5.0	3.8	0.1	1.2	0.3	0.8	1.7	0.3	12.7	0.5	8.0	17.0	7.6	5.3	0.9	7.4	0.4	17.7	3.3	16.8	0.1	0.8	16.9	5.1	0.1	4.4	1.1	23.3	42.4	0.2	0.4	1.2	26.5	1.4	0.6	11.8	5.0	5.5	1.8	4.4	0.9	0.8	36.0	12.5	0.3	9.4	1.6	0.6	1.6	5.9	0.7	2.7	2.4	3.9	6.0	0.8	2.1	5.3	9.2	6.5	4.2	1.0	1.0	3.6	2.8	13.6	9.1	16.3	21.0	11.3	16.4	10.3	1.2	3.2	1.2	0.0	0.6	1.5	4.0	3.2	38.5	10.1	0.0	0.0	0.0	3.5	7.9	2.0	14.9	2.6	72.1	3.6	0.0	0.0	1.1	2.1	12.7	1.7	4.6	0.0	5.6	35.0	10.3	5.5	4.8	161.6	2.0	7.6	5.0	56.9	0.0	12.4	2.9	0.0	3.5	1.1	18.5	0.0	35.9	4.7	8.8	3.0	6.2	7.5	0.1	4.1
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3, super elongation complex subunit"	P42568	9	20341665-20622543	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 14.4"	"Cell line enhanced"	"Detected in many"		"HEL: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	8.6	17.3	18.0	10.4	25.8	19.7	11.4	34.6	20.3	12.3	20.9	7.2	10.6	7.2	13.6	7.9	10.2	11.5	12.7	8.6	18.0	12.8	10.1	2.1	10.7	9.1	14.8	13.8	10.5	4.6	18.3	24.7	10.3	13.2	11.7	22.8	7.4	21.3	12.1	9.1	7.9	12.3	13.5	12.0	5.9	15.3	3.6	21.4	22.1	22.5	6.1	6.5	12.9	10.4	1.4	0.7	1.6	0.3	3.8	14.4	2.8	2.6	7.2	2.6	2.9	6.0	3.7	1.6	6.8	11.5	3.1	3.5	7.0	2.5	10.0	3.7	3.2	0.9	1.3	2.4	11.8	2.8	20.6	6.3	73.6	22.3	3.3	4.3	1.3	6.2	2.8	4.5	1.1	7.4	10.4	3.0	4.2	0.0	12.9	6.4	2.0	7.2	4.3	1.6	14.4	2.1	0.0	4.7	2.7	14.1	3.9	8.3	2.9	5.5	2.8	3.0	2.6	2.9	1.9	2.0	0.0	1.7	1.7	2.4	5.8	5.3	4.1	0.0	3.2	1.4	1.6	0.3	0.5	3.9	0.2	3.6	0.5	7.0	5.3	0.7	1.4	14.4	8.3	0.1	3.8	0.3	0.4	7.3	2.8	18.0	25.8	34.6	20.3	18.0	12.8	14.8	13.8	13.2	21.4	26.8	23.0	7.3	15.3	7.3	5.5	12.1	7.6	9.4	38.7	21.0	31.4	0.9	11.6	23.0	2.7	8.6	13.6	0.0	7.3	5.3	16.7	15.6	11.5	1.7	2.0	4.8	31.7	6.7	2.6	4.2	12.7	3.2	21.9	1.0	101.9	37.2	18.7	17.3	8.9	7.0	1.0	0.0	16.5	0.1	5.6	7.3	1.4	25.4	28.6	13.2
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;testis: 36.4"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.6	1.4	3.2	2.7	4.9	3.2	2.6	35.2	6.7	4.3	2.0	2.1	0.6	2.0	3.2	5.4	2.4	17.6	2.9	2.1	4.1	4.0	7.9	1.8	2.9	1.2	2.1	4.9	4.0	2.1	0.8	10.7	1.4	11.4	3.8	1.9	1.1	1.8	1.7	1.2	1.3	1.8	1.9	3.2	1.3	1.9	36.4	2.4	3.3	2.6	1.4	1.1	1.6	2.2	0.1	0.8	0.0	0.4	0.0	0.0	0.0	19.2	4.5	2.4	7.1	2.0	4.3	0.4	4.7	2.7	5.6	11.9	6.4	9.3	10.8	6.0	2.0	8.1	7.6	2.9	2.7	11.4	0.0	1.2	13.9	5.0	1.1	0.7	4.7	1.5	1.7	0.1	11.3	1.6	2.3	1.0	4.2	3.1	0.0	4.7	2.5	0.1	5.9	0.7	10.0	2.7	9.0	14.2	0.1	5.4	3.8	18.7	5.7	7.8	2.4	8.2	0.6	5.7	7.3	0.4	7.6	8.7	7.3	11.4	2.2	7.1	0.2	8.5	11.2	8.7	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	3.2	4.9	35.2	6.7	4.1	4.0	2.1	4.9	11.4	2.4	0.0	6.6	0.8	7.2	3.0	9.7	5.2	5.1	285.0	42.1	33.2	23.6	0.5	10.0	7.1	279.9	1.4	0.0	0.0	1.7	3.1	10.3	2.0	0.0	0.0	5.6	14.3	1.2	7.4	1.0	16.7	11.8	3.0	0.0	1.0	0.7	12.0	1.2	0.0	8.1	9.1	31.9	0.0	3.6	128.6	20.6	1.3	0.5	0.0	3.7	0.9
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182196-93184928	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	6.9	14.5	21.9	5.7	30.0	15.9	8.6	30.5	69.5	12.8	10.1	7.1	7.7	7.1	9.3	12.0	8.0	11.1	8.2	23.9	24.2	35.9	14.2	9.0	9.7	7.9	22.9	27.8	8.6	9.0	25.0	12.0	7.1	27.8	15.0	7.4	10.1	8.2	14.9	13.9	5.2	7.0	10.1	11.2	7.8	8.3	4.4	7.8	5.9	10.6	3.6	7.5	8.4	3.8	6.3	4.2	16.4	4.4	8.8	14.3	7.5	3.8	3.0	7.3	9.8	6.3	2.4	4.9	4.5	5.2	4.7	5.3	3.2	3.8	11.6	8.3	5.2	3.3	6.0	5.2	4.5	5.2	5.3	6.6	6.5	6.1	4.3	8.2	5.8	11.8	4.3	6.8	2.8	5.7	11.2	5.7	14.1	2.3	7.1	5.3	15.9	9.1	5.5	3.4	7.7	3.9	5.6	9.9	7.0	11.9	10.9	16.9	14.6	4.6	6.5	18.4	6.1	10.0	4.3	6.2	1.8	2.9	4.2	2.2	13.4	13.7	7.0	4.8	3.7	3.2	16.4	4.0	10.3	11.3	4.4	12.6	6.0	10.5	11.5	4.2	6.3	14.3	12.2	3.7	8.8	4.4	4.0	9.8	7.5	21.9	30.0	30.5	69.5	24.2	35.9	22.9	27.8	27.8	7.8	29.8	27.2	31.3	16.6	14.3	94.0	64.3	12.7	6.7	12.5	19.2	47.1	23.2	34.9	26.8	3.8	15.8	10.7	0.0	13.3	4.8	12.5	23.4	26.6	6.4	14.5	79.4	46.6	11.6	10.8	0.9	16.4	10.1	11.8	18.0	18.8	76.4	16.9	10.2	25.8	13.9	85.3	19.4	26.1	9.6	21.3	13.6	39.9	31.9	13.1	18.6
MON2	KIAA1040	ENSG00000061987	"MON2 homolog, regulator of endosome-to-Golgi trafficking"	Q7Z3U7	12	62466817-62600479	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038697, HPA057607"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA038697: AB_10697396, HPA057607: AB_2683482"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.36e-2)"	16.4	14.8	12.1	16.9	20.7	13.3	16.8	28.6	20.6	20.8	14.4	25.8	21.3	13.3	22.3	16.8	16.2	16.8	15.6	14.5	14.2	13.0	17.5	22.6	14.3	14.3	20.4	18.7	22.8	24.0	36.7	31.9	17.8	22.6	16.9	17.3	16.7	22.4	24.3	15.7	16.4	15.0	15.2	17.4	15.7	17.0	11.2	18.1	21.8	21.3	10.9	17.6	15.8	17.2	6.2	5.5	8.9	6.2	3.7	7.2	3.6	10.4	16.2	12.2	6.4	15.9	14.8	11.2	11.4	9.6	10.5	10.5	7.2	4.2	7.4	8.9	11.0	8.2	10.1	12.0	8.3	14.5	9.5	9.4	11.7	11.9	7.3	6.8	10.1	8.3	10.0	6.4	11.4	14.1	14.1	10.1	6.9	11.0	18.0	9.2	12.1	8.9	4.8	7.2	6.4	9.0	8.3	11.0	10.2	5.9	14.2	5.3	5.8	19.2	10.4	7.8	13.1	22.6	7.5	14.1	10.2	7.5	12.8	7.3	10.0	9.2	8.4	10.9	6.4	11.4	2.0	6.1	6.3	5.5	6.2	7.0	5.0	4.4	7.2	5.5	6.2	6.2	6.9	8.9	3.7	4.6	3.2	5.0	3.6	12.1	20.7	28.6	20.6	14.2	13.0	20.4	18.7	22.6	18.1	32.8	18.5	10.7	12.5	14.9	35.8	12.0	15.3	21.4	25.0	26.2	55.0	11.1	0.0	6.5	2.2	15.5	15.3	0.0	9.4	6.0	17.5	19.3	16.2	31.0	9.4	20.6	13.8	23.9	17.6	1.5	20.1	16.2	8.5	8.2	19.8	17.0	8.8	17.3	17.0	4.8	57.6	25.8	20.8	7.9	9.7	17.1	17.0	15.4	13.3	14.1
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968298	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 17.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000436	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000436: AB_1079404"	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	6.7	5.3	4.6	6.0	7.0	5.2	16.9	6.4	7.5	6.8	7.1	6.5	14.8	4.7	7.4	5.9	6.1	6.3	4.7	7.7	4.7	5.0	5.3	9.6	6.3	8.8	4.8	4.1	8.1	7.5	9.4	8.1	7.7	7.7	8.0	4.5	7.7	11.0	7.9	9.8	10.4	5.6	6.7	5.3	7.3	5.9	50.5	5.0	5.5	6.6	6.1	6.6	6.8	9.7	1.7	2.2	0.8	2.0	1.2	17.7	3.9	18.6	17.0	20.2	22.3	21.1	15.7	15.3	13.8	10.8	14.2	14.6	22.2	9.0	16.7	12.4	12.0	10.0	16.0	18.1	8.6	11.8	13.1	21.9	17.4	13.6	26.0	18.2	14.2	18.0	14.9	12.6	14.9	19.3	11.8	14.2	9.8	22.8	17.3	14.8	30.3	15.1	29.0	18.7	22.0	12.6	29.0	11.8	21.5	13.7	17.0	18.0	14.2	14.6	23.9	10.5	16.9	12.8	24.2	14.2	17.2	17.0	12.1	12.2	15.5	19.1	18.8	12.6	10.1	12.2	0.5	1.1	0.8	10.3	1.9	9.1	1.5	14.3	8.3	1.2	1.7	14.7	8.9	0.3	1.2	2.0	2.2	17.7	3.9	4.6	7.0	6.4	7.5	4.7	5.0	4.8	4.1	7.7	5.0	0.0	2.9	5.2	6.2	6.5	7.0	4.5	2.5	2.7	6.8	10.4	9.8	7.0	3.3	6.4	23.5	7.1	4.0	0.0	7.0	9.6	6.6	7.4	1.1	7.8	4.5	12.7	8.6	4.9	4.0	7.4	7.2	3.7	6.8	2.8	5.8	3.5	9.1	3.5	9.6	2.8	9.9	19.4	6.2	20.9	18.8	8.2	5.3	4.4	6.4	4.9
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	18.0	11.2	15.6	15.4	16.4	28.0	17.5	30.9	16.3	20.3	15.3	10.1	14.1	10.6	22.5	10.6	23.0	17.9	13.5	12.5	14.6	7.9	11.6	13.0	17.0	20.6	17.5	12.1	29.3	11.3	14.8	25.1	20.6	16.6	16.1	12.1	7.3	20.6	14.2	28.1	20.1	14.8	21.4	21.0	19.1	14.0	10.8	18.2	25.5	15.0	17.6	20.0	22.9	23.5	11.2	7.6	21.9	10.7	8.2	11.9	6.6	12.2	4.7	11.4	7.5	11.8	12.8	16.1	11.6	20.3	13.4	11.1	7.6	8.0	5.9	4.5	13.3	13.3	6.2	8.9	11.6	14.1	11.1	7.0	24.4	5.1	5.6	7.7	12.5	21.8	8.0	14.5	12.8	17.7	14.0	10.7	9.3	19.5	15.1	10.8	4.0	8.0	6.8	9.4	15.0	5.7	9.9	5.7	10.6	5.9	12.8	4.7	12.3	13.5	8.8	13.8	9.2	9.9	10.5	14.3	13.0	3.2	8.7	10.0	6.7	5.9	5.7	8.4	19.9	9.3	21.9	7.5	16.1	8.4	9.4	8.3	10.0	9.2	7.9	7.6	11.2	11.9	8.5	11.7	8.2	10.7	4.9	11.3	6.6	15.6	16.4	30.9	16.3	14.6	7.9	17.5	12.1	16.6	18.2	26.8	20.8	20.5	44.0	60.8	20.0	17.6	12.7	32.1	25.0	21.0	7.9	13.4	3.3	14.1	38.2	20.4	10.1	23.3	10.9	15.8	35.2	39.4	46.2	13.6	15.7	15.9	10.9	12.9	25.7	13.5	17.3	33.9	23.6	21.6	14.7	15.5	17.4	14.4	25.1	5.3	11.9	12.9	20.2	24.7	32.9	71.4	21.1	24.5	9.0	52.9
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Rod photoreceptor cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	4.2	4.0	6.9	5.6	15.1	2.5	4.9	25.8	6.6	7.3	4.4	6.1	14.4	4.5	9.3	13.9	3.7	23.5	7.4	3.0	5.5	5.7	7.8	4.1	5.8	3.5	3.9	8.0	15.2	8.6	4.9	11.6	2.5	11.7	6.7	3.1	8.8	9.1	11.7	4.7	6.4	4.3	6.0	4.9	4.6	5.4	17.3	4.8	5.8	15.0	3.3	3.8	3.5	4.6	2.1	3.7	4.2	4.3	0.8	2.6	1.0	6.4	7.8	5.4	4.9	1.9	0.9	5.6	2.0	1.4	3.2	2.7	3.7	7.3	1.7	4.2	1.2	2.4	8.0	1.1	3.1	3.1	3.9	8.3	1.7	14.3	4.2	1.6	2.1	0.9	1.1	0.7	3.0	2.7	2.4	2.2	3.4	2.7	2.0	1.1	8.9	2.1	0.8	3.2	3.4	6.9	2.2	5.0	2.7	2.5	2.9	8.9	4.3	5.2	9.5	4.1	2.5	5.0	0.6	0.7	3.7	5.3	2.6	2.3	4.8	1.7	1.1	7.4	1.3	2.5	0.0	0.8	0.2	1.4	0.3	0.8	1.0	1.5	1.1	1.0	2.1	2.6	1.2	4.2	0.8	4.3	3.7	0.1	1.0	6.9	15.1	25.8	6.6	5.5	5.7	3.9	8.0	11.7	4.8	3.0	2.7	1.5	3.6	1.4	8.5	3.2	5.1	34.8	4.5	14.0	19.6	3.1	3.3	1.8	16.8	1.0	2.1	0.0	1.2	1.4	2.1	2.7	5.7	1.0	2.3	9.5	5.2	1.8	0.6	19.5	2.3	0.6	1.7	1.0	0.6	8.4	1.4	0.0	2.8	7.9	21.9	0.0	2.0	19.2	5.9	1.9	1.6	0.8	1.9	2.3
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887626-134915267	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 80.8;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031158	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	11.0	19.7	6.2	6.5	8.0	12.3	7.9	7.8	10.4	11.1	6.9	8.8	5.5	5.4	19.3	12.5	20.5	25.1	6.6	17.4	7.3	6.2	11.8	10.3	8.0	5.5	9.9	7.4	12.9	8.9	10.3	8.1	23.2	21.2	8.1	7.0	10.3	14.6	7.6	17.6	14.5	6.9	10.7	9.0	8.3	7.5	16.4	7.5	10.2	9.1	13.5	10.1	9.5	12.0	6.2	8.3	12.3	6.8	6.0	14.3	5.1	7.7	6.1	5.2	3.6	8.2	4.8	11.3	13.1	23.8	12.6	12.3	15.0	3.1	2.6	18.3	8.3	22.9	2.8	8.0	6.8	16.7	8.7	4.7	2.2	16.2	6.0	34.9	6.1	3.8	8.7	8.3	14.2	6.1	14.4	9.2	5.4	2.7	10.7	15.2	10.8	4.3	2.8	5.3	4.1	13.9	3.3	9.2	4.8	5.4	22.3	3.1	3.8	6.6	6.7	22.5	26.3	2.7	3.8	4.6	6.2	3.8	23.2	11.6	8.3	11.1	4.2	8.5	10.6	8.1	6.0	6.8	12.3	7.6	5.0	10.0	6.2	9.0	8.3	7.5	5.1	10.2	9.8	4.0	6.0	5.5	8.3	14.3	5.1	6.2	8.0	7.8	10.4	7.3	6.2	9.9	7.4	21.2	7.5	6.0	4.3	6.7	9.8	18.9	9.0	42.3	5.1	16.0	6.8	10.4	2.0	6.1	18.3	21.3	80.8	12.7	5.7	46.7	10.7	12.5	9.1	9.7	5.7	4.9	13.2	4.8	4.1	13.5	11.4	57.7	6.4	7.2	28.7	5.4	7.2	8.3	17.9	11.5	10.3	20.2	9.0	6.5	15.3	3.0	5.3	17.9	21.9	10.1	6.6	8.1
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	13.8	22.3	13.0	7.7	12.8	17.4	9.8	9.0	16.9	14.7	9.1	14.5	13.9	9.9	12.0	12.9	22.5	12.0	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12.0	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37.0	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8.0	6.0	8.2	6.6	11.4	3.5	2.6	4.7	4.6	5.5	4.8	4.9	7.6	8.1	3.8	10.2	4.2	6.8	4.7	3.8	6.6	0.9	9.8	5.1	3.9	6.1	11.4	4.5	3.0	15.1	7.4	5.7	4.1	2.4	4.2	8.2	6.4	9.1	7.8	4.9	17.9	8.4	23.0	6.0	7.9	12.4	7.9	6.9	9.1	7.6	9.1	3.6	21.7	8.6	13.4	4.6	2.8	8.1	8.9	9.2	9.3	14.7	19.3	4.4	6.2	5.8	2.6	9.3	33.7	11.4	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13.0	13.5	12.3	20.9	8.5	12.0	29.7	8.0	13.0	12.8	9.0	16.9	11.2	10.8	10.6	11.6	12.0	9.9	8.9	6.5	11.9	14.9	10.8	6.6	3.2	17.8	9.4	4.5	19.2	5.9	6.0	36.5	33.9	271.2	15.7	8.7	0.0	37.6	23.2	22.0	20.1	3.5	26.2	25.2	6.4	20.7	19.0	23.0	1149.7	25.6	15.1	25.3	14.4	14.9	11.4	39.0	17.5	20.5	35.7	3.4	12.9	20.0	17.7	21.5	17.1	5.1	29.3	16.9	17.8
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85853	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	20.8	32.1	18.4	21.1	18.4	25.3	33.2	18.3	32.1	19.5	20.4	12.6	24.6	21.0	22.6	30.5	21.5	18.5	28.5	37.4	16.7	15.1	16.1	32.0	20.1	39.7	15.8	18.2	23.8	36.5	8.0	21.7	19.0	16.5	23.2	7.2	15.2	47.1	24.2	33.6	19.0	19.4	19.2	13.6	25.6	27.3	10.9	11.2	18.3	29.2	22.4	22.8	27.2	25.2	33.5	38.8	27.2	27.4	41.2	31.1	22.4	14.0	20.5	5.6	17.1	10.3	23.5	14.0	20.1	27.8	13.1	14.4	12.9	18.9	10.0	17.6	11.4	6.5	18.0	3.9	8.8	2.0	17.1	14.9	6.5	10.4	19.2	29.8	6.7	40.2	22.6	12.2	14.7	6.1	17.5	22.8	11.3	14.2	18.0	17.0	48.4	11.7	31.1	10.1	8.1	22.4	22.3	6.7	38.0	10.9	5.1	4.6	11.7	10.6	11.5	25.3	2.7	16.4	34.9	19.9	10.7	13.6	14.5	9.9	17.6	5.9	12.7	19.8	19.5	38.1	14.2	27.4	27.2	22.7	19.2	20.6	33.5	21.8	22.6	28.5	30.6	16.8	17.2	14.0	41.2	15.7	38.8	31.1	22.4	18.4	18.4	18.3	32.1	16.7	15.1	15.8	18.2	16.5	11.2	3.0	24.6	65.6	62.0	31.8	13.4	1.1	30.6	20.1	22.7	38.4	3.9	68.9	28.2	68.7	6.3	43.1	60.4	0.0	99.2	74.2	79.8	90.4	54.4	44.9	80.7	9.5	47.8	47.3	65.5	3.6	60.9	47.4	54.0	72.1	66.3	38.4	109.6	66.2	54.5	52.3	9.1	84.1	64.9	18.8	43.7	35.9	51.7	62.9	63.6	97.9
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.6	10.7	24.1	11.7	11.7	16.6	13.3	21.2	25.5	18.5	9.0	17.3	11.5	16.2	12.9	11.6	13.7	20.7	22.9	22.0	24.9	12.0	15.0	13.0	9.0	31.1	11.7	32.3	20.2	10.4	19.8	11.0	31.7	9.4	21.2	22.7	30.5	4.6	28.1	15.9	24.8	38.2	22.0	24.5	14.9	30.8	11.1	10.7	16.7	20.7	16.5	7.1	35.7	15.9	15.2	10.3	27.9	20.1	16.6	17.4	17.3	15.3	15.0	6.8	16.4	64.4	15.7	26.6	22.0	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9	17.9	37.6	25.3	34.6	34.5	13.8	29.0	12.7	34.8	35.2	19.2	9.8	52.1	43.1	41.7	4.8	14.3	15.1	46.7	24.5	35.8	39.3	21.5	17.4	13.0	43.1	19.1	8.6	19.0	33.6	7.6	10.3	56.9	30.4	71.3	17.4	31.2	42.3	28.1	9.6	33.9	22.5	19.4	25.8	30.3	54.8	47.2	27.5	22.9	28.6	40.1
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	7.7	13.7	18.9	14.1	12.3	11.5	8.0	12.1	21.6	6.5	19.9	6.6	15.7	25.9	8.5	7.8	13.8	8.2	11.8	12.1	14.2	11.3	12.8	25.1	14.3	8.5	12.7	20.0	8.7	20.7	14.5	7.2	7.0	11.9	12.1	13.9	11.5	14.3	9.0	17.4	12.5	20.7	9.3	8.9	10.1	12.5	4.2	6.7	13.5	8.6	8.3	10.1	9.3	11.0	3.1	4.5	10.3	6.0	2.4	5.6	1.9	7.9	6.7	11.1	12.7	7.0	3.3	11.3	3.9	3.8	3.2	4.0	12.9	4.1	7.2	12.2	5.0	9.5	8.2	5.0	6.7	1.8	8.1	11.3	5.5	9.5	20.9	5.6	7.4	10.0	5.0	4.9	3.5	3.7	5.0	9.9	19.2	2.9	18.8	4.0	23.0	17.4	6.3	5.1	13.5	9.7	14.3	3.4	10.4	8.2	14.1	12.4	12.7	7.1	10.0	5.3	6.6	6.7	9.1	3.7	5.2	5.6	31.4	7.7	15.7	9.6	4.8	5.7	4.1	5.9	10.3	5.1	2.4	2.2	6.0	3.4	1.8	2.6	3.1	4.5	3.1	1.7	1.9	1.2	2.4	2.7	4.5	5.6	1.9	18.9	12.3	12.1	21.6	14.2	11.3	12.7	20.0	11.9	6.7	0.0	3.0	4.5	6.6	4.7	7.2	11.5	10.2	1.4	3.4	10.4	2.0	11.3	0.0	4.3	0.5	4.9	65.9	0.0	4.4	9.3	3.9	9.1	4.6	21.2	13.6	6.4	16.0	6.7	23.8	2.2	5.8	10.2	3.3	6.4	27.9	3.9	4.9	32.5	3.5	11.4	3.4	6.5	5.1	0.0	5.3	7.3	8.7	5.3	28.8	7.1
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Cell type enhanced"	"Detected in some"	11	"Distal tubular cells: 1.7;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Group enriched"	"Detected in some"	93	"HL-60: 218.1;NB-4: 285.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	285.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	1.2	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 46.7;pons and medulla: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	5.1	2.0	4.8	2.1	2.9	0.6	5.1	46.7	5.2	3.3	1.7	2.2	4.5	1.4	3.5	4.0	3.0	2.7	5.4	12.3	2.7	5.0	2.1	1.2	7.4	1.3	3.0	1.5	1.7	5.9	3.0	2.6	2.1	13.0	3.0	1.1	1.7	1.6	4.3	1.5	2.4	1.3	3.5	2.5	2.2	4.3	3.7	1.1	0.0	1.7	0.9	1.4	1.6	4.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.6	3.1	0.8	0.8	1.8	1.4	0.0	1.6	0.6	1.2	0.7	1.2	1.9	0.0	0.6	1.3	0.8	1.5	1.2	2.3	1.8	0.0	1.6	1.5	3.7	0.7	0.1	0.0	0.1	0.9	3.1	2.1	6.6	3.7	1.6	0.3	0.9	0.0	0.6	0.9	0.0	0.0	0.8	0.7	1.2	0.0	1.0	0.4	4.4	0.6	13.3	3.5	0.8	2.8	0.5	1.1	7.1	1.6	1.4	3.5	3.3	0.9	3.0	0.9	0.4	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	2.9	46.7	3.3	2.7	5.0	3.0	1.5	13.0	1.1	11.9	2.6	0.0	5.5	3.5	1.9	24.5	7.6	0.0	6.8	1.8	0.0	0.1	0.0	3.4	39.4	2.7	0.7	0.0	1.2	0.5	2.6	4.8	1.1	0.9	0.9	9.5	1.2	1.3	0.0	56.6	3.4	2.8	1.7	2.8	0.9	0.8	2.2	3.1	2.5	0.3	1.9	6.5	4.1	0.7	1.9	2.4	0.1	0.0	1.7	2.5
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.2"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.2;Suprabasal keratinocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.0;CACO-2: 20.7;CAPAN-2: 12.9;T-47d: 41.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	1.9	1.2	1.9	3.2	1.9	2.6	3.7	3.2	3.0	2.3	6.3	1.9	1.9	1.8	1.9	3.7	16.3	4.6	2.0	2.0	1.9	0.6	4.9	1.9	3.7	4.6	1.9	1.9	1.9	11.3	1.8	7.8	4.2	2.2	2.8	3.5	2.6	5.0	1.9	4.7	11.2	3.3	3.0	1.9	2.4	5.9	33.2	1.9	1.9	5.7	1.9	3.0	3.4	5.4	0.7	8.1	9.0	8.2	4.9	9.2	5.3	2.6	0.0	0.2	0.0	0.0	0.0	11.0	0.5	0.4	2.2	3.5	20.7	12.9	0.0	0.1	1.5	1.6	4.8	1.8	3.4	5.2	0.0	3.5	0.0	0.6	1.2	0.0	0.0	0.0	0.1	5.5	0.3	0.2	0.0	0.0	1.0	0.5	0.0	2.9	4.9	1.0	0.0	0.6	4.0	1.0	0.5	6.2	0.0	0.2	8.7	0.5	0.0	1.1	5.3	0.0	1.8	41.8	0.5	0.0	0.8	6.0	0.0	0.4	0.1	0.0	0.0	0.0	4.9	0.0	0.0	8.2	9.0	4.3	2.7	6.3	0.7	4.7	2.9	8.1	0.6	9.2	6.4	3.3	4.9	1.4	0.1	1.1	5.3	1.9	1.9	3.2	3.0	1.9	0.6	1.9	1.9	2.2	1.9	41.7	38.7	0.0	9.3	20.5	1.2	9.0	12.7	16.0	23.9	14.0	15.7	38.9	8.3	3.5	55.2	2.8	10.9	0.0	10.9	2.0	2.1	11.1	1.1	2.6	4.7	3.2	6.4	1.8	5.6	13.5	0.9	2.5	6.8	0.0	8.9	22.1	7.6	7.0	0.4	7.3	7.0	0.0	4.7	2.5	9.3	53.3	38.9	8.7	10.7	12.8
MPPE1	PGAP5	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11909223	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 22.1;neutrophil: 66.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 66.2"	"Cell line enhanced"	"Detected in all"		"OE19: 34.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	10	"basal ganglia: 104.4"	HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	15.0	13.7	11.8	16.5	16.0	19.9	15.2	11.4	20.9	14.1	16.4	20.1	18.2	13.5	18.7	22.1	13.4	15.8	23.6	17.2	11.5	14.4	23.7	20.8	24.7	29.0	19.8	12.2	11.7	24.6	22.2	16.5	15.2	14.1	13.1	17.2	14.8	16.8	26.6	19.3	22.4	19.7	14.0	15.1	17.5	17.7	6.7	14.8	22.7	37.1	14.6	17.6	14.9	13.9	4.5	8.5	66.2	9.5	6.3	6.0	6.7	3.9	5.7	4.3	10.5	12.5	14.8	4.1	9.4	13.7	5.6	8.9	10.6	11.3	7.8	20.8	9.1	5.6	4.3	3.0	5.3	5.3	8.6	5.2	2.2	11.5	2.4	17.6	10.1	16.3	21.9	7.0	4.9	3.6	8.4	3.3	7.1	2.8	7.6	9.3	9.3	7.4	6.8	3.0	34.0	1.5	3.0	2.7	9.5	9.2	6.0	6.2	3.5	8.8	6.9	8.2	5.0	5.1	13.2	6.8	11.4	4.4	10.9	5.2	11.9	10.5	9.9	8.5	5.3	11.2	4.1	9.5	22.1	6.0	7.7	4.3	4.0	3.7	5.6	8.5	4.5	4.5	5.7	66.2	6.3	5.2	6.7	5.8	6.7	11.8	16.0	11.4	20.9	11.5	14.4	19.8	12.2	14.1	14.8	53.6	33.6	15.2	11.9	16.0	17.3	1.6	20.4	28.1	18.2	21.0	11.8	22.8	18.3	24.9	15.7	14.7	31.5	23.3	36.6	26.4	17.4	11.4	26.6	23.6	22.2	7.9	9.2	9.8	29.2	25.1	11.8	25.8	18.6	10.0	18.0	19.8	30.1	15.9	14.2	23.0	17.9	12.9	13.7	3.4	7.2	17.6	14.0	30.5	13.7	16.6
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	5.7	7.5	11.9	7.6	10.0	19.7	6.1	17.8	16.0	6.0	8.5	4.5	13.0	16.7	5.4	7.3	9.2	6.8	7.0	5.4	7.0	6.0	8.3	5.8	9.4	8.1	5.2	11.7	5.1	17.3	5.4	11.1	8.3	10.3	9.0	4.5	6.9	14.3	9.8	5.2	13.4	14.3	6.5	3.9	11.5	14.0	7.5	5.0	5.2	33.3	3.9	7.5	8.5	6.6	1.9	5.5	4.4	9.5	1.1	5.6	2.8	9.8	4.1	0.5	4.0	1.9	2.1	18.0	4.4	3.1	2.4	3.4	6.9	17.9	5.3	6.4	2.5	6.0	9.5	0.6	6.7	1.1	3.0	5.8	6.3	12.0	6.2	4.9	2.8	6.7	3.8	7.0	3.9	5.7	2.9	3.5	4.3	2.6	2.4	2.7	21.2	4.8	5.9	1.5	6.8	19.4	6.3	1.3	5.4	3.6	19.7	4.5	3.9	11.0	10.6	3.3	1.6	7.8	3.9	8.7	5.0	9.5	10.1	3.6	4.2	2.0	5.6	9.8	8.5	2.9	4.4	7.4	1.9	2.4	9.5	1.9	1.1	2.1	2.5	5.5	1.9	2.0	1.4	1.5	1.1	7.9	1.7	5.6	2.8	11.9	10.0	17.8	16.0	7.0	6.0	5.2	11.7	10.3	5.0	8.9	29.5	3.9	7.0	5.6	34.8	9.5	2.5	9.4	15.9	5.2	11.8	23.8	3.3	10.4	3.8	5.8	32.2	0.0	14.2	16.8	5.9	13.3	13.9	7.6	17.4	35.0	22.5	3.1	11.3	9.9	2.8	12.0	1.7	8.2	20.3	6.7	14.9	14.4	2.5	4.9	3.5	6.5	5.8	9.3	14.5	5.1	41.9	5.7	18.1	10.6
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059806	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	16.9	19.9	17.4	13.1	22.5	16.0	14.2	13.6	21.8	13.0	15.6	13.3	16.4	20.3	14.1	16.9	13.6	16.2	15.5	31.7	16.0	16.8	20.9	55.0	12.9	16.2	18.8	20.3	15.7	17.4	25.8	17.8	11.7	15.3	12.9	15.0	12.6	21.1	19.6	53.2	13.8	15.2	13.4	12.4	11.5	13.4	21.0	13.2	17.5	15.7	25.5	12.3	12.4	11.9	21.0	26.9	14.3	18.5	17.5	16.9	13.6	10.9	12.6	6.3	11.0	7.7	6.2	9.8	4.9	7.0	12.8	11.5	24.1	3.8	15.5	12.3	6.8	9.5	11.6	13.6	13.1	8.0	9.0	28.2	12.5	10.2	29.1	15.2	10.4	6.1	8.1	13.9	14.8	20.1	6.7	9.0	19.8	20.9	10.4	6.8	21.3	13.4	37.0	5.7	42.2	14.9	15.6	6.3	19.8	9.6	6.9	15.2	7.9	4.8	8.5	15.0	5.6	9.6	18.7	8.1	7.5	10.1	9.9	13.6	12.1	11.0	32.0	5.5	16.8	7.3	6.8	18.5	14.3	13.5	17.2	16.9	20.4	15.6	16.0	25.2	21.0	15.9	16.1	5.5	17.5	13.4	26.9	16.6	13.6	17.4	22.5	13.6	21.8	16.0	16.8	18.8	20.3	15.3	13.2	20.8	15.2	33.7	27.7	21.6	18.7	34.1	35.7	29.4	27.3	57.6	25.5	66.2	157.5	45.9	72.1	31.5	50.7	46.7	46.7	41.8	35.6	25.5	27.7	68.6	44.0	4.8	29.4	30.1	23.0	24.4	50.9	27.0	50.6	45.1	37.0	29.6	38.4	49.5	48.4	109.4	17.2	25.8	39.1	33.4	34.3	23.7	53.1	27.7	57.2	21.0
MRPL21		ENSG00000197345	"Mitochondrial ribosomal protein L21"	Q7Z2W9	11	68891276-68903835	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051657	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"HPA051657: AB_2681565"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.12e-1)"	16.5	18.0	30.5	21.4	29.7	25.5	26.5	27.7	28.0	19.6	24.0	13.3	26.8	18.9	20.4	25.2	24.2	23.0	28.3	47.3	24.6	26.1	33.1	33.7	12.4	30.0	27.6	21.0	21.4	23.8	13.2	17.7	16.1	25.6	18.0	21.8	14.4	56.9	39.4	56.6	17.9	25.0	17.6	16.4	14.9	19.3	18.7	21.9	21.3	22.2	40.3	20.4	17.2	16.5	49.1	42.2	20.3	39.3	29.1	36.4	34.6	23.1	32.2	19.6	18.7	13.8	15.1	23.3	16.2	17.4	30.6	21.1	65.9	29.9	35.9	36.2	17.5	28.1	28.9	32.7	30.8	24.1	23.5	24.6	25.3	24.8	39.5	27.6	43.5	19.2	22.2	15.9	30.5	36.3	14.9	21.0	25.6	49.1	27.3	18.2	42.7	20.5	46.1	17.9	68.0	47.5	29.2	23.7	55.8	30.1	26.8	31.9	25.4	20.6	41.4	64.1	16.6	42.8	25.2	17.5	21.0	21.0	45.9	29.5	20.4	31.4	50.5	28.0	26.8	28.4	20.3	39.3	19.4	25.9	39.3	27.2	49.1	34.1	28.7	42.2	33.4	32.7	27.0	10.8	29.1	36.1	31.0	36.4	34.6	30.5	29.7	27.7	28.0	24.6	26.1	27.6	21.0	25.6	21.9	32.8	37.1	55.8	62.8	44.6	34.3	172.9	79.0	53.5	53.4	76.8	7.9	109.3	253.7	83.0	140.3	46.6	123.2	70.0	91.4	93.2	51.5	65.5	62.5	89.7	95.9	11.1	59.3	38.1	59.5	153.5	69.3	54.4	74.2	72.1	93.9	45.9	78.4	86.8	67.8	152.2	34.6	25.8	64.9	54.9	57.3	45.4	68.0	41.5	111.2	58.8
MRPL43	bMRP36a	ENSG00000055950	"Mitochondrial ribosomal protein L43"	Q8N983	10	100969458-100987515	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA073022			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073022: "	"unprognostic (2.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.11e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.53e-2)"	34.6	34.5	25.9	20.1	24.2	22.5	25.0	24.0	32.9	26.0	26.1	32.5	25.5	28.5	24.7	29.9	31.8	25.9	30.2	25.0	24.4	20.9	37.2	39.6	20.5	20.3	26.5	19.3	32.7	62.2	16.7	21.4	26.6	22.9	31.9	8.3	30.1	61.4	34.4	100.4	26.8	30.1	25.5	32.1	24.8	32.0	28.6	20.3	23.5	45.2	35.2	25.6	27.6	22.6	36.2	36.6	41.3	32.3	36.4	39.4	33.4	30.1	34.3	7.2	12.7	7.5	9.7	22.4	21.1	19.2	16.4	16.7	19.5	23.7	26.0	28.8	8.8	8.9	18.9	2.6	17.6	2.2	19.6	44.6	20.5	24.9	30.2	16.2	16.1	16.5	15.1	13.8	13.9	6.1	7.8	15.4	16.6	10.1	13.3	4.9	31.9	15.0	36.7	11.6	8.2	32.4	16.2	24.1	17.4	9.1	15.6	8.1	20.9	15.4	7.5	23.6	2.4	40.1	7.8	18.8	15.4	20.6	16.5	22.1	27.9	21.2	13.1	19.7	30.2	11.1	41.3	32.3	35.1	32.3	30.0	33.2	36.2	35.7	32.1	36.6	33.3	34.7	30.9	11.0	36.4	28.8	28.6	39.4	33.4	25.9	24.2	24.0	32.9	24.4	20.9	26.5	19.3	22.9	20.3	41.7	35.1	68.5	70.1	49.5	43.4	32.2	84.1	78.9	51.2	71.5	39.3	112.8	152.5	84.3	53.4	47.0	56.3	70.0	110.7	118.6	57.0	57.6	45.1	59.7	86.2	17.5	58.7	51.5	39.7	31.5	79.1	47.5	60.8	68.5	68.0	64.2	77.6	84.2	69.3	155.7	46.0	51.8	80.4	138.2	73.5	59.8	86.7	61.0	79.0	55.9
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	24.3	29.4	31.8	31.8	36.8	27.8	54.5	18.8	34.7	22.7	35.5	13.5	31.4	43.7	21.3	23.5	37.5	20.8	39.2	73.7	28.3	31.0	34.1	41.9	36.9	55.9	35.5	27.8	17.2	58.5	21.6	20.7	20.9	40.1	22.4	22.4	12.7	41.6	43.0	79.5	24.3	35.1	22.9	37.0	27.6	39.9	30.6	24.0	27.8	27.4	38.4	25.2	15.6	31.6	43.9	50.6	25.4	39.0	21.9	30.7	29.7	43.9	34.6	18.9	23.4	11.8	13.9	46.1	30.7	22.2	27.5	26.2	42.4	61.7	33.5	33.9	21.1	28.0	40.1	15.5	42.5	20.7	35.4	25.5	24.9	13.8	96.1	35.9	39.1	35.9	20.8	29.4	35.6	30.4	21.8	43.6	42.7	25.5	33.4	20.1	61.7	31.6	59.5	34.8	54.8	76.5	39.2	23.6	39.5	28.7	26.3	18.9	24.4	23.8	23.3	32.6	14.1	22.4	37.5	33.5	28.8	33.7	36.0	46.5	33.1	39.0	40.8	26.2	26.9	45.9	25.4	36.0	18.0	25.4	39.0	23.2	43.9	27.9	22.9	50.6	37.7	26.4	25.3	6.1	21.9	28.7	41.9	30.7	29.7	31.8	36.8	18.8	34.7	28.3	31.0	35.5	27.8	40.1	24.0	68.5	78.6	124.3	65.2	107.6	20.6	96.4	201.2	95.0	89.9	129.1	17.7	163.2	235.4	222.3	47.9	83.9	246.5	93.5	272.5	246.5	72.7	86.6	121.1	226.4	208.7	19.1	132.6	105.6	152.4	44.5	51.8	104.0	118.1	247.9	188.7	49.5	303.7	207.0	46.3	360.5	27.7	64.7	84.5	124.7	106.0	130.4	105.4	86.1	183.5	87.8
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003634	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003634: AB_1851388"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	12.4	23.4	13.9	18.4	14.8	13.7	17.6	18.1	15.7	10.6	15.2	9.8	17.5	13.1	12.5	15.1	19.4	12.5	16.3	31.2	12.2	12.0	25.7	41.7	10.2	15.2	14.3	14.0	10.5	24.2	13.5	9.1	13.9	14.0	13.6	16.3	10.1	17.7	22.5	57.3	16.5	13.4	14.8	12.9	14.6	15.1	7.6	14.0	13.2	14.8	31.2	15.7	14.3	11.6	18.3	28.9	11.2	22.0	20.0	33.5	20.9	26.1	36.9	12.3	14.1	13.3	13.2	17.2	15.5	16.9	32.4	27.6	28.3	16.5	18.2	12.8	15.4	20.0	18.7	25.2	26.7	34.3	9.3	29.9	14.3	17.5	23.5	25.1	29.8	9.8	14.2	12.8	21.5	34.5	11.0	24.6	18.9	23.0	13.3	18.3	32.7	25.7	20.5	9.3	40.8	50.0	13.3	21.9	26.5	23.8	19.4	11.5	22.0	13.4	24.5	30.1	16.5	32.8	24.6	10.4	17.5	19.2	18.4	29.2	13.9	11.0	20.1	20.0	33.4	14.4	11.2	22.0	10.5	17.3	20.7	14.9	18.3	21.1	17.2	28.9	14.8	15.7	17.6	2.0	20.0	17.4	19.4	33.5	20.9	13.9	14.8	18.1	15.7	12.2	12.0	14.3	14.0	14.0	14.0	29.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	38.8	14.8	24.4	0.0	56.1	48.0	41.8	0.0	0.0	0.0	0.0	52.2	30.7	0.0	0.0	1.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	26.2	0.0	0.0	44.8	0.0	0.0	104.5	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0
MRPS26	"C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13"	ENSG00000125901	"Mitochondrial ribosomal protein S26"	Q9BYN8	20	3045945-3048254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045472, HPA054610"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045472: AB_10962052, HPA054610: AB_2682541"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.14e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.93e-3)"	20.2	30.4	27.1	14.4	29.2	13.4	20.9	25.9	31.7	19.2	19.8	15.3	32.3	22.5	18.1	30.6	19.6	24.4	21.2	25.8	24.4	28.2	28.8	39.6	14.7	15.4	24.6	27.0	28.9	43.4	21.0	28.1	16.4	20.0	31.0	16.4	15.2	32.3	27.9	37.1	22.3	20.1	27.8	19.0	16.2	22.1	13.3	20.7	12.3	28.9	23.0	16.9	18.4	19.2	36.5	28.4	10.3	24.4	29.2	30.8	23.0	26.8	36.2	8.2	14.9	9.0	6.8	21.5	10.5	7.1	12.1	9.3	31.6	12.4	26.7	13.4	5.4	16.0	25.5	16.2	21.7	7.1	6.8	34.6	12.2	13.1	52.4	12.5	19.2	6.0	7.7	16.9	10.0	15.2	8.5	8.9	16.1	19.6	6.3	7.2	23.2	19.8	33.8	40.5	20.5	35.8	22.0	14.2	28.5	11.8	18.0	25.8	33.5	12.1	40.5	24.3	8.5	18.2	10.9	8.4	7.9	12.6	14.2	19.4	28.7	36.9	16.2	5.1	16.1	8.8	7.6	21.4	10.3	24.0	24.4	30.0	36.5	26.6	25.6	28.4	34.9	30.8	26.4	1.7	29.2	19.0	17.2	20.6	23.0	27.1	29.2	25.9	31.7	24.4	28.2	24.6	27.0	20.0	20.7	14.9	23.2	55.8	62.3	72.8	37.0	58.1	63.7	30.8	29.6	52.4	33.4	157.2	177.4	69.1	3.0	39.5	65.6	46.7	47.8	88.9	56.4	71.2	13.9	99.1	71.1	44.5	52.9	30.7	23.5	7.5	63.9	31.3	64.1	32.5	77.7	64.3	51.7	49.1	58.0	189.5	37.6	58.2	67.0	32.2	73.4	80.7	65.7	38.5	105.3	45.7
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 207.0;Late spermatids: 514.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.6"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	207.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.5	514.6	3.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	5.7	2.4	0.3	0.1	0.0	0.0	0.0
MSANTD2	"C11orf61, FLJ23342"	ENSG00000120458	"Myb/SANT DNA binding domain containing 2"	Q6P1R3	11	124766498-124800673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038694, HPA038695"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038694: AB_2676155, HPA038695: AB_10674693"	"unprognostic (2.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.77e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.65e-4)"	12.4	7.3	12.4	11.8	20.3	2.7	13.0	20.8	12.8	13.8	9.4	14.8	14.1	7.7	15.7	17.8	7.7	11.7	10.0	6.4	9.2	7.3	12.8	7.8	9.2	10.4	16.4	7.6	15.8	13.9	12.1	19.9	12.9	12.3	13.3	9.7	8.6	11.0	12.1	7.7	17.5	9.7	9.4	9.2	13.6	10.7	6.2	19.6	8.6	26.2	5.2	10.1	7.7	17.0	2.4	1.3	1.6	1.9	0.5	4.4	1.0	2.9	1.9	15.8	11.4	7.5	9.8	6.4	6.5	7.0	4.6	6.0	6.4	6.7	3.9	6.1	4.7	4.9	5.9	7.3	3.9	7.7	5.5	4.2	3.5	3.7	5.5	4.6	2.8	2.9	4.4	4.3	5.9	5.4	9.9	8.4	3.9	4.0	6.0	7.0	3.3	1.7	9.4	10.0	7.2	14.9	4.5	4.4	3.1	6.3	3.1	4.4	12.9	3.5	5.5	2.7	11.3	9.0	2.9	7.2	17.3	4.4	4.8	6.8	2.9	2.0	2.9	3.5	3.8	9.5	0.0	1.2	1.6	2.2	1.9	1.1	1.5	2.3	3.3	1.3	2.4	2.4	2.0	0.0	0.5	1.9	1.2	4.4	1.0	12.4	20.3	20.8	12.8	9.2	7.3	16.4	7.6	12.3	19.6	3.0	10.1	3.4	4.2	7.8	7.9	2.7	2.5	2.7	1.2	7.0	2.0	2.6	3.3	4.0	3.5	8.4	1.6	0.0	0.9	3.8	8.5	4.2	1.1	2.6	2.5	12.7	1.2	8.6	3.8	1.1	8.9	4.0	1.7	1.0	2.9	6.7	4.3	4.0	6.7	3.3	5.6	12.9	8.5	1.4	1.1	3.6	1.6	4.4	4.1	2.8
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47402969-47663146	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	7.3	9.8	14.2	12.2	25.5	11.4	14.1	22.6	18.1	9.4	11.6	7.6	5.6	6.5	10.5	13.3	10.8	11.1	4.9	8.4	13.0	14.0	7.3	5.5	7.1	19.7	12.5	17.0	7.9	8.4	15.3	9.1	9.9	18.5	7.9	13.8	12.3	9.4	7.3	6.7	10.3	8.0	7.8	13.8	9.4	6.7	13.4	13.5	37.0	13.9	6.6	21.4	8.5	7.6	7.4	2.9	3.9	4.2	12.2	12.6	6.2	28.3	9.7	26.5	14.3	2.0	5.6	16.1	16.9	8.4	21.0	20.3	18.2	12.3	34.9	22.8	5.9	14.8	12.1	19.8	9.6	31.7	18.0	14.8	25.1	11.2	16.5	2.0	24.5	8.8	3.1	2.8	17.8	4.8	4.7	11.5	0.8	41.8	8.1	16.0	11.3	28.4	18.5	49.9	17.2	11.5	38.1	47.4	20.4	9.1	15.0	22.0	23.9	14.9	11.6	11.9	22.3	11.6	9.6	4.6	13.9	18.3	14.4	18.8	5.2	18.5	48.9	8.5	18.1	8.6	2.8	1.0	3.9	7.9	4.2	8.6	6.3	7.4	9.5	2.3	7.4	12.6	11.9	0.7	12.2	3.2	2.9	10.1	6.2	14.2	25.5	22.6	18.1	13.0	14.0	12.5	17.0	18.5	13.5	8.9	11.5	13.7	5.7	7.3	16.8	13.8	5.1	25.4	13.6	8.7	43.2	14.2	3.3	9.6	13.1	11.7	4.6	23.3	7.3	16.3	8.7	3.4	11.5	1.0	9.6	11.1	3.4	3.7	4.0	17.6	4.9	4.0	8.5	6.4	9.1	20.0	6.0	5.8	6.0	3.5	38.3	0.0	5.5	34.2	59.5	5.6	4.2	8.7	9.8	2.7
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	43.8	11.1	0.0	0.0	5.6	0.0	0.0	0.3	0.5	7.7	0.2	0.0	0.6	0.0	0.2	0.1	20.0	0.0	0.1	0.2	4.5	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	22.8	0.2	0.2	0.1	0.0	0.1	0.0	0.0	32.5	15.8	0.0	0.3	0.3	4.4	6.7	0.0	0.0	0.1	6.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4	0.0	0.0	0.0	1.0	0.9	20.9	2.6	0.0	0.0	0.0	0.0	51.1	0.0	1.7	1.0	46.0	0.3	0.5	0.0	4.5	0.5	0.5	5.5	0.0	0.0	0.1	3.2	9.7	0.0	0.0	40.7	0.3	0.0	0.0	1.0	0.7	68.3	2.0	5.5	0.4	0.0	92.6	12.9	2.1	7.0	1.3	0.0	0.3	0.0	2.5	0.3
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148922-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	13.1	10.1	13.3	16.2	15.6	40.2	13.5	31.0	15.8	13.7	11.3	14.8	9.9	11.1	15.5	8.2	12.2	14.1	10.0	9.8	12.4	9.0	10.0	14.1	13.4	23.7	12.6	11.2	18.3	12.7	19.9	19.8	15.9	12.0	13.0	10.1	10.6	13.2	9.8	14.9	14.1	18.2	9.6	14.2	24.2	12.3	13.6	15.6	59.3	13.8	7.4	23.9	13.4	12.9	7.6	3.8	8.7	3.9	6.6	13.3	5.4	12.6	4.2	8.7	9.9	6.0	6.8	15.9	7.7	6.5	6.1	6.2	8.4	6.7	23.7	10.6	5.7	7.5	9.1	10.0	6.6	9.7	12.5	7.7	25.8	8.4	4.7	6.2	21.2	13.5	5.3	7.3	5.0	14.2	6.0	6.1	20.8	9.2	20.6	5.1	7.7	38.3	12.4	11.6	6.0	7.4	17.9	14.8	15.1	3.1	9.0	11.3	8.1	17.5	7.2	11.6	7.0	6.4	13.9	9.6	8.3	7.3	7.7	7.1	24.5	12.7	35.5	7.1	9.0	5.5	5.2	3.7	5.0	7.0	3.9	8.8	4.5	6.6	8.2	3.8	7.6	13.3	8.9	8.7	6.6	2.8	2.5	5.0	5.4	13.3	15.6	31.0	15.8	12.4	9.0	12.6	11.2	12.0	15.6	17.9	9.1	20.4	14.9	24.8	12.8	13.4	10.2	4.0	6.8	12.2	3.9	7.2	3.3	4.6	2.3	10.7	6.9	0.0	4.7	5.4	8.2	10.7	6.9	17.8	7.6	15.9	17.2	19.0	22.8	1.6	8.6	10.5	20.3	9.0	14.4	7.2	5.5	3.5	8.1	5.6	10.1	6.5	12.3	12.6	10.5	23.3	4.0	25.4	10.9	11.2
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.5	104.2	0.0	16.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.8	1.2	0.9	0.0	0.0	0.0	23.1	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0	175.7	67.0	0.0	1.3	0.2	1.3	1.2	50.9	25.4	66.0	24.4	0.0	0.1	0.0	1.6	1.1	0.0	1.9	0.0	0.7	0.0	0.6	1.2	0.0	0.0	2.9	0.0	2.9	0.0	0.6	4.5	4.4	2.6	1.7	7.2	1.3	0.0	19.2	190.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.0	2.5	37.2
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.3	10.7	19.9	19.8	7.6	13.0	17.6	10.7	8.1	10.6	10.2	13.8	18.1	26.2	11.1	7.8	7.5	18.4	14.4	10.2	7.2	17.1	24.2	13.6	9.7	14.1	16.9	17.1	10.5	14.6	12.9	7.5	17.3	14.8	15.0	19.6	15.4	11.4	5.5	24.0	30.8	33.9	28.7	19.1	22.7	29.1	12.1	8.5	8.4	10.5	32.2	33.5	14.4	16.7	15.3	10.6	15.1	16.3	10.8	8.6	9.1	14.1	11.1	23.4	11.2	16.6	10.7	11.6	14.9	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1	3.0	13.6	15.6	26.8	13.9	0.0	8.1	15.3	2.7	7.9	33.2	0.0	10.1	14.9	11.4	24.8	18.0	14.8	23.3	17.3	6.9	18.4	25.2	5.7	11.5	9.4	0.0	17.9	12.9	12.5	9.1	33.4	11.0	11.8	8.2	18.6	0.0	14.9	7.0	30.1	7.7	0.0	19.4	23.4	21.9	11.6	16.7	7.8	15.7	21.8	39.4
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	8.8	35.0	19.2	16.7	21.0	1.6	14.6	11.4	23.7	14.5	12.5	10.2	16.8	9.0	17.2	25.0	16.7	14.1	11.3	11.1	18.3	14.0	14.5	7.6	8.3	11.5	12.3	14.6	33.3	15.0	18.3	15.8	16.1	12.5	15.0	14.1	12.6	10.6	20.8	9.8	15.4	8.7	14.3	10.4	6.4	12.5	21.0	9.3	74.3	13.0	7.7	15.0	13.5	13.4	2.9	3.2	7.7	1.9	3.3	8.8	3.3	7.6	8.0	12.0	7.2	9.6	13.4	23.8	4.8	8.7	10.8	9.3	10.1	13.3	25.1	8.3	10.4	8.2	4.8	25.4	11.4	15.9	9.3	8.6	4.5	4.7	15.9	10.4	2.7	15.3	14.2	12.8	7.3	7.9	14.8	14.5	12.7	8.2	2.9	11.8	11.3	17.5	8.4	42.9	10.2	4.9	10.1	10.5	0.0	10.8	6.3	6.4	20.8	7.4	23.3	9.8	32.7	12.6	3.4	9.0	5.2	8.5	3.8	4.6	6.0	2.8	36.8	6.9	2.8	6.6	7.7	1.9	0.0	4.1	0.7	5.7	2.5	4.4	6.2	3.2	2.9	8.8	5.9	0.3	3.3	1.2	1.0	2.2	3.3	19.2	21.0	11.4	23.7	18.3	14.0	12.3	14.6	12.5	9.3	11.9	12.2	9.0	18.9	13.6	0.0	10.6	10.2	9.4	12.5	21.0	0.0	48.3	14.9	20.3	8.2	11.1	20.0	0.0	24.6	35.3	15.4	16.9	11.5	12.3	10.4	0.0	9.2	16.0	7.3	17.2	31.4	5.9	16.9	8.2	20.7	0.0	18.5	23.5	37.4	26.2	0.0	12.9	14.4	20.0	42.4	15.9	50.1	6.9	19.7	15.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Supported	Nucleoplasm,Cytosol		NA	NA		3100000	Cytosol	Nucleoplasm	"HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.4	2.2	11.7	9.9	9.7	10.0	13.2	21.2	10.4	10.7	12.4	9.9	6.8	7.2	6.6	10.0	8.8	6.7	12.0	29.9	18.3	0.1	9.8	0.1	27.4	13.1	9.4	11.5	12.9	12.0	0.0	19.8	21.7	12.4	11.1	0.2	0.1	9.7	11.2	2.0	13.2	0.3	13.7	6.7	17.7	0.2	8.9	12.7	9.3	0.1	6.7	7.6	6.9	8.1	10.5	8.9	5.2	0.2	12.1	0.1	7.6	0.1	16.8	6.5	11.4	15.1	0.1	11.5	6.2	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1	20.8	16.6	17.1	39.8	12.6	0.0	21.0	25.5	16.0	28.4	14.0	0.0	42.6	13.3	34.0	42.8	11.2	6.9	0.0	24.4	68.9	13.3	17.2	10.4	19.8	23.3	0.0	9.2	16.5	21.0	8.8	13.8	17.0	10.1	12.6	13.2	0.0	37.3	0.0	13.8	15.3	0.0	12.9	13.2	0.9	16.0	11.4	18.9	13.4	18.8	44.6
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Erythroid cells: 23.3;Spermatocytes: 9.2;Spermatogonia: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	3.7	2.4	4.9	8.3	6.9	7.1	5.4	16.8	7.3	3.8	3.4	4.1	3.2	3.0	5.8	5.2	4.2	3.6	2.5	2.2	3.6	3.2	2.3	1.8	2.6	8.2	4.8	3.3	5.3	2.7	2.6	3.9	4.2	5.1	3.2	5.5	3.2	3.6	2.3	2.0	6.0	3.2	4.2	4.6	4.6	2.7	11.0	4.8	12.6	2.3	3.4	8.0	2.9	3.5	2.7	0.6	0.6	2.0	1.7	3.2	1.1	9.8	2.9	9.8	4.0	1.4	2.4	4.8	7.5	4.3	11.1	14.4	3.1	5.5	9.0	7.7	2.5	3.3	8.5	9.2	4.5	13.7	7.4	7.0	7.5	4.2	3.7	0.7	7.9	5.8	0.9	2.0	8.5	5.5	1.7	4.9	8.3	4.8	6.8	6.4	4.4	12.6	4.9	4.4	7.8	5.9	7.3	10.1	6.4	2.6	3.5	5.1	5.9	5.1	30.1	4.5	5.6	5.6	5.8	2.9	4.8	8.7	6.1	12.1	2.7	5.6	5.2	4.5	9.9	5.4	0.0	0.4	0.6	1.3	2.0	2.0	2.7	1.9	2.3	0.6	1.9	3.2	2.7	0.2	1.7	1.0	0.0	2.2	1.1	4.9	6.9	16.8	7.3	3.6	3.2	4.8	3.3	5.1	4.8	0.0	1.0	0.0	1.3	0.7	0.0	1.1	0.0	2.7	1.2	1.8	0.0	1.6	0.0	0.7	0.6	0.0	0.0	23.3	1.5	2.6	1.1	0.9	2.3	0.8	1.4	0.0	0.0	1.3	0.8	0.0	1.4	1.6	1.7	1.0	1.3	0.0	0.3	0.0	1.1	0.0	0.0	0.0	1.6	9.2	7.0	0.5	0.6	2.2	1.0	0.8
MTCP1	"P13MTCP1, p8MTCP1"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155061622-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032040: AB_2674122"	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	6.4	7.1	4.1	5.3	5.3	7.2	15.8	4.4	4.8	6.0	6.2	3.4	7.7	5.7	6.0	8.2	7.0	6.1	4.4	30.1	4.7	2.9	6.7	12.8	8.5	15.5	4.5	2.7	9.1	20.7	3.9	6.5	3.5	6.4	5.8	6.1	3.9	7.3	7.0	11.4	12.0	6.7	8.7	7.2	6.7	6.2	16.1	3.8	2.5	8.2	5.4	7.2	6.9	4.0	0.2	0.0	0.8	0.7	0.5	2.0	0.1	1.4	4.9	2.4	3.9	1.6	1.3	2.7	3.0	1.5	1.9	4.8	4.3	7.5	2.7	3.1	0.6	3.0	4.8	3.2	3.5	2.4	1.8	3.2	1.2	14.3	2.3	1.4	2.9	3.3	2.4	1.7	3.2	3.0	2.3	1.8	4.7	1.1	4.9	1.3	2.0	3.7	6.1	1.1	1.8	0.8	4.0	2.6	6.1	2.4	2.1	1.2	1.8	2.2	1.2	2.1	1.7	2.2	1.3	1.8	2.2	3.9	2.1	2.2	10.7	4.6	5.2	4.3	3.5	3.1	0.0	0.6	0.8	1.1	0.0	2.0	0.2	1.2	0.4	0.0	0.1	0.2	1.4	0.0	0.5	0.7	0.0	0.0	0.1	4.1	5.3	4.4	4.8	4.7	2.9	4.5	2.7	6.4	3.8	0.0	1.0	0.0	0.2	0.2	0.0	0.6	0.0	4.0	2.3	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	1.1	0.2	0.3	0.3	0.0	1.0	0.4	0.0	1.7	0.0	1.0	0.2	1.1	0.5	1.7	1.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.3	0.5	0.2	0.6	0.2	0.0	0.5	0.0
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.5	3.5	3.4	6.0	4.9	3.4	3.0	2.4	4.2	3.1	3.0	2.2	3.0	9.0	3.2	4.3	5.1	7.6	6.4	4.2	3.0	3.4	4.7	3.8	3.4	2.5	5.7	5.2	1.2	4.9	5.3	1.7	3.7	4.4	2.8	8.0	4.0	4.3	4.7	3.5	4.1	5.5	4.7	7.3	6.1	3.8	5.0	4.1	5.1	3.0	3.5	3.6	5.7	5.3	4.3	4.7	3.3	3.7	5.2	3.7	3.8	4.3	4.7	3.7	5.3	3.5	3.3	8.4	3.8	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2	3.0	8.9	11.5	12.6	3.0	0.0	15.0	7.6	5.3	9.1	3.5	0.0	9.0	21.6	10.4	1.6	6.5	11.9	0.0	8.5	10.3	10.0	11.7	8.1	9.5	14.2	0.0	7.5	10.4	10.8	1.4	14.4	11.1	8.5	2.8	9.0	0.0	9.2	16.4	14.5	15.3	0.0	0.0	10.3	10.9	21.6	4.0	7.4	9.6	15.3	13.2
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530176-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	12.6	12.6	10.9	10.0	11.4	7.1	13.1	17.1	16.5	12.1	10.8	19.3	18.2	9.1	17.5	15.6	14.4	16.8	11.9	10.0	11.1	7.9	12.2	11.9	10.4	13.3	13.4	13.6	14.8	14.2	24.0	15.8	10.1	14.4	15.9	13.4	16.2	17.2	15.7	14.7	15.6	12.5	14.1	9.5	15.9	12.1	21.5	12.8	14.7	14.7	13.3	14.9	13.3	18.7	8.3	9.9	10.1	7.6	9.3	9.3	7.2	9.5	9.2	8.9	7.8	7.8	11.9	11.0	9.6	7.1	12.2	6.1	8.0	16.3	8.6	10.4	8.3	6.5	13.3	9.9	9.4	11.5	5.7	8.1	7.6	12.0	7.5	10.4	6.0	4.4	7.5	15.2	15.6	13.5	10.6	7.3	12.9	16.2	0.0	8.8	12.2	7.6	9.2	5.9	8.0	11.5	23.2	5.3	6.8	7.1	5.9	8.8	6.0	21.8	4.3	8.0	9.4	21.8	6.4	7.4	11.8	10.2	7.8	9.2	7.1	8.7	25.3	10.8	9.9	11.5	10.1	7.6	3.8	8.5	5.8	8.8	8.3	9.3	8.5	9.9	6.8	7.8	8.8	3.1	9.3	7.1	4.5	7.6	7.2	10.9	11.4	17.1	16.5	11.1	7.9	13.4	13.6	14.4	12.8	6.0	5.1	5.1	2.5	1.0	0.0	3.5	2.5	8.1	3.4	5.2	0.0	6.1	10.0	4.4	28.8	3.6	5.3	0.0	3.7	4.2	3.0	2.4	4.6	2.8	5.2	0.0	4.1	4.3	5.3	11.9	6.1	3.3	3.3	4.6	4.8	0.0	3.1	3.5	7.8	3.3	0.0	6.5	4.7	9.9	3.2	1.3	6.4	2.9	4.7	1.7
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 461.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	36.9	30.4	29.8	21.9	26.3	8.5	28.4	22.8	26.7	21.5	24.8	16.9	25.9	23.7	15.1	38.5	25.5	16.5	20.5	55.7	27.5	22.8	41.5	38.7	15.1	22.2	28.9	19.7	23.1	28.3	14.5	40.3	20.2	28.3	22.7	24.8	17.4	43.3	28.1	46.1	21.6	29.7	18.2	28.7	24.9	22.7	28.3	26.2	29.7	22.9	38.5	24.0	27.8	16.4	25.3	44.3	35.9	26.5	18.5	24.1	19.4	12.6	8.8	19.9	10.0	22.3	33.5	10.1	18.7	20.5	13.8	14.0	11.7	15.7	13.8	12.7	20.3	9.6	10.9	10.7	14.7	19.0	14.5	13.2	17.5	8.1	14.5	21.8	18.1	16.7	18.8	27.1	11.3	14.4	31.2	23.9	13.7	10.0	5.6	20.8	22.3	15.8	22.1	10.3	40.0	10.0	9.3	10.8	15.8	28.4	13.0	14.6	8.9	11.3	16.7	21.2	22.5	13.0	27.3	16.3	9.3	5.5	24.0	12.7	4.3	6.0	8.0	9.7	18.2	13.3	34.2	26.5	35.9	17.1	25.5	18.4	25.3	21.8	17.2	27.9	21.7	19.3	19.6	17.7	18.5	22.1	44.3	24.1	19.4	29.8	26.3	22.8	26.7	27.5	22.8	28.9	19.7	28.3	26.2	26.8	39.6	74.4	31.9	30.2	0.0	153.3	114.7	80.3	53.4	109.9	0.0	82.5	276.8	69.3	461.6	70.4	109.5	70.0	91.1	54.9	56.4	44.1	70.4	186.6	88.5	0.0	61.7	75.5	115.6	139.9	129.5	86.8	101.3	78.5	97.0	0.0	94.2	104.0	117.4	273.1	0.0	122.9	55.6	149.2	77.3	37.1	47.5	55.4	92.5	39.3
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.5	6.7	11.7	12.4	11.8	8.6	8.6	7.6	11.6	10.5	12.2	6.3	5.2	6.5	5.1	14.7	8.4	10.6	12.3	9.7	10.6	12.9	10.2	11.8	6.8	6.7	10.9	10.0	30.2	9.1	16.1	10.2	18.6	10.3	10.5	7.1	7.3	11.8	6.5	10.7	6.7	7.3	4.3	9.2	5.0	8.0	15.8	6.6	9.9	16.0	12.9	8.9	14.7	13.3	7.9	10.3	7.4	10.1	11.1	17.2	11.7	3.5	5.4	10.2	6.9	6.1	7.5	5.0	7.9	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6	3.0	11.3	4.3	8.7	14.8	0.0	2.8	10.2	6.7	14.8	12.2	0.0	10.4	1.7	9.3	11.6	8.9	12.4	0.0	7.6	5.5	9.4	14.8	7.0	8.5	9.8	0.0	12.0	13.5	24.0	12.1	12.7	12.9	13.5	2.8	11.1	0.0	9.9	8.6	10.6	5.7	0.0	6.5	5.0	20.9	24.0	12.0	11.4	7.0	9.3	11.6
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17298030-17413528	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;parathyroid gland: 17.9"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"							HPA075682			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	4.9	10.9	1.9	16.7	3.4	0.9	16.2	25.8	1.2	1.3	16.0	0.0	2.0	1.8	0.8	1.5	1.5	1.6	1.7	7.5	7.8	2.4	2.2	1.4	1.7	9.2	9.5	3.5	2.6	17.9	10.3	1.8	19.5	1.2	1.3	4.7	1.4	1.1	2.1	2.6	1.9	1.1	11.2	1.4	1.8	2.9	9.4	0.0	6.5	0.0	0.8	1.4	0.7	0.7	0.2	0.8	0.2	0.3	1.4	0.1	0.8	0.7	1.2	1.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.9	0.2	0.9	0.5	0.0	0.8	0.4	4.1	0.1	0.0	0.1	3.0	1.2	1.6	0.5	1.0	0.7	0.9	0.2	0.0	0.1	0.0	0.8	0.2	0.4	0.6	0.7	0.0	0.6	1.3	1.7	5.4	0.7	0.6	0.4	1.8	0.5	0.0	3.4	14.3	8.3	0.6	0.8	0.9	2.0	0.4	0.9	1.5	0.9	0.5	2.0	1.1	0.4	0.4	0.7	2.6	1.3	0.7	0.0	0.1	0.7	0.2	0.2	0.1	0.7	0.1	0.2	0.1	0.0	0.5	0.3	0.8	0.3	0.2	0.2	1.4	0.1	10.9	16.7	16.2	15.2	7.5	7.8	9.2	9.5	19.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	9.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.5	0.6	1.6	0.1	1.1	0.0	0.0	0.0
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	10.4	11.0	11.1	13.5	13.7	14.7	11.5	21.8	13.6	14.0	14.0	11.3	12.4	12.7	12.6	11.2	12.1	10.0	8.1	13.3	10.0	10.9	19.7	28.4	9.8	15.8	19.3	10.0	14.5	12.1	24.6	15.6	8.7	13.9	12.2	12.7	10.1	10.7	12.3	15.8	9.8	13.6	11.9	12.1	18.6	11.9	20.5	15.0	13.0	14.0	11.0	16.6	12.1	15.0	10.4	7.4	5.3	7.8	10.5	14.0	8.7	5.1	4.7	6.5	5.3	9.4	11.0	5.9	10.7	9.8	10.5	12.8	9.7	3.9	13.5	8.4	10.0	8.2	8.8	11.9	8.6	16.1	7.8	7.8	10.3	11.4	10.5	12.4	18.5	7.0	9.5	13.6	11.3	12.7	7.4	7.9	12.0	17.6	13.0	10.9	8.9	5.1	16.0	4.8	7.7	4.8	8.5	18.7	22.4	8.4	8.1	5.5	3.3	5.5	9.3	9.6	6.2	6.1	19.6	5.0	6.2	6.1	3.5	10.1	8.5	13.1	5.4	3.2	13.8	8.2	1.7	6.4	5.3	9.7	7.2	11.9	10.4	11.7	9.8	7.4	7.9	12.9	10.5	1.8	10.5	7.8	5.5	14.0	8.7	11.1	13.7	21.8	13.6	10.0	10.9	19.3	10.0	13.9	15.0	14.9	17.0	14.3	13.5	6.9	0.0	12.9	7.6	6.7	11.4	10.4	0.0	10.2	18.3	6.5	108.3	9.0	9.0	0.0	6.4	6.5	6.9	10.3	5.8	18.4	7.8	0.0	8.1	9.2	5.9	11.0	10.3	10.8	0.0	8.2	8.1	0.0	6.1	7.0	9.2	12.6	0.0	6.5	10.2	21.7	10.2	8.8	8.6	24.2	9.8	9.7
MUM1	"EXPAND1, MUM-1"	ENSG00000160953	"Melanoma associated antigen (mutated) 1"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048063	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243"	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	6.7	5.3	14.4	3.6	20.9	2.1	5.6	21.9	19.2	7.0	5.8	13.6	4.5	3.7	10.4	5.6	4.3	13.0	5.4	5.3	13.6	9.1	4.9	8.3	6.8	3.6	14.2	11.5	18.4	4.0	7.7	7.5	6.0	11.5	6.7	4.8	5.8	6.7	8.7	5.5	8.1	4.8	11.5	10.5	6.0	4.8	19.9	13.1	1.9	6.0	0.9	4.5	5.6	11.5	4.3	3.9	11.8	2.6	3.8	4.5	1.3	7.2	9.3	13.0	13.8	10.6	14.1	15.9	12.6	7.9	11.6	8.6	6.4	4.8	14.7	5.9	16.2	4.1	8.2	13.1	8.2	8.8	15.8	8.3	7.9	9.5	9.6	10.2	6.1	17.8	9.2	5.1	6.5	4.7	14.9	11.8	9.9	12.2	7.4	11.0	8.1	10.4	6.5	14.7	8.1	5.3	16.8	10.9	6.1	7.7	10.5	9.4	21.5	11.1	13.1	8.4	11.8	6.4	14.0	11.3	10.5	14.6	8.5	11.6	15.0	12.6	6.7	14.0	9.9	14.2	11.8	1.1	6.8	4.5	2.6	3.8	3.9	2.5	3.3	2.1	4.3	3.7	4.0	2.2	3.8	2.2	3.9	1.6	1.3	14.4	20.9	21.9	19.2	13.6	9.1	14.2	11.5	11.5	13.1	32.8	18.3	29.6	30.8	15.0	192.5	23.6	48.4	30.8	14.8	17.4	133.5	16.7	10.0	30.8	84.4	21.8	35.5	0.0	19.1	20.1	33.2	18.7	32.4	72.0	15.3	151.0	36.8	28.8	14.8	101.3	53.8	14.7	28.7	20.8	26.2	51.9	24.8	28.3	53.0	11.0	82.1	116.4	31.5	168.6	74.1	12.9	11.9	20.8	29.5	16.6
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: AB_2684052"	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	15.6	14.3	17.2	21.4	19.5	13.6	24.7	21.6	19.5	19.3	22.2	19.1	18.3	22.1	28.2	12.4	14.4	20.4	19.5	18.4	16.6	12.3	17.7	13.8	17.9	22.2	24.0	14.1	23.5	17.0	19.5	17.2	16.6	17.2	19.4	9.8	13.4	14.9	23.2	28.1	18.2	26.5	19.4	17.5	21.6	17.7	11.3	22.4	32.2	17.8	15.6	17.7	18.2	21.7	12.5	13.2	23.2	15.2	10.8	20.0	11.2	10.8	6.9	11.8	11.6	5.2	6.4	15.0	11.7	9.5	15.2	10.2	9.1	17.9	10.5	16.0	9.3	18.9	10.6	10.5	10.5	3.4	22.6	7.7	19.0	18.6	5.5	16.0	13.4	20.3	10.1	19.5	19.2	15.2	11.2	12.8	19.1	11.4	29.6	10.0	7.3	19.1	20.8	8.4	7.3	15.5	18.9	5.6	20.0	11.6	6.9	11.8	13.5	8.0	14.6	25.4	7.6	17.0	14.1	11.2	11.4	9.7	14.5	12.7	19.9	13.2	15.1	12.9	9.0	18.9	16.2	12.4	23.2	20.0	14.3	19.6	12.5	15.1	17.2	13.0	10.6	12.0	14.7	8.5	10.8	15.2	13.2	12.8	11.2	17.2	19.5	21.6	19.5	16.6	12.3	24.0	14.1	17.2	22.4	11.9	17.3	13.7	18.5	7.1	18.0	6.7	15.3	18.7	15.9	7.0	19.6	18.3	5.0	21.3	50.1	11.3	25.7	0.0	19.4	19.4	11.8	9.8	13.9	8.3	16.9	22.3	16.1	14.1	14.6	97.2	20.1	15.3	10.1	36.1	20.9	13.8	21.1	21.0	25.5	12.1	22.2	38.8	16.7	23.6	13.8	6.5	16.5	21.9	18.9	11.2
MVB12A	"FAM125A, FLJ32495"	ENSG00000141971	"Multivesicular body subunit 12A"	Q96EY5	19	17405722-17433724	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041885, HPA042231"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA041885: AB_10964218, HPA042231: AB_10961043"	"unprognostic (1.34e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.96e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.93e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.33e-2)"	18.4	24.6	9.4	16.2	9.8	14.1	21.1	10.1	12.3	13.4	16.3	13.3	22.2	19.0	16.4	15.2	24.0	16.8	17.1	10.4	8.2	6.1	17.4	16.6	12.4	21.1	11.8	7.1	33.8	16.8	9.6	7.2	15.1	8.8	12.5	9.5	15.6	17.0	17.3	11.4	20.0	20.4	9.0	9.2	17.7	14.2	10.7	11.3	19.6	29.5	12.4	22.8	15.6	15.3	13.8	28.2	24.6	30.6	17.7	26.3	17.4	16.6	9.4	4.3	13.1	6.1	9.8	24.0	5.2	10.4	14.1	17.4	8.6	24.8	13.3	17.3	11.4	10.0	8.1	8.5	12.7	3.8	14.1	23.8	3.0	19.4	20.1	18.9	5.3	12.8	10.7	9.9	10.9	6.8	9.2	15.5	10.5	9.3	26.0	5.6	12.5	9.4	8.3	6.3	13.2	26.4	12.0	4.8	19.5	11.5	9.2	8.4	12.4	7.6	11.2	26.9	4.5	14.8	11.1	7.5	10.6	5.6	11.4	6.2	18.5	23.0	14.5	11.1	18.7	13.0	24.6	30.1	19.2	17.3	30.6	16.2	11.9	17.5	16.3	28.2	13.8	14.7	14.4	17.6	17.7	23.8	25.5	26.3	17.4	9.4	9.8	10.1	12.3	8.2	6.1	11.8	7.1	8.8	11.3	8.9	8.0	13.4	34.3	34.7	5.6	5.2	50.9	24.1	6.8	43.6	5.9	48.6	46.4	68.9	9.1	33.7	66.4	0.0	42.2	82.3	43.2	18.8	21.8	25.5	61.9	3.2	25.4	59.5	39.5	12.8	40.3	24.2	30.4	44.1	43.8	29.5	52.9	66.6	44.2	47.1	13.2	6.5	36.3	13.6	10.4	38.3	34.0	23.5	54.2	41.4
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.1	5.6	3.5	9.5	0.2	0.5	5.8	10.6	3.5	4.8	4.6	3.7	8.5	4.3	4.4	1.4	2.6	4.0	0.4	1.2	0.2	59.2	7.2	2.4	8.1	5.4	0.5	2.3	7.5	0.3	0.6	0.3	0.2	0.4	4.4	19.2	1.5	13.6	0.9	10.4	21.6	6.5	1.2	2.5	9.8	10.6	10.8	6.2	1.0	1.1	8.6	7.1	6.8	6.9	3.7	0.5	10.9	6.2	3.2	5.8	15.0	4.6	5.6	18.0	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9	3.0	2.2	0.0	1.5	4.9	2.8	1.2	5.1	5.3	4.5	5.2	0.0	4.5	0.0	1.3	16.3	2.3	4.0	116.8	3.5	7.2	3.4	2.4	9.2	3.9	8.8	3.2	1.7	4.3	4.9	1.9	1.7	5.1	3.3	1.0	5.0	1.0	1.9	3.1	1.4	0.3	2.2	0.0	3.1	0.7	5.9	5.0	11.0	5.1	6.9	1.8
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	25.2	0.1	0.0	0.0	39.5	20.0	0.0	0.0	0.1	0.0	0.0	0.0	24.8	20.4	3.8	0.2	2.0	72.0	37.5	0.2	3.5	0.3	44.5	1.0	6.1	0.0	0.2	1.9	1.2	0.0	2.0	0.0	0.1	1.5	62.8	0.0	0.0	0.3	1.5	0.4	4.8	1.2	12.2	0.0	34.2	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6	0.0	2.2	2.9	1.1	2.4	0.6	0.4	2.5	44.2	10.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	2.9	0.0	0.7	0.6	0.4	2.7	25.4	0.0	0.9	0.0	16.9	0.0	1.2	0.0	0.0	1.5	8.5	0.0	26.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	6.0	0.2	1.9	37.5	2.0
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 103.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	26.3	16.8	14.9	15.4	0.1	0.5	19.3	11.9	4.0	37.8	27.9	82.4	16.6	53.3	6.9	5.2	7.9	16.1	26.9	8.2	14.2	9.9	17.2	24.9	16.8	22.2	0.0	22.7	17.3	0.3	0.7	14.4	3.2	0.8	10.1	26.5	24.8	66.3	3.3	103.7	46.1	32.0	17.1	21.2	14.7	32.1	30.6	30.5	7.0	5.4	13.7	20.0	35.5	35.7	3.6	16.4	23.5	24.9	4.7	2.3	38.0	16.7	20.5	23.0	47.4	83.8	4.9	19.5	14.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.0	13.4	0.2	3.8	0.0	1.7	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.5	93.5	0.8	28.3	0.4	0.1	0.0	0.0	11.2	0.0	0.0	1.3	1.6	10.0	0.0	0.5	1.7	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.4	25.7	2.0	3.1	2.1	2.2	0.9
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862964-38874105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	8.6	10.5	4.8	13.6	7.4	9.0	14.5	4.6	4.9	11.6	14.9	3.6	21.3	10.5	9.6	18.2	23.4	17.7	15.6	16.8	5.2	4.9	26.5	21.1	16.1	20.7	4.6	3.1	9.3	20.0	13.9	12.5	24.8	11.2	13.6	15.6	6.6	22.9	17.3	11.8	12.0	24.4	14.6	4.9	16.8	13.1	28.9	5.2	16.8	24.3	18.1	19.6	13.0	11.9	9.0	21.7	32.1	15.1	11.0	12.9	8.1	18.5	8.1	7.2	5.2	4.2	7.4	28.7	14.9	4.9	15.1	11.9	9.5	22.3	15.3	16.6	6.8	2.4	13.9	11.2	19.4	18.3	19.2	18.6	16.3	11.6	10.0	1.1	40.4	14.8	6.6	15.5	12.5	7.9	5.8	11.0	17.6	23.6	14.2	15.8	10.9	12.9	19.4	18.2	28.1	20.4	12.4	21.2	21.4	19.7	15.7	13.6	9.3	14.3	19.0	9.6	17.2	13.0	19.5	8.7	7.9	13.3	12.1	17.0	9.5	17.0	16.9	7.9	23.8	10.3	14.8	12.6	32.1	7.8	15.1	8.9	9.0	9.7	9.3	16.0	6.4	8.4	9.3	25.1	11.0	13.5	21.7	12.9	8.1	4.8	7.4	4.6	4.9	5.2	4.9	4.6	3.1	11.2	5.2	8.9	13.3	18.6	14.6	9.4	0.6	7.3	22.9	163.3	36.4	26.2	0.0	96.0	54.7	19.6	63.4	10.8	26.5	23.3	23.9	75.4	7.3	14.2	26.4	13.4	19.0	9.5	9.2	6.2	15.1	16.8	6.6	15.9	18.6	23.4	25.1	3.8	23.0	38.6	8.5	34.2	4.5	6.5	12.2	22.9	68.8	15.6	73.7	21.5	26.9	20.0
MYCBP2	"FLJ10106, KIAA0916, PAM"	ENSG00000005810	"MYC binding protein 2, E3 ubiquitin protein ligase"	O75592	13	77044655-77327050	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	28.0	13.4	31.0	26.1	28.8	24.1	22.4	31.3	32.7	15.5	10.9	8.1	11.5	8.0	16.2	26.7	18.9	11.7	11.1	13.5	24.1	18.6	12.3	13.2	12.4	29.8	15.3	31.1	22.8	12.6	14.5	17.2	9.6	20.0	17.9	11.5	9.6	12.9	12.4	13.7	57.6	13.6	13.2	14.0	24.1	10.3	14.1	16.2	18.6	11.6	12.6	30.7	13.3	34.0	8.3	4.6	3.3	3.7	4.2	7.3	2.5	7.8	4.0	4.9	5.3	24.5	10.9	2.8	5.0	7.4	4.4	5.7	3.5	4.1	22.5	3.2	9.8	4.3	7.3	8.4	9.2	6.0	8.9	8.3	19.1	8.2	7.3	8.3	40.0	6.8	12.2	7.7	4.0	8.0	4.3	9.9	8.3	4.0	7.1	7.8	4.7	10.9	27.0	2.6	10.5	5.1	12.5	5.0	5.4	7.4	7.8	7.7	3.6	6.0	8.7	4.5	5.2	3.2	30.7	13.0	4.2	3.5	2.7	4.8	7.7	5.3	16.1	8.5	33.0	4.2	2.0	3.5	3.2	5.8	3.7	5.1	7.9	6.5	5.0	3.2	8.3	7.3	5.8	3.3	4.2	2.5	4.6	7.3	2.5	31.0	28.8	31.3	32.7	24.1	18.6	15.3	31.1	20.0	16.2	35.7	43.3	79.8	35.8	73.2	212.4	65.7	30.6	17.4	26.1	33.2	98.2	33.8	1.7	22.3	46.1	82.8	12.8	23.3	28.6	26.5	62.0	42.9	47.3	46.5	37.4	206.6	31.4	39.3	93.9	20.0	60.9	48.5	30.4	37.9	18.1	141.3	26.4	17.5	90.5	11.2	95.1	103.5	74.0	61.5	64.3	131.7	36.7	68.3	24.7	36.1
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Group enriched"	"Detected in some"	7	"U-266/70: 96.4;U-266/84: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		NA	NA			Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.7	2.0	0.5	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.4	0.0	0.2	0.0	0.2	1.1	0.7	0.0	0.1	0.2	0.0	0.0	2.8	0.4	0.1	0.2	3.4	0.6	0.2	11.6	0.5	0.7	0.2	0.4	0.1	1.1	0.7	3.7	0.0	0.0	1.1	1.3	0.1	96.4	70.7	0.2	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6	0.0	0.6	0.0	9.0	6.0	0.2	3.3	0.0	1.4	4.5	8.7	0.0	21.7	0.0	1.1	0.1	0.5	9.5	0.0	5.1	11.3	0.7	4.8	0.0	21.9	4.9	0.0	16.6	2.5	6.9	0.2	0.0	9.6	1.7	0.0	22.7	1.1	2.4	8.5	0.0	0.0	0.0	0.0	0.3	0.0	0.7	10.3	14.6	0.0	10.5	22.1
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940564-15947007	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 16.8"	"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 75.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0.0	3.0	1.9	0.8	1.3	1.4	2.6	2.3	7.0	4.7	6.0	1.5	1.6	2.9	6.0	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1.0	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4.0	5.7	5.1	2.3	3.5	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	26.6	0.6	0.0	0.0	18.6	3.5	0.0	0.9	0.2	4.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	1.4	7.0	7.0	4.7	6.0	2.2	6.8	4.0	0.0	0.0	0.0	0.1	0.5	2.6	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	0.2	0.0	0.0	0.0	75.4	0.6	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.2	0.0	0.4	2.1	0.1	0.0	0.0	0.5	3.6	0.0	9.6	0.0	0.2	0.0
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 121.1;Ito cells: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 46.9;TIME: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	38.8	0.2	0.3	0.5	0.0	0.4	0.0	5.8	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2	0.0	6.9	0.0	0.1	6.4	0.0	2.8	5.1	29.4	1.2	0.0	0.0	0.0	0.0	0.1	6.0	121.1	0.0	0.0	0.2	0.0	2.4	0.4	1.1	1.0	0.1	0.0	0.0	178.6	9.1	2.9	0.3	0.8	13.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.1	4.8	0.0	0.0	0.0	0.2
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell type enriched"	"Detected in some"	8	"Pancreatic endocrine cells: 116.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	59.2	28.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.7	0.2	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.0	2.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.1	0.8	0.0	13.1	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	15.5	10.5	0.0	0.4	0.0	8.4	0.2	0.2	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	4.7	0.3	0.0	0.0	0.0	1.0	0.0	116.0	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.1	0.1	0.0	0.5	6.8
MYL12A	"MLCB, MRCL3, MRLC3, MYL2B"	ENSG00000101608	"Myosin light chain 12A"	P19105	18	3247481-3256236	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 5937.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004503, HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes		70000000	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.14e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.58e-3)"	"unprognostic (7.13e-2)"	60.9	19.9	7.1	31.1	13.1	21.7	63.9	5.1	7.6	25.1	31.2	7.4	22.5	15.6	24.1	29.0	43.6	22.8	32.4	248.0	8.2	6.8	52.7	43.1	58.3	58.4	14.6	5.7	28.6	24.8	24.9	11.1	49.5	18.9	24.3	27.2	14.7	26.5	18.6	423.8	24.2	41.5	27.9	22.1	68.6	22.5	20.4	10.3	40.3	38.6	80.1	42.0	30.6	31.2	103.4	166.8	173.4	91.9	104.2	168.7	245.4	31.3	20.0	45.6	19.1	53.9	56.8	27.9	71.6	94.5	68.1	74.3	30.2	39.8	15.2	18.9	103.9	47.6	13.7	26.4	44.9	61.1	21.4	9.4	15.5	23.8	26.5	90.3	44.1	30.3	88.8	63.7	52.8	32.0	62.5	106.8	20.4	19.4	53.2	139.6	53.7	20.5	44.4	18.7	36.4	14.8	11.9	23.9	26.7	149.3	50.9	6.4	15.6	56.6	24.4	49.5	44.0	17.2	65.2	114.2	16.9	38.5	46.2	56.5	12.1	17.5	24.6	50.7	17.7	60.4	173.4	74.5	154.6	166.4	77.4	166.7	103.4	156.8	168.7	109.0	80.4	142.5	167.0	122.8	104.2	91.9	166.8	133.2	245.4	7.1	13.1	5.1	7.6	8.2	6.8	14.6	5.7	18.9	10.3	684.9	287.2	341.2	723.8	564.8	28.8	5937.2	466.2	370.7	324.2	485.1	11.8	673.0	399.6	1177.4	18.9	908.8	703.7	0.0	1306.6	996.1	418.1	441.5	501.9	258.7	758.2	54.0	101.2	852.6	651.0	20.6	309.8	806.5	420.1	2189.4	519.0	67.5	1678.2	662.9	372.7	509.4	40.9	562.7	473.8	61.2	173.0	476.5	557.0	1044.7	325.5	594.7
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261909-3278284	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	64.1	82.2	38.7	46.1	38.2	41.9	66.1	27.0	48.9	63.9	84.8	21.4	58.7	67.6	52.9	86.8	106.9	49.6	65.2	53.0	37.8	34.0	150.0	105.3	85.9	68.7	36.0	31.9	53.4	48.9	48.4	37.5	139.8	46.8	56.8	75.0	37.1	69.8	52.8	71.8	59.6	129.4	54.7	30.9	62.2	52.8	42.8	26.0	65.1	107.2	89.8	61.1	58.6	61.5	46.7	83.6	151.5	78.1	47.6	77.7	109.0	49.0	26.0	23.1	22.2	67.3	57.4	39.8	74.9	65.9	70.1	72.2	54.5	39.4	24.6	33.0	101.7	52.8	24.9	38.1	86.1	72.0	14.3	16.1	24.8	29.5	43.7	69.4	55.5	39.1	49.4	82.7	46.6	29.8	61.2	104.8	25.3	21.2	24.2	90.8	99.6	31.7	40.1	15.4	58.9	22.3	15.8	29.1	19.7	147.6	91.0	19.0	19.8	74.4	45.3	45.1	39.9	38.7	33.3	126.2	68.1	101.7	59.4	90.6	13.5	12.9	30.0	41.4	22.6	52.9	123.3	51.4	151.5	72.2	68.0	61.4	46.7	70.7	77.7	60.9	37.8	58.0	66.8	120.5	47.6	78.1	83.6	75.2	109.0	38.7	38.2	27.0	48.9	37.8	34.0	36.0	31.9	46.8	26.0	750.4	480.3	216.3	748.4	563.6	73.7	716.9	471.3	642.4	558.4	514.7	23.6	919.9	888.6	1342.8	114.5	450.9	1252.4	93.5	1292.5	904.2	420.1	592.5	429.2	253.2	547.6	62.0	234.2	683.2	403.1	161.2	413.3	509.2	327.3	1202.0	540.9	131.6	1740.8	831.1	407.3	1106.8	72.8	349.3	305.9	216.8	195.5	496.8	1173.0	496.0	458.6	860.6
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 71.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.0;ASC TERT1: 23.4"					"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.7	13.6	7.2	34.0	23.4	6.5	5.5	7.4	5.6	5.2	4.5	9.6	2.6	2.6	8.9	4.0	3.3	2.1	3.7	1.6	4.8	2.7	3.9	5.1	4.1	11.9	5.9	3.6	17.6	3.6	4.4	4.7	8.2	3.4	5.6	4.0	3.5	6.9	4.2	3.1	4.1	2.8	4.7	5.7	2.8	2.9	1.5	9.2	10.6	6.2	3.5	1.8	4.6	3.7	4.6	7.4	5.4	5.6	4.8	0.9	4.1	3.1	13.6	2.6	1.6	5.3	5.3	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9	0.0	11.0	9.5	6.0	10.6	5.7	1.2	7.6	6.7	2.3	7.0	19.6	5.7	10.0	8.8	16.6	4.5	31.5	0.0	4.0	4.3	6.6	7.4	12.8	14.9	18.5	11.1	5.2	9.2	16.2	71.2	6.6	7.5	6.8	20.8	8.8	16.6	6.2	10.5	3.5	30.0	78.4	6.5	5.0	14.4	3.1	11.7	4.6	6.1	13.3	8.9
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541484-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 717.2;urinary bladder: 496.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 1565.8;Peritubular cells: 1778.4;Sertoli cells: 2108.4;Smooth muscle cells: 1718.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.6;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.3;BJ: 110.6;fHDF/TERT166: 87.8;hTERT-RPE1: 70.2"					"Low region specificity"	"Detected in single"			"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		92000000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	61.9	46.0	2.0	58.1	5.8	0.2	64.8	1.4	6.4	123.3	361.6	6.0	162.9	22.7	278.8	102.0	242.7	80.3	199.0	169.8	1.9	2.1	27.7	6.8	36.0	14.9	4.7	8.7	107.8	5.4	2.8	4.8	31.7	10.5	218.9	30.4	71.8	22.6	203.9	22.2	14.7	70.3	717.2	5.2	22.8	120.7	55.1	1.4	1.4	48.8	21.9	8.7	496.7	107.7	1.2	0.5	2.7	0.2	0.3	0.1	10.8	8.0	0.1	6.4	0.1	85.3	32.8	28.4	110.6	47.9	58.0	37.6	63.8	0.9	0.0	58.0	87.8	12.7	3.0	0.0	0.2	13.7	0.0	0.0	1.6	12.5	5.9	55.1	0.0	1.9	45.9	5.8	38.3	0.1	70.2	2.0	0.0	0.2	2.9	48.6	0.0	0.0	0.8	2.5	1.6	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.4	1.1	2.8	0.0	29.2	24.7	1.6	14.2	55.4	23.4	8.0	0.1	0.0	0.4	0.2	21.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.2	0.0	0.0	2.7	0.3	0.0	0.5	0.0	10.8	2.0	5.8	1.4	6.4	1.9	2.1	4.7	8.7	10.5	1.4	366.3	53.6	10.5	235.7	53.9	0.8	1565.8	30.6	20.1	50.0	85.5	0.0	24.0	23.2	211.4	5.9	105.7	0.0	0.0	105.2	66.4	237.6	45.8	15.0	1.1	29.4	1.6	0.0	219.1	4.8	25.6	307.2	19.2	69.2	26.2	0.1	179.9	56.1	0.0	1778.4	24.0	5.5	2108.4	1718.3	4.2	6.9	46.7	22.4	10.2	0.6	57.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 162.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	1.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0.0	3.5	0.0	0.7	0.0	0.5	162.4	0.0	16.0	6.8	0.0	2.0	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.2	0.4	1.4	0.6	1.1	0.0	0.4	0.0	0.0	0.6	0.0	3.2	0.6	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.2
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Group enriched"	"Detected in some"	45	"Cardiomyocytes: 88.1;Early spermatids: 50.3;Late spermatids: 28.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.8;REH: 11.2;RH-30: 23.8;U-2 OS: 10.5;U-266/70: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.2	0.0	0.0	0.0	11.2	23.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	7.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	28.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979098	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8"	"Cell type enriched"	"Detected in many"	7	"monocytes: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		120000	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.5	1.2	1.6	11.0	3.0	27.4	1.5	0.4	2.0	1.0	1.9	0.7	0.0	1.8	1.2	2.1	2.4	1.9	3.6	3.2	1.0	0.9	1.9	1.9	13.0	18.6	4.5	0.0	0.9	0.8	0.0	0.9	1.5	2.7	1.5	1.1	1.5	5.8	0.5	0.6	1.2	8.3	1.9	2.6	22.3	2.1	0.9	1.8	46.8	2.1	2.2	26.6	4.7	1.3	9.9	14.0	9.4	37.9	6.7	24.4	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	24.5	0.8	0.0	0.0	14.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	31.0	13.1	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	20.2	0.0	9.4	17.0	5.2	19.9	29.6	12.6	9.9	12.7	17.4	14.0	6.6	4.6	9.0	1.7	6.7	37.9	1.2	24.4	19.3	1.6	3.0	0.4	2.0	1.0	0.9	4.5	0.0	2.7	1.8	3.0	11.4	56.6	0.3	2.5	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.9	0.2	1.7	0.4	30.0	0.9	10.8	3.2	0.0	2.5	71.9	1.2	0.0	51.5	3.3	573.5	0.0	0.2	0.2	0.0	0.4	0.3	0.0	6.5	1.6	0.4	0.2	1.5	0.1	86.3	0.0	0.1
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295798	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 122.1;Alveolar cells type 2: 62.6;Ciliated cells: 60.2;Club cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 12.8;MCF7: 22.9;OE19: 20.7;RT4: 13.3;SK-BR-3: 17.5;T-47d: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159"	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favorable (2.47e-5)"	"prognostic favorable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.2	1.5	2.7	4.0	4.0	0.4	10.7	14.7	3.4	11.1	10.0	3.4	9.5	3.7	3.7	9.8	6.6	8.6	12.2	1.7	2.5	1.7	6.4	2.7	11.4	1.2	2.6	3.0	2.6	33.9	18.5	7.8	2.1	7.5	7.8	13.2	6.5	22.6	12.8	2.1	4.3	4.1	4.2	4.3	2.7	14.2	4.7	3.4	0.5	15.1	3.7	3.8	4.5	18.4	1.2	1.6	1.5	0.0	0.0	2.9	0.1	10.6	12.8	1.8	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	1.9	4.5	0.6	2.7	0.0	0.1	1.7	2.7	3.7	0.0	0.5	4.3	0.0	9.1	7.8	0.0	0.0	0.1	0.0	3.7	0.0	3.6	1.9	2.8	0.4	0.0	0.2	0.0	22.9	0.6	0.1	0.7	20.7	6.1	8.7	1.1	5.3	10.2	13.3	1.8	2.0	0.8	17.5	0.0	2.9	21.1	0.0	0.0	0.0	0.1	0.0	1.6	0.3	0.3	1.0	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.2	1.0	0.4	0.4	0.3	1.5	0.0	0.0	1.6	2.9	0.1	2.7	4.0	14.7	3.4	2.5	1.7	2.6	3.0	7.5	3.4	122.1	62.6	0.5	13.4	0.6	0.0	5.8	15.3	60.2	64.8	21.0	0.0	2.2	3.3	17.6	2.0	14.0	14.6	0.0	25.7	1.2	0.6	32.8	3.5	4.2	0.7	0.0	5.2	0.0	0.3	1.8	1.7	0.7	6.8	0.0	44.0	4.9	30.1	23.0	0.4	0.8	0.4	0.0	1.0	6.5	4.7	1.3	0.6	0.0	22.4	35.7
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell type enriched"	"Detected in some"	343	"Cardiomyocytes: 2214.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	1.7	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	10.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.7	0.7	0.0	6.5	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752642-61788518	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.7;stomach 1: 57.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol		NA	NA		550000	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	4.6	1.3	16.4	2.1	42.9	1.4	1.5	3.3	38.5	3.7	4.3	96.7	0.0	12.8	6.9	1.6	2.0	8.0	22.4	1.5	29.2	13.9	4.5	5.8	15.8	1.2	54.3	19.9	5.8	19.7	1.2	0.2	2.6	35.7	1.2	4.0	11.6	1.7	1.6	1.0	1.4	11.4	5.4	53.8	1.3	57.2	3.0	51.4	0.0	1.2	0.0	1.2	1.3	0.3	0.0	0.0	0.2	0.3	0.5	2.1	0.5	1.3	17.5	3.1	1.0	0.0	0.0	0.1	0.1	0.0	0.6	0.7	29.3	16.9	0.6	22.9	0.0	0.8	0.7	1.0	0.1	1.2	0.0	0.3	0.1	0.3	12.4	13.1	0.0	0.3	0.3	0.1	0.4	0.0	7.7	0.1	0.9	5.4	0.2	0.1	0.3	0.0	0.6	0.8	25.8	2.3	0.0	0.1	1.1	7.8	0.1	0.1	0.6	0.1	1.2	0.3	10.9	0.3	0.1	0.6	0.2	10.2	0.2	0.3	0.3	0.1	0.1	0.1	1.2	0.2	0.0	0.0	0.2	2.1	0.3	1.2	0.0	0.7	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.5	16.4	42.9	3.3	29.3	29.2	13.9	54.3	19.9	35.7	51.4	44.7	6.1	0.0	0.0	0.1	0.1	0.8	58.6	0.0	2.3	3.5	0.0	0.2	0.0	29.2	0.3	0.0	8.4	0.0	31.5	0.2	4.9	0.2	0.0	5.3	0.8	0.0	1.2	0.6	0.0	0.2	5.5	0.6	3.3	1.8	3.2	3.7	47.6	11.5	3.5	1.0	0.0	0.0	0.3	1.0	3.2	0.0	0.7	0.0	5.2	0.7
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.5	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.0	0.3	13.3	0.0	0.0	0.0	0.0	16.6	4.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8	0.0	0.0	0.0	0.2	0.0	28.8	1.1	5.1	0.0	0.0	0.0	56.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	25.4	2.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	9.8	0.0	0.0	0.0	0.0	0.0
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 13.1;JURKAT: 12.5;NB-4: 33.0"	"Low region specificity"	"Detected in all"							HPA038971	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038971: AB_10673408"	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	12.1	9.4	19.6	10.5	22.2	29.5	22.1	24.5	21.8	12.3	11.0	9.4	4.2	11.6	14.6	12.8	8.3	14.0	9.6	6.3	15.0	16.6	7.4	57.8	17.3	17.6	12.1	18.8	30.1	11.0	7.3	21.2	10.0	11.0	11.3	11.3	7.3	7.6	9.5	11.0	17.5	13.4	11.3	10.6	19.2	7.2	3.6	15.5	14.2	10.4	5.1	12.9	13.5	16.5	15.9	28.0	24.2	25.5	15.2	13.5	17.4	0.5	0.1	0.7	0.2	2.9	2.3	0.2	0.3	1.2	0.7	1.2	2.1	2.9	5.6	0.8	0.6	2.1	0.0	2.1	0.2	0.9	8.5	1.3	13.1	0.6	6.2	4.6	4.9	0.8	1.6	0.5	0.5	0.6	5.2	0.4	12.5	0.0	10.5	0.5	0.4	10.0	33.0	1.1	0.0	0.3	9.6	0.3	4.7	2.8	1.0	2.0	2.4	2.1	0.0	0.9	1.5	0.3	9.3	0.2	0.2	0.1	0.1	0.1	5.9	3.5	0.3	0.3	1.8	0.4	24.2	25.5	6.6	9.8	23.1	8.5	14.0	9.5	11.9	21.9	15.9	13.1	11.3	6.2	15.2	15.8	28.0	13.5	17.4	19.6	22.2	24.5	21.8	15.0	16.6	12.1	18.8	11.0	15.5	41.7	25.1	28.7	27.2	26.8	7.4	3.4	10.2	5.3	22.7	5.2	0.0	17.0	8.3	8.8	17.8	35.7	4.5	0.0	7.4	0.9	15.9	22.7	8.1	57.2	20.1	0.0	36.5	11.6	41.3	15.5	25.3	44.8	28.7	143.3	11.5	10.0	6.2	10.7	20.8	8.4	1.6	77.6	56.7	0.7	0.2	30.9	8.7	43.1	13.3	12.8
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	8.0	0.0	0.0	0.0	0.0	1.7	0.6	0.7	1.1	0.0	0.1	2.5	0.2	0.0	0.0	1.2	0.4	2.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.4	0.7	1.3	0.5	0.0	10.9	0.1	0.1	6.0	1.8	0.0	6.0	10.9	2.7	0.6	1.2	0.9	0.4	0.3	38.8	2.5	1.6	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.2	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3	3.0	1.1	5.9	11.5	8.4	27.3	1.5	2.5	0.0	0.0	1.8	11.8	1.7	11.6	3.4	0.1	4.0	2.6	0.0	0.7	120.1	0.9	9.9	4.6	0.0	2.0	1.6	4.1	0.0	0.0	0.4	0.6	1.1	11.8	1.8	1.8	1.9	4.7	5.3	1.8	0.3	8.9	0.0	0.9	0.1	6.9	5.9	19.3	1.0	1.9	10.6
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.1	7.8	10.8	6.5	7.2	6.0	7.4	3.1	4.4	2.6	3.8	6.2	3.8	3.8	4.0	7.8	4.1	6.6	3.7	5.4	4.8	5.1	8.0	4.7	4.8	5.8	4.8	3.1	3.7	8.0	4.4	3.1	8.2	3.2	4.7	9.9	6.8	9.0	3.4	2.3	3.9	9.8	7.2	4.3	3.4	7.4	2.9	8.0	5.0	5.9	8.3	6.7	2.4	2.7	7.3	3.3	4.2	7.5	3.7	6.6	6.7	4.5	4.1	4.6	2.1	5.8	12.6	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3	3.0	4.8	1.4	5.3	1.6	11.1	14.0	7.6	21.4	6.8	12.2	7.9	15.0	6.6	9.7	2.5	4.9	0.9	23.3	5.5	9.8	6.1	3.4	1.1	2.8	6.2	9.5	0.0	4.9	1.2	3.4	8.9	2.6	1.7	2.8	2.6	10.3	6.4	4.8	9.6	7.3	10.0	0.0	8.2	2.6	8.1	3.1	12.5	2.5	3.3	4.8
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57088894-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	9.5	12.6	11.7	9.9	14.2	4.8	7.9	33.3	20.4	18.7	13.7	5.3	9.6	8.2	22.8	18.9	10.5	15.6	14.5	9.6	8.6	6.8	8.4	18.7	12.8	9.1	4.4	14.6	29.2	8.5	14.5	17.0	13.4	6.8	15.0	4.4	8.5	5.6	14.5	7.1	18.6	7.1	14.5	4.1	8.0	8.2	11.8	7.0	12.4	9.8	7.7	8.6	14.5	26.5	4.2	1.2	0.9	5.4	0.9	2.5	1.2	5.5	3.6	18.9	17.3	17.0	22.3	2.0	16.8	15.2	10.6	8.9	5.8	3.3	3.5	6.9	16.5	3.2	10.1	6.5	12.4	5.7	1.5	1.7	4.2	2.8	5.9	12.9	3.4	10.1	24.7	13.7	12.6	4.3	16.9	2.8	2.6	9.5	3.7	12.3	26.0	5.1	16.3	3.8	4.8	6.3	3.8	24.9	1.8	4.5	2.2	2.1	5.0	8.1	4.7	35.2	5.1	10.6	7.4	3.2	15.7	13.1	11.1	4.9	8.7	2.1	1.8	15.3	2.2	9.4	0.0	2.3	0.3	1.2	5.3	1.4	2.1	2.0	1.5	1.2	4.2	2.5	2.5	0.9	0.9	5.4	0.0	1.9	1.2	11.7	14.2	33.3	20.4	8.6	6.8	4.4	14.6	6.8	7.0	11.9	15.4	9.0	20.1	26.3	18.7	2.4	0.0	1.4	13.6	8.7	2.0	2.7	6.6	7.2	0.4	10.5	2.6	0.0	1.2	8.8	23.4	12.6	16.2	13.0	10.6	9.5	6.3	16.5	13.7	2.1	18.1	18.0	20.3	0.0	0.5	7.5	3.3	0.0	17.7	4.4	3.8	19.4	16.0	1.6	15.0	28.4	47.0	5.1	1.3	8.4
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191696659	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 620.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	20.8	4.9	2.4	26.0	2.3	4.2	22.2	1.1	2.1	4.4	14.1	1.9	1.6	13.3	6.7	9.2	12.1	4.9	8.1	6.9	4.7	2.0	8.8	8.7	18.6	39.6	3.9	1.3	4.9	6.3	0.8	4.4	28.0	6.1	4.7	5.2	2.6	6.2	3.9	3.1	4.3	30.6	4.7	5.3	40.0	4.6	18.4	1.5	7.4	3.6	12.1	23.0	8.7	8.8	3.8	2.2	18.6	7.7	1.6	14.2	1.9	14.8	2.3	0.3	0.4	11.3	13.7	3.9	23.2	19.0	14.4	8.7	12.3	8.4	0.8	18.4	14.0	11.7	4.2	2.1	9.9	16.0	7.7	1.9	7.4	4.7	3.1	8.2	3.4	8.4	18.0	12.5	20.7	14.9	17.2	5.4	2.2	10.4	32.9	22.5	1.2	1.1	4.0	1.3	3.1	11.7	2.5	2.6	7.0	21.6	11.0	0.5	0.1	8.0	2.8	6.5	14.1	0.7	2.2	13.8	12.1	10.2	6.3	14.5	10.9	4.5	3.1	10.0	4.1	2.1	2.5	4.0	1.9	6.4	6.7	8.7	3.8	8.6	6.6	2.2	0.6	2.2	3.8	18.6	1.6	7.7	1.4	14.2	1.9	2.4	2.3	1.1	1.9	4.7	2.0	3.9	1.3	6.1	1.5	199.5	620.7	29.6	104.4	47.2	3.0	6.7	12.7	85.6	168.4	10.4	2.0	20.0	3.3	17.5	161.5	9.3	94.3	0.0	4.6	34.8	18.6	41.1	131.1	6.7	49.8	3.2	4.1	11.6	96.8	54.0	9.5	125.6	38.8	147.9	15.3	1.1	20.2	31.6	3.5	17.7	3.8	6.5	28.6	21.1	18.0	39.5	122.3	52.2	21.7	106.4
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080438-45088914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.0"	"Cell type enhanced"	"Detected in many"	16	"Horizontal cells: 30.2;Peritubular cells: 11.3"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	12	"monocytes: 1.8;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	4.7	8.9	11.5	2.7	19.4	1.1	2.1	16.7	45.0	4.8	3.5	43.1	0.1	2.1	6.9	2.3	3.9	4.8	3.7	5.1	16.7	15.9	2.2	1.2	3.0	1.9	30.2	12.9	10.4	2.4	3.2	11.7	3.8	26.7	4.7	2.3	1.1	3.2	5.7	2.0	2.1	2.7	7.4	30.8	2.7	2.5	4.5	21.5	0.0	1.4	0.0	1.5	3.2	2.3	0.1	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	1.8	0.0	1.1	0.5	0.0	2.0	2.5	5.6	3.5	0.1	0.1	0.0	1.6	3.6	24.1	0.1	1.6	1.3	2.0	0.0	0.5	0.0	1.2	0.0	1.3	0.0	0.0	1.2	0.0	2.4	0.2	2.9	1.7	0.0	0.0	2.5	1.4	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.7	0.0	0.2	0.0	18.5	12.8	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	1.3	0.7	0.0	1.1	0.0	3.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.1	11.5	19.4	16.7	24.1	16.7	15.9	30.2	12.9	26.7	21.5	0.0	0.0	0.0	2.7	0.6	5.1	4.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.4	2.0	1.0	0.0	0.0	0.2	0.0	3.8	1.7	1.1	0.0	0.1	30.2	1.2	0.6	0.0	3.6	6.4	0.0	1.7	1.8	0.0	1.9	0.1	0.0	11.3	0.0	1.4	6.5	2.2	1.5	0.6	0.1	0.1	0.0	0.0	0.6
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13118103-13141141	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724"	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.5	13.7	27.2	18.2	22.3	10.0	6.7	19.8	38.7	10.8	16.6	20.1	11.7	16.6	12.8	10.0	17.9	10.5	9.4	13.2	23.6	14.2	10.8	15.6	11.3	14.9	17.1	14.2	7.8	16.8	10.5	10.6	15.4	16.0	11.9	8.4	7.8	15.3	15.6	17.6	10.9	18.3	9.2	17.2	15.2	16.1	18.8	15.4	10.7	9.8	9.6	9.9	13.2	7.9	0.7	0.9	1.8	0.8	0.6	1.3	0.5	28.3	34.5	8.0	17.8	4.5	5.7	21.8	13.9	10.5	13.5	10.5	34.7	12.1	14.2	31.2	11.6	10.6	14.1	10.3	25.3	5.0	25.1	16.4	9.1	28.2	24.3	10.8	14.2	25.5	8.6	8.4	13.2	7.2	10.6	15.3	12.8	19.7	5.7	6.6	58.5	22.8	11.3	35.7	8.0	31.9	14.0	9.2	14.2	8.2	31.1	17.5	11.0	13.5	19.8	12.3	8.7	17.6	13.1	21.7	28.7	17.9	21.1	24.4	15.7	24.5	11.8	30.7	14.3	17.8	0.1	0.5	0.0	0.8	0.8	0.6	0.7	1.3	0.8	0.9	0.4	0.4	0.7	1.8	0.6	0.6	0.8	0.2	0.5	27.2	22.3	19.8	38.7	23.6	14.2	17.1	14.2	16.0	15.4	0.0	1.7	11.2	5.7	10.8	15.6	2.0	15.3	0.0	2.3	15.7	2.0	16.1	6.6	11.8	1.6	6.8	16.0	0.0	7.5	16.9	5.4	11.3	10.3	14.5	18.9	25.4	4.7	9.8	8.8	1.6	4.0	8.0	5.0	7.2	14.5	8.3	16.0	10.5	8.9	13.6	7.8	6.5	4.2	10.6	14.0	12.2	22.7	12.1	14.3	16.0
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.4;monocytes: 24.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	24.7	34.3	11.1	19.0	11.9	49.0	25.5	9.9	12.6	12.4	18.2	10.8	14.1	20.3	13.9	14.5	12.5	14.3	17.1	11.9	9.9	7.9	12.7	52.3	17.5	27.0	15.8	8.6	16.9	32.2	8.3	11.9	22.5	10.3	13.7	14.1	13.9	21.4	14.5	10.6	11.7	19.4	14.4	8.3	39.4	22.1	17.3	9.6	10.8	14.0	12.0	19.2	13.7	28.3	1.8	7.2	80.4	24.7	0.5	1.4	10.4	15.1	14.6	13.1	19.2	18.7	13.6	16.9	15.3	13.4	17.5	15.6	15.6	27.9	20.1	11.7	11.3	5.6	12.9	14.0	12.1	7.8	19.5	22.3	16.4	22.9	26.9	18.1	23.0	27.6	15.9	11.0	10.8	15.5	9.5	16.9	16.0	20.1	28.8	13.0	17.3	17.3	20.0	8.9	25.5	16.5	22.0	11.2	41.1	15.1	12.6	17.7	13.5	17.1	37.7	15.7	8.1	12.9	16.1	16.3	12.8	9.2	13.1	13.7	25.7	11.6	45.0	12.6	25.5	6.6	11.8	21.1	49.5	1.2	24.7	1.4	1.8	0.7	0.9	7.2	1.7	0.5	0.7	80.4	0.5	23.8	5.9	1.0	10.4	11.1	11.9	9.9	12.6	9.9	7.9	15.8	8.6	10.3	9.6	11.9	30.7	29.2	12.9	8.8	7.3	5.6	28.1	9.4	18.2	14.0	15.7	22.0	13.3	18.5	13.2	18.0	35.4	23.3	25.3	21.4	15.7	25.2	2.3	80.8	33.4	6.4	21.9	14.7	54.6	20.0	34.8	30.2	8.5	40.5	34.0	5.1	24.7	33.1	32.5	18.2	15.9	12.9	17.0	10.8	20.5	11.2	35.8	13.8	26.2	19.2
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166921	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	13.3	12.3	8.6	9.6	19.8	8.7	11.9	10.7	18.9	12.9	10.6	14.7	6.4	6.2	18.8	8.6	11.0	17.3	10.9	11.7	10.5	7.8	9.5	10.5	10.9	10.7	7.2	9.1	20.1	11.1	15.7	18.7	8.8	10.1	12.0	11.4	13.4	10.4	12.5	36.4	14.3	8.3	12.7	7.4	10.0	11.3	17.2	7.5	12.3	14.0	12.2	12.2	12.5	10.4	2.5	2.4	0.1	1.6	1.2	3.5	1.4	9.1	7.7	10.0	10.2	5.9	9.4	11.7	10.8	7.2	9.5	9.5	8.7	10.9	23.7	3.1	6.6	7.6	7.7	20.2	11.6	12.5	10.4	12.5	25.1	6.9	7.4	10.3	16.2	9.0	8.9	10.4	11.5	9.4	9.9	8.4	7.7	28.1	12.6	12.6	8.9	18.7	9.2	13.0	6.9	7.7	15.6	7.4	12.4	9.4	4.2	10.9	8.2	7.1	13.0	7.7	9.2	7.0	7.1	8.8	11.4	9.8	8.8	12.1	7.9	11.0	18.3	10.8	9.4	11.2	0.0	1.5	0.1	2.2	1.6	0.9	1.9	2.5	3.3	2.4	2.5	3.5	2.3	0.0	1.2	1.5	2.4	0.7	1.4	8.6	19.8	10.7	18.9	10.5	7.8	7.2	9.1	10.1	7.5	6.0	14.7	11.5	15.4	28.7	11.4	3.1	10.2	36.1	7.9	8.7	17.7	12.3	3.3	7.0	37.3	8.5	2.7	0.0	5.9	13.9	10.6	10.3	10.4	4.4	10.8	7.9	18.4	14.1	15.7	16.6	6.4	9.3	8.5	6.4	5.3	9.3	6.7	3.5	4.9	6.9	13.7	32.3	14.4	17.6	14.3	35.9	17.8	10.0	8.4	10.5
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079805	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		690000	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	20.0	17.6	21.8	30.9	24.5	9.8	15.7	13.9	18.8	23.6	15.5	23.7	17.4	11.4	16.4	19.7	67.0	13.7	20.0	14.0	17.6	20.4	16.9	20.2	18.3	30.6	31.1	20.3	15.0	25.8	27.5	21.8	43.9	26.2	15.8	15.8	14.7	49.0	17.8	11.3	29.5	14.6	22.8	21.6	43.4	15.5	24.8	26.7	20.2	13.0	27.2	39.9	24.5	26.1	14.3	53.0	37.4	79.3	8.5	7.1	52.2	19.0	15.5	8.7	8.9	34.8	21.3	34.3	42.5	18.4	28.5	25.9	18.1	10.0	10.6	10.1	29.4	33.6	9.2	6.6	12.6	17.7	15.1	5.2	6.0	5.1	11.2	26.1	3.7	15.2	19.0	13.2	30.6	4.8	20.6	29.9	9.3	2.7	12.0	39.4	17.4	9.4	13.3	9.3	15.2	12.0	7.4	24.4	5.4	17.2	34.1	9.0	5.0	12.8	20.2	13.3	15.6	10.5	4.8	26.2	34.0	13.2	13.1	14.8	8.4	7.3	6.2	23.2	10.2	18.6	10.3	79.3	31.5	5.4	69.8	5.5	14.3	6.4	5.2	53.0	13.3	5.5	4.5	37.4	8.5	46.6	42.4	7.1	52.2	21.8	24.5	13.9	18.8	17.6	20.4	31.1	20.3	26.2	26.7	35.7	38.8	52.2	25.0	23.9	42.8	14.8	22.9	24.1	28.4	36.6	21.6	111.0	34.9	60.8	114.8	28.1	13.8	0.0	39.8	106.9	36.8	15.4	49.8	12.1	191.3	44.5	22.4	30.7	107.2	16.6	27.9	97.6	37.1	45.1	18.1	42.9	52.7	22.6	35.3	46.9	53.5	19.4	33.0	33.7	22.6	36.4	266.6	23.8	13.8	37.2
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in some"	12	"Cone photoreceptor cells: 7.9;Spermatocytes: 5.7"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 52.1"									"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.4	0.9	0.4	0.4	1.0	1.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.1	0.5	0.7	1.7	0.5	0.4	0.4	0.5	0.5	0.0	0.6	0.4	0.4	0.5	0.0	0.4	0.4	0.4	1.1	1.7	0.4	0.4	0.4	1.0	0.7	3.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.1	4.9	3.2	0.7	1.1	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.7	0.5	0.6	0.4	0.4	0.6	0.5	0.4	0.2	1.1	0.7	0.8	2.3	1.1	0.5	4.9	0.3	0.2	0.4	1.0	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.5	1.6	1.4	1.9	0.4	0.0	0.0	0.0	0.0	7.9	1.2	0.0	0.3	1.0	0.3	0.0	0.0	0.3	0.2	0.4	0.8	0.0	0.5	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.4	0.2	1.2	0.0	0.0	5.7	0.4	0.5	0.6	0.0	0.3	1.4
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"		15	35084193-35085110	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 1.5;skin 1: 1.7;testis: 2.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"					"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	85	"NTERA-2: 32.7;SuSa: 15.4"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.0	0.0		0.0		0.1	0.6		0.0	0.0	0.0			0.4	0.0	1.1	0.0	0.0	0.2	0.0			0.0	0.0	0.2	0.0			0.2	0.0	0.8		0.0		0.3	0.1		0.0	0.2	0.0	1.7	0.0	0.1		0.0	0.0	2.3			0.0		0.0	0.1		0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029716-119033732	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	8.5	10.5	8.1	1.0	7.1	1.0	6.4	6.5	4.8	4.9	2.1	4.5	1.3	1.2	2.1	4.4	2.1	1.5	1.0	16.7	5.0	6.7	3.5	1.0	1.3	1.1	3.4	2.4	0.9	3.3	0.9	2.2	8.2	6.0	3.5	1.2	8.8	1.5	2.5	40.7	1.7	1.4	3.4	6.7	0.9	3.1	2.9	3.0	0.1	9.3	0.3	1.0	3.3	9.8	0.6	0.5	3.2	0.3	0.6	0.3	0.1	7.6	0.6	1.1	0.2	3.7	0.5	4.7	0.1	0.2	0.2	0.1	0.9	2.7	4.1	1.0	0.0	0.0	2.8	1.3	1.3	0.3	1.2	3.2	0.1	1.9	0.8	1.7	0.4	0.0	0.7	5.7	0.0	0.8	1.2	0.2	1.4	0.7	0.5	0.2	1.1	1.0	1.3	3.5	1.6	0.6	0.0	1.3	2.7	1.5	0.6	3.0	39.6	2.2	22.7	17.2	6.2	3.6	2.2	0.2	0.0	1.7	0.0	0.3	1.2	3.9	1.4	0.3	1.0	0.0	3.2	0.3	0.4	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.6	0.3	0.2	1.3	0.6	0.2	0.5	0.1	0.1	8.1	7.1	6.5	4.8	5.0	6.7	3.4	2.4	6.0	3.0	6.0	0.6	0.0	3.5	0.7	3.3	10.9	0.0	0.0	1.2	1.8	9.8	5.3	0.0	0.5	0.1	0.6	0.4	0.0	0.2	0.2	4.1	3.2	0.0	0.0	0.5	1.6	2.9	0.6	0.0	0.0	1.7	0.0	0.0	0.0	1.0	8.5	0.2	0.0	0.7	0.2	1.7	0.0	0.5	0.2	0.7	1.1	0.8	0.0	0.6	0.9
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695915-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	7.3	21.8	24.5	3.6	23.3	4.9	4.9	25.8	53.4	6.2	3.1	4.2	2.1	1.9	6.4	10.5	4.1	4.9	5.4	5.6	23.9	52.8	6.1	5.0	3.1	3.0	28.4	33.6	8.2	2.8	7.9	12.9	4.7	35.6	6.7	3.1	3.6	2.5	8.7	1.8	1.7	2.4	6.4	11.5	3.5	2.8	4.9	5.4	0.5	9.3	1.3	2.4	5.2	2.0	0.7	0.9	0.6	0.8	1.5	3.9	1.0	0.0	1.1	7.3	4.4	10.7	6.9	0.0	7.8	4.8	4.0	6.3	0.0	0.9	0.0	3.2	4.5	1.7	1.5	12.9	3.1	7.3	2.4	0.0	13.5	4.7	1.1	9.3	6.9	8.9	10.8	1.0	4.7	0.7	5.2	7.1	7.6	3.8	0.0	11.8	0.1	8.5	0.5	3.0	3.7	0.0	4.6	2.1	0.8	2.7	3.3	9.7	29.5	0.0	1.4	5.7	8.2	0.0	2.0	5.1	4.6	1.1	2.9	3.9	2.0	0.0	0.0	9.8	0.0	3.5	0.0	0.2	0.4	3.9	0.4	2.6	0.0	1.9	3.0	0.9	0.7	3.5	3.3	0.6	1.5	0.8	0.7	1.7	1.0	24.5	23.3	25.8	41.9	23.9	52.8	28.4	33.6	35.6	5.4	3.0	7.0	2.4	3.4	1.5	32.4	4.8	0.0	1.4	6.8	5.2	13.7	12.6	13.3	1.7	0.6	5.4	0.0	0.0	2.2	1.6	8.5	2.9	31.1	2.9	4.8	14.3	16.6	10.4	0.0	0.4	10.0	1.2	5.0	2.8	1.4	32.8	1.0	0.2	17.0	3.4	17.3	19.4	9.8	5.6	2.1	1.3	18.5	7.9	0.9	1.7
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 375.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	13.7	10.6	21.2	15.7	20.2	35.0	17.4	24.2	23.5	8.2	13.1	10.1	11.1	13.8	9.5	11.0	13.1	11.2	10.6	28.5	15.7	12.3	10.1	21.3	11.8	15.1	16.4	15.0	11.2	13.8	9.0	11.9	10.2	16.3	10.9	9.0	14.7	13.6	12.0	44.4	15.4	11.0	9.8	10.6	17.7	13.6	35.4	18.1	12.4	11.7	11.2	11.5	11.7	12.4	11.6	10.1	50.6	10.6	15.9	13.6	11.5	8.7	8.2	14.0	22.1	6.6	6.5	7.9	5.2	5.5	9.0	9.3	9.5	3.1	5.6	5.9	4.2	10.3	7.8	10.2	6.6	6.2	5.9	22.7	11.8	11.8	11.7	5.9	12.0	21.0	9.7	11.0	7.1	2.4	9.1	17.0	18.5	26.8	4.2	4.0	7.5	21.0	19.4	5.9	6.8	17.9	17.5	14.2	8.9	4.2	9.1	17.1	24.3	13.7	9.3	16.0	9.5	8.0	9.8	8.5	11.7	10.0	9.6	8.9	38.7	14.6	12.4	10.7	8.5	6.9	24.4	10.6	29.5	11.6	9.4	12.7	11.6	11.4	11.2	10.1	11.0	13.1	10.9	50.6	15.9	7.0	8.3	13.6	11.5	21.2	20.2	24.2	23.5	15.7	12.3	16.4	15.0	16.3	18.1	11.9	21.0	45.4	29.2	33.2	32.8	37.2	17.8	30.8	12.5	5.2	51.1	27.5	33.2	47.7	143.2	38.3	36.0	93.5	57.8	48.2	29.1	28.2	52.9	17.3	29.6	47.7	54.6	43.0	21.3	375.7	23.3	29.7	59.1	68.5	24.8	23.0	67.6	26.0	17.0	18.3	34.2	12.9	37.1	136.6	75.4	30.9	25.6	45.7	31.0	25.5
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 915.3;Suprabasal keratinocytes: 1140.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	11.2	7.8	5.2	7.3	7.9	2.7	13.4	7.5	6.0	9.2	14.5	6.5	8.4	9.9	19.1	7.0	8.7	7.9	8.9	8.2	4.8	2.9	14.4	12.3	14.7	3.3	5.1	2.7	8.8	8.5	9.2	13.6	10.2	7.0	6.7	14.4	9.7	8.1	10.6	6.9	6.6	11.7	11.9	7.3	5.0	14.7	9.9	6.2	2.8	10.1	6.4	5.3	9.8	9.5	0.9	0.7	0.9	0.6	0.6	3.0	0.2	4.9	4.7	2.0	1.7	12.2	9.5	2.8	4.8	3.5	2.6	3.9	5.2	2.6	1.1	4.0	8.1	5.0	4.1	3.9	5.6	6.0	2.2	1.7	1.9	7.0	2.9	2.9	1.7	2.3	3.6	3.7	4.2	5.3	6.2	4.0	2.0	3.3	1.8	5.8	3.5	0.7	0.9	1.0	2.1	4.3	0.8	3.2	1.1	7.2	9.4	1.3	1.0	4.1	3.1	3.1	5.1	3.6	1.7	6.8	6.8	5.8	3.2	2.2	2.9	2.2	1.5	4.1	0.8	2.3	0.0	0.5	0.9	0.8	0.4	1.0	0.4	0.9	0.5	0.4	0.9	0.7	0.5	0.3	0.6	0.6	0.7	3.0	0.2	5.2	7.9	7.5	6.0	4.8	2.9	5.1	2.7	7.0	6.2	35.7	64.5	271.2	252.7	915.3	18.0	15.9	229.3	49.5	45.5	36.6	25.5	175.9	71.3	47.8	23.3	102.0	184.3	0.0	85.7	226.2	143.2	257.6	106.1	170.8	139.2	77.9	282.5	298.9	603.4	33.7	254.0	131.4	597.2	39.7	387.3	18.1	70.0	210.5	121.6	72.5	26.3	116.4	186.6	37.7	34.6	1140.0	191.8	258.9	547.2	252.4
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933336-90003228	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	19.2	16.1	17.9	23.6	29.5	41.3	23.0	17.4	21.0	19.3	22.6	12.2	16.9	13.3	33.2	16.6	19.7	17.5	20.2	14.2	19.4	16.7	25.9	19.3	17.9	26.7	16.9	18.1	19.3	17.1	21.0	29.4	13.2	18.4	17.6	20.9	7.1	18.4	17.6	15.7	11.2	18.0	22.2	18.1	26.5	14.7	13.9	18.9	23.4	20.8	14.7	22.8	17.5	16.0	10.1	12.0	21.8	18.5	9.7	8.6	7.6	15.4	8.7	8.8	4.6	4.8	12.0	5.6	11.0	14.6	14.0	15.3	5.0	11.8	23.4	12.9	10.0	5.7	5.2	10.6	10.3	18.0	10.9	6.1	19.8	5.4	7.0	9.4	11.8	10.5	9.0	5.5	7.9	17.5	6.9	11.3	9.5	14.5	13.6	15.9	13.7	18.0	7.5	2.5	11.5	9.5	12.1	7.6	13.8	18.1	21.3	2.5	8.1	6.9	78.3	6.5	5.1	14.7	8.8	8.4	12.2	8.7	7.4	10.8	6.3	7.2	13.0	12.3	11.2	11.3	14.1	11.1	20.3	8.1	12.5	8.6	10.1	5.9	5.9	12.0	6.1	5.7	6.2	21.8	9.7	18.5	6.6	3.7	7.6	17.9	29.5	17.4	21.0	19.4	16.7	16.9	18.1	18.4	18.9	44.7	13.9	32.5	12.1	10.5	23.3	25.0	17.8	42.8	42.1	26.2	2.0	18.9	36.5	30.4	10.9	17.9	8.9	0.0	27.9	17.4	18.4	8.7	76.4	27.6	22.9	12.7	11.6	17.2	22.4	5.9	17.5	30.7	11.8	52.3	15.1	27.1	19.1	5.8	24.8	31.1	10.3	6.5	20.6	11.2	43.3	11.8	9.0	23.2	17.4	8.6
NBPF1	"FLJ20719, KIAA1693"	ENSG00000219481	"NBPF member 1"		1	16562319-16613562	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (8.16e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.15e-5)"	"unprognostic (2.16e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-1)"	6.8	23.3	14.2	6.4	18.3	4.5	7.4	32.7	13.1	11.7	11.6	21.5	6.0	7.5	9.5	6.2	6.6	13.9	7.9	5.2	13.4	9.3	8.1	7.7	7.3	3.2	32.8	4.2	18.6	5.5	22.3	12.3	9.7	18.4	9.0	11.3	9.3	6.5	9.6	4.5	5.9	16.6	12.2	21.3	6.7	7.3	22.3	21.5	3.7	9.5	3.3	4.3	10.4	8.5	2.0	0.9	4.3	1.0	0.4	1.7	0.5	5.4	7.8	8.0	4.8	2.2	2.6	1.5	3.8	4.9	7.2	6.5	2.8	2.3	4.3	1.1	10.6	2.9	5.1	3.8	2.3	8.5	2.7	4.2	1.4	2.6	2.7	3.5	2.1	3.4	2.8	2.9	10.4	3.1	3.8	3.2	10.2	4.6	2.5	2.8	4.3	9.3	1.6	1.5	0.9	15.5	8.0	4.3	0.4	2.0	1.1	9.8	9.7	9.7	4.0	5.4	2.4	6.2	1.5	3.8	6.4	3.5	8.6	3.3	1.3	5.9	2.4	1.5	3.2	2.6	0.4	0.7	4.3	1.2	0.8	1.4	1.1	1.1	1.5	0.5	2.0	1.3	1.7	0.2	0.4	1.0	0.9	0.0	0.5	14.2	18.3	32.7	13.1	13.4	9.3	32.8	4.2	18.4	21.5	14.9	11.3	0.0	2.8	7.2	7.6	9.6	12.7	13.4	10.3	10.4	7.9	5.4	3.3	4.7	4.6	7.1	27.6	0.0	2.9	7.4	10.3	5.7	5.8	4.4	10.4	9.5	2.9	4.3	4.5	5.4	6.4	8.1	8.5	2.8	23.2	4.5	4.6	12.9	6.7	7.7	5.7	6.5	17.0	52.6	23.0	6.8	2.6	2.9	10.1	1.8
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064699-146144804	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 71.5;Basal keratinocytes: 50.6;Suprabasal keratinocytes: 92.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	1.5	0.0		0.9		3.3	2.3		0.0	3.0	0.9			0.0	1.6	1.9	1.0	1.3	0.5	0.0			0.4	1.2	1.3	0.6			3.2	1.1	1.5		0.7		1.1	1.1		0.3	1.3	0.0	4.2	0.0	1.5		2.0	0.1	1.2			0.7		0.6	0.2		1.3	2.4	3.7	1.5	0.4	0.4	0.2	5.3	1.4	3.2	2.3	11.3	13.4	2.8	3.1	4.1	3.1	3.2	1.4	2.5	2.5	0.6	6.0	2.7	2.6	3.8	4.1	6.4	2.8	2.4	5.4	3.8	0.7	4.5	2.5	1.7	12.3	4.0	8.3	8.5	10.4	3.7	1.4	1.7	7.6	6.7	6.7	1.0	2.1	1.5	1.5	4.4	1.3	2.0	3.2	2.4	3.6	0.3	0.4	4.7	4.7	1.6	5.5	3.8	3.1	11.3	3.1	2.7	2.8	3.8	4.7	1.9	3.0	2.8	2.7	2.4	0.8	1.5	1.8	0.4	1.1	0.2	1.1	0.2	0.3	0.7	1.3	0.4	0.3	3.7	0.4	1.2	2.4	0.3	0.2											71.5	40.3	0.5	3.4	50.6	0.5	7.2	0.0	14.7	12.5	0.0	0.0	0.6	0.0	4.1	6.4	3.6	1.3	0.0	2.3	4.1	26.7	1.3	18.6	1.3	1.3	0.0	0.0	1.3	4.6	1.3	6.1	18.6	28.7	1.8	2.6	1.7	4.4	28.3	7.8	0.0	2.2	0.0	30.9	9.0	4.3	92.5	0.5	1.8	3.0	3.4
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	1.5	2.1	3.4	2.1	3.9	3.0	3.8	5.7	5.3	4.6	1.5	3.1	9.6	1.4	5.7	9.6	1.2	3.0	1.5	0.7	3.0		1.4	3.7	3.3	3.0	6.0	1.1	5.3	3.2	5.4	1.6	3.3	4.4	2.9	2.4	3.4	3.2	5.6	0.6	5.7	2.0	3.0	5.7	3.1	2.1	1.5	3.1	1.5	3.0	0.0	3.5	1.3	0.0	5.2	3.9	6.1	3.5	1.0	4.1	1.0	5.5	4.4	8.8	8.4	6.1	5.2	5.9	5.0	4.6	4.3	4.5	3.4	5.6	9.2	3.9	5.9	3.9	7.2	5.5	1.8	5.2	5.1	6.0	4.0	13.8	3.7	4.3	5.8	14.9	4.4	5.1	5.4	10.2	6.3	3.1	8.0	6.6	0.6	4.3	10.8	6.6	10.5	7.6	12.3	5.7	8.9	5.1	3.5	4.2	10.7	3.5	9.3	7.9	5.4	7.4	12.1	7.9	9.9	7.6	5.6	4.6	8.6	6.3	5.5	4.5	6.4	5.3	3.7	3.1	6.1	1.9	5.7	4.1	1.3	2.9	3.3	3.4	2.4	1.9	5.2	3.8	2.9	0.3	1.0	3.5	3.9	1.3	1.0											11.9	11.8	0.8	2.0	1.0	4.8	5.1	2.5	6.7	9.1	3.5	9.8	3.9	0.0	2.5	3.5	5.8	3.9	0.0	2.9	2.8	4.1	1.6	12.8	16.6	2.9	4.8	3.4	5.5	7.3	1.0	4.9	3.1	6.8	2.8	6.3	2.7	3.4	7.0	2.5	1.9	7.0	6.5	1.4	6.2	4.5	1.3	2.4	5.0	9.0	1.1
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"		1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"pancreas: 29.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	2.7	1.7	2.2	4.0	3.9	5.1	3.2	4.4	4.7	2.6	1.9	5.8	2.2	2.4	6.0	3.6	1.5	2.4	3.1	0.9	2.3		1.7	6.1	2.8	3.4	4.2	4.2	4.3	29.8	4.2	5.0	1.8	3.8	2.5	1.8	4.2	3.5	4.0	0.9	2.5	1.9	3.0	3.2	3.1	5.3	7.0	1.1	3.3	2.9	0.9	2.9	1.2	3.9	3.8	2.6	6.1	2.3	0.9	3.5	0.8	6.7	5.4	11.4	9.8	5.4	5.0	7.4	7.0	5.3	5.0	5.1	4.9	6.4	15.1	4.4	6.0	5.3	5.0	8.1	4.0	4.8	5.6	5.7	6.6	11.7	4.2	4.5	4.9	9.8	5.3	7.2	4.9	11.4	6.5	4.5	10.9	10.4	2.6	4.0	10.3	10.6	6.2	6.6	8.2	7.1	10.3	4.2	3.6	3.8	14.9	5.7	12.0	9.2	8.2	4.6	17.8	6.9	14.9	5.3	4.4	7.3	10.0	9.7	9.2	6.8	6.3	4.8	3.5	5.0	6.1	2.3	1.8	3.5	1.1	2.0	3.4	2.3	1.9	1.0	3.8	2.6	2.0	0.7	0.9	1.4	2.6	2.2	0.8											29.8	20.0	11.1	2.6	3.4	16.0	7.2	0.0	9.4	11.4	5.2	43.2	3.3	0.0	9.6	5.2	4.5	6.5	0.0	7.5	3.0	5.0	1.4	23.2	11.3	3.3	9.5	10.3	8.6	14.3	2.5	5.2	7.1	1.7	9.0	9.9	9.5	10.0	14.0	9.9	0.8	17.2	6.5	5.0	12.2	5.7	3.8	1.6	10.9	11.5	0.9
NBPF14	DJ328E19.C1.1	ENSG00000270629	"NBPF member 14"		1	148531385-148679751	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 25.2"	"Cell type enhanced"	"Detected in many"	9	"Paneth cells: 190.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in all"	5	"basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.28e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.92e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.69e-4)"	"unprognostic (7.23e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.15e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.52e-2)"	4.4	0.7	2.5	3.2	4.6	6.7	4.3	2.1	4.3	5.4	2.4	2.1	0.9	0.4	4.3	11.2	3.9	3.4	2.9	6.7	4.2		3.4	3.4	3.4	4.0	2.6	2.8	7.7	6.3	3.1	0.9	1.8	4.6	3.6	2.7	6.9	3.2	1.9	1.2	8.5	1.9	4.1	3.8	4.5	0.8	5.2	5.1	2.8	2.6	9.1	4.7	1.8	4.7	21.8	16.5	25.2	17.2	3.4	3.1	3.5	26.7	5.1	10.1	7.4	21.1	29.5	5.0	10.0	10.2	6.9	8.0	4.1	8.9	5.0	2.6	10.3	9.5	8.1	6.7	10.5	10.1	9.8	7.6	13.2	16.4	1.0	8.3	10.4	5.4	29.5	8.7	18.5	24.7	32.9	10.7	4.6	4.4	27.1	16.4	16.0	2.7	7.5	4.3	5.6	12.3	4.3	9.1	15.8	8.6	11.1	0.1	0.1	20.4	11.3	4.8	10.1	14.1	9.0	42.8	7.9	8.8	9.5	16.6	47.8	15.3	12.3	14.3	9.1	11.8	9.8	17.2	25.2	2.3	11.5	1.7	21.8	2.4	2.1	14.9	15.1	3.1	2.6	22.9	3.4	13.1	16.5	3.1	3.5											83.4	73.1	16.4	35.4	1.9	2.0	17.3	10.2	16.0	27.3	12.2	3.9	1.1	0.0	29.4	29.3	0.8	7.7	0.0	13.9	12.6	12.9	19.5	49.9	8.1	12.9	0.0	3.5	3.7	40.0	30.3	26.2	27.4	1.7	20.8	5.3	17.1	21.9	190.4	15.9	4.4	9.8	12.9	11.4	57.2	10.2	5.5	1.3	6.9	16.2	27.9
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7;Club cells: 22.7;Paneth cells: 30.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5"	"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	2.2	1.1	1.3	2.7	3.3	0.0	4.9	6.1	3.6	3.2	1.1	1.8	2.9	0.4	4.0	7.7	1.7	2.4	1.9	0.5	7.1		1.5	4.9	2.8	5.0	1.4	1.5	3.4	1.7	3.6	3.2	2.7	4.2	2.8	2.1	3.0	5.2	3.1	0.7	2.2	0.7	3.8	6.3	3.6	0.9	0.9	4.8	1.0	3.0	1.9	3.7	1.4	0.5	3.1	0.2	0.6	0.4	2.7	5.5	1.8	7.5	4.9	8.9	16.7	10.6	16.7	11.0	13.6	13.3	8.3	8.6	4.2	8.1	3.8	3.8	9.9	9.7	5.9	9.8	4.3	13.3	12.5	5.3	0.3	11.1	5.3	8.0	0.3	3.7	13.6	7.6	9.9	20.7	12.0	11.6	1.5	1.7	11.5	20.1	16.1	0.2	3.4	3.6	2.7	11.1	3.3	5.3	5.9	9.2	6.8	0.8	20.2	5.7	8.9	9.4	12.0	8.9	3.4	12.4	13.5	8.9	11.9	12.6	10.2	11.0	6.4	0.2	0.4	6.2	0.2	0.3	0.1	1.3	0.0	1.9	3.1	3.5	2.4	0.2	1.8	4.2	1.6	0.6	2.7	0.4	0.2	5.5	1.8											41.7	21.0	0.9	0.8	1.8	2.5	7.5	5.1	8.1	22.7	1.8	5.9	1.3	0.0	5.3	1.6	3.8	1.0	0.0	3.7	2.6	3.9	1.2	14.0	7.8	1.4	3.2	5.8	6.2	9.2	0.5	8.1	1.8	1.7	3.6	3.7	2.7	6.0	30.2	9.9	0.9	7.0	0.0	6.2	2.6	1.7	1.1	0.2	2.5	5.0	0.3
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149390623-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 94.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	6.8	0.9	3.2	10.4	2.7	9.5	8.4	1.7	4.5	6.6	3.7	4.0	10.1	1.1	8.8	8.0	5.3	6.0	7.3	4.8	3.4		2.3	3.1	12.1	6.0	3.2	4.7	10.6	6.2	4.0	0.9	7.0	5.5	5.0	3.9	7.5	7.7	8.6	6.2	13.0	1.7	6.0	2.6	6.7	1.7	9.5	2.9	2.5	6.3	5.2	5.2	3.9	7.4	6.2	11.7	18.0	16.7	6.9	7.0	1.5	23.8	6.4	13.9	7.1	27.1	23.5	6.5	11.8	9.1	8.3	8.2	5.6	8.7	7.0	2.9	18.2	10.7	11.0	19.0	11.0	12.9	12.6	10.6	20.0	17.8	1.9	5.6	19.9	7.3	16.3	4.9	23.8	31.1	11.0	5.3	10.4	4.8	11.4	17.4	17.5	10.9	11.9	12.0	6.7	9.9	9.9	15.1	11.5	5.2	12.1	1.2	2.9	27.9	9.8	5.3	20.1	18.1	27.3	31.6	16.6	12.3	10.3	18.2	9.5	5.4	22.1	19.0	13.9	4.9	9.8	16.7	5.3	7.0	6.4	4.7	2.3	3.8	2.5	3.2	6.2	5.2	6.5	18.0	6.9	5.2	11.7	1.4	1.5											47.6	49.9	6.4	15.8	0.0	7.8	21.2	2.5	21.4	18.2	3.5	25.5	1.3	1.7	14.5	16.9	1.9	1.1	23.3	5.3	5.4	5.3	6.2	18.6	7.4	6.5	3.2	1.2	0.6	29.4	4.2	30.0	33.9	0.0	15.4	3.4	25.4	8.8	94.8	28.3	0.3	51.8	19.4	4.2	26.5	6.0	0.0	1.1	7.5	7.7	8.6
NBPF20		ENSG00000162825	"NBPF member 20"		1	145289900-145405778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.3"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 27.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (6.25e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.54e-1)"	"unprognostic (4.26e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.45e-4)"	"unprognostic (9.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.70e-1)"	1.1	1.2	1.1	1.2	1.2	1.0	1.5	2.5	1.2	1.4	1.1			0.0	1.3	1.8	1.1	1.2	0.7	1.1	1.1	1.1	1.1	2.6	1.1	1.2	1.0		2.2	1.3	5.9	1.1	0.0		1.5	1.1		1.6	2.1	1.1	2.4	1.1	1.7	1.0	1.1	1.1	3.6			1.1		1.5	1.4	1.1	4.0	13.3	1.0	1.8	2.9	1.0	0.3	14.7	7.5	2.1	5.9	13.2	23.2	5.4	7.2	1.8	2.6	2.7	8.1	1.8	3.5	2.8	7.4	4.1	4.5	7.3	8.5	7.3	7.0	9.0	2.3	9.4	5.9	2.7	4.0	4.0	6.9	6.6	14.2	12.1	4.8	6.8	1.9	9.2	5.2	10.5	9.6	0.6	1.8	2.0	3.3	12.0	3.5	6.1	2.2	3.8	2.7	3.8	6.7	14.7	7.6	4.1	5.7	5.8	5.6	12.4	12.7	15.9	6.7	16.7	3.1	2.6	8.0	6.9	1.7	1.8	0.5	1.5	0.5	1.0	0.9	0.8	1.5	0.7	1.0	0.4	4.0	1.0	0.9	1.0	2.9	1.8	13.3	0.9	0.3											20.8	27.1	1.9	1.4	2.6	4.3	3.3	0.0	8.1	3.4	0.0	17.7	1.2	0.0	6.7	13.7	2.4	0.6	0.0	9.6	4.0	3.1	1.1	7.0	14.5	1.6	1.6	5.8	2.5	3.7	1.1	5.2	3.8	3.3	5.4	2.8	1.3	8.9	10.5	3.5	0.0	7.5	0.0	2.2	12.7	9.8	2.8	0.6	0.7	4.0	0.9
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723923-120841481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 50.6;Alveolar cells type 2: 23.7;granulocytes: 15.1;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in all"		"neutrophil: 17.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 17.7;monocytes: 10.0"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	2.7	0.8	2.3	4.3	2.2	2.1	1.8	1.1	2.5	3.2	1.9	1.1	1.1	0.0	3.0	5.6	4.8	2.4	3.1	1.1	1.1		3.5	1.7	2.3	2.0	1.1	1.1	3.6	1.1	1.1	1.1	1.1	2.0	2.5	1.4	1.7	1.6	1.3	1.1	9.9	1.1	6.0	2.4	10.6	0.5	3.4	1.1	1.1	1.8	3.3	1.8	2.0	1.1	3.4	2.8	17.7	10.0	2.4	2.1	1.0	27.0	0.1	8.1	8.9	11.5	9.4	0.6	9.6	4.9	6.0	6.5	5.8	1.0	1.9	9.1	11.1	10.7	8.0	13.1	13.8	8.4	12.8	0.5	18.5	2.9	2.3	5.2	7.6	5.6	5.7	6.0	15.7	17.4	19.4	0.3	4.9	1.5	16.7	15.8	15.1	2.1	12.3	2.9	1.0	11.0	3.0	9.2	4.9	4.7	11.0	0.8	0.5	11.2	16.4	8.4	9.6	0.6	3.4	8.2	7.2	19.2	23.8	7.6	7.4	2.0	7.9	6.8	11.5	1.0	7.7	6.4	7.2	1.9	5.2	1.7	1.2	2.0	1.9	2.8	3.4	1.7	2.1	17.7	2.4	10.0	2.1	1.1	1.0											50.6	23.7	1.4	1.3	0.0	0.6	1.4	0.0	6.7	6.8	0.0	0.0	0.4	3.3	3.5	2.2	0.0	0.0	0.0	2.6	1.7	1.0	0.7	15.1	1.3	0.2	0.0	0.0	1.3	3.7	0.0	6.1	1.8	0.0	1.0	0.6	0.8	3.2	23.2	4.2	0.6	1.6	0.0	0.5	4.3	2.6	0.0	0.3	0.0	2.5	0.4
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 29.5"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.4;HHSteC: 14.9"									"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	3.2	5.1	4.5	2.6	4.6	2.3	6.5	12.7	5.3	4.1	3.5	3.7	4.2	1.5	3.7	4.6	3.7	3.6	2.9	2.8	4.7	3.5	4.0	4.6	3.0	3.0	5.0	3.8	4.7	4.3	2.6	9.4	11.7	4.5	4.5	3.6	3.3	4.9	4.0	2.2	6.2	4.0	5.3	4.6	3.2	4.7	29.5	4.9	2.4	4.8	1.3	4.5	5.1	5.6	1.1	0.3	2.3	0.7	1.1	5.3	1.6	1.8	2.5	0.2	5.7	3.8	1.3	4.8	3.2	15.4	4.5	3.8	3.4	5.8	2.9	1.3	8.4	1.3	0.2	2.7	3.8	0.5	1.5	2.9	2.0	0.1	1.2	14.9	1.2	2.0	1.0	1.1	4.1	0.7	2.2	0.4	0.0	0.8	1.0	1.0	6.4	0.0	2.8	0.8	2.6	3.6	0.0	0.0	2.7	0.7	2.4	3.9	4.1	5.0	1.3	3.9	1.4	1.8	2.4	3.7	1.9	2.2	5.6	1.3	0.0	1.6	4.5	0.4	2.5	2.5	0.0	0.5	2.3	3.8	0.7	5.3	1.1	1.6	3.0	0.3	0.5	2.8	3.5	0.2	1.1	0.0	0.0	1.5	1.6	4.5	4.6	12.7	5.3	4.7	3.5	5.0	3.8	4.5	4.9	0.0	3.0	0.8	2.2	1.1	1.4	2.6	2.5	9.4	1.2	1.8	5.9	2.5	0.0	1.0	10.3	1.4	0.0	0.0	2.2	1.0	3.1	1.5	2.3	1.0	0.8	0.0	0.0	3.7	0.6	1.6	2.6	2.2	0.0	0.0	3.3	1.0	2.0	0.0	1.8	1.6	1.8	0.0	1.0	14.4	7.0	2.6	2.1	1.3	1.2	1.6
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	3.5	0.0	13.9	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.7	0.0	0.2	4.2	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF9	AE01	ENSG00000269713	"NBPF member 9"		1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 21.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	3.3	2.0	5.6	6.5	5.3	2.4	2.6	12.3	5.0	4.2	3.3	2.1	4.5	1.7	4.9	7.2	2.8	2.9	4.7	3.8	5.3		3.6	5.4	8.3	4.6	2.8	1.8	4.9	6.3	4.4	1.9	2.2	4.3	3.0	3.1	6.8	2.2	2.4	1.7	4.5	3.2	4.4	2.0	2.7	1.8	2.9	2.0	1.8	5.2	2.5	4.0	2.3	0.0	4.2	5.2	21.9	7.6	5.6	1.8	0.8	22.2	9.8	12.2	16.5	11.1	13.5	9.7	20.6	15.0	10.9	11.8	7.3	9.7	5.3	5.7	10.5	13.1	6.7	8.5	9.6	18.7	13.5	8.9	1.7	16.5	4.4	12.9	2.2	6.5	13.3	7.2	11.9	20.9	20.1	9.5	4.1	6.2	14.0	13.3	17.6	0.7	3.6	4.6	4.0	13.4	6.0	7.6	8.1	8.9	10.3	7.9	16.5	6.7	16.6	9.1	8.0	12.3	4.2	22.2	24.6	7.2	17.9	31.6	17.2	9.1	10.6	9.0	1.6	8.6	21.9	7.6	0.3	0.4	3.6	0.7	1.9	1.3	0.4	1.3	4.2	1.8	1.0	5.8	5.6	1.2	5.2	1.6	0.8											35.7	13.6	5.4	6.7	4.8	4.3	3.9	7.6	8.1	19.4	5.2	5.9	2.3	0.0	2.9	2.8	2.4	0.7	0.0	1.6	3.4	9.1	4.1	17.4	24.5	3.2	0.0	1.7	2.5	9.5	2.1	6.6	14.0	3.3	1.8	0.4	3.7	2.5	7.8	3.9	0.4	11.4	6.5	3.9	9.7	4.1	12.4	1.1	2.2	0.6	5.8
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	30.0	16.0	19.5	12.5	2.9	4.8	7.7	22.0	14.2	27.3	30.6	14.1	15.8	18.6	13.8	9.0	29.0	15.5	16.2	10.1	36.5	19.8	12.0	16.8	19.9	11.1	1.3	20.7	19.0	2.0	1.1	22.2	6.4	5.0	15.1	21.8	20.6	28.0	25.0	32.0	34.4	14.0	19.2	17.1	13.0	20.2	20.5	17.7	6.7	13.5	21.3	16.5	27.2	10.6	6.0	13.0	9.6	13.5	7.9	18.7	14.3	50.4	35.3	18.5	13.6	22.6	19.8	26.5	35.4	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1	6.0	1.0	1.5	1.1	3.5	3.8	3.4	2.5	8.1	6.8	1.8	0.0	2.6	0.0	2.3	9.3	2.2	0.4	0.0	2.9	8.4	2.7	0.9	1.1	2.1	6.1	7.9	0.0	4.3	2.7	4.0	2.6	4.7	1.7	2.8	1.7	1.9	1.6	0.0	3.9	1.1	2.8	6.5	4.1	40.1	15.6	1.8	2.2	5.1	1.8	2.3
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Cell type enhanced"	"Detected in many"	22	"Spermatocytes: 77.0;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	31.2	11.9	30.2	15.6	1.1	1.6	20.0	14.8	10.4	28.7	30.3	21.9	17.5	29.2	10.5	6.5	26.2	14.1	25.8	10.1	30.8	25.6	17.1	30.1	12.4	19.8	0.2	27.8	25.7	0.5	1.1	22.2	9.4	2.7	11.3	23.4	20.8	21.6	13.6	14.7	40.7	29.0	21.6	13.8	15.1	31.7	27.5	23.7	5.7	12.1	17.9	13.7	8.6	12.1	5.2	11.9	8.9	20.6	6.5	21.2	32.4	19.8	23.9	11.6	16.5	31.0	9.1	27.9	23.9	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8	0.0	0.0	0.8	0.2	0.6	0.4	0.4	0.0	2.7	2.3	0.0	7.9	1.1	0.0	0.4	3.9	0.5	0.0	0.0	0.0	14.1	0.4	0.5	1.1	0.5	6.8	0.0	0.0	0.6	3.2	4.0	0.9	3.0	1.7	0.0	1.0	4.7	0.2	0.0	0.4	0.0	2.3	0.0	0.9	77.0	26.2	0.6	1.6	5.4	1.2	0.6
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508216-50523472	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	15.7	12.4	24.5	17.8	18.8	57.4	14.7	33.5	29.4	14.5	14.2	17.4	14.6	15.6	17.5	15.7	18.0	17.2	11.4	18.2	20.0	19.6	14.5	13.8	17.0	22.2	17.8	19.2	22.8	22.6	16.3	22.0	20.0	19.0	15.2	10.8	16.8	22.4	16.6	20.2	23.2	15.7	20.5	15.7	18.4	15.7	26.1	20.4	25.2	16.3	16.8	21.0	12.0	14.5	13.7	10.1	14.5	11.6	11.3	20.9	12.8	19.9	10.8	18.9	19.3	5.6	6.5	24.5	15.8	11.0	28.6	31.2	22.0	13.8	23.1	8.7	11.3	16.0	15.9	17.2	15.1	8.3	13.2	28.5	13.3	27.4	19.7	6.9	29.4	24.0	5.9	9.5	22.6	7.6	4.3	9.2	20.2	16.7	45.0	11.5	27.5	20.1	33.6	13.4	12.0	13.0	33.8	24.6	25.4	8.3	13.1	12.3	16.1	12.4	18.5	14.8	6.3	12.7	29.0	5.9	22.4	27.0	18.3	23.4	23.5	13.1	34.2	16.8	15.1	21.0	10.6	8.4	14.5	17.1	10.4	20.9	13.7	17.7	17.4	7.0	13.2	18.7	15.5	10.2	11.3	11.6	10.1	16.8	12.8	24.5	18.8	33.5	29.4	20.0	19.6	17.8	19.2	19.0	20.4	20.8	26.9	14.1	20.2	16.8	17.5	17.1	15.3	4.0	6.8	8.7	3.9	24.7	13.3	11.3	30.7	11.3	15.5	0.0	20.2	48.4	17.3	13.7	16.2	9.5	16.9	7.9	12.6	11.1	7.2	86.8	16.1	10.9	11.8	19.8	15.5	14.5	14.9	11.5	16.3	7.0	12.9	19.4	21.2	29.6	36.4	16.2	26.3	15.8	15.6	17.6
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633626-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	18.5	17.2	19.8	27.4	26.2	37.2	23.6	25.5	27.1	17.0	21.9	18.7	19.8	18.0	19.2	15.3	21.7	15.9	16.3	20.4	23.7	17.8	17.9	22.7	17.3	25.9	16.6	23.8	22.8	22.0	17.1	26.9	20.3	22.6	18.4	25.7	18.1	18.3	17.7	25.5	22.4	19.3	16.3	18.7	20.5	19.4	26.8	17.8	36.1	22.5	15.1	25.0	18.5	19.4	7.6	13.7	12.9	14.6	14.9	10.0	7.7	24.3	16.8	18.9	17.6	13.3	13.4	18.4	18.7	10.9	17.1	16.1	22.4	12.8	21.0	8.1	16.8	16.3	27.6	30.0	21.3	24.6	14.0	9.7	19.4	25.3	14.0	13.0	25.8	20.2	10.1	10.7	19.9	15.4	12.3	17.7	16.1	28.6	11.8	28.6	17.6	18.7	13.7	20.4	34.8	18.2	18.0	43.8	8.4	13.9	18.2	24.1	16.2	18.7	16.4	9.7	16.8	10.2	15.8	14.8	13.4	12.5	26.6	19.2	11.5	14.0	10.9	12.3	20.1	17.6	12.9	11.4	11.0	8.7	14.6	9.9	6.5	9.9	9.1	13.7	7.6	8.7	10.0	3.5	14.9	14.3	5.9	8.6	7.7	19.8	26.2	25.5	27.1	23.7	17.8	16.6	23.8	22.6	17.8	6.0	12.0	5.8	5.1	12.0	20.2	21.7	2.5	14.7	14.8	8.7	19.6	11.5	3.3	7.8	12.7	8.7	10.7	0.0	6.0	12.8	9.3	6.9	8.1	14.8	10.5	20.6	8.7	8.0	13.7	6.8	6.1	9.5	5.0	14.4	11.4	10.1	8.6	8.6	7.1	4.5	23.7	6.5	9.2	16.8	15.2	6.5	12.0	8.5	8.9	7.4
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA		12000	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	15.8	27.4	10.2	18.2	15.3	31.1	10.2	21.2	23.6	9.3	20.4	14.7	14.9	32.9	12.7	7.2	14.1	11.0	15.5	10.5	12.2	8.5	13.3	48.3	15.5	19.8	9.7	9.0	12.1	41.3	9.5	11.5	11.3	10.8	13.3	9.7	13.0	18.7	9.9	16.3	14.9	27.8	9.5	8.0	20.6	18.9	17.2	12.1	11.8	11.8	11.8	13.2	9.4	11.8	5.3	17.8	8.8	12.2	4.3	7.7	7.1	27.0	31.6	7.9	24.4	7.8	6.4	20.5	29.8	12.5	22.5	18.3	42.8	15.7	16.3	26.0	19.5	14.4	32.1	9.3	22.7	5.0	21.4	21.4	11.4	19.5	29.1	15.5	20.3	21.3	11.2	14.4	18.1	9.9	5.7	12.4	16.2	29.2	18.3	10.2	24.0	17.6	21.7	22.2	16.1	22.4	28.6	8.4	26.0	13.3	18.6	17.0	16.8	12.0	22.5	18.9	4.0	16.3	23.4	16.7	19.5	17.0	31.8	35.9	23.0	20.8	12.6	20.6	26.1	29.9	1.1	11.9	8.8	6.9	12.2	6.1	5.3	4.2	7.7	8.7	4.4	4.6	6.1	7.3	4.3	4.9	17.8	3.8	7.1	10.2	15.3	21.2	23.6	12.2	8.5	9.7	9.0	10.8	12.1	14.9	17.1	21.6	7.6	7.3	14.5	8.7	17.8	5.3	9.1	10.4	9.8	17.5	3.3	30.0	12.3	11.3	71.0	0.0	31.8	38.3	11.6	13.6	16.1	39.4	37.7	22.3	12.1	14.7	22.2	39.2	8.6	12.5	13.5	14.4	38.1	5.0	30.8	40.3	8.5	10.3	12.2	12.9	10.3	12.5	18.3	10.9	14.2	12.8	53.7	13.3
NCOA2	"bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2"	ENSG00000140396	"Nuclear receptor coactivator 2"	Q15596	8	70109762-70403805	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060243			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060243: AB_2684229"	"unprognostic (9.79e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	13.6	13.2	16.9	13.1	14.0	22.5	14.9	19.2	14.0	13.9	17.3	10.1	49.7	12.4	16.6	33.6	20.0	12.5	12.6	15.8	13.9	13.0	16.4	25.5	15.5	16.9	10.8	11.4	18.5	9.7	23.4	17.1	16.2	10.0	14.8	11.8	15.3	14.8	21.7	13.2	14.9	28.8	19.2	9.6	14.5	11.7	15.5	12.9	15.3	13.4	10.3	13.8	18.9	17.2	3.8	2.5	9.4	7.8	2.1	3.8	1.6	8.8	11.0	12.2	6.9	11.1	11.4	12.5	5.1	5.1	3.9	3.8	5.6	10.3	10.5	2.1	9.3	6.5	5.2	14.9	7.0	4.4	24.8	11.8	18.3	5.6	8.9	5.8	3.7	4.9	9.9	7.9	5.3	7.6	6.2	2.7	7.7	5.8	16.0	4.5	8.8	9.1	3.7	6.4	10.1	5.2	9.0	5.1	6.5	6.3	14.7	9.3	6.8	8.8	4.7	7.2	8.9	11.1	6.8	3.5	5.7	7.3	7.2	2.7	21.1	10.8	10.2	5.8	4.9	8.3	4.5	2.5	3.5	3.8	3.9	2.8	2.2	2.3	3.3	2.5	3.8	2.8	2.7	9.4	2.1	7.8	1.1	3.2	1.6	16.9	14.0	19.2	13.5	13.9	13.0	10.8	11.4	10.0	12.9	11.9	24.3	16.7	7.9	14.3	23.6	31.3	33.1	9.4	34.2	24.4	49.1	16.2	10.0	6.0	4.0	14.5	20.6	23.3	10.7	10.2	16.2	17.2	21.9	57.7	14.7	69.9	24.2	22.7	43.2	5.7	18.4	19.9	20.3	4.6	17.5	14.7	10.9	11.5	20.8	15.7	29.6	25.8	15.6	11.2	15.4	18.7	26.5	25.4	16.0	12.2
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 38.1;MCF7: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.9	19.2	5.4	7.3	12.8	15.0	38.1	5.7	8.6	9.8	5.2	9.2	6.5	20.5	3.8	9.8	13.8	14.4	4.2	7.0	7.5	10.8	2.2	2.8	5.4	12.7	7.6	2.2	15.3	6.8	20.2	9.3	10.8	7.9	6.9	3.4	6.3	4.8	5.4	63.9	3.2	3.8	1.9	4.5	7.4	6.1	3.8	8.8	5.4	13.8	1.0	1.9	14.4	17.9	6.1	6.5	8.3	5.6	12.0	5.8	5.1	7.0	2.5	13.2	12.0	21.1	6.8	2.2	3.9	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2	11.9	21.3	77.0	14.2	30.7	16.1	22.0	20.4	22.7	17.0	14.0	7.9	56.2	5.0	11.0	9.0	39.0	7.8	0.0	16.8	23.2	22.6	21.3	8.1	18.4	20.1	12.7	14.3	66.9	49.4	3.6	23.0	45.5	32.1	22.6	11.4	9.7	15.9	14.0	25.8	5.1	22.4	19.4	26.8	22.7	17.8	45.2	74.6	22.4	11.7	56.9
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060985-46089952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	16.0	15.0	20.9	25.8	18.5	8.1	55.1	31.2	25.6	19.3	17.7	12.0	18.5	14.0	23.4	20.3	16.5	21.1	15.8	13.8	19.3	13.1	14.1	12.9	21.7	23.0	14.6	16.2	29.8	27.0	23.4	26.2	18.4	15.7	19.2	16.5	14.7	18.5	23.6	22.8	19.4	18.1	19.8	13.6	23.3	16.5	44.4	16.7	23.8	19.2	14.2	23.8	18.2	42.5	17.4	18.5	10.7	8.6	7.4	14.0	5.4	19.4	17.3	24.5	25.1	11.7	12.4	19.6	13.5	12.2	22.0	18.2	23.9	15.6	32.0	22.9	13.0	18.8	26.1	20.2	16.9	19.1	19.3	10.2	19.2	17.3	20.1	12.4	26.3	18.7	8.9	22.6	11.6	10.6	11.6	15.6	16.8	17.8	26.2	17.3	25.2	36.1	20.4	22.2	16.5	21.4	27.5	16.2	14.0	12.9	22.2	22.0	20.0	21.7	26.5	19.0	14.6	21.1	31.1	14.4	23.4	17.8	13.9	21.0	17.1	24.1	21.6	16.2	15.5	14.8	3.3	8.3	10.7	12.2	8.5	14.0	11.6	12.8	12.3	8.3	17.4	12.3	11.1	6.0	7.4	8.6	18.5	8.2	5.4	20.9	18.5	31.2	25.6	19.3	13.1	14.6	16.2	15.7	16.7	8.9	13.0	7.5	2.8	5.7	12.0	3.9	10.2	9.4	6.8	8.7	21.6	9.3	0.0	7.6	6.0	6.9	6.0	0.0	10.5	8.7	6.7	3.6	1.1	6.8	6.7	3.2	9.1	8.6	8.8	2.7	12.7	6.3	3.3	6.4	9.7	6.8	10.1	2.9	14.5	4.4	9.0	6.5	5.3	23.0	13.6	4.6	5.6	5.7	9.3	3.1
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	20.4	34.2	24.4	20.3	20.1	15.3	12.2	15.1	17.1	16.6	15.1	18.3	9.4	21.5	10.7	26.3	12.4	15.6	30.0	18.3	24.7	28.6	22.2	21.4	29.6	21.4	19.7	13.4	25.6	15.7	19.2	25.7	30.1	14.2	23.0	30.4	18.6	8.9	16.3	13.3	23.6	8.6	12.1	36.0	9.3	23.6	24.8	10.0	17.2	23.2	8.3	13.9	24.9	10.9	11.8	65.5	10.5	15.3	20.0	17.1	10.1	12.5	20.8	6.1	7.1	12.5	16.3	16.0	14.6	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4	74.5	98.7	86.4	91.4	60.2	144.1	78.9	66.2	61.6	72.8	50.6	149.2	79.2	29.9	80.2	53.7	68.9	164.0	93.5	85.1	85.7	74.0	70.9	83.3	105.0	67.5	122.3	84.4	59.5	70.8	35.4	94.0	84.8	35.4	184.0	101.0	81.4	89.5	133.5	114.2	37.3	152.7	90.5	89.5	82.3	75.1	59.6	73.2	110.7	125.6	110.0
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Cell type enhanced"	"Detected in many"	15	"Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.9	5.0	24.8	11.0	1.3	3.0	12.8	25.8	13.9	33.8	28.9	13.6	12.5	24.0	11.7	10.0	14.3	13.6	27.7	11.1	35.8	9.0	7.0	18.9	14.2	10.4	0.5	36.2	15.9	1.5	1.0	19.4	13.8	3.5	15.3	14.9	15.4	30.6	29.5	9.9	17.6	15.8	12.8	14.2	7.3	19.5	25.4	19.2	8.8	10.6	20.1	9.0	23.6	6.2	9.4	10.3	10.4	14.5	9.3	22.1	49.2	17.4	34.0	13.4	21.1	32.2	9.7	16.8	18.6	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6	0.0	1.1	3.7	0.8	2.1	0.0	17.3	0.0	1.4	3.4	0.0	0.0	1.7	0.0	0.9	9.7	0.3	0.2	23.3	0.3	20.1	1.9	0.1	0.0	0.0	9.3	0.0	0.0	6.2	2.5	3.6	6.9	2.2	0.0	0.0	0.9	0.0	0.2	0.0	21.9	0.1	0.0	19.4	3.1	84.6	25.0	0.5	1.7	6.9	2.3	0.9
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687330	"Plasma proteins, Predicted membrane proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 218.9;Peritubular cells: 195.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.5;plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 20.6;ASC diff: 20.3;HSkMC: 27.3;NTERA-2: 16.4;SuSa: 22.6;U-2 OS: 30.6;U-266/70: 19.4;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	29.9	35.5	19.2	7.7	39.1	1.3	25.0	2.6	28.2	32.7	12.9	12.9	8.1	8.0	29.9	17.7	12.3	21.4	19.1	20.3	18.1	40.3	6.9	3.0	10.3	8.9	14.8	17.6	50.7	7.1	2.1	23.2	22.4	19.0	18.8	8.1	16.5	9.2	29.3	9.2	4.7	8.4	23.5	11.8	11.8	8.6	16.4	7.3	7.1	8.4	8.7	4.9	13.1	17.3	0.0	4.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	20.6	0.0	20.3	7.8	0.0	13.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	3.9	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	12.0	27.3	0.0	3.8	0.0	0.0	0.0	8.0	0.4	0.0	6.7	0.0	9.7	0.0	16.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	22.6	3.5	0.0	0.0	0.9	30.6	0.0	0.0	19.4	18.0	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.6	4.3	0.0	0.0	19.2	39.1	2.6	28.2	18.1	40.3	14.8	17.6	19.0	7.3	23.8	8.3	0.0	15.5	11.6	59.9	32.5	12.7	6.7	2.3	12.2	19.6	1.7	19.9	16.4	1.9	15.7	4.6	0.0	9.4	1.1	70.8	4.8	0.0	0.2	6.3	47.7	6.4	30.1	7.8	3.8	218.9	3.2	37.1	0.0	4.5	81.6	7.3	0.0	195.2	0.5	41.1	97.0	76.9	10.9	21.7	7.2	2.1	0.7	6.9	3.1
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 389.7;Horizontal cells: 487.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	3.6	59.2	28.7	2.9	49.4	1.6	2.3	65.4	134.1	3.8	3.5	11.0	15.6	3.4	10.2	5.1	10.0	3.9	3.4	112.6	30.5	32.0	2.3	1.9	6.5	3.4	33.7	35.4	2.1	2.6	10.8	11.6	2.6	81.2	2.1	3.2	8.7	2.9	18.2	5.3	3.9	3.2	8.7	11.7	11.7	2.6	19.9	7.4	0.0	2.6	0.3	3.5	2.7	8.0	1.5	0.1	0.2	0.0	0.1	0.9	0.2	0.1	9.3	8.9	1.7	0.2	1.7	0.7	2.9	4.5	1.4	0.9	3.5	2.4	0.2	18.4	2.2	16.2	0.8	0.7	0.5	1.2	0.0	1.8	0.4	1.5	2.5	2.5	0.1	0.1	2.1	0.2	0.9	0.0	15.2	11.7	0.0	0.1	0.1	1.3	2.3	0.9	0.1	0.8	0.3	6.8	0.2	2.5	0.2	0.4	5.8	27.8	10.4	0.3	0.8	0.1	1.1	0.3	0.1	4.2	1.2	3.5	0.3	0.4	0.5	0.2	3.0	6.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.2	28.7	49.4	65.4	63.4	30.5	32.0	33.7	35.4	81.2	7.4	0.0	3.4	0.0	4.0	1.8	38.9	389.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	4.6	13.5	0.0	0.0	0.2	0.1	1.5	1.4	0.0	0.2	0.0	487.8	1.7	23.9	1.0	6.2	4.0	0.7	6.8	0.0	0.0	74.2	3.2	0.0	2.5	0.0	22.6	6.5	5.7	3.9	3.6	5.1	0.0	0.0	0.0	7.5
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.9	19.8	9.8	13.0	7.2	7.2	28.3	8.4	8.5	16.3	12.4	42.9	22.1	12.4	4.5	9.1	18.4	18.5	14.1	12.4	10.6	24.0	24.8	12.1	21.1	32.4	15.8	17.6	13.1	9.2	12.1	11.1	15.1	10.1	12.2	17.8	8.4	23.5	12.0	21.3	17.6	20.3	25.2	20.7	16.5	24.9	14.4	12.9	22.4	25.1	7.1	8.0	10.6	28.5	14.7	22.2	5.9	16.9	8.5	12.4	25.2	11.3	19.4	4.6	5.4	20.5	13.0	11.0	13.6	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3	26.8	28.0	46.2	52.9	43.0	46.1	165.0	50.9	41.5	36.4	61.1	55.0	100.9	140.9	108.0	102.8	42.7	83.0	23.3	114.3	98.5	39.0	37.2	56.6	65.2	101.8	31.8	45.5	34.4	33.6	461.4	26.2	46.0	52.3	57.7	92.6	40.4	94.0	94.8	34.6	133.6	48.3	19.4	42.6	28.8	28.1	41.3	83.5	45.7	120.3	64.7
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 1253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	28.2	20.9	26.2	23.3	18.7	20.2	36.4	21.8	16.2	22.0	18.1	18.1	23.0	46.8	35.8	15.7	27.4	23.4	45.5	25.9	17.5	26.5	52.6	25.1	37.5	88.9	19.6	46.6	20.9	18.8	36.0	16.2	17.5	20.7	27.9	42.3	52.6	23.8	23.8	42.8	36.0	70.9	68.0	42.2	48.6	49.6	29.5	63.7	20.2	25.4	36.0	28.1	24.4	44.7	40.7	30.1	36.1	39.0	21.9	20.2	21.2	19.5	29.9	30.4	44.2	52.5	22.6	37.7	22.8	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5	92.3	83.8	96.1	105.6	108.4	80.0	1253.7	109.5	175.3	81.9	106.4	43.2	246.2	600.2	140.5	81.4	113.0	204.9	70.0	182.7	251.9	115.6	117.8	83.1	281.9	233.1	49.3	194.3	96.3	110.6	24.0	89.8	100.2	148.5	155.9	210.6	118.9	192.1	168.4	114.2	541.1	90.3	90.5	123.0	114.6	115.3	124.3	187.8	90.6	317.0	150.7
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 153.5"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	25.1	31.2	45.1	19.9	52.5	20.2	27.3	29.1	43.3	21.5	39.0	26.0	25.1	28.3	20.1	29.5	27.7	22.0	25.7	105.5	37.0	36.0	46.6	41.2	18.4	23.8	46.0	35.6	14.5	47.0	26.5	23.9	17.7	33.3	20.7	30.8	28.1	37.6	27.4	127.2	17.2	28.1	38.1	37.7	19.7	26.9	14.3	25.2	15.6	57.6	48.1	21.1	25.5	17.5	94.7	116.5	55.2	108.5	75.9	87.8	153.5	41.1	67.0	24.0	52.4	38.6	39.2	34.9	29.9	26.2	31.0	29.6	51.7	41.1	31.3	44.8	36.2	58.7	20.4	21.4	42.1	24.7	52.2	73.6	22.9	57.3	58.1	30.6	35.3	30.9	43.6	36.5	29.4	18.1	26.6	46.1	44.5	38.7	37.9	42.9	122.0	55.3	91.1	55.6	84.7	76.6	31.9	23.4	72.2	62.1	81.8	48.9	48.3	41.0	67.2	35.9	28.6	29.2	40.5	38.4	41.0	24.1	48.4	51.5	36.2	67.2	54.9	62.4	56.8	51.3	55.2	108.5	48.1	83.5	107.8	71.3	94.7	82.1	81.4	116.5	72.9	87.8	87.7	9.0	75.9	97.1	92.8	73.9	153.5	45.1	52.5	29.1	43.3	37.0	36.0	46.0	35.6	33.3	25.2	175.7	232.0	217.4	229.1	201.1	175.8	3102.3	435.7	235.5	197.9	638.6	92.3	489.8	1692.7	343.0	795.3	237.8	727.9	70.0	273.3	377.8	291.6	360.2	272.6	944.1	632.0	131.9	411.8	215.5	261.6	154.7	206.2	385.8	411.7	381.5	493.4	197.7	268.8	531.3	229.1	1640.6	200.8	194.1	278.2	77.7	190.5	245.3	430.7	214.4	506.9	369.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.4	6.6	16.4	19.9	21.7	29.2	22.2	14.9	18.8	21.3	21.6	19.7	17.1	20.5	45.2	12.6	36.6	26.0	17.7	19.7	21.5	42.4	14.8	22.0	12.0	16.4	19.9	26.3	17.5	26.9	25.5	12.0	20.0	22.1	24.4	20.0	18.6	29.9	22.8	16.7	15.1	20.4	23.7	45.5	26.7	16.8	19.0	63.6	38.6	18.1	11.7	19.6	9.0	50.9	35.1	15.4	77.6	42.9	15.7	14.1	13.4	19.2	35.4	39.8	41.2	30.3	22.8	28.2	20.0	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4	44.7	44.0	87.9	92.8	75.7	45.3	340.1	112.1	52.2	53.4	83.7	31.4	192.8	431.0	110.3	85.8	85.1	125.2	0.0	92.5	115.9	83.1	75.7	92.3	108.0	222.8	38.1	112.9	97.6	229.9	13.7	75.1	156.2	128.2	124.4	173.7	74.4	86.7	189.4	65.7	379.0	54.1	71.1	81.4	233.1	125.2	77.5	192.3	81.2	242.9	137.2
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.1	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	2.3	0.0	1.0	0.0	0.1	0.0	4.6	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	6.4	0.0	1.7	4.0	4.4	0.0	4.9	6.3	3.1	0.8	0.0	0.1	0.0	3.9	0.0	0.0	0.0	4.1	4.3	0.1	0.0	2.1	2.9	0.0	0.2	1.5	3.8	3.8	0.0	1.6	6.0	3.6	3.1	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4	17.9	54.2	0.0	0.2	0.5	3.9	55.7	0.0	0.0	4.5	12.2	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.2	0.0	1.3	0.1	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1.0	2.3	0.7	3.3	0.0	0.0	0.3	0.1	0.0	2.1	5.6	0.5	6.5	2.7	4.3	1.7	0.6	0.0	0.0	0.0	0.0
NEDD8	Nedd-8	ENSG00000129559	"Neural precursor cell expressed, developmentally down-regulated 8"	Q15843	14	24216852-24232454	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		5700000	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	38.2	48.1	55.5	30.7	58.1	34.6	42.2	34.1	62.4	41.0	36.3	26.8	32.6	25.0	32.2	59.9	40.3	34.3	31.3	50.7	47.1	49.5	46.5	48.4	30.5	31.5	49.4	54.6	34.3	33.4	101.1	31.3	39.7	45.5	31.6	40.0	27.4	37.2	40.7	70.7	36.5	28.4	43.0	36.0	34.9	29.9	25.7	34.3	26.9	37.5	44.7	46.8	30.7	32.0	60.2	76.1	90.2	60.1	43.2	64.1	89.9	26.0	45.7	37.1	26.2	42.2	36.9	27.0	35.6	37.8	42.0	38.8	31.5	31.9	22.5	20.9	50.1	35.4	27.5	37.0	55.6	59.1	31.7	22.4	24.0	42.1	107.3	36.6	39.7	25.2	39.2	37.0	35.3	27.8	39.6	50.1	26.4	21.4	26.4	64.7	57.9	31.6	37.7	27.4	48.1	53.5	22.5	29.4	22.9	48.4	49.6	15.7	36.6	30.8	31.4	25.6	39.6	19.0	31.6	37.5	23.9	24.0	30.5	31.5	31.4	47.3	32.6	17.2	22.9	22.6	73.5	57.9	90.2	46.8	60.1	50.7	60.2	54.4	51.9	56.9	51.1	51.2	52.0	62.2	43.2	59.0	76.1	64.1	89.9	55.5	58.1	34.1	62.4	47.1	49.5	49.4	54.6	45.5	34.3	134.0	147.7	239.7	188.0	246.8	91.4	436.0	229.3	136.5	126.3	294.8	45.2	457.7	504.0	309.5	46.7	283.5	261.3	163.5	353.5	526.2	324.5	205.0	213.6	344.7	501.8	100.1	204.1	216.7	303.8	60.6	252.0	280.5	254.8	432.0	208.2	154.8	360.0	256.1	259.2	606.3	68.0	207.0	308.8	113.9	219.0	337.9	350.8	243.7	228.6	222.9
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787346	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	10.2	21.8	18.7	6.8	17.7	2.7	10.3	11.8	20.9	11.3	5.6	9.0	7.0	3.6	9.9	15.4	6.5	17.9	6.9	14.2	15.4	20.0	9.3	11.0	7.7	8.4	18.4	16.1	12.6	10.9	7.8	13.2	7.6	20.3	10.5	6.1	9.7	11.5	10.3	24.7	18.1	4.6	10.2	12.3	9.5	5.1	26.8	13.3	1.8	15.5	7.1	7.9	7.4	15.8	14.7	5.5	0.8	2.5	9.1	13.6	4.7	4.9	14.0	8.8	17.2	4.2	7.9	3.9	7.9	6.6	7.7	5.3	4.3	5.5	1.9	3.1	9.5	16.6	4.4	8.4	8.7	10.6	5.8	4.2	6.8	3.3	8.4	3.4	2.9	5.1	6.9	12.9	6.7	6.2	7.5	7.2	2.3	9.6	6.7	9.1	5.2	0.5	3.1	7.9	20.5	7.5	8.7	11.3	5.3	9.0	7.5	13.6	10.7	6.2	3.3	11.3	7.4	5.2	0.5	8.8	8.8	12.7	2.3	11.1	6.3	13.1	3.5	23.2	10.2	17.8	0.4	1.5	0.1	9.1	2.5	12.1	14.7	9.3	10.8	3.0	11.4	13.6	12.0	0.8	9.1	1.1	5.5	5.8	4.7	18.7	17.7	11.8	19.8	15.4	20.0	18.4	16.1	20.3	13.3	0.0	4.3	12.6	14.3	7.6	25.6	17.8	17.8	5.3	6.8	7.0	15.7	15.6	28.2	17.4	0.8	9.3	0.9	0.0	20.5	13.6	10.8	15.1	2.3	21.2	12.1	7.9	9.7	7.4	4.7	2.1	13.0	6.6	13.5	10.0	4.5	27.9	14.2	0.0	23.0	24.7	13.2	6.5	13.2	14.2	45.1	11.2	4.5	7.2	5.0	9.1
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2.0	1.1	2.0	2.5	0.9	8.3	2.0	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9.0	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1.0	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1.0	2.1	1.1	1.2	0.9	2.1	0.4	7.7	1.2	2.1	1.9	0.0	0.5	0.7	1.9	3.2	1.5	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1.0	2.5	0.5	3.3	0.1	2.7	1.5	4.4	0.1	0.7	10.6	0.1	0.8	0.5	0.7	0.2	0.3	1.0	0.4	0.3	4.1	0.6	0.2	0.2	1.2	0.5	0.6	0.8	6.2	0.4	0.9	5.7	9.0	0.3	0.8	0.3	0.2	0.5	4.8	0.9	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0.0	0.4	0.1	0.5	1.9	0.1	0.0	0.2	0.0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3	6.0	0.0	0.0	0.2	0.2	4.0	10.2	2.5	97.7	13.6	1.8	82.5	0.0	0.0	0.3	98.7	0.7	0.7	0.0	0.0	0.2	2.9	1.5	0.0	0.5	0.2	0.0	0.0	0.6	1.3	45.8	1.7	0.4	0.0	0.0	0.1	1.4	0.2	0.6	1.1	0.0	19.6	0.0	1.1	25.4	1.7	0.4	0.0	0.0	0.1	0.1
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982714-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	14.8	13.7	18.3	17.2	19.0	20.0	16.5	36.4	23.2	17.0	15.1	22.5	15.7	21.6	19.5	15.1	26.1	21.0	11.4	10.8	16.8	12.2	14.7	10.9	11.4	15.8	14.1	12.0	26.9	27.0	12.5	19.1	16.8	13.6	15.7	8.3	16.2	28.6	28.4	17.4	23.4	21.2	13.3	11.9	18.4	20.6	26.5	18.3	18.0	16.8	10.9	21.6	18.1	19.5	20.5	14.9	12.0	14.0	13.1	18.5	10.3	10.8	10.0	8.7	16.0	3.6	3.8	17.4	5.8	4.1	7.0	5.6	16.6	18.7	19.2	8.4	3.7	8.8	10.3	8.8	7.3	3.4	9.8	13.7	12.6	7.4	15.6	5.3	13.0	12.9	3.2	6.5	4.7	5.0	5.2	5.3	10.9	23.8	9.2	3.0	12.6	25.2	37.5	25.3	9.3	15.2	23.0	7.6	12.0	5.0	9.1	23.9	14.9	6.7	8.0	9.9	5.7	15.4	9.9	6.0	7.1	8.1	8.2	12.8	19.7	20.3	21.3	8.2	13.7	8.8	6.0	12.3	12.0	14.2	14.0	17.1	14.6	16.3	12.6	11.9	20.5	14.2	11.0	4.7	13.1	11.2	14.9	18.5	10.3	18.3	19.0	36.4	23.2	16.8	12.2	14.1	12.0	13.6	18.3	11.9	14.1	15.2	15.5	29.0	18.7	4.6	10.2	16.0	18.2	12.2	37.3	23.7	8.3	17.3	20.5	9.3	14.7	0.0	12.1	24.1	15.8	15.0	9.2	6.7	14.0	35.0	15.5	10.4	10.3	6.0	14.4	10.4	13.5	19.8	16.5	20.3	13.5	17.8	12.4	6.5	19.5	0.0	10.3	28.3	36.5	33.4	23.8	13.8	18.7	23.7
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959110	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 512.1;Late spermatids: 1326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	19.4	21.1	18.5	17.6	20.4	18.4	26.8	10.2	18.2	22.8	20.4	19.0	23.5	15.8	20.7	30.2	21.7	30.4	20.4	22.6	18.5	17.0	19.2	13.5	17.0	20.9	18.5	18.7	21.2	46.1	12.4	18.0	23.7	27.5	14.4	17.9	12.7	24.9	22.4	40.4	19.6	18.1	19.5	28.0	16.3	18.1	58.1	18.2	28.3	20.8	16.9	14.7	15.3	18.8	23.6	25.2	28.8	33.4	20.7	22.5	23.4	17.3	12.4	17.4	13.5	6.2	10.2	13.9	12.9	14.0	11.8	6.5	18.7	9.9	13.4	14.5	13.5	29.3	12.7	6.1	6.4	6.9	11.3	13.6	8.0	13.4	23.5	10.2	15.6	9.1	9.1	17.3	10.4	19.5	21.9	10.9	12.1	12.9	16.0	13.4	28.8	22.9	10.2	6.7	21.3	4.3	20.4	13.8	21.0	14.8	16.2	11.1	18.3	10.1	11.2	24.3	12.6	16.8	29.8	10.0	10.8	22.0	11.4	24.0	26.2	27.1	14.9	7.0	9.9	21.0	20.0	25.4	28.8	21.6	30.5	21.8	23.6	22.2	22.5	25.2	23.6	20.1	20.4	14.5	20.7	33.4	18.5	20.5	23.4	18.5	20.4	10.2	18.2	18.5	17.0	18.5	18.7	27.5	18.2	14.9	27.5	38.2	55.6	41.9	14.9	41.2	76.5	119.1	33.0	31.4	11.8	84.5	112.7	75.5	512.1	48.4	82.2	0.0	118.3	93.8	44.0	50.5	43.9	30.6	74.9	11.1	32.8	41.1	50.2	1326.0	65.9	48.4	47.2	80.2	58.5	50.2	89.2	84.2	42.5	78.5	22.9	32.3	48.1	183.6	96.5	36.5	95.7	52.9	62.6	48.2
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Club cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	10.0	8.4	13.4	10.0	4.4	8.0	7.2	9.7	6.1	5.4	3.6	7.6	6.6	13.3	5.3	3.1	7.6	10.6	9.8	4.3	7.5	2.6	6.2	20.4	7.4	5.6	8.0	12.9	7.5	12.6	7.8	4.4	11.2	14.7	4.7	13.2	6.9	10.7	3.9	6.4	11.1	7.6	13.9	8.9	10.8	9.1	10.6	6.9	6.1	8.9	9.3	13.6	5.5	7.0	15.9	10.4	8.0	11.1	9.4	7.5	7.5	2.7	6.8	10.6	8.2	15.7	12.0	10.3	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8	8.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	17.4	0.0	15.4	14.9	12.5	0.0	0.0	0.0	0.0	11.1	12.4	0.0	0.0	16.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	16.2	0.0	0.0	12.4	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412551-5458463	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	19.4	4.8	14.2	25.8	16.7	15.0	39.8	11.8	15.2	30.2	39.3	21.0	32.1	24.1	19.4	25.7	38.2	20.7	25.9	8.4	16.5	12.7	21.3	19.0	9.5	10.5	19.0	9.4	15.2	19.4	2.9	6.6	51.8	20.8	23.0	38.9	20.3	43.0	23.2	16.7	21.8	54.7	33.4	19.9	3.9	33.5	11.8	10.9	14.8	18.1	26.8	20.2	28.0	31.8	1.8	5.9	2.7	1.2	1.0	11.5	2.4	27.9	16.7	11.6	12.9	6.8	3.1	63.7	17.0	9.3	13.7	13.1	9.1	53.3	10.3	7.1	10.3	3.0	45.8	14.0	25.6	16.5	9.6	10.1	18.6	5.6	20.3	1.8	5.3	8.1	4.6	15.3	13.5	3.2	12.0	7.9	10.8	32.8	16.3	7.5	13.3	17.9	7.4	15.6	38.6	12.7	11.3	21.4	8.0	8.4	14.1	10.0	5.5	14.9	27.7	5.0	20.2	9.2	15.9	7.2	5.2	8.2	8.0	13.7	10.0	5.4	13.5	4.7	8.1	10.8	2.7	0.8	1.8	0.9	1.2	0.0	1.8	1.6	0.5	5.9	0.9	11.5	2.1	0.1	1.0	0.6	2.5	5.1	2.4	14.2	16.7	11.8	15.2	16.5	12.7	19.0	9.4	20.8	10.9	29.8	38.9	8.2	74.8	35.7	7.7	10.1	45.9	77.6	83.0	12.2	3.9	84.2	5.0	11.3	2.0	33.2	153.4	0.0	21.4	96.0	33.1	71.1	15.0	45.0	12.6	3.2	77.6	14.1	12.4	1.7	20.1	13.0	33.7	83.0	146.5	3.4	41.8	114.6	82.4	21.2	3.1	109.9	58.2	24.9	18.6	28.2	98.2	7.0	102.0	186.5
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535949	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.1;retina: 7.7;testis: 2.3"	"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 1.3"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 1.3;SCLC-21H: 1.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573238	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.5;intestine: 8.4"	"Group enriched"	"Detected in some"	49	"Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Region enriched"	"Detected in single"	20	"hippocampal formation: 7.5"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;memory B-cell: 1.1"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;T-cells: 2.1"	"Cell line enriched"	"Detected in some"	5	"THP-1: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	7.6	0.0	0.0	8.0	0.0	0.0	0.9	0.0	1.8	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	7.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	15.4	19.1	19.0	17.0	17.1	25.1	15.8	22.4	18.0	19.3	11.9	11.9	12.5	7.7	18.7	19.5	15.7	15.0	11.7	11.6	15.6	8.2	15.7	10.2	15.6	10.5	13.0	12.7	15.6	13.8	35.6	24.2	30.8	13.1	14.7	12.8	13.9	20.1	15.6	12.1	26.5	14.0	12.5	10.5	11.6	12.0	10.1	14.4	10.3	21.9	7.7	10.8	19.6	30.4	2.1	2.9	5.5	4.6	1.1	2.6	0.5	11.1	14.6	7.2	8.9	10.8	13.1	7.9	11.6	13.9	12.3	9.0	11.0	9.2	5.1	6.9	14.0	4.9	9.7	6.4	6.6	13.0	2.9	2.5	4.0	5.3	13.5	8.8	3.9	7.6	9.1	4.5	9.3	11.4	10.2	12.0	3.0	7.8	2.7	11.4	4.9	3.0	5.7	4.2	2.3	1.7	5.3	3.2	2.8	11.8	19.2	3.9	2.4	25.0	2.7	6.9	9.2	5.5	3.1	14.9	10.8	6.6	5.8	3.9	5.9	4.5	8.9	7.2	3.4	6.4	3.5	1.3	1.4	2.2	0.8	1.6	2.1	1.1	2.6	0.6	1.9	0.9	0.8	5.5	1.1	4.6	2.9	1.6	0.5	19.0	17.1	22.4	18.0	15.6	8.2	13.0	12.7	13.1	14.4	44.7	38.8	29.6	89.1	131.5	50.5	7.8	35.7	17.4	37.5	137.9	80.5	49.6	5.0	15.7	6.5	62.4	23.8	0.0	11.1	13.9	39.1	74.1	19.6	23.1	15.6	57.2	23.5	47.3	21.8	4.7	55.0	41.6	55.6	38.7	30.3	54.8	18.7	24.6	51.6	7.0	64.7	25.8	65.5	64.9	26.2	122.5	42.6	32.0	18.1	90.9
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: AB_2686439"	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.2	4.2	4.0	35.4	4.0	4.1	9.2	2.7	3.9	9.3	7.6	5.4	7.0	3.7	10.7	6.5	5.9	7.0	11.8	13.4	3.2	2.9	4.7	2.9	13.9	21.9	4.3	2.2	7.0	8.3	6.4	3.3	4.8	11.4	6.4	2.1	9.9	5.5	9.0	27.9	8.6	10.8	12.0	5.9	16.9	6.0	7.1	4.6	21.1	6.8	15.2	27.0	13.2	14.2	11.3	3.2	7.1	13.4	2.1	6.9	4.9	0.0	2.2	1.1	2.0	1.9	2.1	4.0	1.3	0.1	0.3	0.2	0.2	2.0	12.3	0.9	1.8	3.3	0.2	5.7	0.0	0.4	8.5	4.7	8.6	0.5	0.0	4.3	2.7	4.7	2.5	0.0	0.7	0.1	0.0	6.9	5.1	6.9	2.6	1.3	4.7	7.0	0.9	2.0	1.6	1.5	2.3	1.5	2.7	1.0	0.9	0.0	0.0	1.9	1.5	3.2	2.5	1.8	11.0	6.4	2.9	12.4	0.0	0.1	0.0	0.0	34.5	0.0	3.7	5.3	1.9	3.4	7.1	4.4	9.2	4.7	8.6	6.9	6.2	3.2	11.3	6.0	4.1	3.0	2.1	13.4	3.1	5.0	4.9	4.0	4.0	2.7	3.9	3.2	2.9	4.3	2.2	11.4	4.6	0.0	5.9	43.6	28.8	33.1	0.0	6.3	0.0	2.7	9.1	0.0	0.0	0.2	0.0	5.4	8.9	20.1	0.0	0.0	3.5	5.3	23.6	13.2	32.2	0.8	10.4	0.0	0.0	27.0	12.4	13.6	7.8	12.0	10.1	0.0	0.0	2.2	4.3	0.0	9.2	0.4	0.0	0.0	22.6	3.7	14.0	26.0	0.5	9.6	0.0	2.7
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.6"	"Cell type enhanced"	"Detected in many"	8	"Melanocytes: 59.1;T-cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.4;HMC-1: 16.6;WM-115: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	8.6	2.4	4.1	44.6	8.2	4.4	9.8	1.1	5.1	8.4	7.8	6.8	3.9	8.4	7.0	7.6	4.0	5.6	19.4	8.5	4.1	3.3	3.4	6.7	6.1	25.2	8.4	0.7	5.0	8.7	3.9	3.7	8.1	10.4	5.4	4.1	6.2	7.9	7.2	5.4	7.0	11.7	5.9	6.5	16.0	11.0	4.5	6.5	8.6	7.0	13.2	18.7	4.5	4.9	1.6	1.7	3.8	0.7	7.6	7.7	1.6	1.6	1.7	0.0	2.2	0.0	0.0	4.6	0.2	1.1	0.7	0.3	8.3	1.5	11.1	1.3	0.5	1.6	0.0	0.5	0.0	0.6	14.4	0.2	4.7	1.2	2.1	0.0	1.3	16.6	0.0	0.0	0.6	0.0	0.1	5.1	3.9	4.6	7.4	0.0	1.8	1.9	7.8	0.1	1.0	4.0	0.8	0.0	4.9	0.3	0.0	0.1	0.0	5.2	1.3	12.1	1.1	2.0	3.1	0.5	1.0	1.9	2.5	0.1	6.3	4.1	11.5	1.1	5.2	25.0	0.3	0.0	3.8	7.7	0.7	3.2	1.6	4.3	6.1	1.7	1.6	2.4	4.4	0.2	7.6	0.2	0.6	2.3	1.6	4.1	8.2	1.1	5.1	4.1	3.3	8.4	0.7	10.4	6.5	6.0	4.8	3.9	10.4	12.8	0.0	2.8	5.1	10.7	9.1	0.0	0.0	2.4	1.7	3.6	1.5	16.9	1.1	0.0	4.9	0.5	28.2	7.4	15.0	6.0	28.1	0.0	7.5	9.2	21.2	0.4	2.0	16.7	59.1	3.6	6.2	0.0	8.0	0.0	0.4	0.2	0.0	0.0	12.2	0.5	0.9	11.3	0.8	40.6	7.1	5.6
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 129.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	9.6	6.8	4.3	16.0	6.6	12.0	7.8	7.5	5.8	9.8	11.0	9.7	7.6	7.1	12.2	6.5	7.7	8.3	7.6	7.0	4.7	4.0	8.2	12.1	11.3	14.2	8.7	3.5	10.0	7.0	18.7	6.8	6.6	5.1	10.5	6.1	11.1	7.9	7.6	27.1	14.0	12.0	9.0	6.7	12.3	6.2	25.9	5.8	129.5	11.0	8.1	16.0	10.2	14.1	6.7	3.1	12.0	7.1	13.4	15.6	9.0	4.9	5.9	9.5	10.5	8.6	5.5	8.8	3.3	4.1	9.2	8.1	8.6	4.4	16.8	5.0	5.4	3.0	7.5	11.9	5.6	9.1	3.4	7.7	16.5	6.2	19.2	5.7	14.7	43.4	4.1	7.2	9.3	5.1	4.8	7.8	13.8	21.2	4.8	6.8	10.1	22.7	20.1	6.2	7.7	3.2	12.9	9.2	17.3	4.0	5.8	7.2	7.8	24.5	6.2	3.1	6.1	8.5	11.2	4.9	4.7	5.1	5.5	4.8	6.6	11.4	30.5	3.7	13.7	6.6	12.0	2.4	5.3	15.6	3.7	14.8	5.2	8.9	15.2	2.9	6.7	9.1	14.0	3.3	13.4	7.1	3.1	6.0	9.0	4.3	6.6	7.5	5.8	4.7	4.0	8.7	3.5	5.1	5.8	32.8	43.8	26.5	36.2	69.6	25.5	1.2	58.6	28.1	20.5	55.8	31.4	42.2	19.9	24.1	115.7	21.0	23.8	23.3	19.3	12.6	19.4	42.3	47.4	89.3	20.8	35.0	25.0	35.6	50.9	81.4	20.1	25.0	21.9	16.2	39.9	8.2	24.8	38.6	25.1	33.5	23.7	19.4	17.8	57.1	69.8	125.2	71.1	59.3	49.1	48.0
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 93.5;Kupffer cells: 38.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 119.7;neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 119.7"	"Group enriched"	"Detected in some"	4	"HEL: 85.6;K-562: 37.0;NB-4: 26.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 1.4"	HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	2.3	0.3	0.9	3.5	1.5	54.3	0.5	0.4	1.7	0.9	0.4	0.2	0.0	0.5	0.4	0.4	0.7	2.0	0.9	7.8	1.5	0.4	0.9	2.6	9.6	20.9	5.2	0.2	1.2	0.6	1.2	0.8	15.9	1.2	1.0	0.3	1.2	0.5	0.2	1.0	2.9	0.5	1.1	1.0	32.2	0.7	0.9	0.7	1.8	1.7	0.2	0.5	1.2	8.1	0.0	15.2	119.7	23.1	0.0	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.1	0.2	1.2	2.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	85.6	0.2	1.9	0.0	1.2	11.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	37.0	0.0	0.0	0.0	3.3	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.2	4.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	5.1	0.0	119.7	23.1	21.7	0.0	6.4	0.1	0.0	0.0	0.0	15.2	0.0	0.1	0.0	80.0	0.0	3.8	0.2	0.0	12.9	0.9	1.5	0.4	1.7	1.5	0.4	5.2	0.2	1.2	0.7	0.0	4.8	0.0	0.0	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	93.5	0.0	0.4	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	38.4	11.0	0.0	1.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	1.0	0.0	0.0	0.0
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061487	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 194.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	24.2	25.7	15.5	13.1	15.5	4.6	50.3	9.1	19.8	18.8	17.5	17.4	32.3	17.4	31.4	30.5	21.4	22.7	16.3	85.5	18.2	19.2	27.9	18.4	13.9	12.6	21.7	21.2	26.2	11.1	16.6	16.3	16.6	25.0	16.5	13.6	22.6	17.7	26.1	194.7	19.9	18.3	24.3	27.5	17.7	13.9	18.8	16.5	5.8	22.4	58.9	10.7	17.3	24.2	4.1	9.4	19.7	9.4	2.1	2.6	0.9	19.2	43.0	28.2	23.8	59.2	28.9	21.2	31.5	43.8	22.4	25.0	52.4	22.3	22.2	64.0	39.7	29.1	40.1	19.9	25.1	24.1	38.0	16.6	12.5	29.1	17.5	70.3	27.8	20.2	39.4	62.8	40.7	45.8	37.5	34.9	15.0	22.1	61.6	27.5	16.5	17.6	8.7	18.2	17.4	16.4	12.5	39.9	21.1	24.7	28.9	17.4	26.3	21.5	14.5	44.4	38.3	28.6	19.1	46.7	54.9	23.8	18.5	31.5	103.1	69.0	20.8	52.1	11.8	31.1	7.9	9.4	2.7	2.6	4.8	1.5	3.8	2.5	2.6	1.9	4.1	1.9	2.1	19.7	2.1	5.6	9.4	0.9	0.9	15.5	15.5	9.1	19.8	18.2	19.2	21.7	21.2	25.0	16.5	53.6	49.6	9.7	17.8	49.5	67.0	262.2	61.1	40.2	31.8	73.3	33.4	18.6	21.6	36.9	6.0	55.4	91.6	0.0	31.5	17.7	25.0	31.4	26.7	111.7	30.3	68.3	28.9	55.9	33.7	7.9	94.6	19.5	20.3	41.5	46.8	24.4	46.3	54.1	78.8	38.4	33.8	58.2	41.2	22.3	20.4	42.3	18.7	14.4	38.2	19.7
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.0;NTERA-2: 36.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.7	1.1	0.5	1.3	0.0	0.0	44.0	2.5	5.0	4.9	9.1	8.4	22.3	0.9	16.8	0.2	18.6	2.7	1.9	4.3	11.3	8.7	2.7	1.7	1.8	6.1	3.4	1.5	17.0	0.4	0.5	2.0	0.7	7.3	11.4	3.6	2.6	22.6	1.0	1.7	1.0	2.7	36.9	3.5	4.5	1.5	0.1	6.3	6.7	12.6	4.0	4.7	0.0	1.0	0.4	12.8	0.6	0.9	23.9	0.4	0.7	0.2	10.2	13.8	21.9	1.0	0.0	5.5	17.0	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5	6.0	3.2	0.8	2.8	1.5	1.2	1.4	17.8	1.4	5.7	10.4	0.0	226.3	0.0	9.8	0.7	3.8	3.3	0.0	4.7	28.3	2.3	3.6	27.6	0.0	21.3	0.0	1.2	3.1	12.9	0.0	0.0	11.1	1.7	5.4	6.5	0.9	11.2	4.3	0.0	0.3	1.3	0.0	1.0	0.3	5.7	1.4	584.2	4.9	8.3	5.4
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.0;HBEC3-KT: 22.3;HUVEC TERT2: 22.2;TIME: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	29.3	9.5	22.6	9.2	12.9	1.0	39.7	30.0	22.9	14.8	17.0	13.6	34.1	11.3	16.8	22.3	11.5	17.0	18.0	24.1	22.0	9.3	18.8	22.3	16.3	9.8	10.8	15.5	18.7	17.5	8.2	6.0	14.7	13.7	21.3	10.4	9.2	40.0	41.3	20.8	23.6	16.8	24.2	14.9	10.4	14.2	7.6	15.6	2.7	18.8	13.9	7.7	27.4	23.4	0.3	0.3	2.4	0.4	0.5	1.0	1.3	6.4	4.6	2.9	55.0	13.9	8.1	0.1	0.1	0.0	1.3	4.8	0.0	2.6	0.1	4.3	0.4	4.2	1.4	2.7	22.3	2.4	0.9	2.6	19.8	10.4	0.6	4.6	0.5	0.1	7.0	3.1	5.0	18.5	5.2	22.2	0.0	0.6	0.1	1.8	3.0	0.0	0.1	1.0	2.9	5.4	0.0	2.6	0.0	4.1	2.4	4.6	17.2	4.7	5.8	1.9	0.1	11.7	0.0	21.7	4.3	6.4	3.3	4.0	0.5	0.4	1.6	3.8	0.1	5.4	1.3	0.1	0.2	0.3	0.2	1.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	2.4	0.5	0.4	0.3	0.5	1.3	22.6	12.9	30.0	18.8	22.0	9.3	10.8	15.5	13.7	15.6	47.6	31.8	8.5	155.7	238.9	30.8	173.3	203.8	49.5	63.7	43.6	0.0	4.1	33.2	58.5	2.9	193.3	44.6	0.0	108.3	1.6	65.3	158.3	3.5	91.3	1.9	0.0	21.9	176.8	10.2	2.3	124.0	9.2	89.4	2.8	28.6	261.1	66.5	55.8	45.6	159.0	8.8	84.1	186.4	0.7	0.9	147.9	1.4	2.2	68.3	55.3
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 50.8;U-2197: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	25.1	19.8	8.5	11.1	11.1	5.7	14.9	15.3	19.9	23.3	19.7	16.8	27.1	6.4	20.8	14.2	19.6	18.5	21.5	25.7	9.5	6.3	14.4	29.0	12.9	9.1	11.8	8.1	31.8	46.9	22.7	14.6	5.1	11.7	18.8	5.3	20.4	33.9	22.2	101.7	16.8	8.5	26.5	10.9	11.6	16.4	8.6	11.3	2.7	15.6	23.2	10.2	22.4	17.4	2.3	4.0	11.3	5.3	8.4	3.3	3.2	18.0	26.6	0.3	16.1	14.7	12.7	1.7	16.5	9.3	11.2	8.0	0.6	6.3	0.1	6.0	15.0	7.9	8.8	4.5	11.1	4.6	12.8	3.8	3.4	21.5	5.3	11.6	5.3	6.8	11.1	7.9	15.4	6.0	7.2	10.3	1.0	9.1	17.0	8.1	13.0	3.0	1.1	0.8	0.7	11.0	7.9	10.2	7.1	4.2	3.7	3.7	9.8	50.8	5.1	4.9	0.2	14.9	4.1	15.4	19.2	17.3	50.2	22.5	0.5	0.7	0.1	26.5	11.6	27.8	1.8	5.2	2.4	3.3	5.3	2.8	2.1	3.0	3.0	4.0	2.3	2.1	2.1	11.3	8.4	1.1	1.6	1.1	3.2	8.5	11.1	15.3	19.9	9.5	6.3	11.8	8.1	11.7	11.3	74.5	75.4	25.9	115.4	89.0	183.3	100.5	295.5	62.9	37.5	87.2	55.0	7.9	44.7	127.5	28.8	99.2	19.6	23.3	164.2	5.6	86.6	147.1	25.4	318.2	50.4	76.3	46.0	115.4	123.7	14.1	233.8	34.0	43.9	52.3	35.0	141.1	110.1	39.6	237.9	45.2	62.2	71.1	110.3	9.0	44.9	85.4	7.1	18.8	48.6	91.9
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501329-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 303.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	19.8	14.7	8.2	37.7	12.0	44.5	26.6	12.4	10.3	18.2	17.1	10.4	10.4	10.7	17.5	11.2	20.5	16.4	20.3	14.5	7.5	5.1	13.2	15.8	26.9	46.0	11.4	4.8	17.5	14.3	10.2	8.7	13.7	10.0	18.8	14.6	10.8	17.7	13.5	17.1	19.6	16.7	16.0	10.1	30.0	14.6	9.3	12.5	37.5	14.7	16.3	26.7	18.4	22.7	5.8	10.4	5.5	7.1	14.3	10.6	3.5	17.1	9.7	5.2	7.9	16.2	14.6	6.4	9.9	29.1	12.3	12.5	10.7	24.6	28.1	8.9	15.5	17.8	13.7	10.3	17.2	16.9	25.3	6.1	11.9	7.8	11.5	15.1	21.2	25.4	12.0	12.1	11.9	16.6	8.9	15.4	9.4	11.6	20.6	8.8	12.1	1.8	11.7	3.1	12.7	8.9	15.0	12.4	12.7	11.5	24.2	3.6	5.9	18.1	25.3	9.9	5.2	5.1	15.9	19.7	16.7	8.7	9.0	13.8	9.1	6.3	27.3	10.7	10.9	23.6	5.2	5.4	4.9	3.4	7.1	6.0	5.6	8.4	5.6	10.4	5.8	10.6	8.9	5.5	14.3	5.9	7.4	4.5	3.5	8.2	12.0	12.4	10.3	7.5	5.1	11.4	4.8	10.0	12.5	38.7	46.7	27.4	82.1	147.0	6.7	16.5	12.7	24.1	36.4	19.2	5.9	12.5	3.3	25.5	3.8	30.8	32.3	0.0	31.9	14.4	46.3	57.3	111.6	20.3	23.2	19.1	32.2	22.7	57.1	0.9	22.2	56.9	52.3	303.0	36.5	10.3	40.0	26.9	32.5	21.4	6.5	0.0	61.7	2.1	6.6	131.4	11.9	22.4	32.1	74.8
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5;Karpas-707: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	14.9	10.8	5.6	43.6	7.1	40.6	18.7	2.0	4.9	12.5	20.1	4.2	9.4	11.3	18.8	11.0	12.9	10.8	20.4	10.9	4.6	2.5	15.5	14.5	20.6	34.2	6.6	2.5	15.1	17.4	5.2	6.3	12.8	7.9	19.6	5.2	7.3	16.7	15.1	13.6	10.4	14.1	24.0	7.7	28.0	13.1	6.6	5.8	19.5	11.5	14.8	39.2	21.9	24.4	5.2	1.4	7.5	3.4	1.3	2.0	0.9	21.4	13.4	2.7	10.7	3.3	5.1	6.4	6.1	19.6	6.2	9.0	8.0	17.6	9.9	15.3	3.7	15.5	13.0	6.1	8.4	2.5	50.5	3.6	2.5	3.2	4.6	9.4	1.6	14.4	7.0	4.1	10.4	10.3	8.6	2.2	5.2	2.3	55.2	2.4	7.3	2.5	6.7	3.4	4.7	4.8	5.4	7.4	7.8	10.5	6.3	0.5	3.0	5.0	12.2	8.6	2.9	9.4	4.8	6.4	6.5	9.5	9.1	16.3	36.5	33.8	10.4	10.6	4.2	3.4	0.3	2.4	0.1	1.4	1.5	1.4	5.2	1.7	1.5	1.4	4.5	1.8	1.5	7.5	1.3	3.4	0.9	2.0	0.9	5.6	7.1	2.0	4.9	4.6	2.5	6.6	2.5	7.9	5.8	8.9	9.1	51.9	51.4	38.6	1.9	2.2	17.8	1.4	18.2	17.4	15.7	4.7	5.0	29.4	1.1	15.8	40.4	0.0	18.1	14.3	9.4	46.1	72.5	3.4	19.0	0.0	15.6	9.8	13.8	0.9	6.9	24.3	28.7	115.4	13.1	4.9	35.6	14.0	4.6	9.2	5.1	0.0	25.6	1.7	10.2	39.0	19.3	24.9	10.6	38.3
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1, cysteine desulfurase"	Q9Y697	20	35668055-35699359	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	10.2	28.0	16.9	6.7	19.3	3.7	9.7	15.3	20.8	11.2	11.7	12.0	10.0	11.0	8.4	9.9	10.1	11.7	9.9	19.2	14.6	14.0	36.9	33.0	7.8	7.0	16.5	15.5	12.5	14.0	20.7	14.8	7.8	14.3	9.5	13.0	12.2	12.6	12.2	19.7	9.5	9.6	10.1	12.4	6.6	10.3	25.3	15.8	4.9	10.2	8.4	10.4	8.1	7.7	10.4	11.2	7.4	8.1	12.8	11.4	6.1	13.2	16.5	5.8	6.1	15.8	14.5	11.7	10.1	10.8	15.4	10.0	29.8	7.6	11.3	20.0	9.4	15.7	16.8	19.7	20.5	13.9	5.0	9.3	24.2	17.7	23.1	13.2	10.2	4.7	11.6	19.6	12.0	13.2	11.4	11.4	13.4	17.2	7.6	10.7	20.3	11.4	10.7	6.6	30.4	24.9	4.5	18.8	19.0	15.6	9.0	7.3	6.6	25.3	24.6	16.5	14.2	21.9	9.1	8.3	17.4	8.3	10.1	9.9	11.0	15.1	10.4	14.7	11.1	8.5	2.5	8.1	7.4	7.6	7.7	9.7	10.4	8.8	11.2	11.2	7.6	10.3	9.3	3.4	12.8	6.0	5.6	11.4	6.1	16.9	19.3	15.3	20.8	14.6	14.0	16.5	15.5	14.3	15.8	6.0	16.7	9.7	7.5	5.5	12.2	19.3	20.4	2.7	6.8	17.4	9.8	28.1	28.2	13.8	4.2	5.7	12.1	0.0	9.8	17.9	7.5	4.8	6.9	24.1	14.2	14.3	6.4	8.0	8.9	3.4	5.2	8.5	10.1	15.4	7.8	14.5	9.3	9.9	9.9	41.3	11.8	12.9	8.7	36.8	17.8	5.0	17.6	9.6	13.4	5.0
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69395750-69437628	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	32.3	26.0	24.9	14.7	23.5	14.9	59.9	19.7	40.4	14.7	20.0	12.1	16.0	15.9	17.1	31.8	13.9	17.6	15.9	83.2	21.4	23.6	32.8	20.0	23.0	20.8	24.1	29.7	18.5	21.7	22.9	23.0	19.1	23.7	17.5	20.8	12.2	19.1	19.8	69.3	9.7	16.3	28.9	24.8	13.9	18.7	16.5	16.8	7.8	21.4	28.3	14.4	19.0	19.4	18.2	17.7	16.0	17.5	12.9	18.2	8.0	20.3	18.8	19.7	19.7	25.1	23.8	21.5	22.0	19.4	19.3	14.5	40.9	17.9	12.3	11.5	18.1	30.6	9.2	20.2	20.6	27.0	25.9	19.8	13.8	16.1	37.2	25.7	25.1	21.0	19.9	12.1	20.8	14.3	22.0	24.6	14.5	23.7	15.1	34.7	4.3	13.2	43.1	18.0	21.8	21.3	14.6	30.9	5.0	29.5	21.5	15.9	12.6	12.0	11.0	34.2	21.8	13.3	17.6	24.2	24.6	17.6	19.1	29.4	19.9	16.8	8.1	18.5	25.5	18.9	13.5	8.5	16.0	12.1	12.4	11.8	15.9	12.3	14.4	8.6	18.2	12.8	14.4	2.8	12.9	17.5	17.7	18.2	8.0	24.9	23.5	19.7	40.4	21.4	23.6	24.1	29.7	23.7	16.8	29.8	16.1	41.2	30.6	14.3	22.2	90.1	35.7	50.9	15.9	36.6	11.8	101.7	160.8	46.6	83.4	32.3	30.2	23.3	53.3	58.8	29.6	33.8	57.7	33.6	71.3	17.5	51.2	28.3	33.0	20.9	32.2	38.6	37.1	88.4	43.8	34.7	48.9	45.6	34.6	134.1	25.7	45.3	49.1	77.4	52.4	13.0	51.3	35.0	49.8	27.4
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.3	12.5	11.5	10.9	17.2	19.4	11.6	14.5	14.5	16.5	16.5	11.4	6.3	23.8	9.3	16.7	11.1	8.7	20.5	15.7	15.5	17.4	10.3	12.5	30.6	12.7	21.0	22.2	13.9	18.1	26.3	14.0	35.5	14.8	10.0	13.6	19.0	20.8	17.2	10.8	14.3	20.9	18.7	11.3	14.2	15.4	12.6	13.0	11.1	14.7	16.0	11.2	14.5	15.7	8.3	14.2	9.1	22.2	12.5	13.5	11.3	9.7	15.7	11.2	10.1	23.7	14.8	11.3	7.7	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0	56.6	43.9	35.8	19.9	7.4	27.8	34.3	28.1	53.5	48.9	26.2	51.1	10.2	6.6	13.9	65.8	11.3	19.0	23.3	11.5	10.2	12.0	21.1	17.4	26.0	12.8	20.6	8.7	16.5	16.7	13.3	17.0	11.5	3.3	13.6	22.8	15.1	11.3	17.6	21.5	6.4	32.6	12.9	11.2	12.1	13.1	9.8	15.1	13.1	16.7	16.1
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515017	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 4.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 4.2"	"Group enriched"	"Detected in some"	7	"RH-30: 56.0;WM-115: 62.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		100000	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (3.40e-4)"	30.9	24.0	1.2	9.2	7.4	1.0	11.7	6.1	4.5	7.6	9.4	10.4	7.9	3.2	6.8	15.0	11.3	12.6	10.8	22.2	2.4	2.9	4.8	29.1	1.4	11.6	13.8	1.3	7.6	6.2	2.8	6.7	16.7	15.9	17.7	3.4	20.2	17.2	9.7	4.8	8.4	5.0	10.7	22.4	18.9	4.9	12.2	4.4	0.4	25.8	7.4	7.0	13.1	6.8	0.0	4.2	0.0	0.4	0.0	0.5	0.2	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	1.3	0.4	1.2	0.0	0.1	0.2	0.1	0.0	1.0	0.1	0.0	0.1	6.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	1.0	0.0	0.0	1.0	56.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	3.7	2.2	0.1	0.0	0.0	0.0	1.0	0.1	2.7	0.0	0.0	0.0	0.0	0.5	62.2	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	4.2	0.0	0.2	1.2	7.4	6.1	4.0	2.4	2.9	13.8	1.3	15.9	4.4	0.0	0.0	0.5	33.8	3.2	6.1	0.5	0.0	1.4	2.3	0.0	3.9	0.2	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.4	3.3	2.4	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.9	88.9	1.8	15.1	0.0	0.0	122.0	0.0	0.0	26.2	0.0	5.7	32.3	9.5	0.5	0.9	1.5	0.1	1.0	0.0	2.0
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219075317-219160865	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Enterocytes: 2.5;Intestinal endocrine cells: 2.4;monocytes: 5.4;Mucus-secreting cells: 2.6;Paneth cells: 2.9;Undifferentiated cells: 3.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: AB_2678707"	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	11.0	9.6	5.7	9.3	6.6	4.4	14.5	9.7	6.9	9.5	14.1	6.1	7.0	11.0	10.2	6.1	7.7	6.9	10.9	5.9	6.3	3.7	12.9	8.4	7.5	7.4	9.4	4.3	10.7	13.2	6.6	7.5	6.5	5.3	13.3	18.4	6.4	6.4	6.3	17.5	8.4	20.5	10.2	4.4	8.9	9.4	28.7	5.3	13.5	8.1	5.2	10.6	11.1	15.4	15.0	11.2	7.5	21.1	12.8	18.9	10.1	5.1	7.4	14.0	11.1	15.7	18.1	8.4	10.9	10.0	13.1	12.9	23.9	6.5	10.7	9.5	11.2	12.7	7.2	19.0	9.1	11.9	15.1	9.4	21.0	8.8	19.5	13.9	10.0	14.6	16.1	20.4	11.5	13.5	9.0	10.2	7.2	20.7	13.5	9.3	6.2	10.5	10.7	15.5	6.1	7.9	13.6	9.0	10.0	12.0	7.5	11.1	11.7	6.9	7.8	18.0	15.4	5.3	9.0	9.9	10.0	8.9	4.7	9.7	7.8	7.5	13.6	7.1	17.6	8.2	4.9	14.0	7.5	9.3	21.1	14.2	15.0	13.9	11.8	11.2	12.9	18.9	13.7	3.5	12.8	16.5	5.5	14.6	10.1	5.7	6.6	9.7	6.9	6.3	3.7	9.4	4.3	5.3	5.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	1.3	0.4	0.0	2.5	0.0	1.7	0.2	0.0	0.2	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	5.4	2.6	0.0	1.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	3.2	0.0
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 16.6;skin 1: 10.5"	"Group enriched"	"Detected in some"	7	"Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 36.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.2	0.2	3.4	0.2	0.9	0.2	0.6	16.6	2.4	0.3	0.3	0.4	0.5	0.3	0.2	1.4	2.5	0.2	0.3	0.2	7.1	9.1	0.2	0.2	0.9	0.2	4.1	1.5	0.2	0.2	0.2	0.1	0.5	16.3	0.7	0.4	1.0	0.4	0.7	0.6	10.5	0.3	0.2	3.1	0.2	1.0	1.6	0.6	0.0	0.2	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	16.6	2.4	7.1	9.1	4.1	1.5	16.3	0.6	0.0	0.0	0.0	2.1	2.5	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.5	1.9	0.0	0.0	0.0	0.3
NHP2	"FLJ20479, NOLA2"	ENSG00000145912	"NHP2 ribonucleoprotein"	Q9NX24	5	178149460-178153967	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044171, HPA050400"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044171: AB_2678844, HPA050400: AB_2681113"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (8.87e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.63e-2)"	35.4	41.0	42.5	37.5	46.4	44.2	37.9	26.2	54.2	27.1	37.3	23.7	26.2	29.0	31.9	34.4	59.4	37.6	33.6	52.3	37.7	33.6	31.3	57.1	24.9	60.3	37.1	29.3	38.2	62.1	15.1	25.3	25.0	26.7	28.0	22.4	18.6	40.0	35.5	50.9	39.1	26.7	34.2	34.1	29.9	30.4	26.9	25.6	40.6	34.5	61.9	32.9	26.8	33.4	50.8	78.2	7.1	38.9	37.9	43.8	51.2	32.7	49.5	16.0	46.4	11.0	14.5	55.9	25.6	12.4	27.4	23.8	29.0	28.0	47.0	47.4	14.1	25.5	20.5	24.0	52.9	14.6	89.3	80.8	24.8	38.6	32.5	18.7	42.3	26.8	17.5	25.1	21.5	19.4	10.8	25.6	31.2	25.0	30.3	15.3	142.0	58.6	29.4	24.7	28.3	76.7	39.7	22.0	70.1	20.5	20.9	41.4	48.0	19.2	51.8	44.5	10.3	26.6	29.9	25.9	28.8	32.3	24.3	57.3	38.2	77.0	55.9	29.9	56.0	31.5	7.1	35.3	4.8	31.6	38.9	43.8	50.8	39.2	36.3	48.7	50.0	40.8	42.0	2.7	37.9	27.0	78.2	36.3	51.2	42.5	46.4	26.2	54.2	37.7	33.6	37.1	29.3	26.7	25.6	56.6	57.1	131.8	167.2	171.7	49.1	10.9	119.8	60.2	96.7	120.4	17.7	208.0	303.4	170.3	42.0	112.3	43.9	23.3	260.6	296.0	121.9	161.1	78.4	142.5	155.5	28.6	121.6	77.3	74.8	92.9	124.8	98.1	138.3	123.6	126.5	46.8	190.5	31.6	91.6	215.9	23.6	58.2	119.3	92.2	127.8	212.3	139.6	90.9	179.9	243.4
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 93.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.4;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	7.4	1.1	6.0	5.4	5.7	0.2	2.4	3.7	8.6	2.2	46.3	4.3	3.4	13.4	3.0	11.2	10.0	0.9	7.2	18.4	4.8	3.4	17.4	19.5	15.0	2.0	4.2	1.3	1.2	4.6	2.8	1.7	3.5	6.3	1.7	10.0	7.9	3.4	0.4	2.3	10.5	93.0	3.0	2.8	2.0	6.8	1.6	1.6	0.2	1.2	3.6	1.7	2.4	3.9	0.1	1.2	1.0	3.8	0.1	0.1	0.7	2.6	2.3	16.6	6.9	4.8	6.0	6.2	2.4	1.1	0.9	0.8	3.0	1.5	0.0	3.1	2.0	1.6	6.1	10.0	6.2	0.4	0.2	6.7	1.6	1.1	22.4	7.2	5.9	1.2	8.6	3.5	0.4	7.2	0.9	11.7	0.9	0.0	0.9	3.6	5.2	0.6	0.4	6.6	1.5	4.4	6.8	1.7	0.5	5.7	6.8	6.3	0.0	2.5	5.2	16.7	11.5	1.6	1.9	31.9	2.3	2.3	2.3	6.5	0.6	1.2	0.0	0.2	2.4	12.8	1.0	3.4	0.5	0.1	3.8	0.1	0.1	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	3.8	0.7	0.0	0.7	6.0	5.7	3.7	3.5	4.8	3.4	4.2	1.3	6.3	1.6	56.6	50.9	0.8	2.4	38.0	0.7	20.3	5.1	25.4	12.5	27.9	27.5	12.0	8.3	3.0	0.8	8.3	65.2	0.0	3.1	3.0	11.6	3.5	8.1	32.7	3.9	35.0	19.4	29.4	6.7	0.0	0.6	3.8	20.3	0.0	29.8	14.7	3.5	45.6	0.0	12.9	0.9	6.5	4.6	0.0	0.7	43.0	36.3	0.9	40.2	7.4
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	15.1	10.8	9.2	12.2	12.1	11.0	13.7	13.7	11.1	24.1	17.7	17.4	16.4	27.7	15.4	12.7	10.1	15.2	17.3	21.8	30.7	7.3	13.9	14.4	7.7	22.8	11.9	31.6	9.5	11.8	17.4	22.1	24.5	7.5	13.2	15.0	28.5	5.0	16.6	18.6	19.0	23.2	26.8	14.0	12.6	27.6	9.5	25.3	14.8	11.3	11.7	16.7	27.5	8.8	16.9	10.9	12.0	19.4	11.5	17.6	15.5	13.1	25.3	15.3	11.6	67.8	10.2	18.9	17.5	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5	3.0	10.1	24.6	46.2	47.7	8.2	4.8	17.8	29.4	18.2	19.2	15.7	27.5	18.3	30.3	29.3	22.4	13.8	0.0	22.6	28.1	22.2	16.9	17.3	9.6	21.6	11.1	2.9	18.4	10.8	29.4	15.8	15.5	18.6	16.2	11.7	8.8	30.2	17.5	16.3	21.4	6.9	12.9	19.8	31.2	39.4	45.9	21.4	27.7	16.6	36.0
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943772	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	13.9	17.5	12.2	11.2	16.8	15.9	14.0	11.6	16.9	13.0	13.2	15.6	9.9	10.1	16.2	12.4	12.0	15.2	14.0	15.5	12.9	14.0	14.8	19.5	12.6	14.1	14.5	9.7	23.9	13.5	14.1	21.7	18.1	16.6	16.0	8.5	10.3	13.9	15.0	23.9	13.5	13.7	12.0	19.5	15.8	12.3	11.8	16.7	20.1	16.4	11.6	12.2	17.9	15.3	11.8	9.7	16.5	8.0	7.0	8.1	4.4	6.3	7.6	6.1	5.5	4.9	8.3	8.3	4.9	4.6	6.2	4.7	4.6	4.9	6.5	7.8	4.4	7.8	4.6	11.4	4.6	5.4	8.9	10.9	3.1	5.3	4.0	6.5	7.3	6.3	5.7	8.0	5.8	5.0	6.4	4.3	7.8	7.5	6.3	4.8	7.8	8.0	10.4	6.0	5.0	9.9	8.3	6.7	8.4	3.4	2.4	6.9	8.4	9.7	4.7	10.0	3.7	4.2	6.6	6.5	4.4	2.2	10.4	6.3	8.0	6.4	7.4	6.1	6.9	6.4	11.3	8.0	10.8	6.9	5.9	6.8	9.7	8.1	6.5	6.0	11.8	8.1	7.5	16.5	7.0	6.6	9.7	7.5	4.4	12.2	16.8	11.6	14.6	12.9	14.0	14.5	9.7	16.6	16.7	20.8	36.8	31.3	29.8	23.0	31.8	24.6	17.8	53.5	42.1	19.2	23.6	52.3	31.5	32.4	6.3	40.4	20.0	23.3	38.4	96.9	34.2	30.7	45.2	40.3	46.7	52.4	21.9	35.6	26.7	5.0	41.7	39.0	33.7	35.1	23.0	50.3	32.5	24.1	51.9	32.9	36.1	12.9	39.1	33.7	68.2	25.1	61.0	34.9	24.1	27.3
NKIRAS2	"DKFZP434N1526, kappaB-Ras2, KBRAS2"	ENSG00000168256	"NFKB inhibitor interacting Ras like 2"	Q9NYR9	17	42011382-42025644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062861			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062861: AB_2684884"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (9.37e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.42e-3)"	15.3	10.9	6.7	11.5	8.4	12.5	12.9	9.2	10.3	12.0	14.6	11.0	10.3	8.7	15.4	12.5	22.0	10.5	14.1	27.5	6.1	5.6	14.0	16.1	11.7	10.4	8.5	3.6	14.9	10.7	8.4	9.0	30.8	7.2	12.5	9.9	14.6	12.3	11.1	31.5	16.1	15.6	15.7	8.3	12.4	11.3	17.1	6.0	17.7	9.5	15.4	19.1	14.5	12.7	8.2	23.0	21.0	25.5	12.0	7.4	10.4	9.2	15.9	24.5	12.7	17.2	11.6	14.6	15.7	11.9	24.7	18.5	17.3	13.0	15.3	24.8	15.9	16.4	19.5	19.8	11.8	12.6	12.7	21.6	13.7	14.8	12.7	27.0	18.2	11.3	17.2	21.0	16.3	12.6	16.4	29.9	19.5	19.3	15.5	14.0	9.1	35.1	11.3	14.4	11.9	12.2	27.7	28.2	14.3	15.9	9.5	29.4	38.5	11.5	34.8	15.5	25.0	22.1	22.1	21.6	15.6	16.7	16.7	17.5	20.4	33.0	12.6	10.4	10.9	21.8	21.0	25.5	20.5	7.0	20.5	6.9	7.8	7.1	7.0	20.5	8.2	7.4	7.1	14.4	12.0	21.5	23.0	6.0	10.4	6.7	8.4	9.2	10.3	6.1	5.6	8.5	3.6	7.2	6.0	14.9	9.3	12.9	16.9	15.0	20.3	22.4	2.5	8.1	17.0	15.7	19.6	45.4	18.3	25.5	5.4	22.4	18.3	0.0	24.7	32.7	21.6	17.9	13.9	13.4	33.2	22.3	18.4	12.3	22.5	4.0	18.1	26.6	10.1	33.3	17.6	22.0	22.8	14.0	17.3	15.0	25.1	6.5	19.6	28.1	33.2	22.5	52.1	10.0	14.0	18.0
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	11.0	11.2	6.6	7.7	5.8	5.9	10.1	6.7	5.5	9.1	9.9	11.9	9.5	19.6	11.8	5.8	7.8	13.0	27.7	10.3	11.2	9.8	18.9	10.3	13.4	7.9	5.4	20.0	8.0	6.2	8.5	10.5	12.3	6.2	9.2	9.7	11.1	8.3	8.1	17.0	12.7	16.0	14.8	16.1	12.6	10.0	9.5	20.1	12.0	8.2	10.9	9.1	9.4	14.7	9.9	7.2	6.2	12.2	7.5	5.8	6.2	12.4	16.8	6.8	8.2	20.7	6.0	22.4	6.5	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5	6.0	6.2	9.0	9.2	17.2	13.3	4.0	10.2	2.7	2.3	5.2	25.5	11.6	1.7	3.8	0.1	4.5	2.6	0.0	3.1	13.2	6.2	8.4	14.9	3.4	5.6	7.9	10.3	4.3	6.0	0.0	7.2	7.8	5.0	6.4	3.8	4.0	3.1	0.0	6.3	3.7	8.3	0.0	8.2	0.5	1.1	22.5	12.5	7.0	5.7	8.7
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235357	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 95.6"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.2	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.0	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	4.9	21.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.3	4.2	0.0	9.3	2.9	0.0	0.0	0.0	4.0	17.3	5.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.1	0.1	0.0	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell type enhanced"	"Detected in single"	18	"Basal glandular cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.5	10.0	0.0	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5	0.0	0.0	0.0	2.3	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.3
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678693-23682927	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 95.3"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 52.8;Glandular cells: 96.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"eosinophil: 23.5;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 16.9;SiHa: 16.7;U-138 MG: 17.0;U-251 MG: 14.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	0.6	1.3	0.3	0.6	0.9	0.6	1.5	0.1	0.8	1.1	0.6	0.2	0.5	0.5	0.7	0.5	1.2	0.7	0.8	2.4	0.8	0.3	0.4	1.6	0.8	0.7	0.6	0.2	1.6	0.6	0.5	0.4	0.3	1.2	95.3	0.2	0.5	17.9	0.7	2.0	0.2	0.4	0.7	0.6	0.3	0.5	12.3	0.7	0.0	0.6	3.2	20.5	0.7	2.5	1.0	0.0	23.5	0.0	0.2	1.2	0.1	3.0	2.3	0.0	5.6	2.1	0.5	4.6	4.2	2.7	9.0	10.7	1.3	3.5	0.0	0.6	3.1	16.9	0.8	2.2	4.8	7.1	0.0	1.1	2.1	1.7	3.4	4.0	0.0	0.8	0.8	1.3	9.1	0.5	5.6	0.5	12.9	0.1	0.0	3.5	1.0	7.3	0.6	1.3	0.0	1.6	0.0	3.6	0.3	0.5	3.6	1.1	0.3	16.7	3.1	0.3	6.8	2.2	0.3	0.6	17.0	6.0	1.3	14.5	0.0	0.0	0.0	8.3	1.6	2.0	3.4	0.0	23.5	0.5	0.0	0.1	1.0	0.2	0.5	0.0	0.9	0.7	1.2	23.4	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.8	0.8	0.3	0.6	0.2	1.2	0.7	3.0	4.0	0.5	52.8	4.9	1.7	7.0	0.0	1.4	5.7	0.0	7.9	0.3	0.0	2.4	2.0	6.8	0.4	0.0	6.1	1.2	4.1	96.8	0.0	3.8	0.2	3.2	6.3	4.9	0.3	4.5	2.0	2.9	1.7	1.0	0.4	4.3	4.7	0.0	6.0	0.5	4.5	0.0	13.3	0.7	1.4	1.8	0.2	0.5	0.5	9.3
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.2	20.0	6.7	12.0	4.2	6.3	10.8	7.4	7.0	13.3	11.0	13.8	8.0	18.2	10.2	6.2	9.7	11.0	15.3	19.0	9.1	2.9	23.8	8.2	9.6	17.2	5.7	15.7	6.6	7.1	10.2	13.7	21.0	5.9	8.5	17.9	22.0	6.7	7.8	11.3	24.1	12.8	12.7	6.9	8.9	19.5	11.8	20.1	7.8	8.0	13.9	8.4	7.0	7.2	8.8	6.5	17.6	11.4	7.6	7.2	10.1	6.9	24.8	5.2	4.0	15.3	5.0	13.0	13.7	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4	3.0	0.6	12.4	6.2	7.7	4.1	2.0	12.7	4.0	3.4	3.5	2.0	9.0	0.0	8.7	0.6	4.2	1.6	0.0	12.9	16.0	8.2	4.0	3.5	5.5	6.7	1.6	4.7	4.3	2.8	4.7	3.7	2.2	1.7	3.6	7.8	1.4	9.4	2.9	4.6	5.6	2.9	0.0	4.1	3.6	5.3	8.8	4.1	4.4	12.0	5.1
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 371.4;Muller glia cells: 111.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.7;Karpas-707: 42.0;U-266/70: 21.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	19.5	2.5	2.4	39.9	3.1	15.1	16.4	0.9	2.8	19.1	6.1	5.3	5.6	4.0	16.2	10.2	12.4	7.6	15.5	8.6	4.9	1.8	6.3	3.4	19.1	31.2	4.2	1.9	4.5	2.3	2.2	2.9	8.3	5.2	10.2	5.7	6.3	8.1	11.3	17.8	35.2	18.3	13.1	6.8	34.4	4.4	6.9	3.2	15.9	13.7	11.9	30.8	17.5	16.8	5.3	4.6	16.8	7.5	3.8	7.0	3.7	6.3	0.0	0.0	0.0	3.4	4.7	0.7	2.6	2.5	1.0	2.2	0.1	2.4	2.2	9.9	2.5	0.3	2.8	0.0	10.3	1.6	23.7	0.0	0.6	2.0	0.2	3.1	0.0	0.7	2.8	6.6	8.7	6.4	3.5	11.1	0.4	5.5	42.0	5.1	0.0	0.0	1.8	0.0	0.0	0.1	2.4	1.6	9.9	0.0	2.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.2	10.8	2.2	1.3	1.3	0.4	21.0	6.7	1.7	3.6	0.3	0.1	13.8	6.3	4.4	6.0	4.5	6.6	4.4	4.9	6.1	4.6	5.3	5.5	5.0	16.8	3.8	7.5	0.4	7.0	3.7	2.4	3.1	0.9	2.8	4.9	1.8	4.2	1.9	5.2	3.2	0.0	8.5	24.6	6.0	15.8	56.5	3.9	2.5	10.7	15.9	7.0	3.9	0.6	3.3	0.4	371.4	16.8	0.0	0.0	0.0	0.8	24.2	1.2	3.5	0.2	6.0	81.0	74.8	31.9	19.2	46.3	23.6	25.8	6.8	1.0	0.0	111.8	5.1	0.0	26.5	0.4	10.1	6.5	13.3	14.2	10.0	21.8	1.3	35.5	0.0	7.6
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7959424-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 13.2;skin 1: 10.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4"	"Region enhanced"	"Detected in some"		"olfactory region: 2.6"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	2.7	1.3	2.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	6.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.3	6.1	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6	6.0	9.0	0.0	0.7	0.3	0.8	0.4	0.0	4.0	6.8	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.4	0.7	7.0	0.0	2.4	0.0	0.0	0.0	12.3	0.0	0.3	6.1	1.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.9	12.8	12.7	12.9	15.9	21.9	17.5	25.2	19.1	18.8	22.0	21.7	18.2	28.0	32.2	17.6	13.2	14.5	20.2	18.5	29.5	29.0	12.4	28.8	11.3	13.5	17.5	34.6	17.5	18.3	13.8	13.3	44.0	20.2	20.4	9.8	21.1	15.5	22.2	50.2	15.6	13.2	15.9	26.6	20.5	19.3	18.3	28.3	17.9	49.9	20.2	12.6	14.3	35.2	20.8	14.4	26.2	15.9	17.8	15.1	10.8	17.2	30.3	25.6	17.2	28.7	18.8	22.6	20.5	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1	17.9	13.4	25.1	43.8	57.7	23.4	39.6	20.4	16.0	17.0	10.4	13.7	29.3	29.9	22.3	12.2	23.2	13.4	0.0	33.9	37.0	34.9	39.0	25.3	38.5	21.3	28.6	13.2	20.9	32.4	4.7	23.6	22.5	23.6	25.2	17.7	12.3	30.1	10.5	25.8	26.9	18.0	25.8	91.0	30.3	26.0	65.0	47.4	25.9	18.8	62.7
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.9	0.0	0.8	0.0	3.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	25.6	0.0	5.9	2.2	0.0	0.7	3.8	1.5	0.5	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8	6.0	6.9	0.0	9.1	0.6	11.4	2.8	2.5	327.9	26.1	31.4	13.7	0.4	72.9	18.8	516.0	3.4	0.0	0.0	3.6	0.0	3.2	7.9	0.0	0.5	0.1	6.4	5.2	1.3	0.0	184.0	8.3	0.7	10.1	1.0	2.5	15.8	5.2	0.0	13.1	66.5	21.6	0.0	1.0	142.0	20.4	0.3	0.0	0.0	1.1	5.6
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.9	5.4	0.3	0.0	3.1	8.5	10.7	3.2	7.5	15.4	23.5	1.1	25.0	10.7	11.9	4.8	5.1	6.3	1.1	2.8	3.9	22.7	0.6	30.1	5.6	0.6	13.2	28.5	8.7	5.5	3.8	9.2	2.1	6.8	19.0	11.9	14.9	2.6	2.9	8.4	23.9	42.6	6.3	2.2	8.1	25.8	0.6	9.2	12.7	9.5	1.5	0.0	6.7	7.3	4.1	1.1	1.2	32.5	10.3	2.2	5.0	7.2	4.6	0.4	0.4	0.6	5.3	34.3	2.4	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4	23.8	19.8	16.0	18.1	14.8	0.2	3.1	15.3	38.8	27.3	12.2	0.0	62.5	13.3	54.5	2.6	35.8	24.2	0.0	36.0	53.3	19.2	13.1	34.7	16.0	71.3	0.0	17.3	17.2	39.1	0.0	18.1	53.0	1.7	45.9	20.9	5.8	34.1	23.0	13.1	20.9	0.0	6.5	14.7	3.3	1.7	15.6	45.5	40.7	19.5	19.2
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.8	4.7	6.6	6.3	12.6	11.4	1.6	7.5	6.2	8.8	5.7	2.0	6.5	4.1	4.9	11.4	3.7	3.9	8.0	10.8	10.6	8.4	4.1	6.7	2.9	6.2	10.0	5.5	6.6	12.1	12.1	10.6	15.3	8.3	9.2	9.0	7.8	2.7	9.7	6.5	3.1	3.5	0.8	8.6	8.5	3.6	4.0	2.1	10.2	2.1	4.7	2.5	9.9	8.5	8.5	3.6	3.2	5.9	8.6	3.7	3.2	7.4	3.5	3.9	3.7	4.0	6.2	11.6	7.4	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3	3.0	4.1	1.7	5.2	2.1	7.7	11.8	5.1	8.1	3.4	7.0	5.9	8.3	19.9	7.9	5.8	6.8	17.0	0.0	6.0	4.2	3.7	4.5	4.6	7.3	11.2	9.5	2.9	6.7	6.9	3.2	6.1	8.6	5.0	11.8	7.7	8.5	6.4	3.5	6.0	11.3	6.3	6.5	4.2	11.1	8.3	1.6	7.6	2.9	12.8	4.1
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Cell type enriched"	"Detected in single"	1346	"Cardiomyocytes: 751.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 22.8;NTERA-2: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	751.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.4	23.1	5.1	8.0	2.6	2.7	26.2	8.6	4.4	10.6	5.8	18.8	5.9	19.1	9.5	4.4	6.3	11.2	9.1	9.4	2.3	7.5	25.0	12.8	7.6	12.3	6.8	14.9	15.0	4.0	6.5	8.3	6.7	4.0	7.4	14.7	21.7	4.4	4.3	14.6	14.2	35.1	15.0	7.3	18.4	18.5	5.7	16.7	5.5	9.2	12.6	10.0	7.3	10.0	6.3	3.1	14.0	9.3	9.8	6.3	16.1	10.1	14.3	11.2	6.9	16.7	9.7	12.9	13.3	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6	8.9	7.8	13.0	13.7	19.8	7.9	6.0	25.5	0.0	3.4	3.5	0.0	28.1	6.6	25.9	57.6	11.1	15.2	0.0	28.5	27.4	15.4	9.4	16.1	9.5	22.0	7.9	7.0	11.6	11.0	60.3	13.6	14.1	13.5	13.6	11.1	6.7	23.0	8.6	7.4	16.5	5.0	19.4	14.4	37.9	50.3	18.9	25.5	14.9	16.2	11.9
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	16.3	22.6	13.0	3.2	19.6	1.3	9.4	7.3	14.1	8.4	7.1	10.8	19.7	5.3	7.5	10.5	15.4	7.8	15.7	29.1	11.1	8.3	10.1	12.8	10.1	2.6	15.9	12.3	6.8	12.3	22.8	14.8	8.6	12.7	19.8	6.1	13.8	18.0	13.3	76.1	39.7	5.2	10.6	11.6	3.7	11.1	2.7	15.8	0.6	9.6	27.7	6.3	9.4	9.2	0.0	2.1	1.5	6.8	0.7	3.4	2.5	6.2	10.2	1.7	9.6	8.6	6.5	9.6	5.0	5.4	5.5	3.3	2.2	16.5	0.1	16.8	5.9	1.4	10.5	2.3	7.8	1.3	5.6	3.6	0.2	8.1	3.2	5.4	0.5	1.3	4.0	14.5	4.3	3.1	15.8	2.3	2.2	2.2	6.6	10.3	16.2	0.1	0.8	1.6	5.7	25.2	5.6	3.6	12.4	9.3	1.9	13.6	7.3	21.2	15.4	2.2	2.3	32.8	1.7	5.3	7.3	6.2	7.1	4.3	9.7	3.0	1.7	20.6	1.6	2.4	0.0	6.8	0.0	0.3	0.6	0.1	0.0	3.4	0.3	2.1	0.0	0.0	0.5	1.5	0.7	0.2	2.1	0.0	2.5	13.0	19.6	7.3	14.1	11.1	8.3	15.9	12.3	12.7	15.8	26.8	25.2	2.2	26.4	12.2	16.6	45.2	33.1	8.1	13.6	3.5	15.7	7.0	13.3	54.2	0.9	10.5	15.3	0.0	30.2	9.9	15.1	25.5	2.3	27.7	9.5	52.4	21.5	8.0	5.1	0.4	23.3	3.1	20.3	20.8	17.6	28.3	36.8	10.5	28.3	17.3	46.0	12.9	36.2	0.2	1.1	17.2	9.3	2.2	13.7	21.4
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.6	22.6	8.6	19.5	13.5	9.3	14.8	17.5	13.1	20.5	17.2	24.9	5.8	27.3	8.0	19.6	9.0	11.0	25.0	25.1	21.7	17.3	10.4	14.0	26.3	13.8	13.3	31.9	20.6	10.3	20.8	27.1	26.2	8.5	13.4	10.1	22.8	10.5	16.2	13.8	17.8	32.1	31.2	17.5	20.6	15.4	8.5	14.2	15.8	18.8	10.2	14.1	14.6	18.9	6.2	9.6	7.6	18.6	14.9	12.6	17.0	15.8	30.4	10.0	14.0	23.1	11.2	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8	3.0	14.6	4.5	5.1	17.7	4.5	5.5	7.6	4.0	11.4	3.5	5.9	3.4	3.3	6.7	17.3	6.0	2.3	0.0	3.4	4.8	4.1	6.5	3.5	6.7	4.4	3.2	9.8	3.7	1.2	17.9	5.5	2.7	5.0	1.8	4.1	4.2	4.9	0.0	5.6	2.1	3.5	0.0	5.1	2.3	6.1	22.6	2.5	5.0	6.8	7.4
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.3	13.9	8.3	17.1	11.2	12.7	14.5	15.1	10.8	15.8	13.0	18.1	17.3	46.3	10.7	12.2	11.5	11.3	22.8	19.6	17.0	8.8	21.8	36.8	13.2	16.4	14.8	39.9	16.1	12.8	17.7	17.8	16.3	7.8	13.2	14.3	33.3	16.5	11.8	11.7	42.1	30.1	21.6	15.1	22.8	27.3	12.6	15.4	7.9	26.4	17.2	10.1	12.5	9.3	11.8	7.9	17.8	15.8	16.4	13.2	7.7	16.1	27.7	12.4	19.9	40.0	13.8	29.6	13.7	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4	17.9	22.5	10.4	13.9	23.0	9.0	18.2	15.3	17.4	35.2	1.8	13.7	12.7	10.0	12.9	1.7	14.3	3.6	0.0	20.6	13.2	7.6	9.5	19.7	23.1	9.9	19.1	8.6	9.2	3.2	2.1	11.5	11.3	0.0	15.4	9.7	6.0	16.8	8.6	9.2	10.1	7.1	12.9	13.3	9.2	20.6	28.4	9.6	12.5	13.4	14.8
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.9	19.2	19.0	23.6	14.2	12.8	45.0	26.0	14.0	20.1	18.8	42.3	24.4	41.8	21.7	15.7	25.1	25.1	37.6	32.0	35.5	16.3	34.5	50.4	28.8	41.6	21.1	49.8	24.3	16.5	19.1	28.0	64.3	10.9	18.0	24.9	55.0	31.9	25.1	28.7	45.4	55.1	47.4	30.1	33.3	38.4	28.7	55.1	23.7	32.7	29.3	21.7	24.1	34.7	29.9	31.8	23.7	39.4	15.5	25.7	30.2	22.9	44.4	26.0	47.4	59.8	19.0	35.5	30.5	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8	101.3	103.5	73.0	102.7	76.2	27.1	68.8	38.2	96.4	150.2	38.4	39.3	67.7	24.9	45.7	11.5	57.0	15.0	23.3	58.3	76.0	49.7	70.7	131.9	44.1	43.1	23.8	33.8	29.4	17.4	7.9	40.0	46.4	23.6	73.1	32.3	17.7	45.7	10.5	28.0	32.1	43.5	25.8	81.9	59.1	54.7	65.4	56.9	61.8	56.1	83.8
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	13.1	0.1	8.2	0.1	0.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0	0.0	0.0	0.0	7.9	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	1.0
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069774-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 192.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 6.9;HaCaT: 5.2;HEL: 8.3"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	2.1	7.9	10.2	1.6	7.0	4.8	6.2	23.1	34.1	2.4	3.7	3.1	7.1	2.7	2.4	1.7	2.2	2.6	7.4	2.3	19.0	10.1	2.9	7.6	2.3	1.4	6.5	13.0	1.6	3.5	2.0	2.7	2.2	5.5	2.5	3.9	2.7	4.6	9.7	1.7	2.4	3.1	2.1	4.4	1.3	3.8	4.0	3.1	0.0	1.6	0.2	1.8	1.8	2.2	0.0	0.1	1.1	0.5	0.0	0.3	0.1	6.9	0.0	3.2	1.9	0.1	0.0	0.5	0.6	0.8	0.9	0.8	1.5	1.7	0.0	4.4	0.2	1.1	5.2	1.1	0.2	0.3	0.1	3.2	8.3	1.2	1.7	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.9	1.7	1.0	0.6	0.1	0.1	3.6	0.6	0.0	2.4	1.1	3.1	0.1	1.3	0.2	1.5	2.3	2.6	1.8	1.6	0.3	1.2	0.9	1.9	0.4	0.8	0.1	0.8	0.0	1.2	4.7	0.0	0.0	1.1	0.1	0.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	10.2	7.0	23.1	21.1	19.0	10.1	6.5	13.0	5.5	3.1	0.0	0.3	0.0	5.3	2.6	8.5	1.9	2.5	1.4	1.2	21.0	192.4	0.0	8.3	0.9	24.7	1.6	3.8	0.0	1.0	0.2	1.2	9.9	0.0	19.5	0.1	63.5	6.4	2.5	0.6	8.0	4.0	0.0	0.0	0.0	7.3	20.7	0.6	5.5	6.7	0.2	2.2	6.5	0.3	1.9	1.3	1.8	0.5	0.0	4.4	6.4
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	15.0	5.1	7.9	6.1	33.0	28.3	7.9	11.5	15.9	15.4	16.7	4.7	4.1	0.3	9.7	21.8	13.7	5.7	12.5	10.2	24.6	18.1	8.0	8.7	13.7	0.4	12.3	9.1	2.3	22.7	6.6	46.1	30.7	23.3	7.8	4.1	0.1	19.2	18.5	16.9	3.8	2.6	10.2	1.4	5.7	2.5	27.9	9.7	8.1	9.6	0.3	4.0	15.6	14.7	8.3	16.7	8.1	3.1	27.4	20.1	13.9	30.1	18.0	8.0	3.9	4.4	29.5	8.4	19.1	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4	32.8	21.6	24.1	40.5	41.1	3.5	11.2	25.5	2.7	13.6	17.4	5.9	1.2	0.0	37.1	15.7	3.7	3.0	0.0	11.3	6.7	53.5	36.6	15.1	35.0	29.9	3.2	5.8	5.5	68.6	9.3	50.9	36.3	37.1	13.6	7.5	46.7	22.9	129.8	80.2	4.3	10.2	19.4	32.3	4.8	3.6	77.8	1.4	13.6	13.8	52.7
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202258-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034660, HPA063906"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034660: AB_10601974, HPA063906: "						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.2	0.8	0.3	0.6	0.4	2.3	0.3	1.4	0.2	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.6	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.1	0.0	0.4	0.1	2.4	1.3	0.3	0.6	0.2	0.1	0.5	2.2	2.7	0.1	0.5	0.5	0.5	5.7	0.1	0.7	0.1	0.1	0.1	0.4	0.1	0.8	0.8	2.6	0.8	1.4	1.0	0.3	0.2	0.2	0.4	0.5	0.2	0.3	0.7	0.3	0.0	0.1	0.2	1.1	0.8	0.3	0.2	0.3	0.3	1.1	0.1	0.4	0.5	0.8	0.4	0.5	1.8	0.7	0.0	0.6	1.4	0.2	0.4	0.1	0.0	0.3	0.0	0.5	0.1	1.0	0.0	0.6	0.1	0.4	0.7	0.0	0.5	0.7	0.2	0.3	0.1	0.8	0.9	0.6	1.1	0.8	0.0	0.6	0.7	0.6	1.3	0.8	0.4	0.2	0.7	0.7	0.2	0.8	0.3	1.0	0.2	1.9	0.8	0.3	0.6	0.3	0.9	0.6	0.8	0.5	0.3	0.8	0.8	1.0	2.6	1.4	0.5	0.8	0.5	0.3	0.3	0.4	1.4	0.2	0.2	0.6	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NOVA1		ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443093-26597754	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 25.9;ASC diff: 14.1;HAP1: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	17.8	6.7	17.5	3.4	17.4	1.3	32.9	54.7	49.2	12.2	6.3	13.3	5.0	2.5	9.4	6.9	4.0	6.2	6.2	3.0	17.1	25.1	7.0	2.2	2.7	4.4	19.2	17.8	6.3	2.7	4.4	14.1	1.3	26.4	5.4	6.5	4.0	2.8	17.5	6.9	3.1	3.4	9.9	22.5	2.1	3.3	10.3	14.9	0.0	4.1	2.7	5.2	5.6	9.4	0.3	0.3	0.6	0.4	2.2	0.5	0.0	0.0	6.1	25.9	0.0	14.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.4	4.2	0.1	12.7	0.1	0.0	0.0	1.0	0.0	0.0	0.2	5.3	0.0	1.2	9.4	0.0	1.9	1.9	9.4	5.4	5.4	0.0	0.0	4.1	0.0	5.3	0.1	7.6	0.0	6.1	0.7	8.6	0.1	3.6	4.9	8.3	4.8	0.0	0.0	0.0	2.6	0.7	0.0	0.0	3.6	4.2	3.1	0.7	0.0	0.0	0.0	5.1	0.0	3.8	0.6	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.5	0.6	2.2	0.4	0.3	0.4	0.0	17.5	17.4	54.7	26.9	17.1	25.1	19.2	17.8	26.4	14.9	0.0	1.0	0.0	6.8	4.6	198.3	0.8	2.5	8.1	0.0	14.0	3.9	0.0	8.3	0.0	14.7	6.2	0.5	0.0	0.3	0.0	12.1	2.1	0.0	0.2	0.2	128.7	63.4	35.0	1.2	11.2	139.2	1.9	3.3	0.0	2.3	26.6	3.1	10.5	61.9	20.4	13.0	6.5	19.8	170.1	57.9	2.8	0.0	0.0	3.7	0.6
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222642	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	15.7	9.8	8.5	18.6	11.5	7.1	12.0	24.6	12.8	13.1	9.3	7.5	8.9	7.1	12.0	10.7	10.3	10.7	8.2	9.4	7.8	8.7	10.1	9.5	11.5	23.1	10.7	8.9	15.2	9.1	14.6	21.5	18.3	13.1	10.7	11.0	7.9	11.6	8.4	8.8	12.2	12.2	9.0	13.7	17.1	10.0	11.3	11.1	26.7	14.4	7.5	21.6	15.4	10.7	5.2	2.2	7.4	3.1	5.8	11.6	3.6	5.0	4.1	6.4	8.0	8.0	5.9	5.2	7.5	9.6	6.7	10.1	8.4	11.0	8.7	10.2	4.7	7.5	9.5	8.8	7.7	12.1	7.7	3.5	14.4	4.5	4.3	3.4	10.8	9.6	5.5	4.5	11.8	7.6	5.2	9.4	10.2	13.3	4.3	9.3	2.5	13.2	5.8	5.3	8.1	5.7	9.1	9.1	11.9	4.4	7.4	6.9	6.3	9.7	5.8	7.5	7.1	6.6	5.3	7.7	11.7	6.2	6.9	6.8	3.0	3.7	34.0	2.9	8.0	9.0	7.4	1.7	3.2	6.2	3.1	6.9	4.9	7.2	7.8	2.2	5.2	11.6	9.2	2.2	5.8	3.0	1.7	5.2	3.6	8.5	11.5	24.6	12.8	7.8	8.7	10.7	8.9	13.1	11.1	17.9	10.4	14.6	16.1	14.4	16.6	12.5	2.5	10.7	14.8	12.2	27.5	8.3	1.7	7.3	2.6	17.4	5.4	0.0	5.9	7.4	13.6	12.2	18.5	8.5	6.2	9.5	9.9	20.9	11.2	2.6	14.7	12.4	8.5	8.2	8.2	11.4	5.5	7.0	15.9	4.1	17.4	6.5	8.5	24.1	30.6	11.5	11.8	25.3	8.6	11.9
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.7	4.6	7.4	15.0	11.6	10.5	9.3	20.2	9.9	21.5	7.1	7.8	4.5	7.2	13.4	33.8	15.0	5.8	16.0	8.8	3.5	4.6	1.6	9.7	16.0	21.4	6.1	7.4	11.1	15.9	20.9	70.4	19.6	9.7	5.2	4.8	12.1	11.1	8.1	2.5	3.6	3.2	6.1	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.2	13.7	7.4	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.3	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4	23.8	44.3	6.2	23.3	8.2	5.0	4.4	10.2	0.0	15.9	8.7	17.7	11.6	0.0	9.3	1.1	11.4	11.3	0.0	12.8	6.2	6.5	30.4	10.4	7.9	25.1	3.2	3.5	7.4	9.2	1.4	8.3	17.9	11.8	2.8	4.8	16.2	23.5	14.0	9.9	4.7	12.4	0.0	9.0	12.6	20.4	12.7	19.9	20.3	4.5	51.4
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039470-137046203	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4"	"Lineage enriched"	"Detected in many"	7	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	35.4	21.7	33.1	11.9	35.5	4.1	21.6	59.7	65.6	27.8	27.1	18.4	23.8	22.2	26.7	10.8	11.6	25.4	32.3	20.4	34.5	35.3	12.7	5.9	18.9	11.5	25.1	49.0	12.0	28.6	17.2	47.7	20.1	29.5	73.1	13.3	10.6	58.0	35.5	19.0	17.7	23.0	16.4	30.3	32.4	59.6	10.4	14.5	0.8	11.5	8.6	7.2	12.8	20.2	0.1	2.0	0.5	0.4	0.1	13.6	2.6	9.4	11.4	2.8	18.4	6.6	6.8	0.7	20.4	6.4	4.6	1.8	4.6	5.2	9.4	15.5	7.8	1.4	35.7	2.4	5.5	0.5	7.6	11.6	3.8	29.2	3.3	9.5	3.3	0.0	4.7	8.6	2.5	5.0	12.0	11.8	3.8	0.2	0.2	0.9	35.9	0.2	0.3	6.1	30.0	19.0	5.6	0.0	36.0	7.8	6.1	22.7	15.7	5.4	18.2	12.2	1.1	39.3	4.7	20.3	3.4	6.2	24.3	6.2	0.0	0.1	0.3	5.0	0.3	2.9	0.0	0.4	0.5	8.4	0.0	10.7	0.1	13.2	13.6	0.7	0.0	0.3	2.3	0.0	0.1	0.0	2.0	10.4	2.6	33.1	35.5	59.7	65.6	34.5	35.3	25.1	49.0	29.5	14.5	0.0	10.6	4.2	65.4	20.9	88.5	13.4	79.0	2.7	4.5	27.9	15.7	1.0	0.0	43.0	1.0	147.8	41.7	23.3	59.4	1.0	34.3	329.4	0.0	0.8	17.1	58.8	270.4	337.0	25.4	2.5	149.3	6.8	28.7	2.8	535.1	32.8	34.0	79.7	136.9	0.3	54.6	38.8	34.0	2.9	19.1	20.7	1.5	7.7	84.8	89.4
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	29.0	38.3	15.3	23.8	18.9	15.7	19.0	24.1	26.9	40.1	37.2	29.0	26.3	21.6	19.4	28.1	29.4	23.6	15.0	20.2	34.9	13.5	19.8	25.0	31.0	25.7	18.1	26.3	31.9	15.5	19.6	37.4	13.4	19.4	40.9	20.2	26.3	32.9	24.2	18.8	35.4	14.3	17.9	14.5	24.2	23.4	24.6	17.6	14.4	28.1	20.5	23.7	30.3	42.3	27.3	30.5	33.1	19.4	29.2	52.7	36.6	28.6	38.6	25.1	17.7	26.6	42.0	17.7	33.8	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4	11.9	17.8	16.0	14.4	15.7	22.7	39.6	12.7	8.1	18.2	19.2	27.5	16.5	1.7	17.6	91.1	20.1	26.2	46.7	32.2	17.3	15.5	19.7	3.5	46.4	16.9	19.1	29.2	29.4	24.0	71.7	16.4	19.3	11.8	19.8	15.0	18.4	36.6	20.1	12.0	20.4	35.3	19.4	16.4	22.3	23.3	21.1	31.0	15.0	15.3	23.7
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411137	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		Yes	No		810000	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	56.8	44.7	29.9	61.1	33.6	76.0	67.0	37.7	34.6	113.5	57.8	24.8	39.3	36.7	78.2	50.5	81.6	65.0	44.0	48.5	28.8	31.6	64.9	78.8	59.5	128.1	36.1	27.9	177.4	102.0	27.1	57.9	65.2	36.1	87.2	49.3	29.5	47.3	48.2	67.9	42.7	52.8	92.4	43.2	85.9	54.0	56.7	31.3	111.3	112.6	66.5	82.1	116.8	65.7	85.3	54.1	12.3	29.1	59.0	126.6	91.4	119.9	81.3	98.8	139.9	60.4	110.3	147.3	109.2	99.8	148.0	133.3	193.9	84.8	321.2	86.8	63.1	99.7	70.4	137.0	248.2	192.8	100.0	108.7	113.3	79.7	142.8	89.5	228.2	94.0	97.3	87.5	100.4	198.1	116.7	110.3	74.8	137.8	73.9	107.4	149.0	148.9	162.3	123.6	64.0	99.9	133.7	109.0	164.6	126.2	84.6	77.9	62.6	65.2	106.8	197.6	72.0	131.0	101.3	68.9	49.5	109.2	56.9	183.8	59.2	107.6	193.2	74.9	185.8	98.7	12.3	26.9	8.4	45.7	29.1	84.6	85.3	85.1	66.2	54.1	62.8	126.6	99.0	4.0	59.0	23.1	48.7	73.2	91.4	29.9	33.6	37.7	34.6	28.8	31.6	36.1	27.9	36.1	31.3	321.6	347.3	775.5	994.0	1243.7	166.1	228.8	387.3	346.6	597.1	307.1	41.2	1400.5	630.0	839.1	64.3	646.8	150.8	116.8	796.2	1641.6	855.4	473.8	427.8	235.7	952.5	120.8	347.6	298.3	500.7	53.0	902.7	605.7	578.6	960.4	654.2	214.7	840.7	333.1	610.9	657.5	112.2	426.9	861.0	695.1	635.2	890.7	1286.9	674.9	783.2	797.7
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 28.1;Cone photoreceptor cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.9	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.9	3.8	1.2	2.8	0.0	0.9	0.0	0.2	13.3	0.3	0.0	1.1	0.1	0.3	10.7	0.7	23.7	2.4	1.4	1.0	0.4	1.8	0.0	0.2	2.9	0.0	7.2	0.3	0.0	0.1	0.0	0.1	2.8	0.6	4.7	0.3	0.2	1.0	0.6	4.4	0.0	2.9	0.2	0.0	0.0	3.5	0.0	0.5	8.4	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4	0.0	1.4	0.5	8.2	0.1	28.1	2.0	2.5	9.4	11.4	0.0	19.6	0.1	3.3	6.3	15.2	0.3	0.4	0.0	7.0	0.2	0.4	3.3	0.0	0.4	3.5	6.4	10.9	2.5	0.0	10.4	0.6	1.2	10.1	1.8	1.5	0.9	5.4	0.0	0.4	9.8	3.9	0.0	1.4	0.5	0.3	1.0	0.2	4.3	0.6	5.8
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"monocytes: 212.8;Proximal tubular cells: 716.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.7	21.6	13.2	29.0	23.3	13.8	14.2	12.4	15.9	11.5	12.9	22.7	4.9	11.2	45.3	21.3	26.9	9.8	13.5	8.6	9.0	26.1	11.5	6.9	26.5	22.7	19.0	6.9	22.1	8.5	10.3	13.9	13.0	16.5	11.1	14.6	39.2	6.7	9.5	28.4	7.9	12.8	17.9	26.9	18.0	14.7	15.7	32.7	17.3	6.8	2.8	5.1	18.8	8.0	39.4	24.7	11.0	4.8	19.1	10.8	4.2	14.4	5.4	14.6	33.1	3.4	12.7	21.0	21.3	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5	8.9	17.3	8.1	35.0	31.3	32.4	60.5	50.9	22.7	10.3	24.4	9.8	36.3	137.6	19.8	39.2	32.9	25.6	23.3	55.3	41.3	45.4	32.3	12.8	167.7	66.5	39.7	4.6	20.3	34.6	38.3	33.1	71.3	64.1	212.8	19.0	47.3	40.8	17.3	38.5	716.7	18.8	25.8	46.2	7.0	10.1	36.0	26.1	17.3	20.9	42.3
NR1H2	"LXR-b, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50382982	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	30.1	27.5	24.5	24.7	27.5	98.0	24.4	20.6	33.5	25.1	30.9	23.1	25.2	30.9	31.2	23.1	27.9	26.9	28.7	36.8	23.8	19.4	27.1	31.4	28.3	23.3	31.7	25.9	26.5	37.6	22.0	18.6	30.5	28.1	27.9	10.5	23.2	33.8	33.8	76.2	25.3	30.3	29.9	22.9	29.9	26.7	21.2	29.1	20.4	27.1	24.4	21.7	33.2	27.6	34.1	34.2	63.0	37.7	22.3	28.6	32.5	16.1	42.5	4.1	10.4	12.2	12.9	13.3	22.3	19.0	13.2	15.2	8.8	15.7	10.4	20.0	13.4	10.6	15.1	2.6	12.2	3.2	25.8	22.9	9.9	14.3	9.1	23.4	16.4	27.3	13.5	16.7	13.6	9.2	13.4	12.0	8.3	16.2	21.6	7.4	17.9	11.7	13.5	8.3	10.3	36.5	7.0	10.8	18.0	11.4	18.1	4.6	16.2	14.5	18.0	14.0	2.4	12.4	13.7	15.2	17.8	14.5	18.2	19.8	27.1	22.3	7.6	35.5	10.8	17.9	39.1	35.9	63.0	27.7	35.0	27.0	34.1	27.4	25.9	34.2	34.1	28.6	24.9	55.4	22.3	37.7	29.5	24.4	32.5	24.5	27.5	20.6	33.5	23.8	19.4	31.7	25.9	28.1	29.1	26.8	27.8	34.4	74.6	38.1	39.5	23.4	25.5	9.4	7.9	29.6	13.7	57.0	54.7	54.4	5.2	46.6	78.1	0.0	63.6	44.7	33.4	68.0	50.6	17.4	46.9	35.0	20.0	20.9	26.7	6.8	42.0	44.5	57.3	84.8	39.8	39.5	60.4	87.7	50.2	46.2	21.7	38.8	58.5	32.5	30.0	40.0	117.1	47.8	32.6	81.4
NR1H3	"LXR-a, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269032	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 54.2;Hofbauer cells: 54.7;Kupffer cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.9;HSkMC: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	74.2	9.4	4.8	12.7	6.9	1.2	22.8	7.0	5.5	10.2	17.9	4.4	7.2	23.1	6.7	10.0	6.6	8.1	9.2	8.5	4.0	2.9	10.3	35.7	13.7	29.4	6.8	5.6	7.5	7.8	4.3	3.5	16.1	4.3	10.1	5.9	6.4	7.1	9.0	6.1	5.1	19.0	7.1	3.4	40.2	7.6	13.7	4.1	6.3	9.7	2.6	10.7	10.8	12.9	1.1	4.5	6.5	14.6	6.1	3.8	2.1	1.6	6.8	3.1	3.0	20.9	22.9	14.7	1.7	8.6	2.8	4.4	8.3	21.5	2.9	3.3	1.4	1.0	4.5	3.7	2.9	1.9	2.7	3.0	3.9	9.0	12.4	8.6	1.4	0.5	29.9	1.8	4.4	2.6	4.9	2.4	4.6	4.8	1.2	1.9	7.1	2.7	7.9	3.4	9.1	2.3	4.0	4.2	1.9	2.5	15.3	3.0	1.0	6.1	4.0	5.1	3.2	9.7	3.7	0.6	2.3	3.1	4.5	1.0	6.0	8.7	3.5	4.2	1.8	1.1	6.5	2.9	2.4	1.5	14.6	2.1	1.1	1.7	1.4	4.5	0.9	1.8	1.5	1.5	6.1	4.5	0.8	3.8	2.1	4.8	6.9	7.0	5.5	4.0	2.9	6.8	5.6	4.3	4.1	0.0	9.9	6.1	6.3	3.0	2.1	4.5	22.9	1.4	5.7	5.2	2.0	9.7	10.0	4.4	23.5	12.0	39.9	0.0	7.5	11.4	9.9	3.2	12.7	54.2	54.7	1.6	1.7	21.5	70.5	33.3	8.3	7.9	3.3	6.4	9.7	4.8	4.0	10.5	5.6	19.2	0.9	19.4	6.4	27.2	16.3	2.0	5.5	2.9	12.1	4.1
NR2F1	"COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583224-93594615	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 216.7;Leydig cells: 86.6;Muller glia cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 57.1;HHSteC: 43.9;hTERT-RPE1: 38.5;PC-3: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	15.8	22.9	22.5	5.0	13.7	1.2	9.1	27.4	25.1	31.7	4.6	12.9	10.8	3.3	20.6	24.1	9.4	32.3	30.7	7.2	20.9	13.7	16.4	10.6	18.0	12.7	13.4	23.0	40.4	4.4	1.8	10.3	46.0	14.6	20.5	3.8	44.4	7.2	38.9	1.2	1.6	4.4	14.2	26.7	6.7	12.9	5.9	11.4	0.0	7.5	4.8	4.2	20.9	18.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	4.7	2.3	57.1	22.6	12.1	3.7	2.7	2.8	1.1	1.7	1.7	0.3	0.8	0.0	0.1	1.1	0.7	1.2	1.4	0.0	0.7	5.8	10.9	2.1	13.8	3.5	43.9	0.4	0.2	17.5	0.0	0.8	0.3	38.5	6.4	0.0	0.0	0.0	5.2	0.0	0.0	0.6	0.0	0.3	47.2	0.6	0.4	0.0	0.3	0.2	5.9	11.9	1.2	0.0	0.1	1.0	0.4	0.8	6.4	9.7	0.4	5.0	6.9	0.0	0.0	0.0	15.9	0.2	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	22.5	13.7	27.4	19.8	20.9	13.7	13.4	23.0	14.6	11.4	0.0	1.7	2.2	0.1	1.1	31.9	15.8	2.5	16.0	5.7	14.0	51.1	0.6	6.6	0.9	1.2	13.7	0.0	0.0	1.4	0.4	39.1	0.4	0.0	3.0	1.0	0.0	0.0	216.7	20.5	2.3	86.6	0.5	0.0	0.0	0.0	68.8	3.2	0.0	9.9	27.4	2.5	12.9	31.6	3.7	2.2	0.5	0.9	0.0	0.0	0.6
NR2F2	"ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 273.8;Leydig cells: 472.6;Peritubular cells: 573.9;Sertoli cells: 478.6;Smooth muscle cells: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	30.8	15.0	19.6	13.8	5.3	0.2	81.2	3.7	6.2	85.7	21.9	2.9	22.3	7.0	70.0	32.6	27.7	32.4	50.8	30.1	12.5	8.4	39.8	15.0	25.0	35.4	7.8	3.4	105.1	7.3	12.3	9.6	24.0	7.1	28.6	9.0	30.5	7.7	43.5	18.4	8.3	10.8	27.2	9.8	63.4	26.9	32.5	4.8	1.1	18.5	16.2	7.0	32.6	34.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	31.6	8.2	26.9	16.6	54.6	18.9	9.0	22.9	17.7	23.9	20.5	28.1	32.4	0.0	18.7	11.5	9.5	19.0	4.7	16.4	30.1	0.1	18.3	10.2	10.5	5.0	15.3	7.8	3.8	13.4	5.7	19.8	4.3	28.2	43.8	0.0	27.3	0.0	15.1	21.8	0.0	5.6	0.2	12.3	11.1	0.0	6.6	0.0	52.1	34.6	3.4	0.0	2.5	0.8	3.4	12.4	13.0	0.5	45.1	26.0	8.6	6.0	8.0	0.0	0.0	0.0	14.5	3.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	5.3	3.7	6.2	12.5	8.4	7.8	3.4	7.1	4.8	26.8	17.8	0.0	24.0	12.8	5.0	27.9	168.2	26.8	26.1	59.3	23.6	98.0	39.7	17.6	2.2	116.4	17.6	0.0	9.4	41.1	54.4	18.3	0.0	43.3	8.9	3.2	25.3	273.8	17.3	5.8	472.6	7.1	25.3	1.0	36.2	33.9	13.5	17.5	573.9	53.6	13.0	478.6	322.1	4.1	3.6	9.2	29.5	2.9	25.5	16.9
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507430	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.7;lymphoid tissue: 50.8"	"Group enriched"	"Detected in some"	10	"Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 39.1;Hep G2: 25.3;K-562: 9.3"	"Region enriched"	"Detected in single"	20	"hypothalamus: 6.1"	"Not detected"	"Not detected"			HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.2	47.7	0.2	0.2	0.5	0.0	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	13.1	0.2	0.0	5.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.8	0.0	9.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	25.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Group enriched"	"Detected in many"	7	"Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.8	1.4	0.0	6.4	0.0	0.1	23.4	6.4	0.2	0.1	0.2	11.8	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	0.0	5.3	0.1	6.9	0.1	0.0	7.7	0.1	2.7	17.2	11.5	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	0.7	11.9	1.9	17.1	0.0	0.0	0.1	1.0	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4	0.0	0.0	0.5	2.8	86.2	0.3	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.7	6.0	10.7	0.0	1.0	0.0	0.6	6.0	0.0	0.0	0.4	0.0	9.8	5.5	0.8	2.9	0.0	0.0	16.9	0.0	15.3	9.4	0.6	31.1	0.4	0.0	2.5	6.5	23.4	0.0	0.8	333.1	0.0	0.0	19.6	5.5
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.9"	"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 238.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 100.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 100.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	15.1	10.0	10.7	16.1	10.2	22.1	21.6	10.9	13.9	12.3	12.3	7.0	9.0	12.4	13.9	9.9	13.9	10.0	13.2	13.6	10.9	9.5	10.6	50.2	19.1	29.4	13.1	8.9	9.2	10.3	6.9	11.5	21.3	11.7	8.7	12.8	6.0	14.8	11.0	46.2	14.6	15.0	10.8	11.7	22.9	10.5	10.0	8.9	16.4	14.2	13.9	14.6	14.6	13.5	7.0	10.0	100.9	13.3	4.3	5.7	7.2	8.9	8.1	8.1	7.4	19.5	30.1	8.1	12.8	21.9	10.3	14.6	17.2	9.6	11.6	6.3	14.3	10.3	7.0	7.9	10.8	14.1	10.4	7.9	8.6	4.2	13.7	25.0	11.3	10.0	27.9	23.2	16.7	41.0	19.3	10.5	7.6	8.7	13.5	13.0	6.6	9.5	20.1	9.4	7.3	33.9	9.3	7.3	6.8	11.8	5.1	4.6	8.0	7.6	14.9	22.2	13.9	9.2	11.3	10.7	7.1	10.5	11.1	13.6	17.0	13.0	14.1	19.9	18.2	5.7	13.8	11.8	22.8	4.5	13.3	4.7	7.0	4.6	4.9	10.0	5.9	5.7	5.3	100.9	4.3	12.5	4.9	5.1	7.2	10.7	10.2	10.9	13.9	10.9	9.5	13.1	8.9	11.7	8.9	3.0	27.1	28.8	40.1	25.5	11.4	6.2	10.2	25.4	19.4	12.2	3.9	45.0	19.9	27.6	5.4	22.2	25.7	0.0	30.6	61.0	36.0	34.9	13.9	47.4	43.7	19.1	15.0	14.7	52.1	5.3	21.6	53.4	43.9	52.3	26.6	14.8	33.1	28.5	20.1	23.0	7.6	19.4	24.5	21.3	67.9	27.9	238.6	37.4	22.2	49.9
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267856-90332137	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	7.3	9.1	7.3	7.7	10.1	16.4	8.0	17.6	9.3	6.9	8.1	10.8	4.4	13.5	14.6	8.0	8.1	7.7	6.3	6.3	6.2	5.4	7.4	9.8	7.1	6.8	8.2	4.2	8.7	7.2	10.6	13.8	11.6	8.5	7.0	6.5	10.8	9.2	6.1	23.5	11.1	9.7	7.3	8.4	8.5	7.9	7.1	8.7	11.3	9.4	4.8	8.3	9.2	10.2	3.3	3.5	6.0	2.7	2.2	2.6	0.6	1.3	2.6	3.6	2.2	0.5	1.9	2.5	2.6	1.8	1.9	2.1	3.2	2.3	2.3	1.4	2.5	2.4	3.4	2.0	3.4	3.5	4.4	3.3	3.0	8.6	2.2	1.0	8.0	4.2	3.5	2.5	1.8	1.1	3.9	1.6	5.9	1.4	3.6	1.7	2.5	3.6	3.4	1.2	1.2	2.1	3.2	5.2	0.9	1.1	5.2	3.3	3.9	1.1	6.9	1.7	1.4	3.0	3.3	2.2	2.9	1.3	1.7	1.1	3.0	3.2	2.5	2.7	1.5	3.3	4.5	2.7	3.4	2.6	1.5	2.0	2.5	1.9	2.1	1.3	3.3	1.9	2.2	6.0	2.2	1.2	3.5	1.6	0.6	7.3	10.1	17.6	9.3	6.2	5.4	8.2	4.2	8.5	8.7	32.8	27.2	20.3	6.2	5.3	73.0	12.2	43.3	12.0	22.7	17.4	82.5	15.8	6.6	13.7	6.1	16.9	26.2	46.7	12.8	11.1	11.2	6.9	37.0	37.6	10.5	50.9	23.7	28.8	15.7	6.7	21.9	12.0	8.5	18.0	20.3	40.1	11.2	16.5	31.1	10.3	104.0	0.0	12.0	20.7	37.9	5.5	21.1	16.6	20.3	5.8
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.8	9.7	14.1	12.4	8.5	6.8	11.2	8.3	8.6	12.7	9.9	11.7	7.9	13.6	6.1	9.3	8.0	9.1	15.1	8.4	13.0	13.0	10.8	11.3	8.2	7.9	6.2	13.8	11.3	5.8	7.9	12.5	12.1	7.3	9.3	13.3	13.6	10.5	7.7	10.8	27.0	13.0	13.1	10.9	8.7	17.2	11.4	12.1	7.2	8.7	12.2	13.3	12.5	13.0	8.4	12.0	8.1	13.2	7.2	7.2	10.0	8.4	15.2	11.5	11.4	24.2	7.6	12.8	13.9	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2	3.0	6.2	3.7	2.8	6.0	10.2	5.1	5.1	13.4	5.7	3.5	9.8	2.1	0.0	2.1	0.3	6.7	3.2	0.0	3.1	3.5	3.7	4.4	4.7	4.7	2.6	9.5	6.4	8.0	5.6	1.4	4.9	5.8	5.0	2.8	5.0	5.6	2.4	5.8	4.2	2.2	10.4	6.5	3.6	6.7	6.0	6.8	2.9	9.2	3.9	2.6
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	2.0	0.2	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	4.0	2.4	0.4	0.2	0.1	4.8	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	0.2	0.0	5.6	0.0	0.4	0.0	0.0	0.1	0.0	14.8	0.1	0.0	0.0	7.5	1.8	5.6	3.4	0.0	3.2	3.3	0.0	0.0	0.0	0.2	2.6	0.4	0.0	1.6	1.1	0.0	0.0	3.7	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9	0.0	0.0	0.0	9.0	2.5	15.1	1.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.3	0.5	0.9	0.0	0.0	1.9	0.0	1.8	1.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.6	8.9	0.0	3.3	0.0	0.0	9.7	0.8	0.0	9.6	1.5	0.7	6.5	1.1	3.0	4.3	0.3	0.0	0.8	0.0	5.9
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1"	"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	18.9	0.3	0.0	0.1	0.0	1.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	56.0	16.6	0.2	0.9	0.3	0.0	0.0	0.0	7.2	0.5	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	56.8	0.0	0.0	0.1
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24080107-24115014	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"retina: 124.5"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 2618.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	1.5	2.7	4.4	2.3	4.1	1.0	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1.0	124.5	1.6	2.4	4.1	0.9	1.9	1.0	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2.0	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1.0	1.1	0.8	2.5	0.8	1.0	1.6	1.0	1.0	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1.0	0.6	1.2	0.4	1.1	3.1	1.6	3.0	0.8	2.6	2.2	1.8	0.6	3.4	1.8	2.2	2.1	0.7	1.2	1.7	2.0	2.0	1.3	1.5	1.6	0.7	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0.0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2.0	1.3	1.4	1.0	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2	0.0	0.3	4.4	1.7	0.7	340.0	1.6	0.0	0.0	1.2	7.0	406.4	1.0	11.6	0.5	1.7	0.6	2.1	23.3	1.0	0.8	0.5	2.4	0.0	2.6	1.7	236.8	1.7	0.0	0.6	2.8	1.1	0.2	1.7	1.0	1.8	381.3	0.4	0.9	1.8	6.8	2618.0	0.0	0.5	8.2	3.4	0.4	2.1	1.5	0.9	1.6
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.6	11.3	14.0	18.8	8.7	16.1	21.4	14.8	7.7	9.5	7.5	18.7	20.3	16.7	31.6	8.2	23.3	12.8	11.0	16.3	13.4	11.4	17.0	8.7	22.0	21.4	8.1	15.2	20.5	10.6	15.4	12.7	9.4	15.5	7.9	15.2	8.6	14.1	10.1	15.7	25.5	38.2	9.3	8.8	9.9	18.3	16.4	31.5	11.9	22.8	15.0	19.6	8.9	17.3	39.9	11.0	16.3	43.3	9.1	7.3	22.1	13.7	42.5	14.1	18.8	27.3	18.3	27.0	10.8	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7	74.5	77.0	155.5	140.9	83.6	31.6	79.5	137.6	66.9	104.6	59.3	13.7	119.1	127.6	113.6	331.3	86.4	114.1	116.8	204.5	170.1	84.0	110.5	116.6	184.7	121.5	47.7	134.0	113.5	170.4	102.0	257.7	109.4	79.2	149.7	219.3	47.0	172.0	119.3	161.2	158.4	31.4	135.8	91.0	120.5	95.0	75.2	113.3	107.1	207.0	165.4
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.9	12.8	13.3	11.5	6.6	8.5	0.4	9.0	9.0	12.7	11.8	2.8	8.3	20.5	10.2	12.4	11.7	8.5	21.2	20.0	15.4	34.7	12.8	9.1	14.5	0.1	10.9	19.6	10.8	8.0	12.1	15.0	14.1	9.0	18.4	13.0	12.4	7.2	12.7	20.8	13.6	6.3	14.5	6.7	11.3	15.1	1.7	6.3	8.2	12.1	16.3	11.2	23.4	10.2	7.0	12.9	10.2	16.3	13.5	8.8	12.9	5.6	11.1	8.5	7.4	14.7	5.1	9.6	9.4	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1	20.8	26.1	42.4	26.2	15.0	91.7	37.5	33.1	13.4	36.4	52.4	141.4	34.8	14.9	22.8	25.5	31.5	21.9	0.0	18.5	20.4	23.3	24.0	39.4	16.3	24.2	84.2	40.3	31.3	29.2	33.9	47.2	39.1	15.1	50.5	19.4	35.7	20.1	24.6	31.1	13.9	100.0	51.8	19.6	63.2	47.7	18.1	29.6	51.1	21.5	23.5
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224991-27268794	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 274.2;Late spermatids: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	24.0	37.3	26.7	33.3	27.4	16.9	30.1	16.9	27.2	22.2	24.7	31.4	30.8	14.1	23.1	32.5	34.7	36.0	36.7	21.7	24.3	26.3	30.9	37.4	27.1	36.7	31.9	20.9	29.5	45.3	46.7	20.5	21.4	27.1	33.8	21.2	26.0	37.2	31.5	22.5	19.5	23.8	35.4	32.4	20.9	26.2	55.4	19.3	41.5	33.9	25.7	29.3	27.6	20.4	42.0	38.9	31.8	27.7	60.4	41.6	32.6	14.6	21.0	14.4	15.7	23.5	31.6	11.6	15.7	16.0	11.9	12.5	16.3	35.8	28.8	37.7	23.8	12.3	15.8	27.0	47.0	15.5	35.3	18.8	13.3	19.6	31.2	41.0	15.5	10.1	30.9	32.8	30.0	57.4	34.7	16.0	27.6	17.8	9.1	22.0	24.7	20.2	17.2	12.7	24.3	14.5	17.8	17.8	45.1	34.5	9.5	15.3	13.9	10.7	14.9	26.8	18.5	24.6	18.6	9.9	14.5	9.1	16.5	15.0	27.4	19.7	22.2	31.2	15.4	6.2	31.8	27.7	25.0	25.2	24.3	27.8	24.1	36.0	30.6	38.9	42.0	41.6	32.6	9.0	60.4	22.5	37.7	32.8	32.6	26.7	27.4	16.9	27.2	24.3	26.3	31.9	20.9	27.1	19.3	32.8	38.0	33.8	48.8	25.1	13.2	37.8	66.2	91.0	30.7	41.8	2.0	102.9	109.5	65.4	163.4	30.6	55.1	0.0	63.9	52.2	45.2	45.6	274.2	58.2	73.6	12.7	56.4	52.2	49.4	281.7	22.5	40.9	43.9	118.2	57.5	55.3	42.9	45.9	37.4	129.3	13.5	25.8	50.1	91.7	45.8	28.5	53.8	64.8	42.6	44.4
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA051614: AB_2681551, HPA065734: AB_2685549"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	22.4	22.3	17.6	16.4	20.2	26.2	23.8	21.0	22.6	18.2	19.9	17.1	17.6	12.3	28.3	19.5	18.6	14.3	16.5	22.9	13.7	12.7	18.5	17.2	16.3	19.4	20.2	17.3	21.3	14.9	11.2	32.0	19.1	16.1	15.0	17.8	16.7	19.3	17.4	36.5	18.1	13.4	21.9	18.3	16.6	18.9	19.1	20.6	18.5	18.2	16.8	24.9	18.8	21.2	12.6	12.6	35.3	12.6	11.1	18.8	12.5	16.4	14.2	17.0	10.7	13.5	20.4	8.3	13.3	24.9	23.5	27.4	9.1	15.8	20.7	15.6	12.5	17.4	12.3	13.2	11.1	24.0	23.1	12.9	29.2	8.6	13.1	19.5	8.7	8.9	15.0	15.6	13.6	17.3	15.8	21.2	10.9	16.8	13.7	20.5	28.4	22.3	8.0	3.7	18.7	19.2	12.5	11.9	18.7	14.1	12.6	11.3	12.0	15.8	47.7	22.0	10.5	20.3	10.0	13.1	9.1	25.8	11.2	18.7	18.2	32.5	26.0	14.1	16.9	14.0	5.1	12.6	35.3	12.2	10.9	13.5	12.6	13.0	13.7	12.6	11.5	13.4	14.6	6.1	11.1	10.9	7.4	18.8	12.5	17.6	20.2	21.0	22.6	13.7	12.7	20.2	17.3	16.1	20.6	8.9	9.6	21.4	31.5	21.2	22.5	16.2	15.3	16.0	19.4	10.4	15.7	29.3	23.2	27.2	17.8	22.4	15.4	23.3	37.1	23.3	22.2	22.9	25.3	11.9	38.2	14.3	13.2	22.7	25.4	6.2	21.6	21.5	16.9	32.5	15.5	15.4	28.8	18.7	23.0	26.4	26.1	6.5	25.8	40.0	28.4	16.6	39.0	30.5	19.0	29.9
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.2	17.0	4.8	10.5	2.0	2.5	18.2	5.9	3.4	9.1	9.8	22.9	9.1	20.2	4.0	2.9	13.4	10.6	9.0	5.9	3.0	13.3	20.9	7.6	12.4	13.1	7.8	16.8	10.4	3.4	9.9	7.8	6.6	2.1	1.2	15.2	24.9	4.8	4.3	29.5	14.2	34.6	19.3	9.0	13.1	17.4	3.6	28.9	3.9	6.1	12.4	20.7	10.3	27.6	13.3	5.4	17.7	13.4	1.9	0.1	13.3	13.2	3.9	19.3	24.9	28.8	0.2	23.6	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6	6.0	6.1	51.6	17.1	15.0	25.1	17.1	25.5	10.7	12.5	34.9	11.8	33.4	31.5	36.0	12.8	7.3	18.6	0.0	28.6	37.8	16.9	12.9	26.5	20.3	30.9	30.2	3.5	6.7	17.4	16.3	27.0	19.4	20.3	46.9	16.4	13.8	24.0	17.5	19.4	19.5	21.4	6.5	14.1	60.6	58.5	18.6	18.2	25.4	19.9	15.5
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037853-15056079	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	24.2	8.3	11.7	8.1	11.7	11.9	48.2	5.2	12.1	16.1	18.0	5.4	8.6	6.8	14.4	24.5	14.6	10.2	12.2	23.2	8.0	6.0	10.6	16.9	13.5	12.4	7.4	8.0	13.0	13.3	7.6	5.0	7.8	9.8	15.9	15.7	17.9	11.1	7.7	14.4	13.6	9.7	19.8	7.4	13.7	12.9	14.0	6.4	8.1	10.5	12.7	11.7	18.8	19.9	9.4	12.0	31.2	5.7	5.3	12.3	5.2	10.0	7.3	8.8	7.6	11.3	21.8	3.3	12.2	16.6	12.5	21.6	3.4	7.5	6.9	9.7	23.2	9.8	4.2	7.0	14.3	17.5	6.6	9.7	4.0	6.6	18.8	11.6	2.9	2.2	11.3	8.5	12.0	4.6	7.9	28.3	10.3	4.7	7.9	23.2	8.4	5.9	12.3	6.4	11.7	8.2	11.8	12.0	9.3	9.0	13.9	2.7	10.0	5.0	1.8	8.6	17.9	3.3	4.5	15.9	18.1	7.2	7.6	10.7	7.7	15.3	9.1	10.9	6.5	8.2	2.5	4.1	31.2	5.5	5.7	6.5	9.4	7.2	7.3	3.8	6.1	5.9	3.7	1.9	5.3	5.5	12.0	12.3	5.2	11.7	11.7	5.2	12.1	8.0	6.0	7.4	8.0	9.8	6.4	3.0	4.6	27.4	13.7	29.9	5.6	2.5	10.2	4.0	13.6	17.4	9.8	62.9	38.1	42.6	39.3	51.7	10.5	0.0	20.6	15.7	22.3	22.4	8.1	16.4	96.7	23.8	6.4	46.1	47.3	19.7	76.8	45.7	55.6	55.9	8.1	7.8	42.1	11.8	70.7	27.1	7.4	38.8	29.7	26.5	27.7	19.1	47.6	28.4	14.2	19.2
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 302.3;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.7	34.8	14.4	24.4	9.2	13.7	15.5	31.9	18.9	32.3	28.0	28.5	22.0	21.6	16.4	22.7	23.3	32.7	30.2	28.1	20.4	16.6	16.2	9.0	31.3	28.7	29.5	18.1	13.7	14.6	14.3	33.8	16.9	10.4	17.6	19.3	33.0	16.2	16.8	55.4	20.4	24.5	18.8	31.2	30.4	19.4	17.0	43.2	13.0	9.6	29.3	15.3	15.7	29.5	21.8	9.6	24.5	9.5	11.9	38.9	19.7	36.0	33.4	12.8	15.2	32.8	17.7	18.8	22.2	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7	3.0	11.5	55.2	60.7	88.7	16.0	2.8	20.4	10.7	18.2	21.0	21.6	61.3	82.9	57.5	302.3	31.5	59.1	0.0	48.7	71.0	52.7	55.2	30.0	42.9	59.3	39.7	19.4	20.3	27.3	570.1	32.5	46.3	52.3	28.9	25.6	18.8	57.3	24.6	23.3	72.8	22.1	25.8	84.4	60.3	47.2	86.8	113.4	40.1	37.2	65.8
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	27.0	12.3	16.6	9.8	17.3	21.2	13.8	21.8	20.1	16.6	19.2	12.0	24.0	29.2	28.9	13.6	21.3	13.7	9.9	14.2	10.7	25.8	16.7	10.6	11.7	7.6	24.3	24.6	13.8	13.5	16.7	11.9	11.3	20.6	10.9	14.9	27.7	0.8	13.3	14.5	43.5	18.7	26.0	27.7	16.2	24.2	17.2	4.4	12.3	13.4	15.6	26.0	40.9	17.6	20.8	12.1	12.0	14.2	22.0	14.1	5.0	18.7	20.6	28.5	21.7	25.7	28.5	21.2	23.0	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0	68.5	57.3	44.2	28.5	22.0	35.4	51.7	30.6	72.3	71.7	24.4	11.8	39.1	51.4	43.6	181.4	36.0	42.1	0.0	60.6	37.7	28.4	41.4	69.4	33.4	27.3	46.1	28.2	30.7	34.8	15.4	40.9	42.6	15.1	930.6	41.4	52.7	51.5	17.5	38.5	30.5	40.1	25.8	38.7	96.0	12.7	25.3	41.9	48.0	21.9	30.6
NUBP2	CFD1	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782901-1789191	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	16.9	22.8	12.9	15.4	12.4	19.5	14.7	16.3	19.8	13.9	15.1	14.9	16.1	21.6	14.1	14.2	20.3	15.6	15.2	13.8	12.0	10.4	16.5	32.3	12.1	18.0	14.4	17.4	14.6	37.6	8.3	13.8	14.7	12.9	17.7	6.4	14.8	26.9	16.3	30.2	17.2	19.1	16.4	12.0	17.9	18.8	14.5	13.2	22.7	19.4	20.7	16.6	15.3	13.6	25.8	44.1	28.8	29.7	25.8	41.3	31.1	9.2	30.3	5.3	15.9	4.3	3.1	17.1	11.3	4.8	6.9	7.9	17.0	14.1	15.0	12.4	2.4	5.2	10.8	3.6	10.2	1.3	12.4	29.1	6.3	22.5	26.8	8.3	9.4	13.0	4.5	9.0	5.4	4.0	4.3	8.7	18.3	15.6	9.6	2.8	34.2	19.0	15.5	14.4	8.7	17.7	25.0	11.5	33.3	5.5	7.1	20.1	23.5	11.2	16.5	11.3	1.5	25.2	11.2	9.6	11.0	14.5	10.9	10.9	22.0	14.0	17.4	6.6	11.9	14.3	25.6	29.1	28.8	34.7	29.7	31.7	24.3	30.9	30.5	30.2	25.8	25.8	24.2	14.4	25.8	28.2	44.1	41.3	31.1	12.9	12.4	16.3	19.8	12.0	10.4	14.4	17.4	12.9	13.2	14.9	25.7	52.2	36.7	31.8	32.4	21.2	45.9	13.4	23.9	29.6	19.6	88.5	56.3	58.2	27.4	31.5	37.8	0.0	64.8	66.3	45.0	34.5	19.7	60.6	55.1	22.3	36.7	27.6	44.1	62.9	33.9	27.6	55.6	48.7	43.9	38.9	54.9	31.6	29.0	50.1	34.0	45.3	42.8	35.1	28.3	36.3	34.6	50.1	53.3	20.0
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.5	26.6	18.7	25.9	31.8	29.4	30.3	41.3	33.3	13.7	47.0	45.2	17.1	28.6	13.1	30.1	51.2	24.6	47.4	21.6	25.6	29.4	22.1	14.9	13.8	46.1	10.5	20.5	22.3	24.5	42.8	22.2	32.2	29.3	47.1	14.5	32.2	47.0	41.8	23.3	68.9	16.3	18.7	43.7	83.2	25.9	23.1	25.1	28.1	52.0	43.3	34.7	23.5	54.6	53.1	34.8	32.1	31.7	28.2	36.1	51.9	13.4	15.7	36.5	21.8	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9	199.5	245.2	149.9	252.8	229.2	349.8	365.7	310.8	239.6	291.2	287.9	68.7	230.3	326.6	177.1	41.7	224.6	54.9	233.6	148.6	321.5	312.0	255.4	201.9	550.1	225.1	298.8	172.0	219.1	173.7	32.2	474.1	194.8	165.4	192.0	193.2	516.1	113.3	94.7	456.1	297.2	177.2	310.4	243.6	46.5	115.0	213.3	148.2	154.5	216.0	173.7
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334385	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	22.1	9.2	9.4	10.2	12.7	3.2	17.1	16.4	12.2	14.0	9.1	4.4	9.0	5.0	14.4	9.8	10.9	12.3	9.0	10.9	9.9	8.4	13.6	10.8	12.3	14.1	12.6	8.9	12.0	13.1	9.1	15.2	25.4	9.7	10.7	12.1	4.8	11.4	12.7	10.9	7.5	8.6	13.8	8.6	19.0	10.3	20.1	8.4	19.5	15.6	11.0	14.0	13.8	13.4	4.4	4.4	1.2	4.2	5.1	5.2	2.3	13.1	7.9	11.3	6.4	6.5	8.8	6.2	9.7	11.5	27.1	25.7	8.8	10.3	8.9	6.2	10.2	7.6	7.9	17.1	15.7	37.8	11.3	6.1	13.6	5.4	8.9	13.1	5.9	5.1	5.8	8.7	13.4	18.9	8.4	24.5	10.6	14.9	4.6	22.9	11.2	15.8	6.9	8.0	26.5	10.8	10.0	9.4	8.6	16.7	6.9	9.4	8.3	4.3	11.6	9.2	12.3	9.2	4.6	6.7	13.4	8.1	6.2	8.3	3.5	4.4	10.4	5.1	10.1	11.3	0.0	1.9	1.2	3.3	4.1	4.4	4.4	3.7	4.9	4.4	3.8	4.6	5.2	0.1	5.1	4.2	3.2	4.0	2.3	9.4	12.7	16.4	12.2	9.9	8.4	12.6	8.9	9.7	8.4	3.0	10.6	12.6	15.2	15.8	5.1	7.7	0.0	18.7	27.3	3.5	5.9	22.1	6.6	15.9	72.7	22.5	2.6	0.0	9.4	19.1	11.5	9.5	17.3	5.0	8.7	4.8	8.6	7.4	4.9	13.1	12.0	9.0	6.8	21.6	4.5	4.3	12.3	5.9	6.3	11.0	8.5	0.0	12.8	44.7	31.3	14.6	6.9	8.7	9.0	17.2
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.6	6.8	11.2	5.8	22.5	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	13.9	9.3	9.9	6.5	11.2	6.3	7.2	5.4	8.7	10.0	14.4	9.0	9.9	18.2	5.8	4.6	12.7	6.3	10.9	0.0	6.1	11.0	6.8	13.2	0.0	2.4	8.7	12.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.6	6.2	6.3	9.5	9.9	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6	14.9	31.3	19.1	10.7	7.4	22.7	83.1	40.8	16.0	18.2	19.2	7.9	18.7	58.0	20.4	59.4	30.8	62.9	23.3	32.8	21.8	21.4	14.7	18.5	95.7	54.0	41.3	24.3	84.1	138.2	27.2	24.5	46.3	16.9	14.4	61.2	10.0	23.8	50.3	37.1	92.4	18.3	25.8	23.7	17.6	5.1	4.6	6.1	20.8	42.4	14.7
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106872-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	3.6	2.7	2.9	4.4	6.4	2.9	3.6	5.3	6.8	2.0	6.1	4.3	5.4	5.3	1.6	11.9	3.7	4.3	3.8	2.5	1.7		2.9	2.9	4.5	6.3	3.2	3.3	1.2	8.6	2.1	5.2	1.8	3.7	3.6	3.8	3.8	5.6	11.0	1.0	3.6	5.4	2.7	2.5	6.0	5.6	2.8	3.4	7.1	5.0	2.3	5.8	3.2	0.0	3.6	3.6	5.0	3.2	7.8	4.7	1.5	6.8	14.5	0.5	3.2	11.5	4.3	8.0	4.0	11.1	5.5	6.2	3.4	5.4	5.1	6.6	4.9	13.8	12.0	2.1	6.7	1.8	6.3	2.0	4.3	4.1	3.3	7.6	1.3	13.5	7.9	6.4	2.2	5.7	7.1	6.9	11.3	3.1	8.6	5.1	7.2	5.7	3.9	0.8	4.2	3.5	2.6	1.3	5.5	7.9	6.0	1.6	2.4	2.9	3.5	3.5	3.6	8.2	7.2	5.5	3.5	1.9	4.7	2.1	3.8	0.4	1.6	6.2	3.9	8.6	0.1	2.9	5.0	4.7	3.2	4.3	2.6	3.7	2.7	2.0	3.6	4.0	2.2	0.7	7.8	2.3	3.6	1.4	1.5											3.0	2.1	5.2	3.9	1.8	3.0	1.6	12.7	2.7	1.2	5.2	0.0	5.5	5.0	6.8	10.6	3.0	15.0	0.0	11.8	8.3	3.9	3.7	0.0	2.5	12.8	3.2	2.9	4.9	19.5	10.0	2.8	3.0	5.0	12.6	7.0	3.7	8.6	11.5	3.2	8.8	1.3	0.0	2.8	2.6	2.0	1.6	2.6	8.5	6.3	2.2
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.1"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.9;THP-1: 27.9;U-698: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	8.7	19.0	5.4	4.8	8.3	1.4	6.2	4.2	8.6	4.6	8.4	5.7	5.9	7.1	6.2	12.4	8.6	7.1	5.7	24.8	4.8	7.3	14.8	45.1	5.0	6.8	6.3	6.2	5.2	8.5	9.1	4.7	4.2	7.8	6.4	8.3	11.6	5.9	5.3	5.0	6.0	9.4	7.1	7.2	5.5	5.4	6.7	3.5	6.1	19.7	6.5	5.9	6.3	6.0	13.6	7.9	2.5	11.0	2.3	20.6	6.0	1.1	4.0	3.6	2.0	16.9	4.3	3.4	1.0	5.2	1.6	2.1	1.1	5.0	5.8	3.9	3.9	3.8	4.0	2.7	4.3	0.9	1.8	3.7	0.0	0.2	5.3	1.8	3.9	0.8	7.3	5.5	0.9	3.1	0.7	2.7	8.4	4.1	2.5	0.6	10.6	2.0	9.3	3.8	6.9	1.0	4.3	0.4	1.7	8.1	0.0	3.0	2.9	3.7	1.5	3.0	6.5	10.7	27.9	2.1	1.8	0.2	0.8	0.2	0.0	0.0	22.5	7.1	5.0	0.0	2.5	8.5	1.0	9.1	11.0	10.1	8.8	10.8	10.8	6.8	13.6	14.3	9.9	1.4	2.3	10.6	7.9	20.6	6.0	5.4	8.3	4.2	8.6	4.8	7.3	6.3	6.2	7.8	3.5	14.9	5.4	2.2	7.3	8.7	2.6	16.1	28.1	22.7	4.5	14.0	0.0	15.8	49.7	4.9	8.7	6.7	13.4	0.0	8.3	7.4	8.5	3.2	1.1	37.1	5.5	6.4	6.4	4.9	8.3	3.4	5.2	3.0	8.5	0.0	8.1	22.7	4.2	10.5	4.6	35.0	6.1	6.5	9.2	4.8	11.3	12.2	5.6	6.7	14.6	3.3
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.1	5.0	5.3	8.8	6.5	5.6	12.1	7.8	11.6	8.8	16.0	5.5	6.0	7.3	8.6	13.6	9.2	15.8	4.9	10.7	12.2	2.9	10.4	8.4	15.7	5.0	5.5	8.6	8.1	12.4	4.7	6.0	8.3	9.7	2.7	8.5	6.2	12.9	9.9	17.3	14.6	7.1	12.8	7.0	9.8	7.3	4.7	4.0	9.0	5.6	7.6	7.0	7.2	5.8	8.8	4.5	6.2	5.3	7.9	8.9	3.7	5.7	20.2	7.0	11.1	8.7	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8	6.0	9.8	6.7	10.1	13.7	7.2	4.0	5.1	5.3	18.2	5.2	11.8	13.3	14.9	11.0	34.3	7.7	2.4	23.3	14.4	12.0	9.3	4.8	17.3	8.1	9.3	7.9	5.2	8.0	4.3	47.9	10.0	7.9	8.5	6.4	4.7	8.2	8.9	0.0	10.6	12.2	6.6	6.5	8.5	26.7	28.3	14.4	7.3	6.2	8.1	7.1
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	29.7	33.5	23.6	20.6	28.1	26.8	33.1	38.4	31.8	51.9	37.7	55.6	40.1	25.5	58.3	30.9	34.1	37.8	31.2	21.2	21.6	19.4	23.0	13.1	28.3	23.3	37.6	24.8	51.4	30.0	70.7	29.5	26.0	28.3	50.3	24.2	41.2	35.3	40.1	43.7	41.9	30.2	45.3	29.5	23.0	31.2	25.9	39.5	39.4	32.6	22.5	31.8	50.5	37.2	10.3	12.9	4.9	5.7	7.0	9.7	6.6	18.5	23.6	29.6	19.9	26.4	27.5	15.1	25.1	29.1	26.2	22.9	24.5	34.4	25.3	22.0	30.7	18.8	39.9	27.0	25.4	24.0	26.0	12.7	31.0	37.1	18.6	21.2	23.4	22.6	29.0	16.8	25.6	25.9	40.7	22.1	22.9	18.2	30.6	17.9	35.8	30.2	13.1	18.4	35.6	17.1	37.1	51.7	19.5	19.6	29.1	35.8	50.8	40.1	37.1	37.3	13.4	49.9	13.7	30.5	27.8	21.7	39.3	16.6	19.9	19.6	35.6	18.6	11.1	15.8	4.9	5.6	2.5	9.7	3.5	7.4	5.2	6.0	7.5	4.9	10.3	7.5	5.2	4.6	7.0	5.7	12.9	7.2	6.6	23.6	28.1	38.4	31.8	21.6	19.4	37.6	24.8	28.3	39.5	38.7	32.9	12.4	27.2	23.0	61.9	5.2	35.7	32.1	30.7	50.6	68.7	24.3	14.9	24.4	28.1	29.2	50.4	0.0	27.8	11.2	25.5	31.2	30.1	20.3	24.6	49.3	45.5	31.3	31.9	14.3	63.9	23.2	18.6	20.8	58.2	49.2	27.3	31.6	47.7	22.6	57.0	38.8	21.7	11.9	20.4	24.6	37.6	28.4	48.3	21.6
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163841-45188015	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047162	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA047162: AB_2679963"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	9.0	12.0	8.0	12.3	9.3	26.4	12.8	11.3	11.4	8.7	13.2	6.6	15.8	9.0	9.1	11.0	18.1	10.4	8.0	5.3	7.4	8.6	10.8	13.6	10.4	17.6	7.1	8.4	9.9	11.7	8.2	16.1	12.9	16.8	11.9	9.6	8.2	11.3	15.0	6.5	10.8	18.1	6.2	6.3	19.3	13.4	20.0	7.5	41.3	12.2	5.5	19.5	10.7	15.3	8.2	10.3	37.6	16.2	11.8	12.5	12.3	24.3	11.7	22.4	14.5	10.5	11.0	23.9	20.4	13.6	15.8	16.1	25.3	10.9	26.7	9.6	13.4	11.8	17.2	27.5	16.6	22.9	14.2	29.2	23.4	18.3	15.4	11.0	61.7	24.9	13.3	11.5	20.2	15.4	7.6	17.4	23.6	24.2	28.2	16.2	16.3	27.9	16.0	16.8	16.2	12.1	29.7	13.6	18.7	12.3	23.7	14.0	13.6	20.3	12.6	24.0	17.9	7.8	16.4	15.8	33.6	30.2	17.3	17.1	19.7	15.9	39.3	12.6	16.0	23.3	19.7	15.7	31.0	8.8	16.2	12.0	8.2	10.6	10.0	10.3	7.4	12.5	8.5	37.6	11.8	9.2	5.7	10.1	12.3	8.0	9.3	11.3	11.4	7.4	8.6	7.1	8.4	16.8	7.5	8.9	24.7	25.2	40.1	76.0	14.5	9.0	22.9	33.5	18.2	31.4	11.8	20.7	11.6	16.5	34.0	19.0	21.4	70.0	18.1	32.1	18.9	47.3	32.5	32.4	24.1	12.7	16.7	35.0	41.1	58.5	13.6	24.9	23.6	23.4	22.0	9.7	22.7	31.6	13.1	17.4	16.3	25.8	14.7	31.2	39.5	78.2	47.4	37.1	22.2	77.6
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	32.0	30.5	22.6	19.2	7.1	8.1	21.1	24.3	16.7	25.6	25.6	20.6	18.9	36.1	13.4	15.5	17.2	19.1	27.5	16.8	24.8	52.2	29.3	29.0	15.3	19.0	8.6	26.6	28.9	8.3	11.6	16.9	14.1	11.4	18.8	21.7	35.4	35.3	17.5	15.5	48.0	20.3	21.4	29.0	27.2	43.4	26.4	30.7	12.3	24.9	25.3	18.0	23.2	26.5	12.1	16.9	21.5	13.6	14.6	40.3	23.7	13.0	39.4	25.6	69.7	33.2	16.6	23.2	30.0	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6	23.8	21.9	40.6	17.0	30.3	10.8	12.6	20.4	24.1	19.4	8.7	5.9	23.7	8.3	21.3	98.8	27.0	16.6	23.3	14.1	38.8	21.5	15.3	22.0	11.0	44.5	60.4	20.7	30.1	34.9	254.9	23.0	47.7	20.3	90.2	22.7	18.3	20.1	23.4	21.5	13.6	15.4	19.4	12.2	71.6	37.3	28.0	18.2	26.6	27.6	12.9
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	21.6	12.9	13.7	22.1	14.2	17.9	19.1	43.0	17.9	17.1	17.2	17.2	12.5	16.1	24.1	16.9	19.6	19.0	15.8	14.7	12.7	8.8	14.9	19.8	17.5	25.4	17.5	12.7	21.4	18.5	12.0	13.5	18.8	13.9	17.3	21.8	15.3	16.8	16.3	17.0	23.5	18.4	20.1	15.6	24.6	16.1	24.5	14.1	28.5	17.8	14.0	26.2	15.8	18.2	17.1	19.0	17.6	20.8	12.6	20.5	13.5	22.5	25.7	18.9	13.0	7.3	11.4	26.3	16.4	13.0	38.6	36.3	22.0	21.7	20.8	9.5	14.0	25.1	19.5	30.9	17.3	34.4	6.5	25.0	17.3	29.6	19.2	6.0	17.8	14.5	10.9	10.8	26.9	11.7	8.9	29.5	17.1	21.3	13.4	18.7	24.9	33.4	21.9	14.1	28.1	23.7	23.4	40.9	18.9	14.7	16.5	14.4	13.8	20.2	26.0	14.4	22.0	29.3	20.3	10.8	28.9	26.8	18.5	26.0	8.3	6.8	26.6	14.9	16.3	17.7	5.2	20.8	17.6	14.6	18.1	20.5	14.2	15.7	14.0	17.1	17.1	15.5	11.8	6.7	12.6	12.9	19.0	13.3	13.5	13.7	14.2	43.0	17.9	12.7	8.8	17.5	12.7	13.9	14.1	6.0	12.2	15.0	7.2	5.5	7.8	7.5	10.2	9.4	11.4	7.0	9.8	17.8	6.6	14.0	2.0	14.2	7.3	46.7	16.9	18.4	14.3	6.5	10.5	19.5	19.7	6.4	7.5	20.9	11.1	2.5	13.3	16.2	8.5	13.6	9.7	4.5	15.0	7.0	9.2	7.9	7.4	32.3	6.1	17.4	30.4	6.1	10.6	12.9	10.7	6.7
NUP98	NUP96	ENSG00000110713	"Nucleoporin 98"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 93.4;Late spermatids: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074810			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA074810: AB_2686714"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	20.2	13.5	8.7	23.5	11.7	40.8	23.5	14.2	13.2	18.0	15.3	14.6	17.8	11.2	19.2	17.5	18.6	17.3	17.1	18.2	7.8	8.0	12.8	20.1	20.7	17.4	11.4	8.7	25.5	19.0	25.7	23.6	20.7	12.7	18.6	15.2	17.8	17.4	25.0	35.2	18.5	15.7	20.8	10.4	18.3	16.0	57.0	10.6	27.5	20.9	15.0	26.6	22.6	19.3	8.9	9.9	24.9	10.0	6.1	13.2	8.7	29.8	23.4	19.3	21.3	21.4	17.6	17.0	21.3	24.9	29.3	26.4	25.7	37.1	29.2	10.1	25.5	29.6	32.2	33.9	21.0	40.0	20.7	24.5	31.3	19.2	17.6	18.0	39.9	26.4	20.0	14.5	16.1	29.4	13.0	22.7	33.4	38.9	23.5	31.1	12.2	40.1	13.0	24.4	32.8	18.0	24.5	23.5	14.0	16.7	23.6	17.8	11.9	30.9	25.1	14.2	21.0	15.4	15.7	16.6	23.5	20.4	25.5	19.4	14.2	24.2	31.0	15.9	17.2	24.7	19.1	7.9	15.5	11.0	10.0	11.0	8.9	10.7	9.7	9.9	7.8	12.2	10.5	24.9	6.1	6.3	2.7	13.2	8.7	8.7	11.7	14.2	13.2	7.8	8.0	11.4	8.7	12.7	10.6	26.8	25.1	21.4	28.7	44.3	14.4	14.3	25.5	13.4	22.7	7.0	15.7	18.8	3.3	11.1	93.4	20.3	12.8	23.3	10.3	14.1	19.3	22.7	17.4	20.2	15.1	14.3	20.6	16.5	15.1	116.3	15.8	20.9	15.1	27.9	14.0	12.4	10.6	12.7	13.4	7.4	14.9	32.3	23.7	48.2	32.6	44.2	38.9	20.2	16.2	23.9
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539174	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 297.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.1;hTCEpi: 84.2;SK-MEL-30: 60.2;T-47d: 35.8;U-87 MG: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006349			Supported	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	26.9	38.6	13.1	8.9	20.0	1.7	24.4	13.4	10.1	30.0	28.6	10.4	114.1	4.5	19.9	36.6	31.2	16.5	19.3	16.2	14.8	12.2	19.3	47.1	33.7	7.5	20.5	8.2	41.0	297.9	2.2	5.8	16.1	23.1	46.5	16.5	23.5	89.5	128.3	22.2	27.5	8.9	35.3	23.9	7.6	17.4	18.6	17.6	4.2	146.4	14.4	11.5	47.9	79.1	0.8	0.8	11.5	0.6	1.1	0.5	0.1	0.2	1.6	0.0	13.2	19.7	17.3	10.3	11.5	10.0	0.4	9.3	0.0	0.0	0.0	6.4	17.7	1.1	0.3	0.0	0.3	0.3	0.0	0.5	0.0	0.7	8.3	51.1	0.0	0.0	16.4	84.2	5.4	24.0	12.7	0.0	0.0	0.0	0.5	5.8	2.3	0.0	0.2	0.0	0.0	6.4	0.0	0.0	0.4	0.0	1.1	0.1	0.0	3.3	13.8	60.2	0.2	35.8	1.9	0.0	3.7	9.2	9.8	1.6	0.0	0.0	0.1	32.1	0.0	0.4	11.5	0.6	4.2	0.4	0.4	0.5	0.4	0.4	0.3	0.2	0.8	0.5	0.5	3.1	1.1	0.5	0.8	0.3	0.1	13.1	20.0	13.4	10.1	14.8	12.2	20.5	8.2	23.1	17.6	268.0	266.9	12.9	284.3	281.4	2.7	143.0	84.1	203.4	100.1	307.1	2.0	116.3	18.3	217.4	9.2	223.9	44.6	0.0	489.4	49.3	360.2	373.9	19.7	654.2	297.7	1.6	58.7	232.7	44.1	22.4	489.5	65.6	146.8	10.8	319.6	165.4	272.9	60.4	662.3	199.5	3.2	200.5	420.6	5.8	4.3	464.9	591.9	17.5	358.7	334.3
NUSAP1	"ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41332694-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 38.3;lymphoid tissue: 123.4"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042904, HPA074847"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		Yes	Yes			Nucleoplasm	"Nucleoli fibrillar center"	"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	3.2	12.9	0.7	20.3	1.3	38.3	3.8	0.7	0.9	2.9	5.4	1.1	4.4	5.8	1.5	2.8	16.1	0.9	2.5	2.7	0.7	0.7	2.5	4.2	5.7	16.5	0.9	0.5	4.2	3.0	0.0	0.6	9.2	0.9	1.8	6.5	0.8	3.6	5.6	4.4	6.0	6.3	2.2	1.2	7.4	4.1	8.6	0.6	123.4	0.8	9.7	19.4	2.9	5.3	2.7	3.1	6.4	1.4	1.7	16.3	3.1	37.4	12.6	41.8	19.9	2.2	3.6	13.9	30.0	17.7	33.1	32.1	17.0	19.6	19.4	16.7	11.3	26.6	36.2	32.2	14.7	31.8	34.9	15.8	49.4	31.3	16.0	0.6	31.4	22.2	1.1	1.7	17.6	13.6	6.5	19.8	30.1	27.0	66.3	25.6	10.0	38.8	21.1	21.5	38.5	15.6	41.9	44.6	21.0	11.8	11.7	30.3	20.8	41.3	24.3	8.6	15.9	36.6	23.3	12.0	25.7	32.3	29.0	52.7	24.7	47.7	62.1	13.5	47.2	44.1	6.4	1.4	4.4	0.7	0.9	0.4	2.7	3.5	2.6	3.1	2.1	0.2	1.9	0.8	1.7	1.2	2.9	16.3	3.1	0.7	1.3	0.7	0.9	0.7	0.7	0.9	0.5	0.9	0.6	0.0	1.0	6.7	5.9	34.2	0.8	0.8	22.9	0.0	4.5	0.0	0.0	10.7	3.3	2.1	20.6	0.7	1.8	350.4	0.4	100.9	8.5	4.1	6.9	3.8	30.5	0.0	2.9	9.2	13.2	8.5	0.3	16.4	3.3	6.4	3.4	1.5	1.6	0.0	1.8	3.9	0.9	0.0	4.1	103.5	65.4	21.8	16.1	13.4	10.2	4.7
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.8	12.0	10.4	3.7	11.2	11.7	2.3	8.7	11.1	10.5	15.3	2.8	0.8	11.5	25.8	9.8	12.7	1.7	11.5	9.4	13.0	14.3	3.6	8.9	7.6	7.4	14.8	7.5	8.3	6.7	1.6	8.7	3.2	13.7	11.3	11.2	1.8	37.8	17.3	4.1	10.0	1.8	5.9	0.4	7.4	4.6	12.6	4.9	7.7	2.0	8.2	9.8	3.7	0.9	6.5	6.5	1.7	10.8	9.8	11.7	13.9	1.3	9.0	18.0	17.8	13.6	10.0	33.3	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2	23.8	6.1	9.7	1.9	3.3	23.7	37.8	5.1	2.7	3.4	0.0	7.9	0.7	0.0	2.6	1.0	11.7	0.0	0.0	2.2	1.2	7.8	0.8	12.7	1.6	6.3	46.1	6.9	40.5	18.4	1.3	8.6	9.5	6.8	10.8	0.5	22.7	2.0	0.0	7.1	0.5	15.7	19.4	7.6	9.3	15.2	2.6	0.6	10.9	0.4	1.0
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350736-23354777	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 208.9;Suprabasal keratinocytes: 221.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 61.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047471: AB_2680061"	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	16.0	9.7	6.2	11.9	6.8	35.0	16.7	5.9	7.1	14.0	11.1	6.0	11.9	6.2	14.0	15.8	16.7	16.7	11.6	15.1	5.7	6.4	12.8	18.0	13.7	15.4	8.1	5.2	23.8	15.0	5.8	13.9	17.6	7.5	19.2	9.4	11.0	12.7	14.0	18.1	14.9	9.5	13.6	7.6	17.4	11.1	17.2	5.7	18.3	24.7	15.9	16.3	20.5	24.1	41.8	34.2	9.9	19.9	30.5	32.0	25.6	14.1	15.8	9.6	10.0	6.7	6.6	8.9	8.7	9.7	14.2	14.3	10.4	13.9	16.9	13.0	8.6	23.6	16.6	11.2	22.7	13.9	8.1	10.5	12.5	3.5	18.4	10.1	13.3	9.5	5.8	15.2	13.7	19.5	5.6	11.2	12.5	16.5	16.7	10.9	18.3	27.4	23.4	8.0	25.4	35.0	19.0	15.5	19.7	8.5	11.9	15.6	9.1	7.9	21.3	16.1	6.1	11.9	15.4	7.1	14.5	11.9	12.0	16.6	11.6	11.0	19.2	4.1	61.8	10.7	9.7	14.5	9.9	25.7	19.9	31.4	41.8	26.0	26.7	20.8	37.2	32.0	28.9	3.5	30.5	14.2	34.2	17.7	25.6	6.2	6.8	5.9	7.1	5.7	6.4	8.1	5.2	7.5	5.7	14.9	13.3	51.6	95.5	208.9	10.2	6.9	10.2	17.4	18.2	19.2	3.9	59.8	34.9	30.3	19.6	43.0	5.5	46.7	27.1	61.1	67.7	54.5	76.0	12.8	40.7	11.1	18.0	29.4	12.1	10.0	47.8	37.4	102.9	27.9	21.2	17.6	31.6	7.0	37.8	18.2	16.0	6.5	78.3	63.1	77.2	221.6	33.6	44.0	27.7	89.4
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544690	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.7"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 48.9;U-937: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: AB_2686483"	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	10.1	6.5	10.4	6.0	9.7	12.3	12.9	3.7	8.4	8.1	6.2	9.0	1.3	7.4	4.7	6.1	10.1	5.8	5.0	3.3	9.9	6.9	7.7	9.6	6.4	9.2	10.1	6.3	5.5	7.9	5.5	2.6	17.4	10.6	6.9	7.0	3.8	8.8	3.6	2.6	10.0	9.1	5.9	11.4	7.6	6.7	38.7	9.1	14.0	7.3	6.3	11.1	7.4	7.2	7.4	11.4	4.2	11.6	12.3	11.6	9.3	4.4	3.9	3.8	6.6	5.7	4.6	8.4	2.8	4.8	3.7	4.8	3.0	6.3	5.7	9.0	3.5	10.0	3.4	5.0	4.4	5.6	7.4	3.1	4.8	3.8	5.0	2.3	48.9	20.1	3.3	3.9	3.5	2.2	2.7	3.2	6.0	5.0	23.6	3.6	4.6	7.4	5.2	6.1	6.3	5.9	2.9	5.4	6.8	3.4	4.4	1.5	4.8	12.2	6.9	3.8	3.5	2.9	16.6	2.4	5.3	3.0	7.0	2.9	4.9	6.0	8.7	4.6	53.7	5.4	3.9	8.5	4.2	11.6	11.6	7.5	7.4	8.7	9.5	11.4	6.8	8.6	8.4	1.8	12.3	9.2	7.0	9.9	9.3	10.4	9.7	3.7	8.4	9.9	6.9	10.1	6.3	10.6	9.1	3.0	6.2	5.6	17.9	17.1	1.3	25.0	0.0	8.1	12.5	3.5	0.0	13.0	18.3	10.9	10.7	4.7	5.5	0.0	12.3	20.9	7.8	17.5	5.7	4.4	10.2	0.0	1.2	3.7	7.5	4.0	4.4	9.0	1.7	45.9	5.0	7.1	7.8	8.4	4.2	12.5	0.9	12.9	6.8	17.7	31.4	20.5	24.4	9.5	5.9	19.2
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	11.4	7.4	16.0	10.8	9.2	10.6	9.5	7.0	10.1	8.4	9.4	11.1	8.4	15.8	7.8	4.3	9.2	8.5	9.9	9.5	12.5	13.9	5.4	19.2	7.8	20.8	8.7	13.2	12.6	8.3	14.0	8.1	27.9	7.6	5.8	20.5	24.4	13.6	9.0	17.1	21.4	15.5	15.1	72.4	4.9	10.0	14.0	15.4	16.6	6.3	16.8	11.3	6.6	6.7	23.0	12.8	11.8	12.2	6.0	8.7	10.3	5.6	12.1	18.0	17.9	35.3	7.2	13.4	7.4	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9	14.9	40.0	42.2	37.8	25.3	59.8	37.9	43.3	57.6	34.2	57.6	43.2	77.5	72.9	37.0	142.4	30.6	31.5	0.0	42.0	52.6	25.1	27.9	47.3	57.2	39.6	39.7	21.2	19.6	46.1	120.0	26.2	34.7	33.7	36.9	47.2	59.6	29.7	43.8	24.4	76.7	60.3	25.8	35.0	186.5	159.6	25.6	38.1	48.9	57.7	23.1
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112906777-112933222	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.9"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 91.2;Urothelial cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 83.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4"									"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	31.2	7.3	6.1	16.6	7.1	5.7	8.4	2.1	6.0	16.4	25.4	11.0	2.6	23.6	5.8	21.0	39.1	5.1	10.7	5.1	4.2	5.7	18.3	23.3	20.7	17.3	5.9	5.3	7.4	3.2	4.3	6.1	18.8	8.6	11.5	20.5	11.7	31.8	4.2	2.9	6.3	27.2	7.6	9.4	30.1	22.7	4.2	6.2	21.6	9.4	13.5	27.3	20.9	13.0	18.2	24.4	4.1	83.9	4.5	16.8	29.0	1.0	5.8	0.0	0.0	2.0	1.5	0.4	0.0	7.5	50.8	73.0	3.3	6.2	7.9	2.2	0.0	27.5	2.6	0.0	0.7	0.7	5.8	0.0	0.2	10.4	1.2	0.6	0.1	0.4	0.1	2.2	1.9	0.0	0.8	2.7	0.2	0.0	3.5	0.0	0.1	0.2	3.6	0.3	48.0	5.0	1.6	0.0	3.3	2.5	16.4	0.1	0.3	0.8	1.0	19.4	0.0	0.2	1.3	10.0	0.0	0.1	0.7	0.1	71.6	54.4	5.5	0.6	2.3	0.4	1.0	40.9	0.5	4.9	63.6	4.6	18.2	6.5	6.1	24.4	13.6	2.5	3.3	4.1	4.5	83.9	22.1	16.8	29.0	6.1	7.1	2.1	6.0	4.2	5.7	5.9	5.3	8.6	6.2	3.0	2.1	16.4	10.9	3.1	0.2	1.2	15.3	12.0	7.9	5.2	0.0	11.1	5.0	15.7	0.2	16.3	40.3	23.3	10.7	32.3	5.9	6.4	4.7	9.4	91.2	0.0	4.1	12.3	28.2	0.9	6.6	27.7	5.0	10.0	56.5	14.1	14.1	45.6	9.9	19.4	0.4	6.5	1.4	0.0	0.2	1.9	4.8	7.5	10.4	142.9
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9"	"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.4	0.9	0.0	0.1	0.5	52.2	26.9	0.0	5.0	0.3	1.5	0.0	14.8	2.7	0.0	0.3	3.8	9.2	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.9	0.0	0.1	0.1	0.3	0.0	1.8	0.2	0.5	0.0	2.7	0.0	1.8	1.1	0.0	0.1	0.6	0.2	4.9	0.0	0.0	0.4	0.2	8.2	0.0	0.1	0.8	0.0	0.2	0.4	0.6	0.1	2.0	3.7	0.0	7.8	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6	0.0	6.2	0.0	3.8	1.9	0.0	0.3	0.0	4.0	3.4	0.0	0.0	0.2	0.0	2.7	3.1	2.1	4.2	0.0	3.4	0.6	0.5	1.1	11.5	3.9	12.3	0.0	1.7	0.0	4.0	2.5	0.3	6.8	0.0	4.6	15.9	0.0	7.4	3.5	0.0	0.3	0.0	0.0	2.2	1.9	0.1	0.9	0.1	17.3	1.2	72.1
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	42.0	7.6	5.0	17.9	51.0	49.3	17.1	25.5	52.1	22.8	25.0	19.5	5.5	0.0	18.6	43.0	21.7	44.8	22.8	47.7	24.8	7.4	31.6	47.1	5.3	14.5	26.3	0.0	31.1	32.2	24.6	20.5	24.0	37.8	26.5	8.7	81.0	9.1	31.8	10.9	12.4	2.6	10.0	12.9	10.8	11.6	19.1	11.4	21.8	0.7	10.5	11.2	16.0	42.8	35.9	30.1	14.2	11.6	20.4	13.0	12.2	21.5	15.8	7.8	8.1	11.4	18.0	12.7	6.2	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4	17.9	38.8	36.2	123.3	134.4	27.8	14.0	22.9	44.2	75.1	33.2	25.5	97.9	76.3	32.5	16.9	35.8	49.1	303.7	12.0	67.3	125.7	58.3	43.8	69.3	56.5	41.3	41.3	35.6	32.6	9.0	96.4	49.4	81.0	20.8	48.6	32.0	11.7	36.8	112.8	114.0	21.3	77.6	123.8	32.5	27.0	110.2	40.3	40.6	67.9	76.5
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"salivary gland: 157.7"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Ductal cells: 6.3;Exocrine glandular cells: 7.3;Pancreatic endocrine cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 24.2;OE19: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	2.5	0.2	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.0	0.4	0.1	0.0	157.7	2.6	0.0	0.0	0.3	1.9	0.1	0.0	2.5	0.0	0.0	0.0	5.1	10.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.4	0.0	1.1	0.0	0.0	0.0	2.5	0.0	2.3	1.8	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	15.9	18.2	7.0	22.9	12.2	13.7	27.7	18.7	13.9	10.3	11.4	16.2	12.5	9.6	16.6	9.5	9.1	10.3	11.8	14.3	11.3	16.1	20.0	10.4	6.1	21.9	14.0	12.1	26.5	44.8	26.5	13.4	16.0	16.1	12.8	9.7	18.3	15.3	10.3	9.5	14.8	9.0	21.3	10.1	12.8	8.1	19.1	9.0	19.0	10.1	6.9	10.4	9.7	4.1	8.6	4.4	11.8	10.6	6.2	4.6	7.5	8.5	9.5	7.5	11.6	11.1	18.0	12.4	7.9	8.1	8.0	16.7	17.5	5.4	14.8	6.1	7.3	19.5	6.9	6.6	7.8	4.7	7.1	5.0	10.9	9.5	10.7	8.3	6.3	8.4	13.5	9.4	15.2	8.5	8.6	5.6	18.9	11.0	9.8	8.0	5.9	8.2	13.1	29.4	2.9	6.7	6.4	14.8	16.0	7.7	6.8	10.6	9.4	20.3	14.4	17.5	17.7	7.2	7.9	11.3	7.1	7.8	11.5	13.4	8.1	8.4	6.3	4.5	10.2	1.5	10.5	2.7	3.8	10.0	5.5	4.1	4.8	5.0	8.6	3.1	6.0	4.6	4.4	10.6	11.8	5.4	6.2	4.6	18.2	22.9	27.7	18.7	14.3	11.3	21.9	14.0	16.0	19.1	26.8	28.6	0.0	0.0	0.0	0.0	0.0	0.0	28.1	54.6	24.4	0.0	20.7	8.3	18.4	0.0	0.0	0.0	0.0	22.2	19.9	0.0	0.0	11.6	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	11.8	0.0	0.0	21.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451490-56479100	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	8.8	13.4	10.0	8.0	11.6	3.3	9.4	10.3	14.3	10.8	7.0	12.4	6.0	7.4	9.5	8.4	18.1	10.1	7.8	12.9	7.7	11.1	12.9	13.9	7.5	7.5	9.1	10.4	10.2	6.5	13.7	13.1	8.3	15.6	8.0	8.9	8.5	8.4	10.0	56.1	8.8	5.8	15.1	11.1	8.6	7.4	8.2	6.2	10.6	9.3	12.6	13.0	9.6	8.3	7.8	7.5	11.8	8.9	8.7	12.1	6.5	11.3	13.4	13.2	16.4	15.0	18.1	12.4	18.5	14.9	26.3	19.1	16.3	8.3	20.8	9.5	14.7	11.2	16.3	27.9	12.6	29.8	6.4	15.0	15.1	11.7	16.8	11.5	16.3	17.8	12.0	14.4	19.5	16.3	11.4	21.3	14.0	21.0	4.0	22.2	7.3	12.9	9.3	22.4	10.1	23.2	24.2	20.2	24.2	11.8	8.2	10.6	11.8	22.9	14.8	12.4	14.7	13.5	13.5	13.9	14.7	11.7	11.2	16.3	8.2	15.8	30.5	11.7	11.8	11.6	11.8	4.7	4.8	8.8	6.3	11.9	7.8	11.2	10.4	7.1	6.1	12.1	10.0	1.7	8.7	8.9	7.5	9.3	6.5	10.0	11.6	10.3	14.3	7.7	11.1	9.1	10.4	15.6	6.2	3.0	13.6	19.9	10.7	15.8	10.3	17.9	17.8	8.1	18.2	8.7	9.8	14.3	21.6	13.0	17.1	11.2	3.9	23.3	12.0	16.6	20.5	7.5	45.0	15.3	10.6	12.7	2.4	9.8	8.1	14.5	11.2	11.3	10.1	19.8	6.3	12.1	13.7	5.8	14.9	11.0	14.1	12.9	17.8	14.6	28.1	16.6	9.7	15.0	9.5	7.1
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.8;Late spermatids: 337.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.2	15.0	8.9	11.7	11.7	10.0	7.5	13.4	10.6	7.5	13.4	11.6	14.1	18.5	9.6	14.9	11.2	12.8	13.1	8.5	8.0	8.8	12.9	18.9	8.0	13.4	14.5	9.3	11.6	24.3	10.9	13.5	10.6	13.4	11.4	7.8	9.7	20.1	14.6	13.2	15.9	17.9	8.7	8.0	14.4	11.5	25.1	13.8	10.9	13.3	10.8	12.0	7.4	8.0	16.4	13.4	18.0	16.6	8.8	15.6	9.3	7.2	11.8	4.9	8.0	3.4	3.7	13.3	4.4	4.6	6.2	5.6	11.0	6.5	8.1	9.2	3.8	3.6	10.5	3.5	6.0	2.3	5.6	7.7	12.9	10.0	11.4	7.4	12.8	10.1	5.4	9.1	5.7	5.1	9.0	6.5	15.8	14.9	6.0	3.1	13.9	10.7	24.2	3.0	5.0	15.1	12.0	4.7	14.3	4.7	6.5	6.3	5.8	6.0	8.7	8.3	3.4	21.9	11.0	4.1	8.5	8.7	10.0	4.5	15.2	9.1	7.7	11.7	6.7	8.2	12.5	12.2	18.0	10.1	13.1	8.7	16.4	8.2	9.8	13.4	11.4	9.3	8.5	10.0	8.8	16.6	8.0	15.6	9.3	8.9	11.7	13.4	10.6	8.0	8.8	14.5	9.3	13.4	13.8	0.0	6.5	8.4	5.1	2.6	3.3	0.3	7.6	28.1	6.8	12.2	2.0	21.9	8.3	9.9	85.8	5.4	10.7	0.0	13.0	12.2	4.3	4.0	0.0	18.7	11.3	11.1	2.4	6.2	11.4	337.1	8.1	5.2	6.8	5.4	9.6	7.3	11.3	7.0	4.2	23.7	5.8	12.9	2.7	25.1	15.2	4.0	13.7	7.2	11.0	2.4
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288803-71308950	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	16.9	8.7	20.2	11.3	26.8	16.9	36.0	22.3	33.3	6.7	7.2	29.1	2.8	2.9	8.3	10.7	24.5	5.2	8.3	5.8	30.2	17.6	5.7	4.8	8.5	9.6	27.7	18.3	5.4	6.0	5.8	10.0	9.9	37.8	6.7	4.3	3.3	31.8	10.3	4.1	14.6	5.7	24.1	52.2	11.7	5.4	2.4	29.1	3.2	4.8	4.3	17.8	5.4	9.4	0.7	2.4	12.8	3.0	0.5	0.5	0.6	3.8	1.1	4.1	0.0	11.2	10.3	1.5	17.4	10.8	7.0	7.2	1.4	0.7	23.7	24.0	7.5	6.5	1.9	3.1	12.0	25.0	5.0	2.5	5.2	4.2	0.6	9.1	2.4	1.8	10.3	10.3	5.2	16.4	5.9	5.6	0.0	0.3	1.9	24.1	3.2	0.0	3.8	1.7	1.5	1.0	1.6	12.6	5.4	16.3	0.3	14.1	6.4	5.1	3.2	1.1	6.2	5.5	19.2	8.6	17.3	8.7	1.8	5.7	2.5	0.1	3.1	5.8	16.5	3.0	3.1	3.0	0.1	0.5	2.0	0.5	0.4	0.4	0.5	2.4	0.7	0.1	0.3	12.8	0.5	1.4	0.9	0.2	0.6	20.2	26.8	22.3	27.4	30.2	17.6	27.7	18.3	37.8	29.1	6.0	21.8	14.3	18.0	34.6	15.3	7.8	5.1	1.4	11.4	10.4	23.6	19.2	1.7	12.9	0.4	21.0	0.0	0.0	27.8	10.1	31.4	13.9	5.8	4.0	53.5	36.5	13.8	8.6	79.5	1.1	15.3	93.2	30.4	27.9	2.4	83.6	18.3	0.0	31.1	3.1	5.0	25.8	18.6	0.4	1.1	40.7	15.9	12.1	4.3	14.9
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.2	13.3	17.3	15.2	18.7	17.3	11.7	10.9	19.8	11.9	18.3	14.0	16.4	17.0	7.7	13.4	12.4	17.8	18.9	10.7	14.7	14.5	19.4	10.7	31.9	10.0	14.2	22.0	17.8	16.5	21.8	13.0	24.6	20.6	11.1	36.5	10.8	59.1	11.3	12.1	16.9	26.5	11.5	12.7	18.3	16.8	19.5	21.7	18.4	16.5	8.9	7.8	17.0	11.3	10.5	13.7	8.3	15.0	12.8	12.9	10.5	13.4	6.3	16.1	11.6	20.4	9.1	23.2	7.8	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6	32.8	80.7	38.6	31.8	78.3	24.7	38.6	20.4	20.1	31.8	47.1	7.9	11.8	8.3	11.5	1.7	42.7	29.0	46.7	12.1	7.0	45.0	42.9	26.6	24.9	14.0	38.1	33.6	45.4	64.9	1.8	49.5	36.1	33.7	15.4	36.2	13.8	15.0	31.6	28.0	12.2	23.2	32.3	32.5	1.8	6.0	73.5	9.2	59.0	30.2	38.6
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025845-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 15.4"	"Lineage enriched"	"Detected in single"	154	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			1.3	1.3	24.1	1.4	19.1	1.4	1.3	4.2	66.2	1.3	1.3	41.4	0.0	1.7	1.3	1.3	1.3	1.3	1.3	1.3	23.6	15.6	1.3	1.3	1.3	1.3	20.9	15.5	1.3	1.3	1.3	0.0	1.3	17.1	1.3	1.3	0.0	1.3	1.3	1.3	1.3	1.5	1.3	16.8	1.3	1.4	1.3	16.6	0.0	1.3	0.0	1.3	1.4	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.8	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.7	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.1	1.8	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	19.1	4.2	27.6	23.6	15.6	20.9	15.5	17.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 910.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	3.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.3	0.0	0.1	18.7	3.0	0.7	11.9	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.2	3.6	0.6	0.0	0.4	1.7	0.0	0.1	1.5	0.7	0.0	1.1	0.0	1.6	6.3	9.8	1.6	0.1	0.0	0.2	0.1	0.4	0.7	0.0	1.0	1.3	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6	0.0	0.0	0.0	0.2	0.1	3.0	2.6	155.4	0.0	0.0	7.0	13.7	0.0	0.0	69.5	2.0	0.6	0.3	0.0	7.6	0.1	0.0	0.3	0.0	44.2	0.8	910.5	8.5	9.2	0.6	2.8	0.3	0.0	0.0	0.0	0.7	2.9	24.1	3.1	0.0	0.0	4.9	0.0	0.7	1.4	1.7	0.1	0.0	0.0	0.4	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"OPA3, outer mitochondrial membrane lipid metabolism regulator"	Q9H6K4	19	45527427-45602212	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	21.6	14.8	8.5	9.4	15.9	7.9	21.8	8.5	13.1	6.2	8.9	7.2	5.7	8.4	10.5	7.7	11.3	7.6	9.8	21.8	9.8	9.6	15.9	16.4	19.3	9.7	11.0	4.5	8.9	9.3	23.9	12.3	11.4	18.4	7.9	8.7	12.1	8.2	9.4	19.7	12.5	9.7	10.2	12.4	12.0	9.2	15.7	11.1	5.3	11.8	9.7	9.6	9.5	30.3	6.7	7.8	7.4	13.0	10.9	6.2	4.5	11.5	14.7	5.9	5.9	3.9	4.8	9.0	7.6	7.0	8.1	8.6	6.8	8.3	10.0	5.5	7.5	9.3	9.3	9.9	10.3	7.1	18.1	10.0	15.4	8.2	7.0	7.1	10.8	20.1	7.3	8.1	8.9	9.8	4.7	5.7	6.0	13.1	11.2	5.5	7.1	8.4	4.5	5.2	9.7	10.1	8.5	5.3	5.4	6.3	20.9	4.5	5.3	9.7	8.9	4.1	5.5	5.0	6.2	12.3	6.9	7.9	5.7	12.8	7.6	14.0	8.3	6.7	7.8	10.3	6.0	7.4	3.8	5.3	10.5	5.6	6.7	4.8	4.5	7.8	5.6	6.0	5.9	7.4	10.9	13.0	7.3	6.2	4.5	8.5	15.9	8.5	13.1	9.8	9.6	11.0	4.5	18.4	11.1	11.9	9.4	14.3	16.9	16.7	22.0	21.8	22.9	10.7	9.1	10.4	49.1	23.1	21.6	16.0	12.7	14.1	19.6	0.0	18.5	25.8	9.8	12.5	16.1	19.4	14.5	19.1	13.2	14.1	11.6	15.7	5.8	15.3	13.5	19.0	10.4	13.8	14.0	17.3	6.0	13.4	35.6	0.0	18.6	13.0	14.0	17.1	30.3	13.1	12.1	13.9
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	68042344-68433913	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	5.8	8.2	21.9	2.4	22.6	3.6	7.1	12.3	21.6	9.9	4.9	10.7	3.2	3.5	9.7	4.8	6.1	5.3	4.5	4.1	19.5	9.7	7.0	1.7	6.6	2.0	9.6	12.2	7.1	4.0	6.6	4.8	20.7	9.1	16.2	5.1	7.9	7.2	8.0	7.8	8.6	4.1	6.3	6.2	2.9	5.9	2.9	12.4	0.1	7.2	2.0	2.3	3.9	6.2	2.7	3.3	4.1	1.7	1.7	1.2	0.3	15.1	3.8	2.4	5.9	5.5	5.7	3.9	2.8	3.9	5.3	6.4	2.4	3.1	0.7	10.8	3.4	2.4	4.1	2.1	1.2	8.2	0.4	1.5	3.2	4.3	2.4	1.8	0.8	3.8	3.3	3.9	4.9	4.8	8.9	4.3	0.6	2.1	1.4	3.1	7.8	0.5	0.8	4.6	7.6	3.2	0.4	4.8	0.7	6.9	5.9	0.9	2.3	5.5	7.0	12.4	5.9	4.7	1.3	4.7	3.6	5.8	12.7	3.6	2.1	2.5	0.5	2.8	1.9	2.6	1.1	1.7	0.6	1.2	0.9	1.0	1.3	1.0	0.8	0.7	2.7	1.1	1.2	4.1	1.7	1.2	3.3	0.7	0.3	21.9	22.6	12.3	18.6	19.5	9.7	9.6	12.2	9.1	12.4	14.9	13.4	0.0	4.9	2.9	5.3	3.1	2.5	17.4	7.9	17.4	5.9	18.1	0.0	0.9	1.6	4.5	3.4	0.0	0.7	9.5	11.0	11.1	8.1	0.0	3.9	0.0	4.1	3.7	1.9	0.2	19.5	6.3	8.5	0.0	2.8	18.4	1.0	3.2	11.3	1.6	5.2	0.0	5.1	0.2	1.3	4.4	56.0	0.0	3.4	3.1
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949066-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	13.4	22.9	5.5	13.0	5.6	12.4	14.8	6.0	8.1	17.0	12.8	9.1	13.3	7.5	12.4	16.9	19.9	13.6	16.5	10.8	4.9	5.1	16.5	39.6	15.4	20.7	5.9	3.6	16.9	14.5	13.5	12.1	14.8	5.8	26.2	7.3	13.3	10.3	15.3	9.4	10.2	9.9	16.4	5.1	20.0	10.4	19.7	5.2	14.2	25.6	6.3	13.7	29.1	15.2	5.1	6.8	17.9	8.5	8.1	2.8	2.2	1.0	5.8	3.0	4.0	26.1	23.5	0.2	3.3	23.0	2.5	6.5	0.5	9.6	1.4	7.8	6.5	10.3	4.7	0.5	6.4	1.7	4.4	1.9	3.7	1.8	5.7	36.5	4.0	11.5	25.2	17.2	4.9	9.7	24.2	4.3	0.8	4.1	7.7	8.2	3.8	0.2	15.0	2.4	3.2	1.6	3.1	2.3	10.8	9.7	2.5	0.7	5.0	3.1	0.9	5.2	7.7	7.3	16.5	3.1	1.9	1.3	4.2	0.7	18.9	1.3	1.1	9.6	9.4	2.9	14.1	6.5	17.9	2.5	6.3	2.8	5.1	1.4	2.0	6.1	4.8	1.7	2.3	10.9	8.1	8.5	6.8	1.9	2.2	5.5	5.6	6.0	8.1	4.9	5.1	5.9	3.6	5.8	5.2	6.0	9.6	31.2	20.7	7.0	1.7	5.6	5.1	8.1	3.4	15.7	2.0	19.6	11.6	14.8	48.3	11.6	5.1	0.0	10.1	2.1	16.0	14.7	6.9	65.7	77.4	33.4	14.5	17.2	29.5	24.4	49.2	21.5	20.3	28.9	12.9	22.3	8.7	16.9	40.7	47.0	3.4	25.8	6.6	24.5	1.5	4.0	3.7	15.0	6.2	19.2
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908973-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	11.7	10.6	8.3	15.9	14.0	9.0	14.0	19.0	14.6	12.6	16.1	11.8	15.1	15.7	18.4	12.9	12.3	10.3	10.7	14.6	9.8	9.2	10.8	9.5	9.5	13.5	8.6	10.4	14.6	14.3	13.7	18.0	14.4	12.9	11.8	12.3	10.3	18.1	22.0	16.1	14.6	16.9	8.9	9.0	14.1	12.1	33.2	6.8	20.3	14.7	12.7	14.2	10.9	11.7	8.1	6.9	5.1	3.6	4.6	8.9	2.2	11.3	8.1	9.0	9.0	3.7	6.3	15.4	11.7	7.3	10.7	10.6	16.6	9.1	7.0	8.5	6.8	12.1	9.2	19.6	13.1	16.2	15.7	18.5	16.4	14.3	20.3	7.3	12.9	11.8	6.0	7.8	10.9	13.4	8.4	12.2	11.9	26.1	8.7	9.3	10.7	17.9	12.2	22.0	10.8	19.2	12.8	9.2	10.4	11.2	9.1	14.5	10.9	10.1	9.0	6.4	18.5	6.5	6.4	9.3	9.4	9.8	8.0	11.6	6.3	14.9	11.6	7.4	12.6	8.8	0.3	3.6	5.1	5.0	1.4	6.3	8.1	6.8	4.7	3.0	7.2	8.9	6.0	1.8	4.6	2.4	6.9	4.6	2.2	8.3	14.0	19.0	14.6	9.8	9.2	8.6	10.4	12.9	6.8	8.9	14.4	7.5	8.0	16.9	14.2	14.9	12.7	14.7	20.5	8.7	23.6	18.1	6.6	8.1	29.1	11.7	9.8	0.0	10.9	15.4	8.0	7.9	10.4	9.0	7.8	6.4	4.1	13.5	6.8	6.2	11.2	5.7	10.1	6.4	13.8	8.7	8.4	7.0	7.8	7.0	14.7	19.4	7.1	63.3	19.6	13.6	9.0	12.9	13.4	6.1
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930397-148021604	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	11.5	14.3	19.0	11.4	20.5	19.6	17.3	29.8	27.2	13.6	14.6	11.0	12.0	13.9	14.8	13.5	13.1	17.3	11.9	13.8	18.1	22.3	24.5	15.5	10.9	11.9	18.1	18.1	21.2	12.1	18.9	29.5	14.3	30.9	14.9	16.8	12.7	15.2	14.6	16.0	11.6	15.6	13.8	18.1	11.0	10.9	17.3	11.8	20.4	19.0	12.7	13.6	13.3	12.6	16.1	18.1	21.5	19.1	20.2	16.6	13.1	12.4	10.9	21.4	11.7	8.3	8.2	23.2	14.3	12.0	18.0	18.0	26.8	12.7	16.1	15.6	8.4	16.0	12.7	24.2	14.0	18.8	11.3	20.6	22.3	11.8	18.1	11.1	14.0	8.4	6.9	17.0	19.6	7.9	13.4	12.1	15.4	21.1	8.5	11.7	13.2	10.9	11.4	24.2	10.3	15.9	12.0	14.4	14.6	19.9	25.9	20.3	15.9	12.8	14.1	17.1	20.3	10.8	6.8	8.8	13.7	13.5	9.9	13.0	8.5	20.0	15.3	11.2	11.0	8.3	21.5	15.0	19.8	16.2	19.1	16.6	16.1	15.8	16.6	18.1	15.4	16.6	16.3	21.1	20.2	14.8	9.2	16.0	13.1	19.0	20.5	29.8	27.2	18.1	22.3	18.1	18.1	30.9	11.8	77.4	53.4	11.0	19.9	23.1	44.5	24.2	10.2	96.4	80.8	12.2	37.3	33.7	38.1	27.8	19.2	16.5	17.2	0.0	15.1	40.8	23.7	20.2	42.9	15.3	20.8	50.9	22.1	17.2	20.0	13.4	20.8	22.1	20.3	18.0	18.1	32.9	16.3	14.0	20.1	41.6	35.2	32.3	19.5	55.5	25.3	21.8	27.3	22.4	22.5	17.3
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication, Photosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	12.4	13.7	10.6	9.3	17.9	6.2	16.3	18.7	21.6	12.9	14.2	12.1	9.0	10.1	14.4	17.5	14.1	11.3	8.5	8.2	13.0	12.9	12.6	20.3	10.2	13.7	10.1	11.8	13.8	17.4	10.8	15.9	11.4	17.6	21.5	16.0	14.0	11.8	13.8	10.9	14.8	11.0	14.2	8.6	12.0	12.3	27.3	10.0	20.5	12.6	7.9	15.8	13.4	12.7	14.0	7.2	6.8	7.4	12.5	18.6	8.2	16.3	17.2	10.0	18.0	10.6	10.6	8.9	14.5	13.9	16.4	13.7	11.2	10.7	24.2	12.2	9.0	18.1	15.6	20.0	13.9	19.7	13.1	12.9	8.9	9.8	11.3	14.8	16.8	7.9	10.0	13.3	18.8	17.5	6.9	15.4	13.5	29.0	14.0	13.9	23.2	23.5	17.0	10.7	22.2	18.0	9.8	18.1	24.0	12.6	12.2	13.4	11.3	13.6	27.8	18.6	8.2	9.3	13.0	8.9	14.9	17.5	24.3	18.2	15.5	33.4	31.9	10.7	22.9	18.7	6.8	6.3	4.5	13.1	7.4	17.1	14.0	13.6	15.0	7.2	11.9	17.2	18.6	0.8	12.5	6.0	7.0	11.3	8.2	10.6	17.9	18.7	21.6	13.0	12.9	10.1	11.8	17.6	10.0	3.0	7.4	9.1	2.8	3.9	5.9	4.8	10.2	16.0	7.9	3.5	0.0	18.8	1.7	8.0	4.0	8.0	4.7	0.0	7.7	11.6	5.8	4.1	4.7	8.3	7.7	3.2	5.2	4.9	4.5	4.5	5.8	5.3	1.7	8.2	8.3	2.9	6.4	3.5	7.4	5.7	11.5	0.0	12.3	30.5	22.8	7.4	8.8	9.6	9.1	1.4
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 84.9;Spermatogonia: 102.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.8	1.4	4.1	8.9	7.0	14.2	1.1	3.8	6.1	1.3	2.8	1.2	1.4	2.7	1.5	1.9	6.7	0.9	1.2	2.3	4.4	3.5	0.8	1.6	1.5	10.6	3.1	4.5	0.9	0.6	0.3	1.2	5.2	2.4	0.8	3.1	0.5	1.4	0.6	0.4	1.9	2.7	1.7	2.9	4.1	1.5	23.1	1.4	12.8	0.9	4.2	10.7	2.6	2.0	4.1	3.4	1.0	2.6	2.8	4.1	2.5	10.9	10.1	16.2	12.6	2.0	2.5	12.0	19.6	7.3	21.7	11.4	14.2	6.7	12.7	10.3	3.7	11.0	11.2	20.8	5.4	18.4	6.5	16.8	10.5	5.4	14.3	2.5	17.2	11.1	0.7	1.0	11.8	6.2	3.5	7.1	11.1	12.7	6.5	13.1	9.6	23.1	21.6	17.9	7.6	27.9	27.9	29.8	12.9	5.3	3.8	19.4	11.5	10.0	11.1	6.8	13.5	5.9	13.7	4.3	20.0	13.6	12.6	18.4	5.0	6.7	44.4	8.5	11.3	15.4	0.0	1.1	1.0	3.5	2.6	1.4	2.7	2.0	2.0	2.2	4.1	2.9	1.4	0.5	2.8	2.5	3.4	4.1	2.5	4.1	7.0	3.8	6.1	4.4	3.5	3.1	4.5	2.4	1.4	3.0	16.4	15.2	2.4	6.0	6.1	3.3	2.5	17.4	9.1	5.2	3.9	22.0	1.7	2.6	9.4	3.0	2.1	0.0	0.6	30.9	9.9	1.7	1.1	8.3	13.2	11.1	1.7	0.0	3.3	6.2	2.6	6.1	32.1	0.0	5.6	2.5	1.6	0.0	3.2	0.7	8.4	0.0	2.2	84.9	102.2	5.3	9.2	4.4	10.3	1.7
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595090	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	8.1	5.1	12.6	8.1	16.9	4.7	13.2	5.7	9.7	5.4	7.2	14.1	4.9	5.1	6.1	6.1	6.8	5.0	5.2	5.3	11.0	7.7	6.8	22.4	10.9	11.1	11.2	8.3	4.5	3.8	8.5	5.1	9.0	8.7	4.6	6.6	4.6	5.1	9.7	48.9	6.3	6.0	7.0	10.3	11.4	5.2	7.8	10.9	8.3	5.9	6.0	9.4	6.3	5.3	3.5	11.8	12.8	9.5	1.9	2.2	3.2	13.1	7.1	13.6	7.7	15.5	8.3	17.8	9.9	8.0	12.6	14.5	13.7	4.7	21.7	12.4	8.2	10.4	9.9	15.1	8.7	16.9	5.8	6.5	9.9	8.6	9.1	8.7	7.4	13.6	6.7	10.7	10.5	9.2	5.1	9.1	10.5	10.2	9.9	11.4	7.8	14.7	3.6	18.7	9.7	6.4	13.0	7.9	25.3	10.5	8.2	3.0	8.1	12.2	7.0	10.5	9.8	7.3	3.9	9.4	10.1	9.1	14.6	7.7	6.3	6.6	26.6	7.1	2.6	9.7	10.8	9.3	2.4	1.8	9.5	1.5	3.5	1.0	1.8	11.8	2.7	1.2	1.4	12.8	1.9	7.8	4.5	2.2	3.2	12.6	16.9	5.7	8.4	11.0	7.7	11.2	8.3	8.7	10.9	8.9	11.8	18.6	7.4	8.9	18.9	7.9	5.1	9.4	12.5	8.7	11.8	10.0	5.0	8.2	0.8	9.2	12.6	0.0	6.1	9.0	7.4	5.3	3.5	31.6	22.8	7.9	4.1	11.6	56.9	2.5	6.1	35.7	11.8	13.6	5.2	11.2	8.5	11.9	6.7	8.0	32.0	6.5	8.1	9.1	20.4	13.8	19.3	8.4	6.2	9.6
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162044-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	18	"basophil: 33.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 33.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	32.3	14.3	33.3	5.9	28.9	7.0	23.8	6.2	43.1	27.7	13.8	33.9	6.2	10.2	24.4	9.0	15.5	15.2	10.6	24.7	37.6	22.6	21.7	6.6	11.9	5.0	40.6	27.7	14.3	8.3	21.0	8.8	4.2	29.9	12.0	11.5	16.6	23.3	13.9	73.2	8.7	9.8	20.4	49.0	4.8	9.7	6.9	29.0	1.0	14.6	9.9	4.1	12.0	29.7	0.2	1.8	33.7	1.8	0.1	0.4	0.6	15.3	4.6	11.0	20.5	25.8	21.1	10.3	5.7	16.7	5.2	4.3	2.9	16.1	0.0	6.8	10.2	8.3	15.7	4.3	10.0	4.8	0.0	8.1	4.8	3.3	0.0	12.9	12.1	2.5	27.3	14.5	3.9	16.3	22.9	6.5	4.3	0.0	0.1	6.4	6.5	2.7	3.6	9.0	7.9	15.3	0.0	8.8	1.3	1.4	11.3	7.2	7.0	13.4	15.7	18.3	10.8	5.7	8.7	1.4	19.5	4.1	6.2	5.5	0.1	2.1	0.4	9.4	3.5	11.1	33.7	1.8	0.4	0.1	0.9	0.0	0.0	0.4	0.2	1.7	0.2	0.2	0.2	0.7	0.1	0.3	1.8	0.3	0.6	33.3	28.9	6.2	43.1	37.6	22.6	40.6	27.7	29.9	29.0	14.9	16.3	3.2	36.9	17.9	60.0	66.8	28.1	24.1	23.9	19.2	21.6	9.0	54.7	10.3	58.6	58.9	23.8	0.0	6.7	7.0	27.8	29.4	17.3	10.4	24.0	23.8	4.6	33.7	16.4	59.6	39.7	21.9	55.6	1.8	32.2	86.9	8.0	14.8	51.6	55.2	92.0	32.3	45.3	6.7	10.6	8.9	5.4	4.3	8.6	23.1
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.2	3.3	10.0	5.9	4.0	10.4	5.0	6.5	12.7	12.3	14.0	7.5	13.2	6.5	6.3	5.5	5.5	10.2	10.0	8.0	10.4	13.0	8.3	8.6	18.0	4.3	14.3	11.9	3.1	3.0	15.2	8.1	2.7	8.3	12.0	8.0	7.6	9.9	11.8	14.0	6.2	5.1	18.3	20.3	22.3	6.3	7.4	7.2	7.2	13.2	2.6	8.8	9.3	6.7	2.0	6.2	13.6	3.8	5.3	13.0	6.7	5.9	2.3	12.3	18.0	3.3	22.3	6.4	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2	32.8	30.4	31.8	18.6	10.2	35.1	14.5	17.8	25.4	31.8	22.7	35.3	58.5	29.9	21.8	2.7	18.3	27.1	0.0	25.9	38.4	17.9	13.7	24.4	16.6	56.2	9.5	25.8	22.7	27.5	2.5	17.8	30.6	20.3	17.2	21.1	28.4	19.2	31.5	20.1	30.7	52.1	12.9	23.0	5.1	15.6	10.0	38.6	22.5	29.5	13.6
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83948282-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.5"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 47.5;Enterocytes: 69.2;Hepatocytes: 52.5;Late spermatids: 191.7"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.5;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"A549: 25.7;Hep G2: 38.6;T-47d: 28.7;WM-115: 24.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	4.0	9.8	1.7	3.0	6.5	0.8	28.2	0.6	3.7	1.7	17.4	2.1	0.7	18.1	1.3	1.7	5.6	1.8	5.1	6.9	1.3	1.4	13.8	63.5	8.2	1.6	13.4	0.0	3.2	5.2	2.5	1.4	1.2	6.6	2.1	1.8	5.1	2.0	1.7	7.8	1.6	21.3	5.5	13.7	5.4	5.0	5.6	1.9	0.0	5.2	13.5	2.9	6.0	10.6	0.0	1.0	4.5	12.3	0.0	0.0	0.8	1.7	25.7	0.2	1.1	1.6	2.4	2.0	2.9	2.8	2.6	1.0	6.3	9.3	0.0	6.9	2.4	11.9	4.7	1.1	1.9	1.0	0.3	0.3	0.4	5.7	38.6	5.6	0.9	10.1	1.4	1.5	7.0	1.6	1.5	2.6	1.8	2.3	2.5	3.4	11.9	0.3	0.3	0.2	6.2	5.9	0.8	2.6	1.2	1.8	2.2	0.1	0.6	6.2	2.0	12.5	0.7	28.7	1.0	8.9	4.2	6.3	6.1	2.0	1.1	0.4	0.1	14.0	1.3	24.0	0.1	2.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	0.0	12.3	0.0	0.0	0.8	1.7	6.5	0.6	3.7	1.3	1.4	13.4	0.0	6.6	1.9	14.9	3.8	0.5	8.2	1.3	0.5	6.9	10.2	1.4	1.2	1.8	0.0	1.2	5.0	10.5	47.5	2.7	69.2	0.0	5.7	0.3	2.1	9.5	1.1	52.5	8.5	0.0	4.1	6.7	8.6	191.7	3.7	3.2	6.8	2.8	7.3	7.5	11.6	10.5	11.3	8.7	0.2	12.9	8.0	1.9	1.0	1.5	1.1	0.0	7.1	5.8
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.9"	"Group enriched"	"Detected in many"	7	"Leydig cells: 726.0;Peritubular cells: 712.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 113.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	10.6	2.4	0.5	4.2	0.7	0.0	10.9	0.6	0.5	41.7	3.1	0.5	10.2	0.0	47.9	18.9	4.6	37.6	7.3	1.9	0.5	0.0	1.3	0.5	1.3	2.0	0.8	0.5	36.3	1.4	0.6	1.0	7.7	0.7	20.9	0.8	0.5	1.4	23.7	3.5	6.7	7.4	15.3	0.8	0.5	1.3	27.0	0.6	0.8	1.8	1.8	3.0	6.7	24.1	0.0	0.0	1.0	0.0	0.0	0.6	0.6	6.3	0.9	0.0	0.8	113.9	3.6	0.9	3.5	6.7	2.8	2.8	0.6	0.8	0.0	0.6	5.3	0.1	2.5	0.5	0.9	1.4	0.3	2.6	0.1	0.6	0.3	1.8	0.1	0.1	3.5	2.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.1	2.8	0.5	1.1	0.0	0.5	0.5	2.7	0.3	0.2	0.2	0.5	0.2	0.0	0.3	1.5	0.0	0.0	0.8	1.4	0.0	0.4	0.0	2.8	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.6	0.5	0.5	0.0	0.8	0.5	0.7	0.6	0.0	0.0	0.0	4.2	12.6	0.0	0.6	0.0	0.0	2.3	0.0	0.0	11.1	0.0	0.0	5.0	0.6	1.3	0.0	0.0	96.9	87.0	2.9	0.0	0.0	8.4	0.0	0.0	0.0	0.8	6.4	726.0	1.5	15.1	0.0	1.7	0.0	0.0	0.0	712.8	0.0	0.0	32.3	19.6	3.4	4.7	8.0	20.3	0.0	1.2	0.9
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.7	55.7	30.7	27.2	20.8	23.0	23.7	18.6	27.6	41.4	30.6	37.4	29.5	16.4	35.3	29.8	36.0	38.6	39.7	46.3	25.7	19.0	30.7	27.4	33.5	47.3	29.2	27.1	30.0	24.4	30.1	31.6	20.2	21.5	39.0	15.3	19.1	18.6	27.7	63.4	29.6	35.9	36.1	26.1	26.5	24.3	12.0	28.1	43.0	45.1	23.3	33.6	21.0	32.3	33.9	22.0	50.1	24.0	28.1	22.1	21.5	29.5	24.4	22.0	13.8	23.6	28.6	17.7	21.1	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2	17.9	66.5	50.3	60.6	42.8	41.6	27.7	35.7	62.9	52.4	43.6	37.3	125.6	63.0	73.0	63.0	39.3	99.3	23.3	74.8	89.9	46.6	44.0	46.3	28.0	78.9	28.6	84.2	34.4	55.6	67.0	31.7	66.2	49.0	114.6	62.4	40.9	72.8	56.1	24.1	69.5	48.4	25.8	45.3	45.7	63.7	45.9	162.9	67.3	48.9	63.9
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56810479	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 27.7;retina: 78.2"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 181.3;Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 203.6"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;pons and medulla: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 63.9;NTERA-2: 53.5"	"Low region specificity"	"Detected in many"							"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.2	0.2	0.0	0.2	0.3	0.2	0.2	20.4	0.3	0.2	0.2	3.7	0.0	0.2	0.2	1.0	0.2	0.2	0.2	0.2	1.8	2.7	0.2	0.2	0.2	0.5	4.7	0.0	0.5	0.2	0.2	2.8	0.2	27.7	0.3	0.2	78.2	0.2	1.3	0.2	0.5	0.2	0.2	0.2	0.4	0.2	3.1	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.4	0.3	1.8	2.7	4.7	0.0	27.7	2.3	0.0	0.0	0.0	0.0	0.0	181.3	0.2	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
OVCA2		ENSG00000262664	"OVCA2, serine hydrolase domain containing"	Q8WZ82	17	2041936-2043430	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059002			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA059002: AB_2683875"																		17.0	25.7	13.6	22.3	16.4	23.1	14.4	11.2	17.2	15.4	20.5	12.1	12.1	20.0	12.2	19.1	23.6	12.0	28.4	17.6	12.2	11.3	31.0	46.4	15.6	37.2	11.5	11.8	14.2	25.5	9.6	21.7	26.5	13.3	16.6	17.5	24.5	30.2	21.1	20.4	18.5	32.1	12.4	8.3	28.9	19.0	28.1	9.6	29.7	22.3	34.8	30.3	22.0	12.6	26.2	30.7	12.5	30.7	29.9	43.0	28.4	21.4	21.2	8.9	18.0	11.0	14.6	14.5	14.2	15.5	15.7	14.8	24.3	14.2	4.7	14.5	19.2	11.2	16.8	9.5	22.8	11.5	11.3	24.1	10.6	13.0	8.9	30.1	7.1	21.8	19.0	20.6	15.2	10.3	6.6	26.3	10.4	5.9	22.9	23.3	15.0	10.4	12.0	7.6	16.4	13.6	8.8	9.0	7.3	23.9	14.2	5.9	21.8	9.3	14.6	19.2	9.8	17.1	14.3	20.7	22.9	7.4	16.5	27.6	13.8	14.1	4.1	20.5	16.1	22.5	8.5	30.7	12.5	26.8	26.6	26.9	26.2	26.7	28.3	26.5	21.5	18.5	18.0	8.6	29.9	20.4	30.7	43.0	28.4	13.6	16.4	11.2	17.2	12.2	11.3	11.5	11.8	13.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.3;CACO-2: 4.9;CAPAN-2: 8.4;HaCaT: 6.3;OE19: 11.6;SCLC-21H: 9.8;SK-BR-3: 6.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 10.5;hippocampal formation: 6.8"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 7.6;hippocampal formation: 5.8"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	3.4	0.0	0.0	3.7	0.0	0.6	3.0	9.8	0.0	18.2	5.0	1.0	3.3	7.6	1.6	8.9	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.6	8.7	1.0	1.8	2.5	0.0	7.0	2.6	0.0	10.5	14.2	0.1	7.6	8.7	0.5	0.0	0.0	14.7	1.5	0.0	0.3	18.1	5.0	4.4	2.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	4.9	8.4	0.0	1.2	0.0	0.4	6.3	1.5	1.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	11.6	0.1	0.0	0.0	2.4	0.1	3.1	9.8	0.0	0.0	6.5	0.1	0.1	3.3	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.0	6.7	0.0	9.2	7.3	0.0	0.6	10.2	1.4	7.9	1.8	0.0	1.6	0.0	6.7	14.4	0.0	12.7	0.0	9.7	2.5	0.1	8.2	0.0	0.0	0.1	1.6	3.5	0.0	0.0	3.2	0.3	0.0	0.0	0.0	13.4	0.5	11.5	10.2	0.4	1.2	0.0	0.0	0.1	3.9	0.2	8.5	0.1	0.0	9.7	9.7
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931124	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	9.5	12.8	32.4	6.9	30.6	5.2	12.3	18.0	23.2	11.7	8.7	34.4	7.6	7.8	11.5	17.2	10.0	13.9	8.0	9.9	30.5	27.4	16.0	13.8	7.9	7.6	37.4	19.6	17.8	19.8	16.8	10.1	7.7	25.4	14.5	11.5	12.9	9.9	14.5	11.9	12.8	7.8	12.1	38.9	7.1	6.8	18.8	27.0	8.2	13.0	2.1	11.1	7.9	6.3	22.6	19.3	22.1	15.1	16.5	22.6	15.1	5.6	13.1	11.9	9.3	13.0	13.4	6.8	9.7	11.3	15.6	11.1	25.6	4.5	17.1	15.2	9.9	14.5	13.0	14.5	11.7	23.2	12.7	9.0	17.4	12.9	21.0	15.6	16.2	6.7	13.7	18.4	17.0	20.9	12.6	11.7	13.8	21.0	14.7	14.4	11.0	14.3	16.9	5.5	30.0	10.3	13.3	31.9	27.9	11.5	9.8	12.7	14.9	11.5	7.7	30.0	11.7	23.1	9.2	8.4	11.0	7.0	15.5	9.4	18.2	20.4	34.8	7.7	10.6	11.5	22.1	15.1	17.4	16.0	9.5	17.5	22.6	17.5	16.2	19.3	18.8	22.6	19.4	1.3	16.5	3.4	14.0	19.6	15.1	32.4	30.6	18.0	22.3	30.5	27.4	37.4	19.6	25.4	27.0	3.0	12.2	13.7	9.7	4.1	48.0	18.3	12.7	10.7	9.1	15.7	106.0	29.8	11.6	14.3	27.2	7.1	7.7	23.3	12.1	3.2	10.4	7.7	18.5	11.9	16.3	44.5	3.5	11.1	7.3	17.7	15.5	10.4	13.5	16.2	8.0	35.5	8.4	7.0	17.0	42.1	46.1	6.5	13.7	49.6	25.8	7.0	15.3	11.5	10.3	6.5
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	41.1	46.0	67.4	39.8	73.7	57.1	34.0	79.5	80.2	36.1	42.2	39.4	51.2	55.1	55.3	67.7	38.3	43.2	43.4	35.3	64.4	44.7	46.6	47.1	33.2	46.4	62.4	45.8	48.6	35.2	44.8	54.0	40.6	60.3	46.2	52.8	39.4	42.3	45.2	46.6	53.7	55.9	50.2	47.4	46.0	41.4	54.1	69.3	53.5	51.0	29.6	54.6	33.3	46.5	11.4	15.6	13.1	9.8	12.0	9.0	2.8	25.7	28.9	64.0	50.6	30.1	33.8	41.7	26.8	26.5	36.7	35.2	34.6	48.6	46.2	14.4	33.8	41.2	41.0	71.4	37.0	51.1	39.5	27.2	35.7	41.4	89.5	33.7	55.4	49.1	39.3	37.2	27.3	32.2	55.8	40.1	40.1	33.4	36.3	35.0	49.1	58.1	67.8	70.1	32.3	33.1	58.2	24.8	27.9	41.5	53.6	44.3	34.6	34.4	32.0	27.2	45.5	24.2	40.2	33.8	25.7	32.8	25.1	34.0	43.4	30.0	54.9	15.2	45.5	29.8	13.1	9.8	8.9	7.3	7.0	5.9	8.7	7.3	6.3	7.6	11.4	9.0	8.5	11.9	12.0	7.7	15.6	7.9	2.8	67.4	73.7	79.5	80.2	64.4	44.7	62.4	45.8	60.3	69.3	32.8	49.6	74.5	72.7	140.2	113.5	11.8	99.3	25.4	35.2	120.4	137.4	57.9	11.6	47.7	43.5	69.2	70.8	23.3	49.1	55.5	69.1	73.0	23.1	97.3	54.7	73.1	155.0	58.3	81.4	34.5	75.1	76.0	50.6	58.7	95.5	69.4	49.3	88.5	56.3	31.1	80.6	71.1	69.2	26.5	29.2	157.2	52.5	43.6	98.9	93.2
PACRGL	"C4orf28, MGC29898"	ENSG00000163138	"Parkin coregulated like"	Q8N7B6	4	20696282-20752907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 166.5;Late spermatids: 63.0;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054666			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA054666: AB_2682564"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.90e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (4.85e-4)"	7.9	8.7	12.2	10.7	15.6	3.2	16.5	7.8	19.0	9.1	8.9	9.3	14.6	6.6	13.9	15.1	9.6	14.2	10.0	9.5	14.1	12.4	8.7	4.7	7.7	7.3	12.1	12.9	14.0	6.7	9.7	13.7	7.4	10.5	11.2	9.4	8.4	7.7	11.4	10.1	14.3	7.7	13.1	15.1	6.8	7.7	37.3	10.7	4.5	15.8	10.0	6.3	11.1	8.9	4.3	7.0	1.4	4.7	4.1	6.1	2.9	9.0	7.0	12.4	9.4	16.8	15.6	6.0	11.6	9.2	10.7	13.0	6.3	19.3	9.6	7.8	6.6	17.0	4.3	6.9	8.7	18.4	3.0	6.1	6.0	10.6	10.1	8.9	12.4	6.5	10.8	13.0	13.4	12.5	9.9	10.8	8.7	10.4	5.6	9.1	6.5	12.4	11.5	15.7	7.4	10.0	6.6	13.5	5.9	10.7	5.9	20.5	13.5	8.5	4.4	8.7	6.6	8.0	7.0	8.4	10.5	9.7	14.5	16.0	5.7	1.6	8.9	15.3	8.3	18.0	0.0	3.1	1.4	2.7	4.7	6.1	4.3	3.0	2.7	5.3	4.0	4.7	3.0	1.2	4.1	3.7	7.0	3.5	2.9	12.2	15.6	7.8	19.0	14.1	12.4	12.1	12.9	10.5	10.7	8.9	5.4	0.5	9.6	12.0	5.5	5.2	7.6	32.1	9.1	7.0	3.9	4.9	6.6	6.9	166.5	6.7	5.1	0.0	7.9	5.7	9.6	8.5	2.3	2.9	3.7	4.8	8.6	5.5	4.3	63.0	12.0	4.9	5.0	2.8	5.2	8.4	6.7	8.2	11.7	4.2	10.4	12.9	5.5	76.4	32.5	9.3	4.9	2.2	7.6	6.8
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535231	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 70.2;Cone photoreceptor cells: 76.6;Horizontal cells: 65.2;Rod photoreceptor cells: 88.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 15.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 15.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 9.9;RPMI-8226: 11.5;T-47d: 18.3;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	1.5	2.1	42.5	2.4	33.8	2.0	1.4	29.3	81.7	1.5	1.7	2.1	0.0	1.8	1.9	1.5	1.4	2.0	1.7	4.7	32.8	21.9	1.6	1.4	1.5	4.4	14.6	32.9	1.7	6.1	1.4	1.2	1.4	31.6	1.8	1.6	5.5	1.6	1.7	1.5	1.4	1.8	1.5	3.7	2.5	2.4	1.9	4.1	0.0	1.4	0.0	3.4	2.0	0.0	0.0	15.0	0.0	0.0	3.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.1	0.0	9.9	0.6	0.0	2.4	0.1	0.0	0.1	0.0	11.5	0.0	0.3	3.6	0.2	0.0	1.9	0.0	0.4	18.3	2.0	0.0	0.0	0.3	0.0	0.0	3.0	13.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	15.0	0.0	0.1	42.5	33.8	29.3	56.3	32.8	21.9	14.6	32.9	31.6	4.1	0.0	0.0	0.0	0.0	0.0	70.2	4.0	0.0	0.0	0.0	0.0	76.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	1.1	88.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.5	0.0	4.6	0.4	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	4.9	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	12.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	3.8
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.5	0.0	1.3	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	16.2	0.0	0.0	0.0	2.4	0.1	0.1	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4
PAGE3	"CT16.6, GAGED1, PAGE-3"	ENSG00000204279	"PAGE family member 3"	Q5JUK9	X	55258412-55264846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	111	"testis: 11.1"	"Group enriched"	"Detected in some"	54	"Early spermatids: 91.5;Late spermatids: 208.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;PC-3: 1.9"									"HPA045032, HPA062248"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA045032: , HPA062248: AB_2684725"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
PALM	KIAA0270	ENSG00000099864	Paralemmin	O75781	19	708939-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.6;brain: 56.5"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	35	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	47.6	11.8	49.1	5.1	39.9	2.2	11.3	13.3	56.5	22.7	8.2	12.4	4.2	9.2	10.7	6.7	5.8	17.7	7.2	9.6	37.7	18.9	21.9	3.5	9.0	2.2	19.2	28.1	21.2	2.1	1.2	10.2	17.6	11.9	12.2	2.7	6.1	5.9	18.6	7.0	6.9	7.5	9.0	14.7	10.5	3.6	8.2	12.5	0.0	3.3	3.3	1.9	5.0	8.4	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	4.4	8.6	16.5	1.3	0.1	1.2	1.1	0.0	1.1	0.3	1.0	0.0	0.0	15.3	0.1	0.1	1.5	4.3	0.0	0.2	0.0	8.5	0.0	3.5	5.4	6.0	0.0	0.1	3.9	0.0	0.7	0.0	2.4	0.6	1.9	3.0	0.1	1.1	8.7	0.6	5.1	3.5	0.8	2.4	27.2	0.0	0.1	0.4	0.0	0.9	17.5	4.4	0.0	0.1	2.8	1.5	4.1	0.0	0.0	9.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	49.1	39.9	13.3	44.4	37.7	18.9	19.2	28.1	11.9	12.5	0.0	1.7	1.4	5.5	6.4	7.6	3.6	0.0	0.0	3.4	5.2	11.8	0.8	44.7	1.6	1.1	26.3	2.1	0.0	0.2	2.5	21.8	8.7	0.0	0.2	0.8	23.8	0.0	46.6	2.2	5.3	44.8	1.6	16.9	0.0	0.0	69.4	0.3	0.3	42.5	43.5	4.2	0.0	13.3	0.9	1.3	6.0	1.6	0.0	0.0	5.0
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379234-133391694	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in many"	11	"Early spermatids: 115.5;Late spermatids: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.4;K-562: 5.0;U-266/70: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047782			Uncertain	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favorable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	6.7	4.1	4.3	5.8	6.7	1.5	4.7	6.8	8.7	3.7	6.0	10.8	5.6	5.6	3.7	1.8	7.4	3.4	2.4	2.5	5.7	2.7	8.9	9.2	2.8	5.2	10.0	3.4	3.6	3.2	1.9	2.5	2.1	4.2	4.8	1.5	2.8	9.9	5.1	3.5	4.4	8.5	2.8	4.7	8.2	7.5	36.7	7.6	0.7	2.4	2.1	5.4	4.6	4.2	4.3	1.1	1.0	1.0	1.7	0.3	0.4	6.4	0.0	0.2	1.2	0.0	0.7	1.6	2.9	1.2	1.4	0.2	1.1	0.1	0.0	0.9	0.6	0.8	3.5	0.4	0.8	0.6	4.2	0.5	0.6	0.0	0.2	1.7	0.0	1.0	0.1	0.3	0.9	0.4	0.0	0.1	0.0	5.0	0.3	0.0	0.1	0.0	0.1	1.2	0.0	3.0	4.6	0.0	0.0	0.2	0.0	0.3	2.2	0.9	0.1	0.0	0.0	1.4	0.0	2.8	0.3	1.4	1.2	0.0	18.5	3.4	1.7	0.0	0.0	0.1	1.0	0.3	0.0	0.2	1.0	0.0	1.6	0.3	0.2	1.1	4.3	0.0	0.0	0.0	1.7	0.9	0.8	0.0	0.4	4.3	6.7	6.8	6.5	5.7	2.7	10.0	3.4	4.2	7.6	0.0	5.8	20.9	6.2	3.3	1.5	1.5	5.1	1.4	0.0	1.8	0.0	0.7	5.0	4.5	115.5	2.3	6.8	0.0	3.0	1.7	2.3	4.8	5.7	11.3	4.1	4.8	0.0	3.7	10.4	346.0	8.9	3.9	0.0	17.2	3.4	7.7	2.9	2.9	7.4	13.2	2.7	19.4	2.5	9.9	3.0	3.1	0.2	4.6	3.2	8.6
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.3	61.6	61.4	70.6	66.1	63.6	30.1	63.7	59.8	62.8	50.7	56.2	75.0	84.8	72.1	68.4	44.1	49.2	66.2	85.2	81.6	75.5	71.6	91.2	92.1	83.3	57.1	87.0	56.2	59.9	36.4	63.9	76.9	49.2	65.7	44.7	88.5	63.2	87.0	64.1	60.5	110.6	50.1	84.9	63.7	46.6	82.5	116.3	98.4	35.2	71.9	60.4	63.7	98.5	99.5	53.8	54.9	64.8	62.3	57.9	46.2	53.4	69.8	61.4	98.5	120.8	76.4	133.2	82.0	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2	122.1	136.9	226.3	328.5	185.6	175.5	422.7	221.7	227.5	176.3	235.5	74.6	504.6	721.2	419.3	26.4	207.3	136.6	46.7	416.0	502.3	279.0	413.5	199.9	332.4	385.8	176.4	228.6	156.5	174.9	43.1	331.6	265.8	340.8	806.1	224.5	530.4	359.6	213.9	356.1	742.4	177.0	271.7	346.0	212.8	299.8	125.7	392.7	243.9	261.6	388.0
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.3	14.9	23.0	17.2	7.6	7.3	16.7	22.7	12.4	28.9	35.8	14.1	19.5	15.1	10.3	7.1	25.8	19.2	30.6	10.4	34.2	12.1	14.9	13.8	18.1	23.5	6.8	28.6	7.9	5.0	8.9	18.0	19.9	8.0	14.8	18.5	14.6	20.7	19.8	12.6	14.6	12.3	12.6	23.2	23.3	18.3	31.3	9.8	11.5	10.6	16.0	11.0	25.3	14.1	6.6	15.3	13.0	9.7	10.1	17.6	26.7	12.1	18.4	19.4	24.7	20.1	7.3	12.7	19.5	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4	23.8	6.2	10.4	9.3	5.8	26.8	12.3	5.1	36.1	21.6	7.0	11.8	19.1	6.6	10.5	7.3	10.0	3.4	23.3	7.7	17.9	8.4	3.7	8.1	9.6	10.2	28.6	4.6	6.2	4.9	7.3	10.6	6.4	8.5	4.6	4.2	21.9	8.0	5.5	15.9	5.6	21.7	6.5	9.5	17.7	33.3	4.3	12.5	4.4	5.2	4.6
PARP3	"ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	15.2	29.2	11.2	14.6	17.1	2.8	13.6	5.7	18.8	7.5	17.3	10.6	14.3	26.9	10.3	14.1	10.8	12.1	16.2	12.4	11.6	12.3	17.3	22.3	13.3	9.7	12.0	14.2	8.2	3.9	34.2	9.8	6.2	12.2	12.1	10.7	13.2	14.0	18.1	14.6	6.1	26.3	18.9	8.7	12.8	15.8	4.5	10.2	2.9	17.0	9.6	10.3	15.1	8.9	9.0	2.9	1.7	4.1	6.6	4.9	2.3	5.9	3.3	0.9	9.0	8.7	16.5	2.5	9.8	15.8	12.1	13.6	1.9	15.8	8.1	2.6	16.1	7.0	0.9	2.5	8.8	5.9	19.9	0.6	4.1	6.7	6.3	9.4	2.5	5.7	13.0	5.5	7.7	5.2	18.6	6.0	5.1	1.7	7.7	9.3	1.5	2.2	6.3	1.2	2.0	9.5	3.5	1.5	7.0	7.4	6.5	1.0	3.4	9.9	2.8	5.2	0.7	3.4	2.8	13.6	24.4	5.1	3.6	5.9	11.8	14.3	3.5	15.7	7.4	7.6	0.0	2.6	1.7	3.6	4.1	3.4	9.0	4.2	2.8	2.9	4.3	4.9	4.9	0.1	6.6	2.0	1.2	4.3	2.3	11.2	17.1	5.7	18.8	11.6	12.3	12.0	14.2	12.2	10.2	6.0	10.6	10.1	10.0	2.4	1.7	5.9	12.7	9.4	7.9	0.0	0.0	0.4	6.6	8.8	5.9	3.0	15.8	0.0	5.7	0.3	4.5	3.4	4.6	8.5	3.4	0.0	2.9	1.8	2.2	8.4	4.4	2.9	6.8	6.4	11.0	4.0	7.9	3.5	1.4	16.1	2.1	6.5	6.2	3.2	1.8	1.3	0.5	5.3	11.2	6.4
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Group enriched"	"Detected in some"	19	"Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.5	1.0	0.0	1.7	1.4	2.4	1.3	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	0.3	8.1	1.2	8.1	0.0	30.7	5.4	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.8	0.0	1.2	0.0	0.0	3.5	2.0	0.8	0.1	4.6	0.5	0.0	0.1	1.2	13.2	0.0	0.0	0.0	0.0	4.6	2.3	0.0	0.8	4.1	0.9	0.7	3.5	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.1	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.8	0.0	0.3	0.0	29.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.6	15.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.3	0.1	0.0	0.2	10.8
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771858	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	8.9	10.6	11.9	16.6	19.6	42.0	11.6	25.7	20.0	13.5	14.1	11.3	10.1	15.8	16.3	12.4	10.3	11.6	10.1	8.3	11.2	9.7	11.3	10.3	10.1	13.7	22.7	10.0	19.8	12.3	11.6	19.3	13.2	14.7	11.2	12.6	6.9	10.2	10.5	15.2	12.6	12.8	10.8	19.0	11.2	9.5	12.9	19.7	18.5	11.3	5.0	12.3	11.2	18.9	2.2	1.6	0.3	1.3	0.7	3.1	0.4	7.5	6.2	12.5	9.8	4.9	3.9	17.9	5.6	3.6	7.4	5.4	13.0	6.8	9.0	4.4	3.1	5.7	7.7	12.5	5.2	7.7	7.3	10.4	15.5	10.2	9.4	2.4	17.3	9.2	2.1	7.9	8.6	3.8	4.8	4.8	9.5	18.0	8.3	5.4	6.6	11.8	10.1	35.4	8.4	6.3	11.0	11.9	13.1	5.8	7.0	10.3	5.9	8.0	9.3	6.3	8.1	5.9	9.7	4.2	5.5	7.6	6.4	8.7	8.2	10.2	16.7	4.0	15.8	5.5	0.0	1.3	0.3	2.2	0.6	3.1	1.6	2.5	1.9	1.6	2.2	2.7	2.6	0.0	0.7	0.8	1.1	1.4	0.4	11.9	19.6	25.7	20.0	11.2	9.7	22.7	10.0	14.7	19.7	11.9	16.3	9.8	17.0	22.7	51.8	11.5	15.3	28.1	20.5	19.2	58.9	13.9	5.0	6.5	28.6	16.1	13.2	0.0	6.8	10.2	16.4	18.1	11.5	9.9	9.0	20.6	21.2	12.9	11.8	25.3	13.6	15.8	20.3	2.8	15.4	37.6	6.3	12.2	15.9	5.7	78.8	32.3	15.1	24.2	15.5	22.2	14.9	13.1	18.8	22.8
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003084	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	6.0	5.4	5.7	6.2	5.0	9.7	6.3	32.3	5.7	7.8	5.5	5.8	4.5	5.2	6.5	6.7	7.1	5.7	5.0	4.7	6.0	3.4	5.7	6.9	4.7	9.4	5.7	1.4	7.1	8.4	7.2	8.7	7.9	5.6	7.7	5.7	6.9	6.6	5.4	7.1	7.4	6.9	9.3	4.2	6.4	5.9	10.4	6.2	31.2	6.4	4.7	6.9	6.1	5.9	2.2	3.3	1.4	3.1	2.9	6.5	2.5	9.9	8.2	10.9	18.4	4.8	4.0	9.7	4.4	4.7	6.1	7.2	9.0	7.9	13.1	5.6	5.3	12.7	7.9	13.9	7.0	7.6	13.1	10.9	9.9	5.9	7.7	3.4	13.5	13.3	3.8	5.3	6.1	2.5	3.5	5.8	13.3	13.6	8.8	6.1	13.9	28.7	11.3	17.6	9.8	5.6	16.4	11.1	14.2	6.3	8.4	8.7	5.6	11.8	8.8	5.5	10.3	6.7	11.6	2.9	5.1	0.9	7.3	10.6	9.0	5.2	18.0	12.6	16.0	13.8	0.7	2.3	1.4	2.5	2.6	3.8	1.3	4.0	2.9	2.6	2.2	6.5	1.7	1.0	2.9	3.1	3.3	3.2	2.5	5.7	5.0	32.3	5.7	6.0	3.4	5.7	1.4	5.6	6.2	6.0	7.5	6.5	4.7	5.7	18.0	6.1	7.6	4.0	9.1	8.7	9.8	7.4	5.0	3.5	1.5	5.0	4.7	0.0	2.9	6.4	6.0	6.1	2.3	8.9	3.9	3.2	2.4	3.1	4.0	2.7	8.1	3.6	3.3	3.6	8.7	9.3	4.0	2.9	8.9	3.1	12.8	0.0	2.5	15.2	19.9	6.0	5.1	3.9	9.9	3.5
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 577.2;Proximal tubular cells: 733.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 67.0;Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.2	48.2	2.9	29.9	10.9	10.2	3.9	6.6	10.9	10.2	8.2	67.0	36.0	4.1	19.1	7.2	7.9	13.5	18.2	10.5	7.0	10.9	32.8	3.6	7.7	65.8	11.5	3.6	13.5	10.0	11.5	10.1	4.8	15.5	27.4	2.6	7.1	0.3	7.1	33.9	0.4	12.1	4.0	54.9	45.1	1.9	4.0	13.3	42.9	21.0	12.6	21.4	5.4	37.3	14.2	8.4	10.8	7.0	11.3	1.7	14.3	2.5	16.0	0.1	0.8	0.1	9.3	11.8	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7	38.7	59.6	41.0	140.4	44.3	32.7	140.4	142.7	72.3	73.9	177.9	5.9	105.7	384.7	161.2	1.3	33.8	116.6	23.3	147.5	63.7	71.1	169.6	31.1	577.2	160.3	33.4	169.3	32.5	54.4	5.8	62.5	71.4	74.2	90.2	228.3	70.5	157.8	147.3	89.8	733.2	28.5	84.1	57.7	4.9	7.9	40.0	64.9	33.8	199.7	158.3
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		2000000	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	105.3	106.7	110.8	85.7	93.4	158.1	180.8	136.5	131.5	84.1	67.2	50.5	75.7	69.2	101.7	84.5	75.3	89.5	71.0	112.1	105.0	53.1	112.6	108.3	83.8	118.8	94.5	88.9	124.5	148.2	98.1	88.7	62.4	93.2	61.7	71.0	65.0	88.3	61.2	96.5	94.4	71.3	90.8	115.4	73.0	86.2	98.7	104.2	106.8	91.2	57.1	93.5	76.8	132.5	20.9	31.5	17.2	18.5	12.4	28.8	13.7	55.5	86.6	84.7	68.1	123.4	95.5	65.0	59.3	81.3	97.3	69.7	100.8	83.8	99.8	58.0	88.8	43.8	54.7	93.3	80.8	93.1	61.7	67.3	100.3	67.7	98.8	124.5	97.8	66.2	109.9	67.8	82.2	132.3	162.7	93.2	64.6	85.6	179.3	86.8	151.3	91.9	110.2	108.2	47.1	60.8	73.9	77.0	116.9	76.9	87.1	83.7	73.5	81.1	73.1	57.9	87.6	102.3	85.3	68.0	50.5	69.2	46.0	60.1	99.8	68.7	92.3	59.2	62.9	54.8	8.3	18.1	13.1	15.9	18.5	26.1	20.9	24.5	20.5	22.5	20.9	28.8	23.6	17.2	12.4	17.0	31.5	27.4	13.7	110.8	93.4	136.5	131.5	105.0	53.1	94.5	88.9	93.2	104.2	107.2	169.7	269.4	252.9	347.0	77.7	65.9	252.3	107.1	114.9	280.9	104.1	303.4	417.8	203.7	54.9	263.7	254.4	140.2	207.3	313.2	278.0	194.7	148.2	266.4	321.3	96.9	198.2	268.2	433.2	53.3	286.2	303.9	221.0	344.5	257.9	86.2	233.7	238.4	215.3	588.4	177.3	187.5	295.1	298.6	154.1	334.2	370.7	264.2	295.7	283.3
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.5	12.6	0.0	3.4	2.6	0.0	1.9	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.4	0.0	1.0	0.3	0.6	0.0	5.0	0.1	0.1	0.0	3.3	0.3	0.1	6.3	0.3	1.5	2.5	0.3	1.0	1.1	0.3	0.1	20.8	0.7	5.7	0.0	0.1	0.2	1.2	8.7	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.3	0.0	0.0	24.1	0.7	0.6	2.9	1.0	3.7	0.0	31.7	5.4	0.0	2.5	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9	17.9	45.8	7.2	2.3	1.6	324.5	94.6	0.0	0.0	7.9	5.2	19.6	0.1	8.3	1.7	3.0	2.9	0.0	0.0	0.0	0.2	8.7	2.6	1.1	3.4	0.2	187.5	60.1	19.0	2.2	2.2	27.3	1.0	10.1	0.0	0.2	87.9	0.2	0.3	13.8	0.6	25.3	6.5	25.0	4.7	5.8	0.3	0.0	1.7	0.4	0.7
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966235-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 14.1;parathyroid gland: 52.5"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 36.9"									HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	1.1	1.7	5.7	1.0	9.2	0.5	0.7	13.6	14.1	1.5	0.9	2.3	0.0	0.7	1.2	0.6	0.6	0.8	3.2	1.2	4.5	5.2	0.9	1.3	2.5	2.2	2.9	6.4	0.7	0.9	52.5	3.1	2.2	3.8	0.9	0.9	2.7	1.1	0.7	0.6	0.6	0.7	1.4	2.0	2.1	1.0	2.4	1.7	0.0	1.6	0.0	1.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.7	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.5	0.0	0.7	4.0	0.0	0.0	0.1	0.0	8.4	0.0	0.5	0.0	0.0	0.1	5.5	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.6	6.6	0.0	0.0	0.1	0.8	1.4	0.2	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.2	13.6	14.1	4.5	5.2	2.9	6.4	3.8	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051135-141059344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.3	0.3	0.1	0.5	1.0	0.1	0.1	0.2	0.5	0.5			0.4	0.1	0.6	0.1	1.8	0.0	0.1	0.4	0.4	0.7	0.1	0.2	0.4	0.2		0.1	1.1	0.7	1.9	0.0		0.1	0.0		0.5	0.0	4.9	0.8	0.5	0.0	0.3	0.3	0.8	1.8			0.3		0.0	0.1	0.1	1.3	0.7	2.5	0.6	1.0	0.6	0.2	0.8	0.4	0.8	1.1	0.2	0.2	1.1	1.1	0.2	0.1	0.1	1.6	1.4	1.1	1.6	0.3	1.1	1.5	0.0	0.1	0.2	0.9	1.2	1.2	1.9	0.7	0.1	1.4	1.2	0.2	0.3	0.2	0.2	1.7	0.2	1.0	0.8	2.6	0.2	1.4	0.7	0.9	1.2	1.2	0.4	1.2	1.0	0.9	0.1	1.0	2.2	0.8	0.1	1.8	1.3	1.2	0.6	0.5	1.2	1.0	0.7	0.8	0.6	1.5	0.6	1.0	1.1	1.1	1.2	2.3	0.6	0.7	0.5	0.4	0.5	0.7	0.5	0.4	0.2	1.3	0.6	0.5	2.5	1.0	0.4	0.7	0.3	0.2											0.0	1.4	0.0	1.1	0.0	0.2	2.2	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	18.0	17.3	25.5	21.9	29.1	13.1	14.4	18.7	29.0	17.6	13.4	27.6	18.8	17.1	23.8	20.3	12.6	22.4	23.0	9.7	24.2	17.1	23.1	21.0	16.4	23.5	30.0	20.8	28.4	16.1	38.2	27.0	16.4	25.1	25.4	9.1	21.6	23.7	18.3	6.9	12.7	18.2	15.2	14.5	33.1	20.0	9.4	28.7	14.2	36.0	4.8	16.7	15.8	17.6	9.4	8.2	3.1	7.4	14.2	12.0	6.8	12.5	16.6	16.9	9.3	17.7	24.5	12.2	12.1	13.9	13.0	14.2	11.6	23.2	3.7	8.4	8.2	21.7	20.7	4.0	11.3	6.1	18.2	12.4	14.5	18.4	16.0	14.3	2.8	4.9	32.5	24.1	15.9	21.2	18.7	9.3	18.9	11.4	17.4	9.5	8.7	2.0	18.3	18.6	9.6	9.9	10.0	5.6	7.6	14.6	10.6	15.7	24.2	12.0	15.9	20.8	11.2	20.4	9.8	8.9	12.8	8.8	13.1	5.8	28.7	14.2	1.0	3.1	10.3	15.0	2.9	7.4	3.1	11.0	6.6	10.6	8.6	6.4	9.3	8.2	9.4	12.0	10.6	0.6	14.2	6.1	7.1	4.5	6.8	25.5	29.1	18.7	29.0	24.2	17.1	30.0	20.8	25.1	28.7	14.9	20.3	6.4	10.6	3.5	10.9	4.0	5.1	6.7	10.3	8.7	9.8	4.4	11.6	3.2	0.4	8.3	6.8	0.0	1.8	2.2	8.9	7.3	0.0	11.3	6.1	11.1	8.1	11.6	8.6	2.8	8.3	8.0	1.7	2.8	6.7	9.3	4.1	7.0	2.1	8.4	11.9	6.5	7.6	11.5	7.6	3.1	2.9	11.7	5.4	5.2
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	17.6	15.2	21.8	33.5	23.3	32.1	21.1	29.7	21.3	22.1	19.7	13.6	30.8	14.0	25.6	36.8	21.9	23.4	20.8	14.0	21.7	10.0	15.7	14.5	24.0	25.8	26.6	15.4	28.9	16.1	22.4	32.5	18.9	19.2	25.6	17.9	13.8	22.5	28.5	27.0	32.5	21.2	21.4	20.6	27.2	17.7	20.1	27.4	29.4	23.4	22.5	25.1	24.8	29.3	11.4	6.8	17.5	7.2	13.0	10.5	5.3	11.2	8.1	13.1	11.2	15.8	15.5	10.6	10.8	8.0	10.5	8.0	13.7	11.3	25.4	8.2	7.8	9.9	11.4	19.1	7.4	10.1	18.0	6.5	14.8	10.5	9.6	8.9	17.4	16.6	10.9	14.5	7.9	11.6	14.1	10.5	17.1	17.2	12.4	9.7	12.0	16.3	19.4	13.7	19.3	9.1	15.6	16.6	15.2	9.1	16.8	11.0	12.2	13.2	10.6	10.6	12.7	10.5	12.1	10.8	14.9	7.7	11.0	7.1	11.2	18.7	54.0	6.5	11.6	11.5	12.0	7.2	14.2	10.5	6.9	9.1	11.4	7.4	7.6	6.7	10.4	8.6	8.5	17.5	13.0	5.1	6.8	5.1	5.3	21.8	23.3	29.7	21.3	21.7	10.0	26.6	15.4	19.2	27.4	38.7	59.9	50.4	59.3	47.7	46.6	38.1	30.6	25.4	48.9	43.6	31.4	24.8	21.6	18.2	150.1	49.7	50.2	23.3	15.9	22.0	35.6	61.5	34.8	18.3	32.9	52.4	30.6	53.4	42.5	25.5	55.8	46.3	27.0	28.9	46.6	43.9	16.5	42.1	42.5	12.6	55.5	38.8	61.3	43.2	16.6	54.7	33.0	57.3	41.7	58.5
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284331	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 252.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA038349, HPA059071"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038349: AB_10669523, HPA059071: "	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.90e-4)"	16.0	30.1	28.0	15.0	25.1	6.3	14.6	19.4	24.5	15.9	21.8	18.6	16.9	21.0	15.4	14.7	16.1	15.4	15.7	32.5	24.0	27.5	29.0	31.1	17.2	25.8	27.9	20.5	19.3	19.3	25.3	16.0	18.9	21.0	17.5	17.5	12.4	19.6	18.4	24.5	13.6	30.9	24.4	29.7	20.9	17.3	14.1	24.1	31.6	29.4	13.5	18.4	20.4	21.2	6.1	3.0	8.0	9.9	7.3	7.4	4.0	16.0	7.1	5.9	2.5	8.6	13.5	4.1	9.1	18.8	8.3	11.7	1.0	9.5	21.2	4.2	11.4	6.8	3.1	6.3	6.2	14.7	24.4	4.7	9.9	4.8	10.8	11.4	7.7	15.9	6.1	11.6	6.1	8.7	17.1	6.9	9.5	5.2	12.0	12.8	2.9	17.4	1.9	0.8	3.7	4.0	8.7	10.9	5.7	15.2	2.5	2.8	4.0	4.4	4.8	7.6	2.2	3.8	3.5	17.7	9.8	6.9	6.0	10.7	20.9	12.8	19.2	13.8	5.6	3.0	8.0	2.2	3.8	4.2	5.6	7.4	6.1	6.2	4.2	3.0	5.8	6.3	6.1	3.1	7.3	9.9	0.8	3.4	4.0	28.0	25.1	19.4	24.5	24.0	27.5	27.9	20.5	21.0	24.1	6.0	20.0	51.8	43.3	30.6	19.5	72.2	22.9	29.4	25.0	27.9	15.7	14.5	41.4	31.0	102.3	34.1	68.0	23.3	55.8	3.0	35.8	48.1	22.0	52.5	45.3	47.7	20.7	36.2	58.8	252.4	18.1	52.4	40.5	61.3	57.3	64.5	45.4	44.6	28.0	48.1	18.3	12.9	47.6	57.4	13.2	27.4	4.7	39.9	44.6	47.4
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177539-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	17.6	22.6	13.7	14.6	16.0	11.3	21.0	33.5	15.9	20.9	18.2	14.6	20.4	10.3	24.0	20.7	15.6	22.5	14.7	31.3	12.8	10.8	15.4	18.1	14.8	19.6	16.9	13.0	30.6	28.6	12.1	37.6	13.4	14.9	20.0	16.3	14.4	21.4	19.3	21.6	15.0	15.2	19.7	13.4	20.1	19.2	43.4	16.5	19.4	25.4	11.6	20.6	18.0	21.2	15.1	9.7	8.1	12.5	7.6	32.4	19.0	21.9	9.3	14.3	12.6	26.3	19.8	10.0	16.9	25.5	23.6	21.9	18.3	20.8	17.6	11.3	22.9	30.0	14.0	22.6	15.3	26.3	15.3	22.3	22.7	24.3	16.1	26.2	38.4	9.3	16.2	17.1	14.8	26.3	19.0	18.6	24.6	17.3	7.2	26.7	10.6	20.4	27.2	14.1	40.6	11.9	18.7	15.9	16.8	21.4	11.1	19.1	11.8	10.5	26.3	19.3	15.1	14.5	47.0	12.0	7.0	25.2	10.1	12.7	11.1	10.3	24.6	24.2	26.2	15.9	8.1	9.6	7.1	27.6	12.5	32.4	15.1	23.6	28.7	9.7	14.2	21.5	22.3	1.5	7.6	11.5	9.2	23.5	19.0	13.7	16.0	33.5	15.9	12.8	10.8	16.9	13.0	14.9	16.5	17.9	11.8	26.0	26.1	19.2	21.0	26.8	15.3	30.8	14.8	14.0	15.7	25.3	23.2	19.0	26.4	26.3	7.9	23.3	12.0	20.4	25.7	26.0	10.4	17.8	18.1	35.0	7.5	15.4	20.8	8.0	38.3	13.8	15.1	26.2	14.1	19.5	17.0	19.5	38.2	18.4	24.9	19.4	28.9	129.6	82.8	21.7	26.0	34.8	19.9	21.4
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: AB_2684519"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	22.0	24.1	13.1	18.2	17.1	9.0	41.1	24.3	21.7	22.8	24.4	11.7	33.2	14.8	29.0	24.5	21.6	21.5	22.1	26.1	13.5	12.6	21.5	16.7	29.2	21.0	18.4	11.4	33.3	53.8	57.9	34.2	19.2	15.6	22.8	14.8	15.0	39.8	38.8	45.7	18.0	18.7	38.5	18.9	24.3	19.6	10.4	16.9	27.8	33.6	23.6	15.5	28.4	28.6	16.5	15.4	32.4	12.1	22.3	15.2	10.6	6.5	4.2	14.5	2.6	21.4	20.1	8.3	8.7	15.5	3.7	5.9	1.9	15.1	6.3	12.2	11.6	6.2	16.2	2.5	10.2	6.5	8.0	4.9	7.2	7.5	4.4	28.3	2.6	7.4	19.9	19.5	4.6	12.7	22.7	17.5	9.4	5.5	20.7	5.8	2.7	15.1	6.6	5.6	9.7	1.9	4.7	2.8	8.1	15.1	13.0	9.6	8.1	6.1	8.0	8.7	12.1	7.9	4.0	14.3	3.3	4.4	5.0	3.1	12.6	9.4	2.2	9.9	6.3	4.0	19.6	9.6	22.9	10.2	12.1	12.4	16.2	13.0	12.1	9.7	16.5	15.2	13.4	32.4	22.3	12.1	15.4	13.8	10.6	13.1	17.1	24.3	21.7	13.5	12.6	18.4	11.4	15.6	16.9	107.2	59.0	50.0	62.9	48.0	67.0	80.0	43.3	58.9	44.3	80.3	9.8	30.3	54.7	23.7	3.8	68.6	25.0	46.7	35.1	30.0	62.0	88.3	49.9	30.5	22.5	55.6	44.9	57.1	47.5	4.7	96.4	57.4	67.4	34.3	40.3	112.9	43.4	28.1	112.8	59.7	23.9	38.8	59.7	9.3	14.7	51.8	57.3	41.5	27.0	64.6
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Rod photoreceptor cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	18.5	22.6	24.2	28.9	24.9	9.7	32.4	49.7	27.3	20.1	14.9	21.1	19.2	14.9	26.0	33.5	15.2	17.2	21.2	26.2	19.8	20.2	22.9	20.2	20.0	25.6	18.5	22.8	38.9	18.1	20.4	21.8	26.3	18.0	19.9	13.6	57.8	20.5	16.9	25.7	42.1	15.7	17.3	19.6	22.1	13.7	17.0	18.2	31.2	19.5	10.5	18.5	17.7	18.1	9.5	7.5	8.3	6.6	14.1	18.1	7.9	10.9	4.0	15.9	12.4	15.4	19.1	15.2	6.8	7.5	9.9	6.1	9.4	17.6	16.4	12.1	8.1	7.8	13.6	8.7	11.0	13.4	3.5	11.9	7.9	17.9	15.7	13.0	8.2	12.1	27.0	15.3	5.2	9.0	17.7	14.3	16.7	14.5	14.8	8.0	7.1	18.8	27.1	11.7	15.2	16.9	15.7	6.3	19.5	15.0	12.7	25.3	29.9	13.0	15.0	17.5	26.0	16.0	16.5	10.4	14.9	5.3	9.5	5.4	18.0	14.6	15.8	9.8	8.7	8.6	7.6	6.6	7.6	8.4	4.5	10.0	8.9	12.5	9.5	7.5	9.5	17.7	12.7	8.3	14.1	4.1	4.7	18.1	7.9	24.2	24.9	49.7	27.3	19.8	20.2	18.5	22.8	18.0	18.2	20.8	21.1	17.1	14.0	18.1	110.9	54.5	20.4	30.8	22.7	27.9	88.4	26.4	19.9	6.5	7.3	34.6	6.7	46.7	7.9	6.2	23.4	15.8	12.7	26.8	12.1	35.0	21.9	52.8	33.3	8.2	39.7	12.8	45.5	5.4	18.1	55.9	9.2	16.7	29.0	18.4	170.0	25.8	19.8	42.9	28.3	18.6	18.3	17.5	14.0	7.8
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574095-101594437	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	27.9	30.4	40.0	25.8	48.5	30.7	34.0	48.6	40.2	33.8	32.2	25.0	25.0	24.1	34.1	34.4	30.5	28.3	25.5	35.6	35.1	36.9	32.0	29.7	29.0	32.2	41.1	35.7	45.9	25.2	34.6	32.9	30.7	39.8	36.9	28.6	26.8	25.4	32.8	37.2	24.1	22.8	48.6	32.3	24.3	24.8	17.8	38.0	25.1	38.7	22.4	34.6	40.1	44.3	19.8	15.8	31.0	22.1	23.6	22.9	25.6	39.0	21.5	30.6	24.4	28.8	41.5	34.4	27.0	36.0	27.6	31.3	25.7	21.5	41.5	20.0	28.8	27.4	21.2	41.0	34.3	58.1	30.0	23.3	44.6	26.7	30.7	21.5	40.9	21.7	24.4	33.7	23.3	31.2	39.3	38.1	18.4	41.6	24.4	33.9	16.5	35.1	34.6	49.6	31.9	34.6	20.6	28.8	31.5	36.5	23.1	41.2	32.5	25.1	24.7	36.0	36.3	22.6	31.1	24.4	25.4	35.3	13.2	28.5	18.5	28.6	50.9	25.4	43.7	31.3	31.0	15.1	24.7	15.6	17.7	20.3	19.8	20.5	18.9	15.8	16.0	21.1	19.4	13.7	23.6	22.1	12.5	22.9	25.6	40.0	48.5	48.6	40.2	35.1	36.9	41.1	35.7	39.8	38.0	56.6	85.6	123.1	198.8	206.6	88.0	104.4	40.8	76.3	75.1	61.1	37.3	103.3	225.5	110.5	19.7	119.3	36.9	93.5	83.2	165.8	133.0	159.9	99.4	48.4	81.1	92.2	78.6	69.3	77.9	9.6	121.1	124.6	237.8	140.7	62.5	68.0	98.5	63.1	126.6	113.9	66.7	129.4	228.9	90.0	72.4	208.4	197.3	140.2	67.4	167.6
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.3	1.4	0.0	25.9	7.2	0.0	0.3	0.1	1.2	1.5	0.2	0.5	0.0	1.2	1.9	6.4	0.0	5.1	0.0	1.4	0.0	8.5	0.9	2.8	0.0	0.0	0.5	0.0	2.9	0.0	2.6	0.7	5.9	0.0	0.7	0.2	0.0	0.5	0.7	1.5	0.4	2.1	0.1	9.0	0.0	3.2	13.5	1.3	0.0	2.7	1.7	6.7	0.0	2.5	1.9	0.0	1.8	0.0	2.3	5.2	29.0	2.1	28.7	13.2	0.0	6.4	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3	0.0	2.7	0.0	0.5	6.5	13.2	33.1	0.0	0.0	1.2	12.2	23.6	99.1	0.0	0.0	0.5	2.7	0.0	0.0	0.0	55.3	87.7	0.6	1.1	12.1	13.7	6.4	0.0	0.6	0.6	0.6	0.6	2.6	3.3	0.0	0.0	13.7	0.5	0.0	0.0	0.0	11.1	0.0	6.3	8.7	49.4	6.5	202.1	0.0	0.0	0.1
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867317-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 177.9;seminal vesicle: 234.5"	"Cell type enhanced"	"Detected in many"	23	"Bipolar cells: 431.9;Distal tubular cells: 547.2;Horizontal cells: 1320.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 177.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 57.7;SK-BR-3: 9.7;T-47d: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	2.1	11.0	5.6	1.4	177.9	1.0	2.6	15.8	15.8	39.3	10.6	11.4	50.8	1.9	11.4	65.7	38.4	2.9	1.7	1.7	8.3	14.0	9.7	1.0	1.1	1.0	11.6	3.7	1.2	2.1	3.4	1.0	1.3	20.0	60.9	6.9	49.0	1.7	234.5	1.0	1.4	1.5	93.5	3.7	1.5	1.1	1.2	37.5	0.0	39.2	0.0	1.2	65.6	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	57.7	0.0	0.0	0.1	0.1	0.0	9.7	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	177.9	15.8	15.8	8.3	14.0	11.6	3.7	20.0	37.5	0.0	1.0	0.0	0.5	2.7	431.9	8.1	5.1	0.0	0.0	73.3	58.9	0.2	547.2	0.3	1.1	0.3	0.0	0.0	0.2	0.2	1.5	4.0	0.0	0.0	0.2	1320.5	1.2	0.0	0.0	0.0	8.9	1.9	20.3	0.0	0.0	53.7	1.2	0.0	0.4	219.7	168.9	0.0	3.1	0.5	3.8	5.3	2.4	0.0	0.2	0.9
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"RT4: 16.1;T-47d: 10.5"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	16.1	2.2	0.0	0.0	0.3	0.0	0.2	10.5	0.4	0.2	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3	3.0	5.4	0.0	23.9	0.0	34.5	0.2	0.0	0.0	7.9	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.2	1.8	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	1.8	0.0	4.1	19.4	9.5	0.2	0.2	0.3	1.5	0.0	0.0	42.7
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.8"	"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.7	8.1	6.1	2.2	8.2	8.0	15.7	3.4	4.6	5.5	5.4	9.1	11.4	2.4	26.8	5.4	5.1	4.9	3.5	5.8	5.0	38.8	8.2	21.7	2.4	16.9	7.3	8.2	17.2	6.6	7.7	3.2	6.0	6.8	10.6	7.4	15.6	8.8	6.0	7.6	6.5	6.7	6.6	0.0	7.2	3.3	8.8	2.0	5.8	6.5	3.0	6.9	1.7	3.8	14.5	14.0	10.1	14.3	7.7	6.3	4.5	7.0	4.5	24.9	7.8	1.5	5.8	13.6	10.8	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9	3.0	7.2	5.1	2.5	0.9	3.8	15.3	17.8	2.7	0.0	8.7	2.0	42.8	10.0	11.2	13.2	7.3	11.8	0.0	12.0	61.2	6.7	1.4	15.0	64.8	19.2	1.6	12.6	9.2	22.6	15.4	15.3	12.6	11.8	10.8	16.2	3.5	8.3	7.0	24.4	30.7	2.2	12.9	10.3	9.8	8.1	1.3	56.2	8.5	14.3	1.7
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358007-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted - unknown location"	NA	NA		930000	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	4.8	6.6	4.5	7.2	13.5	6.9	4.0	15.9	19.0	6.5	4.4	8.2	2.7	2.3	6.2	2.7	4.6	7.9	5.8	5.2	4.6	8.9	3.7	1.2	4.2	9.6	5.5	9.9	7.9	6.7	27.0	6.4	6.2	13.7	6.4	2.1	9.4	3.4	6.6	1.6	6.6	5.6	6.0	4.6	6.3	5.8	11.5	2.4	5.8	3.3	3.1	7.4	5.0	4.7	1.8	13.5	3.9	9.6	4.5	7.2	4.5	2.1	1.5	2.9	6.3	2.4	1.5	2.1	5.1	1.0	2.5	5.3	0.4	3.5	9.7	15.4	1.6	14.7	4.3	3.2	7.2	0.3	4.7	4.7	4.5	0.0	0.3	7.0	2.9	4.2	6.4	1.2	5.0	4.4	3.4	7.9	8.4	2.6	19.2	0.2	3.4	2.7	4.2	2.7	3.2	9.2	5.2	2.3	25.7	1.0	0.6	5.9	7.7	10.0	3.6	7.9	1.4	9.5	5.5	4.6	2.9	3.1	7.2	2.0	11.3	15.2	5.5	6.1	17.8	7.4	3.0	7.1	3.9	3.0	9.6	4.0	1.8	5.7	2.3	13.5	1.2	6.8	4.7	1.2	4.5	9.1	1.3	7.2	4.5	4.5	13.5	15.9	19.0	4.6	8.9	5.5	9.9	13.7	2.4	8.9	1.7	0.0	1.1	0.9	4.5	4.5	5.1	1.4	2.3	1.8	0.0	4.0	0.0	2.2	2.8	3.8	0.9	0.0	2.1	6.2	2.8	0.7	2.3	0.0	6.4	11.1	0.0	2.5	4.7	1.1	3.1	4.8	1.7	3.6	1.7	6.8	1.7	1.1	2.5	0.3	12.8	0.0	1.2	0.9	3.3	1.4	1.0	2.1	2.2	0.6
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.7	11.6	8.1	11.9	16.7	18.6	12.3	22.0	15.7	18.9	16.7	28.3	10.5	7.4	73.8	25.2	19.9	22.5	12.9	16.9	16.2	13.4	9.0	21.2	12.2	12.0	15.0	10.2	18.2	15.7	13.0	18.3	13.1	12.2	20.2	6.9	11.8	16.5	18.8	24.3	6.4	5.4	7.0	18.1	17.3	10.6	10.4	11.9	11.6	16.2	8.0	5.9	14.9	25.7	14.3	11.8	37.7	12.8	30.2	15.1	8.4	20.5	29.7	15.3	29.1	13.6	23.1	14.3	18.9	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6	14.9	18.8	17.9	8.2	12.9	14.3	58.5	17.8	33.5	15.9	14.0	23.6	10.4	11.6	21.4	63.4	19.5	43.0	0.0	19.9	14.2	13.7	9.7	19.7	31.7	32.6	7.9	21.2	25.2	28.9	52.1	18.4	30.0	18.6	33.3	20.4	11.8	20.8	14.8	26.5	19.4	12.4	25.8	13.7	30.0	10.6	18.7	15.6	22.7	20.5	11.0
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 615.4;Late spermatids: 2143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7000	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	11.8	6.8	5.5	15.5	27.6	14.5	8.1	8.5	18.4	12.0	14.3	26.7	12.4	4.1	4.7	8.9	22.3	9.8	8.3	15.9	7.0	1.2	6.8	9.0	9.4	61.2	29.5	9.0	7.6	11.9	9.2	10.8	8.4	4.3	11.1	12.7	16.7	8.6	8.9	10.0	10.7	11.1	4.4	41.7	7.3	7.1	5.9	14.7	14.4	22.5	7.0	6.4	6.4	35.5	8.3	11.3	9.8	21.4	7.4	8.9	5.8	6.6	7.0	5.6	2.3	4.0	9.2	12.1	8.7	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0	0.0	15.9	13.0	6.8	4.7	11.8	14.9	56.0	10.7	4.5	24.4	0.0	67.4	101.2	15.9	615.4	7.1	65.6	23.3	16.0	30.7	6.8	9.0	9.2	125.6	20.2	15.9	13.4	20.3	10.0	2143.8	25.6	9.3	32.1	21.6	22.6	19.8	17.5	17.3	24.4	119.0	7.1	25.8	11.4	131.3	17.2	5.0	42.4	12.5	30.7	4.5
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	22.8	24.2	18.1	25.4	16.7	20.0	73.3	14.2	20.2	19.6	25.6	12.0	26.6	21.6	23.1	28.5	29.8	23.3	28.3	32.0	17.0	15.6	28.5	33.4	27.5	52.9	16.5	12.8	24.3	53.4	19.9	16.4	21.2	15.4	21.6	26.8	18.0	27.0	32.0	30.8	19.1	26.1	20.7	20.8	30.3	26.3	17.2	10.5	44.3	31.9	28.5	32.9	25.2	22.3	13.8	15.3	9.6	12.3	16.4	17.5	10.6	13.4	9.9	15.0	35.2	21.7	23.9	16.6	16.1	18.5	19.1	21.4	17.7	11.9	24.5	13.1	17.7	25.6	19.4	32.2	26.7	28.1	20.0	35.2	34.7	12.8	32.0	26.4	43.0	23.4	21.7	26.3	24.2	39.3	20.1	26.5	34.1	68.8	16.0	23.3	29.4	29.8	31.1	21.6	43.7	15.2	21.3	11.6	31.7	28.8	8.0	27.7	28.9	18.3	30.0	18.8	17.1	15.2	44.1	20.0	9.4	20.3	22.4	28.4	21.6	25.1	26.6	17.6	42.1	24.0	3.7	11.0	9.6	13.4	10.6	15.7	13.3	15.3	14.1	15.3	13.8	15.2	14.1	4.7	16.4	12.3	14.2	17.5	10.6	18.1	16.7	14.2	20.2	17.0	15.6	16.5	12.8	15.4	10.5	11.9	11.7	52.0	64.7	44.0	33.6	21.0	35.7	14.7	10.3	27.9	11.8	52.7	66.3	54.2	13.5	31.8	31.0	23.3	64.2	59.4	32.4	48.8	16.1	24.6	43.9	15.9	45.3	38.6	37.4	12.9	45.5	39.8	33.7	35.1	39.8	22.3	51.7	35.1	38.2	65.4	32.9	19.4	39.1	28.4	93.3	40.3	39.0	65.7	63.8	68.2
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581068-32587452	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		31000	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	34.1	40.6	42.1	32.3	35.9	18.9	28.9	28.7	33.0	21.2	31.7	16.4	27.0	31.4	22.9	24.8	33.8	21.4	23.1	63.7	33.0	34.2	37.0	52.0	20.6	25.9	32.9	31.9	25.8	47.6	14.7	38.8	29.5	31.0	23.2	27.6	14.7	27.3	24.5	107.4	23.9	27.1	32.1	26.4	26.8	28.0	52.4	23.5	15.2	25.4	42.7	26.6	30.6	31.8	34.6	29.1	11.2	44.8	24.2	49.8	26.9	69.3	86.3	20.8	22.4	35.2	54.4	26.9	51.2	33.0	41.6	35.9	69.9	26.7	37.8	74.8	25.0	38.4	18.6	28.8	39.1	31.9	68.1	46.3	57.1	37.9	41.7	41.9	72.7	23.0	34.5	37.2	28.2	46.4	20.3	27.7	30.0	51.9	41.5	35.0	44.4	32.5	37.8	22.8	54.1	29.3	32.0	32.0	45.7	31.9	18.1	43.9	25.0	48.6	47.4	35.3	15.2	20.7	42.6	42.7	37.4	41.8	40.3	82.5	40.3	57.1	65.7	44.5	66.7	33.0	6.9	23.1	11.2	26.7	34.9	33.9	34.6	42.9	33.0	28.5	25.5	30.4	29.3	3.2	24.2	44.8	29.1	49.8	26.9	42.1	35.9	28.7	33.0	33.0	34.2	32.9	31.9	31.0	23.5	68.5	54.2	33.4	145.9	108.0	36.9	288.5	96.8	120.5	73.9	71.5	25.5	162.5	160.8	234.0	357.7	120.8	81.3	0.0	214.8	167.1	134.8	123.3	46.1	120.1	128.8	47.7	68.5	80.4	43.1	361.1	132.0	84.8	118.1	147.9	102.5	60.5	238.5	74.8	115.6	146.4	36.6	71.1	140.0	373.0	377.8	104.8	119.6	62.3	133.4	113.1
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-353856	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		2100000	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	28.3	48.5	44.6	36.3	42.1	21.0	44.6	42.1	52.0	37.1	47.3	33.7	35.7	41.4	31.5	59.7	58.0	38.9	46.5	23.5	44.4	39.7	35.5	37.1	39.8	48.1	39.2	38.6	36.9	46.2	28.8	36.2	35.4	39.3	32.9	51.0	26.8	40.3	40.4	19.2	31.1	44.3	31.4	38.4	36.6	32.0	31.7	35.1	31.0	42.3	31.9	41.2	31.3	37.7	69.8	67.2	79.9	62.3	70.6	69.9	89.4	27.3	38.5	16.9	25.2	30.7	27.8	34.7	21.3	28.4	27.4	25.8	27.1	34.7	21.5	53.2	28.7	35.6	20.8	25.5	53.6	22.3	72.7	31.6	19.1	99.1	35.0	37.6	27.6	24.5	24.8	33.1	22.2	40.0	28.5	25.7	15.2	24.0	17.0	24.5	42.8	22.4	48.3	17.9	33.5	54.4	18.4	15.7	30.7	64.8	35.3	16.3	22.0	54.2	58.1	39.7	18.3	40.4	38.5	19.8	18.2	14.7	15.7	18.2	22.6	28.0	25.5	26.6	36.2	24.1	40.8	62.3	79.9	49.6	58.7	61.7	69.8	62.2	55.8	67.2	60.9	69.9	56.2	69.0	70.6	56.1	53.8	66.7	89.4	44.6	42.1	42.1	52.0	44.4	39.7	39.2	38.6	39.3	35.1	59.6	50.2	74.3	103.0	72.9	44.2	43.4	84.1	89.7	69.4	97.7	35.3	208.9	213.9	147.4	51.9	103.4	116.6	23.3	113.2	262.6	88.0	103.4	81.8	70.0	126.3	60.4	76.5	63.8	70.9	40.4	108.7	80.4	118.1	180.3	159.6	116.3	131.1	136.8	109.6	163.7	39.4	84.1	82.4	81.7	129.8	80.8	298.3	82.9	170.4	145.4
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828631	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	20.7	14.8	17.5	14.1	21.0	23.8	23.0	20.5	21.9	19.6	15.1	23.7	11.4	13.2	21.5	12.8	18.4	15.9	14.9	14.6	18.4	17.3	13.7	10.1	19.7	17.5	20.2	17.1	15.5	13.0	17.5	13.7	20.6	22.2	17.1	15.9	13.9	21.7	14.7	8.1	15.4	14.7	17.2	22.8	18.4	15.5	12.1	18.8	19.1	17.3	13.3	17.6	15.8	16.4	12.6	14.7	20.6	16.3	16.2	25.3	10.8	9.6	13.3	23.1	8.5	21.0	14.2	12.8	13.5	14.3	12.5	12.9	8.8	12.8	16.1	11.1	16.2	13.8	18.9	14.2	13.3	14.0	15.7	7.2	16.6	17.8	14.7	10.8	14.0	32.9	12.1	9.7	12.3	6.2	11.8	25.7	10.3	16.6	9.5	14.1	14.8	14.9	12.6	16.9	16.6	10.5	15.7	21.9	11.9	15.2	0.0	18.5	16.5	18.3	10.4	8.1	15.8	15.7	9.7	28.0	11.7	13.9	17.0	13.0	7.3	14.6	17.2	10.0	11.3	11.1	20.6	11.9	19.6	13.9	10.4	15.0	11.4	16.7	12.8	12.3	12.6	17.5	15.2	9.8	16.2	16.3	14.7	25.3	10.8	17.5	21.0	20.5	21.9	18.4	17.3	20.2	17.1	22.2	18.8	8.9	8.6	12.8	13.9	21.5	41.4	3.6	10.2	18.7	4.5	19.2	21.6	24.0	8.3	18.4	4.7	30.5	7.9	0.0	15.8	22.8	25.4	15.3	56.5	6.6	22.4	38.1	12.1	26.4	23.7	2.1	21.3	16.0	18.6	41.5	17.7	34.4	14.0	15.9	15.9	11.8	34.6	19.4	22.7	12.0	17.2	20.3	26.7	20.8	12.1	14.0
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562690-100576735	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 154.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	12.9	15.9	14.7	16.4	16.2	12.0	18.0	10.7	16.5	12.7	18.8	14.3	15.3	10.5	20.1	23.5	22.5	14.9	13.1	17.6	14.6	15.8	20.9	12.2	13.5	14.0	24.4	15.9	15.4	10.4	10.8	11.4	17.1	17.4	19.6	17.9	10.2	12.0	15.4	35.7	22.0	12.1	49.6	18.3	14.5	13.3	14.0	14.5	13.4	13.0	18.8	19.6	29.9	16.8	26.5	33.4	22.2	43.6	25.6	31.4	23.3	12.8	18.0	19.0	16.4	6.1	8.6	21.1	16.0	9.9	29.0	18.1	22.6	8.0	20.7	24.4	18.7	39.1	10.8	23.4	15.4	23.0	33.3	20.2	21.9	9.7	26.4	16.2	23.1	23.4	9.5	28.3	25.6	16.4	7.6	17.8	16.6	18.1	14.1	21.5	21.9	23.1	35.5	24.8	13.8	26.5	22.6	20.3	14.5	17.7	29.8	17.8	15.7	12.6	17.2	17.6	16.0	13.5	16.0	13.9	18.2	19.4	14.1	22.0	8.5	15.8	21.8	11.3	27.0	14.3	18.6	19.3	22.2	19.4	34.9	22.1	26.5	29.7	21.5	33.4	20.8	31.0	23.8	2.1	25.6	43.6	18.4	31.4	23.3	14.7	16.2	10.7	16.5	14.6	15.8	24.4	15.9	17.4	14.5	17.9	28.0	24.3	30.3	58.3	10.6	33.9	20.4	22.7	33.0	14.0	5.9	56.6	51.4	45.5	25.5	21.8	14.2	0.0	33.9	42.2	26.3	23.8	88.1	14.7	52.5	11.1	19.0	15.4	12.4	11.4	13.6	57.2	33.7	154.1	22.6	13.5	29.8	17.5	31.5	63.2	11.2	51.8	50.5	5.2	45.8	50.3	43.8	40.8	28.7	30.1
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469631	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 31.8"	"Cell type enhanced"	"Detected in many"	13	"Late spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.0;NB-4: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	6.4	2.5	9.0	4.2	13.9	3.4	6.3	15.0	38.5	8.4	4.3	3.2	0.4	2.0	4.4	1.1	3.1	4.8	5.0	4.1	12.4	6.9	2.8	1.9	7.7	2.0	5.3	19.4	1.7	9.8	17.3	2.3	4.9	34.7	3.7	3.0	3.1	7.1	4.0	26.1	2.2	2.7	4.7	3.6	4.1	6.1	31.8	4.5	0.0	5.4	1.0	1.9	4.6	3.5	0.2	3.3	5.9	4.4	5.3	2.0	1.3	0.0	1.4	0.3	3.9	11.6	6.9	2.2	3.3	6.6	0.4	1.1	3.5	3.2	1.5	9.7	8.5	0.2	0.3	2.3	0.4	0.2	3.8	3.3	13.6	4.7	3.8	7.5	2.2	22.0	5.1	0.4	3.7	0.0	0.4	3.1	1.2	10.7	3.3	2.3	1.0	1.3	25.3	1.8	3.9	2.8	8.9	2.2	11.7	0.6	0.8	2.5	0.9	0.2	0.1	3.6	0.6	0.5	4.5	6.6	5.0	6.5	3.4	2.1	6.5	0.5	7.2	2.1	0.1	4.0	5.9	2.6	5.1	1.5	4.4	0.8	0.2	0.5	2.0	3.3	0.1	0.1	0.7	0.2	5.3	4.4	0.2	1.2	1.3	9.0	13.9	15.0	38.5	12.4	6.9	5.3	19.4	34.7	4.5	3.0	15.2	8.0	2.7	9.0	23.9	5.8	12.7	10.7	7.9	8.7	0.0	0.3	0.0	2.8	44.2	10.9	1.3	0.0	11.1	4.3	13.4	3.1	32.2	0.8	9.8	52.4	0.0	11.6	18.3	164.4	16.1	37.2	13.5	14.4	6.2	1.3	10.6	0.0	17.0	0.0	2.6	6.5	8.1	7.7	7.8	7.0	0.3	16.0	6.8	1.4
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.4	1.4	0.4	1.2	0.0	0.5	1.1	12.4	0.2	0.1	1.4	0.2	0.5	0.2	0.1	0.3	0.9	0.1	0.0	0.2	0.2	1.1	0.7	28.4	0.3	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.6	0.0	0.6	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.3	0.1	0.8	1.4	0.7	0.0	0.3	3.8	1.1	1.7	7.6	0.8	1.1	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7	3.0	3.2	0.0	1.6	0.3	11.8	26.4	0.0	0.0	2.3	1.8	51.1	0.0	0.0	1.8	3.6	0.7	0.0	0.0	0.0	0.0	2.3	41.8	1.1	0.0	0.3	65.2	4.7	4.3	0.6	3.0	5.5	0.0	1.7	0.0	0.6	77.6	0.2	0.0	0.0	0.8	4.6	6.5	8.2	0.6	2.1	1.0	0.0	0.0	0.5	2.4
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in single"	21	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	9.0	6.1	1.2	2.9	1.8	1.4	10.7	7.6	2.0	5.4	4.7	15.0	6.4	16.7	10.1	2.6	2.5	13.0	3.7	4.0	2.2	4.0	31.0	8.5	5.8	21.4	3.7	11.8	6.8	2.8	7.1	4.8	2.3	0.9	3.1	8.6	20.3	1.9	2.9	11.6	9.2	12.4	7.8	3.3	11.2	21.7	1.9	15.5	4.3	5.7	10.4	8.3	13.1	2.3	6.4	0.5	12.9	3.8	4.7	4.7	8.8	5.4	8.7	15.8	10.5	19.7	3.1	8.8	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.3	24.1	30.2	35.7	36.8	48.2	18.5	40.8	13.6	30.5	33.1	11.1	33.7	22.1	27.3	23.6	24.8	36.4	50.5	36.3	28.6	29.5	20.5	30.3	20.5	28.7	16.9	41.9	30.7	34.1	18.7	18.4	38.7	18.2	27.9	31.0	38.2	20.2	30.4	13.3	21.6	39.3	56.3	26.2	19.3	21.2	22.3	32.2	24.0	41.8	47.6	31.7	22.5	19.1	25.5	20.0	27.2	25.8	36.6	28.7	29.3	35.1	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5	56.6	28.0	47.4	32.8	24.7	30.0	245.7	48.4	69.6	48.9	33.2	23.6	144.4	195.6	84.1	43.2	62.9	34.8	23.3	63.6	85.4	31.9	17.8	38.1	61.1	74.4	54.0	55.7	43.6	38.0	10.4	55.8	41.0	54.0	89.2	44.3	51.8	51.0	41.3	48.1	105.9	44.7	64.7	61.8	85.0	80.3	26.1	131.5	46.0	47.8	28.8
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.2	11.1	10.0	11.8	8.9	1.2	7.0	10.4	10.5	10.2	0.8	7.0	8.1	11.7	19.5	7.1	3.1	7.4	2.8	10.3	16.3	10.3	7.2	9.1	6.8	6.3	0.0	7.8	18.7	10.8	6.8	0.5	18.5	9.1	10.4	2.9	8.1	5.9	8.2	6.0	0.0	2.4	19.5	9.0	9.1	24.9	10.9	5.7	5.5	7.4	11.2	9.9	3.1	4.7	14.2	18.3	7.2	4.7	12.3	10.1	8.4	5.1	16.0	15.1	4.4	18.0	2.6	7.9	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4	8.9	9.3	13.6	13.9	13.5	20.8	5.0	10.2	1.4	11.4	19.2	5.9	15.1	49.7	8.0	7.3	8.3	46.6	0.0	7.9	3.4	19.5	7.6	1.1	39.8	16.7	41.3	13.3	13.5	13.7	15.0	22.5	7.9	23.6	15.4	45.3	33.6	7.9	43.6	49.5	118.5	9.2	19.4	12.1	3.3	4.4	16.4	6.6	15.8	37.1	8.4
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	28.1	14.8	0.0	8.0	20.0	2.4	1.5	7.5	0.0	0.0	0.0	10.7	0.3	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	4.7	0.0	0.0	20.5	0.0	6.7	0.0	2.9	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.8	5.1	0.0	3.7	5.8	4.7	2.2	0.0	0.0	10.1	0.7	11.3	1.0	0.3	0.0	0.1	14.8	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9	0.0	0.0	0.0	9.3	2.2	9.5	61.9	0.0	0.0	0.0	5.2	5.9	0.6	1.7	0.0	0.4	1.3	0.0	0.0	0.4	0.2	24.4	12.7	0.0	0.0	0.7	0.0	20.3	0.0	0.0	0.4	21.6	0.9	15.1	0.0	7.0	20.0	0.4	0.0	26.5	6.3	1.5	0.0	15.5	0.2	4.1	1.6	0.7	0.0	2.3	4.3
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205337-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 199.4"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 420.2;Muller glia cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.6"	"Group enriched"	"Detected in all"	6	"B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		240000	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	45.3	20.4	105.3	28.7	83.6	3.8	25.3	30.5	173.1	25.1	15.5	68.1	5.0	8.0	21.5	21.8	22.6	19.2	22.1	53.9	70.5	81.3	14.8	10.4	23.8	16.6	106.5	67.0	19.7	9.7	14.9	10.2	25.1	74.1	24.4	15.3	18.2	12.3	31.1	10.2	16.9	8.8	47.4	199.4	23.8	10.0	17.5	53.7	1.6	12.6	6.0	22.9	22.4	17.5	7.6	22.1	1.8	30.6	3.1	3.5	5.4	16.9	5.9	24.6	10.6	45.6	25.6	8.2	73.6	64.4	61.3	43.1	13.0	9.2	7.9	26.7	91.9	29.5	18.6	9.1	23.0	48.0	4.2	5.1	6.5	4.1	3.3	56.4	2.1	8.0	21.4	13.0	33.7	43.1	33.9	46.0	5.8	6.7	14.4	81.9	8.4	2.5	5.1	16.3	20.1	17.0	4.2	25.9	5.4	22.2	8.9	4.9	13.0	39.0	26.7	22.4	55.7	16.4	15.3	61.3	40.8	32.0	30.3	31.6	11.4	7.0	15.0	37.6	4.1	57.7	0.3	15.3	1.8	3.5	30.6	2.7	7.6	2.6	2.8	22.1	5.0	1.6	1.8	0.7	3.1	13.9	9.7	2.9	5.4	105.3	83.6	30.5	78.2	70.5	81.3	106.5	67.0	74.1	53.7	14.9	34.6	27.0	105.8	71.2	125.0	203.8	12.7	14.7	27.3	5.2	68.7	17.0	24.9	58.7	49.2	107.8	6.4	0.0	40.4	47.2	66.7	105.1	31.1	4.9	63.6	87.4	11.5	95.2	34.2	51.6	61.9	76.5	70.9	420.2	11.3	271.7	77.0	3.5	103.3	8.1	109.8	45.3	97.6	12.7	2.7	64.1	37.9	14.9	9.7	151.1
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Group enriched"	"Detected in many"	13	"Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.4	95.0	40.1	2.0	3.6	5.5	7.3	4.3	5.2	7.1	22.3	4.4	0.2	0.2	8.4	10.8	0.8	123.3	5.2	7.3	0.3	13.0	0.0	15.3	95.0	1.5	15.1	0.0	8.0	1.7	13.0	9.0	4.6	3.1	0.0	0.0	29.8	10.2	0.6	0.0	0.0	43.5	2.2	8.5	5.7	30.4	7.9	23.9	9.9	60.4	3.4	0.0	2.0	7.2	24.9	12.9	0.0	0.0	4.2	0.2	0.5	5.5	8.0	5.3	11.8	9.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1	142.9	64.2	2.4	7.4	0.7	70.4	25.2	7.6	16.0	126.3	15.7	7.9	1669.7	54.7	10.7	2.8	2.4	0.0	0.0	4.3	85.1	27.1	7.0	2.3	2.9	150.9	35.0	58.0	2.5	0.0	11.4	8.3	1.4	13.5	0.0	0.7	118.3	4.2	0.0	3.9	10.0	25.7	6.5	12.5	16.4	5.1	0.6	2388.4	0.5	0.1	0.6
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.9	35.0	13.9	21.9	10.8	8.0	31.2	11.6	8.1	16.1	17.3	34.1	11.8	38.5	17.9	9.1	11.4	24.6	25.8	18.1	9.2	19.9	36.8	17.1	17.6	27.5	14.0	13.8	23.1	9.8	11.3	19.8	16.7	8.3	11.9	20.8	20.6	16.9	8.8	21.9	26.0	16.3	22.8	15.5	11.8	27.5	12.3	18.9	11.2	12.1	14.0	18.7	19.9	14.7	14.9	13.9	17.7	9.4	12.0	12.5	17.7	18.9	22.3	9.1	15.6	16.0	14.1	14.3	16.0	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1	20.8	29.6	16.3	12.9	13.2	23.9	19.8	5.1	20.1	19.4	8.7	15.7	24.8	1.7	13.2	47.9	13.2	6.2	0.0	12.6	23.5	14.1	12.3	29.0	9.0	14.7	33.4	12.1	4.9	4.5	17.5	8.6	13.8	10.1	107.4	16.1	12.5	11.1	12.4	18.0	4.1	16.6	6.5	9.9	21.4	71.6	14.3	17.7	13.1	18.8	10.6
PER1	"PER, RIGUI"	ENSG00000179094	"Period circadian regulator 1"	O15534	17	8140472-8156506	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.7;hTCEpi: 27.6;hTERT-HME1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047947, HPA067064"			Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA047947: AB_2680219, HPA067064: AB_2685774"	"unprognostic (7.64e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	39.4	33.4	13.2	21.6	15.0	27.3	31.3	19.5	23.9	27.8	24.6	20.9	27.8	6.9	19.5	17.2	31.6	25.2	36.9	24.0	13.3	6.3	14.2	18.6	25.8	10.8	15.6	11.3	50.1	61.8	19.3	29.8	12.7	20.1	23.1	8.1	36.6	23.3	43.5	70.3	47.9	16.9	29.3	17.5	16.7	23.6	13.8	17.1	4.6	28.5	33.1	12.1	30.2	25.0	1.6	4.9	3.3	3.6	0.5	2.1	1.2	1.0	3.9	4.5	6.5	14.8	10.9	2.5	1.5	2.8	2.0	2.4	3.9	2.5	7.3	1.2	2.2	2.2	3.1	4.5	23.7	1.4	2.3	5.6	3.8	8.5	1.1	20.4	1.5	5.8	16.3	27.6	3.4	27.0	2.6	4.3	5.6	4.7	10.1	3.6	3.5	4.4	3.0	3.8	1.2	2.6	6.1	2.5	3.8	4.7	0.8	1.9	4.8	3.3	3.8	3.1	1.9	2.8	1.1	7.3	2.3	4.3	0.8	1.3	6.0	2.2	2.5	3.1	1.9	1.6	0.0	3.6	1.7	1.9	2.5	2.1	1.0	1.7	1.2	4.9	1.6	1.6	1.1	3.3	0.5	1.2	0.7	1.1	1.2	13.2	15.0	19.5	23.9	13.3	6.3	15.6	11.3	20.1	17.1	50.6	66.2	20.2	37.2	47.3	37.1	20.0	33.1	30.8	42.1	26.2	92.3	5.0	5.0	4.0	27.7	50.9	21.9	23.3	3.5	3.3	40.1	42.6	67.1	35.2	17.4	19.1	48.1	36.2	45.9	38.0	38.0	57.8	45.5	7.2	12.9	31.6	7.5	14.4	31.8	3.3	48.6	32.3	42.8	5.2	7.8	52.2	11.3	20.8	9.3	9.3
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244038-238290102	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.7	3.8	5.1	11.4	10.3	7.8	16.1	16.0	13.4	16.4	8.8	9.2	12.8	5.5	15.4	9.7	15.2	11.8	15.6	6.7	5.8	4.7	4.9	13.7	7.9	4.8	4.7	6.8	14.6	15.7	5.5	11.1	8.4	8.0	12.9	7.1	11.6	23.0	20.7	11.9	20.0	9.1	13.5	4.5	4.9	14.8	19.0	5.3	6.0	9.9	21.3	13.7	11.1	11.3	4.5	4.8	4.1	5.6	3.1	4.5	0.8	1.4	10.1	2.2	3.7	0.1	1.1	7.3	1.0	3.6	1.3	1.3	1.5	5.1	8.8	1.0	2.3	1.4	7.5	2.1	3.0	1.9	2.5	1.5	7.7	5.2	6.9	1.8	11.6	8.2	1.4	7.4	1.6	5.4	1.3	0.7	3.6	3.7	5.6	1.1	6.5	5.7	12.8	3.1	6.5	2.0	13.9	4.9	2.9	1.3	2.9	8.6	1.0	2.5	5.5	1.6	0.7	5.2	7.3	1.8	3.2	3.8	2.5	3.5	6.3	1.4	10.7	6.0	5.1	3.9	4.1	3.7	0.9	2.9	5.6	4.5	4.4	4.5	3.4	3.7	4.5	4.4	4.5	2.9	3.1	5.1	4.8	3.1	0.8	5.1	10.3	16.0	13.4	5.8	4.7	4.7	6.8	8.0	5.3	14.9	26.7	4.2	49.4	65.7	21.5	5.2	20.4	41.5	52.4	26.2	2.0	7.0	6.6	6.4	4.2	9.3	14.6	0.0	9.0	5.4	17.7	14.6	9.2	32.6	3.4	11.1	23.6	8.6	8.9	2.5	10.3	9.3	23.6	1.0	21.2	13.2	7.0	24.3	17.3	3.3	8.0	6.5	25.8	24.7	15.9	74.5	10.9	7.2	24.4	18.4
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918837	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017150, HPA050104"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	12.0	17.3	25.9	13.3	29.5	8.5	24.4	25.1	39.6	19.9	18.2	17.3	21.3	18.4	16.2	27.2	21.6	20.1	14.7	17.9	25.8	28.1	25.4	19.8	14.9	18.4	24.0	20.3	19.7	23.2	20.4	16.4	17.3	26.9	18.2	21.7	15.7	19.0	20.9	23.7	20.6	17.2	16.1	14.7	18.7	18.4	18.0	14.8	21.4	20.3	17.2	25.3	16.7	13.9	42.5	42.8	32.0	29.6	29.5	37.0	34.1	11.2	10.3	9.2	9.1	21.5	16.9	9.5	11.4	15.2	15.0	11.6	4.7	13.2	10.6	12.4	16.2	7.3	13.8	8.0	17.0	10.5	11.8	6.0	6.5	6.8	12.2	30.4	19.4	12.0	22.2	21.3	10.1	10.0	19.3	19.0	14.9	11.8	17.6	23.6	17.9	14.9	18.5	3.3	24.1	12.8	13.8	13.8	23.1	25.7	8.0	6.4	10.5	8.6	16.6	10.4	9.6	23.0	30.3	16.9	10.1	8.1	13.2	8.3	19.0	21.9	15.0	17.1	11.0	6.9	32.0	29.6	20.6	28.7	26.3	31.2	42.5	32.9	31.0	32.0	37.2	37.0	33.5	14.7	29.5	25.8	42.8	34.8	34.1	25.9	29.5	25.1	39.6	25.8	28.1	24.0	20.3	26.9	14.8	14.9	10.1	11.9	7.5	17.2	7.2	11.8	17.8	12.0	6.8	38.4	0.0	31.7	38.1	11.9	9.5	11.7	16.7	0.0	12.2	11.2	11.8	8.1	3.5	27.2	19.8	4.8	12.2	12.9	18.1	15.7	13.0	11.3	20.3	31.5	18.1	12.6	12.4	14.0	18.7	27.8	4.5	6.5	6.2	34.7	19.1	19.3	16.7	11.8	14.5	8.6
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.6	3.6	7.7	16.1	12.8	12.6	9.6	13.1	10.7	18.2	22.2	23.6	9.5	25.6	15.6	14.0	19.6	12.4	10.6	18.6	22.5	14.8	13.0	18.1	7.4	15.2	11.8	29.1	7.3	15.3	12.7	17.4	13.1	8.6	9.9	13.3	15.4	11.8	17.3	10.2	14.7	11.8	4.9	8.9	13.1	11.3	17.3	11.0	22.3	6.3	11.9	4.3	17.4	15.1	11.6	7.8	7.6	9.7	9.1	13.0	11.1	22.2	15.5	8.5	10.7	25.6	17.0	20.1	10.2	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7	14.9	11.8	10.0	10.4	23.7	12.3	11.3	5.1	25.4	14.8	8.7	3.9	32.3	16.6	11.5	3.2	11.7	5.5	0.0	8.3	9.5	12.0	7.4	24.3	18.1	9.9	15.9	5.8	12.9	7.5	3.2	12.7	6.4	8.5	9.0	5.0	14.1	7.5	2.9	10.6	19.9	11.9	6.5	14.1	65.4	17.0	30.5	49.1	8.7	7.0	5.9
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	8.6	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.1	5.1	10.2	8.1	5.3	11.7	11.9	5.1	9.7	11.3	3.5	9.9	4.7	12.6	7.9	4.7	4.7	5.0	15.4	6.4	8.8	12.6	6.1	8.8	8.5	5.4	5.7	10.1	4.0	4.7	2.2	7.3	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4	3.0	6.5	1.5	10.9	10.8	8.2	14.1	5.1	8.1	7.9	10.4	7.9	16.2	51.4	13.6	8.7	5.3	10.7	0.0	19.9	17.5	7.5	13.8	13.9	5.7	10.8	0.0	9.9	6.2	5.4	7.3	8.3	7.2	13.5	15.4	17.9	14.0	15.4	14.0	9.2	27.9	8.5	6.5	9.4	34.9	17.6	15.8	14.3	4.3	17.8	15.3
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5;plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	6.1	4.5	7.4	3.8	7.2	2.8	8.5	9.6	12.8	6.1	7.4	4.0	1.3	3.0	9.2	6.0	4.5	4.3	4.0	7.0	7.1	6.3	5.9	5.1	5.4	3.1	7.0	7.7	6.0	4.0	6.6	8.6	4.3	5.1	6.0	4.6	4.4	3.8	7.4	4.1	3.0	4.0	11.7	7.0	4.9	4.8	5.2	3.6	8.9	4.0	3.1	3.4	5.2	3.8	1.0	4.4	3.5	0.2	1.2	1.2	0.3	5.1	2.8	9.1	12.9	7.4	5.3	3.0	6.8	4.7	8.6	9.8	3.2	2.2	3.4	4.3	4.6	9.8	2.3	9.9	5.5	11.3	3.7	5.7	6.2	5.8	4.0	3.5	7.7	0.8	4.3	2.6	8.5	2.9	4.9	10.5	6.7	8.0	0.4	9.5	1.5	6.5	9.7	3.4	0.1	5.8	11.2	11.6	0.0	4.3	2.8	6.3	12.1	4.6	0.8	5.1	9.5	2.5	4.8	7.4	12.9	8.6	0.9	10.6	3.3	3.3	4.4	2.9	4.5	6.0	3.5	0.1	0.0	0.6	0.2	0.3	0.5	0.2	1.2	0.7	1.0	0.1	0.5	0.0	1.2	0.1	4.4	0.5	0.3	7.4	7.2	9.6	12.8	7.1	6.3	7.0	7.7	5.1	3.6	6.0	0.6	1.4	2.2	0.2	6.7	7.0	0.0	6.7	0.0	0.0	2.0	0.6	0.0	0.9	0.4	4.2	0.3	0.0	2.3	2.8	1.6	1.0	3.5	0.0	1.4	4.8	1.2	1.8	2.9	0.9	1.7	1.1	3.3	3.6	0.3	4.1	1.2	0.0	3.2	3.7	3.9	0.0	1.4	4.2	7.5	0.3	0.3	0.5	1.0	0.5
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.5	3.1	3.0	2.0	2.5	2.5	2.7	4.1	2.6	2.4	4.0	5.6	1.4	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	3.4	2.2	7.6	4.6	5.0	4.1	1.4	3.7	5.4	1.0	4.1	2.7	5.6	3.4	2.1	2.6	4.2	3.7	3.4	1.6	3.5	1.1	3.1	3.5	3.6	2.5	6.1	3.5	3.2	2.0	5.9	3.8	2.3	5.4	5.2	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8	0.0	2.7	4.9	1.9	0.7	5.3	3.7	2.5	5.3	3.4	0.0	5.9	1.5	8.3	1.1	8.8	1.4	3.2	0.0	0.6	0.6	0.6	1.8	1.1	1.7	1.1	9.5	0.0	4.3	3.5	10.2	1.1	2.1	0.0	1.8	1.8	3.8	1.7	0.9	0.4	0.7	6.1	12.9	0.9	6.0	0.7	0.3	2.7	4.5	1.7	1.4
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.9	17.1	10.7	7.3	16.5	27.4	20.6	13.0	21.2	13.1	16.9	8.1	28.7	21.0	14.6	20.3	9.3	13.1	6.0	20.3	3.9	10.4	23.5	9.9	7.9	14.5	28.3	10.4	11.0	32.1	28.2	7.8	23.5	13.5	17.6	8.2	11.1	5.1	16.1	20.8	22.9	29.5	14.4	19.7	71.7	15.5	6.9	13.3	17.7	15.3	13.7	16.5	8.3	9.2	18.3	6.1	13.3	19.0	16.4	13.6	3.8	27.1	7.3	9.2	6.4	8.9	19.4	26.9	13.3	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2	26.8	37.6	86.9	79.0	57.4	21.4	7.6	91.7	29.4	39.8	45.4	15.7	102.5	94.5	158.8	26.8	57.1	173.6	23.3	181.6	135.6	85.0	78.7	25.3	85.9	223.6	25.4	127.8	76.1	277.9	55.5	84.0	130.9	70.9	196.6	120.1	61.4	172.0	171.9	65.0	148.8	22.8	51.8	55.6	36.4	23.4	84.1	88.0	79.9	140.5	131.2
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
PHF11	"BCAP, IGER, NY-REN-34"	ENSG00000136147	"PHD finger protein 11"	Q9UIL8	13	49495610-49528987	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA016566, HPA016708"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA016566: AB_2669387, HPA016708: AB_1855286"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.98e-6)"	"unprognostic (3.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (9.81e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.46e-4)"	25.2	32.3	16.8	37.8	23.7	23.3	27.6	6.1	18.8	18.9	20.6	18.0	13.7	17.8	22.0	21.5	19.4	17.2	22.9	19.5	15.2	17.9	22.4	17.1	20.7	38.0	23.3	12.5	19.2	23.1	10.1	13.6	20.8	18.0	21.4	16.2	12.7	27.1	20.5	11.3	19.2	23.1	32.1	22.9	31.3	20.0	9.7	22.2	37.1	25.7	17.8	28.1	25.8	20.3	21.4	20.7	26.2	27.0	14.4	39.3	21.7	5.4	2.2	0.8	0.0	11.4	21.9	7.0	13.2	15.2	19.1	20.3	0.0	13.2	13.3	3.7	14.9	12.7	3.8	4.9	4.6	11.4	26.9	4.1	6.5	4.5	5.8	14.2	4.7	10.3	13.1	7.3	7.7	4.3	7.8	12.2	11.0	1.3	5.9	14.3	4.4	15.0	11.2	2.6	3.6	1.5	14.6	0.0	4.0	17.3	10.1	0.4	0.1	3.5	7.5	0.2	1.1	4.4	10.9	10.8	4.7	1.8	6.6	3.7	4.2	2.1	8.2	9.6	6.8	7.0	13.9	22.3	15.2	23.7	27.0	27.4	21.4	30.3	27.9	20.7	19.3	25.0	27.4	26.2	14.4	24.4	18.0	39.3	21.7	16.8	23.7	6.1	18.8	15.2	17.9	23.3	12.5	18.0	22.2	14.9	26.6	29.9	32.1	20.0	4.6	15.9	17.8	75.0	39.8	34.9	0.0	21.7	29.9	37.6	24.6	32.1	14.7	0.0	36.8	38.1	24.5	26.5	22.1	21.2	37.5	11.1	4.1	28.8	37.5	36.9	29.7	37.9	11.8	57.7	13.3	15.1	36.6	8.6	29.7	21.9	4.2	45.3	27.0	9.1	2.8	17.7	17.6	41.7	11.2	29.2
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576407-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"Early spermatids: 142.5;Late spermatids: 473.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Nucleoli rim"	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	16.8	14.6	17.4	17.7	22.2	16.7	23.2	33.1	19.0	19.8	18.1	27.8	18.6	11.3	22.0	15.9	14.5	18.4	16.7	19.1	15.3	14.5	10.8	9.3	17.8	20.7	23.1	15.6	27.1	18.5	22.6	21.7	17.6	16.6	18.6	10.6	16.9	19.0	21.9	27.8	21.4	13.3	24.9	18.5	21.4	15.9	9.6	18.2	19.8	18.8	12.0	12.1	16.4	32.5	2.5	3.8	5.0	2.6	1.0	4.0	2.2	9.3	7.8	16.4	13.4	10.5	8.2	8.5	7.4	9.9	10.7	7.7	3.6	5.5	6.7	5.5	9.5	9.6	18.3	10.3	7.1	5.7	17.9	6.8	5.4	8.9	5.6	9.4	10.6	18.6	8.2	12.3	5.0	8.5	10.5	8.5	10.3	7.8	11.5	7.4	20.6	20.2	11.8	4.3	16.3	6.8	22.8	12.7	2.6	6.8	11.8	21.6	10.7	7.7	12.7	6.7	5.0	8.5	18.7	9.9	10.2	8.8	11.1	10.5	9.3	1.5	5.0	5.6	6.5	11.4	1.1	2.6	2.5	3.3	1.4	3.1	1.8	3.3	2.1	2.7	2.5	3.6	4.0	5.0	1.0	2.0	3.8	1.9	2.2	17.4	22.2	33.1	19.0	15.3	14.5	23.1	15.6	16.6	18.2	14.9	13.6	5.1	5.8	6.8	13.9	13.8	5.1	18.7	20.5	5.2	7.9	6.2	0.0	5.3	142.5	12.0	4.9	23.3	4.9	3.1	8.5	7.5	16.2	6.8	4.9	9.5	15.6	8.0	11.1	473.2	18.4	7.6	3.3	1.8	7.9	9.9	5.2	2.9	19.1	3.0	7.5	19.4	10.3	1.4	2.5	6.9	5.0	7.0	7.0	7.2
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	14.5	19.9	15.3	15.7	26.6	27.1	17.6	22.2	22.0	15.7	14.2	12.6	11.7	11.6	17.6	13.0	16.0	12.4	13.6	22.5	15.9	10.5	13.6	16.4	12.9	13.5	11.8	14.8	16.9	12.7	22.4	18.6	15.1	12.9	13.1	12.9	10.0	14.9	14.6	27.0	9.5	12.9	14.5	12.9	15.4	12.8	15.9	13.7	38.9	28.5	9.2	14.7	14.7	16.9	2.4	4.0	14.7	4.3	3.0	3.4	1.6	10.1	10.2	16.7	9.6	13.1	15.7	6.0	14.9	11.7	10.3	10.1	5.7	7.0	11.6	13.1	14.9	8.9	6.0	11.3	7.9	12.8	19.5	8.0	12.5	12.1	4.0	13.8	9.9	8.9	11.7	9.9	10.7	16.0	10.0	11.3	18.6	15.3	18.3	15.3	10.1	32.3	4.4	7.4	11.6	13.6	15.8	11.2	10.0	8.4	8.8	41.5	12.1	9.5	6.8	12.0	7.3	13.3	11.3	14.7	16.7	13.4	10.9	14.2	10.9	14.2	14.9	14.8	17.6	14.8	3.7	4.3	7.5	2.5	2.5	2.5	2.2	2.3	2.9	4.0	2.4	3.4	2.7	14.7	3.0	3.8	3.3	2.6	1.6	15.3	26.6	22.2	22.0	15.9	10.5	11.8	14.8	12.9	13.7	23.8	45.9	43.8	43.6	29.9	53.6	77.9	17.8	29.4	46.6	34.9	41.2	23.1	19.9	33.0	47.6	43.8	33.8	23.3	27.3	24.9	37.5	35.9	58.9	30.1	32.0	50.9	42.0	35.6	44.0	39.6	37.2	48.6	21.9	31.5	24.8	47.4	32.7	24.1	40.3	22.0	52.6	45.3	42.3	61.6	42.6	31.7	37.6	42.1	22.2	54.3
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.5	9.6	42.3	17.3	7.9	10.1	8.0	11.6	9.3	12.5	15.5	5.7	12.0	18.6	26.7	7.0	12.2	10.4	29.5	13.1	21.1	15.1	13.7	18.0	16.5	6.6	8.4	17.9	10.0	6.7	10.0	13.6	17.0	12.6	17.4	18.2	13.2	9.2	15.3	7.6	28.9	8.9	12.9	15.8	13.0	28.5	15.4	14.1	13.3	14.0	14.7	17.2	8.9	8.2	12.2	13.1	7.7	9.9	13.2	11.7	8.4	14.6	17.8	4.7	10.9	25.1	7.6	21.4	14.5	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4	20.8	17.3	24.1	12.5	11.6	21.9	13.7	7.6	16.0	13.6	15.7	17.7	9.9	19.9	12.5	2.6	14.3	7.9	0.0	11.8	6.8	11.3	10.2	23.2	12.7	13.2	17.5	10.9	19.6	12.6	2.1	19.2	15.3	6.8	19.0	13.4	25.6	12.4	15.0	14.5	16.5	18.2	25.8	9.2	4.6	17.9	10.0	3.9	22.0	16.6	11.0
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410657-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 260.7"	"Group enriched"	"Detected in many"	45	"Early spermatids: 2196.1;Late spermatids: 5962.4;Spermatocytes: 1575.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.1;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	0.9	0.6	0.3	0.6	1.5	0.8	0.9	1.0	1.4	0.5	1.0	1.2	0.4	0.7	0.5	2.0	0.6	0.6	0.4	1.9	0.6	0.4	0.6	0.9	0.6	0.5	1.1	0.7	0.4	0.9	0.6	0.5	0.5	0.7	0.7	1.0	1.2	1.0	0.7	1.5	1.0	1.0	0.5	0.9	0.7	0.6	260.7	0.4	1.7	0.5	0.6	0.6	0.9	0.5	6.7	2.6	3.9	2.5	2.2	4.9	1.7	2.0	0.6	1.5	6.4	1.1	1.6	2.7	2.0	2.1	1.6	2.0	1.0	0.8	3.4	0.2	1.5	1.0	1.1	1.1	3.2	2.8	4.1	1.5	3.8	0.4	2.3	1.1	4.2	7.2	0.9	3.6	1.5	3.4	0.5	2.3	7.8	2.3	14.1	1.2	0.9	4.9	1.6	0.7	0.6	4.3	2.2	1.4	4.1	1.7	0.9	1.1	1.2	1.8	0.1	1.6	2.0	0.9	2.1	1.7	2.7	1.9	2.9	4.1	16.7	8.0	2.0	1.1	9.7	1.6	0.7	2.2	3.9	2.1	2.5	2.5	6.7	2.5	3.7	1.1	3.8	1.7	3.5	0.5	2.2	1.4	2.6	4.9	1.7	0.3	1.5	1.0	1.4	0.6	0.4	1.1	0.7	0.7	0.4	3.0	2.9	5.6	4.6	4.0	10.6	7.0	2.5	6.7	0.0	7.0	7.9	3.0	11.6	2.4	2196.1	2.9	8.4	0.0	2.5	1.7	2.9	1.7	6.9	4.0	3.7	12.7	11.1	1.8	4.3	5962.4	71.4	2.6	8.5	2.8	3.3	6.5	3.1	0.0	59.4	5.5	15.7	51.8	3.9	1575.4	63.9	2.6	0.5	4.4	11.8	2.2
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.2;ASC TERT1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448, HPA061506"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	40.5	7.4	19.6	9.5	52.2	0.9	19.0	4.6	30.8	25.0	10.7	87.0	3.6	8.1	22.0	9.6	8.2	18.7	18.5	20.8	22.4	11.8	9.6	2.8	13.7	4.0	47.0	19.9	21.4	18.9	4.9	4.5	20.8	26.9	9.4	5.9	8.0	7.1	14.6	10.0	9.2	8.8	16.0	27.6	10.2	7.9	7.0	51.0	0.0	10.7	5.4	2.3	10.8	11.6	0.5	0.4	2.1	0.3	1.9	0.7	0.1	1.6	2.6	10.5	5.1	39.2	39.8	3.7	7.8	9.6	4.6	2.7	3.9	11.4	0.0	14.7	15.6	6.2	6.6	2.3	16.0	0.7	0.2	1.5	3.0	1.9	1.9	10.1	0.0	5.7	20.7	3.5	6.4	4.4	10.4	13.1	0.2	2.6	0.1	5.9	1.2	0.0	0.1	3.7	0.1	1.3	0.4	2.7	0.2	4.6	2.4	2.4	5.2	19.9	1.7	5.5	4.2	7.3	0.9	16.0	9.5	8.6	4.8	6.2	0.0	0.0	0.0	2.7	0.5	10.7	0.5	0.3	0.4	0.2	0.0	0.3	0.2	0.3	0.7	0.0	0.5	0.7	0.5	2.1	1.9	0.2	0.4	0.2	0.1	19.6	52.2	4.6	30.8	22.4	11.8	47.0	19.9	26.9	51.0	6.0	13.6	0.9	8.3	16.4	3.5	3.9	0.0	0.0	10.3	29.6	0.0	0.9	0.0	9.1	68.1	25.1	16.5	0.0	3.9	1.3	32.9	5.0	1.1	0.6	5.0	3.2	8.1	31.3	3.5	60.6	62.2	7.0	11.8	3.6	21.4	6.7	15.4	28.1	41.8	5.7	1.8	38.8	45.5	7.4	5.8	8.0	1.3	2.2	13.5	2.1
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	8.7	4.0	9.0	5.7	9.7	3.3	14.2	14.2	7.8	8.4	8.2	5.8	6.3	8.2	8.6	5.9	4.6	8.1	6.2	5.7	6.7	5.5	7.5	5.0	4.3	3.6	6.0	9.1	8.2	8.9	10.9	21.3	3.9	7.8	17.4	7.8	6.4	10.5	7.8	6.4	5.2	7.9	6.2	9.7	3.4	6.3	25.4	8.0	5.5	13.0	3.9	3.9	9.1	5.7	8.8	4.6	1.5	1.0	10.5	5.7	1.8	5.7	1.6	4.1	5.6	7.9	2.5	16.3	2.5	1.7	3.9	4.4	5.6	4.4	5.6	5.6	1.9	8.1	4.5	5.5	3.0	3.2	8.3	6.4	5.6	4.9	9.6	5.2	4.5	5.1	4.6	5.8	4.5	6.0	3.3	3.5	8.0	9.2	5.8	2.4	5.3	3.1	5.9	5.6	3.7	2.1	3.2	2.5	4.3	6.2	17.3	17.5	6.0	5.4	2.8	6.0	5.2	7.5	2.8	2.0	4.3	4.1	4.0	2.7	5.6	5.2	5.0	5.1	2.8	4.5	0.0	0.9	1.1	3.9	1.0	5.5	6.8	4.3	3.7	1.0	8.8	5.7	5.6	1.5	10.5	0.9	4.6	4.4	1.8	9.0	9.7	14.2	7.8	6.7	5.5	6.0	9.1	7.8	8.0	3.0	2.2	2.7	9.2	2.3	8.7	2.8	2.5	13.4	1.2	3.5	5.9	8.6	8.3	5.9	91.4	4.5	5.9	0.0	9.9	8.8	3.0	7.0	0.0	2.8	2.5	6.4	14.5	2.5	0.0	23.3	4.4	1.9	3.3	1.0	8.2	5.2	6.7	8.4	4.6	9.8	10.2	0.0	5.1	27.9	11.7	3.8	4.6	4.3	8.1	4.3
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.2	7.0	9.6	19.5	8.4	9.3	8.0	27.0	24.7	16.2	18.4	11.9	12.4	13.7	2.2	20.9	17.6	12.7	13.7	7.0	23.1	9.2	10.9	5.6	7.7	3.5	9.2	7.4	15.5	5.5	6.7	9.4	14.2	10.4	5.7	7.7	9.1	24.4	17.2	9.6	6.0	4.8	8.7	4.3	8.3	6.1	19.5	11.2	4.4	20.6	9.3	13.0	15.1	17.2	9.8	14.8	18.2	5.8	5.7	27.9	15.0	15.6	15.8	11.5	13.4	17.1	8.8	12.0	24.0	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8	6.0	17.5	23.8	17.3	14.2	7.8	21.5	15.3	9.4	9.1	7.0	11.8	11.2	0.0	4.0	10.8	9.0	5.3	0.0	5.8	7.0	14.7	6.5	37.1	4.3	10.4	3.2	5.2	23.4	33.1	4.4	11.2	29.4	10.1	1.8	6.0	4.0	6.0	5.8	12.7	1.8	9.3	12.9	12.8	22.9	32.2	15.6	12.4	35.5	4.5	20.4
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219704-22232341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.4;skin 1: 37.9"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.9;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	5.4	18.6	25.0	2.3	71.8	1.3	3.5	58.9	89.4	3.2	2.1	3.0	0.0	2.2	6.0	3.4	7.1	9.8	6.2	2.9	31.2	12.3	2.2	1.4	1.8	1.4	7.3	40.3	2.3	2.2	1.3	5.5	3.0	21.1	3.6	1.7	0.0	1.4	5.9	1.7	37.9	2.4	7.2	3.5	3.6	1.6	5.8	10.4	0.0	2.0	0.0	1.4	7.8	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.5	0.0	0.3	0.8	1.1	0.3	1.3	0.4	0.4	0.1	2.0	0.0	2.2	0.6	1.4	3.8	0.0	0.7	0.1	0.0	0.2	0.0	4.0	1.5	1.7	0.0	0.0	0.9	0.0	0.8	0.0	3.6	2.5	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.9	0.7	0.3	0.0	0.2	12.9	0.0	0.0	4.3	5.0	2.9	0.0	3.4	0.3	0.0	0.3	1.1	0.0	2.1	1.6	0.7	1.0	0.2	0.0	2.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	71.8	58.9	82.9	31.2	12.3	7.3	40.3	21.1	10.4	0.0	0.0	0.0	5.1	16.8	0.7	1.2	0.0	0.0	2.3	3.5	0.0	0.1	0.0	0.2	0.6	1.3	0.5	0.0	1.8	0.2	2.3	0.5	0.0	0.9	0.2	0.0	0.0	1.3	0.0	1.3	2.8	0.0	1.7	0.0	0.3	0.4	0.4	0.0	3.5	2.2	0.9	0.0	7.8	0.2	0.0	9.5	1.8	0.0	0.0	3.9
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.9	8.4	7.4	11.1	21.2	12.8	10.6	9.0	13.7	13.3	13.1	6.5	4.2	18.7	5.4	18.1	13.1	8.8	14.0	8.7	8.2	15.9	21.5	19.2	11.3	7.4	10.6	19.0	15.4	11.4	5.5	11.3	6.3	8.7	10.8	5.7	52.4	15.9	10.3	13.7	16.6	6.5	5.8	17.8	8.7	16.7	16.2	3.4	7.4	15.9	18.2	13.3	11.8	13.8	9.4	10.8	11.6	8.7	10.9	24.3	12.6	8.9	7.6	12.2	12.4	14.9	16.0	13.7	10.1	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2	11.9	25.4	14.0	5.7	9.0	32.8	25.7	25.5	6.7	9.1	7.0	45.2	15.6	1.7	8.5	30.2	12.8	18.2	0.0	5.5	16.0	10.8	10.3	11.5	15.5	17.4	35.0	18.4	14.7	15.5	19.2	18.4	16.5	10.1	6.4	16.8	22.8	7.1	10.5	22.6	9.1	23.8	25.8	10.5	32.1	28.9	8.5	16.7	13.3	12.7	7.0
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 73.5;Late spermatids: 189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.6	7.7	7.2	6.8	3.5	3.2	11.5	6.5	3.6	6.9	6.3	12.0	5.0	8.1	5.9	3.5	7.5	11.2	7.4	5.2	3.0	13.0	11.6	5.8	5.5	9.2	7.3	8.4	10.3	3.7	5.7	6.2	3.8	3.8	8.1	8.5	10.8	11.2	3.3	10.9	15.3	9.9	15.9	5.2	7.1	13.7	7.3	10.6	4.5	6.0	13.2	14.7	9.3	9.1	7.1	5.6	8.4	7.8	5.9	6.9	9.9	14.3	10.1	21.1	15.7	10.3	5.7	10.4	8.4	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9	3.0	12.9	7.5	7.0	16.4	17.6	3.0	5.1	13.4	7.9	8.7	11.8	19.8	6.6	16.0	73.5	9.8	12.3	0.0	15.5	13.7	7.1	11.8	6.9	9.3	12.6	25.4	21.2	10.4	9.8	189.7	13.0	8.3	6.8	11.8	14.3	10.4	13.0	5.8	17.3	10.2	21.3	6.5	7.2	35.8	35.3	13.6	30.4	7.5	10.8	7.4
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	17.3	12.6	11.1	14.3	18.8	8.6	18.0	14.6	15.6	12.9	13.0	17.6	12.8	17.1	19.8	20.2	12.6	13.1	12.7	8.8	8.5	7.5	11.2	18.5	12.5	12.0	14.5	10.7	16.5	16.5	11.9	18.1	10.3	13.6	14.0	14.4	15.5	14.8	16.3	13.4	20.0	15.8	10.1	9.7	12.3	14.8	11.1	13.6	13.7	15.7	11.1	20.4	10.9	12.3	5.2	7.4	5.5	3.7	5.4	9.3	3.3	7.9	11.4	7.7	6.3	11.0	10.4	3.2	4.4	5.3	7.5	13.3	11.6	10.2	3.9	9.1	4.3	4.5	11.6	9.5	5.6	10.7	8.3	24.8	7.7	7.9	13.8	11.8	3.3	5.0	8.8	14.7	13.0	14.8	7.6	8.5	13.1	9.1	5.0	5.9	7.9	6.0	7.7	3.0	15.9	5.9	5.9	6.5	11.2	8.4	4.3	4.1	5.8	4.6	3.3	9.0	20.8	3.5	3.0	5.5	6.8	4.2	4.4	12.5	3.5	0.1	6.3	8.4	8.2	4.2	0.0	3.7	5.5	6.5	3.2	5.6	5.2	8.5	5.0	2.7	4.4	9.3	7.5	0.0	5.4	2.4	7.4	6.7	3.3	11.1	18.8	14.6	15.6	8.5	7.5	14.5	10.7	13.6	13.6	8.9	16.0	3.7	8.0	3.9	11.3	1.7	7.6	10.7	12.5	12.2	9.8	13.3	5.0	5.6	2.1	5.8	6.8	0.0	6.4	6.1	6.0	6.8	4.7	9.4	4.5	6.4	7.5	3.1	2.7	1.9	7.2	5.1	3.3	1.8	10.0	6.7	7.4	7.0	10.6	4.4	12.3	0.0	6.6	13.7	8.3	5.3	8.0	8.7	10.8	8.8
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	9.4	16.6	7.2	8.7	11.7	5.4	11.6	12.6	15.6	10.8	11.5	17.8	15.6	14.1	14.0	13.6	12.6	15.8	13.4	9.5	7.4	6.4	16.1	15.2	10.6	13.8	9.0	10.1	15.9	17.5	47.3	13.4	27.6	11.5	13.1	13.2	18.0	17.5	17.4	7.6	10.0	12.9	10.7	11.0	14.2	13.9	16.5	9.7	11.3	20.0	8.3	13.4	13.6	9.9	7.4	13.7	8.0	8.8	7.1	10.0	4.1	15.9	27.4	7.8	11.2	7.0	7.9	14.0	6.8	11.9	16.5	13.5	10.1	16.3	9.0	12.4	8.1	23.0	11.7	13.1	21.3	10.0	9.9	8.4	5.4	17.9	7.6	13.7	7.3	9.4	9.6	23.6	14.6	24.1	13.1	8.5	13.5	5.9	12.9	13.5	8.8	8.5	8.3	5.0	10.0	11.3	8.9	6.3	9.8	18.1	11.1	6.6	8.9	9.4	23.4	5.3	9.0	17.5	4.8	5.1	12.1	10.7	6.5	12.4	7.9	11.6	3.8	13.1	5.4	15.0	7.0	6.7	8.0	9.2	8.8	9.3	5.0	5.1	10.0	13.7	7.4	6.5	7.6	2.4	7.1	5.9	9.5	7.6	4.1	7.2	11.7	12.6	15.6	7.4	6.4	9.0	10.1	11.5	9.7	3.0	11.5	5.2	4.4	2.3	9.1	2.4	20.4	13.4	7.9	15.7	2.0	17.4	0.0	11.1	0.7	3.1	10.6	0.0	12.1	13.5	3.1	3.6	6.9	11.1	10.0	11.1	2.9	4.9	6.3	1.0	4.0	3.9	3.3	8.2	7.8	14.9	8.2	7.0	2.8	5.6	10.9	6.5	2.5	17.4	7.0	1.8	18.9	7.2	8.5	3.1
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	16.8	17.6	18.9	12.9	23.6	10.0	15.2	15.7	26.5	14.7	21.5	43.0	10.8	13.3	21.8	22.8	20.0	28.2	12.7	17.4	21.4	20.2	18.4	16.3	11.3	11.6	21.5	11.9	23.9	16.2	34.4	21.7	17.3	26.9	14.1	24.9	20.1	17.9	15.9	16.4	14.0	14.2	19.6	30.5	11.1	11.5	22.1	18.1	16.5	14.7	15.9	19.5	14.2	15.0	10.0	10.8	9.4	6.3	12.1	15.0	6.7	11.7	15.0	19.1	14.0	12.6	15.2	19.2	12.1	14.5	20.6	18.2	27.7	25.1	15.2	19.8	11.9	26.4	22.0	17.4	22.9	21.0	6.2	9.4	34.2	9.9	31.1	11.7	20.8	8.2	13.4	14.8	11.8	13.5	9.5	14.8	15.0	17.1	13.5	17.4	13.2	17.6	21.2	9.6	26.8	22.7	12.8	24.0	24.3	18.2	11.0	12.3	11.6	22.7	41.2	14.8	11.2	22.7	14.7	8.7	33.9	12.1	18.3	12.1	9.1	12.7	10.1	20.7	21.8	14.6	9.4	4.4	1.9	13.4	6.3	12.2	9.2	12.4	15.0	10.8	10.0	12.7	12.5	0.9	12.1	5.3	10.6	11.2	6.7	18.9	23.6	15.7	26.5	21.4	20.2	21.5	11.9	26.9	18.1	8.9	3.7	1.5	11.9	3.9	8.5	5.2	12.7	26.8	9.1	10.4	15.7	33.8	1.7	16.1	13.6	5.0	10.3	0.0	15.2	23.8	8.0	10.0	8.1	6.7	13.7	1.6	9.8	8.6	5.6	11.0	5.2	3.5	1.7	6.4	13.8	8.1	9.8	21.0	7.4	8.4	9.5	19.4	12.0	31.9	12.2	5.1	17.7	7.0	22.1	7.6
PIH1D2		ENSG00000150773	"PIH1 domain containing 2"	Q8WWB5	11	112064010-112074274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 41.9"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039496			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039496: AB_10959385"	"unprognostic (8.74e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.82e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	0.7	1.0	1.5	0.3	3.3	0.2	1.6	0.9	2.0	1.6	0.8	3.2	2.3	0.4	1.5	8.1	1.0	14.4	1.2	0.9	2.6	2.0	4.9	0.5	2.8	0.3	1.1	1.8	2.5	1.2	4.4	10.5	0.5	9.7	1.4	0.7	2.7	1.1	1.5	0.9	0.9	0.5	0.9	0.8	0.4	0.8	41.9	1.2	0.1	5.8	0.6	0.3	0.9	0.8	1.2	1.0	0.7	1.2	0.3	0.3	0.2	2.9	1.5	4.6	2.0	2.3	2.6	3.2	1.1	3.8	3.8	3.7	5.7	9.4	1.3	4.0	2.2	4.5	3.7	1.0	2.4	3.7	1.4	3.8	2.1	2.5	2.5	2.1	2.2	1.4	1.6	2.8	7.0	4.0	3.4	2.0	2.7	2.7	0.8	2.3	1.1	0.9	2.8	1.3	1.6	2.5	1.8	3.0	3.2	9.8	1.5	5.9	1.5	3.7	1.4	1.9	1.9	12.6	0.6	1.1	2.1	2.4	1.3	1.0	1.1	0.4	1.6	3.1	0.3	1.7	0.0	0.3	0.7	0.0	1.2	0.3	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	1.5	3.3	0.9	2.0	2.6	2.0	1.1	1.8	9.7	1.2	6.0	0.3	0.0	1.6	0.6	2.0	2.0	7.6	123.1	10.3	3.5	2.0	0.8	13.3	3.1	307.7	0.9	0.2	0.0	2.0	0.6	0.9	0.7	1.1	0.0	0.6	1.6	2.9	0.6	0.3	93.6	2.6	0.8	3.3	1.0	0.3	3.4	1.5	0.0	1.4	6.8	15.4	0.0	1.0	103.7	7.7	0.9	0.2	0.0	0.4	0.8
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 44.0;Cone photoreceptor cells: 43.2;Endothelial cells: 43.8;Rod photoreceptor cells: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RT4: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	33.7	10.9	7.4	7.0	8.2	0.8	24.7	36.4	11.0	16.9	6.3	3.5	9.1	3.3	15.8	11.0	8.4	7.6	10.9	28.7	6.8	8.5	10.4	4.1	20.0	6.0	8.7	3.1	4.6	4.0	18.7	10.2	13.4	10.4	9.0	5.3	13.6	9.4	8.0	14.8	4.6	6.0	12.3	7.1	10.9	7.4	24.0	4.5	5.9	12.7	6.2	5.3	12.3	8.7	0.5	0.6	8.6	3.1	0.1	3.5	0.9	4.7	1.6	21.6	10.9	2.1	0.9	6.9	2.8	2.0	3.7	4.6	0.9	1.4	6.2	8.6	1.1	4.5	2.8	7.5	2.6	2.4	4.8	6.7	3.9	19.4	0.7	0.7	3.5	5.4	2.7	1.5	3.9	1.4	3.6	7.7	14.5	1.4	4.5	5.2	7.2	14.1	2.2	7.6	1.3	4.3	18.2	5.7	7.4	9.3	33.6	15.6	11.3	9.1	24.1	2.6	13.5	6.7	3.2	14.3	4.0	3.7	0.6	2.7	6.4	6.6	3.8	3.1	4.7	2.0	0.0	0.3	8.6	3.3	0.5	3.0	0.5	0.8	2.9	0.0	0.0	0.3	1.9	0.1	0.1	3.1	0.6	3.5	0.9	7.4	8.2	36.4	8.9	6.8	8.5	8.7	3.1	10.4	4.5	0.0	9.6	0.0	3.0	2.3	44.0	17.3	0.0	17.4	5.7	17.4	43.2	4.0	0.0	0.4	8.7	43.8	5.1	0.0	1.0	1.0	4.5	7.4	9.2	0.0	1.4	3.2	7.5	0.0	0.0	12.1	1.1	1.8	5.0	1.0	1.5	30.4	1.3	1.1	7.4	3.4	44.4	0.0	12.5	29.2	28.5	1.6	1.1	1.5	1.7	3.3
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 571.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	26.2	24.1	18.0	16.7	6.3	5.6	10.6	19.7	8.5	14.7	14.2	22.3	8.4	16.3	31.4	7.3	15.3	13.5	12.4	11.9	4.7	34.7	52.6	42.4	29.6	19.2	10.3	19.7	24.9	7.7	8.0	9.5	4.5	11.0	11.9	29.3	19.1	24.8	8.8	18.4	29.9	77.2	17.2	11.0	37.1	27.4	18.7	27.3	10.5	12.9	22.7	26.7	19.0	9.5	22.0	7.7	12.2	23.7	20.1	20.4	16.3	31.5	31.5	32.1	30.1	21.9	21.7	25.3	25.0	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0	26.8	21.5	49.1	53.7	42.8	68.5	65.3	43.3	56.2	14.8	59.3	11.8	107.3	139.3	95.7	197.0	54.9	69.5	46.7	95.4	80.4	81.4	55.2	63.4	41.4	123.0	57.2	95.8	47.3	50.0	571.0	83.4	67.4	118.1	174.1	57.9	60.8	85.6	73.7	122.0	109.4	50.6	64.7	97.1	136.8	72.0	57.6	46.0	94.4	62.6	47.8
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein, cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	20.8	10.0	22.9	18.0	31.0	11.3	16.6	18.9	33.5	12.0	7.5	18.7	7.0	4.6	10.7	11.7	11.0	22.4	12.5	11.7	23.4	19.1	17.3	14.3	13.5	24.3	21.4	17.0	16.7	23.3	5.4	12.3	19.0	22.7	11.2	9.1	31.2	18.3	13.1	5.1	5.2	8.1	11.7	14.8	13.9	11.8	5.1	17.8	14.5	10.4	6.0	27.0	12.0	16.8	1.6	1.6	16.1	5.5	7.2	16.4	5.0	5.9	2.3	5.9	11.6	5.2	7.1	6.9	6.7	5.3	1.3	1.0	0.0	8.8	7.3	2.2	6.2	2.2	2.5	10.5	10.1	1.4	13.4	6.1	0.8	9.8	4.8	1.4	1.4	13.8	5.5	4.4	0.8	5.4	0.7	5.1	9.9	0.6	26.6	5.1	12.8	17.0	6.2	10.1	2.8	12.1	21.6	1.3	6.5	12.6	7.2	7.3	19.3	2.6	5.1	6.0	6.6	3.8	7.3	5.1	3.2	1.3	4.0	3.2	17.3	8.6	5.6	20.2	6.0	2.5	1.1	2.5	16.1	16.4	4.0	9.6	1.0	10.7	15.5	1.6	1.6	12.3	13.0	3.1	7.2	5.5	0.4	4.0	5.0	22.9	31.0	18.9	25.3	23.4	19.1	21.4	17.0	22.7	17.8	8.9	0.6	10.0	40.5	4.7	18.6	5.3	20.4	2.7	2.3	0.0	2.0	7.0	18.3	38.5	0.3	48.5	1.3	0.0	43.0	8.8	5.8	29.8	4.7	7.9	12.4	69.9	5.8	17.2	15.8	1.0	4.6	11.0	10.1	19.0	1.3	25.9	36.1	3.5	13.8	12.6	22.1	25.8	21.1	0.5	3.8	3.8	2.9	45.7	2.8	41.1
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NB-4: 44.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.3	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.1	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.2	0.1	44.9	0.0	4.4	0.3	0.1	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.0	9.9	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7	0.0	0.3	0.0	0.2	1.1	0.6	1.4	10.2	2.7	2.3	0.0	0.0	3.3	1.7	3.6	2.8	0.5	2.9	0.0	1.8	0.3	0.9	0.4	0.0	0.0	1.5	0.0	0.0	1.3	3.1	1.0	0.3	1.5	0.0	1.0	7.8	0.3	2.7	6.5	1.1	0.6	2.8	0.0	0.8	0.7	1.5	0.1	0.8	0.0	4.7	0.0
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.6	8.8	9.3	7.6	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.1	15.6	9.1	38.6	13.7	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.3	6.7	6.4	7.4	5.3	2.9	1.1	6.7	5.6	0.8	3.6	17.1	8.9	13.2	7.5	11.2	2.5	10.6	8.8	18.7	12.1	11.2	1.9	8.5	20.9	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5	14.9	4.5	5.1	14.7	36.5	16.4	6.3	5.1	2.7	11.4	3.5	7.9	30.0	13.3	20.5	77.4	5.1	0.7	0.0	10.2	12.8	18.9	7.8	4.6	1.7	6.7	4.8	5.2	5.5	3.8	22.6	25.0	4.1	5.0	1.8	2.8	28.6	13.9	1.4	18.4	4.4	5.9	6.5	17.0	0.9	1.0	25.7	17.4	7.9	2.3	17.6
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 177.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 58.2;naive B-cell: 62.1"	"Lineage enriched"	"Detected in many"	10	"B-cells: 62.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 104.3;HSkMC: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	21.1	25.1	39.2	22.7	31.9	7.5	18.4	12.9	37.7	28.0	44.0	13.5	15.4	12.5	31.8	19.3	31.7	31.4	29.3	107.1	23.0	17.2	22.9	14.4	39.0	17.9	16.7	25.9	17.2	13.3	13.8	19.5	32.6	14.3	30.2	13.3	26.2	18.8	32.5	25.6	8.0	17.9	52.8	11.9	13.2	24.1	41.5	11.4	3.2	25.8	18.6	18.2	42.2	20.3	62.1	6.2	0.4	0.3	0.7	1.6	3.1	5.3	5.4	8.8	5.8	13.4	27.4	1.3	12.8	104.3	14.5	11.0	12.4	2.4	20.5	10.5	11.2	12.1	2.0	1.7	2.8	4.7	10.4	3.2	3.2	0.8	8.8	12.4	0.4	0.2	42.3	5.7	7.0	1.6	7.3	32.3	5.7	2.5	0.5	1.3	6.7	3.2	5.2	4.7	0.0	7.8	0.5	0.2	0.5	8.0	1.1	3.6	11.8	3.3	1.5	8.6	4.0	4.1	2.6	20.9	19.9	8.9	8.8	6.1	2.8	7.7	14.4	9.9	0.3	8.5	0.4	0.3	0.1	0.2	0.2	0.2	58.2	0.3	0.3	1.5	62.1	1.0	1.6	0.4	0.7	0.2	6.2	0.1	3.1	39.2	31.9	12.9	37.7	23.0	17.2	16.7	25.9	14.3	11.4	8.9	6.7	86.2	15.6	22.3	17.8	177.7	22.9	76.3	13.6	43.6	19.6	11.6	107.8	61.0	80.2	91.6	30.7	0.0	27.2	12.5	63.7	12.6	46.2	28.4	7.2	9.5	42.4	39.3	3.1	23.1	67.6	9.1	47.2	11.8	13.1	46.7	31.9	44.8	57.7	115.7	24.6	116.4	170.2	111.2	27.2	26.2	30.7	5.2	21.3	9.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	5.8	4.1	10.0	3.3	12.4	0.7	1.7	16.3	25.7	5.1	2.8	3.6	0.2	2.0	5.6	4.7	2.7	9.8	3.4	7.9	7.3	6.9	2.9	1.1	9.6	2.4	5.2	12.3	23.6	6.3	0.9	7.3	12.8	6.9	10.2	2.8	24.3	2.5	8.7	19.5	4.0	2.4	4.6	4.6	3.4	2.5	7.2	3.1	0.0	18.3	8.4	2.2	3.3	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	27.2	6.8	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	4.4	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.4	16.3	25.7	7.3	6.9	5.2	12.3	6.9	3.1	0.0	0.0	0.0	0.0	0.8	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.7	28.7	0.5	0.0	0.0	0.2	0.0	1.4	1.8	0.0	0.0	0.2	7.9	0.0	1.3	0.0	7.4	4.6	0.0	8.5	0.0	0.0	3.3	0.2	0.0	16.6	0.0	0.2	6.5	3.1	0.7	0.1	0.4	0.1	0.0	0.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2700000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	45.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2	1.1	26.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	46.2	124.1	6.7	1.3	0.0	0.0	4.5	0.0	2.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	1.0	0.0	7.1	21.9	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	1.2	3.2	9.4	0.0	0.0	0.0	37.2	0.0	3.9	0.0	0.0	357.5	0.1	0.0	0.0	44.2
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.3;OE19: 20.4;SuSa: 45.7"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	15.7	3.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	56.3	14.2	0.0	9.7	0.0	2.1	14.0	1.9	12.4	0.0	0.0	4.5	0.1	0.6	14.7	8.8	0.8	0.2	0.0	11.7	0.0	13.6	6.3	0.5	0.0	2.8	4.4	1.3	4.1	0.0	0.1	8.6	20.4	2.7	0.0	6.8	4.7	4.1	7.5	1.7	1.5	0.6	3.3	0.0	45.7	7.1	0.2	0.1	0.0	6.3	0.0	3.8	3.7	0.0	0.1	0.0	0.0	0.7	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4	0.0	0.0	2.4	42.2	6.3	1.0	399.9	15.3	12.0	19.4	1.8	3.9	39.7	3.3	12.2	3.0	3.5	74.7	0.0	8.6	148.3	17.6	16.8	4.6	39.3	7.7	1.6	26.0	3.7	13.1	1.3	10.9	7.4	10.1	0.0	60.1	13.0	16.5	52.6	2.1	8.4	1.1	0.0	1.4	5.4	7.2	2.9	34.7	0.7	87.1	25.7
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 206.5;Extravillous trophoblasts: 144.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.6	7.3	0.0	0.1	0.0	0.0	15.8	0.3	0.2	0.8	0.4	15.0	26.4	0.0	1.5	0.3	1.7	50.7	0.0	19.2	0.1	0.0	9.5	0.0	4.3	10.4	0.1	0.0	0.0	0.1	33.2	0.1	8.1	0.1	0.1	0.0	11.2	0.2	0.1	23.7	0.1	0.0	0.0	19.0	12.7	0.2	0.0	0.1	0.4	7.6	10.8	0.1	10.9	38.5	0.0	0.5	13.9	0.1	1.3	0.2	1.4	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2	14.9	15.4	0.0	43.7	64.1	0.0	1.1	7.6	9.4	12.5	12.2	0.0	112.3	0.0	83.2	0.0	0.4	206.5	0.0	54.5	144.7	3.5	34.6	13.8	0.0	11.6	0.0	20.8	0.0	0.0	0.0	0.9	1.8	1.7	3.6	76.4	0.5	96.8	93.0	0.0	0.7	0.1	0.0	1.6	0.0	0.4	77.5	91.8	0.0	83.6	52.6
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261062	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 96.5;Syncytiotrophoblasts: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	23.8	9.1	9.6	6.6	9.4	5.6	19.7	16.4	16.1	5.4	6.2	10.0	4.7	5.0	7.7	11.2	5.7	7.2	8.5	31.3	7.9	8.6	24.1	11.8	15.9	23.1	7.5	9.2	7.4	6.4	11.3	9.2	24.4	7.7	6.2	5.7	8.5	7.6	5.8	39.9	10.0	5.3	8.2	6.8	16.2	6.2	9.3	6.2	11.3	10.4	6.8	4.9	9.1	5.0	3.7	8.8	9.4	18.2	1.3	4.5	7.7	4.6	5.0	4.0	12.6	19.0	13.9	9.2	11.6	15.5	17.6	14.8	11.6	8.7	8.5	14.6	16.5	13.7	7.3	4.2	5.0	8.1	2.4	6.4	2.4	4.9	9.2	10.2	2.3	12.6	9.5	5.7	17.6	2.8	22.4	10.7	4.2	3.5	4.5	11.3	10.1	3.2	7.0	2.5	4.4	5.7	4.7	5.7	26.3	8.8	4.3	1.3	2.6	15.5	4.7	9.5	3.5	12.1	11.4	8.7	15.4	7.5	19.8	7.2	17.0	14.4	10.3	14.0	6.6	5.9	9.4	14.4	9.3	3.1	16.8	3.2	3.3	3.4	4.5	8.8	3.7	4.5	3.7	0.6	1.3	18.2	7.8	3.2	7.7	9.6	9.4	16.4	16.1	7.9	8.6	7.5	9.2	7.7	6.2	6.0	3.5	0.0	2.1	4.2	12.2	19.7	2.5	1.4	4.5	8.7	7.9	17.6	5.0	8.5	1.7	6.3	4.0	0.0	6.2	7.0	6.9	2.5	15.0	10.9	96.5	36.5	0.0	11.1	32.7	4.5	2.0	16.4	11.8	6.4	6.1	4.3	5.7	4.5	1.4	18.1	5.5	0.0	4.1	3.9	2.2	3.0	42.4	4.3	3.3	1.7
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 14.1;RT4: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	14.1	0.1	0.0	0.0	0.1	0.0	10.6	0.6	0.1	0.0	1.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	54.9	0.0	3.3	4.8	0.0	3.2	0.0	0.0	0.0	5.2	0.0	1.5	3.3	0.2	0.0	0.0	12.0	0.0	1.2	0.7	0.2	2.7	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	4.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	1.0	0.0	4.3	1.6
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192503-32207791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 46.8;Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 11.7;non-classical monocyte: 20.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 20.7"	"Cell line enhanced"	"Detected in all"		"CACO-2: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	5.9	5.1	6.1	9.0	7.8	30.2	5.8	10.5	7.7	6.9	10.6	6.8	5.6	11.5	9.6	6.6	17.9	10.9	5.8	5.6	6.2	4.0	7.0	6.1	9.3	9.0	5.8	4.9	11.7	11.6	8.5	12.9	5.4	7.2	7.6	9.2	9.8	10.2	6.7	10.1	10.4	24.8	8.3	4.2	10.4	10.1	33.2	7.4	16.4	7.9	13.7	12.9	6.8	11.4	0.9	1.4	1.4	20.7	0.3	1.0	1.2	7.9	4.6	12.2	4.4	4.6	3.5	7.7	3.1	5.0	6.9	6.3	34.2	4.0	8.2	4.4	3.2	9.7	7.9	15.2	7.3	9.2	4.9	6.8	33.2	3.7	16.4	5.6	14.5	7.4	4.3	6.5	5.5	3.9	3.2	4.9	8.8	11.6	7.5	3.6	4.5	15.9	10.0	5.7	6.1	5.3	10.3	15.8	5.2	2.9	6.1	5.6	6.1	7.8	4.2	6.9	7.4	6.3	17.8	3.7	8.4	9.0	6.0	6.4	20.5	11.3	10.6	4.9	30.7	5.1	1.4	2.1	0.5	0.5	11.7	1.0	0.9	0.6	1.0	1.4	0.6	0.8	0.4	0.6	0.3	20.7	0.3	0.5	1.2	6.1	7.8	10.5	7.7	6.2	4.0	5.8	4.9	7.2	7.4	11.9	19.7	6.6	11.4	6.6	6.9	2.9	2.5	4.0	14.8	1.8	29.5	2.9	3.3	3.2	46.8	3.8	13.1	0.0	4.5	2.6	4.0	10.4	2.3	2.4	5.0	3.2	10.3	4.9	5.1	113.2	2.3	6.6	0.0	1.0	10.4	6.6	5.6	8.6	6.7	2.6	20.2	6.5	2.5	9.4	9.2	10.2	3.4	4.4	13.9	20.2
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 54.0;Mucus-secreting cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		94000	"Nucleoplasm, Golgi apparatus"		"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.8	10.0	9.9	14.7	10.4	8.0	9.9	14.2	10.8	12.2	7.4	8.8	13.6	1.2	8.6	17.8	10.5	30.8	11.1	13.3	4.2	8.5	6.1	13.9	20.6	6.6	7.2	3.3	9.2	6.7	8.9	13.2	9.8	13.4	17.7	5.4	6.8	1.5	15.4	21.5	4.2	7.0	16.0	22.7	11.0	9.3	22.3	5.2	7.5	18.9	2.6	10.9	21.0	26.5	10.1	6.4	13.9	6.5	30.7	11.3	13.5	25.8	9.1	1.9	0.9	1.4	18.7	8.0	10.4	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4	3.0	9.3	0.0	5.1	11.6	1.0	2.6	10.2	0.0	3.4	15.7	0.0	7.8	1.7	6.2	0.9	7.3	54.0	0.0	6.7	14.6	9.3	5.1	5.7	2.6	9.0	3.2	2.4	19.6	12.7	1.1	9.2	11.0	8.5	29.7	41.8	4.3	12.8	23.0	11.7	3.3	0.7	25.8	7.2	2.6	8.7	10.3	12.2	1.3	31.0	7.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.1	0.0	0.0	0.1	0.0	13.4	3.8	4.0	2.5	1.2	0.9	0.0	0.2	38.2	14.5	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.6	0.0	0.0	0.9	1.2	5.2	18.7	7.3	0.0	0.0	1.5	0.1	30.8	2.0	0.0	0.0	3.3	17.8	3.9	0.0	0.0	0.2	39.4	2.8	10.2	7.1	0.0	9.2	5.6	4.3	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4	6.0	0.3	0.0	3.6	2.2	79.8	57.6	0.0	56.2	11.4	5.2	0.0	0.0	0.0	0.5	1.0	35.4	2.3	0.0	0.2	0.0	4.8	10.1	0.0	0.0	0.1	155.7	40.4	1.3	0.0	0.4	1.4	0.3	6.8	1.0	35.3	1.9	5.0	7.0	19.4	0.6	5.4	12.9	23.6	1.4	1.3	0.9	0.1	0.0	34.0	1.8
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 261.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	11.7	7.4	18.2	8.7	30.2	2.6	13.6	15.8	37.9	13.6	14.9	25.4	11.4	17.1	17.9	14.5	26.7	8.8	16.3	19.4	19.8	16.6	27.1	25.4	24.4	9.0	15.6	24.4	13.9	18.1	18.8	22.9	30.6	20.7	12.7	13.9	9.5	16.0	13.6	22.5	43.9	17.2	16.0	19.6	8.7	14.0	25.5	15.0	3.4	18.7	13.9	11.7	16.1	16.1	6.9	1.8	1.3	1.6	11.6	16.5	6.2	7.8	7.3	7.4	5.1	10.8	12.3	8.9	8.8	15.4	5.3	5.8	6.1	10.0	4.9	4.3	7.9	5.4	17.4	7.0	26.9	4.9	3.5	6.8	0.0	7.2	7.2	7.1	0.9	2.3	6.7	22.3	4.4	18.8	8.8	17.9	10.4	7.3	0.0	4.9	3.0	4.4	0.7	5.7	12.1	4.9	1.2	10.6	0.9	64.9	8.8	10.1	4.9	11.4	8.5	8.9	10.9	4.7	0.1	17.0	4.5	3.7	4.9	4.4	0.0	0.0	1.6	7.0	0.0	2.8	0.1	1.5	1.3	16.5	1.4	10.8	2.9	10.0	13.2	1.8	6.9	15.9	13.5	0.5	11.6	1.6	0.9	6.6	6.2	18.2	30.2	15.8	37.9	19.8	16.6	15.6	24.4	20.7	15.0	134.0	37.7	19.5	46.6	64.7	41.5	49.8	43.3	33.5	60.3	54.1	70.7	47.5	34.9	55.8	165.5	60.9	41.2	0.0	73.6	39.9	30.4	51.3	4.7	42.4	29.9	25.4	21.5	27.6	18.2	261.8	40.9	15.7	23.6	28.9	21.1	25.4	58.5	28.1	33.9	98.4	50.3	25.8	30.1	90.5	82.0	74.2	33.2	33.3	24.5	60.8
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129752-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 290.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2;NTERA-2: 27.8;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	7.7	52.3	13.8	7.8	22.0	2.9	11.9	13.0	22.4	23.5	9.8	7.2	19.4	10.0	23.1	25.7	16.0	16.0	16.7	25.2	11.2	11.5	32.2	12.1	9.9	2.4	10.7	16.3	26.1	11.3	27.2	14.4	10.2	15.0	17.6	10.8	22.2	11.4	22.7	2.0	13.2	10.0	23.1	23.7	2.8	13.7	14.8	13.0	6.1	11.5	5.9	4.3	18.1	18.1	0.4	2.7	14.8	0.4	1.7	6.4	0.4	10.7	5.3	19.4	0.2	6.6	8.9	6.9	4.6	10.0	2.8	4.4	7.9	9.7	0.2	1.5	5.1	5.7	4.6	13.0	8.5	5.9	27.2	4.6	6.4	11.8	3.8	6.2	0.2	0.9	5.2	9.0	8.0	15.3	15.4	3.0	5.5	2.7	0.4	2.9	3.3	4.1	0.8	27.8	8.7	2.8	0.1	9.0	0.1	19.6	12.7	1.8	4.0	4.4	2.6	16.4	27.5	3.2	1.5	4.5	1.8	7.7	0.4	0.2	0.3	0.2	0.2	4.2	0.1	3.5	14.8	0.4	0.3	2.7	0.3	6.4	0.2	2.5	2.3	1.8	0.4	0.4	1.9	1.0	1.7	0.2	2.7	2.1	0.4	13.8	22.0	13.0	22.4	11.2	11.5	10.7	16.3	15.0	13.0	23.8	23.3	2.7	42.8	18.2	89.3	123.9	50.9	72.3	50.0	43.6	129.6	22.7	29.9	26.9	20.2	15.5	24.5	0.0	28.7	34.1	41.5	27.0	3.5	36.2	5.8	119.2	31.2	16.5	8.6	11.8	37.4	12.0	111.3	290.4	12.7	99.2	39.4	30.6	26.5	85.1	145.1	32.3	27.2	41.2	47.8	22.5	22.1	10.7	33.8	41.1
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	7.3	5.6	9.7	7.2	11.6	3.2	7.5	16.3	13.0	8.5	7.8	8.3	4.8	8.3	8.6	10.0	9.2	5.4	7.7	6.0	8.2	7.5	14.0	6.1	7.1	8.7	9.9	5.8	9.3	9.0	10.5	8.8	21.0	9.9	7.6	8.4	9.1	8.5	9.0	4.8	7.9	9.0	8.7	7.8	5.2	6.9	8.1	9.6	6.9	6.6	1.7	10.2	8.7	8.6	1.2	0.5	2.8	0.9	1.0	1.7	0.3	6.5	4.5	20.6	21.8	5.9	4.7	14.3	4.7	3.8	3.8	5.0	8.5	2.8	15.3	6.5	4.8	9.9	4.8	10.7	5.7	5.4	2.9	7.2	8.8	7.6	7.8	5.1	3.8	3.1	2.3	4.4	5.2	7.4	4.7	8.2	7.5	8.0	5.6	5.4	4.3	7.7	2.7	13.7	3.2	5.1	0.0	5.8	10.3	4.3	5.2	2.7	15.7	5.3	17.2	6.8	19.4	6.0	4.0	6.9	3.4	14.4	3.5	5.5	11.5	20.0	8.9	6.6	2.5	8.0	2.8	0.6	2.5	1.7	0.6	0.9	1.2	1.0	1.1	0.5	0.8	1.2	1.6	0.1	1.0	0.9	0.1	1.0	0.3	9.7	11.6	16.3	13.0	8.2	7.5	9.9	5.8	9.9	9.6	3.0	1.6	4.2	5.3	10.0	14.2	4.1	2.5	0.0	1.2	12.2	23.6	16.1	3.3	9.5	1.5	4.9	6.2	0.0	6.2	15.8	6.2	8.6	4.6	4.0	5.9	9.5	2.4	3.7	2.2	1.1	3.1	4.2	10.1	5.4	4.4	5.8	9.4	23.0	4.6	8.7	19.1	6.5	5.6	8.1	12.2	11.0	16.9	3.3	3.4	8.4
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412585-39428415	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	15.7	6.1	2.9	30.8	4.4	14.8	14.2	2.8	4.0	18.7	12.4	3.9	5.6	5.9	20.3	10.1	9.7	12.6	17.6	13.5	3.5	2.6	10.7	5.1	21.4	20.2	4.5	2.2	17.5	4.4	5.8	7.6	17.4	7.4	12.3	3.9	13.6	6.8	15.0	7.1	4.4	9.6	14.1	6.9	24.8	8.8	8.7	3.6	49.3	11.1	9.5	24.6	13.0	10.1	3.9	4.2	2.8	1.8	1.4	4.4	2.7	3.5	17.6	32.2	17.4	3.1	4.1	4.6	9.5	7.5	6.6	5.7	11.3	6.4	6.3	7.0	12.3	5.5	1.2	4.8	8.4	3.5	20.7	4.4	8.1	9.2	5.1	5.3	0.9	10.2	9.3	1.4	7.9	3.8	11.5	8.4	18.2	5.4	7.4	10.5	7.1	10.1	3.2	7.6	3.3	1.7	36.4	3.9	1.9	5.6	6.6	0.8	10.4	2.1	0.8	3.1	11.7	9.5	9.3	10.7	17.3	13.6	6.4	6.0	5.5	1.7	9.1	9.6	3.7	9.5	2.8	1.4	0.4	4.4	0.8	2.6	3.9	2.1	2.5	1.0	3.6	2.8	3.5	2.6	1.4	1.8	4.2	3.9	2.7	2.9	4.4	2.8	4.0	3.5	2.6	4.5	2.2	7.4	3.6	6.0	30.1	7.5	3.2	3.5	0.6	5.6	5.1	2.7	9.1	0.0	0.0	0.7	0.0	5.3	9.7	8.1	2.6	0.0	4.3	2.3	6.4	2.6	2.3	0.8	8.9	0.0	1.2	10.4	12.9	11.7	6.6	11.4	5.0	7.2	2.6	1.2	3.0	2.3	7.8	0.2	2.6	6.5	8.0	2.6	2.2	2.5	0.9	6.7	3.0	1.3
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 215.9;Sertoli cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	16.9	14.5	8.0	37.4	54.7	30.6	6.4	50.4	67.0	26.6	45.3	16.5	11.1	9.8	53.4	55.7	19.8	14.3	11.6	17.6	18.3	10.2	12.4	5.3	23.3	20.9	33.9	3.3	25.8	37.1	9.3	32.1	12.9	90.3	47.1	2.2	14.8	4.8	27.7	11.0	0.8	8.9	3.5	17.3	21.6	3.9	16.3	21.3	15.3	3.8	3.0	12.7	22.0	15.1	25.4	13.1	7.6	8.5	46.5	30.4	22.8	38.0	24.7	11.3	18.3	5.8	67.4	11.6	49.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4	0.0	9.3	3.7	7.6	6.3	4.2	16.2	10.2	4.0	5.7	10.4	2.0	34.8	3.3	30.5	1.1	20.4	18.7	0.0	8.4	215.9	28.4	9.2	0.0	29.9	41.8	6.4	8.1	46.6	21.6	1.7	41.1	15.6	10.1	18.0	9.8	10.1	24.0	12.9	23.0	13.7	2.7	103.5	26.2	0.5	3.6	4.4	28.1	4.4	11.0	3.8
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	11.0	11.6	8.8	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.4	2.5	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.5	2.9	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.5	7.9	0.0	1.8	0.8	1.3	4.6	0.4	0.0	0.0	0.0	2.3	0.4	0.0	3.5	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.5	19.3	0.1	4.3	5.9	1.9	4.3	0.4	4.8	0.0	4.8	8.1	1.9	0.5	0.9	0.4	1.1	0.0	0.0	1.9	2.9	0.4	11.2	0.0	0.5	11.7	0.6	4.0	1.2	24.1	19.8	0.0	0.0	0.3	2.9	0.1	0.0	0.0	0.8	1.9	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.4	0.0	1.4	1.0	0.3	0.2	40.8	4.1	1.0	9.1	0.8	0.1	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6	3.0	10.1	0.0	4.4	9.6	0.3	3.2	17.8	6.7	10.3	3.5	0.0	0.7	0.0	5.0	0.9	48.7	9.1	23.3	10.2	0.2	48.9	3.1	1.1	39.0	0.7	0.0	9.9	88.4	8.6	1.3	39.7	2.5	3.3	0.0	13.5	48.4	5.7	8.6	30.4	16.5	1.3	0.0	25.0	0.7	0.4	7.5	0.7	1.0	6.6	2.2
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	4.6	2.1	4.4	3.8	2.5	0.0	3.1	5.2	9.3	3.6	2.5	2.5	2.5	1.6	3.8	5.2	3.7	3.3	2.7	10.2	6.2	5.3	2.5	5.3	6.3	3.1	2.9	5.0	5.0	4.9	18.7	2.5	4.9	3.9	3.7	0.7	2.5	7.9	4.1	5.6	8.8	2.5	2.9	2.5	5.6	2.3	5.2	2.5	2.5	3.2	2.5	2.5	3.5	12.6	0.6	0.0	0.0	0.9	0.0	1.1	0.5	18.0	8.6	9.5	7.5	12.6	14.1	15.2	10.8	9.2	6.2	6.2	28.5	8.5	2.0	16.3	11.6	8.4	28.0	4.9	21.2	2.6	2.9	7.7	0.2	5.0	7.3	8.3	2.1	1.5	14.1	14.9	11.5	9.0	6.3	3.1	6.1	10.4	3.8	6.6	10.6	4.2	4.0	9.2	5.7	7.7	5.6	24.4	5.6	5.4	36.5	8.5	9.3	7.8	7.5	10.3	6.5	12.0	13.7	11.4	10.0	12.9	18.2	11.3	2.3	1.5	3.9	14.3	4.1	10.5	0.0	0.0	0.0	0.7	0.1	1.1	0.5	0.6	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.9	0.0	0.8	0.5	4.4	2.5	5.2	9.3	6.2	5.3	2.9	5.0	3.9	2.5	44.7	2.6	1.5	4.5	14.1	3.8	10.9	2.5	5.3	18.2	12.2	3.9	16.8	0.0	7.4	1.2	4.3	5.1	0.0	6.0	2.1	11.4	4.7	0.0	1.0	11.3	19.1	9.2	2.5	5.6	0.8	7.2	2.8	8.5	1.8	4.5	2.4	12.9	2.9	6.0	1.1	2.9	6.5	9.5	6.3	9.2	14.1	6.1	0.0	3.9	5.0
PMF1		ENSG00000160783	"Polyamine modulated factor 1"	Q6P1K2	1	156212993-156240042	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (1.17e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"	20.6	21.7	18.2	19.8	20.4	40.8	23.3	24.3	23.7	27.4	20.3	26.1	25.2	20.1	25.2	27.5	26.4	20.4	24.4	37.9	16.4	15.5	38.0	32.4	21.3	30.5	23.9	17.4	25.1	28.0	23.6	22.8	35.5	17.1	25.5	18.0	27.6	26.8	20.5	65.7	28.9	20.1	20.9	21.3	29.9	22.8	13.4	22.4	23.6	30.5	48.3	29.5	21.6	22.7	22.8	41.1	26.2	36.5	19.9	31.1	29.0	21.2	26.3	28.4	21.4	5.4	11.2	22.1	11.1	15.7	30.1	25.0	32.2	30.7	19.6	24.2	14.1	10.4	14.3	28.5	18.5	15.5	14.0	33.8	14.5	20.1	28.7	11.2	20.4	20.2	10.1	18.7	13.5	14.3	11.6	22.6	14.4	21.6	22.8	14.5	43.4	21.3	26.4	49.3	31.5	23.4	23.5	15.1	38.8	31.4	16.1	26.0	32.7	18.4	21.2	14.4	21.7	34.5	25.1	13.0	13.0	16.7	14.4	21.7	17.1	17.6	38.5	10.4	19.8	18.0	7.9	36.5	16.4	20.2	25.2	18.1	22.8	19.9	18.8	30.0	21.6	19.4	19.5	26.2	19.9	22.1	41.1	31.1	29.0	18.2	20.4	24.3	23.7	16.4	15.5	23.9	17.4	17.1	22.4	17.9	21.4	70.7	66.4	44.3	11.4	9.7	48.4	6.7	22.7	71.5	11.8	119.8	149.2	81.5	4.4	45.6	19.1	23.3	85.9	94.2	46.0	45.9	43.9	44.8	68.8	7.9	47.1	37.4	37.6	4.2	36.2	38.4	81.0	60.5	42.8	53.7	66.2	42.9	26.5	90.8	23.8	25.8	42.9	14.7	35.1	44.5	131.6	52.3	46.9	60.9
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 2.7;Distal tubular cells: 3.3;Proximal tubular cells: 2.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	9.8	15.7	16.2	10.3	16.2	12.1	7.8	18.1	14.6	14.6	13.0	13.9	13.4	8.6	13.1	16.3	11.7	15.0	12.9	24.6	14.1	14.2	20.6	17.4	11.0	16.4	12.6	9.0	15.6	15.0	10.4	16.2	19.2	8.8	15.7	7.0	14.8	21.5	13.2	31.8	10.7	10.5	10.9	11.2	14.0	9.5	7.4	11.8	12.5	16.4	26.4	15.8	9.8	11.1	9.8	7.1	10.2	8.9	5.1	10.7	8.1	7.0	7.3	9.7	6.6	2.6	6.8	4.2	6.4	4.2	6.3	5.2	5.4	6.5	6.2	10.8	5.7	2.6	4.9	9.0	8.2	3.2	10.6	15.2	4.3	7.1	10.0	12.4	4.2	7.7	8.3	7.7	5.7	5.0	7.9	5.9	5.7	4.2	10.0	4.4	8.6	3.7	9.0	19.9	4.8	13.4	7.1	3.8	9.1	4.9	3.4	6.7	8.6	4.2	1.7	11.0	8.8	9.9	17.0	6.5	3.1	3.1	3.9	5.7	6.1	7.3	9.4	4.5	5.6	6.2	3.6	8.9	4.4	4.9	5.8	4.8	4.8	7.7	7.1	6.6	9.8	10.7	6.0	10.2	5.1	6.1	7.1	8.4	8.1	16.2	16.2	18.1	12.8	14.1	14.2	12.6	9.0	8.8	11.8	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.4	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	0.3	0.0	0.0	0.6	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	2.2	0.0	6.5	0.0	0.2	0.5	0.0	0.8	0.0	0.5	0.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.8	24.3	5.4	14.1	9.6	15.2	12.0	17.0	20.6	17.1	18.5	18.2	13.5	17.4	7.2	29.7	9.0	15.1	11.0	20.8	17.5	12.9	12.9	5.7	14.7	31.0	18.3	15.2	13.8	22.7	14.8	18.2	16.8	7.9	17.4	10.8	7.8	17.0	11.3	28.5	15.6	14.0	22.9	25.4	15.8	19.8	12.0	34.6	19.0	19.3	10.3	19.3	14.0	30.9	10.2	9.0	20.1	13.4	20.1	12.3	13.9	33.2	16.6	21.0	17.6	21.9	10.3	19.2	16.3	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8	14.9	17.9	9.8	6.8	3.4	4.8	2.4	5.1	26.8	46.6	0.0	13.7	7.4	8.3	10.9	0.2	4.5	10.2	23.3	24.6	9.5	5.4	9.5	22.0	11.3	5.1	1.6	7.5	3.7	6.0	0.6	5.8	6.3	1.7	8.2	11.5	2.3	17.8	10.2	2.1	10.0	8.9	0.0	5.2	1.6	3.1	3.6	8.9	5.1	9.2	11.3
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 386.0;Late spermatids: 438.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA031013: AB_2673696"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favorable (3.73e-4)"	9.8	8.2	9.6	9.8	12.4	9.9	10.1	14.6	13.2	10.6	7.5	6.9	17.3	6.6	11.8	14.5	7.3	11.4	7.5	7.1	9.7	8.0	6.3	8.6	7.1	11.1	10.1	9.9	12.2	9.8	7.6	18.2	7.6	14.2	8.9	8.2	6.7	8.4	15.0	8.4	9.9	8.5	9.6	10.7	11.1	11.5	38.8	10.9	9.6	9.6	7.3	9.2	8.2	8.4	14.0	8.1	2.9	5.5	9.0	13.2	3.7	7.9	7.1	18.3	14.4	10.1	15.2	16.2	15.2	7.5	12.9	15.7	11.8	10.8	23.6	8.6	6.3	9.2	11.7	17.8	11.2	18.4	17.6	10.4	23.5	13.0	17.6	14.0	13.6	10.6	9.7	11.4	12.0	24.5	11.1	13.3	16.5	19.6	12.9	15.8	5.4	16.0	19.0	18.1	8.4	16.5	18.6	12.5	22.6	12.4	11.6	17.1	12.0	11.2	7.1	10.8	22.8	8.1	11.2	10.4	14.0	9.7	8.8	13.3	10.2	12.6	20.4	8.2	12.0	8.9	2.2	5.5	2.9	12.0	3.3	11.2	11.7	8.8	13.2	5.0	14.0	8.9	11.4	2.8	9.0	4.1	8.1	8.2	3.7	9.6	12.4	14.6	13.2	9.7	8.0	10.1	9.9	14.2	10.9	14.9	11.8	8.2	7.4	6.2	26.5	15.2	7.6	38.8	19.4	5.2	7.9	13.7	0.0	6.1	386.0	12.2	2.9	0.0	7.0	9.4	9.8	6.4	12.7	8.3	8.1	9.5	11.5	9.8	17.0	438.4	20.1	9.2	6.8	5.4	5.9	12.8	5.5	4.8	18.4	4.5	26.1	12.9	6.9	16.6	22.0	6.0	4.3	10.2	10.8	3.9
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	13.0	8.8	8.9	14.0	8.5	6.6	14.5	21.1	10.8	9.8	8.6	7.0	17.2	8.5	6.7	6.4	5.7	10.7	3.2	11.9	5.8	10.9	13.5	14.4	16.6	6.1	6.4	13.6	19.3	6.2	6.3	8.9	5.8	8.7	12.8	10.7	7.0	17.1	12.7	8.3	13.7	10.8	8.3	13.5	18.0	11.7	8.2	17.1	10.0	27.9	10.6	17.1	9.2	27.8	4.7	8.1	4.8	8.4	18.1	19.1	11.7	4.6	17.4	18.9	7.6	6.9	17.3	6.1	15.2	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9	14.9	23.4	40.2	28.5	11.8	40.7	8.9	15.3	24.1	9.1	19.2	76.6	37.9	19.9	36.3	12.0	20.2	24.9	0.0	34.6	29.2	14.8	28.4	27.8	18.7	34.1	31.8	29.3	31.9	22.4	20.0	55.0	24.9	13.5	42.3	23.1	20.6	38.1	20.1	42.1	26.9	76.0	19.4	14.4	18.2	29.6	11.4	41.2	42.4	27.4	25.2
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.3	14.4	9.4	16.3	11.6	31.7	9.0	20.7	12.1	9.5	22.6	13.0	24.7	17.0	25.6	14.4	17.3	20.1	7.9	23.2	14.8	16.0	9.3	10.2	12.6	16.4	18.8	4.7	11.9	13.4	27.7	11.3	14.5	11.1	15.6	15.2	21.6	27.5	18.1	13.3	18.9	22.0	12.4	12.8	13.8	10.2	10.7	13.4	23.1	12.9	9.4	9.0	8.9	18.7	20.2	16.6	39.9	9.1	13.0	32.0	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9	14.9	10.4	31.0	31.3	73.8	22.7	10.4	12.7	33.5	46.6	7.0	11.8	34.1	16.6	26.1	20.1	20.3	4.2	0.0	25.8	33.6	22.6	19.3	30.1	14.3	23.5	17.5	16.6	13.5	10.6	4.2	11.5	23.3	11.8	20.8	9.7	13.7	24.7	7.0	15.6	27.9	40.1	6.5	48.7	23.9	42.8	49.1	39.8	20.4	13.6	22.3
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.6	14.6	1.1	2.7	7.5	5.8	0.0	6.0	3.9	6.7	5.8	23.9	13.0	16.8	28.6	5.9	2.7	10.6	9.1	16.3	9.7	20.4	7.8	11.8	6.8	24.8	8.0	10.5	8.2	7.6	12.7	12.4	15.5	6.2	8.7	12.6	11.1	5.8	7.8	13.1	10.6	3.4	2.1	17.5	18.1	9.0	5.1	12.2	18.6	9.1	5.9	4.9	5.5	8.9	5.0	4.3	15.7	3.8	9.1	10.8	6.4	10.8	12.4	13.9	15.3	8.9	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0	11.9	15.2	1.5	5.9	1.3	0.7	1.7	22.9	5.3	7.9	12.2	3.9	7.5	53.0	15.3	0.4	3.6	11.0	0.0	13.5	2.0	3.1	7.8	12.7	47.2	15.2	3.2	3.5	4.9	7.0	0.4	9.2	8.5	1.7	8.2	9.9	6.7	13.1	10.5	5.6	75.4	1.7	0.0	1.7	0.7	1.3	1.9	5.3	1.0	13.6	4.8
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 1093.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 54.1;hTCEpi: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.1	10.3	24.8	41.8	4.2	3.8	26.8	7.2	16.9	2.4	8.2	6.4	18.7	4.6	29.6	10.1	3.2	5.8	11.0	8.0	10.0	1.1	16.5	7.7	54.1	5.9	14.8	30.0	57.5	4.8	22.2	27.2	11.8	7.6	0.9	19.7	7.9	2.9	1.5	31.3	1.7	3.3	6.1	7.0	7.4	5.1	16.9	5.2	3.9	11.0	9.9	13.6	10.0	19.0	6.7	29.9	11.2	5.7	3.4	4.0	1.4	31.0	15.1	2.1	11.5	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8	131.0	125.0	333.4	716.3	860.7	129.0	174.7	124.9	45.5	52.4	85.5	47.1	189.8	198.9	158.1	59.9	195.6	165.4	23.3	206.9	57.7	278.7	681.2	165.7	181.5	204.0	68.3	237.9	148.0	328.8	20.9	446.1	557.5	416.7	926.1	131.7	222.1	145.2	115.8	354.7	216.2	99.3	413.9	840.5	47.0	44.3	1093.4	229.5	380.5	99.7	411.4
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23959109-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	35.6	32.8	21.1	39.3	21.4	39.0	36.8	22.3	21.0	38.6	40.6	17.1	25.9	32.0	37.5	24.4	28.7	24.9	32.7	41.9	20.9	19.4	33.3	21.3	37.2	40.6	21.8	20.2	39.7	25.2	29.2	28.5	36.2	18.6	37.1	30.8	23.8	26.2	30.1	32.8	18.7	38.4	37.9	26.1	34.4	29.3	16.9	18.7	44.6	56.0	23.0	34.4	49.1	35.6	46.8	38.9	69.5	40.5	36.6	48.9	52.8	23.9	9.5	41.9	28.9	28.9	26.6	16.0	26.7	23.8	31.1	25.0	27.7	30.4	65.5	26.2	16.9	11.7	21.4	28.0	23.2	34.6	46.5	18.1	62.2	29.2	29.1	24.7	60.2	28.5	20.0	29.4	25.4	23.8	20.4	29.9	34.0	52.6	36.9	18.2	19.6	37.2	23.0	56.6	22.8	17.8	42.3	27.2	27.8	31.2	25.8	25.1	21.9	23.1	19.9	27.1	32.0	21.6	38.0	23.9	20.1	19.5	19.7	16.9	31.2	35.8	44.7	13.7	58.4	20.6	69.5	40.0	44.0	39.6	40.5	41.3	46.8	43.3	42.6	38.9	46.7	48.9	41.2	26.7	36.6	37.1	27.9	44.6	52.8	21.1	21.4	22.3	21.0	20.9	19.4	21.8	20.2	18.6	18.7	172.7	84.5	75.1	213.3	11.7	31.2	75.8	33.1	101.7	112.6	59.3	17.7	106.7	202.2	72.5	5.4	75.4	113.0	116.8	112.0	88.3	60.2	176.8	73.0	27.6	59.3	19.1	96.3	74.3	66.3	11.0	73.1	84.5	1.7	63.1	76.5	50.4	90.7	85.4	76.4	88.9	24.5	45.3	47.6	22.4	23.0	11.0	118.5	109.3	95.0	217.3
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 90.6;Mucus-secreting cells: 54.0;Paneth cells: 51.8;Undifferentiated cells: 38.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Group enriched"	"Detected in some"	5	"OE19: 59.5;RT4: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		430000	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.8	3.9	1.1	0.0	0.0	7.9	1.7	0.1	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	3.0	0.0	0.0	0.0	59.5	0.0	0.0	0.3	0.0	0.0	26.5	0.0	0.0	0.0	2.0	0.0	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0	0.0	0.3	0.9	4.2	8.0	0.0	13.2	10.2	8.1	11.4	5.2	0.0	2.1	0.0	10.5	0.0	2.2	90.6	0.0	13.4	0.7	0.2	3.2	0.0	0.0	0.2	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	54.0	0.0	17.7	51.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	25.0	4.5	0.0	38.3	17.2
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2.0	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8.0	9.9	19.3	5.9	13.7	9.6	9.0	17.3	37.0	13.8	4.2	9.4	12.8	7.9	12.6	6.0	5.7	16.3	11.8	5.9	4.6	10.2	7.0	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0.0	9.4	11.4	1.8	2.0	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2.0	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0.0	1.8	3.7	4.5	1.3	0.0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261762-65305589	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	7.5	6.6	4.9	11.9	8.8	9.8	7.5	14.1	8.8	12.0	9.6	9.8	6.4	6.7	10.1	5.5	10.4	9.3	5.9	6.1	5.2	4.5	7.9	7.0	7.5	14.7	10.3	5.5	10.3	7.9	8.0	4.8	9.3	6.5	7.1	9.6	6.7	8.9	7.5	6.5	8.0	9.2	10.7	10.2	13.6	8.8	15.0	8.4	35.7	7.9	10.3	19.7	8.6	7.3	6.0	13.3	8.0	10.1	4.9	7.3	7.7	14.4	13.3	22.0	10.2	3.3	3.9	7.5	9.9	15.8	32.0	23.7	5.3	12.7	17.4	11.4	8.6	15.5	9.1	17.9	14.8	27.4	9.4	6.7	13.1	20.2	6.0	1.9	12.1	10.8	2.7	2.1	27.7	5.8	5.8	11.9	8.9	12.6	11.8	21.6	20.0	26.0	5.4	16.4	10.7	8.5	14.1	12.8	16.8	9.6	10.0	14.4	8.6	9.5	10.4	3.3	14.4	13.0	6.2	4.3	11.8	9.5	15.6	7.2	5.5	6.6	17.9	8.5	7.7	15.8	8.0	10.1	3.9	6.5	9.5	7.3	6.0	6.9	7.1	13.3	5.6	5.6	5.1	5.0	4.9	7.6	10.4	7.1	7.7	4.9	8.8	14.1	8.8	5.2	4.5	10.3	5.5	6.5	8.4	0.0	4.3	0.8	3.8	1.4	2.5	2.7	5.1	2.7	3.4	5.2	2.0	8.3	3.3	5.7	2.1	3.5	1.0	0.0	3.0	14.9	4.4	2.2	0.0	1.6	8.4	3.2	2.9	3.7	2.1	2.9	6.9	4.3	0.0	10.8	2.2	2.3	3.6	2.6	7.1	1.4	4.9	6.5	3.6	12.0	14.5	1.3	6.1	5.1	5.3	3.2
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.2	15.0	22.3	10.6	4.7	3.7	19.9	11.5	5.2	13.8	10.1	18.2	6.7	12.9	4.9	6.2	5.3	15.7	15.5	7.8	8.4	6.0	19.6	20.4	19.4	8.9	0.9	15.9	11.7	2.8	3.1	14.4	4.7	3.8	4.8	16.6	22.8	7.3	6.8	18.2	26.1	29.2	17.3	5.3	9.0	21.7	12.6	5.8	4.4	18.4	18.6	10.7	13.4	11.0	2.5	11.2	16.2	9.9	4.4	12.6	12.9	9.5	11.6	9.7	6.5	20.3	6.9	22.0	8.9	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4	0.0	7.9	4.5	3.5	5.0	8.1	5.6	0.0	2.7	0.0	1.8	0.0	6.2	0.0	2.1	6.5	3.0	4.7	0.0	2.7	9.0	4.7	3.7	2.3	8.9	10.4	0.0	6.9	12.9	7.9	7.0	6.4	3.2	5.0	1.0	6.7	3.7	2.4	5.8	3.2	0.8	5.0	25.8	3.3	25.4	7.9	6.8	3.3	5.7	9.8	2.5
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958492-74970128	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.2	14.5	23.6	15.2	17.3	27.1	21.4	4.4	15.5	18.4	13.4	8.6	7.0	9.0	10.4	9.0	10.0	9.7	13.1	18.1	15.9	10.6	11.6	18.8	10.7	17.0	13.9	12.6	12.8	12.5	2.8	3.9	9.6	12.2	12.0	8.8	13.9	16.2	11.2	28.1	8.1	12.4	14.1	11.7	12.2	12.5	11.0	10.0	5.5	13.1	15.1	10.4	13.9	31.9	14.7	14.7	8.0	22.2	4.4	9.9	12.3	11.8	11.3	1.0	1.0	3.9	8.6	0.0	8.0	10.0	12.9	11.0	15.0	5.3	11.6	6.8	9.1	3.2	5.4	5.4	6.7	15.1	5.3	14.5	9.0	6.5	14.8	14.0	12.7	14.2	8.7	13.1	5.4	11.9	4.0	5.6	1.6	11.0	6.8	9.8	11.5	3.7	35.8	7.9	6.9	21.2	4.5	9.7	9.3	10.7	0.3	3.6	5.4	11.0	4.6	6.4	0.6	3.4	4.1	6.2	2.9	3.3	2.0	7.7	2.4	1.6	4.3	10.5	19.1	14.2	2.3	22.2	8.0	6.3	13.2	7.0	14.7	8.9	7.8	12.9	13.7	9.9	6.9	1.6	4.4	12.4	14.7	8.5	12.3	23.6	17.3	4.4	15.5	15.9	10.6	13.9	12.6	12.2	10.0	23.8	36.0	84.1	81.2	75.1	21.9	40.6	58.6	34.8	21.6	69.8	41.2	124.8	126.0	43.1	10.2	56.2	119.0	23.3	70.2	125.8	83.2	82.4	61.1	123.4	106.6	17.5	11.7	68.7	111.2	19.3	62.2	91.0	92.8	30.7	80.6	78.1	62.4	147.3	51.2	125.5	104.8	77.6	87.3	41.3	86.7	85.4	78.6	69.3	78.6	82.9
POLR1D	"MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 641.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	30.5	43.8	17.0	35.4	22.1	46.5	36.5	41.2	23.7	34.6	40.8	15.9	34.4	30.9	26.0	29.9	58.9	21.4	32.3	28.5	16.7	14.4	27.3	29.9	32.6	36.5	14.8	20.6	43.6	115.9	16.7	24.3	24.7	15.6	37.4	32.7	20.9	46.2	39.5	38.1	44.8	36.4	41.2	17.4	31.9	41.7	23.7	13.0	50.9	32.3	40.7	40.7	56.8	54.0	29.2	42.7	21.4	39.3	27.9	56.6	26.2	20.0	18.9	21.8	22.3	25.1	45.1	29.3	19.9	34.4	26.4	26.2	30.5	40.9	65.1	15.1	22.4	43.8	31.0	40.1	63.6	31.4	20.1	23.8	46.2	20.6	51.1	37.9	42.0	36.4	40.5	67.3	21.4	40.1	29.7	36.4	37.5	25.2	11.6	25.6	20.8	41.2	51.2	52.5	62.8	20.1	28.4	37.5	29.2	41.6	31.2	37.2	29.2	13.3	26.9	71.8	28.7	16.4	39.2	25.2	11.7	18.3	20.0	21.7	19.1	21.5	36.8	10.2	30.4	22.7	21.4	38.4	17.3	24.9	39.3	32.8	28.4	40.2	31.4	42.7	29.2	43.6	34.2	13.7	27.9	34.2	31.2	56.6	26.2	17.0	22.1	41.2	23.7	16.7	14.4	14.8	20.6	15.6	13.0	83.4	87.9	125.7	260.0	299.0	36.8	61.7	99.3	46.8	102.4	27.9	15.7	139.0	63.0	120.2	371.4	103.0	105.8	70.0	267.5	226.2	97.1	149.2	93.5	69.2	148.4	42.9	119.5	90.9	175.3	641.0	107.9	125.4	75.9	153.3	182.4	43.5	227.4	97.9	74.3	100.6	35.5	77.6	116.0	153.7	85.9	277.2	122.0	126.4	173.3	290.2
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485935-37503697	"Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	15.4	12.2	10.5	20.2	11.6	9.3	19.7	10.7	9.0	19.0	13.9	10.0	14.9	7.0	20.5	14.7	15.1	17.3	13.7	14.9	9.1	9.2	7.6	23.9	10.1	15.5	9.0	9.2	36.9	25.9	10.3	9.6	8.7	9.5	17.3	9.3	9.5	19.5	18.4	17.2	13.1	9.0	22.4	10.2	10.8	13.0	11.2	11.5	16.0	15.3	13.3	17.1	21.9	16.8	8.1	3.9	1.4	4.3	9.0	16.9	5.5	19.7	18.6	10.3	16.3	19.3	24.9	6.7	17.6	6.8	18.3	16.2	15.9	6.6	28.8	8.5	20.2	12.4	8.3	25.1	20.9	23.1	27.8	11.8	13.8	23.6	11.3	14.5	26.4	9.8	26.4	7.4	35.7	30.9	11.5	9.2	16.1	36.0	12.7	16.0	9.5	18.2	9.0	18.3	13.6	15.3	16.2	9.5	13.8	9.5	7.4	14.7	12.1	11.7	9.4	15.1	8.9	9.2	17.6	6.3	21.7	33.1	18.5	35.0	7.0	9.8	30.3	7.5	16.8	18.0	0.0	2.5	1.4	10.6	4.3	16.9	7.4	10.2	10.8	3.9	8.1	12.8	11.1	0.8	9.0	3.4	2.7	5.4	5.5	10.5	11.6	10.7	9.0	9.1	9.2	9.0	9.2	9.5	11.5	0.0	6.7	8.5	20.9	25.1	6.4	7.6	15.3	5.3	9.1	0.0	3.9	12.9	6.6	12.3	4.4	7.5	2.7	0.0	18.2	17.4	12.1	6.6	8.1	15.8	6.6	3.2	1.7	3.7	8.6	8.6	13.8	7.3	5.0	8.2	7.3	6.7	14.5	0.0	14.2	4.1	5.7	0.0	17.9	11.5	16.1	15.6	7.0	12.9	12.1	11.6
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"	P24928	17	7484366-7514616	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription"	"DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HL-60: 2.7;HMC-1: 4.0"									"CAB012226, CAB016388, CAB022311"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: "	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	5.0	5.9	4.5	5.7	7.4	26.4	8.5	5.8	7.8	7.2	4.3	4.8	4.5	4.3	5.5	5.4	7.0	4.6	4.2	4.5	6.0	3.5	4.6	4.4	6.4	11.5	4.7	4.2	5.2	5.8	5.4	4.8	4.2	5.4	4.3	4.9	6.3	5.5	8.1	6.6	6.6	6.0	4.5	6.1	6.2	5.3	13.2	2.9	15.0	5.6	4.1	5.0	5.3	4.6	0.7	0.7	4.9	1.0	0.0	1.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.4	3.0	0.7	1.2	0.2	0.0	2.7	4.0	0.4	0.0	0.3	0.0	0.4	0.2	0.7	0.3	0.0	0.5	0.0	0.1	0.8	0.5	0.0	0.9	1.2	0.0	0.0	0.0	1.4	0.3	0.9	1.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.2	0.4	0.0	0.6	0.3	3.0	0.5	0.6	1.2	0.4	0.3	0.3	0.5	0.4	0.1	0.7	0.6	0.5	4.9	0.0	1.0	0.7	0.5	0.0	4.5	7.4	5.8	7.8	6.0	3.5	4.7	4.2	5.4	2.9	20.8	47.7	32.5	35.2	38.0	86.4	20.7	38.2	29.4	23.9	22.7	104.1	31.3	3.3	23.3	19.9	38.6	39.3	0.0	26.5	23.6	28.9	29.0	41.5	22.9	39.8	52.4	73.6	38.6	32.1	7.2	34.2	31.4	35.4	35.1	39.1	29.5	28.0	30.0	39.3	10.6	80.9	6.5	33.7	53.7	121.1	36.0	45.0	39.2	30.5	29.3
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462387-57472010	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	26.2	30.1	24.2	18.4	26.9	23.9	25.8	34.1	37.6	27.2	22.9	28.8	23.1	21.5	26.0	45.0	26.2	30.3	29.9	32.6	24.5	25.9	38.3	44.8	29.9	30.2	25.0	30.1	37.2	39.4	33.7	35.0	29.2	25.5	29.2	26.0	29.6	30.4	31.4	47.5	23.7	27.9	26.1	24.1	22.4	25.2	26.4	21.9	30.5	35.8	27.3	27.1	27.5	22.2	21.8	16.2	41.7	19.8	26.2	28.6	21.9	17.7	29.4	24.6	22.3	22.3	20.1	21.9	23.5	25.6	37.7	24.9	37.6	22.6	20.1	27.6	25.8	22.9	18.7	32.5	24.7	42.0	9.2	24.2	15.4	17.6	42.8	25.3	27.9	29.7	18.0	20.4	28.7	26.6	20.6	22.7	27.5	26.7	11.4	24.6	24.5	30.9	29.6	36.9	21.4	44.8	45.1	29.2	35.6	30.5	17.6	31.3	36.5	38.0	21.3	24.6	24.2	16.2	25.8	17.5	23.8	24.3	18.1	26.7	26.3	22.5	40.9	24.0	24.1	31.4	24.8	17.3	29.0	20.7	16.4	22.6	21.8	23.6	19.1	16.2	20.9	28.6	26.8	41.7	26.2	19.8	13.2	22.5	21.9	24.2	26.9	34.1	37.6	24.5	25.9	25.0	30.1	25.5	21.9	23.8	34.7	45.5	39.7	27.5	84.3	9.7	33.1	28.1	14.8	26.2	53.0	65.7	77.9	47.3	3.0	36.0	36.6	0.0	57.8	72.3	37.6	40.0	61.0	18.5	36.7	49.3	36.7	22.1	18.6	6.6	47.8	21.9	38.8	64.9	27.6	87.9	46.7	36.8	48.8	96.7	87.2	45.3	39.2	40.2	65.5	26.2	77.7	42.4	33.6	35.9
POLR2D	RBP4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843551-127858157	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	8.2	9.4	8.1	8.9	9.1	17.9	7.9	9.3	12.6	6.9	7.7	12.3	6.9	6.3	7.5	6.2	9.8	7.7	7.6	7.3	7.8	6.3	6.3	13.5	7.2	11.8	9.9	7.5	10.3	17.4	7.4	9.4	10.2	8.7	7.2	9.9	7.3	7.6	6.5	21.9	8.9	7.8	9.8	8.8	11.1	7.8	46.4	9.9	16.7	6.3	9.1	16.8	8.0	7.2	16.7	20.6	11.4	22.1	16.7	21.0	14.3	18.4	12.1	22.5	15.7	8.4	9.2	18.1	17.7	8.4	21.4	19.2	27.3	15.3	28.7	15.3	11.9	12.2	9.8	32.3	15.3	33.2	16.8	17.6	28.4	12.1	25.0	9.8	30.4	15.8	6.5	11.5	28.5	16.4	5.9	13.9	21.1	39.5	25.8	12.2	14.7	30.2	13.8	31.5	19.4	14.0	29.1	23.8	25.9	7.1	12.7	14.0	18.7	11.9	14.8	14.9	17.6	16.6	21.1	14.0	18.6	26.2	10.5	20.4	30.5	49.4	51.7	16.2	15.2	18.2	5.7	15.8	11.4	19.4	21.5	18.1	16.7	15.6	16.9	20.6	15.1	21.0	17.8	5.0	16.7	22.1	13.5	13.9	14.3	8.1	9.1	9.3	12.6	7.8	6.3	9.9	7.5	8.7	9.9	3.0	9.4	14.9	17.2	9.6	14.8	9.0	10.2	8.1	12.5	12.2	7.9	26.9	10.0	17.6	54.9	9.5	7.0	23.3	15.2	23.1	10.3	13.9	18.4	14.9	19.4	31.8	8.1	9.2	9.1	142.9	16.4	11.5	8.5	25.2	10.6	11.8	13.4	10.5	17.3	8.7	12.9	12.9	14.1	61.1	55.3	8.8	22.3	13.8	13.4	14.0
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II subunit F"	P61218	22	37952607-38041915	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	31.7	31.4	37.5	23.4	43.8	23.0	28.2	32.6	54.5	25.2	27.8	57.3	20.4	26.3	24.2	18.7	24.6	23.2	20.3	37.8	33.5	31.2	25.1	58.5	17.9	19.8	44.8	44.1	30.2	26.1	43.5	28.8	21.2	38.4	21.4	21.0	21.0	38.0	29.6	67.9	19.0	25.7	20.8	39.6	16.8	26.9	21.9	48.3	13.1	28.5	23.4	18.0	19.0	26.8	36.1	49.5	52.4	36.7	40.1	38.5	29.3	34.3	40.7	28.8	30.7	34.6	20.3	25.7	32.3	18.9	33.1	31.2	47.2	12.2	26.6	23.3	27.9	33.2	24.8	39.6	31.2	16.4	32.5	66.9	24.8	41.9	64.0	30.2	48.3	15.9	26.9	23.7	44.7	17.3	17.2	28.3	29.7	47.3	22.5	24.0	48.9	37.5	58.3	41.4	40.0	31.0	37.4	26.4	31.0	18.2	21.4	43.3	16.2	29.7	21.3	46.5	17.5	14.9	33.5	25.9	29.2	41.5	36.1	36.4	25.3	39.2	55.5	29.7	24.6	32.8	34.5	36.7	52.4	34.3	33.3	32.1	36.1	30.0	33.2	33.4	28.9	27.3	27.2	46.2	40.1	28.1	49.5	38.5	29.3	37.5	43.8	32.6	42.7	33.5	31.2	44.8	44.1	38.4	48.3	35.7	81.8	93.0	98.8	181.6	23.8	0.2	117.2	73.6	56.9	115.1	23.6	207.5	164.2	148.0	67.2	91.8	136.4	46.7	138.2	263.3	141.6	91.0	88.8	237.4	154.9	27.0	112.4	95.2	90.9	30.1	147.9	85.4	214.2	119.0	111.6	70.5	150.4	114.3	142.1	213.7	31.1	155.2	124.9	159.7	214.2	196.1	177.2	87.1	119.2	105.4
POLR3K	RPC11	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53628	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	7.3	12.4	15.4	16.6	17.6	11.3	8.3	14.3	18.8	8.0	9.1	9.0	11.9	9.8	8.3	9.3	9.8	9.3	7.4	12.0	13.7	15.4	9.1	10.3	7.6	19.6	11.9	15.5	9.1	11.0	12.1	7.5	8.0	9.0	10.0	9.2	5.9	11.1	12.7	21.8	5.7	9.3	8.2	9.8	14.0	9.1	5.7	7.9	13.7	11.5	12.4	18.6	9.9	8.6	39.6	25.3	32.2	18.9	13.5	30.0	18.2	10.8	18.7	11.9	12.3	4.9	3.0	9.5	15.5	4.9	13.8	9.1	24.1	11.7	28.2	11.8	5.4	5.5	10.8	27.7	7.1	9.9	16.9	25.5	20.7	14.0	17.1	3.7	18.6	20.4	3.0	6.3	15.3	7.8	3.2	6.7	12.6	29.5	9.0	8.9	26.9	22.3	12.3	19.5	13.7	17.9	27.1	13.8	29.4	7.8	7.8	17.5	10.3	10.6	19.9	9.1	5.2	11.7	16.8	6.4	8.9	10.9	11.9	18.7	5.8	13.9	55.5	3.8	13.7	13.3	9.0	13.6	32.2	15.8	18.9	16.2	39.6	20.3	18.2	12.4	35.1	18.4	17.2	9.8	13.5	17.3	25.3	30.0	18.2	15.4	17.6	14.3	18.8	13.7	15.4	11.9	15.5	9.0	7.9	3.0	9.9	34.1	17.9	29.7	15.1	25.5	25.5	12.0	7.9	17.4	3.9	34.6	41.4	28.4	0.6	20.3	13.2	0.0	30.5	38.6	19.5	23.0	21.9	26.0	38.9	9.5	17.2	19.0	13.1	0.4	19.5	22.5	21.9	56.9	19.5	12.9	29.0	14.0	15.6	36.1	8.4	12.9	17.5	4.7	15.1	38.6	10.8	27.7	24.8	19.5
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	17.1	12.6	15.7	35.3	8.5	7.0	13.1	12.3	10.5	12.3	10.7	22.2	10.9	23.7	4.0	10.6	13.7	13.2	15.6	11.9	13.8	20.5	31.1	17.7	12.6	14.7	8.7	36.6	22.6	9.2	8.5	16.3	15.0	8.0	9.1	13.8	48.4	17.8	12.0	13.2	21.8	23.3	16.5	9.6	15.3	20.0	12.3	20.0	6.2	15.1	22.5	19.8	10.8	20.8	11.0	11.0	17.3	19.3	12.8	22.1	13.6	17.4	24.6	21.4	19.8	34.4	12.9	23.5	21.8	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5	35.7	28.2	12.7	8.8	22.3	31.1	4.4	25.5	17.4	20.5	17.4	92.3	14.5	5.0	10.8	6.8	14.2	16.9	23.3	14.7	10.9	16.5	15.7	16.1	20.3	13.8	38.1	17.2	17.8	15.8	4.2	13.8	18.3	18.6	7.2	19.6	18.3	17.2	10.5	16.6	5.4	23.8	12.9	15.9	14.2	11.8	27.0	16.2	18.1	19.0	18.4
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"		7	75416787-75486271	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	5.5	5.5	6.5	9.9	8.4	11.0	4.5	11.2	7.4	5.9	5.1	5.8	6.5	4.5	7.0	7.5	6.6	5.9	6.0	5.3	6.8		6.9	6.3	5.0	10.3	4.3	4.4	8.4	7.5	7.7	10.1	6.6	5.4	5.4	5.2	9.3	6.5	5.3	5.7	5.5	6.2	6.2	4.6	6.7	5.3	4.6	6.3	13.1	7.0	7.3	12.0	6.6	5.0	3.5	3.4	3.9	1.6	2.7	3.8	1.7	15.8	13.3	18.4	35.2	6.9	7.8	12.1	11.6	10.7	9.5	9.2	15.9	10.3	28.1	4.8	12.6	14.9	14.4	15.6	14.3	15.7	18.9	21.6	13.9	15.3	10.6	9.2	36.8	19.8	6.6	9.1	14.4	10.8	14.0	9.6	11.7	38.9	15.8	15.3	16.0	22.4	18.7	14.6	12.3	15.1	20.2	12.3	14.4	5.2	21.7	20.6	27.0	13.4	21.4	9.4	17.4	18.6	13.1	10.6	23.1	12.5	16.8	23.9	16.9	19.8	34.8	15.0	18.9	21.2	0.6	1.2	1.3	3.8	1.6	3.3	2.6	2.9	1.1	0.9	3.5	1.5	1.9	3.9	2.7	1.0	3.4	0.5	1.7											32.8	22.1	15.2	8.3	16.0	29.4	10.1	30.6	21.4	28.4	12.2	64.8	11.5	5.0	11.7	1.5	15.8	11.4	0.0	14.9	8.4	12.0	18.1	7.0	12.3	10.2	23.8	27.5	12.9	17.3	2.9	16.7	15.5	6.8	7.2	13.8	20.6	15.0	3.5	14.5	8.6	28.6	12.9	12.1	14.0	12.3	16.2	14.2	20.1	16.9	19.0
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein-O-mannose kinase"	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013321	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7.0	3.4	4.5	5.5	6.0	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4.0	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5.0	2.6	2.6	6.7	2.9	1.0	3.3	1.3	3.5	7.6	5.8	15.2	2.8	3.5	5.5	2.1	3.2	5.5	4.1	5.5	9.2	5.0	4.7	3.8	2.3	5.9	8.3	6.4	5.4	1.9	1.4	14.0	5.6	2.5	2.0	4.7	7.9	3.8	2.7	7.4	5.3	1.7	5.4	7.1	3.3	14.9	3.7	1.6	10.0	2.0	11.9	2.1	1.0	6.8	6.8	2.9	1.5	9.9	5.6	4.2	9.1	3.2	3.0	4.4	9.8	3.3	7.5	8.4	8.5	8.7	4.2	4.9	8.6	9.4	3.6	3.2	10.0	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1.0	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7.0	4.8	11.1	10.5	7.2	0.0	0.3	0.0	0.1	0.3	1.4	0.3	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	1.8	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.1	0.4	1.4	0.1	0.5	0.0	0.2	0.1
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 38.3;Late spermatids: 28.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049817	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896"	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	4.0	3.0	4.7	3.4	5.6	6.6	4.5	6.0	5.3	4.7	4.6			2.4	5.8	5.2	3.8	2.8	2.1	3.8	4.7	3.5	4.4	2.2	3.6	3.1	3.5		5.8	4.7	2.0	3.1	1.7		4.5	3.7		4.3	5.1	14.2	5.3	3.0	7.0	4.0	2.5	3.9	9.5			3.9		3.6	4.0	3.9	4.2	3.5	5.7	3.3	3.0	4.8	1.1	1.9	8.1	13.0	16.7	8.6	3.4	1.9	2.9	4.5	2.1	2.7	4.7	3.6	1.2	0.8	2.6	4.6	1.1	3.0	1.3	2.0	4.9	4.6	5.4	4.4	2.7	2.0	2.4	3.6	2.9	5.4	7.2	2.5	1.0	1.3	2.1	2.9	9.4	9.2	2.5	4.2	10.0	5.7	3.0	4.0	1.8	9.5	2.0	1.5	3.0	6.8	12.3	2.5	11.8	4.2	14.4	4.5	3.1	5.0	6.6	0.9	16.4	6.7	2.4	2.1	8.7	1.3	9.7	9.2	1.4	3.3	5.7	2.4	1.5	3.5	2.5	3.9	4.0	3.3	4.2	4.8	2.7	3.8	3.0	1.6	3.5	3.4	1.1											3.0	2.6	3.0	6.4	6.3	4.1	6.0	2.5	4.0	0.0	5.2	11.8	5.7	0.0	1.1	38.3	3.0	4.5	0.0	1.9	3.1	6.0	4.2	5.7	1.7	2.6	3.2	12.5	1.8	4.1	28.3	5.8	3.0	10.1	0.0	2.7	4.6	1.6	4.0	7.4	3.5	5.2	12.9	3.2	22.1	4.1	6.0	8.7	2.2	5.6	8.4
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.6	12.3	15.0	23.4	12.6	19.6	17.0	11.0	20.8	16.0	29.8	9.3	11.9	25.9	13.6	10.9	21.4	20.6	32.4	18.7	28.1	31.2	14.5	22.6	33.7	16.5	20.4	15.2	15.9	18.7	24.0	11.0	11.7	17.3	28.4	17.7	7.7	20.6	44.4	16.6	18.4	14.7	29.3	29.9	19.5	15.1	32.5	29.1	20.8	9.6	10.6	28.8	8.5	21.9	14.6	39.4	19.7	12.5	10.9	16.3	17.3	18.5	19.9	33.5	21.0	21.2	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1	11.9	25.1	40.9	40.5	17.4	19.6	53.8	40.8	25.4	37.5	73.3	13.7	49.9	131.0	34.2	1.3	26.7	23.2	23.3	38.8	36.9	22.4	23.7	54.2	46.1	46.0	17.5	21.2	23.9	18.3	2.7	33.4	31.2	47.2	27.1	27.7	54.1	31.5	24.6	35.3	99.7	28.3	19.4	28.8	19.1	33.4	21.7	14.8	37.4	37.5	25.7
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 262.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	13.3	8.0	0.0	3.4	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	14.2	0.0	75.1	0.3	2.4	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.1	0.0	0.0	96.0	0.0	65.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1	6.0	18.3	0.0	1.4	262.6	0.0	19.4	0.0	9.4	33.0	0.0	0.0	1.5	0.0	0.0	0.4	27.7	0.0	0.0	0.0	0.2	42.9	0.3	3.5	0.0	3.2	0.0	0.0	16.5	0.0	0.2	6.1	0.2	28.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	62.4	1.1	0.2	42.3	2.9	0.0	0.0	0.0
POU1F1	"GHF-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276587	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"pituitary gland: 138.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;SiHa: 1.1;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	138.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.2	2.8	18.5	1.8	3.6	0.1	0.5	39.0	1.0	1.0	0.3	0.3	0.2	3.0	8.3	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.8	0.8	0.6	15.3	1.0	0.1	1.1	0.8	0.4	9.0	0.4	0.3	0.1	2.0	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.2	0.0	4.9	1.5	7.9	0.8	0.0	0.3	27.1	26.2	30.9	15.0	1.0	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2	0.0	9.5	158.6	6.7	6.9	50.4	2.2	5.1	1.4	3.4	0.0	5.9	0.7	0.0	0.9	12.2	1.4	2.7	0.0	2.5	0.8	2.0	2.9	5.8	0.8	41.8	1.6	9.1	4.9	98.2	7.7	0.9	80.0	8.5	1.8	1.1	1.7	2.5	0.0	0.4	0.5	6.9	0.0	2.4	31.0	7.0	7.8	3.1	17.5	0.7	4.7
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 15.3;Collecting duct cells: 8.7;Enterocytes: 8.4;Pancreatic endocrine cells: 8.5"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HAP1: 49.8;NTERA-2: 132.5;SuSa: 87.3"									"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.2	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	2.3	2.3	1.2	1.2	4.9	3.1	5.7	1.2	5.2	4.3	1.2	1.2	0.0	11.1	5.0	2.0	1.2	1.2	1.2	1.2	8.8	0.0	1.2	1.2	1.2	4.7	1.0	1.2	1.2	3.0	1.2	1.8	5.9	1.2	1.2	1.2	6.3	2.2	1.2	1.2	1.2	1.2	1.2	11.2	1.2	3.0	1.8	1.8	1.0	1.1	0.9	0.3	0.5	0.2	7.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.6	49.8	0.6	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	132.5	0.2	0.0	0.1	0.1	0.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	87.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	1.4	1.0	0.5	0.8	0.7	0.5	1.0	0.4	0.4	0.2	3.0	0.9	0.6	1.8	1.1	0.5	1.8	0.3	0.3	1.2	1.2	1.2	1.2	1.2	0.0	1.2	1.2	1.2	1.2	0.0	1.4	0.5	2.4	4.6	0.7	0.4	15.3	1.4	1.2	8.7	2.0	0.0	0.0	4.8	0.0	0.7	8.4	0.0	5.8	0.1	0.5	3.6	0.0	1.5	0.1	0.0	1.2	0.6	0.0	0.0	0.0	0.8	1.7	1.0	3.1	0.0	8.5	3.7	0.7	2.1	0.9	0.0	1.2	0.0	0.4	3.3	0.1	0.0	2.9	3.8
PP2D1	"C3orf48, FLJ25449"	ENSG00000183977	"Protein phosphatase 2C like domain containing 1"	A8MPX8	3	19979961-20012330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 28.8"	"Group enriched"	"Detected in some"	83	"Early spermatids: 319.7;Late spermatids: 185.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/84: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036870, HPA066083"	Enhanced		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036870: AB_10671246, HPA066083: AB_2685611"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-1)"	0.2	0.1	0.1	0.2	0.1	3.0	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.1	0.3	0.2	28.8	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.7	0.5	1.2	0.6	0.0	0.9	0.0	0.3	0.6	0.7	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.8	1.5	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.6	0.6	0.9	0.2	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.5	0.7	0.0	0.2	1.0	0.8	1.0	0.4	0.3	0.9	0.9	1.6	0.0	0.3	0.4	1.9	0.1	2.3	1.4	1.1	0.7	0.8	0.3	0.0	0.3	0.3	0.5	0.6	4.1	1.6	1.8	0.8	0.3	0.0	0.5	0.9	0.8	0.6	0.3	0.2	0.5	0.4	0.1	0.7	0.9	0.8	1.2	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	319.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	3.1	1.3	0.0	0.0	0.0	0.0	0.0
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.7	8.7	0.0	0.0	47.9	27.3	56.5	0.9	10.5	1.3	0.5	1.8	25.2	0.0	0.0	0.9	17.1	4.0	3.5	0.1	0.2	23.5	4.9	0.0	1.9	2.3	12.8	0.0	0.0	28.1	2.3	2.4	9.1	5.0	0.1	0.2	0.0	0.0	2.0	2.5	0.0	0.1	0.1	22.7	25.2	0.0	0.0	0.0	7.2	34.5	0.0	0.2	4.1	1.5	0.5	1.7	0.0	7.8	7.9	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6	3.0	7.4	0.0	33.7	0.9	0.5	5.2	2.5	2.7	3.4	5.2	0.0	90.9	1.7	0.1	2.6	17.7	47.1	0.0	0.6	187.1	4.3	35.2	9.2	3.8	46.3	0.0	8.1	19.6	14.5	0.8	3.7	8.6	3.3	2.8	20.5	0.5	10.2	42.1	0.0	11.3	0.0	12.9	5.7	7.9	21.8	1.0	74.4	1.3	16.6	210.8
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	4.5	2.4	3.9	9.5	7.1	4.3	3.5	16.3	8.7	3.9	15.6	1.6	16.3	13.1	5.4	2.6	9.0	5.5	6.2	10.0	3.3	4.1	2.3	3.7	7.4	3.0	3.3	4.8	3.2	3.4	17.7	2.0	3.2	7.2	6.4	11.6	7.6	4.0	19.7	10.3	6.6	16.6	18.6	2.7	4.2	7.9	2.0	1.3	2.2	1.7	8.4	5.8	11.5	5.6	1.9	2.4	2.2	6.2	0.8	0.7	0.5	0.5	1.9	0.8	4.6	1.8	0.6	7.4	0.3	0.0	0.5	0.7	8.3	1.9	9.0	1.3	0.0	2.1	5.6	6.8	3.4	0.6	0.5	5.9	8.4	3.2	1.7	0.5	11.5	3.4	0.9	4.6	1.8	3.1	0.3	1.0	4.0	5.7	3.0	0.4	2.2	4.2	5.4	3.0	2.5	4.9	8.0	5.0	5.0	1.4	11.0	2.5	0.6	1.3	9.8	1.5	1.4	2.6	3.8	1.3	1.1	1.7	3.7	1.8	3.7	2.7	5.3	2.3	7.3	0.9	1.0	2.0	0.7	0.4	3.8	0.7	1.9	0.4	0.3	2.4	0.9	0.6	0.6	2.2	0.8	6.2	0.3	0.3	0.5	3.9	7.1	16.3	8.7	3.3	4.1	3.3	4.8	7.2	1.3	0.0	0.6	1.5	3.2	4.5	105.6	18.8	2.5	0.0	1.2	1.8	127.6	1.5	1.7	0.2	0.2	3.5	17.2	0.0	0.7	1.2	1.8	1.7	1.1	3.4	6.9	7.9	5.2	5.5	9.5	0.0	1.4	8.3	3.3	1.0	8.5	3.6	0.5	3.5	0.4	1.9	72.0	6.5	6.1	0.2	3.2	9.4	4.1	0.0	19.0	3.4
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 85.8"					"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	25.6	32.4	29.0	37.2	34.2	37.6	27.8	43.0	32.2	24.3	23.7	18.9	27.7	19.2	35.3	27.7	27.0	25.3	24.5	29.0	25.6	28.7	25.2	25.2	23.0	44.3	23.8	35.0	30.6	21.3	20.7	39.9	24.2	26.3	22.6	27.1	21.6	31.1	24.9	32.0	26.1	26.9	28.3	24.6	30.5	23.1	48.4	24.9	51.4	23.1	28.6	47.2	28.1	25.3	25.0	24.1	23.1	14.5	23.7	33.2	12.2	14.7	13.8	16.4	13.6	14.8	16.5	14.5	17.4	19.8	18.3	15.2	22.2	18.7	25.2	22.1	18.5	8.6	13.8	16.8	18.2	22.6	21.6	17.5	39.4	14.2	20.1	15.6	46.4	22.8	19.6	18.7	14.5	14.0	20.9	22.8	22.2	19.2	19.5	20.0	11.3	26.0	28.0	14.2	40.5	13.7	22.2	18.7	23.1	28.5	13.1	11.6	17.1	15.3	12.4	14.9	16.3	18.9	23.3	15.7	10.7	19.1	10.3	14.9	22.5	31.3	40.6	18.1	85.8	7.0	21.0	12.8	23.1	19.3	14.5	23.2	25.0	24.7	25.9	24.1	21.1	22.7	22.6	8.3	23.7	13.4	22.9	33.2	12.2	29.0	34.2	43.0	32.2	25.6	28.7	23.8	35.0	26.3	24.9	38.7	47.5	78.2	56.2	67.3	59.8	29.5	45.9	54.9	54.6	40.1	27.5	73.8	31.5	53.2	175.7	43.2	30.4	23.3	59.6	62.8	45.5	38.3	54.4	29.8	46.7	35.0	32.3	38.1	37.1	48.4	54.1	61.7	60.8	100.0	34.6	43.3	55.2	38.6	49.1	39.8	57.0	51.8	37.6	123.1	54.7	51.7	37.0	76.2	39.2	43.7
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	11.1	6.0	21.0	17.3	12.5	16.4	19.6	22.0	21.0	24.1	25.7	12.6	11.4	11.8	15.2	16.9	14.4	10.1	16.0	8.4	38.3	17.1	15.1	13.0	13.2	21.6	19.7	23.6	11.1	12.8	14.4	24.6	20.6	13.5	13.1	8.6	28.3	7.1	18.7	11.9	13.4	20.3	16.6	11.2	9.5	18.2	19.4	5.9	18.3	8.5	12.4	9.5	26.2	11.5	15.0	15.2	13.5	17.2	15.3	16.0	12.5	28.3	20.9	9.4	4.8	18.5	13.5	19.0	23.0	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4	62.5	64.3	22.6	54.3	43.4	44.2	33.3	17.8	80.3	61.4	43.6	7.9	43.1	36.5	34.7	17.2	37.3	15.2	0.0	23.1	37.9	55.5	27.1	73.0	18.7	31.8	27.0	22.3	30.7	21.3	9.6	57.2	29.9	38.8	47.7	19.7	40.0	26.4	22.9	52.6	27.5	35.5	51.8	68.4	58.2	53.4	39.5	54.6	41.5	20.0	32.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.0	0.0	0.8	0.0	0.0	0.8	1.2	0.0	0.0	6.5	0.1	0.1	2.3	0.0	16.5	0.0	0.4	0.1	4.9	0.0	0.1	0.0	1.2	0.5	2.1	0.3	1.3	0.1	0.0	0.5	0.0	4.1	1.6	0.0	0.0	2.9	7.8	0.0	2.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	7.6	15.8	0.2	0.0	1.0	0.1	0.0	7.0	0.0	0.0	1.9	0.0	2.4	0.0	0.1	4.4	0.3	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0	0.0	0.0	0.0	0.0	0.0	16.0	1.6	0.0	0.0	3.4	0.0	29.5	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.1	73.1	2.9	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	0.0	11.7	0.0	0.0	9.3	2.5	0.0	0.0	0.0	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 61.4;Kupffer cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 36.5;K-562: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.2	9.9	6.4	6.2	3.5	6.3	8.1	10.6	6.3	9.4	6.5	4.5	3.7	5.6	13.3	7.4	4.0	11.2	2.8	6.6	3.3	8.0	9.0	21.7	4.6	4.3	5.9	8.0	5.9	5.9	2.0	9.1	4.3	6.7	36.5	5.6	55.2	2.4	12.0	8.6	4.7	6.2	2.7	2.9	10.9	7.1	16.5	1.6	3.2	3.9	2.6	10.0	10.0	3.3	8.6	2.6	4.1	5.6	30.7	11.3	11.5	10.3	10.1	4.7	3.7	6.2	11.4	15.3	21.6	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9	6.0	5.9	5.1	4.4	7.2	7.0	13.1	15.3	4.0	3.4	1.8	2.0	13.3	3.3	4.9	1.1	31.9	2.0	0.0	4.3	7.2	7.7	3.9	3.5	5.5	17.5	7.9	5.8	61.4	32.9	1.1	6.6	18.0	6.8	8.2	3.9	3.8	5.6	0.0	6.3	3.4	6.5	6.5	5.7	7.4	10.5	5.0	2.5	5.7	3.8	5.4
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 35.6;U-266/70: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.2	0.8	4.1	2.1	2.4	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.9	3.7	3.4	0.2	0.1	35.6	3.6	3.5	3.3	0.4	0.1	2.1	4.1	0.4	1.6	0.1	0.2	0.3	0.2	1.7	0.1	5.6	0.0	1.9	0.8	0.2	2.3	6.5	0.8	4.2	0.7	0.8	0.1	3.8	4.9	4.2	2.0	2.4	0.1	1.4	2.7	2.1	0.2	0.4	0.4	0.3	1.3	35.6	0.1	2.0	0.6	1.8	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7	6.0	2.4	0.0	5.2	7.7	59.9	33.6	10.2	13.4	5.7	1.8	33.4	2.4	0.0	1.5	1.1	2.4	3.8	0.0	3.7	1.6	7.0	6.0	0.0	14.9	5.9	6.4	13.3	0.6	12.4	0.4	4.6	7.2	3.3	2.8	7.6	9.3	1.7	7.0	4.9	3.3	10.1	0.0	11.2	1.5	3.1	7.5	2.2	2.9	4.9	18.0
PPME1	PME-1	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171099-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 69.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	9.4	16.1	13.3	6.2	27.6	8.4	9.3	27.4	38.5	11.4	9.2	13.5	9.4	7.1	13.1	16.5	13.5	15.2	8.9	12.8	14.6	18.3	12.3	6.5	8.2	5.5	13.6	18.6	12.4	10.4	69.0	13.6	15.5	22.4	15.1	9.8	9.6	11.9	15.9	21.0	16.2	7.4	13.4	12.7	5.0	8.3	22.9	9.3	8.6	14.9	7.9	8.5	11.4	10.2	7.5	11.3	10.9	9.6	12.2	14.0	8.4	10.1	13.3	9.1	9.6	9.6	7.9	9.0	15.0	9.9	28.4	22.5	29.3	6.8	5.4	10.5	11.1	15.8	17.0	13.5	10.2	26.7	7.6	5.2	8.1	14.5	12.5	19.0	5.9	7.2	7.6	8.4	15.0	6.6	11.1	8.2	7.8	18.8	4.6	49.5	6.7	6.9	6.3	7.2	12.5	10.6	8.2	92.7	8.2	10.7	7.1	12.4	10.7	17.9	8.2	21.0	9.9	15.0	6.1	5.0	11.4	13.6	10.9	11.4	8.7	11.0	9.6	8.4	5.3	9.2	1.3	8.6	10.9	10.8	9.6	13.3	6.9	13.8	12.7	10.8	7.5	14.0	11.2	5.0	12.2	8.5	11.3	9.7	8.4	13.3	27.6	27.4	38.5	14.6	18.3	13.6	18.6	22.4	9.3	26.8	10.9	9.0	17.3	18.0	29.2	15.3	7.6	36.1	30.7	33.2	35.3	10.9	14.9	14.1	36.8	11.4	10.9	70.0	11.8	27.4	13.1	16.6	8.1	7.4	11.8	31.8	24.6	8.0	5.7	10.9	12.7	13.2	3.3	13.6	11.9	15.0	12.8	10.8	23.7	10.1	18.2	6.5	17.0	60.5	41.0	21.8	12.9	10.4	10.7	15.4
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600400-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	11.5	19.1	10.8	19.6	12.6	5.2	17.4	18.8	16.2	20.4	13.0	24.2	17.0	12.6	14.7	13.0	14.7	15.2	16.4	9.7	15.9	10.3	14.0	20.4	14.6	14.1	14.5	12.4	16.0	21.6	28.8	17.9	10.1	10.4	14.9	15.5	19.6	12.8	21.0	14.1	12.8	13.0	15.4	14.1	17.4	15.6	21.6	11.8	33.5	16.6	12.5	17.0	14.7	13.2	4.8	6.1	6.2	5.4	1.8	5.7	3.5	5.4	6.8	8.7	7.1	7.9	5.4	4.6	5.4	7.0	7.9	6.6	7.3	3.4	5.3	4.0	4.6	7.1	8.5	10.2	10.1	6.0	5.8	5.5	6.6	5.9	3.5	8.1	5.8	6.5	6.4	5.9	6.9	14.4	6.2	7.1	10.5	6.1	6.7	6.9	6.8	7.3	4.9	4.4	4.7	4.8	7.7	9.0	10.3	7.9	6.8	12.1	5.3	7.1	6.8	6.1	7.1	6.8	7.1	4.4	6.1	5.3	6.7	4.4	12.4	6.7	5.8	5.7	6.7	5.3	6.2	5.1	5.6	5.3	4.5	5.7	4.8	3.7	4.3	5.6	4.0	3.5	3.9	6.2	1.8	5.4	6.1	3.9	3.5	10.8	12.6	18.8	16.2	15.9	10.3	14.5	12.4	10.4	11.8	29.8	32.3	50.6	46.1	62.0	63.4	50.4	25.5	45.5	28.4	26.2	123.7	37.8	29.9	22.0	27.0	59.5	73.1	0.0	20.0	22.1	35.9	41.1	42.8	30.7	28.6	33.4	68.5	38.6	27.8	7.7	42.8	51.6	35.4	33.3	69.9	54.1	26.0	52.6	28.3	33.7	94.6	32.3	49.7	44.2	23.8	68.1	74.0	50.1	58.1	29.5
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733752-103847590	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favorable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.1	5.5	12.1	5.0	13.2	1.0	7.7	23.3	16.6	8.6	9.0	7.8	6.4	8.7	9.1	4.5	13.5	12.3	5.8	24.5	10.0	6.5	8.3	5.9	11.9	3.3	5.3	9.8	13.3	13.2	12.2	15.6	7.1	10.5	13.3	7.3	13.9	11.6	8.2	7.6	12.9	11.2	6.7	5.2	13.0	11.9	21.2	6.3	1.1	28.4	4.3	7.9	10.1	7.3	0.7	0.0	0.0	0.0	0.2	2.0	0.3	4.0	3.4	0.4	4.7	0.8	0.3	1.7	2.5	1.9	3.5	1.6	2.6	3.6	1.0	9.8	2.1	4.0	8.4	4.9	3.7	2.9	2.1	3.4	0.0	1.2	4.4	3.2	0.4	3.8	0.9	4.3	0.3	4.0	1.3	6.8	2.4	0.5	1.7	2.2	16.3	0.0	0.3	0.8	9.7	4.3	10.2	2.8	2.3	7.2	10.1	5.5	14.8	7.9	6.2	1.9	2.2	15.5	0.6	5.7	2.5	3.3	2.0	2.4	3.7	4.5	6.8	1.6	2.5	1.2	0.0	0.0	0.0	1.4	0.0	2.0	0.7	1.3	0.0	0.0	0.5	0.2	0.5	0.0	0.2	0.0	0.0	0.9	0.3	12.1	13.2	23.3	16.6	10.0	6.5	5.3	9.8	10.5	6.3	17.9	36.1	4.2	14.2	11.9	13.6	40.4	20.4	6.7	14.8	7.0	11.8	2.3	3.3	6.3	46.9	17.7	20.6	0.0	5.6	0.9	6.1	16.9	0.0	8.6	2.2	14.3	15.0	9.8	0.6	48.7	4.0	2.0	3.3	0.0	14.5	4.5	6.1	19.5	19.1	5.4	12.5	6.5	5.3	14.6	12.3	11.3	1.8	4.3	14.4	13.2
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256591	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Leydig cells: 315.8;Peritubular cells: 616.7;Sertoli cells: 963.6;Smooth muscle cells: 478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3"	"Group enriched"	"Detected in many"	29	"B-cells: 46.4;dendritic cells: 39.3"	"Group enriched"	"Detected in some"	4	"A549: 40.6;EFO-21: 35.0;K-562: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	45.4	34.9	22.5	15.1	28.7	2.6	20.1	4.4	37.9	21.1	56.1	60.9	16.6	13.9	39.6	10.8	32.6	20.1	31.7	13.0	34.4	19.0	8.9	4.0	21.1	2.8	43.6	19.2	22.7	17.1	1.7	1.6	24.2	28.4	29.7	10.0	4.4	10.4	70.3	13.9	3.5	16.5	79.9	76.0	31.1	22.9	18.7	38.2	0.0	3.3	3.4	2.1	51.6	15.6	46.4	39.3	1.1	0.1	1.4	0.1	3.7	0.0	40.6	0.1	0.0	0.2	0.0	1.7	3.8	0.0	0.0	0.0	3.2	0.0	0.0	35.0	0.2	0.0	0.1	3.5	0.0	0.0	0.5	0.0	7.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	16.9	0.1	0.0	0.3	0.0	0.1	1.3	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.0	46.4	0.0	0.0	6.8	42.7	0.1	0.0	0.3	1.4	0.0	39.3	0.0	3.7	22.5	28.7	4.4	29.7	34.4	19.0	43.6	19.2	28.4	38.2	0.0	1.4	18.2	2.3	8.5	0.3	8.4	0.0	0.0	1.2	0.0	0.0	37.8	0.0	0.4	11.0	30.1	2.0	0.0	9.7	3.1	66.4	2.1	3.5	1.6	8.4	0.0	1.7	207.5	6.3	20.1	315.8	19.1	8.5	111.0	0.1	0.5	2.8	1.1	616.7	0.3	0.9	963.6	478.5	9.1	53.5	6.9	22.1	1.9	0.1	0.7
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 35.0;U-937: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	10.0	1.6	6.0	7.2	4.3	11.6	0.2	6.0	7.0	5.3	3.6	1.2	2.0	9.8	5.5	10.5	12.0	6.7	3.0	6.6	2.8	8.2	0.6	23.6	2.9	1.2	3.4	6.1	35.0	7.1	7.7	13.1	11.8	6.3	4.3	16.6	4.3	4.9	6.2	1.1	8.7	12.1	0.0	0.3	0.4	27.8	5.3	8.0	3.1	0.6	0.4	2.0	5.6	2.2	11.1	0.3	1.6	8.4	14.2	21.0	5.3	0.0	14.9	1.8	9.6	12.1	6.0	36.4	24.5	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2	3.0	20.7	66.3	25.5	96.9	1.3	2.8	10.2	6.7	4.5	8.7	0.0	2.5	0.0	20.1	23.9	64.4	0.4	0.0	7.1	17.8	32.0	15.2	51.9	7.8	175.4	3.2	1.7	30.7	131.5	14.6	25.6	119.9	37.1	233.6	0.5	0.9	18.0	0.0	21.9	1.3	2.9	25.8	79.5	0.5	1.4	52.1	3.3	186.8	0.4	22.5
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514425-195543386	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 363.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 67.5"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	16.4	12.7	19.9	17.7	26.0	45.2	18.3	16.2	22.9	16.1	21.2	11.4	17.4	19.5	18.9	20.7	25.6	15.3	15.8	23.3	18.6	21.7	16.7	13.0	21.7	30.4	16.5	15.4	17.1	12.0	9.5	17.6	16.1	21.2	17.0	16.0	13.7	15.0	19.0	57.1	14.1	22.6	17.7	15.4	24.2	13.9	21.8	7.0	38.1	19.1	25.2	23.5	26.5	15.5	26.0	26.6	63.2	16.9	22.8	50.2	30.1	11.6	2.5	4.3	4.9	7.3	7.8	7.9	7.3	10.6	7.8	6.7	39.5	5.3	4.6	29.2	8.9	8.4	5.2	4.5	7.4	9.6	9.1	8.5	5.3	4.2	13.2	11.3	5.5	5.5	9.5	5.7	5.8	11.8	6.2	6.7	4.9	4.0	9.9	6.8	8.1	9.8	6.2	4.5	14.0	11.8	4.6	7.5	13.7	9.3	8.9	10.2	5.6	8.8	9.7	13.1	8.3	15.3	5.6	7.4	5.0	5.8	8.2	9.9	67.5	29.3	22.1	7.0	10.1	9.7	26.3	16.7	63.2	19.6	16.9	26.9	26.0	41.2	27.0	17.6	23.6	50.2	34.0	39.4	22.8	16.4	26.6	41.7	30.1	19.9	26.0	16.2	22.9	18.6	21.7	16.5	15.4	21.2	7.0	20.8	39.2	125.0	121.2	83.7	47.5	46.2	25.5	66.9	38.7	21.0	55.0	57.7	106.1	61.4	363.0	65.1	53.1	46.7	57.9	34.5	51.3	104.3	109.6	24.6	55.6	49.3	55.0	39.3	59.0	190.1	47.8	82.0	92.8	141.5	44.1	50.2	58.5	55.2	59.8	82.6	79.3	25.8	64.1	239.4	84.1	67.9	86.3	140.6	44.9	143.1
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.0	10.4	16.4	8.9	18.7	8.1	7.9	16.2	21.6	8.3	8.8	15.0	7.9	7.0	15.8	18.8	11.2	13.5	9.8	8.9	13.2	12.2	25.6	10.4	10.0	10.9	17.7	13.6	12.7	7.3	35.5	11.9	11.3	14.4	10.8	9.8	8.4	6.8	10.2	6.4	9.5	9.0	11.9	12.0	11.0	9.4	8.4	15.9	10.4	19.5	2.4	10.8	12.7	8.8	7.7	5.6	14.1	6.0	3.8	7.9	2.3	13.8	6.7	5.8	7.1	14.5	10.8	15.2	8.2	9.3	5.0	6.1	3.7	8.7	9.4	13.6	11.5	9.8	7.7	4.8	7.4	10.6	12.0	4.1	10.1	5.7	8.9	10.1	4.5	8.1	13.5	6.8	9.1	11.2	12.8	12.7	4.8	4.0	15.8	13.7	7.6	8.6	7.3	14.6	9.9	7.1	7.2	15.5	10.2	10.6	9.2	7.7	4.8	15.2	4.0	14.7	15.9	7.2	7.3	11.3	5.4	6.7	4.8	6.5	11.8	3.3	8.6	8.6	10.1	7.1	14.1	5.4	8.5	4.4	6.0	3.5	5.9	5.2	5.1	5.6	7.7	7.9	6.4	13.0	3.8	5.1	3.5	5.0	2.3	16.4	18.7	16.2	21.6	13.2	12.2	17.7	13.6	14.4	15.9	20.8	13.9	9.9	27.6	9.3	8.6	9.2	7.6	26.8	9.1	24.4	2.0	18.6	5.0	9.1	1.9	11.3	9.5	0.0	7.4	13.6	10.8	14.2	11.5	12.3	28.7	27.0	18.0	12.9	18.0	4.0	11.2	16.4	11.8	19.0	9.6	20.1	9.9	8.6	19.4	45.5	6.2	12.9	17.6	9.1	12.1	12.3	22.7	10.9	8.0	22.7
PPP1R2B	"MGC87149, PPP1R2P3"	ENSG00000231989	"PPP1R2 family member B"		5	156850538-156852528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	33	"testis: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	13	"U-266/84: 5.3"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.2	0.3		0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	36.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.5	0.4	0.9	0.5	0.5	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.1	0.0	0.1	0.5	0.1	0.9	0.2	0.5	0.5	0.5	0.6	0.5	0.4	0.2	1.1	0.5	0.6	0.5	0.2	0.1	0.7	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269843-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 35.3;Horizontal cells: 46.1;Rod photoreceptor cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"T-reg: 15.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 15.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 18.0;HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.0	7.6	15.9	3.7	13.8	2.7	2.3	17.2	21.2	4.3	3.5	7.6	4.5	2.4	4.7	15.9	5.4	6.7	3.6	16.1	16.0	13.1	3.3	2.8	3.4	4.6	12.3	5.4	7.5	2.6	4.4	8.6	2.4	9.1	4.6	1.7	5.3	5.3	6.1	24.0	3.1	3.1	4.1	11.3	5.1	2.9	4.5	7.3	3.5	5.5	1.9	3.0	3.5	4.8	0.4	0.3	0.0	0.9	0.4	15.3	0.5	2.4	5.0	4.4	4.9	6.1	4.4	2.1	2.9	4.5	1.9	3.1	3.5	2.9	2.9	0.6	2.1	18.0	3.9	1.7	1.2	1.0	15.8	5.5	0.3	2.9	0.3	4.0	0.4	1.8	3.0	3.6	2.0	1.6	4.5	0.5	4.0	0.7	1.2	2.3	8.7	1.1	3.9	13.6	0.6	9.5	6.4	3.8	0.9	1.9	1.1	5.2	4.5	1.5	0.5	7.4	9.8	4.5	2.5	2.3	5.5	1.1	4.8	2.1	3.6	4.5	1.9	1.8	6.2	6.9	0.0	0.2	0.0	0.2	0.4	1.0	0.4	3.0	1.0	0.2	0.1	2.4	1.1	0.0	0.4	0.9	0.3	15.3	0.5	15.9	13.8	17.2	19.3	16.0	13.1	12.3	5.4	9.1	7.3	0.0	0.3	0.5	2.5	1.6	35.3	13.7	0.0	2.7	0.0	3.5	7.9	0.8	6.6	0.4	0.1	1.9	0.0	0.0	0.2	0.1	3.0	1.6	0.0	0.8	0.6	46.1	2.9	1.8	0.0	0.4	4.4	0.9	0.0	0.0	0.0	9.7	0.4	0.0	2.8	4.9	15.4	0.0	3.9	0.5	5.6	1.1	1.0	1.5	0.0	2.2
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830778-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	18.0	14.5	28.6	15.5	37.0	23.2	19.4	23.1	29.7	18.9	16.0	18.2	12.0	13.3	24.0	15.6	19.6	19.4	14.6	16.2	23.4	17.7	13.9	14.8	17.6	28.6	24.6	25.7	24.6	18.5	14.2	18.9	17.4	24.4	15.3	18.0	11.7	15.1	19.5	17.8	17.8	15.1	21.8	24.6	16.9	14.3	21.4	25.6	20.7	17.9	9.4	24.6	18.6	16.0	11.9	9.7	17.0	11.4	14.0	16.5	14.9	21.1	15.0	32.7	21.2	20.6	21.6	18.8	22.8	24.0	39.1	31.7	16.8	24.4	30.3	16.1	25.9	15.2	19.1	38.4	21.3	28.4	25.4	23.4	39.5	20.4	24.7	20.8	36.3	28.1	18.8	23.3	35.4	31.7	17.6	23.1	26.0	33.4	20.7	23.2	13.8	39.6	21.4	40.4	18.7	17.5	32.5	27.1	28.8	21.0	19.5	22.9	20.9	28.0	21.9	27.0	17.5	19.2	22.9	19.0	19.3	17.6	30.2	21.1	19.2	29.3	38.3	18.8	47.4	24.6	17.0	10.0	9.1	14.0	10.0	16.5	11.6	11.6	15.8	9.7	11.9	12.8	12.1	5.9	14.0	11.4	7.3	11.4	14.9	28.6	37.0	23.1	29.7	23.4	17.7	24.6	25.7	24.4	25.6	14.9	7.7	28.1	17.4	15.3	22.6	11.5	7.6	18.7	20.5	5.2	2.0	41.6	26.6	24.8	26.4	14.6	12.6	0.0	22.4	34.1	19.0	13.0	25.4	15.8	23.1	7.9	11.1	20.3	14.3	18.7	22.2	16.9	10.1	40.5	14.5	19.8	24.7	16.1	15.9	19.9	13.9	25.8	16.4	27.9	40.2	12.3	36.7	24.5	15.3	17.4
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 15.5;U-698: 24.3"					"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.3	0.7	2.2	0.1	0.2	7.1	5.9	1.5	5.3	6.3	5.3	0.0	0.0	3.2	4.5	0.6	0.0	0.2	0.0	1.4	3.7	4.3	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.2	0.1	3.2	1.0	0.3	1.2	2.6	9.0	7.8	2.3	0.1	15.5	4.1	3.4	0.3	1.4	1.5	0.0	9.2	0.0	0.9	4.2	4.2	0.0	2.3	0.3	3.1	2.9	0.0	2.0	0.0	0.0	24.3	0.1	2.7	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0	0.0	1.7	0.9	7.8	6.1	11.5	62.0	2.5	2.7	1.2	0.0	25.5	5.6	0.0	2.8	0.5	3.5	1.4	0.0	3.5	5.6	3.0	2.2	0.0	1.0	3.2	6.4	4.6	4.3	2.1	1.5	3.7	5.3	5.0	3.6	3.8	11.2	2.6	0.0	2.8	1.3	19.8	0.0	3.8	12.9	25.5	6.6	3.3	1.9	3.1	3.9
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984499-43012342	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	17.9	14.4	19.7	17.0	31.5	15.1	14.2	28.3	41.0	20.2	24.5	13.7	15.9	31.1	20.7	11.4	18.1	19.0	14.3	22.0	17.7	18.4	15.7	15.8	15.0	16.2	16.6	25.1	20.7	16.5	17.4	11.2	16.6	26.3	18.4	18.6	16.5	13.7	19.2	41.0	17.9	36.4	20.8	11.2	14.4	14.9	27.1	13.1	35.5	13.4	11.1	14.7	19.1	18.5	9.2	12.5	17.9	11.3	11.8	19.7	15.3	24.4	12.9	19.8	25.8	12.3	16.9	11.1	13.6	9.7	27.2	24.1	20.9	6.7	18.3	13.2	16.5	18.8	13.9	26.6	15.6	24.4	15.6	23.1	21.9	16.0	19.6	8.5	15.1	16.1	9.3	10.3	21.7	9.9	15.5	20.7	23.1	22.9	14.2	15.7	10.4	38.8	13.8	8.8	55.4	12.3	27.2	24.5	12.0	8.3	11.6	25.1	16.5	18.4	12.3	14.7	17.1	17.2	14.1	19.6	19.6	18.2	20.5	21.6	14.7	18.5	37.6	7.7	14.1	16.9	14.8	11.3	17.9	16.8	9.8	17.6	9.2	15.3	19.0	11.6	9.0	11.8	14.1	6.9	11.8	7.4	12.5	19.7	15.3	19.7	31.5	28.3	41.0	17.7	18.4	16.6	25.1	26.3	13.1	8.9	7.0	5.2	2.5	7.4	11.6	4.0	5.1	4.0	7.9	7.0	9.8	6.2	5.0	5.8	4.2	6.2	21.7	0.0	6.8	8.7	8.5	2.9	8.1	10.9	8.0	3.2	8.6	8.0	5.9	5.3	8.9	4.2	10.1	6.4	7.6	7.3	7.9	8.4	13.8	3.8	7.5	6.5	8.0	7.5	9.4	8.3	3.8	7.4	9.5	1.7
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 21.0;Ductal cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0"									HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	NA			"Nucleoplasm, Nuclear bodies"		"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.9	18.8	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	12.1	0.6	5.2	0.3	13.4	5.3	0.0	0.3	0.0	17.0	0.1	0.0	0.0	0.1	0.6	3.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0	0.0	0.3	0.0	0.6	0.0	0.3	0.3	2.5	1.4	1.2	21.0	0.0	0.0	0.0	5.8	4.2	0.0	0.0	0.0	1.8	0.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.3	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.7	0.8	1.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Group enriched"	"Detected in some"	5	"Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	33	"PC-3: 92.5"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	92.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	67.9	0.0	0.0	0.0	0.1	118.0	0.0	0.0	0.0	0.0	873.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	545.9	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	434.0	46.7
PRAME	"CT130, MAPE"	ENSG00000185686	"Preferentially expressed antigen in melanoma"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 54.3"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 241.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"K-562: 143.2"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.1	1.7	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.5	0.0	2.8	10.9	0.1	0.2	0.1	0.3	0.2	0.0	0.7	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.0	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.0	54.3	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	9.4	0.0	19.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	14.2	0.0	0.0	0.0	0.6	0.0	0.0	8.6	2.1	5.0	3.7	0.1	0.0	0.4	27.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	143.2	2.3	0.0	1.2	0.0	0.0	0.0	4.2	0.6	0.8	0.0	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	4.3	3.5	0.7	0.0	25.8	0.0	0.0	0.4	2.0	0.1	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	30.6	5.2	0.0	0.0	5.4	0.0	0.2	0.1	0.0	3.2	0.8	0.3	6.5	0.0	29.8	241.6	0.0	0.0	0.0	0.0	0.0
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 15.1;Club cells: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.9;U-266/70: 16.5;U-698: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	4.8	4.7	9.0	8.1	7.0	4.6	5.5	10.4	7.5	4.8	5.4	7.3	8.4	7.9	5.4	4.5	6.7	5.9	4.9	4.4	4.3	3.4	3.9	5.1	4.7	17.0	8.0	4.8	6.7	5.9	5.6	6.4	3.3	6.0	6.3	5.0	4.3	7.6	7.3	9.3	8.3	7.7	5.1	6.6	9.4	5.4	6.2	7.8	10.8	6.1	6.9	16.8	4.8	7.7	3.0	1.5	1.2	2.5	0.1	1.3	1.3	1.3	3.0	2.6	3.3	0.7	1.3	2.7	1.2	0.9	1.3	1.0	2.0	1.7	17.9	1.2	1.4	1.2	2.9	2.3	1.5	1.3	1.7	2.3	3.2	6.8	2.1	0.7	2.8	2.1	0.7	1.8	1.5	1.3	1.4	1.8	2.2	3.0	1.1	1.6	3.7	2.7	2.0	2.8	1.8	1.9	4.6	1.7	2.1	1.4	2.4	4.2	2.6	5.4	2.2	1.0	1.0	2.2	1.6	2.3	2.0	0.7	1.4	2.1	16.5	1.9	32.6	1.6	3.4	2.8	0.0	1.4	1.2	1.3	2.5	0.1	3.0	0.2	1.1	1.5	1.0	0.8	1.2	0.0	0.1	0.6	0.7	0.8	1.3	9.0	7.0	10.4	7.5	4.3	3.4	8.0	4.8	6.0	7.8	3.0	15.1	4.5	1.9	2.6	2.9	3.8	2.5	5.3	12.5	1.8	5.9	1.2	0.0	1.2	1.4	2.0	1.3	0.0	2.2	0.7	2.2	1.8	3.5	1.8	1.7	3.2	0.0	0.6	2.2	2.5	1.1	2.1	1.7	0.0	1.4	1.0	1.3	0.0	0.4	0.6	2.4	0.0	1.4	2.1	3.0	3.0	0.6	2.2	2.0	1.1
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	15.2	14.5	26.0	17.2	28.1	64.1	17.2	32.3	44.9	16.2	18.1	19.8	12.6	12.4	18.8	16.4	19.6	14.4	16.4	14.3	19.8	14.5	10.8	9.3	15.6	23.4	18.9	27.8	30.7	12.8	16.0	26.7	15.7	18.0	17.7	13.6	10.3	15.8	18.9	45.2	21.6	16.8	16.8	21.6	16.9	14.2	17.1	17.8	14.4	23.3	11.7	22.7	19.8	19.3	16.0	5.4	9.7	5.1	5.7	5.7	2.5	6.9	4.0	14.4	5.5	11.4	8.8	6.9	9.0	5.5	6.2	7.0	6.2	7.9	21.2	8.0	8.7	5.2	8.6	10.7	5.3	6.9	13.1	7.6	14.2	4.6	2.9	6.3	4.7	12.3	9.3	9.4	6.5	5.5	5.9	6.1	8.4	12.6	24.6	7.7	3.5	7.6	7.5	4.3	5.5	5.3	10.6	7.8	6.3	3.5	7.8	12.5	8.1	7.2	4.6	9.9	9.0	6.5	7.7	10.8	7.9	8.7	7.2	4.9	36.1	24.4	30.4	7.1	11.1	10.2	3.9	4.8	6.8	5.7	3.1	3.8	16.0	4.5	5.2	2.9	12.5	5.2	4.5	9.7	5.7	5.1	5.4	4.1	2.5	26.0	28.1	32.3	44.9	19.8	14.5	18.9	27.8	18.0	17.8	35.7	37.8	66.5	49.3	55.2	46.9	34.7	25.5	53.5	40.9	22.7	43.2	19.3	14.9	15.3	8.6	29.3	23.6	46.7	11.9	11.9	42.7	46.2	39.3	16.4	14.7	66.7	36.4	25.2	38.9	11.6	40.9	37.0	28.7	28.9	18.8	23.0	13.7	14.4	42.5	6.6	36.8	25.8	27.0	41.2	51.7	45.7	15.3	50.4	15.2	52.5
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303774-177306959	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	18.9	25.0	21.9	33.9	20.3	30.3	21.6	12.0	31.1	16.9	44.6	14.8	15.4	43.5	18.3	15.5	35.6	17.4	20.6	16.8	19.3	18.6	46.1	62.3	18.9	43.0	20.2	14.7	20.3	91.6	12.3	17.7	29.4	21.0	19.8	35.0	18.9	40.1	16.4	11.9	26.2	70.6	19.0	14.8	43.5	24.6	12.9	13.5	25.2	29.3	27.2	33.7	18.0	18.9	27.1	77.4	111.7	94.2	30.4	26.4	49.2	32.3	30.4	18.5	49.4	16.6	18.0	61.7	23.1	16.2	33.8	32.7	68.1	37.1	27.5	27.3	21.7	36.8	18.4	33.0	61.8	23.1	117.7	45.7	23.8	31.5	45.3	17.5	37.3	33.4	16.2	22.3	26.6	22.8	14.0	41.8	19.8	26.1	39.9	32.8	84.0	23.9	54.6	37.7	37.8	50.4	7.7	37.4	49.4	22.0	27.1	29.6	37.2	21.6	43.1	40.1	24.1	27.8	46.0	23.0	31.0	27.1	25.4	55.3	22.4	38.2	40.0	26.7	50.4	32.1	31.5	75.7	111.7	26.4	94.2	25.8	27.1	21.9	26.2	77.4	21.1	19.3	21.1	55.2	30.4	90.3	28.3	23.3	49.2	21.9	20.3	12.0	31.1	19.3	18.6	20.2	14.7	21.0	13.5	20.8	22.6	181.8	227.7	309.4	61.7	0.3	145.2	13.4	28.4	99.5	21.6	650.2	257.0	407.3	4.8	123.4	610.0	116.8	488.9	446.5	187.8	329.7	110.3	191.7	318.8	57.2	151.0	114.8	245.1	15.2	105.6	182.1	243.0	153.3	210.5	81.8	553.8	343.7	102.6	293.8	49.9	45.3	167.5	80.1	183.7	367.9	738.9	173.0	351.5	462.0
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649613-184694963	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	12.3	12.6	8.3	17.0	11.5	9.1	13.5	14.6	11.0	17.7	14.3	15.4	18.1	6.9	25.4	13.1	12.0	15.1	14.6	12.0	8.0	8.3	8.6	9.9	11.3	10.8	8.4	11.5	18.7	9.0	9.8	14.0	10.8	10.2	14.8	13.2	12.0	11.0	17.9	10.3	10.0	11.2	14.8	14.7	11.9	11.0	8.0	10.2	15.0	12.1	6.4	10.8	16.3	15.9	3.3	2.5	18.6	4.1	3.6	4.9	2.6	9.4	3.8	9.6	11.0	12.8	16.7	6.5	9.2	15.2	16.2	14.3	3.0	9.2	5.4	3.5	7.1	9.3	5.6	7.8	9.8	17.2	10.9	4.0	5.7	5.5	3.6	8.3	4.9	8.5	10.5	8.1	14.8	9.8	9.5	8.5	14.7	11.3	18.7	11.5	3.1	9.4	4.2	3.2	4.3	3.4	8.6	7.0	6.1	8.1	5.7	7.3	9.1	5.7	1.6	10.4	8.0	4.9	8.6	4.5	5.4	7.3	4.4	6.2	9.5	6.8	2.7	8.0	6.3	13.5	7.8	2.0	18.6	3.5	1.9	4.9	3.1	3.2	3.4	2.5	3.3	2.7	2.7	1.0	3.6	4.1	2.2	3.7	2.6	8.3	11.5	14.6	11.0	8.0	8.3	8.4	11.5	10.2	10.2	6.0	7.5	3.7	10.1	8.5	5.8	2.0	10.2	17.4	9.1	5.2	0.0	11.3	5.0	6.4	4.0	4.2	6.1	0.0	4.5	8.4	8.3	4.1	15.0	5.4	8.3	7.9	6.4	8.0	11.8	4.1	11.5	6.1	8.5	6.4	61.4	10.1	3.6	7.0	8.5	4.7	8.2	12.9	7.0	18.0	9.4	8.5	4.1	8.6	8.1	3.3
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667753-119681630	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.3	17.2	8.1	16.6	11.9	23.4	13.8	12.5	20.7	16.8	22.8	14.6	6.7	20.4	13.6	13.2	17.9	11.6	19.3	9.2	8.3	7.2	40.1	12.3	21.4	20.6	8.9	9.8	14.2	21.7	11.7	10.8	19.1	11.1	9.7	22.7	20.6	15.3	10.7	12.0	10.6	23.9	12.5	10.5	20.7	25.0	33.4	8.3	20.0	17.5	9.4	16.6	16.3	10.6	26.4	17.4	38.8	19.9	22.1	20.9	18.3	4.7	12.8	10.2	9.6	8.7	7.6	13.4	7.7	10.0	12.6	9.6	13.4	10.9	15.9	10.2	10.5	5.6	6.7	10.2	15.9	11.6	10.2	9.4	24.9	5.6	19.4	15.7	11.5	31.7	11.4	13.5	11.4	15.4	14.2	9.3	23.7	38.0	6.2	9.7	13.1	26.0	12.9	14.3	7.0	14.3	15.1	8.8	9.2	14.3	15.2	8.1	13.8	10.2	3.9	10.5	13.1	12.6	15.1	11.0	7.7	8.2	5.9	7.7	20.0	17.6	11.8	7.6	7.8	11.0	24.8	16.4	38.8	17.2	18.4	20.9	26.4	18.3	18.3	17.4	21.7	19.9	18.6	19.1	22.1	19.9	15.4	19.7	18.3	8.1	11.9	12.5	20.7	8.3	7.2	8.9	9.8	11.1	8.3	44.7	42.5	11.8	5.5	3.0	12.0	4.1	10.2	10.7	17.0	21.0	3.9	15.7	39.7	7.1	1.0	13.5	16.9	0.0	27.0	8.5	8.2	5.6	11.5	5.0	10.3	20.6	18.9	4.3	5.6	1.8	5.2	9.0	3.3	12.6	16.7	11.9	10.0	14.1	6.0	29.4	17.3	6.5	6.0	25.0	9.4	3.8	12.6	10.2	21.5	7.6
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	7.7	7.6	5.6	4.6	7.1	4.7	7.6	13.3	10.9	9.3	24.6	8.9	8.9	19.1	13.0	8.1	10.0	7.4	6.5	15.2	5.6	5.2	6.2	32.6	6.3	3.8	5.9	9.3	8.1	21.0	18.4	6.2	7.5	7.8	10.9	6.9	6.3	5.7	12.6	52.1	9.4	19.1	20.5	8.4	5.7	11.1	6.9	5.5	2.6	5.8	19.9	4.7	19.0	10.3	1.2	1.7	2.9	1.6	5.1	2.5	0.8	3.9	2.2	5.9	4.5	14.0	12.1	21.3	7.5	4.1	5.0	5.5	8.8	7.9	7.2	3.8	5.9	2.9	10.6	6.8	8.4	4.9	2.8	4.7	3.2	7.0	14.2	9.6	3.7	1.4	9.5	16.9	5.2	24.7	7.5	4.9	5.6	4.4	2.9	4.3	4.0	2.7	2.1	12.3	6.8	9.8	4.3	7.9	3.5	3.6	3.2	3.8	7.1	5.6	6.4	26.7	22.0	6.0	4.6	5.6	5.7	12.6	5.2	12.1	4.7	5.1	3.7	5.9	3.3	7.4	2.9	1.2	1.9	1.5	1.2	2.5	1.2	1.6	0.9	1.7	1.1	1.7	1.1	0.3	5.1	1.6	0.8	0.7	0.8	5.6	7.1	13.3	10.9	5.6	5.2	5.9	9.3	7.8	5.5	3.0	1.3	5.0	9.8	14.7	13.2	57.1	25.5	4.0	2.3	17.4	13.7	15.9	1.7	5.0	0.4	6.7	25.7	0.0	6.0	30.8	10.6	4.3	1.1	35.0	5.1	11.1	10.9	6.7	7.3	1.1	8.9	4.1	15.1	9.0	10.7	6.6	7.4	10.1	15.2	4.7	18.6	19.4	21.1	12.4	9.4	12.3	17.2	7.5	8.8	3.9
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49019197	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 80.1"	"Low region specificity"	"Detected in all"							HPA077805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA077805: AB_2686855"	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	23.8	30.3	18.5	13.6	18.6	22.6	25.5	14.2	27.0	19.2	18.8	19.6	18.0	13.3	16.0	23.9	26.8	14.1	14.2	39.4	15.2	18.2	27.1	30.8	13.9	14.9	19.7	18.4	18.9	19.6	19.2	22.2	18.9	22.1	19.1	17.0	20.3	18.4	21.0	58.4	21.7	19.8	20.4	15.9	18.7	17.4	19.2	10.7	22.5	22.5	24.9	23.0	23.2	15.7	29.2	41.0	44.0	35.9	40.1	36.9	37.9	18.1	11.3	12.9	20.2	33.0	33.9	7.3	20.0	26.3	20.4	13.1	11.1	16.2	11.7	18.0	23.0	12.1	15.9	9.3	25.8	19.8	13.4	15.4	15.9	17.5	8.9	27.4	21.0	12.5	26.6	20.3	14.8	31.2	27.1	19.6	17.3	12.1	16.8	27.4	11.7	8.7	8.0	7.9	80.1	23.8	4.9	11.4	14.8	27.4	15.3	10.7	13.7	14.2	26.1	30.3	9.4	31.9	11.8	18.2	9.6	13.0	21.9	15.1	27.7	27.0	7.8	23.3	15.1	8.7	41.1	35.9	33.6	31.5	34.2	30.3	29.2	28.4	29.4	41.0	26.4	25.9	26.8	44.0	40.1	33.0	27.6	36.9	37.9	18.5	18.6	14.2	27.0	15.2	18.2	19.7	18.4	22.1	10.7	8.9	24.3	32.2	25.2	17.7	28.4	45.2	15.3	16.0	11.4	34.9	35.3	58.2	64.6	42.7	7.4	19.4	28.4	0.0	40.9	47.6	27.3	19.9	20.8	18.7	46.3	14.3	20.2	30.7	29.3	10.2	33.9	31.8	35.4	65.9	24.8	35.9	39.1	11.5	25.5	49.6	28.2	19.4	26.9	45.8	41.6	22.7	56.1	26.6	29.9	18.7
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	41.7	2.0	0.0	0.0	6.0	41.8	0.0	0.2	0.0	0.0	0.0	0.0	7.2	59.4	0.1	0.0	0.0	13.1	13.2	0.4	0.0	0.0	12.5	0.1	2.4	0.1	3.6	7.3	0.0	0.0	0.0	0.6	0.2	0.0	18.8	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	16.8	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4	3.0	8.2	149.8	3.5	5.4	172.0	1.7	5.1	2.7	1.2	1.8	2.0	0.1	0.0	0.0	16.3	1.4	1.7	0.0	0.2	0.2	1.3	0.7	69.4	1.6	41.0	74.7	0.0	16.5	192.8	10.0	0.0	22.7	3.3	6.4	0.7	9.9	0.0	9.5	0.4	0.1	7.3	0.0	2.2	3.6	3.7	12.5	0.7	57.5	1.2	4.3
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	17.1	7.6	7.0	25.8	6.5	18.1	18.0	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17.0	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33.0	17.4	37.5	6.6	0.4	7.3	1.0	2.9	6.1	1.9	8.8	13.7	5.4	6.6	4.5	3.6	7.0	4.6	7.3	9.6	10.6	7.6	8.6	10.3	8.1	6.1	5.2	13.2	4.8	12.3	3.0	8.7	7.1	10.8	4.2	3.9	6.0	7.9	16.1	4.4	6.0	5.5	4.7	7.2	16.9	9.7	6.9	14.9	3.9	9.3	15.1	25.6	4.6	12.8	7.0	9.9	2.6	16.7	5.9	13.2	3.5	11.0	8.6	7.2	1.8	5.9	5.7	3.1	8.0	4.1	8.2	3.4	3.7	14.6	58.2	5.1	4.3	6.5	4.3	0.9	1.0	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0.0	4.0	1.9	7.0	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2	8.9	13.5	45.5	26.8	19.6	5.8	11.5	17.8	4.0	10.3	8.7	0.0	11.1	6.6	16.0	0.9	29.2	30.9	23.3	24.3	11.4	10.0	21.5	13.9	7.3	7.7	1.6	20.7	36.2	12.7	2.4	10.9	7.2	11.8	5.4	17.7	6.1	22.1	24.6	6.3	7.1	4.5	12.9	5.9	2.8	15.8	23.3	24.8	23.0	11.2	24.6
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18.0	7.2	7.2	6.0	19.2	16.0	9.8	11.3	10.0	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15.0	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22.0	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.8	5.4	14.5	11.9	11.1	18.6	10.6	8.3	15.5	9.4	9.6	8.7	4.5	18.8	7.0	12.4	14.1	5.1	9.8	10.2	12.7	24.3	14.4	12.4	8.4	5.8	4.5	8.8	7.6	8.8	5.2	14.9	9.8	8.7	16.7	6.3	10.4	23.2	10.9	2.1	3.8	6.9	15.3	0.1	5.3	13.0	22.9	16.1	6.2	14.4	10.9	28.3	8.0	4.6	48.8	7.8	4.9	8.1	16.1	27.0	14.0	10.7	9.3	26.5	49.1	22.0	9.4	3.7	16.2	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8	38.7	16.2	38.3	20.7	33.7	29.6	7.1	15.3	5.3	13.6	17.4	64.8	9.1	3.3	10.9	42.2	44.7	5.4	0.0	9.0	28.2	34.8	27.0	77.1	11.3	11.1	41.3	18.1	38.1	28.4	78.9	31.1	24.5	47.2	12.6	6.1	16.0	12.3	3.5	29.0	7.1	110.0	25.8	26.9	56.0	44.5	20.8	8.1	27.4	11.0	32.3
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431414-178451512	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	15.7	14.5	18.3	11.3	20.3	13.0	31.2	17.1	30.9	15.7	18.7	16.9	10.8	11.0	18.0	19.4	16.6	13.9	13.1	22.2	17.4	17.5	18.0	14.5	13.7	12.1	18.3	17.2	14.9	19.8	17.4	21.5	8.7	18.8	17.4	14.8	13.2	13.8	18.1	55.3	18.2	10.9	33.1	20.2	9.4	15.2	23.5	15.7	13.8	16.7	14.8	14.1	18.5	17.7	19.4	29.2	13.5	13.9	13.5	20.1	16.4	11.0	8.5	25.1	12.3	23.2	26.6	19.8	17.1	16.7	21.6	23.6	23.6	15.9	22.7	19.4	19.6	16.2	10.4	19.6	13.5	24.1	20.2	12.8	14.0	10.2	22.5	27.0	11.0	7.7	15.3	31.1	20.3	22.7	22.7	20.5	18.6	12.8	19.4	29.2	11.6	21.4	28.1	22.8	18.4	17.2	18.9	42.1	22.9	24.3	12.6	15.7	19.7	11.1	10.9	22.2	20.7	15.2	14.3	11.8	18.1	20.5	16.4	14.2	26.8	16.7	27.6	21.0	16.8	10.6	3.1	13.9	13.5	11.0	13.5	15.9	19.4	17.2	13.4	19.9	15.3	19.5	15.9	3.7	13.5	13.2	29.2	20.1	16.4	18.3	20.3	17.1	30.9	17.4	17.5	18.3	17.2	18.8	15.7	14.9	30.2	31.4	76.5	56.0	47.4	39.5	17.8	16.0	18.2	24.4	41.2	34.1	106.1	43.4	109.2	28.7	17.6	0.0	36.9	43.7	38.9	66.8	27.7	15.8	28.1	9.5	46.0	22.1	18.4	249.4	36.5	30.4	65.8	41.5	33.8	31.0	32.9	21.0	35.0	60.8	77.6	45.3	75.2	62.1	50.4	68.5	36.3	27.3	35.9	56.5
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280836-11281350	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	125	"testis: 747.3"	"Group enriched"	"Detected in some"	154	"Early spermatids: 123959.8;Late spermatids: 465852.4"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0"									"HPA055150, HPA059371"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	747.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123959.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	465852.4	1718.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1588.2	0.0	0.0	1138.3	0.0	1916.0	855.6	0.0	0.0	0.0	0.0	0.0
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635167-46665124	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	19.9	14.7	37.1	21.8	43.6	18.7	28.4	21.4	37.2	25.5	25.2	35.4	12.0	14.7	24.5	15.9	30.7	27.1	23.4	29.4	37.4	53.1	19.9	8.5	21.7	28.7	44.8	32.2	48.5	15.1	19.9	20.1	26.2	44.9	22.0	17.1	20.6	21.0	28.0	9.5	28.1	20.0	28.5	69.6	25.6	17.4	10.1	40.3	13.8	20.1	7.4	28.3	23.1	26.0	18.9	27.6	64.2	26.1	50.8	60.2	41.6	22.7	19.5	39.5	14.7	28.9	28.2	9.7	21.5	24.2	24.4	22.4	27.4	18.6	13.4	27.4	38.3	33.3	6.7	18.4	27.1	14.2	33.4	17.7	34.7	16.5	20.4	14.0	10.3	16.5	17.4	27.0	29.6	21.2	27.4	35.3	19.2	22.0	25.2	37.3	25.5	14.8	19.4	21.7	14.5	23.1	19.1	10.0	8.8	19.0	19.5	28.6	17.8	22.7	10.4	41.1	6.1	14.0	10.7	31.8	23.9	16.4	12.7	14.1	6.7	6.1	8.5	21.9	28.1	34.5	44.2	19.6	64.2	60.2	26.0	43.6	18.9	40.5	51.0	27.6	16.7	49.9	56.9	26.3	50.8	26.1	23.8	29.0	41.6	37.1	43.6	21.4	37.2	37.4	53.1	44.8	32.2	44.9	40.3	86.4	33.4	59.7	59.7	41.0	46.0	58.2	71.4	75.0	52.4	71.5	27.5	55.8	76.3	68.8	2.4	76.8	42.4	23.3	45.8	37.4	57.5	64.0	111.2	26.7	91.9	35.0	34.3	129.5	113.7	5.6	51.5	104.6	82.7	214.6	26.3	44.1	63.8	35.4	58.4	73.2	53.9	64.7	66.1	20.2	31.9	39.4	57.9	132.0	32.2	56.9
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.7	39.4	28.5	28.2	13.6	15.5	31.1	28.1	20.9	43.6	37.0	36.0	37.9	39.8	23.0	20.7	25.9	32.6	56.4	47.2	50.5	25.5	27.2	24.7	26.6	55.3	26.1	51.8	21.6	15.2	25.2	33.7	61.6	17.8	20.6	31.8	35.0	21.8	22.5	36.8	37.1	23.2	25.5	35.5	49.8	43.8	34.5	28.9	21.2	28.0	30.7	20.1	30.7	32.9	14.3	25.5	22.2	19.6	19.3	18.5	26.4	26.3	35.8	29.9	63.7	52.9	11.7	25.2	28.9	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3	17.9	10.8	4.5	23.8	23.6	9.5	0.8	28.1	26.8	11.4	7.0	7.9	33.6	19.9	25.6	1.9	11.2	6.3	0.0	23.3	26.7	18.6	11.3	6.9	15.5	17.4	15.9	5.8	11.1	4.9	2.7	15.3	10.4	25.3	11.8	15.7	19.1	60.5	8.6	19.8	18.4	7.5	6.5	27.8	34.9	54.7	24.3	27.9	10.1	19.0	16.8
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.2	16.7	8.0	20.0	7.6	7.2	26.7	10.3	5.6	13.1	10.9	42.3	10.3	21.9	17.4	8.7	4.8	13.4	11.3	10.4	7.3	7.8	16.9	6.5	18.8	19.1	5.5	11.9	10.2	8.0	4.5	10.8	10.2	8.1	7.8	11.4	15.4	1.2	7.1	17.2	14.7	18.5	13.1	10.3	11.4	19.8	11.7	14.8	6.1	9.4	10.9	8.5	34.5	8.7	7.0	6.8	14.5	11.9	9.3	9.3	8.3	11.1	9.2	6.7	12.4	22.5	11.8	12.8	9.6	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1	17.9	11.7	10.4	7.4	6.2	20.5	11.8	15.3	14.7	9.1	8.7	51.1	21.8	5.0	11.0	3.4	6.8	24.9	0.0	14.4	6.5	8.0	6.2	6.9	7.5	10.2	28.6	12.7	6.7	5.9	3.2	10.9	8.3	8.5	4.6	27.0	9.4	15.1	26.9	12.4	6.8	16.4	12.9	5.7	6.3	20.0	5.3	9.7	15.2	23.3	9.3
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 140.6;Proximal tubular cells: 216.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"Hep G2: 26.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.3	0.0	0.0	0.0	12.2	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	0.1	0.0	0.0	1.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009866-39038076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	10.8	9.9	10.6	12.8	13.3	26.8	11.3	22.6	14.3	8.5	13.7	17.4	9.6	12.9	11.9	11.8	14.5	9.2	8.0	8.8	10.7	6.9	12.6	11.3	15.0	15.2	14.8	9.0	10.0	19.0	7.0	19.5	35.4	12.2	13.4	17.3	11.0	17.9	8.3	11.8	18.5	15.0	9.9	16.3	16.6	12.8	19.0	15.0	26.1	14.3	8.2	17.3	10.8	11.2	4.1	4.8	6.0	4.4	7.5	6.4	4.2	7.2	5.6	17.7	12.2	6.1	4.9	28.2	6.9	6.1	6.9	7.5	17.9	11.4	17.0	5.6	6.7	9.4	12.6	19.0	12.4	11.4	25.7	15.6	25.0	6.1	12.3	13.9	26.0	15.5	6.5	15.0	11.0	25.2	4.3	11.3	19.6	12.3	10.3	7.4	12.7	15.8	13.9	26.4	14.4	6.1	16.7	18.8	10.7	7.0	11.4	10.0	11.5	4.8	12.7	10.2	14.4	13.6	15.1	10.3	4.0	6.5	7.9	8.7	9.7	9.9	18.5	6.5	14.5	7.9	6.0	3.4	0.6	5.7	3.2	6.4	4.1	5.5	6.1	4.1	3.1	4.9	5.3	0.9	7.5	4.4	4.8	3.0	4.2	10.6	13.3	22.6	14.3	10.7	6.9	14.8	9.0	12.2	15.0	3.0	15.4	11.2	4.5	6.3	10.5	5.2	2.5	4.0	4.5	0.0	7.9	16.6	1.7	6.4	15.1	7.7	6.3	0.0	11.6	15.4	5.4	9.9	11.5	5.6	9.0	15.9	10.9	6.7	18.3	5.0	6.1	6.5	5.0	4.6	16.0	4.0	13.2	14.4	4.6	2.8	9.3	0.0	3.8	13.4	12.4	6.4	22.4	9.2	13.6	7.4
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.5	0.3	0.0	16.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	1.2	2.8	0.0	0.2	0.0	0.2	0.0	0.8	1.0	0.7	0.0	8.5	1.2	0.1	0.2	1.2	41.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2	0.0	2.9	0.0	1.0	5.3	195.1	97.2	84.1	1.4	2.3	8.7	2.0	0.0	13.3	17.3	37.5	17.8	2.6	0.0	2.4	0.1	6.7	2.3	0.0	270.2	0.7	494.2	64.2	4.9	4.5	5.9	1.1	1.1	10.1	0.0	15.2	38.7	5.2	79.3	1.1	0.3	8.6	0.0	2.7	0.2	0.1	4.0	0.0	0.0	8.0	0.6
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 82.5"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		28000	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	9.5	15.5	18.9	22.7	20.0	16.0	12.7	42.9	23.0	13.6	16.1	27.2	13.7	19.0	16.3	14.6	15.9	16.6	16.6	13.9	20.5	22.0	22.9	16.2	13.7	35.9	23.6	19.4	20.9	16.2	18.5	24.9	10.4	20.2	13.1	19.1	16.2	13.4	13.6	9.8	15.3	16.4	13.5	35.0	14.8	17.0	22.7	22.6	28.1	20.5	10.3	41.1	12.7	13.5	26.0	18.9	17.0	14.7	21.4	29.9	16.7	11.2	12.4	18.0	12.9	7.9	5.0	18.5	8.5	6.6	11.1	10.4	15.5	5.3	28.7	8.7	7.3	11.2	13.7	21.1	10.6	12.2	12.9	16.9	9.0	10.4	12.9	10.9	5.7	8.1	5.7	7.1	14.0	10.8	11.3	10.4	16.2	13.2	4.8	9.9	12.4	12.0	6.7	12.8	22.2	8.2	17.0	29.7	12.7	6.9	7.1	10.6	13.8	12.9	5.1	13.0	82.5	14.2	8.3	6.8	4.6	9.1	15.5	10.4	7.8	9.1	11.9	9.4	8.4	9.4	12.7	13.8	17.0	16.7	14.1	18.5	26.0	21.2	17.1	18.9	24.3	29.9	22.3	5.8	21.4	14.7	13.1	21.1	16.7	18.9	20.0	42.9	20.1	20.5	22.0	23.6	19.4	20.2	22.6	14.9	24.8	27.4	16.5	14.1	35.2	8.6	28.1	30.8	13.6	10.4	27.5	11.2	23.2	20.4	42.2	12.0	14.5	0.0	19.3	30.7	13.4	14.7	45.1	16.3	20.6	15.9	25.4	18.4	14.5	33.2	13.0	15.5	11.8	23.4	21.1	23.3	18.4	11.5	12.7	22.8	31.0	19.4	12.4	47.7	58.0	18.2	11.7	17.5	20.0	13.4
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	3.5	0.6	12.6	1.0	0.0	2.7	4.5	6.7	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	0.0	8.8	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.4	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7	8.9	22.1	16.0	6.3	5.0	9.0	2.4	7.6	14.7	13.6	3.5	13.7	12.1	6.6	4.0	0.6	5.0	7.9	0.0	8.1	6.2	9.1	4.6	11.5	3.9	7.0	6.4	7.5	9.2	6.2	1.8	9.5	7.7	10.1	10.0	7.6	8.0	4.9	5.3	9.6	8.2	18.5	6.5	7.2	8.1	5.9	5.0	8.2	10.2	6.5	3.4
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 23.6;Rod photoreceptor cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		18000	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.6	3.4	12.7	1.7	0.8	1.2	2.4	1.5	3.3	0.2	2.4	1.3	0.3	3.0	1.5	0.2	0.9	3.2	0.6	6.8	1.4	0.5	1.3	0.0	1.3	0.3	1.2	3.2	0.2	1.2	0.5	7.1	0.6	4.3	0.7	3.4	1.8	16.1	3.0	0.2	6.2	0.1	1.5	1.8	0.3	1.3	0.7	0.2	4.9	3.2	1.2	24.2	0.4	1.0	6.5	0.3	0.6	0.3	3.5	0.6	0.9	4.4	4.5	0.4	8.0	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2	0.0	1.3	3.0	3.6	2.4	23.6	2.5	7.6	8.1	1.2	10.4	13.7	0.6	3.3	2.6	3.1	2.8	4.2	0.0	4.4	0.4	4.8	3.6	1.1	2.4	3.1	14.3	10.9	1.8	1.3	2.7	5.2	2.1	1.7	17.2	4.7	9.8	3.2	0.0	2.5	6.2	22.5	0.0	4.7	9.7	5.7	1.9	0.3	4.6	3.6	2.0
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665641-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 24.4;Early spermatids: 53.9;Fibroblasts: 25.4;Smooth muscle cells: 37.7;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;BJ: 17.1;BJ hTERT+: 12.2;fHDF/TERT166: 24.6;U-2197: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	8.4	2.1	0.4	2.5	0.4	0.2	7.3	0.2	0.6	15.6	2.4	0.5	3.5	0.7	4.6	5.4	5.3	2.1	2.3	8.6	0.4	0.2	0.6	0.4	2.8	1.8	0.3	0.1	3.2	2.2	0.3	2.8	2.6	1.7	15.1	0.7	12.8	4.6	5.2	6.6	15.8	1.1	10.2	1.2	0.4	1.6	6.7	0.0	0.6	7.9	9.3	6.5	10.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	2.1	8.1	0.0	17.1	12.2	2.2	2.5	0.0	0.0	0.0	6.2	24.6	0.9	0.2	0.5	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.6	1.2	3.8	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.8	0.0	0.0	0.9	1.6	0.3	0.0	0.0	5.1	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.4	0.2	0.3	0.1	1.7	0.0	0.0	0.0	0.0	1.2	24.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	53.9	0.1	0.0	0.0	0.0	0.3	25.4	2.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	2.6	0.0	8.5	0.0	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	37.7	3.2	6.8	26.0	0.3	0.0	0.0	5.0
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		15000000	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	52.1	54.7	46.6	55.8	52.8	50.4	64.1	30.8	67.2	89.9	63.1	73.2	70.5	47.5	93.4	51.5	47.8	52.4	47.3	57.9	51.3	66.2	47.8	32.8	41.0	54.7	57.1	45.7	45.2	55.0	55.4	84.4	34.7	45.8	62.7	51.3	53.0	93.0	63.3	139.7	54.8	53.9	119.2	77.4	71.0	52.6	34.1	83.8	73.4	42.7	51.8	61.5	35.8	78.3	103.0	60.3	70.7	72.5	39.7	39.5	42.1	41.9	67.6	92.7	106.1	91.6	58.3	40.7	83.0	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3	142.9	125.8	60.3	65.1	68.1	51.9	108.2	81.5	179.3	134.2	68.0	15.7	176.7	87.9	106.1	12.6	85.2	80.0	46.7	168.6	123.7	82.9	62.0	103.4	133.7	108.0	46.1	63.8	90.9	107.2	13.4	96.7	88.1	91.1	226.4	73.7	84.2	122.6	66.6	99.0	122.6	44.8	64.7	80.2	38.6	45.3	66.4	223.6	74.3	80.9	77.2
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		8200000	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.5	48.1	34.4	32.6	46.4	40.1	34.0	32.2	38.4	56.9	48.4	40.5	36.0	28.0	30.1	43.8	39.5	30.8	54.9	40.2	55.0	17.2	37.9	17.8	35.1	142.5	36.6	21.6	21.4	44.7	37.7	42.2	35.2	37.8	58.8	24.7	26.7	16.0	46.5	66.5	12.3	29.6	38.2	43.6	78.0	16.6	26.0	18.7	44.2	32.7	43.9	34.2	22.7	46.1	31.0	47.0	22.2	28.1	31.6	27.9	28.4	25.8	31.6	13.8	27.3	21.0	21.8	17.4	34.5	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3	71.5	50.9	58.0	134.8	124.6	57.4	134.8	129.9	149.9	80.8	90.7	27.5	350.9	233.8	261.5	57.3	106.7	63.2	0.0	201.1	383.6	136.2	130.9	30.1	134.4	190.5	66.7	148.5	90.9	54.9	77.1	109.9	70.7	109.6	199.2	94.1	137.0	244.2	80.7	114.9	331.7	53.8	97.0	134.4	207.4	76.8	137.3	359.7	49.8	123.0	163.4
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome subunit beta 6"	P28072	17	4796144-4798503	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		2800000	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	28.6	35.0	33.7	23.2	36.4	31.7	34.0	24.2	41.5	29.6	31.7	26.7	26.8	22.6	33.4	47.1	41.9	30.3	24.2	72.0	30.4	30.5	41.4	67.1	25.7	35.3	33.4	34.0	25.3	41.8	40.8	26.6	49.6	35.9	26.4	36.1	23.5	30.6	36.6	97.4	33.6	23.2	40.5	29.7	29.0	31.2	27.0	28.0	35.8	34.6	53.8	39.6	27.9	26.0	93.9	96.3	51.1	95.3	60.4	81.2	107.9	46.8	82.1	44.3	37.8	37.8	34.0	51.1	24.9	52.1	76.0	59.7	61.0	38.3	36.5	49.4	59.5	43.8	47.6	67.3	69.6	74.2	47.4	71.0	21.6	54.0	70.8	43.6	22.3	34.5	32.0	53.5	66.4	63.2	42.9	73.8	58.3	33.0	55.5	58.2	55.8	39.4	37.3	37.5	60.6	57.0	44.2	31.5	48.3	57.1	31.6	25.9	31.8	35.7	27.9	25.6	48.4	34.0	25.1	35.2	37.5	28.4	50.4	60.1	23.2	30.9	22.2	53.7	40.8	45.1	51.1	95.3	50.5	57.1	87.5	57.8	93.9	62.3	62.6	96.3	79.8	53.7	56.1	32.9	60.4	78.0	89.7	81.2	107.9	33.7	36.4	24.2	41.5	30.4	30.5	33.4	34.0	35.9	28.0	125.0	90.0	86.3	149.5	203.5	62.3	388.1	150.3	148.5	136.5	127.4	15.7	501.8	303.4	283.2	179.9	152.8	127.2	46.7	303.5	339.8	176.1	166.1	102.7	181.7	306.8	30.2	142.4	94.5	116.6	27.7	101.5	205.7	224.4	422.0	103.5	128.7	291.3	143.8	115.6	455.7	57.6	109.9	242.8	120.2	84.7	242.3	555.7	109.0	129.8	191.2
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256495-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.0"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 478.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000872, HPA016885"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		46000	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705, HPA016885: "	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	23.7	21.6	28.2	16.7	26.6	26.9	24.6	17.1	39.1	18.4	21.0	11.8	14.3	12.7	23.7	27.9	23.4	18.0	13.7	34.5	37.8	19.1	22.8	29.7	17.9	16.2	19.8	29.3	16.1	20.4	21.8	15.9	25.3	37.2	19.0	23.0	12.1	18.9	22.8	178.0	22.9	17.2	23.2	31.3	19.3	20.0	42.1	15.6	14.4	18.0	29.2	25.4	23.3	17.2	21.4	37.7	57.0	38.1	28.7	36.4	37.8	32.4	30.9	35.5	37.0	31.2	28.7	37.4	31.5	44.2	69.7	52.6	28.5	36.7	27.7	48.2	38.1	32.0	33.8	43.4	36.8	81.7	33.1	19.0	21.7	20.7	24.4	27.0	32.9	29.1	25.7	29.2	45.3	33.4	29.2	41.9	30.9	30.6	16.7	47.8	61.7	24.4	42.9	31.3	42.0	38.3	29.4	46.0	22.6	39.2	33.9	37.4	25.0	25.7	67.0	26.3	30.8	42.1	29.1	31.7	26.9	24.0	28.8	45.5	29.0	45.7	41.1	38.9	30.0	40.9	30.9	37.6	57.0	26.6	34.1	26.2	21.4	27.5	27.2	37.7	20.7	25.3	24.8	41.7	28.7	38.1	26.4	36.4	37.8	28.2	26.6	17.1	39.1	37.8	19.1	19.8	29.3	37.2	15.6	95.3	66.7	41.0	73.5	57.8	47.2	33.6	99.3	137.9	116.0	52.4	49.1	265.6	101.2	136.5	478.8	81.7	77.7	46.7	171.7	144.5	72.1	66.8	95.8	167.6	133.3	74.7	54.8	77.3	91.6	350.7	70.8	81.8	64.1	188.4	56.4	79.4	161.0	64.3	77.1	126.3	54.1	84.1	75.2	77.1	45.5	43.8	392.6	74.6	66.8	81.4
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971005-39981441	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 334.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		66000	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	24.0	31.3	23.4	26.1	26.9	15.0	20.3	23.9	37.1	22.8	25.0	26.1	24.9	26.4	29.8	34.0	29.9	25.1	22.2	35.9	24.1	25.4	40.4	65.6	20.1	21.3	25.6	27.4	22.7	19.6	33.1	22.1	29.7	32.3	22.5	24.6	21.8	21.1	28.1	57.3	25.8	24.8	27.1	26.0	25.2	24.1	29.7	25.5	27.9	30.2	28.0	28.5	28.9	20.1	18.1	34.4	16.0	43.1	19.8	28.1	25.8	22.6	73.8	15.0	19.6	12.9	10.7	17.2	13.5	16.5	30.0	23.3	42.6	16.5	11.3	26.3	15.9	17.9	12.3	20.1	18.2	22.8	20.0	21.0	16.7	13.9	34.7	18.9	17.3	20.1	11.3	14.8	24.4	16.7	8.9	19.6	14.4	21.4	17.3	18.3	34.3	20.6	10.0	27.0	28.1	22.5	18.0	18.0	16.3	20.0	34.2	19.4	25.0	15.2	24.3	12.1	14.4	16.8	15.3	12.9	19.7	19.6	17.9	32.7	20.9	36.3	17.5	24.9	18.5	21.6	14.8	20.5	16.0	23.6	32.2	20.0	18.1	21.1	23.9	34.4	16.9	17.1	17.6	11.1	19.8	43.1	17.1	28.1	25.8	23.4	26.9	23.9	37.1	24.1	25.4	25.6	27.4	32.3	25.5	29.8	16.6	42.4	70.2	56.8	48.5	34.4	48.4	48.2	30.7	41.8	13.7	160.1	77.9	114.4	141.3	51.7	104.4	46.7	97.0	94.8	52.8	56.5	40.4	40.6	138.7	39.7	56.7	28.3	37.6	88.3	50.9	55.7	42.2	126.2	23.8	57.9	103.2	84.2	65.7	117.8	40.5	90.5	51.4	54.2	45.4	50.8	334.1	60.9	43.9	72.7
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056864-231172827	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA		49000	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.63e-12)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	21.9	25.5	21.5	19.0	27.8	14.4	18.4	22.3	29.0	17.3	20.6	16.2	15.3	21.7	24.3	17.6	25.3	16.1	13.0	34.9	31.8	22.1	20.9	27.8	16.8	16.3	20.3	27.2	16.4	10.9	73.9	24.6	28.5	34.0	18.7	23.7	15.0	16.7	21.1	75.5	20.2	17.9	27.2	17.5	18.7	17.4	16.8	17.8	20.6	17.3	23.7	22.3	17.8	16.4	14.3	21.2	23.5	26.7	25.6	21.6	15.4	29.1	31.8	35.9	28.0	37.4	27.0	34.7	38.8	40.5	39.4	40.1	38.6	29.1	22.9	36.7	43.3	41.4	28.1	49.8	36.2	53.8	34.7	26.7	42.4	26.1	44.2	19.3	37.2	36.8	23.2	18.0	42.3	22.5	22.4	46.3	21.0	58.5	17.3	46.6	28.4	29.0	21.4	46.2	29.0	25.5	24.7	55.1	21.9	29.0	30.3	24.0	21.5	31.1	28.1	19.0	38.9	22.3	22.0	43.2	31.4	33.1	37.8	36.8	15.1	22.2	40.8	48.4	28.8	35.8	23.5	19.2	14.6	19.2	25.9	19.0	14.3	18.3	16.9	21.2	12.0	14.9	16.8	10.8	25.6	26.7	12.1	21.6	15.4	21.5	27.8	22.3	27.6	31.8	22.1	20.3	27.2	34.0	17.8	47.6	43.2	20.8	30.2	29.5	45.8	114.2	38.2	77.6	44.3	31.4	39.3	104.8	14.9	66.5	4.9	46.6	49.9	0.0	88.3	83.2	46.2	31.9	100.6	73.7	64.0	85.8	37.8	29.4	37.8	8.1	32.2	38.0	16.9	67.7	24.4	50.0	76.2	24.9	43.2	30.0	51.3	71.1	32.5	124.1	96.9	29.0	140.1	29.8	34.0	35.9
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444261-32483318	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		78000	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.0	22.4	20.7	19.9	22.3	19.9	17.4	22.2	27.1	16.3	19.2	23.8	14.9	19.2	24.2	17.2	28.5	17.6	16.5	24.7	18.3	18.7	21.7	38.2	19.1	19.5	24.4	16.9	19.1	25.8	30.1	19.1	27.5	28.1	18.6	23.7	17.3	19.2	16.7	69.0	25.3	18.8	25.4	19.1	20.0	18.3	22.8	19.8	27.7	19.5	26.9	26.8	18.9	18.9	24.4	30.8	22.8	28.0	30.1	33.1	26.8	35.7	39.7	29.0	31.2	19.7	14.7	31.0	20.4	26.5	45.4	36.9	40.0	32.8	28.1	32.6	22.1	43.7	41.7	33.0	28.4	44.7	14.2	22.5	22.7	20.1	30.9	19.2	26.9	24.4	13.1	15.0	39.4	27.4	14.5	31.8	25.2	43.0	33.0	26.6	22.2	40.2	15.9	39.8	19.3	20.0	25.0	37.6	38.0	22.3	26.9	25.7	17.4	25.9	18.8	20.6	31.4	45.5	12.9	21.8	25.4	29.6	31.3	47.1	18.4	28.7	37.2	36.8	21.1	42.6	22.8	27.4	16.7	28.3	27.1	31.0	24.4	27.7	28.4	30.8	23.7	24.9	26.0	12.6	30.1	28.0	25.1	33.1	26.8	20.7	22.3	22.2	27.1	18.3	18.7	24.4	16.9	28.1	19.8	44.7	26.9	44.2	79.8	112.8	41.5	63.9	50.9	28.1	51.2	24.4	29.5	156.7	68.0	89.4	179.8	49.7	62.9	46.7	93.2	121.7	52.5	82.6	45.0	95.7	80.8	35.0	46.7	49.7	44.8	37.3	45.5	50.2	25.3	80.2	45.1	59.3	94.8	45.6	45.6	82.8	40.8	51.8	72.9	151.9	108.8	102.8	258.4	51.7	51.7	105.7
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980797-39997960	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		380000	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	25.1	27.7	20.0	25.0	26.1	22.0	21.3	30.0	40.3	22.5	28.1	22.4	16.8	23.2	26.8	21.2	27.7	22.7	23.7	36.1	20.6	21.4	23.8	54.4	20.8	22.3	19.2	23.7	24.0	23.6	28.1	20.8	33.8	24.5	23.2	25.4	21.4	22.5	21.9	93.2	33.2	23.5	24.7	17.6	26.9	21.1	19.9	17.5	35.7	24.3	39.2	26.3	20.7	21.2	15.6	24.3	14.4	17.0	13.1	17.7	12.0	32.7	40.9	22.5	32.3	18.4	11.9	26.8	24.2	25.2	43.7	34.0	33.8	28.3	39.5	61.0	25.9	29.3	51.5	39.9	31.6	29.6	39.7	44.5	22.8	21.0	33.4	16.7	30.7	25.6	15.8	27.0	46.2	20.3	14.7	24.6	27.7	46.5	24.7	20.2	23.9	47.5	21.1	31.2	21.3	24.3	35.0	31.3	37.0	21.8	22.2	29.7	22.5	23.1	141.9	19.9	28.6	31.9	26.6	21.9	18.9	33.5	27.9	43.2	26.9	34.1	44.0	29.0	23.2	30.5	6.6	16.8	14.4	15.1	17.0	15.1	14.4	14.6	17.7	24.3	15.6	13.7	16.5	5.5	13.1	14.3	16.7	12.6	12.0	20.0	26.1	30.0	40.3	20.6	21.4	19.2	23.7	24.5	17.5	41.7	37.3	61.7	49.4	41.4	70.1	17.3	15.3	16.0	29.6	15.7	19.6	147.2	39.7	91.3	204.0	32.3	72.1	23.3	91.5	109.0	44.2	48.0	24.3	44.4	86.1	57.2	25.3	27.0	23.7	35.1	58.1	39.1	62.4	73.1	44.9	81.4	81.7	58.8	50.9	43.1	47.4	25.8	47.6	47.1	57.9	39.0	227.2	36.2	61.2	47.1
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254703-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	27.5	28.0	44.3	24.4	46.4	25.5	29.9	25.7	50.4	21.9	28.6	28.3	16.5	22.7	25.1	41.5	26.7	31.4	21.8	38.7	37.5	36.8	25.3	44.7	20.2	28.2	47.5	44.8	26.7	27.7	27.4	19.3	30.0	43.2	23.0	28.1	24.3	25.6	31.2	86.7	28.0	20.5	39.3	29.6	26.3	25.8	35.9	29.1	23.1	23.7	25.7	36.2	28.0	19.8	62.7	65.1	111.6	76.0	54.2	74.2	88.2	42.3	51.0	37.7	30.8	41.1	30.5	41.1	28.7	35.3	45.9	36.7	66.7	48.5	34.4	70.6	40.5	31.8	44.4	48.4	43.4	39.3	56.1	42.2	33.6	43.5	68.7	45.4	39.4	39.2	33.0	36.1	52.4	48.5	34.5	40.0	38.7	52.2	43.8	38.4	124.8	36.2	48.0	71.6	65.6	51.6	30.8	36.7	62.1	45.0	36.3	29.6	50.5	31.9	46.9	38.0	58.2	49.0	78.0	35.1	22.9	36.0	28.1	49.0	52.5	65.1	73.4	38.0	37.2	41.7	59.6	71.5	111.6	43.0	76.0	48.4	62.7	50.5	47.3	65.1	61.1	46.4	46.0	95.8	54.2	75.5	39.2	74.2	88.2	44.3	46.4	25.7	50.4	37.5	36.8	47.5	44.8	43.2	29.1	53.6	55.8	113.9	90.7	78.8	48.8	216.6	79.0	80.3	42.1	57.6	25.5	289.4	142.6	149.2	182.3	103.4	106.2	93.5	163.0	189.2	97.9	84.2	80.9	96.2	163.2	31.8	80.8	69.3	92.1	179.3	97.5	96.7	99.5	354.3	71.9	58.4	143.7	95.1	92.6	161.4	44.8	116.4	130.8	169.8	77.8	75.7	346.7	94.7	97.0	85.8
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842984	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		12000000	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	14.1	20.1	10.2	12.2	16.2	14.7	32.5	20.7	21.8	14.6	12.9	10.2	12.3	10.3	14.8	14.1	17.3	13.8	10.6	12.7	11.7	12.3	11.5	21.0	34.8	23.6	9.8	14.1	16.7	32.2	13.3	11.7	10.5	14.5	16.1	12.5	8.8	15.1	15.7	10.0	16.7	11.2	24.5	9.9	12.3	14.4	11.3	8.1	13.0	12.6	9.2	15.5	14.9	13.5	17.5	14.4	15.2	17.9	14.2	25.2	14.2	13.1	17.1	8.3	15.4	18.6	18.5	9.8	19.5	15.3	18.5	16.9	15.2	8.7	13.4	8.9	19.8	14.6	19.7	0.0	19.2	21.6	12.2	1.9	11.2	23.8	8.4	14.0	3.9	4.2	15.5	12.5	17.9	19.2	9.2	10.7	14.7	41.0	9.0	17.2	16.3	11.9	8.1	12.3	32.1	12.2	11.0	18.1	10.6	17.0	11.6	11.4	7.3	23.6	20.1	9.3	6.5	24.0	9.5	16.5	0.0	10.0	7.7	17.2	5.4	5.4	14.7	11.4	12.9	16.3	15.2	14.9	12.3	17.1	16.5	18.6	17.5	19.9	20.5	14.4	13.2	19.4	15.1	8.1	14.2	17.9	10.5	25.2	14.2	10.2	16.2	20.7	21.8	11.7	12.3	9.8	14.1	14.5	8.1	8.9	14.2	12.8	9.5	11.0	14.0	7.5	12.7	6.7	21.6	8.7	11.8	10.1	10.0	10.8	5.2	10.9	9.5	0.0	11.6	9.5	13.9	12.5	13.9	22.2	10.6	4.8	7.5	16.0	13.9	3.2	12.0	10.6	13.5	7.2	14.3	9.5	13.9	10.8	15.2	12.9	10.4	6.5	15.1	21.1	20.0	11.8	9.2	17.5	9.3	8.4
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 93.0"	"Low region specificity"	"Detected in all"							"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	37.3	31.0	24.1	25.2	25.2	42.0	37.4	26.2	27.4	30.5	30.3	24.7	20.6	25.6	34.8	39.6	43.4	27.8	39.2	28.5	23.5	23.4	38.7	46.8	30.9	41.8	24.0	18.9	35.7	44.8	9.9	26.4	35.4	23.0	32.5	35.2	24.8	31.9	28.5	29.0	32.2	34.6	38.1	27.0	35.1	31.0	71.6	20.6	49.0	40.3	37.1	41.3	38.1	29.9	28.8	31.2	33.0	40.9	27.6	41.5	33.2	18.0	11.6	13.5	17.5	25.3	37.0	18.0	17.3	28.4	32.6	36.9	19.7	20.3	20.9	14.2	21.0	23.4	11.5	21.9	23.8	28.5	10.8	10.4	11.4	10.5	23.9	24.2	38.7	17.8	29.6	18.9	19.2	26.3	18.8	22.8	16.2	17.0	26.8	25.3	18.0	24.4	53.6	10.6	93.0	13.7	16.7	20.4	29.9	29.3	25.4	16.6	12.7	17.0	20.1	16.3	14.1	17.5	32.5	14.6	36.3	46.6	30.5	20.2	22.4	31.0	24.6	21.3	20.1	14.5	29.0	35.8	33.0	27.5	36.3	32.7	28.8	36.1	31.6	31.2	26.1	33.1	31.0	12.0	27.6	40.9	25.8	41.5	33.2	24.1	25.2	26.2	27.4	23.5	23.4	24.0	18.9	23.0	20.6	47.6	38.4	56.2	83.4	80.8	24.2	29.0	58.6	49.5	38.7	78.5	21.6	169.1	131.0	97.4	378.7	70.5	65.0	0.0	96.8	115.7	101.3	74.8	60.0	52.1	131.4	23.8	65.8	80.4	130.8	85.9	124.3	107.7	69.2	107.4	75.8	51.3	90.0	80.1	91.2	141.7	16.9	84.1	96.6	169.3	251.7	78.7	155.8	80.3	91.4	103.6
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	13.9	12.7	12.6	13.0	26.1	14.3	16.0	18.5	14.4	15.8	15.1	11.8	11.3	17.3	16.7	23.1	16.9	13.4	18.7	12.9	11.4	14.0	13.1	18.1	11.0	15.2	10.7	12.2	13.8	30.9	8.9	16.2	9.6	10.7	15.5	8.9	13.6	21.0	18.8	36.6	17.9	16.8	18.1	10.6	11.9	17.4	13.3	9.8	13.5	17.2	16.5	14.6	13.1	11.3	25.6	18.5	12.2	20.1	16.2	24.4	13.2	21.5	10.6	6.4	15.7	5.8	8.6	11.0	9.8	7.3	9.4	15.3	8.9	7.5	7.2	26.7	5.8	7.6	10.1	5.3	6.5	6.1	12.2	22.8	5.8	10.9	23.0	6.9	16.7	6.2	7.3	7.3	6.8	10.2	5.4	11.7	14.5	22.5	5.6	5.0	20.6	9.5	31.0	7.8	11.1	20.9	12.8	3.5	40.1	7.4	8.6	27.4	8.0	4.3	6.2	20.9	6.3	7.9	7.5	11.1	8.0	7.6	8.9	9.4	18.2	25.7	13.3	5.6	12.1	10.8	6.2	20.1	12.2	14.8	18.4	17.0	25.3	24.4	17.8	15.5	25.6	24.4	20.9	4.8	16.2	18.1	18.5	20.5	13.2	12.6	26.1	18.5	14.4	11.4	14.0	10.7	12.2	10.7	9.8	20.8	13.9	20.9	23.8	24.7	28.8	18.6	35.7	16.0	19.4	41.8	7.9	32.9	71.3	34.8	24.9	32.9	22.0	0.0	76.0	30.2	26.7	25.6	21.9	55.5	30.7	23.8	21.9	29.4	18.9	9.7	34.2	21.2	28.7	31.5	27.1	15.1	47.9	24.6	21.5	42.5	26.2	45.3	30.9	29.8	76.7	33.4	10.1	20.6	32.0	22.6
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.6	14.6	17.8	14.1	18.7	45.0	16.8	24.6	24.7	13.9	15.0	15.3	11.7	12.6	16.0	23.3	15.6	17.1	12.8	11.4	18.9	19.8	13.1	9.2	10.2	19.0	14.6	18.4	16.3	11.2	8.4	23.6	25.7	15.9	11.9	16.4	17.6	11.4	9.4	20.3	14.7	13.1	15.0	12.2	13.8	12.3	23.9	13.6	27.5	12.9	10.7	21.2	12.3	10.9	18.2	17.8	14.8	18.7	9.6	18.2	12.1	18.4	7.7	18.1	9.0	7.5	8.0	23.5	9.9	13.1	18.8	17.1	25.4	10.7	24.7	10.7	10.5	9.8	9.4	20.9	12.0	19.7	10.6	10.2	28.2	5.5	30.9	14.7	20.3	18.1	12.2	2.5	11.4	12.8	7.4	16.0	24.5	15.3	10.1	16.4	20.0	23.7	19.8	25.3	10.2	10.2	16.3	18.1	12.8	19.3	28.0	16.7	8.6	13.5	22.9	8.6	18.1	13.3	21.4	9.4	11.4	10.9	10.8	9.4	8.8	5.2	42.6	5.2	12.2	13.5	10.6	18.1	11.0	10.2	18.7	11.1	18.2	13.7	9.4	16.6	18.0	13.8	10.4	14.8	9.6	13.5	17.8	18.2	12.1	17.8	18.7	24.6	24.7	18.9	19.8	14.6	18.4	15.9	13.6	17.9	25.6	35.9	21.3	29.7	39.8	24.2	20.4	24.1	15.9	15.7	55.0	59.0	18.3	25.3	13.9	22.2	14.0	0.0	29.7	85.2	25.3	15.0	9.2	9.4	23.6	28.6	24.2	25.2	29.3	17.3	29.1	21.8	18.6	46.9	18.6	25.3	21.5	20.1	25.1	19.5	66.0	32.3	30.3	143.2	73.9	29.7	67.3	30.5	23.2	22.7
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6"	"Cancer enhanced"	"Detected in all"		"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 12.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3"	"Low region specificity"	"Detected in all"			HPA056561			Approved	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	1.7	2.4	17.1	4.3	21.6	8.3	3.0	3.8	27.3	2.0	4.0	31.2	0.3	5.1	3.0	3.4	6.3	3.2	3.7	2.0	25.9	11.2	1.7	2.6	2.2	4.0	29.8	12.9	3.6	1.4	0.8	1.7	4.8	16.8	4.0	3.3	4.5	2.9	5.9	1.0	6.1	5.3	4.7	30.6	2.3	2.4	8.6	20.7	5.5	2.0	0.4	5.0	2.6	2.3	0.0	5.4	7.3	12.3	0.2	0.7	3.2	18.8	9.8	40.0	19.3	1.6	3.2	11.0	15.0	12.2	20.5	19.7	15.0	7.9	9.6	5.5	7.4	9.6	13.6	21.5	12.3	17.2	3.7	10.4	6.0	13.1	12.2	1.8	6.4	6.9	3.6	1.1	8.1	5.8	7.7	10.0	11.5	13.6	4.4	16.4	17.1	9.7	4.3	16.5	8.7	11.2	15.1	38.5	3.2	6.9	5.0	16.8	9.7	8.4	12.9	15.4	15.2	7.8	6.1	5.1	12.7	21.0	8.9	24.6	3.4	2.2	3.3	10.2	15.3	35.3	0.0	12.3	1.8	0.7	4.8	0.5	0.0	0.7	0.2	5.4	0.0	0.4	0.4	7.3	0.2	2.6	0.0	0.7	3.2	17.1	21.6	3.8	16.4	25.9	11.2	29.8	12.9	16.8	20.7	0.0	3.8	0.0	2.3	1.8	6.5	0.9	2.5	1.4	0.0	1.8	23.6	3.4	0.0	0.9	0.5	0.4	0.5	0.0	0.7	28.6	2.3	0.6	1.1	0.9	9.2	3.2	0.0	1.3	4.0	1.9	5.5	1.6	1.7	0.0	3.2	7.7	0.4	0.0	42.1	2.3	70.6	0.0	2.3	2.7	1.2	1.0	2.4	0.0	2.0	0.7
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261715-96336995	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	8.2	7.9	8.0	8.1	14.7	10.2	10.4	10.2	15.0	9.7	8.3	5.1	22.5	10.6	8.4	7.8	9.6	7.0	7.9	20.1	8.6	9.9	9.5	12.8	7.8	21.8	7.1	8.0	9.6	12.1	23.2	4.9	10.8	9.6	5.7	7.4	5.2	8.8	29.8	10.1	10.4	8.3	9.0	6.0	11.8	8.1	5.1	3.6	20.7	11.0	7.7	11.8	9.3	6.8	3.6	6.1	9.4	3.7	5.0	4.6	7.8	10.4	8.1	1.4	3.9	2.9	6.1	2.4	7.6	10.5	7.3	5.1	3.0	3.0	17.2	7.0	7.1	1.5	4.3	9.9	7.6	11.4	8.8	7.1	16.9	15.7	1.6	3.0	12.4	5.9	5.1	7.3	10.2	7.2	1.8	4.7	5.3	8.4	8.9	6.6	3.0	9.6	1.9	2.2	3.4	7.6	7.7	7.3	13.0	4.1	8.9	6.1	2.5	2.8	2.5	1.1	1.7	5.9	4.2	8.3	6.6	4.1	4.6	8.7	1.8	9.3	8.4	4.1	13.1	5.4	9.4	3.7	2.1	2.8	2.5	4.0	2.6	4.6	3.4	6.1	3.6	4.0	2.9	1.3	5.0	2.4	1.8	2.6	7.8	8.0	14.7	10.2	15.0	8.6	9.9	7.1	8.0	9.6	3.6	17.9	10.8	40.8	14.5	28.0	8.9	88.9	22.9	2.7	14.8	10.4	9.8	67.1	1.7	16.6	53.9	21.0	13.3	23.3	38.8	47.5	19.7	14.5	32.3	28.4	42.1	4.8	5.2	19.0	42.5	34.9	21.6	30.4	18.6	17.2	15.0	4.8	21.4	5.8	24.4	15.9	4.3	0.0	17.6	10.3	16.6	29.4	67.6	35.2	29.4	13.6
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.2	4.8	5.5	5.0	12.8	8.8	5.0	5.5	12.2	6.5	9.1	4.9	12.6	12.1	3.7	9.0	3.8	6.2	7.4	6.3	10.3	6.0	2.1	4.0	12.5	6.0	13.7	13.5	6.9	6.0	17.6	8.2	10.6	27.6	9.1	7.7	3.0	32.9	5.9	7.8	7.6	24.6	2.0	8.9	0.0	11.8	2.9	8.9	10.1	5.8	2.0	9.0	7.3	3.5	9.2	4.6	9.7	19.6	7.9	21.4	5.0	8.3	4.4	10.8	14.0	13.8	6.6	12.8	1.2	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5	32.8	55.3	40.2	50.0	49.8	113.3	39.2	40.8	25.4	28.4	27.9	37.3	22.6	28.2	23.2	57.0	44.4	33.9	0.0	25.8	44.5	52.3	36.9	25.3	58.6	31.3	42.9	30.0	47.9	167.4	70.7	52.6	69.1	59.1	27.9	44.1	54.1	30.2	24.6	51.2	30.8	55.8	90.5	118.8	24.9	24.0	52.6	47.9	35.7	39.2	51.2
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	11.1	5.4	21.6	10.6	2.9	1.3	8.7	8.9	30.8	6.2	12.1	1.6	14.5	9.2	5.8	8.1	6.9	3.4	3.8	7.8	22.7	8.9	31.3	21.9	9.2	12.6	4.2	1.3	5.3	17.9	11.1	3.4	11.2	3.1	11.3	5.4	6.8	10.6	12.9	6.2	4.0	21.9	5.7	2.6	11.8	9.2	2.9	1.5	17.2	12.0	3.9	9.6	7.7	10.9	15.3	11.7	6.9	16.7	7.6	19.5	9.4	16.1	9.7	0.1	2.9	4.1	8.1	9.7	4.8	0.5	1.8	2.7	8.9	15.3	17.0	4.0	3.2	1.0	7.4	5.5	3.2	2.7	16.6	7.2	15.8	4.6	3.6	4.9	5.1	4.8	5.9	10.4	5.5	0.9	0.0	0.8	15.4	10.8	6.0	2.8	5.4	11.9	5.1	3.9	11.1	2.4	8.9	1.3	8.9	25.5	5.1	12.3	0.8	8.5	2.4	14.0	3.5	5.7	16.2	2.1	0.1	4.3	3.9	0.1	4.5	5.6	18.0	2.0	9.4	6.0	3.5	11.7	6.9	12.7	16.7	13.5	15.3	14.6	12.6	11.7	8.8	11.0	10.9	2.2	7.6	14.5	9.9	19.5	9.4	21.6	2.9	8.9	30.8	22.7	8.9	4.2	1.3	3.1	1.5	26.8	19.9	5.7	12.7	9.7	0.8	22.7	15.3	17.4	28.4	27.9	0.0	17.1	44.7	19.3	0.2	7.1	13.2	0.0	29.9	14.6	7.8	8.8	23.1	21.2	13.0	0.0	11.1	10.4	11.6	0.0	0.9	17.5	8.5	9.0	12.4	13.5	21.4	28.8	0.0	86.8	8.0	6.5	10.3	0.9	6.8	10.8	10.1	12.5	16.8	19.7
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	81.4	71.0	57.7	34.3	42.5	38.6	87.9	53.4	40.8	68.8	51.4	60.1	85.9	90.3	81.1	45.5	46.3	52.5	108.0	69.7	87.2	66.3	71.9	70.5	44.9	69.5	31.1	83.7	51.2	27.9	51.0	51.9	63.1	65.5	70.7	58.1	113.0	86.5	67.1	50.8	83.1	79.6	98.5	71.9	83.0	72.7	54.4	121.2	60.5	63.8	74.8	43.7	54.5	78.6	46.2	79.6	90.5	70.3	42.3	41.3	48.1	49.5	73.7	36.5	100.4	72.6	45.0	69.1	74.3	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1	166.7	121.6	178.4	623.1	343.3	128.5	151.7	150.3	313.2	146.7	179.7	72.6	370.5	316.7	252.0	38.5	189.7	176.9	116.8	186.9	545.4	268.2	456.4	232.8	165.2	311.0	106.5	250.8	168.1	180.7	81.6	221.2	245.7	268.2	312.0	185.6	201.5	190.6	194.6	200.5	268.7	99.7	142.3	307.9	546.1	341.1	330.1	473.4	233.5	241.8	443.4
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	Yes		610000	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	99.6	59.9	85.5	76.2	26.0	34.7	87.8	68.1	57.2	59.5	62.5	58.0	116.9	157.9	78.1	53.1	41.2	52.8	120.2	83.9	75.7	125.1	94.5	203.5	49.5	93.6	32.3	230.8	87.1	50.3	31.5	52.7	43.6	56.8	97.0	129.0	118.2	67.2	51.9	142.5	324.2	314.8	128.7	99.1	50.0	223.4	60.9	107.3	72.8	89.1	174.5	107.4	78.2	78.3	59.4	70.5	59.0	183.6	72.0	50.2	89.1	61.3	73.1	81.5	40.1	316.2	34.3	141.6	80.4	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2	902.2	1420.8	3111.4	3331.5	6879.8	692.5	258.3	1666.3	1917.9	1803.9	2156.5	276.9	2179.3	3208.0	2815.5	89.5	3767.9	1421.2	1752.0	3609.4	4317.6	3273.0	2682.0	2759.5	1209.1	2876.6	767.5	1629.9	1539.5	3031.9	138.7	1209.6	4164.5	3499.0	2458.1	2866.2	2213.1	3219.9	1988.5	1320.3	2161.4	753.7	1895.0	6501.7	798.6	2809.8	6944.4	2286.6	2724.1	3072.9	3503.3
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.3	43.2	26.6	49.3	18.0	22.1	26.6	25.5	28.9	35.0	24.5	23.1	30.1	25.4	19.3	43.2	39.8	39.7	27.8	31.4	30.2	45.0	15.2	15.7	45.7	21.9	53.6	27.0	34.1	26.5	31.0	25.6	24.4	53.1	35.6	26.6	23.2	28.2	29.4	63.2	24.6	16.7	41.9	66.2	43.0	24.6	24.6	46.6	36.7	30.6	28.9	20.4	51.6	53.3	31.9	26.4	56.5	11.8	26.1	29.1	26.3	30.0	35.9	25.8	65.9	22.9	35.8	17.7	40.1	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	50.6	0.0	42.8	46.4	58.5	0.0	0.0	0.0	0.0	54.1	37.3	0.0	0.0	8.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	37.9	0.0	0.0	49.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase, receptor type A"	P18433	20	2864184-3039076	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		21000	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	21.9	18.5	55.6	14.3	48.6	16.4	23.3	44.5	56.0	29.7	19.7	37.5	9.4	14.7	26.3	18.7	22.7	26.5	21.3	14.0	45.9	41.1	22.1	13.5	21.6	16.9	38.0	46.7	28.6	14.9	41.5	23.4	29.0	52.5	23.5	20.0	18.5	16.7	21.8	8.2	21.0	15.3	25.7	52.6	17.9	16.3	27.4	30.4	20.6	32.4	8.5	20.4	22.9	19.2	7.7	5.7	7.9	6.7	6.2	11.0	3.7	21.0	12.9	37.2	11.4	41.2	75.1	7.9	15.8	31.0	19.6	24.1	15.3	29.2	13.8	12.5	21.2	19.8	22.6	15.0	22.6	22.2	21.3	9.6	19.6	5.4	19.4	14.7	19.7	9.3	33.5	23.5	16.2	17.1	24.2	27.1	19.9	19.7	17.7	19.4	8.6	22.7	22.3	14.3	18.9	10.3	17.4	18.0	17.2	16.7	16.3	20.6	19.7	15.3	26.1	23.5	16.9	16.3	16.9	19.4	17.6	8.7	19.5	13.9	13.0	18.0	18.2	8.1	18.7	16.4	7.9	4.8	7.5	11.0	4.8	9.0	7.7	7.4	7.9	3.7	5.1	7.4	9.0	6.0	6.2	6.7	5.7	8.1	3.7	55.6	48.6	44.5	56.0	45.9	41.1	38.0	46.7	52.5	30.4	20.8	16.3	29.4	29.9	14.1	87.6	6.5	45.9	17.4	27.3	43.6	29.5	25.3	23.2	13.3	11.8	26.9	31.5	23.3	13.4	35.4	36.1	29.8	23.0	28.0	33.5	66.7	42.6	43.6	35.2	12.5	55.8	21.8	35.4	10.8	27.0	77.3	13.8	25.8	46.0	19.2	55.1	38.8	26.4	51.2	75.4	15.1	27.3	39.5	26.2	27.6
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	26.6	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	61.5	0.5	0.7	0.0	0.0	35.5	14.5	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	0.0	19.7	0.3	0.0	0.2	0.1	0.1	22.0	20.0	28.2	0.0	21.5	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3	41.7	86.9	266.4	0.7	14.1	0.0	4.1	7.6	21.4	26.1	1.8	0.0	0.4	0.0	0.0	2.0	11.9	0.1	23.3	0.0	0.5	8.9	0.9	232.9	3.0	90.3	0.0	1.2	14.1	338.8	1.5	1.1	290.3	20.3	120.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	6.5	4.3	0.2	0.2	13.2	0.7	539.1	0.5	0.9
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2500000	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.5	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.6	4.8	0.6	0.0	0.0	0.0	0.2	8.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.7	0.0	1.5	2.9	8.7	0.0	2.1	0.0	4.0	0.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5	0.0	2.7	0.0	0.2	0.5	110.1	4.6	25.5	0.0	2.3	5.2	15.7	0.3	0.0	2.5	13.0	0.4	10.1	0.0	0.0	0.1	7.6	1.7	0.0	12.8	1.0	4.8	34.0	1.3	0.6	3.7	14.7	0.0	0.0	0.0	14.3	44.7	0.3	3.5	0.0	22.3	7.4	0.0	3.7	1.1	1.1	0.6	0.2	0.0	5.2	0.0
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	25.1	26.3	30.1	17.1	35.0	36.3	27.0	38.1	35.9	24.0	20.8	28.1	16.5	17.6	27.6	24.5	22.6	29.1	18.3	22.0	24.2	29.7	23.6	20.3	20.4	18.8	22.8	25.5	33.9	21.8	38.1	31.7	31.4	33.1	22.8	24.0	25.8	25.4	23.9	40.7	29.7	22.8	25.9	20.1	19.1	20.6	15.9	22.1	27.9	28.3	15.6	27.1	23.4	24.1	18.9	25.2	27.6	24.8	28.5	27.1	22.0	16.4	22.1	36.0	22.8	28.4	24.6	24.7	19.8	24.2	20.6	23.5	23.2	28.6	19.5	20.9	26.7	12.9	24.3	29.5	21.8	26.7	16.1	25.7	21.0	25.9	27.5	19.9	25.6	20.2	26.2	27.7	27.3	29.0	27.3	28.1	18.6	28.9	18.4	23.5	13.8	25.0	18.5	36.8	20.6	15.5	26.0	24.6	20.7	30.1	25.1	29.8	22.7	27.3	21.2	23.4	41.7	21.4	19.5	29.2	17.2	15.6	22.8	19.6	14.8	13.6	21.5	15.4	19.0	21.7	27.6	24.8	18.5	25.7	23.8	26.3	18.9	23.2	25.0	25.2	18.8	26.6	26.9	14.8	28.5	24.6	14.6	27.1	22.0	30.1	35.0	38.1	35.9	24.2	29.7	22.8	25.5	33.1	22.1	68.5	50.4	39.5	44.5	80.1	52.6	70.4	76.5	18.7	44.3	34.9	74.6	42.5	19.9	36.8	23.3	48.8	36.7	70.0	31.4	36.3	46.0	63.4	17.4	50.5	29.7	31.8	100.5	44.2	71.5	13.3	66.7	39.7	16.9	15.4	66.5	44.7	48.2	31.6	75.7	38.8	56.7	32.3	42.2	36.3	19.1	81.9	65.2	34.6	58.4	78.2
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.4	20.2	4.8	8.5	4.6	7.9	29.5	11.9	5.0	9.1	5.9	22.3	10.1	18.4	13.8	6.5	7.1	19.6	15.8	11.3	5.9	8.1	31.9	18.5	9.8	19.4	12.5	31.7	17.1	8.0	9.2	10.4	8.9	4.4	8.9	12.9	22.9	5.7	5.2	26.8	20.8	28.5	25.3	12.6	30.8	19.9	6.8	19.1	7.4	21.5	13.4	7.5	10.0	13.7	11.0	4.9	15.0	34.3	7.7	7.3	15.6	15.4	17.2	15.6	11.7	21.9	7.5	25.4	10.0	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4	0.0	6.7	10.0	16.1	26.3	5.2	4.5	12.7	4.0	3.4	5.2	21.6	12.0	5.0	9.3	0.6	9.0	4.5	0.0	8.2	14.4	9.6	13.4	16.1	11.3	13.6	0.0	13.8	8.0	7.3	2.0	7.2	8.9	6.8	8.2	17.2	4.6	12.7	7.0	8.9	10.4	9.6	6.5	11.8	16.5	22.1	19.8	7.2	7.5	15.5	13.7
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.2	14.7	13.5	17.2	6.3	11.7	9.8	6.7	7.5	13.9	13.3	17.9	19.4	5.2	9.8	12.2	21.3	10.9	6.8	15.2	10.3	18.4	5.4	10.0	14.3	11.5	5.4	13.6	13.1	8.0	17.1	9.9	12.3	13.5	18.7	9.3	7.2	2.1	12.8	12.3	11.4	26.3	8.4	2.5	12.0	10.1	11.0	5.6	15.3	13.6	8.0	11.2	6.4	9.9	24.0	7.5	8.3	14.2	5.8	6.7	9.6	7.0	10.5	18.8	3.8	18.6	9.7	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3	8.9	8.6	9.0	9.4	11.4	9.1	5.2	15.3	8.1	14.8	5.2	27.5	7.4	5.0	12.3	5.9	7.7	4.2	23.3	23.5	10.6	5.6	7.1	12.7	28.8	7.2	4.8	4.6	7.4	3.2	4.3	7.2	5.4	1.7	3.6	3.9	8.9	13.5	3.5	7.4	14.6	10.4	6.5	11.0	4.6	6.9	10.3	11.7	7.5	6.0	9.3
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in all"	5	"Bipolar cells: 94.1;Horizontal cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA046733: AB_2679777, HPA058233: AB_2683647"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.51e-4)"	8.4	9.3	9.5	12.7	22.3	11.9	9.1	52.7	16.0	14.4	13.6	19.9	5.3	9.6	10.8	7.2	8.7	9.5	8.1	7.4	15.9	8.8	10.3	8.6	9.8	12.0	25.2	8.9	10.5	10.5	10.6	15.1	11.2	17.0	11.9	14.7	10.3	8.8	8.4	7.0	14.7	10.6	9.3	13.8	12.5	11.8	6.3	21.3	18.6	9.8	5.8	11.4	10.7	10.1	6.0	2.9	6.0	4.4	1.1	4.9	0.9	10.7	5.2	13.5	11.5	15.1	11.8	19.1	8.6	7.0	7.7	7.9	16.8	21.0	17.4	13.2	6.6	12.6	7.8	11.7	13.5	12.7	18.0	13.0	12.5	9.6	8.6	11.5	12.5	9.5	8.4	6.7	15.5	11.8	17.3	12.3	9.9	9.5	11.3	13.0	9.0	10.7	12.2	15.9	9.2	6.7	16.9	12.0	11.1	9.4	7.7	15.9	11.1	14.5	14.7	15.6	11.5	11.3	13.9	16.4	13.5	9.3	10.0	16.7	13.0	11.6	15.5	8.8	12.7	13.2	6.0	4.4	2.4	2.8	2.0	2.2	6.0	3.0	3.3	2.9	3.7	4.9	2.7	5.0	1.1	2.6	2.7	2.5	0.9	9.5	22.3	52.7	16.0	15.9	8.8	25.2	8.9	17.0	21.3	8.9	14.8	18.5	12.5	28.3	94.1	10.6	10.2	14.7	17.0	19.2	68.7	11.2	14.9	11.6	1.5	15.3	18.4	23.3	9.6	10.5	16.2	15.6	23.1	7.6	7.8	89.0	31.6	12.9	11.0	2.1	51.8	14.6	10.1	12.6	19.4	22.7	13.1	14.4	36.0	5.8	50.6	25.8	22.6	9.7	17.2	22.6	7.8	17.3	20.4	11.2
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Group enriched"	"Detected in some"	7	"AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.7	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.6	0.1	0.0	0.0	0.0	0.0
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538890-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.6"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 11.3;Spermatocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	3.0	3.8	3.8	1.6	8.2	0.6	3.1	10.1	5.1	10.8	5.1	2.8	8.2	0.9	9.8	5.8	3.3	4.2	3.9	2.6	5.2	4.3	1.8	0.6	3.2	1.0	4.2	2.8	14.2	2.3	26.6	6.9	3.2	5.0	7.9	1.9	5.5	1.9	9.4	18.7	1.5	1.8	7.9	5.2	0.8	2.8	6.0	3.2	0.0	10.1	5.7	1.0	7.6	9.2	0.6	0.2	0.9	0.2	0.3	0.4	0.0	2.8	5.1	8.9	4.7	3.4	7.7	3.7	6.1	6.7	4.8	5.6	3.4	0.0	0.0	1.8	3.9	6.8	0.0	9.1	0.0	6.2	0.0	3.1	1.3	1.4	0.3	4.9	4.9	0.0	4.1	4.7	4.3	0.7	4.9	2.5	0.7	0.1	0.0	7.6	0.1	0.2	0.0	2.4	0.6	2.6	0.0	11.4	0.0	1.5	2.0	4.9	5.8	5.5	0.0	4.2	1.3	1.7	1.5	0.0	12.1	5.5	0.2	7.1	0.1	0.1	25.9	3.8	0.0	2.8	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.0	0.0	0.6	0.3	0.4	0.9	0.3	0.1	0.2	0.1	0.0	3.8	8.2	10.1	2.8	5.2	4.3	4.2	2.8	5.0	3.2	8.9	4.6	0.0	4.1	1.4	4.9	3.9	0.0	2.7	3.4	8.7	0.0	0.9	0.0	0.3	1.7	0.7	0.0	0.0	0.0	0.1	6.6	4.8	0.0	0.0	0.4	0.0	0.0	0.6	0.6	1.9	9.2	0.8	6.8	0.0	0.0	6.3	0.8	0.0	11.3	0.0	3.1	0.0	4.1	10.7	2.1	0.6	0.2	0.0	0.0	0.5
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.0	28.4	22.2	22.8	23.7	6.6	26.1	28.5	26.8	20.8	20.5	23.4	22.1	21.3	18.7	27.9	21.4	24.1	21.6	15.0	18.7	22.9	19.1	17.4	17.2	26.7	22.2	19.4	32.5	17.5	37.7	31.0	18.4	21.3	24.5	17.9	21.3	25.3	32.6	16.4	25.0	22.5	18.3	22.1	26.4	19.1	15.7	22.1	30.9	35.5	12.9	30.1	20.3	21.8	8.9	4.3	10.5	8.2	6.3	12.8	5.7	12.9	9.2	19.6	17.3	19.8	9.7	18.0	8.1	11.0	12.9	11.1	12.3	16.3	16.3	12.9	9.4	14.0	17.7	17.0	11.3	8.5	16.1	12.1	13.0	15.0	10.9	9.2	11.9	11.6	8.0	16.4	11.6	9.8	14.7	7.9	25.0	17.0	27.8	12.1	19.8	16.4	13.9	20.9	26.1	16.6	18.6	12.5	25.7	13.1	12.3	23.6	35.1	12.8	23.4	16.1	19.9	28.7	21.5	6.6	11.5	17.4	12.4	11.7	27.6	24.4	17.4	9.6	15.2	15.2	2.4	3.9	10.5	9.0	6.8	11.6	7.5	11.5	11.9	4.3	8.9	12.8	9.6	4.0	6.3	8.2	4.2	6.0	5.7	22.2	23.7	28.5	26.8	18.7	22.9	22.2	19.4	21.3	22.1	8.9	8.2	8.4	3.2	4.8	10.2	4.2	5.1	1.4	6.8	12.2	2.0	12.8	16.6	5.0	2.7	6.8	7.0	0.0	5.1	10.1	5.3	4.2	0.0	7.8	5.5	20.6	5.2	6.7	6.9	1.8	8.3	3.9	5.0	4.6	9.7	9.8	8.0	8.6	8.5	7.6	6.1	6.5	6.6	4.1	10.9	4.5	9.7	11.7	9.5	2.8
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977054	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.4;lymphoid tissue: 23.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.4;T-cells: 33.4"	"Cell line enriched"	"Detected in some"	6	"U-698: 33.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	4.0	0.6	0.5	20.1	0.5	3.9	2.1	0.4	0.4	2.0	2.7	0.2	0.3	1.2	2.2	1.4	1.7	1.6	3.2	1.2	0.6	0.5	1.8	2.6	11.7	18.8	0.7	0.0	1.6	0.8	0.0	0.8	1.7	0.4	2.6	1.8	1.2	3.4	1.2	0.7	0.9	7.8	0.4	1.3	20.7	2.0	1.0	0.0	6.6	2.5	1.9	23.3	5.7	1.6	4.9	0.1	1.2	0.1	11.4	33.4	6.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	33.1	0.0	5.1	0.0	0.4	0.1	0.1	33.4	0.1	19.1	4.9	14.2	25.2	0.1	2.4	4.8	16.0	1.2	11.4	0.1	0.1	21.0	6.0	0.5	0.5	0.4	0.4	0.6	0.5	0.7	0.0	0.4	0.0	11.9	3.2	9.5	0.7	0.3	0.2	0.3	0.0	9.4	3.4	3.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.4	2.3	1.3	2.1	0.0	0.0	3.1	4.3	0.0	0.0	1.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.1	0.5	0.1	126.8	0.0	0.3
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32893178-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	10.8	8.3	13.6	9.1	11.3	8.3	22.0	21.3	14.9	13.1	8.7	9.8	9.5	5.4	13.8	13.1	15.9	11.2	8.9	10.0	12.5	7.1	9.3	9.5	9.1	8.2	13.1	10.9	21.4	15.6	16.5	11.4	9.0	11.5	11.5	9.2	10.9	16.7	9.7	9.8	20.1	7.9	10.4	11.5	10.1	9.3	14.2	12.8	14.2	14.2	14.0	10.1	11.8	24.8	2.0	2.2	0.3	2.4	1.7	1.1	0.4	11.4	14.2	16.6	15.3	6.5	12.6	8.0	10.0	9.0	7.3	9.0	12.3	5.4	12.0	6.5	12.1	12.2	14.9	15.2	9.0	15.6	5.1	9.8	11.2	13.7	10.2	4.9	13.5	6.1	6.1	9.6	9.3	15.1	8.9	10.0	7.0	17.1	5.4	11.4	10.2	6.5	5.4	17.6	7.1	8.7	10.8	32.8	5.0	7.5	12.6	8.7	12.4	18.9	10.1	6.3	12.8	10.4	7.1	9.8	17.8	17.9	31.9	21.4	3.7	5.0	12.6	11.5	6.4	11.4	0.0	1.2	0.3	1.1	2.4	0.5	2.0	0.7	1.0	1.1	0.9	0.6	0.7	0.0	1.7	0.6	2.2	0.2	0.4	13.6	11.3	21.3	14.9	12.5	7.1	13.1	10.9	11.5	12.8	17.9	12.0	7.3	8.6	24.7	16.5	26.8	12.7	13.4	19.4	7.0	13.7	10.6	3.3	8.1	11.1	13.5	4.2	0.0	10.3	10.6	16.9	9.2	3.5	9.0	12.2	9.5	0.0	13.5	16.4	7.6	22.7	13.3	15.1	1.8	11.0	11.8	10.0	11.6	19.8	6.9	14.1	6.5	12.0	19.7	19.1	24.1	3.5	4.3	10.4	11.1
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.0	17.1	14.2	18.8	8.0	9.8	17.9	8.9	10.0	17.5	16.1	12.7	15.3	10.8	14.8	12.0	32.2	22.8	16.8	12.9	14.2	15.9	8.4	5.8	28.3	14.0	11.4	17.2	8.9	7.8	13.2	17.3	21.1	7.7	12.8	11.4	14.0	29.3	9.2	11.9	6.3	11.5	16.8	21.2	10.9	11.8	18.5	17.7	6.0	6.3	15.2	11.5	14.1	11.2	7.5	9.7	8.0	10.1	7.3	21.3	15.4	17.4	20.3	10.4	13.8	23.8	14.2	9.1	19.8	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1	8.9	6.4	6.9	2.5	5.0	16.1	3.1	0.0	8.1	5.7	5.2	17.7	1.2	1.7	3.3	4.9	7.0	1.1	0.0	3.4	2.5	4.7	4.8	1.1	3.4	2.0	4.8	15.6	2.5	4.8	4.7	5.5	2.7	0.0	1.0	4.9	2.8	3.5	0.0	6.7	1.9	8.2	6.5	5.7	16.8	26.4	10.0	0.8	3.1	3.4	3.3
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	17.1	13.9	8.7	12.4	10.4	13.3	14.1	6.4	10.3	11.0	11.2	14.9	7.9	10.4	16.1	9.2	13.7	13.1	13.6	7.5	6.7	6.7	15.8	15.7	12.2	14.9	11.0	7.6	12.6	15.3	10.7	16.9	11.6	9.4	11.2	12.5	17.7	11.8	9.8	7.5	12.4	12.9	10.8	11.3	19.9	10.7	14.1	10.0	17.3	13.2	10.9	21.6	11.6	10.9	13.9	15.8	5.3	12.9	6.4	6.6	5.0	13.4	14.0	11.7	12.9	5.2	6.4	11.1	7.1	4.5	12.1	11.2	13.3	9.8	25.1	10.4	6.5	14.5	13.5	22.7	10.7	16.0	4.7	10.2	11.3	8.4	9.4	7.4	20.4	10.6	5.0	9.7	11.0	15.7	4.9	12.5	11.7	11.8	9.0	6.8	10.7	17.1	8.0	22.4	19.2	15.4	15.5	8.2	13.5	9.5	9.3	16.0	7.6	10.3	10.2	13.0	10.2	11.3	10.4	8.2	10.6	11.6	4.1	13.7	6.4	9.2	35.1	9.3	15.2	21.3	0.3	12.4	2.9	5.6	12.9	5.3	13.9	4.8	5.5	15.8	9.5	6.6	5.3	5.3	6.4	9.1	6.6	5.9	5.0	8.7	10.4	6.4	10.3	6.7	6.7	11.0	7.6	9.4	10.0	17.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	8.1	19.4	3.5	0.0	9.4	1.7	13.8	0.0	0.0	0.0	0.0	10.8	8.6	0.0	0.0	14.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	14.4	0.0	0.0	12.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	14.8	14.2	21.4	14.8	20.9	18.4	24.6	16.5	36.3	13.9	18.4	26.0	14.8	14.5	16.4	18.2	12.5	17.9	16.4	23.8	21.5	16.9	13.2	16.6	18.8	15.9	30.1	16.3	22.1	50.3	16.0	14.7	10.4	20.7	14.8	12.0	15.3	24.8	20.7	36.6	16.3	14.4	18.3	33.7	13.0	16.9	17.4	21.4	15.8	13.6	14.7	13.9	12.9	12.6	28.5	29.7	41.6	27.1	29.7	36.5	25.7	21.2	26.7	21.5	20.8	9.2	12.5	14.6	14.0	13.6	24.1	17.6	18.5	10.0	21.5	15.0	17.3	16.5	16.0	22.6	26.2	16.3	13.7	22.2	20.0	18.4	15.5	21.8	13.6	15.0	14.8	20.8	20.6	9.7	17.8	18.4	24.4	23.1	18.2	14.1	17.4	30.7	22.8	17.1	23.0	19.5	21.0	26.2	12.8	11.5	23.4	27.5	23.7	16.0	19.1	22.9	15.4	17.4	16.4	15.6	22.2	18.5	18.4	28.6	13.4	11.9	22.1	17.2	19.1	27.4	17.8	27.1	41.6	36.5	22.6	31.5	28.5	29.6	30.4	29.7	21.0	23.2	26.6	16.6	29.7	24.2	27.7	30.5	25.7	21.4	20.9	16.5	36.3	21.5	16.9	30.1	16.3	20.7	21.4	23.8	14.3	5.2	14.0	13.3	22.4	21.3	17.8	24.1	10.3	5.2	25.5	16.1	48.0	25.7	28.8	17.9	24.9	0.0	43.9	18.7	27.2	9.6	22.0	17.3	25.7	17.5	18.4	12.9	13.7	72.6	16.4	14.0	20.3	15.4	21.3	35.2	32.4	19.2	20.5	24.7	93.2	12.9	29.3	43.5	32.0	14.2	6.4	20.0	22.8	9.9
R3HCC1L	"C10orf28, GIDRP86, PSORT"	ENSG00000166024	"R3H domain and coiled-coil containing 1 like"	Q7Z5L2	10	98134624-98244897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037367	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA037367: AB_10696930"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-2)"	14.5	8.2	9.5	14.9	12.9	19.1	13.0	16.4	11.4	11.1	12.9	8.9	10.3	8.0	11.4	13.0	12.0	8.0	7.7	8.1	10.2	6.2	9.6	10.8	10.9	13.8	11.9	5.4	9.3	10.1	15.6	20.7	14.4	11.8	13.7	13.1	12.9	12.0	9.5	10.0	14.1	15.0	10.1	16.7	13.2	9.4	25.2	12.5	17.1	11.0	6.9	15.7	11.5	16.0	10.2	6.0	18.6	12.9	10.2	13.9	5.5	10.6	7.0	10.7	9.4	9.2	9.8	8.9	12.1	16.9	11.9	13.2	9.5	7.7	15.1	6.5	7.2	6.7	12.2	10.7	7.3	13.5	11.3	7.3	8.9	5.5	10.6	11.3	12.1	10.9	8.9	8.4	10.4	15.5	10.5	7.6	9.5	7.7	9.4	9.2	10.2	9.5	12.6	7.7	5.1	9.2	9.8	12.2	6.1	8.6	6.3	3.7	7.9	6.2	4.6	23.6	14.3	8.3	7.7	8.4	8.0	8.5	8.9	9.0	9.6	10.1	25.8	11.4	12.7	5.8	10.7	6.9	18.6	9.9	9.4	8.8	10.2	10.2	10.0	5.3	9.5	9.0	8.8	8.5	10.2	12.9	6.0	13.9	5.5	9.5	12.9	16.4	11.4	10.2	6.2	11.9	5.4	11.8	12.5	14.9	13.7	6.5	4.8	3.0	6.2	7.7	10.2	17.4	7.9	7.0	5.9	7.9	5.0	6.5	18.2	6.2	10.2	0.0	6.0	8.3	4.5	5.3	16.2	3.9	6.2	4.8	5.8	3.1	9.8	9.4	4.9	9.1	11.8	10.0	10.6	6.2	7.5	5.8	5.3	2.9	13.3	0.0	5.1	40.0	22.6	3.3	10.9	7.5	7.6	7.1
R3HDM1	"KIAA0029, R3HDM"	ENSG00000048991	"R3H domain containing 1"	Q15032	2	135531455-135725270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030936			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA030936: AB_10670835"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (5.83e-7)"	"unprognostic (1.16e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.47e-1)"	6.5	6.4	23.2	8.3	27.8	13.4	5.3	22.2	57.6	6.7	7.5	4.5	2.4	4.5	6.9	6.6	6.2	5.5	6.3	5.3	17.9	15.5	6.0	6.2	5.0	11.0	11.5	32.7	5.3	8.4	20.1	13.2	4.2	7.7	5.4	10.3	4.3	4.3	6.1	13.5	5.3	5.6	8.6	7.9	6.6	5.4	14.3	7.6	14.2	8.7	3.6	13.2	8.4	4.3	6.5	12.7	3.5	8.4	9.6	9.6	5.0	20.2	12.5	17.7	20.4	9.5	13.0	10.4	12.7	13.4	12.9	14.1	22.3	14.1	32.2	10.2	18.1	9.4	9.2	23.0	23.7	22.6	20.2	11.6	26.0	15.9	22.2	11.4	22.1	16.8	12.2	10.6	22.6	29.1	11.7	20.6	35.2	26.8	27.7	14.7	20.9	38.3	15.2	13.6	15.2	14.7	22.8	12.2	19.3	12.8	17.9	18.1	14.1	20.5	8.4	9.2	16.1	11.3	11.9	15.0	11.9	11.9	15.0	16.0	22.2	30.4	30.3	13.5	18.2	15.2	3.5	7.8	3.0	6.1	8.4	5.8	6.5	6.6	9.1	11.2	4.4	6.4	7.2	1.0	9.6	7.1	12.7	9.6	5.0	23.2	27.8	22.2	57.6	17.9	15.5	11.5	32.7	7.7	7.6	6.0	1.9	14.1	5.9	7.0	44.7	14.0	12.7	4.0	18.2	7.0	19.6	6.4	16.6	7.5	37.1	12.0	3.8	23.3	6.5	8.3	7.5	7.5	17.4	10.2	10.6	25.4	22.0	13.5	20.0	33.7	12.7	14.2	6.8	10.8	9.7	8.7	7.2	3.5	10.6	9.0	38.8	0.0	8.6	22.3	25.1	8.4	2.6	13.8	10.3	5.2
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 93.1"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 93.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	15.4	11.7	23.3	33.2	19.5	57.7	15.4	12.7	26.6	15.9	16.5	16.3	10.0	17.1	15.3	13.2	33.0	15.7	20.1	12.5	20.2	11.9	18.8	24.1	22.7	43.3	14.8	11.9	19.2	34.9	10.0	16.2	18.5	12.8	17.7	12.6	15.5	24.2	14.5	21.6	22.4	18.0	13.4	10.3	41.1	24.1	8.1	12.5	31.9	14.6	19.6	43.0	20.6	19.0	6.4	2.2	93.1	2.0	1.2	7.7	3.8	17.8	10.5	11.2	15.2	7.1	12.7	18.5	12.2	9.7	12.3	10.9	11.1	15.4	13.0	10.1	13.7	2.6	16.4	6.5	14.4	5.6	19.8	13.7	17.8	9.2	19.4	21.5	9.7	31.6	16.8	27.9	7.9	16.8	11.3	14.1	15.5	32.9	26.5	11.4	32.0	13.9	18.7	14.5	21.8	17.3	13.7	5.4	24.6	20.3	18.8	19.8	19.2	10.7	23.7	19.9	9.0	20.9	23.6	14.2	22.5	12.5	26.1	12.0	29.5	15.4	18.9	14.3	14.1	19.5	14.6	2.0	16.2	2.5	1.5	3.9	6.4	5.0	3.4	2.2	3.8	4.8	3.3	93.1	1.2	2.0	0.9	7.7	3.8	23.3	19.5	12.7	26.6	20.2	11.9	14.8	11.9	12.8	12.5	17.9	28.7	41.0	33.3	31.1	15.9	6.0	20.4	12.0	13.6	17.4	7.9	34.5	6.6	39.6	0.9	18.0	18.6	23.3	47.7	40.0	23.1	40.7	23.1	10.5	23.7	27.0	31.4	12.9	21.9	1.7	10.3	25.3	23.6	54.1	28.0	6.0	48.9	26.9	11.0	13.6	10.4	25.8	23.1	0.7	3.9	27.7	57.7	29.8	20.7	65.5
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046603	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.8	7.1	11.8	6.4	21.6	12.0	7.2	13.3	19.9	11.4	9.7	7.9	19.0	3.8	23.0	29.8	6.8	12.9	8.6	7.2	10.5	7.1	12.8	5.6	7.7	8.5	8.0	12.9	10.7	7.0	8.6	6.6	8.3	11.5	12.7	5.3	6.9	6.2	27.2	6.5	6.3	6.7	20.0	7.5	7.7	15.5	8.6	8.8	10.0	11.8	3.8	5.6	10.5	13.7	2.3	2.6	1.9	1.2	0.9	2.3	0.4	5.2	6.8	5.7	7.2	9.5	12.2	6.1	10.6	12.3	6.5	6.8	5.5	5.7	10.9	8.5	10.7	4.8	3.7	7.9	4.6	10.1	2.8	8.3	3.9	7.0	3.8	13.8	7.2	4.3	11.9	8.9	9.2	20.3	8.7	4.0	7.1	2.8	9.4	8.4	1.9	5.4	5.4	4.8	2.4	4.8	4.8	20.2	3.6	9.7	4.2	1.3	10.6	7.4	3.0	12.9	7.2	2.3	6.8	5.8	8.8	7.1	10.3	10.4	6.8	5.7	7.1	9.0	12.4	5.4	1.5	1.2	1.4	1.5	0.8	1.4	2.2	1.2	1.5	0.6	2.3	2.3	1.3	1.9	0.9	0.7	2.6	0.6	0.4	11.8	21.6	13.3	19.9	10.5	7.1	8.0	12.9	11.5	8.8	53.6	29.8	9.1	7.7	9.2	29.2	23.6	22.9	6.7	6.8	40.1	27.5	9.0	6.6	10.6	13.5	12.8	4.1	0.0	16.2	7.0	22.4	9.2	3.5	7.7	9.7	36.5	13.9	11.6	25.1	5.0	31.1	14.4	21.9	10.0	6.4	24.9	16.4	5.9	26.9	15.6	29.1	25.8	19.8	10.9	20.9	8.3	4.3	8.6	5.8	5.4
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052265-135176394	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	24.1	18.4	22.1	20.8	32.9	27.3	21.8	27.1	37.2	25.1	24.0	21.2	20.0	15.7	42.2	27.0	26.1	20.1	18.3	28.4	21.4	29.1	20.1	16.9	18.6	19.7	24.5	28.1	31.3	29.4	31.7	50.0	33.0	34.5	26.0	24.0	23.2	37.3	25.4	37.4	25.1	19.4	26.4	26.0	17.5	22.7	19.6	21.3	28.8	26.2	20.9	24.6	25.2	24.8	9.1	5.4	9.3	7.1	3.6	10.7	2.4	19.6	8.0	14.2	11.6	27.9	23.8	13.1	30.3	25.0	24.1	23.9	17.7	16.2	29.3	18.8	30.9	9.2	16.7	14.9	27.9	29.5	13.9	15.1	14.5	10.2	15.4	19.5	17.9	15.9	20.7	37.0	22.1	40.2	21.8	17.4	13.4	18.8	17.1	21.9	11.6	9.1	7.0	10.8	11.9	13.5	15.8	18.2	12.2	14.2	17.6	11.4	9.0	20.5	12.3	14.3	12.9	10.8	13.1	20.9	24.5	18.7	10.5	12.6	12.2	6.8	22.1	16.0	10.9	13.6	9.3	5.0	7.6	2.0	6.7	1.8	7.0	5.0	2.8	5.4	9.1	10.7	5.3	2.0	3.6	7.1	2.9	6.5	2.4	22.1	32.9	27.1	37.2	21.4	29.1	24.5	28.1	34.5	21.3	23.8	26.1	28.6	33.7	26.9	27.2	50.9	43.3	33.5	35.2	29.6	47.1	19.8	10.0	18.0	25.6	25.5	29.6	23.3	23.1	14.0	23.7	41.6	45.1	21.5	19.7	28.6	33.3	27.0	20.9	19.3	28.4	29.1	21.9	17.2	33.0	18.1	30.5	20.1	33.6	17.0	32.0	45.3	27.8	34.5	21.1	26.0	32.7	11.4	20.3	42.6
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947079-19985175	"Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		920000	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	25.8	21.2	42.5	19.3	34.7	26.5	25.5	25.2	36.6	24.8	21.9	26.0	18.1	21.6	17.5	33.4	32.4	16.3	24.7	28.3	38.4	38.0	25.5	31.3	22.5	16.3	43.5	33.8	16.2	21.9	39.2	23.8	36.1	35.1	24.0	23.4	16.2	25.4	23.3	35.8	27.2	21.6	21.2	49.1	17.0	23.6	15.7	30.3	22.7	31.4	22.2	20.8	23.7	23.7	5.0	11.2	22.7	14.8	12.5	7.0	6.8	11.6	10.7	15.7	10.8	27.6	24.6	16.0	20.6	24.2	19.7	22.8	12.6	18.6	8.6	12.5	22.6	11.5	7.4	11.7	15.3	23.1	14.8	9.7	12.5	10.4	12.2	34.6	17.4	15.8	22.5	29.1	23.0	33.9	24.8	24.8	11.5	14.3	13.9	23.5	18.0	13.5	12.5	19.7	16.2	17.3	10.1	11.1	12.5	40.2	15.5	4.9	16.3	14.7	18.5	23.7	24.5	14.4	14.2	24.6	14.4	12.5	18.2	17.4	17.2	28.2	11.4	22.9	16.0	23.3	15.1	11.4	18.7	5.3	12.1	7.0	5.0	6.3	6.4	11.2	3.5	5.9	5.4	22.7	12.5	14.8	7.4	6.6	6.8	42.5	34.7	25.2	36.6	38.4	38.0	43.5	33.8	35.1	30.3	56.6	39.7	36.6	109.3	151.1	33.1	53.1	22.9	46.8	40.9	40.1	29.5	67.4	87.9	48.7	14.5	60.9	53.0	23.3	40.0	57.3	76.1	98.0	84.2	36.4	48.3	14.3	59.4	39.3	42.9	12.4	33.9	55.8	79.2	41.5	43.4	64.7	48.5	38.6	33.2	49.4	31.1	51.8	76.2	19.5	25.5	164.4	137.4	44.9	37.0	131.9
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111629-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Supported	"Nucleoplasm,Plasma membrane"		No	No		16000000	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	23.4	22.8	15.6	24.5	14.1	32.5	15.9	16.6	13.6	18.2	23.1	18.5	15.0	37.6	17.2	11.8	22.9	18.0	17.1	10.6	13.6	11.2	24.8	57.8	19.3	24.9	14.2	8.4	23.3	24.7	8.8	15.5	30.9	13.6	16.3	20.1	16.5	27.4	14.7	5.2	22.3	56.2	14.1	16.7	43.4	20.1	15.9	14.7	33.4	18.5	12.7	36.1	19.7	17.9	34.3	45.4	55.2	81.1	39.0	31.8	75.5	29.0	19.6	16.2	13.6	13.2	11.7	25.4	17.7	15.3	23.6	24.8	22.4	33.6	20.1	20.2	17.3	20.6	19.3	21.7	21.8	15.0	41.2	12.7	42.1	18.3	23.0	15.1	36.5	42.0	12.1	11.3	22.2	9.7	12.7	19.3	20.7	19.5	30.7	18.7	33.5	30.4	32.0	20.3	34.9	31.6	34.6	17.8	35.6	17.4	22.3	15.0	14.8	17.9	21.2	11.2	10.9	17.2	13.6	19.1	19.8	12.9	38.6	30.1	16.7	34.3	30.3	19.1	36.5	21.4	36.0	50.6	55.2	31.8	69.8	28.4	34.3	28.4	28.6	45.4	31.8	22.5	26.5	53.8	39.0	81.1	32.5	26.6	75.5	15.6	14.1	16.6	13.6	13.6	11.2	14.2	8.4	13.6	14.7	23.8	26.1	58.8	41.8	42.4	14.1	2.8	17.8	45.5	23.9	29.6	13.7	78.7	69.6	59.2	24.1	29.5	105.7	0.0	45.1	81.2	38.0	31.1	46.3	44.5	79.7	6.4	29.1	23.9	36.3	12.6	25.6	79.9	32.1	147.9	48.7	29.6	58.4	77.2	23.3	44.7	12.2	32.3	24.7	24.4	19.0	45.9	66.6	64.7	40.4	32.5
RAB8B		ENSG00000166128	"RAB8B, member RAS oncogene family"	Q92930	15	63189469-63267782	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 177.9;Late spermatids: 271.9;monocytes: 180.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074534			Supported	Nucleoplasm,Vesicles		NA	NA		5200000	Vesicles	Nucleoplasm	"HPA074534: AB_2686700"	"unprognostic (7.67e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.47e-2)"	21.8	12.1	15.2	20.9	12.9	50.8	22.6	10.1	12.2	15.8	17.7	11.8	7.6	13.6	14.2	8.6	10.9	12.7	18.4	17.5	19.2	14.4	13.7	11.4	27.7	30.8	15.3	12.9	25.2	5.7	6.6	11.7	22.0	16.9	14.3	9.0	9.8	9.3	11.3	7.5	8.2	21.1	14.3	19.5	33.7	9.8	11.8	11.5	38.8	16.4	4.7	27.8	24.4	23.7	10.7	10.4	30.8	14.5	13.1	19.2	14.3	4.8	4.1	15.7	6.5	30.0	24.8	4.7	4.8	11.0	8.7	17.1	4.4	3.9	13.2	4.4	10.3	10.5	2.4	13.5	6.5	14.7	19.8	2.6	16.6	3.7	2.8	28.0	6.2	10.5	14.9	3.4	16.4	9.6	11.3	22.0	13.8	6.5	12.8	15.9	3.2	10.1	3.4	9.8	4.5	4.0	8.7	21.0	1.9	6.9	22.9	1.3	3.3	7.3	0.9	13.4	10.5	3.5	6.3	24.8	16.3	10.5	8.6	6.4	8.3	8.2	12.5	10.4	17.7	44.1	27.1	14.5	11.9	15.8	13.1	14.4	10.7	12.8	15.0	10.4	10.6	10.0	12.2	30.8	13.1	11.6	1.3	19.2	14.3	15.2	12.9	10.1	12.0	19.2	14.4	15.3	12.9	16.9	11.5	17.9	20.2	18.8	6.9	27.6	1.9	3.1	12.7	8.1	7.9	7.0	11.8	10.5	10.0	19.1	177.9	29.2	2.4	0.0	11.5	84.9	38.5	11.2	38.1	5.5	47.2	19.1	10.3	34.4	65.8	271.9	29.4	57.9	33.7	180.3	4.1	12.8	27.6	0.0	35.7	18.6	12.1	19.4	19.5	43.7	15.9	19.6	31.2	66.1	3.0	20.9
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689125-13710506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 563.5;Syncytiotrophoblasts: 309.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	17.1	36.0	17.7	20.3	17.1	30.6	48.4	16.2	24.1	14.8	17.6	20.2	19.7	9.3	18.8	14.3	19.7	11.9	14.5	23.1	16.9	14.3	19.6	15.6	17.3	21.0	24.7	13.8	18.9	23.6	19.1	11.3	17.8	18.1	13.5	16.2	8.0	22.8	17.6	12.0	21.2	12.3	15.3	25.5	15.1	14.2	6.4	23.4	9.8	16.8	13.2	19.3	16.1	19.7	13.1	19.1	17.7	25.7	19.8	27.3	13.9	12.5	6.7	8.6	20.4	29.0	23.2	7.7	7.0	24.7	10.8	15.7	7.2	14.0	11.4	17.4	11.0	25.8	12.9	12.8	14.9	10.6	25.1	19.9	3.6	14.8	8.2	17.4	6.3	9.8	24.9	26.4	13.5	14.6	17.4	9.9	6.4	6.9	16.8	11.5	8.6	5.9	10.3	9.3	8.7	12.7	8.2	9.1	33.9	29.5	11.6	7.1	5.0	14.9	21.2	24.2	22.5	11.7	6.7	7.7	8.2	4.3	29.0	4.2	13.4	23.2	4.5	8.2	5.5	8.0	17.7	25.7	11.1	27.3	16.6	21.1	13.1	15.0	22.4	17.6	10.0	11.3	19.4	15.3	19.8	14.5	19.1	11.7	13.9	17.7	17.1	16.2	24.1	16.9	14.3	24.7	13.8	18.1	23.4	44.7	26.4	18.5	59.6	57.6	9.0	13.8	43.3	33.5	26.1	31.4	0.0	70.1	68.0	112.1	0.4	21.5	28.9	0.0	55.4	48.9	36.8	75.0	44.9	17.8	51.1	14.3	23.5	13.5	35.6	1.1	34.8	34.0	54.0	563.5	26.2	40.0	73.2	70.2	37.8	51.9	8.8	12.9	28.8	5.9	19.0	72.9	309.7	49.6	23.6	72.2
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236909-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 2715.9;Exocrine glandular cells: 2901.4;Extravillous trophoblasts: 3765.3;Pancreatic endocrine cells: 2156.8;Syncytiotrophoblasts: 2681.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		130000	"Nucleoplasm, Cytosol"		"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	100.5	72.1	32.2	92.0	32.8	74.9	185.3	45.0	34.3	102.3	85.7	36.2	66.0	43.0	86.0	82.9	128.1	98.3	81.8	102.5	29.8	29.2	80.6	113.7	95.7	223.3	38.2	27.6	189.2	330.4	48.8	68.3	72.3	31.8	102.6	61.2	57.8	119.7	66.9	133.8	115.5	72.1	92.8	37.6	107.8	70.5	52.9	32.4	197.4	115.4	117.0	141.8	99.7	113.5	92.9	69.4	19.2	50.8	47.1	81.4	138.7	67.0	57.2	87.0	108.8	133.7	245.8	87.9	60.5	165.0	142.1	143.6	122.8	59.5	136.9	79.3	105.0	94.1	46.4	99.3	336.3	105.2	136.1	107.1	46.7	63.3	61.2	167.3	107.4	47.4	235.1	181.3	106.8	148.8	152.4	144.4	142.6	61.8	100.6	109.0	104.1	106.1	69.1	60.6	79.0	51.9	82.9	53.9	114.2	150.1	64.3	72.4	85.3	30.9	103.3	152.3	58.0	70.5	93.7	76.1	49.3	45.0	43.4	91.4	75.5	108.6	85.3	47.3	83.9	50.2	19.2	50.8	16.3	45.9	43.6	69.5	91.9	70.3	53.8	69.4	92.9	81.4	65.2	7.8	47.1	37.1	53.3	68.6	138.7	32.2	32.8	45.0	34.3	29.8	29.2	38.2	27.6	31.8	32.4	536.0	821.6	0.0	0.0	0.0	0.0	0.0	0.0	465.7	831.4	472.8	0.0	2715.9	1482.2	1555.6	0.0	0.0	0.0	0.0	2901.4	3765.3	0.0	0.0	618.5	0.0	1726.4	0.0	0.0	0.0	0.0	0.0	0.0	340.2	0.0	2040.6	0.0	0.0	2156.8	0.0	0.0	2023.5	0.0	0.0	0.0	0.0	0.0	0.0	2681.1	0.0	0.0	0.0
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905264-34918989	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.1	6.5	3.4	3.2	4.9	4.8	4.4	5.2	4.7	5.4	3.2			2.9	4.6	3.8	3.7	3.5	3.3	6.6	3.5	4.4	3.7	3.5	5.6	6.1	2.9		4.0	3.3	3.0	3.4	6.0		5.3	3.1		4.3	3.7	7.4	4.5	3.6	3.3	2.6	3.1	3.7	5.8			5.2		4.7	3.8	4.7	9.4	7.6	7.2	3.1	4.8	9.3	2.6	5.8	6.8	7.3	14.0	5.1	6.0	10.4	9.2	9.0	9.7	8.0	6.4	8.0	15.2	3.3	8.2	11.7	5.4	8.0	5.6	10.9	6.8	6.8	8.1	20.7	4.4	8.8	11.1	7.5	5.3	4.8	10.6	7.1	3.6	4.7	6.6	14.4	9.1	8.2	7.3	11.3	7.9	9.5	3.8	10.3	10.4	15.2	5.3	4.7	6.2	7.5	7.9	19.0	13.0	8.5	5.3	8.0	9.3	4.2	12.7	9.7	6.5	9.6	5.0	9.1	13.4	6.6	16.8	8.8	7.2	3.0	6.8	5.9	3.1	7.7	8.7	6.5	8.0	2.9	9.4	9.3	8.0	2.3	4.8	2.9	7.6	5.3	2.6											20.8	39.2	16.0	18.1	26.0	22.1	20.7	15.3	9.4	13.6	19.2	25.5	69.8	16.6	14.1	15.1	14.1	9.5	23.3	19.5	44.4	23.7	18.0	20.8	12.1	20.7	22.3	12.6	9.2	13.2	11.8	23.3	15.3	16.9	10.0	11.0	18.9	14.2	10.5	20.5	13.2	33.2	12.9	19.1	59.4	59.0	25.0	67.4	26.3	11.2	19.7
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.9	9.4	7.9	4.7	2.0	4.2	9.7	15.8	5.4	15.2	10.5	8.6	6.4	12.3	3.0	8.9	8.9	3.5	8.3	8.2	15.6	7.6	10.5	10.4	9.5	5.1	1.2	13.7	9.0	1.6	3.0	15.0	10.2	4.1	4.9	10.5	11.1	12.2	13.3	11.5	13.9	9.8	11.0	7.9	17.4	11.1	8.8	9.7	4.4	7.7	3.3	7.5	7.0	6.8	5.1	6.5	7.0	6.1	4.0	12.7	6.9	10.7	13.5	6.2	9.4	26.7	9.3	15.3	9.3	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8	14.9	9.8	8.2	5.8	9.8	5.1	2.0	5.1	4.0	9.1	3.5	2.0	6.6	1.7	6.5	3.3	4.2	3.8	0.0	7.1	10.7	4.3	7.0	12.8	2.9	5.9	3.2	1.7	4.9	3.7	2.1	3.7	4.6	3.3	7.2	5.0	2.8	7.9	5.8	2.5	2.4	2.2	6.5	4.7	15.5	13.6	10.3	5.6	4.6	5.2	2.7
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3100000	Nucleoplasm	Cytosol	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.6	11.7	13.6	14.0	22.6	26.0	22.8	15.5	31.2	36.9	33.6	13.1	22.9	27.0	35.8	23.3	24.9	24.6	18.6	32.2	14.0	38.1	23.6	10.9	15.2	12.6	44.1	23.5	32.0	26.5	48.4	26.6	51.0	22.0	25.3	42.9	27.9	24.9	33.2	31.0	29.2	29.1	18.6	28.7	29.1	15.5	14.1	43.9	28.7	12.7	25.2	19.8	17.2	31.3	34.3	10.4	24.4	40.8	19.8	53.1	14.2	63.0	47.3	36.0	30.2	19.7	43.7	44.5	43.6	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5	80.4	45.1	117.4	151.7	107.0	47.8	58.9	99.3	85.6	69.4	52.4	19.6	181.0	140.9	124.8	141.7	106.7	99.7	397.1	165.8	204.0	114.4	158.2	108.6	79.1	154.6	49.3	83.8	66.9	72.2	22.4	109.6	119.4	135.0	233.6	105.8	52.4	156.1	119.3	107.1	115.4	44.7	109.9	155.2	223.5	168.2	128.1	204.7	114.9	143.0	156.7
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332194	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Late spermatids: 940.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		8200000	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	41.0	30.1	21.9	23.5	24.5	37.0	28.9	33.3	28.1	28.9	31.4	18.4	28.2	21.8	27.0	38.0	45.3	22.6	24.1	45.5	22.2	23.0	29.7	82.0	27.7	20.7	20.8	23.3	31.6	45.9	21.0	24.8	66.1	25.6	31.1	25.9	17.3	28.7	25.8	98.2	38.2	29.1	29.4	22.6	29.8	23.0	38.5	18.6	32.8	30.4	34.0	27.1	42.1	32.6	5.2	2.5	7.1	2.7	5.0	4.9	1.2	32.4	29.0	41.0	26.3	28.2	44.8	46.3	50.5	41.6	44.9	30.9	47.9	35.6	45.6	20.5	55.1	40.8	45.7	56.5	44.9	45.5	31.0	18.5	23.7	30.5	36.6	37.6	42.4	20.4	37.5	42.0	43.0	64.9	35.8	31.2	20.3	38.2	34.4	40.5	53.1	41.3	21.6	43.6	58.0	33.8	30.9	53.8	21.6	38.6	30.8	37.5	25.4	34.9	49.4	31.0	64.7	50.4	17.4	28.6	33.6	33.0	41.4	37.7	23.6	43.2	24.7	35.8	25.3	35.2	1.7	2.7	2.3	4.4	2.7	4.9	4.0	2.6	3.7	2.2	5.2	4.4	3.5	7.1	5.0	1.7	2.5	4.6	1.2	21.9	24.5	33.3	27.4	22.2	23.0	20.8	23.3	25.6	18.6	41.7	36.8	34.3	97.8	173.7	41.1	108.8	76.5	32.1	30.7	33.2	25.5	238.3	43.1	77.6	384.7	63.9	55.5	23.3	67.0	220.2	83.7	122.4	35.7	191.4	88.0	47.7	96.9	48.5	67.6	940.0	69.9	68.6	70.9	80.2	75.4	36.1	76.0	42.1	82.0	75.7	41.1	77.6	91.4	34.9	59.0	210.7	244.1	43.6	64.4	130.5
RAD51B	"hREC2, R51H2, RAD51L1, REC2"	ENSG00000182185	"RAD51 paralog B"	O15315	14	67819779-68730218	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB016191, HPA051869"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"CAB016191: AB_2238209, HPA051869: AB_2681644"	"unprognostic (9.10e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.13e-3)"	5.1	4.9	4.2	4.6	10.1	9.2	8.2	2.0	5.6	8.2	4.3	11.6	11.2	1.7	10.8	13.8	7.0	6.0	6.4	3.4	5.6	3.2	4.3	3.2	5.0	6.6	9.2	4.0	10.0	5.7	8.0	10.0	8.0	7.5	7.0	4.0	9.4	18.7	3.8	2.4	7.1	5.8	6.7	7.3	6.9	3.7	3.4	7.3	12.6	4.9	4.6	12.1	7.7	8.3	13.6	6.6	14.0	5.9	7.8	10.1	4.8	12.2	4.9	5.4	3.3	5.1	8.7	3.4	6.2	4.8	6.9	8.9	3.4	16.7	15.2	4.1	3.8	8.0	11.1	3.4	10.0	9.5	6.7	3.5	7.2	4.4	2.7	2.7	6.1	7.3	4.4	7.7	7.9	8.4	3.2	6.2	11.3	5.8	7.1	5.6	9.6	11.8	2.1	3.2	11.9	4.9	13.4	6.5	5.5	5.4	3.5	3.7	2.4	5.0	1.8	10.8	6.7	8.4	5.5	1.6	8.5	8.2	6.6	5.1	3.4	3.5	12.0	4.7	10.7	4.8	14.0	5.9	5.4	8.6	4.7	7.1	13.6	8.2	9.2	6.5	11.5	10.1	9.7	0.7	7.8	4.5	6.6	9.1	4.8	4.2	10.1	2.0	5.6	5.6	3.2	9.2	4.0	7.5	7.3	0.0	0.6	3.9	4.8	6.0	1.3	1.5	0.0	1.4	2.3	1.8	7.9	4.8	3.3	1.8	1.5	3.6	1.4	0.0	1.2	5.5	2.5	3.4	4.6	0.6	5.7	1.6	4.6	0.6	4.3	1.3	3.4	3.6	8.5	10.0	2.7	5.1	1.1	0.0	4.2	1.6	5.9	0.0	2.0	3.8	3.2	6.0	3.3	2.5	1.3	3.1
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.4	4.1	3.3	3.5	4.3	5.2	4.1	7.8	4.3	3.6	4.4			2.2	5.3	4.6	3.6	3.9	2.5	3.1	3.4	3.5	3.4	8.8	4.2	3.8	3.4		5.6	5.0	5.3	3.9	4.9		3.8	3.5		3.7	4.2	7.3	4.6	4.1	4.3	4.1	4.7	4.4	4.7			4.2		5.2	3.8	3.5	6.9	5.2	6.5	7.1	6.3	8.3	4.0	5.6	4.4	11.4	11.2	6.4	4.6	6.0	4.8	6.8	6.6	6.3	7.8	3.3	14.8	1.4	8.4	6.9	4.4	17.9	6.0	8.2	7.8	4.0	12.7	9.5	5.1	5.8	14.1	7.6	5.2	4.8	10.1	9.8	4.2	7.3	12.9	8.3	8.1	5.2	4.3	12.6	6.4	9.0	2.8	4.8	5.8	8.8	2.0	3.3	7.3	4.7	8.9	7.6	7.3	4.9	7.2	4.7	8.5	9.5	7.0	8.0	7.1	9.3	8.7	8.8	15.0	7.5	8.0	8.8	6.5	4.8	4.7	8.1	6.0	8.3	4.3	7.1	6.6	5.2	6.9	4.7	5.4	2.2	6.3	7.1	5.2	6.3	4.0											8.9	11.8	9.0	6.6	8.1	33.3	9.7	10.2	10.7	7.9	8.7	29.5	13.5	1.7	8.3	6.1	11.1	4.2	0.0	9.0	7.3	8.0	8.9	17.4	20.7	7.7	44.5	15.6	11.1	11.4	1.9	14.1	6.8	13.5	4.6	6.8	10.4	10.2	6.2	15.9	3.4	31.5	12.9	9.2	37.2	39.4	7.9	24.8	9.6	7.0	9.8
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883719	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;testis: 18.5"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	7.5	2.4	4.3	0.8	4.6	0.5	3.7	29.9	9.9	5.9	3.3	3.3	0.7	0.8	6.1	1.4	1.7	6.4	2.1	7.8	4.1	4.0	1.1	0.7	7.5	0.6	3.4	4.4	1.6	2.5	1.5	3.3	7.2	7.5	2.1	1.1	2.7	1.1	4.3	4.5	1.2	1.8	3.1	4.3	1.0	1.4	18.5	4.0	0.0	2.8	0.6	0.7	2.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.8	7.7	0.2	1.9	0.0	0.9	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.1	0.0	3.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.1	0.0	0.4	2.1	0.0	0.0	6.8	0.0	1.3	5.0	0.2	0.0	0.0	0.0	9.5	20.6	0.1	0.0	0.0	1.6	3.0	0.6	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.6	29.9	9.9	4.1	4.0	3.4	4.4	7.5	4.0	3.0	1.0	0.0	0.0	0.7	0.5	1.7	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	1.6	0.0	2.4	0.4	0.0	0.0	0.1	12.7	0.0	0.0	0.0	4.1	3.1	0.0	6.8	0.0	0.1	3.3	0.3	0.0	3.5	0.0	0.5	6.5	3.6	18.2	9.7	0.5	0.1	0.0	0.0	0.0
RAE1	Mnrp41	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351010-57379211	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	9.2	10.0	9.4	11.1	15.2	28.6	12.0	18.1	18.3	9.5	9.7	11.5	9.3	8.0	13.0	13.9	14.0	12.2	7.9	8.1	9.8	11.0	9.2	10.7	7.1	12.5	8.1	12.6	12.1	9.1	12.3	13.7	13.5	10.4	9.2	11.4	9.4	8.9	11.0	9.6	14.8	8.8	11.3	7.3	12.1	8.6	64.8	8.3	19.4	11.7	11.5	17.3	10.0	11.5	17.0	16.6	39.1	21.5	11.8	20.2	17.8	12.8	15.9	15.8	9.0	9.6	8.8	14.4	10.4	14.7	51.4	19.9	50.4	10.3	20.6	14.6	15.0	19.6	17.1	29.7	25.6	42.4	6.2	13.4	14.1	14.2	22.3	18.0	16.9	12.7	12.9	23.1	22.1	24.8	8.6	15.5	14.1	24.7	10.0	16.1	34.7	25.2	14.8	10.0	24.5	28.0	14.1	15.4	13.7	12.0	13.5	17.3	14.3	17.7	40.4	18.2	12.9	22.0	14.8	9.0	21.9	19.7	12.9	17.3	10.9	23.3	23.5	15.3	10.5	10.9	9.1	21.5	39.1	15.6	18.1	18.9	17.0	15.2	15.5	16.6	16.3	20.2	18.4	19.4	11.8	17.9	12.6	12.9	17.8	9.4	15.2	18.1	18.3	9.8	11.0	8.1	12.6	10.4	8.3	17.9	14.7	22.4	14.7	15.2	14.6	8.5	12.7	21.4	12.5	17.4	13.7	44.8	23.2	28.2	84.3	14.2	7.9	23.3	12.5	32.5	15.6	10.5	36.9	11.3	33.3	3.2	6.3	10.4	63.2	48.9	20.1	28.8	10.1	27.1	13.0	17.6	17.6	20.4	21.2	16.6	15.0	19.4	15.0	94.3	78.1	18.3	58.9	21.5	18.0	14.9
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell type enhanced"	"Detected in all"	10	"Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 17.8;naive B-cell: 14.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 17.8"	"Cell line enhanced"	"Detected in many"		"U-266/84: 62.7;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	6.4	5.0	27.9	10.5	6.2	5.4	8.9	5.1	8.0	9.9	1.2	7.2	5.8	8.2	7.3	14.0	8.7	4.7	4.7	6.0	3.2	6.1	16.4	3.7	25.3	2.2	4.1	11.5	5.0	6.2	8.4	4.6	3.8	5.3	6.4	9.9	9.2	7.4	2.1	10.0	19.7	6.1	3.2	26.1	6.8	37.7	2.1	16.0	4.3	4.7	29.4	7.5	8.4	17.8	0.5	1.4	0.1	0.3	0.5	0.8	10.3	3.4	10.5	0.1	11.8	17.3	4.1	9.1	20.1	7.4	6.7	4.1	10.2	22.0	3.0	26.7	3.7	8.6	4.6	2.3	9.7	0.0	2.7	0.0	2.2	3.8	2.0	2.8	0.1	7.6	2.0	9.5	6.7	5.1	6.4	4.1	5.3	0.8	4.8	1.6	4.3	0.9	7.2	4.0	3.6	6.1	10.8	0.2	2.5	6.6	1.6	4.7	5.9	6.6	12.8	7.5	7.9	1.4	4.7	3.4	3.3	12.3	4.3	25.1	62.7	51.4	1.9	1.5	3.8	0.5	0.1	1.4	0.2	0.0	0.2	17.8	0.1	0.1	0.2	14.6	0.5	0.1	0.8	0.3	0.0	0.5	0.0	0.8	5.0	10.5	8.9	5.1	6.0	3.2	2.2	4.1	3.8	2.1	11.9	8.6	135.8	14.0	13.2	83.6	11.7	5.1	26.8	7.9	14.0	194.4	6.4	18.3	12.8	103.8	2.7	23.8	23.3	10.3	8.6	12.0	23.1	8.1	51.8	5.0	12.7	34.4	3.1	7.5	137.4	46.3	3.6	8.5	1.8	18.2	23.8	20.4	24.6	43.9	6.6	376.7	19.4	8.1	162.4	24.7	29.7	2.7	4.8	13.0	54.0
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		12000	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	37.7	23.4	26.3	39.9	30.7	65.2	55.4	22.4	33.9	35.0	43.7	37.6	35.1	41.9	36.4	31.0	41.6	35.2	38.9	51.9	27.3	24.4	39.3	30.3	40.9	53.9	33.0	23.4	38.3	38.5	21.9	20.7	41.9	26.5	34.9	34.9	32.0	38.7	32.7	62.0	39.8	48.8	41.7	40.9	40.4	36.0	56.8	28.9	76.0	76.7	43.6	42.6	33.5	49.7	30.8	40.9	61.6	54.1	54.1	48.4	40.4	37.0	25.6	41.5	31.6	18.6	19.8	33.6	25.9	21.6	34.8	30.1	68.9	33.6	29.2	38.2	21.6	44.6	41.7	19.5	40.5	19.8	19.1	20.2	69.1	15.1	68.8	25.8	35.6	35.3	21.0	24.7	25.8	26.5	26.4	33.8	37.7	28.6	50.1	22.2	35.8	88.6	57.5	21.4	44.5	49.5	52.5	56.7	39.7	21.2	23.5	39.6	44.3	43.3	41.5	58.9	21.5	42.3	38.0	26.5	72.1	43.7	35.0	32.4	50.1	42.0	52.0	36.2	27.0	33.0	32.9	32.4	61.6	44.3	39.9	33.1	30.8	40.1	48.4	40.9	30.7	35.6	33.6	52.9	54.1	54.1	33.8	42.0	40.4	26.3	30.7	22.4	33.9	27.3	24.4	33.0	23.4	26.5	28.9	50.6	54.9	87.2	97.9	70.3	18.7	53.7	58.6	25.4	27.3	52.4	17.7	128.1	107.8	136.9	27.6	80.9	214.0	70.0	140.3	190.7	86.4	99.8	59.9	32.8	138.7	7.9	89.2	68.2	94.3	35.9	60.7	107.6	109.6	188.4	118.3	48.1	145.4	157.8	58.4	84.7	21.3	109.9	97.1	67.3	96.5	70.6	143.4	124.9	145.1	145.7
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912114	"FDA approved drug targets, Predicted membrane proteins"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 91.6;pancreas: 94.7"	"Cell type enhanced"	"Detected in many"	18	"Exocrine glandular cells: 240.1;monocytes: 755.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"NK-cell: 30.0"	"Lineage enriched"	"Detected in many"	16	"NK-cells: 30.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	3.5	13.8	22.4	9.4	23.9	1.2	1.6	7.8	22.5	34.1	38.8	9.9	8.9	24.9	91.6	21.7	8.9	29.1	19.0	61.7	19.6	15.4	3.1	13.4	3.1	3.3	18.0	12.7	8.4	94.7	1.0	1.6	4.5	14.6	25.5	3.5	1.5	1.5	25.1	62.4	2.4	14.4	51.8	19.5	2.4	14.2	4.3	17.1	0.0	1.1	5.4	2.0	18.3	14.0	0.1	0.4	0.2	0.0	30.0	1.8	1.4	7.9	0.0	0.1	0.0	3.4	5.3	0.3	0.5	0.9	0.5	0.4	0.0	13.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	37.9	1.0	0.0	0.0	0.2	10.7	0.0	0.0	4.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.7	0.0	0.3	0.1	0.0	44.2	0.0	0.4	0.2	0.0	0.0	0.4	55.7	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.2	0.1	0.2	30.0	0.0	0.0	0.0	1.4	22.4	23.9	7.8	15.3	19.6	15.4	18.0	12.7	14.6	17.1	0.0	1.0	0.5	11.4	10.3	2.1	136.4	91.7	14.7	9.1	10.4	0.0	2.1	0.0	55.5	0.2	4.2	4.9	0.0	240.1	7.5	28.8	73.7	1.1	137.8	18.7	1.6	110.7	51.5	4.0	0.4	7.8	6.3	60.8	755.6	26.2	3.3	79.4	4.0	10.6	0.0	2.3	6.5	86.3	0.0	4.9	5.1	1.9	3.2	6.6	3.8
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.9;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	12.4	12.7	15.1	14.0	13.6	30.1	24.8	13.1	24.0	14.5	14.4	9.8	9.8	8.3	13.2	14.3	40.8	9.7	15.5	12.2	15.0	16.0	11.8	16.0	17.9	10.5	18.0	14.3	12.4	11.9	14.7	10.6	15.7	13.7	13.9	11.4	8.3	14.4	11.4	31.8	16.9	9.1	14.7	12.4	9.5	11.0	60.1	12.6	20.9	10.7	20.0	18.0	14.4	21.0	2.0	2.3	3.8	2.0	2.7	8.1	1.2	16.4	7.2	17.5	17.6	23.7	22.1	18.5	20.2	22.8	21.2	22.4	11.0	9.7	14.6	33.0	23.5	16.3	9.0	13.4	11.7	29.3	24.4	12.5	14.7	14.3	20.3	32.9	22.8	11.0	22.2	15.2	25.0	20.8	17.2	17.1	25.8	31.0	11.7	23.5	16.5	26.1	19.1	7.7	15.8	10.2	20.9	13.7	20.7	16.8	19.0	22.0	15.5	16.3	30.2	29.9	34.8	16.1	19.5	16.9	19.3	13.7	15.8	20.7	28.2	34.3	19.8	8.9	14.6	35.7	0.8	1.3	3.8	1.9	1.8	3.8	2.0	4.0	2.0	1.4	1.7	3.8	2.6	1.8	2.7	2.0	2.3	8.1	1.2	15.1	13.6	13.1	24.0	15.0	16.0	18.0	14.3	13.7	12.6	17.9	26.2	5.2	7.4	22.0	22.2	34.0	10.2	14.7	19.4	17.4	13.7	13.9	1.7	7.7	73.9	29.8	11.6	0.0	9.3	7.6	18.5	14.9	9.3	15.6	15.1	6.4	12.7	19.0	23.5	76.0	14.7	15.7	16.9	11.8	16.6	18.6	13.3	3.5	23.3	9.1	16.1	6.5	13.7	65.4	35.1	22.8	23.8	15.3	9.9	10.2
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288497-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 361.7;Late spermatids: 822.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	14.5	14.7	24.7	11.7	29.1	11.8	26.5	10.9	19.2	31.5	15.4	7.9	13.5	10.5	20.0	22.5	10.6	21.5	10.9	23.4	15.1	17.8	17.0	11.5	18.9	26.9	16.2	19.2	21.0	6.3	16.2	17.1	14.6	18.8	15.9	10.8	17.2	6.0	19.4	11.4	9.8	11.9	18.8	12.2	15.4	16.7	70.1	15.9	16.8	11.6	9.1	20.3	14.1	10.5	26.8	22.3	25.3	16.3	21.8	40.2	18.2	16.0	18.9	13.9	14.2	10.2	12.9	11.7	9.4	18.6	26.1	24.4	10.1	6.4	30.7	10.2	11.3	10.4	18.2	25.6	12.7	18.7	21.4	32.4	15.3	14.9	13.9	23.1	9.6	22.4	12.6	23.2	22.2	21.3	12.5	20.6	29.8	6.7	8.7	15.9	0.4	29.4	31.5	9.7	9.7	7.3	26.0	10.8	18.3	14.1	7.1	5.4	15.1	7.6	11.3	20.0	9.1	0.9	9.3	11.4	5.7	10.0	11.0	19.0	14.8	11.7	37.0	12.1	19.1	8.3	4.9	16.2	25.3	24.2	16.3	22.6	24.2	29.3	27.4	17.3	26.8	26.2	22.4	2.1	21.8	12.5	22.3	40.2	18.2	24.7	29.1	10.9	19.2	15.1	17.8	16.2	19.2	18.8	15.9	8.9	25.0	41.4	21.7	16.1	23.2	4.0	0.0	14.7	14.8	24.4	11.8	83.8	58.0	22.9	361.7	25.3	11.9	23.3	16.5	38.1	26.0	20.4	26.6	13.6	42.0	19.1	19.0	19.6	11.9	822.0	26.2	23.5	16.9	36.1	15.2	23.5	17.8	24.5	29.7	43.5	28.7	19.4	20.8	112.7	18.1	17.1	94.4	41.5	22.9	11.9
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118238-22357144	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 67.0;parathyroid gland: 258.2"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 81.0;Late spermatids: 45.4;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 11.8;HUVEC TERT2: 25.2;SCLC-21H: 19.5;TIME: 14.3;U-698: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	10.8	5.8	12.6	3.6	22.6	1.8	6.2	5.2	25.1	4.5	4.6	47.6	0.6	3.9	4.4	3.1	6.1	4.2	7.0	6.7	21.3	10.1	7.3	8.5	14.1	5.7	41.8	13.3	3.7	7.9	258.2	3.3	23.2	31.5	2.8	5.2	0.9	3.4	3.4	2.7	4.4	4.1	5.6	67.0	17.1	3.7	3.5	29.5	3.9	5.4	1.8	4.9	3.9	4.9	0.7	0.0	0.0	0.0	0.0	0.2	0.4	1.5	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.0	0.8	11.8	0.6	0.1	0.4	7.4	1.5	1.1	0.0	0.0	2.3	0.1	0.0	2.9	0.0	0.0	0.0	0.3	1.3	0.7	0.4	0.4	25.2	3.3	2.6	0.1	0.0	0.6	1.6	0.0	2.0	2.9	2.3	2.9	0.0	4.0	2.4	1.0	19.5	5.2	0.3	3.4	0.0	0.4	1.7	0.0	14.3	0.0	0.6	0.2	0.6	6.6	1.3	21.2	0.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	22.6	5.2	25.1	21.3	10.1	41.8	13.3	31.5	29.5	8.9	13.9	2.2	4.3	9.7	14.8	7.3	10.2	0.0	5.7	0.0	0.0	0.1	1.7	4.3	41.5	38.5	14.3	0.0	5.9	0.1	2.1	2.2	8.1	5.8	0.2	22.3	6.9	81.0	5.1	45.4	1.7	1.5	6.8	0.0	16.0	0.5	6.0	17.5	4.6	0.2	1.1	84.1	10.3	0.9	1.1	9.8	0.2	2.1	8.8	3.7
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.2	32.4	24.0	26.6	33.2	38.1	41.3	40.2	34.6	41.9	49.0	55.0	29.8	29.0	33.0	38.2	43.1	26.5	31.4	54.1	54.7	30.1	21.6	19.5	29.5	34.5	28.8	46.0	20.8	29.2	28.9	45.6	21.9	25.8	33.5	15.9	29.1	14.7	44.8	25.2	19.1	18.3	39.4	24.0	22.1	8.4	35.0	27.6	37.3	31.1	22.9	28.2	30.7	35.5	41.5	30.5	32.3	19.3	33.2	30.4	27.9	23.4	46.8	14.7	26.9	29.8	33.1	32.9	28.8	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8	53.6	32.3	25.1	37.6	26.3	25.0	43.6	35.7	46.8	39.8	24.4	25.5	88.8	14.9	80.1	16.6	27.5	40.6	23.3	83.1	79.2	34.8	24.5	26.6	31.4	51.1	12.7	12.6	33.2	24.6	11.6	23.0	35.0	27.0	72.1	36.7	22.7	61.2	38.7	23.0	36.0	22.7	19.4	28.9	27.7	42.2	31.1	70.5	20.1	44.8	35.2
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464571	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.9"	"Group enriched"	"Detected in many"	5	"B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	2.8	2.1	3.1	19.2	3.8	16.7	1.7	0.5	1.9	1.4	3.4	4.6	0.7	3.6	1.7	1.1	3.0	1.9	4.5	1.1	4.1	1.8	3.3	2.8	8.0	23.5	4.5	1.3	0.9	1.3	0.3	1.4	0.8	3.7	2.3	1.9	1.5	7.5	1.1	0.7	1.2	14.5	0.9	5.1	29.9	4.0	0.6	4.6	27.3	3.1	1.6	28.9	4.5	2.0	2.9	3.2	8.8	9.3	8.9	16.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	11.9	0.0	0.0	0.2	9.5	23.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	25.7	0.0	0.1	5.0	13.1	0.0	0.0	0.0	1.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	17.1	0.0	0.0	0.0	0.0	0.2	4.6	7.0	0.0	16.1	0.0	4.3	1.7	8.8	14.9	3.4	8.9	2.2	9.5	16.4	2.6	2.9	8.0	9.6	2.5	8.9	9.3	3.2	6.4	3.5	3.1	3.8	0.5	1.9	4.1	1.8	4.5	1.3	3.7	4.6	3.0	9.3	38.9	0.0	0.2	0.0	2.2	0.0	8.1	2.3	0.0	0.0	0.1	0.0	0.1	0.4	2.9	0.0	0.0	0.5	0.2	0.9	0.1	39.2	3.9	9.8	0.0	0.0	4.3	9.2	0.6	0.0	7.4	0.0	2.8	0.0	0.1	0.3	0.0	1.1	0.8	0.0	0.0	0.5	0.4	0.3	0.5	0.3	62.3	0.0	0.1
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	47	"plasmacytoid DC: 48.0"	"Lineage enriched"	"Detected in many"	47	"dendritic cells: 48.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 34.4;HSkMC: 8.4;REH: 32.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	79.6	24.3	14.0	6.2	23.2	8.3	30.4	11.6	32.0	49.1	7.1	8.5	18.6	5.9	19.9	17.1	10.9	11.6	11.8	20.1	14.7	15.5	30.2	85.9	5.6	3.7	10.0	22.5	33.5	17.5	7.2	81.3	2.6	22.2	17.8	6.9	6.6	49.4	51.8	37.2	9.1	6.1	4.3	19.6	12.2	6.1	13.8	8.9	9.1	37.7	9.2	2.5	6.2	5.5	0.0	48.0	0.0	1.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	34.4	1.9	0.1	0.4	0.6	0.0	0.1	1.4	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	3.8	0.2	0.0	0.1	8.4	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	3.4	6.2	0.6	0.7	0.6	2.1	32.9	0.0	0.0	0.7	0.0	6.2	0.2	0.5	0.4	7.2	1.0	0.0	0.0	1.9	0.0	0.3	0.2	0.1	7.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.0	0.0	0.3	14.0	23.2	11.6	32.0	14.7	15.5	10.0	22.5	22.2	8.9	26.8	30.8	3.7	47.7	15.2	21.5	61.3	12.7	8.1	40.9	141.3	3.9	2.5	11.6	55.0	2.1	17.5	18.7	0.0	1.1	2.2	69.9	113.7	8.1	13.2	3.4	6.4	213.7	10.4	3.7	4.2	101.5	8.8	28.7	3.6	239.8	245.0	13.9	15.8	441.6	3.8	20.0	556.2	153.3	1.6	1.6	11.5	5.6	6.9	22.1	20.7
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0"	"Group enriched"	"Detected in many"	5	"B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 12.0;Daudi: 15.4;Karpas-707: 10.4;NTERA-2: 7.1;OE19: 8.5;SCLC-21H: 6.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	11.7	5.3	12.2	8.4	18.9	22.2	14.3	3.5	8.4	7.6	8.0	10.0	2.6	10.8	3.0	9.9	10.9	6.6	10.1	4.9	6.2	8.2	9.4	32.8	19.1	9.2	13.0	3.5	3.3	2.5	1.7	12.6	10.3	38.3	3.8	6.0	6.1	9.7	4.2	3.5	20.3	10.7	5.0	8.7	13.2	12.2	1.9	19.3	8.0	3.9	4.7	8.5	4.8	5.6	8.8	18.0	0.8	12.4	2.5	2.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	12.0	0.3	15.4	0.0	0.0	0.1	0.3	1.0	0.1	0.0	0.1	2.2	1.2	1.0	0.5	0.5	0.3	0.7	0.2	0.5	0.0	0.5	0.1	0.0	2.6	0.2	10.4	0.0	0.5	5.0	0.5	7.1	8.5	3.2	1.5	0.1	5.8	0.5	0.2	6.9	0.1	0.0	2.1	0.0	7.3	1.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	4.7	1.1	0.2	0.1	0.4	2.1	0.2	1.4	7.7	1.5	6.4	1.1	1.1	1.7	8.8	2.0	1.9	0.8	2.5	12.4	18.0	0.3	0.7	12.2	18.9	3.5	8.4	6.2	8.2	13.0	3.5	38.3	19.3	26.8	22.3	27.4	6.7	52.3	9.9	8.1	15.3	44.2	12.5	14.0	35.3	26.8	11.6	2.8	0.4	8.7	10.4	0.0	3.5	2.1	12.4	11.0	104.0	39.5	37.5	3.2	25.7	51.5	43.3	1.1	0.9	59.7	59.1	1.0	6.8	0.8	2.4	5.1	1.8	7.7	4.4	0.0	15.9	0.7	0.2	49.4	9.4	7.5	6.5	6.5
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.4;skeletal muscle: 28.7"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 50.6;Ito cells: 52.2;Urothelial cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4"	"Group enriched"	"Detected in many"	16	"B-cells: 13.4;granulocytes: 11.4"	"Group enriched"	"Detected in some"	6	"Daudi: 29.9;HEL: 31.6;U-266/70: 49.5;U-266/84: 18.9;U-698: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.6	9.4	13.6	13.3	3.2	4.9	2.0	9.6	3.1	3.5	35.0	0.0	5.7	2.6	1.3	2.0	2.1	5.0	24.3	13.4	8.8	5.1	4.1	5.8	19.8	25.2	5.5	1.6	3.7	9.3	3.1	8.2	19.9	2.1	5.3	6.7	5.4	1.7	28.7	2.3	4.5	3.7	42.4	10.1	5.4	1.3	26.3	1.9	6.7	5.0	25.0	5.4	2.1	13.4	0.2	11.4	0.1	0.2	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.5	4.5	0.8	0.2	29.9	0.1	0.2	0.3	0.0	0.0	0.0	0.4	3.1	0.3	31.6	0.2	0.0	0.4	0.1	4.3	0.0	0.0	0.0	0.0	0.6	1.8	0.3	0.1	1.6	0.6	0.0	0.2	2.3	0.1	0.2	0.0	0.0	1.4	0.0	0.3	1.9	0.2	0.0	0.0	0.1	1.4	0.0	0.0	0.2	0.5	0.1	0.1	0.1	0.2	49.5	18.9	13.2	0.0	0.1	0.1	11.4	0.0	0.0	0.3	0.0	0.4	10.4	0.5	0.5	0.2	13.4	0.7	0.2	0.0	0.2	0.1	0.0	0.7	0.9	9.4	13.3	2.0	9.6	13.4	8.8	25.2	5.5	19.9	26.3	0.0	8.0	43.4	28.1	4.7	1.2	45.2	0.0	4.0	5.7	5.2	0.0	0.4	10.0	14.6	1.0	50.6	0.0	0.0	47.5	1.1	3.9	22.2	18.4	4.4	38.6	0.0	0.0	52.2	7.2	0.6	0.9	10.2	38.8	22.6	0.0	0.3	44.4	0.0	1.8	9.8	1.1	0.0	3.8	0.9	2.3	3.1	0.5	4.4	0.0	57.1
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.9"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 70.5;Intestinal endocrine cells: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 6.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 6.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.3;hTERT-HME1: 9.7;RPTEC TERT1: 10.4;RT4: 30.0;U-266/70: 8.9;U-698: 26.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.5	0.3	0.3	12.9	0.3	0.0	4.8	0.3	0.3	1.8	12.1	0.4	3.7	5.8	0.4	3.7	3.7	1.3	7.7	0.3	0.3	0.5	13.4	1.2	4.2	3.0	0.3	0.1	1.8	11.3	0.0	2.2	11.2	1.1	6.4	7.8	0.4	5.1	6.3	0.4	3.1	23.2	2.1	0.5	0.6	21.5	0.9	0.1	77.9	3.3	2.0	8.2	11.0	2.5	6.4	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	5.2	32.3	0.5	0.0	0.1	1.6	0.0	2.6	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.7	0.1	0.0	0.0	0.2	10.4	30.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	6.4	0.4	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.1	1.1	0.1	11.9	3.2	3.2	34.4	8.8	0.0	1.1	25.5	37.5	40.9	7.0	0.0	42.9	14.9	16.0	0.2	0.1	49.3	0.0	70.5	17.2	0.7	17.9	1.1	3.9	3.9	0.0	115.4	0.0	0.8	0.0	0.0	0.7	1.7	1.0	48.1	14.3	57.4	59.6	0.0	32.3	0.4	0.0	1.0	0.0	0.0	1.3	39.5	0.0	16.8	36.0
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.7	11.4	11.0	13.0	15.4	8.9	12.0	10.2	8.8	13.1	13.1	12.0	13.0	16.8	7.9	7.5	10.7	12.4	18.3	6.8	15.6	14.2	9.8	14.0	11.6	9.7	10.0	17.5	11.5	7.1	8.9	12.2	10.4	8.8	10.5	12.1	27.0	17.2	10.9	9.9	16.8	7.5	17.9	9.4	19.0	15.1	23.5	20.9	9.1	7.9	17.3	14.0	14.4	15.3	13.0	13.8	16.5	9.9	7.9	10.9	11.7	15.9	13.4	8.5	11.7	20.6	9.7	11.0	16.7	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7	17.9	13.5	16.3	9.4	23.9	13.8	6.5	7.6	14.7	17.0	21.0	27.5	8.0	8.3	10.8	6.4	13.8	14.0	0.0	10.0	8.2	9.8	10.8	12.8	20.2	9.7	15.9	11.6	17.8	14.1	1.7	11.8	15.2	18.6	10.0	12.4	15.8	11.6	10.5	15.2	23.1	18.8	19.4	9.8	8.8	18.1	29.5	9.0	21.7	13.3	12.2
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028425	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA075862"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006240: AB_1079750, HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	14.0	11.6	25.7	7.6	30.5	0.4	12.7	58.4	37.2	26.4	23.2	7.4	11.2	7.9	38.5	13.8	22.9	20.4	16.7	20.8	19.6	15.9	10.2	10.6	12.7	3.7	12.0	26.3	43.3	9.3	20.5	20.6	21.3	22.8	18.3	13.6	9.7	10.3	20.5	40.7	12.6	10.6	32.6	9.7	5.4	13.3	10.4	10.1	1.8	18.7	5.7	5.3	18.1	15.9	0.0	0.7	0.0	0.0	0.1	3.1	0.1	15.1	9.9	32.3	18.9	20.3	34.2	13.3	28.4	38.1	21.2	23.3	18.9	6.5	9.7	13.7	32.2	12.4	14.7	11.7	13.0	27.1	7.7	13.5	5.4	8.8	7.0	6.1	1.5	4.1	24.8	16.8	20.2	23.0	19.3	25.7	2.4	4.1	1.2	23.2	5.9	1.5	0.8	12.6	5.7	13.7	2.3	28.7	2.2	14.6	17.0	10.0	37.9	32.4	5.1	10.0	17.1	6.0	1.8	31.7	30.3	17.9	17.9	13.1	1.1	3.1	12.0	14.2	2.2	17.1	0.0	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	25.7	30.5	58.4	37.2	19.6	15.9	12.0	26.3	22.8	10.1	62.5	32.6	0.5	41.3	33.0	3.3	54.1	25.5	14.7	33.0	26.2	0.0	50.4	29.9	47.1	14.6	43.8	18.4	0.0	27.9	74.6	68.9	41.7	2.3	20.9	8.6	111.2	54.8	32.5	1.3	5.4	73.6	3.3	15.1	4.6	22.3	15.4	54.8	2.9	87.7	14.0	5.9	51.8	71.0	35.7	22.7	29.5	24.3	2.5	23.4	50.4
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781364-27891098	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 57.6;Proximal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	14.4	22.2	2.5	2.4	5.2	4.1	2.2	2.1	4.1	2.6	3.0	1.7	4.9	12.4	4.7	4.7	3.1	7.4	10.7	3.5	3.7	4.3	15.1	22.6	10.4	0.8	3.0	2.4	24.2	2.4	3.5	10.3	6.2	12.3	6.9	2.4	2.2	1.4	16.8	7.6	1.0	11.8	3.8	4.7	1.7	1.6	4.8	1.4	0.3	4.5	2.8	1.1	4.8	12.0	5.8	5.1	5.6	3.8	4.9	6.5	3.4	3.1	2.1	0.3	0.4	0.4	0.7	2.1	0.8	0.6	0.4	0.6	4.8	1.5	1.1	10.5	1.7	1.5	1.3	0.2	1.0	0.8	0.4	0.2	0.1	0.5	4.1	1.6	0.9	0.2	1.0	1.7	2.7	3.7	0.7	0.6	1.9	0.1	1.3	2.0	4.1	0.7	2.3	0.0	2.1	1.7	0.9	0.2	0.7	22.1	0.2	0.9	1.2	2.9	4.0	1.7	1.1	1.8	4.6	0.2	0.7	0.5	1.9	1.2	6.7	7.9	2.1	1.9	3.1	0.1	5.6	3.8	1.9	3.0	1.6	6.1	5.8	4.0	6.5	5.1	4.6	4.2	3.6	5.6	4.9	0.8	0.8	5.8	3.4	2.5	5.2	2.1	4.1	3.7	4.3	3.0	2.4	12.3	1.4	6.0	5.3	1.9	2.8	1.8	10.3	6.4	2.5	57.6	7.9	17.4	3.9	3.3	39.7	9.3	26.8	4.1	18.8	0.0	11.1	1.1	1.9	1.1	2.3	25.3	5.5	7.9	3.5	1.8	1.8	21.9	1.4	7.2	1.7	2.8	3.2	12.1	7.7	7.0	2.5	88.0	18.7	0.0	2.1	15.4	14.5	1.4	1.3	5.0	6.4	1.7
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 6.7;Club cells: 9.1;Cone photoreceptor cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.3;SK-MEL-30: 7.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	7.3	5.9	5.7	7.4	7.7	13.9	5.0	12.3	8.2	5.4	7.5	6.9	7.5	2.8	8.1	11.4	6.4	4.9	7.1	12.2	5.9	5.4	6.2	14.7	6.3	6.4	8.5	4.9	6.0	7.9	2.8	9.1	5.9	5.5	7.6	4.8	7.5	5.8	5.8	9.3	4.0	6.3	7.3	5.3	7.5	7.7	11.9	6.5	13.2	7.2	4.9	9.2	6.7	5.7	8.6	10.8	7.5	6.4	4.3	5.4	4.4	2.1	1.5	0.8	1.8	1.6	0.2	1.1	1.1	0.5	2.1	0.4	3.5	0.6	0.7	1.2	0.2	1.7	3.7	1.4	0.4	0.5	0.0	0.7	3.3	1.3	2.4	0.6	1.8	1.7	0.0	0.3	0.9	0.2	0.5	0.0	0.6	4.7	1.5	1.1	3.8	2.6	12.3	1.2	2.2	4.7	1.8	5.2	0.6	0.4	2.3	2.6	0.9	0.6	1.7	7.0	0.4	0.8	1.3	0.0	2.7	2.6	1.7	1.5	0.2	0.7	1.6	0.9	1.2	0.8	6.4	6.4	7.5	5.4	5.6	3.8	8.6	3.6	4.1	6.7	8.0	1.3	3.1	3.5	4.3	5.3	10.8	2.3	4.4	5.7	7.7	12.3	8.2	5.9	5.4	8.5	4.9	5.5	6.5	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.0	6.7	9.1	0.0	3.9	0.4	0.0	0.4	1.4	0.4	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.7	0.9	0.1	0.9	0.0	0.2	0.7
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893206-22919184	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	18.7	26.9	22.0	22.1	29.3	28.1	24.8	33.7	35.7	28.6	22.5	26.9	25.9	18.3	35.0	24.7	25.9	36.9	24.2	20.3	19.9	24.2	27.8	27.0	25.2	25.0	19.7	23.7	40.8	23.2	56.6	37.5	43.9	23.9	27.2	25.7	35.4	25.3	25.8	18.0	22.3	24.8	28.2	22.6	32.7	25.3	23.5	26.7	44.0	42.4	19.7	31.2	24.8	34.9	14.0	17.8	49.9	17.2	20.5	14.3	9.8	20.1	31.9	32.6	17.0	17.9	15.4	13.6	22.1	30.4	43.1	33.9	14.4	24.8	33.8	17.5	20.5	20.7	28.7	36.5	18.6	35.2	26.5	30.1	15.9	24.9	1.1	28.2	30.5	26.2	19.7	25.8	24.8	16.5	24.1	24.0	17.0	20.0	22.0	21.1	25.7	33.3	13.7	14.5	30.8	30.0	28.8	27.0	20.5	16.8	28.6	22.5	25.2	33.2	25.8	14.0	22.4	19.0	18.1	22.2	7.5	12.8	17.9	20.4	20.9	26.7	31.9	12.5	17.6	26.7	11.3	17.2	17.6	14.3	13.3	9.8	10.8	10.2	12.3	17.8	14.0	12.5	10.9	49.9	20.5	16.4	9.3	10.4	9.8	22.0	29.3	33.7	35.7	19.9	24.2	19.7	23.7	23.9	26.7	41.7	38.7	72.9	41.5	16.4	60.7	21.2	58.6	76.3	47.8	31.4	110.0	43.5	38.1	32.4	6.9	35.1	49.3	46.7	29.6	40.1	28.0	24.3	68.2	30.6	27.8	47.7	62.8	44.8	37.7	8.2	32.8	36.7	15.1	54.1	33.4	44.2	29.7	35.3	26.5	21.4	123.6	32.3	32.8	39.7	58.7	18.3	84.8	83.0	31.8	22.7
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 165.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	6.0	0.0	0.0	0.0	0.0	9.1	3.3	6.2	6.6	0.0	0.5	0.0	2.9	6.5	9.8	0.0	5.6	0.2	11.3	0.0	0.2	0.0	0.5	3.1	0.2	0.0	0.5	3.3	0.0	1.2	0.2	8.0	0.7	0.0	0.0	0.0	29.0	1.3	0.0	0.0	2.0	0.0	0.7	0.0	29.8	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	4.9	13.9	0.2	0.0	2.1	5.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1	0.0	0.0	0.0	0.2	1.0	1.6	165.8	0.0	20.1	2.3	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	9.2	0.8	0.2	1.1	0.0	0.2	1.6	4.6	0.0	0.0	1.0	0.0	0.0	1.7	0.0	3.9	0.6	0.2	0.0	0.7	0.1	0.0	6.5	16.2	0.3	7.7	0.9	0.7	0.0	1.5	0.1
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391407-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.3;skeletal muscle: 107.9"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;Intestinal endocrine cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;U-698: 41.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	4.4	3.5	4.5	22.8	4.9	64.3	4.3	10.0	5.2	9.2	28.1	6.4	7.1	5.9	13.0	6.7	16.3	10.4	6.5	24.4	4.2	3.9	5.3	6.7	9.8	23.3	4.7	2.3	17.2	5.9	1.9	4.4	9.9	5.0	12.2	3.4	10.9	11.6	8.3	107.9	2.7	12.9	27.4	3.4	22.0	8.1	16.7	4.1	26.8	4.1	18.9	28.0	25.1	11.4	6.4	2.2	3.5	2.9	5.5	7.6	3.4	5.5	5.7	2.9	7.3	0.0	0.4	16.3	1.8	0.4	3.9	1.0	23.4	5.9	39.4	15.6	0.5	3.9	5.1	2.4	2.3	0.6	7.9	9.7	33.4	2.2	14.8	1.8	16.1	15.7	0.5	1.1	1.6	0.3	0.6	2.6	15.1	27.2	7.2	0.4	24.0	11.6	16.6	10.5	3.1	7.2	22.6	7.1	32.0	2.9	2.6	11.9	7.6	4.4	14.6	7.3	2.7	8.1	22.6	4.7	1.3	12.5	1.7	7.6	17.3	22.9	41.5	0.3	11.5	1.2	0.0	1.0	3.5	5.4	2.9	3.5	5.6	4.5	3.7	1.8	6.4	5.7	5.0	1.3	5.5	2.7	2.2	7.6	3.4	4.5	4.9	10.0	5.2	4.2	3.9	4.7	2.3	5.0	4.1	3.0	6.9	45.5	27.2	8.0	0.9	37.4	7.6	12.0	5.7	1.8	0.0	1.3	8.3	5.5	4.0	9.3	25.7	70.0	4.3	4.4	6.0	14.9	8.1	4.5	8.5	0.0	60.3	6.2	7.0	2.7	4.0	11.1	1.7	1.0	49.7	11.8	6.1	28.8	5.6	13.3	1.3	6.5	4.4	1.2	15.1	7.3	1.9	48.7	40.0	16.2
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638617-66666682	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	41.6	50.3	37.1	34.4	37.2	57.5	38.3	55.5	43.9	40.6	39.1	35.5	43.4	33.9	42.2	48.3	44.5	37.4	33.6	33.0	32.1	31.0	40.9	37.2	34.3	44.7	30.1	32.7	51.1	63.9	44.9	41.5	42.5	31.1	42.7	33.2	41.3	54.6	33.2	40.8	37.4	36.2	36.7	26.9	48.5	42.1	47.3	32.2	68.2	59.5	37.9	48.7	36.5	37.2	51.4	45.0	61.7	51.9	57.5	72.7	54.3	26.9	35.7	54.3	30.6	20.0	21.7	33.0	28.5	23.1	30.1	21.6	59.5	35.2	34.9	39.4	28.5	27.1	30.1	57.9	33.9	32.3	34.6	30.2	47.5	36.6	35.5	39.6	32.4	20.7	31.8	29.5	34.6	49.1	30.7	39.8	34.4	37.3	25.8	31.3	55.8	53.3	33.4	68.2	52.8	39.4	50.0	50.9	38.6	39.8	43.7	45.8	32.9	50.2	36.9	79.8	38.3	70.0	32.7	40.4	31.4	27.7	19.4	23.0	32.5	33.9	56.4	25.1	25.6	44.9	61.7	45.7	48.6	56.8	46.8	51.0	48.0	59.0	61.8	45.0	51.4	63.8	63.5	53.6	57.5	51.9	40.6	72.7	54.3	37.1	37.2	55.5	43.9	32.1	31.0	30.1	32.7	31.1	32.2	26.8	35.6	27.0	53.2	15.9	54.4	4.1	12.7	41.5	33.0	19.2	88.4	31.8	13.3	19.9	32.7	23.2	24.5	23.3	20.1	24.9	21.1	36.2	35.8	8.5	12.6	58.8	33.4	19.0	14.3	5.2	25.3	23.5	18.6	25.2	13.9	15.1	17.3	18.2	19.1	8.1	77.2	19.4	25.8	24.7	32.8	19.4	36.6	42.7	18.0	55.6
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 321.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	26.0	22.0	16.6	20.3	16.0	29.2	23.6	12.1	23.4	20.4	27.3	22.6	18.8	24.2	25.5	21.8	25.5	18.3	23.6	24.9	13.7	12.0	22.2	33.3	19.3	19.2	15.7	17.6	27.6	17.7	20.7	15.0	41.3	16.0	19.5	9.9	15.9	25.1	24.6	44.6	31.5	24.7	18.6	18.1	25.4	22.0	23.7	16.0	41.1	25.8	21.9	21.3	21.2	22.4	43.6	49.1	61.3	48.9	38.9	45.6	33.9	32.4	51.2	11.4	15.5	10.4	8.3	31.2	22.4	12.4	26.4	20.8	30.2	21.2	18.1	41.0	14.2	14.3	13.4	13.1	15.7	7.7	46.8	23.5	25.0	17.1	24.6	27.1	22.0	24.1	11.7	12.6	19.4	10.7	8.4	14.4	19.1	25.9	14.9	11.9	37.0	27.9	29.1	13.1	29.5	21.1	30.5	15.6	18.0	12.5	15.1	15.0	21.8	25.4	21.0	17.0	6.6	16.7	34.7	22.0	18.9	25.8	24.9	38.9	36.5	38.4	27.9	18.2	21.0	26.3	46.1	42.1	61.3	45.6	48.9	39.3	41.0	37.9	45.5	49.1	43.6	34.2	37.7	38.6	38.9	45.4	45.4	41.9	33.9	16.6	16.0	12.1	23.4	13.7	12.0	15.7	17.6	16.0	16.0	35.7	21.1	26.7	41.9	46.0	19.2	12.0	50.9	26.8	28.4	50.6	11.8	174.8	63.0	68.5	26.2	42.7	70.6	0.0	78.3	85.4	48.9	29.9	50.7	27.6	78.2	9.5	50.1	48.5	29.8	12.0	53.8	45.9	50.6	83.8	42.6	43.4	64.2	45.6	59.4	63.4	13.9	51.8	59.0	62.6	56.9	38.0	321.4	45.9	48.9	38.9
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261879	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.2;HSkMC: 16.4"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	10.7	14.8	5.2	7.6	6.4	6.0	7.9	1.6	4.9	14.4	8.1	5.4	7.4	3.1	14.6	14.6	8.4	13.6	7.2	4.4	6.0	4.8	7.8	7.0	14.3	13.6	4.5	5.3	17.6	6.8	8.7	7.8	6.0	4.3	14.4	4.7	14.3	6.2	8.9	4.5	6.2	6.3	11.5	5.6	8.4	5.9	6.5	4.1	11.0	13.4	3.6	6.9	20.5	6.6	3.2	1.1	5.9	4.6	5.3	4.9	1.2	2.9	1.9	3.1	4.1	8.3	18.2	2.0	3.4	7.8	4.3	6.3	0.1	4.9	2.3	1.3	6.1	2.3	1.5	0.9	3.9	2.2	3.4	2.1	5.5	0.7	0.2	8.1	6.7	1.9	16.4	4.4	3.4	2.6	6.5	9.1	2.5	2.2	2.6	5.8	2.9	3.8	3.2	1.1	0.0	3.6	2.6	3.5	1.3	7.3	2.5	1.1	3.6	3.3	2.4	6.4	0.5	3.5	4.4	5.1	3.2	2.9	2.8	1.4	0.9	0.6	0.0	8.5	2.7	1.9	1.9	1.7	5.9	2.8	2.1	4.6	2.8	3.9	3.5	1.1	3.2	4.9	3.4	2.0	5.3	4.6	0.5	1.9	1.2	5.2	6.4	1.6	4.9	6.0	4.8	4.5	5.3	4.3	4.1	3.0	6.2	4.7	2.3	3.0	7.5	2.1	15.3	32.1	6.8	17.4	0.0	5.6	23.2	4.9	2.3	9.0	2.9	0.0	5.1	3.3	8.7	3.3	3.5	8.6	4.7	6.4	5.8	15.4	11.3	1.1	25.9	4.8	3.3	8.2	6.9	21.7	3.8	5.3	27.3	8.8	0.9	0.0	5.7	0.7	3.2	2.8	1.1	5.9	4.3	2.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 42.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"A549: 16.8;BEWO: 50.3;CAPAN-2: 22.1;SK-BR-3: 16.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	8.2	33.6	1.9	8.2	2.4	2.6	10.9	0.8	1.2	5.4	22.9	3.3	28.7	24.1	2.6	15.4	27.3	5.3	12.7	4.0	2.4	1.1	37.0	16.1	14.5	11.3	3.0	0.3	4.6	19.2	8.0	2.9	27.2	6.6	13.2	17.3	9.2	60.8	36.0	0.9	6.0	42.8	2.2	4.1	15.0	22.2	7.1	2.2	1.6	31.5	13.7	20.6	7.8	9.7	2.0	11.3	42.4	14.2	0.1	0.1	4.8	11.6	16.8	0.0	0.5	0.0	0.0	50.3	0.3	0.3	0.1	0.1	9.8	22.1	0.0	8.8	0.3	0.9	4.6	0.3	3.3	0.1	0.0	2.8	0.0	1.2	2.7	0.2	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	0.0	0.6	2.5	0.0	6.6	0.0	0.3	5.1	16.3	0.9	0.0	0.0	13.0	15.5	14.8	0.5	0.1	6.6	16.8	0.1	3.8	7.4	3.1	0.0	0.1	0.6	0.1	0.3	8.9	13.2	1.4	1.5	1.4	0.0	0.1	14.2	0.1	0.0	10.9	0.1	2.0	0.0	0.0	11.3	1.2	0.1	0.0	42.4	0.1	8.1	4.6	0.0	4.8	1.9	2.4	0.8	1.2	2.4	1.1	3.0	0.3	6.6	2.2	74.5	109.6	29.8	66.4	52.3	0.0	2.0	63.7	107.1	92.1	106.4	0.0	84.5	54.7	73.9	0.9	3.4	253.2	0.0	99.6	71.8	8.3	174.3	6.9	117.3	81.1	1.6	116.9	35.0	113.3	1.5	2.3	85.9	35.4	57.7	177.9	0.4	94.8	165.8	1.1	114.0	0.0	0.0	3.1	1.9	11.4	65.9	219.6	0.0	144.7	244.6
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677921	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	7.1	12.3	17.6	9.6	17.3	4.0	10.2	35.9	19.3	13.4	10.0	22.8	13.5	9.3	19.0	20.2	10.1	18.3	9.8	9.2	17.5	17.4	9.9	9.8	8.8	13.8	15.4	16.2	29.8	11.8	15.7	25.6	12.2	17.3	14.6	11.5	14.5	14.1	15.0	13.9	17.4	10.3	14.0	16.4	11.8	9.8	17.0	18.7	8.5	12.3	7.6	15.5	11.3	11.5	21.8	11.4	26.8	15.1	13.2	12.5	8.4	13.1	13.2	29.1	24.2	14.3	14.7	9.8	12.7	12.7	14.2	14.6	18.5	13.9	14.7	18.2	16.0	13.9	17.2	19.1	17.5	15.1	14.2	13.0	16.0	16.6	19.7	10.5	16.2	15.8	15.3	12.0	14.5	12.4	16.3	13.7	12.0	12.1	14.8	19.1	21.2	10.0	12.5	17.3	29.7	17.8	20.6	23.2	15.1	12.9	13.3	17.9	16.4	15.1	7.8	28.3	19.5	20.8	15.4	12.6	15.7	16.2	15.3	11.3	7.3	12.3	15.1	14.5	11.5	13.8	12.7	9.6	26.8	10.8	14.1	10.4	21.8	10.1	10.4	11.4	18.6	12.5	9.2	6.1	13.2	15.1	9.4	7.4	8.4	17.6	17.3	35.9	19.3	17.5	17.4	15.4	16.2	17.3	18.7	11.9	5.1	15.9	14.0	7.1	35.5	4.5	7.6	21.4	10.3	17.4	31.4	32.2	10.0	12.0	21.2	7.0	8.5	0.0	5.0	14.2	17.8	7.3	9.2	7.4	11.1	23.8	18.4	6.7	8.7	36.0	17.0	8.2	15.1	9.0	8.6	21.8	5.3	7.4	12.7	11.2	56.8	6.5	11.3	42.1	40.0	6.1	18.5	13.4	10.3	4.3
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 136.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	8.7	0.0	0.4	0.0	6.1	0.1	0.0	0.0	0.7	0.0	0.4	11.2	25.8	0.0	0.0	0.4	0.0	0.0	0.0	26.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	3.2	136.6	5.6	0.0	0.0	2.3	0.5	0.1	0.0	0.0	20.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3	29.8	5.1	10.5	43.6	15.7	12.3	15.5	63.7	5.3	12.5	22.7	2.0	2.6	11.6	920.8	3.9	54.2	0.0	0.0	932.2	6.9	95.1	21.2	0.0	6.6	16.2	3.2	41.3	319.8	11.5	8.3	25.0	2.8	8.5	23.4	0.5	79.7	450.0	0.0	4.2	2.7	7.0	25.8	22.5	2.3	4.1	30.6	3.2	2.5	0.8	27.7
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384479-30572261	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 71.1;RPTEC TERT1: 49.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056999: AB_2683306"	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	71.3	20.4	2.3	28.4	6.9	0.2	112.8	1.4	2.9	81.7	66.1	4.4	46.3	6.9	90.8	31.8	66.2	35.7	50.4	53.8	2.8	2.7	69.1	34.5	36.7	19.3	5.4	3.4	65.5	15.0	12.2	10.4	29.2	9.3	77.3	13.7	41.2	22.9	59.8	14.5	11.8	22.3	181.8	10.3	28.9	38.1	27.4	2.9	4.8	54.1	8.5	10.9	155.4	88.9	0.5	3.9	0.3	0.2	0.7	0.3	0.0	0.1	11.0	12.5	0.0	71.1	21.3	31.3	15.7	21.5	19.4	16.1	16.1	6.6	0.1	8.4	20.1	17.8	6.2	14.3	11.4	23.4	0.0	3.0	0.3	5.2	16.5	30.6	0.1	2.5	24.7	2.9	18.6	2.4	21.8	11.1	0.5	0.1	0.0	9.4	6.7	0.0	0.2	32.1	12.8	7.2	0.7	3.4	0.9	49.1	18.6	0.2	2.5	1.6	11.8	7.8	43.3	2.4	0.0	10.2	9.6	0.9	16.5	2.6	0.0	0.0	0.0	15.8	0.0	4.2	0.0	0.1	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.3	0.7	0.0	3.9	0.1	0.0	2.3	6.9	1.4	2.9	2.8	2.7	5.4	3.4	9.3	2.9	50.6	90.6	2.2	53.3	8.2	6.3	93.4	68.8	17.4	43.3	134.3	2.0	85.5	96.2	84.7	73.8	58.9	0.5	0.0	81.9	170.5	37.3	65.0	9.3	48.4	31.6	0.0	1.7	44.8	2.7	22.7	158.5	7.2	13.5	3.6	0.0	0.8	62.0	0.0	169.4	182.3	5.0	109.9	122.1	30.7	15.5	6.9	34.4	4.9	0.0	117.1
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 25.3;HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	6.1	0.4	0.0	0.0	0.0	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	50.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	5.6	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0	6.0	4.3	0.8	3.8	5.6	19.4	229.0	2.5	0.0	0.0	3.5	3.9	0.0	59.7	5.8	22.0	10.8	0.0	0.0	2.1	0.0	5.6	1.7	0.0	0.2	0.1	28.6	24.1	0.0	0.3	11.0	27.0	1.8	30.4	0.0	0.3	167.3	4.3	0.0	47.4	1.4	8.0	97.0	159.7	0.7	0.9	6.5	0.0	0.0	0.1	1.1
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488959-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	15.8	10.6	9.1	10.3	8.9	3.8	9.7	7.3	12.1	14.2	7.3	19.0	15.2	4.3	22.3	11.1	11.9	11.7	10.5	11.6	9.0	8.6	14.8	8.0	8.8	8.5	15.8	6.2	18.0	6.1	4.7	25.8	14.9	11.4	14.6	7.0	20.0	27.4	18.5	6.1	4.6	6.1	11.9	16.3	14.9	8.0	5.8	12.8	4.4	23.9	6.9	10.6	10.3	11.3	0.5	13.1	25.9	19.0	6.7	7.3	9.1	0.4	0.3	6.5	0.4	5.1	4.5	0.0	1.9	2.4	1.1	0.8	0.2	0.4	1.3	1.4	3.0	0.7	0.8	0.9	0.7	1.3	1.6	1.2	3.4	0.9	0.3	1.9	1.5	2.1	4.6	1.9	1.5	0.7	2.7	3.5	8.7	0.2	2.0	4.1	0.1	78.3	4.4	3.5	0.1	1.0	6.6	0.6	5.6	2.2	1.0	1.4	1.2	1.5	0.3	2.3	2.8	0.1	3.9	3.0	1.3	0.6	0.3	0.7	0.1	0.1	1.5	0.7	3.5	2.5	2.2	19.0	2.1	7.1	13.7	4.3	0.5	6.0	7.3	13.1	0.5	3.6	5.4	25.9	6.7	12.0	0.2	7.1	9.1	9.1	8.9	7.3	9.7	9.0	8.6	15.8	6.2	11.4	12.8	3.0	3.5	7.8	10.6	5.5	1.2	11.8	5.1	2.7	9.1	5.2	2.0	1.2	6.6	0.7	5.6	17.6	0.7	0.0	0.7	1.1	8.7	5.6	8.1	4.7	22.1	1.6	7.9	25.8	30.3	5.9	8.6	30.1	8.5	16.2	2.0	31.9	1.1	0.9	13.4	9.6	3.7	12.9	7.6	10.1	3.2	5.0	0.8	20.8	2.0	6.8
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 181.3;Late spermatids: 634.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	12.3	11.2	7.5	21.1	10.9	32.0	13.9	5.8	10.4	11.6	17.9	5.0	8.0	17.5	12.1	10.1	30.1	12.6	8.6	6.9	8.0	4.6	9.5	23.0	15.3	22.7	14.8	4.0	16.3	21.0	4.7	12.4	17.0	9.8	10.2	19.0	6.0	20.6	7.8	13.6	11.7	14.7	12.7	17.7	23.0	11.8	46.7	10.2	34.2	47.9	28.4	34.2	16.4	16.7	8.4	16.0	4.6	8.7	6.2	11.5	6.9	48.3	21.0	18.2	21.5	13.0	16.9	20.4	19.0	11.6	30.9	24.2	20.8	38.9	62.1	11.7	18.2	12.8	29.1	59.4	30.2	24.3	25.1	35.4	54.8	25.6	27.4	9.8	59.7	32.9	21.3	20.1	29.7	24.5	18.6	21.0	37.5	40.8	19.2	12.5	26.2	47.6	21.7	39.2	22.3	20.5	47.2	32.2	30.3	11.5	22.7	29.3	14.9	20.6	32.7	15.8	10.3	13.8	18.7	16.1	15.9	31.5	19.5	36.8	11.7	16.5	47.5	15.5	88.4	17.1	4.6	8.7	3.2	6.2	8.7	11.5	8.4	9.2	9.6	16.0	7.7	8.3	9.1	1.9	6.2	6.2	9.1	8.4	6.9	7.5	10.9	5.8	10.4	8.0	4.6	14.8	4.0	9.8	10.2	0.0	9.3	16.4	8.8	32.5	0.8	4.0	7.6	9.4	9.1	7.0	2.0	18.6	3.3	28.4	181.3	8.7	7.4	23.3	20.5	31.6	11.8	10.1	1.1	5.3	18.6	12.7	5.2	4.3	10.5	634.1	15.8	9.7	13.5	16.2	15.5	0.2	34.0	3.5	9.9	3.5	0.3	6.5	13.3	11.4	18.1	29.5	20.5	12.9	23.4	16.3
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	7.4	8.5	4.4	7.0	5.1	4.2	3.3	4.3	5.6	5.8	6.4	7.0	7.2	6.4	5.0	4.8	7.4	4.8	7.7	11.5	3.7		7.9	12.0	3.9	5.5	5.6	4.0	7.1	9.1	4.9	3.3	6.5	3.8	7.2	3.2	7.3	7.8	6.4	33.4	4.3	6.0	9.5	2.3	6.8	4.8	5.4	5.7	3.6	8.7	8.4	6.8	5.8	7.7	6.8	5.5	4.8	4.9	6.7	9.2	2.6	15.3	23.5	12.4	21.1	8.9	7.3	17.2	15.0	10.8	12.9	10.6	23.7	18.9	16.3	6.9	12.1	16.9	18.2	10.5	10.0	5.4	17.9	16.7	12.0	15.7	22.1	12.6	19.2	19.5	9.0	8.3	11.2	9.1	8.7	11.4	3.5	38.4	10.6	9.9	32.6	0.9	29.1	29.0	18.6	18.5	9.3	10.1	34.0	11.2	14.0	13.5	20.2	20.1	42.6	18.3	9.1	30.0	20.1	12.8	17.1	14.3	15.2	19.5	11.9	9.4	25.6	13.1	20.4	22.5	4.8	3.8	2.2	7.3	4.9	5.7	5.7	7.8	6.4	5.3	6.8	7.5	9.2	1.4	6.7	3.5	5.5	5.9	2.6											0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	21.0	0.0	50.0	41.4	21.1	0.0	0.0	0.0	0.0	17.7	33.6	0.0	0.0	4.7	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	29.7	0.0	0.0	16.6	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	15.1	15.0	17.2	14.9	19.6	25.8	18.9	33.7	21.7	17.3	16.2	17.3	26.8	11.8	19.1	21.9	13.5	16.0	17.1	20.8	16.3	14.4	15.7	13.5	15.8	15.3	18.8	20.8	27.5	18.2	21.4	23.8	14.1	18.6	23.7	13.4	17.3	18.0	35.5	55.3	17.7	16.5	23.6	18.1	17.5	14.4	31.4	21.3	20.6	30.0	16.4	13.4	17.9	16.3	10.0	9.5	27.3	8.5	11.8	10.7	5.4	9.9	7.8	15.9	8.9	13.8	12.9	17.7	11.3	11.3	12.8	13.3	7.6	13.0	14.6	7.9	14.5	9.0	15.0	12.7	11.2	10.0	14.9	7.5	13.3	14.0	10.1	15.5	20.1	12.9	14.3	10.6	13.9	17.2	14.1	7.9	14.5	13.8	18.3	18.5	6.6	10.3	11.6	17.4	6.8	9.6	11.3	30.8	16.7	10.6	17.2	10.2	22.2	29.0	15.1	21.1	15.7	18.9	14.4	10.8	11.4	13.0	14.7	12.7	16.2	10.6	18.3	9.5	12.0	10.0	15.3	8.1	27.3	6.0	7.5	7.9	10.0	6.5	6.2	8.5	8.0	10.7	7.6	13.7	11.8	8.5	9.5	7.6	5.4	17.2	19.6	33.7	21.7	16.3	14.4	18.8	20.8	18.6	21.3	35.7	41.5	10.2	9.5	12.9	43.2	61.3	28.1	25.4	29.6	14.0	33.4	21.6	18.3	8.4	51.5	15.5	17.7	0.0	13.4	12.4	17.2	13.2	18.5	18.7	17.5	22.3	32.8	20.9	20.2	93.2	20.8	21.1	21.9	17.2	17.5	25.7	9.1	16.7	25.5	19.9	49.5	0.0	20.2	56.9	31.5	14.8	21.3	17.5	16.9	7.6
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.6	5.9	5.0	4.1	15.1	16.1	16.8	11.4	11.7	10.3	10.3	4.6	9.7	18.4	6.8	6.8	13.4	10.2	7.2	13.3	12.1	10.2	19.8	7.2	6.5	13.8	12.9	8.7	9.8	12.2	13.6	10.0	15.7	14.5	9.5	7.5	12.8	6.3	16.9	6.0	7.5	15.4	13.5	14.3	16.9	11.0	13.6	7.9	20.2	12.2	7.7	13.4	6.2	13.7	16.2	10.9	6.8	5.0	9.5	14.7	9.1	11.6	13.5	17.9	14.7	13.7	10.5	6.0	11.5	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8	14.9	10.9	21.4	26.0	21.8	22.4	43.0	22.9	2.7	6.8	15.7	5.9	40.0	26.6	32.8	16.1	17.9	14.0	0.0	30.8	42.8	33.7	31.0	12.7	26.8	21.0	14.3	12.7	17.2	15.1	9.4	61.9	14.8	21.9	22.6	27.1	25.0	23.9	32.3	42.1	30.5	18.0	32.3	30.7	71.9	28.2	16.3	38.2	17.5	29.8	23.7
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296722	"Disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 81.0"	"Cell type enhanced"	"Detected in all"	4	"Alveolar cells type 1: 449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		77000000	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	15.9	81.0	17.9	7.0	29.2	4.2	22.3	9.3	20.2	14.7	10.1	19.5	11.1	2.9	12.7	9.1	11.9	8.8	11.6	16.9	20.8	17.0	21.7	28.6	20.4	8.7	27.5	15.2	23.7	22.0	16.0	16.1	16.4	31.6	11.3	4.9	7.4	9.0	11.9	35.5	5.5	5.3	14.9	50.4	10.6	8.3	13.9	30.6	3.5	19.7	11.8	5.9	13.4	11.9	9.4	9.6	17.1	11.4	13.1	15.8	5.6	17.1	9.1	36.3	14.4	21.4	23.8	20.7	21.8	12.4	14.4	15.9	25.5	30.1	0.0	33.5	27.0	22.6	15.8	20.1	20.9	21.6	10.3	11.1	12.7	30.4	18.9	20.0	4.7	8.8	24.3	11.9	17.9	32.2	23.9	39.1	2.8	18.1	7.7	33.3	30.3	2.7	3.8	11.5	1.0	14.9	7.9	25.5	7.5	18.3	8.6	9.9	10.7	38.4	17.4	13.7	28.5	22.3	7.6	24.1	24.0	17.9	11.5	16.9	2.5	4.1	16.6	9.1	2.8	55.1	17.1	11.4	16.5	9.4	9.4	12.5	9.4	8.4	6.9	9.6	6.1	5.7	4.6	1.3	13.1	7.1	7.8	15.8	5.6	17.9	29.2	9.3	19.0	20.8	17.0	27.5	15.2	31.6	30.6	449.6	96.4	30.6	43.1	49.8	78.4	144.4	71.4	41.5	64.8	71.5	41.2	104.4	92.9	108.4	11.2	193.3	6.7	70.0	374.9	158.2	87.8	55.0	65.8	217.4	75.7	95.3	21.4	279.3	93.7	28.8	254.9	61.2	69.2	186.7	9.3	84.0	127.6	20.1	250.7	141.1	88.4	122.9	79.0	72.1	242.5	35.4	190.1	31.6	16.8	27.6
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.2	20.9	8.5	12.0	11.8	7.9	19.6	8.3	7.0	10.9	9.7	9.2	12.0	13.4	9.1	7.3	14.5	10.8	8.8	10.0	10.4	7.2	16.4	24.4	25.3	13.2	11.9	7.9	12.2	11.2	12.3	10.8	13.1	12.5	14.2	14.9	12.3	11.9	8.0	10.0	16.1	10.7	5.5	10.8	16.2	13.1	19.8	13.5	9.2	13.4	10.2	9.9	9.1	16.4	11.2	12.2	29.5	6.3	7.2	14.1	16.2	7.7	8.6	17.0	9.7	12.9	11.6	7.9	10.1	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0	0.0	9.9	5.4	2.9	0.9	7.9	6.1	5.1	14.7	2.3	26.2	17.7	6.8	5.0	4.6	3.7	3.6	11.1	0.0	2.9	4.2	3.1	2.9	1.1	6.0	4.4	9.5	4.6	8.0	5.9	1.5	3.7	3.9	3.3	1.8	8.5	7.4	5.3	8.2	2.5	3.7	12.8	0.0	1.0	10.9	10.5	1.8	9.7	4.4	6.3	8.9
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001430-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 90.3;Glandular cells: 104.0;monocytes: 170.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.4;HDLM-2: 32.4;U-698: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	8.0	6.8	2.2	27.6	3.6	27.8	6.8	1.2	3.1	4.9	12.2	2.1	1.6	8.8	8.5	4.7	6.4	5.2	10.9	11.9	1.8	1.6	10.1	7.4	12.8	18.2	3.6	0.9	7.8	12.3	1.9	2.1	4.7	2.8	9.9	3.4	3.6	7.3	4.8	8.1	8.3	13.0	8.4	3.9	17.2	8.3	3.7	1.7	17.7	5.6	7.2	24.8	8.8	6.1	8.2	3.9	14.5	5.0	2.1	2.2	1.7	8.9	5.3	0.5	2.4	1.2	4.0	1.9	1.6	11.6	2.5	4.1	1.8	9.9	25.4	4.7	2.6	8.9	4.1	0.2	3.7	2.2	32.4	0.8	0.9	0.3	1.0	10.4	1.9	15.1	6.5	1.5	5.2	6.1	2.3	1.6	0.7	0.2	16.5	0.9	2.1	0.4	6.0	0.8	2.5	1.0	1.9	1.3	3.0	4.2	13.9	0.0	0.8	1.7	4.8	4.6	0.6	1.7	4.9	5.2	6.1	3.0	2.2	5.9	21.0	12.4	27.3	6.7	0.7	3.4	0.0	5.0	2.1	1.4	3.2	2.1	8.2	2.2	2.0	3.6	7.9	1.8	0.9	14.5	2.1	2.6	3.9	1.1	1.7	2.2	3.6	1.2	3.1	1.8	1.6	3.6	0.9	2.8	1.7	6.0	14.3	26.4	90.3	33.7	0.0	1.7	12.7	1.4	11.4	3.5	0.0	3.5	8.3	30.3	5.1	11.3	45.5	0.0	27.0	5.8	13.4	104.0	51.7	3.4	17.6	3.2	21.9	6.7	13.3	2.4	4.4	25.4	23.6	170.5	12.4	0.6	29.3	80.7	2.5	14.3	0.2	6.5	41.2	0.5	1.2	27.9	8.2	7.5	8.1	75.4
REST	"NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966678	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	14.4	11.4	6.0	15.6	8.9	21.5	39.7	2.1	6.3	13.7	11.0	5.6	13.0	6.5	14.2	13.7	14.5	11.2	13.8	22.1	6.1	4.5	13.9	12.0	18.2	35.6	8.2	3.0	13.9	15.9	22.4	4.5	14.4	11.8	17.3	7.6	7.2	14.0	27.6	13.8	11.6	12.0	16.3	15.2	18.7	10.4	15.3	8.2	43.4	13.4	8.3	14.0	15.6	19.5	16.7	10.7	9.0	8.4	16.7	15.3	4.2	7.1	9.0	12.6	12.4	9.5	11.9	15.9	10.6	9.5	11.3	10.3	9.0	11.0	16.9	17.0	11.5	7.5	6.5	9.2	11.2	17.9	8.9	5.5	15.4	7.2	7.9	11.5	19.5	9.3	11.8	10.0	10.9	11.2	14.2	14.0	12.6	9.9	18.2	13.1	11.3	22.4	13.3	10.6	8.0	5.9	19.9	10.8	5.3	12.8	12.8	0.2	5.7	12.8	12.5	9.5	18.1	13.3	12.7	19.7	14.5	12.9	8.1	9.5	7.3	5.4	10.3	9.3	11.1	7.4	9.0	3.6	7.7	10.6	5.3	8.9	12.0	10.5	10.4	8.1	16.7	15.3	9.3	3.7	16.7	8.4	10.7	10.3	4.2	6.0	8.9	2.1	6.3	6.1	4.5	8.2	3.0	11.8	8.2	65.5	53.4	33.5	45.2	50.7	0.7	41.7	45.9	45.5	45.5	27.9	76.6	44.5	19.9	50.7	6.8	41.7	19.2	23.3	33.6	47.5	36.3	41.5	50.7	27.6	29.0	0.0	3.5	39.9	29.8	7.6	36.5	34.3	20.3	92.8	21.2	48.8	37.7	26.8	34.6	18.5	36.6	32.3	40.1	56.1	40.7	40.0	55.5	57.1	21.8	42.5
REXO1	"EloA-BP1, KIAA1138, TCEB3BP1"	ENSG00000079313	"RNA exonuclease 1 homolog"	Q8N1G1	19	1815246-1848463	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 159.9;Horizontal cells: 44.5;Late spermatids: 156.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042155, HPA042552"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042155: AB_10806233, HPA042552: AB_10794280"	"unprognostic (1.36e-1)"	"unprognostic (3.86e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-2)"	10.9	17.6	15.6	11.9	19.5	19.3	11.5	13.0	25.4	6.2	9.3	10.3	3.4	12.1	9.5	5.5	8.3	7.7	7.8	7.7	14.0	5.9	8.3	10.3	9.0	14.2	8.6	10.3	9.7	16.1	5.1	6.6	13.7	8.9	7.8	5.6	7.6	11.1	7.1	13.8	14.2	11.7	9.4	5.7	20.0	10.4	31.7	11.6	9.6	7.8	6.2	9.7	7.8	9.0	1.4	1.2	2.0	0.8	0.7	1.4	1.0	11.9	7.7	7.1	11.0	2.8	3.7	14.4	8.7	4.7	6.4	5.7	10.0	6.7	10.3	5.9	6.0	4.1	10.6	5.3	9.7	2.8	16.3	8.3	10.8	8.4	5.8	6.5	9.5	17.8	6.5	5.6	8.4	5.6	3.6	5.8	14.8	16.2	17.9	3.3	7.5	15.7	10.7	16.0	4.8	7.6	14.1	5.9	9.7	4.2	6.8	10.5	11.5	5.4	9.2	11.2	5.0	8.0	14.1	10.0	10.1	8.8	16.8	14.5	29.2	14.0	8.9	8.1	11.5	13.0	1.3	0.8	0.5	1.0	0.7	0.8	0.6	0.8	0.6	0.6	1.4	1.1	1.4	2.0	0.7	0.8	1.2	0.3	1.0	15.6	19.5	13.0	25.4	14.0	5.9	8.6	10.3	8.9	11.6	0.0	5.1	3.4	6.8	14.2	17.4	1.2	5.1	0.0	6.8	17.4	7.9	17.4	1.7	7.1	159.9	11.1	17.3	0.0	7.4	9.6	9.1	7.7	5.7	13.0	9.4	44.5	17.6	12.3	9.8	156.1	6.9	6.6	6.8	6.4	15.3	7.2	11.6	15.9	7.1	7.1	17.6	0.0	6.6	14.6	16.9	14.6	17.2	8.7	14.4	9.0
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	8.6	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	8.1	7.7	10.2	22.4	8.3	6.7	16.6	16.3	14.0	12.8	20.9	19.4	11.6	10.4	18.7	6.7	5.5	18.2	9.9	10.6	12.4	11.4	6.6	15.2	9.4	6.7	19.4	10.1	9.2	12.1	5.5	6.7	12.9	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4	20.8	16.7	29.8	15.4	22.1	25.1	8.3	20.4	10.7	5.7	24.4	21.6	30.4	16.6	26.8	36.5	13.7	23.1	0.0	24.7	31.4	12.1	12.4	17.3	25.5	18.7	15.9	12.7	14.1	16.4	56.5	26.7	12.6	6.8	50.5	19.2	14.2	26.4	17.5	22.6	14.7	29.5	19.4	11.7	39.0	65.9	24.1	26.3	27.7	26.9	11.2
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	22.9	17.9	20.9	20.7	4.3	5.1	9.6	13.5	14.9	27.5	33.2	19.8	21.4	21.7	3.8	9.5	26.1	15.8	17.0	22.6	28.6	15.5	29.5	13.2	24.9	14.7	3.4	19.8	8.2	5.1	5.1	25.9	17.9	6.0	14.7	20.9	27.4	13.4	21.1	27.1	19.7	38.6	23.8	36.5	15.1	29.5	23.2	27.1	14.7	18.6	17.0	21.6	16.0	30.3	11.0	26.9	21.9	18.3	5.7	27.3	18.1	21.0	30.1	8.2	10.6	37.7	13.8	30.7	28.3	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0	11.9	12.0	15.3	19.1	21.2	14.1	5.0	10.2	9.4	15.9	5.2	2.0	51.5	5.0	14.8	2.2	11.7	9.9	0.0	16.7	50.3	12.7	9.4	22.0	13.1	32.8	3.2	4.6	11.6	12.7	1.8	8.1	24.0	20.3	34.3	7.8	12.8	12.3	5.8	10.3	7.8	8.7	6.5	15.1	23.6	52.6	14.9	38.6	23.6	15.6	12.4
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818049-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 32.4;Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	8.0	17.7	5.7	19.1	7.2	14.4	10.9	19.9	10.2	7.9	7.5	5.6	5.9	6.9	11.6	8.9	10.3	7.0	6.5	6.2	5.2	5.5	5.4	6.2	6.6	19.1	4.7	5.6	9.6	7.6	3.7	5.9	14.2	8.6	5.7	10.3	7.0	7.8	4.6	6.1	7.5	7.0	6.6	5.6	11.8	6.3	17.8	3.7	34.7	6.1	9.7	19.2	5.2	7.0	8.2	7.9	8.5	7.5	3.3	8.3	4.1	11.6	11.7	22.3	18.0	1.7	2.7	12.1	16.2	7.5	21.9	19.0	15.3	18.1	43.8	6.9	6.3	13.4	18.0	28.2	11.5	29.6	16.8	16.8	25.3	13.6	16.6	1.9	30.6	12.2	2.6	1.5	18.8	13.0	3.6	7.2	15.9	17.6	11.1	13.1	13.6	25.8	14.6	26.2	25.1	10.2	9.7	26.0	10.0	6.5	10.5	11.6	20.4	12.2	16.5	8.5	12.7	13.3	17.0	3.8	11.5	12.9	14.6	17.2	6.2	8.5	70.2	8.3	18.1	22.0	1.6	5.7	8.5	4.5	7.5	4.9	8.2	5.5	4.7	7.9	7.8	7.4	6.3	1.3	3.3	6.5	3.3	8.3	4.1	5.7	7.2	19.9	10.2	5.2	5.5	4.7	5.6	8.6	3.7	8.9	3.8	9.7	6.5	10.9	14.0	7.4	2.5	4.0	10.3	3.5	7.9	18.1	3.3	4.6	7.0	5.8	0.4	0.0	7.7	32.4	6.6	2.9	1.1	5.4	10.2	7.9	5.8	8.6	7.3	5.0	5.8	5.0	8.5	6.4	4.3	5.7	3.9	0.0	4.2	3.5	11.3	6.5	3.8	25.0	43.9	6.0	13.7	4.6	4.5	1.4
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"stomach 1: 118.3"	"Cell type enriched"	"Detected in some"	24	"Pancreatic endocrine cells: 66.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3"					"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	5.5	3.0	6.4	5.2	8.6	2.6	8.2	10.8	6.6	11.7	20.9	9.7	7.0	19.5	4.8	4.8	3.0	5.5	3.7	5.1	6.3	6.3	5.4	5.3	3.2	2.8	9.8	5.2	5.2	7.6	2.7	9.4	3.4	9.0	6.3	15.4	6.3	8.7	5.4	8.5	4.2	20.7	3.4	8.3	2.8	118.3	2.7	8.3	1.9	9.6	2.3	2.8	3.3	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.3	0.0	0.0	0.3	0.3	1.1	0.8	0.0	0.1	3.1	0.1	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.0	9.0	0.0	0.5	12.8	1.3	0.0	0.0	22.4	0.0	0.0	0.0	1.9	23.3	0.0	0.0	7.3	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.6	10.8	6.6	6.3	6.3	9.8	5.2	9.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	14.1	18.2	13.8	10.0	2.9	4.0	15.5	12.8	9.9	20.5	17.9	23.7	14.9	19.8	10.5	10.0	10.3	17.1	22.4	13.3	25.2	6.2	13.4	17.5	14.8	13.3	2.5	17.6	18.3	2.8	4.2	25.8	16.0	5.3	8.7	16.9	26.4	8.9	15.4	22.6	25.6	16.1	27.1	8.3	8.8	39.9	9.3	17.4	7.3	15.1	10.2	10.9	20.6	7.3	9.1	13.0	13.4	15.0	8.4	15.0	14.4	8.4	16.1	12.1	22.4	59.4	10.7	13.6	18.2	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2	0.0	5.1	11.2	5.0	9.6	5.8	2.4	2.5	2.7	5.7	1.8	9.8	9.1	10.0	5.6	4.2	5.2	4.2	23.3	6.6	6.6	4.8	9.2	4.6	6.4	7.6	3.2	9.1	10.4	13.7	5.4	3.4	6.1	15.1	3.6	8.3	3.5	8.2	0.0	3.9	3.4	6.8	6.5	5.6	46.5	30.6	8.2	6.3	7.5	7.3	12.0
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961538-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 122.1;Late spermatids: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	7.4	7.4	13.1	8.7	13.1	9.8	7.0	36.2	19.3	10.3	6.0	6.2	10.2	10.6	8.0	4.6	8.0	8.5	6.3	7.0	11.7	5.9	7.9	8.6	7.0	7.2	8.6	9.5	10.2	12.5	11.9	18.9	8.0	9.5	8.5	3.1	9.8	12.7	12.4	11.0	7.0	9.2	4.4	6.8	12.0	11.2	21.0	10.8	11.6	10.9	3.4	9.3	6.8	13.6	3.9	3.5	10.8	3.5	3.4	2.0	1.1	6.2	6.3	3.4	4.1	2.1	2.6	10.3	3.5	2.3	4.0	3.5	6.5	6.3	3.5	7.0	1.8	3.5	8.2	2.5	2.5	1.4	3.5	14.1	4.0	7.1	5.8	3.9	4.1	8.6	1.9	2.7	3.6	2.1	3.6	3.2	3.1	10.2	4.0	2.1	9.5	7.4	8.9	7.7	3.4	9.7	6.5	3.5	5.0	4.0	3.4	14.2	7.5	6.0	5.3	4.8	1.9	5.6	4.3	3.7	7.1	5.8	7.7	5.9	9.4	4.2	2.4	5.6	4.0	6.2	0.7	3.5	1.6	1.4	1.1	1.3	2.9	1.6	1.5	1.7	3.9	1.7	2.0	10.8	3.4	2.0	3.5	1.0	1.1	13.1	13.1	36.2	19.3	11.7	5.9	8.6	9.5	9.5	10.8	14.9	9.9	15.9	8.0	4.9	27.9	7.7	5.1	1.4	12.5	21.0	33.4	8.2	8.3	8.7	122.1	9.8	14.9	0.0	8.4	10.4	9.6	6.2	11.5	14.4	9.2	22.3	16.0	13.5	17.5	79.7	23.9	8.5	1.7	3.6	14.5	13.8	9.3	12.5	26.2	6.7	47.6	12.9	6.1	31.2	17.5	6.6	15.9	15.3	12.7	5.6
RFX3		ENSG00000080298	"Regulatory factor X3"	P48380	9	3218297-3526004	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1;testis: 36.5"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 140.5;Early spermatids: 159.1;Intestinal endocrine cells: 135.5;Late spermatids: 86.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 22.4;HDLM-2: 13.2;SCLC-21H: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035689	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035689: AB_10671224"	"prognostic favorable (1.47e-4)"	"unprognostic (8.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.52e-1)"	"unprognostic (8.89e-3)"	5.2	4.6	17.9	7.6	14.9	11.4	6.7	35.1	19.5	6.9	4.7	6.9	5.0	5.0	6.8	6.3	3.8	22.0	5.2	4.0	12.8	7.5	5.0	4.1	7.2	6.7	6.0	11.9	7.0	5.4	9.0	21.7	5.8	9.9	6.1	5.6	4.2	4.7	4.6	5.7	4.4	5.0	4.0	12.5	5.7	6.6	36.5	11.0	12.7	5.7	2.9	7.5	4.5	7.8	8.3	4.6	8.9	4.8	5.3	9.3	3.2	2.0	2.7	22.4	5.4	0.9	1.0	2.2	0.8	2.4	1.9	1.4	0.8	2.6	3.2	0.9	1.1	1.6	1.1	5.5	2.3	3.4	13.2	1.5	6.0	3.0	1.8	1.1	1.2	0.8	1.4	1.1	2.3	3.8	3.8	3.3	4.2	1.1	3.3	2.0	1.6	3.8	4.4	5.9	1.7	1.2	4.0	1.5	0.8	3.1	1.6	12.0	5.3	1.3	0.6	2.0	4.6	1.1	3.2	2.0	1.4	3.3	0.7	1.3	1.1	0.5	6.4	1.6	1.4	1.5	3.5	3.2	6.2	8.8	4.8	5.4	6.3	8.1	7.2	3.1	8.3	5.7	7.0	8.9	5.3	1.4	4.6	9.3	3.2	17.9	14.9	35.1	19.5	12.8	7.5	6.0	11.9	9.9	11.0	6.0	7.7	6.2	7.4	4.4	22.0	4.9	0.0	140.5	34.2	3.5	23.6	1.6	0.0	3.1	159.1	13.5	2.5	0.0	2.2	2.1	4.3	9.6	5.8	0.9	2.7	36.5	135.5	11.6	6.9	86.4	6.6	6.2	1.7	1.0	9.2	13.8	3.2	5.8	7.1	1.7	25.2	0.0	10.3	10.2	2.5	5.5	1.1	6.7	5.5	3.3
RFX7	"FLJ12994, RFXDC2"	ENSG00000181827	"Regulatory factor X7"	Q2KHR2	15	56087280-56243266	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035462	Supported		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA035462: AB_10602152"	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	6.6	6.6	4.2	4.1	7.1	6.7	5.0	28.2	11.7	4.4	3.5	8.6	3.0	4.3	4.4	4.9	5.1	4.1	3.1	4.2	4.7	3.6	4.4	4.2	4.1	7.1	4.5	8.3	4.7	6.3	7.1	10.6	4.1	8.1	3.9	3.9	2.7	5.3	7.1	13.7	9.8	4.6	4.1	6.4	6.0	4.1	6.0	6.8	15.4	4.2	3.7	7.2	4.9	4.8	1.3	1.5	4.6	0.8	1.4	2.6	0.5	3.9	6.1	14.6	11.1	6.3	7.2	3.8	2.9	4.1	3.9	6.2	4.3	2.9	11.1	4.8	4.3	3.3	10.1	8.8	5.6	5.3	5.9	3.5	13.1	8.3	9.3	6.5	10.6	2.3	5.9	13.3	3.5	8.8	6.9	7.0	11.3	6.1	5.8	6.6	4.6	8.9	4.3	6.9	3.2	2.3	9.9	9.4	10.1	5.7	10.1	8.1	10.2	3.7	4.3	5.2	11.1	3.3	8.6	5.8	10.7	5.4	2.7	6.3	5.5	5.2	12.6	3.8	11.4	4.7	4.6	0.5	0.9	1.2	0.8	1.6	1.2	1.8	1.9	0.9	1.3	1.0	1.3	0.0	1.4	0.4	1.5	2.6	0.5	4.2	7.1	28.2	11.7	4.7	3.6	4.5	8.3	8.1	6.8	6.0	11.2	5.4	4.2	11.8	15.8	5.3	2.5	6.7	4.5	7.0	9.8	3.5	3.3	3.0	16.3	6.2	3.0	23.3	4.0	1.2	5.4	5.4	11.6	7.6	4.7	15.9	4.6	8.0	11.3	9.1	6.1	5.6	5.0	1.8	5.6	4.1	3.0	6.5	9.9	3.7	7.4	0.0	3.6	6.6	5.8	15.4	1.4	6.4	6.2	5.1
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.4;Late spermatids: 6.0;Spermatocytes: 4.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;hTEC/SVTERT24-B: 15.7;LHCN-M2: 7.5;U-87 MG: 10.4;U-937: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	2.0	1.4	1.4	1.4	0.0	3.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.1	0.0	15.7	0.1	0.0	0.0	0.5	0.0	0.0	7.5	0.0	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.4	4.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.5	4.7	0.7	0.0	1.1	0.0	0.0	0.1
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		390000	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	9.0	0.0	1.7	15.4	0.3	0.2	80.7	0.0	0.3	11.2	0.1	26.2	0.2	1.0	0.0	0.2	0.3	0.5	0.1	2.7	1.3	0.0	1.9	0.8	0.9	0.9	0.3	1.2	1.7	0.3	11.2	0.1	9.2	6.1	2.0	0.0	0.2	0.0	5.8	0.5	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.8	0.2	5.0	6.2	0.0	1.0	0.5	0.1	0.0	0.0	27.6	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8	229.3	54.7	23.2	621.5	76.8	0.8	12.0	0.0	38.8	47.8	3.5	2.0	3.9	29.9	0.6	7.3	237.2	0.3	303.7	0.0	5.3	88.9	288.4	49.5	0.8	320.9	0.0	81.3	31.9	23.8	7.0	7.5	180.3	183.9	0.0	7.4	1.4	0.3	3.4	2.1	0.5	1.4	122.9	80.2	14.1	4.1	57.0	9.3	44.5	6.6	105.6
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.8	0.9	1.1	0.5	1.6	8.4	6.0	0.0	5.4	1.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.1	2.6	2.3	0.0	0.0	0.0	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	1.1	0.0	0.6	1.6	5.1	17.4	0.8	4.4	0.2	7.7	2.6	3.1	12.8	0.0	0.0	2.7	0.0	2.0	0.7	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3	17.9	15.2	0.0	2.0	0.1	0.1	2.5	5.1	2.7	22.7	48.8	0.0	12.2	10.0	8.3	0.0	3.9	0.0	0.0	3.6	9.6	4.6	1.0	1.1	4.3	2.6	0.0	9.9	25.8	4.3	0.0	3.4	0.6	5.0	0.0	7.1	28.8	5.8	5.3	0.4	3.0	0.4	38.8	12.4	0.5	1.2	0.0	10.1	0.0	2.7	1.4
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Group enriched"	"Detected in many"	5	"Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		1400000	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	31.0	0.5	6.5	3.6	9.1	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	0.0	2.0	5.2	0.1	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.1	3.8	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.6	9.2	0.1	13.9	0.0	0.0	8.0	7.1	0.0	0.0	0.3	3.3	1.8	0.3	0.1	0.0	1.7	2.5	1.6	0.1	0.0	6.7	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1	0.0	1.0	0.0	15.6	4.8	0.2	3.2	0.0	1.4	2.3	0.0	2.0	3.8	0.0	4.7	0.8	1.1	0.0	0.0	0.6	1.0	7.4	13.3	0.0	0.0	1.8	0.0	0.0	3.1	3.7	2.6	110.1	1.1	3.3	0.0	0.0	4.1	0.6	0.0	110.0	0.0	1.1	12.9	12.3	0.7	37.2	2.5	2.1	0.7	0.0	12.0
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499828-119542708	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.9;lymphoid tissue: 96.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	9.6	7.7	11.9	28.2	12.1	23.6	15.4	2.8	12.4	25.8	44.0	17.0	5.3	12.5	15.3	13.1	21.9	10.8	18.8	11.7	12.0	10.5	8.3	3.9	13.5	47.6	17.4	6.7	10.3	3.9	0.8	6.6	16.9	10.5	17.8	18.9	6.4	18.1	8.2	13.2	9.3	23.1	19.1	28.5	18.7	12.8	3.7	11.1	96.9	14.7	11.1	34.3	17.9	20.0	6.9	40.2	20.5	26.3	7.6	77.9	63.0	30.1	5.6	0.4	53.0	7.6	49.0	5.0	14.1	21.4	8.5	13.7	1.7	7.2	12.9	7.5	10.9	8.3	6.7	7.9	8.5	22.6	6.3	9.1	34.6	1.6	4.1	12.3	7.0	94.1	19.0	11.4	16.5	15.4	29.1	16.1	12.7	8.8	10.5	9.8	13.7	40.9	24.5	2.4	3.7	15.3	8.0	0.0	4.8	4.3	7.1	2.1	1.7	2.7	34.7	49.6	6.8	6.6	12.5	21.3	4.9	4.2	7.0	12.0	0.5	8.1	4.7	1.5	30.7	2.1	20.5	21.5	0.2	15.0	26.3	15.7	6.9	32.5	25.8	40.2	3.6	77.9	58.5	9.9	7.6	21.6	23.9	35.0	63.0	11.9	12.1	2.8	12.4	12.0	10.5	17.4	6.7	10.5	11.1	0.0	19.1	64.8	23.8	32.6	0.0	1.2	0.0	2.7	11.4	1.8	0.0	10.7	51.4	0.7	1.8	5.3	4.2	256.9	5.6	30.7	57.9	75.3	281.0	0.4	444.1	0.0	18.0	14.7	196.4	3.9	46.3	293.8	89.4	273.3	63.2	1.4	8.0	5.8	8.9	3.8	0.8	12.9	31.9	0.2	1.7	24.6	8.5	117.2	14.2	34.9
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 23.2;HEL: 9.5"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.1	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.0	0.1	0.0	0.1	0.2	23.2	0.5	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6	3.0	1.0	0.0	0.9	0.3	21.5	0.4	0.0	1.4	2.3	1.8	306.3	0.0	3.3	6.8	0.6	0.3	0.0	0.0	2.8	0.1	2.3	0.2	0.0	0.0	0.1	49.3	57.3	1.8	0.0	1.7	0.9	3.2	1.7	33.3	2.2	27.8	3.9	0.0	4.6	8.1	472.2	0.0	0.9	0.0	0.4	0.1	0.1	9.2	0.4	0.1
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"bone marrow: 40.5"	"Cell type enriched"	"Detected in some"	33	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"HEL: 44.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.6	0.8	2.0	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1.0	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1.0	2.1	2.5	0.9	9.6	0.5	4.0	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.2	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.3	0.5	0.5	0.0	0.1	0.0	0.1	0.1	0.2	0.0	44.7	0.0	0.0	0.6	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.3	8.7	0.2	0.2	0.4	0.0	0.3	0.9	0.3	0.2	0.1	0.1	1.2	0.0	0.0	0.3	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.1	0.0	0.4	0.0	2.6	0.6	0.5	1.5	0.4	0.2	2.4	0.2	0.6	0.3	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.2	0.0	1.0	0.1	0.0	0.1	0.3	0.9	2.0	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4	0.0	0.0	0.0	0.5	0.5	3.3	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.8	0.0	0.0	210.2	0.2	0.4	0.2	0.4	4.6	0.4	0.2	6.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.7	0.0	2.5	6.5	0.0	2.8	5.1	1.3	0.7	0.0	0.1	0.7
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Cell type enriched"	"Detected in some"	20	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"	"Group enriched"	"Detected in some"	6	"HEL: 28.2;K-562: 8.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	28.2	0.7	0.2	0.0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0.0	0.1	0.2	0.2	3.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	23.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064685-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;brain: 9.5"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.7;U-266/84: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA053111: AB_2682047, HPA061001: AB_2684409"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	1.6	0.6	3.6	2.7	2.0	4.0	2.3	4.0	9.5	0.8	1.1	0.4	1.3	1.1	3.3	2.5	0.9	5.5	1.0	1.4	2.2	2.7	0.9	0.7	2.6	6.8	2.0	5.1	1.0	0.6	0.2	0.7	1.4	1.9	0.5	1.8	0.4	1.0	1.3	0.6	5.6	1.8	1.0	1.2	5.2	1.2	3.0	0.9	2.5	0.8	0.0	3.9	1.0	4.1	3.1	0.9	10.6	1.6	1.3	10.1	1.2	0.9	2.0	1.2	2.9	0.7	0.1	1.2	0.9	2.7	5.1	5.8	1.8	1.6	2.8	0.9	0.2	2.9	0.8	0.8	1.1	2.3	16.7	0.1	2.7	1.4	0.9	0.6	1.1	5.8	0.3	0.4	2.6	0.8	0.3	2.0	5.0	3.5	8.1	1.9	0.8	1.2	6.8	1.8	3.5	2.9	2.6	1.8	4.4	0.4	0.1	0.6	1.7	0.7	0.7	4.5	1.8	0.3	1.8	1.0	1.6	2.6	3.1	0.9	9.8	33.3	1.7	1.3	4.1	0.6	10.6	0.3	0.7	7.3	1.6	10.1	1.9	3.1	3.9	0.7	3.1	1.0	3.8	0.6	1.3	1.4	0.9	6.1	1.2	3.6	2.0	4.0	9.5	2.2	2.7	2.0	5.1	1.9	0.9	0.0	0.0	4.3	0.2	1.1	1.5	0.8	2.5	9.4	2.3	0.0	0.0	0.1	0.0	0.4	0.4	1.4	0.0	23.3	0.2	0.4	0.8	0.3	0.0	0.0	1.5	3.2	0.0	1.3	0.0	0.4	0.0	1.8	0.0	7.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.9	5.0	1.8	0.1	5.1	0.2	0.0
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.2	9.5	0.0	4.5	4.0	0.0	2.7	2.5	2.3	3.5	0.3	0.1	0.0	11.7	14.5	1.1	0.1	2.8	0.8	2.7	0.0	2.5	0.5	4.5	34.5	4.9	0.7	0.2	5.7	1.6	1.4	1.4	8.8	10.8	2.0	5.1	0.0	10.1	0.2	2.6	0.0	4.1	0.1	4.1	2.3	13.3	3.2	7.5	0.3	2.6	10.2	3.3	3.6	3.6	6.2	0.7	1.2	9.6	4.4	11.7	0.1	3.0	0.0	0.0	0.0	2.2	2.0	2.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7	14.9	8.3	0.0	0.8	1.5	2.7	24.9	2.5	12.0	3.4	1.8	127.6	49.5	1.7	3.2	49.1	7.1	0.6	0.0	13.6	3.6	9.0	1.0	0.0	1.8	10.1	316.2	7.9	16.5	12.3	26.5	7.5	3.2	1.7	0.0	6.7	20.9	14.1	3.4	4.6	30.1	26.0	6.5	4.1	1.6	1.0	1.3	252.8	0.0	2.3	0.2
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 150.8;monocytes: 394.1;Pancreatic endocrine cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;HDLM-2: 52.6;PC-3: 36.9;RPTEC TERT1: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		58000	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	5.0	13.8	13.3	19.2	15.6	29.3	5.8	53.2	19.3	16.5	17.8	8.9	15.9	24.7	12.7	17.5	13.7	10.9	10.3	13.5	13.8	9.8	16.4	6.9	18.7	28.6	20.2	8.7	8.8	7.5	9.1	14.7	4.7	14.2	8.3	14.1	12.4	9.6	12.1	8.5	7.3	26.5	9.9	11.2	28.4	20.9	9.0	18.9	27.2	18.3	6.2	24.4	14.2	10.2	17.4	24.2	13.4	21.0	18.5	32.9	13.6	16.4	19.1	3.6	4.2	1.2	1.9	1.6	1.7	1.5	0.7	1.3	7.7	37.5	1.6	12.7	1.7	0.4	2.3	6.3	9.8	0.6	52.6	2.1	8.8	12.9	7.2	2.9	9.8	7.3	2.5	2.1	1.6	0.8	6.4	5.0	12.4	1.5	2.7	0.4	10.5	13.7	14.8	3.0	3.8	36.9	7.2	0.2	2.9	29.8	1.4	2.9	2.4	9.9	1.3	0.7	1.6	5.6	4.3	6.1	1.2	11.4	3.6	0.4	3.8	1.9	5.0	1.5	11.2	0.7	6.2	3.5	13.4	32.9	11.1	31.0	17.4	26.0	28.1	10.9	14.8	20.1	24.5	7.7	18.5	21.0	24.2	27.3	13.6	13.3	15.6	53.2	19.3	13.8	9.8	20.2	8.7	14.2	18.9	35.7	12.5	61.8	1.6	7.7	7.4	1.2	20.4	13.4	12.5	22.7	0.0	1.7	34.9	38.6	18.0	2.0	150.8	0.0	50.1	3.3	7.8	3.4	19.7	4.0	13.6	0.0	6.4	12.3	10.0	46.1	3.7	30.7	20.3	394.1	21.3	4.0	113.8	31.6	2.1	12.4	9.1	6.5	2.2	20.9	2.6	11.5	4.6	105.8	7.6	6.4
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell type enriched"	"Detected in some"	39	"Spermatogonia: 154.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8"									"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.2	3.9	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	0.0	3.9	0.1	1.7	0.1	1.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.4	0.0	1.3	0.0	0.0	2.9	154.2	0.3	0.0	0.0	0.1	0.0
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158561-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 23.0"	"Group enriched"	"Detected in some"	60	"Spermatocytes: 5.2;Spermatogonia: 6.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.0	0.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.4	0.7	1.1	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	6.8	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120070672-120077705	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 2.6;testis: 9.4"	"Cell type enriched"	"Detected in single"	20	"Spermatogonia: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	348	"HL-60: 47.1;K-562: 47.2;NB-4: 76.4"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	9.4			0.0		0.0	0.0	0.0	1.0	1.6	2.6	1.3	1.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.7	0.8	0.5	0.9	1.0	0.7	0.5	0.7	0.7	1.0	0.7	0.7	1.4	1.7	1.3	1.6	0.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	7.1	0.0	11.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1	17.9	1.0	0.0	0.0	0.0	6.7	14.0	0.0	113.8	15.9	5.2	15.7	0.0	3.3	3.1	62.9	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.0	44.4	0.0	0.0	46.5	0.6	0.3	3.3	0.0	2.0	0.8	0.2	0.0	1.4	2.2	2.7	0.0	1.0	14.9	7.8	0.0	0.0	0.0	0.8	0.0
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 171.4;Late spermatids: 230.6;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 31.2;U-698: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	22.5	10.7	15.9	10.7	19.2	15.8	20.1	23.3	21.2	18.1	17.6	16.4	11.2	5.1	35.9	18.2	10.4	25.4	12.5	10.7	17.6	12.8	9.2	3.2	13.9	7.6	10.2	19.0	22.7	7.3	36.2	10.1	21.2	19.9	11.7	6.5	18.0	9.0	13.5	9.5	8.8	8.7	25.5	14.0	11.5	7.7	27.8	12.1	13.6	15.6	4.8	6.4	11.8	18.4	4.0	1.3	5.3	2.9	2.8	3.9	2.5	1.2	7.1	16.5	17.5	2.2	2.0	23.5	6.9	3.3	5.8	4.0	0.6	7.5	10.3	6.5	4.5	6.5	2.6	8.3	9.2	6.5	0.1	5.1	4.8	20.1	0.0	2.6	1.4	4.9	4.3	4.1	5.5	9.6	4.0	7.5	8.7	6.6	0.0	3.6	4.3	9.5	0.6	19.4	0.0	0.4	14.9	22.5	0.0	8.9	3.6	0.5	10.8	7.6	9.8	6.7	31.2	2.1	4.7	14.1	6.1	20.4	3.2	2.2	0.1	0.0	52.5	5.3	0.9	4.2	5.3	2.9	1.2	2.4	1.1	3.0	2.2	2.4	3.5	1.2	4.0	3.9	1.5	0.7	2.8	1.4	1.3	0.1	2.5	15.9	19.2	23.3	19.5	17.6	12.8	10.2	19.0	19.9	12.1	26.8	40.5	5.0	21.6	13.5	20.8	13.7	10.2	41.5	35.2	12.2	0.0	49.9	13.3	12.1	171.4	30.3	2.0	23.3	2.6	14.1	23.7	15.5	11.5	0.0	16.2	12.7	8.6	20.3	7.5	230.6	21.6	7.7	32.1	1.0	2.5	35.5	5.6	2.9	29.0	7.9	3.1	12.9	22.8	49.1	26.8	11.7	114.2	5.1	1.0	15.0
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330242-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.7;non-classical monocyte: 19.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 19.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.7;PC-3: 20.1;U-2197: 29.3"	"Group enriched"	"Detected in many"	6	"amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6"	"Group enriched"	"Detected in many"	6	"amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1"	HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.9	5.1	11.1	7.1	22.7	3.9	3.4	13.0	13.5	5.9	5.2	1.5	2.4	8.0	4.2	2.3	15.8	5.8	8.7	3.3	9.7	2.3	2.3	2.7	3.8	5.4	1.4	5.8	4.8	6.6	1.5	5.0	4.5	2.2	4.7	3.6	2.5	4.8	3.5	10.3	31.5	5.8	2.8	0.8	4.6	11.1	2.8	2.5	0.0	1.5	8.7	8.6	3.4	7.0	0.1	3.3	0.0	19.1	0.0	1.5	2.0	1.6	4.5	1.3	2.8	1.6	8.8	1.0	10.1	9.2	7.8	3.8	2.8	5.1	0.3	5.1	7.3	3.2	10.7	0.0	13.6	1.0	0.5	0.0	0.4	4.3	2.4	3.0	0.1	4.7	8.5	26.7	7.9	4.7	9.7	1.6	0.3	0.2	0.1	3.4	0.3	0.1	11.5	0.6	2.1	20.1	0.1	3.9	0.0	2.3	1.7	10.0	2.7	2.6	1.3	13.8	0.4	0.9	0.8	4.4	12.5	7.4	29.3	2.5	0.2	0.5	0.0	17.4	2.7	5.0	0.0	4.3	0.0	0.2	9.7	1.5	0.1	1.0	0.3	3.3	0.0	1.1	0.5	0.0	0.0	19.1	0.0	0.1	2.0	11.1	22.7	13.0	13.5	9.7	2.3	1.4	5.8	2.2	2.5	0.0	0.3	0.0	7.8	11.8	3.3	0.8	2.5	1.4	1.2	0.0	0.0	0.6	0.0	2.4	0.3	2.9	8.6	0.0	6.1	4.3	5.1	1.9	4.6	0.0	4.3	0.0	2.9	4.9	9.5	1.0	4.0	4.2	1.7	1.0	5.2	0.5	6.7	7.0	1.8	0.0	0.9	0.0	1.4	1.6	0.9	13.2	0.2	1.3	6.6	6.3
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.6	4.2	4.1	4.3	1.4	9.8	11.2	6.8	4.6	4.7	3.8	3.2	7.0	4.7	4.5	5.8	7.7	3.6	3.4	3.2	8.6	2.9	8.4	5.9	7.2	9.7	4.8	6.9	0.0	3.4	4.1	7.6	3.6	1.7	3.8	12.1	5.4	4.8	0.0	0.3	3.7	1.9	3.1	4.6	4.5	7.0	7.7	5.0	3.7	8.4	5.2	4.0	4.3	11.6	1.1	5.0	8.4	2.3	5.1	3.8	0.0	9.2	6.1	6.2	6.7	3.8	4.4	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8	0.0	22.7	20.1	35.5	24.5	30.5	21.4	17.8	17.4	14.8	21.0	15.7	36.0	13.3	28.6	21.1	23.2	23.3	0.0	30.3	27.6	28.0	27.3	19.6	30.5	26.3	23.8	29.4	30.7	29.6	13.2	37.2	20.0	16.9	20.8	19.8	38.3	26.5	21.0	28.0	26.9	18.0	25.8	22.7	32.9	18.8	26.7	52.7	25.4	21.0	24.7
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867834-38878279	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3;Karpas-707: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.5	3.7	6.3	10.2	10.3	5.4	10.4	6.5	5.8	2.6	3.9	4.2	6.2	3.4	1.8	2.4	5.3	4.6	6.1	3.9	5.1	6.4	5.0	6.0	7.0	20.4	5.5	3.8	1.7	17.4	4.9	5.7	3.3	5.5	2.6	3.5	5.9	7.9	4.5	3.0	3.2	6.3	2.6	4.5	13.0	6.1	1.4	3.5	7.6	6.4	3.1	15.7	4.3	2.9	16.6	12.3	3.1	2.1	4.1	8.7	2.9	0.0	1.4	0.4	0.2	0.6	0.3	2.6	0.3	0.2	0.3	0.4	2.3	7.0	7.9	3.7	0.4	0.1	0.2	1.3	3.0	0.4	1.7	0.8	9.8	2.0	5.0	1.7	5.5	17.3	1.6	0.6	0.9	0.6	0.3	3.5	6.1	2.0	20.3	0.0	1.2	1.7	3.9	0.6	4.1	0.3	1.1	0.1	5.9	1.9	0.2	2.6	1.1	3.2	5.2	2.8	0.4	0.6	6.7	2.2	0.1	1.5	0.4	0.0	8.7	7.2	6.2	0.6	3.1	0.4	3.1	0.9	1.5	8.7	2.1	5.5	12.4	5.8	6.3	1.6	16.6	4.6	5.4	2.8	4.1	2.0	12.3	6.1	2.9	6.3	10.3	6.5	5.8	5.1	6.4	5.5	3.8	5.5	3.5	3.0	7.7	15.2	4.6	2.9	3.2	3.0	12.7	1.4	1.2	3.5	7.9	11.3	6.6	5.6	0.4	6.8	0.0	0.0	6.2	5.5	3.8	2.2	15.0	5.4	7.9	0.0	6.9	8.6	5.9	0.4	2.8	5.0	10.1	10.8	0.3	4.8	4.8	1.7	2.5	8.1	10.5	0.0	1.9	2.9	1.8	3.3	3.4	24.5	1.0	3.0
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.3	12.3	4.4	9.5	10.3	15.9	11.6	10.0	7.6	11.8	9.7	8.3	10.8	27.3	11.5	11.3	16.0	11.9	13.9	14.2	18.5	51.7	6.4	8.6	5.4	9.9	16.8	17.6	4.1	12.1	19.2	9.0	22.1	5.8	11.9	12.3	11.9	12.2	11.9	6.0	13.9	5.7	9.5	22.4	16.4	0.0	14.8	27.3	11.9	12.0	23.5	8.5	10.7	14.8	16.6	5.1	13.1	7.3	9.6	11.8	13.0	6.4	20.6	18.0	9.3	27.5	13.9	17.6	12.7	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2	8.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	7.0	0.0	30.5	41.4	14.2	0.0	0.0	0.0	0.0	11.5	36.7	0.0	0.0	2.3	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	12.6	0.0	0.0	10.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.4	4.8	9.5	9.9	8.5	6.9	11.3	4.7	7.0	8.1	10.8	9.7	6.6	12.4	6.2	6.0	6.1	11.8	11.9	8.2	14.8	5.8	8.1	10.2	5.9	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.8	9.7	5.5	6.9	15.5	7.7	7.4	3.9	7.1	5.1	12.6	4.6	5.6	5.6	15.6	7.2	5.2	12.6	6.8	9.5	8.7	11.7	8.3	15.4	5.5	30.8	4.7	9.6	10.2	7.8	8.7	7.0	6.6	11.7	8.3	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8	29.8	10.8	22.4	42.2	58.3	17.2	13.4	5.1	30.8	30.7	3.5	15.7	6.9	5.0	10.9	32.9	23.3	8.4	0.0	5.9	8.0	34.2	25.7	26.5	8.3	8.5	25.4	19.4	16.0	13.9	4.9	8.3	16.8	16.9	10.0	7.8	17.0	9.3	14.0	7.4	5.7	15.8	12.9	27.8	26.5	20.0	53.3	14.4	14.1	6.7	27.2
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.7	14.0	13.6	11.3	13.7	14.5	13.4	13.2	15.4	11.9	14.7	10.9	14.4	7.4	15.5	16.6	16.1	11.9	27.3	15.9	18.2	6.7	14.4	13.0	24.7	6.6	12.2	19.5	23.2	14.0	10.0	16.9	29.1	10.2	13.8	12.4	11.2	13.5	15.6	10.5	14.5	11.1	20.9	8.5	13.5	13.9	28.8	12.5	11.0	16.5	10.0	11.7	24.9	12.1	15.4	13.0	6.8	15.4	18.3	14.4	14.0	14.7	11.5	7.2	13.8	11.9	15.7	19.9	14.0	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4	14.9	17.1	2.9	24.0	31.8	12.3	26.3	15.3	24.1	20.5	24.4	13.7	14.1	10.0	12.7	5.5	27.4	7.8	0.0	9.2	17.5	26.4	21.1	36.9	11.9	16.0	20.6	22.2	20.3	20.2	3.3	9.2	23.6	16.9	3.6	9.8	13.7	11.6	8.6	17.7	9.6	13.8	6.5	17.6	7.2	17.2	33.9	22.0	17.0	10.2	31.0
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980711-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 51.0;Late spermatids: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	9.3	9.9	6.2	16.6	7.5	3.9	5.1	13.1	6.1	5.7	7.6	2.9	5.9	7.6	4.1	6.3	7.7	7.5	3.5	3.8	5.3	8.5	5.5	6.3	7.0	13.2	7.4	3.5	5.4	10.0	9.1	7.5	11.0	9.6	6.6	9.1	3.9	7.7	6.3	6.4	5.4	10.5	4.0	8.1	21.0	7.1	11.7	4.8	35.7	7.3	6.3	11.4	5.6	4.5	4.3	9.8	14.4	8.1	5.1	3.9	3.7	14.0	9.6	20.3	7.0	3.1	4.9	19.1	14.0	8.0	12.9	11.8	4.6	9.5	29.7	5.1	6.9	12.9	20.4	13.5	6.7	15.0	17.0	3.4	12.5	7.8	5.8	4.5	23.0	12.9	4.3	4.4	10.2	7.6	4.0	6.1	17.0	9.3	15.3	13.4	9.9	28.6	8.0	17.4	17.2	9.2	26.5	19.9	11.0	5.9	6.0	17.4	10.7	13.1	10.0	5.4	9.3	10.7	10.2	4.3	13.3	8.7	13.1	11.1	6.6	13.9	11.3	8.5	10.0	14.4	14.4	6.1	11.2	2.8	7.3	3.3	4.3	3.3	2.9	9.8	4.0	3.2	3.7	10.6	5.1	8.1	2.8	3.9	3.7	6.2	7.5	13.1	6.1	5.3	8.5	7.4	3.5	9.6	4.8	8.9	6.1	6.4	2.9	2.4	2.3	7.3	0.0	12.0	12.5	1.8	3.9	5.4	5.0	4.7	51.0	3.8	6.3	23.3	2.6	12.5	2.3	4.8	4.6	11.5	6.8	9.5	6.4	7.4	10.5	50.5	2.0	5.4	11.8	1.8	9.6	8.5	2.4	5.5	2.1	4.1	3.7	0.0	1.0	32.3	22.7	4.3	3.5	2.2	7.6	2.2
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1500000000	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	7.2	0.1	0.0	0.0	0.0	0.5	0.3	16.9	0.0	0.0	0.0	0.3	0.0	29.1	0.3	0.3	0.0	0.2	0.0	0.5	0.0	0.0	38.7	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1	863.6	748.9	16.1	0.9	31.6	0.0	58.9	40.8	58.9	295.7	15.7	0.0	12.0	0.0	8.2	17.6	308.3	107.7	0.0	270.1	10.2	30.9	1.4	23.3	4.9	1257.5	1.6	46.9	532.2	311.7	43.1	29.7	100.6	38.8	4.6	398.3	0.8	308.4	78.7	10.3	0.3	1.8	97.0	15.6	7.0	5.3	24.6	21.6	7.5	165.1	1.7
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3544793-3558616	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	16.6	12.8	10.1	14.5	15.4	14.7	16.1	11.0	13.1	9.7	12.1	11.4	10.8	11.8	13.3	14.0	14.1	10.0	11.0	18.5	13.1	10.3	10.9	17.0	11.2	18.3	12.9	11.4	10.1	15.1	10.5	10.8	11.5	12.3	11.2	12.6	9.5	11.2	16.0	35.3	11.3	11.3	17.7	11.9	12.4	11.8	13.8	12.5	10.9	10.1	10.3	14.5	12.8	11.8	16.6	15.9	7.4	12.8	17.2	14.6	10.8	8.8	20.6	7.1	12.1	7.5	7.8	15.9	14.5	12.6	12.4	10.0	15.7	10.7	17.0	15.7	13.0	17.8	9.7	11.9	11.8	9.9	12.7	7.8	14.7	12.2	26.3	14.2	19.1	13.9	6.9	9.9	13.4	15.8	5.4	10.9	27.2	20.0	17.0	12.7	17.5	11.3	10.7	13.8	17.7	15.4	13.8	11.7	17.8	7.5	15.6	12.0	15.7	12.3	8.6	12.1	6.9	7.3	7.3	11.2	16.4	11.2	13.0	20.1	25.2	34.1	28.4	15.3	14.4	21.4	2.8	11.5	7.4	14.5	12.8	14.6	16.6	12.7	13.6	14.2	13.8	12.9	12.5	3.2	17.2	11.1	15.9	11.2	10.8	10.1	15.4	11.0	13.1	13.1	10.3	12.9	11.4	12.3	12.5	20.8	5.8	33.5	22.9	6.6	24.6	21.5	10.2	13.4	6.8	3.5	19.6	27.2	31.5	32.0	2.8	17.3	13.6	0.0	42.6	35.7	17.7	24.8	27.6	15.3	27.4	33.4	14.5	14.1	16.4	2.3	12.7	15.4	10.1	37.9	11.2	16.4	36.8	7.0	24.8	20.1	17.0	19.4	19.0	18.4	29.0	10.7	30.6	16.0	14.7	29.8
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 97.8;Spermatocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.9	11.3	6.8	6.8	1.0	1.9	8.4	7.0	2.9	10.5	12.1	8.9	5.7	16.0	10.5	1.6	5.9	8.9	5.6	6.9	5.8	8.7	15.1	7.7	12.0	6.8	0.8	7.0	7.1	1.0	1.7	8.8	3.2	2.0	4.0	13.1	10.6	4.8	5.0	25.7	12.9	7.0	6.8	5.6	19.7	13.9	9.9	11.5	2.6	5.9	14.2	8.3	7.5	2.8	3.2	3.1	7.4	4.4	3.8	12.5	6.3	17.7	11.5	11.6	12.8	12.7	7.4	11.3	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4	0.0	1.6	10.4	15.3	12.5	15.9	2.4	10.2	4.0	1.2	0.0	3.9	40.3	0.0	3.9	12.7	4.9	4.6	0.0	5.4	97.8	9.3	6.6	3.5	3.4	41.5	7.9	8.1	10.4	10.3	15.1	7.8	11.9	11.8	6.4	7.7	10.1	1.9	7.0	4.6	0.8	11.2	6.5	11.3	51.9	45.0	11.5	19.0	12.5	19.0	7.3
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	8	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9"									"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	4.8	4.8	2.8	3.5	3.5	5.3	2.9	3.6	4.0	2.0	2.8	0.4	1.5	1.4	4.9	3.3	2.3	2.7	3.2	6.3	2.5	3.3	6.6	14.5	16.7	20.3	2.9	2.4	2.4	7.9	1.4	4.7	2.5	1.8	1.8	1.4	0.4	1.6	5.0	4.2	1.9	6.3	2.3	1.7	9.1	1.6	6.4	0.7	4.1	2.0	4.6	3.4	2.3	1.6	1.9	4.0	7.5	4.3	0.9	1.7	2.8	1.2	3.6	0.5	0.5	0.0	0.0	1.1	2.3	1.9	2.8	2.2	2.3	1.1	1.9	0.2	0.0	0.3	0.6	0.7	5.3	0.8	0.0	4.4	0.0	2.9	1.0	2.8	0.0	0.6	0.0	0.0	1.6	0.0	0.4	0.7	0.2	0.6	0.0	0.0	1.2	1.9	2.3	2.3	0.5	1.2	1.4	0.0	0.0	0.8	0.7	0.5	1.8	0.0	0.0	0.2	0.3	0.6	6.3	0.0	0.0	0.2	3.5	1.0	0.0	0.8	0.2	6.9	0.5	0.0	3.6	4.3	3.4	1.2	3.0	1.7	1.9	1.5	0.8	3.8	1.8	1.4	1.2	7.5	0.9	3.1	4.0	0.9	2.8	2.8	3.5	3.6	4.0	2.5	3.3	2.9	2.4	1.8	0.7	59.6	63.9	0.0	0.0	0.3	0.0	0.0	0.0	103.1	56.9	0.0	0.0	0.2	3.3	6.7	0.0	0.1	2.9	0.0	7.0	0.1	0.2	0.1	55.8	0.0	0.6	0.0	5.2	0.6	1.2	0.0	0.3	1.0	0.0	8.2	4.7	0.0	6.7	6.8	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.7	0.0	2.7	0.1
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	26.2	37.7	32.6	23.0	34.5	64.3	64.2	33.4	44.0	27.7	30.5	25.3	30.1	23.8	24.1	41.4	40.2	22.5	32.2	79.6	32.4	27.0	36.0	37.9	43.8	44.8	27.2	27.0	25.2	34.0	36.0	27.0	26.5	21.9	25.2	27.7	23.8	26.6	33.8	118.9	26.6	29.5	32.1	26.9	29.0	28.1	46.0	23.5	23.9	25.7	45.0	27.0	28.4	51.7	11.3	17.7	49.7	15.2	13.1	17.2	14.0	29.9	39.7	19.5	31.0	38.3	30.4	23.1	28.2	32.2	23.5	25.1	32.7	13.9	35.6	25.9	46.6	18.4	20.7	35.7	38.3	33.6	34.9	20.0	36.3	22.2	33.6	51.5	32.5	25.7	30.9	44.4	33.0	45.4	40.9	47.5	26.9	36.1	24.7	35.2	34.5	21.4	35.8	29.6	28.0	39.6	19.2	25.1	50.8	46.5	61.7	19.2	20.9	39.3	25.4	21.6	28.3	40.9	18.9	37.7	17.1	19.2	27.3	18.2	21.4	38.2	25.2	28.4	22.2	18.3	41.0	15.2	49.7	14.3	13.2	15.5	11.3	14.1	16.3	17.7	10.0	12.8	12.8	35.1	13.1	14.8	9.1	17.2	14.0	32.6	34.5	33.4	44.0	32.4	27.0	27.2	27.0	21.9	23.5	23.8	27.5	42.7	46.5	55.1	36.2	82.7	25.5	8.1	20.5	45.4	21.6	51.8	139.3	44.1	48.0	40.9	63.6	23.3	51.0	58.9	41.3	56.3	36.8	39.4	32.6	52.4	47.3	42.4	43.0	33.1	52.6	32.9	54.0	43.3	45.8	30.4	52.5	56.8	51.6	53.3	50.7	51.8	51.4	131.6	55.8	57.5	93.5	44.8	40.1	68.6
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	12.8	11.2	15.3	15.6	19.3	21.2	12.7	24.1	21.9	15.1	9.8	18.8	10.9	11.4	16.4	9.8	16.2	12.6	13.0	11.0	13.0	13.0	12.9	14.8	13.3	13.9	15.7	15.5	16.8	14.8	20.8	19.2	16.7	17.8	12.7	10.3	12.9	14.9	12.5	15.0	14.1	10.9	11.7	14.2	14.3	12.0	15.7	16.9	14.9	16.4	6.5	17.8	15.8	14.8	7.9	5.2	26.7	9.9	3.3	6.1	2.0	9.6	22.5	14.3	12.3	12.5	14.1	12.3	12.7	14.9	12.7	16.4	9.9	6.5	11.9	14.4	17.7	10.9	19.0	3.9	9.5	15.9	12.3	8.0	14.7	9.2	7.6	13.6	8.6	16.6	11.0	10.3	13.7	15.2	11.6	14.1	11.1	13.6	12.0	15.6	4.7	11.3	5.5	11.8	3.0	8.8	11.4	20.5	9.7	9.7	17.3	11.8	17.2	11.4	11.3	11.0	17.5	8.9	10.6	16.2	20.4	17.0	10.6	12.1	8.7	11.8	14.2	12.4	13.9	15.3	6.4	9.9	9.3	4.8	7.0	4.8	7.4	4.9	4.3	5.2	7.9	5.5	4.2	26.7	3.3	7.6	4.9	6.1	2.0	15.3	19.3	24.1	21.9	13.0	13.0	15.7	15.5	17.8	16.9	3.0	11.8	14.0	10.9	17.9	11.2	16.9	7.6	14.7	9.1	12.2	7.9	7.3	3.3	10.3	18.4	13.4	9.2	0.0	6.0	8.1	9.5	12.3	15.1	9.8	11.7	9.5	15.5	19.0	17.7	7.0	7.2	16.6	11.8	16.2	9.4	9.5	10.9	11.4	13.8	8.4	12.3	25.8	9.2	11.9	7.8	17.3	26.8	11.7	7.9	20.4
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.3	1.7	2.4	12.5	13.6	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	3.1	17.4	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.6	16.1	4.1	8.1	6.5	5.1	3.2	7.2	17.7	21.9	21.7	4.1	20.9	22.1	10.1	19.5	5.5	17.0	16.1	6.3	33.8	6.0	14.5	17.4	13.6	10.3	13.6	13.9	2.6	8.7	17.0	9.4	14.4	10.4	21.1	23.3	38.3	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3	11.9	6.1	54.8	41.2	122.5	31.3	24.2	15.3	12.0	10.3	8.7	15.7	58.6	46.4	55.4	113.7	26.1	51.9	0.0	66.1	118.3	35.3	49.3	14.9	20.2	38.3	30.2	20.8	20.3	27.6	18.2	19.8	38.3	40.5	56.9	34.2	27.0	95.1	54.9	18.4	25.6	22.0	58.2	45.0	118.2	66.8	126.6	73.7	55.3	49.7	76.9
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.7	21.4	15.0	29.5	27.1	28.4	10.1	26.3	14.7	18.5	20.5	17.7	14.9	22.6	30.8	26.9	27.9	7.0	19.1	25.8	16.6	17.0	16.5	14.4	11.2	8.0	29.8	15.7	12.9	21.3	22.8	24.6	30.9	16.1	22.9	15.8	17.4	31.6	37.8	15.2	15.2	5.0	6.3	15.6	24.4	10.1	16.7	24.5	25.4	22.2	16.6	13.5	23.0	42.2	44.6	17.6	29.3	12.3	23.6	24.6	7.9	11.6	24.9	19.9	23.2	20.7	21.1	19.3	30.3	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0	8.9	22.9	9.0	14.0	9.5	20.9	36.8	7.6	13.4	13.6	21.0	15.7	24.8	58.0	23.0	162.7	16.9	20.2	23.3	21.8	21.4	16.2	17.2	21.9	29.6	21.4	22.3	14.5	17.8	25.5	22.0	17.8	19.3	30.4	10.8	14.1	20.6	22.7	11.5	31.5	34.8	14.6	38.8	25.8	42.6	27.1	9.3	50.6	17.5	13.3	12.7
RNF141	"ZFP26, ZNF230"	ENSG00000110315	"Ring finger protein 141"	Q8WVD5	11	10511678-10541230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 903.9;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 63.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018133	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA018133: AB_1859142"	"unprognostic (7.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.88e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-2)"	14.0	17.6	27.9	14.8	39.0	10.0	15.8	10.2	28.8	10.9	10.0	44.4	6.0	12.5	8.2	11.8	33.7	9.7	8.4	12.8	30.1	23.6	14.2	12.4	12.3	9.4	44.7	18.7	6.5	8.2	19.4	9.5	8.5	33.7	13.6	9.9	7.3	20.6	8.8	23.9	24.2	17.5	7.8	56.2	15.1	12.3	42.2	39.3	7.7	13.3	12.8	15.4	10.6	12.9	19.1	8.2	43.5	29.2	2.4	4.2	8.6	17.7	9.3	12.9	7.8	19.7	19.2	9.5	12.1	9.5	4.6	5.6	13.9	63.6	7.3	11.2	9.3	8.3	12.8	5.5	13.9	7.1	8.0	7.4	5.0	5.9	7.2	7.6	7.9	6.0	12.6	16.2	2.5	15.3	17.0	12.4	9.4	13.5	6.9	11.5	7.4	7.8	2.9	6.5	11.4	5.2	10.0	5.8	8.0	7.4	19.2	4.0	8.5	11.7	13.7	7.5	11.3	8.8	4.2	13.1	11.6	7.2	9.5	3.7	3.1	5.9	8.2	14.2	11.2	13.9	8.5	15.0	25.2	2.5	29.2	4.2	19.1	2.9	2.4	8.2	18.4	3.3	2.2	43.5	2.4	27.0	7.6	3.4	8.6	27.9	39.0	10.2	28.4	30.1	23.6	44.7	18.7	33.7	39.3	17.9	42.2	20.1	35.2	36.2	18.2	41.6	17.8	22.7	11.4	19.2	11.8	11.7	34.9	17.4	903.9	18.9	19.7	0.0	21.5	12.7	11.6	45.2	12.7	24.5	34.2	35.0	20.2	22.1	101.8	383.0	18.1	24.1	18.6	27.9	29.7	19.0	35.2	5.8	18.4	25.6	11.0	6.5	13.7	68.5	25.8	35.0	15.0	10.4	22.5	62.0
RNF165	"ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 28.6"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	1.9	1.7	9.9	1.0	9.5	0.9	2.1	28.6	13.8	1.0	0.8	1.7	1.7	0.4	1.0	8.4	2.7	3.0	1.0	2.5	6.1	4.4	2.3	8.3	1.0	0.9	2.2	7.2	0.5	1.0	13.1	4.8	0.8	2.0	3.6	0.6	2.7	1.4	3.9	3.6	3.5	1.0	0.7	1.7	5.3	0.7	1.3	1.0	1.7	8.8	1.2	1.3	1.2	1.0	0.0	1.5	0.5	0.0	3.9	1.1	0.0	1.5	0.1	12.7	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.0	0.5	1.0	0.0	0.0	1.0	0.1	6.9	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.2	0.0	0.2	0.0	0.0	2.3	1.0	1.7	0.3	1.2	2.4	0.5	6.7	0.8	2.1	13.2	15.0	2.3	0.0	0.0	0.9	0.3	0.6	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.5	0.0	0.0	9.9	9.5	28.6	13.8	6.1	4.4	2.2	7.2	2.0	1.0	3.0	1.7	0.0	8.3	2.4	36.3	7.9	0.0	0.0	3.4	0.0	94.2	0.1	3.3	0.0	2.7	1.9	0.0	0.0	0.0	0.2	1.5	1.7	0.0	5.7	0.1	76.3	0.0	0.6	0.8	3.1	2.3	0.0	1.7	0.0	0.0	3.7	0.1	0.0	3.9	0.0	51.7	0.0	0.8	0.5	0.5	1.8	0.2	2.9	0.0	1.6
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 199.9;Late spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.5	5.0	9.0	11.8	8.4	6.1	12.9	7.7	4.9	5.2	8.2	9.8	6.2	13.3	17.8	6.4	7.3	12.8	12.6	9.2	8.0	6.3	6.2	25.2	12.7	12.1	4.4	7.7	6.3	6.1	3.5	8.1	7.2	3.7	7.5	11.0	7.5	14.0	5.2	21.2	25.5	4.6	10.7	6.8	6.5	11.5	10.5	10.8	4.4	17.4	7.5	7.6	8.7	10.7	6.6	7.0	16.2	6.9	7.4	9.0	7.1	9.5	10.1	12.0	11.2	20.2	8.8	9.4	7.1	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4	14.9	29.1	17.1	44.2	89.0	35.1	19.7	12.7	18.7	19.4	14.0	56.9	11.4	14.9	11.9	199.9	29.2	13.6	0.0	7.9	20.7	33.6	23.5	49.6	25.8	15.9	14.3	13.8	17.2	29.0	360.7	18.7	39.0	25.3	37.9	16.0	13.4	8.6	14.4	19.4	8.4	39.6	12.9	35.0	11.1	67.5	110.7	8.9	46.0	18.6	50.5
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597613	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	32.9	41.5	42.2	26.4	36.2	32.8	40.4	19.0	38.7	34.4	40.5	33.0	36.0	34.5	28.1	44.5	40.2	33.3	34.8	52.4	34.5	32.9	57.8	85.1	36.0	33.1	41.2	29.3	31.6	85.1	21.8	20.2	50.7	36.0	34.2	35.4	32.1	42.1	45.7	47.0	30.4	46.5	33.2	42.2	37.2	35.7	36.3	31.3	31.0	43.7	39.2	42.6	43.8	29.4	53.2	80.2	78.6	94.7	39.3	54.4	83.3	32.7	33.2	25.9	28.1	26.4	32.8	41.8	27.7	54.6	59.1	56.3	50.6	34.8	31.2	54.5	41.1	56.1	30.7	22.3	44.3	63.6	35.6	27.5	23.7	17.2	60.8	46.5	26.2	32.5	34.2	59.0	39.4	65.9	45.5	49.1	29.4	27.8	32.5	79.8	52.5	24.7	61.1	18.0	43.3	50.2	26.5	54.4	44.4	55.2	30.5	15.5	20.4	23.4	34.1	45.5	32.5	33.8	34.9	42.4	29.0	20.7	58.0	39.5	45.4	37.8	39.1	45.4	39.7	25.5	40.4	94.7	71.6	40.7	69.3	37.7	53.2	42.6	39.1	71.0	44.3	36.7	36.8	78.6	39.3	51.8	80.2	54.4	83.3	42.2	36.2	19.0	38.7	34.5	32.9	41.2	29.3	36.0	31.3	137.0	86.2	115.3	81.4	103.8	25.0	99.1	145.2	88.3	91.0	143.1	2.0	196.4	353.1	216.8	308.0	104.6	151.4	70.0	252.2	207.3	131.6	104.1	100.4	194.3	230.7	17.5	67.4	87.8	155.3	193.3	81.7	162.9	161.9	198.4	101.4	48.2	256.8	175.4	73.6	513.2	19.4	58.2	121.5	89.5	30.4	103.6	185.0	97.2	90.7	92.8
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.3;U-266/70: 76.8"	"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.4	7.1	5.0	10.5	5.5	3.6	9.7	7.9	4.9	5.0	3.8	3.6	6.6	21.6	16.6	9.0	4.1	7.6	6.3	6.7	1.9	9.8	8.1	6.5	5.3	4.7	15.0	7.4	12.8	6.3	12.1	3.8	5.2	6.1	4.4	16.5	10.4	42.3	3.6	5.3	11.8	6.6	11.2	6.7	7.3	10.1	4.6	20.3	3.6	6.0	11.1	11.2	8.1	16.8	21.4	1.7	11.8	17.8	10.1	6.2	6.4	6.7	7.5	76.8	23.0	11.8	16.7	7.8	10.4	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4	23.8	13.3	36.1	41.5	32.2	84.0	56.1	38.2	8.1	18.2	38.4	17.7	14.3	96.2	13.8	0.5	22.6	33.3	0.0	20.8	20.1	31.6	30.3	44.9	56.2	24.8	52.4	38.4	29.4	29.7	2.5	22.7	23.8	37.1	6.4	26.7	103.2	20.8	20.4	24.4	99.3	37.8	19.4	38.1	4.4	22.0	48.3	14.8	41.5	27.6	24.7
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.8	7.6	28.2	11.2	8.0	13.7	26.8	9.8	12.4	15.5	12.5	12.1	23.1	4.1	12.3	12.0	10.5	4.9	19.3	14.2	18.9	12.1	10.1	22.3	4.7	10.6	11.8	22.8	12.6	12.9	8.7	12.7	16.3	12.6	15.6	14.4	17.6	9.9	11.2	8.6	19.7	6.7	37.8	11.7	4.2	22.6	17.5	3.9	11.7	9.8	8.3	14.3	6.8	4.1	19.9	32.0	8.7	12.2	11.0	11.2	14.5	10.6	12.4	16.4	10.6	15.4	7.0	10.8	12.5	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4	3.0	5.4	10.8	18.7	20.6	9.2	5.9	7.6	5.3	3.4	8.7	3.9	22.5	19.9	10.5	4.8	17.9	4.0	0.0	11.1	42.7	21.1	12.7	12.7	7.3	17.9	6.4	28.4	21.5	20.3	5.2	8.9	21.4	20.3	28.9	10.4	8.5	10.4	11.5	11.0	10.6	5.9	0.0	12.1	29.9	78.0	17.8	23.8	15.0	11.5	33.6
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA074151: AB_2686668"	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favorable (3.02e-4)"	11.9	10.6	18.2	19.6	23.4	10.4	12.3	25.2	26.9	11.2	17.3	21.5	10.0	17.0	15.0	12.7	14.4	11.7	15.5	16.0	17.6	17.7	10.8	11.1	11.6	27.2	19.3	19.4	14.0	12.2	11.1	17.1	10.2	19.3	10.2	14.2	12.7	12.4	12.9	45.7	13.8	16.0	15.0	21.3	19.4	16.3	20.8	17.2	21.7	12.7	9.1	22.5	16.4	11.5	31.8	16.9	36.5	20.3	29.9	42.8	25.8	18.5	22.5	14.7	15.4	11.7	10.8	18.5	19.8	17.8	19.8	15.2	27.9	7.1	26.8	15.3	21.3	10.5	13.4	22.2	12.4	17.7	38.9	13.0	30.9	15.6	25.6	14.0	26.7	21.8	9.5	16.9	17.2	15.0	11.4	20.7	16.1	23.3	12.5	19.4	14.7	23.4	39.1	18.9	11.0	20.5	22.4	19.4	15.7	13.7	22.3	21.8	14.2	24.9	9.3	15.1	14.2	16.1	20.3	16.6	17.1	12.4	14.8	15.6	22.4	36.9	29.1	12.2	18.8	17.1	26.9	17.9	36.5	32.4	19.9	33.0	31.8	37.8	34.1	16.9	25.5	32.8	32.6	27.4	29.9	20.3	14.3	42.8	25.8	18.2	23.4	25.2	26.9	17.6	17.7	19.3	19.4	19.3	17.2	14.9	15.2	25.2	16.8	15.5	12.1	18.7	20.4	17.4	12.5	8.7	3.9	20.4	31.5	27.7	10.1	13.5	18.6	23.3	23.8	32.6	15.4	11.7	17.3	9.0	18.1	12.7	39.2	14.1	14.2	7.0	15.8	11.3	16.9	39.7	16.1	17.1	23.7	16.9	17.0	15.3	18.7	19.4	14.6	73.2	30.9	14.1	20.3	41.5	19.5	21.9
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738204-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 615.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	26.0	44.0	31.4	21.7	37.0	30.7	38.3	19.4	28.6	26.1	37.0	17.5	36.3	38.6	30.4	42.0	37.1	22.9	41.8	47.6	27.4	27.6	33.2	35.3	27.2	32.1	26.7	21.6	30.5	57.6	16.2	33.9	40.6	20.5	37.3	34.5	29.2	36.2	28.9	69.9	35.7	42.7	36.2	23.9	23.7	26.8	44.4	18.7	27.0	35.1	50.6	27.4	37.5	35.2	32.7	44.9	36.3	52.2	22.5	41.7	42.9	46.6	18.9	28.2	22.7	26.9	37.2	18.6	26.2	24.8	22.5	23.9	22.0	23.3	15.7	61.5	29.0	55.4	22.9	17.4	24.6	28.6	15.0	32.6	15.5	17.9	31.8	35.9	24.3	15.2	34.7	27.8	17.9	30.7	30.2	31.8	27.0	16.3	22.0	33.3	35.9	15.3	27.4	29.9	47.4	31.5	16.8	18.0	33.9	48.0	20.6	15.6	19.5	30.0	31.1	43.6	38.3	29.1	32.0	24.1	22.6	21.6	39.9	22.0	21.0	17.5	32.3	35.2	27.0	25.5	36.3	52.2	33.7	33.0	44.5	33.1	32.7	35.6	35.0	44.9	29.3	34.7	35.9	18.5	22.5	46.6	41.4	41.7	42.9	31.4	37.0	19.4	28.6	27.4	27.6	26.7	21.6	20.5	18.7	56.6	51.0	67.8	126.0	117.7	34.2	80.9	84.1	76.3	55.7	96.0	25.5	151.5	215.5	196.2	256.9	96.6	240.4	0.0	216.5	209.1	117.2	147.3	71.5	105.8	191.8	27.0	120.6	99.4	110.4	615.6	109.0	126.7	136.7	155.1	160.5	58.0	201.5	213.1	114.5	270.8	43.1	84.1	120.7	194.2	117.2	126.5	108.6	109.0	157.3	138.1
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.7"					"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.6	4.0	9.7	11.5	7.8	11.3	2.8	6.9	8.6	13.2	14.5	6.0	3.7	8.3	4.2	6.7	11.4	6.3	13.5	8.8	13.8	8.7	13.1	14.2	7.0	8.9	4.5	7.6	10.5	5.6	8.5	7.8	9.1	8.1	12.6	9.8	9.6	2.9	7.5	4.4	9.1	9.4	6.7	3.4	5.3	7.2	8.9	5.7	6.7	4.7	19.1	6.4	5.2	5.9	9.5	6.6	5.3	7.4	5.7	8.7	7.7	8.2	10.2	8.6	11.3	40.7	4.2	10.8	10.0	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8	17.9	23.4	13.0	21.7	16.3	26.0	28.3	10.2	28.1	15.9	24.4	37.3	20.9	13.3	20.8	35.2	15.8	8.6	0.0	16.6	21.6	23.9	20.0	27.7	14.7	15.4	47.7	21.4	22.1	14.2	20.2	24.7	13.8	10.1	20.8	16.1	21.5	23.6	15.6	29.0	16.8	29.6	12.9	16.4	43.0	33.1	19.3	4.9	15.8	16.2	17.0
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	1.7	3.2	8.8	2.6	15.1	3.5	1.4	13.6	21.0	1.5	1.6	6.6	0.0	2.0	1.5	4.3	1.5	1.5	1.6	1.4	9.9	12.1	2.0	1.0	1.5	4.1	9.7	9.8	1.7	1.4	2.6	7.5	2.9	19.0	1.2	1.7	3.6	2.6	1.2	2.1	2.7	1.8	1.4	6.2	2.9	1.9	7.0	3.4	2.5	2.1	0.0	4.4	1.2	0.4	4.3	2.2	4.0	1.1	2.8	3.1	0.9	1.5	9.2	4.8	15.6	0.2	0.0	8.0	0.6	0.7	1.9	1.7	3.6	1.8	8.1	2.3	0.1	2.4	1.9	10.2	0.7	1.9	7.6	5.1	1.5	7.4	4.9	2.1	0.6	4.7	0.2	0.2	3.2	1.0	1.6	0.3	5.7	6.2	2.9	0.2	7.8	7.8	1.9	4.8	2.0	1.8	5.1	2.7	4.1	3.7	1.9	7.4	6.7	2.3	1.2	2.2	3.3	7.3	1.8	0.5	1.3	5.3	3.1	3.1	3.7	12.2	8.4	5.9	0.8	1.0	4.0	1.1	1.3	2.0	0.7	0.6	4.3	1.8	1.4	0.6	3.3	2.9	3.1	3.4	2.8	0.8	2.2	1.1	0.9	8.8	15.1	13.6	20.9	9.9	12.1	9.7	9.8	19.0	3.4	0.0	0.3	0.0	0.2	0.0	15.3	0.8	2.5	1.4	0.0	7.0	15.7	2.7	0.0	0.8	40.0	2.1	0.4	0.0	0.2	2.3	0.6	0.3	0.0	0.0	1.8	9.5	4.1	0.0	2.2	40.6	0.6	1.0	1.7	1.0	0.4	6.9	0.7	0.0	1.4	0.8	8.9	0.0	0.4	2.6	3.6	0.0	1.4	0.0	0.6	0.1
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		27000000	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	39.8	35.7	18.5	27.6	25.7	40.8	57.9	14.7	33.1	34.9	27.8	43.0	25.9	27.3	36.6	34.2	51.4	30.5	32.8	49.5	20.4	16.5	32.6	46.2	36.1	36.6	37.1	25.3	36.2	32.4	25.7	21.1	35.1	24.3	30.7	8.7	25.6	37.5	33.2	41.6	60.7	26.0	37.7	31.7	29.8	25.3	37.9	29.6	17.1	41.4	41.9	25.8	35.5	38.6	12.9	47.8	10.3	53.3	9.8	12.1	35.3	21.3	30.3	3.3	11.3	18.5	26.3	12.5	20.0	13.9	18.3	15.9	17.0	26.1	11.8	15.5	38.1	11.7	20.0	5.8	20.1	2.9	15.0	27.6	7.9	8.4	15.6	62.3	10.4	25.6	22.4	29.8	10.6	13.2	8.1	12.4	7.6	10.3	20.1	10.4	21.3	8.1	19.8	5.5	12.2	30.9	10.3	7.3	15.1	11.2	7.8	9.7	6.6	12.0	17.5	19.9	2.1	12.5	33.0	22.2	31.3	9.2	11.3	13.4	12.8	13.6	8.7	34.2	23.8	20.5	5.7	44.4	10.3	10.4	53.3	12.1	12.9	11.2	10.4	47.8	9.5	10.5	9.3	3.2	9.8	48.7	13.9	10.7	35.3	18.5	25.7	14.7	33.1	20.4	16.5	37.1	25.3	24.3	29.6	104.2	68.6	78.2	202.3	179.6	102.0	71.4	86.6	58.9	50.0	75.0	104.1	190.2	190.6	176.0	77.4	124.7	114.8	23.3	144.3	181.6	179.4	129.6	138.4	60.6	342.3	158.9	55.0	87.8	170.9	28.6	195.9	258.9	183.9	413.0	69.3	139.4	142.6	119.3	169.0	169.2	137.1	174.6	167.4	144.3	173.7	227.2	255.5	84.8	86.0	194.1
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764558	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	18.9	10.1	13.3	12.7	20.4	40.1	16.6	19.7	27.3	14.0	11.5	10.3	12.1	9.1	15.4	13.1	12.6	12.2	9.9	21.2	14.9	18.2	12.9	12.0	12.4	14.6	14.5	21.8	19.6	13.3	16.6	21.2	16.1	28.5	14.7	11.6	10.8	12.8	12.2	29.1	14.3	11.3	15.1	16.1	12.3	11.4	17.1	12.6	12.2	19.2	15.8	15.8	26.5	11.4	20.1	20.8	21.6	13.1	9.4	15.7	4.1	11.5	6.8	13.3	10.0	9.9	12.6	9.3	9.5	11.8	9.9	13.5	8.1	5.6	12.9	11.7	9.7	15.4	4.7	15.7	13.6	16.7	7.1	8.4	9.7	7.0	7.6	10.9	25.3	8.3	9.6	14.8	10.4	29.4	13.0	7.6	14.8	14.5	13.0	11.2	7.2	16.1	9.1	10.1	23.4	5.3	10.5	14.1	17.5	9.1	9.1	10.3	15.5	10.7	7.9	18.2	14.2	6.8	10.6	7.8	19.9	28.0	16.1	10.1	26.2	28.5	26.8	14.6	9.7	9.9	21.6	13.1	8.5	12.5	10.3	10.1	16.2	11.9	10.3	8.1	20.1	15.7	12.2	7.1	9.4	11.4	20.8	12.8	4.1	13.3	20.4	19.7	27.3	14.9	18.2	14.5	21.8	28.5	12.6	68.5	25.1	34.8	48.8	62.5	108.1	45.4	17.8	33.5	27.3	43.6	115.8	54.2	58.0	42.6	22.7	38.6	37.3	0.0	41.9	49.2	49.0	53.0	34.6	31.8	35.7	100.1	71.9	33.2	58.5	8.0	67.3	52.8	47.2	39.7	36.5	38.3	46.4	37.6	57.3	53.0	142.0	38.8	52.5	78.5	106.7	59.7	105.7	61.8	39.2	36.6
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	17.2	13.7	10.1	13.7	8.8	17.2	48.4	7.2	10.5	11.0	21.0	9.5	11.8	18.6	8.0	8.9	22.1	8.0	22.3	28.3	9.2	6.0	18.2	26.7	32.2	54.1	12.9	8.2	7.1	40.0	7.7	4.3	10.1	8.1	14.9	9.1	7.0	21.5	13.5	26.5	22.5	31.0	11.4	9.7	25.7	20.0	5.9	7.6	23.1	8.8	16.7	12.1	14.4	18.8	7.0	7.6	22.4	9.1	7.6	12.4	5.4	6.9	11.7	2.6	6.9	9.6	10.0	8.9	4.5	11.2	5.0	6.3	3.2	20.6	2.0	2.3	11.3	7.1	7.6	2.9	8.4	0.5	12.2	4.0	4.6	3.8	18.9	24.1	3.0	8.4	11.8	13.6	2.6	5.2	8.1	17.3	8.0	3.4	13.6	3.4	9.8	3.7	11.3	3.4	13.6	4.7	7.9	3.9	16.9	20.5	9.6	2.4	5.2	3.0	10.4	20.3	3.1	7.3	13.8	11.8	5.5	5.7	7.6	5.1	12.9	1.9	2.3	11.3	8.4	8.2	5.8	9.1	22.4	12.4	7.8	10.6	7.0	9.6	11.1	6.4	6.8	5.4	8.1	16.0	7.6	7.6	7.6	11.1	5.4	10.1	8.8	7.2	10.5	9.2	6.0	12.9	8.2	8.1	7.6	20.8	28.4	28.0	12.0	6.9	6.3	30.7	15.3	2.7	10.3	12.2	0.0	6.1	14.9	22.4	2.6	17.8	92.4	0.0	42.5	5.7	9.9	19.0	33.5	37.6	38.2	3.2	25.3	28.3	58.8	3.7	8.1	30.5	21.9	22.6	46.2	12.2	47.4	37.7	12.7	26.5	6.2	12.9	16.5	0.9	8.3	8.2	4.2	40.6	33.1	19.2
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 34.7;Horizontal cells: 49.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 15.2;HEL: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013371	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA		660000	"Nucleoplasm, Centriolar satellite"		"HPA013371: AB_1856391"	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	1.1	3.3	6.4	0.8	13.8	0.3	1.1	19.0	26.1	3.6	1.3	2.2	0.0	0.9	2.9	0.8	6.2	0.4	3.1	1.0	6.3	6.5	2.5	1.8	12.3	1.8	9.6	5.5	9.4	2.2	6.8	2.1	6.4	9.9	1.9	0.8	4.8	2.1	7.8	0.4	3.0	1.2	1.9	7.8	3.6	1.1	4.5	3.6	3.6	0.4	4.2	3.0	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.0	4.3	0.0	0.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.0	41.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	4.7	0.0	0.0	0.5	2.7	6.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.8	19.0	11.3	6.3	6.5	9.6	5.5	9.9	3.6	0.0	0.3	0.0	1.5	1.5	34.7	1.9	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.1	49.3	0.0	4.3	0.0	1.7	2.8	0.0	0.0	0.0	1.4	0.9	0.3	0.0	5.6	0.0	4.4	0.0	0.8	0.2	0.7	1.0	0.1	0.0	0.0	0.1
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	18.6	17.1	33.6	24.3	38.8	20.5	26.6	23.6	30.5	20.0	15.4	17.2	17.6	9.9	19.5	26.3	18.7	28.8	19.2	22.5	31.4	22.1	19.5	18.4	19.3	37.1	22.0	26.7	32.6	15.3	16.4	27.0	17.2	25.4	17.2	19.0	18.0	16.2	19.8	45.0	22.6	16.8	18.6	22.1	28.4	15.3	34.6	27.7	25.4	30.7	17.2	37.9	20.3	17.1	46.2	31.5	48.4	18.1	49.3	55.9	65.9	13.2	12.6	21.2	16.0	14.4	13.4	12.9	24.6	16.7	31.5	27.4	17.9	16.4	33.7	15.8	9.7	11.3	12.3	30.0	13.9	30.8	25.0	27.8	39.2	17.1	15.4	7.3	52.0	27.6	5.7	7.8	30.4	15.7	9.8	13.6	30.6	40.9	29.4	18.2	13.4	37.0	22.7	41.6	26.0	27.1	24.7	31.5	15.7	11.3	14.4	18.1	17.6	27.2	11.0	21.5	17.6	11.3	15.4	8.7	7.8	16.9	42.1	16.1	23.9	53.2	29.3	19.3	46.1	14.0	42.8	18.1	48.4	51.6	14.0	55.9	46.2	48.8	47.3	20.4	39.0	55.8	53.9	18.1	49.3	18.1	31.5	42.5	65.9	33.6	38.8	23.6	30.5	31.4	22.1	22.0	26.7	25.4	27.7	20.8	14.9	53.6	28.2	18.7	26.4	26.0	28.1	30.8	25.0	21.0	2.0	71.3	29.9	26.8	35.0	27.8	9.3	23.3	18.1	52.7	29.0	16.7	60.0	13.5	44.9	7.9	13.3	26.4	35.6	17.1	38.3	36.5	35.4	118.2	13.1	96.8	21.4	7.0	43.5	17.7	30.1	32.3	27.8	118.9	183.5	19.6	46.6	91.4	17.8	15.7
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	12.4	19.5	24.4	12.1	26.4	14.9	22.1	18.3	24.0	14.6	13.4	12.1	18.4	12.1	13.8	21.6	11.9	17.0	12.2	25.4	20.2	21.0	17.1	19.3	11.5	12.8	18.0	24.9	17.4	15.8	10.9	25.5	12.0	19.7	14.5	14.6	12.9	11.9	14.0	41.6	12.3	9.5	13.5	17.5	10.5	14.6	11.4	18.9	16.2	12.1	15.8	15.0	12.2	10.5	25.3	19.3	22.3	13.4	12.1	24.7	13.0	8.6	19.4	20.3	16.6	15.4	11.7	8.8	8.7	16.6	19.3	17.3	11.4	3.1	10.4	12.3	5.6	13.6	9.2	26.2	8.3	16.7	10.7	19.0	8.1	9.5	14.4	19.9	10.4	18.7	10.0	17.0	11.7	23.8	23.1	17.0	34.3	8.6	6.7	10.5	7.4	23.9	19.0	10.4	10.6	9.9	11.5	14.6	9.2	14.2	10.1	13.5	24.0	7.9	6.2	22.5	15.6	9.0	14.5	8.3	6.0	8.2	4.9	16.8	6.6	10.9	10.4	8.9	10.7	9.1	11.2	13.4	22.3	12.5	12.0	15.8	25.3	17.0	16.2	12.8	21.4	20.4	18.2	2.4	12.1	10.5	19.3	24.7	13.0	24.4	26.4	18.3	24.0	20.2	21.0	18.0	24.9	19.7	18.9	65.5	50.7	59.6	66.4	56.1	44.3	29.4	56.0	84.3	62.6	38.4	49.1	68.2	87.9	61.5	70.6	39.1	37.3	70.0	50.2	37.9	52.2	69.0	59.1	35.8	48.9	44.5	105.7	37.4	42.9	8.5	65.6	45.6	45.5	56.9	46.6	59.2	64.8	60.0	67.5	60.9	56.8	71.1	54.6	90.7	27.9	65.5	49.9	57.9	50.1	82.7
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041739: AB_2677647"	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (4.30e-3)"	10.1	10.2	12.8	8.5	12.4	4.7	8.1	7.8	15.6	7.8	10.2	12.6	7.9	8.5	10.7	6.0	12.3	10.4	6.9	9.5	10.9	6.1	6.7	10.8	7.3	9.8	12.3	10.1	12.4	9.4	12.9	9.4	8.7	11.9	9.4	7.1	9.5	9.8	9.2	27.0	10.3	8.0	10.1	8.0	9.1	9.4	12.6	11.8	11.2	8.3	7.9	10.7	11.2	8.4	5.9	4.5	0.0	5.9	4.9	7.2	3.3	7.2	8.7	11.9	12.5	10.0	7.3	10.1	7.2	6.2	9.3	9.1	23.5	6.6	5.7	11.9	8.0	15.0	17.2	21.4	10.5	8.0	10.0	10.4	10.7	12.1	10.3	6.3	8.8	6.8	7.4	13.3	11.0	7.7	6.3	10.4	13.0	25.0	6.5	8.6	4.6	9.5	5.4	21.0	11.2	8.1	17.2	10.3	6.1	4.1	17.1	10.9	14.6	9.2	9.6	4.9	10.8	15.9	11.0	9.4	14.7	9.6	14.6	11.5	11.0	30.1	6.4	10.4	9.6	13.8	0.0	2.6	0.0	7.2	3.5	6.6	4.8	4.3	4.5	4.5	5.9	6.1	5.3	0.0	4.9	5.9	2.9	4.4	3.3	12.8	12.4	7.8	15.6	10.9	6.1	12.3	10.1	11.9	11.8	3.0	4.8	9.1	3.8	2.5	9.4	8.1	2.5	5.3	4.5	5.2	11.8	5.6	1.7	4.8	1.1	4.6	3.5	0.0	4.7	5.3	4.1	4.9	2.3	8.1	4.2	15.9	2.4	3.7	4.0	1.3	3.4	3.3	1.7	6.4	5.6	4.8	4.8	0.0	8.9	2.4	7.0	0.0	3.8	11.2	9.8	3.6	2.3	6.9	6.6	2.7
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		320000	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	89.4	25.5	54.4	55.5	38.3	60.3	43.0	78.2	31.5	28.8	24.6	50.6	77.8	138.9	64.4	28.9	19.9	51.8	40.8	40.6	38.0	68.0	66.5	135.0	58.1	62.8	38.0	178.6	54.2	53.1	33.7	25.6	53.1	59.6	35.9	39.0	111.2	84.2	33.0	39.5	78.0	145.7	33.8	59.9	56.7	75.3	112.8	107.6	42.1	31.1	75.2	69.0	63.6	184.4	143.1	49.3	59.3	141.6	87.7	41.1	45.3	54.2	73.4	67.7	92.9	210.2	27.2	184.7	25.4	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0	413.9	647.4	2117.2	1742.6	1617.7	195.0	241.8	1080.3	472.4	833.7	554.8	123.7	1561.4	1614.8	1042.5	368.7	1236.7	707.2	537.3	1569.0	2352.9	1052.3	1320.4	878.8	1234.2	1317.3	133.5	877.3	1218.4	1697.8	247.8	1877.2	1676.9	1020.7	1556.4	1647.3	322.2	1580.5	1090.7	1160.1	1724.2	283.7	763.2	1114.2	317.0	420.5	1692.2	1548.7	1448.0	2302.5	1714.3
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		30000	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	78.4	66.9	61.7	82.2	45.7	150.0	148.7	63.1	82.7	75.1	76.8	27.2	65.4	48.8	74.8	80.1	91.9	64.9	80.8	120.6	46.2	38.5	76.2	121.7	109.5	222.2	49.2	49.0	123.7	185.0	17.2	44.1	81.0	48.3	65.3	55.0	43.8	119.1	78.5	127.5	113.8	61.9	82.4	43.6	84.4	69.7	40.3	28.8	72.6	70.5	153.8	78.5	86.1	80.9	178.5	152.7	44.2	99.0	111.4	184.7	216.0	114.1	144.8	88.7	128.4	157.1	233.0	143.3	133.0	109.3	143.0	102.6	205.0	89.9	216.5	113.2	104.6	77.6	100.2	101.6	169.8	137.6	100.2	241.7	85.0	121.4	216.7	193.9	244.1	89.5	219.6	145.5	96.5	123.8	146.7	118.5	114.9	158.0	134.0	132.0	111.6	203.2	206.9	134.3	132.4	92.7	142.6	249.8	244.5	120.8	154.3	99.8	110.2	52.2	103.0	211.8	125.8	173.2	258.0	133.7	106.6	105.6	130.2	195.6	117.1	188.5	211.9	95.8	151.7	108.6	44.2	99.0	29.5	106.6	87.9	150.2	178.5	159.0	124.5	118.6	168.3	184.7	159.1	20.4	111.4	67.3	152.7	112.5	216.0	61.7	45.7	63.1	82.7	46.2	38.5	49.2	49.0	48.3	28.8	681.9	960.2	2744.7	1731.4	2247.5	123.8	670.7	1245.8	627.7	1104.4	492.0	84.4	1811.7	1268.3	1382.3	339.9	1526.1	906.3	700.8	2626.7	2977.9	1476.5	1638.9	947.9	1517.2	1848.2	62.0	876.6	1298.9	2145.4	659.2	2254.1	2398.0	1353.0	2460.8	1687.2	280.7	2397.9	1157.3	1202.8	1660.9	156.7	853.7	1593.4	457.6	394.4	2946.9	1827.2	1797.0	2037.9	2132.8
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.1	9.4	7.5	7.9	8.5	10.4	8.6	9.3	12.4	14.0	12.3	6.7	12.2	2.0	11.5	10.8	6.2	14.1	12.8	12.1	8.5	7.4	11.6	9.7	6.7	7.7	19.9	9.7	9.3	12.4	14.7	14.1	6.2	9.7	15.0	9.9	8.7	12.0	5.5	13.5	7.0	12.3	8.4	15.4	5.5	7.4	11.8	9.0	14.6	5.9	10.5	8.1	9.7	11.6	6.8	9.3	9.6	8.8	9.4	10.5	9.9	16.3	13.0	22.3	17.6	10.7	14.0	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9	8.9	11.0	7.0	7.1	27.7	24.7	26.6	5.1	8.1	5.7	3.5	23.6	7.2	10.0	5.3	0.7	7.2	11.7	0.0	5.3	5.2	8.4	6.9	3.5	17.9	5.4	17.5	9.2	12.3	11.4	0.9	11.5	9.5	21.9	8.2	12.5	12.9	6.2	3.5	9.2	10.1	28.1	0.0	20.5	8.6	13.5	37.6	8.6	7.0	13.4	6.2
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954416-74957464	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 79.4;Hofbauer cells: 60.4;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.7;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	3.9	7.3	3.0	1.9	4.6	0.0	2.2	3.2	14.0	3.4	6.7	3.7	1.2	6.0	1.7	1.3	3.3	1.8	3.7	2.5	2.5	6.8	2.6	1.9	5.1	2.7	8.0	5.1	12.0	4.9	9.0	2.8	6.1	10.6	2.1	4.1	3.2	2.4	1.3	1.9	2.1	4.6	2.0	7.9	6.2	5.6	1.9	1.8	3.1	4.9	2.6	2.5	4.1	2.4	2.3	16.7	0.3	6.4	0.3	2.7	1.4	8.9	6.8	1.7	0.0	0.6	0.4	2.9	1.7	2.0	0.5	0.4	9.2	8.2	0.0	7.9	1.7	0.5	2.7	5.3	0.3	0.1	3.3	0.2	0.0	7.9	0.2	18.6	0.0	5.3	2.4	0.2	3.4	0.0	0.3	7.9	2.3	6.0	0.0	1.7	3.4	1.4	2.4	8.2	15.7	2.7	0.0	0.0	6.0	1.6	0.1	17.1	12.8	12.8	11.3	25.6	0.9	2.2	7.1	1.8	0.0	0.7	1.6	0.0	0.1	0.0	0.0	0.9	13.9	10.0	0.0	3.3	0.0	1.5	6.4	0.9	2.3	1.1	1.3	3.3	1.9	2.7	2.1	0.3	0.3	4.8	16.7	0.4	1.4	3.0	4.6	3.2	14.0	2.5	6.8	8.0	5.1	10.6	1.8	3.0	0.6	4.5	6.4	9.7	79.4	1.5	10.2	0.0	1.2	8.7	3.9	1.7	11.6	11.4	0.3	5.8	17.2	0.0	16.7	3.9	18.6	13.1	0.0	1.0	60.4	20.6	9.8	36.8	12.1	0.9	36.5	7.9	13.5	22.6	9.4	7.8	15.6	15.8	28.3	12.8	56.0	12.9	10.3	0.5	7.0	10.0	1.9	2.5	18.4	8.7
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 88.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 215.3;Late spermatids: 274.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	16.8	27.0	32.1	12.0	32.0	7.8	19.0	28.5	36.9	16.9	18.1	22.8	26.3	14.4	20.0	88.6	18.4	19.7	14.4	21.3	30.2	27.6	20.8	16.5	14.5	13.8	27.5	31.3	19.3	17.6	20.2	24.0	13.7	30.2	23.3	16.1	13.2	20.2	23.4	36.1	15.3	13.5	21.2	27.8	16.0	14.9	20.3	23.5	10.2	24.4	11.1	14.3	20.6	20.1	8.6	10.7	5.0	8.4	9.3	7.6	4.3	12.1	13.4	22.9	24.3	12.6	14.8	14.3	22.0	21.6	12.8	18.1	3.6	13.5	17.0	23.2	15.9	6.8	20.3	25.3	22.1	18.2	15.1	14.5	18.1	20.2	14.3	22.2	30.0	9.8	11.3	29.6	12.1	34.7	16.1	18.2	20.4	16.2	18.7	16.3	15.1	16.0	12.8	18.4	6.3	9.7	13.4	7.3	27.2	19.5	26.2	40.0	33.7	18.3	10.2	18.7	19.5	14.0	21.7	22.1	13.4	8.4	7.1	17.8	21.2	29.2	17.7	13.6	25.0	13.4	0.9	6.3	3.0	4.4	8.4	6.5	7.5	5.8	5.0	10.7	8.6	7.6	5.8	5.0	9.3	5.5	7.4	3.1	4.3	32.1	32.0	28.5	36.9	30.2	27.6	27.5	31.3	30.2	23.5	29.8	16.5	47.2	28.5	30.6	50.7	32.9	15.3	13.4	13.6	33.2	29.5	13.9	23.2	18.7	215.3	21.0	12.2	0.0	17.2	14.7	15.0	35.2	12.7	22.1	8.8	35.0	27.6	19.6	16.8	274.1	20.4	15.7	28.7	5.4	18.5	29.4	17.3	23.7	21.5	21.4	49.7	12.9	26.9	34.1	37.7	33.4	12.2	20.1	19.5	29.4
RPRD2	"FLJ32145, HSPC099, KIAA0460"	ENSG00000163125	"Regulation of nuclear pre-mRNA domain containing 2"	Q5VT52	1	150363091-150476566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061693	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		91000	"Nucleoplasm, Vesicles"		"HPA061693: AB_2684587"	"unprognostic (1.68e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.38e-1)"	14.0	16.9	16.8	12.0	21.6	13.2	14.0	40.1	22.1	20.2	17.9	21.4	16.6	11.5	21.0	16.4	17.0	24.2	12.2	14.1	16.3	14.1	18.3	12.5	14.0	13.8	16.3	14.1	34.2	17.9	27.5	29.4	10.7	15.2	18.3	16.3	19.8	14.5	19.2	28.5	15.6	13.9	20.1	13.8	16.7	14.2	16.2	17.4	25.6	25.4	10.4	17.3	21.6	17.1	8.0	4.2	6.0	8.6	5.1	9.1	2.5	15.8	12.1	16.1	16.2	16.7	14.2	15.2	11.5	13.7	12.7	12.5	10.4	19.5	25.1	13.2	14.0	7.1	17.6	22.5	17.1	13.9	11.5	9.5	14.4	14.3	12.5	12.0	21.5	17.8	15.0	13.0	17.7	23.4	14.1	15.6	15.4	14.0	27.4	12.8	22.8	18.9	7.0	20.1	20.0	13.7	17.4	11.9	25.3	18.6	14.6	17.1	17.3	23.5	20.0	15.2	15.0	15.8	19.2	14.3	11.8	12.2	9.8	16.2	16.8	18.4	19.0	11.7	16.2	11.5	6.0	3.6	4.4	8.1	2.4	7.4	7.6	7.6	6.4	3.5	8.0	8.9	8.8	2.0	5.1	8.6	4.2	9.1	2.5	16.8	21.6	40.1	22.1	16.3	14.1	16.3	14.1	15.2	17.4	17.9	20.4	25.7	8.7	13.7	32.3	23.0	17.8	20.1	27.3	31.4	15.7	11.8	6.6	11.0	7.2	20.1	14.2	0.0	11.2	7.3	13.6	13.3	17.3	22.2	12.7	11.1	24.8	25.8	16.8	3.2	35.1	10.1	10.1	10.8	22.5	25.1	12.3	14.0	37.4	22.1	27.5	32.3	12.7	21.8	23.4	12.8	8.4	23.6	23.4	9.9
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 85.8;monocytes: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.9;U-937: 32.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.9	3.5	2.8	3.7	0.1	0.0	3.8	0.8	1.6	4.2	4.1	4.0	8.2	18.5	4.6	0.5	5.1	11.7	6.4	22.9	3.0	15.3	4.1	20.3	8.6	7.1	1.3	23.9	29.9	0.7	8.4	3.9	7.0	1.9	1.8	7.4	3.4	6.7	0.2	5.5	0.8	23.6	7.3	19.3	11.1	12.8	3.6	8.1	12.1	2.7	4.1	1.6	7.0	6.6	3.2	3.1	4.2	20.6	1.2	0.2	5.4	0.7	3.3	4.2	4.9	10.1	2.5	32.2	4.1	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0	14.9	23.5	13.7	7.4	16.6	1.3	1.2	10.2	10.7	5.7	8.7	3.9	1.2	6.6	15.5	1.8	4.2	85.8	0.0	16.3	14.5	1.9	13.9	32.2	3.8	43.9	0.0	15.6	12.3	57.1	0.5	0.0	36.8	1.7	68.5	34.3	0.4	21.8	41.9	0.0	13.6	1.7	6.5	2.1	1.1	2.7	10.2	3.4	41.5	32.9	6.8
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	28.1	15.8	2.3	5.7	5.1	4.8	32.6	15.0	7.9	11.8	5.8	15.6	14.8	2.9	17.5	8.6	15.0	26.1	2.7	12.2	5.8	8.9	5.3	6.6	13.5	7.9	5.1	6.7	12.4	4.7	11.5	10.0	8.2	4.2	7.1	5.4	2.7	4.1	5.9	25.8	6.0	10.5	2.5	10.9	33.3	11.8	9.4	9.4	8.1	13.0	3.4	2.7	15.5	9.5	13.0	3.4	11.1	8.3	14.1	16.1	20.2	29.0	13.3	4.9	3.8	2.9	10.6	7.7	8.1	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5	3.0	4.0	5.7	4.6	10.8	6.3	11.8	5.1	0.0	1.2	3.5	3.9	60.8	5.0	13.7	0.2	7.4	17.0	0.0	21.8	31.5	9.1	7.1	19.5	6.4	26.9	7.9	8.1	11.6	29.2	0.7	10.3	15.3	8.5	12.6	11.6	3.1	40.7	10.7	6.3	7.3	2.0	0.0	9.2	0.7	7.2	9.4	39.0	8.7	13.9	8.5
RPUSD2	"C15orf19, C18B11, FLJ31409"	ENSG00000166133	"RNA pseudouridylate synthase domain containing 2"	Q8IZ73	15	40569300-40574943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042079, HPA042194"	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Nucleoplasm, Microtubules"		"HPA042079: AB_10794643, HPA042194: AB_10794416"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.63e-7)"	"unprognostic (7.27e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.75e-2)"	6.6	9.8	7.8	7.7	15.3	14.2	9.3	7.7	14.6	7.7	9.3	7.7	8.1	8.3	10.9	9.9	9.9	8.5	6.4	11.4	7.6	7.4	7.0	12.2	6.5	10.6	6.8	8.8	11.0	9.8	6.9	7.5	7.5	8.4	8.5	7.3	7.7	13.3	8.9	19.8	10.6	8.8	6.5	5.0	11.0	7.9	7.9	6.6	13.7	10.4	10.5	10.5	8.2	6.3	20.1	8.9	2.9	8.9	17.8	16.0	8.1	7.7	8.8	7.5	12.4	6.5	4.9	14.2	7.0	8.3	12.1	9.6	10.8	4.9	7.5	10.1	8.0	11.0	21.1	17.3	12.2	6.9	8.6	11.8	13.2	12.2	12.7	9.7	10.9	9.5	6.9	11.5	7.9	10.9	5.6	7.4	12.3	16.1	8.9	5.9	9.5	13.0	13.8	9.6	11.3	9.6	16.7	8.3	11.4	7.7	6.8	8.6	9.9	9.4	10.7	5.6	6.5	10.2	15.0	4.6	8.3	9.7	10.6	7.9	9.2	18.3	20.0	7.2	17.2	6.4	0.0	3.5	2.9	13.5	4.1	12.4	15.6	13.3	14.3	6.8	20.1	16.0	13.3	0.4	17.8	8.9	8.9	13.6	8.1	7.8	15.3	7.7	14.6	7.6	7.4	6.8	8.8	8.4	6.6	6.0	1.6	5.9	11.3	9.4	12.1	7.0	5.1	10.7	3.4	7.0	15.7	13.5	21.6	7.6	1.6	4.6	3.2	0.0	9.4	7.0	7.1	7.4	4.6	7.8	6.1	17.5	12.7	3.7	1.2	1.5	6.6	3.5	3.3	3.6	5.3	14.0	5.4	3.5	9.6	9.9	14.7	12.9	7.6	5.5	17.0	9.4	4.7	8.4	8.3	7.9
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridylate synthase domain containing 4"	Q96CM3	11	126202094-126211692	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	7.5	6.8	5.1	7.7	7.8	6.0	7.8	8.2	9.6	6.3	6.0	4.8	7.6	6.4	7.0	6.8	7.8	7.2	5.2	13.2	5.1	4.9	6.3	10.2	5.0	7.7	6.5	8.1	10.1	16.1	5.7	5.1	4.5	7.2	6.9	6.9	5.2	9.5	8.2	72.0	8.9	5.9	8.3	4.8	7.6	9.3	7.0	7.1	6.2	7.7	18.2	9.3	6.2	12.0	9.8	11.0	1.0	8.5	8.4	15.2	8.7	6.6	6.7	8.0	9.6	12.6	16.5	5.7	7.5	10.5	8.2	7.3	20.5	13.2	15.7	7.4	6.7	11.4	11.7	18.3	11.5	8.7	13.1	10.1	36.6	7.1	19.2	8.3	19.2	8.4	15.1	17.4	8.9	11.2	12.3	16.4	12.9	22.8	11.6	9.6	6.5	12.0	22.2	8.8	22.7	11.8	14.1	12.2	14.5	12.5	9.7	13.9	9.5	9.6	14.3	7.0	8.7	21.4	10.2	9.9	9.2	6.4	6.9	8.8	4.9	5.2	13.5	4.2	21.9	9.4	1.0	8.5	0.8	10.8	7.7	14.0	9.8	13.3	10.3	11.0	9.5	15.2	12.2	0.7	8.4	8.3	4.7	12.2	8.7	5.1	7.8	8.2	9.6	5.1	4.9	6.5	8.1	7.2	7.1	3.0	6.7	16.7	17.9	24.5	8.9	30.7	12.7	8.1	5.7	7.0	7.9	11.7	8.3	10.7	1.1	11.3	9.7	0.0	16.9	13.7	10.1	10.5	5.7	11.1	11.8	11.1	14.9	8.6	10.2	1.4	8.9	8.5	10.1	21.6	9.3	4.5	13.0	7.0	8.1	11.8	7.6	6.5	10.8	7.7	15.4	21.0	11.1	15.9	15.7	13.3
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859823	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	27.8	14.0	18.6	11.9	24.1	20.1	36.5	15.9	22.3	13.4	19.4	13.3	11.0	14.1	14.9	11.1	20.7	11.8	13.6	19.0	16.7	13.8	18.8	13.9	15.0	14.2	18.9	14.1	17.6	12.9	13.9	8.9	27.6	21.4	12.6	13.3	11.9	12.7	13.8	15.5	24.6	13.0	17.0	15.6	12.8	12.9	12.7	15.9	11.2	12.9	8.2	16.0	16.0	14.9	4.9	11.3	7.7	3.3	2.0	4.0	2.0	12.1	5.5	7.3	7.9	39.0	26.5	11.3	11.3	23.3	15.5	16.4	4.2	8.1	7.6	6.5	17.6	24.9	7.3	13.6	7.5	12.8	12.3	9.6	7.3	6.8	4.8	47.9	8.5	8.3	23.5	19.0	16.5	21.5	12.3	16.1	8.3	7.4	15.4	22.3	3.3	6.1	4.8	9.3	5.3	9.5	5.9	12.9	5.1	10.9	14.2	3.8	5.7	9.0	6.8	23.6	17.2	6.2	6.5	14.2	18.9	7.8	20.6	9.6	12.1	19.4	9.0	17.6	9.6	9.7	0.5	3.3	6.7	2.5	3.0	4.0	4.6	3.7	3.0	3.1	4.9	3.3	3.1	7.7	2.0	2.3	11.3	3.3	2.0	18.6	24.1	15.9	22.3	16.7	13.8	18.9	14.1	21.4	15.9	29.8	28.3	36.0	36.3	99.5	18.7	21.2	22.9	10.7	11.4	12.2	11.8	70.5	10.0	46.2	51.6	21.1	19.1	23.3	41.7	49.6	38.6	38.8	16.1	10.2	61.8	36.5	13.8	38.1	28.2	37.2	28.4	37.6	50.6	80.2	9.7	40.2	38.6	14.4	35.0	23.7	21.1	19.4	41.2	23.3	25.2	122.8	187.4	20.3	13.0	38.8
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277926-14364506	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.3"	"Group enriched"	"Detected in many"	5	"B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	22.3	11.8	8.3	27.5	7.8	2.3	22.6	9.5	7.0	14.1	16.9	6.4	7.8	11.9	16.2	9.8	13.5	11.1	12.9	29.8	8.7	8.1	25.6	33.0	18.1	15.2	6.5	7.6	16.6	18.5	13.5	7.4	50.8	8.4	16.7	11.0	14.5	15.1	12.9	31.4	9.2	37.7	31.4	7.6	17.6	13.7	21.0	5.2	11.3	26.2	14.4	20.8	27.3	15.0	12.3	0.4	1.5	0.0	3.5	6.2	0.9	15.3	6.7	6.4	5.6	22.9	22.4	9.5	54.3	28.4	46.9	59.6	13.5	19.2	17.7	9.1	36.4	15.2	17.7	10.8	19.4	47.3	15.7	10.5	1.1	4.0	10.7	24.5	0.0	0.1	23.7	36.8	18.7	60.1	19.3	23.3	4.3	7.7	0.0	40.7	7.4	3.7	0.9	18.2	3.1	6.3	3.7	21.2	0.3	24.0	8.5	1.7	3.3	13.1	8.4	7.4	22.6	5.4	1.1	53.1	25.4	14.1	48.7	14.7	0.0	0.0	8.3	10.2	0.0	5.1	1.5	0.0	0.0	6.2	0.0	2.6	12.3	1.1	3.2	0.0	6.9	0.6	2.5	0.4	3.5	0.0	0.4	0.0	0.9	8.3	7.8	9.5	7.0	8.7	8.1	6.5	7.6	8.4	5.2	17.9	17.6	46.8	50.4	61.6	5.2	23.2	43.3	10.7	18.2	17.4	0.0	32.7	19.9	40.3	48.4	18.0	39.6	0.0	16.1	49.9	26.8	69.2	9.2	27.6	6.9	12.7	18.3	12.9	1.6	34.5	15.3	2.5	25.3	2.8	16.6	18.6	42.0	25.9	10.6	70.4	10.3	19.4	21.2	34.6	41.4	43.5	24.3	26.6	19.6	64.4
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.0	11.9	7.0	16.8	16.2	9.4	13.0	15.8	7.0	8.2	3.5	4.5	35.8	12.3	14.3	7.1	2.1	5.7	13.2	9.9	5.8	6.2	9.0	4.2	7.5	13.6	2.7	19.2	20.5	24.9	7.7	11.8	16.7	19.6	6.2	6.6	5.5	22.4	5.5	4.7	5.2	6.6	6.1	7.4	3.0	4.8	7.2	16.3	6.4	3.0	5.9	6.8	3.6	7.7	31.0	9.7	6.2	14.9	10.9	21.1	7.5	3.5	5.8	5.3	32.6	16.0	4.2	11.5	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4	53.6	24.0	7.2	8.1	17.2	13.1	17.9	20.4	38.8	25.0	38.4	13.7	11.2	21.6	6.2	1.6	16.4	6.4	0.0	7.0	4.9	10.4	10.8	10.5	20.3	11.1	9.5	28.3	18.4	21.8	1.1	13.3	17.8	16.9	7.2	10.3	23.6	5.5	7.0	13.8	18.1	14.7	6.5	10.8	8.2	10.0	16.2	4.0	12.8	11.7	5.4
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	39.4	22.3	22.2	32.4	24.0	22.5	18.7	31.3	28.4	40.2	39.5	40.5	17.3	18.3	25.6	32.6	29.5	21.2	37.1	38.0	44.5	23.1	37.8	29.4	24.8	43.2	27.9	24.4	22.9	22.7	23.3	48.0	20.6	14.4	32.6	16.6	35.5	20.0	37.2	41.6	29.3	26.7	24.6	70.7	23.2	27.7	21.9	21.1	24.6	37.4	28.5	25.0	23.1	21.2	35.8	21.8	29.2	30.1	26.2	37.2	28.3	24.4	49.1	18.8	28.2	48.9	16.2	30.9	34.5	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8	0.0	14.1	20.6	9.5	11.8	15.3	13.7	28.1	8.1	12.5	19.2	15.7	25.9	11.6	31.6	8.6	11.3	10.5	0.0	38.9	36.9	13.2	13.1	5.8	34.3	25.3	17.5	13.4	22.1	14.3	18.5	10.9	13.4	13.5	28.9	11.3	25.1	32.5	7.0	17.7	16.1	17.2	6.5	12.0	7.6	10.2	16.3	28.1	10.0	12.8	12.1
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	0.9	0.3	1.7	0.4	2.8	2.6	0.1	0.6	2.2	0.6			0.0	1.2	0.0	3.5	1.2	1.1	2.9	0.3	0.5	4.0	7.7	2.7	2.0	0.4		4.6	0.2	2.1	1.3	2.3		3.9	1.3		0.1	0.8	0.6	2.1	0.6	3.0	0.8	0.1	0.6	4.7			1.7		3.2	1.1	2.2	1.1	2.8	0.5	3.5	1.7	2.3	1.5	3.3	3.9	4.8	3.2	6.0	4.2	6.4	2.8	4.7	7.9	7.4	6.4	5.5	7.4	2.8	6.3	3.9	2.3	12.5	4.0	9.7	4.9	3.1	6.9	7.7	6.8	1.3	10.1	3.5	3.3	0.0	13.6	7.5	1.8	4.9	5.0	19.0	7.0	5.7	3.3	5.3	0.0	5.2	1.9	2.2	4.5	6.8	3.1	1.8	6.2	3.9	1.6	5.3	2.4	4.6	4.3	3.4	0.9	4.8	4.0	7.4	3.6	2.1	2.1	4.0	12.9	1.6	2.7	2.8	0.0	1.2	0.5	0.4	3.5	1.4	1.1	0.5	2.3	2.8	0.2	0.6	0.5	0.0	1.7	0.1	0.7	2.3	1.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006714	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	20.4	27.8	27.6	21.6	33.8	34.3	20.4	40.5	34.5	23.7	22.5	14.3	17.6	16.9	25.7	18.4	22.4	18.5	18.4	24.8	26.5	21.4	17.6	19.6	17.2	23.0	17.0	35.1	27.7	15.2	37.0	20.3	36.9	27.2	22.0	20.6	15.4	19.5	23.2	55.2	24.8	20.7	24.7	14.9	23.5	19.0	25.4	13.5	25.3	26.7	15.6	21.6	27.8	20.2	8.0	7.4	11.6	4.3	8.6	5.7	1.4	15.3	10.1	33.4	27.1	19.0	22.6	15.8	20.6	23.2	28.3	23.7	19.7	9.8	14.6	16.7	21.5	12.6	27.4	19.3	17.1	24.3	22.2	18.0	30.7	22.9	14.7	13.3	27.3	18.0	16.2	17.4	15.1	15.3	21.1	22.7	26.8	23.3	17.0	23.1	11.7	26.1	16.9	18.0	19.2	13.9	28.4	26.1	13.9	18.4	33.1	17.2	22.8	18.5	23.7	9.3	19.0	19.4	26.5	18.6	27.8	17.7	27.6	22.5	19.7	30.3	24.3	20.0	26.1	16.9	5.9	4.3	8.4	4.8	2.8	4.4	8.0	4.7	4.1	3.0	6.5	5.7	4.7	11.6	8.6	3.3	7.4	5.4	1.4	27.6	33.8	40.5	34.5	26.5	21.4	17.0	35.1	27.2	13.5	119.1	70.9	118.3	89.5	128.8	209.3	81.2	112.1	69.6	75.1	116.9	88.4	138.6	139.3	89.0	242.0	101.3	97.3	116.8	95.9	97.3	120.4	91.4	89.0	170.3	83.7	139.8	84.2	119.7	72.1	267.8	134.3	89.8	102.9	103.6	107.1	106.0	103.7	94.8	150.3	100.0	188.1	84.1	92.0	109.4	66.6	142.4	183.4	97.8	106.5	90.9
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 133.3;Distal tubular cells: 132.6;monocytes: 160.5;Syncytiotrophoblasts: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	33.4	34.2	43.5	29.1	43.9	52.6	28.9	27.4	48.7	28.8	29.4	53.0	20.1	28.0	31.4	24.1	30.5	31.6	23.2	38.7	40.6	35.6	31.8	30.3	24.2	29.7	49.6	35.7	35.2	27.5	26.0	29.3	30.5	46.6	28.5	26.0	26.0	25.8	31.7	74.6	27.9	29.8	34.1	59.7	30.2	25.3	29.1	45.2	31.4	29.1	28.9	34.4	29.0	23.9	20.0	35.1	91.6	31.8	29.4	23.0	33.2	28.9	20.8	21.1	20.6	26.4	23.6	19.6	45.2	34.2	65.3	37.5	42.4	28.1	24.8	53.7	36.6	32.1	32.5	21.1	34.8	45.2	11.6	16.4	31.0	22.8	32.8	30.3	44.1	42.9	20.9	36.2	29.1	25.3	27.8	28.0	26.6	24.0	26.0	32.0	55.3	36.9	37.6	15.6	41.1	39.7	25.4	57.5	32.7	27.2	19.1	21.8	23.7	47.5	80.6	42.5	16.3	37.3	42.1	30.0	55.9	36.2	30.4	36.5	21.7	24.9	35.3	44.0	30.1	30.4	39.2	31.8	84.1	20.9	29.6	17.6	18.6	18.0	20.3	35.1	20.0	20.5	18.8	91.6	29.4	28.8	29.9	23.0	33.2	43.5	43.9	27.4	48.7	40.6	35.6	49.6	35.7	46.6	45.2	47.6	50.4	0.0	0.0	0.0	0.0	0.0	0.0	62.9	62.6	62.8	0.0	133.3	132.6	81.8	0.0	0.0	0.0	0.0	83.7	92.1	0.0	0.0	83.7	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	160.5	0.0	0.0	80.1	0.0	0.0	106.9	0.0	0.0	0.0	0.0	0.0	0.0	153.0	0.0	0.0	0.0
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425836-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	3.2	4.9	17.1	3.9	24.2	0.4	7.1	3.9	23.6	5.6	8.7	29.7	7.3	21.2	5.1	4.0	8.0	9.0	9.7	7.2	22.2	13.7	27.0	39.0	6.3	1.9	34.8	7.7	3.6	16.3	12.8	5.3	7.9	17.2	6.5	8.8	6.0	17.3	7.0	7.5	21.1	16.4	4.4	36.3	2.2	6.0	1.4	29.4	1.9	7.4	5.3	4.3	3.1	5.6	1.7	9.7	0.0	0.0	3.1	0.4	0.6	16.8	5.2	6.7	19.8	4.1	4.8	29.0	2.6	3.3	3.8	2.8	26.2	9.4	0.1	7.5	2.5	4.7	23.2	2.5	16.9	1.8	3.3	10.9	4.0	0.9	33.0	2.5	0.0	0.0	2.9	13.5	3.3	10.8	7.0	1.9	0.2	2.0	0.1	5.6	12.0	0.6	3.3	7.3	24.5	10.5	3.7	21.0	2.5	18.6	0.1	6.8	6.5	7.2	28.1	14.9	6.5	15.7	1.5	0.2	7.2	5.0	3.2	3.5	1.7	1.1	0.6	6.9	0.0	6.7	0.0	0.0	0.0	0.4	0.0	0.3	1.1	0.2	0.3	0.9	1.7	0.0	0.1	0.0	3.1	0.0	9.7	0.0	0.6	17.1	24.2	3.9	14.9	22.2	13.7	34.8	7.7	17.2	29.4	8.9	10.2	1.7	19.9	17.7	0.0	2.5	17.8	2.7	17.0	10.4	2.0	38.3	18.3	38.6	0.8	7.0	35.9	0.0	17.8	4.0	10.3	22.4	1.1	34.6	8.2	0.0	29.6	3.1	2.6	0.4	11.8	0.0	27.0	1.0	15.4	5.8	24.3	31.6	8.1	43.3	0.4	6.5	3.4	1.1	3.4	18.9	27.9	2.9	21.8	14.5
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lung: 67.6"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 1628.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"T-reg: 15.4"	"Lineage enriched"	"Detected in single"	47	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 25.5;HaCaT: 20.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0.0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3.0	0.3	0.2	0.3	0.1	0.2	15.4	0.2	25.5	1.4	13.7	6.3	0.0	0.1	3.3	3.7	4.3	4.2	6.7	10.6	5.1	0.1	1.6	1.4	4.3	20.5	7.6	0.6	4.4	3.6	5.2	4.2	3.1	4.4	0.0	5.7	3.3	0.2	0.3	5.2	0.5	2.3	0.6	6.8	0.2	0.2	5.6	3.2	11.0	7.3	5.8	3.8	5.2	9.5	14.6	0.0	2.7	11.1	7.5	8.6	2.4	8.6	3.5	4.2	7.8	3.1	0.0	1.9	12.5	0.1	9.3	0.1	0.0	9.8	2.5	0.0	3.0	0.1	0.1	0.1	1.3	0.0	0.1	0.1	2.1	0.4	0.0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1	1628.8	44.5	0.9	8.3	4.1	0.6	0.4	0.0	4.0	15.9	0.0	0.0	3.0	0.0	1.4	376.8	0.1	0.4	0.0	1.4	4.9	2.5	7.0	3.5	0.0	2.1	0.0	1.7	1.8	0.6	65.6	2.0	2.2	1.7	0.0	5.9	0.4	9.1	0.0	1.8	1.4	0.5	0.0	1.9	21.3	23.6	1.6	1.7	12.7	3.3	87.2
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 61.2;HMC-1: 36.9;JURKAT: 56.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	12.2	0.9	0.0	0.0	3.2	4.1	8.1	6.9	7.1	3.9	2.9	0.6	9.4	6.1	0.4	6.1	6.5	11.1	0.7	8.3	5.6	9.3	0.9	61.2	2.4	2.8	5.9	7.0	36.9	8.0	5.0	11.8	11.7	5.4	2.2	56.6	4.1	3.5	8.2	2.6	28.5	11.2	0.5	6.7	3.6	28.9	21.4	3.7	5.2	4.9	0.3	0.0	7.2	1.8	2.5	1.8	3.7	16.6	9.1	6.4	8.3	9.5	10.4	11.8	4.8	5.7	8.0	15.5	9.3	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6	50.6	30.7	14.5	44.6	37.0	2.1	2.2	38.2	56.2	39.8	19.2	0.0	0.8	1.7	35.7	16.8	5.8	12.0	0.0	24.4	19.6	25.7	45.4	16.3	4.3	57.2	0.0	5.8	4.9	79.5	21.7	4.4	63.0	27.0	31.5	10.8	0.5	63.1	12.7	4.2	1.2	0.6	0.0	31.5	23.0	24.9	17.7	2.1	37.4	14.4	53.7
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.9	24.5	15.1	24.5	11.8	11.5	19.7	13.2	11.4	25.5	17.6	25.6	16.1	38.3	13.2	12.6	19.7	21.5	40.1	28.1	29.8	15.6	19.7	31.8	14.2	17.1	12.2	29.7	10.2	11.7	14.8	21.4	27.6	9.7	17.1	14.6	26.0	9.0	14.5	38.4	31.8	22.5	37.9	30.5	21.0	26.2	18.3	26.6	15.3	10.2	25.3	22.7	14.6	12.1	20.2	14.6	22.0	22.0	11.0	11.6	14.2	17.4	20.0	9.2	14.6	37.6	14.3	18.3	14.5	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3	20.8	11.7	25.1	16.5	17.7	16.3	18.7	22.9	208.8	31.8	21.0	2.0	45.7	39.7	29.2	14.5	21.2	2.9	0.0	26.3	53.6	20.6	11.7	25.4	13.2	26.2	22.3	16.3	11.1	5.6	19.6	14.1	10.5	10.1	12.6	12.4	26.0	22.8	14.0	17.3	41.5	16.2	12.9	13.3	96.8	64.3	14.8	20.1	24.9	23.0	11.9
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 186.8;Kupffer cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HaCaT: 27.4;RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.6	15.8	2.0	5.0	3.6	3.3	24.3	3.0	3.5	4.4	2.5	8.8	8.8	0.0	8.3	4.4	3.8	27.4	0.7	10.7	0.2	8.0	2.0	0.0	19.3	13.3	4.6	6.6	2.4	5.4	4.6	5.5	2.6	0.6	3.7	0.9	10.9	0.5	1.0	15.1	0.5	1.4	3.8	4.1	5.5	2.9	7.5	10.9	0.2	24.4	4.5	2.0	9.6	9.2	2.4	0.1	12.8	9.0	4.8	5.4	6.5	5.7	2.7	0.7	0.0	0.1	4.1	6.7	3.5	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1	29.8	22.2	2.2	14.1	30.7	3.8	30.8	79.0	8.1	21.6	8.7	23.6	24.3	1.7	11.9	4.5	17.5	46.7	23.3	12.2	27.0	17.3	15.8	1.1	186.8	29.1	31.8	9.2	72.4	115.8	14.1	30.0	27.5	11.8	5.4	24.8	42.2	14.1	34.5	19.8	16.2	21.2	19.4	17.9	0.7	12.3	40.9	20.0	13.1	23.9	26.0
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 29.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	29.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4	0.0	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.9	4.6	0.0	27.0	0.0	0.0	9.1	0.1	0.0	2.1	0.0	4.0	12.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RXYLT1	"HP10481, TMEM5"	ENSG00000118600	"Ribitol xylosyltransferase 1"	Q9Y2B1	12	63779803-63809558	"Disease related genes, Predicted intracellular proteins"		Transferase	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 25.4;Distal tubular cells: 31.5;Exocrine glandular cells: 26.6;Extravillous trophoblasts: 28.9;Syncytiotrophoblasts: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064014			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA064014: AB_2685176"	"unprognostic (1.19e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.33e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	9.7	19.6	10.3	9.8	11.3	5.7	14.7	8.2	13.6	10.3	9.3	10.6	11.3	7.8	9.2	20.8	9.6	10.9	9.6	21.1	9.8	11.4	15.2	20.1	11.9	14.8	10.7	8.0	17.4	33.4	20.2	19.0	10.5	9.5	12.1	10.1	12.4	17.0	14.5	14.7	11.1	8.2	12.2	13.1	10.6	8.1	16.1	9.0	9.1	17.2	10.7	9.7	11.8	8.1	6.6	7.2	1.8	3.6	4.7	7.0	2.2	7.7	14.3	10.1	8.5	8.8	11.9	11.7	8.7	12.6	13.0	8.6	5.2	7.4	16.6	15.1	9.1	10.5	7.1	12.2	11.1	15.5	17.3	12.4	9.0	4.0	8.2	13.4	13.7	7.9	10.6	11.1	12.6	16.4	12.1	7.2	12.5	10.1	14.2	19.6	12.4	7.4	5.7	6.1	7.1	18.2	7.5	11.7	8.9	12.4	10.2	25.0	4.3	9.1	6.9	17.2	6.6	14.7	6.9	8.3	11.6	12.0	7.2	11.9	9.4	13.5	11.6	7.9	8.3	15.3	1.2	3.1	1.8	4.0	2.9	6.9	6.6	4.4	4.8	3.0	4.2	5.9	4.8	0.6	4.7	3.6	7.2	7.0	2.2	10.3	11.3	8.2	13.6	9.8	11.4	10.7	8.0	9.5	9.0	8.9	5.9	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	15.7	0.0	21.6	31.5	19.6	0.0	0.0	0.0	0.0	26.6	28.9	0.0	0.0	7.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	14.4	0.0	0.0	17.5	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745424	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		8400000	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	18.4	24.9	22.0	18.9	23.3	14.9	18.2	23.3	26.3	19.0	19.4	16.4	21.2	18.9	22.6	19.3	17.0	18.1	16.6	15.6	21.8	22.8	31.9	22.7	23.2	19.9	20.5	24.9	15.7	18.3	25.1	31.9	21.2	28.7	21.1	20.1	17.7	20.0	18.2	12.7	14.7	20.4	17.0	22.2	20.9	20.5	11.0	19.6	26.8	35.8	8.5	19.7	20.9	20.9	5.8	13.7	13.4	8.7	30.1	14.9	13.4	11.0	8.3	15.5	8.6	26.4	18.1	11.9	17.0	18.1	16.0	13.8	11.0	9.0	18.1	9.8	16.3	20.3	8.7	19.1	11.5	20.6	11.4	11.6	18.6	13.6	10.6	14.2	27.9	22.8	11.9	18.2	16.2	12.5	13.1	10.9	17.6	20.4	18.7	26.2	5.4	23.7	15.3	16.6	12.2	17.0	6.2	8.1	17.0	17.5	16.2	6.1	14.7	11.7	15.5	17.9	16.4	11.6	27.0	12.3	14.6	8.1	14.7	17.5	10.7	26.1	12.9	17.0	43.1	14.5	4.3	8.7	13.4	13.6	7.0	14.9	5.8	9.8	13.6	13.7	5.3	10.1	13.1	7.1	30.1	6.0	5.7	8.2	13.4	22.0	23.3	23.3	26.3	21.8	22.8	20.5	24.9	28.7	19.6	26.8	31.2	19.3	7.8	17.4	22.6	14.0	17.8	10.7	13.6	7.0	29.5	17.8	16.6	9.1	1.3	13.5	15.8	0.0	8.7	9.5	15.3	14.3	16.2	13.1	21.0	31.8	11.5	14.7	19.1	2.4	15.5	17.3	16.9	18.0	8.8	14.1	10.7	17.3	21.5	16.5	21.4	6.5	12.0	10.1	10.9	15.2	15.3	41.7	10.3	8.9
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	20.1	17.8	26.7	22.8	30.5	24.0	18.6	21.9	45.9	23.6	50.1	17.6	21.6	14.0	30.2	13.1	27.5	21.3	17.1	22.5	21.2	23.9	14.6	16.0	19.2	30.6	20.4	34.6	19.0	14.4	28.0	13.9	26.8	24.3	20.2	27.3	20.9	15.7	28.6	24.1	19.0	20.1	38.5	15.9	25.8	30.5	60.2	16.2	32.7	37.5	17.2	37.5	33.0	25.8	19.1	22.3	22.8	19.0	35.2	41.3	29.4	36.2	39.8	62.5	29.8	21.5	25.3	21.2	44.9	39.2	50.7	62.0	34.2	24.2	43.7	17.7	36.0	26.9	17.3	64.0	28.3	55.2	36.6	46.5	42.5	26.9	39.0	23.7	47.0	26.5	18.8	14.6	27.7	29.9	20.0	48.5	31.5	50.5	22.1	47.8	29.1	30.8	129.8	31.2	39.3	21.3	48.5	41.9	17.9	22.7	43.0	24.7	27.2	46.0	31.7	27.1	35.8	25.9	28.7	25.2	26.7	30.7	17.5	48.2	27.6	80.2	62.1	18.8	39.1	39.0	22.8	19.0	10.4	23.0	16.9	24.8	19.1	29.0	23.2	22.3	15.7	41.3	31.3	7.9	35.2	11.3	15.0	33.5	29.4	26.7	30.5	21.9	45.9	21.2	23.9	20.4	34.6	24.3	16.2	8.9	16.0	34.0	28.7	22.8	17.8	18.6	7.6	4.0	10.3	12.2	5.9	57.7	10.0	35.8	11.1	31.4	10.5	23.3	30.4	80.2	33.8	28.6	15.0	17.4	48.9	19.1	18.5	20.3	19.0	12.8	14.4	20.0	43.9	71.3	22.5	18.0	30.8	14.4	17.7	11.5	15.0	51.8	35.6	95.2	109.0	21.5	48.1	33.2	28.3	25.8
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		NA	NA			Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	28.7	27.6	26.4	34.8	32.5	50.7	26.2	50.8	36.0	28.9	29.7	34.3	18.6	31.0	32.1	17.3	26.6	25.8	22.6	26.9	28.2	25.8	23.8	29.0	27.1	38.0	31.5	26.2	35.0	29.2	31.2	35.0	35.5	28.1	27.5	20.5	21.4	31.1	28.8	53.6	35.5	31.0	27.8	31.4	39.1	28.4	30.3	32.1	61.4	26.3	19.5	31.3	30.7	45.6	32.8	31.6	48.4	42.3	31.2	37.5	30.5	27.5	24.4	29.8	19.1	13.2	11.9	34.1	20.7	13.5	17.7	15.0	36.6	15.9	44.8	16.5	10.3	14.9	26.0	28.6	17.0	18.7	30.2	28.0	32.9	22.5	34.2	12.5	40.4	29.1	10.6	15.8	15.8	16.9	12.7	14.0	19.7	45.6	23.0	13.5	24.5	42.5	32.0	39.6	19.0	24.4	42.8	32.6	31.0	13.8	23.2	27.4	23.6	23.3	18.8	21.2	17.9	17.4	21.9	21.5	18.1	22.3	22.1	31.8	37.4	31.9	41.0	17.4	33.6	23.9	35.0	28.4	48.4	36.2	28.4	36.7	32.8	36.0	35.2	31.6	32.2	37.5	36.0	30.6	31.2	42.3	26.6	34.5	30.5	26.4	32.5	50.8	36.0	28.2	25.8	31.5	26.2	28.1	32.1	29.8	16.0	30.4	40.5	58.3	38.8	35.0	10.2	85.6	50.0	15.7	33.4	43.6	21.6	36.0	5.2	35.2	30.0	0.0	30.2	47.2	40.1	31.6	48.6	24.5	32.8	47.7	28.6	23.4	21.9	4.5	33.1	39.9	28.7	50.5	36.7	29.9	28.1	28.8	24.4	22.4	44.2	19.4	47.0	78.8	82.8	57.1	52.3	44.7	34.5	34.2
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 10.9"	"Cell type enriched"	"Detected in single"	26	"Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	6.6	16.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521081-21537216	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;parathyroid gland: 36.0"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 14.3;Cone photoreceptor cells: 7.9;Horizontal cells: 12.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"AF22: 46.7;NTERA-2: 35.3;SCLC-21H: 15.9;SuSa: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	2.6	4.7	11.5	1.6	12.7	0.5	5.3	30.9	21.9	7.5	4.5	10.4	2.9	2.3	10.5	6.0	3.5	11.6	4.0	3.7	11.7	8.9	4.2	1.7	4.8	1.9	7.4	9.3	19.5	3.7	36.0	10.9	1.5	13.5	5.8	2.4	4.3	3.3	10.0	2.1	2.2	3.1	10.5	9.5	2.1	3.2	1.9	11.4	3.7	12.0	0.1	1.9	4.6	4.8	0.3	1.7	0.0	0.0	0.5	3.8	0.6	0.0	0.8	46.7	11.6	0.8	0.7	0.0	1.1	1.5	3.7	3.1	0.8	0.7	0.0	1.0	1.3	1.4	0.1	11.4	1.2	4.3	0.7	6.4	0.0	0.4	1.0	1.4	0.0	0.0	3.1	0.3	1.5	0.0	8.1	0.9	5.0	7.6	0.0	2.9	0.8	7.2	0.0	35.3	0.0	0.2	6.8	1.1	0.0	3.4	4.9	15.9	8.9	0.0	0.2	0.1	15.3	4.6	0.1	0.0	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	1.0	0.1	1.5	1.2	0.2	0.3	1.8	3.8	0.0	0.5	0.0	1.7	1.6	0.6	11.5	12.7	30.9	14.3	11.7	8.9	7.4	9.3	13.5	11.4	3.0	2.2	0.0	0.4	0.6	14.3	0.8	2.5	0.0	2.3	5.2	7.9	0.1	1.7	1.6	0.2	0.2	0.0	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.1	12.7	0.0	1.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	11.0	0.5	0.0	5.6	1.0	2.8	0.0	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.1
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923928-944581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 4.7"	"Group enriched"	"Detected in many"	4	"HEK 293: 38.7;HeLa: 42.9;SCLC-21H: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	2.1	10.0	2.4	5.0	3.0	1.0	1.6	1.6	4.7	4.4	3.0	7.2	2.5	5.1	9.5	7.4	4.2	13.6	4.5	8.5	5.7	4.0	10.0	2.9	2.4	2.1	6.9	2.0	5.9	1.8	0.6	21.9	0.6	5.9	12.4	1.4	16.9	2.4	22.1	1.4	0.3	5.6	6.0	8.8	11.7	5.5	2.7	5.1	0.3	4.6	0.6	0.5	7.2	22.8	0.3	0.0	0.0	0.2	4.7	0.4	0.0	0.1	2.7	0.0	2.5	0.1	0.0	0.9	4.2	0.2	0.2	0.1	0.1	0.8	0.0	8.1	8.7	2.2	5.5	2.7	0.0	0.0	0.3	38.7	0.0	42.9	0.1	0.7	0.0	0.3	1.6	0.0	0.0	0.0	4.3	0.0	0.1	1.4	0.0	0.0	2.9	0.0	0.0	1.6	0.1	0.3	0.2	0.6	2.2	0.4	0.0	28.0	8.6	8.8	4.2	0.0	2.6	4.9	0.2	0.5	1.4	6.4	0.1	0.9	0.5	0.0	0.1	1.8	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.3	0.2	0.2	0.0	0.1	0.1	0.4	0.0	4.7	0.1	0.0	0.0	0.0	2.4	3.0	1.6	4.7	5.7	4.0	6.9	2.0	5.9	5.1	0.0	2.6	0.0	0.1	0.3	16.4	0.8	0.0	0.0	3.4	3.5	27.5	0.2	0.0	0.5	2.2	0.8	0.0	0.0	0.3	0.6	2.3	2.5	0.0	0.0	0.2	33.4	25.4	6.7	0.3	7.9	0.9	0.0	0.0	0.0	0.0	15.0	2.6	0.2	3.9	0.2	235.2	0.0	1.4	0.9	16.6	0.5	0.1	0.0	0.0	0.3
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50129882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 45.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 42.7;Horizontal cells: 11.1;Intestinal endocrine cells: 12.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.9;HEL: 6.9;HMC-1: 23.2;SH-SY5Y: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	2.8	3.8	18.3	3.9	19.5	2.0	1.0	45.8	18.5	2.4	2.2	3.1	1.1	2.0	3.2	4.3	1.6	1.3	2.2	1.5	15.4	10.3	2.9	1.7	5.4	2.2	7.9	16.1	1.7	1.5	2.9	2.1	3.9	10.9	3.9	1.8	4.3	1.3	4.0	6.1	1.6	2.6	2.8	6.8	3.0	3.2	4.6	6.9	0.0	1.3	0.0	3.2	2.2	0.9	0.0	0.0	2.3	0.0	0.3	0.0	0.4	0.0	0.1	4.0	0.0	1.1	0.2	0.0	2.5	0.9	0.0	0.0	0.5	0.0	0.1	3.7	1.0	0.0	0.1	0.2	0.0	0.1	10.9	0.1	6.9	0.2	0.0	0.6	0.0	23.2	0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	10.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.4	1.4	0.3	0.0	0.2	0.0	0.0	2.0	0.0	0.8	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	18.3	19.5	45.8	18.5	15.4	10.3	7.9	16.1	10.9	6.9	0.0	0.3	0.0	0.1	0.3	42.7	1.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.3	0.1	1.4	0.1	2.3	0.0	0.1	11.1	12.2	4.9	0.3	1.9	1.4	0.8	0.0	2.8	0.0	1.4	0.3	0.0	3.2	0.8	3.1	0.0	2.2	1.4	1.1	0.1	0.3	0.0	0.0	0.0
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		100000	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.9	1.5	0.7	1.5	58.1	11.0	0.7	2.3	4.2	24.6	26.4	4.9	1.3	8.3	3.3	1.6	15.0	3.0	6.1	2.9	5.2	2.4	2.0	0.4	2.1	2.6	5.1	4.7	1.5	13.5	0.1	8.6	0.2	1.4	3.2	0.0	1.5	2.0	0.5	1.2	0.0	1.8	0.7	2.4	3.2	0.2	4.0	3.2	0.9	0.6	3.0	0.4	3.0	1.1	2.9	0.2	1.4	7.6	0.8	1.9	2.1	2.0	3.4	1.2	3.0	3.5	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0	26.8	30.5	23.8	1.9	5.7	5.3	16.9	25.5	83.0	53.4	1.8	3.9	2.5	0.0	9.3	2.3	36.5	1.1	0.0	8.6	2.8	23.4	2.7	11.6	17.4	131.6	6.4	5.8	47.9	243.3	2.3	76.2	175.7	5.0	16.2	4.3	30.6	11.1	20.1	90.5	1.2	2.6	58.2	29.8	5.1	5.4	5.1	2.4	54.9	4.5	4.7
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1107.2;monocytes: 1399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 60.9;K-562: 72.4;Karpas-707: 31.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	60.9	0.0	0.0	0.0	7.1	2.9	0.0	0.0	0.0	9.0	2.4	0.8	1.1	72.4	31.6	0.0	0.0	3.4	8.7	0.0	0.0	0.0	5.9	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.9	0.0	0.0	0.0	0.0	13.6	0.1	0.0	0.3	4.6	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1	20.8	87.5	39.7	0.8	13.9	54.7	1.2	2.5	14.7	20.5	34.9	0.0	0.4	0.0	0.4	0.0	7.1	0.0	23.3	5.4	0.5	6.2	0.4	1107.2	0.9	57.4	0.0	0.0	3.1	159.2	0.0	0.6	220.5	20.3	1399.5	0.1	1.5	0.6	0.0	0.0	0.4	4.2	0.0	3.3	0.0	0.0	11.5	0.5	120.4	0.0	0.7
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445957-154461054	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	12.1	11.5	14.8	9.5	14.2	2.0	16.9	14.0	16.4	18.1	18.4	15.4	10.2	13.5	18.0	12.4	10.0	17.7	16.4	13.5	14.2	11.1	17.4	12.4	12.1	8.1	14.9	8.7	27.0	8.7	21.5	6.8	10.0	12.7	16.2	11.7	12.7	12.9	17.3	16.6	14.6	18.8	15.7	14.9	10.9	11.1	16.2	12.2	13.0	15.2	8.2	10.5	13.8	34.5	1.9	1.4	1.0	3.6	4.5	2.3	1.1	6.7	5.6	10.3	6.8	22.6	18.1	5.1	7.0	15.3	8.1	8.8	3.7	3.8	7.3	5.6	10.6	9.5	5.4	7.7	5.7	9.1	3.6	7.6	5.9	5.4	2.6	6.8	7.7	4.4	6.5	10.5	3.6	8.9	12.5	6.5	6.9	2.4	4.6	6.7	3.4	7.2	5.0	2.5	6.1	3.8	7.0	10.3	3.6	4.6	3.3	6.3	8.2	5.5	12.1	13.3	10.1	4.3	9.6	9.2	5.7	4.2	7.5	4.9	4.4	6.3	3.8	8.3	6.1	3.3	0.0	1.2	1.0	1.7	1.3	2.3	0.9	2.1	2.1	1.1	1.9	2.1	1.5	0.8	4.5	3.6	1.4	1.9	1.1	14.8	14.2	14.0	16.4	14.2	11.1	14.9	8.7	12.7	12.2	17.9	5.8	3.0	6.8	15.3	4.5	15.7	20.4	9.4	6.8	3.5	5.9	6.4	3.3	4.3	17.1	14.8	23.9	0.0	7.1	10.2	15.1	13.1	1.1	13.1	7.3	9.5	6.9	12.3	11.3	15.9	19.0	7.5	10.1	4.6	12.2	17.0	8.3	12.2	17.0	8.2	5.7	0.0	11.3	15.7	17.6	15.8	5.3	6.7	11.1	11.2
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552050	"Predicted intracellular proteins"			"Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 97.4;Muller glia cells: 93.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	32	"monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.2;ASC TERT1: 22.8;HUVEC TERT2: 21.8;WM-115: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	41.4	5.4	19.6	5.3	21.7	0.7	25.7	9.9	28.1	16.8	9.2	22.2	4.4	5.6	11.2	9.3	35.6	10.0	15.6	13.2	21.9	14.2	13.5	7.7	16.7	4.7	26.3	11.4	5.3	7.7	15.0	3.5	23.5	22.8	9.8	8.3	9.2	12.2	8.1	10.6	17.5	6.7	13.2	28.6	10.3	6.0	4.8	22.3	0.2	30.9	10.4	8.2	13.2	17.9	0.0	0.0	0.1	5.5	0.0	0.1	0.6	1.3	0.8	6.9	2.3	60.2	22.8	1.1	7.9	19.1	6.0	9.2	1.7	1.6	0.0	4.2	21.1	3.0	1.6	2.1	1.9	5.0	0.0	1.5	0.0	3.9	1.6	1.8	0.0	0.4	10.6	1.9	9.0	2.4	2.4	21.8	0.0	0.1	0.0	5.6	1.5	0.0	0.0	2.0	0.7	1.1	0.0	5.0	0.0	4.4	4.3	0.2	0.0	2.4	8.9	6.2	1.8	0.7	3.9	18.9	5.9	1.2	18.6	1.7	0.0	0.0	0.0	9.4	0.0	27.8	0.1	2.9	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.6	19.6	21.7	9.9	17.9	21.9	14.2	26.3	11.4	22.8	22.3	14.9	20.8	0.8	6.3	36.5	12.5	18.3	7.6	14.7	21.6	43.6	5.9	16.4	6.6	2.2	0.5	97.4	2.5	0.0	2.1	55.4	26.8	6.2	2.3	6.6	8.1	3.2	4.6	63.8	31.8	1.1	17.0	12.1	40.5	0.0	4.5	93.7	1.2	2.9	26.5	12.2	3.9	77.6	64.3	0.3	4.5	28.9	27.3	0.0	6.4	5.7
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.6	3.6	0.2	0.7	2.5	0.6	2.0	0.1	4.7	0.9	0.0	0.8	0.2	0.0	9.5	1.1	1.2	91.1	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.5	0.8	0.0	0.1	7.4	0.6	44.0	0.1	5.0	0.4	0.0	21.2	6.8	3.8	0.3	0.3	25.4	1.3	0.9	1.0	3.1	1.2	7.2	0.0	0.8	0.0	2.2	20.4	38.9	0.3	2.6	1.7	1.2	0.7	0.2	0.0	2.0	2.1	20.5	1.1	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5	23.8	26.4	13.7	11.8	12.7	10.1	57.9	22.9	46.8	14.8	29.6	82.5	0.4	1.7	10.0	4.8	11.7	11.0	23.3	10.8	0.1	8.7	29.4	22.0	18.8	9.1	0.0	31.2	31.3	44.9	3.5	7.8	19.2	10.1	1.0	32.6	14.2	11.1	28.1	7.8	7.3	62.2	6.5	9.5	0.7	2.5	19.3	0.2	62.3	25.2	14.4
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0"									HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	3.5	0.0	0.0	0.0	0.6	1.2	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4	11.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	17.4	12.5	0.0	0.0	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.8"	"Cell type enhanced"	"Detected in many"	28	"Ciliated cells: 370.7;Early spermatids: 61.6;Late spermatids: 100.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 12.3;K-562: 11.2;SCLC-21H: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.3	4.1	1.3	5.4	0.7	2.8	4.4	5.3	2.7	1.2	3.5	5.0	0.9	2.1	14.8	0.7	46.8	1.9	1.4	5.5	2.8	2.3	1.1	9.1	1.1	3.1	2.8	9.2	2.6	4.7	11.5	0.7	5.6	2.4	1.8	1.6	2.3	3.0	1.2	1.9	1.6	0.9	2.3	1.3	2.3	18.0	3.7	1.0	3.1	0.1	1.6	1.0	1.2	6.7	1.3	5.3	0.2	3.2	2.7	0.5	1.6	2.2	1.3	4.9	1.1	2.2	0.6	0.5	0.4	0.9	1.8	0.2	2.7	1.6	1.2	0.0	2.6	12.3	2.1	1.8	2.1	1.1	8.0	0.6	3.8	0.0	0.1	0.4	0.5	1.5	2.6	1.7	1.4	2.8	1.9	3.4	11.2	0.9	1.2	1.1	0.6	0.0	3.2	0.6	0.9	1.5	0.6	1.0	0.9	1.1	9.4	1.5	1.3	0.0	1.7	0.8	4.7	0.5	0.2	2.4	1.4	5.0	0.9	2.6	2.8	1.0	2.3	0.6	1.6	0.0	0.1	5.3	1.1	0.0	1.4	2.5	0.4	2.7	0.1	6.7	1.8	0.8	0.1	3.2	0.2	1.3	0.1	0.5	4.1	5.4	4.4	5.3	5.5	2.8	3.1	2.8	5.6	3.7	0.0	2.4	0.0	1.7	0.0	2.6	1.1	2.5	370.7	44.3	3.5	3.9	0.4	1.7	0.4	61.6	0.5	0.0	0.0	0.4	0.4	0.2	1.8	1.1	0.0	0.1	0.0	2.4	0.0	0.0	100.5	2.3	0.0	0.0	0.0	2.1	3.3	0.3	0.0	2.1	3.5	4.9	6.5	0.1	40.5	7.2	0.0	0.2	0.0	0.6	1.2
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS, ribosome maturation factor"	Q9Y3A5	7	66987677-66995601	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1381.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	40.9	34.5	37.7	18.7	44.0	41.7	44.5	23.6	43.2	30.7	37.5	35.3	20.2	39.1	35.6	27.3	40.8	27.7	34.0	70.0	39.2	40.9	36.9	38.4	32.1	16.7	50.6	36.6	31.9	27.5	50.4	26.9	38.6	44.6	35.1	35.7	20.1	23.5	40.5	130.7	26.1	34.4	52.0	63.2	16.7	32.8	15.9	48.2	7.2	33.9	38.7	15.6	54.0	38.0	21.6	15.5	20.8	12.6	16.6	39.1	19.4	31.4	13.3	11.8	10.7	43.2	32.3	13.2	53.5	44.1	41.0	31.5	27.4	16.2	11.7	40.6	48.9	27.1	15.3	19.9	31.8	44.1	11.1	26.3	5.7	24.9	16.4	38.5	14.6	8.0	29.1	42.8	31.1	54.2	21.2	25.2	7.7	42.2	12.8	63.6	18.8	7.7	21.2	13.1	43.4	31.7	5.9	25.5	24.4	43.2	14.1	18.2	12.5	26.8	46.4	35.5	27.3	34.6	12.4	33.5	55.4	18.9	28.0	39.0	7.9	9.3	26.7	19.0	24.0	30.6	20.8	11.1	20.2	23.4	12.6	29.6	21.6	30.6	27.2	11.3	18.7	39.1	31.5	4.7	16.6	11.2	15.5	25.9	19.4	37.7	44.0	23.6	43.2	39.2	40.9	50.6	36.6	44.6	48.2	282.9	101.3	66.6	339.3	412.4	74.2	273.7	79.0	58.9	128.5	87.2	11.8	116.1	222.2	161.5	544.8	139.6	267.8	46.7	145.1	193.1	210.9	212.5	144.6	97.2	95.0	55.6	97.9	127.7	39.0	1381.2	117.6	84.1	243.0	99.2	183.0	124.0	212.7	199.9	158.4	222.6	46.7	161.7	333.7	75.3	45.3	375.9	333.3	96.2	134.2	299.8
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642125-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: AB_2682536"	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	21.6	15.6	22.2	17.0	30.5	14.4	12.9	24.9	48.3	14.1	15.0	27.0	7.4	18.2	18.9	7.4	27.2	24.0	17.2	21.3	21.4	18.9	12.4	13.9	13.9	17.7	17.5	21.6	24.1	21.1	13.7	17.5	18.4	26.1	15.0	8.6	14.1	20.8	11.8	28.4	18.5	17.0	14.6	14.8	20.2	17.0	15.9	15.7	19.7	18.4	8.4	13.1	16.9	13.6	5.1	5.1	7.8	2.9	1.9	4.2	3.2	26.5	46.7	12.8	21.1	6.1	5.8	15.6	20.1	6.6	9.4	8.0	25.3	16.6	15.5	13.8	7.4	14.3	20.5	9.2	12.3	2.8	23.9	26.2	17.4	23.1	12.6	10.5	16.5	17.3	9.7	7.8	11.3	8.0	9.2	7.6	6.4	22.4	16.0	7.4	17.1	16.5	8.8	16.3	12.1	28.0	20.5	17.8	16.0	6.2	38.5	19.1	20.9	20.7	21.9	7.4	8.2	15.2	9.2	20.8	34.4	19.9	12.2	29.4	22.7	33.7	14.8	20.7	10.5	19.4	4.0	2.9	2.7	4.2	2.5	2.7	5.1	2.4	2.8	2.3	4.7	2.2	2.4	7.8	1.9	2.2	5.1	0.5	3.2	22.2	30.5	24.9	48.3	21.4	18.9	17.5	21.6	26.1	15.7	6.0	0.0	14.5	7.4	10.8	11.9	2.4	12.7	0.0	0.0	21.0	3.9	12.5	6.6	11.8	26.1	4.5	25.6	0.0	11.2	11.6	9.9	10.2	5.7	14.4	12.3	9.5	13.8	17.8	9.2	73.7	20.4	6.3	10.1	10.8	18.1	9.9	13.8	17.6	22.3	11.2	6.9	12.9	8.2	13.7	19.2	10.5	18.4	8.9	17.2	10.2
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	34.4	17.0	17.5	34.1	19.5	46.1	25.8	19.1	17.9	29.0	24.5	12.4	29.0	17.0	25.1	25.9	25.8	21.0	21.1	33.6	15.8	16.6	27.9	32.2	27.8	29.9	19.2	12.5	31.7	21.3	32.7	26.8	23.0	20.6	26.5	21.4	15.3	24.3	31.0	35.4	24.1	30.7	25.5	21.7	38.1	17.4	22.7	20.6	42.3	27.8	21.9	28.6	29.1	33.9	18.4	19.2	32.8	13.6	12.9	15.3	7.9	15.1	13.8	17.1	14.2	11.8	16.2	15.9	17.9	14.6	15.5	11.3	49.4	16.7	31.8	20.2	19.0	9.2	15.0	17.5	14.4	17.7	17.4	11.8	29.6	18.3	12.9	9.3	31.0	20.0	13.4	15.5	13.3	20.2	17.9	15.9	13.9	22.6	17.5	19.5	14.3	23.2	17.3	13.3	0.2	18.8	18.9	23.0	16.0	14.7	19.4	9.9	10.1	19.8	17.0	9.6	14.2	15.8	33.6	19.7	16.0	13.2	12.0	9.5	12.7	9.4	52.0	13.5	66.8	6.1	20.9	13.0	17.3	14.7	12.5	13.3	17.7	13.9	14.1	9.8	18.4	15.3	13.7	32.8	12.9	13.6	19.2	12.4	7.9	17.5	19.5	19.1	17.9	15.8	16.6	19.2	12.5	20.6	20.6	163.8	142.7	110.7	106.1	114.1	130.0	160.2	84.1	199.4	167.2	75.0	119.8	73.3	46.4	103.3	42.7	114.7	93.2	23.3	93.9	58.9	105.3	100.7	213.0	117.3	96.4	101.7	99.3	118.4	141.0	26.6	112.8	152.3	64.1	130.8	108.9	103.7	84.4	88.0	97.6	67.1	187.2	122.9	106.1	130.4	56.4	105.3	51.0	110.7	86.0	129.0
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	4.5	6.5	9.5	6.4	14.3	6.8	5.4	9.5	19.1	5.0	4.5	3.5	3.1	3.3	5.9	4.6	4.1	6.1	3.7	3.7	7.1	7.9	4.4	3.8	8.5	7.2	4.6	12.0	7.6	4.6	5.7	4.6	2.7	4.8	5.5	5.0	12.4	3.7	3.3	4.2	6.6	4.0	4.0	4.0	5.0	4.4	5.2	5.1	34.4	5.3	2.1	6.2	4.2	4.5	2.9	3.1	1.5	1.7	2.5	2.6	1.3	3.7	2.9	3.9	3.7	2.2	5.3	6.5	2.3	4.9	2.5	3.6	3.7	3.6	6.7	1.8	2.3	3.0	6.3	5.0	2.6	5.2	4.7	1.8	4.4	5.3	3.2	3.0	4.7	3.4	2.0	2.3	3.9	2.6	4.3	3.6	12.2	6.2	7.9	3.8	4.0	14.9	3.2	3.8	7.2	3.2	9.4	6.2	5.8	1.7	5.1	4.0	2.5	5.5	3.1	2.9	4.4	7.6	2.1	3.7	2.3	4.3	3.8	4.0	4.4	8.3	6.4	2.8	3.8	3.4	0.8	1.2	0.2	1.1	1.7	1.2	2.0	1.9	1.3	0.8	2.9	2.6	1.8	1.5	2.5	0.6	3.1	2.6	1.3	9.5	14.3	9.5	17.0	7.1	7.9	4.6	12.0	4.8	5.1	65.5	23.3	13.0	7.7	2.5	39.5	3.9	17.8	9.4	12.5	17.4	188.5	5.6	1.7	3.0	9.2	6.8	5.0	0.0	1.8	4.3	5.4	6.4	4.7	7.6	3.5	15.9	12.6	13.5	5.6	4.1	8.9	3.2	3.3	1.8	7.1	32.7	2.2	6.6	5.6	1.9	114.6	0.0	3.8	27.2	20.4	3.8	2.2	8.7	8.6	3.7
SCFD1	"C14orf163, KIAA0917, RA410, SLY1, STXBP1L2"	ENSG00000092108	"Sec1 family domain containing 1"	Q8WVM8	14	30622112-30735812	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003579	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	Nucleoplasm	Cytosol	"HPA003579: AB_1079872"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.32e-2)"	22.4	22.7	20.6	17.6	29.7	15.5	21.7	21.9	28.1	27.7	20.0	12.6	19.3	17.1	20.5	23.3	25.9	19.0	13.4	20.9	19.2	17.8	24.5	33.9	18.8	16.6	16.5	19.4	21.8	33.8	28.5	68.5	29.4	26.0	20.3	21.9	14.5	34.5	22.3	24.7	15.7	22.0	19.6	15.6	20.4	18.8	18.8	17.1	24.4	31.0	18.0	19.0	17.2	22.3	14.3	16.3	18.8	17.2	19.4	15.9	9.2	24.4	10.6	13.6	9.0	22.4	25.3	19.8	18.3	25.5	27.0	32.1	17.2	18.5	13.5	8.8	28.9	12.0	14.2	16.7	19.3	31.5	18.9	9.2	9.3	14.9	58.0	28.1	17.4	12.1	18.8	14.8	16.6	28.3	19.2	18.3	8.5	15.3	25.8	26.6	28.8	10.7	10.1	13.0	24.3	18.7	9.4	14.9	16.3	21.8	21.2	14.2	11.9	17.7	17.7	18.1	14.4	25.9	13.0	14.7	18.7	14.4	15.6	15.2	17.8	16.6	18.5	8.8	13.5	19.4	18.8	13.4	15.6	9.6	14.4	12.4	14.3	11.1	12.0	16.3	12.3	10.5	10.7	4.3	19.4	17.2	13.3	15.9	9.2	20.6	29.7	21.9	28.1	19.2	17.8	16.5	19.4	26.0	17.1	47.6	25.3	39.5	46.3	22.1	34.1	32.1	20.4	52.2	36.4	24.4	41.2	55.2	54.7	40.9	20.1	30.2	26.5	23.3	44.2	52.3	39.9	39.2	51.0	18.5	40.8	28.6	45.3	22.1	24.6	13.2	35.6	40.1	35.4	67.7	33.2	29.7	37.5	25.9	37.8	30.5	39.0	12.9	31.2	66.2	51.7	21.3	69.5	39.9	24.8	40.0
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Group enriched"	"Detected in some"	11	"REH: 10.1;RH-30: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	10.1	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 356.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	16.2	26.6	49.3	9.7	45.0	4.5	27.7	36.3	57.1	17.7	16.1	25.0	15.0	16.5	18.8	32.2	20.4	17.3	15.3	38.3	47.1	66.9	38.6	27.9	13.7	9.7	59.7	32.5	16.6	19.0	29.6	30.5	18.5	74.5	24.2	19.2	15.0	17.9	20.1	13.5	11.0	16.0	19.9	61.8	9.9	19.6	11.1	25.0	6.0	26.0	13.0	11.8	14.8	11.8	18.8	14.3	18.5	12.4	19.2	27.9	19.2	14.8	10.1	27.9	14.5	25.0	34.7	20.0	24.4	23.8	19.7	22.2	6.7	22.2	6.1	21.8	25.0	18.2	6.4	16.9	34.7	30.1	21.0	12.1	9.6	5.2	15.9	22.1	19.3	12.2	23.1	47.0	17.5	19.8	38.3	26.3	18.0	14.8	18.2	34.4	9.8	23.9	11.7	8.7	13.1	17.5	14.7	11.7	9.0	57.9	13.7	19.6	20.5	16.5	24.9	26.8	25.9	18.1	11.9	20.0	30.2	17.6	24.8	23.7	27.9	47.7	16.3	35.1	8.8	29.5	18.5	9.0	11.7	15.7	12.4	20.1	18.8	19.0	15.5	11.2	15.2	27.9	21.4	5.2	19.2	12.0	14.3	16.6	19.2	49.3	45.0	36.3	57.1	47.1	66.9	59.7	32.5	74.5	25.0	44.7	38.0	35.7	59.8	54.3	131.0	122.4	43.3	54.9	37.5	120.4	21.6	120.6	271.9	89.4	356.8	55.2	50.3	0.0	99.5	67.4	61.2	77.2	35.8	56.1	42.7	162.1	36.2	44.2	22.2	56.1	55.5	40.5	131.6	45.9	40.9	160.2	87.9	28.8	62.2	179.9	63.0	45.3	62.8	39.4	51.3	49.4	74.4	27.3	40.9	46.3
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		370000	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.6	14.1	19.0	34.8	62.4	53.4	20.6	30.6	45.9	20.1	29.2	12.6	27.8	24.4	33.1	44.8	23.5	18.0	13.0	28.6	30.8	35.5	18.9	26.2	20.3	25.9	41.6	37.7	44.2	43.3	39.0	23.8	11.9	44.1	56.9	28.9	23.3	12.7	40.6	14.8	42.0	32.8	20.8	65.1	27.7	22.0	33.5	33.3	55.8	43.6	15.7	19.0	26.7	54.2	25.6	44.1	27.7	43.2	44.0	27.4	14.2	47.7	24.4	21.3	27.0	28.5	35.5	37.5	25.3	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4	125.0	163.3	99.5	107.7	133.6	35.0	136.8	201.2	147.2	103.5	176.2	29.5	158.8	401.3	140.3	42.8	125.8	592.0	70.0	143.6	134.4	129.4	170.2	138.2	1150.9	181.7	39.7	225.9	115.4	211.6	39.0	170.6	166.5	182.2	152.3	388.8	98.9	131.8	498.1	161.5	617.2	27.0	77.6	119.7	10.6	19.8	149.3	112.0	172.0	297.8	155.6
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841333	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		350000	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20.0	10.9	20.1	9.7	7.3	15.0	9.8	4.0	10.9	8.5	18.1	9.0	11.0	10.7	10.0	16.9	19.2	25.9	13.4	16.5	22.1	10.8	12.0	19.2	5.3	5.1	15.7	12.2	16.3	6.1	12.5	9.4	9.6	14.4	14.4	6.7	12.3	3.2	5.0	6.6	1.7	10.7	3.2	15.9	13.2	6.8	14.1	12.4	5.6	3.2	5.4	11.7	8.1	5.7	4.5	14.0	10.5	16.2	2.3	7.6	12.8	10.9	10.7	5.6	2.7	5.2	7.6	14.3	4.0	26.9	7.4	5.5	4.1	17.2	3.4	7.3	8.0	3.8	16.6	6.4	4.8	8.6	9.2	2.4	2.8	31.5	4.1	3.1	23.3	5.7	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14.0	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9	35.7	25.1	11.2	25.9	14.0	11.3	19.8	12.7	26.8	14.8	15.7	9.8	38.7	63.0	22.9	2.8	20.3	52.0	0.0	53.1	8.3	23.5	18.8	16.1	25.3	19.4	19.1	21.5	23.9	8.1	2.1	30.8	12.7	40.5	11.8	30.3	26.6	27.6	34.5	15.6	296.5	15.6	6.5	17.0	5.2	14.9	10.0	28.3	26.1	34.7	16.9
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.6	5.9	14.6	19.5	17.4	15.7	15.3	20.8	18.1	17.4	15.2	18.2	21.0	23.0	15.7	19.0	16.7	15.1	22.2	20.1	21.9	20.2	11.7	19.6	13.1	15.0	16.4	33.3	22.4	13.7	22.8	18.4	20.3	10.8	15.2	15.7	35.1	19.0	17.8	16.2	33.7	11.8	23.7	23.7	9.0	20.5	27.5	19.3	16.6	16.4	22.1	18.4	14.2	29.0	23.5	16.6	13.3	19.6	14.3	18.8	19.0	22.4	17.3	17.5	18.2	31.4	21.1	15.1	23.2	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9	17.9	26.7	35.6	21.5	24.5	19.7	10.6	15.3	33.5	50.0	21.0	5.9	26.9	29.9	34.3	86.0	21.1	13.9	0.0	21.5	26.1	23.2	22.2	48.5	20.5	32.6	12.7	21.9	16.0	23.5	81.4	23.6	29.5	23.6	39.7	22.8	22.4	28.9	22.9	31.1	37.2	19.7	19.4	24.5	58.5	94.3	29.0	20.9	32.0	26.0	19.7
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869467-30908761	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 52.5;WM-115: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	17.9	48.8	35.4	11.6	44.7	1.9	9.2	10.4	53.1	20.4	20.8	21.7	10.9	6.9	25.6	7.1	9.8	13.7	15.9	11.1	26.8	32.2	4.7	11.5	12.0	15.4	36.1	16.4	6.2	4.4	6.1	5.4	9.7	34.1	14.8	8.1	8.2	8.6	29.2	17.7	5.7	9.1	33.1	28.3	45.3	9.3	2.4	15.5	2.6	5.5	1.7	4.2	14.4	6.0	1.2	1.0	3.2	2.5	2.1	1.2	0.9	2.7	2.0	16.3	7.6	12.6	3.0	3.2	6.8	9.7	3.2	2.0	0.3	2.5	0.2	17.3	19.0	4.6	3.7	1.7	1.5	2.1	1.4	1.4	0.0	0.8	0.4	12.1	0.0	1.8	7.3	7.5	0.2	3.2	17.9	4.0	0.7	1.3	0.2	6.2	2.9	0.1	0.1	8.3	1.9	2.4	0.1	15.6	0.6	4.0	2.9	6.4	4.1	8.6	1.2	52.5	10.9	1.2	1.2	4.4	4.0	6.9	0.5	1.5	0.0	0.1	0.2	0.4	0.0	73.1	3.2	1.3	1.0	0.8	2.5	1.2	0.8	0.8	0.9	0.9	1.2	1.0	1.0	2.5	2.1	1.8	1.0	0.9	0.9	35.4	44.7	10.4	29.5	26.8	32.2	36.1	16.4	34.1	15.5	0.0	2.1	0.8	2.8	2.3	8.1	3.2	15.3	0.0	2.3	45.4	0.0	2.1	0.0	9.0	17.7	8.7	0.0	0.0	2.6	2.8	10.0	6.9	0.0	0.2	13.2	0.0	2.9	28.8	157.7	63.3	2.0	2.2	18.6	5.4	0.9	1.5	6.1	0.6	7.4	0.3	25.6	0.0	5.6	0.7	0.4	1.9	3.0	0.0	1.2	3.7
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	13.4	14.5	18.1	6.5	20.1	6.1	14.3	15.7	25.7	8.3	9.5	7.9	10.3	7.9	9.0	14.6	9.8	16.0	8.5	17.6	18.0	21.2	14.9	10.7	8.4	10.6	14.7	17.4	9.7	14.2	10.5	18.3	10.2	15.5	10.6	10.6	11.1	9.7	8.9	30.5	9.7	7.9	8.8	13.0	6.9	8.8	7.3	9.7	7.4	11.5	10.2	7.8	8.1	6.9	10.5	13.4	9.1	10.5	9.6	9.3	6.2	10.0	3.3	14.3	8.8	7.3	10.9	2.8	5.4	4.2	2.6	4.0	2.9	8.5	6.9	10.4	2.8	6.4	1.8	4.9	4.8	3.9	14.4	3.3	4.8	1.4	2.9	12.4	4.7	3.8	7.8	15.4	2.0	11.8	9.2	6.5	11.6	3.2	10.7	8.6	6.9	4.2	11.7	6.8	5.1	3.3	4.7	9.7	8.0	11.4	3.3	13.2	9.6	3.2	1.6	6.8	6.4	7.3	12.2	4.8	2.7	2.1	2.2	5.8	5.0	3.4	2.2	3.0	11.2	6.4	6.0	10.5	9.1	7.7	9.2	8.0	8.7	8.5	9.0	11.3	10.5	9.3	8.5	7.1	9.6	9.5	13.4	9.1	6.2	18.1	20.1	15.7	25.7	18.0	21.2	14.7	17.4	15.5	9.7	11.9	15.2	2.2	7.2	0.0	7.5	17.6	7.6	25.4	10.3	7.0	7.9	8.8	19.9	8.0	4.0	5.2	3.3	0.0	10.1	7.4	5.1	7.1	4.7	11.3	9.1	17.5	3.5	3.7	4.1	2.2	11.5	8.5	0.0	12.6	6.6	9.9	9.8	3.5	6.3	11.8	5.8	12.9	3.1	10.7	5.3	0.0	4.2	4.4	6.4	6.9
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	19.5	29.3	21.6	12.4	24.1	21.4	15.6	47.7	26.9	13.9	13.5	23.0	17.1	14.8	16.3	16.5	12.0	19.6	10.4	37.1	21.7	18.5	22.2	18.6	11.8	17.0	32.5	19.6	19.2	22.3	17.2	27.9	12.9	22.0	17.2	8.7	19.5	31.1	21.9	64.2	16.2	14.9	13.9	18.8	22.4	16.5	15.2	29.8	13.3	18.0	17.0	12.2	13.9	14.7	25.8	30.6	17.2	19.5	27.5	24.5	15.6	10.6	17.7	12.6	14.8	17.6	13.5	12.9	6.3	7.9	13.1	15.2	13.7	13.3	14.4	15.6	6.4	10.1	18.7	11.2	14.1	5.7	19.6	19.7	12.6	13.2	34.9	8.6	11.5	12.7	15.0	17.1	9.4	13.6	13.5	13.9	32.6	11.3	12.3	12.8	18.6	18.9	18.6	12.1	15.0	16.5	24.3	6.5	10.1	23.0	13.4	22.0	19.1	15.5	27.7	13.6	7.9	19.1	17.0	7.4	4.1	13.8	11.9	7.8	21.2	13.3	17.3	10.8	14.7	10.9	17.2	19.5	11.5	21.9	11.6	21.0	25.8	16.6	17.1	21.9	25.2	23.7	24.5	6.0	27.5	9.5	30.6	19.3	15.6	21.6	24.1	47.7	26.9	21.7	18.5	32.5	19.6	22.0	29.8	26.8	20.8	26.1	35.9	23.6	34.7	0.2	35.7	17.4	26.1	38.4	11.8	43.4	102.8	23.4	11.6	31.5	17.8	46.7	17.5	20.7	25.9	23.5	34.7	34.4	25.8	27.0	26.5	16.5	18.1	19.8	30.5	19.8	40.5	15.4	21.6	56.9	16.4	11.5	29.7	56.4	36.7	0.0	31.9	63.7	13.0	23.8	46.9	27.7	21.3	26.3
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	21.2	32.3	26.0	10.0	42.3	47.0	86.4	43.6	53.3	51.0	58.9	26.7	17.5	19.5	20.0	69.0	28.7	8.7	33.4	38.8	26.2	16.9	34.7	23.8	26.2	64.4	58.1	27.1	21.1	41.6	31.4	53.3	33.2	37.6	60.4	26.2	25.4	28.9	39.3	43.9	26.4	29.8	29.5	27.7	39.2	25.7	18.6	34.6	31.0	16.0	14.6	18.2	19.1	17.8	17.0	22.8	22.9	26.4	45.1	21.0	24.0	31.3	37.3	24.0	33.3	45.1	39.7	38.1	34.6	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5	44.7	52.3	27.4	45.1	34.9	14.7	37.0	17.8	72.3	47.8	26.2	9.8	98.1	56.3	69.8	20.2	33.5	63.9	0.0	95.6	135.9	66.7	49.4	41.6	54.2	93.9	11.1	39.7	36.8	34.0	6.8	49.5	49.1	25.3	67.7	75.6	30.7	74.0	53.4	49.5	72.3	20.1	12.9	43.2	42.4	36.5	35.1	141.0	40.1	67.8	50.4
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Ito cells: 287.8;Late spermatids: 570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 92.7;TIME: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.9	8.7	15.5	23.8	6.5	8.0	5.5	10.9	9.4	12.8	11.2	11.6	7.8	32.0	22.0	15.0	15.8	4.6	6.9	10.6	16.7	5.9	6.2	16.7	6.8	15.1	11.1	3.4	7.8	11.3	4.3	10.7	11.2	17.1	92.7	3.9	10.2	27.1	18.1	6.1	5.9	4.4	5.6	5.2	7.9	4.5	24.9	23.7	21.9	4.8	11.9	9.3	12.0	6.4	6.7	14.9	5.3	3.7	57.9	14.6	13.7	7.9	7.7	15.5	12.1	16.8	6.3	3.5	4.3	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4	38.7	24.7	57.3	18.3	26.1	28.1	14.2	15.3	62.9	25.0	26.2	17.7	8.9	84.6	15.6	199.7	196.1	10.7	23.3	18.0	9.4	22.0	33.6	32.5	9.4	43.6	35.0	18.9	287.8	111.7	570.5	24.5	46.3	33.7	53.3	13.7	19.7	30.2	13.5	16.3	18.1	16.8	38.8	18.7	27.0	43.4	26.6	11.1	35.5	10.7	33.3
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 123.4;Muller glia cells: 99.0;Pancreatic endocrine cells: 69.1;Rod photoreceptor cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.7;hTCEpi: 20.5;hTERT-RPE1: 24.0"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.8	2.4	1.9	2.7	2.9	7.4	0.1	8.0	6.4	4.7	4.9	0.6	6.6	0.2	2.4	9.6	8.0	7.6	1.2	37.7	5.2	0.9	1.9	0.1	2.4	3.5	4.0	0.0	2.5	5.1	20.5	4.3	7.7	24.0	11.8	1.8	0.0	0.2	9.4	1.7	1.0	0.2	0.0	5.1	3.3	0.4	3.4	0.2	8.3	3.3	1.2	1.3	4.9	1.1	4.4	0.1	6.4	0.1	17.9	6.6	4.2	2.7	4.8	0.1	0.0	0.3	14.5	0.0	5.2	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4	3.0	4.3	0.5	13.2	3.7	7.5	1.0	20.4	1.4	4.5	0.0	15.7	2.6	5.0	21.9	6.6	1.5	1.7	0.0	16.4	0.2	3.6	18.3	5.7	123.4	0.4	12.7	1.2	4.3	4.7	7.5	1.1	0.0	6.8	0.0	0.5	99.0	69.1	0.0	0.7	6.1	51.4	0.0	2.0	0.5	1.0	1.8	2.5	5.3	0.2	7.0
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	25.3	20.9	27.6	13.4	30.5	28.0	28.8	19.0	30.5	24.1	21.1	32.8	17.4	28.4	26.2	25.8	16.4	22.2	17.4	22.6	27.5	25.4	22.5	14.1	24.6	18.9	34.7	24.6	29.0	26.6	23.8	23.7	17.7	27.6	36.4	14.5	25.7	23.3	25.1	15.4	14.5	31.6	24.9	49.2	15.8	20.7	32.0	25.6	14.5	23.5	11.8	15.2	18.4	17.6	11.5	10.3	18.8	10.7	9.9	19.4	9.2	12.3	11.6	16.2	14.5	32.5	30.7	4.5	22.4	20.7	21.5	22.7	8.2	18.4	12.0	9.2	23.2	15.5	6.6	12.5	18.9	19.4	16.7	14.2	18.7	19.6	9.3	25.7	10.3	19.2	18.2	23.2	26.9	28.7	20.6	24.5	19.3	18.5	21.1	21.1	8.0	12.3	9.5	10.2	6.8	17.3	6.3	11.5	10.5	17.7	10.1	9.5	13.7	17.1	12.6	15.7	12.4	24.5	9.6	22.3	19.6	15.6	29.7	21.7	17.8	26.9	11.3	21.3	13.2	18.2	8.7	10.7	18.8	13.7	7.7	19.4	11.5	17.7	16.1	9.9	9.8	15.2	13.4	6.0	9.9	8.0	10.3	14.2	9.2	27.6	30.5	19.0	30.5	27.5	25.4	34.7	24.6	27.6	25.6	23.8	25.9	19.9	14.3	13.4	15.4	16.9	25.5	18.7	18.2	10.4	27.5	18.6	34.9	26.6	32.1	31.2	4.2	70.0	28.5	17.2	32.7	23.5	48.5	10.6	28.2	25.4	8.6	27.6	18.3	9.9	30.2	19.3	38.8	45.1	4.4	31.0	23.7	0.0	40.3	22.3	31.8	38.8	31.4	75.8	54.1	8.9	8.8	28.7	6.7	5.4
SEC23A		ENSG00000100934	"Sec23 homolog A, coat complex II component"	Q15436	14	39031919-39109646	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		54000	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	23.9	23.5	10.2	16.8	19.1	7.1	22.1	18.6	20.6	21.4	29.6	8.4	14.0	30.2	30.0	16.8	20.3	19.0	17.2	26.5	11.0	14.8	14.4	55.7	13.5	15.5	12.5	12.8	24.3	8.5	4.7	17.2	15.5	19.8	18.6	18.6	16.2	9.8	31.0	31.7	9.6	38.3	52.8	8.3	11.8	16.9	12.3	6.9	12.9	11.8	11.3	11.3	31.9	18.9	15.6	19.8	38.1	21.6	26.0	26.1	17.9	10.8	20.5	17.9	15.8	32.7	37.6	5.4	43.8	37.9	31.2	39.0	20.5	9.2	2.6	10.7	61.1	13.0	8.7	22.4	17.7	45.7	8.3	7.7	4.5	16.3	66.5	25.0	7.5	6.9	28.7	9.5	21.6	16.0	24.2	26.1	6.0	3.3	6.3	24.3	10.1	6.7	3.1	4.0	16.8	19.6	9.8	24.6	3.9	16.4	16.5	1.9	4.3	30.4	9.0	9.7	15.2	11.1	2.3	29.1	16.6	12.7	24.1	11.0	6.1	7.5	12.3	11.2	6.4	15.8	38.1	21.6	24.2	18.2	18.6	26.1	15.6	23.0	23.4	19.8	14.5	24.2	19.6	19.6	26.0	16.3	17.4	24.0	17.9	10.2	19.1	18.6	20.6	11.0	14.8	12.5	12.8	19.8	6.9	14.9	30.6	32.3	28.2	23.0	39.5	49.2	15.3	2.7	17.0	29.6	64.8	13.2	6.6	7.8	13.7	33.8	75.3	0.0	4.8	35.6	56.3	32.7	27.6	112.9	22.6	28.6	23.5	113.0	33.6	13.4	69.3	27.2	23.6	14.4	25.3	17.0	13.0	30.0	67.1	31.8	52.0	38.8	60.4	16.7	14.3	21.0	20.7	29.8	20.9	29.1
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	25.5	20.2	15.8	18.3	16.5	26.6	34.5	26.9	18.9	21.4	20.0	16.8	19.9	15.5	26.2	19.2	22.6	18.9	18.7	20.5	14.2	12.1	18.9	49.5	20.4	17.8	15.7	11.8	24.9	20.4	30.7	27.7	22.3	15.1	19.1	18.3	22.5	20.2	28.3	37.0	25.8	17.4	25.5	14.8	17.4	18.0	12.1	16.7	31.7	20.8	18.3	21.9	24.9	31.1	13.9	15.7	14.6	13.7	15.7	16.1	10.6	12.1	11.1	17.7	13.2	21.5	21.6	10.1	15.9	19.5	13.6	12.1	10.1	14.1	11.3	8.4	24.1	11.7	10.3	19.7	15.9	20.1	13.8	9.8	11.7	10.2	11.1	14.5	15.4	13.8	21.2	20.4	15.5	18.8	19.3	20.0	11.7	17.8	10.3	20.0	9.9	22.3	7.2	6.7	15.1	9.0	14.5	15.6	6.5	16.5	15.2	12.5	10.0	12.3	26.2	9.4	19.0	7.7	6.0	18.4	16.0	10.7	13.9	11.3	10.0	12.5	10.8	14.2	6.2	12.8	8.2	12.3	14.6	12.3	13.7	13.7	13.9	13.7	12.8	15.7	11.6	16.1	13.2	12.3	15.7	13.2	6.2	11.9	10.6	15.8	16.5	26.9	18.9	14.2	12.1	15.7	11.8	15.1	16.7	23.8	12.5	8.6	17.6	31.5	21.9	25.7	17.8	13.4	17.0	5.2	5.9	10.9	5.0	8.9	3.3	20.2	15.4	23.3	11.2	7.7	14.2	18.4	10.5	24.5	10.7	15.9	15.0	17.8	22.5	5.9	19.0	12.9	16.9	3.6	15.3	19.7	10.8	15.6	20.5	8.4	20.7	12.9	15.0	13.0	13.6	32.0	13.5	12.5	13.2	27.8
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	27.5	49.3	34.8	35.6	49.9	36.2	30.4	17.0	52.5	23.6	30.6	14.8	23.3	38.5	22.1	38.1	36.3	26.9	28.7	32.7	29.7	31.9	33.8	49.5	26.4	40.1	29.3	40.0	28.4	41.5	9.7	30.7	28.9	22.2	32.8	16.2	22.8	48.2	26.0	52.7	21.1	37.8	15.5	19.5	49.3	36.8	30.8	18.7	44.4	43.2	25.4	35.5	21.6	23.3	61.7	83.7	39.6	71.7	29.9	53.1	71.6	32.3	23.7	25.6	14.7	3.9	12.5	4.7	13.1	11.1	11.2	6.6	6.4	16.4	15.6	36.6	7.2	10.4	14.4	11.9	15.9	7.5	22.7	25.7	20.7	15.1	15.6	23.0	30.5	40.6	13.2	13.5	13.2	12.4	16.8	19.5	22.5	19.7	14.8	13.3	31.1	26.3	46.9	45.4	10.5	31.1	33.6	24.7	29.7	10.7	15.1	13.8	28.1	11.5	10.8	33.6	15.8	29.7	22.9	19.4	12.7	28.0	25.0	18.9	74.4	53.4	10.3	27.4	24.3	30.1	39.6	71.7	34.5	29.9	71.0	28.2	59.7	39.7	31.3	71.2	61.7	53.1	37.6	5.4	29.9	65.4	83.7	29.4	71.6	34.8	49.9	17.0	52.5	29.7	31.9	29.3	40.0	22.2	18.7	154.9	129.2	0.0	0.0	0.0	0.0	0.0	0.0	262.3	136.5	143.1	0.0	264.9	376.4	215.3	0.0	0.0	0.0	0.0	273.6	236.1	0.0	0.0	123.2	0.0	352.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	178.5	0.0	0.0	265.5	0.0	0.0	359.8	0.0	0.0	0.0	0.0	0.0	0.0	123.1	0.0	0.0	0.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884410-53891988	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 78.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	20.4	33.5	29.2	19.0	30.2	38.8	24.1	19.7	21.7	18.9	20.5	20.9	28.3	17.3	15.8	49.4	15.0	16.3	17.1	43.2	25.3	26.2	27.6	38.5	18.0	15.1	32.8	16.8	24.8	72.6	20.0	33.0	18.4	27.9	19.3	22.1	27.3	34.2	20.6	41.0	11.5	20.4	16.7	30.1	16.9	18.4	16.8	27.4	8.7	37.7	18.6	20.3	20.2	18.7	12.4	13.4	78.6	10.9	9.9	15.2	15.4	8.8	6.0	13.1	9.7	20.3	12.4	15.5	12.7	14.8	15.1	18.6	13.4	13.6	13.3	5.7	8.2	18.8	5.5	14.6	8.5	13.9	23.3	20.8	8.3	27.0	31.7	18.0	10.9	20.0	7.1	15.1	10.9	14.8	10.2	13.6	9.5	8.0	36.1	14.6	10.0	7.0	13.4	13.6	10.8	22.6	4.6	8.2	24.8	18.8	15.4	7.1	20.5	8.1	12.1	12.6	16.0	7.9	18.0	8.6	10.2	11.8	25.4	17.9	24.9	29.2	11.7	15.4	14.3	15.3	78.6	8.9	21.9	15.2	9.4	14.6	12.4	14.1	15.1	7.5	9.9	12.3	14.1	19.6	9.9	10.9	13.4	14.3	15.4	29.2	30.2	19.7	21.6	25.3	26.2	32.8	16.8	27.9	27.4	125.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	99.0	99.0	141.3	0.0	144.5	160.8	244.0	0.0	0.0	0.0	0.0	174.6	157.8	0.0	0.0	218.6	0.0	145.4	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	130.8	0.0	0.0	237.2	0.0	0.0	306.1	0.0	0.0	0.0	0.0	0.0	0.0	292.8	0.0	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7"	"Group enriched"	"Detected in all"	6	"B-cells: 32.4;T-cells: 51.6"	"Cell line enhanced"	"Detected in many"		"BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	35.9	19.5	19.8	31.3	20.6	2.4	33.4	13.5	20.8	83.5	66.2	9.1	38.3	22.0	67.5	34.2	53.4	46.1	67.2	25.5	19.1	20.6	19.2	6.6	18.2	35.1	20.7	11.7	49.9	38.1	18.1	27.2	22.1	15.9	59.5	10.7	41.4	57.3	89.1	29.4	11.6	24.0	76.2	14.1	18.2	35.2	21.9	8.8	1.4	45.7	12.2	12.8	92.5	36.1	32.4	1.3	2.4	7.5	7.5	51.6	21.9	3.2	6.8	2.0	11.4	19.1	22.4	22.3	40.4	38.8	18.8	13.7	0.2	0.5	0.4	8.4	23.7	8.5	0.3	1.8	2.4	1.3	1.8	6.8	0.7	2.1	3.4	51.1	0.0	3.5	21.8	7.3	8.9	3.4	9.0	2.4	0.6	0.6	3.9	4.7	1.7	0.1	0.4	2.6	3.0	7.3	0.0	0.0	4.6	2.9	0.0	4.4	9.7	12.6	11.2	0.1	0.7	15.5	0.2	8.2	5.7	16.1	21.1	0.0	3.6	1.6	0.2	22.8	0.0	3.6	2.4	2.2	0.9	23.0	3.8	29.7	32.4	38.3	27.4	1.3	24.2	51.6	30.4	1.6	7.5	7.5	0.4	34.7	21.9	19.8	20.6	13.5	20.8	19.1	20.6	20.7	11.7	15.9	8.8	50.6	112.8	0.0	0.0	0.0	0.0	0.0	0.0	37.5	59.1	293.1	0.0	11.2	261.9	97.3	0.0	0.0	0.0	0.0	512.5	132.0	0.0	0.0	27.9	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	74.9	0.0	0.0	240.3	0.0	0.0	109.7	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 92.9;HSkMC: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	2300000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.4	0.1	7.7	2.1	1.4	0.6	1.9	0.0	0.0	2.0	11.0	0.3	6.9	0.2	0.2	0.3	0.0	0.0	0.0	0.4	8.9	0.5	0.0	92.9	4.7	0.5	0.0	81.3	0.1	0.0	0.0	0.3	0.0	0.3	1.0	2.2	4.0	0.2	0.1	1.1	5.4	3.1	0.1	0.2	0.3	15.9	2.1	1.3	0.3	0.5	0.5	2.8	0.2	10.6	21.7	0.1	0.1	0.5	0.3	0.9	0.1	1.5	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3	416.9	429.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	187.7	118.7	0.0	169.8	167.5	38.5	0.0	0.0	0.0	0.0	45.9	18.4	0.0	0.0	24.4	0.0	658.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.8	0.0	0.0	47.6	0.0	0.0	719.9	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.7	10.2	42.8	0.0	1.3	1.0	2.8	33.3	19.6	2.8	1.7	3.6	10.0	0.0	1.6	36.2	0.3	18.5	0.1	7.9	3.9	0.0	1.4	0.0	1.9	0.0	1.1	0.8	0.0	1.3	0.0	6.0	1.4	8.7	10.4	0.0	0.0	0.0	1.1	0.2	0.0	0.0	16.0	0.1	3.7	0.7	18.2	1.0	6.2	0.2	3.3	1.7	0.2	0.0	0.3	7.1	0.2	0.3	5.8	3.7	3.9	10.7	4.8	2.5	1.7	0.0	3.8	1.4	7.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8	3.0	1.7	0.0	0.0	0.8	10.3	4.1	0.0	18.7	20.5	0.0	43.2	0.3	0.0	0.0	0.1	2.7	0.0	0.0	1.8	0.1	4.7	0.3	1.1	0.0	1.0	3.2	0.0	0.6	0.3	0.0	2.3	0.0	1.7	0.0	0.0	16.0	3.2	0.0	0.0	0.0	65.3	0.0	1.0	1.6	1.7	1.1	0.2	0.0	0.0	0.3
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649113	"Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 146.0;Ciliated cells: 62.9;Club cells: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.0;SK-BR-3: 20.6;U-2 OS: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	4.0	1.1	2.4	1.0	12.2	0.6	7.8	2.0	12.2	5.5	6.4	1.9	0.5	2.2	5.4	1.4	4.7	2.3	6.5	0.9	4.0	4.7	1.0	1.0	6.1	0.6	5.9	6.4	0.9	9.6	0.7	1.4	1.1	5.1	15.0	4.9	2.4	6.2	9.1	1.0	2.2	3.6	10.3	6.6	0.7	3.8	0.9	3.1	0.9	2.2	0.5	0.8	9.8	3.3	0.5	0.3	1.4	0.6	0.7	0.5	0.2	0.2	1.1	0.2	0.0	0.5	3.3	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	3.5	0.0	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.5	1.2	0.0	2.1	0.0	0.0	0.8	0.1	0.0	0.0	20.6	0.0	3.6	1.6	0.0	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	1.4	0.3	0.5	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.5	0.5	0.8	0.7	0.6	0.3	0.3	0.2	2.4	12.2	2.0	8.7	4.0	4.7	5.9	6.4	5.1	3.1	163.8	146.0	0.0	1.0	1.0	41.8	1.2	17.8	62.9	75.1	1.8	0.0	0.7	0.0	4.2	0.9	0.5	0.0	0.0	1.0	0.2	2.1	3.6	22.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	1.1	1.7	1.8	0.0	39.8	4.4	0.0	0.0	0.1	2.7	0.0	1.0	0.3	0.4	0.4	0.2	0.0	0.0	1.1
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.1	9.2	11.5	8.6	3.4	5.1	8.5	7.7	8.6	13.2	10.8	11.3	11.6	19.4	6.7	7.0	5.2	7.0	14.2	6.8	13.5	17.6	6.4	17.0	8.9	5.4	5.7	15.8	11.5	4.1	5.6	11.9	10.6	5.9	6.9	13.2	14.9	9.3	6.8	5.7	19.7	5.0	10.5	4.9	7.0	18.7	12.1	9.5	3.6	8.8	12.1	8.3	11.1	6.8	4.5	6.8	10.7	7.6	6.3	11.2	10.1	6.5	8.1	9.6	15.5	19.0	6.9	36.8	5.1	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6	8.9	6.2	5.6	4.2	3.3	8.2	2.1	7.6	5.3	10.3	3.5	3.9	3.1	3.3	3.0	10.2	6.3	2.5	0.0	5.6	2.8	3.7	3.6	5.8	6.6	3.8	14.3	3.4	7.4	10.0	3.3	5.8	4.8	1.7	5.4	3.7	4.8	4.5	2.0	6.3	3.4	8.3	0.0	3.1	64.4	24.9	5.4	2.3	4.4	3.6	3.0
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.5	32.2	19.1	29.6	21.7	15.9	20.0	19.5	20.0	34.0	32.0	19.2	11.6	31.8	19.4	25.6	23.5	25.6	41.1	30.5	28.6	22.4	37.5	16.5	27.3	19.7	29.3	15.1	21.0	20.3	31.2	38.8	38.1	19.6	27.3	36.3	21.1	9.0	26.2	17.8	36.8	11.5	23.7	24.8	19.6	33.7	17.9	18.3	22.7	15.6	19.1	24.7	19.5	18.9	20.7	25.5	15.9	9.9	14.3	19.6	17.0	18.6	41.8	13.2	13.7	20.2	19.7	16.1	28.9	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4	3.0	4.8	2.7	5.7	7.6	5.8	5.9	7.6	1.4	4.5	1.8	21.6	2.6	0.0	1.9	1.1	4.5	2.3	0.0	2.1	1.9	3.9	4.1	1.1	2.6	1.3	6.4	6.3	9.8	6.9	0.4	3.7	4.1	3.3	1.8	2.5	5.0	1.9	0.0	2.1	0.7	8.0	0.0	3.6	2.8	3.5	10.2	3.4	4.9	3.4	5.6
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.9	11.5	26.2	18.7	20.4	27.2	19.5	19.8	22.1	16.8	21.0	15.8	10.6	18.6	18.8	22.8	19.8	14.1	24.6	13.2	26.0	27.4	21.3	28.2	13.9	14.7	28.4	24.5	20.8	21.0	22.1	15.7	35.1	20.4	27.7	15.6	34.1	20.7	20.5	13.4	9.7	13.2	15.9	14.8	9.8	18.3	13.8	27.2	17.9	16.4	22.9	23.7	16.9	15.0	17.2	22.0	13.5	23.4	23.1	15.0	16.4	7.7	20.4	23.8	23.6	14.9	7.5	23.4	15.8	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6	62.5	112.5	47.7	47.5	41.3	58.8	66.9	35.7	56.2	105.8	27.9	86.4	28.4	14.9	28.8	30.6	40.8	33.0	0.0	28.8	23.6	46.3	54.5	61.4	29.8	25.4	57.2	26.5	36.8	38.9	28.6	65.6	37.8	33.7	39.7	33.3	61.0	28.0	24.6	59.4	24.5	62.7	25.8	62.7	116.1	58.3	42.3	34.4	34.8	39.8	53.1
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO/sentrin peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143688	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 71.2;Late spermatids: 177.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	2.5	4.8	6.4	3.4	8.1	5.0	4.4	5.7	8.0	4.0	4.0	3.9	6.4	3.8	3.9	6.7	4.8	5.1	4.2	7.7	7.3	6.9	9.3	5.0	3.3	3.1	6.2	7.7	5.3	6.2	3.9	12.7	3.7	8.0	5.9	4.3	4.2	5.6	6.6	11.0	3.5	3.3	4.2	5.0	3.1	4.3	26.5	4.3	2.2	12.0	4.5	2.7	4.9	3.0	3.0	5.7	2.1	5.6	7.1	3.7	2.1	1.9	3.3	6.4	5.0	7.7	9.3	3.6	5.0	3.2	3.1	2.8	2.7	4.6	1.9	7.5	3.2	5.4	4.6	9.8	7.8	4.5	2.1	5.3	3.1	4.6	2.2	5.4	3.6	1.7	4.5	7.9	1.9	8.5	4.0	2.8	5.9	4.6	3.7	7.2	4.9	3.7	4.8	5.1	4.5	3.3	2.4	5.4	4.1	8.0	3.4	7.8	2.6	5.3	4.4	5.3	8.0	6.8	2.8	2.9	6.2	2.3	10.2	2.6	3.0	3.6	2.3	2.9	5.0	4.4	2.1	1.9	1.4	1.6	3.9	2.3	3.0	2.8	2.5	5.7	1.4	3.1	3.7	0.7	7.1	5.6	1.7	2.1	2.1	6.4	8.1	5.7	8.0	7.3	6.9	6.2	7.7	8.0	4.3	6.0	4.0	0.0	2.0	0.2	4.0	5.2	2.5	8.1	5.7	1.8	3.9	6.1	11.6	2.8	71.2	0.9	1.6	0.0	1.6	3.1	2.1	1.4	0.0	1.0	1.9	1.6	1.2	1.8	1.5	177.0	1.7	2.1	0.0	4.6	1.3	7.2	1.4	1.9	1.1	5.7	3.2	0.0	0.5	10.4	11.4	0.4	6.5	0.5	2.1	0.9
SERF2	"4F5REL, FAM2C, H4F5rel, HsT17089"	ENSG00000140264	"Small EDRK-rich factor 2"	P84101	15	43777087-43802589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056613			Uncertain	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA056613: "	"unprognostic (3.29e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.33e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.42e-2)"	78.4	109.1	61.4	103.2	58.1	110.6	115.0	33.0	45.9	71.2	107.6	45.1	99.7	59.2	65.1	121.7	109.6	60.0	128.9	166.4	56.1	48.2	97.5	153.1	79.7	81.4	72.9	42.6	51.8	125.4	23.5	62.5	102.9	89.4	84.7	87.6	63.0	134.3	106.7	98.7	59.9	86.4	68.5	66.7	79.5	79.5	65.5	45.8	77.0	122.5	116.7	82.9	84.8	116.3	146.1	259.3	225.7	218.7	91.4	142.8	413.5	34.8	58.0	43.3	59.0	150.7	111.1	33.4	62.2	78.0	40.5	51.9	74.4	35.1	18.1	51.6	106.7	53.7	46.4	33.8	46.7	20.3	49.5	40.1	43.7	84.4	142.7	73.9	40.7	94.4	104.9	60.6	32.8	35.2	63.3	59.0	51.4	45.0	119.6	79.4	106.8	52.0	96.5	36.9	136.5	67.6	53.4	28.7	83.0	110.5	127.6	32.5	35.0	33.3	140.1	31.8	39.2	117.3	174.4	49.9	69.4	35.4	104.1	45.4	44.2	59.2	125.6	74.8	74.1	71.8	127.3	218.7	225.7	113.6	194.5	103.1	142.2	125.7	116.0	185.9	146.1	116.7	118.3	129.1	91.4	166.0	259.3	142.8	413.5	61.4	58.1	33.0	45.9	56.1	48.2	72.9	42.6	89.4	45.8	470.5	717.5	1171.8	1145.4	1022.8	54.4	1942.2	1490.4	1019.8	757.5	1647.0	51.1	2342.3	3302.5	1581.0	331.8	1228.3	2242.3	817.7	1967.3	2747.0	1831.7	2360.8	754.3	2534.0	3171.2	44.5	1122.7	1502.0	1926.7	193.3	1134.5	1999.7	1724.2	2939.6	2776.8	318.1	1792.5	2080.9	932.7	3520.7	108.9	595.0	1152.9	641.0	342.8	1360.5	2739.6	1068.3	1696.1	2044.0
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013162	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 115.8;Late spermatids: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	8.2	14.2	30.1	7.5	22.3	4.7	15.2	24.4	31.4	13.1	10.7	9.5	4.3	6.1	11.8	17.7	9.6	13.9	10.3	9.9	28.6	24.1	15.6	12.3	10.0	8.0	27.9	18.1	26.1	17.4	17.7	19.3	4.8	23.0	13.6	11.5	10.1	12.3	17.1	11.8	11.1	6.2	14.4	10.4	7.6	10.1	3.9	10.7	7.8	25.3	8.8	11.8	9.5	15.6	15.4	14.4	8.9	11.8	11.3	22.0	14.1	6.4	7.4	7.1	13.3	12.3	12.7	4.3	5.1	11.6	6.0	7.9	5.3	2.1	5.8	6.7	6.5	17.4	8.4	25.1	16.5	5.2	12.7	20.4	8.9	6.8	21.9	13.8	7.8	10.3	11.4	18.1	2.9	12.9	18.7	6.5	13.2	5.4	11.2	9.2	10.0	7.6	17.1	5.4	21.9	8.9	11.0	7.8	6.4	14.6	9.7	16.6	3.9	9.6	9.6	9.7	15.0	4.5	7.4	3.3	6.3	7.3	8.2	6.1	7.7	9.3	7.5	9.7	9.1	6.0	7.2	11.8	8.9	21.1	9.3	17.4	15.4	21.3	16.0	14.4	11.1	21.7	19.2	1.2	11.3	9.4	5.9	22.0	14.1	30.1	22.3	24.4	31.4	28.6	24.1	27.9	18.1	23.0	10.7	6.0	5.0	11.3	18.7	23.6	13.1	10.4	10.2	5.3	7.9	10.4	2.0	6.2	33.2	14.7	115.8	11.3	7.9	0.0	21.5	10.6	11.8	15.5	13.9	12.3	12.5	11.1	46.6	7.4	15.5	197.3	18.1	11.9	20.3	10.8	13.0	15.2	13.8	7.0	20.1	30.0	8.2	6.5	20.0	6.2	5.6	17.7	2.6	20.6	12.4	17.2
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	13.0	3.1	2.7	8.9	6.0	8.1	7.6	25.2	18.7	1.6	2.0	4.7	47.3	8.6	33.2	23.6	2.0	53.9	0.3	85.2	0.3	0.8	2.0	0.0	2.7	2.4	6.8	0.0	10.1	7.4	48.5	10.4	22.9	7.2	1.0	1.0	0.3	0.0	2.8	2.1	0.3	0.3	2.8	26.1	6.6	0.0	5.4	2.9	9.0	58.3	1.2	6.7	6.4	48.8	1.0	1.4	28.5	1.5	6.2	0.4	2.1	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.1	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8	14.9	6.2	0.5	97.8	11.0	0.0	0.6	127.4	8.1	21.6	111.7	0.0	323.0	61.3	546.6	3.9	4.4	427.6	0.0	288.5	86.2	3.3	137.4	0.0	45.6	43.7	0.0	111.9	8.6	7.6	6.6	2.0	6.8	38.8	83.8	168.4	0.6	386.0	170.9	0.0	57.4	0.0	0.0	1.4	0.6	3.6	18.4	373.5	0.0	116.2	257.8
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 200.2"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1.0	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1.0	1.1	0.9	0.6	0.7	1.0	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.4	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	200.2	0.0	0.0	6.3	4.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 6.7;Club cells: 2.3;Kupffer cells: 3.2;monocytes: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"	"Cell line enriched"	"Detected in some"	7	"U-937: 48.6"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		42000	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	48.6	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63969925-64019779	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.6"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 37.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	12.4	7.4	2.9	9.3	4.2	16.0	6.1	1.3	5.5	7.7	7.4	7.1	0.0	3.7	4.1	4.3	20.6	3.7	13.7	4.5	3.1	3.3	7.1	23.7	8.2	10.1	4.7	4.0	8.1	4.2	1.1	5.0	9.5	7.4	4.2	6.1	3.4	8.1	2.1	4.5	36.6	8.7	4.4	6.0	9.8	4.2	2.9	3.5	4.2	5.0	17.5	11.3	9.6	11.0	5.1	25.3	5.9	20.5	2.1	4.2	5.0	7.6	1.5	1.3	9.4	4.7	6.6	0.6	24.7	24.0	15.7	15.7	0.3	3.4	0.1	9.1	14.7	7.7	12.4	0.2	15.6	22.5	10.5	0.3	0.0	2.9	0.8	10.7	37.9	3.3	6.3	13.6	21.1	6.9	10.2	16.6	1.6	0.2	4.4	10.8	0.6	0.6	4.2	0.5	1.3	7.6	0.5	3.4	0.6	7.0	8.7	0.7	0.7	4.9	0.7	9.1	1.1	0.3	14.3	25.8	24.0	5.1	2.9	9.9	1.9	0.3	0.0	24.6	22.1	20.6	1.1	20.5	0.8	3.8	16.1	3.4	3.6	3.1	2.3	25.3	5.1	1.7	2.6	5.9	2.1	8.0	13.7	4.2	5.0	2.9	4.2	1.3	5.5	3.1	3.3	4.7	4.0	7.4	3.5	3.0	11.7	4.7	24.0	36.5	0.2	1.2	7.6	6.7	12.5	0.0	0.0	2.9	0.0	27.3	0.6	8.8	8.1	0.0	16.7	4.1	9.3	12.1	4.6	10.4	15.0	0.0	1.7	4.9	24.1	1.1	0.9	25.5	15.1	16.2	3.1	1.6	29.4	2.0	0.0	1.6	0.2	0.0	8.6	2.3	1.0	42.3	26.2	3.9	2.8	32.4
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887266-2903280	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.0;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 59.1;SuSa: 62.4;U-698: 25.4"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		4900000	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	5.6	5.1	3.3	15.9	4.1	7.2	2.6	3.6	6.7	3.9	2.1	4.4	1.3	1.7	1.9	1.9	4.6	4.1	5.3	4.9	3.4	3.6	2.5	7.6	13.7	39.6	4.8	3.9	3.8	1.3	4.7	4.9	24.5	4.7	2.6	2.9	3.5	7.5	1.3	2.0	1.0	5.5	2.4	7.1	14.4	2.0	4.4	2.0	6.4	4.2	2.1	18.9	3.4	3.8	10.3	6.4	2.9	38.0	18.8	17.9	12.3	0.0	2.5	0.0	0.0	0.1	0.0	59.1	0.5	0.1	0.6	0.9	0.7	4.8	9.6	6.0	0.5	0.0	0.0	7.1	0.0	0.5	3.1	0.7	0.9	0.9	1.4	3.4	0.0	0.0	2.7	0.0	1.0	0.0	0.0	12.9	0.8	4.4	0.1	0.4	0.2	0.0	0.0	8.2	0.0	0.0	0.9	0.0	0.1	0.4	0.0	0.4	0.1	5.8	0.0	0.0	62.4	0.0	0.1	13.4	0.0	0.1	0.0	0.0	0.0	12.1	25.4	0.0	0.0	0.0	1.7	18.3	0.1	17.9	38.0	14.7	8.3	13.0	16.8	6.1	10.3	12.1	17.5	2.9	18.8	22.0	6.4	13.0	12.3	3.3	4.1	3.6	6.7	3.4	3.6	4.8	3.9	4.7	2.0	17.9	24.9	31.6	1.9	31.4	1.5	4.2	2.5	13.4	14.8	5.2	0.0	62.3	0.0	14.4	0.9	42.0	1.6	0.0	0.2	116.9	44.8	2.2	45.1	6.8	16.6	7.9	14.9	60.2	47.5	2.5	4.0	98.8	84.4	105.6	3.1	4.8	6.2	5.8	16.6	1.4	2.9	12.9	18.1	0.5	2.2	32.2	226.0	48.4	3.5	7.4
SERTAD1	"SEI1, TRIP-Br1"	ENSG00000197019	"SERTA domain containing 1"	Q9UHV2	19	40421592-40426025	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063323			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA063323: AB_2684984"	"unprognostic (2.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.08e-3)"	17.3	10.6	5.7	11.3	6.2	30.4	9.6	4.4	9.0	11.4	10.8	5.3	5.3	7.9	10.7	4.4	18.2	13.1	16.1	13.8	8.0	5.4	10.3	14.3	20.8	7.9	8.1	2.8	10.3	17.3	2.8	7.3	19.5	10.3	15.3	3.9	5.8	10.0	6.8	11.4	10.9	13.7	8.4	6.3	8.9	14.2	5.5	8.6	6.6	19.1	23.7	10.0	10.5	18.9	10.6	20.2	14.4	17.2	12.1	10.5	9.7	11.5	13.7	2.0	4.8	5.5	3.9	5.3	18.6	5.7	10.1	10.0	6.1	9.5	2.3	8.9	6.2	2.9	4.7	1.6	16.8	3.1	6.3	3.4	2.0	3.3	5.1	6.3	0.7	7.3	6.4	10.4	11.0	2.0	4.9	5.7	2.0	4.2	3.7	9.1	17.3	1.0	3.8	1.5	8.3	9.2	1.4	3.1	5.8	5.3	8.2	0.6	0.9	9.8	9.2	9.0	2.3	9.1	1.9	10.4	10.1	11.3	8.1	12.4	5.4	2.2	3.0	14.1	3.0	4.7	14.4	17.2	11.0	8.1	14.9	4.8	10.4	8.0	7.6	20.2	10.6	9.4	6.5	13.9	12.1	14.0	18.4	10.5	9.7	5.7	6.2	4.4	9.0	8.0	5.4	8.1	2.8	10.3	8.6	68.5	63.2	28.7	142.2	112.1	4.5	72.2	20.4	30.8	36.4	29.6	0.0	38.7	19.9	48.9	1.2	96.6	151.4	0.0	54.3	48.2	93.6	137.2	134.6	12.5	49.7	3.2	101.7	70.6	24.6	3.1	15.3	63.6	89.4	41.5	87.8	14.0	62.1	119.3	10.3	15.0	1.7	38.8	145.2	1.0	4.9	114.0	108.9	37.4	53.7	97.0
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 157.8;Suprabasal keratinocytes: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.3	5.5	4.3	11.3	5.5	52.1	10.4	6.4	5.9	12.4	8.6	9.1	5.6	4.6	9.6	7.6	24.7	7.8	8.4	10.9	4.7	3.5	6.7	11.0	11.8	12.5	7.2	4.4	12.1	5.8	8.4	6.2	17.4	6.0	8.6	6.5	10.2	18.4	7.5	10.8	18.8	9.9	9.5	6.7	24.5	7.2	7.4	8.4	53.8	7.6	16.7	25.7	22.0	16.7	5.4	8.8	3.8	3.1	2.6	4.2	1.4	14.6	4.3	8.2	8.1	7.0	18.0	9.4	11.8	11.4	7.0	6.6	11.1	11.3	12.4	6.5	19.2	9.8	5.8	5.3	7.2	14.9	1.1	8.0	8.2	4.1	8.0	1.5	7.2	4.2	12.2	9.5	16.0	10.5	10.5	4.2	6.2	5.1	6.9	16.3	3.5	7.7	7.9	4.5	8.1	11.6	6.8	14.0	4.8	9.5	13.5	9.5	3.7	8.3	5.8	14.8	8.0	3.9	5.8	12.7	38.0	19.6	22.2	9.5	11.9	4.5	14.4	14.1	13.3	14.8	2.3	2.7	3.8	1.8	2.8	1.1	4.7	1.8	2.0	2.8	5.4	4.2	3.1	3.8	2.6	3.1	8.8	0.9	1.4	4.3	5.5	6.4	5.8	4.7	3.5	7.2	4.4	6.0	8.4	6.0	23.4	29.1	32.3	157.8	20.0	20.7	38.2	14.7	23.9	8.7	17.7	31.4	1.7	11.5	39.6	24.5	17.4	46.7	8.6	22.2	26.8	30.6	8.1	23.2	19.8	9.5	10.9	25.2	34.9	27.3	15.8	37.9	37.1	12.6	14.8	16.7	14.4	17.5	9.9	7.8	23.0	12.9	34.0	5.4	2.7	129.6	50.2	17.5	11.5	61.7
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	23.5	14.2	14.5	11.0	23.7	22.7	39.3	21.2	18.9	13.2	16.9	10.2	17.3	10.3	17.1	14.4	11.9	15.2	10.0	32.4	13.0	11.3	8.8	14.1	17.5	54.1	12.2	14.6	33.0	16.1	18.1	25.6	26.8	13.0	15.2	12.8	9.5	10.0	17.2	69.2	19.7	18.6	17.9	13.7	19.3	14.9	20.8	13.6	9.6	18.2	15.4	16.4	16.1	15.3	21.0	2.1	3.9	3.0	21.8	30.6	7.8	1.5	2.5	11.6	5.4	14.8	19.0	36.5	6.1	7.0	2.1	4.1	4.7	1.6	12.8	5.2	4.5	1.6	1.8	3.1	12.2	2.6	1.1	15.5	5.6	3.2	17.7	9.1	2.2	5.8	20.4	19.5	3.8	6.2	9.3	11.0	3.7	4.1	9.2	10.4	3.0	4.8	7.0	4.7	2.4	1.6	3.9	3.3	5.8	4.6	7.7	2.8	5.8	3.3	2.1	2.4	19.6	2.0	14.6	6.7	1.6	3.2	1.5	1.9	9.3	5.3	5.2	3.6	5.6	3.5	3.9	1.0	1.2	14.2	2.3	30.6	4.4	13.3	11.1	1.0	21.0	16.6	8.8	3.9	21.8	3.0	2.1	5.6	7.8	14.5	23.7	21.2	18.9	13.0	11.3	12.2	14.6	13.0	13.6	59.6	15.3	22.2	3.5	5.8	21.5	24.9	17.8	34.8	22.7	14.0	43.2	39.6	8.3	3.4	108.0	6.3	7.9	0.0	4.7	11.8	13.0	7.1	3.5	11.6	35.8	25.4	14.9	11.1	30.9	78.2	31.9	10.8	15.1	9.0	9.7	36.4	2.9	8.6	33.2	5.8	42.4	25.8	13.3	13.2	15.7	7.3	37.3	34.6	11.5	2.3
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 511.2;Late spermatids: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 21.5;SuSa: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	7.3	14.2	22.3	10.4	38.6	11.9	11.6	10.2	20.8	10.3	6.8	11.1	3.3	5.2	9.3	11.7	7.6	7.0	9.9	5.1	15.9	12.9	8.7	6.0	7.2	17.3	12.6	12.0	18.4	3.3	27.7	10.7	6.6	13.9	8.5	5.4	19.7	9.1	4.8	5.4	8.4	10.6	7.6	11.6	12.7	3.9	41.6	14.1	11.3	17.3	4.0	18.3	10.0	7.7	4.2	1.1	1.0	3.5	0.8	4.5	0.8	0.0	0.4	11.6	0.0	19.6	21.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.0	1.4	0.0	0.5	2.3	7.0	5.0	0.0	2.5	3.6	1.5	6.1	0.4	0.3	1.3	0.2	11.8	8.8	0.0	2.6	3.6	0.4	1.8	0.1	0.5	0.9	0.0	0.9	3.5	4.7	0.0	0.5	2.2	0.7	0.2	2.6	7.6	1.5	3.2	0.1	0.1	0.6	47.8	0.0	4.3	0.1	1.3	3.0	0.2	0.4	0.1	0.0	0.4	0.5	1.6	2.8	1.0	0.8	0.6	0.7	1.7	0.8	4.2	2.3	1.3	0.7	2.7	4.5	1.7	0.8	0.8	3.5	1.1	4.0	0.8	22.3	38.6	10.2	20.8	15.9	12.9	12.6	12.0	13.9	14.1	23.8	6.4	52.8	25.9	20.5	48.2	7.5	0.0	2.7	14.8	33.2	21.6	0.8	1.7	4.1	511.2	29.0	9.7	23.3	2.0	0.3	22.8	17.2	6.9	4.9	19.2	0.0	7.0	28.3	40.6	396.5	37.7	20.8	30.4	114.6	14.1	93.1	1.9	5.8	82.0	14.6	12.5	6.5	24.7	35.4	8.3	10.9	1.4	15.2	16.3	9.1
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	51.4	58.8	84.6	66.9	25.2	39.6	78.0	42.5	47.1	61.5	42.4	80.7	63.2	133.1	36.0	43.7	48.1	96.5	124.9	63.9	70.3	60.7	53.2	76.6	91.4	65.6	56.5	139.7	50.2	33.0	50.1	52.3	105.0	49.5	57.5	71.6	148.6	54.0	50.3	86.8	117.0	51.6	141.2	78.7	62.6	107.0	105.1	107.8	47.4	58.1	86.2	54.1	93.6	62.9	50.8	62.8	78.4	43.6	55.0	72.7	54.5	44.8	70.3	42.5	122.1	158.5	34.6	74.5	69.2	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6	113.2	124.3	265.7	328.1	598.4	174.9	190.6	209.0	89.7	129.7	186.7	41.2	273.8	330.0	223.2	30.8	200.0	100.9	93.5	188.0	401.9	250.8	373.4	128.3	164.3	210.2	117.6	245.8	160.2	212.7	25.3	151.8	217.3	310.4	235.4	230.5	205.1	229.0	108.7	163.0	257.3	97.8	129.4	279.5	127.7	287.7	613.8	263.1	219.3	275.8	519.4
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6"	Q8TBK2	16	58515479-58521181	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	7.8	11.3	7.7	7.4	8.8	4.3	12.6	18.6	11.8	8.4	7.1	6.6	17.0	7.0	10.2	14.0	11.5	10.3	9.6	8.6	8.8	7.0	11.7	12.1	7.9	7.9	8.9	9.0	9.0	20.0	22.1	17.1	7.0	8.3	12.2	8.2	7.2	15.5	19.7	14.7	14.4	7.8	9.2	7.7	9.2	9.6	10.2	9.7	5.5	13.6	9.5	8.8	7.4	10.3	3.2	3.9	3.8	3.0	8.6	4.9	2.7	1.8	3.8	0.8	7.3	2.8	2.0	13.7	3.1	3.4	4.4	2.6	6.5	3.8	13.6	5.0	3.1	0.6	5.7	5.7	4.1	3.2	1.7	20.6	0.6	6.3	11.6	2.9	9.9	6.2	2.5	8.3	3.7	5.7	3.2	3.2	0.1	10.8	1.7	0.9	6.6	0.2	11.9	15.5	5.9	8.4	0.2	1.7	18.5	4.6	0.2	13.6	9.6	13.6	10.4	5.1	4.1	6.7	1.2	2.7	1.7	4.9	2.1	5.2	9.4	5.7	10.1	3.5	4.8	3.3	3.8	2.4	0.2	4.6	3.0	3.3	3.2	3.9	4.9	3.9	3.1	4.8	4.8	0.1	8.6	2.9	3.8	3.2	2.7	7.7	8.8	18.6	11.8	8.8	7.0	8.9	9.0	8.3	9.7	6.0	5.8	7.9	8.7	12.4	13.5	7.6	10.2	13.4	7.9	8.7	13.7	14.4	1.7	7.0	6.6	6.7	4.9	0.0	10.5	7.4	5.2	8.3	1.1	6.2	3.2	11.1	4.6	3.7	3.5	14.2	8.3	4.5	5.0	7.2	4.0	12.1	5.3	2.9	9.6	8.4	11.9	12.9	6.3	9.8	20.4	10.7	10.5	5.3	6.8	5.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
SETSIP	SETP18	ENSG00000230667	"SET-like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 3.1;granulocytes: 3.5"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.3"									HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA			Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0		0.1		0.3	0.0		0.8	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.1			0.2	0.0	0.2	0.0			0.2	0.0	0.0		0.3		0.0	0.0		0.3	0.0	0.7	0.0	0.0	0.0		0.0	0.0	1.8			0.0		0.0	0.0		0.3	0.2	0.6	0.3	0.1	0.2	0.1	0.6	0.7	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	1.3	0.5	0.4	0.0	0.1	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.9	1.2	0.0	0.0	2.3	0.0	1.6	0.4	0.5	1.2	1.0	1.4	0.0	0.6	1.5	0.6	1.3	0.9	0.5	0.1	0.7	0.3	0.0	0.7	0.4	0.2	0.2	0.7	0.6	1.3	0.0	0.1	1.9	0.0	0.0	0.6	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1											0.0	1.1	0.0	0.8	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	1.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.5	0.0	0.0	0.9
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354985	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	20.3	12.3	13.0	23.5	15.0	14.0	16.1	16.7	14.8	14.7	16.0	11.2	14.5	9.9	18.3	15.2	13.2	17.5	12.3	13.8	13.0	8.3	12.5	15.8	18.5	23.5	19.8	12.6	15.8	11.0	24.0	24.6	13.4	16.9	13.8	12.6	8.6	16.2	16.1	18.4	15.2	19.4	16.9	20.6	25.7	13.2	34.5	18.1	26.3	31.6	10.8	24.0	18.8	16.3	8.0	5.5	16.9	5.0	5.3	6.5	2.3	9.1	12.3	14.2	15.3	18.3	22.3	8.5	12.2	13.7	9.9	9.3	12.9	10.5	15.6	6.0	22.7	24.4	18.8	14.2	10.5	10.9	14.8	6.1	16.3	13.8	11.2	17.2	25.0	19.9	15.6	16.6	16.9	15.1	12.2	15.9	11.1	18.9	12.6	11.4	13.2	15.4	9.6	15.2	15.5	9.6	14.7	20.6	10.4	11.0	12.0	8.9	13.6	20.1	8.9	11.1	19.7	12.3	12.9	18.1	20.8	9.0	13.9	11.6	7.7	13.0	24.2	9.5	10.0	11.1	7.7	4.9	4.8	6.1	4.5	6.5	6.2	4.6	4.6	3.6	8.0	5.0	4.3	16.9	5.3	5.0	5.5	3.4	2.3	13.0	15.0	16.7	14.8	13.0	8.3	19.8	12.6	16.9	18.1	56.6	43.7	27.4	25.9	26.9	29.3	49.2	20.4	54.9	56.9	19.2	27.5	11.5	3.3	17.7	5.9	43.4	27.4	0.0	12.7	8.9	28.8	33.6	55.6	30.4	24.7	63.5	13.9	58.3	69.1	10.9	28.4	39.3	11.8	16.2	27.3	24.6	20.3	19.8	33.9	18.0	28.0	12.9	22.7	47.4	38.0	29.4	7.9	39.9	17.1	38.1
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356947	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		19000	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	32.6	30.2	23.3	37.3	25.6	44.6	35.0	33.6	37.3	29.2	26.4	24.8	27.7	26.1	36.3	23.0	32.2	29.4	30.7	26.2	21.5	16.6	24.9	29.7	28.5	48.2	23.5	26.1	45.7	31.4	44.4	27.2	25.9	19.6	27.2	24.5	29.7	31.8	33.1	45.5	36.3	29.5	27.6	18.7	34.6	29.1	78.4	25.7	50.9	32.9	26.6	34.9	32.7	42.6	13.2	10.6	16.2	13.7	12.1	16.6	8.3	26.4	18.6	25.6	24.8	15.2	13.7	30.6	21.0	13.4	22.9	17.1	24.6	17.7	33.1	14.5	14.8	18.1	25.5	32.4	22.3	25.2	30.0	28.4	30.9	23.1	20.1	13.8	61.9	34.4	13.7	15.8	28.9	23.6	13.0	16.4	18.0	34.1	34.7	16.6	15.2	30.1	14.1	42.3	20.4	15.6	43.0	32.1	26.8	13.1	29.4	26.6	24.3	26.7	16.3	24.2	17.8	19.9	20.4	22.9	29.4	26.2	20.9	38.7	26.9	32.4	33.5	22.6	23.0	30.2	7.6	9.8	15.0	13.5	11.3	13.7	12.8	13.5	14.4	10.6	13.2	15.3	13.7	16.2	12.1	13.7	6.4	16.6	8.3	23.3	25.6	33.6	37.3	21.5	16.6	23.5	26.1	19.6	25.7	53.6	60.9	28.0	23.1	23.2	17.9	26.6	35.7	48.2	37.5	29.6	15.7	28.2	14.9	22.6	85.6	29.2	25.3	46.7	25.3	33.8	23.4	23.0	50.8	23.6	34.7	25.4	24.1	28.3	35.7	91.2	32.5	26.1	16.9	63.1	29.8	24.6	24.5	31.6	35.3	14.6	17.4	45.3	23.9	54.7	41.0	23.8	28.9	30.5	28.2	22.2
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.9	12.2	22.1	18.8	13.8	12.8	26.7	15.6	14.3	27.5	22.3	20.0	17.0	30.4	13.7	15.2	10.7	13.8	28.0	22.8	33.8	13.9	27.3	38.6	19.5	17.3	12.7	46.9	18.7	12.1	16.0	28.4	18.8	12.6	19.0	23.7	34.0	12.0	19.8	10.7	24.7	27.1	54.5	16.6	19.0	29.5	37.9	21.9	12.6	16.7	19.3	14.3	20.0	9.3	16.5	20.6	11.0	18.6	17.0	14.4	15.8	13.2	30.9	11.5	16.3	31.0	13.9	43.2	17.9	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6											47.6	31.2	43.1	32.7	42.0	34.1	19.8	7.6	28.1	44.3	21.0	21.6	48.1	33.2	40.0	18.5	30.6	15.5	0.0	33.5	56.8	32.4	19.1	40.5	20.8	45.1	25.4	15.0	21.5	25.3	10.0	36.8	36.9	37.1	107.4	22.3	37.9	31.9	7.0	50.9	23.7	34.2	38.8	34.7	116.5	59.6	36.5	27.6	38.9	28.3	25.9
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 33.6;T-cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;REH: 14.7;RPMI-8226: 13.8;SH-SY5Y: 11.3;THP-1: 17.6;U-937: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.0	4.2	9.6	5.9	11.7	6.1	6.2	6.6	13.7	2.5	2.8	26.7	1.1	2.0	4.3	3.7	2.3	3.7	3.6	3.9	12.6	6.9	2.7	1.1	4.1	7.2	14.6	7.4	11.2	3.8	10.1	6.6	3.7	10.8	6.5	3.4	3.9	4.6	3.6	3.9	1.2	3.5	3.4	10.6	9.0	2.9	1.5	9.7	2.0	7.8	1.1	6.2	3.7	4.1	0.1	5.4	1.7	7.4	1.3	1.8	0.4	0.0	3.4	0.2	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.0	0.0	0.9	5.3	0.0	0.1	0.0	1.6	6.0	0.0	0.0	0.3	5.4	0.0	8.9	0.0	0.4	5.8	0.7	0.8	0.2	0.0	0.2	0.0	0.0	7.3	9.0	16.4	0.0	2.3	4.6	9.1	1.1	0.0	0.0	14.7	1.8	13.8	0.0	0.5	1.3	11.3	0.0	0.0	0.0	1.5	0.8	17.6	0.0	0.0	1.8	0.2	0.1	7.0	10.1	0.0	0.7	11.1	0.1	0.1	0.4	1.7	1.4	3.8	0.8	0.1	0.5	0.9	0.7	0.1	1.8	1.1	0.2	1.3	7.4	5.4	0.0	0.4	9.6	11.7	6.6	13.7	12.6	6.9	14.6	7.4	10.8	9.7	0.0	6.9	6.7	1.2	1.3	5.8	9.6	2.5	1.4	1.2	0.0	76.6	5.9	0.0	0.4	0.1	6.7	0.0	0.0	0.2	2.0	1.7	9.3	4.6	0.5	14.1	0.0	4.1	7.4	11.5	0.4	4.6	9.2	5.0	9.0	0.0	12.9	0.2	0.0	2.1	0.1	33.6	0.0	1.0	0.4	3.6	1.1	3.7	24.1	0.0	0.6
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.3;liver: 31.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	4.0	10.1	26.1	4.9	24.6	12.8	3.1	10.1	28.3	3.4	6.6	12.9	3.7	7.6	3.2	18.4	2.7	5.2	4.4	3.6	25.3	12.7	12.7	31.4	3.7	3.6	16.0	18.6	2.9	2.7	3.4	3.1	4.5	14.9	5.2	6.8	2.6	2.1	5.4	6.3	3.2	7.3	4.5	9.6	5.2	5.1	2.9	13.3	1.6	4.3	1.7	3.7	5.0	2.1	3.0	4.2	6.4	8.9	5.8	1.3	2.1	3.4	7.4	11.8	9.1	2.8	1.9	4.3	7.0	4.0	11.2	5.9	11.4	8.9	2.1	7.3	7.3	8.1	3.0	9.1	10.1	5.3	8.5	5.9	8.6	7.3	14.9	3.6	4.3	9.4	4.9	2.8	7.8	0.9	4.0	6.5	2.6	7.4	1.8	3.0	6.7	1.2	6.6	14.5	6.7	4.7	8.1	9.7	2.6	6.5	8.2	7.6	2.1	6.5	3.3	2.7	6.7	1.7	2.2	4.7	3.4	11.2	4.8	8.0	3.0	2.9	2.5	11.7	8.1	4.0	4.8	8.9	4.2	0.9	3.9	1.3	1.6	0.5	1.0	4.2	3.0	0.6	0.8	6.4	5.8	4.3	2.9	1.0	2.1	26.1	24.6	10.1	26.3	25.3	12.7	16.0	18.6	14.9	13.3	0.0	4.1	8.8	4.0	4.1	24.0	5.4	5.1	0.0	4.5	34.9	31.4	7.6	3.3	4.4	100.9	6.0	15.1	23.3	7.9	1.9	7.5	2.9	0.0	53.3	10.6	19.1	13.2	8.6	4.0	111.2	9.8	7.0	8.5	10.0	5.8	76.6	6.2	5.3	10.6	20.2	38.4	12.9	7.7	7.9	13.0	8.2	3.5	5.7	6.8	1.6
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 187.5;Late spermatids: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	11.1	11.4	7.9	11.8	12.5	9.9	15.5	20.9	11.0	19.5	17.1	10.6	16.9	11.6	21.4	10.2	9.0	17.6	11.1	10.7	7.9	6.8	9.8	12.9	11.1	17.2	16.5	7.1	31.5	17.7	8.6	9.4	8.4	10.8	13.1	6.9	12.1	14.8	20.0	36.1	12.2	13.4	21.4	13.4	11.6	13.5	35.6	14.4	17.6	19.5	9.0	10.4	17.1	25.1	25.4	27.6	18.8	18.2	19.5	36.1	20.4	7.0	12.0	9.2	6.0	6.4	6.3	16.8	4.8	5.4	12.6	11.9	13.8	6.4	21.3	12.0	3.7	7.6	8.3	7.0	8.4	3.6	6.8	13.3	13.2	7.4	18.3	15.6	11.8	14.9	6.7	11.5	7.5	7.6	6.8	4.7	13.6	11.1	10.9	4.4	23.6	13.4	23.2	12.7	5.2	11.7	21.0	6.0	18.5	6.3	10.7	14.9	6.9	7.4	14.2	7.9	3.7	11.7	9.8	3.3	8.7	7.4	5.0	8.3	12.7	18.4	12.4	6.2	20.1	7.0	5.0	18.2	18.8	22.3	15.6	26.9	22.2	31.2	27.2	18.3	25.4	36.1	27.8	5.6	19.5	12.5	27.6	29.6	20.4	7.9	12.5	20.9	11.0	7.9	6.8	16.5	7.1	10.8	14.4	14.9	11.8	6.7	16.2	0.0	6.1	0.0	5.1	12.0	13.6	17.4	13.7	15.2	8.3	9.9	187.5	3.6	9.3	0.0	11.3	10.4	9.5	6.7	5.8	14.3	12.7	0.0	3.5	6.2	12.9	270.5	28.4	12.1	0.0	11.8	9.2	11.2	11.3	12.2	20.5	18.8	13.9	19.4	0.0	8.4	19.2	0.0	17.6	13.1	14.0	11.1
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.7	7.4	17.9	8.0	2.4	3.9	11.1	18.1	7.6	15.6	15.7	11.4	10.7	10.3	8.5	8.6	16.5	11.8	15.7	9.4	26.7	20.6	7.8	19.4	10.7	8.1	0.7	20.2	15.7	1.5	1.1	15.7	8.1	3.8	13.8	14.7	14.9	15.2	29.5	7.0	16.2	8.3	12.7	11.2	18.5	12.8	23.6	9.4	6.5	6.2	10.5	7.2	13.3	6.5	7.9	15.1	6.9	11.9	8.3	16.4	16.3	15.0	15.8	6.9	14.4	22.4	10.3	13.6	23.4	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3	3.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	14.7	11.4	0.0	0.0	3.2	3.3	3.1	0.0	0.0	0.0	0.0	2.3	24.6	0.0	0.0	10.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.0	0.0	2.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 8.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	11.1	15.3	51.8	13.3	45.8	17.3	15.9	14.4	43.7	11.6	12.1	12.6	14.9	10.8	13.3	38.6	16.5	12.7	15.1	12.3	43.2	24.9	12.6	6.6	14.7	15.4	13.9	34.8	11.3	14.8	25.4	30.7	11.1	18.9	20.6	7.4	13.6	23.0	18.1	13.4	23.0	13.0	14.2	13.7	16.6	14.2	10.0	17.6	9.4	15.7	6.0	10.8	16.1	10.9	0.6	0.9	8.6	0.4	1.3	2.1	0.7	10.2	15.9	14.5	20.2	8.3	10.0	21.6	8.9	10.5	12.4	12.6	15.9	19.8	4.9	9.7	12.9	4.6	14.5	8.9	10.5	4.3	7.2	18.2	8.7	24.0	16.8	7.1	5.1	13.1	10.7	7.0	12.6	7.3	18.0	12.8	13.6	5.1	7.5	7.4	21.8	11.0	6.9	7.1	7.4	7.0	24.2	7.4	4.0	15.9	21.6	7.1	16.7	11.1	8.4	6.7	9.5	21.7	6.2	14.9	10.0	11.4	14.6	11.7	6.2	0.9	4.5	8.7	6.8	8.7	8.6	0.4	2.1	1.7	0.3	1.5	0.1	0.7	1.0	0.7	0.6	2.1	1.1	0.2	1.3	0.0	0.9	1.0	0.7	51.8	45.8	14.4	43.7	43.2	24.9	13.9	34.8	18.9	17.6	6.0	24.8	3.4	7.1	6.1	54.4	12.4	10.2	6.7	15.9	12.2	127.6	11.8	0.0	5.5	14.7	11.9	6.4	0.0	3.9	7.6	9.1	14.0	19.7	6.8	6.6	28.6	13.3	16.0	6.9	25.3	7.5	8.2	5.0	2.8	9.9	11.7	5.4	3.5	11.3	3.4	55.1	19.4	5.7	3.0	6.7	6.8	11.8	7.5	8.0	11.5
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793023-2841098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 83.9;Suprabasal keratinocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036790	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	17.5	7.0	9.7	20.4	14.5	30.2	13.1	6.1	10.1	9.0	11.6	9.8	7.5	8.9	7.9	18.7	10.8	8.7	9.5	9.9	9.3	8.8	26.3	18.3	20.2	18.5	12.0	3.5	8.8	10.1	3.6	7.6	20.8	15.4	8.4	7.4	11.6	9.3	7.8	11.0	31.2	14.2	8.9	14.5	46.8	10.8	5.0	12.2	5.2	8.0	6.9	17.4	11.6	10.9	4.4	8.6	16.7	21.9	3.8	7.0	5.4	5.3	3.2	3.7	5.2	3.1	7.9	3.5	8.5	7.0	6.6	5.9	2.3	16.7	8.4	9.7	7.1	5.5	2.5	0.2	5.6	4.0	4.3	3.4	19.7	6.6	2.7	10.3	8.1	13.9	14.9	5.3	3.7	3.3	7.2	14.4	7.5	1.1	19.5	7.8	4.3	1.2	9.7	6.0	11.5	6.3	0.4	3.4	3.6	11.2	8.4	11.3	8.4	6.2	5.9	4.2	3.5	9.0	13.5	18.3	6.4	4.9	2.3	6.3	8.2	3.8	1.7	7.5	21.9	6.8	1.8	10.5	6.7	7.0	18.6	4.4	1.4	1.9	4.6	8.6	4.4	1.0	2.7	16.7	3.8	21.9	3.5	3.5	5.4	9.7	14.5	6.1	10.1	9.3	8.8	12.0	3.5	15.4	12.2	3.0	4.3	12.4	8.1	33.9	0.8	6.1	7.6	2.7	9.1	38.4	0.0	0.9	3.3	6.3	7.4	27.2	19.0	0.0	19.1	1.2	11.3	12.4	9.2	40.4	43.6	0.0	9.8	39.9	83.9	5.8	12.7	47.9	18.6	7.2	13.3	30.8	21.0	23.4	9.6	30.1	5.1	38.8	17.5	1.6	3.4	72.9	3.5	17.3	12.1	17.0
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254853-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 199.4;Extravillous trophoblasts: 335.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	38.6	72.5	12.7	20.0	13.4	29.9	35.7	34.8	22.3	30.5	12.7	20.7	42.0	7.5	33.9	20.4	11.9	32.2	29.0	9.6	17.2	11.2	19.6	9.9	38.8	25.1	13.0	18.9	49.6	7.1	30.0	14.7	19.5	15.1	13.5	4.9	12.4	22.4	45.1	61.7	10.1	10.3	21.0	19.0	14.8	7.2	17.0	10.8	9.3	20.8	7.7	18.9	25.3	44.3	13.3	4.8	8.0	3.9	13.0	28.9	9.5	7.4	3.7	1.7	3.5	16.1	13.6	94.1	4.1	2.7	2.2	2.8	2.4	3.4	6.2	1.7	10.8	4.7	0.9	0.8	3.5	1.9	4.8	3.4	4.2	16.9	0.4	6.1	1.1	2.1	10.9	2.6	10.2	2.2	10.6	31.4	8.1	4.6	2.1	3.0	26.6	14.8	6.9	3.7	0.9	5.6	0.2	8.4	28.1	2.7	12.4	4.2	2.2	5.6	5.1	5.9	7.2	4.6	3.1	24.1	6.0	8.4	5.7	3.1	0.8	1.7	4.3	11.5	4.1	8.1	3.5	3.9	4.5	28.9	1.3	9.1	10.9	13.7	19.9	4.8	13.3	7.5	9.8	8.0	13.0	2.1	2.2	5.7	9.5	12.7	13.4	34.8	19.2	17.2	11.2	13.0	18.9	15.1	10.8	0.0	18.9	87.1	5.5	15.0	40.9	0.5	7.6	6.7	17.0	64.6	13.7	9.5	3.3	2.9	199.4	71.8	1.4	0.0	7.7	335.6	62.1	6.6	2.3	5.1	28.9	62.0	2.4	138.1	68.8	76.3	45.5	65.1	32.1	17.2	1.8	4.7	3.6	0.0	111.4	22.1	45.9	6.5	7.7	2.1	3.0	10.7	144.9	40.5	0.9	8.1
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;ASC TERT1: 47.4;HSkMC: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	56.0	9.5	6.8	11.2	14.2	0.0	24.2	4.4	9.2	19.2	28.5	20.1	10.7	20.3	22.8	13.9	23.6	17.3	29.6	31.7	7.8	5.1	12.8	23.1	26.1	3.7	13.6	5.5	27.2	7.8	15.4	6.0	16.8	12.7	18.8	23.0	12.4	14.1	19.8	12.8	17.4	35.9	26.6	7.7	3.1	14.6	12.3	15.1	0.3	15.6	12.8	6.7	27.7	23.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	7.1	5.3	3.4	2.6	55.5	47.4	7.4	8.9	9.5	3.9	4.1	6.8	8.9	0.0	3.6	8.3	6.5	5.3	3.6	10.2	3.9	0.0	2.8	0.0	6.5	7.3	13.4	0.0	0.0	37.6	7.9	5.9	9.2	6.8	23.0	0.0	0.0	0.0	10.4	2.9	0.0	0.1	6.9	11.1	7.7	0.0	0.2	0.1	4.9	5.0	0.2	4.7	6.3	6.5	5.2	7.4	2.1	0.0	16.6	12.5	4.5	5.5	3.5	0.0	0.0	0.0	6.5	0.0	15.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.8	14.2	4.4	9.2	7.8	5.1	13.6	5.5	12.7	15.1	20.8	30.4	2.9	11.9	25.3	5.6	85.4	28.1	40.2	40.9	15.7	13.7	21.5	5.0	10.4	3.7	29.2	75.0	0.0	13.3	16.3	37.6	28.4	19.8	40.8	6.5	6.4	17.9	27.6	5.7	4.7	57.5	5.6	25.3	0.0	33.2	19.1	18.2	54.7	45.3	23.1	11.4	12.9	20.6	2.1	6.6	33.6	22.8	5.0	42.0	28.8
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 13.1;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2"									"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	8.3	0.2	1.6	1.9	0.5	1.0	9.1	4.0	0.8	3.0	1.3	4.7	3.4	1.5	4.4	1.7	0.3	13.5	1.4	3.0	2.5	0.4	0.6	1.3	2.9	3.7	1.3	0.7	2.0	0.5	2.5	2.0	1.5	22.0	1.1	4.1	0.2	2.6	1.4	4.9	1.4	0.7	1.0	2.2	1.6	2.0	0.1	1.0	3.4	1.0	3.4	1.7	0.9	10.1	3.1	11.2	0.3	0.3	2.3	1.2	0.7	4.0	0.4	3.0	0.9	1.7	3.4	0.7	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9	0.0	1.3	0.8	1.5	2.7	5.2	0.9	0.0	0.0	0.0	5.2	0.0	2.5	1.7	0.5	13.1	0.9	11.8	0.0	0.3	2.1	1.4	2.0	1.1	0.0	7.0	11.1	0.0	0.6	3.2	38.8	1.1	4.7	3.3	3.6	2.0	1.0	2.7	0.8	2.5	0.8	1.1	0.0	1.7	2.1	1.5	2.8	4.8	0.0	1.6	1.1
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cytotrophoblasts: 90.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	9.3	18.8	36.9	11.7	27.0	30.4	16.6	31.3	47.2	15.8	16.4	33.0	43.7	25.7	14.4	14.2	29.5	21.0	13.6	14.8	34.2	24.4	15.8	6.6	14.9	13.6	28.8	37.9	20.0	35.9	29.1	26.8	45.2	26.3	21.3	10.1	13.4	30.0	33.8	19.4	46.6	20.4	16.6	30.9	14.9	25.8	7.8	24.1	16.9	16.4	15.0	15.8	27.8	18.1	7.7	7.6	6.6	4.6	5.0	4.9	2.8	13.4	11.4	5.6	7.6	3.4	4.3	16.8	4.7	10.7	9.4	8.6	7.1	23.3	14.2	3.7	8.3	7.2	33.2	1.7	10.2	2.7	9.1	7.7	3.6	18.2	6.2	7.1	3.2	8.7	3.1	11.7	4.8	4.3	10.3	7.8	18.8	4.8	19.0	4.7	33.1	18.2	8.5	5.0	22.8	8.0	37.1	10.6	63.5	10.4	16.3	17.7	14.3	6.8	17.8	7.3	4.9	25.5	4.8	7.1	4.4	7.5	11.1	10.3	18.5	9.0	9.0	10.1	4.0	2.3	4.4	3.3	6.6	4.1	1.6	4.9	7.7	4.7	3.8	2.7	3.8	3.4	3.0	2.7	5.0	4.6	7.6	3.9	2.8	36.9	27.0	31.3	47.2	34.2	24.4	28.8	37.9	26.3	24.1	14.9	30.8	10.4	24.5	18.4	20.3	9.0	12.7	5.3	19.4	45.4	7.9	90.7	13.3	12.2	8.2	11.3	41.2	23.3	22.8	15.3	16.4	24.4	5.8	7.8	17.9	44.5	24.3	11.6	11.6	14.9	17.5	9.8	13.5	4.6	31.4	26.6	19.7	49.9	19.1	6.2	15.6	12.9	16.5	6.1	6.6	46.9	125.1	10.4	29.9	48.9
SH3PXD2B	"FLJ20831, KIAA1295"	ENSG00000174705	"SH3 and PX domains 2B"	A1X283	5	172325000-172454523	"Disease related genes, Predicted intracellular proteins"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 28.3;Leydig cells: 36.8;Peritubular cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"classical monocyte: 1.3;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.7;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5;ASC TERT1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036471	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036471: AB_10670799"	"unprognostic (3.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (5.38e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (8.45e-4)"	26.9	17.8	6.9	12.4	10.1	0.7	28.0	13.3	8.7	28.0	10.0	16.6	13.4	3.1	26.4	19.6	12.3	14.6	21.4	5.8	7.6	4.1	2.8	2.6	13.2	11.4	16.0	4.5	18.1	7.9	16.7	4.3	10.2	10.9	10.6	6.9	15.9	14.8	16.8	5.1	15.0	8.2	25.8	10.0	7.7	11.1	10.9	9.6	1.8	6.5	4.3	4.2	17.0	14.9	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.3	5.4	20.1	13.2	37.5	31.8	17.1	3.2	11.2	2.1	4.2	1.5	0.5	0.0	4.4	12.5	6.4	3.0	7.1	3.7	2.0	0.3	1.3	0.0	5.1	1.0	12.1	0.0	14.1	20.3	5.8	8.6	2.5	2.0	14.4	1.4	0.0	0.1	9.1	1.1	0.0	1.7	7.7	3.0	1.2	6.3	3.2	1.8	2.2	0.5	1.7	11.3	2.2	1.4	4.1	6.6	0.5	0.8	15.4	13.0	5.2	7.9	1.4	0.0	0.0	0.0	8.8	0.8	10.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	10.1	13.3	8.4	7.6	4.1	16.0	4.5	10.9	9.6	0.0	0.6	0.0	2.8	9.0	0.6	1.6	7.6	0.0	2.3	0.0	0.0	3.9	0.0	8.4	0.8	5.8	0.3	0.0	13.8	28.3	12.8	5.6	0.0	2.0	2.7	1.6	2.4	2.5	19.6	1.3	36.8	8.6	13.5	1.0	1.8	4.5	18.6	0.0	25.5	1.4	0.2	12.9	10.5	0.7	4.1	7.0	1.8	0.0	2.8	5.0
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.1;placenta: 22.7;testis: 14.4"	"Cell type enhanced"	"Detected in many"	14	"Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	1.3	0.8	3.3	0.8	15.4	1.2	1.4	0.9	8.6	2.2	1.0	32.1	0.0	0.6	1.0	1.7	2.0	1.3	1.3	3.7	6.0	3.0	0.6	0.7	1.0	0.7	22.7	4.6	0.6	0.5	0.8	0.5	22.7	12.0	0.9	1.8	0.0	1.4	1.4	1.5	1.1	0.7	1.3	12.9	1.0	0.7	14.4	15.6	0.0	0.8	0.0	1.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.2	0.0	0.0	0.0	0.1	0.1	2.9	1.3	0.5	0.2	6.2	5.1	0.0	5.6	0.3	1.7	4.3	0.0	4.1	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	2.0	1.8	1.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	3.1	5.7	0.0	3.9	0.0	2.1	9.9	0.0	0.0	0.0	0.3	8.9	0.2	0.0	0.0	0.3	0.2	1.1	0.2	3.5	0.0	0.0	0.0	0.2	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	15.4	0.9	8.6	6.0	3.0	22.7	4.6	12.0	15.6	3.0	5.9	0.0	0.6	0.8	1.1	1.7	2.5	1.4	4.5	0.0	3.9	0.7	0.0	0.7	4.8	1.4	0.0	0.0	0.2	0.2	0.9	1.0	2.3	0.0	0.3	0.0	0.0	1.3	2.4	1.5	0.3	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	24.7	0.0	0.4	1.4	0.8	0.6	10.0	0.0	0.0	2.6
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell type enriched"	"Detected in some"	5	"Ito cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.4;TIME: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	9.5	5.4	23.5	1.3	26.1	2.6	8.7	13.0	32.4	3.5	2.0	2.4	0.1	5.2	3.8	3.4	2.5	2.8	1.1	4.4	21.6	2.4	2.9	5.1	5.3	2.9	2.5	18.1	1.6	7.6	7.9	1.0	1.7	2.6	1.9	1.9	0.6	8.5	3.4	3.6	3.1	6.6	1.5	2.0	12.3	1.3	3.4	6.4	0.2	4.1	1.4	2.6	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.6	2.9	0.5	0.5	0.0	0.6	0.0	0.2	0.0	0.6	1.7	0.0	1.2	0.2	1.7	0.6	0.9	0.4	0.0	0.0	0.0	6.4	0.4	1.7	1.5	0.8	0.3	1.6	1.1	0.1	0.3	0.1	2.0	0.7	0.1	0.1	0.1	0.9	0.5	0.2	1.3	0.7	1.8	1.7	0.0	0.7	0.3	0.5	1.3	1.9	1.7	0.0	0.8	0.4	0.3	0.4	10.2	0.2	1.7	0.7	0.4	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.1	13.0	32.4	21.6	2.4	2.5	18.1	2.6	6.4	0.0	1.4	0.0	0.0	0.2	0.5	19.6	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.8	16.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	5.6	0.3	0.0	2.4	90.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.4	0.7	0.0	0.0	0.9	0.2	0.4	0.3	0.0	0.0	0.0	0.3
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241263-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;cervix, uterine: 22.4"	"Group enriched"	"Detected in some"	4	"Late spermatids: 9.9;Peritubular cells: 27.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 34.1"	"Low region specificity"	"Detected in many"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	2.2	0.7	5.8	0.6	5.5	0.2	1.2	9.8	7.5	22.4	0.9	2.5	1.9	0.4	4.2	2.4	0.9	1.7	0.5	1.1	12.1	9.9	2.5	0.2	1.5	0.2	11.8	2.9	0.6	1.4	6.0	0.0	0.3	13.6	5.9	0.8	0.8	0.2	10.1	1.0	0.5	0.4	1.2	9.6	0.2	6.0	2.9	2.1	0.0	0.7	0.0	0.2	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	9.8	4.9	12.1	9.9	11.8	2.9	13.6	2.1	0.0	0.0	0.0	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	9.9	4.6	0.0	1.7	0.0	0.0	0.4	0.0	0.0	27.3	0.0	0.1	0.0	0.1	0.5	1.9	0.1	0.0	0.0	0.0	0.1
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 213.8;Proximal tubular cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		240000	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	22.6	23.0	7.3	11.4	18.6	11.6	27.0	4.8	5.9	16.1	17.8	22.8	10.1	17.6	14.3	4.1	11.7	22.4	15.2	19.3	9.2	10.5	22.2	7.9	18.0	17.2	4.7	5.2	8.6	9.7	7.6	12.5	5.6	6.5	11.0	22.7	6.6	4.0	5.7	16.7	26.1	7.3	9.1	34.5	7.5	21.4	28.9	14.9	25.6	15.4	10.0	5.3	32.6	6.2	8.2	38.7	25.4	7.5	2.6	3.1	9.3	28.4	15.1	8.2	7.8	7.1	6.1	12.4	7.4	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8	11.9	26.5	19.1	16.8	9.2	2.8	2.2	25.5	2.7	9.1	34.9	3.9	17.7	69.6	11.6	4.9	4.3	8.4	0.0	7.0	62.1	4.8	6.6	8.1	213.8	31.1	0.0	1.2	10.4	27.9	4.1	5.5	5.0	11.8	5.4	10.3	31.2	5.1	7.0	2.8	332.8	3.9	19.4	3.8	15.6	21.8	9.3	7.1	10.0	29.5	4.8
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2, leucine rich repeat scaffold protein"	Q9UQ13	10	110919547-111013667	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	22.9	13.2	22.3	17.2	32.4	31.2	18.0	24.9	25.2	19.3	16.7	8.9	12.1	12.5	17.3	17.4	19.1	14.1	15.8	14.6	19.0	24.8	20.9	18.2	16.8	20.9	22.3	20.1	21.9	15.7	26.5	33.4	17.9	17.7	18.1	17.0	9.8	13.9	14.4	21.7	15.8	24.2	25.0	23.3	23.2	13.9	26.7	17.7	29.4	21.5	9.4	23.3	23.7	17.1	16.4	11.3	34.6	13.7	9.8	9.6	11.2	11.4	7.2	9.2	15.4	21.1	21.6	5.9	14.0	20.9	13.1	15.9	6.5	10.3	24.9	7.0	25.0	8.1	9.7	11.1	10.0	19.1	13.5	6.6	11.3	11.2	6.3	15.4	19.2	20.4	23.9	15.9	15.1	28.5	17.9	13.2	8.8	7.0	17.8	18.5	6.1	9.4	15.4	5.7	6.1	7.5	13.6	18.5	7.0	13.7	7.8	4.8	9.6	12.2	6.1	13.6	11.0	31.2	16.4	13.3	10.6	9.4	13.3	9.5	16.5	16.8	39.9	12.6	19.9	7.5	20.9	12.0	16.7	7.0	13.7	8.4	16.4	8.3	8.1	11.3	13.0	8.8	8.5	34.6	9.8	13.5	8.1	9.6	11.2	22.3	32.4	24.9	25.2	19.0	24.8	22.3	20.1	17.7	17.7	50.6	40.8	46.7	30.7	49.6	25.8	74.4	40.8	61.6	47.8	29.6	15.7	18.3	54.7	41.5	33.1	58.5	52.5	46.7	51.5	19.5	32.4	33.4	70.6	59.6	26.2	28.6	25.2	48.5	70.5	69.4	60.7	61.5	47.2	51.3	31.7	24.7	51.5	29.4	76.0	48.4	31.4	71.1	53.3	95.1	56.7	61.1	50.7	52.9	26.9	47.7
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"BJ: 19.5;BJ hTERT+: 9.0"									"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9.0	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0.0	1.0	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608262-3636322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		150000	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	8.9	12.9	7.6	6.2	10.6	5.9	8.9	17.3	12.3	8.8	14.1	14.9	8.8	18.5	10.7	6.1	11.6	7.6	5.3	5.9	7.0	5.5	14.3	26.7	6.3	5.3	12.0	4.5	10.2	13.7	11.8	6.2	8.6	9.8	7.4	8.6	12.3	8.9	9.4	7.5	12.1	22.8	5.1	6.7	6.1	9.7	5.2	13.0	7.7	7.7	4.0	7.6	7.5	9.6	5.2	7.1	5.1	4.8	6.4	7.5	5.4	5.3	10.9	11.6	7.4	4.8	4.9	6.4	3.6	3.2	7.0	4.2	18.7	5.0	6.3	8.0	6.9	6.6	10.4	15.4	11.6	5.1	10.1	15.0	6.9	9.3	13.4	5.8	5.9	9.8	8.2	5.6	7.8	5.3	6.0	13.2	5.0	9.1	8.1	6.8	9.5	7.6	4.6	5.8	12.3	7.3	10.5	6.1	10.1	10.0	6.9	3.3	8.9	13.1	12.1	3.6	7.4	10.8	3.5	9.4	10.8	5.1	10.3	8.7	2.7	3.5	4.2	11.7	5.4	5.4	3.3	4.7	5.1	4.6	4.8	4.7	5.2	4.2	3.7	6.5	4.0	7.5	4.7	0.9	6.4	4.1	7.1	3.6	5.4	7.6	10.6	17.3	12.3	7.0	5.5	12.0	4.5	9.8	13.0	0.0	2.7	1.5	0.8	0.0	5.4	0.8	7.6	1.4	1.2	5.2	15.7	8.1	1.7	2.9	0.4	2.2	10.5	0.0	4.1	8.6	0.9	1.9	0.0	14.8	6.9	14.3	3.4	1.8	1.3	0.0	3.7	2.5	0.0	3.6	5.9	3.1	4.3	5.8	2.5	6.5	15.6	0.0	0.8	0.6	1.2	0.4	4.7	1.0	5.5	1.7
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.6	7.8	16.9	15.1	14.6	12.8	17.3	8.1	11.0	12.1	5.9	5.9	11.3	11.2	9.0	10.2	8.4	10.1	11.6	11.8	14.9	4.5	9.4	6.0	6.1	15.4	20.4	5.9	9.3	15.3	21.3	7.0	16.4	13.5	10.1	10.5	9.7	10.7	9.8	5.9	15.9	12.1	20.6	9.6	12.1	18.6	25.4	11.8	11.2	10.9	19.3	17.1	24.0	12.0	20.7	15.2	7.6	13.7	10.7	12.9	11.7	7.0	8.6	14.0	5.8	20.6	9.6	7.4	11.6	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0	11.9	11.9	16.4	51.3	76.1	18.3	12.0	10.2	9.4	10.3	15.7	7.9	161.7	26.6	21.4	60.8	27.0	18.8	0.0	19.9	25.3	52.6	43.7	4.6	19.5	29.5	33.4	21.7	28.8	18.3	53.9	21.0	23.2	47.2	38.7	18.3	30.7	19.2	14.4	18.4	21.1	16.5	19.4	37.1	68.6	47.5	66.1	624.0	13.4	16.7	38.7
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777243-45851736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.2;fallopian tube: 11.8"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.6	1.3	5.1	0.9	8.3	0.9	0.6	5.6	10.2	4.1	0.6	0.0	0.1	0.8	1.7	2.0	0.6	11.8	0.7	0.6	4.0	2.8	1.7	0.6	0.8	0.8	3.4	6.6	0.7	0.6	0.5	0.4	0.5	8.9	0.6	0.7	2.8	1.7	3.6	0.6	0.8	0.8	0.8	1.3	0.8	0.7	0.8	0.7	0.4	0.6	0.0	0.9	0.7	0.4	0.1	0.1	0.5	0.1	0.2	1.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	5.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.7	0.5	0.2	0.0	0.1	0.0	0.0	5.1	8.3	5.6	10.2	4.0	2.8	3.4	6.6	8.9	0.7	0.0	0.0	0.0	0.0	0.0	9.0	0.3	0.0	4.0	0.0	1.8	2.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"lymphoid tissue: 11.3;ovary: 36.6"	"Cell type enhanced"	"Detected in some"	16	"Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"HEL: 15.4"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	0.4	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1		36.6	1.1	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.3	0.1	11.3	1.8	0.5			0.0		0.0	0.3	0.0	0.6	0.5	2.6	3.3	0.8	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	15.4	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.4	0.2	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.5	1.0	2.6	0.1	3.3	0.1	0.5	0.2	0.1	0.5	0.6	0.1	0.2	1.4	0.8	3.3	0.3	0.0	0.3											0.0	1.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	6.3	0.0	0.0	8.6	19.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.1	0.0	0.0	0.0
SIGLEC15	"CD33L3, HsT1361"	ENSG00000197046	"Sialic acid binding Ig like lectin 15"	Q6ZMC9	18	45825512-45844080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 5.9"	"Cell type enhanced"	"Detected in some"	16	"Hofbauer cells: 8.2;Pancreatic endocrine cells: 2.1;Urothelial cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.9;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	40	"dendritic cells: 2.1;monocytes: 5.9"	"Group enriched"	"Detected in some"	7	"PC-3: 8.7;U-87 MG: 26.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053509			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA053509: "	"unprognostic (3.89e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.14e-5)"	1.1	0.3	0.1	4.3	0.1	0.0	3.0	0.2	0.1	2.1	0.2	0.0	0.0	1.6	0.3	0.0	0.3	0.3	3.4	1.9	0.1	0.1	0.5	1.4	2.0	0.9	0.1	0.0	0.5	0.2	0.0	0.1	1.1	0.0	1.1	0.1	0.1	0.2	0.2	0.7	0.3	2.5	3.2	0.1	3.7	0.9	0.3	0.0	1.2	0.2	0.0	2.6	4.2	0.2	0.0	2.1	0.0	5.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.9	0.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.4	0.0	0.0	0.0	26.3	0.6	0.0	0.0	5.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	8.2	1.6	0.0	1.8	1.8	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.2
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 112.3;Basal keratinocytes: 268.2;Melanocytes: 91.1;Suprabasal keratinocytes: 369.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.9;HeLa: 28.1;hTCEpi: 21.8;LHCN-M2: 21.9;U-266/84: 15.9"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.8	0.9	0.3	1.7	1.3	2.4	0.0	2.5	0.7	0.2	9.5	11.2	1.6	16.9	1.0	0.1	0.5	0.7	28.1	0.9	2.3	0.7	0.1	1.0	21.8	0.4	5.2	9.9	0.3	0.0	0.1	0.5	21.9	0.1	0.4	1.7	0.8	0.0	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	11.0	1.9	0.4	0.3	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.9	0.5	4.7	2.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0	26.8	112.3	2.4	0.6	268.2	0.2	9.3	7.6	9.4	17.0	12.2	0.0	0.5	0.0	2.8	0.0	2.2	14.2	0.0	1.8	1.0	5.2	0.4	18.5	7.8	1.7	0.0	26.6	1.8	3.7	0.0	0.0	4.0	91.1	2.8	15.1	0.5	5.0	23.0	0.0	0.0	0.1	0.0	10.8	0.0	0.5	369.5	2.1	1.3	18.6	1.0
SIK1B		ENSG00000275993	"Salt inducible kinase 1B (putative)"		21	6111134-6123739	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 19.8;Ciliated cells: 16.0;Club cells: 6.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.6;hTERT-RPE1: 38.8;Karpas-707: 39.0;LHCN-M2: 26.8;SiHa: 28.1"									"HPA038211, HPA078064"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038211: AB_2675894, HPA078064: "	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.62e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.41e-2)"	9.7	13.7	0.4	3.0	1.7	8.4	5.2	0.4	3.1	2.9	3.0	1.3	4.6	0.9	3.1	1.9	6.8	1.0	15.5	6.2	1.5		1.7	12.3	8.5	1.2	1.8	0.6	10.2	11.2	1.6	2.2	3.2	2.6	5.1	2.3	7.6	3.9	14.3	9.1	2.9	6.1	1.7	2.1	2.0	5.0	1.7	1.0	1.0	0.9	5.6	3.2	7.1	2.7	1.6	5.0	0.0	1.7	0.3	0.5	0.1	3.0	15.1	1.1	0.9	0.2	0.1	2.7	0.3	0.2	0.6	0.3	16.8	2.2	1.0	0.5	0.0	2.4	0.3	1.8	0.0	0.2	2.7	0.5	2.3	28.6	3.2	1.0	0.3	0.2	0.4	13.3	1.5	8.7	38.8	0.6	0.4	0.9	39.0	26.8	1.4	0.3	0.7	1.6	2.7	1.7	0.6	6.9	4.5	1.5	5.1	1.4	0.7	28.1	1.8	1.5	0.8	0.3	1.2	0.7	0.4	1.5	0.6	6.2	5.4	11.7	0.5	4.3	1.0	1.8	0.0	0.1	0.0	0.1	0.8	0.5	1.6	0.0	0.1	0.7	1.6	0.1	0.1	0.0	0.3	1.7	5.0	0.0	0.1											23.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	16.0	6.8	1.8	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Not detected"	"Not detected"			HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	9.0	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	13.3	0.0	0.1	0.1	0.0	8.4	1.9	0.0	0.0	0.2	3.2	23.0	0.0	0.1	0.1	28.9	17.4	0.2	0.3	8.2	0.0	0.7	0.8	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3	0.0	0.0	0.0	8.9	0.2	0.2	2.0	0.0	0.0	0.0	8.7	0.0	0.0	8.3	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.2	0.2	0.4	0.0	0.0	0.0	1.8
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 29.3;testis: 41.5"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	3.1	15.1	5.4	5.0	3.9	2.0	3.3	10.2	5.4	7.5	4.5	2.0	2.9	3.9	8.0	6.8	3.1	9.3	5.3	2.0	6.2	4.4	1.8	5.1	3.1	3.5	2.5	3.0	29.3	3.4	4.2	7.6	3.3	3.4	6.1	4.9	4.0	3.8	4.7	5.5	2.3	5.1	6.2	3.0	5.5	5.1	41.5	3.7	4.5	2.1	2.7	3.4	4.4	5.4	7.1	8.1	10.5	5.3	10.8	6.3	3.5	1.8	5.0	16.3	13.0	8.5	8.4	8.2	6.9	6.8	7.2	9.0	17.5	5.4	0.0	8.6	8.0	14.8	1.7	17.6	12.3	9.0	3.1	13.1	8.8	3.3	2.2	19.1	9.6	6.8	5.6	5.1	4.8	8.7	5.3	6.7	3.2	22.0	8.5	8.5	8.6	9.4	7.6	5.9	2.3	5.5	14.0	10.8	12.1	4.8	3.7	10.7	11.6	7.6	1.1	6.6	5.9	4.4	18.4	4.7	8.8	4.7	8.0	5.9	2.1	2.4	13.8	3.5	6.4	5.0	7.0	5.3	10.5	5.2	5.2	6.3	7.1	6.3	4.0	8.1	6.9	5.3	4.1	0.7	10.8	4.0	3.9	4.1	3.5	5.4	3.9	10.2	5.4	6.2	4.4	2.5	3.0	3.4	3.7	8.9	3.5	2.7	4.8	2.6	15.3	3.1	2.5	2.7	3.4	1.8	3.9	0.2	1.7	3.2	27.6	2.1	5.3	0.0	3.2	2.1	4.3	3.7	0.0	7.5	2.0	17.5	12.7	4.9	4.1	9.8	27.6	2.8	5.0	4.6	9.3	5.8	4.1	7.0	32.5	2.1	4.5	32.3	5.3	64.2	24.7	2.3	0.7	5.0	8.9	2.6
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829400-16880353	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	19.1	17.9	22.2	17.2	28.1	9.8	21.5	25.1	38.6	24.4	16.0	20.8	50.0	12.8	37.5	21.5	14.5	23.3	17.3	15.7	24.2	20.8	15.9	9.8	21.7	20.8	16.5	30.4	32.5	16.2	60.8	17.7	53.2	24.8	22.7	11.0	15.5	20.2	54.7	17.1	22.7	17.7	26.5	14.8	25.1	13.7	30.2	13.4	9.3	22.5	9.6	15.8	17.2	22.2	4.8	2.6	6.1	6.7	1.9	2.0	2.3	14.7	7.9	13.4	17.2	11.1	10.2	42.4	12.6	10.4	17.5	15.6	19.4	13.9	13.3	14.1	14.5	14.8	12.7	11.1	11.3	16.2	13.8	20.0	14.2	17.3	8.8	14.6	8.3	11.5	16.8	14.9	11.7	10.1	13.9	15.8	10.7	11.5	8.2	12.2	17.7	11.2	13.4	16.6	7.7	25.4	14.9	12.3	8.7	9.9	12.6	9.9	12.4	15.9	12.3	9.9	18.8	8.6	7.8	20.7	17.0	10.4	24.5	14.0	11.8	8.6	13.3	11.8	10.9	12.6	0.1	6.7	6.1	1.8	6.0	1.2	4.8	1.7	2.0	2.1	3.8	2.0	1.4	3.3	1.9	5.3	2.6	0.5	2.3	22.2	28.1	25.1	38.6	24.2	20.8	16.5	30.4	24.8	13.4	20.8	14.8	10.7	8.6	7.0	18.1	6.9	2.5	5.3	7.9	3.5	13.7	17.1	3.3	9.2	7.9	11.7	4.7	0.0	7.4	24.5	8.6	10.0	4.7	5.6	15.1	9.5	4.7	8.0	13.0	18.2	46.9	6.6	5.0	10.0	7.9	8.7	12.5	3.5	62.6	4.5	15.7	6.5	6.6	9.3	10.4	7.0	104.5	6.4	5.8	11.2
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 108.4;Club cells: 103.5;Extravillous trophoblasts: 98.9;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 83.1"	"Low region specificity"	"Detected in all"							"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	13.1	6.5	1.6	21.4	5.1	7.9	11.1	4.5	1.9	25.4	15.8	3.4	15.8	6.7	28.3	16.8	19.8	14.6	8.4	5.6	2.9	1.8	16.6	3.3	17.0	22.5	3.4	0.9	18.5	19.6	7.6	19.6	18.9	5.2	18.6	8.3	6.0	16.3	20.1	3.2	12.7	17.0	11.7	3.8	18.5	7.0	13.6	3.7	39.0	14.9	12.3	27.3	19.3	13.6	22.8	28.3	7.9	8.0	19.0	15.1	10.4	3.4	5.1	17.2	3.4	1.0	2.1	31.9	1.8	1.3	3.5	4.7	13.7	9.0	11.9	14.6	0.5	3.8	6.2	14.4	6.9	6.9	12.6	6.4	8.2	3.5	8.5	4.3	13.3	8.0	1.9	10.8	3.0	14.7	6.9	8.1	14.2	11.3	4.6	1.5	2.6	23.8	9.8	83.1	10.7	2.8	20.2	8.2	10.2	7.9	10.3	24.0	16.2	4.2	7.6	9.9	39.4	3.2	7.9	8.9	0.8	5.2	0.4	5.9	5.3	7.6	24.0	2.4	5.1	4.6	7.9	4.8	7.5	8.8	5.8	10.3	22.8	12.3	10.4	10.4	17.9	15.1	11.8	1.5	19.0	8.0	28.3	5.8	10.4	1.6	5.1	4.5	1.9	2.9	1.8	3.4	0.9	5.2	3.7	71.5	30.2	0.0	0.0	0.0	0.0	0.0	0.0	108.4	103.5	43.6	0.0	63.7	69.6	61.6	0.0	0.0	0.0	0.0	37.9	98.9	0.0	0.0	10.5	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	269.7	0.0	0.0	47.6	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 17.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	6.2	5.9	6.7	10.1	12.8	22.6	6.4	17.0	11.4	8.2	12.9	7.0	9.0	14.3	5.5	4.6	28.8	7.2	10.6	3.9	6.7	2.6	7.9	9.8	7.9	11.3	11.0	6.6	4.8	18.7	4.9	7.8	8.8	7.6	7.1	6.7	3.7	12.7	7.0	5.3	15.7	15.3	5.1	5.7	14.1	18.4	8.9	8.8	8.3	6.7	7.3	16.4	8.3	12.3	3.9	1.8	17.4	3.4	1.3	2.6	1.2	15.3	12.8	1.6	5.6	4.2	4.0	10.3	7.8	6.6	9.2	8.7	11.0	12.3	6.9	6.1	4.3	5.8	11.1	6.3	4.8	3.0	5.9	13.6	6.0	6.2	17.3	12.8	7.8	12.4	4.0	15.2	8.8	7.3	3.8	6.8	3.8	6.4	3.4	4.3	12.1	8.3	11.1	4.0	23.9	13.3	5.6	3.3	6.4	8.9	10.1	6.7	8.8	9.0	21.7	10.0	3.2	9.0	18.7	5.3	4.1	9.1	7.7	14.1	5.7	1.8	5.0	10.1	10.7	6.7	3.0	2.3	17.4	2.6	3.4	0.9	3.3	2.0	2.1	1.2	3.9	1.8	0.6	3.8	1.3	2.6	1.8	1.0	1.2	6.7	12.8	17.0	11.4	6.7	2.6	11.0	6.6	7.6	8.8	11.9	9.8	27.4	19.4	33.8	22.2	4.0	20.4	16.0	3.4	17.4	53.0	25.1	8.3	18.8	17.0	15.3	59.6	0.0	12.0	29.1	12.9	25.0	11.5	14.7	23.3	28.6	19.5	14.1	19.8	9.1	13.3	24.8	23.6	45.9	28.5	19.3	36.4	49.1	9.6	10.5	35.9	0.0	17.5	37.1	38.4	48.6	41.2	44.8	31.8	44.5
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in some"	19	"Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.9	0.2	11.9	6.9	8.1	0.1	2.0	4.5	2.3	2.0	0.0	3.8	0.0	1.1	0.4	1.1	2.7	3.9	3.6	0.8	0.0	9.5	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.8	1.6	0.3	14.3	0.1	0.7	2.6	0.0	53.4	1.3	0.0	0.2	0.0	0.0	4.8	0.0	29.2	0.0	2.3	6.5	1.1	0.1	2.3	0.1	2.4	0.2	1.4	0.2	6.8	3.2	3.2	3.7	3.0	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0	3.0	1.0	0.0	23.3	0.1	0.0	0.8	0.0	65.6	33.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.8	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.1	0.0	0.3	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	14.9
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005161-45009430	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.3;skeletal muscle: 21.0"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 2.2;Exocrine glandular cells: 1.9;Melanocytes: 1.7;Pancreatic endocrine cells: 1.2;Smooth muscle cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.9;LHCN-M2: 22.0;RH-30: 15.1;SCLC-21H: 25.8;U-2197: 16.7;U-698: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	5.8	0.2	0.2	0.2	0.4	0.1	3.4	0.5	0.4	13.3	0.4	0.2	0.0	0.1	1.1	0.8	0.8	0.1	0.1	0.8	0.1	0.0	0.4	0.1	0.3	0.2	0.9	1.8	0.3	4.6	5.7	13.5	0.3	1.4	5.2	0.1	9.3	23.3	1.3	21.0	0.3	0.1	0.4	0.8	0.1	7.4	1.1	0.0	3.9	0.7	4.0	0.8	1.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	6.3	23.9	0.0	0.1	1.1	0.4	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	2.2	3.9	0.2	0.0	1.2	0.0	7.7	0.0	0.0	0.0	2.1	1.1	0.0	4.9	0.0	0.1	0.7	0.2	0.1	0.0	22.0	0.8	0.0	1.3	0.2	0.0	4.8	0.0	15.1	0.0	0.0	1.2	25.8	0.2	3.3	0.1	0.0	0.2	0.1	1.9	0.3	0.4	1.3	16.7	0.0	0.5	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.1	0.0	0.9	1.8	1.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.1	0.6	0.0	0.0	0.0	0.1
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667062-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		3200000	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	20.8	22.5	11.5	29.4	12.9	12.8	28.5	6.0	12.8	7.7	15.3	7.6	11.0	10.5	5.2	15.4	14.0	9.4	9.6	12.6	9.5	12.1	20.4	7.8	31.6	36.4	12.0	8.9	13.3	6.1	25.1	10.9	5.3	15.5	10.2	15.0	2.5	5.8	9.8	8.3	8.6	16.5	21.1	42.6	31.8	11.7	10.1	11.5	6.4	6.1	1.9	19.3	19.3	28.1	9.9	12.3	37.3	18.0	8.3	5.1	6.7	11.7	6.2	0.6	15.5	2.9	2.4	3.8	4.8	7.2	2.4	6.0	4.9	47.4	9.1	21.1	9.0	17.5	6.3	8.5	4.9	5.0	5.1	13.7	10.0	1.8	6.5	3.9	18.4	35.4	10.6	4.6	6.9	9.5	0.4	14.4	0.0	5.3	4.7	9.4	2.2	0.0	9.3	0.5	10.5	6.1	11.9	1.5	0.7	29.3	9.2	7.7	0.2	8.7	4.7	6.3	3.7	6.5	9.7	21.0	4.0	0.1	13.3	4.9	7.5	9.5	15.9	9.5	23.9	15.2	8.2	12.6	19.4	3.7	15.0	5.1	9.9	2.1	3.0	9.6	8.0	0.5	2.9	37.3	8.3	18.0	12.3	3.5	6.7	11.5	12.9	6.0	12.8	9.5	12.1	12.0	8.9	15.5	11.5	17.9	29.9	77.3	32.3	23.6	12.3	4.7	5.1	14.7	9.1	22.7	11.8	11.1	54.7	7.9	255.1	35.8	46.2	23.3	20.3	18.4	9.5	16.9	50.9	8.3	82.6	4.8	41.3	90.9	178.5	271.4	8.3	120.8	18.6	28.9	64.6	13.0	15.8	31.6	10.3	65.3	12.7	0.0	12.0	19.9	34.3	37.9	15.6	34.8	45.4	27.2
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228695-2310119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	12.5	4.7	11.8	7.1	22.5	4.8	8.1	34.5	21.2	9.8	8.2	5.5	3.1	4.6	11.9	4.4	5.9	9.1	8.0	9.0	11.0	4.1	4.4	6.1	11.1	6.9	6.2	10.1	10.4	9.6	4.2	6.2	7.4	8.5	8.4	3.5	4.0	12.0	11.9	6.8	11.7	5.9	9.3	5.3	9.3	6.0	7.2	5.3	3.6	6.9	8.1	5.1	7.6	7.8	0.8	0.3	3.0	0.6	1.3	0.6	0.4	10.3	6.0	14.5	14.1	24.3	14.6	9.6	15.5	8.7	9.7	7.1	9.1	8.0	6.5	11.7	19.9	4.0	12.2	8.1	12.6	9.0	7.2	17.6	16.5	9.1	12.8	16.3	9.2	17.8	15.7	7.0	14.6	10.9	18.0	11.8	2.8	9.3	5.1	11.9	6.6	1.1	10.3	14.7	6.8	11.6	5.1	9.2	5.4	8.2	4.1	20.9	13.6	15.1	13.5	15.0	9.7	4.6	12.0	21.4	16.7	10.5	23.5	12.0	4.0	2.8	6.1	8.9	16.2	6.8	0.6	0.5	0.3	0.5	0.6	0.5	0.3	0.4	0.5	0.3	0.8	0.6	0.5	3.0	1.3	0.3	0.1	0.4	0.4	11.8	22.5	34.5	21.2	11.0	4.1	6.2	10.1	8.5	5.3	8.9	9.3	3.9	12.4	41.8	8.0	12.0	15.3	2.7	6.8	7.0	0.0	6.2	1.7	6.9	0.5	30.3	7.0	23.3	5.9	13.9	21.2	11.5	12.7	18.7	12.5	11.1	5.8	34.4	12.9	2.4	46.1	20.1	15.1	1.0	13.5	10.3	9.7	9.3	51.9	5.0	4.4	45.3	30.6	2.6	13.4	39.4	13.6	13.8	9.3	8.4
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	16.2	15.0	10.5	21.1	14.7	22.8	12.4	5.0	18.2	14.0	11.8	12.2	13.4	15.9	17.1	12.7	14.4	12.0	26.8	21.7	11.2	11.4	15.0	18.0	23.8	15.2	11.6	10.6	17.8	11.4	9.6	21.1	26.6	16.0	15.8	11.7	14.8	14.2	17.0	19.5	10.3	28.0	13.5	17.3	12.6	17.9	14.4	8.3	14.0	18.9	13.5	21.1	15.3	16.3	5.7	2.9	5.4	11.3	3.2	2.6	2.3	8.3	10.3	6.9	4.4	8.9	3.9	12.7	8.4	5.8	5.8	4.6	2.1	18.1	10.4	27.0	7.6	9.9	19.2	4.2	3.9	9.3	17.9	4.1	13.8	10.0	4.5	7.7	5.8	7.6	6.7	3.8	8.5	6.6	19.4	14.7	1.0	6.1	11.7	12.2	8.9	2.4	1.8	26.9	9.3	3.6	5.7	23.2	2.1	8.8	13.2	5.1	6.3	20.9	21.3	4.4	14.6	14.2	6.3	28.1	16.9	15.8	14.3	15.6	15.7	7.3	19.9	6.4	3.0	7.8	3.4	4.3	2.0	1.6	9.8	2.3	4.6	1.4	2.1	2.9	5.7	2.5	2.6	5.4	3.2	11.3	2.0	0.5	2.3	10.5	14.7	5.0	18.2	11.2	11.4	11.6	10.6	16.0	8.3	68.5	62.7	31.1	75.8	64.6	24.9	9.5	10.2	92.3	77.3	33.2	51.1	7.8	13.3	46.2	69.5	57.1	35.2	0.0	98.8	47.2	82.2	47.0	200.8	27.0	26.1	50.9	22.8	70.6	59.0	24.0	35.1	68.2	33.7	39.7	42.7	11.8	128.3	18.2	64.0	35.6	30.1	25.8	66.2	51.9	26.9	83.9	34.4	25.5	13.8	127.8
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134177038	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		600000	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	63.7	90.2	101.8	35.1	113.6	59.2	110.3	109.3	152.1	94.0	70.5	78.8	55.7	43.6	73.9	99.3	72.9	84.5	64.4	116.0	112.7	100.7	113.8	83.5	52.8	52.3	109.9	121.7	98.4	44.6	116.8	81.4	83.1	114.2	84.8	69.1	68.5	54.7	113.4	141.7	59.9	55.2	82.3	106.3	47.0	58.8	69.3	79.7	57.5	108.0	82.1	60.9	71.8	58.2	113.5	78.4	136.3	90.7	96.4	157.1	209.1	67.3	52.7	78.5	105.5	121.7	99.4	56.0	78.6	100.0	92.4	95.7	80.8	65.8	49.9	118.0	105.9	105.7	37.7	78.4	118.8	107.7	45.6	55.5	39.3	82.7	57.4	57.4	30.2	48.9	85.0	95.8	80.9	64.1	115.4	98.7	64.7	47.4	44.1	138.1	53.3	65.0	32.4	45.5	64.4	56.7	36.0	84.0	61.1	103.1	75.9	64.3	50.4	106.6	27.3	71.7	106.8	79.0	47.3	74.1	59.7	37.1	62.3	79.6	27.5	45.7	74.2	83.1	57.9	64.6	132.3	83.2	136.3	91.3	78.3	102.0	113.5	131.3	111.8	78.4	99.8	157.1	123.5	78.0	96.4	90.7	69.6	130.2	209.1	101.8	113.6	109.3	152.1	112.7	100.7	109.9	121.7	114.2	79.7	265.0	270.4	263.0	830.1	598.8	220.4	653.1	438.2	570.2	337.8	563.5	68.7	766.8	1437.4	561.3	416.1	363.7	459.0	490.6	329.5	626.8	509.6	661.6	327.0	354.9	416.6	211.4	341.7	300.8	284.1	774.4	556.9	378.1	681.6	669.9	301.7	518.2	333.4	550.6	670.0	1023.7	167.2	498.0	623.8	684.9	643.7	564.2	1126.5	371.9	336.9	686.2
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36184319	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 75.1;RH-30: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	6.5	6.9	7.8	8.0	7.5	12.9	6.5	11.5	9.0	7.5	7.7	10.3	3.7	10.2	9.9	6.3	13.5	8.1	4.9	4.1	7.3	5.1	4.2	14.0	5.8	9.4	8.8	7.4	7.7	6.1	3.9	12.5	49.1	6.5	7.2	9.5	6.1	6.3	5.4	3.4	7.6	7.7	6.4	7.4	9.4	5.3	3.9	7.4	19.5	5.0	7.5	11.7	7.9	8.4	6.5	16.0	14.7	7.9	7.7	8.5	5.0	7.6	3.8	16.2	18.0	3.9	6.4	75.1	9.9	7.5	25.4	19.2	21.0	6.0	11.0	2.7	8.0	4.6	8.0	18.0	12.5	27.3	4.9	10.4	6.4	14.1	9.9	1.9	14.2	2.9	5.8	3.3	4.6	3.2	2.6	7.0	9.9	11.0	2.5	9.1	3.7	16.5	8.2	14.7	7.5	5.8	16.3	94.3	7.0	1.8	8.0	13.9	16.6	31.0	6.8	4.3	12.4	6.8	8.0	3.2	9.5	11.0	3.5	6.8	3.2	3.0	13.6	4.3	17.5	6.8	10.3	7.9	14.7	5.4	7.2	8.5	5.6	5.7	5.8	16.0	6.5	7.9	6.0	1.5	7.7	4.1	4.3	5.3	5.0	7.8	7.5	11.5	9.0	7.3	5.1	8.8	7.4	6.5	7.4	20.8	9.9	6.7	3.2	3.3	7.4	1.1	2.5	6.7	0.0	1.8	9.8	117.2	1.7	2.4	0.4	3.6	2.3	0.0	2.6	184.7	4.7	0.7	2.3	8.6	29.3	0.0	2.9	1.3	9.2	0.0	3.7	2.6	1.7	7.2	3.6	2.3	2.6	3.5	6.0	1.1	6.8	0.0	2.3	0.7	4.0	3.4	70.1	6.4	7.4	0.9
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"kidney: 143.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 177.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.9"	"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.0	0.0	0.3	0.0	1.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	143.2	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.0	0.3	1.0	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	36.6	0.0	0.0	177.4	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 30.1;SK-BR-3: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	30.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	6.8	0.0	0.0	0.0	1.7	1.7	0.6	0.1	0.3	0.0	29.9	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.4	30.6	1.4	2.3	1.8	0.0	0.0	1.7	9.1	0.0	0.0	51.2	0.0	0.7	0.0	0.0	0.8	0.0	29.9	0.1	0.0	3.5	0.6	0.3	0.0	0.0	0.0	1.7	0.0	1.7	0.0	2.9	5.8	0.0	9.8	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	1.7	0.3
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596067-59789855	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.5"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	10.0	2.2	9.2	4.3	4.5	9.2	6.4	8.3	5.4	4.8	1.1	1.1	2.2	8.6	2.7	12.3	4.4	8.9	34.7	2.0	1.9	16.4	5.7	9.4	12.1	3.2	3.3	4.7	13.7	2.2	9.5	2.1	5.5	3.8	3.7	2.7	6.2	2.6	4.2	9.4	4.6	10.5	3.7	16.8	12.8	6.2	2.3	12.8	4.0	8.6	9.4	9.7	8.5	5.8	2.8	0.3	9.1	3.0	7.2	2.4	0.1	2.3	0.5	0.3	10.7	16.3	0.1	9.9	6.4	3.4	3.1	0.2	5.9	5.1	2.3	16.7	3.2	0.5	0.6	1.2	5.2	1.4	0.3	9.2	10.4	0.3	5.6	14.9	0.1	8.4	3.2	0.9	9.8	6.1	1.2	6.2	0.1	11.2	5.5	2.1	4.3	2.2	0.6	1.0	3.1	0.3	0.0	2.4	7.6	14.4	2.6	0.6	0.0	0.2	4.7	0.6	0.3	1.8	0.0	8.1	2.7	14.8	0.3	10.8	0.1	8.6	9.3	0.0	1.3	0.3	2.0	0.0	5.4	3.7	7.2	2.4	4.3	4.8	2.1	5.8	4.9	6.9	0.2	3.0	9.1	2.8	4.8	2.4	2.2	4.3	6.4	8.3	2.0	1.9	3.2	3.3	5.5	2.3	26.8	21.3	14.7	5.7	9.0	23.7	116.7	104.4	24.1	15.9	43.6	9.8	0.2	19.9	46.2	85.1	7.1	0.7	0.0	57.0	0.2	12.5	1.9	9.3	10.5	3.0	7.9	0.0	11.1	27.7	90.6	6.4	8.4	3.3	1.8	24.4	1.3	30.7	0.0	9.6	1.0	5.3	6.5	16.0	4.1	3.0	11.0	0.6	20.8	0.9	2.8
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 218.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0.0	16.4	1.6	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.9	0.1	0.3	0.0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5	0.0	0.0	0.0	1.1	0.1	4.7	2.8	0.0	4.0	9.1	7.0	0.0	0.0	21.6	0.7	0.1	0.0	17.7	0.0	0.0	0.8	1.2	12.7	0.0	0.0	0.1	3.2	19.3	0.0	10.5	0.4	12.7	0.0	3.3	1.0	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0.0	2.8	0.3	0.1	0.1	0.0	0.0	12.8	5.7
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 6.7;Proximal tubular cells: 8.9"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 9.0;U-266/70: 6.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	4.0	2.2	0.8	2.2	0.6	0.4	1.3	2.4	1.6	0.5	0.8	1.5	0.1	3.2	0.7	0.3	0.6	1.9	1.8	2.1	1.9	0.2	0.7	0.2	0.9	0.7	9.0	0.9	2.9	3.6	1.2	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.8	0.2	0.5	0.6	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.4	1.1	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.6	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	2.0	1.1	1.3	0.8	0.3	2.5	0.0	0.0	1.8	0.0	0.2	1.7	0.2	0.0	0.7	6.7	0.0	0.0	0.1	0.6	1.4	0.0	0.5	0.2	0.0	1.7	0.6	0.3	0.0	1.4	0.4	1.7	1.0	2.8	1.9	0.2	3.1	1.1	8.9	0.1	0.0	0.8	0.0	0.1	1.4	0.3	0.0	1.6	0.7
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.4;SK-BR-3: 38.8"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.2	26.4	2.5	12.6	0.9	0.7	5.0	6.0	2.0	7.8	5.9	16.0	6.1	6.4	4.7	1.4	3.8	9.2	3.6	6.3	1.4	4.7	20.4	5.2	16.1	50.4	1.1	11.7	6.4	0.5	3.3	5.5	1.1	1.5	4.5	9.1	8.7	8.1	2.6	26.8	17.1	12.4	2.6	6.0	19.9	13.0	5.4	20.2	6.9	12.9	16.7	11.3	5.7	38.8	1.3	0.7	16.6	6.5	1.9	6.0	19.8	8.7	11.0	5.0	2.5	3.7	2.6	12.4	5.2	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5	0.0	2.1	0.0	5.5	0.0	2.9	3.3	17.8	13.4	5.7	14.0	0.0	11.3	21.6	15.4	23.8	0.5	9.3	0.0	20.3	4.7	0.9	3.9	0.0	37.7	6.8	0.0	4.7	3.1	0.3	65.6	2.0	0.3	0.0	1.0	15.4	1.5	9.6	24.6	1.8	75.1	3.8	0.0	0.2	8.4	2.3	0.0	3.5	1.5	28.8	4.3
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;BEWO: 12.9"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.5	0.9	3.4	0.6	5.7	0.0	12.9	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.0	3.7	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.4	0.0	0.6	0.1	0.8	2.9	1.3	2.1	4.2	1.2	0.0	0.1	0.6	1.2	0.5	0.4	0.6	1.0	2.6	3.7	1.4	0.2	0.2	0.5	0.3	0.4	1.4	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6	26.8	15.9	0.0	0.2	0.0	0.5	1.4	0.0	28.1	12.5	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.5	4.6	5.8	67.6	0.2	0.0	0.0	2.5	4.6	0.6	0.9	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.6	3.2	0.0	0.0	2.7	4.8	0.1	1.5	0.0	0.0	0.1
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.4	15.2	8.9	8.0	3.8	6.8	8.4	11.2	9.4	12.5	7.9	15.0	16.1	7.0	8.4	9.3	14.2	20.8	9.8	13.5	2.8	13.2	18.1	6.4	7.5	9.2	16.2	10.4	10.9	6.8	8.2	9.5	10.2	3.9	5.7	8.3	13.1	11.1	5.5	14.2	10.8	9.8	19.3	14.5	23.4	12.8	4.9	16.6	7.4	3.9	44.3	19.9	6.4	15.5	8.0	1.4	7.5	5.3	5.6	14.0	9.4	6.4	10.5	9.7	5.7	9.0	16.8	9.3	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6	6.0	10.4	2.2	6.3	11.2	147.0	1.8	5.1	2.7	4.5	8.7	31.4	5.9	3.3	22.2	11.5	4.9	7.0	0.0	17.0	8.9	7.4	13.6	2.3	15.3	4.0	41.3	12.5	1.8	1.8	5.6	4.4	2.6	3.3	6.4	7.3	13.4	14.1	7.0	4.6	5.6	29.9	0.0	6.1	1.4	6.3	11.7	2.6	5.2	5.0	8.1
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 32.2;T-cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.7	0.2	6.9	1.3	0.6	3.5	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	1.8	0.6	0.5	0.3	0.0	13.8	1.0	4.5	2.5	0.3	0.8	1.4	4.8	1.6	0.1	0.5	0.4	0.4	0.7	8.0	0.6	18.7	0.7	1.5	3.3	0.1	0.3	0.2	2.2	6.1	0.9	13.6	0.7	0.0	2.3	3.1	1.4	3.7	0.7	0.4	1.9	0.7	1.3	0.5	1.8	4.5	0.3	7.8	4.9	1.2	1.4	1.0	2.7	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0	0.0	3.5	32.2	5.2	2.5	9.0	5.5	10.2	17.4	4.5	12.2	0.0	1.4	0.0	4.9	5.2	2.9	23.9	0.0	4.7	1.0	3.3	7.8	4.6	12.1	6.3	6.4	6.4	7.4	7.0	3.3	6.4	13.8	5.0	18.0	12.9	7.7	4.3	8.6	3.5	6.2	0.3	6.5	2.5	2.3	0.2	1.8	1.3	35.9	7.4	3.5
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041015: AB_2677252"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.5	16.7	14.3	9.1	12.4	4.2	5.1	0.3	16.0	0.0	6.9	16.5	0.0	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	4.9	1.7	0.0	0.1	0.0	7.2	16.6	0.0	0.4	1.7	20.0	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	3.5	2.3	3.7	1.0	9.1	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0	6.0	4.6	0.0	6.8	0.6	0.0	2.2	10.2	33.5	11.4	1.8	0.0	1.9	0.0	5.2	0.1	4.1	2.2	0.0	4.9	12.8	11.7	28.1	5.8	41.2	0.9	0.0	3.5	9.2	2.8	0.9	24.5	0.3	1.7	0.0	60.1	5.6	5.1	2.9	16.3	0.7	0.5	12.9	3.9	0.4	0.2	0.9	1.7	0.0	6.6	10.2
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.0"									"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.6	3.4	0.7	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	1.6	2.2	3.2	0.9	0.9	2.3	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	8.4	0.7	2.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	1.7	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.3	0.8	12.0	2.7	2.1	6.2	0.8	0.5	0.7	1.2	0.7	0.8	7.1	1.9	3.3	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2	17.9	12.9	16.6	8.2	2.9	57.0	29.0	7.6	8.1	4.5	24.4	280.8	7.0	11.6	4.7	5.9	3.3	3.4	0.0	4.9	7.6	4.5	8.0	2.3	5.8	5.2	35.0	10.4	4.9	3.1	8.5	8.6	4.2	3.3	2.8	4.9	15.4	3.5	2.9	9.2	20.7	194.1	0.0	6.2	3.9	5.1	2.8	16.7	7.5	7.3	5.4
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093646-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	19.4	22.1	14.4	19.4	15.7	13.3	29.7	14.9	18.5	25.0	20.9	13.2	33.7	19.7	24.3	32.4	20.5	20.3	23.5	25.4	14.5	15.4	28.6	39.2	24.3	23.7	15.5	13.1	25.4	50.5	29.6	38.1	34.3	13.9	24.5	19.8	17.6	36.8	35.3	17.1	21.2	25.0	18.1	13.2	20.1	20.3	18.1	12.7	22.1	33.5	18.8	19.6	18.2	28.9	8.3	13.2	12.4	6.9	5.6	9.1	3.3	15.7	12.2	11.4	20.0	30.1	23.2	36.2	25.0	22.7	15.8	24.2	11.2	19.8	20.9	31.9	17.0	27.7	17.0	15.8	18.9	26.8	24.9	18.2	23.3	15.4	18.3	24.2	14.6	26.0	15.6	25.1	16.2	19.4	22.2	15.3	14.5	14.0	25.0	20.1	19.9	19.2	30.4	12.9	10.7	14.0	15.4	14.5	37.7	23.6	14.8	20.4	16.2	19.8	19.9	33.9	16.6	19.2	32.5	13.9	10.3	13.4	25.7	24.7	22.7	27.9	16.3	20.3	26.6	25.4	12.4	6.7	10.7	6.1	6.8	6.5	8.3	9.1	8.9	8.4	6.3	8.4	7.1	5.9	5.6	6.9	13.2	6.1	3.3	14.4	15.7	14.9	18.5	14.5	15.4	15.5	13.1	13.9	12.7	17.9	15.5	9.0	22.6	16.7	13.9	26.2	12.7	14.7	14.8	24.4	21.6	35.4	24.9	18.8	5.2	16.6	12.3	23.3	23.5	60.9	24.0	28.7	41.4	17.4	19.6	7.9	12.7	19.0	17.3	6.7	22.5	16.4	13.5	12.6	24.9	13.4	17.8	21.0	20.8	16.1	22.6	25.8	20.9	9.9	14.9	18.7	43.1	20.3	21.7	24.2
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564456-140569103	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	22.0	30.4	12.3	18.6	17.1	8.4	19.6	14.0	21.8	18.2	25.5	24.9	22.6	19.2	18.2	19.8	30.3	20.6	26.0	25.7	13.1	10.3	35.1	39.2	23.1	22.5	16.0	11.1	19.0	28.3	28.2	14.9	24.6	19.4	20.4	26.5	20.5	32.6	15.9	54.3	28.3	30.6	19.8	13.0	28.5	21.7	30.5	15.3	26.0	29.2	28.0	27.5	18.3	18.0	15.4	32.8	15.8	36.9	26.9	27.6	32.4	15.5	46.7	18.7	35.2	25.7	16.1	27.9	22.7	15.3	27.7	29.2	56.5	18.0	46.0	28.1	21.3	32.3	17.2	0.0	33.1	23.8	55.9	25.6	34.4	45.6	0.2	18.3	33.6	26.0	21.3	25.9	27.5	24.7	13.0	23.7	22.8	26.6	46.5	27.4	28.8	35.0	14.6	12.7	22.4	23.9	26.1	37.9	39.9	20.7	30.8	20.9	27.9	28.7	47.8	22.3	19.2	39.7	14.4	27.7	24.9	17.4	24.7	25.4	19.3	45.3	19.3	18.4	38.0	28.9	7.5	26.9	15.8	27.6	36.9	26.3	14.3	22.1	24.7	32.8	15.4	25.9	23.0	9.9	26.9	33.3	12.0	14.7	32.4	12.3	17.1	14.0	21.8	13.1	10.3	16.0	11.1	19.4	15.3	11.9	24.8	21.9	20.2	9.3	12.2	23.8	43.3	6.7	17.0	15.7	3.9	26.8	38.1	28.1	58.7	14.7	37.1	0.0	30.4	42.8	19.5	22.2	20.7	19.5	28.5	12.7	24.2	27.6	21.1	94.4	11.5	15.8	16.9	31.5	27.2	20.3	31.1	21.0	11.7	31.1	8.5	32.3	12.6	5.4	16.4	10.2	25.5	20.3	28.7	29.1
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	16.8	25.9	19.4	26.7	24.0	25.6	17.5	30.3	25.0	19.1	19.3	22.8	21.3	22.0	19.2	20.9	23.4	24.3	20.2	13.5	19.0	12.9	20.7	26.7	17.4	22.9	19.9	13.6	21.0	30.5	18.0	23.7	29.8	17.7	23.6	12.2	28.9	30.9	17.3	13.4	25.6	20.7	15.8	19.3	26.1	21.6	19.6	23.3	19.7	23.0	13.5	23.4	19.1	19.3	17.4	42.9	26.8	21.9	18.3	28.3	23.5	14.3	17.4	8.1	6.4	11.3	10.9	15.0	7.8	14.9	8.8	10.5	24.3	22.9	9.6	26.8	9.3	11.9	20.3	4.6	17.7	3.3	7.8	13.6	8.5	10.6	19.4	21.5	11.0	10.1	15.7	22.7	12.5	14.6	9.7	7.3	10.6	13.3	17.7	6.5	34.8	7.8	16.5	10.5	15.4	16.9	7.3	8.7	18.6	11.1	14.2	12.0	16.6	7.3	38.1	24.4	5.2	22.5	19.3	7.0	22.7	14.5	11.4	12.4	23.7	19.4	9.9	25.7	12.6	10.1	19.0	21.9	26.8	23.8	21.5	22.2	17.4	24.4	24.0	23.9	16.9	28.3	25.5	19.5	18.3	16.7	42.9	22.1	23.5	19.4	24.0	30.3	25.0	19.0	12.9	19.9	13.6	17.7	23.3	14.9	15.5	28.6	25.7	12.8	31.2	5.9	17.8	12.0	18.2	26.2	39.3	80.2	11.6	34.0	4.6	13.5	26.5	0.0	53.8	43.9	23.9	32.4	14.9	23.7	33.9	17.5	20.2	28.3	19.1	4.3	17.8	17.0	20.3	45.1	31.2	21.9	31.3	30.6	18.0	15.4	29.4	19.4	14.4	15.6	21.0	14.4	66.2	25.9	27.7	28.5
SLC35E2	KIAA0447	ENSG00000215790	"Solute carrier family 35 member E2"	P0CK97	1	1724838-1745999	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006118, HPA062711"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA006118: , HPA062711: AB_2684844"	"unprognostic (3.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-4)"	"unprognostic (9.52e-4)"	"unprognostic (6.57e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.87e-4)"	3.0	4.1	8.0	5.2	5.1	0.6	3.0	9.8	6.2	4.0	3.0	2.9	1.6	4.9	6.0	10.5	4.5	5.8	7.6	3.0	5.0	3.5	2.5	2.4	4.8	11.6	4.4	4.7	5.5	3.5	6.9	5.9	3.5	4.0	3.6	5.4	3.6	9.1	1.6	4.7	6.4	4.8	3.7	3.7	6.8	6.2	6.2	5.5	5.5	3.5	3.8	4.3	4.3	7.7	5.0	5.2	6.4	3.4	3.1	6.5	3.2	1.6	1.6	5.4	11.5	11.2	11.0	3.6	7.4	15.3	7.0	9.0	4.6	15.1	4.9	1.3	1.7	1.7	7.5	1.4	2.9	7.6	6.8	1.7	6.4	7.5	1.2	2.3	1.3	7.2	8.8	3.7	1.2	6.3	5.8	2.1	9.2	2.1	2.2	1.3	1.2	1.9	3.2	1.0	0.9	1.9	3.7	5.0	1.0	7.4	5.3	15.2	3.1	2.2	9.2	8.8	1.3	17.9	3.6	9.6	7.3	1.5	2.2	0.4	3.0	0.4	1.6	5.2	3.9	1.2	6.4	3.4	2.1	5.5	2.6	6.5	4.5	4.8	5.3	1.5	5.0	5.5	4.8	4.0	3.1	1.6	5.2	4.5	3.2	8.0	5.1	9.8	6.2	5.0	3.5	4.4	4.7	4.0	5.5	26.8	22.1	0.0	0.5	0.5	5.1	0.0	2.5	10.7	11.4	0.0	2.0	0.8	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.4	1.0	0.4	2.3	0.8	0.6	12.7	0.0	1.8	0.6	0.0	2.8	0.3	0.0	0.0	0.7	1.2	0.0	0.0	3.2	0.0	3.9	0.0	0.0	0.7	1.3	1.5	0.2	4.9	1.2	0.4
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"CACO-2: 22.8;Hep G2: 32.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	22.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	2.2	0.0	0.6	0.6	0.2	12.7	0.0	0.0	3.5	110.0	0.0	16.6	0.3	0.4	0.1	260.0	0.0	17.7	0.0	0.1	0.1	0.0	140.6	0.1	0.0	24.3	2.5	1.3	0.0	0.0	0.0	0.0	1.0	92.0	0.5	12.1	142.5	0.0	149.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	142.6	0.0
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 652.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 132.2;SiHa: 134.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		210000000	"Plasma membrane"	Nucleoplasm	"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.4	69.3	7.1	22.0	8.6	6.9	65.6	28.6	11.0	15.0	13.3	66.2	31.2	18.1	31.8	16.8	28.7	57.0	12.9	56.2	8.0	32.9	12.2	13.0	50.5	29.2	79.9	15.2	19.0	15.1	132.2	18.3	56.1	5.5	8.7	39.4	25.0	40.1	9.2	79.2	15.6	19.4	11.8	20.5	23.5	16.2	10.7	35.4	10.5	9.2	12.1	5.8	134.7	50.5	97.2	12.0	18.1	19.9	16.0	15.3	22.8	22.4	20.1	49.9	55.3	57.4	15.0	23.9	43.6	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8	44.7	40.7	54.9	229.6	193.7	59.3	10.9	20.4	36.1	40.9	47.1	62.8	187.9	28.2	148.4	23.7	94.0	85.3	93.5	129.2	134.7	88.4	145.6	82.0	22.5	178.6	50.9	80.9	70.6	47.5	19.5	28.1	97.7	212.6	153.3	33.1	212.1	128.6	31.6	28.7	161.8	52.2	6.5	137.2	12.6	29.8	131.6	652.9	75.6	40.7	193.5
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Group enriched"	"Detected in many"	11	"Glandular cells: 50.8;granulocytes: 117.6"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 141.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.5	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.5	0.2	0.5	0.0	0.6	0.4	4.7	0.1	0.3	0.3	0.8	141.5	0.0	0.1	0.3	0.0	0.3	1.6	0.7	0.7	0.2	0.2	0.3	0.1	1.3	2.0	2.7	1.7	0.1	0.7	0.2	0.6	2.2	0.2	0.5	0.2	3.5	0.6	0.4	0.8	0.2	1.5	0.2	1.6	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1	0.0	5.6	1.3	1.1	0.0	0.2	1.7	5.1	2.7	1.2	1.8	0.0	0.4	0.0	1.8	0.1	0.6	3.4	0.0	0.5	0.1	0.6	50.8	117.6	4.9	2.0	0.0	0.0	0.0	0.6	0.0	1.7	0.9	0.0	1.0	7.4	0.2	2.4	7.0	1.4	1.8	0.0	6.5	1.0	0.0	1.5	0.1	0.0	0.0	4.4	0.8
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 106.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 36.0;Hep G2: 21.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.4	7.8	0.9	4.1	2.7	0.7	11.1	2.7	1.7	1.4	0.8	0.5	7.2	0.0	3.2	0.9	3.4	36.0	4.2	8.5	0.2	0.0	1.7	0.3	3.4	21.0	1.7	1.9	7.0	0.3	3.5	1.7	1.6	1.2	3.6	5.0	0.7	5.0	1.4	3.5	0.2	0.2	6.2	6.7	10.6	1.2	5.3	1.7	8.7	15.3	0.4	2.5	1.4	9.0	0.2	2.9	3.4	3.4	6.1	1.1	3.7	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2	0.0	0.0	0.0	1.7	0.7	0.1	1.2	0.0	5.3	2.3	106.4	0.0	0.0	0.0	0.7	3.5	0.3	0.0	0.0	0.4	0.1	0.3	2.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	1.5	0.0	0.0	0.0	1.0	0.1	0.0	2.2	0.6	0.4	0.3	0.0	25.8	0.5	0.6	5.2	0.4	0.0	0.0	0.0	2.6
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Predicted membrane proteins"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.0;intestine: 21.8"	"Group enriched"	"Detected in some"	4	"Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 18.9;Karpas-707: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.6	0.6	4.3	0.6	21.8	0.5	2.8	1.9	11.2	0.6	1.7	29.7	0.0	10.9	0.6	0.5	0.5	0.6	1.4	0.7	12.1	7.4	9.9	1.0	0.6	0.7	48.0	2.4	0.6	0.5	0.5	0.2	0.5	18.3	0.6	0.8	0.0	0.6	0.8	0.7	0.5	21.8	0.5	34.7	0.6	0.6	0.8	22.9	0.0	0.6	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	21.8	1.9	8.0	12.1	7.4	48.0	2.4	18.3	22.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	5.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 145.9"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0.0	0.6	0.1	1.1	2.0	0.3	1.7	0.2	0.0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.5	0.0	0.1	8.3	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.3	0.0	145.9	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	12.7	0.0	2.1	0.0	0.0	0.2	0.2	0.0	14.6	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.8	4.4	3.7	0.1	0.0	0.1	4.8	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2	0.0	0.0	0.0	0.2	1.1	7.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	21.8	0.3	0.0	6.3	0.0	1.3	0.0	0.0	0.2	1.5	3.1	0.8	0.0	0.0	1.5
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 26.6;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.9;hTCEpi: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.3	5.5	2.7	7.0	4.4	1.5	6.2	5.9	15.9	9.6	11.9	1.8	2.9	0.1	0.6	16.3	0.0	23.9	4.2	4.7	1.9	0.0	0.7	6.5	13.1	2.1	20.2	1.4	0.3	4.5	41.9	4.7	11.2	6.0	0.2	4.7	5.0	18.8	0.4	4.0	1.0	0.0	2.1	2.8	7.4	0.8	0.0	8.4	0.9	0.8	1.7	1.6	3.0	13.7	2.7	0.7	3.6	3.9	0.1	1.1	4.5	0.9	3.0	20.8	14.3	1.6	3.6	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3	0.0	1.3	0.9	0.7	6.6	26.6	0.6	5.1	8.1	0.0	1.8	15.7	0.4	0.0	3.2	5.8	0.4	9.8	70.0	7.9	0.7	0.9	1.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.4	1.4	0.0	3.3	1.8	2.9	1.2	4.2	2.0	1.4	1.0	10.2	6.5	6.3	0.0	0.4	11.3	0.5	0.0	1.3	2.5
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 1.8;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0
SLC7A6OS	FLJ13291	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	19.8	14.1	15.7	16.1	20.0	20.1	17.4	29.1	18.2	13.2	13.1	20.2	10.9	13.9	15.5	18.0	12.4	13.4	10.7	16.5	14.6	11.7	13.4	9.3	13.8	24.7	19.8	14.2	17.0	14.7	18.8	13.1	15.9	18.1	13.4	13.4	14.2	14.1	15.0	24.5	15.5	16.3	12.3	17.4	20.3	13.7	12.2	24.5	17.0	15.7	8.7	19.8	14.0	21.6	13.3	11.2	21.8	13.3	12.7	14.9	10.6	8.1	8.4	12.3	9.2	7.2	9.9	14.1	10.3	6.0	12.3	10.9	21.2	11.8	14.3	9.5	6.9	7.8	14.8	11.5	8.8	11.2	5.3	7.0	9.5	13.3	17.4	9.3	13.4	10.4	7.6	9.8	10.1	16.4	11.0	9.2	12.4	14.6	6.4	11.2	12.2	17.3	13.6	8.8	9.4	7.2	20.5	7.6	17.5	7.8	10.8	13.0	9.5	19.8	4.6	11.6	10.0	12.4	12.4	13.5	9.9	8.5	9.6	8.2	15.9	12.8	21.3	10.2	16.2	10.1	21.5	11.4	21.8	13.4	13.3	14.9	13.1	13.4	12.0	8.7	13.3	14.5	11.4	10.3	12.7	10.8	11.2	13.3	10.6	15.7	20.0	29.1	18.2	14.6	11.7	19.8	14.2	18.1	24.5	8.9	4.6	16.6	10.7	8.1	22.0	0.8	12.7	14.7	6.8	12.2	33.4	19.6	14.9	11.0	2.5	10.8	7.4	0.0	9.8	9.6	8.7	9.1	13.9	5.8	18.3	15.9	13.3	11.6	16.3	1.3	14.7	10.8	11.8	21.6	7.5	26.5	13.1	7.0	15.2	6.9	22.8	0.0	9.5	12.5	18.9	5.8	18.4	20.2	8.8	12.3
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 601.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0.0	15.4	6.0	5.1	3.3	0.0	2.5	0.0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.9	10.9	2.3	0.4	0.0	0.0	0.2	6.5	0.0	0.4	0.0	0.8	0.1	2.1	4.1	8.1	0.0	1.8	0.2	1.7	0.3	0.0	0.0	0.0	5.6	0.0	0.3	5.2	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3.0	3.2	2.9	0.0	1.1	50.8	601.5	2.5	0.0	1.2	33.2	3.9	0.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	1.4	4.8	0.1	0.0	0.0	28.3	0.0	0.0	20.3	56.6	0.7	0.0	46.7	1.7	1.0	0.6	35.9	0.1	0.0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0.0	0.0	0.0
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 24.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;OE19: 11.4;RT4: 7.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Not detected"	"Not detected"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.4	0.1	2.4	0.0	0.3	0.3	0.0	0.0	0.0	3.9	0.1	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.1	0.1	1.1	11.4	0.4	0.2	0.5	0.3	0.0	7.1	0.2	0.2	0.1	0.4	0.0	0.3	0.2	0.1	0.5	0.4	1.1	0.7	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	3.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	2.7	1.2	24.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.5	15.7	13.1	0.0	12.0	4.8	2.0	1.9	1.3	1.7	16.9	2.1	13.9	2.7	0.8	7.1	5.0	2.8	14.8	4.9	16.9	4.2	12.2	8.4	11.8	5.3	11.5	6.8	4.2	14.7	6.7	8.6	4.8	5.7	12.4	6.2	1.0	9.5	7.3	2.4	0.0	3.8	0.0	3.4	7.4	5.8	1.0	10.8	9.7	5.4	1.4	3.5	0.9	1.5	7.9	10.5	4.5	2.7	7.0	4.1	10.6	7.6	12.3	5.3	10.4	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7	0.0	0.3	6.5	2.6	4.2	8.9	2.4	7.6	0.0	1.2	0.0	25.5	0.3	0.0	5.5	10.6	8.7	0.0	0.0	60.7	2.0	8.8	2.0	1.1	33.1	1.3	7.9	2.9	4.3	1.5	5.0	5.2	2.3	10.1	6.4	0.6	0.6	60.5	0.0	4.9	1.0	2.0	6.5	10.5	1.8	4.3	3.3	0.2	4.6	0.0	0.9
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912569-100965136	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 100.1;Peritubular cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.8	20.2	19.5	17.1	26.6	12.1	11.3	21.4	21.4	12.2	10.7	22.0	13.0	9.4	20.9	56.1	9.4	17.3	9.6	11.6	17.8	14.2	10.9	10.2	11.6	15.6	29.4	17.3	29.4	12.3	11.6	26.8	17.4	18.3	14.5	12.1	7.8	10.3	16.0	17.9	15.1	11.5	12.9	22.7	22.0	9.9	26.7	31.3	14.7	11.3	10.5	13.2	10.8	19.9	13.8	9.5	8.6	8.9	10.9	14.0	5.6	9.9	8.2	12.1	12.5	6.4	8.7	4.6	10.5	7.4	9.9	12.0	5.9	6.9	9.2	6.5	4.4	7.3	10.1	8.3	3.5	12.0	10.4	6.6	8.5	5.5	11.6	4.6	10.9	10.2	4.0	5.1	7.6	8.1	9.9	6.3	5.9	6.0	9.1	14.4	6.6	7.3	6.0	5.4	3.8	6.1	7.2	59.5	3.2	3.9	5.1	2.6	5.2	6.6	1.8	12.1	6.0	10.5	4.0	8.1	11.6	9.7	7.2	12.0	7.4	10.9	7.6	7.9	12.6	6.0	6.8	8.9	8.6	14.0	8.8	12.2	11.1	10.8	11.5	6.5	13.8	12.0	10.6	4.6	10.9	8.8	9.5	9.8	5.6	19.5	26.6	21.4	21.4	17.8	14.2	29.4	17.3	18.3	31.3	23.8	13.9	5.3	7.4	0.0	33.7	0.0	2.5	25.4	15.9	24.4	23.6	14.6	11.6	8.2	6.9	15.7	3.8	0.0	6.8	5.6	11.3	9.9	22.1	13.2	15.4	36.5	11.7	31.3	15.3	3.2	100.1	11.9	0.0	4.6	13.3	23.8	6.6	10.5	99.3	5.8	29.7	19.4	0.0	29.3	40.5	0.0	4.2	17.5	8.7	5.4
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 32.5"									"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	20.9	5.3	5.4	10.3	10.0	6.0	24.1	3.2	5.2	15.5	7.3	4.8	10.3	3.0	12.2	24.6	8.1	15.0	9.9	12.6	6.6	2.8	5.5	3.5	20.4	10.4	6.9	2.2	21.3	4.4	2.1	5.0	5.4	8.9	7.8	6.1	8.9	8.3	9.6	6.0	4.1	10.1	10.3	6.7	17.5	6.1	4.2	7.3	18.3	19.0	4.6	12.9	10.9	17.7	3.1	13.0	1.4	18.3	2.0	6.0	5.2	8.1	7.3	0.0	0.0	7.5	21.7	0.1	10.1	7.3	17.5	30.7	0.0	0.0	0.0	0.1	13.2	5.5	4.0	22.7	0.0	21.3	4.6	27.2	17.7	0.0	0.0	9.9	22.8	0.0	8.8	0.2	19.5	0.0	0.0	28.6	13.5	0.0	0.0	2.9	0.0	32.5	18.5	0.1	0.0	0.0	27.6	21.4	0.0	0.2	3.9	0.0	0.0	0.0	3.8	0.0	0.0	6.0	16.5	14.8	4.8	0.1	18.1	15.1	0.7	0.2	0.0	3.6	19.9	10.3	0.4	11.8	1.4	4.3	18.3	6.0	3.1	2.7	3.9	9.2	1.3	2.1	2.9	1.3	2.0	11.4	13.0	3.9	5.2	5.4	10.0	3.2	5.2	6.6	2.8	6.9	2.2	8.9	7.3	0.0	6.9	9.1	0.7	6.6	0.0	2.5	0.0	16.0	3.4	1.8	0.0	0.7	0.0	0.0	1.2	16.1	0.0	0.0	0.5	0.6	26.8	1.1	3.5	0.0	27.4	0.0	0.0	10.4	33.5	1.1	9.5	35.9	11.8	1.0	0.0	0.1	0.1	0.2	2.8	0.0	0.0	6.5	27.9	0.0	0.0	7.4	0.7	20.3	0.0	0.6
SLFN5	MGC19764	ENSG00000166750	"Schlafen family member 5"	Q08AF3	17	35243036-35273655	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 96.4;T-cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8"	"Group enriched"	"Detected in many"	7	"NK-cells: 16.8;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.8;hTERT-HME1: 45.1"	"Low region specificity"	"Detected in all"							HPA017760	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA017760: AB_2189993"	"unprognostic (3.43e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.48e-1)"	32.9	12.8	2.8	21.2	2.6	2.8	11.5	1.7	3.0	18.9	7.7	6.6	25.3	4.0	13.6	7.7	10.0	9.3	8.3	6.4	3.6	2.8	5.9	4.0	18.6	20.9	4.8	1.2	10.7	5.0	4.5	3.2	9.9	6.0	15.9	5.0	7.9	15.4	43.1	27.5	5.0	8.5	10.9	6.1	25.3	7.6	3.8	2.2	51.4	7.6	7.2	22.3	17.0	8.5	0.7	1.4	1.9	3.0	16.8	27.8	7.1	6.1	3.2	0.4	0.5	9.2	16.3	1.2	16.1	25.5	13.5	15.1	0.0	4.0	0.7	10.4	15.9	3.6	26.0	0.3	7.2	9.5	0.1	0.5	0.1	3.3	0.3	33.8	0.4	0.1	18.5	18.4	10.3	45.1	8.1	6.1	6.4	0.0	9.3	9.4	0.5	7.5	0.3	0.5	1.3	2.4	0.0	5.4	0.0	3.5	15.3	1.0	0.0	1.8	1.7	28.7	1.9	10.7	0.2	24.1	5.4	2.1	3.9	3.6	1.7	0.1	0.1	15.9	0.0	7.7	1.9	1.7	1.1	11.1	2.7	13.7	0.4	13.6	12.6	1.4	0.7	17.0	13.7	0.7	16.8	3.0	0.5	27.8	7.1	2.8	2.6	1.7	3.0	3.6	2.8	4.8	1.2	6.0	2.2	56.6	61.3	2.2	22.6	4.0	0.9	7.8	25.5	96.4	69.4	17.4	0.0	0.2	1.7	58.0	1.5	67.1	1.4	0.0	33.7	1.5	15.3	77.2	57.9	3.9	12.1	6.4	1.2	57.1	21.5	0.0	6.9	15.8	11.8	45.1	4.5	5.8	62.6	2.9	1.4	1.3	4.3	12.9	17.3	0.4	1.9	3.4	0.2	91.8	0.4	70.5
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	5.1	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.7	0.0	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1											0.0	0.6	0.0	1.7	0.1	11.5	1.6	0.0	2.7	0.0	0.0	3.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.1	1.1	0.0	0.0	20.6	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	1.5	6.5	0.0	0.0	4.6	0.0	1.6	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.9
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879045-58933653	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	32.1	20.2	26.1	37.1	27.6	46.9	35.9	38.0	28.8	32.6	28.2	25.9	27.6	27.4	27.4	25.2	35.3	25.0	25.6	24.6	27.2	24.2	29.5	32.1	25.9	35.9	34.1	29.3	29.0	22.4	40.0	40.9	38.2	32.4	26.6	30.5	20.6	38.1	45.6	39.4	32.0	29.2	29.0	34.3	38.2	34.9	24.4	34.6	50.5	32.9	30.5	38.8	31.3	32.8	31.2	32.4	32.6	21.1	27.2	29.8	12.5	27.5	30.3	26.7	13.5	18.3	13.9	22.6	20.1	23.4	18.5	18.1	20.9	16.7	52.0	18.8	18.3	20.3	24.8	26.4	22.8	25.9	33.3	17.2	37.7	31.7	15.8	16.0	29.6	29.2	12.9	22.9	19.6	16.5	11.4	17.1	24.2	33.4	30.3	21.4	19.8	29.4	22.9	29.9	16.5	14.8	22.7	24.4	25.0	22.5	36.0	22.0	19.0	20.8	20.4	20.3	31.0	16.3	32.4	17.7	22.7	33.2	24.7	26.7	21.4	42.2	37.8	18.0	36.6	22.6	32.6	18.9	25.6	29.2	18.0	29.8	31.2	23.4	24.8	18.6	27.6	25.7	23.0	26.9	27.2	21.1	32.4	20.9	12.5	26.1	27.6	38.0	28.8	27.2	24.2	34.1	29.3	32.4	34.6	142.9	158.5	113.0	87.4	86.1	111.1	98.2	50.9	128.5	149.0	101.2	92.3	60.3	66.3	78.9	82.2	77.3	62.6	23.3	101.1	133.7	70.3	79.3	113.5	93.5	57.0	112.8	70.4	49.1	81.2	88.7	80.0	95.3	74.2	90.2	65.9	83.4	100.5	58.8	83.1	61.8	133.5	71.1	74.5	165.4	68.0	91.5	94.1	94.8	69.0	108.9
SLU7	9G8	ENSG00000164609	"SLU7 homolog, splicing factor"	O95391	5	160401641-160421711	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035907, HPA058120"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA035907: AB_10671717, HPA058120: AB_2683612"	"unprognostic (3.70e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.01e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	19.4	18.9	25.7	14.1	30.7	32.9	22.0	30.4	32.9	18.0	16.2	14.2	14.2	12.9	18.1	21.4	17.8	14.6	14.8	19.3	23.7	23.6	19.4	19.0	18.1	19.4	25.7	28.1	17.5	15.4	18.4	21.6	18.5	28.4	17.5	16.8	10.3	18.6	16.6	33.8	17.7	17.0	18.6	26.2	20.6	17.8	20.3	25.8	21.4	26.0	20.2	23.5	20.6	17.7	18.4	13.2	33.5	20.1	20.6	17.9	12.2	12.4	15.8	13.5	19.2	17.9	19.0	17.5	17.6	25.7	19.5	23.6	20.9	15.2	20.3	18.0	18.8	19.3	13.9	11.9	19.5	24.6	32.7	17.4	15.0	21.6	13.4	18.0	25.4	18.6	20.4	18.3	17.8	20.4	19.8	13.3	18.4	13.6	19.0	17.4	11.0	12.4	16.2	9.9	12.7	14.2	10.6	28.2	20.0	17.1	20.3	16.5	22.7	20.6	18.9	31.0	11.8	25.3	24.1	16.9	19.0	9.8	13.7	18.6	21.2	24.3	18.1	27.4	16.9	17.8	24.7	13.2	22.5	17.4	14.8	16.3	18.4	16.3	17.1	12.1	16.6	17.9	17.1	33.5	20.6	20.1	13.2	17.4	12.2	25.7	30.7	30.4	32.9	23.7	23.6	25.7	28.1	28.4	25.8	62.5	60.3	40.4	39.5	39.8	70.1	58.4	20.4	78.9	52.4	24.4	23.6	32.7	43.1	43.6	85.1	35.9	28.4	46.7	48.7	33.2	36.4	32.9	45.1	21.5	33.8	54.0	37.9	28.3	41.9	21.3	44.3	49.1	62.4	61.3	33.0	50.0	45.3	35.3	44.6	29.3	44.2	45.3	40.1	47.9	42.8	36.3	78.7	48.4	28.0	42.3
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145558079	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 132.8;Endothelial cells: 56.4;Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 22.2;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.2;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	20.4	7.8	19.9	7.9	21.3	3.8	21.1	17.9	17.8	18.5	15.5	14.3	13.6	11.9	33.2	22.7	16.2	20.3	13.7	10.3	13.5	10.3	12.7	37.4	11.0	11.9	9.3	10.0	12.3	13.1	33.7	14.7	8.7	12.2	13.6	16.9	7.8	17.5	16.0	22.6	20.2	15.3	24.6	12.6	10.1	11.4	10.5	14.3	15.3	15.2	14.9	10.3	16.5	21.9	0.0	4.0	22.2	11.9	1.2	0.7	0.8	3.9	5.2	9.7	11.7	3.8	5.5	4.8	5.6	13.6	9.2	7.1	2.5	14.5	3.4	3.4	12.9	4.1	5.8	11.0	12.6	5.5	0.0	5.5	0.0	4.3	5.1	10.1	6.5	1.0	7.5	15.0	4.9	9.7	7.5	46.6	8.5	4.4	0.1	11.7	3.8	9.8	0.1	9.0	6.3	6.3	18.9	9.0	11.7	10.0	6.9	15.2	7.3	8.0	17.5	3.5	6.2	5.9	0.0	14.0	4.5	6.2	4.6	3.4	12.9	0.0	22.8	7.2	0.1	4.6	22.2	2.1	0.8	0.0	5.3	0.0	0.0	0.4	0.0	4.0	0.0	0.2	0.0	0.0	1.2	11.9	0.0	0.7	0.8	19.9	21.3	17.9	14.9	13.5	10.3	9.3	10.0	12.2	14.3	8.9	10.4	0.0	14.6	10.2	5.7	3.9	12.7	10.7	12.5	14.0	13.7	4.1	6.6	10.1	132.8	56.4	8.0	0.0	16.1	2.7	6.2	12.3	0.0	10.5	2.1	9.5	8.7	9.8	6.3	63.2	4.0	2.3	1.7	1.0	8.6	4.8	11.9	5.8	5.3	9.8	6.1	0.0	4.6	5.6	11.9	11.0	1.8	0.0	7.5	15.4
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195195	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Glandular cells: 111.1;Urothelial cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	25.3	4.6	12.2	18.5	12.4	12.4	21.6	5.0	12.7	20.9	17.9	7.6	9.5	12.7	19.9	16.6	35.3	14.3	27.7	19.7	7.5	4.8	15.6	13.6	13.9	14.0	6.0	7.5	23.0	12.6	7.0	10.8	11.5	8.2	20.5	9.2	30.8	12.5	10.8	37.3	19.6	19.0	23.2	5.5	11.2	15.8	7.0	7.7	10.5	21.8	23.4	29.7	31.4	24.6	4.8	2.5	3.2	1.9	0.4	6.3	1.8	12.2	41.2	7.7	3.7	13.6	31.4	6.1	7.1	29.3	9.9	8.0	8.5	32.9	4.1	9.6	20.2	44.6	29.1	8.0	30.0	9.9	3.2	3.0	0.4	11.6	6.4	10.2	1.6	0.7	28.4	7.0	8.7	7.4	22.0	33.3	1.3	9.9	11.5	12.3	6.3	0.3	6.2	4.5	6.5	12.9	0.4	2.3	1.5	6.6	39.5	0.2	2.6	9.4	5.2	8.1	15.7	1.4	7.6	28.0	13.4	12.6	9.6	8.0	4.4	1.2	5.1	12.1	1.7	12.0	0.0	1.9	3.2	5.5	1.5	5.7	2.1	6.2	6.3	1.8	4.8	2.8	2.4	0.1	0.4	1.5	2.5	3.1	1.8	12.2	12.4	5.0	12.7	7.5	4.8	6.0	7.5	8.2	7.7	44.7	14.5	13.6	67.6	79.0	8.3	9.5	15.3	24.1	30.7	34.9	5.9	0.8	3.3	53.0	0.9	20.1	34.4	0.0	44.0	4.0	34.3	111.1	24.2	11.3	8.4	0.0	3.4	9.8	4.8	3.7	24.7	13.8	20.3	3.6	11.9	9.7	71.0	21.0	19.4	12.2	0.4	25.8	14.6	0.3	0.7	42.8	1.4	12.5	15.7	247.9
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 33.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058931: AB_2683856"	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	22.6	14.2	13.7	10.2	14.6	8.6	18.2	27.5	15.7	27.9	16.7	19.8	15.9	12.4	33.5	15.8	20.8	17.3	14.0	15.9	14.9	12.4	15.7	20.2	16.7	10.4	18.0	12.2	33.5	15.3	25.2	23.0	24.1	16.4	23.0	16.9	22.0	16.9	18.8	19.3	27.5	12.7	25.7	16.7	16.3	14.4	11.5	19.0	8.4	19.2	15.2	15.7	25.6	27.9	7.3	7.4	33.1	6.1	9.3	7.2	2.4	14.0	11.8	14.6	12.9	15.9	24.4	15.4	19.5	13.8	13.0	20.3	52.1	10.3	15.5	16.4	15.1	13.9	12.9	17.0	22.3	21.3	6.7	10.5	10.3	12.8	9.8	13.2	6.2	11.0	17.5	13.6	20.6	14.3	13.8	16.2	7.8	9.9	10.7	14.3	5.6	5.1	6.4	8.7	5.0	6.0	10.7	28.2	9.1	7.9	14.5	13.2	13.8	17.0	4.4	17.1	18.4	9.9	7.7	18.7	19.8	12.7	14.6	19.3	12.1	14.5	19.6	12.8	8.1	15.0	33.1	6.1	13.0	7.2	3.9	5.5	6.5	4.2	4.6	6.1	7.3	1.4	4.3	1.0	9.3	4.4	7.4	1.1	2.4	13.7	14.6	27.5	15.7	14.9	12.4	18.0	12.2	16.4	19.0	38.7	26.7	14.8	30.0	41.2	26.4	34.1	48.4	34.8	43.3	29.6	19.6	16.7	19.9	22.2	16.0	50.2	12.4	0.0	22.9	9.9	44.5	42.2	8.1	42.9	11.9	49.3	95.7	47.9	32.6	18.0	65.6	20.0	20.3	3.6	36.1	46.2	25.7	17.3	68.2	35.0	27.4	45.3	40.6	21.4	21.4	44.3	9.8	13.4	28.7	30.4
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48950711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 50.6;Ito cells: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	9.5	3.3	3.1	7.4	4.3	8.6	11.6	8.0	7.7	11.4	11.5	4.2	5.1	5.5	6.5	3.0	2.8	4.2	5.7	27.0	5.8	3.1	7.4	6.5	13.7	2.8	6.1	4.4	4.5	5.6	14.6	3.9	11.2	6.0	9.3	7.0	7.1	5.3	11.5	4.9	4.4	15.0	5.0	6.3	2.9	7.2	3.2	2.8	3.6	10.0	5.7	3.4	6.8	19.4	0.1	0.3	8.3	0.8	2.6	1.9	0.4	2.2	1.9	1.6	5.2	9.1	3.8	13.1	10.4	4.4	4.1	1.9	0.5	3.2	0.2	19.7	7.6	3.6	11.9	3.7	3.5	2.2	22.6	5.9	0.1	5.6	4.9	1.6	4.5	11.3	3.2	3.2	4.6	4.9	19.5	0.7	0.3	3.8	14.8	6.2	0.7	0.0	1.3	10.9	15.6	0.7	1.3	1.6	5.0	6.3	2.4	2.9	6.3	4.7	2.2	4.5	13.2	1.8	3.5	9.9	11.0	6.0	3.1	10.2	8.0	4.0	1.3	4.8	2.9	1.7	5.8	0.2	8.3	1.4	0.8	1.2	0.1	1.4	1.3	0.3	0.0	0.4	0.9	0.0	2.6	0.2	0.0	1.9	0.4	3.1	4.3	8.0	7.7	5.8	3.1	6.1	4.4	6.0	2.8	50.6	10.3	1.4	3.2	11.4	5.1	7.9	2.5	4.0	18.2	10.4	5.9	7.9	8.3	12.6	0.1	10.0	22.7	0.0	12.2	2.7	15.4	3.0	17.4	2.6	9.0	0.0	12.2	84.7	16.0	0.2	1.4	7.9	0.0	8.2	17.6	1.3	21.6	17.3	3.2	5.0	2.5	6.5	10.3	0.0	0.1	10.3	10.8	8.4	12.8	2.2
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 26.8;Intestinal endocrine cells: 49.5;Ito cells: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.8;SH-SY5Y: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: AB_2673767"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.47e-2)"	4.4	3.1	7.0	3.2	6.2	0.6	4.1	10.7	11.8	6.3	8.2	14.3	4.1	2.6	10.0	11.3	5.8	5.1	7.4	6.9	15.0	6.2	5.0	1.4	5.3	2.6	10.7	8.9	10.1	1.3	3.0	6.2	6.7	10.2	14.9	6.0	11.9	17.7	12.4	13.8	2.1	4.0	8.4	15.5	1.5	5.9	2.7	11.0	0.0	38.9	1.9	3.4	7.7	12.6	1.7	1.7	1.1	0.8	0.7	1.4	0.2	0.0	0.1	0.5	5.9	1.8	0.8	0.2	6.8	0.7	1.9	1.1	0.0	0.1	0.2	4.3	8.8	0.6	0.3	5.9	0.1	2.0	0.2	8.4	0.0	3.0	4.7	1.8	0.5	0.1	3.0	0.5	0.0	0.0	4.0	3.6	0.8	0.0	0.0	4.3	0.4	0.1	0.5	0.9	0.2	0.6	0.1	6.4	0.0	0.0	1.0	5.3	28.2	1.4	0.2	0.3	1.7	0.4	0.2	6.4	2.8	2.2	1.6	1.6	0.1	0.0	0.0	1.9	0.2	0.4	1.1	0.4	0.3	1.2	0.8	0.8	1.0	1.2	1.3	0.2	1.7	1.2	1.4	0.9	0.7	0.5	1.7	0.4	0.2	7.0	6.2	10.7	7.8	15.0	6.2	10.7	8.9	10.2	11.0	26.8	7.8	0.0	4.2	2.5	8.3	4.2	0.0	2.7	11.4	10.4	3.9	0.1	1.7	0.2	0.1	21.5	0.0	0.0	0.2	0.4	6.6	17.1	0.0	0.0	0.1	0.0	49.5	47.9	2.4	0.0	17.3	0.0	0.0	0.0	13.7	16.3	0.7	3.5	14.2	4.3	3.2	0.0	7.9	0.2	4.7	1.6	0.2	0.9	5.7	0.9
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	10.4	44.6	14.5	5.0	15.2	0.4	11.8	12.0	12.0	17.1	11.4	7.7	25.5	3.9	15.8	31.4	9.6	12.0	12.3	19.3	13.9	17.9	13.9	34.1	9.2	2.5	13.1	8.4	42.2	9.0	34.8	29.9	21.0	14.6	23.8	4.3	9.7	9.8	42.9	8.7	4.6	4.8	17.7	14.0	6.9	10.0	33.0	13.1	2.0	26.0	6.8	2.6	16.8	15.3	0.3	0.8	0.0	0.0	1.6	4.3	0.5	6.6	15.0	31.0	20.2	22.6	20.5	10.7	13.7	39.6	20.4	23.2	5.2	23.9	0.0	21.3	25.7	24.0	6.4	19.2	8.0	23.0	0.0	3.6	0.0	13.6	28.1	9.9	0.0	0.0	25.6	2.3	14.6	2.8	31.2	14.9	3.7	3.4	1.6	22.0	0.0	0.1	0.0	12.4	2.6	8.6	0.0	16.7	0.0	20.1	8.2	7.4	20.4	1.9	0.2	3.4	22.8	13.8	0.1	10.3	13.7	7.0	8.9	7.4	0.0	0.0	0.0	12.1	0.0	8.4	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.0	0.0	0.3	4.3	1.3	0.0	1.6	0.0	0.8	0.0	0.5	14.5	15.2	12.0	12.0	13.9	17.9	13.1	8.4	14.6	13.1	89.3	46.5	1.3	28.2	20.7	25.6	68.0	12.7	60.2	68.2	38.4	43.2	40.5	24.9	23.4	2.0	21.1	0.0	23.3	10.5	11.6	49.7	20.5	2.3	52.9	11.7	87.4	16.1	17.2	2.5	8.2	132.3	3.6	27.0	10.0	1.1	49.1	12.6	0.0	118.1	31.1	13.3	64.7	30.1	12.6	6.1	10.3	48.9	0.0	1.0	24.8
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513463-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751, HPA074181"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: "	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	21.0	39.5	24.7	24.8	32.6	34.5	21.9	26.9	29.2	24.0	23.8	27.7	24.6	17.9	27.3	26.3	19.8	23.0	23.8	29.8	25.0	25.1	21.1	21.0	33.3	29.5	30.2	26.5	29.4	24.6	33.1	33.3	27.7	29.6	23.1	22.5	16.3	22.0	25.7	24.6	14.7	22.6	22.9	34.6	28.6	22.8	37.8	32.8	44.3	28.5	15.1	29.7	25.6	23.7	11.7	13.2	15.4	19.4	15.6	16.3	10.6	11.9	9.4	34.6	21.7	20.3	14.7	20.7	15.2	18.1	22.1	18.8	16.0	16.8	32.4	10.5	12.9	8.9	9.5	31.6	14.2	21.5	21.5	11.2	24.2	13.9	13.1	15.0	29.9	14.3	12.9	10.3	15.7	13.5	13.0	17.1	16.6	21.8	20.5	14.4	10.7	34.8	10.4	28.1	20.0	13.5	38.7	22.2	10.5	17.3	14.6	27.7	23.5	19.8	14.0	17.5	27.1	10.1	14.0	18.2	14.7	11.3	15.3	14.9	22.6	27.0	39.4	11.5	25.1	14.9	5.0	10.7	15.4	13.9	12.7	16.3	11.7	14.2	15.0	13.2	11.5	14.9	14.7	9.7	15.6	19.4	10.1	16.1	10.6	24.7	32.6	26.9	29.2	25.0	25.1	30.2	26.5	29.6	32.8	285.9	217.7	44.0	61.8	41.2	94.8	89.1	28.1	137.9	128.5	41.8	60.9	60.5	33.2	66.8	37.7	52.0	32.2	0.0	53.1	58.4	45.4	47.0	98.4	21.7	39.5	81.0	76.6	36.2	50.0	18.9	55.8	51.0	28.7	101.0	33.6	83.9	56.1	32.8	58.4	29.3	110.5	51.8	54.2	117.2	123.0	35.8	85.4	55.4	37.9	62.6
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838008	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	11.0	15.2	14.6	33.2	15.4	16.9	12.1	30.4	21.9	13.4	25.1	16.4	11.4	41.1	17.2	11.0	15.6	12.3	15.0	12.6	13.2	14.2	14.6	11.7	14.0	32.8	13.0	13.8	21.3	16.1	7.9	15.7	20.8	12.8	11.0	9.4	16.7	40.9	13.1	28.1	14.7	27.4	10.6	12.8	19.8	24.1	37.7	12.9	29.4	15.7	12.0	16.0	21.1	12.2	19.5	9.9	4.8	11.6	7.0	7.5	5.9	1.5	1.0	19.2	1.8	1.8	0.5	3.9	6.1	1.8	1.8	2.9	2.2	1.8	15.7	5.3	0.8	2.0	2.9	4.6	3.0	3.0	2.6	6.7	13.0	1.8	1.3	2.1	13.8	3.8	1.1	2.2	2.1	4.7	0.9	0.9	1.9	3.5	8.7	1.1	3.9	11.2	3.2	5.7	4.7	3.8	7.0	15.5	7.0	1.6	3.0	9.1	6.9	1.4	0.4	10.3	10.4	1.5	2.1	1.6	1.6	6.7	2.6	1.7	9.6	8.8	10.4	1.3	7.6	4.6	4.0	10.0	4.8	3.8	10.2	5.2	19.5	4.6	4.6	9.3	6.4	3.8	2.5	0.8	7.0	11.6	9.9	7.5	5.9	14.6	15.4	30.4	21.9	13.2	14.2	13.0	13.8	12.8	12.9	6.0	10.4	102.1	57.3	44.6	51.7	3.7	38.2	18.7	6.8	45.4	19.6	106.2	71.3	80.0	26.9	31.5	31.9	23.3	67.3	185.0	45.7	53.3	33.5	17.7	66.6	63.5	68.9	36.8	19.7	12.4	33.1	35.4	54.0	63.1	50.5	72.3	62.0	51.8	30.1	65.4	36.9	19.4	58.2	125.7	116.1	46.3	133.9	35.0	61.6	56.7
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50084972-50100712	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	21.3	24.5	16.4	22.6	22.7	29.9	21.3	27.8	28.2	19.8	19.9	29.5	17.6	18.8	23.6	23.4	23.3	19.9	18.2	15.6	16.3	13.8	25.1	18.3	19.4	26.1	15.7	20.4	24.7	19.6	44.3	17.8	24.7	18.8	20.4	22.4	20.3	21.4	25.9	16.6	19.7	24.0	23.8	18.5	28.1	17.4	34.4	14.9	64.3	24.3	17.9	36.7	19.3	18.2	6.0	6.7	4.4	3.4	3.1	6.9	2.3	8.1	13.8	40.7	23.5	12.7	12.0	20.2	10.1	18.0	29.9	17.5	37.7	12.8	31.8	15.3	19.4	13.6	10.5	34.3	26.7	25.9	24.6	25.3	31.4	13.9	21.8	15.1	27.7	12.6	12.1	17.9	17.7	32.0	20.1	35.2	34.0	26.5	19.8	15.1	19.1	40.2	14.9	50.8	12.5	22.6	48.3	10.6	27.8	17.0	19.1	21.9	36.6	21.3	10.9	42.5	31.6	24.5	23.3	21.1	15.4	17.3	9.7	20.7	27.9	24.5	28.3	12.5	11.2	17.4	4.4	2.3	4.1	6.1	2.1	5.8	6.0	3.3	3.9	3.6	5.6	2.1	6.9	1.1	3.1	3.4	6.7	5.0	2.3	16.4	22.7	27.8	28.2	16.3	13.8	15.7	20.4	18.8	14.9	0.0	8.1	33.4	17.8	14.7	31.0	5.7	15.3	9.4	25.0	26.2	19.6	17.5	44.7	25.2	3.2	21.0	17.7	0.0	24.9	16.2	12.9	16.7	16.1	12.7	15.1	25.4	29.9	14.1	10.7	6.6	15.3	11.0	16.9	34.3	18.6	26.7	27.6	14.0	15.2	30.4	26.0	32.3	13.3	21.9	31.5	17.1	9.3	16.0	15.7	14.4
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 35.4"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 487.9;Spermatogonia: 418.0"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.5	0.0	9.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.0	19.1	0.1	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.0	0.3	2.0	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	28.8	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.2	0.0	1.0	97.0	0.0	487.9	418.0	0.0	0.7	0.0	0.0	0.1
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.3	14.2	16.0	14.8	3.4	5.0	15.0	17.0	8.1	15.3	12.9	12.3	14.3	35.2	8.3	8.7	13.2	31.2	23.1	11.0	20.7	22.3	9.7	21.2	22.7	7.9	0.9	12.8	21.4	3.2	2.3	20.7	8.4	5.2	10.8	22.7	17.0	29.0	13.8	8.9	33.3	6.6	13.8	14.9	11.2	22.3	45.9	13.2	6.5	6.7	15.1	11.7	20.3	9.5	5.0	7.0	19.1	8.7	8.6	18.6	19.6	25.7	21.2	10.6	35.7	20.6	12.1	18.8	22.5	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7	23.8	11.0	20.1	9.5	24.3	34.1	38.9	7.6	10.7	14.8	15.7	7.9	30.9	29.9	16.5	27.3	15.5	6.5	0.0	17.9	78.9	14.2	5.9	21.9	6.8	37.8	27.0	4.7	19.6	12.1	20.4	17.3	20.0	6.8	27.1	11.4	14.5	14.2	7.0	11.7	13.3	18.4	12.9	17.5	56.4	96.0	20.3	21.6	14.9	24.7	6.7
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655738-2805017	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 30.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	19.8	8.1	9.1	29.9	11.1	35.6	17.2	18.0	11.3	21.9	17.3	8.2	16.0	13.7	19.2	12.3	12.4	15.6	13.3	12.6	8.3	8.0	9.3	10.2	21.5	31.3	12.7	8.6	20.0	21.2	15.9	14.8	16.2	9.4	15.6	15.3	11.6	14.0	14.0	12.9	10.8	23.7	23.1	9.8	32.0	14.0	13.7	11.5	34.4	12.1	9.6	22.1	25.7	23.5	4.1	1.2	30.3	1.2	1.1	3.2	0.5	10.9	5.0	17.0	10.6	7.3	10.7	12.2	11.0	7.9	10.5	13.4	9.3	3.6	23.7	4.9	9.8	11.8	6.0	13.7	6.3	16.6	4.8	7.1	14.8	9.8	8.9	8.2	42.4	11.6	7.0	5.8	13.3	11.0	8.1	8.6	11.9	17.2	14.8	10.0	3.9	17.7	10.9	6.8	5.9	5.8	14.5	13.8	10.4	6.5	16.9	14.0	8.8	14.9	5.0	8.6	9.9	3.7	18.1	8.1	13.0	18.0	17.6	20.2	9.0	13.5	21.7	8.4	7.9	11.3	1.9	1.2	3.1	1.9	0.8	1.4	2.9	2.5	2.2	0.4	4.1	3.2	2.0	30.3	1.1	1.1	1.2	2.5	0.5	9.1	11.1	18.0	11.3	8.3	8.0	12.7	8.6	9.4	11.5	41.7	46.8	107.2	33.5	24.2	88.8	43.9	12.7	22.7	35.2	17.4	94.2	30.4	5.0	20.1	88.0	41.1	49.1	23.3	16.7	19.9	31.9	43.1	38.3	13.9	17.4	93.8	21.8	28.8	68.9	26.8	38.9	61.6	28.7	64.1	29.6	37.0	20.6	59.6	35.7	6.3	91.7	38.8	36.3	85.4	79.0	21.8	39.2	79.1	25.5	40.9
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.1	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	1.4	2.6	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.3	2.9	5.0	2.1	3.1	5.1	3.5	5.9	4.9	5.3	1.1	5.7	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	1.6	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9	77.4	85.3	270.8	168.6	148.1	59.5	296.6	234.4	179.3	92.1	193.7	19.6	251.6	485.7	138.8	92.3	121.8	346.2	0.0	174.6	167.3	105.2	269.9	91.0	309.5	220.1	52.4	331.5	110.5	164.5	80.6	175.2	186.8	200.8	116.4	276.7	86.2	148.7	295.1	140.0	446.7	82.0	122.9	137.7	196.7	54.5	239.6	258.2	167.5	271.3	230.0
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638600-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 18.8;pituitary gland: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.6	3.2	5.2	0.7	6.6	2.7	0.6	18.8	18.7	0.6	0.7	0.4	0.0	0.6	0.7	0.6	0.7	0.7	0.8	0.9	10.9	10.7	2.9	0.7	0.6	0.6	5.7	7.5	0.7	1.8	0.6	10.7	0.6	11.7	0.7	0.8	0.2	0.6	0.6	0.6	0.7	0.7	0.6	4.6	0.7	0.8	0.7	1.4	0.0	0.7	0.0	0.6	0.6	0.0	2.9	4.1	3.0	2.3	0.2	4.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.0	0.0	0.0	3.0	1.9	1.9	3.7	1.3	3.6	2.9	2.3	2.1	0.9	2.9	3.0	4.3	2.1	0.2	2.3	4.1	2.9	0.3	5.2	6.6	18.8	9.7	10.9	10.7	5.7	7.5	11.7	1.4	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM2	"C13orf44, MGC5590"	ENSG00000139656	"Small integral membrane protein 2"	Q9BVW6	13	44143543-44161257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 15.9"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 36.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 4.4;OE19: 12.1"					"Low region specificity"	"Detected in many"			"HPA026891, HPA077071"	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026891: AB_10602924, HPA077071: "	"unprognostic (4.34e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.87e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.05e-2)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.8			0.9	0.1	2.9	0.1	0.2	0.3	1.2	0.2	0.2	0.9	0.4	0.1	0.0	0.2		0.1	0.7	0.0	0.3	0.2		0.2	0.0		0.6	0.0	1.0	0.1	2.2	0.2	0.2	0.1	0.4	15.9			0.1		0.0	0.2	0.1	0.5	0.0	0.0	0.2	1.8	0.4	0.0	0.9	0.8	0.9	0.2	0.0	0.0	1.1	0.0	4.4	1.0	0.0	1.5	0.2	1.7	1.1	0.0	1.2	2.7	0.0	1.7	1.2	0.0	1.7	0.0	1.9	0.0	1.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.2	1.1	0.0	0.7	12.1	1.2	1.0	0.0	0.2	0.0	0.5	2.3	1.2	3.4	1.5	2.2	1.9	0.0	0.2	0.4	0.0	0.8	1.2	0.2	0.0	0.0	0.7	1.3	0.4	0.8	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0
SMIM22		ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6"	"Not detected"	"Not detected"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	0.8	0.0	0.8	14.4	0.8	0.2	10.9	0.8	0.8	10.8	47.0	0.9	37.8	27.5	2.5	12.1	2.6	18.0	28.1	0.8	0.8	0.0	6.2	0.9	6.8	0.8	0.8	0.8	2.8	36.2	0.0	12.1	4.1	0.8	10.2	28.1	0.8	42.2	35.3	0.8	2.2	54.3	1.7	0.8	0.8	41.7	27.2	0.8	1.0	0.9	2.8	4.5	18.5	3.6	1.9	1.5	3.9	1.3	0.9	1.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	68.7	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	0.2	58.6	0.0	0.1	0.1	5.8	0.3	25.3	17.9	0.3	0.1	51.6	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	3.9	1.3	1.6	1.3	0.5	0.6	0.7	1.3	0.6	0.3	1.9	1.6	0.7	3.3	0.9	0.6	1.5	0.9	0.3	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8	44.7	91.2	2.2	16.6	1.9	3.3	0.4	239.5	456.4	104.6	237.3	0.0	3.6	21.6	209.7	33.3	0.4	1586.1	0.0	336.4	0.4	0.3	47.7	18.4	0.0	0.3	1.6	452.3	0.0	0.0	89.0	0.6	2.7	21.9	9.0	1138.7	0.5	428.0	989.0	1.1	55.8	4.1	0.0	0.2	15.1	0.4	1.9	3.1	0.0	572.8	123.6
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 1384.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7"	"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	42.4	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.2	31.7	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	30.2	4.2	0.0	50.3	0.0	16.6	0.0	1.1	0.4	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.7	0.0	23.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3	0.0	0.0	1.7	0.1	0.0	12.1	0.2	229.3	0.0	0.0	55.8	25.5	0.0	202.2	3.9	5.0	0.0	64.6	23.3	11.3	0.1	0.0	0.3	1.1	8.5	0.1	0.0	133.5	0.6	0.8	11.2	0.3	0.0	0.0	1.0	34.7	2.7	11.1	51.8	0.0	1384.0	32.6	0.0	0.0	0.7	0.4	0.0	0.0	1.0	35.7	0.2
SMIM26	"LINC00493, LOC388789"	ENSG00000232388	"Small integral membrane protein 26"	A0A096LP01	20	18567347-18569563	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 330.0;Proximal tubular cells: 358.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068733			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA068733: AB_2686024"	"unprognostic (1.20e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (7.84e-5)"	6.8	13.2	8.4	6.8	11.6	9.9	15.6	9.2	13.2	8.8	8.8	5.0	11.9	8.6	9.0	20.4	9.3	11.2	10.8	15.0	9.2		13.2	16.4	6.7	13.4	9.2	10.9	17.2	29.4	6.9	10.6	7.4	14.7	9.5	9.7	6.9	16.8	15.7	32.3	7.7	10.9	11.7	8.9	6.2	8.3	5.4	10.8	7.7	12.0	18.7	9.6	11.4	12.6	49.2	52.0	75.1	42.9	29.6	49.8	37.5	23.6	30.7	23.0	24.2	21.3	29.3	27.3	17.7	20.9	20.5	23.5	19.0	27.3	23.4	20.3	18.9	36.9	26.0	21.7	28.8	23.3	10.0	27.5	31.1	14.3	62.5	40.8	20.4	23.9	24.9	38.5	23.2	37.5	35.7	30.7	29.0	22.8	22.0	25.3	29.0	24.0	56.3	13.3	44.5	37.2	15.7	27.3	32.0	45.9	23.7	23.2	24.7	18.5	35.8	68.1	21.3	26.2	30.1	16.0	14.5	15.3	17.9	18.5	21.4	51.7	26.0	13.1	13.2	10.9	34.8	42.9	32.2	33.2	36.2	34.7	49.2	45.0	37.6	52.0	45.1	49.8	46.7	75.1	29.6	33.3	48.6	45.4	37.5											119.1	61.5	0.0	0.0	0.0	0.0	0.0	0.0	160.6	66.0	162.3	0.0	177.5	330.0	123.9	0.0	0.0	0.0	0.0	185.9	113.7	0.0	0.0	32.5	0.0	161.8	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	115.4	0.0	0.0	172.0	0.0	0.0	358.7	0.0	0.0	0.0	0.0	0.0	0.0	173.9	0.0	0.0	0.0
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 211.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	23.0	8.1	9.5	24.0	11.2	5.8	19.4	10.5	4.9	12.1	10.6	9.9	6.2	10.0	4.8	4.4	12.2	12.2	3.1	8.4	4.9	6.6	24.6	9.4	23.2	19.9	17.0	11.1	13.1	12.5	5.2	10.2	7.4	6.6	11.0	11.0	12.4	15.0	8.1	10.0	10.3	15.6	16.1	12.7	17.3	7.1	9.1	19.7	6.7	10.1	10.3	13.0	20.5	6.8	19.8	5.6	7.0	9.4	9.7	6.7	22.0	31.6	21.3	17.5	19.0	21.9	36.8	20.9	9.2	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6	44.7	44.8	30.4	29.5	24.2	16.1	211.3	61.1	62.9	77.3	50.6	11.8	35.0	180.8	36.8	15.8	36.5	60.3	0.0	74.3	16.7	27.7	17.7	56.7	143.5	98.6	3.2	76.2	60.8	84.6	8.0	60.1	52.8	35.4	17.2	57.4	43.6	50.1	28.1	95.1	134.6	12.7	45.3	51.1	7.7	15.8	30.2	23.1	25.9	67.6	18.2
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304951	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	21.3	18.0	16.7	20.0	17.5	38.3	26.6	24.0	20.1	19.0	18.1	17.5	13.5	13.9	23.6	13.1	24.1	18.4	16.7	19.4	15.0	15.4	19.3	20.8	23.5	32.7	15.0	14.4	23.4	15.3	18.0	24.3	25.2	16.5	18.0	16.1	19.6	18.0	17.4	34.3	19.0	16.6	21.3	22.7	21.8	17.0	19.8	16.9	30.0	18.9	14.9	24.7	25.4	22.4	6.2	9.2	17.4	9.7	6.3	8.7	4.5	15.6	11.9	17.5	20.1	13.6	16.3	13.0	18.1	19.0	24.2	24.9	15.3	19.4	22.2	11.8	11.3	13.9	17.0	25.7	12.5	27.3	12.5	13.8	22.2	10.2	17.8	16.3	24.3	21.4	12.6	13.4	19.2	32.4	18.0	13.3	12.9	19.9	20.8	18.6	7.4	25.9	23.7	19.5	12.1	8.3	22.5	35.1	11.6	13.5	11.3	8.8	11.8	11.8	10.0	20.7	15.8	12.3	14.0	14.5	14.2	16.2	13.0	23.0	17.2	17.8	33.7	14.2	34.2	10.9	5.7	9.6	14.7	6.1	9.7	7.5	6.2	7.9	7.6	9.2	5.5	7.1	6.8	17.4	6.3	9.7	5.5	8.7	4.5	16.7	17.5	24.0	20.1	15.0	15.4	15.0	14.4	16.5	16.9	26.8	29.6	33.5	33.3	61.8	25.5	19.0	10.2	34.8	29.6	10.4	19.6	28.1	28.2	21.0	5.4	32.3	18.8	23.3	15.6	27.2	32.9	39.7	57.7	21.2	28.0	31.8	17.9	21.5	34.0	3.8	27.0	39.8	33.7	40.5	14.8	22.3	19.3	17.3	20.8	26.9	30.6	19.4	28.8	44.1	36.1	72.9	38.6	30.5	17.4	60.1
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 267.0;Ito cells: 149.1;Sertoli cells: 181.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		11000	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	17.4	3.3	5.0	8.3	3.8	1.5	13.2	12.7	4.7	34.3	99.3	2.0	7.5	10.3	72.4	12.5	26.4	23.5	32.5	27.6	4.3	1.3	7.0	4.7	9.1	1.7	3.6	2.2	18.2	6.8	1.3	2.0	6.0	5.3	34.5	10.6	14.9	4.6	66.7	28.8	6.4	20.3	91.7	1.7	16.9	36.7	6.2	4.0	1.8	5.1	16.8	2.2	61.3	21.4	4.1	1.3	0.3	2.8	0.3	3.1	1.9	19.9	6.0	2.0	7.7	3.2	5.0	16.6	30.0	14.0	24.7	16.9	8.4	6.4	8.9	2.7	16.5	5.0	2.9	2.0	17.7	11.7	2.9	16.5	9.5	4.8	9.9	2.8	14.0	16.6	4.1	1.6	32.7	5.4	8.4	21.2	3.4	10.1	7.4	16.9	17.9	1.6	3.1	2.3	10.0	25.5	5.5	5.9	9.4	9.9	6.5	3.2	3.6	9.4	4.5	4.4	2.2	5.3	2.2	33.4	18.2	17.2	17.0	22.2	7.1	8.6	5.2	26.4	5.5	56.8	0.0	2.8	0.0	0.5	0.7	0.2	4.1	0.5	1.2	1.3	0.2	3.1	1.7	0.3	0.3	0.7	0.7	0.1	1.9	5.0	3.8	12.7	4.7	4.3	1.3	3.6	2.2	5.3	4.0	6.0	3.5	0.8	24.1	57.9	30.5	32.0	5.1	1.4	2.3	8.7	267.0	9.1	8.3	12.2	0.7	45.4	5.1	0.0	17.0	57.4	41.7	20.3	0.0	2.0	5.1	4.8	28.0	149.1	9.2	1.3	20.8	4.5	13.5	1.0	23.0	35.7	47.3	10.5	45.6	18.6	46.9	181.1	111.4	6.5	5.1	60.6	18.3	3.1	23.8	13.4
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.7	7.9	6.4	4.5	5.1	5.4	9.6	7.7	7.4	6.3	5.9	3.9	11.4	4.3	8.4	7.2	13.9	7.5	3.5	10.0	6.5	3.2	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.8	6.9	9.9	11.5	9.6	5.9	4.2	6.9	7.6	5.8	11.2	4.5	5.4	7.5	7.6	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	11.8	3.1	5.0	8.7	10.0	10.3	17.8	15.4	6.8	4.6	4.5	5.0	5.2	15.4	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8	17.9	28.0	5.2	20.4	23.0	25.8	3.9	20.4	20.1	20.5	12.2	7.9	6.1	1.7	13.9	3.7	10.8	7.8	0.0	13.9	8.0	10.1	31.9	2.3	6.7	5.7	25.4	10.9	7.4	3.1	5.3	5.8	8.5	8.5	4.6	8.7	3.7	25.0	10.5	13.1	4.4	6.9	6.5	15.5	41.5	1.0	19.3	17.6	2.5	7.8	65.2
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20858983-20891218	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 381.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		34000	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151"	"unprognostic (1.76e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	19.4	18.8	15.9	15.5	15.3	15.7	15.5	13.4	19.7	16.0	18.8	15.3	17.1	16.5	15.2	11.6	21.7	12.3	19.9	23.1	13.8	13.0	17.7	36.1	13.4	20.1	15.1	12.3	15.7	16.6	13.1	11.5	26.4	13.7	13.6	17.7	19.0	17.7	17.1	27.6	17.6	16.8	17.6	15.9	24.1	17.4	47.0	14.9	18.3	15.1	15.9	18.2	15.3	16.3	10.8	20.0	23.0	33.2	26.1	14.9	14.0	15.8	6.5	9.3	7.6	10.6	15.5	12.0	15.1	13.7	17.1	17.3	8.9	5.6	9.9	9.7	14.1	17.3	9.4	12.1	10.2	18.5	14.3	9.3	16.5	7.3	9.6	15.1	14.6	13.4	12.2	14.5	17.9	12.9	11.8	11.9	8.6	71.7	14.2	15.7	10.9	13.2	14.1	3.0	18.6	6.9	12.8	20.8	4.0	10.0	8.5	7.6	9.1	16.2	10.2	17.1	12.0	16.0	11.7	10.3	17.5	15.9	11.9	11.8	14.6	23.7	18.3	13.0	9.9	12.5	19.5	20.0	23.0	10.6	27.4	11.0	10.8	10.5	11.4	17.4	9.2	9.7	9.8	22.6	26.1	33.2	20.0	14.9	14.0	15.9	15.3	13.4	19.7	13.8	13.0	15.1	12.3	13.7	14.9	11.9	25.3	19.3	18.6	14.8	11.9	16.5	25.5	41.5	11.4	22.7	11.8	70.8	36.5	35.3	381.3	28.6	30.4	0.0	43.9	127.0	24.8	21.1	28.8	40.8	65.9	19.1	21.2	25.2	35.8	158.3	30.8	40.3	33.7	45.9	26.5	29.2	45.6	17.3	34.3	25.4	12.6	38.8	19.5	70.9	80.9	13.6	82.2	21.7	24.8	25.5
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0"					"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.6	2.8	2.8	6.0	3.2	3.7	3.4	12.4	8.3	14.3	8.5	1.0	3.0	3.0	16.6	5.2	41.4	4.6	2.8	3.7	23.6	3.3	2.0	1.8	1.5	2.0	8.4	1.9	4.0	3.5	2.5	12.0	41.6	5.6	5.4	4.2	2.0	2.8	13.6	1.8	4.6	3.0	2.7	1.6	9.5	3.5	7.5	1.1	11.7	2.3	2.0	4.9	8.2	1.4	9.8	3.7	2.9	3.0	8.3	15.8	55.1	10.2	38.0	1.8	1.9	2.7	10.7	2.4	9.3	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4	32.8	16.5	17.9	48.3	84.6	10.6	18.8	5.1	57.6	28.4	27.9	2.0	14.9	6.6	20.7	35.6	28.5	4.0	0.0	14.0	21.4	31.0	23.1	40.5	5.8	15.6	7.9	4.1	27.6	12.6	8.2	20.4	19.5	16.9	13.6	4.5	42.6	16.7	0.0	19.1	8.2	11.7	19.4	30.3	120.2	67.0	56.3	4.7	15.2	6.4	22.2
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046627, HPA073243"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.8	5.8	7.6	9.5	15.4	12.7	7.6	20.1	19.4	8.0	6.6	10.9	8.7	9.5	9.9	10.1	6.6	14.5	9.2	6.3	10.1	8.0	8.6	11.5	8.0	10.8	7.7	10.1	11.2	17.8	13.4	13.3	6.7	10.4	9.1	7.2	11.8	10.8	8.5	7.2	13.5	7.8	8.0	8.2	11.7	8.1	20.0	10.2	11.2	10.0	5.7	10.2	9.4	7.1	3.4	1.7	3.7	1.6	2.3	2.6	0.6	6.1	7.2	7.4	10.3	4.8	9.4	13.7	8.0	5.4	8.5	6.8	16.5	5.7	9.5	5.8	6.3	5.9	20.0	9.0	10.4	5.1	13.3	14.1	6.4	18.3	7.8	4.3	13.5	7.7	7.4	8.7	7.3	7.0	7.4	7.5	7.9	13.1	7.1	5.9	13.8	7.8	15.2	15.4	9.8	9.5	12.8	7.5	13.5	4.9	11.2	21.5	15.0	8.1	13.4	4.3	6.7	13.7	7.9	10.6	8.8	8.0	15.7	11.4	4.4	5.1	7.7	6.1	6.3	5.1	0.0	1.6	1.3	2.6	1.3	1.2	2.0	1.1	1.1	0.6	3.4	0.9	0.7	3.7	2.3	0.5	1.7	0.9	0.6	7.6	15.4	20.1	19.4	10.1	8.0	7.7	10.1	10.4	10.2	6.0	7.0	2.9	1.9	4.7	7.5	3.2	2.5	17.4	3.4	3.5	2.0	2.4	0.0	5.9	2.6	3.6	3.6	23.3	3.8	1.7	2.7	2.2	1.1	6.4	2.8	3.2	5.1	5.5	1.6	1.5	4.6	2.8	0.0	1.0	5.2	4.8	5.3	6.0	4.6	4.2	11.5	0.0	2.3	8.6	8.8	5.9	1.1	3.2	5.6	2.8
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 22.6;ovary: 32.3"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 26.8;Early spermatids: 55.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 9.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 9.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.7;OE19: 5.8;RPMI-8226: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.9	1.2	2.2	2.1	5.8	0.7	4.1	15.4	6.4	16.0	1.6	3.7	4.0	1.6	22.6	4.3	0.9	4.5	2.4	1.5	3.4	2.2	1.6	0.4	1.4	4.5	1.6	2.4	32.3	0.7	0.3	1.6	2.1	3.2	2.6	1.1	2.3	0.8	2.7	0.7	1.9	1.1	10.6	1.5	6.1	1.2	11.6	2.1	0.5	1.2	3.3	1.4	4.6	4.1	0.4	0.4	9.9	0.3	0.1	0.4	0.0	0.0	0.1	7.7	0.2	0.0	0.5	0.5	3.4	7.4	1.3	0.4	0.5	0.6	0.1	0.2	3.3	0.7	0.2	3.0	0.5	4.7	2.8	1.0	0.0	0.6	0.4	0.1	0.0	0.4	0.6	0.1	0.6	0.4	0.0	2.2	0.3	0.0	2.0	0.0	0.0	0.2	0.1	3.6	5.8	0.6	0.2	0.0	7.9	0.3	1.0	1.5	0.3	0.0	0.7	0.0	2.4	0.6	0.2	0.8	0.4	1.0	0.5	0.8	0.2	0.2	0.3	0.4	0.0	0.5	9.9	0.3	0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.4	0.2	0.4	1.7	0.1	0.1	0.4	0.1	0.0	2.2	5.8	15.4	4.3	3.4	2.2	1.6	2.4	3.2	2.1	0.0	0.3	0.0	3.7	1.5	0.0	0.8	0.0	26.8	2.3	0.0	0.0	0.0	0.0	6.2	55.3	6.8	0.0	0.0	0.0	0.1	2.5	1.8	1.1	0.0	0.2	0.0	0.0	9.2	0.3	11.7	4.9	0.2	1.7	0.0	0.0	0.3	0.6	0.0	5.3	0.0	0.0	0.0	1.7	1.4	1.6	2.4	0.1	0.0	0.0	1.2
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8, ESCRT-II complex subunit"	Q96H20	17	48929316-48945117	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA059320: AB_2683977"	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	22.5	27.8	24.9	20.6	26.2	25.2	32.4	12.9	22.6	17.9	23.5	16.6	29.7	22.1	18.9	28.7	23.0	17.7	24.9	31.5	20.1	19.2	30.8	39.0	18.2	27.3	23.9	21.5	22.3	26.7	17.9	17.4	21.7	19.0	17.6	26.8	18.3	25.2	23.1	40.7	19.2	24.0	25.7	18.2	20.7	24.7	19.8	16.0	28.3	24.0	30.9	26.2	20.5	33.8	5.2	8.3	11.2	6.7	1.7	5.7	1.5	16.2	32.6	20.3	26.0	21.3	12.3	32.1	13.7	19.0	26.9	24.2	80.0	17.0	14.9	24.1	25.8	29.8	10.8	18.9	19.4	30.1	21.3	30.6	16.5	41.3	33.7	18.6	22.3	18.8	15.2	19.4	25.7	19.8	19.7	25.2	19.8	16.3	15.2	27.4	32.5	23.9	19.1	10.0	37.4	27.8	15.8	37.1	17.6	16.1	18.2	13.5	26.9	16.5	7.8	19.5	36.9	19.7	27.6	20.9	29.2	23.2	18.1	25.6	22.4	25.5	17.8	25.7	12.1	22.5	2.3	5.7	11.2	3.2	6.2	1.8	5.2	4.8	3.7	6.4	5.2	3.2	2.7	2.3	1.7	6.7	8.3	5.7	1.5	24.9	26.2	12.9	22.6	20.1	19.2	23.9	21.5	19.0	16.0	41.7	27.2	74.6	57.6	53.0	60.3	44.8	58.6	22.7	21.6	61.1	13.7	113.8	126.0	110.9	94.7	52.8	126.5	46.7	189.8	142.2	81.0	77.8	42.7	60.4	132.7	23.8	68.0	52.2	59.1	220.7	58.1	82.3	81.0	155.1	68.0	59.1	136.4	75.9	58.4	173.8	74.5	45.3	80.6	58.1	73.3	63.2	79.5	65.1	79.7	77.0
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554344	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	10.6	13.4	10.6	13.3	12.4	15.9	15.0	18.4	14.4	12.8	10.8	10.0	14.2	8.5	14.2	11.9	13.5	11.9	10.0	8.5	11.1	9.0	9.9	20.6	10.2	11.7	10.8	10.5	12.7	15.3	9.8	13.1	13.2	9.9	13.3	9.0	12.3	11.7	11.5	13.5	13.2	12.3	11.6	7.9	14.9	11.8	21.7	11.6	16.9	10.5	11.1	14.0	11.7	17.0	3.7	4.3	4.6	3.5	3.1	5.5	1.8	6.2	3.5	7.0	6.9	8.4	8.0	4.8	8.0	9.1	7.7	6.7	3.4	5.7	8.6	6.3	8.5	5.0	6.6	6.5	7.3	6.4	7.7	9.4	13.2	6.2	6.9	9.6	12.2	7.5	7.7	8.6	7.6	9.7	8.3	7.4	6.7	9.3	8.0	5.4	4.7	7.2	9.5	11.3	5.2	8.1	7.6	11.8	7.2	5.6	6.0	5.6	11.3	8.5	5.5	10.4	7.6	4.9	6.7	12.2	6.1	6.8	7.5	7.9	9.5	11.0	7.1	7.2	8.7	5.4	4.1	3.1	3.9	5.5	2.8	5.4	3.7	3.7	5.3	2.6	3.6	5.1	4.5	4.6	3.1	3.5	4.3	4.2	1.8	10.6	12.4	18.4	14.4	11.1	9.0	10.8	10.5	9.9	11.6	17.9	14.8	3.4	10.6	14.3	10.1	4.8	5.1	10.7	19.4	5.2	7.9	4.7	1.7	6.3	4.6	6.5	7.3	0.0	6.2	4.0	8.4	7.8	11.5	10.0	3.9	9.5	8.1	12.3	8.1	7.9	7.5	5.2	8.5	7.2	8.6	11.3	6.5	6.0	7.4	3.5	15.4	0.0	7.5	10.2	13.2	15.7	8.5	10.2	6.6	11.2
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 36.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	36.4	0.5	0.0	1.1	0.0	0.9	0.2	0.5	0.4	1.0	0.4	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.6	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.4	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590199-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	9.5	7.1	12.3	11.7	14.9	15.6	12.6	28.9	13.3	10.5	10.3	7.0	13.6	9.9	11.7	8.6	9.4	9.2	7.1	12.2	11.9	7.5	10.7	12.7	8.6	11.7	14.1	8.1	14.4	10.5	7.3	11.0	9.2	11.4	10.5	10.1	5.9	10.1	13.0	15.8	11.0	11.5	10.5	17.8	11.2	9.6	5.3	14.3	15.3	10.4	7.1	10.0	9.9	30.2	3.3	2.7	6.0	2.0	2.7	3.7	1.7	5.7	4.6	9.7	18.0	5.2	7.7	6.5	6.6	6.1	7.2	8.0	9.8	4.7	13.6	7.1	5.4	6.9	7.4	12.0	7.1	11.1	10.4	11.7	9.8	14.7	18.8	5.5	11.6	6.5	5.4	11.0	8.1	6.2	8.6	6.2	12.2	13.6	2.2	10.0	3.2	19.0	16.9	13.1	9.9	5.2	20.5	8.4	18.2	6.5	5.1	15.0	4.1	12.8	3.3	11.3	18.7	6.5	4.1	6.9	9.6	4.3	5.6	11.3	3.5	19.4	8.4	3.2	9.3	17.1	0.4	2.0	1.0	2.0	1.4	3.4	1.7	2.4	2.6	2.4	3.3	2.1	3.7	6.0	2.7	0.8	2.7	1.7	1.7	12.3	14.9	28.9	13.3	11.9	7.5	14.1	8.1	11.4	14.3	17.9	9.3	14.1	18.6	31.7	17.1	25.2	5.1	8.1	21.6	8.7	19.6	13.5	10.0	15.9	2.2	20.2	18.4	0.0	17.5	12.7	12.9	15.7	23.1	19.5	13.7	4.8	10.9	13.5	16.4	2.2	16.4	16.3	8.5	21.6	15.0	15.3	10.9	15.2	15.6	13.5	17.2	6.5	17.9	10.2	17.9	29.6	13.6	17.5	13.8	18.0
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950868-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 58.0;Horizontal cells: 85.8;Late spermatids: 26.8;Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.7;HAP1: 4.1;JURKAT: 3.8;MOLT-4: 2.4;NTERA-2: 5.0;SCLC-21H: 4.9"	"Low region specificity"	"Detected in single"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	8.8	2.2	0.9	1.2	1.7	0.7	7.5	1.7	1.4	5.6	1.8	0.4	1.0	1.3	10.2	8.1	4.3	2.5	4.9	1.0	2.6	1.4	0.8	0.6	1.3	0.9	1.1	0.3	1.2	6.7	0.9	9.2	0.7	5.1	1.6	1.6	3.5	1.4	0.8	6.4	3.5	1.4	5.2	2.9	7.7	1.4	5.7	0.9	2.2	2.0	3.1	2.0	2.8	2.6	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	1.7	1.4	2.6	1.4	1.1	0.3	5.1	0.9	0.0	0.0	0.0	0.1	0.8	0.7	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	58.0	5.2	0.0	0.0	0.2	0.4	0.4	0.3	0.0	0.0	0.1	85.8	0.0	0.0	0.0	26.8	0.3	0.0	1.7	0.0	0.0	0.5	0.0	0.0	3.9	0.2	4.0	0.0	0.4	17.7	3.1	0.1	0.0	0.0	0.0	0.1
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.3	29.1	30.0	31.8	24.7	27.9	34.9	27.1	23.9	29.8	27.6	28.9	36.2	38.5	24.8	20.1	22.7	38.8	35.9	25.7	40.7	30.6	28.4	31.1	26.3	28.9	35.5	21.7	36.9	21.4	34.5	27.0	37.4	32.5	28.9	37.0	44.4	28.9	22.8	40.3	38.6	36.9	33.5	44.5	39.3	41.8	38.8	26.4	27.7	36.5	32.3	34.9	37.3	33.0	37.3	32.2	47.3	41.8	30.6	32.8	37.5	29.5	32.3	28.7	40.6	42.8	29.7	35.0	36.1	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3	86.4	43.0	62.2	66.5	50.3	55.1	46.0	43.3	109.7	79.6	50.6	33.4	68.5	64.6	65.3	25.3	65.0	31.6	46.7	61.0	83.4	54.9	37.6	88.0	26.6	66.2	36.5	41.9	45.4	48.4	16.5	72.2	71.0	37.1	92.0	37.1	67.4	58.2	45.0	69.6	39.6	63.7	64.7	69.5	252.6	138.5	47.4	91.2	73.9	40.5	62.2
SNX22	FLJ13952	ENSG00000157734	"Sorting nexin 22"	Q96L94	15	64151715-64157481	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;thyroid gland: 41.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 140.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 6.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 11.5"	"Cell line enriched"	"Detected in some"	4	"Daudi: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038470			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038470: AB_10673174"	"prognostic favorable (2.89e-5)"	"unprognostic (8.93e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.74e-2)"	1.1	1.5	11.9	7.6	8.9	10.2	1.2	3.4	16.5	0.7	1.1	23.2	11.8	1.5	1.2	3.5	0.9	0.8	1.3	7.9	13.4	9.0	1.1	1.9	4.7	11.4	13.7	8.1	1.3	1.6	0.4	2.2	1.0	12.3	3.0	0.7	0.0	3.6	8.4	0.7	2.0	2.2	0.9	17.0	6.1	2.1	1.0	6.6	1.6	41.1	0.0	13.3	2.1	0.3	11.5	1.2	0.0	0.2	0.1	0.1	1.6	0.2	0.4	0.9	0.8	0.1	0.0	0.7	0.8	0.0	0.0	0.2	0.4	0.9	19.9	0.5	0.1	0.5	0.4	1.7	0.0	0.0	0.1	2.4	0.4	2.2	2.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.6	3.3	0.0	1.2	0.2	0.0	1.4	0.5	0.3	4.1	0.3	1.2	0.8	0.8	4.6	0.9	0.2	0.7	0.0	0.8	2.0	0.0	0.0	1.1	1.4	0.3	0.5	4.3	1.8	4.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.2	11.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.6	11.9	8.9	3.4	9.3	13.4	9.0	13.7	8.1	12.3	6.6	26.8	9.1	15.2	1.7	1.3	0.8	14.2	0.0	0.0	1.2	0.0	3.9	2.7	0.0	0.4	1.1	0.7	0.7	140.2	3.2	6.1	3.6	3.9	2.3	3.4	4.0	0.0	0.0	2.5	2.2	1.7	0.6	2.7	3.3	1.8	0.8	0.5	1.8	0.0	0.4	1.8	1.8	0.0	1.0	1.1	1.2	2.5	3.3	2.1	0.6	1.4
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.9	8.9	9.5	11.9	15.0	11.1	21.1	3.2	6.7	5.7	6.2	7.2	8.0	5.7	7.1	5.2	6.2	7.5	12.1	6.5	7.2	8.1	4.5	9.1	5.2	8.1	10.0	10.8	6.3	8.8	4.9	6.5	7.5	5.8	6.4	9.1	5.5	35.1	7.5	10.7	6.4	7.5	16.7	11.8	5.8	6.7	9.2	7.3	8.9	9.0	9.5	8.1	8.7	16.2	6.2	10.7	10.4	9.2	8.5	8.1	5.5	8.4	6.7	7.4	7.4	11.5	9.7	7.0	9.0	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7	11.9	21.9	11.2	13.8	18.8	42.4	25.5	20.4	8.1	15.9	27.9	25.5	40.5	21.6	21.5	23.7	16.1	12.3	23.3	18.3	18.4	17.5	15.0	3.5	17.9	37.8	38.1	18.0	22.7	76.7	6.6	28.1	28.6	28.7	32.5	15.2	22.7	21.5	10.5	37.4	51.8	27.3	32.3	19.4	41.7	29.4	21.7	87.6	12.9	15.8	13.2
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107489958-107660167	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.3;Horizontal cells: 87.4;Late spermatids: 46.7;Peritubular cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.0;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 11.0;AN3-CA: 14.2;ASC diff: 13.5;HDLM-2: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	7.6	12.0	19.3	4.4	15.6	1.3	3.6	15.1	30.2	12.7	12.8	11.0	2.5	3.7	9.0	5.5	5.6	6.2	7.6	17.0	18.0	12.4	5.8	3.6	5.0	2.9	12.5	14.9	21.6	3.9	10.9	12.0	6.1	9.6	13.0	4.2	7.4	21.1	7.0	22.1	1.5	3.4	14.3	9.6	4.7	5.6	9.1	11.1	1.0	6.1	4.1	3.3	14.8	8.0	4.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	11.0	14.2	13.5	5.2	1.3	0.1	0.0	0.3	0.6	0.0	0.0	5.8	0.4	0.0	1.0	0.0	7.3	0.2	0.2	9.3	6.9	0.7	0.0	6.8	1.8	3.0	0.6	5.4	0.0	5.3	0.0	1.1	4.4	2.7	0.0	0.3	0.0	2.9	1.4	0.3	2.6	0.2	0.9	3.3	1.4	0.0	0.0	0.2	3.6	5.9	1.3	0.0	0.1	0.5	0.5	2.1	0.1	3.5	1.2	6.0	0.5	2.8	0.5	3.8	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.2	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	19.3	15.6	15.1	20.6	18.0	12.4	12.5	14.9	9.6	11.1	3.0	9.8	8.5	8.9	0.5	36.8	20.2	28.1	16.0	5.7	22.7	0.0	0.1	0.0	1.9	68.3	2.8	0.0	0.0	0.2	0.6	7.3	8.4	0.0	0.6	2.3	87.4	10.4	3.7	7.4	46.7	41.7	1.6	3.3	0.0	0.0	6.9	0.5	0.0	46.0	9.8	9.8	25.8	16.1	3.0	2.2	0.6	0.1	0.0	0.0	0.7
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 63.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.9	1.0	7.5	0.4	0.6	0.3	0.2	2.9	2.2	0.4	1.4	0.5	0.2	0.1	0.1	48.3	0.3	0.8	0.0	3.9	0.7	0.0	8.9	0.7	0.1	1.0	0.1	0.2	0.1	0.3	6.4	0.8	0.0	1.1	3.2	1.8	5.4	0.0	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	1.5	0.0	0.4	0.0	0.6	3.2	0.4	0.6	0.2	0.2	4.5	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4	0.0	4.1	11.5	14.7	10.9	1.9	9.2	5.1	2.7	0.0	48.8	5.9	21.5	19.9	11.3	40.7	3.6	23.6	0.0	7.3	4.3	30.9	5.9	54.0	2.4	4.0	0.0	25.0	10.4	6.5	17.6	6.6	8.4	28.7	24.4	12.9	7.4	6.9	9.1	39.3	7.0	4.2	0.0	16.5	0.9	2.0	5.9	48.3	63.1	6.6	10.8
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049488	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	14.5	11.1	12.5	16.0	21.2	12.7	12.2	12.6	19.1	11.4	12.0	14.0	8.7	11.1	13.6	9.3	13.2	13.9	15.0	13.9	15.5	10.9	17.6	10.6	16.7	18.0	22.6	10.5	12.6	10.2	12.8	18.5	12.4	17.0	11.7	12.8	7.2	11.9	10.3	12.3	10.5	13.2	17.5	29.6	16.4	15.1	9.5	19.6	16.2	15.3	6.5	16.0	16.1	18.9	3.8	4.1	4.5	5.8	6.0	4.9	2.0	10.8	9.4	12.8	15.0	8.4	9.8	10.2	12.7	9.4	8.1	13.4	7.7	11.7	16.4	9.0	9.5	7.8	15.2	17.4	10.3	19.0	16.8	7.0	9.7	12.2	4.6	8.6	11.1	17.2	7.8	10.7	14.6	10.7	9.0	14.6	16.5	5.8	16.5	14.7	10.8	16.6	8.1	10.1	8.7	10.2	15.4	20.0	6.3	11.6	12.0	17.1	14.7	12.8	7.7	12.1	12.2	10.8	8.2	14.8	20.9	21.1	10.2	10.8	5.9	6.3	15.8	13.5	9.0	16.0	1.7	4.2	4.5	3.2	4.9	4.9	3.0	4.0	3.0	3.1	3.8	2.2	2.4	2.6	6.0	5.8	4.1	3.6	2.0	12.5	21.2	12.6	19.1	15.5	10.9	22.6	10.5	17.0	19.6	6.0	11.3	20.6	7.6	21.3	13.1	17.3	7.6	18.7	20.5	14.0	19.6	4.4	11.6	8.1	3.7	15.8	11.5	0.0	7.6	4.8	10.8	6.5	31.3	7.8	6.6	35.0	19.5	15.4	10.4	1.5	6.6	12.4	3.3	15.4	7.9	14.5	11.8	7.2	9.6	11.3	14.5	0.0	20.0	15.1	11.3	20.3	4.1	15.2	6.9	7.9
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;pituitary gland: 11.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.8	2.8	5.0	1.8	5.3	0.4	0.4	11.4	15.3	1.0	0.8	3.7	0.0	0.5	2.1	0.2	2.0	1.0	1.9	0.8	4.2	4.5	0.6	0.6	1.7	0.8	6.7	5.0	3.3	1.7	0.2	11.9	1.2	7.9	1.1	0.6	0.7	1.1	0.5	0.3	1.0	1.9	0.6	11.4	1.4	3.9	1.8	4.3	0.0	1.9	0.0	0.3	1.6	0.8	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.2	3.3	7.5	1.1	0.0	0.6	0.3	0.7	0.9	0.9	2.4	0.2	0.3	0.4	0.2	0.1	6.2	0.0	0.8	0.0	0.7	0.7	0.1	0.6	0.0	0.1	0.0	0.2	0.1	1.2	0.0	3.7	0.0	0.8	0.0	1.1	0.3	0.2	0.5	0.5	4.9	0.0	3.4	0.0	0.8	0.4	1.8	0.0	0.1	0.0	24.3	13.9	0.0	0.0	0.2	0.9	0.0	0.3	0.2	6.0	1.2	0.4	1.7	0.2	0.1	0.1	4.5	1.1	5.9	0.0	0.0	0.0	0.3	0.0	0.4	0.3	2.3	0.8	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.0	5.3	11.4	8.2	4.2	4.5	6.7	5.0	7.9	4.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 66.5;Muller glia cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061916: AB_2684636"	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.5	0.0	6.6	4.2	1.1	16.6	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.2	0.1	0.0	12.5	0.2	3.7	5.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.7	0.0	1.3	7.4	0.2	0.0	0.7	0.6	12.0	0.0	0.0	0.7	0.0	7.0	0.0	4.3	1.3	0.0	0.1	0.0	0.0	0.0	1.4	7.3	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3	3.0	13.7	0.0	0.2	0.1	66.5	2.0	0.0	2.7	7.9	5.2	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.2	1.6	0.0	0.0	0.3	10.2	11.8	0.3	1.7	0.0	0.0	31.9	0.7	0.0	7.4	0.7	2.4	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.4
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117120-50231558	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917"	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	16.0	12.9	16.9	10.5	17.8	25.2	13.4	15.8	14.5	12.9	20.1	19.8	23.4	15.5	14.9	17.3	12.7	11.2	11.4	15.3	17.7	13.4	18.4	9.4	12.5	15.6	19.9	9.8	11.8	11.6	38.6	20.5	30.1	15.1	13.0	13.0	11.1	14.3	14.7	37.1	13.0	26.7	18.3	23.1	17.0	12.1	19.2	16.8	14.7	18.7	14.6	10.3	15.3	15.0	1.2	2.1	8.5	2.8	2.4	1.8	0.6	9.6	7.1	14.6	9.7	11.2	12.3	6.9	8.7	9.7	6.6	8.3	3.1	12.9	10.2	7.9	11.1	11.5	8.9	7.8	6.6	11.8	17.0	2.9	10.2	5.6	5.4	12.4	12.0	11.0	12.7	16.3	6.2	14.4	16.8	14.2	8.5	7.8	25.6	15.8	8.0	9.9	9.5	4.5	7.3	6.3	10.7	20.3	7.6	10.7	9.2	10.6	12.4	9.7	11.5	11.4	11.0	12.7	14.7	15.5	18.3	12.0	8.2	5.6	18.1	19.6	12.6	4.7	6.7	10.7	8.5	1.8	4.1	1.8	1.4	1.5	0.9	1.1	1.3	1.2	1.2	1.3	1.2	7.2	2.4	2.8	2.1	0.1	0.6	16.9	17.8	15.8	14.5	17.7	13.4	19.9	9.8	15.1	16.8	8.9	19.9	1.9	15.2	31.7	16.1	38.0	20.4	14.7	19.4	17.4	15.7	6.4	6.6	10.3	9.6	23.3	24.9	0.0	9.2	6.6	14.1	24.6	19.7	11.9	8.1	23.8	19.5	18.4	30.6	5.6	11.5	17.9	16.9	1.8	18.1	18.5	11.9	22.9	12.7	12.7	22.5	19.4	17.6	38.0	6.9	34.6	10.9	17.3	11.7	28.4
SOX11		ENSG00000176887	"SRY-box 11"	P35716	2	5692667-5701385	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 10.1;Ductal cells: 2.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 26.5;NTERA-2: 12.9;REH: 9.4;RH-30: 10.1;SCLC-21H: 16.3;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.5	0.5	4.2	0.5	7.1	0.6	0.6	0.3	12.3	0.4	3.3	5.8	0.0	0.6	0.7	0.6	0.5	0.5	0.6	5.3	4.4	5.1	0.5	0.5	0.6	0.5	3.3	5.0	0.5	0.4	0.5	0.7	0.5	4.5	0.5	0.8	0.0	0.9	0.4	1.0	0.6	0.7	1.3	6.3	1.0	0.6	3.7	3.6	0.0	0.6	0.0	0.6	0.5	0.1	1.1	0.8	3.1	1.5	1.6	1.1	0.5	0.0	0.0	26.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	2.4	0.0	0.0	0.0	12.9	0.0	0.0	9.4	10.1	0.4	0.0	0.0	16.3	24.6	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.8	0.3	0.6	0.0	0.0	6.1	3.1	0.5	1.0	0.5	0.8	1.1	1.1	0.6	0.7	0.6	0.7	0.9	0.9	1.6	1.6	1.5	0.8	0.9	0.5	4.2	7.1	0.3	6.4	4.4	5.1	3.3	5.0	4.5	3.6	0.0	0.0	0.0	0.0	0.0	1.3	10.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	2.5	0.7	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in many"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	0.7	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	14.2	15.6	30.0	0.1	0.0	1.1	4.3	47.6	4.5	9.9	2.6	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	17.3	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0											184.6	59.8	33.5	82.0	99.9	88.8	228.6	341.4	161.9	235.4	146.5	11.8	61.5	56.3	757.4	3.9	238.0	78.0	0.0	523.0	358.6	243.9	126.1	56.8	5.8	33.0	46.1	327.2	70.6	85.2	8.3	11.2	56.1	231.2	80.2	156.9	228.7	1059.7	155.6	10.6	77.4	25.8	6.5	198.6	3.7	175.2	81.3	25.3	23.5	265.6	178.0
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230544090	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 65.8"									"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	39.7	27.7	7.0	44.0	12.9	56.8	33.4	3.4	9.4	25.6	28.3	5.5	19.1	15.3	18.9	20.5	22.5	16.1	20.3	32.3	7.1	5.3	21.7	24.8	36.0	48.5	13.0	4.0	23.8	19.9	1.8	13.7	25.1	10.9	24.0	12.4	13.9	23.4	17.6	14.6	17.3	35.4	20.2	15.6	52.2	18.6	9.8	10.6	25.9	31.6	17.8	37.4	27.0	34.7	44.1	17.4	75.6	25.2	30.8	33.2	26.1	13.3	4.1	0.2	1.8	21.0	34.0	3.2	17.5	39.3	40.8	65.8	2.4	15.9	6.2	14.2	18.9	24.5	6.6	0.2	16.7	29.9	14.9	0.5	10.7	6.9	5.4	30.3	12.5	14.7	27.9	9.9	19.5	17.7	30.4	30.6	5.1	5.5	10.3	15.5	3.6	7.8	13.4	0.6	5.9	6.4	5.9	9.5	4.3	11.6	11.5	0.1	0.2	7.0	2.3	30.1	0.7	2.1	13.1	36.9	19.7	5.2	11.9	10.0	12.9	4.2	14.0	18.8	13.8	9.5	31.8	22.5	28.6	33.2	19.2	26.3	38.9	32.3	28.5	16.8	44.1	31.0	27.3	75.6	30.8	25.2	17.4	29.1	26.1	7.0	12.9	3.4	9.4	7.1	5.3	13.0	4.0	10.9	10.6	142.9	51.2	83.5	61.5	62.8	0.4	58.9	38.2	71.0	64.8	31.4	2.0	26.2	36.5	81.6	3.8	123.3	44.5	70.0	92.3	63.1	69.1	56.3	53.4	31.4	71.8	0.0	8.6	55.9	66.9	2.4	43.1	86.3	67.4	78.5	26.5	0.3	77.0	45.2	49.5	37.0	0.5	38.8	63.4	0.6	0.6	59.6	13.5	108.3	22.5	63.6
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	18.8	15.0	16.9	21.9	20.5	19.1	21.0	28.5	23.4	17.3	16.3	26.9	12.5	16.9	20.5	16.2	19.9	18.3	14.9	20.2	13.8	11.8	17.2	13.3	17.4	22.3	14.1	13.0	20.5	19.7	31.0	14.5	21.4	18.5	16.2	15.8	26.9	18.7	18.2	30.2	19.2	20.8	16.6	17.6	22.2	16.5	23.2	16.3	31.9	21.7	16.0	28.3	18.9	18.0	8.3	6.3	14.3	9.3	12.7	11.5	7.8	16.5	19.2	13.2	11.1	6.5	6.1	12.6	9.8	7.2	10.2	9.2	20.9	8.4	14.4	8.8	12.8	10.3	12.8	9.2	8.5	10.7	20.9	12.9	14.6	12.9	10.8	6.1	13.0	17.3	8.8	10.1	11.9	11.3	7.2	9.6	13.4	15.8	24.6	9.8	22.5	32.1	8.2	5.9	15.0	12.8	14.6	18.1	9.0	7.1	26.9	13.2	15.8	8.5	9.1	9.7	8.5	13.1	12.4	15.8	17.9	9.6	12.4	15.0	21.9	24.2	12.9	9.7	8.8	14.4	14.3	8.0	12.1	11.5	9.3	10.1	7.0	8.8	10.7	6.3	8.3	10.2	10.3	14.3	12.7	8.1	6.1	8.8	7.8	16.9	20.5	28.5	23.4	13.8	11.8	14.1	13.0	18.5	16.3	8.9	21.6	8.3	13.7	5.6	8.4	8.3	2.5	12.0	5.7	10.4	0.0	9.2	13.3	5.9	7.9	10.0	7.7	0.0	6.7	7.7	6.0	10.4	12.7	5.8	7.8	11.1	15.0	5.5	8.5	7.5	9.8	9.2	8.5	7.2	8.9	11.3	5.4	11.5	3.2	5.9	5.9	6.5	7.8	9.1	7.2	6.6	17.2	12.5	7.3	14.5
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.1	8.1	1.5	1.0	1.5	2.3	1.7	2.7	3.7	3.5	2.7	9.2	1.4	1.5	7.2	2.8	7.5	2.2	5.3	2.7	2.8	4.8	3.3	1.5	1.1	4.0	5.7	1.1	1.9	2.9	3.3	1.4	5.4	6.7	6.0	7.0	2.2	1.0	9.3	2.9	12.3	4.3	2.1	20.9	8.7	3.3	0.9	1.6	6.6	8.2	5.3	2.4	1.8	5.1	2.6	2.9	2.3	4.4	5.5	2.7	4.2	9.3	7.3	14.4	2.5	6.4	6.1	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0	3.0	7.0	5.0	11.4	11.2	15.9	7.6	10.2	1.4	7.9	0.0	7.9	1.0	0.0	1.7	5.5	5.8	1.1	0.0	1.8	1.0	6.1	7.1	4.7	4.0	1.5	17.5	10.3	11.6	6.5	4.1	5.2	5.9	6.8	2.8	1.8	9.8	1.4	8.6	6.3	1.4	18.8	0.0	4.1	7.9	8.3	9.7	1.3	14.6	2.8	4.3
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715351-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 51.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Group enriched"	"Detected in many"	4	"cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6"	HPA074123			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA074123: AB_2686664"	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	8.7	1.8	0.5	2.5	0.6	0.1	7.4	1.6	1.0	11.4	3.9	1.4	3.2	3.1	7.2	3.0	1.9	3.0	5.1	0.8	0.6	1.4	0.8	5.9	4.6	3.1	0.2	0.8	1.5	0.5	0.1	0.1	2.1	0.4	7.2	1.0	3.8	2.1	0.9	0.7	6.6	3.1	3.1	0.1	0.2	7.3	2.4	0.0	0.2	0.1	0.8	6.5	3.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	0.0	1.5	0.1	0.2	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.6	1.0	0.6	1.4	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.9	3.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.3	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.9	0.0
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589435-141590772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002591-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 38.5"	"Group enriched"	"Detected in some"	136	"Early spermatids: 450.0;Late spermatids: 1630.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 41.1;GAMG: 8.8;U-2 OS: 14.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	41.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	14.4	1.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	450.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1630.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	6.5	0.0	7.6	4.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 27.3"	"Group enriched"	"Detected in some"	194	"Early spermatids: 365.4;Late spermatids: 1260.1"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 13.3;U-2 OS: 6.5"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (3.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	13.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	6.5	0.0	0.5	0.0	0.0	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	365.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1260.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0
SPANXD	"CT11.4, SPANXE"	ENSG00000196406	"SPANX family member D"	Q9BXN6	X	141697411-141698739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	216	"testis: 21.5"	"Group enriched"	"Detected in some"	148	"Early spermatids: 386.5;Late spermatids: 1076.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 5.1;U-2 OS: 9.8"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	9.8	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	386.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1076.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.1	1.5	0.0	0.0	0.0	0.0	0.0
SPANXN2	"CT11.7, SPANX-N2"	ENSG00000268988	"SPANX family member N2"	Q5MJ10	X	143711955-143721423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 5.6"	"Group enriched"	"Detected in some"	121	"Early spermatids: 41.8;Late spermatids: 95.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
SPANXN3	"CT11.8, SPANX-N3"	ENSG00000189252	"SPANX family member N3"	Q5MJ09	X	143508735-143517475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 28.4"	"Group enriched"	"Detected in some"	116	"Early spermatids: 353.2;Late spermatids: 183.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2 OS: 6.6"									HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	353.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.8	7.8	12.9	12.6	8.1	9.6	11.6	6.0	8.9	6.3	5.7	10.6	9.5	19.0	5.6	8.3	9.3	7.7	12.7	6.1	7.8	12.7	7.6	20.8	4.2	12.9	7.4	14.5	14.7	5.3	8.1	8.1	7.7	7.7	13.9	6.2	17.0	6.4	6.9	4.6	23.3	12.2	13.4	12.1	4.6	12.4	18.1	12.3	8.6	6.8	18.3	19.7	10.2	8.7	10.0	11.0	5.6	10.0	12.1	7.0	10.8	6.2	7.0	9.7	18.0	15.4	7.6	12.6	8.4	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6	8.9	4.1	4.2	5.3	8.5	14.5	7.5	7.6	13.4	6.8	5.2	21.6	7.6	0.0	5.6	2.5	8.7	9.7	0.0	7.0	6.2	5.0	7.3	9.3	10.9	8.8	9.5	10.4	6.2	14.6	6.4	8.1	16.6	1.7	8.2	10.1	8.0	8.4	8.4	9.6	6.5	14.3	0.0	8.1	15.4	22.2	11.4	6.8	7.5	8.4	5.5
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.6;HDLM-2: 26.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	5.5	11.8	14.7	13.9	23.7	21.4	11.8	5.5	15.2	9.2	8.8	33.7	10.9	9.4	7.8	11.9	3.2	8.2	9.8	6.4	15.3	10.5	13.1	17.8	15.3	16.8	27.9	7.4	12.1	29.7	6.1	8.3	13.7	17.7	12.1	10.2	7.5	6.8	9.8	2.4	6.3	11.5	6.2	25.7	47.8	13.8	5.2	27.2	11.9	10.7	3.1	12.8	6.5	4.5	1.2	2.5	19.3	4.7	9.6	17.7	5.8	1.8	2.9	15.3	1.9	0.5	1.3	0.6	4.5	19.6	2.3	2.0	3.7	7.7	11.7	2.4	4.1	1.2	3.4	4.3	1.3	5.9	26.4	5.2	2.8	2.2	4.3	0.7	4.5	2.2	1.7	0.2	2.5	1.4	2.0	3.8	6.3	0.0	9.9	2.4	6.4	8.2	1.5	5.0	12.4	3.8	7.2	5.9	6.2	10.4	5.8	5.6	4.3	0.9	9.7	8.7	3.5	1.4	2.6	4.4	3.0	2.4	0.2	3.2	2.3	0.0	0.0	2.6	4.3	14.4	2.4	3.1	0.0	17.3	4.0	13.5	1.2	14.7	17.7	2.2	1.0	15.6	16.0	19.3	9.6	4.7	2.5	13.8	5.8	14.7	23.7	5.5	15.2	15.3	10.5	27.9	7.4	17.7	27.2	3.0	25.8	4.5	1.9	4.7	0.7	3.6	0.0	45.5	27.3	14.0	0.0	1.0	3.3	16.3	8.1	18.2	21.2	0.0	13.6	11.9	11.0	26.3	66.1	0.0	10.1	0.0	31.0	0.0	0.0	5.1	6.9	13.4	5.0	1.0	24.3	20.0	17.3	31.7	7.1	4.7	0.5	0.0	7.1	1.9	1.9	5.4	18.7	13.1	22.8	7.8
SPATA17	IQCH	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 48.0"	"Cell type enhanced"	"Detected in many"	21	"Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.5	0.6	1.4	0.3	5.2	2.4	0.9	0.5	1.2	1.0	0.5	2.7	2.9	0.6	0.7	9.7	0.5	6.8	0.8	1.1	2.3	2.2	2.8	0.4	3.0	0.3	0.8	1.6	3.3	0.6	3.0	10.8	0.4	11.1	0.7	0.3	1.2	0.6	1.2	2.9	1.0	0.7	0.2	0.7	0.4	0.6	48.0	1.4	0.0	3.1	0.3	0.2	0.5	0.5	1.3	0.6	2.3	0.6	0.6	1.0	0.1	0.6	1.2	1.2	1.2	0.3	2.0	0.9	0.5	0.7	0.6	0.3	0.8	3.2	0.6	1.0	0.4	0.4	2.2	0.8	1.1	0.7	0.6	1.2	0.5	1.5	0.8	0.6	0.3	0.5	0.7	2.3	1.2	1.2	1.4	0.1	0.7	0.7	1.3	0.6	2.5	0.4	1.0	2.3	1.6	1.2	0.4	0.4	0.4	2.3	0.9	4.8	1.9	0.7	0.8	0.6	2.0	1.5	0.6	0.6	0.8	0.6	0.9	0.5	1.3	0.8	0.3	1.9	0.5	1.1	2.3	0.5	0.5	0.9	0.5	0.8	0.7	0.7	0.7	0.3	1.3	0.9	1.0	1.5	0.6	0.6	0.6	0.3	0.1	1.4	5.2	0.5	1.2	2.3	2.2	0.8	1.6	11.1	1.4	3.0	0.0	0.0	0.8	0.6	0.4	1.4	0.0	161.9	25.0	3.5	19.6	0.7	5.0	1.7	584.1	0.5	0.0	0.0	0.6	0.5	0.7	1.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	424.1	8.1	0.7	1.7	0.0	1.0	5.1	0.2	0.0	6.3	8.4	18.5	0.0	0.1	138.2	8.1	0.9	0.2	0.0	0.6	0.4
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915508	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	4.6	6.2	15.3	5.4	19.3	15.4	5.7	16.6	25.7	5.8	10.5	12.8	4.1	11.7	5.4	6.0	5.7	7.1	5.5	5.5	15.2	11.4	5.8	5.4	5.4	5.1	14.4	15.4	6.0	11.9	7.6	6.9	5.5	10.6	8.1	9.8	5.9	8.8	6.6	12.9	5.1	11.2	5.0	19.9	15.6	8.7	18.5	10.2	4.6	11.0	4.0	5.5	5.2	3.6	4.9	3.3	6.1	3.5	3.4	4.8	2.3	5.5	6.9	4.7	4.2	5.4	3.9	7.7	3.6	5.4	12.6	5.3	21.6	4.5	4.3	7.6	3.6	6.5	10.4	3.5	6.0	6.7	5.9	3.4	2.2	4.0	14.0	5.1	6.1	9.2	3.9	7.2	6.5	4.1	4.2	2.6	6.1	7.6	4.9	3.0	11.8	6.1	15.4	7.1	7.6	8.4	4.7	5.1	4.5	4.1	4.4	4.5	4.8	7.2	22.1	5.6	3.8	5.3	5.3	3.7	9.0	7.4	7.4	5.0	12.2	9.3	4.6	7.1	3.2	4.0	0.3	3.5	3.3	3.7	2.5	3.5	3.6	3.4	4.5	3.3	4.9	4.5	4.8	6.1	3.4	1.3	1.6	3.8	2.3	15.3	19.3	16.6	25.7	15.2	11.4	14.4	15.4	10.6	10.2	8.9	2.1	3.9	5.7	6.5	7.4	3.9	12.7	5.3	0.0	0.0	7.9	9.5	3.3	5.2	31.9	6.3	19.1	0.0	7.1	10.6	5.8	5.5	4.6	5.7	4.2	6.4	25.3	9.8	5.7	41.2	4.6	3.4	5.0	5.4	20.8	4.8	7.0	16.5	5.3	3.6	7.5	6.5	5.1	32.5	16.1	6.4	25.2	4.4	16.1	7.0
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404088	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.2"	"Group enriched"	"Detected in many"	20	"Early spermatids: 924.4;Late spermatids: 2355.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	1.0	2.8	3.6	1.0	3.2	0.3	1.4	1.5	2.7	1.3	1.6	2.7	1.8	2.5	1.6	9.4	1.4	6.4	2.9	8.5	3.4	2.6	6.2	1.9	1.9	2.5	2.4	2.1	1.6	2.2	6.1	7.0	1.0	3.2	2.2	0.9	1.7	3.2	1.5	8.7	0.9	2.6	1.9	2.7	1.9	1.5	52.2	2.1	1.8	2.9	3.4	1.9	1.8	3.5	5.7	3.6	2.0	3.1	2.4	7.7	2.5	6.5	4.1	5.9	3.1	1.7	3.3	4.7	1.6	3.1	3.4	6.1	9.4	8.7	10.4	4.9	3.2	11.7	3.6	4.4	7.2	3.8	41.6	5.1	3.2	7.7	7.1	6.5	0.7	5.7	2.8	3.6	5.1	6.2	3.9	4.1	6.7	3.1	18.3	4.6	3.7	6.5	5.0	4.3	2.6	3.6	15.4	3.9	14.1	8.1	3.3	4.5	4.1	6.3	12.3	2.9	14.8	3.5	7.2	7.6	2.0	2.8	3.9	4.7	4.5	4.2	9.6	4.0	5.4	1.7	0.0	3.1	2.0	4.6	2.3	6.5	5.7	4.9	5.5	3.6	3.3	5.5	7.7	0.2	2.4	0.9	2.1	2.4	2.5	3.6	3.2	1.5	2.7	3.4	2.6	2.4	2.1	3.2	2.1	0.0	2.6	9.0	5.0	1.4	0.2	20.1	7.6	24.1	3.4	5.2	7.9	5.0	11.6	4.0	924.4	4.2	3.2	0.0	1.6	2.8	2.1	3.1	0.0	3.4	4.1	1.6	0.0	4.9	2.1	2355.8	13.3	1.4	1.7	1.0	1.1	2.0	3.3	2.9	12.7	23.3	1.3	25.8	3.6	81.7	16.6	1.6	3.8	2.5	3.3	4.8
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657802-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1519.3;Late spermatids: 2991.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: AB_2686570"	"unprognostic (1.05e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	2.0	2.7	6.9	2.8	7.3	3.3	3.2	7.8	7.7	2.9	2.9	4.3	1.8	4.8	3.2	9.2	2.7	14.8	3.7	2.1	6.0	5.7	5.3	2.9	4.3	2.3	4.7	6.5	2.1	3.0	4.0	7.3	1.9	5.3	3.2	3.4	2.5	2.4	2.8	1.5	4.1	5.7	2.6	3.6	3.0	3.8	70.4	4.3	2.4	5.1	2.2	3.1	2.1	2.5	5.7	5.5	5.8	3.3	7.3	6.3	3.6	10.3	9.9	12.3	4.4	3.3	2.9	4.3	7.0	2.9	10.2	4.4	9.3	8.7	1.1	3.8	4.7	6.9	14.0	5.4	3.8	7.7	2.0	7.6	1.7	12.0	13.7	1.5	2.2	4.2	3.0	4.5	7.0	3.0	3.9	2.3	9.6	11.1	1.5	6.6	12.1	6.5	5.6	6.8	6.2	7.6	13.3	6.8	3.4	6.0	3.5	11.5	6.3	15.6	2.9	3.8	5.8	12.7	3.0	2.1	7.9	9.8	6.6	5.6	3.6	5.3	4.1	7.7	12.4	2.8	5.8	3.3	5.4	5.2	3.2	6.3	5.7	4.7	6.2	2.6	3.2	5.2	4.1	4.1	7.3	2.9	5.5	3.5	3.6	6.9	7.3	7.8	7.7	6.0	5.7	4.7	6.5	5.3	4.3	6.0	8.9	5.1	7.9	6.4	17.7	5.2	10.2	109.7	13.6	27.9	60.9	3.2	19.9	12.3	1519.3	10.2	15.9	0.0	15.4	4.9	10.5	5.5	1.1	9.8	7.9	22.3	16.8	8.6	2.7	2991.1	28.1	7.3	16.9	4.6	8.9	16.6	11.2	8.6	22.3	26.7	69.1	12.9	12.3	232.7	101.0	6.1	1.1	12.5	12.0	5.5
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402331-45421419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	9.0	8.7	10.7	12.3	10.7	11.1	9.5	21.3	8.2	10.3	9.9	10.0	10.2	12.1	9.8	8.4	17.5	8.8	8.3	9.6	9.6	5.9	10.8	14.8	11.2	14.1	13.5	5.8	12.9	12.0	7.6	7.6	10.6	8.9	9.9	10.2	7.2	9.4	12.8	15.9	16.1	13.2	9.4	7.1	8.6	8.2	12.1	12.0	9.9	11.2	12.3	10.9	10.2	11.9	3.6	3.3	4.8	6.4	3.3	4.7	0.7	7.1	5.5	7.4	5.4	6.1	6.0	9.0	6.4	5.8	7.0	6.9	12.6	4.7	5.2	7.1	4.2	12.8	16.5	11.0	8.0	7.9	7.1	6.1	6.8	8.8	9.8	7.0	9.1	2.9	4.9	9.2	5.7	7.7	8.0	5.5	6.9	11.0	8.5	7.8	4.8	6.3	17.5	5.3	18.0	7.1	7.0	10.4	4.9	8.7	7.1	10.2	5.2	5.3	11.6	5.7	9.2	10.2	16.7	3.4	3.4	5.2	20.8	13.6	7.2	14.4	8.1	8.8	15.1	6.1	0.1	2.8	4.8	4.1	2.6	1.5	1.9	2.8	4.7	3.3	3.6	2.9	3.0	4.2	3.3	6.4	2.5	2.6	0.7	10.7	10.7	21.3	8.2	9.6	5.9	13.5	5.8	8.9	12.0	0.0	1.4	5.4	5.2	4.4	5.7	5.6	10.2	0.0	4.5	3.5	15.7	10.2	3.3	5.6	17.3	6.0	5.5	0.0	6.4	8.8	4.6	3.8	4.6	5.0	6.8	6.4	3.5	0.6	4.3	5.3	7.2	4.1	3.3	6.4	7.2	4.4	4.8	0.0	3.5	4.9	6.5	0.0	4.7	5.4	5.7	5.9	5.6	4.9	7.5	7.0
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9.0	20.8	17.6	6.8	8.5	14.3	10.6	11.0	10.8	11.0	9.1	28.0	23.0	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23.0	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16.0	21.4	21.0	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20.0	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7	0.0	0.3	0.0	0.8	1.0	0.0	7.0	2.5	0.0	1.2	5.2	5.9	3.0	0.0	0.2	0.1	0.1	0.7	70.0	0.0	13.5	4.0	0.3	5.7	0.0	11.2	0.0	2.4	2.5	2.8	1.7	0.6	1.3	0.0	0.0	1.1	0.9	0.2	0.0	0.4	0.4	0.3	0.0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in many"	6	"Glandular cells: 80.8;Mucus-secreting cells: 228.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055707			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.1	0.0	28.3	9.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.5	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1	0.0	2.1	0.0	12.1	0.1	0.0	0.1	2.5	0.0	3.4	0.0	0.0	0.0	0.0	3.2	1.1	0.0	8.1	0.0	1.1	0.0	0.0	80.8	0.0	0.0	0.0	0.0	5.2	0.6	0.0	2.9	0.0	0.0	3.3	0.0	228.3	0.0	12.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	26.3	9.7
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Group enriched"	"Detected in some"	7	"Leydig cells: 36.8;Peritubular cells: 25.1"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"HeLa: 102.0"									HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	102.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK9		ENSG00000204909	"Serine peptidase inhibitor, Kazal type 9"	Q5DT21	5	148321203-148339849	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"tongue: 65.0"	"Group enriched"	"Detected in some"	54	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.5;U-266/84: 19.6"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.0	2.3	2.3	2.2	4.0	6.2	1.0	1.3	3.2	1.0	1.2	1.0	1.0	1.1	2.0	1.5	1.5	0.5	1.0	2.3	2.2	3.3	1.3	1.0	1.0	1.9	1.5	1.0	1.4	1.4	0.5	1.4	2.5	1.0	1.8	1.2	1.0	1.0	1.0	2.4	2.7	1.7	1.0	1.1	1.1	2.0	3.8	1.0	2.7	1.0	65.0	1.1	1.2	1.0	3.4	2.7	10.7	2.9	5.8	2.8	0.2	11.1	2.1	2.9	3.0	0.4	1.1	2.4	3.0	0.1	0.2	0.5	4.6	8.6	3.3	18.5	0.2	1.6	2.3	0.9	0.6	0.8	4.7	2.2	6.5	6.9	2.0	0.2	2.3	2.7	0.1	0.6	0.3	0.1	1.7	0.0	2.3	3.9	14.4	0.4	9.5	2.2	3.4	11.4	4.2	4.4	2.9	2.9	3.6	1.4	9.1	5.2	6.0	3.0	6.5	2.0	8.3	10.6	2.1	7.0	3.4	10.7	3.3	3.5	9.1	19.6	3.3	2.8	2.0	4.6	10.7	2.9	1.3	1.8	1.6	2.1	1.3	2.0	2.1	0.7	3.4	2.6	2.8	10.5	5.8	2.8	2.7	1.3	0.2	2.3	4.0	1.3	3.2	2.2	3.3	1.5	1.0	1.0	1.0	14.9	27.5	0.0	0.1	0.0	0.0	0.3	0.0	26.8	27.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1
SPIRE1	"KIAA1135, spir-1"	ENSG00000134278	"Spire type actin nucleation factor 1"	Q08AE8	18	12446512-12658134	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 147.7;Late spermatids: 226.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 41.1;U-2197: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040737, HPA040942"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040737: AB_10960987, HPA040942: AB_10960492"	"unprognostic (3.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-1)"	8.4	20.2	20.6	4.7	16.2	1.7	10.6	20.5	35.3	10.8	6.5	15.0	3.4	2.5	9.2	7.0	8.8	5.6	8.6	22.0	21.6	14.8	12.7	5.5	12.2	3.3	21.3	20.5	9.8	8.5	15.7	8.2	7.5	17.3	10.1	4.3	9.4	10.0	9.9	17.5	7.7	3.5	9.9	17.7	5.3	5.5	34.8	17.5	0.4	15.0	3.6	4.9	8.8	10.7	1.0	1.0	0.0	1.1	0.9	0.6	0.2	7.5	3.3	7.4	8.2	8.3	7.4	0.4	8.2	8.5	8.1	7.8	0.3	1.7	3.6	9.4	10.6	13.6	1.7	9.9	7.3	10.3	5.3	4.9	2.2	7.0	4.3	17.1	1.5	5.7	5.1	14.0	14.0	41.1	9.4	10.8	1.2	5.6	0.1	12.0	10.1	0.4	2.0	3.1	2.7	8.3	0.0	9.1	7.5	9.8	10.3	10.9	4.4	8.9	7.4	18.6	3.4	2.3	4.7	13.2	13.5	4.0	31.5	9.7	2.7	0.3	0.2	10.8	1.0	3.6	0.0	1.1	0.0	0.4	0.8	0.2	0.0	0.2	0.6	1.0	1.0	0.0	0.4	0.0	0.9	1.1	0.0	0.0	0.2	20.6	16.2	20.5	24.3	21.6	14.8	21.3	20.5	17.3	17.5	23.8	39.2	0.0	8.2	3.3	52.8	25.0	7.6	6.7	15.9	12.2	7.9	0.1	18.3	7.4	147.7	7.1	0.0	0.0	4.2	0.7	7.4	18.7	15.1	5.0	11.5	25.4	2.9	6.7	12.7	226.2	5.5	6.0	16.9	2.8	1.0	14.3	8.9	0.0	10.3	1.1	11.8	19.4	9.5	10.5	19.2	1.9	0.5	1.3	0.0	8.9
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.5	38.0	0.2	5.9	15.6	5.7	9.5	6.4	9.3	4.8	4.5	24.2	14.1	9.9	7.7	7.5	24.1	12.9	17.0	10.2	4.0	2.8	13.2	14.9	9.4	24.8	5.8	2.3	4.1	5.0	11.4	5.2	5.9	9.8	12.5	7.4	15.3	2.0	6.2	28.5	0.9	8.8	3.2	40.2	36.4	0.0	24.7	5.8	25.2	21.2	2.4	4.4	11.7	26.5	8.7	5.2	11.9	2.8	15.3	5.2	12.8	9.1	11.2	2.2	4.8	0.6	7.5	5.0	9.1	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2	11.9	5.3	1.9	19.7	7.4	0.6	40.5	40.8	6.7	7.9	40.1	0.0	14.2	18.3	46.9	0.2	17.6	68.6	0.0	71.1	9.3	12.5	27.5	4.6	52.9	35.3	1.6	10.9	11.6	4.7	0.9	8.6	9.4	13.5	34.3	31.7	8.6	48.5	51.8	5.3	75.1	0.5	6.5	12.5	0.3	6.6	5.6	3.7	1.7	50.4	13.2
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 3.2;plasmacytoid DC: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.7;NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	25.1	13.5	21.0	19.3	17.8	6.7	26.2	26.2	28.9	16.9	18.9	9.0	5.8	17.2	20.1	12.3	12.8	13.8	18.3	17.5	19.0	14.3	16.1	28.1	22.0	14.8	15.3	19.0	18.3	20.6	29.5	15.1	18.1	20.5	15.1	18.7	15.1	17.9	13.6	9.6	13.6	20.7	13.7	16.5	11.0	22.6	8.1	12.9	40.3	22.1	10.4	17.1	21.2	30.5	0.1	7.7	1.2	1.2	3.2	1.2	1.5	27.0	14.3	15.6	15.9	20.4	20.4	11.3	8.1	12.0	5.2	7.2	18.8	7.7	20.9	4.3	10.0	15.1	9.1	8.9	18.2	10.7	23.9	6.5	4.3	3.8	20.3	10.3	13.3	8.9	16.3	10.8	18.7	17.9	11.4	3.3	11.7	18.6	8.2	8.4	18.3	10.3	12.4	7.8	21.1	16.8	8.2	14.1	10.8	16.3	22.9	6.7	23.8	8.5	7.3	21.7	10.1	6.9	11.3	5.1	13.3	17.9	11.8	12.9	16.2	6.5	34.1	21.6	12.8	25.6	0.0	0.4	0.0	1.2	1.2	0.1	0.0	0.2	1.0	0.8	0.1	0.2	0.3	1.2	3.2	0.6	7.7	0.0	1.5	21.0	17.8	26.2	26.7	19.0	14.3	15.3	19.0	20.5	12.9	17.9	16.5	2.2	27.6	35.4	14.1	6.5	17.8	6.7	4.5	8.7	5.9	10.2	11.6	10.1	1.3	9.8	16.0	0.0	7.4	7.2	13.1	21.2	1.1	12.7	5.9	23.8	10.9	15.4	6.5	2.5	15.8	7.8	18.6	44.1	19.7	8.9	9.7	15.8	11.7	5.7	10.7	25.8	15.4	2.8	9.8	14.6	2.5	0.7	10.1	22.0
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051402-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 22.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 18.4;Kupffer cells: 4.1;Late spermatids: 6.3;Spermatocytes: 7.6"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.2;NTERA-2: 4.6;RH-30: 5.5;SH-SY5Y: 4.6;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.8	0.9	1.0	0.2	1.5	0.2	0.2	0.2	2.0	0.1	0.3	0.7	0.0	0.2	0.1	0.3	0.2	0.1	0.2	2.2	1.1	1.1	0.4	0.3	1.3	3.2	1.5	0.6	0.1	22.0	0.1	4.6	0.2	1.2	0.2	0.1	0.0	0.1	0.1	1.7	0.2	0.2	0.2	1.9	2.5	0.1	3.6	0.2	0.1	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.3	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	1.1	0.0	4.6	0.0	0.0	0.0	5.5	0.8	0.0	0.0	1.4	4.6	0.0	0.0	0.0	2.7	0.3	0.4	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.5	0.2	1.2	1.1	1.1	1.5	0.6	1.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	7.6	0.7	0.0	0.1	0.0	0.0	0.0
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.3	3.5	5.1	0.0	1.3	0.0	0.0	0.2	0.3	0.9	0.5	0.0	1.1	0.0	0.0	8.0	4.9	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	1.5	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7	0.0	0.0	0.0	0.1	0.1	55.4	4.4	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.2	69.9	15.6	0.6	0.3	0.9	7.5	0.0	1.7	1.0	0.3	4.7	0.2	0.0	6.7	1.4	67.0	0.0	0.9	3.2	4.6	0.4	0.0	0.0	0.2	0.1
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.2	8.1	6.5	9.1	10.9	11.4	10.0	12.2	13.4	10.2	12.3	7.2	3.6	18.5	6.9	11.5	8.0	8.6	10.8	9.6	14.7	9.7	10.1	7.4	4.9	6.6	10.5	15.6	14.8	9.4	10.0	6.5	13.3	7.4	11.2	11.1	10.3	29.5	11.3	8.9	10.4	6.2	5.9	16.2	9.1	9.6	18.1	7.9	10.7	11.9	6.3	8.9	10.9	12.7	8.5	8.9	7.9	6.7	9.8	10.0	8.5	19.4	7.4	10.3	12.7	14.5	11.9	8.7	8.4	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5	23.8	45.0	23.8	18.6	49.6	12.8	23.6	12.7	61.6	34.2	26.2	9.8	12.3	14.9	21.5	1.6	21.9	22.7	0.0	21.7	19.7	31.0	20.1	56.6	25.6	14.3	11.1	42.5	21.5	27.0	1.7	17.5	31.7	15.1	13.6	24.2	13.8	21.6	22.1	13.1	12.6	11.2	32.3	23.0	10.7	14.2	58.1	23.0	35.5	18.6	29.3
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	11.1	13.4	12.8	15.6	14.5	38.0	16.3	24.2	14.7	12.9	10.1	8.9	17.3	10.9	18.5	15.9	9.6	13.6	10.6	8.2	12.4	13.3	10.6	10.5	12.5	12.7	11.1	12.0	12.2	14.3	23.4	30.3	12.2	11.4	12.2	10.7	11.9	12.4	16.5	11.9	20.2	12.6	13.7	11.3	14.9	11.0	11.0	11.4	19.5	14.3	9.8	9.5	10.6	10.5	6.5	6.0	8.5	5.6	7.7	6.0	2.8	5.1	6.3	8.9	5.3	4.2	7.9	8.8	6.0	3.5	3.3	3.5	9.3	6.0	7.7	7.7	4.6	4.4	6.9	4.5	6.0	5.8	5.4	10.2	7.3	16.2	6.8	3.7	6.6	8.6	4.6	6.0	4.0	4.5	6.9	5.2	4.5	6.6	5.6	3.5	5.0	6.9	15.5	4.7	2.1	3.2	9.3	4.1	5.5	5.7	9.3	10.5	7.1	5.7	2.7	4.9	6.9	6.8	8.6	5.5	5.3	3.2	7.2	6.1	6.0	4.1	8.7	5.2	10.7	5.7	8.5	5.6	5.2	5.0	3.9	5.4	6.2	4.7	6.0	4.2	6.5	5.6	5.6	4.1	7.7	3.7	6.0	4.4	2.8	12.8	14.5	24.2	13.8	12.4	13.3	11.1	12.0	11.4	11.4	86.4	149.8	64.8	77.1	58.6	59.7	64.9	66.2	132.5	117.2	43.6	110.0	73.9	31.5	45.7	31.9	85.0	41.6	70.0	48.3	73.9	67.2	73.1	94.7	57.6	44.0	63.5	74.7	58.3	48.5	44.8	77.3	55.5	40.5	37.9	43.9	86.7	44.4	37.0	72.2	27.8	96.5	45.3	63.8	65.4	57.5	60.6	100.9	61.0	47.2	68.6
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718144-64768685	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 266.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: AB_2684881"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	16.3	12.1	12.2	10.9	16.5	8.3	13.8	13.9	12.8	17.0	16.1	4.1	10.8	8.6	12.5	12.4	25.3	10.8	11.6	13.1	12.3	10.7	18.0	13.1	13.2	12.1	10.6	9.5	14.6	11.7	10.8	20.5	20.2	11.9	15.5	10.4	4.7	10.3	15.0	15.7	18.7	15.2	12.6	15.5	19.0	10.9	11.7	11.5	19.2	13.9	17.9	12.3	24.1	14.6	4.0	8.2	3.8	4.1	4.1	4.7	2.1	7.0	3.6	9.2	7.0	8.3	13.7	5.5	10.7	8.6	7.3	9.8	6.7	7.7	7.3	11.0	8.5	7.0	4.6	8.3	16.1	12.9	8.7	10.1	8.0	6.7	5.9	8.5	8.5	8.1	9.0	15.3	10.2	13.3	7.8	10.8	9.2	7.0	4.5	8.6	2.5	15.1	8.6	4.7	1.9	4.9	7.3	7.5	11.6	12.5	5.6	4.0	5.9	6.7	4.8	10.2	6.7	6.1	16.5	10.9	5.4	3.2	6.4	11.0	6.7	11.3	6.5	10.2	13.4	7.2	3.8	4.1	1.7	4.5	3.0	4.7	3.9	4.6	4.2	3.4	4.0	4.5	4.7	1.6	4.1	1.9	8.2	4.0	2.1	12.2	16.5	13.9	12.8	12.3	10.7	10.6	9.5	11.9	11.5	44.7	36.1	35.8	47.3	72.7	50.8	26.2	76.5	41.5	43.3	82.0	29.5	62.3	76.3	67.8	266.8	54.7	61.7	46.7	64.6	64.7	50.4	43.7	52.0	85.5	55.9	92.2	58.6	78.5	70.9	129.9	88.6	70.4	37.1	46.9	60.5	43.1	140.5	64.5	68.2	63.3	36.0	64.7	57.4	32.7	40.7	90.8	40.7	54.9	45.7	82.3
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.1"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 53.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	3.5	2.4		2.2		3.3	0.7		4.3	1.3	0.0			0.0	1.4	2.0	1.2	1.7	1.5	0.5			0.7	0.5	2.4	1.9			3.1	0.5	7.4		3.4		0.1	0.1		0.0	0.9	0.0	8.5	0.0	2.3		4.2	0.6	1.0			0.0		1.8	1.1		4.8	12.7	14.1	9.9	1.4	3.0	2.2	19.1	12.9	43.9	11.1	20.9	18.9	17.2	16.6	12.4	14.5	15.9	8.8	14.7	7.5	9.6	18.3	19.4	15.6	13.0	10.9	14.6	9.3	10.6	15.4	23.1	13.2	8.7	10.6	17.3	17.1	9.5	18.6	13.0	15.8	25.1	9.8	12.6	24.4	9.2	13.3	8.4	9.4	14.1	3.4	14.9	19.1	18.0	17.7	6.2	3.5	14.6	6.7	14.1	10.6	20.6	17.2	13.1	18.9	24.9	14.3	17.3	17.5	15.2	16.2	14.5	7.1	17.2	14.8	34.7	0.6	9.3	0.5	2.6	9.4	1.0	2.2	2.1	2.6	6.3	4.8	0.8	1.8	14.1	1.4	9.9	12.7	3.0	2.2											8.9	15.5	13.7	5.2	21.2	41.0	3.3	12.7	4.0	7.9	10.4	3.9	2.9	0.0	5.7	53.8	24.8	0.3	0.0	1.8	17.0	12.3	3.6	8.1	1.5	15.6	1.6	1.2	35.6	37.7	28.5	7.2	27.3	15.1	17.2	1.5	8.2	3.3	0.2	2.5	0.5	5.3	0.0	11.5	7.9	9.4	31.9	3.5	7.5	1.2	4.9
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Cell type enhanced"	"Detected in all"	7	"Enterocytes: 1052.9;Paneth cells: 1613.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1400000	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.4	13.2	35.8	36.8	58.0	49.0	18.0	20.7	33.5	23.4	27.8	12.3	78.2	38.3	21.9	31.4	57.4	34.9	44.9	46.8	30.6	30.8	20.2	19.8	36.4	0.0	35.1	26.4	21.3	50.1	42.9	24.7	36.0	42.0	70.0	24.5	17.5	33.2	32.0	21.7	38.5	18.2	31.4	48.9	26.7	16.0	50.7	21.2	43.5	34.5	25.9	30.7	63.1	36.3	28.8	35.7	17.1	11.8	43.7	43.9	36.8	40.2	36.8	31.1	14.4	41.0	43.1	25.3	74.2	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0	80.4	103.8	93.1	338.4	84.4	36.4	95.1	30.6	495.2	193.3	148.3	11.8	123.5	374.7	201.2	45.8	112.5	1052.9	210.2	371.4	826.3	181.0	282.1	132.7	33.9	132.6	44.5	90.6	92.1	77.3	23.0	159.3	104.1	99.5	215.6	393.6	112.7	336.5	1613.2	133.0	124.1	19.7	109.9	144.4	65.6	106.7	94.6	165.0	117.6	448.6	382.7
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.4	12.1	40.4	24.2	26.2	19.0	38.8	19.9	55.5	29.8	44.8	15.1	48.3	22.9	33.6	17.4	19.6	38.6	31.2	18.5	23.7	58.4	30.4	40.3	50.4	35.6	51.0	27.9	26.2	22.6	53.7	47.2	13.0	23.4	31.6	49.4	40.9	27.0	54.8	43.5	44.5	26.4	23.0	70.5	32.7	12.5	78.8	19.7	9.9	23.3	22.3	20.1	43.3	30.3	9.8	15.1	25.9	19.4	36.3	28.6	62.8	43.5	33.0	33.3	72.3	25.2	68.6	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1	0.0	2.9	57.4	63.7	84.3	27.7	26.4	30.6	2.7	1.2	27.9	19.6	62.5	64.6	20.3	3.4	46.6	5.1	23.3	36.6	175.3	66.1	60.8	27.5	47.6	85.0	28.6	26.4	35.6	21.8	10.5	66.4	35.3	64.1	8.2	27.0	28.1	26.0	7.0	49.8	69.0	12.3	0.0	49.9	12.8	74.2	98.9	30.1	23.5	26.6	92.1
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.2	30.4	73.8	55.1	55.3	50.1	36.0	44.7	47.4	38.8	39.9	54.7	20.8	20.4	46.6	54.2	62.1	39.3	58.6	46.5	36.8	48.6	41.9	48.6	97.1	64.0	42.4	43.2	39.7	52.1	53.3	32.1	39.4	73.9	65.2	55.9	50.8	37.4	62.0	36.8	63.8	51.0	40.2	94.1	55.2	43.9	33.7	34.3	83.7	72.4	53.8	48.0	45.1	44.8	29.3	47.6	61.6	80.2	56.1	45.2	30.7	42.6	32.6	30.5	85.1	50.5	43.9	47.2	41.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9	428.8	342.1	635.3	745.6	592.5	436.3	765.2	639.5	717.4	483.4	943.9	117.8	766.6	2161.9	1141.2	204.6	898.5	667.3	467.2	948.8	912.5	754.8	783.4	543.5	639.1	894.6	328.9	532.2	609.5	565.3	236.1	962.8	751.5	749.0	1439.1	546.1	918.4	1056.2	782.0	927.8	1642.5	369.6	614.4	716.0	645.9	602.6	620.9	634.6	518.4	577.5	829.8
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1076.1;Late spermatids: 1865.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.3	8.9	14.2	28.1	15.2	17.2	7.9	13.1	15.3	13.1	15.3	6.9	11.4	8.5	16.7	16.9	14.7	8.0	14.3	13.8	16.8	14.7	12.7	12.0	8.4	6.0	17.6	11.4	18.0	11.9	25.7	11.1	20.9	12.7	22.5	20.3	11.8	34.8	14.5	25.2	42.2	8.7	11.7	7.6	9.7	13.7	15.6	18.4	18.9	20.7	20.8	14.4	14.8	22.3	13.8	19.6	8.3	8.0	14.7	24.2	17.6	23.0	12.2	38.2	37.6	20.9	9.5	11.8	18.0	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3	26.8	28.5	33.3	51.2	189.1	70.3	20.1	33.1	48.2	27.3	22.7	47.1	40.1	23.2	44.1	1076.1	52.5	12.9	0.0	40.5	30.6	44.1	65.7	40.4	25.1	41.0	117.6	27.6	43.0	45.7	1865.0	71.1	31.8	55.6	40.5	32.1	65.3	32.7	21.0	90.2	21.7	65.2	45.3	45.3	237.2	50.3	90.3	53.9	56.8	23.6	46.7
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		140000	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	35.4	40.2	20.6	56.6	30.3	73.1	35.3	33.3	36.2	42.1	37.7	34.0	19.5	41.8	37.0	33.6	51.1	35.1	34.8	32.4	19.9	22.6	36.9	66.7	37.3	64.3	21.6	24.0	47.1	34.2	29.1	33.8	51.2	29.5	31.3	36.5	35.5	35.6	40.5	44.9	41.1	46.6	25.5	23.9	52.5	35.6	29.2	18.9	105.3	41.1	41.3	64.5	30.6	35.7	11.1	30.2	4.2	23.5	15.6	12.7	12.2	48.2	38.9	46.2	32.2	11.3	9.6	48.0	31.2	23.1	36.2	33.6	40.8	33.8	74.4	22.8	29.3	26.1	43.7	45.8	36.0	36.5	31.1	79.8	55.8	37.7	47.4	12.9	61.6	33.4	10.6	8.2	30.0	8.7	14.7	28.2	33.3	56.7	32.9	28.3	38.6	67.6	67.3	54.1	28.1	55.5	68.5	49.7	54.9	24.2	34.8	39.4	56.3	35.6	30.6	16.8	25.4	37.5	45.0	29.5	33.5	43.1	22.2	50.4	43.3	32.5	86.0	30.1	49.0	27.6	1.0	17.5	4.2	12.3	23.5	12.6	11.1	8.5	12.7	30.2	9.8	9.8	9.0	2.1	15.6	14.7	22.4	10.6	12.2	20.6	30.3	33.3	36.2	19.9	22.6	21.6	24.0	29.5	18.9	110.2	104.2	263.7	359.4	409.3	143.7	75.1	117.2	84.3	119.4	83.7	86.4	268.2	132.6	175.8	190.8	186.2	246.5	140.2	136.4	478.7	232.5	241.3	217.7	110.3	220.7	93.8	255.6	111.1	135.5	118.5	147.3	197.1	268.2	218.2	170.4	153.0	146.8	241.8	119.9	87.2	188.9	116.4	279.5	292.6	343.6	387.6	264.3	196.1	264.9	438.8
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95067197-95071224	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	5.5	6.4	6.1	4.9	9.6	5.3	9.6	6.0	14.3	8.7	6.9	8.0	9.2	7.1	8.0	8.0	6.8	7.4	6.8	6.4	6.5		9.5	6.8	6.1	8.7	6.1	9.5	10.7	10.4	9.7	8.2	6.5	7.2	9.4	7.5	10.1	11.4	8.6	5.4	6.6	7.8	7.1	4.8	9.0	7.1	3.0	5.0	3.7	11.6	5.3	6.5	6.1	5.5	7.9	3.8	7.0	2.0	5.6	12.4	3.7	4.4	4.7	11.8	0.0	15.8	10.0	13.3	6.7	7.5	3.2	3.4	11.0	14.7	23.8	20.0	10.2	5.8	9.8	9.9	14.7	3.7	14.4	10.7	20.2	5.5	9.8	11.6	20.1	11.0	12.9	15.7	3.4	15.9	9.4	9.9	11.1	15.1	13.3	6.2	6.1	10.4	18.1	6.2	11.8	13.1	13.1	3.6	19.0	12.5	15.0	15.0	15.4	8.3	14.9	9.7	7.8	5.9	11.2	9.1	6.2	8.3	8.3	6.8	7.1	10.9	12.8	3.2	13.6	13.5	7.0	2.0	0.6	5.7	1.1	8.2	7.9	9.6	8.2	3.8	6.9	12.4	9.5	0.6	5.6	1.0	3.5	9.9	3.7											41.7	24.8	82.8	42.9	0.0	45.6	20.1	61.1	17.4	21.6	31.4	31.4	33.1	127.6	32.0	1.3	32.2	43.1	23.3	40.0	43.0	21.6	37.7	10.3	52.9	23.7	17.5	54.6	35.6	22.7	4.2	38.0	25.1	0.0	34.3	75.6	40.4	26.3	42.1	57.3	77.7	48.0	32.3	29.9	3.7	5.9	0.0	42.8	65.1	58.5	30.7
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461668-120469793	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	25.8	50.7	29.5	37.9	28.5	33.8	31.2	24.9	30.6	31.5	36.4	21.7	35.5	29.8	26.7	37.4	53.6	32.6	42.3	20.7	26.7	27.9	37.2	42.5	27.2	41.4	31.6	25.3	37.1	68.5	34.9	36.5	49.3	27.9	33.1	35.8	29.3	33.9	30.4	17.0	32.4	31.0	25.1	23.8	39.6	33.0	52.5	25.0	53.1	43.7	36.8	51.0	26.5	35.7	22.1	18.7	28.8	15.4	15.7	14.8	5.1	55.7	39.0	59.9	38.5	27.4	27.6	64.1	38.3	34.5	49.3	42.4	46.8	26.3	54.4	44.9	32.1	26.8	33.4	53.9	54.5	54.4	40.7	55.4	46.4	26.2	45.6	35.4	57.1	42.4	29.1	35.2	42.8	37.3	52.9	44.8	35.6	58.2	16.5	42.3	78.0	56.3	111.5	75.0	37.9	34.1	62.9	25.1	52.5	42.6	71.2	53.2	38.0	44.9	23.9	44.3	40.8	72.1	50.4	39.0	36.7	43.5	27.5	41.4	50.7	38.0	68.0	38.6	43.1	38.2	12.3	10.7	28.8	14.8	11.7	11.2	22.1	11.7	13.0	13.9	17.7	11.5	12.8	12.2	15.7	15.4	18.7	11.9	5.1	29.5	28.5	24.9	30.6	26.7	27.9	31.6	25.3	27.9	25.0	23.8	30.4	155.5	203.9	235.3	77.2	1.3	147.7	20.1	26.1	153.5	27.5	301.6	414.4	172.1	51.9	119.1	86.4	23.3	135.5	354.8	182.5	290.8	33.4	118.4	178.0	68.3	138.9	108.1	103.3	17.4	115.3	184.7	190.6	190.2	126.0	96.8	139.8	80.7	145.6	272.7	44.3	51.8	162.7	260.2	249.1	273.9	397.6	97.9	129.8	332.4
SS18	"SSXT, SYT"	ENSG00000141380	"SS18, nBAF chromatin remodeling complex subunit"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	26.1	40.5	18.7	30.4	26.4	15.5	26.6	17.6	20.2	24.8	21.4	31.8	32.1	14.0	31.7	32.7	29.8	27.2	23.4	22.4	21.6	16.1	30.0	30.9	21.9	25.8	32.6	16.3	39.4	20.6	39.4	41.8	43.2	25.3	28.6	18.7	26.1	26.0	33.5	10.3	31.3	22.6	31.0	23.7	24.7	22.5	28.3	32.6	27.8	35.6	24.7	35.2	25.5	25.9	15.9	13.1	19.9	17.1	20.7	17.6	13.1	19.2	14.0	34.4	16.8	27.4	24.8	17.4	23.7	21.6	21.0	20.1	9.2	16.0	33.7	19.0	27.7	19.0	25.3	18.6	23.0	26.0	21.5	8.9	16.7	20.5	14.8	21.7	25.5	25.9	31.8	27.2	26.3	28.9	21.0	15.7	9.8	12.2	17.3	28.9	19.4	10.4	14.8	6.5	18.1	13.5	12.1	26.7	16.2	22.2	22.8	14.7	22.2	36.2	16.8	10.2	25.8	17.1	15.1	18.0	44.2	8.8	10.2	23.2	31.3	20.8	24.3	20.7	17.8	23.4	19.9	11.7	16.5	15.1	17.1	17.6	15.9	14.6	15.7	13.1	13.0	15.5	17.4	5.6	20.7	16.7	7.4	15.7	13.1	18.7	26.4	17.6	20.2	21.6	16.1	32.6	16.3	25.3	32.6	26.8	21.3	28.3	27.1	7.9	28.5	14.1	17.8	36.1	23.9	22.7	15.7	57.3	18.3	26.4	40.7	25.3	17.2	0.0	22.5	41.2	19.5	22.9	36.8	30.1	23.9	82.6	23.7	24.5	20.0	31.2	30.8	17.1	5.0	12.6	21.1	51.6	26.7	14.0	38.5	23.8	29.7	38.8	27.1	23.4	19.0	11.5	71.2	25.4	14.5	21.7
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1, nBAF chromatin remodeling complex subunit"	O75177	20	62143795-62182484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: AB_2683888"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	6.6	8.9	11.9	7.7	12.7	7.7	8.6	35.9	15.8	7.0	7.0	9.9	12.2	9.5	9.7	10.9	9.3	6.9	7.2	6.4	11.5	10.9	11.5	33.3	8.2	7.4	11.2	14.5	10.0	10.4	8.4	10.7	8.8	13.1	8.7	7.8	7.4	8.6	11.8	19.2	23.7	9.0	7.7	9.9	9.2	8.8	10.7	10.9	6.0	8.3	6.7	7.1	6.8	8.6	3.6	1.3	2.5	2.7	1.6	2.8	0.5	6.5	7.8	10.9	9.9	4.9	5.7	7.9	6.2	2.4	10.4	5.2	26.8	6.1	4.0	8.3	3.5	5.4	17.0	6.7	5.9	9.5	2.7	4.4	17.8	16.4	13.8	3.6	6.5	15.9	3.4	13.0	5.3	4.4	6.1	4.7	6.9	11.9	7.7	5.8	7.8	9.8	10.1	4.4	6.6	9.0	10.9	14.1	4.5	7.8	8.3	20.7	11.5	11.1	13.6	9.3	7.2	12.7	10.4	5.5	19.9	12.0	7.3	8.6	8.6	7.7	3.6	9.9	6.4	6.5	0.3	1.6	0.6	1.7	1.1	1.1	0.7	0.9	1.4	1.3	3.6	2.8	0.9	2.5	1.6	2.7	0.8	0.8	0.5	11.9	12.7	35.9	15.8	11.5	10.9	11.2	14.5	13.1	10.9	8.9	6.5	6.0	4.4	14.5	14.4	7.7	2.5	4.0	11.4	7.0	21.6	4.5	3.3	4.1	8.6	7.4	6.8	0.0	2.3	2.7	10.4	7.3	1.1	33.3	4.2	14.3	13.7	8.0	11.9	16.0	6.9	7.4	11.8	3.6	6.6	4.9	6.3	7.0	3.2	7.3	17.7	6.5	8.9	3.9	10.6	15.3	6.4	5.0	5.3	4.7
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519098	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 16.7;Peritubular cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		44000000	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	10.7	2.1	3.3	4.9	1.8	0.1	8.1	3.5	1.9	33.0	18.4	1.6	6.3	2.1	33.1	15.2	9.8	11.0	30.9	10.6	1.4	0.6	2.5	1.8	5.8	1.2	1.2	1.6	17.0	1.8	0.3	13.4	2.5	3.0	6.8	3.2	4.7	1.9	15.7	4.7	3.8	5.8	23.8	3.2	7.3	6.9	5.7	1.4	0.5	2.4	4.2	1.6	19.3	10.9	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.2	18.9	0.0	17.8	4.0	2.5	3.0	0.2	0.0	0.7	0.2	18.0	0.8	0.0	0.0	0.0	1.3	0.0	0.1	3.1	0.8	0.0	3.7	0.1	5.6	8.9	0.0	3.3	0.0	17.6	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.4	0.6	0.0	0.1	0.4	0.9	0.1	2.0	0.0	1.9	0.2	0.2	0.0	0.3	0.3	0.2	0.7	7.2	0.8	1.0	0.7	2.8	0.2	0.0	0.1	19.3	0.2	3.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	1.8	3.5	1.9	1.4	0.6	1.2	1.6	3.0	1.4	3.0	1.1	0.0	0.2	1.6	5.4	1.8	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.1	0.4	1.5	1.6	0.0	0.0	0.1	6.0	0.3	0.0	0.0	1.2	3.2	0.0	3.7	0.0	0.4	16.7	1.1	1.7	1.0	0.6	3.2	0.1	0.0	14.9	0.0	1.9	0.0	5.7	0.7	1.1	1.6	0.0	0.0	1.7	0.1
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 172.0;Peritubular cells: 251.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"memory B-cell: 29.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;hTERT-RPE1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	12.5	6.8	13.9	6.6	12.6	0.1	11.5	16.5	11.4	24.9	12.7	11.1	4.1	2.7	14.6	10.3	11.4	15.0	14.3	26.2	21.0	6.1	3.8	1.4	5.4	4.5	17.2	8.7	21.5	4.7	2.9	4.8	2.5	20.9	14.5	7.3	7.8	6.8	21.1	38.7	3.6	6.3	20.1	20.4	4.9	6.7	5.8	19.0	3.2	10.0	15.4	6.5	18.2	10.8	29.7	0.0	1.4	0.0	0.0	0.2	0.3	0.3	0.7	2.0	0.0	13.0	7.4	0.1	3.8	5.3	0.5	1.5	0.0	4.7	0.0	0.8	5.2	3.0	1.5	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.6	0.4	1.7	0.4	46.8	0.2	0.0	0.0	0.0	4.0	0.8	0.2	1.1	4.4	0.2	1.2	0.1	5.3	1.4	1.2	4.0	0.2	3.8	1.4	0.3	3.7	2.1	0.4	0.1	1.4	1.8	1.0	1.8	0.9	0.1	0.5	0.0	2.8	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.2	29.7	0.0	0.0	0.0	6.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	13.9	12.6	16.5	11.4	21.0	6.1	17.2	8.7	20.9	19.0	3.0	2.7	20.9	16.5	12.0	1.7	79.0	7.6	6.7	19.4	17.4	0.0	63.3	5.0	8.5	3.3	8.3	8.4	0.0	6.5	5.6	56.4	10.8	0.0	0.0	12.1	6.4	4.7	8.6	0.0	3.1	172.0	7.9	18.6	32.5	9.1	35.9	2.4	7.0	251.4	2.2	2.6	38.8	42.9	0.3	0.9	6.1	23.2	1.0	5.8	17.1
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325985-57335877	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8300	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	25.3	23.2	23.5	37.7	25.1	32.0	38.4	28.5	27.6	27.2	30.5	19.4	28.8	23.0	34.9	28.2	34.6	34.4	33.1	28.4	22.7	20.3	22.6	27.8	26.5	33.7	21.6	20.7	41.8	39.3	39.7	31.2	34.8	22.0	26.6	33.0	17.2	32.8	27.5	47.7	32.9	26.2	28.9	17.1	28.3	29.3	28.3	25.2	44.0	45.9	37.0	42.5	28.7	51.7	10.2	10.3	4.5	5.2	6.9	12.0	4.7	57.5	55.7	52.8	38.6	16.7	18.6	25.9	31.7	30.7	55.5	39.8	38.2	43.1	70.0	33.9	27.8	35.3	44.6	83.7	49.4	70.1	48.8	47.0	44.7	41.0	41.0	26.3	74.0	33.6	18.7	30.2	57.0	79.4	25.8	36.2	54.2	60.7	35.5	37.7	39.0	74.9	65.5	69.4	30.7	34.3	63.3	89.3	68.0	25.9	41.6	55.3	46.9	44.9	38.6	46.8	28.3	46.8	29.2	27.2	37.9	50.1	51.0	54.2	41.4	41.0	72.4	32.1	41.8	49.9	0.8	4.3	4.5	9.4	5.2	9.1	8.7	8.1	10.2	6.1	10.2	8.9	12.0	1.2	6.9	5.0	10.3	9.6	4.7	23.5	25.1	28.5	27.6	22.7	20.3	21.6	20.7	22.0	25.2	71.5	73.4	41.0	69.0	66.5	23.9	23.5	33.1	148.5	102.4	27.9	23.6	89.5	11.6	62.9	64.9	43.6	26.8	0.0	86.1	90.2	43.5	42.4	38.3	31.8	50.8	23.8	27.6	32.5	32.2	93.2	39.4	40.0	27.0	44.1	40.8	23.8	58.2	35.1	41.8	20.2	16.4	19.4	46.2	55.9	93.5	66.7	56.5	36.3	68.4	62.2
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 520.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	41.4	26.6	19.2	29.6	33.1	32.0	19.7	36.1	28.2	31.5	32.9	24.9	48.2	42.2	19.8	28.4	30.8	32.4	31.0	29.7	30.8	35.1	36.6	26.5	23.3	39.3	37.5	33.5	23.2	28.5	25.1	33.7	32.2	26.5	29.4	25.7	45.8	32.7	24.9	36.9	38.3	53.8	33.6	40.9	40.4	30.5	31.0	59.0	34.5	12.8	35.6	24.4	24.4	62.7	106.5	34.0	32.7	29.2	22.4	30.4	19.3	34.2	30.9	39.9	47.9	52.7	31.8	53.4	14.7	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4	26.8	71.4	136.9	121.9	165.4	98.0	80.5	117.2	36.1	37.5	96.0	19.6	178.0	247.1	62.6	202.0	95.1	177.2	0.0	92.6	189.0	93.0	151.4	60.0	123.8	125.1	106.5	136.4	90.9	152.3	520.2	97.0	118.3	158.6	91.0	137.9	96.8	78.9	168.6	80.6	258.7	57.5	58.2	97.3	81.2	147.4	192.6	205.2	116.7	134.0	129.8
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255317-48267444	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 12.6"	"Group enriched"	"Detected in some"	12	"Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.7	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	9.8	22.6	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"testis: 24.1"	"Cell type enriched"	"Detected in single"	28	"Spermatogonia: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.2;U-2197: 1.9"									"HPA045683, CAB046020"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB046020: AB_2194010, HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.6	0.1	0.6	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 13.5"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 4.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.6	0.5	0.1	0.0	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	2.3	0.0	1.0	0.0	0.5	3.3	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346428-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.0"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 144.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"Karpas-707: 6.9"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.5	0.2	0.2	0.0	0.0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0.0	0.9	0.4	0.4	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.7	144.8	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 10.8"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 8.1;RT4: 4.3"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.1	0.6	0.3	1.7	0.7	0.3	0.0	0.0	8.1	0.0	0.2	0.2	0.0	0.3	0.1	0.4	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.2	0.0	0.4	0.5	0.0	0.0	4.3	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047014			Approved	Nucleoplasm,Vesicles		NA	NA		220000	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902"	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.4	0.0	0.0	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	36.0	72.5	26.1	2.7	0.0	0.0	50.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.2	38.5	0.1	0.0	0.0	47.5	4.7	21.7	2.9	0.0	0.2	33.6	0.0	0.2	50.8	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.6	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5	29.8	25.8	9.3	31.0	36.4	0.0	0.8	38.2	17.4	20.5	59.3	0.0	40.3	3.3	108.8	27.9	0.4	295.9	0.0	80.1	11.6	2.6	89.5	11.5	1.9	60.1	0.0	118.5	0.0	25.4	11.5	1.7	19.0	6.8	8.2	176.7	0.0	114.4	178.5	0.7	10.5	0.0	6.5	1.4	0.2	0.1	38.3	33.2	1.3	155.8	230.3
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.1	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	0.0	6.4	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5	0.0	0.0	0.0	0.1	0.8	7.7	1.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.0	1.2	2.5	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.6	0.5	0.0	1.4	0.0	1.3	0.0	0.2	0.0	1.2	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643838	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell type enriched"	"Detected in many"	6	"Mucus-secreting cells: 708.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"K-562: 23.7;OE19: 44.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		1200000	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2.0	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49.0	1.9	1.5	6.0	23.9	4.0	0.6	0.0	0.5	4.5	21.6	1.9	2.6	0.0	0.0	0.4	0.0	0.0	11.2	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.4	0.0	0.0	4.9	0.0	1.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.7	0.0	0.0	0.0	0.1	0.0	0.0	44.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.2	0.2	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6	14.9	6.9	0.0	5.2	0.1	0.0	1.5	30.6	112.4	76.2	0.0	0.0	0.1	0.0	1.6	0.2	14.2	50.8	0.0	16.6	0.1	0.6	3.2	0.0	0.0	0.2	0.0	31.7	4.3	0.0	0.5	1.4	0.3	0.0	0.0	708.1	0.0	27.0	66.2	0.0	0.0	1.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	108.2	20.7
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230103	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	11.1	20.0	12.9	5.0	18.0	12.0	12.3	63.0	25.7	16.7	10.7	9.2	21.6	9.8	12.3	31.2	8.5	15.8	10.0	19.8	10.9	12.3	23.1	31.5	20.0	5.4	11.1	18.7	15.9	30.8	17.6	30.1	21.8	14.9	11.7	10.1	11.0	24.9	19.3	10.1	9.7	9.7	11.3	8.1	9.1	13.5	15.9	8.2	2.9	23.8	7.6	7.0	10.0	9.8	2.6	6.2	1.6	3.3	7.6	10.6	3.2	13.1	7.6	12.4	10.8	14.4	9.9	5.7	10.4	13.2	10.7	16.0	10.2	15.6	3.4	11.4	9.1	16.3	10.8	10.6	11.1	14.6	4.6	15.3	10.3	12.7	9.0	10.0	11.6	17.7	7.6	11.3	13.9	9.7	10.5	11.2	2.3	15.2	24.8	10.1	7.6	0.1	8.9	12.0	17.0	9.1	2.9	8.4	14.5	11.5	7.0	18.6	15.2	11.8	52.1	13.8	10.0	4.5	9.6	8.5	12.6	5.0	13.6	10.2	15.7	11.9	13.0	10.2	10.4	12.6	1.6	3.3	0.4	8.3	1.2	5.9	2.6	5.1	7.3	6.2	0.9	3.5	3.6	0.1	7.6	1.2	6.2	10.6	3.2	12.9	18.0	63.0	25.7	10.9	12.3	11.1	18.7	14.9	8.2	20.8	30.2	7.2	7.2	6.6	10.2	10.1	12.7	4.0	12.5	5.2	0.0	17.1	5.0	5.8	107.8	6.7	2.6	0.0	11.6	18.9	8.8	8.0	18.5	22.6	7.9	3.2	3.5	6.2	13.0	35.2	10.3	5.8	6.8	9.0	5.9	11.8	8.4	3.4	5.6	14.6	0.6	0.0	6.1	14.0	5.6	4.8	17.7	3.1	3.9	7.8
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380344-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	22	"Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 21.3"	"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	3.7	6.4	1.4	1.1	5.4	0.6	5.7	21.3	0.8	9.2	4.6	1.2	4.7	0.3	9.0	2.2	3.3	4.0	5.1	0.7	0.9	3.9	3.3	1.8	15.0	0.7	1.6	0.2	3.2	0.6	18.8	1.8	0.6	5.2	17.2	1.1	1.9	1.8	5.7	4.0	1.6	0.6	12.5	1.2	0.9	1.5	2.4	0.2	0.7	1.0	4.4	0.5	8.4	15.5	0.0	0.6	3.2	0.4	2.8	3.8	0.2	3.5	1.5	0.8	0.0	3.2	1.0	0.0	9.0	0.2	1.9	2.3	0.0	0.0	0.0	3.7	22.0	6.3	16.2	1.1	3.9	2.0	0.0	2.8	0.5	4.9	0.1	0.0	9.0	0.1	1.2	0.1	0.0	0.3	13.5	0.0	0.9	0.0	0.2	0.2	0.0	1.8	0.1	6.7	0.0	1.4	0.0	0.0	0.0	5.1	0.0	3.0	23.2	3.6	2.5	0.0	7.0	0.0	0.9	4.0	0.2	9.4	0.3	14.1	0.0	0.0	0.0	23.9	3.6	4.0	0.0	0.1	3.2	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.1	0.0	3.8	0.2	1.4	5.4	21.3	0.8	0.9	3.9	1.6	0.2	5.2	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.1	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.1	4.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Cell line enriched"	"Detected in some"	23	"RH-30: 230.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	2.7	0.0	0.0	0.0	1.6	9.8	1.0	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.7	0.5	0.1	3.5	0.0	0.0	0.1	1.2	230.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.2	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.4	1.3	6.4	0.2	2.5	1.4	0.0	0.0	2.0	0.9	0.0	0.8	9.3	0.0	1.1	0.0	0.9	0.5	0.9	0.6	5.7	0.6	36.5	1.6	2.4	2.5	32.7	7.6	1.1	17.2	0.0	16.2	1.1	2.2	1.0	0.0	0.7	0.5	1.9	0.0	0.3	2.4	1.1	0.3	1.1	1.3	1.1	0.3
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336233-136752403	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	26.0	10.9	13.3	12.9	15.6	12.9	17.9	46.5	14.3	24.8	14.9	11.2	12.0	9.1	21.3	10.8	12.8	16.8	10.5	12.3	12.9	7.4	12.0	10.2	13.3	12.9	14.0	7.2	22.6	13.8	17.3	20.4	20.5	14.3	16.3	14.3	13.0	14.5	14.0	20.8	17.2	12.7	16.8	9.5	14.5	12.2	9.5	18.9	29.7	15.6	11.7	18.6	17.0	29.0	8.9	6.7	13.2	4.8	8.0	7.4	2.9	17.6	9.2	15.5	13.3	11.7	20.4	8.3	19.9	25.5	18.7	17.8	15.6	7.8	13.8	12.6	20.6	15.1	12.3	16.7	9.0	25.6	16.9	7.8	14.7	13.4	8.6	8.9	25.6	14.9	12.8	10.3	13.7	15.4	10.9	14.5	15.1	9.4	28.0	11.8	15.1	16.8	8.3	10.1	12.2	7.3	15.1	16.9	18.4	10.2	12.7	7.6	12.2	21.3	8.5	8.9	8.4	12.1	10.9	12.1	21.6	15.8	19.2	17.5	20.9	14.3	31.4	13.3	8.8	13.8	4.8	4.4	6.5	7.0	4.6	7.4	8.9	5.9	6.3	4.1	7.3	6.7	5.2	13.2	8.0	4.8	6.7	6.9	2.9	13.3	15.6	46.5	14.3	12.9	7.4	14.0	7.2	14.3	18.9	23.8	21.6	31.2	28.0	35.5	41.8	8.9	12.7	16.0	29.6	15.7	37.3	24.5	10.0	17.5	1.9	25.1	29.0	23.3	19.2	22.1	23.6	19.6	21.9	17.8	15.8	27.0	18.0	32.5	14.6	2.3	45.8	19.5	15.1	24.4	23.3	29.1	21.6	17.3	30.4	8.4	65.9	25.8	27.2	32.7	43.2	32.0	26.5	27.7	21.2	21.7
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 85.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 4.8;naive B-cell: 7.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.6"	"Group enriched"	"Detected in some"	6	"BEWO: 27.0;HMC-1: 34.2;U-698: 9.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.4	0.7	0.4	0.9	1.0	0.3	0.2	0.6	3.8	0.3	0.3	1.1	0.5	0.1	0.5	0.4	0.3	7.8	0.4	0.5	0.6	0.2	0.2	3.9	0.3	1.2	0.5	0.6	0.4	1.4	0.0	0.2	0.4	0.5	0.3	0.2	0.5	0.2	0.5	4.1	0.5	2.2	0.4	0.7	5.1	0.1	85.4	0.8	0.7	0.3	0.2	1.6	0.3	0.2	7.6	0.5	0.2	0.7	0.2	0.5	0.3	0.0	2.0	0.8	0.1	0.1	0.0	27.0	1.4	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.8	0.4	0.0	0.0	0.6	0.0	0.0	34.2	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.5	1.6	0.1	0.8	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.6	0.4	0.0	0.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.1	4.8	0.2	0.5	0.5	7.6	0.4	0.3	0.2	0.2	0.3	0.1	0.0	0.3	0.4	1.0	0.6	0.7	0.6	0.2	0.5	0.6	0.5	0.8	0.0	2.4	79.6	8.0	6.1	7.0	1.8	2.5	14.7	1.2	7.0	2.0	1.7	11.6	0.1	19.3	2.9	1.1	0.0	0.2	2.7	3.3	7.0	1.1	22.9	2.1	19.1	1.2	3.7	2.1	18.4	4.4	4.8	5.0	4.6	4.1	3.2	0.2	0.0	1.8	3.4	7.3	0.0	7.5	87.4	38.7	7.4	2.4	10.4	1.6	9.6
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 63.5;U-698: 28.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	9.2	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0	0.0	10.1	31.9	0.0	0.2	0.0	0.0	0.0	1.4	1.2	5.2	0.0	0.0	8.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.6	0.0	0.0	0.0	0.0	5.2	0.3	0.6	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.9	0.0	0.0
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.9	9.6	4.5	7.5	19.9	26.9	14.6	13.7	41.9	90.5	101.9	15.2	10.4	3.7	8.7	29.3	30.1	7.6	5.1	10.9	18.0	30.7	4.2	16.6	7.6	8.9	13.8	8.5	10.4	17.8	7.0	16.7	5.9	9.9	10.8	6.5	9.0	22.0	16.6	7.3	6.4	10.8	6.3	5.8	15.8	5.4	12.4	4.5	11.9	11.2	6.3	6.1	16.1	6.2	41.9	6.7	6.4	10.6	9.5	18.0	10.6	15.5	8.8	37.4	54.8	3.5	13.7	7.3	8.3	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4	68.5	26.4	26.1	13.6	19.7	12.8	39.2	48.4	49.5	50.0	50.6	23.6	11.6	6.6	40.3	8.8	23.9	22.2	0.0	32.6	47.9	29.1	25.0	50.7	45.1	91.4	3.2	20.2	25.8	63.7	2.6	20.1	70.4	16.9	25.2	23.9	14.3	30.0	22.8	28.0	36.2	16.5	38.8	21.7	18.5	24.5	27.4	7.0	25.4	27.4	24.1
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388568	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	44.6	30.7	23.2	34.4	27.5	35.3	49.3	15.7	23.5	25.1	31.5	18.4	21.7	20.5	33.2	27.4	36.4	32.7	34.0	82.9	20.1	14.7	34.5	90.0	45.7	45.5	26.0	11.1	40.6	32.1	18.6	27.9	24.6	27.6	28.9	21.8	24.3	29.3	22.9	53.4	28.4	28.6	49.7	25.1	41.4	29.4	15.4	25.7	16.8	38.0	31.2	28.8	40.4	53.1	10.8	13.7	69.7	20.2	13.9	21.7	26.7	17.0	32.3	14.3	14.1	30.5	29.2	10.4	20.0	25.4	17.3	16.9	8.5	16.5	5.3	19.8	19.8	26.2	26.0	12.9	20.4	14.2	43.9	8.9	36.9	19.6	17.4	22.6	9.0	24.1	45.5	20.1	13.8	20.0	18.2	23.5	9.8	22.6	17.0	11.4	12.0	33.3	9.0	8.3	17.4	0.0	7.4	38.2	7.8	27.4	22.1	13.1	8.5	23.0	54.6	8.2	17.9	28.7	13.5	19.7	26.9	13.7	15.9	16.3	26.2	20.4	4.5	16.6	9.5	11.9	26.2	19.4	24.9	21.7	20.2	17.3	10.8	16.0	16.8	13.7	10.4	16.6	15.8	69.7	13.9	18.7	7.5	12.0	26.7	23.2	27.5	15.7	23.5	20.1	14.7	26.0	11.1	27.6	25.7	86.4	150.9	56.2	91.3	115.1	87.1	46.2	43.3	85.6	108.1	127.4	265.1	21.1	14.9	68.7	27.3	107.9	156.0	0.0	83.8	34.3	140.9	148.0	138.6	102.5	60.4	23.8	119.1	104.3	64.9	11.1	66.4	84.8	69.2	88.4	68.1	108.0	75.8	94.7	57.3	38.3	352.3	64.7	221.4	32.2	15.1	139.9	26.1	86.3	72.7	78.8
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 43.3;Peritubular cells: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.8;HEL: 39.1;HMC-1: 22.8;K-562: 65.1;MOLT-4: 47.2;NB-4: 18.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		140000	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	44.0	21.5	3.6	16.5	8.1	30.0	24.1	3.4	4.0	12.6	12.8	6.3	10.5	5.1	11.0	11.4	11.6	9.6	15.3	9.8	3.9	4.7	8.9	5.5	12.8	26.7	9.1	3.2	15.6	8.3	1.9	7.0	11.3	6.1	13.9	5.8	11.9	11.9	11.7	18.3	9.7	11.6	13.6	7.4	17.3	7.9	8.5	6.1	21.9	8.6	9.1	17.0	19.9	20.2	7.2	15.0	15.2	18.5	14.3	16.2	8.8	1.1	1.3	0.1	0.0	9.3	4.5	0.0	0.5	2.0	1.0	0.6	0.1	1.0	0.0	2.4	2.1	0.0	0.0	0.2	0.0	0.3	25.8	0.0	39.1	2.9	0.3	3.8	3.3	22.8	10.4	0.7	0.4	0.5	0.0	3.1	0.9	65.1	0.0	0.5	0.1	47.2	18.6	0.3	0.6	0.0	1.1	0.3	3.3	0.3	0.7	0.1	0.0	2.3	1.2	4.3	0.3	0.7	4.2	1.7	2.4	0.6	1.1	0.0	0.0	0.0	0.0	0.2	6.4	0.6	6.8	11.8	5.9	9.1	15.1	12.8	7.2	15.8	13.2	15.0	6.7	16.2	13.0	15.2	14.3	18.5	5.7	11.2	8.8	3.6	8.1	3.4	4.0	3.9	4.7	9.1	3.2	6.1	6.1	0.0	11.7	17.9	3.4	6.5	1.5	20.2	5.1	5.3	2.3	5.2	0.0	1.2	5.0	4.9	0.3	21.8	3.8	0.0	11.8	2.1	15.5	6.7	22.0	2.6	19.4	0.0	0.0	5.5	19.7	2.1	30.2	22.7	8.5	43.3	4.2	5.1	8.2	7.0	38.5	8.4	0.3	6.5	18.7	0.0	0.7	6.8	1.1	19.1	6.2	4.1
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (7.76e-4)"	"prognostic favorable (1.14e-4)"	33.6	34.9	10.4	35.9	12.8	12.8	27.9	4.6	11.6	37.8	47.3	6.2	28.4	23.9	44.5	26.6	40.8	31.8	33.8	20.9	10.2	3.9	35.0	31.0	34.9	25.2	13.3	12.0	41.9	21.2	18.1	9.2	22.0	9.8	42.3	26.2	23.3	30.1	26.5	11.4	39.1	59.4	43.8	12.2	48.4	32.1	13.3	7.9	29.3	31.1	24.4	42.8	43.1	34.0	6.2	9.6	27.6	13.0	4.7	5.9	14.0	16.7	16.7	4.1	6.8	40.8	39.7	11.9	13.3	29.4	14.9	10.9	7.5	22.8	40.2	20.9	29.6	0.1	23.4	5.1	25.9	11.0	18.0	1.9	9.2	17.8	9.4	24.4	10.7	30.4	55.3	21.5	18.0	16.0	39.3	26.2	13.2	6.5	5.7	19.1	5.7	11.7	12.0	6.3	20.9	3.4	13.6	0.3	13.7	25.7	28.0	0.1	0.4	12.5	10.4	12.6	5.9	15.5	24.6	21.7	0.3	8.7	15.5	0.2	0.1	0.4	10.0	13.4	10.4	17.9	9.8	12.5	6.8	5.9	13.0	5.2	6.2	4.8	4.8	9.6	6.2	4.7	4.3	27.6	4.7	11.0	4.6	4.9	14.0	10.4	12.8	4.6	11.6	10.2	3.9	13.3	12.0	9.8	7.9	44.7	57.5	34.4	35.4	26.6	1.0	12.0	22.9	45.5	46.6	47.1	0.0	1.6	13.3	32.2	6.4	29.9	63.9	0.0	31.0	8.4	26.5	42.7	55.6	33.4	31.9	0.0	31.8	38.6	76.0	8.6	55.0	54.0	20.3	52.3	38.2	3.3	38.1	49.1	47.7	21.9	1.0	25.8	27.8	0.9	1.1	28.7	5.3	29.9	37.3	48.9
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 56.6"	"Low region specificity"	"Detected in all"							"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	17.8	15.0	25.5	10.3	24.4	14.0	11.7	27.2	46.1	10.8	12.1	13.2	8.4	9.3	11.9	12.8	22.6	11.0	15.7	42.7	24.3	23.0	18.9	15.9	11.4	11.0	27.9	15.4	12.2	10.2	17.8	19.9	11.1	27.3	13.9	12.0	10.0	13.0	14.0	60.3	9.5	15.4	14.9	18.1	13.3	10.1	10.3	16.3	18.6	14.7	21.3	13.4	14.8	10.4	11.9	15.9	26.1	13.3	27.6	19.2	7.9	12.6	15.0	24.0	13.1	14.0	10.3	7.4	11.6	10.6	10.5	14.0	5.9	13.7	20.1	11.9	9.0	9.0	10.3	16.3	10.9	15.6	20.5	8.2	27.3	8.0	9.6	7.5	10.3	9.9	7.1	8.5	8.9	5.9	21.0	20.5	18.6	18.3	9.5	14.1	8.6	56.6	8.2	12.1	20.4	10.0	16.3	11.4	17.5	22.5	14.0	9.2	15.3	6.1	16.9	10.3	18.5	19.4	12.3	15.9	10.6	18.0	10.2	8.5	14.9	14.2	19.2	11.6	15.7	8.2	13.9	11.7	26.1	19.2	11.4	14.6	10.1	13.1	16.4	11.6	11.9	11.7	15.1	19.8	27.6	13.3	15.9	15.9	7.9	25.5	24.4	27.2	46.1	24.3	23.0	27.9	15.4	27.3	16.3	8.9	23.6	31.8	12.5	9.4	26.5	66.9	22.9	33.5	42.1	19.2	39.3	14.9	36.5	17.3	17.3	23.3	25.3	0.0	18.9	8.4	12.4	10.7	19.7	47.1	13.9	27.0	28.7	39.3	27.2	26.1	8.3	16.9	15.1	12.6	16.6	21.2	15.1	16.7	8.9	28.7	21.2	0.0	12.2	8.6	10.4	16.8	10.2	22.3	12.8	15.8
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	39.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.9	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4	50.6	320.5	0.0	6.3	8.4	1.1	4.0	0.0	97.7	178.6	0.0	2.0	0.3	0.0	11.7	12.9	8.9	0.0	0.0	8.2	9.0	11.1	62.8	15.1	0.4	2.1	0.0	0.0	19.0	5.1	1.9	106.4	7.7	5.0	0.0	0.0	2.4	16.5	0.0	8.5	0.0	0.2	452.7	115.4	0.9	0.2	16.4	9.2	0.0	0.0	12.2
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 78.5;T-cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.8	7.3	4.5	6.8	5.3	6.6	11.6	10.2	8.5	7.4	6.9	3.8	10.4	9.5	5.4	12.6	15.7	9.2	2.0	12.5	4.8	12.3	3.4	11.4	3.0	2.1	7.6	11.5	13.5	6.5	2.7	10.1	8.4	2.7	6.4	3.7	1.0	13.3	5.2	12.6	8.2	25.8	1.8	3.9	5.8	13.6	3.6	6.2	3.0	9.9	3.1	3.8	5.9	8.3	28.0	5.9	2.9	24.4	8.9	8.3	4.2	5.8	5.5	11.2	16.5	6.0	10.9	17.7	52.3	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5	3.0	12.8	25.0	7.9	6.0	3.8	3.6	2.5	5.3	5.7	1.8	5.9	2.8	1.7	4.4	1.7	17.8	8.4	0.0	5.3	25.1	7.4	6.7	26.7	2.1	30.8	44.5	11.5	20.3	78.5	2.7	2.6	39.2	8.5	9.0	15.0	3.1	7.9	7.0	1.4	1.5	2.2	12.9	8.2	5.7	6.8	3.6	4.2	70.5	4.7	9.5
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 124.0;Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.2	10.3	7.8	14.8	7.4	6.7	16.5	10.4	10.9	9.8	10.4	8.4	14.9	13.9	11.5	10.8	4.4	13.8	7.7	16.0	3.0	26.0	18.8	14.2	0.6	10.5	16.0	14.3	23.9	12.2	11.7	7.5	11.2	8.9	9.8	11.1	26.6	19.2	5.5	15.9	13.7	14.5	15.0	7.3	12.7	21.8	8.4	15.6	8.8	15.6	18.1	13.1	0.0	7.7	11.2	4.7	12.1	23.5	13.2	10.1	11.5	19.8	16.5	37.8	15.9	10.4	10.1	19.1	10.4	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5	6.0	13.6	11.1	6.4	14.8	23.6	11.8	17.8	2.7	6.8	22.7	17.7	6.7	6.6	8.1	124.0	14.7	29.5	0.0	11.9	4.5	10.4	14.2	2.3	25.2	12.9	17.5	14.5	16.0	22.2	234.7	22.7	10.4	15.1	17.2	29.2	19.3	13.0	25.9	19.4	8.6	19.8	12.9	20.8	49.9	19.4	13.6	7.3	8.6	33.0	10.9
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	15.1	12.9	10.0	17.2	4.6	6.4	12.2	6.2	7.7	8.3	8.6	16.9	11.8	10.4	5.1	7.7	13.0	22.9	11.8	14.3	9.5	4.1	5.6	9.9	4.5	18.3	5.9	8.9	4.6	5.5	12.6	13.3	11.5	7.7	7.9	10.1	9.5	8.6	5.4	6.7	11.1	12.6	18.6	12.1	8.7	9.7	9.0	6.6	7.5	15.2	16.7	8.1	11.1	19.9	9.9	12.2	9.8	8.9	6.6	14.3	9.8	7.1	9.8	7.6	9.8	7.3	7.6	9.7	6.2	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4	11.9	9.8	1.9	4.0	10.3	110.1	11.0	0.0	0.0	6.8	3.5	141.4	6.0	1.7	5.5	169.1	7.7	8.1	0.0	5.9	9.9	6.4	5.1	9.2	7.8	5.0	278.1	5.8	4.3	6.0	665.5	6.4	3.9	6.8	1.8	7.6	155.8	8.1	11.5	5.6	3.1	88.5	0.0	4.6	14.9	11.5	10.3	4.8	6.4	9.9	5.1
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.1	3.1	15.7	16.3	11.1	6.5	8.8	7.2	9.8	8.8	9.5	17.2	10.3	30.2	5.9	6.7	9.3	7.2	14.3	3.1	6.5	13.1	11.2	19.7	2.9	21.9	11.1	11.5	26.3	5.8	11.9	6.7	3.5	4.7	5.5	23.4	24.2	11.0	5.4	11.2	11.9	15.2	10.1	12.9	4.3	13.7	10.7	20.0	5.5	8.0	19.3	9.8	5.5	8.7	24.1	10.4	5.9	13.6	9.1	5.5	11.6	16.2	15.9	11.5	6.4	25.5	28.9	10.1	18.1	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9	11.9	18.3	19.8	48.5	54.5	12.0	21.1	2.5	6.7	7.9	10.4	3.9	4.7	14.9	14.5	92.4	11.0	27.7	0.0	27.1	8.3	15.3	55.1	12.7	19.5	21.4	9.5	22.4	12.9	20.3	181.6	21.3	21.3	28.7	14.4	12.9	4.5	23.4	14.4	31.5	10.5	9.5	25.8	30.9	12.6	8.7	65.9	47.8	14.6	10.8	43.7
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155378	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;RT4: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	29.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.1	0.0	0.3	0.4	0.1	0.2	0.8	0.5	0.5	0.4	0.4	0.5	0.0	0.2	0.0	0.7	0.5	0.5	0.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	1.0	0.1	0.8	0.3	0.2	0.1	6.6	0.9	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.1	0.4	1.8	0.4	0.1	0.0	0.4	0.1	0.3	0.0	0.2	0.6	0.3	0.9	0.1	0.2	0.8	0.2	0.0	0.0	0.6	0.2	0.0	0.1	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.7	8.4	11.0	8.6	11.7	9.9	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.1	13.3	22.0	17.3	13.9	11.8	18.8	13.4	24.2	14.1	9.4	6.2	12.4	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	20.4	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.6	13.9	14.2	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4	8.9	8.2	2.2	0.1	0.0	1.5	0.5	0.0	2.7	4.5	8.7	0.0	1.5	0.0	6.0	1.1	0.6	1.6	0.0	2.5	0.7	0.7	0.3	2.3	0.0	1.3	1.6	0.0	0.6	0.3	1.6	0.6	4.6	0.0	29.7	1.6	1.0	3.9	2.5	1.4	0.6	3.7	0.0	1.4	2.7	0.5	0.4	2.1	1.0	1.9	0.1
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36843640-36966472	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No		11000	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	11.8	8.1	11.4	11.0	22.1	17.4	13.3	16.4	14.2	11.2	14.0	10.9	8.9	10.1	8.6	7.1	25.9	6.8	8.4	25.7	16.2	10.2	11.6	10.2	10.3	9.6	16.9	9.4	9.9	7.1	11.3	6.3	12.6	10.5	8.1	13.7	5.6	16.2	6.9	16.0	16.1	13.2	11.1	34.3	10.9	11.4	9.8	14.8	18.6	8.1	15.5	16.7	11.3	14.4	1.5	0.8	3.7	1.5	0.5	2.1	0.4	23.3	11.8	15.8	6.6	8.7	12.2	15.8	9.5	8.9	9.2	8.5	12.0	7.6	15.5	7.6	11.9	13.2	11.1	13.3	10.4	11.4	17.5	10.2	25.1	10.4	6.2	8.3	15.0	14.1	7.3	9.1	14.7	11.6	6.8	11.7	6.2	18.7	12.3	11.3	6.7	14.9	6.6	12.6	9.5	6.0	9.7	25.0	6.7	7.6	19.3	2.9	9.6	14.1	10.9	8.9	9.2	7.8	5.8	15.5	16.5	16.7	10.2	12.4	12.5	18.8	13.7	8.4	15.1	11.4	3.4	0.8	1.4	2.1	1.5	0.7	1.5	1.5	1.3	0.4	0.9	0.8	0.9	3.7	0.5	1.4	0.8	0.3	0.4	11.4	22.1	16.4	13.0	16.2	10.2	16.9	9.4	10.5	14.8	8.9	7.7	5.2	9.0	18.3	11.7	51.7	10.2	1.4	17.0	22.7	19.6	6.9	8.3	8.8	1.7	17.5	17.3	0.0	7.2	7.9	7.9	14.5	4.7	7.3	7.6	17.5	10.9	15.4	22.2	0.9	8.9	11.0	8.5	10.8	16.4	9.3	12.8	10.5	11.7	7.7	15.4	0.0	10.3	10.3	18.1	29.1	13.6	10.2	13.8	29.3
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	18.0	24.5	16.6	28.0	37.9	34.7	9.5	24.6	29.0	29.3	26.1	30.4	23.1	18.3	17.5	41.3	18.9	15.4	20.4	37.1	12.2	20.1	67.6	11.4	35.3	25.4	54.6	19.1	22.7	41.3	39.8	34.3	21.7	23.1	29.6	17.9	18.3	30.6	45.3	71.5	20.7	18.8	18.5	29.0	26.8	32.1	10.9	45.0	39.1	18.0	28.9	23.5	19.8	43.5	30.9	11.0	27.7	36.7	23.4	26.9	23.6	22.2	29.6	30.3	31.3	29.5	21.2	17.3	30.3	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4	35.7	24.7	77.5	88.5	102.0	92.7	1.1	101.9	28.1	22.7	123.9	49.1	67.7	242.1	127.5	6.6	66.9	130.5	23.3	147.7	75.3	72.2	130.8	20.7	112.4	99.1	79.4	72.9	61.4	56.4	11.8	100.9	74.8	111.3	200.2	92.2	123.1	150.1	93.1	105.4	269.6	58.7	71.1	101.9	23.5	69.3	105.3	84.2	61.0	87.3	99.9
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806897-62832088	"Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	21.3	20.0	17.5	16.2	17.0	28.3	22.6	33.0	24.2	26.9	19.6	17.6	40.9	17.2	21.6	36.4	22.3	23.7	20.1	17.7	17.6	15.7	22.3	42.6	21.0	17.7	18.6	16.7	29.3	33.7	22.8	20.2	37.4	17.4	27.9	18.2	20.6	47.3	32.2	17.1	26.4	23.0	19.2	16.0	24.0	22.1	16.1	19.7	29.1	33.7	16.4	29.0	22.5	22.3	9.4	10.0	24.9	10.4	9.5	9.7	4.7	17.6	11.3	15.1	13.4	20.9	23.1	14.1	17.4	24.6	29.4	23.8	8.4	17.5	11.3	16.3	24.8	17.4	18.6	13.1	16.6	21.8	26.3	12.6	9.8	15.2	17.2	25.3	11.6	15.0	19.0	18.8	26.1	31.8	22.7	14.2	16.6	8.8	31.5	15.6	21.3	15.7	18.9	5.1	15.9	16.7	16.2	14.7	30.1	13.2	9.3	11.5	9.7	14.1	22.3	26.6	12.1	24.7	15.7	15.3	21.5	11.3	24.7	11.1	28.8	16.2	11.9	17.3	8.2	13.0	8.2	8.8	24.9	8.5	10.4	7.4	8.7	6.7	8.2	8.1	9.4	6.4	6.2	14.0	9.5	9.1	10.0	9.7	4.7	17.5	17.0	33.0	24.2	17.6	15.7	18.6	16.7	17.4	19.7	20.8	27.7	62.4	62.4	59.6	17.5	5.3	17.8	18.7	14.8	10.4	25.5	47.3	24.9	37.5	99.8	34.9	32.1	23.3	52.1	66.0	46.9	54.7	52.9	23.6	41.5	17.5	31.6	25.2	33.5	98.9	36.2	32.1	43.9	64.1	31.6	29.4	37.9	31.7	23.7	26.4	17.6	32.3	51.8	27.9	31.3	56.1	148.5	46.7	21.7	66.2
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	6.3	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	18.1	20.2	9.4	12.2	7.1	13.3	14.2	9.1	9.0	17.1	12.4	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	19.7	15.6	8.7	16.6	13.9	7.3	12.9	10.1	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0	14.9	15.2	3.7	16.3	43.5	11.7	5.6	0.0	13.4	11.4	17.4	5.9	22.0	10.0	9.1	6.4	22.4	7.8	0.0	8.5	21.8	11.5	17.4	11.5	4.3	24.6	7.9	22.4	11.1	21.9	8.0	7.8	30.2	6.8	19.0	12.7	6.0	11.1	14.0	12.4	6.7	10.1	6.5	13.3	4.7	14.5	33.0	17.2	13.3	9.8	18.7
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.1	8.6	8.3	9.3	18.8	16.2	7.5	14.5	7.4	8.7	7.7	0.4	4.9	4.0	8.1	9.4	24.3	1.5	7.2	8.9	10.7	9.3	4.9	5.5	23.4	1.5	9.5	0.5	4.8	12.2	5.0	22.8	11.1	14.0	10.3	13.9	5.5	6.3	14.6	7.6	3.9	1.7	7.1	6.7	11.9	2.3	3.9	9.8	7.2	0.2	47.7	23.2	24.4	12.1	41.2	7.7	1.8	1.7	15.4	9.9	5.0	19.5	5.4	13.6	22.3	5.5	19.5	5.9	9.1	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3	23.8	57.7	0.8	7.5	10.3	111.5	13.2	0.0	17.4	12.5	3.5	147.3	2.1	6.6	12.0	1.6	21.6	0.0	0.0	7.4	4.6	12.7	9.7	4.7	0.4	3.7	79.4	43.8	20.9	2.7	1.5	19.0	3.2	10.1	1.0	8.8	24.1	5.7	0.0	41.8	8.6	147.7	12.9	12.3	17.7	6.8	6.6	20.5	0.9	0.6	5.5
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809526	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	18.3	18.4	29.8	18.7	42.1	15.2	20.9	21.9	27.1	19.4	20.5	26.3	15.6	18.7	20.3	19.9	18.8	16.0	20.8	14.3	30.4	22.1	30.2	17.8	16.8	18.2	48.0	28.0	16.2	20.5	31.9	18.0	20.3	31.4	18.1	21.9	9.8	17.5	21.3	15.4	19.7	23.8	18.4	56.6	19.8	18.0	11.3	42.5	20.0	27.8	14.6	17.8	20.2	18.3	5.9	8.3	26.2	11.6	8.7	10.2	5.9	22.3	8.9	15.3	8.0	18.7	18.1	21.6	20.8	19.3	14.1	14.4	8.2	9.0	19.9	14.2	16.8	12.8	13.5	10.3	12.3	19.8	22.1	14.3	16.4	12.1	10.6	14.8	25.5	28.2	14.0	17.4	15.7	17.3	17.4	17.3	12.8	12.1	19.6	19.4	15.2	16.1	20.6	16.3	14.8	14.1	13.5	22.3	10.9	22.8	18.7	9.2	8.5	25.5	24.7	30.2	14.6	9.9	24.3	19.4	18.4	10.8	25.5	17.8	13.2	11.4	16.5	33.1	19.7	27.9	26.2	8.8	20.8	7.8	10.6	9.9	5.9	9.2	7.8	8.3	5.4	7.9	7.5	24.3	8.7	11.6	3.9	10.2	5.9	29.8	42.1	21.9	27.1	30.4	22.1	48.0	28.0	31.4	42.5	11.9	25.1	16.6	33.8	39.0	22.8	30.7	25.5	28.1	34.2	19.2	19.6	36.5	38.1	31.9	4.1	26.9	28.6	0.0	24.1	27.4	24.9	28.7	68.1	15.3	28.0	25.4	20.2	14.7	42.9	2.5	31.1	37.2	37.1	42.3	29.5	38.2	25.3	23.0	29.7	42.3	18.4	19.4	27.8	20.9	24.3	35.3	79.9	26.1	24.1	35.8
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	3.0	0.1	0.0	0.4	0.0	0.0	0.9	4.9	0.5	2.3	2.2	1.6	18.5	0.2	3.1	1.2	2.9	0.8	1.0	5.1	4.9	10.9	0.3	0.7	1.3	0.1	0.0	1.4	12.1	0.2	0.3	3.4	0.2	0.4	16.6	0.1	0.2	0.2	5.3	1.7	0.1	0.8	2.7	7.5	1.3	0.0	1.4	0.2	1.6	9.5	0.6	0.0	2.8	2.9	0.0	4.5	2.3	0.3	15.4	0.6	2.6	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7	0.0	2.1	0.0	0.6	0.2	0.4	0.4	2.5	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	12.5	0.0	0.2	0.5	0.0	5.9	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	3.6	9.5	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.9	0.2	0.7	6.8	4.8
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 165.5"	"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	22.1	18.3	36.4	34.1	22.2	39.5	22.9	38.7	28.2	35.1	32.4	26.5	35.0	11.2	27.0	26.7	35.9	15.1	30.5	31.7	47.3	46.8	28.1	37.7	44.7	50.2	31.5	65.6	51.6	27.6	27.5	37.2	26.7	19.4	26.2	43.1	43.7	165.5	30.9	19.7	61.9	104.8	24.0	26.3	37.6	27.5	47.6	71.7	34.8	20.1	19.8	16.4	60.0	28.3	27.5	24.0	31.3	61.0	27.1	38.0	41.3	32.0	29.1	64.8	111.6	19.6	35.0	71.3	23.1	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8	134.0	164.3	396.8	516.1	519.5	114.4	178.2	247.1	151.3	121.7	294.8	41.2	431.0	855.4	544.4	65.7	278.7	291.1	256.9	284.6	652.5	391.4	435.3	302.3	359.4	432.3	81.0	269.9	203.1	322.6	51.2	222.1	419.5	501.0	571.7	258.1	146.4	357.5	396.3	323.9	714.8	66.1	200.5	303.1	377.2	414.8	494.2	699.8	467.7	329.5	537.0
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 170.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	7.8	13.9	27.2	11.8	27.0	24.5	9.9	36.0	34.4	9.0	10.1	15.4	10.8	11.8	14.8	15.0	7.8	13.5	9.0	18.2	23.0	17.0	9.9	7.4	9.4	15.0	16.8	24.2	13.8	9.1	13.3	22.8	9.8	16.0	16.1	11.7	14.5	14.1	11.9	19.5	12.2	10.6	11.2	15.1	13.9	11.4	56.5	16.9	11.0	19.0	6.7	13.6	10.7	9.7	4.3	4.1	5.3	3.2	9.0	4.7	1.7	12.9	12.3	31.6	22.7	14.8	14.7	15.9	16.3	12.2	19.0	16.4	8.0	11.5	25.6	13.5	12.9	22.5	9.6	25.6	9.8	17.4	9.0	23.1	16.1	18.2	10.4	10.7	13.5	16.3	15.2	10.5	11.6	9.5	25.5	9.9	20.1	24.3	18.5	20.5	10.9	15.8	25.5	16.3	15.2	18.1	15.9	16.2	14.2	9.7	13.1	35.1	14.4	14.3	10.1	7.1	25.4	10.5	12.7	10.8	18.8	11.4	21.8	19.0	23.6	17.9	19.0	18.9	21.4	19.7	5.3	3.1	2.4	4.7	3.2	2.5	2.5	2.9	2.7	3.1	4.3	2.7	3.2	2.8	9.0	2.8	4.1	2.7	1.7	27.2	27.0	36.0	34.4	23.0	17.0	16.8	24.2	16.0	16.9	38.7	39.7	19.0	19.9	15.7	80.7	31.9	17.8	41.5	39.8	26.2	88.4	13.2	8.3	14.7	63.8	22.6	13.7	0.0	9.3	8.6	20.8	23.4	25.5	24.6	19.8	100.1	39.9	27.6	18.0	97.3	37.4	23.8	11.8	16.2	21.7	49.8	15.7	24.3	35.3	7.8	102.0	51.8	15.7	170.1	42.8	16.4	6.3	26.1	24.1	20.2
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 232.6;Paneth cells: 154.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 48.3;OE19: 11.1;TIME: 15.6;U-2197: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.6	0.3	0.4	0.4	0.5	0.0	0.1	0.3	0.7	0.4	0.5	0.5	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	0.5	48.3	0.7	0.3	1.1	0.4	0.3	0.3	0.5	0.4	11.1	0.2	0.2	1.7	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.3	0.7	0.3	15.6	0.5	0.8	13.9	0.3	0.9	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7	17.9	17.3	2.2	0.0	0.2	0.0	0.4	0.0	22.7	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	232.6	0.0	4.0	0.1	0.2	0.1	15.1	42.3	0.3	0.0	32.4	4.3	35.4	0.0	0.0	5.4	0.0	0.0	38.4	0.0	11.4	154.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.8	43.0	0.1
SUMO2	"SMT3B, SMT3H2"	ENSG00000188612	"Small ubiquitin-like modifier 2"	P61956	17	75165586-75182983	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037314, HPA042123, HPA048064"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (6.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (9.80e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (5.23e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.89e-3)"	69.0	70.0	77.8	62.6	70.9	63.5	62.6	105.3	73.1	75.4	55.4	50.4	44.5	52.3	69.5	55.7	77.2	58.8	64.3	51.7	68.2	59.4	67.8	60.9	58.0	63.4	57.5	48.3	81.0	62.3	27.9	51.0	60.4	41.5	65.6	48.8	49.7	54.7	53.8	66.9	51.0	53.9	69.9	59.0	69.2	65.8	59.7	44.8	92.6	65.5	50.7	72.1	80.3	61.6	90.7	107.4	130.6	89.3	73.9	119.0	122.6	81.1	33.5	119.0	61.0	34.9	33.7	56.0	64.3	31.5	44.5	41.3	38.4	44.8	71.1	46.1	36.7	58.1	39.7	53.4	39.6	52.6	41.0	81.1	71.1	33.8	65.7	22.9	93.2	64.1	34.1	22.6	39.5	21.7	71.5	45.8	71.0	58.5	58.2	32.8	35.1	142.1	80.6	72.5	61.2	50.7	99.4	113.5	59.3	44.5	68.5	73.1	85.6	77.9	64.8	51.6	96.4	70.1	73.6	51.4	64.9	67.4	49.3	103.1	41.0	37.0	108.9	40.8	55.9	51.8	113.4	76.1	130.6	73.2	84.7	75.9	90.7	92.3	84.5	78.8	77.6	85.6	83.0	68.0	73.9	89.3	107.4	119.0	122.6	77.8	70.9	105.3	73.1	68.2	59.4	57.5	48.3	41.5	44.8	151.8	131.7	396.7	508.4	626.5	212.3	52.6	267.5	252.9	166.1	336.8	47.1	464.8	820.7	515.3	191.2	443.3	254.6	163.5	464.8	790.2	521.7	552.5	345.8	247.7	547.3	220.9	424.4	377.5	577.0	387.5	560.1	510.2	438.6	716.9	336.1	326.4	540.6	399.5	568.9	627.1	118.6	562.7	497.4	793.1	668.9	649.2	472.7	438.0	415.6	703.2
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin-like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	32.2	23.8	37.4	17.7	43.8	50.0	25.0	31.6	43.4	26.9	28.0	17.5	19.4	24.0	21.7	23.9	23.4	22.1	21.9	36.6	27.6	38.7	24.4	29.2	26.2	32.0	30.8	29.0	26.3	26.2	14.6	15.6	21.7	26.6	21.8	15.5	30.6	28.3	30.2	62.4	18.9	28.9	17.4	19.7	28.2	27.7	17.3	17.3	23.9	26.1	18.4	20.8	22.5	20.3	23.8	46.0	14.0	35.7	18.5	27.6	38.4	45.6	18.5	17.4	7.2	20.2	23.4	18.2	31.9	35.0	45.2	36.3	27.5	18.2	16.2	50.6	29.7	21.4	9.1	15.0	24.8	11.1	22.4	22.6	66.4	13.2	21.8	22.1	37.4	32.9	26.4	23.6	26.4	15.1	10.4	18.3	34.0	37.9	27.0	18.1	58.8	31.8	25.9	41.4	30.1	37.1	37.1	1.5	36.1	11.8	17.8	17.0	32.8	28.5	21.0	22.1	4.8	28.2	26.9	36.0	13.5	29.7	28.8	32.8	33.5	46.8	40.9	12.2	51.3	18.7	0.6	34.6	14.0	23.5	35.7	23.9	23.8	22.8	22.8	37.5	21.5	27.6	24.8	4.1	18.5	32.0	46.0	24.7	38.4	37.4	43.8	31.6	43.4	27.6	38.7	30.8	29.0	26.6	17.3	59.6	47.4	74.9	104.6	85.3	68.8	55.4	53.5	20.1	38.7	90.7	19.6	109.8	140.9	91.8	47.0	107.9	85.0	46.7	98.1	85.9	94.3	117.4	28.9	88.9	177.5	58.8	56.7	85.3	119.6	80.4	66.7	155.6	92.8	368.9	80.7	78.5	112.8	93.7	68.2	95.9	44.8	58.2	77.3	58.8	72.0	68.1	114.0	79.9	86.4	112.9
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin-like modifier 4"	Q6EEV6	6	149400227-149401292	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;HeLa: 4.2"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	1.5	0.8	0.7	1.9	1.7	3.6	2.7	5.1	6.5	2.1	1.1	1.2	1.4	1.6	3.0	3.2	1.7	0.7	1.5	3.6	1.0	0.8	2.3	6.6	2.8	3.9	0.7	1.7	2.9	2.2	1.2	2.6	1.8	2.8	3.1	1.7	1.7	2.5	1.1	2.3	1.3	1.4	1.9	1.9	2.2	1.5	2.0	0.2	1.4	2.1	0.7	1.8	1.4	3.5	1.9	0.7	5.6	1.1	3.2	2.6	0.5	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.8	0.2	0.4	0.3	0.3	0.3	1.6	0.3	0.0	0.3	0.3	0.0	0.6	0.4	2.9	0.3	0.3	4.2	0.3	0.3	0.2	0.3	0.3	0.2	0.5	1.0	0.2	0.0	0.0	0.6	1.2	0.2	0.0	0.5	0.6	0.5	0.0	0.3	0.4	0.6	0.5	0.0	1.5	0.9	0.2	0.6	0.0	0.0	0.7	0.0	1.7	1.4	0.8	0.7	0.7	0.5	0.6	0.1	0.1	0.5	0.6	0.0	0.3	0.5	0.9	1.3	0.6	0.7	1.1	2.6	1.9	0.7	1.9	1.7	2.4	5.6	3.2	1.1	0.5	2.5	0.5	0.7	1.7	5.1	6.5	1.0	0.8	0.7	1.7	2.8	0.2	3.0	1.0	0.0	1.3	2.6	4.3	9.2	0.0	1.4	1.2	1.8	3.9	0.7	0.0	0.6	0.0	2.1	1.0	0.0	0.8	0.3	1.7	3.5	1.1	1.5	0.9	0.0	1.7	1.3	1.0	0.7	2.0	4.4	0.0	4.6	0.2	2.3	0.9	0.0	1.1	0.0	4.2	6.5	1.4	1.4	0.9	0.6	0.2	1.7	0.4	2.2
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	30.4	28.8	39.9	29.2	18.1	18.1	28.4	27.6	22.0	33.7	31.8	27.8	27.5	64.7	10.6	20.0	21.7	32.6	50.5	24.9	51.1	20.6	21.5	39.2	26.3	39.0	18.5	55.4	29.2	15.9	15.3	28.1	31.8	16.3	22.8	36.9	32.2	27.9	27.8	19.7	51.7	16.9	44.6	28.0	28.6	56.0	45.6	35.0	13.5	33.7	40.0	34.1	44.6	26.8	16.7	26.9	14.8	26.3	19.2	29.6	24.7	18.3	29.8	27.8	46.5	65.2	10.9	32.7	22.4	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0	59.6	49.3	32.0	29.5	31.6	44.4	58.8	33.1	42.8	59.1	50.6	45.2	48.1	21.6	50.6	100.7	39.8	13.9	23.3	52.8	51.4	33.7	25.7	81.0	29.7	36.5	52.4	22.4	28.3	36.2	67.9	55.3	36.3	16.9	116.4	31.1	49.8	52.6	10.5	56.3	25.0	40.5	19.4	44.2	130.3	136.3	36.3	38.1	45.9	38.2	26.4
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715142	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.4	17.4	9.2	26.0	11.9	40.2	19.5	36.4	12.3	12.1	25.0	15.5	14.8	17.2	13.0	31.0	27.0	16.1	19.6	13.2	11.4	8.4	16.7	11.6	30.9	25.3	15.1	8.2	13.4	20.9	13.7	14.6	14.1	13.9	16.0	13.4	14.6	26.6	17.5	10.6	22.5	36.7	14.0	14.1	30.9	17.3	9.1	12.9	12.7	23.4	14.8	27.4	16.4	15.3	4.1	5.3	23.1	9.1	2.9	4.2	5.0	10.8	2.8	4.1	3.7	8.4	6.2	7.5	6.2	13.1	3.5	3.4	3.3	9.7	12.8	7.0	7.7	2.8	15.3	2.3	12.7	3.3	21.8	1.7	10.4	2.2	5.5	13.6	1.7	27.0	9.9	12.7	5.9	11.1	3.8	7.2	4.0	3.1	11.4	4.9	5.3	2.5	4.5	0.8	6.4	2.9	4.3	3.6	5.1	6.8	5.6	1.7	2.8	5.1	14.8	2.2	3.1	6.0	4.7	11.1	8.2	4.9	5.1	2.5	8.0	1.7	9.1	5.3	5.8	4.3	8.9	7.5	8.3	4.1	7.3	4.2	3.9	3.6	2.5	5.3	4.1	3.5	2.5	23.1	2.9	9.1	3.0	3.2	5.0	9.2	11.9	36.4	12.3	11.4	8.4	15.1	8.2	13.9	12.9	11.9	28.8	5.7	25.4	0.0	16.6	11.8	35.7	20.1	20.5	17.4	19.6	3.8	6.6	22.7	0.6	24.8	36.2	23.3	21.3	1.5	7.9	43.6	8.1	12.8	21.0	14.3	7.0	19.6	57.1	1.5	4.9	22.6	0.0	2.8	14.9	3.8	31.1	21.2	6.3	13.3	21.3	25.8	14.4	4.4	14.6	0.0	7.7	13.8	7.8	41.2
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell type enriched"	"Detected in some"	4	"Intestinal endocrine cells: 19.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0.0	0.0	0.0	0.5	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.1	0.0	19.0	0.6	0.0	0.7	0.0	0.0	3.3	0.0	0.5	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	1.1
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"	Q1ZZU3	9	128275379-128288990	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 892.4;Late spermatids: 836.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	10.2	11.7	14.7	11.8	15.9	6.0	17.9	18.0	13.2	18.2	9.0	12.3	48.0	9.9	13.0	44.8	13.5	20.4	12.7	14.8	12.5	13.2	14.2	18.0	12.5	8.7	16.7	11.0	19.6	13.2	26.5	23.8	10.7	13.6	14.6	8.1	14.1	15.2	50.7	14.1	10.3	9.5	12.8	13.7	7.7	9.2	57.1	16.2	8.9	27.8	12.5	10.5	12.4	17.1	12.6	14.2	28.1	9.6	13.4	15.3	10.0	9.5	17.1	10.2	11.8	27.6	25.3	11.5	16.9	22.5	22.0	14.9	21.9	11.3	9.1	22.6	27.5	13.6	16.1	16.2	22.5	15.0	13.7	12.1	6.9	32.8	17.1	35.6	4.4	6.5	21.2	10.8	36.6	19.8	19.5	21.0	33.6	16.3	14.8	22.4	39.0	9.6	6.4	6.9	22.2	35.7	9.0	14.0	14.5	14.7	5.0	11.7	6.5	21.0	13.5	20.0	11.8	22.4	4.8	13.0	16.0	13.3	30.9	14.2	15.7	23.5	12.1	21.8	6.9	17.2	28.1	9.6	16.4	10.2	5.7	12.0	12.6	10.1	10.2	9.8	12.5	12.2	15.3	6.4	13.4	5.6	14.2	10.0	10.0	14.7	15.9	18.0	13.2	12.5	13.2	16.7	11.0	13.6	16.2	6.0	19.5	14.5	34.6	21.8	13.1	30.0	30.6	14.7	18.2	34.9	11.8	55.7	56.3	21.8	892.4	21.5	27.0	0.0	33.5	35.4	41.0	29.6	9.2	68.6	29.0	1.6	24.5	27.6	19.7	836.9	40.0	17.2	35.4	27.1	23.4	24.7	25.7	20.1	29.7	53.2	17.7	32.3	26.4	56.3	38.7	19.2	97.8	18.3	20.5	27.5
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374685-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.9	7.8	1.9	3.6	2.7	5.8	8.3	5.0	2.5	5.3	4.3	2.7	5.9	4.5	4.8	6.0	6.2	5.4	3.9	3.8	2.1	2.0	6.9	12.8	5.8	6.1	2.8	1.8	6.0	10.2	2.9	5.3	11.9	3.5	4.7	3.2	4.5	6.8	5.1	10.7	5.4	5.1	2.0	2.5	10.5	5.0	15.3	2.7	12.2	7.6	4.8	7.8	5.0	3.4	10.6	11.9	13.5	16.4	8.8	9.6	5.9	4.8	3.9	2.6	2.0	2.7	2.2	3.7	1.3	1.4	2.8	2.6	4.3	3.9	9.1	6.2	1.2	2.1	3.7	2.2	5.0	0.3	3.1	5.3	4.6	2.4	5.8	2.1	7.4	8.1	3.6	4.6	1.6	1.4	2.1	3.4	4.4	5.0	4.7	1.5	9.9	4.1	9.1	6.0	3.8	5.8	3.4	1.2	9.5	5.2	3.4	5.0	4.0	2.0	6.1	3.5	1.6	8.0	7.9	3.4	2.9	1.9	3.5	2.6	6.4	8.0	6.0	1.5	7.9	2.0	2.0	16.4	4.0	7.1	14.6	6.8	10.6	7.4	7.5	11.9	10.2	9.6	8.0	13.5	8.8	13.5	8.3	6.7	5.9	1.9	2.7	5.0	2.5	2.1	2.0	2.8	1.8	3.5	2.7	3.0	1.3	12.6	8.4	2.4	7.1	2.8	2.5	5.3	1.2	15.7	7.9	15.4	34.9	5.9	7.7	5.0	8.4	0.0	9.3	9.5	3.7	5.2	1.1	11.3	10.5	9.5	2.4	4.9	7.1	1.3	10.9	7.6	6.8	6.4	12.0	12.1	5.1	11.5	7.4	13.4	11.0	6.5	4.9	10.3	11.9	2.8	26.5	6.2	7.4	4.7
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 182.4;Bipolar cells: 303.5;Ciliated cells: 222.1;Cone photoreceptor cells: 188.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 33.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 19.2"									HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	12.7	11.5	18.2	9.1	30.2	41.7	9.0	62.0	25.0	16.8	7.3	9.8	12.4	2.7	15.2	18.4	6.2	12.9	7.9	22.7	21.0	17.5	18.4	11.2	16.1	13.7	13.2	15.1	27.7	10.6	37.3	37.0	4.7	19.7	10.1	6.3	10.5	3.6	12.5	22.0	16.9	5.3	19.1	9.7	15.5	9.0	8.3	11.6	9.0	20.6	9.5	12.1	10.0	12.3	3.2	0.8	33.8	1.5	4.7	6.4	1.4	0.1	4.0	2.8	3.2	4.0	8.8	1.1	9.0	4.7	2.3	4.3	0.9	0.1	8.4	0.5	4.9	7.7	0.2	1.0	2.3	2.4	10.1	2.8	3.5	2.7	2.7	9.2	0.6	1.6	5.6	0.5	5.1	10.5	6.5	4.5	4.4	0.0	9.7	6.3	0.4	1.4	0.1	0.6	0.7	1.5	1.9	5.6	2.4	9.0	0.1	1.7	2.7	1.5	0.6	6.2	2.6	0.5	0.3	6.0	10.9	14.7	3.8	4.9	19.2	8.2	13.5	6.0	2.0	3.1	3.0	1.1	33.8	6.4	0.7	4.1	2.9	4.2	6.1	0.8	3.2	4.0	5.1	1.1	4.7	1.5	0.7	5.1	1.4	18.2	30.2	62.0	25.0	21.0	17.5	13.2	15.1	19.7	11.6	154.9	182.4	21.6	6.0	11.3	303.5	110.2	2.5	222.1	95.5	41.8	188.5	0.8	3.3	20.2	8.3	87.0	0.0	0.0	6.6	5.4	44.0	3.0	14.0	19.5	7.2	130.3	2.9	65.7	9.2	9.0	30.8	11.2	15.1	1.0	6.7	24.3	4.5	0.0	37.4	14.1	150.7	25.8	40.0	2.9	5.8	8.4	1.0	49.8	0.2	1.6
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;fallopian tube: 8.1"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055426			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA055426: AB_2682812"	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.3	1.5	0.6	0.7	10.1	0.1	0.3	0.2	4.1	2.9	3.6	0.9	3.0	1.0	0.3	0.8	0.3	8.1	0.4	0.5	0.8	3.1	3.3	1.4	0.2	0.1	0.6	3.4	0.4	0.2	0.1	5.8	0.2	14.6	1.6	1.6	0.1	1.8	3.2	0.2	0.2	1.3	0.6	2.7	0.2	1.6	0.6	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	7.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.0	4.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.1	0.2	4.1	0.8	3.1	0.6	3.4	14.6	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	1.4	4.5	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	4.5	0.0	0.1	0.0	0.0	0.0
SYT17		ENSG00000103528	"Synaptotagmin 17"	Q9BSW7	16	19167971-19268334	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 21.0;Distal tubular cells: 23.2;Intestinal endocrine cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4"	"Group enriched"	"Detected in many"	8	"B-cells: 14.7;monocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.4;CAPAN-2: 20.2;Daudi: 8.9;MCF7: 15.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042059			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042059: AB_2677827"	"unprognostic (3.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.32e-2)"	"unprognostic (4.95e-3)"	3.8	5.2	16.5	1.4	9.2	0.4	4.7	1.0	25.2	3.5	2.4	6.1	1.2	4.3	1.2	3.1	4.0	2.5	1.3	1.3	15.5	16.5	3.8	12.1	7.8	3.2	13.9	10.2	0.8	2.5	21.3	13.4	3.9	7.5	9.7	3.0	7.6	1.5	3.8	0.4	9.9	2.1	1.0	5.5	1.4	4.3	0.6	7.4	0.0	7.1	0.8	4.7	4.2	3.8	14.7	1.6	0.4	13.4	0.0	0.0	0.6	0.0	7.4	0.1	0.0	0.2	0.5	10.4	0.0	0.0	0.1	0.0	0.3	20.2	8.9	2.5	0.0	2.8	3.6	0.5	0.3	0.0	0.0	1.5	0.0	7.4	0.1	0.0	0.0	0.0	0.7	1.8	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.9	5.8	4.1	0.0	0.8	0.7	2.5	4.4	1.6	0.9	2.9	8.0	0.4	5.1	7.9	1.9	0.0	0.0	5.3	0.1	0.0	1.5	0.0	8.2	0.0	0.0	0.0	0.4	0.5	0.0	0.0	4.1	0.0	5.1	0.0	0.0	1.6	14.7	0.0	0.0	0.1	0.0	13.4	0.2	0.0	0.6	16.5	9.2	1.0	22.9	15.5	16.5	13.9	10.2	7.5	7.4	6.0	9.4	2.7	10.1	3.4	0.6	1.4	0.0	5.3	3.4	21.0	0.0	4.2	23.2	3.4	0.1	1.6	1.3	0.0	0.6	11.3	2.4	8.2	0.0	12.4	4.0	1.6	20.7	3.1	1.9	0.0	1.4	2.0	11.8	9.0	9.1	13.2	2.7	7.0	0.7	0.0	0.3	0.0	0.7	0.5	1.7	8.4	3.3	0.0	3.1	6.3
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	34.9	30.7	23.1	25.0	26.3	37.5	33.1	17.1	20.6	30.7	29.0	20.8	15.4	23.0	38.5	23.2	33.7	26.5	30.5	37.0	23.5	14.3	39.8	41.4	26.2	27.2	27.4	11.8	36.3	25.1	32.2	16.8	46.4	22.4	24.8	20.9	27.9	20.8	23.7	55.2	24.9	39.3	31.3	20.9	40.6	27.1	18.3	25.0	32.1	35.0	27.6	33.6	34.3	35.1	30.4	19.2	34.3	36.7	20.0	25.5	29.6	37.4	28.8	39.9	27.6	34.1	39.4	13.2	38.4	50.0	45.7	35.6	28.8	33.4	32.9	43.1	51.2	25.1	20.7	35.7	42.3	33.9	56.6	30.9	37.7	31.0	22.6	30.8	36.6	37.2	39.7	35.5	49.8	33.4	32.3	39.5	28.6	33.8	31.0	41.7	36.4	35.7	28.0	27.8	27.8	33.0	36.7	42.1	38.7	31.0	17.6	31.7	33.0	33.7	21.8	48.6	17.2	22.5	24.2	44.0	31.2	36.5	48.6	38.1	17.2	18.9	39.6	34.8	50.1	41.2	15.0	24.3	34.3	24.5	33.2	24.2	28.3	21.2	22.8	19.2	30.4	19.6	21.1	27.1	20.0	36.7	14.9	25.5	29.6	23.1	26.3	17.1	20.6	23.5	14.3	27.4	11.8	22.4	25.0	17.9	24.2	44.6	45.3	40.5	19.7	39.9	48.4	8.1	12.5	38.4	2.0	50.0	59.7	57.9	17.5	35.9	61.6	23.3	46.5	67.2	40.6	49.4	36.8	45.6	64.1	41.3	45.9	29.4	42.2	39.0	33.4	33.2	42.2	108.2	41.3	23.4	53.3	42.1	33.6	40.9	17.7	38.8	49.1	20.2	19.8	51.1	70.3	40.6	41.6	56.6
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877778-34888089	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	20.6	25.5	22.2	26.8	28.1	43.1	27.2	30.1	29.8	23.0	23.2	17.5	26.7	21.1	23.6	24.2	23.5	22.7	22.0	33.3	21.5	17.9	20.7	28.7	23.2	28.6	24.8	22.1	27.9	25.4	16.7	18.8	30.6	26.7	23.8	25.3	20.4	20.3	31.0	39.3	31.2	24.2	26.8	23.4	31.1	22.6	32.7	29.0	29.4	23.3	24.6	28.7	22.8	22.6	14.9	20.1	26.5	23.6	13.2	16.7	12.8	14.7	6.5	21.3	37.5	13.3	14.2	18.8	11.9	10.0	20.5	19.8	14.9	9.5	20.3	15.9	11.3	9.9	9.4	26.1	11.0	16.7	12.2	21.0	22.7	13.4	25.0	18.8	28.7	16.0	15.9	18.0	13.8	11.3	12.5	24.9	22.7	35.8	15.7	9.8	26.9	18.3	24.0	19.0	31.0	11.1	20.0	18.9	15.9	15.1	9.6	25.7	23.2	14.0	15.4	26.8	19.1	24.9	36.1	14.3	14.2	18.7	8.2	14.4	14.2	35.0	29.1	5.3	34.4	20.5	26.5	23.6	19.3	12.6	21.0	12.1	11.6	13.4	13.5	20.1	14.9	15.7	14.0	14.6	13.2	16.8	17.7	16.7	12.8	22.2	28.1	30.1	29.8	21.5	17.9	24.8	22.1	26.7	29.0	26.8	15.0	26.1	25.7	40.9	27.7	20.1	17.8	9.4	27.3	40.1	11.8	61.7	54.7	36.9	4.5	33.1	30.6	46.7	54.7	56.3	29.1	24.0	21.9	52.1	38.6	30.2	37.9	55.9	51.2	5.7	31.4	34.5	23.6	33.3	34.7	36.0	41.8	49.1	35.0	24.2	31.6	32.3	23.1	88.2	45.3	51.1	64.2	35.9	39.2	25.5
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.2	12.2	16.9	5.2	8.5	13.1	27.3	13.4	13.4	14.7	12.7	11.3	9.9	14.4	7.1	10.9	14.3	7.0	14.7	16.6	16.3	14.0	16.0	15.5	5.2	15.1	11.0	12.2	17.4	10.3	9.7	10.8	15.9	11.6	22.0	7.9	10.3	15.4	14.7	8.1	9.1	10.4	20.4	7.9	9.0	5.5	14.3	4.5	14.9	11.0	7.2	18.4	11.5	15.6	11.8	11.7	5.4	9.7	10.2	17.7	20.9	17.3	18.5	7.5	9.0	20.5	10.7	14.1	15.1	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2	17.9	19.5	12.3	24.6	14.3	21.2	3.7	2.5	40.2	38.7	12.2	25.5	22.4	11.6	17.0	4.7	12.8	1.6	0.0	16.3	29.6	12.8	9.4	8.1	4.9	11.3	14.3	1.7	8.6	12.9	1.5	17.5	12.3	0.0	14.4	2.9	23.3	13.4	3.5	12.4	19.9	20.2	19.4	13.4	35.8	32.4	11.5	19.8	13.1	4.0	20.2
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.0	11.6	19.0	16.7	18.5	22.8	18.9	21.8	17.8	17.3	12.3	16.4	14.3	15.5	20.4	14.9	16.7	16.9	19.5	15.5	16.2	9.1	15.8	9.7	13.1	19.8	18.2	13.0	30.4	19.1	13.0	16.9	12.4	15.5	17.5	6.3	17.2	22.7	17.8	13.6	21.3	14.2	12.1	12.0	25.1	14.9	13.0	17.0	12.7	15.2	10.3	15.6	14.3	16.3	3.1	4.0	1.0	3.4	3.5	4.7	2.2	5.9	6.6	3.7	13.2	3.3	3.4	19.2	7.2	2.9	5.9	2.1	7.1	4.6	6.7	9.7	2.7	3.4	11.8	2.3	2.9	1.4	5.8	9.9	3.8	9.9	4.9	2.4	4.0	12.2	5.2	3.8	5.0	1.9	2.4	11.6	11.0	9.2	2.3	3.0	13.2	6.3	13.4	15.2	2.2	6.8	16.0	3.2	5.3	2.5	5.3	19.2	9.3	14.6	4.1	24.2	2.6	16.2	4.2	4.5	11.0	9.4	10.8	6.5	11.1	8.5	13.9	5.6	4.9	7.0	0.0	3.2	1.0	4.1	3.4	4.7	2.3	1.6	2.6	4.0	3.1	1.9	3.4	0.2	3.5	1.4	1.5	2.3	2.2	19.0	18.5	21.8	17.8	16.2	9.1	18.2	13.0	15.5	17.0	17.9	18.6	9.0	6.3	5.8	9.1	2.5	2.5	5.3	7.9	3.5	19.6	7.5	5.0	4.4	0.4	13.9	7.4	0.0	6.1	5.3	6.5	3.3	5.8	10.9	5.8	1.6	6.9	29.4	11.3	1.8	10.9	5.4	6.8	5.4	7.5	9.4	4.5	3.5	8.5	3.8	9.7	6.5	4.4	8.8	10.9	4.5	6.2	6.4	7.6	2.6
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818504-8016627	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA066184: AB_2685631"	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	11.2	11.2	10.6	13.5	13.9	13.1	9.5	24.5	13.0	10.7	10.0	11.1	12.7	6.4	11.7	6.0	7.9	8.3	8.2	11.5	11.5	12.1	9.3	8.2	8.6	12.0	12.8	8.4	16.1	9.5	16.1	15.9	9.9	11.6	9.6	8.1	9.6	7.6	13.3	20.8	10.6	9.6	9.5	12.4	11.4	8.1	15.8	14.2	17.4	9.7	7.3	9.9	10.0	14.4	8.8	4.7	7.7	8.6	8.3	10.8	5.0	7.0	6.6	7.5	3.9	8.5	6.0	10.4	8.4	3.3	6.3	7.3	14.1	5.3	12.1	6.5	4.9	2.6	7.7	8.2	7.3	8.0	9.7	9.0	10.3	4.6	8.9	7.4	6.9	9.5	4.0	7.3	8.9	4.4	4.0	6.0	13.3	11.5	12.6	7.2	13.3	15.6	4.9	5.7	10.3	3.9	12.7	7.1	8.1	3.7	4.4	4.0	5.7	9.1	6.6	8.2	7.7	12.1	7.3	7.4	5.8	10.1	15.2	8.2	7.5	8.9	13.3	5.6	7.9	5.2	7.3	5.6	7.7	9.3	5.0	10.8	7.6	8.4	9.0	4.7	8.8	10.5	9.0	2.2	8.3	8.6	4.6	6.9	5.0	10.6	13.9	24.5	13.0	11.5	12.1	12.8	8.4	11.6	14.2	26.8	28.5	29.8	19.4	28.4	28.0	36.6	10.2	24.1	9.1	26.2	33.4	22.7	0.0	15.2	30.9	22.2	17.1	0.0	12.7	30.6	16.8	12.5	20.9	11.9	17.4	25.4	18.0	13.5	17.5	17.0	25.3	21.9	23.6	16.2	12.1	29.9	12.3	2.9	26.9	3.4	40.5	25.8	28.4	48.9	42.1	37.6	16.7	30.9	11.5	17.3
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26225936-26391685	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 71.3;Suprabasal keratinocytes: 68.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.3;U-266/70: 12.0;U-698: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	5.0	5.0	1.9	7.8	7.0	5.7	5.8	4.9	7.1	3.5	3.6	1.7	0.6	1.5	4.8	1.7	5.1	4.2	3.4	2.6	2.0	3.1	3.5	0.9	2.6	11.8	2.3	3.4	8.1	5.2	2.3	2.7	11.5	5.8	2.8	3.3	2.6	4.1	2.1	6.4	5.6	3.9	2.8	1.9	12.8	4.7	9.9	1.4	6.5	3.8	2.4	9.1	4.6	3.5	4.4	1.8	0.0	1.0	0.8	4.0	1.0	1.8	0.2	0.1	0.4	0.5	0.9	1.0	0.5	0.4	0.3	0.6	0.3	0.8	25.3	2.3	0.1	0.9	1.9	1.3	1.2	1.2	7.7	5.1	2.7	0.6	0.3	0.7	6.9	1.7	1.3	0.5	0.2	3.8	0.2	0.5	2.9	4.5	3.2	0.1	1.2	3.9	1.2	1.4	0.8	3.0	0.0	3.0	6.8	0.3	0.1	2.6	1.2	1.3	1.8	0.9	0.6	0.8	1.2	0.2	1.0	0.8	1.3	2.0	12.0	8.0	9.3	0.4	4.3	0.9	0.0	0.6	0.0	0.2	1.0	1.9	3.9	1.2	1.8	1.8	4.4	4.0	2.2	0.0	0.8	0.4	0.8	0.2	1.0	1.9	7.0	4.9	7.1	2.0	3.1	2.3	3.4	5.8	1.4	6.0	4.5	18.2	8.4	71.3	1.0	1.7	0.0	1.4	3.4	0.0	0.0	15.3	14.9	1.2	0.5	1.4	1.1	0.0	1.7	3.1	10.4	8.3	1.1	0.0	2.2	4.8	0.0	1.8	0.6	1.0	3.1	2.5	21.9	1.0	4.7	0.1	1.8	2.9	3.9	2.8	1.0	0.0	14.4	11.4	23.4	68.9	8.1	0.7	4.6	5.8
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	14.1	19.8	21.5	15.4	23.6	13.9	12.0	23.5	35.8	19.4	17.5	12.7	12.6	12.1	24.1	17.6	16.8	23.6	16.8	17.2	20.5	16.3	16.1	10.2	12.9	14.3	13.1	15.9	26.2	16.6	22.6	21.7	19.5	19.3	15.8	13.7	15.6	17.9	23.3	23.1	17.9	13.2	23.7	13.1	14.6	14.0	27.3	14.7	21.7	21.3	11.5	17.0	19.6	14.9	15.3	14.3	13.2	25.7	14.0	18.7	13.1	17.1	32.2	20.9	34.2	27.5	14.6	29.3	18.9	21.2	24.4	22.6	23.9	21.0	15.7	21.6	28.9	41.9	14.6	28.6	22.5	26.3	25.6	18.6	15.1	31.3	15.8	27.4	14.6	14.3	14.9	14.1	35.7	39.5	19.7	19.7	27.9	26.1	29.1	22.0	61.0	31.0	23.7	30.8	15.5	26.0	22.9	25.7	23.3	17.4	14.0	19.0	27.6	23.9	37.1	15.8	31.5	13.5	14.5	19.5	37.0	38.1	47.8	24.4	18.0	31.1	26.4	25.1	20.5	31.8	12.7	11.0	13.2	15.6	11.4	18.7	10.2	15.0	15.7	14.3	15.3	15.3	14.3	6.4	14.0	25.7	8.5	13.9	13.1	21.5	23.6	23.5	35.8	20.5	16.3	13.1	15.9	19.3	14.7	8.9	10.2	11.1	17.3	10.1	12.5	0.9	15.3	16.0	6.8	24.4	0.0	61.4	14.9	20.7	21.7	10.8	11.9	0.0	14.6	30.0	16.7	12.7	0.0	6.4	18.1	12.7	15.0	10.4	7.8	34.8	20.1	9.7	11.8	24.4	11.8	16.7	14.1	14.2	29.4	17.8	11.6	25.8	18.9	24.5	61.1	10.3	28.8	17.5	14.3	12.2
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320821	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	33.2	29.9	29.2	28.8	32.2	31.6	38.7	39.6	33.6	28.6	24.1	26.0	21.0	20.2	34.6	39.8	24.9	35.0	22.2	46.4	30.3	30.8	28.6	29.7	25.3	32.9	32.0	26.1	50.7	24.8	20.1	47.1	38.8	28.9	34.8	26.5	21.3	26.8	28.0	69.5	26.9	30.0	31.8	32.9	37.0	23.9	33.5	28.9	65.5	45.7	33.9	39.1	32.3	53.6	18.8	17.8	49.6	16.5	27.1	29.8	19.8	20.1	16.9	38.6	28.2	34.5	32.1	24.1	26.4	23.6	37.6	36.8	23.7	22.8	54.5	53.0	26.8	40.8	17.4	24.3	24.5	38.0	23.8	27.1	9.8	20.9	19.7	31.5	13.4	20.7	29.2	36.6	14.6	26.0	29.7	27.0	25.0	20.8	42.8	36.0	25.4	30.1	32.7	13.9	25.7	6.2	38.6	51.7	39.8	27.6	27.3	31.0	35.5	21.6	31.2	29.4	30.9	44.4	44.3	24.7	5.3	18.3	17.3	32.0	11.6	47.0	49.4	23.2	31.4	21.2	44.7	11.4	49.6	18.3	13.9	23.7	18.8	21.5	20.3	16.1	18.7	29.8	24.6	34.6	27.1	16.5	17.8	17.9	19.8	29.2	32.2	39.6	33.6	30.3	30.8	32.0	26.1	28.9	28.9	80.4	57.2	110.4	280.4	107.0	136.8	146.1	48.4	112.4	73.9	78.5	90.3	83.2	69.6	99.8	22.8	91.5	110.7	23.3	66.3	65.8	100.9	202.5	150.3	64.8	46.3	114.4	80.8	81.6	47.6	26.8	136.1	79.3	106.3	113.6	89.5	127.1	95.5	150.8	121.3	60.6	90.0	161.7	131.0	119.8	145.9	149.1	118.2	132.3	79.0	199.6
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 36.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	17	"SiHa: 36.0"					"Low region specificity"	"Detected in all"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.4	0.1	1.7	0.2	0.1	0.1	0.6	1.6	0.5	0.2	0.1	0.0	0.7	3.5	0.1	0.0	0.1	0.1	0.8	0.2	0.3	0.5	0.1	0.1	0.1	0.8	0.1	0.1	2.5	0.2	0.4	0.3	1.8	0.0	0.4	0.1	1.8	0.1	0.6	0.3	0.1	0.4	0.1	0.1	36.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.7	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.6	0.0	0.1	0.2	0.1	1.7	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	36.0	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.1	0.6	0.8	0.2	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.4	0.1	0.0	0.0	0.6	0.0	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.2	29.8	20.2	0.1	1.4	0.0	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Cell type enhanced"	"Detected in all"	6	"monocytes: 1009.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	42.2	53.5	15.5	29.3	32.1	18.7	45.7	32.1	41.4	31.8	26.3	22.7	92.2	23.6	43.7	42.1	24.6	45.7	24.5	34.7	16.6	30.8	49.7	40.8	20.7	79.4	34.3	65.2	60.9	15.3	28.0	21.4	17.4	23.0	43.7	29.8	52.9	39.5	29.5	40.4	37.9	77.3	24.3	62.0	43.4	31.6	18.2	84.5	57.8	24.6	38.3	13.4	30.0	62.0	31.1	14.4	29.4	49.6	58.0	14.6	13.7	11.5	30.1	16.7	16.2	28.0	32.4	57.0	58.9	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0	131.0	100.4	88.6	136.2	65.4	45.6	40.9	122.3	141.8	86.4	143.1	13.7	355.3	212.2	199.7	61.7	74.4	141.1	280.4	236.4	383.3	78.6	213.8	155.0	128.2	368.8	47.7	97.4	79.8	301.9	17.2	109.0	235.0	133.3	1009.1	137.9	126.1	238.1	181.4	97.9	218.5	43.3	71.1	73.5	122.7	154.7	72.6	440.3	79.1	199.9	251.7
TARBP2	Trbp	ENSG00000139546	"TARBP2, RISC loading complex RNA binding subunit"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	7.3	12.0	7.5	11.5	8.0	6.1	18.6	24.0	9.5	10.7	11.6	11.0	11.0	10.9	8.3	15.7	11.8	14.7	15.8	8.0	7.0	6.1	14.8	27.3	10.3	15.7	9.5	6.3	9.8	17.0	8.6	8.2	23.5	6.6	10.2	7.1	10.3	13.4	11.1	10.9	12.2	10.3	7.6	6.9	13.9	10.3	18.3	6.9	14.8	15.5	8.6	12.9	10.2	12.8	11.1	12.7	5.5	9.8	9.5	12.7	10.7	10.1	29.5	10.6	11.7	6.9	9.4	15.4	8.7	8.5	15.0	8.9	23.9	14.0	9.2	19.0	10.1	9.1	8.1	14.4	13.6	9.0	12.0	22.7	10.8	11.6	17.6	14.4	18.4	12.8	10.2	9.3	14.8	7.5	10.1	17.7	14.9	14.4	16.2	10.9	41.9	12.8	25.9	21.6	7.7	15.3	9.7	6.3	13.1	9.6	11.1	14.3	10.0	4.6	12.0	24.3	8.7	16.5	27.2	8.7	12.9	11.7	4.8	11.0	7.4	14.8	9.8	15.2	9.8	14.8	1.7	9.8	5.5	12.6	9.7	12.1	10.5	12.0	10.9	12.7	11.1	12.7	11.4	0.4	9.5	5.9	11.3	9.9	10.7	7.5	8.0	24.0	9.5	7.0	6.1	9.5	6.3	6.6	6.9	0.0	8.0	13.8	10.6	5.7	7.9	5.5	7.6	4.0	5.7	8.7	9.8	40.0	18.3	18.6	7.5	7.7	8.0	0.0	22.9	39.5	8.5	7.8	10.4	16.8	22.3	1.6	5.2	6.7	7.5	19.2	5.2	7.3	13.5	13.6	9.0	9.5	16.3	10.5	3.9	20.3	11.4	0.0	6.2	10.9	12.9	4.1	26.9	10.2	12.4	7.5
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.2	14.4	9.7	14.7	11.0	10.1	18.5	8.4	9.2	16.7	16.8	11.7	16.1	25.0	18.6	6.3	11.5	18.0	23.6	19.5	12.8	15.0	20.5	11.8	13.7	11.8	10.9	16.3	18.1	8.9	16.4	12.6	17.2	10.9	10.7	14.0	20.5	17.6	11.6	20.8	13.7	13.3	12.0	23.9	21.5	14.2	12.4	30.9	11.3	8.1	13.8	16.2	12.7	28.2	19.8	14.4	22.7	25.5	6.3	9.7	10.4	8.0	14.1	17.0	20.0	18.8	14.5	19.0	9.4	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6	3.0	13.8	7.2	4.6	3.0	15.8	19.0	12.7	10.7	12.5	7.0	19.6	21.6	10.0	9.9	0.9	6.3	6.6	0.0	8.6	11.4	6.0	3.8	21.9	15.3	11.8	14.3	4.1	7.4	6.5	2.1	7.8	8.0	3.3	16.2	8.9	8.4	9.9	0.0	6.7	6.3	15.4	6.5	7.2	15.4	11.1	3.4	11.8	7.0	10.8	4.1
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	28.5	63.0	31.1	19.5	49.8	34.9	30.7	33.5	48.4	33.8	33.4	16.1	26.7	23.7	27.4	35.5	46.6	30.7	28.2	47.4	30.8	31.9	51.0	35.3	28.7	23.0	41.0	34.8	32.0	29.7	46.3	69.4	65.8	54.1	36.4	31.1	18.7	32.3	32.6	50.3	23.5	41.0	48.8	41.7	34.5	30.3	30.3	35.2	34.2	44.5	27.0	24.6	51.3	29.0	21.1	17.5	59.7	31.3	17.3	33.0	22.5	39.8	22.1	22.6	21.4	35.9	26.2	15.4	29.8	36.7	22.4	28.1	17.9	32.5	8.5	28.2	43.5	38.7	28.4	21.2	19.5	35.1	15.9	11.0	23.0	23.7	35.5	34.0	33.5	27.4	22.1	40.6	26.0	29.9	27.0	24.1	14.8	25.5	26.2	45.2	14.7	14.7	33.1	25.5	52.3	20.8	12.3	24.3	17.4	31.7	45.2	15.0	24.5	41.8	54.7	62.2	45.5	25.5	50.6	25.9	21.2	33.2	26.3	19.6	48.2	33.4	15.9	24.8	63.7	48.4	37.4	24.2	59.7	21.8	29.3	26.3	21.1	25.9	25.3	17.5	17.9	24.0	24.0	48.9	17.3	31.3	16.2	33.0	22.5	31.1	49.8	33.5	48.4	30.8	31.9	41.0	34.8	54.1	35.2	199.5	169.7	106.1	180.8	162.8	267.0	498.7	129.9	654.5	232.0	122.1	90.3	129.6	349.8	187.1	99.7	143.3	138.9	70.0	229.8	91.8	123.1	243.4	143.4	96.2	109.6	151.0	134.4	76.7	127.2	72.2	108.1	171.8	108.0	226.4	131.6	177.5	242.3	125.6	139.7	231.8	140.4	103.5	117.9	217.7	133.4	167.7	519.6	133.7	103.0	398.4
TBC1D12	KIAA0608	ENSG00000108239	"TBC1 domain family member 12"	O60347	10	94402504-94535930	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038277, HPA038645"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA038277: AB_10672584, HPA038645: AB_10672650"	"unprognostic (7.23e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.79e-5)"	"unprognostic (7.83e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-1)"	6.9	4.9	8.9	4.0	18.1	1.2	8.1	7.5	14.8	5.3	8.4	39.2	7.1	6.2	5.6	4.0	4.7	4.3	5.1	4.4	12.4	8.5	5.8	4.1	5.2	3.0	25.5	8.7	5.8	7.1	16.8	3.2	7.8	23.1	6.0	9.7	5.9	3.6	6.5	4.3	5.7	6.9	6.0	41.6	5.6	4.2	10.9	21.3	0.2	4.3	1.5	3.5	5.7	4.9	1.4	2.2	0.0	1.1	0.0	0.1	0.2	7.6	3.4	4.5	6.7	6.3	7.7	5.9	5.0	10.3	5.6	5.3	13.6	3.4	0.0	3.0	7.3	5.5	4.3	5.4	3.7	7.2	0.0	6.1	2.4	3.1	4.3	4.8	0.0	1.9	5.2	4.7	5.9	7.6	9.5	6.0	0.0	3.5	8.0	9.0	4.2	0.0	0.0	1.4	5.5	3.6	0.0	5.8	4.0	5.0	3.4	1.9	4.5	5.0	4.3	4.0	4.3	9.4	4.6	5.9	3.9	5.4	6.3	3.9	5.7	5.4	0.0	3.9	0.0	2.1	0.0	1.1	0.0	0.0	0.7	0.0	0.5	0.0	0.0	2.2	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.9	18.1	7.5	13.4	12.4	8.5	25.5	8.7	23.1	21.3	8.9	4.0	4.5	4.9	17.3	17.2	4.8	2.5	2.7	4.5	8.7	9.8	14.8	0.0	5.2	13.8	10.5	13.6	0.0	4.4	10.7	13.8	9.3	5.7	3.4	16.5	7.9	8.1	9.2	18.7	7.4	7.8	18.3	15.1	10.8	7.6	8.1	6.2	10.5	9.9	5.2	26.8	12.9	11.8	44.7	10.8	16.8	20.4	0.0	11.2	7.6
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26755351	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	6.1	13.9	8.6	5.4	10.2	2.8	6.8	11.5	11.2	11.8	8.8	8.7	7.7	3.1	22.4	11.0	4.8	11.9	11.8	10.7	6.6	9.0	24.9	4.6	6.6	3.5	9.3	7.7	13.9	7.7	21.9	23.4	6.1	14.8	8.7	5.1	8.4	5.8	10.4	5.7	4.2	3.8	13.5	8.6	4.4	6.9	10.0	7.1	33.3	12.1	2.9	4.2	8.3	7.0	4.1	2.4	2.3	0.9	6.6	8.7	1.8	1.4	1.3	4.6	2.8	6.8	10.5	1.4	5.9	4.6	2.7	3.0	2.1	3.4	3.2	5.3	8.3	8.8	0.6	2.5	3.3	2.6	1.0	1.3	0.7	3.7	0.7	3.6	1.6	0.7	5.1	2.5	5.4	3.1	11.2	3.7	4.2	2.5	0.0	40.9	0.0	3.4	1.9	2.1	1.7	4.9	2.5	4.7	0.3	10.5	1.3	4.6	1.9	2.8	0.6	2.8	3.7	1.2	0.7	3.3	3.5	1.0	2.6	1.4	0.8	1.7	1.4	12.2	0.9	3.6	1.6	0.9	2.3	8.1	0.9	8.7	3.2	6.2	8.3	1.4	4.1	4.9	5.1	0.1	6.6	0.8	2.4	3.0	1.8	8.6	10.2	11.5	11.2	6.6	9.0	9.3	7.7	14.8	7.1	3.0	2.6	4.7	4.8	3.2	7.5	5.3	2.5	18.7	0.0	19.2	13.7	3.6	5.0	4.8	4.8	5.7	0.4	0.0	2.8	1.7	6.2	2.5	9.2	1.8	1.6	4.8	9.1	6.7	1.6	1.9	8.3	2.3	10.1	1.0	1.9	8.2	2.1	0.0	8.5	11.3	19.4	0.0	4.7	22.0	5.7	4.0	1.6	17.5	1.3	1.6
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	11.5	17.9	9.6	11.0	12.1	26.0	12.8	15.2	17.1	9.7	13.1	11.2	14.3	13.1	13.9	13.0	19.8	14.1	16.8	11.2	10.5	10.5	13.3	8.7	11.7	9.0	8.9	9.9	15.0	20.9	16.8	11.8	13.3	13.1	12.3	13.3	12.2	21.6	11.8	32.7	20.7	16.1	11.5	8.3	11.1	10.6	19.9	8.2	20.7	13.0	10.5	14.4	10.4	13.3	4.6	7.7	8.0	6.6	5.7	6.2	4.6	7.0	3.0	5.6	6.1	5.2	5.2	8.0	4.0	8.3	7.5	9.2	6.8	4.7	6.6	4.2	5.0	10.1	4.9	7.0	6.3	8.4	10.7	5.7	10.5	5.0	9.2	7.5	5.9	9.0	4.4	9.3	7.3	8.7	7.1	10.4	11.2	11.9	1.7	5.3	6.4	8.7	4.5	7.2	8.1	2.8	5.8	5.1	5.2	7.6	5.2	7.3	4.7	4.3	6.3	7.7	7.8	4.5	10.7	10.1	4.5	7.0	3.0	5.2	6.3	6.5	43.8	3.1	9.0	7.0	2.4	5.0	8.0	4.8	6.6	5.6	3.6	5.3	4.6	7.7	4.6	6.2	5.0	2.2	5.7	2.9	2.2	3.6	4.6	9.6	12.1	15.2	17.1	10.5	10.5	8.9	9.9	13.1	8.2	3.0	6.4	2.7	7.2	7.2	5.1	3.5	2.5	12.0	9.1	1.8	3.9	5.5	3.3	10.8	4.4	4.9	11.1	23.3	13.4	7.1	4.1	7.9	5.7	3.6	4.9	0.0	1.7	4.3	4.3	2.9	2.8	4.3	1.7	7.2	5.1	3.8	13.3	5.8	1.1	7.7	4.6	0.0	2.5	5.5	5.1	13.9	5.6	4.9	4.7	10.1
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007617-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 76.0;skeletal muscle: 66.3"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 32.5;Ciliated cells: 41.5;Glandular cells: 38.4;monocytes: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 16.6;non-classical monocyte: 20.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.7;ASC TERT1: 26.1;BJ hTERT+: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	14.4	4.0	3.0	5.5	4.2	7.3	14.1	10.1	5.1	7.6	19.6	2.2	52.8	4.3	7.8	12.2	8.4	13.2	12.0	24.1	4.8	2.7	8.9	12.8	11.8	6.8	3.0	3.8	5.1	27.5	3.9	8.5	4.4	6.1	25.7	3.8	6.7	15.1	76.0	66.3	15.2	22.7	7.7	5.0	11.3	13.3	11.3	2.8	3.3	5.3	8.3	8.0	8.7	8.6	0.6	4.0	0.2	20.6	0.0	0.3	1.8	2.0	12.8	1.0	3.7	36.7	26.1	10.5	1.2	22.5	0.9	1.1	4.5	3.3	0.9	11.5	0.9	18.0	6.5	2.1	9.9	0.6	0.6	1.9	0.6	4.3	15.6	2.5	0.1	11.0	12.1	9.4	1.2	9.4	0.7	13.1	1.8	0.2	1.1	1.1	5.6	1.1	6.4	2.8	1.4	13.8	2.5	3.2	0.2	7.5	13.7	8.1	3.9	1.7	3.1	4.4	1.8	0.9	9.4	10.8	0.5	1.9	1.9	0.8	2.1	0.1	0.0	4.7	3.2	3.3	0.0	5.1	0.2	0.1	16.6	0.2	0.2	0.1	0.1	2.8	0.6	0.3	0.2	0.2	0.0	20.6	4.0	0.1	1.8	3.0	4.2	10.1	5.1	4.8	2.7	3.0	3.8	6.1	2.8	3.0	2.9	0.0	32.5	3.7	5.8	10.6	20.4	41.5	20.5	5.2	3.9	3.9	0.0	5.9	4.8	4.9	1.3	0.0	2.6	2.5	2.3	38.4	6.9	5.0	3.6	1.6	2.9	7.4	11.2	8.6	2.8	12.2	5.0	33.3	1.7	0.9	2.8	0.6	1.8	0.7	3.6	6.5	4.2	1.4	1.9	5.5	2.9	0.0	0.9	24.3
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620765-140756120	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 52.4"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.0"	"Group enriched"	"Detected in many"	38	"B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	15.9	6.2	8.1	9.2	10.0	1.0	33.6	37.6	13.7	9.2	6.7	3.8	32.1	5.2	5.5	6.4	5.9	6.7	9.4	5.7	7.5	13.9	10.7	8.0	10.4	9.6	9.6	8.2	10.9	6.0	9.9	5.7	13.1	11.0	9.8	4.3	10.6	7.3	27.4	1.7	2.8	9.9	5.0	5.3	20.4	10.0	2.9	3.8	1.6	4.3	3.0	12.2	11.1	8.9	9.0	4.6	0.1	2.4	0.1	0.0	0.9	0.4	6.4	6.0	5.1	14.6	13.8	12.2	8.1	8.8	5.9	7.6	1.3	5.6	0.0	5.2	10.6	7.4	1.2	7.4	5.8	5.6	0.0	4.1	3.6	4.6	5.5	5.3	0.5	0.5	11.3	9.7	5.1	20.6	17.3	16.4	2.0	0.0	0.0	5.5	6.3	0.8	0.0	0.9	6.7	5.6	3.9	9.8	9.3	6.8	11.8	8.8	6.2	8.5	15.0	5.5	10.6	3.5	0.2	25.4	15.7	4.7	10.2	7.0	0.0	0.0	0.0	9.5	0.7	8.5	0.0	2.4	0.0	0.0	1.9	0.0	9.0	0.0	0.0	4.0	4.0	0.0	0.0	0.1	0.1	0.7	4.6	0.0	0.9	8.1	10.0	37.6	13.7	7.5	13.9	9.6	8.2	11.0	3.8	50.6	9.4	15.7	8.9	4.0	33.1	6.5	17.8	5.3	6.8	52.4	3.9	10.8	6.6	13.3	0.4	24.1	4.1	0.0	15.0	3.9	11.5	19.8	0.0	14.5	15.9	9.5	7.5	17.8	30.7	0.0	12.0	30.7	8.5	25.2	4.5	40.9	13.2	5.9	25.1	3.8	7.0	0.0	9.5	0.7	1.5	3.3	36.2	0.5	1.7	8.4
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 44.5;HBF TERT88: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	12.8	19.0	14.2	7.6	15.2	3.4	10.0	16.3	15.2	13.5	8.3	10.0	11.0	4.4	10.9	14.9	10.6	13.0	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15.0	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9.0	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12.0	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.2	1.9	19.6	12.3	0.9	3.9	6.3	25.3	44.5	4.5	3.9	1.7	5.9	13.2	3.7	2.3	3.5	4.8	30.4	2.4	1.0	5.4	2.1	4.7	5.1	2.2	3.2	11.4	4.0	2.3	4.0	11.1	6.6	3.2	4.2	2.1	7.7	3.4	2.8	2.1	1.2	6.6	1.8	2.1	3.2	3.6	6.6	4.5	2.8	2.2	3.4	2.4	3.4	7.3	3.4	4.9	3.7	4.5	2.2	1.0	1.9	1.0	2.8	3.7	6.2	3.3	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15.0	8.5	12.1	13.8	17.9	28.0	8.9	5.8	2.1	19.0	6.7	5.1	14.7	20.5	14.0	19.6	9.6	3.3	3.8	35.4	8.2	3.8	0.0	0.8	5.5	7.0	4.2	10.5	4.4	5.8	11.1	5.2	9.8	4.7	28.9	10.3	4.3	5.0	2.8	6.4	10.1	2.1	5.8	12.0	6.9	15.8	0.0	3.8	10.4	8.2	2.0	6.2	6.9	5.5	4.2
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.4	8.8	12.8	15.8	16.0	19.4	14.7	21.5	13.9	13.2	8.7	8.2	18.8	12.8	15.9	20.1	12.7	11.3	12.4	16.4	17.3	10.8	20.2	11.2	12.0	17.3	20.6	25.2	12.0	11.3	13.9	13.4	24.1	18.5	7.2	15.4	27.4	17.9	16.4	0.6	16.1	17.6	12.3	9.0	9.6	9.8	18.1	15.1	24.4	7.4	10.7	19.4	20.0	14.3	15.3	20.4	15.0	17.1	12.5	12.1	10.0	14.4	17.4	30.2	18.3	15.8	11.4	16.1	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9	17.9	15.6	14.7	23.9	9.7	18.4	10.0	7.6	18.7	19.4	21.0	9.8	24.9	10.0	17.0	24.8	24.1	10.7	0.0	20.6	24.3	13.6	35.1	41.6	14.3	18.1	17.5	16.6	16.5	19.0	20.1	17.8	26.2	13.5	27.9	8.0	13.0	14.3	10.2	19.4	11.6	15.8	25.8	17.8	49.9	12.9	13.0	77.5	25.8	9.3	32.4
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 65.3;Hepatocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"	"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	22.9	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.3	0.3	10.3	4.3	3.1	18.8	4.0	14.6	5.9	9.2	9.0	16.5	11.8	11.3	3.2	32.3	7.4	4.7	10.4	5.5	5.4	9.2	7.9	15.7	25.0	5.7	11.4	7.8	12.1	17.1	6.4	14.5	17.6	6.8	17.6	13.5	7.6	11.0	5.0	12.5	3.1	7.4	23.6	6.1	7.0	13.3	3.5	8.7	0.3	2.0	15.3	11.8	11.4	12.9	7.8	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5	0.0	5.0	15.2	9.4	5.8	11.5	9.5	22.9	12.0	6.8	29.6	21.6	65.3	11.6	9.9	0.8	9.4	2.6	0.0	6.7	2.4	10.0	18.9	10.5	59.7	10.0	6.4	21.9	11.6	32.3	1.7	13.3	19.9	5.0	10.8	4.8	38.8	8.5	3.5	26.9	17.0	22.7	0.0	25.9	1.4	17.9	10.8	37.6	10.7	4.7	22.3
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	28.2	12.0	0.0	2.4	3.3	6.4	10.8	0.0	0.0	0.0	1.4	14.4	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	20.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.1	1.2	0.0	0.1	0.0	15.3	0.2	1.6	0.7	0.3	0.0	0.8	0.0	0.3	0.3	0.0	0.3	0.0	3.5	2.1	14.3	0.1	0.2	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.1	1.8	0.0	0.0	0.0	0.0
TBX2		ENSG00000121068	"T-box 2"	Q13207	17	61399896-61409466	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 76.5;Collecting duct cells: 90.7;Muller glia cells: 126.1;Sertoli cells: 168.1;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.6;MCF7: 28.5;SH-SY5Y: 22.7;SK-MEL-30: 15.5;WM-115: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	11.5	3.4	2.0	2.9	3.1	0.4	9.9	1.3	2.3	14.8	4.4	1.9	30.4	4.9	12.2	37.0	5.9	11.3	16.8	6.8	1.8	1.8	28.9	4.6	35.7	1.3	3.6	1.5	8.3	1.8	1.8	3.7	30.4	3.6	15.1	2.2	33.7	2.2	38.1	5.8	2.9	5.5	16.4	1.7	8.8	8.1	9.6	1.5	0.0	8.6	5.0	1.8	19.5	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	48.6	1.6	1.7	5.9	7.5	7.9	0.4	0.1	1.3	0.1	0.0	0.6	1.2	0.9	0.0	0.9	0.0	0.1	0.0	2.9	0.8	0.0	2.3	5.4	0.1	0.7	3.1	0.1	8.9	0.5	0.1	0.0	0.0	0.1	0.0	0.5	28.5	0.0	0.1	0.0	0.0	3.4	0.0	1.9	0.2	0.0	11.5	0.1	22.7	0.0	0.0	15.5	0.1	0.6	0.9	0.0	1.1	0.0	2.8	1.7	0.0	0.1	0.0	6.7	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	1.3	2.3	1.8	1.8	3.6	1.5	3.6	1.5	0.0	1.1	0.0	0.2	0.6	76.5	6.7	0.0	0.0	0.0	90.7	21.6	0.3	1.7	0.0	0.7	4.2	0.0	0.0	0.0	0.2	3.7	0.6	0.0	0.0	0.8	1.6	0.0	14.1	1.8	0.0	36.5	1.7	1.7	0.0	0.0	126.1	0.0	0.0	44.6	23.8	11.5	168.1	66.5	0.4	0.6	0.3	0.2	0.0	0.0	0.1
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 513.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	6.0	0.0	0.0	9.0	12.4	13.5	34.0	32.4	13.2	13.1	5.3	1.4	0.0	0.5	5.9	0.8	1.5	2.8	1.2	16.3	0.0	4.1	0.0	1.5	15.5	2.9	0.0	0.0	5.5	0.8	4.4	9.1	0.0	0.1	0.0	1.2	0.0	1.1	0.5	0.0	0.1	0.0	17.2	1.8	0.0	0.0	0.8	0.0	42.4	2.2	6.6	4.8	2.2	1.1	15.8	1.7	0.0	0.0	4.0	2.6	2.3	11.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2	0.0	3.4	0.9	88.0	8.8	6.3	9.8	0.0	0.0	0.0	33.2	3.9	39.8	0.0	0.4	1.3	26.5	25.4	0.0	0.0	5.9	9.5	74.0	0.0	31.0	5.4	1.6	4.7	0.6	1.6	1.8	4.9	0.8	3.3	0.0	13.8	1.5	0.5	23.0	5.6	0.0	2.0	38.8	34.1	0.1	4.7	8.5	513.4	0.7	4.5	62.6
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779751-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 100.1"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 183.3;Pancreatic endocrine cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 32.2"	"Group enriched"	"Detected in many"	46	"NK-cells: 12.9;T-cells: 32.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;OE19: 31.5;RT4: 18.5;SK-BR-3: 22.5;T-47d: 11.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	6.6	1.5	0.9	15.8	0.9	1.9	12.3	0.4	1.9	8.9	10.2	0.6	16.7	5.4	7.6	7.0	11.6	5.4	24.9	4.7	0.9	1.0	3.7	6.8	13.5	11.3	0.8	0.5	5.5	100.1	12.4	8.4	13.1	1.6	9.3	7.0	6.6	29.8	20.1	2.1	6.9	11.7	3.2	1.1	12.3	10.8	4.9	0.1	8.7	10.3	5.8	27.9	8.3	9.5	0.2	0.0	0.4	0.0	12.9	32.2	7.7	4.5	0.7	0.0	0.0	0.8	0.0	6.3	0.0	0.1	0.0	0.0	3.2	9.8	3.0	0.2	0.0	0.1	0.5	4.5	4.6	0.0	0.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.2	0.0	0.0	0.2	0.0	2.4	0.0	8.1	0.0	0.0	0.6	31.5	0.0	0.0	0.0	0.0	2.2	18.5	3.4	0.0	0.4	22.5	0.0	1.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	32.2	0.2	16.2	18.6	0.0	0.1	13.3	11.0	0.4	12.9	0.0	0.0	5.2	7.7	0.9	0.9	0.4	1.9	0.9	1.0	0.8	0.5	1.6	0.1	38.7	70.6	6.7	26.4	47.5	0.0	0.7	30.6	68.3	59.1	24.4	0.0	0.9	1.7	55.7	12.8	4.0	23.4	0.0	183.3	3.0	10.8	49.3	6.9	0.8	0.2	0.0	30.5	5.5	1.0	21.7	52.6	2.2	57.3	1.0	54.7	3.7	110.5	40.8	12.0	7.7	0.0	0.0	4.3	35.2	8.1	72.1	4.6	54.6	33.0	58.8
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	26.7	25.3	30.7	40.5	31.5	29.6	31.1	26.1	27.4	26.0	28.3	21.9	26.6	20.3	27.3	20.9	27.5	23.6	24.7	21.4	27.8	24.2	26.5	56.8	22.3	39.2	29.7	17.6	28.5	38.4	32.2	28.7	21.1	27.1	31.3	22.5	20.6	25.4	25.4	21.8	22.8	22.4	38.9	36.8	30.0	26.1	17.3	31.3	39.9	54.6	18.6	46.9	39.6	37.3	60.0	31.9	20.5	17.8	25.2	40.1	17.8	27.3	27.7	24.8	25.5	17.6	21.9	17.8	21.7	25.5	25.7	28.7	15.8	22.9	67.2	24.7	24.9	27.4	21.1	31.3	19.9	37.5	38.4	15.7	50.8	13.5	23.3	55.3	19.9	21.9	15.7	53.8	24.2	106.8	21.3	21.9	23.2	32.2	58.4	23.3	13.0	41.1	13.9	40.3	44.5	8.3	31.9	8.7	12.0	35.4	18.7	23.3	16.9	17.9	15.8	58.3	24.2	22.8	22.3	19.4	18.9	17.4	21.2	19.5	36.1	22.6	45.5	33.3	22.8	26.6	18.1	17.8	20.5	30.1	16.8	28.6	60.0	31.4	27.7	22.1	44.4	28.0	29.1	6.4	25.2	15.6	31.9	40.1	17.8	30.7	31.5	26.1	27.4	27.8	24.2	29.7	17.6	27.1	31.3	83.4	82.6	150.6	116.2	120.3	70.8	20.7	79.0	139.2	124.0	94.2	84.4	99.1	142.6	96.9	85.2	85.7	52.6	93.5	95.8	104.8	89.7	121.1	94.9	140.5	76.9	54.0	83.7	48.5	68.2	129.1	124.8	89.2	111.3	118.2	83.8	139.0	101.0	71.9	124.8	130.8	97.6	77.6	122.7	77.9	84.3	131.6	93.7	107.1	78.7	109.8
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA043836: AB_2678694"	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	14.8	19.5	31.4	7.9	32.8	6.6	9.3	34.7	40.4	18.3	11.7	17.7	11.0	5.6	18.8	10.9	8.4	24.5	13.5	19.1	27.7	30.0	14.8	27.5	10.9	9.2	27.2	32.8	30.3	16.1	18.6	17.9	14.7	26.5	16.9	3.2	14.5	17.9	22.3	30.7	10.4	7.8	11.7	18.3	16.2	10.5	32.0	18.9	8.7	15.0	6.1	5.2	10.9	15.4	9.7	3.0	4.4	2.6	3.6	5.5	1.6	7.6	8.3	13.2	22.4	11.8	7.4	5.4	8.0	8.9	14.1	6.8	4.9	13.6	8.7	18.0	9.2	8.1	20.5	5.2	6.8	2.8	5.4	10.5	3.3	14.5	12.8	17.6	3.6	4.6	11.5	6.1	3.6	4.7	18.9	9.6	10.9	5.7	16.4	4.3	16.6	14.8	17.7	8.5	9.3	20.0	14.5	10.0	22.5	7.1	5.1	13.1	22.1	8.1	5.5	20.0	4.4	15.2	9.1	13.7	25.5	13.5	14.3	4.9	19.1	12.5	4.6	22.7	4.2	5.0	2.4	1.7	4.4	3.6	1.6	1.6	9.7	3.2	2.6	2.1	5.0	5.5	3.4	0.8	3.6	2.6	3.0	5.4	1.6	31.4	32.8	34.7	37.6	27.7	30.0	27.2	32.8	26.5	18.9	0.0	1.9	12.3	28.6	20.0	50.6	26.9	22.9	6.7	7.9	68.0	25.5	21.6	91.2	30.0	85.6	40.8	1.7	0.0	13.9	11.1	39.4	27.1	2.3	35.5	14.9	62.0	18.3	33.7	14.8	118.7	48.1	23.3	59.1	21.6	2.8	84.3	20.7	2.5	46.3	82.3	30.1	25.8	42.9	95.9	31.9	17.7	17.4	13.8	1.7	17.4
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23381061-23424740	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 114.0"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 307.1;Undifferentiated cells: 204.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.0;Hep G2: 33.2;OE19: 17.1;SiHa: 11.0;T-47d: 17.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	5.4	17.8	2.5	10.7	1.9	0.1	3.6	1.5	1.5	9.1	12.2	2.2	12.0	4.6	3.8	14.5	12.0	6.2	13.0	20.3	2.4	0.8	12.1	38.0	6.0	1.3	1.2	2.3	19.8	60.4	4.5	3.3	2.5	2.2	16.7	12.5	8.7	32.7	15.9	114.0	8.9	11.9	13.7	2.0	1.6	11.5	2.6	1.3	0.5	8.6	58.3	16.0	8.4	6.9	0.0	2.8	0.0	0.7	0.2	14.3	2.5	0.0	0.1	0.3	0.3	1.7	10.0	5.5	3.9	2.5	2.1	1.2	2.5	0.3	0.1	0.4	4.8	0.6	5.4	0.4	0.0	1.8	0.0	0.0	0.0	4.1	33.2	1.2	0.4	0.0	6.5	1.8	1.8	0.0	4.5	0.2	0.0	0.0	0.0	0.6	0.9	0.2	3.6	0.0	17.1	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	11.0	0.5	0.4	1.0	17.5	1.6	0.2	0.0	0.1	0.4	0.0	0.3	2.9	0.0	0.3	0.3	0.3	0.0	0.1	0.0	0.5	0.7	0.5	0.0	8.5	1.2	2.8	0.0	14.3	6.3	0.0	0.2	0.2	0.9	0.7	2.5	2.5	1.9	1.5	1.5	2.4	0.8	1.2	2.3	2.2	1.3	116.1	83.2	2.2	44.3	24.4	1.5	92.9	68.8	45.5	71.7	40.1	2.0	3.0	169.1	22.0	4.7	12.7	145.7	0.0	86.0	28.5	32.8	62.5	9.2	177.9	1.2	23.8	53.7	9.8	7.3	7.2	15.8	16.2	23.6	2.8	307.1	2.9	40.2	98.2	14.5	173.6	1.5	19.4	20.6	0.5	3.5	47.9	1.8	6.1	204.2	55.5
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 939.8;Distal tubular cells: 305.1;Extravillous trophoblasts: 389.4;Syncytiotrophoblasts: 652.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	28.2	61.0	17.9	14.7	20.9	3.7	42.1	20.7	24.0	30.8	20.6	10.9	35.0	7.6	32.3	59.6	21.4	20.1	25.6	29.4	19.5	20.5	38.8	12.6	25.9	9.5	23.7	15.0	93.4	15.7	19.6	54.5	67.1	40.3	27.6	17.7	15.2	15.7	45.4	7.8	12.1	11.7	30.2	44.1	26.4	23.1	27.5	23.6	5.4	58.6	18.5	7.6	35.5	75.7	1.8	18.6	0.9	1.3	1.1	3.5	1.3	17.8	8.8	28.0	14.3	60.7	59.2	21.0	37.7	50.5	26.8	43.9	17.0	19.1	0.0	56.0	30.8	49.5	10.8	4.8	24.0	36.1	0.0	10.4	18.3	21.6	10.9	41.8	0.0	0.0	40.5	23.4	35.7	35.8	46.9	44.4	7.8	16.2	1.3	63.4	0.0	8.9	0.1	17.4	0.0	17.0	0.0	55.9	0.0	32.3	33.3	12.7	15.3	23.7	0.7	24.6	31.5	3.8	1.0	36.1	23.9	10.4	71.9	10.4	0.0	1.0	0.1	58.1	0.0	19.0	0.9	1.3	0.0	0.2	0.7	0.0	1.8	1.5	0.5	1.0	1.0	3.5	2.9	0.0	1.1	0.1	18.6	0.9	1.3	17.9	20.9	20.7	24.0	19.5	20.5	23.7	15.0	40.3	23.6	160.8	68.5	0.0	0.0	0.0	0.0	0.0	0.0	18.7	86.4	221.6	0.0	939.8	305.1	198.1	0.0	0.0	0.0	0.0	124.7	389.4	0.0	0.0	10.5	0.0	127.3	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	6.4	0.0	0.0	126.5	0.0	0.0	165.0	0.0	0.0	0.0	0.0	0.0	0.0	652.4	0.0	0.0	0.0
TCEANC2	"C1orf83, FLJ32112"	ENSG00000116205	"Transcription elongation factor A N-terminal and central domain containing 2"	Q96MN5	1	54053587-54112519	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1;Early spermatids: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046918	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046918: AB_2679864"	"unprognostic (2.80e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.73e-5)"	"unprognostic (8.64e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.57e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.08e-1)"	5.9	5.9	7.9	7.6	11.1	6.5	5.9	3.0	7.9	6.1	5.4	13.4	6.6	6.8	5.3	6.2	7.9	5.2	4.4	4.4	8.3	6.4	7.2	4.7	4.8	9.4	10.2	4.5	4.3	6.4	6.6	6.2	6.0	8.8	5.1	8.1	6.5	5.5	4.1	9.4	6.8	6.4	6.3	14.1	8.2	5.2	15.4	8.8	15.7	5.7	3.0	10.8	7.3	5.1	7.8	7.6	10.1	8.9	10.2	6.3	3.8	5.2	2.3	5.9	4.9	4.0	6.3	5.7	5.6	4.3	6.3	5.6	1.4	3.3	4.6	4.9	2.4	6.3	5.3	7.8	4.3	8.0	10.2	4.2	6.8	5.5	2.7	2.5	5.0	6.9	4.7	3.7	5.5	3.2	2.8	8.1	10.6	6.7	4.3	5.2	1.9	10.0	3.7	13.7	5.8	3.9	10.0	10.8	6.8	2.3	3.1	5.1	5.4	3.6	5.6	6.7	8.7	5.5	9.5	4.2	5.7	3.6	5.5	6.8	10.0	14.3	6.4	4.8	6.9	7.1	5.9	7.3	10.1	4.7	8.9	4.6	7.3	5.4	5.8	7.6	7.8	6.3	6.2	9.4	10.2	6.5	6.9	4.1	3.8	7.9	11.1	3.0	7.9	8.3	6.4	10.2	4.5	8.8	8.8	8.9	9.1	0.8	1.5	0.6	3.0	7.5	10.2	24.1	7.9	10.4	11.8	4.9	1.7	2.9	22.3	4.4	3.3	0.0	1.6	5.2	3.1	1.7	2.3	4.0	4.2	7.9	3.5	2.5	6.3	18.0	2.8	3.7	1.7	6.4	4.4	3.1	3.2	3.5	2.8	3.4	3.1	0.0	2.5	12.7	2.6	0.9	3.3	5.1	4.4	1.4
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.7;thyroid gland: 24.1"	"Cell type enriched"	"Detected in some"	10	"Horizontal cells: 96.9"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.4	1.9	2.7	0.4	4.1	0.4	0.6	3.0	9.7	0.5	0.4	0.0	0.0	0.4	0.6	1.1	0.6	0.4	0.4	0.4	3.8	3.5	0.4	0.4	0.5	0.4	0.9	3.9	5.5	0.8	0.4	4.8	0.4	1.5	1.4	0.4	3.8	0.3	1.3	0.3	1.2	0.4	0.4	2.2	0.6	0.5	1.8	0.0	0.6	24.1	0.0	0.6	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	4.1	3.0	9.7	3.8	3.5	0.9	3.9	1.5	0.0	0.0	0.0	0.0	0.1	0.6	4.5	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.6	0.0	0.0	0.0	96.9	0.0	0.0	0.0	0.0	4.4	0.0	10.1	0.0	0.0	0.8	0.1	0.0	4.2	0.0	3.6	0.0	0.0	0.1	4.7	0.5	0.1	0.0	0.0	0.0
TCF12	"bHLHb20, HEB, HsT17266, HTF4"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: AB_2685564"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	20.9	14.3	24.9	12.6	37.5	10.9	18.4	32.7	41.8	48.2	16.5	33.6	14.0	16.0	28.1	15.0	14.8	28.2	21.4	15.7	28.4	16.4	17.0	14.4	17.3	13.7	33.9	15.3	26.2	12.5	29.2	15.7	19.1	27.9	26.3	17.9	14.7	20.1	17.5	18.1	16.0	15.8	25.8	25.3	13.6	17.3	14.7	41.3	89.4	17.0	9.6	15.8	23.3	21.2	11.8	15.9	16.0	19.3	12.2	17.6	10.2	6.5	12.3	54.1	17.4	24.7	21.7	9.5	13.5	23.7	12.0	15.9	7.9	5.3	9.0	11.1	20.4	8.6	7.9	21.1	9.7	15.3	11.8	7.9	18.0	13.3	9.5	17.0	11.3	9.5	19.0	17.6	11.0	29.2	16.0	21.4	40.5	20.1	11.3	16.2	2.2	26.7	6.3	14.6	6.8	5.3	36.5	62.8	8.4	16.5	12.2	11.0	32.0	14.5	5.3	13.1	18.0	8.2	22.3	16.4	19.3	14.8	8.2	19.6	6.5	11.6	15.0	10.8	22.1	23.1	16.0	11.2	8.7	15.0	14.3	12.4	10.8	12.2	13.6	15.9	11.8	14.1	12.7	1.3	12.2	19.3	6.6	17.6	10.2	24.9	37.5	32.7	26.9	28.4	16.4	33.9	15.3	27.9	41.3	50.6	15.8	14.2	18.0	23.7	12.8	14.5	20.4	16.0	27.3	15.7	33.4	8.5	11.6	15.2	19.4	27.4	15.8	0.0	10.3	12.7	31.5	19.7	22.0	16.0	23.5	12.7	8.6	22.7	34.0	15.6	23.9	26.0	13.5	10.0	16.5	26.9	13.8	17.5	32.5	13.6	25.1	45.3	20.6	18.9	12.5	29.5	10.9	16.0	16.4	15.6
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158542-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3"	"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.3	1.5	1.3	12.4	4.1	2.3	5.2	8.2	3.9	7.0	5.6	2.3	3.7	9.2	4.2	6.2	11.2	3.2	3.8	3.4	1.7	1.1	4.3	1.6	4.8	18.0	3.0	1.0	4.6	3.6	0.4	0.9	1.5	2.0	5.5	4.0	2.3	4.1	6.7	2.5	11.5	6.0	3.9	1.8	8.6	5.9	3.1	1.8	31.3	2.8	14.4	13.8	4.8	6.7	2.0	0.9	0.2	0.3	1.2	3.8	1.2	33.2	0.3	0.3	0.0	2.3	3.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.0	7.5	8.2	19.8	0.0	0.0	12.4	0.0	0.2	18.7	2.9	1.9	0.8	0.0	0.1	8.8	1.2	0.0	0.9	0.0	1.8	7.4	17.0	0.0	16.2	3.2	0.1	0.4	5.3	0.0	0.0	0.0	0.4	2.0	0.2	2.9	0.1	20.6	0.2	0.2	0.0	0.2	2.7	0.0	2.4	0.0	20.6	0.1	0.1	0.1	5.3	6.0	10.2	0.0	0.1	0.1	0.0	0.3	0.0	0.7	0.0	3.8	1.6	1.9	3.4	0.9	2.0	2.4	0.9	0.2	1.2	0.1	0.0	2.6	1.2	1.3	4.1	8.2	3.9	1.7	1.1	3.0	1.0	2.0	1.8	3.0	1.1	6.0	2.1	4.5	2.6	1.2	0.0	0.0	3.4	3.5	0.0	0.6	6.6	1.6	0.3	3.3	1.1	0.0	1.6	7.2	2.7	1.0	1.1	0.2	7.5	1.6	1.2	1.3	1.9	0.4	4.6	4.3	11.8	10.0	3.3	3.3	0.8	0.0	6.0	0.3	0.5	0.0	6.8	0.5	12.8	3.3	0.3	5.1	7.7	0.9
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	4.1	4.3	10.2	5.5	16.4	5.4	4.6	6.6	17.1	5.4	5.6	22.6	4.4	5.7	6.1	4.3	10.9	5.6	4.2	2.7	7.3	5.4	4.9	4.6	4.7	6.5	14.7	14.6	5.7	6.7	6.9	10.2	4.3	10.5	4.4	6.1	9.9	6.5	4.2	3.1	8.5	6.4	4.6	5.8	5.5	6.0	9.3	12.2	3.5	9.2	2.3	7.5	5.5	6.8	0.3	0.3	0.9	0.3	0.0	0.5	0.0	6.4	3.7	5.5	5.0	2.9	2.7	5.7	3.0	3.5	3.5	4.6	5.4	2.7	10.8	2.7	2.6	5.0	6.5	5.4	6.0	4.4	7.7	4.3	3.1	3.9	3.6	3.1	7.1	4.2	2.4	6.0	3.9	7.7	2.6	2.6	4.2	4.6	5.7	1.9	5.8	7.2	3.9	4.1	5.7	3.0	4.1	3.1	5.7	3.5	6.0	5.5	2.3	5.1	4.9	5.0	5.4	2.6	4.4	3.2	4.4	7.1	2.6	3.3	4.6	5.6	5.5	2.7	4.4	3.0	0.0	0.1	0.0	0.4	0.0	0.4	0.2	0.5	0.1	0.0	0.3	0.5	0.4	0.9	0.0	0.3	0.3	0.3	0.0	10.2	16.4	6.6	17.1	7.3	5.4	14.7	14.6	10.5	12.2	0.0	8.1	6.5	9.2	20.0	23.2	5.2	12.7	9.4	5.7	8.7	17.7	5.9	0.0	9.9	125.1	8.3	11.7	0.0	6.6	4.6	8.2	12.2	1.1	11.9	5.4	9.5	16.1	8.0	6.6	27.6	11.5	6.9	6.8	10.0	13.1	5.1	11.5	14.0	6.0	5.6	11.9	6.5	5.1	17.2	13.4	19.9	3.8	11.4	17.9	14.1
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222331-55664787	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.8"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 425.9;Muller glia cells: 397.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8"	"Group enriched"	"Detected in many"	36	"B-cells: 29.7;dendritic cells: 85.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.4;SH-SY5Y: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	34.6	16.0	20.3	14.4	17.0	10.7	23.5	48.7	32.4	35.4	13.5	14.9	12.0	6.6	27.4	9.6	12.5	16.9	20.4	19.9	23.5	11.9	6.0	6.2	21.9	16.8	16.7	20.3	31.8	7.2	16.2	15.7	32.8	16.1	9.5	10.1	9.2	9.4	13.2	12.1	12.2	10.7	28.4	15.0	14.6	7.4	17.0	17.5	6.4	16.4	12.7	17.0	18.3	14.5	29.7	85.8	0.3	1.2	1.5	0.1	1.7	0.0	1.1	12.0	3.6	2.8	5.0	0.0	6.0	13.4	4.3	5.7	7.4	1.1	9.2	0.0	13.3	0.9	1.5	5.5	5.3	3.0	42.4	4.1	3.6	0.0	0.0	1.3	1.6	0.9	6.5	1.7	6.0	0.2	2.9	15.6	0.5	5.9	6.9	3.7	0.0	2.2	0.0	3.5	0.0	0.7	13.5	5.0	20.5	0.0	0.2	4.2	53.7	0.0	0.5	0.0	3.8	0.5	0.4	15.7	16.3	5.7	0.6	4.7	5.2	9.7	8.2	3.6	1.6	4.7	0.1	1.1	0.1	0.1	1.2	0.1	29.7	0.0	0.0	3.3	22.0	0.0	0.0	0.3	1.5	1.1	85.8	0.1	1.7	20.3	17.0	48.7	26.9	23.5	11.9	16.7	20.3	16.1	17.5	6.0	19.1	128.9	31.3	103.9	238.0	27.8	2.5	30.8	38.7	21.0	78.5	1.9	0.0	1.2	78.3	425.9	0.0	0.0	6.2	1.2	151.6	15.4	12.8	4.4	33.4	23.8	5.2	251.0	98.7	90.2	190.1	63.0	60.8	33.3	0.0	397.9	3.2	0.0	171.1	1.7	54.4	232.8	142.8	6.7	4.4	73.8	2.2	1.9	0.0	10.9
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133410-85310388	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 37.8;Ito cells: 37.4;Leydig cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.2;NTERA-2: 42.5;RH-30: 19.3;T-47d: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA071298: AB_2686383"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.06e-4)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (5.38e-4)"	21.0	3.9	3.3	6.5	6.4	4.2	28.7	5.1	5.3	28.2	14.7	7.5	14.5	4.1	21.2	11.8	13.8	10.4	9.1	11.6	6.0	3.0	9.3	7.6	11.1	5.5	4.5	3.8	20.3	3.2	11.6	5.7	4.8	6.3	14.0	4.3	16.8	8.8	19.6	13.4	8.3	6.9	17.8	5.9	7.9	6.8	7.3	5.5	2.2	18.6	8.7	6.1	18.0	20.4	3.7	2.0	8.4	1.2	1.8	2.2	0.4	0.9	0.7	14.5	11.0	5.5	1.1	8.8	1.0	3.6	2.5	2.3	2.1	0.9	0.4	1.7	2.3	2.8	2.3	11.0	18.2	1.7	0.8	1.8	0.3	0.8	0.9	0.5	0.8	2.2	0.9	3.4	0.2	0.6	1.2	4.8	0.7	0.3	0.8	2.9	0.6	0.0	0.8	42.5	0.5	0.4	0.3	19.3	0.2	1.2	1.6	0.5	4.5	1.7	7.4	0.5	11.7	18.9	0.3	5.2	2.8	4.2	0.2	1.3	0.5	0.2	0.3	0.1	0.5	2.2	8.4	1.2	2.2	1.2	1.0	1.5	2.1	1.4	1.6	0.4	3.7	1.7	2.2	3.4	1.8	1.0	2.0	1.1	0.4	3.3	6.4	5.1	4.0	6.0	3.0	4.5	3.8	6.3	5.5	6.0	37.8	0.0	11.9	5.4	0.0	6.2	5.1	9.4	11.4	15.7	0.0	5.3	0.0	3.0	22.5	21.0	0.7	0.0	5.0	4.0	12.1	7.6	4.7	5.9	1.5	0.0	0.0	37.4	6.6	3.6	60.4	2.8	3.3	1.8	1.7	5.2	1.3	0.0	26.9	1.4	0.2	6.5	18.1	1.9	10.9	3.0	1.1	0.5	1.2	2.2
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110649430	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 186.0;Spermatocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Actin filaments"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Actin filaments"		"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.0	12.4	11.2	5.1	13.8	3.0	8.9	5.6	10.1	17.7	5.4	12.3	20.6	4.1	10.3	28.7	5.4	35.4	12.3	14.4	11.0	13.0	16.1	7.2	11.6	5.5	11.0	5.3	15.5	9.1	24.1	32.9	8.4	22.1	14.5	4.0	16.3	10.2	20.6	8.0	5.3	4.1	10.3	8.9	6.0	7.2	24.7	8.0	4.4	25.5	3.9	5.2	8.8	12.2	13.7	5.0	8.4	3.5	1.1	2.9	1.9	6.9	8.8	6.2	16.9	17.7	15.4	3.1	4.9	10.2	4.6	4.0	2.0	2.1	1.4	4.4	12.2	4.5	4.9	3.6	3.7	3.3	3.0	5.7	0.4	3.6	4.2	8.4	0.7	0.7	9.6	5.7	6.0	7.3	29.2	3.3	2.2	4.8	2.9	5.6	10.1	0.5	2.4	3.0	3.7	11.8	1.7	3.3	9.9	14.1	1.6	5.3	7.0	8.5	2.0	4.1	4.8	14.2	8.0	3.6	7.9	2.0	2.8	4.2	2.8	1.3	1.9	7.9	0.7	6.3	0.3	2.4	0.4	1.3	3.5	2.9	6.3	1.9	2.7	3.7	13.7	2.9	2.4	8.4	1.1	2.0	5.0	0.6	1.9	11.2	13.8	5.6	10.1	11.0	13.0	11.0	5.3	22.1	8.0	3.0	13.1	7.7	24.6	12.2	10.1	10.2	22.9	186.0	23.9	15.7	29.5	22.5	8.3	18.4	56.3	9.8	0.4	0.0	4.2	7.8	27.9	22.4	3.5	6.8	10.3	3.2	17.3	8.6	3.2	9.5	15.8	7.6	21.9	1.0	5.6	27.8	5.2	0.0	26.9	32.2	30.2	6.5	15.6	102.1	36.2	9.8	15.3	2.2	3.9	12.4
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965804-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	12.3	16.6	7.0	17.9	11.1	15.9	12.8	10.7	13.4	17.7	14.7	10.0	11.3	11.0	15.8	17.8	23.8	12.4	12.8	12.0	7.7	6.9	13.4	17.4	13.7	19.7	8.7	7.9	14.4	13.2	11.0	21.0	27.9	10.8	13.0	16.8	10.9	13.2	11.3	11.1	16.3	18.7	17.8	8.8	19.8	13.1	5.8	8.1	33.4	12.4	15.3	19.6	13.3	14.7	18.9	41.4	18.8	24.3	14.2	13.6	7.2	13.3	6.8	21.5	12.5	5.3	4.8	21.7	10.1	4.2	14.2	8.0	11.6	6.1	31.6	6.2	8.4	2.3	9.0	25.6	11.9	11.2	12.9	20.7	24.8	10.3	5.2	5.0	30.7	18.8	5.6	15.9	10.5	8.5	8.7	13.9	18.7	27.7	5.3	6.8	14.0	34.3	17.3	26.0	9.9	10.9	35.4	11.1	11.2	15.5	19.8	28.3	19.6	12.3	14.5	9.0	13.2	23.2	16.6	8.4	4.4	7.3	4.7	12.0	11.6	15.3	27.1	4.9	16.6	8.5	18.5	24.3	18.8	13.6	16.3	10.3	17.7	13.0	11.2	14.9	18.9	13.5	12.1	16.0	14.2	15.9	41.4	12.6	7.2	7.0	11.1	10.7	13.4	7.7	6.9	8.7	7.9	10.8	8.1	35.7	18.4	41.0	33.6	70.2	45.5	23.0	35.7	40.2	40.9	31.4	25.5	58.2	31.5	66.4	3.9	43.9	26.9	23.3	46.9	70.7	38.1	38.3	38.3	30.1	39.3	33.4	78.4	36.2	38.6	2.1	25.3	39.1	15.1	39.7	39.8	23.0	64.5	34.5	28.3	18.0	37.1	45.3	30.7	9.9	25.0	89.8	131.0	39.9	38.9	48.0
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044768	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	6.3	6.9	10.8	10.4	11.4	8.3	11.0	10.8	6.6	7.1	7.3	8.4	5.9	9.1	5.6	11.1	8.8	6.2	3.5	5.5	6.3	6.8	5.9	5.5	16.1	6.2	8.1	6.8	7.0	5.5	11.0	7.5	6.3	5.7	9.6	6.1	8.1	4.2	3.1	7.7	7.9	5.8	5.7	11.7	7.0	23.3	3.7	29.8	4.5	4.4	21.0	7.6	7.0	16.4	11.2	15.5	10.6	16.3	23.2	10.7	13.8	7.9	17.6	15.9	4.4	6.1	14.0	13.3	11.0	16.5	15.0	5.7	15.0	17.7	10.0	9.1	5.5	14.3	7.7	12.4	24.1	17.9	8.3	17.9	7.2	6.9	3.8	29.9	10.4	4.4	5.6	11.6	10.8	9.5	20.9	24.3	12.3	18.6	19.5	14.6	22.8	16.1	4.2	16.5	18.6	17.4	33.3	14.0	10.6	11.4	13.2	9.0	11.3	33.2	4.2	12.2	13.2	12.8	16.6	7.2	6.8	9.8	11.9	13.7	23.8	21.6	15.4	13.5	10.4	15.5	6.6	10.7	14.5	10.6	14.3	16.4	15.7	16.3	10.4	13.5	17.7	18.2	4.5	16.3	9.7	11.2	23.2	10.7	6.9	10.4	11.0	10.8	5.5	6.3	6.2	8.1	6.3	3.7	0.0	1.4	6.7	4.6	4.1	3.0	1.1	2.5	12.0	3.4	14.0	7.9	9.1	5.0	7.3	97.8	2.7	2.3	0.0	4.8	12.5	3.9	3.6	2.3	2.9	7.8	3.2	3.5	4.3	5.6	25.8	2.6	6.1	1.7	9.0	5.0	0.6	5.0	3.2	2.8	5.7	2.2	0.0	4.7	26.1	23.8	4.0	8.5	8.7	7.6	2.6
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 434.9;Paneth cells: 431.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.2	18.6	25.1	25.7	12.6	15.8	20.4	15.2	20.4	19.4	10.1	21.4	27.9	16.6	35.4	13.1	19.6	18.0	20.8	27.4	20.6	20.0	15.0	31.5	16.0	30.7	19.4	17.1	17.0	15.8	14.4	18.1	24.5	20.8	17.9	9.2	22.7	12.7	23.8	19.6	14.4	20.5	12.2	20.8	17.0	23.0	26.1	25.3	20.4	11.7	12.9	32.8	25.8	17.2	15.1	17.8	18.2	14.8	12.4	11.0	23.1	13.3	39.1	29.2	10.2	40.5	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7	6.0	14.7	22.2	25.0	12.6	10.6	16.2	30.6	26.8	20.5	21.0	5.9	16.0	41.4	30.3	141.5	21.2	434.9	0.0	31.2	20.7	17.0	29.4	23.1	27.3	64.5	6.4	50.6	22.7	22.6	63.7	16.7	28.7	11.8	84.8	117.3	17.2	19.7	431.3	21.9	159.2	13.9	32.3	20.6	8.9	20.2	14.4	37.1	27.7	86.0	22.3
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97411950-97496125	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 33.9;Rod photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.9;HDLM-2: 25.1;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	9.5	7.1	10.6	9.1	11.5	8.9	7.7	7.1	10.2	8.8	12.8	8.9	3.7	14.0	9.8	6.0	10.5	8.2	9.2	5.7	8.6	6.6	6.4	7.3	9.8	7.0	10.2	8.8	8.3	9.7	12.5	9.3	7.9	11.6	7.1	12.7	19.0	8.8	7.0	5.1	6.1	16.5	9.6	12.6	8.8	7.6	31.1	9.8	9.3	7.3	4.7	7.3	12.1	8.6	4.3	4.6	9.8	6.1	1.6	2.9	1.8	7.7	5.4	0.0	1.8	4.2	5.5	4.6	4.9	12.4	17.0	19.1	6.9	6.6	0.5	2.4	6.9	26.9	5.9	4.5	2.5	4.6	25.1	3.9	3.5	2.7	5.0	3.8	7.9	8.5	1.8	5.0	5.6	0.5	5.1	7.3	3.8	1.9	0.4	4.4	4.6	3.9	3.9	0.8	9.1	2.9	1.7	2.8	0.1	4.1	5.2	0.8	2.3	6.8	3.1	18.6	3.0	1.8	24.8	7.4	2.1	2.1	5.4	3.7	2.6	3.0	0.4	5.0	4.3	5.5	2.4	3.1	9.8	1.7	6.1	2.4	4.3	2.4	1.8	4.6	3.4	1.8	2.9	5.7	1.6	5.8	0.9	1.6	1.8	10.6	11.5	7.1	10.2	8.6	6.6	10.2	8.8	11.6	9.8	0.0	4.0	4.5	2.4	1.4	6.5	5.2	2.5	16.0	4.5	3.5	17.7	1.3	5.0	4.0	33.9	4.3	8.3	0.0	4.3	1.9	1.5	2.0	0.0	2.4	4.3	4.8	5.8	3.1	3.7	19.8	4.0	4.6	1.7	11.8	7.0	7.8	5.2	7.6	3.5	2.9	41.7	6.5	1.4	19.1	13.6	1.9	0.6	2.6	6.3	3.2
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460080-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3;testis: 12.5"	"Cell type enhanced"	"Detected in some"	16	"Cytotrophoblasts: 7.9;Extravillous trophoblasts: 12.0;Hofbauer cells: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavorable (2.43e-5)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.8	1.8	2.3	6.2	4.1	9.3	1.1	2.8	4.6	1.2	2.6	0.8	0.0	4.3	1.2	1.4	4.5	1.2	1.4	1.3	2.3	2.7	2.2	1.7	1.0	5.6	2.1	1.9	1.0	1.9	0.3	2.4	3.8	2.0	1.3	2.2	1.0	1.3	0.8	1.0	2.6	3.8	1.1	1.4	2.5	2.2	12.5	0.8	15.3	0.9	4.2	3.9	0.6	2.2	1.2	1.4	0.0	1.0	0.0	2.1	0.7	5.2	16.7	9.6	11.2	0.1	0.6	9.7	4.2	2.5	6.8	6.6	11.5	4.4	7.3	7.0	1.8	3.7	8.1	6.9	4.2	1.6	8.1	9.2	6.6	11.8	11.8	0.2	6.4	8.9	0.6	0.5	6.0	1.6	0.5	3.1	12.3	11.3	2.8	2.3	10.1	11.2	11.9	21.3	5.1	6.1	27.4	8.3	16.6	1.4	2.3	9.1	14.9	4.9	5.2	3.6	2.6	7.6	7.4	1.1	7.3	10.6	6.9	9.5	6.2	10.2	14.7	3.7	6.4	9.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	2.1	0.0	0.3	1.2	0.7	1.3	0.0	0.0	1.0	1.4	1.9	0.7	2.3	4.1	2.8	4.6	2.3	2.7	2.1	1.9	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	1.7	2.8	0.0	0.0	0.0	0.0	1.1	12.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413429	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	14.7	10.4	5.4	22.0	8.7	4.5	11.4	5.8	6.6	8.9	24.1	11.2	7.7	27.7	12.9	11.3	9.4	7.9	15.7	9.3	6.3	3.5	9.4	9.2	14.1	15.0	7.7	3.0	9.2	8.7	28.2	11.7	7.0	7.3	10.8	18.1	8.1	11.4	8.3	13.4	10.0	38.3	10.9	12.2	19.5	11.1	3.6	8.7	14.2	11.2	6.6	20.8	9.7	10.9	4.2	8.3	7.8	4.4	0.9	1.8	0.5	7.0	2.8	3.2	3.5	19.9	8.3	5.6	4.8	4.5	2.9	4.1	6.1	7.4	5.5	3.3	13.4	5.7	7.0	2.6	9.5	5.1	6.9	2.7	6.7	6.1	4.1	6.0	5.5	12.1	11.5	9.0	6.0	4.6	13.4	13.5	5.2	2.3	4.4	10.6	4.3	4.1	3.8	1.3	19.8	2.6	9.1	7.8	1.9	9.8	10.1	1.0	1.3	3.8	9.8	3.1	8.9	5.3	3.7	13.8	11.6	8.1	4.3	1.4	9.9	5.6	3.6	2.7	5.2	4.2	4.1	4.0	0.2	1.8	4.4	1.7	2.9	0.8	1.6	1.3	4.2	0.9	1.1	7.8	0.9	4.4	8.3	1.3	0.5	5.4	8.7	5.8	6.6	6.3	3.5	7.7	3.0	7.3	8.7	8.9	13.1	6.2	4.1	2.5	0.1	2.8	7.6	13.4	5.7	1.8	2.0	1.7	1.7	3.6	0.2	3.6	18.8	0.0	4.4	2.0	1.7	5.2	10.4	4.2	5.7	0.0	4.1	8.0	8.9	0.0	4.6	11.8	5.0	3.6	11.6	3.7	5.2	11.9	3.5	2.9	2.1	0.0	3.3	0.0	0.7	1.3	1.6	4.4	7.4	4.2
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956702-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 51.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041780			Uncertain	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355561-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.6	14.9	22.1	18.2	24.4	16.1	14.1	32.2	30.0	16.2	15.2	20.0	13.3	13.4	19.2	16.4	15.3	16.1	14.0	14.7	21.2	22.1	13.2	14.9	12.6	32.6	19.6	21.6	20.5	22.2	26.9	13.4	15.8	17.1	15.5	15.0	14.5	12.0	15.3	28.9	15.3	13.6	19.6	17.3	14.9	12.6	15.8	16.5	23.0	16.9	9.6	42.2	17.2	21.5	15.2	5.4	11.2	4.1	4.9	7.5	2.9	8.2	13.5	12.2	12.2	11.6	8.6	10.4	8.4	10.6	20.1	15.6	12.2	11.3	37.9	11.5	10.3	7.2	13.4	14.8	10.3	18.9	7.1	11.7	10.9	7.1	11.1	9.9	10.8	9.2	8.8	10.5	16.0	19.6	9.0	13.8	15.1	20.6	5.5	12.9	11.2	21.4	13.9	14.0	9.1	6.5	30.0	8.1	21.8	8.6	6.1	13.8	10.8	28.0	6.4	7.5	11.5	12.1	12.6	8.4	12.6	11.1	8.6	10.0	14.8	15.4	47.8	10.9	9.8	12.1	11.2	4.1	4.5	6.8	3.4	5.1	15.2	6.8	5.9	4.1	8.7	7.5	7.5	4.7	4.9	3.5	5.4	5.2	2.9	22.1	24.4	32.2	30.0	21.2	22.1	19.6	21.6	17.1	16.5	14.9	12.2	20.8	10.2	11.1	23.2	13.5	10.2	8.1	4.5	8.7	17.7	6.7	1.7	4.5	25.7	16.5	10.2	0.0	6.6	6.5	8.5	11.9	13.9	16.6	10.3	42.9	9.8	14.7	15.4	16.2	8.6	10.1	3.3	2.8	10.0	17.6	7.0	7.0	13.4	7.0	12.8	19.4	10.8	7.7	12.0	11.3	7.0	8.7	10.0	11.2
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647786-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	22.5	45.0	51.0	17.9	71.8	35.3	18.2	70.1	64.9	20.9	12.6	30.5	12.5	12.5	21.7	28.3	13.6	17.4	17.2	30.0	44.2	68.4	21.5	19.6	17.2	28.4	47.5	53.5	30.9	16.7	37.6	41.8	12.6	48.3	23.4	13.0	18.9	15.5	22.3	18.5	15.1	12.7	18.5	39.4	22.3	14.0	24.3	32.5	20.5	26.2	10.5	27.6	16.2	15.6	20.4	8.9	40.5	12.4	17.1	23.9	7.2	6.5	6.2	14.0	10.8	15.9	16.7	4.4	19.9	17.2	17.0	12.7	6.8	7.2	33.5	26.7	13.4	8.4	9.5	13.8	5.7	14.5	12.5	20.0	17.0	9.6	15.5	20.8	22.9	24.4	14.1	16.2	13.6	21.2	18.8	11.4	22.2	19.9	14.2	19.4	19.3	27.6	29.3	7.0	8.5	14.4	31.4	9.0	27.5	12.6	6.0	34.0	20.5	25.9	6.1	15.8	5.3	14.0	22.6	12.4	16.3	8.6	14.0	15.2	59.4	51.6	47.1	17.1	15.7	15.4	20.2	9.1	40.5	13.1	8.0	16.3	16.9	20.1	21.6	8.9	20.4	23.9	15.4	14.6	17.1	12.4	8.7	18.6	7.2	51.0	71.8	70.1	58.6	44.2	68.4	47.5	53.5	48.3	32.5	44.7	58.4	95.8	104.6	173.7	401.9	88.0	58.6	66.9	62.6	89.0	88.4	58.2	114.4	66.6	5.3	93.4	31.5	373.8	44.4	27.1	105.9	83.9	122.3	51.2	54.5	267.0	93.8	76.7	65.2	15.0	107.0	85.4	114.7	101.0	37.4	289.1	40.5	40.2	122.7	55.7	146.1	135.8	124.6	277.5	103.3	169.9	102.3	207.5	28.1	86.4
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.8;salivary gland: 92.6"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 186.0;Exocrine glandular cells: 427.3;Late spermatids: 257.6;Pancreatic endocrine cells: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 55.8"	"Lineage enriched"	"Detected in all"	5	"monocytes: 55.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.5;NB-4: 103.8;OE19: 43.8;U-937: 34.5"					"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053200: AB_2682079"	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	1.8	8.4	5.0	2.4	12.1	25.5	2.3	1.2	6.8	1.8	1.2	1.8	19.4	1.8	1.3	32.9	1.3	1.3	45.8	13.2	6.2	2.2	4.6	1.9	2.9	1.8	2.4	3.3	1.5	40.5	0.7	4.0	2.5	2.2	2.5	0.7	0.3	92.6	24.4	1.3	1.8	1.7	1.4	1.6	2.7	34.4	5.0	2.2	1.2	2.1	1.2	2.5	6.5	2.3	1.9	8.5	11.3	55.8	2.5	2.3	3.9	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.3	0.7	0.0	0.0	0.1	1.2	0.0	0.0	6.3	4.1	17.7	1.4	12.1	0.0	7.5	64.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	8.4	0.1	0.0	0.3	14.6	103.8	1.4	43.8	0.0	0.0	0.0	8.3	9.0	2.3	2.7	0.9	0.0	0.0	0.5	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	2.7	6.1	0.0	0.0	34.5	0.0	0.0	11.9	11.3	1.8	14.9	0.1	1.3	0.6	2.3	8.5	1.9	0.0	1.0	3.0	2.5	55.8	0.6	0.7	3.9	5.0	12.1	1.2	6.8	6.2	2.2	2.4	3.3	2.2	2.2	0.0	0.0	14.1	0.2	2.4	0.6	39.2	186.0	0.0	1.2	12.2	0.0	0.4	63.0	131.7	86.8	9.5	0.0	116.8	427.3	0.6	1.2	3.9	71.4	0.2	36.5	0.0	1.7	1.8	23.5	257.6	2.8	6.3	69.2	10.0	0.1	0.0	170.4	0.0	3.2	2.8	1.4	142.3	48.4	44.5	16.4	1.8	1.0	33.7	0.2	0.7
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.9	7.8	0.7	0.6	15.3	0.4	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.1	0.0	17.4	0.0	0.7	0.2	2.8	1.8	0.0	4.1	1.0	1.6	0.9	0.9	0.1	0.4	0.0	1.4	0.1	2.9	9.7	1.2	0.6	0.5	2.7	1.2	10.2	0.0	0.9	2.7	2.2	0.2	0.3	0.7	1.9	3.1	0.3	0.4	1.4	7.2	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9	3.0	3.8	0.0	1.9	1.0	2.2	4.5	2.5	1.4	4.5	0.0	9.8	16.6	0.0	1.4	0.4	3.3	0.0	0.0	0.3	59.1	11.8	2.1	0.0	2.1	3.3	33.4	13.2	7.4	0.0	0.6	23.9	0.1	1.7	0.0	0.0	17.3	0.9	0.0	19.4	0.8	10.8	6.5	3.8	0.5	0.7	1.0	23.3	1.7	0.4	0.3
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	11.1	8.5	7.6	14.0	10.1	12.2	11.3	12.6	11.1	12.2	9.5	7.7	7.5	6.1	14.2	9.9	12.5	12.1	10.3	10.4	7.7	7.1	7.5	7.9	9.7	15.1	7.3	5.9	14.9	10.3	9.8	13.5	25.4	9.4	10.2	8.1	6.3	10.2	9.1	25.4	16.2	8.7	11.8	9.9	14.4	9.2	24.5	7.2	32.9	10.0	10.2	15.0	11.2	11.9	13.0	9.3	12.4	9.0	9.9	12.6	7.2	11.7	12.9	17.0	19.0	6.2	11.1	26.3	14.8	15.4	19.4	18.1	13.2	13.9	33.4	8.0	9.6	17.9	16.0	24.2	19.1	22.8	13.4	10.7	18.1	8.4	11.5	13.4	26.2	13.6	9.6	10.8	19.7	20.9	9.6	10.5	11.9	20.2	11.0	25.0	18.4	19.1	16.8	34.7	22.9	15.6	18.7	29.0	10.1	14.3	7.7	15.1	12.8	8.1	13.5	13.1	10.9	5.6	7.7	10.7	13.0	11.5	17.3	13.8	7.8	13.2	13.4	13.2	11.8	13.4	12.4	7.6	2.5	9.8	9.0	10.7	12.7	10.0	9.8	9.3	13.0	10.7	12.6	1.9	9.9	6.7	5.4	11.4	7.2	7.6	10.1	12.6	11.1	7.7	7.1	7.3	5.9	9.4	7.2	3.0	9.4	10.0	8.3	19.7	6.7	10.6	0.0	6.7	17.0	8.7	11.8	44.5	3.3	5.8	9.9	8.3	2.1	0.0	7.5	12.7	13.0	6.1	16.2	6.8	8.4	7.9	5.1	6.7	3.8	10.0	8.1	7.5	16.9	7.2	5.2	3.4	6.3	5.3	7.4	3.0	5.9	0.0	12.8	28.4	34.5	19.7	38.6	6.5	6.0	7.1
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3"					"Not detected"	"Not detected"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.0	8.9	1.1	0.0	1.2	3.2	20.1	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.6	0.0	0.0	0.1	0.1	0.1	3.8	4.1	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.3	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	38.7	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	4.2	0.0	0.0	12.9	0.0	14.2	62.1	0.0	0.1	0.0	0.0	0.0
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985938-70994945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	22.9	27.1	14.5	11.1	15.4	9.3	22.2	13.4	21.4	19.9	15.9	21.6	20.9	13.8	17.3	27.2	17.3	20.9	21.2	21.6	14.4	12.0	25.1	36.9	19.8	16.1	17.0	10.9	23.7	50.8	36.1	20.1	19.3	15.0	18.9	18.9	28.7	22.3	21.0	33.5	12.9	23.6	19.6	17.4	16.0	18.4	23.8	15.3	15.5	31.7	14.3	16.3	14.9	13.9	3.8	4.4	12.0	5.3	3.4	6.7	2.8	20.0	19.0	13.3	16.9	40.7	20.8	15.1	23.2	22.2	27.1	17.1	22.2	16.7	16.4	8.8	40.7	25.6	15.2	25.3	27.7	39.5	12.3	21.1	19.6	9.8	23.5	24.0	22.8	16.5	18.7	18.5	26.0	17.8	14.9	27.5	17.1	24.3	10.9	31.6	15.7	19.6	12.6	8.8	32.6	22.4	14.0	41.2	14.1	19.7	17.6	21.9	11.5	24.1	24.1	15.1	9.4	15.6	13.5	22.0	33.4	28.9	17.7	30.8	8.5	7.5	19.5	29.1	30.1	27.9	12.0	5.3	10.0	5.1	5.3	4.3	2.6	5.4	6.7	4.0	3.8	6.2	4.9	4.0	3.4	5.2	4.4	4.3	2.8	14.5	15.4	13.4	21.4	14.4	12.0	17.0	10.9	15.0	15.3	3.0	17.1	18.2	9.4	7.3	13.4	19.8	17.8	1.4	7.9	22.7	35.3	14.3	6.6	21.9	12.0	14.6	19.3	0.0	20.5	14.3	14.1	13.7	2.3	30.4	17.3	7.9	8.1	18.4	15.1	21.6	14.7	8.4	18.6	9.0	17.0	20.6	18.7	13.6	17.3	14.1	68.9	0.0	16.0	46.6	10.9	6.6	15.0	9.2	16.5	7.1
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	158	"testis: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	8.2	7.0	9.6	11.8	9.6	3.4	7.3	31.6	15.6	10.0	6.8	6.6	5.7	11.1	10.1	3.7	9.9	12.5	7.0	4.8	8.0	6.3	4.4	6.3	5.5	11.1	11.1	7.1	18.7	22.2	6.3	6.7	6.9	8.8	9.0	3.9	6.1	13.2	7.0	8.6	12.2	10.1	5.5	12.8	10.2	8.3	3.1	14.9	13.0	8.4	4.5	7.3	7.4	11.0	1.7	0.5	0.9	0.1	0.1	1.2	1.0	7.0	7.4	6.4	9.4	2.7	7.3	10.7	2.7	7.3	4.8	5.2	3.8	11.1	24.2	7.2	2.7	2.2	10.5	11.7	9.4	1.5	14.2	8.3	7.4	6.9	9.9	3.8	13.0	4.3	6.7	6.1	5.2	14.7	2.2	3.1	8.2	13.7	6.5	1.8	11.1	18.3	21.5	14.7	7.1	9.8	16.1	14.3	25.1	1.8	5.3	13.3	10.0	9.2	9.8	9.0	1.0	4.8	10.2	2.0	6.6	5.1	22.9	7.1	10.6	8.8	20.4	4.4	13.0	4.5	0.0	0.0	0.9	0.4	0.0	1.2	1.7	0.2	0.0	0.3	0.4	0.3	0.7	0.0	0.1	0.1	0.5	0.2	1.0	9.6	9.6	31.6	15.6	8.0	6.3	11.1	7.1	8.8	14.9	3.0	0.0	9.1	8.8	19.2	4.4	2.0	10.2	1.4	1.2	26.2	0.0	7.1	6.6	3.4	0.0	2.9	5.4	0.0	4.9	10.4	8.4	3.9	0.0	2.4	3.7	0.0	7.5	4.9	4.1	0.0	10.9	2.9	3.3	0.0	13.4	1.9	2.7	3.5	4.9	3.8	2.1	6.5	6.6	0.9	0.7	19.4	1.8	8.7	15.8	3.3
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093663-51173134	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA070247: AB_2686239"	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	17.4	16.7	21.1	29.3	21.6	9.6	17.7	22.7	21.6	20.2	19.0	20.5	20.8	15.7	19.3	18.9	16.7	21.1	20.7	17.7	20.0	18.7	17.2	12.5	14.1	20.4	19.4	24.9	20.8	14.6	29.2	23.2	22.4	15.4	20.3	21.7	16.4	17.8	19.0	26.6	15.4	15.9	23.8	21.3	18.4	16.1	11.2	18.6	32.1	17.9	12.9	25.9	19.0	18.1	4.5	8.2	9.1	9.4	9.4	6.1	5.0	7.5	13.0	19.5	17.5	11.2	14.1	28.6	14.7	8.0	12.9	7.7	24.8	16.3	0.7	12.9	12.8	10.3	14.5	24.9	15.8	12.9	16.2	14.4	22.9	12.5	10.3	9.4	25.9	22.2	9.6	14.3	13.3	21.2	15.3	12.0	7.5	23.1	0.0	13.6	0.0	23.3	17.2	28.2	17.8	23.6	18.0	10.8	0.1	16.8	18.2	18.6	16.2	18.2	14.9	11.9	19.0	5.6	21.6	12.1	11.9	12.9	12.3	12.7	14.1	23.8	0.0	11.3	16.1	8.5	9.1	9.2	9.0	3.9	7.7	6.1	4.5	4.1	4.2	8.2	3.4	4.9	4.0	3.5	9.4	9.4	3.5	5.4	5.0	21.1	21.6	22.7	19.4	20.0	18.7	19.4	24.9	15.4	18.6	8.9	16.0	9.8	6.7	6.0	19.0	21.8	7.6	2.7	5.7	12.2	19.6	10.4	5.0	8.7	0.4	9.2	9.2	0.0	6.7	8.9	8.4	9.3	10.4	8.9	11.7	9.5	10.4	9.8	24.1	0.4	11.2	12.1	10.1	16.2	11.9	8.7	9.6	8.6	10.3	7.2	25.6	0.0	7.5	6.1	11.1	4.5	14.0	8.7	14.0	5.4
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641470	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033605, HPA044754, HPA068909"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056"	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	16.0	13.3	20.1	28.0	21.1	71.6	16.4	24.4	22.4	19.3	19.6	16.3	28.6	16.0	16.8	20.5	36.2	18.0	27.0	26.3	19.0	16.8	17.9	20.9	16.5	32.5	18.0	12.7	14.4	26.7	9.9	16.3	21.8	15.2	16.0	23.0	20.2	18.9	24.2	26.9	22.3	21.3	18.4	23.5	25.6	16.4	37.5	10.3	38.8	21.7	32.7	34.4	18.5	20.8	3.6	4.7	20.4	4.0	1.6	5.4	2.0	62.0	15.3	19.8	16.8	26.9	24.0	22.5	35.0	31.8	45.5	42.1	31.8	29.2	57.9	11.7	33.5	24.9	29.9	34.3	31.1	44.7	39.4	39.9	33.6	25.0	19.9	16.9	84.3	29.7	19.8	28.0	28.8	16.8	16.3	30.5	21.7	27.6	15.6	40.4	21.3	37.0	32.8	18.2	59.1	19.7	25.3	17.6	33.1	17.3	23.8	51.2	15.1	15.7	43.2	10.5	15.0	29.7	68.0	21.2	14.8	23.6	31.3	38.5	13.3	16.3	59.7	33.0	52.3	25.0	20.4	2.3	3.6	2.6	3.0	2.9	3.6	3.5	3.1	4.7	2.6	5.4	2.7	3.1	1.6	4.0	2.4	4.2	2.0	20.1	21.1	24.4	22.4	19.0	16.8	18.0	12.7	15.2	10.3	8.9	18.6	29.0	26.5	53.0	10.1	22.2	20.4	17.4	14.8	27.9	13.7	64.5	68.0	8.5	3.4	21.1	23.1	93.5	10.3	105.6	35.0	28.2	20.7	49.1	42.0	6.4	38.6	31.3	34.8	7.9	26.4	29.8	33.7	6.4	30.0	8.6	15.2	21.0	26.5	46.4	19.9	6.5	21.2	62.4	52.9	52.4	55.7	23.5	39.7	26.8
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043486	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	20.9	12.6	18.2	14.4	22.6	53.1	16.5	18.1	22.6	17.7	16.6	30.0	9.9	22.8	21.9	20.5	18.8	16.4	15.1	11.3	11.8	21.6	14.1	22.8	10.3	13.2	9.4	24.4	15.9	16.5	16.3	22.0	15.9	21.2	10.4	15.7	12.6	30.6	13.6	14.1	13.5	21.2	14.8	23.0	14.7	10.4	15.2	4.2	21.7	10.8	10.5	28.6	20.5	1.2	1.9	10.5	4.4	0.4	1.4	1.6	11.8	15.3	5.1	14.7	16.6	15.1	5.1	15.7	18.2	16.0	13.7	9.3	9.5	4.5	6.7	23.0	17.7	9.8	9.6	14.1	13.0	9.8	5.2	4.1	11.3	8.7	22.4	4.3	10.2	13.0	9.1	26.3	18.8	14.9	7.7	3.1	7.9	19.6	13.6	7.0	2.8	4.0	13.9	3.5	13.8	4.3	8.8	10.1	10.2	5.5	4.9	4.8	16.7	7.2	5.5	18.0	10.2	3.9	16.2	17.6	18.8	17.5	8.6	12.1	11.3	3.7	21.0	5.3	12.0	0.0	3.5	1.6	0.5	4.3	0.9	0.6	0.9	0.5	1.9	1.2	0.6	0.4	10.5	0.4	4.4	0.4	1.4	1.6	12.6	14.4	16.5	14.9	11.3	11.8	13.2	9.4	15.9	15.2	14.9	9.1	5.2	18.6	17.5	6.5	6.2	17.8	4.0	11.4	19.2	3.9	13.6	8.3	16.6	0.6	14.6	11.8	0.0	13.7	7.4	16.4	16.4	5.7	13.9	19.2	17.5	12.0	9.8	23.8	1.3	25.3	13.0	8.5	10.0	8.5	9.6	17.6	14.0	23.0	8.6	5.3	12.9	13.3	2.6	0.9	19.3	31.0	8.6	6.5	15.8
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell type enriched"	"Detected in many"	21	"Mucus-secreting cells: 36697.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Not detected"	"Not detected"			"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.5	0.1	44.4	4.3	0.0	3.2	0.3	0.0	0.0	8.7	0.1	0.0	0.8	0.0	0.0	13.3	0.0	36.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17.0	37.0	0.0	13.4	1110.8	464.4	316.2	21.0	0.0	0.3	0.0	9.0	0.0	51.4	1768.3	0.0	62.1	0.6	20.3	103.0	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0.0	36697.4	0.0	28.0	1779.2	7.4	0.0	0.0	0.0	6.1	0.3	0.3	33.8	0.7	1.0	1243.2	29.6
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	11.8	13.5	12.7	12.7	13.8	43.9	10.9	13.8	15.4	9.4	9.5	13.1	8.9	9.9	11.8	8.9	14.5	10.7	10.3	11.8	13.2	9.6	12.3	24.7	11.0	17.7	15.5	12.0	10.3	16.3	11.1	12.0	11.5	12.2	10.5	9.8	11.9	10.9	8.7	34.2	16.3	12.7	10.2	10.6	17.8	11.1	40.6	12.3	23.8	15.4	11.0	19.0	11.1	11.5	23.8	15.5	35.4	23.8	19.6	25.5	17.8	11.1	13.2	11.4	12.9	18.3	11.1	11.5	13.7	17.5	21.5	20.4	9.9	8.1	21.8	8.6	17.0	14.2	16.6	16.3	13.2	15.9	15.9	15.5	13.4	8.5	10.1	16.8	31.0	17.2	14.2	18.0	20.4	16.1	11.6	16.4	11.3	18.0	20.8	14.3	13.7	14.1	17.0	11.0	16.3	11.0	21.4	17.6	19.3	12.4	11.3	8.7	12.5	16.4	11.8	16.1	11.8	9.6	14.7	16.1	18.2	29.7	11.4	12.6	15.4	19.6	43.1	14.4	12.5	13.5	35.4	16.9	28.6	23.8	18.2	22.1	22.9	21.1	22.2	15.5	23.8	20.2	18.4	26.8	19.6	23.8	9.7	25.5	17.8	12.7	13.8	13.8	15.4	13.2	9.6	15.5	12.0	12.2	12.3	8.9	8.9	8.2	9.4	14.9	8.0	2.8	15.3	9.4	10.3	12.2	7.9	14.9	11.6	12.8	41.4	9.5	11.9	0.0	17.8	11.7	7.3	6.8	8.1	9.7	11.7	14.3	15.5	11.1	5.6	5.4	10.3	7.4	6.8	10.0	9.6	7.3	21.6	7.6	9.2	8.0	6.4	0.0	5.9	15.6	21.3	14.6	16.2	11.7	7.1	10.0
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	7.0	1.7	20.3	23.0	3.0	2.7	7.4	4.0	4.7	9.7	7.3	10.4	9.0	19.0	10.7	3.9	4.4	7.3	16.5	10.5	9.5	8.9	5.9	23.8	4.1	13.7	4.6	10.0	5.8	4.3	7.0	2.0	7.6	8.8	9.6	9.2	11.4	11.7	4.7	10.0	17.0	19.2	17.0	10.3	5.1	14.7	24.3	10.3	6.4	4.7	6.1	18.1	1.3	10.8	10.1	17.0	12.9	22.5	6.9	1.5	6.4	0.1	7.6	13.4	5.0	17.9	0.1	12.1	7.6	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8	8.9	9.1	6.5	26.2	39.6	0.1	11.2	12.7	5.3	9.1	7.0	2.0	5.2	6.6	16.4	2.0	14.3	0.0	0.0	6.7	1.0	16.9	15.0	16.1	5.9	8.7	0.0	6.3	11.6	7.0	1.9	5.8	8.8	13.5	7.2	2.6	7.2	13.3	6.2	7.1	6.1	1.9	6.5	15.6	2.3	25.6	22.2	7.6	12.8	3.3	13.9
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328425	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		9800000	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	40.0	40.7	34.3	38.4	38.0	55.6	36.5	51.7	43.1	33.3	50.0	38.7	31.5	53.2	41.2	31.1	23.9	33.3	44.9	43.2	31.9	34.4	59.6	66.2	44.1	37.4	35.4	36.7	36.1	34.4	39.5	21.8	50.4	35.8	34.0	50.1	26.9	38.9	36.5	23.7	23.7	63.1	36.0	40.3	47.1	36.8	22.3	33.2	31.8	44.8	17.0	37.7	39.9	32.9	9.4	14.9	34.2	34.1	8.6	12.3	22.7	11.3	29.4	12.5	16.5	30.2	31.7	29.2	34.6	40.4	23.5	18.9	24.5	34.5	14.3	27.4	47.8	32.3	18.6	9.0	16.9	39.1	23.3	9.0	20.4	10.4	26.3	16.4	39.5	47.4	23.4	10.8	30.4	18.4	36.6	34.0	12.1	11.8	23.5	34.7	10.3	12.7	20.1	11.1	25.4	12.0	13.5	46.0	10.5	25.3	17.9	11.8	9.8	30.2	22.8	20.0	15.4	12.7	17.8	36.0	50.5	18.8	38.1	41.4	15.3	19.7	13.9	37.4	30.7	32.9	17.6	27.5	23.5	12.3	26.9	9.6	9.4	9.2	8.3	14.9	9.1	9.6	9.1	34.2	8.6	34.1	5.6	7.2	22.7	34.3	38.0	51.7	43.1	31.9	34.4	35.4	36.7	35.8	33.2	95.3	89.8	56.6	49.3	34.0	49.1	62.0	180.9	111.1	77.3	171.0	37.3	50.3	8.3	79.9	4.7	71.6	170.0	0.0	81.2	69.6	67.3	78.0	151.6	221.1	103.3	197.0	86.0	81.6	146.0	5.6	45.8	116.6	57.3	39.7	94.6	52.5	79.1	98.9	65.0	89.4	34.5	64.7	48.7	22.3	32.7	30.6	37.3	74.8	88.0	60.7
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842082-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	15.2	12.1	13.4	13.5	14.5	8.5	31.4	15.0	17.2	23.8	19.1	16.7	13.0	12.0	19.9	13.3	18.9	18.0	16.7	29.5	12.4	12.4	13.9	13.5	14.9	22.2	11.8	9.7	22.6	23.1	17.2	13.3	14.2	12.7	20.4	11.0	17.2	14.8	20.6	40.7	17.7	16.0	19.8	10.4	21.0	15.8	11.8	9.8	30.2	29.0	17.3	18.0	21.7	27.1	10.3	8.7	8.5	10.8	11.5	19.9	10.6	12.5	16.4	11.5	10.8	16.1	11.0	12.1	6.5	11.2	15.6	13.5	21.0	9.8	27.5	13.4	6.5	9.4	14.8	20.1	11.9	8.9	10.2	23.0	10.9	9.5	25.5	14.7	13.9	12.5	10.1	11.8	10.7	9.4	11.4	11.4	19.0	15.7	6.4	9.4	19.6	15.0	25.0	23.1	15.0	14.4	29.7	13.7	24.7	7.8	8.2	16.1	18.2	18.8	6.8	13.5	8.6	16.7	14.3	9.1	10.0	12.2	9.0	7.9	25.8	25.6	27.1	7.7	15.4	10.7	3.5	8.4	8.5	16.8	10.8	13.4	8.9	15.4	15.4	8.7	10.3	19.9	15.8	2.5	11.5	9.7	7.0	18.4	10.6	13.4	14.5	15.0	17.2	12.4	12.4	11.8	9.7	12.7	9.8	20.8	12.5	18.4	21.0	26.0	25.3	13.7	10.2	5.3	4.5	10.4	3.9	17.7	44.7	7.4	0.8	21.5	10.9	0.0	8.1	20.8	20.6	18.6	7.0	10.9	19.5	7.9	12.7	17.2	15.0	1.7	21.9	13.4	10.1	15.4	14.6	27.8	6.0	0.0	29.4	16.5	13.5	19.4	23.6	17.9	25.4	34.3	11.3	30.5	16.0	14.7
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71663009-71680639	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 335.0;Late spermatids: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	19.8	31.3	10.9	9.9	13.3	14.2	6.1	24.1	14.1	7.7	6.4	7.3	6.2	6.6	7.1	20.0	10.0	6.9	10.2	7.9	11.6	8.1	6.7	5.9	6.8	7.9	16.3	10.4	9.9	6.1	5.5	20.6	7.9	12.6	8.4	6.8	2.5	5.4	5.5	5.7	6.5	6.3	5.3	18.2	7.4	8.2	21.0	16.0	7.0	8.0	4.2	7.7	7.8	11.6	6.5	3.8	2.8	4.1	8.4	11.4	3.1	3.7	4.8	11.3	8.5	8.4	7.0	5.6	6.0	5.5	5.8	4.9	4.6	4.9	2.6	4.1	3.9	7.0	6.8	10.8	3.4	7.5	11.1	5.9	7.3	8.1	7.6	7.5	4.4	3.4	5.2	14.5	5.6	12.2	12.0	8.9	12.9	5.4	5.6	7.7	1.2	3.6	4.4	5.6	7.7	8.0	5.2	3.7	12.7	6.7	5.9	7.9	12.5	6.3	3.9	5.2	8.2	7.1	4.7	3.9	6.0	2.8	5.1	3.9	7.0	8.6	6.0	3.4	5.2	3.6	2.0	2.8	2.8	5.0	3.9	8.2	5.7	7.0	4.8	3.8	6.5	11.4	7.6	2.5	8.4	4.1	1.9	6.8	3.1	10.9	13.3	24.1	14.1	11.6	8.1	16.3	10.4	12.6	16.0	0.0	11.2	16.7	23.3	17.4	11.7	8.7	5.1	10.7	4.5	3.5	3.9	3.4	8.3	6.8	335.0	7.1	11.8	0.0	4.8	6.0	13.1	14.5	57.7	3.9	11.9	12.7	5.2	8.0	7.5	120.5	10.6	15.9	74.2	10.0	7.2	9.8	6.1	10.2	5.3	12.4	7.0	0.0	22.7	17.6	6.8	25.7	2.5	15.0	7.3	21.8
THAP4	CGI-36	ENSG00000176946	"THAP domain containing 4"	Q8WY91	2	241584405-241637449	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"		"DNA-binding, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 189.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044982, HPA053448"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA044982: AB_10959786, HPA053448: AB_2682154"	"unprognostic (3.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.07e-1)"	11.9	11.5	19.3	13.0	22.5	13.3	26.3	13.8	27.5	12.8	21.3	13.5	10.8	23.7	12.7	19.1	23.6	15.3	16.9	52.4	15.4	18.1	38.2	25.1	13.6	11.9	18.3	11.7	16.7	25.0	30.9	15.0	11.2	15.6	17.1	15.4	12.5	19.7	17.4	55.8	18.5	20.4	13.7	11.3	10.3	18.5	22.7	11.4	16.0	19.0	26.1	15.7	19.4	18.3	14.3	13.9	22.9	12.7	12.5	30.2	9.8	15.3	19.3	11.7	21.6	15.7	16.5	18.3	10.1	15.6	17.5	15.5	17.5	14.4	13.7	5.9	18.1	20.0	17.8	23.4	25.8	6.6	10.3	27.4	14.1	13.3	49.8	21.0	16.7	9.9	16.9	20.5	18.6	25.9	12.1	16.1	22.0	24.1	4.8	13.3	30.1	17.0	40.7	20.0	15.7	16.4	19.5	16.3	18.4	36.2	20.5	27.8	18.3	8.5	27.9	23.1	7.5	13.8	19.7	14.0	18.6	13.0	17.6	20.5	11.3	6.6	14.1	14.3	14.3	14.2	15.4	9.3	22.9	17.5	10.8	18.5	13.8	19.4	16.2	9.7	14.3	18.7	14.9	6.5	12.5	12.7	13.9	30.2	9.8	19.3	22.5	13.8	27.5	15.4	18.1	18.3	11.7	15.6	11.4	17.9	14.2	19.1	33.6	17.7	10.1	47.6	35.7	21.4	26.1	38.4	3.9	20.4	189.0	35.2	14.5	15.5	59.6	0.0	24.5	22.1	17.9	31.3	6.9	31.1	15.9	7.9	27.6	13.5	11.0	4.8	16.7	12.4	11.8	18.0	46.5	9.0	25.0	37.4	18.4	59.2	5.1	32.3	17.5	19.3	21.1	22.6	23.0	10.2	47.2	39.1
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 108.2;Spermatocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.9	5.0	11.1	7.7	12.7	12.5	6.3	16.6	8.6	8.7	9.1	6.3	17.4	10.1	8.6	5.4	9.8	7.4	9.9	7.9	10.7	11.5	6.9	7.3	8.2	8.0	17.5	9.8	8.3	10.5	13.8	9.9	15.4	14.0	4.7	12.1	12.6	20.9	9.2	8.1	8.9	6.7	6.3	9.7	5.1	8.7	12.2	7.0	8.1	5.9	8.5	8.8	7.8	10.7	9.2	9.7	11.6	8.2	5.7	14.9	9.9	17.2	8.5	18.7	9.2	9.6	10.4	7.9	12.5	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3	11.9	8.3	14.8	14.8	7.3	20.4	15.1	10.2	22.7	9.1	21.0	29.5	8.4	13.3	7.2	108.2	7.9	9.3	0.0	5.6	7.9	10.4	10.1	10.4	8.5	6.5	15.9	12.1	8.6	13.9	18.2	13.0	10.9	6.8	6.4	10.3	14.3	6.5	7.8	10.6	10.2	17.2	0.0	9.9	56.5	15.1	5.9	6.4	10.1	7.4	6.4
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049741	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	690000	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	27.0	6.3	1.4	10.5	6.7	6.9	11.8	1.2	2.7	13.2	14.4	1.4	4.3	2.9	9.7	11.5	21.7	15.8	18.2	24.3	5.0	1.5	7.0	10.0	61.9	26.8	2.5	0.1	10.2	7.2	10.0	10.9	16.4	6.2	6.1	3.3	8.8	6.0	4.2	55.5	32.4	14.1	8.5	7.7	44.4	14.4	15.8	2.4	2.1	18.3	32.2	10.4	14.2	10.4	0.0	7.8	17.7	6.2	1.5	0.0	1.1	5.6	5.0	0.1	0.0	12.8	0.7	0.1	0.1	0.0	0.0	0.0	0.0	19.9	0.0	17.3	1.7	0.8	16.7	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.1	0.5	22.0	0.3	1.4	11.9	5.6	0.0	2.1	0.0	0.5	0.4	0.0	2.0	0.0	14.8	0.8	0.0	0.0	2.4	0.1	8.1	0.3	0.0	4.7	0.6	8.6	1.6	0.0	12.3	10.9	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.0	2.9	0.4	0.0	2.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	17.7	1.5	5.8	7.8	0.0	1.1	1.4	6.7	1.2	2.7	5.0	1.5	2.5	0.1	6.2	2.4	20.8	30.8	2.2	6.9	30.5	0.0	9.0	0.0	2.7	18.2	0.0	0.0	2.5	0.0	1.4	0.7	100.4	0.0	0.0	0.2	35.7	22.8	3.0	7.0	0.8	14.1	0.0	0.0	52.2	38.0	4.5	121.1	62.8	15.1	1.0	0.0	0.0	5.3	0.0	243.6	0.2	0.0	6.5	63.8	0.2	0.9	86.2	35.5	0.0	0.0	32.5
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Group enriched"	"Detected in some"	4	"HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4	0.0	4.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	40.2	0.0	0.1
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.4"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 149.1;Spermatocytes: 102.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	2.3	3.5	8.5	2.3	5.8	8.3	6.0	12.5	6.4	4.7	7.3			3.0	3.4	20.0	21.5	4.0	1.6	1.7	8.5	3.2	4.4	6.0	2.8	7.3	2.6		5.3	3.4	0.4	3.7	4.5		3.8	5.9		5.5	4.1	2.6	7.2	4.1	3.0	2.0	4.3	4.5	11.9			5.1		12.5	5.1	7.6	24.0	13.9	4.7	10.5	12.6	41.4	19.2	22.3	12.5	13.3	29.1	12.8	11.5	48.6	13.5	12.6	29.9	34.8	17.7	18.3	29.2	19.6	7.7	32.3	19.3	20.2	57.5	31.6	20.0	29.5	15.7	12.4	19.2	4.2	25.7	14.2	9.7	24.5	25.7	13.0	6.7	16.4	27.5	23.8	13.2	18.8	26.9	17.3	15.8	11.4	22.3	45.8	30.2	16.9	30.4	21.3	16.8	25.8	14.9	28.0	13.7	13.8	20.2	15.6	23.6	12.5	10.3	11.8	15.9	24.1	6.6	11.6	17.5	7.7	25.0	8.0	4.4	9.0	4.7	13.7	10.5	16.5	16.5	28.3	16.8	13.9	24.0	34.9	21.9	1.3	12.6	9.4	12.9	41.4	19.2											11.9	7.5	18.0	23.9	39.5	12.1	3.1	7.6	8.1	5.7	24.4	9.8	43.8	34.9	21.6	149.1	14.1	7.8	46.7	16.8	69.7	17.4	13.6	11.5	19.0	21.6	6.4	16.1	16.5	9.9	84.4	13.6	13.4	8.5	15.4	15.9	7.8	19.7	7.0	18.0	35.5	10.9	19.4	18.4	102.0	45.3	35.8	16.7	23.5	28.5	21.7
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 98.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	10.5	12.0	7.8	14.6	8.2	16.7	12.8	7.0	9.8	10.0	13.7	9.1	11.9	15.5	15.7	8.6	13.7	10.4	19.3	9.5	7.0	5.6	12.9	17.5	12.4	15.5	11.0	4.8	13.2	20.7	11.8	13.2	28.0	9.0	15.1	8.6	7.2	16.6	11.0	17.0	20.6	17.6	10.5	6.5	16.9	10.5	9.0	6.8	27.3	12.7	19.4	17.9	10.0	11.6	17.8	34.5	5.0	24.4	14.3	16.4	16.3	12.8	20.9	15.2	16.0	7.8	9.0	26.8	3.9	9.2	9.3	13.8	13.8	15.2	24.3	13.0	6.6	6.9	17.7	16.5	12.6	5.1	21.5	21.2	13.2	19.3	20.1	13.3	19.2	29.0	9.0	15.3	11.3	28.3	11.8	8.6	14.1	19.1	13.1	4.6	30.0	10.8	35.7	27.3	7.4	9.0	29.3	11.4	28.4	9.7	6.5	31.3	14.8	11.3	17.9	7.2	6.9	12.8	21.0	7.1	9.7	22.6	10.9	14.3	9.5	8.0	29.5	2.5	13.2	9.7	0.8	24.4	5.0	14.8	23.7	14.9	15.3	13.7	14.3	34.5	17.8	16.0	16.4	1.8	14.3	13.1	29.1	14.2	16.3	7.8	8.2	7.0	9.8	7.0	5.6	11.0	4.8	9.0	6.8	17.9	9.0	19.5	75.5	60.7	3.6	2.8	10.2	4.0	9.1	17.4	2.0	92.0	29.9	28.5	4.9	9.0	19.6	0.0	20.6	98.4	42.7	41.2	11.5	9.2	45.3	3.2	24.8	7.4	23.0	2.2	13.8	29.1	23.6	44.1	22.9	3.0	19.1	27.5	11.3	22.4	2.0	6.5	38.1	0.9	24.8	39.3	64.5	17.5	41.3	38.7
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Daudi: 10.3;SCLC-21H: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3	0.0	0.0	0.0	0.4	0.1	1.2	0.6	0.0	0.0	0.0	0.0	23.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	85.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	31.7	6.5	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.1
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	14.9	19.5	27.7	12.2	23.3	7.6	12.9	16.4	24.3	12.3	14.0	20.7	15.9	15.7	13.3	18.4	10.1	17.7	16.8	16.3	23.3	17.4	16.3	12.1	10.7	10.7	21.9	13.3	15.4	12.7	25.0	12.4	7.6	16.1	18.8	12.3	17.1	18.0	23.5	21.9	7.4	11.7	13.7	19.5	11.3	11.6	18.8	14.3	14.1	15.9	12.3	11.2	9.9	7.9	14.3	17.0	11.1	14.4	6.9	11.6	8.7	2.7	17.1	8.4	9.1	19.3	10.9	4.6	8.0	7.1	7.9	7.9	3.5	11.3	5.2	7.0	9.6	9.0	8.5	8.8	10.0	5.9	10.9	9.6	7.0	12.1	9.3	9.8	6.4	6.4	14.8	7.4	12.1	8.9	16.7	9.5	8.4	5.3	11.4	11.5	8.2	10.1	2.6	3.0	14.6	14.6	6.9	5.7	9.4	13.9	5.4	16.2	7.7	7.9	16.2	4.6	5.2	10.8	3.1	7.4	5.2	5.5	10.7	4.7	13.5	8.2	2.9	5.4	2.9	8.0	11.1	14.4	7.3	9.6	10.6	9.5	9.6	6.9	7.5	13.2	14.3	11.6	9.9	1.5	6.9	13.4	17.0	5.4	8.7	27.7	23.3	16.4	24.3	23.3	17.4	21.9	13.3	16.1	14.3	6.0	6.9	15.9	5.8	0.0	27.6	0.0	10.2	5.3	6.8	7.0	7.9	9.0	46.4	13.0	16.7	2.9	8.4	0.0	10.7	4.4	7.2	8.5	23.1	7.6	15.9	7.9	5.8	8.0	10.0	16.8	10.6	8.2	0.0	11.8	6.4	18.8	8.1	8.6	7.1	24.6	9.4	12.9	0.1	19.6	8.7	0.0	5.6	6.4	8.5	5.4
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119417378-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;smooth muscle: 91.5"	"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		9800000	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	28.7	5.9	42.0	23.2	72.4	0.4	7.0	17.6	97.7	26.9	9.0	7.2	2.1	3.5	20.3	13.9	9.8	7.5	31.6	4.3	63.4	41.1	46.6	2.6	6.5	10.9	29.8	34.8	3.2	5.0	7.3	5.5	19.1	53.8	4.6	13.6	8.5	2.9	15.7	1.4	4.2	4.6	91.5	9.3	6.7	5.7	4.0	6.9	3.1	12.0	1.0	10.8	36.9	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.3	12.5	0.0	53.5	38.7	0.0	83.7	93.7	30.0	33.3	0.0	0.0	0.0	0.0	146.5	14.5	0.1	0.4	0.1	22.9	7.1	0.0	4.4	1.5	0.0	16.5	0.0	0.0	28.7	0.0	38.1	1.3	41.7	0.0	2.6	0.0	0.0	23.1	0.0	0.0	0.0	20.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	2.1	5.7	0.0	0.0	0.0	4.0	0.1	0.2	0.0	43.2	14.4	12.4	12.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	42.0	72.4	17.6	97.7	63.4	41.1	29.8	34.8	53.8	6.9	0.0	2.6	0.0	0.4	15.8	13.9	0.8	0.0	0.0	0.0	8.7	0.0	1.5	18.3	1.1	0.8	14.3	0.0	0.0	0.0	2.3	117.3	0.2	1.1	0.0	3.6	30.2	0.0	27.0	0.0	0.9	89.2	1.4	16.9	0.0	0.0	84.4	0.5	0.0	72.9	127.2	19.0	32.3	114.6	0.4	0.4	15.4	3.3	0.0	0.0	0.1
TIA1		ENSG00000116001	"TIA1 cytotoxic granule associated RNA binding protein"	P31483	2	70209444-70248660	"Disease related genes, Predicted intracellular proteins"	Apoptosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056961			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056961: AB_2683289"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.51e-3)"	"unprognostic (3.37e-3)"	"prognostic favorable (6.79e-5)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (4.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.02e-5)"	15.6	20.4	15.9	29.3	20.5	14.8	28.2	36.3	22.0	30.2	23.6	25.3	24.6	20.6	42.1	43.5	15.9	28.4	21.6	16.0	17.2	14.7	20.7	18.0	19.1	26.4	21.9	16.5	46.9	24.3	26.0	48.7	21.2	19.0	26.2	24.1	27.1	27.8	24.2	13.2	23.4	25.9	24.9	21.0	30.8	20.8	13.4	25.2	65.3	29.3	15.1	21.2	23.1	23.5	9.7	11.6	12.4	7.9	10.9	9.8	5.6	7.2	8.1	42.4	23.7	12.0	20.5	20.5	12.9	9.2	12.6	12.6	10.8	11.3	16.5	11.2	9.7	7.3	11.9	20.5	7.0	17.9	15.3	9.0	16.9	14.0	25.8	9.7	16.9	9.6	15.2	10.5	7.2	8.0	30.0	23.2	13.3	13.1	15.1	17.6	6.2	31.2	26.9	34.5	10.4	9.7	38.3	23.1	16.8	19.3	14.3	25.8	22.1	15.4	18.2	12.4	22.9	10.9	12.6	18.9	15.5	16.3	7.2	12.7	12.6	12.6	30.4	9.1	21.6	20.6	12.4	7.9	10.8	8.3	6.5	7.8	9.7	8.0	8.2	11.6	8.0	7.3	7.9	3.0	10.9	3.8	6.0	9.8	5.6	15.9	20.5	36.3	22.0	17.2	14.7	21.9	16.5	19.0	25.2	77.4	52.4	36.5	27.5	22.6	49.4	26.2	30.6	77.6	72.8	19.2	45.2	26.3	0.0	23.1	17.7	28.7	20.4	0.0	23.5	27.5	28.6	28.9	53.2	25.6	18.8	33.4	50.5	36.8	32.1	7.1	33.4	26.5	15.1	32.5	33.0	38.0	25.1	27.9	33.6	9.1	53.0	25.8	26.9	28.1	16.2	21.0	20.7	39.8	28.1	23.8
TIAL1	TIAR	ENSG00000151923	"TIA1 cytotoxic granule associated RNA binding protein like 1"	Q01085	10	119571802-119597029	"Predicted intracellular proteins"	Apoptosis	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060962			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA060962: "	"unprognostic (1.61e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.81e-6)"	"unprognostic (5.54e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (6.48e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.26e-2)"	30.0	29.6	31.4	29.4	44.4	39.2	46.6	72.8	47.3	27.7	27.3	26.7	26.9	23.8	35.0	37.9	43.9	27.1	27.9	30.1	32.5	20.4	25.7	35.3	30.2	39.5	48.2	25.0	34.6	35.5	40.2	30.7	33.2	33.6	27.7	34.3	20.3	33.6	32.0	51.5	31.7	32.5	30.3	39.3	33.3	32.5	28.1	47.8	38.0	33.3	23.6	40.9	29.5	45.8	5.7	6.6	4.9	5.9	7.8	8.6	2.6	35.2	23.4	40.0	43.7	24.2	33.3	26.7	31.5	39.8	38.6	37.2	27.9	42.7	35.2	19.5	28.6	25.0	33.5	39.2	25.6	50.5	34.4	17.5	26.4	25.9	29.1	29.0	39.9	32.4	28.5	31.5	30.6	51.5	54.2	37.7	26.4	26.4	37.7	35.8	30.6	35.1	36.9	20.0	31.3	19.5	30.2	31.5	23.3	32.0	20.0	14.4	16.9	21.2	20.4	28.1	33.3	21.2	23.8	26.1	24.5	20.8	20.0	33.2	24.8	31.1	28.3	23.1	38.0	17.9	3.7	4.5	3.9	7.2	3.6	7.3	5.4	7.4	6.7	4.6	5.7	7.9	8.3	4.9	7.8	5.9	6.6	8.6	2.6	31.4	44.4	72.8	47.3	32.5	20.4	48.2	25.0	33.6	47.8	41.7	52.6	50.7	60.2	56.4	52.2	33.9	40.8	45.5	53.4	22.7	29.5	57.7	39.7	44.1	8.8	46.0	41.6	70.0	47.3	83.1	46.4	58.7	33.6	41.9	50.6	42.9	50.6	47.3	55.6	5.2	56.7	50.2	35.4	66.7	45.7	43.3	56.5	40.3	42.5	39.4	46.3	51.8	43.6	45.1	43.1	56.1	64.8	68.2	49.4	75.8
TIGD3		ENSG00000173825	"Tigger transposable element derived 3"	Q6B0B8	11	65354767-65357613	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 14.9;brain: 8.6"	"Cell type enhanced"	"Detected in some"	16	"Spermatocytes: 16.6;Spermatogonia: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA040016			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA040016: AB_10805600"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.48e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-3)"	0.1	0.7	1.8	0.8	2.7	1.3	3.0	8.6	4.6	0.3	4.1	0.9	0.0	2.6	0.4	0.8	0.4	0.5	0.6	0.4	2.0	1.9	0.8	0.7	1.1	1.1	1.2	0.0	1.0	1.5	1.5	1.9	0.4	3.1	0.5	0.4	1.1	0.5	0.5	0.3	0.2	6.4	0.3	2.0	2.6	1.0	6.9	0.4	3.0	0.4	1.0	0.8	0.6	0.0	0.3	1.2	14.9	1.2	0.1	0.1	0.1	1.4	2.6	2.3	6.0	0.0	0.0	0.8	0.1	0.3	0.6	0.8	2.1	0.3	1.0	1.0	0.2	1.0	1.4	2.3	0.1	0.2	1.8	2.3	0.4	1.4	4.7	0.1	0.9	4.4	0.0	0.2	0.3	0.0	0.1	0.3	2.3	1.4	3.1	0.0	3.4	2.9	1.9	1.3	1.3	1.1	4.2	1.0	4.0	0.1	1.3	6.7	4.2	1.7	2.6	1.1	0.2	4.3	1.4	0.0	0.2	1.1	1.6	1.0	6.4	4.1	1.3	0.1	1.8	0.7	6.5	0.5	8.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.1	0.0	14.9	0.1	1.2	1.2	0.0	0.1	1.8	2.7	8.6	4.6	2.0	1.9	1.2	0.0	3.1	0.4	0.0	0.6	0.0	0.2	1.3	3.7	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	2.2	0.0	1.0	0.0	0.5	0.3	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.8	1.8	0.0	0.9	1.7	1.0	0.3	1.0	0.6	0.0	0.4	0.5	3.8	0.0	0.8	16.6	5.3	1.4	0.7	0.0	0.4	0.1
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 76.3;Rod photoreceptor cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	3.0	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.6	1.3	1.0	0.1	0.1	1.4	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.6	0.1	2.2	0.4	4.6	0.3	0.3	2.9	0.4	1.4	0.4	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.9	1.4	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.8	13.2	0.6	1.0	1.6	2.2	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3	0.0	1.0	0.0	0.4	0.0	6.7	0.0	0.0	12.0	0.0	1.8	11.8	0.1	0.0	0.5	76.3	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.5	1.6	1.2	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.1	12.1	0.4	0.0	0.4	1.5	29.0	0.0	0.0	5.1	1.7	0.0	0.2	0.0	0.4	0.3
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	26.4	27.0	24.5	29.3	20.7	21.7	41.4	42.3	30.3	34.8	31.3	31.6	27.6	36.7	15.6	36.2	25.5	21.2	44.9	25.3	37.5	26.9	28.1	20.2	35.9	29.9	21.4	43.1	21.8	25.0	28.2	35.5	29.8	25.1	36.3	23.2	51.0	20.6	40.8	16.9	23.1	23.4	31.1	26.7	14.6	22.9	28.5	46.0	42.7	25.2	37.0	26.2	25.9	66.4	39.1	32.5	36.7	29.3	29.0	23.3	24.7	27.0	43.9	31.3	33.7	30.8	24.8	32.9	25.9	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2	35.7	37.0	55.2	74.7	81.9	22.9	117.0	40.8	46.8	42.1	36.6	33.4	102.6	116.0	97.2	44.4	41.4	33.9	0.0	74.9	170.0	67.6	57.0	54.3	165.4	105.8	33.4	32.6	35.6	45.4	26.9	31.1	72.6	50.6	99.2	41.2	32.7	83.8	23.0	36.0	93.3	25.4	25.8	62.2	38.1	50.8	86.4	222.1	56.4	49.3	91.8
TIMM29	C19orf52	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928733-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	13.4	11.4	13.8	11.0	18.0	18.4	8.0	19.9	16.4	8.5	9.9	10.3	7.6	17.5	11.3	7.1	13.8	8.6	9.4	12.5	15.1	8.9	10.5	13.5	8.1	11.6	13.5	9.3	8.3	17.1	7.0	10.8	12.2	11.9	9.9	5.1	11.3	16.8	9.5	30.9	12.1	12.4	10.3	8.3	11.7	15.0	11.3	13.2	12.0	9.2	8.9	9.7	10.1	10.6	13.6	10.3	8.7	8.7	10.9	12.0	3.2	10.7	3.9	3.1	5.2	2.7	2.6	8.9	7.5	3.8	5.4	5.0	7.0	3.5	9.1	13.3	3.4	2.9	10.0	1.6	4.4	0.9	10.9	13.1	10.5	4.0	4.7	4.3	7.5	8.0	2.2	4.3	3.7	1.5	2.1	3.2	7.8	11.4	7.7	2.0	8.8	8.5	14.6	11.3	3.2	17.4	11.6	4.5	11.0	2.2	4.1	8.1	8.4	8.6	4.5	8.8	1.2	6.5	8.2	5.4	8.7	5.3	11.1	11.4	26.7	26.0	9.7	5.4	9.6	7.2	3.5	7.9	8.7	5.6	8.7	8.8	13.6	10.8	12.0	5.6	10.6	10.1	8.5	1.7	10.9	6.7	10.3	11.0	3.2	13.8	18.0	19.9	16.4	15.1	8.9	13.5	9.3	11.9	13.2	3.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	15.7	0.0	31.3	16.6	17.6	0.0	0.0	0.0	0.0	9.2	25.5	0.0	0.0	1.1	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	26.2	0.0	0.0	13.2	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0
TIMM50	TIM50L	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	21.3	20.2	17.9	17.0	25.8	23.0	15.7	14.3	38.2	13.4	18.4	18.0	14.4	18.0	19.0	11.7	22.6	15.8	12.5	42.2	17.6	17.4	23.9	28.0	14.2	16.6	17.8	20.2	16.4	19.8	16.4	13.4	20.0	22.0	15.3	12.0	18.1	18.3	14.6	58.1	14.0	16.1	16.5	12.7	15.1	16.9	40.4	14.7	18.5	24.0	25.5	16.9	16.9	18.2	19.3	27.4	10.3	25.3	17.0	19.9	27.8	26.5	63.9	11.9	29.6	10.5	9.5	21.6	21.0	10.8	25.0	20.4	45.7	18.8	30.1	22.4	14.2	14.0	15.3	23.8	21.7	13.3	26.2	34.6	27.9	18.7	31.6	15.9	54.3	19.3	12.2	15.5	18.7	17.1	7.1	16.2	35.8	44.6	18.1	15.7	35.2	33.2	20.9	20.7	31.3	24.4	33.9	23.7	23.2	17.2	36.7	31.5	17.7	25.3	36.8	43.2	8.6	17.2	29.6	16.2	31.0	28.9	25.5	48.9	17.1	31.4	45.4	23.3	27.3	34.4	10.3	25.3	6.1	16.9	24.0	17.3	19.3	16.2	18.5	27.4	18.1	18.4	17.0	2.1	17.0	22.4	20.6	19.9	27.8	17.9	25.8	14.3	38.2	17.6	17.4	17.8	20.2	22.0	14.7	20.8	24.2	14.2	35.2	23.1	10.0	41.2	22.9	12.0	23.9	24.4	11.8	72.5	56.3	52.0	155.0	24.1	24.2	0.0	44.6	67.0	29.8	28.0	39.2	29.6	59.4	27.0	22.4	19.6	11.8	445.2	21.6	26.0	28.7	22.6	20.3	12.8	42.9	14.4	19.8	53.1	10.4	6.5	34.0	92.9	48.7	23.3	79.1	17.5	42.6	40.9
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.3	13.5	6.7	5.8	26.2	17.7	15.2	4.2	14.1	12.2	14.0	9.1	8.8	10.5	7.3	14.8	8.4	6.8	16.9	13.7	20.0	8.8	6.1	7.7	6.3	10.2	13.8	6.0	5.1	15.5	21.1	9.8	12.8	7.8	17.2	9.9	10.5	10.1	22.4	17.8	6.3	12.7	9.0	12.1	16.8	5.3	4.7	13.8	18.3	7.2	8.9	16.6	4.3	6.6	16.1	9.5	10.8	16.5	8.6	6.9	5.2	6.3	7.3	6.5	6.1	14.3	11.7	15.3	10.8	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6	23.8	35.3	16.0	40.6	33.3	24.2	144.4	40.8	61.6	37.5	38.4	13.7	129.0	127.6	61.0	5.3	55.2	40.2	23.3	54.8	92.7	41.0	35.4	40.4	45.5	75.0	20.6	27.6	31.3	30.4	5.2	43.7	39.7	42.2	83.0	41.1	57.9	47.3	40.1	51.2	112.8	25.9	71.1	52.6	99.3	50.0	36.8	148.4	31.6	44.9	43.4
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	6.5	22.3	4.0	0.6	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	9.8	0.0	0.1	0.4	17.4	0.1	0.0	0.0	2.9	0.7	3.4	0.1	0.1	0.8	13.0	0.0	1.7	27.4	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2	8.9	10.7	0.0	6.7	0.0	0.0	0.8	30.6	34.8	12.5	29.6	0.0	26.9	16.6	16.8	259.3	0.0	138.3	0.0	21.0	3.5	0.2	4.8	4.6	4.9	2.4	0.0	12.0	0.0	0.0	10.7	1.7	0.1	3.3	0.0	40.6	0.0	16.7	101.7	1.1	5.1	0.0	0.0	0.2	2.1	3.3	0.1	33.6	1.5	46.1	23.1
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Proximal tubular cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		4800000	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.1	15.6	2.7	9.5	3.4	3.7	7.7	3.6	3.9	3.4	2.2	7.1	14.8	7.6	12.6	2.6	3.5	8.6	5.1	6.7	1.1	13.1	6.8	4.7	8.2	40.5	5.9	3.9	7.9	5.9	4.6	3.2	11.2	2.9	3.3	5.3	8.2	14.8	2.4	27.9	3.5	3.6	7.5	5.8	10.7	6.2	4.3	42.7	5.4	10.9	10.6	9.5	6.6	11.6	6.0	1.9	42.8	2.8	4.0	6.7	7.0	5.3	2.1	27.4	22.6	6.9	6.9	3.7	6.1	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4	0.0	12.6	6.7	10.8	0.0	12.9	3.4	12.7	20.1	12.5	14.0	13.7	25.7	24.9	15.5	7.9	4.5	5.4	0.0	12.8	4.4	3.0	11.6	7.0	92.7	14.9	7.9	12.9	6.2	18.3	9.3	14.1	5.9	0.0	27.9	13.9	8.7	12.3	18.1	21.2	63.4	16.0	6.5	2.4	39.2	14.5	0.0	12.7	5.7	18.4	10.6
TLNRD1	"MESDC1, MGC99595"	ENSG00000140406	"Talin rod domain containing 1"	Q9H1K6	15	81000944-81005788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.2;Extravillous trophoblasts: 28.3;Hofbauer cells: 29.4;Pancreatic endocrine cells: 35.9;Proximal tubular cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 25.9;SK-MEL-30: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071716			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA071716: AB_2732183"	"unprognostic (1.32e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.37e-3)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.82e-3)"	24.4	13.1	5.8	11.8	19.2	13.7	11.1	18.5	12.6	8.2	12.0	7.0	10.3	8.8	9.7	8.2	9.6	8.7	14.4	10.0	5.9	6.0	9.2	10.1	17.9	12.5	5.8	4.6	6.5	11.9	4.4	7.3	10.7	5.9	7.2	7.4	10.8	7.5	6.6	5.6	4.5	10.1	6.2	8.2	21.4	15.7	2.8	4.6	15.0	6.5	11.0	10.4	7.8	8.7	3.0	2.2	2.0	1.9	4.7	2.9	1.2	6.1	2.0	5.4	3.9	2.4	1.4	9.0	5.7	1.6	3.6	2.6	3.5	5.6	6.8	8.0	1.4	2.1	8.0	3.3	1.8	2.0	25.9	9.7	13.2	1.2	3.8	1.8	4.6	9.6	1.5	2.4	2.2	2.1	1.3	5.3	5.8	7.4	16.8	2.4	3.1	7.2	5.4	8.6	4.0	2.9	9.4	5.5	15.2	2.2	6.3	8.5	7.2	3.2	3.5	25.1	4.9	3.1	4.1	6.3	4.1	13.0	5.7	8.4	11.7	11.5	7.2	2.8	6.7	4.2	2.0	1.3	1.4	2.7	1.9	2.0	3.0	2.9	2.8	0.9	2.3	1.5	2.1	2.0	4.7	1.6	2.2	1.2	1.2	5.8	19.2	18.5	12.6	5.9	6.0	5.8	4.6	5.9	4.6	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.9	12.2	0.0	7.5	1.7	12.2	0.0	0.0	0.0	0.0	27.2	28.3	0.0	0.0	2.3	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	5.4	0.0	0.0	35.9	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	4.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	0.0	3.6	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.9	0.5	7.5	7.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.4	0.0	1.6	0.1	0.0	0.0	7.7	9.5	0.0	0.2	0.4	0.0	1.8	0.2	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5	6.0	64.7	0.8	1.1	1.0	0.0	1.2	5.1	2.7	12.5	3.5	0.0	0.1	0.0	4.8	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.0	3.5	0.9	16.3	0.0	0.0	2.5	106.5	0.0	0.6	52.5	1.7	0.0	0.1	0.0	3.1	0.0	0.4	1.0	0.3	12.9	0.4	0.2	0.4	1.0	0.1	0.7	0.0	1.4
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046058: AB_2679519, HPA055621: AB_2682865"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	24.2	30.7	32.5	20.0	42.8	16.2	30.1	24.7	50.1	26.2	22.1	25.3	21.2	16.6	26.3	38.9	19.3	25.1	23.7	36.5	27.9	28.3	32.3	23.5	35.9	27.0	32.7	22.2	31.4	27.6	25.9	24.0	28.8	33.6	28.3	23.9	24.4	23.1	25.6	29.6	16.0	20.1	24.2	45.6	20.3	23.4	27.0	22.3	20.2	33.7	16.6	16.0	21.9	20.5	15.3	22.6	27.2	15.7	14.7	15.2	12.5	11.7	5.8	9.0	7.1	27.5	27.0	11.5	21.1	21.6	10.4	14.0	3.7	15.1	9.6	28.2	17.6	20.9	13.5	11.4	15.3	16.2	15.6	13.4	10.6	9.5	8.2	27.0	15.3	19.0	30.0	26.5	12.0	15.2	25.6	19.7	13.0	12.2	18.7	25.2	3.8	7.7	12.1	9.8	10.5	8.3	6.7	17.0	11.8	30.8	9.3	10.1	12.3	12.6	25.1	37.9	12.6	13.7	16.6	17.4	14.1	7.1	7.8	15.9	15.8	14.5	11.8	24.5	15.0	12.4	26.6	12.6	27.2	11.2	14.6	11.1	15.3	13.0	13.5	11.8	13.0	12.3	14.1	7.6	14.7	15.7	22.6	15.2	12.5	32.5	42.8	24.7	50.1	27.9	28.3	32.7	22.2	33.6	22.3	38.7	38.1	38.9	83.1	69.5	54.4	36.2	38.2	58.9	37.5	75.0	56.9	45.4	33.2	46.4	4.1	53.0	41.7	23.3	39.6	53.3	78.6	77.5	60.0	45.7	45.3	65.2	42.2	74.3	58.7	6.8	73.9	51.2	86.0	39.7	38.7	80.4	42.9	56.0	49.8	58.8	62.9	38.8	59.7	165.1	61.8	66.9	44.7	47.9	41.6	90.1
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	17.8	25.1	32.8	14.1	33.1	15.4	26.0	30.7	46.7	24.9	16.9	21.3	15.3	15.2	26.3	29.1	15.3	22.5	18.7	28.3	35.3	49.8	20.6	32.8	17.5	23.0	28.2	35.8	37.6	28.2	23.5	25.7	19.6	26.8	21.5	15.6	19.1	20.9	24.0	22.6	16.8	15.0	20.7	22.7	17.0	15.8	20.6	19.1	16.0	29.1	14.2	19.2	19.2	16.1	21.4	14.3	38.4	20.2	24.1	24.1	18.0	8.5	21.3	11.4	20.6	32.9	24.5	14.0	11.3	18.8	13.5	15.1	11.4	24.4	14.0	15.7	15.4	22.7	20.2	17.7	14.6	10.7	13.3	39.0	20.9	18.5	19.3	21.7	16.2	25.0	20.3	29.6	8.1	16.9	18.9	18.5	18.2	17.1	21.2	21.2	17.3	11.8	17.2	17.6	38.9	7.2	14.5	14.5	21.7	27.2	22.6	15.4	14.1	15.6	16.6	22.5	20.5	15.7	21.5	14.7	14.3	14.7	9.5	12.4	20.1	29.7	15.1	12.1	20.4	11.7	14.8	20.2	38.4	21.7	19.9	24.1	15.5	17.9	16.5	14.3	21.4	23.9	22.1	34.4	24.1	15.0	12.1	18.0	18.0	32.8	33.1	30.7	46.7	35.3	49.8	28.2	35.8	26.8	19.1	23.8	33.2	37.0	49.5	58.8	44.9	33.5	22.9	16.0	28.4	40.1	31.4	64.8	16.6	54.9	5.7	52.5	22.0	0.0	37.4	54.4	51.9	46.9	24.3	51.6	29.9	65.2	25.9	53.4	45.9	8.8	68.1	37.2	25.3	39.7	23.1	57.0	28.6	23.2	59.1	32.7	43.7	71.1	42.7	85.4	85.7	48.4	76.1	47.2	25.4	34.6
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26973195-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	12.0	27.6	12.1	8.1	17.4	18.5	15.9	7.9	18.9	12.4	17.2	18.1	13.1	10.7	10.9	16.6	27.8	12.7	16.4	10.6	11.7	11.6	69.8	39.9	15.9	15.0	13.0	11.6	12.1	52.6	15.4	33.2	11.0	10.7	14.5	19.7	20.5	21.9	14.2	5.8	15.4	12.8	13.2	13.9	12.0	14.9	11.0	10.6	31.2	14.1	12.3	17.1	15.3	16.5	10.5	10.6	16.0	6.9	11.8	11.4	3.9	8.4	20.1	12.0	14.5	18.3	12.1	63.1	10.5	17.0	8.6	14.9	11.1	36.2	11.4	13.5	9.8	7.8	9.3	12.5	70.9	12.0	11.1	7.4	17.0	25.3	21.0	12.1	61.3	12.0	7.4	60.5	18.5	16.7	26.3	22.7	30.9	7.3	7.8	13.0	17.3	29.9	35.7	24.4	32.7	12.0	28.0	18.9	20.1	15.0	38.7	2.0	10.7	12.9	6.9	18.4	59.2	19.1	13.0	8.5	7.6	12.4	20.7	12.9	4.7	12.1	21.3	14.6	20.9	11.4	8.6	6.9	16.0	6.0	6.9	5.7	7.3	7.6	7.8	10.2	10.5	10.9	7.2	7.8	11.8	3.5	10.6	11.4	3.9	12.1	17.4	7.9	18.9	11.7	11.6	13.0	11.6	10.7	10.6	11.9	22.2	20.8	43.3	25.5	44.9	8.6	94.3	5.3	25.0	40.1	41.2	35.0	14.9	48.9	75.7	18.9	16.7	23.3	35.2	13.0	17.5	22.1	13.9	37.8	34.8	22.3	12.7	15.4	19.7	123.7	14.4	20.3	62.4	21.6	21.2	29.6	27.4	31.6	21.5	79.2	34.9	6.5	12.8	6.2	26.2	24.3	13.6	20.3	29.9	34.1
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.7	8.3	13.4	12.2	5.6	9.6	13.8	18.5	9.3	10.1	8.6	8.0	21.6	35.0	7.7	9.8	8.3	8.0	15.6	13.2	12.8	18.0	13.4	48.8	7.9	12.7	12.4	38.5	15.2	6.2	12.0	8.5	10.7	8.4	11.0	11.3	17.1	25.7	11.0	14.2	23.1	20.0	14.9	8.6	12.2	22.1	12.7	22.1	8.0	7.8	7.8	11.5	11.7	15.7	13.8	8.9	9.4	15.0	19.3	8.1	15.3	7.7	19.5	18.7	24.0	40.7	16.0	20.5	24.2	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5	20.8	28.2	49.6	29.7	29.2	13.2	32.7	50.9	14.7	27.3	31.4	3.9	47.8	54.7	39.8	141.5	25.9	10.6	23.3	60.9	76.4	30.6	17.5	27.8	47.0	32.6	14.3	29.3	38.6	33.4	132.5	51.5	37.8	25.3	35.1	34.4	14.7	45.8	28.1	30.1	37.2	13.4	38.8	30.6	59.7	38.5	34.6	25.5	21.7	37.6	23.0
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.3;OE19: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.5	5.8	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.2	0.0	0.1	2.3	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.3	21.6	1.6	0.0	0.0	1.3	0.1	0.1	0.3	0.1	0.0	1.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2	145.9	125.6	0.0	19.6	0.7	0.1	0.8	122.3	547.4	299.1	21.0	2.0	31.1	0.0	107.5	21.7	0.4	170.3	0.0	144.9	1.6	0.8	88.4	5.7	0.0	2.3	3.2	37.4	0.6	0.0	28.2	0.3	0.9	1.7	1.8	97.1	0.1	236.7	190.0	0.7	0.4	1.5	0.0	0.9	1.8	1.1	1.5	13.6	0.0	77.1	46.1
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639427-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	9.0	15.9	4.0	10.2	6.0	4.9	9.1	9.9	7.9	10.0	10.3	9.6	5.8	5.6	9.6	8.0	9.6	11.8	9.0	5.2	4.4	5.2	6.1	21.4	5.8	9.9	6.1	5.8	13.2	9.9	6.1	7.2	10.5	6.0	7.5	4.3	6.0	16.9	5.9	5.4	7.4	8.5	5.6	6.6	12.0	6.7	19.0	5.2	14.7	8.4	5.5	11.4	7.7	7.7	9.1	7.6	13.4	10.2	4.3	11.3	4.8	3.0	5.9	4.0	5.8	4.0	4.2	14.8	2.5	2.7	3.0	3.2	9.1	5.5	12.1	6.4	1.8	3.5	6.0	3.1	6.7	1.4	4.4	11.2	9.3	2.7	6.3	5.4	5.3	3.5	6.9	1.6	3.8	6.0	2.1	7.1	10.2	3.8	4.0	3.6	5.9	12.1	11.9	4.5	6.9	9.2	10.3	8.3	12.2	3.6	2.7	7.0	2.9	6.9	13.1	6.1	2.5	10.6	6.1	3.3	0.1	2.9	1.1	0.9	7.0	4.1	5.5	1.9	8.2	3.6	10.6	7.3	5.8	6.1	9.9	6.8	9.1	8.1	6.2	7.6	6.4	11.3	4.8	13.4	4.3	10.2	2.1	8.7	4.8	4.0	6.0	9.9	7.9	4.4	5.2	6.1	5.8	6.0	5.2	6.0	1.3	5.1	6.5	1.6	5.0	0.6	2.5	5.3	0.0	10.4	5.9	6.3	0.0	3.2	1.7	4.2	3.5	0.0	2.1	6.8	2.8	3.2	0.0	8.5	4.1	0.0	7.0	6.2	4.1	0.9	3.7	2.7	1.7	4.6	3.7	3.9	3.4	4.3	4.6	1.6	4.2	6.5	2.2	16.6	15.1	1.9	5.3	9.6	6.8	5.7
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	11.0	10.9	8.4	7.3	14.2	5.1	58.9	6.3	16.5	22.7	11.4	13.7	7.7	8.4	33.3	14.5	15.1	19.2	15.4	12.4	8.7	8.6	37.2	12.0	11.4	16.1	9.5	9.4	13.0	27.8	10.7	8.5	17.8	11.6	13.9	8.6	11.5	20.9	59.7	15.5	13.8	9.5	11.6	10.1	11.0	13.6	16.9	8.9	10.0	25.4	12.9	13.2	12.5	11.6	23.8	25.9	11.7	25.0	23.8	27.2	17.8	9.8	24.2	8.6	7.2	20.6	19.9	8.7	10.3	15.7	20.5	19.6	17.9	25.7	11.1	2.9	10.6	16.0	15.2	10.0	17.9	15.7	12.0	20.2	8.3	19.4	36.2	17.8	13.4	14.5	17.8	20.5	14.5	20.6	18.5	17.9	19.5	17.1	21.9	12.7	13.2	14.4	15.4	4.0	10.8	27.3	12.5	18.8	20.1	17.1	8.0	11.3	9.0	6.6	0.2	24.5	11.4	11.9	25.8	10.7	18.8	12.7	8.2	20.2	22.8	15.7	5.1	19.7	12.7	16.7	11.7	24.9	8.6	19.4	25.0	21.8	22.7	24.5	22.3	25.9	23.8	27.2	22.1	9.1	23.8	17.8	25.2	25.1	17.8	8.4	14.2	6.3	16.5	8.7	8.6	9.5	9.4	11.6	8.9	17.9	12.5	26.3	26.3	18.3	10.4	28.5	20.4	22.7	13.6	38.4	5.9	59.3	31.5	30.3	10.8	20.2	20.8	0.0	43.1	35.2	18.8	20.8	23.0	18.6	33.4	11.1	22.5	31.3	25.9	8.7	12.0	20.9	32.1	47.7	31.6	16.0	40.2	17.5	11.7	25.6	11.4	6.5	16.0	48.6	17.9	19.7	37.3	17.9	43.5	22.6
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776483-74839779	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	11.5	15.5	10.6	11.6	12.1	15.4	7.7	10.5	13.9	8.1	7.9	19.1	9.5	7.6	7.4	8.9	9.3	6.8	9.6	9.0	11.4	8.2	10.9	19.9	14.7	19.0	17.3	9.1	9.4	18.7	21.0	14.7	12.5	13.1	8.0	6.7	10.0	15.1	9.1	7.5	9.7	7.7	9.4	18.5	10.4	8.3	17.4	14.2	7.5	11.7	6.5	10.2	10.6	6.1	4.9	8.8	5.7	7.7	3.9	7.9	5.0	6.3	15.6	8.4	9.4	11.9	7.4	5.0	11.0	11.1	14.1	15.7	12.8	6.9	3.4	3.5	12.5	14.4	7.2	8.4	6.1	7.5	2.5	11.9	8.4	6.3	8.8	8.7	13.7	7.8	5.9	6.8	14.3	3.1	4.2	10.0	8.3	4.8	5.3	9.6	6.0	8.2	5.6	4.6	8.4	12.5	5.2	13.2	5.6	6.3	5.6	7.1	9.3	6.1	7.9	8.1	6.6	10.1	21.4	7.9	29.8	7.6	11.3	14.2	3.6	3.1	3.8	11.5	14.4	11.3	2.2	7.7	5.7	7.9	6.5	4.0	4.9	7.6	7.2	8.3	1.6	6.3	4.4	3.6	3.9	6.6	8.8	7.5	5.0	10.6	12.1	10.5	13.9	11.4	8.2	17.3	9.1	13.1	14.2	6.0	7.2	0.8	1.0	2.3	2.3	36.1	10.2	0.0	3.4	5.2	2.0	3.3	0.0	3.9	1.6	2.3	3.9	0.0	4.8	3.3	2.7	2.1	1.1	11.5	10.6	0.0	7.9	3.1	6.3	1.7	2.6	5.5	0.0	4.6	4.0	4.0	5.3	3.1	2.1	1.6	3.0	0.0	1.4	4.3	4.1	1.9	3.2	2.9	2.6	1.3
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 48.7;Spermatocytes: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"RT4: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.7	10.7	4.4	3.0	8.4	1.0	10.2	6.7	6.6	5.3	4.1	11.2	9.1	9.5	3.9	6.4	4.9	4.2	5.8	20.2	5.3	3.7	26.8	10.0	7.2	3.7	8.7	5.5	4.7	4.1	31.2	9.6	2.7	14.0	4.5	3.4	5.9	12.5	7.0	5.0	11.8	9.0	5.1	8.2	3.9	8.7	20.8	7.3	6.0	6.6	3.6	5.6	8.6	4.5	2.5	3.0	3.0	3.3	1.5	14.9	3.4	4.2	4.4	6.3	7.0	6.3	5.0	4.3	3.4	5.6	4.5	4.9	3.3	3.5	4.9	2.2	2.6	5.5	4.3	3.5	3.7	3.9	11.7	2.8	3.1	4.2	4.1	10.1	1.2	0.5	6.1	6.4	5.8	10.1	4.8	1.5	9.4	5.9	4.0	4.6	6.3	1.8	10.0	7.8	10.2	2.9	5.0	2.5	8.4	14.1	23.9	6.0	4.0	3.7	3.3	5.8	8.9	11.9	16.5	1.1	4.3	1.3	3.8	1.5	4.7	8.2	4.6	6.0	3.9	6.0	0.8	1.8	3.0	6.5	3.3	5.2	2.1	14.9	12.1	2.1	2.5	7.9	8.6	0.3	1.5	2.4	3.0	13.5	3.4	4.4	8.4	6.7	6.6	5.3	3.7	8.7	5.5	14.0	7.3	3.0	14.4	1.5	6.8	4.8	10.6	21.6	5.1	12.0	2.3	27.9	15.7	16.1	19.9	3.0	48.7	3.4	7.8	0.0	3.6	4.8	5.6	3.6	5.7	5.0	4.5	9.5	0.0	1.8	5.2	26.7	8.6	3.7	6.8	2.8	2.4	13.0	3.0	1.9	4.6	8.8	17.6	6.5	4.2	128.4	21.3	4.6	33.5	12.9	2.6	5.9
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	18.3	17.4	24.9	15.9	23.3	23.7	20.0	13.2	30.0	13.9	16.2	9.5	15.6	19.8	13.2	20.6	17.2	12.5	16.0	44.4	20.9	20.7	22.0	28.5	12.6	15.0	21.8	22.9	13.7	27.7	13.1	19.9	14.1	19.9	14.0	18.3	8.9	25.2	15.7	49.5	12.2	15.1	16.5	18.0	14.1	19.1	21.4	18.8	10.5	16.5	36.4	15.6	14.0	18.7	14.5	19.1	6.3	15.3	8.4	16.5	11.1	14.7	18.6	16.7	11.5	22.5	22.7	13.6	17.6	19.2	26.4	26.1	22.9	23.8	8.5	21.0	21.1	10.1	16.2	17.2	18.6	24.5	21.6	9.6	23.3	22.1	24.9	28.3	29.4	19.7	19.6	22.9	23.3	25.0	14.2	24.1	23.2	16.4	14.0	29.3	19.6	15.9	37.5	17.1	56.2	21.2	16.3	16.8	27.5	18.5	19.5	12.0	12.2	15.9	25.1	14.6	16.2	31.2	20.2	14.2	25.7	18.3	48.0	20.1	9.4	16.5	22.3	13.5	21.2	30.4	2.9	13.4	6.3	12.5	15.3	16.5	14.5	16.4	14.6	19.1	13.2	15.6	15.4	1.2	8.4	13.1	14.4	14.1	11.1	24.9	23.3	13.2	30.0	20.9	20.7	21.8	22.9	19.9	18.8	26.8	18.7	34.9	49.1	28.2	13.7	101.5	20.4	36.1	39.8	36.6	5.9	57.3	124.3	42.5	119.6	29.2	27.0	0.0	80.4	63.4	39.0	59.0	36.9	66.1	83.8	7.9	20.8	21.5	49.7	48.6	27.3	53.8	32.1	67.7	42.7	22.6	54.2	31.6	25.1	79.5	15.1	19.4	51.4	99.1	51.5	36.8	44.3	39.2	55.6	50.7
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671109-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	8.7	24.4	26.7	6.2	32.0	4.3	12.9	25.7	40.0	13.9	12.5	13.5	5.8	18.9	14.3	19.3	18.0	16.3	12.6	8.1	25.5	40.7	25.8	52.7	9.0	8.8	28.3	22.6	21.0	23.8	9.2	12.9	7.9	31.7	19.0	13.3	25.7	9.6	11.7	2.0	6.8	17.4	13.4	29.1	6.5	20.3	8.4	10.7	5.8	14.6	11.1	11.6	14.1	11.6	22.3	14.3	6.4	0.2	4.0	25.7	11.9	67.3	10.2	7.6	21.5	20.8	16.1	6.4	13.6	18.7	12.6	19.6	15.6	17.5	8.3	15.2	17.1	26.6	25.8	16.8	22.8	21.3	33.3	13.8	12.2	16.7	25.5	6.8	6.2	15.3	14.4	16.1	13.8	3.1	16.7	17.0	10.6	2.5	23.7	14.9	13.7	12.1	7.1	4.5	44.7	17.9	9.6	10.8	6.5	24.4	13.0	39.6	19.2	15.2	12.2	25.4	9.9	18.8	12.0	12.5	17.5	23.6	6.8	21.9	11.4	9.6	12.5	24.6	3.9	13.9	6.4	0.2	6.4	16.4	0.0	10.6	22.3	21.2	17.2	7.8	13.2	16.4	17.5	0.9	4.0	0.0	14.3	25.7	11.9	26.7	32.0	25.7	40.0	25.5	40.7	28.3	22.6	31.7	10.7	23.8	14.5	18.0	51.6	42.9	20.8	12.5	50.9	61.6	33.0	48.8	7.9	51.8	54.7	95.2	1.1	42.1	22.0	0.0	122.4	120.9	88.8	80.6	25.3	119.7	38.4	4.8	32.1	33.7	7.3	2.0	40.3	16.9	84.4	6.4	47.0	24.6	77.7	28.8	47.0	136.7	10.1	6.5	75.2	4.4	24.5	33.4	12.9	22.7	47.2	49.8
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.2	0.0	0.1	0.0	0.2	3.5	5.6	3.1	11.5	3.4	6.5	0.1	1.6	12.6	1.3	2.8	3.7	9.0	0.0	24.7	6.3	0.0	0.0	0.7	0.1	0.0	3.7	9.7	28.5	3.4	11.9	10.9	9.5	0.0	8.4	7.8	0.0	22.2	0.2	0.8	3.8	3.0	0.6	0.0	2.9	0.4	0.0	0.0	19.5	7.5	0.0	0.5	0.7	2.4	0.4	3.5	0.3	6.9	3.4	0.5	2.0	0.3	4.3	27.8	9.4	6.9	4.7	22.1	2.6	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1	11.9	22.9	42.2	7.7	65.9	0.0	1.4	0.0	60.2	19.4	21.0	2.0	21.8	0.0	6.1	0.0	5.7	0.0	0.0	3.3	12.7	5.5	5.3	97.2	3.9	4.2	3.2	1.2	0.6	8.7	0.0	0.6	15.0	5.0	0.0	0.6	0.0	12.8	9.1	0.0	0.3	0.4	0.0	1.9	0.0	0.2	169.9	21.6	15.8	3.1	23.5
TMEM173	"ERIS, FLJ38577, MITA, MPYS, NET23, STING"	ENSG00000184584	"Transmembrane protein 173"	Q86WV6	5	139475534-139482935	"Disease related genes, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 25.3;EFO-21: 38.2;HDLM-2: 81.1;Karpas-707: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	22.9	6.5	6.3	17.4	6.7	18.1	15.9	1.2	4.5	22.5	9.4	6.0	13.3	6.4	16.7	18.1	16.0	24.4	13.5	26.3	3.8	3.1	12.5	8.1	32.0	41.3	7.9	2.3	30.7	3.9	1.9	8.1	13.9	6.8	20.3	8.8	14.7	16.6	14.6	10.3	9.6	10.9	16.2	7.1	35.8	8.0	11.1	6.3	15.8	13.0	16.5	29.7	17.7	17.9	0.3	26.9	5.8	29.1	39.8	28.9	26.1	1.2	0.5	0.0	0.0	1.3	4.1	0.1	6.6	25.3	3.2	10.5	0.0	9.1	0.0	38.2	19.7	0.7	4.8	0.1	9.7	1.2	81.1	0.9	5.5	2.5	0.3	2.2	1.6	0.1	5.8	0.4	2.2	2.6	4.4	11.3	0.6	1.7	25.4	11.8	0.0	0.8	8.5	0.0	0.2	1.9	0.3	2.4	7.5	2.9	2.5	2.5	0.0	2.2	2.4	6.3	0.2	0.3	22.0	8.2	0.9	0.4	2.5	1.9	0.0	7.7	0.0	0.1	23.7	2.9	5.8	29.1	0.0	28.8	19.4	14.2	0.3	28.2	23.2	26.9	0.2	19.4	17.5	2.4	39.8	7.8	9.2	28.9	26.1	6.3	6.7	1.2	4.5	3.8	3.1	7.9	2.3	6.8	6.3	41.7	56.7	6.7	69.0	27.4	0.1	22.6	2.5	152.6	59.1	7.0	0.0	0.7	0.0	26.9	1.0	87.0	0.5	0.0	14.2	0.7	35.0	14.4	48.7	0.0	55.0	0.0	8.1	57.7	62.8	0.4	47.8	46.4	33.7	45.9	13.3	0.0	50.6	5.8	34.3	0.0	0.3	45.3	78.8	0.0	0.3	14.6	1.5	66.0	28.2	26.1
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.1	3.5	4.8	17.0	8.9	8.2	8.2	6.0	5.0	7.5	2.8	13.4	2.5	5.1	8.6	8.8	5.5	3.2	6.5	2.2	6.2	7.5	5.2	9.0	2.8	9.8	2.7	9.7	12.6	7.9	4.5	3.0	3.6	3.1	5.4	5.2	20.9	4.4	10.9	6.9	11.2	2.2	3.9	17.2	4.8	2.1	7.2	4.8	3.2	9.6	8.5	5.7	3.6	5.4	1.8	16.0	7.5	4.1	9.3	2.1	10.7	6.3	14.2	3.7	4.9	9.0	6.0	7.5	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9	11.9	9.9	12.9	8.5	5.6	24.5	8.7	5.1	4.0	5.7	14.0	3.9	21.7	1.7	7.4	4.4	8.2	12.4	0.0	10.0	9.3	12.7	8.2	6.9	23.8	13.5	44.5	15.5	8.6	15.3	3.2	11.5	11.0	18.6	4.6	8.1	43.7	8.0	14.4	15.2	6.7	25.4	12.9	9.5	22.3	10.2	6.8	15.8	13.1	7.0	5.4
TMEM177	MGC10993	ENSG00000144120	"Transmembrane protein 177"	Q53S58	2	119679167-119686507	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036689, HPA053816"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA036689: AB_2675253, HPA053816: AB_2682272"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.05e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	3.5	9.5	10.0	6.0	11.4	1.3	8.8	10.4	16.9	6.7	13.5	9.0	6.1	20.1	8.1	11.9	6.7	13.5	9.4	9.2	9.5	8.7	15.2	27.9	4.6	7.6	7.6	9.8	10.5	10.4	7.7	19.2	4.1	6.6	7.2	11.7	7.3	9.1	9.0	13.5	8.3	16.5	8.1	6.6	5.1	7.7	9.0	8.8	6.7	7.3	4.9	6.4	6.3	5.7	7.4	4.9	2.1	2.3	5.7	15.9	5.3	11.2	10.0	8.8	8.4	2.4	2.4	4.5	4.2	5.3	12.5	9.6	25.1	6.3	18.7	10.5	3.7	10.3	6.9	14.2	14.5	7.3	8.8	26.4	9.6	5.9	27.8	5.3	6.0	7.1	6.5	10.4	9.9	6.5	4.8	8.0	11.4	14.8	2.5	6.7	9.3	10.5	12.0	22.5	8.3	15.3	9.6	8.6	11.0	12.5	5.9	17.4	10.2	5.7	11.8	13.1	8.7	9.0	10.4	6.4	6.2	15.2	4.7	8.3	2.5	1.8	11.4	2.3	7.6	11.1	0.0	2.3	2.1	7.7	1.9	7.8	6.0	6.6	7.6	4.3	7.4	15.9	9.8	0.7	5.7	1.1	4.9	6.2	5.3	10.0	11.4	10.4	16.9	9.5	8.7	7.6	9.8	6.6	8.8	3.0	0.0	3.7	5.8	2.6	11.5	13.4	15.3	5.3	10.3	5.2	13.7	11.2	56.3	13.6	1.9	4.1	9.8	0.0	12.5	8.5	4.7	5.0	0.0	23.7	5.4	11.1	2.4	2.5	0.8	1.3	6.9	2.2	13.5	7.2	5.3	8.4	10.6	7.0	11.7	28.6	19.9	0.0	3.1	7.2	4.8	1.8	1.7	2.5	12.4	3.8
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.1	0.1	0.0	0.6	0.0	0.0	0.4	0.1	10.4	0.2	0.0	0.2	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3	0.0	1.3	0.0	0.6	0.3	2.1	3.7	0.0	4.0	1.2	12.2	5.9	0.3	0.0	0.3	0.3	3.1	0.4	0.0	0.2	0.0	0.2	4.1	0.0	0.2	0.2	1.6	15.4	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.3	0.0	0.0	0.7	5.8	0.0	0.4	0.2	0.2	0.5	0.5	0.0	0.4	0.1
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA045861			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.4	1.1	1.2	1.0	1.3	0.3	1.1	1.7	1.8	1.4	1.0	0.5	1.5	1.0	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1.0	1.1	1.5	6.8	0.8	2.8	1.9	1.0	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.4	1.8	2.0	37.8	4.0	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.9	2.8	2.1	6.6	2.7	2.7	7.7	2.7	2.4	2.7	3.9	9.2	6.9	4.1	9.2	0.9	4.4	2.9	2.3	3.7	5.7	9.1	1.8	6.1	1.3	5.8	3.2	5.5	4.9	3.4	6.8	4.3	3.8	1.9	0.4	5.9	4.3	1.6	2.7	3.6	2.9	5.3	3.6	4.7	3.0	3.1	5.6	3.9	3.8	4.3	5.5	1.9	3.6	3.9	8.6	2.9	3.3	2.9	0.3	4.3	3.1	3.3	3.3	4.0	10.0	3.4	4.4	9.1	6.5	0.0	0.0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4	20.8	10.5	5.9	0.8	0.3	0.1	134.4	0.0	17.4	23.9	3.5	0.0	1.9	0.0	1.3	0.6	0.0	0.4	23.3	2.9	2.1	1.0	1.0	3.5	1.9	1.0	0.0	6.3	0.0	0.6	0.4	0.6	0.7	6.8	0.0	2.2	2.3	1.7	0.0	0.7	2.4	0.3	0.0	0.9	0.9	2.2	0.5	0.9	1.0	1.7	2.7
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617383-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	10.4	18.4	11.3	9.6	13.1	5.5	10.0	12.3	15.9	11.8	13.0	12.3	14.3	11.8	12.4	9.8	10.7	10.0	9.6	14.3	11.8	11.3	18.0	18.7	9.2	7.7	16.1	11.8	15.7	11.6	107.2	10.5	14.0	12.7	12.0	11.6	9.3	12.1	12.8	16.2	9.5	14.8	10.1	14.0	10.0	10.6	8.3	14.1	11.7	32.9	10.3	9.4	11.8	11.2	12.8	17.3	17.7	18.1	14.7	22.8	11.6	9.2	14.5	18.4	14.0	25.2	24.6	12.1	17.3	20.3	12.9	15.0	11.9	17.7	8.6	8.7	13.5	12.8	11.1	14.9	13.3	14.3	19.1	8.7	11.1	11.2	8.6	19.4	14.8	16.6	18.3	18.0	14.2	14.9	18.8	16.6	9.8	14.2	24.3	18.0	13.8	12.8	5.4	11.8	21.1	8.5	12.8	6.3	14.8	14.3	17.3	14.3	18.5	9.4	14.7	15.1	14.9	14.7	9.3	16.2	16.4	8.9	13.3	11.0	26.6	34.8	11.5	19.2	8.9	17.7	17.7	14.1	15.5	18.0	18.0	22.8	12.3	16.7	16.4	17.3	12.8	15.9	14.8	11.0	14.7	18.1	11.9	15.3	11.6	11.3	13.1	12.3	15.9	11.8	11.3	16.1	11.8	12.7	14.1	8.9	5.7	6.4	6.6	4.0	7.7	16.5	10.2	5.3	14.8	5.2	11.8	12.5	1.7	10.6	19.6	9.8	8.5	0.0	11.1	10.6	8.4	7.2	20.8	8.5	9.0	11.1	5.2	6.7	10.4	10.3	10.0	8.8	5.0	4.6	8.3	7.8	7.5	3.5	13.8	5.3	6.2	6.5	7.3	5.4	4.9	3.0	7.2	6.4	9.9	6.4
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 51.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 8.8;ASC TERT1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.8	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588922-9614873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	6.2	7.3	9.6	5.7	9.4	10.3	4.0	8.7	11.9	4.4	3.9	10.5	4.4	5.4	6.9	5.1	5.9	5.8	4.0	13.2	9.3	7.9	5.7	2.7	4.5	5.0	9.4	8.3	9.0	9.2	5.5	12.6	4.5	7.9	4.9	2.8	12.6	6.7	5.6	37.0	7.1	3.9	4.9	6.7	5.3	4.0	8.2	7.1	6.9	4.5	13.9	5.4	3.8	4.3	1.4	4.3	0.0	0.8	0.4	1.9	1.0	7.7	10.5	6.6	15.5	2.8	1.9	5.9	9.1	2.8	10.9	7.7	19.3	7.1	13.5	11.6	3.1	5.3	16.2	7.3	7.2	3.7	8.9	18.3	9.5	10.0	9.8	5.1	11.5	9.9	3.4	3.3	14.6	2.4	2.3	4.3	6.4	12.1	3.9	4.3	9.2	10.0	8.4	6.7	6.0	9.8	21.2	11.3	11.1	3.9	4.3	15.9	11.9	7.2	17.6	7.9	2.4	5.4	7.3	3.9	13.0	11.3	14.3	17.1	6.6	5.5	12.1	9.0	19.0	11.4	0.0	0.8	0.0	1.1	0.6	0.6	1.4	1.4	1.9	1.1	1.1	1.0	0.7	0.0	0.4	0.4	4.3	1.8	1.0	9.6	9.4	8.7	11.9	9.3	7.9	9.4	8.3	7.9	7.1	3.0	1.3	1.9	1.7	6.3	14.7	10.6	2.5	2.7	2.3	0.0	25.5	2.8	1.7	2.0	1.1	4.5	0.7	0.0	0.8	1.8	2.3	1.4	4.6	1.5	3.0	9.5	6.4	4.3	3.7	1.3	3.7	2.5	3.3	0.0	3.6	4.8	1.3	0.0	4.2	1.9	16.3	0.0	3.8	4.7	5.3	4.8	0.7	1.0	4.0	1.7
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	8.4	13.4	10.8	6.0	14.1	4.7	15.9	6.9	13.5	14.1	13.1	11.7	14.7	10.1	12.4	40.1	35.8	17.3	10.5	4.8	9.4	6.3	10.0	30.8	6.8	9.0	7.7	9.0	8.7	12.1	8.3	10.1	14.8	9.5	25.8	13.7	10.7	16.3	9.1	3.0	43.9	13.4	6.6	8.2	6.9	9.0	21.5	8.8	8.6	11.8	12.4	15.4	13.0	20.5	12.6	14.7	27.7	18.1	9.8	22.9	11.9	7.3	7.0	11.9	9.1	14.6	18.3	18.1	7.1	5.2	5.2	5.3	5.3	22.7	5.6	12.1	9.0	4.9	7.8	4.8	5.9	5.5	9.2	8.5	1.5	2.3	7.4	6.6	6.9	7.5	11.8	26.9	4.6	4.0	11.3	4.6	4.8	4.1	12.2	5.2	14.9	5.6	5.1	6.4	6.4	23.0	6.9	1.4	4.8	7.2	6.1	4.2	6.9	6.6	16.5	7.1	8.3	23.4	4.6	6.7	4.1	7.1	6.9	4.0	8.4	11.9	0.4	10.3	7.1	3.4	27.7	16.2	7.4	11.9	18.1	14.9	12.6	13.8	12.3	13.2	9.6	22.9	15.6	1.7	9.8	17.6	14.7	16.0	11.9	10.8	14.1	6.9	13.5	9.4	6.3	7.7	9.0	9.5	8.8	8.9	8.1	6.0	5.0	7.2	7.4	2.6	15.3	37.5	14.8	8.7	15.7	33.9	18.3	12.1	3.1	5.2	10.5	0.0	7.5	30.9	5.3	21.9	5.7	28.8	17.1	15.9	8.1	5.5	11.1	5.9	8.6	9.2	3.3	16.2	22.8	14.5	9.5	18.2	11.0	17.0	11.1	12.9	3.8	24.2	8.7	21.0	19.0	6.9	18.7	6.5
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	1.8	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.3	0.3	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	3.5	0.2	0.3	0.0	18.1	0.2	0.0	0.2	0.0	0.0	7.8	0.0	2.8	0.0	3.3	2.4	19.8	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8	3.0	0.0	0.0	0.0	0.3	0.6	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.6	1.1	0.6	0.7	5.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.0
TMEM267	"C5orf28, FLJ21657"	ENSG00000151881	"Transmembrane protein 267"	Q0VDI3	5	43444252-43483893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 15.7;Cytotrophoblasts: 23.5;Distal tubular cells: 23.2;Ductal cells: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059946, HPA072991"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA059946: AB_2684175, HPA072991: "	"unprognostic (8.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.77e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.40e-3)"	9.9	8.1	9.0	7.8	9.4	3.9	14.2	13.8	12.5	11.7	7.7	5.7	6.8	7.1	11.1	11.7	9.4	8.9	7.5	8.3	6.3	8.5	12.1	7.1	8.1	9.0	9.9	11.2	10.9	17.3	9.9	23.0	6.3	11.6	9.6	9.7	8.9	12.3	9.9	7.1	9.8	8.6	9.2	9.4	9.5	9.1	7.9	7.9	6.1	36.8	7.6	8.8	10.4	9.0	11.6	9.7	9.0	11.6	13.7	18.0	11.0	10.1	9.3	5.0	11.2	9.5	19.1	5.7	14.6	9.0	7.9	5.8	4.0	21.8	11.3	20.1	14.8	8.3	8.6	4.8	6.6	11.5	13.5	7.8	6.5	20.1	4.5	17.4	13.3	9.5	15.6	18.9	11.8	16.8	8.0	8.8	13.6	8.5	21.0	17.3	8.7	7.3	7.9	2.2	10.2	9.2	5.0	12.4	13.7	9.8	10.3	7.0	5.0	29.1	16.7	14.2	4.8	24.2	9.7	11.4	12.9	10.5	7.9	7.2	9.0	12.8	11.1	9.7	19.3	11.3	9.0	8.6	3.1	12.3	10.0	18.0	11.6	16.4	13.0	9.7	9.6	16.9	14.0	1.6	13.7	11.6	7.5	13.0	11.0	9.0	9.4	13.8	12.5	6.3	8.5	9.9	11.2	11.6	7.9	6.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.4	15.7	0.0	23.5	23.2	13.2	0.0	0.0	0.0	0.0	12.1	8.1	0.0	0.0	2.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.4	0.0	0.0	10.7	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;CAPAN-2: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	23.1	20.6	6.4	10.7	8.0	5.3	24.4	5.7	7.9	23.7	13.8	9.3	12.6	7.4	22.3	19.0	15.2	19.7	26.1	17.6	6.4	5.8	27.5	24.4	25.3	28.0	9.9	7.6	20.0	20.5	9.2	14.6	29.5	9.6	29.6	12.6	26.6	14.2	17.4	10.5	7.2	16.0	18.3	10.2	19.0	12.9	21.4	7.8	17.9	48.7	9.8	18.4	22.0	19.1	24.9	37.3	29.4	26.8	36.4	53.1	38.4	9.1	7.0	1.7	2.8	43.0	25.5	3.5	10.0	16.8	7.2	9.8	6.9	40.6	4.7	15.6	10.3	11.1	9.9	3.1	8.5	5.8	17.3	4.7	9.8	3.7	8.2	23.6	6.5	10.3	25.3	8.0	6.4	13.6	14.5	14.0	9.7	6.3	13.4	12.5	5.6	4.7	6.5	7.6	0.0	4.9	6.4	13.8	1.5	19.2	9.1	4.2	1.4	15.2	0.2	13.4	8.3	3.8	9.9	14.2	9.6	9.0	8.4	5.7	7.8	4.4	3.2	9.7	10.6	8.0	29.4	24.5	25.4	47.3	26.8	50.7	24.9	52.3	51.9	16.8	21.0	46.1	46.3	7.6	36.4	21.9	37.3	53.1	38.4	6.4	8.0	5.7	7.9	6.4	5.8	9.9	7.6	9.6	7.8	20.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	11.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TMEM39A	FLJ10902	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119429500-119468830	"Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	13.7	12.7	5.6	13.0	8.8	9.3	13.2	10.5	6.4	18.3	8.7	10.4	27.0	9.6	20.8	18.3	10.9	13.5	13.4	14.4	5.1	3.8	9.7	16.7	15.2	11.0	8.9	2.4	17.6	37.5	8.3	47.9	19.5	7.6	13.9	9.5	12.1	30.2	30.0	8.7	10.7	10.6	9.6	8.4	11.8	11.5	15.4	8.0	11.3	17.4	9.5	19.2	11.9	13.0	8.6	18.1	11.5	11.2	11.9	13.8	9.2	15.9	8.0	14.3	10.1	28.5	26.7	15.1	15.8	27.1	17.1	23.8	14.0	12.2	6.7	15.0	14.5	21.2	16.6	14.7	6.2	18.9	6.6	5.7	8.2	6.1	14.2	19.2	15.2	12.3	16.1	10.4	12.4	30.3	19.5	11.3	10.4	8.0	19.3	9.5	7.3	8.0	5.5	13.7	15.9	16.0	8.7	7.4	14.3	5.0	6.2	6.2	8.7	14.9	8.6	21.3	10.5	8.1	14.3	9.7	10.6	10.1	7.4	9.9	22.2	6.2	15.9	15.9	11.0	15.1	11.5	11.2	8.0	13.5	6.2	13.8	8.5	8.4	11.3	13.2	8.6	7.0	7.1	4.7	11.9	4.8	18.1	9.8	9.2	5.6	8.8	10.5	6.4	5.1	3.8	8.9	2.4	7.6	8.0	8.9	12.0	7.5	13.8	20.3	4.5	9.8	2.5	12.0	7.9	7.0	5.9	22.9	5.0	10.2	19.6	8.0	5.6	0.0	12.5	45.9	30.1	16.5	1.1	9.8	12.1	1.6	10.4	7.4	21.0	4.2	15.8	13.2	10.1	45.9	14.6	4.8	9.1	3.5	12.4	3.4	6.3	6.5	13.9	23.2	14.7	19.1	50.0	15.8	10.8	17.5
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861869-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052569: AB_2681871"	"prognostic favorable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	11.1	14.6	18.6	5.7	26.1	4.6	13.4	7.8	17.3	12.7	8.5	17.7	8.5	6.1	10.4	25.9	7.2	16.8	8.9	10.2	18.4	19.7	12.9	19.1	9.7	9.3	19.1	14.1	17.1	17.5	12.7	16.5	8.9	16.4	12.7	8.5	8.5	10.9	12.7	16.6	8.6	6.2	9.2	19.8	8.7	9.9	20.0	15.5	11.6	17.1	6.5	9.1	7.5	8.7	13.9	11.8	4.2	10.2	9.1	15.9	9.2	4.1	4.2	1.2	2.4	16.1	12.7	0.1	3.4	4.8	4.2	4.2	0.9	8.2	2.8	6.7	6.6	1.9	2.8	0.3	5.2	4.2	4.4	0.0	1.7	5.4	4.4	17.1	2.0	0.1	13.1	13.4	4.3	9.7	9.0	7.1	7.2	0.1	5.8	6.3	3.2	1.7	3.4	2.3	5.0	1.9	1.5	0.7	0.6	9.1	1.6	1.3	1.7	4.1	1.4	1.6	4.2	3.0	3.5	4.6	3.7	0.4	5.4	3.7	2.0	1.5	0.8	7.4	2.4	1.6	3.7	8.6	4.2	7.8	7.7	8.2	13.9	11.6	7.2	10.6	11.9	15.9	12.6	1.6	9.1	10.2	11.8	9.2	9.2	18.6	26.1	7.8	17.3	18.4	19.7	19.1	14.1	16.4	15.5	20.8	4.8	10.7	14.4	5.5	8.0	10.1	15.3	16.0	4.5	31.4	2.0	17.6	11.6	15.3	56.7	9.3	5.2	0.0	8.9	11.3	14.2	14.8	3.5	15.3	19.8	17.5	11.5	11.6	13.3	73.6	25.3	10.3	6.8	9.0	9.1	20.9	11.7	8.4	18.4	17.0	15.9	6.5	6.9	36.1	19.3	7.9	8.1	13.1	11.8	6.2
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220480	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.7;monocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	4.6	14.1	4.7	7.7	4.4	0.4	7.0	14.2	5.1	9.7	22.4	4.5	14.3	15.9	5.3	7.6	12.0	7.2	25.3	3.7	5.0	2.2	23.5	3.9	10.4	7.4	4.1	3.4	15.4	36.7	14.5	5.2	7.5	4.2	12.3	7.8	16.1	7.5	15.5	1.2	5.3	22.9	8.9	5.7	7.1	18.9	3.4	3.9	2.0	3.8	12.3	8.4	18.5	22.2	0.0	1.7	0.0	2.8	0.0	0.0	0.3	19.1	10.3	5.9	1.4	1.0	2.2	0.0	2.2	9.3	6.8	9.3	13.5	21.6	0.0	7.3	1.4	9.8	18.6	2.0	7.2	3.9	0.0	5.1	0.4	0.5	13.3	8.6	0.0	18.8	0.7	6.4	8.9	9.8	4.4	6.3	0.8	2.9	0.0	3.5	6.6	0.0	0.0	1.0	15.3	3.9	2.7	3.7	3.3	17.3	19.9	0.9	17.5	1.8	7.6	18.4	3.7	1.0	2.0	4.4	7.1	6.3	3.1	6.9	0.2	0.3	0.0	7.0	0.3	8.3	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	4.7	4.4	14.2	5.1	5.0	2.2	4.1	3.4	4.2	3.9	0.0	1.6	2.7	51.9	16.3	0.0	1.8	20.4	6.7	4.5	47.1	0.0	4.2	5.0	64.9	0.4	8.7	12.9	0.0	64.3	0.7	5.6	48.2	0.0	0.4	43.7	0.0	18.4	8.6	24.2	0.0	2.6	18.8	13.5	19.8	16.3	0.0	65.3	25.9	13.1	11.8	0.0	32.3	39.4	0.5	1.9	18.4	1.1	0.0	13.2	98.9
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.2	9.0	7.2	7.5	8.5	7.3	7.4	9.6	8.7	10.7	8.7	8.4	6.5	15.2	8.3	6.4	9.1	10.2	13.8	9.2	12.1	9.8	9.4	15.2	5.9	11.2	8.5	8.2	8.1	6.8	8.6	6.8	3.6	4.1	9.0	7.7	11.4	7.5	11.4	8.3	18.8	15.6	6.7	14.4	11.2	13.3	7.1	12.9	11.3	10.6	16.4	7.3	5.9	43.0	12.1	6.0	8.9	7.6	5.7	6.3	7.6	11.4	9.0	11.2	9.6	14.9	9.1	6.4	6.9	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1	14.9	36.2	37.2	32.5	59.8	24.1	39.1	15.3	42.8	23.9	21.0	7.9	61.6	56.3	28.4	11.2	35.3	22.8	0.0	55.5	44.6	47.0	32.0	38.2	44.2	119.9	9.5	13.3	28.3	89.0	5.6	27.6	68.1	38.8	36.1	27.6	19.7	38.3	37.1	27.3	55.5	15.9	38.8	44.8	32.9	28.3	52.1	58.8	34.8	29.0	23.3
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.9;intestine: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	2.3	0.3	4.3	0.3	13.9	0.0	1.1	2.3	7.3	0.1	0.7			12.5	0.6	0.3	0.7	3.9	2.5	3.9	2.3	6.9	0.6	1.0	9.4	0.9	2.3		0.0	0.6	0.2	3.5	12.2		0.5	0.9		3.3	11.3	2.9	4.6	16.0	1.1	1.1	0.6	2.7	0.9			1.6		0.4	0.7	0.0	1.6	0.1	0.0	0.1	0.0	0.5	0.3	0.0	5.0	2.8	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.7	0.1	1.0	0.0	2.9	0.3	3.7	0.5	0.1	0.0	4.7	1.1	0.0	9.9	0.0	0.0	1.4	0.0	1.1	0.0	0.2	0.2	0.1	0.7	16.8	7.6	0.0	0.1	0.1	0.1	3.4	1.2	0.4	0.0	0.2	0.0	0.8	0.7	0.7	2.1	0.1	0.0	0.1	1.2	0.0	0.1	2.0	0.0	3.3	0.1	0.2	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3											0.0	0.0	0.0	0.4	0.2	10.3	1.6	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.5	0.8	3.6	2.0	0.0	0.2	1.0	0.2	0.7	0.0	0.6	0.0	17.5	15.0	3.1	0.8	0.4	0.0	0.0	1.7	1.8	2.7	0.2	1.4	1.7	0.0	0.3	2.7	19.4	5.7	0.2	0.2	0.6	1.1	0.0	0.8	0.4
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Group enriched"	"Detected in some"	9	"Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.1	6.6	0.0	0.0	0.0	86.8	0.0	0.2	1.9	0.0	0.0	0.0	38.2	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	57.5	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.3	0.0
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.5"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	6.9	4.9	4.7	3.6	5.7	0.7	5.6	3.4	9.7	3.8	3.3	7.0	1.2	2.5	4.0	3.8	3.9	4.4	6.6	8.1	6.9	3.7	15.3	6.7	5.7	11.1	6.7	3.2	12.3	8.2	7.0	3.9	7.1	5.0	2.9	3.2	16.7	4.6	2.7	4.7	24.4	3.2	3.4	7.2	9.2	3.3	4.1	3.7	5.3	3.7	3.9	4.2	5.2	5.4	0.2	6.5	0.3	3.7	0.2	1.7	1.4	0.0	0.2	0.7	3.4	3.1	0.0	0.1	0.7	0.6	0.6	0.5	0.0	0.4	0.0	1.3	0.6	3.4	0.3	0.2	0.1	0.4	0.2	2.0	0.2	0.1	0.0	2.4	0.0	3.0	4.3	1.3	0.1	0.3	0.8	1.8	1.9	0.6	0.0	1.4	1.8	0.0	0.0	0.2	0.5	1.8	0.0	5.6	0.0	19.2	4.1	1.1	1.4	1.0	3.5	1.5	1.3	4.2	0.4	2.1	0.6	0.3	0.2	0.1	3.5	2.7	0.0	1.2	0.0	1.2	0.0	3.7	0.3	0.4	2.8	1.0	0.0	0.4	0.9	6.5	0.2	1.0	1.7	0.0	0.2	0.9	3.8	1.0	1.4	4.7	5.7	3.4	9.7	6.9	3.7	6.7	3.2	5.0	3.7	0.0	0.0	0.0	0.6	0.1	3.9	2.0	0.0	0.0	0.0	10.4	7.9	0.4	6.6	5.3	6.8	0.6	0.0	0.0	6.9	0.3	0.8	0.9	0.0	1.0	34.1	0.0	3.4	4.3	6.4	6.3	2.0	5.7	0.0	1.8	0.6	2.9	7.5	0.0	1.8	5.6	4.5	6.5	0.1	6.5	0.7	0.3	1.9	0.0	0.0	0.3
TMEM8A	"M83, PGAP6, TMEM6, TMEM8"	ENSG00000129925	"Transmembrane protein 8A"	Q9HCN3	16	370773-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 67.7;Syncytiotrophoblasts: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	8.4	9.3	6.9	9.5	7.8	15.2	13.5	7.7	7.9	6.8	16.6	7.3	24.1	17.7	7.3	29.6	11.8	6.5	15.2	10.0	5.6	4.3	28.7	33.5	13.0	10.7	7.1	3.2	8.3	44.2	11.5	10.7	45.5	6.7	11.4	6.0	8.8	22.5	8.8	12.8	3.7	25.0	5.0	4.7	13.2	17.5	26.3	6.0	12.6	12.3	5.2	14.6	9.3	8.8	2.0	2.9	24.3	5.5	0.9	7.6	3.3	4.4	11.8	6.8	12.5	9.3	8.4	13.6	12.9	13.5	6.6	9.5	46.4	21.1	4.8	17.5	12.4	10.1	6.4	3.0	14.2	1.8	13.6	11.3	7.9	8.0	26.4	21.6	5.9	15.0	9.7	4.3	10.1	2.9	6.7	15.2	5.4	12.6	7.4	8.2	27.8	8.3	11.7	10.8	7.2	4.7	18.1	7.8	10.9	10.7	11.5	8.1	9.3	7.2	7.3	37.9	3.7	13.1	11.9	22.1	18.8	20.3	13.0	6.8	14.9	7.4	9.5	9.5	6.3	11.9	4.6	5.0	6.3	7.4	5.5	5.9	1.8	5.8	5.8	2.5	2.0	7.6	5.5	24.3	0.9	3.8	2.9	4.3	3.3	6.9	7.8	7.7	7.9	5.6	4.3	7.1	3.2	6.7	6.0	14.9	12.5	10.7	3.2	2.6	5.7	12.5	10.2	1.4	1.2	22.7	9.8	46.7	5.0	27.5	15.5	8.7	67.7	23.3	36.8	5.9	6.6	11.5	1.1	25.5	24.7	17.5	26.6	14.7	14.5	58.4	2.6	10.1	6.8	8.2	26.1	8.2	42.6	38.6	1.8	9.9	7.8	12.9	6.1	1.1	2.5	2.8	83.8	7.5	18.9	6.8
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500090	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	14.6	25.6	26.6	11.2	32.0	13.9	9.8	24.4	32.7	11.7	16.7	30.3	8.2	15.4	13.0	8.5	14.5	27.4	13.7	21.1	21.7	13.3	14.0	9.6	17.0	10.6	24.0	23.0	17.1	13.9	17.2	18.6	18.6	21.9	12.5	11.5	25.4	11.8	12.5	40.4	16.2	15.2	9.4	15.9	14.3	14.8	16.5	23.4	10.7	18.4	9.6	9.2	13.7	7.1	4.6	6.2	5.5	4.6	4.3	7.1	4.5	7.6	20.1	16.6	26.1	8.3	9.5	23.9	4.6	10.2	7.9	8.1	6.7	12.1	10.9	15.4	8.0	12.2	10.1	8.0	12.7	4.4	9.6	11.3	11.0	9.0	10.1	11.3	12.2	24.0	16.4	7.1	7.8	6.9	6.9	14.3	9.3	11.4	12.7	10.3	8.9	25.3	7.6	6.9	9.4	7.8	18.0	19.7	10.0	7.7	20.2	14.8	15.7	5.5	23.9	13.8	12.8	14.8	14.6	8.2	7.9	10.0	8.2	6.5	27.5	7.8	5.9	9.3	11.3	10.7	0.2	4.6	5.5	7.1	2.9	5.4	2.0	3.3	4.7	4.6	4.6	2.8	4.4	1.2	4.3	2.7	6.2	4.1	4.5	26.6	32.0	24.4	32.7	21.7	13.3	24.0	23.0	21.9	23.4	11.9	12.0	0.0	3.8	0.0	39.1	0.0	7.6	5.3	11.4	8.7	29.5	12.8	0.0	6.3	3.5	3.6	13.2	0.0	8.1	8.9	1.3	3.8	5.8	7.2	13.1	19.1	7.0	14.1	8.9	1.6	6.4	3.6	0.0	2.8	11.6	14.5	5.6	10.5	8.5	3.3	33.4	6.5	0.0	13.3	7.8	0.0	16.8	2.5	11.0	2.4
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751561-51816368	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.6"	"Cell type enhanced"	"Detected in many"	11	"Horizontal cells: 82.6"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.8;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	5.9	6.3	25.4	6.1	29.6	1.6	5.1	22.0	68.6	7.0	6.1	9.1	4.6	3.1	6.0	4.4	4.9	6.0	5.2	4.9	21.6	18.1	3.5	2.2	4.5	4.9	16.9	22.6	6.5	3.1	6.7	4.4	3.0	29.5	3.7	5.1	2.9	3.8	9.6	2.7	4.6	4.7	6.7	11.4	4.5	3.7	3.1	9.6	1.2	4.3	0.2	4.7	4.7	4.6	2.5	1.6	12.8	8.8	1.3	2.2	1.1	0.8	0.5	1.7	4.0	8.2	8.9	0.3	4.5	1.5	3.5	3.7	0.0	0.4	3.6	0.1	3.5	3.6	2.4	7.2	4.0	1.1	0.0	3.5	0.0	0.7	0.0	1.4	1.4	0.2	5.1	5.5	0.5	1.0	4.6	0.7	9.6	0.0	0.1	4.3	0.6	2.9	0.5	1.1	0.0	0.8	2.3	1.0	0.1	0.5	1.2	26.5	6.5	4.2	0.0	1.2	2.3	1.0	0.2	1.6	9.4	0.7	5.9	3.2	0.0	0.0	0.0	2.9	9.8	4.3	0.1	5.9	7.8	2.2	2.3	1.0	2.5	1.3	1.0	1.6	1.8	1.7	0.7	12.8	1.3	8.8	1.2	0.4	1.1	25.4	29.6	22.0	38.3	21.6	18.1	16.9	22.6	29.5	9.6	0.0	5.5	3.0	2.9	4.2	24.2	5.4	0.0	4.0	2.3	10.4	21.6	0.1	6.6	3.4	20.6	11.4	0.3	0.0	1.5	0.0	2.8	1.7	0.0	0.2	4.2	82.6	22.4	13.5	7.8	15.1	10.3	5.7	1.7	27.9	0.3	11.6	2.1	0.0	5.3	1.0	19.7	6.5	4.2	6.3	4.7	6.6	0.2	4.4	0.4	1.8
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9"	"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.5	1.2	20.6	0.0	0.0	0.0	1.3	0.5	33.9	0.0	0.4	0.0	6.9	0.1	0.2	5.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3	47.6	88.6	0.0	31.0	0.2	0.0	0.6	25.5	14.7	38.7	45.4	0.0	0.5	19.9	30.0	19.4	0.0	190.3	0.0	52.6	0.1	0.6	290.4	6.9	28.7	0.1	0.0	17.3	0.0	0.8	3.5	0.0	1.5	10.1	1.0	79.6	0.0	53.4	127.7	0.0	3.7	0.0	0.0	1.0	0.2	0.0	0.1	0.2	0.0	73.2	115.9
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	37.9	0.0	1.4	0.0	0.0	16.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	64.5	0.0	0.0	0.0	0.0	26.6	33.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.0	1.7	0.0	21.5	1.0	0.0	0.6	0.0	17.4	36.4	10.4	0.0	0.1	0.0	0.1	2.6	0.0	108.9	0.0	6.6	1.6	0.2	6.8	5.7	0.0	0.2	0.0	4.1	0.0	0.0	1.3	0.0	1.0	0.0	0.0	49.1	0.0	30.7	61.7	0.0	1.4	0.0	0.0	0.7	0.0	0.1	5.5	0.2	0.0	54.6	226.3
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane and tetratricopeptide repeat containing 1"	Q8IUR5	12	29500840-29784759	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 23.2;Endothelial cells: 46.9;Ito cells: 33.2;Sertoli cells: 45.3;Smooth muscle cells: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.2;HSkMC: 19.9;hTERT-HME1: 35.8;LHCN-M2: 19.9;RH-30: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	29.3	12.8	12.9	4.6	30.8	0.5	25.8	2.2	9.0	11.4	8.4	2.9	4.3	3.0	7.4	2.9	6.1	12.6	6.2	15.7	15.2	8.1	13.1	2.4	6.7	2.4	5.4	7.8	8.7	2.9	10.0	18.7	2.7	9.1	6.4	5.4	7.1	3.7	8.3	13.7	2.9	4.6	12.7	4.9	34.1	7.4	2.8	6.2	0.8	3.7	4.4	2.0	8.9	10.5	0.1	0.1	0.4	2.3	0.1	0.1	0.3	0.0	0.0	5.2	0.0	16.6	11.2	0.0	5.4	11.1	1.4	1.2	0.0	0.0	0.0	2.7	3.4	6.1	0.0	0.1	0.1	0.0	0.1	1.6	0.0	15.7	0.2	29.2	0.7	0.0	19.9	1.9	13.8	35.8	4.2	0.8	0.0	0.0	0.7	19.9	0.0	0.0	0.0	4.0	0.0	7.2	0.0	41.8	0.7	0.0	0.1	0.4	0.4	0.6	0.0	1.3	2.0	0.0	0.2	2.2	1.3	0.8	0.7	4.3	7.3	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	2.3	0.1	0.0	0.3	12.9	30.8	2.2	7.6	15.2	8.1	5.4	7.8	9.1	6.2	3.0	1.1	0.0	1.0	3.0	7.1	23.2	0.0	1.4	0.0	3.5	0.0	0.0	0.0	0.0	6.5	46.9	0.0	0.0	0.0	0.0	7.5	2.4	0.0	4.9	0.5	0.0	0.0	33.2	14.6	4.8	7.5	2.4	10.1	0.0	0.0	0.4	0.0	0.0	17.3	0.6	1.2	45.3	28.9	0.5	0.4	1.8	1.6	0.0	0.0	0.1
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.4	22.1	5.2	26.8	3.4	4.2	19.5	10.0	8.5	9.0	10.0	19.0	29.9	16.4	21.6	4.9	11.6	16.7	5.8	8.9	2.0	30.0	20.5	7.0	20.5	28.8	8.8	8.6	24.8	6.5	7.4	7.5	2.0	6.8	6.6	17.0	43.7	22.4	4.0	39.5	28.7	37.2	22.3	14.4	13.4	18.0	6.6	30.3	9.3	19.0	19.1	21.3	8.1	12.5	13.1	3.2	9.8	12.0	8.0	11.4	8.4	14.3	16.5	35.3	19.4	11.2	26.4	16.2	14.4	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5	6.0	5.6	49.1	25.7	23.5	14.7	8.1	22.9	0.0	0.0	21.0	13.7	83.6	29.9	61.9	8.5	23.9	135.7	0.0	95.6	50.7	20.3	31.1	16.1	44.1	39.1	19.1	39.6	21.5	20.8	2.5	11.5	25.8	30.4	58.7	75.9	22.0	80.5	108.7	15.6	34.6	14.8	38.8	29.9	25.1	10.6	32.2	79.1	52.4	64.5	33.0
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712600-57740973	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	29.5	40.5	33.6	21.0	39.0	13.7	30.8	26.5	60.5	28.0	40.6	50.7	29.0	33.3	22.5	36.7	32.7	25.5	20.0	33.0	32.6	32.1	47.4	71.7	24.4	22.1	40.4	30.4	25.9	40.6	49.8	25.8	26.2	45.3	31.1	49.3	38.4	27.9	34.4	21.9	21.9	34.0	26.1	42.3	25.4	29.9	19.1	31.3	24.0	34.4	25.8	27.0	22.2	22.6	17.7	23.1	17.9	37.5	16.5	21.8	18.8	28.5	33.5	19.3	34.7	36.0	19.3	21.1	34.5	26.8	34.0	28.9	31.8	49.2	26.8	38.6	27.7	50.6	52.8	48.8	27.6	36.1	19.2	21.2	25.9	27.1	31.8	29.7	36.1	35.7	23.6	40.4	37.6	60.0	18.7	19.3	22.6	44.4	31.7	37.9	14.6	21.3	41.2	37.3	53.3	46.0	29.0	24.2	56.7	42.3	32.3	22.1	31.6	26.6	61.9	38.3	19.6	55.3	23.9	16.1	32.1	21.0	42.7	35.6	31.2	60.8	27.1	36.1	25.7	47.5	15.9	19.6	17.9	17.1	33.1	21.6	17.7	17.3	20.0	19.0	15.3	21.8	21.8	5.2	16.5	37.5	23.1	14.3	18.8	33.6	39.0	26.5	60.5	32.6	32.1	40.4	30.4	45.3	31.3	35.7	30.6	38.1	36.3	28.5	43.9	38.7	40.8	34.8	34.2	47.1	29.5	94.9	36.5	67.4	1.6	34.9	38.2	0.0	37.5	68.8	35.4	39.2	42.7	45.2	57.0	28.6	27.6	33.7	27.3	1.9	45.1	35.0	45.5	31.5	45.0	90.9	45.2	35.1	41.1	38.0	52.4	38.8	26.2	56.1	68.8	28.5	83.3	22.4	61.2	41.0
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 9.9;Leydig cells: 8.3;Smooth muscle cells: 9.2;Spermatocytes: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.9;ASC TERT1: 32.9;HSkMC: 12.1;HUVEC TERT2: 28.1;LHCN-M2: 26.4;TIME: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.9	32.9	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.8	4.1	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.1	3.4	0.1	0.7	12.1	2.6	2.4	9.5	2.2	28.1	0.0	0.0	0.0	26.4	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.2	37.7	2.9	0.2	9.7	0.7	0.1	0.0	0.0	6.1	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1	0.0	0.3	0.0	0.6	3.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.0	3.7	0.4	0.0	0.0	2.7	0.0	9.9	2.5	2.5	0.4	8.3	2.8	1.7	1.0	2.8	0.0	0.1	1.1	4.9	0.0	0.2	6.5	9.2	16.8	0.4	7.3	0.0	0.0	2.6	0.4
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.2	0.0	1.6	16.5	1.2	1.2	26.9	0.6	0.9	7.8	0.0	0.0	0.0	20.4	0.1	0.0	1.1	0.9	1.2	0.0	0.9	0.2	0.8	27.9	0.7	0.0	0.3	7.8	0.2	7.8	0.1	0.5	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.7	9.6	1.7	0.0	4.5	0.0	2.8	0.1	10.7	1.8	0.0	0.0	46.5	1.3	0.0	0.1	0.0	3.9	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.9	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1	0.0	17.3	0.0	3.6	55.3	0.6	19.1	2.5	84.3	14.8	8.7	7.9	0.2	0.0	9.9	1.1	2.9	0.0	0.0	0.9	0.0	9.8	18.5	1.1	0.6	0.1	0.0	0.0	0.0	0.0	0.8	10.6	0.2	13.5	0.0	0.0	3.0	7.4	0.0	13.1	18.8	2.5	0.0	5.7	0.9	2.1	70.1	0.0	0.5	0.0	0.5
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183734-173207313	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.5;testis: 14.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;monocytes: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6"									HPA059579	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	2.1	4.0	1.7	8.2	2.3	0.9	3.7	4.5	3.4	1.7	1.8	1.0	0.8	0.3	1.5	1.5	1.6	1.4	2.1	2.1	3.0	2.0	1.5	1.6	2.5	11.5	1.9	0.8	2.7	2.1	1.0	3.3	1.2	1.2	2.8	2.5	1.0	0.8	1.0	0.8	0.3	2.5	1.6	1.9	9.7	1.4	14.4	1.2	9.3	0.8	0.8	3.7	1.6	1.6	1.3	2.6	1.7	0.2	3.4	1.2	6.5	0.0	0.0	0.2	0.5	1.3	6.7	0.0	1.8	0.4	0.1	0.1	0.0	0.0	0.0	0.3	18.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	8.1	0.1	0.0	2.9	0.1	0.9	0.1	0.6	36.8	0.7	0.0	0.2	30.6	0.0	0.3	0.1	0.1	0.0	0.3	0.9	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.3	0.6	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.4	0.6	0.1	0.1	3.4	2.0	0.0	0.2	0.3	1.1	0.1	0.8	1.1	0.7	0.9	0.8	1.3	1.2	1.1	1.7	3.4	0.1	2.6	0.9	6.5	1.7	2.3	4.5	3.4	3.0	2.0	1.9	0.8	1.2	1.2	0.0	0.3	0.0	0.4	0.7	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.1	1.2	0.5	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.3	0.2	1.7	12.6	0.0	1.0	0.2	0.0	1.8	0.0	0.3	0.0	1.9	0.2	0.2	0.5	0.0	1.5	0.0	0.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 79.9;Muller glia cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.9	2.1	0.3	0.0	4.7	4.1	1.2	3.3	2.2	17.8	7.4	0.0	1.5	3.8	3.0	6.1	2.8	1.1	3.6	0.1	4.4	27.0	1.5	0.0	9.5	5.3	30.8	2.9	3.0	1.9	0.4	7.7	19.8	4.5	9.7	0.0	0.5	0.4	1.7	6.8	8.2	14.2	7.7	0.0	5.1	7.1	6.4	0.0	0.9	1.0	2.5	0.2	4.4	2.2	9.0	1.3	0.2	0.0	3.5	9.0	3.0	0.0	0.0	0.0	0.9	6.0	23.0	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1	6.0	37.9	0.5	1.4	2.3	9.3	25.7	25.5	2.7	12.5	8.7	13.7	4.7	5.0	9.2	29.5	1.6	26.2	0.0	6.8	1.8	4.4	0.6	79.9	6.8	2.5	0.0	12.7	1.3	5.6	33.0	2.3	3.3	1.7	0.0	9.4	79.4	4.8	16.5	6.0	14.9	27.7	0.0	7.6	2.8	1.0	1.4	2.1	31.2	15.3	2.4
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"monocytes: 370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476"	"prognostic favorable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	49.8	16.8	8.9	32.2	10.7	35.8	68.8	10.1	11.4	16.5	38.8	10.2	22.9	23.8	13.6	21.2	28.9	11.2	33.2	30.1	8.9	8.7	27.8	34.3	29.0	35.1	11.2	7.2	14.6	42.2	16.4	9.5	15.7	10.6	18.5	17.4	13.9	18.2	27.6	61.7	19.5	37.2	21.0	10.7	39.5	20.6	9.9	10.9	21.0	19.6	27.7	41.9	20.6	35.0	10.9	7.7	26.0	7.4	7.0	12.5	5.3	23.2	16.6	3.1	11.4	12.4	12.6	8.4	11.3	36.1	10.1	19.1	15.8	31.8	19.5	38.2	15.1	59.6	14.1	5.1	82.9	12.4	33.3	7.2	7.8	9.3	10.2	23.8	8.7	35.5	18.0	15.4	16.8	34.9	28.1	14.4	7.8	4.8	19.4	25.1	8.7	9.4	12.0	2.9	8.2	9.2	7.8	24.5	25.9	31.6	17.1	4.5	10.5	8.7	27.3	11.5	9.0	14.0	11.0	22.1	34.4	11.3	5.9	16.0	39.0	20.1	8.7	37.2	12.9	8.2	9.7	7.4	20.4	7.8	6.8	9.1	8.4	9.0	7.7	5.6	10.9	4.7	5.1	26.0	7.0	6.1	7.7	12.5	5.3	8.9	10.7	10.1	11.4	8.9	8.7	11.2	7.2	10.6	10.9	53.6	47.9	57.0	38.7	26.4	14.5	44.5	43.3	34.8	43.3	26.2	3.9	15.1	61.3	215.3	2.7	46.5	218.6	23.3	121.4	25.8	41.8	84.1	47.3	52.9	35.3	17.5	35.8	41.7	42.7	5.6	25.0	50.8	25.3	370.7	58.2	18.6	194.1	86.5	22.3	40.4	14.0	32.3	51.5	2.3	13.4	25.0	40.3	63.3	62.8	120.2
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756376	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	16.7	10.3	7.8	14.5	14.0	18.9	32.5	3.4	12.4	9.8	26.4	7.3	7.1	16.4	11.9	10.1	14.5	9.6	13.7	26.6	7.4	6.5	23.4	16.6	16.0	17.9	11.2	4.7	12.3	24.2	3.5	11.4	15.3	12.4	13.6	10.1	9.7	10.7	13.5	21.9	10.5	37.2	23.9	12.2	17.8	15.3	11.7	11.1	8.1	14.2	12.3	18.2	15.1	33.7	9.8	7.3	20.9	11.8	4.4	11.2	4.7	12.2	16.7	5.3	8.0	17.0	11.7	23.0	13.4	12.0	12.5	12.2	19.1	19.9	11.2	15.2	14.6	28.1	8.1	9.5	15.4	7.4	8.7	11.9	13.4	9.9	21.1	21.2	10.9	17.0	15.1	14.0	13.8	12.5	9.7	17.8	10.3	13.6	15.9	8.6	25.4	14.3	27.0	13.9	18.3	28.6	9.5	8.1	5.8	13.4	13.8	8.0	9.0	10.4	10.9	14.7	9.6	12.0	16.1	20.6	9.7	10.7	15.1	20.5	16.5	11.2	8.1	17.7	19.8	10.4	6.4	7.2	20.9	6.7	11.2	7.2	7.8	10.2	11.2	7.3	9.8	8.4	7.0	7.1	4.4	11.8	3.4	10.2	4.7	7.8	14.0	3.4	12.4	7.4	6.5	11.2	4.7	12.4	11.1	6.0	9.8	20.6	45.8	54.5	2.1	12.0	5.1	6.7	11.4	14.0	2.0	44.9	11.6	51.5	2.1	31.7	65.3	0.0	52.5	89.5	32.8	52.4	12.7	14.9	31.4	0.0	18.4	28.8	18.9	5.4	19.8	35.5	25.3	104.6	33.4	10.0	53.3	52.6	16.6	33.2	6.5	19.4	37.0	15.8	60.0	69.1	80.0	34.8	32.9	71.1
TNNC2		ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"FDA approved drug targets, Predicted intracellular proteins"		"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 851.6"	"Group enriched"	"Detected in many"	6	"Enterocytes: 242.7;Mucus-secreting cells: 94.6;Paneth cells: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 9.9;HSkMC: 15.7;SCLC-21H: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		63000	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	12.0	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	2.7	4.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.0	7.8	0.1	851.6	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	169.1	6.6	0.1	0.1	6.0	0.8	2.4	1.1	0.3	4.1	11.9	0.1	0.0	0.3	0.5	1.7	1.2	1.8	0.2	0.4	0.0	0.1	0.2	1.2	0.4	1.2	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	9.9	0.4	0.3	0.2	15.7	0.2	0.1	0.8	0.4	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.1	11.8	0.6	1.7	0.1	0.4	0.5	1.4	0.4	0.5	0.3	0.4	0.9	0.2	1.6	0.4	0.3	1.6	0.1	0.2	0.0	0.7	1.4	0.2	1.1	0.7	6.0	1.5	0.2	0.3	3.8	0.0	0.3	2.4	0.3	0.8	0.8	4.1	11.9	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	3.0	1.1	4.2	0.5	0.7	1.3	0.4	2.5	0.0	4.5	3.5	0.0	2.1	3.3	1.3	2.9	0.1	242.7	0.0	4.7	0.2	2.6	0.7	0.0	0.8	0.2	0.0	22.0	0.0	0.0	26.3	1.1	0.5	0.0	0.0	94.6	1.4	2.5	103.7	2.8	0.7	1.7	0.0	3.6	2.3	5.8	7.3	0.1	0.0	25.8	0.5
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 50.9"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"RH-30: 106.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA		25000	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	106.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	50.9	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	2.7	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	21.7	19.8	37.1	16.0	35.7	17.8	13.5	33.1	44.7	17.9	13.9	23.2	12.7	13.4	20.7	20.9	22.9	22.4	15.9	20.0	31.1	24.9	14.3	10.1	13.7	16.6	24.8	36.6	32.9	16.0	26.6	19.1	16.1	22.2	16.8	15.9	18.2	15.1	20.0	15.2	36.6	12.5	23.3	25.2	15.3	12.9	24.1	20.9	14.9	17.8	9.9	17.8	18.9	14.7	1.6	4.3	2.6	1.2	0.4	3.3	0.7	17.6	13.5	20.8	26.5	12.7	16.8	13.5	20.4	13.5	29.6	20.9	18.4	9.6	12.0	16.0	17.2	8.3	23.6	36.8	20.2	16.5	14.8	29.5	18.5	21.2	22.3	14.3	32.6	17.8	14.9	16.0	19.6	20.9	19.2	13.8	24.4	28.7	11.5	16.3	30.6	27.3	22.5	24.1	13.1	40.8	26.3	16.2	22.0	17.5	12.9	51.0	25.3	16.6	21.1	10.1	14.7	14.7	11.6	13.8	45.5	12.0	24.3	29.9	22.9	22.0	20.5	13.5	29.7	16.1	0.6	0.9	0.3	2.1	0.8	3.0	1.5	1.5	1.7	1.2	1.6	2.7	3.3	2.6	0.4	1.2	4.3	0.5	0.7	37.1	35.7	33.1	42.1	31.1	24.9	24.8	36.6	22.2	20.9	6.0	19.9	11.8	8.5	27.5	38.9	15.9	17.8	6.7	9.1	21.0	94.2	9.1	5.0	8.3	9.5	17.5	10.5	0.0	7.3	5.6	14.7	12.6	3.5	15.3	8.9	54.0	22.0	18.4	11.3	15.4	28.7	9.5	8.5	10.8	17.0	24.7	13.1	5.8	30.4	14.6	32.2	6.5	17.8	24.7	10.0	36.3	12.1	11.5	15.0	8.0
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	14.3	68.4	10.5	10.4	15.7	19.6	29.5	11.3	13.4	20.9	24.2	23.6	24.2	16.9	7.9	12.9	30.2	17.4	42.7	21.7	12.0	11.8	22.5	57.5	17.7	7.5	12.0	10.2	21.5	74.4	30.2	20.0	5.6	13.9	24.5	18.3	36.5	32.4	56.0	60.4	44.7	26.3	23.7	11.9	6.1	28.8	9.0	13.1	8.9	30.3	31.0	13.8	38.8	22.9	7.8	21.3	63.0	25.1	4.8	51.2	25.2	11.0	22.8	7.4	3.0	14.0	7.0	5.6	8.3	20.6	5.4	6.7	9.1	14.3	10.1	16.0	11.3	5.4	15.8	5.0	14.1	5.7	5.0	7.3	1.2	26.7	15.0	19.5	5.1	5.0	14.9	17.5	6.2	32.3	7.3	2.6	3.1	4.1	8.9	11.4	30.1	4.0	4.9	2.6	27.8	8.7	3.5	9.4	12.0	21.4	23.0	4.3	10.6	14.1	42.1	4.9	11.9	66.4	6.9	3.4	6.3	4.4	6.9	3.9	13.6	14.2	4.7	5.1	2.6	2.4	63.0	10.5	49.9	46.6	18.6	51.2	7.8	43.4	36.4	21.3	6.2	38.4	46.2	23.6	4.8	25.1	6.9	35.9	25.2	10.5	15.7	11.3	13.4	12.0	11.8	12.0	10.2	13.9	13.1	107.2	101.9	31.7	161.4	251.6	130.0	101.0	127.4	71.0	51.2	64.6	53.0	14.5	87.9	38.8	73.3	29.2	99.6	23.3	47.3	1.2	76.4	113.9	61.3	179.4	31.5	17.5	195.2	33.2	33.0	32.8	24.5	54.0	67.4	26.2	199.4	88.3	38.3	178.0	56.3	51.2	56.2	161.7	81.2	43.1	8.3	201.7	9.2	75.9	142.2	265.3
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45339670-45343975	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	7.4	9.2	8.9	8.0	10.6	9.7	8.1	11.6	9.4	7.4	8.9	8.7	11.2	9.8	10.8	11.0	8.3	8.9	8.7	7.5	6.4	5.6	7.1	7.9	9.4	8.7	5.1	7.4	9.4	7.4	10.8	7.8	8.2	7.7	8.8	9.2	10.0	9.9	7.7	4.3	6.9	9.4	10.0	9.4	11.0	9.4	18.7	5.0	14.6	10.3	6.1	8.8	9.1	7.3	8.7	6.0	13.8	6.8	3.2	9.6	4.7	8.2	4.5	6.4	7.6	3.8	3.1	11.5	6.7	6.0	12.4	11.8	5.6	4.4	14.5	6.8	7.9	11.0	7.5	10.0	11.6	8.7	9.2	8.2	15.3	8.8	6.2	3.3	9.2	8.4	4.5	2.0	12.5	8.0	4.3	9.9	12.0	12.0	8.0	8.5	6.4	16.4	7.8	14.2	9.2	6.2	11.8	11.3	6.3	4.9	11.0	6.8	7.0	6.8	17.5	13.0	11.0	4.4	14.7	6.7	5.3	11.2	9.6	11.9	5.7	7.6	9.2	7.9	12.1	6.8	13.8	5.7	5.7	7.9	6.8	9.6	6.2	7.7	8.4	5.5	8.7	6.9	8.3	0.8	3.2	5.9	6.0	8.5	4.7	8.9	10.6	11.6	9.4	6.4	5.6	5.1	7.4	7.7	5.0	6.0	3.7	9.5	5.0	1.5	9.9	1.4	7.6	4.0	9.1	7.0	11.8	33.5	6.6	4.8	8.9	9.0	6.7	0.0	5.5	10.3	5.2	5.5	11.5	4.5	8.0	7.9	2.9	7.4	3.5	6.5	6.4	4.9	3.3	13.6	5.9	12.3	2.8	10.5	6.0	5.8	17.6	12.9	7.2	31.0	18.1	1.3	19.0	7.0	5.7	3.7
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 56.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.3	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.8	0.3	2.7	0.3	1.0	0.8	0.2	0.8	3.6	2.7	1.2	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	56.2	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444444	"Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 31.4;Enterocytes: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.4	2.8	1.4	11.0	1.8	11.7	1.9	6.1	2.7	1.9	5.5	1.4	3.2	5.5	2.2	1.8	5.6	1.7	1.3	1.6	1.2	1.1	2.0	2.3	2.6	3.7	1.9	1.2	2.4	2.3	1.1	1.1	2.6	2.9	2.1	1.7	0.8	3.1	2.2	1.0	4.0	6.8	1.4	1.9	5.6	3.5	4.8	2.1	10.3	3.3	3.6	5.3	3.9	5.1	0.6	0.1	0.0	0.2	1.9	0.6	0.1	6.9	6.2	4.7	7.4	0.3	0.6	11.4	5.9	1.1	3.6	2.8	5.0	6.1	6.5	6.1	0.9	1.7	4.8	4.6	3.6	0.8	6.7	9.1	15.4	8.0	5.2	0.2	4.7	9.7	0.6	0.5	3.7	0.7	0.9	1.7	9.0	17.3	4.9	1.4	14.4	11.6	8.0	6.7	6.8	9.2	14.1	3.1	6.7	2.0	7.6	7.9	4.5	6.2	4.2	2.6	1.9	6.0	4.4	2.0	4.4	18.4	5.0	7.2	1.7	3.2	3.9	4.3	10.0	5.1	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.2	0.6	0.1	0.6	0.5	0.4	0.0	1.9	0.0	0.0	0.2	0.1	1.4	1.8	6.1	2.7	1.2	1.1	1.9	1.2	2.9	2.1	6.0	31.4	5.2	3.3	7.9	2.4	2.1	10.2	6.7	5.7	1.8	2.0	2.5	0.0	1.0	0.2	2.3	32.9	0.0	0.9	4.4	4.1	3.1	2.3	8.6	3.7	1.6	2.4	4.3	1.6	0.2	0.3	5.8	13.5	1.0	8.4	0.8	0.8	5.7	1.1	3.7	2.5	6.5	3.3	2.8	8.1	9.8	1.0	3.9	9.6	3.1
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028818-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 670.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	26.6	31.0	24.6	46.3	25.3	55.3	37.4	39.6	31.1	21.3	30.0	11.1	26.7	29.7	22.9	22.5	36.0	20.5	29.2	21.0	23.0	18.3	31.8	32.7	37.9	38.6	21.9	20.9	25.5	22.5	22.2	39.9	43.9	25.2	23.3	27.2	13.6	25.3	34.3	26.2	24.6	48.4	23.1	27.4	36.9	26.7	14.2	24.2	54.2	31.5	25.1	40.6	25.2	41.7	9.0	17.2	18.4	11.1	5.8	8.2	4.6	22.0	15.4	28.9	23.7	11.7	14.0	28.7	20.0	17.6	23.2	21.2	40.5	27.8	62.9	21.4	10.3	24.8	21.5	34.7	31.9	34.1	13.6	17.7	80.2	12.4	28.7	30.6	34.5	27.6	15.8	17.0	22.6	37.2	20.8	24.2	23.0	34.7	21.9	26.2	49.0	48.8	21.9	23.3	22.1	28.8	41.7	27.2	33.4	24.8	20.5	24.1	16.7	31.3	19.4	20.3	21.8	21.6	30.9	23.7	18.8	16.0	17.4	21.4	13.9	15.6	73.3	25.3	19.4	17.8	9.1	9.2	14.3	6.5	9.2	8.2	9.0	7.2	6.8	8.6	8.7	7.7	6.9	18.4	5.8	11.1	17.2	7.9	4.6	24.6	25.3	39.6	31.1	23.0	18.3	21.9	20.9	25.2	24.2	110.2	181.3	71.6	274.4	218.4	93.3	38.9	84.1	73.6	228.6	94.2	56.9	139.0	63.0	78.8	6.3	78.8	108.1	210.2	57.1	149.4	129.3	136.7	76.2	114.3	86.4	68.3	88.0	63.8	84.7	6.5	55.3	93.8	69.2	72.1	73.8	94.4	93.7	112.2	65.4	91.4	80.4	84.1	77.1	95.2	57.3	187.2	670.2	61.2	78.0	206.2
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	34.3	45.6	58.1	26.6	2.9	5.9	12.9	47.1	25.4	43.4	38.5	21.4	26.3	55.4	24.0	15.9	26.0	54.7	44.6	18.8	58.3	29.5	29.8	36.6	29.2	35.6	0.2	51.2	39.0	1.3	1.5	30.5	31.1	9.4	22.8	36.1	39.5	38.0	46.8	11.9	59.3	34.4	24.1	24.9	18.2	50.4	90.2	23.0	10.4	22.0	34.3	24.7	38.0	47.5	15.0	35.3	39.8	23.6	14.9	28.6	40.4	33.0	45.2	21.8	24.6	48.3	16.1	35.3	47.7	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3	0.0	1.3	28.7	1.4	10.4	0.0	1.1	2.5	0.0	6.8	0.0	0.0	8.4	0.0	0.9	12.5	0.7	2.1	280.4	0.0	81.4	9.7	1.2	0.0	3.9	64.5	0.0	0.0	27.6	30.0	15.2	4.4	13.1	1.7	2.8	5.9	0.0	0.2	3.6	1.8	0.0	0.0	71.1	1.4	527.8	241.9	5.4	7.4	7.7	24.2	2.6
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805418-59119208	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 88.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 30.6;Intestinal endocrine cells: 44.1;Mucus-secreting cells: 25.4;T-cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 27.9;MOLT-4: 52.6;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	1.3	1.2	10.5	15.7	6.3	2.8	1.5	1.9	15.6	2.1	13.4	1.5	1.2	10.0	1.5	1.1	3.7	1.1	5.0	0.9	6.3	9.8	3.2	1.7	4.9	17.7	4.8	12.0	6.6	2.4	2.9	3.7	1.5	2.2	2.4	9.3	2.6	1.8	1.3	0.5	1.0	10.7	2.8	2.3	5.7	10.0	6.5	2.5	88.8	1.5	0.8	19.4	2.6	2.3	3.4	0.8	10.2	0.1	10.4	21.0	3.1	0.3	0.0	5.8	0.0	0.6	1.3	0.0	1.2	2.8	0.7	0.1	0.0	0.0	0.0	0.0	5.2	0.3	0.4	1.4	0.0	0.1	0.2	0.5	0.0	1.1	0.0	4.9	1.0	0.2	0.7	0.1	0.8	1.1	0.3	9.5	27.9	0.0	0.0	0.4	0.0	52.6	0.0	1.0	0.0	0.1	1.1	4.0	0.0	0.1	0.1	5.4	16.5	0.0	0.0	0.0	1.4	0.0	0.0	0.1	1.5	0.7	4.8	1.6	0.0	0.0	3.6	0.1	0.0	1.0	10.2	0.1	1.8	7.5	0.0	3.4	3.4	5.5	11.3	0.8	0.6	2.1	6.3	0.2	10.4	0.0	0.0	21.0	3.1	10.5	6.3	1.9	15.6	6.3	9.8	4.8	12.0	2.2	2.5	8.9	30.6	6.0	0.1	1.1	15.4	1.2	2.5	18.7	4.5	1.8	0.0	2.6	0.0	0.7	1.3	1.6	4.0	0.0	0.6	0.2	1.9	0.1	16.1	0.0	2.9	0.0	44.1	0.0	0.0	1.7	0.9	1.5	0.0	0.0	25.4	12.4	2.1	2.9	0.4	0.7	1.9	0.0	1.0	1.2	0.4	1.1	0.7	35.8	5.1	0.1
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52438005-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 18.7"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.7	3.1	7.1	5.0	4.7	0.0	3.9	0.6	6.0	7.0	13.5	6.0	0.2	9.4	1.3	9.2	0.9	3.0	14.8	0.2	3.2	5.3	9.5	5.8	2.7	0.1	5.4	3.6	1.0	7.8	0.0	5.8	0.3	5.1	1.8	15.1	2.7	11.0	0.7	0.3	1.1	13.5	0.9	7.0	0.2	18.7	0.7	4.7	0.0	0.2	0.3	2.1	7.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	1.7	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	10.4	0.0	0.0	3.4	0.1	4.7	38.0	13.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	4.7	0.6	4.3	3.2	5.3	5.4	3.6	5.1	4.7	6.0	5.1	0.0	0.2	0.9	2.6	0.6	40.8	17.4	6.8	33.2	0.0	0.0	3.3	1.4	2.5	0.0	22.3	0.0	4.4	0.0	0.3	13.0	0.0	4.9	0.1	38.1	59.2	1.3	0.0	0.8	0.6	0.1	0.0	0.0	31.7	158.0	9.8	8.6	0.0	8.6	1.5	0.0	0.3	0.0	0.7	0.3	0.0	0.0	28.7	1.1
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"CAB004083: AB_10694558, HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	7.2	12.9	13.4	9.0	20.7	8.9	9.6	21.9	22.9	17.2	10.0	12.5	10.1	5.7	14.6	15.1	7.0	13.8	9.8	10.7	13.9	12.9	8.6	4.1	8.0	7.2	7.1	14.8	15.9	7.4	30.0	34.8	10.7	17.9	11.4	9.5	7.9	9.8	12.3	7.9	8.2	7.2	15.0	7.9	7.2	7.7	18.3	9.3	15.2	16.2	4.9	10.8	11.5	11.1	5.4	3.5	3.7	1.9	2.1	4.8	1.8	5.9	10.2	29.8	18.6	12.4	15.4	7.2	10.3	15.6	14.6	18.7	8.7	7.2	6.4	9.1	17.5	31.5	14.8	21.4	12.6	17.4	17.4	7.3	12.2	17.8	5.2	8.1	13.4	17.6	11.9	8.9	19.6	14.7	24.4	17.2	11.1	11.9	5.7	16.9	4.1	10.4	6.3	19.1	10.9	6.3	11.2	11.2	4.1	10.9	14.1	26.9	12.5	14.8	6.6	4.0	23.8	13.7	7.6	12.3	15.7	10.7	12.4	9.1	4.6	9.9	15.1	13.1	6.6	8.0	3.7	1.2	2.5	4.1	1.9	3.5	5.4	4.4	4.1	2.9	4.9	4.8	4.4	1.4	2.1	1.2	3.5	3.4	1.8	13.4	20.7	21.9	22.9	13.9	12.9	7.1	14.8	17.9	9.3	20.8	18.2	11.5	8.9	5.7	34.5	12.5	7.6	69.6	28.4	27.9	45.2	11.0	8.3	12.2	30.9	14.8	3.5	0.0	6.2	9.4	15.3	10.6	25.5	3.0	9.2	44.5	40.2	11.6	3.8	13.9	21.9	6.0	1.7	1.8	14.2	12.9	7.1	3.5	16.6	5.9	54.7	12.9	8.1	30.7	34.0	4.5	15.4	11.7	12.0	7.0
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	2.0	0.1	0.2	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.5	3.2	2.0	1.6	0.0	0.7	3.4	2.1	0.7	0.0	0.6	6.9	0.1	3.2	2.0	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.6	1.5	11.4	1.5	0.4	0.0	0.1	0.0	9.3	0.1	0.2	3.0	14.6	6.8	0.3	0.0	0.6	0.0	8.7	7.1	0.0	2.3	6.2	0.0	4.5	2.7	0.5	14.6	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3	0.0	1.0	0.0	3.9	2.7	0.5	1.2	0.0	17.4	7.9	0.0	0.0	0.2	0.0	0.0	18.5	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.0	10.0	0.6	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	0.0	0.0	0.1
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	115.0	103.1	54.7	84.5	53.6	56.6	96.6	83.3	92.0	157.5	191.0	106.5	63.3	67.6	16.8	82.2	81.5	57.3	130.0	139.2	174.7	89.1	96.8	87.5	75.6	70.2	39.9	99.6	71.9	61.4	58.1	121.4	104.7	221.1	95.7	34.4	45.2	26.0	120.8	84.7	52.3	84.2	134.8	98.1	65.8	30.7	90.0	69.3	98.6	82.2	38.9	64.8	72.7	75.6	40.3	119.8	17.3	74.9	59.1	84.5	72.3	54.6	122.1	50.8	20.8	100.9	169.5	62.0	60.6	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4	125.0	186.6	268.1	429.8	608.3	247.2	505.0	410.2	145.9	159.3	369.9	104.1	935.0	1278.3	1116.4	147.7	369.6	973.7	70.0	686.0	1611.5	538.5	310.9	357.6	425.4	827.4	281.3	408.6	284.8	382.5	523.4	258.3	552.8	639.4	1545.5	419.4	603.3	953.1	852.2	247.5	1236.2	208.3	194.1	473.8	15.1	66.8	538.4	1279.9	363.9	717.3	571.4
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.8	13.1	33.0	16.8	9.6	7.6	18.2	25.8	16.7	28.5	22.6	21.1	16.8	30.8	31.1	13.2	19.7	20.8	36.1	25.1	33.6	25.9	22.9	28.8	11.9	28.0	12.8	30.5	23.3	7.3	12.5	16.8	16.3	9.2	21.8	15.4	27.5	19.7	21.8	16.7	75.5	44.3	49.2	31.1	20.5	45.9	26.6	35.9	27.7	13.9	24.5	24.4	17.0	24.0	30.4	17.7	24.2	33.9	12.4	19.3	25.3	16.1	38.8	36.3	88.4	57.5	19.9	35.5	30.4	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1	59.6	114.4	168.3	155.0	229.4	101.5	57.6	104.4	62.9	102.4	66.3	184.6	157.7	61.3	105.4	125.7	154.8	106.8	233.6	94.8	196.4	163.4	151.8	191.8	78.1	151.9	68.3	218.4	179.9	244.9	31.1	118.2	213.7	128.2	216.4	142.0	89.2	85.0	121.0	110.3	42.8	196.4	103.5	173.1	132.6	147.0	227.8	179.8	202.0	165.8	133.4
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185915-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	8.9	10.3	8.3	28.8	13.4	45.5	12.0	15.3	11.4	10.6	14.7	7.4	19.9	15.9	9.3	15.6	19.9	9.2	18.1	10.0	9.0	4.9	13.4	20.0	13.1	25.6	12.4	6.1	10.2	42.9	5.9	12.0	9.6	9.5	14.8	6.0	8.4	24.6	19.5	14.0	13.0	18.3	9.3	9.6	19.5	16.5	9.7	11.8	21.0	13.2	13.2	33.1	11.5	13.1	6.9	33.0	23.0	14.2	14.7	13.6	9.2	22.6	15.0	5.4	8.9	2.9	3.5	13.7	7.9	5.2	6.6	5.6	9.5	10.9	14.1	7.8	3.6	5.2	14.2	6.9	14.0	1.3	9.8	32.5	8.0	23.3	16.0	11.7	16.4	16.1	5.6	8.6	4.8	6.6	3.8	6.4	13.6	9.9	23.0	2.8	25.1	11.3	18.6	7.9	7.6	14.3	31.7	7.4	29.6	5.1	22.0	6.3	10.7	6.8	24.6	11.2	2.4	10.5	16.6	7.1	5.6	13.8	7.2	8.8	28.1	4.9	16.8	6.8	11.4	8.6	7.0	14.2	23.0	10.9	12.5	10.2	6.9	9.8	9.8	15.4	3.6	6.7	7.7	19.5	14.7	7.6	33.0	13.6	9.2	8.3	13.4	15.3	11.4	9.0	4.9	12.4	6.1	9.5	11.8	8.9	22.9	69.8	39.9	37.4	31.1	8.3	12.7	13.4	18.2	31.4	17.7	22.9	23.2	46.8	13.0	20.2	51.8	0.0	54.3	43.7	24.4	43.9	27.6	21.2	42.8	41.3	17.3	12.3	48.9	6.3	30.0	57.1	40.5	126.2	38.4	28.4	67.6	66.2	30.4	24.5	29.9	19.4	25.5	52.8	29.8	39.9	25.6	58.6	43.9	81.4
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125501-112153609	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"monocytes: 186.7;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	15.1	13.1	11.0	21.9	19.2	20.5	16.6	11.9	19.8	15.6	31.6	42.1	15.2	12.7	15.1	12.8	26.0	12.8	14.0	16.9	12.2	10.8	12.7	12.5	21.2	25.5	26.2	10.7	15.3	10.2	15.3	14.9	15.5	22.2	18.5	16.8	22.7	16.4	16.7	10.3	28.1	16.0	20.5	25.0	25.0	15.2	30.9	23.4	28.2	13.0	13.0	29.7	25.6	17.4	13.2	11.4	59.1	21.4	14.8	13.8	19.3	10.7	12.2	19.8	18.4	13.5	12.9	10.2	12.3	17.9	17.5	13.9	13.1	9.8	12.2	10.6	13.0	7.5	21.9	19.2	12.1	11.8	21.3	18.3	19.9	17.3	7.1	23.5	12.3	31.0	16.6	20.5	12.4	17.0	17.5	15.2	7.7	22.2	7.6	11.0	18.1	13.5	16.9	16.2	13.1	14.4	19.2	12.1	20.6	11.3	40.6	16.8	13.0	25.6	25.3	6.8	15.5	16.4	17.1	9.7	8.0	5.7	7.8	6.5	18.5	16.3	13.1	8.5	9.7	8.6	59.1	21.4	48.3	10.7	19.4	7.3	13.2	10.5	9.6	11.4	12.2	9.7	8.9	42.8	14.8	20.0	7.5	13.8	19.3	11.0	19.2	11.9	19.8	12.2	10.8	26.2	10.7	22.2	23.4	17.9	9.6	8.8	6.8	10.9	7.0	8.9	7.6	4.0	13.6	12.2	23.6	17.2	5.0	18.4	1.0	9.5	9.3	0.0	18.2	12.6	12.4	16.5	11.5	4.0	13.2	14.3	15.0	8.6	12.5	1.7	10.9	14.1	6.8	186.7	9.2	8.8	21.6	14.0	12.0	4.2	10.9	0.0	6.4	51.7	15.3	13.2	22.1	9.6	9.7	9.0
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.5	6.6	13.1	5.6	9.2	9.0	17.2	10.2	11.5	6.7	7.3	4.3	10.7	14.8	5.4	25.3	7.3	3.6	9.1	23.5	7.3	13.4	6.5	10.2	6.7	12.1	4.6	11.6	8.1	7.7	10.1	14.8	13.6	9.7	13.4	4.0	5.2	11.9	8.5	3.1	1.2	6.1	5.7	20.6	5.1	5.4	4.9	12.4	9.2	57.0	8.5	9.9	3.9	5.7	5.4	11.4	5.1	9.8	13.7	5.8	6.9	34.8	5.9	8.9	7.5	13.4	6.4	10.2	5.6	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6	29.8	26.7	25.6	13.5	33.8	21.5	240.0	28.1	84.3	35.2	14.0	94.2	20.3	1.7	9.5	1.0	20.2	61.3	0.0	10.9	15.7	10.1	17.2	10.4	8.5	13.4	31.8	21.9	4.3	13.9	2.7	1.7	23.7	23.6	4.6	35.6	32.5	17.2	36.5	2.5	7.9	131.7	32.3	18.4	0.7	3.6	37.8	13.2	5.3	28.1	23.2
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 239.6;Late spermatids: 372.4;Spermatocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	18.2	17.3	15.2	19.7	19.7	14.6	12.8	18.3	25.3	20.3	16.4	21.1	15.2	15.8	19.7	14.4	16.7	14.8	17.9	26.8	16.0	15.6	16.1	29.2	16.8	22.0	15.4	15.6	19.3	16.4	16.5	20.4	12.8	20.6	18.5	8.3	16.3	24.4	16.9	40.7	41.3	17.6	16.4	13.1	19.9	17.1	50.8	12.2	23.2	16.8	17.3	18.6	16.9	14.1	1.0	7.5	6.0	5.5	1.4	3.9	1.2	8.4	14.7	4.8	5.5	10.9	13.6	12.8	13.9	3.4	4.1	2.2	9.2	7.1	9.7	15.4	4.7	3.6	10.9	5.6	6.2	1.6	11.6	21.0	8.3	4.2	31.2	4.9	10.4	15.0	9.9	4.8	4.5	11.5	3.1	3.5	11.3	12.9	5.3	7.2	11.8	10.4	17.9	11.9	3.7	20.8	7.9	6.6	7.7	4.4	7.0	12.5	20.3	5.5	6.3	9.1	2.2	7.3	8.4	9.0	10.1	5.7	10.0	12.2	15.3	11.2	7.6	11.7	8.2	5.5	1.2	1.8	6.0	1.4	4.1	3.6	0.9	2.3	3.8	2.4	1.0	1.6	1.9	1.7	1.4	5.5	7.5	3.9	1.2	15.2	19.7	18.3	25.3	16.0	15.6	15.4	15.6	20.6	12.2	8.9	10.9	22.3	14.0	10.2	31.0	55.8	20.4	10.7	4.5	12.2	31.4	18.9	49.7	18.3	239.6	14.6	14.7	0.0	15.7	12.5	15.8	12.4	5.7	13.1	22.8	25.4	3.4	10.4	12.6	372.4	24.5	13.7	15.1	30.7	15.7	39.8	19.8	10.5	22.6	22.6	37.7	25.8	18.6	93.2	21.0	15.6	14.8	7.1	14.0	10.5
TRAPPC13	"C5orf44, FLJ13611, FLJ26957, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65624716-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.4	12.9	16.1	10.3	22.5	7.5	14.0	14.5	22.7	12.1	11.3	12.8	10.2	9.8	11.9	10.4	13.4	9.7	9.8	17.7	17.1	17.7	21.6	16.9	11.0	10.2	17.3	14.2	10.1	8.2	20.6	22.4	11.8	19.5	20.6	14.3	10.5	9.9	12.4	15.2	8.0	13.3	13.9	18.9	10.7	11.0	10.6	15.1	18.0	18.7	11.7	10.8	11.5	9.9	6.6	10.1	14.7	13.7	9.1	13.1	9.8	12.8	8.7	13.8	24.8	10.7	13.7	13.3	15.3	13.9	18.9	20.8	7.4	18.2	13.1	16.9	12.3	20.4	11.9	15.6	15.9	22.4	9.1	11.5	8.4	10.9	6.8	14.6	10.2	12.7	9.7	12.6	14.7	19.0	11.5	16.7	19.2	10.0	12.5	16.7	13.5	17.0	3.9	6.3	7.6	4.7	14.9	17.3	15.2	13.8	14.7	17.4	12.5	18.7	11.3	14.0	8.0	16.4	13.4	11.4	6.7	9.3	14.8	15.4	8.3	16.0	20.9	14.1	18.5	12.7	14.7	9.4	3.8	10.1	10.1	13.1	6.6	9.9	8.4	10.1	5.4	9.9	9.9	3.6	9.1	13.7	7.6	10.4	9.8	16.1	22.5	14.5	22.7	17.1	17.7	17.3	14.2	19.5	15.1	17.9	10.9	3.7	6.2	5.0	12.2	5.9	15.3	9.4	6.8	7.0	9.8	10.4	13.3	10.8	15.5	11.2	7.9	0.0	9.3	8.2	8.5	9.8	3.5	9.7	10.9	12.7	14.9	8.6	12.6	7.9	6.9	9.9	6.8	10.0	8.4	11.8	8.6	3.5	12.4	18.9	14.3	6.5	10.1	15.1	8.0	5.9	12.7	8.3	8.3	10.8
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443961-120446412	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	11.7	16.8	10.6	12.5	13.1	14.6	20.6	9.1	12.4	9.4	12.5	8.0	12.0	10.0	9.9	11.6	15.4	9.3	12.7	17.3	13.6	8.3	12.5	34.5	14.2	13.6	15.5	11.9	7.7	36.5	5.7	8.6	17.8	13.5	12.4	17.0	6.8	19.3	8.6	29.1	16.8	12.1	11.1	10.4	12.3	12.3	11.2	11.6	11.7	11.2	21.5	13.9	12.0	10.0	17.4	28.2	9.0	24.8	22.2	25.5	19.6	15.9	21.9	20.1	13.7	17.5	27.1	48.2	21.0	15.0	18.7	15.5	18.2	8.9	31.7	17.9	17.1	7.5	11.0	23.3	34.7	19.8	14.0	26.0	19.2	15.3	47.8	26.1	32.2	14.9	27.9	43.8	18.3	26.3	18.8	38.6	17.6	30.7	8.2	27.2	20.1	24.1	43.5	28.7	19.6	17.8	20.1	19.0	32.8	24.0	17.9	19.8	13.0	24.2	8.3	17.9	33.2	27.8	18.9	21.8	12.1	18.2	12.1	12.7	21.2	33.4	34.0	18.5	25.0	21.0	9.0	22.0	8.0	20.7	24.8	24.9	17.4	20.3	19.7	28.2	15.8	25.5	22.0	1.9	22.2	16.5	25.4	17.6	19.6	10.6	13.1	9.1	12.4	13.6	8.3	15.5	11.9	13.5	11.6	3.0	14.6	36.3	21.1	45.4	8.2	10.2	45.9	17.4	6.8	7.0	5.9	113.6	56.3	43.3	5.9	25.3	16.1	0.0	43.5	66.9	27.2	25.9	17.3	49.7	46.9	3.2	21.2	22.7	22.8	3.9	15.3	20.8	37.1	53.3	21.2	9.4	40.3	14.0	17.3	36.6	9.3	19.4	26.9	34.9	34.6	62.4	63.0	29.9	38.3	23.3
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 89.7;Muller glia cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 24.8"	"Group enriched"	"Detected in many"	9	"B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.0;HEL: 40.3;K-562: 54.8;SK-MEL-30: 40.0;WM-115: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	19.6	30.9	13.2	17.7	13.3	7.0	23.2	23.2	23.0	10.8	12.3	10.5	6.7	8.7	23.0	22.6	8.1	11.6	14.5	18.2	15.0	10.8	24.8	10.6	18.9	33.0	13.4	16.2	52.3	14.4	6.6	11.3	23.0	15.5	16.3	6.9	35.7	9.9	13.6	6.9	8.2	11.9	17.6	10.4	38.9	19.5	13.9	10.1	37.3	12.1	6.2	33.4	21.9	23.2	7.1	0.6	1.5	0.1	9.5	24.8	4.5	0.0	0.0	31.3	41.0	11.3	10.4	0.0	1.7	1.6	1.1	1.8	0.2	3.4	3.5	1.2	3.7	0.2	0.5	2.3	3.5	0.9	3.9	6.4	40.3	0.1	0.6	14.0	2.2	15.4	9.6	3.6	4.5	1.2	11.1	4.9	5.3	54.8	0.0	1.7	0.3	5.1	9.6	14.8	1.5	4.0	0.0	10.4	1.4	7.1	5.1	26.9	12.8	0.2	1.6	40.0	9.8	0.0	0.2	3.0	14.9	7.5	0.1	3.8	0.0	0.0	5.0	8.0	7.9	54.9	0.8	0.1	1.5	7.3	0.0	8.8	5.3	14.4	7.7	0.6	7.1	8.5	5.2	0.3	9.5	0.1	0.0	24.8	4.5	13.2	13.3	23.2	23.0	15.0	10.8	13.4	16.2	15.5	10.1	3.0	8.8	8.0	10.2	5.5	46.7	13.3	20.4	6.7	11.4	15.7	29.5	1.9	6.6	13.3	3.9	36.4	0.0	0.0	89.7	0.1	7.1	10.3	33.5	5.4	4.4	19.1	0.0	63.3	5.3	10.7	71.7	2.5	28.7	1.8	0.0	115.1	49.1	0.0	70.0	0.7	66.1	51.8	22.5	0.9	2.7	4.6	0.7	20.8	0.0	11.1
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.9	13.2	7.1	9.7	5.4	4.4	33.6	9.1	6.1	10.6	8.5	16.1	12.2	10.5	10.2	6.1	7.0	22.7	8.6	8.8	4.5	11.6	20.6	8.7	12.2	8.6	14.6	10.9	13.2	6.0	14.0	11.0	5.5	5.4	5.2	17.2	19.7	13.5	5.4	9.0	13.2	17.2	18.1	11.8	11.7	13.0	6.4	12.6	6.9	17.1	11.9	21.8	7.6	21.6	12.0	3.0	15.3	18.3	5.8	6.8	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.8	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8	3.0	7.2	3.9	12.3	14.1	12.6	2.8	7.6	4.0	7.9	1.8	2.0	13.8	14.9	13.0	105.9	8.3	22.7	0.0	9.7	12.0	7.0	15.1	5.7	4.9	10.0	4.8	13.8	6.7	10.0	12.4	8.9	9.7	5.0	25.2	16.1	8.1	14.3	17.3	7.1	6.3	1.7	6.5	9.7	5.5	11.8	16.9	47.9	24.9	13.4	22.9
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689689-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 48.4;HSkMC: 42.4;TIME: 33.7"									"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	34.3	6.9	8.8	32.8	13.3	22.2	17.3	3.2	10.3	14.4	12.2	10.6	15.1	6.5	20.0	18.9	17.6	17.2	20.2	12.4	10.3	6.6	13.9	19.3	29.8	62.2	15.5	6.5	21.9	5.6	2.1	8.1	9.4	13.3	20.4	13.7	15.0	17.2	14.6	7.1	7.8	28.7	13.5	22.9	65.4	11.2	6.3	12.0	35.6	15.5	13.4	40.6	19.8	13.5	49.0	55.2	33.0	50.3	18.0	58.1	47.3	0.8	0.2	3.4	0.6	18.7	37.6	1.1	11.0	19.3	21.0	48.4	0.3	2.2	23.2	3.4	15.6	4.9	2.3	7.7	11.5	2.1	0.5	0.0	1.3	1.3	0.4	24.5	3.5	2.2	42.4	10.9	4.2	1.9	26.0	25.8	0.2	0.5	1.2	22.8	0.4	12.1	3.7	9.9	0.1	1.2	15.0	0.8	0.5	11.0	3.6	0.4	0.8	1.0	1.0	0.5	13.6	1.2	3.9	33.7	13.0	7.1	0.6	0.6	1.3	1.1	2.6	16.3	6.5	1.7	27.4	35.7	23.8	35.8	43.5	47.0	46.5	39.0	37.8	42.8	49.0	35.2	33.7	33.0	18.0	50.3	55.2	58.1	47.3	8.8	13.3	3.2	10.3	10.3	6.6	15.5	6.5	13.3	12.0	62.5	55.5	76.7	13.5	11.2	0.6	5.6	7.6	41.5	44.3	27.9	0.0	1.0	5.0	10.5	0.1	36.1	2.0	0.0	7.2	3.3	14.7	9.9	16.3	4.9	18.1	1.6	4.1	26.4	62.2	0.2	33.4	49.6	5.0	13.6	7.8	8.0	3.9	5.8	28.3	2.6	0.9	12.9	14.5	0.5	0.2	7.5	1.9	55.8	3.8	16.3
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	11.9	12.6	10.6	20.0	12.2	13.8	13.2	17.6	14.9	10.7	16.1	15.9	14.5	18.5	12.9	18.4	21.5	21.1	18.6	8.4	10.8	11.3	19.5	19.2	12.2	21.3	13.1	8.1	10.9	15.3	16.3	11.5	10.8	12.3	13.4	9.8	17.7	18.4	20.6	9.9	21.5	21.9	14.2	13.1	17.6	15.2	10.9	14.0	13.7	15.8	10.7	21.7	14.7	24.6	3.6	3.8	1.7	4.2	2.1	4.1	3.6	10.2	2.2	0.0	14.5	4.8	2.9	4.8	2.8	3.3	7.3	7.2	0.0	0.4	23.0	8.3	7.1	10.1	11.7	0.0	10.0	2.3	0.0	6.7	3.6	1.6	8.3	4.5	4.5	2.9	3.0	3.5	7.3	4.6	0.0	4.5	11.0	1.6	0.0	0.0	0.0	7.5	11.1	0.0	0.0	3.9	9.9	6.9	3.4	6.0	9.6	0.4	6.2	10.6	4.6	2.9	2.5	3.6	1.5	7.6	5.6	3.9	0.0	0.1	9.2	16.4	12.1	0.0	13.0	9.0	1.7	3.1	0.5	3.9	4.2	3.2	3.2	2.9	3.8	3.8	3.6	1.8	2.7	1.7	2.1	2.6	1.9	4.1	3.6	10.6	12.2	17.6	14.9	10.8	11.3	13.1	8.1	12.3	14.0	26.8	17.1	17.1	21.1	26.8	20.4	11.8	22.9	28.1	13.6	12.2	15.7	16.4	10.0	13.3	0.3	16.1	16.5	0.0	13.7	10.8	12.8	21.2	4.7	45.0	12.2	12.7	21.5	8.6	13.2	1.3	6.9	20.9	16.9	17.2	13.7	11.2	10.2	14.2	11.3	13.0	18.9	6.5	12.5	2.4	12.6	29.6	14.8	22.4	13.3	19.5
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	13.1	7.1	13.4	10.0	5.7	6.0	22.9	6.7	7.2	9.4	10.0	8.0	5.6	14.1	7.0	7.8	6.1	7.6	12.2	7.8	13.0	10.6	7.2	13.6	9.4	9.3	6.3	17.1	11.3	5.7	5.8	11.1	11.4	7.2	7.8	12.0	16.9	10.0	8.9	49.4	17.2	7.3	18.1	5.0	7.2	14.9	20.5	4.6	6.7	20.7	9.3	9.8	12.7	15.4	12.1	9.0	7.0	9.4	8.8	6.5	10.6	15.1	9.4	7.0	6.5	14.7	9.2	10.0	18.5	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3	17.9	29.5	19.1	25.9	46.9	71.6	22.0	25.5	10.7	25.0	52.4	92.3	49.7	1.7	18.3	155.1	31.1	23.6	23.3	20.5	27.8	32.1	38.2	36.9	40.5	26.3	25.4	50.1	37.4	44.7	78.9	45.5	39.2	18.6	17.2	31.4	33.5	25.3	32.6	34.6	12.6	58.2	32.3	23.7	54.0	29.6	48.4	73.3	35.5	28.9	48.8
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Group enriched"	"Detected in many"	39	"Early spermatids: 1875.0;Late spermatids: 3810.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	8.8	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	1.4	0.0	8.2	0.1	5.9	1.7	3.3	1.1	3.8	4.9	0.4	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	0.6	4.3	5.4	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7	0.0	4.3	0.0	0.8	2.1	4.8	2.0	0.0	6.7	0.0	1.8	53.0	0.0	0.0	0.4	1875.0	0.7	21.6	0.0	1.6	0.4	0.6	8.8	1.1	0.0	2.5	4.8	3.4	0.6	1.6	3810.8	13.8	6.3	8.5	5.4	11.8	5.7	1.4	9.1	12.0	0.0	73.6	6.5	2.8	33.1	23.0	1.1	0.2	0.0	7.0	0.1
TRIM42	"FLJ40097, PPP1R40, T4A1"	ENSG00000155890	"Tripartite motif containing 42"	Q8IWZ5	3	140678039-140701150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 43.2"	"Group enriched"	"Detected in some"	113	"Early spermatids: 249.5;Late spermatids: 89.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003581, HPA022481"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003581: AB_1080383, HPA022481: AB_1858301"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	249.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"blood: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	199	"basophil: 19.8"	"Lineage enriched"	"Detected in single"	199	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 2.1"									HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"blood: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	160	"basophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.5"									HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0		0.1		0.6	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.3	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.6			0.0		0.0	0.1		0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	18.8	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	13.2	7.1	7.6	12.9	15.0	9.3	13.6	11.0	14.6	5.4	5.3	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	7.2	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0	68.5	72.4	41.5	67.9	4.6	3.2	19.1	89.2	77.6	52.4	48.8	2.0	33.7	3.3	51.6	1.8	75.8	45.5	23.3	41.2	22.2	26.5	58.9	14.0	41.9	17.0	9.5	28.1	86.5	38.1	0.8	122.6	36.3	1.7	21.6	43.9	23.6	46.8	49.1	88.8	6.7	2.8	64.7	27.4	4.7	6.6	2.9	24.9	62.3	41.9	50.8
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608259	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	7.7	11.3	11.1	8.0	11.1	3.1	10.6	15.2	12.8	16.3	10.9	12.6	18.2	10.3	10.6	12.2	8.0	12.6	10.3	9.4	9.6	7.9	14.9	12.7	11.7	7.6	13.1	10.5	17.3	9.9	12.6	10.5	9.8	10.0	16.8	10.1	9.9	12.0	17.5	8.7	7.6	9.8	9.8	11.9	10.7	12.4	13.2	9.5	10.0	17.8	6.7	8.9	11.7	8.4	9.1	5.9	8.9	5.2	5.5	12.8	7.6	8.4	9.5	3.9	6.4	6.4	10.5	0.0	9.3	6.9	8.5	7.8	1.2	8.8	5.8	5.7	4.7	8.1	10.0	3.9	6.5	7.3	14.4	7.6	7.1	2.4	0.0	7.4	11.3	10.0	8.1	9.6	5.0	7.6	8.9	10.7	5.4	6.5	3.0	7.6	2.0	9.3	3.1	4.6	5.9	7.9	7.5	5.6	0.2	5.5	3.8	2.1	3.8	0.0	9.5	5.9	8.1	4.1	5.7	8.6	11.4	7.9	11.5	4.1	11.9	12.9	8.4	7.9	5.0	10.7	6.4	2.7	8.9	9.0	5.1	10.1	9.1	9.9	10.0	5.9	7.9	12.8	10.1	0.3	5.5	5.2	4.0	8.7	7.6	11.1	11.1	15.2	12.8	9.6	7.9	13.1	10.5	10.0	9.5	0.0	2.2	0.9	1.1	0.7	3.7	4.3	0.0	0.0	6.8	5.2	2.0	4.9	5.0	2.5	0.4	2.2	2.3	0.0	2.9	2.1	1.6	1.8	3.5	4.5	2.0	0.0	6.4	3.1	2.2	0.0	1.7	1.5	0.0	2.8	5.9	3.7	2.4	0.0	1.8	1.7	2.7	6.5	2.1	2.6	4.3	0.9	3.7	1.3	4.3	0.5
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.2	0.2	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.7	0.3	0.2	4.8	0.2	1.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.5	8.9	0.2	0.1	0.4	0.2	0.1	0.3	0.3	23.1	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.3	0.2	2.0	0.1	0.2	0.3	0.2	0.1	14.4	1.2	0.2	0.2	0.4	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	6.7	0.0	2.0	0.1	0.8	2.6	0.0	0.0	4.5	0.0	2.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	1.4	1.1	0.0	0.2	0.0	0.0	0.6	1.9	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	1.6
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 342.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.8	16.3	5.7	8.6	22.5	23.7	20.6	17.4	20.1	19.9	17.4	22.1	15.5	0.5	23.5	14.6	16.1	20.0	12.9	25.3	11.8	16.9	5.2	8.7	15.4	16.8	18.5	0.4	2.8	27.3	17.2	17.7	13.6	26.3	20.4	1.2	12.7	7.4	14.5	9.1	2.3	6.0	12.1	16.8	13.9	3.9	11.8	7.8	16.7	13.4	0.0	6.6	22.8	10.3	6.5	13.9	10.7	4.7	39.7	13.4	24.0	34.9	18.2	7.8	4.2	2.6	21.7	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4	26.8	20.3	3.7	99.7	75.9	13.2	7.5	17.8	9.4	30.7	15.7	35.3	6.1	5.0	41.3	9.7	37.9	25.1	0.0	33.6	32.8	73.7	86.2	27.8	3.4	8.7	0.0	7.5	38.1	4.0	10.0	51.8	30.9	35.4	342.7	15.5	11.4	60.8	24.3	33.9	18.2	16.8	32.3	85.5	1.9	5.9	72.8	11.9	4.3	21.7	106.3
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	13.0	15.0	10.5	10.8	12.5	7.7	12.1	18.5	14.1	17.4	13.0	8.8	15.2	11.1	13.3	12.7	14.7	11.4	11.2	12.9	9.2	6.7	15.5	16.1	10.6	9.4	12.2	11.1	16.0	27.1	27.1	34.9	24.4	15.2	14.5	11.0	9.4	15.1	15.3	24.0	12.4	15.9	11.2	10.7	15.2	16.2	14.0	13.5	16.4	18.4	11.1	11.9	15.8	12.5	20.0	12.7	17.0	13.0	12.1	14.1	3.9	12.5	12.8	8.3	8.8	14.7	22.8	12.6	20.0	15.4	10.0	11.4	7.7	20.5	8.8	14.8	17.6	7.8	16.6	10.9	9.7	21.8	13.4	3.3	9.9	11.5	7.3	11.2	11.6	9.9	8.7	11.9	17.6	15.1	11.1	15.8	4.9	6.5	10.2	15.5	17.6	6.6	2.9	3.8	12.3	9.2	8.2	16.0	4.4	8.9	20.6	6.1	5.5	16.2	9.5	6.2	8.8	20.8	5.9	20.9	11.6	8.2	12.0	9.0	9.1	13.9	8.0	13.6	6.6	14.5	8.2	8.8	17.0	13.3	8.0	12.8	11.8	14.1	12.1	6.9	20.0	13.5	14.1	8.7	12.1	13.0	12.7	12.2	3.9	10.5	12.5	18.5	14.1	9.2	6.7	12.2	11.1	15.2	13.5	50.6	65.6	24.1	27.5	14.7	56.7	99.6	35.7	71.0	62.6	36.6	68.7	34.2	14.9	55.0	10.9	42.7	24.5	0.0	40.6	23.8	31.0	32.3	35.9	30.6	22.0	41.3	30.9	30.7	25.7	8.5	57.5	21.2	6.8	33.3	38.0	54.1	40.4	28.1	50.9	21.4	64.7	58.2	23.7	107.2	64.1	14.9	60.6	21.0	28.1	33.1
TRIP4	"HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: AB_2681211"	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	17.1	14.7	14.2	18.8	15.1	13.7	18.3	15.9	19.6	14.3	20.8	16.6	23.5	17.5	17.1	14.6	22.6	15.3	15.6	15.5	12.4	11.2	28.5	15.8	15.3	15.0	17.1	14.6	15.9	19.9	22.9	19.6	19.3	15.3	15.7	20.4	12.7	16.5	13.6	14.6	20.6	26.2	17.3	15.7	20.0	17.4	15.0	14.4	28.0	27.1	17.4	18.6	16.8	17.5	8.6	10.4	30.9	19.7	9.7	11.5	8.3	10.6	15.9	14.0	9.9	11.6	15.3	13.2	11.3	14.7	19.7	19.2	13.2	24.0	7.7	3.8	17.2	16.1	15.2	22.7	13.0	18.9	15.5	6.4	11.2	11.4	13.9	20.7	12.0	21.3	19.0	17.0	15.6	16.4	11.3	17.2	11.4	12.8	9.7	18.0	12.2	7.6	12.5	8.2	19.0	8.5	11.7	10.6	12.7	19.3	20.5	7.6	11.9	10.2	12.4	20.5	27.5	15.6	18.2	15.1	14.1	9.6	9.3	16.0	8.1	14.5	7.7	11.7	12.4	17.6	30.9	11.4	26.6	11.3	14.6	9.6	8.4	10.8	11.4	10.4	8.6	9.2	9.7	16.1	9.7	19.7	8.2	11.5	8.3	14.2	15.1	15.9	19.6	12.4	11.2	17.1	14.6	15.3	14.4	20.8	10.4	9.0	8.2	7.4	10.6	8.5	7.6	29.4	12.5	12.2	11.8	19.6	11.6	20.2	14.3	13.9	11.8	0.0	23.8	22.2	11.5	5.7	18.5	3.2	19.0	14.3	10.9	9.8	12.5	1.8	10.9	14.9	13.5	32.5	7.3	9.5	25.4	10.2	12.0	30.0	16.4	6.5	9.9	19.3	19.2	5.5	20.3	15.3	8.0	7.2
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.3	6.3	8.2	7.3	5.0	4.1	3.8	5.3	3.8	5.4	4.7	3.8	4.7	10.0	3.9	4.0	3.2	6.2	3.9	6.4	4.9	4.3	6.9	8.7	15.6	3.9	9.2	8.9	6.3	4.7	6.6	4.7	9.1	6.5	5.5	12.1	7.0	4.4	4.1	3.8	9.1	7.0	7.3	5.6	7.8	9.3	2.9	5.2	5.2	4.9	11.2	10.8	4.3	5.4	4.7	5.4	5.9	6.5	5.4	4.2	6.1	6.7	4.6	5.0	6.8	7.9	2.5	7.1	8.5	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4	3.0	6.2	23.8	10.8	6.5	15.5	7.4	10.2	8.1	9.1	3.5	5.9	13.3	10.0	9.6	1.6	12.0	7.8	23.3	11.0	7.0	7.4	11.1	13.9	6.6	7.2	15.9	13.3	9.2	11.4	0.2	13.6	12.3	10.1	7.2	12.9	12.8	8.8	7.0	22.3	6.7	12.8	25.8	8.6	4.4	3.2	6.6	10.2	19.2	9.0	7.8
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	21.0	10.3	13.7	13.8	12.6	10.8	12.8	12.6	12.3	16.4	18.4	15.6	14.3	43.8	16.4	7.8	13.3	21.3	26.4	19.2	22.7	15.6	13.0	29.4	8.2	11.3	9.7	25.8	12.5	12.6	20.0	14.3	13.4	8.8	15.9	16.8	24.9	9.8	17.6	14.4	20.6	18.9	25.5	27.4	22.4	15.4	11.2	19.5	21.0	17.9	34.2	19.5	9.8	20.9	27.6	12.6	27.6	28.4	10.5	9.0	17.0	5.9	13.2	11.4	20.8	42.0	15.2	18.6	13.4	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6	20.8	20.0	45.2	114.9	83.8	27.3	45.1	15.3	44.2	47.8	27.9	13.7	57.1	44.7	44.7	22.0	33.0	12.7	0.0	29.3	34.7	35.1	33.3	46.1	46.1	28.0	20.6	34.3	28.8	19.4	6.3	34.5	28.4	13.5	36.9	26.7	27.5	31.9	14.0	35.3	55.3	29.1	32.3	41.5	61.4	51.3	91.8	54.8	41.7	40.3	115.3
TRMT112	"HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2"	ENSG00000173113	"TRNA methyltransferase subunit 11-2"	Q9UI30	11	64316460-64318084	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039901, HPA040006"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA039901: AB_10796334, HPA040006: AB_10793859"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (6.08e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.28e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-2)"	44.2	77.0	41.9	40.9	37.6	48.3	57.9	30.9	48.5	52.8	39.2	33.5	38.4	25.9	50.9	58.6	54.2	68.1	49.4	47.4	37.4	51.8	47.4	68.6	41.7	58.2	42.8	34.3	81.9	53.4	36.3	54.0	54.5	35.1	55.7	26.9	50.0	44.5	50.5	53.6	38.6	28.6	50.3	38.7	52.7	35.6	54.6	31.0	64.7	85.5	55.2	57.3	56.2	62.8	132.1	97.2	92.4	58.5	53.2	98.2	112.6	55.2	81.2	27.2	41.5	26.2	21.5	28.3	25.0	24.9	25.3	20.3	41.6	54.4	39.1	80.5	20.8	49.3	46.9	40.9	45.4	19.4	48.8	45.9	43.6	73.3	97.6	29.2	34.9	30.6	25.7	46.4	22.8	43.3	33.7	25.6	29.3	36.6	53.7	23.7	147.4	52.5	71.2	75.8	38.5	71.1	31.6	30.4	58.3	29.3	58.0	18.2	85.4	34.6	43.0	75.3	26.5	69.3	33.4	24.2	32.4	41.1	56.1	49.0	44.7	73.3	65.1	44.2	36.2	34.4	92.4	58.5	81.7	67.6	47.2	69.2	132.1	88.5	74.6	59.3	112.8	98.2	85.3	69.7	53.2	42.3	97.2	77.4	112.6	41.9	37.6	30.9	48.5	37.4	51.8	42.8	34.3	35.1	31.0	148.9	141.4	296.9	372.8	310.8	83.7	116.1	109.5	184.7	136.5	260.0	21.6	493.9	416.1	187.8	41.9	242.2	75.4	93.5	194.0	407.3	280.9	262.1	212.4	203.5	342.2	49.3	148.3	151.6	168.6	45.5	277.3	210.4	318.9	410.2	121.7	120.6	209.3	112.3	205.4	428.2	59.7	213.4	272.5	160.9	491.0	346.4	344.5	233.3	139.2	362.3
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.2"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	10.8	11.6	16.7	8.4	20.9	4.1	15.0	13.8	18.3	11.8	9.5	8.0	6.8	7.5	11.9	10.7	9.6	13.2	8.6	9.9	19.4	9.9	12.9	9.8	9.8	11.8	13.6	14.3	8.8	10.1	14.7	17.7	8.9	14.7	12.0	11.2	7.8	12.0	11.0	18.0	9.9	9.6	14.3	12.9	11.0	10.6	11.7	13.4	9.1	14.9	12.0	10.7	10.2	8.5	5.8	5.0	6.3	6.1	5.1	7.6	4.4	7.4	6.5	5.4	4.2	10.3	5.3	1.3	4.7	5.6	7.0	6.0	4.0	5.2	7.6	6.6	4.8	4.5	5.2	7.7	7.8	8.3	7.5	5.9	7.3	6.2	1.3	8.1	0.0	6.0	6.6	10.4	6.8	8.7	2.0	5.8	8.0	10.2	5.3	4.3	37.2	8.6	3.1	0.0	17.4	6.1	2.7	3.6	5.0	6.4	8.1	9.2	7.4	7.0	26.2	9.8	4.8	7.4	3.1	4.6	4.9	12.8	3.6	5.3	5.5	7.7	2.9	4.4	2.6	3.9	0.5	6.1	6.3	4.5	4.9	5.6	4.0	6.1	4.6	5.0	5.8	7.6	7.4	2.4	5.1	5.5	1.5	3.7	4.4	16.7	20.9	13.8	18.3	19.4	9.9	13.6	14.3	14.7	13.4	8.9	6.9	5.9	5.4	4.6	5.6	2.7	7.6	8.1	1.2	3.5	15.7	5.8	5.0	4.9	11.1	5.2	3.6	0.0	5.4	4.5	3.3	3.4	9.2	5.1	4.5	7.9	2.9	3.7	3.2	14.2	3.7	3.3	5.0	2.8	4.2	3.9	3.6	3.5	5.6	6.6	8.3	0.0	5.5	10.7	3.8	3.8	4.1	4.3	3.7	4.3
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	7.8	14.5	10.0	7.5	14.8	13.6	14.2	7.6	6.9	10.4	11.0	13.1	15.2	8.6	19.1	5.2	16.0	10.2	16.8	10.0	10.3	10.2	7.3	8.2	11.0	13.3	10.3	12.1	13.7	6.5	13.6	10.6	10.8	11.1	11.4	11.7	21.6	11.9	12.4	6.6	9.2	7.1	16.5	16.2	3.0	10.9	14.4	13.7	10.0	8.8	8.9	7.9	14.8	14.5	10.3	23.9	14.8	6.8	11.0	9.6	7.7	6.6	10.2	19.1	25.6	13.7	6.3	10.8	9.2	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8	11.9	10.4	9.8	7.8	2.4	8.7	25.8	10.2	45.5	15.9	15.7	7.9	13.5	23.2	9.3	32.0	7.0	7.9	0.0	5.3	9.1	7.4	5.4	8.1	20.2	11.2	3.2	5.8	8.6	13.7	15.5	11.5	12.8	1.7	18.0	7.9	9.5	6.6	10.5	11.3	18.8	8.2	0.0	5.2	83.9	26.0	2.0	9.5	7.5	7.1	4.7
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111866-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.6;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	14.3	22.5	12.6	18.8	13.6	14.3	13.4	16.3	19.7	13.9	16.6	17.4	15.4	18.2	13.1	15.6	16.1	15.3	17.1	12.8	13.1	11.4	13.2	22.8	11.1	22.8	12.4	14.4	15.2	23.6	10.8	18.5	15.8	11.2	16.8	6.1	14.2	36.5	16.1	14.8	18.4	16.2	12.4	12.7	23.2	16.7	16.9	13.4	26.8	15.6	12.7	18.3	13.1	11.0	9.7	14.0	7.0	14.9	9.5	15.2	11.5	6.4	7.5	2.9	4.7	2.9	2.2	10.0	5.8	3.0	4.6	4.1	8.9	5.6	8.9	5.0	2.7	3.6	10.1	2.1	3.3	0.6	9.2	24.4	10.3	10.0	8.0	8.0	16.1	10.3	3.9	4.3	4.9	1.8	3.2	4.8	7.7	38.5	6.2	3.2	10.2	9.1	10.2	5.5	7.3	9.5	10.5	5.0	3.7	2.6	7.3	7.7	5.9	3.6	9.3	9.3	1.3	6.4	13.7	4.5	5.7	7.6	4.4	5.0	22.2	9.9	6.8	7.6	6.9	5.7	6.6	11.5	7.0	10.5	14.9	15.2	9.7	10.9	12.1	14.0	6.8	12.2	11.5	1.5	9.5	12.0	12.4	8.5	11.5	12.6	13.6	16.3	19.7	13.1	11.4	12.4	14.4	11.2	13.4	11.9	17.3	11.5	8.8	8.8	13.6	5.2	12.7	6.7	10.3	10.4	7.9	21.8	11.6	9.3	119.6	8.7	12.3	0.0	11.3	15.3	11.3	9.1	25.3	15.5	22.1	14.3	17.9	7.4	20.8	166.9	16.4	12.7	6.8	14.4	10.6	21.7	11.7	10.1	13.4	8.4	12.4	6.5	8.8	17.3	12.1	9.8	23.8	17.8	15.1	8.5
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	7.6	10.4	6.9	8.9	10.3	9.1	8.5	7.0	14.2	9.6	11.4	6.9	10.7	8.1	8.1	8.6	12.9	7.4	7.3	13.0	10.7	6.6	12.3	9.5	9.4	12.6	9.5	6.6	11.3	10.4	18.5	17.6	5.9	10.7	10.1	12.6	13.4	15.3	10.4	17.6	9.5	13.5	7.9	8.4	16.6	11.4	4.0	7.9	18.2	12.8	5.3	17.7	9.9	9.5	16.5	8.1	14.8	8.2	14.4	19.2	11.5	15.3	13.3	2.7	6.3	6.3	3.3	8.4	8.0	10.7	8.9	13.4	14.3	12.3	13.6	15.9	7.3	18.2	9.6	12.2	11.1	11.3	11.7	7.7	8.6	11.0	6.7	5.6	15.3	14.1	4.2	6.6	12.9	6.0	6.3	17.2	14.8	8.8	13.0	8.2	15.5	19.0	8.1	3.7	18.9	9.9	15.6	13.1	13.0	6.6	9.1	4.0	5.2	13.6	9.9	7.9	7.8	6.5	7.4	10.1	11.4	6.9	10.5	7.1	8.3	12.5	12.7	8.8	17.6	8.7	9.6	8.2	14.8	13.8	6.5	14.6	14.9	16.1	13.3	7.4	16.5	19.2	16.1	4.8	14.4	7.0	8.1	13.0	11.5	6.9	10.3	7.0	14.2	10.7	6.6	9.5	6.6	10.7	7.9	6.0	7.5	4.4	5.2	2.1	0.4	9.0	2.5	5.3	3.4	14.0	2.0	5.0	6.6	3.6	0.0	3.7	4.2	0.0	3.1	2.6	1.6	4.2	12.7	3.0	3.0	1.6	6.4	2.5	3.5	0.0	3.1	2.8	1.7	2.8	5.2	4.5	3.9	6.0	3.5	5.6	1.8	0.0	1.4	0.2	3.6	1.4	4.2	8.7	5.6	4.7
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.9	7.4	10.9	15.2	9.7	14.5	11.9	10.9	8.4	11.7	9.4	5.4	17.4	14.9	12.2	7.9	8.8	13.4	13.7	15.8	15.4	14.7	6.9	10.9	5.0	6.0	15.8	19.3	6.1	11.4	15.3	10.6	15.8	10.4	10.2	13.0	14.2	5.4	17.1	10.9	9.9	9.7	10.0	11.3	12.3	3.2	25.3	12.6	9.9	9.9	13.4	13.3	12.1	12.2	9.7	9.9	20.4	11.6	9.6	13.6	16.5	9.6	10.4	3.3	6.1	7.0	9.5	4.2	12.6	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9	6.0	7.5	8.3	16.7	5.7	5.0	7.1	0.0	18.7	25.0	10.4	3.9	11.0	1.7	7.1	162.4	8.6	2.9	0.0	6.5	11.6	7.7	5.7	5.8	5.9	9.5	3.2	5.2	11.6	6.1	35.3	10.3	8.2	6.8	4.6	7.3	10.4	7.2	3.5	7.1	8.8	4.5	12.9	6.2	10.9	10.9	3.8	16.0	4.6	7.1	10.7
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.5	12.6	8.5	13.0	4.8	6.2	11.9	12.3	6.3	12.1	10.1	16.6	11.3	30.5	6.4	6.8	15.8	19.6	17.0	19.6	20.2	6.3	11.9	25.1	5.8	14.8	9.5	23.0	6.6	6.2	10.3	21.5	16.2	4.1	5.1	11.9	15.1	9.5	13.8	7.1	23.9	12.5	19.2	16.5	15.9	15.9	16.9	16.7	8.2	16.3	16.6	25.7	15.0	19.4	19.7	8.5	10.3	11.2	5.0	14.3	13.4	13.2	24.7	15.5	29.9	35.7	6.3	19.0	14.0	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9	6.0	16.9	15.9	15.9	19.1	17.7	21.3	12.7	34.8	34.2	27.9	9.8	23.4	29.9	18.1	3.0	15.3	3.9	0.0	26.5	20.1	12.3	14.0	34.6	16.3	15.9	25.4	13.2	3.7	13.2	6.3	10.6	27.0	16.9	9.0	8.2	12.2	17.8	7.0	6.7	17.9	9.8	12.9	20.5	59.7	110.3	21.0	24.5	17.5	9.9	14.2
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.1	0.0	0.0	0.0	1.7	10.2	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.7	1.3	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.6	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.1	4.8	0.2	5.2	0.1	0.1	0.1	0.2	2.4	0.2	0.0	0.0	0.2	0.9	1.0	0.2	0.4	4.9	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0	6.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	26.8	18.2	14.0	0.0	0.9	10.0	0.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	11.4	10.5	12.6	11.3	14.7	9.3	13.4	19.6	14.1	12.4	10.9	15.4	12.0	7.0	11.7	14.8	10.8	13.2	8.7	12.3	11.7	12.1	11.4	8.7	13.2	15.7	19.3	13.3	12.8	11.6	14.0	9.2	10.8	13.6	10.3	11.6	10.7	10.5	14.0	7.9	17.3	9.4	14.0	12.8	11.1	10.2	7.2	17.1	15.4	8.4	9.0	16.9	12.9	9.5	4.8	4.3	9.1	5.9	12.9	7.5	2.7	4.5	2.7	8.0	5.4	7.4	14.1	3.8	6.2	12.5	11.5	10.3	4.2	7.2	7.0	2.4	6.8	5.4	3.5	8.7	9.8	11.5	6.1	9.9	5.2	9.6	2.8	6.8	4.0	4.5	15.1	8.5	8.9	7.0	8.1	16.2	7.2	6.1	5.7	11.1	3.1	6.8	4.7	5.7	4.9	6.0	4.9	5.6	4.9	12.4	4.6	4.7	6.2	7.3	6.5	6.7	9.0	7.1	4.9	4.6	3.0	2.9	4.6	5.5	7.5	9.4	4.3	7.2	8.8	8.4	6.9	3.5	9.1	5.7	5.9	6.0	4.8	6.2	7.2	4.3	4.7	7.5	4.8	2.2	12.9	3.5	2.8	4.0	2.7	12.6	14.7	19.6	14.1	11.7	12.1	19.3	13.3	13.6	17.1	32.8	33.0	23.2	18.6	15.7	33.7	18.5	22.9	54.9	35.2	17.4	33.4	27.7	14.9	32.7	9.3	19.6	14.6	23.3	28.3	39.5	19.7	18.5	33.6	7.8	29.5	22.3	9.9	25.2	25.4	3.2	26.7	27.0	13.5	36.1	13.0	23.6	32.8	13.6	21.2	15.0	33.0	32.3	25.7	15.4	24.9	17.9	57.2	30.0	15.1	26.0
TROVE2	"Ro60, SSA2"	ENSG00000116747	"TROVE domain family member 2"	P10155	1	193059422-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002835, HPA005142"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		28000	Cytosol	Nucleoplasm	"HPA002835: AB_1857490, HPA005142: AB_2667307"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	21.2	13.7	13.3	11.4	16.2	29.7	18.5	13.7	16.5	16.9	12.3	13.2	11.7	8.4	15.3	10.9	16.8	11.3	10.9	18.0	13.9	7.7	14.3	13.6	15.0	13.0	19.6	11.8	19.8	12.1	16.8	13.0	13.6	15.1	17.3	9.4	11.4	14.8	14.7	23.4	16.5	11.6	22.7	20.4	14.7	10.9	24.3	17.0	15.1	14.9	8.7	12.9	19.9	19.8	19.1	13.9	38.3	14.6	19.6	24.3	14.5	8.8	15.8	18.3	17.1	15.9	14.7	11.1	13.5	12.6	9.4	12.7	8.1	12.1	18.3	12.5	15.1	8.9	13.6	14.4	10.2	16.6	22.6	11.0	22.1	15.1	10.8	14.6	25.7	16.2	13.7	12.2	17.2	19.2	9.5	15.2	8.0	24.0	24.6	16.1	14.4	15.4	6.8	13.8	7.5	5.2	12.8	15.8	20.8	9.1	18.4	6.5	12.9	16.5	20.2	17.3	13.2	16.6	8.8	20.4	18.0	6.6	16.9	17.2	14.4	14.7	17.4	9.6	12.9	27.6	38.3	13.9	17.4	24.3	13.1	23.4	19.1	17.9	20.3	13.9	17.2	19.0	21.2	22.7	19.6	14.6	12.2	17.9	14.5	13.3	16.2	13.7	16.0	13.9	7.7	19.6	11.8	15.1	17.0	71.5	25.9	47.7	45.1	63.0	52.6	45.3	35.7	34.8	28.4	45.4	117.8	40.8	34.9	43.8	316.3	70.0	20.6	46.7	33.6	38.5	64.8	51.1	57.8	29.4	29.3	44.5	32.6	40.5	33.7	126.5	78.9	44.3	45.5	49.5	21.2	163.1	32.0	20.1	97.9	43.8	149.2	129.4	76.9	43.9	41.4	67.5	40.2	59.1	19.9	30.7
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	9.6	14.2	10.7	18.4	13.4	18.8	14.9	22.8	14.4	14.1	11.3	15.4	10.0	10.6	15.1	10.1	11.3	17.1	11.4	11.4	10.7	9.5	10.8	11.0	13.1	17.1	12.4	9.4	22.4	16.2	26.7	29.9	12.2	9.6	11.8	10.2	13.7	11.8	16.7	11.7	16.9	13.3	16.9	14.2	14.5	11.5	19.3	12.1	37.1	16.6	7.7	19.3	12.8	11.5	2.7	3.1	5.7	0.9	1.3	2.7	0.3	12.3	14.4	15.0	12.7	7.4	7.6	7.5	5.4	7.3	8.6	8.3	11.2	5.5	17.2	8.7	10.1	16.6	6.4	15.5	7.5	9.5	9.9	15.2	10.5	10.5	6.5	5.5	18.8	7.8	7.1	4.4	14.0	12.0	6.0	11.0	15.6	17.9	32.7	8.0	23.8	23.0	7.5	11.4	7.5	8.9	17.0	8.6	13.1	4.5	13.8	11.9	14.8	13.8	9.1	4.6	12.8	4.6	8.5	11.5	11.6	16.9	15.3	12.7	13.5	15.3	25.5	8.2	9.7	11.4	5.7	0.9	0.6	1.5	0.6	2.7	2.0	2.7	1.3	0.9	2.7	1.9	1.8	2.9	1.3	0.9	3.1	2.0	0.3	10.7	13.4	22.8	14.4	10.7	9.5	12.4	9.4	9.6	12.1	14.9	13.9	4.5	3.7	14.1	13.1	9.2	5.1	4.0	10.3	14.0	25.5	7.7	0.0	6.7	3.0	9.0	6.1	0.0	5.7	4.3	8.0	6.5	5.7	10.9	7.0	20.6	12.1	9.2	8.7	4.0	8.1	8.4	8.5	5.4	10.6	5.8	7.9	3.5	8.1	4.3	8.5	0.0	6.1	14.4	8.0	18.6	9.2	9.2	9.5	6.0
TSACC	"C1orf182, SIP, SSTK-IP"	ENSG00000163467	"TSSK6 activating cochaperone"	Q96A04	1	156337314-156346995	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 262.0"	"Group enriched"	"Detected in many"	10	"Early spermatids: 5429.3;Late spermatids: 13574.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"basophil: 12.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029897			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA029897: AB_2756315"	"unprognostic (3.95e-1)"	"unprognostic (5.82e-3)"	"unprognostic (8.24e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.63e-6)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.28e-2)"	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.1	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	262.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.0	2.1	12.0	0.6	2.3	2.1	0.4	3.3	4.5	2.0	2.2	1.5	2.7	3.7	1.6	0.9	2.2	2.4	4.1	2.4	4.8	2.6	0.9	2.4	3.8	3.8	0.5	2.1	2.8	8.3	3.3	6.6	4.4	1.0	3.0	2.9	1.0	6.4	2.2	2.9	1.2	0.7	4.8	9.0	3.1	0.4	5.7	2.9	1.8	6.2	8.1	5.5	3.4	0.8	4.7	5.7	2.0	3.1	1.7	2.3	6.3	2.5	9.1	3.4	3.2	1.6	1.4	2.3	1.2	2.2	5.7	9.1	7.3	0.9	1.7	1.2	12.0	0.5	0.1	1.5	0.3	0.7	1.7	1.1	1.3	0.3	2.0	2.1	1.8	0.2	2.3	0.6	2.1	1.2	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.2	0.2	0.2	0.6	0.0	4.0	2.3	3.5	0.0	4.6	1.7	1.0	5429.3	0.0	0.0	0.0	0.6	1.1	0.3	0.4	0.0	3.0	0.9	0.0	0.0	0.0	0.3	13574.2	103.3	0.0	0.0	0.0	0.4	0.3	1.3	0.0	80.6	3.7	0.9	51.8	0.1	941.5	81.3	0.4	2.3	0.0	0.4	0.6
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"HEL: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	43.1	38.6	71.6	23.7	82.3	6.6	56.6	32.6	94.8	73.7	49.9	27.9	14.1	27.3	68.3	62.5	46.4	67.6	49.7	54.1	64.2	63.9	46.3	36.7	37.7	14.1	71.2	49.2	63.7	15.5	44.7	36.4	40.8	54.6	72.6	47.7	56.6	31.0	39.5	49.6	20.4	48.6	64.4	46.0	11.1	36.7	27.9	38.6	31.7	38.2	24.3	17.4	39.7	31.6	1.1	8.9	17.7	2.3	7.9	2.5	24.6	5.1	16.4	16.1	6.5	10.2	12.8	18.7	5.7	23.5	6.3	6.7	18.4	18.4	8.5	12.0	13.6	13.6	13.1	6.9	46.5	8.8	1.6	5.4	58.6	30.0	5.6	9.5	3.3	7.5	19.2	20.3	16.7	40.8	48.9	14.0	4.7	1.6	0.0	11.7	5.2	10.5	2.7	11.4	35.8	15.4	7.6	3.2	2.5	12.4	8.6	8.4	11.3	15.7	15.6	4.5	17.4	7.6	4.7	12.2	7.0	6.4	14.5	8.3	0.1	1.5	2.7	17.7	2.8	16.2	17.7	1.0	2.7	2.5	0.9	2.4	0.7	0.8	1.1	0.9	1.1	0.9	1.3	4.8	7.9	2.3	8.9	1.5	24.6	71.6	82.3	32.6	94.8	64.2	63.9	71.2	49.2	54.6	38.6	110.2	291.2	23.4	328.2	392.6	138.9	236.4	86.6	290.4	395.8	413.5	108.0	484.2	313.4	140.3	674.0	250.8	383.6	0.0	140.7	189.0	164.9	477.0	312.3	64.8	94.3	120.8	215.8	101.3	19.7	989.9	84.8	43.1	381.3	11.8	181.4	229.5	176.7	143.7	128.3	121.8	134.1	439.8	322.5	50.2	24.5	533.2	978.5	27.4	139.7	385.5
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.7	7.6	9.9	12.2	8.3	7.9	28.2	10.9	19.6	16.5	16.3	7.1	9.9	14.8	12.0	12.2	10.1	10.5	10.7	9.2	16.9	21.7	6.8	6.7	5.7	9.4	15.3	26.4	9.4	5.4	17.9	7.2	15.1	6.7	9.2	25.6	14.9	41.5	14.6	11.0	26.3	13.4	21.2	27.1	8.6	16.7	16.5	31.3	10.5	7.6	10.3	15.2	14.3	11.4	27.6	10.9	14.4	16.6	4.7	11.0	24.8	7.5	17.4	56.5	38.6	22.6	10.5	14.8	23.9	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2	44.7	7.2	17.1	10.6	9.8	8.6	28.6	10.2	6.7	14.8	12.2	3.9	38.5	46.4	27.7	1.2	12.0	3.3	0.0	36.4	40.6	19.8	10.9	31.2	33.9	27.3	3.2	6.4	17.8	13.1	1.7	20.1	20.1	32.1	24.4	7.9	13.0	30.5	3.5	18.4	51.8	12.1	12.9	20.6	40.8	50.7	11.5	18.9	35.9	10.2	9.5
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782589-57808071	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 157.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	14.5	46.2	16.6	14.7	21.5	15.3	18.5	18.2	24.3	12.7	18.8	13.3	17.6	17.8	11.6	13.7	16.1	12.4	10.3	27.7	14.6	15.6	27.0	30.2	10.1	14.6	15.4	20.8	10.3	19.6	17.0	13.1	11.6	17.8	11.7	18.3	11.1	13.5	14.1	33.5	14.7	13.4	17.7	11.6	12.5	14.0	23.2	13.6	11.3	15.4	26.9	13.4	14.4	13.0	18.5	18.7	9.0	16.8	20.0	23.5	16.0	8.4	9.8	5.9	8.8	5.5	5.5	8.6	7.1	6.3	11.6	8.1	11.4	11.2	21.2	13.6	6.2	6.5	10.0	9.9	10.2	8.8	8.6	12.0	12.9	8.3	10.0	8.4	16.4	7.8	6.4	10.5	8.8	5.0	8.9	7.1	12.0	16.6	11.5	8.7	9.8	9.7	17.9	9.1	12.3	13.1	11.8	157.2	19.0	11.0	9.6	12.8	7.9	7.6	13.4	12.9	5.5	23.2	12.0	5.2	6.3	8.9	9.2	7.6	8.5	17.4	16.5	8.9	9.9	7.5	3.7	14.8	9.0	18.6	13.8	23.5	18.5	20.9	18.4	18.7	16.4	21.2	21.7	4.2	20.0	16.8	14.7	18.1	16.0	16.6	21.5	18.2	24.3	14.6	15.6	15.4	20.8	17.8	13.6	17.9	9.6	15.6	12.7	23.0	19.8	29.9	35.7	20.1	13.6	43.6	13.7	59.0	81.2	56.0	69.4	9.6	12.7	23.3	75.2	41.0	20.6	14.1	21.9	32.5	31.6	14.3	13.3	17.8	7.3	33.2	21.0	18.6	25.3	102.8	18.4	20.6	51.6	17.5	22.6	110.7	16.3	58.2	17.6	36.4	60.1	31.7	39.8	15.0	32.8	9.2
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972407-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Leydig cells: 433.5;Peritubular cells: 755.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.9;ASC diff: 8.7;HeLa: 17.4;SiHa: 11.3;U-2197: 10.2"	"Low region specificity"	"Detected in many"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	16.2	12.3	2.8	5.7	3.5	0.2	10.3	1.0	9.8	12.9	7.4	1.8	27.7	2.0	11.8	15.9	7.6	7.3	11.4	3.9	4.8	3.5	2.7	11.1	3.0	3.6	3.5	5.8	17.2	3.4	2.1	2.6	1.2	4.6	7.6	1.9	0.1	11.2	35.8	3.9	4.9	3.1	8.3	14.3	4.4	4.4	9.6	2.5	0.0	5.0	5.8	3.0	9.0	16.5	0.9	0.3	1.3	0.1	0.2	6.1	1.0	0.0	0.0	1.3	19.9	8.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	3.7	1.1	0.0	17.4	0.0	0.2	0.0	0.4	3.1	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	11.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	10.2	0.0	0.0	0.2	0.0	2.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.8	4.1	0.2	0.0	0.9	6.1	0.4	1.3	0.2	0.1	0.3	4.3	1.0	2.8	3.5	1.0	9.8	4.8	3.5	3.5	5.8	4.6	2.5	0.0	1.1	5.4	18.1	40.3	4.5	2.8	43.3	5.3	10.3	34.9	2.0	1.0	0.0	36.1	8.8	67.1	0.0	0.0	8.9	0.6	19.5	29.7	1.1	80.0	1.1	0.0	6.3	12.3	1.0	6.7	433.5	1.5	11.8	1.0	0.6	53.3	10.9	0.6	755.6	0.1	1.3	38.8	7.8	1.8	1.7	35.4	0.7	8.7	1.5	6.7
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31274945-31349547	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	35	"granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 20.4;hippocampal formation: 16.8"	"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	5.7	3.3	4.4	4.0	6.6	1.0	5.2	1.1	17.3	13.0	11.6	0.7	2.4	2.5	19.4	8.5	5.6	9.5	11.5	4.6	3.3	2.0	2.8	1.3	4.9	1.2	1.6	8.0	28.0	1.5	1.1	7.2	4.8	2.8	9.5	3.7	4.9	2.8	8.9	1.6	2.5	4.3	16.4	3.3	4.5	6.1	3.3	1.2	0.0	8.5	1.7	0.7	11.1	11.4	0.0	0.0	4.9	2.2	0.0	3.2	0.7	0.0	1.1	0.4	0.0	5.9	13.0	0.0	3.4	4.9	2.1	3.8	0.0	0.7	0.0	0.0	8.4	4.4	0.5	1.5	3.1	4.7	0.0	1.3	0.0	0.0	0.0	11.4	2.8	5.3	7.6	2.8	7.8	3.9	0.0	0.0	2.5	0.0	0.0	9.8	0.5	0.0	0.0	0.5	0.0	0.0	3.3	26.7	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.6	2.7	0.0	2.0	0.0	18.9	6.0	2.1	4.8	0.0	0.0	0.0	12.2	4.9	0.5	0.0	2.2	0.0	3.2	0.8	0.1	0.0	0.9	1.0	0.0	0.0	0.3	0.8	4.9	0.0	0.4	0.0	0.7	0.7	4.4	6.6	1.1	17.3	3.3	2.0	1.6	8.0	2.8	1.2	3.0	0.6	0.0	6.8	4.2	13.9	1.6	0.0	1.4	6.8	3.5	0.0	0.3	0.0	0.3	0.1	6.7	0.0	0.0	0.6	0.2	18.6	3.3	1.1	0.0	9.1	15.9	0.0	19.6	11.6	0.0	16.4	6.1	5.0	0.0	0.0	0.2	0.5	0.0	27.6	0.0	0.1	0.0	10.3	0.0	5.0	1.5	0.7	0.5	0.0	2.4
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 41.4;ASC diff: 70.9;OE19: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	NA	NA		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3.0	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2.0	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8	0.0	0.3	0.0	13.0	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0.0	42.8	0.0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0.0	7.5	8.6	9.5	1.2	34.5	1.6	5.0	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0.0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17.0
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		320000	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	14.9	18.7	23.1	13.0	24.6	43.0	25.6	17.8	27.7	18.6	23.1	23.7	11.8	17.2	17.9	19.1	18.2	15.2	16.3	18.7	20.6	23.0	24.7	22.0	15.0	22.6	22.8	20.1	17.5	20.7	19.3	17.9	13.8	23.3	15.0	18.9	16.5	16.3	18.2	29.4	18.9	16.4	14.3	22.0	17.5	15.4	33.9	17.6	28.3	17.2	18.7	17.4	13.9	14.2	22.1	22.7	22.0	24.4	19.6	23.1	20.7	21.4	9.8	14.4	12.1	13.4	10.6	8.0	18.4	16.7	19.4	19.2	27.2	11.9	30.0	21.7	16.6	11.5	10.1	21.0	16.9	26.9	16.6	17.2	17.7	14.0	24.3	15.0	24.7	12.6	9.0	18.8	21.9	14.5	8.5	15.8	14.6	26.7	14.4	17.5	11.1	15.0	27.7	17.5	11.4	18.6	25.3	16.2	22.1	23.4	14.2	18.9	11.8	12.0	17.4	20.7	11.6	11.6	18.4	11.8	14.0	23.8	9.2	17.4	13.3	37.9	33.6	16.2	16.7	16.9	17.2	24.4	22.0	19.6	22.2	22.7	22.1	20.4	17.0	22.7	18.0	23.1	20.1	7.9	19.6	19.0	16.5	20.2	20.7	23.1	24.6	17.8	27.7	20.6	23.0	22.8	20.1	23.3	17.6	29.8	26.1	37.9	30.5	34.8	31.1	31.9	35.7	21.4	25.0	40.1	21.6	29.5	36.5	47.5	50.8	37.3	18.6	23.3	52.8	29.2	29.4	23.8	39.3	39.9	31.5	15.9	19.1	60.8	29.8	10.8	33.6	31.9	64.1	36.9	25.3	80.9	38.3	21.0	29.4	48.2	26.8	25.8	37.1	109.7	104.5	38.3	23.8	36.3	34.9	22.0
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.2;testis: 40.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 46.8;Early spermatids: 85.4;Late spermatids: 137.1;Spermatocytes: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.1;SiHa: 4.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053516			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.9	1.9	4.8	1.1	9.2	0.6	0.9	2.0	3.9	1.3	0.9	3.3	1.9	0.5	1.8	3.6	0.7	14.2	1.2	0.7	3.8	3.3	1.6	0.8	2.1	0.7	1.2	3.7	2.5	2.2	2.9	6.9	0.7	6.3	1.0	0.7	1.0	1.0	2.0	0.5	0.8	0.6	1.2	0.9	0.8	1.2	40.6	2.5	0.0	1.1	0.0	0.7	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.4	1.1	0.4	2.5	7.1	3.5	0.9	0.9	0.0	1.6	0.5	2.4	0.7	0.8	1.1	1.1	0.2	0.8	1.4	1.0	1.1	1.5	0.4	0.9	0.0	0.8	0.1	1.1	1.7	0.2	0.9	0.9	3.6	0.5	0.5	0.0	1.4	0.5	0.3	0.0	0.0	0.3	0.6	0.7	0.2	0.4	1.7	0.7	0.1	3.6	0.7	2.0	2.1	4.5	0.1	0.4	0.9	1.8	0.1	0.9	0.4	0.1	0.3	0.2	1.3	2.1	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.8	9.2	2.0	3.9	3.8	3.3	1.2	3.7	6.3	2.5	0.0	2.4	0.0	0.4	0.1	3.1	8.1	0.0	46.8	5.7	5.2	3.9	0.4	0.0	0.6	85.4	0.6	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.8	0.2	3.2	0.0	0.6	0.0	137.1	2.6	0.5	0.0	0.0	0.0	3.5	0.1	0.0	1.8	2.1	10.0	6.5	0.3	56.4	11.2	0.3	0.5	0.0	0.0	0.1
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185958	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.0;testis: 119.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	90	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in some"		"A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.7	0.6	1.7	4.8	2.4	0.0	1.5	11.4	3.5	9.0	59.9	1.8	1.5	2.2	1.8	4.6	1.9	13.9	2.6	2.6	2.2	0.0	46.0	1.9	5.7	2.1	2.4	1.7	1.5	1.5	15.4	3.3	1.5	2.1	22.7	70.0	3.3	16.1	7.8	1.5	0.1	18.3	1.9	1.8	1.6	24.6	119.0	1.9	1.6	13.9	1.8	1.9	21.0	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	36.8	0.0	6.9	0.0	0.0	25.7	0.0	18.8	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	29.8	0.1	10.6	0.6	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	42.8	1.3	0.0	0.0	0.2	107.8	51.7	0.3	0.0	0.0	2.2	0.1	0.1	1.5	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	1.7	2.4	11.4	3.5	2.2	0.0	2.4	1.7	2.1	1.9	23.8	19.0	15.7	180.5	0.9	0.0	0.6	15.3	1113.5	208.1	549.6	0.0	0.1	39.7	40.8	130.9	1.2	573.6	0.0	480.2	0.1	1.0	212.2	11.5	2.6	0.2	0.0	193.7	2.5	0.3	654.5	4.6	4.0	5.0	2.8	525.2	0.0	292.8	587.5	1.8	400.8	0.0	0.0	0.3	4.2	1.9	1.1	0.0	0.8	136.2	439.3
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 483.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7"	"Group enriched"	"Detected in all"	5	"B-cells: 69.7;dendritic cells: 46.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	64.0	31.4	71.6	16.9	66.5	6.0	43.3	36.8	67.5	31.4	75.3	49.4	74.2	70.6	28.4	95.9	16.8	53.8	39.4	24.6	58.1	63.7	44.9	17.8	41.9	22.9	64.4	45.8	33.0	31.6	53.6	44.0	23.1	54.1	21.3	82.7	44.3	30.8	60.9	79.3	16.3	71.2	27.6	49.2	19.1	46.1	21.3	40.4	14.2	43.0	24.7	25.4	23.2	15.2	69.7	46.7	1.5	10.8	8.3	6.9	12.1	20.8	56.9	47.3	29.8	83.1	51.2	15.6	33.4	36.4	41.2	45.1	34.6	43.6	20.5	49.7	34.5	39.4	47.4	44.8	22.9	31.0	22.9	67.9	14.6	43.6	32.7	40.3	18.8	10.8	48.1	27.7	22.7	20.3	63.0	50.4	13.7	15.4	18.1	40.3	7.9	16.6	17.9	33.4	67.0	25.3	21.0	58.8	21.6	67.8	11.9	42.9	47.5	22.9	19.4	62.1	47.4	20.8	35.7	47.7	38.3	15.0	23.0	46.7	39.9	54.2	10.9	33.9	28.2	21.8	0.8	7.5	1.5	5.1	9.9	5.4	69.4	2.6	3.7	14.8	69.7	6.9	6.3	0.7	8.3	10.8	46.7	0.6	12.1	71.6	66.5	36.8	64.2	58.1	63.7	64.4	45.8	54.1	40.4	104.2	182.8	49.0	53.9	30.8	241.7	81.1	112.1	176.7	158.1	64.6	172.8	77.0	21.6	218.3	24.0	52.8	344.7	0.0	309.7	26.2	81.8	155.9	22.0	27.0	57.7	120.8	87.8	60.2	53.5	44.3	59.5	31.1	69.2	23.4	234.6	483.1	209.9	302.5	48.4	50.7	133.3	25.8	63.7	84.0	50.0	29.9	63.5	26.1	164.4	170.4
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.2	13.0	16.8	30.6	29.8	19.7	14.1	21.3	21.3	19.6	22.5	16.8	9.7	28.4	26.8	24.6	17.6	23.5	13.2	36.4	21.0	11.5	34.4	11.4	19.3	30.4	18.9	18.7	6.9	23.0	28.5	20.1	19.6	20.4	18.6	12.6	20.1	22.1	27.2	29.1	12.4	11.0	8.3	12.7	12.2	11.5	14.5	15.5	33.8	25.9	14.8	14.6	17.7	23.8	10.2	19.9	31.3	23.3	22.4	13.2	11.8	10.6	23.0	12.1	13.1	15.6	21.8	12.2	8.5	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2	32.8	41.6	47.2	90.2	147.6	76.3	93.6	53.5	20.1	39.8	99.5	25.5	48.1	131.0	34.9	24.0	35.6	43.4	0.0	38.5	23.1	50.3	71.7	31.1	71.3	35.6	36.5	71.6	63.3	55.3	16.8	69.9	47.1	82.7	28.9	56.9	82.6	40.7	56.1	89.8	169.2	50.8	129.4	74.1	48.1	24.5	141.5	49.9	52.4	55.2	61.6
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: AB_2683811"	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	25.6	11.7	12.1	13.9	12.5	33.0	13.2	10.7	20.9	17.5	21.5	12.7	10.9	15.9	20.6	13.3	16.7	16.4	15.1	23.2	11.9	11.0	14.1	19.4	13.8	16.8	15.2	12.7	17.7	20.9	10.3	14.7	19.8	11.2	18.2	5.6	13.1	20.2	19.0	32.5	16.2	16.1	19.0	10.5	18.5	14.0	29.1	10.7	21.7	22.7	25.2	14.7	20.2	36.2	54.0	44.9	55.3	44.7	43.0	49.0	37.3	19.6	24.6	8.1	12.8	6.9	5.0	15.5	13.4	9.3	16.4	11.3	18.1	25.5	14.3	11.9	10.6	18.6	19.5	9.4	15.6	3.1	16.4	25.7	8.3	13.1	18.4	18.8	14.3	17.6	12.0	22.5	10.5	10.0	7.1	11.3	14.6	18.9	16.1	7.7	25.4	17.0	26.0	23.5	15.0	29.0	19.3	7.2	12.8	8.2	16.5	21.0	21.4	11.5	26.0	15.7	4.5	13.6	16.9	14.9	21.7	11.3	20.1	15.5	32.5	27.9	12.0	18.6	14.7	22.5	55.3	44.7	43.8	46.1	38.2	49.0	43.5	45.9	47.2	44.9	54.0	41.4	39.0	43.2	43.0	40.1	43.3	47.8	37.3	12.1	12.5	10.7	20.9	11.9	11.0	15.2	12.7	11.2	10.7	17.9	16.2	42.7	41.3	59.8	34.6	18.3	10.2	4.0	9.1	12.2	11.8	43.5	43.1	51.7	56.0	37.9	61.3	0.0	43.9	40.6	30.5	45.3	17.3	25.6	34.2	27.0	54.9	31.9	25.2	132.0	41.1	33.6	30.4	52.3	30.7	42.1	51.2	49.1	31.8	36.6	29.3	38.8	55.1	87.9	67.3	72.0	68.7	43.7	31.2	45.8
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	16.4	12.0	6.0	18.0	5.1	4.9	11.2	13.6	13.4	9.7	7.3	14.6	17.5	7.2	13.4	9.6	4.0	11.8	9.1	18.5	4.4	18.6	13.2	10.6	21.2	16.9	10.4	7.1	12.2	6.1	9.6	6.5	23.3	7.9	15.7	12.9	11.8	10.5	7.3	49.8	9.2	10.8	8.2	47.2	16.4	10.6	4.6	22.1	19.6	16.5	12.4	9.7	9.3	18.4	13.7	4.5	23.4	10.4	13.1	6.4	25.6	7.6	13.1	7.9	5.6	5.3	9.9	16.3	9.6	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6	14.9	27.3	38.0	42.2	74.1	12.6	12.5	61.1	18.7	12.5	8.7	5.9	73.8	46.4	110.8	79.5	30.8	86.0	46.7	170.3	125.9	25.3	69.4	25.3	62.7	61.4	12.7	59.5	26.4	25.1	197.6	38.0	25.2	28.7	33.3	168.9	16.3	123.1	69.1	32.2	68.8	9.3	12.9	27.2	56.2	48.1	108.3	73.3	42.9	88.1	73.3
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 21.3;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	1.1	3.9	12.4	1.3	12.9	0.9	1.0	14.9	28.9	1.0	1.4	8.2	0.0	4.6	1.0	1.0	1.0	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1.0	1.4	1.6	7.7	1.0	9.0	1.3	1.3	0.7	1.0	1.2	1.0	1.0	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0.0	1.0	0.0	1.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	21.3	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9.0	8.3	0.0	0.0	0.0	0.0	0.0	6.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	4.8	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.7	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.4	4.8	6.8	4.8	2.2	6.1	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.0	2.8	1.1	4.8	2.3	2.9	0.8	0.5	3.5	2.9	4.4	2.6	1.8	2.0	1.2	2.9	8.8	0.6	6.3	1.5	10.8	7.2	2.5	4.9	3.0	8.1	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.2	2.1	0.4	7.7	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1	8.9	1.9	0.0	1.1	0.7	2.2	3.1	2.5	29.4	4.5	7.0	2.0	0.8	1.7	4.1	31.2	1.4	1.7	0.0	3.5	0.7	1.5	1.0	0.0	2.9	0.7	15.9	6.9	4.3	0.3	6.8	2.0	0.2	1.7	0.0	2.5	10.6	2.4	0.0	2.1	3.8	11.3	0.0	0.9	33.6	4.6	0.4	0.2	0.0	2.3	0.3
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177553014	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 42.8;Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	2.4	4.6	4.4	1.9	4.9	0.7	10.5	3.2	5.1	4.8	4.0	7.7	3.8	3.1	4.9	8.9	3.7	13.2	4.5	2.3	3.9	3.8	10.8	4.3	5.5	2.5	3.1	1.5	6.0	5.2	8.0	7.0	3.3	3.4	3.5	3.7	4.5	4.4	4.2	1.2	3.0	3.7	3.1	5.2	3.1	4.7	11.5	2.9	7.7	10.4	1.6	2.8	3.3	2.2	3.2	3.9	6.5	3.4	1.9	2.2	1.6	2.8	4.3	5.7	1.1	5.1	6.0	3.9	1.8	5.3	4.7	5.0	2.4	7.1	1.1	4.7	3.3	5.4	7.0	6.8	7.2	4.5	1.6	3.4	2.0	2.7	2.1	4.3	2.5	3.5	4.9	6.8	4.6	3.5	5.7	3.7	5.4	2.6	1.0	2.8	4.8	5.0	3.9	2.6	3.9	1.1	3.9	4.9	1.2	7.0	3.1	13.9	7.8	2.1	4.9	3.3	8.1	5.0	4.8	3.2	2.6	1.4	3.3	1.5	2.6	2.9	0.3	5.9	1.0	4.3	6.5	3.4	2.8	1.7	3.3	1.1	1.4	1.2	1.8	3.9	3.2	2.2	2.2	2.0	1.9	2.2	2.8	1.0	1.6	4.4	4.9	3.2	5.1	3.9	3.8	3.1	1.5	3.4	2.9	3.0	2.9	0.5	0.4	0.6	2.1	0.8	5.1	42.8	9.1	0.0	2.0	2.1	5.0	3.6	6.2	1.6	2.3	0.0	2.5	1.1	2.1	0.5	1.1	2.4	1.1	4.8	1.2	2.5	1.8	4.0	1.4	1.0	1.7	0.0	2.5	6.6	2.4	0.0	2.1	3.7	11.0	0.0	1.3	23.3	3.4	0.6	0.5	0.5	2.3	0.1
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (2.49e-4)"	9.2	8.9	7.4	12.3	11.7	11.5	8.6	13.8	9.3	9.0	15.7	8.6	5.3	10.5	11.6	9.4	8.7	7.9	14.5	7.4	8.9	3.7	9.9	23.6	8.2	10.4	10.4	7.7	9.7	13.4	13.2	10.0	13.7	8.3	8.0	9.5	10.5	8.1	7.5	6.5	11.1	16.2	9.3	7.0	13.6	11.6	8.6	12.2	11.5	7.7	9.7	11.5	10.6	8.5	9.3	9.7	8.1	10.2	7.5	9.0	7.8	11.1	10.1	6.6	3.4	3.8	11.3	7.7	6.2	8.6	11.3	7.9	8.6	8.3	15.7	4.9	4.9	10.4	8.1	6.1	6.7	5.6	17.2	6.3	16.7	9.0	14.7	7.5	6.8	11.1	8.2	9.0	9.6	6.0	7.6	7.6	7.2	11.1	6.7	7.0	10.3	10.1	4.0	4.1	8.2	5.0	10.0	17.3	7.4	6.2	8.3	3.3	12.2	5.8	9.1	6.3	3.8	6.8	3.8	14.0	7.8	12.9	4.8	9.1	9.9	7.9	10.2	9.6	7.9	7.2	6.4	10.2	8.1	8.4	10.2	9.0	9.3	6.5	8.0	9.7	7.3	6.3	6.8	1.4	7.5	10.2	5.7	8.3	7.8	7.4	11.7	13.8	9.3	8.9	3.7	10.4	7.7	8.3	12.2	14.9	8.6	11.5	3.5	2.5	10.2	2.9	12.7	4.0	9.1	8.7	37.3	7.1	1.7	4.7	3.3	4.5	8.1	0.0	4.8	4.3	3.5	2.7	18.5	18.6	7.3	4.8	5.8	4.3	7.3	3.8	5.8	7.8	3.3	10.8	5.3	8.1	4.8	5.5	5.3	5.0	22.2	6.5	4.1	8.9	8.7	2.9	6.8	7.5	6.3	3.3
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896643-19901986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.9	12.8	10.8	24.7	30.1	17.4	24.1	18.9	10.8	11.0	17.5	11.9	11.5	13.6	28.5	7.8	11.8	11.8	7.3	14.9	11.8	9.4	12.6	10.1	13.7	29.6	9.2	16.9	8.7	13.4	17.0	8.2	16.9	16.6	10.4	14.5	11.4	13.1	19.6	14.2	12.1	9.4	18.4	13.9	10.6	12.9	23.6	15.5	13.7	12.9	9.5	11.9	11.7	9.3	5.4	21.6	5.9	4.5	12.8	3.8	14.4	9.2	8.3	6.1	3.8	8.3	1.7	3.1	5.3	5.3	3.5	4.6	16.7	9.1	1.8	3.3	6.4	9.2	3.9	10.3	3.4	13.3	15.8	9.3	12.3	8.3	8.2	9.1	16.8	7.8	6.3	5.8	14.1	4.2	4.9	15.0	17.3	18.8	4.4	4.4	6.5	13.5	6.5	5.6	16.3	7.8	5.6	15.3	14.5	5.7	13.7	12.8	10.8	5.8	11.5	10.2	7.9	3.5	3.4	7.4	8.2	7.7	4.2	19.0	17.3	15.4	12.0	8.9	4.3	6.1	5.9	16.5	5.9	4.3	6.7	8.8	9.2	6.1	5.4	9.3	12.8	9.7	21.6	4.5	4.8	3.8	10.9	3.8	12.8	24.7	24.1	18.9	14.9	11.8	29.6	9.2	16.9	23.6	8.9	11.8	18.3	25.0	16.8	36.8	13.2	12.7	44.2	14.8	12.2	13.7	11.6	38.1	9.2	12.5	15.7	9.3	0.0	21.9	9.3	13.9	17.2	8.1	23.3	8.0	39.7	27.2	5.5	7.1	4.6	18.4	17.0	6.8	11.8	16.5	44.9	10.9	15.0	9.2	18.7	34.7	12.9	16.5	86.3	21.3	22.8	8.0	17.3	13.6	17.4
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95463895-95555007	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037905	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	29.6	21.8	18.9	16.1	19.4	6.9	19.2	35.7	37.9	21.1	19.7	8.2	20.7	15.6	17.3	15.5	27.5	14.8	13.7	17.5	20.2	14.1	28.2	25.2	17.1	13.8	21.5	21.5	21.3	22.2	40.2	42.1	20.7	26.5	21.1	16.8	6.6	16.8	17.4	33.1	23.9	22.7	21.5	29.8	16.0	18.8	9.1	25.0	25.2	19.7	23.5	15.3	28.1	16.1	10.3	14.8	3.5	7.4	8.2	12.0	3.7	12.4	13.3	16.9	5.8	28.4	38.7	15.1	23.8	19.3	15.5	23.4	14.1	9.2	22.0	15.8	22.6	16.2	12.3	21.3	28.8	26.1	12.8	17.4	14.8	27.0	9.3	24.3	9.5	10.7	25.6	14.8	19.8	27.8	24.0	24.5	7.4	11.6	14.5	29.3	7.1	12.4	7.7	9.5	5.7	11.3	10.6	23.7	23.1	17.2	9.8	21.2	16.6	19.6	9.7	21.8	14.8	15.1	8.2	33.7	21.3	12.2	16.7	18.2	14.0	17.6	20.5	21.5	14.1	27.3	3.5	6.0	2.1	9.9	7.4	12.0	9.6	9.7	8.0	7.2	10.3	10.0	10.4	0.2	8.2	6.7	14.8	8.8	3.7	18.9	19.4	35.7	37.9	20.2	14.1	21.5	21.5	26.5	25.0	71.5	37.6	23.1	17.3	17.3	59.4	74.7	12.7	45.5	47.8	26.2	47.1	24.9	13.3	32.7	1.2	35.9	25.6	0.0	34.8	37.4	22.4	24.3	39.4	30.6	23.4	55.6	31.2	33.2	29.8	1.5	57.8	23.5	8.5	54.1	32.2	20.3	37.0	14.0	60.8	25.9	34.0	38.8	24.7	6.5	8.3	28.7	16.6	21.8	31.5	16.5
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.7	7.3	9.2	8.4	6.5	9.8	7.2	7.3	8.3	12.3	7.1	6.2	11.2	18.0	11.2	6.5	10.6	7.9	7.8	5.6	10.7	5.5	5.6	15.0	9.2	4.4	7.7	8.5	6.3	7.8	8.4	20.4	11.2	10.8	7.6	11.2	34.6	9.1	18.6	13.3	11.0	22.1	14.0	14.6	7.8	6.1	9.0	15.4	11.8	9.0	6.0	10.1	11.0	8.0	8.0	16.1	9.9	13.5	9.8	5.1	14.4	15.0	9.1	12.3	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7	23.8	16.3	52.5	19.7	8.8	26.4	37.0	20.4	24.1	13.6	17.4	56.9	21.3	16.6	23.7	13.3	29.0	11.8	46.7	18.3	18.6	14.6	18.1	22.0	7.3	16.3	28.6	11.6	25.8	18.6	5.6	21.9	22.5	1.7	22.6	13.5	19.1	21.2	20.3	24.4	12.9	53.5	25.8	18.4	48.9	61.5	7.4	21.1	34.9	16.6	19.5
TTI1	"KIAA0406, smg-10"	ENSG00000101407	"TELO2 interacting protein 1"	O43156	20	37983007-38033468	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034230, HPA068338"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB034230: AB_1564322, HPA068338: AB_2685975"	"unprognostic (7.14e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (1.11e-1)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	9.2	14.2	16.6	10.5	16.2	9.5	11.1	15.5	16.3	10.8	9.8	16.0	9.2	7.4	12.7	12.7	10.2	12.8	7.3	11.3	10.2	9.0	10.7	15.2	9.6	13.4	14.9	12.9	15.4	24.5	16.6	22.8	13.2	15.6	12.8	13.5	13.9	11.7	14.9	22.0	10.4	9.8	13.8	15.8	12.5	11.3	13.0	14.1	17.6	15.4	4.9	15.3	13.7	10.0	10.2	12.9	17.0	11.6	10.3	13.9	9.1	9.8	14.6	16.2	6.1	6.6	9.3	17.4	11.2	6.6	16.7	14.3	34.1	12.9	16.2	11.7	6.3	18.6	15.7	18.1	23.4	16.6	6.4	7.1	22.2	14.5	17.5	7.5	17.7	10.5	7.1	15.5	16.6	10.1	6.4	12.4	17.3	23.3	11.1	12.6	10.1	23.9	12.4	15.9	15.4	15.4	15.7	26.1	19.0	6.4	10.6	14.8	13.2	17.1	30.4	3.9	17.5	17.2	8.6	8.1	22.6	15.0	12.0	11.4	9.7	8.4	18.3	13.2	11.7	11.6	12.9	9.8	17.0	11.9	11.6	13.4	10.2	9.3	11.7	12.9	9.7	13.9	11.1	6.2	10.3	6.9	6.3	11.7	9.1	16.6	16.2	15.5	16.3	10.2	9.0	14.9	12.9	15.6	14.1	8.9	12.3	4.9	2.9	2.7	7.3	11.5	10.2	20.1	9.1	3.5	9.8	12.3	1.7	3.9	5.3	4.6	2.9	0.0	2.8	8.9	3.5	5.2	2.3	6.8	4.6	7.9	2.9	5.5	0.6	2.7	6.1	3.8	3.3	7.2	5.0	6.4	3.7	4.8	6.3	3.7	8.2	0.0	3.6	13.1	11.5	2.6	12.0	5.0	4.5	3.5
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482154-112541739	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	4.4	4.0	9.9	4.2	11.9	7.1	11.3	5.0	12.5	3.3	4.1	9.2	2.5	3.1	4.6	4.2	5.2	3.2	4.9	10.3	9.4	6.5	3.9	3.3	5.9	4.4	8.1	5.3	3.2	3.8	4.1	2.4	5.3	5.9	3.2	3.9	2.6	3.0	3.7	13.1	6.0	3.2	5.8	5.4	4.0	3.2	3.0	6.5	5.1	4.2	5.2	3.8	4.8	2.9	1.8	1.2	2.7	1.3	1.0	1.3	0.5	3.7	2.9	3.7	8.2	4.4	6.3	1.4	6.4	5.3	6.9	5.9	3.5	1.4	3.5	3.6	5.5	4.5	2.6	6.4	3.3	8.3	2.4	3.6	2.9	4.1	4.4	2.0	4.1	1.5	2.8	2.3	10.0	5.3	3.1	5.8	2.4	4.8	2.8	5.4	1.9	3.6	2.3	3.2	1.1	5.8	3.9	4.1	1.9	2.1	2.9	7.8	5.4	5.0	1.7	8.9	2.5	1.7	2.4	5.8	8.2	6.0	6.4	4.8	1.6	3.1	2.9	9.0	3.1	3.5	2.7	1.3	1.0	1.3	0.8	1.1	0.8	1.0	1.0	0.4	1.8	0.9	1.1	2.4	1.0	1.1	1.2	0.8	0.5	9.9	11.9	5.0	12.5	9.4	6.5	8.1	5.3	5.9	6.5	11.9	8.3	3.7	4.2	18.0	16.4	32.0	5.1	2.7	7.9	12.2	11.8	2.6	0.0	6.0	6.1	13.0	5.0	46.7	8.3	2.1	9.4	5.0	0.0	9.4	10.2	7.9	10.9	20.9	24.8	3.6	2.8	15.5	6.8	10.8	5.5	9.1	8.6	5.8	5.3	4.9	21.2	6.5	9.0	1.9	4.3	15.7	1.0	6.1	5.2	3.7
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"		Ligase	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 30.5;Ciliated cells: 65.6;Early spermatids: 31.2;Late spermatids: 53.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.8;REH: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules		NA	NA			"Nucleoplasm, Microtubules"		"HPA041772: AB_10959904, HPA055676: AB_2682881"	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.4	0.6	3.4	0.5	8.9	0.4	1.3	1.0	2.8	0.6	0.5	10.9	1.8	0.6	1.1	8.9	0.6	9.2	0.8	0.5	4.8	3.7	0.8	0.5	1.7	0.7	5.2	0.6	1.8	0.4	2.8	2.8	0.7	16.0	0.6	0.5	0.0	0.5	1.8	0.4	0.6	0.4	0.6	4.5	0.5	0.6	11.0	4.0	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	1.8	0.0	0.9	0.0	0.8	0.0	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.5	0.3	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	8.9	1.0	2.7	4.8	3.7	5.2	0.6	16.0	4.0	11.9	30.5	0.0	0.9	0.1	1.7	0.8	0.0	65.6	13.6	0.0	3.9	0.1	0.0	0.1	31.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	7.0	0.0	0.0	4.8	0.0	0.6	0.0	53.4	1.4	0.8	0.0	1.0	0.0	0.3	0.2	0.0	1.1	0.0	0.5	0.0	0.0	9.7	1.1	0.1	0.0	0.0	0.0	0.3
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859482-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	8.7	8.0	9.3	8.1	13.8	6.8	12.4	19.9	12.2	12.3	11.2	13.5	16.6	6.7	13.6	16.4	18.2	10.0	8.3	8.4	8.9	7.2	8.5	9.3	8.8	10.2	16.1	8.5	16.3	13.2	10.4	18.7	7.2	12.3	12.3	8.2	11.7	11.4	12.2	9.9	11.6	7.5	9.3	13.4	9.3	9.6	9.2	16.4	16.2	15.5	10.3	13.8	14.1	13.0	10.1	8.8	14.1	7.6	8.1	17.6	6.9	6.0	8.3	6.5	6.8	3.7	2.6	5.5	4.7	2.8	6.3	5.2	9.0	3.9	5.5	8.1	1.1	4.3	5.1	9.1	2.8	6.0	3.2	11.1	6.4	7.0	10.6	2.0	3.8	3.5	1.4	4.5	5.4	2.0	2.2	4.9	5.5	13.8	3.8	2.1	42.9	7.8	4.4	5.7	6.7	3.7	8.4	9.6	8.6	2.4	2.8	6.1	3.7	3.4	2.7	3.2	8.2	6.4	3.7	1.5	4.5	10.1	3.1	5.1	4.5	6.8	8.4	2.1	4.3	4.0	5.6	7.6	14.1	10.9	5.0	12.4	10.1	13.5	11.5	5.2	8.6	17.6	14.2	8.2	8.1	5.3	8.8	14.1	6.9	9.3	13.8	19.9	12.2	8.9	7.2	16.1	8.5	12.3	16.4	11.9	45.1	5.4	12.7	14.0	7.1	4.8	7.6	12.0	20.5	3.5	5.9	5.1	10.0	4.6	1.3	7.7	2.6	0.0	4.2	6.5	8.2	11.1	10.5	3.2	3.5	3.2	9.9	6.7	4.8	0.4	5.2	6.2	6.8	3.6	5.5	7.7	3.3	4.9	7.8	3.1	7.7	6.5	10.3	11.4	28.1	14.8	3.3	13.6	5.4	5.7
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Ciliated cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.3	25.5	9.4	9.6	10.1	11.0	12.1	14.4	23.4	17.8	18.0	26.6	12.9	13.9	8.1	16.4	6.5	12.4	12.6	11.8	7.9	13.0	24.1	8.9	12.6	14.6	12.7	19.0	16.4	11.4	10.3	16.5	20.6	18.1	11.7	9.2	10.8	11.3	14.4	25.1	10.4	21.0	8.2	12.0	20.3	8.3	11.0	6.0	11.6	9.6	6.5	12.8	10.3	11.6	11.5	6.0	8.4	9.7	14.1	8.7	7.8	11.4	12.8	11.3	7.7	16.2	34.9	8.6	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4	44.7	36.3	20.8	22.9	12.4	41.4	30.5	22.9	143.2	43.3	38.4	29.5	33.5	19.9	30.5	19.9	21.8	31.4	23.3	32.0	27.4	24.7	25.0	38.2	26.3	41.0	36.5	28.2	28.3	39.5	22.0	31.4	45.0	13.5	75.7	32.6	38.3	28.6	31.7	33.2	44.0	69.1	32.3	15.9	63.2	56.2	12.0	35.6	26.1	32.4	26.7
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	19.8	13.1	10.9	6.2	12.2	3.6	13.8	9.9	17.4	15.3	13.2	10.7	9.7	11.3	17.6	14.0	9.3	15.0	11.0	11.0	10.4	10.5	13.8	12.2	9.3	4.3	12.3	11.3	16.5	10.3	9.6	9.1	17.9	10.4	15.8	8.4	10.2	14.9	14.2	15.6	14.8	11.9	12.1	8.6	7.5	11.8	32.0	11.9	2.9	20.0	11.4	6.7	11.0	14.9	0.6	1.8	0.0	0.8	0.0	0.1	0.0	6.6	1.4	1.5	0.0	4.9	4.1	0.0	5.1	0.0	2.0	2.4	0.1	2.4	0.0	1.6	6.0	5.3	0.0	3.6	6.4	1.2	0.0	7.1	25.9	7.7	0.0	2.4	0.0	0.0	5.0	9.0	2.2	5.1	0.0	2.1	0.0	0.0	0.0	2.3	3.3	0.0	0.1	1.3	5.3	6.6	0.0	1.0	0.1	2.7	3.1	0.5	11.7	6.3	5.3	5.2	3.0	4.6	7.3	4.5	0.0	9.5	0.1	0.0	0.0	0.0	0.0	6.2	1.7	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.8	1.8	0.0	0.0	10.9	12.2	9.9	17.4	10.4	10.5	12.3	11.3	10.4	11.9	11.9	5.4	0.0	35.5	54.0	25.2	9.7	17.8	2.7	5.7	15.7	3.9	24.7	56.3	6.4	50.7	21.8	8.0	0.0	10.7	12.0	22.0	30.2	0.0	16.4	8.1	20.6	12.6	15.4	2.2	5.0	28.4	5.3	27.0	1.0	12.7	29.9	6.4	10.5	20.5	18.1	13.4	32.3	39.6	89.6	11.5	33.1	24.3	0.0	12.8	15.6
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.3	9.2	6.4	8.9	7.8	4.5	8.3	7.9	4.8	6.7	5.8	8.2	14.4	11.7	18.2	3.8	8.4	13.8	11.7	9.2	3.4	9.0	6.2	12.0	9.4	7.8	8.7	8.5	5.5	6.3	9.9	8.3	12.8	6.3	6.4	15.2	18.0	12.1	5.6	16.0	12.0	18.1	7.3	4.8	11.3	13.5	10.2	28.4	6.2	4.2	10.6	14.9	6.0	11.4	9.8	5.6	15.9	8.3	5.7	7.6	6.8	8.8	6.0	21.1	18.5	14.4	8.9	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2	0.0	7.9	8.1	4.8	2.4	7.4	3.2	10.2	9.4	2.3	10.4	5.9	10.6	5.0	7.3	25.9	13.4	5.6	0.0	6.4	6.5	3.8	6.1	2.3	16.2	5.0	1.6	6.9	12.3	4.0	12.8	6.6	3.1	10.1	2.8	6.0	9.3	5.4	3.5	3.2	4.9	8.7	0.0	1.4	9.2	14.8	1.9	11.7	6.9	6.0	2.8
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	33.5	21.3	0.0	27.2	85.8	12.7	19.2	0.0	0.0	0.0	0.8	38.9	1.0	0.2	0.3	2.2	9.3	0.0	2.9	0.0	1.6	0.1	5.7	0.0	0.6	4.9	1.2	6.1	5.1	1.5	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.3	4.7	0.5	0.9	33.2	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5	0.0	1.6	0.0	14.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	25.5	2.5	1.1	0.0	2.0	0.0	0.0	4.3	0.0	0.2	44.5	0.0	1.7	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	5.1	0.5	1.7	1.5	1.4	0.0	0.0	3.0
TWISTNB		ENSG00000105849	"TWIST neighbor"	Q3B726	7	19695462-19709087	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	16.4	13.9	11.5	13.6	17.6	21.5	15.8	13.2	20.8	16.1	14.0	9.9	12.3	8.5	20.4	9.4	14.8	14.3	9.7	14.6	13.5	12.5	13.3	15.9	9.9	16.6	13.1	11.7	17.5	12.6	15.4	12.0	16.4	13.5	15.3	11.0	6.4	11.4	14.5	25.5	13.8	11.4	22.7	13.4	17.7	12.4	10.8	11.3	20.8	13.6	14.1	18.8	20.2	14.4	10.8	7.7	3.5	5.0	14.6	11.6	5.0	11.7	9.0	6.6	9.9	7.8	9.6	5.2	6.8	5.1	8.0	9.3	7.3	10.4	13.2	19.9	8.4	10.1	10.7	13.5	12.7	14.9	4.1	10.4	12.2	7.2	5.6	11.9	24.9	8.9	8.7	9.0	8.7	10.5	5.4	13.0	9.3	18.8	11.9	11.4	4.3	13.7	23.3	17.3	12.3	10.2	11.2	11.5	13.9	13.1	6.1	4.8	7.3	6.2	16.9	8.4	11.4	6.8	22.4	10.8	16.6	8.9	15.3	16.4	15.3	9.4	33.6	11.2	37.5	24.2	3.5	3.9	1.1	7.2	5.0	10.8	10.8	8.6	9.5	6.0	10.4	10.0	11.6	0.3	14.6	4.7	7.7	7.8	5.0	11.5	17.6	13.2	20.8	13.5	12.5	13.1	11.7	13.5	11.3	14.9	23.5	21.4	59.8	110.2	25.7	20.1	10.2	24.1	37.5	8.7	11.8	32.6	36.5	21.9	4.1	30.8	6.3	23.3	23.7	26.9	40.3	29.1	118.6	27.1	30.4	31.8	23.4	29.4	15.2	2.5	29.7	41.4	59.1	25.2	16.5	19.0	19.5	14.0	32.9	24.5	12.1	19.4	57.7	25.0	44.7	125.0	13.8	37.3	21.5	43.6
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Cell type enriched"	"Detected in all"	10	"monocytes: 27271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Cell line enhanced"	"Detected in all"		"OE19: 265.0"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	45.9	63.1	17.1	18.8	43.2	56.3	25.2	55.9	52.2	39.0	29.7	40.9	55.4	40.9	24.0	51.6	85.4	103.8	24.3	74.5	38.3	60.7	54.1	20.5	59.2	70.8	49.4	50.9	62.7	39.9	49.1	57.0	43.2	36.3	34.2	26.1	34.5	39.4	53.3	37.2	42.3	76.4	36.4	265.0	77.0	17.8	58.0	47.6	49.8	32.6	37.2	13.3	60.3	49.0	37.9	34.4	47.0	35.2	41.0	40.2	26.0	75.4	69.2	20.0	56.4	34.8	58.3	44.4	55.8	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0	363.3	237.5	189.1	832.3	1158.8	34.8	96.1	504.4	436.3	374.2	249.5	19.6	560.0	824.0	1017.1	20.9	327.5	1162.8	233.6	1150.3	840.4	409.8	774.5	261.1	685.2	516.6	27.0	534.8	206.2	278.9	11.1	373.3	793.2	723.7	27271.2	934.3	40.9	1608.6	1292.8	268.3	2636.4	24.8	142.3	563.4	10.6	70.3	1303.3	391.5	213.2	1478.0	1356.2
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	11.1	10.0	14.1	11.5	16.3	15.6	12.3	18.6	17.0	11.0	11.7	18.5	10.4	12.8	10.2	10.3	12.2	13.3	11.2	9.3	13.2	12.2	9.8	20.8	8.8	13.0	20.9	13.6	27.8	12.6	11.0	19.9	9.4	13.7	9.8	10.8	9.8	10.7	10.3	11.3	10.1	10.4	8.7	17.2	10.0	10.0	18.9	15.3	14.0	10.9	6.0	11.9	8.6	13.7	10.8	9.4	18.3	14.2	5.0	13.7	9.9	6.9	10.5	5.8	7.9	4.3	5.1	12.9	9.2	7.5	16.1	12.2	10.7	6.4	10.2	6.7	4.7	7.5	9.5	10.2	5.4	12.6	5.1	9.6	9.4	8.0	16.0	9.2	11.1	8.2	5.3	3.8	14.2	13.4	6.2	6.8	11.4	22.6	6.2	7.6	13.3	13.3	9.7	10.5	4.4	9.7	13.8	7.3	13.7	5.9	5.3	13.2	11.4	8.6	4.0	11.9	4.6	9.4	7.1	6.5	7.7	11.2	6.4	8.6	12.3	19.8	42.5	8.7	7.6	7.6	18.3	9.8	12.9	9.2	10.9	13.7	10.8	9.5	7.8	8.5	9.0	13.1	12.7	13.9	5.0	14.2	9.4	10.5	9.9	14.1	16.3	18.6	17.0	13.2	12.2	20.9	13.6	13.7	15.3	3.0	8.8	13.1	6.9	7.6	3.4	1.4	7.6	8.1	5.7	5.2	2.0	11.7	5.0	9.4	1.6	7.9	8.4	0.0	8.8	14.7	6.5	6.9	9.2	11.9	10.8	9.5	8.6	8.0	8.7	3.2	10.9	7.4	6.8	9.0	8.4	5.8	6.2	3.5	8.5	9.9	4.5	0.0	8.2	7.4	7.5	7.2	16.2	7.5	7.3	5.7
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674715	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	32.1	39.3	40.0	51.9	40.0	68.2	34.1	53.4	44.1	39.6	43.7	41.2	37.0	46.2	45.0	32.5	47.9	43.6	35.4	33.8	35.0	29.4	36.5	39.1	35.6	59.6	41.1	33.7	51.4	38.3	37.7	48.1	42.9	31.5	36.8	29.7	35.9	36.4	39.5	33.3	42.7	43.0	34.7	32.4	58.1	37.4	104.4	41.4	68.4	42.0	34.0	50.4	36.3	42.9	3.0	4.1	5.5	4.0	1.4	3.0	1.7	44.2	72.7	44.5	36.5	21.1	21.4	48.0	35.9	33.8	61.8	60.2	42.2	42.2	53.6	29.2	30.4	30.6	36.3	55.2	50.0	27.5	40.3	92.3	44.9	32.5	38.7	34.3	51.0	51.5	29.1	30.3	46.1	30.5	23.2	35.5	36.3	53.5	34.6	31.2	41.6	70.8	44.9	49.0	38.3	57.9	77.3	28.7	42.8	33.9	51.9	52.9	41.1	39.4	37.3	22.7	26.0	36.4	54.0	30.3	54.4	39.5	25.0	75.8	31.5	42.6	63.6	24.2	50.6	46.2	0.2	2.6	2.2	3.0	4.0	2.6	2.1	2.7	2.4	2.4	3.0	2.2	2.0	5.5	1.4	2.6	4.1	2.9	1.7	40.0	40.0	53.4	44.1	35.0	29.4	41.1	33.7	31.5	41.4	3.0	7.8	30.2	34.6	40.3	39.4	2.0	28.1	2.7	10.3	26.2	29.5	50.4	16.6	27.1	3.6	25.3	37.1	0.0	20.6	50.3	29.4	26.5	34.5	24.6	32.5	33.4	43.7	25.2	23.2	5.2	41.1	28.1	18.6	39.7	38.5	23.8	24.5	21.0	32.2	19.6	49.8	0.0	31.7	23.3	28.8	34.4	60.1	33.7	38.2	39.4
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.0"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 148.5;Leydig cells: 115.9;Peritubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	11	"B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"BJ: 62.0;BJ hTERT+: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	21.7	8.9	4.7	8.6	8.1	0.4	25.9	2.9	5.8	15.4	14.1	8.4	22.8	10.6	17.2	22.3	15.6	10.5	15.7	18.0	6.1	4.2	16.4	8.2	23.7	7.5	9.0	4.6	17.5	8.6	8.2	6.5	13.7	9.6	15.5	7.6	26.7	18.8	26.9	68.0	10.1	16.9	11.4	14.9	15.7	8.4	10.1	7.1	1.0	18.6	32.4	5.3	9.9	13.5	3.4	2.0	0.2	4.3	0.1	0.3	0.7	10.5	8.7	3.9	5.1	7.9	34.2	0.0	62.0	37.9	16.2	14.1	14.6	15.6	7.2	17.1	15.4	4.7	12.2	8.8	4.9	20.5	0.0	3.9	4.0	6.8	3.0	10.3	0.1	1.5	16.1	2.8	9.6	7.3	26.9	17.2	1.7	1.0	0.0	20.1	3.4	0.0	0.6	3.2	4.8	4.6	0.0	28.3	0.0	7.8	3.6	1.0	2.0	11.7	1.8	12.5	8.2	3.4	1.2	33.0	0.9	6.5	5.3	9.8	0.6	2.1	0.0	8.2	1.1	7.0	0.2	2.2	0.0	0.0	4.3	0.0	1.2	0.1	0.0	2.0	3.4	0.3	0.1	0.2	0.1	2.9	0.1	0.0	0.7	4.7	8.1	2.9	5.8	6.1	4.2	9.0	4.6	9.6	7.1	6.0	8.3	4.7	14.2	10.1	7.0	148.5	12.7	87.0	22.7	47.1	3.9	0.8	3.3	42.5	15.2	80.4	36.5	0.0	42.6	1.0	25.7	13.4	15.0	14.8	8.6	23.8	8.7	43.6	19.1	8.1	115.9	9.6	28.7	11.8	23.3	55.9	56.3	28.5	132.6	3.0	3.4	51.8	46.4	38.5	29.6	11.4	0.8	3.2	20.0	9.6
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	15.1	8.5	14.1	11.0	7.0	8.2	9.5	31.4	12.3	14.4	16.9	8.9	20.5	19.2	11.2	12.9	14.7	9.0	14.5	15.6	21.8	22.1	4.0	12.3	15.0	8.3	6.0	21.6	9.5	5.9	5.0	18.6	11.3	9.9	12.7	9.9	29.2	11.4	17.0	5.7	22.4	4.9	8.3	10.8	10.3	13.3	28.9	7.1	11.8	17.2	6.9	8.7	17.7	12.6	5.9	12.3	8.4	5.8	18.3	13.4	15.1	10.8	13.7	8.2	6.4	19.4	23.8	6.0	12.8	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6	23.8	20.8	33.8	52.9	62.3	46.2	14.4	12.7	25.4	20.5	15.7	51.1	22.4	3.3	21.4	1.4	34.4	21.2	0.0	14.8	12.9	28.2	64.5	30.1	17.3	20.5	31.8	31.0	17.8	27.9	4.0	19.8	35.3	23.6	33.3	24.7	19.8	36.7	21.0	18.7	10.2	42.3	19.4	23.0	37.9	35.1	40.4	49.2	29.9	19.6	126.8
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Cell type enriched"	"Detected in some"	14	"T-cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Group enriched"	"Detected in some"	6	"HEL: 13.4;JURKAT: 23.5;MOLT-4: 27.5"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	13.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	2.5	0.0	0.0	0.0	27.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	16.2	0.0	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Group enriched"	"Detected in some"	16	"Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RT4: 13.8"	"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	3.0	1.9	0.0	0.0	0.1	0.0	0.0	22.9	16.0	15.9	0.0	0.0	0.0	1.7	316.2	0.0	0.0	3.3	0.0	231.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	265.1	3.1	0.0	685.5	6.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.1	21.6	15.8	17.7	18.7	30.8	20.8	16.7	19.8	17.5	15.9	10.9	33.4	21.8	20.4	16.2	23.1	26.8	19.3	32.0	17.5	21.8	12.5	12.3	18.1	17.4	18.1	23.7	15.9	28.9	18.8	27.4	14.0	26.5	22.5	21.8	36.2	16.3	9.5	23.0	16.6	23.8	15.8	12.0	29.9	11.4	30.5	23.1	14.0	9.3	17.4	19.6	17.1	16.1	33.3	16.7	11.9	19.8	19.9	15.2	23.3	23.2	14.1	16.5	47.2	15.3	17.0	15.3	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6	20.8	11.8	63.6	34.1	254.1	16.5	62.6	30.6	13.4	13.6	24.4	5.9	36.7	69.6	27.6	105.5	28.7	35.4	0.0	23.2	45.9	34.4	47.3	20.7	52.9	41.3	14.3	36.9	32.5	36.1	173.0	18.1	34.1	64.1	33.3	32.7	23.0	32.9	27.5	19.8	61.3	13.9	6.5	47.9	63.9	47.7	209.5	55.8	43.3	26.8	53.3
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 110.3"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.9	14.4	21.1	16.5	23.1	20.7	12.2	21.1	24.1	27.1	25.8	16.4	12.1	23.6	10.6	27.9	20.5	21.4	28.1	22.9	27.1	23.5	30.4	27.3	14.1	19.5	15.4	39.0	19.7	18.2	20.0	19.7	14.3	19.6	30.4	14.7	110.3	12.7	29.3	18.4	20.2	28.2	15.5	28.0	15.2	16.6	31.8	6.4	25.4	20.1	19.0	14.1	16.8	21.2	19.4	20.3	13.2	21.6	21.8	19.3	24.8	16.2	21.4	12.4	20.0	21.6	26.1	18.1	18.2	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6	101.3	71.0	116.9	138.6	111.5	51.2	50.6	107.0	125.8	95.5	68.0	15.7	283.0	167.5	270.4	53.8	105.0	174.1	140.2	335.7	335.1	102.8	131.4	126.9	137.0	262.0	65.2	120.8	104.3	125.9	41.0	80.8	163.0	119.8	326.4	95.3	76.6	339.4	136.8	97.6	204.5	41.2	103.5	83.5	134.5	117.6	113.3	311.1	142.4	115.8	190.0
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"		13	30422488-30428616	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	9	"testis: 31.5"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	31.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	1.9	2.7	3.6	1.9	2.0	2.8	0.7	0.3	1.3	1.6	0.6	0.7	0.7	1.2	0.6	0.4	0.2	0.0	3.1	1.4	0.6	1.3	1.3	0.6	0.8	0.4	1.1	2.5	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	1.4	0.9	0.9	0.8	1.3	0.3	0.0	1.6	2.6	1.4	0.2	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.9	0.6	2.4	0.0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1.0	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2.0	2.7	1.9	1.6	1.9	2.0	2.8											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2177.0;Late spermatids: 6552.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	36.5	26.5	44.7	28.6	17.3	17.2	31.2	51.1	27.3	41.1	34.5	47.1	15.9	74.4	11.6	29.9	27.2	29.1	49.3	37.5	39.2	61.9	25.6	50.0	14.6	41.5	22.2	59.7	33.4	18.0	15.5	24.5	30.6	29.2	31.6	29.2	55.6	11.6	42.6	30.0	59.0	55.6	58.2	32.3	37.1	45.9	36.3	36.4	34.2	55.3	43.8	39.9	27.0	31.8	25.0	25.2	41.6	36.8	32.6	27.9	23.3	25.0	36.8	20.0	54.3	63.2	10.9	31.9	33.9	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4	35.7	44.5	137.9	175.3	286.2	65.4	70.5	33.1	62.9	66.0	85.5	25.5	212.3	162.5	138.2	2177.0	83.9	61.7	70.0	87.1	187.9	124.3	118.3	92.3	44.8	144.3	82.6	71.7	46.1	58.9	6552.8	86.9	108.4	140.0	201.0	50.2	87.6	106.5	77.7	80.9	127.4	40.9	45.3	165.8	246.5	216.4	281.9	238.1	122.0	65.5	190.8
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389451-76453206	"Enzymes, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 42.3;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		1600000	Nucleoplasm	"Nuclear bodies"	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	8.5	8.5	13.8	10.2	22.6	19.2	7.3	25.2	38.1	9.4	7.2	12.2	7.4	9.9	9.9	8.2	11.7	10.8	7.1	15.4	12.7	15.2	6.5	7.6	6.6	12.8	11.7	14.6	13.9	14.4	16.4	14.3	9.8	30.6	9.4	6.0	10.5	13.4	10.4	23.0	15.2	8.2	8.0	8.0	10.8	10.8	18.1	12.2	10.9	15.8	6.9	9.2	8.6	9.1	4.9	4.1	2.7	1.7	1.5	4.0	1.9	13.1	15.1	15.5	19.0	9.7	6.2	13.4	6.2	6.7	10.1	9.9	13.1	6.7	18.7	4.4	7.7	15.9	13.4	18.0	10.7	7.2	5.3	22.2	18.9	9.9	21.9	8.0	11.4	11.5	6.3	8.7	9.6	8.3	8.8	13.6	10.4	15.7	16.7	5.1	10.8	22.5	13.2	14.3	7.9	20.3	22.3	20.0	20.6	4.5	11.3	23.0	20.7	9.0	23.6	12.4	14.8	13.5	8.2	8.0	11.9	11.2	10.0	10.2	13.8	4.5	15.8	13.0	9.6	7.7	0.0	1.7	2.7	4.0	0.8	2.2	2.6	2.6	2.0	1.0	4.9	2.1	3.0	0.4	1.5	1.0	4.1	2.3	1.9	13.8	22.6	25.2	38.1	12.7	15.2	11.7	14.6	30.6	12.2	3.0	7.7	17.1	5.1	7.7	42.3	23.4	7.6	4.0	6.8	7.0	39.3	5.0	0.0	5.2	1.1	7.5	4.7	0.0	8.0	6.4	7.7	7.2	6.9	5.0	7.0	42.9	22.4	8.6	7.9	1.1	8.9	3.9	5.0	9.0	8.7	8.2	6.5	7.0	7.4	3.1	23.7	6.5	10.0	16.6	18.4	10.8	4.3	6.4	7.9	4.8
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.0	3.1	0.0	0.0	0.2	0.0	15.2	0.1	0.0	6.7	0.0	0.0	14.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	34.1	30.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0	0.0	0.0	0.0	0.6	1.1	23.6	25.0	0.0	0.0	0.0	0.0	5.9	0.0	5.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.8	0.1	42.9	5.2	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	8.4	0.2	0.0	6.3	0.0	49.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 226.9;Spermatocytes: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	60.3	32.7	28.8	22.9	1.8	2.6	5.1	49.2	14.9	30.4	27.7	22.1	21.6	58.8	20.4	12.3	36.6	17.8	28.8	12.8	13.5	46.0	95.7	35.1	18.8	7.1	5.5	42.0	34.2	2.9	3.6	22.3	21.6	6.6	11.9	32.1	34.9	41.2	19.0	16.0	56.8	21.8	72.2	16.9	55.5	50.1	22.2	21.1	8.1	12.9	73.1	39.6	62.7	15.6	27.9	9.1	11.1	22.8	18.2	18.3	52.1	15.6	116.9	33.2	79.7	69.0	19.2	29.7	66.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2	0.0	4.3	37.3	136.4	144.5	56.5	2.4	7.6	0.0	0.0	19.2	51.1	34.3	13.3	44.4	86.7	31.2	25.8	70.0	26.4	226.9	94.9	63.2	18.4	9.6	55.5	30.2	88.9	22.7	24.7	27.7	16.1	39.9	70.9	55.1	28.4	76.7	57.6	28.1	11.7	14.8	59.0	12.9	96.6	216.2	140.8	101.4	50.0	44.7	30.4	121.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.9	30.9	11.6	11.0	29.6	28.8	15.9	27.3	33.5	32.8	31.6	38.5	21.6	20.3	39.2	33.5	41.2	16.2	14.6	25.5	41.9	67.1	15.8	18.4	20.5	23.9	34.2	13.0	19.8	24.5	28.3	26.7	34.6	35.1	24.0	9.7	13.4	26.5	35.1	39.8	14.0	12.9	10.8	30.5	27.1	11.3	29.6	11.5	25.6	24.6	12.0	18.2	18.5	10.0	18.6	27.4	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.6	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4	23.8	16.3	32.1	40.1	46.9	52.1	29.9	30.6	18.7	10.3	34.9	39.3	29.1	18.3	38.9	1.4	40.2	31.5	0.0	46.7	25.9	26.8	61.1	5.8	22.9	22.6	41.3	46.7	39.9	23.9	2.9	25.9	27.7	28.7	52.3	35.4	30.6	59.6	28.1	27.3	20.7	33.6	32.3	35.3	21.4	22.7	49.8	35.8	22.3	24.7	60.4
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.6	11.1	28.1	16.7	16.4	19.5	13.8	30.3	19.0	21.5	19.6	25.7	9.8	35.4	23.0	22.6	21.2	18.2	35.5	21.4	26.3	18.2	11.9	29.3	18.8	15.2	24.7	35.3	21.7	23.1	20.1	20.3	26.0	22.4	16.9	31.1	29.5	25.3	33.7	10.7	29.3	10.3	18.2	21.5	16.2	30.0	42.0	15.6	19.5	31.0	28.9	21.8	24.6	26.7	34.9	19.0	21.8	20.0	21.6	37.7	31.2	18.1	22.1	28.9	34.1	47.7	21.6	19.3	19.6	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4	89.3	73.3	52.7	60.3	63.2	78.1	154.5	43.3	71.0	67.1	36.6	53.0	43.4	16.6	42.2	101.1	45.8	39.4	0.0	43.1	41.8	44.5	85.9	62.2	52.0	41.5	76.3	65.9	47.3	56.6	43.8	52.6	44.6	50.6	37.9	48.7	54.8	47.5	42.1	60.8	44.0	56.4	77.6	54.5	143.0	88.7	79.3	61.9	44.9	47.9	87.8
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557362-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	10.2	16.2	11.9	8.9	13.0	7.1	10.0	23.1	19.5	11.7	9.2	9.4	15.2	6.1	16.4	14.9	9.6	13.9	11.8	21.2	11.3	17.6	12.3	15.4	7.6	8.7	13.0	11.8	14.5	17.5	28.5	17.2	16.5	13.6	12.5	9.4	12.3	12.3	12.6	52.8	7.6	7.0	14.6	7.4	9.1	8.1	27.6	7.0	16.2	16.4	11.1	11.7	10.9	12.9	2.8	4.1	1.0	1.9	3.0	4.0	1.1	6.5	14.8	21.1	15.2	24.2	30.2	19.8	20.2	16.6	16.1	15.2	11.2	11.2	14.5	31.6	24.7	10.9	9.0	33.2	13.4	20.8	24.0	19.6	7.5	13.4	24.4	12.9	7.9	14.6	21.5	10.1	15.7	14.8	24.9	15.5	11.8	19.1	8.0	17.7	13.6	11.2	14.3	50.3	10.7	6.6	20.5	13.0	11.9	15.1	5.5	21.0	19.2	6.7	13.1	11.8	21.1	17.9	11.7	16.4	9.1	10.5	9.8	10.5	12.0	12.0	8.8	16.6	9.5	13.7	0.0	1.3	1.0	4.0	1.9	2.3	1.6	2.8	3.9	3.0	2.8	1.7	2.3	0.0	3.0	1.0	4.1	2.3	1.1	11.9	13.0	23.1	19.5	11.3	17.6	13.0	11.8	13.6	7.0	6.0	1.6	3.0	8.4	7.8	11.4	31.3	10.2	5.3	3.4	19.2	21.6	16.4	13.3	11.9	38.7	10.5	5.5	0.0	9.9	21.4	13.5	12.6	0.0	16.6	11.5	6.4	6.9	4.3	7.5	54.1	17.3	4.3	10.1	10.8	9.3	10.8	9.0	7.6	9.2	13.6	14.1	25.8	8.2	20.4	22.5	12.4	30.1	5.3	8.6	10.7
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486670	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003617	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	11.5	15.3	14.1	7.3	16.0	6.6	12.4	11.9	28.2	11.7	12.2	8.7	11.0	12.2	10.2	13.8	14.0	10.9	10.5	26.5	14.1	11.0	10.6	13.7	10.9	12.1	11.2	16.9	11.2	25.4	11.3	8.3	9.4	13.6	15.4	9.0	8.0	18.8	15.7	59.2	13.3	9.3	14.8	8.6	9.8	10.9	4.3	6.1	8.2	12.2	20.6	11.7	14.9	10.4	10.1	9.9	32.9	10.0	14.3	22.9	17.9	29.1	18.4	5.5	15.0	11.7	11.6	18.5	13.0	9.4	13.5	14.4	18.2	11.6	22.5	39.3	11.8	11.4	11.3	27.4	14.3	7.5	14.7	17.4	16.1	17.6	10.7	14.4	19.0	17.4	9.1	17.1	8.9	15.6	13.5	9.6	16.6	17.7	11.2	10.9	24.1	17.1	18.9	6.4	25.8	30.7	15.4	16.5	23.7	11.4	12.6	10.6	16.0	7.2	24.0	20.8	7.1	11.1	14.4	9.6	13.7	15.6	22.0	27.0	22.7	21.9	40.0	14.4	32.9	15.8	32.9	10.0	9.6	16.5	8.5	22.9	10.1	15.4	17.3	9.9	8.3	13.3	14.9	3.4	14.3	7.1	5.8	15.0	17.9	14.1	16.0	11.9	28.2	14.1	11.0	11.2	16.9	13.6	6.1	3.0	7.9	15.9	10.0	8.5	16.9	28.1	12.7	4.0	9.1	15.7	3.9	22.4	36.5	22.3	0.2	14.8	17.7	0.0	27.8	38.0	13.6	14.1	9.2	14.7	21.3	17.5	8.2	8.0	14.0	0.8	11.5	11.1	27.0	20.8	16.2	14.5	24.7	14.1	17.7	19.5	9.8	0.0	12.3	0.0	6.3	10.7	10.9	18.4	16.6	7.2
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: AB_2677732"	"unprognostic (4.21e-2)"	"prognostic favorable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	14.4	18.0	30.0	16.6	31.8	16.4	17.0	20.8	58.4	20.7	19.4	22.7	15.2	18.2	17.9	19.6	18.4	22.0	15.9	27.6	29.0	21.1	18.6	17.2	16.4	23.1	26.8	26.1	18.4	21.4	30.2	14.3	18.9	33.0	17.5	20.7	15.0	19.8	21.4	45.5	23.0	16.1	23.0	28.3	22.5	18.5	34.8	16.1	36.9	28.2	18.6	34.9	17.7	14.4	26.6	75.5	32.8	28.7	25.8	31.6	23.1	11.5	12.6	20.6	27.6	21.6	28.4	13.9	18.8	23.1	24.8	30.6	15.4	16.9	17.0	20.3	23.1	32.1	18.9	57.3	25.5	23.6	22.4	35.0	22.2	21.1	27.6	20.8	13.7	19.2	21.7	23.2	20.5	28.3	21.3	20.5	38.6	19.0	25.5	25.1	15.9	17.0	21.4	49.2	19.8	15.5	18.4	16.2	37.9	21.2	13.5	20.3	40.2	18.4	17.4	25.1	29.7	18.4	23.0	11.9	22.9	13.5	11.4	23.3	25.7	48.9	18.9	14.9	25.1	19.7	13.6	26.2	28.5	18.8	28.7	17.9	26.6	18.9	19.5	35.1	26.4	18.5	21.8	32.8	25.8	25.7	75.5	31.6	23.1	30.0	31.8	20.8	58.4	29.0	21.1	26.8	26.1	33.0	16.1	29.8	12.8	34.0	19.7	14.1	5.1	24.3	17.8	14.7	9.1	14.0	7.9	57.5	49.7	32.9	58.1	18.2	27.7	23.3	30.3	57.0	17.9	16.9	18.5	15.8	37.4	4.8	22.5	19.6	32.9	133.3	22.7	32.8	20.3	111.8	22.7	16.2	27.8	26.6	19.8	36.8	7.7	19.4	20.0	48.1	27.4	22.0	57.2	32.0	28.2	21.8
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882360	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.1	12.4	10.5	16.6	11.5	38.2	19.8	20.2	15.4	12.6	12.4	11.0	18.1	13.4	13.1	11.8	24.5	11.7	16.6	15.5	11.2	6.5	10.4	15.3	19.1	16.5	9.4	10.8	14.4	12.9	17.6	12.3	10.4	9.1	11.7	13.4	15.9	15.9	14.5	20.9	15.1	15.2	12.8	6.6	21.2	12.5	36.7	10.1	27.1	12.0	13.8	13.7	11.6	15.8	1.2	1.7	15.1	1.2	0.9	1.6	0.9	9.2	11.5	13.3	13.2	11.9	11.0	11.0	11.7	10.9	13.4	13.0	9.5	11.1	17.3	10.9	11.1	14.6	12.5	17.1	10.4	11.4	17.0	9.0	14.1	15.3	7.5	11.4	17.0	15.6	7.5	14.0	15.6	16.8	10.2	17.5	17.1	23.3	14.7	9.9	13.3	18.6	7.9	11.5	9.6	9.0	30.0	16.7	16.3	7.1	10.6	18.3	10.1	20.0	16.4	10.1	10.4	16.1	15.3	17.8	14.4	13.9	46.5	14.3	14.3	14.9	34.5	8.5	10.9	24.2	1.4	1.2	0.9	1.6	1.2	1.1	0.9	1.2	1.4	0.8	1.2	1.3	0.8	15.1	0.9	0.9	1.7	0.8	0.9	10.5	11.5	20.2	15.4	11.2	6.5	9.4	10.8	9.1	10.1	8.9	15.7	27.8	19.9	16.0	51.1	22.6	22.9	8.1	9.1	8.7	104.1	20.7	6.6	15.5	36.6	25.1	29.2	0.0	15.6	20.6	17.1	24.2	7.0	24.6	19.9	47.7	29.6	25.2	29.7	42.8	27.0	21.1	25.3	14.4	24.1	26.6	21.6	28.8	21.2	11.3	98.8	12.9	17.8	91.9	111.7	19.4	24.4	26.7	23.3	22.9
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659963-83708203	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	26.8	33.9	27.2	26.2	38.7	41.1	38.1	35.0	42.2	24.9	24.4	21.2	27.8	21.9	29.1	22.2	30.5	21.4	21.0	34.5	28.9	32.1	31.6	40.8	23.3	25.8	30.0	27.8	21.5	28.1	36.0	29.5	30.4	37.2	26.5	23.7	15.2	23.8	28.9	79.1	27.8	27.6	26.9	33.9	28.6	23.1	22.9	23.3	59.8	25.7	16.2	34.8	24.8	27.3	16.0	19.2	23.4	25.0	24.7	18.8	14.9	43.9	40.7	29.9	23.1	24.9	26.6	49.6	41.1	36.5	43.7	33.2	16.7	31.4	43.7	26.6	34.3	41.7	50.6	41.4	29.2	45.5	23.0	19.2	26.8	31.3	25.9	33.0	32.5	29.5	22.0	36.8	36.8	51.3	27.0	32.6	21.0	28.9	31.3	35.7	26.1	45.4	18.0	39.1	41.6	37.4	33.7	33.5	22.8	28.5	19.2	27.0	30.2	38.0	38.2	29.3	30.9	19.1	23.6	32.3	28.0	26.1	46.2	41.1	43.9	62.0	21.4	41.6	24.0	33.8	23.4	17.1	17.6	16.6	25.0	16.2	16.0	14.5	15.2	19.2	15.5	14.7	16.0	18.5	24.7	23.1	8.2	18.8	14.9	27.2	38.7	35.0	38.7	28.9	32.1	30.0	27.8	37.2	23.3	32.8	35.6	44.2	53.6	91.8	58.5	67.1	20.4	26.8	45.5	21.0	19.6	52.3	16.6	46.7	25.2	35.9	44.6	0.0	46.1	65.6	43.2	59.5	49.6	65.2	47.2	71.5	49.3	27.0	44.2	14.7	22.7	44.6	40.5	33.3	38.0	27.6	56.0	40.3	26.2	29.3	30.6	38.8	45.3	69.1	46.4	80.8	137.4	30.9	34.3	72.7
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.9	7.6	8.1	10.7	16.2	12.9	6.8	16.2	9.4	9.4	7.6	11.7	5.7	10.2	14.1	12.6	7.6	11.9	9.7	8.2	11.7	10.5	8.3	37.1	8.1	12.3	8.1	12.2	12.0	7.7	7.7	12.3	8.2	7.5	9.2	5.1	19.3	11.1	16.0	8.4	7.9	6.0	6.3	9.1	6.4	7.6	13.3	10.8	6.8	12.7	16.0	8.7	11.4	10.5	6.5	6.8	6.9	6.9	11.7	14.2	5.7	11.1	10.2	9.0	7.0	9.4	11.7	7.2	7.8	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4	41.7	21.1	7.5	11.4	23.0	40.4	97.6	15.3	9.4	19.4	12.2	76.6	14.8	3.3	8.0	6.6	23.7	13.4	23.3	9.5	6.8	18.3	22.3	16.1	32.7	8.9	60.4	16.0	31.9	21.5	7.4	23.9	16.8	15.1	4.6	12.5	63.3	9.4	14.0	18.0	10.2	53.7	25.8	26.4	13.0	7.6	25.3	19.2	13.1	9.9	12.3
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053688: AB_2682230"	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.6	10.6	20.5	10.4	20.2	20.6	18.9	17.9	15.8	14.0	12.3	10.6	15.9	47.1	15.5	16.7	9.2	14.4	17.5	15.5	19.7	20.4	8.6	39.3	14.5	19.0	18.0	12.2	21.7	23.6	15.5	14.4	25.2	16.0	16.8	13.5	18.9	26.8	13.7	21.4	31.0	14.6	15.4	22.9	12.0	18.1	12.1	22.3	12.8	23.2	15.1	12.6	12.5	12.1	12.4	18.6	19.6	13.0	16.8	15.0	17.5	13.4	12.4	14.4	13.8	48.5	14.8	19.1	12.1	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3	23.8	27.7	29.8	38.5	46.4	48.4	35.8	5.1	40.2	63.7	29.6	64.8	19.1	8.3	15.1	25.0	38.3	17.3	0.0	13.1	14.9	48.2	37.7	28.9	15.8	15.4	54.0	32.0	23.4	29.4	20.2	36.8	28.9	42.2	27.1	17.9	31.5	16.2	17.3	34.3	6.7	44.0	12.9	38.7	64.7	30.4	53.3	58.2	30.5	17.7	46.9
UBXN1	"2B28, LOC51035, SAKS1, UBXD10"	ENSG00000162191	"UBX domain protein 1"	Q04323	11	62676498-62679117	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012669, HPA076932"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		12000	Cytosol	Nucleoplasm	"HPA012669: AB_1853149, HPA076932: "	"unprognostic (1.76e-3)"	"unprognostic (8.72e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.94e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.42e-1)"	40.4	37.8	33.1	33.8	35.1	27.6	44.1	27.7	37.8	36.0	36.6	36.3	32.3	36.1	38.0	33.7	36.7	37.8	42.3	38.2	30.8	27.2	30.4	26.1	27.3	46.9	33.7	28.5	62.3	41.7	31.4	25.0	29.3	27.2	37.6	19.5	26.6	29.5	32.1	115.3	42.8	31.2	51.5	36.6	37.9	35.0	35.8	29.0	58.9	56.6	40.9	41.2	43.5	67.2	84.1	54.9	27.8	64.2	44.6	85.4	77.8	19.6	31.7	23.8	33.2	33.2	35.7	21.8	17.3	31.9	33.1	22.6	22.6	25.4	31.4	31.9	23.0	29.2	28.1	19.0	29.5	15.4	28.1	24.4	21.9	28.2	30.4	65.1	34.5	24.3	46.1	45.9	29.1	45.0	35.5	30.7	39.7	33.7	20.2	20.6	44.0	26.0	63.7	1.2	15.2	22.0	19.7	26.0	30.6	26.6	19.9	23.7	41.1	16.5	25.3	74.9	10.7	35.3	42.8	30.2	26.9	20.3	27.3	19.5	26.0	19.7	28.1	31.1	14.8	24.4	21.0	51.1	24.4	46.3	53.1	58.9	83.4	70.6	54.2	54.9	84.1	85.4	62.3	27.8	44.6	64.2	43.7	84.9	77.8	33.1	35.1	27.7	37.8	30.8	27.2	33.7	28.5	27.2	29.0	86.4	85.3	236.7	136.4	234.5	60.3	74.7	104.4	105.7	99.0	71.5	43.2	143.5	132.6	157.2	130.0	200.5	201.1	93.5	159.6	151.0	161.2	139.3	157.2	69.5	190.4	28.6	121.1	125.2	291.0	195.1	193.3	259.6	173.7	301.2	133.8	117.2	161.2	178.9	134.7	178.9	48.1	194.1	250.4	238.0	204.7	264.7	271.5	236.6	131.7	176.3
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	56.1	11.6	0.0	1.5	1.9	0.0	58.7	30.3	20.8	21.0	11.3	0.0	0.0	99.0	29.9	31.4	0.1	21.4	0.0	8.5	0.1	8.7	0.0	0.3	0.0	44.9	0.0	0.0	10.8	0.2	16.7	0.0	34.7	0.1	0.0	0.0	0.2	11.0	0.0	0.0	0.9	33.6	0.0	63.4	0.0	24.8	0.0	31.4	0.0	98.8	62.0	0.3	0.2	0.2	13.9	0.0	0.5	0.3	1.3	0.4	0.0	90.4	46.4	87.2	0.2	96.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3	0.0	1.9	0.8	0.8	1.4	19.7	2.5	0.0	12.0	5.7	109.9	7.9	2.5	218.8	3.6	2.0	2.1	0.0	0.0	0.7	0.8	15.8	2.8	2.3	0.4	4.7	138.2	4.1	11.1	0.3	4.4	34.2	1.7	3.3	1.0	0.0	22.6	4.0	0.0	16.3	7.9	39.1	0.0	7.3	6.6	90.2	1.4	1.3	0.0	0.0	0.6
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		490000	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	13.7	39.1	23.6	11.9	37.6	17.4	21.4	17.5	18.7	10.6	21.2	11.4	12.8	12.8	9.0	40.5	37.7	8.1	12.4	15.5	20.6	12.6	20.7	36.8	10.3	12.2	18.2	13.5	7.7	20.8	9.5	28.9	26.3	14.7	12.4	25.0	6.1	24.0	14.9	31.7	28.8	15.0	16.9	13.3	15.3	14.5	24.6	18.6	18.9	28.1	29.8	20.2	16.0	16.2	17.4	46.0	15.8	43.5	20.5	23.4	17.3	51.7	8.7	7.6	5.2	14.2	17.0	21.9	19.6	19.5	25.6	28.7	48.0	25.2	26.8	14.2	20.6	19.5	28.6	17.7	47.7	38.9	14.3	15.5	16.9	14.4	30.6	20.5	40.3	12.7	15.0	33.1	20.0	32.2	10.8	24.9	21.8	18.5	7.7	38.4	18.6	16.4	26.4	11.3	60.9	26.2	13.1	12.2	17.6	30.1	21.1	22.9	6.7	11.2	21.8	9.0	17.1	12.5	11.5	19.2	11.2	13.3	11.9	26.2	10.8	12.0	31.2	22.6	43.7	8.0	15.6	24.1	15.8	10.9	43.5	14.2	17.4	19.9	15.5	33.6	16.0	19.8	18.3	5.4	20.5	36.2	46.0	23.4	17.3	23.6	37.6	17.5	18.7	20.6	12.6	18.2	13.5	14.7	18.6	8.9	22.6	16.0	62.8	67.9	8.8	22.6	35.7	28.1	42.1	43.6	2.0	84.6	77.9	139.8	157.4	22.0	32.0	0.0	124.1	137.9	25.4	82.5	23.1	42.0	76.8	15.9	23.1	17.2	26.4	26.7	15.5	32.1	25.3	20.8	45.7	8.6	125.1	31.7	11.0	96.2	8.8	19.4	18.6	110.6	30.9	69.3	141.3	20.3	55.3	79.8
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.2	7.5	21.1	15.2	19.1	19.8	11.7	12.7	12.9	15.2	14.4	12.5	15.7	12.3	5.9	15.3	11.4	9.7	16.4	20.6	15.8	13.2	9.5	6.5	7.3	11.3	21.1	9.9	8.1	11.6	16.1	13.3	13.7	19.6	24.3	16.0	16.5	24.9	19.6	7.4	13.2	7.4	5.4	8.9	10.8	13.0	8.3	14.8	14.6	7.1	12.6	11.8	7.9	12.9	15.4	13.1	9.9	7.0	14.1	6.3	11.2	4.4	9.8	22.7	8.7	5.9	20.5	6.2	16.1	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6	6.0	19.2	16.7	28.0	19.6	46.6	23.8	10.2	28.1	29.6	19.2	62.8	22.2	94.5	25.2	125.0	22.7	9.1	23.3	28.8	24.6	26.8	16.4	27.8	14.9	23.8	17.5	18.6	14.1	16.7	32.5	32.8	19.1	33.7	14.4	16.8	50.3	19.5	19.3	39.6	62.7	79.4	64.7	30.1	53.7	53.4	16.6	35.0	21.5	15.3	15.4
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 111.3;Spermatogonia: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	12.7	11.1	11.8	17.3	13.7	35.3	12.6	27.8	12.7	12.2	13.8	7.8	12.0	6.4	14.9	11.7	8.9	10.7	8.8	16.0	9.5	6.6	8.7	8.1	12.1	36.7	11.2	8.9	18.2	12.7	7.0	10.6	8.7	10.4	10.5	9.0	8.8	8.5	10.8	22.9	10.9	10.9	13.7	7.8	15.0	10.4	47.5	11.5	22.1	11.8	7.3	29.5	13.6	28.2	8.5	4.9	32.5	6.3	7.4	7.8	3.3	11.1	11.1	11.6	14.8	11.0	10.3	17.0	12.0	13.2	15.0	15.9	13.1	13.1	45.9	14.4	9.5	16.3	8.9	11.8	25.9	18.0	38.3	10.6	14.5	12.3	11.1	12.1	18.2	9.7	7.2	12.4	11.4	31.1	11.7	17.4	20.1	12.9	11.1	12.4	10.6	19.4	11.9	8.3	9.4	6.8	19.0	16.6	19.4	15.7	7.4	12.6	10.0	25.3	8.6	12.5	12.8	7.5	11.0	13.8	8.7	9.5	7.7	15.7	19.8	20.6	24.6	8.5	19.7	9.4	7.0	6.3	16.8	5.0	4.0	5.5	6.4	5.8	4.8	3.8	8.5	5.6	4.6	32.5	7.4	2.8	4.9	7.8	3.3	11.8	13.7	27.8	12.7	9.5	6.6	11.2	8.9	10.4	11.5	11.9	16.0	17.9	15.5	9.3	19.7	16.2	7.6	25.4	22.7	8.7	13.7	11.1	6.6	11.6	15.8	17.5	6.7	0.0	11.4	10.7	12.4	10.1	17.4	6.6	9.1	15.9	12.6	10.4	16.2	7.5	14.4	12.6	1.7	12.6	6.4	10.0	14.2	8.6	11.7	6.4	35.0	12.9	12.1	111.3	78.8	10.5	5.7	15.3	7.5	12.4
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.6;pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0"	"Low region specificity"	"Detected in all"							HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	1.1	3.9	7.1	1.0	12.1	0.9	1.0	17.6	14.6	1.0	1.1	4.5	0.0	1.1	1.1	1.1	1.2	2.0	1.1	1.2	6.7	5.8	1.4	1.1	1.0	1.0	3.2	9.1	1.1	5.0	1.4	18.9	1.0	6.8	1.0	1.1	1.3	1.0	1.0	1.6	1.0	1.1	1.2	3.0	0.9	1.9	7.0	3.5	0.0	1.3	0.0	1.0	1.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.1	0.0	0.0	8.5	0.0	0.0	0.2	0.2	6.3	4.0	0.1	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	7.1	12.1	17.6	14.6	6.7	5.8	3.2	9.1	6.8	3.5	0.0	0.0	0.0	0.2	0.2	42.7	2.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.3	28.8	0.3	0.4	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.2	38.1	0.0	0.0	0.6	12.6	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.4	1.4	4.7	0.0	1.0	3.3	1.6	0.3	0.6	0.0	0.1	0.3
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75274085-75304600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	8.8	15.3	14.6	7.9	15.8	14.9	10.7	20.3	18.7	11.5	9.9	10.8	10.8	14.2	10.0	12.5	13.0	10.2	8.4	12.0	13.1	17.7	15.5	11.3	10.0	10.7	14.9	9.6	8.7	14.1	18.7	19.5	7.6	13.2	12.8	11.0	9.1	13.1	8.6	13.3	7.4	10.5	14.0	10.9	11.0	13.9	3.0	12.4	10.6	13.9	6.5	11.9	9.1	7.9	8.3	11.1	8.9	16.4	14.7	13.3	7.4	7.8	5.6	6.2	5.8	6.7	7.3	5.9	5.5	6.6	6.0	6.7	4.9	5.3	11.0	4.8	5.7	10.6	3.4	14.3	5.0	9.7	10.0	5.7	6.9	5.9	6.2	6.5	13.5	14.4	5.5	3.5	8.3	4.3	9.5	10.4	9.1	8.0	11.1	15.6	3.3	15.3	8.3	12.6	5.8	9.2	7.2	16.4	5.3	15.3	4.6	0.4	6.5	7.8	8.1	7.6	11.5	3.6	8.6	8.7	7.6	4.6	13.9	4.7	7.6	24.6	10.7	8.1	14.9	4.8	5.1	7.4	8.9	8.3	10.7	9.5	8.3	8.3	8.5	11.1	7.2	10.5	9.3	1.3	14.7	16.4	5.0	13.3	7.4	14.6	15.8	20.3	18.7	13.1	17.7	14.9	9.6	13.2	12.4	6.0	5.3	8.2	7.9	5.6	6.2	5.2	0.0	1.4	6.8	8.7	0.0	6.4	23.2	7.6	1.4	7.1	5.2	0.0	5.3	11.5	5.6	6.9	24.2	5.8	10.5	9.5	5.8	14.1	10.8	0.5	4.0	11.0	13.5	4.6	5.9	8.8	4.7	2.9	3.2	13.4	6.3	6.5	7.2	0.4	1.7	5.3	10.2	8.9	6.0	5.6
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1, prefoldin like chaperone"	O94763	19	29923644-30016608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 391.0;Late spermatids: 335.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	16.4	21.2	19.7	15.9	21.5	17.8	21.0	21.7	19.8	18.4	18.0	18.9	16.6	12.9	19.7	19.4	20.5	17.7	14.2	17.5	19.2	16.5	16.6	22.9	13.0	20.7	22.7	15.4	26.3	21.8	21.8	28.8	15.0	21.1	22.6	18.8	12.7	16.7	18.5	45.0	25.3	17.7	15.7	28.3	18.7	14.0	69.2	22.8	21.0	32.1	14.5	20.3	18.6	17.2	6.6	3.1	3.8	2.5	3.7	6.2	1.4	22.7	31.0	14.6	22.6	10.4	15.2	24.6	14.9	12.6	10.9	12.6	16.3	15.1	35.5	29.6	17.3	8.7	16.2	30.8	19.1	24.9	24.6	17.6	32.2	15.4	21.0	15.0	31.0	13.8	13.3	26.2	9.5	35.8	11.8	8.1	21.2	38.2	10.0	13.7	19.5	20.2	13.1	13.6	29.7	9.5	20.0	27.1	14.3	7.2	27.1	23.5	18.5	17.0	20.7	21.8	16.2	8.6	19.6	10.5	27.0	24.0	13.1	22.5	27.6	29.7	24.0	13.3	27.4	16.2	3.8	2.4	3.2	5.7	2.5	4.8	3.5	5.1	5.8	2.0	6.6	6.2	6.1	0.3	3.7	2.3	3.1	3.8	1.4	19.7	21.5	21.7	19.8	19.2	16.5	22.7	15.4	21.1	22.8	41.7	32.1	25.5	69.0	50.6	54.2	48.9	40.8	46.8	36.4	38.4	23.6	16.4	89.5	13.7	391.0	26.4	17.0	0.0	23.9	21.7	30.1	73.3	29.0	41.9	13.6	49.3	27.7	27.6	28.0	335.1	40.6	27.0	30.4	9.0	34.9	44.1	17.2	24.6	38.9	64.7	59.6	12.9	29.4	63.7	50.0	64.4	11.0	35.4	30.6	76.8
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371319-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	27.2	28.9	25.4	22.4	25.5	31.3	23.2	19.4	40.9	23.4	26.3	36.0	19.7	30.9	25.0	24.4	26.5	26.9	22.9	32.3	25.0	21.4	25.5	39.1	20.8	28.5	29.2	22.9	23.4	53.2	21.2	19.6	28.6	32.0	23.7	25.2	22.2	29.2	23.9	34.9	24.4	36.6	26.4	31.8	30.6	25.6	19.2	21.4	34.9	28.0	29.7	28.8	23.0	20.5	12.4	16.7	10.2	17.7	11.3	15.5	11.5	9.0	17.7	16.0	10.8	16.3	16.1	14.5	8.3	14.7	21.4	14.7	14.0	14.5	18.1	7.0	18.9	14.1	30.3	20.3	18.8	10.8	12.8	14.0	15.3	21.3	16.4	15.9	18.5	15.4	20.8	16.8	16.7	14.4	15.5	25.9	21.0	20.6	12.9	15.2	20.3	26.3	27.3	20.0	36.6	21.2	21.6	20.7	22.8	17.3	8.1	14.4	19.0	15.8	26.8	20.3	10.0	25.7	15.4	14.6	15.8	15.0	15.7	14.4	12.4	22.9	18.6	16.5	16.1	19.5	5.6	14.3	10.2	15.5	17.7	13.1	12.3	13.5	14.2	16.7	12.4	13.5	14.4	3.7	11.3	16.1	12.4	14.9	11.5	25.4	25.5	19.4	40.9	25.0	21.4	29.2	22.9	32.0	21.4	14.9	23.2	41.0	28.6	20.1	18.6	19.3	15.3	14.7	10.3	26.2	13.7	74.6	59.7	60.6	1.9	40.5	64.5	0.0	97.1	67.0	38.6	29.5	36.9	19.5	72.0	9.5	21.4	36.2	33.2	2.7	28.7	35.3	50.6	87.4	43.2	22.6	72.9	43.2	29.4	39.9	14.1	19.4	24.2	21.3	25.3	20.8	60.0	45.0	55.7	26.7
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Erythroid cells: 607.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.7	8.4	13.4	17.7	23.3	21.9	6.5	15.6	40.4	33.0	25.4	12.1	6.8	9.1	16.6	23.7	23.3	6.6	25.6	30.5	23.0	8.1	26.9	47.0	19.4	39.9	27.1	14.3	8.7	22.7	19.4	31.4	25.5	24.4	42.3	17.6	81.5	10.0	31.4	10.7	9.7	12.4	20.9	10.2	29.7	14.7	20.0	13.1	28.7	10.9	14.4	11.3	17.1	12.9	26.4	15.9	10.1	15.0	27.3	18.8	14.7	6.5	25.2	10.4	11.1	7.6	29.4	21.7	9.4	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5	41.7	38.9	45.2	26.1	20.4	23.6	60.9	40.8	22.7	18.2	26.2	15.7	83.3	76.3	62.1	7.2	47.7	22.7	607.3	55.7	45.2	63.6	19.5	50.8	86.0	88.6	12.7	17.2	30.7	34.3	12.5	73.6	37.9	45.5	163.3	18.4	80.8	47.4	21.8	52.6	99.3	21.8	38.8	41.5	35.1	38.5	21.7	41.6	21.8	17.4	22.2
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.7	19.3	14.1	31.2	18.8	19.1	19.0	23.0	39.8	16.2	16.2	8.3	21.6	24.8	10.7	28.5	11.3	10.2	8.1	16.3	15.2	30.6	15.5	52.7	10.9	13.7	26.6	22.2	12.4	23.9	9.4	11.3	30.3	22.5	14.8	18.4	9.1	23.6	27.0	21.2	19.4	25.0	15.3	13.3	20.1	13.8	15.5	14.7	21.2	11.0	11.0	19.0	23.0	17.8	31.2	15.0	15.8	21.2	14.7	21.5	8.0	16.5	19.5	21.8	15.8	16.9	29.9	9.0	10.1	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8	17.9	20.2	41.0	10.4	8.2	45.4	60.5	33.1	20.1	17.0	34.9	43.2	49.6	86.2	49.2	45.5	19.3	27.7	186.9	52.4	38.4	25.6	22.0	11.5	53.9	68.9	44.5	13.9	27.6	41.0	95.8	33.1	23.1	59.1	66.7	19.6	51.6	42.5	10.5	38.2	117.1	33.3	6.5	28.2	41.5	71.3	11.2	16.7	38.9	37.7	19.7
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268978-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	40.6	48.6	50.9	42.7	56.8	52.8	53.0	52.5	60.5	23.4	26.2	41.2	25.9	36.5	26.3	23.4	25.8	23.6	23.1	52.6	50.8	35.5	22.1	47.9	29.1	48.8	48.6	43.6	54.1	41.8	34.9	36.4	22.1	40.2	22.5	19.7	31.7	34.0	21.6	108.9	35.1	35.8	24.4	48.5	42.9	30.6	13.0	51.2	22.7	29.9	24.9	32.5	26.8	35.6	7.1	27.3	17.8	5.8	5.8	7.2	3.7	38.7	39.0	20.4	19.2	35.2	18.0	19.1	21.0	25.0	19.1	14.5	18.1	20.1	37.2	33.7	17.9	20.9	11.8	18.8	16.4	10.0	62.5	29.0	22.1	23.4	29.0	21.4	36.9	38.1	15.6	23.2	12.5	19.5	33.3	13.0	25.0	26.5	55.8	15.0	44.4	40.4	14.7	16.9	35.8	13.2	39.7	25.9	35.1	15.9	24.8	34.4	26.1	39.1	42.6	70.6	18.6	17.2	29.7	21.9	32.5	21.9	21.3	28.2	56.2	56.2	40.4	30.1	23.6	42.3	17.8	4.7	5.7	3.9	5.8	4.8	5.6	4.0	5.1	7.1	7.1	3.6	3.5	4.2	5.8	3.5	27.3	7.2	3.7	50.9	56.8	52.5	60.5	50.8	35.5	48.6	43.6	40.2	51.2	6.0	19.0	63.3	21.7	21.1	61.7	62.0	20.4	5.3	9.1	29.6	31.4	20.0	48.0	27.2	0.6	27.9	41.8	0.0	49.5	31.8	22.8	23.4	19.7	42.9	101.1	89.0	50.1	31.3	52.2	2.4	29.7	43.7	25.3	34.3	33.1	60.1	34.5	36.6	29.4	35.6	44.7	12.9	29.9	9.5	10.4	21.7	14.6	39.9	28.2	27.4
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.9	19.3	18.8	23.3	6.9	11.8	25.4	13.8	14.6	23.4	12.9	27.2	12.2	24.2	16.0	14.4	11.7	16.0	26.1	21.9	31.2	9.8	13.7	13.9	9.1	18.0	9.2	20.6	8.4	7.4	17.0	24.4	28.3	13.9	17.9	16.2	37.9	5.3	16.2	29.2	21.3	10.0	22.6	15.6	13.1	27.8	10.3	11.5	14.7	11.4	17.6	10.4	33.0	10.7	9.3	17.2	24.7	13.2	13.1	16.3	13.0	8.2	13.1	8.9	12.3	61.4	10.5	13.3	16.6	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2	50.6	41.3	27.5	36.9	45.7	24.1	56.0	25.5	124.5	62.6	26.2	27.5	85.2	26.6	26.4	61.2	28.2	27.5	23.3	21.5	65.0	33.0	35.8	53.5	33.4	27.3	19.1	27.7	27.0	34.9	79.4	21.9	31.0	23.6	27.9	26.5	20.1	22.1	17.5	21.2	35.6	48.5	25.8	38.2	32.5	29.0	43.3	50.9	25.4	33.2	36.5
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Cell type enhanced"	"Detected in all"	6	"Bipolar cells: 178.6;Horizontal cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.4	22.8	39.3	26.7	14.9	10.0	10.9	11.1	17.5	22.1	24.7	21.7	11.9	9.6	8.8	20.0	23.6	17.3	31.8	7.8	19.7	14.8	24.1	11.2	18.1	19.2	17.3	12.6	23.4	14.3	3.3	23.3	10.0	12.4	8.8	22.5	8.3	1.3	17.2	22.0	24.3	13.4	29.2	7.9	20.3	27.4	38.5	8.0	10.8	20.0	22.3	38.1	20.3	4.1	12.0	26.2	8.6	7.2	9.2	18.6	19.7	26.2	12.6	17.8	11.2	16.7	11.6	15.7	16.6	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6	20.8	15.3	34.1	35.1	12.0	178.6	20.7	12.7	41.5	29.6	31.4	53.0	16.9	43.1	13.8	20.4	19.6	7.8	23.3	9.0	11.2	33.9	14.4	45.0	6.6	12.0	131.9	34.0	23.4	8.8	28.3	27.3	12.9	27.0	26.2	7.9	89.6	11.0	7.0	39.6	12.5	53.1	25.8	33.0	11.7	38.3	5.6	13.6	30.6	8.0	25.7
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13.0	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0.0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2.0	20.0	9.0	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3.0	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3	8.9	31.0	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1.0	2.1	9.7	0.3	0.0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2.0	8.6	4.7	13.5	0.0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 399.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	22.0	8.8	14.1	12.6	10.0	16.5	13.3	21.6	14.4	15.0	14.3	11.0	14.4	22.5	6.5	20.7	22.9	10.1	17.4	15.7	19.6	21.6	18.5	30.1	10.7	12.2	14.9	29.5	16.7	14.1	16.6	19.5	18.1	11.1	14.3	12.9	24.7	39.9	17.3	10.1	18.1	10.8	15.0	18.0	11.5	12.2	34.8	25.8	12.3	16.0	15.3	16.3	14.0	22.4	18.9	10.0	15.4	20.2	14.4	17.6	21.8	16.1	22.1	34.1	46.8	23.7	18.3	21.4	17.4	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3	80.4	84.0	98.9	106.9	50.8	161.8	74.6	53.5	112.4	87.6	50.6	84.4	70.3	112.7	61.8	399.0	40.7	72.4	23.3	103.3	66.4	62.2	82.7	136.5	77.6	53.4	68.3	79.3	46.1	54.6	89.6	81.1	59.7	59.1	95.6	64.7	103.3	77.6	75.8	81.7	60.8	186.0	58.2	71.0	80.0	64.3	56.2	135.5	69.2	70.2	111.6
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.7	9.8	12.3	6.6	16.0	14.1	14.2	7.9	9.9	11.4	11.9	13.9	6.3	14.3	8.7	14.6	23.4	14.4	16.3	13.3	17.9	14.9	9.8	28.6	21.4	16.3	9.5	19.7	22.2	12.3	11.8	17.2	19.6	11.0	10.3	14.6	26.3	6.0	15.1	4.2	11.8	10.5	18.0	8.6	11.9	12.3	15.7	6.2	19.8	12.0	10.8	7.6	13.4	9.6	11.7	19.5	6.7	9.8	13.9	10.4	10.1	12.5	12.5	7.6	5.6	18.8	9.9	16.4	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7	14.9	18.3	14.2	7.0	13.3	12.9	28.1	10.2	8.1	15.9	12.2	68.7	3.6	0.0	8.8	0.4	13.1	6.8	0.0	8.7	6.5	9.6	9.6	12.7	10.9	8.4	36.5	16.6	10.4	17.5	1.3	10.9	12.2	10.1	12.6	16.4	7.1	9.9	11.5	7.4	4.5	16.7	6.5	10.5	8.6	5.8	15.1	1.3	17.1	14.9	8.6
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	1.8	4.7	5.5	6.3	5.2	4.3	4.6	2.1	3.4	2.4	2.0	8.5	2.1	1.2	2.0	5.4	7.9	3.0	7.8	5.2	3.5	2.4	3.7	2.0	1.4	7.7	3.5	0.6	4.3	6.0	3.6	3.4	3.4	5.9	3.3	5.5	3.9	2.0	3.8	4.5	2.9	1.7	6.0	3.5	3.3	3.1	4.8	0.4	3.9	1.8	1.4	4.1	4.0	3.8	4.9	17.9	4.4	1.4	2.5	2.8	5.4	4.8	0.8	1.9	0.5	0.8	3.2	1.7	3.0	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4											17.9	13.3	0.0	4.1	2.6	9.7	2.3	0.0	24.1	13.6	0.0	0.0	34.3	5.0	1.1	0.0	3.1	0.7	0.0	0.6	2.0	1.8	2.5	2.3	1.7	3.4	4.8	4.1	3.1	0.3	0.0	2.0	1.1	0.0	1.0	1.2	10.2	1.2	0.0	3.2	2.6	2.0	6.5	1.7	0.0	1.4	1.9	21.9	1.3	1.7	1.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	8.6	9.7	13.1	17.3	10.8	10.7	9.3	6.4	8.8	8.6	14.8	14.4	12.5	11.5	14.6	8.6	19.9	17.0	18.5	12.0	12.0	12.8	8.4	6.1	6.8	7.7	6.6	7.8	6.1	6.4	9.1	10.0	11.9	12.6	15.5	5.7	10.5	7.5	9.0	4.4	5.9	12.8	15.7	16.0	7.0	14.7	18.3	13.9	9.5	8.5	5.7	6.2	15.2	5.2	4.9	42.9	12.6	2.7	8.2	9.6	14.4	8.7	6.5	5.1	7.3	9.7	0.9	15.3	6.2	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8	8.9	9.1	10.0	6.9	1.4	16.1	130.6	5.1	14.7	10.3	5.2	17.7	3.5	5.0	5.7	1.4	4.3	5.1	0.0	3.4	3.7	4.7	6.2	1.1	6.7	3.9	4.8	4.7	6.2	4.1	1.4	6.4	6.5	1.7	5.4	10.3	10.1	4.4	3.5	13.1	6.3	20.2	6.5	5.2	10.8	10.0	1.8	0.9	24.5	9.2	4.9
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	No	No			Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.2	15.6	9.8	7.7	12.6	13.8	7.9	9.9	7.7	9.5	11.8	17.3	9.4	12.6	7.9	5.1	11.7	14.6	12.3	7.5	15.3	7.9	10.6	10.8	12.7	6.6	6.3	12.8	9.0	16.3	9.3	16.2	7.8	16.7	16.9	14.1	12.0	4.9	14.3	13.1	10.2	19.7	18.9	13.1	19.2	9.4	16.6	9.2	31.7	13.7	10.6	4.9	16.2	9.7	8.9	9.7	12.3	15.8	8.9	18.6	5.2	10.5	10.8	19.9	20.8	8.6	17.5	7.4	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8	35.7	60.4	35.8	31.2	46.8	31.1	9.1	20.4	36.1	43.3	15.7	11.8	17.3	34.9	36.4	19.7	20.3	33.9	0.0	32.3	46.8	16.4	35.8	25.5	20.8	22.8	12.7	42.1	11.1	75.5	53.6	14.7	64.4	40.5	27.1	32.5	24.6	35.0	31.7	17.3	19.9	17.8	12.9	25.2	10.2	41.8	51.6	28.5	37.4	34.7	33.1
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.1	7.4	25.6	17.7	36.9	32.3	22.0	17.7	16.9	21.6	24.3	9.8	14.0	12.1	16.8	17.2	35.5	12.8	18.6	12.1	26.6	11.1	14.5	42.7	18.1	8.5	23.0	14.5	10.8	23.7	9.5	20.9	15.4	20.9	19.2	11.1	16.6	10.6	16.2	6.2	13.1	14.5	24.7	12.6	14.7	12.6	27.0	8.5	20.4	16.6	21.5	16.6	12.4	16.5	24.7	22.8	9.2	15.8	16.1	20.0	14.2	20.1	16.7	8.7	11.0	11.8	15.1	17.2	10.1	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6	41.7	36.3	21.6	16.5	15.2	50.9	31.5	20.4	36.1	25.0	33.2	55.0	21.0	8.3	16.9	2.8	26.4	26.8	0.0	13.4	15.9	21.2	23.9	22.0	18.1	16.5	58.8	34.1	28.8	33.6	3.6	33.1	22.3	21.9	19.8	26.0	34.5	15.7	28.6	30.1	19.2	40.3	19.4	17.5	36.1	26.3	14.3	10.0	27.5	22.9	20.0
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78214711	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 32.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 20.7;Late spermatids: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	4.9	17.1	5.1	5.4	9.3	3.8	5.2	10.4	15.0	6.4	5.8	8.0	6.3	5.5	6.8	5.4	5.6	5.4	5.6	8.7	6.1	6.7	5.0	13.8	5.6	4.8	6.7	8.8	6.6	6.4	32.4	12.0	7.1	15.0	5.0	3.4	7.7	4.0	5.6	5.6	3.2	5.3	7.8	4.5	4.6	3.9	5.3	4.0	1.9	7.7	2.9	4.1	5.2	6.6	0.0	0.1	3.4	0.6	0.1	0.3	0.2	2.1	3.3	5.7	6.0	9.7	9.0	3.9	4.9	5.8	5.8	4.1	8.3	4.6	1.7	5.1	9.2	6.2	5.7	3.8	7.6	3.4	12.2	2.0	2.8	8.6	4.8	7.6	1.8	8.3	7.6	5.1	12.1	3.5	11.5	7.1	6.2	3.9	4.2	4.5	1.9	4.6	7.2	1.7	6.0	5.3	2.8	5.3	2.0	4.6	3.9	2.8	5.4	3.8	5.0	1.8	8.5	4.2	1.5	8.6	10.7	6.1	12.6	2.6	5.7	1.8	2.6	3.2	1.9	6.2	0.0	0.2	3.4	0.1	0.6	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.2	5.1	9.3	10.4	15.0	6.1	6.7	6.7	8.8	15.0	4.0	0.0	2.6	0.0	0.1	0.7	0.7	1.8	0.0	0.0	0.0	0.0	5.9	0.6	0.0	0.8	20.7	1.5	0.8	0.0	1.7	1.3	2.0	0.2	0.0	3.0	1.3	0.0	0.0	2.5	0.8	31.6	1.4	0.9	1.7	3.6	0.6	0.5	1.8	0.0	2.8	0.8	0.5	6.5	0.9	0.9	1.6	0.9	0.2	3.9	0.7	0.1
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 117.3;Late spermatids: 116.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.4	5.4	11.5	8.8	3.0	3.7	9.8	5.7	4.1	9.9	11.2	10.2	5.9	6.8	6.2	4.4	7.6	7.1	12.5	6.3	10.9	9.2	6.6	18.3	11.0	6.7	3.4	11.9	9.2	2.0	3.8	10.4	7.5	3.6	4.2	11.9	13.2	13.1	6.2	5.5	15.3	8.2	9.8	4.8	4.7	12.4	17.2	6.2	3.4	8.8	12.6	6.8	9.1	4.5	5.7	11.5	5.2	8.4	5.4	11.2	9.8	6.2	7.4	8.9	7.9	13.9	6.0	8.8	7.6	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5	0.0	8.3	11.5	5.5	17.3	16.4	3.3	2.5	10.7	10.3	7.0	25.5	6.1	0.0	4.6	117.3	9.0	5.1	0.0	2.0	5.4	9.3	10.2	4.7	10.2	6.5	14.3	9.9	11.6	8.1	116.2	9.2	13.7	20.3	5.4	8.1	9.9	4.6	6.8	9.2	3.6	21.1	6.5	10.3	40.0	12.8	18.1	6.1	17.9	7.0	5.8
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.2	3.0	6.0	8.5	11.2	10.6	6.4	7.4	8.3	7.7	11.1	6.3	4.8	11.3	5.5	7.4	9.1	5.8	9.2	7.3	10.7	8.9	8.8	11.0	6.0	4.9	8.6	10.2	6.3	11.3	5.9	6.9	11.9	8.2	11.4	10.3	26.5	11.3	7.3	3.9	3.2	9.8	9.7	6.6	6.5	4.8	4.5	6.3	10.8	5.0	8.5	7.0	5.3	6.9	5.4	7.9	3.7	5.0	11.5	4.2	5.4	6.2	11.2	4.8	4.4	20.7	7.3	9.7	7.5	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4	3.0	4.3	4.4	6.8	2.1	7.9	7.1	7.6	12.0	3.4	3.5	17.7	5.3	5.0	3.9	10.8	5.3	5.8	0.0	2.3	5.9	3.8	5.6	2.3	3.8	3.5	9.5	2.4	8.0	4.1	5.9	12.0	3.9	3.3	13.6	2.3	5.6	4.3	2.9	8.1	13.4	7.6	0.0	6.2	1.8	5.5	2.5	6.2	5.1	6.0	6.5
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.6	40.1	27.0	30.5	18.4	17.0	34.5	27.9	21.4	33.4	24.4	37.9	25.5	31.0	14.7	29.0	26.5	22.7	29.6	27.7	21.4	58.2	25.1	28.4	32.3	20.6	14.3	25.6	30.0	17.1	16.1	28.9	20.0	22.4	28.5	12.5	24.4	12.5	27.5	28.1	38.5	12.8	52.6	26.2	17.0	30.3	35.2	21.5	19.1	25.0	14.9	30.1	19.0	29.0	12.1	35.1	11.6	21.1	27.6	28.3	34.3	21.5	34.7	15.0	34.6	47.3	31.5	16.4	27.5	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7	8.9	12.5	13.0	9.5	10.3	18.1	8.1	17.8	4.0	5.7	21.0	56.9	38.0	10.0	25.9	8.7	7.9	17.7	0.0	17.8	24.3	16.4	7.4	14.9	19.7	24.7	38.1	16.0	9.2	12.1	15.5	21.3	9.6	15.1	47.7	14.7	13.8	16.9	17.8	31.8	14.7	14.5	32.3	9.7	24.5	23.8	13.6	44.2	14.1	22.7	5.6
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892094-8964514	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	17.8	16.8	23.9	25.8	22.9	37.6	21.3	28.7	24.5	21.2	26.3	16.2	18.4	17.7	23.5	16.4	24.4	20.3	18.7	23.7	22.8	20.8	16.5	21.3	21.0	30.5	19.6	22.6	22.5	24.0	44.4	19.7	19.3	16.2	18.5	27.4	16.0	18.4	20.3	42.2	25.2	21.5	22.7	15.3	22.9	22.6	43.3	16.5	68.8	19.5	22.3	35.1	23.9	31.7	7.5	9.8	5.5	7.8	3.9	8.7	1.8	12.4	23.3	20.6	15.4	11.7	15.0	14.2	17.2	14.8	16.1	13.7	20.8	15.3	30.1	11.0	19.9	9.2	15.6	31.5	20.6	27.0	19.7	12.5	25.0	15.7	42.9	16.9	27.5	16.2	12.9	13.1	17.5	20.7	12.4	22.8	45.5	24.1	33.4	16.4	23.8	40.3	5.3	14.4	15.8	13.5	35.9	23.1	27.5	11.3	24.5	19.5	12.0	19.3	18.2	9.5	22.0	18.1	12.3	19.5	17.5	17.9	26.8	12.9	16.2	39.6	46.0	16.3	16.0	14.0	5.5	3.3	3.8	7.1	3.2	8.7	5.9	6.6	8.2	3.3	7.5	8.0	6.8	5.2	3.9	7.8	9.8	7.0	1.8	23.9	22.9	28.7	24.5	22.8	20.8	19.6	22.6	16.2	16.5	32.8	46.2	23.4	19.2	41.3	47.4	61.8	20.4	46.8	46.6	27.9	23.6	18.4	5.0	21.1	217.0	25.9	29.6	46.7	28.3	12.6	24.0	27.0	25.5	34.2	17.5	41.3	40.6	25.2	28.0	84.4	23.6	28.5	18.6	16.2	46.7	25.0	27.8	28.8	32.5	11.8	41.6	6.5	29.2	29.9	31.9	43.7	17.6	26.6	47.0	32.7
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6000000	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	34.5	14.1	11.6	34.5	23.5	22.9	25.4	3.1	11.3	32.6	15.3	6.8	21.9	7.7	28.8	21.5	17.7	21.4	15.8	13.8	9.2	12.8	15.5	11.8	35.2	30.9	12.7	8.8	22.7	23.8	53.1	13.0	21.1	16.0	23.4	15.2	17.3	18.4	24.8	11.7	16.7	14.8	19.8	16.6	45.8	13.3	45.0	8.5	27.4	32.4	20.0	25.7	20.7	23.4	11.7	15.0	10.6	48.0	10.3	12.6	3.7	6.9	5.9	10.5	13.6	18.3	16.8	6.3	10.3	10.1	8.4	12.3	22.5	2.6	2.2	9.1	23.1	9.9	4.1	58.4	8.7	12.1	23.3	6.7	8.3	6.4	13.3	7.2	9.2	0.1	9.7	1.8	12.4	6.5	7.9	41.7	6.6	0.5	6.1	11.8	4.6	7.3	4.0	4.2	4.3	6.3	6.6	19.0	0.2	9.7	0.2	13.4	0.2	16.1	2.2	6.4	16.8	8.9	12.5	53.6	8.1	10.1	4.1	9.8	4.7	6.3	0.3	4.9	5.6	13.2	9.8	12.3	6.6	12.6	36.3	9.0	7.4	8.0	10.2	5.1	11.7	7.0	7.3	10.6	10.3	48.0	15.0	6.4	3.7	11.6	23.5	3.1	11.3	9.2	12.8	12.7	8.8	16.0	8.5	381.2	100.6	59.6	24.2	26.2	6.0	51.2	35.7	125.8	185.4	29.6	0.0	73.5	0.0	20.7	418.2	142.7	5.3	0.0	27.6	3.8	38.2	40.0	27.8	12.1	19.7	57.2	30.0	68.2	90.1	250.3	22.2	56.1	37.1	8.2	14.2	29.3	24.9	10.5	31.5	4.9	3.4	142.3	109.3	5.7	4.6	39.6	108.1	64.0	20.4	18.4
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651798-47659161	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	30.9	37.4	21.7	33.7	23.6	54.4	38.9	20.0	27.3	26.7	31.9	24.8	33.5	23.2	26.8	39.8	30.1	32.4	31.3	47.3	20.9	16.5	34.7	66.8	24.9	46.1	23.6	24.9	50.5	54.1	21.4	29.6	39.0	26.0	30.0	31.1	19.5	46.5	30.5	42.1	36.2	29.1	21.1	27.6	37.1	31.9	24.7	22.6	50.4	37.0	33.2	41.6	24.5	32.5	58.2	60.2	26.2	35.8	36.0	73.5	52.0	45.8	50.9	21.7	28.8	49.7	60.0	38.2	29.8	43.6	51.1	48.5	43.7	43.8	52.6	21.7	42.4	47.3	37.3	30.8	40.7	36.4	34.3	61.1	26.5	58.0	43.1	57.9	58.3	52.1	42.1	52.2	43.0	46.3	35.6	41.1	45.4	28.9	50.9	43.2	50.5	39.8	81.3	31.1	42.0	58.1	35.5	44.0	72.3	41.1	33.8	20.6	27.0	33.1	36.0	46.0	41.5	42.3	54.1	30.0	35.8	39.0	49.2	32.6	40.2	35.4	47.2	45.6	64.9	36.1	18.7	35.8	26.2	40.2	35.5	54.1	58.2	57.7	43.2	47.4	56.7	73.5	60.2	23.0	36.0	32.4	60.2	52.9	52.0	21.7	23.6	20.0	27.3	20.9	16.5	23.6	24.9	26.0	22.6	68.5	66.8	281.0	227.2	190.8	23.2	91.3	173.3	104.4	77.3	92.5	15.7	159.9	266.9	141.0	57.0	149.5	224.3	70.0	277.6	166.5	144.8	211.1	151.2	220.1	215.1	9.5	179.6	164.5	216.2	146.7	194.8	227.9	187.3	293.1	261.4	59.3	182.8	282.8	184.2	337.2	20.1	142.3	173.2	63.7	82.2	178.2	178.7	244.2	308.1	250.0
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584408-85593412	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	26.2	25.8	12.6	18.9	14.1	11.7	27.5	4.3	9.2	17.9	22.1	8.5	9.2	7.6	18.9	27.2	24.3	18.3	18.8	37.0	11.0	10.9	18.5	31.2	28.8	32.1	16.8	9.6	19.6	6.3	3.2	7.2	24.4	17.7	29.0	6.9	16.0	7.7	13.0	70.9	9.5	17.0	25.5	14.1	33.3	12.3	13.7	8.1	18.0	17.5	19.8	13.0	21.8	25.8	10.2	13.8	27.5	80.4	14.3	39.4	39.3	0.1	0.0	0.4	0.0	16.3	28.6	0.4	17.3	27.5	17.0	18.8	6.8	2.6	0.0	0.4	29.9	9.2	0.2	0.0	0.4	7.6	24.5	0.5	0.3	0.4	9.5	34.3	0.7	0.1	19.8	1.7	7.1	0.2	25.1	64.1	10.9	0.0	0.0	75.3	2.4	10.6	2.3	0.0	4.7	0.1	15.9	0.0	0.4	0.4	0.6	0.0	0.6	0.1	4.9	0.1	0.4	0.5	0.8	43.8	0.4	1.2	1.3	0.0	0.0	0.5	0.4	20.0	0.9	11.6	8.2	38.1	27.5	31.7	80.4	29.8	9.7	24.1	23.5	12.8	10.2	18.5	22.3	11.8	14.3	64.4	13.8	39.4	39.3	12.6	14.1	4.3	9.2	11.0	10.9	16.8	9.6	17.7	8.1	17.9	30.0	50.0	38.6	54.0	0.8	75.5	81.5	29.4	37.5	41.8	0.0	16.6	24.9	28.6	1.2	294.0	58.6	0.0	43.2	6.9	187.6	42.9	43.8	141.5	73.6	3.2	12.1	443.2	298.8	4.7	178.4	77.9	261.5	100.0	11.0	11.5	39.6	48.9	155.2	64.7	0.5	58.2	94.7	4.8	3.2	39.5	18.1	106.6	7.6	32.9
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 21.8"	"Cell type enhanced"	"Detected in single"	27	"Cardiomyocytes: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 7.7;WM-115: 5.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8"	"Low region specificity"	"Detected in many"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA			"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.4	0.4	1.4	0.4	21.8	0.4	0.4	0.0	7.0	0.5	0.5	9.5	0.0	0.4	0.4	0.4	0.5	0.4	0.5	0.4	1.5	5.2	0.4	0.4	0.4	0.4	0.7	4.3	0.4	0.4	0.7	0.5	0.4	1.2	0.4	0.5	0.0	0.4	0.5	0.7	0.4	0.5	0.4	1.3	0.4	0.4	2.1	2.9	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	21.8	0.0	7.0	1.5	5.2	0.7	4.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302790	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	12.3	21.4	15.4	14.3	17.2	5.1	14.6	28.3	27.2	12.9	14.4	9.1	19.0	9.5	17.1	15.9	15.6	11.5	12.1	14.7	11.8	9.5	12.1	10.4	13.8	9.6	11.0	14.0	13.3	12.6	15.7	20.4	19.6	11.4	15.8	10.6	10.3	10.9	13.9	42.7	16.1	11.0	16.2	12.5	7.2	10.7	7.2	12.2	13.6	29.8	14.5	10.0	15.7	12.2	5.2	4.4	1.1	3.5	2.4	5.0	1.2	10.3	9.6	13.3	7.2	10.2	7.3	5.1	7.6	9.6	6.1	9.7	3.5	4.9	13.4	5.0	6.6	3.3	5.4	9.5	6.7	11.4	9.0	5.3	5.1	2.5	3.6	5.5	10.1	3.0	9.2	11.7	5.7	16.5	14.2	12.8	6.6	3.0	5.3	5.5	2.8	8.7	4.8	6.7	3.3	9.8	7.9	6.3	4.3	17.7	7.5	9.0	7.8	7.3	11.1	3.5	12.4	13.7	1.7	10.2	5.5	2.1	2.4	4.2	5.2	7.8	11.4	2.1	3.7	2.8	0.5	3.1	1.1	3.6	3.5	4.7	5.2	5.0	2.1	4.4	3.6	2.4	2.0	0.3	2.4	0.9	1.8	3.5	1.2	15.4	17.2	28.3	18.8	11.8	9.5	11.0	14.0	11.4	12.2	65.5	43.0	27.5	49.9	69.0	66.8	41.6	33.1	29.4	47.8	31.4	80.5	32.2	8.3	45.1	8.5	39.8	29.7	0.0	39.7	17.6	29.0	46.9	28.8	32.6	18.8	58.8	36.9	40.5	28.3	8.3	30.2	23.7	35.4	20.8	26.8	23.0	54.7	29.1	31.1	18.9	146.1	6.5	34.3	27.3	17.9	63.2	92.6	20.3	20.7	66.0
VGLL4	KIAA0121	ENSG00000144560	"Vestigial like family member 4"	Q14135	3	11556070-11771350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038225, HPA038614"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038225: AB_10674549, HPA038614: AB_2676115"	"unprognostic (1.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.26e-1)"	22.3	29.3	26.6	20.7	25.1	10.5	28.2	18.0	23.8	32.3	18.6	22.8	17.8	18.9	35.6	23.3	23.6	36.0	28.9	20.7	23.3	13.2	22.5	10.6	20.4	15.2	22.4	14.9	65.4	18.4	27.2	19.6	19.9	19.7	21.8	14.7	28.8	28.7	23.5	13.8	24.2	18.6	24.7	28.2	15.8	18.6	25.4	23.3	30.0	37.5	21.3	19.9	23.4	30.3	5.6	5.3	16.2	5.8	6.3	11.3	5.8	10.3	7.0	20.1	6.1	25.5	13.8	37.7	6.9	14.3	6.1	6.0	5.9	10.3	14.1	16.0	10.9	10.7	7.0	9.2	11.5	4.3	8.5	14.0	15.1	7.0	9.8	19.9	11.8	10.0	17.2	24.0	8.3	10.7	36.0	22.8	15.0	5.4	2.4	9.4	8.9	14.0	13.6	12.4	15.3	12.4	18.1	13.6	18.4	14.0	15.0	8.8	25.4	7.9	8.5	17.7	13.8	8.3	11.7	12.0	16.6	8.1	10.8	17.4	3.8	10.9	30.9	18.3	20.2	32.1	16.2	4.4	1.0	11.3	2.5	7.3	5.6	6.2	9.2	5.3	4.0	8.5	8.9	2.6	6.3	5.8	4.5	3.1	5.8	26.6	25.1	18.0	23.8	23.3	13.2	22.4	14.9	19.7	23.3	29.8	14.4	15.2	51.3	57.4	41.2	2.8	43.3	53.5	31.8	41.8	139.4	60.4	53.0	61.8	12.4	50.4	28.1	23.3	31.6	68.9	55.2	68.7	13.9	13.0	28.2	69.9	33.3	55.9	17.0	12.4	67.9	13.8	42.2	25.2	29.4	89.9	45.9	42.1	85.2	21.3	50.6	32.3	46.2	10.2	27.7	66.6	37.4	18.8	36.0	58.0
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 54.7"									"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969"	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.8	6.6	14.6	8.9	13.6	10.5	54.7	6.1	8.7	7.8	9.2	7.8	8.6	24.3	8.3	8.2	11.0	5.9	13.5	8.5	9.6	11.6	12.2	18.9	10.8	10.7	12.9	16.6	15.2	10.6	9.7	10.3	13.0	10.4	8.9	15.3	16.8	18.5	7.6	12.4	15.8	12.2	9.8	7.4	8.5	20.1	12.9	12.2	9.5	17.8	5.5	18.3	12.8	6.8	7.3	9.2	13.4	21.1	7.7	7.7	10.4	7.2	9.5	13.2	26.9	38.8	8.6	20.0	7.0	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2	11.9	12.2	25.5	15.5	13.1	15.6	5.0	20.4	5.3	5.7	15.7	17.7	13.9	6.6	9.9	7.6	12.1	10.5	0.0	4.5	15.8	9.5	19.0	4.7	12.3	12.9	17.5	13.8	17.2	20.2	6.1	13.0	18.5	11.8	15.4	9.3	10.4	8.5	9.3	10.6	7.3	13.9	6.5	6.2	14.4	25.6	17.9	14.4	17.5	10.7	19.5
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487693-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 23.8;Club cells: 27.3;Cytotrophoblasts: 20.9;Extravillous trophoblasts: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	25.0	16.5	14.6	19.1	16.9	30.9	23.4	20.9	16.9	21.5	16.0	16.6	17.4	10.7	20.4	13.7	16.5	18.9	12.6	13.9	12.9	11.7	15.0	16.3	14.1	17.6	13.8	14.3	23.3	21.7	25.2	23.8	19.0	15.5	15.4	16.0	12.2	15.2	15.6	16.2	14.5	15.4	23.3	17.8	16.7	19.1	21.2	14.7	30.8	18.0	18.5	19.3	22.2	15.2	8.2	6.0	12.3	14.3	10.5	13.3	6.3	21.0	13.5	14.6	8.0	18.0	23.9	9.4	14.7	15.1	16.1	16.5	9.4	17.9	22.9	14.0	19.2	12.6	13.8	19.5	17.9	23.7	20.2	10.7	27.4	11.2	9.2	13.2	13.5	9.8	18.3	7.3	19.3	18.6	16.4	20.2	15.2	27.9	14.4	16.1	12.4	26.1	7.5	9.4	21.6	10.3	15.6	13.3	12.7	10.4	14.7	11.5	15.9	11.6	2.9	12.8	15.0	16.9	10.9	19.9	14.8	8.8	12.6	13.5	11.4	14.2	27.4	14.6	17.9	14.1	12.3	5.6	9.8	8.4	7.4	13.3	8.2	9.3	11.2	6.0	6.7	11.5	9.8	7.1	10.5	14.3	3.8	7.8	6.3	14.6	16.9	20.9	16.9	12.9	11.7	13.8	14.3	15.5	14.7	23.8	15.5	0.0	0.0	0.0	0.0	0.0	0.0	16.0	27.3	7.0	0.0	20.9	6.6	13.2	0.0	0.0	0.0	0.0	10.6	20.0	0.0	0.0	4.7	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	8.2	0.0	0.0	12.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7"									HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.1	1.4	2.0	0.3	2.9	0.3	1.5	9.2	3.5	0.2	0.7			0.0	0.5	5.3	0.9	0.8	0.6	1.9	1.9	2.0	0.8	0.9	0.9	0.7	1.5		1.6	0.4	3.6	3.5	1.1		2.0	0.4		0.8	1.3	3.6	4.0	0.5	0.5	1.5	1.1	0.9	1.4			2.7		0.4	0.5	0.3	2.3	0.3	0.5	0.3	0.6	0.4	0.1	0.5	0.1	1.8	1.9	0.1	0.5	0.9	0.5	0.7	0.4	1.9	0.0	0.2	0.2	0.9	0.2	0.3	0.0	0.4	0.2	0.7	0.0	6.2	0.9	0.0	0.6	0.3	0.4	1.2	0.7	0.7	0.1	0.4	1.0	0.2	0.6	0.3	0.9	0.9	0.3	0.4	2.1	0.5	0.1	0.6	0.4	1.2	0.9	0.6	1.1	3.4	1.4	0.0	0.5	0.1	1.0	0.9	0.6	0.1	1.5	0.2	0.4	0.6	5.6	6.7	0.5	0.5	0.1	1.1	0.5	0.3	0.3	0.4	0.0	0.2	1.3	0.3	0.3	0.2	2.3	0.4	0.3	0.5	0.6	0.2	0.3	0.0	0.1											0.0	0.6	0.5	0.0	0.0	4.8	0.2	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.7	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3
VPS37C	FLJ20847	ENSG00000167987	"VPS37C, ESCRT-I subunit"	A5D8V6	11	61130256-61161617	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043348	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043348: AB_10794658"	"unprognostic (1.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-1)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.37e-7)"	"unprognostic (1.99e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.05e-2)"	12.8	12.7	15.6	13.8	14.5	9.8	13.9	10.0	17.4	15.4	18.4	16.0	17.3	19.1	16.1	15.0	20.9	14.5	14.3	15.0	15.5	9.2	15.4	12.1	13.9	8.0	12.5	10.2	16.3	22.6	14.7	19.8	19.5	13.4	19.5	12.5	18.2	29.1	18.2	20.6	24.1	26.4	16.7	13.6	13.0	23.7	18.6	15.3	5.9	14.0	14.9	14.4	17.3	14.6	1.1	1.9	6.8	4.5	0.4	0.8	1.0	17.4	7.1	9.0	8.3	4.4	9.4	19.9	8.9	23.8	13.4	9.0	8.3	8.0	4.5	12.5	12.0	10.7	9.7	8.1	9.5	6.9	10.0	6.2	6.0	4.9	9.0	14.1	4.6	7.1	8.1	14.6	11.1	14.1	7.8	8.6	3.2	15.3	7.4	8.8	21.2	0.9	6.7	10.8	7.6	10.1	1.6	4.0	10.9	10.1	9.4	5.5	13.6	9.0	27.3	14.1	7.9	26.1	11.1	6.6	13.0	9.4	12.8	10.8	3.7	5.0	3.8	11.5	5.6	8.4	0.8	2.5	2.8	0.6	4.5	0.8	1.1	0.4	0.7	1.9	1.1	0.5	0.3	6.8	0.4	4.1	0.3	0.3	1.0	15.6	14.5	10.0	17.4	15.5	9.2	12.5	10.2	13.4	15.3	14.9	5.9	3.7	11.5	11.1	4.1	5.6	12.7	9.4	5.7	12.2	9.8	24.3	10.0	13.7	7.3	7.0	14.8	0.0	17.2	18.7	12.1	15.6	0.0	5.5	15.3	23.8	15.6	4.9	10.5	5.8	7.2	10.5	6.8	11.8	16.5	8.8	18.1	10.5	12.7	5.4	36.8	0.0	14.3	13.2	13.4	17.3	29.4	3.3	9.9	12.2
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54, GARP complex subunit"	Q9P1Q0	2	63892146-64019072	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	15.5	14.2	10.1	11.1	13.2	12.6	14.3	22.1	12.9	18.6	17.1	11.4	17.3	12.9	16.3	14.4	13.3	14.4	13.7	12.5	11.3	8.5	15.8	15.5	15.2	9.6	14.3	10.6	18.0	21.0	34.2	32.1	13.0	12.1	17.3	13.5	14.3	31.9	19.4	12.2	13.1	16.9	17.5	10.4	13.3	13.7	12.2	12.5	18.3	17.5	11.3	11.3	13.5	26.2	3.1	2.8	4.1	3.2	3.0	4.3	1.0	16.7	9.3	17.0	13.3	12.5	13.2	12.5	10.9	16.4	11.6	11.5	16.9	10.9	11.7	8.2	14.3	17.2	7.8	16.7	9.8	20.6	16.6	11.1	11.1	7.1	28.5	11.7	7.5	4.7	12.2	14.8	8.2	17.8	13.9	17.4	8.4	12.1	9.9	14.6	7.4	7.7	7.4	10.3	17.0	6.7	7.8	16.7	6.6	12.7	9.8	9.8	14.7	9.4	12.1	12.4	14.0	8.7	14.8	12.4	14.9	11.9	9.0	17.7	22.8	6.2	15.0	10.9	15.1	12.6	4.1	3.2	1.3	2.1	3.2	2.6	2.4	2.1	2.5	1.8	3.1	2.8	2.2	3.0	3.0	2.5	2.8	4.3	1.0	10.1	13.2	22.1	12.9	11.3	8.5	14.3	10.6	12.1	12.5	14.9	18.2	4.6	7.4	9.8	17.8	11.7	7.6	8.1	18.2	1.8	11.8	5.3	1.7	6.5	41.8	11.3	9.5	0.0	11.3	5.4	11.3	16.0	2.3	14.3	7.0	22.3	12.7	8.6	8.6	28.3	17.3	8.8	5.0	0.0	17.7	8.9	10.1	11.5	11.7	8.4	16.4	19.4	8.9	13.2	6.0	9.2	4.6	6.4	11.0	12.2
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720986	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 16.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	8.6	15.4	16.1	19.2	17.9	14.2	5.3	22.7	30.6	6.7	7.1	13.3	8.8	16.6	7.1	7.2	17.0	7.0	9.3	11.0	17.2	16.3	11.7	15.0	8.2	10.4	12.6	24.1	6.4	12.2	16.5	17.6	6.8	17.6	7.9	4.9	10.2	15.3	8.4	12.8	12.6	13.0	6.2	9.3	15.7	10.3	13.5	10.6	1.7	9.3	7.5	7.7	8.5	7.6	0.2	0.2	16.6	0.6	0.1	0.4	0.1	4.6	6.9	7.7	8.3	7.8	7.7	6.5	8.5	8.8	7.3	3.6	6.0	10.2	4.7	5.5	9.2	4.1	10.6	0.6	4.8	2.1	4.2	11.8	3.3	6.0	7.2	6.0	1.9	8.2	8.4	4.4	8.8	2.0	11.9	5.0	4.4	8.4	2.9	4.8	20.7	3.5	7.4	2.9	3.6	8.0	8.8	6.4	2.9	5.8	7.3	6.5	6.9	10.8	4.1	8.6	2.5	18.3	8.2	7.9	9.7	12.1	7.8	5.1	13.4	4.2	4.1	14.0	5.1	8.0	1.2	0.6	0.3	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.4	0.2	16.6	0.1	0.2	0.0	0.2	0.1	16.1	17.9	22.7	30.6	17.2	16.3	12.6	24.1	17.6	10.6	6.0	6.1	4.1	1.8	1.8	12.3	7.2	2.5	1.4	5.7	8.7	9.8	2.6	6.6	4.4	10.5	2.2	9.8	0.0	6.7	1.9	4.1	1.4	4.6	9.6	4.3	7.9	10.4	8.6	9.4	16.4	5.8	6.4	3.3	1.0	4.1	6.6	4.9	3.6	5.6	4.9	11.9	0.0	4.3	8.6	4.3	3.3	2.5	3.1	6.3	1.7
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.8	9.1	22.7	10.1	2.7	5.0	14.1	12.0	9.3	19.2	19.2	10.9	15.8	40.4	8.1	7.1	11.8	17.6	21.2	15.7	26.5	23.0	11.3	25.1	6.0	11.1	3.0	48.4	15.8	2.7	2.8	14.5	10.6	3.9	13.3	31.0	21.4	25.6	16.5	18.1	38.4	20.8	14.5	12.1	17.5	36.0	39.7	13.7	8.8	16.4	16.0	9.1	10.6	10.8	8.1	11.9	12.4	19.2	7.1	8.8	7.8	15.1	12.0	13.4	15.8	39.1	13.7	21.2	10.4	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9	3.0	2.9	30.5	11.8	14.9	12.3	10.6	15.3	42.8	13.6	14.0	7.9	19.7	10.0	9.8	13.3	11.3	2.4	93.5	16.8	39.6	10.4	5.3	27.7	2.4	16.3	9.5	2.9	6.2	9.7	10.8	5.2	11.5	11.8	12.6	8.0	5.2	7.6	0.0	9.2	8.4	6.6	19.4	11.3	141.1	122.1	12.2	12.6	26.7	11.2	8.4
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 469.4;Late spermatids: 1260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.0	16.7	12.3	13.2	16.3	15.1	12.8	11.6	13.9	17.3	19.1	8.9	18.0	19.4	8.3	11.2	12.1	12.0	11.4	9.9	14.0	16.9	23.4	15.1	10.1	15.4	12.3	18.8	26.6	13.5	14.9	10.0	10.6	15.5	14.2	21.3	18.3	29.0	12.4	6.8	25.4	12.7	6.6	28.6	14.4	20.5	12.9	24.8	14.7	17.0	13.8	6.7	11.4	14.0	12.6	11.4	12.9	20.1	10.7	17.7	10.3	7.1	9.0	18.8	23.9	10.2	14.2	11.7	12.1	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1	6.0	29.4	27.3	13.1	6.0	34.9	7.1	20.4	56.2	26.1	14.0	135.5	38.6	26.6	25.3	469.4	15.8	62.6	23.3	28.7	31.8	13.8	24.2	17.4	37.6	29.7	30.2	21.4	25.2	25.0	1260.7	20.4	23.9	13.5	47.7	27.2	28.4	29.0	71.9	24.4	60.6	112.4	12.9	10.5	91.2	49.8	9.5	47.9	33.7	27.6	26.7
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014245-49115509	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	13.0	31.6	7.2	3.4	6.7	0.4	10.5	3.3	7.1	18.2	6.2	9.3	3.1	2.0	13.2	5.9	6.1	6.5	11.7	10.3	7.2	4.4	9.3	3.0	8.9	7.0	8.9	5.4	27.2	1.3	22.8	4.6	7.7	10.1	11.2	4.4	15.1	2.8	9.2	3.8	4.2	4.1	12.5	7.9	2.8	5.4	7.8	6.0	2.9	20.8	6.9	3.4	9.4	8.6	1.8	0.9	2.7	0.9	1.7	0.7	0.2	0.0	0.1	2.7	0.1	1.1	0.6	0.1	2.1	3.5	0.8	0.2	0.1	0.1	0.1	0.1	5.0	2.9	0.1	0.1	0.0	0.4	2.6	1.2	0.1	0.0	0.1	0.1	0.1	0.0	4.1	0.0	3.6	0.0	0.0	0.0	0.7	6.9	0.1	0.6	0.1	0.0	0.1	0.5	0.0	0.0	0.0	8.0	4.1	0.0	0.1	0.1	6.8	0.1	0.1	0.0	0.3	0.1	0.2	0.0	9.1	1.1	20.4	0.1	0.0	5.5	0.0	10.0	0.1	0.1	1.9	0.9	0.4	0.6	0.3	0.5	0.8	0.4	0.3	0.2	1.8	0.7	0.6	2.7	1.7	0.5	0.9	0.3	0.2	7.2	6.7	3.3	7.1	7.2	4.4	8.9	5.4	10.1	6.0	3.0	17.4	0.0	1.7	5.8	5.0	12.1	0.0	6.7	17.0	0.0	2.0	0.4	1.7	0.1	81.0	6.4	0.0	0.0	0.0	0.3	22.4	0.7	11.6	3.2	0.5	4.8	0.0	3.7	1.9	104.4	8.9	4.0	6.8	1.0	0.0	10.9	0.2	0.0	13.8	6.1	2.7	58.2	30.0	1.4	3.4	3.8	0.3	1.3	0.0	0.6
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.0;U-138 MG: 1.7"					"Low region specificity"	"Detected in many"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3	0.0	0.6	0.0	1.1	0.2	0.6	0.8	0.0	178.0	19.4	1.8	29.5	0.0	0.0	0.0	410.6	0.0	0.2	0.0	0.4	0.1	0.4	0.3	0.0	0.0	0.2	0.0	1.7	1.8	0.0	741.4	4.4	0.9	0.0	1.0	1.3	0.3	0.1	1.5	5.3	0.0	0.5	0.0	0.3	16.1	5.4	0.4	0.0	0.0	0.8	0.5
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"granulocytes: 538.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.9	3.6	1.3	0.5	0.2	0.3	0.1	0.2	28.2	0.0	3.5	0.6	4.9	0.1	0.7	6.4	0.0	9.6	0.0	20.3	5.1	0.6	15.8	0.2	9.5	10.7	0.7	0.6	2.1	1.4	18.7	2.7	1.1	3.5	1.1	0.1	0.4	0.3	5.7	0.0	0.7	0.0	12.6	0.1	20.6	0.2	3.2	0.3	0.5	0.2	1.0	8.7	2.5	0.9	0.5	0.1	2.7	0.1	0.0	1.3	1.1	0.0	11.7	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6	8.9	36.5	0.8	11.6	15.2	2.9	2.4	7.6	25.4	14.8	31.4	2.0	7.8	8.3	19.7	32.8	3.6	25.8	0.0	25.0	2.1	7.8	8.4	538.2	2.4	29.2	30.2	14.5	1.8	5.6	3.6	2.6	6.0	5.0	2.8	22.5	12.0	20.8	17.3	0.4	11.5	1.1	0.0	3.8	0.2	2.3	10.9	1.6	4.9	22.5	14.0
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 35.9;brain: 10.1;pancreas: 11.0"	"Cell type enriched"	"Detected in some"	34	"Intestinal endocrine cells: 107.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11.0	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	27.1	1.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.7	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	3.2	107.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Cytosol	Nucleoplasm	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.8	0.0	2.1	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.7	0.4	2.1	2.0	0.6	4.0	2.2	3.5	4.8	0.0	0.0	1.1	2.4	0.1	0.3	0.0	1.2	2.7	0.8	1.2	10.8	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.6	0.0	0.0	1.6	0.0	1.3	8.7	1.4	0.0	1.7	0.0	1.4	0.0	1.1	0.1	0.0	1.0	0.0	0.9	3.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0	0.0	1.0	0.0	1.7	0.2	0.0	4.7	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.4	1.6
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743970-102816267	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	23.8	23.0	11.5	12.9	13.7	2.3	14.2	9.5	14.2	19.0	14.5	12.2	13.3	9.0	18.9	14.9	13.1	18.9	15.3	23.6	11.9	8.9	11.6	21.3	13.3	11.5	14.9	8.0	23.6	9.3	12.5	13.5	14.1	17.5	15.2	9.2	20.2	21.8	14.9	77.3	20.1	12.3	16.3	15.0	12.5	15.0	11.0	10.1	23.2	26.1	35.5	11.1	17.6	11.4	6.1	8.2	14.7	16.7	12.4	8.7	8.9	10.1	13.2	7.3	12.3	24.3	19.8	14.9	10.4	28.3	10.4	13.1	9.0	15.9	8.8	14.1	16.0	8.4	11.3	5.3	9.0	7.9	8.8	5.6	17.8	6.0	6.4	15.8	8.5	21.2	21.3	16.2	13.3	10.3	23.9	20.2	10.7	8.6	11.1	17.7	13.3	10.3	9.5	5.5	7.8	6.5	20.7	19.2	5.6	9.2	10.1	1.7	7.0	5.7	5.8	11.7	13.7	23.7	9.5	15.0	10.0	10.4	11.3	9.2	20.6	10.8	6.5	14.2	16.5	4.4	6.6	11.8	14.7	8.7	13.7	6.9	6.1	7.4	8.4	8.2	6.0	6.8	7.2	14.4	12.4	16.7	5.2	7.5	8.9	11.5	13.7	9.5	14.2	11.9	8.9	14.9	8.0	17.5	10.1	20.8	21.3	12.6	8.9	7.2	5.5	12.1	15.3	20.1	17.0	12.2	0.0	27.0	1.7	13.1	1.9	18.4	17.0	0.0	22.1	12.1	18.9	19.8	38.0	44.0	23.3	12.7	8.7	23.9	39.9	1.0	12.0	16.5	10.1	18.0	15.7	8.3	18.1	11.5	18.4	9.2	3.7	19.4	19.6	5.0	6.1	10.3	33.4	8.7	10.9	8.9
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Approved	Nucleoplasm,Cytosol		No	No		870000	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	37.4	50.4	59.5	22.8	79.8	29.9	22.6	62.5	119.3	24.3	20.4	75.2	15.0	27.0	22.9	19.7	25.7	36.6	26.4	51.6	58.7	56.4	32.0	48.7	31.9	22.3	62.1	56.2	41.8	35.7	36.8	24.5	23.0	110.8	32.2	17.2	40.3	55.5	33.6	47.1	28.2	25.9	23.0	55.6	30.5	27.4	28.5	44.3	10.6	26.8	15.7	21.5	24.5	18.3	14.9	11.1	63.5	25.5	11.2	15.1	16.8	25.5	29.8	11.2	13.3	23.1	23.1	14.8	8.3	26.2	19.2	23.9	14.8	26.2	13.3	21.3	11.8	61.1	15.4	11.7	25.1	17.7	9.8	22.6	24.5	18.1	24.0	47.7	10.1	41.9	25.6	24.0	22.7	31.9	33.9	37.2	20.6	16.4	40.3	15.4	26.1	20.8	20.8	9.5	18.1	19.8	14.3	22.5	24.7	27.9	15.9	18.9	29.5	14.5	25.3	40.4	21.4	34.1	25.3	21.3	19.6	17.3	19.0	13.1	37.3	26.7	9.9	55.0	9.4	13.9	42.8	16.7	56.0	11.6	20.5	12.9	14.9	13.0	11.7	11.1	12.0	12.6	10.3	63.5	11.2	25.5	8.6	15.1	16.8	59.5	79.8	62.5	119.3	58.7	56.4	62.1	56.2	110.8	44.3	77.4	66.5	53.1	106.6	54.1	107.3	69.8	50.9	25.4	33.0	50.6	70.7	59.5	137.6	109.6	243.3	60.2	61.9	23.3	166.3	55.9	37.9	110.3	63.7	57.0	115.5	106.5	32.2	41.7	53.9	234.4	55.0	64.6	57.3	124.4	36.0	83.7	108.2	69.1	50.5	60.3	104.3	25.8	37.3	33.5	25.6	69.9	154.5	55.4	22.9	81.3
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"	10	"B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7"	"Group enriched"	"Detected in many"	7	"B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4"	"Low region specificity"	"Detected in many"							HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	2.7	1.5	3.6	31.2	5.4	8.6	1.5	0.9	2.7	1.2	1.6	5.2	0.0	1.1	1.2	1.5	1.5	1.5	2.6	1.4	3.1	1.9	1.7	1.2	9.4	20.8	5.3	0.6	1.1	1.1	0.2	1.1	0.8	3.7	1.2	1.5	1.2	5.7	0.4	0.9	2.0	10.2	1.3	7.3	19.1	1.6	1.5	4.4	4.1	1.6	0.9	26.6	3.0	1.2	12.5	19.7	6.2	1.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	3.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	12.4	0.0	0.0	1.7	0.0	0.0	1.6	0.0	8.9	0.0	0.1	6.7	12.5	0.0	0.0	6.2	0.0	0.8	19.7	0.0	0.6	3.6	5.4	0.9	2.7	3.1	1.9	5.3	0.6	3.7	4.4	0.0	0.6	20.5	0.0	0.3	0.0	1.1	0.0	0.0	1.2	1.8	0.0	0.1	1.7	0.0	25.8	0.3	0.0	0.0	0.0	0.1	0.9	0.0	5.7	0.0	11.8	0.0	0.0	0.0	11.7	11.6	0.3	21.6	1.7	17.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.6	0.3	0.2	0.0	0.0	0.0
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701022-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: AB_2679686"	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	19.8	19.2	18.1	22.5	22.5	18.8	21.7	51.4	24.3	20.9	19.8	22.0	22.8	18.2	32.2	19.0	20.6	18.6	17.9	16.8	17.7	16.5	22.3	32.3	18.5	25.0	19.4	14.5	29.2	21.8	26.4	41.8	20.9	22.0	21.9	19.5	24.4	25.3	17.4	22.0	27.8	21.3	21.0	22.2	28.1	18.0	24.5	20.8	39.5	25.2	16.6	30.5	21.5	22.4	24.4	21.6	26.7	18.3	25.9	26.3	14.4	18.5	10.5	18.4	14.9	10.9	11.4	19.1	17.0	13.6	18.0	17.1	24.4	14.3	23.6	18.9	11.2	16.6	15.2	20.7	14.4	23.7	21.6	12.4	22.7	13.4	26.0	12.3	27.3	17.0	11.1	15.3	17.2	14.7	12.9	15.3	21.4	18.8	21.2	12.6	11.7	28.3	20.0	22.3	12.1	12.0	19.9	18.6	18.7	10.3	24.2	17.2	13.4	15.2	14.1	12.0	18.1	10.9	16.0	14.2	14.2	20.8	15.8	14.5	20.7	31.6	45.0	11.6	10.9	13.2	21.2	16.7	26.7	21.5	18.3	21.9	24.4	21.9	20.6	21.6	23.0	23.3	22.1	11.4	25.9	18.2	15.8	26.3	14.4	18.1	22.5	51.4	24.3	17.7	16.5	19.4	14.5	22.0	20.8	32.8	38.9	53.6	65.1	97.7	50.6	43.7	50.9	26.8	25.0	34.9	60.9	70.6	39.7	41.7	25.0	53.7	27.8	46.7	39.3	76.0	51.5	42.9	63.5	58.0	43.8	57.2	37.8	42.4	42.9	17.6	46.6	47.4	72.6	84.8	34.6	30.4	34.6	31.7	47.4	42.1	55.4	45.3	50.9	89.8	72.4	101.3	92.5	69.8	38.3	50.3
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	9.1	9.3	8.4	14.2	8.4	12.1	7.5	9.3	11.1	7.6	7.2	6.7	6.5	10.7	12.5	5.1	17.4	8.2	8.1	6.1	8.3	4.9	7.3	12.2	7.8	18.2	8.9	8.4	9.7	22.0	6.9	8.4	8.9	8.5	7.0	7.0	6.8	11.8	8.4	13.1	10.2	7.5	7.4	6.6	11.7	7.3	10.9	9.6	10.1	9.3	11.3	17.0	8.5	11.1	7.5	9.1	0.2	8.8	4.4	5.5	4.4	14.6	20.6	5.5	7.8	3.3	3.6	13.4	8.5	3.1	7.2	4.7	20.6	7.6	24.5	5.0	6.0	10.5	8.1	19.1	10.8	5.1	7.8	18.2	24.6	21.5	17.3	5.9	15.1	6.1	2.0	4.7	9.8	7.2	2.6	9.4	8.8	29.6	9.1	6.3	12.2	15.5	8.6	13.8	11.0	20.2	17.1	3.3	24.2	5.4	9.0	13.1	8.4	8.9	13.3	4.2	1.9	8.7	11.7	6.9	11.2	7.4	5.1	17.0	12.5	8.7	19.8	5.4	24.1	13.1	0.0	5.4	0.2	3.5	8.8	4.7	7.5	4.7	4.3	9.1	7.2	4.8	4.9	0.0	4.4	5.0	4.4	5.5	4.4	8.4	8.4	9.3	11.1	8.3	4.9	8.9	8.4	8.5	9.6	0.0	4.5	6.0	7.4	7.6	3.4	2.0	0.0	1.4	1.2	0.0	2.0	14.1	0.0	6.4	2.9	4.9	3.3	0.0	5.7	17.8	3.8	5.6	10.3	6.4	11.5	3.2	5.2	3.7	1.8	2.5	2.6	4.8	6.8	1.8	3.6	2.4	6.8	0.0	2.8	5.7	4.0	6.5	6.2	9.7	9.1	9.5	9.6	3.8	7.0	8.8
WDR47	KIAA0893	ENSG00000085433	"WD repeat domain 47"	O94967	1	108970214-109042113	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 83.1;Suprabasal keratinocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027287, HPA027289"	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA027287: AB_10599416, HPA027289: AB_10601862"	"unprognostic (8.55e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.05e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.39e-3)"	"unprognostic (7.90e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.09e-2)"	7.1	7.2	17.7	5.1	24.0	10.1	6.4	19.9	42.6	8.0	5.6	9.5	3.4	3.7	9.4	5.8	13.7	8.4	7.1	7.5	20.1	20.6	7.5	3.6	6.7	5.0	14.8	21.0	7.6	5.6	10.4	4.4	6.3	24.8	7.3	5.4	5.8	4.7	7.2	14.2	20.3	4.1	9.8	12.7	5.3	5.6	19.9	11.3	5.5	6.1	4.8	7.0	6.8	6.3	3.5	5.6	18.8	5.0	2.2	4.6	2.0	10.8	3.3	6.3	8.0	12.6	11.1	3.4	12.4	7.6	8.3	9.3	3.2	1.6	4.9	6.7	11.8	6.1	12.2	9.0	5.4	10.9	9.0	5.0	4.1	7.3	3.6	7.2	6.3	6.1	6.8	9.1	12.9	6.3	10.1	9.8	5.8	2.4	6.9	14.1	6.4	6.1	5.0	2.7	3.5	6.6	8.7	16.2	2.7	13.8	9.4	11.3	10.2	10.8	5.8	8.6	7.1	2.7	6.5	16.7	11.1	5.1	19.3	10.1	4.4	3.6	4.0	12.9	6.3	16.4	11.4	4.7	5.8	3.2	5.0	2.8	2.0	2.9	3.4	5.1	3.5	2.6	2.2	18.8	2.2	4.5	5.6	4.6	2.0	17.7	24.0	19.9	32.4	20.1	20.6	14.8	21.0	24.8	11.3	11.9	9.2	1.9	4.3	83.1	15.1	17.6	12.7	18.7	10.3	7.0	43.2	2.1	5.0	2.7	24.9	11.7	2.4	0.0	0.8	1.6	6.1	2.2	2.3	1.7	3.9	11.1	2.9	4.9	5.6	30.9	7.8	8.6	23.6	5.4	1.0	12.6	3.3	0.0	14.2	4.8	31.5	6.5	17.6	25.7	26.2	91.2	4.1	4.3	1.7	3.3
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.9	10.9	5.3	21.3	8.3	6.7	14.9	7.9	9.8	8.5	9.7	18.7	10.9	7.5	10.7	10.3	15.3	9.9	7.2	13.9	6.6	6.9	5.9	8.5	9.0	7.6	8.0	8.9	16.1	7.9	8.1	11.6	6.2	5.8	9.0	8.4	5.9	5.9	9.3	11.3	8.2	8.0	5.6	11.4	9.6	7.0	7.7	7.0	10.1	12.0	5.2	7.0	10.9	31.9	12.1	6.8	22.6	9.6	8.0	11.1	5.8	12.7	10.7	9.8	7.6	5.9	14.3	11.9	6.5	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5	8.9	18.4	22.6	8.8	12.9	12.9	4.5	5.1	17.4	18.2	17.4	11.8	19.4	18.3	17.5	20.3	9.5	24.1	0.0	24.4	36.3	12.9	11.7	19.6	13.5	18.9	22.3	14.3	8.6	12.4	6.8	8.9	18.9	8.5	26.2	17.8	5.6	23.0	28.1	7.1	15.6	7.8	12.9	12.3	7.1	9.6	11.7	19.5	20.0	19.8	12.9
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299794	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	23.8	34.3	23.5	17.2	31.2	29.6	34.5	25.2	32.1	24.3	22.0	27.6	22.7	20.3	24.2	69.4	25.9	27.4	19.6	23.1	23.7	28.2	34.2	28.2	22.4	18.7	26.8	23.1	20.7	30.7	22.4	37.7	27.7	30.8	27.4	25.7	24.9	28.1	23.1	26.3	29.9	18.5	23.6	27.8	18.6	20.9	38.5	20.9	26.9	32.5	30.1	24.6	19.1	20.3	21.9	45.2	11.1	32.4	22.7	25.2	28.7	9.4	24.0	19.0	19.5	18.8	17.3	14.3	14.4	16.2	18.3	18.1	22.9	17.2	18.1	18.0	16.4	29.2	20.1	40.2	17.4	15.2	11.7	31.5	14.6	22.2	22.1	16.4	22.5	16.4	13.3	13.4	7.1	6.1	13.0	20.6	19.0	26.7	20.4	23.9	29.5	19.7	21.9	14.0	23.7	19.3	18.3	14.4	22.1	21.3	29.3	26.5	14.4	19.7	22.2	78.5	20.1	14.2	31.1	12.4	14.4	17.0	10.3	24.8	17.6	26.4	25.7	20.9	36.6	28.6	11.1	31.6	10.5	21.5	32.4	23.2	21.9	21.6	22.3	45.2	16.9	23.0	25.2	2.6	22.7	26.3	24.2	23.5	28.7	23.5	31.2	25.2	32.1	23.7	28.2	26.8	23.1	30.8	20.9	32.8	43.1	20.1	47.2	43.6	50.0	23.2	30.6	62.9	22.7	36.6	45.2	87.6	106.1	52.5	15.9	38.7	22.6	23.3	48.6	62.8	54.1	49.6	46.2	41.4	58.3	41.3	22.4	45.4	29.1	10.0	46.3	46.3	55.6	48.7	33.3	72.9	38.7	28.1	47.7	102.6	46.0	6.5	49.5	95.0	66.6	51.3	77.2	35.9	50.2	41.4
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57036606	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	8.0	11.3	14.2	7.9	21.2	9.1	6.8	16.7	34.0	7.5	7.7	11.9	6.1	6.0	7.1	8.1	6.6	6.4	7.7	8.8	17.3	17.9	7.9	10.4	7.2	9.5	14.4	16.4	6.6	6.2	15.6	19.0	6.9	21.1	11.1	7.4	7.9	6.1	8.8	10.5	5.7	6.1	8.3	12.5	8.3	6.9	6.2	12.1	13.2	13.1	4.0	8.2	7.4	6.3	4.5	6.3	9.2	8.7	7.4	9.0	3.2	3.9	6.6	7.6	4.2	12.0	7.0	1.9	7.8	6.7	6.5	7.7	2.6	2.5	10.9	3.1	7.0	5.5	4.2	7.6	6.1	8.1	12.6	4.6	10.3	5.4	2.4	7.2	15.4	13.1	5.9	5.1	8.6	5.8	5.4	8.0	5.2	4.9	15.1	8.0	3.8	10.6	4.6	3.2	2.0	4.4	4.8	5.8	5.3	4.9	7.1	9.9	4.9	5.6	2.7	3.6	6.7	4.2	4.4	7.0	9.3	4.7	2.8	4.2	15.2	11.3	11.9	7.6	7.8	6.2	7.2	5.0	9.2	6.6	7.6	8.2	4.4	7.5	6.7	6.3	4.5	7.9	7.2	4.6	7.4	8.7	3.0	9.0	3.2	14.2	21.2	16.7	23.7	17.3	17.9	14.4	16.4	21.1	12.1	3.0	4.5	3.7	1.4	2.6	22.0	11.0	7.6	5.3	10.3	0.0	29.5	1.6	3.3	2.6	13.5	6.7	3.6	0.0	3.1	1.0	3.0	3.7	10.4	6.2	5.2	25.4	8.1	8.6	19.1	4.3	5.2	6.4	0.0	4.6	2.7	7.4	2.7	2.9	7.8	3.1	26.3	6.5	3.8	1.9	1.5	2.0	0.6	4.3	3.5	1.4
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Group enriched"	"Detected in many"	4	"Club cells: 168.4;Early spermatids: 612.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.4	19.8	7.7	12.8	6.4	8.8	24.0	9.2	10.0	20.1	13.4	28.9	20.2	28.9	26.3	7.6	16.2	22.0	23.7	18.4	15.8	18.4	17.5	14.6	21.8	25.0	18.8	28.9	9.6	8.5	20.7	12.8	42.6	6.6	9.8	21.1	31.8	8.6	9.1	31.6	27.6	46.0	31.5	18.9	26.3	28.2	13.3	50.4	14.2	9.4	17.2	19.4	10.7	22.0	29.7	7.8	15.5	22.4	7.0	11.8	14.2	26.3	23.1	21.4	29.7	35.1	13.0	17.7	15.3	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6	35.7	64.8	46.3	33.6	92.8	13.9	1.4	33.1	44.2	168.4	15.7	15.7	47.5	36.5	39.1	612.8	32.3	22.2	0.0	34.8	40.2	35.6	20.1	41.7	28.4	34.0	3.2	39.4	17.8	30.3	74.1	30.5	38.9	28.7	18.0	28.7	13.4	36.2	26.6	20.1	37.0	11.0	19.4	37.3	14.7	27.4	95.5	29.1	57.9	38.1	31.5
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175795	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 25.2"	"Group enriched"	"Detected in some"	15	"Early spermatids: 24.8;Late spermatids: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 6.4"					"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.3	0.5	0.4	1.1	0.6	1.0	0.3	0.7	1.4	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.7	0.2	0.6	1.2	0.4	0.4	0.3	0.3	0.3	1.6	0.3	0.3	1.0	1.0	0.0	0.5	0.3	0.3	0.3	0.0	0.3	1.1	0.3	0.3	0.9	0.9	0.3	0.3	0.6	0.3	25.2	0.3	0.3	1.4	0.3	0.3	0.3	0.3	1.2	0.6	0.6	1.3	2.9	1.4	0.3	1.0	2.2	1.5	2.7	0.8	0.0	2.0	0.8	0.0	0.2	0.0	1.1	2.2	2.7	1.4	0.0	1.6	0.8	0.0	0.3	0.0	5.5	0.8	2.5	1.7	0.5	0.0	1.9	2.2	0.0	0.0	0.0	0.0	0.6	0.0	6.4	1.7	2.8	0.0	3.2	1.1	1.2	1.1	0.9	0.9	2.1	0.8	0.5	0.0	1.3	3.9	3.9	2.7	1.2	0.6	1.9	3.4	2.0	1.5	0.7	2.1	1.2	0.4	2.6	1.8	1.5	0.4	4.2	1.1	0.0	0.4	0.4	1.4	1.3	1.3	0.0	1.2	1.0	0.3	1.2	0.8	0.7	0.6	2.9	0.6	0.6	0.2	0.3	0.4	0.6	0.7	0.8	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0
WDYHV1	"C8orf32, FLJ10204"	ENSG00000156795	"WDYHV motif containing 1"	Q96HA8	8	123416725-123467230	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.8"	"Low region specificity"	"Detected in all"							"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	10.5	15.5	13.2	7.9	13.6	6.3	17.2	14.3	16.8	14.5	9.9	13.9	10.7	5.8	11.2	12.0	10.2	9.8	8.8	24.8	12.8	19.8	13.6	9.1	8.6	11.4	17.0	10.8	20.4	21.3	9.0	12.8	8.2	16.2	13.5	9.5	9.7	8.3	12.5	19.2	9.8	5.4	13.0	17.0	7.9	10.0	17.5	15.6	5.3	14.4	9.1	11.3	10.1	9.1	5.9	7.2	8.7	7.5	13.1	9.2	5.5	9.1	10.8	12.7	6.7	5.5	12.6	5.7	7.6	6.7	7.2	9.2	6.4	6.1	7.3	6.9	5.3	10.2	5.3	8.1	8.8	9.7	17.2	7.1	7.9	5.2	8.7	7.7	3.0	3.4	8.5	5.4	9.6	11.8	9.3	7.2	13.8	5.9	10.1	10.6	28.5	8.8	6.2	5.1	21.2	7.4	5.1	8.0	5.8	9.6	8.1	6.5	14.1	7.8	39.8	12.1	14.3	6.6	3.3	3.9	9.6	15.1	7.1	9.2	7.6	15.4	9.0	7.8	4.6	6.0	8.7	6.3	2.5	7.8	7.5	8.4	5.2	8.4	7.3	7.2	5.9	6.5	7.4	1.8	13.1	4.0	4.6	9.2	5.5	13.2	13.6	14.3	16.8	12.8	19.8	17.0	10.8	16.2	15.6	3.0	6.7	12.0	8.7	6.6	5.4	16.2	7.6	1.4	5.7	14.0	2.0	10.4	33.2	10.5	7.6	8.2	3.3	0.0	13.2	18.4	7.7	13.3	8.1	4.2	12.0	4.8	0.0	10.4	9.5	11.5	8.1	7.2	10.1	9.0	6.2	6.0	10.4	9.1	11.0	11.2	7.2	12.9	11.3	20.6	28.7	7.9	8.4	4.3	8.8	8.7
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190188-5233826	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	24.5	23.6	33.9	17.8	34.7	32.7	21.9	30.6	47.4	20.6	21.7	27.8	17.4	20.3	24.4	23.1	25.4	25.3	20.5	30.5	27.9	27.2	23.5	27.5	21.9	22.3	26.0	31.2	25.0	30.8	28.7	23.2	27.0	26.1	25.0	17.2	25.0	34.7	25.5	28.3	31.8	18.2	22.9	25.6	22.0	23.0	49.3	26.0	26.6	24.1	15.9	23.4	22.9	20.5	6.1	6.9	13.0	6.3	2.6	9.2	2.2	27.2	17.4	17.1	29.1	26.3	27.6	26.3	24.3	28.0	26.0	27.5	16.9	25.4	19.5	18.7	30.4	32.4	20.0	17.2	19.8	20.3	10.0	26.7	13.3	17.6	18.6	26.0	20.8	14.6	29.0	23.9	29.5	16.4	26.0	36.1	26.8	37.6	17.7	23.5	28.3	15.8	36.1	35.5	14.6	25.6	26.1	24.4	32.0	17.1	13.3	21.3	32.1	17.8	30.7	21.1	29.9	18.8	39.8	28.6	16.6	35.0	27.7	18.1	31.8	29.6	22.2	27.1	24.2	24.5	0.3	4.9	13.0	5.1	6.3	3.1	5.6	6.7	9.1	4.5	6.1	8.5	5.4	9.9	2.6	4.2	6.9	9.2	2.2	33.9	34.7	30.6	47.4	27.9	27.2	26.0	31.2	26.1	26.0	35.7	26.9	47.2	36.3	48.8	67.7	25.4	25.5	21.4	17.0	17.4	58.9	79.1	61.3	36.3	146.8	28.9	32.1	46.7	36.2	84.9	33.8	70.9	31.1	55.0	59.9	44.5	37.9	47.9	51.5	127.3	39.4	39.2	42.2	65.9	47.0	87.1	45.2	38.5	52.6	60.3	50.4	51.8	32.0	181.0	130.5	62.0	126.1	42.4	42.2	42.4
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.3	13.4	17.0	19.3	7.9	10.9	14.2	7.0	11.9	8.2	8.2	25.5	11.3	23.5	12.9	7.2	11.6	7.3	10.0	2.9	8.8	12.5	8.2	7.2	6.4	12.3	9.4	12.3	14.0	13.2	8.6	9.4	7.4	10.7	8.9	12.8	9.7	8.0	27.6	17.1	8.7	18.1	13.3	22.2	16.0	6.1	11.4	7.7	10.6	18.3	23.3	12.5	11.4	9.2	4.8	12.5	8.9	17.2	27.3	10.8	21.4	18.1	14.4	8.6	12.2	11.4	11.4	18.4	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8	11.9	5.8	8.5	5.5	14.1	8.8	9.1	12.7	0.0	3.4	12.2	0.0	6.1	3.3	12.3	6.3	13.5	5.0	0.0	17.1	8.3	9.9	8.6	1.1	13.2	6.7	6.4	6.4	13.5	10.2	6.4	14.7	7.1	6.8	5.4	9.5	7.1	16.5	0.0	18.0	4.7	7.5	12.9	10.8	27.2	26.0	17.8	6.2	4.4	10.5	11.8
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 74.2;Peritubular cells: 185.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	0.4	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	13.0	1.2	0.6	0.2	1.9	1.7	0.5	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.1	0.5	0.1	0.5	0.0	2.4	0.4	0.5	0.5	1.3	0.2	1.1	5.3	0.1	0.4	5.2	0.5	2.0	1.3	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8	11.9	3.5	0.5	1.6	9.0	13.0	3.9	2.5	4.0	2.3	1.8	25.5	1.6	0.0	0.7	3.5	8.4	2.3	0.0	1.2	0.7	7.8	1.5	2.3	0.0	1.0	4.8	8.1	4.9	1.6	2.8	74.2	5.7	3.3	1.8	1.7	8.2	1.6	4.2	185.6	0.6	30.4	0.0	2.8	4.2	4.2	12.2	1.6	1.9	1.5	2.0
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;lymphoid tissue: 16.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5"	"Group enriched"	"Detected in many"	7	"glioma: 18.8;renal cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	3.9	2.6	11.2	1.6	7.3	0.4	1.3	17.1	24.7	1.5	8.7	11.2	0.0	4.7	1.5	1.4	1.2	1.7	1.6	3.8	10.5	9.7	6.2	1.1	1.8	1.9	11.9	5.3	0.8	2.4	2.3	2.7	6.5	8.5	1.2	5.4	1.1	1.8	1.3	13.3	2.0	5.7	2.1	12.2	16.7	1.4	12.9	10.5	0.6	1.3	0.0	1.6	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	3.1	21.9	1.7	0.1	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.4	0.1	0.0	0.0	7.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	13.4	0.0	0.0	0.5	0.6	0.4	0.0	0.0	7.3	13.9	13.5	0.0	27.7	0.8	4.6	1.1	8.5	0.0	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.2	7.3	17.1	7.3	10.5	9.7	11.9	5.3	8.5	10.5	0.0	0.0	0.0	0.0	0.3	5.6	2.8	0.0	0.0	0.0	1.8	0.0	0.7	1.7	0.3	70.9	3.0	18.3	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	1.6	0.0	8.0	0.3	67.5	0.6	0.0	1.7	0.0	2.8	9.1	0.3	5.7	0.0	1.2	2.8	0.0	1.4	0.5	2.8	0.5	0.0	0.0	5.6	0.1
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629565	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	13.5	18.4	12.2	13.3	17.8	35.7	17.8	22.9	22.6	16.3	12.1	19.2	12.1	16.3	15.5	12.1	17.8	18.9	12.7	17.5	11.9	10.3	20.1	24.6	13.0	17.0	16.8	11.4	29.6	34.3	11.9	12.2	14.6	13.3	15.2	5.3	13.6	28.7	18.1	18.0	19.5	13.8	13.7	13.4	18.8	22.8	30.2	15.8	24.8	21.4	13.2	15.9	18.6	15.6	15.2	9.0	9.9	14.1	8.9	16.7	13.8	15.5	14.3	8.7	11.3	9.2	6.9	17.0	9.2	10.8	16.3	16.6	18.4	10.3	10.5	18.2	8.5	11.9	13.8	12.3	13.3	4.2	18.5	15.8	14.0	12.1	16.1	11.9	18.5	12.7	12.1	11.1	11.5	8.3	8.8	9.9	22.8	12.5	28.2	5.0	17.3	17.3	28.9	19.7	9.8	28.3	19.4	11.0	18.4	6.5	12.3	12.4	14.2	10.4	10.2	9.0	6.0	13.0	16.5	9.7	7.5	12.3	16.9	15.4	48.6	28.6	15.3	12.8	15.8	11.1	8.3	12.2	9.9	14.8	11.6	13.6	12.3	13.8	11.0	9.0	15.2	16.7	12.6	7.3	8.9	14.1	7.8	15.8	13.8	12.2	17.8	22.9	22.6	11.9	10.3	16.8	11.4	13.3	15.8	0.0	2.6	13.7	12.3	17.4	13.6	0.8	22.9	0.0	3.4	45.4	11.8	36.8	29.9	16.2	26.4	13.5	25.0	0.0	30.1	23.1	15.3	13.9	19.6	36.5	17.5	3.2	17.9	14.7	16.5	13.5	26.2	9.3	25.3	31.5	17.7	13.8	14.4	14.4	20.5	74.5	11.3	38.8	18.8	34.6	47.5	15.6	55.2	20.3	16.2	12.7
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	6	"testis: 5.1"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 9.6"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	34	"U-2 OS: 22.7"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.6	0.0	1.6	0.0	0.0	0.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Group enriched"	"Detected in many"	5	"Enterocytes: 95.3;Hepatocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No			Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.2	3.6	0.7	1.1	0.2	1.7	0.0	1.2	0.2	0.6	3.2	0.0	15.3	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.9	24.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.9	0.1	0.0	1.1	3.3	4.5	3.9	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	3.0	1.9	0.1	6.7	2.0	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.0	3.7	0.0	2.6	0.5	0.3	0.3	2.5	0.0	2.3	0.0	0.0	0.1	0.0	2.4	0.2	0.0	95.3	0.0	7.2	0.5	0.0	0.5	0.0	35.8	0.0	0.0	11.3	1.8	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.1	8.8	7.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.3	0.0	12.8	14.2
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell type enriched"	"Detected in some"	66	"Cardiomyocytes: 1858.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697357	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	18.7	17.5	20.1	17.1	21.0	10.6	17.4	26.8	20.8	20.3	25.2	17.2	11.7	20.6	25.5	15.4	18.9	15.0	19.5	12.9	17.2	15.3	24.9	24.2	14.8	16.7	18.6	17.5	17.2	14.5	23.0	23.1	12.8	17.7	20.3	13.6	16.4	16.1	21.7	43.3	16.3	22.2	27.5	17.1	16.2	25.1	6.4	15.8	15.7	31.5	11.9	21.6	22.0	16.4	22.2	23.4	12.7	15.8	19.7	21.6	11.3	23.0	5.4	8.1	10.0	9.9	9.7	5.6	6.3	10.0	11.5	7.8	14.1	19.4	13.0	6.1	6.9	7.7	11.6	6.4	7.6	9.8	8.9	12.9	10.2	11.8	7.8	10.8	12.1	12.4	8.4	8.2	5.3	5.5	7.8	12.8	10.8	14.1	10.2	6.3	7.2	15.7	14.6	5.5	22.0	9.0	16.0	17.3	11.0	18.3	9.0	11.4	11.5	9.0	6.9	8.1	6.4	10.1	7.3	8.0	4.0	10.1	15.9	13.6	18.1	14.5	8.2	10.0	8.7	7.9	6.0	13.3	12.7	16.2	13.1	18.7	19.5	17.7	15.6	13.5	22.2	21.6	18.6	1.5	19.7	15.8	23.4	18.3	11.3	20.1	21.0	26.8	20.8	17.2	15.3	18.6	17.5	17.7	15.8	23.8	31.5	27.5	17.4	15.3	99.5	29.1	50.9	34.8	40.9	21.0	76.6	27.4	102.8	31.2	1.2	29.2	16.9	0.0	33.5	8.3	24.2	16.3	29.0	40.6	30.4	79.4	21.5	17.8	17.5	2.6	40.9	29.8	13.5	49.5	21.3	71.6	24.5	21.0	44.6	38.3	99.8	32.3	31.9	12.8	16.4	16.4	11.7	25.3	26.3	20.2
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178783	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	20.2	17.1	14.2	24.0	30.2	8.4	21.4	16.1	19.3	22.3	18.9	20.8	27.5	18.0	24.6	18.3	16.9	24.9	25.1	12.4	16.2	14.4	24.6	23.4	19.9	21.1	33.4	15.2	35.0	20.9	35.4	26.7	28.0	22.1	20.9	15.9	16.7	17.6	30.3	22.4	30.5	23.6	17.7	22.6	23.3	15.9	12.9	30.6	18.5	25.7	12.4	20.8	22.4	22.3	10.9	7.0	34.6	8.8	8.8	12.2	6.1	4.5	11.6	13.1	8.4	19.7	13.6	44.5	11.3	32.3	10.9	8.5	4.2	5.4	15.1	5.0	13.7	5.1	5.7	8.6	18.0	9.0	6.1	7.4	8.0	12.3	7.8	17.5	6.0	15.3	19.3	21.4	14.5	29.1	12.8	12.9	6.9	11.0	8.2	12.1	9.5	4.9	5.7	7.8	7.4	7.9	6.3	5.9	12.1	13.8	13.5	2.8	10.2	12.3	10.2	8.1	21.5	10.7	4.9	20.2	4.2	11.5	6.4	5.2	18.9	13.7	8.9	10.1	7.0	15.2	12.0	8.2	9.4	9.8	6.3	9.6	10.7	11.2	9.6	7.0	10.9	12.2	8.7	34.6	8.8	8.8	6.7	9.2	6.1	14.2	30.2	16.1	19.3	16.2	14.4	33.4	15.2	22.1	30.6	56.6	54.6	22.2	18.7	12.2	33.8	11.2	33.1	84.3	73.9	15.7	37.3	34.0	29.9	16.3	1.9	24.9	12.3	46.7	16.9	17.1	16.4	15.5	44.1	30.4	16.2	25.4	15.6	22.1	24.3	1.8	28.4	28.4	8.5	38.7	12.2	29.9	15.2	14.8	26.5	34.1	50.6	25.8	18.0	22.7	57.3	9.7	26.8	34.6	13.3	8.7
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.7	5.1	8.4	8.0	4.1	7.2	8.7	7.7	5.7	9.1	7.6	10.4	8.5	14.9	4.2	7.4	6.9	11.1	19.4	10.4	17.1	10.1	5.5	23.6	6.4	6.9	6.2	20.6	7.7	7.0	6.6	9.2	17.6	5.3	11.0	8.6	11.1	4.9	8.6	5.5	9.8	9.1	9.5	14.3	4.8	11.0	13.9	6.2	6.3	8.2	9.6	6.6	6.6	9.7	7.9	8.9	5.7	11.3	9.0	6.5	5.1	7.9	10.9	3.3	4.8	12.4	3.2	13.3	9.6	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0	11.9	15.1	10.4	7.2	7.3	14.3	19.9	10.2	2.7	0.0	8.7	60.9	6.9	0.0	4.9	8.1	7.1	3.5	0.0	3.6	6.4	7.7	6.1	15.0	9.6	9.1	9.5	1.2	13.5	7.9	6.1	16.1	8.0	11.8	6.4	6.8	6.4	4.3	3.5	7.8	3.4	21.0	32.3	9.3	10.9	17.2	9.8	10.8	11.5	8.5	8.7
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404350-64451127	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.3	19.4	20.7	19.3	22.8	26.9	29.9	17.9	21.7	16.9	12.4	18.7	13.2	10.5	16.1	19.8	21.3	12.5	12.6	12.7	19.0	19.4	14.7	35.7	18.3	18.9	22.4	15.5	17.3	30.1	21.4	18.5	18.6	23.5	15.3	14.7	15.8	21.3	13.7	15.6	17.3	11.6	16.7	21.7	14.5	14.7	17.9	21.3	18.2	48.7	14.1	21.4	15.8	27.8	7.9	10.2	10.1	7.5	11.1	14.7	6.5	17.8	12.4	12.6	15.8	19.0	20.3	23.1	23.9	20.1	16.1	14.7	12.3	6.1	36.3	17.1	30.1	17.2	13.5	23.9	18.4	23.4	22.6	12.6	20.2	11.6	10.7	33.7	37.1	18.3	14.4	47.5	17.9	55.3	20.9	14.2	27.2	33.5	72.9	17.0	21.9	20.4	14.7	24.0	12.6	22.2	16.3	15.2	27.1	8.8	10.5	14.1	16.5	14.0	16.1	34.6	12.8	28.6	37.0	14.9	12.7	12.8	18.2	18.7	45.9	35.2	28.1	28.1	29.0	20.4	5.8	7.5	10.1	10.9	7.5	14.7	7.9	12.4	11.3	10.2	5.3	11.4	9.6	2.3	11.1	6.7	3.5	10.3	6.5	20.7	22.8	17.9	21.2	19.0	19.4	22.4	15.5	23.5	21.3	11.9	7.8	10.7	12.2	17.4	16.4	9.8	12.7	5.3	11.4	14.0	11.8	21.2	14.9	8.8	3.3	16.7	5.4	23.3	11.0	17.4	18.5	18.0	24.3	28.2	12.9	12.7	10.9	24.5	21.3	4.1	18.7	12.1	20.3	3.6	10.9	71.1	13.5	3.5	19.1	11.3	21.2	12.9	19.6	11.8	12.7	19.6	14.2	15.0	12.7	12.8
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644779-152676165	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.7;testis: 11.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 19.4;Spermatocytes: 22.4;Spermatogonia: 24.3;Syncytiotrophoblasts: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	1.3	1.3	3.4	4.5	2.0	5.4	2.4	4.4	2.6	1.6	1.5	2.5	0.6	1.1	1.9	2.2	2.6	1.3	0.6	2.5	3.3	1.1	1.1	1.3	1.4	3.0	1.9	1.9	2.0	1.2	0.4	1.3	7.2	2.7	1.5	2.9	0.6	1.5	1.3	1.1	1.6	1.9	1.3	1.8	1.8	1.5	11.7	2.2	12.7	1.2	1.1	3.6	1.3	1.6	1.8	1.0	3.1	1.1	1.1	1.6	0.6	7.5	4.5	6.7	7.3	0.8	0.7	7.7	5.4	2.0	4.7	4.7	5.7	6.6	10.7	4.2	2.1	7.4	5.5	5.4	4.4	8.7	5.1	5.6	7.7	6.1	3.1	0.3	11.5	3.8	0.5	0.4	7.7	2.0	1.0	1.6	6.4	15.9	9.2	2.7	5.2	10.6	2.7	8.8	4.5	4.1	8.5	9.0	6.0	1.4	5.0	6.4	6.1	6.1	2.7	1.1	4.5	2.2	2.5	3.2	6.3	2.8	5.9	10.0	3.3	6.5	9.4	3.3	6.2	8.2	2.0	0.9	1.5	1.6	0.6	1.1	1.3	1.3	1.1	0.3	1.8	1.6	0.8	3.1	1.1	1.1	1.0	1.5	0.6	3.4	2.0	4.4	2.6	3.3	1.1	1.9	1.9	2.7	2.2	0.0	1.4	1.5	0.9	1.1	4.8	0.6	0.0	0.0	2.3	1.8	0.0	7.1	0.0	0.6	6.1	0.6	0.0	0.0	0.2	19.4	1.9	0.5	0.0	0.0	2.1	0.0	0.0	1.8	1.2	3.6	0.9	0.4	0.0	1.0	1.4	2.0	0.3	0.0	1.1	0.1	2.0	0.0	0.5	22.4	24.3	1.3	10.5	0.5	1.5	0.8
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.4	32.7	36.1	27.6	27.0	33.3	35.8	25.3	33.1	33.8	39.5	21.8	31.6	27.1	15.1	26.5	46.1	32.7	40.6	42.6	43.5	12.2	20.5	35.0	12.3	41.1	23.8	31.4	30.5	31.5	21.6	37.2	32.7	30.2	29.0	26.1	28.0	23.3	31.3	21.5	46.2	20.8	28.1	26.8	22.1	34.0	61.4	23.1	28.8	29.2	28.0	36.4	29.5	36.4	27.1	29.2	20.4	37.5	26.7	34.0	25.5	7.7	31.9	20.6	26.4	29.1	13.1	14.7	25.6	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3	56.6	105.5	63.6	78.1	56.4	39.0	48.7	53.5	108.4	109.2	38.4	39.3	93.9	23.2	104.4	113.2	77.5	32.5	0.0	104.1	85.7	61.2	59.6	79.9	61.8	93.6	47.7	57.1	43.0	136.4	16.3	53.5	87.6	57.3	76.7	45.4	69.3	88.3	45.9	52.3	62.6	44.7	58.2	72.1	99.1	113.5	58.7	88.0	62.3	54.7	73.2
XRRA1	FLJ00225	ENSG00000166435	"X-ray radiation resistance associated 1"	Q6P2D8	11	74807739-74949200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 131.6;Spermatocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039263			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039263: AB_2676419"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-1)"	7.1	7.9	6.2	19.5	8.6	3.7	10.7	5.7	7.5	8.6	7.3	7.6	22.9	5.8	9.0	13.5	6.6	9.6	8.7	9.5	7.9	5.9	6.9	8.1	9.5	4.1	5.7	7.0	9.3	22.7	11.9	8.1	5.3	10.8	10.5	5.6	7.4	13.1	16.8	15.7	5.8	5.9	10.1	13.7	7.2	6.4	35.0	6.1	5.6	14.3	4.1	5.8	6.3	7.4	3.5	3.4	6.2	5.2	2.0	8.5	3.0	3.9	2.3	0.5	3.7	5.9	3.9	1.6	1.7	1.9	1.0	1.0	1.2	2.1	1.6	6.4	1.9	8.5	3.2	4.6	2.3	2.2	6.4	0.4	1.4	1.3	2.2	1.7	0.8	0.7	3.7	2.6	4.2	27.9	8.1	2.0	5.4	3.6	3.8	4.9	1.4	1.4	2.0	1.3	4.8	2.0	0.7	3.0	1.2	0.8	3.0	3.6	3.0	8.0	3.4	10.7	1.9	2.1	4.1	1.3	6.0	3.9	4.4	1.6	5.4	4.7	4.4	1.4	0.8	2.0	2.9	4.3	3.8	6.3	5.2	6.6	3.5	4.6	4.7	3.4	3.5	4.6	4.5	6.2	2.0	3.2	2.5	8.5	3.0	6.2	8.6	5.7	7.5	7.9	5.9	5.7	7.0	10.8	6.1	8.9	9.1	42.7	9.6	9.7	52.4	5.5	7.6	14.7	11.4	21.0	131.6	10.3	13.3	6.9	31.4	11.9	13.5	0.0	7.0	8.3	11.6	7.7	11.5	10.2	6.9	46.1	11.6	17.8	10.4	63.5	27.6	7.4	27.0	9.0	13.3	27.7	5.6	14.4	28.7	13.9	79.0	25.8	8.4	100.4	34.9	6.6	9.2	37.0	16.9	5.8
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.7	11.0	30.7	15.0	33.6	32.1	25.7	27.7	31.7	27.0	22.3	27.4	28.6	0.0	22.9	36.2	20.1	20.8	15.2	39.5	28.7	3.4	5.4	0.0	15.0	18.6	25.7	0.0	0.5	25.6	26.0	29.6	48.3	30.2	8.4	1.4	0.0	0.0	30.5	5.6	0.5	0.0	14.5	28.3	10.5	0.0	17.3	0.0	19.9	21.0	0.1	1.0	32.6	12.3	9.2	29.4	22.2	0.1	9.2	38.5	15.1	19.3	11.6	0.0	0.0	0.1	11.2	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7	32.8	51.8	1.7	40.6	101.0	0.3	34.4	76.5	24.1	35.2	87.2	0.0	79.0	10.0	28.8	3.9	26.3	16.2	0.0	15.8	14.7	61.4	50.8	0.0	36.0	9.2	0.0	7.0	24.5	1.3	2.7	35.1	2.3	42.2	1.8	13.7	26.2	23.1	20.9	38.2	20.0	1.0	38.8	48.4	2.7	0.9	107.6	51.5	0.0	24.7	55.2
YEATS4	"GAS41, NuBI-1, YAF9"	ENSG00000127337	"YEATS domain containing 4"	O95619	12	69359703-69390796	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Spermatocytes: 352.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072532			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA072532: AB_2686530"	"unprognostic (7.23e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.05e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.77e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	10.0	13.4	10.7	12.9	11.7	33.1	15.6	21.2	16.0	9.4	10.3	8.2	5.6	11.4	10.6	13.6	12.7	10.8	7.3	10.2	10.2	11.4	13.0	12.6	8.8	17.6	13.8	8.1	10.7	19.2	6.0	14.7	9.2	11.5	9.6	12.1	12.1	12.1	9.0	12.5	9.5	11.2	9.7	11.7	12.1	10.3	51.6	10.9	22.6	12.2	13.4	16.7	10.1	9.8	13.5	10.7	14.7	15.1	12.8	23.1	13.0	17.3	8.9	17.5	10.8	4.1	6.6	14.1	10.5	11.3	18.7	15.6	10.3	5.2	35.4	10.3	5.7	9.5	13.5	13.9	10.7	18.4	17.3	15.2	20.3	7.1	12.5	5.7	29.4	18.0	4.8	13.7	9.9	14.8	9.5	10.6	29.4	17.1	43.3	9.1	8.7	41.3	32.2	24.5	11.7	12.3	22.0	16.5	17.2	10.4	15.8	19.5	13.3	10.9	10.6	17.1	11.5	20.3	17.4	6.2	7.7	7.8	21.3	12.8	11.5	14.0	38.6	8.3	14.1	13.4	5.2	7.8	14.7	13.5	11.0	15.1	13.2	18.9	14.1	10.7	13.5	23.1	19.5	4.0	12.8	15.1	8.9	18.3	13.0	10.7	11.7	21.2	16.0	10.2	11.4	13.8	8.1	11.5	10.9	6.0	19.6	31.4	31.2	26.4	23.3	22.2	15.3	24.1	25.0	10.4	11.8	38.5	39.7	23.6	5.4	14.6	15.1	46.7	33.9	48.2	16.2	30.4	18.5	16.6	33.0	17.5	16.9	9.8	10.0	12.0	17.3	24.0	11.8	56.9	25.2	21.7	26.2	17.5	22.6	28.7	21.9	19.4	14.6	352.0	74.5	28.0	19.7	33.1	35.3	31.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	19.0	13.4	19.8	38.3	44.6	36.1	11.9	23.0	35.7	19.1	24.2	16.0	13.9	7.8	18.4	42.2	16.5	19.2	14.5	22.4	12.1	14.3	20.8	12.2	19.8	30.4	34.6	12.9	18.4	36.0	29.3	16.2	16.1	32.5	28.7	13.3	13.2	18.1	22.7	29.2	9.8	16.5	10.2	99.8	14.9	8.7	9.1	20.6	34.0	20.3	16.0	22.9	10.4	13.9	24.3	15.7	22.9	27.2	27.3	21.7	11.4	11.9	15.8	21.3	17.1	15.5	15.4	11.2	14.6	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6	32.8	25.2	38.7	57.7	36.1	56.4	26.7	56.0	32.1	39.8	52.4	35.3	167.5	41.4	124.0	24.9	56.8	99.6	23.3	88.8	180.7	66.2	64.5	40.3	62.3	87.8	55.6	102.8	65.7	41.3	59.8	64.7	40.3	62.4	92.8	108.3	110.5	105.8	94.7	62.9	58.6	49.3	32.3	47.5	38.7	38.1	31.0	220.8	42.4	69.7	72.1
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763366-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	17.2	19.0	28.9	21.7	33.4	26.1	21.0	51.4	32.6	18.6	15.4	24.9	18.8	13.1	23.8	20.6	17.4	20.6	15.9	15.8	24.2	18.2	15.7	14.0	16.4	20.8	24.1	24.8	31.3	21.0	30.9	30.5	19.8	22.5	20.0	17.2	18.8	20.6	22.8	20.7	23.0	16.5	17.7	21.2	18.9	16.2	28.8	27.6	24.7	22.5	8.7	20.6	22.4	18.7	5.5	7.8	3.3	3.9	5.4	4.6	3.0	19.2	21.4	23.5	4.5	16.9	16.5	12.7	13.4	13.7	13.6	13.7	18.8	13.9	28.9	10.0	15.1	9.7	17.5	20.3	13.9	21.6	17.4	11.7	20.9	13.6	12.8	9.1	15.9	16.0	14.4	9.3	15.3	11.6	16.1	18.5	16.1	16.5	13.8	16.7	19.8	18.3	12.9	14.0	11.9	18.0	27.7	23.4	10.1	10.8	27.8	17.2	16.9	21.5	13.3	5.1	15.7	15.9	10.6	27.7	16.5	21.1	11.8	16.8	16.9	16.3	31.9	14.3	11.7	12.3	0.7	3.4	3.3	3.8	3.9	4.2	4.4	3.2	3.2	3.1	5.5	4.6	4.6	2.7	5.4	3.1	7.8	2.7	3.0	28.9	33.4	51.4	32.6	24.2	18.2	24.1	24.8	22.5	27.6	23.8	29.3	17.9	9.5	17.6	43.2	36.4	17.8	38.8	30.7	8.7	39.3	17.3	1.7	12.8	28.4	22.5	12.1	0.0	13.5	12.1	17.6	15.9	16.3	16.0	16.1	49.3	19.7	20.3	19.1	12.5	31.4	16.6	5.0	15.4	17.9	27.2	14.2	10.5	45.6	11.8	28.3	19.4	15.1	59.1	47.3	20.5	13.2	17.0	19.4	10.5
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.9"	"Cell type enhanced"	"Detected in all"	4	"monocytes: 480.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	29.6	32.5	39.0	20.1	38.2	164.9	32.9	34.2	52.9	31.2	34.6	20.7	38.2	19.4	28.7	40.9	35.1	25.6	30.8	26.1	38.1	39.5	40.5	29.8	31.9	30.5	35.3	32.5	30.0	23.4	24.6	26.0	48.1	36.4	33.8	22.2	33.1	28.7	47.6	27.7	26.1	29.1	36.8	30.6	29.6	27.2	31.4	18.3	34.2	39.0	20.6	28.2	40.1	25.2	21.3	35.0	72.4	31.9	12.5	21.6	30.9	9.9	5.5	12.0	5.9	34.1	33.1	10.2	14.1	43.7	8.2	12.7	4.5	10.3	5.9	9.6	28.4	19.0	5.4	2.7	14.4	11.6	26.1	5.4	3.1	2.5	7.2	29.1	1.0	7.2	34.1	29.4	15.5	20.0	35.6	15.5	3.9	4.3	10.5	22.1	5.2	3.2	7.2	6.7	11.5	6.5	1.9	16.3	5.6	27.5	19.4	4.8	14.9	7.2	6.9	17.5	23.0	7.7	5.8	20.3	22.3	8.6	6.1	3.9	25.1	9.8	7.9	15.9	2.8	9.0	41.7	19.6	43.1	13.6	21.8	13.5	21.3	16.6	15.9	18.2	17.4	16.0	14.1	72.4	12.5	31.9	35.0	21.6	30.9	39.0	38.2	34.2	52.9	38.1	39.5	35.3	32.5	36.4	18.3	77.4	75.1	107.8	142.4	118.9	71.0	67.4	35.7	57.6	64.8	96.0	45.2	147.4	117.7	76.8	214.0	63.9	69.5	116.8	69.5	110.5	88.3	121.7	81.7	36.8	91.0	60.4	200.3	49.1	87.4	400.6	53.5	101.5	161.9	480.7	69.6	83.5	86.2	73.7	77.8	97.1	49.3	51.8	103.9	99.6	72.4	124.6	341.2	117.6	43.7	247.9
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350089	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	22.1	16.6	25.1	28.8	33.2	101.8	24.3	38.4	25.8	30.3	20.8	24.4	24.0	16.7	29.2	25.1	25.4	20.2	17.6	18.5	23.5	19.6	19.8	19.5	21.1	26.8	26.1	23.4	39.7	24.2	27.6	32.4	33.2	22.8	25.2	21.3	13.8	22.7	30.2	32.9	26.1	21.2	27.6	25.4	23.6	20.6	17.7	35.1	30.2	23.8	20.2	26.7	34.8	30.3	18.0	15.1	41.6	9.3	7.5	11.1	3.2	17.6	10.6	21.7	13.0	13.1	11.4	18.0	19.5	12.3	12.2	12.9	13.1	16.3	29.0	16.0	9.9	9.9	13.4	20.3	17.1	19.9	21.4	12.3	22.1	15.2	14.5	13.4	23.3	17.1	10.8	18.6	10.9	26.2	15.7	13.2	14.1	20.8	17.1	17.8	13.5	27.1	21.0	16.3	17.3	10.5	23.8	24.6	12.9	19.1	20.5	18.9	14.8	17.0	18.4	14.1	21.2	14.4	16.3	13.9	14.1	14.9	9.7	12.8	17.8	11.9	30.3	9.5	15.2	12.9	20.2	8.3	14.7	9.9	5.0	7.7	12.7	8.0	7.9	4.6	18.0	11.1	9.2	41.6	7.5	9.3	15.1	7.3	3.2	25.1	33.2	38.4	25.8	23.5	19.6	26.1	23.4	22.8	35.1	104.2	120.5	72.4	101.3	106.6	102.8	78.1	73.9	139.2	159.3	69.8	66.8	58.2	44.7	60.9	61.3	76.3	40.0	23.3	49.7	94.0	62.9	98.5	88.2	72.1	37.8	85.8	82.2	47.9	51.2	14.3	69.0	70.8	60.8	45.1	60.5	91.4	65.5	48.7	63.6	32.1	131.7	51.8	97.3	131.7	89.6	117.6	99.5	74.8	54.4	85.9
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087323	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.9;JURKAT: 19.6;MOLT-4: 17.8"					"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA055995: AB_2683000"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	14.4	5.2	8.0	3.0	16.6	3.4	13.0	6.7	10.8	10.5	6.9	20.5	6.4	5.7	15.8	12.7	3.8	10.6	5.3	6.5	9.5	6.2	18.0	16.2	7.3	3.3	22.7	7.2	12.2	10.9	13.9	9.0	3.6	9.5	7.8	6.5	8.3	8.3	10.3	3.7	3.9	5.0	13.0	10.5	5.0	8.7	4.0	13.7	5.2	16.4	1.6	2.8	5.4	5.8	0.2	1.8	0.3	1.1	0.1	0.8	0.2	3.2	2.6	3.4	18.9	14.5	1.0	0.2	1.1	3.2	1.7	4.5	5.6	1.5	0.0	7.1	2.1	0.7	0.4	1.8	1.1	1.5	1.0	3.5	2.5	5.7	6.4	8.6	3.3	1.0	16.2	4.4	0.8	3.3	2.7	5.3	19.6	0.0	7.0	1.0	3.2	17.8	0.5	2.3	0.8	1.6	7.5	6.6	1.0	7.8	1.2	3.8	8.0	3.8	3.2	5.4	1.4	4.8	2.4	2.1	1.5	2.9	3.3	4.4	5.1	4.8	7.3	2.3	6.5	3.4	0.0	1.1	0.3	0.4	0.4	0.4	0.1	0.3	0.5	0.9	0.2	0.8	0.8	0.3	0.1	0.1	1.8	0.0	0.2	8.0	16.6	6.7	10.8	9.5	6.2	22.7	7.2	9.5	13.7	0.0	3.2	3.0	3.4	1.1	8.3	9.6	10.2	0.0	3.4	12.2	11.8	1.3	14.9	4.1	3.4	9.0	2.0	0.0	5.1	0.2	4.8	4.4	1.1	24.6	8.2	3.2	15.5	9.2	10.2	1.5	16.4	4.6	6.8	0.0	5.1	13.8	3.7	3.5	10.6	16.5	14.4	0.0	3.3	1.4	3.3	1.3	0.2	0.0	6.4	1.4
ZBED6		ENSG00000257315	"Zinc finger BED-type containing 6"	P86452	1	203795714-203854999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526, HPA068807"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: AB_2686040"	"unprognostic (1.79e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.47e-2)"	9.1	10.1	7.8	4.9	6.3	4.3	21.8	13.3	7.3	12.1	8.4	6.8	6.2	8.4	12.2	4.7	8.7	7.4	8.1	6.8	8.6	2.4	8.3	9.9	8.9	6.7	9.6	4.1	12.0	10.0	10.1	18.9	13.3	7.7	7.6	5.4	4.0	11.0	7.4	11.7	10.6	10.8	6.3	8.5	8.8	7.6	18.6	7.6	9.7	11.9	5.5	6.9	9.0	19.8	0.7	1.5	0.4	0.5	1.8	0.8	0.1	3.8	5.3	8.6	4.0	10.7	19.2	3.9	4.6	13.9	4.4	5.6	1.2	4.1	2.8	1.1	10.4	2.2	5.4	2.8	5.1	7.8	6.0	2.1	5.6	5.2	1.4	4.9	3.4	3.5	9.8	3.4	5.1	5.5	9.9	13.6	3.3	5.9	10.0	9.8	2.4	2.8	3.3	2.2	2.1	2.3	1.8	7.2	2.5	3.9	5.3	1.8	9.9	6.1	9.1	2.4	9.6	10.5	5.1	15.9	7.7	6.2	3.0	3.3	4.0	1.4	1.0	7.2	2.3	6.3	0.0	0.5	0.2	0.8	0.2	0.1	0.7	0.3	0.6	0.4	0.2	0.1	0.6	0.4	1.8	0.2	1.5	0.3	0.1	7.8	6.3	13.3	7.3	8.6	2.4	9.6	4.1	7.7	7.6	8.9	4.6	4.8	31.2	14.2	18.0	1.7	7.6	13.4	17.0	0.0	29.5	12.1	0.0	0.1	0.8	11.5	20.6	0.0	0.0	11.2	15.3	35.0	33.4	3.8	5.4	11.1	17.7	7.4	5.0	0.8	18.4	9.8	13.5	0.0	5.4	18.8	0.1	14.4	14.2	0.0	18.7	25.8	18.6	5.6	5.4	14.9	29.2	15.2	10.6	38.3
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364117-151391548	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	11.1	7.7	10.3	10.6	8.6	14.4	13.3	11.7	10.7	9.3	10.3	8.2	9.2	7.9	11.1	8.1	8.5	10.7	11.5	8.4	8.4	6.6	7.7	9.9	13.1	14.4	11.0	6.8	17.4	14.4	8.6	5.3	9.2	10.3	8.7	9.9	6.9	11.1	12.3	14.0	8.6	10.6	14.6	9.6	12.0	9.4	7.7	11.1	27.7	32.2	8.0	13.0	11.2	13.9	5.7	6.6	15.1	10.7	7.8	14.1	6.3	8.8	6.4	9.9	7.4	10.6	11.2	10.6	14.1	20.3	17.8	17.0	12.4	7.3	22.8	7.9	14.1	18.0	10.6	15.8	17.1	22.3	10.3	11.8	10.2	7.7	18.7	15.8	27.6	12.7	11.8	10.3	16.3	20.0	10.2	10.4	10.8	18.6	13.4	12.5	19.8	14.9	12.9	12.0	11.0	9.8	14.3	9.3	9.1	13.5	13.5	11.0	7.7	11.1	14.6	11.0	10.4	9.8	16.6	8.5	15.1	16.4	6.9	18.6	17.9	18.6	25.5	6.2	15.1	10.7	13.6	6.0	15.1	11.3	6.6	14.1	5.7	10.3	13.4	6.6	4.4	8.7	10.5	6.9	7.8	10.7	2.7	8.3	6.3	10.3	8.6	11.7	10.7	8.4	6.6	11.0	6.8	10.3	11.1	8.9	5.8	5.9	7.3	14.0	2.9	7.6	5.1	8.1	11.4	0.0	0.0	5.2	11.6	4.2	7.2	8.7	4.6	0.0	2.5	16.2	8.2	12.0	9.2	2.4	6.6	1.6	8.6	4.3	7.6	8.9	8.1	9.4	10.1	1.0	6.6	2.9	3.9	0.0	3.9	4.1	1.8	6.5	14.2	3.2	6.8	15.9	10.4	14.9	6.4	8.2
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314501-115147271	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 279.2;Early spermatids: 317.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	10.7	7.3	6.3	2.9	12.3	4.0	6.2	17.3	9.3	7.2	4.2	10.8	5.3	1.7	6.6	17.4	3.5	4.9	4.3	6.1	9.7	5.2	9.8	9.8	4.4	3.3	14.9	3.7	12.7	5.9	5.3	26.1	2.2	11.5	10.0	2.7	7.9	5.4	9.2	12.1	4.4	4.0	7.5	19.2	4.4	3.9	44.6	14.2	2.1	9.1	8.1	3.3	5.2	5.0	18.2	4.3	7.8	3.6	4.1	7.7	2.7	2.3	4.4	1.7	4.2	6.3	2.8	0.0	1.8	3.9	1.1	0.9	2.5	0.8	0.6	6.1	4.6	1.5	0.1	6.1	1.0	1.1	0.5	0.1	0.6	2.1	1.9	1.5	0.3	0.0	2.7	0.3	2.5	0.8	3.9	1.3	0.5	0.1	1.0	6.4	0.0	0.3	0.2	0.4	0.0	0.2	0.2	5.1	0.0	4.3	0.0	0.4	1.0	0.8	0.0	1.3	0.2	0.0	0.5	7.2	1.6	5.5	0.3	2.7	1.6	0.0	0.3	2.6	0.4	2.0	7.8	1.4	5.1	6.1	2.0	4.2	18.2	6.0	5.6	1.6	10.7	7.7	6.6	3.1	4.1	3.6	4.3	2.8	2.7	6.3	12.3	17.3	9.3	9.7	5.2	14.9	3.7	11.5	14.2	148.9	92.8	51.6	33.4	22.9	70.0	42.8	101.9	45.5	35.2	279.2	56.9	0.2	41.4	165.4	317.2	68.7	13.9	0.0	71.6	0.5	90.0	35.5	79.6	95.2	3.8	76.3	30.5	49.7	16.5	71.3	97.8	22.0	30.4	34.3	15.3	183.7	101.7	11.4	113.5	147.9	113.2	84.1	55.2	6.6	4.3	16.2	0.5	36.3	16.6	21.7
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.6	3.6	6.5	6.0	5.6	7.9	6.8	6.6	6.1	4.9	4.4	8.7	3.2	6.5	3.1	6.2	9.9	13.5	5.8	6.1	6.1	6.1	3.8	4.5	10.6	3.7	7.5	6.2	8.5	9.6	15.5	7.9	19.9	4.7	3.7	5.4	7.7	15.1	7.2	5.0	5.4	4.0	5.9	5.0	6.2	4.7	21.1	5.2	5.4	5.4	5.8	5.4	6.7	6.4	5.8	6.2	5.9	4.0	3.5	5.9	5.7	6.6	5.3	16.2	11.5	2.5	7.4	5.3	4.8	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3	32.8	40.1	29.9	62.2	75.4	37.7	33.5	22.9	20.1	46.6	26.2	102.1	15.5	1.7	27.3	73.1	17.3	40.0	0.0	16.1	10.4	25.7	47.1	30.1	22.9	13.6	25.4	10.9	17.2	14.6	30.4	16.4	26.4	23.6	11.8	16.6	33.0	31.3	14.2	13.4	5.8	56.4	12.9	25.9	42.1	61.8	102.6	43.5	20.1	18.1	123.4
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6580001-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.8	12.0	9.6	15.1	12.6	13.3	12.3	11.1	16.3	13.5	12.2	12.7	21.4	11.7	13.2	15.1	12.7	14.2	17.6	9.6	8.9	7.5	12.9	21.6	14.3	17.1	7.0	11.3	19.9	15.8	17.1	14.0	10.7	11.4	17.2	13.2	16.9	12.6	11.7	10.9	14.4	17.2	11.3	8.8	17.1	12.9	28.2	10.3	19.9	18.4	7.4	15.9	13.0	14.4	7.5	7.8	26.7	6.8	6.6	6.4	5.3	3.9	4.8	7.6	11.1	8.5	6.6	3.9	4.0	4.8	7.7	8.4	4.9	9.1	13.1	7.2	3.5	5.3	7.4	11.5	8.0	6.2	13.3	10.9	10.6	13.9	4.8	10.1	17.0	28.8	6.6	6.2	7.5	12.1	10.4	5.6	10.0	10.4	8.6	5.7	7.6	8.3	12.2	5.7	7.7	8.3	9.5	7.1	14.4	6.9	3.7	14.9	6.9	6.0	13.8	9.2	8.3	7.9	13.7	6.3	5.3	3.5	5.7	5.0	9.4	8.1	20.3	4.9	13.7	3.0	10.9	6.8	26.7	6.0	4.2	6.0	6.5	4.7	5.7	7.8	7.5	6.4	5.5	10.0	6.6	6.6	5.0	3.8	5.3	9.6	12.6	11.1	16.3	8.9	7.5	7.0	11.3	11.4	10.3	3.0	10.5	6.7	8.5	4.1	7.1	4.5	12.7	13.4	7.9	10.4	5.9	5.1	10.0	4.1	36.3	4.7	15.8	0.0	3.2	4.1	5.8	5.2	26.5	11.6	9.6	9.5	14.9	4.3	6.2	14.2	8.1	9.8	5.0	10.0	12.7	10.4	2.7	14.0	5.3	10.5	7.4	19.4	5.2	17.7	10.4	4.8	4.2	10.1	9.5	5.8
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	11.9	10.4	10.7	11.8	12.2	5.2	12.9	17.7	13.2	13.7	9.4	9.0	10.7	10.4	12.6	8.2	11.6	9.4	7.3	9.7	10.2	9.4	11.0	9.2	12.4	26.2	15.6	10.3	13.8	10.0	11.6	14.0	14.1	10.5	10.2	9.0	6.3	9.9	11.4	14.0	10.0	15.0	10.0	13.2	14.0	9.7	9.5	14.4	22.7	13.8	10.1	16.0	11.1	9.3	2.1	2.3	11.8	3.9	3.8	4.0	2.4	4.1	4.8	7.9	7.2	8.4	8.1	8.0	7.0	8.6	7.0	6.3	5.0	5.3	6.6	4.4	6.3	6.3	19.0	8.2	8.6	8.8	9.3	6.5	7.0	10.4	4.6	8.3	9.2	12.7	6.6	13.1	6.4	10.7	8.7	6.4	8.4	7.3	8.2	10.1	7.7	9.3	6.2	9.9	12.3	8.3	5.0	21.7	9.2	7.4	6.8	10.0	12.9	10.8	10.6	6.6	8.7	13.3	6.1	6.5	7.7	6.0	7.8	8.0	14.4	17.2	1.8	9.0	6.3	7.8	11.8	2.3	3.3	2.0	2.5	2.7	2.1	2.8	1.9	2.3	1.7	4.0	3.5	3.0	3.8	3.9	1.3	2.9	2.4	10.7	12.2	17.7	12.1	10.2	9.4	15.6	10.3	10.5	14.4	6.0	2.2	0.0	2.7	1.9	7.3	2.8	7.6	4.0	9.1	1.8	9.8	1.7	0.0	2.1	7.6	2.9	2.6	0.0	2.1	1.0	2.5	3.2	7.0	2.4	2.1	6.4	2.9	7.4	9.2	3.2	2.8	5.4	1.7	1.8	4.2	7.4	2.6	3.4	7.4	3.3	9.1	6.5	2.5	5.2	3.0	2.4	1.6	5.1	3.3	2.7
ZC3H12A	"FLJ23231, MCPIP1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474552-37484379	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.7;tongue: 56.9"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 174.0;Suprabasal keratinocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;RT4: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	11.7	8.4	0.8	15.0	2.9	58.7	8.2	1.3	1.3	6.4	13.3	2.9	5.6	7.0	5.0	6.9	25.2	8.1	22.6	6.3	2.1	0.7	6.7	10.7	21.0	11.3	1.8	0.7	7.1	6.8	1.0	4.6	8.1	3.8	16.1	4.2	3.0	10.9	6.3	11.8	23.1	14.1	8.5	2.6	10.9	11.0	3.4	1.1	8.3	4.0	56.9	34.8	17.0	22.2	6.1	2.6	8.9	2.1	5.5	5.5	2.3	3.7	2.7	0.3	1.7	1.4	2.0	3.1	2.7	24.3	1.7	2.3	3.0	8.5	4.2	11.6	2.6	19.2	8.2	1.1	17.5	1.0	8.5	1.6	1.1	8.9	4.7	2.0	2.2	1.8	4.4	9.0	15.2	2.7	4.0	1.9	2.2	2.1	7.0	1.6	4.5	1.7	3.9	2.1	5.0	2.4	2.5	1.1	2.5	4.4	30.1	0.8	0.5	5.4	8.6	0.6	2.8	3.0	2.5	2.0	5.2	2.9	3.8	4.1	5.6	2.0	3.1	11.9	4.6	1.0	1.8	2.1	5.8	5.4	2.1	5.5	5.2	2.2	3.3	2.6	6.1	1.3	2.5	8.9	5.5	1.9	2.5	2.8	2.3	0.8	2.9	1.3	1.3	2.1	0.7	1.8	0.7	3.8	1.1	14.9	39.3	19.1	112.5	174.0	0.0	3.9	38.2	8.1	21.6	10.4	0.0	3.1	0.0	64.4	17.4	11.7	60.6	0.0	65.3	7.5	22.6	104.0	42.6	11.6	9.3	0.0	61.3	1.8	10.8	2.4	0.9	50.4	45.5	20.8	50.6	0.8	44.4	38.4	1.1	0.3	4.3	6.5	45.7	1.4	0.9	196.9	9.8	17.3	33.3	73.7
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485061	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 38.1"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 5.4;Kupffer cells: 10.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 27.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	3.3	0.8	0.5	33.4	1.0	3.4	1.2	0.7	0.6	0.8	3.0	0.1	1.0	3.0	0.6	1.2	0.8	0.8	0.9	0.6	0.5	0.7	1.3	0.8	2.0	10.6	0.5	0.0	0.4	0.7	0.0	0.6	0.8	0.5	0.7	1.5	0.9	2.0	0.2	0.4	1.1	7.7	0.4	0.7	9.5	0.7	0.7	0.4	4.8	0.9	1.6	38.1	1.7	0.6	3.2	1.7	1.3	2.7	0.7	7.2	1.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	6.4	0.1	0.0	0.2	0.2	0.0	0.0	0.1	27.0	0.2	0.2	0.8	2.2	0.0	2.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	5.6	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	3.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.3	2.1	0.1	1.3	1.8	0.4	0.3	1.0	0.5	3.1	3.2	1.5	1.7	3.2	2.0	0.5	1.3	0.7	2.7	1.0	7.2	1.5	0.5	1.0	0.7	0.6	0.5	0.7	0.5	0.0	0.5	0.4	3.0	3.8	3.2	0.5	0.3	0.6	1.1	2.5	0.0	1.2	0.0	3.9	0.0	1.7	0.0	0.3	1.1	5.4	0.0	0.3	0.0	0.6	0.3	0.0	0.0	3.2	0.0	0.0	2.5	10.8	0.2	0.0	3.6	1.7	0.0	1.5	0.8	0.2	0.0	0.0	1.4	0.6	0.0	0.3	0.1	0.4	1.3	0.0	5.7	2.1	0.3
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113752	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		8500	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.23e-4)"	12.0	8.2	8.6	14.5	16.9	8.5	18.2	25.6	13.9	8.9	9.6	14.7	9.8	11.5	12.8	6.0	11.8	10.4	6.5	8.2	9.3	7.6	9.2	10.9	19.9	14.1	16.5	5.2	14.6	12.5	10.4	45.4	15.4	13.9	9.7	7.2	10.8	11.8	10.4	14.1	13.5	11.5	8.5	26.0	16.0	11.5	14.5	12.4	17.5	10.5	9.3	11.5	10.3	24.0	5.2	6.8	6.2	3.7	5.2	5.6	1.2	8.8	13.8	8.6	12.2	4.8	3.0	8.8	7.1	4.0	6.7	4.5	9.8	9.9	18.7	5.3	4.8	4.1	15.4	3.8	10.1	4.3	11.5	6.1	13.3	8.4	7.4	4.2	12.6	14.2	5.1	2.8	6.2	4.9	3.6	5.4	11.6	12.8	7.1	4.3	15.4	14.2	21.3	12.8	6.0	4.7	22.4	7.4	8.4	5.0	14.5	10.5	14.9	10.8	9.1	5.3	4.4	9.5	10.2	9.5	9.1	8.9	5.8	9.9	9.3	7.5	16.7	7.1	10.3	12.9	4.6	2.2	3.2	5.5	3.7	5.6	5.2	4.9	5.5	2.9	5.1	4.3	4.8	6.2	5.2	3.5	6.8	3.1	1.2	8.6	16.9	25.6	13.9	9.3	7.6	16.5	5.2	13.9	12.4	3.0	13.3	13.6	5.5	19.8	24.1	11.2	25.5	12.0	12.5	19.2	13.7	5.7	8.3	9.9	11.9	13.0	15.8	23.3	10.1	5.8	13.5	7.5	11.6	11.9	10.9	15.9	18.4	17.2	27.8	5.4	15.5	14.8	6.8	13.6	20.6	17.4	10.3	16.7	9.2	7.0	23.0	6.5	10.2	13.0	9.2	19.6	7.2	14.4	14.9	6.7
ZC3H6	"FLJ41410, FLJ45877, KIAA2035, ZC3HDC6"	ENSG00000188177	"Zinc finger CCCH-type containing 6"	P61129	2	112275594-112340063	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036019, HPA036020, HPA076065"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.99e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.45e-2)"	10.9	8.8	8.1	6.2	18.9	5.8	11.2	16.6	14.3	10.9	8.1	11.4	7.7	5.3	9.1	11.9	6.7	10.3	6.5	9.4	8.9	7.4	7.6	6.4	7.4	8.9	15.6	10.5	20.5	7.1	13.8	18.3	7.0	11.1	9.8	6.2	8.6	8.2	8.0	16.4	14.3	7.5	10.5	11.5	10.0	6.9	9.4	13.1	12.4	12.5	5.2	8.6	13.4	8.6	5.5	2.9	3.9	3.4	1.8	4.5	1.1	1.7	0.8	4.0	3.7	3.5	7.0	1.2	2.0	3.1	1.2	2.6	0.4	2.4	2.9	1.5	1.1	3.4	1.1	1.2	0.5	1.7	3.2	0.4	0.5	0.9	0.1	3.3	0.9	0.8	2.7	5.4	1.4	9.2	5.7	1.9	3.6	0.7	4.9	2.8	1.6	1.7	1.2	2.5	1.1	0.9	1.1	0.2	2.5	1.7	0.3	2.8	3.9	1.9	1.1	2.0	2.2	1.2	1.1	3.0	2.0	0.3	2.2	0.9	5.2	1.5	2.5	3.7	1.9	4.9	1.5	1.8	2.3	2.9	1.3	3.2	3.7	3.9	3.0	1.6	5.5	4.5	3.7	3.9	1.8	3.4	2.9	3.2	1.1	8.1	18.9	16.6	14.3	8.9	7.4	15.6	10.5	11.1	13.1	35.7	23.5	7.8	27.2	15.3	64.1	63.7	17.8	37.5	26.1	21.0	51.1	17.6	24.9	10.4	9.8	27.8	9.0	0.0	13.1	6.2	18.3	24.3	25.5	15.8	10.9	108.1	15.5	23.4	15.2	11.0	42.8	13.5	5.0	16.2	13.3	47.9	11.9	9.1	33.9	18.3	82.7	32.3	26.8	70.4	48.8	16.2	6.6	22.4	14.0	17.2
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211525-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA034803: AB_2674338, HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	6.5	7.9	13.0	9.0	15.9	9.1	13.6	18.2	19.6	7.5	7.7	7.2	9.1	8.8	8.4	7.5	16.1	8.8	4.5	13.7	11.1	8.6	9.2	9.8	5.0	12.8	11.6	12.6	10.3	15.4	15.2	35.7	6.2	13.6	9.8	10.4	5.2	11.3	11.7	33.1	12.5	8.3	7.6	13.7	11.7	7.8	14.1	13.8	12.6	12.2	12.8	13.8	9.0	12.4	7.2	4.7	2.4	2.8	8.7	10.6	2.9	11.8	5.8	7.4	7.6	4.2	4.6	11.7	3.8	3.2	5.3	4.5	13.9	4.6	24.8	7.0	2.6	7.5	7.2	10.8	7.6	7.2	8.7	4.9	16.4	6.4	7.0	6.7	15.2	7.6	5.7	15.3	10.4	16.2	3.9	4.0	15.1	20.9	6.9	4.1	7.8	16.4	13.8	6.9	12.6	16.4	11.5	12.7	10.1	4.9	5.3	11.2	8.7	7.1	7.7	16.0	6.8	6.1	8.2	5.3	7.0	9.0	4.9	9.5	12.4	14.8	24.4	5.0	12.8	2.7	2.4	2.8	0.9	5.1	2.3	10.6	6.4	5.1	5.3	2.9	7.2	8.8	7.5	1.5	8.7	2.7	4.7	5.1	2.9	13.0	15.9	18.2	19.6	11.1	8.6	11.6	12.6	13.6	13.8	8.9	14.6	28.4	15.7	11.2	45.9	34.3	10.2	18.7	30.7	7.0	39.3	15.2	23.2	12.4	23.9	13.4	10.6	0.0	16.0	12.8	10.8	12.6	33.6	7.8	10.0	36.5	14.3	13.5	13.3	27.2	20.4	12.4	1.7	4.6	20.0	17.8	16.0	10.5	19.1	15.3	46.6	12.9	12.7	52.3	34.2	15.6	11.9	21.8	22.1	10.8
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018286-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	11.0	13.8	8.1	10.0	10.3	4.9	14.2	9.5	12.6	9.5	9.2	9.9	5.9	6.0	14.5	11.0	7.9	9.4	7.5	16.3	8.2	8.9	13.2	14.8	6.9	13.6	7.3	8.4	10.7	10.6	10.5	9.6	10.0	10.5	9.0	8.4	9.6	10.5	8.4	33.0	7.1	7.8	12.9	5.5	13.7	9.0	24.6	6.6	15.4	8.3	11.9	11.5	8.5	9.6	23.1	20.2	17.4	17.7	17.4	23.8	15.8	7.0	12.0	14.9	16.8	8.5	7.8	10.3	9.2	11.0	17.4	18.1	14.1	12.1	16.3	6.7	11.7	23.8	6.5	19.5	13.9	17.2	10.6	16.7	11.3	10.9	13.7	13.7	13.0	11.6	9.4	10.5	18.1	11.8	9.9	19.0	14.0	33.9	5.7	17.6	12.4	15.3	25.1	30.4	12.4	13.7	14.5	11.5	14.2	17.6	4.8	9.6	17.2	13.3	19.3	14.7	22.3	8.4	13.8	8.7	11.9	5.8	10.4	15.4	11.1	16.7	21.2	18.8	16.7	20.2	17.4	16.2	14.5	17.0	17.7	19.5	23.1	18.2	18.2	20.2	20.6	23.8	18.8	1.3	17.4	16.3	11.9	18.5	15.8	8.1	10.3	9.5	12.6	8.2	8.9	7.3	8.4	10.5	6.6	6.0	2.9	5.1	4.3	1.3	5.8	12.1	7.6	10.7	3.4	7.0	0.0	16.1	14.9	10.7	2.6	6.5	2.1	0.0	8.4	13.7	4.8	2.2	4.6	8.5	7.8	6.4	3.5	11.6	3.2	4.3	8.1	4.1	1.7	15.4	4.1	7.2	7.8	7.0	6.0	17.0	5.6	0.0	5.1	31.6	18.8	1.5	6.2	5.7	4.2	1.4
ZCCHC10	FLJ20094	ENSG00000155329	"Zinc finger CCHC-type containing 10"	Q8TBK6	5	132996985-133026604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038944	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA038944: AB_10673601"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.89e-3)"	18.6	17.3	14.5	18.2	14.1	30.6	16.4	18.1	20.6	17.4	24.1	10.5	15.4	18.3	18.7	15.4	26.9	14.9	14.2	17.3	13.7	12.4	19.6	23.5	21.0	26.0	11.9	15.2	17.3	17.7	9.8	27.4	23.0	15.3	16.1	22.1	10.0	17.9	16.8	31.5	14.0	21.7	14.0	17.5	23.6	17.8	20.3	14.1	25.6	13.9	22.4	26.5	17.8	17.3	48.1	27.2	16.5	28.0	22.9	27.7	18.8	11.9	12.4	16.5	13.6	8.3	7.5	21.6	12.6	9.8	16.1	18.7	31.4	14.8	33.2	19.3	8.4	12.7	15.1	20.1	16.1	17.5	19.5	26.7	19.3	15.3	23.2	12.3	16.5	22.5	6.8	18.5	9.8	16.0	8.8	15.9	16.5	20.8	18.4	12.2	15.6	25.7	19.2	17.9	12.7	13.1	23.1	19.5	14.4	14.8	17.2	13.0	10.9	20.1	8.2	23.2	23.4	18.2	21.5	16.1	13.8	16.4	9.0	18.1	15.6	24.7	46.6	11.3	29.6	16.2	16.5	28.0	16.4	19.7	25.3	20.6	39.7	24.1	23.5	27.2	48.1	21.2	21.8	14.6	22.9	25.3	24.0	27.7	18.8	14.5	14.1	18.1	20.6	13.7	12.4	11.9	15.2	15.3	14.1	26.8	38.6	82.1	33.1	29.7	26.0	45.6	61.1	30.8	35.2	12.2	7.9	43.8	28.2	33.8	5.0	32.1	53.0	0.0	58.5	44.4	38.5	26.8	32.3	53.9	41.1	27.0	36.4	38.1	58.5	5.0	22.7	44.8	33.7	38.7	50.6	17.3	47.2	73.7	28.0	70.8	25.2	12.9	34.4	62.4	63.2	33.1	51.5	45.7	45.4	45.6
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	27.9	9.0	30.9	9.5	54.4	1.8	9.8	11.1	36.0	22.9	19.8	56.8	4.2	4.6	18.0	6.9	10.3	15.5	16.8	19.1	30.6	19.7	3.5	13.5	10.2	4.8	56.7	23.5	20.1	4.0	3.9	3.0	11.4	36.2	14.5	6.8	4.5	6.2	20.7	34.8	5.0	5.4	25.6	36.8	7.0	9.0	6.6	51.9	0.0	6.0	2.5	3.2	14.9	7.3	0.0	3.4	0.6	2.4	0.7	0.9	0.5	0.9	0.9	3.2	2.8	43.5	37.4	0.8	7.5	28.5	4.5	5.2	0.8	0.0	0.0	4.1	15.1	1.5	0.0	0.5	0.1	3.8	1.8	2.0	0.4	2.3	0.9	11.3	1.1	0.6	38.8	0.4	4.0	1.1	13.3	0.9	0.2	1.4	1.6	3.8	0.3	0.0	4.4	0.7	0.2	9.3	0.2	3.8	0.6	0.5	1.2	0.1	4.0	2.3	0.3	9.4	3.2	1.1	2.1	0.6	4.3	4.0	11.7	2.5	2.9	1.9	0.0	8.8	1.4	15.3	0.0	2.4	0.6	0.9	1.1	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.2	0.6	0.7	0.1	3.4	0.4	0.5	30.9	54.4	11.1	36.0	30.6	19.7	56.7	23.5	36.2	51.9	0.0	1.6	0.0	1.5	6.8	0.0	16.5	7.6	1.4	1.2	0.0	0.0	0.6	0.0	0.8	1.7	17.0	0.0	0.0	0.7	0.8	40.7	3.6	1.1	44.7	8.5	0.0	0.0	57.1	15.9	3.7	63.6	6.8	15.1	1.0	0.4	16.4	0.7	0.0	61.5	1.4	0.7	12.9	21.2	0.7	1.0	4.0	1.3	4.3	0.0	1.1
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.9	10.8	6.4	9.3	16.5	25.1	7.9	13.6	13.3	6.0	7.0	4.9	8.9	14.2	12.4	9.0	6.2	17.6	7.6	7.7	9.0	16.6	4.1	10.2	11.5	9.1	14.0	11.6	14.9	16.6	16.1	9.6	11.4	9.5	10.1	7.9	9.6	15.4	16.8	10.7	9.7	7.0	5.2	17.2	7.3	4.9	11.2	6.5	10.7	19.6	4.7	3.7	8.3	11.0	4.7	8.2	4.1	5.3	15.5	5.8	7.0	10.2	9.3	17.8	13.9	10.6	13.8	7.0	7.6	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7	59.6	30.7	5.3	28.7	28.0	13.1	0.0	12.7	26.8	37.5	0.0	17.7	18.4	0.0	0.0	77.5	14.4	23.4	0.0	0.0	14.3	9.9	42.1	45.1	45.3	20.1	17.5	16.0	17.2	62.4	17.6	15.8	40.3	30.4	0.0	18.3	11.4	0.0	20.7	12.4	0.0	14.9	12.9	10.3	19.8	7.8	35.4	77.3	27.7	17.7	54.5
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301590-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	14.4	12.9	11.7	16.1	10.5	8.9	15.2	14.3	11.5	21.1	19.7	7.4	14.5	13.9	18.4	16.4	21.4	13.9	14.3	11.9	10.0	10.7	23.0	36.3	10.7	16.2	11.1	10.1	19.6	13.8	10.9	22.6	23.0	10.4	23.1	14.6	13.6	12.2	18.1	14.4	15.2	27.7	22.5	12.2	18.0	14.5	14.8	10.0	17.9	19.6	19.1	16.4	26.8	23.5	14.9	17.5	12.8	16.2	11.6	19.1	7.3	10.3	7.3	18.1	9.5	15.7	14.9	24.4	15.6	18.6	12.1	16.9	16.1	14.3	9.6	6.5	7.8	20.9	7.7	14.3	14.3	19.3	21.5	13.5	9.9	8.2	18.9	18.5	12.5	8.2	11.5	12.5	10.3	25.8	9.4	10.1	10.6	16.5	9.4	12.4	14.1	20.7	18.9	13.1	5.8	9.4	12.4	23.3	14.1	9.4	10.4	8.8	8.4	12.4	7.5	55.7	13.7	9.3	20.3	6.9	7.6	9.3	13.5	17.0	13.5	13.9	14.7	13.4	18.3	16.2	12.8	12.3	11.9	12.8	16.2	16.3	14.9	17.2	15.5	14.8	13.2	16.7	17.1	12.0	11.6	14.0	17.5	19.1	7.3	11.7	10.5	14.3	11.5	10.0	10.7	11.1	10.1	10.4	10.0	8.9	15.2	18.2	10.8	8.0	16.3	10.0	38.2	34.8	18.2	29.6	13.7	24.6	26.6	18.8	41.9	12.3	15.4	0.0	17.9	44.7	16.4	11.3	12.7	47.4	31.3	25.4	7.5	32.5	16.7	12.8	30.2	22.3	3.3	32.5	18.1	18.2	22.3	18.7	27.3	37.0	28.3	19.4	24.8	64.6	31.5	8.2	19.2	17.5	18.1	11.4
ZDBF2	"FLJ45338, KIAA1571, Slx9"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SuSa: 13.4"					"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	4.4	12.0	8.6	3.5	26.9	2.2	4.2	14.7	12.7	5.4	3.7	2.1	5.1	2.0	7.2	6.1	3.1	5.1	4.4	4.5	8.9	8.3	4.9	3.6	3.2	3.8	3.7	10.8	14.8	8.3	5.6	20.9	7.5	9.0	4.7	2.6	3.8	3.7	5.3	5.4	3.9	3.0	5.1	4.0	4.2	3.4	5.4	3.1	2.5	6.5	2.9	3.3	3.7	3.5	0.7	0.5	0.3	0.0	0.3	1.4	0.2	1.7	0.3	6.0	1.1	2.0	1.8	8.4	1.7	2.0	0.8	1.2	0.9	1.4	0.0	0.8	2.1	3.5	0.4	3.8	1.3	1.6	2.1	3.6	0.0	3.4	0.2	2.6	1.8	3.8	1.8	2.1	1.5	3.6	6.1	2.2	1.4	0.3	2.3	2.6	0.3	0.4	0.0	8.1	0.1	1.7	0.0	6.2	0.0	1.0	0.9	3.1	7.5	3.0	0.0	2.4	13.4	0.2	0.0	3.3	0.7	2.9	0.7	1.3	5.4	1.3	0.3	4.2	0.0	2.0	0.3	0.0	0.0	0.3	0.0	0.9	0.5	1.0	0.6	0.0	0.7	1.1	0.7	0.0	0.3	0.0	0.5	1.4	0.2	8.6	26.9	14.7	12.7	8.9	8.3	3.7	10.8	9.0	3.1	3.0	3.8	0.5	1.6	3.5	24.3	7.6	2.5	13.4	5.7	10.4	13.7	3.9	0.0	2.3	2.8	3.6	0.7	0.0	1.9	5.9	4.8	3.0	12.7	2.0	0.4	7.9	7.5	3.7	0.3	4.2	4.0	0.0	1.7	0.0	1.1	9.7	1.7	0.0	4.9	1.7	16.8	0.0	13.7	4.7	8.0	2.9	7.6	1.3	0.4	0.9
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.8"	"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.2	39.0	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.1	6.8	31.9	16.5	9.9	8.6	6.9	17.6	37.7	3.5	18.2	1.0	18.2	9.4	5.2	29.7	14.0	10.4	8.7	24.2	5.6	12.6	8.2	3.1	4.8	7.4	18.8	5.2	25.3	1.9	54.8	11.9	17.5	7.2	31.7	32.3	5.4	5.9	28.5	7.7	13.4	11.6	8.4	12.5	17.3	4.9	2.7	26.7	9.3	7.4	0.0	10.5	7.1	12.3	16.4	28.9	4.4	16.8	10.1	11.1	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7	14.9	8.1	54.1	42.0	14.3	0.9	9.6	79.0	4.0	11.4	43.6	0.0	147.4	11.6	94.7	58.6	14.7	157.1	70.0	176.4	191.0	11.1	49.6	18.4	48.9	121.4	0.0	49.2	28.3	52.9	22.4	8.9	39.8	40.5	159.7	93.7	14.5	109.4	171.9	6.7	32.7	1.7	6.5	9.5	23.1	17.5	24.6	112.1	48.4	94.2	52.6
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	28.4	31.6	12.4	12.6	27.5	21.2	23.4	26.8	32.1	22.4	16.8	19.1	35.1	19.2	34.8	31.6	19.3	40.3	19.3	31.7	20.0	23.6	8.7	16.3	14.5	17.0	30.8	30.5	27.7	29.8	28.7	33.1	33.7	18.6	25.2	16.2	21.4	24.3	28.3	17.1	17.1	8.5	15.0	21.1	19.0	17.1	25.1	23.7	25.6	42.2	9.0	11.5	24.9	28.2	26.1	17.5	30.2	17.5	29.5	29.1	15.1	30.5	18.6	17.7	21.9	16.5	21.6	15.8	25.2	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8	14.9	10.9	5.3	10.2	14.3	17.5	18.1	12.7	14.7	20.5	12.2	35.3	8.5	3.3	13.1	15.8	11.7	31.9	0.0	15.7	8.4	8.5	14.0	19.6	13.2	11.0	12.7	11.1	13.5	16.1	6.8	10.9	12.0	1.7	9.0	16.2	9.6	19.0	19.3	7.1	10.2	45.0	0.0	9.2	6.5	6.6	17.3	15.6	8.7	15.8	15.9
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type containing 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	20.7	19.2	25.7	16.9	23.0	9.2	23.4	24.4	35.3	14.3	9.9	14.0	17.3	11.6	16.0	10.9	13.9	13.6	14.4	16.0	18.7	10.6	15.2	16.5	14.6	15.4	17.7	17.6	18.0	23.9	17.4	21.0	16.4	19.0	13.4	7.0	17.5	20.4	16.6	20.5	22.2	11.2	13.0	10.4	19.8	15.9	8.4	18.6	8.9	18.5	7.9	11.1	12.9	14.5	2.0	4.1	4.0	1.5	1.3	2.5	0.5	11.5	7.4	11.8	15.5	17.3	10.4	10.6	21.8	14.9	14.8	13.3	3.8	6.0	0.0	9.0	18.1	8.0	15.9	6.2	16.7	7.3	16.6	23.7	5.6	19.4	8.8	14.3	0.0	7.9	18.1	11.3	11.4	9.6	9.1	16.5	8.3	38.6	9.1	13.1	5.6	6.8	15.1	6.0	5.1	11.7	14.6	10.3	4.1	6.4	14.1	19.0	9.6	8.8	4.3	10.4	5.6	0.3	7.9	18.9	33.7	24.7	18.9	9.7	13.2	4.3	4.4	9.9	7.3	9.9	4.0	1.2	0.3	2.5	1.5	1.3	0.8	0.7	1.2	0.4	2.0	1.3	1.8	0.0	1.3	0.8	4.1	2.0	0.5	25.7	23.0	24.4	35.3	18.7	10.6	17.7	17.6	19.0	18.6	3.0	1.9	2.7	3.4	8.0	11.5	6.8	5.1	0.0	3.4	10.4	13.7	3.1	1.7	4.5	0.5	9.0	2.4	0.0	3.8	6.1	8.0	4.0	5.7	7.8	4.2	12.7	4.1	11.6	4.9	1.3	10.0	5.0	5.0	2.8	5.5	8.3	6.2	4.3	13.8	1.9	11.0	6.5	5.5	0.3	2.3	8.5	2.9	2.5	4.8	2.7
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 99.5;Early spermatids: 98.1;Endothelial cells: 105.0;Late spermatids: 111.0;Peritubular cells: 95.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 47.1;RH-30: 27.8;TIME: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	18.8	7.4	14.4	13.9	14.4	6.1	11.4	15.5	24.1	31.3	31.2	7.1	8.0	4.9	32.9	14.1	17.3	12.0	16.0	27.9	12.9	14.7	5.9	8.1	12.5	7.0	13.7	11.9	11.5	3.4	2.7	9.3	13.3	13.1	20.4	11.0	4.8	5.9	24.2	36.2	5.1	8.3	40.4	20.4	6.6	14.8	7.3	14.9	22.6	8.3	18.7	8.0	53.1	20.7	5.4	3.8	11.5	0.0	7.2	10.2	2.2	0.0	6.1	15.4	15.0	21.6	47.1	0.0	13.4	18.7	2.5	4.9	0.0	0.0	4.3	6.4	16.2	3.6	0.0	6.5	0.0	4.6	8.2	3.2	0.0	3.6	2.7	18.0	3.4	0.1	21.8	0.0	8.0	8.1	8.2	23.7	3.6	3.0	5.7	16.7	0.0	11.9	1.8	0.9	0.0	3.1	4.3	27.8	1.7	4.4	0.0	0.4	5.7	4.6	0.0	0.0	3.0	0.0	2.3	36.2	15.2	3.6	3.4	6.4	2.8	2.3	5.1	4.3	0.0	1.7	5.1	0.0	6.6	3.6	0.0	4.8	5.4	4.5	2.3	1.5	4.7	10.2	4.5	11.5	7.2	0.0	3.8	5.8	2.2	14.4	14.4	15.5	11.9	12.9	14.7	13.7	11.9	13.1	14.9	0.0	11.4	18.0	2.5	10.0	38.8	99.5	2.5	1.4	5.7	1.8	43.2	0.2	0.0	1.8	98.1	105.0	0.0	0.0	2.2	0.4	37.0	2.6	1.1	11.3	1.2	9.5	0.0	44.8	5.3	111.0	28.4	5.0	25.3	17.2	0.0	3.1	1.9	0.0	95.8	1.4	39.7	77.6	47.8	16.3	15.3	7.5	0.6	14.9	0.0	3.7
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819499-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	23	"Early spermatids: 795.9;Late spermatids: 2445.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	26.7	27.5	31.0	26.0	31.1	23.9	37.6	26.2	31.4	28.6	27.0	26.6	26.0	24.5	25.9	31.2	22.2	21.4	33.5	30.5	29.9	24.1	31.6	35.6	24.8	26.1	30.4	22.2	23.9	26.1	33.9	31.6	31.4	24.2	23.7	20.2	24.3	20.3	31.0	77.9	19.4	26.9	35.4	33.4	21.9	25.1	60.5	27.3	26.4	32.1	19.7	19.3	30.7	34.0	3.0	4.4	9.2	2.8	2.9	2.6	1.4	17.2	10.7	37.0	26.2	22.4	23.3	12.8	28.9	33.7	26.1	27.9	21.0	10.2	7.2	22.2	30.7	30.6	11.9	14.1	21.3	35.9	27.4	9.0	21.7	5.6	20.0	52.6	9.0	19.0	29.3	28.1	27.5	46.8	32.1	22.5	17.1	10.3	15.3	19.7	14.9	14.1	7.6	11.0	25.6	11.2	14.9	14.9	8.7	24.7	29.5	23.0	20.2	16.2	14.2	49.7	31.4	21.8	19.1	24.5	27.5	20.9	14.7	18.0	14.9	13.5	21.8	10.3	14.3	28.3	0.7	2.7	8.8	2.6	2.8	1.8	1.9	1.9	2.0	1.3	3.0	1.7	2.6	9.2	2.9	2.1	4.4	2.4	1.4	31.0	31.1	26.2	31.4	29.9	24.1	30.4	22.2	24.2	27.3	20.8	8.6	15.7	25.6	24.3	24.2	20.2	20.4	6.7	3.4	45.4	21.6	27.7	63.0	22.6	795.9	23.8	49.2	23.3	25.1	25.5	23.1	42.8	4.7	43.1	29.1	28.6	15.5	24.5	37.3	2445.8	35.9	24.9	13.5	20.8	27.9	32.1	31.8	24.1	51.9	29.5	21.8	32.3	24.0	65.7	37.2	26.3	72.0	21.8	17.2	47.7
ZFAT	"KIAA1485, ZFAT1, ZNF406"	ENSG00000066827	"Zinc finger and AT-hook domain containing"	Q9P243	8	134477788-134713049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 68.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 57.3;Early spermatids: 44.4;Late spermatids: 36.0;Syncytiotrophoblasts: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020989, HPA063592"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA020989: AB_2670552, HPA063592: AB_2685051"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-3)"	"unprognostic (5.91e-3)"	"unprognostic (2.45e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.33e-1)"	4.5	2.9	4.2	3.5	4.2	1.7	5.0	6.8	4.5	3.0	7.8	2.6	2.8	3.2	5.0	3.1	4.2	3.3	2.4	3.8	3.0	1.7	12.4	2.8	4.1	4.5	2.5	2.8	3.3	3.3	3.7	4.6	68.8	2.9	3.9	2.6	4.3	3.7	4.2	8.5	3.4	3.8	3.9	2.0	4.4	3.6	3.5	3.0	4.8	3.3	2.8	4.0	6.0	5.3	0.6	22.1	0.8	0.5	0.0	0.5	0.5	5.7	9.0	3.3	4.1	6.4	6.4	2.8	6.2	5.5	5.8	5.8	6.2	7.2	6.4	5.5	6.4	3.4	4.4	6.6	7.8	7.4	5.4	8.8	12.0	9.2	4.6	5.0	6.7	5.9	5.4	4.0	6.4	8.2	5.2	7.0	2.4	4.5	12.0	4.8	7.4	6.9	0.8	4.6	5.8	5.9	4.3	4.3	2.7	5.4	8.6	3.7	3.1	6.4	4.9	5.2	3.9	4.1	6.4	7.6	3.4	5.0	4.8	7.0	4.4	5.8	6.4	4.3	5.0	6.4	0.7	0.3	0.8	0.3	0.5	0.3	0.6	0.2	0.5	0.3	0.6	0.4	0.2	0.7	0.0	0.3	22.1	0.1	0.5	4.2	4.2	6.8	4.5	3.0	1.7	2.5	2.8	2.9	3.0	3.0	3.5	6.0	1.2	1.3	3.6	1.6	0.0	0.0	3.4	1.8	3.9	57.3	0.0	2.0	44.4	1.1	1.1	0.0	1.3	13.9	2.4	1.2	2.3	1.0	7.1	1.6	0.0	0.6	2.4	36.0	3.1	2.0	8.5	3.6	1.3	2.6	2.9	0.0	2.5	9.2	5.9	0.0	1.6	2.9	5.5	1.5	106.0	1.3	1.1	1.1
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609472-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	12.1	12.8	17.6	19.1	17.4	22.7	12.9	35.3	23.8	15.4	16.9	6.7	14.6	8.0	13.7	17.3	15.1	12.8	12.7	12.1	14.6	7.7	10.7	8.0	16.4	19.1	14.8	12.3	17.1	11.6	17.6	17.6	14.6	14.9	12.6	13.2	6.7	12.0	14.2	11.6	12.2	15.2	12.4	14.7	15.9	13.5	17.5	17.6	16.8	13.5	8.4	17.1	15.7	20.8	14.8	12.7	29.7	10.3	4.2	7.2	1.1	10.4	10.6	7.7	5.3	10.7	19.1	4.6	8.2	13.2	13.0	12.9	9.8	5.8	13.5	4.7	10.1	5.3	11.3	10.9	4.8	17.3	13.7	8.0	13.2	16.4	4.5	6.0	14.4	6.5	10.6	10.4	9.1	3.9	16.7	13.0	11.1	12.2	6.0	11.9	3.2	10.1	5.0	7.7	4.9	6.1	8.8	9.4	10.4	9.8	7.7	5.3	4.8	8.3	5.3	5.4	8.7	14.2	9.5	9.8	7.3	5.0	4.2	4.1	10.4	6.3	10.5	8.5	10.1	5.1	20.7	10.3	12.1	7.2	4.8	5.5	9.2	6.2	4.6	3.9	14.8	5.8	4.9	29.7	4.2	8.7	12.7	4.9	1.1	17.6	17.4	35.3	23.8	14.6	7.7	14.8	12.3	14.9	17.6	32.8	23.8	26.2	48.6	42.6	31.6	15.1	5.1	21.4	34.2	14.0	21.6	11.9	1.7	17.8	75.9	28.7	28.5	0.0	14.5	12.8	33.8	39.6	47.4	9.8	15.6	55.6	20.1	20.9	18.0	52.4	29.7	35.1	10.1	27.1	23.4	18.9	21.4	35.1	21.5	5.8	31.7	25.8	25.5	29.6	25.8	35.8	9.6	24.9	21.5	64.9
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520855-23556192	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 17.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;SuSa: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	1.7	2.6	5.1	1.9	5.8	0.9	1.7	15.5	12.4	1.7	1.6	3.9	1.2	1.1	1.9	2.0	1.2	6.6	1.9	1.2	6.8	4.9	3.0	1.1	2.1	1.5	4.5	6.3	2.0	1.9	7.4	8.1	1.2	5.4	2.0	1.2	1.6	1.8	4.0	2.3	2.1	1.2	2.4	3.2	1.1	1.8	17.9	6.1	0.0	2.1	0.0	1.4	1.8	0.7	0.3	0.5	2.3	0.4	0.0	0.9	0.0	0.2	5.1	4.1	8.1	2.8	0.4	0.3	1.1	0.4	0.6	2.1	0.5	0.4	0.3	0.5	0.1	0.5	0.1	2.1	0.3	0.9	3.6	1.3	4.1	0.0	1.0	0.4	0.7	3.0	0.6	0.1	0.8	0.3	2.2	0.5	3.6	0.6	0.7	0.1	1.4	0.5	0.5	5.0	0.6	1.2	2.2	0.1	0.0	2.2	1.9	4.5	2.9	0.7	1.1	0.3	6.6	1.7	1.0	0.1	0.0	2.1	1.3	0.5	0.5	1.6	0.2	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.2	0.5	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	5.1	5.8	15.5	12.4	6.8	4.9	4.5	6.3	5.4	6.1	0.0	0.6	0.0	0.4	0.1	9.0	2.0	0.0	6.7	3.4	1.8	0.0	0.2	1.7	2.8	30.6	0.6	0.0	0.0	2.1	0.0	0.8	1.2	0.0	0.0	0.8	7.9	6.4	0.6	0.6	13.8	0.6	0.7	0.0	1.8	0.7	3.9	1.3	0.0	0.4	1.0	3.2	0.0	0.2	19.2	1.1	0.0	0.2	0.0	0.6	0.1
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681219-76867285	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 75.7;Cholangiocytes: 48.4;Early spermatids: 49.4;Hepatocytes: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 13.1;TIME: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	4.9	8.8	6.2	2.1	10.7	0.8	5.8	1.4	8.5	6.3	5.1	7.7	14.1	1.0	2.2	8.9	1.7	2.0	2.9	1.5	7.2	4.3	1.6	7.3	1.1	1.5	8.3	4.3	5.5	1.5	1.2	13.7	1.1	5.9	3.2	2.0	8.0	1.6	29.1	6.5	1.4	1.3	11.8	11.6	1.2	2.0	15.6	9.8	0.0	1.2	2.4	1.0	7.8	5.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	2.5	0.0	4.9	6.4	0.0	2.1	3.0	2.4	2.6	0.0	0.0	0.0	4.0	3.5	1.2	0.2	4.9	0.6	4.5	0.0	7.2	0.1	0.0	0.0	1.3	0.0	0.3	13.1	0.2	6.4	2.6	4.5	0.4	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.4	0.2	4.2	0.0	4.4	0.0	3.9	0.0	0.0	4.6	0.0	0.5	0.0	0.0	0.6	0.0	28.6	2.5	3.8	7.2	4.8	7.4	0.7	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	10.7	1.4	8.5	7.2	4.3	8.3	4.3	5.9	9.8	0.0	1.0	0.0	0.0	0.5	75.7	3.2	48.4	0.0	0.0	5.2	2.0	0.0	0.0	0.0	49.4	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	24.6	0.3	4.8	0.0	1.8	0.3	17.6	12.7	1.1	0.0	0.0	0.0	19.8	0.0	0.0	20.1	0.0	5.3	0.0	1.6	8.6	1.5	1.0	0.0	0.0	0.0	0.6
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556810	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	3.1	3.6	4.9	1.4	4.1	0.4	3.7	6.1	7.0	3.4	2.5			1.1	5.6	4.2	2.3	3.1	3.2	3.6	5.4	5.7	3.1	0.1	3.5	1.6	5.0		10.1	2.5	6.1	4.0	2.9		4.3	1.6		2.3	4.0	1.9	2.7	1.2	4.4	5.5	2.8	2.1	5.1			4.0		1.8	2.8	2.5	3.1	1.5	3.9	0.5	2.4	3.7	0.9	0.0	1.7	7.9	2.4	2.7	2.6	4.1	5.1	4.9	4.1	6.8	0.0	1.1	0.0	2.6	6.1	8.0	0.2	3.8	1.7	6.3	0.0	6.6	5.2	0.2	0.0	7.6	0.2	6.0	7.1	2.2	6.2	0.1	8.2	0.8	2.8	1.0	0.1	5.3	0.0	2.6	0.9	3.6	0.0	1.7	4.0	10.2	0.0	5.5	3.3	0.0	7.2	0.0	0.3	1.2	7.5	3.0	5.2	1.9	3.8	4.2	0.4	6.2	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.5	3.9	0.5	0.3	2.6	1.9	2.6	1.8	1.1	3.1	2.1	1.6	0.5	2.4	0.4	1.5	3.7	0.9											8.9	2.2	0.0	2.2	5.0	7.8	3.9	0.0	2.7	2.3	5.2	3.9	0.8	6.6	2.4	2.4	3.7	0.2	0.0	0.7	0.6	2.4	2.3	3.5	0.4	0.7	9.5	2.4	2.5	0.0	1.4	3.7	1.3	5.0	1.8	0.3	5.6	1.0	1.5	4.6	2.3	5.4	0.0	4.1	3.8	5.3	3.3	0.6	1.0	0.9	1.3
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078248-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 13.4;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.5;SH-SY5Y: 7.7;SiHa: 7.0"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	4.9	6.3	11.0	10.0	10.4	1.9	8.9	19.6	14.7	6.8	8.9	11.9	9.6	13.0	6.9	6.9	6.7	11.2	6.3	12.4	9.8	7.6	10.2	3.3	7.3	9.2	7.9	8.3	9.9	11.3	16.6	10.8	5.2	11.4	7.9	10.9	7.4	10.7	15.4	33.3	6.7	11.3	6.3	8.5	10.2	8.3	9.9	11.8	10.6	11.1	3.5	11.2	6.6	5.7	5.4	1.4	1.4	2.2	1.9	4.3	1.6	0.0	1.3	0.3	0.0	1.2	0.6	0.0	2.8	0.0	2.2	2.5	5.6	2.6	0.0	4.0	2.8	1.0	5.7	0.0	0.0	1.2	0.0	0.1	0.2	2.1	0.0	3.9	0.0	7.5	2.0	0.0	1.5	0.0	0.0	0.7	0.2	0.0	0.1	0.4	0.0	0.1	0.2	0.3	4.0	0.6	0.0	0.8	1.8	3.5	3.4	3.6	7.7	7.0	5.8	3.6	1.3	3.5	5.5	0.0	0.0	1.2	2.0	4.0	0.1	0.2	0.0	0.0	0.0	3.2	0.0	2.0	1.4	2.8	2.2	1.7	2.1	1.6	2.5	1.4	5.4	4.3	3.0	0.2	1.9	1.9	0.9	1.6	1.6	11.0	10.4	19.6	14.7	9.8	7.6	7.9	8.3	11.4	11.8	0.0	3.4	0.0	0.4	0.2	3.9	6.3	0.0	13.4	2.3	1.8	7.9	1.0	0.0	1.3	0.4	1.6	2.1	0.0	1.0	0.3	0.9	0.4	1.1	0.0	1.4	3.2	0.0	5.5	1.2	0.0	1.4	1.2	0.0	0.0	1.7	3.2	0.4	0.0	1.1	1.1	6.0	0.0	0.5	6.6	4.3	0.1	0.7	0.0	2.5	0.4
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038380-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	3.8	4.4	4.9	3.1	19.2	0.9	6.7	10.9	9.9	6.5	3.6	5.3	4.0	2.1	10.5	5.8	3.2	6.3	3.5	3.7	10.5	5.6	5.8	1.7	3.2	2.8	6.7	10.6	17.0	3.2	4.3	8.5	3.2	10.7	6.3	2.9	2.8	3.2	4.8	3.2	3.2	2.5	6.2	9.1	4.7	3.0	5.1	5.9	0.4	6.9	2.4	3.2	4.3	5.6	2.3	0.9	0.2	0.4	1.3	5.6	0.7	0.6	1.8	7.7	6.4	4.3	8.3	3.9	2.4	3.6	2.7	2.3	0.0	1.8	4.3	1.9	2.5	3.5	1.6	0.0	0.9	4.2	5.3	0.9	0.2	3.8	2.0	2.3	0.0	0.9	2.3	0.8	3.2	6.3	6.6	1.5	0.0	0.4	3.8	5.6	0.0	0.0	0.0	7.9	4.6	0.0	0.0	10.7	0.6	2.0	0.0	6.6	6.2	7.5	1.6	1.4	4.0	6.3	0.0	0.6	6.3	2.8	7.3	3.6	1.5	2.9	0.0	4.8	0.1	3.8	0.2	0.1	0.1	2.5	0.4	1.9	2.3	2.2	2.2	0.9	1.1	1.8	2.5	0.2	1.3	0.0	0.1	5.6	0.7	4.9	19.2	10.9	9.9	10.5	5.6	6.7	10.6	10.7	5.9	0.0	0.3	0.0	0.8	0.2	10.6	2.0	0.0	0.0	0.0	0.0	5.9	0.7	3.3	1.2	0.6	2.2	0.0	0.0	0.8	1.3	2.1	0.4	5.7	1.1	0.4	6.4	1.2	1.3	0.0	0.0	2.0	0.4	0.0	0.0	0.1	3.1	0.2	0.2	2.1	2.2	5.2	6.5	1.5	5.6	4.1	0.0	0.1	0.5	0.1	0.4
ZFP62	"FLJ34231, ZET, ZNF755"	ENSG00000196670	"ZFP62 zinc finger protein"	Q8NB50	5	180847611-180861285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048629	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA048629: AB_2680467"	"unprognostic (2.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.11e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.29e-3)"	10.9	8.6	17.2	16.0	20.2	4.0	14.4	19.9	16.5	14.3	14.5	11.9	15.1	13.7	15.6	16.4	15.1	16.8	13.2	9.7	17.6	9.5	11.9	8.3	10.4	17.7	18.3	12.8	22.5	15.2	18.9	16.3	10.1	16.4	15.1	18.4	10.1	15.6	18.5	14.5	16.0	15.5	18.8	15.7	13.4	16.3	8.8	22.1	26.9	25.4	10.5	20.0	16.0	14.8	7.0	3.8	7.7	4.9	4.8	10.3	4.2	7.9	5.9	12.8	16.5	9.4	8.4	15.8	8.1	6.2	6.8	9.4	14.4	19.9	19.6	13.1	3.7	7.8	11.9	6.1	14.5	10.2	33.4	11.3	11.0	15.9	4.8	6.4	10.0	6.6	6.5	11.6	6.9	11.9	10.4	6.0	11.7	9.1	10.8	9.2	18.7	14.4	5.5	9.0	7.2	14.4	12.8	13.1	10.9	5.6	14.4	16.9	11.8	11.9	9.0	8.8	9.4	13.8	9.0	8.6	10.4	9.1	5.0	8.2	11.4	13.0	9.8	8.6	13.5	8.1	7.7	3.2	3.9	4.0	4.3	7.8	6.9	5.5	5.8	3.4	7.0	10.3	8.6	1.5	4.8	4.9	3.8	5.6	4.2	17.2	20.2	19.9	16.5	17.6	9.5	18.3	12.8	16.4	22.1	8.9	11.2	13.8	7.6	6.4	8.3	8.1	5.1	4.0	5.7	0.0	2.0	5.5	13.3	8.5	17.8	8.4	10.9	23.3	14.2	5.8	3.7	6.8	8.1	4.3	5.6	1.6	9.9	9.8	7.9	25.0	15.8	3.3	5.0	6.4	15.8	10.0	12.1	3.5	11.0	7.7	13.3	12.9	6.1	24.7	13.6	4.1	4.7	8.5	15.7	7.4
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 2.9;Spermatogonia: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	1.6	1.7	7.8	4.6	11.1	1.1	2.8	8.2	12.8	3.1	2.5	1.8	0.1	2.6	4.3	2.4	2.2	1.6	3.3	1.8	6.3	4.9	1.6	2.4	1.6	3.7	3.6	5.8	2.0	3.5	3.2	3.6	1.1	4.7	2.0	3.1	1.2	1.9	1.8	1.2	1.4	1.8	3.0	3.2	2.3	2.5	4.0	3.8	5.0	2.7	0.9	5.5	3.8	1.7	2.1	1.2	0.9	2.1	1.3	4.1	1.0	3.3	1.3	5.7	14.0	2.1	5.7	1.6	3.2	3.1	1.5	2.8	1.6	2.2	6.3	3.2	2.8	2.9	1.2	2.9	2.8	3.3	5.5	1.2	2.6	3.2	4.8	1.5	0.4	4.2	1.3	4.7	5.2	6.9	1.5	2.0	8.5	6.8	6.4	4.4	2.3	8.5	0.6	7.7	1.2	1.4	4.8	5.6	3.0	2.9	3.3	7.7	8.0	5.1	4.4	2.2	3.4	2.3	7.4	4.3	4.8	10.1	4.4	4.6	9.8	9.3	13.8	6.3	0.9	4.9	0.0	0.3	0.9	2.6	2.1	3.5	2.0	1.8	1.4	1.2	2.1	3.4	3.0	0.2	1.3	0.7	0.5	4.1	1.0	7.8	11.1	8.2	12.8	6.3	4.9	3.6	5.8	4.7	3.8	0.0	0.0	0.0	0.6	0.2	2.9	0.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.0	0.0	0.3	0.0	0.0	0.2	1.3	0.4	0.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.9	0.0	0.4	0.0	1.7	0.0	0.3	1.5	5.9	0.1	0.0	0.8	0.1	0.3
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.8	14.3	16.8	17.0	16.1	19.5	9.2	20.6	38.7	23.8	20.4	7.8	26.3	29.8	20.4	25.9	23.8	22.2	17.0	21.8	31.4	15.8	9.6	19.6	14.5	8.4	18.3	24.7	32.4	17.0	21.5	33.5	39.3	19.8	23.6	20.2	19.4	28.3	30.6	8.3	21.3	13.7	8.8	14.4	13.9	16.6	28.4	19.7	17.5	24.0	18.0	14.4	26.2	24.1	33.5	9.5	26.9	18.6	26.4	30.2	20.8	45.3	22.8	16.4	12.1	24.7	26.6	13.9	30.7	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4	23.8	34.8	33.2	21.5	53.3	28.8	39.5	48.4	25.4	21.6	17.4	15.7	10.3	11.6	19.8	181.7	27.0	27.7	46.7	27.1	10.5	32.9	25.9	48.6	41.4	14.5	33.4	24.2	25.8	36.8	146.8	28.4	27.0	21.9	20.8	30.4	19.8	24.5	11.5	25.5	19.1	19.0	19.4	20.6	142.7	40.2	58.2	11.6	21.8	37.2	34.3
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	19.3	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	9.5	11.0	5.6	9.7	10.1	6.3	4.4	7.7	8.0	6.5	3.5	8.4	10.6	9.0	8.1	5.2	13.0	6.0	9.0	23.0	9.2	7.4	7.8	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7	17.9	11.8	18.4	16.0	19.6	19.3	13.7	22.9	16.0	22.7	7.0	19.6	46.1	5.0	13.6	1.5	25.5	11.9	23.3	13.8	10.2	28.3	17.9	27.6	20.7	15.1	14.3	19.7	27.6	25.3	3.1	33.1	20.1	28.7	19.8	15.1	15.6	11.6	14.2	33.6	9.4	19.1	32.3	26.9	9.3	25.2	18.2	17.3	22.5	15.1	15.4
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein, Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	4.1	2.9	2.8	6.8	4.3	9.6	3.4	6.8	5.3	0.0	5.4	2.8	14.1	3.2	0.0	9.1	7.2	0.0	7.0	6.1	3.0	3.0	2.7	13.1	10.1	10.9	2.6	0.0	0.0	10.0	0.1	3.3	5.8	4.5	10.6	8.0	3.5	15.8	10.2	7.0	2.9	6.3	5.8	3.3	9.1	4.7	10.5	0.0	12.6	7.2	5.7	5.8	6.1	0.0	5.8	5.9	4.7	4.7	6.2	7.0	2.7	0.0	3.6	0.0	0.0	0.0	0.0	6.5	9.1	8.8	7.8	7.6	0.0	0.0	7.0	0.0	9.5	0.0	0.0	0.0	0.0	10.5	10.5	0.0	12.9	0.1	4.6	6.9	0.0	0.0	7.6	6.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.8	0.0	5.3	0.0	2.9	0.0	0.0	0.0	5.7	2.7	5.3	11.9	6.2	0.0	0.0	0.0	9.1	4.3	0.0	4.2	7.9	7.6	0.0	0.0	4.6	4.9	0.0	11.8	1.0	0.0	0.0	0.0	4.7	4.7	5.0	3.9	7.0	4.3	5.5	2.8	5.9	5.8	6.3	3.0	3.2	6.2	3.3	4.3	3.1	2.7	2.8	4.3	6.8	5.3	3.0	3.0	2.6	0.0	4.5	0.0	8.9	8.0	16.9	9.6	9.8	11.8	5.9	5.1	8.1	13.6	1.8	7.9	4.4	0.0	2.7	28.3	7.3	0.0	0.0	0.0	1.2	7.8	7.9	6.9	0.5	2.6	12.7	1.7	8.0	5.0	59.3	9.2	8.5	3.3	3.6	0.0	11.2	2.1	0.0	10.3	2.9	7.8	12.9	7.6	19.0	3.8	8.3	3.1	11.4	0.0	10.5
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"salivary gland: 1069.4"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8"									"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0	1.6	0.3	0.0	1069.4	0.2	0.1	0.8	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	78.5	3.7	0.2	0.2	0.0	1.1	1.7	11.4	1.1	0.4	1.7	0.0	0.6	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	1.2	0.0	2.5	0.0	0.0	0.0	5.0	1.4	1.3	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	2.1	0.1	15.2	0.0	0.2	0.1	32.4	2.9	0.0	0.0	4.8	0.1	3.6	0.0	0.0	0.0	14.0	0.0	0.1	12.8	0.0	1.8	0.0	0.3	1.1	0.0	0.0	0.2	0.2	0.2	3.7	0.1	1.7	6.7	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	1.1	7.3	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	8.0	0.0	0.0	89.2	1.4	5.7	1.8	0.0	0.0	0.0	3.6	5.3	0.1	36.1	0.0	25.2	2.7	0.8	457.9	5.7	0.0	13.1	0.0	55.9	0.6	2.9	3.1	0.0	2.6	79.2	1.8	224.9	0.0	30.0	80.9	0.0	0.0	0.0	0.0	0.3	1.0	0.1	21.0	0.2	0.0	68.0	223.9
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger, GATA-like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 12.3;Kupffer cells: 16.8;Macrophages: 7.8;Spermatogonia: 16.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 26.6;U-937: 6.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049855: AB_2680916"	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	0.5	0.9	2.5	2.0	6.5	0.9	1.0	8.0	5.4	1.4	0.9			2.2	2.1	0.7	0.6	2.6	1.8	0.6	2.9	3.4	2.4	3.0	1.0	3.6	1.0		3.9	3.1	1.9	4.8	2.0		3.4	0.3		5.1	2.5	1.4	4.8	1.6	0.2	0.9	2.6	1.4	3.7			5.3		1.4	1.2	0.9	0.3	0.3	0.1	0.3	0.0	1.0	0.1	0.4	1.0	1.4	0.5	0.9	0.4	3.6	0.8	0.2	0.7	1.5	1.0	0.3	1.5	0.8	0.2	0.6	1.5	1.0	0.3	0.2	1.3	4.6	1.4	1.3	0.5	0.6	0.0	0.4	0.8	2.1	0.7	0.4	0.6	0.2	1.2	1.4	1.0	0.9	1.6	0.1	26.6	2.2	0.3	1.7	1.5	0.7	0.7	0.6	0.6	1.2	1.4	0.3	0.3	1.2	0.4	2.1	0.4	0.5	2.1	2.4	2.0	0.2	5.2	6.1	0.6	0.4	6.7	0.9	0.0	0.3	0.0	1.0	0.1	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1											0.0	2.6	0.9	0.4	0.8	1.4	0.4	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.4	0.4	0.8	0.4	0.0	0.0	0.3	0.6	0.8	0.0	1.0	12.3	6.4	0.0	0.6	16.8	0.6	0.9	7.8	3.3	1.8	0.2	1.1	0.3	0.8	0.7	0.3	1.3	0.0	0.4	1.8	16.8	0.6	0.1	0.0	1.1	0.0
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	9.3	9.8	9.6	13.6	14.5	14.5	8.0	20.2	13.2	7.6	8.9	12.0	10.8	11.1	12.9	6.1	9.1	8.1	11.2	8.8	10.3	7.1	11.7	56.1	7.2	11.0	16.9	10.7	7.3	12.6	8.3	10.8	9.0	14.2	8.3	3.9	8.0	14.0	8.8	9.2	10.5	10.8	9.4	8.5	11.7	10.3	14.9	15.0	11.3	8.0	5.8	13.5	8.3	9.2	15.6	21.7	19.2	16.4	20.2	23.8	13.0	8.6	11.1	4.4	7.0	3.6	2.5	10.1	9.0	6.0	14.3	6.0	23.8	11.9	9.0	17.2	5.0	13.8	15.8	2.9	10.6	1.8	6.0	7.7	8.4	9.7	24.3	7.1	5.2	14.9	6.4	9.0	5.8	2.3	3.8	7.7	10.9	9.2	8.5	4.7	8.6	12.9	12.5	7.1	12.8	14.0	13.6	3.3	9.1	7.9	8.0	8.3	10.4	12.8	14.5	8.0	2.3	9.9	14.8	8.7	22.3	7.9	8.4	11.4	8.4	13.2	12.3	14.0	5.2	9.9	6.6	16.0	19.2	23.8	16.4	23.1	15.6	20.4	21.5	15.1	14.5	20.3	20.5	17.0	20.2	13.2	21.7	19.8	13.0	9.6	14.5	20.2	13.2	10.3	7.1	16.9	10.7	14.2	15.0	3.0	4.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.2	0.2	0.0	2.3	1.6	0.2	0.0	1.7	0.6	1.8	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.0	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.0	0.1
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 9.5;Urothelial cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.3"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	8.6	7.4	11.4	5.0	11.0	25.9	8.7	10.3	10.7	8.5	6.2	5.9	8.9	8.1	7.3	8.1	10.4	5.9	5.4	8.7	11.2	5.0	7.1	9.7	9.7	8.7	9.6	7.4	8.7	6.8	7.1	12.7	7.1	8.8	8.7	9.9	4.5	9.0	8.7	11.9	9.9	9.3	7.7	11.4	10.5	6.6	5.1	11.7	5.8	10.5	4.6	10.2	7.5	11.6	5.5	4.6	8.0	8.3	4.8	8.5	3.3	3.0	3.9	2.9	2.0	1.8	2.0	2.1	1.3	1.4	3.4	2.6	3.2	2.4	1.8	1.2	2.3	2.0	2.1	3.3	1.8	5.1	2.9	6.7	5.3	2.7	3.8	1.9	1.1	3.0	2.7	2.7	2.8	1.7	1.5	3.9	5.6	4.4	2.6	3.0	9.5	4.4	3.5	0.7	6.2	4.4	3.5	1.9	2.5	2.4	3.1	4.5	3.3	2.8	24.3	1.4	1.7	3.6	1.0	0.3	1.5	2.7	2.3	3.2	3.7	4.5	3.9	2.0	2.9	1.0	3.1	5.7	8.0	4.1	8.3	3.7	5.5	5.3	3.5	4.6	4.6	4.4	3.6	1.8	4.8	5.9	4.0	8.5	3.3	11.4	11.0	10.3	10.7	11.2	5.0	9.6	7.4	8.8	11.7	0.0	1.4	0.5	3.5	0.0	0.4	0.8	2.5	2.7	1.2	3.5	0.0	1.6	1.7	1.6	0.7	1.5	1.1	0.0	1.6	2.0	0.1	2.4	0.0	0.9	2.5	9.5	2.9	1.3	0.6	0.9	0.9	1.2	0.0	1.8	1.3	0.8	1.7	0.0	1.1	1.2	1.1	0.0	0.9	2.5	2.2	0.0	0.8	0.7	1.0	6.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	5.3	2.2	4.0	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	4.4	2.0	0.0	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 48.9"	"Cell type enhanced"	"Detected in some"	29	"Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	24	"cerebellum: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 53.2"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.1	0.0	1.2	0.0	0.5	0.0	0.1	48.9	4.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	11.2	0.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.6	0.0	0.5	0.0	2.2	0.0	0.0	1.9	6.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.0	0.8	7.6	0.0	0.1	0.9	0.4	0.0	0.0	0.0	43.8	0.0	1.2	1.0	0.0	0.8	0.0	1.4	0.0	0.6	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.5	48.9	1.3	1.5	0.5	0.4	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141910-28159472	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	16.5	12.1	13.4	10.3	15.6	17.7	16.1	27.7	16.5	17.7	16.3	20.8	12.5	9.2	21.8	19.9	10.0	17.2	11.0	10.7	13.5	9.3	11.2	10.9	14.1	13.9	18.4	13.3	25.0	15.4	21.9	22.6	12.8	14.0	15.1	11.9	17.2	13.9	17.2	12.0	11.5	15.9	18.3	18.2	14.4	14.1	12.8	18.2	18.1	17.1	8.8	14.5	16.7	12.4	3.8	1.9	4.1	4.2	3.0	3.1	1.3	5.8	3.7	18.1	17.9	11.6	10.9	5.7	6.7	12.1	8.5	10.9	4.1	3.5	12.9	10.9	6.4	7.4	5.1	11.5	4.4	12.7	6.9	9.8	11.7	7.1	9.5	10.7	14.3	8.8	11.4	7.6	8.9	13.6	15.2	8.8	11.5	17.9	4.9	9.1	3.0	10.0	12.7	6.8	1.5	4.2	10.7	11.4	10.2	6.3	7.2	13.7	17.3	7.8	3.7	8.5	10.8	4.2	8.1	7.3	13.0	7.5	4.3	8.8	12.0	8.5	10.7	3.7	10.1	6.9	4.1	1.3	1.3	2.7	3.3	3.1	1.5	1.7	1.2	1.0	3.8	2.8	2.3	0.5	3.0	4.2	1.9	1.6	1.3	13.4	15.6	27.7	16.5	13.5	9.3	18.4	13.3	14.0	18.2	3.0	9.4	0.9	2.0	4.2	8.8	6.9	10.2	5.3	5.7	7.0	5.9	3.3	0.0	2.5	2.9	7.0	1.7	0.0	2.5	1.7	5.4	3.9	4.7	7.8	3.6	6.4	6.9	7.4	9.1	3.4	8.3	4.7	1.7	2.8	4.9	7.5	2.4	0.0	8.5	1.4	8.1	0.0	7.2	10.8	5.7	2.5	1.9	6.9	3.9	2.0
ZMAT2	"FLJ31121, hSNU23, Snu23"	ENSG00000146007	"Zinc finger matrin-type 2"	Q96NC0	5	140698680-140706676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036518	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036518: AB_10671960"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.38e-3)"	"unprognostic (6.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.84e-2)"	25.3	25.1	36.7	19.9	50.4	32.1	31.9	31.2	52.4	23.6	26.7	16.0	24.9	17.7	27.7	29.1	29.7	27.1	17.6	18.1	60.2	27.6	31.2	29.4	21.3	25.3	28.4	53.8	26.5	17.6	36.5	21.9	24.1	33.6	22.7	30.0	13.9	24.6	26.5	102.9	25.1	19.9	25.2	36.1	26.2	24.7	15.2	19.8	24.4	23.7	29.8	33.9	20.9	30.7	12.3	11.8	42.5	15.1	11.2	17.1	11.5	22.3	37.6	24.5	41.7	40.2	27.0	33.0	23.4	25.6	32.5	35.6	57.6	37.4	25.2	37.9	40.0	36.5	21.5	34.6	46.7	41.4	27.5	30.8	20.4	45.5	40.0	25.5	47.5	27.1	31.0	36.0	33.5	39.2	32.5	27.4	40.6	22.7	28.1	29.9	34.3	38.4	33.4	18.2	15.8	24.2	26.9	28.9	27.4	28.5	32.8	29.1	22.3	32.9	33.1	34.3	36.3	45.3	41.8	22.7	28.6	15.4	14.8	35.7	18.4	37.3	28.5	30.5	33.2	21.7	20.9	15.1	23.6	13.4	12.3	17.1	12.3	14.8	13.7	10.9	12.0	14.0	14.7	42.5	11.2	12.0	11.8	13.9	11.5	36.7	50.4	31.2	52.4	60.2	27.6	28.4	53.8	33.6	19.8	47.6	66.5	76.7	61.0	50.5	28.3	71.2	79.0	100.4	79.6	66.3	5.9	109.7	99.5	67.5	6.5	62.6	68.8	163.5	58.5	105.3	53.9	57.5	77.7	83.2	72.9	15.9	66.0	46.6	91.4	9.8	52.3	72.0	55.6	129.0	47.6	71.0	61.9	73.7	54.5	126.4	18.0	51.8	51.5	36.1	75.4	55.3	173.5	79.8	53.0	81.0
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.5;brain: 21.6;thyroid gland: 29.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 18.2;Late spermatids: 39.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"NK-cell: 11.5"	"Lineage enriched"	"Detected in single"	115	"NK-cells: 11.5"	"Group enriched"	"Detected in some"	5	"AF22: 21.1;U-2197: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.8	2.0	4.4	0.9	15.3	0.8	0.9	0.6	20.4	3.3	1.0	0.9	0.0	0.7	1.4	1.0	0.7	0.9	1.0	1.5	6.1	4.0	1.2	0.7	0.8	0.9	3.3	7.8	1.6	0.7	0.7	5.3	1.0	21.6	1.6	1.2	1.4	0.8	1.5	0.7	0.7	0.8	0.8	1.0	1.3	1.0	2.9	3.9	0.0	29.1	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	1.2	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	1.2	0.3	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	4.4	15.3	0.6	20.4	6.1	4.0	3.3	7.8	21.6	3.9	0.0	0.0	0.0	0.2	0.0	6.0	0.4	2.5	0.0	0.0	0.0	5.9	0.0	1.7	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	39.7	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0
ZMIZ1	"FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10"	ENSG00000108175	"Zinc finger MIZ-type containing 1"	Q9ULJ6	10	79069035-79316528	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 174.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045144, HPA071156"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045144: AB_10962360, HPA071156: "	"unprognostic (4.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.90e-2)"	"prognostic favorable (3.64e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.34e-2)"	24.7	21.1	15.9	15.8	18.9	20.0	24.1	43.7	35.7	41.5	21.3	23.8	26.0	16.5	42.4	18.0	28.1	22.2	35.5	25.1	19.0	17.1	17.4	13.9	23.5	13.7	22.2	15.7	44.3	20.2	14.6	12.7	18.7	22.1	21.9	13.0	33.3	24.6	26.9	38.0	24.5	21.2	25.6	16.4	36.2	21.4	8.4	21.5	16.0	33.3	22.4	16.5	25.6	30.1	1.0	4.6	5.7	6.1	5.4	2.3	1.8	7.1	9.0	17.1	7.3	17.8	5.1	5.9	6.9	12.4	4.9	2.8	2.6	3.3	3.7	5.6	16.1	12.8	10.1	2.8	5.1	2.6	7.9	1.5	13.1	3.4	7.7	12.6	7.2	27.7	6.7	5.7	7.0	5.0	31.1	7.8	3.1	5.0	19.6	4.1	13.6	7.2	11.3	5.0	4.1	13.7	32.2	3.2	3.6	3.6	6.0	17.9	26.1	4.5	54.9	14.2	6.4	17.5	7.0	10.9	18.6	7.5	9.3	8.7	3.6	6.3	0.0	24.4	12.9	3.5	1.8	3.7	2.7	2.3	6.1	1.6	1.0	1.6	1.2	4.6	0.4	0.6	1.2	5.7	5.4	5.1	4.5	1.6	1.8	15.9	18.9	43.7	19.1	19.0	17.1	22.2	15.7	22.1	21.5	35.7	24.2	15.7	8.0	20.3	45.8	47.8	22.9	18.7	18.2	15.7	0.0	6.1	6.6	17.8	40.8	38.3	20.5	0.0	21.1	4.7	23.1	10.7	48.6	8.6	34.9	60.4	13.3	62.0	35.9	174.4	26.2	39.9	23.6	13.6	15.9	13.3	18.0	20.1	22.3	7.3	3.4	19.4	18.9	1.7	2.3	20.7	3.0	8.5	13.6	10.7
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	14.3	16.0	31.7	24.5	31.5	19.8	13.3	24.0	43.2	12.7	15.2	22.9	17.5	23.8	16.4	16.8	16.8	17.3	17.3	15.9	28.2	15.4	19.0	10.1	18.3	24.0	17.0	27.2	17.9	32.3	19.8	23.0	11.0	17.0	16.4	12.5	16.5	32.5	23.0	18.7	31.1	22.2	17.9	16.5	28.8	21.3	20.8	17.5	16.7	25.1	14.0	19.1	15.5	13.2	4.9	4.1	1.0	2.4	3.4	2.5	0.9	14.4	16.6	7.8	15.0	5.3	3.5	8.2	7.4	7.1	6.4	7.7	9.4	22.7	9.9	11.7	7.7	15.9	19.8	4.8	8.4	3.8	23.5	9.2	4.0	15.6	7.4	10.9	5.7	8.9	5.4	5.2	10.0	6.6	5.7	11.8	10.8	11.7	22.6	9.3	13.8	12.7	15.9	14.7	11.0	16.2	15.9	4.3	12.9	7.5	11.1	27.7	18.3	10.0	19.6	4.5	7.7	18.6	8.9	17.5	6.1	13.4	16.4	17.0	33.3	10.5	7.7	11.8	10.2	24.9	1.0	1.6	0.7	2.5	2.4	1.6	2.7	1.2	1.8	1.6	4.9	0.8	0.9	0.7	3.4	1.2	4.1	1.1	0.9	31.7	31.5	24.0	43.2	28.2	15.4	17.0	27.2	17.0	17.5	11.9	19.2	10.7	3.8	9.0	10.7	14.5	2.5	8.1	11.4	22.7	13.7	6.7	1.7	15.0	24.7	12.3	15.8	0.0	13.5	2.1	9.7	8.2	13.9	14.5	9.7	11.1	19.1	15.4	17.9	62.4	12.4	14.8	13.5	32.5	17.7	4.9	20.5	14.0	17.0	6.9	6.9	6.5	9.8	4.5	5.3	16.2	6.1	9.6	20.0	8.4
ZMYM2	"FIM, MYM, RAMP, ZNF198"	ENSG00000121741	"Zinc finger MYM-type containing 2"	Q9UBW7	13	19958670-20091829	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031765	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA031765: AB_10601927"	"unprognostic (2.96e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.80e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.07e-4)"	15.0	17.3	15.9	18.1	23.3	22.2	16.1	23.9	26.8	18.3	16.8	14.0	13.7	13.3	20.0	14.0	18.5	16.1	15.7	17.1	14.4	12.0	17.3	13.7	15.4	14.2	12.9	20.2	21.7	16.2	17.1	32.1	14.0	23.2	19.4	13.8	13.8	18.2	17.6	19.7	18.3	14.5	15.3	16.2	16.3	16.0	44.5	16.5	38.0	24.3	10.4	19.7	19.5	17.2	5.5	6.3	7.4	5.9	5.4	7.9	3.5	6.4	5.8	22.3	9.6	9.9	10.6	10.6	6.7	10.8	8.7	10.4	8.9	13.3	15.4	6.2	9.4	8.3	10.3	16.4	7.2	11.8	6.1	4.6	27.2	8.7	4.4	9.9	22.9	8.3	10.5	13.5	6.9	7.1	13.8	14.7	15.9	10.3	11.0	11.9	9.1	22.1	6.5	20.6	19.5	3.6	24.7	24.3	7.2	6.7	9.4	26.1	26.0	13.0	9.3	12.2	15.7	12.3	16.4	8.6	4.3	6.9	5.2	3.5	8.7	6.8	15.9	3.7	5.4	10.3	0.2	5.2	4.0	5.5	5.9	6.7	5.5	7.5	5.6	6.1	4.5	7.9	6.9	7.4	5.4	4.9	6.3	5.4	3.5	15.9	23.3	23.9	26.8	14.4	12.0	12.9	20.2	23.2	16.5	41.7	35.3	47.7	40.3	48.9	111.9	33.0	28.1	36.1	46.6	48.8	106.0	13.1	5.0	20.1	90.8	35.1	23.6	0.0	15.4	10.5	38.8	45.9	45.1	28.4	19.1	68.3	53.6	43.6	57.0	140.1	51.8	45.1	32.1	20.8	31.0	48.9	25.9	31.6	38.5	13.7	112.6	32.3	39.3	94.3	48.9	39.0	9.5	45.9	27.6	70.2
ZMYM5	"MYM, ZNF198L1, ZNF237"	ENSG00000132950	"Zinc finger MYM-type containing 5"	Q9UJ78	13	19823482-19863636	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015544, HPA020879"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015544: , HPA020879: AB_2670524"	"unprognostic (4.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	10.2	10.6	7.4	10.5	8.6	11.4	10.7	18.2	11.9	9.7	8.5	6.0	6.2	6.9	9.3	10.6	12.4	8.5	10.9	9.0	8.5	5.6	7.6	7.8	8.9	10.6	13.7	5.5	11.0	8.2	6.4	18.6	8.1	9.2	9.7	7.5	7.6	9.5	9.4	9.5	8.7	10.7	9.7	13.2	9.6	8.1	25.2	10.6	22.1	10.8	7.5	12.3	10.9	10.9	12.8	9.9	15.6	8.7	9.3	13.1	5.4	6.6	3.4	8.2	6.3	5.8	9.2	2.9	6.5	10.0	10.3	8.7	8.3	13.2	9.2	6.8	9.3	12.9	6.3	5.9	7.5	12.1	7.3	4.7	17.1	6.2	5.7	17.8	12.6	9.3	11.2	9.2	5.6	10.7	11.0	10.6	6.1	6.9	8.0	9.8	16.4	9.2	12.6	4.3	8.8	5.3	10.3	10.2	3.6	8.8	7.4	7.4	7.1	8.0	6.9	20.9	8.9	10.3	10.8	8.4	5.7	4.2	7.6	4.5	13.1	5.7	13.7	5.6	5.4	9.1	15.6	7.0	9.9	11.7	6.3	12.4	12.8	13.1	11.2	7.0	11.1	10.4	11.1	13.7	9.3	8.7	9.9	10.5	5.4	7.4	8.6	18.2	11.9	8.5	5.6	13.7	5.5	9.2	10.6	26.8	12.9	4.8	15.6	21.6	30.4	12.6	20.4	8.1	15.9	10.4	17.7	15.2	6.6	13.9	11.9	15.5	9.6	23.3	9.2	8.4	17.8	15.9	32.4	7.3	9.9	27.0	26.5	16.0	14.9	16.7	21.0	16.5	20.3	11.8	10.2	15.2	11.9	11.5	17.3	8.4	27.9	32.3	22.6	66.1	52.8	19.1	7.0	28.7	9.3	27.5
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	11.9	30.2	22.0	18.3	26.9	24.1	16.1	33.2	30.5	12.1	15.0	18.1	24.1	11.8	11.2	37.4	15.2	17.7	13.4	10.0	21.0	18.1	12.3	9.5	11.9	13.3	28.7	17.8	15.5	13.1	17.0	43.2	12.6	23.0	10.7	16.0	14.8	14.6	17.0	15.9	17.8	15.0	9.6	17.4	16.8	20.9	13.7	30.0	25.5	12.1	6.2	17.8	17.5	12.6	15.3	12.6	19.3	5.9	12.4	9.4	3.0	8.1	5.1	27.9	11.2	4.8	6.7	18.3	6.5	5.4	6.9	7.1	32.1	7.9	7.8	10.7	4.9	8.4	5.7	12.0	29.0	10.4	3.3	4.5	32.7	1.8	28.3	17.5	3.4	17.3	6.6	13.4	7.6	29.4	12.6	18.5	2.8	26.3	5.4	12.5	9.5	1.2	13.4	26.4	6.0	7.4	16.5	4.6	6.7	9.3	14.9	11.7	4.4	3.1	9.9	13.3	22.8	5.2	6.7	43.3	7.4	5.2	7.2	6.0	3.8	7.1	7.1	25.2	5.5	24.4	19.3	5.9	7.6	7.0	5.6	6.9	11.1	7.0	7.1	3.5	15.3	9.4	9.3	15.4	12.4	4.8	12.6	6.7	3.0	22.0	26.9	33.2	30.5	21.0	18.1	28.7	17.8	23.0	30.0	41.7	63.3	14.9	25.6	7.8	102.2	20.6	35.7	92.3	75.1	85.5	151.2	21.5	13.3	25.2	13.5	34.3	43.4	70.0	24.8	35.2	26.0	18.1	30.2	13.1	18.8	81.0	54.1	34.4	37.6	17.0	25.6	18.4	10.1	19.0	47.7	29.6	39.0	37.9	25.1	10.5	45.8	32.3	14.7	7.2	23.8	7.3	55.6	15.2	28.6	22.7
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270102-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 11.5"	"Cell type enhanced"	"Detected in many"	12	"Club cells: 4.5;Syncytiotrophoblasts: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;Hep G2: 19.9;NTERA-2: 10.3;REH: 10.5"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	1.5	1.0	3.7	2.2	2.7	2.1	1.2	1.2	3.3	2.3	0.6	2.1	1.0	0.9	2.4	2.4	1.3	1.9	1.5	1.7	3.7	4.6	1.6	0.5	1.4	1.9	2.6	0.8	1.2	5.3	4.2	1.6	7.5	2.1	3.1	0.4	2.5	3.7	1.3	3.7	3.7	0.7	1.4	3.5	1.6	0.7	1.6	1.7	1.0	11.5	0.5	1.1	1.3	5.7	2.6	3.5	5.4	0.7	2.0	0.6	0.4	2.7	4.3	5.2	0.5	0.3	0.0	17.0	0.5	0.0	1.6	2.1	1.5	4.3	0.1	5.0	0.3	1.9	5.6	7.1	0.3	1.8	0.1	0.4	0.6	1.3	19.9	1.6	2.7	0.5	0.3	0.5	0.8	0.1	0.5	0.3	0.7	0.7	0.4	0.3	8.1	0.2	8.4	10.3	7.4	0.9	10.5	0.0	0.3	0.2	2.3	2.1	2.4	2.8	0.0	3.0	3.3	1.1	5.0	0.7	0.8	1.8	1.5	0.5	0.4	0.1	0.1	0.2	1.5	0.8	3.3	0.7	0.9	0.5	0.6	0.3	0.9	0.6	0.4	1.7	2.6	0.5	0.4	5.4	2.0	0.7	3.5	0.2	0.4	3.7	2.7	1.2	3.3	3.7	4.6	2.6	0.8	2.1	1.7	3.0	2.6	0.0	0.8	0.3	1.2	0.4	0.0	1.4	4.5	0.0	0.0	1.9	1.7	0.1	2.1	1.1	0.0	0.0	0.5	2.1	0.8	0.7	0.0	0.4	1.4	0.0	0.0	1.8	0.8	0.0	1.1	1.1	0.0	0.0	0.0	1.3	0.4	0.0	0.7	0.0	0.6	0.0	0.8	0.5	2.7	0.1	12.8	0.0	0.0	1.0
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.0	5.7	11.4	14.3	11.7	12.0	11.0	7.6	13.8	9.8	10.3	7.8	7.0	9.2	5.3	9.4	22.1	14.5	9.4	7.4	15.0	3.5	7.1	9.2	8.6	7.7	11.0	14.6	10.0	13.1	16.6	7.0	11.4	14.6	7.1	7.4	14.6	8.5	12.9	9.5	5.6	13.5	13.8	3.8	8.8	7.4	16.4	5.6	8.0	12.0	10.5	18.6	8.8	16.1	9.2	15.0	10.2	16.7	7.0	11.1	14.0	8.8	10.0	8.1	5.2	9.4	9.0	9.9	14.6	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9	8.9	9.9	13.7	14.1	23.9	26.7	16.2	12.7	9.4	10.3	3.5	15.7	9.8	1.7	7.7	0.4	15.5	6.8	23.3	5.7	7.5	14.2	10.8	11.5	9.0	8.4	35.0	7.5	16.0	11.5	0.8	20.8	7.2	5.0	5.4	11.1	19.5	7.5	7.0	21.2	5.7	19.8	25.8	14.4	12.3	6.0	19.6	7.2	6.4	11.5	14.9
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.7;salivary gland: 23.4"	"Group enriched"	"Detected in many"	31	"Early spermatids: 319.1;Late spermatids: 835.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.03e-4)"	1.9	1.1	1.2	1.9	1.0	2.8	2.1	1.9	1.4	1.6	3.9			3.5	4.1	2.3	1.7	1.7	1.8	1.5	1.5	1.7	3.4	1.9	2.8	3.0	1.8		3.1	3.9	0.5	0.8	2.2		2.3	4.0		23.4	1.2	1.1	2.2	4.2	1.8	2.1	5.2	2.6	2.8			2.4		3.4	3.1	1.8	10.6	12.6	10.0	14.7	9.9	12.3	6.3	3.6	2.8	7.9	10.4	3.0	1.9	19.9	3.8	2.3	4.0	4.1	4.2	3.3	7.4	4.5	3.0	2.7	4.0	9.4	3.0	5.7	0.4	2.6	6.5	3.3	8.9	2.9	11.6	7.5	2.3	2.4	3.9	3.8	1.9	5.7	8.7	9.1	5.2	5.0	3.2	11.9	7.5	20.5	7.1	6.5	12.6	6.4	5.2	3.8	11.0	12.4	12.6	5.6	4.4	3.8	9.9	3.2	18.6	6.5	3.0	4.5	3.3	6.8	4.5	5.5	10.9	1.2	11.9	6.3	6.2	8.8	10.0	7.0	9.9	10.1	10.6	9.1	8.5	12.6	6.7	12.3	11.8	2.0	9.9	14.7	9.9	6.7	6.3											14.9	9.9	3.7	3.6	3.2	3.3	4.4	5.1	4.0	7.9	3.5	3.9	3.1	1.7	4.3	319.1	8.8	6.6	0.0	4.3	5.7	2.7	4.0	10.5	0.8	7.2	0.0	7.5	2.5	18.7	835.8	11.2	14.2	6.8	5.4	5.6	2.1	3.7	10.7	11.3	4.9	5.2	6.5	3.3	7.4	12.8	1.4	1.1	4.3	8.0	5.7
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	16.0	14.3	15.0	18.6	16.7	24.3	20.3	24.8	18.5	18.9	13.0	10.6	10.3	10.0	19.3	10.3	15.3	13.4	13.3	10.8	15.1	13.0	12.3	14.8	12.6	21.6	12.8	14.6	21.6	16.1	13.9	17.3	20.0	14.2	13.9	13.8	8.1	11.9	16.0	16.5	18.2	12.9	16.5	11.9	16.1	12.5	31.0	13.0	27.2	15.5	15.3	17.2	15.5	18.0	13.0	8.9	7.9	7.1	11.7	18.3	7.4	10.5	6.5	14.2	18.8	13.5	9.3	12.0	14.0	11.5	14.0	11.9	10.1	9.5	21.4	11.5	9.4	13.1	7.6	16.7	8.9	19.9	10.4	14.8	13.2	37.4	7.5	12.4	22.8	10.8	8.4	17.0	10.3	16.9	10.0	10.6	16.8	16.8	23.0	15.9	10.3	22.3	28.8	9.4	9.9	10.8	14.8	21.6	16.7	11.8	10.4	8.8	12.9	35.9	17.4	18.0	10.0	9.7	21.8	7.9	17.7	16.4	9.0	13.1	9.3	13.1	24.5	9.3	30.1	11.7	7.9	6.1	4.1	15.0	7.1	15.3	10.1	14.9	14.5	8.9	13.0	18.3	14.6	3.1	11.7	4.8	8.5	10.8	7.4	15.0	16.7	24.8	18.5	15.1	13.0	12.8	14.6	14.2	13.0	20.8	18.7	38.9	47.9	44.1	49.5	17.3	15.3	17.4	18.2	8.7	49.1	22.3	26.6	12.1	29.7	27.5	27.7	0.0	10.3	21.3	29.8	30.2	23.1	10.9	14.4	36.5	30.0	23.9	22.5	12.8	19.0	31.2	20.3	22.6	19.5	24.0	13.8	24.6	19.8	9.8	60.6	25.8	37.3	81.7	71.0	57.2	21.3	41.7	27.6	33.9
ZNF133	"pHZ-13, pHZ-66, ZNF150"	ENSG00000125846	"Zinc finger protein 133"	P52736	20	18288283-18316996	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001493	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA001493: AB_1080666"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.46e-6)"	"unprognostic (6.01e-3)"	"unprognostic (8.60e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-1)"	10.0	10.1	12.4	11.4	15.9	5.6	20.8	25.4	18.4	13.9	11.6	14.4	12.6	7.7	18.2	24.9	13.2	14.2	11.2	10.6	12.0	12.0	12.1	9.6	10.6	7.4	10.3	12.1	19.5	12.5	17.9	24.7	12.5	14.1	14.9	10.2	9.2	13.6	13.9	17.2	22.2	8.1	15.7	12.1	12.5	9.9	8.9	13.2	7.1	14.7	9.3	9.5	10.0	12.1	5.4	5.4	3.4	4.5	10.7	8.7	3.5	7.0	7.7	6.1	8.7	14.9	10.4	13.0	6.6	9.8	8.5	12.3	6.1	8.3	1.8	4.0	7.8	9.7	15.4	5.8	17.3	8.0	2.0	4.0	4.8	6.6	13.6	11.3	4.0	0.7	10.1	11.9	7.1	20.8	11.6	8.1	8.0	5.6	2.1	7.3	7.0	5.0	6.7	5.0	8.4	7.7	4.4	8.4	4.5	8.3	4.8	8.6	8.8	5.1	13.9	9.5	8.9	5.3	11.1	5.7	9.0	4.3	6.3	6.5	6.7	6.7	0.6	2.7	2.7	5.1	1.2	4.3	3.4	8.7	3.0	5.8	4.7	7.4	5.9	5.4	5.4	5.8	6.8	1.5	10.7	4.5	2.8	5.5	3.5	12.4	15.9	25.4	18.4	12.0	12.0	10.3	12.1	14.1	13.2	6.0	11.6	3.2	2.4	1.9	7.1	5.9	2.5	4.0	3.4	1.8	3.9	3.5	3.3	3.9	11.4	3.6	1.5	0.0	2.0	2.7	4.2	2.1	6.9	3.4	3.8	3.2	1.2	4.9	1.9	18.8	7.2	2.1	0.0	1.0	3.9	3.1	3.3	0.0	4.2	2.7	5.2	0.0	3.0	5.4	1.7	2.8	1.9	0.5	3.3	2.3
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710471-19733097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	7.4	5.3	7.9	8.7	10.5	11.9	12.8	23.3	10.3	11.3	7.0	8.1	6.6	3.9	9.4	9.6	5.7	9.3	6.0	6.6	8.1	7.6	8.4	1.7	4.9	10.5	12.2	6.0	15.7	7.5	12.7	10.7	8.8	9.4	12.3	5.1	6.5	7.1	9.9	3.4	7.2	7.2	8.9	9.0	9.4	7.0	6.2	10.7	7.1	13.8	3.1	10.9	9.8	7.7	10.3	3.0	11.4	3.6	6.5	18.4	6.3	3.5	3.6	6.1	7.9	4.1	4.5	7.3	3.7	5.1	5.5	6.0	3.4	2.8	9.5	6.2	3.9	3.1	3.6	6.3	3.7	6.9	2.3	7.3	4.5	2.7	4.5	5.0	0.1	6.9	4.5	3.9	3.8	3.3	7.3	3.4	4.7	5.2	4.5	5.4	5.9	8.0	5.1	7.9	6.7	10.4	4.2	9.9	4.6	3.9	7.2	6.1	4.4	0.1	4.3	5.8	5.4	6.0	9.2	2.1	4.8	1.3	5.6	4.8	3.6	4.2	8.4	0.3	5.0	2.8	11.4	1.8	6.1	9.6	3.1	15.1	10.3	13.1	12.0	2.6	8.2	18.4	14.5	4.1	6.5	3.6	3.0	8.4	6.3	7.9	10.5	23.3	10.3	8.1	7.6	12.2	6.0	9.4	10.7	0.0	3.0	1.5	3.8	2.2	4.5	1.9	0.0	4.0	1.2	3.5	0.0	2.6	3.3	1.3	0.5	2.3	0.3	0.0	1.2	1.5	2.8	1.8	1.1	0.0	1.5	6.4	2.9	1.3	0.6	0.5	1.7	2.4	3.3	0.0	1.6	3.5	1.0	0.9	3.5	2.2	5.6	6.5	2.1	3.2	3.0	1.3	1.8	5.3	1.5	2.0
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218637916-218659655	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	10.4	10.4	16.7	13.6	18.2	23.6	10.9	22.8	21.0	11.8	12.5	18.2	8.4	8.2	14.4	7.7	13.6	12.6	12.3	12.5	17.0	11.7	11.2	7.7	11.3	15.0	14.3	15.0	12.9	14.7	19.8	15.5	9.0	12.5	12.7	10.0	10.2	11.7	15.5	18.7	18.7	12.2	14.4	12.6	14.4	12.7	12.3	15.7	16.3	13.2	7.9	14.3	14.9	11.7	4.4	3.5	3.1	3.1	1.7	4.5	2.0	6.0	10.5	8.4	11.5	7.8	6.6	9.1	7.2	4.2	10.0	7.2	20.3	4.8	8.7	6.7	6.2	8.6	11.4	16.7	9.8	6.6	10.7	14.3	11.2	20.7	10.8	5.0	15.8	11.9	4.5	9.0	12.0	10.7	5.0	8.0	9.8	17.9	16.7	5.5	14.1	12.0	8.9	10.8	3.3	9.7	18.3	4.5	8.4	6.0	12.3	14.0	10.6	5.3	11.9	4.0	8.4	6.6	5.5	9.1	10.6	11.0	7.5	10.5	10.4	6.1	14.8	6.1	7.4	9.9	2.3	3.1	3.1	4.5	0.7	2.3	4.4	3.2	2.4	2.7	2.2	4.0	2.4	1.9	1.7	0.5	3.5	4.0	2.0	16.7	18.2	22.8	21.0	17.0	11.7	14.3	15.0	12.5	15.7	3.0	0.3	2.2	1.7	5.3	2.6	4.8	2.5	0.0	2.3	3.5	5.9	1.8	0.0	2.4	1.5	1.9	3.0	0.0	3.2	1.8	2.0	2.1	1.1	2.9	2.5	1.6	0.0	4.3	5.1	3.1	3.4	2.9	3.3	1.8	2.7	2.0	3.8	2.6	3.5	1.7	3.2	6.5	0.8	4.8	4.9	5.4	0.9	4.4	3.2	2.0
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.4	12.2	13.3	11.8	11.9	12.9	10.1	16.8	19.7	18.9	18.1	11.5	10.3	14.9	11.8	24.8	15.3	15.1	14.5	12.7	27.0	6.6	5.5	18.3	14.7	5.9	8.8	12.5	18.5	10.4	13.3	17.7	18.8	12.5	12.9	10.9	8.9	12.7	13.9	14.4	15.5	4.6	8.5	12.5	10.5	11.2	14.6	8.3	10.8	20.6	11.5	9.7	22.4	11.4	18.7	7.7	14.2	12.6	16.6	14.4	15.5	18.0	10.7	11.1	12.6	22.6	10.8	8.0	13.2	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9	86.4	32.9	27.3	25.1	31.6	67.0	66.1	28.1	24.1	43.3	31.4	37.3	23.6	21.6	32.2	73.6	43.1	22.7	46.7	32.7	20.8	30.5	30.4	48.6	37.5	26.6	71.5	46.0	36.8	37.3	83.4	44.5	32.2	16.9	28.9	37.1	41.2	29.0	17.5	55.5	36.0	37.8	32.3	38.1	18.2	18.1	33.5	26.4	45.9	33.3	32.5
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 7.6;Cone photoreceptor cells: 7.9;granulocytes: 10.4;Horizontal cells: 7.9;Rod photoreceptor cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;HSkMC: 4.6;MOLT-4: 6.5;NTERA-2: 4.5;SuSa: 10.0"									HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	2.8	5.9	7.9	5.7	10.2	2.5	4.3	17.9	9.3	3.1	5.7	2.6	9.9	2.2	2.8	3.6	4.4	3.1	4.1	5.6	7.8	3.1	3.8	1.8	3.6	8.8	2.2	6.4	3.4	3.4	11.9	11.5	6.0	5.1	4.5	2.8	7.3	5.0	12.6	3.1	2.0	5.4	5.6	3.6	8.4	3.2	2.3	3.9	11.4	10.5	0.6	8.3	6.6	2.1	3.1	1.5	5.1	0.3	2.7	3.2	0.8	0.2	0.3	8.1	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.1	0.2	0.4	0.4	0.2	2.0	0.3	0.2	0.0	0.0	0.2	0.2	0.6	0.3	1.1	0.2	2.9	0.4	0.8	4.6	0.0	0.5	0.0	2.8	0.1	0.4	0.3	0.6	1.8	0.1	6.5	0.3	4.5	0.3	0.2	0.3	0.8	0.2	0.1	1.1	0.5	0.3	0.3	0.3	0.1	10.0	0.4	0.5	0.2	0.2	0.5	0.2	0.3	0.8	0.3	0.4	0.1	0.3	0.2	1.8	0.3	5.1	1.1	0.1	3.2	1.3	0.6	1.5	0.3	3.1	1.0	1.4	1.9	2.7	0.2	1.5	0.1	0.8	7.9	10.2	17.9	9.3	7.8	3.1	2.2	6.4	5.1	3.9	0.0	3.4	2.2	1.1	0.3	7.6	3.1	0.0	1.4	0.0	1.8	7.9	0.2	0.0	1.7	0.0	1.6	0.0	0.0	0.2	0.1	1.4	1.7	10.4	0.2	1.3	7.9	0.0	1.8	0.0	0.0	0.3	1.1	0.0	1.0	0.0	3.2	0.1	0.0	1.4	0.0	10.1	0.0	0.4	0.4	0.9	0.4	0.2	3.1	0.0	1.5
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	9.9	9.7	6.1	5.2	9.4	4.2	9.4	16.0	11.1	10.1	7.6	11.7	9.6	5.4	12.8	12.0	7.0	7.7	6.2	9.7	7.2	7.5	8.9	10.6	7.4	8.0	6.8	5.4	10.6	5.7	15.8	13.0	7.1	9.4	9.9	8.0	7.7	10.0	8.1	6.2	8.8	10.8	10.1	9.4	11.5	8.3	5.2	7.4	10.1	13.3	8.5	8.9	13.1	6.4	6.2	5.1	11.8	3.5	6.4	9.3	4.9	4.5	3.8	9.7	8.8	5.4	6.2	2.8	3.7	3.5	2.7	3.8	2.5	2.3	0.0	4.8	5.8	3.7	3.5	3.2	8.0	4.4	5.0	8.0	9.5	8.1	2.7	5.5	3.0	5.6	8.8	6.4	5.4	8.0	7.8	6.1	0.2	0.1	0.1	7.1	4.0	4.3	3.5	5.9	1.9	3.4	0.0	10.3	3.4	7.1	14.8	6.5	8.7	9.2	0.5	3.6	8.8	6.2	8.4	4.5	5.9	8.7	3.8	5.4	10.8	7.7	0.0	5.0	0.7	5.4	10.3	3.4	11.8	8.5	3.5	8.4	5.3	6.1	9.3	5.1	6.2	7.4	6.8	3.0	6.4	2.7	3.0	5.2	4.9	6.1	9.4	16.0	11.1	7.2	7.5	6.8	5.4	9.4	7.4	0.0	2.2	0.0	1.1	1.3	4.2	0.4	0.0	0.0	1.2	0.0	0.0	1.5	1.7	1.5	0.3	1.7	1.6	0.0	1.3	0.4	1.5	0.9	1.1	1.3	1.5	6.4	0.0	2.5	0.3	0.5	2.6	1.1	1.7	1.0	1.3	3.8	0.9	0.0	5.3	1.8	2.8	0.0	1.9	0.9	1.0	1.1	0.9	1.8	1.3	1.0
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	8.1	6.0	8.9	7.1	9.0	3.4	9.7	8.1	10.1	9.7	10.1	7.8	7.1	7.2	13.8	11.1	9.4	11.2	13.3	6.5	7.5	4.9	8.5	5.9	5.7	5.0	6.4	7.5	17.4	12.1	15.9	7.0	6.0	6.5	8.9	7.3	7.7	7.4	9.2	12.4	14.0	10.8	10.3	4.9	6.4	7.7	10.9	5.3	6.7	10.8	5.3	6.8	9.1	10.1	5.6	6.4	3.5	4.0	12.2	7.8	4.1	4.9	4.4	8.7	4.8	7.5	10.5	6.3	4.5	10.0	9.1	8.3	3.3	5.1	7.9	6.0	5.8	4.9	4.0	6.1	10.0	8.3	3.3	5.1	9.0	4.9	4.9	12.5	3.3	5.3	12.8	10.1	5.8	15.3	9.1	5.0	6.0	6.1	5.3	7.2	6.7	6.5	3.3	5.4	7.6	10.0	8.2	5.1	5.0	7.7	7.5	7.3	5.4	9.5	5.8	7.7	7.0	10.8	6.1	5.3	4.1	8.8	4.8	5.0	3.9	3.2	7.2	4.8	4.5	6.5	3.5	4.0	2.7	6.9	3.7	7.8	4.1	5.5	6.3	6.4	5.6	5.6	5.1	0.5	12.2	3.7	3.5	7.2	4.1	8.9	9.0	8.1	10.1	7.5	4.9	6.4	7.5	6.5	5.3	3.0	4.1	0.0	5.7	2.4	10.8	3.6	7.6	2.7	0.0	8.7	11.8	4.6	1.7	5.6	8.1	3.1	4.5	0.0	3.8	2.9	3.8	3.2	6.9	3.4	3.1	6.4	4.1	6.2	3.2	1.9	5.8	2.6	1.7	4.6	4.7	6.0	3.5	3.5	6.0	3.6	23.7	0.0	2.0	14.0	12.4	4.0	4.6	5.3	4.9	4.7
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.24e-4)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.79e-7)"	12.2	11.3	14.0	13.2	18.8	15.0	20.9	28.0	22.7	13.4	15.4	19.6	10.8	13.5	13.4	25.3	10.8	12.6	11.1	9.6	15.2	16.9	16.4	14.6	12.7	16.5	16.9	10.5	10.6	16.0	8.8	20.8	9.9	22.5	16.4	19.4	9.3	13.2	9.7	13.0	13.5	14.0	11.3	15.4	19.5	13.3	6.9	20.0	25.8	15.9	8.6	15.9	13.1	12.9	13.6	12.2	9.9	9.2	13.0	19.1	8.2	8.1	8.8	15.2	18.4	5.3	6.7	22.3	8.3	7.1	8.9	11.1	9.3	15.1	13.2	5.2	5.4	12.3	11.3	16.9	10.1	12.9	6.4	14.1	9.8	8.7	9.3	6.9	16.1	14.7	8.5	9.8	7.4	12.5	6.3	11.1	17.3	17.1	8.6	9.7	6.5	19.1	12.8	35.4	9.1	9.0	16.8	9.4	6.7	14.0	19.1	25.5	25.3	9.1	11.5	7.6	14.4	5.6	14.5	7.8	4.2	8.1	7.6	7.3	7.9	11.0	20.9	4.3	11.9	7.4	1.9	8.4	9.9	12.0	9.2	15.2	13.6	14.8	14.6	12.2	12.7	14.0	15.6	1.4	13.0	7.7	10.7	19.1	8.2	14.0	18.8	28.0	22.7	15.2	16.9	16.9	10.5	22.5	20.0	14.9	21.6	16.5	15.0	10.8	14.9	15.5	10.2	21.4	21.6	7.0	9.8	8.4	8.3	20.8	2.4	11.1	8.5	0.0	16.3	9.2	6.2	6.5	5.8	6.7	9.6	17.5	19.5	9.2	11.4	0.0	5.5	8.5	6.8	7.2	13.1	17.0	22.6	11.5	5.3	9.1	12.8	0.0	7.5	10.0	8.7	5.9	3.3	12.8	14.5	15.4
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 34.4;Late spermatids: 39.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	3.3	4.0	2.7	3.5	4.0	4.9	6.3	3.5	3.7	7.3	4.4	2.3	9.5	1.8	6.3	7.8	4.5	10.3	2.7	2.5	3.0	2.8	5.6	2.6	3.6	4.3	2.8	1.3	6.6	6.1	4.0	9.5	3.8	4.0	9.1	4.4	2.7	4.6	4.0	1.9	6.2	7.5	3.9	2.9	6.0	4.4	14.8	3.8	8.9	9.3	3.9	3.9	5.3	4.5	2.3	2.2	18.5	2.2	6.0	3.3	1.0	3.3	0.1	4.6	9.6	2.1	3.5	3.6	3.0	5.3	2.7	3.8	1.0	1.9	3.2	3.4	3.4	4.0	2.1	2.5	2.1	2.8	2.6	0.7	1.3	3.5	1.6	1.2	0.1	3.0	3.0	4.6	1.1	1.6	3.1	1.6	6.5	2.0	0.5	5.7	1.3	4.1	3.6	7.8	1.6	2.6	3.1	2.6	1.7	3.4	7.3	2.0	4.6	2.7	1.9	3.9	4.7	3.6	5.2	0.0	6.5	2.2	6.3	2.0	5.3	2.9	3.1	0.4	0.0	2.5	9.7	2.2	5.1	1.5	1.1	1.5	1.5	1.3	1.5	1.2	2.3	1.4	1.2	18.5	6.0	2.0	2.2	3.3	1.0	2.7	4.0	3.5	3.7	3.0	2.8	2.8	1.3	4.0	3.8	0.0	0.0	0.0	0.7	0.1	0.5	0.7	2.5	32.1	0.0	1.8	2.0	0.8	1.7	2.0	34.4	0.1	2.3	0.0	2.1	1.0	0.4	1.7	2.3	2.1	1.3	0.0	4.1	0.0	1.0	39.3	0.6	0.2	0.0	1.8	1.3	0.5	1.9	2.5	0.0	1.9	1.3	0.0	0.4	7.6	1.7	0.5	0.9	0.0	1.2	1.4
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 7.0;Cone photoreceptor cells: 5.9;Spermatogonia: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 18.1"					"Low region specificity"	"Detected in all"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA047243: , HPA051010: AB_2681308"	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	1.2	1.4	1.5	9.0	1.8	1.4	2.7	0.7	4.0	1.9	4.2	0.3	0.9	4.6	2.3	5.2	2.8	1.4	1.1	1.4	1.2	2.2	2.9	1.6	1.5	6.7	0.7	1.4	1.9	10.4	0.0	0.8	0.7	1.9	2.7	5.5	1.2	4.2	2.0	0.9	1.6	5.5	0.9	1.1	4.8	1.6	6.1	0.0	6.5	2.7	2.1	11.6	3.3	2.2	2.5	2.9	4.0	1.8	1.5	1.4	0.8	2.6	1.2	1.8	0.6	1.3	1.6	5.8	6.2	5.3	3.2	6.4	0.2	0.1	8.7	2.0	3.3	4.1	3.1	5.1	6.1	6.1	0.0	7.0	0.1	0.8	0.1	1.3	5.3	0.4	2.8	2.9	0.1	6.7	1.6	5.1	0.1	10.2	3.0	1.3	0.1	0.2	0.2	8.5	0.0	1.7	0.2	0.1	1.0	0.2	4.8	0.1	0.2	0.0	2.2	0.2	4.5	0.2	2.2	2.4	2.0	5.8	2.4	0.1	0.4	0.1	18.1	4.6	0.3	1.8	4.0	1.8	0.6	0.8	1.0	0.3	2.5	0.6	1.4	1.7	2.5	1.4	0.8	2.7	1.5	0.5	2.9	0.7	0.8	1.5	1.8	0.7	4.0	1.2	2.2	0.7	1.4	1.9	0.0	0.0	0.0	2.2	1.3	0.3	0.5	0.2	0.0	0.0	1.2	7.0	5.9	0.3	1.7	0.1	0.2	0.0	1.3	0.0	1.5	2.2	0.5	0.4	1.1	1.0	0.4	3.2	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.6	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.9	1.5	7.5	0.3	0.0	0.0	2.5	0.6
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	4.8	7.7	8.1	5.1	9.1	8.0	8.3	18.3	12.6	6.2	4.4	7.5	5.3	2.9	5.1	7.3	3.5	5.5	6.4	7.5	11.5	8.2	5.9	5.1	5.7	7.2	8.8	7.8	8.9	5.4	6.6	12.7	5.4	10.7	6.6	5.0	5.7	6.9	6.4	3.7	4.5	5.0	6.0	9.3	8.8	5.5	15.4	11.1	10.3	7.6	5.0	7.3	8.5	6.6	7.6	4.0	8.9	3.6	6.1	9.7	4.0	3.9	4.6	7.9	7.1	6.1	6.2	0.4	4.2	7.6	5.0	7.8	2.4	2.6	1.4	6.6	4.7	6.0	1.3	5.4	4.0	6.3	5.8	5.9	6.5	5.8	3.8	7.6	0.2	5.9	4.7	5.5	4.1	7.1	8.0	4.6	5.8	1.2	2.8	6.2	0.5	4.4	2.6	4.7	1.8	2.3	0.1	8.4	2.1	4.2	12.4	4.2	9.7	6.9	1.3	5.7	7.2	1.7	6.3	3.4	5.5	5.3	3.2	5.2	11.3	9.2	0.1	2.9	0.1	6.1	8.9	3.6	7.0	9.2	2.3	7.7	7.4	8.7	8.9	3.6	7.6	9.7	7.3	7.5	6.1	2.8	4.0	6.0	4.0	8.1	9.1	18.3	12.6	11.5	8.2	8.8	7.8	10.7	11.1	0.0	1.0	0.0	1.7	2.3	4.9	1.9	0.0	0.0	1.2	5.2	0.0	1.8	6.6	2.3	43.5	1.8	0.7	0.0	1.1	0.9	2.1	1.0	4.6	1.0	2.0	6.4	2.9	1.3	1.2	1.5	1.7	1.2	1.7	1.0	1.7	6.5	0.8	0.0	2.1	1.2	2.6	0.0	2.7	5.1	1.2	1.5	0.9	4.1	1.2	0.6
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067991	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 21.6"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	6.5	8.0	6.6	5.9	14.7	3.2	10.1	19.8	17.3	7.6	8.0	9.6	6.0	7.1	7.7	11.3	6.5	7.5	9.5	8.8	9.4	8.5	7.5	4.7	7.0	6.0	6.7	7.4	7.7	6.2	10.8	9.8	9.7	15.3	12.3	10.7	7.1	7.7	9.4	3.5	8.8	9.2	7.8	5.7	8.6	8.8	6.2	7.9	6.7	11.7	4.6	7.6	9.0	6.2	4.4	7.7	11.6	7.1	6.6	9.3	2.6	2.5	1.4	5.5	1.3	3.6	4.6	0.1	3.9	4.3	3.5	5.1	2.6	4.3	0.0	3.7	3.0	2.1	2.5	0.0	4.4	3.8	0.0	4.1	5.1	3.9	3.5	2.7	0.2	0.1	4.5	3.5	3.0	2.9	5.0	3.9	0.1	0.2	0.0	3.9	2.0	0.0	1.8	4.1	1.7	1.9	0.0	2.2	1.2	4.2	21.6	3.4	8.1	6.8	0.9	2.7	7.4	3.9	4.7	3.9	3.3	3.2	1.8	1.4	2.6	4.4	0.0	1.4	0.0	3.2	11.6	5.8	8.7	2.8	7.1	4.3	3.6	4.7	2.4	6.4	4.4	9.3	4.0	0.5	6.6	2.9	7.7	4.0	2.6	6.6	14.7	19.8	17.3	9.4	8.5	6.7	7.4	15.3	7.9	0.0	0.6	0.0	0.5	0.0	2.9	0.8	2.5	1.4	0.0	1.8	2.0	1.6	3.3	1.9	2.7	2.1	0.7	0.0	0.4	0.4	0.2	0.5	0.0	0.6	1.4	3.2	0.0	2.5	1.6	0.8	1.4	1.2	0.0	1.0	2.4	1.5	1.1	0.0	1.8	1.0	1.2	0.0	0.0	1.9	1.9	0.0	0.8	0.0	2.1	0.7
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	13.5	13.3	12.4	13.6	17.7	6.9	14.4	29.2	20.2	13.6	11.0	10.8	17.7	14.8	14.9	20.3	10.0	13.5	11.6	9.0	16.4	7.8	12.7	13.3	14.6	17.1	20.3	11.0	18.6	13.1	16.6	25.0	12.1	15.4	15.0	18.1	11.6	13.8	13.9	6.6	20.2	19.4	15.0	12.3	23.6	13.1	5.4	15.8	14.9	18.0	8.7	18.3	12.1	11.3	11.6	6.5	25.0	8.1	10.0	14.5	6.7	6.1	10.2	11.0	9.0	10.9	11.5	9.0	7.7	11.5	5.4	12.4	5.0	4.9	7.4	8.6	10.1	4.1	6.9	6.0	6.6	7.2	7.5	12.2	14.1	16.9	5.2	5.8	10.1	16.6	14.2	12.0	6.6	9.9	17.1	9.6	7.4	4.3	9.0	8.9	1.6	8.9	12.3	4.7	3.3	7.1	5.3	11.9	4.5	8.1	19.6	5.6	12.9	10.6	4.6	3.5	11.4	4.5	13.3	10.0	11.9	7.7	5.3	5.4	12.1	11.3	4.2	6.4	7.9	5.5	25.0	6.1	14.1	13.3	4.1	14.5	11.2	11.2	13.1	6.5	11.6	14.1	10.9	4.5	10.0	8.1	5.8	12.5	6.7	12.4	17.7	29.2	20.2	16.4	7.8	20.3	11.0	15.4	15.8	20.8	13.4	27.2	6.3	4.9	25.7	4.0	22.9	5.3	7.9	24.4	17.7	10.3	1.7	6.4	11.3	9.5	18.0	0.0	4.6	6.2	10.0	8.4	20.7	5.3	6.6	25.4	9.2	12.9	8.8	2.9	15.0	11.5	5.0	19.0	8.8	17.8	6.3	17.5	13.1	1.4	21.3	12.9	6.4	3.7	3.7	5.9	6.9	29.4	8.5	8.0
ZNF239	"HOK-2, MOK2"	ENSG00000196793	"Zinc finger protein 239"	Q16600	10	43556344-43574618	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 26.8;Late spermatids: 9.8;Spermatogonia: 7.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 4.2;T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 18.1;T-47d: 14.1"					"Low region specificity"	"Detected in all"			"HPA030843, HPA046679"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA030843: AB_2673632, HPA046679: AB_10960498"	"unprognostic (1.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-7)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.90e-3)"	"unprognostic (4.13e-2)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	5.0	5.0	8.8	5.6	9.3	0.9	10.4	5.7	8.2	6.8	5.3	5.2	2.1	2.9	8.8	4.5	2.5	8.7	3.5	4.1	6.5	5.1	4.6	2.6	2.7	5.3	5.3	8.5	8.1	8.7	9.9	8.6	2.0	7.2	10.6	5.8	1.7	6.2	9.4	4.9	1.3	3.3	9.8	3.7	2.7	4.7	14.5	6.8	1.6	6.5	1.4	5.1	6.1	10.4	4.2	0.1	0.0	0.0	0.5	8.8	1.9	0.0	3.1	3.7	3.6	5.2	3.9	0.0	6.6	0.7	7.9	7.0	8.0	7.2	0.0	2.5	3.5	3.0	0.2	0.0	0.3	10.1	0.1	5.3	0.0	5.3	0.0	4.1	0.0	2.4	4.3	0.1	6.2	0.0	2.4	0.2	0.0	10.3	0.0	6.5	3.4	1.0	1.0	18.1	3.4	3.6	0.0	0.0	0.2	6.6	2.8	7.0	9.5	2.9	0.1	0.4	5.4	14.1	4.4	0.8	0.0	8.1	0.2	8.3	0.9	6.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	5.0	3.6	4.8	3.2	0.1	4.2	8.8	5.2	0.0	0.5	0.0	0.0	2.5	1.9	8.8	9.3	5.7	8.2	6.5	5.1	5.3	8.5	7.2	6.8	0.0	0.3	0.0	1.4	0.0	3.1	0.4	0.0	0.0	2.3	3.5	0.0	0.1	1.7	1.7	26.8	0.1	0.0	0.0	0.3	1.1	0.7	0.8	0.0	0.2	0.3	0.0	0.0	0.6	0.0	9.8	0.3	0.0	0.0	1.0	0.6	1.2	1.2	0.0	1.4	1.4	0.6	0.0	1.0	5.7	7.5	0.0	0.1	0.0	1.2	0.1
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949572-37976633	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	9.7	12.1	17.0	4.0	21.7	2.7	8.7	23.2	27.6	10.9	8.1	7.3	3.4	2.7	11.3	7.5	6.5	7.3	7.1	11.1	13.3	16.7	6.8	3.5	6.9	4.9	12.7	23.7	13.1	4.0	7.1	10.7	5.4	16.0	8.9	5.4	5.1	4.5	11.0	22.9	5.1	3.7	11.6	9.5	7.1	4.4	5.2	11.6	1.2	6.3	5.7	4.9	8.4	5.4	2.3	3.4	6.0	8.5	1.8	3.7	2.2	1.6	3.0	3.3	6.7	12.5	9.6	0.6	3.6	4.9	2.8	4.3	0.5	2.3	3.0	1.0	6.3	1.1	0.4	0.9	1.5	4.6	7.0	1.6	4.8	0.0	1.0	7.9	3.2	3.1	6.8	6.6	3.1	3.6	11.3	4.8	3.9	0.4	2.3	6.8	0.9	1.0	2.4	0.6	0.5	2.2	1.1	3.7	0.6	3.4	0.6	1.2	7.7	1.2	0.2	4.5	1.3	2.9	5.1	6.9	4.4	0.8	7.1	2.2	2.9	1.3	1.2	8.4	6.2	2.9	2.3	2.8	6.0	3.1	4.7	3.4	2.0	2.7	2.6	3.4	2.3	3.7	3.0	0.5	1.8	8.5	0.5	2.2	2.2	17.0	21.7	23.2	27.6	13.3	16.7	12.7	23.7	16.0	11.6	3.0	2.7	3.4	2.0	3.1	17.7	20.4	5.1	12.0	3.4	7.0	5.9	1.0	1.7	1.7	26.3	5.8	0.8	0.0	2.1	0.4	8.5	2.0	8.1	2.9	5.1	15.9	0.0	10.4	10.2	20.4	11.2	10.1	3.3	5.4	1.1	12.8	1.6	0.0	15.2	3.0	7.1	0.0	13.3	3.2	7.2	3.4	0.2	4.5	0.7	0.7
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510695-36528660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	8.4	9.4	10.3	7.6	16.8	2.3	12.0	18.4	14.1	10.8	7.0	6.2	9.4	6.2	11.2	7.9	8.0	8.4	8.2	7.5	11.2	9.5	11.6	8.5	7.3	12.4	17.1	9.1	13.4	6.6	20.4	19.5	10.9	11.9	10.3	7.1	5.9	8.8	7.6	4.8	10.0	7.7	8.1	20.6	8.3	8.1	4.5	15.4	17.3	14.7	5.5	9.7	10.7	8.4	5.9	3.2	6.8	3.5	4.1	7.2	3.0	7.9	8.1	18.8	14.1	5.8	8.9	8.2	7.0	7.5	6.5	8.3	3.6	4.5	5.2	11.5	5.6	4.9	3.0	9.4	4.3	10.0	6.9	4.1	7.8	6.2	4.1	8.1	3.9	6.5	8.0	7.2	6.7	10.3	9.3	8.6	7.9	6.1	5.8	12.8	4.3	14.4	2.5	11.9	4.9	3.5	9.6	11.6	3.9	7.2	14.3	13.6	14.9	15.5	8.3	5.7	12.1	7.0	7.4	7.4	11.3	11.8	6.6	6.2	7.5	14.3	12.3	0.3	4.1	15.2	6.8	2.8	3.0	4.0	2.5	4.2	5.1	5.3	3.2	3.2	5.9	7.2	5.5	1.6	4.1	3.5	2.2	4.6	3.0	10.3	16.8	18.4	14.1	11.2	9.5	17.1	9.1	11.9	15.4	8.9	3.8	4.4	7.3	9.2	7.6	7.5	0.0	5.3	12.5	0.0	7.9	5.5	5.0	7.1	7.4	6.7	2.5	0.0	3.9	5.7	6.1	7.0	8.1	3.0	4.1	20.6	11.5	9.8	3.3	3.1	5.5	4.9	1.7	7.2	6.6	7.5	5.2	2.9	7.8	6.7	7.4	6.5	4.8	5.6	3.7	11.4	3.4	6.9	5.0	10.8
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 39.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	9.0	6.4	10.7	4.4	6.8	10.1	10.4	7.5	4.1	8.2	7.4	3.7	6.7	3.1	4.9	4.6	8.8	2.6	5.0	10.5	11.4	6.4	39.1	14.6	6.3	6.0	11.1	10.4	24.2	8.0	13.5	10.1	19.5	8.5	6.5	5.0	10.9	14.1	6.1	5.9	5.6	9.3	10.2	5.3	6.3	12.7	2.7	13.4	6.2	3.8	7.0	3.1	10.0	4.4	8.4	8.5	10.6	19.7	6.2	4.5	6.7	5.1	8.4	6.4	6.8	10.3	2.0	11.5	9.3	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9	14.9	18.7	18.2	36.1	9.3	30.1	14.3	12.7	10.7	10.3	17.4	41.2	9.0	1.7	10.9	14.5	11.3	11.9	0.0	4.9	9.9	6.6	25.3	28.8	6.8	6.8	19.1	6.3	4.3	10.2	8.1	11.2	13.4	6.8	10.0	8.8	20.1	9.3	17.5	11.3	9.0	60.4	19.4	11.8	17.9	12.8	10.7	14.0	25.3	7.6	21.2
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206588-112343096	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.2	14.8	11.2	12.9	16.2	10.9	20.1	9.3	13.8	13.6	13.9	8.4	8.8	13.7	14.7	8.8	18.4	12.6	14.3	14.4	11.8	9.1	22.7	30.0	19.2	14.3	11.3	11.9	15.4	23.5	13.5	16.4	8.1	11.6	17.1	14.2	5.5	14.9	12.9	12.7	17.7	13.4	15.9	16.1	13.7	14.6	10.2	14.1	23.9	22.4	11.1	15.6	26.6	13.6	13.3	10.4	9.5	14.3	12.4	17.2	9.1	5.9	6.2	8.3	10.3	13.7	38.1	6.4	5.8	12.8	4.9	10.4	5.7	9.3	13.3	11.6	6.2	11.1	5.0	5.2	10.1	11.6	7.0	8.0	5.4	6.1	12.6	13.4	10.3	7.9	21.9	18.1	9.4	12.4	19.8	16.9	14.7	9.5	14.2	9.2	9.6	14.4	20.1	4.9	7.9	6.4	8.0	9.8	13.8	14.4	6.8	6.3	12.7	7.1	13.7	14.1	13.3	5.5	11.0	10.4	6.8	4.1	17.7	5.5	10.4	8.4	13.2	5.8	10.2	7.6	7.1	11.6	9.5	11.2	14.3	15.9	13.3	15.2	17.2	10.4	11.2	16.3	13.5	9.3	12.4	11.6	10.1	17.0	9.1	11.2	16.2	9.3	13.8	11.8	9.1	11.3	11.9	11.6	14.1	35.7	18.2	13.7	16.1	18.3	10.0	11.8	22.9	10.7	18.2	5.2	2.0	10.4	23.2	20.2	37.5	16.5	11.8	0.0	27.0	13.8	12.7	16.7	7.0	17.3	19.2	30.2	17.7	10.4	39.5	4.4	15.8	26.3	11.8	36.9	21.0	5.8	24.3	21.0	23.7	25.9	11.4	19.4	13.3	20.6	7.8	21.2	11.6	28.4	22.1	18.1
ZNF280C	"FLJ20095, SUHW3, ZNF633"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202711-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 11.4;Spermatogonia: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: AB_2681506, HPA055788: AB_2682921"	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	5.4	4.5	3.9	7.1	6.8	6.2	4.9	5.6	6.8	7.6	4.4	5.4	2.9	3.7	10.6	13.3	4.6	5.0	5.1	3.3	3.8	4.2	4.0	4.1	4.1	5.7	4.2	4.2	6.8	4.6	4.9	12.5	4.8	5.8	5.5	4.0	5.1	4.1	3.8	4.5	4.5	4.4	5.0	5.8	6.0	3.8	21.5	2.8	8.2	4.9	3.6	6.8	4.9	5.4	4.0	2.3	2.7	2.9	4.5	4.9	1.1	3.4	4.4	11.8	10.5	3.5	4.9	4.4	3.3	4.4	3.6	5.4	2.7	5.6	8.3	13.3	2.4	7.0	3.4	8.1	2.6	6.3	7.2	2.3	3.6	3.4	2.0	2.8	11.5	3.3	3.6	1.2	5.0	5.3	3.5	4.0	5.4	1.7	5.1	4.1	4.4	6.2	4.7	6.8	5.2	3.7	8.7	4.0	3.2	3.7	5.6	5.7	7.9	3.2	1.9	3.8	5.0	2.1	4.0	4.0	3.9	3.3	6.4	8.6	2.1	1.3	4.7	3.6	10.5	3.6	2.7	1.4	1.5	3.0	2.2	4.9	4.0	3.8	3.5	1.9	3.2	2.7	3.7	0.8	4.5	2.9	2.3	4.8	1.1	3.9	6.8	5.6	6.8	3.8	4.2	4.2	4.2	5.8	2.8	3.0	2.2	3.7	1.9	0.8	2.6	1.0	0.0	4.0	1.2	1.8	2.0	1.6	0.0	1.1	0.2	1.8	1.1	0.0	1.6	1.5	1.7	1.3	0.0	2.1	1.4	4.8	4.6	3.1	1.9	0.0	3.1	1.7	0.0	4.6	0.7	0.8	1.0	1.9	2.8	1.9	2.9	6.5	1.5	11.4	35.1	1.4	0.7	1.5	1.9	2.0
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195485-149226248	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	13.6	11.7	12.6	12.7	11.5	17.5	13.1	20.7	18.1	19.1	16.1	16.6	16.8	17.7	17.9	14.1	17.9	17.2	18.1	12.5	10.2	8.4	12.4	14.4	12.3	11.2	10.8	11.8	18.5	26.6	12.2	12.3	24.9	10.8	21.4	7.8	13.3	17.8	15.8	20.7	19.5	14.5	15.1	8.9	15.2	14.6	6.4	12.9	14.2	14.1	16.3	12.7	17.0	13.8	3.9	2.4	3.5	1.8	1.8	3.4	1.0	11.6	11.5	6.8	16.3	6.0	7.1	10.0	10.6	7.8	9.4	9.4	10.5	12.8	11.7	16.1	6.6	8.3	12.9	8.0	10.1	3.6	17.6	28.2	9.8	7.5	8.9	8.9	12.3	11.1	8.1	13.8	9.0	9.9	7.1	9.7	7.9	18.8	9.2	5.0	13.7	25.9	18.3	22.0	6.7	14.5	16.9	6.6	16.3	5.1	11.2	15.5	14.8	11.8	14.2	9.7	3.8	9.1	12.0	12.1	13.5	3.0	16.1	15.4	13.3	7.9	8.7	11.2	10.7	11.5	0.0	1.8	3.5	2.1	1.5	2.3	0.9	2.7	2.1	1.0	3.9	1.4	1.8	1.8	1.8	1.7	2.4	3.4	1.0	12.6	11.5	20.7	18.1	10.2	8.4	10.8	11.8	10.8	12.9	3.0	5.0	1.9	2.4	6.4	10.9	4.0	7.6	0.0	2.3	1.8	3.9	9.2	0.0	4.4	25.4	4.5	8.3	0.0	3.7	4.7	4.7	4.3	5.7	7.5	5.3	14.3	12.6	6.2	4.5	21.6	5.8	2.5	1.7	3.6	10.2	5.4	5.3	9.5	5.3	3.2	7.0	12.9	3.8	1.1	1.2	5.6	4.2	1.5	9.3	3.3
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87264196	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	11.8	10.2	15.2	16.7	16.8	31.1	14.5	31.1	19.7	15.0	13.9	10.3	11.4	11.2	16.4	15.1	11.1	11.1	9.8	11.6	13.6	9.0	9.8	10.8	9.7	14.8	18.2	9.8	20.6	12.5	14.6	20.7	12.3	15.3	14.0	10.2	12.0	15.0	11.2	9.3	14.0	15.7	12.3	18.6	12.2	11.6	8.7	19.6	25.6	14.1	5.7	16.5	22.6	22.9	16.7	10.4	35.8	7.6	4.3	8.3	3.0	6.3	3.8	12.8	11.2	7.3	6.7	13.3	4.9	6.4	5.9	8.2	6.4	4.5	9.8	7.3	6.5	8.4	6.6	7.9	7.5	12.9	22.2	6.0	13.2	4.9	5.1	5.5	10.6	6.0	6.6	7.4	5.8	7.6	9.5	5.4	10.6	9.6	15.1	6.4	3.5	6.1	9.5	6.4	2.2	3.5	12.9	12.7	3.7	5.2	13.8	9.6	13.5	6.3	4.2	4.8	7.7	4.2	12.8	6.1	7.9	5.5	5.8	7.8	14.0	9.1	6.7	8.7	9.2	5.7	18.0	7.6	7.9	6.9	2.2	6.5	16.6	7.4	7.5	3.2	16.7	8.3	7.1	35.8	4.3	2.3	10.4	7.1	3.0	15.2	16.8	31.1	19.7	13.6	9.0	18.2	9.8	15.3	19.6	56.6	56.6	44.4	25.9	58.7	160.5	61.0	40.8	32.1	48.9	24.4	115.8	19.3	8.3	84.7	16.4	40.7	47.6	0.0	33.2	25.7	35.7	37.4	27.8	15.3	23.3	176.4	45.4	36.2	26.5	6.4	55.5	39.5	30.4	44.1	44.3	74.5	51.7	42.1	62.2	11.6	93.9	32.3	37.3	48.7	29.8	44.9	177.1	57.3	40.7	34.6
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4"	"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.8	0.5	0.0	0.2	0.2	3.5	1.2	16.6	1.9	0.1	0.0	5.8	0.8	1.3	0.0	3.5	4.4	4.8	0.9	3.4	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.1	0.5	0.3	3.5	5.9	0.0	4.6	0.2	4.6	1.9	2.0	4.4	9.3	0.0	10.0	0.4	1.1	3.1	0.3	2.1	11.2	0.1	0.3	2.4	5.5	1.1	0.0	1.7	0.1	0.0	6.1	6.1	19.4	0.1	3.5	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6	0.0	1.1	18.6	12.1	10.8	0.9	0.9	0.0	2.7	1.2	3.5	3.9	0.3	0.0	1.9	0.4	0.0	13.3	0.0	0.8	1.9	1.7	2.8	9.2	0.0	3.0	0.0	5.1	1.3	3.0	0.0	0.0	4.1	3.3	36.9	19.9	0.5	1.0	28.6	1.1	0.3	1.6	0.0	2.0	0.9	10.9	8.8	0.7	10.2	23.5	5.7
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 12.7;Rod photoreceptor cells: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	3.4	5.2	11.1	2.6	10.9	0.7	5.9	21.4	11.6	5.3	3.9	5.0	2.9	4.2	4.5	3.4	3.4	7.0	2.6	5.0	7.0	5.4	4.6	6.5	6.0	5.1	10.0	6.5	5.6	6.9	6.4	7.7	3.3	6.6	5.8	4.5	5.8	4.6	5.2	5.3	5.6	3.9	5.1	7.2	5.4	4.8	3.9	8.3	2.4	4.4	2.0	5.1	3.8	4.0	3.4	1.3	2.8	0.4	6.9	7.2	1.8	3.6	8.2	3.5	8.8	6.3	4.0	0.1	3.6	2.6	3.3	3.7	5.8	1.2	0.0	4.8	2.3	1.2	2.3	10.1	5.1	4.2	0.0	4.8	2.7	4.4	4.4	3.2	3.6	2.5	3.5	4.6	3.3	4.4	1.4	5.2	7.2	8.7	0.0	5.3	2.7	2.6	1.6	4.9	8.9	4.3	3.4	2.7	0.9	2.5	3.2	4.6	6.6	0.0	0.1	3.4	3.8	3.3	1.0	3.7	7.0	3.7	2.5	4.8	2.4	11.5	1.0	1.4	0.0	4.0	2.8	0.1	0.1	4.8	0.4	4.7	3.4	3.8	2.2	1.3	2.1	7.2	7.2	0.0	6.9	0.0	1.2	3.4	1.8	11.1	10.9	21.4	11.6	7.0	5.4	10.0	6.5	6.6	8.3	0.0	0.6	0.0	0.2	0.3	5.3	2.8	0.0	4.0	0.0	1.8	5.9	0.1	3.3	0.9	0.2	3.5	0.0	0.0	1.2	0.5	0.6	0.3	5.7	1.0	0.7	12.7	1.2	5.5	1.8	0.4	2.0	0.1	1.7	0.0	1.4	3.5	1.0	0.0	2.1	1.3	10.0	0.0	1.0	2.6	2.4	0.1	0.0	1.7	1.3	0.3
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369478	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 78.2;Spermatogonia: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.3	7.1	14.2	15.3	13.7	9.9	12.2	24.7	17.7	12.5	8.9	10.4	9.2	7.1	12.7	11.1	7.0	9.0	7.1	7.6	12.8	6.3	7.3	8.3	9.2	23.6	15.4	9.4	13.2	8.6	14.6	8.0	7.9	11.4	10.2	8.2	7.9	7.9	8.6	8.6	11.7	10.0	9.2	9.0	14.6	6.8	39.2	16.8	10.0	13.7	4.7	23.6	9.8	10.9	6.3	0.9	0.4	0.7	0.7	1.4	0.5	15.4	3.9	11.3	18.8	10.0	9.0	5.6	6.7	8.9	8.2	7.1	4.1	2.0	24.6	3.8	8.9	9.6	7.0	12.6	5.9	10.7	6.4	6.4	6.8	5.0	6.5	5.0	12.1	5.5	5.7	6.3	6.9	6.1	6.9	6.3	7.0	9.1	12.3	8.6	5.5	3.6	7.7	5.1	26.2	3.7	4.5	11.0	3.9	4.5	3.7	10.4	6.4	5.2	4.6	5.5	9.2	5.7	16.9	6.3	11.5	5.7	7.7	6.6	7.3	5.9	17.6	3.6	9.3	6.4	0.0	0.7	0.0	1.4	0.5	0.4	1.4	1.2	0.9	0.9	6.3	0.9	1.0	0.4	0.7	0.4	0.7	1.2	0.5	14.2	13.7	24.7	17.7	12.8	6.3	15.4	9.4	11.4	16.8	8.9	12.6	7.3	4.2	8.7	15.4	7.7	12.7	6.7	7.9	8.7	7.9	4.9	3.3	4.1	21.1	4.7	5.7	0.0	4.0	3.8	6.4	3.2	5.8	16.8	5.5	23.8	5.2	14.1	10.8	12.9	5.8	6.6	3.3	4.6	4.9	10.2	4.2	9.1	9.2	3.4	12.1	25.8	3.9	78.2	41.7	4.4	1.5	5.0	8.5	1.3
ZNF32	KOX30	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643859-43648856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	14.4	16.2	24.4	12.4	23.6	4.4	29.2	21.1	20.1	20.2	20.4	19.0	18.0	7.9	21.9	37.7	12.6	20.7	14.7	26.1	22.2	20.8	22.1	17.7	13.7	12.2	27.7	17.7	28.7	26.0	18.7	20.3	10.3	22.5	22.5	15.1	14.7	18.5	25.4	45.7	14.4	11.0	23.4	19.8	14.2	14.5	8.6	25.8	15.4	25.8	14.5	15.4	17.9	25.4	14.2	11.2	8.5	6.9	23.0	21.7	10.3	9.6	8.6	13.0	19.6	24.0	25.9	4.2	8.6	26.2	16.2	14.7	5.8	4.9	0.0	15.3	18.4	7.6	5.7	8.3	8.4	11.9	10.5	9.1	2.5	5.4	6.6	22.5	0.2	7.9	26.5	19.4	10.0	12.1	15.6	12.2	34.5	7.4	0.0	20.3	8.8	9.5	8.8	10.1	9.8	4.5	14.8	14.6	2.2	16.2	3.8	16.7	14.8	7.1	5.3	13.5	15.0	19.6	9.0	5.2	9.1	11.0	6.6	2.1	5.8	15.1	0.0	3.2	6.2	8.4	4.1	6.9	8.5	19.3	6.1	19.1	13.3	15.5	21.4	11.2	14.2	20.0	21.7	0.6	23.0	5.4	9.5	10.8	10.3	24.4	23.6	21.1	20.1	22.2	20.8	27.7	17.7	22.5	25.8	8.9	14.7	20.1	21.3	9.7	22.4	10.9	15.3	13.4	11.4	17.4	7.9	14.8	89.5	34.7	1.8	18.7	6.1	0.0	41.6	15.5	19.7	29.1	29.0	22.5	26.1	15.9	26.7	17.2	15.9	0.4	39.1	14.8	16.9	12.6	17.5	29.0	29.6	14.0	51.2	43.0	19.9	32.3	22.7	11.2	13.0	13.4	5.6	23.0	18.1	13.6
ZNF320	"DKFZp686G16228, ZFPL"	ENSG00000182986	"Zinc finger protein 320"	A2RRD8	19	52863790-52897693	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 24.5;U-266/84: 20.2"									"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: AB_2732685"	"unprognostic (3.33e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.47e-4)"	"unprognostic (8.90e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.75e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.61e-3)"	6.3	8.6	10.5	8.7	11.7	8.3	9.9	15.5	12.2	10.8	9.9	9.4	27.7	7.1	13.8	12.7	7.0	11.3	9.5	9.8	9.0	7.0	11.8	2.5	7.1	6.8	9.1	10.1	15.5	10.3	17.7	15.7	15.7	10.9	12.1	10.9	9.7	9.7	23.8	7.4	13.1	7.8	8.6	11.4	9.8	8.7	6.3	12.6	8.9	13.0	5.3	6.8	19.4	11.0	5.0	3.7	5.9	3.4	10.1	5.1	2.6	3.5	0.3	4.7	10.8	0.7	1.7	8.1	1.8	1.7	3.0	3.9	1.4	1.3	3.2	3.2	2.1	1.5	1.8	0.0	0.6	1.4	0.0	1.2	4.0	4.9	0.0	2.1	0.4	4.2	2.6	1.7	3.8	0.4	1.2	2.0	2.1	3.5	0.5	2.4	0.0	3.6	3.6	5.5	0.1	3.3	4.2	6.0	4.3	1.7	24.5	4.1	8.5	0.1	2.8	1.7	4.8	3.0	0.0	2.2	1.6	3.5	0.8	3.5	6.3	20.2	2.8	0.2	0.1	2.3	3.1	3.3	2.6	3.9	3.4	3.5	3.2	2.6	2.9	2.6	5.0	4.7	5.1	5.9	10.1	2.6	3.7	2.5	2.6	10.5	11.7	15.5	12.2	9.0	7.0	9.1	10.1	10.9	12.6	3.0	1.7	2.2	5.4	1.6	7.2	10.0	17.8	1.4	4.5	1.8	9.8	8.1	0.0	0.2	3.8	5.0	5.1	0.0	0.0	5.5	4.3	6.8	1.1	0.8	3.6	15.9	10.3	5.5	1.9	2.1	4.0	1.5	3.3	0.0	9.4	5.6	0.1	3.5	2.5	0.2	12.6	0.0	2.7	3.4	5.3	3.8	6.4	0.7	4.3	6.7
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.7;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.6;NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.1;BEWO: 15.2;NTERA-2: 8.1;SCLC-21H: 10.1;SuSa: 18.1"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.1	7.3	11.1	2.2	14.3	1.9	9.5	18.2	12.0	6.4	2.6	8.1	11.5	2.9	9.2	13.4	2.4	12.1	5.8	2.1	9.8	7.8	6.8	4.1	4.7	2.1	5.8	6.9	22.5	7.5	2.9	20.4	7.0	11.5	12.8	3.5	7.0	6.8	10.0	1.5	3.0	3.8	4.9	7.6	3.1	7.0	8.3	8.8	2.7	10.8	1.7	1.8	5.2	4.5	0.4	3.6	0.2	0.5	2.7	0.1	0.1	0.0	0.0	12.1	0.0	0.8	0.1	15.2	1.0	0.1	0.9	0.1	0.0	3.1	0.0	0.0	0.3	3.7	0.0	0.0	0.2	0.4	0.0	2.5	3.8	0.1	4.3	3.3	0.0	0.0	3.9	0.0	1.0	0.0	0.5	0.1	0.1	2.5	0.0	0.1	0.0	0.0	6.8	8.1	2.0	1.0	0.0	0.0	0.0	3.3	2.9	10.1	5.7	0.0	0.3	0.2	18.1	0.0	3.4	0.0	0.1	5.5	0.1	0.0	0.9	4.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.2	0.2	0.1	0.0	0.1	2.7	0.0	3.6	0.0	0.1	11.1	14.3	18.2	12.0	9.8	7.8	5.8	6.9	11.5	8.8	8.9	5.0	0.0	3.4	0.1	11.8	1.4	2.5	13.4	9.1	3.5	2.0	3.6	5.0	3.8	0.4	1.1	0.0	0.0	1.1	3.1	2.0	2.2	2.3	1.0	1.4	9.5	0.0	3.7	0.0	1.3	2.6	0.0	0.0	0.0	1.3	11.0	1.9	0.0	1.8	2.8	11.0	0.0	1.6	5.1	7.7	0.0	0.8	0.0	1.6	1.4
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144773114-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725"	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.0	5.7	12.3	4.1	11.5	4.6	8.6	28.5	14.4	10.0	9.4	12.6	7.8	3.6	10.0	8.0	6.3	10.4	6.6	7.5	13.4	7.8	6.4	6.5	7.5	5.8	17.2	13.8	17.0	7.8	12.5	11.5	7.6	12.2	8.7	6.0	8.3	5.6	12.7	5.9	8.0	5.4	10.7	11.8	6.0	5.9	7.1	16.0	4.1	11.1	1.8	4.7	8.7	7.8	7.2	10.4	12.7	15.2	5.5	8.5	5.0	3.0	5.3	8.9	6.6	7.6	7.4	2.4	2.9	6.2	7.3	6.1	1.2	5.1	5.0	5.5	7.3	4.2	3.1	5.1	5.8	5.5	4.9	4.3	9.6	8.2	4.0	6.9	2.5	5.0	7.9	6.8	5.8	11.9	7.5	4.9	3.2	6.4	4.1	6.3	7.8	5.5	3.9	6.4	7.1	5.6	5.0	3.6	6.0	4.1	3.1	8.4	6.3	6.7	4.7	4.5	5.9	5.3	3.2	3.5	6.7	5.9	5.6	5.6	5.1	1.7	5.7	4.9	4.1	8.0	8.1	7.0	12.7	7.4	6.4	6.5	6.8	6.9	8.5	10.4	7.2	4.9	7.4	1.0	5.5	15.2	4.9	5.4	5.0	12.3	11.5	28.5	14.4	13.4	7.8	17.2	13.8	12.2	16.0	6.0	3.2	0.9	1.5	3.3	7.1	2.0	0.0	1.4	4.5	0.0	0.0	2.2	5.0	2.7	6.0	4.9	1.3	0.0	1.2	2.1	3.3	1.5	4.7	2.4	1.6	12.7	0.0	3.7	1.9	5.5	6.6	3.1	3.3	12.6	1.9	5.4	1.2	1.9	4.6	1.4	8.7	6.5	4.7	9.3	6.3	4.3	1.9	4.1	2.3	0.7
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964343-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favorable (2.54e-4)"	10.5	6.5	10.1	5.9	14.4	25.6	16.3	19.9	10.2	8.8	8.3	9.2	7.1	6.4	9.8	10.3	8.0	7.5	6.3	8.4	13.4	6.5	9.0	6.3	7.5	10.1	14.8	10.9	10.6	6.9	9.0	14.2	10.4	10.0	32.1	10.7	6.3	8.3	8.0	10.3	9.5	12.9	7.9	14.9	11.4	8.5	8.1	14.0	13.6	12.5	6.7	10.1	11.6	7.6	10.1	8.4	29.8	9.0	13.0	12.0	4.9	0.7	4.4	5.6	6.5	7.6	6.7	1.1	4.7	6.2	4.6	9.4	0.0	3.3	1.9	3.6	5.1	8.8	5.5	5.0	6.5	6.4	0.0	10.0	7.9	6.7	3.9	6.4	2.0	10.1	10.3	9.7	6.1	7.0	9.3	5.4	3.3	2.1	0.1	5.7	2.6	7.9	9.3	3.5	0.4	6.5	3.8	8.3	6.3	7.4	11.4	4.6	6.2	0.0	5.7	4.5	8.1	9.5	7.3	5.5	5.0	3.7	3.0	4.5	1.6	2.5	2.6	1.0	0.1	5.4	29.8	7.1	15.6	10.6	7.8	10.8	10.1	10.2	10.2	8.4	10.0	12.0	9.5	19.4	13.0	9.0	5.5	8.1	4.9	10.1	14.4	19.9	10.2	13.4	6.5	14.8	10.9	10.0	14.0	0.0	5.3	6.7	9.8	5.3	9.2	6.2	2.5	8.1	11.4	8.7	11.8	9.9	6.6	5.8	8.8	6.8	5.1	0.0	4.6	8.5	6.6	15.3	11.5	2.4	7.3	6.4	7.0	6.2	9.7	1.5	10.3	11.4	11.8	9.0	6.3	7.0	4.9	5.3	5.6	4.1	12.1	0.0	8.9	7.9	5.3	6.0	19.3	17.5	4.5	11.1
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256545-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	21.6	14.0	18.1	12.0	17.2	8.9	21.7	24.5	30.5	18.6	17.3	13.8	9.6	11.0	23.7	23.8	14.2	20.1	20.7	28.0	15.4	13.8	16.8	8.8	18.7	26.3	12.8	15.6	23.3	19.9	16.4	19.1	17.9	12.3	20.4	8.8	27.4	22.8	21.7	26.1	23.5	11.6	28.1	13.1	22.6	14.0	8.5	10.3	17.9	17.4	14.1	15.3	20.1	15.4	6.0	8.3	6.0	4.6	4.2	4.7	2.5	3.3	5.4	23.7	9.4	6.3	4.4	15.6	4.7	5.5	5.8	6.2	5.6	11.4	1.7	10.3	5.9	1.8	11.3	5.5	2.6	2.4	10.0	5.0	8.5	3.3	6.8	5.6	4.0	6.9	9.4	6.6	2.5	2.2	5.9	7.9	11.3	0.9	2.9	4.4	8.1	13.0	6.7	14.1	2.0	5.1	21.3	5.6	0.7	4.6	5.4	8.4	25.4	13.3	4.2	20.9	10.6	4.1	10.4	11.4	3.5	4.8	8.3	3.1	8.9	8.2	1.8	2.8	3.6	10.4	3.8	4.6	6.0	4.7	4.1	3.4	3.0	3.5	4.1	3.3	6.0	3.1	2.9	3.5	4.2	4.5	8.3	2.6	2.5	18.1	17.2	24.5	30.5	15.4	13.8	12.8	15.6	12.3	10.3	8.9	11.3	1.9	4.0	9.0	12.3	19.4	7.6	1.4	9.1	10.4	0.0	9.4	1.7	5.5	0.9	10.5	3.1	0.0	6.5	5.7	9.7	2.2	9.3	6.6	8.7	7.9	1.7	19.6	14.5	5.4	12.7	6.1	8.5	1.0	4.0	7.7	3.7	8.5	20.1	9.9	4.5	6.5	11.3	0.9	2.5	8.3	3.0	4.9	6.9	1.3
ZNF383	FLJ35863	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	9.1	7.5	9.3	10.4	12.1	6.9	10.7	20.4	10.8	9.1	8.2	12.6	10.4	7.5	11.6	7.8	8.9	8.2	6.1	9.6	8.7	6.9	9.3	7.4	7.2	11.3	14.2	6.5	12.9	9.2	9.4	11.0	6.5	11.8	9.6	7.4	8.7	8.5	8.7	14.0	11.8	9.5	10.8	13.7	10.8	8.4	10.5	12.1	13.2	11.4	5.7	11.9	10.2	9.4	11.4	4.0	6.3	5.4	5.7	11.6	4.8	3.8	8.7	6.1	9.2	7.6	7.8	4.0	5.2	7.2	5.3	8.0	4.0	4.6	5.2	8.0	5.0	4.9	3.8	5.0	7.0	7.8	7.2	5.4	7.8	6.5	3.2	8.5	9.0	8.6	10.0	6.0	5.1	10.0	6.9	4.8	7.4	4.0	2.7	6.8	1.6	7.7	4.1	5.4	7.5	3.0	5.6	10.9	4.6	4.6	10.8	7.3	5.4	8.4	5.0	7.3	8.2	5.9	5.3	3.0	7.0	4.7	4.8	5.0	8.5	8.0	10.0	1.0	4.3	6.3	3.6	4.1	6.3	7.6	4.7	10.7	9.8	7.2	9.2	4.0	11.4	11.6	9.1	5.0	5.7	5.4	3.8	7.0	4.8	9.3	12.1	20.4	10.8	8.7	6.9	14.2	6.5	11.8	12.1	3.0	4.1	6.5	3.7	2.4	8.3	11.7	2.5	2.7	2.3	1.8	13.7	3.4	1.7	3.0	7.3	4.2	4.1	0.0	3.1	3.6	2.9	3.9	5.7	2.1	3.1	14.3	2.4	6.2	5.0	2.5	6.1	4.8	8.5	4.6	4.5	7.3	2.6	3.5	7.1	3.7	9.5	12.9	5.1	4.8	5.3	2.9	4.1	7.2	5.0	3.3
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 81.6"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 219.7;Cone photoreceptor cells: 161.0;Horizontal cells: 136.7;Rod photoreceptor cells: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 16.6;monocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 29.4;HBEC3-KT: 28.0;HEL: 35.2;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	23.7	4.3	23.6	16.3	27.3	16.8	7.9	13.2	32.5	7.9	5.7	12.8	2.3	4.8	3.2	10.7	28.1	6.2	8.9	4.3	18.4	22.6	2.3	3.8	11.6	8.9	31.8	15.4	2.0	2.0	13.8	8.5	12.6	19.4	10.3	5.4	35.5	8.9	10.1	5.9	81.6	5.7	8.7	16.4	13.9	4.4	2.1	16.1	5.5	18.1	21.9	21.9	25.8	14.9	0.8	16.6	1.6	16.8	0.0	0.2	6.6	0.8	3.4	5.3	6.6	6.1	4.1	14.6	0.6	2.6	2.8	2.4	7.0	2.6	1.9	2.4	1.4	2.2	29.4	2.0	28.0	0.9	1.8	2.8	35.2	2.3	1.3	2.7	0.5	24.7	3.6	31.6	3.1	7.9	6.8	1.7	4.9	16.9	0.1	1.2	15.6	1.7	5.0	3.0	3.3	2.7	6.2	0.4	6.9	2.1	23.0	2.3	10.6	0.2	19.9	1.4	6.4	23.5	14.7	1.7	1.5	3.5	1.7	1.7	0.5	0.1	1.6	6.3	1.6	3.8	1.6	15.3	0.0	0.0	16.8	0.0	0.6	0.0	0.0	16.6	0.8	0.0	0.2	1.2	0.0	11.9	1.6	0.0	6.6	23.6	27.3	13.2	32.5	18.4	22.6	31.8	15.4	19.4	16.1	0.0	0.0	5.0	20.2	32.2	219.7	3.1	2.5	2.7	2.3	8.7	161.0	56.0	8.3	3.5	0.4	2.9	0.0	0.0	0.5	5.3	14.9	11.9	1.1	1.0	53.9	136.7	4.6	2.5	63.8	0.0	13.8	52.2	8.5	19.0	0.0	74.9	2.2	0.0	8.5	2.1	153.5	0.0	4.7	2.2	2.5	57.7	91.1	1.3	0.0	27.3
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.8	7.8	5.3	11.1	8.2	5.6	10.5	6.7	8.9	7.8	7.6	8.2	8.7	9.4	9.7	6.9	11.0	7.6	7.1	8.5	7.7	6.8	9.4	9.2	9.3	9.0	6.6	13.1	16.1	7.4	7.4	7.6	8.1	5.8	8.9	8.4	13.2	18.7	7.1	14.7	13.5	21.5	11.8	9.8	9.4	7.7	5.8	16.3	8.4	11.2	6.3	13.1	7.8	19.0	12.6	13.5	4.9	16.3	9.3	9.5	9.5	13.6	8.3	15.4	16.1	15.2	6.7	13.3	9.9	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0	14.9	22.4	32.0	29.5	31.6	8.1	7.0	2.5	20.1	11.4	10.4	11.8	13.3	14.9	13.3	5.6	16.9	25.5	0.0	12.4	14.8	17.4	23.7	57.7	10.5	16.3	14.3	20.0	12.9	22.1	1.1	14.4	20.8	27.0	15.4	14.7	12.4	14.1	18.6	12.7	9.5	10.6	12.9	17.0	42.5	30.3	31.0	24.8	44.5	15.8	52.9
ZNF395	"DKFZp434K1210, HDBP2, PBF, PRF-1"	ENSG00000186918	"Zinc finger protein 395"	Q9H8N7	8	28345585-28402701	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049382, HPA076275"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049382: , HPA076275: "	"unprognostic (1.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (9.35e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.42e-2)"	17.4	10.7	10.0	13.3	10.9	18.6	19.0	7.4	10.1	16.8	22.5	9.7	13.4	12.1	12.0	11.9	27.2	16.9	14.1	15.0	10.4	5.4	13.1	19.5	11.3	18.0	9.0	6.8	33.8	27.8	9.8	9.5	19.6	7.6	22.1	8.3	13.7	21.7	11.1	13.8	23.2	16.3	13.8	8.8	11.9	14.2	12.3	10.8	9.6	18.2	10.2	25.3	27.5	27.6	13.7	6.4	10.6	4.2	3.3	7.2	2.1	49.8	7.1	6.9	18.8	5.2	7.6	19.7	6.1	10.8	4.9	11.8	11.3	8.8	23.8	21.2	9.5	11.5	10.8	6.1	15.0	9.7	3.9	4.8	5.9	1.5	2.3	5.4	2.4	2.5	13.3	20.7	0.9	12.9	14.2	2.6	8.1	6.1	5.3	6.8	8.5	11.2	7.7	10.7	12.2	8.4	11.0	7.4	7.9	11.5	9.9	18.9	19.6	1.5	3.8	9.8	6.2	7.5	5.9	0.7	10.5	12.8	5.6	2.5	6.5	3.3	15.6	27.7	4.9	9.2	6.7	4.2	10.6	4.8	0.8	4.6	10.0	5.6	5.6	1.6	13.7	7.2	4.9	1.8	3.3	0.6	6.4	2.1	2.1	10.0	10.9	7.4	10.1	10.4	5.4	9.0	6.8	7.6	10.8	29.8	20.7	18.5	16.7	14.9	9.0	9.3	2.5	13.4	18.2	8.7	13.7	12.7	3.3	15.9	0.6	11.7	16.0	0.0	20.7	16.9	18.0	13.9	10.5	26.8	5.1	6.4	26.2	22.1	13.8	0.6	23.0	4.7	10.1	0.0	22.3	17.3	27.8	0.0	17.0	6.7	9.7	25.8	10.3	0.5	2.1	10.0	5.3	8.3	29.2	8.1
ZNF398	"KIAA1339, P51, P71, ZER6"	ENSG00000197024	"Zinc finger protein 398"	Q8TD17	7	149126416-149182802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071533			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA071533: AB_2686412"	"unprognostic (4.11e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.97e-2)"	"unprognostic (9.27e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.89e-1)"	8.9	8.1	12.7	10.2	12.5	15.6	10.6	25.9	16.0	11.7	10.7	10.2	10.5	8.8	9.8	10.2	14.3	10.4	8.6	9.3	10.9	9.0	9.3	10.7	9.2	10.0	10.7	11.4	11.1	13.4	14.7	20.9	8.6	9.8	12.7	8.6	8.5	11.2	12.5	10.0	17.2	9.5	9.7	9.8	12.6	11.1	18.1	12.6	13.0	8.7	7.4	12.3	9.9	11.1	2.9	1.6	6.1	2.0	1.9	3.8	1.2	7.6	6.4	5.0	9.7	7.5	5.3	6.4	4.7	6.0	5.4	5.9	5.4	3.6	8.9	5.4	7.8	4.8	6.4	8.6	5.9	3.8	5.9	11.9	5.9	5.1	3.5	5.2	6.6	6.2	6.0	8.7	5.8	6.2	3.9	3.6	3.6	9.1	3.2	5.7	9.6	9.8	6.8	36.0	6.4	6.8	7.7	5.7	6.7	4.0	12.8	7.5	8.3	6.5	8.0	3.9	5.6	5.0	7.4	4.8	5.5	1.6	9.8	5.8	10.3	4.9	6.9	7.5	5.5	5.3	5.1	1.6	6.1	3.1	2.0	3.7	2.9	2.1	3.4	1.5	2.5	3.3	3.8	3.1	1.9	1.7	1.6	3.0	1.2	12.7	12.5	25.9	16.0	10.9	9.0	10.7	11.4	9.8	12.6	6.0	2.9	3.7	3.5	6.9	7.4	5.8	0.0	2.7	4.5	5.2	5.9	3.1	0.0	3.6	19.4	4.5	3.3	0.0	2.5	4.0	4.7	4.5	4.6	2.8	3.2	3.2	1.7	4.9	4.7	19.2	6.6	3.4	8.5	2.8	3.3	5.3	4.4	2.6	8.5	2.4	9.7	0.0	2.5	16.6	7.9	7.4	2.6	1.8	3.3	8.1
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	7.7	6.3	8.5	11.7	11.4	12.0	7.6	15.5	10.5	11.8	9.4	5.3	5.8	5.8	11.7	5.2	7.3	9.4	5.5	8.1	7.3	5.2	6.6	6.0	7.4	7.9	7.8	5.7	12.8	6.0	14.9	13.2	10.8	9.0	7.6	6.0	5.9	8.4	7.7	13.3	7.7	10.3	8.7	7.5	11.2	7.5	10.0	7.7	18.1	9.4	8.2	7.6	9.9	9.2	2.4	3.6	6.0	2.6	3.0	3.1	0.9	4.6	4.9	5.6	5.1	4.1	6.1	4.0	6.2	5.5	4.6	5.0	2.0	2.7	6.7	1.9	8.7	3.1	5.5	5.2	6.8	6.9	11.1	3.2	8.6	6.6	3.8	3.7	13.0	7.6	5.5	3.1	7.4	6.5	4.4	6.9	4.8	4.9	10.0	7.0	3.7	6.3	1.8	3.2	1.7	4.4	6.5	7.2	5.3	3.3	8.8	5.3	5.0	5.8	3.7	4.4	4.2	4.2	5.6	9.6	10.5	4.4	2.9	4.9	3.5	7.2	7.1	3.8	5.6	6.2	4.0	1.9	2.3	3.1	2.6	2.9	2.1	2.3	1.7	0.7	2.4	2.6	3.1	6.0	3.0	1.6	3.6	0.6	0.9	8.5	11.4	15.5	10.5	7.3	5.2	7.8	5.7	9.0	7.7	6.0	4.6	6.1	4.7	2.9	10.7	16.5	5.1	8.1	5.7	5.2	5.9	3.4	0.0	3.8	3.2	5.8	5.4	0.0	2.5	2.3	3.8	4.2	1.1	5.1	2.7	4.8	4.1	2.5	5.6	2.2	4.9	4.4	5.0	2.8	4.9	8.1	3.4	3.7	4.2	1.9	13.7	6.5	3.3	9.6	12.2	3.6	4.3	5.1	3.3	3.8
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	16.6	16.2	14.3	13.6	22.7	20.8	10.6	17.6	28.6	13.2	10.9	22.4	5.6	21.4	16.6	10.0	11.6	11.6	9.7	9.9	14.1	11.4	12.0	13.1	10.7	15.8	15.5	14.8	16.7	13.7	9.2	15.3	14.0	17.3	15.8	4.6	13.4	20.5	14.1	23.6	25.5	16.6	7.7	12.5	22.8	19.1	13.6	20.3	19.9	15.7	6.1	13.5	11.8	12.3	3.0	3.4	5.4	2.1	2.5	2.7	1.2	5.4	4.7	2.6	4.2	0.7	1.7	5.8	4.1	1.6	2.7	2.5	4.2	2.7	7.6	12.2	1.3	2.0	7.7	0.8	3.4	0.4	6.8	19.1	4.8	4.4	4.9	3.8	4.1	6.5	3.1	2.5	2.2	0.9	1.5	1.1	4.8	6.3	11.2	1.7	6.8	9.3	24.2	7.7	1.4	13.5	10.9	1.3	7.6	1.9	4.5	9.0	14.0	4.6	3.5	3.7	0.5	6.7	4.8	4.3	8.1	4.1	11.7	5.4	16.4	6.8	5.9	6.5	3.5	4.3	3.0	1.6	0.8	1.8	1.4	1.0	2.5	2.7	2.7	1.6	3.0	2.6	2.6	5.4	2.5	2.1	3.4	1.4	1.2	14.3	22.7	17.6	28.6	14.1	11.4	15.5	14.8	17.3	20.3	0.0	0.6	4.9	12.9	10.5	17.5	1.7	7.6	0.0	0.0	3.5	9.8	23.8	13.3	3.0	21.5	6.7	11.9	0.0	4.7	18.3	12.7	8.8	4.6	9.7	11.4	11.1	21.4	11.1	9.1	59.9	19.0	9.6	8.5	5.4	12.8	17.9	3.8	11.5	15.2	13.5	18.9	12.9	7.8	24.4	30.2	10.7	26.3	10.5	11.7	8.1
ZNF419	"ZAPHIR, ZNF419A"	ENSG00000105136	"Zinc finger protein 419"	Q96HQ0	19	57487711-57496097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 24.5"									"HPA003152, HPA003274"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716, HPA003274: AB_1080714"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.55e-5)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.53e-5)"	7.1	10.3	11.0	8.9	12.4	4.4	11.9	20.4	14.3	8.6	7.1	8.4	8.7	6.4	7.6	17.0	5.7	11.0	6.5	8.0	10.9	9.4	9.4	8.4	10.0	11.2	11.4	11.7	13.4	6.0	17.4	17.3	10.2	12.4	10.6	6.4	7.0	9.1	11.6	17.4	12.0	7.1	7.1	10.2	12.7	7.4	7.2	12.1	8.4	14.1	4.8	14.2	6.6	5.6	12.4	4.1	5.4	3.2	8.7	13.3	4.5	3.7	3.8	7.5	7.8	3.6	5.6	6.4	4.6	6.5	4.3	24.5	2.7	2.3	1.3	3.6	3.3	3.8	1.1	3.3	9.3	6.2	0.3	16.8	5.8	5.9	2.9	12.6	4.6	4.4	7.8	14.2	4.2	10.6	8.9	4.7	5.9	0.6	0.9	5.6	0.6	7.3	4.8	5.1	0.4	5.5	6.9	7.4	5.1	4.6	8.1	6.1	7.1	4.4	4.3	4.4	7.0	3.8	6.9	4.7	5.1	5.6	1.8	4.1	10.8	12.2	3.3	4.0	2.5	4.2	3.8	2.5	5.4	5.3	3.2	8.5	12.4	8.5	6.6	4.1	12.1	13.3	7.7	3.2	8.7	2.4	3.0	5.4	4.5	11.0	12.4	20.4	14.3	10.9	9.4	11.4	11.7	12.4	12.1	0.0	7.7	11.5	4.7	3.7	8.2	3.9	2.5	0.0	3.4	7.0	5.9	4.3	0.0	5.2	0.2	3.6	1.3	0.0	1.6	2.1	2.3	6.3	4.6	4.2	2.8	9.5	1.2	7.4	3.1	0.4	1.7	1.8	5.0	5.4	2.3	5.8	1.9	0.9	5.3	1.7	9.5	6.5	2.4	1.4	7.9	3.3	7.0	7.5	1.2	4.3
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369442	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.2;HSkMC: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	14.5	18.6	10.1	4.7	13.0	2.9	12.9	13.6	15.8	10.7	8.7	11.8	8.6	6.3	15.1	17.5	18.4	10.2	11.2	11.7	9.9	6.1	6.7	4.3	7.8	5.6	12.9	9.6	20.3	8.1	11.6	6.5	8.5	11.3	12.1	6.9	6.3	16.9	13.4	7.2	15.6	6.1	12.7	12.6	8.0	6.8	10.4	10.0	5.7	12.3	9.7	8.0	12.5	11.2	1.6	2.8	1.6	2.1	6.6	2.3	1.6	2.8	1.8	6.5	3.4	7.3	15.2	3.1	2.5	3.5	3.3	3.9	1.0	2.4	1.9	2.9	3.6	2.1	3.5	11.6	4.3	3.6	2.3	2.5	2.0	3.7	1.6	2.9	0.8	1.4	27.7	6.3	2.8	3.3	6.0	4.7	2.3	2.4	1.4	3.5	1.3	2.1	1.6	0.2	1.3	2.8	2.8	2.7	1.8	2.7	7.2	3.0	3.7	7.1	3.6	2.8	2.3	2.0	1.0	3.7	2.8	2.1	2.2	1.4	2.1	2.6	1.6	2.2	1.7	2.2	0.0	1.8	1.6	2.0	2.1	2.0	1.3	1.4	2.1	2.8	1.6	2.3	2.0	1.3	6.6	2.0	0.4	2.2	1.6	10.1	13.0	13.6	15.8	9.9	6.1	12.9	9.6	11.3	10.0	0.0	0.3	0.8	1.0	4.6	3.6	4.8	2.5	2.7	0.0	5.2	5.9	2.9	0.0	2.7	0.9	8.7	2.7	0.0	4.3	1.5	4.6	3.4	0.0	3.0	1.8	9.5	3.5	1.8	2.6	1.1	9.2	0.7	5.0	6.4	3.9	11.8	3.9	5.8	11.0	2.1	2.1	0.0	2.0	4.7	6.0	8.4	2.4	1.0	2.9	1.1
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.5;HUVEC TERT2: 14.6;U-937: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	21.8	5.8	9.8	10.0	10.2	7.9	9.7	11.8	9.9	10.6	12.9	13.0	2.6	6.2	22.6	11.3	8.3	10.2	9.2	13.8	9.3	6.2	6.2	8.6	12.0	7.1	10.1	6.6	10.2	4.5	6.6	17.3	6.4	9.6	9.0	6.9	7.7	9.5	9.6	29.1	8.9	7.6	14.3	8.6	13.6	8.3	10.1	11.9	7.7	15.8	8.7	5.2	10.5	12.1	3.1	3.1	14.1	7.8	3.8	3.9	3.5	2.8	2.8	2.4	2.1	14.5	10.1	1.4	2.2	3.2	3.5	4.4	0.1	3.4	3.8	2.6	3.9	3.3	0.7	1.2	1.7	5.0	8.7	0.9	1.6	1.6	0.1	8.1	1.3	1.8	4.8	2.9	5.0	2.9	3.2	14.6	4.5	3.2	2.7	4.8	2.0	4.3	7.3	0.2	2.0	1.2	1.9	3.5	2.2	5.0	0.7	1.8	2.0	1.1	0.4	1.5	1.7	1.1	12.3	6.1	1.6	2.7	4.7	2.7	0.6	1.0	0.0	3.2	19.2	1.1	1.4	7.8	3.3	2.3	7.4	1.7	1.2	1.8	3.0	2.4	3.1	3.6	2.0	14.1	3.8	4.4	3.1	3.9	3.5	9.8	10.2	11.8	9.9	9.3	6.2	10.1	6.6	9.6	11.9	3.0	3.7	0.5	1.9	0.9	5.4	10.1	2.5	5.3	5.7	3.5	5.9	2.7	6.6	3.0	9.5	3.7	2.0	0.0	3.8	4.0	3.1	1.0	11.6	1.0	7.0	3.2	0.0	6.2	11.7	5.7	3.7	9.1	0.0	3.6	2.5	1.8	3.2	0.0	7.8	2.7	5.0	6.5	5.1	6.4	6.4	2.0	1.4	1.8	2.3	2.0
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429707-12441112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.9"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	5.5	3.4	5.5	9.5	6.9	1.0	8.5	13.6	5.9	7.6	7.2	2.0	21.4	4.0	6.6	6.3	4.9	5.2	4.2	3.3	4.3	4.5	10.6	5.8	4.7	3.2	4.2	3.0	4.9	5.9	9.3	4.1	6.3	5.0	7.0	6.7	1.9	5.7	12.9	1.9	7.3	8.9	3.6	5.9	3.6	4.7	3.4	4.1	16.9	4.8	3.7	4.3	7.9	9.6	4.0	2.2	4.8	1.2	3.1	7.1	2.0	3.3	1.4	6.0	5.3	1.8	1.5	8.2	2.5	1.8	3.3	3.1	3.2	0.9	3.9	4.4	1.9	1.3	2.0	3.8	2.4	2.8	0.0	2.1	1.6	1.9	7.4	0.4	3.7	4.6	1.4	1.5	1.6	0.7	2.2	1.9	5.0	2.7	0.0	3.6	4.0	13.9	5.1	5.1	3.3	5.2	1.6	6.2	4.7	4.0	12.4	2.8	4.7	4.0	2.2	0.6	3.4	0.1	4.7	1.2	6.6	2.7	3.7	2.3	2.5	3.6	2.5	0.9	3.8	1.4	4.8	1.2	1.6	2.1	0.6	7.1	4.0	4.5	4.3	2.2	3.2	4.0	2.7	0.7	3.1	0.3	1.1	3.3	2.0	5.5	6.9	13.6	5.9	4.3	4.5	4.2	3.0	5.0	4.1	0.0	0.3	2.2	1.2	0.9	1.5	1.6	2.5	2.7	1.2	0.0	3.9	6.5	1.7	2.6	4.1	1.6	1.5	0.0	1.0	0.9	1.1	0.5	0.0	1.6	1.1	1.6	2.9	1.3	1.9	1.3	0.6	0.7	0.0	0.0	2.3	2.5	1.0	1.7	2.1	1.7	2.2	0.0	1.4	1.2	4.9	2.3	1.4	3.2	2.6	0.6
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.7	9.1	8.4	7.3	3.6	3.7	5.5	6.1	4.0	5.2	5.7	10.0	5.4	8.4	5.4	3.5	2.6	4.4	5.2	4.1	2.2	7.3	51.5	8.2	6.1	18.0	5.9	3.6	7.7	4.3	3.8	4.2	3.3	7.9	4.6	10.5	10.6	3.7	3.6	6.2	11.8	10.3	9.1	9.5	16.7	13.8	5.4	4.4	5.7	4.4	9.0	12.4	3.1	10.3	4.5	4.8	10.2	6.7	6.0	9.4	8.1	2.0	6.6	9.1	7.7	6.3	5.9	5.0	6.1	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4	3.0	14.9	10.2	14.2	2.7	16.7	11.4	33.1	13.4	9.1	10.4	7.9	16.2	8.3	23.1	26.9	15.8	12.8	0.0	19.3	7.9	9.2	13.8	10.3	34.7	9.4	19.1	28.2	19.6	5.3	28.6	11.2	3.9	15.1	19.8	24.4	16.6	21.0	10.5	11.3	18.8	13.6	25.8	13.2	10.4	19.8	4.5	10.4	13.1	19.3	8.9
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363152	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	13.7	15.8	5.3	6.7	10.4	1.9	11.6	7.5	10.8	10.1	7.2	6.0	4.8	5.0	14.0	10.9	7.5	6.0	8.6	8.3	5.0	6.1	6.1	5.0	7.3	5.8	6.3	9.6	9.7	16.1	12.5	9.8	11.0	12.2	9.6	5.5	6.6	8.6	7.5	7.6	5.8	5.3	12.4	5.0	9.5	7.6	4.8	4.7	5.3	10.6	4.6	6.4	12.1	8.9	1.5	2.6	3.6	6.6	5.6	5.7	2.2	2.9	4.3	8.7	7.1	7.9	15.9	4.3	5.7	4.4	3.7	9.0	1.4	4.0	1.8	7.4	4.5	5.0	3.4	6.1	2.5	5.9	2.5	5.1	2.4	4.1	2.1	6.0	1.9	3.7	6.1	7.7	3.1	9.2	5.2	6.9	4.7	2.3	2.1	10.4	1.7	2.4	2.2	3.0	2.9	4.7	2.0	5.9	2.7	5.5	1.7	2.1	5.2	1.4	4.2	4.3	5.8	3.1	2.1	6.8	8.5	3.1	5.7	5.0	1.6	2.0	1.4	3.3	3.3	5.5	1.7	2.7	3.6	3.0	3.4	5.7	1.5	2.7	4.1	2.6	1.1	2.6	2.6	0.6	5.6	6.6	1.5	2.4	2.2	5.3	10.4	7.5	10.8	5.0	6.1	6.3	9.6	12.2	4.7	0.0	2.1	0.5	0.8	0.8	6.6	8.1	0.0	2.7	1.2	1.8	0.0	1.9	0.0	1.4	0.2	3.6	0.4	0.0	0.6	1.7	2.5	1.0	1.1	0.5	3.3	9.5	2.9	8.0	2.2	0.0	4.9	2.2	3.3	5.4	1.1	4.4	1.2	0.8	3.9	0.3	2.9	0.0	1.3	1.0	2.2	1.9	1.0	1.8	0.6	0.3
ZNF468		ENSG00000204604	"Zinc finger protein 468"	"A2RRD8, Q5VIY5"	19	52838008-52890375	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 46.9"									"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: AB_2732685"	"prognostic unfavorable (6.87e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (3.94e-7)"	"unprognostic (1.04e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.59e-2)"	6.6	7.6	6.6	3.5	5.1	5.2	6.9	8.4	5.1	6.2	6.2	4.3	11.0	3.2	4.7	6.4	6.3	6.3	8.0	4.6	4.2	2.9	8.2	3.4	4.9	9.8	4.2	2.8	4.8	10.0	8.8	5.5	65.5	5.2	7.9	7.2	3.1	7.0	5.8	3.7	4.6	10.8	6.2	3.9	5.1	7.1	3.4	3.3	12.0	10.4	1.9	5.5	8.0	5.4	8.8	7.0	11.5	10.3	19.1	12.5	8.6	6.2	0.8	5.7	10.0	6.1	4.5	16.7	5.0	6.3	6.5	9.7	6.2	3.9	9.6	5.1	5.3	7.7	3.3	3.9	5.1	8.6	0.0	5.8	7.3	6.4	2.6	12.4	0.4	9.4	7.2	6.1	8.0	6.6	3.6	5.4	5.3	7.2	0.4	5.7	1.4	9.1	5.9	7.0	4.5	6.1	5.5	8.2	6.4	8.8	46.9	5.9	8.7	6.3	5.7	1.5	12.6	7.5	5.7	4.4	2.2	5.7	3.0	7.3	3.9	13.9	8.6	0.5	0.8	8.0	8.3	6.1	11.5	12.3	10.3	12.5	8.1	8.0	9.8	7.0	8.8	10.0	9.2	6.3	19.1	8.0	5.3	9.3	8.6	6.6	5.1	8.4	5.1	4.2	2.9	4.2	2.8	5.2	3.3	3.0	3.7	4.5	4.7	3.0	1.0	3.3	7.6	0.0	5.7	8.7	0.0	6.4	14.9	6.1	2.4	3.1	5.3	0.0	8.3	10.7	2.5	8.9	17.3	2.6	5.4	0.0	8.2	3.1	10.0	0.4	0.9	3.5	1.7	3.6	12.2	0.8	7.5	7.0	2.5	5.4	0.2	0.0	2.7	0.5	4.0	4.6	20.1	6.9	6.9	9.7
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567511-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 11.1;Spermatogonia: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.3"					"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	4.6	6.5	11.7	2.9	10.6	1.4	5.3	12.7	12.1	6.3	4.8	5.5	1.3	2.8	5.7	8.8	4.3	5.8	5.1	5.4	12.4	11.7	6.7	8.6	5.1	3.6	11.8	9.4	7.2	4.5	9.3	7.2	4.6	9.8	7.0	3.4	5.8	3.8	6.9	3.0	5.1	3.1	5.4	11.6	4.4	3.6	8.3	9.9	3.6	6.8	1.2	4.6	4.6	5.2	3.2	2.0	2.9	1.0	2.3	4.4	0.9	0.0	1.7	6.5	2.8	3.6	3.3	5.5	3.1	1.2	2.3	4.5	0.4	1.5	0.0	2.0	3.3	4.1	0.1	2.7	1.4	2.6	0.0	13.3	5.7	0.1	0.4	3.1	1.2	6.7	3.9	2.0	2.6	0.8	2.6	1.5	0.3	0.1	0.1	3.5	0.1	1.2	2.0	5.5	0.0	0.7	0.2	4.7	0.9	2.7	4.0	2.5	6.3	0.1	0.5	0.9	4.5	2.1	3.5	1.1	0.2	2.7	2.2	4.2	2.1	2.8	0.2	0.0	3.5	1.0	1.3	0.8	2.9	2.2	0.6	4.4	2.5	1.9	1.3	1.4	3.2	3.0	3.0	2.2	2.3	1.0	2.0	1.5	0.9	11.7	10.6	12.7	12.1	12.4	11.7	11.8	9.4	9.8	9.9	3.0	2.2	0.0	1.4	0.9	8.5	6.3	5.1	1.4	2.3	0.0	9.8	0.9	1.7	2.1	1.0	1.6	0.9	0.0	0.6	0.8	1.8	1.4	6.9	1.7	1.1	11.1	0.0	0.6	0.6	1.0	2.0	2.6	1.7	1.8	0.7	4.0	1.0	0.8	2.8	2.2	6.2	6.5	1.9	3.9	10.6	0.5	0.2	0.0	1.8	0.8
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297177-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042218	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	9.8	8.4	8.2	7.9	15.4	7.0	7.1	13.6	12.5	6.5	8.3	4.8	3.4	7.9	6.2	2.4	8.5	4.5	4.7	17.9	8.7	3.2	10.9	7.5	8.4	9.8	13.1	4.1	6.0	3.8	5.6	10.7	6.2	12.5	5.9	8.6	4.9	8.4	5.5	12.9	8.0	9.3	5.1	8.7	15.0	8.0	3.3	12.6	10.8	8.4	7.9	12.3	8.7	8.2	16.6	17.0	9.4	9.1	14.6	15.0	5.9	3.2	13.4	8.8	10.2	10.4	9.8	7.0	8.6	12.7	6.2	7.3	6.0	4.8	16.7	5.4	7.1	11.4	7.2	9.4	8.7	9.0	0.1	15.8	17.0	6.7	5.7	10.0	24.0	13.9	8.9	11.2	8.5	10.1	13.0	8.9	14.6	12.2	6.0	13.8	5.4	21.9	4.9	6.8	10.9	11.0	11.3	9.3	13.8	8.9	23.9	8.6	7.2	12.5	9.1	3.5	18.9	7.5	17.7	15.2	6.2	7.8	3.5	13.3	13.7	25.3	34.6	2.7	13.2	10.9	7.7	8.5	9.4	12.0	8.2	13.7	16.6	12.0	13.9	10.4	16.5	11.5	15.0	3.6	14.6	9.1	17.0	13.4	5.9	8.2	15.4	13.6	12.5	8.7	3.2	13.1	4.1	12.5	12.6	32.8	10.2	16.1	11.4	4.8	4.0	37.0	10.2	20.1	14.8	3.5	2.0	7.5	14.9	15.0	1.5	18.5	10.3	23.3	24.0	12.9	7.1	10.7	11.6	13.5	15.1	6.4	12.1	14.7	14.0	2.1	8.3	16.7	6.8	19.8	17.3	4.1	29.6	8.6	7.8	20.7	6.6	0.0	9.2	1.8	5.6	7.3	12.4	23.5	16.1	18.3
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 30.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	6.8	1.2	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.7	6.4	0.1	0.4	0.0	2.7	23.7	0.6	2.6	0.3	34.3	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.2	0.2	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.1	1.8	5.1	0.6	0.0	3.0	0.0	0.1	19.1	5.7	1.0	1.6	0.2	0.0	2.7	0.5	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	5.6	5.0	0.3	0.0	0.0	1.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	30.2	0.0	0.8	0.3
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Ciliated cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5"									HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047872: AB_2680196"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.8	2.3	3.3	2.8	5.5	2.3	5.0	7.5	6.2	3.3	1.7	3.1	3.0	2.0	4.1	3.7	3.6	9.1	3.1	2.0	7.2	3.3	3.7	5.0	3.2	3.8	2.0	4.5	4.5	6.0	3.8	5.9	1.8	5.8	3.2	1.2	1.4	7.7	1.9	0.8	4.6	3.1	0.6	3.5	3.6	2.8	2.3	0.6	2.5	4.9	2.0	1.5	1.4	2.1	4.7	4.8	2.3	2.8	2.1	4.8	1.9	1.7	5.9	5.3	5.1	0.2	0.1	7.1	3.2	0.0	0.0	0.0	0.4	1.9	3.4	1.7	0.0	3.0	0.8	0.6	0.4	0.0	3.6	17.5	3.1	1.6	1.0	0.3	1.2	8.2	0.4	0.8	0.1	0.6	5.9	0.0	8.6	2.5	0.5	0.1	6.0	4.3	4.4	3.3	1.4	1.8	10.7	3.9	1.8	0.5	1.4	4.1	5.9	1.7	5.2	2.9	2.8	7.1	3.5	0.5	5.9	3.1	0.5	1.0	7.7	9.1	3.0	1.6	3.5	3.2	2.3	2.8	0.9	2.4	1.1	2.6	3.8	2.8	2.9	2.7	4.7	2.9	4.8	1.0	2.1	0.9	4.8	3.1	1.9	3.3	5.5	7.5	4.2	7.2	3.3	2.0	4.5	5.8	0.6	6.0	0.3	0.0	0.4	0.2	1.4	0.6	0.0	5.3	1.2	0.0	0.0	1.7	1.7	1.1	1.0	0.3	0.4	0.0	0.2	0.4	0.2	0.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	1.1	0.4	0.3	0.0	0.7	1.5	0.0	0.0	0.0	1.1	0.3	0.2	0.0	1.2	0.0
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: AB_2683565"	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	8.1	6.4	10.2	9.4	7.5	5.9	8.1	13.8	11.4	10.3	8.0	11.7	11.5	8.4	12.2	10.9	6.2	8.9	10.4	6.0	6.2	5.1	6.0	5.2	7.2	12.5	6.6	9.4	13.9	8.5	9.1	8.0	6.7	6.6	9.3	5.3	10.6	11.3	14.9	7.5	8.5	7.5	7.5	5.4	11.4	7.7	7.2	8.4	9.9	9.2	7.1	8.3	9.2	8.4	5.3	6.5	3.4	2.5	3.0	4.9	2.1	2.0	8.4	2.8	7.3	3.3	3.0	12.8	6.1	6.8	7.6	5.2	3.7	4.0	4.4	5.3	3.3	2.8	4.7	5.8	3.2	5.6	3.2	8.8	3.6	10.6	5.0	4.7	2.5	4.0	3.5	7.8	3.4	6.5	7.5	4.3	5.6	5.3	7.0	3.0	4.6	5.2	4.4	3.6	1.6	3.0	9.3	6.7	8.7	2.5	2.4	10.4	6.8	5.2	7.9	2.3	2.0	5.1	4.1	4.8	7.2	5.5	8.0	2.9	6.7	4.5	3.9	2.2	2.1	4.5	2.3	2.5	3.4	3.9	2.4	3.3	4.9	2.5	3.0	1.4	5.3	4.2	4.9	2.9	3.0	1.7	6.5	3.9	2.1	10.2	7.5	13.8	11.4	6.2	5.1	6.6	9.4	6.6	8.4	11.9	2.4	8.9	2.6	2.2	16.8	4.8	2.5	5.3	2.3	7.0	23.6	4.9	1.7	3.8	6.8	4.9	4.9	0.0	2.7	3.8	3.6	4.3	6.9	4.0	2.7	17.5	8.1	9.2	3.3	1.3	10.6	3.1	1.7	9.0	4.9	12.1	2.9	0.0	10.6	2.2	20.5	0.0	4.1	12.6	8.3	1.9	3.8	5.7	5.2	1.6
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96755865-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	9.1	9.2	10.9	6.5	15.7	5.7	12.7	23.0	13.9	14.4	8.8	6.3	11.6	4.6	11.5	8.1	7.9	10.7	6.5	7.4	11.5	10.3	8.9	8.5	8.4	11.4	8.6	12.3	14.9	10.7	13.5	19.8	6.9	10.1	12.6	9.3	5.2	7.5	11.2	9.2	6.2	6.8	11.3	9.2	10.1	6.8	8.2	9.1	14.9	11.2	4.3	13.3	13.9	10.7	5.9	1.3	3.8	2.9	6.4	7.7	2.1	5.1	5.2	11.5	8.5	9.8	9.2	5.9	5.8	11.4	9.7	8.6	4.9	3.8	6.7	3.1	6.1	9.5	11.2	3.3	5.4	8.7	10.7	5.5	9.4	9.7	2.5	5.8	3.6	6.2	7.9	7.2	8.3	10.4	9.1	9.3	12.9	9.6	6.5	9.4	4.6	10.4	4.8	8.1	7.5	5.3	6.8	18.8	3.3	5.1	4.9	11.9	9.5	11.2	5.2	5.7	8.4	3.8	6.8	8.2	6.2	5.9	7.0	6.7	11.4	12.0	4.9	3.5	2.5	6.2	2.3	1.2	3.8	3.8	1.9	7.7	3.6	5.0	3.0	1.0	5.9	5.7	5.2	0.4	6.4	2.9	1.3	7.1	2.1	10.9	15.7	23.0	13.9	11.5	10.3	8.6	12.3	10.1	9.1	3.0	2.7	2.0	1.4	1.4	10.5	4.4	0.0	4.0	3.4	3.5	2.0	2.0	1.7	1.9	5.0	2.7	1.0	0.0	2.3	1.2	1.7	1.4	1.1	1.0	1.7	15.9	1.2	5.5	3.4	5.6	5.5	2.2	5.0	1.0	1.8	3.8	1.3	1.7	3.9	1.5	7.0	6.5	1.4	3.2	4.9	1.3	0.7	3.2	1.4	1.0
ZNF514	FLJ14457	ENSG00000144026	"Zinc finger protein 514"	Q96K75	2	95147330-95165413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028974	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028974: AB_10603845"	"unprognostic (8.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-2)"	7.1	7.6	7.8	5.1	16.4	1.7	12.7	14.9	12.9	10.4	10.5	15.7	12.0	9.4	15.0	27.1	8.1	11.5	6.7	8.4	14.2	8.4	9.8	5.0	8.4	7.0	17.0	9.9	20.6	9.6	12.5	23.5	7.9	11.5	12.1	9.6	10.1	11.5	11.6	12.0	11.6	9.4	10.6	12.5	8.9	10.0	19.8	18.0	14.0	15.2	10.3	7.8	8.9	10.9	7.7	5.2	10.4	5.3	6.4	11.3	5.5	13.4	4.7	12.5	8.4	9.4	12.6	9.7	5.3	5.7	8.6	9.2	7.0	5.0	2.1	2.7	5.7	14.3	8.2	6.6	4.9	9.8	4.4	8.8	2.5	6.3	5.7	4.0	1.4	6.8	7.7	15.1	5.4	3.8	13.5	4.2	7.6	6.9	2.4	6.7	6.4	3.6	6.8	4.2	4.4	4.7	6.5	4.4	4.7	5.8	5.7	11.7	8.5	5.6	2.7	5.7	19.1	5.2	5.0	4.4	6.2	8.5	2.0	4.3	7.1	5.2	3.5	6.8	2.8	4.1	10.4	5.3	9.9	5.1	2.6	6.1	7.3	6.8	4.8	5.2	7.7	11.3	9.2	1.5	6.4	3.0	4.1	7.1	5.5	7.8	16.4	14.9	12.9	14.2	8.4	17.0	9.9	11.5	18.0	8.9	6.4	7.8	7.3	4.9	14.3	11.4	17.8	8.1	4.5	0.0	17.7	5.3	23.2	5.3	34.4	8.3	5.3	0.0	4.5	3.0	5.6	9.3	1.1	6.4	6.8	14.3	9.2	7.4	3.5	34.3	9.8	3.8	6.8	3.6	10.1	11.8	4.6	3.5	7.1	15.0	34.1	6.5	4.1	12.2	10.6	5.5	3.1	6.9	6.8	9.5
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76358190-76495190	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	4.2	5.4	8.3	5.7	9.9	15.1	4.7	2.0	4.8	20.8	5.9	4.5	18.6	4.1	25.2	8.0	6.3	15.8	3.9	3.5	5.1	2.9	3.4	5.1	5.0	4.2	4.7	3.9	17.0	4.6	8.7	10.8	2.6	6.4	7.3	1.8	13.1	6.4	13.3	8.6	6.3	4.1	9.1	3.3	6.3	4.5	18.6	4.6	3.0	4.8	4.0	4.9	8.0	10.9	0.4	1.6	12.2	2.2	1.0	0.6	0.4	1.5	1.7	12.4	16.3	3.7	5.5	1.5	9.4	7.9	2.0	3.8	3.5	5.7	8.1	2.0	10.0	5.1	3.3	6.8	9.0	1.4	0.0	5.3	0.7	0.0	7.6	9.1	5.3	5.4	10.4	4.1	4.3	4.5	2.8	2.3	3.4	0.0	0.0	2.0	3.2	0.1	9.5	6.2	1.0	0.4	3.5	1.3	4.1	3.2	7.0	12.5	7.7	0.1	0.0	10.1	5.2	2.0	21.7	1.5	4.7	8.2	0.1	0.9	0.0	0.2	6.2	2.8	3.7	12.0	2.7	2.2	3.0	0.1	1.5	0.6	0.1	0.2	0.1	1.6	0.4	0.6	0.3	12.2	1.0	1.6	1.0	0.0	0.4	8.3	9.9	2.0	4.8	5.1	2.9	4.7	3.9	6.4	4.6	8.9	8.5	3.9	14.0	17.3	14.8	7.6	7.6	9.4	2.3	1.8	29.5	0.2	3.3	4.9	69.3	9.0	5.2	0.0	2.5	0.3	10.2	10.7	1.1	11.3	7.1	3.2	12.1	8.0	20.3	27.6	28.1	14.9	11.8	8.2	5.4	6.5	4.5	5.3	32.9	4.4	29.5	12.9	17.3	3.4	33.4	17.7	0.5	2.9	3.5	17.5
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	12.3	7.0	14.3	8.0	17.1	0.6	11.4	44.6	22.5	17.5	12.3	23.7	11.6	3.7	35.5	11.2	12.3	15.0	13.1	18.6	14.7	11.9	7.2	2.3	10.4	7.8	14.2	13.4	29.6	4.2	14.5	18.2	13.7	15.0	27.1	7.2	14.5	7.8	19.6	29.5	8.8	6.1	22.5	18.9	8.5	7.1	12.5	17.2	2.5	13.6	7.0	8.9	13.0	19.8	6.7	1.4	0.0	2.2	0.4	1.0	0.7	6.9	9.8	40.7	21.4	6.7	15.0	2.0	12.9	12.0	8.8	8.0	3.4	7.6	8.5	9.9	15.7	4.6	11.5	0.3	9.4	8.8	6.3	8.5	0.0	14.7	0.2	8.9	0.0	0.0	11.6	18.4	9.2	16.9	12.2	9.9	0.0	0.1	10.7	10.4	0.0	0.0	0.1	21.5	0.3	6.3	0.2	10.5	1.4	6.1	0.9	9.2	24.5	8.4	0.9	14.2	29.0	10.3	5.7	7.3	24.0	17.9	0.1	10.1	0.1	7.1	2.3	8.6	0.0	18.4	0.0	0.4	0.0	1.0	2.2	0.3	6.7	0.5	0.5	1.4	3.6	0.1	0.3	0.0	0.4	0.3	0.2	0.0	0.7	14.3	17.1	44.6	21.4	14.7	11.9	14.2	13.4	15.0	17.2	11.9	9.8	8.2	10.0	9.4	31.7	13.7	10.2	9.4	10.3	1.8	25.5	1.7	0.0	4.5	3.4	21.0	0.0	0.0	0.4	1.7	15.8	38.3	0.0	0.0	3.8	33.4	4.1	17.8	8.8	2.8	10.6	10.9	8.5	3.6	0.0	23.3	3.8	0.3	17.0	1.4	8.5	12.9	15.6	2.3	21.3	8.2	2.9	2.5	0.3	10.3
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.2;Horizontal cells: 66.7;Muller glia cells: 58.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HAP1: 8.9;SH-SY5Y: 24.4;U-937: 5.9;WM-115: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	1.1	6.0	9.9	2.0	21.0	0.6	0.8	14.3	24.1	4.2	4.0	44.5	0.0	2.7	1.7	1.3	6.9	1.0	1.3	2.9	13.3	7.7	0.8	0.7	1.0	0.7	20.9	9.6	0.9	0.9	0.7	3.4	0.7	18.3	3.7	4.1	4.8	1.6	2.4	1.4	1.2	4.2	1.2	23.1	1.5	2.1	5.0	18.4	0.0	6.9	0.0	0.7	2.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	8.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	24.4	0.0	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	5.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	21.0	14.3	15.1	13.3	7.7	20.9	9.6	18.3	18.4	0.0	0.0	0.0	0.1	0.3	29.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.5	66.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	9.5	0.0	1.9	0.3	0.4	0.3	0.0	0.0	0.0	0.1
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 18.8;Late spermatids: 8.5;Proximal tubular cells: 10.3;Spermatocytes: 28.8;Spermatogonia: 9.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"					"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"HEL: 3.1;SiHa: 10.2;U-87 MG: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.2	2.6	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.4			0.1	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.9	0.0	0.1	0.1	0.0		2.2	0.0	0.0	0.4	0.3		0.0	0.0		0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.5	0.0	17.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	1.0	0.3	0.0	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	1.1	1.5	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	18.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	8.5	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.3	0.8	0.0	0.0	28.8	9.8	0.1	0.0	0.0	0.0	0.0
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 25.9;Spermatocytes: 50.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030838			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	4.1	5.1	5.0	3.7	7.1	2.5	4.7	7.9	6.6	4.2	3.6	7.6	7.3	2.0	6.3	3.8	2.8	5.7	2.9	4.9	4.7	3.8	4.8	5.5	3.2	3.8	7.9	4.4	7.3	3.7	6.5	8.5	3.1	6.8	4.6	2.7	5.2	2.9	6.1	5.6	3.8	3.4	5.3	8.3	5.4	3.1	20.8	7.9	6.6	6.0	2.8	4.4	3.6	3.3	2.7	2.8	2.6	2.4	2.5	4.7	1.2	0.2	4.6	2.0	2.6	4.7	3.4	0.3	1.8	2.8	2.2	3.0	0.2	0.6	2.5	2.1	1.6	1.2	0.2	1.0	0.3	3.3	2.6	3.3	3.2	3.2	1.7	2.5	3.2	2.2	2.7	2.0	1.3	3.5	2.8	2.8	4.5	4.0	6.1	2.3	0.6	1.5	0.7	0.7	0.3	0.6	1.8	1.7	1.2	1.1	0.4	1.4	1.5	1.0	0.2	1.8	2.7	0.9	1.4	1.1	0.7	1.5	0.3	1.4	4.6	4.4	0.5	1.7	1.3	1.4	1.6	1.5	2.6	3.7	2.4	2.5	2.7	2.4	2.2	2.8	2.4	4.7	4.1	1.1	2.5	1.2	0.7	3.0	1.2	5.0	7.1	7.9	6.6	4.7	3.8	7.9	4.4	6.8	7.9	0.0	5.8	1.9	0.7	0.5	8.2	5.1	2.5	5.3	1.2	3.5	11.8	1.0	1.7	1.0	25.9	2.9	0.3	0.0	0.4	0.1	1.3	0.7	0.0	2.9	1.6	1.6	0.0	5.5	2.1	4.8	4.0	1.8	0.0	0.0	0.0	5.6	0.5	0.0	3.9	3.1	9.1	0.0	1.2	50.8	2.6	0.0	0.2	1.3	0.8	0.6
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.1"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	18.6	9.2	11.0	17.0	18.1	26.8	17.5	27.5	16.3	9.7	13.1	13.2	7.4	7.5	14.3	12.7	11.0	14.3	13.4	16.0	9.2	7.0	9.6	9.5	16.1	24.0	12.9	10.7	18.6	8.1	14.5	14.0	10.6	11.5	13.1	10.3	14.1	10.5	10.1	13.5	12.8	19.6	16.1	9.1	23.6	10.6	9.8	10.4	13.5	14.6	9.8	20.4	12.2	11.5	10.2	4.9	3.4	3.3	7.3	9.7	3.8	5.6	5.1	10.1	7.1	5.3	5.8	1.9	4.5	7.0	6.9	13.2	1.1	14.4	5.6	2.9	4.5	4.5	2.3	4.1	5.2	7.6	2.8	13.3	5.9	33.1	6.5	4.2	6.5	12.0	6.7	7.3	6.7	10.4	6.6	3.5	11.6	0.3	0.0	6.0	1.5	10.2	2.2	2.7	0.2	5.7	11.7	10.9	8.0	3.9	10.1	6.0	7.2	6.2	2.6	3.2	8.8	5.9	5.6	5.4	8.1	7.6	2.7	7.3	13.9	9.2	8.4	5.7	3.4	8.1	2.2	2.4	3.4	6.8	2.6	9.7	6.6	6.3	8.4	4.9	10.2	9.1	9.5	2.1	7.3	3.3	4.1	9.3	3.8	11.0	18.1	27.5	16.3	9.2	7.0	12.9	10.7	11.5	10.4	3.0	7.0	7.2	4.9	6.0	4.6	4.5	10.2	5.3	3.4	7.0	5.9	3.6	3.3	3.6	7.4	9.0	2.1	0.0	2.1	2.3	4.4	3.1	9.2	6.4	3.6	1.6	5.8	10.4	4.1	3.4	5.2	2.8	0.0	2.8	3.4	5.7	2.5	0.0	3.9	2.4	9.1	0.0	8.1	11.6	5.7	5.0	3.7	7.5	2.1	1.7
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 13.4"	"Group enriched"	"Detected in all"	4	"B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 16.5"									HPA039511	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	4.7	6.2	7.3	11.8	11.0	5.9	9.3	18.8	10.3	5.2	5.8	8.0	4.0	3.6	7.2	7.7	3.9	8.0	6.9	5.4	9.0	6.2	5.6	2.6	7.6	8.8	9.5	7.0	11.2	4.5	12.5	13.8	6.9	7.0	8.3	4.4	6.5	5.6	6.7	5.4	7.3	6.1	7.3	10.6	9.9	5.2	7.2	8.5	11.2	9.1	3.0	9.7	6.5	11.6	4.7	1.8	1.8	1.2	13.4	5.8	2.1	1.4	1.8	7.4	6.1	2.2	1.8	1.8	3.4	4.2	3.4	16.5	1.9	1.3	2.0	2.5	3.1	4.2	0.8	2.3	5.0	5.6	0.2	13.6	9.2	1.4	2.8	3.2	7.6	6.5	3.3	3.9	3.4	4.8	4.9	2.1	5.3	0.1	0.3	6.1	0.8	8.5	3.2	6.3	0.2	4.9	6.1	6.1	4.1	1.3	3.5	3.0	5.3	0.1	0.5	4.0	6.6	4.1	6.0	1.8	6.5	4.5	0.3	5.0	3.5	10.1	6.4	1.1	2.6	5.9	0.7	1.0	1.8	3.0	0.8	4.1	2.7	4.1	4.6	1.8	4.7	5.8	3.7	0.8	13.4	1.2	1.6	2.4	2.1	7.3	11.0	18.8	10.3	9.0	6.2	9.5	7.0	7.0	8.5	0.0	3.2	2.7	1.0	1.4	8.6	2.7	5.1	8.1	0.0	1.8	13.7	1.4	3.3	1.2	0.4	2.9	0.4	0.0	0.6	0.7	2.1	1.4	5.8	0.6	1.3	7.9	3.5	4.9	1.6	0.0	2.8	1.1	5.0	0.0	0.3	4.1	0.6	1.5	2.1	0.6	14.6	6.5	1.4	0.7	3.8	1.4	0.9	2.9	0.8	0.9
ZNF551	DKFZp686H1038	ENSG00000204519	"Zinc finger protein 551"	Q7Z340	19	57681969-57717301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.4"	"Low region specificity"	"Detected in all"							HPA038187			Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA038187: AB_2675884"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.83e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.54e-1)"	6.6	5.6	4.4	8.3	6.9	12.8	7.9	17.3	5.2	5.2	5.1	6.8	8.6	4.2	6.3	5.9	5.3	5.9	6.1	4.9	4.9	4.6	5.1	3.2	3.8	10.8	3.8	3.3	6.8	10.7	6.1	11.3	5.3	4.9	6.0	5.1	6.4	6.0	5.8	8.8	7.3	5.6	6.8	4.0	8.2	5.1	18.1	5.7	13.0	11.1	5.2	10.3	6.4	6.0	6.6	4.7	2.1	3.1	4.7	8.1	3.8	2.6	5.9	7.3	5.3	1.4	1.7	7.8	3.2	2.3	4.5	2.1	5.0	2.6	4.8	2.1	2.4	3.3	3.0	4.9	7.3	7.1	0.0	21.4	8.5	0.2	2.2	1.3	6.0	7.8	3.0	2.8	4.6	4.2	2.6	1.8	5.1	5.8	0.0	4.0	2.5	12.3	2.4	15.4	5.1	9.6	7.8	12.7	6.4	1.8	15.4	7.1	5.9	4.8	3.1	2.5	7.3	3.9	7.9	2.2	5.2	5.4	1.7	6.0	5.3	11.3	11.0	1.0	3.0	4.9	1.9	2.1	2.1	3.3	3.1	6.2	6.6	4.9	5.2	4.7	5.5	8.1	7.3	1.1	4.7	1.6	3.8	3.9	3.8	4.4	6.9	17.3	5.2	4.9	4.6	3.8	3.3	4.9	5.7	6.0	3.8	2.2	5.2	4.6	7.5	1.2	2.5	6.7	9.1	1.8	7.9	3.4	1.7	2.7	9.6	2.0	1.6	0.0	0.9	2.4	1.9	2.9	1.1	1.7	2.3	3.2	2.4	2.5	2.4	2.7	3.1	2.1	1.7	0.0	3.3	4.0	1.4	0.0	4.6	0.6	14.6	0.0	1.3	7.0	14.0	6.1	2.4	3.3	4.1	7.9
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	3.8	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	3.0	0.4	4.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.2	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	4.2	1.4	1.8	0.0	0.4	1.0	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5	11.9	15.1	0.9	2.6	1.1	4.1	2.8	2.5	8.1	6.8	0.0	7.9	1.9	3.3	2.0	0.4	2.5	3.8	0.0	1.2	1.0	2.0	2.5	0.0	1.9	1.3	3.2	3.5	2.5	1.0	0.2	2.8	2.0	0.0	1.0	1.7	4.6	1.7	0.0	2.5	2.1	4.7	0.0	1.5	4.4	10.4	1.3	7.3	4.5	2.2	1.5
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	9.3	11.1	17.7	8.4	16.2	2.7	14.1	39.5	16.1	13.6	10.4	17.2	11.4	5.1	18.8	18.8	5.9	17.3	8.2	11.9	14.2	8.2	11.2	7.5	10.4	11.8	17.6	15.5	24.0	7.6	22.1	29.2	9.8	16.2	13.6	9.3	11.2	8.3	11.4	3.3	8.7	9.8	16.3	16.2	14.9	8.8	13.7	19.8	10.7	14.0	3.4	10.3	10.2	11.3	12.5	5.3	18.9	4.3	14.2	15.8	6.2	8.7	4.7	9.3	11.3	5.5	5.0	2.4	5.3	11.0	8.0	6.8	2.3	1.0	7.1	6.3	7.7	10.9	3.1	5.6	5.0	10.2	11.4	7.5	9.6	7.8	3.1	9.8	8.4	10.6	10.5	9.1	9.0	11.2	6.8	6.7	10.7	7.0	25.2	5.0	0.0	11.4	26.6	15.1	1.5	7.8	5.6	11.3	9.6	4.9	12.3	10.5	8.8	10.4	1.7	12.5	14.2	7.5	6.4	5.6	14.7	3.3	12.0	8.0	2.0	0.0	6.9	2.6	5.3	9.2	18.9	3.4	7.5	9.1	3.2	12.0	11.9	9.6	9.6	5.3	12.5	15.8	12.7	1.9	14.2	4.3	4.4	8.4	6.2	17.7	16.2	39.5	16.1	14.2	8.2	17.6	15.5	16.2	19.8	3.0	3.5	6.2	5.8	3.4	26.6	7.1	10.2	6.7	3.4	3.5	25.5	5.9	1.7	5.9	7.0	10.5	1.7	0.0	2.7	3.8	8.9	4.1	2.3	2.1	4.2	25.4	2.9	12.3	3.8	1.8	11.8	5.7	3.3	5.4	3.7	25.1	2.8	2.9	12.7	2.4	27.1	6.5	11.3	15.7	34.5	2.6	2.4	10.1	3.8	2.2
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 48.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	11.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.0	8.3	0.0	0.0	0.0	0.0	0.0
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182060-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 18.7;Late spermatids: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	5.9	5.7	12.1	4.2	11.6	7.1	7.1	10.4	12.8	5.7	5.2	16.8	4.8	4.4	7.1	6.5	5.2	6.7	4.8	5.3	8.0	7.7	5.5	6.2	4.6	4.4	17.3	10.1	11.1	5.7	4.9	7.5	4.6	12.1	7.0	5.8	4.1	8.0	5.6	7.8	6.6	4.1	6.2	17.3	4.5	6.1	13.5	14.9	2.3	6.8	3.5	5.7	6.6	8.4	2.1	3.6	13.8	3.7	3.1	4.5	2.3	3.8	5.5	6.6	4.6	10.4	6.9	1.8	3.8	6.3	4.6	7.9	3.2	3.4	2.9	5.0	4.9	2.2	2.3	3.3	2.8	7.3	5.0	1.5	5.3	4.8	4.2	4.4	3.5	3.7	8.1	8.0	3.0	8.0	4.9	5.5	3.4	3.5	3.6	5.6	4.9	4.2	0.9	2.6	8.4	2.6	3.6	3.9	2.9	4.6	5.2	5.3	5.5	3.1	3.6	3.5	4.2	2.5	3.8	4.5	6.6	3.8	4.8	5.5	1.1	1.8	1.9	6.3	2.9	3.2	13.8	3.1	4.8	3.5	3.2	3.8	2.1	4.0	3.4	3.6	2.1	4.5	3.5	1.5	3.1	3.7	1.9	2.0	2.3	12.1	11.6	10.4	12.8	8.0	7.7	17.3	10.1	12.1	14.9	3.0	0.6	0.0	5.2	1.9	3.6	2.5	0.0	4.0	0.0	1.8	5.9	1.1	0.0	2.5	18.7	3.0	0.9	0.0	2.6	1.6	2.5	3.3	0.0	0.8	1.4	1.6	1.2	1.3	2.4	12.4	4.9	1.7	0.0	1.0	1.0	2.4	2.4	0.0	2.5	1.0	4.6	6.5	2.3	10.9	7.3	1.3	1.7	2.2	1.5	3.7
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 64.6;Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	5.9	7.0	6.3	6.7	6.9	5.0	10.2	12.2	10.2	8.0	6.3	4.7	6.6	3.8	9.2	7.5	7.8	7.0	5.5	5.3	7.7	6.0	6.0	7.7	5.8	8.6	7.1	2.3	8.4	4.9	10.4	15.8	13.0	8.0	9.3	5.0	5.1	7.3	12.1	7.4	5.6	5.5	9.7	9.1	7.2	5.5	14.2	9.6	9.0	8.3	3.3	8.2	6.6	7.5	8.8	3.9	7.0	2.3	7.9	8.2	3.0	6.8	5.3	9.8	8.7	5.7	5.6	9.4	5.0	7.8	5.7	9.3	3.0	2.4	4.3	6.1	4.5	4.3	1.8	9.0	5.2	7.9	8.4	4.7	8.1	5.9	2.9	5.2	10.2	6.3	8.7	6.3	5.4	10.6	7.5	6.6	8.8	3.2	2.3	6.8	4.2	13.2	3.9	9.4	4.6	4.3	6.5	13.5	6.1	3.7	10.5	7.4	7.9	9.3	4.7	5.0	11.6	5.9	7.0	4.1	7.6	7.7	3.8	5.6	8.8	7.3	14.3	0.0	4.1	6.6	5.7	2.3	7.0	7.7	2.0	6.3	7.3	8.2	7.1	3.9	8.8	8.2	8.2	1.3	7.9	2.0	2.7	6.6	3.0	6.3	6.9	12.2	10.2	7.7	6.0	7.1	2.3	8.0	9.6	6.0	5.8	9.4	9.2	10.4	7.7	5.3	2.5	2.7	7.9	8.7	9.8	13.1	3.3	7.5	64.6	8.9	3.2	0.0	4.4	11.7	5.8	10.4	17.3	6.6	6.3	11.1	4.1	12.3	4.7	69.6	9.2	3.8	6.8	7.2	4.8	8.1	4.2	7.0	14.2	5.6	5.7	6.5	9.2	35.8	10.4	15.4	23.0	11.8	4.1	10.3
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	11.1	6.8	7.9	6.6	10.2	14.9	9.7	15.6	17.8	11.2	10.2	12.5	4.6	10.2	13.0	4.5	12.2	12.4	8.0	8.0	8.0	6.8	6.8	8.4	8.6	9.0	11.7	8.5	15.4	12.1	8.7	8.3	8.8	8.4	10.8	4.5	10.8	12.1	11.1	10.4	14.3	8.6	10.3	5.6	10.8	8.7	28.5	12.3	15.6	10.2	9.1	12.4	10.6	9.3	18.7	12.5	15.6	10.5	10.1	18.9	11.6	10.3	28.6	6.4	8.2	5.8	5.9	6.9	7.8	6.8	10.3	9.8	11.2	7.0	15.0	7.0	6.2	5.3	6.3	7.3	9.8	3.8	7.9	12.3	14.2	6.9	9.5	6.4	8.8	9.8	6.9	9.8	9.3	7.9	6.1	5.5	8.3	11.7	9.5	7.0	21.1	10.3	7.3	11.5	9.0	11.4	14.2	6.2	6.4	5.0	13.7	10.8	9.2	8.0	17.0	5.1	4.3	8.0	13.9	6.7	13.9	11.0	4.1	11.5	10.4	6.3	10.9	7.8	8.2	7.9	11.1	10.4	15.6	17.5	7.9	18.7	18.7	13.1	18.9	12.5	14.8	13.8	12.8	13.3	10.1	10.5	11.0	10.1	11.6	7.9	10.2	15.6	17.8	8.0	6.8	11.7	8.5	8.4	12.3	0.0	3.5	1.9	14.4	26.1	6.7	3.5	0.0	2.7	3.4	1.8	2.0	6.5	1.7	5.8	17.4	5.8	5.1	0.0	4.5	5.5	8.0	8.8	12.7	2.5	4.3	3.2	3.4	8.0	1.0	11.6	5.2	3.3	8.5	10.0	7.3	3.8	4.4	6.6	8.1	3.7	9.2	6.5	8.9	29.4	18.1	19.8	4.0	6.4	7.5	10.2
ZNF576	MGC2508	ENSG00000124444	"Zinc finger protein 576"	Q9H609	19	43596392-43601157	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050064	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA050064: AB_2681003"	"unprognostic (1.28e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.60e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.34e-3)"	11.8	14.4	14.5	11.4	18.7	5.2	11.3	28.0	19.4	11.2	11.5	15.3	11.4	16.0	12.7	9.0	15.0	14.2	13.4	16.0	13.3	13.7	12.1	23.5	8.7	12.5	15.7	16.8	17.9	14.7	11.4	16.4	10.2	16.5	16.9	8.5	9.5	17.7	12.9	21.0	11.3	15.1	9.8	13.4	10.3	11.9	13.2	13.3	13.3	13.9	8.4	10.2	16.1	10.5	22.3	22.2	13.9	13.6	15.7	17.7	10.3	15.7	18.4	6.8	8.7	9.2	8.2	6.2	13.2	8.8	13.3	14.9	9.0	12.1	10.4	15.0	9.9	7.8	6.4	9.8	9.3	3.6	11.2	16.7	7.6	12.8	11.1	7.6	10.2	14.3	7.0	11.8	11.6	4.7	6.7	9.4	9.2	9.5	13.5	10.1	15.6	14.2	4.6	4.8	13.2	15.7	12.0	6.1	10.2	7.9	14.2	12.7	8.0	8.7	17.6	6.7	5.2	8.2	11.8	9.8	17.9	9.9	7.9	19.2	7.1	8.0	7.1	15.4	11.9	15.3	9.3	13.6	13.9	15.9	12.6	14.3	22.3	16.0	13.5	13.9	16.7	17.7	14.0	7.3	15.7	12.5	22.2	15.9	10.3	14.5	18.7	28.0	19.4	13.3	13.7	15.7	16.8	16.5	13.3	6.0	5.3	15.6	7.4	9.4	23.0	10.4	10.2	6.7	7.9	14.0	29.5	12.5	18.3	15.8	29.8	10.5	16.5	0.0	16.6	17.4	10.4	14.8	9.2	17.0	13.7	22.3	10.9	15.4	5.9	70.7	12.4	7.8	18.6	12.6	10.9	22.7	16.0	11.5	14.5	24.5	31.2	6.5	9.2	28.6	15.8	10.8	4.8	11.5	12.8	9.8
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	4.4	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.8	2.8	4.3	9.6	5.0	4.4	1.3	9.5	1.5	0.0	2.7	0.0	3.8	0.0	7.8	3.6	7.6	0.0	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	7.0	1.3	3.1	1.0	5.5	7.7	1.6	2.7	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9	0.0	1.6	6.7	3.0	3.9	11.1	7.8	5.1	1.4	1.2	17.4	9.8	6.0	33.2	3.1	47.8	6.0	2.7	0.0	1.0	4.5	5.5	6.1	4.7	1.5	4.7	6.4	2.9	4.3	2.4	35.6	7.5	5.1	0.0	5.4	5.0	14.0	1.2	0.0	12.0	4.2	9.3	0.0	6.6	10.7	14.4	4.5	3.8	2.5	4.2	2.1
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 11.6;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 24.3"					"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	4.8	8.7	7.7	4.7	8.9	2.7	6.3	9.4	9.0	4.7	4.9	7.8	3.6	2.3	7.9	13.5	4.8	6.1	6.4	8.0	8.2	7.1	5.9	4.8	5.2	8.0	9.6	3.9	10.2	4.0	7.5	11.4	5.4	8.9	8.4	2.7	4.4	4.1	5.5	3.5	5.6	3.3	5.5	7.7	7.2	3.4	8.9	13.1	7.8	13.8	2.2	3.7	5.4	5.9	5.9	3.4	5.9	3.3	11.0	6.5	2.8	0.0	1.1	6.1	1.2	1.5	1.6	0.0	2.4	2.6	1.6	1.3	0.0	0.3	0.0	1.6	1.4	3.5	0.0	0.8	0.3	1.3	0.0	24.3	5.8	0.0	0.4	2.6	1.6	4.7	5.4	1.3	1.0	0.0	1.5	1.0	0.6	1.3	0.0	1.0	0.0	3.4	3.7	3.3	0.0	0.0	1.6	2.1	2.1	1.3	3.3	0.0	3.9	0.0	0.8	0.0	4.7	2.7	3.2	1.0	3.2	6.4	0.8	3.3	5.2	5.6	3.7	0.2	0.4	1.8	4.3	2.2	5.9	4.4	3.3	6.5	5.9	5.2	4.4	3.3	4.3	3.8	4.8	0.5	11.0	2.4	3.4	1.6	2.8	7.7	8.9	9.4	9.0	8.2	7.1	9.6	3.9	8.9	13.1	0.0	0.0	5.2	2.1	1.1	3.3	2.7	0.0	1.4	1.2	7.0	2.0	2.1	11.6	2.4	0.7	5.3	0.0	0.0	0.6	0.6	2.6	3.3	8.1	2.1	2.5	1.6	0.0	1.8	1.0	0.4	2.0	2.9	3.3	1.8	0.6	8.0	1.0	0.0	3.9	3.3	5.7	12.9	2.1	1.8	5.7	0.9	3.0	2.5	0.6	1.7
ZNF585B	"FLJ14928, SZFP41"	ENSG00000245680	"Zinc finger protein 585B"	Q52M93	19	37181579-37218153	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA075556			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA075556: AB_2686757"	"unprognostic (9.53e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-3)"	6.6	8.3	11.2	5.8	13.4	2.6	9.3	17.9	12.9	10.0	8.1	8.7	11.4	5.6	11.6	15.2	5.8	8.8	7.5	7.2	9.8	10.0	8.7	5.2	6.2	7.3	14.1	9.8	15.0	6.2	23.4	22.6	8.0	10.1	8.9	7.2	8.3	6.3	11.6	5.0	6.3	7.2	10.1	12.3	9.7	7.6	9.2	12.4	9.5	13.1	5.6	9.1	9.3	7.2	6.5	1.9	3.7	4.2	2.9	7.1	2.9	2.4	4.2	3.8	7.5	6.3	9.9	2.1	3.2	5.2	5.9	8.9	2.3	3.1	0.1	6.9	4.2	4.2	0.7	0.1	5.0	7.4	4.9	1.9	3.2	5.5	1.2	6.1	0.3	6.8	7.7	3.0	6.7	3.5	4.7	2.4	0.4	0.0	0.2	3.5	1.5	5.6	2.1	4.2	1.2	1.2	0.2	2.1	0.1	3.2	10.0	6.7	4.3	0.0	0.3	1.5	5.1	2.9	3.5	2.0	0.6	1.4	5.0	3.8	5.7	7.5	6.9	0.3	0.1	6.5	3.3	1.6	3.7	5.0	3.1	6.3	6.5	3.6	4.4	1.9	4.9	5.2	7.1	2.5	2.9	4.2	1.7	3.5	2.9	11.2	13.4	17.9	12.9	9.8	10.0	14.1	9.8	10.1	12.4	6.0	6.4	1.4	1.6	1.4	6.1	5.0	7.6	8.1	12.5	12.2	2.0	2.3	1.7	2.5	13.5	3.3	2.8	0.0	1.7	2.1	2.6	1.9	6.9	1.7	3.0	3.2	0.0	2.5	3.3	5.9	3.7	2.2	1.7	1.0	3.3	3.7	2.0	2.0	6.3	3.0	3.9	0.0	3.3	4.1	4.3	1.4	2.6	3.2	2.5	2.1
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.1	11.1	3.8	13.4	3.7	4.9	20.2	9.0	4.6	10.5	10.1	17.0	12.2	23.6	16.6	5.6	8.4	13.2	12.9	11.7	3.8	14.1	41.4	16.0	9.1	25.7	16.1	22.1	14.1	8.8	11.5	11.6	12.2	4.4	8.8	5.8	24.0	9.1	6.2	15.4	9.0	41.1	15.1	19.5	39.5	11.3	6.7	23.8	7.5	8.9	10.1	11.0	10.9	27.4	34.2	3.3	11.3	12.5	9.1	10.1	11.9	21.1	16.8	18.0	18.2	25.5	11.8	45.9	12.9	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3	11.9	63.0	48.3	137.4	152.1	16.6	5.9	58.6	21.4	40.9	57.6	2.0	93.3	87.9	89.4	5.0	36.0	55.3	23.3	126.2	135.2	54.6	99.4	51.7	184.5	69.6	3.2	105.3	38.6	55.7	10.0	30.0	42.5	47.2	47.7	71.1	18.5	122.6	60.4	21.9	148.8	11.7	12.9	55.6	33.0	56.3	147.0	186.2	28.8	68.1	152.9
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432422-3443542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	6.7	6.7	4.5	4.6	8.5	5.0	5.9	5.2	8.7	4.7	4.2	7.3	2.4	3.8	5.6	6.8	4.0	5.9	6.0	5.4	4.8	4.4	5.2	5.4	7.4	6.1	4.5	4.5	7.2	5.2	4.5	7.7	7.9	8.9	4.8	3.2	5.8	4.6	4.9	3.6	4.4	5.1	4.1	4.6	5.4	4.8	13.2	5.4	5.4	6.4	2.6	5.6	5.7	4.6	1.4	1.1	11.3	2.2	0.9	2.2	0.8	0.0	1.8	2.3	5.4	1.7	2.6	8.7	2.6	3.2	2.5	3.2	0.0	3.3	4.4	2.5	2.9	1.9	1.4	5.1	2.3	3.3	2.6	2.0	7.5	4.8	3.1	2.5	4.4	4.5	3.3	3.7	2.8	3.2	2.5	6.8	2.4	1.6	2.9	2.9	1.4	3.1	4.7	7.3	1.9	0.0	2.0	6.7	3.0	2.1	7.1	2.9	4.1	5.1	2.7	1.9	6.4	2.3	6.7	4.4	4.2	2.2	0.0	2.5	3.8	4.0	0.5	0.0	2.6	2.5	3.8	1.1	11.3	1.3	2.2	2.2	1.4	1.0	1.1	1.1	1.1	1.9	1.4	0.3	0.9	1.0	0.5	1.6	0.8	4.5	8.5	5.2	8.7	4.8	4.4	4.5	4.5	8.9	5.4	23.8	1.6	2.7	1.6	0.1	1.9	1.4	0.0	1.4	9.1	1.8	0.0	1.0	0.0	0.9	3.8	2.2	0.7	0.0	0.9	1.6	1.0	2.1	3.5	1.0	1.0	0.0	2.4	3.1	1.5	3.3	1.1	0.9	0.0	2.8	1.6	1.5	1.6	0.0	2.1	1.2	3.2	6.5	1.0	4.2	6.9	0.4	1.3	0.7	2.3	1.8
ZNF605		ENSG00000196458	"Zinc finger protein 605"	Q86T29	12	132918308-132956306	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA061970, HPA062655"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061970: AB_2684649, HPA062655: AB_2684820"	"unprognostic (2.38e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.16e-6)"	"unprognostic (3.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.53e-2)"	"unprognostic (9.06e-3)"	5.5	8.2	10.9	7.6	9.9	3.2	12.2	19.0	12.8	10.1	8.3	8.4	9.5	6.7	10.2	13.1	7.3	9.3	6.6	9.9	10.8	7.9	9.9	8.1	7.6	8.0	7.8	8.2	13.3	8.2	16.9	12.9	10.2	8.1	10.7	6.9	9.9	8.8	9.6	14.6	11.5	8.3	8.2	7.4	7.4	8.7	4.8	9.1	8.5	15.5	6.1	7.5	8.5	9.9	2.6	1.4	1.9	1.2	1.7	3.0	0.8	4.5	3.7	9.6	9.1	5.3	10.9	7.2	6.3	3.6	2.9	2.1	0.6	0.6	1.9	3.4	5.4	3.6	2.5	4.2	1.6	3.6	1.6	7.1	8.7	2.9	2.9	4.0	3.6	9.7	7.0	7.0	2.0	4.5	9.0	2.2	4.6	1.3	0.1	7.3	1.3	4.8	5.1	7.4	1.3	5.1	4.4	6.3	1.3	5.0	7.9	6.2	7.1	2.8	1.7	4.3	5.9	10.4	10.6	4.3	3.7	5.9	5.4	2.5	0.0	0.0	1.6	0.1	3.1	2.1	1.6	1.2	1.3	1.6	0.8	0.9	2.6	1.4	1.7	0.9	2.2	3.0	1.9	1.9	1.7	0.9	1.4	0.4	0.8	10.9	9.9	19.0	12.8	10.8	7.9	7.8	8.2	8.1	9.1	17.9	36.9	2.7	8.2	3.1	33.5	19.9	20.4	21.4	39.8	8.7	27.5	5.6	8.3	5.7	1.5	8.3	4.5	0.0	3.0	3.1	7.6	7.4	9.3	4.3	3.2	38.1	5.8	13.5	6.5	1.3	14.7	3.8	0.0	4.6	9.8	19.8	6.8	0.0	12.7	4.2	36.9	12.9	6.2	5.4	7.3	4.0	4.7	5.0	7.3	6.5
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.2;naive B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.1;AN3-CA: 16.0;REH: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	8.5	14.7	17.0	7.5	17.2	2.0	10.1	25.5	16.5	11.5	10.4	28.3	2.8	15.7	7.5	7.1	5.4	13.6	10.1	12.5	19.7	8.8	8.2	3.9	15.3	10.8	21.8	10.7	9.6	12.0	9.1	11.6	4.5	18.0	8.5	10.7	14.1	8.3	7.1	8.9	4.8	9.1	6.4	22.9	3.9	9.8	13.0	24.5	4.6	13.4	3.3	11.0	6.6	6.6	3.1	1.1	5.2	0.0	0.0	0.0	0.0	0.1	0.4	25.1	16.0	3.7	6.1	0.0	0.0	0.6	0.1	1.5	2.6	7.5	8.2	8.4	0.0	4.0	0.3	1.7	1.5	0.1	0.0	4.0	0.0	0.0	0.1	5.8	0.0	0.7	6.1	4.5	0.7	0.7	3.8	5.3	0.0	0.8	0.1	1.3	0.0	0.0	0.0	10.6	0.2	0.3	43.6	2.2	0.0	3.6	0.3	3.8	13.2	0.0	0.3	5.6	14.9	1.4	0.7	1.4	5.1	9.8	0.1	1.5	4.0	3.9	14.8	1.3	0.2	7.2	5.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	3.1	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	17.0	17.2	25.5	14.3	19.7	8.8	21.8	10.7	18.0	24.5	29.8	27.0	3.7	10.9	1.1	34.0	19.7	10.2	20.1	60.3	14.0	37.3	0.6	3.3	12.1	10.4	13.7	9.3	0.0	7.7	3.3	4.7	3.1	0.0	0.9	0.6	39.7	38.4	11.6	0.3	5.7	2.0	1.2	6.8	3.6	5.3	38.4	5.6	7.6	1.4	5.7	37.0	0.0	1.6	12.0	5.8	0.6	0.3	0.0	7.0	1.6
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	11.1	11.2	14.5	14.5	12.6	7.3	11.4	17.1	15.1	17.9	14.2	16.2	19.1	12.1	18.7	8.4	10.2	15.7	14.0	10.9	12.3	10.4	9.1	10.2	13.9	11.3	10.9	11.0	29.9	11.6	18.1	11.6	16.3	10.9	15.2	11.4	14.6	12.6	22.8	9.2	11.9	11.2	16.1	12.7	12.9	11.4	28.9	13.6	21.4	12.4	4.5	12.1	15.6	28.4	1.2	2.8	3.2	1.7	4.0	3.0	0.5	6.1	15.6	16.9	6.4	6.5	8.3	5.8	8.1	10.8	10.2	10.3	9.6	9.8	10.6	6.8	9.5	13.9	13.2	24.7	11.1	10.7	12.3	5.3	19.4	9.0	4.7	12.0	11.1	13.0	8.4	10.2	10.6	21.0	14.8	18.8	9.1	30.4	6.9	8.3	5.6	8.6	4.7	12.8	8.3	4.4	7.9	15.4	5.5	7.4	11.1	13.7	10.5	11.0	12.6	7.5	16.9	6.2	7.8	18.7	9.5	15.2	4.9	10.0	7.7	8.7	9.6	5.9	12.2	7.7	3.2	1.7	1.9	2.3	0.7	1.6	0.7	1.3	1.6	0.6	1.2	3.0	3.0	2.1	4.0	0.8	2.8	0.8	0.5	14.5	12.6	17.1	15.1	12.3	10.4	10.9	11.0	10.9	13.6	11.9	20.1	6.1	13.9	16.0	28.1	18.3	17.8	30.8	25.0	17.4	133.5	12.7	3.3	12.3	17.2	14.4	9.9	0.0	12.8	11.9	12.1	18.2	9.3	11.6	8.7	42.9	17.9	17.8	23.1	9.6	16.7	11.6	13.5	9.0	10.8	19.5	11.6	11.5	13.1	3.1	56.5	19.4	9.2	31.7	14.0	15.2	26.1	13.3	10.5	15.6
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 25.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favorable (1.92e-6)"	4.7	5.3	7.1	3.9	7.4	1.6	9.5	14.2	7.4	5.3	6.5	5.2	1.9	2.8	5.5	5.3	4.7	4.3	3.7	4.3	9.7	4.7	8.7	4.0	4.9	6.3	7.2	4.9	6.5	3.4	7.4	7.0	8.2	8.8	25.4	6.7	5.4	4.5	5.6	3.9	4.5	4.9	5.8	7.5	6.7	4.2	3.5	7.0	9.0	7.3	2.6	5.2	5.8	4.1	10.1	9.6	14.1	11.3	9.5	14.3	7.0	3.1	4.1	6.8	6.8	5.9	6.8	1.7	5.2	8.4	7.0	9.1	1.3	3.7	2.6	2.8	6.5	6.2	3.5	6.6	6.5	7.6	0.1	8.6	5.5	2.9	3.9	6.1	0.3	7.8	5.0	7.5	6.6	5.4	8.6	7.5	6.5	2.5	0.0	7.0	0.5	9.1	4.0	4.9	1.3	5.9	5.0	7.3	2.8	6.8	10.7	4.6	4.5	8.5	6.2	5.0	11.2	6.5	6.7	4.8	3.1	5.8	2.3	5.6	6.0	0.0	5.1	0.2	0.0	9.2	7.7	7.4	14.1	10.4	7.5	9.3	7.6	11.1	12.1	9.6	10.1	11.2	14.3	7.6	9.5	11.3	4.8	10.0	7.0	7.1	7.4	14.2	7.4	9.7	4.7	7.2	4.9	8.8	7.0	3.0	1.6	0.0	0.5	0.5	2.1	3.1	2.5	0.0	3.4	3.5	0.0	4.9	3.3	2.1	2.0	2.4	1.0	0.0	1.9	1.5	0.9	1.1	1.1	1.5	2.6	0.0	1.2	1.8	1.8	0.4	1.1	1.1	0.0	3.6	2.9	2.2	1.7	2.8	1.4	1.4	4.2	0.0	0.5	1.6	1.1	0.5	5.9	0.9	1.7	0.5
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40490236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	8.8	7.6	6.3	9.2	9.5	9.0	9.2	7.9	8.7	7.0	6.7	13.3	8.4	7.3	9.3	6.6	6.4	8.4	8.9	6.9	7.8	5.8	7.1	8.1	9.6	18.0	12.7	9.2	9.4	12.3	14.0	6.6	6.3	7.3	7.0	8.2	9.7	8.6	10.4	8.5	7.3	7.5	7.6	9.6	9.0	7.3	3.8	9.3	6.0	10.2	5.0	9.4	8.0	6.8	4.1	4.5	5.1	4.5	5.2	5.1	2.7	2.7	4.0	4.7	4.1	6.9	7.2	1.7	3.6	4.5	7.0	7.0	1.2	3.9	0.3	2.3	3.4	3.2	3.0	4.3	7.5	7.6	4.8	1.6	8.3	3.2	1.9	7.2	5.8	7.5	5.8	5.6	7.1	10.5	6.2	6.5	0.3	5.5	3.9	4.3	3.4	0.1	2.6	2.5	3.4	3.6	1.6	4.8	4.5	2.9	6.3	3.0	3.1	4.1	6.0	3.2	4.4	4.8	3.9	4.9	5.1	4.0	2.8	4.1	2.2	2.8	0.3	3.1	3.6	5.4	2.8	3.2	5.1	3.0	4.5	3.3	3.3	3.0	3.8	4.5	4.1	3.1	3.9	3.8	5.2	4.3	2.8	5.1	2.7	6.3	9.5	7.9	8.7	7.8	5.8	12.7	9.2	7.3	9.3	0.0	0.6	0.0	0.7	0.2	3.8	0.8	0.0	1.4	0.0	3.5	2.0	1.2	0.0	1.1	0.0	1.1	1.0	0.0	1.3	0.8	0.6	0.5	0.0	0.5	1.0	0.0	0.0	1.8	1.0	0.0	1.1	0.2	0.0	1.0	0.7	2.9	0.6	0.0	0.4	1.3	3.7	0.0	0.5	1.0	1.3	0.1	0.3	0.0	1.0	0.6
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	4.9	5.2	6.7	3.4	5.4	3.8	8.5	11.2	8.3	7.2	5.1	5.6	7.5	2.8	8.3	10.6	4.7	6.0	4.7	3.7	6.0	8.8	6.0	2.8	4.8	5.2	6.6	5.5	13.1	5.4	6.9	9.4	6.4	6.4	7.3	3.5	7.5	4.0	7.1	2.0	7.3	3.3	6.6	4.7	5.8	3.8	4.6	2.9	1.0	8.7	3.2	3.9	7.3	7.2	1.4	0.4	1.3	0.5	2.9	2.1	0.7	0.7	0.0	6.5	10.8	2.8	2.0	1.1	2.7	3.5	4.0	4.4	0.1	0.2	0.0	5.0	2.1	3.0	0.6	0.0	3.5	3.8	0.0	2.0	2.9	0.0	2.9	1.3	0.2	4.1	1.7	1.4	3.3	2.1	2.8	3.1	0.2	0.0	0.0	6.0	2.1	0.1	1.3	7.8	0.0	3.9	0.2	5.8	0.0	3.4	8.7	4.4	3.0	0.0	0.1	2.2	8.3	4.7	0.2	2.4	9.3	4.2	6.9	3.6	7.1	5.6	0.0	2.2	0.0	3.3	0.7	0.4	0.2	0.7	0.5	0.9	0.5	1.0	1.2	0.4	1.4	1.5	1.2	1.3	2.9	0.1	0.3	2.1	0.7	6.7	5.4	11.2	6.8	6.0	8.8	6.6	5.5	6.4	2.9	3.0	1.0	0.0	0.5	0.3	5.4	0.0	5.1	4.0	0.0	1.8	9.8	3.6	3.3	2.8	0.1	1.5	0.0	0.0	2.7	3.1	1.9	0.5	0.0	0.6	1.2	4.8	1.2	6.2	4.5	1.3	0.6	1.0	0.0	2.8	0.3	4.4	3.1	1.7	1.4	2.1	8.7	0.0	2.3	1.9	8.3	0.6	1.0	0.0	1.2	0.3
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	10.3	8.4	9.9	10.1	11.1	10.5	17.5	15.6	12.8	13.8	9.2	11.1	15.4	8.1	16.7	14.6	7.9	19.4	10.1	8.4	9.2	10.0	15.4	11.0	9.6	10.3	12.3	10.0	20.9	19.7	9.3	17.8	9.8	10.3	13.4	11.0	12.5	11.6	14.8	7.7	10.1	8.5	14.1	9.6	9.9	9.2	12.1	11.8	17.4	19.9	7.8	11.3	11.9	13.8	10.2	8.0	13.4	5.6	7.9	8.9	4.8	4.7	3.9	12.8	15.7	5.8	6.1	7.2	7.0	8.3	8.0	8.2	3.2	3.3	3.5	7.1	5.5	4.1	4.3	5.1	6.9	9.1	6.3	2.3	9.9	2.5	6.2	10.9	5.6	5.7	7.3	9.9	5.5	12.2	12.5	8.8	9.0	9.3	5.1	10.6	9.8	9.0	5.6	9.4	3.2	8.6	10.0	9.6	4.8	9.1	7.5	17.7	12.8	9.2	5.2	9.8	11.4	9.1	15.9	7.8	8.7	4.0	4.9	4.9	7.2	7.0	3.9	4.0	9.3	7.1	13.4	4.9	7.8	5.4	5.6	6.4	10.2	6.6	6.6	8.0	6.9	8.9	7.9	2.6	7.9	5.3	3.1	3.6	4.8	9.9	11.1	15.6	12.8	9.2	10.0	12.3	10.0	10.3	11.8	11.9	5.1	11.9	3.2	1.1	4.7	11.5	10.2	9.4	1.2	8.7	3.9	4.3	14.9	4.7	6.0	3.2	3.2	0.0	2.1	3.5	3.3	4.2	1.1	5.3	2.8	6.4	5.1	4.3	5.7	2.4	4.9	2.1	0.0	3.6	3.8	5.5	4.0	3.5	4.9	6.0	5.6	0.0	4.1	14.4	3.9	2.4	3.9	3.2	3.7	2.6
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778449-30787202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	8.6	12.8	8.4	5.2	12.7	6.3	9.4	15.1	21.1	11.3	9.8	16.4	8.2	9.4	13.6	8.4	7.4	11.9	9.2	19.5	9.0	7.7	10.9	8.2	9.0	3.4	9.4	7.9	15.6	8.9	30.2	9.1	6.5	12.2	9.6	8.1	14.8	10.4	11.5	14.0	12.0	10.3	11.9	7.6	6.7	10.5	6.4	8.9	11.8	9.9	10.2	6.7	11.2	7.4	0.3	2.9	0.8	1.6	1.4	1.3	0.7	6.2	10.3	16.1	12.4	7.9	7.4	2.4	7.1	10.4	11.2	9.5	6.3	5.8	1.1	6.9	11.5	3.5	7.5	7.8	9.4	7.5	0.2	11.7	8.8	9.1	6.5	8.5	3.1	5.4	12.2	7.1	6.9	5.8	8.8	5.9	0.5	12.8	0.2	9.7	13.4	4.6	4.1	8.4	3.0	4.3	15.6	12.4	0.5	9.4	10.4	15.3	17.1	6.9	13.0	1.7	5.5	9.7	11.3	7.1	10.6	6.9	7.1	5.3	0.2	0.0	0.3	6.9	7.8	3.5	0.0	1.6	0.8	0.3	0.2	0.5	0.2	0.3	0.2	1.3	0.3	1.3	1.0	0.1	1.4	0.4	2.9	0.0	0.7	8.4	12.7	15.1	21.1	9.0	7.7	9.4	7.9	12.2	8.9	17.9	10.3	2.0	2.8	1.6	16.3	24.6	5.1	6.7	7.9	8.7	3.9	1.0	1.7	7.0	1.1	6.8	4.3	0.0	6.9	0.3	3.3	3.0	2.3	3.8	3.7	15.9	11.1	6.7	4.1	2.4	8.6	2.5	1.7	10.8	6.2	11.3	9.0	3.5	4.2	3.3	11.1	0.0	3.4	2.6	1.7	1.6	0.5	0.0	9.5	3.4
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Intestinal endocrine cells: 4.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	4.0	5.2	5.3	6.4	9.0	2.1	6.7	8.8	8.5	7.0	5.4	5.9	11.3	3.5	6.3	7.5	5.0	4.8	5.8	5.9	6.0	4.6	5.2	3.0	5.0	5.4	12.3	5.8	11.2	8.3	11.9	10.1	4.9	8.8	8.4	6.2	6.4	6.1	6.9	2.3	4.0	4.2	7.5	7.3	4.8	6.8	1.8	10.1	1.0	9.3	1.5	3.6	8.4	13.7	2.6	3.8	5.8	1.9	1.5	2.8	2.0	1.4	1.1	0.3	0.0	0.1	0.1	0.0	1.9	0.6	1.0	0.9	3.3	5.4	0.1	1.0	2.0	2.3	2.3	0.0	1.0	1.3	0.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	1.3	5.6	3.2	0.0	3.9	1.0	0.0	0.0	5.4	3.6	5.7	0.0	0.0	2.1	4.8	1.6	0.7	1.2	0.0	2.5	3.0	3.2	2.6	7.0	4.8	2.1	5.0	5.7	1.3	1.2	0.0	2.5	2.5	0.0	0.0	4.7	0.0	0.0	0.1	4.5	5.8	1.9	4.8	2.2	1.0	2.4	2.6	2.0	2.0	3.8	1.8	2.5	2.8	2.1	1.5	0.6	0.9	1.1	2.0	5.3	9.0	8.8	8.5	6.0	4.6	12.3	5.8	8.8	10.1	0.0	0.0	0.0	1.0	0.1	2.1	1.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	1.2	0.0	0.6	0.7	0.0	1.0	0.7	0.6	0.9	0.0	0.0	0.8	0.0	4.1	2.5	0.0	0.0	0.3	0.0	0.0	1.0	1.4	1.1	0.8	0.0	0.4	0.6	0.9	6.5	1.0	0.1	0.5	0.3	0.2	0.8	1.0	0.7
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	20.7	19.1	22.4	14.9	26.0	18.7	19.8	51.3	25.5	19.8	19.7	23.4	13.0	11.3	26.0	14.8	17.3	20.1	14.3	16.0	20.1	11.9	18.7	22.9	16.4	16.9	25.4	19.9	31.1	15.4	28.9	46.7	16.9	23.9	17.2	14.7	14.1	20.6	15.5	33.2	16.9	15.8	18.4	22.7	16.0	17.3	21.0	29.7	26.0	22.5	11.2	16.1	26.6	17.8	14.8	10.2	32.4	12.8	11.8	14.1	6.0	14.8	21.5	33.1	15.4	19.5	21.4	25.5	17.0	19.8	14.5	13.1	20.5	14.6	24.5	15.9	15.5	22.7	12.6	30.7	17.5	21.2	24.9	17.1	32.2	23.5	18.6	16.9	29.4	21.9	13.6	17.1	15.6	29.1	20.8	22.3	16.6	32.2	14.5	21.1	14.9	20.7	21.7	28.6	22.4	13.8	17.7	50.1	17.1	15.5	22.8	25.5	16.8	21.0	14.8	21.5	34.5	13.8	18.2	22.8	18.0	26.3	13.3	17.1	11.9	18.3	24.3	15.1	19.3	19.5	32.4	10.1	18.7	11.4	9.5	10.6	14.5	10.6	10.4	7.9	14.8	14.1	10.3	17.1	11.8	12.8	10.2	8.9	6.0	22.4	26.0	51.3	25.5	20.1	11.9	25.4	19.9	23.9	29.7	62.5	96.8	21.9	49.0	28.2	107.5	95.4	33.1	95.0	67.1	38.4	115.8	33.4	16.6	33.6	9.1	50.4	34.1	0.0	35.4	23.2	45.8	52.3	76.3	39.4	28.2	63.5	36.9	35.0	35.3	11.0	69.6	45.7	21.9	49.5	31.9	69.1	35.4	26.0	60.1	17.0	107.8	32.3	40.0	110.7	64.1	26.5	42.0	42.7	33.6	45.0
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	14.6	19.0	17.4	24.1	20.7	10.3	16.9	31.1	20.3	18.8	20.2	19.7	18.0	22.2	15.3	19.0	39.2	15.6	15.1	11.3	14.7	14.4	19.1	21.2	19.9	23.8	21.3	16.1	19.4	30.8	13.9	25.0	21.1	20.4	16.9	16.8	14.1	25.5	19.0	18.2	25.5	19.7	19.8	21.3	22.2	24.1	11.1	19.4	27.8	16.0	14.3	23.1	21.4	20.7	15.0	17.5	44.7	22.2	14.7	25.7	21.4	16.2	15.8	5.8	8.6	6.6	9.9	5.0	9.8	18.5	17.0	16.3	8.7	16.0	11.4	0.1	13.7	22.6	10.3	6.8	11.9	17.2	13.7	9.9	7.9	6.7	11.0	10.1	14.4	15.3	8.5	14.5	15.7	22.2	8.2	7.4	9.7	21.0	15.8	10.6	0.0	20.1	13.2	6.8	0.0	0.0	7.2	5.4	22.4	11.2	17.9	6.7	12.4	9.3	0.3	9.8	9.6	5.3	8.6	5.2	9.5	25.1	15.6	17.6	18.6	27.1	24.8	9.7	7.3	15.3	44.7	18.8	31.2	22.3	19.9	20.5	15.0	20.5	25.6	17.5	13.3	16.5	20.7	21.9	14.7	22.2	10.1	25.7	21.4	17.4	20.7	31.1	20.3	14.7	14.4	21.3	16.1	20.4	19.4	89.3	73.3	45.4	33.6	39.8	46.9	31.5	33.1	26.8	48.9	22.7	39.3	24.8	28.2	24.8	7.8	13.4	38.0	0.0	31.4	35.4	23.7	39.5	17.4	20.8	32.5	47.7	39.9	19.0	58.3	7.1	23.6	52.1	21.9	33.3	34.0	23.0	36.8	49.1	23.7	33.4	45.2	12.9	24.1	30.2	25.1	42.8	61.6	48.4	25.9	52.5
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247036784-247078755	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 21.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	3.5	2.2	3.1	2.9	5.5	0.7	6.2	12.0	6.1	4.1	2.6	3.2	0.0	2.8	5.7	3.4	1.9	3.7	3.8	2.5	4.5		3.9	3.0	4.0	3.4	1.8	1.3	5.5	2.8	3.1	1.3	1.4	4.0	3.4	3.5	2.5	1.9	3.1	1.6	2.6	2.4	4.3	2.9	3.1	3.3	4.8	2.7	5.4	3.7	3.0	4.7	4.2	1.0	6.6	4.1	1.7	2.3	2.8	6.5	2.3	3.8	2.7	7.8	9.6	2.0	3.4	18.1	4.9	3.3	5.9	5.9	3.2	4.1	6.2	8.2	3.0	3.2	3.2	8.6	3.8	11.2	4.6	1.1	5.5	1.8	4.9	1.7	6.8	3.4	1.9	4.0	3.8	7.4	0.9	3.8	4.9	7.9	2.7	5.9	1.5	8.0	3.3	14.5	8.6	4.9	8.3	9.7	5.8	3.5	8.4	9.0	8.2	6.9	2.7	3.8	4.6	2.8	14.3	2.4	3.6	4.1	2.6	5.4	5.2	9.9	12.7	1.3	4.9	4.5	0.0	2.0	1.7	4.4	2.3	2.3	6.6	4.1	4.6	4.1	5.9	6.5	4.9	0.2	2.8	1.4	2.3	3.0	2.3											3.0	1.7	0.0	8.6	21.5	4.3	0.6	7.6	6.7	4.5	5.2	0.0	2.2	5.0	4.6	5.2	4.4	0.4	0.0	2.5	6.7	2.3	3.8	0.0	2.8	2.1	6.4	0.0	4.9	1.9	1.0	1.7	1.6	6.8	2.8	2.7	2.0	2.7	1.5	1.4	2.8	1.4	0.0	4.4	1.6	3.3	9.8	0.7	0.0	1.1	3.7
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 557.4;Late spermatids: 339.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.6;SuSa: 17.4"									HPA023106	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.4	0.4	3.9	6.0	2.0	7.4	5.6	7.7	7.0	0.0	0.4	0.1	5.6	6.4	9.7	0.7	0.0	5.8	2.3	0.2	4.1	0.3	0.5	0.2	9.6	0.1	7.6	10.3	0.0	7.4	0.1	0.2	3.4	0.1	0.1	0.5	5.2	0.2	6.2	0.2	19.6	0.1	2.6	0.1	0.0	0.2	2.2	3.0	0.2	10.8	0.2	2.8	0.1	17.4	0.4	0.3	2.1	12.1	0.2	0.2	4.9	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7	23.8	3.2	10.7	23.0	10.2	23.9	15.9	15.3	9.4	17.0	19.2	13.7	10.7	29.9	13.8	557.4	22.4	0.7	23.3	6.0	17.2	15.5	23.9	13.9	0.4	6.7	27.0	0.0	22.7	4.0	339.6	25.3	10.3	13.5	9.0	2.4	20.1	6.5	0.0	16.3	2.2	19.1	19.4	17.6	39.3	35.1	12.8	9.8	10.4	1.9	22.1
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531561-40548169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 28.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	3.6	6.4	4.1	2.9	8.9	8.2	4.2	5.8	7.4	3.6	3.8	2.3	5.4	3.2	3.6	4.3	3.2	3.1	3.4	10.6	4.4	3.3	18.3	20.8	3.4	4.4	9.8	3.6	3.8	5.4	2.5	4.6	2.1	5.4	5.1	4.8	1.6	3.5	4.1	4.4	4.1	3.4	3.2	5.9	5.1	4.2	4.3	7.8	6.4	5.6	4.1	3.5	3.1	2.7	6.0	3.9	7.0	7.7	3.5	5.9	2.4	2.2	0.7	2.8	3.8	2.6	3.8	1.7	2.0	2.0	2.4	4.1	1.4	2.9	3.8	1.7	1.3	1.6	2.7	2.8	2.0	3.8	3.3	4.7	4.1	2.6	3.6	1.3	4.4	4.5	2.5	0.8	2.9	1.1	1.4	3.7	3.0	2.1	5.7	3.4	0.6	6.4	5.1	6.8	0.9	2.3	3.0	8.4	2.6	3.6	1.9	2.1	3.6	3.7	3.7	4.1	3.6	1.6	28.0	2.1	2.5	5.2	2.4	3.9	4.8	3.4	4.4	2.2	4.7	3.8	7.0	4.0	1.9	5.9	7.7	3.2	6.0	4.2	3.6	2.4	3.5	2.8	5.5	2.3	3.5	4.1	3.9	4.7	2.4	4.1	8.9	5.8	7.4	4.4	3.3	9.8	3.6	5.4	7.8	6.0	2.7	3.7	1.7	2.1	3.0	9.9	2.5	5.3	3.4	7.0	0.0	1.0	14.9	4.4	1.8	3.5	1.3	0.0	12.9	2.1	2.8	1.0	2.3	14.5	4.2	3.2	1.2	4.3	4.3	2.6	2.3	4.3	8.5	7.2	1.7	3.5	4.9	2.0	2.8	12.4	2.3	0.0	4.7	6.1	3.2	1.1	0.0	4.8	3.8	0.9
ZNF689	FLJ90415	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.7;Late spermatids: 41.2;Spermatocytes: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	5.9	5.7	5.6	4.7	7.5	7.8	15.0	7.5	10.7	7.4	6.2	8.6	5.4	6.7	8.5	4.1	3.7	6.4	6.1	5.2	4.7	4.5	5.2	6.3	4.9	5.2	8.0	4.9	8.0	7.2	11.8	7.7	4.6	4.8	6.1	4.6	7.7	4.8	7.1	6.7	3.8	6.7	6.0	4.8	7.3	5.7	28.2	8.2	11.4	6.7	4.3	6.5	6.8	4.6	4.4	9.6	2.7	10.5	9.3	6.0	4.4	3.5	6.3	8.8	9.2	3.8	3.8	4.4	4.4	6.4	7.2	7.0	7.4	2.8	10.2	6.9	3.8	5.2	2.7	11.0	4.8	5.8	8.3	18.7	8.6	5.5	11.3	4.0	8.4	6.6	3.6	4.6	4.9	4.9	3.9	5.0	9.4	10.1	5.9	4.6	5.3	15.5	8.0	10.0	2.8	6.5	19.6	8.5	9.1	3.0	3.5	11.1	6.7	3.2	5.8	5.0	4.6	6.1	7.4	3.9	9.4	4.0	4.5	6.0	10.9	12.5	12.3	3.4	9.3	9.0	0.2	6.8	2.7	5.9	10.0	4.3	4.4	5.0	6.0	9.6	3.7	4.5	4.2	0.4	9.3	10.5	3.6	4.7	4.4	5.6	7.5	7.5	10.7	4.7	4.5	8.0	4.9	4.8	8.2	3.0	1.3	10.9	4.5	1.4	7.9	3.9	10.2	1.4	0.0	1.8	5.9	3.5	0.0	5.4	39.7	6.7	6.1	0.0	5.9	3.0	4.5	4.5	13.9	5.0	4.3	9.5	5.8	5.5	3.5	41.2	7.5	4.4	0.0	1.8	5.5	5.2	4.7	3.5	9.9	3.5	5.9	0.0	4.5	48.6	7.7	0.9	0.7	5.0	6.0	2.3
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143298061	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	8.5	6.9	10.3	8.1	10.6	6.3	6.9	13.9	13.7	5.6	5.4	9.8	5.4	13.5	8.8	4.8	5.0	6.6	7.1	5.2	10.4	10.3	7.2	8.1	7.6	8.6	12.6	7.2	9.8	13.7	8.6	6.7	5.5	10.6	7.5	4.1	7.2	11.9	5.1	7.7	13.3	8.0	10.7	8.9	8.3	6.5	6.9	12.8	6.5	7.5	3.0	6.6	7.2	5.2	6.4	6.4	2.3	3.3	5.3	7.5	3.3	6.3	5.9	5.7	6.8	2.5	1.7	12.4	5.0	1.6	3.6	2.1	3.4	5.0	0.4	7.0	1.7	2.0	4.5	6.6	2.7	3.2	7.1	14.4	8.5	5.6	5.1	2.5	3.4	10.9	1.5	4.5	2.4	5.0	2.3	1.7	5.1	17.6	3.9	2.1	12.7	3.7	7.0	8.1	6.9	15.1	7.8	3.6	6.2	1.9	4.6	9.7	13.6	7.6	4.9	6.2	3.9	8.0	6.2	3.6	4.9	11.2	4.3	8.8	8.1	5.4	7.9	3.3	7.0	5.7	1.1	3.3	2.3	5.3	1.9	5.8	4.2	4.0	5.9	3.7	6.4	7.5	6.2	1.4	5.3	2.9	6.4	1.3	3.3	10.3	10.6	13.9	13.5	10.4	10.3	12.6	7.2	10.6	12.8	0.0	0.0	0.0	2.1	2.6	4.3	2.4	0.0	0.0	0.0	3.5	5.9	1.2	3.3	2.3	0.6	2.1	2.0	0.0	1.8	2.1	1.5	1.2	0.0	2.1	1.1	3.2	0.0	1.8	0.0	1.6	3.7	0.0	1.7	1.0	0.9	2.5	1.6	0.0	1.1	1.9	3.4	6.5	1.6	2.1	5.9	1.8	0.3	1.5	1.9	0.7
ZNF701	FLJ10891	ENSG00000167562	"Zinc finger protein 701"	Q9NV72	19	52555457-52587174	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.4"									HPA005532	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA005532: AB_1080746"	"unprognostic (1.21e-1)"	"unprognostic (4.98e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.46e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.17e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.89e-5)"	10.0	7.8	9.5	13.5	13.8	11.0	9.9	12.1	8.6	8.8	12.1	7.0	9.2	6.1	8.9	9.8	8.1	9.5	6.2	6.7	9.0	4.6	11.5	3.8	7.1	9.1	11.9	2.7	10.0	7.2	9.6	11.7	22.4	10.3	10.2	9.0	3.6	9.4	8.8	6.4	9.1	10.5	6.0	14.5	11.4	7.8	7.3	12.5	28.0	12.1	4.1	8.8	10.1	11.6	8.1	5.9	19.9	8.8	11.5	8.8	6.0	1.8	0.4	4.1	7.5	4.2	5.4	7.5	4.7	4.9	6.5	6.8	3.8	4.4	8.3	2.6	3.7	6.2	2.8	1.8	5.3	7.2	0.3	5.5	2.4	6.8	1.0	4.9	0.3	11.7	6.0	3.8	5.0	8.4	3.4	6.1	4.4	10.7	1.3	5.6	1.5	8.6	4.0	4.0	2.2	6.2	8.7	5.4	3.7	5.0	23.4	4.0	4.6	3.2	7.8	2.4	8.9	10.1	5.3	5.4	5.2	2.6	2.5	8.4	1.0	5.5	11.3	0.2	9.2	8.2	15.3	8.1	15.5	8.7	8.8	7.3	7.9	6.9	7.4	5.9	8.1	8.2	8.8	19.9	11.5	6.5	5.7	8.0	6.0	9.5	13.8	12.1	8.6	9.0	4.6	11.9	2.7	10.3	12.5	0.0	6.7	6.2	5.8	1.9	5.4	3.6	2.5	6.7	6.8	14.0	13.7	12.0	3.3	5.9	1.6	5.6	8.6	0.0	3.5	8.2	4.0	7.0	2.3	0.5	4.7	3.2	2.4	6.7	5.3	1.0	5.8	8.3	3.3	9.0	4.9	3.5	4.5	5.8	3.5	2.4	5.6	0.0	4.6	3.0	7.7	3.1	19.7	14.9	3.6	10.2
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595264-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.3"					"Low region specificity"	"Detected in all"			HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	11.8	6.4	12.9	6.9	8.7	3.5	11.7	12.0	12.5	7.9	9.9	10.2	6.5	6.7	12.3	6.6	8.6	8.7	7.0	10.5	9.3	8.0	6.4	3.4	9.6	10.6	7.7	10.2	12.3	8.8	7.6	8.5	8.0	9.3	8.7	5.0	6.4	8.9	10.5	10.6	7.4	6.0	16.6	8.5	10.2	7.0	8.7	8.2	9.8	7.5	5.9	6.2	10.0	10.7	7.0	4.9	6.8	4.2	9.0	8.3	4.2	3.4	6.6	9.8	8.1	4.1	3.6	6.3	4.0	3.8	2.8	4.0	1.2	1.0	2.9	3.7	3.4	3.3	1.2	2.2	3.1	2.4	0.0	20.3	4.4	0.9	2.6	3.4	5.5	4.3	4.1	3.3	2.8	1.8	4.3	4.5	7.3	2.6	0.0	3.0	0.0	11.3	2.1	7.6	0.0	6.5	4.2	6.1	2.4	2.0	3.9	8.7	10.6	2.8	3.7	4.0	4.0	2.1	5.7	5.9	9.4	5.3	2.2	6.4	2.8	3.5	4.5	3.1	3.3	2.5	2.9	3.2	6.8	7.7	2.0	8.3	6.5	6.4	7.3	4.9	7.0	7.2	7.4	1.3	9.0	4.2	3.7	6.6	4.2	12.9	8.7	12.0	12.5	9.3	8.0	7.7	10.2	9.3	8.2	3.0	1.7	2.2	2.5	2.6	7.8	3.2	2.5	0.0	1.2	7.0	3.9	4.5	3.3	8.7	2.2	6.0	0.7	0.0	4.3	5.2	5.3	1.9	0.0	0.6	5.1	11.1	2.4	3.1	1.6	3.1	5.8	3.9	3.3	5.4	1.7	3.2	5.5	2.3	5.3	4.6	7.7	0.0	4.1	2.1	8.0	3.8	1.3	5.4	2.4	1.0
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001392-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 79.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	2.6	2.1	5.6	8.7	6.7	4.3	3.2	2.9	5.0	3.1	4.3	6.6	1.7	5.3	3.3	4.1	9.5	2.9	4.8	5.9	3.9	3.5	2.7	3.4	6.4	7.9	4.0	4.1	3.4	79.6	1.5	2.5	3.2	5.0	4.2	4.0	3.5	5.2	2.6	18.3	6.7	4.5	4.3	6.3	8.6	5.9	2.4	4.1	11.7	3.5	5.2	7.0	4.4	4.9	0.3	2.3	3.0	7.9	0.4	0.8	0.9	5.8	6.9	13.3	5.0	1.8	2.7	7.0	6.1	5.7	4.5	5.8	4.9	5.4	6.0	2.9	5.9	4.2	4.0	3.4	8.7	2.5	3.8	6.3	10.9	2.8	8.2	3.7	3.1	17.0	4.4	4.8	9.6	5.3	2.1	7.7	6.6	3.6	4.1	1.7	15.1	7.0	8.8	10.4	7.2	4.5	8.6	3.0	6.5	1.8	7.3	12.2	8.3	8.2	29.5	4.2	3.6	6.4	10.9	11.0	9.3	4.6	2.8	4.7	3.3	1.7	5.8	7.1	9.4	4.8	0.0	2.6	1.8	0.4	5.7	0.3	0.2	0.2	0.3	1.9	0.3	0.8	0.8	3.0	0.4	7.9	2.3	0.7	0.9	5.6	6.7	2.9	4.3	3.9	3.5	4.0	4.1	5.0	4.1	3.0	8.0	1.5	3.9	4.7	1.8	7.6	7.6	1.4	6.8	10.4	2.0	2.0	0.0	2.9	0.6	2.9	3.5	0.0	5.3	2.6	2.7	5.9	1.1	1.0	10.4	3.2	4.6	8.0	13.9	2.9	2.3	12.8	1.7	9.0	8.1	0.9	8.0	10.5	2.8	0.7	0.8	6.5	2.3	0.2	1.9	6.6	1.9	2.9	5.8	12.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	15.1	15.8	11.1	13.7	11.8	9.9	12.7	16.8	17.6	14.3	12.4	11.3	17.7	7.2	11.7	17.4	16.4	12.8	10.3	10.1	11.1	15.1	14.2	11.6	10.7	17.5	15.5	11.0	9.6	12.9	13.4	24.5	19.4	15.5	14.5	14.0	11.4	13.9	17.7	10.3	17.3	10.1	13.2	14.3	18.4	14.1	13.7	15.9	16.6	19.2	11.0	18.1	14.6	11.6	14.4	8.9	23.0	5.5	12.8	14.2	5.0	10.3	7.3	9.1	8.0	7.9	12.1	8.8	11.0	7.2	5.4	7.2	5.2	11.1	5.0	19.5	3.7	8.0	7.2	8.8	4.3	8.1	22.3	4.7	2.8	3.9	14.9	11.9	5.9	15.4	8.2	11.9	3.8	5.4	10.9	10.1	12.3	9.3	6.6	5.8	16.7	6.1	7.8	8.9	7.2	5.8	11.5	4.0	7.8	6.1	6.5	4.1	6.2	11.2	5.1	9.9	14.9	9.7	11.8	6.6	3.9	3.1	7.9	3.3	11.1	12.1	14.4	3.5	9.2	6.2	13.9	4.8	23.0	14.2	5.4	10.6	13.7	10.0	12.7	5.2	14.4	9.3	11.7	6.3	12.8	5.5	8.9	12.2	5.0	11.1	11.8	16.8	17.6	11.1	15.1	15.5	11.0	15.5	15.9	14.9	15.2	14.3	15.8	8.0	23.9	12.0	5.1	20.1	13.6	5.2	5.9	27.2	19.9	15.4	1.7	17.9	6.3	0.0	11.9	10.9	12.4	22.4	20.8	8.9	14.6	22.3	16.7	16.0	9.7	1.5	12.4	15.1	10.1	12.6	12.4	19.0	14.5	10.5	17.3	11.8	8.9	32.3	11.4	24.1	17.6	10.0	59.4	16.0	10.7	18.7
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 28.2"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	3.7	4.3	6.1	3.1	7.7	1.3	5.9	9.5	11.1	7.0	6.3	8.0	5.8	2.9	7.7	5.8	4.6	7.5	3.8	4.0	6.5	6.2	4.2	3.2	5.0	3.3	7.9	7.0	11.5	6.9	7.0	7.2	3.9	6.2	6.6	4.0	3.8	7.5	8.2	9.7	4.2	3.6	6.4	5.2	3.5	4.1	2.3	6.9	4.3	5.1	3.0	3.1	6.6	6.8	2.3	3.5	1.6	2.0	6.5	5.3	3.3	2.5	2.9	7.2	10.5	2.1	2.1	5.2	2.7	2.1	3.6	3.3	3.2	1.3	0.0	3.4	2.2	1.1	3.5	5.5	3.5	1.9	1.8	10.9	2.7	1.3	4.9	3.5	6.9	3.4	2.0	6.1	2.6	2.7	2.6	3.4	6.3	28.2	0.0	2.4	3.7	6.4	2.8	7.1	6.0	3.4	8.8	4.0	1.1	2.1	3.0	14.2	8.9	2.8	5.0	6.4	3.8	1.8	2.9	2.6	2.5	5.8	4.0	2.0	2.6	3.8	0.0	0.7	3.0	2.3	0.0	1.8	1.6	4.1	2.0	3.2	2.3	2.9	5.3	3.5	1.8	3.9	3.1	0.0	6.5	1.3	2.5	2.5	3.3	6.1	7.7	9.5	11.1	6.5	6.2	7.9	7.0	6.2	6.9	3.0	1.3	0.0	1.7	1.3	5.4	2.5	2.5	0.0	3.4	0.0	2.0	2.7	3.3	3.2	0.5	0.7	1.1	0.0	2.1	3.8	2.7	2.0	0.0	0.8	1.9	3.2	4.1	3.7	0.0	0.0	6.6	0.1	0.0	1.8	1.9	2.3	2.6	0.0	4.6	1.3	1.8	6.5	2.1	2.8	1.3	0.9	0.9	1.5	2.8	0.9
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.0;neutrophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	11.9	9.9	10.6	12.0	11.6	33.9	9.1	15.6	17.2	10.5	9.0	11.7	9.1	8.0	11.5	8.7	8.5	10.3	8.7	7.6	11.2	9.7	10.0	10.9	10.3	12.1	9.5	8.7	10.4	13.7	10.2	13.5	21.0	11.4	10.6	6.3	11.4	10.7	8.5	8.9	10.8	9.2	9.5	9.0	20.2	9.8	22.0	10.4	18.7	10.6	5.5	10.3	10.9	15.9	0.6	0.9	10.4	1.0	0.5	1.6	0.5	7.1	11.5	6.1	16.6	6.9	6.0	9.3	7.3	6.0	5.9	5.1	7.3	5.4	10.3	10.7	6.4	8.6	8.0	7.9	8.3	3.5	13.0	11.0	5.0	5.8	10.0	8.4	9.7	13.4	6.6	10.1	4.8	5.3	5.3	6.1	8.5	15.2	8.0	7.4	11.0	21.9	13.1	15.1	4.4	8.0	14.6	5.7	9.0	5.6	8.6	8.7	12.0	9.7	10.7	6.8	3.8	5.0	12.0	8.5	7.5	2.7	12.7	10.6	14.8	7.0	8.3	9.8	7.8	13.0	3.0	1.0	1.1	0.7	0.7	0.7	0.4	0.9	1.6	0.6	0.6	1.1	0.9	10.4	0.5	0.5	0.9	1.5	0.5	10.6	11.6	15.6	17.2	11.2	9.7	9.5	8.7	11.4	10.4	0.0	7.4	3.4	4.9	3.2	15.5	6.7	5.1	4.0	4.5	10.4	3.9	5.9	0.0	2.8	8.2	5.3	2.0	46.7	2.1	5.2	3.6	5.1	5.8	6.8	7.0	25.4	5.8	3.1	15.5	10.8	5.8	6.8	3.3	5.4	4.0	8.8	4.0	3.5	6.3	3.1	10.8	0.0	3.7	16.2	7.0	3.0	7.3	4.1	3.7	4.4
ZNF749	FLJ16360	ENSG00000186230	"Zinc finger protein 749"	O43361	19	57435329-57445485	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 23.5"									"HPA042082, HPA042091, HPA056001"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005"	"unprognostic (2.54e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.05e-5)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-1)"	5.8	5.6	7.2	7.6	8.0	5.0	8.4	12.4	10.7	6.3	8.1	5.2	7.5	6.6	6.3	5.1	7.4	7.9	8.3	5.1	6.4	6.0	5.3	12.4	5.4	7.5	9.0	7.7	8.2	7.0	11.4	7.2	6.3	6.0	6.2	4.5	8.5	12.8	10.8	6.2	9.7	7.1	5.9	5.3	6.7	5.5	6.2	6.8	7.8	6.7	12.1	8.0	6.0	6.1	2.9	3.2	0.2	2.7	1.9	4.1	2.8	2.7	6.4	5.7	5.8	1.5	1.5	2.3	1.7	1.4	2.8	5.1	2.6	2.0	5.3	1.5	1.6	1.9	2.0	5.4	4.3	4.2	2.3	23.5	4.7	6.7	3.0	1.8	5.2	3.1	1.8	4.8	3.6	7.7	2.8	1.5	5.7	4.5	6.3	2.1	1.1	6.4	1.8	5.4	2.0	8.9	6.7	8.2	3.9	1.3	6.5	5.6	4.6	3.2	1.9	1.3	4.7	2.8	1.7	1.6	5.2	3.8	1.6	4.7	4.8	6.2	5.5	2.9	2.2	3.1	0.1	1.2	0.2	2.1	2.7	3.4	2.7	3.5	3.1	3.2	2.9	4.1	3.0	0.2	1.9	1.2	1.6	2.6	2.8	7.2	8.0	12.4	10.7	6.4	6.0	9.0	7.7	6.0	6.8	3.0	0.6	0.8	0.6	2.2	0.8	0.4	5.1	2.7	3.4	0.0	0.0	0.9	3.3	0.9	0.6	1.6	1.3	0.0	0.3	0.7	0.8	0.7	0.0	2.9	0.8	3.2	2.9	1.3	0.3	0.0	0.6	1.0	21.9	1.0	0.7	0.4	0.8	0.0	0.0	3.1	0.9	6.5	1.2	0.7	1.7	2.8	0.7	2.1	0.9	0.9
ZNF75A	FLJ31529	ENSG00000162086	"Zinc finger protein 75a"	Q96N20	16	3305406-3318852	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA001665	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA001665: AB_1080751"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.79e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.97e-3)"	10.0	11.4	13.6	14.8	15.7	9.0	15.0	19.6	15.4	10.6	10.1	17.2	14.4	8.0	12.4	26.1	9.5	14.1	9.0	9.0	13.2	12.2	12.7	16.2	10.4	18.1	12.8	14.4	19.3	13.6	32.1	23.5	12.7	17.7	16.2	15.1	10.1	10.6	15.4	10.4	13.8	12.8	10.8	10.3	15.6	10.1	13.5	15.9	15.8	17.9	7.7	18.0	10.2	8.6	25.2	13.8	15.2	9.1	17.8	23.0	3.3	4.5	6.8	12.7	6.4	6.0	5.5	10.8	7.3	3.0	6.9	8.2	0.1	5.9	7.3	5.0	5.3	8.5	3.4	7.6	4.4	10.4	3.1	10.2	15.6	7.9	0.6	4.3	9.9	15.8	7.5	4.6	7.3	5.5	6.8	6.2	7.1	8.8	12.1	9.6	6.3	15.1	6.8	19.6	4.4	4.7	31.5	6.2	8.8	7.4	7.5	11.5	8.2	11.5	4.6	4.5	18.2	14.9	12.7	7.2	5.1	13.0	4.9	5.8	8.4	7.4	21.0	1.7	11.3	7.9	13.3	6.7	15.2	13.0	6.2	16.0	16.8	14.8	13.3	5.2	25.2	23.0	17.2	4.8	17.8	9.1	13.8	11.9	3.3	13.6	15.7	19.6	15.4	13.2	12.2	12.8	14.4	17.7	15.9	20.8	9.4	33.5	23.3	3.7	39.7	10.6	10.2	9.4	14.8	15.7	31.4	15.0	5.0	18.8	2.1	11.8	12.0	0.0	8.9	8.4	8.8	17.0	12.8	7.8	9.0	46.1	5.8	12.9	9.5	1.9	21.6	13.3	8.5	17.2	7.9	32.0	10.4	9.5	25.1	6.3	63.2	25.8	9.5	37.6	26.6	3.0	13.2	34.9	11.5	14.6
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344087	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 162.9;Late spermatids: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	8.4	18.8	8.2	14.6	9.7	9.2	9.9	11.4	10.5	11.8	10.6	9.2	10.4	6.9	10.7	12.8	7.6	9.8	7.9	7.6	5.6	7.7	10.6	13.4	9.7	11.2	6.2	7.7	10.1	12.9	12.6	14.7	8.0	9.2	15.0	8.4	7.5	10.0	11.8	6.6	9.9	10.6	7.5	5.9	18.6	9.7	3.4	6.7	16.6	13.2	9.3	13.3	8.0	8.6	3.7	1.8	4.1	2.1	5.2	6.5	2.9	3.5	4.6	5.1	8.1	8.6	10.5	7.7	5.9	8.1	4.9	10.5	2.8	4.4	3.6	8.8	5.0	9.4	4.8	16.5	2.7	4.7	3.5	4.4	2.5	8.4	3.7	3.8	4.3	7.3	5.1	6.5	3.0	3.7	6.1	4.9	4.8	2.2	5.9	4.2	8.4	5.2	7.8	2.4	7.1	6.3	5.0	5.0	3.2	5.4	4.8	1.7	5.7	3.3	5.7	0.9	5.6	2.0	6.2	5.2	4.6	1.1	7.8	5.6	3.0	4.2	2.7	2.9	4.7	2.9	4.1	2.1	3.7	4.9	1.5	4.5	2.9	5.2	5.6	1.8	3.7	6.5	5.9	2.6	5.2	1.5	1.6	6.3	2.9	8.2	9.7	11.4	10.5	5.6	7.7	6.2	7.7	9.2	6.7	6.0	14.6	1.4	1.1	1.5	4.2	3.9	0.0	5.3	6.8	0.0	5.9	1.9	1.7	1.5	162.9	7.0	2.7	0.0	3.5	1.1	3.1	2.1	5.8	4.3	2.0	4.8	1.7	6.2	3.1	247.1	6.1	3.3	0.0	1.0	5.3	4.5	2.7	2.9	3.2	3.1	4.5	0.0	3.1	3.5	2.7	1.3	1.5	5.4	3.1	1.4
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.8	9.8	7.8	4.5	9.0	14.5	8.6	8.6	9.4	3.8	11.3	8.7	5.7	21.6	17.0	13.9	9.4	7.2	11.4	7.0	8.3	10.8	5.5	11.2	10.6	6.0	8.8	14.9	10.2	15.3	8.8	14.6	11.7	8.2	6.6	5.4	5.9	11.3	7.0	13.3	8.7	9.3	21.2	7.8	7.0	9.0	17.3	4.7	13.5	22.7	6.7	6.9	6.0	4.7	8.2	15.5	10.7	13.5	6.0	11.0	18.0	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4	14.9	8.1	9.5	6.7	5.0	27.5	18.5	7.6	6.7	7.9	8.7	47.1	20.4	18.3	10.5	17.1	10.1	10.5	0.0	13.4	11.0	8.5	5.8	12.7	7.4	9.8	28.6	11.6	6.2	7.8	12.0	10.3	5.8	5.0	6.4	12.5	10.3	7.1	9.7	5.6	10.5	30.2	19.4	8.6	20.9	10.0	5.5	19.0	8.6	9.0	5.8
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524001-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	11.7	9.2	12.7	12.0	15.6	8.0	17.8	11.1	12.2	11.4	26.0	13.9	11.5	20.4	13.1	7.4	12.6	13.1	11.2	26.2	11.1	9.3	18.9	14.4	8.6	4.7	13.5	6.0	15.9	14.3	25.4	11.5	10.1	11.5	14.2	12.1	13.9	17.5	16.0	56.6	11.2	31.6	16.0	12.8	13.1	11.7	14.0	14.4	3.8	10.1	14.2	7.8	14.1	24.5	3.7	1.8	3.1	1.9	1.8	0.5	0.6	10.1	12.7	14.5	14.0	7.0	8.2	11.4	7.7	8.7	12.8	11.2	8.1	14.2	6.4	11.9	5.4	10.3	13.6	9.6	9.2	7.7	14.3	20.3	15.1	8.5	11.2	17.8	10.0	47.8	7.2	20.5	9.8	12.7	11.9	8.5	2.6	17.5	10.9	6.6	28.0	3.6	24.2	13.5	8.3	10.5	19.0	9.6	15.8	9.4	5.3	17.2	19.1	4.4	23.3	29.3	6.5	23.1	25.2	5.7	13.5	10.3	7.6	8.5	16.2	11.8	7.9	11.3	15.7	13.6	0.2	1.4	3.1	0.1	1.9	0.4	3.7	0.5	0.2	1.8	1.4	0.4	0.1	1.7	1.8	0.3	1.7	0.1	0.6	12.7	15.6	11.1	12.2	11.1	9.3	13.5	6.0	11.5	14.4	8.9	3.4	0.5	6.1	4.8	13.0	7.0	17.8	1.4	4.5	15.7	2.0	6.1	10.0	10.4	6.4	7.7	34.2	0.0	13.9	6.8	6.5	6.6	3.5	14.3	10.7	20.6	17.3	13.5	5.7	6.1	10.0	5.6	5.0	7.2	27.7	12.9	10.6	39.1	12.4	13.5	9.2	6.5	7.6	12.7	5.3	5.0	3.0	1.9	24.7	4.8
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	6.3	6.6	6.6	5.4	8.9	5.6	13.2	18.2	9.8	8.4	6.1	8.4	9.9	4.1	8.5	8.5	7.5	7.3	4.2	7.4	5.9	5.8	6.4	6.3	12.7	6.6	7.0	7.8	9.7	8.2	8.2	8.2	8.2	6.5	6.9	6.4	8.9	11.4	6.7	6.1	8.3	6.1	8.7	5.5	6.8	8.1	8.3	4.3	9.6	8.8	4.0	9.3	6.4	6.7	5.5	3.7	1.3	3.1	3.9	6.2	3.3	4.7	2.2	10.8	6.3	2.3	3.0	4.9	2.9	4.3	5.8	6.9	7.3	1.9	5.3	2.4	3.2	3.2	3.8	7.0	4.7	9.8	0.4	5.1	6.4	3.4	8.1	5.7	0.2	5.3	4.6	6.5	4.5	6.7	7.2	8.0	10.5	8.4	0.0	3.9	5.2	7.8	4.6	2.4	4.1	3.1	8.9	8.3	3.7	4.6	7.4	4.4	8.3	4.4	4.2	5.0	5.5	4.0	11.1	3.8	2.4	3.1	6.8	5.2	5.5	5.3	2.5	6.2	0.1	4.4	0.0	2.7	1.3	5.5	2.6	6.2	5.5	5.8	5.9	3.7	5.3	4.5	6.2	0.2	3.9	3.1	3.0	2.8	3.3	6.6	8.9	18.2	9.8	5.9	5.8	7.0	7.8	6.5	4.3	3.0	3.8	0.0	4.2	10.3	2.8	2.0	0.0	2.7	4.5	1.8	2.0	2.9	0.0	1.8	1.6	2.1	1.3	0.0	1.5	2.6	2.2	2.0	2.3	1.5	1.5	0.0	6.9	3.1	0.6	0.0	2.6	1.6	1.7	0.0	2.2	3.0	2.0	1.9	1.4	1.0	5.5	0.0	2.1	10.0	7.3	9.5	5.1	1.9	3.1	1.8
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 27.0;REH: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.6	5.0	4.1	7.2	3.0	3.8	4.7	2.3	3.0	3.1	1.6	1.6	3.8	8.0	2.3	3.7	2.4	5.2	2.1	3.1	1.3	27.0	3.2	2.4	4.8	3.7	1.6	3.8	4.6	1.6	3.7	2.3	3.1	3.0	4.0	7.7	2.3	2.5	5.7	3.8	5.2	4.0	1.9	2.9	17.3	3.7	2.4	1.7	1.3	7.9	5.0	2.5	2.2	3.0	2.7	2.9	1.8	2.7	5.0	6.0	2.9	3.3	3.5	3.7	1.9	3.3	3.5	3.2	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1	3.0	0.3	2.2	10.4	4.5	11.2	6.3	15.3	0.0	1.2	5.2	9.8	4.8	28.2	6.4	1.3	5.8	5.3	0.0	3.7	2.6	9.4	8.8	1.1	16.3	2.9	11.1	4.1	14.7	0.6	1.5	23.3	2.8	5.0	1.0	8.1	15.1	3.6	4.2	28.0	23.6	7.1	12.9	8.9	1.1	1.6	5.8	3.0	3.9	9.8	3.4
ZNF773	"MGC4728, ZNF419B"	ENSG00000152439	"Zinc finger protein 773"	Q6PK81	19	57499915-57518404	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003152	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716"	"unprognostic (6.53e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.50e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.71e-3)"	9.0	10.3	7.3	7.0	10.8	10.7	12.5	15.4	11.3	6.0	7.7	6.0	11.2	8.2	8.4	11.4	6.8	8.7	8.4	7.3	7.2	6.9	8.2	4.9	8.1	16.1	8.6	7.8	12.1	5.6	16.0	14.6	8.7	8.2	9.7	7.1	9.6	9.0	8.1	17.8	10.7	7.9	8.8	9.7	11.3	6.9	8.8	4.7	12.7	12.3	6.2	10.4	9.2	9.6	14.8	6.9	16.2	4.8	8.9	17.2	5.8	1.8	3.2	5.6	7.3	4.0	5.0	0.3	5.4	8.1	4.8	19.9	3.3	2.7	3.5	2.9	3.5	3.6	1.4	2.7	5.7	7.1	0.1	17.4	5.9	0.4	2.0	7.7	4.4	4.8	11.4	8.2	3.5	13.9	6.1	3.4	6.3	0.3	0.6	6.1	0.4	8.4	3.1	5.8	0.8	9.6	4.6	9.0	5.4	3.3	6.5	6.0	7.3	1.0	2.5	6.2	5.4	4.2	8.2	2.9	7.6	3.4	1.9	5.7	8.9	9.1	5.7	2.9	4.4	6.8	16.2	4.8	7.6	8.4	3.6	13.6	11.8	10.4	9.0	6.4	14.8	17.2	13.8	2.2	8.9	3.1	6.9	7.2	5.8	7.3	10.8	15.4	11.3	7.2	6.9	8.6	7.8	8.2	4.7	0.0	1.6	2.2	2.5	0.9	4.8	1.2	2.5	0.0	5.7	0.0	5.9	2.4	3.3	2.5	0.4	3.0	0.0	0.0	0.6	0.8	1.3	2.8	1.1	0.8	0.8	6.4	0.0	1.8	1.5	0.0	1.1	2.1	1.7	1.8	0.4	3.8	0.7	1.1	3.5	0.8	7.4	12.9	2.1	1.8	4.2	0.5	2.4	3.8	1.0	1.8
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746796-57758159	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	5.8	9.8	14.0	10.8	15.9	19.4	12.2	34.9	15.2	9.4	8.6	7.9	17.3	8.4	8.2	29.9	7.8	10.3	6.9	9.8	11.0	9.5	10.7	9.5	8.6	11.0	10.7	8.9	12.4	7.1	17.0	18.8	10.2	12.8	11.9	9.3	9.6	10.8	13.4	11.4	8.6	8.7	7.3	9.6	11.6	10.0	8.7	15.0	19.3	14.5	6.0	10.7	10.7	8.0	4.2	2.5	11.1	2.4	7.5	4.3	2.1	4.7	4.0	12.7	8.4	2.1	6.5	5.4	3.7	6.6	6.6	4.3	2.4	5.1	5.3	3.4	3.4	3.5	3.1	6.6	6.5	10.6	5.0	24.1	7.2	9.4	2.7	4.8	4.0	5.8	7.5	5.5	4.4	4.8	7.1	5.1	8.7	4.8	3.8	8.5	2.1	13.0	3.8	7.4	2.1	8.3	8.4	9.6	6.0	4.8	14.9	14.5	10.5	6.9	5.8	4.1	7.2	5.9	5.7	4.5	7.1	3.8	0.6	5.6	10.7	12.0	8.8	4.2	3.8	5.8	7.9	2.4	11.1	1.8	1.7	3.9	3.5	2.8	3.4	2.2	4.2	4.3	3.2	6.2	7.5	2.1	2.5	2.3	2.1	14.0	15.9	34.9	15.2	11.0	9.5	10.7	8.9	12.8	15.0	3.0	2.6	5.2	3.6	2.4	7.8	10.9	10.2	5.3	1.2	8.7	2.0	2.8	5.0	2.5	0.4	5.5	2.9	0.0	1.2	2.0	2.5	4.5	3.5	6.6	2.9	11.1	8.1	11.1	5.6	0.2	1.1	3.7	0.0	1.8	4.1	10.0	2.2	2.6	4.6	2.2	7.1	0.0	2.2	2.7	4.3	1.5	2.4	1.0	3.3	4.3
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237071	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 20.6;Late spermatids: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA052057: AB_2681710, HPA057151: AB_2683352"	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	5.9	6.7	9.3	4.7	9.5	4.1	6.6	11.2	9.8	5.4	5.8	8.8	4.4	3.1	6.9	5.1	6.0	6.1	3.7	6.0	7.4	4.7	8.7	5.9	5.8	4.6	8.9	6.7	5.8	12.0	22.4	8.9	5.4	7.5	6.5	5.0	6.1	6.3	7.8	10.4	8.2	4.9	6.7	8.1	5.7	6.8	12.5	7.8	4.1	8.4	5.5	6.3	6.9	6.8	1.7	2.0	10.9	2.7	1.4	4.1	1.5	4.2	2.1	6.8	5.8	4.3	3.6	8.9	3.3	5.2	4.8	2.6	6.5	2.5	2.0	5.9	3.9	2.4	3.3	9.3	4.5	7.7	0.8	6.7	5.6	4.2	3.2	2.4	1.6	3.3	2.7	3.2	6.3	4.5	2.9	4.0	3.9	6.3	1.0	4.0	11.1	3.2	2.5	10.1	3.2	4.1	8.8	15.9	0.8	2.4	3.8	13.8	10.3	7.5	3.7	2.7	6.6	11.5	3.3	4.8	5.3	3.8	3.1	4.0	3.6	5.2	4.3	7.5	3.2	3.3	10.9	1.7	3.9	4.1	2.0	2.1	1.3	1.9	2.1	2.0	1.7	1.5	2.6	0.6	1.4	2.7	0.8	2.3	1.5	9.3	9.5	11.2	9.8	7.4	4.7	8.9	6.7	7.5	7.8	11.9	4.1	0.0	1.7	1.4	9.2	4.2	2.5	0.0	3.4	5.2	13.7	1.9	0.0	2.4	13.4	2.7	1.6	0.0	4.8	1.7	1.6	4.4	0.0	4.9	2.3	20.6	2.9	4.9	5.3	24.8	2.3	1.1	1.7	1.8	2.6	4.8	2.5	1.5	2.8	2.1	9.4	12.9	2.4	12.7	11.4	1.4	1.9	3.9	2.3	2.8
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.9	9.4	6.2	5.7	5.6	5.2	4.4	5.8	4.7	4.7	7.2	6.1	3.4	4.4	3.8	2.8	4.7	4.2	3.9	3.3	5.3	7.5	5.3	6.9	7.8	5.8	5.0	7.2	5.8	5.3	3.7	4.8	4.0	6.4	4.9	5.0	7.8	7.5	4.0	2.9	2.9	2.4	4.9	4.8	2.9	2.3	10.9	2.6	3.9	10.2	3.8	7.3	8.6	3.3	3.8	5.7	4.1	8.7	3.6	5.8	7.7	5.3	4.6	7.4	6.5	4.4	3.7	5.0	3.9	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7	8.9	12.2	4.4	3.5	3.4	5.7	3.7	7.6	8.1	9.1	8.7	2.0	5.0	8.3	11.9	17.3	7.7	7.4	0.0	42.0	6.3	5.5	3.0	16.1	33.6	13.1	4.8	3.4	11.6	25.0	1.1	4.0	17.9	11.8	8.2	7.2	3.5	24.5	8.6	4.9	13.3	6.6	6.5	6.2	5.8	2.5	2.3	4.9	11.5	6.6	2.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.5	5.9	4.1	3.6	2.4	0.0	3.1	2.3	3.4	4.5	6.3	2.4	6.6	2.9	3.2	3.4	1.6	4.9	1.9	4.0	5.5	2.5	5.1	6.2	3.9	2.4	7.6	4.3	3.4	1.2	4.7	2.9	2.6	3.2	3.0	5.3	8.9	3.4	1.2	2.5	1.2	5.8	2.3	3.7	3.5	10.4	2.3	2.0	14.5	6.5	6.9	5.4	2.4	1.9	3.7	2.8	3.3	5.8	3.3	8.3	5.8	4.7	6.7	8.6	5.1	3.1	4.0	2.8	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4	8.9	8.1	4.2	2.3	1.6	28.1	13.0	10.2	4.0	10.3	8.7	31.4	1.6	3.3	4.4	6.0	5.8	2.6	0.0	8.6	1.2	2.7	2.1	7.0	4.9	3.2	9.5	9.9	9.8	4.8	1.1	3.4	7.2	5.0	5.4	4.3	7.2	4.7	4.5	2.8	2.4	35.0	6.5	3.9	2.7	1.3	2.6	0.6	5.2	4.2	2.2
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816472-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	5.3	4.2	7.4	7.4	8.4	2.5	7.6	19.8	8.0	7.5	5.3	6.9	5.9	6.1	7.9	8.5	5.2	5.5	5.8	4.0	6.8	4.5	7.1	5.5	4.4	5.9	5.9	4.8	9.3	12.7	11.8	15.1	4.9	7.7	7.5	6.9	5.4	8.0	7.3	9.2	8.6	7.1	5.3	6.5	6.4	6.6	13.9	8.3	6.0	8.8	2.5	7.4	5.6	10.8	2.3	0.2	0.7	0.5	1.0	2.2	0.4	2.9	2.3	5.8	8.9	1.6	2.2	4.0	2.8	2.8	4.6	3.4	2.7	3.1	5.7	3.7	2.0	5.4	4.1	5.1	1.8	4.5	5.7	2.2	5.3	4.7	2.7	1.7	7.3	3.7	1.3	3.8	3.7	1.9	2.2	1.5	7.0	7.0	5.8	2.7	5.0	7.6	3.6	4.3	5.2	5.1	6.8	7.1	1.9	3.1	1.9	5.9	4.5	3.8	2.3	3.0	4.9	4.3	4.2	3.3	6.0	3.5	6.0	3.1	5.5	3.9	2.7	2.5	1.8	4.3	0.0	0.5	0.2	1.1	0.5	2.2	2.0	1.0	0.0	0.2	2.3	0.9	0.7	0.7	1.0	0.2	0.2	0.6	0.4	7.4	8.4	19.8	8.0	6.8	4.5	5.9	4.8	7.7	8.3	0.0	5.5	0.9	1.4	1.6	5.7	1.4	0.0	1.4	0.0	1.8	7.9	0.7	0.0	1.3	5.6	1.6	1.7	0.0	1.5	0.2	0.5	1.7	5.7	1.0	1.1	3.2	0.0	1.8	0.6	6.9	1.7	0.7	0.0	3.6	1.4	2.2	1.0	0.0	2.8	1.6	6.5	0.0	1.0	8.6	2.4	0.9	0.6	0.7	1.2	1.8
ZNF792	FLJ38451	ENSG00000180884	"Zinc finger protein 792"	Q3KQV3	19	34956354-34964049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 4.5;Ito cells: 8.6;T-cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.0;HMC-1: 15.9;HUVEC TERT2: 10.7;SH-SY5Y: 10.3"					"Low region specificity"	"Detected in many"			"HPA035157, HPA035158"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA035157: AB_2674497, HPA035158: AB_10603010"	"unprognostic (1.31e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (2.72e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.77e-3)"	9.4	3.9	3.6	7.3	5.8	2.3	8.9	11.6	5.4	6.1	6.1	5.9	8.9	4.3	6.3	4.3	3.1	5.8	7.9	4.1	2.3	2.0	4.5	3.7	9.4	8.3	2.2	2.0	5.2	5.0	6.9	3.4	7.1	3.8	8.8	5.1	5.7	5.7	4.9	3.1	4.0	6.0	5.6	2.8	8.6	5.1	3.7	2.1	12.0	5.4	3.4	5.8	7.3	4.0	1.8	1.1	6.9	0.7	4.4	5.5	2.2	1.0	3.6	1.7	2.7	1.8	1.4	0.0	1.0	1.9	1.3	1.6	1.4	1.7	1.5	3.3	1.4	0.6	0.7	2.5	1.9	2.0	4.4	0.5	12.0	1.1	2.8	1.3	1.0	15.9	1.6	0.6	1.0	0.5	2.3	10.7	1.0	3.2	0.0	2.1	0.8	4.1	1.1	1.3	9.1	0.8	2.8	0.0	0.2	1.0	3.3	0.9	10.3	1.0	1.0	1.3	1.7	1.2	3.3	4.3	1.9	2.4	0.8	1.1	0.3	0.9	0.9	2.0	0.2	0.8	6.9	0.7	6.1	3.1	0.7	4.1	1.8	4.9	4.3	1.1	1.7	5.5	4.6	0.2	4.4	0.5	0.1	4.6	2.2	3.6	5.8	11.6	5.4	2.3	2.0	2.2	2.0	3.8	2.1	0.0	0.6	2.0	0.1	0.5	0.7	1.2	0.0	0.0	0.0	0.0	2.0	0.1	0.0	1.4	0.1	4.5	0.2	0.0	2.3	0.3	0.6	0.3	1.1	0.2	1.2	0.0	1.7	8.6	3.2	0.0	1.4	0.0	0.0	1.8	1.9	0.8	2.2	0.0	0.0	0.0	1.5	0.0	0.5	0.0	1.1	0.4	0.1	4.5	1.3	0.1
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 13.2;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	7.9	7.2	6.1	11.9	5.5	3.2	10.1	7.7	8.0	12.6	8.2	4.6	12.9	4.7	6.9	5.8	7.6	9.3	4.9	4.1	6.6	4.3	7.8	8.3	6.6	5.3	6.3	1.8	10.8	10.7	7.6	2.8	10.5	6.3	8.4	6.2	3.3	6.2	6.8	5.5	5.6	6.1	5.6	5.0	7.4	4.5	5.8	6.7	9.1	7.5	6.4	5.2	7.1	6.5	7.5	4.6	4.6	4.3	4.5	10.3	3.9	3.8	2.9	4.1	9.4	2.1	2.1	8.2	2.1	2.9	5.1	5.0	6.0	1.5	4.9	3.8	2.4	2.6	3.1	3.1	3.7	5.0	0.1	3.1	3.8	2.4	9.7	0.7	3.0	7.2	2.5	2.3	3.6	2.9	1.5	2.5	4.7	4.0	0.0	3.3	5.2	6.2	4.2	2.1	4.9	8.2	0.7	6.0	4.9	5.2	9.4	3.0	3.1	4.3	0.9	1.1	3.1	4.2	5.4	2.3	5.5	3.1	6.3	2.4	3.5	5.5	3.9	0.8	3.1	2.2	4.4	4.1	4.6	6.9	4.3	8.3	7.5	6.5	10.3	3.4	6.7	6.5	5.0	4.3	4.5	2.6	4.6	6.9	3.9	6.1	5.5	7.7	8.0	6.6	4.3	6.3	1.8	6.3	6.7	6.0	1.0	0.5	2.7	2.2	2.5	3.0	2.5	5.3	2.3	3.5	0.0	13.2	5.0	3.8	5.4	4.9	2.6	0.0	1.2	2.1	3.2	2.2	3.5	0.9	3.6	0.0	4.1	3.7	1.5	2.1	2.3	2.3	0.0	1.8	5.2	1.3	2.3	2.9	1.1	2.8	2.5	12.9	5.1	4.8	4.4	1.3	3.8	3.3	3.7	2.0
ZNF8	"HF.18, Zfp128"	ENSG00000278129	"Zinc finger protein 8"	P17098	19	58278951-58302805	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034797, HPA034798"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA034797: AB_10696364, HPA034798: AB_10602785"	"unprognostic (1.41e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.56e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.28e-2)"	2.7	3.1	4.6	2.7	5.5	7.7	4.3	6.4	7.5	3.4	2.6	6.1	2.7	3.0	4.9	4.0	2.8	3.5	2.8	3.7	4.7		3.4	2.2	3.4	3.4	4.1	3.3	3.8	3.1	7.5	4.3	3.8	4.1	3.3	3.1	4.4	3.0	3.7	2.1	6.6	2.2	3.9	4.6	4.5	3.6	3.5	4.3	9.2	3.9	1.5	3.5	3.0	3.9	2.3	1.6	4.7	2.4	1.9	1.9	1.9	2.2	3.2	4.9	8.7	3.1	2.7	4.0	1.1	1.8	1.2	1.4	3.5	1.7	2.8	1.4	1.9	1.0	2.1	3.5	3.8	1.6	2.1	14.1	5.5	6.2	2.9	2.8	1.8	4.5	4.9	2.4	2.1	4.0	3.6	2.1	4.6	2.8	1.2	2.5	2.4	4.2	2.5	4.2	1.6	2.3	4.7	4.5	2.0	2.3	7.8	8.3	4.5	3.4	2.5	1.1	3.8	2.4	3.4	3.1	8.8	2.2	1.3	2.2	4.4	3.5	3.5	1.5	0.1	2.2	3.6	2.4	1.6	1.6	1.3	1.9	1.5	1.4	1.2	1.6	2.3	1.5	1.7	4.7	1.9	1.0	1.4	0.7	1.9											0.0	5.5	1.7	2.7	0.0	10.4	2.4	0.0	4.0	3.4	5.2	11.8	1.7	3.3	2.9	1.5	1.6	0.5	0.0	2.0	1.2	1.9	3.5	1.1	1.0	2.2	11.1	5.2	6.2	1.0	0.0	3.7	1.8	0.0	1.8	2.1	4.9	2.7	0.0	1.8	2.3	11.0	6.5	1.4	5.0	2.3	0.0	2.2	4.4	1.7	2.6
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;testis: 23.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 11.5"	"Group enriched"	"Detected in many"	8	"B-cells: 11.5;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"AF22: 14.0;SCLC-21H: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	4.2	6.3	3.7	7.5	3.1	4.8	26.9	13.4	4.3	3.8	5.1	2.3	2.1	5.8	11.1	2.5	3.5	3.9	2.9	5.7	7.6	5.9	2.6	3.4	6.0	5.2	6.0	7.3	2.4	5.6	9.2	2.5	7.1	4.4	5.0	5.2	5.2	5.1	4.0	6.0	4.3	3.0	4.8	3.7	3.3	23.7	3.4	2.2	6.1	0.7	7.3	2.4	4.0	11.5	0.9	0.4	0.5	1.0	5.1	0.7	1.1	0.9	14.0	6.7	2.8	3.6	2.4	1.4	3.1	3.1	4.9	1.9	0.9	2.6	2.4	2.7	3.4	2.0	4.6	2.1	3.8	3.9	5.2	0.5	1.0	0.8	1.7	0.9	3.0	3.1	3.5	2.1	1.3	5.3	2.4	0.6	1.6	2.0	3.4	3.3	1.5	0.9	5.5	4.0	0.6	6.1	3.0	4.5	3.5	0.4	14.1	6.7	1.8	1.2	1.5	6.3	4.7	3.0	4.6	3.3	3.5	1.2	0.9	4.7	2.4	10.6	1.1	2.6	3.2	0.0	0.5	0.4	2.2	0.0	1.9	9.3	2.3	1.6	0.9	11.5	1.4	0.5	0.4	1.0	0.5	0.0	5.1	0.7	6.3	7.5	26.9	13.4	5.7	7.6	5.2	6.0	7.1	3.4	0.0	3.4	20.5	6.0	7.1	41.7	1.1	12.7	2.7	1.2	15.7	43.2	5.2	18.3	8.1	108.2	5.8	26.4	0.0	4.1	4.3	8.5	6.0	9.2	1.7	6.8	30.2	22.5	12.9	4.0	40.3	11.5	9.3	3.3	2.8	9.2	20.9	5.9	14.4	11.7	8.6	47.4	12.9	4.7	50.4	18.3	6.6	5.1	17.5	6.4	3.4
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.1"	"Cell type enriched"	"Detected in many"	8	"Early spermatids: 241.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.0"									HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	2.6	2.8	4.9	2.4	5.9	1.9	4.3	8.0	4.8	2.9	2.6	2.3	5.0	1.7	3.6	2.0	2.2	3.1	1.8	2.4	3.3	2.5	2.6	1.8	2.2	2.8	6.4	2.9	5.3	2.1	3.8	3.4	3.6	3.3	3.6	1.6	1.6	2.6	3.0	1.9	3.5	2.1	4.8	4.4	2.8	2.3	20.1	5.1	3.4	5.2	1.0	2.9	3.1	4.7	3.3	1.4	4.2	0.8	2.1	4.9	1.0	0.0	1.2	3.3	0.1	1.8	2.8	1.4	3.7	2.2	4.6	7.1	0.1	0.6	0.1	4.4	2.3	4.3	0.7	0.0	2.7	5.4	0.0	5.3	1.9	0.1	0.1	1.8	0.0	5.2	2.8	2.6	5.1	0.0	1.5	0.5	1.4	0.0	0.1	5.0	0.8	0.7	0.8	5.5	0.0	0.0	0.0	4.5	1.7	1.3	5.5	3.8	5.6	0.1	0.0	3.1	4.9	3.5	0.3	1.4	3.0	3.9	3.8	4.0	9.8	15.0	6.3	0.0	0.1	6.9	4.2	0.6	2.9	3.2	0.7	4.2	2.2	3.2	4.9	1.0	3.3	4.1	4.2	1.3	2.1	0.8	1.4	3.2	1.0	4.9	5.9	8.0	4.8	3.3	2.5	6.4	2.9	3.3	5.1	0.0	4.3	1.3	1.8	1.3	5.8	4.6	5.1	1.4	5.7	3.5	3.9	3.2	0.0	2.3	241.5	3.9	0.0	0.0	0.9	2.1	2.8	1.6	1.1	0.0	1.4	11.1	0.0	1.3	0.3	29.7	5.5	2.5	3.3	1.8	0.9	2.4	0.8	0.0	6.7	1.1	11.3	0.0	2.3	9.5	10.0	2.4	3.5	2.9	0.4	0.7
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	8.9	9.9	10.9	10.6	14.1	11.3	15.7	11.6	16.9	11.1	10.2	14.4	9.0	8.1	15.3	11.2	8.4	19.7	7.8	8.4	11.1	10.1	9.7	13.0	6.8	11.0	8.8	13.4	12.9	15.6	14.3	13.2	9.0	8.9	10.1	9.5	13.0	11.9	13.4	18.6	21.6	10.3	10.6	8.3	15.2	8.7	39.7	7.8	11.3	12.9	8.8	11.8	7.8	9.5	1.9	2.1	3.5	1.9	0.3	2.6	0.4	8.7	8.0	10.4	18.7	4.8	8.3	17.8	6.8	5.6	8.6	7.1	3.0	7.5	9.0	5.6	4.6	3.5	8.6	6.7	17.2	6.6	12.0	12.8	6.3	7.2	5.0	4.3	5.8	5.5	6.6	13.0	16.6	15.5	13.1	11.4	12.8	13.3	11.9	12.0	16.2	8.9	9.4	13.9	4.8	8.0	19.3	6.3	5.7	7.6	7.2	5.6	17.7	5.7	7.2	6.0	10.3	16.3	9.7	4.4	5.5	5.0	7.6	6.0	11.7	8.4	10.3	4.3	7.0	9.1	0.0	0.7	2.3	2.4	1.9	2.6	1.9	1.6	1.5	1.3	1.4	2.6	2.2	3.5	0.3	0.4	2.1	2.1	0.4	10.9	14.1	11.6	16.9	11.1	10.1	8.8	13.4	8.9	7.8	0.0	7.7	0.0	2.3	2.7	6.8	2.0	5.1	6.7	4.5	10.4	7.9	4.6	10.0	3.1	12.3	1.8	3.9	23.3	2.5	2.5	2.1	2.0	3.5	4.7	2.6	3.2	1.2	5.5	2.2	1.4	4.6	2.1	3.3	1.0	5.8	6.0	2.1	0.0	3.9	5.5	9.0	0.0	0.9	12.5	12.7	2.3	4.7	2.5	5.2	1.4
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 4.3;Cardiomyocytes: 4.8;Glandular cells: 3.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.9;EFO-21: 4.7;HMC-1: 4.3"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	1.2	1.4	3.5	2.5	3.4	0.8	1.7	3.9	5.4	3.5	1.2	2.3	1.9	0.6	2.8	5.6	1.2	3.3	2.0	7.4	3.0	3.2	1.8	0.9	2.4	0.8	2.5	2.3	10.6	5.0	3.1	5.7	2.2	1.9	3.2	0.4	3.9	7.5	3.2	5.1	2.5	1.3	1.9	1.9	1.1	0.9	1.2	1.7	0.1	2.6	2.8	0.6	1.0	1.3	1.0	0.9	2.5	0.6	4.8	2.3	2.2	0.3	0.7	0.7	3.2	5.9	1.7	0.2	0.6	0.5	0.0	0.3	0.4	0.9	0.1	4.7	0.8	0.2	0.3	0.3	0.3	0.3	0.5	0.0	0.2	0.6	0.2	1.7	0.5	4.3	3.1	0.8	0.0	0.3	2.0	0.0	0.5	0.5	0.7	1.6	2.1	0.2	1.0	1.7	0.2	0.2	0.4	0.0	0.1	0.4	0.2	0.1	1.8	1.9	0.3	0.8	0.6	0.4	0.6	0.1	0.7	0.5	2.0	0.1	0.7	0.4	0.3	0.2	0.3	1.0	2.3	0.6	0.6	2.2	0.4	1.3	0.6	0.8	2.3	0.3	1.0	0.6	1.6	2.5	4.8	0.4	0.9	0.4	2.2	3.5	3.4	3.9	3.5	3.0	3.2	2.5	2.3	1.9	1.7	0.0	0.3	0.0	4.3	0.7	2.4	4.8	0.0	0.0	1.2	0.0	2.0	0.2	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.9	3.2	1.1	0.0	0.5	0.0	1.2	1.3	0.8	0.0	1.4	0.2	0.0	0.0	0.0	1.1	0.1	0.0	1.4	0.4	1.9	0.0	1.4	0.5	0.9	1.3	0.2	0.0	0.0	2.0
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605405-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.2"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	12.1	7.5	8.3	11.0	10.5	11.1	8.2	12.3	15.1	8.0	10.0	9.7	6.6	11.0	11.5	6.8	6.2	8.7	7.0	12.2	7.3	5.8	8.3	6.7	8.7	13.3	7.4	8.5	10.3	11.2	9.9	9.5	6.1	7.4	9.9	4.8	8.1	12.1	7.7	56.2	11.1	10.4	7.4	7.3	16.0	12.2	4.7	7.9	14.0	9.5	8.0	9.1	9.3	9.9	1.2	0.5	1.4	0.1	0.1	0.6	0.1	6.4	5.3	2.3	3.7	2.5	1.9	6.3	4.6	2.6	2.5	2.4	1.7	4.2	7.5	5.4	3.4	1.3	5.4	1.4	2.8	1.0	7.4	17.6	4.3	3.2	2.2	4.0	4.9	8.4	2.9	4.5	3.1	1.9	2.3	1.7	4.7	8.2	5.1	1.6	3.0	7.7	5.3	5.2	3.7	9.2	12.0	3.6	4.7	2.9	4.4	5.5	8.9	6.4	3.9	3.9	1.2	3.1	7.7	5.0	3.9	9.3	3.5	5.8	10.8	9.3	3.9	4.8	3.8	6.2	0.0	0.0	1.4	0.3	0.1	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.6	0.8	0.1	0.1	0.5	0.0	0.1	8.3	10.5	12.3	15.1	7.3	5.8	7.4	8.5	7.4	7.9	0.0	0.0	1.9	1.0	3.7	3.7	18.6	2.5	0.0	0.0	14.0	0.0	2.1	5.0	3.1	1.9	5.2	5.2	0.0	3.8	2.7	3.8	1.2	0.0	5.4	4.0	9.5	5.8	6.7	5.4	3.2	4.9	4.2	5.0	1.8	6.3	3.9	4.7	0.0	9.6	3.6	3.2	6.5	4.1	1.2	1.4	3.8	2.2	4.8	5.7	0.9
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Cytotrophoblasts: 1.1;Spermatogonia: 1.5;Syncytiotrophoblasts: 1.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.4"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	1.1	1.4	0.4	1.5	3.1	5.8	0.8	2.5	2.4	1.5	1.2	0.4	0.0	0.6	1.8	1.2	1.4	1.2	1.4	0.7	1.9	0.5	7.7	2.5	1.5	1.4	4.4	0.3	2.4	5.0	0.8	2.4	5.1	7.4	1.4	1.2	0.4	3.2	0.3	0.5	1.0	1.3	1.4	1.9	1.3	1.2	4.6	2.2	1.7	1.4	0.0	1.3	1.2	1.7	0.3	0.1	0.5	0.0	1.5	0.5	0.1	3.0	0.0	1.7	6.4	0.1	0.0	3.8	1.0	0.5	1.3	1.7	2.5	0.4	1.4	1.5	0.4	1.8	0.8	0.6	0.9	1.2	0.0	0.9	1.8	0.0	3.5	0.0	1.2	3.3	0.2	0.0	0.7	0.0	0.1	0.0	3.9	0.0	0.0	1.3	0.0	2.9	1.7	3.6	0.0	0.5	2.4	3.3	0.0	2.2	2.2	1.7	0.3	0.0	0.1	0.3	3.5	3.3	3.9	0.0	1.9	1.4	1.5	1.8	1.2	3.8	0.3	0.0	0.6	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.5	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.4	3.1	2.5	2.4	1.9	0.5	4.4	0.3	7.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.0
ZNF891		ENSG00000214029	"Zinc finger protein 891"	A8MT65	12	133106817-133130473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 52.6;Horizontal cells: 38.1;Rod photoreceptor cells: 34.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA040301	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA040301: AB_10795380"	"unprognostic (3.05e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.72e-1)"	"unprognostic (7.51e-3)"	"unprognostic (5.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.07e-3)"	"unprognostic (6.68e-2)"	3.6	5.3	7.0	4.0	9.3	4.2	5.4	13.2	7.2	4.6	4.4	3.6	2.6	3.4	5.5	4.6	2.9	4.0	2.9	3.5	7.9	3.3	3.4	2.9	2.9	4.3	7.8	2.7	6.4	3.8	4.9	8.8	3.0	6.6	3.8	3.5	2.3	4.5	4.0	4.3	6.9	3.3	4.5	7.0	4.5	4.0	14.0	8.9	4.2	5.6	2.9	3.8	4.3	4.5	2.9	1.6	2.3	1.2	2.4	2.7	0.7	1.5	1.7	4.6	0.3	1.9	2.2	3.0	0.8	0.9	1.2	1.0	1.3	0.7	0.3	1.3	1.0	2.0	2.1	2.4	1.2	1.3	0.1	2.3	3.8	5.0	1.7	0.9	3.4	2.7	1.6	1.2	1.9	1.6	2.3	1.0	4.1	2.3	0.8	1.6	1.0	3.8	4.1	2.9	1.2	1.9	3.5	2.6	1.5	1.0	2.7	4.6	2.9	3.0	1.1	1.0	2.9	3.1	1.4	1.8	2.4	2.4	2.1	1.3	0.5	0.2	3.1	0.6	1.3	1.8	2.0	1.2	1.4	1.8	0.7	1.6	1.9	1.7	1.7	0.6	2.9	2.7	2.3	2.3	2.4	0.8	1.6	1.1	0.7	7.0	9.3	13.2	7.2	7.9	3.3	7.8	2.7	6.6	8.9	3.0	4.0	2.7	5.5	1.5	30.2	4.4	2.5	16.0	10.3	10.4	27.5	3.1	0.0	3.5	52.6	3.9	1.4	0.0	1.7	1.9	3.1	2.9	1.1	1.9	1.6	38.1	6.4	4.3	1.0	4.2	4.9	3.2	1.7	0.0	2.4	10.9	1.6	2.5	5.6	1.3	34.9	19.4	5.2	14.0	14.6	1.5	1.9	5.0	3.1	2.3
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.3;seminal vesicle: 36.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 192.8;Suprabasal keratinocytes: 245.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.4;NTERA-2: 16.0;SuSa: 11.7;U-2197: 6.7"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	1.5	1.0	1.1	3.6	2.5	1.6	1.8	6.9	1.1	3.0	1.7	1.2	20.3	0.5	3.3	2.7	2.1	2.8	1.0	1.4	0.8	0.6	1.7	0.7	2.4	3.0	2.1	0.3	4.7	3.4	12.7	1.4	3.8	1.7	4.1	2.1	3.2	1.2	36.4	1.2	2.8	2.3	3.3	1.6	2.3	2.7	1.6	2.2	4.1	10.3	0.7	2.9	4.9	2.9	0.5	0.4	1.8	0.2	0.3	0.9	0.2	0.0	0.0	3.8	9.4	0.0	0.0	0.0	1.0	0.4	3.6	4.3	3.2	2.2	1.4	1.7	0.6	2.5	0.9	0.0	0.5	6.3	0.0	0.9	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.9	5.4	16.0	0.0	0.0	0.0	3.4	0.2	2.0	3.3	0.0	3.4	0.0	1.1	0.1	11.7	1.9	0.0	0.0	0.9	0.0	6.7	3.6	0.0	1.5	0.0	0.0	0.0	1.4	0.8	0.2	0.3	0.1	0.0	0.9	0.2	0.2	0.4	0.4	0.5	0.3	0.1	1.8	0.3	0.0	0.2	0.7	0.2	1.1	2.5	6.9	1.1	0.8	0.6	2.1	0.3	1.7	2.2	6.0	5.9	72.1	60.7	192.8	0.6	1.7	56.0	0.0	7.9	7.0	2.0	81.3	14.9	2.0	5.9	31.2	3.3	70.0	1.8	83.3	43.9	74.9	1.1	52.0	41.8	0.0	8.2	48.5	105.1	17.6	56.4	28.6	118.1	1.0	14.4	1.4	1.0	10.5	32.5	4.6	2.1	19.4	51.2	8.2	14.3	245.0	68.2	76.2	20.2	56.5
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	5.1	9.3	4.9	1.9	4.7	7.9	5.3	11.9	6.0	6.3	5.2			1.4	5.9	5.2	4.1	4.4	3.6	7.3	4.6	4.0	4.2	10.4	4.2	2.5	4.4		8.6	3.1	7.1	3.9	3.9		4.6	3.3		3.4	5.8	18.0	5.2	3.0	6.3	3.8	2.8	3.6	7.7			3.8		3.9	4.2	4.8	3.4	1.4	4.6	1.1	3.8	4.4	0.8	7.7	4.4	9.5	6.9	14.8	12.5	4.0	7.6	20.8	14.5	16.9	6.6	6.1	8.1	5.7	9.6	4.7	5.6	12.0	5.6	19.6	8.6	5.9	4.6	5.1	7.1	31.6	6.9	3.5	13.8	16.5	10.6	22.8	20.3	9.1	7.5	0.6	6.7	7.8	6.1	8.1	6.0	3.4	4.2	4.8	7.0	6.7	3.6	6.4	5.6	4.8	8.1	6.4	5.0	8.4	9.3	5.5	5.9	6.7	6.2	6.4	5.1	9.4	7.2	6.2	9.4	7.0	4.9	3.0	2.1	1.1	3.0	2.2	0.4	1.9	2.4	2.6	2.2	0.9	3.4	4.4	3.3	4.6	3.8	0.5	1.4	2.2	0.8											17.9	25.9	5.7	19.6	21.9	32.7	21.0	15.3	21.4	19.4	17.4	47.1	10.6	0.0	11.6	60.8	18.8	11.6	0.0	10.0	8.1	20.6	26.5	25.4	38.0	10.6	35.0	25.7	15.4	16.8	27.1	22.2	19.1	15.1	8.2	15.7	23.9	15.7	8.2	21.5	8.7	24.5	12.9	24.7	23.3	19.0	24.3	23.0	17.5	10.5	20.0
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell type enhanced"	"Detected in single"	25	"Cytotrophoblasts: 1.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 36.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 11.4;Early spermatids: 20.4;Spermatocytes: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA006732"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006637: AB_1080646, HPA006732: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	6.4	5.5	8.0	7.4	8.6	3.7	11.4	12.1	9.0	8.1	7.2	5.7	6.9	4.9	9.4	7.6	4.6	7.3	4.6	4.7	7.2	5.0	6.0	3.8	5.7	8.3	5.0	3.9	11.4	9.0	10.1	14.1	7.0	7.6	8.9	6.0	4.8	6.9	9.9	2.8	4.5	6.6	7.5	5.1	7.2	5.8	9.5	6.9	11.5	10.3	3.7	7.7	9.4	10.2	6.1	2.2	5.2	1.7	3.9	4.5	1.9	5.3	1.7	8.1	0.1	4.2	3.3	5.8	3.7	5.1	5.6	7.8	1.2	2.0	5.1	7.0	2.5	2.8	2.4	0.0	4.5	5.8	0.0	6.6	7.4	5.3	3.7	3.9	2.6	1.9	4.4	4.3	5.6	10.1	6.1	1.5	0.0	10.8	1.2	3.5	0.6	0.0	5.8	5.1	0.5	0.9	8.9	7.4	1.3	4.2	3.5	10.0	10.2	1.9	4.4	6.2	8.5	1.7	6.6	1.5	2.2	4.8	1.7	2.9	3.2	3.3	1.0	2.0	0.7	3.4	5.2	1.6	3.3	3.6	1.0	3.4	4.3	2.7	4.2	2.2	6.1	4.5	3.8	0.5	3.9	1.7	2.0	2.1	1.9	8.0	8.6	12.1	9.0	7.2	5.0	5.0	3.9	7.6	6.9	6.0	3.2	1.7	1.4	0.3	5.6	2.8	0.0	0.0	11.4	0.0	3.9	1.2	1.7	1.3	20.4	1.3	0.5	0.0	2.2	0.9	0.9	1.2	1.1	0.8	0.9	6.4	1.2	4.3	0.6	4.5	1.7	0.6	1.7	1.8	0.9	3.5	1.3	0.0	3.2	0.9	5.4	6.5	1.9	11.3	2.7	0.3	0.5	1.3	2.1	0.5
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.6	9.5	7.5	12.3	4.4	3.0	6.5	1.8	5.2	3.9	5.3	7.3	3.9	3.5	5.3	2.9	7.2	4.1	6.3	3.6	3.5	7.2	9.7	4.5	5.5	15.4	3.8	2.8	3.6	4.4	4.3	5.1	4.9	5.4	11.8	18.7	5.9	2.8	4.8	4.7	13.0	6.7	13.7	3.3	5.7	13.6	4.2	6.6	4.2	12.1	10.5	18.5	5.7	3.2	8.8	11.7	6.6	8.0	7.7	4.9	9.4	2.3	2.3	4.9	6.4	11.8	3.2	6.6	3.0	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0	0.0	1.3	2.2	1.1	0.8	3.5	2.2	7.6	2.7	0.0	7.0	2.0	1.4	5.0	5.4	11.3	1.9	1.1	0.0	7.3	3.9	2.2	2.8	1.1	7.8	3.1	0.0	2.9	0.6	3.2	9.5	0.9	3.1	1.7	7.2	2.9	2.4	10.1	3.5	1.4	14.3	2.9	6.5	1.4	3.4	8.1	0.4	1.1	3.2	2.4	1.3
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	10.8	10.0	11.4	12.2	12.5	12.3	14.5	18.5	14.6	11.3	11.0	13.1	16.9	7.4	14.5	11.7	12.7	12.4	9.6	7.7	9.4	6.9	9.4	9.1	10.0	16.4	10.3	12.2	18.5	12.3	15.0	12.3	9.4	9.2	12.7	8.6	10.3	15.4	13.9	9.7	15.6	10.8	12.6	8.7	13.6	10.3	15.7	11.0	14.9	11.2	8.7	11.8	11.7	11.4	3.3	3.0	5.5	4.2	4.2	9.0	4.7	5.7	2.7	8.0	9.1	3.6	2.7	7.8	6.4	5.4	7.4	7.7	7.2	4.8	8.2	7.5	5.3	6.8	7.5	8.6	7.3	9.3	4.5	7.3	5.4	4.6	6.1	6.1	12.5	4.9	4.3	9.3	5.9	6.2	3.0	4.6	9.2	15.2	6.6	5.2	6.3	18.0	17.4	14.6	3.3	6.3	7.6	8.2	8.7	3.2	7.9	5.4	13.5	8.4	12.8	9.1	9.9	3.5	8.6	3.3	11.6	9.3	6.6	10.7	5.9	9.4	14.0	6.2	7.9	16.9	5.5	3.8	4.8	7.4	4.2	9.0	3.3	5.1	6.9	3.0	2.9	8.7	8.4	4.6	4.2	3.7	2.4	7.2	4.7	11.4	12.5	18.5	14.6	9.4	6.9	10.3	12.2	9.2	11.0	0.0	3.8	0.0	1.8	3.1	4.6	3.2	0.0	1.4	0.0	1.8	7.9	3.7	1.7	2.5	3.9	3.6	2.6	0.0	2.5	3.1	2.3	2.4	4.7	3.4	3.1	4.8	2.4	5.5	3.5	3.0	3.4	1.0	1.7	3.6	5.3	2.6	1.7	3.5	5.6	2.1	4.3	6.5	2.1	6.5	5.1	1.9	1.6	5.3	3.7	1.4
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.6	4.8	13.7	11.7	14.9	14.3	3.1	11.2	11.2	14.8	15.3	3.5	4.1	3.2	17.4	7.1	11.1	4.3	6.3	8.2	16.3	6.8	6.8	8.5	6.7	7.5	10.3	7.0	5.5	11.9	7.8	11.3	10.3	19.1	14.9	5.0	7.0	6.8	11.6	4.7	7.4	9.6	4.0	3.0	7.3	7.5	11.9	5.4	12.5	5.8	9.9	7.7	6.9	2.9	9.3	11.6	4.8	4.8	9.7	11.9	8.7	4.2	13.6	7.2	9.6	6.2	4.3	7.9	10.3	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6											0.0	3.5	10.4	2.8	0.0	8.6	8.7	0.0	2.7	11.4	0.0	3.9	3.8	3.3	4.2	3.2	6.8	2.6	0.0	4.4	2.7	3.5	3.0	5.8	1.5	5.0	1.6	6.4	4.3	5.0	1.7	8.3	1.9	0.0	1.0	2.3	11.7	3.0	4.0	12.4	4.9	9.7	19.4	2.7	5.5	8.1	0.0	1.1	7.5	2.7	0.9
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.4	14.4	11.8	9.2	19.1	7.9	12.2	23.0	19.9	9.4	8.9	20.9	9.8	10.1	14.2	13.9	6.7	10.3	10.4	16.4	12.2	10.6	12.1	8.7	10.3	12.4	11.8	12.8	10.7	9.7	19.8	27.3	9.6	14.7	11.1	8.4	12.8	9.2	9.4	15.4	11.7	12.8	9.4	15.0	12.1	10.0	10.5	15.0	13.0	15.2	6.8	9.4	8.6	8.2	7.7	5.4	4.8	1.9	4.0	5.6	2.5	4.4	1.2	10.1	13.3	6.8	13.5	6.9	8.6	11.5	5.0	9.9	3.6	5.5	8.0	5.7	9.1	8.5	3.1	4.7	9.0	13.6	8.0	2.7	5.2	5.7	2.5	7.1	4.4	5.2	8.7	7.1	13.5	11.4	13.2	9.1	11.4	8.3	9.6	13.1	2.0	6.4	7.3	6.5	1.3	4.2	9.5	3.3	5.8	7.6	3.0	14.2	7.4	8.5	2.7	3.6	10.8	4.2	5.9	11.4	18.1	3.9	2.8	3.4	17.1	7.3	7.1	13.7	4.9	10.2	2.4	1.3	4.4	4.6	1.6	3.0	5.3	4.2	2.7	2.2	7.7	5.0	5.6	4.8	4.0	1.9	5.4	3.7	2.5	11.8	19.1	23.0	19.9	12.2	10.6	11.8	12.8	14.7	15.0	8.9	5.4	1.5	1.7	1.5	28.2	11.2	7.6	6.7	13.6	1.8	19.6	2.9	5.0	3.4	8.3	6.7	3.2	0.0	3.0	1.2	3.1	2.1	8.1	4.3	2.2	19.1	6.9	9.8	4.8	6.5	5.5	2.0	0.0	1.0	3.6	13.6	3.2	4.2	7.4	3.8	18.6	0.0	2.4	10.7	5.2	0.9	1.5	4.9	3.6	1.7
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 13.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.2	4.0	11.3	2.2	12.1	3.5	11.2	36.4	27.6	8.0	9.9	3.6	5.9	3.2	16.3	8.4	9.9	6.8	15.5	6.4	8.0	3.8	5.2	4.5	8.7	1.9	16.7	5.6	17.7	8.1	4.8	8.3	2.3	14.9	7.1	5.1	3.5	6.5	8.3	7.0	11.0	3.5	10.7	21.9	2.1	13.3	18.4	11.8	0.6	21.0	5.6	3.1	7.3	6.9	1.5	2.0	13.4	0.3	1.4	1.5	0.3	1.0	1.4	2.2	10.3	0.3	0.5	3.3	0.5	0.6	0.5	0.4	1.3	15.7	0.2	21.8	0.7	3.2	3.3	1.1	0.9	0.3	1.8	0.9	3.6	8.1	2.4	0.9	7.3	4.5	0.3	8.7	0.6	0.9	1.0	14.9	2.8	3.9	2.8	2.3	1.5	1.2	1.7	0.7	0.7	6.4	3.2	2.0	1.9	1.5	1.3	7.3	2.0	13.9	9.0	2.0	1.7	4.5	2.5	16.3	3.3	26.6	0.7	1.2	1.1	1.6	0.2	0.4	3.5	0.7	13.4	0.3	0.6	1.5	0.2	1.3	1.5	1.2	1.2	0.3	1.3	1.0	1.5	0.3	1.4	0.3	2.0	0.2	0.3	11.3	12.1	36.4	27.6	8.0	3.8	16.7	5.6	14.9	11.8	26.8	3.5	0.0	2.2	0.7	6.5	6.1	5.1	2.7	12.5	3.5	0.0	1.8	6.6	2.4	114.2	4.5	1.6	0.0	7.1	0.8	1.5	1.7	2.3	3.9	0.6	1.6	5.8	2.5	0.3	52.0	3.4	1.1	1.7	1.0	2.2	7.3	4.0	3.5	4.9	4.2	4.9	6.5	1.7	2.3	2.5	1.9	0.7	1.5	2.3	1.3
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	7.4	10.0	12.0	11.1	19.7	4.7	9.2	12.0	11.9	9.5	9.0	12.5	5.5	11.6	10.8	7.2	7.5	10.6	9.9	8.0	11.5	10.3	9.3	8.3	9.2	11.2	19.3	7.3	12.4	9.8	14.3	13.2	8.0	14.1	9.5	9.0	8.3	7.2	11.7	5.6	8.3	12.4	9.1	14.1	10.1	8.7	11.1	16.1	13.9	10.9	5.9	13.7	8.9	7.0	8.2	5.1	6.9	12.2	16.3	10.4	6.0	4.7	7.4	10.9	12.9	8.6	8.7	7.7	6.1	10.7	8.7	8.3	3.6	6.7	15.6	6.5	8.6	4.8	4.3	8.6	8.8	9.9	9.9	6.3	13.9	6.5	5.4	11.1	9.4	10.1	8.5	14.6	8.1	14.7	9.0	8.1	17.1	13.1	5.7	11.5	5.4	12.3	6.4	11.2	8.3	4.3	13.1	11.7	13.4	7.5	5.2	8.7	6.8	11.5	7.7	5.0	6.6	8.2	11.2	10.6	6.5	6.8	5.7	7.0	10.1	11.4	19.3	2.4	7.5	10.6	4.9	4.9	6.9	10.4	4.3	8.8	8.2	7.2	6.6	4.6	7.4	9.8	8.8	6.0	16.3	12.2	5.1	9.4	6.0	12.0	19.7	12.0	11.9	11.5	10.3	19.3	7.3	14.1	16.1	17.9	4.0	4.4	1.9	2.1	4.5	0.8	7.6	1.4	9.1	1.8	7.9	3.6	10.0	4.3	1.4	2.7	2.5	0.0	5.3	2.5	2.3	3.2	4.7	3.0	2.5	7.9	0.0	2.5	3.5	0.7	4.0	2.2	1.7	5.4	3.0	4.8	4.9	2.9	4.9	4.1	4.4	0.0	1.9	7.1	13.4	2.5	2.2	7.5	2.5	1.3
ZUFSP	"C6orf113, dJ412I7.3"	ENSG00000153975	"Zinc finger with UFM1 specific peptidase domain"	Q96AP4	6	116635618-116668794	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	8.0	8.4	8.8	9.7	14.1	19.0	9.7	18.8	14.4	7.2	10.3	7.3	5.1	16.5	7.3	7.3	11.0	6.7	9.0	5.4	10.5	8.7	9.3	11.9	10.2	12.8	14.3	8.0	5.6	9.7	6.0	18.1	8.5	11.3	8.6	9.8	5.2	8.2	7.3	6.2	10.3	13.5	6.8	10.5	12.3	8.4	9.5	11.5	15.4	7.6	7.5	13.9	8.9	8.2	11.1	11.1	17.3	11.5	9.2	12.6	7.1	4.5	4.4	10.6	19.0	6.1	8.1	7.7	10.2	9.7	10.2	12.1	7.5	5.3	16.5	8.5	6.3	11.7	7.6	12.0	7.0	13.6	9.6	12.3	12.6	6.4	13.8	9.4	14.9	15.5	7.1	11.9	8.0	14.2	7.8	8.9	12.8	22.3	8.6	13.3	7.1	7.5	11.4	7.6	7.3	4.9	9.9	8.9	6.9	11.1	4.8	8.8	10.0	7.0	6.2	6.2	9.5	3.8	11.6	7.0	6.4	4.3	3.7	8.9	7.9	10.1	16.7	5.8	9.0	9.4	17.3	8.5	8.4	8.4	9.9	9.7	11.1	9.3	9.5	11.1	10.3	10.7	7.8	3.3	9.2	11.5	7.9	12.6	7.1	8.8	14.1	18.8	14.4	10.5	8.7	14.3	8.0	11.3	11.5	6.0	3.4	2.4	12.4	11.0	8.7	0.0	5.1	8.1	7.9	0.0	7.9	9.2	0.0	0.0	1.6	5.8	6.0	0.0	0.0	7.3	6.5	10.1	10.3	5.9	6.6	11.1	5.8	3.1	6.0	0.8	2.0	10.5	1.7	0.0	5.8	9.4	0.0	6.5	1.8	0.0	7.8	0.0	7.1	15.0	18.3	12.0	7.8	10.2	5.5	11.6
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143020	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Enterocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	11.3	11.7	8.0	13.5	10.2	21.1	10.5	14.4	14.3	11.3	23.8	17.5	9.2	17.7	11.6	11.0	12.8	9.9	11.1	10.7	7.7	7.7	8.8	9.6	12.1	15.6	8.3	8.4	12.0	15.3	18.0	12.6	13.1	11.3	11.4	17.3	17.6	10.1	11.8	37.7	13.9	42.4	10.9	7.5	16.1	12.8	8.1	9.7	22.5	12.1	6.5	14.2	12.4	9.8	1.5	1.8	3.8	3.4	1.1	4.2	1.5	10.5	16.5	6.0	8.1	15.0	8.5	7.2	9.2	11.6	10.8	10.5	8.1	3.7	10.1	6.2	12.3	7.2	12.1	12.0	6.3	11.0	11.7	12.5	9.6	13.3	5.3	10.2	8.1	19.2	10.9	8.5	10.6	12.5	5.6	13.8	10.2	7.0	10.3	6.7	7.2	10.1	4.8	3.6	10.2	6.4	11.3	7.3	4.3	6.1	10.9	4.7	7.0	10.4	6.5	8.9	6.2	6.4	6.2	16.2	9.5	4.8	11.8	12.0	4.5	2.4	5.2	9.5	7.3	8.8	2.8	2.3	2.3	3.2	3.2	4.2	1.5	2.2	2.0	1.8	1.3	1.5	2.5	3.8	1.1	3.4	1.7	1.4	1.5	8.0	10.2	14.4	14.3	7.7	7.7	8.3	8.4	11.3	9.7	53.6	63.9	15.9	4.6	6.4	30.7	15.7	20.4	26.8	45.5	8.7	92.3	6.0	0.0	6.4	43.0	14.8	92.3	0.0	9.7	5.4	7.4	9.7	24.4	11.5	10.5	38.1	12.7	24.5	24.0	17.3	13.8	14.5	11.8	7.2	30.4	16.0	11.9	29.4	9.2	4.1	53.7	6.5	10.3	10.4	11.3	8.8	7.4	20.8	24.7	7.6